PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Hofweber, M; Dormann, D				Hofweber, Mario; Dormann, Dorothee			Friend or foePost-translational modifications as regulators of phase separation and RNP granule dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						ribonuclear protein (RNP); RNA-binding protein; post-translational modification (PTM); protein methylation; phosphorylation; liquid-liquid phase separation (LLPS); membrane-less organelle (MLO); phase transitions; protein aggregation; stress granules	PROTEIN ARGININE METHYLTRANSFERASES; FRONTOTEMPORAL LOBAR DEGENERATION; NUCLEAR IMPORT RECEPTOR; LOW-COMPLEXITY DOMAINS; DNA-BINDING PROTEIN; CELL-FREE FORMATION; STRESS GRANULE; POSTTRANSLATIONAL MODIFICATIONS; ALZHEIMERS-DISEASE; O-GLCNACYLATION	Ribonucleoprotein (RNP) granules are membrane-less organelles consisting of RNA-binding proteins (RBPs) and RNA. RNA granules form through liquid-liquid phase separation (LLPS), whereby weak promiscuous interactions among RBPs and/or RNAs create a dense network of interacting macromolecules and drive the phase separation. Post-translational modifications (PTMs) of RBPs have emerged as important regulators of LLPS and RNP granule dynamics, as they can directly weaken or enhance the multivalent interactions between phase-separating macromolecules or can recruit or exclude certain macromolecules into or from condensates. Here, we review recent insights into how PTMs regulate phase separation and RNP granule dynamics, in particular arginine (Arg)-methylation and phosphorylation. We discuss how these PTMs regulate the phase behavior of prototypical RBPs and how, as friend or foe, they might influence the assembly, disassembly, or material properties of cellular RNP granules, such as stress granules or amyloid-like condensates. We particularly highlight how PTMs control the phase separation and aggregation behavior of disease-linked RBPs. We also review how disruptions of PTMs might be involved in aberrant phase transitions and the formation of amyloid-like protein aggregates as observed in neurodegenerative diseases.	[Hofweber, Mario; Dormann, Dorothee] Ludwig Maximilians Univ Munchen, Biomed Ctr, Cell Biol, Grosshaderner Str 9, D-82152 Planegg Martinsried, Germany; [Hofweber, Mario; Dormann, Dorothee] Ludwig Maximilians Univ Munchen, Grad Sch Syst Neurosci, Grosshaderner Str 2, D-82152 Planegg Martinsried, Germany; [Dormann, Dorothee] Munich Cluster Syst Neurol SyNergy, Feodor Lynen Str 17, D-81377 Munich, Germany	University of Munich; University of Munich; University of Munich	Dormann, D (corresponding author), Ludwig Maximilians Univ Munchen, Biomed Ctr, Cell Biol, Grosshaderner Str 9, D-82152 Planegg Martinsried, Germany.	dorothee.dormann@med.uni-muenchen.de		Dormann, Dorothee/0000-0002-9260-2775	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) within the Emmy Noether [DO 1804/1-1]; Munich Cluster for Systems Neurology [EXC 1010]; Graduate School of Systemic Neurosciences (GSN) Munich, Germany	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) within the Emmy Noether(German Research Foundation (DFG)); Munich Cluster for Systems Neurology; Graduate School of Systemic Neurosciences (GSN) Munich, Germany	This work was supported in part by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) within the Emmy Noether Grant DO 1804/1-1 (to D.D.) and Munich Cluster for Systems Neurology Grant EXC 1010, SyNergy (to D.D.). This article is part of the thematic series, Phase separation of RNA-binding proteins in physiology and disease. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Graduate School of Systemic Neurosciences (GSN) Munich, Germany.	Afroz T, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00062-0; Alberti S, 2017, CURR BIOL, V27, pR1097, DOI 10.1016/j.cub.2017.08.069; Alberti S, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00084; Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Ambadipudi S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00480-0; Aoki K, 2002, NUCLEIC ACIDS RES, V30, P5182, DOI 10.1093/nar/gkf638; Arai T, 2009, ACTA NEUROPATHOL, V117, P125, DOI 10.1007/s00401-008-0480-1; Aranda S, 2011, FASEB J, V25, P449, DOI 10.1096/fj.10-165837; Arribas-Layton M, 2016, MOL CELL BIOL, V36, P2226, DOI 10.1128/MCB.01102-15; Bah A, 2016, J BIOL CHEM, V291, P6696, DOI 10.1074/jbc.R115.695056; Banani SF, 2016, CELL, V166, P651, DOI 10.1016/j.cell.2016.06.010; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Berchowitz LE, 2015, CELL, V163, P406, DOI 10.1016/j.cell.2015.08.060; Boehning M, 2018, NAT STRUCT MOL BIOL, V25, P833, DOI 10.1038/s41594-018-0112-y; Boeynaems S, 2017, MOL CELL, V65, P1044, DOI 10.1016/j.molcel.2017.02.013; Bogaert E, 2018, CELL REP, V24, P529, DOI 10.1016/j.celrep.2018.06.070; Boke E, 2016, CELL, V166, P637, DOI 10.1016/j.cell.2016.06.051; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Burke KA, 2015, MOL CELL, V60, P231, DOI 10.1016/j.molcel.2015.09.006; Carlonnagno Y, 2017, J BIOL CHEM, V292, P15277, DOI 10.1074/jbc.M117.794602; Carpenter K, 2018, DEV CELL, V45, P392, DOI 10.1016/j.devcel.2018.04.001; Chang BS, 2007, SCIENCE, V318, P444, DOI 10.1126/science.1145801; Choksi DK, 2014, HUM MOL GENET, V23, P1025, DOI 10.1093/hmg/ddt498; Chong PA, 2018, J MOL BIOL, V430, P4650, DOI 10.1016/j.jmb.2018.06.014; Chong PA, 2016, CURR OPIN STRUC BIOL, V41, P180, DOI 10.1016/j.sbi.2016.08.001; Cohen TJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6845; Dao TP, 2018, MOL CELL, V69, P965, DOI 10.1016/j.molcel.2018.02.004; De Leeuw F, 2007, EXP CELL RES, V313, P4130, DOI 10.1016/j.yexcr.2007.09.017; Deng QD, 2014, J NEUROSCI, V34, P7802, DOI 10.1523/JNEUROSCI.0172-14.2014; Dolzhanskaya N, 2006, J CELL SCI, V119, P1933, DOI 10.1242/jcs.02882; Dormann D, 2012, EMBO J, V31, P4258, DOI 10.1038/emboj.2012.261; Elbaum-Garfinkle S, 2015, P NATL ACAD SCI USA, V112, P7189, DOI 10.1073/pnas.1504822112; Evich M, 2016, PROTEIN SCI, V25, P479, DOI 10.1002/pro.2838; Fackelmayer FO, 2005, TRENDS BIOCHEM SCI, V30, P666, DOI 10.1016/j.tibs.2005.10.002; Ferreon JC, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051360; Friesen WJ, 2001, MOL CELL, V7, P1111, DOI 10.1016/S1097-2765(01)00244-1; Fronz K, 2011, J BIOL CHEM, V286, P32986, DOI 10.1074/jbc.M111.273912; Galligan JJ, 2018, P NATL ACAD SCI USA, V115, P9228, DOI 10.1073/pnas.1802901115; Goedert M, 2011, J MOL NEUROSCI, V45, P425, DOI 10.1007/s12031-011-9593-4; Goh CW, 2018, J BIOL CHEM, V293, P163, DOI 10.1074/jbc.M117.814111; Gong CX, 2005, J NEURAL TRANSM, V112, P813, DOI 10.1007/s00702-004-0221-0; Gu JL, 2018, FEBS LETT, V592, P402, DOI 10.1002/1873-3468.12976; Guenther EL, 2018, NAT STRUCT MOL BIOL, V25, P463, DOI 10.1038/s41594-018-0064-2; Guil S, 2006, MOL CELL BIOL, V26, P5744, DOI 10.1128/MCB.00224-06; Haj-Yahya M, 2018, J AM CHEM SOC, V140, P6611, DOI 10.1021/jacs.8b02668; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425; Hernandez-Vega A, 2017, CELL REP, V20, P2304, DOI 10.1016/j.celrep.2017.08.042; Hofweber M, 2018, CELL, V173, P706, DOI 10.1016/j.cell.2018.03.004; Hong E, 2012, BIOGERONTOLOGY, V13, P329, DOI 10.1007/s10522-012-9379-2; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Hughes MP, 2018, SCIENCE, V359, P698, DOI 10.1126/science.aan6398; Inukai Y, 2008, FEBS LETT, V582, P2899, DOI 10.1016/j.febslet.2008.07.027; Itakura AK, 2018, BIOCHEMISTRY-US, V57, P2520, DOI 10.1021/acs.biochem.8b00205; Jain A, 2017, NATURE, V546, P243, DOI 10.1038/nature22386; Jawaid A, 2019, MOL NEUROBIOL, V56, P3451, DOI 10.1007/s12035-018-1314-3; Jayabalan AK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12125; Jongjitwimol J, 2016, J CELL SCI, V129, P2407, DOI 10.1242/jcs.184614; Josephs KA, 2014, ACTA NEUROPATHOL, V127, P441, DOI 10.1007/s00401-013-1211-9; Kaehler C, 2015, EXP CELL RES, V334, P114, DOI 10.1016/j.yexcr.2015.02.022; Kametani F, 2016, SCI REP-UK, V6, DOI 10.1038/srep23281; Kametani F, 2009, BIOCHEM BIOPH RES CO, V382, P405, DOI 10.1016/j.bbrc.2009.03.038; Kampers T, 1996, FEBS LETT, V399, P344, DOI 10.1016/S0014-5793(96)01386-5; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Khoury GA, 2011, SCI REP-UK, V1, DOI 10.1038/srep00090; KOPKE E, 1993, J BIOL CHEM, V268, P24374; Krisenko MO, 2015, J BIOL CHEM, V290, P27803, DOI 10.1074/jbc.M115.642900; Kwon S, 2007, GENE DEV, V21, P3381, DOI 10.1101/gad.461107; Larson AG, 2017, NATURE, V547, P236, DOI 10.1038/nature22822; Lee YJ, 2014, FEBS J, V281, P352, DOI 10.1111/febs.12606; Lee YJ, 2012, J CELL BIOCHEM, V113, P2721, DOI 10.1002/jcb.24151; Li HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023075; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Liachko NF, 2016, ACTA NEUROPATHOL, V132, P545, DOI 10.1007/s00401-016-1600-y; Liachko NF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004803; Lin Y, 2017, J BIOL CHEM, V292, P19110, DOI 10.1074/jbc.M117.800466; Lu HS, 2018, NATURE, V558, P318, DOI 10.1038/s41586-018-0174-3; Luo F, 2018, NAT STRUCT MOL BIOL, V25, P341, DOI 10.1038/s41594-018-0050-8; Mahboubi H, 2016, MOL PHARMACOL, V90, P460, DOI 10.1124/mol.116.105494; Mahboubi H, 2015, BBA-MOL CELL RES, V1853, P1725, DOI 10.1016/j.bbamcr.2015.03.015; Martin L, 2013, AGEING RES REV, V12, P289, DOI 10.1016/j.arr.2012.06.003; Matsumoto K, 2012, RNA BIOL, V9, P610, DOI 10.4161/rna.19527; Maziuk BF, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0574-5; McGurk L, 2018, MOL CELL, V71, P703, DOI 10.1016/j.molcel.2018.07.002; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Monahan Z, 2017, EMBO J, V36, P2951, DOI 10.15252/embj.201696394; Murray DT, 2017, CELL, V171, P615, DOI 10.1016/j.cell.2017.08.048; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, ACTA NEUROPATHOL, V117, P137, DOI 10.1007/s00401-008-0477-9; Nonaka T, 2016, J BIOL CHEM, V291, P5473, DOI 10.1074/jbc.M115.695379; Nostramo R, 2016, MOL CELL BIOL, V36, P173, DOI 10.1128/MCB.00609-15; Nott TJ, 2015, MOL CELL, V57, P936, DOI 10.1016/j.molcel.2015.01.013; Ohn T, 2008, NAT CELL BIOL, V10, P1224, DOI 10.1038/ncb1783; Ong SE, 2004, NAT METHODS, V1, P119, DOI 10.1038/NMETH715; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Poornima G, 2016, NUCLEIC ACIDS RES, V44, P9358, DOI 10.1093/nar/gkw762; Qamar S, 2018, CELL, V173, P720, DOI 10.1016/j.cell.2018.03.056; Rai AK, 2018, NATURE, V559, P211, DOI 10.1038/s41586-018-0279-8; Rajyaguru P, 2012, MOL CELL, V45, P244, DOI 10.1016/j.molcel.2011.11.026; Ramaswami M, 2013, CELL, V154, P727, DOI 10.1016/j.cell.2013.07.038; Rappsilber J, 2003, ANAL CHEM, V75, P3107, DOI 10.1021/ac026283q; Reineke LC, 2018, J CELL SCI, V131, DOI 10.1242/jcs.220244; Rhoads SN, 2018, MOL BIOL CELL, V29, P1786, DOI 10.1091/mbc.E17-12-0735; Rhoads SN, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030886; Rigbolt KTG, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001570; Roovers EF, 2018, DEV CELL, V46, P285, DOI 10.1016/j.devcel.2018.07.009; Roth S, 2017, EXP CELL RES, V350, P210, DOI 10.1016/j.yexcr.2016.11.023; Ryan VH, 2018, MOL CELL, V69, P465, DOI 10.1016/j.molcel.2017.12.022; Saha S, 2017, J CELL BIOL, V216, P2235, DOI 10.1083/jcb.201706034; Saha S, 2016, CELL, V166, P1572, DOI 10.1016/j.cell.2016.08.006; Saito M, 2019, NAT CHEM BIOL, V15, P51, DOI 10.1038/s41589-018-0180-7; Salado IG, 2014, J MED CHEM, V57, P2755, DOI 10.1021/jm500065f; Sato S, 2006, J NEUROCHEM, V98, P1573, DOI 10.1111/j.1471-4159.2006.04059.x; Scaramuzzino C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061576; Sergeant N, 2008, EXPERT REV PROTEOMIC, V5, P207, DOI 10.1586/14789450.5.2.207; Sfakianos AP, 2018, CELL DEATH DIFFER, V25, P1766, DOI 10.1038/s41418-018-0076-9; Shin Y, 2017, SCIENCE, V357, DOI 10.1126/science.aaf4382; Simandi Z, 2018, J NEUROSCI, V38, P7683, DOI 10.1523/JNEUROSCI.3389-17.2018; Slade DJ, 2014, BIOPOLYMERS, V101, P133, DOI 10.1002/bip.22256; Stetler A, 2006, HUM MOL GENET, V15, P87, DOI 10.1093/hmg/ddi429; Su XL, 2016, SCIENCE, V352, P595, DOI 10.1126/science.aad9964; Suarez-Calvet M, 2016, ACTA NEUROPATHOL, V131, P587, DOI 10.1007/s00401-016-1544-2; Sun SY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7171; Tang J, 2000, J BIOL CHEM, V275, P7723, DOI 10.1074/jbc.275.11.7723; Tanikawa C, 2018, CELL REP, V22, P1473, DOI 10.1016/j.celrep.2018.01.031; Taylor JP, 2016, NATURE, V539, P197, DOI 10.1038/nature20413; Taylor LM, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0237-9; Thandapani P, 2013, MOL CELL, V50, P613, DOI 10.1016/j.molcel.2013.05.021; Tompa P, 2014, MOL CELL, V55, P161, DOI 10.1016/j.molcel.2014.05.032; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Tourriere H, 2001, MOL CELL BIOL, V21, P7747, DOI 10.1128/MCB.21.22.7747-7760.2001; Trinidad JC, 2012, MOL CELL PROTEOMICS, V11, P215, DOI 10.1074/mcp.O112.018366; Tsai WC, 2017, J BIOL CHEM, V292, P18886, DOI 10.1074/jbc.M117.800706; Tsai WC, 2016, J BIOL CHEM, V291, P22671, DOI 10.1074/jbc.M116.739573; Uversky VN, 2015, FEBS LETT, V589, P2498, DOI 10.1016/j.febslet.2015.06.004; Vanderweyde T, 2016, CELL REP, V15, P1455, DOI 10.1016/j.celrep.2016.04.045; Vanderweyde T, 2012, J NEUROSCI, V32, P8270, DOI 10.1523/JNEUROSCI.1592-12.2012; Wall ML, 2017, J MOL BIOL, V429, P295, DOI 10.1016/j.jmb.2016.12.011; Walport LJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11974; Wang AL, 2018, EMBO J, V37, DOI 10.15252/embj.201797452; Wang AC, 2016, P NATL ACAD SCI USA, V113, P15120, DOI 10.1073/pnas.1606899113; Wang CZ, 2018, NAT MED, V24, P647, DOI 10.1038/s41591-018-0004-z; Wang J, 2018, CELL, V174, P688, DOI 10.1016/j.cell.2018.06.006; Wang XS, 2006, PROTEIN PEPTIDE LETT, V13, P679, DOI 10.2174/092986606777790566; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1; Wegmann S, 2018, EMBO J, V37, DOI 10.15252/embj.201798049; Wippich F, 2013, CELL, V152, P791, DOI 10.1016/j.cell.2013.01.033; Woodruff JB, 2018, TRENDS BIOCHEM SCI, V43, P81, DOI 10.1016/j.tibs.2017.11.005; Xie HB, 2007, J PROTEOME RES, V6, P1917, DOI 10.1021/pr060394e; Xie X, 2018, J CELL SCI, V131, DOI 10.1242/jcs.210856; Yamazaki T, 2012, CELL REP, V2, P799, DOI 10.1016/j.celrep.2012.08.025; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409; Zhang XQ, 2018, NAT CHEM BIOL, V14, P909, DOI 10.1038/s41589-018-0120-6; Zhang XM, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002183; Zhang YJ, 2013, HUM MOL GENET, V22, P3112, DOI 10.1093/hmg/ddt166	158	164	164	15	73	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2019	294	18					7137	7150		10.1074/jbc.TM118.001189	http://dx.doi.org/10.1074/jbc.TM118.001189			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PT	30587571	Green Published, hybrid			2022-12-28	WOS:000468402900004
J	Snyder, NA; Palmer, MV; Reinhardt, TA; Cunningham, KW				Snyder, Nathan A.; Palmer, Mitchell V.; Reinhardt, Timothy A.; Cunningham, Kyle W.			Milk biosynthesis requires the Golgi cation exchanger TMEM165	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						galactosyltransferase; Golgi; calcium transport; mammary gland; manganese; pH regulation	SECRETORY PATHWAY CA2+; MAMMARY-GLAND; GLYCOSYLATION; PROTEIN; DEFICIENCY; EXPRESSION; MUTATIONS; MANGANESE; CELLS; YEAST	Milk is a hallmark of mammals that is critical for normal growth and development of offspring. During biosynthesis of lactose in the Golgi complex, H+ is produced as a by-product, and there is no known mechanism for maintaining luminal pH within the physiological range. Here, using conditional, tissue-specific knockout mice, immunostaining, and biochemical assays, we test whether the putative H+/Ca2+/Mn2+ exchanger known as TMEM165 (transmembrane protein 165) participates in normal milk production. We find TMEM165 is crucial in the lactating mammary gland for normal biosynthesis of lactose and for normal growth rates of nursing pups. The milk of TMEM165-deficient mice contained elevated concentrations of fat, protein, iron, and zinc, which are likely caused by decreased osmosis-mediated dilution of the milk caused by the decreased biosynthesis of lactose. When normalized to total protein levels, only calcium and manganese levels were significantly lower in the milk from TMEM165-deficient dams than control dams. These findings suggest that TMEM165 supplies Ca2+ and Mn2+ to the Golgi complex in exchange for H+ to sustain the functions of lactose synthase and potentially other glycosyl-transferases. Our findings highlight the importance of cation and pH homeostasis in the Golgi complex of professional secretory cells and the critical role of TMEM165 in this process.	[Snyder, Nathan A.; Cunningham, Kyle W.] Johns Hopkins Univ, Dept Biol, 3400 N Charles St, Baltimore, MD 21218 USA; [Reinhardt, Timothy A.] USDA ARS, Ruminant Dis & Immunol Res Unit, Natl Anim Dis Ctr, Ames, IA 50010 USA; [Palmer, Mitchell V.] USDA ARS, Bacterial Dis Livestock, Res Unit, Natl Anim Dis Ctr, Ames, IA 50010 USA	Johns Hopkins University; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Cunningham, KW (corresponding author), Johns Hopkins Univ, Dept Biol, 3400 N Charles St, Baltimore, MD 21218 USA.; Reinhardt, TA (corresponding author), USDA ARS, Ruminant Dis & Immunol Res Unit, Natl Anim Dis Ctr, Ames, IA 50010 USA.	tim.reinhardt@ars.usda.gov; kwc@jhu.edu	; Reinhardt, Timothy/A-7536-2009	Snyder, Nathan/0000-0001-9204-8420; Reinhardt, Timothy/0000-0001-5552-2509; Cunningham, Kyle/0000-0001-6877-6321	National Institutes of Health from the NICHD [R21HD080102]; NIAID [R21AI115016]; NIGMS [T32GM007231]; United States Department of Agriculture [5030-32000-115-00-D]; Johns Hopkins University	National Institutes of Health from the NICHD; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); United States Department of Agriculture(United States Department of Agriculture (USDA)); Johns Hopkins University(Johns Hopkins University)	This work was supported by grants from the National Institutes of Health Grants R21HD080102 from the NICHD, R21AI115016 from the NIAID, and T32GM007231 from the NIGMS, by United States Department of Agriculture Project 5030-32000-115-00-D, and by funds from Johns Hopkins University. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AOKI T, 1987, BIOCHIM BIOPHYS ACTA, V911, P238, DOI 10.1016/0167-4838(87)90013-6; Axelsson MAB, 2001, GLYCOBIOLOGY, V11, P633, DOI 10.1093/glycob/11.8.633; Bammens R, 2015, GLYCOBIOLOGY, V25, P669, DOI 10.1093/glycob/cwv009; BERLINER LJ, 1982, BIOCHEMISTRY-US, V21, P6340, DOI 10.1021/bi00268a003; Colinet AS, 2016, SCI REP-UK, V6, DOI 10.1038/srep24282; Cross BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067348; Dulary E, 2017, TISSUE CELL, V49, P150, DOI 10.1016/j.tice.2016.06.006; Durr G, 1998, MOL BIOL CELL, V9, P1149, DOI 10.1091/mbc.9.5.1149; Foulquier F, 2012, AM J HUM GENET, V91, P15, DOI 10.1016/j.ajhg.2012.05.002; FRASER IH, 1976, BIOCHEM J, V156, P347, DOI 10.1042/bj1560347; HOLT C, 1983, J THEOR BIOL, V101, P247, DOI 10.1016/0022-5193(83)90339-9; KAUFMAN RJ, 1994, BIOCHEMISTRY-US, V33, P9813, DOI 10.1021/bi00199a001; Kornak U, 2008, NAT GENET, V40, P32, DOI 10.1038/ng.2007.45; LAPINSKAS PJ, 1995, MOL CELL BIOL, V15, P1382; Mehta S, 2009, MOL CELL BIOL, V29, P2777, DOI 10.1128/MCB.01197-08; Ng BG, 2018, TRENDS GENET, V34, P466, DOI 10.1016/j.tig.2018.03.002; Park JH, 2015, AM J HUM GENET, V97, P894, DOI 10.1016/j.ajhg.2015.11.003; Potelle S, 2016, HUM MOL GENET, V25, P1489, DOI 10.1093/hmg/ddw026; POWELL JT, 1976, J BIOL CHEM, V251, P3645; Reinhardt TA, 2000, AM J PHYSIOL-CELL PH, V279, pC1595, DOI 10.1152/ajpcell.2000.279.5.C1595; Reinhardt TA, 2004, J BIOL CHEM, V279, P42369, DOI 10.1074/jbc.M407788200; Reinhardt TA, 2014, BIOCHEM BIOPH RES CO, V445, P417, DOI 10.1016/j.bbrc.2014.02.020; Rosnoblet C, 2013, HUM MOL GENET, V22, P2914, DOI 10.1093/hmg/ddt146; Sheehan D.C., 1980, THEORY PRACTICE HIST; Snyder NA, 2017, G3-GENES GENOM GENET, V7, P3913, DOI 10.1534/g3.117.300339; STACEY A, 1995, P NATL ACAD SCI USA, V92, P2835, DOI 10.1073/pnas.92.7.2835; Stein T, 2004, BREAST CANCER RES, V6, pR75, DOI 10.1186/bcr753; STINNAKRE MG, 1994, P NATL ACAD SCI USA, V91, P6544, DOI 10.1073/pnas.91.14.6544; Thines L, 2018, J BIOL CHEM, V293, P8048, DOI 10.1074/jbc.RA118.002324; Ton VK, 2002, J BIOL CHEM, V277, P6422, DOI 10.1074/jbc.M110612200; Wagner KU, 1997, NUCLEIC ACIDS RES, V25, P4323, DOI 10.1093/nar/25.21.4323; Wu ZL, 2011, GLYCOBIOLOGY, V21, P727, DOI 10.1093/glycob/cwq187; Xiang MH, 2005, J BIOL CHEM, V280, P11608, DOI 10.1074/jbc.M413116200	33	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2019	294	9					3181	3191		10.1074/jbc.RA118.006270	http://dx.doi.org/10.1074/jbc.RA118.006270			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU0SA	30622138	hybrid, Green Published			2022-12-28	WOS:000464980100017
J	Roland, BP; Naito, T; Best, JT; Arnaiz-Yepez, C; Takatsu, H; Yu, RJ; Shin, HW; Graham, TR				Roland, Bartholomew P.; Naito, Tomoki; Best, Jordan T.; Arnaiz-Yepez, Cayetana; Takatsu, Hiroyuki; Yu, Roger J.; Shin, Hye-Won; Graham, Todd R.			Yeast and human P4-ATPases transport glycosphingolipids using conserved structural motifs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						sphingolipid; glycolipid; lipid transport; membrane bilayer; enzyme mechanism; cerebroside; flippase; glucosylceramide; membrane asymmetry; P4-ATPase; membrane biology; glycosphingolipids	P-TYPE ATPASE; AMINOPHOSPHOLIPID TRANSLOCASE; PLASMA-MEMBRANE; PHOSPHOLIPID TRANSLOCATION; CRYSTAL-STRUCTURE; APOPTOTIC CELLS; CDC50 PROTEINS; GOLGI NETWORK; PHOSPHATIDYLSERINE; MECHANISM	Lipid transport is an essential process with manifest importance to human health and disease. Phospholipid flippases (P4-ATPases) transport lipids across the membrane bilayer and are involved in signal transduction, cell division, and vesicular transport. Mutations in flippase genes cause or contribute to a host of diseases, such as cholestasis, neurological deficits, immunological dysfunction, and metabolic disorders. Genome-wide association studies have shown that ATP10A and ATP10D variants are associated with an increased risk of diabetes, obesity, myocardial infarction, and atherosclerosis. Moreover, ATP10D SNPs are associated with elevated levels of glucosylceramide (GlcCer) in plasma from diverse European populations. Although sphingolipids strongly contribute to metabolic disease, little is known about how GlcCer is transported across cell membranes. Here, we identify a conserved clade of P4-ATPases from Saccharomyces cerevisiae (Dnf1, Dnf2), Schizosaccharomyces pombe (Dnf2), and Homo sapiens (ATP10A, ATP10D) that transport GlcCer bearing an sn2 acyl-linked fluorescent tag. Further, we establish structural determinants necessary for recognition of this sphingolipid substrate. Using enzyme chimeras and site-directed mutagenesis, we observed that residues in transmembrane (TM) segments 1, 4, and 6 contribute to GlcCer selection, with a conserved glutamine in the center of TM4 playing an essential role. Our molecular observations help refine models for substrate translocation by P4-ATPases, clarify the relationship between these flippases and human disease, and have fundamental implications for membrane organization and sphingolipid homeostasis.	[Roland, Bartholomew P.; Best, Jordan T.; Arnaiz-Yepez, Cayetana; Yu, Roger J.; Graham, Todd R.] Vanderbilt Univ, Dept Biol Sci, 221 Kirkland Hall, Nashville, TN 37235 USA; [Naito, Tomoki; Takatsu, Hiroyuki; Shin, Hye-Won] Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan	Vanderbilt University; Kyoto University	Graham, TR (corresponding author), Vanderbilt Univ, Dept Biol Sci, 221 Kirkland Hall, Nashville, TN 37235 USA.	tr.graham@vanderbilt.edu	Shin, Hye-Won/P-5398-2018	Shin, Hye-Won/0000-0002-9138-9554; Arnaiz, Cayetana/0000-0001-5069-1469; Naito, Tomoki/0000-0002-8393-3601; Roland, Bartholomew/0000-0002-9033-9942	National Institutes of Health [R01-GM107978, F32-GM116310]; Japan Society for the Promotion of Science (JSPS) KAKENHI [JP16H00764, JP17H03655]; Japan Foundation for Applied Enzymology;  [JP16J05381]; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH065215] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Foundation for Applied Enzymology; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health Grants R01-GM107978 (to T.R.G.) and F32-GM116310 (to B.P.R.), Japan Society for the Promotion of Science (JSPS) KAKENHI Grants JP16H00764 and JP17H03655 and a grant from the Japan Foundation for Applied Enzymology (to H.-W.S), and Grant-in-Aid for JSPS Research Fellow JP16J05381 (to T.N.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abe K, 2009, EMBO J, V28, P1637, DOI 10.1038/emboj.2009.102; Andersen JP, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00275; Astudillo L, 2016, BIOCHIMIE, V125, P267, DOI 10.1016/j.biochi.2015.11.009; Baldridge RD, 2013, J BIOL CHEM, V288, P19516, DOI 10.1074/jbc.M113.476911; Baldridge RD, 2013, P NATL ACAD SCI USA, V110, pE358, DOI 10.1073/pnas.1216948110; Baldridge RD, 2012, P NATL ACAD SCI USA, V109, pE290, DOI 10.1073/pnas.1115725109; Bratton DL, 1997, J BIOL CHEM, V272, P26159, DOI 10.1074/jbc.272.42.26159; Brunner JD, 2014, NATURE, V516, P207, DOI 10.1038/nature13984; Bryde S, 2010, J BIOL CHEM, V285, P40562, DOI 10.1074/jbc.M110.139543; Bull LN, 1998, NAT GENET, V18, P219, DOI 10.1038/ng0398-219; Chen CY, 1999, J CELL BIOL, V147, P1223, DOI 10.1083/jcb.147.6.1223; Coleman JA, 2014, J CELL SCI, V127, P1138, DOI 10.1242/jcs.145052; Coleman JA, 2009, J BIOL CHEM, V284, P32670, DOI 10.1074/jbc.M109.047415; DAWSON G, 1976, J LIPID RES, V17, P125; Dhar M, 2002, OBES RES, V10, P695, DOI 10.1038/oby.2002.94; Dhar MS, 2004, J NUTR, V134, P799, DOI 10.1093/jn/134.4.799; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; Fadok VA, 1998, CELL DEATH DIFFER, V5, P551, DOI 10.1038/sj.cdd.4400404; Fahy E, 2009, J LIPID RES, V50, pS9, DOI 10.1194/jlr.R800095-JLR200; Flamant S, 2003, MAMM GENOME, V14, P21, DOI 10.1007/s00335-002-3032-3; Focht D, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00202; Folmer DE, 2009, BBA-MOL CELL BIOL L, V1791, P628, DOI 10.1016/j.bbalip.2009.02.008; Gall WE, 2002, CURR BIOL, V12, P1623, DOI 10.1016/S0960-9822(02)01148-X; Gantzel RH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10741-z; Hannun YA, 2018, NAT REV MOL CELL BIO, V19, P175, DOI 10.1038/nrm.2017.107; Hicks AA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000672; Hoffmann PR, 2001, J CELL BIOL, V155, P649, DOI 10.1083/jcb.200108080; Holland WL, 2008, ENDOCR REV, V29, P381, DOI 10.1210/er.2007-0025; Irvin MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024052; Jensen MS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17742-y; Jiang YN, 2017, SCIENCE, V356, P1172, DOI 10.1126/science.aam9970; Kato U, 2002, J BIOL CHEM, V277, P37855, DOI 10.1074/jbc.M205564200; Kazmier K, 2017, CURR OPIN STRUC BIOL, V45, P100, DOI 10.1016/j.sbi.2016.12.006; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kengia JT, 2013, ATHEROSCLEROSIS, V231, P158, DOI 10.1016/j.atherosclerosis.2013.08.034; Kuhlbrandt W, 2002, SCIENCE, V297, P1692, DOI 10.1126/science.1072574; Leipelt M, 2001, J BIOL CHEM, V276, P33621, DOI 10.1074/jbc.M104952200; Liu K, 2008, MOL BIOL CELL, V19, P3526, DOI 10.1091/mbc.E08-01-0025; Lopez-Marques RL, 2015, BBA-GEN SUBJECTS, V1850, P461, DOI 10.1016/j.bbagen.2014.04.008; Luginbuehl LH, 2017, SCIENCE, V356, P1175, DOI 10.1126/science.aan0081; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Naito T, 2015, J BIOL CHEM, V290, P15004, DOI 10.1074/jbc.M115.655191; Natarajan P, 2004, P NATL ACAD SCI USA, V101, P10614, DOI 10.1073/pnas.0404146101; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Onat OE, 2013, EUR J HUM GENET, V21, P281, DOI 10.1038/ejhg.2012.170; Platt FM, 2014, NATURE, V510, P68, DOI 10.1038/nature13476; Pomorski T, 2003, MOL BIOL CELL, V14, P1240, DOI 10.1091/mbc.E02-08-0501; Primeau JO, 2018, SUBCELL BIOCHEM, V87, P229, DOI 10.1007/978-981-10-7757-9_8; Roelants FM, 2010, P NATL ACAD SCI USA, V107, P34, DOI 10.1073/pnas.0912497106; Roland BP, 2016, CRIT REV BIOCHEM MOL, V51, P513, DOI 10.1080/10409238.2016.1237934; Roland BP, 2016, P NATL ACAD SCI USA, V113, pE4460, DOI 10.1073/pnas.1525730113; Sabourdy F, 2015, BBA-MOL CELL BIOL L, V1851, P1040, DOI 10.1016/j.bbalip.2015.01.010; Saito K, 2004, MOL BIOL CELL, V15, P3418, DOI 10.1091/mbc.E03-11-0829; Sawada K, 2015, APPL ENVIRON MICROB, V81, P3688, DOI 10.1128/AEM.00454-15; Shin HW, 2004, MOL BIOL CELL, V15, P5283, DOI 10.1091/mbc.E04-05-0388; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Sidransky E, 2012, LANCET NEUROL, V11, P986, DOI 10.1016/S1474-4422(12)70190-4; Sigruener A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178368; Stone A, 2012, J BIOL CHEM, V287, P41139, DOI 10.1074/jbc.M112.413039; SURWIT RS, 1995, METABOLISM, V44, P645, DOI 10.1016/0026-0495(95)90123-X; Takada N, 2018, EMBO J, V37, DOI 10.15252/embj.201797705; Takatsu H, 2014, J BIOL CHEM, V289, P33543, DOI 10.1074/jbc.M114.593012; Takatsu H, 2011, J BIOL CHEM, V286, P38159, DOI 10.1074/jbc.M111.281006; Uchida K, 1998, J BIOCHEM-TOKYO, V123, P1073; van der Velden LM, 2010, J BIOL CHEM, V285, P40088, DOI 10.1074/jbc.M110.139006; Vance D. E., 2008, BIOCH LIPIDS LIPOPRO, P364; Vestergaard AL, 2014, P NATL ACAD SCI USA, V111, pE1334, DOI 10.1073/pnas.1321165111; Vitner Einat B, 2013, Handb Exp Pharmacol, P405, DOI 10.1007/978-3-7091-1511-4_20; Xu P, 2013, J CELL BIOL, V202, P875, DOI 10.1083/jcb.201305094; Yoshida H, 2005, NATURE, V437, P754, DOI 10.1038/nature03964; Zhou XM, 2009, P NATL ACAD SCI USA, V106, P16586, DOI 10.1073/pnas.0904293106; Zhu XJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002853	72	38	38	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2019	294	6					1794	1806		10.1074/jbc.RA118.005876	http://dx.doi.org/10.1074/jbc.RA118.005876			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM8EO	30530492	Green Published, hybrid			2022-12-28	WOS:000459711400003
J	Taylor, CA; Hutchens, S; Liu, CY; Jursa, T; Shawlot, W; Aschner, M; Smith, DR; Mukhopadhyay, S				Taylor, Cherish A.; Hutchens, Steven; Liu, Chunyi; Jursa, Thomas; Shawlot, William; Aschner, Michael; Smith, Donald R.; Mukhopadhyay, Somshuvra			SLC30A10 transporter in the digestive system regulates brain manganese under basal conditions while brain SLC30A10 protects against neurotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						manganese; transporter; metal homeostasis; Parkinson disease; mouse genetics; cation diffusion facilitator; solute carrier; thyroid; toxicity; ZnT; SLC30; ZnT10; parkinsonism; neurotoxicity	EFFLUX TRANSPORTER; HEPATIC CIRRHOSIS; ZIP14 SLC39A14; PARKINSONISM; MUTATIONS; EXCRETION; EXPOSURE; LIVER; GENE; POLYCYTHEMIA	The essential metal manganese becomes neurotoxic at elevated levels. Yet, the mechanisms by which brain manganese homeostasis is regulated are unclear. Loss-of-function mutations in SLC30A10, a cell surface-localized manganese efflux transporter in the brain and liver, induce familial manganese neurotoxicity. To elucidate the role of SLC30A10 in regulating brain manganese, we compared the phenotypes of whole-body and tissue-specific Slc30a10 knockout mice. Surprisingly, unlike whole-body knockouts, brain manganese levels were unaltered in pan-neuronal/glial Slc30a10 knockouts under basal physiological conditions. Further, although transport into bile is a major route of manganese excretion, manganese levels in the brain, blood, and liver of liver-specific Slc30a10 knockouts were only minimally elevated, suggesting that another organ compensated for loss-of-function in the liver. Additional assays revealed that SLC30A10 was also expressed in the gastrointestinal tract. In differentiated enterocytes, SLC30A10 localized to the apical/luminal domain and transported intracellular manganese to the lumen. Importantly, endoderm-specific knockouts, lacking SLC30A10 in the liver and gastrointestinal tract, had markedly elevated manganese levels in the brain, blood, and liver. Thus, under basal physiological conditions, brain manganese is regulated by activity of SLC30A10 in the liver and gastrointestinal tract, and not the brain or just the liver. Notably, however, brain manganese levels of endoderm-specific knockouts were lower than whole-body knockouts, and only whole-body knockouts exhibited manganese-induced neurobehavioral defects. Moreover, after elevated exposure, pan-neuronal/glial knockouts had higher manganese levels in the basal ganglia and thalamus than controls. Therefore, when manganese levels increase, activity of SLC30A10 in the brain protects against neurotoxicity.	[Taylor, Cherish A.; Hutchens, Steven; Liu, Chunyi; Mukhopadhyay, Somshuvra] Univ Texas Austin, Coll Pharm, Inst Cellular & Mol Biol, Div Pharmacol & Toxicol, Austin, TX 78712 USA; [Taylor, Cherish A.; Hutchens, Steven; Liu, Chunyi; Mukhopadhyay, Somshuvra] Univ Texas Austin, Inst Neurosci, Austin, TX 78712 USA; [Shawlot, William] Univ Texas Austin, Mouse Genet Engn Facil, Austin, TX 78712 USA; [Jursa, Thomas; Smith, Donald R.] Univ Calif Santa Cruz, Dept Microbiol & Environm Toxicol, Santa Cruz, CA 95064 USA; [Aschner, Michael] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of California System; University of California Santa Cruz; Yeshiva University; Albert Einstein College of Medicine	Mukhopadhyay, S (corresponding author), Univ Texas Austin, Div Pharmacol & Toxicol, 3-510E BME,107 W Dean Keeton St, Austin, TX 78712 USA.	som@austin.utexas.edu	Liu, Chunyi/AAJ-9340-2021	aschner, michael/0000-0002-2619-1656	NIEHS, National Institutes of Health [R01-ES024812, R01-ES024812S1]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES024812] Funding Source: NIH RePORTER	NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NIEHS, National Institutes of Health, Grants R01-ES024812 and R01-ES024812S1 (to S.M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aschner M, 2009, NEUROMOL MED, V11, P252, DOI 10.1007/s12017-009-8083-0; Aydemir TB, 2017, J NEUROSCI, V37, P5996, DOI 10.1523/JNEUROSCI.0285-17.2017; BALLATORI N, 1987, AM J PHYSIOL, V252, pR842, DOI 10.1152/ajpregu.1987.252.5.R842; Beaudin SA, 2017, ENVIRON HEALTH PERSP, V125, P230, DOI 10.1289/EHP258; Beaudin SA, 2013, NEUROTOXICOL TERATOL, V38, P36, DOI 10.1016/j.ntt.2013.04.004; BERTINCHAMPS AJ, 1966, AM J PHYSIOL, V211, P217, DOI 10.1152/ajplegacy.1966.211.1.217; Bouabid S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098952; Bowman AB, 2014, NEUROTOXICOLOGY, V41, P141, DOI 10.1016/j.neuro.2014.01.010; Butterworth RF, 2013, METAB BRAIN DIS, V28, P261, DOI 10.1007/s11011-012-9341-7; Chen Pan, 2015, Worm, V4, pe1042648, DOI 10.1080/21624054.2015.1042648; Cordova FM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033057; Ferruzza S, 2012, TOXICOL IN VITRO, V26, P1252, DOI 10.1016/j.tiv.2012.01.008; Garrison WD, 2006, GASTROENTEROLOGY, V130, P1207, DOI 10.1053/j.gastro.2006.01.003; Giusti SA, 2014, J PSYCHIATR RES, V55, P87, DOI 10.1016/j.jpsychires.2014.04.002; Greenberg David M., 1943, JOUR BIOL CHEM, V147, P749; Guthrie GJ, 2015, AM J PHYSIOL-GASTR L, V308, pG171, DOI 10.1152/ajpgi.00021.2014; Hojyo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018059; Hutchens S, 2017, J BIOL CHEM, V292, P9760, DOI 10.1074/jbc.M117.783605; Jenkitkasemwong S, 2018, P NATL ACAD SCI USA, V115, pE1769, DOI 10.1073/pnas.1720739115; Jursa T, 2009, TOXICOL SCI, V107, P182, DOI 10.1093/toxsci/kfn231; KLAASSEN CD, 1974, TOXICOL APPL PHARM, V29, P458, DOI 10.1016/0041-008X(74)90117-3; Lechpammer M, 2014, ANN NEUROL, V75, P608, DOI 10.1002/ana.24131; Lee CS, 2005, DEV BIOL, V278, P484, DOI 10.1016/j.ydbio.2004.10.012; Leyva-Illades D, 2014, J NEUROSCI, V34, P14079, DOI 10.1523/JNEUROSCI.2329-14.2014; Liu CY, 2017, J BIOL CHEM, V292, P16605, DOI 10.1074/jbc.M117.804989; Liu XH, 2006, TOXICOL SCI, V91, P521, DOI 10.1093/toxsci/kfj150; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lucchini RG, 2014, NEUROTOXICOLOGY, V45, P309, DOI 10.1016/j.neuro.2014.05.006; Lucchini RG, 2012, NEUROTOXICOLOGY, V33, P687, DOI 10.1016/j.neuro.2012.01.005; Ma RE, 2018, NEUROTOXICOLOGY, V64, P30, DOI 10.1016/j.neuro.2017.08.013; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Magnuson MA, 2013, CELL METAB, V18, P9, DOI 10.1016/j.cmet.2013.06.011; Mukhopadhyay S, 2018, NEUROTOXICOLOGY, V64, P278, DOI 10.1016/j.neuro.2017.07.030; Nam H, 2013, HAEMATOLOGICA, V98, P1049, DOI 10.3324/haematol.2012.072314; Nam J, 2008, BIOL PHARM BULL, V31, P1894, DOI 10.1248/bpb.31.1894; Nishito Y, 2016, J BIOL CHEM, V291, P14773, DOI 10.1074/jbc.M116.728014; Olanow CW, 2004, ANN NY ACAD SCI, V1012, P209, DOI 10.1196/annals.1306.018; Oulhote Y, 2014, ENVIRON HEALTH PERSP, V122, P1343, DOI 10.1289/ehp.1307918; PAPAVASILIOU PS, 1966, AM J PHYSIOL, V211, P211, DOI 10.1152/ajplegacy.1966.211.1.211; Perl DP, 2007, J NEUROPATH EXP NEUR, V66, P675, DOI 10.1097/nen.0b013e31812503cf; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Quadri M, 2015, MOVEMENT DISORD, V30, P996, DOI 10.1002/mds.26202; Quadri M, 2012, AM J HUM GENET, V90, P467, DOI 10.1016/j.ajhg.2012.01.017; Selyunin AS, 2017, J CELL BIOL, V216, P3249, DOI 10.1083/jcb.201704015; Selyunin AS, 2015, TRAFFIC, V16, P1270, DOI 10.1111/tra.12338; Takeo T, 2011, BIOL REPROD, V85, P1066, DOI 10.1095/biolreprod.111.092536; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Tuschl K, 2008, J INHERIT METAB DIS, V31, P151, DOI 10.1007/s10545-008-0813-1; Tuschl K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11601; Tuschl K, 2012, AM J HUM GENET, V90, P457, DOI 10.1016/j.ajhg.2012.01.018; Voikar V, 2001, PHYSIOL BEHAV, V72, P271, DOI 10.1016/S0031-9384(00)00405-4; Wahlberg K, 2016, TOXICOL SCI, V149, P473, DOI 10.1093/toxsci/kfv252; Xin YJ, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.25; Zogzas CE, 2018, METALLOMICS, V10, DOI 10.1039/c8mt00115d; Zogzas CE, 2016, J BIOL CHEM, V291, P15940, DOI 10.1074/jbc.M116.726935; Zorn AM, 2009, ANNU REV CELL DEV BI, V25, P221, DOI 10.1146/annurev.cellbio.042308.113344	56	47	48	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2019	294	6					1860	1876		10.1074/jbc.RA118.005628	http://dx.doi.org/10.1074/jbc.RA118.005628			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM8EO	30559290	hybrid, Green Published			2022-12-28	WOS:000459711400008
J	Chu, KY; O'Reilly, L; Mellet, N; Meikle, PJ; Bartley, C; Biden, TJ				Chu, Kwan Yi; O'Reilly, Liam; Mellet, Natalie; Meikle, Peter J.; Bartley, Clarissa; Biden, Trevor J.			Oleate disrupts cAMP signaling, contributing to potent stimulation of pancreatic beta-cell autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						pancreatic islet; lipid; autophagy; cyclic AMP (cAMP); beta cell (B-cell)	ENDOPLASMIC-RETICULUM STRESS; FREE FATTY-ACIDS; INSULIN-SECRETION; PROTEIN-KINASE; MAMMALIAN TARGET; ACTIVATION; APOPTOSIS; MASS; HOMEOSTASIS; INHIBITION	Autophagy is critical for maintaining cellular function via clearance of excess nutrients and damaged organelles. In pancreatic beta-cells, it helps counter the endoplasmic reticulum (ER) stress that impairs insulin secretory capacity during Type 2 diabetes. Chronic exposure of beta-cells to saturated fatty acids (FAs) such as palmitate stimulates ER stress and modulates autophagy, but the effects of unsaturated FAs such as oleate, which are also elevated during obesity, are less well understood. We therefore treated MIN6 cells and mouse islets for 8-48 h with either palmitate or oleate, and then monitored autophagic flux, signaling pathways, lysosomal biology, and phospholipid profiles. Compared with palmitate, oleate more effectively stimulated both autophagic flux and clearance of autophagosomes. The flux stimulation occurred independently of ER stress, nutrient-sensing (mTOR) and signaling pathways (protein kinases A, C, and D). Instead the mechanism involved the exchange factor directly activated by cAMP 2 (EPAC2). Oleate reduced cellular cAMP, and its effects on autophagic flux were reproduced or inhibited, respectively, by Epac2 knockdown or activation. Oleate also increased lysosomal acidity and increased phospholipid saturation, consistent with improved autophagosomal fusion with lysosomes. We conclude that a potent stimulation of autophagy might help explain the known benefits of unsaturated FAs in countering the toxicity of saturated FAs in beta-cells during obesity and lipid loading.	[Chu, Kwan Yi; O'Reilly, Liam; Bartley, Clarissa; Biden, Trevor J.] Garvan Inst Med Res, Div Diabet & Metab, 384 Victoria St, Darlinghurst, NSW 2010, Australia; [Chu, Kwan Yi; Biden, Trevor J.] UNSW Sydney, Fac Med, St Vincents Clin Sch, Sydney, NSW 2052, Australia; [Mellet, Natalie; Meikle, Peter J.] Baker IDI Heart & Diabet Inst, Prahran, Vic 3004, Australia	Garvan Institute of Medical Research; University of New South Wales Sydney; Baker Heart and Diabetes Institute	Biden, TJ (corresponding author), Garvan Inst Med Res, Div Diabet & Metab, 384 Victoria St, Darlinghurst, NSW 2010, Australia.	t.biden@garvan.org.au	Biden, Trevor/AAW-2829-2021	Biden, Trevor/0000-0001-5211-0234; Meikle, Peter/0000-0002-2593-4665	National Health and Medical Research Council of Australia [1051658, 1024961]; Diabetes Australia Research Trust	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Diabetes Australia Research Trust	This work was supported by Projects Grant 1051658 and Fellowship 1024961 from the National Health and Medical Research Council of Australia (to T. J. B.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Diabetes Australia Research Trust.	Abe H, 2013, ENDOCRINOLOGY, V154, P4512, DOI 10.1210/en.2013-1578; Akerfeldt MC, 2008, DIABETES, V57, P3034, DOI 10.2337/db07-1802; Bartolome A, 2012, AUTOPHAGY, V8, P1757, DOI 10.4161/auto.21994; Mestre MB, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002664; Biden TJ, 2014, TRENDS ENDOCRIN MET, V25, P389, DOI 10.1016/j.tem.2014.02.003; Boslem E, 2013, J BIOL CHEM, V288, P26569, DOI 10.1074/jbc.M113.489310; Boslem E, 2011, BIOCHEM J, V435, P267, DOI 10.1042/BJ20101867; Boya P, 2013, NAT CELL BIOL, V15, P713, DOI 10.1038/ncb2788; Busch AK, 2005, DIABETES, V54, P2917, DOI 10.2337/diabetes.54.10.2917; Busch AK, 2002, DIABETES, V51, P977, DOI 10.2337/diabetes.51.4.977; Cantley J, 2009, DIABETES, V58, P1826, DOI 10.2337/db09-0132; Carlessi R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02838-2; Chen ML, 2013, AUTOPHAGY, V9, P2033, DOI 10.4161/auto.26336; Cheng CI, 2017, J CELL BIOCHEM, V118, P1249, DOI 10.1002/jcb.25784; Choi SE, 2009, ENDOCRINOLOGY, V150, P126, DOI 10.1210/en.2008-0483; Christensen AE, 2003, J BIOL CHEM, V278, P35394, DOI 10.1074/jbc.M302179200; Chu KY, 2015, DIABETOLOGIA, V58, P2074, DOI 10.1007/s00125-015-3665-x; Cnop M, 2001, DIABETES, V50, P1771, DOI 10.2337/diabetes.50.8.1771; Cnop M, 2008, BIOCHEM SOC T, V36, P909, DOI 10.1042/BST0360909; Codogno P, 2012, NAT REV MOL CELL BIO, V13, P7, DOI 10.1038/nrm3249; Ebato C, 2008, CELL METAB, V8, P325, DOI 10.1016/j.cmet.2008.08.009; Eisenberg-Lerner A, 2012, CELL DEATH DIFFER, V19, P788, DOI 10.1038/cdd.2011.149; Ferdaoussi M, 2012, DIABETOLOGIA, V55, P2682, DOI 10.1007/s00125-012-2650-x; Fu A, 2013, MOL CELL ENDOCRINOL, V366, P127, DOI 10.1016/j.mce.2012.06.020; Goginashvili A, 2015, SCIENCE, V347, P878, DOI 10.1126/science.aaa2628; Han D, 2010, BIOCHEM J, V425, P541, DOI 10.1042/BJ20090429; Hatanaka M, 2014, DIABETES, V63, P3404, DOI 10.2337/db14-0105; Holen I, 1996, EUR J BIOCHEM, V236, P163, DOI 10.1111/j.1432-1033.1996.00163.x; Janikiewicz J, 2015, J LIPID RES, V56, P1901, DOI 10.1194/jlr.M059980; Jung HS, 2008, CELL METAB, V8, P318, DOI 10.1016/j.cmet.2008.08.013; Kim J, 2014, J CLIN INVEST, V124, P3311, DOI 10.1172/JCI69625; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Komiya K, 2010, BIOCHEM BIOPH RES CO, V401, P561, DOI 10.1016/j.bbrc.2010.09.101; Kondo M, 2018, DIABETOLOGIA, V61, P2189, DOI 10.1007/s00125-018-4679-y; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Lai E, 2008, AM J PHYSIOL-ENDOC M, V294, pE540, DOI 10.1152/ajpendo.00478.2007; Las G, 2011, J BIOL CHEM, V286, P42534, DOI 10.1074/jbc.M111.242412; Laurent AC, 2015, CARDIOVASC RES, V105, P55, DOI 10.1093/cvr/cvu242; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Lee MS, 2014, TRENDS ENDOCRIN MET, V25, P620, DOI 10.1016/j.tem.2014.08.005; Lim SW, 2016, SCI REP-UK, V6, DOI 10.1038/srep29921; Marsh BJ, 2007, MOL ENDOCRINOL, V21, P2255, DOI 10.1210/me.2007-0077; Masini M, 2009, DIABETOLOGIA, V52, P1083, DOI 10.1007/s00125-009-1347-2; Mei S, 2011, J PHARMACOL EXP THER, V339, P487, DOI 10.1124/jpet.111.184341; Mir SUR, 2015, J BIOL CHEM, V290, P6071, DOI 10.1074/jbc.M114.605345; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Nakatogawa H, 2016, MOL CELL ONCOL, V3, DOI 10.1080/23723556.2015.1073416; Niso-Santano M, 2015, EMBO J, V34, P1025, DOI 10.15252/embj.201489363; Pearson GL, 2014, DIABETOLOGIA, V57, P129, DOI 10.1007/s00125-013-3083-x; PRENTKI M, 1992, J BIOL CHEM, V267, P5802; Quan W, 2012, DIABETOLOGIA, V55, P392, DOI 10.1007/s00125-011-2350-y; Rehmann H, 2013, SCI REP-UK, V3, DOI 10.1038/srep03032; Riahi Y, 2016, DIABETOLOGIA, V59, P1480, DOI 10.1007/s00125-016-3868-9; Rutter GA, 2009, MOL CELL ENDOCRINOL, V297, P41, DOI 10.1016/j.mce.2008.05.020; Seino S, 2012, DIABETES OBES METAB, V14, P9, DOI 10.1111/j.1463-1326.2011.01507.x; Shahnazari S, 2011, AUTOPHAGY, V7, P957, DOI 10.4161/auto.7.9.16435; Shaked M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028804; Sheng QF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16485-0; Shigihara N, 2014, J CLIN INVEST, V124, P3634, DOI 10.1172/JCI69866; Stienstra R, 2014, DIABETOLOGIA, V57, P1505, DOI 10.1007/s00125-014-3255-3; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Tan SH, 2012, J BIOL CHEM, V287, P14364, DOI 10.1074/jbc.M111.294157; Ugland H, 2011, AUTOPHAGY, V7, P1199, DOI 10.4161/auto.7.10.16649; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Velazquez AR, 2016, J CELL BIOL, V212, P621, DOI 10.1083/jcb.201508102; Wang X, 2007, BIOCHEM BIOPH RES CO, V352, P463, DOI 10.1016/j.bbrc.2006.11.032; Watada H, 2015, MOL ENDOCRINOL, V29, P338, DOI 10.1210/me.2014-1367; Wauson EM, 2014, TRENDS ENDOCRIN MET, V25, P274, DOI 10.1016/j.tem.2014.03.006; Xie JL, 2012, CELL MOL LIFE SCI, V69, P1289, DOI 10.1007/s00018-011-0874-4; Yuan T, 2018, J MOL BIOL, V430, P904, DOI 10.1016/j.jmb.2018.02.013; Zummo FP, 2017, DIABETES, V66, P1272, DOI 10.2337/db16-1009	72	13	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1218	1229		10.1074/jbc.RA118.004833	http://dx.doi.org/10.1074/jbc.RA118.004833			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30518550	Green Published, hybrid			2022-12-28	WOS:000457879500013
J	Chu, TY; Weng, X; Law, COK; Kong, HK; Lau, J; Li, S; Pham, HQ; Wang, R; Zhang, L; Kao, RYT; Lau, KF; Ngo, JCK; Lau, TCK				Chu, Tinyi; Weng, Xing; Law, Carmen Oi Kwan; Kong, Hoi-Kuan; Lau, Jeffrey; Li, Sheila; Hoa Quynh Pham; Wang, Rui; Zhang, Liang; Kao, Richard Y. T.; Lau, Kwok-Fai; Ngo, Jacky Chi Ki; Lau, Terrence Chi Kong			The ribosomal maturation factor P from Mycobacterium smegmatis facilitates the ribosomal biogenesis by binding to the small ribosomal protein S12	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ribosome assembly; crystal structure; mycobacteria; protein-protein interaction; protein complex; RimP; ribosomal maturation factor P; ribosomal biogenesis; MSMEG 2624; Mycobacterium smegmatis; small ribosomal protein S12; RpsL; tuberculosis; bacterial translation		The ribosomal maturation factor P (RimP) is a highly conserved protein in bacteria and has been shown to be important in ribosomal assembly in Escherichia coli. Because of its central importance in bacterial metabolism, RimP represents a good potential target for drug design to combat human pathogens such as Mycobacterium tuberculosis. However, to date, the only RimP structure available is the NMR structure of the ortholog in another bacterial pathogen, Streptococcus pneumoniae. Here, we report a 2.2 angstrom resolution crystal structure of MSMEG_2624, the RimP ortholog in the close M. tuberculosis relative Mycobacterium smegmatis, and using in vitro binding assays, we show that MSMEG_2624 interacts with the small ribosomal protein S12, also known as RpsL. Further analyses revealed that the conserved residues in the linker region between the N- and C-terminal domains of MSMEG_2624 are essential for binding to RpsL. However, neither of the two domains alone was sufficient to form strong interactions with RpsL. More importantly, the linker region was essential for in vivo ribosomal biogenesis. Our study provides critical mechanistic insights into the role of RimP in ribosome biogenesis. We anticipate that the MSMEG_2624 crystal structure has the potential to be used for drug design to manage M. tuberculosis infections.	[Chu, Tinyi; Weng, Xing; Law, Carmen Oi Kwan; Kong, Hoi-Kuan; Lau, Jeffrey; Li, Sheila; Hoa Quynh Pham; Wang, Rui; Zhang, Liang; Lau, Terrence Chi Kong] City Univ Hong Kong, Dept Biomed Sci, Kowloon, Hong Kong, Peoples R China; [Kao, Richard Y. T.] Univ Hong Kong, Dept Microbiol, Hong Kong, Peoples R China; [Lau, Kwok-Fai; Ngo, Jacky Chi Ki] Chinese Univ Hong Kong, Sch Life Sci, Hong Kong, Peoples R China	City University of Hong Kong; University of Hong Kong; Chinese University of Hong Kong	Lau, TCK (corresponding author), City Univ Hong Kong, Dept Biomed Sci, Kowloon, Hong Kong, Peoples R China.; Ngo, JCK (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Hong Kong, Peoples R China.	jackyngo@cuhk.edu.hk; chiklau@cityu.edu.hk	Lau, Terrence/ABB-7900-2021; Ngo, Jacky C/O-8093-2017	Lau, Terrence/0000-0002-7505-7306; Ngo, Jacky C/0000-0002-6004-7041; PHAM, Quynh Hoa/0000-0001-6165-3628; ZHANG, Liang/0000-0003-3100-8593; Chu, Tinyi/0000-0003-3369-6692; WANG, Rui/0000-0003-3830-4133; Lau, Kwok-Fai/0000-0002-0193-1152	General Research Fund (GRF) [11101518, 9042616, 21101917]; Health and Medical Research Fund (HMRF) Grant [15140342]	General Research Fund (GRF); Health and Medical Research Fund (HMRF) Grant	This work was supported by General Research Fund (GRF) 11101518, 9042616, and 21101917 and Health and Medical Research Fund (HMRF) Grant 15140342. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bunner AE, 2010, J MOL BIOL, V398, P1, DOI 10.1016/j.jmb.2010.02.036; Bylund GO, 1998, J BACTERIOL, V180, P73, DOI 10.1128/JB.180.1.73-82.1998; CHAMPNEY WS, 1977, MOL GEN GENET, V152, P259, DOI 10.1007/BF00693079; Chang J, 2008, FEMS IMMUNOL MED MIC, V53, P26, DOI 10.1111/j.1574-695X.2008.00394.x; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cowtan K, 1999, ACTA CRYSTALLOGR D, V55, P1555, DOI 10.1107/S0907444999007416; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; DeLano W. L., 2015, PYMOL MOL GRAPH SYST; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Kerrien S, 2012, NUCLEIC ACIDS RES, V40, pD841, DOI 10.1093/nar/gkr1088; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neidhardt FC, 1990, PHYSL BACTERIAL CELL, P520; Ness SR, 2004, STRUCTURE, V12, P1753, DOI 10.1016/j.str.2004.07.018; NIERHAUS KH, 1974, P NATL ACAD SCI USA, V71, P4713, DOI 10.1073/pnas.71.12.4713; Nord S, 2009, J MOL BIOL, V386, P742, DOI 10.1016/j.jmb.2008.12.076; Sashital DG, 2014, ELIFE, V3, DOI 10.7554/eLife.04491; van Kessel JC, 2007, NAT METHODS, V4, P147, DOI 10.1038/nmeth996; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; World Health Organization (WHO), 2016, WHO GLOB TUB REP 201; Yu LP, 2001, J MOL BIOL, V311, P593, DOI 10.1006/jmbi.2001.4894	22	10	10	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2019	294	1					372	378		10.1074/jbc.RA118.002298	http://dx.doi.org/10.1074/jbc.RA118.002298			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG6PT	30409901	Green Published, hybrid			2022-12-28	WOS:000455105500038
J	Cuypers, MG; Subramanian, C; Gullett, JM; Frank, MW; White, SW; Rock, CO				Cuypers, Maxime G.; Subramanian, Chitra; Gullett, Jessica M.; Frank, Matthew W.; White, Stephen W.; Rock, Charles O.			Acyl-chain selectivity and physiological roles of Staphylococcus aureus fatty acid-binding proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane lipid; fatty acid binding protein; Staphylococcus aureus (S; aureus); X-ray crystallography; fatty acid metabolism; acyl-phosphate; fatty acid kinase; membrane phospholipid; nutrient acquisition	KINASE; IDENTIFICATION	Fatty acid (FA) kinase produces acyl-phosphate for the synthesis of membrane phospholipids in Gram-positive bacterial pathogens. FA kinase consists of a kinase protein (FakA) that phosphorylates an FA substrate bound to a second module, an FA-binding protein (FakB). Staphylococcus aureus expresses two distinct, but related, FakBs with different FA selectivities. Here, we report the structures of FakB1 bound to four saturated FAs at 1.6-1.93 resolution. We observed that the different FA structures are accommodated within a slightly curved hydrophobic cavity whose length is governed by the conformation of an isoleucine side chain at the end of the tunnel. The hydrophobic tunnel in FakB1 prevents the binding of cis-unsaturated FAs, which are instead accommodated by the kinked tunnel within the FakB2 protein. The differences in the FakB interiors are not propagated to the proteins' surfaces, preserving the protein-protein interactions with their three common partners, FakA, PlsX, and PlsY. Using cellular thermal shift analyses, we found that FakB1 binds FA in vivo, whereas a significant proportion of FakB2 does not. Incorporation of exogenous FA into phospholipid in fakB1 and fakB2 S. aureus knockout strains revealed that FakB1 does not efficiently activate unsaturated FAs. FakB2 preferred unsaturated FAs, but also allowed the incorporation of saturated FAs. These results are consistent with a model in which FakB1 primarily functions in the recycling of the saturated FAs produced by S. aureus metabolism, whereas FakB2 activates host-derived oleate, which S. aureus does not produce but is abundant at infection sites.	[Cuypers, Maxime G.; White, Stephen W.] St Jude Childrens Res Hosp, Dept Struct Biol, 262 Danny Thomas Pl, Memphis, TN 38105 USA; [Subramanian, Chitra; Gullett, Jessica M.; Frank, Matthew W.; Rock, Charles O.] St Jude Childrens Res Hosp, Dept Infect Dis, 262 Danny Thomas Pl, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	Rock, CO (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	charles.rock@stjude.org	Cuypers, Maxime G./R-7475-2019; White, Stephen W/N-8164-2018; Subramanian, Chitra/N-9210-2018; Rock, Charles/N-2256-2018	Cuypers, Maxime G./0000-0002-8826-2317; Subramanian, Chitra/0000-0003-1101-5307; Rock, Charles/0000-0001-8648-4189	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034496] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Tyler Broussard for obtaining the initial crystals of FakB1(16:0); Megan Ericson for input at the beginning of the project; Caroline Pate for CETSA experiments; Katie Wells for biochemical assays; and Karen Miller for protein purification and FA analysis. The X-ray diffraction data were collected at APS beamline SER-CAT ID-22 and BM-22. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. W-31-109-Eng-38.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bose JL, 2014, INFECT IMMUN, V82, P1813, DOI 10.1128/IAI.01655-13; Broussard TC, 2016, J BIOL CHEM, V291, P6292, DOI 10.1074/jbc.M115.706820; D'Elia MA, 2006, J BACTERIOL, V188, P4183, DOI 10.1128/JB.00197-06; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ericson ME, 2017, MBIO, V8, DOI 10.1128/mBio.00988-17; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fey PD, 2013, MBIO, V4, DOI 10.1128/mBio.00537-12; Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17; Hauff S, 2010, J CHROMATOGR A, V1217, P1683, DOI 10.1016/j.chroma.2010.01.036; Jafari R, 2014, NAT PROTOC, V9, P2100, DOI 10.1038/nprot.2014.138; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kinch LN, 2005, PROTEIN SCI, V14, P360, DOI 10.1110/ps.041114805; Li M, 2009, ANTIMICROB AGENTS CH, V53, P4200, DOI 10.1128/AAC.00428-09; Lu YJ, 2006, MOL CELL, V23, P765, DOI 10.1016/j.molcel.2006.06.030; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Molina DM, 2013, SCIENCE, V341, P84, DOI 10.1126/science.1233606; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nan J, 2009, ACTA CRYSTALLOGR D, V65, P440, DOI 10.1107/S0907444909007756; Parsons JB, 2014, P NATL ACAD SCI USA, V111, P10532, DOI 10.1073/pnas.1408797111; Parsons JB, 2014, MOL MICROBIOL, V92, P234, DOI 10.1111/mmi.12556; Sabirova JS, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1956-8; Schulze-Gahmen U, 2003, PROTEINS, V50, P526, DOI 10.1002/prot.10305; Storch J, 2008, ANNU REV NUTR, V28, P73, DOI 10.1146/annurev.nutr.27.061406.093710; Storch J, 2009, J LIPID RES, V50, pS126, DOI 10.1194/jlr.R800084-JLR200; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	28	15	15	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2019	294	1					38	49		10.1074/jbc.RA118.006160	http://dx.doi.org/10.1074/jbc.RA118.006160			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG6PT	30429218	Green Published, hybrid			2022-12-28	WOS:000455105500005
J	Moore, KS; 't Hoen, PAC				Moore, Kat S.; 't Hoen, Peter A. C.			Computational approaches for the analysis of RNA-protein interactions: A primer for biologists	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						RNA-protein interaction; RNA-binding protein; translation control; computational biology; statistics; next generation sequencing; RNA-seq	HIDDEN MARKOV-MODELS; BINDING PROTEIN; SEQUENCE; PREDICTION; SITES; SELECTION; CLIP	RNA-binding proteins (RBPs) play important roles in the control of gene expression and the coordination of different layers of post-transcriptional regulation. Interactions between certain RBPs and mRNA transcripts are notoriously difficult to predict, as any given protein-RNA interaction may rely not only on RNA sequence, but also on three-dimensional RNA structures, competitive inhibition from other RBPs, and input from cellular signaling pathways. Advanced and high-throughput technologies for the identification of RNA-protein interactions have come to the rescue, but the identification of binding sites and downstream functional effects of RBPs from the resulting data can be challenging. In this review, we discuss statistical inference and machine-learning approaches and tools relevant for the study of RBPs and the analysis of large-scale RNA-protein interaction datasets. This primer is intended for life scientists who are interested in incorporating these tools into their own research. We begin with the demystification of regression models, as used in the analysis of next-generation sequencing data, and progress to a discussion of Hidden Markov Models, which are of particular value in analyzing cross-linking followed by immunoprecipitation data. We then continue with examples of machine learning techniques, such as support vector machines and gradient tree boosting. We close with a brief discussion of current trends in the field, including deep learning architectures.	[Moore, Kat S.] Sanquin, Dept Hematopoiesis, NL-1066 CX Amsterdam, Netherlands; [Moore, Kat S.] UvA, AMC, Landsteiner Lab, NL-1066 CX Amsterdam, Netherlands; ['t Hoen, Peter A. C.] Radboud Univ Nijmegen Med Ctr, Radboud Inst Mol Life Sci, Ctr Mol & Biomol Informat, Rte 260,POB 9101, NL-6500 HB Nijmegen, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Radboud University Nijmegen	't Hoen, PAC (corresponding author), Radboud Univ Nijmegen Med Ctr, Radboud Inst Mol Life Sci, Ctr Mol & Biomol Informat, Rte 260,POB 9101, NL-6500 HB Nijmegen, Netherlands.	peter-bram.thoen@radboudumc.nl	Hoen, Peter A 't/D-3950-2018	Hoen, Peter A 't/0000-0003-4450-3112; Moore, Kat/0000-0002-5746-4098				Abdi H, 2010, WIRES COMPUT STAT, V2, P433, DOI 10.1002/wics.101; ALTMAN NS, 1992, AM STAT, V46, P175, DOI 10.2307/2685209; [Anonymous], 1993, CLASSIFICATION REGRE; [Anonymous], 2001, REGRESSION MODELING; Baird SD, 2006, RNA, V12, P1755, DOI 10.1261/rna.157806; Baldi P., 2013, ADV NEURAL INFORM PR, VVolume 2; Breiman L., 1993, CLASSIFICATION REGRE, p[18, 18]; Burger K, 2013, RNA BIOL, V10, P1623, DOI 10.4161/rna.26214; Cao CS, 2018, GENOM PROTEOM BIOINF, V16, P17, DOI 10.1016/j.gpb.2017.07.003; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; de Boer E, 2003, P NATL ACAD SCI USA, V100, P7480, DOI 10.1073/pnas.1332608100; Everitt BS., 2010, CAMBRIDGE DICT STAT; Freedman D.A., 2009, STAT MODELS THEORY P; Friedersdorf MB, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r2; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Han A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003442; Harrell F. E., 2001, REGRESSION MODELING, P94; Hastie T., 2009, SPRINGER SERIES STAT, DOI 10.1007/978-0-387-84858-7; Hawkins DM, 2004, J CHEM INF COMP SCI, V44, P1, DOI 10.1021/ci0342472; He Aibin, 2010, Curr Protoc Mol Biol, VChapter 21, DOI 10.1002/0471142727.mb2120s92; Heller D, 2017, NUCLEIC ACIDS RES, V45, P11004, DOI 10.1093/nar/gkx756; Hong JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079288; Johnson CP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178189; Konig J, 2010, NAT STRUCT MOL BIOL, V17, P909, DOI 10.1038/nsmb.1838; Kolekar P, 2016, SCI REP-UK, V6, DOI 10.1038/srep27436; Lambert N, 2014, MOL CELL, V54, P887, DOI 10.1016/j.molcel.2014.04.016; Lewis BA, 2011, NUCLEIC ACIDS RES, V39, pD277, DOI 10.1093/nar/gkq1108; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; McLachlan G. J., 2004, ANAL MICROARRAY GENE, P213; Milek M, 2012, SEMIN CELL DEV BIOL, V23, P206, DOI 10.1016/j.semcdb.2011.12.001; Min S, 2017, BRIEF BIOINFORM, V18, P851, DOI 10.1093/bib/bbw068; MITCHELL T, 1989, ANNU REV COMPUT SCI, V4, P417; Moore KS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20518-7; Moore MJ, 2014, NAT PROTOC, V9, P263, DOI 10.1038/nprot.2014.012; Narayanan BC, 2014, NUCLEIC ACIDS RES, V42, pD114, DOI 10.1093/nar/gkt980; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Neuwald AF, 2000, NUCLEIC ACIDS RES, V28, P3570, DOI 10.1093/nar/28.18.3570; Neyman J., 1967, P 5 BERK S MATH STAT, P281; Nicholson CO, 2017, RNA, V23, P32, DOI 10.1261/rna.058115.116; Nishtala S, 2016, SCI REP-UK, V6, DOI 10.1038/srep25711; Noble WS, 2009, NAT BIOTECHNOL, V27, P1135, DOI 10.1038/nbt1209-1135; Pan XY, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4889-1; Raschka S., 2015, PYTHON MACHINE LEARN; Ray D, 2009, NAT BIOTECHNOL, V27, P667, DOI 10.1038/nbt.1550; Ren HZ, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0691-0; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robert Hecht-Nielsen, 1992, NEURAL NETWORKS PERC, P65, DOI DOI 10.1016/B978-0-12-741252-8.50010-8; Robinson D. J. S., 2003, AN INTRODUCTION TO A; Rokach L, 2010, ARTIF INTELL REV, V33, P1, DOI 10.1007/s10462-009-9124-7; Russell S. J., 2010, ARTIF INTELL, P694; Russell S. J., 2010, ARTIF INTELL, P727; Si JN, 2015, INT J MOL SCI, V16, P26303, DOI 10.3390/ijms161125952; Sugimoto Y, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r67; Suresh V, 2015, NUCLEIC ACIDS RES, V43, P1370, DOI 10.1093/nar/gkv020; Tang YJ, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1879-2; Thompson SR, 2012, TRENDS MICROBIOL, V20, P558, DOI 10.1016/j.tim.2012.08.002; Tibshirani R, 1997, STAT MED, V16, P385, DOI 10.1002/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Towfic F, 2010, INT J DATA MIN BIOIN, V4, P21, DOI 10.1504/IJDMB.2010.030965; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Wheeler EC, 2018, WIRES RNA, V9, DOI 10.1002/wrna.1436; Yoon BJ, 2009, CURR GENOMICS, V10, P402, DOI 10.2174/138920209789177575; Zhang S, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1025	64	9	9	0	27	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2019	294	1					1	9		10.1074/jbc.REV118.004842	http://dx.doi.org/10.1074/jbc.REV118.004842			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG6PT	30455357	Green Published, hybrid			2022-12-28	WOS:000455105500001
J	Yin, WJ; Song, Y; Chang, X				Yin, Weijie; Song, Yan; Chang, Xing			Single-cell RNA-Seq analysis identifies a noncoding interleukin 4 (IL-4) RNA that post-transcriptionally up-regulates IL-4 production in T helper cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytokine; post-transcriptional regulation; T helper cells; long noncoding RNA (long ncRNA; lncRNA); transcriptomics; adaptive immunity; alternative promoter; IL4; single-cell RNA-Seq; type 2 T helper cells	CYTOKINE GENE-EXPRESSION; TRANSCRIPTION FACTOR; FOLLICULAR-HELPER; TH2 CELLS; GENERATION; T(H)2; DIFFERENTIATION; ACCESSIBILITY; BIMODALITY; INSIGHTS	High-throughput sequencing has revealed a tremendous complexity of cellular transcriptomes, which is partly due to the generation of multiple alternative transcripts from a single gene locus. Because alternative transcripts often have low abundance in bulk cells, the functions of most of these transcripts and their relationship with their canonical counterparts remain unclear. Here we applied single-cell RNA-Seq to analyze the transcriptome complexity of in vitro-differentiated, murine type 2 T helper (Th2) cells. We found that cytokine gene transcripts contribute most of the intercellular heterogeneity, with a group of universal cytokines, including interleukins 1a, 2, 3, and 16, being bimodally expressed. At the single-cell level, use of alternative promoters prevalently generated alternative transcripts. For instance, although undetectable in bulk cells, a noncoding RNA isoform of IL-4 (IL4nc), which was driven by an intronic promoter in the IL-4 locus, was predominantly expressed in a subset of Th2 cells. IL4nc displayed distinct temporal expression patterns compared with the canonical IL-4 mRNA and post-transcriptionally promoted the production of IL-4 protein in Th2 cells. In conclusion, our findings reveal a mechanism whereby minor noncanonical transcripts post-transcriptionally regulate expression of their cognate canonical genes.	[Yin, Weijie; Chang, Xing] Chinese Acad Sci, Univ Chinese Acad Sci, Key Lab Tissue Microenvironm & Tumor, Shanghai Inst Nutr & Hlth,Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Song, Yan] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92037 USA	Chinese Academy of Sciences; Shanghai Institute of Nutrition & Health, CAS; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; University of California System; University of California San Diego	Chang, X (corresponding author), Chinese Acad Sci, Univ Chinese Acad Sci, Key Lab Tissue Microenvironm & Tumor, Shanghai Inst Nutr & Hlth,Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China.	changxing@sibs.ac.cn		Chang, Xing/0000-0002-5072-9225	Ministry of Science and Technology of the People's Republic of China [2014CB943600, 2018YFA0107500]; National Natural Science Foundation of China [31370858, 81671552]; Science and Technology Commission of Shanghai Municipality [17ZR449700]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by Grants 2014CB943600 and 2018YFA0107500 from the Ministry of Science and Technology of the People's Republic of China, Grants 31370858 and 81671552 from the National Natural Science Foundation of China, and Grant 17ZR449700 from the Science and Technology Commission of Shanghai Municipality. The authors declare that they have no conflicts of interest with the contents of this article.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Altan-Bonnet G, 2005, PLOS BIOL, V3, P1925, DOI 10.1371/journal.pbio.0030356; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Bancroft AJ, 2000, EUR J IMMUNOL, V30, P2083, DOI 10.1002/1521-4141(200007)30:7&lt;2083::AID-IMMU2083&gt;3.0.CO;2-3; Brennecke P, 2013, NAT METHODS, V10, P1093, DOI [10.1038/nmeth.2645, 10.1038/NMETH.2645]; Cech TR, 2014, CELL, V157, P77, DOI 10.1016/j.cell.2014.03.008; de Klerk E, 2015, TRENDS GENET, V31, P128, DOI 10.1016/j.tig.2015.01.001; Fu JD, 2013, STEM CELL REP, V1, P235, DOI 10.1016/j.stemcr.2013.07.005; Gribnau J, 2000, MOL CELL, V5, P377, DOI 10.1016/S1097-2765(00)80432-3; Guo LY, 2004, IMMUNITY, V20, P193, DOI 10.1016/S1074-7613(04)00025-1; Guo LY, 2002, P NATL ACAD SCI USA, V99, P10623, DOI 10.1073/pnas.162360199; Ho IC, 2002, CELL, V109, pS109, DOI 10.1016/S0092-8674(02)00705-5; Kang SA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003410; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Kubo M, 2017, ALLERGOL INT, V66, P377, DOI 10.1016/j.alit.2017.04.006; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; LEGROS G, 1990, J EXP MED, V172, P921, DOI 10.1084/jem.172.3.921; Li WB, 2016, NAT REV GENET, V17, P207, DOI 10.1038/nrg.2016.4; Licona-Limon P, 2013, NAT IMMUNOL, V14, P536, DOI 10.1038/ni.2617; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Mahata B, 2014, CELL REP, V7, P1130, DOI 10.1016/j.celrep.2014.04.011; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; NobenTrauth N, 1997, P NATL ACAD SCI USA, V94, P10838, DOI 10.1073/pnas.94.20.10838; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; OJEDA G, 1995, CELL IMMUNOL, V164, P265, DOI 10.1006/cimm.1995.1170; Onodera CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043511; Paul WE, 2015, CYTOKINE, V75, P3, DOI 10.1016/j.cyto.2015.01.038; Proserpio V, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0957-5; Quinn JJ, 2016, NAT REV GENET, V17, P47, DOI 10.1038/nrg.2015.10; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; SWAIN SL, 1990, J IMMUNOL, V145, P3796; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Tanaka S, 2011, NAT IMMUNOL, V12, P77, DOI 10.1038/ni.1966; Wang J, 2009, CANCER INFORM, V7, P199; Yamane H, 2005, J EXP MED, V202, P793, DOI 10.1084/jem.20051304; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhu JF, 2006, CELL RES, V16, P3, DOI 10.1038/sj.cr.7310002; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	41	2	2	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2019	294	1					290	298		10.1074/jbc.RA118.004111	http://dx.doi.org/10.1074/jbc.RA118.004111			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG6PT	30404921	Green Published, hybrid			2022-12-28	WOS:000455105500031
J	Adrian-Segarra, JM; Sreenivasan, K; Gajawada, P; Lorchner, H; Braun, T; Poling, J				Adrian-Segarra, Juan M.; Sreenivasan, Krishnamoorthy; Gajawada, Praveen; Loerchner, Holger; Braun, Thomas; Poeling, Jochen			The AB loop of oncostatin M (OSM) determines species-specific signaling in humans and mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; cytokine; signal transduction; STAT3; protein-protein interaction; LIFR; oncostatin M; OSM; OSMR	LEUKEMIA-INHIBITORY FACTOR; CILIARY NEUROTROPHIC FACTOR; FACTOR-RECEPTOR; CRYSTAL-STRUCTURE; TRANSDUCING RECEPTOR; FACTOR LIF; BINDING; MURINE; GENES; CELLS	The pleiotropic interleukin-6 (IL-6)-type cytokine oncostatin M (OSM) signals in multiple cell types, affecting processes such as cell differentiation, hematopoiesis, and inflammation. In humans, OSM exerts its effects through activation of either of two different heterodimeric receptor complexes, formed by glycoprotein 130 (gp130) and either OSM receptor (OSMR) or leukemia inhibitory factor receptor (LIFR). In contrast, the mouse OSM orthologue acts mainly through dimers containing OSMR and gp130 and shows limited activity through mouse LIFR. Despite their structural similarity, neither human nor mouse OSM signal through the other species' OSMR. The molecular basis for such species-specific signaling, however, remains poorly understood. To identify key molecular features of OSM that determine receptor activation in humans and mice, we generated chimeric mouse-human cytokines. Replacing regions within binding site III of murine OSM with the human equivalents showed that the cytokine's AB loop was critical for receptor selection. Substitutions of individual amino acids within this region demonstrated that residues Asn-37, Thr-40, and Asp-42 of the murine cytokine were responsible for limited LIFR activation and absence of human OSMR/LIFR signaling. In human OSM, Lys-44 appeared to be the main residue preventing mouse OSMR activation. Our data reveal that individual amino acids within the AB loop of OSM determine species-specific activities. These mutations might reflect a key step in the evolutionary process of this cytokine, in which receptor promiscuity gives way to ligand-receptor specialization.	[Adrian-Segarra, Juan M.; Sreenivasan, Krishnamoorthy; Gajawada, Praveen; Loerchner, Holger; Braun, Thomas; Poeling, Jochen] Max Planck Inst Heart & Lung Res, Dept Cardiac Dev & Remodeling, Ludwigstr 43, D-61231 Bad Nauheim, Germany; [Loerchner, Holger; Braun, Thomas; Poeling, Jochen] German Ctr Cardiovasc Res DZHK, Partner Site Rhein Main, Frankfurt, Germany	Max Planck Society; German Centre for Cardiovascular Research	Braun, T; Poling, J (corresponding author), Max Planck Inst Heart & Lung Res, Dept Cardiac Dev & Remodeling, Ludwigstr 43, D-61231 Bad Nauheim, Germany.; Braun, T; Poling, J (corresponding author), German Ctr Cardiovasc Res DZHK, Partner Site Rhein Main, Frankfurt, Germany.	thomas.braun@mpi-bn.mpg.de; jochen.poeling@mpi-bn.mpg.de	Braun, Thomas/B-2310-2008	Braun, Thomas/0000-0002-6165-4804; Sreenivasan, Krishnamoorthy/0000-0001-8771-5911; Adrian-Segarra, Juan M./0000-0002-3712-0554	Max Planck Society; Excellence Initiative "Cardiopulmonary System" (ECCPS); DFG collaborative research center Pulmonary Hypertension and Core Pulmonale Grants [5E61213, TP A02]; Foundation Leducq [3CVD01]; German Center for Cardiovascular Research; European Research Area Network on Cardiovascular Diseases Grant CLARIFY	Max Planck Society(Max Planck SocietyFoundation CELLEX); Excellence Initiative "Cardiopulmonary System" (ECCPS)(German Research Foundation (DFG)); DFG collaborative research center Pulmonary Hypertension and Core Pulmonale Grants; Foundation Leducq(Leducq Foundation); German Center for Cardiovascular Research; European Research Area Network on Cardiovascular Diseases Grant CLARIFY	This work was supported by the Max Planck Society; the Excellence Initiative "Cardiopulmonary System" (ECCPS); DFG collaborative research center Pulmonary Hypertension and Core Pulmonale Grants 5E61213, TP A02, and B02; Foundation Leducq Grant 3CVD01; the German Center for Cardiovascular Research; and European Research Area Network on Cardiovascular Diseases Grant CLARIFY. The authors declare that they have no conflicts of interest with the contents of this article.	Aakre CD, 2015, CELL, V163, P594, DOI 10.1016/j.cell.2015.09.055; Adrian-Segarra JM, 2018, J BIOL CHEM, V293, P7017, DOI 10.1074/jbc.RA118.001920; BAZAN JF, 1990, IMMUNOL TODAY, V11, P350, DOI 10.1016/0167-5699(90)90139-Z; Betts M.J., 2007, BIOINFORMATICS GENET, DOI [10.1002/9780470059180.ch13, DOI 10.1002/0470867302.CH14]; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Broxmeyer HE, 2007, EXP HEMATOL, V35, P78, DOI 10.1016/j.exphem.2007.01.028; Capra EJ, 2012, CELL, V150, P222, DOI 10.1016/j.cell.2012.05.033; Deller MC, 2000, STRUCT FOLD DES, V8, P863, DOI 10.1016/S0969-2126(00)00176-3; Derouet D, 2004, P NATL ACAD SCI USA, V101, P4827, DOI 10.1073/pnas.0306178101; Dillon SR, 2004, NAT IMMUNOL, V5, P752, DOI 10.1038/ni1084; Drechsler J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043155; Ehlers M, 1996, J INTERF CYTOK RES, V16, P569, DOI 10.1089/jir.1996.16.569; Elson GCA, 2000, NAT NEUROSCI, V3, P867, DOI 10.1038/78765; GEARING DP, 1992, SCIENCE, V255, P1434, DOI 10.1126/science.1542794; GIOVANNINI M, 1993, CYTOGENET CELL GENET, V64, P240, DOI 10.1159/000133586; Hanington PC, 2007, DEV COMP IMMUNOL, V31, P817, DOI 10.1016/j.dci.2006.12.001; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Helaers R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-379; Hermanns HM, 2015, CYTOKINE GROWTH F R, V26, P545, DOI 10.1016/j.cytogfr.2015.07.006; Hermanns HM, 1999, J IMMUNOL, V163, P6651; HIRANO T, 1985, P NATL ACAD SCI USA, V82, P5490, DOI 10.1073/pnas.82.16.5490; Hoover DM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e43; Ichihara M, 1997, BLOOD, V90, P165; IP NY, 1992, CELL, V69, P1121, DOI 10.1016/0092-8674(92)90634-O; JEFFERY E, 1993, CYTOKINE, V5, P107, DOI 10.1016/1043-4666(93)90048-A; Juan TSC, 2009, VET PATHOL, V46, P124, DOI 10.1354/vp.46-1-124; Kallen KJ, 1999, J BIOL CHEM, V274, P11859, DOI 10.1074/jbc.274.17.11859; KALLESTAD JC, 1991, J BIOL CHEM, V266, P8940; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; LAYTON MJ, 1994, J BIOL CHEM, V269, P29891; Lemmon AR, 2002, P NATL ACAD SCI USA, V99, P10516, DOI 10.1073/pnas.162224399; Lindberg RA, 1998, MOL CELL BIOL, V18, P3357, DOI 10.1128/MCB.18.6.3357; Liongue C, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-120; Maglott DR, 2000, NUCLEIC ACIDS RES, V28, P126, DOI 10.1093/nar/28.1.126; MCDONALD NQ, 1995, EMBO J, V14, P2689, DOI 10.1002/j.1460-2075.1995.tb07269.x; Milholland B, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15183; Mosley B, 1996, J BIOL CHEM, V271, P32635, DOI 10.1074/jbc.271.51.32635; Negoro S, 2001, CIRCULATION, V104, P979, DOI 10.1161/hc3401.095947; PENNICA D, 1995, J BIOL CHEM, V270, P10915, DOI 10.1074/jbc.270.18.10915; Pflanz S, 2004, J IMMUNOL, V172, P2225, DOI 10.4049/jimmunol.172.4.2225; Rappsilber J, 2000, ANAL CHEM, V72, P267, DOI 10.1021/ac991081o; Richards Carl D, 2013, ISRN Inflamm, V2013, P512103, DOI 10.1155/2013/512103; RICHARDS CD, 1993, J IMMUNOL, V150, P5596; ROBINSON RC, 1994, CELL, V77, P1101, DOI 10.1016/0092-8674(94)90449-9; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; ROSE TM, 1991, P NATL ACAD SCI USA, V88, P8641, DOI 10.1073/pnas.88.19.8641; ROSE TM, 1993, GENOMICS, V17, P136, DOI 10.1006/geno.1993.1294; SADOWSKI HB, 1993, SCIENCE, V261, P1739, DOI 10.1126/science.8397445; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; SHIELDS DC, 1995, CYTOKINE, V7, P679, DOI 10.1006/cyto.1995.0080; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Sreenivasan K, 2017, METHODS MOL BIOL, V1556, P343, DOI 10.1007/978-1-4939-6771-1_19; Varadarajan N, 2009, NAT PROTOC, V4, P893, DOI 10.1038/nprot.2009.60; Vasse M, 1999, ARTERIOSCL THROM VAS, V19, P1835, DOI 10.1161/01.ATV.19.8.1835; Vollmer S, 2009, HEPATOLOGY, V50, P253, DOI 10.1002/hep.22928; Walker EC, 2016, J BIOL CHEM, V291, P21703, DOI 10.1074/jbc.M116.748483; Walker EC, 2010, J CLIN INVEST, V120, P582, DOI 10.1172/JCI40568; Wang YP, 2000, J BIOL CHEM, V275, P25273, DOI 10.1074/jbc.M002296200; YIN TG, 1993, J IMMUNOL, V151, P2555; Zarrinpar A, 2003, NATURE, V426, P676, DOI 10.1038/nature02178	62	13	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					20181	20199		10.1074/jbc.RA118.004375	http://dx.doi.org/10.1074/jbc.RA118.004375			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30373773	Green Published, hybrid			2022-12-28	WOS:000454685900025
J	Nielsen, MI; Stegmayr, J; Grant, OC; Yang, Z; Nilsson, UJ; Boos, I; Carlsson, MC; Woods, RJ; Unverzagt, C; Leffler, H; Wandall, HH				Nielsen, Mathias Ingemann; Stegmayr, John; Grant, Oliver C.; Yang, Zhang; Nilsson, Ulf J.; Boos, Irene; Carlsson, Michael C.; Woods, Robert J.; Unverzagt, Carlo; Leffler, Hakon; Wandall, Hans H.			Galectin binding to cells and glycoproteins with genetically modified glycosylation reveals galectin-glycan specificities in a natural context	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						galectin; glycobiology; sialic acid; molecular genetics; carbohydrate-binding protein; glycoprotein; GalNAc; genetic engineering; glycan; LacNAc; glycation; glycolipid	HUMAN SERUM GLYCOPROTEINS; TERMINAL DOMAIN; HIGH-AFFINITY; N-GLYCANS; CHO-CELLS; LECTIN; RECOGNITION; APOPTOSIS; ADHESION; LIGANDS	Galectins compose a protein family defined by a conserved sequence motif conferring affinity for -galactose-containing glycans. Moreover, galectins gain higher affinity and fine-tune specificity by glycan interactions at sites adjacent to their -galactoside-binding site, as revealed by extensive testing against panels of purified glycans. However, in cells, galectins bind glycans on glycoproteins and glycolipids in the context of other cellular components, such as at the cell surface. Because of difficulties in characterizing natural cellular environments, we currently lack a detailed understanding of galectin-binding specificities in the cellular context. To address this challenge, we used a panel of genetically stable glycosylation mutated CHO cells that express defined glycans to evaluate the binding affinities of 10 different carbohydrate-recognition domains in galectins to N-glycans and mucin-type O-glycans. Using flow cytometry, we measured the cell-surface binding of the galectins. Moreover, we used fluorescence anisotropy to determine the galectin affinities to recombinant erythropoietin used as a reporter glycoprotein produced by the glycoengineered cells and to synthetic N-glycans with defined branch structures. We found that all galectins, apart from galectin-8N, require complex N-glycans for high-affinity binding. Galectin-8N targeted both N- and O-linked glycans with high affinity, preferring 2,3-sialylated N-acetyllactosamine (LacNAc) structures. Furthermore, we found that 2,3-sialylation suppresses high-affinity binding of select galectins, including galectin-2, -3, -4N, and -7. Structural modeling provided a basis for interpreting the observed binding preferences. These results underscore the power of a glycoengineered platform to dissect the glycan-binding specificities of carbohydrate-binding proteins.	[Nielsen, Mathias Ingemann; Yang, Zhang; Carlsson, Michael C.; Wandall, Hans H.] Univ Copenhagen, Copenhagen Ctr Glyc, Dept Cellular & Mol Med, Fac Hlth & Med Sci, DK-2200 Copenhagen N, Denmark; [Stegmayr, John; Carlsson, Michael C.; Leffler, Hakon] Lund Univ, Div Microbiol Immunol & Glycobiol MIG, Dept Lab Med, Fac Med, S-22100 Lund, Sweden; [Grant, Oliver C.; Woods, Robert J.] Univ Georgia, Complex Carbohydrate Res Ctr, Dept Biochem & Mol Biol, 220 Riverbend Rd, Athens, GA 30602 USA; [Nilsson, Ulf J.] Lund Univ, Ctr Anal & Synth, Dept Chem, S-22100 Lund, Sweden; [Boos, Irene; Unverzagt, Carlo] Univ Bayreuth, Bioorgan Chem, Gebaude NW 1, D-95440 Bayreuth, Germany	University of Copenhagen; Lund University; University System of Georgia; University of Georgia; Lund University; University of Bayreuth	Wandall, HH (corresponding author), Univ Copenhagen, Copenhagen Ctr Glyc, Dept Cellular & Mol Med, Fac Hlth & Med Sci, DK-2200 Copenhagen N, Denmark.	hhw@sund.ku.dk	Boos, Irene/K-3382-2015; Leffler, Hakon/A-2416-2019; Nilsson, Ulf J./L-3219-2014; Yang, Zhang/I-8934-2016	Boos, Irene/0000-0002-8244-4312; Nilsson, Ulf J./0000-0001-5815-9522; Stegmayr, John/0000-0002-8167-9259; Yang, Zhang/0000-0002-4756-5813; Carlsson, Michael/0000-0001-8567-2284; Wandall, Hans H./0000-0003-0240-9232; Woods, Robert/0000-0002-2400-6293; Grant, Oliver/0000-0003-4835-5161; Nielsen, Mathias Alexander Ingemann/0000-0002-6823-5354	European Research Council (ERC) [772735]; Danish Research Councils (Sapere Aude); Danish Research Council of Independent Research; Danish Research Councils for Strategic Research; Lundbeck Foundation; Agnes and Poul Friis Foundation; Vera og Carl Johan Michaelsens Legat; Danish National Research Foundation [DNRF 107]; University of Copenhagen [CDO2016]	European Research Council (ERC)(European Research Council (ERC)European Commission); Danish Research Councils (Sapere Aude); Danish Research Council of Independent Research; Danish Research Councils for Strategic Research; Lundbeck Foundation(Lundbeckfonden); Agnes and Poul Friis Foundation; Vera og Carl Johan Michaelsens Legat; Danish National Research Foundation(Danmarks Grundforskningsfond); University of Copenhagen	This work was in part supported by the European Research Council (ERC Consolidator Grant, EU project 772735), Danish Research Councils (Sapere Aude), the Danish Research Council of Independent Research, the Danish Research Councils for Strategic Research, Programme of Excellence 2016 Grant CDO2016 from the University of Copenhagen, The Lundbeck Foundation, Agnes and Poul Friis Foundation, Vera og Carl Johan Michaelsens Legat, and Danish National Research Foundation Grant DNRF 107. U. J. N. and H. L. are shareholders in Galecto Biotech, AB, a company that develops galectin inhibitors. H. H. W. is a shareholder and has a consultancy arrangement with Go-Therapeutics, who have provided consulting fees not related to this study.	Amano M, 2003, J BIOL CHEM, V278, P7469, DOI 10.1074/jbc.M209595200; Bohari MH, 2016, SCI REP-UK, V6, DOI 10.1038/srep39556; Brewer CF, 2002, GLYCOCONJUGATE J, V19, P459, DOI 10.1023/B:GLYC.0000014075.62724.d0; Bum-Erdene K, 2015, FEBS J, V282, P3348, DOI 10.1111/febs.13348; Carlsson MC, 2013, J BIOL CHEM, V288, P28398, DOI 10.1074/jbc.M113.487793; Carlsson MC, 2012, BBA-GEN SUBJECTS, V1820, P1366, DOI 10.1016/j.bbagen.2012.01.007; Carlsson MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026560; Carlsson S, 2007, GLYCOBIOLOGY, V17, P906, DOI 10.1093/glycob/cwm059; Carlsson S, 2007, GLYCOBIOLOGY, V17, P663, DOI 10.1093/glycob/cwm026; Cederfur C, 2008, GLYCOBIOLOGY, V18, P384, DOI 10.1093/glycob/cwn015; Chen WS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11302; Cooper D, 2012, ANN NY ACAD SCI, V1253, P181, DOI 10.1111/j.1749-6632.2011.06291.x; COOPER DNW, 1991, J CELL BIOL, V115, P1437, DOI 10.1083/jcb.115.5.1437; Croci DO, 2014, CELL, V156, P744, DOI 10.1016/j.cell.2014.01.043; Croset A, 2012, J BIOTECHNOL, V161, P336, DOI 10.1016/j.jbiotec.2012.06.038; Delacour D, 2007, TRAFFIC, V8, P379, DOI 10.1111/j.1600-0854.2007.00539.x; Delaine T, 2016, CHEMBIOCHEM, V17, P1759, DOI 10.1002/cbic.201600285; Duda K, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku251; Earl LA, 2010, J BIOL CHEM, V285, P2242, DOI 10.1074/jbc.M109.066191; Grant OC, 2016, GLYCOBIOLOGY, V26, P1027, DOI 10.1093/glycob/cww094; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ideo H, 2011, J BIOL CHEM, V286, P11346, DOI 10.1074/jbc.M110.195925; Johannes L, 2018, J CELL SCI, V131, DOI 10.1242/jcs.208884; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE, V3rd, P353; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Lee JH, 2001, J BIOL CHEM, V276, P13924, DOI 10.1074/jbc.M010046200; LEFFLER H, 1986, J BIOL CHEM, V261, P119; Leffler H, 2002, GLYCOCONJUGATE J, V19, P433, DOI 10.1023/B:GLYC.0000014072.34840.04; Leppanen A, 2005, J BIOL CHEM, V280, P5549, DOI 10.1074/jbc.m412019200; Lin YH, 2017, J BIOL CHEM, V292, P17845, DOI 10.1074/jbc.M117.802793; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Mehta-D'souza P, 2015, METHODS MOL BIOL, V1207, P105, DOI 10.1007/978-1-4939-1396-1_7; MERKLE RK, 1988, J BIOL CHEM, V263, P16143; Noll AJ, 2016, GLYCOBIOLOGY, V26, P655, DOI 10.1093/glycob/cww002; Patnaik SK, 2006, GLYCOBIOLOGY, V16, P305, DOI 10.1093/glycob/cwj063; PERILLO NL, 1995, NATURE, V378, P736, DOI 10.1038/378736a0; Perillo NL, 1998, J MOL MED, V76, P402, DOI 10.1007/s001090050232; Perillo NL, 1997, J EXP MED, V185, P1851, DOI 10.1084/jem.185.10.1851; Peterson K, 2018, J MED CHEM, V61, P1164, DOI 10.1021/acs.jmedchem.7b01626; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Rawley O., 2015, BLOOD, V118, P2234; Reticker-Flynn NE, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2128; Salomonsson E, 2010, BIOCHEMISTRY-US, V49, P9518, DOI 10.1021/bi1009584; Salomonsson E, 2010, J BIOL CHEM, V285, P35079, DOI 10.1074/jbc.M109.098160; Saravanan C, 2009, J CELL SCI, V122, P3684, DOI 10.1242/jcs.045674; Song XZ, 2009, CHEM BIOL, V16, P36, DOI 10.1016/j.chembiol.2008.11.004; Sorme P, 2005, J AM CHEM SOC, V127, P1737, DOI 10.1021/ja043475p; Sorme P, 2004, ANAL BIOCHEM, V334, P36, DOI 10.1016/j.ab.2004.06.042; STANLEY P, 1980, J CELL BIOL, V85, P60, DOI 10.1083/jcb.85.1.60; Stegmayr J, 2016, J BIOL CHEM, V291, P13318, DOI 10.1074/jbc.M116.721464; Stillman BN, 2006, J IMMUNOL, V176, P778, DOI 10.4049/jimmunol.176.2.778; Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200; Thiemann S, 2016, ANNU REV IMMUNOL, V34, P243, DOI 10.1146/annurev-immunol-041015-055402; Thode C, 2015, J INVEST DERMATOL, V135, P238, DOI 10.1038/jid.2014.284; Toscano MA, 2007, NAT IMMUNOL, V8, P825, DOI 10.1038/ni1482; Varki A., 2017, ESSENTIALS GLYCOBIOL, P469; Vasta GR, 2009, NAT REV MICROBIOL, V7, P424, DOI 10.1038/nrmicro2146; Vespa GNR, 1999, J IMMUNOL, V162, P799; WARNOCK DE, 1993, J BIOL CHEM, V268, P10145; WOO HJ, 1990, J BIOL CHEM, V265, P7097; Woods Group, 2005, GLYCAM WEB; Yang Ri-Yao, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000719; Yang Z, 2015, NAT BIOTECHNOL, V33, P842, DOI 10.1038/nbt.3280; ZHOU Q, 1990, ARCH BIOCHEM BIOPHYS, V281, P27, DOI 10.1016/0003-9861(90)90408-Q; Zhuo Y, 2008, J BIOL CHEM, V283, P22177, DOI 10.1074/jbc.M8000015200	67	38	39	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					20249	20262		10.1074/jbc.RA118.004636	http://dx.doi.org/10.1074/jbc.RA118.004636			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30385505	Green Published, hybrid			2022-12-28	WOS:000454685900030
J	Hudson, NO; Whitby, FG; Buck-Koehntop, BA				Hudson, Nicholas O.; Whitby, Frank G.; Buck-Koehntop, Bethany A.			Structural insights into methylated DNA recognition by the C-terminal zinc fingers of the DNA reader protein ZBTB38	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epigenetics; zinc finger; X-ray crystallography; DNA methylation; protein-DNA interaction; DNA reader; methyl-CpG binding protein; transcriptional regulation; zinc finger and BTB domain-containing protein	HISTONE DEACETYLASE; TRANSCRIPTIONAL REPRESSOR; CPG METHYLATION; BINDING; CIBZ; DISEASE; EPIGENOME; PROGRAM; COMPLEX; SYSTEM	Methyl-CpG-binding proteins (MBPs) are selective readers of DNA methylation that play an essential role in mediating cellular transcription processes in both normal and diseased cells. This physiological function of MBPs has generated significant interest in understanding the mechanisms by which these proteins read and interpret DNA methylation signals. Zinc finger and BTB domain-containing 38 (ZBTB38) represents one member of the zinc finger (ZF) family of MBPs. We recently demonstrated that the C-terminal ZFs of ZBTB38 exhibit methyl-selective DNA binding within the ((A/G)TmCG(G/A)(mC/T)(G/A)) context both in vitro and within cells. Here we report the crystal structure of the first four C-terminal ZBTB38 ZFs (ZFs 6-9) in complex with the previously identified methylated consensus sequence at 1.75 resolution. From the structure, methyl-selective binding is preferentially localized at the 5 mCpG site of the bound DNA, which is facilitated through a series of base-specific interactions from residues within the -helices of ZF7 and ZF8. ZF6 and ZF9 primarily stabilize ZF7 and ZF8 to facilitate the core base-specific interactions. Further structural and biochemical analyses, including solution NMR spectroscopy and electrophoretic mobility gel shift assays, revealed that the C-terminal ZFs of ZBTB38 utilize an alternative mode of mCpG recognition from the ZF MBPs structurally evaluated to date. Combined, these findings provide insight into the mechanism by which this ZF domain of ZBTB38 selectively recognizes methylated CpG sites and expands our understanding of how ZF-containing proteins can interpret this essential epigenetic mark.	[Hudson, Nicholas O.; Buck-Koehntop, Bethany A.] Univ Utah, Dept Chem, Salt Lake City, UT 84112 USA; [Whitby, Frank G.] Univ Utah, Dept Biochem, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Buck-Koehntop, BA (corresponding author), Univ Utah, Dept Chem, Salt Lake City, UT 84112 USA.	koehntop@chem.utah.edu	Buck-Koehntop, Bethany A./ABI-2583-2020		National Science Foundation [MCB-1715370]; Department of Energy Office of Biological and Environmental Research; NIGMS, National Institutes of Health [P41GM103393]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by MCB-1715370 from the National Science Foundation. The Stanford Synchrotron Radiation Lightsource Structural Molecular Biology Program is supported by the Department of Energy Office of Biological and Environmental Research and by NIGMS, National Institutes of Health (including P41GM103393). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allers J, 2001, J MOL BIOL, V311, P75, DOI 10.1006/jmbi.2001.4857; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Buck-Koehntop BA, 2013, EPIGENETICS-US, V8, P131, DOI 10.4161/epi.23632; Buck-Koehntop BA, 2012, P NATL ACAD SCI USA, V109, P15229, DOI 10.1073/pnas.1213726109; Buck-Koehntop BA, 2012, FEBS LETT, V586, P734, DOI 10.1016/j.febslet.2012.01.045; Cai YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033156; Defossez PA, 2011, PROG MOL BIOL TRANSL, V101, P377, DOI 10.1016/B978-0-12-387685-0.00012-3; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DEREWENDA ZS, 1995, J MOL BIOL, V252, P248, DOI 10.1006/jmbi.1995.0492; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Esteller M, 2005, ANNU REV PHARMACOL, V45, P629, DOI 10.1146/annurev.pharmtox.45.120403.095832; Filion GJP, 2006, MOL CELL BIOL, V26, P169, DOI 10.1128/MCB.26.1.169-181.2006; Fournier A, 2012, BRIEF FUNCT GENOMICS, V11, P251, DOI 10.1093/bfgp/elr040; Hashimoto H, 2017, MOL CELL, V66, P711, DOI 10.1016/j.molcel.2017.05.004; Hashimoto H, 2016, NUCLEIC ACIDS RES, V44, P10165, DOI 10.1093/nar/gkw766; Hashimoto H, 2014, GENE DEV, V28, P2304, DOI 10.1101/gad.250746.114; Horowitz S, 2012, J BIOL CHEM, V287, P41576, DOI 10.1074/jbc.R112.418574; Hu SH, 2013, ELIFE, V2, DOI 10.7554/eLife.00726; Jin ZL, 2018, GENES DIS, V5, P1, DOI 10.1016/j.gendis.2018.01.002; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Liu YW, 2014, NUCLEIC ACIDS RES, V42, P4859, DOI 10.1093/nar/gku134; Liu YW, 2013, TRENDS BIOCHEM SCI, V38, P177, DOI 10.1016/j.tibs.2012.12.005; Liu YW, 2012, GENE DEV, V26, P2374, DOI 10.1101/gad.202200.112; Lv J, 2012, NUCLEIC ACIDS RES, V40, pD1030, DOI 10.1093/nar/gkr1169; Mandel-Gutfreund Y, 1998, J MOL BIOL, V277, P1129, DOI 10.1006/jmbi.1998.1660; Miotto B, 2014, CELL REP, V7, P575, DOI 10.1016/j.celrep.2014.03.030; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Ng HH, 1999, NAT GENET, V23, P58, DOI 10.1038/12659; Nikolova EN, 2018, BIOCHEMISTRY-US, V57, P2109, DOI [10.1021/acs.biochem.8600065, 10.1021/acs.biochem.8b00065]; Nishii T, 2012, J BIOL CHEM, V287, P12417, DOI 10.1074/jbc.M111.333856; Oikawa Y, 2008, J BIOL CHEM, V283, P14242, DOI 10.1074/jbc.M802257200; Oikawa Y, 2011, CELL RES, V21, P1578, DOI 10.1038/cr.2011.90; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pozner A, 2018, J MOL BIOL, V430, P258, DOI 10.1016/j.jmb.2017.12.014; Ren R, 2018, CURR OPIN STRUC BIOL, V53, P88, DOI 10.1016/j.sbi.2018.06.004; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Sansom OJ, 2007, NAT CLIN PRACT ONCOL, V4, P305, DOI 10.1038/ncponc0812; Sasai N, 2005, GENES CELLS, V10, P871, DOI 10.1111/j.1365-2443.2005.00885.x; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Segal DJ, 2006, J MOL BIOL, V363, P405, DOI 10.1016/j.jmb.2006.08.016; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Weber A, 2008, EMBO J, V27, P1563, DOI 10.1038/emboj.2008.85; Xiong YC, 2017, NUCLEIC ACIDS RES, V45, pD888, DOI 10.1093/nar/gkw1123; Yesselman JD, 2015, PROTEINS, V83, P403, DOI 10.1002/prot.24724; Yin YM, 2017, SCIENCE, V356, DOI 10.1126/science.aaj2239; Yoon HG, 2003, MOL CELL, V12, P723, DOI 10.1016/j.molcel.2003.08.008; Zandarashvili L, 2015, FEBS LETT, V589, P1748, DOI 10.1016/j.febslet.2015.05.022; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Zhu H, 2016, NAT REV GENET, V17, P551, DOI 10.1038/nrg.2016.83; Zou XQ, 2012, NUCLEIC ACIDS RES, V40, P2747, DOI 10.1093/nar/gkr1057	57	12	12	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19835	19843		10.1074/jbc.RA118.005147	http://dx.doi.org/10.1074/jbc.RA118.005147			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30355731	Green Published, hybrid			2022-12-28	WOS:000454294900027
J	Turner, R; Brennan, SO; Ashby, LV; Dickerhof, N; Hamzah, MR; Pearson, JF; Stamp, LK; Kettle, AJ				Turner, Rufus; Brennan, Stephen O.; Ashby, Louisa V.; Dickerhof, Nina; Hamzah, Melanie R.; Pearson, John F.; Stamp, Lisa K.; Kettle, Anthony J.			Conjugation of urate-derived electrophiles to proteins during normal metabolism and inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						uric acid; oxidative stress; neutrophil; NADPH oxidase; myeloperoxidase; post-translational modification (PTM); biomarker; uratylation; protein adduct; lysine modification	URIC-ACID; RHEUMATOLOGY/EUROPEAN LEAGUE; CLASSIFICATION CRITERIA; LIPID-PEROXIDATION; OXIDATIVE STRESS; AMERICAN-COLLEGE; REDOX REACTIONS; FREE-RADICALS; MYELOPEROXIDASE; ANTIOXIDANT	Urate is often viewed as an antioxidant. Here, we present an alternative perspective by showing that, when oxidized, urate propagates oxidative stress. Oxidation converts urate to the urate radical and the electrophilic products dehydrourate, 5-hydroxyisourate, and urate hydroperoxide, which eventually break down to allantoin. We investigated whether urate-derived electrophiles are intercepted by nucleophilic amino acid residues to form stable adducts on proteins. When urate was oxidized in the presence of various peptides and proteins, two adducts derived from urate (M-r 167 Da) were detected and had mass additions of 140 and 166 Da, occurring mainly on lysine residues and N-terminal amines. The adduct with a 140-Da mass addition was detected more frequently and was stable. Dehydrourate (M-r 166 Da) also formed transient adducts with cysteine residues. Urate-derived adducts were detected on human serum albumin in plasma of healthy donors. Basal adduct levels increased when neutrophils were added to plasma and stimulated, and relied on the NADPH oxidase, myeloperoxidase, hydrogen peroxide, and superoxide. Adducts of oxidized urate on serum albumin were elevated in plasma and synovial fluid from individuals with gout and rheumatoid arthritis. We propose that rather than acting as an antioxidant, urate's conversion to electrophiles contributes to oxidative stress. The addition of urate-derived electrophiles to nucleophilic amino acid residues, a process we call oxidative uratylation, will leave a footprint on proteins that could alter their function when critical sites are modified.	[Turner, Rufus; Ashby, Louisa V.; Dickerhof, Nina; Hamzah, Melanie R.; Kettle, Anthony J.] Univ Otago Christchurch, Ctr Free Radical Res, POB 4345, Christchurch 8011, New Zealand; [Turner, Rufus; Brennan, Stephen O.; Ashby, Louisa V.; Dickerhof, Nina; Hamzah, Melanie R.; Kettle, Anthony J.] Univ Otago Christchurch, Dept Pathol & Biomed Sci, POB 4345, Christchurch 8011, New Zealand; [Pearson, John F.] Univ Otago Christchurch, Biostat & Computat Biol Unit, POB 4345, Christchurch 8011, New Zealand; [Stamp, Lisa K.] Univ Otago Christchurch, Dept Med, POB 4345, Christchurch 8011, New Zealand	University of Otago; University of Otago; University of Otago; University of Otago	Kettle, AJ (corresponding author), Univ Otago Christchurch, Ctr Free Radical Res, POB 4345, Christchurch 8011, New Zealand.; Kettle, AJ (corresponding author), Univ Otago Christchurch, Dept Pathol & Biomed Sci, POB 4345, Christchurch 8011, New Zealand.	tony.kettle@otago.ac.nz	Brennan, Stephen/AAW-9929-2020; Ashby, Louisa/GRN-9388-2022	Ashby, Louisa/0000-0001-8247-096X; Kettle, Tony/0000-0002-8218-7766; Dickerhof, Nina/0000-0003-2269-4595	Manatu Hauora Health Research Council of New Zealand	Manatu Hauora Health Research Council of New Zealand	This work was supported by grants from the Manatu Hauora Health Research Council of New Zealand. The authors declare that they have no conflicts of interest with the contents of this article.	ALLISON WS, 1964, J BIOL CHEM, V239, P2140; AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; ARUOMA OI, 1989, FEBS LETT, V244, P76, DOI 10.1016/0014-5793(89)81166-4; Ashby MT, 2008, J DENT RES, V87, P900, DOI 10.1177/154405910808701003; BECKER BF, 1993, FREE RADICAL BIO MED, V14, P615, DOI 10.1016/0891-5849(93)90143-I; BEERS RF, 1952, J BIOL CHEM, V195, P133; Brennan SO, 2016, CLIN CHIM ACTA, V457, P125, DOI 10.1016/j.cca.2016.04.014; BUETTNER GR, 1993, ARCH BIOCHEM BIOPHYS, V300, P535, DOI 10.1006/abbi.1993.1074; Cantu-Medellin N, 2013, REDOX BIOL, V1, P353, DOI 10.1016/j.redox.2013.05.002; Carvalho LAC, 2017, J BIOL CHEM, V292, P8705, DOI 10.1074/jbc.M116.767657; CROW JP, 1995, BIOCHEMISTRY-US, V34, P3544, DOI 10.1021/bi00011a008; Dickerhof N, 2017, J CYST FIBROS, V16, P214, DOI 10.1016/j.jcf.2016.10.012; Domazou AS, 2012, FREE RADICAL BIO MED, V52, P1929, DOI 10.1016/j.freeradbiomed.2012.02.045; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; FREI B, 1989, P NATL ACAD SCI USA, V86, P6377, DOI 10.1073/pnas.86.16.6377; FREI B, 1988, P NATL ACAD SCI USA, V85, P9748, DOI 10.1073/pnas.85.24.9748; Fridovich I., 1985, HDB METHODS OXYGEN R, P51; Gersch C, 2009, NUCLEOS NUCLEOT NUCL, V28, P118, DOI 10.1080/15257770902736400; Kahn K, 1998, BIOCHEMISTRY-US, V37, P11651, DOI 10.1021/bi980446g; Kanbay M, 2016, EUR J INTERN MED, V29, P3, DOI 10.1016/j.ejim.2015.11.026; Kand'ar R, 2011, J CHROMATOGR B, V879, P2834, DOI 10.1016/j.jchromb.2011.08.007; KETTLE AJ, 1992, J BIOL CHEM, V267, P8319; Kettle AJ, 1997, REDOX REP, V3, P3, DOI 10.1080/13510002.1997.11747085; Kettle AJ, 2007, BIOCHEMISTRY-US, V46, P4888, DOI 10.1021/bi602587k; Kettle AJ, 2016, RSC METALLOBIO SER, V4, P272; Kettle AJ, 2011, FREE RADICAL BIO MED, V51, P2190, DOI 10.1016/j.freeradbiomed.2011.09.019; KITTRIDGE KJ, 1984, FEBS LETT, V170, P162, DOI 10.1016/0014-5793(84)81391-5; Li M, 2016, SCI REP-UK, V6, DOI 10.1038/srep19520; Li X, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2376; MAPLES KR, 1988, J BIOL CHEM, V263, P1709; Meotti FC, 2011, J BIOL CHEM, V286, P12901, DOI 10.1074/jbc.M110.172460; Neogi T, 2015, ARTHRITIS RHEUMATOL, V67, P2557, DOI 10.1002/art.39254; Neogi T, 2010, ARTHRITIS RHEUM-US, V62, P2582, DOI 10.1002/art.27580; Paganoni S, 2017, NEUROTHERAPEUTICS, V14, P148, DOI 10.1007/s13311-016-0497-4; Patricio ES, 2015, CHEM RES TOXICOL, V28, P1556, DOI 10.1021/acs.chemrestox.5b00132; Peskin AV, 2006, FREE RADICAL BIO MED, V40, P45, DOI 10.1016/j.freeradbiomed.2005.08.019; Ramazzina I, 2006, NAT CHEM BIOL, V2, P144, DOI 10.1038/nchembio768; Santos CXC, 1999, ARCH BIOCHEM BIOPHYS, V372, P285, DOI 10.1006/abbi.1999.1491; Santus R, 2001, FREE RADICAL RES, V35, P129, DOI 10.1080/10715760100300671; Sautin YY, 2008, NUCLEOS NUCLEOT NUCL, V27, P608, DOI 10.1080/15257770802138558; Seet RCS, 2011, STROKE, V42, P2326, DOI 10.1161/STROKEAHA.111.618835; SEGAL AW, 1980, J CELL BIOL, V85, P42, DOI 10.1083/jcb.85.1.42; Seidel A, 2014, J BIOL CHEM, V289, P21937, DOI 10.1074/jbc.M113.544957; SIMIC MG, 1989, J AM CHEM SOC, V111, P5778, DOI 10.1021/ja00197a042; Soltani Z, 2013, CURR HYPERTENS REP, V15, P175, DOI 10.1007/s11906-013-0344-5; Stamp LK, 2014, RHEUMATOLOGY, V53, P1958, DOI 10.1093/rheumatology/keu218; Stamp LK, 2012, RHEUMATOLOGY, V51, P1796, DOI 10.1093/rheumatology/kes193; Stevenson WS, 2010, P NATL ACAD SCI USA, V107, P16625, DOI 10.1073/pnas.1010390107; Tiden AK, 2011, J BIOL CHEM, V286, P37578, DOI 10.1074/jbc.M111.266981; Tipton PA, 2006, NAT CHEM BIOL, V2, P124, DOI 10.1038/nchembio0306-124; Turner R, 2012, J CHROMATOGR B, V891, P85, DOI 10.1016/j.jchromb.2012.02.009; VOLK KJ, 1989, ANAL CHEM, V61, P1709, DOI 10.1021/ac00190a024; VOLK KJ, 1990, J PHARMACEUT BIOMED, V8, P205, DOI 10.1016/0731-7085(90)80028-N; WILLSON RL, 1985, PHILOS T R SOC B, V311, P545, DOI 10.1098/rstb.1985.0163; WINTERBOURN CC, 1985, BIOCHIM BIOPHYS ACTA, V840, P204, DOI 10.1016/0304-4165(85)90120-5; WOLFF SP, 1994, METHOD ENZYMOL, V233, P182; Ximenes VF, 2005, J BIOL CHEM, V280, P38160, DOI 10.1074/jbc.M506384200; Yakubenko VP, 2018, BLOOD, V132, P78, DOI 10.1182/blood-2017-10-810176	58	7	7	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19886	19898		10.1074/jbc.RA118.005237	http://dx.doi.org/10.1074/jbc.RA118.005237			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30385504	hybrid, Green Published			2022-12-28	WOS:000454294900032
J	Wang, L; Wang, QM; Wang, YR; Xi, XG; Hou, XM				Wang, Lei; Wang, Qing-Man; Wang, Yi-Ran; Xi, Xu-Guang; Hou, Xi-Miao			DNA-unwinding activity of Saccharomyces cerevisiae Pif1 is modulated by thermal stability, folding conformation, and loop lengths of G-quadruplex DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELICASE; INSTABILITY; MECHANISM; LONG	G-quadruplexes (G4s) are four-stranded DNA structures formed by Hoogsteen base pairing between stacked sets of four guanines. Pif1 helicase plays critical roles in suppressing genomic instability in the yeast Saccharomyces cerevisiae by resolving G4s. However, the structural properties of G4s in S. cerevisiae and the substrate preference of Pif1 for different G4s remain unknown. Here, using CD spectroscopy and 83 G4 motifs from S. cerevisiae ranging in length from 30 to 60 nucleotides, we first show that G4 structures can be formed with a broad range of loop sizes in vitro and that a parallel conformation is favored. Using single-molecule FRET analysis, we then systematically addressed Pif1-mediated unwinding of various G4s and found that Pif1 is sensitive to G4 stability. Moreover, Pif1 preferentially unfolded antiparallel G4s rather than parallel G4s having similar stability. Furthermore, our results indicate that most G4 structures in S. cerevisiae sequences have long loops and can be efficiently unfolded by Pif1 because of their low stability. However, we also found that G4 structures with short loops can be barely unfolded. This study highlights the formidable capability of Pif1 to resolve the majority of G4s in S. cerevisiae sequences, narrows the fractions of G4s that may be challenging for genomic stability, and provides a framework for understanding the influence of different G4s on genomic stability via their processing by Pif1.	[Wang, Lei; Wang, Qing-Man; Wang, Yi-Ran; Xi, Xu-Guang; Hou, Xi-Miao] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling 712100, Shaanxi, Peoples R China; [Wang, Lei; Wang, Qing-Man; Wang, Yi-Ran; Xi, Xu-Guang; Hou, Xi-Miao] Northwest A&F Univ, Coll Life Sci, Yangling 712100, Shaanxi, Peoples R China; [Xi, Xu-Guang] Ecole Normale Super, CNRS, Lab Biol & Pharmacol Appl, 61 Ave President Wilson, F-94235 Cachan, France	Northwest A&F University - China; Northwest A&F University - China; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Hou, XM (corresponding author), Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling 712100, Shaanxi, Peoples R China.; Hou, XM (corresponding author), Northwest A&F Univ, Coll Life Sci, Yangling 712100, Shaanxi, Peoples R China.	houximiao@nwsuaf.edu.cn	wang, yi/GVT-8516-2022; Wang, Yijun/GXW-1763-2022; Hou, Ximiao/P-2542-2017; Wang, Yixuan/GZK-6559-2022; Hou, Xi-Miao/AAA-7919-2021; Xi, Xu Guang/AAK-4511-2020; wang, yixuan/GXW-2866-2022; Wang, Yin/HCI-9352-2022	Hou, Ximiao/0000-0003-3499-443X	Chinese Universities Scientific Fund Grant [Z109021718]; National Natural Science Foundation of China [11574252]	Chinese Universities Scientific Fund Grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Chinese Universities Scientific Fund Grant Z109021718 and National Natural Science Foundation of China Grant 11574252. The authors declare that they have no conflicts of interest with the contents of this article.	Ambrus A, 2006, NUCLEIC ACIDS RES, V34, P2723, DOI 10.1093/nar/gkl348; Barranco-Medina S, 2010, BIOCHEMISTRY-US, V49, P8445, DOI 10.1021/bi100984j; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296; Bochman ML, 2010, DNA REPAIR, V9, P237, DOI 10.1016/j.dnarep.2010.01.008; Boule JB, 2007, NUCLEIC ACIDS RES, V35, P5809, DOI 10.1093/nar/gkm613; Boule JB, 2006, NUCLEIC ACIDS RES, V34, P4147, DOI 10.1093/nar/gkl561; Bugaut A, 2008, BIOCHEMISTRY-US, V47, P689, DOI 10.1021/bi701873c; Byrd AK, 2017, BIOCHEM SOC T, V45, P1159, DOI 10.1042/BST20170096; Byrd AK, 2015, J BIOL CHEM, V290, P6482, DOI 10.1074/jbc.M114.630749; Capra JA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000861; Chambers VS, 2015, NAT BIOTECHNOL, V33, P877, DOI 10.1038/nbt.3295; Cheng X, 2007, MITOCHONDRION, V7, P211, DOI 10.1016/j.mito.2006.11.023; Chung WH, 2014, J MICROBIOL, V52, P89, DOI 10.1007/s12275-014-3524-3; De Cian A, 2007, METHODS, V42, P183, DOI 10.1016/j.ymeth.2006.10.004; del Villar-Guerra R, 2018, ANGEW CHEM INT EDIT, V57, P7171, DOI 10.1002/anie.201709184; Dou SX, 2004, J BIOL CHEM, V279, P6354, DOI 10.1074/jbc.M311272200; Guedin A, 2010, NUCLEIC ACIDS RES, V38, P7858, DOI 10.1093/nar/gkq639; Hazel P, 2004, J AM CHEM SOC, V126, P16405, DOI 10.1021/ja045154j; Hershman SG, 2008, NUCLEIC ACIDS RES, V36, P144, DOI 10.1093/nar/gkm986; Hou XM, 2017, NUCLEIC ACIDS RES, V45, P11401, DOI 10.1093/nar/gkx766; Hou XM, 2015, BIOCHEM J, V466, P189, DOI 10.1042/BJ20140997; Lane AN, 2008, NUCLEIC ACIDS RES, V36, P5482, DOI 10.1093/nar/gkn517; Lim KW, 2009, J AM CHEM SOC, V131, P4301, DOI 10.1021/ja807503g; Lu KY, 2018, NUCLEIC ACIDS RES, V46, P1486, DOI 10.1093/nar/gkx1217; Masiero S, 2010, ORG BIOMOL CHEM, V8, P2683, DOI 10.1039/c003428b; Mendoza O, 2016, NUCLEIC ACIDS RES, V44, P1989, DOI 10.1093/nar/gkw079; Mendoza O, 2015, NUCLEIC ACIDS RES, V43, pE71, DOI 10.1093/nar/gkv193; Murat P, 2014, CURR OPIN GENET DEV, V25, P22, DOI 10.1016/j.gde.2013.10.012; Paeschke K, 2013, NATURE, V497, P458, DOI 10.1038/nature12149; Paeschke K, 2011, CELL, V145, P678, DOI 10.1016/j.cell.2011.04.015; Piazza A, 2015, EMBO J, V34, P1718, DOI 10.15252/embj.201490702; Piazza A, 2010, NUCLEIC ACIDS RES, V38, P4337, DOI 10.1093/nar/gkq136; Rachwal PA, 2007, NUCLEIC ACIDS RES, V35, P4214, DOI 10.1093/nar/gkm316; Ramanagoudr-Bhojappa R, 2013, J BIOL CHEM, V288, P16185, DOI 10.1074/jbc.M113.470013; Ribeyre C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000475; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Sauer M, 2017, BIOCHEM SOC T, V45, P1173, DOI 10.1042/BST20170097; Tippana R, 2016, P NATL ACAD SCI USA, V113, P8448, DOI 10.1073/pnas.1603724113; Ying LM, 2003, P NATL ACAD SCI USA, V100, P14629, DOI 10.1073/pnas.2433350100; Zhang B, 2016, NUCLEIC ACIDS RES, V44, P8385, DOI 10.1093/nar/gkw669; Zhou RB, 2014, ELIFE, V3, DOI 10.7554/eLife.02190	42	22	23	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2018	293	48					18504	18513		10.1074/jbc.RA118.005071	http://dx.doi.org/10.1074/jbc.RA118.005071			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NX	30305390	hybrid, Green Published			2022-12-28	WOS:000458467300008
J	Pietrocola, G; Nobile, G; Alfeo, MJ; Foster, TJ; Geoghegan, JA; De Filippis, V; Speziale, P				Pietrocola, Giampiero; Nobile, Giulia; Alfeo, Mariangela J.; Foster, Timothy J.; Geoghegan, Joan A.; De Filippis, Vincenzo; Speziale, Pietro			Fibronectin-binding protein B (FnBPB) from Staphylococcus aureus protects against the antimicrobial activity of histones	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Staphylococcus aureus (S; aureus); histone; plasminogen; innate immunity; cell surface protein; virulence factor; methicillin-resistant Staphylococcus aureus (MRSA); adhesin; extracellular trap; fibronectin-binding protein B	COMMUNITY-ASSOCIATED MRSA; EXTRACELLULAR HISTONES; BIOFILM FORMATION; CLUMPING FACTOR; FIBRINOGEN; MSCRAMM; RESISTANCE; DOMAIN; MODEL; PLASMINOGEN	Staphylococcus aureus is a Gram-positive bacterium that can cause both superficial and deep-seated infections. Histones released by neutrophils kill bacteria by binding to the bacterial cell surface and causing membrane damage. We postulated that cell wall-anchored proteins protect S. aureus from the bactericidal effects of histones by binding to and sequestering histones away from the cell envelope. Here, we focused on S. aureus strain LAC and by using an array of biochemical assays, including surface plasmon resonance and ELISA, discovered that fibronectin-binding protein B (FnBPB) is the main histone receptor. FnBPB bound all types of histones, but histone H3 displayed the highest affinity and bactericidal activity and was therefore investigated further. H3 bound specifically to the A domain of recombinant FnBPB with a K-D of 86 nm, approximate to 20-fold lower than that for fibrinogen. Binding apparently occurred by the same mechanism by which FnBPB binds to fibrinogen, because FnBPB variants defective in fibrinogen binding also did not bind H3. An FnBPB-deletion mutant of S. aureus LAC bound less H3 and was more susceptible to its bactericidal activity and to neutrophil extracellular traps, whereas an FnBPB-overexpressing mutant bound more H3 and was more resistant than the WT. FnBPB bound simultaneously to H3 and plasminogen, which after activation by tissue plasminogen activator cleaved the bound histone. We conclude that FnBPB provides a dual immune-evasion function that captures histones and prevents them from reaching the bacterial membrane and simultaneously binds plasminogen, thereby promoting its conversion to plasmin to destroy the bound histone.	[Pietrocola, Giampiero; Nobile, Giulia; Alfeo, Mariangela J.; Speziale, Pietro] Univ Pavia, Dept Mol Med, Biochem Unit, Viale Taramelli 3-B, I-27100 Pavia, Italy; [Foster, Timothy J.] Trinity Coll Dublin, Dept Microbiol, Dublin 2, Ireland; [Geoghegan, Joan A.] Trinity Coll Dublin, Dept Microbiol, Moyne Inst Prevent Med, Sch Genet & Microbiol, Dublin 2, Ireland; [De Filippis, Vincenzo] Univ Padua, Lab Prot Chem & Mol Hematol, Dept Pharmaceut & Pharmacol Sci, I-36131 Padua, Italy; [Speziale, Pietro] Univ Pavia, Dept Ind & Informat Engn, I-27100 Pavia, Italy	University of Pavia; Trinity College Dublin; Trinity College Dublin; University of Padua; University of Pavia	Pietrocola, G; Speziale, P (corresponding author), Univ Pavia, Dept Mol Med, Biochem Unit, Viale Taramelli 3-B, I-27100 Pavia, Italy.	giampiero.pietrocola@unipv.it; pspeziale@unipv.it		Alfeo, Mariangela Jessica/0000-0002-4600-1901; PIETROCOLA, GIAMPIERO/0000-0002-7069-8155	Fondazione CARIPLO Grant Vaccines [2009-3546]; PRAT-2015 Grant	Fondazione CARIPLO Grant Vaccines(Fondazione Cariplo); PRAT-2015 Grant	This work was supported by Fondazione CARIPLO Grant Vaccines 2009-3546 (to P. S.) and in part by PRAT-2015 Grant (to V. D. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Bowden MG, 2008, J BIOL CHEM, V283, P638, DOI 10.1074/jbc.M706252200; Burke FM, 2011, FEBS J, V278, P2359, DOI 10.1111/j.1742-4658.2011.08159.x; Burke FM, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-160; Chambers HF, 2005, NEW ENGL J MED, V352, P1485, DOI 10.1056/NEJMe058023; Chaput C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071097; Chow OA, 2010, CELL HOST MICROBE, V8, P445, DOI 10.1016/j.chom.2010.10.005; Corriden R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9369; Deivanayagam CCS, 2002, EMBO J, V21, P6660, DOI 10.1093/emboj/cdf619; DELANGE RJ, 1971, ANNU REV BIOCHEM, V40, P279, DOI 10.1146/annurev.bi.40.070171.001431; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Dohrmann S, 2017, SCI REP-UK, V7, P1, DOI 10.1038/srep43039; Eisenbeis J, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00235; Foster TJ, 2019, TRENDS MICROBIOL, V27, P26, DOI 10.1016/j.tim.2018.06.005; Foster TJ, 2017, FEMS MICROBIOL REV, V41, P430, DOI 10.1093/femsre/fux007; Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161; Fridkin SK, 2005, NEW ENGL J MED, V352, P1436, DOI 10.1056/NEJMoa043252; Geoghegan JA, 2013, J BACTERIOL, V195, P2675, DOI 10.1128/JB.02128-12; GREENE C, 1995, MOL MICROBIOL, V17, P1143, DOI 10.1111/j.1365-2958.1995.mmi_17061143.x; Horsburgh MJ, 2002, J BACTERIOL, V184, P5457, DOI 10.1128/JB.184.19.5457-5467.2002; Keane FM, 2007, MOL MICROBIOL, V63, P711, DOI 10.1111/j.1365-2958.2006.05552.x; Kristian SA, 2005, J BACTERIOL, V187, P6719, DOI 10.1128/JB.187.19.6719-6725.2005; Lee DY, 2009, J INVEST DERMATOL, V129, P2489, DOI 10.1038/jid.2009.106; Loughman A, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-74; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; McCourt J, 2014, FEMS MICROBIOL LETT, V353, P157, DOI 10.1111/1574-6968.12424; MCDEVITT D, 1994, MOL MICROBIOL, V11, P237, DOI 10.1111/j.1365-2958.1994.tb00304.x; Meenan NAG, 2007, J BIOL CHEM, V282, P25893, DOI 10.1074/jbc.M703063200; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Morita S, 2013, PEPTIDES, V48, P75, DOI 10.1016/j.peptides.2013.07.025; Mulcahy ME, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003092; Murphy EC, 2014, J INNATE IMMUN, V6, P394, DOI 10.1159/000356432; Nitzsche R, 2016, J INNATE IMMUN, V8, P589, DOI 10.1159/000448039; Noskin GA, 2005, ARCH INTERN MED, V165, P1756, DOI 10.1001/archinte.165.15.1756; NOVICK R, 1967, VIROLOGY, V33, P155, DOI 10.1016/0042-6822(67)90105-5; O'Connell DP, 1998, J BIOL CHEM, V273, P6821, DOI 10.1074/jbc.273.12.6821; O'Neill E, 2008, J BACTERIOL, V190, P3835, DOI 10.1128/JB.00167-08; Otto M, 2013, INT J MED MICROBIOL, V303, P324, DOI 10.1016/j.ijmm.2013.02.007; Pietrocola G, 2016, J BIOL CHEM, V291, P18148, DOI 10.1074/jbc.M116.731125; Ponnuraj K, 2003, CELL, V115, P217, DOI 10.1016/S0092-8674(03)00809-2; Roche FM, 2004, J BIOL CHEM, V279, P38433, DOI 10.1074/jbc.M402122200; Roche FM, 2003, MICROBIOL-SGM, V149, P2759, DOI 10.1099/mic.0.26412-0; Rose-Martel M, 2014, INT J ANTIMICROB AG, V44, P470, DOI 10.1016/j.ijantimicag.2014.07.008; Schorn C, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00277; Schwarz-Linek U, 2003, NATURE, V423, P177, DOI 10.1038/nature01589; SHERERTZ RJ, 1993, J INFECT DIS, V167, P98, DOI 10.1093/infdis/167.1.98; Sollberger G, 2018, DEV CELL, V44, P542, DOI 10.1016/j.devcel.2018.01.019; Stapels DAC, 2014, P NATL ACAD SCI USA, V111, P13187, DOI 10.1073/pnas.1407616111; Ueki S, 2013, BLOOD, V121, P2074, DOI 10.1182/blood-2012-05-432088; Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639; Vazquez V, 2011, J BIOL CHEM, V286, P29797, DOI 10.1074/jbc.M110.214981; Vergara-Irigaray M, 2009, INFECT IMMUN, V77, P3978, DOI 10.1128/IAI.00616-09; Westman J, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00236; Westman J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005319; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053; Zong YN, 2005, EMBO J, V24, P4224, DOI 10.1038/sj.emboj.7600888	57	18	20	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3588	3602		10.1074/jbc.RA118.005707	http://dx.doi.org/10.1074/jbc.RA118.005707			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30622139	Green Published, hybrid			2022-12-28	WOS:000461853900023
J	Chou, AC; Aslanian, A; Sun, HY; Hunter, T				Chou, Annie C.; Aslanian, Aaron; Sun, Huaiyu; Hunter, Tony			An internal ribosome entry site in the coding region of tyrosyl-DNA phosphodiesterase 2 drives alternative translation start	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						eukaryotic translation initiation; translation; translation initiation; translation regulation; translation control; alternative translation initiation start; DNA repair; internal ribosomal entry site (IRES); phosphodiesterase; tyrosyl-DNA phosphodiesterase 2 (TDP2)	GENE-EXPRESSION; CANCER DEVELOPMENT; TTRAP; PROTEINS; APOPTOSIS; REPAIR	Tyrosyl-DNA phosphodiesterase 2 (TDP2) is a multifunctional protein that has been implicated in a myriad of cellular pathways. Although most well-known for its phosphodiesterase activity removing stalled topoisomerase 2 from DNA, TDP2 has also been shown to interact with both survival and apoptotic mitogen-activated protein kinase (MAPK) signaling cascades. Moreover, it facilitates enterovirus replication and has been genetically linked to neurological disorders ranging from Parkinson's disease to dyslexia. To accurately evaluate TDP2 as a therapeutic target, we need to understand how TDP2 performs such a wide diversity of functions. Here, we use cancer cell lines modified with CRISPR/Cas9 or stably-expressed TDP2-targeted shRNA and transfection of various TDP2 mutants to show that its expression is regulated at the translational level via an internal ribosome entry site (IRES) that initiates translation at codon 54, the second in-frame methionine of the TDP2 coding sequence. We observed that this IRES drives expression of a shorter, N-terminally truncated isoform of TDP2, Delta N-TDP2, which omits a nuclear localization sequence. Additionally, we noted that Delta N-TDP2 retains phosphodiesterase activity and is protective against etoposide-induced cell death, but co-immunoprecipitates with fewer high-molecular-weight ubiquitinated peptide species, suggesting partial loss-of-function of TDP2's ubiquitin-association domain. In summary, our findings suggest the existence of an IRES in the 5 ' coding sequence of TDP2 that translationally regulates expression of an N-terminally truncated, cytoplasmic isoform of TDP2. These results shed light on the regulation of this multifunctional protein and may inform the design of therapies targeting TDP2 and associated pathways.	[Chou, Annie C.] Univ Calif San Diego, Grad Program Biomed Sci, La Jolla, CA 92093 USA; [Chou, Annie C.; Aslanian, Aaron; Sun, Huaiyu; Hunter, Tony] Salk Inst Biol Studies, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Aslanian, Aaron] Illumina Inc, 5200 Illumina Way, San Diego, CA 92122 USA	University of California System; University of California San Diego; Salk Institute; Illumina	Hunter, T (corresponding author), Salk Inst Biol Studies, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	hunter@salk.edu			National Institutes of Health NCICCSG [P30 014195]; National Institutes of Health NCI CCSG [P30 014195]; National Institutes of Health NINDS Neuroscience Core Grant [NS072031]; Waitt Foundation; NATIONAL CANCER INSTITUTE [T32CA009523, R01CA082683, P30CA014195, R01CA080100] Funding Source: NIH RePORTER	National Institutes of Health NCICCSG(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health NCI CCSG; National Institutes of Health NINDS Neuroscience Core Grant; Waitt Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We have received numerous reagents from many groups without which this project would not have been possible, including Juan Carlos Izpisua Belmonte, px458 plasmid; Clodagh O'Shea, U2OS and A549 cell lines; Reuben Shaw, H1299, H460, H358, and A549 cell lines; Dwayne Stupack (UCSD), OVCAR3, HCT116, and HT29 cell lines; Richard Lloyd (Baylor College of Medicine, Houston, TX), pRL-FFL and pRL-HCV-FFL plasmids; and Felipe Cortes Ledesma (Cabimer Centro Andaluz de Biologia Molecular y SSMedicina Regenerativa, Sevilla, Spain) TDP2<SUP>fl/fl</SUP> and TDP2<SUP>Delta ex1-3/Delta ex1-3</SUP> MEFs. We thank the staff of the Flow Cytometry Core Facility, especially Carolyn O'Connor and Conor Fitzpatrick of the Salk Institute which was funded by National Institutes of Health NCICCSG Grant P30 014195, the Functional Genomics Core Facility, especially James Nguyen of the Salk Institute which was funded by National Institutes of Health NCICCSG Grant P30 014195, and the Waitt Advanced Biophotonics Core Facility of the Salk Institute which was funded by National Institutes of Health NCI CCSG Grant P30 014195, National Institutes of Health NINDS Neuroscience Core Grant NS072031, and the Waitt Foundation.	Adhikari S, 2011, ANAL BIOCHEM, V416, P112, DOI 10.1016/j.ab.2011.05.008; Babendure JR, 2006, RNA, V12, P851, DOI 10.1261/rna.2309906; Benson DA, 2005, NUCLEIC ACIDS RES, V33, pD34, DOI 10.1093/nar/gki063; Bian K, 2016, ONCOTARGET, V7, P6665, DOI 10.18632/oncotarget.6682; Conidi A, 2011, CYTOKINE GROWTH F R, V22, P287, DOI 10.1016/j.cytogfr.2011.11.006; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Esguerra CV, 2007, DEVELOPMENT, V134, P4381, DOI 10.1242/dev.000026; Feoktistova Maria, 2016, Cold Spring Harb Protoc, V2016, DOI 10.1101/pdb.prot087379; Gomez-Herreros F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003226; Huang SYN, 2018, EMBO REP, V19, DOI 10.15252/embr.201642139; Jackson RJ, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011569; Kosugi S, 2008, CHEM BIOL, V15, P940, DOI 10.1016/j.chembiol.2008.07.019; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; Ledesma FC, 2009, NATURE, V461, P674, DOI 10.1038/nature08444; Li C, 2011, ONCOGENE, V30, P3802, DOI 10.1038/onc.2011.94; Li CY, 2011, CELL CYCLE, V10, P3274, DOI 10.4161/cc.10.19.17763; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; McDonald WH, 2004, RAPID COMMUN MASS SP, V18, P2162, DOI 10.1002/rcm.1603; Muthalagu N, 2014, CELL REP, V8, P1347, DOI 10.1016/j.celrep.2014.07.057; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Pype S, 2000, J BIOL CHEM, V275, P18586, DOI 10.1074/jbc.M000531200; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rao T, 2016, NUCLEIC ACIDS RES, V44, P10201, DOI 10.1093/nar/gkw719; Raskatov JA, 2012, P NATL ACAD SCI USA, V109, P16041, DOI 10.1073/pnas.1214267109; Ray PS, 2006, EMBO REP, V7, P404, DOI 10.1038/sj.embor.7400623; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Rubtsova MP, 2003, J BIOL CHEM, V278, P22350, DOI 10.1074/jbc.M303213200; Sharathchandra A, 2014, WIRES RNA, V5, P131, DOI 10.1002/wrna.1202; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Van Eden ME, 2004, RNA, V10, P720, DOI 10.1261/rna.5225204; Varady G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025548; Virgen-Slane R, 2012, P NATL ACAD SCI USA, V109, P14634, DOI 10.1073/pnas.1208096109; Wang T, 2013, NUCLEIC ACIDS RES, V41, P4743, DOI 10.1093/nar/gkt178; Xiong W, 2016, BIOCHEM BIOPH RES CO, V473, P1019, DOI 10.1016/j.bbrc.2016.04.009; Xu T, 2015, J PROTEOMICS, V129, P16, DOI 10.1016/j.jprot.2015.07.001; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006; Zhou CH, 2013, BMB REP, V46, P113, DOI 10.5483/BMBRep.2013.46.2.150; Zucchelli S, 2009, CELL DEATH DIFFER, V16, P428, DOI 10.1038/cdd.2008.169; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	41	6	6	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2665	2677		10.1074/jbc.RA118.006269	http://dx.doi.org/10.1074/jbc.RA118.006269			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30593505	Green Published, hybrid			2022-12-28	WOS:000459601600009
J	Hong, HL; Koon, AC; Chen, ZS; Wei, YM; An, Y; Li, W; Lau, MHY; Lau, KF; Ngo, JCK; Wong, CH; Au-Yeung, HY; Zimmerman, SC; Chan, HYE				Hong, Huiling; Koon, Alex Chun; Chen, Zhefan Stephen; Wei, Yuming; An, Ying; Li, Wen; Lau, Matthew Ho Yan; Lau, Kwok-Fai; Ngo, Jacky Chi Ki; Wong, Chun-Ho; Au-Yeung, Ho Yu; Zimmerman, Steven C.; Chan, Ho Yin Edwin			AQAMAN, a bisamidine-based inhibitor of toxic protein inclusions in neurons, ameliorates cytotoxicity in polyglutamine disease models	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aggregation; autophagy; Drosophila; neurodegeneration; trinucleotide repeat disease; neurodegenerative disease; Huntington disease; cytotoxic protein; neuronal inclusion; neurotoxicity	ENDOPLASMIC-RETICULUM STRESS; PEPTIDYLIC INHIBITOR; MUTANT HUNTINGTIN; NUCLEOLAR STRESS; RNA TOXICITY; CELL-DEATH; ER STRESS; AUTOPHAGY; NEURODEGENERATION; AGGREGATION	Polyglutamine (polyQ) diseases are a group of dominantly inherited neurodegenerative disorders caused by the expansion of an unstable CAG repeat in the coding region of the affected genes. Hallmarks of polyQ diseases include the accumulation of misfolded protein aggregates, leading to neuronal degeneration and cell death. PolyQ diseases are currently incurable, highlighting the urgent need for approaches that inhibit the formation of disaggregate cytotoxic polyQ protein inclusions. Here, we screened for bisamidine-based inhibitors that can inhibit neuronal polyQ protein inclusions. We demonstrated that one inhibitor, AQAMAN, prevents polyQ protein aggregation and promotes de-aggregation of self-assembled polyQ proteins in several models of polyQ diseases. Using immunocytochemistry, we found that AQAMAN significantly reduces polyQ protein aggregation and specifically suppresses polyQ protein-induced cell death. Using a recombinant and purified polyQ protein (thioredoxin-Huntingtin-Q46), we further demonstrated that AQAMAN interferes with polyQ self-assembly, preventing polyQ aggregation, and dissociates preformed polyQ aggregates in a cell-free system. Remarkably, AQAMAN feeding of Drosophila expressing expanded polyQ disease protein suppresses polyQ-induced neurodegeneration in vivo. In addition, using inhibitors and activators of the autophagy pathway, we demonstrated that AQAMAN's cytoprotective effect against polyQ toxicity is autophagy-dependent. In summary, we have identified AQAMAN as a potential therapeutic for combating polyQ protein toxicity in polyQ diseases. Our findings further highlight the importance of the autophagy pathway in clearing harmful polyQ proteins.	[Hong, Huiling; Koon, Alex Chun; Chen, Zhefan Stephen; Wei, Yuming; An, Ying; Chan, Ho Yin Edwin] Chinese Univ Hong Kong, Lab Drosophila Res, Shatin, Hong Kong, Peoples R China; [Hong, Huiling; Koon, Alex Chun; Chen, Zhefan Stephen; Wei, Yuming; An, Ying; Li, Wen; Lau, Kwok-Fai; Ngo, Jacky Chi Ki; Wong, Chun-Ho; Chan, Ho Yin Edwin] Chinese Univ Hong Kong, Sch Life Sci, Fac Sci, Shatin, Hong Kong, Peoples R China; [Chan, Ho Yin Edwin] Chinese Univ Hong Kong, Gerald Choa Neurosci Ctr, Shatin, Hong Kong, Peoples R China; [Lau, Matthew Ho Yan; Au-Yeung, Ho Yu] Univ Hong Kong, Dept Chem, Pok Fu Lam Rd, Hong Kong, Peoples R China; [Zimmerman, Steven C.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; University of Hong Kong; University of Illinois System; University of Illinois Urbana-Champaign	Chan, HYE (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China.	hyechan@cuhk.edu.hk	An, Ying/GQP-4457-2022; Chen, Zhefan Stephen/L-9888-2019; HONG, HUILING/AAT-9954-2020; Chan, Edwin/A-9478-2011; Ngo, Jacky C/O-8093-2017	Chen, Zhefan Stephen/0000-0002-9276-0378; Chan, Edwin/0000-0003-4307-474X; Ngo, Jacky C/0000-0002-6004-7041; Koon, Alex/0000-0002-4274-7052; Lau, Kwok-Fai/0000-0002-0193-1152	CUHK Vice-Chancellor's One-Off Discretionary Fund [VCF2014011, EC/2017/012]; CUHK Lui Che Woo Institute of Innovative Medicine [8303404]; CUHK Gerald Choa Neuroscience Centre [7105306]; Croucher Foundation; Hong Kong Postgraduate Fellowship (HKPF); Hong Kong Spinocerebellar Ataxia Association [6903291]; National Institutes of Health [RO1 AR069645]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR069645] Funding Source: NIH RePORTER	CUHK Vice-Chancellor's One-Off Discretionary Fund; CUHK Lui Che Woo Institute of Innovative Medicine; CUHK Gerald Choa Neuroscience Centre; Croucher Foundation; Hong Kong Postgraduate Fellowship (HKPF); Hong Kong Spinocerebellar Ataxia Association; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the CUHK Vice-Chancellor's One-Off Discretionary Fund VCF2014011 and EC/2017/012, CUHK Lui Che Woo Institute of Innovative Medicine Grant 8303404, CUHK Gerald Choa Neuroscience Centre Grant 7105306, the Croucher Foundation, the Hong Kong Postgraduate Fellowship (HKPF), donations from the Hong Kong Spinocerebellar Ataxia Association 6903291, and National Institutes of Health Grant RO1 AR069645. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; BAILLY C, 1994, MOL PHARMACOL, V46, P313; Banez-Coronel M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002481; Bennett MJ, 2002, P NATL ACAD SCI USA, V99, P11634, DOI 10.1073/pnas.182393899; Berger Z, 2006, HUM MOL GENET, V15, P433, DOI 10.1093/hmg/ddi458; Cai Y, 2016, AUTOPHAGY, V12, P225, DOI 10.1080/15548627.2015.1121360; Chan WM, 2011, HUM MOL GENET, V20, P1738, DOI 10.1093/hmg/ddr049; Chen ZS, 2018, EMBO REP, V19, DOI 10.15252/embr.201745409; Darrow MC, 2015, J BIOL CHEM, V290, P17451, DOI 10.1074/jbc.M115.655373; Ding Y, 2016, NEUROSCIENCE, V327, P20, DOI 10.1016/j.neuroscience.2016.03.064; Duennwald ML, 2008, GENE DEV, V22, P3308, DOI 10.1101/gad.1673408; El-Ami T, 2014, AGING CELL, V13, P165, DOI 10.1111/acel.12171; Fardghassemi Y, 2017, DIS MODEL MECH, V10, P1465, DOI 10.1242/dmm.029736; Garcia-Huerta P, 2016, BRAIN RES, V1649, P173, DOI 10.1016/j.brainres.2016.02.052; Gardner BM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013169; Hands SL, 2010, ACTA NEUROPATHOL, V120, P419, DOI 10.1007/s00401-010-0703-0; Hazeki N, 2000, BIOCHEM BIOPH RES CO, V277, P386, DOI 10.1006/bbrc.2000.3682; Hsieh CH, 2016, DRUG DES DEV THER, V10, P2947, DOI 10.2147/DDDT.S111903; Jiang YW, 2016, BRAIN RES, V1648, P650, DOI 10.1016/j.brainres.2016.03.034; Kim M, 2013, PRION, V7, P221, DOI 10.4161/pri.23807; Kouroku Y, 2002, HUM MOL GENET, V11, P1505, DOI 10.1093/hmg/11.13.1505; Lajoie P, 2011, J CELL SCI, V124, P3332, DOI 10.1242/jcs.087510; Lee SJ, 2011, NEUROSCI RES, V70, P339, DOI 10.1016/j.neures.2011.05.008; Li LB, 2008, NATURE, V453, P1107, DOI 10.1038/nature06909; Li M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056026; Nguyen L, 2014, CHEMMEDCHEM, V9, P2455, DOI 10.1002/cmdc.201402095; Liu HB, 2014, J CHEM INF MODEL, V54, P1050, DOI 10.1021/ci500004h; McMillan D. Randy, 1994, Current Opinion in Biotechnology, V5, P540, DOI 10.1016/0958-1669(94)90071-X; Menzies FM, 2017, NEURON, V93, P1015, DOI 10.1016/j.neuron.2017.01.022; Nagai Y, 2003, HUM MOL GENET, V12, P1253, DOI 10.1093/hmg/ddg144; Nagai Y, 2000, J BIOL CHEM, V275, P10437, DOI 10.1074/jbc.275.14.10437; Nagai Y, 2007, NAT STRUCT MOL BIOL, V14, P332, DOI 10.1038/nsmb1215; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Paulson HL, 1997, ANN NEUROL, V41, P453, DOI 10.1002/ana.410410408; Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5; Pedersen JT, 2013, ANAL CHEM, V85, P4215, DOI 10.1021/ac400023c; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Ross CA, 2002, NEURON, V35, P819, DOI 10.1016/S0896-6273(02)00872-3; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Rusmini P, 2016, J MOL NEUROSCI, V58, P348, DOI 10.1007/s12031-015-0675-6; Sarkar S, 2009, CELL DEATH DIFFER, V16, P46, DOI 10.1038/cdd.2008.110; Shamu Caroline E., 1994, Trends in Cell Biology, V4, P56, DOI 10.1016/0962-8924(94)90011-6; Shekhar S, 2017, HUM MOL GENET, V26, P420, DOI 10.1093/hmg/ddw398; Shin BH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064953; Singh V, 2018, MOL PHARMACEUT, V15, P3356, DOI 10.1021/acs.molpharmaceut.8b00380; Takahashi T, 2010, J MOL CELL BIOL, V2, P180, DOI 10.1093/jmcb/mjq005; Tanaka M, 2004, J BIOL CHEM, V279, P4625, DOI 10.1074/jbc.M310994200; Tanious FA, 2001, EUR J BIOCHEM, V268, P3455, DOI 10.1046/j.1432-1327.2001.02242.x; Tsoi H, 2012, P NATL ACAD SCI USA, V109, P13428, DOI 10.1073/pnas.1204089109; Tsoi H, 2011, HUM MOL GENET, V20, P3787, DOI 10.1093/hmg/ddr297; Vidal RL, 2012, AUTOPHAGY, V8, P970, DOI 10.4161/auto.20139; Vitalis A, 2009, BIOPHYS J, V97, P303, DOI 10.1016/j.bpj.2009.05.003; Wang M, 2009, ANTIOXID REDOX SIGN, V11, P2307, DOI [10.1089/ars.2009.2485, 10.1089/ARS.2009.2485]; Wang T, 2009, J CELL BIOL, V186, P703, DOI 10.1083/jcb.200904090; Warrick JM, 2005, MOL CELL, V18, P37, DOI 10.1016/j.molcel.2005.02.030; Wong CH, 2014, J AM CHEM SOC, V136, P6355, DOI 10.1021/ja5012146; Yamamoto A, 2006, J CELL BIOL, V172, P719, DOI 10.1083/jcb.200510065; Yang YP, 2013, ACTA PHARMACOL SIN, V34, P625, DOI 10.1038/aps.2013.5; Zhang Q, 2018, RNA, V24, P486, DOI 10.1261/rna.062703.117; Zhang Q, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11695-y; Zhang Q, 2016, DIS MODEL MECH, V9, P321, DOI 10.1242/dmm.022350; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	63	8	8	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2757	2770		10.1074/jbc.RA118.006307	http://dx.doi.org/10.1074/jbc.RA118.006307			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30593503	hybrid, Green Published			2022-12-28	WOS:000459601600016
J	Peshenko, IV; Yu, QH; Lim, S; Cudia, D; Dizhoor, AM; Ames, JB				Peshenko, Igor V.; Yu, Qinhong; Lim, Sunghyuk; Cudia, Diana; Dizhoor, Alexander M.; Ames, James B.			Retinal degeneration 3 (RD3) protein, a retinal guanylyl cyclase regulator, forms a monomeric and elongated four-helix bundle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						guanylate cyclase (guanylyl cyclase); nuclear magnetic resonance (NMR); retinal degeneration; phototransduction; photoreceptor	LEBER CONGENITAL AMAUROSIS; ACTIVATING PROTEINS; MYRISTOYLATED RECOVERIN; LIGHT-SCATTERING; NMR STRUCTURE; 1 RETGC1; BINDING; CALCIUM; LOCALIZATION; TRAFFICKING	Retinal degeneration 3 (RD3) protein promotes accumulation of retinal membrane guanylyl cyclase (RetGC) in the photoreceptor outer segment and suppresses RetGC activation by guanylyl cyclase-activating proteins (GCAPs). Mutations truncating RD3 cause severe congenital blindness by preventing the inhibitory binding of RD3 to the cyclase. The high propensity of RD3 to aggregate in solution has prevented structural analysis. Here, we produced a highly soluble variant of human RD3 (residues 18-160) that is monomeric and can still bind and negatively regulate RetGC. The NMR solution structure of RD3 revealed an elongated backbone structure (70 A long and 30 A wide) consisting of a four-helix bundle with a long unstructured loop between helices 1 and 2. The structure reveals that RD3 residues previously implicated in the RetGC binding map to a localized and contiguous area on the structure, involving a loop between helices 2 and 3 and adjacent parts of helices 3 and 4. The NMR structure of RD3 was validated by mutagenesis. Introducing Trp(85) or Phe(29) to replace Cys or Leu, respectively, disrupts packing in the hydrophobic core and lowers RD3's apparent affinity for RetGC1. Introducing a positive charge at the interface (Glu(32) to Lys) also lowered the affinity. Conversely, introducing Val in place of Cys(93) stabilized the hydrophobic core and increased the RD3 affinity for the cyclase. The NMR structure of RD3 presented here provides a structural basis for elucidating RD3-RetGC interactions relevant for normal vision or blindness.	[Peshenko, Igor V.; Dizhoor, Alexander M.] Salus Univ, Penn Coll Optometry, Elkins Pk, PA 19027 USA; [Yu, Qinhong; Lim, Sunghyuk; Cudia, Diana; Ames, James B.] Univ Calif Davis, Dept Chem, 1 Shields Ave, Davis, CA 95616 USA	University of California System; University of California Davis	Ames, JB (corresponding author), Univ Calif Davis, Dept Chem, 1 Shields Ave, Davis, CA 95616 USA.; Dizhoor, AM (corresponding author), Salus Univ, Res S416,8360 Old York Rd, Elkins Pk, PA 19027 USA.	adizhoor@salus.edu; jbames@ucdavis.edu	Yu, Qinhong/ABH-1965-2020	Ames, James/0000-0003-0934-2595; Dizhoor, Alexander/0000-0001-6770-9186; Yu, Qinhong/0000-0003-3855-5469	National Institutes of Health [EY11522, EY012347]; Pennsylvania Department of Health CURE Formula grant; NATIONAL EYE INSTITUTE [R01EY012347, R01EY011522] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health CURE Formula grant; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grants EY11522 (to A. M. D.) and EY012347 (to J. B. A.) and a Pennsylvania Department of Health CURE Formula grant (to A. M. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AMES JB, 1994, BIOCHEMISTRY-US, V33, P10743, DOI 10.1021/bi00201a023; Arshavsky Vadim Y, 2014, Cell Logist, V4, pe29390; Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; Azadi S, 2010, P NATL ACAD SCI USA, V107, P21158, DOI 10.1073/pnas.1010460107; Baehr W., 2007, V45, P71; Baehr W, 2007, J BIOL CHEM, V282, P8837, DOI 10.1074/jbc.M610369200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clore GM, 1998, CURR OPIN CHEM BIOL, V2, P564, DOI 10.1016/S1367-5931(98)80084-7; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dizhoor AM, 2010, MOL CELL BIOCHEM, V334, P117, DOI 10.1007/s11010-009-0328-6; DIZHOOR AM, 1994, NEURON, V12, P1345, DOI 10.1016/0896-6273(94)90449-9; Friedman JS, 2006, AM J HUM GENET, V79, P1059, DOI 10.1086/510021; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Jacobson SG, 2013, HUM MOL GENET, V22, P168, DOI 10.1093/hmg/dds421; Koch KW, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00067; KOCH KW, 1991, J BIOL CHEM, V266, P8634; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee W, 2016, J BIOMOL NMR, V65, P51, DOI 10.1007/s10858-016-0036-y; Lim S, 2018, BIOMOL NMR ASSIGN, V12, P167, DOI 10.1007/s12104-018-9802-y; Lim S, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00019; Liu Y, 1997, P NATL ACAD SCI USA, V94, P13414, DOI 10.1073/pnas.94.25.13414; LOWE DG, 1995, P NATL ACAD SCI USA, V92, P5535, DOI 10.1073/pnas.92.12.5535; Meyer M, 2003, BIOMACROMOLECULES, V4, P1727, DOI 10.1021/bm0341531; Molday LL, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00044; Molday LL, 2013, HUM MOL GENET, V22, P3894, DOI 10.1093/hmg/ddt244; Ottiger M, 1998, J MAGN RESON, V134, P365, DOI 10.1006/jmre.1998.1546; Peshenko IV, 2008, J BIOL CHEM, V283, P21747, DOI 10.1074/jbc.M801899200; Peshenko IV, 2006, J BIOL CHEM, V281, P23830, DOI 10.1074/jbc.M600257200; Peshenko IV, 2016, J BIOL CHEM, V291, P19713, DOI 10.1074/jbc.M116.742288; Peshenko IV, 2015, J BIOL CHEM, V290, P19584, DOI 10.1074/jbc.M115.661371; Peshenko IV, 2015, J BIOL CHEM, V290, P6913, DOI 10.1074/jbc.M114.629642; Peshenko IV, 2011, BIOCHEMISTRY-US, V50, P9511, DOI 10.1021/bi201342b; Peshenko IV, 2004, J BIOL CHEM, V279, P16903, DOI 10.1074/jbc.C400065200; Preising MN, 2012, INVEST OPHTH VIS SCI, V53, P3463, DOI 10.1167/iovs.12-9519; Ramamurthy V, 2001, J BIOL CHEM, V276, P26218, DOI 10.1074/jbc.M010495200; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Sharon D, 2018, PROG RETIN EYE RES, V63, P69, DOI 10.1016/j.preteyeres.2017.10.003; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Stone EM, 2007, AM J OPHTHALMOL, V144, P791, DOI 10.1016/j.ajo.2007.08.022; Tanaka T, 1998, J BIOMOL NMR, V11, P135, DOI 10.1023/A:1008212316986; Tjandra N, 1997, SCIENCE, V278, P1111, DOI 10.1126/science.278.5340.1111; TSIEN RY, 1989, METHOD CELL BIOL, V30, P127; Tucker CL, 1998, P NATL ACAD SCI USA, V95, P5993, DOI 10.1073/pnas.95.11.5993; Wimberg H, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00052; WYATT PJ, 1991, BIOCHEM SOC T, V19, P485, DOI 10.1042/bst0190485; Xu XZ, 2010, BIOCHEMISTRY-US, V49, P1469, DOI 10.1021/bi9020132; YANG RB, 1995, P NATL ACAD SCI USA, V92, P602, DOI 10.1073/pnas.92.2.602; Zinchuk Vadim, 2008, Curr Protoc Cell Biol, VChapter 4, DOI 10.1002/0471143030.cb0419s39; Zulliger R, 2015, J BIOL CHEM, V290, P3488, DOI 10.1074/jbc.M114.616656; Zweckstetter M, 2008, NAT PROTOC, V3, P679, DOI 10.1038/nprot.2008.36	50	8	8	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2019	294	7					2318	2328		10.1074/jbc.RA118.006106	http://dx.doi.org/10.1074/jbc.RA118.006106			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL7CN	30559291	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000458895400010
J	Long, YX; Sou, WH; Yung, KWY; Liu, HZ; Wan, SWC; Li, QY; Zeng, CY; Law, COK; Chan, GHC; Lau, TCK; Ngo, JCK				Long, Yunxin; Sou, Weng Hong; Yung, Kristen Wing Yu; Liu, Haizhen; Wan, Stephanie Winn Chee; Li, Qingyun; Zeng, Chuyue; Law, Carmen Oi Kwan; Chan, Gordon Ho Ching; Lau, Terrence Chi Kong; Ngo, Jacky Chi Ki			Distinct mechanisms govern the phosphorylation of different SR protein splicing factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphoryl transfer; protein kinase; protein phosphorylation; serine/threonine protein kinase; RNA splicing; post-translational modification (PTM); localization; speckles; SR protein; SRPK; SRSF; processive phosphorylation; kinase-substrate interaction; post-translational mechanism; regulatory mechanism; nuclear speckle; subcellular localization	CRYO-EM STRUCTURE; MESSENGER-RNA; PROCESSIVE PHOSPHORYLATION; NUCLEAR IMPORT; FACTOR ASF/SF2; RS DOMAIN; SRP20; KINASES; SPLICEOSOME; TRANSPORTIN-SR2	Serine-arginine (SR) proteins are essential splicing factors containing a canonical RNA recognition motif (RRM), sometimes followed by a pseudo-RRM, and a C-terminal arginine/serine-rich (RS) domain that undergoes multisite phosphorylation. Phosphorylation regulates the localization and activity of SR proteins, and thus may provide insight into their differential biological roles. The phosphorylation mechanism of the prototypic SRSF1 by serine-arginine protein kinase 1 (SRPK1) has been well-studied, but little is known about the phosphorylation of other SR protein members. In the present study, interaction and kinetic assays unveiled how SRSF1 and the single RRM-containing SRSF3 are phosphorylated by SRPK2, another member of the SRPK family. We showed that a conserved SRPK-specific substrate-docking groove in SRPK2 impacts the binding and phosphorylation of both SR proteins, and the localization of SRSF3. We identified a nonconserved residue within the groove that affects the kinase processivity. We demonstrated that, in contrast to SRSF1, for which SRPK-mediated phosphorylation is confined to the N-terminal region of the RS domain, SRSF3 phosphorylation sites are spread throughout its entire RS domain in vitro. Despite this, SRSF3 appears to be hypophosphorylated in cells at steady state. Our results suggest that the absence of a pseudo-RRM renders the single RRM-containing SRSF3 more susceptible to dephosphorylation by phosphatase. These findings suggest that the single RRM- and two RRM-containing SR proteins represent two subclasses of phosphoproteins in which phosphorylation statuses are maintained by unique mechanisms, and pose new directions to explore the distinct roles of SR proteins in vivo.	[Long, Yunxin; Sou, Weng Hong; Yung, Kristen Wing Yu; Liu, Haizhen; Wan, Stephanie Winn Chee; Li, Qingyun; Zeng, Chuyue; Chan, Gordon Ho Ching; Ngo, Jacky Chi Ki] Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China; [Law, Carmen Oi Kwan; Lau, Terrence Chi Kong] City Univ Hong Kong, Dept Biomed Sci, Kowloon, Hong Kong, Peoples R China; [Sou, Weng Hong] Univ Macau, Fac Hlth Sci, Taipa, Macau, Peoples R China	Chinese University of Hong Kong; City University of Hong Kong; University of Macau	Ngo, JCK (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China.	jackyngo@cuhk.edu.hk	Lau, Terrence/ABB-7900-2021; Ngo, Jacky C/O-8093-2017	Lau, Terrence/0000-0002-7505-7306; Ngo, Jacky C/0000-0002-6004-7041; Yung, Kristen Wing Yu/0000-0001-7389-3012; Wan, Stephanie Winn Chee/0000-0001-5395-4746	Hong Kong SAR Research Grant Council General Research Fund [473310, 14122615, 3132811]	Hong Kong SAR Research Grant Council General Research Fund	This work was supported by Hong Kong SAR Research Grant Council General Research Fund Grants 473310 and 14122615 and The Chinese University of Hong Kong direct grant scheme Grant 3132811 (to J. C. K. N.). The authors declare that they have no conflicts of interest with the contents of this article.	Ajiro M, 2016, NUCLEIC ACIDS RES, V44, P1854, DOI 10.1093/nar/gkv1500; Aubol BE, 2003, P NATL ACAD SCI USA, V100, P12601, DOI 10.1073/pnas.1635129100; Aubol BE, 2018, BIOCHEM J, V475, P677, DOI 10.1042/BCJ20170672; Aubol BE, 2017, J MOL BIOL, V429, P2178, DOI 10.1016/j.jmb.2017.05.022; Aubol BE, 2016, MOL CELL, V63, P218, DOI 10.1016/j.molcel.2016.05.034; Bedard KM, 2007, EMBO J, V26, P459, DOI 10.1038/sj.emboj.7601494; Bertram K, 2017, CELL, V170, P701, DOI 10.1016/j.cell.2017.07.011; Bertram K, 2017, NATURE, V542, P318, DOI 10.1038/nature21079; Caceres JF, 1997, J CELL BIOL, V138, P225, DOI 10.1083/jcb.138.2.225; Caceres JF, 1998, GENE DEV, V12, P55, DOI 10.1101/gad.12.1.55; Cao WH, 1997, RNA, V3, P1456; Cho SY, 2011, P NATL ACAD SCI USA, V108, P8233, DOI 10.1073/pnas.1017700108; Clery A, 2013, P NATL ACAD SCI USA, V110, pE2802, DOI 10.1073/pnas.1303445110; Corbo C, 2013, BIOCHEM BIOPH RES CO, V436, P1, DOI 10.1016/j.bbrc.2013.05.027; Cvitkovic I, 2013, NUCLEIC ACIDS RES, V41, pD132, DOI 10.1093/nar/gks999; Das R, 2007, MOL CELL, V26, P867, DOI 10.1016/j.molcel.2007.05.036; Ding JH, 2006, MOL BIOL CELL, V17, P876, DOI 10.1091/mbc.E05-10-0963; Fukuhara T, 2006, P NATL ACAD SCI USA, V103, P11329, DOI 10.1073/pnas.0604616103; Ghosh G, 2011, FEBS J, V278, P587, DOI 10.1111/j.1742-4658.2010.07992.x; Hamelberg D, 2007, P NATL ACAD SCI USA, V104, P14947, DOI 10.1073/pnas.0703151104; Huang YQ, 2005, MOL CELL, V17, P613, DOI 10.1016/j.molcel.2005.02.020; Huang YQ, 2003, MOL CELL, V11, P837, DOI 10.1016/S1097-2765(03)00089-3; Huang YQ, 2001, MOL CELL, V7, P899, DOI 10.1016/S1097-2765(01)00233-7; Jumaa H, 1997, EMBO J, V16, P5077, DOI 10.1093/emboj/16.16.5077; Koizumi J, 1999, J BIOL CHEM, V274, P11125, DOI 10.1074/jbc.274.16.11125; Lai MC, 2004, J BIOL CHEM, V279, P31745, DOI 10.1074/jbc.C400173200; Lai MC, 2001, P NATL ACAD SCI USA, V98, P10154, DOI 10.1073/pnas.181354098; Lai MC, 2000, J BIOL CHEM, V275, P7950, DOI 10.1074/jbc.275.11.7950; Liang N, 2014, BIOCHEM J, V459, P181, DOI 10.1042/BJ20131091; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Loomis RJ, 2009, MOL CELL, V33, P450, DOI 10.1016/j.molcel.2009.02.003; Lou H, 1998, MOL CELL BIOL, V18, P4977, DOI 10.1128/MCB.18.9.4977; Lukasiewicz R, 2007, J BIOL CHEM, V282, P23036, DOI 10.1074/jbc.M611305200; Ma CT, 2008, J MOL BIOL, V376, P55, DOI 10.1016/j.jmb.2007.08.029; Ma CT, 2009, J MOL BIOL, V390, P618, DOI 10.1016/j.jmb.2009.05.060; Manley JL, 2010, GENE DEV, V24, P1073, DOI 10.1101/gad.1934910; Ngo JCK, 2008, MOL CELL, V29, P563, DOI 10.1016/j.molcel.2007.12.017; Ngo JCK, 2005, MOL CELL, V20, P77, DOI 10.1016/j.molcel.2005.08.025; Prasad J, 1999, MOL CELL BIOL, V19, P6991; Saeki K, 2005, AM J PHYSIOL-ENDOC M, V289, pE419, DOI 10.1152/ajpendo.00512.2004; Sanford JR, 2005, P NATL ACAD SCI USA, V102, P15042, DOI 10.1073/pnas.0507827102; Sanford JR, 2004, GENE DEV, V18, P755, DOI 10.1101/gad.286404; Sen S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2342; Sen S, 2009, MOL CELL BIOL, V29, P871, DOI 10.1128/MCB.01709-08; Serrano P, 2016, J MOL BIOL, V428, P2430, DOI 10.1016/j.jmb.2016.04.009; Tang Y, 2013, ONCOGENE, V32, P2792, DOI 10.1038/onc.2012.288; Walsh CM, 2013, J BIOL CHEM, V288, P2816, DOI 10.1074/jbc.M112.410803; Xiang SQ, 2013, STRUCTURE, V21, P2162, DOI 10.1016/j.str.2013.09.014; Xiao SH, 1997, GENE DEV, V11, P334, DOI 10.1101/gad.11.3.334; Xu XD, 2005, CELL, V120, P59, DOI 10.1016/j.cell.2004.11.036; Yu QM, 2004, J NEUROCHEM, V90, P164, DOI 10.1111/j.1471-4159.2004.02477.x; Zhang Z, 2004, MOL CELL, V16, P597, DOI 10.1016/j.molcel.2004.10.031; Zhou ZH, 2013, CHROMOSOMA, V122, P191, DOI 10.1007/s00412-013-0407-z	53	31	32	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1312	1327		10.1074/jbc.RA118.003392	http://dx.doi.org/10.1074/jbc.RA118.003392			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30478176	Green Published, hybrid			2022-12-28	WOS:000457879500022
J	Malecki, JM; Willemen, HLDM; Pinto, R; Ho, AYY; Moen, A; Kjonstad, IF; Burgering, BMT; Zwartkruis, F; Eijkelkamp, N; Falnes, PO				Malecki, Jedrzej M.; Willemen, Hanneke L. D. M.; Pinto, Rita; Ho, Angela Y. Y.; Moen, Anders; Kjonstad, Ingrid F.; Burgering, Boudewijn M. T.; Zwartkruis, Fried; Eijkelkamp, Niels; Falnes, Pal O.			Lysine methylation by the mitochondrial methyltransferase FAM173B optimizes the function of mitochondrial ATP synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP synthase; post-translational modification (PTM); metabolic regulation; mitochondrial respiratory chain complex; mitochondria; protein methylation; ATP synthase c-subunit; FAM173B; methyltransferase; oxidative phosphorylation; protein lysine methylation; KMT; ATPSc-KMT	ELONGATION-FACTOR 1A; SEQUENCE-ANALYSIS; ROTOR RING; SUBUNIT-C; PROTEIN; TRANSLATION; IDENTIFICATION; RESIDUES; METTL21B; SET	Lysine methylation is an important post-translational modification that is also present on mitochondrial proteins, but the mitochondrial lysine-specific methyltransferases (KMTs) responsible for modification are in most cases unknown. Here, we set out to determine the function of human family with sequence similarity 173 member B (FAM173B), a mitochondrial methyltransferase (MTase) reported to promote chronic pain. Using bioinformatics analyses and biochemical assays, we found that FAM173B contains an atypical, noncleavable mitochondrial targeting sequence responsible for its localization to mitochondria. Interestingly, CRISPR/Cas9-mediated KO of FAM173B in mammalian cells abrogated trimethylation of Lys-43 in ATP synthase c-subunit (ATPSc), a modification previously reported as ubiquitous among metazoans. ATPSc methylation was restored by complementing the KO cells with enzymatically active human FAM173B or with a putative FAM173B orthologue from the nematode Caenorhabditis elegans. Interestingly, lack of Lys-43 methylation caused aberrant incorporation of ATPSc into the ATP synthase complex and resulted in decreased ATP-generating ability of the complex, as well as decreased mitochondrial respiration. In summary, we have identified FAM173B as the long-sought KMT responsible for methylation of ATPSc, a key protein in cellular ATP production, and have demonstrated functional significance of ATPSc methylation. We suggest renaming FAM173B to ATPSc-KMT (gene name ATPSCKMT).	[Malecki, Jedrzej M.; Pinto, Rita; Ho, Angela Y. Y.; Moen, Anders; Kjonstad, Ingrid F.; Falnes, Pal O.] Univ Oslo, Fac Math & Nat Sci, Dept Biosci, N-0316 Oslo, Norway; [Willemen, Hanneke L. D. M.; Eijkelkamp, Niels] Univ Utrecht, Univ Med Ctr Utrecht, Oncode Inst, Ctr Mol Med,LTI, NL-3584 EA Utrecht, Netherlands; [Burgering, Boudewijn M. T.; Zwartkruis, Fried] Univ Utrecht, Univ Med Ctr Utrecht, Oncode Inst, Ctr Mol Med,Mol Canc Res, NL-3584 EA Utrecht, Netherlands; [Kjonstad, Ingrid F.] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Dept Canc Immunol, N-0310 Oslo, Norway	University of Oslo; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Oslo	Malecki, JM; Falnes, PO (corresponding author), Univ Oslo, Fac Math & Nat Sci, Dept Biosci, N-0316 Oslo, Norway.	j.m.malecki@ibv.uio.no; pal.falnes@ibv.uio.no	Falnes, Pål Ø./AAA-4581-2020	Falnes, Pal/0000-0001-8114-6025; Burgering, Boudewijn/0000-0002-4044-9596; Malecki, Jedrzej/0000-0003-0825-7962; Fadum Kjonstad, Ingrid/0000-0001-5306-3492	Research Council of Norway [FRIMEDBIO-240009]; Norwegian Cancer Society [107744-PR-2007-0132]	Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society)	This work was supported by Research Council of Norway Grant FRIMEDBIO-240009 and Norwegian Cancer Society Grant 107744-PR-2007-0132. The authors declare that they have no conflicts of interest with the contents of this article.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Bedford MT, 2007, J CELL SCI, V120, P4243, DOI 10.1242/jcs.019885; Billiard J, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-19; Bolender N, 2008, EMBO REP, V9, P42, DOI 10.1038/sj.embor.7401126; Chen RM, 2004, J BIOL CHEM, V279, P21883, DOI 10.1074/jbc.M402074200; Chu YD, 2012, J BACTERIOL, V194, P6917, DOI 10.1128/JB.01535-12; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Cloutier P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003210; Davydova E, 2014, J BIOL CHEM, V289, P30499, DOI 10.1074/jbc.M114.601658; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Duncan AL, 2016, P NATL ACAD SCI USA, V113, P8687, DOI 10.1073/pnas.1608396113; Dzialo MC, 2014, BIOCHEM BIOPH RES CO, V455, P382, DOI 10.1016/j.bbrc.2014.11.022; Falnes PO, 2016, BIOCHEM J, V473, P1995, DOI 10.1042/BCJ20160117; Figaro S, 2008, FEBS LETT, V582, P2352, DOI 10.1016/j.febslet.2008.05.045; Fujikawa M, 2015, FEBS LETT, V589, P2707, DOI 10.1016/j.febslet.2015.08.006; GAY NJ, 1985, EMBO J, V4, P3519, DOI 10.1002/j.1460-2075.1985.tb04111.x; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hamey JJ, 2017, MOL CELL PROTEOMICS, V16, P2229, DOI 10.1074/mcp.M116.066308; Hamey JJ, 2016, MOL CELL PROTEOMICS, V15, P164, DOI 10.1074/mcp.M115.052449; Herz HM, 2013, TRENDS BIOCHEM SCI, V38, P621, DOI 10.1016/j.tibs.2013.09.004; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Jakobsson ME, 2017, NUCLEIC ACIDS RES, V45, P8239, DOI 10.1093/nar/gkx432; Jakobsson ME, 2013, J BIOL CHEM, V288, P27752, DOI 10.1074/jbc.M113.483248; KATZ ML, 1994, J BIOL CHEM, V269, P9906; Kernstock S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2041; KLEMENT P, 1995, ANAL BIOCHEM, V231, P218, DOI 10.1006/abio.1995.1523; Lanouette S, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.134974; Lipson RS, 2010, ARCH BIOCHEM BIOPHYS, V500, P137, DOI 10.1016/j.abb.2010.05.023; Malecki J, 2017, J BIOL CHEM, V292, P17950, DOI 10.1074/jbc.M117.808451; Malecki J, 2017, NUCLEIC ACIDS RES, V45, P4370, DOI 10.1093/nar/gkx002; Malecki J, 2016, J BIOL CHEM, V291, P9581, DOI 10.1074/jbc.M115.709261; Malecki J, 2015, J BIOL CHEM, V290, P423, DOI 10.1074/jbc.M114.614115; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Moore KE, 2014, BBA-GENE REGUL MECH, V1839, P1395, DOI 10.1016/j.bbagrm.2014.02.008; Niu YL, 2013, J BIOL CHEM, V288, P13728, DOI 10.1074/jbc.M113.452979; Peters MJ, 2013, ANN RHEUM DIS, V72, P427, DOI 10.1136/annrheumdis-2012-201742; Petrossian TC, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000976; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rhein VF, 2017, FEBS LETT, V591, P1641, DOI 10.1002/1873-3468.12649; Rhein VF, 2014, J BIOL CHEM, V289, P24640, DOI 10.1074/jbc.M114.580464; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Shimazu T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105394; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Van Bergen NJ, 2014, MITOCHONDRION, V15, P24, DOI 10.1016/j.mito.2014.03.003; Vollmar M, 2009, J BIOL CHEM, V284, P18228, DOI 10.1074/jbc.M109.006916; Walker JE, 2013, BIOCHEM SOC T, V41, P1, DOI 10.1042/BST20110773; Walpole TB, 2015, MOL CELL PROTEOMICS, V14, P828, DOI 10.1074/mcp.M114.047456; Wang XH, 2017, ELIFE, V6, DOI 10.7554/eLife.23908; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Watt IN, 2010, P NATL ACAD SCI USA, V107, P16823, DOI 10.1073/pnas.1011099107; Webb KJ, 2010, J BIOL CHEM, V285, P37598, DOI 10.1074/jbc.M110.170787; Willemen HLDM, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2003452; Xu T, 2015, MICROB CELL, V2, P105, DOI 10.15698/mic2015.04.197; YAN WL, 1994, GENOMICS, V24, P375, DOI 10.1006/geno.1994.1631	55	11	13	3	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1128	1141		10.1074/jbc.RA118.005473	http://dx.doi.org/10.1074/jbc.RA118.005473			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30530489	Green Published, hybrid			2022-12-28	WOS:000457879500006
J	Wollenberg, RD; Taft, MH; Giese, S; Thiel, C; Balazs, Z; Giese, H; Manstein, DJ; Sondergaard, TE				Wollenberg, Rasmus D.; Taft, Manuel H.; Giese, Sven; Thiel, Claudia; Balazs, Zoltan; Giese, Henriette; Manstein, Dietmar J.; Sondergaard, Teis E.			Phenamacril is a reversible and noncompetitive inhibitor of Fusarium class I myosin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fungi; myosin; ATPase; inhibitor; allosteric regulation; inhibition mechanism; cytoskeleton; fungicide; motor protein; phenamacril	ADENOSINE-TRIPHOSPHATASE; BLEBBISTATIN INHIBITION; FUNGICIDE JS399-19; CRYSTAL-STRUCTURE; MOTOR DOMAIN; DICTYOSTELIUM; MECHANISM; SPECIFICITY; PROTEIN; RESISTANCE	The cyanoacrylate compound phenamacril (also known as JS399-19) is a recently identified fungicide that exerts its antifungal effect on susceptible Fusarium species by inhibiting the ATPase activity of their myosin class I motor domains. Although much is known about the antifungal spectrum of phenamacril, the exact mechanism behind the phenamacril-mediated inhibition remains to be resolved. Here, we describe the characterization of the effect of phenamacril on purified myosin motor constructs from the model plant pathogen and phenamacril-susceptible species Fusarium graminearum, phenamacril-resistant Fusarium species, and the mycetozoan model organism Dictyostelium discoideum. Our results show that phenamacril potently (IC50 similar to 360 nm), reversibly, and noncompetitively inhibits ATP turnover, actin binding during ATP turnover, and motor activity of F. graminearum myosin-1. Phenamacril also inhibits the ATPase activity of Fusarium avenaceum myosin-1 but has little or no inhibitory effect on the motor activity of Fusarium solani myosin-1, human myosin-1c, and D. discoideum myosin isoforms 1B, 1E, and 2. Our findings indicate that phenamacril is a species-specific, noncompetitive inhibitor of class I myosin in susceptible Fusarium sp.	[Wollenberg, Rasmus D.; Balazs, Zoltan; Giese, Henriette; Sondergaard, Teis E.] Aalborg Univ, Dept Chem & Biosci, DK-9220 Aalborg, Denmark; [Taft, Manuel H.; Giese, Sven; Manstein, Dietmar J.] Hannover Med Sch, Inst Biophys Chem, OE4350, D-30623 Hannover, Germany; [Thiel, Claudia; Manstein, Dietmar J.] Hannover Med Sch, Div Struct Biochem, OE8830, D-30623 Hannover, Germany	Aalborg University; Hannover Medical School; Hannover Medical School	Sondergaard, TE (corresponding author), Aalborg Univ, Dept Chem & Biosci, DK-9220 Aalborg, Denmark.; Manstein, DJ (corresponding author), Hannover Med Sch, Inst Biophys Chem, OE4350, D-30623 Hannover, Germany.; Manstein, DJ (corresponding author), Hannover Med Sch, Div Struct Biochem, OE8830, D-30623 Hannover, Germany.	manstein.dietmar@mh-hannover.de; tes@bio.aau.dk	Manstein, Dietmar J./AAG-2640-2019; Taft, Manuel H/T-2508-2017; Taft, Manuel/O-1396-2019; Manstein, Dietmar J. J/M-1034-2013; Sondergaard, Teis/F-4122-2014	Manstein, Dietmar J./0000-0003-0763-0147; Taft, Manuel H/0000-0001-5853-8629; Taft, Manuel/0000-0001-5853-8629; Manstein, Dietmar J. J/0000-0003-0763-0147; Wollenberg, Rasmus/0000-0002-8320-2497; Sondergaard, Teis/0000-0002-4455-7498; Giese, Sven/0000-0003-0984-0543	Danish Ministry of Higher Education and Science [4005-00204B]; Deutsche Forschungsgemeinschaft [MA1081/22-01]; Volkswagen Foundation [VWZN3012]	Danish Ministry of Higher Education and Science; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Volkswagen Foundation(Volkswagen)	This work was supported by The Danish Ministry of Higher Education and Science Grant 4005-00204B (to T. E. S.), Deutsche Forschungsgemeinschaft Grant MA1081/22-01 (to D. J. M), and Volkswagen Foundation Grant VWZN3012 (to M. H. T. and D. J. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Allingham JS, 2005, NAT STRUCT MOL BIOL, V12, P378, DOI 10.1038/nsmb908; Anson M, 1996, EMBO J, V15, P6069, DOI 10.1002/j.1460-2075.1996.tb00995.x; BAGSHAW CR, 1975, FEBS LETT, V58, P197, DOI 10.1016/0014-5793(75)80258-4; Behrens VA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07933-y; Bird JE, 2014, P NATL ACAD SCI USA, V111, P12390, DOI 10.1073/pnas.1409459111; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Chen Y, 2008, PHYTOPARASITICA, V36, P326, DOI 10.1007/BF02980812; Chen Y, 2011, AGR SCI CHINA, V10, P1906, DOI 10.1016/S1671-2927(11)60191-0; Chinthalapudi K, 2011, J BIOL CHEM, V286, P29700, DOI 10.1074/jbc.M111.239210; DELOZANNE A, 1987, SCIENCE, V236, P1086, DOI 10.1126/science.3576222; Donau SS, 2017, EUR J ORG CHEM, V2017, P6408, DOI 10.1002/ejoc.201701235; Durrwang U, 2006, J CELL SCI, V119, P550, DOI 10.1242/jcs.02774; Fedorov R, 2009, NAT STRUCT MOL BIOL, V16, P80, DOI 10.1038/nsmb.1542; Furch M, 1998, BIOCHEMISTRY-US, V37, P6317, DOI 10.1021/bi972851y; Hou YP, 2018, PEST MANAG SCI, V74, P607, DOI 10.1002/ps.4742; Kollmar M, 2002, EMBO J, V21, P2517, DOI 10.1093/emboj/21.11.2517; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; Krieger E, 2014, BIOINFORMATICS, V30, P2981, DOI 10.1093/bioinformatics/btu426; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; KRON SJ, 1986, P NATL ACAD SCI USA, V83, P6272, DOI 10.1073/pnas.83.17.6272; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; Kurzawa SE, 1997, BIOCHEMISTRY-US, V36, P317, DOI 10.1021/bi962166b; LEHRER SS, 1972, BIOCHEMISTRY-US, V11, P1211, DOI 10.1021/bi00757a015; Li B, 2016, PLANT DIS, V100, P1754, DOI 10.1094/PDIS-02-16-0169-RE; Li HK, 2008, CROP PROT, V27, P90, DOI 10.1016/j.cropro.2007.04.010; Limouze J, 2004, J MUSCLE RES CELL M, V25, P337, DOI 10.1007/s10974-004-6060-7; Lysoe E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112703; Madrid MP, 2003, MOL MICROBIOL, V47, P257, DOI 10.1046/j.1365-2958.2003.03299.x; Makowska KA, 2015, CELL REP, V13, P2118, DOI 10.1016/j.celrep.2015.11.012; MANSTEIN DJ, 1989, SCIENCE, V246, P656, DOI 10.1126/science.2530629; MANSTEIN DJ, 1989, EMBO J, V8, P923, DOI 10.1002/j.1460-2075.1989.tb03453.x; McCluskey K, 2010, J BIOSCIENCES, V35, P119, DOI 10.1007/s12038-010-0014-6; Munnich S, 2014, J MOL BIOL, V426, P2070, DOI 10.1016/j.jmb.2014.03.004; Odronitz F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r196; Planelles-Herrero VJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00176-5; Preller M, 2013, STRUCTURE, V21, P1911, DOI 10.1016/j.str.2013.09.015; Preller M, 2011, J MED CHEM, V54, P3675, DOI 10.1021/jm200259f; Salvesen GS, 2007, STRUCTURE, V15, P513, DOI 10.1016/j.str.2007.04.006; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Schweizer A, 2007, STRUCTURE, V15, P625, DOI 10.1016/j.str.2007.03.014; Sirigu S, 2016, P NATL ACAD SCI USA, V113, pE7448, DOI 10.1073/pnas.1609342113; Song B, 2013, FUNGAL GENET BIOL, V54, P60, DOI 10.1016/j.fgb.2013.02.010; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Taft MH, 2008, J BIOL CHEM, V283, P26902, DOI 10.1074/jbc.M802957200; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tsiavaliaris G, 2008, J BIOL CHEM, V283, P4520, DOI 10.1074/jbc.M708113200; Vallotton P, 2013, MICROSC MICROANAL, V19, P451, DOI 10.1017/S1431927612014328; WESSELS D, 1991, CELL MOTIL CYTOSKEL, V20, P301, DOI 10.1002/cm.970200406; WOLENSKI JS, 1995, TRENDS CELL BIOL, V5, P310, DOI 10.1016/S0962-8924(00)89053-4; Wollenberg RD, 2016, PESTIC BIOCHEM PHYS, V134, P24, DOI 10.1016/j.pestbp.2016.05.002; Zhang CQ, 2015, ENVIRON MICROBIOL, V17, P2735, DOI 10.1111/1462-2920.12711; Zheng ZT, 2018, PESTIC BIOCHEM PHYS, V147, P119, DOI 10.1016/j.pestbp.2017.12.007; Zheng ZT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154058; Zheng ZT, 2015, SCI REP-UK, V5, DOI 10.1038/srep08248	54	8	9	7	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1328	1337		10.1074/jbc.RA118.005408	http://dx.doi.org/10.1074/jbc.RA118.005408			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30504222	Green Published, hybrid			2022-12-28	WOS:000457879500023
J	Zysnarski, CJ; Lahiri, S; Javed, FT; Martinez-Marquez, JY; Trowbridge, JW; Duncan, MC				Zysnarski, Christopher J.; Lahiri, Sagar; Javed, Fatima T.; Martinez-Marquez, Jorge Y.; Trowbridge, Justin W.; Duncan, Mara C.			Adaptor protein complex-1 (AP-1) is recruited by the HEATR5 protein Laa1 and its co-factor Laa2 in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						clathrin; protein trafficking (Golgi); endosome; membrane trafficking; adaptor protein; gamma-ear; CLBA; HEAT repeat-containing 5; HEATR5; lysosome	CLATHRIN ADAPTER; GAMMA-ADAPTIN; STRUCTURAL BASIS; BUDDING YEAST; GOLGI; BINDING; LOCALIZATION; VERSATILE; SELECTION; DELETION	Cellular membrane trafficking mediated by the clathrin adaptor protein complex-1 (AP-1) is important for the proper composition and function of organelles of the endolysosomal system. Normal AP-1 function requires proteins of the HEAT repeat-containing 5 (HEATR5) family. Although HEATR5 proteins were first identified based on their ability to interact with AP-1, the functional significance of this interaction was unknown. We used bioinformatics-based phenotypic profiling and information from genome-wide fluorescence microscopy studies in the budding yeast Saccharomyces cerevisiae to identify a protein, Laa2, that mediates the interaction between AP-1 and the yeast HEATR5 protein Laa1. Further characterization of Laa2 revealed that it binds to both Laa1 and AP-1. Laa2 contains a motif similar to the characterized gamma-ear-binding sites found in other AP-1-binding proteins. This motif in Laa2 is essential for the Laa1-AP-1 interaction. Moreover, mutation of this motif disrupted AP-1 localization and function and caused effects similar to mutations that remove the gamma-ear of AP-1. These results indicate that Laa2 mediates the interaction between Laa1 and AP-1 and reveal that this interaction promotes the stable association of AP-1 with membranes in yeast.	[Zysnarski, Christopher J.; Javed, Fatima T.; Martinez-Marquez, Jorge Y.; Trowbridge, Justin W.; Duncan, Mara C.] Univ Michigan, Cell & Dev Biol Dept, Ann Arbor, MI 48109 USA; [Lahiri, Sagar] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Duncan, MC (corresponding author), Univ Michigan, Cell & Dev Biol Dept, Ann Arbor, MI 48109 USA.	mcduncan@umich.edu	Duncan, Mara/Z-6236-2019	Duncan, Mara/0000-0002-2383-0109; Zysnarski, Christopher/0000-0002-1474-9499; Javed, Fatima/0000-0002-5939-8039; Martinez-Marquez, Jorge/0000-0003-1485-4800	National Institutes of Health [R01 GM092741, F31-GM112470]; Michigan Protein Folding Disease Initiative	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan Protein Folding Disease Initiative	This work was supported by National Institutes of Health Grants R01 GM092741 (to M. C. D.) and F31-GM112470 (J. Y. M.-M) and by funds from the Michigan Protein Folding Disease Initiative (to M. C. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aoh QL, 2011, MOL BIOL CELL, V22, P3671, DOI 10.1091/mbc.E11-04-0309; Aravamudhan P, 2014, CURR BIOL, V24, P1437, DOI 10.1016/j.cub.2014.05.014; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Canagarajah BJ, 2013, PROTEIN SCI, V22, P517, DOI 10.1002/pro.2235; Crottet P, 2002, MOL BIOL CELL, V13, P3672, DOI 10.1091/mbc.E02-05-0309; Daboussi L, 2012, NAT CELL BIOL, V14, P239, DOI 10.1038/ncb2427; Day KJ, 2018, DEV CELL, V44, P56, DOI 10.1016/j.devcel.2017.12.014; Duncan MC, 2003, TRENDS CELL BIOL, V13, P211, DOI 10.1016/S0962-8924(03)00076-X; Duncan MC, 2003, NAT CELL BIOL, V5, P77, DOI 10.1038/ncb901; Fernandez GE, 2006, MOL BIOL CELL, V17, P3304, DOI 10.1091/mbc.E06-02-0096; Giaever G, 2014, GENETICS, V197, P451, DOI 10.1534/genetics.114.161620; Gillard G, 2015, DEVELOPMENT, V142, P1684, DOI 10.1242/dev.118216; Hirst J, 2005, MOL BIOL CELL, V16, P2554, DOI 10.1091/mbc.E04-12-1077; Hoepfner D, 2014, MICROBIOL RES, V169, P107, DOI 10.1016/j.micres.2013.11.004; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Hung CW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30305-z; Hung CW, 2016, MOL BIOL CELL, V27, P1143, DOI 10.1091/mbc.E15-08-0588; Hung CW, 2012, J BIOL CHEM, V287, P17398, DOI 10.1074/jbc.M112.349035; James P, 1996, GENETICS, V144, P1425; Karathia H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016015; Kirchhausen T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016725; Lang MJ, 2014, J BIOL CHEM, V289, P16736, DOI 10.1074/jbc.M113.525782; Le Bras S, 2012, J CELL SCI, V125, P4886, DOI 10.1242/jcs.110171; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Losev E, 2006, NATURE, V441, P1002, DOI 10.1038/nature04717; Lui WWY, 2003, MOL BIOL CELL, V14, P2385, DOI 10.1091/mbc.e02-11-0735; Lui-Roberts WWY, 2008, MOL BIOL CELL, V19, P5072, DOI 10.1091/mbc.E08-03-0301; Lund FW, 2014, TRAFFIC, V15, P1406, DOI 10.1111/tra.12228; Matsuura-Tokita K, 2006, NATURE, V441, P1007, DOI 10.1038/nature04737; Mattera R, 2004, J BIOL CHEM, V279, P8018, DOI 10.1074/jbc.M311873200; Nogi T, 2002, NAT STRUCT BIOL, V9, P527, DOI 10.1038/nsb808; Noguchi Chiaki, 2008, Biotechnology Journal, V3, P1280, DOI 10.1002/biot.200800140; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Owen DJ, 2004, ANNU REV CELL DEV BI, V20, P153, DOI 10.1146/annurev.cellbio.20.010403.104543; Paczkowski JE, 2015, TRENDS CELL BIOL, V25, P408, DOI 10.1016/j.tcb.2015.02.005; RAD MR, 1995, J CELL SCI, V108, P1605; Rainey MM, 2010, GENETICS, V185, P1221, DOI 10.1534/genetics.110.117846; Ren XF, 2013, CELL, V152, P755, DOI 10.1016/j.cell.2012.12.042; Renard HF, 2010, TRAFFIC, V11, P931, DOI 10.1111/j.1600-0854.2010.01070.x; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; ROBINSON MS, 1993, J CELL BIOL, V123, P67, DOI 10.1083/jcb.123.1.67; STEPP JD, 1995, MOL BIOL CELL, V6, P41, DOI 10.1091/mbc.6.1.41; Takatsu H, 2000, BIOCHEM BIOPH RES CO, V271, P719, DOI 10.1006/bbrc.2000.2700; Traub LM, 2005, BBA-MOL CELL RES, V1744, P415, DOI 10.1016/j.bbamcr.2005.04.005; Valdivia RH, 2002, DEV CELL, V2, P283, DOI 10.1016/S1534-5807(02)00127-2; Whitfield ST, 2016, MOL BIOL CELL, V27, P588, DOI 10.1091/mbc.E15-09-0621; Yeung BG, 1999, MOL BIOL CELL, V10, P3643, DOI 10.1091/mbc.10.11.3643; Yip CK, 2010, NAT STRUCT MOL BIOL, V17, P1298, DOI 10.1038/nsmb.1914; Yoshimura SH, 2016, J CELL SCI, V129, P3963, DOI 10.1242/jcs.185710; Yu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068488; Yu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045324	51	6	6	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1410	1419		10.1074/jbc.RA118.005253	http://dx.doi.org/10.1074/jbc.RA118.005253			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30523155	hybrid, Green Published			2022-12-28	WOS:000457879500029
J	Ding, MR; Jiang, JY; Yang, FR; Zheng, F; Fang, JW; Wang, Q; Wang, JY; Yao, W; Liu, X; Gao, XJ; Mullen, M; He, P; Rono, C; Ding, X; Hong, JJ; Fu, CH; Liu, X; Yao, XB				Ding, Mingrui; Jiang, Jiying; Yang, Fengrui; Zheng, Fan; Fang, Jingwen; Wang, Qian; Wang, Jianyu; Yao, William; Liu, Xu; Gao, Xinjiao; Mullen, McKay; He, Ping; Rono, Cathy; Ding, Xia; Hong, Jingjun; Fu, Chuanhai; Liu, Xing; Yao, Xuebiao			Holliday junction recognition protein interacts with and specifies the centromeric assembly of CENP-T	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitosis; centromere; chromosomes; chaperone; kinetochore; CENP-A; CENP-E; CENP-T; HJURP; Synthelin	A NUCLEOSOMES; AURORA B; HJURP; KINETOCHORES; COMPLEX; FORMS; SCM3; VISUALIZATION; LOCALIZATION; MICROTUBULES	The centromere is an evolutionarily conserved eukaryotic protein machinery essential for precision segregation of the parental genome into two daughter cells during mitosis. Centromere protein A (CENP-A) organizes the functional centromere via a constitutive centromere-associated network composing the CENP-T complex. However, how CENP-T assembles onto the centromere remains elusive. Here we show that CENP-T binds directly to Holliday junction recognition protein (HJURP), an evolutionarily conserved chaperone involved in loading CENP-A. The binding interface of HJURP was mapped to the C terminus of CENP-T. Depletion of HJURP by CRISPR-elicited knockout minimized recruitment of CENP-T to the centromere, indicating the importance of HJURP in CEPN-T loading. Our immunofluorescence analyses indicate that HJURP recruits CENP-T to the centromere in S/G(2) phase during the cell division cycle. Significantly, the HJURP binding-deficient mutant CENP-T-6L failed to locate to the centromere. Importantly, CENP-T insufficiency resulted in chromosome misalignment, in particular chromosomes 15 and 18. Taken together, these data define a novel molecular mechanism underlying the assembly of CENP-T onto the centromere by a temporally regulated HJURP-CENP-T interaction.	[Ding, Mingrui; Jiang, Jiying; Yang, Fengrui; Zheng, Fan; Fang, Jingwen; Wang, Qian; Wang, Jianyu; Liu, Xu; Gao, Xinjiao; Hong, Jingjun; Fu, Chuanhai; Liu, Xing; Yao, Xuebiao] Univ Sci & Technol China, Anhui Key Lab Cellular Dynam & Chem Biol, Hefei Natl Ctr Phys Sci Microscale, Chinese Acad Sci,Ctr Excellence Cell Sci,Sch Life, Hefei 230027, Anhui, Peoples R China; [Ding, Mingrui; Wang, Jianyu; Yao, William; Liu, Xu; Mullen, McKay; He, Ping; Rono, Cathy] Morehouse Sch Med, Keck Ctr Cellular Dynam & Organoid Plast, Atlanta, GA 30310 USA; [Ding, Xia] Beijing Univ Chinese Med, Beijing 100029, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Morehouse School of Medicine; Beijing University of Chinese Medicine	Liu, X; Yao, XB (corresponding author), Univ Sci & Technol China, Anhui Key Lab Cellular Dynam & Chem Biol, Hefei Natl Ctr Phys Sci Microscale, Chinese Acad Sci,Ctr Excellence Cell Sci,Sch Life, Hefei 230027, Anhui, Peoples R China.	xing1017@ustc.edu.cn; yaoxb@ustc.edu.cn	Zheng, Fan/GNM-9399-2022; Yao, Xuebiao/P-5771-2014; Liu, Xing/H-2989-2018; Fu, Chuanhai/G-8303-2016; Hong, Jingjun/V-7281-2019	Zheng, Fan/0000-0001-7005-0941; Liu, Xing/0000-0002-7480-5085; Fu, Chuanhai/0000-0003-4354-3796; 	National Natural Science Foundation of China [31320103904, 31621002, 31430054, 31671405]; National Key Research and Development Program of China [2017YFA0503600, 2016YFA0100500]; Chinese Academy of Sciences [XDB19000000]; 973 Project Grants [2012CB917204, 2014CB964803, 2002CB713703]; Chinese Academy of Sciences Center for Excellence in Molecular Cell Sciences [2015HSC-UE010]; MOE [IRT_17R102]; NIDDK, National Institutes of Health [DK56292, DK115812]; NCI, National Institutes of Health [CA164133]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK115812] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Chinese Academy of Sciences(Chinese Academy of Sciences); 973 Project Grants(National Basic Research Program of China); Chinese Academy of Sciences Center for Excellence in Molecular Cell Sciences; MOE(Ministry of Higher Education & Scientific Research (MHESR)); NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Natural Science Foundation of China Grants 31320103904, 31621002, 31430054, and 31671405; National Key Research and Development Program of China Grants 2017YFA0503600 and 2016YFA0100500; Strategic Priority Research Program of the Chinese Academy of Sciences Grant XDB19000000; 973 Project Grants 2012CB917204, 2014CB964803, and 2002CB713703; Chinese Academy of Sciences Center for Excellence in Molecular Cell Sciences Grant 2015HSC-UE010; MOE Innovative Team Grant IRT_17R102; NIDDK, National Institutes of Health Grants DK56292 and DK115812; and NCI, National Institutes of Health Grant CA164133. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alabert C, 2012, NAT REV MOL CELL BIO, V13, P153, DOI 10.1038/nrm3288; Barnhart MC, 2011, J CELL BIOL, V194, P229, DOI 10.1083/jcb.201012017; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Bassett EA, 2012, DEV CELL, V22, P749, DOI 10.1016/j.devcel.2012.02.001; Black BE, 2010, COLD SH Q B, V75, P403, DOI 10.1101/sqb.2010.75.038; Black BE, 2007, P NATL ACAD SCI USA, V104, P5008, DOI 10.1073/pnas.0700390104; Bodor DL, 2013, EMBO J, V32, P2090, DOI 10.1038/emboj.2013.150; Bodor DL, 2013, MOL BIOL CELL, V24, P923, DOI 10.1091/mbc.E13-01-0034; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Carroll CW, 2009, NAT CELL BIOL, V11, P896, DOI 10.1038/ncb1899; Chittori S, 2018, SCIENCE, V359, P339, DOI 10.1126/science.aar2781; Cho US, 2011, P NATL ACAD SCI USA, V108, P9367, DOI 10.1073/pnas.1106389108; Chu LL, 2012, J MOL CELL BIOL, V4, P331, DOI 10.1093/jmcb/mjs023; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Dornblut C, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.130229; Dou Z, 2015, P NATL ACAD SCI USA, V112, pE4546, DOI 10.1073/pnas.1508791112; Dunleavy EM, 2009, CELL, V137, P485, DOI 10.1016/j.cell.2009.02.040; Fang C, 2017, J MOL CELL BIOL, V9, P504, DOI 10.1093/jmcb/mjx043; Foltz DR, 2009, CELL, V137, P472, DOI 10.1016/j.cell.2009.02.039; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Hong JJ, 2013, J MOL BIOL, V425, P536, DOI 10.1016/j.jmb.2012.11.021; Hu H, 2011, GENE DEV, V25, P901, DOI 10.1101/gad.2045111; Hua SS, 2011, J BIOL CHEM, V286, P1627, DOI 10.1074/jbc.M110.174946; in't Veld PJH, 2016, ELIFE, V5, DOI 10.7554/eLife.21007; Krizaic I, 2015, NUCLEUS-PHILA, V6, P133, DOI 10.1080/19491034.2014.1003509; Liu D, 2009, SCIENCE, V323, P1350, DOI 10.1126/science.1167000; Liu D, 2016, J MOL CELL BIOL, V8, P144, DOI 10.1093/jmcb/mjv066; Liu X, 2014, J BIOL CHEM, V289, P20638, DOI 10.1074/jbc.M114.572842; Ly P, 2017, NAT CELL BIOL, V19, P68, DOI 10.1038/ncb3450; Ma HH, 2013, P NATL ACAD SCI USA, V110, P21048, DOI 10.1073/pnas.1319097110; McKinley KL, 2015, MOL CELL, V60, P886, DOI 10.1016/j.molcel.2015.10.027; McKinley KL, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.5; Mo F, 2016, NAT CHEM BIOL, V12, P226, DOI [10.1038/NCHEMBIO.2017, 10.1038/nchembio.2017]; Muller S, 2014, CELL REP, V8, P190, DOI 10.1016/j.celrep.2014.06.002; Nishino T, 2013, EMBO J, V32, P424, DOI 10.1038/emboj.2012.348; Nishino T, 2012, CELL, V148, P487, DOI 10.1016/j.cell.2011.11.061; Pentakota S, 2017, ELIFE, V6, DOI 10.7554/eLife.33442; Pidoux AL, 2009, MOL CELL, V33, P299, DOI 10.1016/j.molcel.2009.01.019; Prendergast L, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001082; Rago F, 2015, CURR BIOL, V25, P671, DOI 10.1016/j.cub.2015.01.059; Sanchez-Pulido L, 2009, CELL, V137, P1173, DOI 10.1016/j.cell.2009.06.010; Sarangapani KK, 2014, TRENDS GENET, V30, P150, DOI 10.1016/j.tig.2014.02.004; Schleiffer A, 2012, NAT CELL BIOL, V14, P604, DOI 10.1038/ncb2493; Shuaib M, 2010, P NATL ACAD SCI USA, V107, P1349, DOI 10.1073/pnas.0913709107; Smith L, 2017, DEV CELL, V42, P110, DOI 10.1016/j.devcel.2017.07.011; Stoler S, 2007, P NATL ACAD SCI USA, V104, P10571, DOI 10.1073/pnas.0703178104; Takeuchi K, 2014, NUCLEIC ACIDS RES, V42, P1644, DOI 10.1093/nar/gkt1124; Tian T, 2018, CELL RES, V28, P374, DOI 10.1038/cr.2018.13; Wang JY, 2014, J BIOL CHEM, V289, P8326, DOI 10.1074/jbc.M113.529958; Yang Y, 2018, J MOL CELL BIOL, V10, P89, DOI 10.1093/jmcb/mjx048; Yao XB, 2000, NAT CELL BIOL, V2, P484, DOI 10.1038/35019518; Yao XB, 2009, CELL RES, V19, P152, DOI 10.1038/cr.2009.7; Zasadzinska E, 2018, DEV CELL, V47, P348, DOI 10.1016/j.devcel.2018.09.003; Zasadzinska E, 2013, EMBO J, V32, P2113, DOI 10.1038/emboj.2013.142; Zhou Z, 2011, NATURE, V472, P234, DOI 10.1038/nature09854; Zhu LJ, 2015, J BIOL CHEM, V290, P27053, DOI 10.1074/jbc.M115.658534	56	6	7	1	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2019	294	3					968	980		10.1074/jbc.RA118.004688	http://dx.doi.org/10.1074/jbc.RA118.004688			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL4FC	30459232	Green Published, hybrid			2022-12-28	WOS:000458670200021
J	Prasad, Y; Kumar, R; Chaudhary, AK; Dhanaraju, R; Majumdar, S; Rao, DN				Prasad, Yedu; Kumar, Ritesh; Chaudhary, Awanish Kumar; Dhanaraju, Rajkumar; Majumdar, Soneya; Rao, Desirazu N.			Kinetic and catalytic properties of M.HpyAXVII, a phase-variable DNA methyltransferase from Helicobacter pylori	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA methyltransferase; enzyme kinetics; enzyme mechanism; S-adenosylmethionine (AdoMet); bioinformatics; allosteric regulation; DNA binding; M.HpyAXVII; ordered Bi Bi mechanism; phase variation	AMINO-ACID-RESIDUES; FUNCTIONAL ROLES; SEQUENCE; MECHANISM; METHYLATION; PROTEINS; TRANSCRIPTION; RECOGNITION; MUTAGENESIS; SYSTEM	The bacterium Helicobacter pylori is one of the most common infectious agents found in the human stomach. H. pylori has an unusually large number of DNA methyltransferases (MTases), prompting speculation that they may be involved in the cancerization of epithelial cells. The mod-4a/4b locus, consisting of the hp1369 and hp1370 ORFs, encodes for a truncated and inactive MTase in H. pylori strain 26695. However, slipped-strand synthesis within the phase-variable polyguanine tract in hp1369 results in expression of an active HP1369-1370 fusion N-6-adenine methyltransferase, designated M.HpyAXVII. Sequence analysis of the mod-4a/4b locus across 74 H. pylori strain genomes has provided insights into the regulation of M.HpyAXVII expression. To better understand the role of M.HpyAXVII in the H. pylori biology, here we cloned and overexpressed the hp1369-70 fusion construct in Escherichia coli BL21(DE3) cells. Results from size-exclusion chromatography and multi-angle light scattering (MALS) analyses suggested that M.HpyAXVII exists as a dimer in solution. Kinetic studies, including product and substrate inhibition analyses, initial velocity dependence between substrates, and isotope partitioning, suggested that M.HpyAXVII catalyzes DNA methylation in an ordered Bi Bi mechanism in which the AdoMet binding precedes DNA binding and AdoMet's methyl group is then transferred to an adenine within the DNA recognition sequence. Altering the highly conserved catalytic motif (DPP(Y/F)) as well as the AdoMet-binding motif (FXGXG) by site-directed mutagenesis abolished the catalytic activity of M.HpyAXVII. These results provide insights into the enzyme kinetic mechanism of M.HpyAXVII. We propose that AdoMet binding conformationally "primes" the enzyme for DNA binding.	[Prasad, Yedu; Kumar, Ritesh; Chaudhary, Awanish Kumar; Dhanaraju, Rajkumar; Rao, Desirazu N.] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [Majumdar, Soneya] Indian Inst Technol, Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India; [Prasad, Yedu] CSIR, Shyama Prasad Mukherjee Fellowship Program, New Delhi, India; [Kumar, Ritesh] CSIR, New Delhi, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur; Council of Scientific & Industrial Research (CSIR) - India; Council of Scientific & Industrial Research (CSIR) - India	Rao, DN (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	dnrao@iisc.ac.in	KUMAR, RITESH/P-1265-2019	KUMAR, RITESH/0000-0001-7170-8645; Prasad, Yedu/0000-0002-1481-9071	Department of Science and Technology; DBT-IISc Partnership Program	Department of Science and Technology(Department of Science & Technology (India)); DBT-IISc Partnership Program	This work was supported by grants from the Department of Science and Technology (J. C. Bose fellowship) and the DBT-IISc Partnership Program (to D. N. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Adhikari S, 2016, FEMS MICROBIOL REV, V40, P575, DOI 10.1093/femsre/fuw023; Ahmad I, 1996, CRIT REV BIOCHEM MOL, V31, P361, DOI 10.3109/10409239609108722; AHMAD I, 1995, GENE, V157, P143, DOI 10.1016/0378-1119(95)00671-R; BALDWIN GS, 1994, J MOL BIOL, V235, P545, DOI 10.1006/jmbi.1994.1012; Bhattacharya SK, 1999, J BIOL CHEM, V274, P14743, DOI 10.1074/jbc.274.21.14743; Bheemanaik S, 2003, J BIOL CHEM, V278, P7863, DOI 10.1074/jbc.M211458200; Bheemanaik S, 2006, BIOCHEM J, V399, P177, DOI 10.1042/BJ20060854; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chung D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043844; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; de Vries N, 2002, J BACTERIOL, V184, P6615, DOI 10.1128/JB.184.23.6615-6624.2002; DELACAMPA AG, 1987, J MOL BIOL, V196, P457, DOI 10.1016/0022-2836(87)90024-6; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EHRLICH M, 1987, J BACTERIOL, V169, P939, DOI 10.1128/jb.169.3.939-943.1987; Evdokimov AA, 2002, J BIOL CHEM, V277, P279, DOI 10.1074/jbc.M108864200; Furuta Y, 2012, NUCLEIC ACIDS RES, V40, P9218, DOI 10.1093/nar/gks681; HERMAN GE, 1982, J BIOL CHEM, V257, P2605; HOCHULI E, 1987, J CHROMATOGR, V411, P177, DOI 10.1016/S0021-9673(00)93969-4; Humbert O, 2008, NUCLEIC ACIDS RES, V36, P6893, DOI 10.1093/nar/gkn718; Jeltsch A, 2002, CHEMBIOCHEM, V3, P275, DOI 10.1002/1439-7633(20020402)3:4<274::AID-CBIC274>3.0.CO;2-S; Kirsch RD, 1998, NUCLEIC ACIDS RES, V26, P1848, DOI 10.1093/nar/26.7.1848; Krebes J, 2014, NUCLEIC ACIDS RES, V42, P2415, DOI 10.1093/nar/gkt1201; Kumar R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042303; Kumar R, 2012, FEBS J, V279, P1080, DOI 10.1111/j.1742-4658.2012.08502.x; Kumar R, 2010, FEBS J, V277, P1666, DOI 10.1111/j.1742-4658.2010.07593.x; Kumar S, 2018, NUCLEIC ACIDS RES, V46, P3429, DOI 10.1093/nar/gky126; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; MALONE T, 1995, J MOL BIOL, V253, P618, DOI 10.1006/jmbi.1995.0577; Marinus MG, 2009, FEMS MICROBIOL REV, V33, P488, DOI 10.1111/j.1574-6976.2008.00159.x; Minton AP, 2016, ANAL BIOCHEM, V501, P4, DOI 10.1016/j.ab.2016.02.007; Pues H, 1999, BIOCHEMISTRY-US, V38, P1426, DOI 10.1021/bi9818016; RAO DN, 1989, J MOL BIOL, V209, P599, DOI 10.1016/0022-2836(89)90597-4; REICH NO, 1991, BIOCHEMISTRY-US, V30, P2933, DOI 10.1021/bi00225a029; Roth M, 1998, J BIOL CHEM, V273, P17333, DOI 10.1074/jbc.273.28.17333; RUBIN RA, 1977, J BIOL CHEM, V252, P7265; Sankpal UT, 2002, NUCLEIC ACIDS RES, V30, P2628, DOI 10.1093/nar/gkf380; Saunders NJ, 1998, MOL MICROBIOL, V27, P1091, DOI 10.1046/j.1365-2958.1998.00768.x; Scarlato V, 2001, INT J MED MICROBIOL, V291, P107, DOI 10.1078/1438-4221-00107; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Shier VK, 2001, J BIOL CHEM, V276, P14744, DOI 10.1074/jbc.M010688200; Sitaraman R, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00115; Srikhanta YN, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15721-x; Srikhanta YN, 2010, NAT REV MICROBIOL, V8, P196, DOI 10.1038/nrmicro2283; Szegedi SS, 2000, NUCLEIC ACIDS RES, V28, P3962, DOI 10.1093/nar/28.20.3962; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; WILLEMS R, 1990, EMBO J, V9, P2803, DOI 10.1002/j.1460-2075.1990.tb07468.x; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Yokochi T, 2002, J BIOL CHEM, V277, P11735, DOI 10.1074/jbc.M106590200	49	4	4	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2019	294	3					1019	1034		10.1074/jbc.RA118.003769	http://dx.doi.org/10.1074/jbc.RA118.003769			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL4FC	30478171	hybrid, Green Published			2022-12-28	WOS:000458670200025
J	Yan, Y; Zhou, XE; Novick, SJ; Shaw, SJ; Li, YW; Brunzelle, JS; Hitoshi, Y; Griffin, PR; Xu, HE; Melcher, K				Yan, Yan; Zhou, X. Edward; Novick, Scott J.; Shaw, Simon J.; Li, Yingwu; Brunzelle, Joseph S.; Hitoshi, Yasumichi; Griffin, Patrick R.; Xu, H. Eric; Melcher, Karsten			Structures of AMP-activated protein kinase bound to novel pharmacological activators in phosphorylated, non-phosphorylated, and nucleotide-free states	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated kinase (AMPK); AMP; hydrogen exchange mass spectrometry; X-ray crystallography; phosphorylation; activation loop phosphorylation; ADaM site; CBS3; R734; R739; metabolic disorder; energy sensor	GAMMA-SUBUNIT ISOFORMS; UPSTREAM KINASE; ENERGY SENSOR; METFORMIN; MECHANISM; DRUGS; BETA; IDENTIFICATION; HEPATOCYTES; A-769662	AMP-activated protein kinase (AMPK) is an attractive therapeutic target for managing metabolic diseases. A class of pharmacological activators, including Merck 991, binds the AMPK ADaM site, which forms the interaction surface between the kinase domain (KD) of the alpha-subunit and the carbohydrate-binding module (CBM) of the beta-subunit. Here, we report the development of two new 991-derivative compounds, R734 and R739, which potently activate AMPK in a variety of cell types, including beta(2)-specific skeletal muscle cells. Surprisingly, we found that they have only minor effects on direct kinase activity of the recombinant alpha(1)beta(2)gamma(1) isoform yet robustly enhance protection against activation loop dephosphorylation. This mode of activation is reminiscent of that of ADP, which activates AMPK by binding to the nucleotide-binding sites in the gamma-subunit, more than 60 A away from the ADaM site. To understand the mechanisms of full and partial AMPK activation, we determined the crystal structures of fully active phosphorylated AMPK alpha(1)beta(1)gamma(1) bound to AMP and R734/R739 as well as partially active nonphosphorylated AMPK bound to R734 and AMP and phosphorylated AMPK bound to R734 in the absence of added nucleotides at <3-A resolution. These structures and associated analyses identified a novel conformational state of the AMPK autoinhibitory domain associated with partial kinase activity and provide new insights into phosphorylation-dependent activation loop stabilization in AMPK.	[Yan, Yan; Zhou, X. Edward; Xu, H. Eric; Melcher, Karsten] Van Andel Res Inst, Ctr Canc & Cell Biol, Grand Rapids, MI 49503 USA; [Yan, Yan; Xu, H. Eric] Chinese Acad Sci, Shanghai Inst Materia Med VARI SIMM Ctr, Shanghai Inst Materia Med,CAS Key Lab Receptor Re, Ctr Struct & Funct Drug Targets,Van Andel Res Ins, Shanghai 201203, Peoples R China; [Yan, Yan] Univ Chinese Acad Sci, 19A Yuquan Rd, Beijing 100049, Peoples R China; [Novick, Scott J.; Griffin, Patrick R.] Scripps Res Inst, Scripps Florida, Dept Mol Med, Jupiter, FL 33458 USA; [Shaw, Simon J.; Li, Yingwu; Hitoshi, Yasumichi] Rigel Pharmaceut Inc, San Francisco, CA 94080 USA; [Brunzelle, Joseph S.] Northwestern Univ, Life Sci Collaborat Access Team, Synchrotron Res Ctr, Argonne, IL 60439 USA	Van Andel Institute; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Scripps Research Institute; State University System of Florida; University of Florida; Northwestern University	Melcher, K (corresponding author), Van Andel Res Inst, Ctr Canc & Cell Biol, Lab Struct Biol & Biochem, 333 Bostwick Ave Northeast, Grand Rapids, MI 49503 USA.	karsten.melcher@vai.org	Melcher, Karsten/AAZ-3861-2020; Xu, H. Eric/ABD-7487-2021	Melcher, Karsten/0000-0002-9125-4027; Xu, H. Eric/0000-0002-6829-8144; Brunzelle, Joseph/0000-0001-9197-0018	Van Andel Research Institute; National Institutes of Health [R01 GM102545, R01 GM129436, DK071662]; National Natural Science Foundation of China [31300245]; Ministry of Science and Technology (China) [2012ZX09301001, 2012CB910403, 2013CB910600, XDB08020303, 2013ZX09507001]; Amway (China); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071662] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM129436] Funding Source: NIH RePORTER	Van Andel Research Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology (China)(Ministry of Science and Technology, China); Amway (China); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Van Andel Research Institute (to H.E.X. and K.M.); National Institutes of Health Grants R01 GM102545 and R01 GM129436 (to K. M.) and DK071662 (to H.E.X.); National Natural Science Foundation of China Grant 31300245 (to H. E. X.); Ministry of Science and Technology (China) Grants 2012ZX09301001, 2012CB910403, 2013CB910600, XDB08020303, and 2013ZX09507001 (to H.E.X.); and Amway (China) (to H. E. X.). S.J.S., Y.L., and Y.H. are or have been employees and shareholders of Rigel Pharmaceuticals, Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Birk JB, 2006, J PHYSIOL-LONDON, V577, P1021, DOI 10.1113/jphysiol.2006.120972; Calabrese MF, 2014, STRUCTURE, V22, P1161, DOI 10.1016/j.str.2014.06.009; Cao J, 2014, J BIOL CHEM, V289, P20435, DOI 10.1074/jbc.M114.567271; Chen L, 2013, NATURE, V498, pE8, DOI 10.1038/nature12189; Chen L, 2012, NAT STRUCT MOL BIOL, V19, P716, DOI 10.1038/nsmb.2319; Chen L, 2009, NATURE, V459, P1146, DOI 10.1038/nature08075; Cheung PCF, 2000, BIOCHEM J, V346, P659, DOI 10.1042/0264-6021:3460659; Cokorinos EC, 2017, CELL METAB, V25, P1147, DOI 10.1016/j.cmet.2017.04.010; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feng DQ, 2018, ACS MED CHEM LETT, V9, P39, DOI 10.1021/acsmedchemlett.7b00417; Foretz M, 2014, CELL METAB, V20, P953, DOI 10.1016/j.cmet.2014.09.018; Goransson O, 2007, J BIOL CHEM, V282, P32549, DOI 10.1074/jbc.M706536200; Gowans GJ, 2013, CELL METAB, V18, P556, DOI 10.1016/j.cmet.2013.08.019; Gu X, 2017, J BIOL CHEM, V292, P12653, DOI 10.1074/jbc.M117.793018; Hardie DG, 2017, SCIENCE, V357, P455, DOI 10.1126/science.aao1913; Hardie DG, 2016, TRENDS CELL BIOL, V26, P190, DOI 10.1016/j.tcb.2015.10.013; Hardie DG, 2013, DIABETES, V62, P2164, DOI 10.2337/db13-0368; Hardie DG, 2012, CHEM BIOL, V19, P1222, DOI 10.1016/j.chembiol.2012.08.019; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hardie DG, 2000, METH MOL B, V99, P63; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; He L, 2015, CELL METAB, V21, P159, DOI 10.1016/j.cmet.2015.01.003; Hutcheson M. C., 1995, THESIS; Li XD, 2015, CELL RES, V25, P50, DOI 10.1038/cr.2014.150; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meng SM, 2015, J BIOL CHEM, V290, P3793, DOI 10.1074/jbc.M114.604421; Myers RW, 2017, SCIENCE, V357, P507, DOI 10.1126/science.aah5582; Ngoei KRW, 2018, CELL CHEM BIOL, V25, P728, DOI 10.1016/j.chembiol.2018.03.008; Oligschlaeger Y, 2015, J BIOL CHEM, V290, P11715, DOI 10.1074/jbc.M114.633271; Pascal BD, 2012, J AM SOC MASS SPECTR, V23, P1512, DOI 10.1007/s13361-012-0419-6; Rena G, 2017, DIABETOLOGIA, V60, P1577, DOI 10.1007/s00125-017-4342-z; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Scott JW, 2014, CHEM BIOL, V21, P619, DOI 10.1016/j.chembiol.2014.03.006; Scott JW, 2008, CHEM BIOL, V15, P1220, DOI 10.1016/j.chembiol.2008.10.005; Shao D, 2014, CELL METAB, V19, P232, DOI 10.1016/j.cmet.2013.12.013; STAPLETON D, 1994, J BIOL CHEM, V269, P29343; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Stephenne X, 2011, DIABETOLOGIA, V54, P3101, DOI 10.1007/s00125-011-2311-5; Thornton C, 1998, J BIOL CHEM, V273, P12443, DOI 10.1074/jbc.273.20.12443; Willows R, 2017, BIOCHEM J, V474, P3059, DOI 10.1042/BCJ20170458; Willows R, 2017, BIOCHEM J, V474, P1741, DOI 10.1042/BCJ20170046; Xiao B, 2007, NATURE, V449, P496, DOI 10.1038/nature06161; Xiao B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms4017; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932; Xin FJ, 2013, CELL RES, V23, P1237, DOI 10.1038/cr.2013.121; Yan Y, 2018, METHOD PROTOCOL, V1, DOI 10.3390/mps1010003; Zhang CS, 2016, CELL METAB, V24, P521, DOI 10.1016/j.cmet.2016.09.003	48	16	17	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2019	294	3					953	967		10.1074/jbc.RA118.004883	http://dx.doi.org/10.1074/jbc.RA118.004883			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL4FC	30478170	Green Published, hybrid			2022-12-28	WOS:000458670200020
J	Asan, A; Skoko, JJ; Woodcock, CSC; Wingert, BM; Woodcock, SR; Normolle, D; Huang, Y; Stark, JM; Camacho, CJ; Freeman, BA; Neumann, CA				Asan, Alparslan; Skoko, John J.; Woodcock, Chen-Shan Chen; Wingert, Bentley M.; Woodcock, Steven R.; Normolle, Daniel; Huang, Yi; Stark, Jeremy M.; Camacho, Carlos J.; Freeman, Bruce A.; Neumann, Carola A.			Electrophilic fatty acids impair RAD51 function and potentiate the effects of DNA-damaging agents on growth of triple-negative breast cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						homologous recombination; breast cancer; drug action; drug discovery; DNA repair; signal transduction; cysteine-mediated cross-linking; homologous recombination; nitro fatty acid; Rad51; triple negative breast cancer; nitroalkene; PARP1	HOMOLOGOUS RECOMBINATION; REPAIR; PHOSPHORYLATION; INSIGHTS; REVEALS	Homologous recombination (HR)-directed DNA double-strand break (DSB) repair enables template-directed DNA repair to maintain genomic stability. RAD51 recombinase (RAD51) is a critical component of HR and facilitates DNA strand exchange in DSB repair. We report here that treating triple-negative breast cancer (TNBC) cells with the fatty acid nitroalkene 10-nitro-octadec-9-enoic acid (OA-NO2) in combination with the antineoplastic DNA-damaging agents doxorubicin, cisplatin, olaparib, and -irradiation (IR) enhances the antiproliferative effects of these agents. OA-NO2 inhibited IR-induced RAD51 foci formation and enhanced H2A histone family member X (H2AX) phosphorylation in TNBC cells. Analyses of fluorescent DSB reporter activity with both static-flow cytometry and kinetic live-cell studies enabling temporal resolution of recombination revealed that OA-NO2 inhibits HR and not nonhomologous end joining (NHEJ). OA-NO2 alkylated Cys-319 in RAD51, and this alkylation depended on the Michael acceptor properties of OA-NO2 because nonnitrated and saturated nonelectrophilic analogs of OA-NO2, octadecanoic acid and 10-nitro-octadecanoic acid, did not react with Cys-319. Of note, OA-NO2 alkylation of RAD51 inhibited its binding to ssDNA. RAD51 Cys-319 resides within the SH3-binding site of ABL proto-oncogene 1, nonreceptor tyrosine kinase (ABL1), so we investigated the effect of OA-NO2-mediated Cys-319 alkylation on ABL1 binding and found that OA-NO2 inhibits RAD51-ABL1 complex formation both in vitro and in cell-based immunoprecipitation assays. The inhibition of the RAD51-ABL1 complex also suppressed downstream RAD51 Tyr-315 phosphorylation. In conclusion, RAD51 Cys-319 is a functionally significant site for adduction of soft electrophiles such as OA-NO2 and suggests further investigation of lipid electrophile-based combinational therapies for TNBC.	[Asan, Alparslan; Skoko, John J.; Woodcock, Chen-Shan Chen; Woodcock, Steven R.; Huang, Yi; Freeman, Bruce A.; Neumann, Carola A.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Asan, Alparslan; Skoko, John J.; Huang, Yi; Neumann, Carola A.] UPMC, Hillman Canc Ctr, Womens Canc Res Ctr, Pittsburgh, PA 15213 USA; [Asan, Alparslan; Skoko, John J.; Huang, Yi; Neumann, Carola A.] Univ Pittsburgh, Med Ctr, Magee Womens Res Hosp, Magee Womens Res Inst, Pittsburgh, PA 15213 USA; [Stark, Jeremy M.] Beckman Res Inst City Hope, Dept Canc Genet & Epigenet, Duarte, CA 91010 USA; [Wingert, Bentley M.; Camacho, Carlos J.] Univ Pittsburgh, Dept Computat & Syst Biol, Pittsburgh, PA 15260 USA; [Normolle, Daniel] Univ Pittsburgh, Dept Biostat, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; City of Hope; Beckman Research Institute of City of Hope; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Skoko, JJ; Neumann, CA (corresponding author), Univ Pittsburgh, Magee Womens Res Inst, Dept Pharmacol & Chem Biol, 204 Craft Ave, Pittsburgh, PA 15213 USA.	jskoko@pitt.edu; neumannc@upmc.edu	Woodcock, Steven/AAE-9199-2020; Skoko, John/AAL-1885-2021; Huang, Yi/AAW-7892-2021	Huang, Yi/0000-0002-9982-117X; Neumann, Carola/0000-0003-2801-9531; Asan, Alparslan/0000-0003-2495-5875	National Institutes of Health [R01-CA131350, P30-CA047904, T32-EB009403, R01-CA197506, R01-HL058115, R01-HL64937, P30-DK072506, P01-HL103455]; Basic Biology of Aging, University of Pittsburgh; University of Pittsburgh Department of Pharmacology and Chemical Biology; William C. de Groat predoctoral fellowships; Cotswold Foundation postdoctoral fellowship; NATIONAL CANCER INSTITUTE [P30CA047904, R01CA197506] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL103455, R01HL132550, R37HL058115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072506] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Basic Biology of Aging, University of Pittsburgh; University of Pittsburgh Department of Pharmacology and Chemical Biology(University of Pittsburgh); William C. de Groat predoctoral fellowships; Cotswold Foundation postdoctoral fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01-CA131350 and P30-CA047904 (to the UPMC Hillman Cancer Center and D.N.), T32-EB009403 (to B.M.W.), R01-CA197506 (to J.M.S), and R01-HL058115, R01-HL64937, P30-DK072506, and P01-HL103455 (to B.A.F.); Basic Biology of Aging, University of Pittsburgh (to C.A.N.); University of Pittsburgh Department of Pharmacology and Chemical Biology and William C. de Groat predoctoral fellowships (to A. A.); and a Cotswold Foundation postdoctoral fellowship (to J.J.S.). B.A.F. and C.-S.C.W. acknowledge an interest in Complexa, Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alagpulinsa DA, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00289; Asakawa H, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2486; Baker PRS, 2005, J BIOL CHEM, V280, P42464, DOI 10.1074/jbc.M504212200; Baker PRS, 2004, P NATL ACAD SCI USA, V101, P11577, DOI 10.1073/pnas.0402587101; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Budke B, 2012, NUCLEIC ACIDS RES, V40, P7347, DOI 10.1093/nar/gks353; Chen JH, 2015, NUCLEIC ACIDS RES, V43, P1098, DOI 10.1093/nar/gku1337; Cui T, 2006, J BIOL CHEM, V281, P35686, DOI 10.1074/jbc.M603357200; Curtin NJ, 2012, NAT REV CANCER, V12, P801, DOI 10.1038/nrc3399; Delmastro-Greenwood M, 2014, ANNU REV PHYSIOL, V76, P79, DOI 10.1146/annurev-physiol-021113-170341; Dunphy Karen A, 2010, J Vis Exp, DOI 10.3791/1849; Godin SK, 2016, BIOCHEM CELL BIOL, V94, P407, DOI 10.1139/bcb-2016-0012; Graeser M, 2010, CLIN CANCER RES, V16, P6159, DOI 10.1158/1078-0432.CCR-10-1027; Grover P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133590; Gunn Amanda, 2012, Methods Mol Biol, V920, P379, DOI 10.1007/978-1-61779-998-3_27; Hopkins BL, 2018, ANTIOXID REDOX SIGN, V28, P62, DOI 10.1089/ars.2016.6871; Huang F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100993; Lamont KR, 2013, J EXP MED, V210, P1021, DOI 10.1084/jem.20121258; Maacke H, 2000, INT J CANCER, V88, P907, DOI 10.1002/1097-0215(20001215)88:6<907::AID-IJC11>3.0.CO;2-4; Martin RW, 2007, CANCER RES, V67, P9658, DOI 10.1158/0008-5472.CAN-07-0290; Modesti M, 2007, STRUCTURE, V15, P599, DOI 10.1016/j.str.2007.04.003; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Pellegrini L, 2002, NATURE, V420, P287, DOI 10.1038/nature01230; Popova M, 2009, FEBS LETT, V583, P1867, DOI 10.1016/j.febslet.2009.04.044; Pozarowski Piotr, 2004, Methods Mol Biol, V281, P301; Prakash R, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016600; Richardson C, 1998, GENE DEV, V12, P3831, DOI 10.1101/gad.12.24.3831; Robert M, 2017, EXPERT OPIN INV DRUG, V26, P751, DOI 10.1080/13543784.2017.1318847; Schopfer FJ, 2011, CHEM REV, V111, P5997, DOI 10.1021/cr200131e; Sharma P, 2018, CURR TREAT OPTION ON, V19, DOI 10.1007/s11864-018-0539-8; Slupianek A, 2011, BLOOD, V118, P1062, DOI 10.1182/blood-2010-09-307256; Subramanyam S, 2016, P NATL ACAD SCI USA, V113, pE6045, DOI 10.1073/pnas.1604807113; Wiegmans AP, 2014, ONCOTARGET, V5, P3261, DOI 10.18632/oncotarget.1923; Woodcock CSC, 2018, J BIOL CHEM, V293, P1120, DOI 10.1074/jbc.M117.814368; Zhu JW, 2013, EMBO MOL MED, V5, P353, DOI 10.1002/emmm.201201760	37	7	7	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2019	294	2					397	404		10.1074/jbc.AC118.005899	http://dx.doi.org/10.1074/jbc.AC118.005899			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HI2GP	30478172	Green Published, hybrid			2022-12-28	WOS:000456263600001
J	Dong, YX; Ng, E; Lu, J; Fenwick, T; Tao, YM; Bertain, S; Sandoval, M; Bermudez, E; Hou, ZL; Patten, P; Lassner, M; Siehl, D				Dong, Yuxia; Ng, Emily; Lu, Jian; Fenwick, Tamara; Tao, Yumin; Bertain, Sean; Sandoval, Marian; Bermudez, Ericka; Hou, Zhenglin; Patten, Phil; Lassner, Michael; Siehl, Daniel			Desensitizing plant EPSP synthase to glyphosate: Optimized global sequence context accommodates a glycine-to-alanine change in the active site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						molecular evolution; enzyme inhibitor; protein engineering; biotechnology; plant biochemistry; 5-enolpyruvylshikimate-3-phosphate synthase; glyphosate; glyphosate resistance; herbicide resistance; plant EPSP synthase	5-ENOLPYRUVYLSHIKIMATE 3-PHOSPHATE SYNTHASE; AMINO-ACID SUBSTITUTION; ESCHERICHIA-COLI; STRUCTURAL BASIS; MOLECULAR-BASIS; RESISTANCE; HERBICIDE; MUTATION; IDENTIFICATION; INHIBITION	5-Enolpyruvylshikimate-3-phosphate synthase (EPSPS) catalyzes the transfer of a carboxyvinyl group from phosphoenolpyruvate (PEP) to shikimate-3-phosphate and in plants is the target of the herbicide glyphosate. EPSPSs with high catalytic efficiency and insensitivity to glyphosate are of microbial origin, including the enzyme from Agrobacterium strain CP4, in which insensitivity is conferred by an active site alanine. In the sequence context of plant EPSPSs, alanine in place of glycine at the equivalent position interferes with the binding of both glyphosate and PEP. We show here that iterative optimization of maize EPSPS containing the G101A substitution yielded variants on par with CP4 in terms of catalytic activity in the presence of glyphosate. The improvement relative to G101A alone was entirely due to reduction in K-m for PEP from 333 to 18 m, versus 9.5 m for native maize EPSPS. A large portion of the reduction in K-m was conferred by two down-sizing substitutions (L97C and V332A) within 8 of glyphosate, which together reduced K-m for PEP to 43 m. Although the original optimization was conducted with maize EPSPS, contextually homologous substitutions conferred similar properties to the EPSPSs of other crops. We also discovered a variant having the known glyphosate-desensitizing substitution P106L plus three additional ones that reduced the K-m for PEP from 47 m, observed with P106L alone, to 10.3 m. The improvements obtained with both Ala(101) and Leu(106) have implications regarding glyphosate-tolerant crops and weeds.	[Dong, Yuxia; Ng, Emily; Lu, Jian; Fenwick, Tamara; Tao, Yumin; Bertain, Sean; Sandoval, Marian; Bermudez, Ericka; Hou, Zhenglin; Patten, Phil; Lassner, Michael; Siehl, Daniel] Corteva Agrisci, Agr Div DowDuPont, Hayward, CA 94545 USA; [Patten, Phil] DiCE Mol, 220 Penobscot Dr, Redwood City, CA 94063 USA; [Lassner, Michael] Amfora Inc, San Francisco, CA 94104 USA		Siehl, D (corresponding author), 4010 Point Eden Way, Hayward, CA 94545 USA.	dan.siehl@pioneer.com						Baerson SR, 2002, PLANT PHYSIOL, V129, P1265, DOI 10.1104/pp.001560; Barry GF, 1997, US Patent, Patent No. [5 633 435, 5633435]; BOOCOCK MR, 1983, FEBS LETT, V154, P127, DOI 10.1016/0014-5793(83)80888-6; Chauhan RD, 2017, IN VITRO CELL DEV-AN, V53, pS35; Chen JC, 2015, PLANTA, V242, P859, DOI 10.1007/s00425-015-2324-2; Cuin TA, 2003, J EXP BOT, V54, P657, DOI 10.1093/jxb/erg072; Duke SO, 2008, PEST MANAG SCI, V64, P319, DOI 10.1002/ps.1518; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Eschenburg S, 2002, PLANTA, V216, P129, DOI 10.1007/s00425-002-0908-0; Franz J. E., 1997, GLYPHOSATE UNIQUE GL; Funke T, 2006, P NATL ACAD SCI USA, V103, P13010, DOI 10.1073/pnas.0603638103; Funke T, 2009, J BIOL CHEM, V284, P9854, DOI 10.1074/jbc.M809771200; Gianessi LP, 2013, PEST MANAG SCI, V69, P1099, DOI 10.1002/ps.3598; Han HP, 2017, PLANT CELL ENVIRON, V40, P3031, DOI 10.1111/pce.13067; Healy-Fried ML, 2007, J BIOL CHEM, V282, P32949, DOI 10.1074/jbc.M705624200; Heck GR, 2005, CROP SCI, V45, P329, DOI 10.2135/cropsci2005.0329; Hummel AW, 2018, PLANT BIOTECHNOL J, V16, P1275, DOI 10.1111/pbi.12868; Kirkwood RC, 2000, PEST MANAG SCI, V56, P359, DOI 10.1002/(SICI)1526-4998(200004)56:4<359::AID-PS145>3.0.CO;2-S; Kronzucker HJ, 2003, PLANTA, V217, P540, DOI 10.1007/s00425-003-1032-5; Li JB, 2018, J AGR FOOD CHEM, V66, P7880, DOI 10.1021/acs.jafc.8b01651; Li J, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.139, 10.1038/nplants.2016.139]; Lu J, 2017, PROTEIN ENG DES SEL, V30, P395, DOI 10.1093/protein/gzx012; MANEN D, 1991, MOL MICROBIOL, V5, P233, DOI 10.1111/j.1365-2958.1991.tb02103.x; MORRISON JF, 1982, TRENDS BIOCHEM SCI, V7, P102, DOI 10.1016/0968-0004(82)90157-8; MOUSDALE DM, 1984, PLANTA, V160, P78, DOI 10.1007/BF00392469; Ness JE, 2002, NAT BIOTECHNOL, V20, P1251, DOI 10.1038/nbt754; Ngo TD, 2018, PEST MANAG SCI, V74, P1094, DOI 10.1002/ps.4512; Nielsen LN, 2018, ENVIRON POLLUT, V233, P364, DOI 10.1016/j.envpol.2017.10.016; PADGETTE SR, 1995, CROP SCI, V35, P1451, DOI 10.2135/cropsci1995.0011183X003500050032x; PADGETTE SR, 1991, J BIOL CHEM, V266, P22364; Pollegioni L, 2011, FEBS J, V278, P2753, DOI 10.1111/j.1742-4658.2011.08214.x; Record MT, 1998, TRENDS BIOCHEM SCI, V23, P143, DOI 10.1016/S0968-0004(98)01196-7; Sammons RD, 2014, PEST MANAG SCI, V70, P1367, DOI 10.1002/ps.3743; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Schlegel S, 2015, CELL REP, V10, P1758, DOI 10.1016/j.celrep.2015.02.029; Schonbrunn E, 2001, P NATL ACAD SCI USA, V98, P1376, DOI 10.1073/pnas.98.4.1376; Sikorski JA, 1997, ACCOUNTS CHEM RES, V30, P2, DOI 10.1021/ar950122+; Solomon K., 2017, OUTLOOKS PEST MANAGE, V28, P173, DOI [10.1564/v28_aug_08, DOI 10.1564/V28_AUG_08]; SOST D, 1984, FEBS LETT, V173, P238, DOI 10.1016/0014-5793(84)81054-6; SOST D, 1990, ARCH BIOCHEM BIOPHYS, V282, P433, DOI 10.1016/0003-9861(90)90140-T; STALKER DM, 1985, J BIOL CHEM, V260, P4724; Tarone RE, 2018, REGUL TOXICOL PHARM, V98, pA1, DOI 10.1016/j.yrtph.2018.09.005; VAARA M, 1992, MICROBIOL REV, V56, P395, DOI 10.1128/MMBR.56.3.395-411.1992; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; WEISS U, 1953, J AM CHEM SOC, V75, P5572, DOI 10.1021/ja01118a028; Yu Q, 2015, PLANT PHYSIOL, V167, P1440, DOI 10.1104/pp.15.00146; Zhou M, 2006, PLANT PHYSIOL, V140, P184, DOI 10.1104/pp.105.068577; [No title captured], Patent No. 6040497	48	10	10	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2019	294	2					716	725		10.1074/jbc.RA118.006134	http://dx.doi.org/10.1074/jbc.RA118.006134			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HI2GP	30425098	Green Published, hybrid			2022-12-28	WOS:000456263600026
J	Hu, QH; Zhu, ZD; Zhao, DH; Zeng, BJ; Zheng, SC; Song, QS; Deng, HM; Feng, QL				Hu, Qihao; Zhu, Zidan; Zhao, Danhui; Zeng, Baojuan; Zheng, Sichun; Song, Qisheng; Deng, Huimin; Feng, Qili			Bombyx mori transcription factors FoxA and SAGE divergently regulate the expression of wing cuticle protein gene 4 during metamorphosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						transcription factor; gene regulation; DNA-binding protein; protein-protein interaction; gene expression; 20-hydroxyecdysone; BmFoxA; BmSAGE; metamorphosis; wing cuticle protein; Bombyx mori; Forkhead box A; WCP4	FORK HEAD; SILK GLAND; DNA-BINDING; FACTOR SGF1; DROSOPHILA; BMWCP4; DOMAIN; BMPOUM2; FAMILY	Stage-specific gene expression governs metamorphosis of the silkworm, Bombyx mori. B. mori wing cuticle protein gene 4 (BmWCP4) is an essential gene for wing disc development expressed specifically during pupation. BmWCP4 transcription is suppressed at the larval stage by unknown mechanisms, which we sought to elucidate here. Bioinformatics analysis predicted seven potential Forkhead box (Fox) cis-regulatory elements (CREs) in the BmWCP4 promoter region, and we found that Fox CRE6 contributes to suppression of BmWCP4 expression. Electrophoretic mobility shift (EMSA) and DNA pull-down assays revealed that BmFoxA suppressed activity at the BmWCP4 promoter by specifically binding to the Fox CRE6. The expression level of BmFoxA in the wing discs was higher during the larval stage than at the pupal stage. In contrast, expression of another transcription factor, BmSAGE, increased over the course of development. Of note, the hormone 20-hydroxyecdysone (20E), which governs molting in insects, suppressed BmFoxA expression in the wing discs and up-regulated that of BmSage. EMSA and cell co-transfection assays indicated that BmSAGE interacted with BmFoxA and suppressed its binding to the Fox CRE6, thereby releasing BmFoxA-mediated suppression of BmWCP4. In summary, higher BmFoxA expression during the larval stage suppresses BmWCP4 expression by binding to the Fox CRE6 on the BmWCP4 promoter. During metamorphosis, BmSAGE forms a complex with BmFoxA to relieve this repression, initiating BmWCP4 expression. Taken together, this study reveals a switchlike role for BmFoxA in regulating BmWCP4 expression and provides new insights into the regulatory regulation of wing disc development in insects.	[Hu, Qihao; Zhu, Zidan; Zhao, Danhui; Zeng, Baojuan; Zheng, Sichun; Deng, Huimin; Feng, Qili] South China Normal Univ, Inst Insect Sci & Technol, Guangzhou Key Lab Insect Dev Regulat & Applicat R, Guangzhou 510631, Guangdong, Peoples R China; [Hu, Qihao; Zhu, Zidan; Zhao, Danhui; Zeng, Baojuan; Zheng, Sichun; Deng, Huimin; Feng, Qili] South China Normal Univ, Sch Life Sci, Guangzhou 510631, Guangdong, Peoples R China; [Song, Qisheng] Univ Missouri, Div Plant Sci, Columbia, MO 65211 USA	South China Normal University; South China Normal University; University of Missouri System; University of Missouri Columbia	Deng, HM; Feng, QL (corresponding author), South China Normal Univ, Inst Insect Sci & Technol, Guangzhou Key Lab Insect Dev Regulat & Applicat R, Guangzhou 510631, Guangdong, Peoples R China.; Deng, HM; Feng, QL (corresponding author), South China Normal Univ, Sch Life Sci, Guangzhou 510631, Guangdong, Peoples R China.	denghuiminmin@163.com; qlfeng@scnu.edu.cn			Chinese National Natural Science Foundation [31330071, 31301918]; Guangdong Provincial Natural Science Foundation [2017A030306003]; Guangdong Provincial Special Support Program Grant [2017TQ04N744]; andScientific Research Cultivation Fund for Young Faculty of South China Normal University [14KJ15]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Guangdong Provincial Special Support Program Grant; andScientific Research Cultivation Fund for Young Faculty of South China Normal University	This work was supported by Chinese National Natural Science Foundation Grants 31330071 and 31301918, Guangdong Provincial Natural Science Foundation Grant 2017A030306003, Guangdong Provincial Special Support Program Grant 2017TQ04N744, andScientific Research Cultivation Fund for Young Faculty of South China Normal University Grant 14KJ15. The authors declare that they have no conflicts of interest with the contents of this article.	Abrams EW, 2006, DEVELOPMENT, V133, P3517, DOI 10.1242/dev.02525; Ashok M, 1998, P NATL ACAD SCI USA, V95, P2761, DOI 10.1073/pnas.95.6.2761; Bandukwala HS, 2011, IMMUNITY, V34, P479, DOI 10.1016/j.immuni.2011.02.017; Bao B, 2011, INSECT BIOCHEM MOLEC, V41, P670, DOI 10.1016/j.ibmb.2011.04.009; Brown NL, 1996, DEV BIOL, V179, P65, DOI 10.1006/dbio.1996.0241; Cao CK, 2007, J CELL BIOL, V176, P843, DOI 10.1083/jcb.200611155; Chandrasekaran V, 2003, DEVELOPMENT, V130, P4719, DOI 10.1242/dev.00677; de Folter S, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-47; Deng H, 2011, INSECT MOL BIOL, V20, P45, DOI 10.1111/j.1365-2583.2010.01041.x; Deng HM, 2016, INSECT SCI, V23, P782, DOI 10.1111/1744-7917.12231; Deng HM, 2015, INSECT BIOCHEM MOLEC, V66, P42, DOI 10.1016/j.ibmb.2015.09.006; Deng HM, 2012, P NATL ACAD SCI USA, V109, P12598, DOI 10.1073/pnas.1203149109; Dong XL, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-53; Fatima A, 2016, J CLIN INVEST, V126, P2437, DOI 10.1172/JCI80465; Fox RM, 2013, DEVELOPMENT, V140, P2160, DOI 10.1242/dev.092924; Friedman JR, 2006, CELL MOL LIFE SCI, V63, P2317, DOI 10.1007/s00018-006-6095-6; Hsu HT, 2015, SCIENCE, V348, P1372, DOI 10.1126/science.aab1223; Isaac DD, 1996, GENE DEV, V10, P103, DOI 10.1101/gad.10.1.103; Iwafuchi-Doi M, 2014, GENE DEV, V28, P2679, DOI 10.1101/gad.253443.114; Julien E, 2002, INSECT BIOCHEM MOLEC, V32, P377, DOI 10.1016/S0965-1748(01)00170-9; Kaestner KH, 2010, CURR OPIN GENET DEV, V20, P527, DOI 10.1016/j.gde.2010.06.005; Kayukawa T, 2012, P NATL ACAD SCI USA, V109, P11729, DOI 10.1073/pnas.1204951109; Lehmann M, 1996, EMBO J, V15, P4825, DOI 10.1002/j.1460-2075.1996.tb00863.x; Letunic I, 2018, NUCLEIC ACIDS RES, V46, pD493, DOI 10.1093/nar/gkx922; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Li JH, 2017, INSECT BIOCHEM MOLEC, V88, P1, DOI 10.1016/j.ibmb.2017.07.004; Liu Y, 2008, INSECT MOL BIOL, V17, P91, DOI 10.1111/j.1365-2583.2007.00785.x; Liu ZY, 2016, GENE, V587, P70, DOI 10.1016/j.gene.2016.04.034; Ma L, 2018, BBA-MOL CELL RES, V1865, P560, DOI 10.1016/j.bbamcr.2018.01.007; Mach V, 1996, NUCLEIC ACIDS RES, V24, P2387, DOI 10.1093/nar/24.12.2387; MACH V, 1995, J BIOL CHEM, V270, P9340, DOI 10.1074/jbc.270.16.9340; Marlow H, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-7; Martinez-Gac L, 2004, MOL CELL BIOL, V24, P2181, DOI 10.1128/MCB.24.5.2181-2189.2004; Maruyama R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020901; Myat MM, 2000, DEVELOPMENT, V127, P4217; Park D, 2008, MOL CELL BIOL, V28, P410, DOI 10.1128/MCB.01104-07; Rausa FM, 2003, MOL CELL BIOL, V23, P437, DOI 10.1128/MCB.23.2.437-449.2003; RIDDIFORD LM, 1980, ANNU REV PHYSIOL, V42, P511, DOI 10.1146/annurev.ph.42.030180.002455; Riddiford LM, 2007, J EXP BIOL, V210, P3133, DOI 10.1242/jeb.001321; Roth GE, 1999, GENETICS, V153, P753; Singh A, 2016, AGING CELL, V15, P694, DOI 10.1111/acel.12477; Song JB, 2015, FUNCT INTEGR GENOMIC, V15, P511, DOI 10.1007/s10142-015-0440-5; Stroud JC, 2006, STRUCTURE, V14, P159, DOI 10.1016/j.str.2005.10.005; Takiya S, 2003, INSECT BIOCHEM MOLEC, V33, P1145, DOI 10.1016/s0965-1748(03)00134-6; Thummel CS, 2007, J CELL BIOL, V176, P737, DOI 10.1083/jcb.200702075; Truman JW, 1999, NATURE, V401, P447, DOI 10.1038/46737; Xin HH, 2015, ARCH INSECT BIOCHEM, V90, P59, DOI 10.1002/arch.21244; Yachdav G, 2014, NUCLEIC ACIDS RES, V42, pW337, DOI 10.1093/nar/gku366; Yalley A, 2016, J BIOL CHEM, V291, P8848, DOI 10.1074/jbc.M115.677583; Zhao XM, 2015, J BIOL CHEM, V290, P972, DOI 10.1074/jbc.M114.606921; Zhao XM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094091	51	5	6	1	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2019	294	2					632	643		10.1074/jbc.RA118.004395	http://dx.doi.org/10.1074/jbc.RA118.004395			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HI2GP	30429222	hybrid, Green Published			2022-12-28	WOS:000456263600020
J	Weishaupl, D; Schneider, J; Peixoto Pinheiro, B; Ruess, C; Dold, SM; von Zweydorf, F; Gloeckner, CJ; Schmidt, J; Riess, O; Schmidt, T				Weishaeupl, Daniel; Schneider, Juliane; Pinheiro, Barbara Peixoto; Ruess, Corinna; Dold, Sandra Maria; von Zweydorf, Felix; Gloeckner, Christian Johannes; Schmidt, Jana; Riess, Olaf; Schmidt, Thorsten			Physiological and pathophysiological characteristics of ataxin-3 isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						alternative splicing; deubiquitylation (deubiquitination); E3 ubiquitin ligase; enzyme degradation; enzyme kinetics; genetic polymorphism; polyglutamine disease; protein aggregation; proteomics; neurodegenerative disease	MACHADO-JOSEPH-DISEASE; EXPANDED POLYGLUTAMINE PROTEIN; CAG REPEAT LENGTH; SPINOCEREBELLAR ATAXIA; ALZHEIMERS-DISEASE; ANDROGEN RECEPTOR; MOUSE MODEL; INTRANUCLEAR INCLUSIONS; COMPUTATIONAL PLATFORM; NUCLEAR-LOCALIZATION	Ataxin-3 is a deubiquitinating enzyme and the affected protein in the neurodegenerative disorder Machado-Joseph disease (MJD). The ATXN3 gene is alternatively spliced, resulting in protein isoforms that differ in the number of ubiquitin-interacting motifs. Additionally, nonsynonymous SNPs in ATXN3 cause amino acid changes in ataxin-3, and one of these polymorphisms introduces a premature stop codon in one isoform. Here, we examined the effects of different ataxin-3 isoforms and of the premature stop codon on ataxin-3's physiological function and on main disease mechanisms. At the physiological level, we show that alternative splicing and the premature stop codon alter ataxin-3 stability and that ataxin-3 isoforms differ in their enzymatic deubiquitination activity, subcellular distribution, and interaction with other proteins. At the pathological level, we found that the expansion of the polyglutamine repeat leads to a stabilization of ataxin-3 and that ataxin-3 isoforms differ in their aggregation properties. Interestingly, we observed a functional interaction between normal and polyglutamine-expanded ATXN3 allelic variants. We found that interactions between different ATXN3 allelic variants modify the physiological and pathophysiological properties of ataxin-3. Our findings indicate that alternative splicing and interactions between different ataxin-3 isoforms affect not only major aspects of ataxin-3 function but also MJD pathogenesis. Our results stress the importance of considering isoforms of disease-causing proteins and their interplay with the normal allelic variant as disease modifiers in MJD and autosomal-dominantly inherited diseases in general.	[Weishaeupl, Daniel; Schneider, Juliane; Pinheiro, Barbara Peixoto; Ruess, Corinna; Dold, Sandra Maria; Schmidt, Jana; Riess, Olaf; Schmidt, Thorsten] Univ Tubingen, Inst Med Genet & Appl Genom, D-72076 Tubingen, Germany; [Weishaeupl, Daniel; Schneider, Juliane; Pinheiro, Barbara Peixoto; Ruess, Corinna; Dold, Sandra Maria; Schmidt, Jana; Riess, Olaf; Schmidt, Thorsten] Ctr Rare Dis, D-72076 Tubingen, Germany; [Weishaeupl, Daniel; Schneider, Juliane; Pinheiro, Barbara Peixoto; Ruess, Corinna; Dold, Sandra Maria; Schmidt, Jana; Riess, Olaf; Schmidt, Thorsten] NGS Competence Ctr, D-72076 Tubingen, Germany; [Weishaeupl, Daniel] Grad Training Ctr Neurosci, D-72074 Tubingen, Germany; [von Zweydorf, Felix; Gloeckner, Christian Johannes] German Ctr Neurodegenerat Dis DZNE, D-72076 Tubingen, Germany; [Gloeckner, Christian Johannes] Univ Tubingen, Inst Ophthalm Res, Ctr Ophthalmol, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Schmidt, T (corresponding author), Univ Tubingen, Inst Med Genet & Appl Genom, D-72076 Tubingen, Germany.	thorsten.schmidt@med.uni-tuebingen.de	Gloeckner, Christian Johannes/R-5374-2019; Schmidt, Thorsten/AAR-6486-2021	Schmidt, Thorsten/0000-0002-1862-655X; Gloeckner, Christian Johannes/0000-0001-6494-6944	National Ataxia Foundation through the Spinocerebellar Ataxia Research Award; Landesgraduiertenforderung Baden-Wurttemberg	National Ataxia Foundation through the Spinocerebellar Ataxia Research Award; Landesgraduiertenforderung Baden-Wurttemberg	This work was supported by the National Ataxia Foundation through the Spinocerebellar Ataxia Research Award (to T. S.) and a fellowship from the Landesgraduiertenforderung Baden-Wurttemberg (to D. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Alvarez-Castelao B, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/823597; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; [Anonymous], R LANG ENV STAT COMP; Antony PMA, 2009, NEUROBIOL DIS, V36, P280, DOI 10.1016/j.nbd.2009.07.020; Bailey CK, 2002, HUM MOL GENET, V11, P515, DOI 10.1093/hmg/11.5.515; Becher MW, 1998, NEUROBIOL DIS, V4, P387, DOI 10.1006/nbdi.1998.0168; Bettencourt C, 2013, J MOL NEUROSCI, V49, P539, DOI 10.1007/s12031-012-9832-3; Bettencourt C, 2010, EUR J HUM GENET, V18, P621, DOI 10.1038/ejhg.2009.215; Bettencourt C, 2010, NEUROGENETICS, V11, P193, DOI 10.1007/s10048-009-0216-y; Beyer K, 2006, ACTA NEUROPATHOL, V112, P237, DOI 10.1007/s00401-006-0104-6; Bichelmeier U, 2007, J NEUROSCI, V27, P7418, DOI 10.1523/JNEUROSCI.4540-06.2007; Blount JR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5638; Boy J, 2009, HUM MOL GENET, V18, P4282, DOI 10.1093/hmg/ddp381; Brignone C, 2004, ONCOGENE, V23, P4121, DOI 10.1038/sj.onc.1207540; Burnett B, 2003, HUM MOL GENET, V12, P3195, DOI 10.1093/hmg/ddg344; Burr AA, 2014, J NEUROSCI RES, V92, P1100, DOI 10.1002/jnr.23395; Cartegni L, 2002, NAT GENET, V30, P377, DOI 10.1038/ng854; Chatr-aryamontri A, 2017, NUCLEIC ACIDS RES, V45, pD369, DOI 10.1093/nar/gkw1102; Costa MD, 2012, PROG NEUROBIOL, V97, P239, DOI 10.1016/j.pneurobio.2011.11.006; Costa MD, 2004, GENOMICS, V84, P361, DOI 10.1016/j.ygeno.2004.02.012; Cox J, 2009, NAT PROTOC, V4, P698, DOI 10.1038/nprot.2009.36; Cullen DA, 2004, NEUROSCI LETT, V357, P175, DOI 10.1016/j.neulet.2003.12.055; D'Souza I, 1999, P NATL ACAD SCI USA, V96, P5598, DOI 10.1073/pnas.96.10.5598; De Jonghe C, 1999, HUM MOL GENET, V8, P1529, DOI 10.1093/hmg/8.8.1529; DeStefano AL, 1996, AM J HUM GENET, V59, P119; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Durcan TM, 2011, HUM MOL GENET, V20, P141, DOI 10.1093/hmg/ddq452; Durr A, 1996, ANN NEUROL, V39, P490, DOI 10.1002/ana.410390411; Evert BO, 2006, J NEUROSCI, V26, P11474, DOI 10.1523/JNEUROSCI.2053-06.2006; Gaspar C, 2001, AM J HUM GENET, V68, P523, DOI 10.1086/318184; Globas C, 2008, MOVEMENT DISORD, V23, P2232, DOI 10.1002/mds.22288; Gloeckner CJ, 2007, PROTEOMICS, V7, P4228, DOI 10.1002/pmic.200700038; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Goto J, 1997, NEUROSCI RES, V28, P373, DOI 10.1016/S0168-0102(97)00056-4; Haacke A, 2006, HUM MOL GENET, V15, P555, DOI 10.1093/hmg/ddi472; Harmuth T, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00368; Harris GM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013695; Havugimana PC, 2012, CELL, V150, P1068, DOI 10.1016/j.cell.2012.08.011; Holmberg M, 1998, HUM MOL GENET, V7, P913, DOI 10.1093/hmg/7.5.913; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hubener J, 2013, HUM MOL GENET, V22, P508, DOI 10.1093/hmg/dds449; Hubener J, 2010, NEUROBIOL DIS, V38, P116, DOI 10.1016/j.nbd.2010.01.005; Huynh DP, 1999, ANN NEUROL, V45, P232, DOI 10.1002/1531-8249(199902)45:2<232::AID-ANA14>3.0.CO;2-7; Ichikawa Y, 2001, J HUM GENET, V46, P413, DOI 10.1007/s100380170060; Ikeda H, 1996, NAT GENET, V13, P196, DOI 10.1038/ng0696-196; Junck L, 1996, NEUROLOGY, V46, P4, DOI 10.1212/WNL.46.1.4; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; Kim H, 2011, NAT METHODS, V8, P941, DOI [10.1038/NMETH.1733, 10.1038/nmeth.1733]; Kim Y, 2013, NAT BIOTECHNOL, V31, P251, DOI 10.1038/nbt.2517; Koch P, 2011, NATURE, V480, P543, DOI 10.1038/nature10671; KOVACS J, 1974, ACTA MORPHOL HUNG, V22, P69; Kristensen LV, 2017, NEUROCHEM INT, V105, P42, DOI 10.1016/j.neuint.2016.12.019; LAWRENCE BP, 1993, J CELL SCI, V105, P473; Li M, 1998, ANN NEUROL, V44, P249, DOI 10.1002/ana.410440216; Lim J, 2008, NATURE, V452, P713, DOI 10.1038/nature06731; Lima M, 2005, HUM HERED, V60, P156, DOI 10.1159/000090035; Maciel P, 2001, ARCH NEUROL-CHICAGO, V58, P1821, DOI 10.1001/archneur.58.11.1821; Maciel P, 1999, EUR J HUM GENET, V7, P147, DOI 10.1038/sj.ejhg.5200264; MACIEL P, 1995, AM J HUM GENET, V57, P54; Majorek KA, 2014, PROTEIN SCI, V23, P1359, DOI 10.1002/pro.2520; Martins S, 2006, EUR J HUM GENET, V14, P932, DOI 10.1038/sj.ejhg.5201643; Matsumoto M, 2004, EMBO J, V23, P659, DOI 10.1038/sj.emboj.7600081; Mauri PL, 2006, FEBS J, V273, P4277, DOI 10.1111/j.1742-4658.2006.05419.x; Medicherla B, 2004, EMBO REP, V5, P692, DOI 10.1038/sj.embor.7400164; Mills JD, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.10.030; Mueller T, 2009, HUM MOL GENET, V18, P3334, DOI 10.1093/hmg/ddp274; Ooms J., 2017, MAGICK ADV GRAPHICS; PAPADOPOULOS T, 1986, LAB INVEST, V54, P100; Park H, 2001, P NATL ACAD SCI USA, V98, P11163, DOI 10.1073/pnas.201393498; Pau G, 2010, BIOINFORMATICS, V26, P979, DOI 10.1093/bioinformatics/btq046; Paulson HL, 1997, ANN NEUROL, V41, P453, DOI 10.1002/ana.410410408; Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5; Pozzi C, 2008, NEUROBIOL DIS, V30, P190, DOI 10.1016/j.nbd.2008.01.011; Ramani B, 2015, HUM MOL GENET, V24, P1211, DOI 10.1093/hmg/ddu532; REZ G, 1991, ACTA BIOL HUNG, V42, P133; Riley BE, 2004, J BIOL CHEM, V279, P42290, DOI 10.1074/jbc.M406284200; Rodrigues AJ, 2007, FASEB J, V21, P1126, DOI 10.1096/fj.06-7002com; Roscic A, 2011, J NEUROCHEM, V119, P398, DOI 10.1111/j.1471-4159.2011.07435.x; Sato N, 1999, J NEUROCHEM, V72, P2498, DOI 10.1046/j.1471-4159.1999.0722498.x; Schmidt T, 1998, BRAIN PATHOL, V8, P669, DOI 10.1111/j.1750-3639.1998.tb00193.x; Schmitt I, 2007, BIOCHEM BIOPH RES CO, V362, P734, DOI 10.1016/j.bbrc.2007.08.062; SCHOLS L, 1995, HUM MOL GENET, V4, P1001, DOI 10.1093/hmg/4.6.1001; Shenkman M, 2007, BIOCHEM J, V404, P509, DOI 10.1042/BJ20061854; Singleton AB, 2000, BRAIN, V123, P2467, DOI 10.1093/brain/123.12.2467; Skinner PJ, 1997, NATURE, V389, P971, DOI 10.1038/40153; Sowa AS, 2018, P NATL ACAD SCI USA, V115, pE2624, DOI 10.1073/pnas.1716071115; Sutton JR, 2017, HUM MOL GENET, V26, P1419, DOI 10.1093/hmg/ddx039; Suzuki Keiko, 2010, BMC Res Notes, V3, P294, DOI 10.1186/1756-0500-3-294; Todi SV, 2007, J BIOL CHEM, V282, P29348, DOI 10.1074/jbc.M704126200; Todi SV, 2009, EMBO J, V28, P372, DOI 10.1038/emboj.2008.289; Trottier Y, 1998, NEUROBIOL DIS, V5, P335, DOI 10.1006/nbdi.1998.0208; Tsou WL, 2015, NEUROBIOL DIS, V82, P12, DOI 10.1016/j.nbd.2015.05.010; Tsou WL, 2013, J BIOL CHEM, V288, P34460, DOI 10.1074/jbc.M113.513903; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Tzvetkov N, 2007, BIOL CHEM, V388, P973, DOI 10.1515/BC.2007.107; Wang HF, 2007, J NEUROCHEM, V101, P1651, DOI 10.1111/j.1471-4159.2007.04460.x; Warrenburg BPCV, 2005, ANN NEUROL, V57, P505, DOI 10.1002/ana.20424; Warrick JM, 2005, MOL CELL, V18, P37, DOI 10.1016/j.molcel.2005.02.030; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3; Watanabe-Asano T, 2014, BIOCHEM BIOPH RES CO, V445, P334, DOI 10.1016/j.bbrc.2014.01.180; Weber JJ, 2017, BRAIN, V140, P1280, DOI 10.1093/brain/awx039; Wellington CL, 1998, J BIOL CHEM, V273, P9158, DOI 10.1074/jbc.273.15.9158; West AB, 2002, HUM MOL GENET, V11, P2787, DOI 10.1093/hmg/11.22.2787; Winborn BJ, 2008, J BIOL CHEM, V283, P26436, DOI 10.1074/jbc.M803692200; Wood A, 2003, MOL CELL, V11, P267, DOI 10.1016/S1097-2765(02)00802-X; Zhao JH, 2015, P NATL ACAD SCI USA, V112, P15790, DOI 10.1073/pnas.1521919112; Zhou YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054214; Zuccato C, 2005, PHARMACOL RES, V52, P133, DOI 10.1016/j.phrs.2005.01.001	109	20	20	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2019	294	2					644	661		10.1074/jbc.RA118.005801	http://dx.doi.org/10.1074/jbc.RA118.005801			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HI2GP	30455355	Green Published, hybrid			2022-12-28	WOS:000456263600021
J	van Huizen, NA; van den Braak, RRJC; Doukas, M; Dekker, LJM; IJzermans, JNM; Luider, TM				van Huizen, Nick A.; van den Braak, Robert R. J. Coebergh; Doukas, Michael; Dekker, Lennard J. M.; IJzermans, Jan N. M.; Luider, Theo M.			Up-regulation of collagen proteins in colorectal liver metastasis compared with normal liver tissue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						collagen; colorectal cancer; mass spectrometry (MS); extracellular matrix protein; liver cancer; proteomics; colon cancer; colorectal liver metastasis (CRLM); hepatocarcinoma; immunohistochemistry; metastasis	BASEMENT-MEMBRANE ZONES; MATRIX METALLOPROTEINASES; CANCER; EXPRESSION; CELLS; MARKER; XVIII; MICROENVIRONMENT; HEPATOCYTES; PROLYL	Changes to extracellular matrix (ECM) structures are linked to tumor cell proliferation and metastasis. We previously reported that naturally occurring peptides of collagen type I are elevated in urine of patients with colorectal liver metastasis (CRLM). In the present study, we took an MS-based proteomic approach to identify specific collagen types that are up-regulated in CRLM tissues compared with healthy, adjacent liver tissues from the same patients. We found that 19 of 22 collagen- chains are significantly up-regulated (p < 0.05) in CRLM tissues compared with the healthy tissues. At least four collagen- chains were absent or had low expression in healthy colon and adjacent tissues, but were highly abundant in both colorectal cancer (CRC) and CRLM tissues. This expression pattern was also observed for six noncollagen colon-specific proteins, two of which (CDH17 and PPP1R1B/DARP-32) had not previously been linked to CRLM. Furthermore, we observed CRLM-associated up-regulation of 16 proteins (of 20 associated proteins identified) known to be required for collagen synthesis, indicating increased collagen production in CRLM. Immunohistochemistry validated that collagen type XII is significantly up-regulated in CRLM. The results of this study indicate that most collagen isoforms are up-regulated in CRLM compared with healthy tissues, most likely as a result of an increased collagen production in the metastatic cells. Our findings provide further insight into morphological changes in the ECM in CRLM and help explain the finding of tumor metastasis-associated proteins and peptides in urine, suggesting their utility as metastasis biomarkers.	[van Huizen, Nick A.; van den Braak, Robert R. J. Coebergh; IJzermans, Jan N. M.] Erasmus Univ, Med Ctr, Dept Surg, POB 1738, NL-3015 GE Rotterdam, Netherlands; [Doukas, Michael] Erasmus Univ, Med Ctr, Dept Pathol, POB 1738, NL-3015 GE Rotterdam, Netherlands; [van Huizen, Nick A.; Dekker, Lennard J. M.; Luider, Theo M.] Erasmus Univ, Med Ctr, Dept Neurol, POB 1738, NL-3015 GE Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Luider, TM (corresponding author), Erasmus Univ, Med Ctr, Dept Neurol, POB 1738, NL-3015 GE Rotterdam, Netherlands.	t.luider@erasmusmc.nl	Coebergh, Robert/AAG-2520-2019	Coebergh van den Braak, Robert/0000-0001-9310-6629				Afik R, 2016, J EXP MED, V213, P2315, DOI 10.1084/jem.20151193; Bartolome RA, 2014, ONCOGENE, V33, P1658, DOI 10.1038/onc.2013.117; Belov L, 2011, INT J MOL SCI, V12, P78, DOI 10.3390/ijms12010078; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; Blumenthal RD, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-2; Broker MEE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070918; Cerna M, 2006, ANTICANCER RES, V26, P803; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Du HZ, 2017, BIOMED PHARMACOTHER, V90, P670, DOI 10.1016/j.biopha.2017.04.023; Fabregat A, 2016, NUCLEIC ACIDS RES, V44, pD481, DOI 10.1093/nar/gkv1351; Federation of Dutch Medical Scientific Societies (FDMSS), 2011, HUM TISS MED RES COD; Fukai N, 2002, EMBO J, V21, P1535, DOI 10.1093/emboj/21.7.1535; Gilkes DM, 2013, CANCER RES, V73, P3285, DOI 10.1158/0008-5472.CAN-12-3963; Gjaltema RAF, 2017, CRIT REV BIOCHEM MOL, V52, P74, DOI 10.1080/10409238.2016.1269716; Gout S, 2008, CANCER MICROENVIRON, V1, P69, DOI 10.1007/s12307-008-0007-2; Gupta BK, 2012, J HISTOCHEM CYTOCHEM, V60, P822, DOI 10.1369/0022155412460678; Kahlert C, 2014, BRIT J CANCER, V110, P441, DOI 10.1038/bjc.2013.745; Kaplan RN, 2006, CANCER RES, V66, P11089, DOI 10.1158/0008-5472.CAN-06-2407; Karagiannis GS, 2012, ONCOTARGET, V3, P267, DOI 10.18632/oncotarget.451; Kawashima Y, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-4; Kopljar M, 2015, INT SURG, V100, P213, DOI 10.9738/INTSURG-D-14-00022.1; Lalmahomed ZS, 2016, AM J CANCER RES, V6, P321; Mori K, 2017, INT J CANCER, V140, P1425, DOI 10.1002/ijc.30557; Musso O, 1998, HEPATOLOGY, V28, P98, DOI 10.1002/hep.510280115; Musso O, 2001, HEPATOLOGY, V33, P868, DOI 10.1053/jhep.2001.23189; Naba A, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-518; Nystrom H, 2015, TUMOR BIOL, V36, P9839, DOI 10.1007/s13277-015-3729-z; Nystrom H, 2012, ANTICANCER RES, V32, P5183; Olsen JV, 2004, MOL CELL PROTEOMICS, V3, P608, DOI 10.1074/mcp.T400003-MCP200; Peinado H, 2017, NAT REV CANCER, V17, P302, DOI 10.1038/nrc.2017.6; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Piehowski PD, 2013, J PROTEOME RES, V12, P2128, DOI 10.1021/pr301146m; Provenzano PP, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-11; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Saarela J, 1998, AM J PATHOL, V153, P611, DOI 10.1016/S0002-9440(10)65603-9; Schmidt T, 2018, NUCLEIC ACIDS RES, V46, pD1271, DOI 10.1093/nar/gkx1029; Scott AM, 2005, CLIN CANCER RES, V11, P4810, DOI 10.1158/1078-0432.CCR-04-2329; Seubert B, 2015, HEPATOLOGY, V61, P238, DOI 10.1002/hep.27378; Singh V, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000155; Sluijter JPG, 2006, CARDIOVASC RES, V69, P595, DOI 10.1016/j.cardiores.2005.11.026; Snoek-van Beurden PAM, 2005, BIOTECHNIQUES, V38, P73, DOI 10.2144/05381RV01; Sole X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106748; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Wu XZ, 2010, WORLD J GASTROENTERO, V16, P4084, DOI 10.3748/wjg.v16.i32.4084; Zeng ZS, 1998, BRIT J CANCER, V78, P349, DOI 10.1038/bjc.1998.497; Zucker S, 2004, CANCER METAST REV, V23, P101, DOI 10.1023/A:1025867130437	47	40	42	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2019	294	1					281	289		10.1074/jbc.RA118.005087	http://dx.doi.org/10.1074/jbc.RA118.005087			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG6PT	30409905	Green Published, hybrid			2022-12-28	WOS:000455105500030
J	Lynch, JM; Li, B; Katoli, P; Xiang, CX; Leehy, B; Rangaswamy, N; Saenz-Vash, V; Wang, YK; Lei, H; Nicholson, TB; Meredith, E; Rice, DS; Prasanna, G; Chen, A				Lynch, Jeffrey M.; Li, Bing; Katoli, Parvaneh; Xiang, Chuanxi; Leehy, Barrett; Rangaswamy, Nalini; Saenz-Vash, Veronica; Wang, Y. Karen; Lei, Hong; Nicholson, Thomas B.; Meredith, Erik; Rice, Dennis S.; Prasanna, Ganesh; Chen, Amy			Binding of a glaucoma-associated myocilin variant to the B-crystallin chaperone impedes protein clearance in trabecular meshwork cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						animal model; aggregation; cell biology; aging; crystallin; CRISPR; Cas; genetic disease; secretion; glaucoma; myocilin	OPEN-ANGLE GLAUCOMA; ENDOPLASMIC-RETICULUM STRESS; OLFACTOMEDIN-HOMOLOGY DOMAIN; HEAT-SHOCK PROTEINS; TARGETING SIGNAL 1; GENE-EXPRESSION; MOUSE MODEL; ER STRESS; MICROARRAY ANALYSIS; CHEMICAL CHAPERONE	Myocilin (MYOC) was discovered more than 20 years ago and is the gene whose mutations are most commonly observed in individuals with glaucoma. Despite extensive research efforts, the function of WT MYOC has remained elusive, and how mutant MYOC is linked to glaucoma is unclear. Mutant MYOC is believed to be misfolded within the endoplasmic reticulum, and under normal physiological conditions misfolded MYOC should be retro-translocated to the cytoplasm for degradation. To better understand mutant MYOC pathology, we CRISPR-engineered a rat to have a MYOC Y435H substitution that is the equivalent of the pathological human MYOC Y437H mutation. Using this engineered animal model, we discovered that the chaperone B-crystallin (CRYAB) is a MYOC-binding partner and that co-expression of these two proteins increases protein aggregates. Our results suggest that the misfolded mutant MYOC aggregates with cytoplasmic CRYAB and thereby compromises protein clearance mechanisms in trabecular meshwork cells, and this process represents the primary mode of mutant MYOC pathology. We propose a model by which mutant MYOC causes glaucoma, and we propose that therapeutic treatment of patients having a MYOC mutation may focus on disrupting the MYOC-CRYAB complexes.	[Lynch, Jeffrey M.; Li, Bing; Katoli, Parvaneh; Xiang, Chuanxi; Leehy, Barrett; Rangaswamy, Nalini; Rice, Dennis S.; Prasanna, Ganesh; Chen, Amy] Novartis Inst BioMed Res, Ophthalmol, 22 Windsor St, Cambridge, MA 02139 USA; [Saenz-Vash, Veronica; Wang, Y. Karen] Novartis Inst BioMed Res, Analyt Sci & Imaging, Cambridge, MA 02139 USA; [Lei, Hong] Novartis Inst BioMed Res, Lab Anim Serv, Cambridge, MA 02139 USA; [Nicholson, Thomas B.] Novartis Inst BioMed Res, Chem Biol & Therapeut, Cambridge, MA 02139 USA; [Meredith, Erik] Novartis Inst BioMed Res, Global Dev Chem, Cambridge, MA 02139 USA	Novartis; Novartis; Novartis; Novartis; Novartis	Lynch, JM (corresponding author), Novartis Inst BioMed Res, Ophthalmol, 22 Windsor St, Cambridge, MA 02139 USA.	jeffrey.lynch@novartis.com		Lynch, Jeff/0000-0002-4042-7872	Novartis Institutes for BioMedical Research	Novartis Institutes for BioMedical Research	This work was supported by Novartis Institutes for BioMedical Research. Authors are all employees of Novartis Institutes for BioMedical Research (NIBR) and receive salary. As NIBR is a publicly traded pharmaceutical company, the authors may hold stock.	Adam MF, 1997, HUM MOL GENET, V6, P2091, DOI 10.1093/hmg/6.12.2091; Alward WLM, 1998, NEW ENGL J MED, V338, P1022, DOI 10.1056/NEJM199804093381503; Alward WLM, 2000, EYE, V14, P429, DOI 10.1038/eye.2000.127; Andley UP, 2007, PROG RETIN EYE RES, V26, P78, DOI 10.1016/j.preteyeres.2006.10.003; Anholt RRH, 2013, TRENDS MOL MED, V19, P586, DOI 10.1016/j.molmed.2013.06.005; Aroca-Aguilar JD, 2011, INVEST OPHTH VIS SCI, V52, P179, DOI 10.1167/iovs.09-4866; Arrigo AP, 2007, FEBS LETT, V581, P3665, DOI 10.1016/j.febslet.2007.04.033; Benjamin IJ, 1998, CIRC RES, V83, P117, DOI 10.1161/01.RES.83.2.117; Brocard C, 2006, BBA-MOL CELL RES, V1763, P1565, DOI 10.1016/j.bbamcr.2006.08.022; Brubaker RF, 1998, EYES AQUEOUS HUMOR S, P234; Bui BV, 2004, J PHYSIOL-LONDON, V555, P153, DOI 10.1113/jphysiol.2003.052738; Caballero M, 2001, BIOCHEM BIOPH RES CO, V282, P662, DOI 10.1006/bbrc.2001.4624; Chis R, 2012, AM J PHYSIOL-HEART C, V303, pH967, DOI 10.1152/ajpheart.00040.2012; Chou TH, 2014, INVEST OPHTH VIS SCI, V55, P5602, DOI 10.1167/iovs.14-14793; Donegan RK, 2015, HUM MOL GENET, V24, P2111, DOI 10.1093/hmg/ddu730; Ecroyd H, 2010, PROTEIN SCI ENG, P189; Eisele YS, 2015, NAT REV DRUG DISCOV, V14, P759, DOI 10.1038/nrd4593; Elgersma Y, 1996, J BIOL CHEM, V271, P26375, DOI 10.1074/jbc.271.42.26375; Faucher M, 2002, HUM MOL GENET, V11, P2077, DOI 10.1093/hmg/11.18.2077; Fautsch MP, 2006, EXP EYE RES, V82, P1046, DOI 10.1016/j.exer.2005.09.016; Fingert JH, 1999, HUM MOL GENET, V8, P899, DOI 10.1093/hmg/8.5.899; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P532; Glembotski CC, 2007, CIRC RES, V101, P975, DOI 10.1161/CIRCRESAHA.107.161273; Gobeil S, 2006, EXP EYE RES, V82, P1017, DOI 10.1016/j.exer.2005.11.002; Gould DB, 2006, MOL CELL BIOL, V26, P8427, DOI 10.1128/MCB.01127-06; Hagemann TL, 2009, HUM MOL GENET, V18, P1190, DOI 10.1093/hmg/ddp013; Hamanaka T, 2017, INVEST OPHTH VIS SCI, V58, P2818, DOI 10.1167/iovs.16-20646; Hewitt AW, 2008, HUM MUTAT, V29, P207, DOI 10.1002/humu.20634; Hill SE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130888; Ishibashi T, 2002, INVEST OPHTH VIS SCI, V43, P3691; Jacobson N, 2001, HUM MOL GENET, V10, P117, DOI 10.1093/hmg/10.2.117; Jobling AI, 2001, INVEST OPHTH VIS SCI, V42, P1829; Joe MK, 2003, BIOCHEM BIOPH RES CO, V312, P592, DOI 10.1016/j.bbrc.2003.10.162; Johnson DH, 2000, ARCH OPHTHALMOL-CHIC, V118, P974; Johnson M, 2017, EXP EYE RES, V158, P94, DOI 10.1016/j.exer.2016.01.017; JOHNSON WG, 1980, AM J HUM GENET, V32, P374; Jones-Odeh E, 2015, EYE, V29, P1270, DOI 10.1038/eye.2015.158; Kim BS, 2001, MOL CELL BIOL, V21, P7707, DOI 10.1128/MCB.21.22.7707-7713.2001; Kore RA, 2016, BBA-MOL CELL RES, V1863, P368, DOI 10.1016/j.bbamcr.2015.11.027; Kwon YH, 2009, NEW ENGL J MED, V360, P1113, DOI 10.1056/NEJMra0804630; Lametschwandtner G, 1998, J BIOL CHEM, V273, P33635, DOI 10.1074/jbc.273.50.33635; Li C, 2014, CHINESE PHYS C, V38, DOI 10.1088/1674-1137/38/3/037005; Liton P, 2006, MOL VIS, V12, P774; Lundvall A, 2011, J GLAUCOMA, V20, P7, DOI 10.1097/IJG.0b013e3181d1d1ef; Lutjen-Drecoll E, 1998, INVEST OPHTH VIS SCI, V39, P517; Lynch JM, 2012, CELL, V149, P1257, DOI 10.1016/j.cell.2012.03.050; Maezawa I, 2008, J NEUROCHEM, V104, P457, DOI 10.1111/j.1471-4159.2007.04972.x; Makley LN, 2015, SCIENCE, V350, P674, DOI 10.1126/science.aac9145; Malmos KG, 2017, AMYLOID, V24, P1, DOI 10.1080/13506129.2017.1304905; Massaad CA, 2009, P NATL ACAD SCI USA, V106, P13576, DOI 10.1073/pnas.0902714106; Meyer A, 1996, HUM GENET, V98, P567, DOI 10.1007/s004390050260; Mirzaei M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12858-7; Miyara N, 2008, JPN J OPHTHALMOL, V52, P84, DOI 10.1007/s10384-007-0507-5; Morissette J, 1998, NAT GENET, V19, P319, DOI 10.1038/1203; Nag A, 2017, OPHTHALMOLOGY, V124, P547, DOI 10.1016/j.ophtha.2016.11.018; Nguyen TD, 1998, J BIOL CHEM, V273, P6341, DOI 10.1074/jbc.273.11.6341; Oliveira AO, 2016, HUM MOL GENET, V25, P1677, DOI 10.1093/hmg/ddw028; Ortego J, 1997, FEBS LETT, V413, P349, DOI 10.1016/S0014-5793(97)00934-4; PANG IH, 1994, CURR EYE RES, V13, P51, DOI 10.3109/02713689409042398; Patel HR, 2014, J PHYS CHEM LETT, V5, P1864, DOI 10.1021/jz5001775; PENN RD, 1969, NATURE, V223, P201, DOI 10.1038/223201a0; Piri N, 2007, BRAIN RES, V1141, P1, DOI 10.1016/j.brainres.2006.11.095; Piri N, 2013, MOL NEUROBIOL, V48, P819, DOI 10.1007/s12035-013-8470-2; Polansky JR, 2000, EYE, V14, P503, DOI 10.1038/eye.2000.137; Qiu Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0095838, 10.1371/journal.pone.0092845]; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; ROCKEN C, 1992, VIRCHOWS ARCH A, V421, P339, DOI 10.1007/BF01660981; Scheier B, 1996, MOL CELL ENDOCRINOL, V123, P187, DOI 10.1016/S0303-7207(96)03922-6; Schlunck G, 2008, INVEST OPHTH VIS SCI, V49, P262, DOI 10.1167/iovs.07-0956; Senatorov V, 2006, J NEUROSCI, V26, P11903, DOI 10.1523/JNEUROSCI.3020-06.2006; Shepard AR, 2007, HUM MOL GENET, V16, P609, DOI 10.1093/hmg/ddm001; Shepard AR, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-5; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shimizu S, 2000, AM J OPHTHALMOL, V130, P165, DOI 10.1016/S0002-9394(00)00536-5; Snider EJ, 2018, J TISSUE ENG REGEN M, V12, P695, DOI 10.1002/term.2488; Souzeau E, 2013, OPHTHALMOLOGY, V120, P1135, DOI 10.1016/j.ophtha.2012.11.029; Steele MR, 2006, INVEST OPHTH VIS SCI, V47, P977, DOI 10.1167/iovs.05-0865; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Stothert AR, 2014, HUM MOL GENET, V23, P6470, DOI 10.1093/hmg/ddu367; Sunden SLF, 1996, GENOME RES, V6, P862, DOI 10.1101/gr.6.9.862; SWINKELS BW, 1992, FEBS LETT, V305, P133, DOI 10.1016/0014-5793(92)80880-P; Tamm ER, 2002, PROG RETIN EYE RES, V21, P395, DOI 10.1016/S1350-9462(02)00010-1; Weinreb RN, 2014, JAMA-J AM MED ASSOC, V311, P1901, DOI 10.1001/jama.2014.3192; Wentz-Hunter K, 2002, INVEST OPHTH VIS SCI, V43, P176; Wiggs JL, 1998, AM J HUM GENET, V63, P1549, DOI 10.1086/302098; Wirtz MK, 2008, MOL VIS, V14, P774; Yam GHT, 2007, INVEST OPHTH VIS SCI, V48, P1683, DOI 10.1167/iovs.06-0943; Young TK, 2012, MOL VIS, V18, P3064; Zhou Y, 2008, INVEST OPHTH VIS SCI, V49, P1932, DOI 10.1167/iovs.07-1339; Zhuo YH, 2008, MOL VIS, V14, P1533; Zillig M, 2005, INVEST OPHTH VIS SCI, V46, P223, DOI 10.1167/iovs.04-0988; Zode GS, 2011, J CLIN INVEST, V121, P3542, DOI 10.1172/JCI58183	92	6	6	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					20137	20156		10.1074/jbc.RA118.004325	http://dx.doi.org/10.1074/jbc.RA118.004325			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30389787	Green Published, hybrid			2022-12-28	WOS:000454685900022
J	Bravo-Arredondo, JM; Kegulian, NC; Schmidt, T; Pandey, NK; Situ, AJ; Ulmer, TS; Langen, R				Bravo-Arredondo, Jose M.; Kegulian, Natalie C.; Schmidt, Thomas; Pandey, Nitin K.; Situ, Alan J.; Ulmer, Tobias S.; Langen, Ralf			The folding equilibrium of huntingtin exon 1 monomer depends on its polyglutamine tract	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Huntington disease; electron paramagnetic resonance (EPR); nuclear magnetic resonance (NMR); polyglutamine; neurodegeneration; protein misfolding; conformational equilibrium	STRUCTURAL FEATURES; FLANKING SEQUENCES; SOLUTION NMR; CAG REPEAT; N-TERMINUS; DISEASE; AGGREGATION; PROTEIN; EXPANSION; CONFORMATION	Expansion of the polyglutamine (polyQ) tract in exon 1 of the huntingtin protein (Httex1) leads to Huntington's disease resulting in fatal neurodegeneration. However, it remains poorly understood how polyQ expansions alter protein structure and cause toxicity. Using CD, EPR, and NMR spectroscopy, we found here that monomeric Httex1 consists of two co-existing structural states whose ratio is determined by polyQ tract length. We observed that short Q-lengths favor a largely random-coil state, whereas long Q-lengths increase the proportion of a predominantly -helical state. We also note that by following a mobility gradient, Httex1 -helical conformation is restricted to the N-terminal N17 region and to the N-terminal portion of the adjoining polyQ tract. Structuring in both regions was interdependent and likely stabilized by tertiary contacts. Although little helicity was present in N17 alone, each Gln residue in Httex1 enhanced helix stability by 0.03-0.05 kcal/mol, causing a pronounced preference for the -helical state at pathological Q-lengths. The Q-length-dependent structuring and rigidification could be mimicked in proteins with shorter Q-lengths by a decrease in temperature, indicating that lower temperatures similarly stabilize N17 and polyQ intramolecular contacts. The more rigid -helical state of Httex1 with an expanded polyQ tract is expected to alter interactions with cellular proteins and modulate the toxic Httex1 misfolding process. We propose that the polyQ-dependent shift in the structural equilibrium may enable future therapeutic strategies that specifically target Httex1 with toxic Q-lengths.	[Bravo-Arredondo, Jose M.; Pandey, Nitin K.; Situ, Alan J.; Ulmer, Tobias S.; Langen, Ralf] Univ Southern Calif, Dept Physiol & Neurosci, Zilkha Neurogenet Inst, Keck Sch Med, Los Angeles, CA 90033 USA; [Kegulian, Natalie C.; Schmidt, Thomas; Ulmer, Tobias S.; Langen, Ralf] Univ Southern Calif, Dept Biochem & Mol Med, Zilkha Neurogenet Inst, Keck Sch Med, Los Angeles, CA 90033 USA; [Bravo-Arredondo, Jose M.] Univ Autonoma Tlaxcala, Fac Ciencias Basicas Ingn & Tecnol, Calzada Apizaquito S-N, Apizaco 90300, Tlaxcala, Mexico; [Kegulian, Natalie C.] Univ Southern Calif, Herman Ostrow Sch Dent, Ctr Craniofacial Mol Biol, Los Angeles, CA 90033 USA; [Schmidt, Thomas] NIDDK, Lab Chem Phys, NIH, Bethesda, MD 20892 USA	University of Southern California; University of Southern California; University of Southern California; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Langen, R (corresponding author), Univ Southern Calif, Dept Physiol & Neurosci, Zilkha Neurogenet Inst, Keck Sch Med, Los Angeles, CA 90033 USA.; Langen, R (corresponding author), Univ Southern Calif, Dept Biochem & Mol Med, Zilkha Neurogenet Inst, Keck Sch Med, Los Angeles, CA 90033 USA.	langen@usc.edu	Kegulian, Natalie/AFF-8981-2022; Pandey, Nitin K./AAP-1523-2021; Kegulian, Natalie/AAF-1086-2022	Pandey, Nitin K./0000-0001-6124-4090; Kegulian, Natalie/0000-0002-8574-1099; Bravo-Arredondo, Jose M./0000-0001-7052-7076	Cure Huntington's Disease Initiative (CHDI) Award [A-12640]; National Institutes of Health [NS084345]; University of Southern California-Consejo Nacional de Ciencia y Tecnologia (USC-CONACyT) postdoctoral fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS084345] Funding Source: NIH RePORTER	Cure Huntington's Disease Initiative (CHDI) Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Southern California-Consejo Nacional de Ciencia y Tecnologia (USC-CONACyT) postdoctoral fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by Cure Huntington's Disease Initiative (CHDI) Award A-12640 and National Institutes of Health Grant NS084345. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by University of Southern California-Consejo Nacional de Ciencia y Tecnologia (USC-CONACyT) postdoctoral fellowship.	Baias M, 2017, J AM CHEM SOC, V139, P1168, DOI 10.1021/jacs.6b10893; Bennett MJ, 2002, P NATL ACAD SCI USA, V99, P11634, DOI 10.1073/pnas.182393899; Bugg CW, 2012, J BIOL CHEM, V287, P31739, DOI 10.1074/jbc.M112.353839; Caron NS, 2013, P NATL ACAD SCI USA, V110, P14610, DOI 10.1073/pnas.1301342110; Ceccon A, 2018, J AM CHEM SOC, V140, P6199, DOI 10.1021/jacs.8b02619; Chiki A, 2017, ANGEW CHEM INT EDIT, V56, P5202, DOI 10.1002/anie.201611750; Clabough Erin B. D., 2013, Yale Journal of Biology and Medicine, V86, P217; Cornett J, 2005, NAT GENET, V37, P198, DOI 10.1038/ng1503; CRAMPIN J, 1978, NATURE, V272, P558, DOI 10.1038/272558a0; Crick SL, 2013, P NATL ACAD SCI USA, V110, P20075, DOI 10.1073/pnas.1320626110; Cui XT, 2014, SCI REP-UK, V4, DOI 10.1038/srep05601; De Genst E, 2015, J MOL BIOL, V427, P2166, DOI 10.1016/j.jmb.2015.03.021; DeGuire SM, 2018, J BIOL CHEM, V293, P18540, DOI 10.1074/jbc.RA118.004621; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fodale V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112262; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; Gu XF, 2009, NEURON, V64, P828, DOI 10.1016/j.neuron.2009.11.020; Harjes P, 2003, TRENDS BIOCHEM SCI, V28, P425, DOI 10.1016/S0968-0004(03)00168-3; Hoffner G, 2005, J NEUROCHEM, V95, P125, DOI 10.1111/j.1471-4159.2005.03348.x; Hoffner G, 2015, MOL NEUROBIOL, V52, P1297, DOI 10.1007/s12035-014-8932-1; Hoffner G, 2014, BRAIN SCI, V4, P91, DOI 10.3390/brainsci4010091; Isas JM, 2015, BIOCHEMISTRY-US, V54, P3942, DOI 10.1021/acs.biochem.5b00281; Jayaraman M, 2012, BIOCHEMISTRY-US, V51, P2706, DOI 10.1021/bi3000929; Jayaraman M, 2012, J MOL BIOL, V415, P881, DOI 10.1016/j.jmb.2011.12.010; Jayasinghe SA, 2005, BIOCHEMISTRY-US, V44, P12113, DOI 10.1021/bi050840w; Kaliszewski M, 2015, CELL DEATH DIFFER, V22, P1413, DOI 10.1038/cdd.2015.80; Kang H, 2017, J AM CHEM SOC, V139, P8820, DOI 10.1021/jacs.7b00838; Kim MW, 2009, STRUCTURE, V17, P1205, DOI 10.1016/j.str.2009.08.002; Kim M, 2013, PRION, V7, P221, DOI 10.4161/pri.23807; LOGAN TM, 1993, J BIOMOL NMR, V3, P225; Luo PZ, 1997, BIOCHEMISTRY-US, V36, P8413, DOI 10.1021/bi9707133; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Margulis BA, 2013, FEBS LETT, V587, P1997, DOI 10.1016/j.febslet.2013.05.022; Miller J, 2011, NAT CHEM BIOL, V7, P925, DOI [10.1038/nchembio.694, 10.1038/NCHEMBIO.694]; Modregger J, 2002, HUM MOL GENET, V11, P2547, DOI 10.1093/hmg/11.21.2547; Nagai Y, 2007, NAT STRUCT MOL BIOL, V14, P332, DOI 10.1038/nsmb1215; Newcombe EA, 2018, J MOL BIOL, V430, P1442, DOI 10.1016/j.jmb.2018.03.031; Owens GE, 2015, J MOL BIOL, V427, P2507, DOI 10.1016/j.jmb.2015.05.023; Pandey NK, 2018, J BIOL CHEM, V293, P2597, DOI 10.1074/jbc.M117.813667; Peters-Libeu C, 2012, J MOL BIOL, V421, P587, DOI 10.1016/j.jmb.2012.01.034; Posey AE, 2018, J BIOL CHEM, V293, P3734, DOI 10.1074/jbc.RA117.000357; Rosenblatt A, 2012, MOVEMENT DISORD, V27, P272, DOI 10.1002/mds.24024; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Sittler A, 1998, MOL CELL, V2, P427, DOI 10.1016/S1097-2765(00)80142-2; Sivanandam VN, 2011, J AM CHEM SOC, V133, P4558, DOI 10.1021/ja110715f; SPERA S, 1991, J AM CHEM SOC, V113, P5490, DOI 10.1021/ja00014a071; Tam S, 2009, NAT STRUCT MOL BIOL, V16, P1279, DOI 10.1038/nsmb.1700; Truant R, 2008, FEBS J, V275, P4252, DOI 10.1111/j.1742-4658.2008.06561.x; Urbanek A, 2018, ANGEW CHEM INT EDIT, V57, P3598, DOI 10.1002/anie.201711530; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Warner JB, 2017, J AM CHEM SOC, V139, P14456, DOI 10.1021/jacs.7b06659; Williamson TE, 2010, J MOL BIOL, V396, P1295, DOI 10.1016/j.jmb.2009.12.017; Zhang QC, 2011, J BIOL CHEM, V286, P8188, DOI 10.1074/jbc.M110.192013	53	22	22	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19613	19623		10.1074/jbc.RA118.004808	http://dx.doi.org/10.1074/jbc.RA118.004808			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30315108	hybrid, Green Published			2022-12-28	WOS:000454294900010
J	Hua, Y; Yang, YL; Li, Q; He, XY; Zhu, W; Wang, JY; Gan, XQ				Hua, Yue; Yang, Yilin; Li, Qian; He, Xinyu; Zhu, Wei; Wang, Jiyong; Gan, Xiaoqing			Oligomerization of Frizzled and LRP5/6 protein initiates intracellular signaling for the canonical WNT/beta-catenin pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; receptor endocytosis; Wnt signaling; cancer; tumor development; Frizzled; hepatoma; LRP5; 6; SFRP2; signalosome	WNT; LRP6; INHIBITION; ACTIVATION; DOMAIN; SFRP2; SIGNALOSOME; SELECTIVITY; DRIVEN; BINDS	Upon binding to the canonical WNT glycoproteins, Frizzled family receptors (FZDs) and low-density lipoprotein receptor-related protein 5/6 (LRP5/6) undergo a series of polymerizations on the cell surface that elicit canonical WNT/-catenin signaling. The hyperactivation of WNT/-catenin signaling is the major cause of tumorigenesis, but the mechanism in tumors such as hepatoma remains unclear. Here, we observed that WNT3A manifested the hyperactivity in -catenin-dependent signaling after binding to FZD's competitive inhibitory molecule secreted Frizzled-related protein 2 (SFRP2). To understand the mechanism of FZDs in the presence of SFRP2, we explored how FZDs can bind and activate the LRP5/6 signalosome independently of WNT glycoproteins. Our findings further revealed that oligomerizations of FZDs and LRP5/6 can integrate the cytoplasmic protein Dishevelled into the LRP5/6 signalosome, resulting in a robust activation of ligand-independent -catenin signaling. We propose that besides WNT-bridged FZD-WNT-LRP5/6 protein complexes, the homo- and hetero-oligomerizations of WNT receptors may contribute to the formation of the LRP5/6 signalosome on the cell surface. Of note, we identified four highly expressed FZDs in the hepatoma cell line HepG2, all of which significantly promoted ligand-independent LRP5/-catenin signaling. As FZDs are ectopically expressed in numerous tumors, our findings may provide a new perspective on tumor pathologies. Furthermore, the results in our study suggest that the composition and stoichiometry of FZDs and LRP5/6 within the LRP5/6 signalosome may tune the selection of bound WNT glycoproteins and configure downstream WNT/-catenin signaling.	[Hua, Yue; Yang, Yilin; Li, Qian; He, Xinyu; Zhu, Wei; Wang, Jiyong; Gan, Xiaoqing] Fudan Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Key Lab Metab & Mol Med,Minist Educ, POB 240, Shanghai 200032, Peoples R China	Fudan University	Wang, JY; Gan, XQ (corresponding author), Fudan Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Key Lab Metab & Mol Med,Minist Educ, POB 240, Shanghai 200032, Peoples R China.	jiyongwang73@gmail.com; xiaoqinggan@fudan.edu.cn			National Natural Science Foundation of China (NSFC) [31471317, 31671466]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (NSFC) Grants 31471317 and 31671466. The authors declare that they have no conflicts of interest with the contents of this article.	Bienz M, 2014, TRENDS BIOCHEM SCI, V39, P487, DOI 10.1016/j.tibs.2014.08.006; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Blitzer JT, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-28; Bourhis E, 2010, J BIOL CHEM, V285, P9172, DOI 10.1074/jbc.M109.092130; Brinkmann EM, 2016, J BIOL CHEM, V291, P13730, DOI 10.1074/jbc.M116.733766; Chan KKS, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010313; Chen JX, 2014, CELL SIGNAL, V26, P1068, DOI 10.1016/j.cellsig.2013.12.020; Chen S, 2011, DEV CELL, V21, P848, DOI 10.1016/j.devcel.2011.09.007; Dijksterhuis JP, 2014, BRIT J PHARMACOL, V171, P1195, DOI 10.1111/bph.12364; Esteve P, 2011, DEVELOPMENT, V138, P4179, DOI 10.1242/dev.065839; Ettenberg SA, 2010, P NATL ACAD SCI USA, V107, P15473, DOI 10.1073/pnas.1007428107; Feng Q, 2015, J CELL PHYSIOL, V230, P1170, DOI 10.1002/jcp.24853; Gammons MV, 2016, J CELL SCI, V129, P3892, DOI 10.1242/jcs.195685; Gan XQ, 2008, J CELL BIOL, V180, P1087, DOI 10.1083/jcb.200710050; Hsieh JC, 2003, CELL, V112, P355, DOI 10.1016/S0092-8674(03)00045-X; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Kilander MBC, 2014, FASEB J, V28, P2293, DOI 10.1096/fj.13-246363; Laurent-Puig P, 2006, ONCOGENE, V25, P3778, DOI 10.1038/sj.onc.1209547; Liu GZ, 2003, MOL CELL BIOL, V23, P5825, DOI 10.1128/MCB.23.16.5825-5835.2003; Liu J, 2013, P NATL ACAD SCI USA, V110, P20224, DOI 10.1073/pnas.1314239110; MacDonald BT, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007880; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Mii Y, 2009, DEVELOPMENT, V136, P4083, DOI 10.1242/dev.032524; Miki T, 2011, STEM CELL REV REP, V7, P836, DOI 10.1007/s12015-011-9275-1; Murillo-Garzon V, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04042-w; Nusse R, 2017, CELL, V169, P985, DOI 10.1016/j.cell.2017.05.016; Ren DN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7906; Rodriguez J, 2005, NAT NEUROSCI, V8, P1301, DOI 10.1038/nn1547; Saito-Diaz K, 2018, DEV CELL, V44, P566, DOI 10.1016/j.devcel.2018.02.013; Schinner S, 2009, HORM METAB RES, V41, P159, DOI 10.1055/s-0028-1119408; Schulte G, 2015, EUR J PHARMACOL, V763, P191, DOI 10.1016/j.ejphar.2015.05.031; Schwarz-Romond T, 2007, NAT STRUCT MOL BIOL, V14, P484, DOI 10.1038/nsmb1247; Sugiyama Y, 2013, DEV BIOL, V384, P181, DOI 10.1016/j.ydbio.2013.10.008; Takagi H, 2008, J GASTROENTEROL, V43, P378, DOI 10.1007/s00535-008-2170-0; Uren A, 2000, J BIOL CHEM, V275, P4374, DOI 10.1074/jbc.275.6.4374; von Marschall Z, 2010, BIOCHEM BIOPH RES CO, V400, P299, DOI 10.1016/j.bbrc.2010.08.043; Xavier CP, 2014, CELL SIGNAL, V26, P94, DOI 10.1016/j.cellsig.2013.09.016; Yamamoto H, 2006, DEV CELL, V11, P213, DOI 10.1016/j.devcel.2006.07.003; Zeng CM, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051543; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540	41	33	36	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19710	19724		10.1074/jbc.RA118.004434	http://dx.doi.org/10.1074/jbc.RA118.004434			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30361437	Green Published, hybrid			2022-12-28	WOS:000454294900018
J	Ohlemacher, SI; Xu, YQ; Kober, DL; Malik, M; Nix, JC; Brett, TJ; Henderson, JP				Ohlemacher, Shannon I.; Xu, Yiquan; Kober, Daniel L.; Malik, Mahnoor; Nix, Jay C.; Brett, Tom J.; Henderson, Jeffrey P.			YbtT is a low-specificity type II thioesterase that maintains production of the metallophore yersiniabactin in pathogenic enterobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						siderophore; biosynthesis; crystallography; mass spectrometry (MS); Escherichia coli (E; coli); metal uptake; metallophore; thioesterase; virulence; yersiniabactin; editing thioesterase	CARRIER PROTEIN DOMAINS; ESCHERICHIA-COLI; SIDEROPHORE YERSINIABACTIN; SUBSTRATE-SPECIFICITY; FUNCTIONAL-ANALYSIS; STRUCTURAL BASIS; CHAIN RELEASE; BIOSYNTHESIS; SYNTHETASE; GENES	Clinical isolates of Yersinia, Klebsiella, and Escherichia coli frequently secrete the small molecule metallophore yersiniabactin (Ybt), which passivates and scavenges transition metals during human infections. YbtT is encoded within the Ybt biosynthetic operon and is critical for full Ybt production in bacteria. However, its biosynthetic function has been unclear because it is not essential for Ybt production by the in vitro reconstituted nonribosomal peptide synthetase/polyketide synthase (NRPS/PKS) pathway. Here, we report the structural and biochemical characterization of YbtT. YbtT structures at 1.4-1.9 resolution possess a serine hydrolase catalytic triad and an associated substrate chamber with features similar to those previously reported for low-specificity type II thioesterases (TEIIs). We found that YbtT interacts with the two major Ybt biosynthetic proteins, HMWP1 (high-molecular-weight protein 1) and HMWP2 (high-molecular-weight protein 2), and hydrolyzes a variety of aromatic and acyl groups from their phosphopantetheinylated carrier protein domains. In vivo YbtT titration in uropathogenic E. coli revealed a distinct optimum for Ybt production consistent with a tradeoff between clearing both stalled inhibitory intermediates and productive Ybt precursors from HMWP1 and HMWP2. These results are consistent with a model in which YbtT maintains cellular Ybt biosynthesis by removing nonproductive, inhibitory thioesters that form aberrantly at multiple sites on HMWP1 and HMWP2.	[Ohlemacher, Shannon I.; Xu, Yiquan; Malik, Mahnoor; Henderson, Jeffrey P.] Washington Univ, Ctr Womens Infect Dis Res, St Louis, MO 63110 USA; [Ohlemacher, Shannon I.; Xu, Yiquan; Malik, Mahnoor; Henderson, Jeffrey P.] Washington Univ, Div Infect Dis, St Louis, MO 63110 USA; [Ohlemacher, Shannon I.; Xu, Yiquan; Kober, Daniel L.; Malik, Mahnoor; Brett, Tom J.; Henderson, Jeffrey P.] Washington Univ, Dept Internal Med, St Louis, MO 63110 USA; [Kober, Daniel L.; Brett, Tom J.] Washington Univ, Div Pulm & Crit Care Med, St Louis, MO 63110 USA; [Kober, Daniel L.; Brett, Tom J.] Washington Univ, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Nix, Jay C.] Lawrence Berkeley Natl Lab, Adv Light Source, Mol Biol Consortium, Berkeley, CA 94720 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Brett, TJ (corresponding author), Box 8052,660 South Euclid St, St Louis, MO 63110 USA.; Henderson, JP (corresponding author), Box 8051,660 South Euclid St, St Louis, MO 63110 USA.	tbrett@wustl.edu; hendersonj@wustl.edu	Brett, Thomas/AAC-9147-2019; Henderson, Jeffrey P/D-3337-2015	Brett, Thomas/0000-0002-6871-6676; Kober, Daniel/0000-0001-8657-9348	National Institutes of Health Training Grant from NIAID [5T32AI007172-35]; National Science Foundation Graduate Research Fellowship Program [DGE-1143954]; National Institutes of Health [T32GM007067, R01HL119813]; American Heart Association [15PRE22110004, 17PRE32780001]; Summer Focus Program; National Institutes of Health from NIDDK [R01DK099534, R01DK111930]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119813] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK111930] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007067] Funding Source: NIH RePORTER	National Institutes of Health Training Grant from NIAID; National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Summer Focus Program; National Institutes of Health from NIDDK; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by National Institutes of Health Training Grant 5T32AI007172-35 from NIAID and National Science Foundation Graduate Research Fellowship Program DGE-1143954.; Supported by National Institutes of Health T32GM007067 and American Heart Association Grants 15PRE22110004 and 17PRE32780001.; Supported by the Summer Focus Program, run by the Young Scientist Program at Washington University.; Recipient of National Institutes of Health Grant R01HL119813.; Recipient of National Institutes of Health Grants R01DK099534 and R01DK111930 from NIDDK.	ACHSTETTER T, 1981, ARCH BIOCHEM BIOPHYS, V207, P445, DOI 10.1016/0003-9861(81)90052-7; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bruner SD, 2002, STRUCTURE, V10, P301, DOI 10.1016/S0969-2126(02)00716-5; Butler AR, 1999, CHEM BIOL, V6, P287, DOI 10.1016/S1074-5521(99)80074-X; Chaturvedi KS, 2012, NAT CHEM BIOL, V8, P731, DOI [10.1038/NCHEMBIO.1020, 10.1038/nchembio.1020]; Chen DQ, 2009, BIOCHEMISTRY-US, V48, P511, DOI 10.1021/bi802207t; Chen SL, 2006, P NATL ACAD SCI USA, V103, P5977, DOI 10.1073/pnas.0600938103; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; Claxton HB, 2009, J BIOL CHEM, V284, P5021, DOI 10.1074/jbc.M808604200; Copeland R. A., 2002, ENZYMES, P109; Crosa JH, 2002, MICROBIOL MOL BIOL R, V66, P223, DOI 10.1128/MMBR.66.2.223-249.2002; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dorrestein PC, 2006, BIOCHEMISTRY-US, V45, P12756, DOI 10.1021/bi061169d; Drake EJ, 2016, NATURE, V529, P235, DOI 10.1038/nature16163; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frueh DP, 2008, NATURE, V454, P903, DOI 10.1038/nature07162; Gehring AM, 1998, BIOCHEMISTRY-US, V37, P11637, DOI 10.1021/bi9812571; Geoffroy VA, 2000, INFECT IMMUN, V68, P4452, DOI 10.1128/IAI.68.8.4452-4461.2000; Gulick AM, 2018, NAT PROD REP, V35, P1156, DOI 10.1039/c8np00044a; Guntaka NS, 2017, ACS CHEM BIOL, V12, P2598, DOI 10.1021/acschembio.7b00479; Harvey BM, 2006, CHEMBIOCHEM, V7, P1435, DOI 10.1002/cbic.200500474; Heathcole ML, 2001, CHEM BIOL, V8, P207, DOI 10.1016/S1074-5521(01)00002-3; Henderson JP, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000305; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keating TA, 2000, BIOCHEMISTRY-US, V39, P4729, DOI 10.1021/bi992923g; Koglin A, 2008, NATURE, V454, P907, DOI 10.1038/nature07161; Koh EI, 2017, NAT CHEM BIOL, V13, P1016, DOI [10.1038/nchembio.2441, 10.1038/NCHEMBIO.2441]; Kotowska M, 2014, APPL MICROBIOL BIOT, V98, P7735, DOI 10.1007/s00253-014-5952-8; Kotowska M, 2009, APPL ENVIRON MICROB, V75, P887, DOI 10.1128/AEM.01371-08; Kozlikova B, 2014, BIOINFORMATICS, V30, P2684, DOI 10.1093/bioinformatics/btu364; Leduc D, 2007, J BACTERIOL, V189, P7112, DOI 10.1128/JB.00755-07; Liu TG, 2006, CHEM BIOL, V13, P945, DOI 10.1016/j.chembiol.2006.07.006; Lv HT, 2011, J PROTEOME RES, V10, P5547, DOI 10.1021/pr200756n; Mady ASA, 2011, MOL BIOSYST, V7, P1999, DOI 10.1039/c1mb05044c; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meier JL, 2009, CHEM SOC REV, V38, P2012, DOI 10.1039/b805115c; Meluzzi D, 2008, BIOORG MED CHEM LETT, V18, P3107, DOI 10.1016/j.bmcl.2007.10.104; Meneely KM, 2012, BIOCHEMISTRY-US, V51, P9002, DOI 10.1021/bi3011016; Meyer PA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10882; Miller DA, 2002, CHEM BIOL, V9, P333, DOI 10.1016/S1074-5521(02)00115-1; Miller MC, 2010, MICROBIOL-SGM, V156, P2226, DOI 10.1099/mic.0.037945-0; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Mulvey MA, 2001, INFECT IMMUN, V69, P4572, DOI 10.1128/IAI.69.7.4572-4579.2001; Mulyani S, 2010, CHEMBIOCHEM, V11, P266, DOI 10.1002/cbic.200900600; Ohlemacher SI, 2017, J CLIN INVEST, V127, P4018, DOI 10.1172/JCI92464; Perry RD, 2011, MICROBES INFECT, V13, P808, DOI 10.1016/j.micinf.2011.04.008; Quadri LEN, 1998, BIOCHEMISTRY-US, V37, P1585, DOI 10.1021/bi9719861; Reimmann C, 2004, J BACTERIOL, V186, P6367, DOI 10.1128/JB.186.19.6367-6373.2004; Ritchie MK, 2016, J BIOL CHEM, V291, P3520, DOI 10.1074/jbc.M115.702597; Robinson AE, 2018, J BIOL CHEM, V293, P14953, DOI 10.1074/jbc.RA118.004483; Robinson AE, 2018, FUTURE MICROBIOL, V13, P813, DOI 10.2217/fmb-2017-0295; Schwarzer D, 2002, P NATL ACAD SCI USA, V99, P14083, DOI 10.1073/pnas.212382199; Suo ZC, 2000, P NATL ACAD SCI USA, V97, P14188, DOI 10.1073/pnas.260495697; Suo ZC, 2001, P NATL ACAD SCI USA, V98, P99, DOI 10.1073/pnas.021537498; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tronnet S, 2016, INFECT IMMUN, V84, P3358, DOI 10.1128/IAI.00659-16; Whicher JR, 2011, J BIOL CHEM, V286, P22558, DOI 10.1074/jbc.M110.213512; Yin J, 2006, NAT PROTOC, V1, P280, DOI 10.1038/nprot.2006.43	59	9	9	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19572	19585		10.1074/jbc.RA118.005752	http://dx.doi.org/10.1074/jbc.RA118.005752			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30355735	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000454294900007
J	Potapenko, E; Cordeiro, CD; Huang, GZ; Storey, M; Wittwer, C; Dutta, AK; Jessen, HJ; Starai, VJ; Docampo, R				Potapenko, Evgeniy; Cordeiro, Ciro D.; Huang, Guozhong; Storey, Melissa; Wittwer, Christopher; Dutta, Amit K.; Jessen, Henning J.; Starai, Vincent J.; Docampo, Roberto			5-Diphosphoinositol pentakisphosphate (5-IP7) regulates phosphate release from acidocalcisomes and yeast vacuoles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRYPANOSOMA-BRUCEI; POLYPHOSPHATE METABOLISM; GROWTH; CELL; PYROPHOSPHATASE; SPECIFICITY; HOMEOSTASIS; TRANSPORT; MEMBRANE	Acidocalcisomes of Trypanosoma brucei and the acidocalcisome-like vacuoles of Saccharomyces cerevisiae are acidic calcium compartments that store polyphosphate (polyP). Both organelles possess a phosphate-sodium symporter (TbPho91 and Pho91p in T. brucei and yeast, respectively), but the roles of these transporters in growth and orthophosphate (P-i) transport are unclear. We found here that Tbpho91(-/-) trypanosomes have a lower growth rate under phosphate starvation and contain larger acidocalcisomes that have increased P-i content. Heterologous expression of TbPHO91 in Xenopus oocytes followed by two-electrode voltage clamp recordings disclosed that myo-inositol polyphosphates stimulate both sodium-dependent depolarization of the oocyte membrane potential and P-i conductance. Deletion of the SPX domain in TbPho91 abolished this stimulation. Inositol pyrophosphates such as 5-diphosphoinositol pentakisphosphate generated outward currents in Na+/P-i-loaded giant vacuoles prepared from WT or from TbPHO91-expressing pho91 Delta strains but not from the pho91 Delta yeast strains or from the pho91 Delta strains expressing PHO91 or TbPHO91 with mutated SPX domains. Our results indicate that TbPho91 and Pho91p are responsible for vacuolar P-i and Na+ efflux and that myo-inositol polyphosphates stimulate the Na+/P-i symporter activities through their SPX domains.	[Potapenko, Evgeniy; Cordeiro, Ciro D.; Huang, Guozhong; Storey, Melissa; Docampo, Roberto] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Potapenko, Evgeniy; Cordeiro, Ciro D.; Docampo, Roberto] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; [Starai, Vincent J.] Univ Georgia, Dept Microbiol & Infect Dis, Athens, GA 30602 USA; [Wittwer, Christopher; Dutta, Amit K.; Jessen, Henning J.] Univ Freiburg, Dept Chem & Pharm, D-79098 Freiburg, Germany	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of Freiburg	Docampo, R (corresponding author), Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA.; Docampo, R (corresponding author), Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA.	rdocampo@uga.edu	Docampo, Roberto/X-9424-2019; Jessen, Henning/O-1157-2019	Docampo, Roberto/0000-0003-4229-8784; Jessen, Henning/0000-0002-1025-9484	NIAID, National Institutes of Health [AI077538]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060546, R01AI077538] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the NIAID, National Institutes of Health Grant AI077538 (to R. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akoda K, 2009, J MED ENTOMOL, V46, P1446, DOI 10.1603/033.046.0629; Albert C, 1997, BIOCHEM J, V327, P553, DOI 10.1042/bj3270553; Andreeva N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119594; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Bru S, 2016, MOL MICROBIOL, V101, P367, DOI 10.1111/mmi.13396; CUNNINGHAM I, 1977, J PROTOZOOL, V24, P325, DOI 10.1111/j.1550-7408.1977.tb00987.x; Dean S, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.140197; Desfougeres Y, 2016, J BIOL CHEM, V291, P22262, DOI 10.1074/jbc.M116.746784; Diaz P, 2008, PLACENTA, V29, P883, DOI 10.1016/j.placenta.2008.07.002; FERREIRA GC, 1993, J BIOENERG BIOMEMBR, V25, P483, DOI 10.1007/BF01108405; Gerasimaite R, 2017, J CELL SCI, V130, P1625, DOI 10.1242/jcs.201061; Gerasimaite R, 2017, ACS CHEM BIOL, V12, P648, DOI 10.1021/acschembio.7b00026; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Hartman ML, 2013, CONTRIB NEPHROL, V180, P138, DOI 10.1159/000346793; Hothorn M, 2009, SCIENCE, V324, P513, DOI 10.1126/science.1168120; Huang GZ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004555; Hurlimann BC, 2007, MOL BIOL CELL, V18, P4438, DOI 10.1091/mbc.E07-05-0457; Jimenez V, 2015, MOL MICROBIOL, V97, P911, DOI 10.1111/mmi.13075; Lander N, 2013, J BIOL CHEM, V288, P34205, DOI 10.1074/jbc.M113.518993; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Lemercier G, 2004, J BIOL CHEM, V279, P3420, DOI 10.1074/jbc.M309974200; Michaillat L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054160; Neef DW, 2003, MOL CELL BIOL, V23, P3788, DOI 10.1128/MCB.23.11.3788-3797.2003; Niyogi S, 2015, J CELL SCI, V128, P2363, DOI 10.1242/jcs.169466; Ramakrishnan S, 2018, PATHOGENS, V7, DOI 10.3390/pathogens7020033; Ravera S, 2007, AM J PHYSIOL-CELL PH, V293, pC606, DOI 10.1152/ajpcell.00064.2007; Rodrigues CO, 1999, MOL CELL BIOL, V19, P7712; Ruiz FA, 2001, J BIOL CHEM, V276, P26114, DOI 10.1074/jbc.M102402200; Saliba KJ, 2006, NATURE, V443, P582, DOI 10.1038/nature05149; Sethuraman A, 2001, P NATL ACAD SCI USA, V98, P8542, DOI 10.1073/pnas.151269398; SZCZEPANSKAKONKEL M, 1987, J BIOL CHEM, V262, P8000; Thomas MR, 2005, P NATL ACAD SCI USA, V102, P9565, DOI 10.1073/pnas.0501122102; Ulrich PN, 2014, J EUKARYOT MICROBIOL, V61, P155, DOI 10.1111/jeu.12093; Villa-Bellosta R, 2009, PFLUG ARCH EUR J PHY, V458, P1151, DOI 10.1007/s00424-009-0688-5; Virkki LV, 2007, AM J PHYSIOL-RENAL, V293, pF643, DOI 10.1152/ajprenal.00228.2007; Wild R, 2016, SCIENCE, V352, P986, DOI 10.1126/science.aad9858; Yabe I, 1999, J BIOL CHEM, V274, P34903, DOI 10.1074/jbc.274.49.34903; Yang YY, 2016, ACS CHEM BIOL, V11, P1362, DOI 10.1021/acschembio.5b00724	38	19	20	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2018	293	49					19101	19112		10.1074/jbc.RA118.005884	http://dx.doi.org/10.1074/jbc.RA118.005884			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NY	30315104	Green Published, hybrid			2022-12-28	WOS:000458467400030
J	Fujimoto, T; Nakamura, O; Saito, M; Tsuru, A; Matsumoto, M; Kohno, K; Inaba, K; Kadokura, H				Fujimoto, Takushi; Nakamura, Orie; Saito, Michiko; Tsuru, Akio; Matsumoto, Masaki; Kohno, Kenji; Inaba, Kenji; Kadokura, Hiroshi			Identification of the physiological substrates of PDIp, a pancreas-specific protein-disulfide isomerase family member	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; REDUCTASE; EXPRESSION; PEPTIDES; NETWORK; PATHWAY; OXIDASE; BINDING; ERDJ5; ERAD	About 20 members of the protein-disulfide isomerase (PDI) family are present in the endoplasmic reticulum of mammalian cells. They are thought to catalyze thiol-disulfide exchange reactions within secretory or membrane proteins to assist in their folding or to regulate their functions. PDIp is a PDI family member highly expressed in the pancreas and known to bind estrogen in vivo and in vitro. However, the physiological functions of PDIp remained unclear. In this study, we set out to identify its physiological substrates. By combining acid quenching and thiol alkylation, we stabilized and purified the complexes formed between endogenous PDIp and its target proteins from the mouse pancreas. MS analysis of these complexes helped identify the disulfide-linked PDIp targets in vivo, revealing that PDIp interacts directly with a number of pancreatic digestive enzymes. Interestingly, when pancreatic elastase, one of the identified proteins, was expressed alone in cultured cells, its proenzyme formed disulfide-linked aggregates within cells. However, when pancreatic elastase was co-expressed with PDIp, the latter prevented the formation of these aggregates and enhanced the production and secretion of proelastase in a form that could be converted to an active enzyme upon trypsin treatment. These findings indicate that the main targets of PDIp are digestive enzymes and that PDIp plays an important role in the biosynthesis of a digestive enzyme by assisting with the proper folding of the proenzyme within cells.	[Fujimoto, Takushi; Nakamura, Orie; Inaba, Kenji; Kadokura, Hiroshi] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Saito, Michiko; Tsuru, Akio; Kohno, Kenji] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300192, Japan; [Saito, Michiko] Kyoto Pharmaceut Univ, Biosci Res Ctr, Yamashina Ku, Kyoto 6078412, Japan; [Matsumoto, Masaki] Kyushu Univ, Med Inst Bioregulat, Higashi Ku, Fukuoka, Fukuoka 8128582, Japan; [Kohno, Kenji] Nara Inst Sci & Technol, Inst Res Initiat, Nara 6300192, Japan; [Inaba, Kenji] Japan Sci & Technol Agcy JST, CREST, Saitama 3320012, Japan	Tohoku University; Nara Institute of Science & Technology; Kyoto Pharmaceutical University; Kyushu University; Nara Institute of Science & Technology; Japan Science & Technology Agency (JST)	Kadokura, H (corresponding author), Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi 9808577, Japan.	hiroshi.kadokura.b3@tohoku.ac.jp	Kadokura, Hiroshi/AAE-1645-2019; Kohno, Kenji/AAZ-6573-2020	Kohno, Kenji/0000-0002-3503-6551; Kadokura, Hiroshi/0000-0001-7308-7141; Inaba, Kenji/0000-0001-8229-0467	Japan Society for the Promotion of Science (JSPS) KAKENHI [JP15K07381, JP15H04335, JP24228002]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI [JP26116005]; CREST [JPMJCR13M6]; Noda Institute for Scientific Research	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); CREST(Core Research for Evolutional Science and Technology (CREST)); Noda Institute for Scientific Research(Noda Institute for Scientific Research)	This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grants JP15K07381 (to H. K.), JP15H04335 (to K. I.), and JP24228002 (to K. K.); Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI Grant JP26116005 (to H. K. and K. I.); and CREST Grant JPMJCR13M6 (to K. I.). This work was also supported, in part, by a grant from the Noda Institute for Scientific Research (to H. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Araki K, 2013, J CELL BIOL, V202, P861, DOI 10.1083/jcb.201303027; Bowley SR, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14151; Braakman I, 2011, ANNU REV BIOCHEM, V80, P71, DOI 10.1146/annurev-biochem-062209-093836; Desilva MG, 1996, DNA CELL BIOL, V15, P9, DOI 10.1089/dna.1996.15.9; DeSilva MG, 1997, DNA CELL BIOL, V16, P269, DOI 10.1089/dna.1997.16.269; Eletto D, 2014, MOL CELL, V53, P562, DOI 10.1016/j.molcel.2014.01.004; Fu XM, 2010, BIOCHEM J, V429, P157, DOI 10.1042/BJ20091954; Fu XM, 2009, J MOL HISTOL, V40, P189, DOI 10.1007/s10735-009-9230-5; Fu XM, 2012, BIOCHEM J, V447, P115, DOI 10.1042/BJ20120868; Hagiwara M, 2011, MOL CELL, V41, P432, DOI 10.1016/j.molcel.2011.01.021; Higa A, 2014, MOL CELL BIOL, V34, P1839, DOI 10.1128/MCB.01484-13; Jessop CE, 2007, EMBO J, V26, P28, DOI 10.1038/sj.emboj.7601505; Jessop CE, 2009, J CELL SCI, V122, P4287, DOI 10.1242/jcs.059154; Kadokura H, 2004, SCIENCE, V303, P534, DOI 10.1126/science.1091724; Kadokura H, 2013, BIOCHEM BIOPH RES CO, V440, P245, DOI 10.1016/j.bbrc.2013.09.063; Kadokura H, 2010, ANTIOXID REDOX SIGN, V13, P1231, DOI 10.1089/ars.2010.3187; Kim K, 2013, BLOOD, V122, P1052, DOI 10.1182/blood-2013-03-492504; Klappa P, 1998, EUR J BIOCHEM, V254, P63, DOI 10.1046/j.1432-1327.1998.2540063.x; KNAPPIK A, 1994, BIOTECHNIQUES, V17, P754; Lang T, 2009, ANESTH ANALG, V108, P751, DOI 10.1213/ane.0b013e3181966675; LOGSDON CD, 1985, J CELL BIOL, V100, P1200, DOI 10.1083/jcb.100.4.1200; Maegawa K, 2017, STRUCTURE, V25, P846, DOI 10.1016/j.str.2017.04.001; Oka OBV, 2015, BIOCHEM J, V469, P279, DOI 10.1042/BJ20141423; Oka OBV, 2013, MOL CELL, V50, P793, DOI 10.1016/j.molcel.2013.05.014; Okumura M, 2015, FREE RADICAL BIO MED, V83, P314, DOI 10.1016/j.freeradbiomed.2015.02.010; OSHIMA G, 1984, ARCH BIOCHEM BIOPHYS, V233, P212, DOI 10.1016/0003-9861(84)90619-2; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Pagani M, 2000, J BIOL CHEM, V275, P23685, DOI 10.1074/jbc.M003061200; Pandol S. J, 2010, EXOCRINE PANCREAS, P29; Poet GJ, 2017, EMBO J, V36, P693, DOI 10.15252/embj.201695336; RAJASEKARAN AK, 1993, J CELL SCI, V105, P333; Rajpal G, 2012, J BIOL CHEM, V287, P43, DOI 10.1074/jbc.C111.279927; Rawlings ND, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P1; Ruddock LW, 2000, PROTEIN SCI, V9, P758; RUDLING MJ, 1990, P NATL ACAD SCI USA, V87, P3469, DOI 10.1073/pnas.87.9.3469; Sato Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02456; Sato Y, 2012, FEBS J, V279, P2262, DOI 10.1111/j.1742-4658.2012.08593.x; Schulman S, 2016, ANTIOXID REDOX SIGN, V24, P1, DOI 10.1089/ars.2015.6530; SHIRASU Y, 1987, J BIOCHEM-TOKYO, V102, P1555, DOI 10.1093/oxfordjournals.jbchem.a122204; Sopha P, 2012, CELL STRUCT FUNCT, V37, P177, DOI 10.1247/csf.12017; Stopa JD, 2017, J BIOL CHEM, V292, P9063, DOI 10.1074/jbc.M116.771832; Tavender TJ, 2010, EMBO J, V29, P4185, DOI 10.1038/emboj.2010.273; Tsuchiya Y, 2018, J CELL BIOL, V217, P1287, DOI 10.1083/jcb.201707143; Ushioda R, 2016, P NATL ACAD SCI USA, V113, pE6055, DOI 10.1073/pnas.1605818113; Zhang LL, 2009, J BIOL CHEM, V284, P5289, DOI 10.1074/jbc.M805477200; Zito E, 2010, J CELL BIOL, V188, P821, DOI 10.1083/jcb.200911086	46	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2018	293	48					18421	18433		10.1074/jbc.RA118.003694	http://dx.doi.org/10.1074/jbc.RA118.003694			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NX	30315102	Green Published, hybrid			2022-12-28	WOS:000458467300001
J	Phillips, MA				Phillips, Margaret A.			Polyamines in protozoan pathogens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							S-ADENOSYLMETHIONINE DECARBOXYLASE; PARASITE PLASMODIUM-FALCIPARUM; TRYPANOSOMA-BRUCEI; ORNITHINE-DECARBOXYLASE; SPERMIDINE SYNTHASE; LEISHMANIA-DONOVANI; MALARIA PARASITE; BIOCHEMICAL-CHARACTERIZATION; TRICHOMONAS-VAGINALIS; BIOSYNTHETIC ENZYME	Polyamines are polycationic organic amines that are required for all eukaryotic life, exemplified by the polyamine spermidine, which plays an essential role in translation. They also play more specialized roles that differ across species, and their chemical versatility has been fully exploited during the evolution of protozoan pathogens. These eukaryotic pathogens, which cause some of the most globally widespread infectious diseases, have acquired species-specific polyamine-derived metabolites with essential cellular functions and have evolved unique mechanisms that regulate their core polyamine biosynthetic pathways. Many of these parasitic species have lost enzymes and or transporters from the polyamine metabolic pathway that are found in the human host. These pathway differences have prompted drug discovery efforts to target the parasite polyamine pathways, and indeed, the only clinically approved drug targeting the polyamine biosynthetic pathway is used to manage human African trypanosomiasis. This Minireview will primarily focus on polyamine metabolism and function in Trypanosoma, Leishmania, and Plasmodium species, which are the causative agents of human African trypanosomiasis (HAT) and Chagas disease, Leishmaniasis, and malaria, respectively. Aspects of polyamine metabolism across a diverse group of protozoan pathogens will also be explored.	[Phillips, Margaret A.] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, 5253 Harry Hines Blvd, Dallas, TX 75390 USA; [Phillips, Margaret A.] Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Phillips, MA (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, 5253 Harry Hines Blvd, Dallas, TX 75390 USA.	margaret.phillips@utsouthwestern.edu			National Institutes of Health [2R37AI034432]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI034432] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant 2R37AI034432. This article is part of a series on "Polyamines," written in honor of Dr. Herbert Tabor's 100th birthday. The author declares that she has no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Afanador G. A, 2018, STRUCTURE, V2018; Alvarez-Sanchez ME, 2017, CURR PHARM DESIGN, V23, P3359, DOI 10.2174/1381612823666170703162754; Ariyanayagam MR, 1997, MOL BIOCHEM PARASIT, V84, P111, DOI 10.1016/S0166-6851(96)02788-0; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Aurrecoechea C, 2011, NUCLEIC ACIDS RES, V39, pD612, DOI 10.1093/nar/gkq1006; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD526, DOI 10.1093/nar/gkn631; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; BACCHI CJ, 1979, J PROTOZOOL, V26, P484, DOI 10.1111/j.1550-7408.1979.tb04658.x; BACCHI CJ, 1980, SCIENCE, V210, P332, DOI 10.1126/science.6775372; BACCHI CJ, 1992, ANTIMICROB AGENTS CH, V36, P2736, DOI 10.1128/AAC.36.12.2736; Bacchi CJ, 2009, ANTIMICROB AGENTS CH, V53, P3269, DOI 10.1128/AAC.00076-09; Barker RH, 2009, ANTIMICROB AGENTS CH, V53, P2052, DOI 10.1128/AAC.01674-08; BELLOFATTO V, 1987, MOL BIOCHEM PARASIT, V25, P227, DOI 10.1016/0166-6851(87)90086-7; Birkholtz LM, 2011, BIOCHEM J, V438, P229, DOI 10.1042/BJ20110362; Bogacz M, 2018, ELIFE, V7, DOI 10.7554/eLife.37503; Boitz JM, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00554-16; Boitz JM, 2009, INFECT IMMUN, V77, P756, DOI 10.1128/IAI.01236-08; BOLLINGER JM, 1995, J BIOL CHEM, V270, P14031, DOI 10.1074/jbc.270.23.14031; Brockway AJ, 2017, BIOORGAN MED CHEM, V25, P5433, DOI 10.1016/j.bmc.2017.07.063; Brun R, 1996, ANTIMICROB AGENTS CH, V40, P1442, DOI 10.1128/AAC.40.6.1442; Bushell E, 2017, CELL, V170, P260, DOI 10.1016/j.cell.2017.06.030; Casero RA, 2018, NAT REV CANCER, V18, P681, DOI 10.1038/s41568-018-0050-3; Chattopadhyay MK, 2013, FEMS MICROBIOL LETT, V338, P132, DOI 10.1111/1574-6968.12035; Chawla B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033138; Chawla B, 2010, J BIOL CHEM, V285, P453, DOI 10.1074/jbc.M109.048850; Creek DJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004689; Das Gupta R, 2005, ANTIMICROB AGENTS CH, V49, P2857, DOI 10.1128/AAC.49.7.2857-2864.2005; De Muylder G, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003731; Dever TE, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a032649; Dever TE, 2014, CRIT REV BIOCHEM MOL, V49, P413, DOI 10.3109/10409238.2014.939608; FAIRLAMB AH, 1985, SCIENCE, V227, P1485, DOI 10.1126/science.3883489; Field MC, 2017, NAT REV MICROBIOL, V15, DOI 10.1038/nrmicro.2016.193; Fletcher SM, 2012, CLIN MICROBIOL REV, V25, P420, DOI 10.1128/CMR.05038-11; Fyfe PK, 2008, J BIOL CHEM, V283, P17672, DOI 10.1074/jbc.M801850200; Gajria B, 2008, NUCLEIC ACIDS RES, V36, pD553, DOI 10.1093/nar/gkm981; Gibson AR, 2018, CURR BIOL, V28, pR193, DOI 10.1016/j.cub.2017.11.070; Gilroy C, 2011, INFECT IMMUN, V79, P2764, DOI 10.1128/IAI.00073-11; Grishin NV, 1999, BIOCHEMISTRY-US, V38, P15174, DOI 10.1021/bi9915115; Hai Y, 2015, BIOCHEMISTRY-US, V54, P458, DOI 10.1021/bi501366a; Haider N, 2005, MOL BIOCHEM PARASIT, V142, P224, DOI 10.1016/j.molbiopara.2005.04.004; Hasne MP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152715; Hasne MP, 2010, MOL MICROBIOL, V76, P78, DOI 10.1111/j.1365-2958.2010.07081.x; Hasne MP, 2005, J BIOL CHEM, V280, P15188, DOI 10.1074/jbc.M411331200; Heiges M, 2006, NUCLEIC ACIDS RES, V34, pD419, DOI 10.1093/nar/gkj078; Huynh TT, 2003, J BIOL CHEM, V278, P39794, DOI 10.1074/jbc.M306306200; Quintas-Granados LI, 2016, BIOCHIMIE, V123, P37, DOI 10.1016/j.biochi.2015.09.027; Jacobs RT, 2011, CURR TOP MED CHEM, V11, P1255; Jiang C, 2018, SCIENCE, V359, DOI 10.1126/science.aas8953; Jiang YQ, 1999, J BIOL CHEM, V274, P3781, DOI 10.1074/jbc.274.6.3781; Kim DH, 2015, METABOLOMICS, V11, P1721, DOI 10.1007/s11306-015-0827-2; Kissinger P, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1055-0; Krauth-Siegel RL, 2008, BBA-GEN SUBJECTS, V1780, P1236, DOI 10.1016/j.bbagen.2008.03.006; Krauth-Siegel RL, 2012, ANTIOXID REDOX SIGN, V17, P583, DOI 10.1089/ars.2011.4392; Krieger S, 2000, MOL MICROBIOL, V35, P542, DOI 10.1046/j.1365-2958.2000.01721.x; Leija C, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006010; Leroux AE, 2016, MOL BIOCHEM PARASIT, V206, P67, DOI 10.1016/j.molbiopara.2015.11.003; Li B, 2015, MOL MICROBIOL, V97, P791, DOI 10.1111/mmi.13066; Li F, 1998, EXP PARASITOL, V88, P255, DOI 10.1006/expr.1998.4237; Macedo JP, 2017, FASEB J, V31, P4649, DOI 10.1096/fj.201700311R; Michael AJ, 2016, BIOCHEM J, V473, P2315, DOI 10.1042/BCJ20160185; Mittal N, 2014, MOL BIOCHEM PARASIT, V195, P14, DOI 10.1016/j.molbiopara.2014.05.005; Montoya J.G., 2015, MANDELL DOUGLAS BENN, P3122; Muller IB, 2008, MOL BIOCHEM PARASIT, V160, P1, DOI 10.1016/j.molbiopara.2008.03.008; Muller S, 2000, J BIOL CHEM, V275, P8097, DOI 10.1074/jbc.275.11.8097; Murray-Stewart TR, 2016, BIOCHEM J, V473, P2937, DOI 10.1042/BCJ20160383; Niemand J, 2012, INT J PARASITOL, V42, P921, DOI 10.1016/j.ijpara.2012.07.005; Olenyik T, 2011, MOL BIOCHEM PARASIT, V176, P109, DOI 10.1016/j.molbiopara.2010.12.004; Oza SL, 2002, J BIOL CHEM, V277, P35853, DOI 10.1074/jbc.M204403200; Park MH, 2010, AMINO ACIDS, V38, P491, DOI 10.1007/s00726-009-0408-7; Pegg AE, 2009, IUBMB LIFE, V61, P880, DOI 10.1002/iub.230; PHILLIPS MA, 1987, MOL BIOCHEM PARASIT, V22, P9, DOI 10.1016/0166-6851(87)90064-8; PHILLIPS MA, 1987, J BIOL CHEM, V262, P8721; Phillips MA, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.50; Pratt C, 2014, EUKARYOT CELL, V13, P614, DOI 10.1128/EC.00015-14; Priotto G, 2009, LANCET, V374, P56, DOI 10.1016/S0140-6736(09)61117-X; Roberts SC, 2004, J BIOL CHEM, V279, P23668, DOI 10.1074/jbc.M402042200; Roberts SC, 2002, J BIOL CHEM, V277, P5902, DOI 10.1074/jbc.M110118200; Roberts S, 2017, CURR PHARM DESIGN, V23, P3325, DOI 10.2174/1381612823666170601101644; Roberts SC, 2007, ANTIMICROB AGENTS CH, V51, P438, DOI 10.1128/AAC.01193-06; Sakata K, 2003, BIOCHEM BIOPH RES CO, V305, P143, DOI 10.1016/S0006-291X(03)00716-2; Schuller AP, 2017, MOL CELL, V66, P194, DOI 10.1016/j.molcel.2017.03.003; Smithson DC, 2010, J BIOL CHEM, V285, P16771, DOI 10.1074/jbc.M109.081588; Stuart K, 2008, J CLIN INVEST, V118, P1301, DOI 10.1172/JCI33945; Nguyen S, 2015, J BIOL CHEM, V290, P19987, DOI 10.1074/jbc.M115.656785; Nguyen S, 2013, J BIOL CHEM, V288, P15256, DOI 10.1074/jbc.M113.461137; TABOR H, 1975, J BIOL CHEM, V250, P2648; Taylor MC, 2008, BIOCHEM J, V409, P563, DOI 10.1042/BJ20071185; Tetaud E, 1998, J BIOL CHEM, V273, P19383, DOI 10.1074/jbc.273.31.19383; van Brummelen AC, 2009, J BIOL CHEM, V284, P4635, DOI 10.1074/jbc.M807085200; Vincent IM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001618; Vincent IM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001204; Volkov OA, 2018, J MED CHEM, V61, P1182, DOI 10.1021/acs.jmedchem.7b01654; Volkov OA, 2017, ACS INFECT DIS, V3, P512, DOI 10.1021/acsinfecdis.7b00022; Volkov OA, 2016, ELIFE, V5, DOI [10.7554/eLife.20198, 10.7554/elife.20198]; Willert E, 2012, TRENDS PARASITOL, V28, P66, DOI 10.1016/j.pt.2011.11.001; Willert EK, 2007, P NATL ACAD SCI USA, V104, P8275, DOI 10.1073/pnas.0701111104; Willert EK, 2009, MOL BIOCHEM PARASIT, V168, P1, DOI 10.1016/j.molbiopara.2009.05.009; Willert EK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000183; Wyllie S, 2008, ANTIMICROB AGENTS CH, V52, P1359, DOI 10.1128/AAC.01563-07; Wyllie S, 2009, MOL MICROBIOL, V74, P529, DOI 10.1111/j.1365-2958.2009.06761.x; Xiao YJ, 2013, MOL MICROBIOL, V88, P846, DOI 10.1111/mmi.12226; Xiao YJ, 2009, EUKARYOT CELL, V8, P747, DOI 10.1128/EC.00047-09; Yamasaki K, 2016, J MED CHEM, V59, P2261, DOI 10.1021/acs.jmedchem.5b01769; YARLETT N, 1993, BIOCHEM J, V293, P487, DOI 10.1042/bj2930487; Yarlett N, 2000, MICROBIOL-UK, V146, P2715, DOI 10.1099/00221287-146-10-2715; Yun O, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000720	106	20	20	3	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2018	293	48					18746	18756		10.1074/jbc.TM118.003342	http://dx.doi.org/10.1074/jbc.TM118.003342			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NX	30333232	Green Published, hybrid			2022-12-28	WOS:000458467300030
J	Yun, H; Lee, M; Kim, SS; Ha, J				Yun, Hee; Lee, Minyoung; Kim, Sung-Soo; Ha, Joohun			RETRACTION: Glucose deprivation increases mRNA stability of vascular endothelial growth factor through activation of AMP-activated protein kinase in DU145 prostate carcinoma. (Retraction of Vol 280, Pg 9963, 2005)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction													Kim, Sung Soo/S-2540-2017	Kim, Sung Soo/0000-0002-6817-7668				Yun H, 2005, J BIOL CHEM, V280, P9963, DOI 10.1074/jbc.M412994200	1	0	0	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2018	293	46					18014	18014		10.1074/jbc.W118.006428	http://dx.doi.org/10.1074/jbc.W118.006428			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HA6SG	30446604	Green Published, hybrid			2022-12-28	WOS:000450409500031
J	Wang, XH; Chen, QQ; Yi, S; Liu, QY; Zhang, RR; Wang, P; Qian, TM; Li, SY				Wang, Xinghui; Chen, Qianqian; Yi, Sheng; Liu, Qianyan; Zhang, Ruirui; Wang, Pan; Qian, Tianmei; Li, Shiying			The microRNAs let-7 and miR-9 down-regulate the axon-guidance genes Ntn1 and Dcc during peripheral nerve regeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						axon; microRNA (miRNA); regeneration; Schwann cells; neuron; translation regulation; deleted in colorectal carcinoma; let-7; miR-9; Netrin-1; peripheral nerve regeneration	SCIATIC-NERVE; EXPRESSION; NETRIN-1; DEADENYLATION; MIRNA; MIGRATION; GROWTH; CANCER; UNC5	Axon guidance helps growing neural axons to follow precise paths to reach their target locations. It is a critical step for both the formation and regeneration of neuronal circuitry. Netrin-1 (Ntn1) and its receptor, deleted in colorectal carcinoma (Dcc) are essential factors for axon guidance, but their regulation in this process is incompletely understood. In this study, using quantitative real-time RT-PCR (qRT-PCR) and biochemical and reporter gene assays, we found that the Ntn1 and Dcc genes are both robustly up-regulated in the sciatic nerve stump after peripheral nerve injury. Moreover, we found that the microRNA (miR) let-7 directly targets the Ntn1 transcript by binding to its 3-untranslated region (3-UTR), represses Ntn1 expression, and reduces the secretion of Ntn1 protein in Schwann cells. We also identified miR-9 as the regulatory miRNA that directly targets Dcc and found that miR-9 down-regulates Dcc expression and suppresses the migration ability of Schwann cells by regulating Dcc abundance. Functional examination in dorsal root ganglion neurons disclosed that let-7 and miR-9 decrease the protein levels of Ntn1 and Dcc in these neurons, respectively, and reduce axon outgrowth. Moreover, we identified a potential regulatory network comprising let-7, miR-9, Ntn1, Dcc, and related molecules, including the RNA-binding protein Lin-28 homolog A (Lin28), SRC proto-oncogene nonreceptor tyrosine kinase (Src), and the transcription factor NF-B. In summary, our findings reveal that the miRs let-7 and miR-9 are involved in regulating neuron pathfinding and extend our understanding of the regulatory pathways active during peripheral nerve regeneration.	[Wang, Xinghui; Chen, Qianqian; Yi, Sheng; Liu, Qianyan; Zhang, Ruirui; Wang, Pan; Qian, Tianmei; Li, Shiying] Nantong Univ, Key Lab Neuroregenerat Jiangsu, Nanjing 226001, Jiangsu, Peoples R China; [Wang, Xinghui; Chen, Qianqian; Yi, Sheng; Liu, Qianyan; Zhang, Ruirui; Wang, Pan; Qian, Tianmei; Li, Shiying] Nantong Univ, Minist Educ, Coinnovat Ctr Neuroregenerat, Nanjing 226001, Jiangsu, Peoples R China	Nantong University; Nantong University	Li, SY (corresponding author), Nantong Univ, Key Lab Neuroregenerat Jiangsu, Nanjing 226001, Jiangsu, Peoples R China.	lisy0379@ntu.edu.cn	Yi, Sheng/AAA-6017-2020	Yi, Sheng/0000-0003-1316-3370; Liu, Qianyan/0000-0003-2818-8511	National Key RAMP;D Program of China [2017YFA0104703]; National Key Research and Development Program of China [31730031]; Collegiate Natural Science Fund of Jiangsu Province [16KJA310005]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Natural Science Foundation of Nantong Grant [MS12017015-2]; Postgraduate Research AMP; Practice Innovation Program of Jiangsu Province [KYCX18-2398]	National Key RAMP;D Program of China; National Key Research and Development Program of China; Collegiate Natural Science Fund of Jiangsu Province; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Natural Science Foundation of Nantong Grant; Postgraduate Research AMP; Practice Innovation Program of Jiangsu Province	This work was supported by National Key R&D Program of China Grant 2017YFA0104703, National Key Research and Development Program of China Grant 31730031, Collegiate Natural Science Fund of Jiangsu Province Grant 16KJA310005, the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), Natural Science Foundation of Nantong Grant MS12017015-2, and Postgraduate Research & Practice Innovation Program of Jiangsu Province Grant KYCX18-2398. The authors declare that they have no conflicts of interest with the contents of this article.	Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Basu A, 2017, P NATL ACAD SCI USA, V114, pE10206, DOI 10.1073/pnas.1704372114; Bazzoni F, 2009, P NATL ACAD SCI USA, V106, P5282, DOI 10.1073/pnas.0810909106; Bosse F, 2006, J NEUROCHEM, V96, P1441, DOI 10.1111/j.1471-4159.2005.03635.x; Bosse F, 2012, CELL TISSUE RES, V349, P5, DOI 10.1007/s00441-012-1389-5; Cai Yan, 2011, Chinese Medical Sciences Journal, V26, P175; Cheng XL, 2015, NEURAL REGEN RES, V10, P1663, DOI 10.4103/1673-5374.167767; da Silva TF, 2014, J CLIN INVEST, V124, P2560, DOI 10.1172/JCI72063; Dajas-Bailador F, 2012, NAT NEUROSCI, V15, P697, DOI 10.1038/nn.3082; Djuranovic S, 2012, SCIENCE, V336, P237, DOI 10.1126/science.1215691; Faria AM, 2015, CLIN ENDOCRINOL, V82, P481, DOI 10.1111/cen.12607; Flamand MN, 2016, NUCLEIC ACIDS RES, V44, P5924, DOI 10.1093/nar/gkw276; Gaudet AD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-110; Geisbrecht BV, 2003, J BIOL CHEM, V278, P32561, DOI 10.1074/jbc.M302943200; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Hamasaki T, 2001, J NEUROSCI, V21, P4272, DOI 10.1523/JNEUROSCI.21-12-04272.2001; Han L, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-40; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Horn KE, 2013, CELL REP, V3, P173, DOI 10.1016/j.celrep.2012.12.005; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Iyer AN, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00078; Jiang JJ, 2017, MOL PAIN, V13, DOI 10.1177/1744806917711612; Kefeli U, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317698388; Keleman K, 2001, NEURON, V32, P605, DOI 10.1016/S0896-6273(01)00505-0; Li SY, 2017, MOL NEUROBIOL, V54, P4379, DOI 10.1007/s12035-016-9965-4; Li SY, 2017, ENGINEERING-PRC, V3, P3, DOI 10.1016/J.ENG.2017.01.005; Li SY, 2015, MOL THER, V23, P423, DOI 10.1038/mt.2014.220; Li SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057000; Li SY, 2011, SCI CHINA LIFE SCI, V54, P806, DOI 10.1007/s11427-011-4213-7; Liu S, 2014, J CELL BIOCHEM, V115, P1368, DOI 10.1002/jcb.24786; Marler KJ, 2014, J NEUROSCI, V34, P969, DOI 10.1523/JNEUROSCI.1910-13.2014; Mediero A, 2016, FASEB J, V30, P3835, DOI 10.1096/fj.201600615R; Moon C, 2006, J NEUROIMMUNOL, V172, P66, DOI 10.1016/j.jneuroim.2005.11.002; Namgung U, 2014, CELLS TISSUES ORGANS, V200, P6, DOI 10.1159/000370324; O'Donnell MP, 2013, J NEUROSCI, V33, P305, DOI 10.1523/JNEUROSCI.2756-12.2013; Piao XH, 2010, MOL CELL BIOL, V30, P1486, DOI 10.1128/MCB.01481-09; Poliak S, 2015, ELIFE, V4, DOI 10.7554/eLife.10841; Shibata M, 2011, J NEUROSCI, V31, P3407, DOI 10.1523/JNEUROSCI.5085-10.2011; Wang XD, 2013, NEURAL REGEN RES, V8, P64, DOI 10.3969/j.issn.1673-5374.2013.01.008; Wu D, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00055; Yao C, 2018, J NEUROSCI, V38, P6574, DOI 10.1523/JNEUROSCI.3790-16.2018; Yi S, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00022; Yi S, 2016, SCI REP-UK, V6, DOI 10.1038/srep29121; Yi S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143491; Zhou SL, 2014, J CELL SCI, V127, P967, DOI 10.1242/jcs.131672	46	31	31	4	21	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3489	3500		10.1074/jbc.RA119.007389	http://dx.doi.org/10.1074/jbc.RA119.007389			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30626732	Green Published, hybrid			2022-12-28	WOS:000461853900016
J	Tak, U; Vlach, J; Garza-Garcia, A; William, D; Danilchanka, O; de Carvalho, LPS; Saad, JS; Niederweis, M				Tak, Uday; Vlach, Jiri; Garza-Garcia, Acely; William, Doreen; Danilchanka, Olga; de Carvalho, Luiz Pedro Sorio; Saad, Jamil S.; Niederweis, Michael			The tuberculosis necrotizing toxin is an NAD(+) and NADP(+) glycohydrolase with distinct enzymatic properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial toxin; tuberculosis; enzyme kinetics; enzyme mechanism; host-pathogen interaction	TRANSITION-STATE STRUCTURE; BACTERIAL PROTEIN TOXINS; PROGRESS CURVE ANALYSIS; MYCOBACTERIUM-TUBERCULOSIS; ADP-RIBOSYLATION; CELL-DEATH; MACROPHAGE; BINDING; HYDROLYSIS; MECHANISMS	Upon host infection, Mycobacterium tuberculosis secretes the tuberculosis necrotizing toxin (TNT) into the cytosol of infected macrophages, leading to host cell death by necroptosis. TNT hydrolyzes NAD(+) in the absence of any exogenous cofactor, thus classifying it as a -NAD(+) glycohydrolase. However, TNT lacks sequence similarity with other NAD(+) hydrolyzing enzymes and lacks the essential motifs involved in NAD(+) binding and hydrolysis by these enzymes. In this study, we used NMR to examine the enzymatic activity of TNT and found that TNT hydrolyzes NADP(+) as fast as NAD(+) but does not cleave the corresponding reduced dinucleotides. This activity of TNT was not inhibited by ADP-ribose or nicotinamide, indicating low affinity of TNT for these reaction products. A selection assay for nontoxic TNT variants in Escherichia coli identified four of six residues in the predicted NAD(+)-binding pocket and four glycine residues that form a cradle directly below the NAD(+)-binding site, a conserved feature in the TNT protein family. Site-directed mutagenesis of residues near the predicted NAD(+)-binding site revealed that Phe(727), Arg(757), and Arg(780) are essential for NAD(+) hydrolysis by TNT. These results identify the NAD(+)-binding site of TNT. Our findings also show that TNT is an NAD(+) glycohydrolase with properties distinct from those of other bacterial glycohydrolases. Because many of these residues are conserved within the TNT family, our findings provide insights into understanding the function of the >300 TNT homologs.	[Tak, Uday; Vlach, Jiri; William, Doreen; Danilchanka, Olga; Saad, Jamil S.; Niederweis, Michael] Univ Alabama Birmingham, Dept Microbiol, BBRB 609,845 19th St S, Birmingham, AL 35205 USA; [Garza-Garcia, Acely; de Carvalho, Luiz Pedro Sorio] Francis Crick Inst, London NW1 1AT, England; [Vlach, Jiri] Univ Georgia, Athens, GA 30602 USA; [William, Doreen] Univ Rostock, D-18055 Rostock, Germany; [Danilchanka, Olga] Merck Exploratory Sci Ctr, Cambridge, MA 02141 USA	University of Alabama System; University of Alabama Birmingham; Francis Crick Institute; University System of Georgia; University of Georgia; University of Rostock	Niederweis, M (corresponding author), Univ Alabama Birmingham, Dept Microbiol, BBRB 609,845 19th St S, Birmingham, AL 35205 USA.	mnieder@uab.edu	William, Doreen/AHA-1288-2022	Vlach, Jiri/0000-0002-0874-2055; Saad, Jamil/0000-0001-9503-6484; Niederweis, Michael/0000-0003-4068-8092; Garza-Garcia, Acely/0000-0003-0307-0138; Tak, Uday/0000-0001-7907-3840	NCI, National Institutes of Health [P30 CA013148]; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI121354] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the comprehensive cancer center at the University of Alabama at Birmingham (funded by NCI, National Institutes of Health Grant P30 CA013148) for supporting the High-Field NMR facility.	Aktories K, 2011, NAT REV MICROBIOL, V9, P487, DOI 10.1038/nrmicro2592; Baldari CT, 2006, TRENDS IMMUNOL, V27, P434, DOI 10.1016/j.it.2006.07.002; Belenky P, 2007, CELL, V129, P473, DOI 10.1016/j.cell.2007.03.024; Berthelier V, 1998, BIOCHEM J, V330, P1383, DOI 10.1042/bj3301383; Berti PJ, 1997, J AM CHEM SOC, V119, P12079, DOI 10.1021/ja971317a; Boshoff HIM, 2008, J BIOL CHEM, V283, P19329, DOI 10.1074/jbc.M800694200; Braun V, 2013, FEMS MICROBIOL LETT, V345, P13, DOI 10.1111/1574-6968.12180; Cakir-Kiefer C, 2000, BIOCHEM J, V349, P203, DOI 10.1042/0264-6021:3490203; Cakir-Kiefer I, 2001, BIOCHEM J, V358, P399, DOI 10.1042/bj3580399; CAPARON M, 1988, REV INFECT DIS, V10, pS377; Danilchanka O, 2014, P NATL ACAD SCI USA, V111, P6750, DOI 10.1073/pnas.1400136111; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Deng Q, 2008, ANNU REV MICROBIOL, V62, P271, DOI 10.1146/annurev.micro.62.081307.162848; DUGGLEBY RG, 1995, METHOD ENZYMOL, V249, P61; Evans Charles, 2010, BMC Chemical Biology, V10, P2, DOI 10.1186/1472-6769-10-2; Exnowitz F, 2012, BBA-PROTEINS PROTEOM, V1824, P443, DOI 10.1016/j.bbapap.2011.10.011; Fieldhouse RJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001029; Fjeld CC, 2003, P NATL ACAD SCI USA, V100, P9202, DOI 10.1073/pnas.1633591100; GALLOWAY TS, 1987, BIOCHEM J, V244, P225, DOI 10.1042/bj2440225; Ghosh J, 2010, J BIOL CHEM, V285, P5683, DOI 10.1074/jbc.M109.070300; GOPINATHAN KP, 1964, BIOCHEM J, V91, P277, DOI 10.1042/bj0910277; Goudar CT, 2012, MICROB ECOL, V63, P898, DOI 10.1007/s00248-011-9996-3; Henkel JS, 2010, EXPERIENTIA SUPPL, V100, P1; Hmama Z, 2015, IMMUNOL REV, V264, P220, DOI 10.1111/imr.12268; Lebrun I, 2009, MINI-REV MED CHEM, V9, P820, DOI 10.2174/138955709788452603; Madden JC, 2001, CELL, V104, P143, DOI 10.1016/S0092-8674(01)00198-2; Meijers R, 2001, J BIOL CHEM, V276, P9316, DOI 10.1074/jbc.M010870200; Mozola CC, 2015, MOL MICROBIOL, V97, P1036, DOI 10.1111/mmi.13085; MULLERSTEFFNER HM, 1992, J BIOL CHEM, V267, P9606; Nambi S, 2015, CELL HOST MICROBE, V17, P829, DOI 10.1016/j.chom.2015.05.008; OPPENHEIMER NJ, 1994, MOL CELL BIOCHEM, V138, P245, DOI 10.1007/BF00928468; Oswald E, 2005, CURR OPIN MICROBIOL, V8, P83, DOI 10.1016/j.mib.2004.12.011; Pajuelo D, 2018, CELL REP, V24, P429, DOI 10.1016/j.celrep.2018.06.042; PAPPENHEIMER AM, 1993, PROTEIN SCI, V2, P292; Parikh SL, 2004, BIOCHEMISTRY-US, V43, P1204, DOI 10.1021/bi035907z; Parrini C, 2005, STRUCTURE, V13, P1143, DOI 10.1016/j.str.2005.04.022; Queval CJ, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02284; Rajararna MVS, 2014, SEMIN IMMUNOL, V26, P471, DOI 10.1016/j.smim.2014.09.010; Riese MJ, 2002, J BIOL CHEM, V277, P12082, DOI 10.1074/jbc.M109039200; Sauve AA, 1998, BIOCHEMISTRY-US, V37, P13239, DOI 10.1021/bi981248s; Simon NC, 2014, NAT REV MICROBIOL, V12, P599, DOI 10.1038/nrmicro3310; Spaulding AR, 2013, CLIN MICROBIOL REV, V26, P422, DOI 10.1128/CMR.00104-12; Steinhauer K, 2010, APPL ENVIRON MICROB, V76, P546, DOI 10.1128/AEM.01660-09; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sun J, 2015, NAT STRUCT MOL BIOL, V22, P672, DOI 10.1038/nsmb.3064; Tang JY, 2018, J BIOL CHEM, V293, P1504, DOI 10.1074/jbc.RA117.000178; VANDENBERG JI, 1986, ANAL BIOCHEM, V155, P38, DOI 10.1016/0003-2697(86)90221-6; VanderVen BC, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.TBTB2-0025-2016; Wallace AJ, 2000, CELL, V100, P265, DOI 10.1016/S0092-8674(00)81564-0; Whitney JC, 2017, ELIFE, V6, DOI 10.7554/eLife.26938; Whitney JC, 2015, CELL, V163, P607, DOI 10.1016/j.cell.2015.09.027; Yan BX, 1997, J BIOL CHEM, V272, P3190, DOI 10.1074/jbc.272.6.3190; Yates SP, 2006, TRENDS BIOCHEM SCI, V31, P123, DOI 10.1016/j.tibs.2005.12.007; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672	54	19	19	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2019	294	9					3024	3036		10.1074/jbc.RA118.005832	http://dx.doi.org/10.1074/jbc.RA118.005832			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU0SA	30593509	Green Published, hybrid			2022-12-28	WOS:000464980100005
J	Lamar, JM; Xiao, YX; Norton, E; Jiang, ZG; Gerhard, GM; Kooner, S; Warren, JSA; Hynes, RO				Lamar, John M.; Xiao, Yuxuan; Norton, Emily; Jiang, Zhi-Gang; Gerhard, Genevieve M.; Kooner, Simrin; Warren, Janine S. A.; Hynes, Richard O.			SRC tyrosine kinase activates the YAP/TAZ axis and thereby drives tumor growth and metastasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Yes-associated protein (YAP); cancer; metastasis; Src; LATS (Warts, Wts); Hippo pathway; Non-receptor tyrosine kinase (nRTK); GIT1; TAZ; transcriptional regulator	HIPPO SIGNALING PATHWAY; C-SRC; REGULATES YAP; THERAPEUTIC TARGETS; CELL-PROLIFERATION; SUPPRESSOR LATS1; FAMILY KINASES; PHOSPHORYLATION; TAZ; PIX	When properly employed, targeted therapies are effective cancer treatments. However, the development of such therapies requires the identification of targetable drivers of cancer development and metastasis. The expression and nuclear localization of the transcriptional coactivators Yes-associated protein (YAP) and transcriptional co-activator with PDZ-binding motif (TAZ) are increased in many human cancers, and experimental evidence indicates that aberrant YAP or TAZ activation drives tumor formation and metastasis. Although these findings make YAP and TAZ appealing therapeutic targets, both have important functions in adult tissues, so directly targeting them could cause adverse effects. The identification of pathways active in cancer cells and required for YAP/TAZ activity could provide a way to inhibit YAP and TAZ. Here, we show that SRC proto-oncogene, nonreceptor tyrosine kinase (SRC) is an important driver of YAP/TAZ activity in human breast cancer and melanoma cells. SRC activation increased YAP/TAZ activity and the expression of YAP/TAZ-regulated genes. In contrast, SRC inhibition or knockdown repressed both YAP/TAZ activity and the expression of YAP/TAZ-regulated genes. We also show that SRC increases the activity of YAP and TAZ by repressing large tumor suppressor homolog (LATS), and we identify the GTPase-activating protein GIT ArfGAP 1 (GIT1) as an SRC effector that regulates both YAP and TAZ. Importantly, we demonstrate that SRC-mediated YAP/TAZ activity promotes tumor growth and enhances metastasis and that SRC-dependent tumor progression depends, at least in part, on YAP and TAZ. Our findings suggest that therapies targeting SRC could help manage some YAP/TAZ-dependent cancers.	[Lamar, John M.; Xiao, Yuxuan; Norton, Emily; Gerhard, Genevieve M.; Kooner, Simrin; Warren, Janine S. A.] Albany Med Coll, Dept Mol & Cellular Physiol, Albany, NY 12208 USA; [Lamar, John M.; Jiang, Zhi-Gang; Hynes, Richard O.] MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Hynes, Richard O.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Jiang, Zhi-Gang; Hynes, Richard O.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Albany Medical College; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Lamar, JM (corresponding author), Albany Med Coll, Dept Mol & Cellular Physiol, Albany, NY 12208 USA.; Hynes, RO (corresponding author), MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA.; Hynes, RO (corresponding author), MIT, Koch Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	lamarj@amc.edu; rohynes@mit.edu	Lamar, John Michael/R-5053-2019	Lamar, John Michael/0000-0001-5406-8391	Susan G. Komen Career Catalyst Grant [CCR17477184]; National Institutes of Health (NIH) National Research Service Award [CA1421442]; NCI, NIH, Integrative Center Biology Program [U54CA112967]; NIH Tumor Microenvironment Network Grant [U54CA163109]; Department of Defense Breast Cancer Research Program [W81XWH-14-1-0240]; Koch Institute Frontier Research Fund; MIT Ludwig Center for Molecular Oncology; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P30CA014051] Funding Source: NIH RePORTER	Susan G. Komen Career Catalyst Grant(Susan G. Komen Breast Cancer Foundation); National Institutes of Health (NIH) National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI, NIH, Integrative Center Biology Program; NIH Tumor Microenvironment Network Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Research Program(United States Department of Defense); Koch Institute Frontier Research Fund; MIT Ludwig Center for Molecular Oncology; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Susan G. Komen Career Catalyst Grant CCR17477184 (to J. M. L.); a National Institutes of Health (NIH) National Research Service Award CA1421442 (to J. M. L.); NCI, NIH, Integrative Center Biology Program Grant U54CA112967 (to R. O. H.); NIH Tumor Microenvironment Network Grant U54CA163109 (to R. O. H.); Department of Defense Breast Cancer Research Program Grant W81XWH-14-1-0240 (to R. O. H.); the Koch Institute Frontier Research Fund (to J. M. L.); the MIT Ludwig Center for Molecular Oncology; and the Howard Hughes Medical Institute. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abram CL, 2000, EXP CELL RES, V254, P1, DOI 10.1006/excr.1999.4732; Ames JJ, 2016, J BIOL CHEM, V291, P2731, DOI 10.1074/jbc.M115.669614; Ando T, 2018, ONCOGENE, V37, P263, DOI 10.1038/onc.2017.321; Arash EH, 2014, EMBO J, V33, P2997, DOI 10.15252/embj.201490230; Audebert S, 2004, CURR BIOL, V14, P987, DOI 10.1016/j.cub.2004.05.051; Bae JS, 2017, ONCOTARGET, V8, P16084, DOI 10.18632/oncotarget.14306; Baker AM, 2013, ONCOGENE, V32, P1863, DOI 10.1038/onc.2012.202; Byun MR, 2017, CANCER LETT, V410, P32, DOI 10.1016/j.canlet.2017.09.003; Callus BA, 2006, FEBS J, V273, P4264, DOI 10.1111/j.1742-4658.2006.05427.x; Chen PH, 2011, J NUTR BIOCHEM, V22, P732, DOI 10.1016/j.jnutbio.2010.06.004; Cui X, 2018, BIOMATERIALS, V161, P164, DOI 10.1016/j.biomaterials.2018.01.053; Dent LG, 2015, CURR BIOL, V25, P124, DOI 10.1016/j.cub.2014.11.041; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Elbediwy A, 2016, DEVELOPMENT, V143, P1674, DOI 10.1242/dev.133728; Enomoto M, 2013, EMBO REP, V14, P65, DOI 10.1038/embor.2012.185; Fan R, 2013, P NATL ACAD SCI USA, V110, P2569, DOI 10.1073/pnas.1216462110; Felley-Bosco E, 2014, TRANSL LUNG CANCER R, V3, P75, DOI 10.3978/j.issn.2218-6751.2014.02.03; Feng JT, 2016, ONCOTARGETS THER, V9, P5235, DOI 10.2147/OTT.S109540; Feng QY, 2006, NAT CELL BIOL, V8, P945, DOI 10.1038/ncb1453; Feng QY, 2010, J BIOL CHEM, V285, P18806, DOI 10.1074/jbc.M109.098079; Fisher ML, 2016, CANCER RES, V76, P7265, DOI 10.1158/0008-5472.CAN-16-2032; Genevet A, 2011, BIOCHEM J, V436, P213, DOI 10.1042/BJ20110217; Gong R, 2015, CURR MED CHEM, V22, P4104, DOI 10.2174/0929867322666151002112256; Gonzalez L, 2006, J BIOL CHEM, V281, P20851, DOI 10.1074/jbc.M601570200; Guarino M, 2010, J CELL PHYSIOL, V223, P14, DOI 10.1002/jcp.22011; Haendeler J, 2003, J BIOL CHEM, V278, P49936, DOI 10.1074/jbc.M307317200; Hanna SC, 2013, J CLIN INVEST, V123, P2078, DOI 10.1172/JCI66715; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Hergovich A, 2006, BIOCHEM BIOPH RES CO, V345, P50, DOI 10.1016/j.bbrc.2006.03.244; Hoefen RJ, 2006, J CELL SCI, V119, P1469, DOI 10.1242/jcs.02925; Homsi J, 2007, EXPERT OPIN THER TAR, V11, P91, DOI 10.1517/14728222.11.1.91; Hu JKH, 2017, CELL STEM CELL, V21, P91, DOI 10.1016/j.stem.2017.03.023; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Kapoor A, 2014, CELL, V158, P185, DOI 10.1016/j.cell.2014.06.003; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Kim MK, 2018, BMB REP, V51, P126, DOI 10.5483/BMBRep.2018.51.3.015; Kim NG, 2015, J CELL BIOL, V210, P503, DOI 10.1083/jcb.201501025; Lamar JM, 2012, P NATL ACAD SCI USA, V109, pE2441, DOI 10.1073/pnas.1212021109; Lee JH, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-116; Li P, 2016, GENE DEV, V30, P798, DOI 10.1101/gad.274951.115; Lin KC, 2017, TRENDS BIOCHEM SCI, V42, P862, DOI 10.1016/j.tibs.2017.09.003; Liu CY, 2010, J BIOL CHEM, V285, P37159, DOI 10.1074/jbc.M110.152942; Liu H, 2011, P NATL ACAD SCI USA, V108, P1379, DOI 10.1073/pnas.1017228108; Luo W, 2008, J PROTEOME RES, V7, P3447, DOI 10.1021/pr800187n; Luttrell DK, 2004, ONCOGENE, V23, P7969, DOI 10.1038/sj.onc.1208162; Ma JG, 2011, BREAST CANCER RES TR, V130, P85, DOI 10.1007/s10549-010-1302-4; Mahoney WM, 2005, BIOCHEM J, V388, P217, DOI 10.1042/BJ20041434; McLachlan RW, 2007, MOL BIOL CELL, V18, P3214, DOI 10.1091/mbc.E06-12-1154; Meng ZP, 2016, GENE DEV, V30, P1, DOI 10.1101/gad.274027.115; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Naba A, 2014, ELIFE, V3, DOI 10.7554/eLife.01308; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Planas-Silva MD, 2006, BIOCHEM BIOPH RES CO, V341, P73, DOI 10.1016/j.bbrc.2005.12.164; Praskova M, 2008, CURR BIOL, V18, P311, DOI 10.1016/j.cub.2008.02.006; Reginensi A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003380; Ren YX, 2012, MOL CELL BIOCHEM, V365, P109, DOI 10.1007/s11010-012-1249-3; Rosenbluh J, 2012, CELL, V151, P1457, DOI 10.1016/j.cell.2012.11.026; Santinon G, 2016, TRENDS CELL BIOL, V26, P289, DOI 10.1016/j.tcb.2015.11.004; Schlenker O, 2009, J MOL BIOL, V386, P280, DOI 10.1016/j.jmb.2008.12.050; Sero JE, 2017, CELL SYST, V4, P84, DOI 10.1016/j.cels.2016.11.015; Shanzer M, 2015, ONCOGENE, V34, P4190, DOI 10.1038/onc.2014.347; Shanzer M, 2017, P NATL ACAD SCI USA, V114, P1678, DOI 10.1073/pnas.1610223114; Shao DD, 2014, CELL, V158, P171, DOI 10.1016/j.cell.2014.06.004; Si Y, 2017, CANCER RES, V77, P4868, DOI 10.1158/0008-5472.CAN-17-0391; Smoot RL, 2018, J CELL BIOCHEM, V119, P824, DOI 10.1002/jcb.26246; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Sun ZQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135119; Taniguchi K, 2015, NATURE, V519, P57, DOI 10.1038/nature14228; Thakur R, 2015, SCI REP-UK, V5, DOI 10.1038/srep10194; van Rensburg HJJ, 2016, CELL SIGNAL, V28, P1761, DOI 10.1016/j.cellsig.2016.08.004; Vergani E, 2011, NEOPLASIA, V13, P1132, DOI 10.1593/neo.111102; Vlahov N, 2015, CURR BIOL, V25, P3019, DOI 10.1016/j.cub.2015.09.072; Warren JSA, 2018, CANCERS, V10, DOI 10.3390/cancers10040115; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Ye S, 2016, PHARMACOL RES, V103, P270, DOI 10.1016/j.phrs.2015.11.025; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Zaidi SK, 2004, EMBO J, V23, P790, DOI 10.1038/sj.emboj.7600073; Zanconato F, 2016, CANCER CELL, V29, P783, DOI 10.1016/j.ccell.2016.05.005; Zhang JM, 2008, CANCER RES, V68, P2789, DOI 10.1158/0008-5472.CAN-07-6205; Zhang SY, 2013, CANCER RES, V73, P5764, DOI 10.1158/0008-5472.CAN-12-1803; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zhou W, 2016, J CELL SCI, V129, P1963, DOI 10.1242/jcs.179465; Zhu C, 2015, ACTA BIOCH BIOPH SIN, V47, P16, DOI 10.1093/abbs/gmu110	85	88	90	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2019	294	7					2302	2317		10.1074/jbc.RA118.004364	http://dx.doi.org/10.1074/jbc.RA118.004364			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL7CN	30559289	Green Published, hybrid			2022-12-28	WOS:000458895400009
J	Kuusk, S; Kont, R; Kuusk, P; Heering, A; Sorlie, M; Bissaro, B; Eijsink, VGH; Valjamae, P				Kuusk, Silja; Kont, Riin; Kuusk, Piret; Heering, Agnes; Sorlie, Morten; Bissaro, Bastien; Eijsink, Vincent G. H.; Valjamae, Priit			Kinetic insights into the role of the reductant in H2O2-driven degradation of chitin by a bacterial lytic polysaccharide monooxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hydrogen peroxide; copper monooxygenase; polysaccharide; enzyme kinetics; Serratia marcescens; chitin; enzyme inactivation; CBP21; lytic polysaccharide monooxygenase; oxidative degradation; reductant; SmLPMO10A; binding; oxidative degradation	CHELATE CATALYZED OXIDATION; MOLECULAR-OXYGEN; METAL-ION; SERRATIA-MARCESCENS; ACTIVITY ASSAY; ASCORBIC-ACID; BINDING; HYDROLYSIS; CELLULOSE; CELLULASES	Lytic polysaccharide monooxygenases (LPMOs) are monocopper enzymes that catalyze oxidative cleavage of glycosidic bonds in polysaccharides in the presence of an external electron donor (reductant). In the classical O-2-driven monooxygenase reaction, the reductant is needed in stoichiometric amounts. In a recently discovered, more efficient H2O2-driven reaction, the reductant would be needed only for the initial reduction (priming) of the LPMO to its catalytically active Cu(I) form. However, the influence of the reductant on reducing the LPMO or on H2O2 production in the reaction remains undefined. Here, we conducted a detailed kinetic characterization to investigate how the reductant affects H2O2-driven degradation of C-14-labeled chitin by a bacterial LPMO, SmLPMO10A (formerly CBP21). Sensitive detection of C-14-labeled products and careful experimental set-ups enabled discrimination between the effects of the reductant on LPMO priming and other effects, in particular enzyme-independent production of H2O2 through reactions with O-2. When supplied with H2O2, SmLPMO10A catalyzed 18 oxidative cleavages per molecule of ascorbic acid, suggesting a "priming reduction" reaction. The dependence of initial rates of chitin degradation on reductant concentration followed hyperbolic saturation kinetics, and differences between the reductants were manifested in large variations in their half-saturating concentrations (KmRapp). Theoretical analyses revealed that KmRapp decreases with a decreasing rate of polysaccharide-independent LPMO reoxidation (by either O-2 or H2O2). We conclude that the efficiency of LPMO priming depends on the relative contributions of reductant reactivity, on the LPMO's polysaccharide monooxygenase/peroxygenase and reductant oxidase/peroxidase activities, and on reaction conditions, such as O-2, H2O2, and polysaccharide concentrations.	[Kuusk, Silja; Kont, Riin; Valjamae, Priit] Univ Tartu, Inst Mol & Cell Biol, EE-51010 Tartu, Estonia; [Kuusk, Piret] Univ Tartu, Inst Phys, EE-51010 Tartu, Estonia; [Heering, Agnes] Univ Tartu, Inst Chem, EE-51010 Tartu, Estonia; [Sorlie, Morten; Bissaro, Bastien; Eijsink, Vincent G. H.] Norwegian Univ Life Sci, Fac Chem Biotechnol & Food Sci, N-1433 As, Norway	University of Tartu; University of Tartu; University of Tartu Institute of Physics; University of Tartu; Norwegian University of Life Sciences	Valjamae, P (corresponding author), Riia 23b-202, EE-51010 Tartu, Estonia.	priit.valjamae@ut.ee	Väljamäe, Priit/O-6468-2018; BISSARO, Bastien/AAL-7130-2021; Bissaro, Bastien/AAI-6814-2020; Heering, Agnes/N-1760-2017	Väljamäe, Priit/0000-0002-1035-9493; Heering, Agnes/0000-0002-0893-8015; Bissaro, Bastien/0000-0001-8354-3892; Eijsink, Vincent/0000-0002-9220-8743; Sorlie, Morten/0000-0001-7259-6710	Estonian Research Council [PUT1024]; Research Council of Norway [262853, 269408]	Estonian Research Council(Estonian Research Council); Research Council of Norway(Research Council of Norway)	This work was supported by Estonian Research Council Grant PUT1024 and Research Council of Norway Grants 262853 and 269408. The authors declare that they have no conflicts of interest with the contents of this article.	Aachmann FL, 2012, P NATL ACAD SCI USA, V109, P18779, DOI 10.1073/pnas.1208822109; Arteaga JF, 2012, MOLECULES, V17, P5126, DOI 10.3390/molecules17055126; Bertini L, 2018, INORG CHEM, V57, P86, DOI 10.1021/acs.inorgchem.7b02005; Bissaro B, 2016, BIORXIV, P1, DOI [10.1101/097022, DOI 10.1101/097022]; Bissaro B, 2018, MICROBIOL MOL BIOL R, V82, DOI 10.1128/MMBR.00029-18; Bissaro B, 2018, BIOCHEMISTRY-US, V57, P1893, DOI 10.1021/acs.biochem.8b00138; Bissaro B, 2017, NAT CHEM BIOL, V13, P1123, DOI [10.1038/NCHEMBIO.2470, 10.1038/nchembio.2470]; Bissaro B, 2016, GREEN CHEM, V18, P5357, DOI [10.1039/C6GC01666A, 10.1039/c6gc01666a]; Boatright WL, 2016, FOOD CHEM, V196, P1361, DOI 10.1016/j.foodchem.2015.07.141; Bradshaw MP, 2011, CRIT REV FOOD SCI, V51, P479, DOI 10.1080/10408391003690559; Brenelli L, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-017-0985-8; Breslmayr E, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-018-1063-6; Bulakhov AG, 2016, BIOCHEMISTRY-MOSCOW+, V81, P530, DOI 10.1134/S0006297916050102; Camci-Unal G, 2010, J CHEM ENG DATA, V55, P1117, DOI 10.1021/je900552w; Chaplin AK, 2016, J BIOL CHEM, V291, P12838, DOI 10.1074/jbc.M116.722447; Forsberg Z, 2018, J BIOL CHEM, V293, P1397, DOI 10.1074/jbc.M117.817130; Franzle S, 2015, ANN BOT-COENOL PLANT, V5, P79, DOI 10.4462/annbotrm-13065; Frommhagen M, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01080; Frommhagen M, 2018, APPL MICROBIOL BIOT, V102, P1281, DOI 10.1007/s00253-017-8541-9; Frommhagen M, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-017-0810-4; Frommhagen M, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0594-y; Hangasky JA, 2018, P NATL ACAD SCI USA, V115, P4915, DOI 10.1073/pnas.1801153115; Hangasky JA, 2018, BIOCHEMISTRY-US, V57, P3191, DOI 10.1021/acs.biochem.8b00129; Hansberg W, 2012, ARCH BIOCHEM BIOPHYS, V525, P170, DOI 10.1016/j.abb.2012.05.014; Harris PV, 2010, BIOCHEMISTRY-US, V49, P3305, DOI 10.1021/bi100009p; Hedegard ED, 2018, CHEM SCI, V9, P3866, DOI 10.1039/c8sc00426a; Holtmann D, 2016, CHEMBIOCHEM, V17, P1391, DOI 10.1002/cbic.201600176; Hu JG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21016-6; Hu JG, 2014, ENERG ENVIRON SCI, V7, P2308, DOI 10.1039/c4ee00891j; ILAN YA, 1976, BIOCHIM BIOPHYS ACTA, V430, P209, DOI 10.1016/0005-2728(76)90080-3; Isaksen T, 2014, J BIOL CHEM, V289, P2632, DOI 10.1074/jbc.M113.530196; Kari J, 2017, ACS CATAL, V7, P4904, DOI 10.1021/acscatal.7b00838; Karlsen V, 2010, THERMOCHIM ACTA, V501, P119, DOI 10.1016/j.tca.2010.01.007; KHAN MMT, 1967, J AM CHEM SOC, V89, P7104, DOI 10.1021/ja01002a046; KHAN MMT, 1967, J AM CHEM SOC, V89, P4176, DOI 10.1021/ja00992a036; Kittl R, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-79; Kjaergaard CH, 2014, P NATL ACAD SCI USA, V111, P8797, DOI 10.1073/pnas.1408115111; Kracher D, 2018, J BIOL CHEM, V293, P1676, DOI 10.1074/jbc.RA117.000109; Kracher D, 2016, SCIENCE, V352, P1098, DOI 10.1126/science.aaf3165; Kruer-Zerhusen N, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-017-0925-7; Kuusk S, 2018, J BIOL CHEM, V293, P523, DOI 10.1074/jbc.M117.817593; Kuusk S, 2015, J BIOL CHEM, V290, P11678, DOI 10.1074/jbc.M114.635631; Loose JSM, 2018, BIOCHEMISTRY-US, V57, P4114, DOI 10.1021/acs.biochem.8b00484; Loose JSM, 2016, PROTEIN SCI, V25, P2175, DOI 10.1002/pro.3043; Loose JSM, 2014, FEBS LETT, V588, P3435, DOI 10.1016/j.febslet.2014.07.036; Meier KK, 2018, CHEM REV, V118, P2593, DOI 10.1021/acs.chemrev.7b00421; Modenbach AA, 2012, BIOTECHNOL BIOENG, V109, P1430, DOI 10.1002/bit.24464; Mollers KB, 2017, CARBOHYD RES, V448, P182, DOI 10.1016/j.carres.2017.03.013; Muller G, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-018-1199-4; Muraleedharan MN, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-018-1294-6; Peciulyte A, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-018-1159-z; Qi F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-238; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; Rodriguez-Zuniga UF, 2015, GREEN CHEM, V17, P2896, DOI [10.1039/c4gc02179g, 10.1039/C4GC02179G]; Sabbadin F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03142-x; SCARPA M, 1983, J BIOL CHEM, V258, P6695; Scott BR, 2016, BIOTECHNOL LETT, V38, P425, DOI 10.1007/s10529-015-1989-8; Sun CL, 2011, BIOSENS BIOELECTRON, V26, P3450, DOI 10.1016/j.bios.2011.01.023; Switala J, 2002, ARCH BIOCHEM BIOPHYS, V401, P145, DOI 10.1016/S0003-9861(02)00049-8; Vaaje-Kolstad G, 2005, J BIOL CHEM, V280, P28492, DOI 10.1074/jbc.M504468200; Vaaje-Kolstad G, 2005, J BIOL CHEM, V280, P11313, DOI 10.1074/jbc.M407175200; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Walton PH, 2016, CURR OPIN CHEM BIOL, V31, P195, DOI 10.1016/j.cbpa.2016.04.001; Wang BJ, 2018, ACS CATAL, V8, P1346, DOI 10.1021/acscatal.7b03888; Westereng B, 2015, SCI REP-UK, V5, DOI 10.1038/srep18561	65	38	41	4	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2019	294	5					1516	1528		10.1074/jbc.RA118.006196	http://dx.doi.org/10.1074/jbc.RA118.006196			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GC	30514757	Green Published, hybrid			2022-12-28	WOS:000457879200008
J	Li, A; Schertzer, JW; Yong, X				Li, Ao; Schertzer, Jeffrey W.; Yong, Xin			Molecular conformation affects the interaction of the Pseudomonas quinolone signal with the bacterial outer membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						molecular dynamics; Pseudomonas aeruginosa (P. aeruginosa); lipid A; small molecule; outer membrane; hydrogen bond; quorum sensing; cell communication; membrane dynamics; outer membrane vesicle biogenesis	VESICLES; GROMACS; BIOGENESIS; SIMULATION; SECRETION	Gram-negative bacteria produce outer-membrane vesicles (OMVs) that package genetic elements, virulence factors, and cell-to-cell communication signaling compounds. Despite their importance in many disease-related processes, how these versatile structures are formed is incompletely understood. A self-produced secreted small molecule, the Pseudomonas quinolone signal (PQS), has been shown to initiate OMV formation in Pseudomonas aeruginosa by interacting with the outer membrane (OM) and inducing its curvature. Other bacterial species have also been shown to respond to PQS, supporting a common biophysical mechanism. Here, we conducted molecular dynamics simulations to elucidate the specific interactions between PQS and a model P. aeruginosa OM at the atomistic scale. We discovered two characteristic states of PQS interacting with the biologically relevant membrane, namely attachment to the membrane surface and insertion into the lipid A leaflet. The hydrogen bonds between PQS and the lipid A phosphates drove the PQS-membrane association. An analysis of PQS trajectory and molecular conformation revealed sequential events critical for spontaneous insertion, including probing, docking, folding, and insertion. Remarkably, PQS bent its hydrophobic side chain into a closed conformation to lower the energy barrier for penetration through the hydrophilic headgroup zone of the lipid A leaflet, which was confirmed by the potential of mean force (PMF) measurements. Attachment and insertion were simultaneously observed in the simulation with multiple PQS molecules. Our findings uncover a sequence of molecular interactions that drive PQS insertion into the bacterial OM and provide important insight into the biophysical mechanism of small molecule-induced OMV biogenesis.	[Li, Ao; Yong, Xin] SUNY Binghamton, Dept Mech Engn, Binghamton, NY 13902 USA; [Schertzer, Jeffrey W.] SUNY Binghamton, Dept Biol Sci, Binghamton, NY 13902 USA; [Schertzer, Jeffrey W.; Yong, Xin] SUNY Binghamton, Binghamton Biofilm Res Ctr, Binghamton, NY 13902 USA	State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton	Yong, X (corresponding author), SUNY Binghamton, Dept Mech Engn, Binghamton, NY 13902 USA.	xyong@binghamton.edu	Yong, Xin/ABC-1912-2020; Yong, Xin/G-5828-2012	Yong, Xin/0000-0002-8894-2750; Yong, Xin/0000-0002-8894-2750	NIAID, National Institutes of Health [R21AI121848]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI121848] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIAID, National Institutes of Health Grant R21AI121848. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Bernadac A, 1998, J BACTERIOL, V180, P4872, DOI 10.1128/JB.180.18.4872-4878.1998; Beveridge TJ, 1999, J BACTERIOL, V181, P4725, DOI 10.1128/JB.181.16.4725-4733.1999; Deatherage BL, 2009, MOL MICROBIOL, V72, P1395, DOI 10.1111/j.1365-2958.2009.06731.x; Devos S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00298; Dupradeau FY, 2010, PHYS CHEM CHEM PHYS, V12, P7821, DOI 10.1039/c0cp00111b; Florez C, 2017, MBIO, V8, DOI 10.1128/mBio.01034-17; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Horspool AM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28042-4; Li A, 2018, PHYS CHEM CHEM PHYS, V20, P23635, DOI 10.1039/c8cp04278k; Li ZS, 1996, J BACTERIOL, V178, P2479, DOI 10.1128/jb.178.9.2479-2488.1996; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Mashburn LM, 2005, NATURE, V437, P422, DOI 10.1038/nature03925; Mashburn-Warren L, 2008, MOL MICROBIOL, V69, P491, DOI 10.1111/j.1365-2958.2008.06302.x; Mashburn-Warren L, 2009, J BACTERIOL, V191, P3411, DOI 10.1128/JB.00052-09; McBroom AJ, 2007, MOL MICROBIOL, V63, P545, DOI 10.1111/j.1365-2958.2006.05522.x; Pall S, 2015, LECT NOTES COMPUT SC, V8759, P3, DOI 10.1007/978-3-319-15976-8_1; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Roier S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10515; Schertzer JW, 2013, J MOL MICROB BIOTECH, V23, P118, DOI 10.1159/000346770; Schertzer JW, 2012, MBIO, V3, DOI 10.1128/mBio.00297-11; Schertzer JW, 2010, MOL MICROBIOL, V77, P1527, DOI 10.1111/j.1365-2958.2010.07303.x; van der Spoel D, 2006, J PHYS CHEM B, V110, P4393, DOI 10.1021/jp0572535; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vella BD, 2015, PSEUDOMONAS, VVII, P217, DOI DOI 10.1007/978-94-017-9555-5_9; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; WENSINK J, 1981, EUR J BIOCHEM, V116, P331, DOI 10.1111/j.1432-1033.1981.tb05338.x; Zhou L, 1998, FEMS MICROBIOL LETT, V163, P223, DOI 10.1111/j.1574-6968.1998.tb13049.x	29	14	14	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1089	1094		10.1074/jbc.AC118.006844	http://dx.doi.org/10.1074/jbc.AC118.006844			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30563840	hybrid, Green Published			2022-12-28	WOS:000457879500002
J	Nambayan, RJT; Sandin, SI; Quint, DA; Satyadi, DM; de Alba, E				Nambayan, Reinard Jeffrey T.; Sandin, Suzanne I.; Quint, David A.; Satyadi, David M.; de Alba, Eva			The inflammasome adapter ASC assembles into filaments with integral participation of its two Death Domains, PYD and CARD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						inflammasome; apoptosis; Death Domain; inflammation; protein assembly; ASC; CARD; NMR; PYD; transmission electron microscopy	SPECK-LIKE PROTEIN; NMR-SPECTROSCOPY; MECHANISM; SUPERFAMILY; APOPTOSIS; REVEALS; RECRUITMENT; NLRP3	The inflammasome is a multiprotein complex necessary for the onset of inflammation. The adapter protein ASC assembles inflammasome components by acting as a molecular glue between danger-signal sensors and procaspase-1. The assembly is mediated by ASC self-association and protein interactions via its two Death Domains, PYD and CARD. Truncated versions of ASC have been shown to form filaments, but information on the filaments formed by full-length ASC is needed to construct a meaningful model of inflammasome assembly. To gain insights into this system, we used a combination of transmission EM, NMR, and computational analysis to investigate intact ASC structures. We show that ASC forms approximate to 6-7-nm-wide filaments that stack laterally to form bundles. The structural characteristics and dimensions of the bundles indicate that both PYD and CARD are integral parts of the filament. A truncated version of ASC with only the CARD domain (ASC(CARD)) forms different filaments (approximate to 3-4-nm width), providing further evidence that both domains work in concert in filament assembly. Ring-shaped protein particles bound to pre-existing filaments match the size of ASC dimer structures generated by NMR-based protein docking, suggesting that the ASC dimer could be a basic building block for filament formation. Solution NMR binding studies identified the protein surfaces involved in the ASC(CARD)-ASC(CARD) interaction. These data provide new insights into the structural underpinnings of the inflammasome and should inform future efforts to interrogate this important biological system.	[Nambayan, Reinard Jeffrey T.; Sandin, Suzanne I.; Satyadi, David M.; de Alba, Eva] Univ Calif, Dept Bioengn, 5200 N Lake Rd, Merced, CA 95343 USA; [Sandin, Suzanne I.] Univ Calif, Chem & Chem Biol Grad Program, Merced, CA 95343 USA; [Quint, David A.] Univ Calif, NSF CREST Ctr Cellular & Biomol Machines, Merced, CA 95343 USA; [Quint, David A.] Univ Calif, Dept Phys, Merced, CA 95343 USA	University of California System; University of California Merced; University of California System; University of California Merced; University of California System; University of California Merced; University of California System; University of California Merced	de Alba, E (corresponding author), Univ Calif, Dept Bioengn, 5200 N Lake Rd, Merced, CA 95343 USA.	edealbabastarrechea@ucmerced.edu		Quint, David/0000-0003-0323-0402	National Institutes of Health [1S10OD018455]; NSF-CREST Center for Cellular and Biomolecular Machines	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF-CREST Center for Cellular and Biomolecular Machines	We thank the University of California Merced Imaging Facility and manager, Michael Dunlap, for assistance in TEM image acquisition. We are grateful to Robert Tycko (NIDDK, National Institutes of Health), and Eva Nogales and Patricia Grob (University of California, Berkeley) for advice on TEM sample preparation and preliminary image acquisition and analysis. We thank Mourad Sadqi (University of California, Merced) for MS data of proteins used in this work and Victor Munoz (University of California, Merced) for helpful discussions. We thank the NMR Facility at the University of California, Santa Cruz, and its Director Jack Lee (National Institutes of Health Grant 1S10OD018455 for funding the University of California, Santa Cruz, 800-MHz NMR spectrometer). We are grateful for the support of the NSF-CREST Center for Cellular and Biomolecular Machines (to D. A. Q. and Mourad Sadqi). We acknowledge University of California, Merced, undergraduate students Andrea Gould and Itati Campos for assisting in protein expression and purification.	BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Chu LH, 2015, APOPTOSIS, V20, P157, DOI 10.1007/s10495-014-1065-1; de Alba E., 2014, INFLAMMASOME, V1, P44; de Alba E, 2007, BIOMOL NMR ASSIGM, V1, P135, DOI 10.1007/s12104-007-9036-x; de Alba E, 2009, J BIOL CHEM, V284, P32932, DOI 10.1074/jbc.M109.024273; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dorfleutner A, 2015, IMMUNOL REV, V265, P205, DOI 10.1111/imr.12290; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Fielding L, 2007, PROG NUCL MAG RES SP, V51, P219, DOI 10.1016/j.pnmrs.2007.04.001; Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W; Gambin Y, 2018, J MOL BIOL, V430, P491, DOI 10.1016/j.jmb.2017.12.013; Goddard T. D., SPARKY 3; Haka AS, 2009, MOL BIOL CELL, V20, P4932, DOI 10.1091/mbc.E09-07-0559; Halff EF, 2012, J BIOL CHEM, V287, P38460, DOI 10.1074/jbc.M112.393512; Humke EW, 2000, CELL, V103, P99, DOI 10.1016/S0092-8674(00)00108-2; Kersse K, 2011, TRENDS BIOCHEM SCI, V36, P541, DOI 10.1016/j.tibs.2011.06.006; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kwon D, 2012, NUCLEIC ACIDS RES, V40, pD331, DOI 10.1093/nar/gkr1149; Lardner A, 2001, J LEUKOCYTE BIOL, V69, P522; Lu A, 2016, NAT STRUCT MOL BIOL, V23, P416, DOI 10.1038/nsmb.3199; Lu A, 2015, FEBS J, V282, P435, DOI 10.1111/febs.13133; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Man SM, 2014, P NATL ACAD SCI USA, V111, P7403, DOI 10.1073/pnas.1402911111; Oroz J, 2016, J BIOL CHEM, V291, P19487, DOI 10.1074/jbc.M116.741082; Park HH, 2007, CELL, V128, P533, DOI 10.1016/j.cell.2007.01.019; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Ratsimandresy RA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15556; Sborgi L, 2015, P NATL ACAD SCI USA, V112, P13237, DOI 10.1073/pnas.1507579112; Schanda P, 2005, J AM CHEM SOC, V127, P8014, DOI 10.1021/ja051306e; Schmidt FI, 2016, J EXP MED, V213, P771, DOI 10.1084/jem.20151790; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shi B, 2017, AUTOPHAGY, V13, P285, DOI 10.1080/15548627.2016.1261238; Stehlik C, 2003, J IMMUNOL, V171, P6154, DOI 10.4049/jimmunol.171.11.6154; Tenthorey JL, 2017, SCIENCE, V358, P888, DOI 10.1126/science.aao1140; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; Weber CH, 2001, TRENDS BIOCHEM SCI, V26, P475, DOI 10.1016/S0968-0004(01)01905-3; Wright JA, 2016, CELL DEATH DIFFER, V23, P1897, DOI 10.1038/cdd.2016.100; Wu B, 2014, MOL CELL, V55, P511, DOI 10.1016/j.molcel.2014.06.010; Zhang LM, 2015, SCIENCE, V350, P404, DOI 10.1126/science.aac5789	41	24	24	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2019	294	2					439	452		10.1074/jbc.RA118.004407	http://dx.doi.org/10.1074/jbc.RA118.004407			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HI2GP	30459235	Green Published, hybrid			2022-12-28	WOS:000456263600006
J	Kumar, Y; Kapoor, I; Khan, K; Thacker, G; Khan, MP; Shukla, N; Kanaujiya, JK; Sanyal, S; Chattopadhyay, N; Trivedi, AK				Kumar, Yogesh; Kapoor, Isha; Khan, Kainat; Thacker, Gatha; Khan, Mohd. Parvez; Shukla, Nidhi; Kanaujiya, Jitendra Kumar; Sanyal, Sabyasachi; Chattopadhyay, Naibedya; Trivedi, Arun Kumar			RETRACTION: Withdrawal: E3 ubiquitin ligase Fbw7 negatively regulates osteoblast differentiation by targeting Runx2 for degradation. (Retraction of Vol 290, Pg 30975, 2015)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction													KUMAR, YOGESH/GXN-1220-2022; Chattopadhyay, Naibedya/AAQ-3213-2021	Chattopadhyay, Naibedya/0000-0003-2473-0246; Trivedi, Arun/0000-0002-6316-0947				Kumar Y, 2015, J BIOL CHEM, V290, P30975, DOI 10.1074/jbc.M115.669531	1	1	1	3	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2019	294	1					68	68		10.1074/jbc.W118.007037	http://dx.doi.org/10.1074/jbc.W118.007037			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG6PT	30610124	Green Published, hybrid			2022-12-28	WOS:000455105500011
J	Roenn, CP; Li, M; Schack, VR; Forster, IC; Holm, R; Toustrup-Jensen, MS; Andersen, JP; Petrou, S; Vilsen, B				Roenn, Christian P.; Li, Melody; Schack, Vivien R.; Forster, Ian C.; Holm, Rikke; Toustrup-Jensen, Mads S.; Andersen, Jens P.; Petrou, Steven; Vilsen, Bente			Functional consequences of the CAPOS mutation E818K of Na+,K+-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme mechanism; membrane enzyme; membrane transport; mutant; Na; K plus -ATPase; neurological disease; site-directed mutagenesis; sodium transport; potassium transport; ATP1A3; electrophysiology; Na plus site; Na; K plus -pump; P-type ATPase	NEUROLOGICAL DISEASE MUTATIONS; SENSORINEURAL HEARING-LOSS; 4TH TRANSMEMBRANE SEGMENT; NA,K-ATPASE ALPHA-SUBUNIT; DE-NOVO MUTATIONS; ALTERNATING HEMIPLEGIA; CEREBELLAR-ATAXIA; NA+ AFFINITY; VOLTAGE-DEPENDENCE; CRYSTAL-STRUCTURE	The cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss (CAPOS) syndrome is caused by the single mutation E818K of the 3-isoform of Na+,K+-ATPase. Here, using biochemical and electrophysiological approaches, we examined the functional characteristics of E818K, as well as of E818Q and E818A mutants. We found that these amino acid substitutions reduce the apparent Na+ affinity at the cytoplasmic-facing sites of the pump protein and that this effect is more pronounced for the lysine and glutamine substitutions (3-4-fold) than for the alanine substitution. The electrophysiological measurements indicated a more conspicuous, approximate to 30-fold reduction of apparent Na+ affinity for the extracellular-facing sites in the CAPOS mutant, which was related to an accelerated transition between the phosphoenzyme intermediates E1P and E2P. The apparent affinity for K+ activation of the ATPase activity was unaffected by these substitutions, suggesting that primarily the Na+-specific site III is affected. Furthermore, the apparent affinities for ATP and vanadate were WT-like in E818K, indicating a normal E-1-E-2 equilibrium of the dephosphoenzyme. Proton-leak currents were not increased in E818K. However, the CAPOS mutation caused a weaker voltage dependence of the pumping rate and a stronger inhibition by cytoplasmic K+ than the WT enzyme, which together with the reduced Na+ affinity of the cytoplasmic-facing sites precluded proper pump activation under physiological conditions. The functional deficiencies could be traced to the participation of Glu-818 in an intricate hydrogen-bonding/salt-bridge network, connecting it to key residues involved in Na+ interaction at site III.	[Roenn, Christian P.; Schack, Vivien R.; Holm, Rikke; Toustrup-Jensen, Mads S.; Andersen, Jens P.; Vilsen, Bente] Aarhus Univ, Dept Biomed, Ole Worms Alle 4,Bldg 1160, DK-8000 Aarhus C, Denmark; [Li, Melody; Forster, Ian C.; Petrou, Steven] Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia	Aarhus University; Florey Institute of Neuroscience & Mental Health	Vilsen, B (corresponding author), Aarhus Univ, Dept Biomed, Ole Worms Alle 4,Bldg 1160, DK-8000 Aarhus C, Denmark.	bv@biomed.au.dk		Toustrup-Jensen, Mads Schak/0000-0003-2064-5861; Petrou, Steven/0000-0002-4960-6375; Andersen, Jens Peter/0000-0003-0654-4300; Vilsen, Bente/0000-0002-4727-9382; Forster, Ian/0000-0003-3087-9952; Schack, Vivien/0000-0002-1365-3938				Aguiar PD, 2004, NEURON, V43, P169, DOI 10.1016/j.neuron.2004.06.028; Azizan EAB, 2013, NAT GENET, V45, P1055, DOI 10.1038/ng.2716; BAGINSKI ES, 1967, CLIN CHEM, V13, P326; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; Chang IJ, 2018, AM J MED GENET A, V176, P235, DOI 10.1002/ajmg.a.38502; Cornelius F, 2011, J BIOL CHEM, V286, P29882, DOI 10.1074/jbc.M111.259663; Dard R, 2015, DEV MED CHILD NEUROL, V57, P1183, DOI 10.1111/dmcn.12927; De Fusco M, 2003, NAT GENET, V33, P192, DOI 10.1038/ng1081; Demos MK, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-15; Rodriguez AD, 2017, PEDIATR NEUROL, V71, P60, DOI 10.1016/j.pediatrneurol.2017.01.009; Han KH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16676-9; Hayashida T, 2018, BRAIN DEV-JPN, V40, P576, DOI 10.1016/j.braindev.2018.03.004; Heimer G, 2015, J CHILD NEUROL, V30, P1749, DOI 10.1177/0883073815579708; Heinzen EL, 2012, NAT GENET, V44, P1030, DOI 10.1038/ng.2358; Holm R, 2016, BBA-BIOENERGETICS, V1857, P1807, DOI 10.1016/j.bbabio.2016.08.009; Holm R, 2015, J BIOL CHEM, V290, P9801, DOI 10.1074/jbc.M114.625509; Kanai R, 2013, NATURE, V502, P201, DOI 10.1038/nature12578; Kaneko M, 2014, NAT GENET, V46, P144, DOI 10.1038/ng.2850; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Li CM, 2005, P NATL ACAD SCI USA, V102, P12706, DOI 10.1073/pnas.0505980102; Li M, 2015, NEUROBIOL DIS, V77, P88, DOI 10.1016/j.nbd.2015.02.002; Maas RPPWM, 2016, PEDIATR NEUROL, V59, P71, DOI 10.1016/j.pediatrneurol.2016.02.010; McLean WJ, 2009, JARO-J ASSOC RES OTO, V10, P37, DOI 10.1007/s10162-008-0152-9; Meier S, 2010, J GEN PHYSIOL, V135, P115, DOI 10.1085/jgp.200910301; Meyer DJ, 2017, J GEN PHYSIOL, V149, P1009, DOI 10.1085/jgp.201711827; Mitchell TJ, 2014, BIOPHYS J, V106, P2555, DOI 10.1016/j.bpj.2014.04.053; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; NAKAO M, 1986, NATURE, V323, P628, DOI 10.1038/323628a0; Nicolaides P, 1996, J MED GENET, V33, P419, DOI 10.1136/jmg.33.5.419; Paciorkowski AR, 2015, EPILEPSIA, V56, P422, DOI 10.1111/epi.12914; Panagiotakaki E, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0335-5; Petrou S, 1997, FEBS LETT, V411, P339, DOI 10.1016/S0014-5793(97)00700-X; Poulsen H, 2010, NATURE, V467, P99, DOI 10.1038/nature09309; PRICE EM, 1988, BIOCHEMISTRY-US, V27, P8400, DOI 10.1021/bi00422a016; RAKOWSKI RF, 1993, J GEN PHYSIOL, V101, P117, DOI 10.1085/jgp.101.1.117; Rosewich H, 2014, NEUROLOGY, V83, P861, DOI 10.1212/WNL.0000000000000735; Rosewich H, 2012, LANCET NEUROL, V11, P764, DOI 10.1016/S1474-4422(12)70182-5; SAGAR A, 1994, J GEN PHYSIOL, V103, P869, DOI 10.1085/jgp.103.5.869; SHULL GE, 1986, BIOCHEMISTRY-US, V25, P8125, DOI 10.1021/bi00373a001; SKOU JC, 1957, BIOCHIM BIOPHYS ACTA, V23, P394, DOI 10.1016/0006-3002(57)90343-8; Toustrup-Jensen M, 2002, J BIOL CHEM, V277, P38607, DOI 10.1074/jbc.M203665200; Toustrup-Jensen MS, 2014, J BIOL CHEM, V289, P3186, DOI 10.1074/jbc.M113.543272; Toustrup-Jensen MS, 2009, J BIOL CHEM, V284, P18715, DOI 10.1074/jbc.M109.015099; Tranebjaerg L, 2018, HUM GENET, V137, P111, DOI 10.1007/s00439-017-1862-z; Vedovato N, 2014, J GEN PHYSIOL, V143, P449, DOI 10.1085/jgp.201311148; VILSEN B, 1992, FEBS LETT, V314, P301, DOI 10.1016/0014-5793(92)81494-7; Vilsen B, 1997, BIOCHEMISTRY-US, V36, P13312, DOI 10.1021/bi971030q; WANG XY, 1995, AM J PHYSIOL-CELL PH, V268, pC590, DOI 10.1152/ajpcell.1995.268.3.C590; Yaragatupalli S, 2009, P NATL ACAD SCI USA, V106, P15507, DOI 10.1073/pnas.0903752106	49	8	9	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2019	294	1					269	280		10.1074/jbc.RA118.004591	http://dx.doi.org/10.1074/jbc.RA118.004591			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG6PT	30409907	Green Published, hybrid			2022-12-28	WOS:000455105500029
J	Alanjary, M; Medema, MH				Alanjary, Mohammad; Medema, Marnix H.			Mining bacterial genomes to reveal secret synergy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							CLUSTER	The medical treatment of infectious diseases often requires combination therapies that blend two molecules to enhance drug efficacy. Nature does the same. In a new article, Mrak et al. identify and functionally characterize natural products from Streptomyces rapamycinicus that show synergistic antifungal activity with the well-known immunosuppressant metabolite rapamycin, produced by the same strain. The genomic co-association of the two biosynthetic gene clusters paves the way toward new strategies to discover synergistic pairs of antibiotics through large-scale genome mining.	[Alanjary, Mohammad; Medema, Marnix H.] Wageningen Univ, Bioinformat Grp, Wageningen, Netherlands	Wageningen University & Research	Medema, MH (corresponding author), Wageningen Univ, Bioinformat Grp, Wageningen, Netherlands.	marnix.medema@wur.nl	Medema, Marnix H./AAR-3138-2021	Medema, Marnix H./0000-0002-2191-2821				Alanjary M, 2017, NUCLEIC ACIDS RES, V45, pW42, DOI 10.1093/nar/gkx360; Arp J, 2018, P NATL ACAD SCI USA, V115, P3758, DOI 10.1073/pnas.1721790115; Belousoff MJ, 2011, P NATL ACAD SCI USA, V108, P2717, DOI 10.1073/pnas.1019406108; Koumoutsi A, 2004, J BACTERIOL, V186, P1084, DOI 10.1128/JB.186.4.1084-1096.2004; Mast Y, 2011, MICROB BIOTECHNOL, V4, P192, DOI 10.1111/j.1751-7915.2010.00213.x; Mrak P, 2018, J BIOL CHEM, V293, P19982, DOI 10.1074/jbc.RA118.005314; Navarro-Munoz J.C., 2018, BIORXIV, DOI [10.1101/445270, DOI 10.1101/445270]; WARD JM, 1993, FEMS MICROBIOL LETT, V110, P239; Wiemann P, 2013, P NATL ACAD SCI USA, V110, P17065, DOI 10.1073/pnas.1313258110	9	6	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					19996	19997		10.1074/jbc.H118.006669	http://dx.doi.org/10.1074/jbc.H118.006669			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30593529	Green Published, hybrid			2022-12-28	WOS:000454685900005
J	Gupta, D; Lacayo, AA; Greene, SM; Leahy, JL; Jetton, TL				Gupta, Dhananjay; Lacayo, Adam A.; Greene, Shane M.; Leahy, John L.; Jetton, Thomas L.			-Cell mass restoration by 7 nicotinic acetylcholine receptor activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						beta cell (-cell); cholinergic receptor; autoimmune disease; diabetes; STAT3; ion channel; nicotinic acetylcholine receptors (nAChR); islet; pancreatic islet	VAGUS NERVE; INSULIN; EXPRESSION; APOPTOSIS; SYSTEM; DEATH; INFLAMMATION; SECRETION; PATHWAYS; GROWTH	Although it is well-established how nutrients, growth factors, and hormones impact functional -cell mass (BCM), the influence of the central nervous system in this regard, and especially in the context of islet immune modulation, has been understudied. Here we investigated the expression and activity of pancreatic islet 7 nicotinic acetylcholine receptor (7nAChR) in islet anti-inflammatory and prosurvival signaling. Systemic administration of 7nAChR agonists in mice improved glucose tolerance and curtailed streptozotocin-induced hyperglycemia by retaining BCM, in part through maintaining Pdx1 and MafA expression and reducing apoptosis. 7nAChR activation of mouse islets ex vivo led to reduced inflammatory drive through a JAK2-STAT3 pathway that couples with CREB/Irs2/Akt survival signaling. Because the vagus nerve conveys anti-inflammatory signals to immune cells of the spleen and other nonneural tissues in the viscera by activating 7nAChR agonists, our study suggests a novel role for -cell 7nAChR that functions to maintain -cell survival and mass homeostasis through modulating islet cytokine and phosphatidylinositol 3-kinase-dependent signaling pathways. Exploiting these pathways may have therapeutic potential for the treatment of autoimmune diabetes.	[Gupta, Dhananjay; Lacayo, Adam A.; Greene, Shane M.; Leahy, John L.; Jetton, Thomas L.] Univ Vermont, Div Endocrinol Diabet & Metab, Dept Med, Larner Coll Med, Burlington, VT 05446 USA	University of Vermont	Jetton, TL (corresponding author), Univ Vermont, Dept Med, Larner Coll Med, Colchester Res Facil, 360 South Pk Dr, Colchester, VT 05446 USA.	tjetton@uvm.edu			Juvenile Diabetes Research Foundation (JDRF), United States of America [17-2013-399, 27-2008-669]	Juvenile Diabetes Research Foundation (JDRF), United States of America	This work was supported by Research Awards 17-2013-399 and 27-2008-669 from the Juvenile Diabetes Research Foundation (JDRF), United States of America (to T.L.J.).	Ali MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134648; Andersson AK, 2005, MOL CELL ENDOCRINOL, V240, P50, DOI 10.1016/j.mce.2005.06.001; Bending D, 2012, INT IMMUNOL, V24, P339, DOI 10.1093/intimm/dxs049; Czura CJ, 2005, J INTERN MED, V257, P156, DOI 10.1111/j.1365-2796.2004.01442.x; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; Delbro DS, 2012, AUTON NEUROSCI-BASIC, V167, P75, DOI 10.1016/j.autneu.2011.11.006; Downs AM, 2014, NEUROSCIENCE, V266, P178, DOI 10.1016/j.neuroscience.2014.02.011; Drago J, 2003, CELL MOL LIFE SCI, V60, P1267, DOI 10.1007/s00018-003-2259-9; Edvell A, 1998, AM J PHYSIOL-ENDOC M, V274, pE1034, DOI 10.1152/ajpendo.1998.274.6.E1034; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; Fujimoto K, 2009, DIABETES OBES METAB, V11, P30, DOI 10.1111/j.1463-1326.2009.01121.x; Ganic E, 2016, CELL REP, V14, P1991, DOI 10.1016/j.celrep.2016.02.002; Gautam D, 2006, CELL METAB, V3, P449, DOI 10.1016/j.cmet.2006.04.009; George JA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00419; Imai J, 2008, SCIENCE, V322, P1250, DOI 10.1126/science.1163971; Jetton TL, 2008, AM J PHYSIOL-ENDOC M, V294, pE679, DOI 10.1152/ajpendo.00569.2007; Jetton TL, 2005, DIABETES, V54, P2294, DOI 10.2337/diabetes.54.8.2294; Kiba T, 2002, DIGESTION, V66, P79, DOI 10.1159/000065594; Kitagawa H, 2003, NEUROPSYCHOPHARMACOL, V28, P542, DOI 10.1038/sj.npp.1300028; Klee P, 2016, ENDOCRINOLOGY, V157, P3800, DOI 10.1210/en.2015-2057; KOLB H, 1987, DIABETES METAB REV, V3, P751, DOI 10.1002/dmr.5610030308; Koopman FA, 2015, ORAL DIS, V21, P858, DOI 10.1111/odi.12354; Koster JC, 2000, CELL, V100, P645, DOI 10.1016/S0092-8674(00)80701-1; Lausier J, 2010, AM J PHYSIOL-ENDOC M, V299, pE786, DOI 10.1152/ajpendo.00202.2010; Mabley JG, 2002, J PHARMACOL EXP THER, V300, P876, DOI 10.1124/jpet.300.3.876; Maier B, 2010, J CLIN INVEST, V120, P2156, DOI 10.1172/JCI38924; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; Mellado-Gil J, 2011, DIABETES, V60, P525, DOI 10.2337/db09-1305; Mundinger TO, 2016, DIABETOLOGIA, V59, P2058, DOI 10.1007/s00125-016-4026-0; Pavlov VA, 2012, NAT REV ENDOCRINOL, V8, P743, DOI 10.1038/nrendo.2012.189; Rodriguez-Diaz R, 2011, NAT MED, V17, P888, DOI 10.1038/nm.2371; Rosas-Ballina M, 2008, P NATL ACAD SCI USA, V105, P11008, DOI 10.1073/pnas.0803237105; Rosas-Ballina M, 2009, NEURON, V64, P28, DOI 10.1016/j.neuron.2009.09.039; Saravia F, 2003, TRENDS IMMUNOL, V24, P574, DOI 10.1016/j.it.2003.09.010; Vinik Aaron I, 2012, Front Endocrinol (Lausanne), V3, P71, DOI 10.3389/fendo.2012.00071; Walker DP, 2006, BIOORGAN MED CHEM, V14, P8219, DOI 10.1016/j.bmc.2006.09.019; WOODS SC, 1974, PHYSIOL REV, V54, P596, DOI 10.1152/physrev.1974.54.3.596; Xu TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051217; Yamamoto J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01869-7; Yoshikawa H, 2005, METABOLISM, V54, P247, DOI 10.1016/j.metabol.2004.08.020; Yu ZY, 2004, J AM SOC NEPHROL, V15, P585, DOI 10.1097/01.ASN.0000114556.19556.F9; Yu ZY, 2002, BIOCHEM J, V367, P97, DOI 10.1042/BJ20020588; Zhang B, 2012, ACTA BIOCH BIOPH SIN, V44, P207, DOI 10.1093/abbs/gmr121; Zumsteg U, 2000, DIABETES, V49, P39, DOI 10.2337/diabetes.49.1.39	45	15	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					20295	20306		10.1074/jbc.RA118.004617	http://dx.doi.org/10.1074/jbc.RA118.004617			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30397183	Green Published, hybrid			2022-12-28	WOS:000454685900034
J	Shetty, SP; Sturts, R; Vetick, M; Copeland, PR				Shetty, Sumangala P.; Sturts, Ryan; Vetick, Michael; Copeland, Paul R.			Processive incorporation of multiple selenocysteine residues is driven by a novel feature of the selenocysteine insertion sequence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						selenocysteine; selenoprotein; selenium; mRNA; ribonucleoprotein (RNP); RNA structure; 21st amino acid; stem loop structure	RNA-BINDING PROTEIN; SELENOPROTEIN MESSENGER-RNAS; MAMMALIAN SELENOCYSTEINE; SECIS RNA; UGA; EFFICIENCY; ELEMENT; CODON; MOTIF; SUBSET	RNA stem loop structures have been frequently shown to regulate essential cellular processes. The selenocysteine insertion sequence (SECIS) element, found in the 3 UTRs of all selenoprotein mRNAs, is an example of such a structure, as it is required for the incorporation of the 21st amino acid, selenocysteine (Sec). Selenoprotein synthesis poses a mechanistic challenge because Sec is incorporated during translation in response to a stop codon (UGA). Although it is known that a SECIS-binding protein (SBP2) is required for Sec insertion, the mechanism of action remains elusive. Additional complexity is present in the synthesis of selenoprotein P (SELENOP), which is the only selenoprotein that contains multiple UGA codons and possesses two SECIS elements in its 3 UTR. Thus, full-length SELENOP synthesis requires processive Sec incorporation. Using zebrafish Selenop, in vitro translation assays, and Se-75 labeling in HEK293 cells, we found here that processive Sec incorporation is an intrinsic property of the SECIS elements. Specifically, we identified critical features of SECIS elements that are required for processive Sec incorporation. A screen of the human SECIS elements revealed that most of these elements support processive Sec incorporation in vitro; however, we also found that the processivity of Sec incorporation into Selenop in cells is tightly regulated. We propose a model for processive Sec incorporation that involves differential recruitment of SECIS-binding proteins.	[Shetty, Sumangala P.; Sturts, Ryan; Vetick, Michael; Copeland, Paul R.] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Copeland, PR (corresponding author), Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, 675 Hoes Ln, Piscataway, NJ 08854 USA.	paul.copeland@rutgers.edu		Vetick, Michael/0000-0003-2457-0481; Copeland, Paul/0000-0003-3343-0587	National Institutes of Health [GM077073, R21HD83616]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD083616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077073] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM077073 and R21HD83616 (to P. R. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BERRY MJ, 1993, EMBO J, V12, P3315, DOI 10.1002/j.1460-2075.1993.tb06001.x; BERRY MJ, 1991, NATURE, V353, P273, DOI 10.1038/353273a0; Bifano AL, 2013, BMC MOL BIOL, V14, DOI 10.1186/1471-2199-14-12; Bubenik JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062102; Budiman ME, 2009, MOL CELL, V35, P479, DOI 10.1016/j.molcel.2009.06.026; Caban K, 2007, MOL CELL BIOL, V27, P6350, DOI 10.1128/MCB.00632-07; Chapple CE, 2009, BIOINFORMATICS, V25, P674, DOI 10.1093/bioinformatics/btp020; Copeland PR, 2000, EMBO J, V19, P306, DOI 10.1093/emboj/19.2.306; Fagegaltier D, 2000, NUCLEIC ACIDS RES, V28, P2679, DOI 10.1093/nar/28.14.2679; Fagegaltier D, 2000, EMBO J, V19, P4796, DOI 10.1093/emboj/19.17.4796; Fixsen SM, 2010, J MOL BIOL, V399, P385, DOI 10.1016/j.jmb.2010.04.033; Fletcher JE, 2001, RNA, V7, P1442; Goody TA, 2004, RNA, V10, P254, DOI 10.1261/rna.5176604; Grundner-Culemann E, 1999, RNA, V5, P625, DOI 10.1017/S1355838299981542; Gupta M, 2007, J BIOL CHEM, V282, P36797, DOI 10.1074/jbc.M707061200; Gupta N, 2013, J MOL BIOL, V425, P2415, DOI 10.1016/j.jmb.2013.04.016; HILL KE, 1992, BIOCHEM BIOPH RES CO, V185, P260, DOI 10.1016/S0006-291X(05)80984-2; Howard MT, 2005, EMBO J, V24, P1596, DOI 10.1038/sj.emboj.7600642; Huang L, 2016, J MOL BIOL, V428, P790, DOI 10.1016/j.jmb.2015.09.026; Klein DJ, 2001, EMBO J, V20, P4214, DOI 10.1093/emboj/20.15.4214; Kryukov GV, 2000, GENES CELLS, V5, P1049, DOI 10.1046/j.1365-2443.2000.00392.x; LEE BJ, 1989, J BIOL CHEM, V264, P9724; Lesoon A, 1997, MOL CELL BIOL, V17, P1977, DOI 10.1128/MCB.17.4.1977; Maiti B, 2009, HUM MUTAT, V30, P411, DOI 10.1002/humu.20879; Mariotti M, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx982; Mariotti M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt550; Martin GW, 1996, RNA, V2, P171; Mehta A, 2004, J BIOL CHEM, V279, P37852, DOI 10.1074/jbc.M404639200; Miniard AC, 2010, NUCLEIC ACIDS RES, V38, P4807, DOI 10.1093/nar/gkq247; Nasim MT, 2000, J BIOL CHEM, V275, P14846, DOI 10.1074/jbc.275.20.14846; Shetty SP, 2014, J BIOL CHEM, V289, P25317, DOI 10.1074/jbc.M114.590430; Stoytcheva Z, 2006, MOL CELL BIOL, V26, P9177, DOI 10.1128/MCB.00856-06; Sunde RA, 2009, BIOSCIENCE REP, V29, P329, DOI 10.1042/BSR20080146; Suppmann S, 1999, EMBO J, V18, P2284, DOI 10.1093/emboj/18.8.2284; Tujebajeva RM, 2000, EMBO REP, V1, P158, DOI 10.1093/embo-reports/kvd033; Tujebajeva RM, 2000, GENES CELLS, V5, P897, DOI 10.1046/j.1365-2443.2000.00375.x; Walczak R, 1996, RNA, V2, P367; Walczak R, 1998, RNA, V4, P74; Wen W, 1998, J BIOL CHEM, V273, P28533, DOI 10.1074/jbc.273.43.28533; Wu S, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160241	40	7	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2018	293	50					19377	19386		10.1074/jbc.RA118.005211	http://dx.doi.org/10.1074/jbc.RA118.005211			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HE6RA	30323062	Green Published, hybrid			2022-12-28	WOS:000453537300019
J	Volkel, S; Stielow, B; Finkernagel, F; Berger, D; Stiewe, T; Nist, A; Suske, G				Voelkel, Sara; Stielow, Bastian; Finkernagel, Florian; Berger, Dana; Stiewe, Thorsten; Nist, Andrea; Suske, Guntram			Transcription factor Sp2 potentiates binding of the TALE homeoproteins Pbx1:Prep1 and the histone-fold domain protein Nf-y to composite genomic sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromatin immunoprecipitation (ChiP); gene regulation; transcription factor; transcription target gene; specificity protein 1 (Sp1); nuclear factor y (Nf-y); Pbx1; Prep1; TALE homeoproteins; transcription factor Sp2	DNA-BINDING; EXPRESSION; FAMILY; PREP1; PBX1; LOCALIZATION; INSIGHTS; MEIS1	Different transcription factors operate together at promoters and enhancers to regulate gene expression. Transcription factors either bind directly to their target DNA or are tethered to it by other proteins. The transcription factor Sp2 serves as a paradigm for indirect genomic binding. It does not require its DNA-binding domain for genomic DNA binding and occupies target promoters independently of whether they contain a cognate DNA-binding motif. Hence, Sp2 is strikingly different from its closely related paralogs Sp1 and Sp3, but how Sp2 recognizes its targets is unknown. Here, we sought to gain more detailed insights into the genomic targeting mechanism of Sp2. ChIP-exo sequencing in mouse embryonic fibroblasts revealed genomic binding of Sp2 to a composite motif where a recognition sequence for TALE homeoproteins and a recognition sequence for the trimeric histone-fold domain protein nuclear transcription factor Y (Nf-y) are separated by 11 bp. We identified a complex consisting of the TALE homeobox protein Prep1, its partner PBX homeobox 1 (Pbx1), and Nf-y as the major partners in Sp2-promoter interactions. We found that the Pbx1:Prep1 complex together with Nf-y recruits Sp2 to co-occupied regulatory elements. In turn, Sp2 potentiates binding of Pbx1:Prep1 and Nf-y. We also found that the Sp-box, a short sequence motif close to the Sp2 N terminus, is crucial for Sp2's cofactor function. Our findings reveal a mechanism by which the DNA binding-independent activity of Sp2 potentiates genomic loading of Pbx1:Prep1 and Nf-y to composite motifs present in many promoters of highly expressed genes.	[Voelkel, Sara; Stielow, Bastian; Finkernagel, Florian; Berger, Dana; Suske, Guntram] Philipps Univ Marburg, Ctr Tumor Biol & Immunol ZTI, Inst Mol Biol & Tumor Res IMT, D-35043 Marburg, Germany; [Stiewe, Thorsten; Nist, Andrea] Philipps Univ Marburg, Ctr Tumor Biol & Immunol ZTI, Genom Core Facil, D-35043 Marburg, Germany	Philipps University Marburg; Philipps University Marburg	Suske, G (corresponding author), Philipps Univ Marburg, Ctr Tumor Biol & Immunol ZTI, Inst Mol Biol & Tumor Res IMT, D-35043 Marburg, Germany.	Suske@imt.uni-marburg.de		Stiewe, Thorsten/0000-0003-0134-7826	Deutsche Forschungsgemeinschaft [SU102/8-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SU102/8-2 (to G. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Baur F, 2010, PLOS ONE, V5, pA202, DOI 10.1371/journal.pone.0009587; Berger I, 2004, NAT BIOTECHNOL, V22, P1583, DOI 10.1038/nbt1036; Berthelsen J, 1998, EMBO J, V17, P1423, DOI 10.1093/emboj/17.5.1423; Berthelsen J, 1999, GENE DEV, V13, P946, DOI 10.1101/gad.13.8.946; Blasi F, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201600245; Bouwman P, 2000, EMBO J, V19, P655, DOI 10.1093/emboj/19.4.655; Dardaei L, 2014, P NATL ACAD SCI USA, V111, pE896, DOI 10.1073/pnas.1321200111; Dolfini D, 2009, CELL CYCLE, V8, P4127, DOI 10.4161/cc.8.24.10240; Fitzgerald DJ, 2006, NAT METHODS, V3, P1021, DOI 10.1038/nmeth983; Foley JW, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-720; HAGEN G, 1995, J BIOL CHEM, V270, P24989, DOI 10.1074/jbc.270.42.24989; HAGEN G, 1992, NUCLEIC ACIDS RES, V20, P5519, DOI 10.1093/nar/20.21.5519; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Knoepfler PS, 1997, P NATL ACAD SCI USA, V94, P14553, DOI 10.1073/pnas.94.26.14553; Ladam F, 2018, ELIFE, V7, DOI 10.7554/eLife.36144; Lelli KM, 2012, ANNU REV GENET, V46, P43, DOI 10.1146/annurev-genet-110711-155437; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Longobardi E, 2014, DEV DYNAM, V243, P59, DOI 10.1002/dvdy.24016; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Marin M, 1997, CELL, V89, P619, DOI 10.1016/S0092-8674(00)80243-3; Mathiasen L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125789; Moorefield KS, 2004, J BIOL CHEM, V279, P13911, DOI 10.1074/jbc.M313589200; Nakamura M, 2004, J CELL BIOCHEM, V93, P887, DOI 10.1002/jcb.20255; Nardini M, 2013, CELL, V152, P132, DOI 10.1016/j.cell.2012.11.047; Penkov D, 2013, CELL REP, V3, P1321, DOI 10.1016/j.celrep.2013.03.029; Pereira F, 2016, SCI REP-UK, V6, DOI 10.1038/srep38383; Philipsen S, 1999, NUCLEIC ACIDS RES, V27, P2991, DOI 10.1093/nar/27.15.2991; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; Sapetschnig A, 2004, J BIOL CHEM, V279, P42095, DOI 10.1074/jbc.M404989200; Schaeper ND, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-88; Slattery M, 2014, TRENDS BIOCHEM SCI, V39, P381, DOI 10.1016/j.tibs.2014.07.002; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Suske G, 2005, GENOMICS, V85, P551, DOI 10.1016/j.ygeno.2005.01.005; Suske G, 2017, BBA-GENE REGUL MECH, V1860, P590, DOI 10.1016/j.bbagrm.2016.08.011; Terrados G, 2012, NUCLEIC ACIDS RES, V40, P7844, DOI 10.1093/nar/gks544; Volkel S, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005102; Wang LG, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku846; Wernet MF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004210; Xie D, 2013, CELL, V155, P713, DOI 10.1016/j.cell.2013.09.043; Xie JZ, 2010, J BIOL CHEM, V285, P4153, DOI 10.1074/jbc.M109.078881; Yip KY, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r48; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	44	6	6	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2018	293	50					19250	19262		10.1074/jbc.RA118.005341	http://dx.doi.org/10.1074/jbc.RA118.005341			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HE6RA	30337366	Green Published, hybrid			2022-12-28	WOS:000453537300009
J	Reich, NO; Dang, E; Kurnik, M; Pathuri, S; Woodcock, CB				Reich, Norbert O.; Dang, Eric; Kurnik, Martin; Pathuri, Sarath; Woodcock, Clayton B.			The highly specific, cell cycle-regulated methyltransferase from Caulobacter crescentus relies on a novel DNA recognition mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PUR-ALPHA; BASE; METHYLATION; BINDING; STABILIZATION; CATALYSIS; REVEALS; CCRM	Two DNA methyltransferases, Dam and beta-class cell cycle-regulated DNA methyltransferase (CcrM), are key mediators of bacterial epigenetics. CcrM from the bacterium Caulobacter crescentus (CcrM C. crescentus, methylates adenine at 5'-GANTC-3') displays 10(5)-10(7)-fold sequence discrimination against noncognate sequences. However, the underlying recognition mechanism is unclear. Here, CcrM C. crescentus activity was either improved or mildly attenuated with substrates having one to three mismatched bp within or adjacent to the recognition site, but only if the strand undergoing methylation is left unchanged. By comparison, single-mismatched substrates resulted in up to 10(6)-fold losses of activity with alpha (Dam) and gamma-class (M. HhaI) DNAmethyltransferases. Wefound that CcrM C. crescentus has a greatly expanded DNA-interaction surface, covering six nucleotides on the 5' side and eight nucleotides on the 3' side of its recognition site. Such a large interface may contribute to the enzyme's high sequence fidelity. CcrM C. crescentus displayed the same sequence discrimination with single-stranded substrates, and a surprisingly large (>10(7)-fold) discrimination against ssRNA was largely due to the presence of two or more riboses within the cognate (DNA) site but not outside the site. Results from C-terminal truncations and point mutants supported our hypothesis that the recently identified C-terminal, 80-residue segment is essential for dsDNA recognition but is not required for single-stranded substrates. CcrM orthologs from Agrobacterium tumefaciens and Brucella abortus share some of these newly discovered features of the C. crescentus enzyme, suggesting that the recognition mechanism is conserved. In summary, CcrM C. crescentus uses a previously unknown DNA recognition mechanism.	[Reich, Norbert O.; Dang, Eric; Kurnik, Martin; Pathuri, Sarath; Woodcock, Clayton B.] Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Reich, NO (corresponding author), Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA.	reich@chem.ucsb.edu	Kurnik, Martin/AFZ-2568-2022					Adhikari S, 2016, FEMS MICROBIOL REV, V40, P575, DOI 10.1093/femsre/fuw023; BASSING CH, 1992, GENE, V113, P83, DOI 10.1016/0378-1119(92)90672-C; Cheng XD, 2001, NUCLEIC ACIDS RES, V29, P3784, DOI 10.1093/nar/29.18.3784; Cheng XD, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018747; Darbinian N, 2001, J CELL BIOCHEM, V80, P589, DOI 10.1002/1097-4644(20010315)80:4<589::AID-JCB1013>3.0.CO;2-0; Estabrook RA, 2009, J BIOL CHEM, V284, P22690, DOI 10.1074/jbc.M109.015966; Gonzalez D, 2014, NUCLEIC ACIDS RES, V42, P3720, DOI 10.1093/nar/gkt1352; Graebsch A, 2009, P NATL ACAD SCI USA, V106, P18521, DOI 10.1073/pnas.0907990106; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; Kozdon JB, 2013, P NATL ACAD SCI USA, V110, pE4658, DOI 10.1073/pnas.1319315110; Lu D, 2003, NATURE, V426, P96, DOI 10.1038/nature02088; Roberts RJ, 1998, ANNU REV BIOCHEM, V67, P181, DOI 10.1146/annurev.biochem.67.1.181; Robertson GT, 2000, J BACTERIOL, V182, P3482, DOI 10.1128/JB.182.12.3482-3489.2000; Rohs R, 2010, ANNU REV BIOCHEM, V79, P233, DOI 10.1146/annurev-biochem-060408-091030; Shamoo Y., 2002, ENCY LIFE SCI, P1; Shieh FK, 2006, J MOL BIOL, V362, P516, DOI 10.1016/j.jmb.2006.07.030; Weber J, 2016, ELIFE, V5, DOI 10.7554/eLife.11297; Woodcock CB, 2017, BIOCHEMISTRY-US, V56, P3913, DOI 10.1021/acs.biochem.7b00378; Wortman MJ, 2005, BBA-MOL CELL RES, V1743, P64, DOI 10.1016/j.bbamcr.2004.08.010; Wright R, 1997, J BACTERIOL, V179, P5869, DOI 10.1128/jb.179.18.5869-5877.1997; Youngblood B, 2008, NUCLEIC ACIDS RES, V36, P2917, DOI 10.1093/nar/gkn131; Youngblood B, 2006, BIOCHEMISTRY-US, V45, P15563, DOI 10.1021/bi061414t; Zhou B, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004831	23	3	3	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2018	293	49					19038	19046		10.1074/jbc.RA118.005212	http://dx.doi.org/10.1074/jbc.RA118.005212			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NY	30323065	Green Published, hybrid			2022-12-28	WOS:000458467400018
J	Farrar, CS; Hocking, DC				Farrar, Christopher S.; Hocking, Denise C.			Assembly of fibronectin fibrils selectively attenuates platelet-derived growth factor-induced intracellular calcium release in fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; EXTRACELLULAR-MATRIX; SIGNAL-TRANSDUCTION; PHOSPHOLIPASE-C; FACTOR PDGF; CELLS; SHP-1; ACTIVATION; EXPRESSION; RECEPTOR	Cellular responses to platelet-derived growth factor (PDGF) are altered in a variety of pathological conditions, including cancers, fibroses, and vascular diseases, making PDGF-induced signaling pathways important therapeutic targets. The limited success of therapies designed to impact PDGF pathways may be overcome with a clearer understanding of how cells integrate signals from PDGF and the extracellular matrix (ECM). Here, we assessed the effects of fibronectin matrix assembly on the responsiveness of mesenchymal cells to PDGF. Our results indicate that fibroblast-mediated assembly of fibronectin fibrils attenuates intracellular calcium release in response to PDGF. The dose-dependent inhibition of PDGF-induced intracellular calcium release was specific to the ECM form of fibronectin. Further, a recombinant protein engineered to mimic ECM fibronectin similarly attenuated intracellular calcium release in response to PDGF. Of note, fibronectin attenuated the PDGF-calcium signaling axis at the level of phosphoinositide 3-kinase (PI3K) activation. Interestingly, ECM fibronectin did not alter other intracellular signals activated by PDGF, including activation of PDGF receptor beta, AKT Ser/Thr kinase, phospholipase C gamma 1, and extracellular signal-regulated kinase 1/2 (ERK1/2). Rather, fibronectin inhibited activation of the p55 regulatory subunit of PI3K in response to a variety of stimuli, indicating that ECM fibronectin selectively attenuates the intracellular calcium release cascade while leaving intact other PDGF signaling pathways. Selective regulation of calcium signaling by ECM fibronectin via the p55 regulatory subunit of PI3K represents a mechanism by which cells tune their response to PDGF and may therefore serve as a target to selectively regulate one branch of PDGF signaling.	[Farrar, Christopher S.; Hocking, Denise C.] Univ Rochester, Sch Med & Dent, Dept Biomed Engn, Rochester, NY 14642 USA; [Hocking, Denise C.] Univ Rochester, Sch Med & Dent, Dept Physiol & Pharmacol, Rochester, NY 14642 USA; [Farrar, Christopher S.] Vertex Pharmaceut, 50 Northern Ave, Boston, MA 02210 USA	University of Rochester; University of Rochester; Vertex Pharmaceuticals	Hocking, DC (corresponding author), Univ Rochester, Box 711,601 Elmwood Ave, Rochester, NY 14642 USA.	denise_hocking@urmc.rochester.edu			National Institutes of Health [R01 EB018210, R01 GM081513]; National Institutes of Health (NIH) [T32 HL066988]; NIH NRSA Predoctoral Fellowship [F31 HL132559]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL066988, F31HL132559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB018210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081513] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NRSA Predoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 EB018210 and R01 GM081513 (to D. C. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the National Institutes of Health (NIH) predoctoral training grant, "Multidisciplinary Training in Pulmonary Research" (Grant T32 HL066988) and by NIH NRSA Predoctoral Fellowship F31 HL132559. Present address: Vertex Pharmaceuticals, 50 Northern Ave., Boston, MA 02210.	Akiyama SK, 2013, CURR PROT CELL BIOL, V60, DOI DOI 10.15.11-10.15.13; ANTONIADES HN, 1992, P NATL ACAD SCI USA, V89, P3942, DOI 10.1073/pnas.89.9.3942; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; BERK BC, 1986, SCIENCE, V232, P87, DOI 10.1126/science.3485309; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; CHERNOUSOV MA, 1991, J BIOL CHEM, V266, P10851; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Cuddon P, 2008, BIOL RES, V41, P183, DOI 10.4067/S0716-97602008000200008; Cuevas B, 1999, J BIOL CHEM, V274, P27583, DOI 10.1074/jbc.274.39.27583; Eriksson A, 1992, GROWTH FACTORS, V6, DOI 10.3109/08977199209008867; Evren S, 2013, GENOMICS, V102, P491, DOI 10.1016/j.ygeno.2013.10.001; Faes S, 2015, INT J MOL SCI, V16, P21138, DOI 10.3390/ijms160921138; Falasca M, 1998, EMBO J, V17, P414, DOI 10.1093/emboj/17.2.414; Gildner CD, 2014, MATRIX BIOL, V34, P33, DOI 10.1016/j.matbio.2014.01.017; Gomez MA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000213; Heldin CH, 1998, BBA-REV CANCER, V1378, pF79, DOI 10.1016/S0304-419X(98)00015-8; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Hocking DC, 2003, AM J PHYSIOL-LUNG C, V285, pL169, DOI 10.1152/ajplung.00371.2002; Hocking DC, 2002, J CELL BIOL, V158, P175, DOI 10.1083/jcb.200112031; Hollenbeck ST, 2004, J VASC SURG, V40, P351, DOI 10.1016/j.jvs.2004.03.047; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; Jiang MH, 2016, CELL REP, V16, P769, DOI 10.1016/j.celrep.2016.06.035; Johenning FW, 2002, J NEUROSCI, V22, P5344; KLINGHOFFER RA, 1995, J BIOL CHEM, V270, P22208, DOI 10.1074/jbc.270.38.22208; Lin FB, 2014, J INVEST DERMATOL, V134, P1119, DOI 10.1038/jid.2013.420; Lorenz U, 2009, IMMUNOL REV, V228, P342, DOI 10.1111/j.1600-065X.2008.00760.x; Mahajan K, 2012, J CELL PHYSIOL, V227, P3178, DOI 10.1002/jcp.24065; Martini M, 2014, ANN MED, V46, P372, DOI 10.3109/07853890.2014.912836; Martino MM, 2014, SCIENCE, V343, P885, DOI 10.1126/science.1247663; Martino MM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002614; Matsuoka T, 2014, CANCERS, V6, P1441, DOI 10.3390/cancers6031441; Maurer LM, 2010, J BIOL CHEM, V285, P41087, DOI 10.1074/jbc.M110.153692; MCNEIL PL, 1985, J CELL BIOL, V101, P372, DOI 10.1083/jcb.101.2.372; Mukherjee S, 2013, INT J BIOCHEM CELL B, V45, P1516, DOI 10.1016/j.biocel.2013.04.018; Ornitz DM, 2015, WIRES DEV BIOL, V4, P215, DOI 10.1002/wdev.176; Park CS, 2003, J BIOL CHEM, V278, P37064, DOI 10.1074/jbc.M304968200; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; ROBSON MC, 1992, LANCET, V339, P23, DOI 10.1016/0140-6736(92)90143-Q; SALTER MW, 1995, J NEUROSCI, V15, P2961; Sarelius IH, 2016, J PHYSIOL-LONDON, V594, P687, DOI 10.1113/JP271478; Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x; Shi F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094988; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; Sottile J, 1998, J CELL SCI, V111, P2933; Straub SV, 2000, J GEN PHYSIOL, V116, P547, DOI 10.1085/jgp.116.4.547; TIAN WN, 1994, J BIOL CHEM, V269, P14798; Tomasini-Johansson BR, 2001, J BIOL CHEM, V276, P23430, DOI 10.1074/jbc.M103467200; Valdes JA, 2013, J CELL PHYSIOL, V228, P1452, DOI 10.1002/jcp.24298; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Veevers-Lowe J, 2011, J CELL SCI, V124, P1288, DOI 10.1242/jcs.076935; Windsor L. J, 2002, MATRIX METALLOPROTEI, DOI DOI 10.8.6-10.8.7; Wojciechowski K, 2004, PROTEIN EXPRES PURIF, V36, P131, DOI 10.1016/j.pep.2004.04.004; YI TL, 1992, MOL CELL BIOL, V12, P836, DOI 10.1128/MCB.12.2.836; Yu ZB, 1998, J BIOL CHEM, V273, P3687, DOI 10.1074/jbc.273.6.3687; Zhang JN, 2015, INT J CANCER, V136, P1769, DOI 10.1002/ijc.29234	55	2	2	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2018	293	48					18655	18666		10.1074/jbc.RA118.004020	http://dx.doi.org/10.1074/jbc.RA118.004020			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NX	30323067	Green Published, hybrid			2022-12-28	WOS:000458467300020
J	Chiodi, CG; Baptista-Hon, DT; Hunter, WN; Hales, TG				Chiodi, Carla Gottschald; Baptista-Hon, Daniel T.; Hunter, William N.; Hales, Tim G.			Amino acid substitutions in the human homomeric beta(3) GABA(A) receptor that enable activation by GABA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gamma-aminobutyric acid (GABA); GABA receptor; Cys-loop receptor; mutagenesis in vitro; receptor structure-function; anesthetic; ion channel; ligand-binding protein; patch clamp; gating; benzodiazepine; general anaesthetic; propofol	BINDING-SITE; GATING MECHANISM; AGONIST BINDING; LOOP G; DESENSITIZATION; PROPOFOL; REGION; DEACTIVATION; POTENTIATION; MODULATION	GABA(A) receptors (GABA(A)Rs) are pentameric ligand-gated ion channels that mediate synaptic inhibition throughout the central nervous system. The alpha(1)beta(2)gamma(2) receptor is the major subtype in the brain; GABA binds at the beta(2)(+)alpha(1)(-) interface. The structure of the homomeric beta(3) GABA(A)R, which is not activated by GABA, has been solved. Recently, four additional heteromeric structures were reported, highlighting key residues required for agonist binding. Here, we used a protein engineering method, taking advantage of knowledge of the key binding residues, to create a beta(3)(+)alpha(1)(-) heteromeric interface in the homomeric human beta(3) GABA(A)R that enables GABA-mediated activation. Substitutions were made in the complementary side of the orthosteric binding site in loop D (Y87F and Q89R), loop E (G152T), and loop G (N66D and A70T). The Q89R and G152T combination enabled low-potency activation by GABA and potentiation by propofol but impaired direct activation by higher propofol concentrations. At higher concentrations, GABA inhibited gating of beta(3) GABA(A)R variants containing Y87F, Q89R, and G152T. Reversion of Phe(87) to tyrosine abolished GABA's inhibitory effect and partially recovered direct activation by propofol. This tyrosine is conserved in homomeric GABA(A)Rs and in the Erwinia chrysanthemi ligand-gated ion channel and may be essential for the absence of an inhibitory effect of GABA on homomeric channels. This work demonstrated that only two substitutions, Q89R and G152T, in beta(3) GABA(A)R are sufficient to reconstitute GABA-mediated activation and suggests that Tyr(87) prevents inhibitory effects of GABA.	[Chiodi, Carla Gottschald; Hunter, William N.] Univ Dundee, Sch Life Sci, Biol Chem & Drug Discovery, Dundee DD1 5EH, Scotland; [Baptista-Hon, Daniel T.; Hales, Tim G.] Univ Dundee, Ninewells Hosp, Sch Med, Inst Acad Anaesthesia,Div Syst Med, Dundee DD1 9SY, Scotland	University of Dundee; University of Dundee	Hales, TG (corresponding author), Univ Dundee, Ninewells Hosp, Sch Med, Inst Acad Anaesthesia,Div Syst Med, Dundee DD1 9SY, Scotland.	t.g.hales@dundee.ac.uk	Baptista-Hon, Daniel/AAI-6776-2021; Hunter, William/AAE-3947-2019; Gottschald Chiodi, Carla/D-4191-2013; Chiodi, Carla Gottschald/M-9242-2019	Baptista-Hon, Daniel/0000-0002-5358-1035; Gottschald Chiodi, Carla/0000-0002-6362-5388; Chiodi, Carla Gottschald/0000-0002-6362-5388	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) Science without Borders Scheme [BEX 0321/13-3]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) Science without Borders Scheme	This work was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) Science without Borders Scheme Grant BEX 0321/13-3 (to C. G. C.). The authors declare that they have no conflicts of interest with the contents of this article.	ADODRA S, 1995, BRIT J PHARMACOL, V115, P953, DOI 10.1111/j.1476-5381.1995.tb15903.x; Althoff T, 2014, NATURE, V512, P333, DOI 10.1038/nature13669; Ashby JA, 2012, BIOPHYS J, V103, P2071, DOI 10.1016/j.bpj.2012.10.016; Bai DL, 1999, J NEUROSCI, V19, P10635, DOI 10.1523/JNEUROSCI.19-24-10635.1999; Baptista-Hon DT, 2017, J PHYSIOL-LONDON, V595, P1725, DOI 10.1113/JP273752; Baptista-Hon DT, 2016, J PHYSIOL-LONDON, V594, P5555, DOI 10.1113/JP272463; Baptista-Hon DT, 2013, J BIOL CHEM, V288, P21558, DOI 10.1074/jbc.M113.481689; Bergmann R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052323; Boileau AJ, 2002, J BIOL CHEM, V277, P2931, DOI 10.1074/jbc.M109334200; Calimet N, 2013, P NATL ACAD SCI USA, V110, pE3987, DOI 10.1073/pnas.1313785110; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Davies PA, 1997, BRIT J PHARMACOL, V120, P899, DOI 10.1038/sj.bjp.0700987; Dawson GR, 2005, CNS SPECTRUMS, V10, P21, DOI 10.1017/S1092852900009871; Defeudis F. V., 1986, THE RECEPTORS, P135; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Feng HJ, 2004, MOL PHARMACOL, V66, P988, DOI 10.1124/mol.104.002543; HALES TG, 1991, BRIT J PHARMACOL, V104, P619, DOI 10.1111/j.1476-5381.1991.tb12479.x; Hales TG, 2006, J BIOL CHEM, V281, P17034, DOI 10.1074/jbc.M603599200; Harrison NJ, 2006, J BIOL CHEM, V281, P24455, DOI 10.1074/jbc.M601775200; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Holden JH, 2002, J BIOL CHEM, V277, P18785, DOI 10.1074/jbc.M111778200; Hollands EC, 2009, J BIOMOL SCREEN, V14, P769, DOI 10.1177/1087057109335675; Johnston GAR, 2005, CURR PHARM DESIGN, V11, P1867, DOI 10.2174/1381612054021024; Jones MV, 1998, J NEUROSCI, V18, P8590; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; Kelley SP, 2003, NATURE, V424, P321, DOI 10.1038/nature01788; Khom S, 2007, NEUROPHARMACOLOGY, V53, P178, DOI 10.1016/j.neuropharm.2007.04.018; Kloda JH, 2007, MOL PHARMACOL, V71, P483, DOI 10.1124/mol.106.028662; Kumar M, 2016, EUR J PHARMACOL, V775, P149, DOI 10.1016/j.ejphar.2016.02.031; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lavoie AM, 1997, BIOPHYS J, V73, P2518, DOI 10.1016/S0006-3495(97)78280-8; McCartney MR, 2007, MOL PHARMACOL, V71, P539, DOI 10.1124/mol.106.028597; Mellor JR, 1997, J PHYSIOL-LONDON, V503, P353, DOI 10.1111/j.1469-7793.1997.353bh.x; Miller P, 2018, BIORXIV, DOI [10.1101/338343, DOI 10.1101/338343]; Miller PS, 2014, NATURE, V512, P270, DOI 10.1038/nature13293; Neves MAC, 2012, J COMPUT AID MOL DES, V26, P675, DOI 10.1007/s10822-012-9547-0; Nys M, 2013, BIOCHEM PHARMACOL, V86, P1042, DOI 10.1016/j.bcp.2013.07.001; ORSER BA, 1994, J NEUROSCI, V14, P7747; Phulera S, 2018, ELIFE, V7, DOI 10.7554/eLife.39383; ROGNAN D, 1992, J MED CHEM, V35, P1969, DOI 10.1021/jm00089a005; Saras A, 2008, J BIOL CHEM, V283, P10470, DOI 10.1074/jbc.M709993200; SCHWARTZ RD, 1986, MOL PHARMACOL, V30, P419; Seeger C, 2012, BIOCHEM PHARMACOL, V84, P341, DOI 10.1016/j.bcp.2012.04.008; Shan QA, 2010, J NEUROSCI METH, V193, P86, DOI 10.1016/j.jneumeth.2010.08.033; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Sigel E, 2012, J BIOL CHEM, V287, P40224, DOI 10.1074/jbc.R112.386664; Spurny R, 2012, P NATL ACAD SCI USA, V109, pE3028, DOI 10.1073/pnas.1208208109; Szczot M, 2014, J NEUROSCI, V34, P3193, DOI 10.1523/JNEUROSCI.2533-13.2014; Thompson SA, 1996, BRIT J PHARMACOL, V117, P521, DOI 10.1111/j.1476-5381.1996.tb15221.x; Torres VI, 2002, J BIOL CHEM, V277, P43741, DOI 10.1074/jbc.M202007200; Trumper P., 2014, THESIS; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Webb Benjamin, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi0506s47; Whiting PJ, 2003, DRUG DISCOV TODAY, V8, P445, DOI 10.1016/S1359-6446(03)02703-X; Wooltorton JRA, 1997, EUR J NEUROSCI, V9, P2225, DOI 10.1111/j.1460-9568.1997.tb01641.x; Zhang JL, 2013, MOL NEUROBIOL, V48, P97, DOI 10.1007/s12035-013-8420-z; Zhu ST, 2018, NATURE, V559, P67, DOI 10.1038/s41586-018-0255-3	58	3	3	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2019	294	7					2375	2385		10.1074/jbc.RA118.006229	http://dx.doi.org/10.1074/jbc.RA118.006229			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL7CN	30545943	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000458895400015
J	Aloor, JJ; Azzam, KM; Guardiola, JJ; Gowdy, KM; Madenspacher, JH; Gabor, KA; Mueller, GA; Lin, WC; Lowe, JM; Gruzdev, A; Henderson, MW; Draper, DW; Merrick, BA; Fessler, MB				Aloor, Jim J.; Azzam, Kathleen M.; Guardiola, John J.; Gowdy, Kymberly M.; Madenspacher, Jennifer H.; Gabor, Kristin A.; Mueller, Geoffrey A.; Lin, Wan-Chi; Lowe, Julie M.; Gruzdev, Artiom; Henderson, Michael W.; Draper, David W.; Merrick, B. Alex; Fessler, Michael B.			Leucine-rich repeats and calponin homology containing 4 (Lrch4) regulates the innate immune response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						innate immunity; macrophage; lipid raft; toll-like receptor (TLR); lipopolysaccharide (LPS); leucine-rich repeat	TOLL-LIKE RECEPTORS; FREE-CHOLESTEROL; CD14 EXPRESSION; GENE-EXPRESSION; LIPID RAFTS; RECOGNITION; INFLAMMATION; BINDING; ACCUMULATION; MACROPHAGES	Toll-like receptors (TLRs) are pathogen-recognition receptors that trigger the innate immune response. Recent reports have identified accessory proteins that provide essential support to TLR function through ligand delivery and receptor trafficking. Herein, we introduce leucine-rich repeats (LRRs) and calponin homology containing 4 (Lrch4) as a novel TLR accessory protein. Lrch4 is a membrane protein with nine LRRs in its predicted ectodomain. It is widely expressed across murine tissues and has two expression variants that are both regulated by lipopolysaccharide (LPS). Predictive modeling indicates that Lrch4 LRRs conform to the horseshoe-shaped structure typical of LRRs in pathogen-recognition receptors and that the best structural match in the protein database is to the variable lymphocyte receptor of the jawless vertebrate hagfish. Silencing Lrch4 attenuates cytokine induction by LPS and multiple other TLR ligands and dampens the in vivo innate immune response. Lrch4 promotes proper docking of LPS in lipid raft membrane microdomains. We provide evidence that this is through regulation of lipid rafts as Lrch4 silencing reduces cell surface gangliosides, a metric of raft abundance, as well as expression and surface display of CD14, a raft-resident LPS co-receptor. Taken together, we identify Lrch4 as a broad-spanning regulator of the innate immune response and a potential molecular target in inflammatory disease.	[Aloor, Jim J.; Azzam, Kathleen M.; Guardiola, John J.; Gowdy, Kymberly M.; Madenspacher, Jennifer H.; Gabor, Kristin A.; Lin, Wan-Chi; Lowe, Julie M.; Henderson, Michael W.; Draper, David W.; Fessler, Michael B.] NIEHS, Immun Inflammat & Dis Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Mueller, Geoffrey A.] NIEHS, Genome Integr & Struct Biol Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Gruzdev, Artiom] NIEHS, Reprod & Dev Biol Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Merrick, B. Alex] NIEHS, Natl Toxicol Program, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Aloor, Jim J.] East Carolina Univ, East Carolina Diabet & Obes Inst, Dept Physiol, Greenville, NC 27834 USA; [Gowdy, Kymberly M.] East Carolina Univ, Dept Pharmacol & Toxicol, Greenville, NC 27834 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of North Carolina; East Carolina University; University of North Carolina; East Carolina University	Fessler, MB (corresponding author), NIEHS, NIH, 111 TW Alexander Dr,POB 12233,MD D2-01, Res Triangle Pk, NC 27709 USA.	fesslerm@niehs.nih.gov	Mueller, Geoffrey A/I-2909-2017; Fessler, Michael B/C-6323-2019	Mueller, Geoffrey A/0000-0001-8361-5323; Fessler, Michael B/0000-0002-8262-8613; Henderson, Michael/0000-0001-9098-3853; Gowdy, Kymberly/0000-0002-7227-0697; Guardiola, John/0000-0002-4934-8628	Intramural Research Program of the NIEHS, National Institutes of Health [Z01 ES102005]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102005, ZICES102425] Funding Source: NIH RePORTER	Intramural Research Program of the NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by Grant Z01 ES102005 from the Intramural Research Program of the NIEHS, National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alper S, 2008, P NATL ACAD SCI USA, V105, P7016, DOI 10.1073/pnas.0802405105; Bjorkbacka H, 2004, PHYSIOL GENOMICS, V19, P319, DOI 10.1152/physiolgenomics.00128.2004; Blumenthal A, 2009, CELL HOST MICROBE, V5, P35, DOI 10.1016/j.chom.2008.12.002; Carpenter S, 2009, J IMMUNOL, V183, P3989, DOI 10.4049/jimmunol.0901518; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Dhungana S, 2009, MOL CELL PROTEOMICS, V8, P201, DOI 10.1074/mcp.M800286-MCP200; Di Gioia M, 2015, MOL IMMUNOL, V63, P143, DOI 10.1016/j.molimm.2014.05.008; Divanovic S, 2005, NAT IMMUNOL, V6, P571, DOI 10.1038/ni1198; Dolan J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-320; Fessler MB, 2011, J IMMUNOL, V187, P1529, DOI 10.4049/jimmunol.1100253; Foussard H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012257; Gale SC, 2014, J ALLERGY CLIN IMMUN, V134, P127, DOI 10.1016/j.jaci.2014.01.032; Gokhale NA, 2013, BIOCHEM J, V453, P413, DOI 10.1042/BJ20121528; Hennessy EJ, 2010, NAT REV DRUG DISCOV, V9, P293, DOI 10.1038/nrd3203; Hofmann K., 1993, BIOL CHEM H-S, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Hong MG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003024; Jha SS, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-100; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee CC, 2008, MOL THER, V16, P60, DOI 10.1038/sj.mt.6300309; Lee CC, 2012, NAT REV IMMUNOL, V12, P168, DOI 10.1038/nri3151; Liu SB, 2000, GENE, V250, P137, DOI 10.1016/S0378-1119(00)00179-7; Liu SB, 2000, J LEUKOCYTE BIOL, V67, P894, DOI 10.1002/jlb.67.6.894; Lobley A, 2009, BIOINFORMATICS, V25, P1761, DOI 10.1093/bioinformatics/btp302; Madenspacher JH, 2013, J EXP MED, V210, P891, DOI 10.1084/jem.20121674; Murphy AJ, 2008, ARTERIOSCL THROM VAS, V28, P2071, DOI 10.1161/ATVBAHA.108.168690; Murphy AJ, 2011, J CLIN INVEST, V121, P4138, DOI 10.1172/JCI57559; Ng ACY, 2011, P NATL ACAD SCI USA, V108, P4631, DOI 10.1073/pnas.1000093107; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Pan Z, 1999, J BIOL CHEM, V274, P23242, DOI 10.1074/jbc.274.33.23242; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Pasare C, 2004, SEMIN IMMUNOL, V16, P23, DOI 10.1016/j.smim.2003.10.006; Raby AC, 2009, J IMMUNOL, V183, P506, DOI 10.4049/jimmunol.0802909; Rahimi AAR, 2005, J IMMUNOL, V174, P7823, DOI 10.4049/jimmunol.174.12.7823; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reynolds SM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000213; Salmon Patrick, 2006, Curr Protoc Neurosci, VChapter 4, DOI 10.1002/0471142301.ns0421s37; Siner JM, 2007, FASEB J, V21, P1422, DOI 10.1096/fj.06-6661com; Sjoblom B, 2008, CURR OPIN STRUC BIOL, V18, P702, DOI 10.1016/j.sbi.2008.10.003; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Takahashi K, 2007, J EXP MED, V204, P2963, DOI 10.1084/jem.20071132; Triantafilou M, 2002, J CELL SCI, V115, P2603; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005; Yvan-Charvet L, 2008, CIRCULATION, V118, P1837, DOI 10.1161/CIRCULATIONAHA.108.793869; Zhao F, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-479; Zhu X, 2008, J BIOL CHEM, V283, P22930, DOI 10.1074/jbc.M801408200; Zhu XW, 2010, J LIPID RES, V51, P3196, DOI 10.1194/jlr.M006486	52	13	13	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2019	294	6					1997	2008		10.1074/jbc.RA118.004300	http://dx.doi.org/10.1074/jbc.RA118.004300			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM8EO	30523158	hybrid, Green Published			2022-12-28	WOS:000459711400019
J	Ito, S; Nagata, K				Ito, Shinya; Nagata, Kazuhiro			Roles of the endoplasmic reticulum-resident, collagen-specific molecular chaperone Hsp47 in vertebrate cells and human disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						heat shock protein (HSP); molecular chaperone; collagen; serpin; endoplasmic reticulum (ER); fibrosis; thrombosis; FKBP65; IRE1alpha; Osteogenesis imperfecta; TANGO1	HEAT-SHOCK-PROTEIN; A-COUPLED LIPOSOMES; OSTEOGENESIS IMPERFECTA; DISULFIDE-ISOMERASE; ANTISENSE OLIGONUCLEOTIDES; PERITONEAL FIBROSIS; PULMONARY-FIBROSIS; BINDING PROTEIN; CROSS-LINKING; TRIPLE-HELIX	Heat shock protein 47 (Hsp47) is an endoplasmic reticulum (ER)-resident molecular chaperone essential for correct folding of procollagen in mammalian cells. In this Review, we discuss the role and function of Hsp47 in vertebrate cells and its role in connective tissue disorders. Hsp47 binds to collagenous (Gly-Xaa-Arg) repeats within triple-helical procollagen in the ER and can prevent its local unfolding or aggregate formation, resulting in accelerating triple-helix formation of procollagen. Hsp47 pH-dependently dissociates from procollagen in the cis-Golgi or ER-Golgi intermediate compartment and is then transported back to the ER. Although Hsp47 belongs to the serine protease inhibitor (serpin) superfamily, it does not possess serine protease inhibitory activity. Whereas general molecular chaperones such as Hsp70 and Hsp90 exhibit broad substrate specificity, Hsp47 has narrower specificity mainly for procollagens. However, other Hsp47-interacting proteins have been recently reported, suggesting a much broader role for Hsp47 in the cell that warrants further investigation. Other ER-resident stress proteins, such as binding immunoglobulin protein (BiP), are induced by ER stress, whereas Hsp47 is induced only by heat shock. Constitutive expression of Hsp47 is always correlated with expression of various collagen types, and disruption of the Hsp47 gene in mice causes embryonic lethality due to impaired basement membrane and collagen fibril formation. Increased Hsp47 expression is associated with collagen-related disorders such as fibrosis, characterized by abnormal collagen accumulation, highlighting Hsp47's potential as a clinically relevant therapeutic target.	[Ito, Shinya; Nagata, Kazuhiro] Kyoto Sangyo Univ, Inst Prot Dynam, Kyoto 6038555, Japan; [Nagata, Kazuhiro] Kyoto Sangyo Univ, Fac Life Sci, Dept Mol Biosci, Kyoto 6038555, Japan; [Nagata, Kazuhiro] Kyoto Sangyo Univ, Japan Sci & Technol Agcy, CREST, Kyoto 6038555, Japan	Kyoto Sangyo University; Kyoto Sangyo University; Japan Science & Technology Agency (JST); Kyoto Sangyo University	Nagata, K (corresponding author), Kyoto Sangyo Univ, Inst Prot Dynam, Kyoto 6038555, Japan.; Nagata, K (corresponding author), Kyoto Sangyo Univ, Fac Life Sci, Dept Mol Biosci, Kyoto 6038555, Japan.; Nagata, K (corresponding author), Kyoto Sangyo Univ, Japan Sci & Technol Agcy, CREST, Kyoto 6038555, Japan.	nagata@cc.kyoto-su.ac.jp			Japan Society for the Promotion of Science (JSPS) [24227009]; JSPS KAKENHI [JP18K14393, JP18H04002]; Takeda Science Foundation; Japan Agency for Medical Research and Development (AMED)	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This work was supported by Grant-in-aid for Scientific Research (S) 24227009 from the Japan Society for the Promotion of Science (JSPS) (to K. N.), JSPS KAKENHI Grant JP18H04002 (to K. N.), Takeda Science Foundation (to K. N.), and JSPS KAKENHI Grant JP18K14393 (to S. I.) and in part by ACceleration of Transformative Research for Medical Innovation Setup (ACT-MS) from Japan Agency for Medical Research and Development (AMED). This is the sixth article in the JBC Reviews series "Molecular chaperones and protein quality control." The authors declare that they have no conflicts of interest with the contents of this article.	Bekhouche M, 2015, MATRIX BIOL, V44-46, P46, DOI 10.1016/j.matbio.2015.04.001; Bonfanti L, 1998, CELL, V95, P993, DOI 10.1016/S0092-8674(00)81723-7; Bose D, 2017, IUBMB LIFE, V69, P647, DOI 10.1002/iub.1656; BRUCKNER P, 1981, ANAL BIOCHEM, V110, P360, DOI 10.1016/0003-2697(81)90204-9; Christiansen HE, 2010, AM J HUM GENET, V86, P389, DOI 10.1016/j.ajhg.2010.01.034; Drogemuller C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000579; Duffield JS, 2013, ANNU REV PATHOL-MECH, V8, P241, DOI 10.1146/annurev-pathol-020712-163930; Duran I, 2015, HUM MOL GENET, V24, P1918, DOI 10.1093/hmg/ddu608; Eletto D, 2012, J CELL SCI, V125, P4865, DOI 10.1242/jcs.108928; ENGEL J, 1991, ANNU REV BIOPHYS BIO, V20, P137, DOI 10.1146/annurev.biophys.20.1.137; Essawi O, 2018, MOL GENET GENOM MED, V6, P15, DOI 10.1002/mgg3.331; Eyre DR, 2013, CALCIFIED TISSUE INT, V93, P338, DOI 10.1007/s00223-013-9723-9; Forlino A, 2016, LANCET, V387, P1657, DOI 10.1016/S0140-6736(15)00728-X; Gjaltema RAF, 2016, P NATL ACAD SCI USA, V113, P7142, DOI 10.1073/pnas.1600074113; Gorres KL, 2010, CRIT REV BIOCHEM MOL, V45, P106, DOI 10.3109/10409231003627991; Gorur A, 2017, J CELL BIOL, V216, P1745, DOI 10.1083/jcb.201702135; Hattori T, 2001, J CELL PHYSIOL, V186, P268; Herchenhan A, 2015, J BIOL CHEM, V290, P16440, DOI 10.1074/jbc.M115.641670; Hetz C, 2018, MOL CELL, V69, P169, DOI 10.1016/j.molcel.2017.06.017; Hirai K, 2006, ANTICANCER RES, V26, P71; HIRAYOSHI K, 1991, MOL CELL BIOL, V11, P4036, DOI 10.1128/MCB.11.8.4036; Holmes DF, 2018, CURR TOP DEV BIOL, V130, P107, DOI 10.1016/bs.ctdb.2018.02.004; Honzawa Y, 2014, GUT, V63, P1902, DOI 10.1136/gutjnl-2013-305632; HOSOKAWA N, 1993, GENE, V126, P187, DOI 10.1016/0378-1119(93)90366-B; Huang XL, 2010, BIOMATERIALS, V31, P6142, DOI 10.1016/j.biomaterials.2010.04.055; Ishida Y, 2006, MOL BIOL CELL, V17, P2346, DOI 10.1091/mbc.E05-11-1065; Ishida Y, 2009, MOL BIOL CELL, V20, P2744, DOI 10.1091/mbc.E08-11-1092; Ishikawa T, 2017, J CELL BIOL, V216, P1761, DOI 10.1083/jcb.201609100; Ishikawa T, 2013, MOL BIOL CELL, V24, P1387, DOI 10.1091/mbc.E12-11-0830; Ishikawa Y, 2008, J BIOL CHEM, V283, P31584, DOI 10.1074/jbc.M802535200; Ishikawa Y, 2017, J BIOL CHEM, V292, P17216, DOI 10.1074/jbc.M117.802298; Ishikawa Y, 2016, P NATL ACAD SCI USA, V113, pE6036, DOI 10.1073/pnas.1609571113; Ishiwatari H, 2013, GUT, V62, P1328, DOI 10.1136/gutjnl-2011-301746; Ito S, 2017, J BIOL CHEM, V292, P20076, DOI 10.1074/jbc.M117.815936; Ito S, 2017, SEMIN CELL DEV BIOL, V62, P142, DOI 10.1016/j.semcdb.2016.11.005; Ito S, 2016, BIOCHEM BIOPH RES CO, V469, P437, DOI 10.1016/j.bbrc.2015.12.028; Kaiser WJ, 2009, J PROTEOME RES, V8, P2903, DOI 10.1021/pr900027j; Katarkar A, 2015, BIOCHEM BIOPH RES CO, V456, P707, DOI 10.1016/j.bbrc.2014.12.051; Kawasaki K, 2015, J BIOL CHEM, V290, P3639, DOI 10.1074/jbc.M114.592139; Kisseleva T, 2012, P NATL ACAD SCI USA, V109, P9448, DOI 10.1073/pnas.1201840109; Koide T, 2006, J BIOL CHEM, V281, P3432, DOI 10.1074/jbc.M509707200; Koide T, 2002, J BIOL CHEM, V277, P6178, DOI 10.1074/jbc.M106497200; Koide T, 2000, J BIOL CHEM, V275, P27957; Kumar A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10740-0; Kurochkina Natalya, 2013, Biophys Rev, V5, P29, DOI 10.1007/s12551-012-0081-z; LAMANDE SR, 1995, J BIOL CHEM, V270, P8642, DOI 10.1074/jbc.270.15.8642; Lietman CD, 2014, HUM MOL GENET, V23, P4822, DOI 10.1093/hmg/ddu197; Maitra A, 2002, AM J CLIN PATHOL, V118, P52; Marshall C, 2016, GENE, V595, P49, DOI 10.1016/j.gene.2016.09.035; Marutani T, 2004, J CELL SCI, V117, P5913, DOI 10.1242/jcs.01514; Masago Y, 2012, J CELL SCI, V125, P1118, DOI 10.1242/jcs.089748; MASUDA H, 1994, J CLIN INVEST, V94, P2481, DOI 10.1172/JCI117617; Matsuoka Y, 2004, MOL BIOL CELL, V15, P4467, DOI 10.1091/mbc.E04-01-0050; Miyata S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069732; MORI K, 1992, EMBO J, V11, P2583, DOI 10.1002/j.1460-2075.1992.tb05323.x; Mori K, 2009, J BIOCHEM, V146, P743, DOI 10.1093/jb/mvp166; Morry J, 2015, BIOMATERIALS, V66, P41, DOI 10.1016/j.biomaterials.2015.07.005; Nagai N, 2000, J CELL BIOL, V150, P1499, DOI 10.1083/jcb.150.6.1499; NAGATA K, 1986, J CELL BIOL, V103, P223, DOI 10.1083/jcb.103.1.223; NEUMAN RE, 1950, J BIOL CHEM, V186, P549; Nishino T, 2003, KIDNEY INT, V64, P887, DOI 10.1046/j.1523-1755.2003.00169.x; Obata Y, 2012, ACTA BIOMATER, V8, P2688, DOI 10.1016/j.actbio.2012.03.050; Oecal S, 2016, J BIOL CHEM, V291, P12612, DOI 10.1074/jbc.M115.706069; Otsuka M, 2017, EXP LUNG RES, V43, P271, DOI 10.1080/01902148.2017.1354946; Razzaque MS, 1998, VIRCHOWS ARCH, V432, P455, DOI 10.1007/s004280050191; Ricard-Blum S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004978; Rodriguez-Pascual F, 2016, SCI REP-UK, V6, DOI 10.1038/srep37374; SAGA S, 1987, J CELL BIOL, V105, P517, DOI 10.1083/jcb.105.1.517; Saito K, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00075; Saito K, 2009, CELL, V136, P891, DOI 10.1016/j.cell.2008.12.025; Santos AJM, 2016, J CELL BIOL, V213, P343, DOI 10.1083/jcb.201603072; Sasikumar P, 2018, J THROMB HAEMOST, V16, P946, DOI 10.1111/jth.13998; Sato Y, 2008, NAT BIOTECHNOL, V26, P431, DOI 10.1038/nbt1396; Satoh M, 1996, J CELL BIOL, V133, P469, DOI 10.1083/jcb.133.2.469; Senoo H, 2017, ANAT SCI INT, V92, P387, DOI 10.1007/s12565-017-0395-9; Sepulveda D, 2018, MOL CELL, V69, P238, DOI 10.1016/j.molcel.2017.12.028; Sharma U, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14671; SILLENCE DO, 1979, J MED GENET, V16, P101, DOI 10.1136/jmg.16.2.101; Song Y, 2018, OSTEOPOROSIS INT, V29, P1389, DOI 10.1007/s00198-018-4448-2; Sunamoto M, 1998, LAB INVEST, V78, P967; Thomson CA, 2000, BIOCHEM J, V349, P877, DOI 10.1042/bj3490877; Thomson CA, 2005, J MED CHEM, V48, P1680, DOI 10.1021/jm049148+; Vadon-Le Goff S, 2015, MATRIX BIOL, V44-46, P14, DOI 10.1016/j.matbio.2015.02.006; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang L, 2013, BLOOD, V122, P3642, DOI 10.1182/blood-2013-06-506691; Wang ZL, 2003, PLAST RECONSTR SURG, V111, P1980, DOI 10.1097/01.PRS.0000054844.41243.F2; Widmer C, 2012, P NATL ACAD SCI USA, V109, P13243, DOI 10.1073/pnas.1208072109; Wilson DG, 2011, J CELL BIOL, V194, P347, DOI 10.1083/jcb.2010071621942c; Wilson R, 1998, J BIOL CHEM, V273, P9637, DOI 10.1074/jbc.273.16.9637; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Yamakawa T, 2018, BLOOD, V131, P1476, DOI 10.1182/blood-2017-04-779934; Yamamoto N, 2013, INT J ONCOL, V43, P1855, DOI 10.3892/ijo.2013.2145; YOSHIMORI T, 1990, J BIOL CHEM, V265, P15984; Zhou JS, 2017, BLOOD, V130, P817, DOI 10.1182/blood-2016-12-755587; Zhu JQ, 2015, CANCER RES, V75, P1580, DOI 10.1158/0008-5472.CAN-14-1027	95	61	63	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2019	294	6					2133	2141		10.1074/jbc.TM118.002812	http://dx.doi.org/10.1074/jbc.TM118.002812			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM8EO	30541925	hybrid, Green Published			2022-12-28	WOS:000459711400031
J	Sepulchre, JA; Reverchon, S; Gouze, JL; Nasser, W				Sepulchre, Jacques-Alexandre; Reverchon, Sylvie; Gouze, Jean-Luc; Nasser, William			Modeling the bioconversion of polysaccharides in a continuous reactor: A case study of the production of oligogalacturonates by Dickeya dadantii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						polysaccharide; oligosaccharide; enzyme kinetics; gene regulation; microbiology; mathematical modeling; continuous reactor; Dickeya dadantii; galacturonate; pectate lyases; pectin; unsaturated oligogalacturonate; galacturonic acid; dimensionless parameter	EXTRACELLULAR PECTATE LYASE; BIOCHEMICAL-CHARACTERIZATION; ALKALIPHILIC STRAIN; GALACTURONIC ACID; PECTIN; PURIFICATION	In the quest for a sustainable economy of the Earth's resources and for renewable sources of energy, a promising avenue is to exploit the vast quantity of polysaccharide molecules contained in green wastes. To that end, the decomposition of pectin appears to be an interesting target because this polymeric carbohydrate is abundant in many fruit pulps and soft vegetables. To quantitatively study this degradation process, here we designed a bioreactor that is continuously fed with de-esterified pectin (PGA). Thanks to the pectate lyases produced by bacteria cultivated in the vessel, the PGA is depolymerized into oligogalacturonates (UGA), which are continuously extracted from the tank. A mathematical model of our system predicted that the conversion efficiency of PGA into UGA increases in a range of coefficients of dilution until reaching an upper limit where the fraction of UGA that is extracted from the bioreactor is maximized. Results from experiments with a continuous reactor hosting a strain of the plant pathogenic bacterium Dickeya dadantii and in which the dilution coefficients were varied quantitatively validated the predictions of our model. A further theoretical analysis of the system enabled an a priori comparison of the efficiency of eight other pectate lyase-producing microorganisms with that of D. dadantii. Our findings suggest that D. dadantii is the most efficient microorganism and therefore the best candidate for a practical implementation of our scheme for the bioproduction of UGA from PGA.	[Sepulchre, Jacques-Alexandre] Univ Cote Azur, Inst Phys Nice, UMR7010, CNRS, F-06560 Sophia Antipolis, France; [Reverchon, Sylvie; Nasser, William] Univ Claude Bernard Lyon 1, Univ Lyon, INSA Lyon, CNRS,UMR5240,Microbiol,Adaptat,Pathogenie, 10 Rue Raphael Dubois, F-69622 Villeurbanne, France; [Gouze, Jean-Luc] Univ Cote Azur, INRIA, INRA, CNRS,Sorbonne Univ,Biocore Team, F-06560 Sophia Antipolis, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); INRAE; Inria; UDICE-French Research Universities; Sorbonne Universite; Universite Cote d'Azur	Sepulchre, JA (corresponding author), Univ Cote Azur, Inst Phys Nice, Route Lucioles 1381, F-06560 Valbonne, France.	jacques-alexandre.sepulchre@univ-cotedazur.fr	NASSER, William/C-9611-2019; Sylvie, Reverchon/P-7932-2016	NASSER, William/0000-0001-9848-3597; Sylvie, Reverchon/0000-0002-0478-3474; Gouze, Jean-Luc/0000-0001-7156-7934	CNRS, France	CNRS, France(Centre National de la Recherche Scientifique (CNRS))	This work was initiated in the framework of the project PEPS BMI Pectolyse funded in 2013-2014 by the CNRS, France. The authors declare that they have no conflicts of interest with the contents of this article.	Bekri MA, 1999, J BACTERIOL, V181, P2440, DOI 10.1128/JB.181.8.2440-2447.1999; Berensmeier S, 2004, APPL MICROBIOL BIOT, V64, P560, DOI 10.1007/s00253-003-1446-9; BRUHLMANN F, 1995, APPL ENVIRON MICROB, V61, P3580; Burana-osot J, 2010, CARBOHYD POLYM, V81, P461, DOI 10.1016/j.carbpol.2010.03.001; Combo AMM, 2012, FOOD BIOPROD PROCESS, V90, P588, DOI 10.1016/j.fbp.2011.09.003; CRAWFORD MS, 1987, ARCH BIOCHEM BIOPHYS, V258, P196, DOI 10.1016/0003-9861(87)90336-5; Dochain D., 2008, AUTOMATIC CONTROL BI; Dubey A., 2016, BRIT BIOTECHNOLOGY J, V13, P1, DOI DOI 10.9734/BBJ/2016/24893; Edwards MC, 2012, APPL MICROBIOL BIOT, V95, P565, DOI 10.1007/s00253-012-4173-2; Eszter M, 2009, DESALINATION, V241, P81, DOI 10.1016/j.desal.2008.01.059; Hatada Y, 2000, EUR J BIOCHEM, V267, P2268, DOI 10.1046/j.1432-1327.2000.01243.x; Kapoor S, 2017, CARBOHYD POLYM, V160, P52, DOI 10.1016/j.carbpol.2016.12.046; Kepseu WD, 2010, J BIOL CHEM, V285, P28565, DOI 10.1074/jbc.M110.114710; KOTOUJANSKY A, 1982, J BACTERIOL, V150, P122, DOI 10.1128/JB.150.1.122-131.1982; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Liao CH, 1997, J APPL MICROBIOL, V83, P10, DOI 10.1046/j.1365-2672.1997.00158.x; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Monteiro AC., 2009, OPEN BIOTECHNOL J, V3, P9, DOI [10.2174/1874070700903010009, DOI 10.2174/1874070700903010009]; MORAN F, 1968, ARCH BIOCHEM BIOPHYS, V123, P298, DOI 10.1016/0003-9861(68)90138-0; Naqash F, 2017, CARBOHYD POLYM, V168, P227, DOI 10.1016/j.carbpol.2017.03.058; NASSER W, 1990, BIOCHIMIE, V72, P689, DOI 10.1016/0300-9084(90)90053-J; Nasser W, 1997, MOL MICROBIOL, V26, P1071, DOI 10.1046/j.1365-2958.1997.6472020.x; Gerschenson LN, 2017, FOOD HYDROCOLLOID, V68, P23, DOI 10.1016/j.foodhyd.2016.11.030; Payasi A, 2009, WORLD J MICROB BIOT, V25, P1, DOI 10.1007/s11274-008-9870-8; Rao MN, 1996, BIOCHEM J, V319, P159, DOI 10.1042/bj3190159; Sawada K, 2000, EUR J BIOCHEM, V267, P1510, DOI 10.1046/j.1432-1327.2000.01146.x; Sepulchre JA, 2017, AICHE J, V63, P4738, DOI 10.1002/aic.15853; Tardy F, 1997, J BACTERIOL, V179, P2503, DOI 10.1128/jb.179.8.2503-2511.1997; Xiao CW, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00067; Yadav S, 2009, PROCESS BIOCHEM, V44, P1, DOI 10.1016/j.procbio.2008.09.012; Zhang WB, 2015, TRENDS FOOD SCI TECH, V44, P258, DOI 10.1016/j.tifs.2015.04.001	31	2	2	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2019	294	5					1753	1762		10.1074/jbc.RA118.004615	http://dx.doi.org/10.1074/jbc.RA118.004615			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GC	30510137	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000457879200035
J	Tanaka, KJ; Pinkett, HW				Tanaka, Kari J.; Pinkett, Heather W.			Oligopeptide-binding protein from nontypeable Haemophilus influenzae has ligand-specific sites to accommodate peptides and heme in the binding pocket	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						heme; peptide transport; bacterial metabolism; ABC transporter; ligand-binding protein; Cluster C; oligopeptide-binding protein; opportunistic pathogen; PepT importer	ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; STRUCTURAL BASIS; ABC TRANSPORTER; YERSINIA-PESTIS; OPPA; PERMEASE; ACQUISITION; LIPOPROTEIN; RESISTANCE	In nontypeable Haemophilus influenzae (NTHi), the oligopeptide-binding protein (OppA) serves as the substrate-binding protein (SBP) of the oligopeptide transport system responsible for the import of peptides. We solved the crystal structure of nthiOppA in complex with hydrophobic peptides of various sizes. Our novel hexapeptide complex demonstrates the flexibility of the nthiOppA-binding cavity to expand and accommodate the longer peptide while maintaining similar protein-peptide interactions of smaller peptide complexes. In addition to acquiring peptides from the host environment, as a heme auxotroph NTHi utilizes host hemoproteins as a source of essential iron. OppA is a member of the Cluster C SBP family, and unlike other SBP families, some members recognize two distinctly different substrates. DppA (dipeptide), MppA (murein tripeptide), and SapA (antimicrobial peptides) are Cluster C proteins known to also transport heme. We observed nthiOppA shares this heme-binding characteristic and established heme specificity and affinity by surface plasmon resonance (SPR) of the four Cluster C proteins in NTHi. Ligand-docking studies predicted a distinct heme-specific cleft in the binding pocket, and using SPR competition assays, we observed that heme does not directly compete with peptide in the substrate-binding pocket. Additionally, we identified that the individual nthiOppA domains differentially contribute to substrate binding, with one domain playing a dominant role in heme binding and the other in peptide binding. Our results demonstrate the multisubstrate specificity of nthiOppA and the role of NTHi Cluster C proteins in the heme-uptake pathway for this pathogen.	[Tanaka, Kari J.; Pinkett, Heather W.] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA	Northwestern University	Pinkett, HW (corresponding author), Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA.	h-pinkett@northwestern.edu	Pinkett, Heather Wendy/M-9235-2014		Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust; National Science Foundation [MCB-1121872]; National Institutes of Health NIGMS [T32 GM008382]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008382] Funding Source: NIH RePORTER	Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Chicago Biomedical Consortium with support from the Searle Funds at The Chicago Community Trust, National Science Foundation Grant MCB-1121872, and National Institutes of Health NIGMS Molecular Biophysics Training Program Grant T32 GM008382. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Flores-Valdez MA, 2009, FASEB J, V23, P4091, DOI 10.1096/fj.09-132407; Berntsson RPA, 2012, J BIOL CHEM, V287, P37165, DOI 10.1074/jbc.M112.386334; Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; Berntsson RPA, 2009, EMBO J, V28, P1332, DOI 10.1038/emboj.2009.65; Carter DM, 2006, J BIOL CHEM, V281, P35413, DOI 10.1074/jbc.M607611200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Detmers FJM, 2000, P NATL ACAD SCI USA, V97, P12487, DOI 10.1073/pnas.220308797; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faraldo-Gomez JD, 2003, NAT REV MOL CELL BIO, V4, P105, DOI 10.1038/nrm1015; Gominet M, 2001, MOL MICROBIOL, V40, P963, DOI 10.1046/j.1365-2958.2001.02440.x; GOODELL EW, 1987, J BACTERIOL, V169, P3861, DOI 10.1128/jb.169.8.3861-3865.1987; GRANICK S, 1946, J GEN PHYSIOL, V30, P1, DOI 10.1085/jgp.30.1.1; GUYER CA, 1986, J BACTERIOL, V168, P775, DOI 10.1128/jb.168.2.775-779.1986; Handali M, 2015, J BIOL CHEM, V290, P29984, DOI 10.1074/jbc.M115.684506; HANSON MS, 1991, MOL MICROBIOL, V5, P267, DOI 10.1111/j.1365-2958.1991.tb02107.x; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; Ilari A, 2014, BBA-GEN SUBJECTS, V1840, P535, DOI 10.1016/j.bbagen.2013.10.010; James KJ, 2009, BIOCHEMISTRY-US, V48, P9212, DOI 10.1021/bi900722p; Jones MM, 2014, INFECT IMMUN, V82, P4758, DOI 10.1128/IAI.02185-14; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Klepsch MM, 2011, J MOL BIOL, V414, P75, DOI 10.1016/j.jmb.2011.09.043; Lanfermeijer FC, 1999, BIOCHEMISTRY-US, V38, P14440, DOI 10.1021/bi9914715; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lassaux P, 2013, STRUCTURE, V21, P167, DOI 10.1016/j.str.2012.10.005; Lee EM, 2004, FEMS MICROBIOL LETT, V240, P21, DOI 10.1016/j.femsle.2004.09.007; Lennon CW, 2015, J MOL BIOL, V427, P2983, DOI 10.1016/j.jmb.2015.05.013; Letoffe S, 2006, P NATL ACAD SCI USA, V103, P12891, DOI 10.1073/pnas.0605440103; Levdikov VM, 2005, J MOL BIOL, V345, P879, DOI 10.1016/j.jmb.2004.10.089; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Lyskov S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063906; Mason KM, 2011, J BACTERIOL, V193, P2527, DOI 10.1128/JB.01313-10; Mistry A, 2013, ANTIMICROB AGENTS CH, V57, P5565, DOI 10.1128/AAC.01198-13; MONSO E, 1995, AM J RESP CRIT CARE, V152, P1316, DOI 10.1164/ajrccm.152.4.7551388; Morton Daniel J, 2009, BMC Res Notes, V2, P166, DOI 10.1186/1756-0500-2-166; Morton DJ, 2005, FEMS MICROBIOL LETT, V253, P193, DOI 10.1016/j.femsle.2005.09.016; Murphy TF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158689; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; O'Neill MJ, 2012, P NATL ACAD SCI USA, V109, P5639, DOI 10.1073/pnas.1121549109; Park JT, 1998, J BACTERIOL, V180, P1215, DOI 10.1128/JB.180.5.1215-1223.1998; PARRALOPEZ C, 1993, EMBO J, V12, P4053, DOI 10.1002/j.1460-2075.1993.tb06089.x; Rajan Sujatha, 2002, Semin Respir Infect, V17, P47, DOI 10.1053/srin.2002.31690; Richarme G, 1997, J BIOL CHEM, V272, P15607, DOI 10.1074/jbc.272.25.15607; Shepherd M, 2007, BIOCHEMISTRY-US, V46, P5030, DOI 10.1021/bi700183u; SILHAVY TJ, 1975, P NATL ACAD SCI USA, V72, P2120, DOI 10.1073/pnas.72.6.2120; Tame JRH, 1995, STRUCTURE, V3, P1395, DOI 10.1016/S0969-2126(01)00276-3; TAME JRH, 1994, SCIENCE, V264, P1578, DOI 10.1126/science.8202710; Tanabe M, 2007, ACTA CRYSTALLOGR D, V63, P1185, DOI 10.1107/S0907444907048299; Thompson JM, 1999, INFECT IMMUN, V67, P3879, DOI 10.1128/IAI.67.8.3879-3892.1999; TURK DC, 1984, J MED MICROBIOL, V18, P1, DOI 10.1099/00222615-18-1-1; Vergauwen B, 2010, P NATL ACAD SCI USA, V107, P13270, DOI 10.1073/pnas.1005198107; Vogel AR, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00042; Wang CH, 2005, INFECT IMMUN, V73, P2881, DOI 10.1128/IAI.73.5.2881-2890.2005; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu LF, 1995, BIOCHIMIE, V77, P744, DOI 10.1016/0300-9084(96)88192-2	56	5	5	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2019	294	3					1070	1082		10.1074/jbc.RA118.004479	http://dx.doi.org/10.1074/jbc.RA118.004479			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL4FC	30455346	Green Published, hybrid			2022-12-28	WOS:000458670200029
J	Mani, RS; Mermershtain, I; Abdou, I; Fanta, M; Hendzel, MJ; Glover, JNM; Weinfeld, M				Mani, Rajam S.; Mermershtain, Inbal; Abdou, Ismail; Fanta, Mesfin; Hendzel, Michael J.; Glover, J. N. Mark; Weinfeld, Michael			Domain analysis of PNKP-XRCC1 interactions: Influence of genetic variants of XRCC1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA repair; protein-protein interaction; protein-nucleic acid interaction; circular dichroism (CD); single-nucleotide polymorphism (SNP); fluorescence spectroscopy; laser-microirradiation; polynucleotide kinase; phosphatase; X-ray repair cross-complementing; XRCC1	REPAIR PROTEIN XRCC1; STRAND BREAK REPAIR; HUMAN POLYNUCLEOTIDE KINASE; BASE EXCISION-REPAIR; DNA-POLYMERASE BETA; LIGASE III-ALPHA; POLY(ADP-RIBOSE) POLYMERASE; COLORECTAL-CANCER; POTENTIAL TARGET; POLYMORPHISMS	Polynucleotide kinase/phosphatase (PNKP) and X-ray repair cross-complementing 1 (XRCC1) are key proteins in the single-strand DNA break repair pathway. Phosphorylated XRCC1 stimulates PNKP by binding to its forkhead-associated (FHA) domain, whereas nonphosphorylated XRCC1 stimulates PNKP by interacting with the PNKP catalytic domain. Here, we have further studied the interactions between these two proteins, including two variants of XRCC1 (R194W and R280H) arising from single-nucleotide polymorphisms (SNPs) that have been associated with elevated cancer risk in some reports. We observed that interaction of the PNKP FHA domain with phosphorylated XRCC1 extends beyond the immediate, well-characterized phosphorylated region of XRCC1 (residues 515-526). We also found that an XRCC1 fragment, comprising residues 166-436, binds tightly to PNKP and DNA and efficiently activates PNKP's kinase activity. However, interaction of either of the SNP-derived variants of this fragment with PNKP was considerably weaker, and their stimulation of PNKP was severely reduced, although they still could bind DNA effectively. Laser microirradiation revealed reduced recruitment of PNKP to damaged DNA in cells expressing either XRCC1 variant compared with PNKP recruitment in cells expressing WT XRCC1 even though WT and variant XRCC1s were equally efficient at localizing to the damaged DNA. These findings suggest that the elevated risk of cancer associated with these XRCC1 SNPs reported in some studies may be due in part to the reduced ability of these XRCC1 variants to recruit PNKP to damaged DNA.	[Mani, Rajam S.; Abdou, Ismail; Fanta, Mesfin; Hendzel, Michael J.; Weinfeld, Michael] Univ Alberta, Dept Oncol, Edmonton, AB T6G 1Z2, Canada; [Mermershtain, Inbal; Glover, J. N. Mark] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; [Mermershtain, Inbal] Minist Hlth, Govt Cent Labs, Jerusalem, Israel; [Abdou, Ismail] AstraZeneca FZLLC, Dubai Healthcare City, Dubai, U Arab Emirates	University of Alberta; University of Alberta	Weinfeld, M (corresponding author), Univ Alberta, Cross Canc Inst, Dept Oncol, Edmonton, AB T6G 1Z2, Canada.	mweinfel@ualberta.ca	Hendzel, Michael/C-3391-2009; Classen, Scott/AAY-8176-2020	Hendzel, Michael/0000-0002-9603-7945; Weinfeld, Michael/0000-0002-8773-1425	Canadian Institutes of Health Research [MOP 15385]; National Institutes of Health [PO1CA092584]; Alberta Cancer Foundation [ACF GSA 26283]; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alberta Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Grant MOP 15385 from the Canadian Institutes of Health Research (to M. W. and M. J. H.), Grant PO1CA092584 from the National Institutes of Health (to J. N. M. G.), and Alberta Cancer Foundation Graduate Studentship Grant ACF GSA 26283 (to I. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ali AAE, 2009, NUCLEIC ACIDS RES, V37, P1701, DOI 10.1093/nar/gkn1086; Allinson SL, 2010, FUTURE ONCOL, V6, P1031, DOI [10.2217/fon.10.40, 10.2217/FON.10.40]; Audebert M, 2006, J MOL BIOL, V356, P257, DOI 10.1016/j.jmb.2005.11.028; Bernstein NK, 2008, ANTI-CANCER AGENT ME, V8, P358, DOI 10.2174/187152008784220311; Berquist BR, 2010, NUCLEIC ACIDS RES, V38, P5023, DOI 10.1093/nar/gkq193; Breslin C, 2017, J BIOL CHEM, V292, P16024, DOI 10.1074/jbc.M117.806638; Breslin C, 2009, MOL CELL BIOL, V29, P4653, DOI 10.1128/MCB.00677-09; Caldecott KW, 1996, NUCLEIC ACIDS RES, V24, P4387, DOI 10.1093/nar/24.22.4387; CALDECOTT KW, 1994, MOL CELL BIOL, V14, P68, DOI 10.1128/MCB.14.1.68; Chen J, 2019, PATHOL ONCOL RES, V25, P897, DOI 10.1007/s12253-017-0364-6; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Cherry AL, 2015, DNA REPAIR, V35, P116, DOI 10.1016/j.dnarep.2015.10.002; Cuneo MJ, 2011, NUCLEIC ACIDS RES, V39, P7816, DOI 10.1093/nar/gkr419; Della-Maria J, 2012, J BIOL CHEM, V287, P39233, DOI 10.1074/jbc.M112.369975; El-Khamisy SF, 2003, NUCLEIC ACIDS RES, V31, P5526, DOI 10.1093/nar/gkg761; Fang ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064001; Freschauf GK, 2010, J BIOL CHEM, V285, P2351, DOI 10.1074/jbc.M109.055764; Gabel SA, 2013, DNA REPAIR, V12, P1105, DOI 10.1016/j.dnarep.2013.08.015; Hanssen-Bauer A, 2012, DNA REPAIR, V11, P357, DOI 10.1016/j.dnarep.2012.01.001; Hanssen-Bauer A, 2011, ENVIRON MOL MUTAGEN, V52, P623, DOI 10.1002/em.20663; Horton JK, 2018, DNA REPAIR, V64, P26, DOI 10.1016/j.dnarep.2018.02.004; Jilani A, 1999, J BIOL CHEM, V274, P24176, DOI 10.1074/jbc.274.34.24176; Karimi-Busheri F, 1999, J BIOL CHEM, V274, P24187, DOI 10.1074/jbc.274.34.24187; Kim IK, 2015, J BIOL CHEM, V290, P3775, DOI 10.1074/jbc.M114.624718; Kobayashi M, 2010, J BIOL CHEM, V285, P10087, DOI 10.1074/jbc.M109.054106; Kubota Y, 1996, EMBO J, V15, P6662, DOI 10.1002/j.1460-2075.1996.tb01056.x; Lau TP, 2017, EUR J CANCER PREV, V26, P506, DOI [10.1097/CEJ.0000000000000336, 10.1097/cej.0000000000000336]; Loizou JI, 2004, CELL, V117, P17, DOI 10.1016/S0092-8674(04)00206-5; Lu ML, 2010, NUCLEIC ACIDS RES, V38, P510, DOI 10.1093/nar/gkp1023; Mani RS, 2007, J BIOL CHEM, V282, P28004, DOI 10.1074/jbc.M704867200; MANI RS, 1993, BIOCHEMISTRY-US, V32, P11217, DOI 10.1021/bi00092a035; Mani RS, 2004, BIOCHEMISTRY-US, V43, P16505, DOI 10.1021/bi048615m; Mani RS, 2003, BIOCHEMISTRY-US, V42, P12077, DOI 10.1021/bi030127b; Marintchev A, 1999, NAT STRUCT BIOL, V6, P884; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; Palmirotta Raffaele, 2018, Oncotarget, V9, P25355, DOI 10.18632/oncotarget.25256; PRENDERGAST FG, 1983, J BIOL CHEM, V258, P7541; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Sizova DV, 2015, DNA REPAIR, V31, P73, DOI 10.1016/j.dnarep.2015.05.005; Stankova K, 2012, BIOCHEM J, V443, P701, DOI 10.1042/BJ20112151; Taylor RM, 1998, CURR BIOL, V8, P877, DOI 10.1016/S0960-9822(07)00350-8; Unger T, 2010, J STRUCT BIOL, V172, P34, DOI 10.1016/j.jsb.2010.06.016; Wang LM, 2016, J CANCER RES THER, V12, P264, DOI 10.4103/0973-1482.200753; Weinfeld M, 2011, TRENDS BIOCHEM SCI, V36, P262, DOI 10.1016/j.tibs.2011.01.006; Whitehouse CJ, 2001, CELL, V104, P107, DOI 10.1016/S0092-8674(01)00195-7; Wiederhold L, 2004, MOL CELL, V15, P209, DOI 10.1016/j.molcel.2004.06.003; Zhang YM, 2013, DNA CELL BIOL, V32, P111, DOI 10.1089/dna.2012.1840; Zhang Y, 2013, TUMOR BIOL, V34, P2321, DOI 10.1007/s13277-013-0779-y	48	5	5	3	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2019	294	2					520	530		10.1074/jbc.RA118.004262	http://dx.doi.org/10.1074/jbc.RA118.004262			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HI2GP	30446622	Green Published, hybrid			2022-12-28	WOS:000456263600012
J	Kim, MK; Song, JY; Koh, DI; Kim, JY; Hatano, M; Jeon, BN; Kim, MY; Cho, SY; Kim, KS; Hur, MW				Kim, Min-Kyeong; Song, Ji-Yang; Koh, Dong-In; Kim, Jin Young; Hatano, Masahiko; Jeon, Bu-Nam; Kim, Min-Young; Cho, Su-Yeon; Kim, Kyung-Sup; Hur, Man-Wook			Reciprocal negative regulation between the tumor suppressor protein p53 and B cell CLL/lymphoma 6 (BCL6) via control of caspase-1 expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						p53; caspase 1 (CASP1); proteolysis; E1A binding protein p300 (P300); post-translational modification (PTM); acetylation; acetylation; BCL6; caspase-1; p300; p53; memory B cell; lymphocyte; cancer development; lymphoma	GENE; MUTATIONS; APOPTOSIS; TRANSCRIPTION; SENESCENCE; LYMPHOMA; PATHWAY; CYCLE	Even in the face of physiological DNA damage or expression of the tumor suppressor protein p53, B cell CLL/lymphoma 6 (BCL6) increases proliferation and antagonizes apoptotic responses in B cells. BCL6 represses TP53 transcription and also appears to inactivate p53 at the protein level, and additional findings have suggested negative mutual regulation between BCL6 and p53. Here, using Bcl6(-/-) knockout mice, HEK293A and HCT116 p53(-/-) cells, and site-directed mutagenesis, we found that BCL6 interacts with p53 and thereby inhibits acetylation of Lys-132 in p53 by E1A-binding protein p300 (p300), a modification that normally occurs upon DNA damage-induced cellular stress and whose abrogation by BCL6 diminished transcriptional activation of p53 target genes, including that encoding caspase-1. Conversely, we also found that BCL6 protein is degraded via p53-induced, caspase-mediated proteolytic cleavage, and the formation of a BCL6-p53-caspase-1 complex. Our results suggest that p53 may block oncogenic transformation by decreasing BCL6 stability via caspase-1 up-regulation, whereas aberrant BCL6 expression inactivates transactivation of p53 target genes, either by inhibiting p53 acetylation by p300 or repressing TP53 gene transcription. These findings have implications for B cell development and lymphomagenesis.	[Kim, Min-Kyeong; Song, Ji-Yang; Koh, Dong-In; Jeon, Bu-Nam; Kim, Min-Young; Cho, Su-Yeon; Kim, Kyung-Sup; Hur, Man-Wook] Yonsei Univ, Brain Korea 21 Plus Project Med Sci, Severance Biomed Res Inst, Dept Biochem & Mol Biol,Sch Med, 50 Yonsei Ro, Seoul 03722, South Korea; [Kim, Jin Young] Korea Basic Sci Inst, Biomed Om Grp, 162 Yoengudanji Ro, Ochang 28119, Chungbuk, South Korea; [Hatano, Masahiko] Chiba Univ, Grad Sch Med, Dept Biomed Sci, Chuo Ku, 1-8-1 Inohana, Chiba, Chiba 2600856, Japan	Yonsei University; Korea Basic Science Institute (KBSI); Chiba University	Hur, MW (corresponding author), Yonsei Univ, Sch Med, Dept Biochem & Mol Biol, 50-1 Yonsei Ro, Seoul 03722, South Korea.	mwhur2@yuhs.ac		Hur, Man-Wook/0000-0002-3416-1334; Kim, Kyung-sup/0000-0001-8483-8537	JeonRack-HooSok Grant [2016R1E1A1A02921938]; Do-Yak Research Grant [2011-0028817]; Medical Research Center Research Grant from the National Research Foundation of Korea (NRF) of the Korean Government (Ministry of Science, ICT and Future Planning (MSIP)) [2011-0030086]	JeonRack-HooSok Grant; Do-Yak Research Grant; Medical Research Center Research Grant from the National Research Foundation of Korea (NRF) of the Korean Government (Ministry of Science, ICT and Future Planning (MSIP))	This work was supported by JeonRack-HooSok Grant 2016R1E1A1A02921938 (to M.-W.H.), Do-Yak Research Grant 2011-0028817 (to M.-W.H.), and Medical Research Center Research Grant 2011-0030086 (to M.-W.H.) from the National Research Foundation of Korea (NRF) of the Korean Government (Ministry of Science, ICT and Future Planning (MSIP)). The authors declare that they have no conflicts of interest with the contents of this article.	Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Arend WP, 2008, IMMUNOL REV, V223, P20, DOI 10.1111/j.1600-065X.2008.00624.x; Basso K, 2010, ADV IMMUNOL, V105, P193, DOI 10.1016/S0065-2776(10)05007-8; Bellido M, 2002, HAEMATOLOGICA, V87, P908; Bereshchenko OR, 2002, NAT GENET, V32, P606, DOI 10.1038/ng1018; Chan WM, 2006, MOL CANCER RES, V4, P15, DOI 10.1158/1541-7786.MCR-05-0097; Ding HF, 2000, J BIOL CHEM, V275, P38905, DOI 10.1074/jbc.M004714200; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Gaidano G, 1997, AM J HEMATOL, V56, P206, DOI 10.1002/(SICI)1096-8652(199712)56:4<206::AID-AJH2>3.0.CO;2-0; Gupta S, 2001, J BIOL CHEM, V276, P10585, DOI 10.1074/jbc.C100025200; Hu Wenwei, 2012, Genes Cancer, V3, P199, DOI 10.1177/1947601912454734; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; Khanna KK, 1998, NAT GENET, V20, P398, DOI 10.1038/3882; Knights CD, 2006, J CELL BIOL, V173, P533, DOI 10.1083/jcb.200512059; Koh DI, 2014, P NATL ACAD SCI USA, V111, P15078, DOI 10.1073/pnas.1318780111; Kubbutat MHG, 1998, MOL MED TODAY, V4, P250, DOI 10.1016/S1357-4310(98)01260-X; Kusam S, 2004, ONCOGENE, V23, P839, DOI 10.1038/sj.onc.1207065; Lan Q, 2009, BLOOD, V114, P264, DOI 10.1182/blood-2009-01-198697; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Lavrik IN, 2005, J CLIN INVEST, V115, P2665, DOI 10.1172/JCI26252; MacLachan TK, 2002, P NATL ACAD SCI USA, V99, P9492, DOI 10.1073/pnas.132241599; Martinez-Climent JA, 2003, BLOOD, V101, P3109, DOI 10.1182/blood-2002-07-2119; MIURA M, 1993, CELL, V75, P653, DOI 10.1016/0092-8674(93)90486-A; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; Pasqualucci L, 2003, BLOOD, V101, P2914, DOI 10.1182/blood-2002-11-3387; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Phan RT, 2007, NAT IMMUNOL, V8, P1132, DOI 10.1038/ni1508; Ranuncolo SM, 2008, J BIOL CHEM, V283, P22565, DOI 10.1074/jbc.M803490200; REYNAUD CA, 1989, CELL, V59, P171, DOI 10.1016/0092-8674(89)90879-9; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rivlin Noa, 2011, Genes Cancer, V2, P466, DOI 10.1177/1947601911408889; Saito M, 2007, CANCER CELL, V12, P280, DOI 10.1016/j.ccr.2007.08.011; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Scott AM, 2007, CELL DEATH DIFFER, V14, P23, DOI 10.1038/sj.cdd.4402026; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Shvarts A, 2002, GENE DEV, V16, P681, DOI 10.1101/gad.929302; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Zheng HW, 2002, NATURE, V419, P849, DOI 10.1038/nature01116	41	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2019	294	1					299	313		10.1074/jbc.RA118.004204	http://dx.doi.org/10.1074/jbc.RA118.004204			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG6PT	30409904	Green Published, hybrid			2022-12-28	WOS:000455105500032
J	McRae, S; Iqbal, J; Sarkar-Dutta, M; Lane, S; Nagaraj, A; Ali, N; Waris, G				McRae, Steven; Iqbal, Jawed; Sarkar-Dutta, Mehuli; Lane, Samantha; Nagaraj, Abhiram; Ali, Naushad; Waris, Gulam			RETRACTION: Withdrawal: The hepatitis C virus-induced NLRP3 inflammasome activates the sterol regulatory element-binding protein (SREBP) and regulates lipid metabolism. (Retraction of Vol 291, Pg 3254, 2016)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		McRae S, 2016, J BIOL CHEM, V291, P3254, DOI 10.1074/jbc.M115.694059	1	3	4	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					20011	20011		10.1074/jbc.W118.006979	http://dx.doi.org/10.1074/jbc.W118.006979			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30593532	hybrid, Green Published			2022-12-28	WOS:000454685900009
J	Xi, TY; Jin, F; Zhu, Y; Wang, JL; Tang, L; Wang, YZ; Liebeskind, DS; Scalzo, F; He, ZY				Xi, Tianyang; Jin, Feng; Zhu, Ying; Wang, Jialu; Tang, Ling; Wang, Yanzhe; Liebeskind, David S.; Scalzo, Fabien; He, Zhiyi			miR-27a-3p protects against blood-brain barrier disruption and brain injury after intracerebral hemorrhage by targeting endothelial aquaporin-11	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						brain; endothelium; microRNA (miRNA); aquaporin; post-transcriptional regulation; blood-brain barrier; brain injury; intracerebral hemorrhage; miR-27a-3p; neurological deficit	EDEMA; ANGIOGENESIS; PERMEABILITY; MICRORNAS; MIR-23A; MODEL; WATER	Previous studies have reported that miR-27a-3p is down-regulated in the serum of patients with intracerebral hemorrhage (ICH), but the implication of miR-27a-3p down-regulation in post-ICH complications remains elusive. Here we verified miR-27a-3p levels in the serum of ICH patients by real-time PCR and observed that miR-27a-3p is also significantly reduced in the serum of these patients. We then further investigated the effect of miR-27a-3p on post-ICH complications by intraventricular administration of a miR-27a-3p mimic in rats with collagenase-induced ICH. We found that the hemorrhage markedly reduced miR-27a-3p levels in the hematoma, perihematomal tissue, and serum and that intracerebroventricular administration of the miR-27a-3p mimic alleviated behavioral deficits 24 h after ICH. Moreover, ICH-induced brain edema, vascular leakage, and leukocyte infiltration were also attenuated by this mimic. Of note, miR-27a-3p mimic treatment also inhibited neuronal apoptosis and microglia activation in the perihematomal zone. We further observed that the miR-27a-3p mimic suppressed the up-regulation of aquaporin-11 (AQP11) in the perihematomal area and in rat brain microvascular endothelial cells (BMECs). Moreover, miR-27a-3p down-regulation increased BMEC monolayer permeability and impaired BMEC proliferation and migration. In conclusion, miR-27a-3p down-regulation contributes to brain edema, blood-brain barrier disruption, neuron loss, and neurological deficits following ICH. We conclude that application of exogenous miR-27a-3p may protect against post-ICH complications by targeting AQP11 in the capillary endothelial cells of the brain.	[Xi, Tianyang; Jin, Feng; Zhu, Ying; Wang, Jialu; Tang, Ling; Wang, Yanzhe; He, Zhiyi] China Med Univ, Affiliated Hosp 1, Dept Neurol, 155 N Nanjing St, Shenyang 110001, Liaoning, Peoples R China; [Liebeskind, David S.; Scalzo, Fabien] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90095 USA	China Medical University; University of California System; University of California Los Angeles	He, ZY (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Neurol, 155 N Nanjing St, Shenyang 110001, Liaoning, Peoples R China.	hezhiyi0301@sina.com	Scalzo, Fabien/AAM-6328-2020	Scalzo, Fabien/0000-0001-9755-8104	National Natural Science Foundation of China [81271291]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by a grant from the National Natural Science Foundation of China (81271291). The authors declare that they have no conflicts of interest with the contents of this article.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Appelboom G, 2013, J NEUROL NEUROSUR PS, V84, P488, DOI 10.1136/jnnp-2012-303160; Balami JS, 2012, LANCET NEUROL, V11, P101, DOI 10.1016/S1474-4422(11)70264-2; Ban JJ, 2017, BIOCHEM BIOPH RES CO, V488, P316, DOI 10.1016/j.bbrc.2017.05.040; BETZ A L, 1989, Cerebrovascular and Brain Metabolism Reviews, V1, P133; Chen Q, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.92; Corsten MF, 2010, CIRC-CARDIOVASC GENE, V3, P499, DOI 10.1161/CIRCGENETICS.110.957415; Di Stefano V, 2011, VASC PHARMACOL, V55, P111, DOI 10.1016/j.vph.2011.08.001; do Amaral AE, 2018, PHARMACOL RES, V128, P274, DOI 10.1016/j.phrs.2017.10.002; Doebele C, 2010, BLOOD, V115, P4944, DOI 10.1182/blood-2010-01-264812; Gong C, 2000, BRAIN RES, V871, P57, DOI 10.1016/S0006-8993(00)02427-6; Gong Y, 2004, STROKE, V35, P2571, DOI 10.1161/01.STR.0000145485.67827.d0; He QW, 2013, MOL NEUROBIOL, V47, P976, DOI 10.1007/s12035-013-8396-8; Ikeda M, 2011, J BIOL CHEM, V286, P3342, DOI 10.1074/jbc.M110.180968; Koike S, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060861; Liu DZ, 2010, J CEREBR BLOOD F MET, V30, P92, DOI 10.1038/jcbfm.2009.186; Madeira A, 2014, OBESITY, V22, P2010, DOI 10.1002/oby.20792; Musto A, 2015, CELL DEATH DIFFER, V22, P1047, DOI 10.1038/cdd.2014.198; Ng EKO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053141; OHLSSON AL, 1995, STROKE, V26, P644, DOI 10.1161/01.STR.26.4.644; Qureshi AI, 2001, NEW ENGL J MED, V344, P1450, DOI 10.1056/NEJM200105103441907; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; ROSENBERG GA, 1990, STROKE, V21, P801, DOI 10.1161/01.STR.21.5.801; Rump K, 2018, CELL BIOSCI, V8, DOI 10.1186/s13578-018-0211-9; Sabirzhanov B, 2014, J NEUROSCI, V34, P10055, DOI 10.1523/JNEUROSCI.1260-14.2014; Stylli SS, 2017, J NEUROSURG, V126, P1131, DOI 10.3171/2016.1.JNS151454; Sun LQ, 2017, BIOCHEM BIOPH RES CO, V482, P1141, DOI 10.1016/j.bbrc.2016.12.001; Urbich C, 2008, CARDIOVASC RES, V79, P581, DOI 10.1093/cvr/cvn156; Urbich C, 2012, BLOOD, V119, P1607, DOI 10.1182/blood-2011-08-373886; Wang J, 2003, ANN NEUROL, V54, P655, DOI 10.1002/ana.10750; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Xi GH, 2002, NEUROSURG CLIN N AM, V13, P371, DOI 10.1016/S1042-3680(02)00007-4; Xi TY, 2017, BIOCHEM BIOPH RES CO, V494, P144, DOI 10.1016/j.bbrc.2017.10.064; Yakata K, 2011, J STRUCT BIOL, V174, P315, DOI 10.1016/j.jsb.2011.01.003; YANG GY, 1994, J NEUROSURG, V81, P93, DOI 10.3171/jns.1994.81.1.0093; Yang J, 2015, STROKE, V46, P1009, DOI 10.1161/STROKEAHA.114.007154; Young JA, 2013, BLOOD, V122, P2911, DOI 10.1182/blood-2012-12-473017; Zazulia AR, 1999, STROKE, V30, P1167, DOI 10.1161/01.STR.30.6.1167; Zhou SS, 2018, ACTA PHARMACOL SIN, V39, P1073, DOI 10.1038/aps.2018.30; Zhu YP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121608	41	63	66	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					20041	20050		10.1074/jbc.RA118.001858	http://dx.doi.org/10.1074/jbc.RA118.001858			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30337368	hybrid, Green Published			2022-12-28	WOS:000454685900014
J	Roberts, JT; Barb, AW				Roberts, Jacob T.; Barb, Adam W.			A single amino acid distorts the Fc receptor IIIb/CD16b structure upon binding immunoglobulin G1 and reduces affinity relative to CD16a	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						N-linked glycosylation; posttranslational modification (PTM); X-ray crystallography; protein-protein interaction; IgG; molecular dynamics; monoclonal antibody; fragment crystallizable region; immunity	NATURAL-KILLER-CELLS; DEPENDENT CELLULAR CYTOTOXICITY; N-LINKED OLIGOSACCHARIDE; GAMMA-RIIIA; THERAPEUTIC ANTIBODIES; POLYMORPHISM INFLUENCES; IGG; EXPRESSION; FUCOSE; COMPLEX	Therapeutic mAbs engage Fc receptor III (CD16) to elicit a protective cell-mediated response and destroy the target tissue. Newer drugs designed to bind CD16a with increased affinity surprisingly also elicit protective CD16b-mediated responses. However, it is unclear why IgG binds CD16a with more than 10-fold higher affinity than CD16b even though these receptors share more than 97% identity. Here we identified one residue, Gly-129, that contributes to the greater IgG binding affinity of CD16a. The CD16b variant D129G bound IgG1 Fc with 2-fold higher affinity than CD16a and with 90-fold higher affinity than the WT. Conversely, the binding affinity of CD16a-G129D was decreased 128-fold relative to WT CD16a and comparably to that of WT CD16b. The interaction of IgG1 Fc with CD16a, but not with CD16b, is known to be sensitive to the composition of the asparagine-linked carbohydrates (N-glycans) attached to the receptor. CD16a and CD16b-D129G displaying minimally processed oligomannose N-glycans bound to IgG1 Fc with about 5.2-fold increased affinity compared with variants with highly processed complex-type N-glycans. CD16b and the CD16a-G129D variant exhibited a smaller 1.9-fold affinity increase with oligomannose N-glycans. A model of glycosylated CD16b bound to IgG1 Fc determined to 2.2 resolution combined with a 250-ns all-atom molecular dynamics simulation showed that the larger Asp-129 residue deformed the Fc-binding surface. These results reveal how Asp-129 in CD16b affects its binding affinity for IgG1 Fc and suggest that antibodies engineered to engage CD16b with high affinity must accommodate the Asp-129 side chain.	[Roberts, Jacob T.; Barb, Adam W.] Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, 4210 Mol Biol Bldg, Ames, IA 50011 USA	Iowa State University	Barb, AW (corresponding author), Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, 4210 Mol Biol Bldg, Ames, IA 50011 USA.	abarb@iastate.edu		Barb, Adam/0000-0003-3290-8649	NIGMS, National Institutes of Health [R01 GM115489]; Roy J. Carver Department of Biochemistry, Biophysics, and Molecular Biology at Iowa State University; Department of Energy [GUP-48455]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115489] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Roy J. Carver Department of Biochemistry, Biophysics, and Molecular Biology at Iowa State University; Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health under Award R01 GM115489, the Roy J. Carver Department of Biochemistry, Biophysics, and Molecular Biology at Iowa State University, and by the Department of Energy for synchrotron time at the Argonne National Laboratory Advanced Photon Source (GUP-48455). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the Department of Energy.	Barb AW, 2012, BIOCHEMISTRY-US, V51, P4618, DOI 10.1021/bi300319q; Battella S, 2016, J LEUKOCYTE BIOL, V99, P87, DOI 10.1189/jlb.5VMR0415-141R; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; CLARKSON SB, 1988, J EXP MED, V167, P408, DOI 10.1084/jem.167.2.408; Congy-Jolivet N, 2008, CANCER RES, V68, P976, DOI 10.1158/0008-5472.CAN-07-6523; Davoine F, 2002, J ALLERGY CLIN IMMUN, V109, P463, DOI 10.1067/mai.2002.121952; deHaas M, 1996, J IMMUNOL, V156, P2948; Dekkers G, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00877; Edberg JC, 1997, J IMMUNOL, V159, P3849; EDBERG JC, 1990, J IMMUNOL, V144, P4729; Falconer DJ, 2018, ACS CHEM BIOL, V13, P2179, DOI 10.1021/acschembio.8b00342; Ferrara C, 2006, J BIOL CHEM, V281, P5032, DOI 10.1074/jbc.M510171200; Ferrara C, 2011, P NATL ACAD SCI USA, V108, P12669, DOI 10.1073/pnas.1108455108; Golay J, 2013, BLOOD, V122, P3482, DOI 10.1182/blood-2013-05-504043; Guillerey C, 2016, NAT IMMUNOL, V17, P1025, DOI 10.1038/ni.3518; Hayes JM, 2017, MOL CELL PROTEOMICS, V16, P1770, DOI 10.1074/mcp.M117.066944; Hayes JM, 2014, CURR TOP MICROBIOL, V382, P165, DOI 10.1007/978-3-319-07911-0_8; KIMBERLY RP, 1989, J IMMUNOL, V142, P3923; Koene HR, 1997, BLOOD, V90, P1109, DOI 10.1182/blood.V90.3.1109.1109_1109_1114; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Matsumiya S, 2007, J MOL BIOL, V368, P767, DOI 10.1016/j.jmb.2007.02.034; Meknache N, 2009, J IMMUNOL, V182, P2542, DOI 10.4049/jimmunol.0801665; Mellor JD, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-1; Mizushima T, 2011, GENES CELLS, V16, P1071, DOI 10.1111/j.1365-2443.2011.01552.x; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; NAGLER A, 1989, J IMMUNOL, V143, P3183; Natsume A, 2006, J BIOCHEM, V140, P359, DOI 10.1093/jb/mvj157; Niwa R, 2005, CLIN CANCER RES, V11, P2327, DOI 10.1158/1078-0432.CCR-04-2263; Oboshi W, 2016, HUM IMMUNOL, V77, P165, DOI 10.1016/j.humimm.2015.11.001; Okazaki A, 2004, J MOL BIOL, V336, P1239, DOI 10.1016/j.jmb.2004.01.007; Patel KR, 2018, J BIOL CHEM, V293, P3477, DOI 10.1074/jbc.RA117.001207; Radaev S, 2001, J BIOL CHEM, V276, P16469, DOI 10.1074/jbc.M100350200; RAVETCH JV, 1989, J EXP MED, V170, P481, DOI 10.1084/jem.170.2.481; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Reusch D, 2015, GLYCOBIOLOGY, V25, P1325, DOI 10.1093/glycob/cwv065; Robinson JI, 2018, P NATL ACAD SCI USA, V115, pE72, DOI 10.1073/pnas.1707856115; SALMON JE, 1992, J CLIN INVEST, V89, P1274, DOI 10.1172/JCI115712; Shibata-Koyama M, 2009, GLYCOBIOLOGY, V19, P126, DOI 10.1093/glycob/cwn110; Shibata-Koyama M, 2009, EXP HEMATOL, V37, P309, DOI 10.1016/j.exphem.2008.11.006; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Shinkawa T, 2003, J BIOL CHEM, V278, P3466, DOI 10.1074/jbc.M210665200; Sondermann P, 2000, NATURE, V406, P267, DOI 10.1038/35018508; STANLEY P, 1975, P NATL ACAD SCI USA, V72, P3323, DOI 10.1073/pnas.72.9.3323; Subedi GP, 2018, J BIOL CHEM, V293, P16842, DOI 10.1074/jbc.RA118.004998; Subedi GP, 2016, MABS-AUSTIN, V8, P1512, DOI 10.1080/19420862.2016.1218586; Subedi GP, 2014, STRUCTURE, V22, P1478, DOI 10.1016/j.str.2014.08.002; Summers C, 2010, TRENDS IMMUNOL, V31, P318, DOI 10.1016/j.it.2010.05.006; Thomann M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134949; Yagi H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21145-y	49	14	14	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19899	19908		10.1074/jbc.RA118.005273	http://dx.doi.org/10.1074/jbc.RA118.005273			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30361439	Green Published, hybrid			2022-12-28	WOS:000454294900033
J	Zhou, JY; Yang, LY; Ozohanics, O; Zhang, X; Wang, JJ; Ambrus, A; Arjunan, P; Brukh, R; Nemeria, NS; Furey, W; Jordan, F				Zhou, Jieyu; Yang, Luying; Ozohanics, Oliver; Zhang, Xu; Wang, Junjie; Ambrus, Attila; Arjunan, Palaniappa; Brukh, Roman; Nemeria, Natalia S.; Furey, William; Jordan, Frank			A multipronged approach unravels unprecedented protein-protein interactions in the human 2-oxoglutarate dehydrogenase multienzyme complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						tricarboxylic acid cycle (TCA cycle) (Krebs cycle); hydrogen exchange mass spectrometry; isothermal titration calorimetry (ITC); dehydrogenase; mass spectrometry (MS); chemical cross-linking MS; human 2-oxoglutarate dehydrogenase complex; neurodegeneration; oxidative stress; protein complex interaction loci; site-selected fluorescent labeling	ALPHA-KETOGLUTARATE DEHYDROGENASE; DIHYDROLIPOAMIDE SUCCINYLTRANSFERASE COMPONENT; MAMMALIAN PYRUVATE-DEHYDROGENASE; EXCHANGE MASS-SPECTROMETRY; CLEAVABLE CROSS-LINKER; ESCHERICHIA-COLI; 3-DIMENSIONAL STRUCTURE; CRYSTAL-STRUCTURE; BINDING DOMAIN; E1 COMPONENT	The human 2-oxoglutaric acid dehydrogenase complex (hOGDHc) plays a pivotal role in the tricarboxylic acid (TCA) cycle, and its diminished activity is associated with neurodegenerative diseases. The hOGDHc comprises three components, hE1o, hE2o, and hE3, and we recently reported functionally active E1o and E2o components, enabling studies on their assembly. No atomic-resolution structure for the hE2o component is currently available, so here we first studied the interactions in the binary subcomplexes (hE1o-hE2o, hE1o-hE3, and hE2o-hE3) to gain insight into the strength of their interactions and to identify the interaction loci in them. We carried out multiple physico-chemical studies, including fluorescence, hydrogen-deuterium exchange MS (HDX-MS), and chemical cross-linking MS (CL-MS). Our fluorescence studies suggested a strong interaction for the hE1o-hE2o subcomplex, but a much weaker interaction in the hE1o-hE3 subcomplex, and failed to identify any interaction in the hE2o-hE3 subcomplex. The HDX-MS studies gave evidence for interactions in the hE1o-hE2o and hE1o-hE3 subcomplexes comprising full-length components, identifying: (i) the N-terminal region of hE1o, in particular the two peptides (YVEEM22)-Y-18 and (ENPKSVHKSWDIF39)-E-27 as constituting the binding region responsible for the assembly of the hE1o with both the hE2o and hE3 components into hOGDHc, an hE1 region absent in available X-ray structures; and (ii) a novel hE2o region comprising residues from both a linker region and from the catalytic domain as being a critical region interacting with hE1o. The CL-MS identified the loci in the hE1o and hE2o components interacting with each other.	[Zhou, Jieyu; Yang, Luying; Zhang, Xu; Wang, Junjie; Brukh, Roman; Nemeria, Natalia S.; Jordan, Frank] Rutgers State Univ, Dept Chem, Newark, NJ 07102 USA; [Ozohanics, Oliver; Ambrus, Attila] Semmelweis Univ, MTA SE Lab Neurobiochem, Dept Med Biochem, 27-29 Tuzolto Utca, H-1094 Budapest, Hungary; [Arjunan, Palaniappa; Furey, William] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Arjunan, Palaniappa; Furey, William] Vet Affairs Med Ctr, Biocrystallog Lab, Pittsburgh, PA 15240 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Semmelweis University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Nemeria, NS; Jordan, F (corresponding author), Rutgers State Univ, Dept Chem, Newark, NJ 07102 USA.	nemeria@newark.rutgers.edu; frjordan@newark.rutgers.edu	ZHANG, XU/AAL-6729-2020; Ozohanics, Oliver/AAH-4449-2019; Ambrus, Attila/O-4301-2017	Ozohanics, Oliver/0000-0002-2705-9921; Ambrus, Attila/0000-0001-6014-3175; Furey, William/0000-0002-7788-0689	Hungarian Academy of Sciences MTA Grant [02001]; Hungarian Scientific Research Fund OTKA Grant [112230]; Hungarian Brain Research Program Grants [KTIA_13_NAP-A-III/6, 2017-1.2.1-NKP-2017-00002]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM121469] Funding Source: NIH RePORTER	Hungarian Academy of Sciences MTA Grant; Hungarian Scientific Research Fund OTKA Grant(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Brain Research Program Grants; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research at Semmelweis Medical University was supported by the following grants, all awarded to Professor Veronika Adam-Vizi (Dept. of Medical Biochemistry, MTA-SE Laboratory for Neurobiochemistry, Semmelweis University, H-1094 Budapest, Hungary), Hungarian Academy of Sciences MTA Grant 02001, Hungarian Scientific Research Fund OTKA Grant 112230, and Hungarian Brain Research Program Grants KTIA_13_NAP-A-III/6 and 2017-1.2.1-NKP-2017-00002.	Al-Alaway A. I. A., 2013, THESIS; Ambrus A, 2016, BBA-MOL BASIS DIS, V1862, P2098, DOI 10.1016/j.bbadis.2016.08.013; Arjunan P, 2014, J BIOL CHEM, V289, P30161, DOI 10.1074/jbc.M114.592915; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; BEHAL RH, 1994, J BIOL CHEM, V269, P31372; BRADFORD AP, 1987, FEBS LETT, V222, P211, DOI 10.1016/0014-5793(87)80221-1; Brautigam CA, 2011, J BIOL CHEM, V286, P23476, DOI 10.1074/jbc.M110.202960; Byron O, 2017, SUBCELL BIOCHEM, V83, P523, DOI 10.1007/978-3-319-46503-6_19; CAROTHERS DJ, 1989, ARCH BIOCHEM BIOPHYS, V268, P409, DOI 10.1016/0003-9861(89)90309-3; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Chambers MC, 2012, NAT BIOTECHNOL, V30, P918, DOI 10.1038/nbt.2377; Chandrasekhar K, 2013, J BIOL CHEM, V288, P15402, DOI 10.1074/jbc.M113.466789; Chen HL, 2016, J NEUROCHEM, V139, P823, DOI 10.1111/jnc.13836; Frank RAW, 2007, J MOL BIOL, V368, P639, DOI 10.1016/j.jmb.2007.01.080; Gibson GE, 2015, J NEUROCHEM, V134, P86, DOI 10.1111/jnc.13096; Gotze M, 2015, J AM SOC MASS SPECTR, V26, P83, DOI 10.1007/s13361-014-1001-1; Grimm M, 2015, NUCLEIC ACIDS RES, V43, pW362, DOI 10.1093/nar/gkv463; Guevara EL, 2017, SCI REP-UK, V7, DOI 10.1038/srep42760; Hage C, 2017, ANGEW CHEM INT EDIT, V56, P14551, DOI 10.1002/anie.201708273; Hamuro Y, 2008, RAPID COMMUN MASS SP, V22, P1041, DOI 10.1002/rcm.3467; Han MK, 2002, BIOCHEMISTRY-US, V41, P3468, DOI 10.1021/bi015901e; Harris RA, 1997, ADV ENZYME REGUL, V37, P271, DOI 10.1016/S0065-2571(96)00009-X; Hiromasa Y, 2004, J BIOL CHEM, V279, P6921, DOI 10.1074/jbc.M308172200; HUNTER A, 1986, EUR J BIOCHEM, V155, P103, DOI 10.1111/j.1432-1033.1986.tb09464.x; Kan ZY, 2011, J AM SOC MASS SPECTR, V22, P1906, DOI 10.1007/s13361-011-0236-3; Kikuchi G, 2008, P JPN ACAD B-PHYS, V84, P246, DOI 10.2183/pjab/84.246; Knapp JE, 1998, J MOL BIOL, V280, P655, DOI 10.1006/jmbi.1998.1924; Koike K, 2000, EUR J BIOCHEM, V267, P3005, DOI 10.1046/j.1432-1033.2000.01320.x; Li W., 2015, NUCLEIC ACIDS RES, V43, pW58, DOI DOI 10.1093/nar/gkv316; Mande SS, 1996, STRUCTURE, V4, P277, DOI 10.1016/S0969-2126(96)00032-9; Marrott NL, 2014, BIOCHEM J, V463, P405, DOI 10.1042/BJ20140359; MATTEVI A, 1993, J MOL BIOL, V230, P1200, DOI 10.1006/jmbi.1993.1236; McCartney RG, 1998, J BIOL CHEM, V273, P24158, DOI 10.1074/jbc.273.37.24158; Muller MQ, 2010, ANAL CHEM, V82, P6958, DOI 10.1021/ac101241t; Murphy GE, 2005, STRUCTURE, V13, P1765, DOI 10.1016/j.str.2005.08.016; NAKANO K, 1994, EUR J BIOCHEM, V224, P179, DOI 10.1111/j.1432-1033.1994.tb20010.x; Nemeria NS, 2018, BBA-BIOENERGETICS, V1859, P932, DOI 10.1016/j.bbabio.2018.05.001; Nemeria NS, 2014, J BIOL CHEM, V289, P29859, DOI 10.1074/jbc.M114.591073; PACKMAN LC, 1987, BIOCHEM J, V242, P531, DOI 10.1042/bj2420531; PATEL MS, 1990, FASEB J, V4, P3224, DOI 10.1096/fasebj.4.14.2227213; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; Perham RN, 2002, BIOCHEM SOC T, V30, P47, DOI 10.1042/bst0300047; PERHAM RN, 1991, BIOCHEMISTRY-US, V30, P8501, DOI 10.1021/bi00099a001; Quinlan CL, 2014, J BIOL CHEM, V289, P8312, DOI 10.1074/jbc.M113.545301; Reed LJ, 2001, J BIOL CHEM, V276, P38329, DOI 10.1074/jbc.R100026200; REED LJ, 1975, P NATL ACAD SCI USA, V72, P3068, DOI 10.1073/pnas.72.8.3068; REED LJ, 1974, ACCOUNTS CHEM RES, V7, P40, DOI 10.1021/ar50074a002; Ricaud PM, 1996, J MOL BIOL, V264, P179, DOI 10.1006/jmbi.1996.0632; RICE JE, 1992, EMBO J, V11, P3229, DOI 10.1002/j.1460-2075.1992.tb05400.x; ROBIEN MA, 1992, BIOCHEMISTRY-US, V31, P3463, DOI 10.1021/bi00128a021; Sanderson SJ, 1996, BIOCHEM J, V319, P109, DOI 10.1042/bj3190109; SCHULDINER S, 1977, P NATL ACAD SCI USA, V74, P1851, DOI 10.1073/pnas.74.5.1851; Scott MS, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-317; Scott MS, 2010, NUCLEIC ACIDS RES, V38, P7388, DOI 10.1093/nar/gkq653; Smolle M, 2006, J BIOL CHEM, V281, P19772, DOI 10.1074/jbc.M601140200; Tretter L, 2005, PHILOS T R SOC B, V360, P2335, DOI 10.1098/rstb.2005.1764; Vijayakrishnan S, 2010, J MOL BIOL, V399, P71, DOI 10.1016/j.jmb.2010.03.043; WAGENKNECHT T, 1992, J STRUCT BIOL, V109, P70, DOI 10.1016/1047-8477(92)90069-M; WAGENKNECHT T, 1990, J BIOL CHEM, V265, P22402; Wagner T, 2011, CHEM BIOL, V18, P1011, DOI 10.1016/j.chembiol.2011.06.004; Wang J., 2014, THESIS; Wang JJ, 2015, BIOCHEMISTRY-US, V54, P69, DOI 10.1021/bi5013113; Wang JJ, 2014, J BIOL CHEM, V289, P15215, DOI 10.1074/jbc.M113.544080; Wang YG, 2017, NATURE, V552, P273, DOI 10.1038/nature25003; Weis DD, 2006, J AM SOC MASS SPECTR, V17, P1700, DOI 10.1016/j.jasms.2006.07.025; YEAMAN SJ, 1986, TRENDS BIOCHEM SCI, V11, P293, DOI 10.1016/0968-0004(86)90033-2	66	13	13	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2018	293	50					19213	19227		10.1074/jbc.RA118.005432	http://dx.doi.org/10.1074/jbc.RA118.005432			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HE6RA	30323066	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000453537300006
J	Razidlo, GL; Johnson, HJ; Stoeger, SM; Cowan, KH; Bessho, T; Lewis, RE				Razidlo, Gina L.; Johnson, Heidi J.; Stoeger, Scott M.; Cowan, Kenneth H.; Bessho, Tadayoshi; Lewis, Robert E.			KSR1 is required for cell cycle reinitiation following DNA damage (vol 284, pg 6705, 2009)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Razidlo GL, 2009, J BIOL CHEM, V284, P6705, DOI 10.1074/jbc.M806457200	1	0	0	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2018	293	49					19136	19136		10.1074/jbc.AAC118.006696	http://dx.doi.org/10.1074/jbc.AAC118.006696			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NY	30530853	hybrid, Green Published			2022-12-28	WOS:000458467400025
J	Sherp, AM; Lee, SG; Schraft, E; Jez, JM				Sherp, Ashley M.; Lee, Soon Goo; Schraft, Evelyn; Jez, Joseph M.			Modification of auxinic phenoxyalkanoic acid herbicides by the acyl acid amido synthetase GH3.15 from Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arabidopsis; X-ray crystallography; enzyme kinetics; auxin; protein structure; 2; 4-D; acyl acid amido synthetase; Gretchen Hagen 3; herbicide tolerance; herbicides; Arabidopsis thaliana; structure-activity relationship	BOX PROTEIN TIR1; INDOLE-3-BUTYRIC ACID; PLANT HORMONES; ENZYME ACTION; FAMILY; RESISTANCE; BIOSYNTHESIS; MECHANISM; REVEALS; PATHWAY	Herbicide-resistance traits are the most widely used agriculture biotechnology products. Yet, to maintain their effectiveness and to mitigate selection of herbicide-resistant weeds, the discovery of new resistance traits that use different chemical modes of action is essential. In plants, the Gretchen Hagen 3 (GH3) acyl acid amido synthetases catalyze the conjugation of amino acids to jasmonate and auxin phytohormones. This reaction chemistry has not been explored as a possible approach for herbicide modification and inactivation. Here, we examined a set of Arabidopsis GH3 proteins that use the auxins indole-3-acetic acid (IAA) and indole-3-butyric acid (IBA) as substrates along with the corresponding auxinic phenoxyalkanoic acid herbicides 2,4-dichlorophenoxylacetic acid (2,4-D) and 4-(2,4-dichlorophenoxy)butyric acid (2,4-DB). The IBA-specific AtGH3.15 protein displayed high catalytic activity with 2,4-DB, which was comparable to its activity with IBA. Screening of phenoxyalkanoic and phenylalkyl acids indicated that side-chain length of alkanoic and alkyl acids is a key feature of AtGH3.15's substrate preference. The X-ray crystal structure of the AtGH3.152,4-DB complex revealed how the herbicide binds in the active site. In root elongation assays, Arabidopsis AtGH3.15-knockout and -overexpression lines grown in the presence of 2,4-DB exhibited hypersensitivity and tolerance, respectively, indicating that the AtGH3.15-catalyzed modification inactivates 2,4-DB. These findings suggest a potential use for AtGH3.15, and perhaps other GH3 proteins, as herbicide-modifying enzymes that employ a mode of action different from those of currently available herbicide-resistance traits.	[Sherp, Ashley M.; Lee, Soon Goo; Schraft, Evelyn; Jez, Joseph M.] Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA	Washington University (WUSTL)	Jez, JM (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	jjez@wustl.edu		Lee, Soon Goo/0000-0002-1541-8587	National Science Foundation [DBI-1427621]; Department of Energy Office of Biological and Environmental Research [DE-AC02-06CH11357]	National Science Foundation(National Science Foundation (NSF)); Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE))	The MS measurement was performed at the Proteomics & Mass Spectrometry Facility at the Donald Danforth Plant Science Center based upon work supported by grants from the National Science Foundation (DBI-1427621) for acquisition of the QTRAP 6500 LC-MS/MS. Portions of this research were carried out at the Argonne National Laboratory Structural Biology Center of the Advanced Photon Source, a national user facility operated by the University of Chicago for the Department of Energy Office of Biological and Environmental Research under Grant DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Behrens MR, 2007, SCIENCE, V316, P1185, DOI 10.1126/science.1141596; Castle LA, 2004, SCIENCE, V304, P1151, DOI 10.1126/science.1096770; CHALEFF RS, 1984, SCIENCE, V224, P1443, DOI 10.1126/science.224.4656.1443; Charles JM, 2000, MUTAT RES-GEN TOX EN, V472, P75, DOI 10.1016/S1383-5718(00)00130-3; Chen QF, 2010, J BIOL CHEM, V285, P29780, DOI 10.1074/jbc.M110.146431; Detzel C, 2013, APPL MICROBIOL BIOT, V97, P4887, DOI 10.1007/s00253-012-4401-9; DHALLUIN K, 1992, METHOD ENZYMOL, V216, P415; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enders TA, 2015, AM J BOT, V102, P180, DOI 10.3732/ajb.1400285; Eyer L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159269; Grossmann K, 2010, PEST MANAG SCI, V66, P113, DOI 10.1002/ps.1860; Harrison DHT, 1997, BIOCHEMISTRY-US, V36, P16134, DOI 10.1021/bi9717136; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Korasick DA, 2015, CURR OPIN PLANT BIOL, V27, P22, DOI 10.1016/j.pbi.2015.05.007; Korasick DA, 2013, J EXP BOT, V64, P2541, DOI 10.1093/jxb/ert080; LeClere S, 2002, J BIOL CHEM, V277, P20446, DOI 10.1074/jbc.M111955200; McErlich A.F., 2014, AUTOMATION FUTURE WE, P11, DOI [10.1007/978-94-007-7512-1_2, DOI 10.1007/978-94-007-7512-1_2]; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Peterson MA, 2016, WEED TECHNOL, V30, P303, DOI 10.1614/WT-D-15-00131.1; Rao V. S., 1940, PRINCIPLES WEED SCI, P199; Rippert P, 2004, PLANT PHYSIOL, V134, P92, DOI 10.1104/pp.103.032441; Salehin M, 2015, PLANT CELL, V27, P9, DOI 10.1105/tpc.114.133744; Service RF, 2007, SCIENCE, V316, P1114, DOI 10.1126/science.316.5828.1114; Shaner DL, 2000, PEST MANAG SCI, V56, P320, DOI 10.1002/(SICI)1526-4998(200004)56:4<320::AID-PS125>3.3.CO;2-2; Sherp AM, 2018, J BIOL CHEM, V293, P4277, DOI 10.1074/jbc.RA118.002006; Song YL, 2014, J INTEGR PLANT BIOL, V56, P106, DOI 10.1111/jipb.12131; Staswick PE, 2005, PLANT CELL, V17, P616, DOI 10.1105/tpc.104.026690; Staswick PE, 2002, PLANT CELL, V14, P1405, DOI 10.1105/tpc.000885; Steiner HY, 2013, PLANT PHYSIOL, V161, P1587, DOI 10.1104/pp.112.209817; Sterling T, 1997, HERBICIDE ACTIVITY T, V1, P111; Strader Lucia C, 2010, Plant Physiol, V153, P1577, DOI 10.1104/pp.110.157461; Tan S, 2006, AMINO ACIDS, V30, P195, DOI 10.1007/s00726-005-0254-1; Terol J, 2006, GENE, V371, P279, DOI 10.1016/j.gene.2005.12.014; United States Environmental Protection Agency, 2005, EPA738F05002; United States Environmental Protection Agency, 2005, EPA738F05001; Westfall CS, 2016, P NATL ACAD SCI USA, V113, P13917, DOI 10.1073/pnas.1612635113; Westfall CS, 2013, J BIOL CHEM, V288, P19304, DOI 10.1074/jbc.R113.475160; Westfall CS, 2012, SCIENCE, V336, P1708, DOI 10.1126/science.1221863; Westfall CS, 2010, PLANT SIGNAL BEHAV, V5, P1607, DOI 10.4161/psb.5.12.13941; Wright TR, 2010, P NATL ACAD SCI USA, V107, P20240, DOI 10.1073/pnas.1013154107; Zolman BK, 2000, GENETICS, V156, P1323	43	6	8	4	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2018	293	46					17731	17738		10.1074/jbc.RA118.004975	http://dx.doi.org/10.1074/jbc.RA118.004975			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HA6SG	30315112	Green Published, hybrid			2022-12-28	WOS:000450409500006
J	Mehta, K; Chacko, LA; Chug, MK; Jhunjhunwala, S; Ananthanarayanan, V				Mehta, Kritika; Chacko, Leeba Ann; Chug, Manjyot Kaur; Jhunjhunwala, Siddharth; Ananthanarayanan, Vaishnavi			Association of mitochondria with microtubules inhibits mitochondrial fission by precluding assembly of the fission protein Dnm1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitochondria; microtubule; in vivo imaging; Schizosaccharomyces pombe; cell biology; cytoskeleton; molecular motor; mitosis; Dnm1; mitochondrial dynamics	DYNAMIN-RELATED PROTEIN; AXONAL-TRANSPORT; CELL-DIVISION; FUSION; YEAST; GTPASE; DRP1; KINESIN; PHOSPHORYLATION; ORGANIZATION	Mitochondria are organized as tubular networks in the cell and undergo fission and fusion. Although several of the molecular players involved in mediating mitochondrial dynamics have been identified, the precise cellular cues that initiate mitochondrial fission or fusion remain largely unknown. In fission yeast (Schizosaccharomyces pombe), mitochondria are organized along microtubule bundles. Here, we employed deletions of kinesin-like proteins to perturb microtubule dynamics and used high-resolution and time-lapse fluorescence microscopy, revealing that mitochondrial lengths mimic microtubule lengths. Furthermore, we determined that compared with WT cells, mutant cells with long microtubules exhibit fewer mitochondria, and mutant cells with short microtubules have an increased number of mitochondria because of reduced mitochondrial fission in the former and elevated fission in the latter. Correspondingly, upon onset of closed mitosis in fission yeast, wherein interphase microtubules assemble to form the spindle within the nucleus, we observed increased mitochondrial fission. We found that the consequent rise in the mitochondrial copy number is necessary to reduce partitioning errors during independent segregation of mitochondria between daughter cells. We also discovered that the association of mitochondria with microtubules physically impedes the assembly of the fission protein Dnm1 around mitochondria, resulting in inhibition of mitochondrial fission. Taken together, we demonstrate a mechanism for the regulation of mitochondrial fission that is dictated by the interaction between mitochondria and the microtubule cytoskeleton.	[Mehta, Kritika; Chacko, Leeba Ann; Chug, Manjyot Kaur; Jhunjhunwala, Siddharth; Ananthanarayanan, Vaishnavi] Indian Inst Sci, Ctr Biosyst Sci & Engn, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Ananthanarayanan, V (corresponding author), Indian Inst Sci, Ctr Biosyst Sci & Engn, Bangalore 560012, Karnataka, India.	vaishnavi@iisc.ac.in	Chug, Manjyot Kaur/AFQ-2443-2022; Ananthanarayanan, Vaishnavi/AAJ-7170-2020; Jhunjhunwala, Siddharth/K-1526-2013	Ananthanarayanan, Vaishnavi/0000-0003-2936-7853; Jhunjhunwala, Siddharth/0000-0001-8046-2288; Chacko, Leeba Ann/0000-0001-5636-504X; Mehta, Kritika/0000-0002-4312-9950	Department of Science and Technology (India)-Innovation of Science Pursuit for Inspired Research (INSPIRE) Faculty Award; Department of Biotechnology (India) Innovative Young Biotechnologist Award; Science and Engineering Research Board (SERB; India) Early Career Research Award; SERB Early Career Research Award	Department of Science and Technology (India)-Innovation of Science Pursuit for Inspired Research (INSPIRE) Faculty Award(Department of Science & Technology (India)); Department of Biotechnology (India) Innovative Young Biotechnologist Award; Science and Engineering Research Board (SERB; India) Early Career Research Award; SERB Early Career Research Award(Department of Science & Technology (India)Science Engineering Research Board (SERB), India)	This work was supported by the Department of Science and Technology (India)-Innovation of Science Pursuit for Inspired Research (INSPIRE) Faculty Award, the Department of Biotechnology (India) Innovative Young Biotechnologist Award, and the Science and Engineering Research Board (SERB; India) Early Career Research Award (to V. A.) and by the SERB Early Career Research Award (to S. J.). The authors declare that they have no conflicts of interest with the contents of this article.	Ashrafian H, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001000; Basu K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179397; Bergeland T, 2001, CURR BIOL, V11, P644, DOI 10.1016/S0960-9822(01)00177-4; BIRKY CW, 1983, INT REV CYTOL, P49; Bleazard W, 1999, NAT CELL BIOL, V1, P298, DOI 10.1038/13014; Brazer SCW, 2000, YEAST, V16, P149, DOI 10.1002/(SICI)1097-0061(20000130)16:2<149::AID-YEA514>3.0.CO;2-C; Browning H, 2000, J CELL BIOL, V151, P15, DOI 10.1083/jcb.151.1.15; Busch KE, 2004, DEV CELL, V6, P831, DOI 10.1016/j.devcel.2004.05.008; Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Chen YM, 2013, J CELL BIOL, V202, P351, DOI 10.1083/jcb.201302040; Chiron S, 2008, J CELL BIOL, V182, P41, DOI 10.1083/jcb.200712147; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Ding R, 1997, MOL BIOL CELL, V8, P1461, DOI 10.1091/mbc.8.8.1461; Eura Y, 2003, J BIOCHEM, V134, P333, DOI 10.1093/jb/mvg150; Fehrenbacher KL, 2004, CURR BIOL, V14, P1996, DOI 10.1016/j.cub.2004.11.004; Ferreira-da-Silva A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122308; Forsburg SL, 2006, YEAST, V23, P173, DOI 10.1002/yea.1347; Fu CH, 2011, CURR BIOL, V21, P1431, DOI 10.1016/j.cub.2011.07.013; Glater EE, 2006, J CELL BIOL, V173, P545, DOI 10.1083/jcb.200601067; Graves JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037699; Guillou E, 2005, FEBS LETT, V579, P1109, DOI 10.1016/j.febslet.2004.12.083; Han XJ, 2008, J CELL BIOL, V182, P573, DOI 10.1083/jcb.200802164; HENNIS AS, 1984, J CELL SCI, V70, P1; Hermann GJ, 1998, J CELL BIOL, V143, P359, DOI 10.1083/jcb.143.2.359; Hirai K, 2001, J NEUROSCI, V21, P3017, DOI 10.1523/JNEUROSCI.21-09-03017.2001; Hoog JL, 2007, DEV CELL, V12, P349, DOI 10.1016/j.devcel.2007.01.020; Huh D, 2011, P NATL ACAD SCI USA, V108, P15004, DOI 10.1073/pnas.1013171108; Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078; Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907; Itoh K, 2013, TRENDS CELL BIOL, V23, P64, DOI 10.1016/j.tcb.2012.10.006; Jajoo R, 2016, SCIENCE, V351, P169, DOI 10.1126/science.aaa8714; Jourdain I, 2009, CELL MOTIL CYTOSKEL, V66, P509, DOI 10.1002/cm.20351; Kang JS, 2008, CELL, V132, P137, DOI 10.1016/j.cell.2007.11.024; KANTERSMOLER G, 1994, BIOTECHNIQUES, V16, P798; Kruger N, 2008, CURR BIOL, V18, pR646, DOI 10.1016/j.cub.2008.06.069; Lawrence Elizabeth, 2013, Commun Integr Biol, V6, pe27557, DOI 10.4161/cib.27557; Li TP, 2015, SCI REP-UK, V5, DOI 10.1038/srep11023; Liu XG, 2009, EMBO J, V28, P3074, DOI 10.1038/emboj.2009.255; Mears JA, 2011, NAT STRUCT MOL BIOL, V18, P20, DOI 10.1038/nsmb.1949; Mishra P, 2016, J CELL BIOL, V212, P379, DOI 10.1083/jcb.201511036; Mishra P, 2014, NAT REV MOL CELL BIO, V15, P634, DOI 10.1038/nrm3877; Mitra K, 2009, P NATL ACAD SCI USA, V106, P11960, DOI 10.1073/pnas.0904875106; Pilling AD, 2006, MOL BIOL CELL, V17, P2057, DOI 10.1091/mbc.E05-06-0526; Pletjushkina OY, 2006, BBA-BIOENERGETICS, V1757, P518, DOI 10.1016/j.bbabio.2006.03.018; Sesaki H, 2003, MOL BIOL CELL, V14, P2342, DOI 10.1091/mbc.E02-12-0788; Shima DT, 1998, J CELL BIOL, V141, P955, DOI 10.1083/jcb.141.4.955; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Stowers RS, 2002, NEURON, V36, P1063, DOI 10.1016/S0896-6273(02)01094-2; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Tischer C, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.5; van Spronsen M, 2013, NEURON, V77, P485, DOI 10.1016/j.neuron.2012.11.027; Varadi A, 2004, J CELL SCI, V117, P4389, DOI 10.1242/jcs.01299; West RR, 2001, MOL BIOL CELL, V12, P3919, DOI 10.1091/mbc.12.12.3919; Yaffe MP, 2003, P NATL ACAD SCI USA, V100, P11424, DOI 10.1073/pnas.1534703100	56	26	26	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3385	3396		10.1074/jbc.RA118.006799	http://dx.doi.org/10.1074/jbc.RA118.006799			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30602572	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000461853900007
J	Darrah, K; Wang, T; Cook, I; Cacace, M; Deiters, A; Leyh, TS				Darrah, Kristie; Wang, Ting; Cook, Ian; Cacace, Mary; Deiters, Alexander; Leyh, Thomas S.			Allosteres to regulate neurotransmitter sulfonation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						sulfotransferase; allosteric regulation; enzyme inhibitor; enzyme structure; neurotransmitter; catecholamine; dopamine; nuclear magnetic resonance (NMR); enzyme mechanism; enzyme kinetics; epinephrine; norepinephrine; serotonin; spin label; allostery; mechanism; inhibition	NUCLEAR-MAGNETIC-RESONANCE; MOLECULAR-DYNAMICS; MENTAL-DISORDERS; SULFOTRANSFERASE; DOPAMINE; PARALLEL; GROMACS; SITE; NMR; GOVERNS	Catecholamine neurotransmitter levels in the synapses of the brain shape human disposition-cognitive flexibility, aggression, depression, and reward seeking-and manipulating these levels is a major objective of the pharmaceutical industry. Certain neurotransmitters are extensively sulfonated and inactivated by human sulfotransferase 1A3 (SULT1A3). To our knowledge, sulfonation as a therapeutic means of regulating transmitter activity has not been explored. Here, we describe the discovery of a SULT1A3 allosteric site that can be used to inhibit the enzyme. The structure of the new site is determined using spin-label-triangulation NMR. The site forms a cleft at the edge of a conserved similar to 30-residue active-site cap that must open and close during the catalytic cycle. Allosteres anchor into the site via pi-stacking interactions with two residues that sandwich the planar core of the allostere and inhibit the enzyme through cap-stabilizing interactions with substituents attached to the core. Changes in cap free energy were calculated ab initio as a function of core substituents and used to design and synthesize a series of inhibitors intended to progressively stabilize the cap and slow turnover. The inhibitors bound tightly (34 nm to 7.4 mu m) and exhibited progressive inhibition. The cap-stabilizing effects of the inhibitors were experimentally determined and agreed remarkably well with the theoretical predictions. These studies establish a reliable heuristic for the design of SULT1A3 allosteric inhibitors and demonstrate that the free-energy changes of a small, dynamic loop that is critical for SULT substrate selection and turnover can be calculated accurately.	[Darrah, Kristie; Cacace, Mary; Deiters, Alexander] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA; [Wang, Ting; Cook, Ian; Leyh, Thomas S.] Albert Einstein Coll Med, Dept Microbiol & Immunol, 1300 Morris Pk Ave, Bronx, NY 10461 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Yeshiva University; Albert Einstein College of Medicine	Leyh, TS (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	tom.leyh@einstein.yu.edu	Deiters, Alexander/L-3722-2013	Deiters, Alexander/0000-0003-0234-9209	National Institutes of Health [GM112728, GM121849, GM127144]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM127144, R01GM121849, R01GM112728] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM112728 (to A. D.) and GM121849 and GM127144 (to T. S. L.). A provisional patent covering the compounds described in this paper has been submitted. All authors listed are co-inventors on the patent. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Baker J, 2009, J COMPUT CHEM, V30, P317, DOI 10.1002/jcc.21052; Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Berton O, 2006, NAT REV NEUROSCI, V7, P137, DOI 10.1038/nrn1846; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Case DA, 2014, AMBER 14; Castanar L, 2015, ANNU REP NMR SPECTRO, V84, P163; Chesney E, 2014, WORLD PSYCHIATRY, V13, P153, DOI 10.1002/wps.20128; Cook I, 2017, P NATL ACAD SCI USA, V114, pE5317, DOI 10.1073/pnas.1704500114; Cook I, 2016, P NATL ACAD SCI USA, V113, P14312, DOI 10.1073/pnas.1613913113; Cook I, 2016, CELL CHEM BIOL, V23, P579, DOI 10.1016/j.chembiol.2016.04.009; Cook I, 2015, DRUG METAB DISPOS, V43, P418, DOI 10.1124/dmd.114.061887; Cook I, 2013, J BIOL CHEM, V288, P34494, DOI 10.1074/jbc.M113.510974; Cook I, 2013, J BIOL CHEM, V288, P8619, DOI 10.1074/jbc.M112.445015; Cook I, 2013, BIOCHEMISTRY-US, V52, P415, DOI 10.1021/bi301492j; Cook I, 2012, BIOCHEMISTRY-US, V51, P5674, DOI 10.1021/bi300631g; Dajani R, 1998, MOL PHARMACOL, V54, P942, DOI 10.1124/mol.54.6.942; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; GIRVIN ME, 1995, BIOCHEMISTRY-US, V34, P1635, DOI 10.1021/bi00005a020; Gochin M, 2011, ACS CHEM BIOL, V6, P267, DOI 10.1021/cb100368d; Goldstein DS, 1999, J CLIN ENDOCR METAB, V84, P2523, DOI 10.1210/jc.84.7.2523; HEROUX JA, 1988, MOL PHARMACOL, V34, P194; Hildebrandt HAT, 2004, BIOCHEM BIOPH RES CO, V321, P870, DOI 10.1016/j.bbrc.2004.07.038; LECORRE P, 1993, CRIT CARE MED, V21, P1652; Lu JH, 2005, BIOCHEM BIOPH RES CO, V335, P417, DOI 10.1016/j.bbrc.2005.07.091; Merikangas KR, 2010, J AM ACAD CHILD PSY, V49, P980, DOI 10.1016/j.jaac.2010.05.017; Olgiati P, 2018, J AFFECT DISORDERS, V227, P777, DOI 10.1016/j.jad.2017.11.004; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Riches Z, 2009, DRUG METAB DISPOS, V37, P2255, DOI 10.1124/dmd.109.028399; Salman ED, 2009, DRUG METAB DISPOS, V37, P706, DOI 10.1124/dmd.108.025767; SCHMITZ U, 1993, J MOL BIOL, V234, P373, DOI 10.1006/jmbi.1993.1593; SOLOMON I, 1955, PHYS REV, V99, P559, DOI 10.1103/PhysRev.99.559; Souery D, 1999, EUR NEUROPSYCHOPHARM, V9, P83, DOI 10.1016/S0924-977X(98)00004-2; Strott CA, 2002, ENDOCR REV, V23, P703, DOI 10.1210/er.2001-0040; Sun MH, 2010, BIOCHEMISTRY-US, V49, P4779, DOI 10.1021/bi902190r; Suominen T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068007; Tang QX, 2010, J PHYS CHEM B, V114, P16131, DOI 10.1021/jp1055528; Thomas SJ, 2015, PHARMACOTHERAPY, V35, P433, DOI 10.1002/phar.1576; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang B, 2006, J CHEM THEORY COMPUT, V2, P209, DOI 10.1021/ct050212s; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang T, 2016, DRUG METAB DISPOS, V44, P616, DOI 10.1124/dmd.115.068205err; Wang T, 2017, J BIOL CHEM, V292, P20305, DOI 10.1074/jbc.M117.817387; Wang T, 2016, BIOCHEMISTRY-US, V55, P4036, DOI 10.1021/acs.biochem.6b00401; Wang T, 2014, BIOCHEMISTRY-US, V53, P6893, DOI 10.1021/bi501120p; Wang T, 2014, J BIOL CHEM, V289, P26474, DOI 10.1074/jbc.M114.573501; Whiteley CG, 1999, BIOCHEM EDUC, V27, P15, DOI 10.1016/S0307-4412(98)00265-9; YAMAMOTO T, 1985, J CHROMATOGR, V342, P261, DOI 10.1016/S0378-4347(00)84516-8	49	7	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2019	294	7					2293	2301		10.1074/jbc.RA118.006511	http://dx.doi.org/10.1074/jbc.RA118.006511			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL7CN	30545938	hybrid, Green Published			2022-12-28	WOS:000458895400008
J	Konarzewska, P; Wang, YN; Han, GS; Goh, KJ; Gao, YG; Carman, GM; Xue, CY				Konarzewska, Paulina; Wang, Yina; Han, Gil-Soo; Goh, Kwok Jian; Gao, Yong-Gui; Carman, George M.; Xue, Chaoyang			Phosphatidylserine synthesis is essential for viability of the human fungal pathogen Cryptococcus neoformans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphatidylserine; phospholipid metabolism; inositol phospholipid; fungi; microbial pathogenesis; antifungal drug; Cryptococcus neoformans; mitochondria; phosphatidylserine synthase; reactive oxygen species; virulence	SACCHAROMYCES-CEREVISIAE; PHOSPHOLIPID-SYNTHESIS; GLOBAL BURDEN; YEAST; SYNTHASE; MITOCHONDRIAL; GENE; IDENTIFICATION; MENINGITIS; RESISTANCE	Phospholipids are an integral part of the cellular membrane structure and can be produced by a de novo biosynthetic pathway and, alternatively, by the Kennedy pathway. Studies in several yeast species have shown that the phospholipid phosphatidylserine (PS) is synthesized from CDP-diacylglycerol and serine, a route that is different from its synthesis in mammalian cells, involving a base-exchange reaction from preexisting phospholipids. Fungal-specific PS synthesis has been shown to play an important role in fungal virulence and has been proposed as an attractive drug target. However, PS synthase, which catalyzes this reaction, has not been studied in the human fungal pathogen Cryptococcus neoformans. Here, we identified and characterized the PS synthase homolog (Cn Cho1) in this fungus. Heterologous expression of Cn CHO1 in a Saccharomyces cerevisiae cho1 Delta mutant rescued the mutant's growth defect in the absence of ethanolamine supplementation. Moreover, an Sc cho1 Delta mutant expressing Cn CHO1 had PS synthase activity, confirming that the Cn CHO1 encodes PS synthase. We also found that PS synthase in C. neoformans is localized to the endoplasmic reticulum and that it is essential for mitochondrial function and cell viability. Of note, its deficiency could not be complemented by ethanolamine or choline supplementation for the synthesis of phosphatidylethanolamine (PE) or phosphatidylcholine (PC) via the Kennedy pathway. These findings improve our understanding of phospholipid synthesis in a pathogenic fungus and indicate that PS synthase may be a useful target for antifungal drugs.	[Konarzewska, Paulina; Wang, Yina; Xue, Chaoyang] Rutgers State Univ, New Jersey Med Sch, Publ Hlth Res Inst, Newark, NJ 07103 USA; [Xue, Chaoyang] Rutgers State Univ, New Jersey Med Sch, Dept Microbiol Biochem & Mol Genet, Newark, NJ 07103 USA; [Han, Gil-Soo; Carman, George M.; Xue, Chaoyang] Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA; [Han, Gil-Soo; Carman, George M.] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08901 USA; [Goh, Kwok Jian; Gao, Yong-Gui] Nanyang Technol Univ, Sch Biol Sci, Singapore 117597, Singapore	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Xue, CY (corresponding author), Rutgers State Univ, Publ Hlth Res Inst, ICPH Bldg,Rm W250H,225 Warren St, Newark, NJ 07103 USA.	xuech@njms.rutgers.edu	Wang, Yina/N-8534-2017; Gao, Yong Gui/A-2187-2011; Gao, Yonggui/A-9473-2015	Wang, Yina/0000-0003-1909-728X; Gao, Yonggui/0000-0001-7298-0835; Goh, Kwok Jian/0000-0002-9825-8071; Carman, George/0000-0003-4951-8233	National Institutes of Health [R01AI123315, R37GM028140]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI123315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028140] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants R01AI123315 (to C. X.) and R37GM028140 (to G. M. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ATKINSON K, 1980, J BIOL CHEM, V255, P6653; ATKINSON KD, 1980, J BACTERIOL, V141, P558, DOI 10.1128/JB.141.2.558-564.1980; BAELEE MS, 1984, J BIOL CHEM, V259, P857; Birge RB, 2016, CELL DEATH DIFFER, V23, P962, DOI 10.1038/cdd.2016.11; CARMAN GM, 1992, METHOD ENZYMOL, V209, P298; Carman GM, 2004, BIOCHEM CELL BIOL, V82, P62, DOI 10.1139/o03-064; Cassilly CD, 2018, J FUNGI, V4, DOI 10.3390/jof4010028; Chen YL, 2010, MOL MICROBIOL, V75, P1112, DOI 10.1111/j.1365-2958.2009.07018.x; Choi HS, 2010, J BIOL CHEM, V285, P11526, DOI 10.1074/jbc.M110.100727; COUSMINER JJ, 1981, CAN J MICROBIOL, V27, P544, DOI 10.1139/m81-080; Davidson RC, 2000, FUNGAL GENET BIOL, V29, P38, DOI 10.1006/fgbi.1999.1180; Davidson RC, 2002, MICROBIOL-SGM, V148, P2607, DOI 10.1099/00221287-148-8-2607; Davis SE, 2018, INFECT IMMUN, V86, DOI [10.1128/IAI.00815-17, 10.1128/iai.00815-17]; Ding C, 2013, CELL HOST MICROBE, V13, P265, DOI 10.1016/j.chom.2013.02.002; Farine L, 2015, SCI REP-UK, V5, DOI 10.1038/srep16787; Fraser JA, 2003, EUKARYOT CELL, V2, P1036, DOI 10.1128/EC.2.5.1036-1045.2003; Grant CM, 1997, FEBS LETT, V410, P219, DOI 10.1016/S0014-5793(97)00592-9; Harashima T, 2002, MOL CELL, V10, P163, DOI 10.1016/S1097-2765(02)00569-5; Heitman J, 2011, CRYPTOCOCCUS: FROM HUMAN PATHOGEN TO MODEL YEAST, P1; Hu G, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12718; Huang W, 2016, MBIO, V7, DOI 10.1128/mBio.00478-16; Idnurm A, 2010, GENETICS, V185, P153, DOI 10.1534/genetics.109.113027; Ingavale SS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000155; Kay JG, 2012, MOL BIOL CELL, V23, P2198, DOI 10.1091/mbc.E11-11-0936; KELLEY MJ, 1988, J BIOL CHEM, V263, P18078; KOHLWEIN SD, 1988, J BACTERIOL, V170, P3778, DOI 10.1128/jb.170.8.3778-3781.1988; LETTS VA, 1983, P NATL ACAD SCI-BIOL, V80, P7279, DOI 10.1073/pnas.80.23.7279; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Liu TB, 2014, INFECT IMMUN, V82, P557, DOI 10.1128/IAI.00994-13; NEWTON AC, 1994, BIOCHEMISTRY-US, V33, P6651, DOI 10.1021/bi00187a035; Ory JJ, 2004, YEAST, V21, P919, DOI 10.1002/yea.1139; Panatala R, 2015, J CELL SCI, V128, P2021, DOI 10.1242/jcs.102715; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; PERFECT JR, 1993, J MED VET MYCOL, V31, P175; Rajasingham R, 2017, LANCET INFECT DIS, V17, P873, DOI [10.1016/S1473-3099(17)30243-8, 10.1016/s1473-3099(17)30243-8]; Saag MS, 2000, CLIN INFECT DIS, V30, P710, DOI 10.1086/313757; Segawa K, 2015, TRENDS CELL BIOL, V25, P639, DOI 10.1016/j.tcb.2015.08.003; Shor E, 2016, MICROB CELL, V3, P358, DOI 10.15698/mic2016.08.521; SIMBENI R, 1991, J BIOL CHEM, V266, P10047; Siniossoglou S, 1998, EMBO J, V17, P6449, DOI 10.1093/emboj/17.22.6449; Vance JE, 2015, TRAFFIC, V16, P1, DOI 10.1111/tra.12230; WALLIS JW, 1989, CELL, V58, P409, DOI 10.1016/0092-8674(89)90855-6; Wu Y, 2006, TRENDS CELL BIOL, V16, P189, DOI 10.1016/j.tcb.2006.02.003; Xue CY, 2010, MBIO, V1, DOI 10.1128/mBio.00084-10	44	9	10	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2019	294	7					2329	2339		10.1074/jbc.RA118.006738	http://dx.doi.org/10.1074/jbc.RA118.006738			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL7CN	30602568	Green Published, hybrid			2022-12-28	WOS:000458895400011
J	Sabrin, A; Gioe, BW; Gupta, A; Grove, A				Sabrin, Afsana; Gioe, Brennan W.; Gupta, Ashish; Grove, Anne			An EmrB multidrug efflux pump in Burkholderia thailandensis with unexpected roles in antibiotic resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibiotic; reactive oxygen species (ROS); transcription factor; gene regulation; multidrug transporter; oxidative stress; bacterial virulence; efflux pump; EmrB; MarR; multidrug resistance	SECONDARY STRUCTURE ANALYSES; DNA-BINDING; IDENTIFICATION; PSEUDOMALLEI; MECHANISMS; EXPRESSION	The antibiotic trimethoprim is frequently used to manage Burkholderia infections, and members of the resistance-nodulation-division (RND) family of efflux pumps have been implicated in multidrug resistance of this species complex. We show here that a member of the distinct Escherichia coli multidrug resistance B (EmrB) family is a primary exporter of trimethoprim in Burkholderia thailandensis, as evidenced by increased trimethoprim sensitivity after inactivation of emrB, the gene that encodes EmrB. We also found that the emrB gene is up-regulated following the addition of gentamicin and that this up-regulation is due to repression of the gene encoding OstR, a member of the multiple antibiotic resistance regulator (MarR) family. The addition of the oxidants H2O2 and CuCl2 to B. thailandensis cultures resulted in OstR-dependent differential emrB expression, as determined by qRT-PCR analysis. Specifically, OstR functions as a rheostat that optimizes emrB expression under oxidizing conditions, and it senses oxidants by a unique mechanism involving two vicinal cysteines and one distant cysteine (Cys(3), Cys(4), and Cys(169)) per monomer. Paradoxically, emrB inactivation increased resistance of B. thailandensis to tetracycline, a phenomenon that correlated with up-regulation of an RND efflux pump. These observations highlight the intricate mechanisms by which expression of genes that encode efflux pumps is optimized depending on cellular concentrations of antibiotics and oxidants.	[Sabrin, Afsana; Gioe, Brennan W.; Gupta, Ashish; Grove, Anne] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Gupta, Ashish] Novavax Inc, Proc Dev Dept, Gaithersburg, MD 20878 USA	Louisiana State University System; Louisiana State University	Grove, A (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	agrove@lsu.edu	Grove, Anne/O-5998-2015; Sabrin, Afsana/S-5527-2019	Grove, Anne/0000-0002-4390-0354; Gupta, Ashish/0000-0002-1800-2755; Sabrin, Afsana/0000-0002-7761-0881	National Science Foundation [MCB-1714219]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant MCB-1714219 (to A. Grove) and by a donation from P. Campbell in support of undergraduate research. The authors declare that they have no conflicts of interest with the contents of this article.	Antelmann H, 2011, ANTIOXID REDOX SIGN, V14, P1049, DOI 10.1089/ars.2010.3400; Biot FV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084068; Bordelon T, 2006, J MOL BIOL, V360, P168, DOI 10.1016/j.jmb.2006.05.005; Choi KH, 2008, APPL ENVIRON MICROB, V74, P1064, DOI 10.1128/AEM.02430-07; COHEN SP, 1993, J BACTERIOL, V175, P7856, DOI 10.1128/JB.175.24.7856-7862.1993; Deochand DK, 2016, MOL BIOSYST, V12, P2417, DOI 10.1039/c6mb00304d; Deochand DK, 2017, CRIT REV BIOCHEM MOL, V52, P595, DOI 10.1080/10409238.2017.1344612; Deochand DK, 2016, ACS CHEM BIOL, V11, P2049, DOI 10.1021/acschembio.6b00168; Fang FC, 2011, MBIO, V2, DOI 10.1128/mBio.00141-11; Gallagher LA, 2013, MBIO, V4, DOI 10.1128/mBio.00604-13; Garcia Erin C, 2017, Curr Protoc Microbiol, V45, DOI 10.1002/cpmc.27; Gupta A, 2019, MICROBIOL MOL BIOL R, V83, DOI 10.1128/MMBR.00039-18; Gupta A, 2017, BIOCHEMISTRY-US, V56, P2315, DOI 10.1021/acs.biochem.7b00103; Gupta A, 2014, BIOCHEMISTRY-US, V53, P4368, DOI 10.1021/bi500219t; Hao ZY, 2014, NAT CHEM BIOL, V10, P21, DOI [10.1038/NCHEMBIO.1380, 10.1038/nchembio.1380]; Haraga A, 2008, INFECT IMMUN, V76, P5402, DOI 10.1128/IAI.00626-08; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; Jones DT, 2015, BIOINFORMATICS, V31, P857, DOI 10.1093/bioinformatics/btu744; KEYER K, 1995, J BACTERIOL, V177, P6782, DOI 10.1128/jb.177.23.6782-6790.1995; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Kumar A, 2006, ANTIMICROB AGENTS CH, V50, P3460, DOI 10.1128/AAC.00440-06; Kushwaha AK, 2015, PROTEIN SCI, V24, P253, DOI 10.1002/pro.2612; Lemire JA, 2013, NAT REV MICROBIOL, V11, P371, DOI 10.1038/nrmicro3028; Micsonai A, 2015, P NATL ACAD SCI USA, V112, pE3095, DOI 10.1073/pnas.1500851112; Palm GJ, 2012, NUCLEIC ACIDS RES, V40, P4178, DOI 10.1093/nar/gkr1316; Pande A, 2018, INFECT IMMUN, V86, DOI [10.1128/IAI.00322-18, 10.1128/iai.00322-18]; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; Poole LB, 2015, FREE RADICAL BIO MED, V80, P148, DOI 10.1016/j.freeradbiomed.2014.11.013; Quade N, 2012, J BIOL CHEM, V287, P35796, DOI 10.1074/jbc.M112.379156; Rhodes KA, 2016, DRUG RESIST UPDATE, V28, P82, DOI 10.1016/j.drup.2016.07.003; Sahl JW, 2016, MBIO, V7, DOI 10.1128/mBio.00846-16; Saier MH, 2016, CURR OPIN STRUC BIOL, V38, P9, DOI 10.1016/j.sbi.2016.05.001; Scoffone VC, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01592; Titball RW, 2017, VACCINE, V35, P5981, DOI 10.1016/j.vaccine.2017.03.022; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wigfield SM, 2002, J ANTIMICROB CHEMOTH, V49, P619, DOI 10.1093/jac/49.4.619; Yu YT, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-46	38	8	8	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2019	294	6					1891	1903		10.1074/jbc.RA118.006638	http://dx.doi.org/10.1074/jbc.RA118.006638			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM8EO	30545940	Green Published, hybrid			2022-12-28	WOS:000459711400010
J	Warren, NJH; Eastman, A				Warren, Nicholas J. H.; Eastman, Alan			Inhibition of checkpoint kinase 1 following gemcitabine-mediated S phase arrest results in CDC7-and CDK2-dependent replication catastrophe	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer; cell cycle; cell division cycle 7-related protein kinase (Cdc7); cyclin-dependent kinase (CDK); DNA-damage response; Chk1; gemcitabine; replication catastrophe; single-strand binding protein RPA	MINICHROMOSOME MAINTENANCE PROTEINS; DNA-REPLICATION; CELL-CYCLE; ATAXIA-TELANGIECTASIA; COMET ASSAY; CHK1; ATR; PHOSPHORYLATION; CDK2; CANCER	Combining DNA-damaging drugs with DNA checkpoint inhibitors is an emerging strategy to manage cancer. Checkpoint kinase 1 inhibitors (CHK1is) sensitize most cancer cell lines to DNA-damaging drugs and also elicit single-agent cytotoxicity in 15% of cell lines. Consequently, combination therapy may be effective in a broader patient population. Here, we characterized the molecular mechanism of sensitization to gemcitabine by the CHK1i MK8776. Brief gemcitabine incubation irreversibly inhibited ribonucleotide reductase, depleting dNTPs, resulting in durable S phase arrest. Addition of CHK1i 18 h after gemcitabine elicited cell division cycle 7 (CDC7)- and cyclin-dependent kinase 2 (CDK2)-dependent reactivation of the replicative helicase, but did not reinitiate DNA synthesis due to continued lack of dNTPs. Helicase reactivation generated extensive single-strand (ss)DNA that exceeded the protective capacity of the ssDNA-binding protein, replication protein A. The subsequent cleavage of unprotected ssDNA has been termed replication catastrophe. This mechanism did not occur with concurrent CHK1i plus gemcitabine treatment, providing support for delayed administration of CHK1i in patients. Alternative mechanisms of CHK1i-mediated sensitization to gemcitabine have been proposed, but their role was ruled out; these mechanisms include premature mitosis, inhibition of homologous recombination, and activation of double-strand break repair nuclease (MRE11). In contrast, single-agent activity of CHK1i was MRE11-dependent and was prevented by lower concentrations of a CDK2 inhibitor. Hence, both pathways require CDK2 but appear to depend on different CDK2 substrates. We conclude that a small-molecule inhibitor of CHK1 can elicit at least two distinct, context-dependent mechanisms of cytotoxicity in cancer cells.	[Warren, Nicholas J. H.; Eastman, Alan] Norris Cotton Canc Ctr, Geisel Sch Med Dartmouth, Dept Mol & Syst Biol, Lebanon, NH 03756 USA	Dartmouth College; Norris Cotton Cancer Center	Eastman, A (corresponding author), Norris Cotton Canc Ctr, Rubin Bldg,Level 6,One Med Ctr Dr, Lebanon, NH 03756 USA.	alan.r.eastman@dartmouth.edu		Warren, Nicholas/0000-0003-4640-2868	National Institutes of Health [2RO1CA117874]; NATIONAL CANCER INSTITUTE [P30CA023108, R01CA117874] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021616] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grant 2RO1CA117874 (to A.E.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aarts M, 2012, CANCER DISCOV, V2, P524, DOI 10.1158/2159-8290.CD-11-0320; Arooz T, 2000, BIOCHEMISTRY-US, V39, P9494, DOI 10.1021/bi0009643; Bahassi EM, 2008, ONCOGENE, V27, P3977, DOI 10.1038/onc.2008.17; Brooks EE, 1997, J BIOL CHEM, V272, P29207, DOI 10.1074/jbc.272.46.29207; Brown JS, 2017, CANCER DISCOV, V7, P20, DOI 10.1158/2159-8290.CD-16-0860; Buisson R, 2015, MOL CELL, V59, P1011, DOI 10.1016/j.molcel.2015.07.029; Bunch RT, 1996, CLIN CANCER RES, V2, P791; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Chen YH, 2015, MOL CELL, V58, P323, DOI 10.1016/j.molcel.2015.02.031; Chuang LC, 2009, MOL CELL, V35, P206, DOI 10.1016/j.molcel.2009.06.014; Collins AR, 2004, MOL BIOTECHNOL, V26, P249, DOI 10.1385/MB:26:3:249; Cortez D, 2004, P NATL ACAD SCI USA, V101, P10078, DOI 10.1073/pnas.0403410101; Coudreuse D, 2010, NATURE, V468, P1074, DOI 10.1038/nature09543; Coulonval K, 2003, J BIOL CHEM, V278, P52052, DOI 10.1074/jbc.M307012200; Du JY, 2004, CANCER CELL, V6, P565, DOI 10.1016/j.ccr.2004.10.014; Dungrawala H, 2015, MOL CELL, V59, P998, DOI 10.1016/j.molcel.2015.07.030; Forment JV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023517; Fugger K, 2015, CELL REP, V10, P1749, DOI 10.1016/j.celrep.2015.02.028; Fugger K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2395; Garner KM, 2009, NAT CHEM BIOL, V5, P129, DOI 10.1038/nchembio0309-129; Ge XQ, 2010, J CELL BIOL, V191, P1285, DOI 10.1083/jcb.201007074; Gyori BM, 2014, REDOX BIOL, V2, P457, DOI 10.1016/j.redox.2013.12.020; Hashimoto Y, 2006, GENES CELLS, V11, P993, DOI 10.1111/j.1365-2443.2006.00998.x; Hauge S, 2017, ONCOTARGET, V8, P10966, DOI 10.18632/oncotarget.14089; HEINEMANN V, 1990, MOL PHARMACOL, V38, P567; Karp JE, 2012, CLIN CANCER RES, V18, P6723, DOI 10.1158/1078-0432.CCR-12-2442; King C, 2015, MOL CANCER THER, V14, P2004, DOI 10.1158/1535-7163.MCT-14-1037; Kohler C, 2016, CELL CYCLE, V15, P974, DOI 10.1080/15384101.2016.1152424; Koh SB, 2018, CANCER RES, V78, P3054, DOI 10.1158/0008-5472.CAN-17-3932; Koh SB, 2015, CANCER RES, V75, P3583, DOI 10.1158/0008-5472.CAN-14-3347; Lee AYL, 2012, J BIOL CHEM, V287, P2531, DOI 10.1074/jbc.M111.291104; Liu SQ, 2012, NUCLEIC ACIDS RES, V40, P10780, DOI 10.1093/nar/gks849; Marechal A, 2015, CELL RES, V25, P9, DOI 10.1038/cr.2014.147; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Mitov MI, 2009, ELECTROPHORESIS, V30, P848, DOI 10.1002/elps.200800583; Molenaar JJ, 2009, P NATL ACAD SCI USA, V106, P12968, DOI 10.1073/pnas.0901418106; Montagnoli A, 2006, J BIOL CHEM, V281, P10281, DOI 10.1074/jbc.M512921200; Montano R, 2017, ONCOTARGET, V8, P67754, DOI 10.18632/oncotarget.18834; Montano R, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-604; Montano R, 2012, MOL CANCER THER, V11, P427, DOI 10.1158/1535-7163.MCT-11-0406; Neganova I, 2011, STEM CELLS, V29, P651, DOI 10.1002/stem.620; Petermann E, 2010, NAT REV MOL CELL BIO, V11, P683, DOI 10.1038/nrm2974; Petermann E, 2010, MOL CELL, V37, P492, DOI 10.1016/j.molcel.2010.01.021; RAO J, 1992, ANAL BIOCHEM, V207, P186, DOI 10.1016/0003-2697(92)90521-8; Sakurikar N, 2016, CELL CYCLE, V15, P1184, DOI 10.1080/15384101.2016.1160983; Sakurikar N, 2016, ONCOTARGET, V7, P1380, DOI 10.18632/oncotarget.6364; Sanjiv K, 2016, CELL REP, V14, P298, DOI 10.1016/j.celrep.2015.12.032; SCHLEGEL R, 1986, SCIENCE, V232, P1264, DOI 10.1126/science.2422760; Scully R, 1999, MOL CELL, V4, P1093, DOI 10.1016/S1097-2765(00)80238-5; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Swaffer MP, 2016, CELL, V167, P1750, DOI 10.1016/j.cell.2016.11.034; Syljuasen RG, 2005, MOL CELL BIOL, V25, P3553, DOI 10.1128/MCB.25.9.3553-3562.2005; Takeda DY, 2005, ONCOGENE, V24, P2827, DOI 10.1038/sj.onc.1208616; Thangavel S, 2015, J CELL BIOL, V208, P545, DOI 10.1083/jcb.201406100; Thompson R, 2013, BRIT J CLIN PHARMACO, V76, P358, DOI 10.1111/bcp.12139; Thompson R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044021; Toledo L, 2017, MOL CELL, V66, P735, DOI 10.1016/j.molcel.2017.05.001; Toledo LI, 2013, CELL, V155, P1088, DOI 10.1016/j.cell.2013.10.043; Welcker M, 2003, MOL CELL, V12, P381, DOI 10.1016/S1097-2765(03)00287-9; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897	61	21	21	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2019	294	6					1763	1778		10.1074/jbc.RA118.005231	http://dx.doi.org/10.1074/jbc.RA118.005231			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM8EO	30573684	Green Published, hybrid			2022-12-28	WOS:000459711400001
J	Tatavosian, R; Kent, S; Brown, K; Yao, TT; Huy, ND; Huynh, TN; Zhen, CY; Ma, B; Wang, HB; Ren, XJ				Tatavosian, Roubina; Kent, Samantha; Brown, Kyle; Yao, Tingting; Huy Nguyen Duc; Thao Ngoc Huynh; Zhen, Chao Yu; Ma, Brian; Wang, Haobin; Ren, Xiaojun			Nuclear condensates of the Polycomb protein chromobox 2 (CBX2) assemble through phase separation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Polycomb; epigenetics; heterochromatin; chromatin; gene regulation; histone methylation; histone; chromatin modification; chromatin structure; chromatin regulation; CBX2; liquid-liquid phase separation; PcG; phase separation; PRC1	HISTONE METHYLTRANSFERASE ACTIVITY; REPRESSIVE COMPLEX; FACULTATIVE HETEROCHROMATIN; PRC1 COMPLEX; SAM DOMAIN; CHROMATIN; H3; H2A; METHYLATION; TRANSITION	Polycomb group (PcG) proteins repress master regulators of development and differentiation through organization of chromatin structure. Mutation and dysregulation of PcG genes cause developmental defects and cancer. PcG proteins form condensates in the cell nucleus, and these condensates are the physical sites of PcG-targeted gene silencing via formation of facultative heterochromatin. However, the physiochemical principles underlying the formation of PcG condensates remain unknown, and their determination could shed light on how these condensates compact chromatin. Using fluorescence live-cell imaging, we observed that the Polycomb repressive complex 1 (PRC1) protein chromobox 2 (CBX2), a member of the CBX protein family, undergoes phase separation to form condensates and that the CBX2 condensates exhibit liquid-like properties. Using site-directed mutagenesis, we demonstrated that the conserved residues of CBX2 within the intrinsically disordered region (IDR), which is the region for compaction of chromatin in vitro, promote the condensate formation both in vitro and in vivo. We showed that the CBX2 condensates concentrate DNA and nucleosomes. Using genetic engineering, we report that trimethylation of Lys-27 at histone H3 (H3K27me3), a marker of heterochromatin formation produced by PRC2, had minimal effects on the CBX2 condensate formation. We further demonstrated that the CBX2 condensate formation does not require CBX2-PRC1 subunits; however, the condensate formation of CBX2-PRC1 subunits depends on CBX2, suggesting a mechanism underlying the assembly of CBX2-PRC1 condensates. In summary, our results reveal that PcG condensates assemble through liquid-liquid phase separation (LLPS) and suggest that phase-separated condensates can organize PcG-bound chromatin.	[Tatavosian, Roubina; Kent, Samantha; Brown, Kyle; Huy Nguyen Duc; Thao Ngoc Huynh; Zhen, Chao Yu; Ma, Brian; Wang, Haobin; Ren, Xiaojun] Univ Colorado, Dept Chem, Denver, CO 80217 USA; [Yao, Tingting] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA	University of Colorado System; University of Colorado Denver; Colorado State University	Ren, XJ (corresponding author), Univ Colorado, Dept Chem, Denver, CO 80217 USA.	xiaojun.ren@ucdenver.edu	WANG, Haobin/S-1187-2019	Brown, Kyle/0000-0001-9640-6520; Wang, Haobin/0000-0002-3532-7770; Ren, Xiaojun/0000-0002-3931-7625	NCI, National Institutes of Health [R03CA191443]; National Science Foundation [CHE-1500285]; NIGMS, National Institutes of Health [R01GM098401]; Office of Research Services (ORS) at the University of Colorado Denver; NATIONAL CANCER INSTITUTE [R03CA191443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098401] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Foundation(National Science Foundation (NSF)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Office of Research Services (ORS) at the University of Colorado Denver; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NCI, National Institutes of Health Grant R03CA191443 (to X. R.), National Science Foundation Grant CHE-1500285 (to H. W.), NIGMS, National Institutes of Health Grant R01GM098401 (to T. Y.), and the Office of Research Services (ORS) at the University of Colorado Denver. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alkema MJ, 1997, GENE DEV, V11, P226, DOI 10.1101/gad.11.2.226; Allshire RC, 2018, NAT REV MOL CELL BIO, V19, P229, DOI 10.1038/nrm.2017.119; Altmeyer M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9088; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Banani SF, 2016, CELL, V166, P651, DOI 10.1016/j.cell.2016.06.010; Bernstein E, 2006, MOL CELL BIOL, V26, P2560, DOI 10.1128/MCB.26.7.2560-2569.2006; Blackledge NP, 2015, NAT REV MOL CELL BIO, V16, P643, DOI 10.1038/nrm4067; Blackledge NP, 2014, CELL, V157, P1445, DOI 10.1016/j.cell.2014.05.004; Boehning M, 2018, NAT STRUCT MOL BIOL, V25, P833, DOI 10.1038/s41594-018-0112-y; Boeynaems S, 2018, TRENDS CELL BIOL, V28, P420, DOI 10.1016/j.tcb.2018.02.004; Boeynaems S, 2017, MOL CELL, V65, P1044, DOI 10.1016/j.molcel.2017.02.013; BROWN SW, 1966, SCIENCE, V151, P417, DOI 10.1126/science.151.3709.417; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cho WK, 2018, SCIENCE, V361, P412, DOI 10.1126/science.aar4199; Chong SS, 2018, SCIENCE, V361, DOI 10.1126/science.aar2555; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Elbaum-Garfinkle S, 2015, P NATL ACAD SCI USA, V112, P7189, DOI 10.1073/pnas.1504822112; Endoh M, 2008, DEVELOPMENT, V135, P1513, DOI 10.1242/dev.014340; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; Feric M, 2016, CELL, V165, P1686, DOI 10.1016/j.cell.2016.04.047; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Grau DJ, 2011, GENE DEV, V25, P2210, DOI 10.1101/gad.17288211; Gunster MJ, 1997, MOL CELL BIOL, V17, P2326, DOI 10.1128/MCB.17.4.2326; Heard E, 2005, CURR OPIN GENET DEV, V15, P482, DOI 10.1016/j.gde.2005.08.009; Hemenway CS, 1998, ONCOGENE, V16, P2541, DOI 10.1038/sj.onc.1202042; Duc HN, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2526; Hyman AA, 2014, ANNU REV CELL DEV BI, V30, P39, DOI 10.1146/annurev-cellbio-100913-013325; Isono K, 2013, DEV CELL, V26, P565, DOI 10.1016/j.devcel.2013.08.016; Jiang H, 2015, CELL, V163, P108, DOI 10.1016/j.cell.2015.08.010; Kalb R, 2014, NAT STRUCT MOL BIOL, V21, P569, DOI 10.1038/nsmb.2833; Katoh-Fukui Y, 1998, NATURE, V393, P688, DOI 10.1038/31482; Kaustov L, 2011, J BIOL CHEM, V286, P521, DOI 10.1074/jbc.M110.191411; Kawaguchi T, 2017, J BIOCHEM, V162, P343, DOI 10.1093/jb/mvx040; Kim CA, 2003, TRENDS BIOCHEM SCI, V28, P625, DOI 10.1016/j.tibs.2003.11.001; Kim CA, 2002, NAT STRUCT BIOL, V9, P453, DOI 10.1038/nsb802; King IFG, 2005, MOL CELL BIOL, V25, P6578, DOI 10.1128/MCB.25.15.6578-6591.2005; Kondo T, 2014, DEV CELL, V28, P94, DOI 10.1016/j.devcel.2013.11.021; Kundu S, 2017, MOL CELL, V65, P432, DOI 10.1016/j.molcel.2017.01.009; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Larson AG, 2018, BIOCHEMISTRY-US, V57, P2540, DOI 10.1021/acs.biochem.8b00401; Larson AG, 2017, NATURE, V547, P236, DOI 10.1038/nature22822; Lau MS, 2017, SCIENCE, V355, DOI 10.1126/science.aah5403; Lee KH, 2016, CELL, V167, P774, DOI 10.1016/j.cell.2016.10.002; Levine SS, 2002, MOL CELL BIOL, V22, P6070, DOI 10.1128/MCB.22.17.6070-6078.2002; Lu HS, 2018, NATURE, V558, P318, DOI 10.1038/s41586-018-0174-3; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Meldi L, 2011, TRENDS CELL BIOL, V21, P701, DOI 10.1016/j.tcb.2011.08.001; Mitrea DM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03255-3; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Nott TJ, 2015, MOL CELL, V57, P936, DOI 10.1016/j.molcel.2015.01.013; Pak CW, 2016, MOL CELL, V63, P72, DOI 10.1016/j.molcel.2016.05.042; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Piovesan D, 2018, NUCLEIC ACIDS RES, V46, pD471, DOI 10.1093/nar/gkx1071; Pirrotta V, 2012, CURR OPIN GENET DEV, V22, P101, DOI 10.1016/j.gde.2011.11.004; Reinberg D, 2018, SCIENCE, V361, P33, DOI 10.1126/science.aat7871; Ren XJ, 2008, MOL CELL BIOL, V28, P2884, DOI 10.1128/MCB.00949-07; Sabari BR, 2018, SCIENCE, V361, DOI 10.1126/science.aar3958; Satijn DPE, 1999, MOL CELL BIOL, V19, P57; Satijn DPE, 1997, MOL CELL BIOL, V17, P4105, DOI 10.1128/MCB.17.7.4105; Schoenfelder S, 2015, NAT GENET, V47, P1179, DOI 10.1038/ng.3393; Schoorlemmer J, 1997, EMBO J, V16, P5930, DOI 10.1093/emboj/16.19.5930; Schuettengruber B, 2017, CELL, V171, P34, DOI 10.1016/j.cell.2017.08.002; Semenov AN, 1998, MACROMOLECULES, V31, P1373, DOI 10.1021/ma970616h; Senthilkumar R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-549; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Shin Y, 2017, SCIENCE, V357, DOI 10.1126/science.aaf4382; Strom AR, 2017, NATURE, V547, P241, DOI 10.1038/nature22989; Tardat M, 2015, MOL CELL, V58, P157, DOI 10.1016/j.molcel.2015.02.013; Tatavosian R, 2015, J BIOL CHEM, V290, P28038, DOI 10.1074/jbc.M115.671115; Huynh TN, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2333; Trojer P, 2007, MOL CELL, V28, P1, DOI 10.1016/j.molcel.2007.09.011; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang J, 2018, CELL, V174, P688, DOI 10.1016/j.cell.2018.06.006; Wang RJ, 2008, BIOCHEMISTRY-US, V47, P8007, DOI 10.1021/bi800857f; Wang RJ, 2010, STRUCTURE, V18, P966, DOI 10.1016/j.str.2010.04.013; Wani AH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10291; Woodruff JB, 2018, TRENDS BIOCHEM SCI, V43, P81, DOI 10.1016/j.tibs.2017.11.005; Xu C, 2010, P NATL ACAD SCI USA, V107, P19266, DOI 10.1073/pnas.1008937107; Zhen CY, 2016, ELIFE, V5, DOI 10.7554/eLife.17667; Zhen CY, 2014, MOL BIOL CELL, V25, P3726, DOI 10.1091/mbc.E14-06-1109	82	159	161	6	64	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2019	294	5					1451	1463		10.1074/jbc.RA118.006620	http://dx.doi.org/10.1074/jbc.RA118.006620			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GC	30514760	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000457879200002
J	Gas-Pascual, E; Ichikawa, HT; Sheikh, MO; Serji, MI; Deng, BW; Mandalasi, M; Bandini, G; Samuelson, J; Wells, L; West, CM				Gas-Pascual, Elisabet; Ichikawa, Hiroshi Travis; Sheikh, Mohammed Osman; Serji, Mariam Isabella; Deng, Bowen; Mandalasi, Msano; Bandini, Giulia; Samuelson, John; Wells, Lance; West, Christopher M.			CRISPR/Cas9 and glycomics tools for Toxoplasma glycobiology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CRISPR/Cas; glycomics; Toxoplasma gondii; mass spectrometry (MS); parasitology; glycobiology; glycosyltransferase; glycan; glycogene; protein glycosylation	ASPARAGINE-LINKED GLYCANS; QUALITY-CONTROL; PLASMODIUM-FALCIPARUM; GONDII; PROTEIN; IDENTIFICATION; GLYCOSYLATION; DIVERSITY; SKP1; GLYCOPROTEIN	Infection with the protozoan parasite Toxoplasma gondii is a major health risk owing to birth defects, its chronic nature, ability to reactivate to cause blindness and encephalitis, and high prevalence in human populations. Unlike most eukaryotes, Toxoplasma propagates in intracellular parasitophorous vacuoles, but like nearly all other eukaryotes, Toxoplasma glycosylates many cellular proteins and lipids and assembles polysaccharides. Toxoplasma glycans resemble those of other eukaryotes, but species-specific variations have prohibited deeper investigations into their roles in parasite biology and virulence. The Toxoplasma genome encodes a suite of likely glycogenes expected to assemble N-glycans, O-glycans, a C-glycan, GPI-anchors, and polysaccharides, along with their precursors and membrane transporters. To investigate the roles of specific glycans in Toxoplasma, here we coupled genetic and glycomics approaches to map the connections between 67 glycogenes, their enzyme products, the glycans to which they contribute, and cellular functions. We applied a double-CRISPR/Cas9 strategy, in which two guide RNAs promote replacement of a candidate gene with a resistance gene; adapted MS-based glycomics workflows to test for effects on glycan formation; and infected fibroblast monolayers to assess cellular effects. By editing 17 glycogenes, we discovered novel Glc(0-2)-Man(6)-GlcNAc(2)-type N-glycans, a novel HexNAc-GalNAc-mucin-type O-glycan, and Tn-antigen; identified the glycosyltransferases for assembling novel nuclear O-Fuc-type and cell surface Glc-Fuc-type O-glycans; and showed that they are important for in vitro growth. The guide sequences, editing constructs, and mutant strains are freely available to researchers to investigate the roles of glycans in their favorite biological processes.	[Gas-Pascual, Elisabet; Ichikawa, Hiroshi Travis; Serji, Mariam Isabella; Deng, Bowen; Mandalasi, Msano; Wells, Lance; West, Christopher M.] Univ Georgia, Dept Biochem & Mol Biol, 120 E Green St,Davison Life Sci B129, Athens, GA 30602 USA; [Gas-Pascual, Elisabet; Deng, Bowen; Mandalasi, Msano; West, Christopher M.] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Sheikh, Mohammed Osman; Wells, Lance; West, Christopher M.] Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA; [Bandini, Giulia; Samuelson, John] Boston Univ, Henry M Goldman Sch Dent Med, Dept Mol & Cell Biol, Boston, MA 02118 USA; [Ichikawa, Hiroshi Travis] Univ Georgia, New Mat Inst, Athens, GA 30602 USA; [Serji, Mariam Isabella] George Washington Univ, Sch Publ Hlth, Washington, DC 20009 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Boston University; University System of Georgia; University of Georgia; George Washington University	West, CM (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, 120 E Green St,Davison Life Sci B129, Athens, GA 30602 USA.	westcm@uga.edu	Bandini, Giulia/ABC-4413-2021	Wells, Lance/0000-0003-4956-5363; Sheikh, Mohammed/0000-0002-9481-8318; Mandalasi, Msano/0000-0002-5906-7387; Deng, Bowen/0000-0003-1423-4302; Bandini, Giulia/0000-0002-8885-3643	National Institutes of Health Common Fund [5R21 AI123161]; National Institutes of Health [R01-GM037539, R01-GM084383, P41-GM103490, 8P41-GM103390]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI123161, T32AI060546, R01AI110638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084383, P41GM103490, P41GM103390, R01GM037539] Funding Source: NIH RePORTER	National Institutes of Health Common Fund(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the National Institutes of Health Common Fund to Promote the Glycosciences (Grant 5R21 AI123161) and received additional support from National Institutes of Health Grants R01-GM037539 (to C. M. W.), R01-GM084383 (to C. M. W.), P41-GM103490 (to L. W., senior investigator), and 8P41-GM103390 (Resource for Integrated Glycotechnology). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; ALMEIDA IC, 1994, BIOCHEM J, V304, P793, DOI 10.1042/bj3040793; Alvarez-Manilla G, 2010, J PROTEOME RES, V9, P2062, DOI 10.1021/pr8007489; Anish C, 2014, CHEM BIOL, V21, P38, DOI 10.1016/j.chembiol.2014.01.002; ANUMULA KR, 1992, ANAL BIOCHEM, V203, P101, DOI 10.1016/0003-2697(92)90048-C; Aoki K, 2008, J BIOL CHEM, V283, P30385, DOI 10.1074/jbc.M804925200; Aoki K, 2007, J BIOL CHEM, V282, P9127, DOI 10.1074/jbc.M606711200; Aspinall TV, 2002, J INFECT DIS, V185, P1637, DOI 10.1086/340577; Avonce N, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-109; Azzouz N, 2002, INT J PARASITOL, V32, P677, DOI 10.1016/S0020-7519(02)00009-7; Azzouz N, 2006, INT J BIOCHEM CELL B, V38, P1914, DOI 10.1016/j.biocel.2006.05.006; Baatz H, 2006, OCUL IMMUNOL INFLAMM, V14, P185, DOI 10.1080/09273940600659740; Bandini G., 2018, BIORXIV, DOI [10.1101/382515, DOI 10.1101/382515]; Bandini G, 2016, P NATL ACAD SCI USA, V113, P11567, DOI 10.1073/pnas.1613653113; Bandini G, 2012, MOL MICROBIOL, V85, P513, DOI 10.1111/j.1365-2958.2012.08124.x; Banerjee S, 2007, P NATL ACAD SCI USA, V104, P11676, DOI 10.1073/pnas.0704862104; Blader IJ, 2015, ANNU REV MICROBIOL, V69, P463, DOI 10.1146/annurev-micro-091014-104100; Blume M, 2015, CELL HOST MICROBE, V18, P210, DOI 10.1016/j.chom.2015.07.008; Blume M, 2009, P NATL ACAD SCI USA, V106, P12998, DOI 10.1073/pnas.0903831106; Botte C, 2008, J LIPID RES, V49, P746, DOI 10.1194/jlr.M700476-JLR200; Bullard Whitney, 2014, J Biol Chem, V289, P20273, DOI 10.1074/jbc.M114.579821; Bushkin GG, 2012, MBIO, V3, DOI 10.1128/mBio.00258-12; Bushkin GG, 2010, EUKARYOT CELL, V9, P228, DOI 10.1128/EC.00197-09; Caffaro CE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003331; Coppin A, 2005, J MOL EVOL, V60, P257, DOI 10.1007/s00239-004-0185-6; Cova M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22441-3; Cova M, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0949-z; Damerow S, 2010, J BIOL CHEM, V285, P878, DOI 10.1074/jbc.M109.067223; DANNEMANN B, 1992, ANN INTERN MED, V116, P33, DOI 10.7326/0003-4819-116-1-33; de Macedo CS, 2010, MEM I OSWALDO CRUZ, V105, P949, DOI 10.1590/S0074-02762010000800001; Debierre-Grockiego F, 2010, J BIOL CHEM, V285, P32744, DOI 10.1074/jbc.M110.137588; Esko Jeffrey D., 2017, ESSENTIALS GLYCOBIOL, V3rd; Fauquenoy S, 2008, MOL CELL PROTEOMICS, V7, P891, DOI 10.1074/mcp.M700391-MCP200; Fauquenoy Sylvain, 2011, Mol Cell Proteomics, V10, DOI 10.1074/mcp.M111.008953; Feasley CL, 2015, GLYCOCONJUGATE J, V32, P345, DOI 10.1007/s10719-015-9592-8; Feasley Christa L, 2013, Methods Mol Biol, V983, P205, DOI 10.1007/978-1-62703-302-2_11; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gajria B, 2008, NUCLEIC ACIDS RES, V36, pD553, DOI 10.1093/nar/gkm981; Garenaux E, 2008, BIOCHEMISTRY-US, V47, P12270, DOI 10.1021/bi801090a; Ghiselli G, 2017, MED RES REV, V37, P1051, DOI 10.1002/med.21429; Guerardel Y, 2005, MICROBES INFECT, V7, P41, DOI 10.1016/j.micinf.2004.09.007; Hardiville S, 2014, CELL METAB, V20, P208, DOI 10.1016/j.cmet.2014.07.014; Haserick JR, 2017, MOL CELL PROTEOMICS, V16, pS42, DOI [10.1074/mcp.M116.066035, 10.1074/mcp.m116.066035]; Heimburg-Molinaro J, 2013, INT J PARASITOL, V43, P901, DOI 10.1016/j.ijpara.2013.05.012; Hoppe CM, 2018, GLYCOBIOLOGY, V28, P333, DOI 10.1093/glycob/cwy013; Hutter Julia, 2015, Methods Mol Biol, V1331, P1, DOI 10.1007/978-1-4939-2874-3_1; Hykollari A, 2014, ELECTROPHORESIS, V35, P2116, DOI 10.1002/elps.201300612; Imada M, 2010, PARASITOL INT, V59, P206, DOI 10.1016/j.parint.2010.01.007; Katlama C, 1996, CLIN INFECT DIS, V22, P268, DOI 10.1093/clinids/22.2.268; Khurana S., 2018, BIORXIV, DOI [10.1101/391623, DOI 10.1101/391623]; Kim K, 2004, INT J PARASITOL, V34, P423, DOI 10.1016/j.ijpara.2003.12.009; Koeller CM, 2014, EUKARYOT CELL, V13, P1312, DOI 10.1128/EC.00165-14; KOZULIC B, 1979, ANAL BIOCHEM, V94, P36, DOI 10.1016/0003-2697(79)90786-3; Lambert H, 2010, CELL MICROBIOL, V12, P292, DOI 10.1111/j.1462-5822.2009.01417.x; Lobo-Rojas AE, 2016, PARASITOL INT, V65, P472, DOI 10.1016/j.parint.2016.06.008; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Long SJ, 2016, INFECT IMMUN, V84, P1262, DOI 10.1128/IAI.01173-15; Lopaticki S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00571-y; LUFT BJ, 1992, CLIN INFECT DIS, V15, P211, DOI 10.1093/clinids/15.2.211; Luk FCY, 2008, MOL BIOCHEM PARASIT, V157, P169, DOI 10.1016/j.molbiopara.2007.10.012; Luo QL, 2011, MICROBES INFECT, V13, P1199, DOI 10.1016/j.micinf.2011.08.013; Marechal E, 2002, EUKARYOT CELL, V1, P653, DOI 10.1128/EC.1.4.653-656.2002; Masuishi Y, 2016, J PROTEOMICS, V139, P77, DOI 10.1016/j.jprot.2016.03.008; Niehus S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085386; Olszewski NE, 2010, BBA-GEN SUBJECTS, V1800, P49, DOI 10.1016/j.bbagen.2009.11.016; Pappas G, 2009, INT J PARASITOL, V39, P1385, DOI 10.1016/j.ijpara.2009.04.003; Peng D, 2015, MICROB GENOMICS, V1, DOI 10.1099/mgen.0.000033; Pereira-Chioccola VL, 2009, FUTURE MICROBIOL, V4, P1363, DOI [10.2217/fmb.09.89, 10.2217/FMB.09.89]; Rahman K, 2017, J BIOL CHEM, V292, P18644, DOI 10.1074/jbc.M117.809301; Rahman K, 2016, J BIOL CHEM, V291, P4268, DOI 10.1074/jbc.M115.703751; Rodrigues JA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005169; Saha S, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00521-17; Saito T, 2002, INT J PARASITOL, V32, P961, DOI 10.1016/S0020-7519(02)00059-0; Samuelson J, 2005, P NATL ACAD SCI USA, V102, P1548, DOI 10.1073/pnas.0409460102; Samuelson J, 2015, SEMIN CELL DEV BIOL, V41, P121, DOI 10.1016/j.semcdb.2014.11.008; Samuelson J, 2013, EUKARYOT CELL, V12, P1578, DOI 10.1128/EC.00213-13; Sanz S, 2013, J BIOL CHEM, V288, P16506, DOI 10.1074/jbc.M112.439828; Schiller B, 2012, BIOL CHEM, V393, P661, DOI 10.1515/hsz-2012-0150; Seron K, 2000, EUR J BIOCHEM, V267, P6571, DOI 10.1046/j.1432-1327.2000.01749.x; Shams-Eldin H, 2005, MOL BIOCHEM PARASIT, V143, P6, DOI 10.1016/j.molbiopara.2005.04.008; Shcherbakova A, 2017, P NATL ACAD SCI USA, V114, P2574, DOI 10.1073/pnas.1613165114; Sheikh MO, 2017, J BIOL CHEM, V292, P18897, DOI 10.1074/jbc.M117.809160; Shen B, 2017, METHODS MOL BIOL, V1498, P79, DOI 10.1007/978-1-4939-6472-7_6; Shukla A, 2018, INT J PARASITOL, V48, P955, DOI 10.1016/j.ijpara.2018.05.013; Sidik SM, 2016, CELL, V166, P1423, DOI 10.1016/j.cell.2016.08.019; Stanley P, 2015, ESSENTIALS GLYCOBIOL, P99, DOI DOI 10.1101/GLYCOBIOLOGY.3E.009; Steentoft C, 2011, NAT METHODS, V8, P977, DOI [10.1038/nmeth.1731, 10.1038/NMETH.1731]; Striepen B., 2007, P391, DOI 10.1016/B978-012369542-0/50017-9; Stwora-Wojczyk MM, 2004, ARCH BIOCHEM BIOPHYS, V426, P231, DOI 10.1016/j.abb.2004.02.013; Sucgang R, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r20; Sugi T, 2017, MBIO, V8, DOI [10.1128/mBio.01289-17, 10.1128/mbio.01289-17]; Swearingen KE, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005606; Tachibana K, 2006, GLYCOBIOLOGY, V16, P46, DOI 10.1093/glycob/cwj038; Tomita T, 2017, MBIO, V8, DOI [10.1128/mBio.02048-16, 10.1128/mbio.02048-16]; Tomita T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003823; TOMIYA N, 1991, ANAL BIOCHEM, V193, P90, DOI 10.1016/0003-2697(91)90047-W; Tyrrell BE, 2017, CRIT REV MICROBIOL, V43, P521, DOI 10.1080/1040841X.2016.1242868; Uboldi AD, 2015, CELL HOST MICROBE, V18, P670, DOI 10.1016/j.chom.2015.11.004; Varki A, 2015, GLYCOBIOLOGY, V25, P1323, DOI 10.1093/glycob/cwv091; Vasudevan D, 2015, CURR BIOL, V25, P286, DOI 10.1016/j.cub.2014.11.049; Wang K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150561; Weiss LM, 2000, FRONT BIOSCI-LANDMRK, V5, pD391, DOI 10.2741/Weiss; West C. M., 2017, ESSENTIALS GLYCOBIOL; West C. M., 2005, DICTYOSTELIUM GENOMI, P235; West CM, 2015, CURR OPIN MICROBIOL, V26, P41, DOI 10.1016/j.mib.2015.04.006; West CM, 2004, BBA-GEN SUBJECTS, V1673, P29, DOI 10.1016/j.bbagen.2004.04.007; Xu YC, 2012, J BIOL CHEM, V287, P25098, DOI 10.1074/jbc.M112.355446; Yang T, 2010, BIOCHEM J, V430, P275, DOI 10.1042/BJ20100315; Yang T, 2010, BIOCHEM J, V429, P533, DOI 10.1042/BJ20100238; Zentella R, 2017, NAT CHEM BIOL, V13, P479, DOI [10.1038/NCHEMBIO.2320, 10.1038/nchembio.2320]; Zinecker CF, 1998, MOL BIOCHEM PARASIT, V97, P241, DOI 10.1016/S0166-6851(98)00136-4	111	29	29	3	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1104	1125		10.1074/jbc.RA118.006072	http://dx.doi.org/10.1074/jbc.RA118.006072			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30463938	Green Published, hybrid			2022-12-28	WOS:000457879500004
J	Miao, K; Zhang, X; Su, SM; Zeng, JM; Huang, ZB; Chan, UI; Xu, XL; Deng, CX				Miao, Kai; Zhang, Xin; Su, Sek Man; Zeng, Jianming; Huang, Zebin; Chan, Un In; Xu, Xiaoling; Deng, Chu-Xia			Optimizing CRISPR/Cas9 technology for precise correction of the Fgfr3-G374R mutation in achondroplasia in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fibroblast growth factor receptor (FGFR); CRISPR/Cas; gene therapy; genetic disease; bone	MOUSE MODEL; GENOME; EFFICIENT; DISEASE; GROWTH; MUSCLE	CRISPR/Cas9 is a powerful technology widely used for genome editing, with the potential to be used for correcting a wide variety of deleterious disease-causing mutations. However, the technique tends to generate more indels (insertions and deletions) than precise modifications at the target sites, which might not resolve the mutation and could instead exacerbate the initial genetic disruption. We sought to develop an improved protocol for CRISPR/Cas9 that would correct mutations without unintended consequences. As a case study, we focused on achondroplasia, a common genetic form of dwarfism defined by missense mutation in the Fgfr3 gene that results in glycine to arginine substitution at position 374 in mice in fibroblast growth factor receptor 3 (Fgfr3-G374R), which corresponds to G380R in humans. First, we designed a GFP reporter system that can evaluate the cutting efficiency and specificity of single guide RNAs (sgRNAs). Using the sgRNA selected based on our GFP reporter system, we conducted targeted therapy of achondroplasia in mice. We found that we achieved higher frequency of precise correction of the Fgfr3-G374R mutation using Cas9 protein rather than Cas9 mRNA. We further demonstrated that targeting oligos of 100 and 200 nucleotides precisely corrected the mutation at equal efficiency. We showed that our strategy completely suppressed phenotypes of achondroplasia and whole genome sequencing detected no off-target effects. These data indicate that improved protocols can enable the precise CRISPR/Cas9-mediated correction of individual mutations with high fidelity.	[Miao, Kai; Zhang, Xin; Su, Sek Man; Zeng, Jianming; Huang, Zebin; Chan, Un In; Xu, Xiaoling; Deng, Chu-Xia] Univ Macau, Fac Hlth Sci, Canc Ctr, Macau, Peoples R China; [Miao, Kai; Su, Sek Man; Zeng, Jianming; Huang, Zebin; Xu, Xiaoling; Deng, Chu-Xia] Univ Macau, Fac Hlth Sci, Ctr Precis Med Res & Training, Macau, Peoples R China; [Zhang, Xin; Chan, Un In; Xu, Xiaoling] Univ Macau, Fac Hlth Sci, Transgen & Knockout Core, Macau, Peoples R China	University of Macau; University of Macau; University of Macau	Xu, XL; Deng, CX (corresponding author), Univ Macau, Fac Hlth Sci, Canc Ctr, Macau, Peoples R China.; Xu, XL; Deng, CX (corresponding author), Univ Macau, Fac Hlth Sci, Ctr Precis Med Res & Training, Macau, Peoples R China.; Xu, XL (corresponding author), Univ Macau, Fac Hlth Sci, Transgen & Knockout Core, Macau, Peoples R China.	xiaolingx@umac.mo; cxdeng@umac.mo			University of Macau, Macau SAR, China [2016-00088-FHS]; Macao Science and Technology Development Fund (FDCT) Grants [065/2015/A2, 094/2015/A3, 027/2015/A1, 111/2017/A]	University of Macau, Macau SAR, China; Macao Science and Technology Development Fund (FDCT) Grants	This work was supported by a Chair Professor Grant (to C. D.) and multi-year research Grant (MYRG) 2016-00088-FHS (to X. X.) by the University of Macau, Macau SAR, China, Macao Science and Technology Development Fund (FDCT) Grants 065/2015/A2, 094/2015/A3 (to C. D.), 027/2015/A1 (to X. X.), and 111/2017/A (to K. M.). The authors declare that they have no conflicts of interest with the contents of this article.	BELLUS GA, 1995, AM J HUM GENET, V56, P368; Chen S, 2016, INT J BIOL SCI, V12, P1427, DOI 10.7150/ijbs.17421; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; Chu V, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0234-4; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cui YB, 2018, INTERDISCIP SCI, V10, P455, DOI 10.1007/s12539-018-0298-z; DENG CX, 1992, MOL CELL BIOL, V12, P3365, DOI 10.1128/MCB.12.8.3365; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Kim ST, 2018, NAT METHODS, V15, P239, DOI [10.1038/NMETH.4554, 10.1038/nmeth.4554]; Knott GJ, 2018, SCIENCE, V361, P866, DOI 10.1126/science.aat5011; Lareau CA, 2018, NAT METHODS, V15, P238, DOI [10.1038/NMETH.4541, 10.1038/nmeth.4541]; Lescarbeau RM, 2018, NAT METHODS, V15, P237, DOI [10.1038/NMETH.4553, 10.1038/nmeth.4553]; Listgarten J, 2018, NAT BIOMED ENG, V2, P38, DOI 10.1038/s41551-017-0178-6; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Luther DC, 2018, EXPERT OPIN DRUG DEL, V15, P905, DOI 10.1080/17425247.2018.1517746; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Martin F, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091507; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Nutter LMJ, 2018, NAT METHODS, V15, P234, DOI 10.1038/NMETH.4559; Ornitz DM, 2017, DEV DYNAM, V246, P291, DOI 10.1002/dvdy.24479; Ou ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep32463; Rastogi A, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1143-1; STOILOV I, 1995, AM J MED GENET, V55, P127, DOI 10.1002/ajmg.1320550132; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Wang Jian-min, 2004, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V21, P537; Wang LR, 2015, SCI REP-UK, V5, DOI 10.1038/srep17517; Wilson CJ, 2018, NAT METHODS, V15, P235, DOI [10.1038/NMETH.4552, 10.1038/nmeth.4552, 10.1038/nmeth.4559]; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016; Yang Y, 2016, NAT BIOTECHNOL, V34, P334, DOI 10.1038/nbt.3469; Yao X, 2018, DEV CELL, V45, P526, DOI 10.1016/j.devcel.2018.04.021; Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884	34	8	9	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1142	1151		10.1074/jbc.RA118.006496	http://dx.doi.org/10.1074/jbc.RA118.006496			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30487289	hybrid, Green Published			2022-12-28	WOS:000457879500007
J	Shioi, N; Tadokoro, T; Shioi, S; Okabe, Y; Matsubara, H; Kita, S; Ose, T; Kuroki, K; Terada, S; Maenaka, K				Shioi, Narumi; Tadokoro, Takashi; Shioi, Seijiro; Okabe, Yuki; Matsubara, Haruki; Kita, Shunsuke; Ose, Toyoyuki; Kuroki, Kimiko; Terada, Shigeyuki; Maenaka, Katsumi			Crystal structure of the complex between venom toxin and serum inhibitor from Viperidae snake	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium channel; crystal structure; snake venom; inhibitor; serum; protein complex	ANTIHEMORRHAGIC FACTOR; CDNA CLONING; PROTEIN; PROSTATE; MODEL; MICROSEMINOPROTEIN; METALLOPROTEINASE; IDENTIFICATION; SEQUENCE; BETA	Venomous snakes have endogenous proteins that neutralize the toxicity of their venom components. We previously identified five small serum proteins (SSP-1-SSP-5) from a highly venomous snake belonging to the family Viperidae as inhibitors of various toxins from snake venom. The endogenous inhibitors belong to the prostate secretory protein of 94 amino acids (PSP94) family. SSP-2 interacts with triflin, which is a member of the cysteine-rich secretory protein (CRISP) family that blocks smooth muscle contraction. However, the structural basis for the interaction and the biological roles of these inhibitors are largely unknown. Here, we determined the crystal structure of the SSP-2-triflin complex at 2.3 A resolution. A concave region centrally located in the N-terminal domain of triflin is fully occupied by the terminal beta-strands of SSP-2. SSP-2 does not bind tightly to the C-terminal cysteine-rich domain of triflin; this domain is thought to be responsible for its channel-blocker function. Instead, the cysteine-rich domain is tilted 7.7 degrees upon binding to SSP-2, and the inhibitor appears to sterically hinder triflin binding to calcium channels. These results help explain how an endogenous inhibitor prevents the venomous protein from maintaining homeostasis in the host. Furthermore, this interaction also sheds light on the binding interface between the human homologues PSP94 and CRISP-3, which are up-regulated in prostate and ovarian cancers.	[Shioi, Narumi; Okabe, Yuki; Terada, Shigeyuki] Fukuoka Univ, Fac Sci, Dept Chem, Jonan Ku, 19-1,8 Chome Nanakuma, Fukuoka, Fukuoka 8140180, Japan; [Tadokoro, Takashi; Matsubara, Haruki; Kita, Shunsuke; Ose, Toyoyuki; Kuroki, Kimiko; Maenaka, Katsumi] Hokkaido Univ, Fac Pharmaceut Sci, Kita Ku, Kita 12,Nishi 6, Sapporo, Hokkaido 0600812, Japan; [Shioi, Seijiro] Fukuoka Univ, Radioisotope Ctr, Fukuoka, Fukuoka 8140180, Japan	Fukuoka University; Hokkaido University; Fukuoka University	Shioi, N (corresponding author), Fukuoka Univ, Fac Sci, Dept Chem, Jonan Ku, 19-1,8 Chome Nanakuma, Fukuoka, Fukuoka 8140180, Japan.; Tadokoro, T; Maenaka, K (corresponding author), Hokkaido Univ, Fac Pharmaceut Sci, Kita Ku, Kita 12,Nishi 6, Sapporo, Hokkaido 0600812, Japan.	anarumi@fukuoka-u.ac.jp; tadokorot@pharm.hokudai.ac.jp; maenaka@pharm.hokudai.ac.jp	Ose, Toyoyuki/AAW-7821-2020	Ose, Toyoyuki/0000-0002-2001-9388; maenaka, katsumi/0000-0002-5459-521X; Kita, Shunsuke/0000-0003-3969-302X	NMR Facility Yokohama Institute, RIKEN; Central Research Institute of Fukuoka University [131042]; Female Researcher Support Programme of Fukuoka University; JSPS KAKENHI [22121007]; Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS)) from AMED [18am0101093j0002]; Hokkaido University; Global Facility Center (GFC); Pharma Science Open Unit (PSOU) - MEXT; Hokkaido University Biosurface Project; Takeda Science Foundation	NMR Facility Yokohama Institute, RIKEN; Central Research Institute of Fukuoka University; Female Researcher Support Programme of Fukuoka University; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS)) from AMED; Hokkaido University; Global Facility Center (GFC); Pharma Science Open Unit (PSOU) - MEXT; Hokkaido University Biosurface Project; Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by the NMR Facility Yokohama Institute, RIKEN, to provide insight into structural information of the SSP-2-triflin complex. This work was supported in part by the Central Research Institute of Fukuoka University Grant 131042 and supported by the Female Researcher Support Programme of Fukuoka University (to N.S.). This work was partly supported by JSPS KAKENHI Grant 22121007, Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS)) from AMED under Grant 18am0101093j0002, Hokkaido University, Global Facility Center (GFC), Pharma Science Open Unit (PSOU), funded by MEXT under "Support Program for Implementation of New Equipment Sharing System," Hokkaido University Biosurface Project, and Takeda Science Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aoki N, 2008, GENE, V426, P7, DOI 10.1016/j.gene.2008.08.021; Aoki N, 2008, BBA-PROTEINS PROTEOM, V1784, P621, DOI 10.1016/j.bbapap.2007.12.010; Aoki N, 2007, BIOCHEM BIOPH RES CO, V359, P330, DOI 10.1016/j.bbrc.2007.05.091; Asmann YW, 2002, CANCER RES, V62, P3308; Breed AA, 2013, BBA-GEN SUBJECTS, V1830, P3019, DOI 10.1016/j.bbagen.2013.01.015; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Deshimaru M, 2005, TOXICON, V46, P937, DOI 10.1016/j.toxicon.2005.09.003; Dunn RD, 2001, BBA-MOL CELL BIOL L, V1533, P29, DOI 10.1016/S1388-1981(01)00138-X; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ghasriani H, 2009, BIOCHEM BIOPH RES CO, V378, P235, DOI 10.1016/j.bbrc.2008.11.040; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Grande G, 2017, CLIN PROTEOM, V14, DOI 10.1186/s12014-017-9142-4; Guo M, 2005, J BIOL CHEM, V280, P12405, DOI 10.1074/jbc.M413566200; Hansson K, 2009, TOXICON, V54, P128, DOI 10.1016/j.toxicon.2009.03.023; Kasturiratne A, 2008, PLOS MED, V5, P1591, DOI 10.1371/journal.pmed.0050218; Kratzschmar J, 1996, EUR J BIOCHEM, V236, P827, DOI 10.1111/j.1432-1033.1996.t01-1-00827.x; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar A, 2010, J MOL BIOL, V397, P947, DOI 10.1016/j.jmb.2010.02.035; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Ma J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.64; Masuda S, 2001, EUR J BIOCHEM, V268, P3339, DOI 10.1046/j.1432-1327.2001.02246.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Shikamoto Y, 2005, J MOL BIOL, V350, P735, DOI 10.1016/j.jmb.2005.05.020; Shioi N, 2015, J BIOCHEM, V158, P37, DOI 10.1093/jb/mvv017; Shioi N, 2014, BIOSCI BIOTECH BIOCH, V78, P410, DOI 10.1080/09168451.2014.890030; Suzuki N, 2008, ACTA CRYSTALLOGR D, V64, P1034, DOI 10.1107/S0907444908023512; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Whitaker HC, 2010, PROSTATE, V70, P333, DOI 10.1002/pros.21059; YAMAKAWA Y, 1992, J BIOCHEM-TOKYO, V112, P583, DOI 10.1093/oxfordjournals.jbchem.a123944; Yamazaki Y, 2004, TOXICON, V44, P227, DOI 10.1016/j.toxicon.2004.05.023; Yamazaki Y, 2002, EUR J BIOCHEM, V269, P2708, DOI 10.1046/j.1432-1033.2002.02940.x; Zhou Q, 2008, BIOPHYS J, V95, P4289, DOI 10.1529/biophysj.108.137224	35	8	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1250	1256		10.1074/jbc.RA118.006840	http://dx.doi.org/10.1074/jbc.RA118.006840			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30504218	Green Published, hybrid			2022-12-28	WOS:000457879500016
J	Hwang, JS; Kim, KH; Park, J; Kim, SM; Cho, H; Lee, Y; Han, IO				Hwang, Ji-Sun; Kim, Kyung-Hong; Park, Jiwon; Kim, Sang-Min; Cho, Hyeongjin; Lee, Yunkyoung; Han, Inn-Oc			Glucosamine improves survival in a mouse model of sepsis and attenuates sepsis-induced lung injury and inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						O-GlcNAcylation; sepsis; inflammation; lung injury; glucose metabolism	NF-KAPPA-B; NITRIC-OXIDE SYNTHASE; O-GLCNACYLATION; POLARIZATION; EXPRESSION; RESOLUTION; ZEBRAFISH; INDUCTION; PROTEIN; GLCNAC	The aim of the current study was to investigate the effects of glucosamine (GlcN) on septic lethality and sepsis-induced inflammation using animal models of mice and zebrafish. GlcN pretreatment improved survival in the cecal ligation and puncture (CLP)-induced sepsis mouse model and attenuated lipopolysaccharide (LPS)-induced septic lung injury and systemic inflammation. GlcN suppressed LPS-induced M1-specific but not M2-specific gene expression. Furthermore, increased expressions of inflammatory genes in visceral tissue of LPS-injected zebrafish were suppressed by GlcN. GlcN suppressed LPS-induced activation of mitogen-activated protein kinase (MAPK) and NF-B in lung tissue. LPS triggered a reduction in O-GlcNAc levels in nucleocytoplasmic proteins of lung, liver, and spleen after 1 day, which returned to normal levels at day 3. GlcN inhibited LPS-induced O-GlcNAc down-regulation in mouse lung and visceral tissue of zebrafish. Furthermore, the O-GlcNAcase (OGA) level was increased by LPS, which were suppressed by GlcN in mouse and zebrafish. OGA inhibitors suppressed LPS-induced expression of inflammatory genes in RAW264.7 cells and the visceral tissue of zebrafish. Stable knockdown of Oga via short hairpin RNA led to increased inducible nitric oxide synthase (iNOS) expression in response to LPS with or without GlcN in RAW264.7 cells. Overall, our results demonstrate a protective effect of GlcN on sepsis potentially through modulation of O-GlcNAcylation of nucleocytoplasmic proteins.	[Hwang, Ji-Sun; Kim, Kyung-Hong; Park, Jiwon; Kim, Sang-Min; Lee, Yunkyoung; Han, Inn-Oc] Inha Univ, Coll Med, Dept Physiol & Biophys, 100 Inha Ro, Incheon 22212, South Korea; [Cho, Hyeongjin] Inha Univ, Dept Chem, Incheon, South Korea	Inha University; Inha University	Han, IO (corresponding author), Inha Univ, Coll Med, Dept Physiol & Biophys, 100 Inha Ro, Incheon 22212, South Korea.	iohan@inha.ac.kr			National Research Foundation (NRF) of Korea [NRF-2017R1A2B2007199, NRF-2016R1D1A1B03934289, NRF-2017R1C1B1007283]; WCSL (World Class Smart Lab) research grant of Inha University	National Research Foundation (NRF) of Korea(National Research Foundation of Korea); WCSL (World Class Smart Lab) research grant of Inha University	This work was supported by National Research Foundation (NRF) of Korea Grants NRF-2017R1A2B2007199, NRF-2016R1D1A1B03934289, and NRF-2017R1C1B1007283 and a WCSL (World Class Smart Lab) research grant of Inha University. The authors declare that they have no conflicts of interest with the contents of this article.	Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Bai D, 2009, INT J CANCER, V125, P2863, DOI 10.1002/ijc.24748; Butkinaree C, 2010, BBA-GEN SUBJECTS, V1800, P96, DOI 10.1016/j.bbagen.2009.07.018; Chou WY, 2015, J CELL PHYSIOL, V230, P2240, DOI 10.1002/jcp.24955; Chuang KH, 2013, AM J RESP CELL MOL, V49, P1110, DOI 10.1165/rcmb.2013-0022OC; Comer FI, 2000, J BIOL CHEM, V275, P29179, DOI 10.1074/jbc.R000010200; D'Alessio FR, 2012, J IMMUNOL, V189, P2234, DOI 10.4049/jimmunol.1102606; Fan J, 2001, AM J PHYSIOL-LUNG C, V281, pL1037, DOI 10.1152/ajplung.2001.281.5.L1037; Fleischmann C, 2016, AM J RESP CRIT CARE, V193, P259, DOI 10.1164/rccm.201504-0781OC; Forn-Cuni G, 2017, SCI REP-UK, V7, DOI 10.1038/srep41905; Fulop N, 2007, AM J PHYSIOL-HEART C, V292, pH2227, DOI 10.1152/ajpheart.01091.2006; Morales MG, 2015, CLIN SCI, V129, P461, DOI 10.1042/CS20140840; Hasan Z, 2011, SHOCK, V35, P567, DOI 10.1097/SHK.0b013e3182144935; He YT, 2017, J CEREBR BLOOD F MET, V37, P2938, DOI 10.1177/0271678X16679671; Hu P, 2010, FEBS LETT, V584, P2526, DOI 10.1016/j.febslet.2010.04.044; Hwang JS, 2017, J BIOL CHEM, V292, P1724, DOI 10.1074/jbc.M116.737940; Hwang SY, 2013, AM J PHYSIOL-CELL PH, V305, pC601, DOI 10.1152/ajpcell.00042.2013; Hwang SY, 2010, GLIA, V58, P1881, DOI 10.1002/glia.21058; Kabir K, 2002, SHOCK, V17, P300, DOI 10.1097/00024382-200204000-00010; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Levy BD, 2014, ANNU REV PHYSIOL, V76, P467, DOI 10.1146/annurev-physiol-021113-170408; Liao LF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02490-w; Lien E, 2000, J CLIN INVEST, V105, P497, DOI 10.1172/JCI8541; Lieschke GJ, 2009, CURR BIOL, V19, pR678, DOI 10.1016/j.cub.2009.06.068; Novoa B, 2009, FISH SHELLFISH IMMUN, V26, P326, DOI 10.1016/j.fsi.2008.12.004; Poli-De-Figueiredo LF, 2008, SHOCK, V30, P53, DOI 10.1097/SHK.0b013e318181a343; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Sakaguchi M, 2014, ANESTHESIOLOGY, V121, P1248, DOI 10.1097/ALN.0000000000000456; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Stachura DL, 2013, BLOOD, V122, P3918, DOI 10.1182/blood-2012-12-475392; Sunyer JO, 2013, NAT IMMUNOL, V14, P320, DOI 10.1038/ni.2549; Thimmulappa RK, 2006, J CLIN INVEST, V116, P984, DOI 10.1172/JCI25790; Toleman C, 2004, J BIOL CHEM, V279, P53665, DOI 10.1074/jbc.M410406200; Trede NS, 2004, IMMUNITY, V20, P367, DOI 10.1016/S1074-7613(04)00084-6; Tsai CY, 2009, J CELL BIOCHEM, V108, P489, DOI 10.1002/jcb.22278; van der Vaart Michiel, 2012, Adv Hematol, V2012, P159807, DOI 10.1155/2012/159807; Wang N, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00614; Wong J M, 1995, Adv Pharmacol, V34, P155; Zhang DM, 2015, INFLAMM RES, V64, P943, DOI 10.1007/s00011-015-0877-y; Zheng GM, 2012, INT J ONCOL, V40, P1610, DOI 10.3892/ijo.2012.1331	41	52	56	3	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2019	294	2					608	622		10.1074/jbc.RA118.004638	http://dx.doi.org/10.1074/jbc.RA118.004638			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HI2GP	30455348	hybrid, Green Published			2022-12-28	WOS:000456263600018
J	Nile, AH; Hannoush, RN				Nile, Aaron H.; Hannoush, Rami N.			Fatty acid recognition in the Frizzled receptor family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						fatty acid; Wnt signaling; lipid-protein interaction; dimerization; stem cells; cancer; G protein-coupled receptor (GPCR); cell signaling; binding; cysteine-rich domain (CRD); frizzled (FZD); glycoprotein; lipid-binding protein; glycoprotein	STRUCTURAL BASIS; VASCULAR DEVELOPMENT; WNT RECOGNITION; SECRETION; PROTEINS; IDENTIFICATION; DIMERIZATION; DESATURASE; EXPRESSION; ACYLATION	Wnt signaling regulates physiological processes ranging from cell differentiation to bone formation. Dysregulation of Wnt signaling is linked to several human ailments, including colorectal, pancreatic, and breast cancers. As such, modulation of this pathway has been an attractive strategy for therapeutic development of anticancer agents. Since the discovery of Wnt proteins more than 35 years ago, research efforts continue to focus on understanding the biochemistry of their molecular interactions and their biological functions. Wnt is a secreted glycoprotein covalently modified with a cis-unsaturated fatty acyl group at a conserved serine residue, and this modification is required for Wnt secretion and activity. To initiate signaling, Wnt proteins bind to cell-surface Frizzled (FZD) receptors, but the molecular basis for recognition of Wnt's fatty acyl moiety by the extracellular cysteine-rich domain of FZD has become clear only very recently. Here, we review the most recent developments in the field, focusing on structural and biochemical studies of the FZD receptor family and highlighting new insights into their molecular arrangement and mode of regulation by cis-unsaturated fatty acids. Additionally, we examine how other lipid-binding proteins recognize fatty acyl chains on Wnt proteins in the regulation of Wnt secretion and activities. Altogether, this perspective expands our understanding of fatty acid-protein interactions in the FZD system and provides a basis for guiding future research in the field.	[Nile, Aaron H.; Hannoush, Rami N.] Genentech Inc, Dept Early Discovery Biochem, 1 DNA Way, San Francisco, CA 94080 USA	Roche Holding; Genentech	Hannoush, RN (corresponding author), Genentech Inc, Dept Early Discovery Biochem, 1 DNA Way, San Francisco, CA 94080 USA.	hannoush.rami@gene.com		Nile, Aaron/0000-0002-7370-8769				Altamirano A, 2018, J PROTEOME RES, V17, P1269, DOI 10.1021/acs.jproteome.7b00867; Bafico A, 1999, J BIOL CHEM, V274, P16180, DOI 10.1074/jbc.274.23.16180; Bai YH, 2015, NATURE, V524, P252, DOI 10.1038/nature14549; Banziger C, 2006, CELL, V125, P509, DOI 10.1016/j.cell.2006.02.049; Barrott JJ, 2011, P NATL ACAD SCI USA, V108, P12752, DOI 10.1073/pnas.1006437108; Bartscherer K, 2006, CELL, V125, P523, DOI 10.1016/j.cell.2006.04.009; Bazan JF, 2012, DEV CELL, V23, P227, DOI 10.1016/j.devcel.2012.07.011; Carron C, 2003, J CELL SCI, V116, P2541, DOI 10.1242/jcs.00451; Chang TH, 2015, ELIFE, V4, DOI 10.7554/eLife.06554; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chen P, 2018, SCIENCE, V360, P664, DOI 10.1126/science.aar1999; Coombs GS, 2010, J CELL SCI, V123, P3357, DOI 10.1242/jcs.072132; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601; DeBruine ZJ, 2017, GENE DEV, V31, P916, DOI 10.1101/gad.298331.117; Flanagan DJ, 2015, STEM CELL REP, V4, P759, DOI 10.1016/j.stemcr.2015.03.003; Galli LM, 2014, DEV DYNAM, V243, P833, DOI 10.1002/dvdy.24123; Gao XX, 2014, NAT CHEM BIOL, V10, P61, DOI [10.1038/NCHEMBIO.1392, 10.1038/nchembio.1392]; Goodman RM, 2006, DEVELOPMENT, V133, P4901, DOI 10.1242/dev.02674; Herr P, 2012, DEV BIOL, V361, P392, DOI 10.1016/j.ydbio.2011.11.003; Huang HC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-234; Janda CY, 2017, NATURE, V545, P234, DOI 10.1038/nature22306; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Kakugawa S, 2015, NATURE, V519, P187, DOI 10.1038/nature14259; Kaykas A, 2004, NAT CELL BIOL, V6, P52, DOI 10.1038/ncb1081; Kumar S, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-44; Mihara E, 2016, ELIFE, V5, DOI 10.7554/eLife.11621; Miranda M, 2014, FEBS LETT, V588, P4815, DOI 10.1016/j.febslet.2014.11.016; Najdi R, 2012, DIFFERENTIATION, V84, P203, DOI 10.1016/j.diff.2012.06.004; Naschberger A, 2017, STRUCTURE, V25, P1907, DOI 10.1016/j.str.2017.10.006; Nile AH, 2018, NAT CHEM BIOL, V14, P582, DOI 10.1038/s41589-018-0035-2; Nile AH, 2017, P NATL ACAD SCI USA, V114, P4147, DOI 10.1073/pnas.1618293114; Nile AH, 2016, NAT CHEM BIOL, V12, P60, DOI [10.1038/NCHEMBIO.2005, 10.1038/nchembio.2005]; Phesse T, 2016, CANCERS, V8, pE50; Rios-Esteves J, 2014, J BIOL CHEM, V289, P17009, DOI 10.1074/jbc.M114.561209; Rios-Esteves J, 2013, CELL REP, V4, P1072, DOI 10.1016/j.celrep.2013.08.027; Shen GB, 2015, CELL RES, V25, P1078, DOI 10.1038/cr.2015.92; Smallwood PM, 2007, J BIOL CHEM, V282, P4057, DOI 10.1074/jbc.M609618200; Steinhart Z, 2017, NAT MED, V23, P60, DOI 10.1038/nm.4219; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Tao L, 2016, NATURE, V538, P350, DOI 10.1038/nature19799; Wang H, 2015, NAT STRUCT MOL BIOL, V22, P581, DOI 10.1038/nsmb.3049; Wang YS, 2012, CELL, V151, P1332, DOI 10.1016/j.cell.2012.10.042; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wilson MA, 2017, STRUCTURE, V25, P1781, DOI 10.1016/j.str.2017.11.009; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8; Yang SF, 2018, NATURE, V560, P666, DOI 10.1038/s41586-018-0447-x; Zhang XJ, 2015, DEV CELL, V32, P719, DOI 10.1016/j.devcel.2015.02.014	47	12	12	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2019	294	2					726	736		10.1074/jbc.REV118.005205	http://dx.doi.org/10.1074/jbc.REV118.005205			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HI2GP	30530496	Green Published, hybrid			2022-12-28	WOS:000456263600027
J	Hirota, A; Nakajima-Koyama, M; Ashida, Y; Nishida, E				Hirota, Akira; Nakajima-Koyama, May; Ashida, Yuhei; Nishida, Eisuke			The nucleosome remodeling and deacetylase complex protein CHD4 regulates neural differentiation of mouse embryonic stem cells by down-regulating p53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						embryonic stem cell; neurodifferentiation; nucleosome remodeling deacetylase (NuRD); p53; protein degradation; chromodomain helicase DNA-binding protein 4 (CHD4); lineage specification; methyl-CpG binding domain protein 3 (MBD3)	HISTONE DEACETYLASE; NURD; PLURIPOTENCY; EXPRESSION; MI-2-BETA; GENE; SPECIFICITY; COMMITMENT; INDUCTION; BRACHYURY	Lineage specification of the three germ layers occurs during early embryogenesis and is critical for normal development. The nucleosome remodeling and deacetylase (NuRD) complex is a repressive chromatin modifier that plays a role in lineage commitment. However, the role of chromodomain helicase DNA-binding protein 4 (CHD4), one of the core subunits of the NuRD complex, in neural lineage commitment is poorly understood. Here, we report that the CHD4/NuRD complex plays a critical role in neural differentiation of mouse embryonic stem cells (ESCs). We found that RNAi-mediated Chd4 knockdown suppresses neural differentiation, as did knockdown of methyl-CpG-binding domain protein Mbd3, another NuRD subunit. Chd4 and Mbd3 knockdowns similarly affected changes in global gene expression during neural differentiation and up-regulated several mesendodermal genes. However, inhibition of mesendodermal genes by knocking out the master regulators of mesendodermal lineages, Brachyury and Eomes, through a CRISPR/Cas9 approach could not restore the impaired neural differentiation caused by the Chd4 knockdown, suggesting that CHD4 controls neural differentiation by not repressing other lineage differentiation processes. Notably, Chd4 knockdown increased the acetylation levels of p53, resulting in increased protein levels of p53. Double knockdown of Chd4 and p53 restored the neural differentiation rate. Furthermore, overexpression of BCL2, a downstream factor of p53, partially rescued the impaired neural differentiation caused by the Chd4 knockdown. Our findings reveal that the CHD4/NuRD complex regulates neural differentiation of ESCs by down-regulating p53.	[Hirota, Akira; Nakajima-Koyama, May; Ashida, Yuhei; Nishida, Eisuke] Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Sakyo Ku, Kyoto 6068502, Japan; [Nakajima-Koyama, May; Nishida, Eisuke] AMED CREST, Chiyoda Ku, 1-7-1 Otemachi, Tokyo 1000004, Japan	Kyoto University	Nakajima-Koyama, M (corresponding author), Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Sakyo Ku, Kyoto 6068502, Japan.; Nakajima-Koyama, M (corresponding author), AMED CREST, Chiyoda Ku, 1-7-1 Otemachi, Tokyo 1000004, Japan.; Nishida, E (corresponding author), RIKEN Ctr Biosyst Dynam Res, Lab Mol Biol Aging, Chuou Ku, 2-2-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	mnakajima.m07@lif.kyoto-u.ac.jp; nishida@lif.kyoto-u.ac.jp		Hirota, Akira/0000-0003-3301-089X				Allen HF, 2013, CELL MOL LIFE SCI, V70, P3513, DOI 10.1007/s00018-012-1256-2; Aloia L, 2014, GENE DEV, V28, P182, DOI 10.1101/gad.228510.113; Amaya M, 2013, BLOOD, V121, P3493, DOI 10.1182/blood-2012-11-466227; Arnold SJ, 2009, NAT REV MOL CELL BIO, V10, P91, DOI 10.1038/nrm2618; Baubec T, 2013, CELL, V153, P480, DOI 10.1016/j.cell.2013.03.011; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Costello I, 2011, NAT CELL BIOL, V13, P1084, DOI 10.1038/ncb2304; Faial T, 2015, DEVELOPMENT, V142, P2121, DOI 10.1242/dev.117838; Gomez-del Arco P, 2016, CELL METAB, V23, P881, DOI 10.1016/j.cmet.2016.04.008; Hassig CA, 1998, P NATL ACAD SCI USA, V95, P3519, DOI 10.1073/pnas.95.7.3519; Hemann MT, 2006, CELL DEATH DIFFER, V13, P1256, DOI 10.1038/sj.cdd.4401962; Hoch RV, 2006, DEVELOPMENT, V133, P663, DOI 10.1242/dev.02242; Hosokawa H, 2013, P NATL ACAD SCI USA, V110, P4691, DOI 10.1073/pnas.1220865110; Huang CY, 2017, GENE DEV, V31, P241, DOI 10.1101/gad.292169.116; Huang CY, 2010, CELL RES, V20, P154, DOI 10.1038/cr.2010.5; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; Iwafuchi-Doi M, 2012, DEVELOPMENT, V139, P3926, DOI 10.1242/dev.085936; Izumi N, 2007, STEM CELLS, V25, P1664, DOI 10.1634/stemcells.2006-0681; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Kalisz M, 2012, DEV BIOL, V362, P94, DOI 10.1016/j.ydbio.2011.11.017; Kamiya D, 2011, NATURE, V470, P503, DOI 10.1038/nature09726; Kashiwagi M, 2007, DEVELOPMENT, V134, P1571, DOI 10.1242/dev.001750; Knock E, 2015, NEURAL DEV, V10, DOI 10.1186/s13064-015-0040-z; Le Guezennec X, 2006, MOL CELL BIOL, V26, P843, DOI 10.1128/MCB.26.3.843-851.2006; Lolas M, 2014, P NATL ACAD SCI USA, V111, P4478, DOI 10.1073/pnas.1402612111; Masui S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni043; Munoz-Sanjuan I, 2002, NAT REV NEUROSCI, V3, P271, DOI 10.1038/nrn786; Nitarska J, 2016, CELL REP, V17, P1683, DOI 10.1016/j.celrep.2016.10.022; O'Shaughnessy-Kirwan A, 2015, DEVELOPMENT, V142, P2586, DOI 10.1242/dev.125450; Polo SE, 2010, EMBO J, V29, P3130, DOI 10.1038/emboj.2010.188; Reynolds N, 2012, CELL STEM CELL, V10, P583, DOI 10.1016/j.stem.2012.02.020; Spruijt CG, 2010, MOL BIOSYST, V6, P1700, DOI 10.1039/c004108d; Teo AKK, 2011, GENE DEV, V25, P238, DOI 10.1101/gad.607311; Thornton SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110498; Trouillas M, 2008, CELL DEATH DIFFER, V15, P1450, DOI 10.1038/cdd.2008.63; Williams CJ, 2004, IMMUNITY, V20, P719, DOI 10.1016/j.immuni.2004.05.005; Wilson SI, 2001, NAT NEUROSCI, V4, P1161, DOI 10.1038/nn747; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Yildirim O, 2011, CELL, V147, P1498, DOI 10.1016/j.cell.2011.11.054; Yoshida T, 2008, GENE DEV, V22, P1174, DOI 10.1101/gad.1642808; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4; Zhao HX, 2017, J BIOL CHEM, V292, P8507, DOI 10.1074/jbc.M116.770248	43	5	5	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2019	294	1					195	209		10.1074/jbc.RA118.004086	http://dx.doi.org/10.1074/jbc.RA118.004086			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG6PT	30409903	hybrid, Green Published			2022-12-28	WOS:000455105500023
J	Li, FF; Lang, YE; Ji, ZL; Xia, ZQ; Han, YW; Cheng, YT; Liu, GM; Sun, F; Zhao, YH; Gao, MJ; Chen, ZY; Wu, YL; Li, WX; Cao, ZJ				Li, Fangfang; Lang, Yange; Ji, Zhenglin; Xia, Zhiqiang; Han, Yuewen; Cheng, Yuting; Liu, Gaomin; Sun, Fang; Zhao, Yonghui; Gao, Minjun; Chen, Zongyun; Wu, Yingliang; Li, Wenxin; Cao, Zhijian			A scorpion venom peptide Ev37 restricts viral late entry by alkalizing acidic organelles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						peptides; infection; dengue virus (DENV); hepatitis C virus (HCV); virus entry; antiviral agent; antiviral mechanism; antiviral peptide; dengue virus; scorpion venom peptide; Zika virus; herpes simplex virus; membrane fusion; endosome	INHIBITORY-ACTIVITY; VIRUS-INFECTION; HOST-CELLS; BIOAVAILABILITY; ACIDIFICATION; REPLICATION; EXPRESSION; TARGETS	Viral infections still threaten human health all over the world, and many people die from viral diseases every year. However, there are no effective vaccines or drugs for preventing or managing most viral diseases. Thus, the discovery and development of broad-spectrum antiviral agents remain urgent. Here, we expressed and purified a venom peptide, Ev37, from the scorpion Euscorpiops validus in a prokaryotic system. We found that rEv37 can inhibit dengue virus type 2 (DENV-2), hepatitis C virus (HCV), Zika virus (ZIKV), and herpes simplex virus type 1 (HSV-1) infections in a dose-dependent manner at noncytotoxic concentrations, but that it has no effect on Sendai virus (SeV) and adenovirus (AdV) infections in vitro. Furthermore, rEv37 alkalized acidic organelles to prevent low pH-dependent fusion of the viral membrane-endosomal membrane, which mainly blocks the release of the viral genome from the endosome to the cytoplasm and then restricts viral late entry. Taken together, our results indicate that the scorpion venom peptide Ev37 is a broad-spectrum antiviral agent with a specific molecular mechanism against viruses undergoing low pH-dependent fusion activation during entry into host cells. We conclude that Ev37 is a potential candidate for development as an antiviral drug.	[Li, Fangfang; Lang, Yange; Ji, Zhenglin; Xia, Zhiqiang; Han, Yuewen; Cheng, Yuting; Liu, Gaomin; Sun, Fang; Zhao, Yonghui; Gao, Minjun; Chen, Zongyun; Wu, Yingliang; Li, Wenxin; Cao, Zhijian] Wuhan Univ, State Key Lab Virol, Modern Virol Res Ctr, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China; [Wu, Yingliang; Li, Wenxin; Cao, Zhijian] Wuhan Univ, Biodrug Res Ctr, Wuhan 430072, Hubei, Peoples R China; [Cao, Zhijian] Wuhan Univ, Hubei Prov Engn & Technol Res, Ctr Fluorinated Pharmaceut, Wuhan 430072, Hubei, Peoples R China	Wuhan University; Wuhan University; Wuhan University	Cao, ZJ (corresponding author), Wuhan Univ, State Key Lab Virol, Modern Virol Res Ctr, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China.	zjcao@whu.edu.cn						Bagh MB, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14612; Carballar-Lejarazu R, 2008, CELL MOL LIFE SCI, V65, P3081, DOI 10.1007/s00018-008-8250-8; Cheng G, 2008, P NATL ACAD SCI USA, V105, P3088, DOI 10.1073/pnas.0712380105; Conde R, 2000, FEBS LETT, V471, P165, DOI 10.1016/S0014-5793(00)01384-3; El-Bitar AMH, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0276-6; FAN DP, 1978, CELL, V15, P985, DOI 10.1016/0092-8674(78)90282-9; Feng J, 2013, PROTEIN EXPRES PURIF, V88, P127, DOI 10.1016/j.pep.2012.12.004; Goh KCM, 2016, SCI REP-UK, V6, DOI 10.1038/srep26100; da Mata ECG, 2017, J VENOM ANIM TOXINS, V23, DOI 10.1186/s40409-016-0089-0; Hong W, 2013, BIOMATERIALS, V34, P3511, DOI 10.1016/j.biomaterials.2013.01.075; Hover S, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006845; Huang S, 1999, J VIROL, V73, P2798, DOI 10.1128/JVI.73.4.2798-2802.1999; Jones JC, 2006, J VIROL, V80, P11960, DOI 10.1128/JVI.01678-06; Kang S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003084; Kaptein SJF, 2016, CURR OPIN PHARMACOL, V30, P1, DOI 10.1016/j.coph.2016.06.002; Li ZJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097539; Lin LT, 2015, J HEPATOL, V62, P541, DOI 10.1016/j.jhep.2014.10.040; Low JG, 2014, LANCET INFECT DIS, V14, P706, DOI 10.1016/S1473-3099(14)70730-3; Marvin SA, 2012, BIOL CELL, V104, P188, DOI 10.1111/boc.201100096; Mercer J, 2010, ANNU REV BIOCHEM, V79, P803, DOI 10.1146/annurev-biochem-060208-104626; Narayana SK, 2015, J BIOL CHEM, V290, P25946, DOI 10.1074/jbc.M115.657346; Nicola AV, 2016, TRAFFIC, V17, P965, DOI 10.1111/tra.12408; Paul D, 2014, CELL HOST MICROBE, V16, P569, DOI 10.1016/j.chom.2014.10.008; Rattanaburee T, 2015, ANTIVIR RES, V124, P83, DOI 10.1016/j.antiviral.2015.10.005; Ravindran MS, 2016, NAT REV MICROBIOL, V14, P407, DOI 10.1038/nrmicro.2016.60; Rodenhuis-Zybert IA, 2010, CELL MOL LIFE SCI, V67, P2773, DOI 10.1007/s00018-010-0357-z; Sakurai Y, 2015, SCIENCE, V347, P995, DOI 10.1126/science.1258758; Scott CC, 2011, BIOESSAYS, V33, P103, DOI 10.1002/bies.201000108; Shan C, 2018, J VIROL, V92, DOI 10.1128/JVI.01002-18; Sinha S, 2003, ANTIMICROB AGENTS CH, V47, P494, DOI 10.1128/AAC.47.2.494-500.2003; Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213; van der Schaar HM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000244; Wiethoff CM, 2005, J VIROL, V79, P1992, DOI 10.1128/JVI.79.4.1992-2000.2005; Yacoub Sophie, 2016, F1000Res, V5, DOI 10.12688/f1000research.6233.1; Yang DQ, 2012, J BONE MINER RES, V27, P1695, DOI 10.1002/jbmr.1623; Zeng XC, 2012, PEPTIDES, V33, P44, DOI 10.1016/j.peptides.2011.11.012; Zeng ZY, 2018, THERANOSTICS, V8, P199, DOI 10.7150/thno.21425; Zeng ZY, 2016, TOXINS, V8, DOI 10.3390/toxins8050124; Zhao ZH, 2012, J BIOL CHEM, V287, P30181, DOI 10.1074/jbc.M112.370312	39	16	16	2	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2019	294	1					182	194		10.1074/jbc.RA118.005015	http://dx.doi.org/10.1074/jbc.RA118.005015			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG6PT	30404919	Green Published, hybrid			2022-12-28	WOS:000455105500022
J	Yang, YY; Hu, JC; Selby, CP; Li, WT; Yimit, A; Jiang, YC; Sancar, A				Yang, Yanyan; Hu, Jinchuan; Selby, Christopher P.; Li, Wentao; Yimit, Askar; Jiang, Yuchao; Sancar, Aziz			Single-nucleotide resolution analysis of nucleotide excision repair of ribosomal DNA in humans and mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						precursor ribosomal RNA (pre-rRNA); DNA repair; DNA damage; DNA transcription; bioinformatics; transcription-coupled repair; XR-seq	RNA-POLYMERASE-II; TRANSCRIPTION-COUPLED REPAIR; COCKAYNE-SYNDROME; UV DAMAGE; GROUP-C; MECHANISMS; INITIATION; CHROMATIN; PROTEIN; GENOME	The unique nucleolar environment, the repetitive nature of ribosomal DNA (rDNA), and especially the possible involvement of RNA polymerase I (RNAPI) in transcription-coupled repair (TCR) have made the study of repair of rDNA both interesting and challenging. TCR, the transcription-dependent, preferential excision repair of the template strand compared with the nontranscribed (coding) strand has been clearly demonstrated in genes transcribed by RNAPII. Whether TCR occurs in rDNA is unresolved. In the present work, we have applied analytical methods to map repair events in rDNA using data generated by the newly developed XR-seq procedure, which measures excision repair genome-wide with single-nucleotide resolution. We find that in human and mouse cell lines, rDNA is not subject to TCR of damage caused by UV or by cisplatin.	[Yang, Yanyan; Hu, Jinchuan; Selby, Christopher P.; Li, Wentao; Yimit, Askar; Sancar, Aziz] Univ N Carolina, Dept Biochem & Biophys, Sch Med, Chapel Hill, NC 27599 USA; [Jiang, Yuchao] Univ N Carolina, Dept Biostat & Genet, Chapel Hill, NC 27599 USA; [Jiang, Yuchao; Sancar, Aziz] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Hu, Jinchuan] Fudan Univ, Peoples Hosp Shanghai 5, Shanghai 200032, Peoples R China; [Hu, Jinchuan] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Fudan University; Fudan University	Sancar, A (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Sch Med, Chapel Hill, NC 27599 USA.; Jiang, YC (corresponding author), Univ N Carolina, Dept Biostat & Genet, Chapel Hill, NC 27599 USA.; Jiang, YC; Sancar, A (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	yuchaoj@email.unc.edu; aziz_sancar@med.unc.edu	Li, Wentao/AAU-1637-2020	Li, Wentao/0000-0003-2313-6384; Jiang, Yuchao/0000-0001-6905-6377; Hu, Jinchuan/0000-0001-7096-0195	NATIONAL CANCER INSTITUTE [P01CA142538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126, R01ES027255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118102] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA142538] Funding Source: Medline; NIEHS NIH HHS [R01 ES027255, P30 ES010126] Funding Source: Medline; NIGMS NIH HHS [R35 GM118102] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adebali O, 2017, J BIOL CHEM, V292, P18386, DOI 10.1074/jbc.C117.818807; Andrade-Lima LC, 2015, NUCLEIC ACIDS RES, V43, P2744, DOI 10.1093/nar/gkv148; Barnett DW, 2011, BIOINFORMATICS, V27, P1691, DOI 10.1093/bioinformatics/btr174; Charton R, 2015, DNA REPAIR, V36, P49, DOI 10.1016/j.dnarep.2015.09.007; Chiou YY, 2018, J BIOL CHEM, V293, P2476, DOI 10.1074/jbc.RA117.000971; CHRISTIANS FC, 1994, MUTAT RES, V323, P179, DOI 10.1016/0165-7992(94)90031-0; CHRISTIANS FC, 1993, BIOCHEMISTRY-US, V32, P10512, DOI 10.1021/bi00090a030; Daniel L, 2018, P NATL ACAD SCI USA, V115, pE6770, DOI 10.1073/pnas.1716581115; DONAHUE BA, 1994, P NATL ACAD SCI USA, V91, P8502, DOI 10.1073/pnas.91.18.8502; Fritz LK, 1996, J BIOL CHEM, V271, P12972, DOI 10.1074/jbc.271.22.12972; FRITZ LK, 1995, BIOCHEMISTRY-US, V34, P13117, DOI 10.1021/bi00040a024; Gauger MA, 2005, CANCER RES, V65, P6828, DOI 10.1158/0008-5472.CAN-05-1119; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Hara R, 2000, MOL CELL BIOL, V20, P9173, DOI 10.1128/MCB.20.24.9173-9181.2000; Hu JC, 2019, NAT PROTOC, V14, P248, DOI 10.1038/s41596-018-0093-7; Hu JC, 2017, J BIOL CHEM, V292, P15588, DOI 10.1074/jbc.R117.807453; Hu JC, 2016, P NATL ACAD SCI USA, V113, P11507, DOI 10.1073/pnas.1614430113; Hu JC, 2015, GENE DEV, V29, P948, DOI 10.1101/gad.261271.115; Laine JP, 2006, EMBO J, V25, P387, DOI 10.1038/sj.emboj.7600933; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu XQ, 2015, DNA REPAIR, V36, P68, DOI 10.1016/j.dnarep.2015.09.026; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355; Sancar A, 2016, ANGEW CHEM INT EDIT, V55, P8502, DOI 10.1002/anie.201601524; Sanz-Murillo M, 2018, P NATL ACAD SCI USA, V115, P8972, DOI 10.1073/pnas.1802626115; Selby CP, 2017, PHOTOCHEM PHOTOBIOL, V93, P280, DOI 10.1111/php.12675; Selby CP, 1997, NUCLEIC ACIDS RES, V25, P787, DOI 10.1093/nar/25.4.787; Selby CP, 1997, P NATL ACAD SCI USA, V94, P11205, DOI 10.1073/pnas.94.21.11205; Selby CP, 1997, J BIOL CHEM, V272, P1885, DOI 10.1074/jbc.272.3.1885; SELBY CP, 1993, SCIENCE, V260, P53, DOI 10.1126/science.8465200; STEVNSNER T, 1993, CARCINOGENESIS, V14, P1591, DOI 10.1093/carcin/14.8.1591; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tremeau-Bravard A, 2004, J BIOL CHEM, V279, P7751, DOI 10.1074/jbc.M309853200; VENEMA J, 1990, P NATL ACAD SCI USA, V87, P4707, DOI 10.1073/pnas.87.12.4707; VENEMA J, 1991, MOL CELL BIOL, V11, P4128, DOI 10.1128/MCB.11.8.4128; Wood RD, 1997, J BIOL CHEM, V272, P23465, DOI 10.1074/jbc.272.38.23465; Xu BS, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006771; Xu J, 2017, NATURE, V551, P653, DOI 10.1038/nature24658	38	14	14	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2019	294	1					210	217		10.1074/jbc.RA118.006121	http://dx.doi.org/10.1074/jbc.RA118.006121			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG6PT	30413533	hybrid, Green Published			2022-12-28	WOS:000455105500024
J	Zhu, YF; Gao, MR; Zhou, TT; Xie, MX; Mao, AQ; Feng, L; Yao, XQ; Wong, WT; Ma, X				Zhu, Yifei; Gao, Mengru; Zhou, Tingting; Xie, Mingxu; Mao, Aiqin; Feng, Lei; Yao, Xiaoqiang; Wong, Wing Tak; Ma, Xin			The TRPC5 channel regulates angiogenesis and promotes recovery from ischemic injury in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ion channel; calcium channel; transient receptor potential channels (TRP channels); angiogenesis; vascular biology; ischemia; hypoxia; cardiovascular disease	ENDOTHELIAL GROWTH-FACTOR; LIMB ISCHEMIA; DOUBLE-BLIND; DISEASE; MECHANISMS; THERAPIES; RILUZOLE; DELIVERY; SAFETY; ENTRY	Ischemia-related diseases are a leading cause of death worldwide, and promoting therapeutic angiogenesis is key for effective recovery from hypoxia-ischemia. Given the limited success of angiogenic factors, such as vascular endothelial growth factor, in clinical trials, it is important to find more promising angiogenic targets. Here, using both cell- and tissue-based assays and a mouse model of injury-induced ischemia, we investigated the involvement of the transient receptor potential canonical 5 (TRPC5) ion channel in angiogenesis and the effects of a TRPC5 activator, the Food and Drug Administration-approved drug riluzole, on recovery from ischemic injury. We demonstrate that TRPC5 is involved in endothelial cell sprouting, angiogenesis, and blood perfusion in an oxygen-induced retinopathy model and a hind limb ischemia model. We found a potential regulatory link between nuclear factor of activated T cell isoform c3 and angiopoietin-1 that could provide the mechanistic basis for the angiogenic function of TRPC5. Importantly, treatment with riluzole, which can activate TRPC5 in endothelial cells, improved recovery from ischemia in mice. Our study reveals TRPC5 as a potential angiogenic target and suggests riluzole as a promising drug for managing ischemic diseases.	[Zhu, Yifei; Gao, Mengru; Zhou, Tingting; Xie, Mingxu; Mao, Aiqin; Feng, Lei; Ma, Xin] Jiangnan Univ, Wuxi Sch Med, 1800 Lihu Rd, Wuxi 214000, Jiangsu, Peoples R China; [Zhu, Yifei; Xie, Mingxu; Yao, Xiaoqiang] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong 999077, Peoples R China; [Wong, Wing Tak] Chinese Univ Hong Kong, Sch Life Sci, State Key Lab Agrobiotechnol CUHK, Hong Kong 999077, Peoples R China	Jiangnan University; Chinese University of Hong Kong; Chinese University of Hong Kong	Ma, X (corresponding author), Jiangnan Univ, Wuxi Sch Med, 1800 Lihu Rd, Wuxi 214000, Jiangsu, Peoples R China.	maxin@jiangnan.edu.cn	Yao, Xiaoqiang/I-5413-2016; Wong, Wing Tak Jack/Q-4512-2018	Yao, Xiaoqiang/0000-0002-0687-8186; Wong, Wing Tak Jack/0000-0002-4514-3780	National Natural Science Foundation of China [81572940, 81622007, 81800430, 81870362]; Chang Jiang Scholars Programme [Q2015106]; Fundamental Research Funds for the Central Universities [JUSRP51704A, JUSRP51615B]; National First-Class Discipline Program of Food Science and Technology [JUF-STR20180101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chang Jiang Scholars Programme; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National First-Class Discipline Program of Food Science and Technology	This work was supported by the National Natural Science Foundation of China Grants 81572940, 81622007, 81800430, and 81870362, Chang Jiang Scholars Programme (Q2015106), Fundamental Research Funds for the Central Universities Grants JUSRP51704A and JUSRP51615B, and National First-Class Discipline Program of Food Science and Technology Grant JUF-STR20180101. The authors declare that they have no conflicts of interest with the contents of this article.	Albrecht-Schgoer K, 2017, J CONTROL RELEASE, V250, P1, DOI 10.1016/j.jconrel.2017.02.004; Antigny F, 2012, J BIOL CHEM, V287, P5917, DOI 10.1074/jbc.M111.295733; Armstrong EJ, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000697; Banumathi E, 2011, INVEST OPHTH VIS SCI, V52, P3103, DOI 10.1167/iovs.10-6574; Briquez PS, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2015.6; Broker-Lai J, 2017, EMBO J, V36, P2770, DOI 10.15252/embj.201696369; Bruns A., 2014, FASEB J, V28; Chaudhuri P, 2008, MOL BIOL CELL, V19, P3203, DOI 10.1091/mbc.E07-08-0765; Dal Monte M, 2015, INVEST OPHTH VIS SCI, V56, P59, DOI 10.1167/iovs.14-15263; Gaunt HJ, 2016, EUR BIOPHYS J BIOPHY, V45, P611, DOI 10.1007/s00249-016-1142-1; Ge RL, 2009, CANCER LETT, V283, P43, DOI 10.1016/j.canlet.2009.03.023; Khurana R, 2005, CIRCULATION, V112, P1813, DOI 10.1161/CIRCULATIONAHA.105.535294; Korff T, 2004, EXP CELL RES, V297, P415, DOI 10.1016/j.yexcr.2004.03.043; Kusumanto YH, 2006, HUM GENE THER, V17, P683, DOI 10.1089/hum.2006.17.683; Lacomblez L, 2002, AMYOTROPH LATERAL SC, V3, P23, DOI 10.1080/146608202317576507; Lee J, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006666; Li J, 2015, ARTERIOSCL THROM VAS, V35, P1987, DOI 10.1161/ATVBAHA.115.305969; Li J, 2011, CIRC RES, V108, P1190, DOI 10.1161/CIRCRESAHA.111.243352; Ma X, 2012, P NATL ACAD SCI USA, V109, P16282, DOI 10.1073/pnas.1202989109; Makarevich PI, 2017, PHYSIOLOGIC AND PATHOLOGIC ANGIOGENESIS - SIGNALING MECHANISMS AND TARGETED THERAPY, P343, DOI 10.5772/66411; Mathiyalagan P, 2017, CIRC RES, V120, P1466, DOI 10.1161/CIRCRESAHA.116.310557; Menard MT, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003219; Metheny-Barlow LJ, 2003, CELL RES, V13, P309, DOI 10.1038/sj.cr.7290176; Muona K, 2012, GENE THER, V19, P392, DOI 10.1038/gt.2011.109; Naylor J, 2016, BRIT J PHARMACOL, V173, P562, DOI 10.1111/bph.13387; Niiyama Hiroshi, 2009, J Vis Exp, DOI 10.3791/1035; Nilius B, 2014, HANDB EXP PHARMACOL, V223, pV; Noren DP, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad3188; Ogawa N, 2016, CELL CALCIUM, V60, P115, DOI 10.1016/j.ceca.2016.02.009; Pitulescu ME, 2010, NAT PROTOC, V5, P1518, DOI 10.1038/nprot.2010.113; Rajagopalan S, 2003, CIRCULATION, V108, P1933, DOI 10.1161/01.CIR.0000093398.16124.29; Riccio A, 2009, CELL, V137, P761, DOI 10.1016/j.cell.2009.03.039; Richter JM, 2014, MOL PHARMACOL, V86, P514, DOI 10.1124/mol.114.093229; Richter JM, 2014, BRIT J PHARMACOL, V171, P158, DOI 10.1111/bph.12436; Roth GA, 2017, J AM COLL CARDIOL, V70, P1, DOI 10.1016/j.jacc.2017.04.052; Saharinen P, 2017, NAT REV DRUG DISCOV, V16, P635, DOI 10.1038/nrd.2016.278; Stahl A, 2010, INVEST OPHTH VIS SCI, V51, P2813, DOI 10.1167/iovs.10-5176; Strubing C, 2003, J BIOL CHEM, V278, P39014, DOI 10.1074/jbc.M306705200; Suzuki J, 2016, HYPERTENS RES, V39, P183, DOI 10.1038/hr.2015.134; Takahashi N, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00324; Vartanian SM, 2015, CIRC RES, V116, P1614, DOI 10.1161/CIRCRESAHA.116.303504; Velazquez EJ, 2016, NEW ENGL J MED, V374, P1511, DOI 10.1056/NEJMoa1602001; Veliceasa D, 2007, FEBS J, V274, P6365, DOI 10.1111/j.1742-4658.2007.06159.x; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Wiviott SD, 2004, CIRCULATION, V109, P3064, DOI 10.1161/01.CIR.0000134701.40946.30; Wong CO, 2010, PFLUG ARCH EUR J PHY, V460, P121, DOI 10.1007/s00424-010-0823-3; Yla-Herttuala S, 2017, EUR HEART J, V38, P1365, DOI 10.1093/eurheartj/ehw547; Yu PC, 2010, CIRC RES, V106, P1221, DOI 10.1161/CIRCRESAHA.109.207670; Zhang ZG, 2009, LANCET NEUROL, V8, P491, DOI 10.1016/S1474-4422(09)70061-4	49	21	22	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2019	294	1					28	37		10.1074/jbc.RA118.005392	http://dx.doi.org/10.1074/jbc.RA118.005392			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG6PT	30413532	Green Published, hybrid			2022-12-28	WOS:000455105500004
J	Brumshtein, B; Esswein, SR; Sawaya, MR; Rosenberg, G; Ly, AT; Landau, M; Eisenberg, DS				Brumshtein, Boris; Esswein, Shannon R.; Sawaya, Michael R.; Rosenberg, Gregory; Ly, Alan T.; Landau, Meytal; Eisenberg, David S.			Identification of two principal amyloid-driving segments in variable domains of Ig light chains in systemic light-chain amyloidosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid; antibody; crystallography; electron microscopy (EM); protein aggregation; light chain (LC); light-chain amyloidosis (AL); steric zipper; thioflavin T (ThT); variable domain (VL)	ALPHA-SYNUCLEIN STRAINS; FIBRIL FORMATION; PROTEINS; DESIGN; NOMENCLATURE; AGGREGATION; INSULIN; SUITE; AL-09; STATE	Systemic light-chain amyloidosis (AL) is a human disease caused by overexpression of monoclonal immunoglobulin light chains that form pathogenic amyloid fibrils. These amyloid fibrils deposit in tissues and cause organ failure. Proteins form amyloid fibrils when they partly or fully unfold and expose segments capable of stacking into -sheets that pair and thereby form a tight, dehydrated interface. These structures, termed steric zippers, constitute the spines of amyloid fibrils. Here, using a combination of computational (with ZipperDB and Boston University ALBase), mutational, biochemical, and protein structural analyses, we identified segments within the variable domains of Ig light chains that drive the assembly of amyloid fibrils in AL. We demonstrate that there are at least two such segments and that each one can drive amyloid fibril assembly independently of the other. Our analysis revealed that peptides derived from these segments form steric zippers featuring a typical dry interface with high-surface complementarity and occupy the same spatial location of the Greek-key immunoglobulin fold in both and variable domains. Of note, some predicted steric-zipper segments did not form amyloid fibrils or assembled into fibrils only when removed from the whole protein. We conclude that steric-zipper propensity must be experimentally validated and that the two segments identified here may represent therapeutic targets. In addition to elucidating the molecular pathogenesis of AL, these findings also provide an experimental approach for identifying segments that drive fibril formation in other amyloid diseases.	[Brumshtein, Boris; Esswein, Shannon R.; Sawaya, Michael R.; Rosenberg, Gregory; Ly, Alan T.; Eisenberg, David S.] Univ Calif Los Angeles, DOE Inst, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA; [Brumshtein, Boris; Esswein, Shannon R.; Sawaya, Michael R.; Rosenberg, Gregory; Ly, Alan T.; Eisenberg, David S.] Univ Calif Los Angeles, DOE Inst, Howard Hughes Med Inst, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Landau, Meytal] Technion Israel Inst Technol, Dept Biol, IL-3200003 Haifa, Israel	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; Technion Israel Institute of Technology	Eisenberg, DS (corresponding author), Univ Calif Los Angeles, DOE Inst, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA.; Eisenberg, DS (corresponding author), Univ Calif Los Angeles, DOE Inst, Howard Hughes Med Inst, Dept Chem & Biochem, Los Angeles, CA 90095 USA.	david@mbi.ucla.edu	Landau, Meytal/AAF-3479-2021; Landau, Meytal/J-3075-2012	Landau, Meytal/0000-0002-1743-3430; Landau, Meytal/0000-0002-1743-3430; Esswein, Shannon/0000-0002-5142-0190; Sawaya, Michael/0000-0003-0874-9043; Eisenberg, David/0000-0003-2432-5419	National Institutes of Health from the NIA [1R01AG048120-01]; Howard Hughes Medical Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029205] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL068705] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM055052, P41GM103403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG048120, RF1AG048120] Funding Source: NIH RePORTER	National Institutes of Health from the NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by National Institutes of Health Grant 1R01AG048120-01 from the NIA and the Howard Hughes Medical Institute. D.S.E. is an equity holder of ADRx, Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams D, 2013, THER ADV NEUROL DISO, V6, P129, DOI 10.1177/1756285612470192; Andrich K, 2017, J BIOL CHEM, V292, P2328, DOI 10.1074/jbc.M116.750323; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Baden EM, 2008, J BIOL CHEM, V283, P30950, DOI 10.1074/jbc.M804822200; Baden EM, 2008, J BIOL CHEM, V283, P15853, DOI 10.1074/jbc.M705347200; Baden EM, 2009, CURR PROTEIN PEPT SC, V10, P500, DOI 10.2174/138920309789351949; Bellotti V, 2000, J STRUCT BIOL, V130, P280, DOI 10.1006/jsbi.2000.4248; Blancas-Mejia LM, 2015, BIOPHYS CHEM, V207, P13, DOI 10.1016/j.bpc.2015.07.005; Blancas-Mejia LM, 2013, ANNU REV BIOCHEM, V82, P745, DOI 10.1146/annurev-biochem-072611-130030; Bodi K, 2009, AMYLOID, V16, P1, DOI 10.1080/13506120802676781; Brumshtein B, 2014, J BIOL CHEM, V289, P27513, DOI 10.1074/jbc.M114.585638; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; BUXBAUM J, 1986, J CLIN INVEST, V78, P798, DOI 10.1172/JCI112643; DAHLIN DC, 1950, AM J PATHOL, V26, P581; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Eisenberg DS, 2017, ANNU REV BIOCHEM, V86, P69, DOI 10.1146/annurev-biochem-061516-045104; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Falk RH, 1997, NEW ENGL J MED, V337, P898, DOI 10.1056/NEJM199709253371306; FRASER PE, 1991, J NEUROSCI RES, V28, P474, DOI 10.1002/jnr.490280404; FRASER PE, 1991, BIOPHYS J, V60, P1190, DOI 10.1016/S0006-3495(91)82154-3; GLENNER GG, 1971, SCIENCE, V172, P1150, DOI 10.1126/science.172.3988.1150; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Gray KA, 2015, NUCLEIC ACIDS RES, V43, pD1079, DOI 10.1093/nar/gku1071; HOBBS JR, 1973, P ROY SOC MED, V66, P705, DOI 10.1177/003591577306600751; Hora M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181799; Ivanova MI, 2009, P NATL ACAD SCI USA, V106, P18990, DOI 10.1073/pnas.0910080106; Ivanova MI, 2006, P NATL ACAD SCI USA, V103, P4079, DOI 10.1073/pnas.0511298103; Jones H.B., 1848, PHIL T ROY SOC LOND, V138, P55, DOI DOI 10.1098/RSTL.1848.0003; Khurana R, 2001, BIOCHEMISTRY-US, V40, P3525, DOI 10.1021/bi001782b; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Kyle RA, 2011, AMYLOID, V18, P6, DOI 10.3109/13506129.2011.574354001; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lefranc MP, 2001, EXP CLIN IMMUNOGENET, V18, P242, DOI 10.1159/000049203; Lefranc MP, 2001, EXP CLIN IMMUNOGENET, V18, P161, DOI 10.1159/000049195; MARCHALONIS JJ, 1989, FASEB J, V3, P2469, DOI 10.1096/fasebj.3.13.2509274; Martin DJ, 2010, AMYLOID, V17, P129, DOI 10.3109/13506129.2010.530081; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Melki R, 2015, J PARKINSON DIS, V5, P217, DOI 10.3233/JPD-150543; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Olsen KE, 1998, BIOCHEM BIOPH RES CO, V251, P642, DOI 10.1006/bbrc.1998.9508; Peelaerts W, 2015, NATURE, V522, P340, DOI 10.1038/nature14547; Piehl DW, 2017, BIOMOL NMR ASSIGN, V11, P45, DOI 10.1007/s12104-016-9718-3; Piehl DW, 2017, ACS OMEGA, V2, P712, DOI 10.1021/acsomega.6b00494; Pinney JH, 2013, BRIT J HAEMATOL, V161, P525, DOI 10.1111/bjh.12286; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; RICHARDSON JS, 1992, BIOPHYS J, V63, P1186, DOI 10.1016/S0006-3495(92)81696-X; SAKANO H, 1979, NATURE, V280, P288, DOI 10.1038/280288a0; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Sievers SA, 2011, NATURE, V475, P96, DOI 10.1038/nature10154; Sipe JD, 2000, J STRUCT BIOL, V130, P88, DOI 10.1006/jsbi.2000.4221; Sipe JD, 2014, AMYLOID, V21, P221, DOI 10.3109/13506129.2014.964858; Tartaglia GG, 2008, CHEM SOC REV, V37, P1395, DOI 10.1039/b706784b; Thompson MJ, 2006, P NATL ACAD SCI USA, V103, P4074, DOI 10.1073/pnas.0511295103; Wall J, 1999, BIOCHEMISTRY-US, V38, P14101, DOI 10.1021/bi991131j; Wall J, 1999, METHOD ENZYMOL, V309, P204; Wechalekar AD, 2016, LANCET, V387, P2641, DOI 10.1016/S0140-6736(15)01274-X; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	58	18	18	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19659	19671		10.1074/jbc.RA118.004142	http://dx.doi.org/10.1074/jbc.RA118.004142			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30355736	Green Published, hybrid			2022-12-28	WOS:000454294900014
J	Lellahi, SM; Rosenlund, IA; Hedberg, A; Kiaer, LT; Mikkola, I; Knutsen, E; Perander, M				Lellahi, S. Mohammad; Rosenlund, Ingrid Arctander; Hedberg, Annica; Kiaer, Liv Torill; Mikkola, Ingvild; Knutsen, Erik; Perander, Maria			The long noncoding RNA NEAT1 and nuclear paraspeckles are up-regulated by the transcription factor HSF1 in the heat shock response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-TRANSCRIPTION; STRESS-RESPONSE; PROTEIN; HSP70; BINDING; TARGET; CANCER; SUBPOPULATION; PROTEOSTASIS; DEGRADATION	The long noncoding RNA (lncRNA) NEAT1 (nuclear enriched abundant transcript 1) is the architectural component of nuclear paraspeckles, and it has recently gained considerable attention as it is abnormally expressed in pathological conditions such as cancer and neurodegenerative diseases. NEAT1 and paraspeckle formation are increased in cells upon exposure to a variety of environmental stressors and believed to play an important role in cell survival. The present study was undertaken to further investigate the role of NEAT1 in cellular stress response pathways. We show that NEAT1 is a novel target gene of heat shock transcription factor 1 (HSF1) and is up-regulated when the heat shock response pathway is activated by sulforaphane (SFN) or elevated temperature. HSF1 binds specifically to a newly identified conserved heat shock element in the NEAT1 promoter. In line with this, SFN induced the formation of NEAT1-containing paraspeckles via an HSF1-dependent mechanism. HSF1 plays a key role in the cellular response to proteotoxic stress by promoting the expression of a series of genes, including those encoding molecular chaperones. We have found that the expression of HSP70, HSP90, and HSP27 is amplified and sustained during heat shock in NEAT1-depleted cells compared with control cells, indicating that NEAT1 feeds back via an unknown mechanism to regulate HSF1 activity. This interrelationship is potentially significant in human diseases such as cancer and neurodegenerative disorders.	[Lellahi, S. Mohammad; Rosenlund, Ingrid Arctander; Hedberg, Annica; Kiaer, Liv Torill; Knutsen, Erik; Perander, Maria] UiT, Fac Hlth Sci, Dept Med Biol, N-9037 Tromso, Norway; [Mikkola, Ingvild] UiT, Fac Hlth Sci, Dept Pharm, N-9037 Tromso, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso	Perander, M (corresponding author), UiT, Fac Hlth Sci, Dept Med Biol, RNA & Mol Pathol Res Grp, N-9037 Tromso, Norway.	maria.perander@uit.no	Knutsen, Erik/ABH-6287-2020	Knutsen, Erik/0000-0002-4903-0150; Lellahi, Seyed Mohammad/0000-0003-3633-8065; Perander, Maria/0000-0002-1177-2407	Helse Nord RHF (Northern Norway Regional Health Authority)	Helse Nord RHF (Northern Norway Regional Health Authority)	This work was supported by Helse Nord RHF (Northern Norway Regional Health Authority). The authors declare that they have no conflicts of interest with the contents of this article.	ABRAVAYA K, 1992, GENE DEV, V6, P1153, DOI 10.1101/gad.6.7.1153; Adriaens C, 2016, NAT MED, V22, P861, DOI 10.1038/nm.4135; Ahn SG, 2003, GENE DEV, V17, P516, DOI 10.1101/gad.1044503; Ali A, 1998, MOL CELL BIOL, V18, P4949, DOI 10.1128/MCB.18.9.4949; Anckar J, 2011, ANNU REV BIOCHEM, V80, P1089, DOI 10.1146/annurev-biochem-060809-095203; Beeharry Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24500-1; Brown JA, 2012, P NATL ACAD SCI USA, V109, P19202, DOI 10.1073/pnas.1217338109; Chakravarty D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6383; Chen HJ, 2016, BRAIN, V139, P1417, DOI 10.1093/brain/aww028; Chen LL, 2009, MOL CELL, V35, P467, DOI 10.1016/j.molcel.2009.06.027; Choudhry H, 2015, ONCOGENE, V34, P4482, DOI 10.1038/onc.2014.378; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Dai C, 2016, TRENDS CELL BIOL, V26, P17, DOI 10.1016/j.tcb.2015.10.011; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Gan NQ, 2010, J BIOL CHEM, V285, P35528, DOI 10.1074/jbc.M110.152686; Gao FB, 2017, EMBO J, V36, P2931, DOI 10.15252/embj.201797568; Gibbs A, 2009, P NATL ACAD SCI USA, V106, P16663, DOI 10.1073/pnas.0908908106; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Gomez-Pastor R, 2018, NAT REV MOL CELL BIO, V19, P4, DOI 10.1038/nrm.2017.73; Gomez-Pastor R, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14405; Hirose T, 2014, MOL BIOL CELL, V25, P169, DOI 10.1091/mbc.E13-09-0558; Holmberg CI, 2000, CELL STRESS CHAPERON, V5, P219, DOI 10.1379/1466-1268(2000)005<0219:FONHGV>2.0.CO;2; Huang C, 2018, EUR J PHARMACOL, V822, P69, DOI 10.1016/j.ejphar.2018.01.005; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; Idogawa M, 2017, INT J CANCER, V140, P2785, DOI 10.1002/ijc.30689; Imamura K, 2014, MOL CELL, V53, P393, DOI 10.1016/j.molcel.2014.01.009; Kensler TW, 2013, TOP CURR CHEM, V329, P163, DOI 10.1007/128_2012_339; Kim D, 1999, BIOCHEM BIOPH RES CO, V254, P264, DOI 10.1006/bbrc.1998.9840; KROEGER PE, 1994, MOL CELL BIOL, V14, P7592, DOI 10.1128/MCB.14.11.7592; Labbadia J, 2015, ANNU REV BIOCHEM, V84, P435, DOI 10.1146/annurev-biochem-060614-033955; Li J, 2017, TRENDS CELL BIOL, V27, P895, DOI 10.1016/j.tcb.2017.08.002; Li YY, 2012, J NUTR BIOCHEM, V23, P1617, DOI 10.1016/j.jnutbio.2011.11.004; Lin D, 2012, J BIOL CHEM, V287, P4299, DOI 10.1074/jbc.M111.282152; Lu M, 2008, BIOCHEMISTRY-US, V47, P6007, DOI 10.1021/bi702185u; Ma HW, 2017, J VIROL, V91, DOI 10.1128/JVI.02250-16; Mello SS, 2017, GENE DEV, V31, P1095, DOI 10.1101/gad.284661.116; Mendillo ML, 2012, CELL, V150, P549, DOI 10.1016/j.cell.2012.06.031; Naganuma T, 2012, EMBO J, V31, P4020, DOI 10.1038/emboj.2012.251; Naidu SD, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201700908; Naidu SD, 2017, FEBS J, V284, P1606, DOI 10.1111/febs.13999; Naidu SD, 2015, TRENDS PHARMACOL SCI, V36, P6, DOI 10.1016/j.tips.2014.10.011; Nakagawa S, 2014, DEVELOPMENT, V141, P4618, DOI 10.1242/dev.110544; Nakagawa S, 2011, J CELL BIOL, V193, P31, DOI 10.1083/jcb.201011110; Neef DW, 2014, CELL REP, V9, P955, DOI 10.1016/j.celrep.2014.09.056; Neef DW, 2011, NAT REV DRUG DISCOV, V10, P930, DOI 10.1038/nrd3453; Nishimoto Y, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-31; Radons J, 2016, CELL STRESS CHAPERON, V21, P379, DOI 10.1007/s12192-016-0676-6; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Santagata S, 2011, P NATL ACAD SCI USA, V108, P18378, DOI 10.1073/pnas.1115031108; Schonrock N, 2016, CURR GENE THER, V16, P220, DOI 10.2174/1566523216666160524144159; Schopf FH, 2017, NAT REV MOL CELL BIO, V18, P345, DOI 10.1038/nrm.2017.20; Shelkovnikova TA, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0263-7; Shelkovnikova TA, 2014, HUM MOL GENET, V23, P2298, DOI 10.1093/hmg/ddt622; Shi YH, 1998, GENE DEV, V12, P654, DOI 10.1101/gad.12.5.654; Standaert L, 2014, RNA, V20, P1844, DOI 10.1261/rna.047332.114; Sunwoo H, 2009, GENOME RES, V19, P347, DOI 10.1101/gr.087775.108; Sunwoo JS, 2017, MOL NEUROBIOL, V54, P1577, DOI 10.1007/s12035-016-9928-9; Trinklein ND, 2004, CELL STRESS CHAPERON, V9, P21, DOI 10.1379/1466-1268(2004)009<0021:TRABOH>2.0.CO;2; Vujanac M, 2005, TRAFFIC, V6, P214, DOI 10.1111/j.1600-0854.2005.00266.x; Wang P, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00088-4; Wilusz JE, 2008, CELL, V135, P919, DOI 10.1016/j.cell.2008.10.012; Zhang Q, 2013, MBIO, V4, DOI 10.1128/mBio.00596-12; Zhang Y, 2011, CHEM BIOL, V18, P1355, DOI 10.1016/j.chembiol.2011.09.008; Zhou MY, 1996, J BIOL CHEM, V271, P24769, DOI 10.1074/jbc.271.40.24769; Zhou W, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4461-z; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3	66	37	40	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2018	293	49					18965	18976		10.1074/jbc.RA118.004473	http://dx.doi.org/10.1074/jbc.RA118.004473			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NY	30305397	Green Published, hybrid			2022-12-28	WOS:000458467400012
J	Mihalas, BP; Bromfield, EG; Sutherland, JM; De Iuliis, GN; McLaughlin, EA; Aitken, RJ; Nixon, B				Mihalas, Bettina P.; Bromfield, Elizabeth G.; Sutherland, Jessie M.; De Iuliis, Geoffry N.; McLaughlin, Eileen A.; Aitken, R. John; Nixon, Brett			Oxidative damage in naturally aged mouse oocytes is exacerbated by dysregulation of proteasomal activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							20S PROTEASOME; LIPID-PEROXIDATION; FOLLICULAR-FLUID; PROTEIN OXIDATION; OXIDIZED PROTEINS; SPINDLE DISRUPTION; HYDROGEN-PEROXIDE; CELL-DEATH; STRESS; DEGRADATION	An increase in oxidative protein damage is a leading contributor to the age-associated decline in oocyte quality. By removing such damaged proteins, the proteasome plays an essential role in maintaining the fidelity of oocyte meiosis. In this study, we established that decreased proteasome activity in naturally aged, germinal vesicle (GV) mouse oocytes positively correlates with increased protein modification by the lipid aldehyde 4-hydroxynonenal (4-HNE). Furthermore, attenuation of proteasome activity in GV oocytes of young animals was accompanied by an increase in 4-HNE-modified proteins, including alpha-tubulin, thereby contributing to a reduction in tubulin polymerization, microtubule stability, and integrity of oocyte meiosis. A decrease in proteasome activity was also recapitulated in theGV oocytes of young animals following exposure to oxidative insults in the form of either hydrogen peroxide (H2O2) or 4-HNE. We also observed that upon oxidative insult, 4-HNE exhibits elevated adduction to multiple proteasomal subunits. Notably, the inclusion of the antioxidant penicillamine, to limit propagation of oxidative stress cascades, led to a complete recovery of proteasome activity and enhanced clearance of 4-HNE-adducted alpha-tubulin during a 6-h post-treatment recovery period. This strategy also proved effective in reducing the incidence of oxidative stress-induced aneuploidy following in vitro oocyte maturation, but was ineffective for naturally aged oocytes. Taken together, our results implicate proteasome dysfunction as an important factor in the accumulation of oxidatively induced protein damage in the female germline. This discovery holds promise for the design of therapeutic interventions to address the age-dependent decline in oocyte quality.	[Mihalas, Bettina P.; Bromfield, Elizabeth G.; Sutherland, Jessie M.; De Iuliis, Geoffry N.; McLaughlin, Eileen A.; Aitken, R. John; Nixon, Brett] Univ Newcastle, Sch Environm & Life Sci, Prior Res Ctr Reprod Sci, Univ Dr, Callaghan, NSW 2308, Australia; [McLaughlin, Eileen A.] Univ Auckland, Sch Biol Sci, Auckland 1142, New Zealand	University of Newcastle; University of Auckland	Mihalas, BP; Nixon, B (corresponding author), Univ Newcastle, Sch Environm & Life Sci, Prior Res Ctr Reprod Sci, Univ Dr, Callaghan, NSW 2308, Australia.	Bettina.Mihalas@uon.edu.au; Brett.Nixon@newcastle.edu.au	Aitken, Robert John/AAY-8238-2020; McLaughlin, Eileen/AAF-5588-2021; De Iuliis, Geoffry N./G-7042-2013; McLaughlin, Eileen A/G-7620-2013; Nixon, Brett/B-5121-2012; Bromfield, Elizabeth Grace/S-5043-2016	Aitken, Robert John/0000-0002-9152-156X; De Iuliis, Geoffry N./0000-0002-6978-6123; Mihalas, Bettina/0000-0002-6006-8475; Nixon, Brett/0000-0003-2745-8188; McLaughlin, Eileen/0000-0002-5837-3876; Bromfield, Elizabeth Grace/0000-0001-7256-1403; Sutherland, Jessie/0000-0001-9672-2371	University of Newcastle's Priority Research Centre for Reproductive Science; Hunter Medical Research Institute's (HMRI) Pregnancy and Reproduction Program; Research Training Program Scholarship; Emlyn and Jennie Thomas Postgraduate Medical Research Scholarship	University of Newcastle's Priority Research Centre for Reproductive Science; Hunter Medical Research Institute's (HMRI) Pregnancy and Reproduction Program; Research Training Program Scholarship; Emlyn and Jennie Thomas Postgraduate Medical Research Scholarship	This work was supported in part by the University of Newcastle's Priority Research Centre for Reproductive Science and the Hunter Medical Research Institute's (HMRI) Pregnancy and Reproduction Program. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a Research Training Program Scholarship and an Emlyn and Jennie Thomas Postgraduate Medical Research Scholarship.	Agarwal A, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-49; Aiken CE, 2015, SCI REP-UK, V5, DOI 10.1038/srep16175; Aiken CT, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006924; Aitken RJ, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102020; Aitken RJ, 2012, J BIOL CHEM, V287, P33048, DOI 10.1074/jbc.M112.366690; Ayala A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/360438; Babuska V, 2012, Ceska Gynekol, V77, P543; Baker MA, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.123679; Bardag-Gorce F, 1999, MOL BIOL REP, V26, P89, DOI 10.1023/A:1006968208077; Berkers CR, 2005, NAT METHODS, V2, P357, DOI 10.1038/nmeth759; Bhattacharya S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082249; Bromfield EG, 2017, MOL HUM REPROD, V23, P91, DOI 10.1093/molehr/gaw074; Bromfield EG, 2015, HUM REPROD, V30, P2597, DOI 10.1093/humrep/dev214; Bulteau AL, 2002, ARCH BIOCHEM BIOPHYS, V397, P298, DOI 10.1006/abbi.2001.2663; Bulteau AL, 2001, J BIOL CHEM, V276, P30057, DOI 10.1074/jbc.M100142200; Bulteau AL, 2000, EXP GERONTOL, V35, P767, DOI 10.1016/S0531-5565(00)00136-4; Camlin NJ, 2017, MOL REPROD DEV, V84, P6, DOI 10.1002/mrd.22766; Camlin NJ, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.135848; Canu N, 2000, J NEUROSCI, V20, P589, DOI 10.1523/JNEUROSCI.20-02-00589.2000; Carrard G, 2003, INT J BIOCHEM CELL B, V35, P728, DOI 10.1016/S1357-2725(02)00356-4; Casarejos MJ, 2011, NEUROCHEM INT, V58, P512, DOI 10.1016/j.neuint.2011.01.008; Chaube SK, 2005, APOPTOSIS, V10, P863, DOI 10.1007/s10495-005-0367-8; Chavez J, 2010, CHEM RES TOXICOL, V23, P37, DOI 10.1021/tx9002462; Chiang T, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094367; Chiang T, 2010, CURR BIOL, V20, P1522, DOI 10.1016/j.cub.2010.06.069; Choi WJ, 2007, FERTIL STERIL, V88, P1220, DOI 10.1016/j.fertnstert.2007.02.067; Chondrogianni N, 2003, J BIOL CHEM, V278, P28026, DOI 10.1074/jbc.M301048200; Collins JK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9553; Compton DA, 2011, CURR OPIN CELL BIOL, V23, P109, DOI 10.1016/j.ceb.2010.08.007; Conconi M, 1996, ARCH BIOCHEM BIOPHYS, V331, P232, DOI 10.1006/abbi.1996.0303; Dalleau S, 2013, CELL DEATH DIFFER, V20, P1615, DOI 10.1038/cdd.2013.138; Das S, 2006, HUM REPROD, V21, P2403, DOI 10.1093/humrep/del156; Davies KJA, 2001, BIOCHIMIE, V83, P301, DOI 10.1016/S0300-9084(01)01250-0; Devroey P, 1996, HUM REPROD, V11, P1324; Ding QX, 2006, ANTIOXID REDOX SIGN, V8, P130, DOI 10.1089/ars.2006.8.130; Ding QX, 2003, FEBS LETT, V546, P228, DOI 10.1016/S0014-5793(03)00582-9; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Doorn JA, 2002, CHEM RES TOXICOL, V15, P1445, DOI 10.1021/tx025590o; Dunmore BJ, 2013, HUM MOL GENET, V22, P3667, DOI 10.1093/hmg/ddt216; Elizur SE, 2014, GYNECOL ENDOCRINOL, V30, P705, DOI 10.3109/09513590.2014.924100; Elofsson M, 1999, CHEM BIOL, V6, P811, DOI 10.1016/S1074-5521(99)80128-8; ESTERBAUER H, 1993, AM J CLIN NUTR, V57, P779, DOI 10.1093/ajcn/57.5.779S; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Farout L, 2006, ARCH BIOCHEM BIOPHYS, V453, P135, DOI 10.1016/j.abb.2006.02.003; Ferrington DA, 2004, FEBS LETT, V578, P217, DOI 10.1016/j.febslet.2004.11.003; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; Girotti AW, 1998, J LIPID RES, V39, P1529; Grune T, 2001, J GERONTOL A-BIOL, V56, pB459, DOI 10.1093/gerona/56.11.B459; Grune Tilman, 2003, Molecular Aspects of Medicine, V24, P195, DOI 10.1016/S0098-2997(03)00014-1; Haglund C, 2014, MEDCHEMCOMM, V5, P376, DOI 10.1039/c3md00386h; Halliwell B, 2000, IUBMB LIFE, V50, P251, DOI 10.1080/15216540051080930; Han SJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13688-3; HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Hochrainer K, 2012, STROKE, V43, P2229, DOI 10.1161/STROKEAHA.112.650416; Holt JE, 2012, MOL BIOL CELL, V23, P3970, DOI 10.1091/mbc.E12-05-0352; Huo LJ, 2004, MECH DEVELOP, V121, P1275, DOI 10.1016/j.mod.2004.05.007; Hussong SA, 2010, J NEUROCHEM, V113, P1481, DOI 10.1111/j.1471-4159.2010.06688.x; Hyun DH, 2002, J NEUROCHEM, V83, P360, DOI 10.1046/j.1471-4159.2002.01125.x; Jennings PC, 2011, HUM REPROD, V26, P878, DOI 10.1093/humrep/deq393; Josefsberg LBY, 2000, BIOL REPROD, V62, P1270, DOI 10.1095/biolreprod62.5.1270; Jung T, 2014, REDOX BIOL, V2, P388, DOI 10.1016/j.redox.2013.12.029; Just J, 2015, FREE RADICAL BIO MED, V89, P786, DOI 10.1016/j.freeradbiomed.2015.10.405; KANNER J, 1987, CRC CR REV FOOD SCI, V25, P317, DOI 10.1080/10408398709527457; Kerr JB, 2013, REPRODUCTION, V146, pR205, DOI 10.1530/REP-13-0181; Kinnunen PKJ, 2012, BBA-BIOMEMBRANES, V1818, P2446, DOI 10.1016/j.bbamem.2012.04.008; Koh YH, 2005, J BIOL CHEM, V280, P32499, DOI 10.1074/jbc.M506199200; Kokubo J, 2008, CELL STRUCT FUNCT, V33, P51, DOI 10.1247/csf.07038; Lim J, 2011, BIOL REPROD, V84, P775, DOI 10.1095/biolreprod.110.088583; Lister LM, 2010, CURR BIOL, V20, P1511, DOI 10.1016/j.cub.2010.08.023; Liu L, 2002, HUM REPROD, V17, P2678, DOI 10.1093/humrep/17.10.2678; Lord T, 2015, DEV BIOL, V406, P1, DOI 10.1016/j.ydbio.2015.07.024; Lord T, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.122820; Ma JY, 2013, CELL CYCLE, V12, P1233, DOI 10.4161/cc.24311; Maiti K, 2017, AM J OBSTET GYNECOL, V217, DOI 10.1016/j.ajog.2017.06.015; Marangos P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9706; McLaughlin EA, 2009, REPRODUCTION, V137, P1, DOI 10.1530/REP-08-0118; Miao YL, 2009, HUM REPROD UPDATE, V15, P573, DOI 10.1093/humupd/dmp014; Mihalas BP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06372-z; Mihalas BP, 2015, REPRODUCTION, V150, P485, DOI 10.1530/REP-14-0585; Monroy CA, 2013, CHEM RES TOXICOL, V26, P1832, DOI 10.1021/tx400212q; Nederlof PM, 1995, P NATL ACAD SCI USA, V92, P12060, DOI 10.1073/pnas.92.26.12060; Neely MD, 1999, J NEUROCHEM, V72, P2323, DOI 10.1046/j.1471-4159.1999.0722323.x; Nixon B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135605; Nunez-Calonge R, 2016, REPROD BIOMED ONLINE, V32, P446, DOI 10.1016/j.rbmo.2015.12.010; Okada K, 1999, J BIOL CHEM, V274, P23787, DOI 10.1074/jbc.274.34.23787; Pan H, 2008, DEV BIOL, V316, P397, DOI 10.1016/j.ydbio.2008.01.048; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Petropoulos I, 2000, J GERONTOL A-BIOL, V55, pB220, DOI 10.1093/gerona/55.5.B220; Pickering AM, 2010, BIOCHEM J, V432, P585, DOI 10.1042/BJ20100878; Pizzimenti S, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00242; Reeg S, 2015, ANTIOXID REDOX SIGN, V23, P239, DOI 10.1089/ars.2014.6062; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Saez I, 2014, CURR GENOMICS, V15, P38, DOI 10.2174/138920291501140306113344; Sayre LM, 2006, DRUG METAB REV, V38, P651, DOI 10.1080/03602530600959508; SCHWARTZ D, 1982, NEW ENGL J MED, V306, P404, DOI 10.1056/NEJM198202183060706; Selesniemi K, 2011, P NATL ACAD SCI USA, V108, P12319, DOI 10.1073/pnas.1018793108; Shang F, 2001, EXP EYE RES, V73, P229, DOI 10.1006/exer.2001.1029; Shibatani T, 1996, J GERONTOL A-BIOL, V51, pB316, DOI 10.1093/gerona/51A.5.B316; Shringarpure R, 2003, J BIOL CHEM, V278, P311, DOI 10.1074/jbc.M206279200; Shringarpure R, 2000, CELL MOL LIFE SCI, V57, P1802, DOI 10.1007/PL00000660; Silber SJ, 2017, FERTIL STERIL, V107, P1232, DOI 10.1016/j.fertnstert.2017.03.014; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Stewart BJ, 2007, CHEM RES TOXICOL, V20, P1111, DOI 10.1021/tx700106v; Taiyeb AM, 2014, CLIN EXP PHARMACOL P, V41, P147, DOI 10.1111/1440-1681.12193; Takeo S, 2017, REPROD FERT DEVELOP, V29, P759, DOI 10.1071/RD15228; Tamura H, 2008, J PINEAL RES, V44, P280, DOI 10.1111/j.1600-079X.2007.00524.X; TANAKA K, 1990, FEBS LETT, V271, P41, DOI 10.1016/0014-5793(90)80367-R; Tarin JJ, 2004, MOL REPROD DEV, V69, P402, DOI 10.1002/mrd.20180; TARIN JJ, 1995, HUM REPROD, V10, P1563, DOI 10.1093/HUMREP/10.6.1563; Tarin JJ, 1996, MOL HUM REPROD, V2, P895, DOI 10.1093/molehr/2.12.895; Tarin JJ, 1996, MOL HUM REPROD, V2, P717, DOI 10.1093/molehr/2.10.717; Tomaru U, 2012, AM J PATHOL, V180, P963, DOI 10.1016/j.ajpath.2011.11.012; UCHIDA K, 1992, P NATL ACAD SCI USA, V89, P4544, DOI 10.1073/pnas.89.10.4544; Uchida K, 2003, PROG LIPID RES, V42, P318, DOI 10.1016/S0163-7827(03)00014-6; WAGNER BJ, 1995, ARCH BIOCHEM BIOPHYS, V323, P455, DOI 10.1006/abbi.1995.0067; Wang Q, 2007, REPROD FERT DEVELOP, V19, P1, DOI 10.1071/RD06103; Wang XM, 2015, GUT, V64, P459, DOI 10.1136/gutjnl-2014-307213; Wiener-Megnazi Z, 2004, FERTIL STERIL, V82, P1171, DOI 10.1016/j.fertnstert.2004.06.013; Wojcik C, 2000, MOL HUM REPROD, V6, P331, DOI 10.1093/molehr/6.4.331; Yin HY, 2011, CHEM REV, V111, P5944, DOI 10.1021/cr200084z; Yun Y, 2014, CELL CYCLE, V13, P1938, DOI 10.4161/cc.28897; Zhang X, 2006, CELL RES, V16, P841, DOI 10.1038/sj.cr.7310095	123	22	22	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2018	293	49					18944	18964		10.1074/jbc.RA118.005751	http://dx.doi.org/10.1074/jbc.RA118.005751			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology	HL1NY	30305393	hybrid, Green Published			2022-12-28	WOS:000458467400011
J	Ferreira, M; Verbinnen, I; Fardilha, M; Van Eynde, A; Bollen, M				Ferreira, Monica; Verbinnen, Iris; Fardilha, Margarida; Van Eynde, Aleyde; Bollen, Mathieu			The deletion of the protein phosphatase 1 regulator NIPP1 in testis causes hyperphosphorylation and degradation of the histone methyltransferase EZH2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell cycle; chromatin; epigenetics; histone methylation; phosphoprotein phosphatase 1 (PP1); protein phosphorylation; protein stability; proteolysis; spermatogenesis; testis; EZH2; germ cells; NIPP1; Polycomb group; protein phosphatase 1; PRC2; RBAP48; SUZ12; enhancer of zeste homolog 2	POLYCOMB GROUP PROTEIN; NUCLEAR INHIBITOR; CELL FATE; PHOSPHORYLATION; METHYLATION; BINDING; SUZ12; PP1; DIFFERENTIATION; REPRESSION	Germ cell proliferation is epigenetically controlled, mainly through DNA methylation and histone modifications. However, the pivotal epigenetic regulators of germ cell self-renewal and differentiation in postnatal testis are still poorly defined. The histone methyltransferase enhancer of zeste homolog 2 (EZH2) is the catalytic subunit of Polycomb repressive complex 2, represses target genes through trimethylation of histone H3 at Lys-27 (H3K27me3), and interacts (in)directly with both protein phosphatase 1 (PP1) and nuclear inhibitor of PP1 (NIPP1). Here, we report that postnatal, testis-specific ablation of NIPP1 in mice results in loss of EZH2 and reduces H3K27me3 levels. Mechanistically, the NIPP1 deletion abrogated PP1-mediated EZH2 dephosphorylation at two cyclin-dependent kinase sites (Thr-345/487), thereby generating hyperphosphorylated EZH2, which is a substrate for proteolytic degradation. Accordingly, alanine mutation of these residues prolonged the half-life of EZH2 in male germ cells. Our study discloses a key role for the PP1:NIPP1 holoenzyme in stabilizing EZH2 and maintaining the H3K27me3 mark on genes that are important for germ cell development and spermatogenesis.	[Ferreira, Monica; Verbinnen, Iris; Van Eynde, Aleyde; Bollen, Mathieu] Univ Leuven, KU Leuven, Dept Cellular & Mol Med, Lab Biosignaling & Therapeut, B-3000 Leuven, Belgium; [Ferreira, Monica; Fardilha, Margarida] Univ Aveiro, Dept Hlth Sci, Inst Res Biomed iBiMED, P-3810 Aveiro, Portugal	KU Leuven; Universidade de Aveiro	Van Eynde, A; Bollen, M (corresponding author), Campus Gasthuisberg,Herestr 49,O&N1,PB901, B-3000 Leuven, Belgium.	Aleyde.VanEynde@kuleuven.be; Mathieu.Bollen@kuleuven.be	Fardilha, Margarida/G-3182-2010	Fardilha, Margarida/0000-0001-7459-9173; Ferreira, Monica/0000-0001-9609-5099	Fonds Wetenschappelijk Onderzoek [G078717N]; Bijzonder Onderzoeksfonds [BOF-GOA 10/18]; FCT/Portuguese Ministry of Science and Technology (MEC Fundacao para a Ciencia e a Tecnologia (FCT))	Fonds Wetenschappelijk Onderzoek(FWO); Bijzonder Onderzoeksfonds; FCT/Portuguese Ministry of Science and Technology (MEC Fundacao para a Ciencia e a Tecnologia (FCT))	This work was supported by the Fonds Wetenschappelijk Onderzoek G078717N and by the Bijzonder Onderzoeksfonds (BOF-GOA 10/18). This work was also supported by a doctoral fellowship from FCT/Portuguese Ministry of Science and Technology (MEC Fundacao para a Ciencia e a Tecnologia (FCT)) (to M.F.). The authors declare that they have no conflicts of interest with the contents of this article.	Aranda S, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500737; Ardehali MB, 2017, MOL CELL, V68, P872, DOI 10.1016/j.molcel.2017.10.025; Beullens M, 2000, BIOCHEM J, V352, P651, DOI 10.1042/0264-6021:3520651; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Chen SA, 2010, NAT CELL BIOL, V12, P1108, DOI 10.1038/ncb2116; Comet I, 2014, NAT STRUCT MOL BIOL, V21, P573, DOI 10.1038/nsmb.2848; Ferreira M, 2019, BBA-MOL CELL RES, V1866, P16, DOI 10.1016/j.bbamcr.2018.07.019; Ferreira M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13809-y; Heroes E, 2013, FEBS J, V280, P584, DOI 10.1111/j.1742-4658.2012.08547.x; Jin QM, 2003, J BIOL CHEM, V278, P30677, DOI 10.1074/jbc.M302273200; Kaneko S, 2010, GENE DEV, V24, P2615, DOI 10.1101/gad.1983810; Komai Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep06175; Kubo N, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1833-5; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Ly L, 2015, SEMIN CELL DEV BIOL, V43, P96, DOI 10.1016/j.semcdb.2015.07.006; Minnebo N, 2013, NUCLEIC ACIDS RES, V41, P842, DOI 10.1093/nar/gks1255; Montgomery ND, 2005, CURR BIOL, V15, P942, DOI 10.1016/j.cub.2005.04.051; Mu WP, 2017, DEV BIOL, V424, P198, DOI 10.1016/j.ydbio.2017.02.017; Mu WP, 2014, GENE DEV, V28, P2056, DOI 10.1101/gad.246124.114; Nishioka K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30649-6; Nuytten M, 2008, ONCOGENE, V27, P1449, DOI 10.1038/sj.onc.1210774; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Prieto I, 2001, NAT CELL BIOL, V3, P761, DOI 10.1038/35087082; Roy N, 2007, BBA-GENE STRUCT EXPR, V1769, P541, DOI 10.1016/j.bbaexp.2007.07.004; Sahasrabuddhe AA, 2015, ONCOGENE, V34, P445, DOI 10.1038/onc.2013.571; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; Tanuma N, 2008, J BIOL CHEM, V283, P35805, DOI 10.1074/jbc.M805468200; Van Dessel N, 2015, FEBS LETT, V589, P1314, DOI 10.1016/j.febslet.2015.04.017; Van Dessel N, 2010, NUCLEIC ACIDS RES, V38, P7500, DOI 10.1093/nar/gkq643; Vasanthakumar A, 2017, EMBO REP, V18, P619, DOI 10.15252/embr.201643237; Wei YK, 2011, NAT CELL BIOL, V13, P87, DOI 10.1038/ncb2139; Winkler C, 2018, J CELL SCI, V131, DOI 10.1242/jcs.214932; Winkler C, 2015, J CELL SCI, V128, P4526, DOI 10.1242/jcs.175588; Wu D, 2018, J BIOL CHEM, V293, P15152, DOI 10.1074/jbc.RA118.004132; Wu SC, 2011, J BIOL CHEM, V286, P28511, DOI 10.1074/jbc.M111.240515; Xu KX, 2012, SCIENCE, V338, P1465, DOI 10.1126/science.1227604; Yang CC, 2015, AM J TRANSL RES, V7, P1009	41	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2018	293	47					18031	18039		10.1074/jbc.AC118.005577	http://dx.doi.org/10.1074/jbc.AC118.005577			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8XM	30305391	Green Published, hybrid			2022-12-28	WOS:000451375200002
J	Chiba, Y; He, B; Yoshizaki, K; Rhodes, C; Ishijima, M; Bleck, CKE; Stempinski, E; Chu, EY; Nakamura, T; Iwamoto, T; de Vega, S; Saito, K; Fukumoto, S; Yamada, Y				Chiba, Yuta; He, Bing; Yoshizaki, Keigo; Rhodes, Craig; Ishijima, Muneaki; Bleck, Christopher K. E.; Stempinski, Erin; Chu, Emily Y.; Nakamura, Takashi; Iwamoto, Tsutomu; de Vega, Susana; Saito, Kan; Fukumoto, Satoshi; Yamada, Yoshihiko			The transcription factor AmeloD stimulates epithelial cell motility essential for tooth morphology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						basic helix-loop-helix transcription factor (bHLH); cadherin-1 (CDH1); epithelial cadherin (E-cadherin); cell migration; epithelial-mesenchymal transition (EMT); gene knockout; tooth development; inner enamel epithelium; AmeloD; epiprofin; ectodermal organ	BRANCHING MORPHOGENESIS; MOLECULAR-MECHANISMS; FACTOR EPIPROFIN; EXPRESSION; CADHERIN; DIFFERENTIATION; PROLIFERATION; AMELOBLASTIN; DYNAMICS; TWIST1	The development of ectodermal organs, such as teeth, requires epithelial-mesenchymal interactions. Basic helix-loop-helix (bHLH) transcription factors regulate various aspects of tissue development, and we have previously identified a bHLH transcription factor, AmeloD, from a tooth germ cDNA library. Here, we provide both in vitro and in vivo evidence that AmeloD is important in tooth development. We created AmeloD-knockout (KO) mice to identify the in vivo functions of AmeloD that are critical for tooth morphogenesis. We found that AmeloD-KO mice developed enamel hypoplasia and small teeth because of increased expression of E-cadherin in inner enamel epithelial (IEE) cells, and it may cause inhibition of the cell migration. We used the CLDE dental epithelial cell line to conduct further mechanistic analyses to determine whether AmeloD overexpression in CLDE cells suppresses E-cadherin expression and promotes cell migration. Knockout of epiprofin (Epfn), another transcription factor required for tooth morphogenesis and development, and analysis of AmeloD expression and deletion revealed that AmeloD also contributed to multiple tooth formation in Epfn-KO mice by promoting the invasion of dental epithelial cells into the mesenchymal region. Thus, AmeloD appears to play an important role in tooth morphogenesis by modulating E-cadherin and dental epithelial-mesenchymal interactions. These findings provide detailed insights into the mechanism of ectodermal organ development.	[Chiba, Yuta; He, Bing; Yoshizaki, Keigo; Rhodes, Craig; Ishijima, Muneaki; Nakamura, Takashi; Iwamoto, Tsutomu; de Vega, Susana; Fukumoto, Satoshi; Yamada, Yoshihiko] NIDCR, Mol Biol Sect, NIH, Bethesda, MD 20892 USA; [Chiba, Yuta; Saito, Kan; Fukumoto, Satoshi] Tohoku Univ, Grad Sch Dent, Dept Oral Hlth & Dev Sci, Div Pediat Dent, Sendai, Miyagi 9808575, Japan; [Nakamura, Takashi] Tohoku Univ, Grad Sch Dent, Dept Oral Biol, Div Mol Pharmacol & Cell Biophys, Sendai, Miyagi 9808575, Japan; [He, Bing] Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu 610041, Sichuan, Peoples R China; [Yoshizaki, Keigo] Kyushu Univ, Fac Dent Sci, Div Oral Hlth Growth & Dev, Fukuoka, Fukuoka 8128582, Japan; [Ishijima, Muneaki] Juntendo Univ, Grad Sch Med, Dept Med Orthopaed & Motor Organ, Tokyo 1138421, Japan; [de Vega, Susana] Juntendo Univ, Grad Sch Med, Res Dept Pathophysiol Locomot & Neoplast Dis, Tokyo 1138421, Japan; [Bleck, Christopher K. E.; Stempinski, Erin] NHLBI, Electron Microscopy Core Facil, NIH, Bethesda, MD 20892 USA; [Chu, Emily Y.] NIAMS, Lab Oral Connect Tissue Biol, NIH, Bethesda, MD 20892 USA; [Iwamoto, Tsutomu] Tokushima Univ, Grad Sch, Inst Biomed Sci, Dept Pediat Dent, Tokushima 7708504, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Tohoku University; Tohoku University; Sichuan University; Kyushu University; Juntendo University; Juntendo University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Tokushima University	Yamada, Y (corresponding author), NIDCR, NIH, Bldg 30,Rm 407,30 Convent Dr,MSC 4370, Bethesda, MD 20892 USA.	yoshi.yamada@nih.gov	de Vega, Susana/AAH-4775-2020; Iwamoto, Tsutomu/AAI-8952-2021; Iwamoto, Tsutomu/AAA-6597-2019; He, Bing/V-5552-2019; Saito, Kan/AAG-3507-2020; Nakamura, Takashi/A-8931-2012; Ishijima, Muneaki/L-4816-2016; Saito, Kan/AFS-5564-2022	Iwamoto, Tsutomu/0000-0001-8472-605X; Saito, Kan/0000-0002-2151-6204; Nakamura, Takashi/0000-0001-9904-1037; Ishijima, Muneaki/0000-0002-0920-0805; Saito, Kan/0000-0002-2151-6204; Yoshizaki, Keigo/0000-0002-0598-5879; Chiba, Yuta/0000-0001-5414-4411; rhodes, craig/0000-0001-5440-587X; Fukumoto, Satoshi/0000-0002-5046-6891; Bleck, Christopher/0000-0003-1029-3444	NIDCR, National Institutes of Health Intramural Research Program [1ZIADE000720-07]; NIDCR, National Institutes of Health Transfer Core Facility Grant [ZIC DE000744-04]; Japan Society for the Promotion of Science (JSPS) KAKENHI [17H01606, 15J04116]; National Nature Science Foundation of China [NSFC81500811]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL005906] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZICDE000744] Funding Source: NIH RePORTER	NIDCR, National Institutes of Health Intramural Research Program; NIDCR, National Institutes of Health Transfer Core Facility Grant; Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported in part by NIDCR, National Institutes of Health Intramural Research Program Grant 1ZIADE000720-07 (to Y. Y.). and NIDCR, National Institutes of Health Transfer Core Facility Grant ZIC DE000744-04. This work was also supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grants-in-aid 17H01606 (to S. F.) and 15J04116 (to Y. C.) and National Nature Science Foundation of China Grant NSFC81500811 (to B. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abe M, 2002, CELL TISSUE RES, V310, P201, DOI 10.1007/s00441-002-0611-2; Aurrekoetxea M, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00025; Borkosky SS, 2008, BIOCELL, V32, P251; Cai DF, 2014, CELL, V157, P1146, DOI 10.1016/j.cell.2014.03.045; Daley WP, 2017, DEVELOPMENT, V144, P2200, DOI 10.1242/dev.146894; Fukumoto S, 2004, J CELL BIOL, V167, P973, DOI 10.1083/jcb.200409077; He B, 2019, J DENT RES, V98, P234, DOI 10.1177/0022034518808254; Ibarretxe G, 2012, CELL TISSUE RES, V350, P95, DOI 10.1007/s00441-012-1459-8; Jimenez-Rojo L, 2010, HISTOL HISTOPATHOL, V25, P1621, DOI 10.14670/HH-25.1621; Jones S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-226; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Li CY, 2012, DEV BIOL, V366, P357, DOI 10.1016/j.ydbio.2012.03.012; Li JY, 2017, DEVELOPMENT, V144, P374, DOI 10.1242/dev.137216; Lim J, 2012, DEVELOPMENT, V139, P3471, DOI 10.1242/dev.071209; Meng T, 2015, J BIOL CHEM, V290, P29593, DOI 10.1074/jbc.M115.680546; Nakamura T, 2004, J BIOL CHEM, V279, P626, DOI 10.1074/jbc.M307502200; Nakamura T, 2008, J BIOL CHEM, V283, P4825, DOI 10.1074/jbc.M708388200; Nakamura T, 2017, J BONE MINER RES, V32, P601, DOI 10.1002/jbmr.3024; Nakamura T, 2016, INT J ORAL SCI, V8, P205, DOI 10.1038/ijos.2016.35; Nakamura T, 2014, J CELL SCI, V127, P5261, DOI 10.1242/jcs.156778; Nakamura T, 2011, J ORAL BIOSCI, V53, P22, DOI 10.2330/joralbiosci.53.22; Obara N, 1998, ANAT EMBRYOL, V197, P469, DOI 10.1007/s004290050157; Onodera T, 2010, SCIENCE, V329, P562, DOI 10.1126/science.1191880; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Pispa J, 2003, DEV BIOL, V262, P195, DOI 10.1016/S0012-1606(03)00325-7; Poulin G, 1997, MOL CELL BIOL, V17, P6673, DOI 10.1128/MCB.17.11.6673; Rice R, 2005, DEV DYNAM, V234, P28, DOI 10.1002/dvdy.20501; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Sakai T, 2013, J ORAL BIOSCI, V55, P73, DOI 10.1016/j.job.2013.03.002; Sohn WJ, 2014, J DENT RES, V93, P78, DOI 10.1177/0022034513511247; Sun Z, 2016, DEVELOPMENT, V143, P4115, DOI 10.1242/dev.138883; Yoshizaki K, 2008, J BIOL CHEM, V283, P3385, DOI 10.1074/jbc.M704913200; Yoshizaki K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099991; Yuan XX, 2016, SCI REP-UK, V6, DOI 10.1038/srep20005; Zhang YP, 2012, DEV DYNAM, V241, P924, DOI 10.1002/dvdy.23776	36	16	16	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3406	3418		10.1074/jbc.RA118.005298	http://dx.doi.org/10.1074/jbc.RA118.005298			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30504223	Green Published, hybrid			2022-12-28	WOS:000461853900009
J	Peshenko, IV; Cideciyan, AV; Sumaroka, A; Olshevskaya, EV; Scholten, A; Abbas, S; Koch, KW; Jacobson, SG; Dizhoor, AM				Peshenko, Igor V.; Cideciyan, Artur V.; Sumaroka, Alexander; Olshevskaya, Elena V.; Scholten, Alexander; Abbas, Seher; Koch, Karl-Wilhelm; Jacobson, Samuel G.; Dizhoor, Alexander M.			A G86R mutation in the calcium-sensor protein GCAP1 alters regulation of retinal guanylyl cyclase and causes dominant cone-rod degeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium-binding protein; eye; cyclic GMP (cGMP); phototransduction; photoreceptor; retinal degeneration; guanylate cyclase (guanylyl cyclase); calcium sensor; GUCA1A; RetGC; retinopathy	LEBER CONGENITAL AMAUROSIS; ACTIVATING PROTEIN-1; PHOTORECEPTOR DEGENERATION; CONFORMATIONAL-CHANGES; PROGRESSIVE CONE; TARGET ENZYME; GENE; BINDING; GUCA1A; CA2+	The guanylyl cyclase-activating protein, GCAP1, activates photoreceptor membrane guanylyl cyclase (RetGC) in the light, when free Ca2+ concentrations decline, and decelerates the cyclase in the dark, when Ca2+ concentrations rise. Here, we report a novel mutation, G86R, in the GCAP1 (GUCA1A) gene in a family with a dominant retinopathy. The G86R substitution in a hinge region connecting EF-hand domains 2 and 3 in GCAP1 strongly interfered with its Ca2+-dependent activator-to-inhibitor conformational transition. The G86R-GCAP1 variant activated RetGC at low Ca2+ concentrations with higher affinity than did the WT GCAP1, but failed to decelerate the cyclase at the Ca2+ concentrations characteristic of dark-adapted photoreceptors. Ca2+-dependent increase in Trp(94) fluorescence, indicative of the GCAP1 transition to its RetGC inhibiting state, was suppressed and shifted to a higher Ca2+ range. Conformational changes in G86R GCAP1 detectable by isothermal titration calorimetry (ITC) also became less sensitive to Ca2+, and the dose dependence of the G86R GCAP1-RetGC1 complex inhibition by retinal degeneration 3 (RD3) protein was shifted toward higher than normal concentrations. Our results indicate that the flexibility of the hinge region between EF-hands 2 and 3 is required for placing GCAP1-regulated Ca2+ sensitivity of the cyclase within the physiological range of intracellular Ca2+ at the expense of reducing GCAP1 affinity for the target enzyme. The disease-linked mutation of the hinge Gly(86), leading to abnormally high affinity for the target enzyme and reduced Ca2+ sensitivity of GCAP1, is predicted to abnormally elevate cGMP production and Ca2+ influx in photoreceptors in the dark.	[Peshenko, Igor V.; Olshevskaya, Elena V.; Dizhoor, Alexander M.] Salus Univ, Penn Coll Optometry, Elkins Pk, PA 19027 USA; [Cideciyan, Artur V.; Sumaroka, Alexander; Jacobson, Samuel G.] Univ Penn, Dept Ophthalmol, Philadelphia, PA 19104 USA; [Scholten, Alexander; Abbas, Seher; Koch, Karl-Wilhelm] Carl von Ossietzky Univ Oldenburg, Dept Neurosci, D-26129 Oldenburg, Germany	University of Pennsylvania; Carl von Ossietzky Universitat Oldenburg	Jacobson, SG (corresponding author), Univ Penn, Dept Ophthalmol, Philadelphia, PA 19104 USA.; Dizhoor, AM (corresponding author), Salus Univ, Res S416,8360 Old York Rd, Elkins Pk, PA 19027 USA.	jacobsos@pennmedicine.upenn.edu; adizhoor@salus.edu	Koch, Karl-Wilhelm/C-9551-2015	Koch, Karl-Wilhelm/0000-0003-1501-0044; Dizhoor, Alexander/0000-0001-6770-9186	National Institutes of Health [EY11522]; Macula Vision Research Foundation; Pennsylvania Department of Health; Deutsche Forschungsgemeinschaft [GRK1885]; German Academic Exchange Program; NATIONAL EYE INSTITUTE [R01EY011522] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Macula Vision Research Foundation; Pennsylvania Department of Health; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Academic Exchange Program(Deutscher Akademischer Austausch Dienst (DAAD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grant EY11522 (to A. M. D.), grants from the Macula Vision Research Foundation (to S. G. J., A. V. C.), Pennsylvania Department of Health (to A. M. D.), Deutsche Forschungsgemeinschaft Grant GRK1885 (to S. A., K. W. K., A. S.), and a fellowship from the German Academic Exchange Program (to S. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ames JB, 1996, CURR OPIN STRUC BIOL, V6, P432, DOI 10.1016/S0959-440X(96)80106-0; Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; Azadi S, 2010, P NATL ACAD SCI USA, V107, P21158, DOI 10.1073/pnas.1010460107; BROOKS SPJ, 1992, ANAL BIOCHEM, V201, P119, DOI 10.1016/0003-2697(92)90183-8; Burgoyne RD, 2007, NAT REV NEUROSCI, V8, P182, DOI 10.1038/nrn2093; Burns ME, 2002, NEURON, V36, P81, DOI 10.1016/S0896-6273(02)00911-X; Chen CH, 2003, J PHYSIOL-LONDON, V553, P125, DOI 10.1113/jphysiol.2003.053280; Cideciyan AV, 2007, J OPT SOC AM A, V24, P1457, DOI 10.1364/JOSAA.24.001457; Cideciyan AV, 2015, INVEST OPHTH VIS SCI, V56, P3393, DOI 10.1167/iovs.15-16726; Cideciyan AV, 2013, HUM GENE THER, V24, P993, DOI 10.1089/hum.2013.153; Dell'Orco D, 2010, CELL MOL LIFE SCI, V67, P973, DOI 10.1007/s00018-009-0243-8; Dizhoor AM, 2016, J BIOL CHEM, V291, P24504, DOI 10.1074/jbc.M116.755553; Dizhoor AM, 2010, MOL CELL BIOCHEM, V334, P117, DOI 10.1007/s11010-009-0328-6; Dizhoor AM, 1998, J BIOL CHEM, V273, P17311, DOI 10.1074/jbc.273.28.17311; DIZHOOR AM, 1995, J BIOL CHEM, V270, P25200, DOI 10.1074/jbc.270.42.25200; DIZHOOR AM, 1994, NEURON, V12, P1345, DOI 10.1016/0896-6273(94)90449-9; Ermilov AN, 2001, J BIOL CHEM, V276, P48143, DOI 10.1074/jbc.M107539200; Friedman JS, 2006, AM J HUM GENET, V79, P1059, DOI 10.1086/510021; Hunt DM, 2010, MOL CELL BIOCHEM, V334, P157, DOI 10.1007/s11010-009-0331-y; Imanishi Y, 2004, J MOL EVOL, V59, P204, DOI 10.1007/s00239-004-2614-y; Imanishi Y, 2002, EUR J NEUROSCI, V15, P63, DOI 10.1046/j.0953-816x.2001.01835.x; Jacobson SG, 2013, HUM MOL GENET, V22, P168, DOI 10.1093/hmg/dds421; JACOBSON SG, 1986, OPHTHALMOLOGY, V93, P1604; JACOBSON SG, 1989, EXP EYE RES, V48, P679, DOI 10.1016/0014-4835(89)90009-2; Jiang L, 2005, MOL VIS, V11, P143; Jiang L, 2008, VISION RES, V48, P2425, DOI 10.1016/j.visres.2008.07.016; Kamenarova K, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/517570; Kelsell RE, 1998, HUM MOL GENET, V7, P1179, DOI 10.1093/hmg/7.7.1179; Kitiratschky VBD, 2008, INVEST OPHTH VIS SCI, V49, P5015, DOI 10.1167/iovs.08-1901; Kitiratschky VBD, 2009, HUM MUTAT, V30, pE782, DOI 10.1002/humu.21055; Koch KW, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00067; Lim S, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00019; Lim S, 2009, BIOCHEMISTRY-US, V48, P850, DOI 10.1021/bi801897p; Lopez-Begines S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20893-1; LOWE DG, 1995, P NATL ACAD SCI USA, V92, P5535, DOI 10.1073/pnas.92.12.5535; Makino CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047637; Marino V, 2015, HUM MOL GENET, V24, P6653, DOI 10.1093/hmg/ddv370; MARKS PW, 1991, ANAL BIOCHEM, V193, P61, DOI 10.1016/0003-2697(91)90044-T; Mendez A, 2001, P NATL ACAD SCI USA, V98, P9948, DOI 10.1073/pnas.171308998; Michaelides M, 2005, OPHTHALMOLOGY, V112, P1442, DOI 10.1016/j.ophtha.2005.02.024; Michaelides M, 2006, SURV OPHTHALMOL, V51, P232, DOI 10.1016/j.survophthal.2006.02.007; Molday LL, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00044; Nishiguchi KM, 2004, INVEST OPHTH VIS SCI, V45, P3863, DOI 10.1167/iovs.04-0590; Nong E, 2014, DOC OPHTHALMOL, V128, P59, DOI 10.1007/s10633-013-9420-z; Olshevskaya EV, 2012, J NEUROSCI, V32, P7208, DOI 10.1523/JNEUROSCI.0976-12.2012; Olshevskaya EV, 2004, J NEUROSCI, V24, P6078, DOI 10.1523/JNEUROSCI.0963-04.2004; PALCZEWSKI K, 1994, NEURON, V13, P395, DOI 10.1016/0896-6273(94)90355-7; Payne AM, 2001, J MED GENET, V38, P611, DOI 10.1136/jmg.38.9.611; Payne AM, 1998, HUM MOL GENET, V7, P273, DOI 10.1093/hmg/7.2.273; Peshenko IV, 2008, J BIOL CHEM, V283, P21747, DOI 10.1074/jbc.M801899200; Peshenko IV, 2007, J BIOL CHEM, V282, P21645, DOI 10.1074/jbc.M702368200; Peshenko IV, 2006, J BIOL CHEM, V281, P23830, DOI 10.1074/jbc.M600257200; Peshenko IV, 2016, J BIOL CHEM, V291, P19713, DOI 10.1074/jbc.M116.742288; Peshenko IV, 2014, J BIOL CHEM, V289, P10140, DOI 10.1074/jbc.M113.540716; Peshenko IV, 2012, J BIOL CHEM, V287, P13972, DOI 10.1074/jbc.M112.341883; Peshenko IV, 2011, BIOCHEMISTRY-US, V50, P9511, DOI 10.1021/bi201342b; Peshenko IV, 2004, BIOCHEMISTRY-US, V43, P13796, DOI 10.1021/bi048943m; Peshenko IV, 2004, J BIOL CHEM, V279, P16903, DOI 10.1074/jbc.C400065200; Robin J, 2015, ACS CHEM BIOL, V10, P2344, DOI 10.1021/acschembio.5b00278; Sakurai K, 2011, J NEUROSCI, V31, P7991, DOI 10.1523/JNEUROSCI.6650-10.2011; Sato M, 2005, GRAEF ARCH CLIN EXP, V243, P235, DOI 10.1007/s00417-004-1015-7; Sato S, 2018, J NEUROSCI, V38, P2990, DOI 10.1523/JNEUROSCI.2985-17.2018; Sharon D, 2018, PROG RETIN EYE RES, V63, P69, DOI 10.1016/j.preteyeres.2017.10.003; Sokal I, 1998, MOL CELL, V2, P129, DOI 10.1016/S1097-2765(00)80121-5; Sokal I, 2005, INVEST OPHTH VIS SCI, V46, P1124, DOI 10.1167/iovs.04-1431; Sokal I, 2001, J BIOL CHEM, V276, P43361, DOI 10.1074/jbc.M103614200; Sokal I, 1999, J BIOL CHEM, V274, P19829, DOI 10.1074/jbc.274.28.19829; Stephen R, 2007, STRUCTURE, V15, P1392, DOI 10.1016/j.str.2007.09.013; Stone EM, 2007, AM J OPHTHALMOL, V144, P791, DOI 10.1016/j.ajo.2007.08.022; Stunkel ML, 2018, AM J OPHTHALMOL, V190, P58, DOI 10.1016/j.ajo.2018.03.021; Sulmann S, 2014, CHEM-EUR J, V20, P6756, DOI 10.1002/chem.201402146; To K, 1998, AM J OPHTHALMOL, V126, P140, DOI 10.1016/S0002-9394(98)00085-3; TSIEN R, 1989, METHOD ENZYMOL, V172, P230; Vinberg F, 2018, J BIOL CHEM, V293, P7457, DOI 10.1074/jbc.RA117.001574; Vocke F, 2017, HUM MOL GENET, V26, P133, DOI 10.1093/hmg/ddw374; Wilkie SE, 2001, AM J HUM GENET, V69, P471, DOI 10.1086/323265; Woodruff ML, 2007, J NEUROSCI, V27, P8805, DOI 10.1523/JNEUROSCI.2751-07.2007; Woodruff ML, 2002, J PHYSIOL-LONDON, V542, P843, DOI 10.1113/jphysiol.2001.013987; YANG RB, 1995, P NATL ACAD SCI USA, V92, P602, DOI 10.1073/pnas.92.2.602; Zulliger R, 2015, J BIOL CHEM, V290, P3488, DOI 10.1074/jbc.M114.616656	80	24	24	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3476	3488		10.1074/jbc.RA118.006180	http://dx.doi.org/10.1074/jbc.RA118.006180			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30622141	Green Published, hybrid			2022-12-28	WOS:000461853900015
J	Hackshaw, KV; Aykas, DP; Sigurdson, GT; Plans, M; Madiai, F; Yu, LB; Buffington, CAT; Giusti, MM; Rodriguez-Saona, L				Hackshaw, Kevin V.; Aykas, Didem P.; Sigurdson, Gregory T.; Plans, Marcal; Madiai, Francesca; Yu, Lianbo; Buffington, Charles A. T.; Giusti, M. Monica; Rodriguez-Saona, Luis			Metabolic fingerprinting for diagnosis of fibromyalgia and other rheumatologic disorders	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biomarker; pain; Raman spectroscopy; infrared spectroscopy (IR spectroscopy); blood; fibromyalgia; biomarker; fingerprinting; high-performance liquid chromatography (HPLC); mass spectrometry (MS)	CENTRAL SENSITIVITY SYNDROMES; AMERICAN-COLLEGE; INFRARED-SPECTROSCOPY; CHRONIC PAIN; CRITERIA; RAMAN; CLASSIFICATION; RECOGNITION; INVENTORY; ARTHRITIS	Diagnosis and treatment of fibromyalgia (FM) remains a challenge owing to the lack of reliable biomarkers. Our objective was to develop a rapid biomarker-based method for diagnosing FM by using vibrational spectroscopy to differentiate patients with FM from those with rheumatoid arthritis (RA), osteoarthritis (OA), or systemic lupus erythematosus (SLE) and to identify metabolites associated with these differences. Blood samples were collected from patients with a diagnosis of FM (n = 50), RA (n = 29), OA (n = 19), or SLE (n = 23). Bloodspot samples were prepared, and spectra collected with portable FT-IR and FT-Raman microspectroscopy and subjected to metabolomics analysis by ultra-HPLC (uHPLC), coupled to a photodiode array (PDA) and tandem MS/MS. Unique IR and Raman spectral signatures were identified by pattern recognition analysis and clustered all study participants into classes (FM, RA, and SLE) with no misclassifications (p < 0.05, and interclass distances > 2.5). Furthermore, the spectra correlated (r = 0.95 and 0.83 for IR and Raman, respectively) with FM pain severity measured with fibromyalgia impact questionnaire revised version (FIQR) assessments. Protein backbones and pyridine-carboxylic acids dominated this discrimination and might serve as biomarkers for syndromes such as FM. uHPLC-PDA-MS/MS provided insights into metabolites significantly differing among the disease groups, not only in molecular m/z(+) and m/z(-) values but also in UV-visible chromatograms. We conclude that vibrational spectroscopy may provide a reliable diagnostic test for differentiating FM from other disorders and for establishing serologic biomarkers of FM-associated pain.	[Hackshaw, Kevin V.; Madiai, Francesca] Ohio State Univ, Dept Internal Med, Div Rheumatol & Immunol, Columbus, OH 43210 USA; [Aykas, Didem P.; Sigurdson, Gregory T.; Plans, Marcal; Giusti, M. Monica; Rodriguez-Saona, Luis] Ohio State Univ, Dept Food Sci & Technol, Columbus, OH 43210 USA; [Yu, Lianbo] Ohio State Univ, Ctr Biostat & Bioinformat, Columbus, OH 43210 USA; [Buffington, Charles A. T.] Univ Calif Davis, Dept Med & Epidemiol, Sch Vet Med, Davis, CA 95616 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of California System; University of California Davis	Hackshaw, KV (corresponding author), Ohio State Univ, 480 Med Ctr Dr,Rm S2056, Columbus, OH 43210 USA.	Kevin.Hackshaw@osumc.edu	Plans, Marcal/AAD-3579-2020; yu, lianbo/B-3472-2010	Plans, Marcal/0000-0001-9894-2626; Hackshaw, Kevin/0000-0002-9780-7171; Giusti, M. Monica/0000-0002-2348-3530	Columbus Research Foundation	Columbus Research Foundation	Supported by a grant from the Columbus Research Foundation.	Ablin JN, 2017, J RHEUMATOL, V44, P1271, DOI 10.3899/jrheum.170095; Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Annemans L, 2008, ARTHRITIS RHEUM-US, V58, P895, DOI 10.1002/art.23265; Arnold LM, 2011, MAYO CLIN PROC, V86, P457, DOI 10.4065/mcp.2010.0738; Ashton L, 2017, ANALYST, V142, P808, DOI 10.1039/c6an02516a; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bennett RM, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2783; Bersani D, 2016, J RAMAN SPECTROSC, V47, P499, DOI 10.1002/jrs.4914; Bjorsvik H. R., 1982, HDB NEAR INFRARED AN, P159; Caboni P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107626; Carvalho CS, 2011, THEOR CHEM ACC, V130, P1211, DOI 10.1007/s00214-011-0905-0; Cheng QH, 2011, APPL PHYS A-MATER, V102, P309, DOI 10.1007/s00339-010-5997-1; CLAUW DJ, 1995, MED HYPOTHESES, V44, P369; Coates J., 2000, ENCY ANAL CHEM, DOI DOI 10.1002/9780470027318.A5606; Dadabhoy D., 2008, PRIMER RHEUMATIC DIS, P87; De Maesschalck R, 1999, CHEMOMETR INTELL LAB, V47, P65, DOI 10.1016/S0169-7439(98)00159-2; Eikje NS, 2005, BIOTECHNOL ANN REV, V11, P191, DOI 10.1016/S1387-2656(05)11006-0; Esmonde-White KA, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3130338; Gladman DD, 2002, J RHEUMATOL, V29, P288; Hackshaw KV, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1316-0; Hackshaw KV, 2013, ANALYST, V138, P4453, DOI 10.1039/c3an36615d; Harte SE, 2018, J APPL BIOBEHAV RES, V23, DOI 10.1111/jabr.12137; Hughes G, 2006, ARTHRITIS RHEUM-US, V54, P177, DOI 10.1002/art.21545; Kendall C, 2009, ANALYST, V134, P1029, DOI 10.1039/b822130h; Kvalheim O.M., 1992, MULTIVARIATE PATTERN, VVolume 9, P209; Lavine B.K., 2012, ENCY ANAL CHEM, DOI [10.1002/9780470027318.a5204.pub2, DOI 10.1002/9780470027318.A5204.PUB2]; Lechowicz L, 2016, MOL BIOL REP, V43, P1321, DOI 10.1007/s11033-016-4079-7; Maixner W, 2016, J PAIN, V17, pT93, DOI 10.1016/j.jpain.2016.06.002; Malatji BG, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0863-9; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; Muhamadali H, 2015, ANAL CHEM, V87, P4578, DOI 10.1021/acs.analchem.5b00892; Osterberg EC, 2014, TRANSL ANDROL UROL, V3, P84, DOI 10.3978/j.issn.2223-4683.2014.01.02; Robinson R., 2012, J PAIN, V13, pS88, DOI [10.1016/j.jpain.2012.01.367, DOI 10.1016/J.JPAIN.2012.01.367]; Robotti E, 2013, J PROTEOM BIOINFORM, V3, DOI [10.4172/jpb.S3-003, DOI 10.4172/JPB.S3-003]; Roggo Y, 2007, J PHARMACEUT BIOMED, V44, P683, DOI 10.1016/j.jpba.2007.03.023; Romeo M.J., 2008, VIB SPECTROSC, P1, DOI DOI 10.1002/0470027320.S8923; Rubio-Diaz DE, 2009, ANALYST, V134, P1133, DOI 10.1039/b901736d; Santos MI, 2015, FOODS, V4, P283, DOI 10.3390/foods4030283; Schwarz MJ, 2002, NEUROBIOL DIS, V11, P434, DOI 10.1006/nbdi.2002.0563; Segura-Jimenez V., 2015, CLIN EXP RHEUMATOL, V34, pS26; Serban D, 2003, BIOCHEMISTRY-US, V42, P7390, DOI 10.1021/bi030050r; Silverman S, 2009, CURR MED RES OPIN, V25, P829, DOI [10.1185/03007990902728456, 10.1185/03007990902728456 ]; SJOSTROM M, 1983, ANAL CHIM ACTA, V150, P61, DOI 10.1016/S0003-2670(00)85460-4; Smith HS, 2011, PAIN PHYSICIAN, V14, pE217; STEWART AL, 1988, MED CARE, V26, P724, DOI 10.1097/00005650-198807000-00007; Vincent A, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0463-7; Walitt B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138024; White LA, 2008, J OCCUP ENVIRON MED, V50, P13, DOI 10.1097/JOM.0b013e31815cff4b; Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD608, DOI 10.1093/nar/gkx1089; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Wolfe F, 2010, ARTHRIT CARE RES, V62, P600, DOI 10.1002/acr.20140; Yu C, 2014, J AUTOIMMUN, V48-49, P10, DOI 10.1016/j.jaut.2014.01.004; Yunus MB, 2008, SEMIN ARTHRITIS RHEU, V37, P339, DOI 10.1016/j.semarthrit.2007.09.003; Yunus MB, 2015, CURR RHEUMATOL REV, V11, P70, DOI 10.2174/157339711102150702112236	55	25	25	2	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2019	294	7					2555	2568		10.1074/jbc.RA118.005816	http://dx.doi.org/10.1074/jbc.RA118.005816			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL7CN	30523152	hybrid, Green Published			2022-12-28	WOS:000458895400029
J	Li, J; Kolberg, K; Schlecht, U; St Onge, RP; Aparicio, AM; Horecka, J; Davis, RW; Hillenmeyer, ME; Harvey, CJB				Li, Jian; Kolberg, Kristen; Schlecht, Ulrich; St Onge, Robert P.; Aparicio, Ana Maria; Horecka, Joe; Davis, Ronald W.; Hillenmeyer, Maureen E.; Harvey, Colin J. B.			A biosensor-based approach reveals links between efflux pump expression and cell cycle regulation in pleiotropic drug resistance of yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biosensor; drug resistance; gene regulation; multidrug transporter; microarray	BINDING CASSETTE TRANSPORTER; MULTIDRUG-RESISTANCE; SPINDLE CHECKPOINT; WALL INTEGRITY; MECHANISMS; ANEUPLOIDY; PATHWAYS; PROTEINS; CANCER; GENES	Multidrug resistance is highly conserved in mammalian, fungal, and bacterial cells, is characterized by resistance to several unrelated xenobiotics, and poses significant challenges to managing infections and many cancers. Eukaryotes use a highly conserved set of drug efflux transporters that confer pleiotropic drug resistance (PDR). To interrogate the regulation of this critical process, here we developed a small molecule-responsive biosensor that couples transcriptional induction of PDR genes to growth rate in the yeast Saccharomyces cerevisiae. Using diverse PDR inducers and the homozygous diploid deletion collection, we applied this biosensor system to genome-wide screens for potential PDR regulators. In addition to recapitulating the activity of previously known factors, these screens identified a series of genes involved in a variety of cellular processes with significant but previously uncharacterized roles in the modulation of yeast PDR. Genes identified as down-regulators of the PDR included those encoding the MAD family of proteins involved in the mitotic spindle assembly checkpoint (SAC) complex. Of note, we demonstrated that genetic disruptions of the mitotic spindle assembly checkpoint elevate expression of PDR-mediating efflux pumps in response to exposure to a variety of compounds that themselves have no known influence on the cell cycle. These results not only establish our biosensor system as a viable tool for investigating PDR in a high-throughput fashion, but also uncover critical control mechanisms governing the PDR response and a previously uncharacterized link between PDR and cell cycle regulation in yeast.	[Li, Jian; Kolberg, Kristen; Schlecht, Ulrich; St Onge, Robert P.; Aparicio, Ana Maria; Horecka, Joe; Davis, Ronald W.; Hillenmeyer, Maureen E.; Harvey, Colin J. B.] Stanford Univ, Sch Med, Dept Biochem, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA; [Hillenmeyer, Maureen E.] Hexagon Bio, Menlo Pk, CA 94025 USA	Stanford University	Harvey, CJB (corresponding author), Hexagon Bio, Menlo Pk, CA 94025 USA.	colinjbharvey@gmail.com		Harvey, Colin/0000-0002-4719-7627	National Institutes of Health [U01 GM110706]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM110706] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant U01 GM110706. U.S., C. J. B. H., and M. E. H. own shares in Hexagon Bio. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bharadwaj R, 2004, ONCOGENE, V23, P2016, DOI 10.1038/sj.onc.1207374; Boujaoude LC, 2001, J BIOL CHEM, V276, P35258, DOI 10.1074/jbc.M105442200; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Calkins GN, 1914, SCIENCE, V40, P857, DOI DOI 10.1126/SCIENCE.40.1041.857; Chan KS, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.148; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Cui ZF, 1999, BIOSCI BIOTECH BIOCH, V63, P162, DOI 10.1271/bbb.63.162; da Rosa JL, 2012, BBA-GENE REGUL MECH, V1819, P349, DOI 10.1016/j.bbagrm.2011.08.007; DECOTTIGNIES A, 1995, J BIOL CHEM, V270, P18150, DOI 10.1074/jbc.270.30.18150; Denning DW, 2015, SCIENCE, V347, P1414, DOI 10.1126/science.aaa6097; Deutschbauer AM, 2005, GENETICS, V169, P1915, DOI 10.1534/genetics.104.036871; Dubey R, 2016, CANCER RES, V76, P5810, DOI 10.1158/0008-5472.CAN-16-0716; Ghosh M, 1999, P NATL ACAD SCI USA, V96, P5001, DOI 10.1073/pnas.96.9.5001; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gietz RD, 2007, NAT PROTOC, V2, P38, DOI 10.1038/nprot.2007.15; Gillet JP, 2010, METHODS MOL BIOL, V596, P47, DOI 10.1007/978-1-60761-416-6_4; Gulshan K, 2008, MOL CELL BIOL, V28, P5851, DOI 10.1128/MCB.00405-08; Gulshan K, 2007, EUKARYOT CELL, V6, P1933, DOI 10.1128/EC.00254-07; Hallstrom TC, 1998, J BIOL CHEM, V273, P2098, DOI 10.1074/jbc.273.4.2098; James P, 1996, GENETICS, V144, P1425; Kathawala RJ, 2015, DRUG RESIST UPDATE, V18, P1, DOI 10.1016/j.drup.2014.11.002; Katzmann DJ, 1996, J BIOL CHEM, V271, P23049, DOI 10.1074/jbc.271.38.23049; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Le Crom S, 2002, MOL CELL BIOL, V22, P2642, DOI 10.1128/MCB.22.8.2642-2649.2002; Lee AY, 2014, SCIENCE, V344, P208, DOI 10.1126/science.1250217; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Musacchio A, 2015, CURR BIOL, V25, pR1002, DOI 10.1016/j.cub.2015.08.051; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Nikaido H, 2009, ANNU REV BIOCHEM, V78, P119, DOI 10.1146/annurev.biochem.78.082907.145923; Nishida N, 2014, CURR GENET, V60, P149, DOI 10.1007/s00294-013-0419-5; Paul S, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00143; Piecuch A, 2014, CELL MOL BIOL LETT, V19, P1, DOI 10.2478/s11658-013-0111-2; Prasad R, 2012, ANNU REV MICROBIOL, V66, P39, DOI 10.1146/annurev-micro-092611-150111; Rogers B, 2001, J MOL MICROB BIOTECH, V3, P207; Salmela AL, 2013, CHROMOSOMA, V122, P431, DOI 10.1007/s00412-013-0419-8; Schlecht U, 2012, P NATL ACAD SCI USA, V109, P9213, DOI 10.1073/pnas.1204952109; Shekhar-Guturja T, 2016, NAT CHEM BIOL, V12, P867, DOI [10.1038/nchembio.2165, 10.1038/NCHEMBIO.2165]; Smith E, 2010, MOL CELL, V40, P689, DOI 10.1016/j.molcel.2010.11.031; Vashist S, 2002, MOL BIOL CELL, V13, P3955, DOI 10.1091/mbc.02-06-0090; Vasudevan S, 2015, CARCINOGENESIS, V36, P883, DOI 10.1093/carcin/bgv072; Yamada HY, 2006, MOL CANCER THER, V5, P2963, DOI 10.1158/1535-7163.MCT-06-0319; Yibmantasiri P, 2014, MOL BIOSYST, V10, P128, DOI 10.1039/c3mb70351g; Zhang XT, 2001, J BIOL CHEM, V276, P8812, DOI 10.1074/jbc.M010686200	43	1	1	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1257	1266		10.1074/jbc.RA118.003904	http://dx.doi.org/10.1074/jbc.RA118.003904			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30514758	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000457879500017
J	Douillet, DC; Pinson, B; Ceschin, J; Hurlimann, HC; Saint-Marc, C; Laporte, D; Claverol, S; Konrad, M; Bonneu, M; Daignan-Fornier, B				Douillet, Delphine C.; Pinson, Benoit; Ceschin, Johanna; Huerlimann, Hans C.; Saint-Marc, Christelle; Laporte, Damien; Claverol, Stephane; Konrad, Manfred; Bonneu, Marc; Daignan-Fornier, Bertrand			Metabolomics and proteomics identify the toxic form and the associated cellular binding targets of the anti-proliferative drug AICAR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						purine; yeast genetics; yeast metabolism; nucleoside/nucleotide analogue; proteomics; drug metabolism; small molecule	SACCHAROMYCES-CEREVISIAE; PURINE BIOSYNTHESIS; PROTEIN-KINASE; GENE ONTOLOGY; AMP; YEAST; IDENTIFICATION; PROLIFERATION; ACTIVATOR; PARADIGM	5-Aminoimidazole-4-carboxamide 1-beta-d-ribofuranoside (AICAR, or acadesine) is a precursor of the monophosphate derivative 5-amino-4-imidazole carboxamide ribonucleoside 5 '-phosphate (ZMP), an intermediate in de novo purine biosynthesis. AICAR proved to have promising anti-proliferative properties, although the molecular basis of its toxicity is poorly understood. To exert cytotoxicity, AICAR needs to be metabolized, but the AICAR-derived toxic metabolite was not identified. Here, we show that ZMP is the major toxic derivative of AICAR in yeast and establish that its metabolization to succinyl-ZMP, ZDP, or ZTP (di- and triphosphate derivatives of AICAR) strongly reduced its toxicity. Affinity chromatography identified 74 ZMP-binding proteins, including 41 that were found neither as AMP nor as AICAR or succinyl-ZMP binders. Overexpression of karyopherin-beta Kap123, one of the ZMP-specific binders, partially rescued AICAR toxicity. Quantitative proteomic analyses revealed 57 proteins significantly less abundant on nuclei-enriched fractions from AICAR-fed cells, this effect being compensated by overexpression of KAP123 for 15 of them. These results reveal nuclear protein trafficking as a function affected by AICAR.	[Douillet, Delphine C.; Pinson, Benoit; Ceschin, Johanna; Huerlimann, Hans C.; Saint-Marc, Christelle; Laporte, Damien; Daignan-Fornier, Bertrand] Univ Bordeaux, IBGC, UMR 5095, F-33077 Bordeaux, France; [Douillet, Delphine C.; Pinson, Benoit; Ceschin, Johanna; Huerlimann, Hans C.; Saint-Marc, Christelle; Laporte, Damien; Daignan-Fornier, Bertrand] CNRS, UMR 5095, IBGC, F-33077 Bordeaux, France; [Claverol, Stephane; Bonneu, Marc] Univ Bordeaux, Bordeaux INP, Plateforme Proteome, F-33076 Bordeaux, France; [Konrad, Manfred] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; [Douillet, Delphine C.] Northeastern Univ, Feinberg Sch Med, 320 East Super St, Chicago, IL 60611 USA; [Huerlimann, Hans C.] Martin Luther Univ Halle Wittenberg, Genet, Mol Genet, Weinbergweg 10, D-06120 Halle, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Max Planck Society; Northwestern University; Feinberg School of Medicine; Martin Luther University Halle Wittenberg	Daignan-Fornier, B (corresponding author), CNRS, UMR 5095, Inst Biochim & Genet Cellulaires, 1 Rue C St Saens,CS 61390, F-33077 Bordeaux, France.	b.daignan-fornier@ibgc.cnrs.fr		Pinson, Benoit/0000-0003-2936-9058; Daignan-Fornier, Bertrand/0000-0003-2352-9700; ceschin, johanna/0000-0001-7771-531X; DOUILLET, Delphine/0000-0002-9529-1255	Ligue contre le Cancer Dordogne	Ligue contre le Cancer Dordogne	This work was supported by a Ligue contre le Cancer Dordogne 2016-2017 grant (to B.D.-F.). The authors declare that they have no conflicts of interest with the contents of this article.	Albrecht D, 2018, CURR GENET, V64, P1275, DOI 10.1007/s00294-018-0843-7; Albrecht D, 2016, GENETICS, V204, P1447, DOI 10.1534/genetics.116.192518; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Carbon S, 2017, NUCLEIC ACIDS RES, V45, pD331, DOI 10.1093/nar/gkw1108; Ceballos-Picot I, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-014-0219-0; Ceschin J, 2015, J BIOL CHEM, V290, P23947, DOI 10.1074/jbc.M115.656017; Ceschin J, 2014, J BIOL CHEM, V289, P16844, DOI 10.1074/jbc.M114.551192; Daignan-Fornier B, 2012, METABOLITES, V2, DOI 10.3390/metabo2020292; Day P, 2007, ACTA CRYSTALLOGR D, V63, P587, DOI 10.1107/S0907444907009110; Dumon-Seignovert L, 2004, PROTEIN EXPRES PURIF, V37, P203, DOI 10.1016/j.pep.2004.04.025; Escusa S, 2006, MOL MICROBIOL, V60, P1014, DOI 10.1111/j.1365-2958.2006.05153.x; Guetsova ML, 1997, GENETICS, V147, P383; Guo DL, 2009, P NATL ACAD SCI USA, V106, P12932, DOI 10.1073/pnas.0906606106; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Hurlimann HC, 2011, J BIOL CHEM, V286, P30994, DOI 10.1074/jbc.M111.262659; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Kim PB, 2015, MOL CELL, V57, P317, DOI 10.1016/j.molcel.2015.01.001; Liu XN, 2014, P NATL ACAD SCI USA, V111, pE435, DOI 10.1073/pnas.1311121111; Marie S, 2004, AM J HUM GENET, V74, P1276, DOI 10.1086/421475; Mayer FV, 2011, CELL METAB, V14, P707, DOI 10.1016/j.cmet.2011.09.009; Medina-Franco JL, 2013, DRUG DISCOV TODAY, V18, P495, DOI 10.1016/j.drudis.2013.01.008; Mosammaparast N, 2002, J BIOL CHEM, V277, P862, DOI 10.1074/jbc.M106845200; Nakamaru K, 2005, BIOCHEM BIOPH RES CO, V328, P449, DOI 10.1016/j.bbrc.2005.01.004; Pinson B, 2009, GENE DEV, V23, P1399, DOI 10.1101/gad.521809; Rattan R, 2005, J BIOL CHEM, V280, P39582, DOI 10.1074/jbc.M507443200; Rebora K, 2005, GENETICS, V170, P61, DOI 10.1534/genetics.104.039396; Rebora K, 2001, MOL CELL BIOL, V21, P7901, DOI 10.1128/MCB.21.23.7901-7912.2001; Robert G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007889; Schlenstedt G, 1997, EMBO J, V16, P6237, DOI 10.1093/emboj/16.20.6237; SCHRICKER R, 1992, GENE, V122, P111, DOI 10.1016/0378-1119(92)90038-Q; SULLIVAN JE, 1994, FEBS LETT, V353, P33, DOI 10.1016/0014-5793(94)01006-4; SULLIVAN JE, 1994, BIOCHEM BIOPH RES CO, V200, P1551, DOI 10.1006/bbrc.1994.1627; Tang YC, 2011, CELL, V144, P499, DOI 10.1016/j.cell.2011.01.017; Tibbetts AS, 1997, ARCH BIOCHEM BIOPHYS, V340, P195, DOI 10.1006/abbi.1997.9919; Van Den Neste E, 2013, CANCER CHEMOTH PHARM, V71, P581, DOI 10.1007/s00280-012-2033-5	35	6	6	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2019	294	3					805	815		10.1074/jbc.RA118.004964	http://dx.doi.org/10.1074/jbc.RA118.004964			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL4FC	30478173	Green Published, hybrid			2022-12-28	WOS:000458670200007
J	Marino, MM; Rega, C; Russo, R; Valletta, M; Gentile, MT; Esposito, S; Baglivo, I; De Feis, I; Angelini, C; Xiao, TJ; Felsenfeld, G; Chambery, A; Pedone, PV				Marino, Maria Michela; Rega, Camilla; Russo, Rosita; Valletta, Mariangela; Gentile, Maria Teresa; Esposito, Sabrina; Baglivo, Ilaria; De Feis, Italia; Angelini, Claudia; Xiao, Tioajiang; Felsenfeld, Gary; Chambery, Angela; Pedone, Paolo Vincenzo			Interactome mapping defines BRG1, a component of the SWI/SNF chromatin remodeling complex, as a new partner of the transcriptional regulator CTCF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mass spectrometry (MS); protein-protein interaction; proteomics; chromatin; transcription factor; BRG1; CTCF; Interactomics; SWI/SNF; transcriptional regulation	INSULATOR PROTEIN CTCF; INTERACTION NETWORK; BINDING PROTEIN; GENE-EXPRESSION; RNA HELICASES; ZINC FINGERS; CELL-LINE; GENOME; METHYLATION; P68	The highly conserved zinc finger CCCTC-binding factor (CTCF) regulates genomic imprinting and gene expression by acting as a transcriptional activator or repressor of promoters and insulator of enhancers. The multiple functions of CTCF are accomplished by co-association with other protein partners and are dependent on genomic context and tissue specificity. Despite the critical role of CTCF in the organization of genome structure, to date, only a subset of CTCF interaction partners have been identified. Here we present a large-scale identification of CTCF-binding partners using affinity purification and high-resolution LC-MS/MS analysis. In addition to functional enrichment of specific protein families such as the ribosomal proteins and the DEAD box helicases, we identified novel high-confidence CTCF interactors that provide a still unexplored biochemical context for CTCF's multiple functions. One of the newly validated CTCF interactors is BRG1, the major ATPase subunit of the chromatin remodeling complex SWI/SNF, establishing a relationship between two master regulators of genome organization. This work significantly expands the current knowledge of the human CTCF interactome and represents an important resource to direct future studies aimed at uncovering molecular mechanisms modulating CTCF pleiotropic functions throughout the genome.	[Marino, Maria Michela; Rega, Camilla; Russo, Rosita; Valletta, Mariangela; Gentile, Maria Teresa; Esposito, Sabrina; Baglivo, Ilaria; Chambery, Angela; Pedone, Paolo Vincenzo] Univ Campania Luigi Vanvitelli, Dept Environm Biol & Pharmaceut Sci & Technol, I-81100 Caserta, Italy; [De Feis, Italia; Angelini, Claudia] CNR, Inst Appl Math Mauro Picone IAC, I-80131 Naples, Italy; [Xiao, Tioajiang; Felsenfeld, Gary] NIDDK, Lab Mol Biol, NIH, Bethesda, MD 20892 USA	Universita della Campania Vanvitelli; Consiglio Nazionale delle Ricerche (CNR); Istituto per le Applicazioni del Calcolo "Mauro Picone" (IAC-CNR); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Chambery, A; Pedone, PV (corresponding author), Univ Campania Luigi Vanvitelli, Dept Environm Biol & Pharmaceut Sci & Technol, I-81100 Caserta, Italy.	angela.chambery@unicampania.it; paolovincenzo.pedone@unicampania.it	Angelini, Claudia/AAL-2555-2020; Baglivo, Ilaria/U-2444-2017; DEFEIS, ITALIA/N-7506-2015; Angelini, Claudia/J-4106-2012	DEFEIS, ITALIA/0000-0002-3694-8202; Russo, Rosita/0000-0002-2235-6302; ESPOSITO, Sabrina/0000-0001-6750-7365; Angelini, Claudia/0000-0001-8350-8464	University of Campania "Luigi Vanvitelli" through the VALERE program; NIDDK, National Institutes of Health; National Institutes of Health	University of Campania "Luigi Vanvitelli" through the VALERE program; NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by University of Campania "Luigi Vanvitelli" through the VALERE program and the intramural research program of the NIDDK, National Institutes of Health. The National Institutes of Health also provided support to P.V.P. as a visitor. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alami J, 2003, INT J CANCER, V107, P365, DOI 10.1002/ijc.11429; Barutcu AR, 2017, NUCLEUS-PHILA, V8, P150, DOI 10.1080/19491034.2016.1276145; Barutcu AR, 2016, GENOME RES, V26, P1188, DOI 10.1101/gr.201624.115; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Breuer K, 2013, NUCLEIC ACIDS RES, V41, pD1228, DOI 10.1093/nar/gks1147; Caretti G, 2006, DEV CELL, V11, P547, DOI 10.1016/j.devcel.2006.08.003; Choi H, 2011, NAT METHODS, V8, P70, DOI 10.1038/NMETH.1541; Chung JH, 1997, P NATL ACAD SCI USA, V94, P575, DOI 10.1073/pnas.94.2.575; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Euskirchen GM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002008; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; Fuller-Pace FV, 2006, NUCLEIC ACIDS RES, V34, P4206, DOI 10.1093/nar/gkl460; Fuller-Pace FV, 2013, BBA-GENE REGUL MECH, V1829, P756, DOI 10.1016/j.bbagrm.2013.03.004; Gentile MT, 2008, DIABETES, V57, P577, DOI 10.2337/db07-0557; Gentile MT, 2012, J NEUROCHEM, V123, P963, DOI 10.1111/jnc.12004; Ghirlando R, 2016, GENE DEV, V30, P881, DOI 10.1101/gad.277863.116; Giambruno R, 2013, J PROTEOME RES, V12, P4018, DOI 10.1021/pr4003323; Gingras AC, 2007, NAT REV MOL CELL BIO, V8, P645, DOI 10.1038/nrm2208; Hadjur S, 2009, NATURE, V460, P410, DOI 10.1038/nature08079; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Holwerda SJB, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0369; Imbalzano Anthony N, 2013, Commun Integr Biol, V6, pe25153, DOI 10.4161/cib.25153; Jabbari K., 2018, LIFE-BASEL, V8, pE4, DOI [10.1074/jbc.RA117.001068, DOI 10.1074/JBC.RA117.001068]; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; KLENOVA EM, 1993, MOL CELL BIOL, V13, P7612, DOI 10.1128/MCB.13.12.7612; Kocher T, 2007, NAT METHODS, V4, P807, DOI 10.1038/NMETH1093; LOBANENKOV VV, 1990, ONCOGENE, V5, P1743; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Morris JH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-436; Nakahashi H, 2013, CELL REP, V3, P1678, DOI 10.1016/j.celrep.2013.04.024; Nativio R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000739; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Ong CT, 2014, NAT REV GENET, V15, P234, DOI 10.1038/nrg3663; Pena-Hernandez R, 2015, P NATL ACAD SCI USA, V112, pE677, DOI 10.1073/pnas.1416674112; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Ramirez F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02525-w; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Renda M, 2007, J BIOL CHEM, V282, P33336, DOI 10.1074/jbc.M706213200; Ross-Innes CS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-593; Rossow KL, 2003, ONCOGENE, V22, P151, DOI 10.1038/sj.onc.1206067; Sardiu ME, 2008, P NATL ACAD SCI USA, V105, P1454, DOI 10.1073/pnas.0706983105; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Sofueva S, 2013, EMBO J, V32, P3119, DOI 10.1038/emboj.2013.237; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Tolstorukov MY, 2013, P NATL ACAD SCI USA, V110, P10165, DOI 10.1073/pnas.1302209110; Varjosalo M, 2013, CELL REP, V3, P1306, DOI 10.1016/j.celrep.2013.03.027; Vostrov AA, 1997, J BIOL CHEM, V272, P33353, DOI 10.1074/jbc.272.52.33353; Wallace JA, 2007, CURR OPIN GENET DEV, V17, P400, DOI 10.1016/j.gde.2007.08.005; Wang H, 2012, GENOME RES, V22, P1680, DOI 10.1101/gr.136101.111; Xia JG, 2014, NUCLEIC ACIDS RES, V42, pW167, DOI 10.1093/nar/gku443; Yao HJ, 2010, GENE DEV, V24, P2543, DOI 10.1101/gad.1967810; Yu GC, 2015, BIOINFORMATICS, V31, P2382, DOI 10.1093/bioinformatics/btv145; Yusufzai TM, 2004, MOL CELL, V13, P291, DOI 10.1016/S1097-2765(04)00029-2; Zhu LJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-237; Zhu LJ, 2013, METHODS MOL BIOL, V1067, P105, DOI 10.1007/978-1-62703-607-8_8; Zlatanova J, 2009, CELL MOL LIFE SCI, V66, P1647, DOI 10.1007/s00018-009-8647-z; Zlatanova J, 2009, J CELL SCI, V122, P1275, DOI 10.1242/jcs.039990; Zuin J, 2014, P NATL ACAD SCI USA, V111, P996, DOI 10.1073/pnas.1317788111	65	25	25	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2019	294	3					861	873		10.1074/jbc.RA118.004882	http://dx.doi.org/10.1074/jbc.RA118.004882			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL4FC	30459231	Green Published, hybrid			2022-12-28	WOS:000458670200012
J	Freyaldenhoven, S; Li, YC; Kocabas, AM; Ziu, E; Ucer, S; Ramanagoudr-Bhojappa, R; Miller, GP; Kilic, F				Freyaldenhoven, Samuel; Li, Yicong; Kocabas, Arif M.; Ziu, Enrit; Ucer, Serra; Ramanagoudr-Bhojappa, Raman; Miller, Grover P.; Kilic, Fusun			RETRACTION: Withdrawal: The role of ERp44 in maturation of serotonin transporter protein. (Retraction of Vol 287, Pg 17801, 2012)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction													Miller, Grover P/AAY-7582-2020					Freyaldenhoven S, 2012, J BIOL CHEM, V287, P17801, DOI 10.1074/jbc.M112.345058	1	0	0	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2019	294	1					70	70		10.1074/jbc.W118.007073	http://dx.doi.org/10.1074/jbc.W118.007073			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG6PT	30610126	Green Published, hybrid			2022-12-28	WOS:000455105500013
J	Mrak, P; Krastel, P; Lukancic, PP; Tao, JS; Pistorius, D; Moore, CM				Mrak, Peter; Krastel, Philipp; Lukancic, Petra Pivk; Tao, Jianshi; Pistorius, Dominik; Moore, Charles M.			Discovery of the actinoplanic acid pathway in Streptomyces rapamycinicus reveals a genetically conserved synergism with rapamycin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actinobacteria; natural product biosynthesis; polyketide; protein farnesylation; genomics; target of rapamycin (TOR); peptide biosynthesis; tricarboxylic acid cycle (TCA cycle) (Krebs cycle); actinoplanic acid; pathway; rapamycin; synergy	BIOSYNTHETIC GENE-CLUSTER; POTENT INHIBITORS; ESCHERICHIA-COLI; NATURAL-PRODUCTS; RAS; EVOLUTION; METHYLTRANSFERASE; ELAIOPHYLIN; EXPRESSION; CHEMISTRY	Actinobacteria possess a great wealth of pathways for production of bioactive compounds. Following advances in genome mining, dozens of natural product (NP) gene clusters are routinely found in each actinobacterial genome; however, the modus operandi of this large arsenal is poorly understood. During investigations of the secondary metabolome of Streptomyces rapamycinicus, the producer of rapamycin, we observed accumulation of two compounds never before reported from this organism. Structural elucidation revealed actinoplanic acid A and its demethyl analogue. Actinoplanic acids (APLs) are potent inhibitors of Ras farnesyltransferase and therefore represent bioactive compounds of medicinal interest. Supported with the unique structure of these polyketides and using genome mining, we identified a gene cluster responsible for their biosynthesis in S. rapamycinicus. Based on experimental evidence and genetic organization of the cluster, we propose a stepwise biosynthesis of APL, the first bacterial example of a pathway incorporating the rare tricarballylic moiety into an NP. Although phylogenetically distant, the pathway shares some of the biosynthetic principles with the mycotoxins fumonisins. Namely, the core polyketide is acylated with the tricarballylate by an atypical nonribosomal peptide synthetase-catalyzed ester formation. Finally, motivated by the conserved colocalization of the rapamycin and APL pathway clusters in S. rapamycinicus and all other rapamycin-producing actinobacteria, we confirmed a strong synergism of these compounds in antifungal assays. Mining for such evolutionarily conserved coharboring of pathways would likely reveal further examples of NP sets, attacking multiple targets on the same foe. These could then serve as a guide for development of new combination therapies.	[Mrak, Peter; Lukancic, Petra Pivk] Novartis Tech Operat, Antiinfect, Kolodvorska 27, SI-1234 Menges, Slovenia; [Krastel, Philipp; Pistorius, Dominik; Moore, Charles M.] Novartis Inst BioMed Res, Novartis Campus, CH-4056 Basel, Switzerland; [Tao, Jianshi] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; [Mrak, Peter] Univ Ljubljana, Ljubljana 1000, Slovenia	Novartis; Novartis; University of Ljubljana	Mrak, P (corresponding author), Novartis Tech Operat, Antiinfect, Kolodvorska 27, SI-1234 Menges, Slovenia.; Moore, CM (corresponding author), Novartis Inst BioMed Res, Novartis Campus, CH-4056 Basel, Switzerland.	peter.mrak@novartis.com; charles-1.moore@novartis.com		Pistorius, Dominik/0000-0003-1949-9924				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Arp J, 2018, P NATL ACAD SCI USA, V115, P3758, DOI 10.1073/pnas.1721790115; Baranasic D, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00581-13; BERGSTROM JD, 1995, ANNU REV MICROBIOL, V49, P607, DOI 10.1146/annurev.mi.49.100195.003135; BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; Bisang C, 1999, NATURE, V401, P502, DOI 10.1038/46829; Blank L, 2002, MICROBIOL-SGM, V148, P133, DOI 10.1099/00221287-148-1-133; Blazic M, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0352-z; Bloudoff K, 2017, BBA-PROTEINS PROTEOM, V1865, P1587, DOI 10.1016/j.bbapap.2017.05.010; Butchko RAE, 2006, J AGR FOOD CHEM, V54, P9398, DOI 10.1021/jf0617869; Challis GL, 2003, P NATL ACAD SCI USA, V100, P14555, DOI 10.1073/pnas.1934677100; Chang CY, 2018, BIOCHEMISTRY-US, V57, P3278, DOI 10.1021/acs.biochem.8b00174; Cheong JW, 2007, BLOOD, V110, p539A; Condurso HL, 2012, NAT PROD REP, V29, P1099, DOI 10.1039/c2np20023f; Deepa N., 2017, J VET MED RES, V4, P1093; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Du LC, 2010, NAT PROD REP, V27, P255, DOI 10.1039/b912037h; Duran RV, 2012, EMBO REP, V13, P121, DOI 10.1038/embor.2011.257; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fang AQ, 2000, J ANTIBIOT, V53, P158, DOI 10.7164/antibiotics.53.158; Flanagan PR, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00477-17; Gaubitz C, 2016, TRENDS BIOCHEM SCI, V41, P532, DOI 10.1016/j.tibs.2016.04.001; Gerber R, 2009, J AM CHEM SOC, V131, P3148, DOI 10.1021/ja8091054; Gonzalez S, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00061; Haydock SF, 2004, J BIOTECHNOL, V113, P55, DOI 10.1016/j.jbiotec.2004.03.022; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Horn F, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00616-14; Huang H, 2015, CHIN J NAT MEDICINES, V13, P90, DOI 10.1016/S1875-5364(15)60012-7; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; JAKLITSCH WM, 1991, J GEN MICROBIOL, V137, P533, DOI 10.1099/00221287-137-3-533; Katz L, 2016, J IND MICROBIOL BIOT, V43, P155, DOI 10.1007/s10295-015-1723-5; Khanna A, 2016, SCI REP-UK, V6, DOI 10.1038/srep25823; Kieser T, 2000, PRACTICAL STREPTOMYC, P249; Kong FM, 2011, J NAT PROD, V74, P547, DOI 10.1021/np1003388; Kosec G, 2012, METAB ENG, V14, P39, DOI 10.1016/j.ymben.2011.11.003; Kumar Y, 2008, INT J SYST EVOL MICR, V58, P1369, DOI 10.1099/ijs.0.65408-0; Kuscer E, 2007, J BACTERIOL, V189, P4756, DOI 10.1128/JB.00129-07; Ladner CC, 2016, J IND MICROBIOL BIOT, V43, P371, DOI 10.1007/s10295-015-1704-8; Lia Y, 2013, MYCOLOGY, V4, P179, DOI DOI 10.1080/21501203.2013.874540; Lin SJ, 2009, P NATL ACAD SCI USA, V106, P4183, DOI 10.1073/pnas.0808880106; Massengo-Tiasse RP, 2009, CELL MOL LIFE SCI, V66, P1507, DOI 10.1007/s00018-009-8704-7; Melchinger W., 2013, BLOOD, V122, P3076; Moorthy NSHN, 2013, CURR MED CHEM, V20, P4888, DOI 10.2174/09298673113206660262; Mott BT, 2015, SCI REP-UK, V5, DOI 10.1038/srep13891; Niessner H, 2011, J INVEST DERMATOL, V131, P468, DOI 10.1038/jid.2010.297; Nikodinovic J, 2003, BIOTECHNIQUES, V35, P932, DOI 10.2144/03355bm05; Paradkar A, 2013, J ANTIBIOT, V66, P411, DOI 10.1038/ja.2013.26; Patridge E, 2016, DRUG DISCOV TODAY, V21, P204, DOI 10.1016/j.drudis.2015.01.009; Petronikolou N, 2015, CHEM BIOL, V22, P1480, DOI 10.1016/j.chembiol.2015.09.011; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Proctor RH, 2003, FUNGAL GENET BIOL, V38, P237, DOI 10.1016/S1087-1845(02)00525-X; Proctor RH, 1999, FUNGAL GENET BIOL, V27, P100, DOI 10.1006/fgbi.1999.1141; Pye CR, 2017, P NATL ACAD SCI USA, V114, P5601, DOI 10.1073/pnas.1614680114; Ramon-Garcia S, 2011, ANTIMICROB AGENTS CH, V55, P3861, DOI 10.1128/AAC.00474-11; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rudolph MM, 2013, MICROBIOL-SGM, V159, P1416, DOI 10.1099/mic.0.067322-0; Saxena N, 2008, CANCER INVEST, V26, P948, DOI 10.1080/07357900802087275; Seo HS, 2001, P NATL ACAD SCI USA, V98, P4788, DOI 10.1073/pnas.081557298; Siegl T, 2013, METAB ENG, V19, P98, DOI 10.1016/j.ymben.2013.07.006; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SILVERMAN KC, 1995, APPL MICROBIOL BIOT, V43, P610; SINGH SB, 1994, J AM CHEM SOC, V116, P11606, DOI 10.1021/ja00104a066; SINGH SB, 1995, J ORG CHEM, V60, P7896, DOI 10.1021/jo00129a033; Struck AW, 2012, CHEMBIOCHEM, V13, P2642, DOI 10.1002/cbic.201200556; Sun YH, 2009, APPL MICROBIOL BIOT, V82, P303, DOI 10.1007/s00253-008-1793-7; Tatebe H, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7040077; Tsao CC, 2009, FUNGAL GENET BIOL, V46, P126, DOI 10.1016/j.fgb.2008.11.008; van Dam TJP, 2011, J MOL EVOL, V73, P209, DOI 10.1007/s00239-011-9469-9; Wambaugh MA, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001644; Wang JY, 2017, MEDCHEMCOMM, V8, P841, DOI 10.1039/c7md00030h; Weber T, 2015, NUCLEIC ACIDS RES, V43, pW237, DOI 10.1093/nar/gkv437; WHO, 2017, 20 WHO MOD LIST ESS; Yoo YJ, 2017, J IND MICROBIOL BIOT, V44, P537, DOI 10.1007/s10295-016-1834-7; Zaleta-Rivera K, 2006, BIOCHEMISTRY-US, V45, P2561, DOI 10.1021/bi052085s; Ziemert N, 2016, NAT PROD REP, V33, P988, DOI 10.1039/c6np00025h	76	11	12	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					19982	19995		10.1074/jbc.RA118.005314	http://dx.doi.org/10.1074/jbc.RA118.005314			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30327433	Green Published, hybrid			2022-12-28	WOS:000454685900004
J	Spiering, MJ				Spiering, Martin J.			The discovery of GABA in the brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material												mspiering@asbmb.org		Spiering, Martin/0000-0002-9160-5296				AWAPARA J, 1950, J BIOL CHEM, V187, P35; BAZEMORE AW, 1957, J NEUROCHEM, V1, P334, DOI 10.1111/j.1471-4159.1957.tb12090.x; ROBERTS E, 1950, J BIOL CHEM, V187, P55; ROBERTS E, 1950, FED PROC, V9, P219; UDENFRIEND S, 1950, J BIOL CHEM, V187, P65	5	11	11	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2018	293	49					19159	19160		10.1074/jbc.CL118.006591	http://dx.doi.org/10.1074/jbc.CL118.006591			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NY	30530855	hybrid, Green Published			2022-12-28	WOS:000458467400029
J	Jeschke, GR; Lou, HJ; Weise, K; Hammond, CI; Demonch, M; Brennwald, P; Turk, BE				Jeschke, Grace R.; Lou, Hua Jane; Weise, Keith; Hammond, Charlotte I.; Demonch, Mallory; Brennwald, Patrick; Turk, Benjamin E.			Substrate priming enhances phosphorylation by the budding yeast kinases Kin1 and Kin2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein kinase; protein phosphorylation; signal transduction; exocytosis; endoplasmic reticulum stress (ER stress); yeast; SNARE proteins; kinase priming; phosphorecognition; Sec9	PROTEIN-KINASE; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; BINDING DOMAINS; SNARE COMPLEX; CELL-CYCLE; SPECIFICITY; PHOSPHOPROTEINS; INTEGRATION; MECHANISM	Multisite phosphorylation of proteins is a common mechanism for signal integration and amplification in eukaryotic signaling networks. Proteins are commonly phosphorylated at multiple sites in an ordered manner, whereby phosphorylation by one kinase primes the substrate by generating a recognition motif for a second kinase. Here we show that substrate priming promotes phosphorylation by Saccharomyces cerevisiae Kin1 and Kin2, kinases that regulate cell polarity, exocytosis, and the endoplasmic reticulum (ER) stress response. Kin1/Kin2 phosphorylated substrates within the context of a sequence motif distinct from those of their most closely related kinases. In particular, the rate of phosphorylation of a peptide substrate by Kin1/Kin2 increased >30-fold with incorporation of a phosphoserine residue two residues downstream of the phosphorylation site. Recognition of phosphorylated substrates by Kin1/Kin2 was mediated by a patch of basic residues located in the region of the kinase C helix. We identified a set of candidate Kin1/Kin2 substrates reported to be dually phosphorylated at sites conforming to the Kin1/Kin2 consensus sequence. One of these proteins, the t-SNARE protein Sec9, was confirmed to be a Kin1/Kin2 substrate both in vitro and in vivo. Sec9 phosphorylation by Kin1 in vitro was enhanced by prior phosphorylation at the +2 position. Recognition of primed substrates was not required for the ability of Kin2 to suppress the growth defect of secretory pathway mutants but was necessary for optimal growth under conditions of ER stress. These results suggest that at least some endogenous protein substrates of Kin1/Kin2 are phosphorylated in a priming-dependent manner.	[Jeschke, Grace R.; Lou, Hua Jane; Weise, Keith; Turk, Benjamin E.] Yale Sch Med, Dept Pharmacol, POB 208066,333 Cedar St, New Haven, CT 06520 USA; [Hammond, Charlotte I.] Quinnipiac Univ, Dept Biol, Hamden, CT 06518 USA; [Demonch, Mallory; Brennwald, Patrick] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA	Yale University; Quinnipiac University; University of North Carolina; University of North Carolina Chapel Hill	Turk, BE (corresponding author), Yale Sch Med, Dept Pharmacol, POB 208066,333 Cedar St, New Haven, CT 06520 USA.	ben.turk@yale.edu		Jeschke, Grace/0000-0001-6271-7750	National Institutes of Health [R01 GM104047, R01 GM105947, R01 GM054712-21]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054712, R01GM104047, R01GM105947] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 GM104047 and R01 GM105947 (to B. E. T.) and R01 GM054712-21 (to P. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anshu A, 2015, MOL CELL BIOL, V35, P199, DOI 10.1128/MCB.00981-14; Bachmann M, 2004, J BIOL CHEM, V279, P48319, DOI 10.1074/jbc.M404440200; Begley MJ, 2015, NAT STRUCT MOL BIOL, V22, P983, DOI 10.1038/nsmb.3117; Bodenmiller B, 2008, NAT BIOTECHNOL, V26, P1339, DOI 10.1038/nbt1208-1339; BRENNWALD P, 1994, CELL, V79, P245, DOI 10.1016/0092-8674(94)90194-5; Cadou A, 2010, MOL MICROBIOL, V77, P1186, DOI 10.1111/j.1365-2958.2010.07281.x; Cadou A, 2009, CELL CYCLE, V8, P2451, DOI 10.4161/cc.8.15.9219; Cesaro L, 2015, MOL BIOSYST, V11, P2666, DOI 10.1039/c5mb00337g; Chen S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003936; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Cho WH, 2006, P NATL ACAD SCI USA, V103, P11521, DOI 10.1073/pnas.0604990103; Cox JS, 1997, MOL BIOL CELL, V8, P1805, DOI 10.1091/mbc.8.9.1805; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; DALE S, 1995, FEBS LETT, V361, P191, DOI 10.1016/0014-5793(95)00172-6; DONOVAN M, 1994, YEAST, V10, P113, DOI 10.1002/yea.320100111; Drewes G, 2003, FEBS LETT, V554, P45, DOI 10.1016/S0014-5793(03)01080-9; Elbert M, 2005, MOL BIOL CELL, V16, P532, DOI 10.1091/mbc.E04-07-0549; Elbing K, 2006, BIOCHEM J, V393, P797, DOI 10.1042/BJ20051213; FIOL CJ, 1987, J BIOL CHEM, V262, P14042; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; Gelperin DM, 2005, GENE DEV, V19, P2816, DOI 10.1101/gad.1362105; Gerber SA, 2003, P NATL ACAD SCI USA, V100, P6940, DOI 10.1073/pnas.0832254100; Goodwin JM, 2014, MOL CELL, V55, P436, DOI 10.1016/j.molcel.2014.06.021; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Koivomagi M, 2013, NAT STRUCT MOL BIOL, V20, P1415, DOI 10.1038/nsmb.2706; La Carbona S, 2004, BIOL CELL, V96, P169, DOI 10.1016/j.biolcel.2003.12.004; La Carbona S, 2006, CURR GENET, V50, P377, DOI 10.1007/s00294-006-0099-5; LAMB A, 1991, YEAST, V7, P219, DOI 10.1002/yea.320070304; LasaBenito M, 1996, FEBS LETT, V382, P149, DOI 10.1016/0014-5793(96)00136-6; Lee ME, 2018, CURR BIOL, V28, P84, DOI 10.1016/j.cub.2017.11.034; Lee YJ, 2012, MOL CELL BIOL, V32, P4705, DOI 10.1128/MCB.00897-12; LEVIN DE, 1990, P NATL ACAD SCI USA, V87, P8272, DOI 10.1073/pnas.87.21.8272; LEVIN DE, 1987, P NATL ACAD SCI USA, V84, P6035, DOI 10.1073/pnas.84.17.6035; Miller CJ, 2018, TRENDS BIOCHEM SCI, V43, P380, DOI 10.1016/j.tibs.2018.02.009; Mok J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000482; Moravcevic K, 2010, CELL, V143, P966, DOI 10.1016/j.cell.2010.11.028; Nesic D, 2010, NAT STRUCT MOL BIOL, V17, P130, DOI 10.1038/nsmb.1705; Parsons AB, 2004, NAT BIOTECHNOL, V22, P62, DOI 10.1038/nbt919; Picotti P, 2009, CELL, V138, P795, DOI 10.1016/j.cell.2009.05.051; Reinhardt HC, 2013, NAT REV MOL CELL BIO, V14, P563, DOI 10.1038/nrm3640; Rice LM, 1997, FEBS LETT, V415, P49, DOI 10.1016/S0014-5793(97)01091-0; Sarno S, 1997, BIOCHEMISTRY-US, V36, P11717, DOI 10.1021/bi9705772; Scrimale T, 2009, MOL BIOL CELL, V20, P164, DOI 10.1091/mbc.E08-08-0809; Serber Z, 2007, CELL, V128, P441, DOI 10.1016/j.cell.2007.01.018; Tagliabracci VS, 2012, SCIENCE, V336, P1150, DOI 10.1126/science.1217817; Tassan JP, 2004, BIOL CELL, V96, P193, DOI 10.1016/j.biolcel.2003.10.009; Uboha NV, 2007, J NEUROSCI, V27, P4413, DOI 10.1523/JNEUROSCI.0725-07.2007; Xiao JY, 2013, P NATL ACAD SCI USA, V110, P10574, DOI 10.1073/pnas.1309211110; Yaffe MB, 2002, NAT REV MOL CELL BIO, V3, P177, DOI 10.1038/nrm759; Yuan SM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153992	51	1	1	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2018	293	47					18353	18364		10.1074/jbc.RA118.005651	http://dx.doi.org/10.1074/jbc.RA118.005651			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8XM	30305396	Green Published, hybrid			2022-12-28	WOS:000451375200026
J	Chamakura, K; Young, R				Chamakura, Karthik; Young, Ry			Phage single-gene lysis: Finding the weak spot in the bacterial cell wall	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						peptidoglycan; bacteriophage; chaperone DnaJ (DnaJ); cell wall; enzyme inhibitor; antibiotic; autolysin; flippase; single-gene lysis; phage; peptidoglycan biosynthesis; MurA; MraY; MurJ	LIPID II FLIPPASE; COMPLETE NUCLEOTIDE-SEQUENCE; STRANDED RNA PHAGE; ESCHERICHIA-COLI; PHI-X174 LYSIS; PROTEIN-E; PEPTIDOGLYCAN BIOSYNTHESIS; BACTERIOPHAGE PHI-X174; CRYSTAL-STRUCTURE; MEMBRANE	In general, the last step in the vegetative cycle of bacterial viruses, or bacteriophages, is lysis of the host. dsDNA phages require multiple lysis proteins, including at least one enzyme that degrades the cell wall (peptidoglycan (PG)). In contrast, the lytic ssDNA and ssRNA phages have a single lysis protein that achieves cell lysis without enzymatically degrading the PG. Here, we review four single-gene lysis or Sgl proteins. Three of the Sgls block bacterial cell wall synthesis by binding to and inhibiting several enzymes in the PG precursor pathway. The target of the fourth Sgl, L from bacteriophage MS2, is still unknown, but we review evidence indicating that it is likely a protein involved in maintaining cell wall integrity. Although only a few phage genomes are available to date, the ssRNA Leviviridae are a rich source of novel Sgls, which may facilitate further unraveling of bacterial cell wall biosynthesis and discovery of new antibacterial agents.	[Chamakura, Karthik; Young, Ry] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Chamakura, Karthik; Young, Ry] Texas A&M Univ, Ctr Phage Technol, Texas A&M AgriLife Res, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research	Young, R (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	ryland@tamu.edu	Chamakura, Karthik Reddy/J-2004-2019	Chamakura, Karthik Reddy/0000-0002-6196-8571; Young, Ry/0000-0001-8001-2914	National Institutes of Health - Texas AM AgriLife [GM27099]; Center for Phage Technology at Texas A&M University - Texas AM AgriLife; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027099] Funding Source: NIH RePORTER	National Institutes of Health - Texas AM AgriLife; Center for Phage Technology at Texas A&M University - Texas AM AgriLife; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM27099 and by the Center for Phage Technology at Texas A&M University, jointly sponsored by Texas A&M AgriLife. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ADHIN MR, 1989, VIROLOGY, V170, P238, DOI 10.1016/0042-6822(89)90371-1; BEREMAND MN, 1979, CELL, V18, P257, DOI 10.1016/0092-8674(79)90045-X; BERKHOUT B, 1985, EMBO J, V4, P3315, DOI 10.1002/j.1460-2075.1985.tb04082.x; Bernhardt TG, 2000, P NATL ACAD SCI USA, V97, P4297, DOI 10.1073/pnas.97.8.4297; Bernhardt TG, 2002, MOL MICROBIOL, V45, P99, DOI 10.1046/j.1365-2958.2002.02984.x; Bernhardt TG, 2002, RES MICROBIOL, V153, P493, DOI 10.1016/S0923-2508(02)01330-X; Bernhardt TG, 2001, J BIOL CHEM, V276, P6093, DOI 10.1074/jbc.M007638200; Bernhardt TG, 2001, SCIENCE, V292, P2326, DOI 10.1126/science.1058289; BLASI U, 1985, J GEN MICROBIOL, V131, P1107; Blasi U., 1984, MICROBIAL CELL WALL, P213; Bolla JR, 2018, NAT CHEM, V10, P363, DOI [10.1038/NCHEM.2919, 10.1038/nchem.2919]; BRADLEY DE, 1969, J GEN VIROL, V5, P113, DOI 10.1099/0022-1317-5-1-113; BRAUN V, 1975, BIOCHIM BIOPHYS ACTA, V415, P335, DOI 10.1016/0304-4157(75)90013-1; BROWN ED, 1995, J BACTERIOL, V177, P4194, DOI 10.1128/jb.177.14.4194-4197.1995; BUCKLEY KJ, 1986, MOL GEN GENET, V204, P120, DOI 10.1007/BF00330198; Butler EK, 2013, J BACTERIOL, V195, P4639, DOI 10.1128/JB.00731-13; Chamakura KR, 2017, NAT MICROBIOL, V2, P1480, DOI 10.1038/s41564-017-0023-4; Chamakura KR, 2017, MICROBIOL-SGM, V163, P961, DOI 10.1099/mic.0.000485; Chamakura KR, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00058-17; Cho H, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.172, 10.1038/nmicrobiol.2016.172]; Chung BC, 2013, SCIENCE, V341, P1012, DOI 10.1126/science.1236501; COLEMAN J, 1983, J BACTERIOL, V153, P1098, DOI 10.1128/JB.153.2.1098-1100.1983; Cowles CE, 2011, MOL MICROBIOL, V79, P1168, DOI 10.1111/j.1365-2958.2011.07539.x; Cui ZC, 2017, P NATL ACAD SCI USA, V114, P11697, DOI 10.1073/pnas.1707102114; Domingo E, 1997, ANNU REV MICROBIOL, V51, P151, DOI 10.1146/annurev.micro.51.1.151; Friedman SD, 2009, J VIROL METHODS, V159, P47, DOI 10.1016/j.jviromet.2009.02.028; Gan L, 2008, P NATL ACAD SCI USA, V105, P18953, DOI 10.1073/pnas.0808035105; GOESSENS WHF, 1988, EMBO J, V7, P867, DOI 10.1002/j.1460-2075.1988.tb02886.x; HAHN FE, 1957, SCIENCE, V125, P119, DOI 10.1126/science.125.3238.119; Hatfull GF, 2001, SCIENCE, V292, P2263, DOI 10.1126/science.1062957; HENRICH B, 1982, MOL GEN GENET, V185, P493, DOI 10.1007/BF00334146; HOLTJE JV, 1988, J BIOL CHEM, V263, P3539; Holtje JV, 1984, MICROBIAL CELL WALL, P195; HUTCHISON CA, 1978, J BIOL CHEM, V253, P6551; INOKUCHI Y, 1988, NUCLEIC ACIDS RES, V16, P6205, DOI 10.1093/nar/16.13.6205; INOKUCHI Y, 1982, J MOL BIOL, V158, P711, DOI 10.1016/0022-2836(82)90256-X; INOKUCHI Y, 1986, J BIOCHEM-TOKYO, V99, P1169, DOI 10.1093/oxfordjournals.jbchem.a135580; Kannoly S, 2012, J BACTERIOL, V194, P5073, DOI 10.1128/JB.00929-12; Kay JE, 1996, BIOCHEM J, V314, P361, DOI 10.1042/bj3140361; Kazaks A, 2011, J VIROL, V85, P4628, DOI 10.1128/JVI.02256-10; Kim MS, 2011, APPL ENVIRON MICROB, V77, P8062, DOI 10.1128/AEM.06331-11; Klovins J, 2002, J GEN VIROL, V83, P1523, DOI 10.1099/0022-1317-83-6-1523; KOZAK M, 1971, NATURE-NEW BIOL, V234, P209, DOI 10.1038/newbio234209a0; Krishnamurthy SR, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002409; Kuk ACY, 2017, NAT STRUCT MOL BIOL, V24, P171, DOI 10.1038/nsmb.3346; Lovering AL, 2012, ANNU REV BIOCHEM, V81, P451, DOI 10.1146/annurev-biochem-061809-112742; LUBITZ W, 1984, J GEN MICROBIOL, V130, P1079; LUBITZ W, 1983, CURR MICROBIOL, V8, P63, DOI 10.1007/BF01567316; MARATEA D, 1985, GENE, V40, P39, DOI 10.1016/0378-1119(85)90022-8; Meeske AJ, 2016, NATURE, V537, P634, DOI 10.1038/nature19331; Meeske AJ, 2015, P NATL ACAD SCI USA, V112, P6437, DOI 10.1073/pnas.1504967112; MODEL P, 1979, CELL, V18, P235, DOI 10.1016/0092-8674(79)90043-6; Mohammadi T, 2014, J BIOL CHEM, V289, P14707, DOI 10.1074/jbc.M114.557371; Mohammadi T, 2011, EMBO J, V30, P1425, DOI 10.1038/emboj.2011.61; OLSTHOORN RCL, 1995, VIROLOGY, V206, P611, DOI 10.1016/S0042-6822(95)80078-6; POLLOCK TJ, 1978, J VIROL, V28, P408, DOI 10.1128/JVI.28.1.408-410.1978; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Reed CA, 2012, MOL MICROBIOL, V86, P836, DOI 10.1111/mmi.12021; Reed CA, 2013, MICROBIOL-SGM, V159, P507, DOI 10.1099/mic.0.064790-0; ROOF WD, 1994, J BIOL CHEM, V269, P2902; Ruiz N, 2008, P NATL ACAD SCI USA, V105, P15553, DOI 10.1073/pnas.0808352105; Rumnieks J, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-277; Ruokoranta TM, 2006, J VIROL, V80, P9326, DOI 10.1128/JVI.01005-06; SANGER F, 1977, NATURE, V265, P687, DOI 10.1038/265687a0; Sham LT, 2014, SCIENCE, V345, P220, DOI 10.1126/science.1254522; Shi M, 2016, NATURE, V540, P539, DOI 10.1038/nature20167; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Sjodt M, 2018, NATURE, V556, P118, DOI 10.1038/nature25985; Smith HO, 2003, P NATL ACAD SCI USA, V100, P15440, DOI 10.1073/pnas.2237126100; Stewart JR, 2006, APPL ENVIRON MICROB, V72, P1226, DOI 10.1128/AEM.72.2.1226-1230.2006; STOCK JB, 1977, J BIOL CHEM, V252, P7850; Tanaka S, 2012, MOL MICROBIOL, V85, P975, DOI 10.1111/j.1365-2958.2012.08153.x; THWAITES JJ, 1989, INT J BIOL MACROMOL, V11, P201, DOI 10.1016/0141-8130(89)90069-X; Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; WALDERICH B, 1988, J BACTERIOL, V170, P5027, DOI 10.1128/jb.170.11.5027-5033.1988; WALDERICH B, 1989, J BACTERIOL, V171, P3331, DOI 10.1128/jb.171.6.3331-3336.1989; Weber K, 1975, RNA PHAGES, V5, P51; WINTER RB, 1983, CELL, V33, P877, DOI 10.1016/0092-8674(83)90030-2; WITTE A, 1990, J BACTERIOL, V172, P4109, DOI 10.1128/jb.172.7.4109-4114.1990; YOUNG KD, 1982, J VIROL, V44, P993, DOI 10.1128/JVI.44.3.993-1002.1982; Young R, 2013, CURR OPIN MICROBIOL, V16, P790, DOI 10.1016/j.mib.2013.08.008; Young R, 2014, J MICROBIOL, V52, P243, DOI 10.1007/s12275-014-4087-z; Zheng SD, 2018, P NATL ACAD SCI USA, V115, P6709, DOI 10.1073/pnas.1802192115; Zheng Y, 2008, GENETICS, V180, P1459, DOI 10.1534/genetics.108.093443; Zheng Y, 2009, BIOCHEMISTRY-US, V48, P4999, DOI 10.1021/bi900469g	86	15	15	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3350	3358		10.1074/jbc.TM118.001773	http://dx.doi.org/10.1074/jbc.TM118.001773			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30420429	Green Published, hybrid			2022-12-28	WOS:000461853900003
J	Sanchez, E; Gonzalez, EA; Moreno, DS; Cardenas, RA; Ramos, MA; Davalos, AJ; Manllo, J; Rodarte, AI; Petrova, Y; Moreira, DC; Chavez, MA; Tortoriello, A; Lara, A; Gutierrez, BA; Burns, AR; Heidelberger, R; Adachi, R				Sanchez, Elizabeth; Gonzalez, Erika A.; Moreno, David S.; Cardenas, Rodolfo A.; Ramos, Marco A.; Davalos, Alfredo J.; Manllo, John; Rodarte, Alejandro I.; Petrova, Youlia; Moreira, Daniel C.; Chavez, Miguel A.; Tortoriello, Alejandro; Lara, Adolfo; Gutierrez, Berenice A.; Burns, Alan R.; Heidelberger, Ruth; Adachi, Roberto			Syntaxin 3, but not syntaxin 4, is required for mast cell-regulated exocytosis, where it plays a primary role mediating compound exocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						exocytosis; SNARE proteins; mast cell; allergy; immunoglobulin E (IgE); anaphylaxis; syntaxin	SNARE COMPLEX; CAPACITANCE MEASUREMENTS; SECRETORY GRANULES; FUSION; MOUSE; DEGRANULATION; SNAP-23; RELEASE; HISTAMINE; PROTEINS	Mast cells (MCs) participate in allergy, inflammation, and defense against pathogens. They release multiple immune mediators via exocytosis, a process that requires SNARE proteins, including syntaxins (Stxs). The identity of the Stxs involved in MC exocytosis remains controversial. Here, we studied the roles of Stx3 and -4 in fully developed MCs from conditional knockout mice by electrophysiology and EM, and found that Stx3, and not Stx4, is crucial for MC exocytosis. The main defect seen in Stx3-deficient MCs was their inability to engage multigranular compound exocytosis, while leaving most single-vesicle fusion events intact. We used this defect to show that this form of exocytosis is not only required to accelerate MC degranulation but also essential to achieve full degranulation. The exocytic defect was severe but not absolute, indicating that an Stx other than Stx3 and -4 is also required for exocytosis in MCs. The removal of Stx3 affected only regulated exocytosis, leaving other MC effector responses intact, including the secretion of cytokines via constitutive exocytosis. Our in vivo model of passive systemic anaphylaxis showed that the residual exocytic function of Stx3-deficient MCs was sufficient to drive a full anaphylactic response in mice.	[Sanchez, Elizabeth; Gonzalez, Erika A.; Moreno, David S.; Cardenas, Rodolfo A.; Ramos, Marco A.; Davalos, Alfredo J.; Manllo, John; Petrova, Youlia; Moreira, Daniel C.; Chavez, Miguel A.; Tortoriello, Alejandro; Gutierrez, Berenice A.; Adachi, Roberto] Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, 2121 W Holcombe Blvd, Houston, TX 77030 USA; [Sanchez, Elizabeth; Gonzalez, Erika A.; Moreno, David S.; Cardenas, Rodolfo A.; Ramos, Marco A.; Davalos, Alfredo J.; Manllo, John; Rodarte, Alejandro I.; Moreira, Daniel C.; Chavez, Miguel A.; Tortoriello, Alejandro; Gutierrez, Berenice A.] Tecnol Monterrey, Escuela Med & Ciencias Salud, Monterrey 64710, Nuevo Leon, Mexico; [Lara, Adolfo; Heidelberger, Ruth] Univ Texas Hlth Sci Ctr Houston, Dept Neurobiol & Anat, McGovern Med Sch, Houston, TX 77030 USA; [Burns, Alan R.] Univ Houston, Coll Optometry, Houston, TX 77204 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; UTMD Anderson Cancer Center; Tecnologico de Monterrey; University of Texas System; University of Texas Health Science Center Houston; University of Houston System; University of Houston	Adachi, R (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, 2121 W Holcombe Blvd, Houston, TX 77030 USA.	radachi@mdanderson.org		Lara, Adolfo/0000-0002-4258-1304; Moreno McNeill, David/0000-0003-0049-1770; Adachi, Roberto/0000-0002-0146-0768; Heidelberger, Ruth/0000-0002-8033-2050	National Institutes of Health [AI093533, CA016672, EY007551, EY012128]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY012128] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grants AI093533, CA016672, EY007551, and EY012128. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adachi R, 2012, J BIOL CHEM, V287, P20047, DOI 10.1074/jbc.M112.360388; Adhikari P, 2018, INFLAMM RES, V67, P1, DOI 10.1007/s00011-017-1097-4; Azouz NP, 2014, J IMMUNOL, V192, P4043, DOI 10.4049/jimmunol.1302196; Baram D, 1999, J EXP MED, V189, P1649, DOI 10.1084/jem.189.10.1649; Bin NR, 2015, J CELL SCI, V128, P1946, DOI 10.1242/jcs.165662; Bin NR, 2013, P NATL ACAD SCI USA, V110, P4610, DOI 10.1073/pnas.1214887110; Blank U, 2004, TRENDS IMMUNOL, V25, P266, DOI 10.1016/j.it.2004.03.005; Blank U, 2002, MOL IMMUNOL, V38, P1341, DOI 10.1016/S0161-5890(02)00085-8; Blank U, 2011, ADV EXP MED BIOL, V716, P107, DOI 10.1007/978-1-4419-9533-9_7; Boyce JA, 2005, CHEM IMMUNOL ALLERGY, V87, P59, DOI 10.1159/000087571; Brochetta C, 2014, J IMMUNOL, V192, P41, DOI 10.4049/jimmunol.1301277; BURGESS TL, 1987, ANNU REV CELL BIOL, V3, P243, DOI 10.1146/annurev.cellbio.3.1.243; Burgoyne RD, 2003, PHYSIOL REV, V83, P581, DOI 10.1152/physrev.00031.2002; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Dernick G, 2007, FRONT NEUROENG, V1, P315; DETOLEDO GA, 1990, J CELL BIOL, V110, P1033, DOI 10.1083/jcb.110.4.1033; DETOLEDO GA, 1990, J GEN PHYSIOL, V95, P397, DOI 10.1085/jgp.95.3.397; Dieckmann NMG, 2015, TRAFFIC, V16, P1330, DOI 10.1111/tra.12337; Dombrowicz D, 1997, J CLIN INVEST, V99, P915, DOI 10.1172/JCI119256; FERNANDEZ JM, 1984, NATURE, V312, P453, DOI 10.1038/312453a0; Frank SPC, 2011, MOL IMMUNOL, V49, P353, DOI 10.1016/j.molimm.2011.09.011; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; Galli SJ, 2010, EUR J IMMUNOL, V40, P1843, DOI 10.1002/eji.201040559; Gilfillan AM, 2011, CRIT REV IMMUNOL, V31, P475, DOI 10.1615/CritRevImmunol.v31.i6.30; Gutierrez BA, 2018, J BIOL CHEM, V293, P7148, DOI 10.1074/jbc.RA118.002455; Hackmann Y, 2013, P NATL ACAD SCI USA, V110, pE4482, DOI 10.1073/pnas.1313474110; HELANDER HF, 1974, J MICROSC-OXFORD, V100, P315, DOI 10.1111/j.1365-2818.1974.tb03943.x; Hibi T, 2000, BIOCHEM BIOPH RES CO, V271, P36, DOI 10.1006/bbrc.2000.2591; Kim K, 2012, BIOCHEM J, V446, P383, DOI 10.1042/BJ20120057; KOPS SK, 1990, CELL TISSUE RES, V262, P415, DOI 10.1007/BF00305238; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; Liu S, 2012, IMMUNOL CELL BIOL, V90, P337, DOI 10.1038/icb.2011.41; Makabe-Kobayashi Y, 2002, J ALLERGY CLIN IMMUN, V110, P298, DOI 10.1067/mai.2002.125977; Marti-Verdeaux S, 2003, J CELL SCI, V116, P325, DOI 10.1242/jcs.00216; Melicoff E, 2009, J BIOL CHEM, V284, P19445, DOI 10.1074/jbc.M109.002550; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Morey C, 2017, J BIOL CHEM, V292, P20449, DOI 10.1074/jbc.M117.811182; Naskar P, 2018, J BIOSCIENCES, V43, P127, DOI 10.1007/s12038-018-9740-y; Oberhauser AF, 1996, P NATL ACAD SCI USA, V93, P14349, DOI 10.1073/pnas.93.25.14349; Ochs M, 2006, J MICROSC-OXFORD, V222, P188, DOI 10.1111/j.1365-2818.2006.01587.x; Paumet F, 2000, J IMMUNOL, V164, P5850, DOI 10.4049/jimmunol.164.11.5850; Pickett JA, 2006, TRAFFIC, V7, P109, DOI 10.1111/j.1600-0854.2005.00372.x; Puri N, 2006, TRAFFIC, V7, P1482, DOI 10.1111/j.1600-0854.2006.00490.x; Rodarte EM, 2018, J BIOL CHEM, V293, P345, DOI 10.1074/jbc.M117.816884; ROYET JP, 1991, PROG NEUROBIOL, V37, P433, DOI 10.1016/0301-0082(91)90009-P; Salinas E, 2008, J INVEST ALLERG CLIN, V18, P366; Sander LE, 2008, EUR J IMMUNOL, V38, P855, DOI 10.1002/eji.200737634; Schnutgen F, 2005, P NATL ACAD SCI USA, V102, P7221, DOI 10.1073/pnas.0502273102; Scholten J, 2008, TRANSGENIC RES, V17, P307, DOI 10.1007/s11248-007-9153-4; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Stevens RL, 2007, IMMUNOL REV, V217, P155, DOI 10.1111/j.1600-065X.2007.00525.x; Strait RT, 2002, J ALLERGY CLIN IMMUN, V109, P658, DOI 10.1067/mai.2002.123302; Sudhof TC, 2013, NEURON, V80, P675, DOI 10.1016/j.neuron.2013.10.022; Suzuki K, 2008, CELL, V134, P485, DOI 10.1016/j.cell.2008.05.050; Tadokoro S, 2005, J CELL SCI, V118, P2239, DOI 10.1242/jcs.02338; Tadokoro S, 2007, MOL IMMUNOL, V44, P3427, DOI 10.1016/j.molimm.2007.02.013; Tadokoro S, 2016, CELL BIOL INT, V40, P589, DOI 10.1002/cbin.10600; Tadokoro S, 2010, CELL IMMUNOL, V261, P51, DOI 10.1016/j.cellimm.2009.10.011; Tamori Y, 1998, J BIOL CHEM, V273, P19740, DOI 10.1074/jbc.273.31.19740; Tellam JT, 1997, J BIOL CHEM, V272, P6179, DOI 10.1074/jbc.272.10.6179; Teng FYH, 2001, GENOME BIOL, V2; Thakurdas SM, 2007, J BIOL CHEM, V282, P20809, DOI 10.1074/jbc.M611842200; Tiwari N, 2008, BLOOD, V111, P3665, DOI 10.1182/blood-2007-07-103309; Tschanz SA, 2011, J MICROSC-OXFORD, V243, P47, DOI 10.1111/j.1365-2818.2010.03481.x; Vardar G, 2016, J NEUROSCI, V36, P7911, DOI 10.1523/JNEUROSCI.1314-16.2016; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wendler F, 2001, MOL BIOL CELL, V12, P1699, DOI 10.1091/mbc.12.6.1699; Woska JR, 2011, SCAND J IMMUNOL, V73, P8, DOI 10.1111/j.1365-3083.2010.02471.x; Woska JR, 2012, J CELL MOL MED, V16, P649, DOI 10.1111/j.1582-4934.2011.01443.x; Wu LG, 2014, ANNU REV PHYSIOL, V76, P301, DOI 10.1146/annurev-physiol-021113-170305; Yang Y, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00725; Ye SJ, 2012, BLOOD, V120, P2484, DOI 10.1182/blood-2012-05-430603; ZIMMERBERG J, 1987, P NATL ACAD SCI USA, V84, P1585, DOI 10.1073/pnas.84.6.1585	73	16	16	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2019	294	9					3012	3023		10.1074/jbc.RA118.005532	http://dx.doi.org/10.1074/jbc.RA118.005532			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU0SA	30563839	hybrid, Green Published			2022-12-28	WOS:000464980100004
J	Wu, CH; Silvers, CR; Messing, EM; Lee, YF				Wu, Chia-Hao; Silvers, Christopher R.; Messing, Edward M.; Lee, Yi-Fen			Bladder cancer extracellular vesicles drive tumorigenesis by inducing the unfolded protein response in endoplasmic reticulum of nonmalignant cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum stress (ER stress); extracellular vesicles; inflammation; cytokine; unfolded protein response (UPR); exosome (vesicle); bladder cancer; cell stress; extracellular vesicles; filed cancerization; urothelial carcinoma	ER STRESS; IN-VITRO; EXOSOMES; INHIBITOR; PROMOTES; INFLAMMATION; GROWTH; ACID; DHA	The field cancerization effect has been proposed to explain bladder cancer's multifocal and recurrent nature, yet the mechanisms of this effect remain unknown. In this work, using cell biology, flow cytometry, and qPCR analyses, along with a xenograft mouse tumor model, we show that chronic exposure to tumor-derived extracellular vesicles (TEVs) results in the neoplastic transformation of nonmalignant human SV-HUC urothelial cells. Inhibition of EV uptake prevented this transformation. Transformed cells not only possessed several oncogenic properties, such as increased genome instability, loss of cell-cell contact inhibition, and invasiveness, but also displayed altered morphology and cell structures, such as an enlarged cytoplasm with disrupted endoplasmic reticulum (ER) alignment and the accumulation of smaller mitochondria. Exposure of SV-HUC cells to TEVs provoked the unfolded protein response in the endoplasmic reticulum (UPRER). Prolonged induction of UPRER signaling activated the survival branch of the UPRER pathway, in which cells had elevated expression of inositol-requiring enzyme 1 (IRE1), NF-B, and the inflammatory cytokine leptin, and incurred loss of the pro-apoptotic protein C/EBP homologous protein (CHOP). More importantly, inhibition of ER stress by docosahexaenoic acid prevented TEV-induced transformation. We propose that TEVs promote malignant transformation of predisposed cells by inhibiting pro-apoptotic signals and activating tumor-promoting ER stress-induced unfolded protein response and inflammation. This study provides detailed insight into the mechanisms underlying the bladder cancer field effect and tumor recurrence.	[Wu, Chia-Hao; Lee, Yi-Fen] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA; [Silvers, Christopher R.; Messing, Edward M.; Lee, Yi-Fen] Univ Rochester, Med Ctr, Dept Urol, 601 Elmwood Ave,Box 656, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Lee, YF (corresponding author), Univ Rochester, Med Ctr, Dept Urol, 601 Elmwood Ave,Box 656, Rochester, NY 14642 USA.	yifen_lee@urmc.rochester.edu			NCI, National Institutes of Health [R01 CA173986]; NATIONAL CANCER INSTITUTE [R01CA173986] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by NCI, National Institutes of Health Grant R01 CA173986 (to Y.-F. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abd Elmageed ZY, 2014, STEM CELLS, V32, P983, DOI 10.1002/stem.1619; Abdollah F, 2013, CANCER EPIDEMIOL, V37, P219, DOI 10.1016/j.canep.2013.02.002; ABERCROMBIE M, 1979, NATURE, V281, P259, DOI 10.1038/281259a0; Atkins C, 2013, CANCER RES, V73, P1993, DOI 10.1158/0008-5472.CAN-12-3109; Axten JM, 2012, J MED CHEM, V55, P7193, DOI 10.1021/jm300713s; Beckham CJ, 2014, J UROLOGY, V192, P583, DOI 10.1016/j.juro.2014.02.035; Begum G, 2013, TRANSL STROKE RES, V4, P635, DOI 10.1007/s12975-013-0282-1; Begum G, 2012, J NEUROCHEM, V120, P622, DOI 10.1111/j.1471-4159.2011.07606.x; Blaveri E, 2005, CLIN CANCER RES, V11, P4044, DOI 10.1158/1078-0432.CCR-04-2409; BOURRE JM, 1989, J NUTR, V119, P1880, DOI 10.1093/jn/119.12.1880; Chen C, 2017, CANCER LETT, V388, P21, DOI 10.1016/j.canlet.2016.11.027; Choi D, 2017, SEMIN CELL DEV BIOL, V67, P11, DOI 10.1016/j.semcdb.2017.01.003; CHRISTIAN BJ, 1987, CANCER RES, V47, P6066; Cianciulli AM, 2003, HUM PATHOL, V34, P214, DOI 10.1053/hupa.2003.30; Clarke HJ, 2014, CANCER CELL, V25, P563, DOI 10.1016/j.ccr.2014.03.015; D'Eliseo D, 2016, J CLIN MED, V5, DOI 10.3390/jcm5020015; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Dutta S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097580; Felicetti F, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0811-2; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Garg AD, 2012, TRENDS MOL MED, V18, P589, DOI 10.1016/j.molmed.2012.06.010; Griffiths SG, 2017, PROTEOMES, V5, DOI 10.3390/proteomes5040025; Hamam D, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0360-9; Heusermann W, 2016, J CELL BIOL, V213, P173, DOI 10.1083/jcb.201506084; Javeed N, 2015, CLIN CANCER RES, V21, P1722, DOI 10.1158/1078-0432.CCR-14-2022; JENSEN KLD, 1992, ULTRASTRUCT PATHOL, V16, P51, DOI 10.3109/01913129209074550; Jones TD, 2005, CLIN CANCER RES, V11, P6512, DOI 10.1158/1078-0432.CCR-05-0891; Kanada M, 2016, TRENDS CANCER, V2, P84, DOI 10.1016/j.trecan.2015.12.005; Koivusalo M, 2010, J CELL BIOL, V188, P547, DOI 10.1083/jcb.200908086; Kreger BT, 2016, J BIOL CHEM, V291, P19774, DOI 10.1074/jbc.M116.725705; Liu YC, 2013, PROTEIN CELL, V4, P932, DOI 10.1007/s13238-013-3092-z; Lobb RJ, 2017, PROTEOMICS, V17, DOI 10.1002/pmic.201600432; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Maia J, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00018; Marleau AM, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-134; Melo SA, 2014, CANCER CELL, V26, P707, DOI 10.1016/j.ccell.2014.09.005; Michell AR, 2008, ANNU REV PHYSIOL, V70, P379, DOI 10.1146/annurev.physiol.69.040705.141330; Mimura N, 2012, BLOOD, V119, P5772, DOI 10.1182/blood-2011-07-366633; Mulcahy LA, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24641; Ngoh GA, 2012, J BIOL CHEM, V287, P20321, DOI 10.1074/jbc.M112.359174; Oakes SA, 2015, ANNU REV PATHOL-MECH, V10, P173, DOI 10.1146/annurev-pathol-012513-104649; Munoz JP, 2013, EMBO J, V32, P2348, DOI 10.1038/emboj.2013.168; Papandreou I, 2011, BLOOD, V117, P1311, DOI 10.1182/blood-2010-08-303099; Parada B, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/368178; Redon CE, 2011, AGING-US, V3, P168, DOI 10.18632/aging.100284; Richards KE, 2017, ONCOGENE, V36, P1770, DOI 10.1038/onc.2016.353; Said N, 2013, J CLIN INVEST, V123, P751, DOI 10.1172/JCI64782; Sanchez-Carbayo M, 2006, J CLIN ONCOL, V24, P778, DOI 10.1200/JCO.2005.03.2375; Segditsas S, 2009, ONCOGENE, V28, P146, DOI 10.1038/onc.2008.361; SHIN SI, 1975, P NATL ACAD SCI USA, V72, P4435, DOI 10.1073/pnas.72.11.4435; Silvers CR, 2017, ONCOTARGET, V8, P91199, DOI 10.18632/oncotarget.20043; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; SLAUGHTER DP, 1953, CANCER, V6, P963, DOI 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q; Steinbichler TB, 2017, SEMIN CANCER BIOL, V44, P170, DOI 10.1016/j.semcancer.2017.02.006; Stillwell W, 2003, CHEM PHYS LIPIDS, V126, P1, DOI 10.1016/S0009-3084(03)00101-4; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Tu BP, 2000, SCIENCE, V290, P1571, DOI 10.1126/science.290.5496.1571; Tuzesi A, 2017, ONCOTARGET, V8, P90164, DOI 10.18632/oncotarget.21621; Veron P, 2005, BLOOD CELL MOL DIS, V35, P81, DOI 10.1016/j.bcmd.2005.05.001; Wang M, 2014, NAT REV CANCER, V14, P581, DOI 10.1038/nrc3800; Wieckowski EU, 2009, J IMMUNOL, V183, P3720, DOI 10.4049/jimmunol.0900970; Yadav Raj Kumar, 2014, J Cancer Prev, V19, P75, DOI 10.15430/JCP.2014.19.2.75	62	37	37	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2019	294	9					3207	3218		10.1074/jbc.RA118.006682	http://dx.doi.org/10.1074/jbc.RA118.006682			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU0SA	30593508	Green Published, hybrid			2022-12-28	WOS:000464980100019
J	Kelsall, IR; Kristariyanto, YA; Knebel, A; Wood, NT; Kulathu, Y; Alpi, AF				Kelsall, Ian R.; Kristariyanto, Yosua A.; Knebel, Axel; Wood, Nicola T.; Kulathu, Yogesh; Alpi, Arno F.			Coupled monoubiquitylation of the co-E3 ligase DCNL1 by Ariadne-RBR E3 ubiquitin ligases promotes cullin-RING ligase complex remodeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						post-translational modification; ubiquitin; ubiquitin ligase; ubiquitylation (ubiquitination); cell signaling; ARIH1; ARIH2; coupled monoubiquitylation; DCNL1; NEDD8 E3 ligase	CONJUGATING ENZYMES; STRUCTURAL BASIS; MECHANISM; LIGATION; BINDING; SCF; SUBSTRATE; FAMILY; NEDDYLATION; SPECIFICITY	Cullin-RING E3 ubiquitin ligases (CRLs) are large and diverse multisubunit protein complexes that contribute to about one-fifth of ubiquitin-dependent protein turnover in cells. CRLs are activated by the attachment of the ubiquitin-like protein neural precursor cell expressed, developmentally down-regulated 8 (NEDD8) to the cullin subunits. This cullin neddylation is essential for a plethora of CRL-regulated cellular processes and is vital for life. In mammals, neddylation is promoted by the five co-E3 ligases, defective in cullin neddylation 1 domain-containing 1-5 (DCNL1-5); however, their functional regulation within the CRL complex remains elusive. We found here that the ubiquitin-associated (UBA) domain-containing DCNL1 is monoubiquitylated when bound to CRLs and that this monoubiquitylation depends on the CRL-associated Ariadne RBR ligases TRIAD1 (ARIH2) and HHARI (ARIH1) and strictly requires the DCNL1's UBA domain. Reconstitution of DCNL1 monoubiquitylation in vitro revealed that autoubiquitylated TRIAD1 mediates binding to the UBA domain and subsequently promotes a single ubiquitin attachment to DCNL1 in a mechanism previously dubbed coupled monoubiquitylation. Moreover, we provide evidence that DCNL1 monoubiquitylation is required for efficient CRL activity, most likely by remodeling CRLs and their substrate receptors. Collectively, this work identifies DCNL1 as a critical target of Ariadne RBR ligases and coupled monoubiquitylation of DCNL1 as an integrated mechanism that affects CRL activity and client-substrate ubiquitylation at multiple levels.	[Kelsall, Ian R.; Kristariyanto, Yosua A.; Knebel, Axel; Wood, Nicola T.; Kulathu, Yogesh; Alpi, Arno F.] Univ Dundee, Sch Life Sci, MRC Prot Phosphorylat & Ubiquitylat Unit, Dundee DD1 5EH, Scotland	University of Dundee	Alpi, AF (corresponding author), Max Planck Inst Biochem, Dept Mol Machines & Signaling, D-82152 Martinsried, Germany.	aalpi@biochem.mpg.de		Knebel, Axel/0000-0002-9197-6054; Wood, Nicola/0000-0002-3347-6625; Alpi, Arno/0000-0002-9572-7266; Kelsall, Ian/0000-0002-7501-6504	RCUK; Medical Research Council; Max-Planck-Gesellschaft; MRC [MC_UU_00018/3, MC_UU_12016/6] Funding Source: UKRI	RCUK(UK Research & Innovation (UKRI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Max-Planck-Gesellschaft(Max Planck Society); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by RCUK, Medical Research Council, and Max-Planck-Gesellschaft. The authors declare that they have no conflicts of interest with the contents of this article.	Alpi AF, 2016, BIOCHEM J, V473, P3401, DOI 10.1042/BCJ20160028; Bandau S, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-36; Broderick SR, 2010, NEOPLASIA, V12, P476, DOI 10.1593/neo.10202; Cope GA, 2003, CELL, V114, P663, DOI 10.1016/S0092-8674(03)00722-0; den Besten W, 2012, NAT STRUCT MOL BIOL, V19, P511, DOI 10.1038/nsmb.2269; Deshaies RJ, 2010, SUBCELL BIOCHEM, V54, P41, DOI 10.1007/978-1-4419-6676-6_4; Dove KK, 2017, P NATL ACAD SCI USA, V114, pE6576, DOI 10.1073/pnas.1705060114; Duda DM, 2013, STRUCTURE, V21, P1030, DOI 10.1016/j.str.2013.04.019; Goldenberg SJ, 2004, CELL, V119, P517, DOI 10.1016/j.cell.2004.10.019; Gong LM, 1999, J BIOL CHEM, V274, P12036, DOI 10.1074/jbc.274.17.12036; Heir P, 2013, MOL CELL BIOL, V33, P1621, DOI 10.1128/MCB.01342-12; Hibbert RG, 2012, J BIOL CHEM, V287, P39216, DOI 10.1074/jbc.M112.389890; Hoeller D, 2006, NAT CELL BIOL, V8, P163, DOI 10.1038/ncb1354; Hoeller D, 2007, MOL CELL, V26, P891, DOI 10.1016/j.molcel.2007.05.014; Hoeller D, 2010, SUBCELL BIOCHEM, V54, P31, DOI 10.1007/978-1-4419-6676-6_3; Huang DT, 2009, MOL CELL, V33, P483, DOI 10.1016/j.molcel.2009.01.011; Huang G, 2015, J BIOL CHEM, V290, P296, DOI 10.1074/jbc.M114.560169; Huang GC, 2011, J BIOL CHEM, V286, P10297, DOI 10.1074/jbc.M110.203729; Kelsall IR, 2013, EMBO J, V32, P2848, DOI 10.1038/emboj.2013.209; Keuss MJ, 2016, J CELL SCI, V129, P1441, DOI 10.1242/jcs.181784; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kristariyanto YA, 2015, MOL CELL, V58, P83, DOI 10.1016/j.molcel.2015.01.041; Kurz T, 2005, NATURE, V435, P1257, DOI 10.1038/nature03662; Kurz T, 2008, MOL CELL, V29, P23, DOI 10.1016/j.molcel.2007.12.012; Lingaraju GM, 2014, NATURE, V512, P161, DOI 10.1038/nature13566; Liu JD, 2002, MOL CELL, V10, P1511, DOI 10.1016/S1097-2765(02)00783-9; Lydeard JR, 2013, EMBO REP, V14, P1050, DOI 10.1038/embor.2013.173; Mendoza HM, 2003, J BIOL CHEM, V278, P25637, DOI 10.1074/jbc.M212948200; Meyer-Schaller N, 2009, P NATL ACAD SCI USA, V106, P12365, DOI 10.1073/pnas.0812528106; Monda JK, 2013, STRUCTURE, V21, P42, DOI 10.1016/j.str.2012.10.013; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pierce NW, 2013, CELL, V153, P206, DOI 10.1016/j.cell.2013.02.024; Reitsma JM, 2017, CELL, V171, P1326, DOI 10.1016/j.cell.2017.10.016; Sarkaria I, 2006, CANCER RES, V66, P9437, DOI 10.1158/0008-5472.CAN-06-2074; Scott DC, 2017, NAT CHEM BIOL, V13, P850, DOI 10.1038/nchembio.2386; Scott DC, 2016, CELL, V166, P1198, DOI 10.1016/j.cell.2016.07.027; Scott DC, 2014, CELL, V157, P1671, DOI 10.1016/j.cell.2014.04.037; Scott DC, 2011, SCIENCE, V334, P674, DOI 10.1126/science.1209307; Scott DC, 2010, MOL CELL, V39, P784, DOI 10.1016/j.molcel.2010.08.030; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Straube R, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005869; Thomas Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199197; Woelk T, 2006, NAT CELL BIOL, V8, P1246, DOI 10.1038/ncb1484; Wu K, 2011, J BIOL CHEM, V286, P34060, DOI 10.1074/jbc.M111.273045; Wu SD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2636; Yang XY, 2007, J BIOL CHEM, V282, P24490, DOI 10.1074/jbc.C700038200; Zemla A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2628; Zheng JY, 2002, MOL CELL, V10, P1519, DOI 10.1016/S1097-2765(02)00784-0; Zhou HB, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01243-7; Ziemba A, 2013, J BIOL CHEM, V288, P34882, DOI 10.1074/jbc.M113.509190	50	9	9	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2651	2664		10.1074/jbc.RA118.005861	http://dx.doi.org/10.1074/jbc.RA118.005861			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30587576	Green Published, hybrid			2022-12-28	WOS:000459601600008
J	Cornell, RB; Taneva, SG; Dennis, MK; Tse, R; Dhillon, RK; Lee, J				Cornell, Rosemary B.; Taneva, Svetla G.; Dennis, Melissa K.; Tse, Ronnie; Dhillon, Randeep K.; Lee, Jaeyong			Disease-linked mutations in the phosphatidylcholine regulatory enzyme CCT alpha impair enzymatic activity and fold stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lipodystrophy; phosphatidylcholine; protein folding; enzyme catalysis; mutant; PCYT1A; retinal dystrophy; Spondylometaphyseal dysplasia	CTP-PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; RAT-LIVER CTP; CAUSE SPONDYLOMETAPHYSEAL DYSPLASIA; MEMBRANE-BINDING DOMAIN; AMPHITROPIC ENZYME; TARGETED DELETION; AMPHIPATHIC HELIX; LIPID-MEMBRANES; PCYT1A; ACTIVATION	CTP:phosphocholine cytidylyltransferase (CCT) is the key regulatory enzyme in phosphatidylcholine (PC) synthesis and is activated by binding to PC-deficient membranes. Mutations in the gene encoding CCT alpha (PCYT1A) cause three distinct pathologies in humans: lipodystrophy, spondylometaphyseal dysplasia with cone-rod dystrophy (SMD-CRD), and isolated retinal dystrophy. Previous analyses showed that for some disease-linked PCYT1A variants steady state levels of CCT alpha and PC synthesis were reduced in patient fibroblasts, but other variants impaired PC synthesis with little effect on CCT levels. To explore the impact on CCT stability and function we expressed WT and mutant CCTs in COS-1 cells, which have very low endogenous CCT. Over-expression of two missense variants in the catalytic domain (V142M and P150A) generated aggregated enzymes that could not be refolded after solubilization by denaturation. Other mutations in the catalytic core that generated CCTs with reduced solubility could be purified. Five variants destabilized the catalytic domain-fold as assessed by lower transition temperatures for unfolding, and three of these manifested defects in substrate K-m values. A mutation (R223S) in a signal-transducing linker between the catalytic and membrane-binding domains also impaired enzyme kinetics. E280del, a single amino acid deletion in the autoinhibitory helix increased the constitutive (lipid-independent) enzyme activity similar to 4-fold. This helix also participates in membrane binding, and surprisingly E280del enhanced the enzyme's response to anionic lipid vesicles similar to 4-fold. These in vitro analyses on purified mutant CCTs will complement future measurements of their impact on PC synthesis in cultured cells and in tissues with a stringent requirement for CCT alpha.	[Cornell, Rosemary B.; Taneva, Svetla G.; Dennis, Melissa K.; Tse, Ronnie; Dhillon, Randeep K.; Lee, Jaeyong] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; [Cornell, Rosemary B.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada; [Dennis, Melissa K.] Symvivo Corp, 102,4475 Wayburne Dr, Burnaby, BC V5G 4X4, Canada	Simon Fraser University; Simon Fraser University	Cornell, RB (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada.; Cornell, RB (corresponding author), Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada.	cornell@sfu.ca			Canadian Institutes for Health Research	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Canadian Institutes for Health Research (to R. B. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Agassandian M, 2005, J BIOL CHEM, V280, P21577, DOI 10.1074/jbc.M412409200; Arnold RS, 1996, BIOCHEMISTRY-US, V35, P9917, DOI 10.1021/bi960397c; Benedetti CE, 2003, MOL BIOCHEM PARASIT, V128, P157, DOI 10.1016/S0166-6851(03)00057-4; Cornell R, 2018, DEV CELL, V45, P419, DOI 10.1016/j.devcel.2018.05.001; Cornell RB, 2016, BBA-MOL CELL BIOL L, V1861, P847, DOI 10.1016/j.bbalip.2015.12.022; Cornell RB, 2015, PROG LIPID RES, V59, P147, DOI 10.1016/j.plipres.2015.07.001; Davies SMA, 2001, BIOCHEMISTRY-US, V40, P10522, DOI 10.1021/bi010904c; Dennis MK, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201715; Ding ZW, 2012, J BIOL CHEM, V287, P38980, DOI 10.1074/jbc.M112.402081; Fagone P, 2013, BBA-MOL CELL BIOL L, V1831, P523, DOI 10.1016/j.bbalip.2012.09.009; FELDMAN DA, 1978, J BIOL CHEM, V253, P4980; Gehrig K, 2008, MOL BIOL CELL, V19, P237, DOI 10.1091/mbc.E07-02-0179; Haider A, 2018, DEV CELL, V45, P481, DOI 10.1016/j.devcel.2018.04.012; Hanakam F, 1996, BIOCHEMISTRY-US, V35, P11036, DOI 10.1021/bi960789j; Hoover-Fong J, 2014, AM J HUM GENET, V94, P105, DOI 10.1016/j.ajhg.2013.11.018; Huang HKH, 2013, J MOL BIOL, V425, P1546, DOI 10.1016/j.jmb.2012.12.003; Jacobs RL, 2004, J BIOL CHEM, V279, P47402, DOI 10.1074/jbc.M404027200; Jank JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093852; Johnson JE, 2003, J BIOL CHEM, V278, P514, DOI 10.1074/jbc.M206072200; Jurgens J., 2017, THESIS; Karim M, 2003, BBA-MOL CELL BIOL L, V1633, P1, DOI 10.1016/S1388-1981(03)00067-2; KELLIS JT, 1989, BIOCHEMISTRY-US, V28, P4914, DOI 10.1021/bi00437a058; Krahmer N, 2011, CELL METAB, V14, P504, DOI 10.1016/j.cmet.2011.07.013; Lavinder JJ, 2009, J AM CHEM SOC, V131, P3794, DOI 10.1021/ja8049063; Lee J, 2014, J BIOL CHEM, V289, P1742, DOI 10.1074/jbc.M113.526970; Lee JY, 2009, J BIOL CHEM, V284, P33535, DOI 10.1074/jbc.M109.053363; Longo PA, 2013, METHOD ENZYMOL, V529, P227, DOI 10.1016/B978-0-12-418687-3.00018-5; Lykidis A, 1998, J BIOL CHEM, V273, P14022, DOI 10.1074/jbc.273.22.14022; MacCallum JL, 2007, J GEN PHYSIOL, V129, P371, DOI 10.1085/jgp.200709745; MACDONALD JIS, 1993, PROTEIN EXPRES PURIF, V4, P1, DOI 10.1006/prep.1993.1001; Maier EM, 2009, HUM MOL GENET, V18, P1612, DOI 10.1093/hmg/ddp079; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Payne F, 2014, P NATL ACAD SCI USA, V111, P8901, DOI 10.1073/pnas.1408523111; Ramezanpour M, 2018, J BIOL CHEM, V293, P7070, DOI 10.1074/jbc.RA118.002053; SERRANO L, 1992, J MOL BIOL, V224, P783, DOI 10.1016/0022-2836(92)90562-X; SOHAL PS, 1990, J BIOL CHEM, V265, P11746; SWEITZER TD, 1994, ARCH BIOCHEM BIOPHYS, V311, P107, DOI 10.1006/abbi.1994.1215; Taneva S, 2008, J BIOL CHEM, V283, P28137, DOI 10.1074/jbc.M802595200; Testa F, 2017, EUR J HUM GENET, V25, P651, DOI 10.1038/ejhg.2017.23; Tian Y, 2008, J CELL BIOL, V181, P945, DOI 10.1083/jcb.200706152; Tian Y, 2007, MOL CELL BIOL, V27, P975, DOI 10.1128/MCB.01512-06; VANCE DE, 1979, TRENDS BIOCHEM SCI, V4, P145, DOI 10.1016/0968-0004(79)90001-X; Wang LM, 2005, MOL CELL BIOL, V25, P3357, DOI 10.1128/MCB.25.8.3357-3363.2005; WANG Y, 1995, J BIOL CHEM, V270, P18948, DOI 10.1074/jbc.270.32.18948; Xie MT, 2004, J BIOL CHEM, V279, P28817, DOI 10.1074/jbc.M403311200; Yamamoto GL, 2014, AM J HUM GENET, V94, P113, DOI 10.1016/j.ajhg.2013.11.022; Zhang DJ, 2000, J BIOL CHEM, V275, P35368, DOI 10.1074/jbc.M007099200	47	11	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2019	294	5					1490	1501		10.1074/jbc.RA118.006457	http://dx.doi.org/10.1074/jbc.RA118.006457			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GC	30559292	Green Published, hybrid			2022-12-28	WOS:000457879200006
J	Khurana, S; Coffey, MJ; John, A; Uboldi, AD; Huynh, MH; Stewart, RJ; Carruthers, VB; Tonkin, CJ; Goddard-Borger, ED; Scott, NE				Khurana, Sachin; Coffey, Michael J.; John, Alan; Uboldi, Alessandro D.; Huynh, My-Hang; Stewart, Rebecca J.; Carruthers, Vern B.; Tonkin, Christopher J.; Goddard-Borger, Ethan D.; Scott, Nichollas E.			Protein O-fucosyltransferase 2-mediated O-glycosylation of the adhesin MIC2 is dispensable for Toxoplasma gondii tachyzoite infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycosylation; Toxoplasma gondii; fucosyltransferase; proteomics; MS	PETERS PLUS SYNDROME; HOST-CELLS; GLIDING MOTILITY; INVASION; IDENTIFICATION; MUTATIONS; SECRETION; EGRESS	Toxoplasma gondii is a ubiquitous, obligate intracellular eukaryotic parasite that causes congenital birth defects, disease in immunocompromised individuals, and blindness. Protein glycosylation plays an important role in the infectivity and evasion of immune responses of many eukaryotic parasites and is also of great relevance to vaccine design. Here we demonstrate that micronemal protein 2 (MIC2), a motility-associated adhesin of T. gondii, has highly glycosylated thrombospondin repeat (TSR) domains. Using affinity-purified MIC2 and MS/MS analysis along with enzymatic digestion assays, we observed that at least seven C-linked and three O-linked glycosylation sites exist within MIC2, with >95% occupancy at these O-glycosylation sites. We found that addition of O-glycans to MIC2 is mediated by a protein O-fucosyltransferase 2 homolog (TgPOFUT2) encoded by the TGGT1_273550 gene. Even though POFUT2 homologs are important for stabilizing motility-associated adhesins and for host infection in other apicomplexan parasites, loss of TgPOFUT2 in T. gondii had only a modest impact on MIC2 levels and the wider parasite proteome. Consistent with this, both plaque formation and tachyzoite invasion were broadly similar in the presence or absence of TgPOFUT2. These findings indicate that TgPOFUT2 O-glycosylates MIC2 and that this glycan, in contrast to previous findings in another study, is dispensable in T. gondii tachyzoites and for T. gondii infectivity.	[Khurana, Sachin; Coffey, Michael J.; John, Alan; Uboldi, Alessandro D.; Stewart, Rebecca J.; Tonkin, Christopher J.; Goddard-Borger, Ethan D.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3025, Australia; [Khurana, Sachin; Coffey, Michael J.; John, Alan; Uboldi, Alessandro D.; Stewart, Rebecca J.; Tonkin, Christopher J.; Goddard-Borger, Ethan D.] Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia; [Huynh, My-Hang; Carruthers, Vern B.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Scott, Nichollas E.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic, Australia	Walter & Eliza Hall Institute; University of Melbourne; University of Michigan System; University of Michigan; University of Melbourne	Goddard-Borger, ED (corresponding author), Walter & Eliza Hall Inst Med Res, Parkville, Vic 3025, Australia.; Goddard-Borger, ED (corresponding author), Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia.	tonkin@wehi.edu.au; goddard-borger.e@wehi.edu.au; nichollas.scott@unimelb.edu.au	John, Alan/AAX-1829-2020; Tonkin, Christopher/K-6534-2019	John, Alan/0000-0002-6855-5470; Tonkin, Christopher/0000-0002-7036-6222; Goddard-Borger, Ethan/0000-0002-8181-9733; Scott, Nichollas/0000-0003-2556-8316; Coffey, Michael/0000-0002-8025-4558	National Health and Medical Research Council of Australia (NHMRC) [APP1100164]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council of Australia (NHMRC) Project Grant APP1100164 (to N. E. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Andenmatten N, 2013, NAT METHODS, V10, P125, DOI 10.1038/NMETH.2301; Bandini G, 2019, J BIOL CHEM, V294, P1967, DOI 10.1074/jbc.RA118.005179; Benz BA, 2016, DEV BIOL, V416, P111, DOI 10.1016/j.ydbio.2016.05.038; Boucher LE, 2015, J STRUCT BIOL, V190, P93, DOI 10.1016/j.jsb.2015.02.008; Carruthers VB, 1999, CELL MICROBIOL, V1, P225, DOI 10.1046/j.1462-5822.1999.00023.x; Chen CI, 2012, EMBO J, V31, P3183, DOI 10.1038/emboj.2012.143; Coffey MJ, 2018, MBIO, V9, DOI [10.1128/mBio.01796-18, 10.1128/mbio.01796-18]; Cowman AF, 2017, CELL HOST MICROBE, V22, P232, DOI 10.1016/j.chom.2017.07.003; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Du JG, 2010, DEV BIOL, V346, P25, DOI 10.1016/j.ydbio.2010.07.008; Frenal K, 2017, NAT REV MICROBIOL, V15, P645, DOI 10.1038/nrmicro.2017.86; Frese CK, 2012, ANAL CHEM, V84, P9668, DOI 10.1021/ac3025366; Furtado JM, 2011, J GLOB INFECT DIS, V3, P281, DOI 10.4103/0974-777X.83536; Goddard-Borger ED, 2018, FUTURE MICROBIOL, V13, P609, DOI 10.2217/fmb-2017-0284; Gras Simon, 2017, Wellcome Open Res, V2, P32, DOI [10.12688/wellcomeopenres.11594.2, 10.12688/wellcomeopenres.11594.1]; Hartmann S, 2000, J BIOL CHEM, V275, P28569, DOI 10.1074/jbc.M001732200; Hofsteenge J, 2001, J BIOL CHEM, V276, P6485, DOI 10.1074/jbc.M008073200; Hoppe CM, 2018, GLYCOBIOLOGY, V28, P333, DOI 10.1093/glycob/cwy013; HORUK R, 1993, SCIENCE, V261, P1182, DOI 10.1126/science.7689250; Humphrey SJ, 2015, NAT BIOTECHNOL, V33, P990, DOI 10.1038/nbt.3327; Huynh MH, 2004, CELL MICROBIOL, V6, P771, DOI 10.1111/j.1462-5822.2004.00403.x; Huynh MH, 2003, EMBO J, V22, P2082, DOI 10.1093/emboj/cdg217; Huynh MH, 2006, PLOS PATHOG, V2, P753, DOI 10.1371/journal.ppat.0020084; Huynh MH, 2015, J BIOL CHEM, V290, P1432, DOI 10.1074/jbc.M114.613646; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Jones J, 2003, AM FAM PHYSICIAN, V67, P2131; Jung C, 2004, INT J PARASITOL, V34, P285, DOI 10.1016/j.ijpara.2003.12.004; Kafsack BFC, 2004, MOL BIOCHEM PARASIT, V136, P309, DOI 10.1016/j.molbiopara.2004.04.004; Kang D., 2002, B KOREAN CHEM SOC, V23, P2; Kozma K, 2006, J BIOL CHEM, V281, P36742, DOI 10.1074/jbc.M605912200; Long SJ, 2016, INFECT IMMUN, V84, P1262, DOI 10.1128/IAI.01173-15; Lopaticki S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00571-y; Marino ND, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006828; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Moudy R, 2001, J BIOL CHEM, V276, P41492, DOI 10.1074/jbc.M106154200; Niwa Y, 2015, FEBS LETT, V589, P3287, DOI 10.1016/j.febslet.2015.09.012; Nothaft H, 2013, J BIOL CHEM, V288, P6912, DOI 10.1074/jbc.R112.417857; Oberstein SAJL, 2006, AM J HUM GENET, V79, P562, DOI 10.1086/507567; Peng D, 2015, MICROB GENOMICS, V1, DOI 10.1099/mgen.0.000033; Pinger J, 2018, NAT MICROBIOL, V3, P932, DOI 10.1038/s41564-018-0187-6; Rabenau KE, 2001, MOL MICROBIOL, V41, P537, DOI 10.1046/j.1365-2958.2001.02513.x; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Ricketts LM, 2007, J BIOL CHEM, V282, P17014, DOI 10.1074/jbc.M700317200; Sato T, 2006, GLYCOBIOLOGY, V16, P1194, DOI 10.1093/glycob/cwl035; Scott NE, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M000031-MCP201; Shen B, 2014, MBIO, V5, DOI 10.1128/mBio.01114-14; Sidik SM, 2016, CELL, V166, P1423, DOI 10.1016/j.cell.2016.08.019; Sultan AA, 1997, CELL, V90, P511, DOI 10.1016/S0092-8674(00)80511-5; Swearingen KE, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005791; Swearingen KE, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005606; Tardieux I, 2016, J CELL BIOL, V214, P507, DOI 10.1083/jcb.201605100; Tyanova S, 2015, PROTEOMICS, V15, P1453, DOI 10.1002/pmic.201400449; Valero-Gonzalez J, 2016, NAT CHEM BIOL, V12, P240, DOI [10.1038/NCHEMBIO.2019, 10.1038/nchembio.2019]; Vasudevan D, 2015, CURR BIOL, V25, P286, DOI 10.1016/j.cub.2014.11.049; Vasudevan D, 2014, GLYCOCONJUGATE J, V31, P417, DOI 10.1007/s10719-014-9556-4; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wang LW, 2007, J BIOL CHEM, V282, P17024, DOI 10.1074/jbc.M701065200; Wasmuth JD, 2012, MBIO, V3, DOI 10.1128/mBio.00321-12; Whitelaw JA, 2017, BMC BIOL, V15, DOI 10.1186/s12915-016-0343-5; Yang XY, 2017, NAT REV MOL CELL BIO, V18, P452, DOI 10.1038/nrm.2017.22	62	9	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2019	294	5					1541	1553		10.1074/jbc.RA118.005357	http://dx.doi.org/10.1074/jbc.RA118.005357			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GC	30514763	Green Published, hybrid			2022-12-28	WOS:000457879200010
J	Ali, M; Roback, L; Mocarski, ES				Ali, Mohammad; Roback, Linda; Mocarski, Edward S.			Herpes simplex virus 1 ICP6 impedes TNF receptor 1-induced necrosome assembly during compartmentalization to detergent-resistant membrane vesicles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lipid raft; caveolin; oligomerization; tumor necrosis factor (TNF); cell death; detergent-resistant membranes; necrosome; RHIM-signaling; RIPK1; RIPK3	MIXED LINEAGE KINASE; DOMAIN-LIKE PROTEIN; CELL-DEATH; PROGRAMMED NECROSIS; NECROPTOSIS; MLKL; PHOSPHORYLATION; SUPPRESSION; APOPTOSIS; REQUIRES	Receptor-interacting protein (RIP) kinase 3 (RIPK3)-dependent necroptosis directs inflammation and tissue injury, as well as anti-viral host defense. In human cells, herpes simplex virus 1 (HSV1) UL39-encoded ICP6 blocks RIP homotypic interacting motif (RHIM) signal transduction, preventing this leakage form of cell death and sustaining viral infection. TNF receptor 1 (TNFR1)-induced necroptosis is known to require the formation of a RIPK1-RIPK3-mixed lineage kinase domain-like pseudokinase (MLKL) signaling complex (necrosome) that we find compartmentalizes exclusively to caveolin-1-associated detergent-resistant membrane (DRM) vesicles in HT-29 cells. Translocation proceeds in the presence of RIPK3 kinase inhibitor GSK ' 840 or MLKL inhibitor necrosulfonomide but requires the kinase activity, as well as RHIM signaling of RIPK1. ICP6 impedes the translocation of RIPK1, RIPK3, and MLKL to caveolin-1-containing DRM vesicles without fully blocking the activation of RIPK3 or phosphorylation of MLKL. Consistent with the important contribution of RIPK1 RHIM-dependent recruitment of RIPK3, overexpression of RHIM-deficient RIPK3 results in phosphorylation of MLKL, but this does not lead to either translocation or necroptosis. Combined, these data reveal a critical role of RHIM signaling in the recruitment of the MLKL-containing necrosome to membrane vesicle-associated sites of aggregation. A similar mechanism is predicted for other RHIM-containing signaling adaptors, Z-nucleic acid-binding protein 1 (ZBP1) (also called DAI and DLM1), and TIR domain-containing adapter-inducing interferon-beta (TRIF).	[Ali, Mohammad; Roback, Linda; Mocarski, Edward S.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Emory Vaccine Ctr, Atlanta, GA 30322 USA	Emory University	Mocarski, ES (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Emory Vaccine Ctr, Atlanta, GA 30322 USA.	mocarski@emory.edu	Mocarski, Edward/ABC-2893-2020		Emory-Onyx (Amgen) Alliance Fund Award; Public Health Service from the National Institutes of Health [AI020211, AI118853]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI118853, R01AI020211] Funding Source: NIH RePORTER	Emory-Onyx (Amgen) Alliance Fund Award(Amgen); Public Health Service from the National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by an Emory-Onyx (Amgen) Alliance Fund Award (to M. A.) and Public Health Service Grants AI020211 and AI118853 from the National Institutes of Health (to E. S. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ali M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.451; Ali M, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0371-x; Berger SB, 2015, CELL DEATH DISCOV, V1, DOI 10.1038/cddiscovery.2015.9; Brenner D, 2015, NAT REV IMMUNOL, V15, P362, DOI 10.1038/nri3834; Ch'en IL, 2011, J EXP MED, V208, P633, DOI 10.1084/jem.20110251; Chen X, 2014, CELL RES, V24, P105, DOI 10.1038/cr.2013.171; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Daley-Bauer LP, 2017, P NATL ACAD SCI USA, V114, pE2786, DOI 10.1073/pnas.1616829114; Dovey CM, 2018, MOL CELL, V70, P936, DOI 10.1016/j.molcel.2018.05.010; Dufour F, 2011, J VIROL, V85, P8689, DOI 10.1128/JVI.00362-11; Dufour F, 2011, APOPTOSIS, V16, P256, DOI 10.1007/s10495-010-0560-2; ECK MJ, 1989, J BIOL CHEM, V264, P17595; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; Gong YN, 2017, CELL, V169, P286, DOI 10.1016/j.cell.2017.03.020; Guo HY, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0868-3; Guo HY, 2015, MED MICROBIOL IMMUN, V204, P439, DOI 10.1007/s00430-015-0410-5; Guo HY, 2015, CELL HOST MICROBE, V17, P243, DOI 10.1016/j.chom.2015.01.003; He SD, 2011, P NATL ACAD SCI USA, V108, P20054, DOI 10.1073/pnas.1116302108; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Huang DL, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00497-16; Huang Z, 2015, CELL HOST MICROBE, V17, P229, DOI 10.1016/j.chom.2015.01.002; Kaiser WJ, 2014, P NATL ACAD SCI USA, V111, P7753, DOI 10.1073/pnas.1401857111; Kaiser WJ, 2013, J BIOL CHEM, V288, P31268, DOI 10.1074/jbc.M113.462341; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kalliolias GD, 2016, NAT REV RHEUMATOL, V12, P49, DOI 10.1038/nrrheum.2015.169; Koehler H, 2017, P NATL ACAD SCI USA, V114, P11506, DOI 10.1073/pnas.1700999114; Legler DF, 2003, IMMUNITY, V18, P655, DOI 10.1016/S1074-7613(03)00092-X; Li DR, 2017, ELIFE, V6, DOI 10.7554/eLife.27692.001; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Mandal P, 2014, MOL CELL, V56, P481, DOI 10.1016/j.molcel.2014.10.021; Mocarski ES, 2015, VIROLOGY, V479, P160, DOI 10.1016/j.virol.2015.03.016; Mocarski ES, 2012, NAT REV IMMUNOL, V12, P79, DOI 10.1038/nri3131; Mompean M, 2018, CELL, V173, P1244, DOI 10.1016/j.cell.2018.03.032; Newton K, 2016, NATURE, V540, P129, DOI 10.1038/nature20559; Nogusa S, 2016, CELL HOST MICROBE, V20, P13, DOI 10.1016/j.chom.2016.05.011; Omoto S, 2015, J BIOL CHEM, V290, P11635, DOI 10.1074/jbc.M115.646042; Orozco S, 2014, CELL DEATH DIFFER, V21, P1511, DOI 10.1038/cdd.2014.76; Park JW, 2013, HEPATOLOGY, V57, P525, DOI 10.1002/hep.26015; Petrie EJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04714-7; Philipp S, 2010, P NATL ACAD SCI USA, V107, P1112, DOI 10.1073/pnas.0908486107; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; Schneider-Brachert W, 2006, J CLIN INVEST, V116, P2901, DOI 10.1172/JCI23771; Schutze S, 2008, NAT REV MOL CELL BIO, V9, P655, DOI 10.1038/nrm2430; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Tanzer MC, 2015, BIOCHEM J, V471, P255, DOI 10.1042/BJ20150678; Tenev T, 2011, MOL CELL, V43, P432, DOI 10.1016/j.molcel.2011.06.006; Thapa RJ, 2013, P NATL ACAD SCI USA, V110, pE3109, DOI 10.1073/pnas.1301218110; Upton JW, 2008, J BIOL CHEM, V283, P16966, DOI 10.1074/jbc.C800051200; Upton JW, 2012, CELL HOST MICROBE, V11, P290, DOI [10.1016/j.chom.2012.01.016, 10.1016/j.chom.2019.09.004]; Upton JW, 2010, CELL HOST MICROBE, V7, P302, DOI 10.1016/j.chom.2010.03.006; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; Vitiello G, 2015, SOFT MATTER, V11, P3003, DOI 10.1039/c4sm02769h; Wang HY, 2014, MOL CELL, V54, P133, DOI 10.1016/j.molcel.2014.03.003; Weinlich R, 2017, NAT REV MOL CELL BIO, V18, P127, DOI 10.1038/nrm.2016.149; Wertz IE, 2014, CURR OPIN CHEM BIOL, V23, P71, DOI 10.1016/j.cbpa.2014.10.011; WILLINGHAM MC, 1980, CELL, V21, P67, DOI 10.1016/0092-8674(80)90115-4; Wu XN, 2014, CELL DEATH DIFFER, V21, P1709, DOI 10.1038/cdd.2014.77; Xie T, 2013, CELL REP, V5, P70, DOI 10.1016/j.celrep.2013.08.044; Yatim N, 2015, SCIENCE, V350, P328, DOI 10.1126/science.aad0395; Yoon S, 2017, IMMUNITY, V47, P51, DOI 10.1016/j.immuni.2017.06.001; Yu XL, 2016, J VIROL, V90, P1088, DOI 10.1128/JVI.02446-15	62	12	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2019	294	3					991	1004		10.1074/jbc.RA118.004651	http://dx.doi.org/10.1074/jbc.RA118.004651			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL4FC	30504227	Green Published, hybrid			2022-12-28	WOS:000458670200023
J	Fu, XH; Xu, MK; Song, YB; Li, YQ; Zhang, HW; Zhang, JH; Zhang, CG				Fu, Xuanhe; Xu, Mingkai; Song, Yubo; Li, Yongqiang; Zhang, Huiwen; Zhang, Jinghai; Zhang, Chenggang			Enhanced interaction between SEC2 mutant and TCR V induces MHC II-independent activation of T cells via PKC/NF-B and IL-2R/STAT5 signaling pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						interleukin; NF-B (NF-KB); STAT transcription factor; signaling; signal transduction; IL-2; staphylococcal enterotoxin C2; superantigen; T-cell receptor; T-cell activation	KINASE C-THETA; RECEPTOR; SUPERANTIGEN; GENE; TRANSDUCTION; EXPRESSION; INHIBITOR; CD28	SEC2, a major histocompatibility complex class II (MHC II)-dependent T-cell mitogen, binds MHC II and T-cell receptor (TCR) Vs to induce effective co-stimulating signals for clonal T-cell expansion. We previously characterized a SEC2 mutant with increased recognition of TCR Vs, ST-4, which could intensify NF-B signaling transduction, leading to IL-2 production and T-cell activation. In this study, we found that in contrast to SEC2, ST-4 could induce murine CD4(+) T-cell proliferation in a V8.2- and V8.3-specific manner in the absence of MHC II+ antigen-presenting cells (APCs). Furthermore, although IL-2 secretion in response to either SEC2 or ST-4 stimulation was accompanied by up-regulation of protein kinase C (PKC), inhibitor of B (IB), and IB kinase (IKK/), IB, and NF-B in mouse splenocytes, only ST-4 could activate CD4(+) T cells in the absence of MHC II+ APCs through the PKC/NF-B signaling pathway. The PKC inhibitor AEB071 significantly suppressed SEC2/ST-4-induced T-cell proliferation, CD69 and CD25 expression, and IL-2 secretion with or without MHC II+ APCs. Further, SEC2/ST-4-induced changes in PKC/NF-B signaling were significantly relieved by AEB071 in a dose-dependent manner. Using Lck siRNA, we found that Lck controlled SEC2/ST-4-induced phosphorylation of PKC. We also demonstrated that the IL-2R/STAT5 pathway is essential for SEC2/ST-4-induced T-cell activation. Collectively, our data demonstrate that an enhanced ST-4-TCR interaction can compensate for lack of MHC II and stimulate MHC II-free CD4(+) T-cell proliferation via PKC/NF-B and IL-2R/STAT5 signaling pathways. Compared with SEC2, intensified PKC/NF-B and IL-2R/STAT5 signals induced by ST-4 lead to enhanced T-cell activation. The results of this study will facilitate better understanding of TCR-based immunotherapies for cancer.	[Fu, Xuanhe; Xu, Mingkai; Song, Yubo; Li, Yongqiang; Zhang, Huiwen; Zhang, Chenggang] Chinese Acad Sci, Inst Appl Ecol, 72 WenHua Rd, Shenyang 110016, Liaoning, Peoples R China; [Fu, Xuanhe; Zhang, Jinghai] Shenyang Pharmaceut Univ, Sch Life Sci & Biopharmaceut, 103 WenHua Rd, Shenyang 110016, Liaoning, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Shenyang Pharmaceutical University	Xu, MK (corresponding author), Chinese Acad Sci, Inst Appl Ecol, 72 WenHua Rd, Shenyang 110016, Liaoning, Peoples R China.; Zhang, JH (corresponding author), Shenyang Pharmaceut Univ, Sch Life Sci & Biopharmaceut, 103 WenHua Rd, Shenyang 110016, Liaoning, Peoples R China.	mkxu@iae.ac.cn; zhangjinghai@foxmail.com	zhang, hui/GXH-6098-2022; Zhang, Hui/HHN-8494-2022		Strategic Priority Research Program of the Chinese Academy of Sciences Grant [XDA12020225]; Science and Technology Plan Projects of Shenyang City [Z17-7-013, Y17-4-003]	Strategic Priority Research Program of the Chinese Academy of Sciences Grant; Science and Technology Plan Projects of Shenyang City	This work was supported by Strategic Priority Research Program of the Chinese Academy of Sciences Grant XDA12020225 and Science and Technology Plan Projects of Shenyang City Grants Z17-7-013 and Y17-4-003. The authors declare that they have no conflicts of interest with the contents of this article.	Andersen PS, 2001, J BIOL CHEM, V276, P33452, DOI 10.1074/jbc.M103750200; Arad G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001149; BAIER G, 1993, J BIOL CHEM, V268, P4997; BOHACH GA, 1990, CRIT REV MICROBIOL, V17, P251, DOI 10.3109/10408419009105728; Bours V, 1992, Curr Top Microbiol Immunol, V182, P411; Brezar V, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00530; Bueno C, 2006, IMMUNITY, V25, P67, DOI 10.1016/j.immuni.2006.04.012; Coudronniere N, 2000, P NATL ACAD SCI USA, V97, P3394, DOI 10.1073/pnas.060028097; Evenou JP, 2009, J PHARMACOL EXP THER, V330, P792, DOI 10.1124/jpet.109.153205; FRASER JD, 1992, J EXP MED, V175, P1131, DOI 10.1084/jem.175.4.1131; Fraser JD, 2008, IMMUNOL REV, V225, P226, DOI 10.1111/j.1600-065X.2008.00681.x; Fu XH, 2017, TOXICOL APPL PHARM, V333, P51, DOI 10.1016/j.taap.2017.08.006; Hashimoto-Tane A, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00255; HOVDE CJ, 1990, MOL GEN GENET, V220, P329; Isakov N, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00273; Kaempfer R, 2013, TOXINS, V5, P1531, DOI 10.3390/toxins5091531; Kersh GJ, 1998, IMMUNITY, V9, P817, DOI 10.1016/S1074-7613(00)80647-0; Khoshnan A, 2000, J IMMUNOL, V165, P6933, DOI 10.4049/jimmunol.165.12.6933; Kim HP, 2006, CYTOKINE GROWTH F R, V17, P349, DOI 10.1016/j.cytogfr.2006.07.003; Krakauer T, 2013, TOXINS, V5, P1629, DOI 10.3390/toxins5091629; Kuroda K, 1996, J IMMUNOL, V157, P1422; Lamphear JG, 1998, J IMMUNOL, V160, P2107; Lando PA, 1996, J IMMUNOL, V157, P2857; Li LY, 2017, P NATL ACAD SCI USA, V114, pE5891, DOI 10.1073/pnas.1701990114; Liu Y, 2012, LETT APPL MICROBIOL, V55, P362, DOI 10.1111/j.1472-765X.2012.03303.x; Liu YH, 2000, J BIOL CHEM, V275, P3603, DOI 10.1074/jbc.275.5.3603; Marti F, 2006, J EXP MED, V203, P479, DOI 10.1084/jem.20051637020206c; Monks CRF, 1997, NATURE, V385, P83, DOI 10.1038/385083a0; Nakajima H, 1997, IMMUNITY, V7, P691, DOI 10.1016/S1074-7613(00)80389-1; Newton DW, 1998, INT J MOL MED, V1, P157; Parmar KM, 2005, J BIOL CHEM, V280, P26714, DOI 10.1074/jbc.C500144200; Rajasekaran K, 2013, NAT IMMUNOL, V14, P1127, DOI 10.1038/ni.2708; Saito T, 2010, FEBS LETT, V584, P4865, DOI 10.1016/j.febslet.2010.11.036; Shatrova AN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167215; Spitaler M, 2004, NAT IMMUNOL, V5, P785, DOI 10.1038/ni1097; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Thebault S, 2004, MOL IMMUNOL, V40, P931, DOI 10.1016/j.molimm.2003.10.014; Tomasello E, 1998, J BIOL CHEM, V273, P34115, DOI 10.1074/jbc.273.51.34115; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Villalba M, 2000, IMMUNITY, V12, P151, DOI 10.1016/S1074-7613(00)80168-5; Xu MK, 2011, CANCER IMMUNOL IMMUN, V60, P705, DOI 10.1007/s00262-011-0986-6; Yamasaki S, 1997, J BIOL CHEM, V272, P14787, DOI 10.1074/jbc.272.23.14787; Yokosuka T, 2010, CURR TOP MICROBIOL, V340, P81, DOI 10.1007/978-3-642-03858-7_5; Zhang GJ, 2016, TOXICOL APPL PHARM, V313, P1, DOI 10.1016/j.taap.2016.10.009; Zhang SK, 2015, INT J CLIN EXP MED, V8, P15146; Zheng Y, 2007, J IMMUNOL, V178, P2163, DOI 10.4049/jimmunol.178.4.2163	46	17	17	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19771	19784		10.1074/jbc.RA118.003668	http://dx.doi.org/10.1074/jbc.RA118.003668			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30352872	Green Published, hybrid			2022-12-28	WOS:000454294900022
J	Maziarz, M; Leyme, A; Marivin, A; Luebbers, A; Patel, PP; Chen, Z; Sprang, SR; Garcia-Marcos, M				Maziarz, Marcin; Leyme, Anthony; Marivin, Arthur; Luebbers, Alex; Patel, Prachi P.; Chen, Zhe; Sprang, Stephen R.; Garcia-Marcos, Mikel			Atypical activation of the G protein G(q) by the oncogenic mutation Q209P	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein-coupled receptor (GPCR); heterotrimeric G protein; melanoma; signal transduction; cancer biology; GTPase; cell signaling; GNAQ; oncogenesis; uveal melanoma	SMALL-MOLECULE INHIBITORS; UVEAL MELANOMA; G-ALPHA; TREATMENT OPTIONS; HIGH-THROUGHPUT; GTP HYDROLYSIS; GNAQ; REVEALS; BETA; G-ALPHA(Q)	The causative role of G protein-coupled receptor (GPCR) pathway mutations in uveal melanoma (UM) has been well-established. Nearly all UMs bear an activating mutation in a GPCR pathway mediated by G proteins of the G(q/11) family, driving tumor initiation and possibly metastatic progression. Thus, targeting this pathway holds therapeutic promise for managing UM. However, direct targeting of oncogenic G(q/11) mutants, present in approximate to 90% of UMs, is complicated by the belief that these mutants structurally resemble active G(q/11) WT. This notion is solidly founded on previous studies characterizing G mutants in which a conserved catalytic glutamine (Gln-209 in G(q)) is replaced by leucine, which leads to GTPase function deficiency and constitutive activation. Whereas Q209L accounts for approximately half of GNAQ mutations in UM, Q209P is as frequent as Q209L and also promotes oncogenesis, but has not been characterized at the molecular level. Here, we characterized the biochemical and signaling properties of G(q) Q209P and found that it is also GTPase-deficient and activates downstream signaling as efficiently as G(q) Q209L. However, G(q) Q209P had distinct molecular and functional features, including in the switch II region of G(q) Q209P, which adopted a conformation different from that of G(q) Q209L or active WT G(q), resulting in altered binding to effectors, G, and regulators of G-protein signaling (RGS) proteins. Our findings reveal that the molecular properties of G(q) Q209P are fundamentally different from those in other active G(q) proteins and could be leveraged as a specific vulnerability for the approximate to 20% of UMs bearing this mutation.	[Maziarz, Marcin; Leyme, Anthony; Marivin, Arthur; Luebbers, Alex; Patel, Prachi P.; Garcia-Marcos, Mikel] Boston Univ, Sch Med, Dept Biochem, 72 E Concord St,Silvio Conte Bldg K, Boston, MA 02118 USA; [Chen, Zhe] Univ Texas Southwestern Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA; [Sprang, Stephen R.] Univ Montana, Ctr Biomol Struct & Dynam, Missoula, MT 59812 USA	Boston University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Montana System; University of Montana	Garcia-Marcos, M (corresponding author), Boston Univ, Sch Med, Dept Biochem, 72 E Concord St,Silvio Conte Bldg K, Boston, MA 02118 USA.	mgm1@bu.edu	patel, prachi/GRY-0386-2022	Chen, Zhe/0000-0002-1668-4051	National Institutes of Health [R01GM108733, R01 GM130120, R21MH118745, R01DK46371]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM130120, R01GM108733, R01GM105993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH118745] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health Grants R01GM108733, R01 GM130120, and R21MH118745 (to M. G.-M.) and R01DK46371 (to S. R. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aittaleb M, 2010, MOL PHARMACOL, V77, P111, DOI 10.1124/mol.109.061234; Amaro A, 2017, CANCER METAST REV, V36, P109, DOI 10.1007/s10555-017-9663-3; Anger T, 2004, J BIOL CHEM, V279, P3906, DOI 10.1074/jbc.M309496200; Arkin MR, 2014, CHEM BIOL, V21, P1102, DOI 10.1016/j.chembiol.2014.09.001; Arkin MR, 2009, CURR OPIN CHEM BIOL, V13, P284, DOI 10.1016/j.cbpa.2009.05.125; Augsburger JJ, 2009, AM J OPHTHALMOL, V148, P119, DOI 10.1016/j.ajo.2009.01.023; Basse MJ, 2013, NUCLEIC ACIDS RES, V41, pD824, DOI 10.1093/nar/gks1002; Berg T, 2008, CURR OPIN DRUG DISC, V11, P666; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Carman CV, 1999, J BIOL CHEM, V274, P34483, DOI 10.1074/jbc.274.48.34483; Carvajal RD, 2017, BRIT J OPHTHALMOL, V101, P38, DOI 10.1136/bjophthalmol-2016-309034; Chen X, 2017, CANCER CELL, V31, P685, DOI 10.1016/j.ccell.2017.04.002; Chidiac P, 1999, BIOCHEM PHARMACOL, V58, P39, DOI 10.1016/S0006-2952(99)00080-5; Chidiac P, 1999, J BIOL CHEM, V274, P19639, DOI 10.1074/jbc.274.28.19639; Chikumi H, 2002, J BIOL CHEM, V277, P27130, DOI 10.1074/jbc.M204715200; Chua V, 2017, MOL CANCER RES, V15, P501, DOI 10.1158/1541-7786.MCR-17-0007; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; Damato B, 2012, EYE, V26, P1157, DOI 10.1038/eye.2012.126; DER CJ, 1986, CELL, V44, P167, DOI 10.1016/0092-8674(86)90495-2; Feng XD, 2014, CANCER CELL, V25, P831, DOI 10.1016/j.ccr.2014.04.016; Field MG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02428-w; Fischer T, 2003, P NATL ACAD SCI USA, V100, P8270, DOI 10.1073/pnas.1432965100; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; Garcia-Marcos M, 2010, J BIOL CHEM, V285, P12765, DOI 10.1074/jbc.M109.045161; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Gresset Aurelie, 2012, Subcell Biochem, V58, P61, DOI 10.1007/978-94-007-3012-0_3; Griewank KG, 2012, PIGM CELL MELANOMA R, V25, DOI 10.1111/j.1755-148X.2012.00971.x; Hollins B, 2009, CELL SIGNAL, V21, P1015, DOI 10.1016/j.cellsig.2009.02.017; Hu Q, 2018, CELL, V173, P1254, DOI 10.1016/j.cell.2018.03.018; Huang JLY, 2015, CANCER RES, V75, P3384, DOI 10.1158/0008-5472.CAN-14-3229; Hubbard KB, 2006, CELL SIGNAL, V18, P135, DOI 10.1016/j.cellsig.2005.08.004; Johansson P, 2016, ONCOTARGET, V7, P4624, DOI 10.18632/oncotarget.6614; Johnston CA, 2006, BIOCHEMISTRY-US, V45, P11390, DOI 10.1021/bi0613832; Kadamur G, 2013, ANNU REV PHYSIOL, V75, P127, DOI 10.1146/annurev-physiol-030212-183750; Kaliki S, 2015, INDIAN J OPHTHALMOL, V63, P93, DOI 10.4103/0301-4738.154367; KALINEC G, 1992, MOL CELL BIOL, V12, P4687, DOI 10.1128/MCB.12.10.4687; KLEUSS C, 1994, P NATL ACAD SCI USA, V91, P9828, DOI 10.1073/pnas.91.21.9828; Kusters-Vandevelde HVN, 2015, BRAIN PATHOL, V25, P209, DOI 10.1111/bpa.12241; Kujala E, 2003, INVEST OPHTH VIS SCI, V44, P4651, DOI 10.1167/iovs.03-0538; Kusters-Vandevelde HVN, 2015, PATHOL ONCOL RES, V21, P439, DOI 10.1007/s12253-014-9841-3; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; Leyme A, 2017, P NATL ACAD SCI USA, V114, pE10319, DOI 10.1073/pnas.1707992114; Luke JJ, 2015, PIGM CELL MELANOMA R, V28, P135, DOI 10.1111/pcmr.12304; Lutz S, 2007, SCIENCE, V318, P1923, DOI 10.1126/science.1147554; Lyon AM, 2013, NAT STRUCT MOL BIOL, V20, P355, DOI 10.1038/nsmb.2497; Marivin A, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad2429; Masuho I, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab4068; Maziarz M, 2017, METHOD CELL BIOL, V142, P145, DOI 10.1016/bs.mcb.2017.08.001; Moore AR, 2018, CELL REP, V22, P2455, DOI 10.1016/j.celrep.2018.01.081; Moore AR, 2016, NAT GENET, V48, P675, DOI 10.1038/ng.3549; Nance MR, 2013, STRUCTURE, V21, P438, DOI 10.1016/j.str.2012.12.016; Offermanns S, 1998, EMBO J, V17, P4304, DOI 10.1093/emboj/17.15.4304; Onken MD, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aao6852; Onken MD, 2008, INVEST OPHTH VIS SCI, V49, P5230, DOI 10.1167/iovs.08-2145; Pereira PR, 2013, CLIN OPHTHALMOL, V7, P1669, DOI 10.2147/OPTH.S28863; Posokhova E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076973; Qin K, 2011, NAT CHEM BIOL, V7, P740, DOI [10.1038/nchembio.642, 10.1038/NCHEMBIO.642]; Rettenmaier TJ, 2014, P NATL ACAD SCI USA, V111, P18590, DOI 10.1073/pnas.1415365112; Robertson AG, 2017, CANCER CELL, V32, P204, DOI 10.1016/j.ccell.2017.07.003; Rojas RJ, 2007, J BIOL CHEM, V282, P29201, DOI 10.1074/jbc.M703458200; Scheschonka A, 2000, MOL PHARMACOL, V58, P719, DOI 10.1124/mol.58.4.719; Singh AD, 2011, OPHTHALMOLOGY, V118, P1881, DOI 10.1016/j.ophtha.2011.01.040; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Stols L, 2007, PROTEIN EXPRES PURIF, V53, P396, DOI 10.1016/j.pep.2007.01.013; Tang W, 2006, J BIOL CHEM, V281, P4746, DOI 10.1074/jbc.M510573200; Taylor VG, 2016, J BIOL CHEM, V291, P5138, DOI 10.1074/jbc.M115.712075; Tesmer VM, 2005, SCIENCE, V310, P1686, DOI 10.1126/science.1118890; Thomas CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023197; van de Nes JAP, 2017, J INVEST DERMATOL, V137, P2033, DOI 10.1016/j.jid.2017.04.022; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Vaque JP, 2013, MOL CELL, V49, P94, DOI 10.1016/j.molcel.2012.10.018; Virgili G, 2007, OPHTHALMOLOGY, V114, P2309, DOI 10.1016/j.ophtha.2007.01.032; Waldo GL, 2010, SCIENCE, V330, P974, DOI 10.1126/science.1193438; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; WEDEGAERTNER PB, 1993, J BIOL CHEM, V268, P25001; Yoo JH, 2016, CANCER CELL, V29, P889, DOI 10.1016/j.ccell.2016.04.015; Yu FX, 2014, CANCER CELL, V25, P822, DOI 10.1016/j.ccr.2014.04.017	79	19	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19586	19599		10.1074/jbc.RA118.005291	http://dx.doi.org/10.1074/jbc.RA118.005291			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30352874	hybrid, Green Published			2022-12-28	WOS:000454294900008
J	Ojelabi, OA; Lloyd, KP; De Zutter, JK; Carruthers, A				Ojelabi, Ogooluwa A.; Lloyd, Kenneth P.; De Zutter, Julie K.; Carruthers, Anthony			Red wine and green tea flavonoids are cis-allosteric activators and competitive inhibitors of glucose transporter 1 (GLUT1)-mediated sugar uptake	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glucose transport; structure-function; membrane transport; allosteric regulation; oligomerization	TRANSPORTER OLIGOMERIC STRUCTURE; BRUSH-BORDER-MEMBRANE; GLUCOSE-UPTAKE; SEQUENCE DETERMINANTS; CELLULAR UPTAKE; BINDING-SITES; QUERCETIN; GLUT1; CATECHINS; MECHANISMS	The antioxidant- and flavonoid-rich contents of red wine and green tea are reported to offer protection against cancer, cardiovascular disease, and diabetes. Some studies, however, show that flavonoids inhibit GLUT1-mediated, facilitative glucose transport, raising the possibility that their interaction with GLUT1 and subsequent downstream effects on carbohydrate metabolism may also impact health. The present study explores the structure-function relationships of flavonoid-GLUT1 interactions. We find that low concentrations of flavonoids act as cis-allosteric activators of sugar uptake, whereas higher concentrations competitively inhibit sugar uptake and noncompetitively inhibit sugar exit. Studies with heterologously expressed human GLUT1, -3, or -4 reveal that quercetin-GLUT1 and -GLUT4 interactions are stronger than quercetin-GLUT3 interactions, that epicatechin gallate (ECG) is more selective for GLUT1, and that epigallocatechin gallate (EGCG) is less GLUT isoform-selective. Docking studies suggest that only one flavonoid can bind to GLUT1 at any instant, but sugar transport and ligand-binding studies indicate that human erythrocyte GLUT1 can bind at least two flavonoid molecules simultaneously. Quercetin and EGCG are each characterized by positive, cooperative binding, whereas ECG shows negative cooperative binding. These findings support recent studies suggesting that GLUT1 forms an oligomeric complex of interacting, allosteric, alternating access transporters. We discuss how modulation of facilitative glucose transporters could contribute to the protective actions of the flavonoids against diabetes and Alzheimer's disease.	[Ojelabi, Ogooluwa A.; Lloyd, Kenneth P.; De Zutter, Julie K.; Carruthers, Anthony] Univ Massachusetts, Med Sch, Grad Sch Biomed Sci, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Carruthers, A (corresponding author), 364 Plantat St,LRB Rm 926, Worcester, MA 01605 USA.	anthony.carruthers@umassmed.edu			National Institutes of Health [DK36081, DK44888]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036081, R01DK044888, R56DK036081] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK36081 and DK44888. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BASKETTER DA, 1978, J PHYSIOL-LONDON, V278, P389, DOI 10.1113/jphysiol.1978.sp012311; CARRUTHERS A, 1991, BIOCHEMISTRY-US, V30, P3907, DOI 10.1021/bi00230a015; Cermak R, 2004, BRIT J NUTR, V91, P849, DOI 10.1079/BJN20041128; Choi JY, 2002, NEUROTOXICOLOGY, V23, P367, DOI 10.1016/S0161-813X(02)00079-7; Choi YT, 2001, LIFE SCI, V70, P603, DOI 10.1016/S0024-3205(01)01438-2; Cloherty EK, 2001, BIOCHEMISTRY-US, V40, P15549, DOI 10.1021/bi015586w; Cloherty EK, 1996, BIOCHEMISTRY-US, V35, P10411, DOI 10.1021/bi953077m; Cunningham P, 2006, J BIOL CHEM, V281, P5797, DOI 10.1074/jbc.M509422200; Day AJ, 2000, FEBS LETT, V468, P166, DOI 10.1016/S0014-5793(00)01211-4; De Zutter JK, 2013, J BIOL CHEM, V288, P20734, DOI 10.1074/jbc.M113.469023; Del Rio D, 2013, ANTIOXID REDOX SIGN, V18, P1818, DOI 10.1089/ars.2012.4581; Deng D, 2015, NATURE, V526, P391, DOI 10.1038/nature14655; Deng D, 2014, NATURE, V510, P121, DOI 10.1038/nature13306; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Formica JV, 1995, FOOD CHEM TOXICOL, V33, P1061, DOI 10.1016/0278-6915(95)00077-1; Gee JM, 2000, J NUTR, V130, P2765, DOI 10.1093/jn/130.11.2765; Graybill C, 2006, BIOCHEMISTRY-US, V45, P8096, DOI 10.1021/bi060398x; Hamakawa H, 2013, ADV EXP MED BIOL, V765, P73, DOI 10.1007/978-1-4614-4989-8_11; Hamill S, 1999, BIOCHEMISTRY-US, V38, P16974, DOI 10.1021/bi9918792; HEBERT DN, 1992, J BIOL CHEM, V267, P23829; HELGERSON AL, 1987, J BIOL CHEM, V262, P5464; HERTOG MGL, 1993, LANCET, V342, P1007, DOI 10.1016/0140-6736(93)92876-U; Hung CH, 2015, MOL NUTR FOOD RES, V59, P1905, DOI 10.1002/mnfr.201500144; Jeon SY, 2003, BIOORG MED CHEM LETT, V13, P3905, DOI 10.1016/j.bmcl.2003.09.018; Johnston K, 2005, FEBS LETT, V579, P1653, DOI 10.1016/j.febslet.2004.12.099; Joost HG, 2002, AM J PHYSIOL-ENDOC M, V282, pE974, DOI 10.1152/ajpendo.00407.2001; Kao Y, 2000, AM J CLIN NUTR, V72, P1232; Kerry NL, 1997, ATHEROSCLEROSIS, V135, P93, DOI 10.1016/S0021-9150(97)00156-1; Kim HS, 2014, REDOX BIOL, V2, P187, DOI 10.1016/j.redox.2013.12.022; Kuhnau J, 1976, World Rev Nutr Diet, V24, P117; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Levine KB, 2002, BIOCHEMISTRY-US, V41, P12629, DOI 10.1021/bi0258997; Li N, 2011, J AGR FOOD CHEM, V59, P6082, DOI 10.1021/jf200203n; Liu Y, 2012, MOL CANCER THER, V11, P1672, DOI 10.1158/1535-7163.MCT-12-0131; Lloyd KP, 2018, J MEMBRANE BIOL, V251, P131, DOI 10.1007/s00232-017-0006-7; Lloyd KP, 2017, J BIOL CHEM, V292, P21035, DOI 10.1074/jbc.M117.815589; Mandel S, 2004, FREE RADICAL BIO MED, V37, P304, DOI 10.1016/j.freeradbiomed.2004.04.012; Martinez-Perez C, 2016, BRIT J CANCER, V114, P905, DOI 10.1038/bjc.2016.6; McDonald MS, 1998, J AGR FOOD CHEM, V46, P368, DOI 10.1021/jf970677e; Moreira L, 2013, EXP CELL RES, V319, P1784, DOI 10.1016/j.yexcr.2013.05.001; Naftalin RJ, 2003, BRIT J PHARMACOL, V140, P487, DOI 10.1038/sj.bjp.0705460; Nijveldt RJ, 2001, AM J CLIN NUTR, V74, P418; Nishimuro H, 2015, NUTRIENTS, V7, P2345, DOI 10.3390/nu7042345; Ojelabi OA, 2016, J BIOL CHEM, V291, P26762, DOI 10.1074/jbc.M116.759175; Perez A, 2011, BIOCHEMISTRY-US, V50, P8834, DOI 10.1021/bi200748b; Prinz Heino, 2010, J Chem Biol, V3, P37, DOI 10.1007/s12154-009-0029-3; Robichaud T, 2011, BIOCHEMISTRY-US, V50, P3137, DOI 10.1021/bi1020327; Segel I. H., 1975, ENZYME KINETICS BEHA, P379; Singh BN, 2011, BIOCHEM PHARMACOL, V82, P1807, DOI 10.1016/j.bcp.2011.07.093; Sirk TW, 2009, J AGR FOOD CHEM, V57, P6720, DOI 10.1021/jf900951w; Strobel P, 2005, BIOCHEM J, V386, P471, DOI 10.1042/BJ20040703; Sultzman LA, 1999, BIOCHEMISTRY-US, V38, P6640, DOI 10.1021/bi990130o; Sutherland BA, 2006, J NUTR BIOCHEM, V17, P291, DOI 10.1016/j.jnutbio.2005.10.005; Szablewski L, 2013, BBA-REV CANCER, V1835, P164, DOI 10.1016/j.bbcan.2012.12.004; Tian W, 2018, NUCLEIC ACIDS RES, V46, pW363, DOI 10.1093/nar/gky473; Tsuneki Hiroshi, 2004, BMC Pharmacology, V4, P18, DOI 10.1186/1471-2210-4-18; Uekusa Y, 2007, J AGR FOOD CHEM, V55, P9986, DOI 10.1021/jf0712402; Vaidyanathan JB, 2003, J PHARMACOL EXP THER, V307, P745, DOI 10.1124/jpet.103.054296; Vera JC, 2001, BIOCHEMISTRY-US, V40, P777, DOI 10.1021/bi001660j; Vollers SS, 2012, J BIOL CHEM, V287, P42533, DOI 10.1074/jbc.M112.369587; Walgren RA, 2000, J PHARMACOL EXP THER, V294, P837; Wolffram S, 2002, J NUTR, V132, P630, DOI 10.1093/jn/132.4.630; Wu LY, 2004, EUR J NUTR, V43, P116, DOI 10.1007/s00394-004-0450-x; Yang CG, 2016, MOLECULES, V21, DOI 10.3390/molecules21121660; Yang CS, 2008, MOL NUTR FOOD RES, V52, pS139, DOI 10.1002/mnfr.200700234; ZOTTOLA RJ, 1995, BIOCHEMISTRY-US, V34, P9734, DOI 10.1021/bi00030a011	67	15	15	7	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19823	19834		10.1074/jbc.RA118.002326	http://dx.doi.org/10.1074/jbc.RA118.002326			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30361436	Green Published, hybrid			2022-12-28	WOS:000454294900026
J	Unlu, I; Lu, YY; Wang, XZ				Unlu, Irem; Lu, Yanyan; Wang, Xiaozhong			The cyclic phosphodiesterase CNP and RNA cyclase RtcA fine-tune noncanonical XBP1 splicing during ER stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						X-box binding protein 1 (XBP1); signaling; RNA splicing; unfolded protein response (UPR); stress response; gene regulation; RNA processing; CNP; RtcA; RtcB; Trpt1	UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; MESSENGER-RNA; TRANSCRIPTION FACTOR; LIGASE; MECHANISM; CLP1; PROTEOSTASIS; 2'-PHOSPHATE; ACTIVATION	The activity of X box-binding protein 1 (XBP1), a master transcriptional regulator of endoplasmic reticulum (ER) homeostasis and the unfolded protein response (UPR), is controlled by a two-step noncanonical splicing reaction in the cytoplasm. The first step of nuclease cleavage by inositol-requiring enzyme 1 (IRE1), a protein kinase/endoribonuclease, is conserved in all eukaryotic cells. The second step of RNA ligation differs biochemically among species. In yeast, tRNA ligase 1 (Trl1) and tRNA 2-phosphotransferase 1 (Tpt1) act through a 5-PO4/3-OH pathway. In metazoans, RNA 2,3-cyclic phosphate and 5-OH ligase (RtcB) ligate XBP1 exons via a 3-PO4/5-OH reaction. Although RtcB has been identified as the primary RNA ligase, evidence suggests that yeast-like ligase components may also operate in mammals. In this study, using mouse and human cell lines along with in vitro splicing assays, we investigated whether these components contribute to XBP1 splicing during ER stress. We found that the mammalian 2-phosphotransferase Trpt1 does not contribute to XBP1 splicing even in the absence of RtcB. Instead, we found that 2,3-cyclic nucleotide phosphodiesterase (CNP) suppresses RtcB-mediated XBP1 splicing by hydrolyzing 2,3-cyclic phosphate into 2-phosphate on the cleaved exon termini. By contrast, RNA 3-terminal cyclase (RtcA), which converts 2-phosphate back to 2,3-cyclic phosphate, facilitated XBP1 splicing by increasing the number of compatible RNA termini for RtcB. Taken together, our results provide evidence that CNP and RtcA fine-tune XBP1 output during ER stress.	[Unlu, Irem; Lu, Yanyan; Wang, Xiaozhong] Northwestern Univ, Dept Mol Biosci, 2205 Tech Dr,Hogan 2-100, Evanston, IL 60208 USA	Northwestern University	Wang, XZ (corresponding author), Northwestern Univ, Dept Mol Biosci, 2205 Tech Dr,Hogan 2-100, Evanston, IL 60208 USA.	awang@northwestern.edu		Wang, Xiaozhong/0000-0003-0219-0752	NIGMS, National Institutes of Health [5R01GM120307]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM120307] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health Grant 5R01GM120307 (to X. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abelson J, 1998, J BIOL CHEM, V273, P12685, DOI 10.1074/jbc.273.21.12685; Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; Allagnat F, 2010, DIABETOLOGIA, V53, P1120, DOI 10.1007/s00125-010-1699-7; Braakman I, 2011, ANNU REV BIOCHEM, V80, P71, DOI 10.1146/annurev-biochem-062209-093836; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Cubillos-Ruiz JR, 2017, CELL, V168, P692, DOI 10.1016/j.cell.2016.12.004; Culver GM, 1997, J BIOL CHEM, V272, P13203, DOI 10.1074/jbc.272.20.13203; Das U, 2013, RNA, V19, P1355, DOI 10.1261/rna.039917.113; DRUMMOND GI, 1962, J BIOL CHEM, V237, P3535; Englert M, 2011, P NATL ACAD SCI USA, V108, P1290, DOI 10.1073/pnas.1018307108; FILIPOWICZ W, 1983, NUCLEIC ACIDS RES, V11, P1405, DOI 10.1093/nar/11.5.1405; Filipowicz Witold, 2016, Postepy Biochem, V62, P327; Gonzalez TN, 1999, EMBO J, V18, P3119, DOI 10.1093/emboj/18.11.3119; GREER CL, 1983, CELL, V32, P537, DOI 10.1016/0092-8674(83)90473-7; Hanada T, 2013, NATURE, V495, P474, DOI 10.1038/nature11923; Harding HP, 2008, RNA, V14, P225, DOI 10.1261/rna.859908; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Hetz C, 2018, MOL CELL, V69, P169, DOI 10.1016/j.molcel.2017.06.017; Hetz C, 2014, NAT REV NEUROSCI, V15, P233, DOI 10.1038/nrn3689; Hetz C, 2009, GENE DEV, V23, P2294, DOI 10.1101/gad.1830709; Hu QD, 2003, CELL MOL LIFE SCI, V60, P1725, DOI 10.1007/s00018-003-3107-7; Jurkin J, 2014, EMBO J, V33, P2922, DOI 10.15252/embj.201490332; Kakiuchi C, 2003, NAT GENET, V35, P171, DOI 10.1038/ng1235; Karaca E, 2014, CELL, V157, P636, DOI 10.1016/j.cell.2014.02.058; Kosmaczewski SG, 2015, P NATL ACAD SCI USA, V112, P8451, DOI 10.1073/pnas.1502948112; Kosmaczewski SG, 2014, EMBO REP, V15, P1278, DOI 10.15252/embr.201439531; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AH, 2011, P NATL ACAD SCI USA, V108, P8885, DOI 10.1073/pnas.1105564108; Liu SY, 2013, CNS NEUROSCI THER, V19, P229, DOI 10.1111/cns.12064; Lu YY, 2014, MOL CELL, V55, P758, DOI 10.1016/j.molcel.2014.06.032; Lu YY, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp686; MCCRAITH SM, 1990, MOL CELL BIOL, V10, P1049, DOI 10.1128/MCB.10.3.1049; Oakes SA, 2015, ANNU REV PATHOL-MECH, V10, P173, DOI 10.1146/annurev-pathol-012513-104649; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Oishi N, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.108; PEEBLES CL, 1983, CELL, V32, P525, DOI 10.1016/0092-8674(83)90472-5; Phizicky EM, 2010, GENE DEV, V24, P1832, DOI 10.1101/gad.1956510; Popow J, 2012, CELL MOL LIFE SCI, V69, P2657, DOI 10.1007/s00018-012-0944-2; Popow J, 2011, SCIENCE, V331, P760, DOI 10.1126/science.1197847; Ramirez A, 2008, RNA, V14, P1737, DOI 10.1261/rna.1142908; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Ryoo HD, 2007, EMBO J, V26, P242, DOI 10.1038/sj.emboj.7601477; Sado M, 2009, BRAIN RES, V1257, P16, DOI 10.1016/j.brainres.2008.11.104; Sawaya R, 2003, J BIOL CHEM, V278, P43928, DOI 10.1074/jbc.M307839200; Schaffer AE, 2014, CELL, V157, P651, DOI 10.1016/j.cell.2014.03.049; Schwer B, 2008, RNA, V14, P204, DOI 10.1261/rna.858108; Sha HB, 2011, TRENDS ENDOCRIN MET, V22, P374, DOI 10.1016/j.tem.2011.05.002; Shoulders MD, 2013, CELL REP, V3, P1279, DOI 10.1016/j.celrep.2013.03.024; Sidrauski C, 1996, CELL, V87, P405, DOI 10.1016/S0092-8674(00)81361-6; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Song YQ, 2015, NAT NEUROSCI, V18, P817, DOI 10.1038/nn.4019; Spinelli SL, 1997, RNA, V3, P1388; Tanaka N, 2011, J BIOL CHEM, V286, P7727, DOI 10.1074/jbc.C111.219022; Valenzuela V, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.8; Vidal RL, 2012, HUM MOL GENET, V21, P2245, DOI 10.1093/hmg/dds040; VOGEL US, 1988, J NEUROCHEM, V50, P1667, DOI 10.1111/j.1471-4159.1988.tb02461.x; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang M, 2016, NATURE, V529, P326, DOI 10.1038/nature17041; Weitzer S, 2015, WIRES RNA, V6, P47, DOI 10.1002/wrna.1255; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2006, J CELL BIOL, V172, P565, DOI 10.1083/jcb.200508145; ZILLMANN M, 1991, MOL CELL BIOL, V11, P5410, DOI 10.1128/MCB.11.11.5410	64	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2018	293	50					19365	19376		10.1074/jbc.RA118.004872	http://dx.doi.org/10.1074/jbc.RA118.004872			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HE6RA	30355738	Green Published, hybrid			2022-12-28	WOS:000453537300018
J	McDonald, ND; DeMeester, KE; Lewis, AL; Grimes, CL; Boyd, EF				McDonald, Nathan D.; DeMeester, Kristen E.; Lewis, Amanda L.; Grimes, Catherine Leimkuhler; Boyd, E. Fidelma			Structural and functional characterization of a modified legionaminic acid involved in glycosylation of a bacterial lipopolysaccharide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONTYPABLE HAEMOPHILUS-INFLUENZAE; N-ACETYLNEURAMINIC ACID; SIALIC-ACID; VIBRIO-VULNIFICUS; ESCHERICHIA-COLI; FACTOR-H; 5,7-DIACETAMIDO-3,5,7,9-TETRADEOXY-D-GLYCERO-D-GALACTO-NON-2-ULOSONIC ACID; CAPSULAR POLYSACCHARIDE; NONULOSONIC ACIDS; BIOFILM FORMATION	Nonulosonic acids (NulOs) are a diverse family of alpha-keto acid carbohydrates present across all branches of life. Bacteria biosynthesize NulOs among which are several related prokaryotic-specific isomers and one of which, N-acetylneuraminic acid (sialic acid), is common among all vertebrates. Bacteria display various NulO carbohydrates on lipopolysaccharide (LPS), and the identities of these molecules tune host-pathogen recognition mechanisms. The opportunistic bacterial pathogen Vibrio vulnificus possesses the genes for NulO biosynthesis; however, the structures and functions of the V. vulnificus NulO glycan are unknown. Using genetic and chemical approaches, we show here that the major NulO produced by a clinical V. vulnificus strain CMCP6 is 5-N-acetyl-7-N-acetyl-D-alanyl-legionaminic acid (Leg5Ac7AcAla). The CMCP6 strain could catabolize modified legionaminic acid, whereas V. vulnificus strain YJ016 produced but did not catabolize a NulO without the N-acetyl-D-alanyl modification. In silico analysis suggested that Leg5Ac7 AcAla biosynthesis follows a noncanonical pathway but appears to be present in several bacterial species. Leg5Ac7AcAla contributed to bacterial outer-membrane integrity, as mutant strains unable to produce or incorporate Leg5Ac7AcAla into the LPS have increased membrane permeability, sensitivity to bile salts and antimicrobial peptides, and defects in biofilm formation. Using the crustacean model, Artemia franciscana, we demonstrate that Leg5Ac7AcAla-deficient bacteria have decreased virulence potential compared with WT. Our data indicate that different V. vulnificus strains produce multiple NulOs and that the modified legionaminic acid Leg5Ac7AcAla plays a critical role in the physiology, survivability, and pathogenicity of V. vulnificus CMCP6.	[McDonald, Nathan D.; Grimes, Catherine Leimkuhler; Boyd, E. Fidelma] Univ Delaware, Dept Biol Sci, 341 Wolf Hall, Newark, DE 19716 USA; [DeMeester, Kristen E.; Grimes, Catherine Leimkuhler] Univ Delaware, Dept Chem & Biochem, Newark, DE 19716 USA; [Lewis, Amanda L.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	University of Delaware; University of Delaware; Washington University (WUSTL)	Boyd, EF (corresponding author), Univ Delaware, Dept Biol Sci, 341 Wolf Hall, Newark, DE 19716 USA.	fboyd@udel.edu		McDonald, Nathan/0000-0003-3650-9493; Lewis, Amanda/0000-0001-6195-3030	National Science Foundation Career Award [DEB-0844409]; University of Delaware graduate fellowship award; National Institutes of Health Chemistry-Biology Interface (CBI) Training Grant [5T32GM008550]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM110758, P20GM104316, P20GM103446] Funding Source: NIH RePORTER	National Science Foundation Career Award(National Science Foundation (NSF)); University of Delaware graduate fellowship award; National Institutes of Health Chemistry-Biology Interface (CBI) Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Science Foundation Career Award DEB-0844409 (to E. F. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Funded by a University of Delaware graduate fellowship award.; Supported by National Institutes of Health Chemistry-Biology Interface (CBI) Training Grant 5T32GM008550.	Almagro-Moreno S, 2009, INFECT IMMUN, V77, P3807, DOI 10.1128/IAI.00279-09; Almagro-Moreno S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-118; Anderson GG, 2010, INFECT IMMUN, V78, P963, DOI 10.1128/IAI.00925-09; Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; Bax M, 2011, INFECT IMMUN, V79, P2681, DOI 10.1128/IAI.00009-11; Carda-Dieguez M, 2018, VIRULENCE, V9, P981, DOI 10.1080/21505594.2018.1455464; Carlin AF, 2007, J BACTERIOL, V189, P1231, DOI 10.1128/JB.01155-06; Carlin AF, 2009, BLOOD, V113, P3333, DOI 10.1182/blood-2008-11-187302; Chang DE, 2004, P NATL ACAD SCI USA, V101, P7427, DOI 10.1073/pnas.0307888101; Chang YC, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003846; Chen CY, 2003, GENOME RES, V13, P2577, DOI 10.1101/gr.1295503; Davis KM, 2011, INFECT IMMUN, V79, P562, DOI 10.1128/IAI.00651-10; Friedrich V, 2017, GLYCOBIOLOGY, V27, P342, DOI 10.1093/glycob/cww129; Greiner LL, 2004, INFECT IMMUN, V72, P4249, DOI 10.1128/IAI.72.7.4249-4260.2004; Ha C, 2014, MICROB PATHOGENESIS, V71-72, P8, DOI 10.1016/j.micpath.2014.04.001; Haines-Menges B, 2014, INFECT IMMUN, V82, P3667, DOI 10.1128/IAI.01854-14; Hashii N, 2003, CARBOHYD RES, V338, P2711, DOI 10.1016/j.carres.2003.06.003; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Inzana TJ, 2012, VET MICROBIOL, V161, P113, DOI 10.1016/j.vetmic.2012.07.008; Inzana TJ, 2002, INFECT IMMUN, V70, P4870, DOI 10.1128/IAI.70.9.4870-4879.2002; Jurcisek J, 2005, INFECT IMMUN, V73, P3210, DOI 10.1128/IAI.73.6.3210-3218.2005; Kenyon JJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11166-4; Kenyon JJ, 2015, GLYCOBIOLOGY, V25, P644, DOI 10.1093/glycob/cwv007; Kim BS, 2018, MBIO, V9, DOI 10.1128/mBio.02262-17; Kim YR, 2003, INFECT IMMUN, V71, P5461, DOI 10.1128/IAI.71.10.5461-5471.2003; King SJ, 2010, MOL ORAL MICROBIOL, V25, P15, DOI 10.1111/j.2041-1014.2009.00564.x; KNIREL YA, 1994, EUR J BIOCHEM, V221, P239, DOI 10.1111/j.1432-1033.1994.tb18734.x; Knirel YA, 2003, ADV CARBOHYD CHEM BI, V58, P371, DOI 10.1016/S0065-2318(03)58007-6; KNIREL YA, 1984, CARBOHYD RES, V133, pC5, DOI 10.1016/0008-6215(84)85213-1; Kondadi PK, 2012, J BACTERIOL, V194, P2540, DOI 10.1128/JB.00126-12; KOVACH ME, 1994, BIOTECHNIQUES, V16, P800; Kurniyati K, 2017, MOL MICROBIOL, V103, P67, DOI 10.1111/mmi.13544; Lee MN, 2014, J GEN APPL MICROBIOL, V60, P169, DOI 10.2323/jgam.60.169; Lewis AL, 2004, P NATL ACAD SCI USA, V101, P11123, DOI 10.1073/pnas.0403010101; Lewis AL, 2016, GLYCOBIOLOGY, V26, P1107, DOI 10.1093/glycob/cww068; Lewis AL, 2011, APPL ENVIRON MICROB, V77, P5782, DOI 10.1128/AEM.00712-11; Lewis AL, 2009, P NATL ACAD SCI USA, V106, P13552, DOI 10.1073/pnas.0902431106; Li XM, 2010, CARBOHYD RES, V345, P1581, DOI 10.1016/j.carres.2010.04.008; Lubin JB, 2015, INFECT IMMUN, V83, P3126, DOI 10.1128/IAI.00345-15; Lubin JB, 2012, APPL ENVIRON MICROB, V78, P3407, DOI 10.1128/AEM.07395-11; MacLean LL, 2011, CARBOHYD RES, V346, P2589, DOI 10.1016/j.carres.2011.09.003; Matthew Z, 2013, RSC ADV, V4, P3413; McDonald ND, 2016, MBIO, V7, DOI 10.1128/mBio.02237-15; McNally DJ, 2007, J BIOL CHEM, V282, P14463, DOI 10.1074/jbc.M611027200; Naito M, 2010, J BACTERIOL, V192, P2182, DOI 10.1128/JB.01222-09; PARSONS NJ, 1988, MICROB PATHOGENESIS, V5, P303, DOI 10.1016/0882-4010(88)90103-9; Philippe N, 2004, PLASMID, V51, P246, DOI 10.1016/j.plasmid.2004.02.003; Ram S, 1998, J EXP MED, V187, P743, DOI 10.1084/jem.187.5.743; Schirm M, 2003, MOL MICROBIOL, V48, P1579, DOI 10.1046/j.1365-2958.2003.03527.x; Schneider MC, 2006, J IMMUNOL, V176, P7566, DOI 10.4049/jimmunol.176.12.7566; Schoenhofen IC, 2009, GLYCOBIOLOGY, V19, P715, DOI 10.1093/glycob/cwp039; Severi E, 2007, MICROBIOL-SGM, V153, P2817, DOI 10.1099/mic.0.2007/009480-0; SILVER RP, 1988, REV INFECT DIS, V10, pS282; Thibault P, 2001, J BIOL CHEM, V276, P34862, DOI 10.1074/jbc.M104529200; Tsvetkov YE, 2001, CARBOHYD RES, V331, P233, DOI 10.1016/S0008-6215(01)00041-6; Twine SM, 2008, FEBS J, V275, P4428, DOI 10.1111/j.1742-4658.2008.06589.x; Velkov T, 2013, INNATE IMMUN-LONDON, V19, P265, DOI 10.1177/1753425912459092; VIMR E, 1995, J IND MICROBIOL, V15, P352, DOI 10.1007/BF01569991; Vimr ER, 2004, MICROBIOL MOL BIOL R, V68, P132, DOI 10.1128/MMBR.68.1.132-153.2004; VIMR ER, 1989, J BACTERIOL, V171, P1106, DOI 10.1128/jb.171.2.1106-1117.1989; Vinogradov E, 2017, CARBOHYD RES, V440-441, P10, DOI 10.1016/j.carres.2017.01.002; Vinogradov E, 2009, CARBOHYD RES, V344, P484, DOI 10.1016/j.carres.2008.12.017; WESSELS MR, 1987, J BIOL CHEM, V262, P8262; Westphal O., 1965, METHODS CARBOHYDRATE, V5, P83, DOI DOI 10.1016/J.WATRES.2010.04.030; Williams TC, 2014, PATHOGENS, V3, P822, DOI 10.3390/pathogens3040822; Yamamoto M, 2015, J VET MED SCI, V77, P823, DOI 10.1292/jvms.14-0655	66	3	3	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2018	293	49					19113	19126		10.1074/jbc.RA118.004966	http://dx.doi.org/10.1074/jbc.RA118.004966			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NY	30315110	Green Published, hybrid			2022-12-28	WOS:000458467400023
J	Bachmann, AS; Geerts, D				Bachmann, Andre S.; Geerts, Dirk			Polyamine synthesis as a target of MYC oncogenes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ORNITHINE-DECARBOXYLASE GENE; C-MYC; N-MYC; TRANSCRIPTIONAL PROGRAM; SIGNALING PATHWAYS; ANTIZYME INHIBITOR; THERAPEUTIC TARGET; PROTEIN-SYNTHESIS; STRUCTURAL BASIS; CIRCADIAN CLOCK	This paper is in recognition of the 100th birthday of Dr. Her-bert Tabor, a true pioneer in the polyamine field for over 70 years, who served as the editor-in-chief of the Journal of Biological Chemistry from 1971 to 2010. Wereview current knowledge of MYC proteins (c-MYC, MYCN, and MYCL) and focus on ornithine decarboxylase 1 (ODC1), an important bona fide gene target of MYC, which encodes the sentinel, rate- limiting enzyme in polyamine biosynthesis. Although notable advances have been made in designing inhibitors against the "undruggable" MYCs, their downstream targets and pathways are currently the main avenue for therapeutic anticancer interventions. To this end, the MYC-ODCaxis presents an attractive target for managing cancers such as neuroblastoma, a pediatric malignancy in which MYCN gene amplification correlates with poor prognosis and high-risk disease. ODC and polyamine levels are often up-regulated and contribute to tumor hyperproliferation, especially of MYC-driven cancers. We therefore had proposed to repurpose alpha-difluoromethylornithine (DFMO), an FDA-approved, orally available ODC inhibitor, for management of neuroblastoma, and this intervention is now being pursued in several clinical trials. We discuss the regulation of ODC and polyamines, which besides their well-known interactions with DNA and tRNA/rRNA, are involved in regulating RNA transcription and translation, ribosome function, proteasomal degradation, the circadian clock, and immunity, events that are also controlled by MYC proteins.	[Bachmann, Andre S.] Michigan State Univ, Coll Human Med, Dept Pediat & Human Dev, 400 Monroe Ave NW, Grand Rapids, MI 49503 USA; [Geerts, Dirk] Univ Amsterdam, Amsterdam Univ Med Ctr, Dept Med Biol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands	Michigan State University; Michigan State University College of Human Medicine; University of Amsterdam	Bachmann, AS (corresponding author), Michigan State Univ, Coll Human Med, Dept Pediat & Human Dev, 400 Monroe Ave NW, Grand Rapids, MI 49503 USA.	andre.bachmann@hc.msu.edu	Geerts, Dirk/K-8260-2015	Geerts, Dirk/0000-0002-6386-8187				Albeck S, 2008, PROTEIN SCI, V17, P793, DOI 10.1110/ps.073427208; Alexander ET, 2017, ONCOTARGET, V8, P84140, DOI 10.18632/oncotarget.20493; Altman BJ, 2015, CELL METAB, V22, P1009, DOI 10.1016/j.cmet.2015.09.003; AMES BN, 1958, SCIENCE, V127, P814, DOI 10.1126/science.127.3302.814-a; Arruabarrena-Aristorena A, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar2606; Auvinen M, 2003, INT J BIOCHEM CELL B, V35, P496, DOI 10.1016/S1357-2725(02)00305-9; AUVINEN M, 1992, NATURE, V360, P355, DOI 10.1038/360355a0; BACHMANN A, 1994, NEW PHYTOL, V126, P593, DOI 10.1111/j.1469-8137.1994.tb02953.x; Bachmann Andre S, 2004, Hawaii Med J, V63, P371; Bachmann AS, 2012, PED CANCER, V1, P91, DOI 10.1007/978-94-007-2418-1_9; Bachmann AS, 2003, PHYSIOL MOL PLANT P, V63, P57, DOI 10.1016/j.pmpp.2003.09.005; Bachmann AS, 2004, LEUKEMIA RES, V28, P301, DOI 10.1016/j.leukres.2003.07.002; Bachmann AS, 1998, PHYSIOL MOL PLANT P, V53, P287, DOI 10.1006/pmpp.1998.0183; Bachmann AS, 2012, POLYAMINE DRUG DISCO, P257; Bachrach U, 2010, PLANT PHYSIOL BIOCH, V48, P490, DOI 10.1016/j.plaphy.2010.02.003; Bandino A, 2014, CELL ONCOL, V37, P387, DOI 10.1007/s13402-014-0201-9; Bassiri H, 2015, TRANSL PEDIATR, V4, P226, DOI 10.3978/j.issn.2224-4336.2015.04.06; Bello-Fernandez C, 1992, Curr Top Microbiol Immunol, V182, P445; BELLOFERNANDEZ C, 1993, P NATL ACAD SCI USA, V90, P7804, DOI 10.1073/pnas.90.16.7804; Ben-Yosef T, 1998, ONCOGENE, V17, P165, DOI 10.1038/sj.onc.1201939; Bouvard C, 2017, P NATL ACAD SCI USA, V114, P3497, DOI 10.1073/pnas.1702663114; Brockmann M, 2016, CANCER CELL, V30, P357, DOI 10.1016/j.ccell.2016.07.002; Brockmann M, 2013, CANCER CELL, V24, P75, DOI 10.1016/j.ccr.2013.05.005; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Bupp CP, 2018, AM J MED GENET A, V176, P2548, DOI 10.1002/ajmg.a.40523; Campaner S, 2010, NAT CELL BIOL, V12, P54, DOI 10.1038/ncb2004; Carroll PA, 2018, FRONT MED-PRC, V12, P412, DOI 10.1007/s11684-018-0650-z; Casero RA, 2007, NAT REV DRUG DISCOV, V6, P373, DOI 10.1038/nrd2243; Casero RA, 2018, NAT REV CANCER, V18, P681, DOI 10.1038/s41568-018-0050-3; Casey SC, 2017, TRENDS IMMUNOL, V38, P298, DOI 10.1016/j.it.2017.01.002; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cermelli S, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014209; Chan DA, 2011, NAT REV DRUG DISCOV, V10, P351, DOI 10.1038/nrd3374; Chen H, 2018, SIGNAL TRANSDUCT TAR, V3, DOI 10.1038/s41392-018-0008-7; Chen ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep29090; Chidley C, 2011, NAT CHEM BIOL, V7, P375, DOI [10.1038/NCHEMBIO.557, 10.1038/nchembio.557]; Childs AC, 2003, CELL MOL LIFE SCI, V60, P1394, DOI 10.1007/s00018-003-2332-4; Chipumuro E, 2014, CELL, V159, P1126, DOI 10.1016/j.cell.2014.10.024; Coffino P, 2001, NAT REV MOL CELL BIO, V2, P188, DOI 10.1038/35056508; Coffino P, 2001, BIOCHIMIE, V83, P319, DOI 10.1016/S0300-9084(01)01252-4; Cohen S. S, 1998, GUIDE POLYAMINES, P512; COHEN SS, 1969, P NATL ACAD SCI USA, V64, P669, DOI 10.1073/pnas.64.2.669; COHEN SS, 1960, J BIOL CHEM, V235, P2112; Cole KA, 2011, P NATL ACAD SCI USA, V108, P3336, DOI 10.1073/pnas.1012351108; Coude MM, 2015, ONCOTARGET, V6, P17698, DOI 10.18632/oncotarget.4131; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Dauch D, 2016, NAT MED, V22, P744, DOI 10.1038/nm.4107; Dejure FR, 2017, EMBO J, V36, P3409, DOI 10.15252/embj.201796438; Dutta D, 2018, NUCLEIC ACIDS RES, V46, P5355, DOI 10.1093/nar/gky385; Dwivedi RS, 1999, CANCER RES, V59, P1852; Evageliou NF, 2016, CLIN CANCER RES, V22, P4391, DOI 10.1158/1078-0432.CCR-15-2539; Evageliou NF, 2009, CLIN CANCER RES, V15, P5956, DOI 10.1158/1078-0432.CCR-08-3213; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Flynn A. T., 2018, MED SCI, V6, pE41, DOI DOI 10.3390/MEDSCI6020041; Galluzzi L, 2015, CELL METAB, V22, P757, DOI 10.1016/j.cmet.2015.10.007; Gamble LD, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00162; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Garcia YR, 2017, CHEM COMMUN, V53, P6653, DOI 10.1039/c7cc01705g; Geerts D, 2010, INT J CANCER, V126, P2012, DOI 10.1002/ijc.25074; George RE, 1996, ONCOGENE, V12, P1583; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; Gjertsen BT, 2015, LEUKEMIA, V29, P11, DOI 10.1038/leu.2014.222; GUILLEM JG, 1990, MOL CARCINOGEN, V3, P68, DOI 10.1002/mc.2940030204; Gustafson WC, 2014, CANCER CELL, V26, P414, DOI 10.1016/j.ccr.2014.07.015; Hackett CS, 2014, CELL REP, V9, P1034, DOI 10.1016/j.celrep.2014.09.046; Ham J, 2016, CANCER CELL, V29, P159, DOI 10.1016/j.ccell.2016.01.002; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Herranz D, 2014, NAT MED, V20, P1130, DOI 10.1038/nm.3665; HERSHEY AD, 1957, VIROLOGY, V4, P237, DOI 10.1016/0042-6822(57)90061-2; Hobbs CA, 2006, POLYAMINE CELL SIGNALING: PHYSIOLOGY, PHARMACOLOGY, AND CANCER RESEARCH, P75, DOI 10.1007/978-1-59745-145-1_5; Hogarty MD, 2008, CANCER RES, V68, P9735, DOI 10.1158/0008-5472.CAN-07-6866; Hsu TYT, 2015, NATURE, V525, P384, DOI 10.1038/nature14985; Hydbring P, 2010, P NATL ACAD SCI USA, V107, P58, DOI 10.1073/pnas.0900121106; Jacob NT, 2018, BIOORGAN MED CHEM, V26, P4234, DOI 10.1016/j.bmc.2018.07.019; Jeong KC, 2010, MOL BIOSYST, V6, P1503, DOI 10.1039/c002534h; Jung JH, 2015, CANCER BIOL THER, V16, P412, DOI 10.1080/15384047.2014.1002698; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Kalkat M, 2017, GENES-BASEL, V8, DOI 10.3390/genes8060151; Kim HI, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189044; Koh CM, 2016, BIOESSAYS, V38, P266, DOI 10.1002/bies.201500134; Koomoa DLT, 2013, INT J ONCOL, V42, P1219, DOI 10.3892/ijo.2013.1835; Koomoa DLT, 2009, MOL CANCER THER, V8, P2067, DOI 10.1158/1535-7163.MCT-08-1217; Koomoa DLT, 2008, CANCER RES, V68, P9825, DOI 10.1158/0008-5472.CAN-08-1865; Lange I, 2014, J MOL BIOL, V426, P332, DOI 10.1016/j.jmb.2013.09.037; Lewenhoeck D. A., 1677, PHIL T, V12, P1040; Li B, 2013, CLIN CANCER RES, V19, P5835, DOI 10.1158/1078-0432.CCR-12-3629; Li X, 2015, CURR CANCER DRUG TAR, V15, P99, DOI 10.2174/1568009615666150121162921; Li X, 2015, CURR CANCER DRUG TAR, V15, P53, DOI 10.2174/1568009615666150105120055; LI XQ, 1993, MOL CELL BIOL, V13, P2377, DOI 10.1128/MCB.13.4.2377; LIQUORI AM, 1967, J MOL BIOL, V24, P113, DOI 10.1016/0022-2836(67)90094-0; Local A, 2018, MOL CANCER THER, V17, P1177, DOI 10.1158/1535-7163.MCT-17-1209; Lozier AM, 2015, ONCOTARGET, V6, P196, DOI 10.18632/oncotarget.2768; Madeo F, 2018, SCIENCE, V359, P410, DOI 10.1126/science.aan2788; Mangold U, 2006, CELL MOL LIFE SCI, V63, P2095, DOI 10.1007/s00018-005-5583-4; Mangold U, 2005, IUBMB LIFE, V57, P671, DOI 10.1080/15216540500307031; MATSUFUJI S, 1995, CELL, V80, P51, DOI 10.1016/0092-8674(95)90450-6; MATTHEWS HR, 1993, BIOESSAYS, V15, P561, DOI 10.1002/bies.950150811; METCALF BW, 1978, J AM CHEM SOC, V100, P2551, DOI 10.1021/ja00476a050; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Meyskens FL, 2008, CANCER PREV RES, V1, P32, DOI 10.1158/1940-6207.CAPR-08-0042; Molenaar JJ, 2012, NAT GENET, V44, P1199, DOI 10.1038/ng.2436; Molenaar JJ, 2009, P NATL ACAD SCI USA, V106, P12968, DOI 10.1073/pnas.0901418106; Mollaoglu G, 2017, CANCER CELL, V31, P270, DOI 10.1016/j.ccell.2016.12.005; MORRIS DR, 1988, BIOCHEMISTRY-US, V27, P8689, DOI 10.1021/bi00423a027; Murai N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21189-0; Murray-Stewart TR, 2016, BIOCHEM J, V473, P2937, DOI 10.1042/BCJ20160383; Mussai F, 2015, CANCER RES, V75, P3043, DOI 10.1158/0008-5472.CAN-14-3443; Nakanishi S, 2016, AMINO ACIDS, V48, P2353, DOI 10.1007/s00726-016-2275-3; Nilsson JA, 2005, CANCER CELL, V7, P433, DOI 10.1016/j.ccr.2005.03.036; O'Neil NJ, 2017, NAT REV GENET, V18, P613, DOI 10.1038/nrg.2017.47; Paz EA, 2014, MOL CARCINOGEN, V53, pE96, DOI 10.1002/mc.22051; Pegg AE, 2006, J BIOL CHEM, V281, P14529, DOI 10.1074/jbc.R500031200; Pegg AE, 2016, J BIOL CHEM, V291, P14904, DOI 10.1074/jbc.R116.731661; Pistoia V, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00174; Popov N, 2007, NAT CELL BIOL, V9, P765, DOI 10.1038/ncb1601; Pourdehnada M, 2013, P NATL ACAD SCI USA, V110, P11988, DOI 10.1073/pnas.1310230110; Priotto G, 2009, LANCET, V374, P56, DOI 10.1016/S0140-6736(09)61117-X; Puissant A, 2013, CANCER DISCOV, V3, P308, DOI 10.1158/2159-8290.CD-12-0418; Raul F, 2007, BIOCHEM SOC T, V35, P353, DOI 10.1042/BST0350353; Reyes-Gonzalez JM, 2015, MOL CANCER THER, V14, P2260, DOI 10.1158/1535-7163.MCT-14-0801; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Richards MW, 2016, P NATL ACAD SCI USA, V113, P13726, DOI 10.1073/pnas.1610626113; Rickman DS, 2018, CANCER DISCOV, V8, P150, DOI 10.1158/2159-8290.CD-17-0273; ROSENWALD IB, 1993, P NATL ACAD SCI USA, V90, P6175, DOI 10.1073/pnas.90.13.6175; Rounbehler RJ, 2009, CANCER RES, V69, P547, DOI 10.1158/0008-5472.CAN-08-2968; Ruggero D, 2004, NAT MED, V10, P484, DOI 10.1038/nm1042; Ruggero D, 2009, CANCER RES, V69, P8839, DOI 10.1158/0008-5472.CAN-09-1970; Ruiz-Perez MV, 2017, GENES-BASEL, V8, DOI 10.3390/genes8040113; Sabnis HS, 2017, GENES-BASEL, V8, DOI 10.3390/genes8040114; Samal K, 2013, INT J CANCER, V133, P1323, DOI 10.1002/ijc.28139; Schaub FX, 2018, CELL SYST, V6, P282, DOI 10.1016/j.cels.2018.03.003; Schultz CR, 2018, BIOCHEM J, V475, P531, DOI 10.1042/BCJ20170597; Sebastian M, 2010, J THORAC ONCOL, V5, P1060, DOI 10.1097/JTO.0b013e3181d95dd4; Sewastianik T, 2014, BBA-REV CANCER, V1846, P457, DOI 10.1016/j.bbcan.2014.08.006; Shan C, 2015, NUCLEIC ACIDS RES, V43, P6677, DOI 10.1093/nar/gkv641; Shantz LM, 1999, INT J BIOCHEM CELL B, V31, P107, DOI 10.1016/S1357-2725(98)00135-6; Sholler GLS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32659-w; Sholler GLS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127246; Siu KT, 2017, LEUKEMIA, V31, P1760, DOI 10.1038/leu.2016.355; Smith MA, 2011, PEDIATR BLOOD CANCER, V57, P268, DOI 10.1002/pbc.22797; Soderstjerna E, 2010, ANTI-CANCER DRUG, V21, P917, DOI 10.1097/CAD.0b013e32833d1cae; Stellas D, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju320; STIMAC E, 1987, J CELL PHYSIOL, V133, P590, DOI 10.1002/jcp.1041330323; SUWALSKY M, 1969, J MOL BIOL, V42, P363, DOI 10.1016/0022-2836(69)90049-7; TABIB A, 1994, BIOCHEM BIOPH RES CO, V202, P720, DOI 10.1006/bbrc.1994.1990; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; Tavana O, 2016, NAT MED, V22, P1180, DOI 10.1038/nm.4180; TONIN PN, 1989, ONCOGENE, V4, P1117; Truitt ML, 2016, NAT REV CANCER, V16, P288, DOI 10.1038/nrc.2016.27; Ruiz-Perez MV, 2015, J BIOL CHEM, V290, P6106, DOI 10.1074/jbc.M114.619197; Wallace HM, 2007, EXPERT OPIN PHARMACO, V8, P2109, DOI 10.1517/14656566.8.13.2109; Wallace HM, 2003, BIOCHEM J, V376, P1, DOI 10.1042/BJ20031327; Wallick CJ, 2005, ONCOGENE, V24, P5606, DOI 10.1038/sj.onc.1208808; Wang HB, 2015, ONCOTARGET, V6, P32380, DOI 10.18632/oncotarget.6116; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warburg O, 1924, BIOCHEM Z, V152, P319; Weicht R. R, 2018, MED SCI, V6, pE65; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Williams K, 1997, BIOCHEM J, V325, P289, DOI 10.1042/bj3250289; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Xiao DB, 2016, MOL CELL, V64, P493, DOI 10.1016/j.molcel.2016.09.016; Yco LP, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1447-y; Yu C, 2016, SCI REP-UK, V6, DOI 10.1038/srep22298; Zell JA, 2009, CLIN CANCER RES, V15, P6208, DOI 10.1158/1078-0432.CCR-09-0592; Zhang MS, 2003, EMBO J, V22, P1488, DOI 10.1093/emboj/cdg158; Zhang WQ, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0694-1; Zirath H, 2013, P NATL ACAD SCI USA, V110, P10258, DOI 10.1073/pnas.1222404110; Zwighaft Z, 2015, CELL METAB, V22, P874, DOI 10.1016/j.cmet.2015.09.011	170	56	59	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2018	293	48					18757	18769		10.1074/jbc.TM118.003336	http://dx.doi.org/10.1074/jbc.TM118.003336			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NX	30404920	hybrid, Green Published			2022-12-28	WOS:000458467300031
J	Madison, BJ; Clark, KA; Bhachech, N; Hollenhorst, PC; Graves, BJ; Currie, SL				Madison, Bethany J.; Clark, Kathleen A.; Bhachech, Niraja; Hollenhorst, Peter C.; Graves, Barbara J.; Currie, Simon L.			Electrostatic repulsion causes anticooperative DNA binding between tumor suppressor ETS transcription factors and JUN-FOS at composite DNA sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTATIONAL LANDSCAPE; CRYSTAL-STRUCTURE; PROTEIN; SPECIFICITY; FAMILY; ACTIVATION; EXPRESSION; REVEAL; DOMAIN; PHOSPHORYLATION	Many different transcription factors (TFs) regulate gene expression in a combinatorial fashion, often by binding in close proximity to each other on composite cis-regulatory DNA elements. Here, we investigated how ETS TFs bind with the AP1 TFs JUN-FOS at composite DNA-binding sites. DNA-binding ability with JUN-FOS correlated with the phenotype of ETS proteins in prostate cancer. We found that the oncogenic ETS-related gene (ERG) and ETS variant (ETV) 1/4/5 subfamilies co-occupy ETS-AP1 sites with JUN-FOS in vitro, whereas JUN-FOS robustly inhibited DNA binding by the tumor suppressors ETS homologous factor (EHF) and SAM pointed domain-containing ETS TF (SPDEF). EHF bound ETS-AP1 DNA with tighter affinity than ERG in the absence of JUN-FOS, possibly enabling EHF to compete with ERG and JUN-FOS for binding to ETS-AP1 sites. Genome-wide mapping of EHF- and ERG-binding sites in prostate epithelial cells revealed that EHF is preferentially excluded from closely spaced ETS-AP1 DNA sequences. Structural modeling and mutational analyses indicated that adjacent positively charged surfaces from EHF and JUN-FOS use electrostatic repulsion to disfavor simultaneous DNA binding. Conservation of positive residues on the JUN-FOS interface identified E74-like ETS TF 1 (ELF1) as an additional ETS TF exhibiting anticooperative DNA binding with JUN-FOS, and we found that ELF1 is frequently down-regulated in prostate cancer. In summary, divergent electrostatic features of ETSTFs at their JUN-FOS interface enable distinct binding events at ETS-AP1 DNA sites, which may drive specific targeting of ETS TFs to facilitate distinct transcriptional programs.	[Madison, Bethany J.; Clark, Kathleen A.; Bhachech, Niraja; Graves, Barbara J.; Currie, Simon L.] Univ Utah, Sch Med, Dept Oncol Sci, Salt Lake City, UT 84112 USA; [Madison, Bethany J.; Clark, Kathleen A.; Bhachech, Niraja; Graves, Barbara J.; Currie, Simon L.] Univ Utah, Sch Med, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [Hollenhorst, Peter C.] Indiana Univ Sch Med, Med Sci Program, Bloomington, IN 47405 USA; [Graves, Barbara J.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Currie, Simon L.] Univ Texas Southwestern Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA	Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Indiana University System; Indiana University Bloomington; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Graves, BJ (corresponding author), Univ Utah, Sch Med, Dept Oncol Sci, Salt Lake City, UT 84112 USA.; Graves, BJ (corresponding author), Univ Utah, Sch Med, Huntsman Canc Inst, Salt Lake City, UT 84112 USA.; Graves, BJ (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	barbara.graves@hci.utah.edu		Currie, Simon/0000-0001-5083-1484	National Institutes of Health [R01GM38663, R01CA204121]; NATIONAL CANCER INSTITUTE [P30CA042014, R01CA204121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038663] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants R01GM38663 (to B. J. G.) and R01CA204121 (to P. C. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Agarkar VB, 2010, J MOL BIOL, V397, P278, DOI 10.1016/j.jmb.2010.01.017; Albino D, 2012, CANCER RES, V72, P2889, DOI 10.1158/0008-5472.CAN-12-0212; Ando M, 2016, CANCER RES, V76, P1814, DOI 10.1158/0008-5472.CAN-14-3816; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Benjamini Y, 2006, BIOMETRIKA, V93, P491, DOI 10.1093/biomet/93.3.491; Bosc DG, 2001, ONCOGENE, V20, P6215, DOI 10.1038/sj.onc.1204820; Bose R, 2017, NATURE, V546, P671, DOI 10.1038/nature22820; Cangemi R, 2008, ONCOGENE, V27, P2877, DOI 10.1038/sj.onc.1210953; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cheng XH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004656; Currie SL, 2017, J MOL BIOL, V429, P2975, DOI 10.1016/j.jmb.2017.06.024; Currie SL, 2017, NUCLEIC ACIDS RES, V45, P2223, DOI 10.1093/nar/gkx068; Ferguson HA, 2001, NUCLEIC ACIDS RES, V29, part. no., DOI 10.1093/nar/29.20.e98; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Garvie CW, 2002, J BIOL CHEM, V277, P45529, DOI 10.1074/jbc.M206327200; GLOVER JNM, 1995, NATURE, V373, P257, DOI 10.1038/373257a0; Goetz TL, 2000, MOL CELL BIOL, V20, P81, DOI 10.1128/MCB.20.1.81-90.2000; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Hollenhorst PC, 2004, NUCLEIC ACIDS RES, V32, P5693, DOI 10.1093/nar/gkh906; Hollenhorst PC, 2007, GENE DEV, V21, P1882, DOI 10.1101/gad.1561707; Hollenhorst PC, 2011, GENE DEV, V25, P2147, DOI 10.1101/gad.17546311; Hollenhorst PC, 2011, ANNU REV BIOCHEM, V80, P437, DOI 10.1146/annurev.biochem.79.081507.103945; Hollenhorst PC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000778; Jolma A, 2015, NATURE, V527, P384, DOI 10.1038/nature15518; Joshi R, 2007, CELL, V131, P530, DOI 10.1016/j.cell.2007.09.024; Kim S, 2006, MOL CELL BIOL, V26, P2467, DOI 10.1128/MCB.26.7.2467-2478.2006; Kim S, 2013, SCIENCE, V339, P816, DOI 10.1126/science.1229223; Kumar A, 2016, NAT MED, V22, P369, DOI 10.1038/nm.4053; LaRonde-LeBlanc NA, 2003, GENE DEV, V17, P2060, DOI 10.1101/gad.1103303; Lee TI, 2000, ANNU REV GENET, V34, P77, DOI 10.1146/annurev.genet.34.1.77; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; NYE JA, 1992, GENE DEV, V6, P975, DOI 10.1101/gad.6.6.975; Panne D, 2008, CURR OPIN STRUC BIOL, V18, P236, DOI 10.1016/j.sbi.2007.12.002; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Plotnik JP, 2014, NUCLEIC ACIDS RES, V42, P11928, DOI 10.1093/nar/gku929; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Regan MC, 2013, P NATL ACAD SCI USA, V110, P13374, DOI 10.1073/pnas.1301726110; Robinson D, 2015, CELL, V162, P454, DOI 10.1016/j.cell.2015.06.053; Selvaraj N, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0089-7; SGOURAS DN, 1995, EMBO J, V14, P4781, DOI 10.1002/j.1460-2075.1995.tb00160.x; Shah NH, 2018, ELIFE, V7, DOI 10.7554/eLife.35190; Shah NH, 2016, ELIFE, V5, DOI 10.7554/eLife.20105; Shiina M, 2015, J MOL BIOL, V427, P1655, DOI 10.1016/j.jmb.2014.07.020; Shrivastava T, 2014, LEUKEMIA, V28, P2040, DOI 10.1038/leu.2014.111; Sizemore GM, 2017, NAT REV CANCER, V17, P337, DOI 10.1038/nrc.2017.20; Stephens DN, 2013, J BIOL CHEM, V288, P34304, DOI 10.1074/jbc.M113.504399; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Thomas-Chollier M, 2008, NUCLEIC ACIDS RES, V36, pW119, DOI 10.1093/nar/gkn304; Tomlins SA, 2006, CANCER RES, V66, P3396, DOI 10.1158/0008-5472.CAN-06-0168; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tugores A, 2001, J BIOL CHEM, V276, P20397, DOI 10.1074/jbc.M010930200; Uhlen M, 2017, SCIENCE, V357, P660, DOI 10.1126/science.aan2507; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	59	7	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2018	293	48					18624	18635		10.1074/jbc.RA118.003352	http://dx.doi.org/10.1074/jbc.RA118.003352			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NX	30315111	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000458467300017
J	McCulloch, KM; Yamakawa, I; Shifrin, DA; McConnell, RE; Foegeding, NJ; Singh, PK; Mao, SL; Tyska, MJ; Iverson, TM				McCulloch, Kathryn M.; Yamakawa, Izumi; Shifrin, David A., Jr.; McConnell, Russell E.; Foegeding, Nora J.; Singh, Prashant K.; Mao, Suli; Tyska, Matthew J.; Iverson, T. M.			An alternative N-terminal fold of the intestine-specific annexin A13a induces dimerization and regulates membrane-binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						annexin; protein structure; protein folding; membrane fusion; oligomerization; calcium regulation; intestinal microvilli; membrane curvature; structure-function	CRYSTAL-STRUCTURE; COMPLEX PROVIDES; CALCIUM; SYNEXIN; A2; CHANNELS; FORM	Annexin proteins function as Ca2+-dependent regulators of membrane trafficking and repair that may also modulate membrane curvature. Here, using high-resolution confocal imaging, we report that the intestine-specific annexin A13 (ANX A13) localizes to the tips of intestinal microvilli and determined the crystal structure of the ANX A13a isoform to 2.6 resolution. The structure revealed that the N terminus exhibits an alternative fold that converts the first two helices and the associated helix-loop-helix motif into a continuous -helix, as stabilized by a domain-swapped dimer. We also found that the dimer is present in solution and partially occludes the membrane-binding surfaces of annexin, suggesting that dimerization may function as a means for regulating membrane binding. Accordingly, as revealed by in vitro binding and cellular localization assays, ANX A13a variants that favor a monomeric state exhibited increased membrane association relative to variants that favor the dimeric form. Together, our findings support a mechanism for how the association of the ANX A13a isoform with the membrane is regulated.	[McCulloch, Kathryn M.; Yamakawa, Izumi; Singh, Prashant K.; Iverson, T. M.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; [Shifrin, David A., Jr.; McConnell, Russell E.; Foegeding, Nora J.; Mao, Suli; Tyska, Matthew J.] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Iverson, T. M.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Iverson, T. M.] Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37232 USA; [Iverson, T. M.] Vanderbilt Univ, Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA; [McCulloch, Kathryn M.] Calif State Polytech Univ Pomona, Pomona, CA 91768 USA; [McConnell, Russell E.] Codiak Biosci, Cambridge, MA 02139 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; California State University System; California State Polytechnic University Pomona	Iverson, TM (corresponding author), Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA.; Iverson, TM (corresponding author), Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA.	tina.iverson@vanderbilt.edu		McCulloch, Kathryn/0000-0001-9077-3821	Vanderbilt University Medical Center's Digestive Disease Research Center - National Institutes of Health [P30DK058404]; National Institutes of Health [GM095633, DK075555, DK095811, DK111949]; National Institutes of Health Training Grant in Molecular Biophysics [T32GM008320]; National Institutes of Health Training Grant in Mechanisms of Vascular Disease [T32 HL007751]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI106987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404, R01DK075555, R01DK111949, R01DK095811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008320] Funding Source: NIH RePORTER	Vanderbilt University Medical Center's Digestive Disease Research Center - National Institutes of Health; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Training Grant in Molecular Biophysics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Training Grant in Mechanisms of Vascular Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by pilot funds from Vanderbilt University Medical Center's Digestive Disease Research Center supported by National Institutes of Health Grant P30DK058404 (to T. M. I.). This work was also supported by National Institutes of Health Grants GM095633 (to T. M. I.) and DK075555, DK095811, and DK111949 (to M. J. T.), National Institutes of Health Training Grant in Molecular Biophysics T32GM008320 (to N. J. F.), and National Institutes of Health Training Grant in Mechanisms of Vascular Disease T32 HL007751 (to K. M. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Lizarbe MA, 2013, INT J MOL SCI, V14, P2652, DOI 10.3390/ijms14022652; Bouter A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1270; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Burmann BM, 2012, CELL, V150, P291, DOI 10.1016/j.cell.2012.05.042; Capila I, 2001, STRUCTURE, V9, P57, DOI 10.1016/S0969-2126(00)00549-9; Choi SH, 2009, MOL BIOCHEM PARASIT, V163, P48, DOI 10.1016/j.molbiopara.2008.09.009; CONCHA NO, 1992, FEBS LETT, V314, P159, DOI 10.1016/0014-5793(92)80964-I; CREUTZ CE, 1978, J BIOL CHEM, V253, P2858; Dempsey BR, 2012, STRUCTURE, V20, P1737, DOI 10.1016/j.str.2012.08.004; Ecsedi P, 2017, STRUCTURE, V25, P1195, DOI 10.1016/j.str.2017.06.001; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FavierPerron B, 1996, BIOCHEMISTRY-US, V35, P1740, DOI 10.1021/bi952092o; Fernandez-Lizarbe S, 2017, BIOL CHEM, V398, P359, DOI 10.1515/hsz-2016-0242; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Grega-Larson NE, 2015, MOL BIOL CELL, V26, P3803, DOI 10.1091/mbc.E15-06-0443; Hatoum D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169925; HUBER R, 1992, Behring Institute Mitteilungen, P107; Iglesias JM, 2002, MOL BIOL EVOL, V19, P608, DOI 10.1093/oxfordjournals.molbev.a004120; Langen R, 1998, P NATL ACAD SCI USA, V95, P14060, DOI 10.1073/pnas.95.24.14060; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Leow CY, 2014, FEBS J, V281, P1209, DOI 10.1111/febs.12700; Liu YD, 2015, BRIT J PHARMACOL, V172, P1664, DOI 10.1111/bph.12978; LUECKE H, 1995, NATURE, V378, P512, DOI 10.1038/378512a0; Massey-Harroche D, 1998, J CELL SCI, V111, P3007; Mazerik JN, 2012, J BIOL CHEM, V287, P13104, DOI 10.1074/jbc.M111.336313; McConnell RE, 2009, J CELL BIOL, V185, P1285, DOI 10.1083/jcb.200902147; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ozorowski G, 2013, ACTA CRYSTALLOGR D, V69, P92, DOI 10.1107/S0907444912043429; PIGAULT C, 1994, J MOL BIOL, V236, P199, DOI 10.1006/jmbi.1994.1129; POLLARD HB, 1989, METHOD CELL BIOL, V31, P207; POLLARD HB, 1988, P NATL ACAD SCI USA, V85, P2974, DOI 10.1073/pnas.85.9.2974; Rety S, 2005, J MOL BIOL, V345, P1131, DOI 10.1016/j.jmb.2004.11.015; Rezvanpour A, 2011, J BIOL CHEM, V286, P40174, DOI 10.1074/jbc.M111.244038; ROJAS E, 1987, FEBS LETT, V217, P25, DOI 10.1016/0014-5793(87)81235-8; ROJAS E, 1990, J BIOL CHEM, V265, P21207; SOPKOVA J, 1993, J MOL BIOL, V234, P816, DOI 10.1006/jmbi.1993.1627; SWAIRJO MA, 1995, NAT STRUCT BIOL, V2, P968, DOI 10.1038/nsb1195-968; TAIT JF, 1992, ARCH BIOCHEM BIOPHYS, V298, P187, DOI 10.1016/0003-9861(92)90111-9; Turnay J, 2005, BIOCHEM J, V389, P899, DOI 10.1042/BJ20041918; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; WICE BM, 1992, J CELL BIOL, V116, P405, DOI 10.1083/jcb.116.2.405; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	45	5	5	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3454	3463		10.1074/jbc.RA118.004571	http://dx.doi.org/10.1074/jbc.RA118.004571			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30610115	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000461853900013
J	Zygiel, EM; Nelson, CE; Brewer, LK; Oglesby-Sherrouse, AG; Nolan, EM				Zygiel, Emily M.; Nelson, Cassandra E.; Brewer, Luke K.; Oglesby-Sherrouse, Amanda G.; Nolan, Elizabeth M.			The human innate immune protein calprotectin induces iron starvation responses in Pseudomonas aeruginosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Pseudomonas aeruginosa (P; aeruginosa); bacteria; iron; innate immunity; metal homeostasis; calprotectin; nutritional immunity; phenazine; virulence; metal sequestration	NUTRITIONAL IMMUNITY; METAL SEQUESTRATION; HOST; MANGANESE; DEFENSE; PYOVERDINE; EXPRESSION; PATHWAYS; ACCUMULATION; LACTOFERRIN	Most microbial pathogens have a metabolic iron requirement, necessitating the acquisition of this nutrient in the host. In response to pathogen invasion, the human host limits iron availability. Although canonical examples of nutritional immunity are host strategies that limit pathogen access to Fe(III), little is known about how the host restricts access to another biologically relevant oxidation state of this metal, Fe(II). This redox species is prevalent at certain infection sites and is utilized by bacteria during chronic infection, suggesting that Fe(II) withholding by the host may be an effective but unrecognized form of nutritional immunity. Here, we report that human calprotectin (CP; S100A8/S100A9 or MRP8/MRP14 heterooligomer) inhibits iron uptake and induces an iron starvation response in Pseudomonas aeruginosa cells by sequestering Fe(II) at its unusual His(6) site. Moreover, under aerobic conditions in which the Fe(III) oxidation state is favored, Fe(II) withholding by CP was enabled by (i) its ability to stabilize this redox state in solution and (ii) the production and secretion of redox-active, P. aeruginosa-produced phenazines, which reduce Fe(III) to Fe(II). Analyses of the interplay between P. aeruginosa secondary metabolites and CP indicated that Fe(II) withholding alters P. aeruginosa physiology and expression of virulence traits. Lastly, examination of the effect of CP on cell-associated metal levels in diverse human pathogens revealed that CP inhibits iron uptake by several bacterial species under aerobic conditions. This work implicates CP-mediated Fe(II) sequestration as a component of nutritional immunity in both aerobic and anaerobic milieus during P. aeruginosa infection.	[Zygiel, Emily M.; Nolan, Elizabeth M.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Nelson, Cassandra E.; Brewer, Luke K.; Oglesby-Sherrouse, Amanda G.] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA; [Oglesby-Sherrouse, Amanda G.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA	Massachusetts Institute of Technology (MIT); University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Nolan, EM (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.; Oglesby-Sherrouse, AG (corresponding author), Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA.; Oglesby-Sherrouse, AG (corresponding author), Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA.	aoglesby@rx.umaryland.edu; lnolan@mit.edu	Nelson, Cassandra/U-7963-2017	Nelson, Cassandra/0000-0002-7284-5198; Oglesby, Mandy/0000-0003-4440-3840	National Institutes of Health [R01 GM126376, T32 AI095190, T32 GM066706]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI095190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066706, R01GM126376] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 GM126376 (to E. M. N. and A. G. O.-S.), T32 AI095190 (to C. E. N.), and T32 GM066706 (to L. K. B.) The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aron AT, 2017, P NATL ACAD SCI USA, V114, P12669, DOI 10.1073/pnas.1708747114; Becker KW, 2014, FEMS MICROBIOL REV, V38, P1235, DOI 10.1111/1574-6976.12087; Besold AN, 2018, METALLOMICS, V10, DOI 10.1039/c8mt00133b; Braud A, 2010, ENV MICROBIOL REP, V2, P419, DOI 10.1111/j.1758-2229.2009.00126.x; Brophy MB, 2012, J AM CHEM SOC, V134, P18089, DOI 10.1021/ja307974e; Caldwell CC, 2009, AM J PATHOL, V175, P2473, DOI 10.2353/ajpath.2009.090166; Cassat JE, 2013, CELL HOST MICROBE, V13, P510, DOI 10.1016/j.chom.2013.04.010; Corbin BD, 2008, SCIENCE, V319, P962, DOI 10.1126/science.1152449; Cornelis P, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00075; Cowley ES, 2015, MBIO, V6, DOI 10.1128/mBio.00767-15; CUNLIFFE HE, 1995, J BACTERIOL, V177, P2744, DOI 10.1128/jb.177.10.2744-2750.1995; Cunrath O, 2016, ENVIRON MICROBIOL, V18, P3258, DOI 10.1111/1462-2920.12971; Damo SM, 2013, P NATL ACAD SCI USA, V110, P3841, DOI 10.1073/pnas.1220341110; Diaz-Ochoa VE, 2016, CELL HOST MICROBE, V19, P814, DOI 10.1016/j.chom.2016.05.005; Dietrich LEP, 2006, MOL MICROBIOL, V61, P1308, DOI 10.1111/j.1365-2958.2006.05306.x; Djapgne L, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00704-17; Garcia YM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006125; Glasser NR, 2014, MOL MICROBIOL, V92, P399, DOI 10.1111/mmi.12566; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Gray RD, 2010, J CYST FIBROS, V9, P193, DOI 10.1016/j.jcf.2010.01.005; Green M. R., 2012, MOL CLONING LAB MANU, P1346; Hadley RC, 2018, BIOCHEMISTRY-US, V57, P2846, DOI 10.1021/acs.biochem.8b00309; Hayden JA, 2013, J AM CHEM SOC, V135, P775, DOI 10.1021/ja3096416; Hernandez ME, 2004, APPL ENVIRON MICROB, V70, P921, DOI 10.1128/AEM.70.2.921-928.2004; Hider RC, 2010, NAT PROD REP, V27, P637, DOI 10.1039/b906679a; Hoang TT, 2000, PLASMID, V43, P59, DOI 10.1006/plas.1999.1441; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; Huang WL, 2017, ANNU REV BIOCHEM, V86, P799, DOI 10.1146/annurev-biochem-060815-014214; Hunter RC, 2013, MBIO, V4, DOI 10.1128/mBio.00557-13; Johne B, 1997, J CLIN PATHOL-MOL PA, V50, P113; Kehl-Fie TE, 2011, CELL HOST MICROBE, V10, P158, DOI 10.1016/j.chom.2011.07.004; Kelliher JL, 2016, PROG MOL BIOL TRANSL, V142, P1, DOI 10.1016/bs.pmbts.2016.05.002; Konings AF, 2013, INFECT IMMUN, V81, P2697, DOI 10.1128/IAI.00418-13; Korndorfer IP, 2007, J MOL BIOL, V370, P887, DOI 10.1016/j.jmb.2007.04.065; Lau CKY, 2016, FEMS MICROBIOL REV, V40, P273, DOI 10.1093/femsre/fuv049; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; MACHAN ZA, 1992, J ANTIMICROB CHEMOTH, V30, P615, DOI 10.1093/jac/30.5.615; Masse E, 2005, J BACTERIOL, V187, P6962, DOI 10.1128/JB.187.20.6962-6971.2005; Mastropasqua MC, 2018, J TRACE ELEM MED BIO, V48, P74, DOI 10.1016/j.jtemb.2018.03.009; Meirelles LA, 2018, MOL MICROBIOL, V110, P995, DOI 10.1111/mmi.14132; MEYER JM, 1978, J GEN MICROBIOL, V107, P319, DOI 10.1099/00221287-107-2-319; Minandri F, 2016, INFECT IMMUN, V84, P2324, DOI 10.1128/IAI.00098-16; Nakashige TG, 2017, METALLOMICS, V9, P1086, DOI 10.1039/c7mt00044h; Nakashige TG, 2017, J AM CHEM SOC, V139, P8828, DOI 10.1021/jacs.7b01212; Nakashige TG, 2015, NAT CHEM BIOL, V11, P765, DOI [10.1038/NCHEMBIO.1891, 10.1038/nchembio.1891]; Nguyen AT, 2015, BIOMETALS, V28, P433, DOI 10.1007/s10534-015-9848-6; Nguyen AT, 2014, J BACTERIOL, V196, P2265, DOI 10.1128/JB.01491-14; Oglesby AG, 2008, J BIOL CHEM, V283, P15558, DOI 10.1074/jbc.M707840200; Pantopoulos K, 2012, BIOCHEMISTRY-US, V51, P5705, DOI 10.1021/bi300752r; Price-Whelan A, 2007, J BACTERIOL, V189, P6372, DOI 10.1128/JB.00505-07; Radin JN, 2019, INFECT IMMUN, V87, DOI 10.1128/IAI.00642-18; Radin JN, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006040; Ran HM, 2003, P NATL ACAD SCI USA, V100, P14315, DOI 10.1073/pnas.2332354100; Recinos DA, 2012, P NATL ACAD SCI USA, V109, P19420, DOI 10.1073/pnas.1213901109; Reinhart AA, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00764-16; Reinhart AA, 2016, GENES-BASEL, V7, DOI 10.3390/genes7120126; Schaible UE, 2002, J EXP MED, V196, P1507, DOI 10.1084/jem.20020897; Wakeman CA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11951; Wang Y, 2008, ENVIRON SCI TECHNOL, V42, P2380, DOI 10.1021/es702290a; Wang Y, 2011, J BACTERIOL, V193, P3606, DOI 10.1128/JB.00396-11; WEINBERG ED, 1975, JAMA-J AM MED ASSOC, V231, P39, DOI 10.1001/jama.231.1.39; Wilderman PJ, 2004, P NATL ACAD SCI USA, V101, P9792, DOI 10.1073/pnas.0403423101; WILKINSON MM, 1988, J CELL SCI, V91, P221; Xiao R, 1997, MICROBIOL-UK, V143, P2509, DOI 10.1099/00221287-143-7-2509; Zygiel EM, 2018, ANNU REV BIOCHEM, V87, P621, DOI 10.1146/annurev-biochem-062917-012312	65	44	44	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3549	3562		10.1074/jbc.RA118.006819	http://dx.doi.org/10.1074/jbc.RA118.006819			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30622135	Green Published, hybrid			2022-12-28	WOS:000461853900020
J	Aggarwal, S; Gabrovsek, L; Langeberg, LK; Golkowski, M; Ong, SE; Smith, FD; Scott, JD				Aggarwal, Stacey; Gabrovsek, Laura; Langeberg, Lorene K.; Golkowski, Martin; Ong, Shao-En; Smith, F. Donelson; Scott, John D.			Depletion of dAKAP1-protein kinase A signaling islands from the outer mitochondrial membrane alters breast cancer cell metabolism and motility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						A-kinase-anchoring protein (AKAP); protein kinase A (PKA); cell signaling; signal transduction; breast cancer; cancer biology; cell migration; mitochondria; signaling islands	EPITHELIAL-MESENCHYMAL TRANSITION; DEPENDENT PROTEIN-KINASE; ANCHORING PROTEIN; PROGRESSION; FISSION; DRP1; PHOSPHORYLATION; DEGRADATION; REGULATOR; MIGRATION	Breast cancer screening and new precision therapies have led to improved patient outcomes. Yet, a positive prognosis is less certain when primary tumors metastasize. Metastasis requires a coordinated program of cellular changes that promote increased survival, migration, and energy consumption. These pathways converge on mitochondrial function, where distinct signaling networks of kinases, phosphatases, and metabolic enzymes regulate these processes. The protein kinase A-anchoring protein dAKAP1 compartmentalizes protein kinase A (PKA) and other signaling enzymes at the outer mitochondrial membrane and thereby controls mitochondrial function and dynamics. Modulation of these processes occurs in part through regulation of dynamin-related protein 1 (Drp1). Here, we report an inverse relationship between the expression of dAKAP1 and mesenchymal markers in breast cancer. Molecular, cellular, and in silico analyses of breast cancer cell lines confirmed that dAKAP1 depletion is associated with impaired mitochondrial function and dynamics, as well as with increased glycolytic potential and invasiveness. Furthermore, disruption of dAKAP1-PKA complexes affected cell motility and mitochondrial movement toward the leading edge in invasive breast cancer cells. We therefore propose that depletion of dAKAP1-PKA signaling islands from the outer mitochondrial membrane augments progression toward metastatic breast cancer.	[Aggarwal, Stacey; Gabrovsek, Laura; Langeberg, Lorene K.; Golkowski, Martin; Ong, Shao-En; Smith, F. Donelson; Scott, John D.] Univ Washington, Sch Med, Dept Pharmacol, 1959 NE Pacific St, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Smith, FD; Scott, JD (corresponding author), Univ Washington, Sch Med, Dept Pharmacol, 1959 NE Pacific St, Seattle, WA 98195 USA.	smithdon@uw.edu; scottjdw@uw.edu		Aggarwal, Stacey/0000-0002-7346-0716	National Institutes of Health [DK105542]; Dept. of Molecular and Cellular Biology at the University of Washington; U.S. Dept. of Defense [CA150370]; National Institutes of Health Grant from NIGMS [PHS NRSA T32GM007270]; National Institutes of Health Grant from NIAMS [AR065459]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dept. of Molecular and Cellular Biology at the University of Washington; U.S. Dept. of Defense(United States Department of Defense); National Institutes of Health Grant from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health Grant from NIAMS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported in part by National Institutes of Health Grant PHS NRSA T32GM007270 from NIGMS.; Supported in part by a grant from the Dept. of Molecular and Cellular Biology at the University of Washington.; Supported by Grant CA150370 from the U.S. Dept. of Defense and National Institutes of Health Grant AR065459 from NIAMS.; Supported by National Institutes of Health Grant DK105542.	Aggarwal-Howarth S, 2017, BIOCHEM SOC T, V45, P371, DOI 10.1042/BST20160329; Alto NM, 2002, J CELL BIOL, V158, P659, DOI 10.1083/jcb.200204081; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Caino MC, 2017, J CLIN INVEST, V127, P3755, DOI 10.1172/JCI93172; Caino MC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13730; Campello S, 2006, J EXP MED, V203, P2879, DOI 10.1084/jem.20061877; Cardone L, 2004, MOL CELL BIOL, V24, P4613, DOI 10.1128/MCB.24.11.4613-4626.2004; Carlucci A, 2008, EMBO J, V27, P1073, DOI 10.1038/emboj.2008.33; Casey T, 2009, BREAST CANCER RES TR, V114, P47, DOI 10.1007/s10549-008-9982-8; Cavalli LR, 1997, CELL GROWTH DIFFER, V8, P1189; Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200; Chiarugi P, 2016, CANCER LETT, V380, P272, DOI 10.1016/j.canlet.2015.10.027; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; Cunniff B, 2016, MOL BIOL CELL, V27, P2662, DOI 10.1091/mbc.E16-05-0286; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; DeBerardinis RJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600200; Desai SP, 2013, BIOPHYS J, V104, P2077, DOI 10.1016/j.bpj.2013.03.025; Flippo KH, 2018, J NEUROSCI, V38, P8233, DOI 10.1523/JNEUROSCI.0649-18.2018; Glaven JA, 1996, J BIOL CHEM, V271, P27374, DOI 10.1074/jbc.271.44.27374; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Gujral TS, 2014, CELL, V159, P844, DOI 10.1016/j.cell.2014.10.032; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harbeck N, 2017, LANCET, V389, P1134, DOI [10.1016/s0140-6736(16)31891-8, 10.1016/S0140-6736(16)31891-8]; Hoppins S, 2014, CURR OPIN CELL BIOL, V29, P46, DOI 10.1016/j.ceb.2014.03.005; Huang LJS, 1997, J BIOL CHEM, V272, P8057, DOI 10.1074/jbc.272.12.8057; Huang LJS, 1999, J CELL BIOL, V145, P951, DOI 10.1083/jcb.145.5.951; JOHNSON LV, 1981, J CELL BIOL, V88, P526, DOI 10.1083/jcb.88.3.526; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kim H, 2011, MOL CELL, V44, P532, DOI 10.1016/j.molcel.2011.08.045; Kjallquist U, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4021-6; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kovanich D, 2010, CHEMBIOCHEM, V11, P963, DOI 10.1002/cbic.201000058; Langeberg LK, 2015, NAT REV MOL CELL BIO, V16, P232, DOI 10.1038/nrm3966; Lawrence RT, 2015, CELL REP, V11, P630, DOI 10.1016/j.celrep.2015.03.050; Li J, 2017, ONCOGENE, V36, P4901, DOI 10.1038/onc.2017.98; LIN RY, 1995, J BIOL CHEM, V270, P27804, DOI 10.1074/jbc.270.46.27804; Liu XG, 2009, EMBO J, V28, P3074, DOI 10.1038/emboj.2009.255; Livigni A, 2006, MOL BIOL CELL, V17, P263, DOI 10.1091/mbc.e05-09-0827; Ma YL, 2008, J BIOL CHEM, V283, P11743, DOI 10.1074/jbc.M710494200; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; McAllister SS, 2014, NAT CELL BIOL, V16, P717, DOI 10.1038/ncb3015; McKenzie AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026552; Means CK, 2011, P NATL ACAD SCI USA, V108, pE1227, DOI 10.1073/pnas.1107182108; Meiri D, 2009, MOL CELL BIOL, V29, P5963, DOI 10.1128/MCB.01268-08; Merrill RA, 2014, INT J BIOCHEM CELL B, V48, P92, DOI 10.1016/j.biocel.2013.12.012; Merrill RA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000612; Mertins P, 2016, NATURE, V534, P55, DOI 10.1038/nature18003; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Noone AM, 2018, SEER CANC STAT REV 1; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Pattabiraman DR, 2016, SCIENCE, V351, P1042, DOI 10.1126/science.aad3680; Pelicano H, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0434-6; Pidoux G, 2011, EMBO J, V30, P4371, DOI 10.1038/emboj.2011.365; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Pryde KR, 2016, J CELL BIOL, V213, P163, DOI 10.1083/jcb.201509003; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108; Rinaldi L, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.241; Saris NEL, 2005, BIOCHEMISTRY-MOSCOW+, V70, P187, DOI 10.1007/s10541-005-0100-9; Sciacovelli M, 2017, FEBS J, V284, P3132, DOI 10.1111/febs.14090; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Smith FD, 2018, P NATL ACAD SCI USA, V115, pE11465, DOI 10.1073/pnas.1816614115; Smith FD, 2017, SCIENCE, V356, P1288, DOI 10.1126/science.aaj1669; Smith FD, 2013, ELIFE, V2, DOI 10.7554/eLife.01319; Smith FD, 2010, NAT CELL BIOL, V12, P1242, DOI 10.1038/ncb2130; Sotgia F, 2012, CELL CYCLE, V11, P4390, DOI 10.4161/cc.22777; Steen RL, 2000, J CELL BIOL, V150, P1251, DOI 10.1083/jcb.150.6.1251; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Vander Heiden MG, 2017, CELL, V168, DOI 10.1016/j.cell.2016.12.039; Viale A, 2015, CANCER RES, V75, P3687, DOI 10.1158/0008-5472.CAN-15-0491; Xu K, 2017, SCI REP-UK, V7, DOI 10.1038/srep41718; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhao J, 2013, ONCOGENE, V32, P4814, DOI 10.1038/onc.2012.494	74	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2019	294	9					3152	3168		10.1074/jbc.RA118.006741	http://dx.doi.org/10.1074/jbc.RA118.006741			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU0SA	30598507	hybrid, Green Published			2022-12-28	WOS:000464980100015
J	Chun, HR; Korolnek, T; Lee, CJ; Coyne, HJ; Winge, DR; Kim, BE; Petris, MJ				Chun, Haarin; Korolnek, Tamara; Lee, Chul-Jin; Coyne, H. Jerome, III; Winge, Dennis R.; Kim, Byung-Eun; Petris, Michael J.			An extracellular histidine-containing motif in the zinc transporter ZIP4 plays a role in zinc sensing and zinc-induced endocytosis in mammalian cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						metal homeostasis; endocytosis; zinc; transport; trafficking; cellular import; extracellular sensing; metal toxicity; protein trafficking; ZIP4	BIOCHEMICAL-CHARACTERIZATION; PROTEIN; MUTATIONS; SLC39A4; GENE; LOCALIZATION; FAMILY; MODEL	Zinc is an essential trace element that serves as a cofactor for enzymes in critical biochemical processes and also plays a structural role in numerous proteins. Zinc transporter ZIP4 (ZIP4) is a zinc importer required for dietary zinc uptake in the intestine and other cell types. Studies in cultured cells have reported that zinc stimulates the endocytosis of plasma membrane-localized ZIP4 protein, resulting in reduced cellular zinc uptake. Thus, zinc-regulated trafficking of ZIP4 is a key means for regulating cellular zinc homeostasis, but the underlying mechanisms are not well understood. In this study, we used mutational analysis, immunoblotting, HEK293 cells, and immunofluorescence microscopy to identify a histidine-containing motif ((HTH)-H-398) in the first extracellular loop that is required for high sensitivity to low zinc concentrations in a zinc-induced endocytic response of mouse ZIP4 (mZIP4). Moreover, using synthetic peptides with selective substitutions and truncated mZIP4 variants, we provide evidence that histidine residues in this motif coordinate a zinc ion in mZIP4 homodimers at the plasma membrane. These findings suggest that (HTH)-H-398 is an important zinc-sensing motif for eliciting high-affinity zinc-stimulated endocytosis of mZIP4 and provide insight into cellular mechanisms for regulating cellular zinc homeostasis in mammalian cells.	[Chun, Haarin; Korolnek, Tamara; Kim, Byung-Eun] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA; [Kim, Byung-Eun] Univ Maryland, Biol Sci Grad Program, College Pk, MD 20742 USA; [Lee, Chul-Jin] NICHD, Unit Struct & Chem Biol Membrane Prot, NIH, Bethesda, MD 20892 USA; [Coyne, H. Jerome, III; Winge, Dennis R.] Univ Utah, Hlth Sci Ctr, Dept Med, Salt Lake City, UT 84132 USA; [Coyne, H. Jerome, III; Winge, Dennis R.] Univ Utah, Hlth Sci Ctr, Dept Biochem, Salt Lake City, UT 84132 USA; [Petris, Michael J.] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA; [Petris, Michael J.] Univ Missouri, Dept Nutr & Exercise Physiol, Columbia, MO 65211 USA; [Petris, Michael J.] Univ Missouri, Christopher S Bond Life Sci Ctr, Columbia, MO 65211 USA; [Coyne, H. Jerome, III] Beckman Coulter, Chaska, MN 55318 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Beckman Coulter Inc.	Kim, BE (corresponding author), Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA.; Petris, MJ (corresponding author), Univ Missouri, Dept Biochem, Columbia, MO 65211 USA.	bekim@umd.edu; petrism@missouri.edu		Winge, Dennis/0000-0003-1160-1189; Korolnek, Tamara/0000-0003-2562-0831; Chun, Haarin/0000-0002-2668-6296	National Institutes of Health [DK110195, DK66333]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK110195] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK110195 (to B.-E. K.) and DK66333 (to M. J. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andrews GK, 2008, BIOCHEM SOC T, V36, P1242, DOI 10.1042/BST0361242; Antala S, 2015, J BIOL CHEM, V290, P17796, DOI 10.1074/jbc.M114.617613; Bin BH, 2011, J BIOL CHEM, V286, P40255, DOI 10.1074/jbc.M111.256784; Dufner-Beattie J, 2003, J BIOL CHEM, V278, P33474, DOI 10.1074/jbc.M305000200; Dufner-Beattie J, 2004, J BIOL CHEM, V279, P49082, DOI 10.1074/jbc.M409962200; Fukada T, 2011, METALLOMICS, V3, P662, DOI 10.1039/c1mt00011j; Fukunaka A, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.227173; Fukunaka A, 2009, J BIOL CHEM, V284, P30798, DOI 10.1074/jbc.M109.026435; Geiser J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002766; Gogada R, 2011, J BIOL CHEM, V286, P28749, DOI 10.1074/jbc.M110.202440; Huang LP, 2007, FEBS J, V274, P3986, DOI 10.1111/j.1742-4658.2007.05933.x; Ishihara K, 2006, J BIOL CHEM, V281, P17743, DOI 10.1074/jbc.M602470200; Jeong J, 2013, MOL ASPECTS MED, V34, P612, DOI 10.1016/j.mam.2012.05.011; Kambe T, 2004, CELL MOL LIFE SCI, V61, P49, DOI 10.1007/s00018-003-3148-y; Kambe T, 2009, MOL CELL BIOL, V29, P129, DOI 10.1128/MCB.00963-08; Kambe T, 2008, GENESIS, V46, P214, DOI 10.1002/dvg.20382; Kim BE, 2004, J BIOL CHEM, V279, P4523, DOI 10.1074/jbc.M310799200; Kimura T, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030336; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kury S, 2002, NAT GENET, V31, P239, DOI 10.1038/ng913; Kury S, 2016, EUR J HUM GENET, V24, DOI 10.1038/ejhg.2015.203; Kury Sebastien, 2003, Hum Mutat, V22, P337, DOI 10.1002/humu.9178; Lee J, 2002, J BIOL CHEM, V277, P4380, DOI 10.1074/jbc.M104728200; Liuzzi JP, 2004, P NATL ACAD SCI USA, V101, P14355, DOI 10.1073/pnas.0406216101; Liuzzi JP, 2009, AM J PHYSIOL-GASTR L, V296, pG517, DOI 10.1152/ajpgi.90568.2008; Mao XQ, 2007, J BIOL CHEM, V282, P6992, DOI 10.1074/jbc.M610552200; Maret W, 2009, CHEM REV, V109, P4682, DOI 10.1021/cr800556u; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Nakano A, 2003, J INVEST DERMATOL, V120, P963, DOI 10.1046/j.1523-1747.2003.12243.x; Pawa S, 2008, AM J MED SCI, V336, P430, DOI 10.1097/MAJ.0b013e31815f2c05; PRASAD AS, 1995, NUTRITION, V11, P93; Puig S, 2002, J BIOL CHEM, V277, P26021, DOI 10.1074/jbc.M202547200; Rogers EE, 2000, P NATL ACAD SCI USA, V97, P12356, DOI 10.1073/pnas.210214197; Schmitt S, 2009, HUM MUTAT, V30, P926, DOI 10.1002/humu.20988; Taylor KM, 2003, BBA-BIOMEMBRANES, V1611, P16, DOI 10.1016/S0005-2736(03)00048-8; Wang FD, 2004, J BIOL CHEM, V279, P51433, DOI 10.1074/jbc.M408361200; Wang FD, 2004, J BIOL CHEM, V279, P24631, DOI 10.1074/jbc.M400680200; Wang FD, 2004, HUM MOL GENET, V13, P563, DOI 10.1093/hmg/ddh049; Wang K, 2002, AM J HUM GENET, V71, P66, DOI 10.1086/341125; Zhang T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11979	40	11	11	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2815	2826		10.1074/jbc.RA118.005203	http://dx.doi.org/10.1074/jbc.RA118.005203			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30593504	Green Published, hybrid			2022-12-28	WOS:000459601600020
J	Levanova, N; Mattheis, C; Carson, D; To, KN; Jank, T; Frankel, G; Aktories, K; Schroeder, GN				Levanova, Nadezhda; Mattheis, Corinna; Carson, Danielle; To, Ka-Ning; Jank, Thomas; Frankel, Gad; Aktories, Klaus; Schroeder, Gunnar Neels			The Legionella effector LtpM is a new type of phosphoinositide-activated glucosyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial pathogenesis; infection; host-pathogen interaction; glycosyltransferase; protein secretion; effector; endosomal system; Legionella; phosphoinositide binding domain; type IV secretion system (T4SS)	PNEUMOPHILA EFFECTOR; LEGIONNAIRES-DISEASE; STRUCTURAL BASIS; PROTEIN DRRA; GLYCOSYLTRANSFERASE; TRAFFICKING; FAMILY; TRANSFORMATION; AUTOPHAGOSOME; EXPRESSION	Legionella pneumophila causes Legionnaires' disease, a severe form of pneumonia. L. pneumophila translocates more than 300 effectors into host cells via its Dot/Icm (Defective in organelle trafficking/Intracellular multiplication) type IV secretion system to enable its replication in target cells. Here, we studied the effector LtpM, which is encoded in a recombination hot spot in L. pneumophila Paris. We show that a C-terminal phosphoinositol 3-phosphate (PI3P)-binding domain, also found in otherwise unrelated effectors, targets LtpM to the Legionella-containing vacuole and to early and late endosomes. LtpM expression in yeast caused cytotoxicity. Sequence comparison and structural homology modeling of the N-terminal domain of LtpM uncovered a remote similarity to the glycosyltransferase (GT) toxin PaTox from the bacterium Photorhabdus asymbiotica; however, instead of the canonical DxD motif of GT-A type glycosyltransferases, essential for enzyme activity and divalent cation coordination, we found that a DxN motif is present in LtpM. Using UDP-glucose as sugar donor, we show that purified LtpM nevertheless exhibits glucohydrolase and autoglucosylation activity in vitro and demonstrate that PI3P binding activates LtpM's glucosyltransferase activity toward protein substrates. Substitution of the aspartate or the asparagine in the DxN motif abolished the activity of LtpM. Moreover, whereas all glycosyltransferase toxins and effectors identified so far depend on the presence of divalent cations, LtpM is active in their absence. Proteins containing LtpM-like GT domains are encoded in the genomes of other L. pneumophila isolates and species, suggesting that LtpM is the first member of a novel family of glycosyltransferase effectors employed to subvert hosts.	[Levanova, Nadezhda; Jank, Thomas; Aktories, Klaus] Univ Freiburg, Fac Med, Inst Expt & Clin Pharmacol & Toxicol, D-79104 Freiburg, Germany; [Mattheis, Corinna; Carson, Danielle; To, Ka-Ning; Frankel, Gad; Schroeder, Gunnar Neels] Imperial Coll London, Dept Life Sci, MRC Ctr Mol Bacteriol & Infect, London SW7 2AZ, England; [Schroeder, Gunnar Neels] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Wellcome Wolfson Inst Expt Med, Belfast BT9 7BL, Antrim, North Ireland; [To, Ka-Ning] Imperial Coll London, Dept Med, St Marys Med Sch Bldg, London W2 1PG, England	University of Freiburg; Imperial College London; Queens University Belfast; Imperial College London	Aktories, K (corresponding author), Univ Freiburg, Fac Med, Inst Expt & Clin Pharmacol & Toxicol, D-79104 Freiburg, Germany.; Schroeder, GN (corresponding author), Queens Univ Belfast, Sch Med Dent & Biomed Sci, Wellcome Wolfson Inst Expt Med, Belfast BT9 7BL, Antrim, North Ireland.	klaus.aktories@pharmakol.uni-freiburg.de; g.schroeder@qub.ac.uk	Schroeder, Gunnar Neels/AAJ-2591-2020; Aktories, Klaus/CAJ-5682-2022	Schroeder, Gunnar Neels/0000-0002-0412-7741; Aktories, Klaus/0000-0002-5397-0436; Carson, Danielle/0000-0003-1200-2022	Medical Research Council UK [MR/L018225/1, MR/R010552/1]; German Academic Exchange Service; German Research Foundation (DFG) [DFG AK6/24-1, DFG SFB746]; MRC [G1001729, MR/R010552/1, MR/P028225/1, MR/L018225/1] Funding Source: UKRI	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); German Research Foundation (DFG)(German Research Foundation (DFG)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council UK Grants MR/L018225/1 (to G. N. S., G. F., and D. C.) and MR/R010552/1 (to G. N. S.), the German Academic Exchange Service (to C. M.), and German Research Foundation (DFG) Grants DFG AK6/24-1 (to K. A.) and DFG SFB746 (to K. A. and T. J.). The authors declare that they have no conflicts of interest with the contents of this article.	Aktories K, 2017, ANNU REV MICROBIOL, V71, P281, DOI 10.1146/annurev-micro-090816-093458; Belyi Y, 2008, J BACTERIOL, V190, P3026, DOI 10.1128/JB.01798-07; Belyi Y, 2006, P NATL ACAD SCI USA, V103, P16953, DOI 10.1073/pnas.0601562103; Belyi Y, 2009, J BIOL CHEM, V284, P20167, DOI 10.1074/jbc.M109.008441; Brachmann CB, 1998, YEAST, V14, P115; Brombacher E, 2009, J BIOL CHEM, V284, P4846, DOI 10.1074/jbc.M807505200; Burstein D, 2016, NAT GENET, V48, P167, DOI 10.1038/ng.3481; Busch C, 1998, J BIOL CHEM, V273, P19566, DOI 10.1074/jbc.273.31.19566; Castonguay J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10607-4; Cavallius J, 1998, J BIOL CHEM, V273, P28752, DOI 10.1074/jbc.273.44.28752; Cazalet C, 2004, NAT GENET, V36, P1165, DOI 10.1038/ng1447; Chen DQ, 2006, MICROBIOL RES, V161, P246, DOI 10.1016/j.micres.2005.09.001; Chien MC, 2004, SCIENCE, V305, P1966, DOI 10.1126/science.1099776; Chiu CPC, 2004, NAT STRUCT MOL BIOL, V11, P163, DOI 10.1038/nsmb720; Choudhury A, 2002, J CLIN INVEST, V109, P1541, DOI 10.1172/JCI200215420; Choy A, 2012, SCIENCE, V338, P1072, DOI 10.1126/science.1227026; Clements A, 2014, CELL MICROBIOL, V16, P1693, DOI 10.1111/cmi.12319; David S, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006855; de Felipe KS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000117; de Felipe KS, 2005, J BACTERIOL, V187, P7716, DOI 10.1128/JB.187.22.7716-7726.2005; Del Campo CM, 2014, STRUCTURE, V22, P397, DOI 10.1016/j.str.2013.12.018; Dinkel H, 2016, NUCLEIC ACIDS RES, V44, pD294, DOI 10.1093/nar/gkv1291; Dolezal P, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002459; EDELSTEIN PH, 1986, J HOSP INFECT, V8, P109, DOI 10.1016/0195-6701(86)90037-X; ENGLEBERG NC, 1984, INFECT IMMUN, V44, P222, DOI 10.1128/IAI.44.2.222-227.1984; Ensminger AW, 2009, CURR OPIN MICROBIOL, V12, P67, DOI 10.1016/j.mib.2008.12.004; Fields BS, 2002, CLIN MICROBIOL REV, V15, P506, DOI 10.1128/CMR.15.3.506-526.2002; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Finsel I, 2013, CELL HOST MICROBE, V14, P38, DOI 10.1016/j.chom.2013.06.001; Folly-Klan M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003747; Franco IS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002546; GALAN JE, 1992, J BACTERIOL, V174, P4338; Gaspar AH, 2014, P NATL ACAD SCI USA, V111, P4560, DOI 10.1073/pnas.1316376111; Gomez-Valero L, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0505-0; Gomez-Valero L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-536; Haneburger I, 2014, CURR TOP MICROBIOL, V376, P155, DOI 10.1007/82_2013_341; Harding CR, 2013, INFECT IMMUN, V81, P4261, DOI 10.1128/IAI.01054-13; Heidtman M, 2009, CELL MICROBIOL, V11, P230, DOI 10.1111/j.1462-5822.2008.01249.x; Herwaldt LA, 2018, CURR OPIN INFECT DIS, V31, P325, DOI 10.1097/QCO.0000000000000468; Horenkamp FA, 2015, DEV CELL, V34, P569, DOI 10.1016/j.devcel.2015.08.010; Hovel-Miner G, 2010, J BACTERIOL, V192, P4504, DOI 10.1128/JB.00465-10; Isaac DT, 2014, FUTURE MICROBIOL, V9, P343, DOI 10.2217/fmb.13.162; Itakura E, 2010, AUTOPHAGY, V6, P764, DOI 10.4161/auto.6.6.12709; Itzen A, 2011, CELL HOST MICROBE, V10, P89, DOI 10.1016/j.chom.2011.08.002; Jank T, 2007, J BIOL CHEM, V282, P35222, DOI 10.1074/jbc.M703138200; Jank T, 2015, CELL MICROBIOL, V17, P1752, DOI 10.1111/cmi.12533; Jank T, 2013, NAT STRUCT MOL BIOL, V20, P1273, DOI 10.1038/nsmb.2688; Jank T, 2012, CELL MICROBIOL, V14, P852, DOI 10.1111/j.1462-5822.2012.01761.x; Kanai F, 2001, NAT CELL BIOL, V3, P675, DOI 10.1038/35083070; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; Luo X, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004965; Machner MP, 2006, DEV CELL, V11, P47, DOI 10.1016/j.devcel.2006.05.013; Michard C, 2015, MBIO, V6, DOI 10.1128/mBio.00354-15; Mousnier A, 2014, MBIO, V5, DOI 10.1128/mBio.01148-14; Muller MP, 2010, SCIENCE, V329, P946, DOI 10.1126/science.1192276; Murata T, 2006, NAT CELL BIOL, V8, P971, DOI 10.1038/ncb1463; Ninio S, 2007, TRENDS MICROBIOL, V15, P372, DOI 10.1016/j.tim.2007.06.006; O'Connor TJ, 2011, P NATL ACAD SCI USA, V108, P14733, DOI 10.1073/pnas.1111678108; Pak JE, 2006, J BIOL CHEM, V281, P26693, DOI 10.1074/jbc.M603534200; Pan XX, 2008, SCIENCE, V320, P1651, DOI 10.1126/science.1158160; Pham TTK, 2014, J BIOL CHEM, V289, P8041, DOI 10.1074/jbc.M113.545384; Qiu JZ, 2017, NAT REV MICROBIOL, V15, P591, DOI 10.1038/nrmicro.2017.67; Reinert DJ, 2005, J MOL BIOL, V351, P973, DOI 10.1016/j.jmb.2005.06.071; Richards AM, 2013, VIRULENCE, V4, P307, DOI 10.4161/viru.24290; Rothmeier E, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003598; ROWBOTHAM TJ, 1980, J CLIN PATHOL, V33, P1179, DOI 10.1136/jcp.33.12.1179; Schroeder GN, 2015, INFECT IMMUN, V83, P3989, DOI 10.1128/IAI.00785-15; Schroeder GN, 2010, J BACTERIOL, V192, P6001, DOI 10.1128/JB.00778-10; So EC, 2015, CAN J MICROBIOL, V61, P617, DOI 10.1139/cjm-2015-0166; Soda EA, 2017, MMWR-MORBID MORTAL W, V66, P584, DOI 10.15585/mmwr.mm6622e1; Steiner B, 2018, INT J MED MICROBIOL, V308, P49, DOI 10.1016/j.ijmm.2017.08.004; Stone BJ, 1999, J BACTERIOL, V181, P1395, DOI 10.1128/JB.181.5.1395-1402.1999; Sun QM, 2010, P NATL ACAD SCI USA, V107, P19338, DOI 10.1073/pnas.1010554107; Swanson MS, 2000, ANNU REV MICROBIOL, V54, P567, DOI 10.1146/annurev.micro.54.1.567; Tinevez JY, 2017, METHODS, V115, P80, DOI 10.1016/j.ymeth.2016.09.016; Tumbale P, 2009, J BIOL CHEM, V284, P25126, DOI 10.1074/jbc.M109.033878; Weber Stefan S., 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020046; Weber SS, 2009, CELL MICROBIOL, V11, P442, DOI 10.1111/j.1462-5822.2008.01266.x	81	8	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2862	2879		10.1074/jbc.RA118.005952	http://dx.doi.org/10.1074/jbc.RA118.005952			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30573678	Green Published, hybrid			2022-12-28	WOS:000459601600024
J	Mori, T; Koyama, N; Tan, J; Segawa, T; Maeda, M; Town, T				Mori, Takashi; Koyama, Naoki; Tan, Jun; Segawa, Tatsuya; Maeda, Masahiro; Town, Terrence			Combined treatment with the phenolics (-)-epigallocatechin-3-gallate and ferulic acid improves cognition and reduces Alzheimer-like pathology in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; flavonoid; amyloid precursor protein (APP); amyloid-beta (AB); secretase; transgenic mice; neuroinflammation; oxidative stress; nonamyloidogenic; phenol; plant; polyphenol	AMYLOID PRECURSOR PROTEIN; BETA-SECRETASE CLEAVAGE; TRANSGENIC MOUSE MODEL; LONG-TERM POTENTIATION; GREEN TEA; MEMORY DEFICITS; A-BETA; EPIGALLOCATECHIN-3-GALLATE EGCG; CEREBRAL AMYLOIDOSIS; OXIDATIVE STRESS	"Nutraceuticals" are well-tolerated natural dietary compounds with drug-like properties that make them attractive as Alzheimer's disease (AD) therapeutics. Combination therapy for AD has garnered attention following a recent National Institute on Aging mandate, but this approach has not yet been fully validated. In this report, we combined the two most promising nutraceuticals with complementary anti-amyloidogenic properties: the plant-derived phenolics (-)-epigallocatechin-3-gallate (EGCG, an alpha-secretase activator) and ferulic acid (FA, a beta-secretase modulator). We used transgenic mice expressing mutant human amyloid beta-protein precursor and presenilin 1 (APP/PS1) to model cerebral amyloidosis. At 12 months of age, we orally administered EGCG and/or FA (30 mg/kg each) or vehicle once daily for 3 months. At 15 months, combined EGCG-FA treatment reversed cognitive impairment in most tests of learning and memory, including novel object recognition and maze tasks. Moreover, EGCG- and FA-treated APP/PS1 mice exhibited amelioration of brain parenchymal and cerebral vascular beta-amyloid deposits and decreased abundance of amyloid beta-proteins compared with either EGCG or FA single treatment. Combined treatment elevated nonamyloidogenic soluble APP-alpha and alpha-secretase candidate and down-regulated amyloidogenic soluble APP-beta, beta-C-terminal APP fragment, and beta-secretase protein expression, providing evidence for a shift toward nonamyloidogenic APP processing. Additional beneficial co-treatment effects included amelioration of neuroinflammation, oxidative stress, and synaptotoxicity. Our findings offer preclinical evidence that combined treatment with EGCG and FA is a promising AD therapeutic approach.	[Mori, Takashi; Koyama, Naoki] Saitama Med Ctr & Univ, Dept Biomed Sci, 1981 Kamoda, Kawagoe, Saitama 3508550, Japan; [Mori, Takashi] Saitama Med Ctr & Univ, Dept Pathol, 1981 Kamoda, Kawagoe, Saitama 3508550, Japan; [Tan, Jun] Univ S Florida, Morsoni Coll Med, Dept Psychiat & Behav Neurosci, Rashid Lab Dev Neurobiol,Silver Child Dev Ctr, Tampa, FL 33613 USA; [Segawa, Tatsuya; Maeda, Masahiro] Immunobiol Labs Co Ltd, Fujioka, Gunma 3750005, Japan; [Town, Terrence] Univ Southern Calif, Keck Sch Med, Dept Physiol & Neurosci, Zilkha Neurogenet Inst, Los Angeles, CA 90089 USA	Saitama Medical University; Saitama Medical University; State University System of Florida; University of South Florida; Immuno-Biological Laboratories Co. Ltd.; University of Southern California	Mori, T (corresponding author), Saitama Med Ctr & Univ, Dept Biomed Sci, 1981 Kamoda, Kawagoe, Saitama 3508550, Japan.; Mori, T (corresponding author), Saitama Med Ctr & Univ, Dept Pathol, 1981 Kamoda, Kawagoe, Saitama 3508550, Japan.; Town, T (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Physiol & Neurosci, 1501 San Pablo St,Rm 337, Los Angeles, CA 90089 USA.	t_mori@saitama-med.ac.jp; ttown@usc.edu			National Institutes of Health [2R01NS076794-06A1, 1RF1AG053982-01A1, 5P01AG052350-03, 5R21AG053884-02]; Japan Society for the Promotion of Science KAKENHI [JP26430058]; Alzheimer's Association Sex and Gender in Alzheimer's disease grant (SAGA); Cure Alzheimer's Fund; Coins for Alzheimer's Research Trust; Zilkha Neurogenetic Institute of the Keck School of Medicine at the University of Southern California; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG050253, P01AG052350, R21AG053884, RF1AG053982, R21AG055116] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Alzheimer's Association Sex and Gender in Alzheimer's disease grant (SAGA); Cure Alzheimer's Fund; Coins for Alzheimer's Research Trust; Zilkha Neurogenetic Institute of the Keck School of Medicine at the University of Southern California; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants 2R01NS076794-06A1, 1RF1AG053982-01A1, 5P01AG052350-03 and 5R21AG053884-02 (to T. T.), the Japan Society for the Promotion of Science KAKENHI JP26430058 (to T. M.), an Alzheimer's Association Sex and Gender in Alzheimer's disease grant (SAGA; to T. T.), Cure Alzheimer's Fund (to T. T.), Coins for Alzheimer's Research Trust (to T. T.), and generous start-up funds from the Zilkha Neurogenetic Institute of the Keck School of Medicine at the University of Southern California (to T. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Alamed J, 2006, NAT PROTOC, V1, P1671, DOI 10.1038/nprot.2006.275; Andreasson KI, 2016, J NEUROCHEM, V138, P653, DOI 10.1111/jnc.13667; Arendash GW, 2001, BRAIN RES, V891, P42, DOI 10.1016/S0006-8993(00)03186-3; BARNES DG, 1988, REGUL TOXICOL PHARM, V8, P471, DOI 10.1016/0273-2300(88)90047-5; Bertram L, 2012, PROG MOL BIOL TRANSL, V107, P79, DOI 10.1016/B978-0-12-385883-2.00008-4; Bourne LC, 1998, BIOCHEM BIOPH RES CO, V253, P222, DOI 10.1006/bbrc.1998.9681; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; De Rosa R, 2005, P NATL ACAD SCI USA, V102, P3811, DOI 10.1073/pnas.0500195102; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; DeMattos RB, 2002, SCIENCE, V295, P2264, DOI 10.1126/science.1067568; Ellis RJ, 1996, NEUROLOGY, V46, P1592, DOI 10.1212/WNL.46.6.1592; Franklin K. B. J., 2001, MOUSE BRAIN STEREOTA; Gasperotti M, 2015, ACS CHEM NEUROSCI, V6, P1341, DOI 10.1021/acschemneuro.5b00051; Gralle M, 2009, J BIOL CHEM, V284, P15016, DOI 10.1074/jbc.M808755200; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Harnly JM, 2006, J AGR FOOD CHEM, V54, P9966, DOI 10.1021/jf061478a; Hartman RE, 2005, J NEUROSCI, V25, P6213, DOI 10.1523/JNEUROSCI.0664-05.2005; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Holcomb LA, 1999, BEHAV GENET, V29, P177, DOI 10.1023/A:1021691918517; Horikoshi Y, 2004, BIOCHEM BIOPH RES CO, V319, P733, DOI 10.1016/j.bbrc.2004.05.051; Ishida A, 1997, NEUROREPORT, V8, P2133, DOI 10.1097/00001756-199707070-00009; Jankowsky JL, 2004, NEUROBIOL AGING, V25, P885, DOI 10.1016/j.neurobiolaging.2003.09.008; Jeon SY, 2003, BIOORG MED CHEM LETT, V13, P3905, DOI 10.1016/j.bmcl.2003.09.018; Kaden D, 2008, J BIOL CHEM, V283, P7271, DOI 10.1074/jbc.M708046200; Kanski J, 2002, J NUTR BIOCHEM, V13, P273, DOI 10.1016/S0955-2863(01)00215-7; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kern SM, 2003, J AGR FOOD CHEM, V51, P6050, DOI 10.1021/jf0302299; Kim KS, 2006, J NEUROSCI RES, V83, P497, DOI 10.1002/jnr.20754; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; King DL, 1999, BEHAV BRAIN RES, V103, P145, DOI 10.1016/S0166-4328(99)00037-6; Klyubin I, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-25; Kotilinek LA, 2002, J NEUROSCI, V22, P6331; Lee MJ, 2002, CANCER EPIDEM BIOMAR, V11, P1025; Legeay S, 2015, NUTRIENTS, V7, P5443, DOI 10.3390/nu7075230; Lin LC, 2007, J AGR FOOD CHEM, V55, P1517, DOI 10.1021/jf062816a; Markesbery WR, 1997, FREE RADICAL BIO MED, V23, P134, DOI 10.1016/S0891-5849(96)00629-6; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Moore RJ, 2009, BRIT J NUTR, V102, P1790, DOI 10.1017/S0007114509991218; Mori T, 2014, J BIOL CHEM, V289, P30303, DOI 10.1074/jbc.M114.568212; Mori T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055774; Mori T, 2012, J BIOL CHEM, V287, P6912, DOI 10.1074/jbc.M111.294025; Mouri A, 2007, FASEB J, V21, P2135, DOI 10.1096/fj.06-7685com; Mufson EJ, 2016, NEUROBIOL AGING, V37, P147, DOI 10.1016/j.neurobiolaging.2015.10.012; Obregon D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1781; Obregon DF, 2006, J BIOL CHEM, V281, P16419, DOI 10.1074/jbc.M600617200; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Price JL, 2009, NEUROBIOL AGING, V30, P1026, DOI 10.1016/j.neurobiolaging.2009.04.002; Qin J, 2008, DRUG DEV IND PHARM, V34, P602, DOI [10.1080/03639040701833559, 10.1080/03639040701833559 ]; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Rezai-Zadeh K, 2005, J NEUROSCI, V25, P8807, DOI 10.1523/JNEUROSCI.1521-05.2005; Robinson JL, 2011, BRAIN, V134, P3705, DOI 10.1093/brain/awr308; Sabbagh MN, 2010, CURR ALZHEIMER RES, V7, P280, DOI 10.2174/156720510791162340; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-48; Singh NA, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0179-4; Sinha S, 1999, P NATL ACAD SCI USA, V96, P11049, DOI 10.1073/pnas.96.20.11049; Srinivasan M, 2007, J CLIN BIOCHEM NUTR, V40, P92, DOI 10.3164/jcbn.40.92; Sultana R, 2005, J NEUROCHEM, V92, P749, DOI 10.1111/j.1471-4159.2004.02899.x; Town T, 2008, NAT MED, V14, P681, DOI 10.1038/nm1781; Ullmann U, 2003, J INT MED RES, V31, P88, DOI 10.1177/147323000303100205; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Valtorta F, 2004, BIOESSAYS, V26, P445, DOI 10.1002/bies.20012; van't Slot G, 2009, J AGR FOOD CHEM, V57, P8041, DOI 10.1021/jf900458e; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; Williamson G, 2005, AM J CLIN NUTR, V81, p243S, DOI [10.1093/ajcn/81.1.230S, 10.1093/ajcn/81.1.243S]; Williamson G, 2011, MOL NUTR FOOD RES, V55, P864, DOI 10.1002/mnfr.201000631; Wu K, 2014, J ETHNOPHARMACOL, V151, P1133, DOI 10.1016/j.jep.2013.12.027; Xia WM, 2009, ARCH NEUROL-CHICAGO, V66, P190, DOI 10.1001/archneurol.2008.565; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yang C, 2007, J PHARMACEUT BIOMED, V43, P945, DOI 10.1016/j.jpba.2006.09.027; Young-Pearse TL, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-15; Zhao ZH, 2004, J NUTR, V134, P3083, DOI 10.1093/jn/134.11.3083; Zhao ZH, 2008, FOOD CHEM, V109, P691, DOI 10.1016/j.foodchem.2008.02.039	81	43	44	3	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2714	2731		10.1074/jbc.RA118.004280	http://dx.doi.org/10.1074/jbc.RA118.004280			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30563837	hybrid, Green Published			2022-12-28	WOS:000459601600013
J	You, YY; Chen, JL; Zhu, FM; Xu, Q; Han, L; Gao, X; Zhang, XY; Luo, HBR; Miao, JM; Sun, XD; Ren, HY; Du, Y; Guo, LJ; Wang, XY; Wang, Y; Chen, SZ; Huang, N; Li, JY				You, Yuanyuan; Chen, Junli; Zhu, Feimei; Xu, Qian; Han, Lu; Gao, Xiang; Zhang, Xiaoyu; Luo, Hongbo R.; Miao, Junming; Sun, Xiaodong; Ren, Hongyu; Du, Yu; Guo, Lijuan; Wang, Xiaoying; Wang, Yi; Chen, Shanze; Huang, Ning; Li, Jingyu			Glutaredoxin 1 up-regulates deglutathionylation of alpha 4 integrin and thereby restricts neutrophil mobilization from bone marrow	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glutathionylation; reactive oxygen species (ROS); integrin; neutrophil; inflammation; alpha 4 integrin; glutaredoxin; immune response; neutrophil mobilization; vascular cell adhesion molecular 1 (VCAM-1)	PROTEIN S-GLUTATHIONYLATION; REACTIVE OXYGEN; PLASMA GLUTAREDOXIN; LIGAND-BINDING; CELLS; ADHESION; VLA-4; INFLAMMATION; THIOREDOXIN; RECRUITMENT	alpha 4 integrin plays a crucial role in retention and release of neutrophils from bone marrow. Although alpha 4 integrin is known to be a potential target of reactive oxygen species (ROS)-induced cysteine glutathionylation, the physiological significance and underlying regulatory mechanism of this event remain elusive. Here, using in vitro and in vivo biochemical and cell biology approaches, we show that physiological ROS-induced glutathionylation of alpha 4 integrin in neutrophils increases the binding of neutrophil-associated alpha 4 integrin to vascular cell adhesion molecule 1 (VCAM-1) on human endothelial cells. This enhanced binding was reversed by extracellular glutaredoxin 1 (Grx1), a thiol disulfide oxidoreductase promoting protein deglutathionylation. Furthermore, in a murine inflammation model, Grx1 disruption dramatically elevated alpha 4 glutathionylation and subsequently enhanced neutrophil egress from the bone marrow. Corroborating this observation, intravenous injection of recombinant Grx1 into mice inhibited alpha 4 glutathionylation and thereby suppressed inflammation-induced neutrophil mobilization from the bone marrow. Taken together, our results establish ROS-elicited glutathionylation and its modulation by Grx1 as pivotal regulatory mechanisms controlling alpha 4 integrin affinity and neutrophil mobilization from the bone marrow under physiological conditions.	[You, Yuanyuan; Chen, Junli; Zhu, Feimei; Xu, Qian; Miao, Junming; Ren, Hongyu; Du, Yu; Guo, Lijuan; Wang, Xiaoying; Wang, Yi; Chen, Shanze; Huang, Ning; Li, Jingyu] Sichuan Univ, West China Sch Basic Med Sci & Forens Med, Dept Pathophysiol, Chengdu 610041, Sichuan, Peoples R China; [Sun, Xiaodong] Sichuan Univ, West China Sch Basic Med Sci & Forens Med, Dept Pharmacol, Chengdu 610041, Sichuan, Peoples R China; [Han, Lu; Gao, Xiang] Sichuan Univ, Collaborat Innovat Ctr Biotherapy, State Key Lab Biotherapy, Chengdu 610041, Sichuan, Peoples R China; [Han, Lu; Gao, Xiang] Sichuan Univ, Collaborat Innovat Ctr Biotherapy, Canc Ctr, Chengdu 610041, Sichuan, Peoples R China; [Zhang, Xiaoyu] Chinese Acad Med Sci, Inst Hematol & Blood Dis Hosp, State Key Lab Expt Hematol, Tianjin 300020, Peoples R China; [Zhang, Xiaoyu] Peking Union Med Coll, Tianjin 300020, Peoples R China; [Luo, Hongbo R.] Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA; [Luo, Hongbo R.] Childrens Hosp Boston, Dept Lab Med, Boston, MA 02115 USA; [Luo, Hongbo R.] Dana Farber Harvard Canc Ctr, Boston, MA 02115 USA	Sichuan University; Sichuan University; Sichuan University; Sichuan University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute	Huang, N; Li, JY (corresponding author), Sichuan Univ, West China Sch Basic Med Sci & Forens Med, Dept Pathophysiol, Chengdu 610041, Sichuan, Peoples R China.	ninghuang2018@163.com; jingyuli@scu.edu.cn	Zhang, xiaoyu/GXA-3206-2022; Li, Jingyu/GSD-1924-2022; Li, Jing/GYU-5036-2022		National Science Foundation of China [81803648, 81770580, 31701098, 81803183, 81470931, 31401188]; Sichuan University [2018SCUH0039, 2014ASCU11042]; Applied Basic Research Program of Sichuan Province [2016JY0027]; Science Foundation for Excellent Youth Scholars of Sichuan University [2016SCU04A08]; Sichuan Association for Science and Technology [2018RCTJ04]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sichuan University(Sichuan University); Applied Basic Research Program of Sichuan Province; Science Foundation for Excellent Youth Scholars of Sichuan University; Sichuan Association for Science and Technology	Supported by National Science Foundation of China Grant 81803648 and Sichuan University Grant 2018SCUH0039.; Supported by National Science Foundation of China Grant 81770580.; Supported by Applied Basic Research Program of Sichuan Province Grant 2016JY0027.; Supported by National Science Foundation of China Grant 31701098.; Supported by Grant National Science Foundation of China 81803183.; Supported by National Science Foundation of China Grant 81470931.; Supported by National Science Foundation of China Grant 31401188, Science Foundation for Excellent Youth Scholars of Sichuan University Grant 2016SCU04A08, Sichuan Association for Science and Technology 2018RCTJ04, and Sichuan University Grant 2014ASCU11042.	Anathy V, 2018, NAT MED, V24, P1128, DOI 10.1038/s41591-018-0090-y; Bajrami B, 2016, J EXP MED, V213, P1999, DOI 10.1084/jem.20160393; BOCHNER BS, 1991, J EXP MED, V173, P1553, DOI 10.1084/jem.173.6.1553; Burdon PCE, 2005, BLOOD, V105, P2543, DOI 10.1182/blood-2004-08-3193; Chen CA, 2010, NATURE, V468, P1115, DOI 10.1038/nature09599; Chrestensen CA, 2000, J BIOL CHEM, V275, P26556, DOI 10.1074/jbc.M004097200; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; Du YT, 2014, ACTA DIABETOL, V51, P225, DOI 10.1007/s00592-013-0498-2; Eash KJ, 2010, J CLIN INVEST, V120, P2423, DOI 10.1172/JCI41649; Fernandes AP, 2004, ANTIOXID REDOX SIGN, V6, P63, DOI 10.1089/152308604771978354; Giganti D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02528-7; Harp JA, 2005, VET IMMUNOL IMMUNOP, V104, P99, DOI 10.1016/j.vetimm.2004.10.007; HOLMGREN A, 1976, P NATL ACAD SCI USA, V73, P2275, DOI 10.1073/pnas.73.7.2275; Hyun YM, 2017, J LEUKOCYTE BIOL, V102, P617, DOI 10.1189/jlb.1RU1216-521R; Ibbotson GC, 2001, NAT MED, V7, P465, DOI 10.1038/86539; Kirveskari J, 2000, J LEUKOCYTE BIOL, V68, P243; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kuipers I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038984; Laragione T, 2003, P NATL ACAD SCI USA, V100, P14737, DOI 10.1073/pnas.2434516100; Lillig CH, 2008, BBA-GEN SUBJECTS, V1780, P1304, DOI 10.1016/j.bbagen.2008.06.003; Liu SY, 2008, EUR J IMMUNOL, V38, P410, DOI 10.1002/eji.200737556; Miller OG, 2019, ANTIOXID REDOX SIGN, V30, P1352, DOI 10.1089/ars.2017.7411; Nakamura H, 1998, FREE RADICAL BIO MED, V24, P1176, DOI 10.1016/S0891-5849(97)00429-2; Papayannopoulou T, 2001, BLOOD, V98, P2403, DOI 10.1182/blood.V98.8.2403; Pastore A, 2012, EUR J PHARM SCI, V46, P279, DOI 10.1016/j.ejps.2012.03.010; Peltoniemi MJ, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-133; Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813; Petty JM, 2009, J IMMUNOL, V182, P604, DOI 10.4049/jimmunol.182.1.604; Popov D, 2014, ARCH PHYSIOL BIOCHEM, V120, P123, DOI 10.3109/13813455.2014.944544; Pujades C, 1996, BIOCHEM J, V313, P899, DOI 10.1042/bj3130899; Rettig MP, 2012, LEUKEMIA, V26, P34, DOI 10.1038/leu.2011.197; Richter R, 2017, TRANSFUS MED HEMOTH, V44, P151, DOI 10.1159/000477262; Rose DM, 2002, IMMUNOL REV, V186, P118, DOI 10.1034/j.1600-065X.2002.18611.x; Sadik CD, 2011, TRENDS IMMUNOL, V32, P452, DOI 10.1016/j.it.2011.06.008; Sakai J, 2012, IMMUNITY, V37, P1037, DOI 10.1016/j.immuni.2012.08.017; Sevilla F, 2015, J EXP BOT, V66, P2945, DOI 10.1093/jxb/erv146; Shelton MD, 2008, MOL CELLS, V25, P332; Shimizu Y, 1999, ADV IMMUNOL, V72, P325, DOI 10.1016/S0065-2776(08)60024-3; Stojkov D, 2017, J CELL BIOL, V216, P4073, DOI 10.1083/jcb.201611168; Tafani M, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3907147; TAKADA Y, 1989, EMBO J, V8, P1361, DOI 10.1002/j.1460-2075.1989.tb03516.x; THOMAS JA, 1995, METHOD ENZYMOL, V251, P423, DOI 10.1016/0076-6879(95)51145-8; Tseng A, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00134; Ullevig S, 2012, ARTERIOSCL THROM VAS, V32, P415, DOI 10.1161/ATVBAHA.111.238899; Valcarcell M, 2014, J INVEST DERMATOL, V134, P470, DOI 10.1038/jid.2013.342; Yang XL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17070979; Yu YM, 2013, J BIOL CHEM, V288, P32314, DOI 10.1074/jbc.M113.501668; Yuan Y, 2013, RADIAT RES, V179, P62, DOI 10.1667/RR3119.1; Zhang X, 2017, CELL REP, V20, P224, DOI 10.1016/j.celrep.2017.05.070; Zhao ED, 2012, CELL MOL IMMUNOL, V9, P11, DOI 10.1038/cmi.2011.47; Zhu HY, 2017, J IMMUNOL, V198, P2854, DOI 10.4049/jimmunol.1602006	51	12	12	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2616	2627		10.1074/jbc.RA118.006096	http://dx.doi.org/10.1074/jbc.RA118.006096			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30598505	hybrid, Green Published			2022-12-28	WOS:000459601600005
J	Piccirillo, AR; Cattley, RT; D'Cruz, LM; Hawse, WF				Piccirillo, Ann R.; Cattley, Richard T.; D'Cruz, Louise M.; Hawse, William F.			Histone acetyltransferase CBP is critical for conventional effector and memory T-cell differentiation in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						T-cell; T-cell receptor (TCR); Janus kinase (JAK); infection; differentiation; cytokine; histone; acetyllysine; bromo domain; CREB binding protein; signal transduction; CD8(+) T cell; memory T cell; proteomics; kinase signaling; Jak2; immune response; adaptive immunity	NAIVE; PHENOTYPE; SURVIVAL; INTERLEUKIN-15; PROLIFERATION; MATURATION; RECALL; IL-10	Compared with naive T cells, memory CD8(+) T cells have a transcriptional landscape and proteome that are optimized to generate a more rapid and robust response to secondary infection. Additionally, rewired kinase signal transduction pathways likely contribute to the superior recall response of memory CD8(+) T cells, but this idea has not been experimentally confirmed. Herein, we utilized an MS approach to identify proteins that are phosphorylated on tyrosine residues in response to Listeria-induced T-cell receptor (TCR) stimulation in both naive and memory CD8(+) T cells from mice and separated by fluorescence- and flow cytometry-based cell sorting. This analysis identified substantial differences in tyrosine kinase signaling networks between naive and memory CD8(+) T cells. We also observed that an important axis in memory CD8(+) T cells couples Janus kinase 2 (JAK2) hyperactivation to the phosphorylation of CREB-binding protein (CBP). Functionally, JAK2-catalyzed phosphorylation enabled CBP to bind with higher affinity to acetylated histone peptides, indicating a potential epigenetic mechanism that could contribute to rapid initiation of transcriptional programs in memory CD8(+) T cells. Moreover, we found that CBP itself is essential for conventional effector and memory CD8(+) T-cell formation. These results indicate how signaling pathways are altered to promote CD8(+) memory cell formation and rapid responses to and protection from repeat infections.	[Piccirillo, Ann R.; Cattley, Richard T.; D'Cruz, Louise M.; Hawse, William F.] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	D'Cruz, LM; Hawse, WF (corresponding author), Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15213 USA.	ldcruz@pitt.edu; whawse@pitt.edu			National Institutes of Health [R21AI135406]; University of Pittsburgh; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI135406] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pittsburgh(University of Pittsburgh); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant R21AI135406 (to L. M. D. and W. F. H.) and seed funding from the University of Pittsburgh (to W. F. H. and L. M. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bachmann MF, 1999, J EXP MED, V189, P1521, DOI 10.1084/jem.189.10.1521; Becker TC, 2002, J EXP MED, V195, P1541, DOI 10.1084/jem.20020369; Castellino F, 2007, J IMMUNOL, V178, P778, DOI 10.4049/jimmunol.178.2.778; Chandok MR, 2007, J IMMUNOL, V179, P3689, DOI 10.4049/jimmunol.179.6.3689; Cho JH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13373; Cui WG, 2011, IMMUNITY, V35, P792, DOI 10.1016/j.immuni.2011.09.017; Falvo JV, 2000, P NATL ACAD SCI USA, V97, P3925, DOI 10.1073/pnas.97.8.3925; Farber DL, 2009, SEMIN IMMUNOL, V21, P84, DOI 10.1016/j.smim.2009.02.003; Feng J, 1997, MOL CELL BIOL, V17, P2497, DOI 10.1128/MCB.17.5.2497; Foulds KE, 2006, J IMMUNOL, V177, P2565, DOI 10.4049/jimmunol.177.4.2565; Fukuyama T, 2009, MOL CELL BIOL, V29, P3894, DOI 10.1128/MCB.01598-08; Goldrath AW, 2002, J EXP MED, V195, P1515, DOI 10.1084/jem.20020033; Judge AD, 2002, J EXP MED, V196, P935, DOI 10.1084/jem.20020772; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Kasper LH, 2006, MOL CELL BIOL, V26, P789, DOI 10.1128/MCB.26.3.789-809.2006; Kersh EN, 2003, J IMMUNOL, V170, P5455, DOI 10.4049/jimmunol.170.11.5455; Kouskouti A, 2005, EMBO J, V24, P347, DOI 10.1038/sj.emboj.7600516; Laidlaw BJ, 2015, NAT IMMUNOL, V16, P871, DOI 10.1038/ni.3224; Lee YJ, 2011, TRENDS IMMUNOL, V32, P50, DOI 10.1016/j.it.2010.12.004; Nish SA, 2014, ELIFE, V3, DOI 10.7554/eLife.01949; Pihlgren M, 1996, J EXP MED, V184, P2141, DOI 10.1084/jem.184.6.2141; Raeber ME, 2018, IMMUNOL REV, V283, P176, DOI 10.1111/imr.12644; Rathmell JC, 2001, J IMMUNOL, V167, P6869, DOI 10.4049/jimmunol.167.12.6869; Rolf J, 2013, EUR J IMMUNOL, V43, P889, DOI 10.1002/eji.201243008; Ruby CE, 2007, EUR J IMMUNOL, V37, P157, DOI 10.1002/eji.200636428; Sen N, 2008, NAT CELL BIOL, V10, P866, DOI 10.1038/ncb1747; Sosinowski T, 2013, J IMMUNOL, V190, P1936, DOI 10.4049/jimmunol.1203149; Sprent J, 2011, NAT IMMUNOL, V12, P478, DOI 10.1038/ni.2018; Vig M, 2004, J CLIN INVEST, V113, P1734, DOI 10.1172/JCI200420225; Weinreich MA, 2010, NAT IMMUNOL, V11, P709, DOI 10.1038/ni.1898; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Zeng L, 2008, STRUCTURE, V16, P643, DOI 10.1016/j.str.2008.01.010	32	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2019	294	7					2397	2406		10.1074/jbc.RA118.006977	http://dx.doi.org/10.1074/jbc.RA118.006977			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL7CN	30573679	Green Published, hybrid			2022-12-28	WOS:000458895400017
J	Tillander, V; Miniami, A; Alves-Bezerra, M; Coleman, RA; Cohen, DE				Tillander, Veronika; Miniami, Akihiro; Alves-Bezerra, Michele; Coleman, Rosalind A.; Cohen, David E.			Thioesterase superfamily member 2 promotes hepatic insulin resistance in the setting of glycerol-3-phosphate acyltransferase 1-induced steatosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						diacylglycerol; fatty acid; fatty acid metabolism; insulin resistance; liver; triacylglycerol	FATTY-ACID OXIDATION; PROTEIN-KINASE-C; TRIACYLGLYCEROL SYNTHESIS; LIVER; OVEREXPRESSION; PHOSPHORYLATION; THERMOGENESIS; HEPATOCYTES; RATS	Hepatic insulin resistance in the setting of steatosis is attributable at least in part to the accumulation of bioactive lipids that suppress insulin signaling. The mitochondria-associated glycerol-3-phosphate acyltransferase 1 (GPAT1) catalyzes the first committed step in glycerolipid synthesis, and its activity diverts fatty acids from mitochondrial -oxidation. GPAT1 overexpression in mouse liver leads to hepatic steatosis even in the absence of overnutrition. The mice develop insulin resistance owing to the generation of saturated diacylglycerol and phosphatidic acid molecular species that reduce insulin signaling by activating PKCE and by suppressing mTORC2, respectively. Them2, a mitochondria-associated acyl-CoA thioesterase, also participates in the trafficking of fatty acids into oxidative versus glycerolipid biosynthetic pathways. Them2(-/-) mice are protected against diet-induced hepatic steatosis and insulin resistance. To determine whether Them2 contributes to hepatic insulin resistance due to hepatic overexpression of GPAT1, recombinant adenovirus was used to overexpress GPAT1 in livers of chow-fed Them2(+/+) and Them2(-/-) mice. Hepatic GPAT1 overexpression led to steatosis in both genotypes. In the setting of GPAT1 overexpression, glucose tolerance was reduced in Them2(+/+) but not Them2(-/-) mice, without influencing whole-body insulin sensitivity or basal hepatic glucose production. Improved glucose tolerance in Them2(-/-) mice was associated with reduced PKCE translocation. Preserved insulin receptor activity was supported by Thr-308 phosphorylation of Akt following GPAT1 overexpression in Them2(-/-) hepatocytes. These findings suggest a pathogenic role of Them2 in the biosynthesis of glycerolipid metabolites that promote hepatic insulin resistance.	[Tillander, Veronika; Miniami, Akihiro; Alves-Bezerra, Michele; Cohen, David E.] Weill Cornell Med Coll, Joan & Sanford I Weill Dept Med, New York, NY 10021 USA; [Tillander, Veronika] Karolinska Inst, Dept Lab Med, Div Clin Chem, S-14152 Huddinge, Sweden; [Miniami, Akihiro] Kobe Univ, Grad Sch Med, Dept Gastroenterol, Kobe, Hyogo 6500017, Japan; [Coleman, Rosalind A.] Univ N Carolina, Dept Nutr, Chapel Hill, NC 27599 USA	Cornell University; Karolinska Institutet; Kobe University; University of North Carolina; University of North Carolina Chapel Hill	Cohen, DE (corresponding author), Belfer Res Bldg,413 E 69th St,Rm 630, New York, NY 10021 USA.	dcohen@med.cornell.edu	Alves-Bezerra, Michele/B-4662-2014; Alves-Bezerra, Michele/AAJ-8017-2021	Alves-Bezerra, Michele/0000-0003-4430-6434; Alves-Bezerra, Michele/0000-0003-4430-6434; Coleman, Rosalind/0000-0003-4379-3824	NIDDK, National Institutes of Health [R37 DK048873, R01 DK056626, R01 DK56598]; Swedish Society for Medical Research (SSMF) Postdoctoral Research Fellowship [201525]; American Heart Association Postdoctoral Fellowship [18POST33990445]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056598, R37DK048873, R01DK056626] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Swedish Society for Medical Research (SSMF) Postdoctoral Research Fellowship; American Heart Association Postdoctoral Fellowship(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIDDK, National Institutes of Health, Grants R37 DK048873 and R01 DK056626 (to D.E.C.) and R01 DK56598 (to R.A.C.), the Swedish Society for Medical Research (SSMF) Postdoctoral Research Fellowship 201525 (to V.T.), and American Heart Association Postdoctoral Fellowship 18POST33990445 (to M.A.-B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agouni A, 2010, BIOCHEM BIOPH RES CO, V401, P104, DOI 10.1016/j.bbrc.2010.09.018; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cheng ZJ, 2006, BIOCHEM BIOPH RES CO, V349, P172, DOI 10.1016/j.bbrc.2006.08.025; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Cooper DE, 2015, J BIOL CHEM, V290, P20023, DOI 10.1074/jbc.R115.663260; Ersoy BA, 2018, J CLIN INVEST, V128, P141, DOI 10.1172/JCI93123; Ersoy BA, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004111; FOLCH J, 1957, J BIOL CHEM, V226, P497; Hammond LE, 2005, J BIOL CHEM, V280, P25629, DOI 10.1074/jbc.M503181200; Han SX, 2012, J LIPID RES, V53, P2620, DOI 10.1194/jlr.M029538; Hutchins PM, 2008, J LIPID RES, V49, P804, DOI 10.1194/jlr.M700521-JLR200; Kang HW, 2013, J BIOL CHEM, V288, P33376, DOI 10.1074/jbc.M113.481408; Kang HW, 2012, FASEB J, V26, P2209, DOI 10.1096/fj.11-202853; Kawano Y, 2014, MOL CELL BIOL, V34, P2396, DOI 10.1128/MCB.01601-13; Leiker TJ, 2011, INT J MASS SPECTROM, V305, P103, DOI 10.1016/j.ijms.2010.09.008; Lewin TM, 2005, AM J PHYSIOL-ENDOC M, V288, pE835, DOI 10.1152/ajpendo.00300.2004; Linden D, 2004, J LIPID RES, V45, P1279, DOI 10.1194/jlr.M400010-JLR200; Linden D, 2006, FASEB J, V20, P434, DOI 10.1096/fj.05-4568com; MONROY G, 1972, J BIOL CHEM, V247, P6884; Nagle CA, 2007, J BIOL CHEM, V282, P14807, DOI 10.1074/jbc.M611550200; Neschen S, 2005, CELL METAB, V2, P55, DOI 10.1016/j.cmet.2005.06.006; Neuschwander-Tetri BA, 2010, HEPATOLOGY, V52, P774, DOI 10.1002/hep.23719; Okada K, 2016, MOL METAB, V5, P340, DOI 10.1016/j.molmet.2016.02.002; Petersen MC, 2017, TRENDS PHARMACOL SCI, V38, P649, DOI 10.1016/j.tips.2017.04.004; Petersen MC, 2016, J CLIN INVEST, V126, P4361, DOI 10.1172/JCI86013; Qu X, 1999, J ENDOCRINOL, V162, P207, DOI 10.1677/joe.0.1620207; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; SCHLOSSMAN DM, 1976, J BIOL CHEM, V251, P5738; ter Horst KW, 2017, CELL REP, V19, P1997, DOI 10.1016/j.celrep.2017.05.035; Tillander V, 2017, TRENDS ENDOCRIN MET, V28, P473, DOI 10.1016/j.tem.2017.03.001; Wei J, 2009, BIOCHEM J, V421, P311, DOI 10.1042/BJ20090039; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Zhang CB, 2015, J BIOL CHEM, V290, P3519, DOI 10.1074/jbc.M114.602789; Zhang CB, 2012, P NATL ACAD SCI USA, V109, P1667, DOI 10.1073/pnas.1110730109	34	5	5	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2019	294	6					2009	2020		10.1074/jbc.RA118.005184	http://dx.doi.org/10.1074/jbc.RA118.005184			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM8EO	30523156	Green Published, hybrid			2022-12-28	WOS:000459711400020
J	Bittova, L; Jedlicka, P; Dracinsky, M; Kirubakaran, P; Vondrasek, J; Hanus, R; Jindra, M				Bittova, Lenka; Jedlicka, Pavel; Dracinsky, Martin; Kirubakaran, Palani; Vondrasek, Jiri; Hanus, Robert; Jindra, Marek			Exquisite ligand stereoselectivity of a Drosophila juvenile hormone receptor contrasts with its broad agonist repertoire	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						juvenile hormone (JH); hormone receptor; insect; Drosophila; basic helix-loop-helix transcription factor (bHLH); ligand-binding protein; stereoselectivity; development; reproduction	KRUPPEL HOMOLOG 1; METHOPRENE-TOLERANT; BINDING-PROTEIN; ABSOLUTE-CONFIGURATION; LIQUID-CHROMATOGRAPHY; METHYL FARNESOATE; MANDUCA-SEXTA; IN-VITRO; HEMOLYMPH; METAMORPHOSIS	The sesquiterpenoid juvenile hormone (JH) is vital to insect development and reproduction. Intracellular JH receptors have recently been established as basic helix-loop-helix transcription factor (bHLH)/PAS proteins in Drosophila melanogaster known as germ cell-expressed (Gce) and its duplicate paralog, methoprene-tolerant (Met). Upon binding JH, Gce/Met activates its target genes. Insects possess multiple native JH homologs whose molecular activities remain unexplored, and diverse synthetic compounds including insecticides exert JH-like effects. How the JH receptor recognizes its ligands is unknown. To determine which structural features define an active JH receptor agonist, we tested several native JHs and their nonnative geometric and optical isomers for the ability to bind the Drosophila JH receptor Gce, to induce Gce-dependent transcription, and to affect the development of the fly. Our results revealed high ligand stereoselectivity of the receptor. The geometry of the JH skeleton, dictated by two stereogenic double bonds, was the most critical feature followed by the presence of an epoxide moiety at a terminal position. The optical isomerism at carbon C11 proved less important even though Gce preferentially bound a natural JH enantiomer. The results of receptor-ligand-binding and cell-based gene activation assays tightly correlated with the ability of different geometric JH isomers to induce gene expression and morphogenetic effects in the developing insects. Molecular modeling supported the requirement for the proper double-bond geometry of JH, which appears to be its major selective mechanism. The strict stereoselectivity of Gce toward the natural hormone contrasts with the high potency of synthetic Gce agonists of disparate chemistries.	[Bittova, Lenka; Jindra, Marek] Czech Acad Sci, Biol Ctr, Inst Entomol, Ceske Budejovice 37005, Czech Republic; [Jedlicka, Pavel; Dracinsky, Martin; Kirubakaran, Palani; Vondrasek, Jiri; Hanus, Robert] Czech Acad Sci, Inst Organ Chem & Biochem, Flemingovo Nam 2, Prague 16610, Czech Republic	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences	Hanus, R (corresponding author), Czech Acad Sci, Inst Organ Chem & Biochem, Flemingovo Nam 2, Prague 16610, Czech Republic.; Jindra, M (corresponding author), Czech Acad Sci, Biol Ctr, Branisovska 31, Ceske Budejovice 37005, Czech Republic.	robert.hanus@uochb.cas.cz; jindra@entu.cas.cz	Jindra, Marek/H-2082-2014; Hanus, Robert/D-4765-2013; Palani, Kirubakaran/H-5173-2012; Bittova, Lenka/K-4375-2015	Jindra, Marek/0000-0002-2196-9924; Hanus, Robert/0000-0002-7054-1975; Palani, Kirubakaran/0000-0002-9749-729X; Bittova, Lenka/0000-0002-3556-5234	Czech Science Foundation [15-23681S]; European Commission H2020-MSCA-IF Program Project [708832]; Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences [RVO 61388963]	Czech Science Foundation(Grant Agency of the Czech Republic); European Commission H2020-MSCA-IF Program Project; Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences	This work was supported by Czech Science Foundation Project 15-23681S (to M.J.), European Commission H2020-MSCA-IF Program Project 708832 (to L.B.), and Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences Project RVO 61388963. The authors declare that they have no conflicts of interest with the contents of this article.	[Anonymous], 2017, MOL OP ENV MOE 2013; [Anonymous], 2014, LIGPREP VERS 3 2; Ashok M, 1998, P NATL ACAD SCI USA, V95, P2761, DOI 10.1073/pnas.95.6.2761; Charles JP, 2011, P NATL ACAD SCI USA, V108, P21128, DOI 10.1073/pnas.1116123109; CUSSON M, 1991, INSECT BIOCHEM, V21, P1, DOI 10.1016/0020-1790(91)90058-M; DAHM KH, 1968, LIFE SCI PT 1 PHYSI, V7, P129; Daimon T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002486; Denison Michael S., 2017, Current Opinion in Toxicology, V2, P124, DOI 10.1016/j.cotox.2017.01.006; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; GOODMAN W, 1978, P NATL ACAD SCI USA, V75, P185, DOI 10.1073/pnas.75.1.185; Goodman W.G., 2012, INSECT ENDOCRINOLOGY, P310, DOI DOI 10.1016/B978-0-12-384749-2.10008-1; Graham LD, 2007, INSECT BIOCHEM MOLEC, V37, P611, DOI 10.1016/j.ibmb.2007.03.006; Harshman LG, 2010, J INSECT PHYSIOL, V56, P1465, DOI 10.1016/j.jinsphys.2010.06.003; He QY, 2014, J BIOL CHEM, V289, P27874, DOI 10.1074/jbc.M114.582825; Helvig C, 2004, P NATL ACAD SCI USA, V101, P4024, DOI 10.1073/pnas.0306980101; Hill RJ, 2013, ANNU REV ENTOMOL, V58, P251, DOI 10.1146/annurev-ento-120811-153610; Ichikawa A, 2007, J CHROMATOGR A, V1161, P252, DOI 10.1016/j.chroma.2007.06.003; Jindra M, 2015, CURR OPIN INSECT SCI, V11, P39, DOI 10.1016/j.cois.2015.08.004; Jindra M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005394; Jindra M, 2013, ANNU REV ENTOMOL, V58, P181, DOI 10.1146/annurev-ento-120811-153700; Jones D, 2013, GEN COMP ENDOCR, V194, P326, DOI 10.1016/j.ygcen.2013.09.021; Jones G, 2013, GEN COMP ENDOCR, V182, P73, DOI 10.1016/j.ygcen.2012.11.009; JUDY KJ, 1973, P NATL ACAD SCI USA, V70, P1509, DOI 10.1073/pnas.70.5.1509; Kayukawa T, 2016, J BIOL CHEM, V291, P1751, DOI 10.1074/jbc.M115.686121; Kayukawa T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01570; Kayukawa T, 2012, P NATL ACAD SCI USA, V109, P11729, DOI 10.1073/pnas.1204951109; Kewley RJ, 2004, INT J BIOCHEM CELL B, V36, P189, DOI 10.1016/S1357-2725(03)00211-5; Kim IH, 2017, J BIOL CHEM, V292, P15329, DOI [10.1074/jbc.M117.802009, 10.1074/jbc.m117.802009]; KOELLE MR, 1991, CELL, V67, P59, DOI 10.1016/0092-8674(91)90572-G; Kolodziejczyk R, 2008, J MOL BIOL, V377, P870, DOI 10.1016/j.jmb.2008.01.026; Konopova B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028728; Kotaki T, 2009, ORG LETT, V11, P5234, DOI 10.1021/ol902161x; Li M, 2014, MOL CELL ENDOCRINOL, V394, P47, DOI 10.1016/j.mce.2014.06.021; Li M, 2011, P NATL ACAD SCI USA, V108, P638, DOI 10.1073/pnas.1013914108; Lozano J, 2011, SCI REP-UK, V1, DOI 10.1038/srep00163; MEYER AS, 1971, P NATL ACAD SCI USA, V68, P2312, DOI 10.1073/pnas.68.9.2312; Minakuchi C, 2009, DEV BIOL, V325, P341, DOI 10.1016/j.ydbio.2008.10.016; Minakuchi C, 2008, MECH DEVELOP, V125, P91, DOI 10.1016/j.mod.2007.10.002; Miura K, 2005, FEBS J, V272, P1169, DOI 10.1111/j.1742-4658.2005.04552.x; Miyakawa H, 2017, J APPL TOXICOL, V37, P1082, DOI 10.1002/jat.3459; OZYHAR A, 1987, EUR J BIOCHEM, V162, P675, DOI 10.1111/j.1432-1033.1987.tb10690.x; PETERSON RC, 1977, BIOCHEMISTRY-US, V16, P2305, DOI 10.1021/bi00629a040; Pfiffner A., 1971, ASPECTS TERPENOID CH, P95; PRESTWICH GD, 1987, INSECT BIOCHEM, V17, P551, DOI 10.1016/0020-1790(87)90054-0; PRESTWICH GD, 1985, P NATL ACAD SCI USA, V82, P5290, DOI 10.1073/pnas.82.16.5290; Ramaseshadri P, 2012, ADV INSECT PHYSIOL, V43, P353, DOI 10.1016/B978-0-12-391500-9.00005-X; RICHARD DS, 1989, P NATL ACAD SCI USA, V86, P1421, DOI 10.1073/pnas.86.4.1421; RIDDIFORD LM, 1991, GEN COMP ENDOCR, V82, P172, DOI 10.1016/0016-6480(91)90181-5; Roller H, 1968, Recent Prog Horm Res, V24, P651; Romanuk M., 1974, P194; Roy S, 2018, ANNU REV ENTOMOL, V63, P489, DOI 10.1146/annurev-ento-020117-043258; Saha TT, 2016, P NATL ACAD SCI USA, V113, pE735, DOI 10.1073/pnas.1523838113; Scheuermann TH, 2009, P NATL ACAD SCI USA, V106, P450, DOI 10.1073/pnas.0808092106; SCHOOLEY DA, 1978, BIOCHEM BIOPH RES CO, V81, P743, DOI 10.1016/0006-291X(78)91414-6; Schrodinger LLC, 2014, EPIK VERS 2 4; Schrodinger LLC, 2014, PROT PREP WIZ 2014 4; Schrodinger LLC, 2014, GLIDE VERS 6 5; Schrodinger LLC, 2014, PRIM VERS 3 2; Schrodinger LLC, 2014, IMP VERS 5 9; Stockinger B, 2014, ANNU REV IMMUNOL, V32, P403, DOI 10.1146/annurev-immunol-032713-120245; Suzuki R, 2011, SCI REP-UK, V1, DOI 10.1038/srep00133; TOUHARA K, 1993, BIOCHEMISTRY-US, V32, P2068, DOI 10.1021/bi00059a026; Wen D, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005038; WESTERMANN J, 1969, Z NATURFORSCH PT B, VB 24, P378, DOI 10.1515/znb-1969-0402; WIGGLESWORTH VB, 1969, J INSECT PHYSIOL, V15, P73, DOI 10.1016/0022-1910(69)90213-3; Wimmer Z, 1997, J CHEM ECOL, V23, P605, DOI 10.1023/B:JOEC.0000006399.07779.16; YIN CM, 1995, J INSECT PHYSIOL, V41, P473, DOI 10.1016/0022-1910(94)00134-3; Zhang ZL, 2011, J BIOL CHEM, V286, P8437, DOI 10.1074/jbc.M110.191684; Zhou XF, 2002, DEVELOPMENT, V129, P2259; Zou Z, 2013, P NATL ACAD SCI USA, V110, pE2173, DOI 10.1073/pnas.1305293110	70	26	27	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2019	294	2					410	423		10.1074/jbc.RA118.005992	http://dx.doi.org/10.1074/jbc.RA118.005992			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HI2GP	30455350	Green Published, hybrid			2022-12-28	WOS:000456263600003
J	Pena-Cardena, A; Grande, R; Sanchez, J; Tabashnik, BE; Bravo, A; Soberon, M; Gomez, I				Pena-Cardena, Arlen; Grande, Ricardo; Sanchez, Jorge; Tabashnik, Bruce E.; Bravo, Alejandra; Soberon, Mario; Gomez, Isabel			The C-terminal protoxin region of Bacillus thuringiensis Cry1Ab toxin has a functional role in binding to GPI-anchored receptors in the insect midgut	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacillus; bacterial toxin; glycosylphosphatidylinositol (GPI anchor); aminopeptidase; cadherin; alkaline phosphatase; aminopeptidase; Bacillus thuringiensis; C-terminal region; Cry toxin	EUROPEAN CORN-BORER; MANDUCA-SEXTA; DOMAIN-II; DELTA-ENDOTOXIN; BT COTTON; ALKALINE-PHOSPHATASE; IRREVERSIBLE BINDING; LOOP 2; RESISTANCE; CADHERIN	Bacillus thuringiensis Cry toxins are used worldwide for controlling insects. Cry1Ab is produced as a 130-kDa protoxin that is activated by proteolytic removal of an inert 500 amino-acid-long C-terminal region, enabling the activated toxin to bind to insect midgut receptor proteins, leading to its membrane insertion and pore formation. It has been proposed that the C-terminal region is only involved in toxin crystallization, but its role in receptor binding is undefined. Here we show that the C-terminal region of Cry1Ab protoxin provides additional binding sites for alkaline phosphatase (ALP) and aminopeptidase N (APN) insect receptors. ELISA, ligand blot, surface plasmon resonance, and pulldown assays revealed that the Cry1Ab C-terminal region binds to both ALP and APN but not to cadherin. Thus, the C-terminal region provided a higher binding affinity of the protoxin to the gut membrane that correlated with higher toxicity of protoxin than activated toxin. Moreover, Cry1Ab domain II loop 2 or 3 mutations reduced binding of the protoxin to cadherin but not to ALP or APN, supporting the idea that protoxins have additional binding sites. These results imply that two different regions mediate the binding of Cry1Ab protoxin to membrane receptors, one located in domain II-III of the toxin and another in its C-terminal region, suggesting an active role of the C-terminal protoxin fragment in the mode of action of Cry toxins. These results suggest that future manipulations of the C-terminal protoxin region could alter the specificity and increase the toxicity of B. thuringiensis proteins.	[Pena-Cardena, Arlen; Sanchez, Jorge; Bravo, Alejandra; Soberon, Mario; Gomez, Isabel] Univ Nacl Autonoma Mexico, Dept Microbiol Mol, Inst Biotecnol, Ave Univ 2001, Cuernavaca 62210, Morelos, Mexico; [Grande, Ricardo] Univ Nacl Autonoma Mexico, Unidad Secuenciac Mas & Bioinformat, Inst Biotecnol, Ave Univ 2001, Cuernavaca 62210, Morelos, Mexico; [Tabashnik, Bruce E.] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; University of Arizona	Gomez, I (corresponding author), Univ Nacl Autonoma Mexico, Dept Microbiol Mol, Inst Biotecnol, Ave Univ 2001, Cuernavaca 62210, Morelos, Mexico.	isabelg@ibt.unam.mx	de la Parra, Maria Alejandra Bravo/R-6740-2017		Consejo Nacional de Ciencia y Tecnologia [Fronteras 008]; PAPIIT-UNAM (Programa de Apoyo a Proyectos de Investigation e Innovation Tecnologica-Universidad Nacional Autonoma de Mexico) [IN202718, IN213514]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); PAPIIT-UNAM (Programa de Apoyo a Proyectos de Investigation e Innovation Tecnologica-Universidad Nacional Autonoma de Mexico)	This work was supported in part by Consejo Nacional de Ciencia y Tecnologia Fronteras 008 and PAPIIT-UNAM (Programa de Apoyo a Proyectos de Investigation e Innovation Tecnologica-Universidad Nacional Autonoma de Mexico) IN202718 and IN213514.	Adang MJ, 2014, ADV INSECT PHYSIOL, V47, P39, DOI 10.1016/B978-0-12-800197-4.00002-6; Adegawa S, 2017, BBA-PROTEINS PROTEOM, V1865, P220, DOI 10.1016/j.bbapap.2016.11.011; Anilkumar KJ, 2008, APPL ENVIRON MICROB, V74, P462, DOI 10.1128/AEM.01612-07; Arenas I, 2010, J BIOL CHEM, V285, P12497, DOI 10.1074/jbc.M109.085266; Badran AH, 2016, NATURE, V533, P58, DOI 10.1038/nature17938; Bravo A, 2013, MICROB BIOTECHNOL, V6, P17, DOI 10.1111/j.1751-7915.2012.00342.x; Chen J, 2007, P NATL ACAD SCI USA, V104, P13901, DOI 10.1073/pnas.0706011104; CHOMA CT, 1990, EUR J BIOCHEM, V189, P523, DOI 10.1111/j.1432-1033.1990.tb15518.x; Comas C, 2014, TRANSGENIC RES, V23, P135, DOI 10.1007/s11248-013-9737-0; de Maagd RA, 2003, ANNU REV GENET, V37, P409, DOI 10.1146/annurev.genet.37.110801.143042; deMaagd RA, 1996, APPL ENVIRON MICROB, V62, P1537, DOI 10.1128/AEM.62.5.1537-1543.1996; Dively GP, 2018, P NATL ACAD SCI USA, V115, P3320, DOI 10.1073/pnas.1720692115; Downes S, 2010, EVOL APPL, V3, P574, DOI 10.1111/j.1752-4571.2010.00146.x; EDER J, 1995, MOL MICROBIOL, V16, P609, DOI 10.1111/j.1365-2958.1995.tb02423.x; Evdokimov AG, 2014, PROTEIN SCI, V23, P1491, DOI 10.1002/pro.2536; Fabrick JA, 2007, INSECT BIOCHEM MOLEC, V37, P97, DOI 10.1016/j.ibmb.2006.10.010; Flores-Escobar B, 2013, APPL ENVIRON MICROB, V79, P4543, DOI 10.1128/AEM.01062-13; Gahan LJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001248; Gomez I, 2003, BIOCHEMISTRY-US, V42, P10482, DOI 10.1021/bi034440p; Gomez I, 2014, BIOCHEM J, V459, P383, DOI 10.1042/BJ20131408; Hutchison WD, 2010, SCIENCE, V330, P222, DOI 10.1126/science.1190242; Iacovache I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002135; Jenkins J L, 2000, Genet Eng (N Y), V22, P33; Jimenez-Juarez N, 2007, J BIOL CHEM, V282, P21222, DOI 10.1074/jbc.M701314200; Lee MK, 2000, MOL MICROBIOL, V38, P289, DOI 10.1046/j.1365-2958.2000.02109.x; LERECLUS D, 1995, BIO-TECHNOL, V13, P67, DOI 10.1038/nbt0195-67; Li XM, 2018, CELL CHEM BIOL, V25, P1, DOI 10.1016/j.chembiol.2018.01.003; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; Mendelsohn M, 2003, NAT BIOTECHNOL, V21, P1003, DOI 10.1038/nbt0903-1003; Meza R, 1996, FEMS MICROBIOL LETT, V145, P333, DOI 10.1111/j.1574-6968.1996.tb08597.x; Nicolia A, 2014, CRIT REV BIOTECHNOL, V34, P77, DOI 10.3109/07388551.2013.823595; Pacheco S, 2009, PEPTIDES, V30, P583, DOI 10.1016/j.peptides.2008.08.006; Pardo-Lopez L, 2013, FEMS MICROBIOL REV, V37, P3, DOI 10.1111/j.1574-6976.2012.00341.x; Park Y, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-46; Rajamohan F, 1996, J BIOL CHEM, V271, P2390, DOI 10.1074/jbc.271.5.2390; RAJAMOHAN F, 1995, J BACTERIOL, V177, P2276, DOI 10.1128/jb.177.9.2276-2282.1995; Rodriguez-Almazan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005545; Sanahuja G, 2011, PLANT BIOTECHNOL J, V9, P283, DOI 10.1111/j.1467-7652.2011.00595.x; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Sellman BR, 1997, MOL MICROBIOL, V25, P429, DOI 10.1046/j.1365-2958.1997.4541820.x; Siqueira HAA, 2004, PEST MANAG SCI, V60, P1189, DOI 10.1002/ps.935; Smedley DP, 1996, MICROBIOL-SGM, V142, P1617, DOI 10.1099/13500872-142-7-1617; Tabashnik BE, 2017, NAT BIOTECHNOL, V35, P926, DOI 10.1038/nbt.3974; Tabashnik BE, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005646; Tabashnik BE, 2015, SCI REP-UK, V5, DOI 10.1038/srep15107; Tabashnik BE, 2010, NAT BIOTECHNOL, V28, P1304, DOI 10.1038/nbt.1704; THOMAS WE, 1983, J CELL SCI, V60, P181; Torres-Quintero MC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22740-9; Wan P, 2008, ENVIRON ENTOMOL, V37, P1043, DOI 10.1603/0046-225X(2008)37[1043:PDOSLL]2.0.CO;2; WOLFERSBERGER MG, 1993, ARCH INSECT BIOCHEM, V24, P139, DOI 10.1002/arch.940240304; Wu YD, 2014, ADV INSECT PHYSIOL, V47, P297, DOI 10.1016/B978-0-12-800197-4.00006-3; Xie RY, 2005, J BIOL CHEM, V280, P8416, DOI 10.1074/jbc.M408403200; Zhang XB, 2006, P NATL ACAD SCI USA, V103, P9897, DOI 10.1073/pnas.0604017103	53	19	20	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					20263	20272		10.1074/jbc.RA118.005101	http://dx.doi.org/10.1074/jbc.RA118.005101			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30385510	Green Published, hybrid			2022-12-28	WOS:000454685900031
J	Hargrove, TY; Wawrzak, Z; Fisher, PM; Child, SA; Nes, WD; Guengerich, FP; Waterman, MR; Lepesheva, GI				Hargrove, Tatiana Y.; Wawrzak, Zdzislaw; Fisher, Paxtyn M.; Child, Stella A.; Nes, W. David; Guengerich, F. Peter; Waterman, Michael R.; Lepesheva, Galina I.			Binding of a physiological substrate causes large-scale conformational reorganization in cytochrome P450 51	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytochrome P450; conformational change; catalysis; X-ray crystallography; structure-function; drug target; druggability; sterol 14alpha-demethylase (CYP51); sterol biosynthesis; substrate binding	STEROL 14-ALPHA-DEMETHYLASE CYP51; STRUCTURAL-BASIS; CRYSTAL-STRUCTURES; TRYPANOSOMA-CRUZI; INHIBITION; P450; PREFERENCES; ACTIVATION; MECHANISMS; OXIDATION	Sterol 14-demethylases (CYP51s) are phylogenetically the most conserved cytochromes P450, and their three-step reaction is crucial for biosynthesis of sterols and serves as a leading target for clinical and agricultural antifungal agents. The structures of several (bacterial, protozoan, fungal, and human) CYP51 orthologs, in both the ligand-free and inhibitor-bound forms, have been determined and have revealed striking similarity at the secondary and tertiary structural levels, despite having low sequence identity. Moreover, in contrast to many of the substrate-promiscuous, drug-metabolizing P450s, CYP51 structures do not display substantial rearrangements in their backbones upon binding of various inhibitory ligands, essentially representing a snapshot of the ligand-free sterol 14-demethylase. Here, using the obtusifoliol-bound I105F variant of Trypanosoma cruzi CYP51, we report that formation of the catalytically competent complex with the physiological substrate triggers a large-scale conformational switch, dramatically reshaping the enzyme active site (3.5-6.0 movements in the FG arm, HI arm, and helix C) in the direction of catalysis. Notably, our X-ray structural analyses revealed that the substrate channel closes, the proton delivery route opens, and the topology and electrostatic potential of the proximal surface reorganize to favor interaction with the electron-donating flavoprotein partner, NADPH-cytochrome P450 reductase. Site-directed mutagenesis of the amino acid residues involved in these events revealed a key role of active-site salt bridges in contributing to the structural dynamics that accompanies CYP51 function. Comparative analysis of apo-CYP51 and its sterol-bound complex provided key conceptual insights into the molecular mechanisms of CYP51 catalysis, functional conservation, lineage-specific substrate complementarity, and druggability differences.	[Hargrove, Tatiana Y.; Child, Stella A.; Guengerich, F. Peter; Waterman, Michael R.; Lepesheva, Galina I.] Vanderbilt Univ, Sch Med, Dept Biochem, 622 Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA; [Wawrzak, Zdzislaw] Northwestern Univ, Life Sci Collaborat Access Team, Synchrotron Res Ctr, Argonne, IL 60439 USA; [Fisher, Paxtyn M.; Nes, W. David] Texas Tech Univ, Dept Chem & Biochem, Lubbock, TX 79409 USA; [Lepesheva, Galina I.] Vanderbilt Univ, Struct Biol Ctr, 221 Kirkland Hall, Nashville, TN 37235 USA	Vanderbilt University; Northwestern University; Texas Tech University System; Texas Tech University; Vanderbilt University	Lepesheva, GI (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 622 Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	galina.i.lepesheva@vanderbilt.edu			National Institutes of Health [R33 AI119782, R01 GM067871]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI119782] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067871] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 GM067871 (to G. I. L. and F. P. G.). Synthesis of obtusifoliol and eburicol was supported by National Institutes of Health Grant R33 AI119782 (to W. D. N.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Conner KP, 2014, BIOCHEMISTRY-US, V53, P1428, DOI 10.1021/bi401547j; Conner KP, 2011, ARCH BIOCHEM BIOPHYS, V507, P56, DOI 10.1016/j.abb.2010.10.006; Denisov IG, 2007, J BIOL CHEM, V282, P7066, DOI 10.1074/jbc.M609589200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Guengerich FP, 2007, J BIOCHEM MOL TOXIC, V21, P163, DOI 10.1002/jbt.20174; Guengerich FP, 1997, BIOCHEMISTRY-US, V36, P14741, DOI 10.1021/bi9719399; Hannemann F, 2007, BBA-GEN SUBJECTS, V1770, P330, DOI 10.1016/j.bbagen.2006.07.017; Hargrove TY, 2017, J BIOL CHEM, V292, P6728, DOI 10.1074/jbc.M117.778308; Hargrove TY, 2016, J LIPID RES, V57, P1552, DOI 10.1194/jlr.M069229; Hargrove TY, 2015, J BIOL CHEM, V290, P23916, DOI 10.1074/jbc.M115.677310; Hargrove TY, 2013, J BIOL CHEM, V288, P31602, DOI 10.1074/jbc.M113.497990; Hargrove TY, 2012, J LIPID RES, V53, P311, DOI 10.1194/jlr.M021865; Hargrove TY, 2011, J BIOL CHEM, V286, P26838, DOI 10.1074/jbc.M111.237099; Hiruma Y, 2013, J MOL BIOL, V425, P4353, DOI 10.1016/j.jmb.2013.07.006; Lepesheva GI, 2007, CHEM BIOL, V14, P1283, DOI 10.1016/j.chembiol.2007.10.011; Lepesheva GI, 2007, ARCH BIOCHEM BIOPHYS, V464, P221, DOI 10.1016/j.abb.2007.05.017; Lepesheva GI, 2007, BBA-GEN SUBJECTS, V1770, P467, DOI 10.1016/j.bbagen.2006.07.018; Lepesheva GI, 2018, PARASITOLOGY, V145, P1820, DOI 10.1017/S0031182018000562; Lepesheva GI, 2011, BBA-PROTEINS PROTEOM, V1814, P88, DOI 10.1016/j.bbapap.2010.06.006; Lepesheva GI, 2010, J BIOL CHEM, V285, P25582, DOI 10.1074/jbc.M110.133215; Lepesheva GI, 2010, J BIOL CHEM, V285, P1773, DOI 10.1074/jbc.M109.067470; Lepesheva GI, 2006, J BIOL CHEM, V281, P3577, DOI 10.1074/jbc.M510317200; Lockart MM, 2018, J INORG BIOCHEM, V183, P157, DOI 10.1016/j.jinorgbio.2018.02.021; Mast N, 2008, P NATL ACAD SCI USA, V105, P9546, DOI 10.1073/pnas.0803717105; Mast N, 2011, J BIOL CHEM, V286, P5607, DOI 10.1074/jbc.M110.188433; Monk BC, 2014, P NATL ACAD SCI USA, V111, P3865, DOI 10.1073/pnas.1324245111; Nelson DR, 1999, ARCH BIOCHEM BIOPHYS, V369, P1, DOI 10.1006/abbi.1999.1352; Patil PV, 2000, ANAL BIOCHEM, V286, P187, DOI 10.1006/abio.2000.4802; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Rittle J, 2010, SCIENCE, V330, P933, DOI 10.1126/science.1193478; Sen K, 2009, J PHYS CHEM B, V113, P8170, DOI 10.1021/jp902932p; Sevrioukova IF, 1999, P NATL ACAD SCI USA, V96, P1863, DOI 10.1073/pnas.96.5.1863; Sevrioukova IF, 2017, P NATL ACAD SCI USA, V114, P486, DOI 10.1073/pnas.1616198114; Strushkevich N, 2011, P NATL ACAD SCI USA, V108, P10139, DOI 10.1073/pnas.1019441108; Tripathi S, 2013, SCIENCE, V340, P1227, DOI 10.1126/science.1235797; Vidakovic M, 1998, BIOCHEMISTRY-US, V37, P9211, DOI 10.1021/bi980189f; Yoshida Y, 2000, BIOCHEM BIOPH RES CO, V273, P799, DOI 10.1006/bbrc.2000.3030	37	13	13	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2018	293	50					19344	19353		10.1074/jbc.RA118.005850	http://dx.doi.org/10.1074/jbc.RA118.005850			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HE6RA	30327430	hybrid, Green Published			2022-12-28	WOS:000453537300016
J	Chen, A; Akhshi, TK; Lavoie, BD; Wilde, A				Chen, Anan; Akhshi, Tara K.; Lavoie, Brigitte D.; Wilde, Andrew			Importin beta 2 mediates the spatio-temporal regulation of anillin through a noncanonical nuclear localization signal (vol 290, pg 13500, 2015)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction															Natural Sciences and Engineering Research Council of Canada (NSERC) [5139]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	A. W. was funded by Natural Sciences and Engineering Research Council of Canada (NSERC) Discover Grant 5139.	Chen AA, 2015, J BIOL CHEM, V290, P13500, DOI 10.1074/jbc.M115.649160	1	0	0	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2018	293	47					18402	18402		10.1074/jbc.AAC118.006473	http://dx.doi.org/10.1074/jbc.AAC118.006473			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8XM	30470727	Green Published, hybrid			2022-12-28	WOS:000451375200031
J	Lou, B; Liu, Q; Hou, JH; Kabir, I; Liu, PP; Ding, T; Dong, JB; Mo, MG; Ye, DY; Chen, Y; Bui, HH; Roth, K; Cao, Y; Jiang, XC				Lou, Bin; Liu, Qi; Hou, Jiahui; Kabir, Inamul; Liu, Peipei; Ding, Tingbo; Dong, Jibin; Mo, Mingguang; Ye, Deyong; Chen, Yang; Bui, Hai H.; Roth, Kenneth; Cao, Yu; Jiang, Xian-Cheng			2-Hydroxy-oleic acid does not activate sphingomyelin synthase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						sphingolipid; phospholipid; lipid; lipid metabolism; cancer; 2-hydroxy-oleic acid (2OHOA); anti-cancer drug; lysophosphatidylcholine acyltransferase (LPCAT); sphingomyelin synthase (SMS); sphingomyelin; phosphatidylcholine	LYSOPHOSPHATIDYLCHOLINE ACYLTRANSFERASE; ANTICANCER ACTIVITY; MEMBRANE; METABOLISM; CANCER; LIVER; IDENTIFICATION; DEFICIENCY; CLONING; CELLS	2-Hydroxy-oleic acid (2OHOA) is a potent anticancer drug that induces cancer cell cycle arrest and apoptosis. Previous studies have suggested that 2OHOA's anticancer effect is mediated by SMS activation in cancer cells, including A549 and U118 cells. To confirm this phenomenon, in this study, we treated both A549 and U118 cells with 2OHOA and measured SMS activity. To our surprise, we found neither 2OHOA-mediated SMS activation nor sphingomyelin accumulation in the cells. However, we noted that 2OHOA significantly reduces phosphatidylcholine in these cells. We also did not observe 2OHOA-mediated SMS activation in mouse tissue homogenates. Importantly, 2OHOA inhibited rather than activated recombinant SMS1 (rSMS1) and rSMS2 in a dose-dependent fashion. Intra-gastric treatment of C57BL/6J mice with 2OHOA for 10 days had no effects on liver and small intestine SMS activities and plasma sphingomyelin levels. The treatment inhibited lysophosphatidylcholine acyltransferase (LPCAT) activity, consistent with the aforementioned reduction in plasma phosphatidylcholine. Because total cellular phosphatidylcholine is used as a predictive biomarker for monitoring tumor responses, the previously reported 2OHOA-mediated cancer suppression could be related to this phosphatidylcholine reduction, which may influence cell membrane structure and properties. We conclude that 2OHOA is not a SMS activator and that its anticancer property may be related to an effect on phosphatidylcholine metabolism.	[Lou, Bin; Liu, Qi; Hou, Jiahui; Liu, Peipei; Ding, Tingbo; Dong, Jibin; Mo, Mingguang; Ye, Deyong; Jiang, Xian-Cheng] Fudan Univ, Sch Pharm, Shanghai 201203, Peoples R China; [Kabir, Inamul; Jiang, Xian-Cheng] Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA; [Chen, Yang; Cao, Yu] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Inst Precis Med, Shanghai 200000, Peoples R China; [Bui, Hai H.; Roth, Kenneth] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA; [Jiang, Xian-Cheng] Vet Affairs New York Harbor Healthcare Syst, Mol & Cellular Cardiol Program, Brooklyn, NY 11209 USA	Fudan University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Shanghai Jiao Tong University; Eli Lilly	Lou, B (corresponding author), Fudan Univ, Sch Pharm, Shanghai 201203, Peoples R China.; Cao, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Inst Precis Med, Shanghai 200000, Peoples R China.	blou@shmu.edu.cn; yu.cao@shsmu.edu.cn	Ye, Deyong/AAE-2173-2022	Ye, Deyong/0000-0003-0498-3019; Kabir, Inamul/0000-0001-6207-1785	National Institutes of Health [1R01 HL139582-01A1]; Veterans Affairs Merit Grant [000900-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL139582] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Grant(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant 1R01 HL139582-01A1 and Veterans Affairs Merit Grant 000900-01 (to X.-C. J.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barcelo-Coblijn G, 2011, P NATL ACAD SCI USA, V108, P19569, DOI 10.1073/pnas.1115484108; Chen XN, 2006, P NATL ACAD SCI USA, V103, P11724, DOI 10.1073/pnas.0604946103; Cheng ML, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00266; Dobrzynska I, 2005, MOL CELL BIOCHEM, V276, P113, DOI 10.1007/s11010-005-3557-3; Dobrzynska I, 2015, J MEMBRANE BIOL, V248, P301, DOI 10.1007/s00232-015-9770-4; Fan YF, 2010, ARTERIOSCL THROM VAS, V30, P2114, DOI 10.1161/ATVBAHA.110.213363; Fernandez R, 2016, ANAL CHEM, V88, P1022, DOI 10.1021/acs.analchem.5b03978; Gandola YB, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/687037; Hailemariam TK, 2008, ARTERIOSCL THROM VAS, V28, P1519, DOI 10.1161/ATVBAHA.108.168682; Hishikawa D, 2008, P NATL ACAD SCI USA, V105, P2830, DOI 10.1073/pnas.0712245105; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; Ibarguren M, 2013, BBA-BIOMEMBRANES, V1828, P2553, DOI 10.1016/j.bbamem.2013.06.014; Ishitsuka R, 2004, BIOPHYS J, V86, P296, DOI 10.1016/S0006-3495(04)74105-3; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; LANDS WEM, 1958, J BIOL CHEM, V231, P883; Martin ML, 2013, BBA-BIOMEMBRANES, V1828, P1405, DOI 10.1016/j.bbamem.2013.01.013; Li Y, 2013, ARTERIOSCL THROM VAS, V33, P1513, DOI 10.1161/ATVBAHA.113.301498; Li ZQ, 2012, ARTERIOSCL THROM VAS, V32, P1577, DOI 10.1161/ATVBAHA.112.251538; Li ZQ, 2011, MOL CELL BIOL, V31, P4205, DOI 10.1128/MCB.05893-11; Liu J, 2009, CIRC RES, V105, P295, DOI 10.1161/CIRCRESAHA.109.194613; Liu J, 2009, ARTERIOSCL THROM VAS, V29, P850, DOI 10.1161/ATVBAHA.109.185223; Llado V, 2010, J CELL MOL MED, V14, P659, DOI 10.1111/j.1582-4934.2008.00625.x; Llado V, 2009, P NATL ACAD SCI USA, V106, P13754, DOI 10.1073/pnas.0907300106; Lou B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102641; Ma ZM, 1999, J BIOL CHEM, V274, P9607, DOI 10.1074/jbc.274.14.9607; Martinez J, 2005, J PHARMACOL EXP THER, V315, P466, DOI 10.1124/jpet.105.088716; Martinez J, 2005, MOL PHARMACOL, V67, P531, DOI 10.1124/mol.104.000778; MERRILL AH, 1990, BIOCHIM BIOPHYS ACTA, V1044, P1, DOI 10.1016/0005-2760(90)90211-F; Mitsutake S, 2011, J BIOL CHEM, V286, P28544, DOI 10.1074/jbc.M111.255646; Nakanishi H, 2006, J BIOL CHEM, V281, P20140, DOI 10.1074/jbc.M600225200; Ridgway ND, 2013, CRIT REV BIOCHEM MOL, V48, P20, DOI 10.3109/10409238.2012.735643; Rong X, 2013, CELL METAB, V18, P685, DOI 10.1016/j.cmet.2013.10.002; SAKAI K, 1992, CARCINOGENESIS, V13, P579, DOI 10.1093/carcin/13.4.579; Sakamoto H, 2017, BIOCHEM BIOPH RES CO, V482, P202, DOI 10.1016/j.bbrc.2016.11.041; Shindou H, 2007, J BIOL CHEM, V282, P6532, DOI 10.1074/jbc.M609641200; Sugimoto M, 2016, BBA-MOL CELL BIOL L, V1861, P688, DOI 10.1016/j.bbalip.2016.04.019; Szachowicz-Petelska B, 2013, J MEMBRANE BIOL, V246, P421, DOI 10.1007/s00232-013-9554-7; Teres S, 2012, P NATL ACAD SCI USA, V109, P8489, DOI 10.1073/pnas.1118349109; Vacaru AM, 2009, J CELL BIOL, V185, P1013, DOI 10.1083/jcb.200903152; Vance DE, 2014, BBA-BIOMEMBRANES, V1838, P1477, DOI 10.1016/j.bbamem.2013.10.018; Yamaoka S, 2004, J BIOL CHEM, V279, P18688, DOI 10.1074/jbc.M401205200; Yano M, 2011, J BIOL CHEM, V286, P3992, DOI 10.1074/jbc.M110.179176; Zhao Y, 2008, J BIOL CHEM, V283, P8258, DOI 10.1074/jbc.M710422200	43	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2018	293	47					18328	18336		10.1074/jbc.RA118.005904	http://dx.doi.org/10.1074/jbc.RA118.005904			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8XM	30305392	Green Published, hybrid			2022-12-28	WOS:000451375200024
J	Cho, YK; Park, D; Yang, AM; Chen, F; Chuong, AS; Klapoetke, NC; Boyden, ES				Cho, Yong Ku; Park, Demian; Yang, Aimei; Chen, Fei; Chuong, Amy S.; Klapoetke, Nathan C.; Boyden, Edward S.			Multidimensional screening yields channelrhodopsin variants having improved photocurrent and order-of-magnitude reductions in calcium and proton currents	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						optogenetics; calcium; protein engineering; physiology; neurobiology; channelrhodopsin; proton; screening	ION SELECTIVITY; LIGHT; PHOSPHORYLATION; ACTIVATION; EXPRESSION; EXCITATION; CHANNEL; TOOLS	Channelrhodopsins (ChRs) are light-gated ion channels in widespread use in neuroscience for mediating the genetically targetable optical control of neurons (optogenetics). ChRs pass multiple kinds of ions, and although nonspecific ChR-mediated conductance is not an issue in many neuroscience studies, conductance of calcium and protons, which can mediate diverse cellular signals, may be undesirable in some instances. Here, we turned our attention to the creation of ChRs that have high cation photocurrent but pass fewer calcium ions and protons. We developed an automated, time-resolved screening method capable of rapidly phenotyping channelrhodopsin-2 (ChR2) variants. We found substitution mutations throughout ChR2 that could boost current while altering ion selectivity and observed that the mutations that reduced calcium or proton conductance have additive effects. By combining four mutations, we obtained a ChR, ChromeQ, with improved photocurrent that possesses order-of-magnitude reductions in calcium and proton conductance and high fidelity in driving repetitive action potentials in neurons. The approach presented here offers a viable pathway toward customization of complex physiological properties of optogenetic tools. We propose that our screening method not only enables elucidation of new ChR variants that affect microbial opsin performance but may also reveal new principles of optogenetic protein engineering.	MIT, Dept Biol Engn, McGovern Inst, Media Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA; MIT, Dept Biol Engn, Koch Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, McGovern Inst, Media Lab, E25-618, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, Koch Inst, E25-618, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Boyden, ES (corresponding author), MIT, Media Lab, Dept Biol Engn, Bldg E15 E15-485,20 Ames St, Cambridge, MA 02139 USA.; Boyden, ES (corresponding author), MIT, Media Lab, Dept Brain & Cognit Sci, Bldg E15 E15-485,20 Ames St, Cambridge, MA 02139 USA.; Boyden, ES (corresponding author), McGovern Inst, Bldg E15 E15-485,20 Ames St, Cambridge, MA 02139 USA.	esb@media.mit.edu		Cho, Yong Ku/0000-0001-5621-521X	ATT Foundation; Benesse Foundation; Defense Advanced Research Projects Agency (DARPA) Living Foundries Program [HR0011-12-C-0068]; Harvard/Massachusetts Institute of Technology (MIT) Joint Grants Program in Basic Neuroscience; Human Frontiers Science Program; MIT McGovern Institute; MIT Media Lab; MIT Neurotechnology Fund; New York Stem Cell Foundation-Robertson Investigator Award; National Institutes of Health (NIH) Director's New Innovator Award [1DP2OD002002]; NIH EUREKA Award [1R01NS075421]; NIH [1R01DA029639]; National Science Foundation (NSF) CAREER Award [CBET 1053233]; SkTech; Wallace H. Coulter Foundation; MIT McGovern Institute Neurotechnology (MINT) Program; MIT Media Lab Consortia; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA029639] Funding Source: NIH RePORTER	ATT Foundation; Benesse Foundation; Defense Advanced Research Projects Agency (DARPA) Living Foundries Program(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Harvard/Massachusetts Institute of Technology (MIT) Joint Grants Program in Basic Neuroscience; Human Frontiers Science Program(Human Frontier Science Program); MIT McGovern Institute; MIT Media Lab; MIT Neurotechnology Fund; New York Stem Cell Foundation-Robertson Investigator Award; National Institutes of Health (NIH) Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH EUREKA Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF) CAREER Award(National Science Foundation (NSF)NSF - Office of the Director (OD)); SkTech; Wallace H. Coulter Foundation; MIT McGovern Institute Neurotechnology (MINT) Program; MIT Media Lab Consortia; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the AT&T Foundation, the Benesse Foundation, Jerry and Marge Burnett, Defense Advanced Research Projects Agency (DARPA) Living Foundries Program Grant HR0011-12-C-0068, the Harvard/Massachusetts Institute of Technology (MIT) Joint Grants Program in Basic Neuroscience, the Human Frontiers Science Program, the MIT McGovern Institute and McGovern Institute Neurotechnology (MINT) Program, the MIT Media Lab and Media Lab Consortia, the MIT Neurotechnology Fund (and its generous donors), the New York Stem Cell Foundation-Robertson Investigator Award, National Institutes of Health (NIH) Director's New Innovator Award 1DP2OD002002, NIH EUREKA Award 1R01NS075421, NIH Grant 1R01DA029639, National Science Foundation (NSF) CAREER Award CBET 1053233, SkTech, and the Wallace H. Coulter Foundation (all to E. S. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agarwal N, 2009, PROTEOMICS, V9, P1099, DOI 10.1002/pmic.200800368; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; Beppu K, 2014, NEURON, V81, P314, DOI 10.1016/j.neuron.2013.11.011; Berndt A, 2016, P NATL ACAD SCI USA, V113, P822, DOI 10.1073/pnas.1523341113; Berndt A, 2014, SCIENCE, V344, P420, DOI 10.1126/science.1252367; Berndt A, 2010, BIOPHYS J, V98, P753, DOI 10.1016/j.bpj.2009.10.052; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; CWIRLA SE, 1990, P NATL ACAD SCI USA, V87, P6378, DOI 10.1073/pnas.87.16.6378; Eisenhauer K, 2012, J BIOL CHEM, V287, P6904, DOI 10.1074/jbc.M111.327700; Figueiredo M, 2014, CELL CALCIUM, V56, P208, DOI 10.1016/j.ceca.2014.07.007; Gonzalez JE, 2002, RECEPTOR CHANNEL, V8, P283, DOI 10.1080/10606820214644; GONZALEZ JE, 1995, BIOPHYS J, V69, P1272, DOI 10.1016/S0006-3495(95)80029-9; Govorunova EG, 2017, SCI REP-UK, V7, DOI 10.1038/srep43358; Govorunova EG, 2016, PHOTOCHEM PHOTOBIOL, V92, P257, DOI 10.1111/php.12558; Gradmann D, 2002, J MEMBRANE BIOL, V189, P93, DOI 10.1007/s00232-002-1006-8; Gradmann D, 2011, BIOPHYS J, V101, P1057, DOI 10.1016/j.bpj.2011.07.040; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; Kato HE, 2012, NATURE, V482, P369, DOI 10.1038/nature10870; Klapoetke NC, 2014, NAT METHODS, V11, P338, DOI [10.1038/NMETH.2836, 10.1038/nmeth.2836]; Kleinlogel S, 2011, NAT NEUROSCI, V14, P513, DOI 10.1038/nn.2776; Krishtal O, 2003, TRENDS NEUROSCI, V26, P477, DOI 10.1016/S0166-2236(03)00210-8; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Nikolic K, 2009, PHOTOCHEM PHOTOBIOL, V85, P400, DOI 10.1111/j.1751-1097.2008.00460.x; Perea G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4262; Plazzo AP, 2012, J BIOL CHEM, V287, P4818, DOI 10.1074/jbc.M111.326207; Prigge M, 2012, J BIOL CHEM, V287, P31804, DOI 10.1074/jbc.M112.391185; Richards R, 2017, J BIOL CHEM, V292, P7314, DOI 10.1074/jbc.M116.770321; Ruffert K, 2011, BIOCHEM BIOPH RES CO, V410, P737, DOI 10.1016/j.bbrc.2011.06.024; Schneider F, 2013, BIOPHYS J, V105, P91, DOI 10.1016/j.bpj.2013.05.042; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; Stehfest K, 2010, J MOL BIOL, V398, P690, DOI 10.1016/j.jmb.2010.03.031; Stuart A., 2010, KENDALLS ADV THEORY, V1; Sugiyama Y, 2009, PHOTOCH PHOTOBIO SCI, V8, P328, DOI 10.1039/b815762f; Volkov O, 2017, SCIENCE, V358, DOI 10.1126/science.aan8862; Wang SY, 2016, METHODS MOL BIOL, V1408, P243, DOI 10.1007/978-1-4939-3512-3_16; Wietek J, 2016, J BIOL CHEM, V291, P4121, DOI 10.1074/jbc.M115.699637; Wietek J, 2014, SCIENCE, V344, P409, DOI 10.1126/science.1249375; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zal T, 2004, BIOPHYS J, V86, P3923, DOI 10.1529/biophysj.103.022087; Zhang F, 2008, NAT NEUROSCI, V11, P631, DOI 10.1038/nn.2120; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	47	16	16	0	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					3806	3821		10.1074/jbc.RA118.006996	http://dx.doi.org/10.1074/jbc.RA118.006996			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30610117	hybrid, Green Published			2022-12-28	WOS:000461854400001
J	Bradford, HN; Krishnaswamy, S				Bradford, Harlan N.; Krishnaswamy, Sriram			Occlusion of anion-binding exosite 2 in meizothrombin explains its impaired ability to activate factor V	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						coagulation factor; serine protease; thrombin; proteolytic enzyme; enzyme kinetics; proteolysis; hemostasis; blood clotting; factor V; prothrombinase	HUMAN-FACTOR-X; CATALYZED ACTIVATION; HUMAN PROTHROMBINASE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; THROMBIN; CLEAVAGE; DOMAIN; SUBSTRATE; VENOM	The proteolytic conversion of factor V to factor Va is central for amplified flux through the blood coagulation cascade. Heterodimeric factor Va is produced by cleavage at three sites in the middle of factor V by thrombin, yielding an N terminus-derived heavy chain and a C terminus-derived light chain. Here, we show that light chain formation resulting from the C-terminal cleavage is the rate-limiting step in the formation of fully cleaved Va. This rate-limiting step also corresponded to and was sufficient for the ability of cleaved factor V to bind Xa and assemble into the prothrombinase complex. Meizothrombin, the proteinase intermediate in thrombin formation, cleaves factor V more slowly than does thrombin, resulting in a pronounced defect in the formation of the light chain. A similar to 100-fold reduced rate of meizothrombin-mediated light chain formation by meizothrombin corresponded to equally slow production of active cofactor and an impaired ability to amplify flux through the coagulation cascade initiated in plasma. We show that this defect arises from the occlusion of anion-binding exosite 2 in the catalytic domain by the covalently retained propiece in meizothrombin. Our findings provide structural insights into the prominent role played by exosite 2 in the rate-limiting step of factor V activation. They also bear on how factor V is converted into a cofactor capable of assembling into prothrombinase.	[Bradford, Harlan N.; Krishnaswamy, Sriram] Childrens Hosp Philadelphia, Res Inst, Philadelphia, PA 19104 USA; [Krishnaswamy, Sriram] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Krishnaswamy, S (corresponding author), Childrens Hosp Philadelphia, 3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	skrishna@pennmedicine.upenn.edu	Krishnaswamy, Sriram/Z-4380-2019	Bradford, Harlan/0000-0001-5582-278X	NHLBI, National Institutes of Health [R01 HL-125422, P01 HL-139420]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL139420, R01HL125422] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NHLBI, National Institutes of Health, Grants R01 HL-125422 and P01 HL-139420 (to S. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Corral-Rodriguez MA, 2011, BLOOD, V117, P7164, DOI 10.1182/blood-2010-10-315309; ARNI RK, 1993, BIOCHEMISTRY-US, V32, P4727, DOI 10.1021/bi00069a006; Baugh RJ, 1996, J BIOL CHEM, V271, P16126, DOI 10.1074/jbc.271.27.16126; Bos MHA, 2012, J BIOL CHEM, V287, P26342, DOI 10.1074/jbc.M112.377168; Bradford HN, 2013, J BIOL CHEM, V288, P27789, DOI 10.1074/jbc.M113.502005; Bradford HN, 2012, J BIOL CHEM, V287, P30414, DOI 10.1074/jbc.M112.394809; Buddai SK, 2002, J BIOL CHEM, V277, P26689, DOI 10.1074/jbc.M202507200; Bukys MA, 2006, J BIOL CHEM, V281, P18569, DOI 10.1074/jbc.M600752200; Bunce MW, 2013, J BIOL CHEM, V288, P30151, DOI 10.1074/jbc.M113.506840; Camire RM, 2009, J THROMB HAEMOST, V7, P1951, DOI 10.1111/j.1538-7836.2009.03622.x; Camire RM, 1998, BIOCHEMISTRY-US, V37, P11896, DOI 10.1021/bi980520v; COTE HCF, 1994, J BIOL CHEM, V269, P11374; DISCIPIO RG, 1977, BIOCHEMISTRY-US, V16, P5253, DOI 10.1021/bi00643a015; DOYLE MF, 1990, J BIOL CHEM, V265, P10693; Esmon CT, 1996, J BIOL CHEM, V271, P13882, DOI 10.1074/jbc.271.23.13882; FOSTER WB, 1983, J BIOL CHEM, V258, P3970; Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636; JENNY RJ, 1987, P NATL ACAD SCI USA, V84, P4846, DOI 10.1073/pnas.84.14.4846; Kamath P, 2010, J BIOL CHEM, V285, P28651, DOI 10.1074/jbc.M110.154914; Khan AR, 1998, PROTEIN SCI, V7, P815; KIM DJ, 1994, BIOTECHNOL LETT, V16, P549, DOI 10.1007/BF00128598; KISIEL W, 1981, METHOD ENZYMOL, V80, P275; KRISHNASWAMY S, 1993, METHOD ENZYMOL, V222, P260; Krishnaswamy S, 1997, BIOCHEMISTRY-US, V36, P12080, DOI 10.1021/bi970979+; KRISHNASWAMY S, 1987, J BIOL CHEM, V262, P3291; Lechtenberg BC, 2013, BLOOD, V122, P2777, DOI 10.1182/blood-2013-06-511733; Lu WP, 2003, ANAL BIOCHEM, V316, P58, DOI 10.1016/S0003-2697(03)00034-4; Lundblad R L, 1976, Methods Enzymol, V45, P156; MANN KG, 1981, METHOD ENZYMOL, V80, P286; MANN KG, 1988, ANNU REV BIOCHEM, V57, P915, DOI 10.1146/annurev.bi.57.070188.004411; Mann KG, 2003, BLOOD, V101, P20, DOI 10.1182/blood-2002-01-0290; MANN KG, 1990, BLOOD, V76, P1; Martin PD, 1997, STRUCTURE, V5, P1681, DOI 10.1016/S0969-2126(97)00314-6; MONKOVIC DD, 1990, BIOCHEMISTRY-US, V29, P1118, DOI 10.1021/bi00457a004; Myles T, 2001, J BIOL CHEM, V276, P25143, DOI 10.1074/jbc.M011324200; Nakayama D, 2011, FEBS LETT, V585, P3020, DOI 10.1016/j.febslet.2011.08.022; NESHEIM ME, 1981, METHOD ENZYMOL, V80, P249; NESHEIM ME, 1984, J BIOL CHEM, V259, P3187; NESHEIM ME, 1979, J BIOL CHEM, V254, P952; OMarcaigh AS, 1996, BLOOD, V88, P2611, DOI 10.1182/blood.V88.7.2611.bloodjournal8872611; Orcutt SJ, 2004, J BIOL CHEM, V279, P54927, DOI 10.1074/jbc.M410866200; Orcutt SJ, 2002, J BIOL CHEM, V277, P46191, DOI 10.1074/jbc.M208677200; Orfeo T, 2004, J BIOL CHEM, V279, P19580, DOI 10.1074/jbc.M400727200; RABIET MJ, 1986, J BIOL CHEM, V261, P5045; ROSING J, 1986, J BIOL CHEM, V261, P4224; Segers K, 2007, J BIOL CHEM, V282, P33915, DOI 10.1074/jbc.M701123200; Shaw MA, 2016, BLOOD, V128, P721, DOI 10.1182/blood-2015-11-680280; STEARNS DJ, 1988, J BIOL CHEM, V263, P826; STUBBS MT, 1995, TRENDS BIOCHEM SCI, V20, P23, DOI 10.1016/S0968-0004(00)88945-8; SUZUKI K, 1982, J BIOL CHEM, V257, P6556; TANS G, 1994, J BIOL CHEM, V269, P15969; Thorelli E, 1997, EUR J BIOCHEM, V247, P12, DOI 10.1111/j.1432-1033.1997.00012.x; TOKUNAGA F, 1988, J BIOL CHEM, V263, P17471; Wood JP, 2013, P NATL ACAD SCI USA, V110, P17838, DOI 10.1073/pnas.1310444110	54	3	3	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2019	294	7					2422	2435		10.1074/jbc.RA118.006510	http://dx.doi.org/10.1074/jbc.RA118.006510			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL7CN	30578302	Green Published, hybrid			2022-12-28	WOS:000458895400019
J	Zhang, YH; Feng, XL; Sun, WQ; Zhang, J; Chen, XB				Zhang, Yanhong; Feng, Xiuli; Sun, Wenqiang; Zhang, Jin; Chen, Xinbin			Serine 195 phosphorylation in the RNA-binding protein Rbm38 increases p63 expression by modulating Rbm38's interaction with the Ago2-miR203 complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						p63; protein phosphorylation; transcription factor; post-transcriptional regulation; microRNA (miRNA); Argonaute 2; mRNA stability; RNA-binding motif protein 38 (Rbm38)	GLYCOGEN-SYNTHASE KINASE-3; P53 FAMILY; TRANSLATIONAL REPRESSION; TARGET; RNPC1; PROLIFERATION; DIFFERENTIATION; DEADENYLATION; APOPTOSIS; HOMOLOG	The p63 transcription factor, a p53 family protein, regulates genes involved in various cellular processes, including cell growth and differentiation. We previously showed that RNA-binding motif protein (Rbm38) is a p63 target and, in turn, regulates p63 alpha mRNA stability by binding to the AU/U-rich element in its 3 ' UTR. Interestingly, Rbm38 can be phosphorylated at serine 195, altering its ability to regulate mRNA translation. However, whether the Ser-195 phosphorylation affects Rbm38's ability to destabilize p63 mRNA remains unclear. Here, using MCF7 and HaCaT cells, we showed that ectopic expression of phosphomimetic Rbm38-S195D increases, whereas WT Rbm38 and nonphosphorylatable Rbm38-S195A decrease p63 alpha protein and transcript levels. We also found that upon activation of glycogen synthase kinase 3 beta (GSK3 beta), phosphorylation of Rbm38 at Ser-195 is increased, enhancing p63 alpha expression in an Rbm38-dependent manner. To confirm this, we generated mouse embryo fibroblasts (MEFs) in which Ser-193 in mouse Rbm38 (equivalent to Ser-195 in human Rbm38) was substituted with aspartic acid (Rbm38(S193D/S193D)) or alanine (Rbm38(S193A/S193A)). We observed that the p63 transcript level was increased in Rbm38(S193D/S193D) MEFs, but decreased in Rbm38(S193A/S193A) MEFs. Mechanistically, we found that WT Rbm38, but not Rbm38-S195D, is required for p63 mRNA degradation mediated by microRNA 203 (miR203). Furthermore, we noted that Argonaute 2 (Ago2), a key regulator in microRNA-mediated mRNA decay, associates with WT Rbm38, and this association was reduced by Ser-195 phosphorylation. Together, our results reveal a critical mechanism by which Ser-195 phosphorylation in Rbm38 increases p63 expression by attenuating the association of Rbm38 with the Ago2-miR203 complex.	[Zhang, Yanhong; Feng, Xiuli; Sun, Wenqiang; Zhang, Jin; Chen, Xinbin] Univ Calif Davis, Sch Med, Comparat Oncol Lab, Davis, CA 95616 USA; [Zhang, Yanhong; Feng, Xiuli; Sun, Wenqiang; Zhang, Jin; Chen, Xinbin] Univ Calif Davis, Sch Vet Med, Comparat Oncol Lab, Davis, CA 95616 USA; [Feng, Xiuli] Nanjing Agr Univ, Coll Vet Med, Nanjing 210095, Jiangsu, Peoples R China	University of California System; University of California Davis; University of California System; University of California Davis; Nanjing Agricultural University	Chen, XB (corresponding author), Univ Calif Davis, Sch Med, Comparat Oncol Lab, Davis, CA 95616 USA.; Chen, XB (corresponding author), Univ Calif Davis, Sch Vet Med, Comparat Oncol Lab, Davis, CA 95616 USA.	xbchen@ucdavis.edu		chen, xinbin/0000-0002-4582-6506	National Institutes of Health [CA195828]; NATIONAL CANCER INSTITUTE [R01CA195828] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported in part by National Institutes of Health Grant CA195828. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Charvet C, 2011, MOL CELL, V42, P584, DOI 10.1016/j.molcel.2011.03.033; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Daugherty RL, 2007, PHYSIOLOGY, V22, P303, DOI 10.1152/physiol.00020.2007; Feldstein O, 2012, MOL CANCER RES, V10, P1169, DOI 10.1158/1541-7786.MCR-12-0331; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012; Jacobs Keith M, 2012, Int J Cell Biol, V2012, P930710, DOI 10.1155/2012/930710; Jiang YQ, 2018, ONCOGENE, V37, P2863, DOI 10.1038/s41388-018-0176-5; Kockeritz L, 2006, CURR DRUG TARGETS, V7, P1377, DOI 10.2174/1389450110607011377; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Kouwenhoven EN, 2015, EMBO REP, V16, P863, DOI 10.15252/embr.201439941; Leveille N, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1519; Levrero M, 2000, J CELL SCI, V113, P1661; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Osada M, 1998, NAT MED, V4, P839, DOI 10.1038/nm0798-839; Peritz T, 2006, NAT PROTOC, V1, P577, DOI 10.1038/nprot.2006.82; Qu LK, 2004, GENE DEV, V18, P261, DOI 10.1101/gad.1165804; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; ROUET P, 1994, P NATL ACAD SCI USA, V91, P6064, DOI 10.1073/pnas.91.13.6064; Shu LM, 2006, GENE DEV, V20, P2961, DOI 10.1101/gad.1463306; Truong AB, 2007, CELL CYCLE, V6, P295, DOI 10.4161/cc.6.3.3753; Viticchie G, 2011, CELL CYCLE, V10, P1121, DOI 10.4161/cc.10.7.15180; Wu J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.239; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Xu E, 2013, ONCOGENE, V32, P2169, DOI 10.1038/onc.2012.238; Xu ES, 2014, MOL CANCER RES, V12, P359, DOI 10.1158/1541-7786.MCR-13-0526; Yan WS, 2017, ONCOTARGET, V8, P78327, DOI 10.18632/oncotarget.18463; Yan WS, 2012, MOL CELL BIOL, V32, P2336, DOI 10.1128/MCB.00215-12; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Zhang J, 2018, CANCER RES, V78, P1511, DOI 10.1158/0008-5472.CAN-17-2457; Zhang J, 2011, GENE DEV, V25, P1528, DOI 10.1101/gad.2069311; Zhang J, 2010, P NATL ACAD SCI USA, V107, P9614, DOI 10.1073/pnas.0912594107; Zhang M, 2013, GENE DEV, V27, P2246, DOI 10.1101/gad.221739.113; Zhang Y, 2014, ONCOGENE, V33, P1548, DOI 10.1038/onc.2013.101; Zhang YH, 2017, GENE DEV, V31, P1243, DOI 10.1101/gad.299388.117	42	9	9	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2019	294	7					2449	2459		10.1074/jbc.RA118.005779	http://dx.doi.org/10.1074/jbc.RA118.005779			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL7CN	30567739	hybrid, Green Published			2022-12-28	WOS:000458895400021
J	Lee, BS; Kalia, NP; Jin, XEF; Hasenoehrl, EJ; Berney, M; Pethe, K				Lee, Bei Shi; Kalia, Nitin P.; Jin, Xin Er F.; Hasenoehrl, Erik J.; Berney, Michael; Pethe, Kevin			Inhibitors of energy metabolism interfere with antibiotic-induced death in mycobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell death; ATP; tuberculosis; antibiotics; Mycobacterium tuberculosis; antagonism; Bedaquiline; oxidative phosphorylation; Q203; Telacebec	DRUG-RESISTANT TUBERCULOSIS; BACTERICIDAL ACTIVITY; MULTIDRUG-RESISTANT; DISCOVERY; BEDAQUILINE; EMERGENCE; PHASE	Energy metabolism has recently gained interest as a target space for antibiotic drug development in mycobacteria. Of particular importance is bedaquiline (Sirturo), which kills mycobacteria by inhibiting the F1F0 ATP synthase. Other components of the electron transport chain such as the NADH dehydrogenases (NDH-2 and NdhA) and the terminal respiratory oxidase bc(1):aa(3) are also susceptible to chemical inhibition. Because antituberculosis drugs are prescribed as part of combination therapies, the interaction between novel drugs targeting energy metabolism and classical first and second line antibiotics must be considered to maximize treatment efficiency. Here, we show that subinhibitory concentration of drugs targeting the F1F0 ATP synthase and the cytochrome bc(1):aa(3), as well as energy uncouplers, interfere with the bactericidal potency of isoniazid and moxifloxacin. Isoniazid- and moxifloxacin-induced mycobacterial death correlated with a transient increase in intracellular ATP that was dissipated by co-incubation with energy metabolism inhibitors. Although oxidative phosphorylation is a promising target space for drug development, a better understanding of the link between energy metabolism and antibiotic-induced mycobacterial death is essential to develop potent drug combinations for the treatment of tuberculosis.	[Lee, Bei Shi; Pethe, Kevin] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore; [Kalia, Nitin P.; Jin, Xin Er F.; Pethe, Kevin] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 636921, Singapore; [Hasenoehrl, Erik J.; Berney, Michael] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Yeshiva University; Albert Einstein College of Medicine	Pethe, K (corresponding author), Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 636921, Singapore.	kevin.pethe@ntu.edu.sg	Pethe, Kevin/F-9495-2015; Berney, Michael/GQZ-2111-2022; Kalia, Nitin Pal/AAE-5959-2019	Berney, Michael/0000-0002-4833-0573; Pethe, Kevin/0000-0003-0916-8873; Kalia, Nitin Pal/0000-0003-4346-6567; Lee, Bei Shi/0000-0003-1104-9486	Singapore Ministry of Education under Academic Research Fund Tier 1 [2016-T1-001-034]; Lee Kong Chian School of Medicine, Nanyang Technological University Start-Up Grant; Nanyang President's Graduate Scholarship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI139465] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER	Singapore Ministry of Education under Academic Research Fund Tier 1(Ministry of Education, Singapore); Lee Kong Chian School of Medicine, Nanyang Technological University Start-Up Grant(Nanyang Technological University); Nanyang President's Graduate Scholarship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Singapore Ministry of Education under Academic Research Fund Tier 1 Grant 2016-T1-001-034 (to K.P.), by a Lee Kong Chian School of Medicine, Nanyang Technological University Start-Up Grant (to K.P.), and by a Nanyang President's Graduate Scholarship (to B.S.L.). The authors declare that they have no conflicts of interest with the contents of this article.	Abrahams KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052951; Altaf M, 2010, TUBERCULOSIS, V90, P333, DOI 10.1016/j.tube.2010.09.002; [Anonymous], 2012, PRINCIPLES PHARM PAT; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Chahine EB, 2014, ANN PHARMACOTHER, V48, P107, DOI 10.1177/1060028013504087; de Steenwinkel JEM, 2010, J ANTIMICROB CHEMOTH, V65, P2582, DOI 10.1093/jac/dkq374; Debnath J, 2012, J MED CHEM, V55, P3739, DOI 10.1021/jm201608g; Dheda K, 2017, LANCET RESP MED, V5, P291, DOI [10.1016/s2213-2600(17)30079-6, 10.1016/S2213-2600(17)30079-6]; Dunn EA, 2014, BIOORGAN MED CHEM, V22, P5320, DOI 10.1016/j.bmc.2014.07.050; Gagneux S, 2018, NAT REV MICROBIOL, V16, P202, DOI 10.1038/nrmicro.2018.8; Guglielmetti L, 2015, CLIN INFECT DIS, V60, P188, DOI 10.1093/cid/ciu786; Gumbo T, 2007, J INFECT DIS, V195, P194, DOI 10.1086/510247; HSE National Drug Treatment Centre, 2016, CERV SMEAR GUID; Kalia NP, 2017, P NATL ACAD SCI USA, V114, P7426, DOI 10.1073/pnas.1706139114; Khan SR, 2013, INT J ANTIMICROB AG, V41, P41, DOI 10.1016/j.ijantimicag.2012.09.012; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Koul A, 2007, NAT CHEM BIOL, V3, P323, DOI 10.1038/nchembio884; Lobritz MA, 2015, P NATL ACAD SCI USA, V112, P8173, DOI 10.1073/pnas.1509743112; Lu XQ, 2012, CHEMBIOCHEM, V13, P129, DOI 10.1002/cbic.201100585; Matsumoto M, 2006, PLOS MED, V3, P2131, DOI 10.1371/journal.pmed.0030466; Moraski GC, 2013, ACS MED CHEM LETT, V4, P110, DOI 10.1021/ml400088y; Pethe K, 2013, NAT MED, V19, P1157, DOI 10.1038/nm.3262; Prasad R, 2017, INDIAN J MED RES, V145, P271, DOI 10.4103/ijmr.IJMR_177_16; Rao SPS, 2008, P NATL ACAD SCI USA, V105, P11945, DOI 10.1073/pnas.0711697105; Rybniker J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8659; Shin HJ, 2015, TUBERC RESPIR DIS, V78, P161, DOI 10.4046/trd.2015.78.3.161; Sulochana S, 2009, J CHEMOTHERAPY, V21, P127, DOI 10.1179/joc.2009.21.2.127; Veziris N, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01719-2016; Warman AJ, 2013, J ANTIMICROB CHEMOTH, V68, P869, DOI 10.1093/jac/dks483; Weinstein EA, 2005, P NATL ACAD SCI USA, V102, P4548, DOI 10.1073/pnas.0500469102; WHO, 2017, TREATMENT TUBERCULOS; WHO, 2017, GLOB TUB REP 2017; Zheng J, 2013, J BIOL CHEM, V288, P23447, DOI 10.1074/jbc.M113.475798	33	28	28	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2019	294	6					1936	1943		10.1074/jbc.RA118.005732	http://dx.doi.org/10.1074/jbc.RA118.005732			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM8EO	30530783	Green Published, hybrid			2022-12-28	WOS:000459711400014
J	Turowec, JP; Lau, EWT; Wang, XW; Brown, KR; Fellouse, FA; Jawanda, KK; Pan, J; Moffat, J; Sidhu, SS				Turowec, Jacob P.; Lau, Esther W. T.; Wang, Xiaowei; Brown, Kevin R.; Fellouse, Frederic A.; Jawanda, Kamaldeep K.; Pan, James; Moffat, Jason; Sidhu, Sachdev S.			Functional genomic characterization of a synthetic anti-HER3 antibody reveals a role for ubiquitination by RNF41 in the anti-proliferative response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibody; antibody engineering; ubiquitylation (ubiquitination); functional genomics; E3 ubiquitin ligase; cell signaling; short hairpin RNA (shRNA); cancer; protein engineering; HER3; RNF41	EPIDERMAL-GROWTH-FACTOR; HER3 MONOCLONAL-ANTIBODY; CRYSTAL-STRUCTURE; PHOSPHATIDYLINOSITOL 3-KINASE; PREDICTIVE BIOMARKER; EXTRACELLULAR DOMAIN; MEK INHIBITION; EGF RECEPTOR; ERBB3; CANCER	Dysregulation of the ErbB family of receptor tyrosine kinases is involved in the progression of many cancers. Antibodies targeting the dimerization domains of family members EGFR and HER2 are approved cancer therapeutics, but efficacy is restricted to a subset of tumors and resistance often develops in response to treatment. A third family member, HER3, heterodimerizes with both EGFR and HER2 and has also been implicated in cancer. Consequently, there is strong interest in developing antibodies that target HER3, but to date, no therapeutics have been approved. To aid the development of anti-HER3 antibodies as cancer therapeutics, we combined antibody engineering and functional genomics screens to identify putative mechanisms of resistance or synthetic lethality with antibody-mediated anti-proliferative effects. We developed a synthetic antibody called IgG 95, which binds to HER3 and promotes ubiquitination, internalization, and receptor down-regulation. Using an shRNA library targeting enzymes in the ubiquitin proteasome system, we screened for genes that effect response to IgG 95 and uncovered the E3 ubiquitin ligase RNF41 as a driver of IgG 95 anti-proliferative activity. RNF41 has been shown previously to regulate HER3 levels under normal conditions and we now show that it is also responsible for down-regulation of HER3 upon treatment with IgG 95. Moreover, our findings suggest that down-regulation of RNF41 itself may be a mechanism for acquired resistance to treatment with IgG 95 and perhaps other anti-HER3 antibodies. Our work deepens our understanding of HER3 signaling by uncovering the mechanistic basis for the anti-proliferative effects of potential anti-HER3 antibody therapeutics.	[Turowec, Jacob P.; Lau, Esther W. T.; Wang, Xiaowei; Brown, Kevin R.; Fellouse, Frederic A.; Jawanda, Kamaldeep K.; Pan, James; Moffat, Jason; Sidhu, Sachdev S.] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Turowec, Jacob P.; Lau, Esther W. T.; Wang, Xiaowei; Brown, Kevin R.; Fellouse, Frederic A.; Jawanda, Kamaldeep K.; Pan, James; Moffat, Jason; Sidhu, Sachdev S.] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Dept Med Genet, Toronto, ON M5S 3E1, Canada; [Turowec, Jacob P.; Lau, Esther W. T.; Wang, Xiaowei; Brown, Kevin R.; Fellouse, Frederic A.; Jawanda, Kamaldeep K.; Pan, James; Moffat, Jason; Sidhu, Sachdev S.] Banting & Best Inst, Ctr Commercializat Antibodies & Biol, 100 Coll St, Toronto, ON M5G 1L5, Canada	University of Toronto; University of Toronto; University of Toronto	Moffat, J; Sidhu, SS (corresponding author), 160 Coll St, Toronto, ON M5S 3E1, Canada.	j.moffat@utoronto.ca; sachdev.sidhu@utoronto.ca	Moffat, Jason/AAC-1110-2020	Moffat, Jason/0000-0002-5663-8586; Brown, Kevin/0000-0002-5514-2538	Canadian Institutes of Health Research (CIHR) [MOP-136944]; CIHR post-doctoral fellowship; Mitacs Elevate fellowship	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR post-doctoral fellowship(Canadian Institutes of Health Research (CIHR)); Mitacs Elevate fellowship	This work was supported by Canadian Institutes of Health Research (CIHR) Grant MOP-136944 (to S. S.). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by a CIHR post-doctoral fellowship and a Mitacs Elevate fellowship.	Abel EV, 2013, J CLIN INVEST, V123, P2155, DOI 10.1172/JCI65780; Agus DB, 2002, CANCER CELL, V2, P127, DOI 10.1016/S1535-6108(02)00097-1; ALIMANDI M, 1995, ONCOGENE, V10, P1813; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Arteaga CL, 2014, CANCER CELL, V25, P282, DOI 10.1016/j.ccr.2014.02.025; Blakely K, 2011, METHODS MOL BIOL, V781, P161, DOI 10.1007/978-1-61779-276-2_9; Bouyain S, 2005, P NATL ACAD SCI USA, V102, P15024, DOI 10.1073/pnas.0507591102; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Cao ZW, 2007, MOL CELL BIOL, V27, P2180, DOI 10.1128/MCB.01245-06; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chen XM, 2000, BIOCHEM BIOPH RES CO, V277, P757, DOI 10.1006/bbrc.2000.3731; Cho HS, 2002, SCIENCE, V297, P1330, DOI 10.1126/science.1074611; Clague MJ, 2010, CELL, V143, P682, DOI 10.1016/j.cell.2010.11.012; Diamonti AJ, 2002, P NATL ACAD SCI USA, V99, P2866, DOI 10.1073/pnas.052709799; Fellouse FA, 2007, J MOL BIOL, V373, P924, DOI 10.1016/j.jmb.2007.08.005; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Freed DM, 2017, CELL, V171, P683, DOI 10.1016/j.cell.2017.09.017; Gaborit N, 2016, HUM VACC IMMUNOTHER, V12, P576, DOI 10.1080/21645515.2015.1102809; Garner AP, 2013, CANCER RES, V73, P6024, DOI 10.1158/0008-5472.CAN-13-1198; Garrett TPJ, 2003, MOL CELL, V11, P495, DOI 10.1016/S1097-2765(03)00048-0; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Gijsen M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000563; Hellyer NJ, 2001, J BIOL CHEM, V276, P42153, DOI 10.1074/jbc.M102079200; Hellyer NJ, 1998, BIOCHEM J, V333, P757, DOI 10.1042/bj3330757; Huang Z, 2015, ONCOGENE, V34, P1105, DOI 10.1038/onc.2014.56; HYNES NE, 1989, J CELL BIOCHEM, V39, P167, DOI 10.1002/jcb.240390208; Junttila TT, 2009, CANCER CELL, V15, P429, DOI 10.1016/j.ccr.2009.03.020; Lazrek Y, 2013, NEOPLASIA, V15, P335, DOI 10.1593/neo.121960; Le Clorennec C, 2017, MOL CANCER THER, V16, P1312, DOI 10.1158/1535-7163.MCT-16-0886; Le Clorennec C, 2016, ONCOTARGET, V7, P37013, DOI 10.18632/oncotarget.9455; Lee S, 2015, P NATL ACAD SCI USA, V112, P13225, DOI 10.1073/pnas.1518361112; Lefranc MP, 2003, DEV COMP IMMUNOL, V27, P55, DOI 10.1016/S0145-305X(02)00039-3; Liu JF, 2016, J CLIN ONCOL, V34, P4345, DOI 10.1200/JCO.2016.67.1891; Liu P, 2012, P NATL ACAD SCI USA, V109, P10861, DOI 10.1073/pnas.1201114109; Lu H, 2014, TUMOR BIOL, V35, P8639, DOI 10.1007/s13277-014-2132-5; Malm M, 2016, MABS-AUSTIN, V8, P1195, DOI 10.1080/19420862.2016.1212147; Marcotte R, 2012, CANCER DISCOV, V2, P172, DOI 10.1158/2159-8290.CD-11-0224; Meetze K, 2015, CLIN CANCER RES, V21, P1106, DOI 10.1158/1078-0432.CCR-14-2407; Mendell J, 2015, EBIOMEDICINE, V2, P264, DOI 10.1016/j.ebiom.2015.02.005; Meulendijks D, 2016, CLIN CANCER RES, V22, P877, DOI 10.1158/1078-0432.CCR-15-1683; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Montero-Conde C, 2013, CANCER DISCOV, V3, P520, DOI 10.1158/2159-8290.CD-12-0531; Nahta R, 2007, ONCOGENE, V26, P3637, DOI 10.1038/sj.onc.1210379; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Parakh S, 2017, CANCER TREAT REV, V59, P1, DOI 10.1016/j.ctrv.2017.06.005; Persson H, 2013, J MOL BIOL, V425, P803, DOI 10.1016/j.jmb.2012.11.037; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PinkasKramarski R, 1996, EMBO J, V15, P2452, DOI 10.1002/j.1460-2075.1996.tb00603.x; PRIGENT SA, 1994, EMBO J, V13, P2831, DOI 10.1002/j.1460-2075.1994.tb06577.x; Qiu XB, 2002, P NATL ACAD SCI USA, V99, P14843, DOI 10.1073/pnas.232580999; Rajan S, 2012, METHOD ENZYMOL, V502, P3, DOI 10.1016/B978-0-12-416039-2.00001-X; Ridgway JBB, 1996, PROTEIN ENG, V9, P617, DOI 10.1093/protein/9.7.617; Roepstorff K, 2009, TRAFFIC, V10, P1115, DOI 10.1111/j.1600-0854.2009.00943.x; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schoeberl B, 2010, CANCER RES, V70, P2485, DOI 10.1158/0008-5472.CAN-09-3145; Schulze Waltraud X, 2005, Mol Syst Biol, V1; Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474; Sheng Q, 2010, CANCER CELL, V17, P298, DOI 10.1016/j.ccr.2009.12.047; Shi FM, 2010, P NATL ACAD SCI USA, V107, P7692, DOI 10.1073/pnas.1002753107; Sidhu SS, 2004, J MOL BIOL, V338, P299, DOI 10.1016/j.jmb.2004.02.050; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; SOLTOFF SP, 1994, MOL CELL BIOL, V14, P3550, DOI 10.1128/MCB.14.6.3550; Steinhart Z, 2017, NAT MED, V23, P60, DOI 10.1038/nm.4219; Steinkamp MP, 2014, MOL CELL BIOL, V34, P965, DOI 10.1128/MCB.01605-13; Sun C, 2014, CELL REP, V7, P86, DOI 10.1016/j.celrep.2014.02.045; Tong JF, 2014, MOL CELL PROTEOMICS, V13, P1644, DOI 10.1074/mcp.M114.038596; Turke AB, 2012, CANCER RES, V72, P3228, DOI 10.1158/0008-5472.CAN-11-3747; Wilson TR, 2011, CANCER CELL, V20, P158, DOI 10.1016/j.ccr.2011.07.011; Xiao Z, 2016, MOL CANCER THER, V15, P689, DOI 10.1158/1535-7163.MCT-15-0555; Yen L, 2006, CANCER RES, V66, P11279, DOI 10.1158/0008-5472.CAN-06-2319; Yonesaka K, 2017, LUNG CANCER, V105, P1, DOI 10.1016/j.lungcan.2016.12.018; Zhang NY, 2016, ACTA BIOCH BIOPH SIN, V48, P39, DOI 10.1093/abbs/gmv103	72	1	1	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1396	1409		10.1074/jbc.RA118.004420	http://dx.doi.org/10.1074/jbc.RA118.004420			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30523157	Green Published, hybrid			2022-12-28	WOS:000457879500028
J	Tezuka, T; Ota, A; Karnan, S; Matsuura, K; Yokoo, K; Hosokawa, Y; Vigetti, D; Passi, A; Hatano, S; Umezawa, K; Watanabe, H				Tezuka, Takehiko; Ota, Akinobu; Karnan, Sivasundaram; Matsuura, Katsuhiko; Yokoo, Kazuhisa; Hosokawa, Yoshitaka; Vigetti, Davide; Passi, Alberto; Hatano, Sonoko; Umezawa, Kazuo; Watanabe, Hideto			The plant alkaloid conophylline inhibits matrix formation of fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						extracellular matrix; fibroblast; transforming growth factor (TGF); hyaluronan; collagen; fibrosis; anti-fibrotic; conophylline; stellate cell; Vinca alkaloid	EPITHELIAL-MESENCHYMAL TRANSITION; STELLATE CELLS; HYALURONAN; DIFFERENTIATION; TRANSCRIPTION; SUPPRESSES; EXPRESSION; FIBROSIS; COLLAGEN; BIOSYNTHESIS	Conophylline is a Vinca alkaloid from leaves of the tropical plant Ervatamia microphylla and has been shown to mimic the effect of the growth and differentiation factor activin A on pancreatic progenitor cells. However, activin A stimulates fibrosis of pancreatic stellate cells, whereas conophylline inhibits it, suggesting that this compound may serve as an antifibrotic drug. Here we investigated the effects of conophylline on human foreskin fibroblasts, especially focusing on extracellular matrix (ECM) proteins. A gene microarray analysis revealed that conophylline remarkably suppressed expression of the gene for hyaluronan synthase 2 (HAS2) and of its antisense RNA, whereas the expression of collagen genes was unaffected. Of note, immunostaining experiments revealed that conophylline substantially inhibits incorporation of versican and collagens into the ECM in cells treated with transforming growth factor (TGF), which promotes collagen synthesis, but not in cells not treated with TGF. Moreover, a protein biosynthesis assay disclosed that conophylline decreases collagen biosynthesis, concomitant with a decrease in total protein biosynthesis, indicating that conophylline-mediated inhibition of fibrosis is not specific to collagen synthesis. Conophylline affected neither TGF-induced nuclear translocation of SMAD family member 2/3 (SMAD2/3) nor phosphorylation of SMAD2. However, conophylline substantially inhibited phosphorylation of extracellular signal-regulated kinase 1/2 (ERK1/2), suggesting that conophylline inhibits HAS2 expression via TGF-mediated activation of the ERK1/2 pathway. Taken together, our results indicate that conophylline may be a useful inhibitor of ECM formation in fibrosis.	[Tezuka, Takehiko; Matsuura, Katsuhiko] Aichi Med Univ, Sch Med, Dept Pharm, 1-1 Yazakokarimata, Nagakute, Aichi 4801195, Japan; [Ota, Akinobu; Karnan, Sivasundaram; Hosokawa, Yoshitaka] Aichi Med Univ, Sch Med, Dept Biochem, 1-1 Yazakokarimata, Nagakute, Aichi 4801195, Japan; [Yokoo, Kazuhisa] Aichi Med Univ, Sch Med, Dept Plast & Reconstruct Surg, 1-1 Yazakokarimata, Nagakute, Aichi 4801195, Japan; [Umezawa, Kazuo] Aichi Med Univ, Sch Med, Dept Mol Target Med, 1-1 Yazakokarimata, Nagakute, Aichi 4801195, Japan; [Tezuka, Takehiko; Hatano, Sonoko; Watanabe, Hideto] Aichi Med Univ, Sch Med, Inst Mol Sci Med, 1-1 Yazakokarimata, Nagakute, Aichi 4801195, Japan; [Vigetti, Davide; Passi, Alberto] Univ Insubria, Dept Med & Surg, Via Guicciardini 9, I-21100 Varese, Italy	Aichi Medical University; Aichi Medical University; Aichi Medical University; Aichi Medical University; Aichi Medical University; University of Insubria	Watanabe, H (corresponding author), Aichi Med Univ, Inst Mol Sci Med, 1-1 Yazakokarimata, Nagakute, Aichi 4801195, Japan.	wannabee@aichi-med-u.ac.jp	Ota, Akinobu/CAC-5999-2022; passi, alberto g/A-1752-2018; Ota, Akinobu/AAI-9396-2020; Ota, Akinobu/H-4510-2019	Ota, Akinobu/0000-0002-6296-2921; passi, alberto g/0000-0003-3328-3089; Watanabe, Hideto/0000-0001-5291-0696	 [25293096];  [15K19561];  [25460395]	; ; 	This work was supported in part by Grant-in-Aid (KAKENHI) for Scientific Research B, 25293096 (to H. W.), Grant-in-Aid (KAKENHI) for Young Scientists B, 15K19561 (to A. O.), and Grant-in-Aid (KAKENHI) for Scientific Research C, 25460395 (to S. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Atsumi S, 2003, CELL MOL LIFE SCI, V60, P2516, DOI 10.1007/s00018-003-3299-x; Bedi A, 2012, MOL CANCER THER, V11, P2429, DOI 10.1158/1535-7163.MCT-12-0101-T; Birbrair A, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt512; BLOM A, 1995, J BIOL CHEM, V270, P9698, DOI 10.1074/jbc.270.17.9698; Chao H, 2005, J BIOL CHEM, V280, P27513, DOI 10.1074/jbc.M411544200; Etscheid M, 2005, CELL SIGNAL, V17, P1486, DOI 10.1016/j.cellsig.2005.03.007; Evanko SP, 2007, ADV DRUG DELIVER REV, V59, P1351, DOI 10.1016/j.addr.2007.08.008; Evanko SP, 2015, MATRIX BIOL, V42, P74, DOI 10.1016/j.matbio.2014.12.001; Ghatak S, 2017, J BIOL CHEM, V292, P10465, DOI 10.1074/jbc.M116.752451; HATA RI, 1980, BIOCHEMISTRY-US, V19, P169, DOI 10.1021/bi00542a026; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; KNUDSON CB, 1993, J CELL BIOL, V120, P825, DOI 10.1083/jcb.120.3.825; Kojima I, 2006, INT J BIOCHEM CELL B, V38, P923, DOI 10.1016/j.biocel.2005.09.019; Kolosova I, 2011, J CELL PHYSIOL, V226, P1248, DOI 10.1002/jcp.22448; Kubo N, 2014, LIVER INT, V34, P1057, DOI 10.1111/liv.12328; Li LL, 2007, BIOCHEM J, V404, P327, DOI 10.1042/BJ20061757; Li YJ, 2007, INT J CANCER, V120, P2557, DOI 10.1002/ijc.22550; Liu XY, 2014, CELL SIGNAL, V26, P2276, DOI 10.1016/j.cellsig.2014.05.018; Maeda-Sano K, 2014, BBA-MOL CELL BIOL L, V1841, P1256, DOI 10.1016/j.bbalip.2014.05.004; Makkonen KM, 2009, J BIOL CHEM, V284, P18270, DOI 10.1074/jbc.M109.012492; Michael DR, 2011, J BIOL CHEM, V286, P19523, DOI 10.1074/jbc.M111.233916; Monslow J, 2006, J BIOL CHEM, V281, P18043, DOI 10.1074/jbc.M510467200; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Murasawa Y, 2018, AM J PATHOL, V188, P432, DOI 10.1016/j.ajpath.2017.10.015; Nakade Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178436; Neary R, 2015, FIBROGENESIS TISSUE, V8, DOI 10.1186/s13069-015-0035-8; Ogata T, 2004, DIABETES, V53, P2596, DOI 10.2337/diabetes.53.10.2596; Porsch H, 2013, ONCOGENE, V32, P4355, DOI 10.1038/onc.2012.475; Renzoni EA, 2004, RESP RES, V5, DOI 10.1186/1465-9921-5-24; Saito R, 2012, ENDOCRINOLOGY, V153, P621, DOI 10.1210/en.2011-1767; Salustri A, 2004, DEVELOPMENT, V131, P1577, DOI 10.1242/dev.01056; Schiller M, 2010, J BIOL CHEM, V285, P409, DOI 10.1074/jbc.M109.038620; SCHRIER DJ, 1983, AM REV RESPIR DIS, V127, P614, DOI 10.1164/arrd.1983.127.5.614; Seubwai W, 2015, ONCOL RES, V23, P21, DOI 10.3727/096504015X14424348426071; Suwan K, 2009, J BIOL CHEM, V284, P8596, DOI 10.1074/jbc.M806927200; Tammi RH, 2011, FEBS J, V278, P1419, DOI 10.1111/j.1742-4658.2011.08070.x; Udabage L, 2005, CANCER RES, V65, P6139, DOI 10.1158/0008-5472.CAN-04-1622; UMEZAWA K, 1994, ANTICANCER RES, V14, P2413; Vigetti D, 2014, FASEB J, V28; Vigetti D, 2014, J BIOL CHEM, V289, P28816, DOI 10.1074/jbc.M114.597401; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	41	5	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					20214	20226		10.1074/jbc.RA118.005783	http://dx.doi.org/10.1074/jbc.RA118.005783			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30377255	hybrid, Green Published			2022-12-28	WOS:000454685900027
J	Waris, G; Livolsi, A; Imbert, V; Peyron, JF; Siddiqui, A				Waris, Gulam; Livolsi, Antonia; Imbert, Veronique; Peyron, Jean-Francois; Siddiqui, Aleem			RETRACTION: Withdrawal: Hepatitis C virus NS5A and subgenomic replicon activate NF-kappa B via tyrosine phosphorylation of I kappa B alpha and its degradation by calpain protease. (Retraction of Vol 278, Pg 40778, 2003)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Waris G, 2003, J BIOL CHEM, V278, P40778, DOI 10.1074/jbc.M303248200	1	0	0	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					20012	20012		10.1074/jbc.W118.007016	http://dx.doi.org/10.1074/jbc.W118.007016			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30593533	Green Published, hybrid			2022-12-28	WOS:000454685900010
J	Borchert, AJ; Downs, DM				Borchert, Andrew J.; Downs, Diana M.			Analyses of variants of the Ser/Thr dehydratase IlvA provide insight into 2-aminoacrylate metabolism in Salmonella enterica	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						pyridoxal phosphate; reactive nitrogen species (RNS); bacterial metabolism; Salmonella enterica; stress; 2-aminoacrylate; mathematical modeling; metabolic network; RidA; serine; threonine dehydratase	THREONINE DEAMINASE; ESCHERICHIA-COLI; REACTION SPECIFICITY; TYPHIMURIUM; FAMILY; YJGF; BIOSYNTHESIS; PURIFICATION; TRANSDUCTION; ISOLEUCINE	RidA is a conserved and broadly distributed protein that has enamine deaminase activity. In a variety of organisms tested thus far, lack of RidA results in the accumulation of the reactive metabolite 2-aminoacrylate (2AA), an obligate intermediate in the catalytic mechanism of several pyridoxal 5-phosphate (PLP)-dependent enzymes. This study reports the characterization of variants of the biosynthetic serine/threonine dehydratase (EC 4.3.1.19; IlvA), which is a significant generator of 2AA in the bacteria Salmonella enterica, Escherichia coli, and Pseudomonas aeruginosa and the yeast Saccharomyces cerevisiae. Two previously identified mutations, ilvA3210 and ilvA3211, suppressed the phenotypic growth consequences of 2AA accumulation in S. enterica. Characterization of the respective protein variants suggested that they affect 2AA metabolism in vivo by two different catalytic mechanisms, both leading to an overall reduction in serine dehydratase activity. To emphasize the physiological relevance of the in vitro enzyme characterization, we sought to explain in vivo phenotypes using these data. A simple mathematical model describing the impact these catalytic deficiencies had on 2AA production was generally supported by our data. However, caveats arose when kinetic parameters, determined in vitro, were used to predict formation of the isoleucine precursor 2-ketobutyrate and model in vivo (growth) behaviors. Altogether, our data support the need for a holistic approach, including in vivo and in vitro analyses, to generate data used in understanding and modeling metabolism.	[Borchert, Andrew J.; Downs, Diana M.] Univ Georgia, Dept Microbiol, 361 Biol Sci Bldg,120 Cedar St, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Downs, DM (corresponding author), Univ Georgia, Dept Microbiol, 361 Biol Sci Bldg,120 Cedar St, Athens, GA 30602 USA.	dmdowns@uga.edu	Borchert, Andrew John/AAH-5655-2021	Borchert, Andrew John/0000-0003-1435-3643	National Institutes of Health Competitive Grants Program Award [GM095837]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095837] Funding Source: NIH RePORTER	National Institutes of Health Competitive Grants Program Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Competitive Grants Program Award GM095837 (to D. M. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALBE KR, 1990, J THEOR BIOL, V143, P163, DOI 10.1016/S0022-5193(05)80266-8; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BALCH WE, 1976, APPL ENVIRON MICROB, V32, P781, DOI 10.1128/AEM.32.6.781-791.1976; BARAK Z, 1987, J BACTERIOL, V169, P3750, DOI 10.1128/jb.169.8.3750-3756.1987; Bazurto JV, 2016, MICROB CELL, V3, P260, DOI 10.15698/mic2016.06.509; Bazurto JV, 2016, MBIO, V7, DOI 10.1128/mBio.01840-15; Bazurto JV, 2011, GENETICS, V187, P623, DOI 10.1534/genetics.110.124362; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Borchert AJ, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00140-17; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURNS RO, 1968, J BIOL CHEM, V243, P178; Burns RO., 1971, METHOD ENZYMOL, V17B, P555; Cardinale S, 2012, BIOTECHNOL J, V7, P856, DOI 10.1002/biot.201200085; CHAN RK, 1972, VIROLOGY, V50, P883, DOI 10.1016/0042-6822(72)90442-4; CHEN JW, 1991, J BACTERIOL, V173, P2328, DOI 10.1128/JB.173.7.2328-2340.1991; Christopherson MR, 2008, J BACTERIOL, V190, P3057, DOI 10.1128/JB.01700-07; Christopherson MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043082; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DAVIS L, 1965, ANAL BIOCHEM, V12, P36, DOI 10.1016/0003-2697(65)90139-9; Downs DM, 2018, AIMS MICROBIOL, V4, P289, DOI 10.3934/microbiol.2018.2.289; Downs DM, 2015, MOL MICROBIOL, V96, P211, DOI 10.1111/mmi.12945; DOWNS DM, 1994, J BACTERIOL, V176, P4858, DOI 10.1128/jb.176.16.4858-4864.1994; EISENSTEIN E, 1995, ARCH BIOCHEM BIOPHYS, V316, P311, DOI 10.1006/abbi.1995.1042; Enos-Berlage JL, 1998, J BACTERIOL, V180, P6519, DOI 10.1128/JB.180.24.6519-6528.1998; Ernst DC, 2018, MBIO, V9, DOI 10.1128/mBio.00084-18; Ernst DC, 2016, MOL MICROBIOL, V101, P210, DOI 10.1111/mmi.13384; Ernst DC, 2016, J BACTERIOL, V198, P536, DOI 10.1128/JB.00804-15; Flynn JM, 2013, MOL MICROBIOL, V89, P751, DOI 10.1111/mmi.12313; Flynn JM, 2013, J BACTERIOL, V195, P3603, DOI 10.1128/JB.00463-13; Gallagher DT, 2004, METHOD ENZYMOL, V380, P85; Galloway NR, 2013, CRYST GROWTH DES, V13, P2833, DOI 10.1021/cg400171z; Hodge-Hanson KM, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00751-17; Hodge-Hanson KM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185544; HOFLER JG, 1978, J BIOL CHEM, V253, P1245; Kim JH, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.88; Kittleson JT, 2012, CURR OPIN CHEM BIOL, V16, P329, DOI 10.1016/j.cbpa.2012.06.009; Koenigsknecht MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048207; Koenigsknecht MJ, 2010, TRENDS MICROBIOL, V18, P240, DOI 10.1016/j.tim.2010.03.003; Kuznetsova IM, 2014, INT J MOL SCI, V15, P23090, DOI 10.3390/ijms151223090; Lal PB, 2014, MOL MICROBIOL, V94, P843, DOI 10.1111/mmi.12801; Lambrecht JA, 2013, MBIO, V4, DOI 10.1128/mBio.00033-13; Lambrecht JA, 2012, J BIOL CHEM, V287, P3454, DOI 10.1074/jbc.M111.304477; Lambrecht JA, 2010, J BIOL CHEM, V285, P34401, DOI 10.1074/jbc.M110.160515; LAROSSA RA, 1987, BIOESSAYS, V7, P125, DOI 10.1002/bies.950070308; Mehta V, 2016, BIOORG MED CHEM LETT, V26, P1005, DOI 10.1016/j.bmcl.2015.12.044; SCHMIEGER H, 1972, MOL GEN GENET, V119, P75, DOI 10.1007/BF00270447; Schmitz G, 2004, J BACTERIOL, V186, P803, DOI 10.1128/JB.186.3.803-810.2004; SEGEL IH, 1992, BIOCHEM EDUC, V20, P155, DOI 10.1016/0307-4412(92)90060-Y; Toney MD, 2005, ARCH BIOCHEM BIOPHYS, V433, P279, DOI 10.1016/j.abb.2004.09.037; Toney MD, 2011, BBA-PROTEINS PROTEOM, V1814, P1407, DOI 10.1016/j.bbapap.2011.05.019; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; ZARLENGO MH, 1968, J BIOL CHEM, V243, P186	53	4	4	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2018	293	50					19240	19249		10.1074/jbc.RA118.005626	http://dx.doi.org/10.1074/jbc.RA118.005626			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HE6RA	30327426	Green Published, hybrid			2022-12-28	WOS:000453537300008
J	Cai, R; Qimuge, N; Ma, ML; Wang, YQ; Tang, GR; Zhang, Q; Sun, YM; Chen, XC; Yu, TY; Dong, WZ; Yang, GS; Pang, WJ				Cai, Rui; Qimuge, Naren; Ma, Meilin; Wang, Yingqian; Tang, Guorong; Zhang, Que; Sun, Yunmei; Chen, Xiaochang; Yu, Taiyong; Dong, Wuzi; Yang, Gongshe; Pang, Weijun			MicroRNA-664-5p promotes myoblast proliferation and inhibits myoblast differentiation by targeting serum response factor and Wnt1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						microRNA (miRNA); muscle; myogenesis; Wnt pathway; cell proliferation; cell differentiation; post-transcriptional regulation	SKELETAL-MUSCLE; SIGNALING PATHWAY; GENE ONTOLOGY; CELL; EXPRESSION; SRF; TRANSCRIPTION; MYOCARDIN; MYOGENESIS; GROWTH	MicroRNAs (miRNAs) are noncoding RNAs that regulate gene expression at the post-transcriptional level and are involved in the regulation of the formation, maintenance, and function of skeletal muscle. Using miRNA sequencing and bioinformatics analysis, we previously found that the miRNA miR-664-5p is significantly differentially expressed in longissimus dorsi muscles of Rongchang pigs. However, the molecular mechanism by which miR-664-5p regulates myogenesis remains unclear. In this study, using flow cytometry, 5-ethynyl-2-deoxyuridine staining, and cell count and immunofluorescent assays, we found that cell-transfected miR-664-5p mimics greatly promoted proliferation of C2C12 mouse myoblasts by increasing the proportion of cells in the S- and G(2)-phases and up-regulating the expression of cell cycle genes. Moreover, miR-664-5p inhibited myoblast differentiation by down-regulating myogenic gene expression. In contrast, miR-664-5p inhibitor repressed myoblast proliferation and promoted myoblast differentiation. Mechanistically, using dual-luciferase reporter gene experiments, we demonstrated that miR-664-5p directly targets the 3-UTR of serum response factor (SRF) and Wnt1 mRNAs. We also observed that miR-664-5p inhibits both mRNA and protein levels of SRF and Wnt1 during myoblast proliferation and myogenic differentiation, respectively. Furthermore, the activating effect of miR-664-5p on myoblast proliferation was attenuated by SRF overexpression, and miR-664-5p repressed myogenic differentiation by diminishing the accumulation of nuclear -catenin. Of note, miR-664-5p's inhibitory effect on myogenic differentiation was abrogated by treatment with Wnt1 protein, the key activator of the Wnt/-catenin signaling pathway. Collectively, our findings suggest that miR-664-5p controls SRF and canonical Wnt/-catenin signaling pathways in myogenesis.	[Cai, Rui; Qimuge, Naren; Ma, Meilin; Wang, Yingqian; Tang, Guorong; Zhang, Que; Sun, Yunmei; Chen, Xiaochang; Yu, Taiyong; Dong, Wuzi; Yang, Gongshe; Pang, Weijun] Northwest A&F Univ, Coll Anim Sci & Technol, Lab Anim Fat Deposit & Muscle Dev, Yangling 712100, Shaanxi, Peoples R China	Northwest A&F University - China	Pang, WJ (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Lab Anim Fat Deposit & Muscle Dev, Yangling 712100, Shaanxi, Peoples R China.	pwj1226@nwsuaf.edu.cn	Tang, jay/GXF-3897-2022; Cai, Rui/GRO-1869-2022	Tang, Guping/0000-0003-3256-740X	National Natural Science Foundation [31572366, 31872979]; National Basic Research Programs of China [2015CB943102]; National Key Research and Development Program of China [2017YFD0502002]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Basic Research Programs of China(National Basic Research Program of China); National Key Research and Development Program of China	This work was supported by National Natural Science Foundation Grants 31572366 and 31872979, National Basic Research Programs of China Grant 2015CB943102, and the National Key Research and Development Program of China Grant 2017YFD0502002. The authors declare that they have no conflicts of interest with the contents of this article.	Abraham ST, 2016, IN VITRO CELL DEV-AN, V52, P935, DOI 10.1007/s11626-016-0058-5; Abu-Elmagd M, 2010, DEV BIOL, V337, P211, DOI 10.1016/j.ydbio.2009.10.023; Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Anderson C, 2006, NUCLEIC ACIDS RES, V34, P5863, DOI 10.1093/nar/gkl743; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Buckingham M, 2001, CURR OPIN GENET DEV, V11, P440, DOI 10.1016/S0959-437X(00)00215-X; Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x; Buckingham M, 2006, CURR OPIN GENET DEV, V16, P525, DOI 10.1016/j.gde.2006.08.008; Carbon S, 2017, NUCLEIC ACIDS RES, V45, pD331, DOI 10.1093/nar/gkw1108; Chen B, 2015, BIOMED PHARMACOTHER, V75, P1, DOI 10.1016/j.biopha.2015.08.012; Chen H, 2016, FISH SHELLFISH IMMUN, V55, P577, DOI 10.1016/j.fsi.2016.06.036; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen JF, 2010, J CELL BIOL, V190, P867, DOI 10.1083/jcb.200911036; DALTON S, 1993, PHILOS T ROY SOC B, V340, P325, DOI 10.1098/rstb.1993.0074; Du JJ, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/5276271; Du JJ, 2016, BIOSCI BIOTECH BIOCH, V80, P706, DOI 10.1080/09168451.2015.1123604; Feng Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.462; Goljanek-Whysall K, 2012, CLIN SCI, V123, P611, DOI 10.1042/CS20110634; Grumolato L, 2010, GENE DEV, V24, P2517, DOI 10.1101/gad.1957710; Han XR, 2015, FASEB J, V29, P3054, DOI 10.1096/fj.14-259952; Hauschka SD, 2001, MOL CELL, V8, P1, DOI 10.1016/S1097-2765(01)00297-0; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; L'honore A, 2003, MOL BIOL CELL, V14, P2151, DOI 10.1091/mbc.e02-07-0451; Lee I, 2009, GENOME RES, V19, P1175, DOI 10.1101/gr.089367.108; Li SJ, 2005, P NATL ACAD SCI USA, V102, P1082, DOI 10.1073/pnas.0409103102; Ma ML, 2017, RNA BIOL, V14, P347, DOI 10.1080/15476286.2017.1279786; MUNSTERBERG AE, 1995, GENE DEV, V9, P2911, DOI 10.1101/gad.9.23.2911; NORMAN C, 1988, CELL, V55, P989, DOI 10.1016/0092-8674(88)90244-9; Nusse R, 2008, CELL RES, V18, P523, DOI 10.1038/cr.2008.47; O'Rourke JR, 2007, DEV BIOL, V311, P359, DOI 10.1016/j.ydbio.2007.08.032; Polioudakis D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126535; Price MA, 1996, PHILOS T ROY SOC B, V351, P551, DOI 10.1098/rstb.1996.0054; Sethi JK, 2010, BIOCHEM J, V427, P1, DOI 10.1042/BJ20091866; Shi L, 2015, CELL SIGNAL, V27, P1895, DOI 10.1016/j.cellsig.2015.05.001; Sokol NS, 2012, CURR TOP DEV BIOL, V99, P59, DOI 10.1016/B978-0-12-387038-4.00003-3; Song P, 2014, MOL MED REP, V10, P1030, DOI 10.3892/mmr.2014.2261; Sun ZR, 2014, INT J MOL MED, V33, P1097, DOI 10.3892/ijmm.2014.1672; Tajbakhsh S, 1998, DEVELOPMENT, V125, P4155; TREISMAN R, 1995, EMBO J, V14, P4905, DOI 10.1002/j.1460-2075.1995.tb00173.x; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; van Delft JHM, 2010, TOXICOL SCI, V117, P381, DOI 10.1093/toxsci/kfq214; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Wang HY, 2015, INT J ONCOL, V47, P641, DOI 10.3892/ijo.2015.3034; Wang R, 2015, GENET MOL RES, V14, P7315, DOI 10.4238/2015.July.3.7; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Wei W, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.184; Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104; Yang Y, 2015, INT J CLIN EXP MED, V8, P18123; Yun KS, 1996, CURR OPIN CELL BIOL, V8, P877, DOI 10.1016/S0955-0674(96)80091-3; Zeng CX, 2015, ONCOTARGET, V6, P12224, DOI 10.18632/oncotarget.3652; Zhou HL, 2014, RNA, V20, P1431, DOI 10.1261/rna.045757.114	59	17	18	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2018	293	50					19177	19190		10.1074/jbc.RA118.003198	http://dx.doi.org/10.1074/jbc.RA118.003198			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HE6RA	30323063	Green Published, hybrid			2022-12-28	WOS:000453537300002
J	Zhang, Q; Han, X; Chen, JF; Xie, XM; Xu, JF; Zhao, Y; Shen, J; Hu, L; Xu, PL; Song, H; Zhang, L; Zhao, B; Wang, YJ; Xia, ZP				Zhang, Qiong; Han, Xu; Chen, Jinfeng; Xie, Xiaomei; Xu, Jiafeng; Zhao, Yang; Shen, Jie; Hu, Lin; Xu, Pinglong; Song, Hai; Zhang, Long; Zhao, Bin; Wang, Ying-jie; Xia, Zongping			Yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ) mediate cell density-dependent proinflammatory responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Hippo pathway; NF-B; histone deacetylase (HDAC); inflammation; cytokine; cell signaling; Yes-associated protein (YAP); COX-2; TAZ; TEADs	NF-KAPPA-B; HIPPO PATHWAY; CYCLOOXYGENASE-2 EXPRESSION; TUMOR-SUPPRESSOR; PROLIFERATION ARREST; TEAD/TEF FAMILY; UP-REGULATION; ORGAN SIZE; GROWTH; DROSOPHILA	A proper inflammatory response is critical to the restoration of tissue homeostasis after injury or infection, but how such a response is modulated by the physical properties of the cellular and tissue microenvironments is not fully understood. Here, using H358, HeLa, and HEK293T cells, we report that cell density can modulate inflammatory responses through the Hippo signaling pathway. We found that NF-B activation through the proinflammatory cytokines interleukin-1 (IL-1) and tumor necrosis factor (TNF) is not affected by cell density. However, we also noted that specific NF-B target genes, such as cyclooxygenase 2 (COX-2), are induced much less at low cell densities than at high cell densities. Mechanistically, we observed that the transcriptional coactivators Yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ) are localized to the nucleus, bind to TEA domain transcription factors (TEADs), recruit histone deacetylase 7 (HDAC7) to the promoter region of COX-2, and repress its transcription at low cell density and that high cell density abrogates this YAP/TAZ-mediated transcriptional repression. Of note, IL-1 stimulation promoted cell migration and invasion mainly through COX-2 induction, but YAP inhibited this induction and thus cell migration and invasion. These results suggest that YAP/TAZ-TEAD interactions can repress COX-2 transcription and thereby mediate cell density-dependent modulation of proinflammatory responses. Our findings highlight that the cellular microenvironment significantly influences inflammatory responses via the Hippo pathway.	[Zhang, Qiong; Han, Xu; Xie, Xiaomei; Xu, Jiafeng; Zhao, Yang; Xu, Pinglong; Song, Hai; Zhang, Long; Zhao, Bin; Xia, Zongping] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Zhang, Qiong; Han, Xu; Xie, Xiaomei; Xu, Jiafeng; Zhao, Yang; Xu, Pinglong; Song, Hai; Zhang, Long; Zhao, Bin; Xia, Zongping] Zhejiang Univ, Innovat Ctr Cell Signaling Network, Hangzhou 310058, Zhejiang, Peoples R China; [Zhang, Qiong; Chen, Jinfeng; Xia, Zongping] Zhengzhou Univ, Affiliated Hosp 1, Translat Med Ctr, Zhengzhou 450052, Henan, Peoples R China; [Zhang, Qiong; Wang, Ying-jie] Zhejiang Univ, Coll Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China; [Shen, Jie] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Med Oncol, Hangzhou 310003, Zhejiang, Peoples R China; [Xie, Xiaomei] Zhejiang Gongshang Univ, Youth League Comm, Hangzhou 310018, Zhejiang, Peoples R China; [Hu, Lin] Soochow Univ, Inst Biol Sci, Suzhou 215000, Jiangsu, Peoples R China; [Hu, Lin] Soochow Univ, Inst Med Sci, Suzhou 215000, Jiangsu, Peoples R China	Zhejiang University; Zhejiang University; Zhengzhou University; Zhejiang University; Zhejiang University; Zhejiang Gongshang University; Soochow University - China; Soochow University - China	Xia, ZP (corresponding author), Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China.; Xia, ZP (corresponding author), Zhejiang Univ, Innovat Ctr Cell Signaling Network, Hangzhou 310058, Zhejiang, Peoples R China.; Xia, ZP (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Translat Med Ctr, Zhengzhou 450052, Henan, Peoples R China.	zxia2018@zzu.edu.cn	Zhang, Long/AAT-6571-2021; Xu, Pinglong/AAF-6838-2019; Xu, Pinglong/AAN-2506-2021	Zhang, Long/0000-0001-8139-0474; Xu, Pinglong/0000-0001-7726-5443; Hu, Lin/0000-0001-8986-3918	National Key Research and Development Program of China, Stem Cell and Translational Research Grant [2016YFA0100300]; Natural Science Foundation of China [31571445, 31371416, 31401200]	National Key Research and Development Program of China, Stem Cell and Translational Research Grant; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Key Research and Development Program of China, Stem Cell and Translational Research Grant 2016YFA0100300 (to Z.X. and Y.W.) and Natural Science Foundation of China Grants 31571445 and 31371416 (to Z.X.) and 31401200 (to X.H.). The authors declare that they have no conflicts of interest with the contents of this article.	Abolhassani M, 2008, INFLAMM RES, V57, P419, DOI 10.1007/s00011-007-7213-0; Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Basan M, 2009, HFSP J, V3, P265, DOI 10.2976/1.3086732; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Cha YI, 2006, DEV BIOL, V289, P263, DOI 10.1016/j.ydbio.2005.10.013; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; Chen CL, 2010, P NATL ACAD SCI USA, V107, P15810, DOI 10.1073/pnas.1004060107; Cianchi F, 2001, GASTROENTEROLOGY, V121, P1339, DOI 10.1053/gast.2001.29691; Creasy CL, 1995, GENE, V167, P303, DOI 10.1016/0378-1119(95)00653-2; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dubois RN, 1998, FASEB J, V12, P1063, DOI 10.1096/fasebj.12.12.1063; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Ehsanian R, 2010, ONCOGENE, V29, P6160, DOI 10.1038/onc.2010.339; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Guo XC, 2017, GENE DEV, V31, P247, DOI 10.1101/gad.294348.116; Halder G, 2012, NAT REV MOL CELL BIO, V13, P591, DOI 10.1038/nrm3416; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Howe LR, 2001, J BIOL CHEM, V276, P20108, DOI 10.1074/jbc.M010692200; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Huang SP, 2005, J BIOMED SCI, V12, P229, DOI 10.1007/s11373-004-8177-5; Jang BC, 2000, J BIOL CHEM, V275, P39507, DOI 10.1074/jbc.M003224200; Jiang SW, 1996, J BIOL CHEM, V271, P9510, DOI 10.1074/jbc.271.16.9510; Kaidi A, 2006, CANCER RES, V66, P6683, DOI 10.1158/0008-5472.CAN-06-0425; Kango-Singh M, 2002, DEVELOPMENT, V129, P5719, DOI 10.1242/dev.00168; Kim HS, 2003, LUNG CANCER-J IASLC, V42, P163, DOI 10.1016/S0169-5002(03)00290-3; Kim M, 2015, CELL REP, V11, P270, DOI 10.1016/j.celrep.2015.03.015; Komuro A, 2003, J BIOL CHEM, V278, P33334, DOI 10.1074/jbc.M305597200; Kulinsky VI, 2007, BIOCHEMISTRY-MOSCOW+, V72, P595, DOI 10.1134/S0006297907060028; Lai ZC, 2005, CELL, V120, P675, DOI 10.1016/j.cell.2004.12.036; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liu B, 2016, CELL, V164, P406, DOI 10.1016/j.cell.2015.12.029; Liu CY, 2010, J BIOL CHEM, V285, P37159, DOI 10.1074/jbc.M110.152942; Liu T, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.23; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Moroishi T, 2016, CELL, V167, P1525, DOI 10.1016/j.cell.2016.11.005; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Nowell CS, 2016, NAT CELL BIOL, V18, P168, DOI 10.1038/ncb3290; Park HW, 2015, CELL, V162, P780, DOI 10.1016/j.cell.2015.07.013; Praskova M, 2008, CURR BIOL, V18, P311, DOI 10.1016/j.cub.2008.02.006; Rauskolb C, 2014, CELL, V158, P143, DOI 10.1016/j.cell.2014.05.035; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Schmedtje JF, 1997, J BIOL CHEM, V272, P601; Schwartz L, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-21; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Sharif GM, 2015, ONCOGENE, V34, P5879, DOI 10.1038/onc.2015.44; Sheehan KM, 1999, JAMA-J AM MED ASSOC, V282, P1254, DOI 10.1001/jama.282.13.1254; Shimomura T, 2014, BIOCHEM BIOPH RES CO, V443, P917, DOI 10.1016/j.bbrc.2013.12.100; Sorokin L, 2010, NAT REV IMMUNOL, V10, P712, DOI 10.1038/nri2852; Stein C, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005465; Strano S, 2001, J BIOL CHEM, V276, P15164, DOI 10.1074/jbc.M010484200; Tse JM, 2012, P NATL ACAD SCI USA, V109, P911, DOI 10.1073/pnas.1118910109; Tucker ON, 1999, CANCER RES, V59, P987; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748; Wada KI, 2011, DEVELOPMENT, V138, P3907, DOI 10.1242/dev.070987; Wang DZ, 2004, P NATL ACAD SCI USA, V101, P415, DOI 10.1073/pnas.0307640100; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Williams CS, 2000, J CLIN INVEST, V105, P1589, DOI 10.1172/JCI9621; Wu S, 2008, DEV CELL, V14, P388, DOI 10.1016/j.devcel.2008.01.007; XU TA, 1995, DEVELOPMENT, V121, P1053; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; Yip-Schneider MT, 2000, CARCINOGENESIS, V21, P139, DOI 10.1093/carcin/21.2.139; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Yu SJ, 2013, CLIN CANCER RES, V19, P1389, DOI 10.1158/1078-0432.CCR-12-1959; Zelenay S, 2015, CELL, V162, P1257, DOI 10.1016/j.cell.2015.08.015; Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006; Zhang Q, 2017, NAT CELL BIOL, V19, P362, DOI 10.1038/ncb3496; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2012, GENE DEV, V26, P54, DOI 10.1101/gad.173435.111; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810	75	22	24	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2018	293	47					18071	18085		10.1074/jbc.RA118.004251	http://dx.doi.org/10.1074/jbc.RA118.004251			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8XM	30315101	hybrid, Green Published			2022-12-28	WOS:000451375200005
J	Katagiri, Y; Morgan, AA; Yu, PP; Bangayan, NJ; Junka, R; Geller, HM				Katagiri, Yasuhiro; Morgan, Ashlea A.; Yu, Panpan; Bangayan, Nathanael J.; Junka, Radoslaw; Geller, Herbert M.			Identification of novel binding sites for heparin in receptor protein-tyrosine phosphatase (RPTP sigma): Implications for proteoglycan signaling (vol 293, pg 11639, 2018)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction									[Katagiri, Yasuhiro] Kanazawa Univ, Cellular Transplantat Biol, Grad Sch Med Sci, Kanazawa, Ishikawa 9201192, Japan	Kanazawa University	Katagiri, Y (corresponding author), Kanazawa Univ, Cellular Transplantat Biol, Grad Sch Med Sci, Kanazawa, Ishikawa 9201192, Japan.			Morgan, Ashlea/0000-0002-3235-2567	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006021] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Katagiri Y, 2018, J BIOL CHEM, V293, P11639, DOI 10.1074/jbc.RA118.003081	1	0	0	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2018	293	41					15887	15887		10.1074/jbc.AAC118.005864	http://dx.doi.org/10.1074/jbc.AAC118.005864			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW8UH	30315085	hybrid, Green Published			2022-12-28	WOS:000447256000011
J	Chepurny, OG; Matsoukas, MT; Liapakis, G; Leech, CA; Milliken, BT; Doyle, RP; Holz, GG				Chepurny, Oleg G.; Matsoukas, Minos-Timotheos; Liapakis, George; Leech, Colin A.; Milliken, Brandon T.; Doyle, Robert P.; Holz, George G.			Nonconventional glucagon and GLP-1 receptor agonist and antagonist interplay at the GLP-1 receptor revealed in high-throughput FRET assays for cAMP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glucagon; G protein-coupled receptor (GPCR); pharmacology; fluorescence resonance energy transfer (FRET); type 2 diabetes; GLP-1; high-throughput microplate assay	DEPENDENT INSULINOTROPIC POLYPEPTIDE; PANCREATIC BETA-CELLS; NEUROPEPTIDE YY2 RECEPTOR; CRYO-EM STRUCTURE; PEPTIDE-1 RECEPTOR; PROTEIN-KINASE; FUNCTIONAL EXPRESSION; GLUCOSE-HOMEOSTASIS; BLOOD-GLUCOSE; CLONING	G protein-coupled receptors (GPCRs) for glucagon (GluR) and glucagon-like peptide-1 (GLP-1R) are normally considered to be highly selective for glucagon and GLP-1, respectively. However, glucagon secreted from pancreatic -cells may accumulate at high concentrations to exert promiscuous effects at the -cell GLP-1R, as may occur in the volume-restricted microenvironment of the islets of Langerhans. Furthermore, systemic administration of GluR or GLP-1R agonists and antagonists at high doses may lead to off-target effects at other receptors. Here, we used molecular modeling to evaluate data derived from FRET assays that detect cAMP as a read-out for GluR and GLP-1R activation. This analysis established that glucagon is a nonconventional GLP-1R agonist, an effect inhibited by the GLP-1R orthosteric antagonist exendin(9-39) (Ex(9-39)). The GluR allosteric inhibitors LY2409021 and MK 0893 antagonized glucagon and GLP-1 action at the GLP-1R, whereas des-His(1)-[Glu(9)]glucagon antagonized glucagon action at the GluR, while having minimal inhibitory action versus glucagon or GLP-1 at the GLP-1R. When testing Ex(9-39) in combination with des-His(1)-[Glu(9)]glucagon in INS-1 832/13 cells, we validated a dual agonist action of glucagon at the GluR and GLP-1R. Hybrid peptide GGP817 containing glucagon fused to a fragment of peptide YY (PYY) acted as a triagonist at the GluR, GLP-1R, and neuropeptide Y2 receptor (NPY2R). Collectively, these findings provide a new triagonist strategy with which to target the GluR, GLP-1R, and NPY2R. They also provide an impetus to reevaluate prior studies in which GluR and GLP-1R agonists and antagonists were assumed not to exert promiscuous actions at other GPCRs.	[Chepurny, Oleg G.; Doyle, Robert P.; Holz, George G.] SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA; [Leech, Colin A.] SUNY Upstate Med Univ, Dept Surg, Syracuse, NY 13210 USA; [Holz, George G.] SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA; [Matsoukas, Minos-Timotheos] Univ Patras, Dept Pharm, Patras 26500, Greece; [Liapakis, George] Univ Crete, Dept Pharmacol, Sch Med, Iraklion 71003, Crete, Greece; [Milliken, Brandon T.; Doyle, Robert P.] Syracuse Univ, Dept Chem, Syracuse, NY 13244 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; University of Patras; University of Crete; Syracuse University	Doyle, RP; Holz, GG (corresponding author), SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA.; Holz, GG (corresponding author), SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA.; Doyle, RP (corresponding author), Syracuse Univ, Dept Chem, Syracuse, NY 13244 USA.	rpdoyle@syr.edu; holzg@upstate.edu	Matsoukas, Minos-Timotheos/B-8746-2012; Doyle, Robert P/W-1921-2018; Holz, George G/A-3386-2012	Matsoukas, Minos-Timotheos/0000-0002-4642-8163; Holz, George/0000-0002-1781-3580	National Institutes of Health [R01-DK069575]; Holz Laboratory Diabetes Research Fund; SUNY Upstate Medical University Health Science Center Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069575] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Holz Laboratory Diabetes Research Fund; SUNY Upstate Medical University Health Science Center Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant R01-DK069575 (to G. G. H.) and by the Holz Laboratory Diabetes Research Fund, dedicated to Mignon M. Holz of the SUNY Upstate Medical University Health Science Center Foundation. Syracuse University holds patent rights on GGP817 conceived of by R. P. D. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alhadeff AL, 2012, ENDOCRINOLOGY, V153, P647, DOI 10.1210/en.2011-1443; Allen MD, 2006, BIOCHEM BIOPH RES CO, V348, P716, DOI 10.1016/j.bbrc.2006.07.136; Batterham RL, 2002, NATURE, V418, P650, DOI 10.1038/nature00887; Brandt SJ, 2018, PEPTIDES, V100, P190, DOI 10.1016/j.peptides.2017.12.021; Calabria AC, 2012, DIABETES, V61, P2585, DOI 10.2337/db12-0166; Capozzi ME, 2018, ENDOCR REV, V39, P719, DOI 10.1210/er.2018-00117; Chabenne J, 2014, MOL METAB, V3, P293, DOI 10.1016/j.molmet.2014.01.006; Chambers AP, 2017, CELL METAB, V25, P927, DOI 10.1016/j.cmet.2017.02.008; Chepurny OG, 2002, ENDOCRINOLOGY, V143, P2303, DOI 10.1210/en.143.6.2303; Chepurny OG, 2007, J BIOMOL SCREEN, V12, P740, DOI 10.1177/1087057107301856; Chepurny OG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22106-1; Chepurny OG, 2009, J BIOL CHEM, V284, P10728, DOI 10.1074/jbc.M900166200; Cooper J, 1997, BRIT J PHARMACOL, V122, P546, DOI 10.1038/sj.bjp.0701401; Cypess A. M., 1999, THESIS; D'Alessio D, 2016, J DIABETES INVEST, V7, P50, DOI 10.1111/jdi.12466; Day JW, 2009, NAT CHEM BIOL, V5, P749, DOI 10.1038/nchembio.209; Donath MY, 2013, DIABETES CARE, V36, pS145, DOI 10.2337/dcS13-2015; Dong MQ, 2008, MOL ENDOCRINOL, V22, P1489, DOI 10.1210/me.2008-0025; Dumont Y, 2000, BRIT J PHARMACOL, V129, P1075, DOI 10.1038/sj.bjp.0703162; Engel SS, 2011, DIABETES, V60, pA85; Evers A, 2017, J MED CHEM, V60, P4293, DOI 10.1021/acs.jmedchem.7b00174; Finan B, 2015, NAT MED, V21, P27, DOI 10.1038/nm.3761; Gault VA, 2013, J BIOL CHEM, V288, P35581, DOI 10.1074/jbc.M113.512046; GOKE R, 1993, J BIOL CHEM, V268, P19650; GREMLICH S, 1995, DIABETES, V44, P1202, DOI 10.2337/diabetes.44.10.1202; GROMADA J, 1995, FEBS LETT, V373, P182, DOI 10.1016/0014-5793(95)01070-U; Guzman CB, 2017, DIABETES OBES METAB, V19, P1521, DOI 10.1111/dom.12958; Habib AM, 2013, DIABETOLOGIA, V56, P1413, DOI 10.1007/s00125-013-2887-z; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Holz G, 2004, HORM METAB RES, V36, P787, DOI 10.1055/s-2004-826165; Holz G. G., 2015, CYCLIC NUCLEOTIDE SI, P35; Holz George G, 2005, Sci STKE, V2005, ppe2; Holz GG, 2003, CURR MED CHEM, V10, P2471, DOI 10.2174/0929867033456648; HOLZ GG, 1992, TRENDS BIOCHEM SCI, V17, P388, DOI 10.1016/0968-0004(92)90006-U; HOLZ GG, 1993, NATURE, V361, P362, DOI 10.1038/361362a0; Jazayeri A, 2016, NATURE, V533, P274, DOI 10.1038/nature17414; JELINEK LJ, 1993, SCIENCE, V259, P1614, DOI 10.1126/science.8384375; Jiang YW, 2001, P NATL ACAD SCI USA, V98, P10102, DOI 10.1073/pnas.131200398; Karageorgos V, 2018, HORM-INT J ENDOCRINO, V17, P45, DOI 10.1007/s42000-018-0009-5; KAWAI K, 1995, DIABETOLOGIA, V38, P274, DOI 10.1007/BF00400630; Kazda CM, 2016, DIABETES CARE, V39, P1241, DOI 10.2337/dc15-1643; Kelly RP, 2015, DIABETES OBES METAB, V17, P414, DOI 10.1111/dom.12446; Kim SJ, 2005, J BIOL CHEM, V280, P28692, DOI 10.1074/jbc.M504913200; Kjaergaard M, 2019, NEUROPEPTIDES, V73, P89, DOI 10.1016/j.npep.2018.11.004; Klarenbeek J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122513; Koebel MR, 2016, J CHEM INF MODEL, V56, P2298, DOI 10.1021/acs.jcim.6b00236; Larsen PJ, 1997, NEUROSCIENCE, V77, P257, DOI 10.1016/S0306-4522(96)00434-4; Leech CA, 2011, PROG BIOPHYS MOL BIO, V107, P236, DOI 10.1016/j.pbiomolbio.2011.07.005; Liang YL, 2018, NATURE, V555, P121, DOI 10.1038/nature25773; Liapakis G, 2017, CURR MED CHEM, V24, P3323, DOI 10.2174/0929867324666170303162416; Marchetti P, 2012, DIABETOLOGIA, V55, P3262, DOI 10.1007/s00125-012-2716-9; Moens K, 1998, DIABETES, V47, P66, DOI 10.2337/diabetes.47.1.66; Muller TD, 2017, PHYSIOL REV, V97, P721, DOI 10.1152/physrev.00025.2016; Nadkarni P, 2014, PROG MOL BIOL TRANSL, V121, P23, DOI 10.1016/B978-0-12-800101-1.00002-8; Nie Y, 2000, J CLIN INVEST, V105, P955, DOI 10.1172/JCI7456; O'Malley TJ, 2014, DIABETES-METAB RES, V30, P661, DOI 10.1002/dmrr.2534; Parker SL, 2008, BRIT J PHARMACOL, V153, P420, DOI 10.1038/sj.bjp.0707445; ROSE PM, 1995, J BIOL CHEM, V270, P22661, DOI 10.1074/jbc.270.39.22661; Runge S, 2008, J BIOL CHEM, V283, P11340, DOI 10.1074/jbc.M708740200; Sanchez-Garrido MA, 2017, DIABETOLOGIA, V60, P1851, DOI 10.1007/s00125-017-4354-8; Sathananthan M, 2013, DIABETES, V62, P2752, DOI 10.2337/db13-0140; Schirra J, 1998, J CLIN INVEST, V101, P1421, DOI 10.1172/JCI1349; Schwede F, 2015, MOL ENDOCRINOL, V29, P988, DOI 10.1210/me.2014-1330; Scott RV, 2018, PEPTIDES, V100, P36, DOI 10.1016/j.peptides.2017.11.013; Serre V, 1998, ENDOCRINOLOGY, V139, P4448, DOI 10.1210/en.139.11.4448; Skow MA, 2016, DIABETES OBES METAB, V18, P847, DOI 10.1111/dom.12685; Song GJ, 2017, NATURE, V546, P312, DOI 10.1038/nature22378; Svendsen B, 2018, CELL REP, V25, P1127, DOI 10.1016/j.celrep.2018.10.018; THORENS B, 1993, DIABETES, V42, P1678, DOI 10.2337/diabetes.42.11.1678; THORENS B, 1992, P NATL ACAD SCI USA, V89, P8641, DOI 10.1073/pnas.89.18.8641; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Underwood CR, 2010, J BIOL CHEM, V285, P723, DOI 10.1074/jbc.M109.033829; UNSON CG, 1987, P NATL ACAD SCI USA, V84, P4083, DOI 10.1073/pnas.84.12.4083; Whalley NM, 2011, J ENDOCRINOL, V211, P99, DOI 10.1530/JOE-11-0094; Wootten D, 2013, P NATL ACAD SCI USA, V110, P5211, DOI 10.1073/pnas.1221585110; Wren AM, 2007, GASTROENTEROLOGY, V132, P2116, DOI 10.1053/j.gastro.2007.03.048; Xiao Q, 2000, J MOL ENDOCRINOL, V25, P321, DOI 10.1677/jme.0.0250321; Xiong YS, 2012, J MED CHEM, V55, P6137, DOI 10.1021/jm300579z; Zhang HN, 2018, NATURE, V553, P106, DOI 10.1038/nature25153; Zhang HN, 2017, NATURE, V546, P259, DOI 10.1038/nature22363; Zhang Y, 2017, NATURE, V546, P248, DOI 10.1038/nature22394	81	20	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3514	3531		10.1074/jbc.RA118.005682	http://dx.doi.org/10.1074/jbc.RA118.005682			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30622136	Green Published, hybrid			2022-12-28	WOS:000461853900018
J	Watari, M; Ikuta, T; Yamada, D; Shihoya, W; Yoshida, K; Tsunoda, SP; Nureki, O; Kandori, H				Watari, Masahito; Ikuta, Tatsuya; Yamada, Daichi; Shihoya, Wataru; Yoshida, Kazuho; Tsunoda, Satoshi P.; Nureki, Osamu; Kandori, Hideki			Spectroscopic study of the transmembrane domain of a rhodopsin-phosphodiesterase fusion protein from a unicellular eukaryote	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphodiesterase; spectroscopy; photoreceptor; proton transport; structure-function; rhodopsin; microbial rhodopsin; photoisomerization; proton transfer; structural change; optogenetics; light-activated enzyme; chromophore	ANABAENA SENSORY RHODOPSIN; INDUCED STRUCTURAL-CHANGES; INTERNAL WATER-MOLECULES; HYDROGEN-BONDED WATER; SCHIFF-BASE REGION; MICROBIAL RHODOPSINS; FTIR SPECTROSCOPY; ADENYLYL-CYCLASE; BACTERIORHODOPSIN; CHANNELRHODOPSIN-2	The choanoflagellate Salpingoeca rosetta contains a chimeric rhodopsin protein composed of an N-terminal rhodopsin (Rh) domain and a C-terminal cyclic nucleotide phosphodiesterase (PDE) domain. The Rh-PDE enzyme light-dependently decreases the concentrations of cyclic nucleotides such as cGMP and cAMP. Photoexcitation of purified full-length Rh-PDE yields an M intermediate with a deprotonated Schiff base, and its recovery is much faster than that of the enzyme domain. To gain structural and mechanistic insights into the Rh domain, here we expressed and purified the transmembrane domain of Rh-PDE, Rh-PDE(TMD), and analyzed it with transient absorption, light-induced difference UV-visible, and FTIR spectroscopy methods. These analyses revealed that the K intermediate forms within 0.005 ms and converts into the M intermediate with a time constant of 4 ms, with the latter returning to the original state within 4 s. FTIR spectroscopy revealed that all-trans to 13-cis photoisomerization occurs as the primary event during which chromophore distortion is located at the middle of the polyene chain, allowing the Schiff base to form a stronger hydrogen bond. We also noted that the peptide backbone of the -helix becomes deformed upon M intermediate formation. Results from site-directed mutagenesis suggested that Glu-164 is protonated and that Asp-292 acts as the only Schiff base counterion in Rh-PDE. A strong reduction of enzymatic activity in a D292N variant, but not in an E164Q variant, indicated an important catalytic role of the negative charge at Asp-292. Our findings provide further mechanistic insights into rhodopsin-mediated, light-dependent regulation of second-messenger levels in eukaryotic microbes.	[Watari, Masahito; Yamada, Daichi; Yoshida, Kazuho; Tsunoda, Satoshi P.; Kandori, Hideki] Nagoya Inst Technol, Dept Life Sci & Appl Chem, Showa Ku, Nagoya, Aichi 4668555, Japan; [Tsunoda, Satoshi P.; Kandori, Hideki] Nagoya Inst Technol, OptoBioTechnol Res Ctr, Showa Ku, Nagoya, Aichi 4668555, Japan; [Ikuta, Tatsuya; Shihoya, Wataru; Nureki, Osamu] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Tsunoda, Satoshi P.] Japan Sci & Technol Agcy, PRESTO, 4-1-8 Honcho, Kawaguchi, Saitama 3320012, Japan	Nagoya Institute of Technology; Nagoya Institute of Technology; University of Tokyo; Japan Science & Technology Agency (JST)	Kandori, H (corresponding author), Nagoya Inst Technol, Dept Life Sci & Appl Chem, Showa Ku, Nagoya, Aichi 4668555, Japan.; Kandori, H (corresponding author), Nagoya Inst Technol, OptoBioTechnol Res Ctr, Showa Ku, Nagoya, Aichi 4668555, Japan.	kandori@nitech.ac.jp	Tsunoda, Satoshi/AAN-7023-2021; NUREKI, OSAMU/G-4960-2014	Ikuta, Tatsuya/0000-0002-8597-0609; Tsunoda, Satoshi/0000-0003-3636-1521	Japanese Ministry of Education, Culture, Sports, Science, and Technology [17J30010, 18K14634, 18K06109, 16H06294, 25104009, 15H02391, 18H03986]; CREST, Japan Science and Technology Agency [JPMJCR1753]; PRESTO, Japan Science and Technology Agency [JPMJPR1688]	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); CREST, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); PRESTO, Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by Japanese Ministry of Education, Culture, Sports, Science, and Technology Grants 17J30010 and 18K14634 (to W. S.), 18K06109 (to S. P. T.) and 16H06294 (to O. N.), and 25104009, 15H02391, and 18H03986 (to H. K.); by CREST, Japan Science and Technology Agency, Grant JPMJCR1753 (to H. K.); and by PRESTO, Japan Science and Technology Agency, Grant JPMJPR1688 (to S. P. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Avelar GM, 2014, CURR BIOL, V24, P1234, DOI 10.1016/j.cub.2014.04.009; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brown LS, 2014, BBA-BIOENERGETICS, V1837, P553, DOI 10.1016/j.bbabio.2013.05.006; Eisenhauer K, 2012, J BIOL CHEM, V287, P6904, DOI 10.1074/jbc.M111.327700; Ernst OP, 2014, CHEM REV, V114, P126, DOI 10.1021/cr4003769; Furutani Y, 2005, BIOCHEMISTRY-US, V44, P12287, DOI 10.1021/bi050841o; Furutani Y, 2004, BIOCHEMISTRY-US, V43, P5204, DOI 10.1021/bi036316b; Gao SQ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9046; Goehring A, 2014, NAT PROTOC, V9, P2574, DOI 10.1038/nprot.2014.173; Govorunova EG, 2017, ANNU REV BIOCHEM, V86, P845, DOI 10.1146/annurev-biochem-101910-144233; Grote M, 2014, BBA-BIOENERGETICS, V1837, P533, DOI 10.1016/j.bbabio.2013.08.006; Hashimoto K, 2010, BIOCHEMISTRY-US, V49, P3343, DOI 10.1021/bi100184k; Ikeda D, 2007, BIOCHEMISTRY-US, V46, P5365, DOI 10.1021/bi700143g; Inaguma A, 2015, J BIOL CHEM, V290, P11623, DOI 10.1074/jbc.M115.642256; Inoue K, 2015, TRENDS MICROBIOL, V23, P91, DOI 10.1016/j.tim.2014.10.009; Inoue K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2689; Inoue K, 2012, J PHYS CHEM B, V116, P5888, DOI 10.1021/jp302357m; Iseki M, 2002, NATURE, V415, P1047, DOI 10.1038/4151047a; Ito S, 2014, J AM CHEM SOC, V136, P3475, DOI 10.1021/ja410836g; Kandori H, 2002, BIOCHEMISTRY-US, V41, P6026, DOI 10.1021/bi025585j; Kandori H., 2011, SUPRAMOLECULAR PHOTO, P571; Kawanabe A, 2006, BIOCHEMISTRY-US, V45, P4362, DOI 10.1021/bi052324b; Kawanabe A, 2007, J AM CHEM SOC, V129, P8644, DOI 10.1021/ja072085a; Lamarche LB, 2017, BIOCHEMISTRY-US, V56, P5812, DOI 10.1021/acs.biochem.7b00519; Lorenz-Fonfria VA, 2015, P NATL ACAD SCI USA, V112, pE5796, DOI 10.1073/pnas.1511462112; Lorenz-Fonfria VA, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4895796; Lorenz-Fonfria VA, 2013, P NATL ACAD SCI USA, V110, pE1273, DOI 10.1073/pnas.1219502110; Luck M, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.401604; Mizuide N, 2006, BIOCHEMISTRY-US, V45, P10674, DOI 10.1021/bi060958s; Moltke S, 1995, BIOPHYS J, V69, P2074, DOI 10.1016/S0006-3495(95)80078-0; Muroda K, 2012, BIOCHEMISTRY-US, V51, P4677, DOI 10.1021/bi300485r; Nack M, 2010, PHOTOCH PHOTOBIO SCI, V9, P194, DOI 10.1039/b9pp00157c; Radu I, 2009, J AM CHEM SOC, V131, P7313, DOI 10.1021/ja8084274; Ritter E, 2008, J BIOL CHEM, V283, P35033, DOI 10.1074/jbc.M806353200; Ryu MH, 2010, J BIOL CHEM, V285, P41501, DOI 10.1074/jbc.M110.177600; Scheib U, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab0611; Shibata N, 2005, BIOCHEMISTRY-US, V44, P7406, DOI 10.1021/bi050122+; Singh M, 2018, BIOCHEMISTRY-US, V57, P5041, DOI 10.1021/acs.biochem.8b00637; Stierl M, 2011, J BIOL CHEM, V286, P1181, DOI 10.1074/jbc.M110.185496; Sumii M, 2005, BIOCHEMISTRY-US, V44, P15159, DOI 10.1021/bi0513498; Tanimoto T, 2003, BIOCHEMISTRY-US, V42, P2300, DOI 10.1021/bi026990d; Tian YH, 2018, BIOCHEM J, V475, P1121, DOI 10.1042/BCJ20180010; Tsunoda SP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179232; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Yoshida K, 2017, J BIOL CHEM, V292, P7531, DOI 10.1074/jbc.M117.775569; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	46	17	17	0	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3432	3443		10.1074/jbc.RA118.006277	http://dx.doi.org/10.1074/jbc.RA118.006277			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30622140	Green Published, hybrid			2022-12-28	WOS:000461853900011
J	Castle, AR; Daude, N; Gilch, S; Westaway, D				Castle, Andrew R.; Daude, Nathalie; Gilch, Sabine; Westaway, David			Application of high-throughput, capillary-based Western analysis to modulated cleavage of the cellular prion protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						prion disease; neurodegeneration; proteolysis; high-throughput screening (HTS); glycoprotein; protein misfolding; capillary Western; PrPC; simple Western	ALPHA-CLEAVAGE; PEPTIDE APTAMERS; AMINO-TERMINUS; IMPAIRMENT; DOMAIN; PRPC	The cellular prion protein (PrPC) is a glycoprotein that is processed through several proteolytic pathways. Modulators of PrPC proteolysis are of interest because full-length PrPC and its cleavage fragments differ in their propensity to misfold, a process that plays a key role in the pathogenesis of prion diseases. PrPC may also act as a receptor for neurotoxic, oligomeric species of other proteins that are linked to neurodegeneration. Importantly, the PrPC C-terminal fragment C1 does not contain the reported binding sites for these oligomers. Western blotting would be a simple end point detection method for cell-based screening of compound libraries for effects on PrPC proteolysis or overall expression level. However, traditional Western blotting methods provide unreliable quantification and have only low throughput. Consequently, we explored capillary-based Western technology as a potential alternative; we believe that this study is the first to report analysis of PrPC using such an approach. We successfully optimized the detection and quantification of the deglycosylated forms of full-length PrPC and its C-terminal cleavage fragments C1 and C2, including simultaneous quantification of beta-tubulin levels to control for loading error. We also developed and tested a method for performing all cell culture, lysis, and deglycosylation steps in 96-well microplates prior to capillary Western analysis. These advances represent steps along the way to the development of an automated, high-throughput screening pipeline to identify modulators of PrPC expression levels or proteolysis.	[Castle, Andrew R.; Daude, Nathalie; Westaway, David] Univ Alberta, Ctr Prions & Prot Folding Dis, 2-04 Brain & Aging Res Bldg, Edmonton, AB T6G 2M8, Canada; [Castle, Andrew R.; Westaway, David] Univ Alberta, Dept Med, Edmonton, AB T6G 2G3, Canada; [Gilch, Sabine] Univ Calgary, Fac Vet Med, Calgary Prion Res Unit, Dept Ecosyst & Publ Hlth, Calgary, AB T2N 1N4, Canada; [Gilch, Sabine] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB T2N 1N4, Canada; [Westaway, David] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2R3, Canada	University of Alberta; University of Alberta; University of Calgary; University of Calgary; University of Alberta	Westaway, D (corresponding author), Univ Alberta, Ctr Prions & Prot Folding Dis, 2-04 Brain & Aging Res Bldg, Edmonton, AB T6G 2M8, Canada.	david.westaway@ualberta.ca		Castle, Andrew/0000-0003-2590-9555	Canadian Institutes of Health Research [MOP123525, MOP137094]; Alberta Prion Research Institute [APRIEP 201600033]; Canada Research Chairs Program (CRC Tier 1 Grant) [230404]; Canada Foundation for Innovation [NIF21633]; Alzheimer's Society of Alberta and Northwest Territories/University Hospital Foundation "Hope for Tomorrow" catalyst grant	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Prion Research Institute; Canada Research Chairs Program (CRC Tier 1 Grant)(Canada Research Chairs); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Alzheimer's Society of Alberta and Northwest Territories/University Hospital Foundation "Hope for Tomorrow" catalyst grant	Funding was provided by Canadian Institutes of Health Research Grants MOP123525 and MOP137094 (to D. W.), Alberta Prion Research Institute Grant APRIEP 201600033 (to D. W. and A. C.), Canada Research Chairs Program (CRC Tier 1 Grant 230404 (to D. W.), Canada Foundation for Innovation Grant NIF21633 (to D. W.), and an Alzheimer's Society of Alberta and Northwest Territories/University Hospital Foundation "Hope for Tomorrow" catalyst grant (to D. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Altmeppen HC, 2013, FEBS J, V280, P4338, DOI 10.1111/febs.12196; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Chen SG, 2010, J BIOL CHEM, V285, P26377, DOI 10.1074/jbc.M110.145516; Corda E, 2018, MOL NEUROBIOL, V55, P7758, DOI 10.1007/s12035-018-0944-9; Feraudet C, 2005, J BIOL CHEM, V280, P11247, DOI 10.1074/jbc.M407006200; Ferreira DG, 2017, NAT NEUROSCI, V20, P1569, DOI 10.1038/nn.4648; Fourier A, 2018, MOL NEUROBIOL, V55, P3537, DOI 10.1007/s12035-017-0607-2; Fourier A, 2019, ANAL BIOANAL CHEM, V411, P267, DOI 10.1007/s00216-018-1437-4; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gilch S, 2007, J MOL BIOL, V371, P362, DOI 10.1016/j.jmb.2007.05.052; HILZ H, 1975, EUR J BIOCHEM, V56, P103, DOI 10.1111/j.1432-1033.1975.tb02211.x; Johanssen VA, 2014, BIOCHEM J, V459, P103, DOI 10.1042/BJ20131378; Langeveld Jan P M, 2006, BMC Vet Res, V2, P19, DOI 10.1186/1746-6148-2-19; Lau A, 2015, EMBO MOL MED, V7, P339, DOI 10.15252/emmm.201404588; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lewis V, 2009, J NEUROPATH EXP NEUR, V68, P1125, DOI 10.1097/NEN.0b013e3181b96981; Mange A, 2004, BIOL CELL, V96, P125, DOI 10.1016/j.biolcel.2003.11.007; McDonald AJ, 2014, J BIOL CHEM, V289, P803, DOI 10.1074/jbc.M113.502351; McMahon HEM, 2001, J BIOL CHEM, V276, P2286, DOI 10.1074/jbc.M007243200; Orr ME, 2015, NEUROBIOL AGING, V36, P1496, DOI 10.1016/j.neurobiolaging.2014.12.004; Saleem F, 2014, PRION, V8, P221, DOI 10.4161/pri.28939; Smith SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026908; Sunyach C, 2007, J BIOL CHEM, V282, P1956, DOI 10.1074/jbc.M609663200; Vincent B, 2000, J BIOL CHEM, V275, P35612, DOI 10.1074/jbc.M004628200; Westergard L, 2011, J NEUROSCI, V31, P14005, DOI 10.1523/JNEUROSCI.1243-11.2011	26	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2642	2650		10.1074/jbc.RA118.006367	http://dx.doi.org/10.1074/jbc.RA118.006367			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30578300	hybrid, Green Published			2022-12-28	WOS:000459601600007
J	Li, YH; Guan, JM; Wang, WJ; Hou, C; Zhou, L; Ma, J; Cheng, YF; Jiao, S; Zhou, ZC				Li, Yehua; Guan, Jingmin; Wang, Wenjia; Hou, Chun; Zhou, Li; Ma, Jian; Cheng, Yunfeng; Jiao, Shi; Zhou, Zhaocai			TRAF3-interacting JNK-activating modulator promotes inflammation by stimulating translocation of Toll-like receptor 4 to lipid rafts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Toll-like receptor 4 (TLR4); inflammation; lipopolysaccharide (LPS); lipid raft; macrophage; innate immunity; lipopolysaccharide; membrane transfer; Toll-like receptor; transmembrane protein	RECOGNITION; INNATE; TLR4; PATTERN; PROTEIN; MICRODOMAINS; ENDOCYTOSIS; MECHANISMS; RESPONSES; MST4	Toll-like receptors (TLRs) are key players of the innate immune system and contribute to inflammation and pathogen clearance. Although TLRs have been extensively studied, it remains unclear how exactly bacterial lipopolysaccharide (LPS)-induced conformational changes of the extracellular domain of the TLRs trigger the dimerization of their intracellular domain across the plasma membrane and thereby stimulate downstream signaling. Here, using LPS-stimulated THP-1-derived macrophages and murine macrophages along with immunoblotting and immunofluorescence and quantitative analyses, we report that in response to inflammatory stimuli, the coiled-coil protein TRAF3-interacting JNK-activating modulator (T3JAM) associates with TLR4, promotes its translocation to lipid rafts, and thereby enhances macrophage-mediated inflammation. T3JAM overexpression increased and T3JAM depletion decreased TLR4 signaling through both the MyD88-dependent pathway and TLR4 endocytosis. Importantly, deletion or mutation of T3JAM to disrupt its coiled-coil-mediated homoassociation abrogated TLR4 recruitment to lipid rafts. Consistently, T3JAM depletion in mice dampened TLR4 signaling and alleviated LPS-induced inflammatory damage. Collectively, our findings reveal an additional molecular mechanism by which TLR4 activity is regulated and suggest that T3JAM may function as a molecular clamp to "tighten up" TLR4 and facilitate its translocation to lipid rafts.	[Li, Yehua; Guan, Jingmin; Wang, Wenjia; Ma, Jian; Jiao, Shi; Zhou, Zhaocai] Chinese Acad Sci, Univ Chinese Acad Sci, Shanghai Biochem & Cell Biol, State Key Lab Cell Biol,CAS Ctr Excellence Mol Ce, Shanghai 200031, Peoples R China; [Hou, Chun; Zhou, Li; Zhou, Zhaocai] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China; [Cheng, Yunfeng] Fudan Univ, Zhongshan Hosp, Dept Hematol, Shanghai 200032, Peoples R China; [Cheng, Yunfeng] Fudan Univ, Zhongshan Hosp, Inst Clin Sci, Shanghai 200032, Peoples R China	Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; ShanghaiTech University; Fudan University; Fudan University	Jiao, S; Zhou, ZC (corresponding author), 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	jiaoshi@sibcb.ac.cn; zczhou@sibcb.ac.cn			National Key R&D Program of China [2017YFA0504504]; National Natural Science Foundation of China [81725014, 81822035]; Strategic Priority Research Program [XDB19020202]; China Postdoctoral Science Foundation [2018M630482]; Science and Technology Commission of Shanghai Municipality [17YF1422200, 17ZR1435400]; Youth Innovation Promotion Association of Chinese Academy of Sciences	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program(Chinese Academy of Sciences); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Youth Innovation Promotion Association of Chinese Academy of Sciences	This work was supported by the National Key R&D Program of China (2017YFA0504504), National Natural Science Foundation of China Grants 81725014 and 81822035, the "Strategic Priority Research Program" (XDB19020202) and China Postdoctoral Science Foundation Funded Project (2018M630482), Science and Technology Commission of Shanghai Municipality Grants 17YF1422200 and 17ZR1435400, and the Youth Innovation Promotion Association of Chinese Academy of Sciences. The authors declare that they have no conflicts of interest with the contents of this article.	Cochet F, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112318; Dadgostar H, 2003, FEBS LETT, V553, P403, DOI 10.1016/S0014-5793(03)01072-X; Dajon M, 2017, IMMUNOBIOLOGY, V222, P89, DOI 10.1016/j.imbio.2016.06.009; Daringer NM, 2015, J BIOL CHEM, V290, P8764, DOI 10.1074/jbc.M114.610063; Fekonja O, 2012, J BIOL CHEM, V287, P30993, DOI 10.1074/jbc.M112.376186; Ferrao R, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003124; Fessler MB, 2011, J IMMUNOL, V187, P1529, DOI 10.4049/jimmunol.1100253; Garibotto G, 2017, J NEPHROL, V30, P719, DOI 10.1007/s40620-017-0432-8; Guven-Maiorov E, 2015, SCI REP-UK, V5, DOI 10.1038/srep13128; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Jiao S, 2015, NAT IMMUNOL, V16, P246, DOI 10.1038/ni.3097; Kaisho T, 2001, ACTA ODONTOL SCAND, V59, P124, DOI 10.1080/000163501750266701; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kruger CL, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aan1308; Kuzmich NN, 2017, VACCINES-BASEL, V5, DOI 10.3390/vaccines5040034; Latty SL, 2018, ELIFE, V7, DOI 10.7554/eLife.31377; Leifer CA, 2016, J LEUKOCYTE BIOL, V100, P927, DOI 10.1189/jlb.2MR0316-117RR; Lennartz Michelle, 2018, F1000Res, V7, P21, DOI 10.12688/f1000research.12679.1; Liaunardy-Jopeace A, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00473; Molteni M, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/6978936; Olsson S, 2006, MOL IMMUNOL, V43, P607, DOI 10.1016/j.molimm.2005.04.011; Park BS, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.97; Parker LC, 2008, J IMMUNOL, V181, P5606, DOI 10.4049/jimmunol.181.8.5606; Peng S, 2015, CLIN EXP IMMUNOL, V182, P57, DOI 10.1111/cei.12658; Plociennikowska A, 2015, CELL MOL LIFE SCI, V72, P557, DOI 10.1007/s00018-014-1762-5; Rajaiah R, 2015, P NATL ACAD SCI USA, V112, P8391, DOI 10.1073/pnas.1424980112; Ryu JK, 2017, IMMUNITY, V46, P38, DOI 10.1016/j.immuni.2016.11.007; Schoeniger A, 2011, INT J MOL SCI, V12, P7510, DOI 10.3390/ijms12117510; Schumann RR, 2011, BIOCHEM SOC T, V39, P989, DOI 10.1042/BST0390989; Shang LM, 2014, J BIOL CHEM, V289, P15309, DOI 10.1074/jbc.M113.537936; Shi DW, 2013, J BIOL CHEM, V288, P12605, DOI 10.1074/jbc.M112.399477; Shi Z, 2016, ONCOGENE, V35, P4549, DOI 10.1038/onc.2016.9; Shi ZB, 2013, STRUCTURE, V21, P449, DOI 10.1016/j.str.2013.01.007; Tan YH, 2015, IMMUNITY, V43, P909, DOI 10.1016/j.immuni.2015.10.008; Toshchakov VY, 2011, J IMMUNOL, V186, P4819, DOI 10.4049/jimmunol.1002424; Vallance TM, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/9605894; Wong SW, 2009, J BIOL CHEM, V284, P27384, DOI 10.1074/jbc.M109.044065; Yao Y, 2009, CELL RES, V19, P497, DOI 10.1038/cr.2009.27; Yin Q, 2015, ANNU REV IMMUNOL, V33, P393, DOI 10.1146/annurev-immunol-032414-112258; Zhang M, 2013, STRUCTURE, V21, P680, DOI 10.1016/j.str.2013.02.015; Zou Q, 2015, J EXP MED, V212, P1323, DOI 10.1084/jem.20150110	41	10	11	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2744	2756		10.1074/jbc.RA118.003137	http://dx.doi.org/10.1074/jbc.RA118.003137			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30573680	Green Published, hybrid			2022-12-28	WOS:000459601600015
J	McCarthy, EL; Rankin, AN; Dill, ZR; Booker, SJ				McCarthy, Erin L.; Rankin, Ananda N.; Dill, Zerick R.; Booker, Squire J.			The A-type domain in Escherichia coli NfuA is required for regenerating the auxiliary [4Fe-4S] cluster in Escherichia coli lipoyl synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						iron-sulfur protein; S-adenosylmethionine (SAM); radical; sulfur; enzyme mechanism; metalloenzyme; Fe-S cluster carrier; lipoic acid; NfuA; radical SAM enzyme	IRON-SULFUR CLUSTER; FUNCTIONAL-CHARACTERIZATION; RADICAL MECHANISMS; BIOSYNTHESIS; INTERMEDIATE; PROTEIN; ACID; COMPETENT; SUBSTRATE; CATALYSIS	The lipoyl cofactor plays an integral role in several essential biological processes. The last step in its de novo biosynthetic pathway, the attachment of two sulfur atoms at C6 and C8 of an n-octanoyllysyl chain, is catalyzed by lipoyl synthase (LipA), a member of the radical SAM superfamily. In addition to the [4Fe-4S] cluster common to all radical SAM enzymes, LipA contains a second [4Fe-4S] auxiliary cluster, which is sacrificed during catalysis to supply the requisite sulfur atoms, rendering the protein inactive for further turnovers. Recently, it was shown that the Fe-S cluster carrier protein NfuA from Escherichia coli can regenerate the auxiliary cluster of E. coli LipA after each turnover, but the molecular mechanism is incompletely understood. Herein, using protein-protein interaction and kinetic assays as well as site-directed mutagenesis, we provide further insight into the mechanism of NfuA-mediated cluster regeneration. In particular, we show that the N-terminal A-type domain of E. coli NfuA is essential for its tight interaction with LipA. Further, we demonstrate that NfuA from Mycobacterium tuberculosis can also regenerate the auxiliary cluster of E. coli LipA. However, an Nfu protein from Staphylococcus aureus, which lacks the A-type domain, was severely diminished in facilitating cluster regeneration. Of note, addition of the N-terminal domain of E. coli NfuA to S. aureus Nfu, fully restored cluster-regenerating activity. These results expand our understanding of the newly discovered mechanism by which the auxiliary cluster of LipA is restored after each turnover.	[McCarthy, Erin L.; Booker, Squire J.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Rankin, Ananda N.; Dill, Zerick R.; Booker, Squire J.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Booker, Squire J.] Penn State Univ, Howard Hughes Med Inst, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Howard Hughes Medical Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Booker, SJ (corresponding author), 302 Chem Bldg, University Pk, PA 16802 USA.	squire@psu.edu			National Institutes of Health [GM-122595]; National Science Foundation [MCB-1716686, CHE-1659679]; Howard Hughes Medical Institute EXROP program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM122595] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Howard Hughes Medical Institute EXROP program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM-122595 and National Science Foundation Grants MCB-1716686 and CHE-1659679. This work was also supported by the Howard Hughes Medical Institute EXROP program (to Z. R. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Angelini S, 2008, J BIOL CHEM, V283, P14084, DOI 10.1074/jbc.M709405200; Ayala-Castro C, 2008, MICROBIOL MOL BIOL R, V72, P110, DOI 10.1128/MMBR.00034-07; Bandyopadhyay S, 2008, J BIOL CHEM, V283, P14092, DOI 10.1074/jbc.M709161200; BEINERT H, 1983, ANAL BIOCHEM, V131, P373, DOI 10.1016/0003-2697(83)90186-0; Beinert H, 1978, Methods Enzymol, V54, P435; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Broderick JB, 2014, CHEM REV, V114, P4229, DOI 10.1021/cr4004709; Cicchillo RM, 2004, BIOCHEMISTRY-US, V43, P6378, DOI 10.1021/bi049528x; Cicchillo RM, 2004, BIOCHEMISTRY-US, V43, P11770, DOI 10.1021/bi0488505; Douglas P, 2006, ANGEW CHEM INT EDIT, V45, P5197, DOI 10.1002/anie.200601910; Fontecave M, 2008, ARCH BIOCHEM BIOPHYS, V474, P226, DOI 10.1016/j.abb.2007.12.014; Frey PA, 2001, ADV PROTEIN CHEM, V58, P1; HAYDEN MA, 1993, BIOCHEMISTRY-US, V32, P3778, DOI 10.1021/bi00065a033; Hurley JK, 1997, BIOCHEMISTRY-US, V36, P15109, DOI 10.1021/bi972001i; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Lanz ND, 2015, J AM CHEM SOC, V137, P13216, DOI 10.1021/jacs.5b04387; Lanz ND, 2015, BBA-MOL CELL RES, V1853, P1316, DOI 10.1016/j.bbamcr.2015.01.002; Lanz ND, 2014, BIOCHEMISTRY-US, V53, P4557, DOI 10.1021/bi500432r; Lanz ND, 2012, METHOD ENZYMOL, V516, P125, DOI 10.1016/B978-0-12-394291-3.00030-7; Mashruwala AA, 2015, MOL MICROBIOL, V95, P383, DOI 10.1111/mmi.12860; McCarthy EL, 2018, METHOD ENZYMOL, V606, P217, DOI 10.1016/bs.mie.2018.06.006; McCarthy EL, 2017, SCIENCE, V358, P373, DOI 10.1126/science.aan4574; McLaughlin MI, 2016, P NATL ACAD SCI USA, V113, P9446, DOI 10.1073/pnas.1602486113; Py B, 2012, MOL MICROBIOL, V86, P155, DOI 10.1111/j.1365-2958.2012.08181.x; REED KE, 1993, J BACTERIOL, V175, P1325, DOI 10.1128/JB.175.5.1325-1336.1993; Rouault TA, 2008, TRENDS GENET, V24, P398, DOI 10.1016/j.tig.2008.05.008; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Subramanian S, 2015, J AM CHEM SOC, V137, P4567, DOI 10.1021/jacs.5b01869; WHITE RH, 1980, J AM CHEM SOC, V102, P6605, DOI 10.1021/ja00541a059	29	13	14	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2019	294	5					1609	1617		10.1074/jbc.RA118.006171	http://dx.doi.org/10.1074/jbc.RA118.006171			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GC	30538130	Green Published, hybrid			2022-12-28	WOS:000457879200016
J	Coelho, C; Brown, L; Maryam, M; Vij, R; Smith, DFQ; Burnet, MC; Kyle, JE; Heyman, HM; Ramirez, J; Prados-Rosales, R; Lauvau, G; Nakayasu, ES; Brady, NR; Hamacher-Brady, A; Coppens, I; Casadevall, A				Coelho, Carolina; Brown, Lisa; Maryam, Maria; Vij, Raghav; Smith, Daniel F. Q.; Burnet, Meagan C.; Kyle, Jennifer E.; Heyman, Heino M.; Ramirez, Jasmine; Prados-Rosales, Rafael; Lauvau, Gregoire; Nakayasu, Ernesto S.; Brady, Nathan R.; Hamacher-Brady, Anne; Coppens, Isabelle; Casadevall, Arturo			Listeria monocytogenes virulence factors, including listeriolysin O, are secreted in biologically active extracellular vesicles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						exosome (vesicle); extracellular vesicles; virulence factor; phospholipase C; Gram-positive bacteria; hemolysis; Listeria monocytogenes; listeriolysin O; MPLEx; multiomics	GRAM-POSITIVE BACTERIA; MEMBRANE-VESICLES; PHOSPHOLIPASE-C; CRYPTOCOCCUS-NEOFORMANS; INTRACELLULAR GROWTH; FATTY-ACIDS; LIPIDS; ROLES; STIMULATION; BIOGENESIS	Outer membrane vesicles produced by Gram-negative bacteria have been studied for half a century but the possibility that Gram-positive bacteria secrete extracellular vesicles (EVs) was not pursued until recently due to the assumption that the thick peptidoglycan cell wall would prevent their release to the environment. However, following their discovery in fungi, which also have cell walls, EVs have now been described for a variety of Gram-positive bacteria. EVs purified from Gram-positive bacteria are implicated in virulence, toxin release, and transference to host cells, eliciting immune responses, and spread of antibiotic resistance. Listeria monocytogenes is a Gram-positive bacterium that causes listeriosis. Here we report that L. monocytogenes produces EVs with diameters ranging from 20 to 200 nm, containing the pore-forming toxin listeriolysin O (LLO) and phosphatidylinositol-specific phospholipase C (PI-PLC). Cell-free EV preparations were toxic to mammalian cells, the murine macrophage cell line J774.16, in a LLO-dependent manner, evidencing EV biological activity. The deletion of plcA increased EV toxicity, suggesting PI-PLC reduced LLO activity. Using simultaneous metabolite, protein, and lipid extraction (MPLEx) multiomics we characterized protein, lipid, and metabolite composition of bacterial cells and secreted EVs and found that EVs carry the majority of listerial virulence proteins. Using immunogold EM we detected LLO at several organelles within infected human epithelial cells and with high-resolution fluorescence imaging we show that dynamic lipid structures are released from L. monocytogenes during infection. Our findings demonstrate that L. monocytogenes uses EVs for toxin release and implicate these structures in mammalian cytotoxicity.	[Coelho, Carolina; Maryam, Maria; Vij, Raghav; Smith, Daniel F. Q.; Ramirez, Jasmine; Brady, Nathan R.; Hamacher-Brady, Anne; Coppens, Isabelle; Casadevall, Arturo] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Brown, Lisa; Lauvau, Gregoire; Casadevall, Arturo] Yeshiva Univ, Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; [Lauvau, Gregoire; Casadevall, Arturo] Yeshiva Univ, Albert Einstein Coll Med, Dept Med, Div Infect Dis, Bronx, NY 10461 USA; [Burnet, Meagan C.; Kyle, Jennifer E.; Heyman, Heino M.; Nakayasu, Ernesto S.] Pacific Northwest Natl Lab, Biol Sci Div, Richland, WA 99352 USA; [Prados-Rosales, Rafael] CIC bioGUNE, Derio 48160, Bizkaia, Spain	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; United States Department of Energy (DOE); Pacific Northwest National Laboratory; CIC bioGUNE	Coelho, C (corresponding author), Hopkins Bloomberg Sch Publ Hlth, 615 North Wolfe St, Baltimore, MD 21205 USA.; Casadevall, A (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, 615 North Wolfe St, Baltimore, MD 21205 USA.	carolina.coelho@abdn.ac.uk; acasade1@jhu.edu	Heyman, Heino Martin/I-1670-2014; Prados-Rosales, Rafael/D-5840-2019; Hamacher-Brady, Anne/G-4268-2013; Brown, Lisa/U-8366-2019; Vij, Raghav/GQY-8282-2022; Nakayasu, Ernesto S./AAJ-8374-2020	Heyman, Heino Martin/0000-0003-0941-2506; Prados-Rosales, Rafael/0000-0001-5964-0166; Brown, Lisa/0000-0002-7719-6596; Vij, Raghav/0000-0001-5812-0484; Nakayasu, Ernesto S./0000-0002-4056-2695; Smith, Daniel/0000-0002-7674-9988; Hamacher-Brady, Anne/0000-0001-5042-1338; Coelho, Carolina/0000-0002-7523-3031; Brady, Nathan/0000-0002-1901-5996	DOE [DE-AC05-76RLO01830]; MRC [MR/N006364/1] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI103338] Funding Source: NIH RePORTER	DOE(United States Department of Energy (DOE)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Geoffrey Perumal, Benjamin Clark, and Leslie Gunther at the Analytical Imaging Facility, Albert Einstein College of Medicine, for assistance with the transmission EM. Negative staining was performed at the Johns Hopkins Microscopy Facility, and we particularly acknowledge Barbara McClintock. We also thank the technical competence of Kimberley Zichichi from the Electron Microscopy Facility at Yale University for the immuno-EM. We thank Howard Goldfine for the kind gift of PI-PLC antiserum. The MPLEx experiment was performed in the Environmental Molecular Science Laboratory, a United States Department of Energy (DOE) national scientific user facility at the Pacific Northwest National Laboratory (PNNL) in Richland, WA. Battelle operates PNNL for the DOE under contract DE-AC05-76RLO01830.	Alvarez-Jimenez VD, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00272; Bannam T, 1999, INFECT IMMUN, V67, P182, DOI 10.1128/IAI.67.1.182-186.1999; Beveridge TJ, 1999, J BACTERIOL, V181, P4725, DOI 10.1128/JB.181.16.4725-4733.1999; BISHOP DK, 1987, J IMMUNOL, V139, P2005; Bonnemain C, 2004, MOL MICROBIOL, V51, P1251, DOI 10.1111/j.1365-2958.2004.03916.x; Brown L, 2015, NAT REV MICROBIOL, V13, P620, DOI 10.1038/nrmicro3480; Brown L, 2014, MOL MICROBIOL, V93, P183, DOI 10.1111/mmi.12650; Camejo A, 2011, VIRULENCE, V2, P379, DOI 10.4161/viru.2.5.17703; CAMILLI A, 1991, J EXP MED, V173, P751, DOI 10.1084/jem.173.3.751; CAMILLI A, 1993, MOL MICROBIOL, V8, P143, DOI 10.1111/j.1365-2958.1993.tb01211.x; Carvalho F, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00048; Coconnier MH, 2000, CELL MICROBIOL, V2, P487, DOI 10.1046/j.1462-5822.2000.00073.x; Deatherage BL, 2012, INFECT IMMUN, V80, P1948, DOI 10.1128/IAI.06014-11; Elluri S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106731; Fischer W, 1999, INT J SYST BACTERIOL, V49, P653, DOI 10.1099/00207713-49-2-653; Folsch H, 2001, J CELL BIOL, V152, P595, DOI 10.1083/jcb.152.3.595; Frydrychowicz M, 2015, SCAND J IMMUNOL, V81, P2, DOI 10.1111/sji.12247; GAILLARD JL, 1987, INFECT IMMUN, V55, P2822, DOI 10.1128/IAI.55.11.2822-2829.1987; GEOFFROY C, 1987, INFECT IMMUN, V55, P1641, DOI 10.1128/IAI.55.7.1641-1646.1987; Gurung M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027958; Hamon MA, 2012, TRENDS MICROBIOL, V20, P360, DOI 10.1016/j.tim.2012.04.006; Hiller K, 2009, ANAL CHEM, V81, P3429, DOI 10.1021/ac802689c; Horstman AL, 2000, J BIOL CHEM, V275, P12489, DOI 10.1074/jbc.275.17.12489; Huang QY, 2016, BBA-PROTEINS PROTEOM, V1864, P697, DOI 10.1016/j.bbapap.2016.03.008; Jaskolski F, 2005, J NEUROSCI METH, V146, P42, DOI 10.1016/j.jneumeth.2005.01.012; Jiang YL, 2014, INT J MED MICROBIOL, V304, P431, DOI 10.1016/j.ijmm.2014.02.006; Johansson J, 2002, CELL, V110, P551, DOI 10.1016/S0092-8674(02)00905-4; JONES S, 1994, INFECT IMMUN, V62, P5608, DOI 10.1128/IAI.62.12.5608-5613.1994; Jung AL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06443-1; Kanehisa M, 2016, J MOL BIOL, V428, P726, DOI 10.1016/j.jmb.2015.11.006; Kind T, 2009, ANAL CHEM, V81, P10038, DOI 10.1021/ac9019522; KOCKS C, 1992, CELL, V68, P521, DOI 10.1016/0092-8674(92)90188-I; Kong MY, 2005, GEOL SOC AM BULL, V117, P244, DOI 10.1130/B25000.1; Koutero M., 2016, THESIS; Kuehn MJ, 2005, GENE DEV, V19, P2645, DOI 10.1101/gad.1299905; Kyle JE, 2017, BIOINFORMATICS, V33, P1744, DOI 10.1093/bioinformatics/btx046; Lecuit M, 2005, CLIN MICROBIOL INFEC, V11, P430, DOI 10.1111/j.1469-0691.2005.01146.x; Lecuit M, 1997, INFECT IMMUN, V65, P5309, DOI 10.1128/IAI.65.12.5309-5319.1997; Lee EY, 2009, PROTEOMICS, V9, P5425, DOI 10.1002/pmic.200900338; Lee JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073196; MacDonald IA, 2012, RES MICROBIOL, V163, P607, DOI 10.1016/j.resmic.2012.10.020; Marsollier L, 2007, PLOS PATHOG, V3, P582, DOI 10.1371/journal.ppat.0030062; Mastronlcolis SK, 2008, APPL ENVIRON MICROB, V74, P4543, DOI 10.1128/AEM.02041-07; Meyer-Morse N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008610; Muraille E, 2007, CELL MICROBIOL, V9, P1445, DOI 10.1111/j.1462-5822.2007.00883.x; Olaya-Abril A, 2014, J PROTEOMICS, V106, P46, DOI 10.1016/j.jprot.2014.04.023; Piercey MJ, 2016, INT J FOOD MICROBIOL, V223, P63, DOI 10.1016/j.ijfoodmicro.2016.02.009; Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395; Polpitiya AD, 2008, BIOINFORMATICS, V24, P1556, DOI 10.1093/bioinformatics/btn217; PORTNOY DA, 1988, J EXP MED, V167, P1459, DOI 10.1084/jem.167.4.1459; Poussin MA, 2009, MICROB PATHOGENESIS, V46, P1, DOI 10.1016/j.micpath.2008.09.008; Resch U, 2016, MBIO, V7, DOI 10.1128/mBio.00207-16; Rivera J, 2010, P NATL ACAD SCI USA, V107, P19002, DOI 10.1073/pnas.1008843107; Rodrigues ML, 2008, EUKARYOT CELL, V7, P58, DOI 10.1128/EC.00370-07; Sawyer RT, 1996, J LEUKOCYTE BIOL, V60, P603, DOI 10.1002/jlb.60.5.603; Schnupf P, 2007, INFECT IMMUN, V75, P5135, DOI 10.1128/IAI.00164-07; Schrempf H, 2015, MICROB BIOTECHNOL, V8, P644, DOI 10.1111/1751-7915.12274; Seveau S, 2004, J CELL BIOL, V166, P743, DOI 10.1083/jcb.200406078; SMITH GA, 1995, INFECT IMMUN, V63, P4231, DOI 10.1128/IAI.63.11.4231-4237.1995; Sontag RL, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00032-15; Stavru F, 2011, P NATL ACAD SCI USA, V108, P3612, DOI 10.1073/pnas.1100126108; Sun Y, 2012, J BACTERIOL, V194, P5274, DOI 10.1128/JB.00045-12; Thay B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054661; Thumser AE, 2007, MOL CELL BIOCHEM, V299, P67, DOI 10.1007/s11010-005-9041-2; TILNEY LG, 1989, J CELL BIOL, V109, P1597, DOI 10.1083/jcb.109.4.1597; Toyofuku M, 2019, NAT REV MICROBIOL, V17, P13, DOI 10.1038/s41579-018-0112-2; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; Vadia S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002356; van Bergenhenegouwen J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089121; Vdovikova S, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00154; VILLANUEVA MS, 1995, J IMMUNOL, V155, P5227; Wolf JM, 2012, CELL MICROBIOL, V14, P762, DOI 10.1111/j.1462-5822.2012.01757.x; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380	73	61	64	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1202	1217		10.1074/jbc.RA118.006472	http://dx.doi.org/10.1074/jbc.RA118.006472			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30504226	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000457879500012
J	Cantero-Recasens, G; Butnaru, CM; Brouwers, N; Mitrovic, S; Valverde, MA; Malhotra, V				Cantero-Recasens, Gerard; Butnaru, Cristian M.; Brouwers, Nathalie; Mitrovic, Sandra; Valverde, Miguel A.; Malhotra, Vivek			Sodium channel TRPM4 and sodium/calcium exchangers (NCX) cooperate in the control of Ca2+-induced mucin secretion from goblet cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mucin; sodium-calcium exchange; transient receptor potential channels (TRP channels); secretion; cystic fibrosis; goblet cell; MUC2; MUC5AC; TRPM4; TRPM5	PROTEIN-KINASE-C; NA+/CA2+ EXCHANGE; INHIBITOR KB-R7943; MUCUS SECRETION; SENSITIVITY; ACTIVATION; EXOCYTOSIS; NEURONS; HEALTH; FAMILY	Regulated mucin secretion is essential for the formation of the mucus layer that protects the underlying epithelial cells from foreign particles. Alterations in the quantity or quality of secreted mucins are therefore detrimental to airway and colon physiology. Based on various biochemical assays in several human cell lines, we report here that Na+/Ca2+ exchanger 2 (NCX2) works in conjunction with transient receptor potential cation channel subfamily M member 4 (TRPM4), and perhaps TRPM5, Na+ channels to control Ca2+-mediated secretion of both mucin 2 (MUC2) and MUC5AC from HT29-18N2 colonic cancer cells. Differentiated normal bronchial epithelial (NHBE) cells and tracheal cells from patients with cystic fibrosis (CFT1-LC3) expressed only TRPM4 and all three isoforms of NCXs. Blocking the activity of TRPM4 or NCX proteins abrogated MUC5AC secretion from NHBE and CFT1-LC3 cells. Altogether, our findings reveal that NCX and TRPM4/TRPM5 are both required for mucin secretion. We therefore propose that these two proteins could be potential pharmacological targets to control mucus-related pathologies such as cystic fibrosis.	[Cantero-Recasens, Gerard; Butnaru, Cristian M.; Brouwers, Nathalie; Malhotra, Vivek] Barcelona Inst Sci & Technol, Ctr Genom Regulat CRG, Dr Aiguader 88, Barcelona 08003, Spain; [Malhotra, Vivek] UPF, Barcelona, Spain; [Mitrovic, Sandra] Univ Hosp Basel, Clin Chem, Petersgraben 4, CH-4031 Basel, Switzerland; [Valverde, Miguel A.] Univ Pompeu Fabra, Fac Hlth & Life Sci, Lab Mol Physiol, Barcelona 08003, Catalonia, Spain; [Malhotra, Vivek] ICREA, Pg Lluis Co 23, Barcelona 08010, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; University of Basel; Pompeu Fabra University; ICREA	Malhotra, V (corresponding author), Ctr Genom Regulat CRG, Dept Cell & Dev Biol, Carrer Dr Aiguader 88, Barcelona 08003, Spain.	vivek.malhotra@crg.eu	Brouwers, Nathalie/L-2089-2014; Cantero-Recasens, Gerard/AAE-9003-2022; Cantero-Recasens, Gerard/AAH-1697-2019	Brouwers, Nathalie/0000-0002-9808-9394; Cantero-Recasens, Gerard/0000-0001-6452-782X; Valverde, Miguel A./0000-0002-6961-3361	Spanish Ministry of Economy and Competitiveness, through the Programmes Centro de Excelencia Severo Ochoa 2013-2017 [SEV-2012-0208]; Spanish Ministry of Economy and Competitiveness [SAF2015-69762R]; Maria de Maeztu Units of Excellence in RD [MDM-2015-0502, FPDI-2013-16916]	Spanish Ministry of Economy and Competitiveness, through the Programmes Centro de Excelencia Severo Ochoa 2013-2017; Spanish Ministry of Economy and Competitiveness(Spanish Government); Maria de Maeztu Units of Excellence in RD	This work was supported by the Spanish Ministry of Economy and Competitiveness, through the Programmes Centro de Excelencia Severo Ochoa 2013-2017 (SEV-2012-0208) and Maria de Maeztu Units of Excellence in R&D (MDM-2015-0502) and Grant FPDI-2013-16916 (to G.C.-R.). The research leading to these results was supported by Spanish Ministry of Economy and Competitiveness Grant SAF2015-69762R (to M. A. V.). The authors declare that they have no conflicts of interest with the contents of this article. This work reflects only the authors' views and the Community is not liable for any use that may be made of the information contained therein.	Abdullah LH, 1997, AM J PHYSIOL-LUNG C, V273, pL201, DOI 10.1152/ajplung.1997.273.1.L201; Adler Kenneth B, 2013, Front Endocrinol (Lausanne), V4, P129, DOI 10.3389/fendo.2013.00129; Arakawa N, 2000, BIOCHEM BIOPH RES CO, V279, P354, DOI 10.1006/bbrc.2000.3968; Betz A, 1998, NEURON, V21, P123, DOI 10.1016/S0896-6273(00)80520-6; Birchenough GMH, 2015, MUCOSAL IMMUNOL, V8, P712, DOI 10.1038/mi.2015.32; Cantero-Recasens G, 2018, ELIFE, V7, DOI 10.7554/eLife.39729; Conway JD, 2003, AM J PHYSIOL-LUNG C, V284, pL945, DOI 10.1152/ajplung.00410.2002; Davis CW, 2008, ANNU REV PHYSIOL, V70, P487, DOI 10.1146/annurev.physiol.70.113006.100638; Dickinson JD, 2016, AUTOPHAGY, V12, P397, DOI 10.1080/15548627.2015.1056967; Fernandes J, 2008, J CELL BIOL, V181, P143, DOI 10.1083/jcb.200712058; Gray TE, 1996, AM J RESP CELL MOL, V14, P104, DOI 10.1165/ajrcmb.14.1.8534481; Guinamard R, 2014, BRIT J PHARMACOL, V171, P1600, DOI 10.1111/bph.12582; Guinamard R, 2011, ADV EXP MED BIOL, V704, P147, DOI 10.1007/978-94-007-0265-3_8; Harper AGS, 2016, ADV EXP MED BIOL, V898, P67, DOI 10.1007/978-3-319-26974-0_4; Hattrup CL, 2008, ANNU REV PHYSIOL, V70, P431, DOI 10.1146/annurev.physiol.70.113006.100659; Larsson JMH, 2013, AM J PHYSIOL-GASTR L, V305, pG357, DOI 10.1152/ajpgi.00048.2013; Iwamoto T, 2004, MOL PHARMACOL, V66, P45, DOI 10.1124/mol.66.1.45; Iwamoto T, 2001, MOL PHARMACOL, V59, P524, DOI 10.1124/mol.59.3.524; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Jones LC, 2012, J PHYSIOL-LONDON, V590, P545, DOI 10.1113/jphysiol.2011.222091; Khananshvili D, 2013, MOL ASPECTS MED, V34, P220, DOI 10.1016/j.mam.2012.07.003; Kimura J, 1999, BRIT J PHARMACOL, V128, P969, DOI 10.1038/sj.bjp.0702869; Kreda SM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009589; Lee H, 2014, INVEST OPHTH VIS SCI, V55, DOI 10.1167/iovs.14-13875; Li DY, 2012, INVEST OPHTH VIS SCI, V53, P6928, DOI 10.1167/iovs.12-10163; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; Lorenz Holger, 2008, V440, P227, DOI 10.1007/978-1-59745-178-9_17; Lu S, 2011, J PHARMACOL EXP THER, V336, P178, DOI 10.1124/jpet.110.171561; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Matsuda T, 2001, J PHARMACOL EXP THER, V298, P249; Mitrovic S, 2013, ELIFE, V2, DOI 10.7554/eLife.00658; Niu CF, 2007, EUR J PHARMACOL, V573, P161, DOI 10.1016/j.ejphar.2007.06.033; OLSEN JC, 1992, HUM GENE THER, V3, P253, DOI 10.1089/hum.1992.3.3-253; Park JA, 2007, AM J PATHOL, V171, P1822, DOI 10.2353/ajpath.2007.070318; PHILLIPS TE, 1995, IN VITRO CELL DEV-AN, V31, P421, DOI 10.1007/BF02634251; Pintado AJ, 2000, BRIT J PHARMACOL, V130, P1893, DOI 10.1038/sj.bjp.0703519; Ren BH, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150004; Rose MC, 2006, PHYSIOL REV, V86, P245, DOI 10.1152/physrev.00010.2005; Rossi AH, 2004, J PHYSIOL-LONDON, V559, P555, DOI 10.1113/jphysiol.2004.070433; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sobolevsky AI, 1999, NEUROPHARMACOLOGY, V38, P1235, DOI 10.1016/S0028-3908(99)00040-4; Talavera K, 2005, NATURE, V438, P1022, DOI 10.1038/nature04248; Thornton DJ, 2008, ANNU REV PHYSIOL, V70, P459, DOI 10.1146/annurev.physiol.70.113006.100702; Tuvim MJ, 2009, J BIOL CHEM, V284, P9781, DOI 10.1074/jbc.M807849200; Van Kolen Kristof, 2006, Purinergic Signal, V2, P451, DOI 10.1007/s11302-006-9008-0; Vazquez E, 2001, P NATL ACAD SCI USA, V98, P5329, DOI 10.1073/pnas.091096498; Watanabe Y, 2006, J PHARMACOL SCI, V102, P7, DOI 10.1254/jphs.FMJ06002X2; YANKASKAS JR, 1993, AM J PHYSIOL, V264, pC1219, DOI 10.1152/ajpcell.1993.264.5.C1219; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134	49	16	16	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2019	294	3					816	826		10.1074/jbc.RA117.000848	http://dx.doi.org/10.1074/jbc.RA117.000848			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL4FC	30482841	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000458670200008
J	Alonzo, JR; Venkataraman, C; Field, MS; Stover, PJ				Alonzo, Judith R.; Venkataraman, Chantel; Field, Martha S.; Stover, Patrick J.			The mitochondrial inner membrane protein MPV17 prevents uracil accumulation in mitochondrial DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						folate; one-carbon metabolism; mitochondria; thymidine kinase 2; nucleoside; nucleotide transport; mitochondrial transport; nucleoside; nucleotide biosynthesis; mitochondrial disease; mitochondrial thymidylate synthesis; MPV17; mitochondrial DNA-depletion syndrome (MDS); deoxythymidine monophosphate (dTMP)	NOVO THYMIDYLATE BIOSYNTHESIS; ONE-CARBON METABOLISM; DEPLETION SYNDROME; MICROBIOLOGICAL ASSAY; MAMMALIAN-CELLS; FOLATE; DELETIONS; MUTATION; ENCODES; METHYLENETETRAHYDROFOLATE	Mitochondrial inner membrane protein MPV17 is a protein of unknown function that is associated with mitochondrial DNA (mtDNA)-depletion syndrome (MDS). MPV17 loss-of-function has been reported to result in tissue-specific nucleotide pool imbalances, which can occur in states of perturbed folate-mediated one-carbon metabolism (FOCM), but MPV17 has not been directly linked to FOCM. FOCM is a metabolic network that provides one-carbon units for the de novo synthesis of purine and thymidylate nucleotides (e.g. dTMP) for both nuclear DNA (nuDNA) and mtDNA replication. In this study, we investigated the impact of reduced MPV17 expression on markers of impaired FOCM in HeLa cells. Depressed MPV17 expression reduced mitochondrial folate levels by 43% and increased uracil levels, a marker of impaired dTMP synthesis, in mtDNA by 3-fold. The capacity of mitochondrial de novo and salvage pathway dTMP biosynthesis was unchanged by the reduced MPV17 expression, but the elevated levels of uracil in mtDNA suggested that other sources of mitochondrial dTMP are compromised in MPV17-deficient cells. These results indicate that MPV17 provides a third dTMP source, potentially by serving as a transporter that transfers dTMP from the cytosol to mitochondria to sustain mtDNA synthesis. We propose that MPV17 loss-of-function and related hepatocerebral MDS are linked to impaired FOCM in mitochondria by providing insufficient access to cytosolic dTMP pools and by severely reducing mitochondrial folate pools.	[Alonzo, Judith R.; Stover, Patrick J.] Cornell Univ, Grad Field Biochem Mol & Cellular Biol, Ithaca, NY 14853 USA; [Venkataraman, Chantel; Field, Martha S.; Stover, Patrick J.] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA	Cornell University; Cornell University	Stover, PJ (corresponding author), Texas A&M Univ, Coll Agr & Life Sci, Agr & Life Sci Bldg,600 John Kimbrough Blvd, College Stn, TX 77843 USA.	Patrick.Stover@ag.tamu.edu		Field, Martha/0000-0001-7547-5180	Public Health Service Grant [R37DK58144]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK058144] Funding Source: NIH RePORTER	Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Public Health Service Grant R37DK58144 (to P.J.S.). The authors declare that they have no conflicts of interest with the contents of this article.	AlSaman A, 2012, SAUDI J GASTROENTERO, V18, P285, DOI 10.4103/1319-3767.98439; Anderson DD, 2012, J BIOL CHEM, V287, P7051, DOI 10.1074/jbc.M111.333120; Anderson DD, 2011, P NATL ACAD SCI USA, V108, P15163, DOI 10.1073/pnas.1103623108; Antonenkov VD, 2015, J BIOL CHEM, V290, P13840, DOI 10.1074/jbc.M114.608083; Bailey LB., 2009, FOLATE HLTH DIS; Basten GP, 2006, BRIT J CANCER, V94, P1942, DOI 10.1038/sj.bjc.6603197; Bijarnia-Mahay S, 2014, INDIAN PEDIATR, V51, P666, DOI 10.1007/s13312-014-0475-z; Blakely EL, 2012, NEUROMUSCULAR DISORD, V22, P587, DOI 10.1016/j.nmd.2012.03.006; Blount BC, 1997, P NATL ACAD SCI USA, V94, P3290, DOI 10.1073/pnas.94.7.3290; Branda RF, 2002, MUTAT RES-FUND MOL M, V501, P29, DOI 10.1016/S0027-5107(02)00014-3; Casalena G, 2014, AM J PHYSIOL-RENAL, V306, pF1372, DOI 10.1152/ajprenal.00608.2013; Chou YF, 2009, EUR J NUTR, V48, P429, DOI 10.1007/s00394-009-0031-0; Crott JW, 2005, MUTAT RES-FUND MOL M, V570, P63, DOI 10.1016/j.mrfmmm.2004.09.009; DAS KC, 1989, AM J HEMATOL, V31, P11, DOI 10.1002/ajh.2830310103; Di Noia MA, 2014, J BIOL CHEM, V289, P33137, DOI 10.1074/jbc.M114.610808; Dotzlaf J, 2007, HYBRIDOMA, V26, P155, DOI 10.1089/hyb.2007.004; El-Hattab A. W., 2012, GENEREVIEWS; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Ferraro P, 2006, P NATL ACAD SCI USA, V103, P18586, DOI 10.1073/pnas.0609020103; Field MS, 2014, J BIOL CHEM, V289, P29642, DOI 10.1074/jbc.M114.599589; Fox JT, 2008, VITAM HORM, V79, P1, DOI 10.1016/S0083-6729(08)00401-9; Friso S, 2002, P NATL ACAD SCI USA, V99, P5606, DOI 10.1073/pnas.062066299; Gonzalez-Vioque E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002035; Herbig K, 2002, J BIOL CHEM, V277, P38381, DOI 10.1074/jbc.M205000200; Horne DW, 1997, METHOD ENZYMOL, V281, P38; LIN BF, 1993, J BIOL CHEM, V268, P21674; Lollgen S, 2015, BIOL CHEM, V396, P13, DOI 10.1515/hsz-2014-0198; LOWE KE, 1993, J BIOL CHEM, V268, P21665; MacFarlane AJ, 2008, J BIOL CHEM, V283, P25846, DOI 10.1074/jbc.M802671200; Molloy AM, 1997, METHOD ENZYMOL, V281, P43; Neuburger M, 1996, J BIOL CHEM, V271, P9466, DOI 10.1074/jbc.271.16.9466; Rosa ID, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005779; Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765; Stover PJ, 2012, CANCER CELL, V22, P3, DOI 10.1016/j.ccr.2012.06.010; Tibbetts AS, 2010, ANNU REV NUTR, V30, P57, DOI 10.1146/annurev.nutr.012809.104810; TRENT DF, 1991, BIOCHEM PHARMACOL, V42, P1015, DOI 10.1016/0006-2952(91)90283-B; Venegas V, 2011, CURR PROTOC HUM GENE, V19, P17, DOI DOI 10.1002/0471142905.HG1907S68; WEIHER H, 1990, CELL, V62, P425, DOI 10.1016/0092-8674(90)90008-3; Woeller CF, 2007, J BIOL CHEM, V282, P17623, DOI 10.1074/jbc.M702526200; Ye YL, 2010, J NUTR BIOCHEM, V21, P793, DOI 10.1016/j.jnutbio.2009.05.005; ZWACKA RM, 1994, EMBO J, V13, P5129, DOI 10.1002/j.1460-2075.1994.tb06842.x	41	18	19	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					20285	20294		10.1074/jbc.RA118.004788	http://dx.doi.org/10.1074/jbc.RA118.004788			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30385507	hybrid, Green Published			2022-12-28	WOS:000454685900033
J	Simon, EJ; Linstedt, AD				Simon, Emily J.; Linstedt, Adam D.			Site-specific glycosylation of Ebola virus glycoprotein by human polypeptide GalNAc-transferase 1 induces cell adhesion defects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycosylation; Ebola virus; viral protein; glycoprotein; adhesion; acetylgalactosaminyltransferase; deadhesion; mucin-like domain; pathogenesis; ppGalNAc-T1	O-GLYCOSYLATION; ENVELOPE	The surface glycoprotein (GP) of Ebola virus causes many of the virus's pathogenic effects, including a dramatic loss of endothelial cell adhesion associated with widespread hemorrhaging during infection. Although the GP-mediated deadhesion depends on its extracellular mucin-like domain, it is unknown whether any, or all, of this domain's densely clustered O-glycosylation sites are required. It is also unknown whether any of the 20 distinct polypeptide GalNAc-transferases (ppGalNAc-Ts) that initiate mucin-type O-glycosylation in human cells are functionally required. Here, using HEK293 cell lines lacking specific glycosylation enzymes, we demonstrate that GP requires extended O-glycans to exert its deadhesion effect. We also identified ppGalNAc-T1 as largely required for the GP-mediated adhesion defects. Despite its profound effect on GP function, the absence of ppGalNAc-T1 only modestly reduced the O-glycan mass of GP, indicating that even small changes in the bulky glycodomain can cause loss of GP function. Indeed, protein-mapping studies identified a small segment of the mucin-like domain critical for function and revealed that mutation of five glycan acceptor sites within this segment are sufficient to abrogate GP function. Together, these results argue against a mechanism of Ebola GP-induced cell detachment that depends solely on ectodomain bulkiness and identify a single host-derived glycosylation enzyme, ppGalNAc-T1, as a potential target for therapeutic intervention against Ebola virus disease.	[Simon, Emily J.; Linstedt, Adam D.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA	Carnegie Mellon University	Linstedt, AD (corresponding author), Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA.	linstedt@cmu.edu			National Institutes of Health [1R21DE026714, UO1 CA230677]; NATIONAL CANCER INSTITUTE [U01CA230677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R21DE026714] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health Grants 1R21DE026714 and UO1 CA230677 (to A. D. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bagdonaite I, 2016, J BIOL CHEM, V291, P12014, DOI 10.1074/jbc.M116.721746; Bagdonaite I, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004784; Beniac D, 2017, SCI REP-UK, V7, DOI 10.1038/srep46374; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Chan SY, 2000, J GEN VIROL, V81, P2155, DOI 10.1099/0022-1317-81-9-2155; Collar AL, 2017, VIROLOGY, V502, P39, DOI 10.1016/j.virol.2016.12.010; Escudero-Perez B, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004509; Francica JR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001098; Francica JR, 2009, VIROLOGY, V383, P237, DOI 10.1016/j.virol.2008.10.029; Goth CK, 2015, P NATL ACAD SCI USA, V112, P14623, DOI 10.1073/pnas.1511175112; Liu F, 2017, J BIOL CHEM, V292, P21304, DOI 10.1074/jbc.M117.814202; Miwa HE, 2010, J BIOL CHEM, V285, P1208, DOI 10.1074/jbc.M109.035436; Mukhopadhyay S, 2010, MOL BIOL CELL, V21, P1282, DOI 10.1091/mbc.E09-11-0985; Okumura A, 2010, J VIROL, V84, P27, DOI 10.1128/JVI.01462-09; Schjoldager KT, 2015, EMBO REP, V16, P1713, DOI 10.15252/embr.201540796; Simmons G, 2002, J VIROL, V76, P2518, DOI 10.1128/JVI.76.5.2518-2528.2002; Song L, 2017, ELIFE, V6, DOI 10.7554/eLife.24051; Song LN, 2014, J BIOL CHEM, V289, P30556, DOI 10.1074/jbc.M114.599563; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Steentoft C, 2011, NAT METHODS, V8, P977, DOI [10.1038/nmeth.1731, 10.1038/NMETH.1731]; Tenno M, 2007, MOL CELL BIOL, V27, P8783, DOI 10.1128/MCB.01204-07; Tian E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115861; Tian E, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1874; Tran EEH, 2014, J VIROL, V88, P10958, DOI 10.1128/JVI.00870-14; Van den Steen P, 1998, CRIT REV BIOCHEM MOL, V33, P151; Wang SJ, 2018, J BIOL CHEM, V293, P7408, DOI 10.1074/jbc.M117.817981; Wang YC, 2010, P NATL ACAD SCI USA, V107, P9228, DOI 10.1073/pnas.0914004107; Yang ZY, 2000, NAT MED, V6, P886, DOI 10.1038/78654	28	11	11	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19866	19873		10.1074/jbc.RA118.005375	http://dx.doi.org/10.1074/jbc.RA118.005375			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30389789	Green Published, hybrid			2022-12-28	WOS:000454294900030
J	Xu, L; Chirasani, VR; Carter, JS; Pasek, DA; Dokholyan, NV; Yamaguchi, N; Meissner, G				Xu, Le; Chirasani, Venkat R.; Carter, Jordan S.; Pasek, Daniel A.; Dokholyan, Nikolay V.; Yamaguchi, Naohiro; Meissner, Gerhard			Ca2+-mediated activation of the skeletal-muscle ryanodine receptor ion channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ryanodine receptor; skeletal muscle; mutagenesis; computation; sarcoplasmic reticulum (SR); Ca2+activation; Ca2+release channel; calcium homeostasis; ion gating; structure-function analysis	RELEASE CHANNEL; CALCIUM-RELEASE; SARCOPLASMIC-RETICULUM; STRUCTURAL BASIS; RYR1; CAFFEINE; HELIX; S6	Cryo-electron micrograph studies recently have identified a Ca2+-binding site in the 2,200-kDa ryanodine receptor ion channel (RyR1) in skeletal muscle. To clarify the role of this site in regulating RyR1 activity, here we applied mutational, electrophysiological, and computational methods. Three amino acid residues that interact directly with Ca2+ were replaced, and these RyR1 variants were expressed in HEK293 cells. Single-site RyR1-E3893Q, -E3893V, -E3967Q, -E3967V, and -T5001A variants and double-site RyR1-E3893Q/E3967Q and -E3893V/E3967V variants displayed cellular Ca2+ release in response to caffeine, which indicated that they retained functionality as caffeine-sensitive, Ca2+-conducting channels in the HEK293 cell system. Using [H-3]ryanodine binding and single-channel measurements of membrane isolates, we found that single- and double-site RyR1-E3893 and -E3967 variants are not activated by Ca2+. We also noted that RyR1-E3893Q/E3967Q and -E3893V/E3967V variants maintain caffeine- and ATP-induced activation and that RyR1-E3893Q/E3967Q is inhibited by Mg2+ and elevated Ca2+. RyR1-T5001A exhibited decreased Ca2+ sensitivity compared with WT-RyR1 in single-channel measurements. Computational methods suggested that electrostatic interactions between Ca2+ and negatively charged glutamate residues have a critical role in transducing the functional effects of Ca2+ on RyR1. We conclude that the removal of negative charges in the recently identified RyR1 Ca2+-binding site impairs RyR1 activation by physiological Ca2+ concentrations and results in loss of binding to Ca2+ or reduced Ca2+ affinity of the binding site.	[Xu, Le; Chirasani, Venkat R.; Pasek, Daniel A.; Dokholyan, Nikolay V.; Meissner, Gerhard] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Chirasani, Venkat R.; Dokholyan, Nikolay V.] Penn State Coll Med, Dept Pharmacol, Hershey, PA 17033 USA; [Chirasani, Venkat R.; Dokholyan, Nikolay V.] Penn State Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA; [Carter, Jordan S.; Yamaguchi, Naohiro] Med Univ South Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA; [Carter, Jordan S.; Yamaguchi, Naohiro] Clemson Univ, Cardiac Signaling Ctr, Charleston, SC 29425 USA	University of North Carolina; University of North Carolina Chapel Hill; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Medical University of South Carolina; Clemson University	Meissner, G (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	meissner@med.unc.edu	Chirasani, Venkata Reddy/AFN-6812-2022; Chirasani, Venkata Reddy/ABB-4967-2021; Xu, Le/HDN-9623-2022; Dokholyan, Nikolay/B-2238-2009	Chirasani, Venkata Reddy/0000-0003-1416-0438; Chirasani, Venkata Reddy/0000-0003-1416-0438; Dokholyan, Nikolay/0000-0002-8225-4025; Meissner, Gerhard/0000-0001-5185-4389	National Institutes of Health [AR018687, P20GM103499, UL1TR001450]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001450] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR018687] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103499] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants AR018687 (to G. M.) and P20GM103499 and UL1TR001450 (to N. Y.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bai XC, 2016, CELL RES, V26, P995, DOI 10.1038/cr.2016.89; Barg S, 1997, AM J PHYSIOL-CELL PH, V272, pC1726, DOI 10.1152/ajpcell.1997.272.5.C1726; Bhat MB, 1997, BIOPHYS J, V73, P1329, DOI 10.1016/S0006-3495(97)78166-9; BRILLANTES AMB, 1994, CELL, V77, P513, DOI 10.1016/0092-8674(94)90214-3; DeLano WL, 2011, PYMOL MOL GRAPH SYST; des Georges A, 2016, CELL, V167, P145, DOI 10.1016/j.cell.2016.08.075; Efremov RG, 2015, NATURE, V517, P39, DOI 10.1038/nature13916; Endo M, 2009, PHYSIOL REV, V89, P1153, DOI 10.1152/physrev.00040.2008; Fessenden JD, 2001, P NATL ACAD SCI USA, V98, P2865, DOI 10.1073/pnas.041608898; FranziniArmstrong C, 1997, PHYSIOL REV, V77, P699, DOI 10.1152/physrev.1997.77.3.699; Gao L, 1997, FEBS LETT, V412, P223, DOI 10.1016/S0014-5793(97)00781-3; Gomez AC, 2014, BIOCHEMISTRY-US, V53, P1373, DOI 10.1021/bi401586h; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Lanner JT, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003996; Mei YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054208; Meissner G, 2017, J GEN PHYSIOL, V149, P1065, DOI 10.1085/jgp.201711878; Murayama T, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0103-x; Murayama T, 2011, J BIOL CHEM, V286, P35571, DOI 10.1074/jbc.M111.255240; O'Brien JJ, 2002, BIOPHYS J, V82, P2428, DOI 10.1016/S0006-3495(02)75586-0; Patterson RL, 2004, ANNU REV BIOCHEM, V73, P437, DOI 10.1146/annurev.biochem.73.071403.161303; Peng W, 2016, SCIENCE, V354, DOI 10.1126/science.aah5324; Ramachandran S, 2013, J BIOL CHEM, V288, P6154, DOI 10.1074/jbc.M112.433789; Rios E, 2018, J GEN PHYSIOL, V150, P521, DOI 10.1085/jgp.201711959; ROUSSEAU E, 1988, ARCH BIOCHEM BIOPHYS, V267, P75, DOI 10.1016/0003-9861(88)90010-0; Samso M, 2009, PLOS BIOL, V7, P980, DOI 10.1371/journal.pbio.1000085; SCHNEIDER MF, 1973, NATURE, V242, P244, DOI 10.1038/242244a0; SMITH JS, 1985, NATURE, V316, P446, DOI 10.1038/316446a0; Sun B, 2016, J BIOL CHEM, V291, P26024, DOI 10.1074/jbc.M116.758821; Sutko JL, 1996, PHYSIOL REV, V76, P1027, DOI 10.1152/physrev.1996.76.4.1027; Tsai J, 1999, J MOL BIOL, V290, P253, DOI 10.1006/jmbi.1999.2829; Wang Y, 2006, J BIOL CHEM, V281, P15572, DOI 10.1074/jbc.M600090200; Wei RS, 2016, CELL RES, V26, P977, DOI 10.1038/cr.2016.99; Xu L, 2006, BIOPHYS J, V90, P443, DOI 10.1529/biophysj.105.072538; Xu L, 2018, J BIOL CHEM, V293, P2015, DOI 10.1074/jbc.M117.803247; Yan Z, 2015, NATURE, V517, P50, DOI 10.1038/nature14063; Zalk R, 2007, ANNU REV BIOCHEM, V76, P367, DOI 10.1146/annurev.biochem.76.053105.094237; Zalk R, 2015, NATURE, V517, P44, DOI 10.1038/nature13950	37	15	15	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2018	293	50					19501	19509		10.1074/jbc.RA118.004453	http://dx.doi.org/10.1074/jbc.RA118.004453			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HE6RA	30341173	Green Published, hybrid			2022-12-28	WOS:000453537300029
J	Russell, DW				Russell, David W.			Lucky, times ten: A career in Texas science	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Biographical-Item							DENSITY-LIPOPROTEIN RECEPTOR; BILE-ACID SYNTHESIS; RIBOSOME DISSOCIATION FACTOR; ALU-ALU RECOMBINATION; COENZYME-A REDUCTASE; 7 ALPHA-HYDROXYLASE; OXYSTEROL 7-ALPHA-HYDROXYLASE GENE; NEGATIVE FEEDBACK-REGULATION; MAMMALIAN WAX BIOSYNTHESIS; B-CELL MIGRATION	On January 21, 2017, I received an E-mail from Herb Tabor that I had been simultaneously hoping for and dreading for several years: an invitation to write a "Reflections" article for the Journal of Biological Chemistry. On the one hand, I was honored to receive an invitation from Herb, a man I have admired for over 40 years, known for 24 years, and worked with as a member of the Editorial Board and Associate Editor of the Journal of Biological Chemistry for 17 years. On the other hand, the invitation marked the waning of my career as an academic scientist. With these conflicting emotions, I wrote this article with the goals of recording my career history and recognizing the many mentors, trainees, and colleagues who have contributed to it and, perhaps with pretension, with the desire that students who are beginning a career in research will find inspiration in the path I have taken and appreciate the importance of luck.	[Russell, David W.] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Genet, 5323 Harry Hines Blvd, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Russell, DW (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Mol Genet, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	david.russell@utsouthwestern.edu			National Institutes of Health [HL01287, HL20948, HL31346, HD38127, DK47657, AR51943, DK81182]; Robert A. Welch Foundation; Eugene McDermott Foundation; Perot Family Foundation; Clayton Foundation for Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051943] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [PL1DK081182] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); Eugene McDermott Foundation; Perot Family Foundation; Clayton Foundation for Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	I thank Mike Brown, Joe Goldstein, Helen Hobbs, and Linda Spremulli for critical reading of the manuscript, and Nancy Heard for the figures appearing in this manuscript as well as all of those I have published over the last several decades. The research described in this article was supported by National Institutes of Health Grants HL01287, HL20948, HL31346, HD38127, DK47657, AR51943, and DK81182; and by grants from the Robert A. Welch Foundation, the Eugene McDermott Foundation, the Perot Family Foundation, and the Clayton Foundation for Research.	Al Mutair AN, 2012, J CLIN ENDOCR METAB, V97, pE2022, DOI 10.1210/jc.2012-1340; ANDERSSON S, 1990, P NATL ACAD SCI USA, V87, P3640, DOI 10.1073/pnas.87.10.3640; Andersson S, 1996, TRENDS ENDOCRIN MET, V7, P121, DOI 10.1016/1043-2760(96)00034-3; ANDERSSON S, 1989, J BIOL CHEM, V264, P16249; ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; ANDERSSON S, 1991, NATURE, V354, P159, DOI 10.1038/354159a0; Basu U, 2001, MOL CELL BIOL, V21, P1453, DOI 10.1128/MCB.21.5.1453-1462.2001; Bauman DR, 2009, P NATL ACAD SCI USA, V106, P16764, DOI 10.1073/pnas.0909142106; BEIER DR, 1985, MOL CELL BIOL, V5, P1743, DOI 10.1128/MCB.5.7.1743; Bensch WR, 1999, J PHARMACOL EXP THER, V289, P85; BERMAN DM, 1995, MOL ENDOCRINOL, V9, P1561, DOI 10.1210/me.9.11.1561; Biswas MG, 1997, J BIOL CHEM, V272, P15959, DOI 10.1074/jbc.272.25.15959; Bjorkhem I, 1999, CURR OPIN LIPIDOL, V10, P161, DOI 10.1097/00041433-199904000-00010; BJORKHEM I, 2001, METABOLIC MOL BASES, P2961; Blanc M, 2013, IMMUNITY, V38, P106, DOI 10.1016/j.immuni.2012.11.004; Bowling N, 1996, J LIPID RES, V37, P2586; BREITENBERGER CA, 1979, ANAL BIOCHEM, V99, P434, DOI 10.1016/S0003-2697(79)80029-9; Brown MS, 2009, J LIPID RES, V50, pS15, DOI 10.1194/jlr.R800054-JLR200; BROWN MS, 1974, P NATL ACAD SCI USA, V71, P788, DOI 10.1073/pnas.71.3.788; BROWN MS, 1980, J LIPID RES, V21, P505; BROWN MS, 1974, J BIOL CHEM, V249, P7306; CALI JJ, 1991, J BIOL CHEM, V266, P7774; CALI JJ, 1991, J BIOL CHEM, V266, P7779; Chan TD, 2010, IMMUNOL REV, V237, P90, DOI 10.1111/j.1600-065X.2010.00942.x; Chang KH, 2011, P NATL ACAD SCI USA, V108, P13728, DOI 10.1073/pnas.1107898108; CHANG MS, 1987, P NATL ACAD SCI USA, V84, P5640, DOI 10.1073/pnas.84.16.5640; Chen WL, 2007, CELL METAB, V5, P73, DOI 10.1016/j.cmet.2006.11.012; CHEN WJ, 1991, CELL, V66, P327, DOI 10.1016/0092-8674(91)90622-6; Chendrimada TP, 2007, NATURE, V447, P823, DOI 10.1038/nature05841; Cheng JB, 2004, P NATL ACAD SCI USA, V101, P7711, DOI 10.1073/pnas.0402490101; Cheng JB, 2003, J BIOL CHEM, V278, P38084, DOI 10.1074/jbc.M307028200; Cheng JB, 2003, J CLIN ENDOCR METAB, V88, P1833, DOI 10.1210/jc.2002-021580; Cheng JB, 2004, J BIOL CHEM, V279, P37789, DOI 10.1074/jbc.M406225200; Cheng JB, 2004, J BIOL CHEM, V279, P37798, DOI 10.1074/jbc.M406226200; CHIN DJ, 1984, NATURE, V308, P613, DOI 10.1038/308613a0; COHEN JC, 1992, GENOMICS, V14, P153, DOI 10.1016/S0888-7543(05)80298-8; CUTHBERT JA, 1989, J BIOL CHEM, V264, P1298; Dang EV, 2017, CELL, V171, P1057, DOI 10.1016/j.cell.2017.09.029; DAVIS CG, 1987, NATURE, V326, P760, DOI 10.1038/326760a0; DAVIS CG, 1986, CELL, V45, P15, DOI 10.1016/0092-8674(86)90533-7; DAVIS CG, 1986, J BIOL CHEM, V261, P2828; DAVIS CG, 1987, J BIOL CHEM, V262, P4075; Dennis EA, 2016, J BIOL CHEM, V291, P24431, DOI 10.1074/jbc.X116.723791; Diczfalusy U, 2009, J LIPID RES, V50, P2258, DOI 10.1194/jlr.M900107-JLR200; ESSER V, 1988, J BIOL CHEM, V263, P13282; ESSER V, 1988, J BIOL CHEM, V263, P13276; GEISSLER WM, 1994, NAT GENET, V7, P34, DOI 10.1038/ng0594-34; GOLDSTEIN JL, 1979, NATURE, V279, P679, DOI 10.1038/279679a0; Groft CM, 2000, NAT STRUCT BIOL, V7, P1156; Hammer MB, 2013, AM J HUM GENET, V92, P245, DOI 10.1016/j.ajhg.2012.12.012; Hannedouche S, 2011, NATURE, V475, P524, DOI 10.1038/nature10280; HOBBS HH, 1986, J BIOL CHEM, V261, P3114; HOBBS HH, 1985, P NATL ACAD SCI USA, V82, P7651, DOI 10.1073/pnas.82.22.7651; HOBBS HH, 1987, NEW ENGL J MED, V317, P734, DOI 10.1056/NEJM198709173171204; HOFMANN SL, 1987, P NATL ACAD SCI USA, V84, P6312, DOI 10.1073/pnas.84.17.6312; HOFMANN SL, 1988, SCIENCE, V239, P1277, DOI 10.1126/science.3344433; HUTCHISON CA, 1978, J BIOL CHEM, V253, P6551; Ishibashi S, 1996, J BIOL CHEM, V271, P18017, DOI 10.1074/jbc.271.30.18017; IYER V, 1995, EMBO J, V14, P2570, DOI 10.1002/j.1460-2075.1995.tb07255.x; Janowski BA, 2001, J BIOL CHEM, V276, P45408, DOI 10.1074/jbc.M108348200; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; JELINEK DF, 1990, BIOCHEMISTRY-US, V29, P7781, DOI 10.1021/bi00486a001; JELINEK DF, 1990, J BIOL CHEM, V265, P8190; KANDUTSCH AA, 1974, J BIOL CHEM, V249, P6057; Kerr TA, 2002, DEV CELL, V2, P713, DOI 10.1016/S1534-5807(02)00154-5; Klinge S, 2011, SCIENCE, V334, P941, DOI 10.1126/science.1211204; Kotti T, 2008, P NATL ACAD SCI USA, V105, P11394, DOI 10.1073/pnas.0805556105; Kotti TJ, 2006, P NATL ACAD SCI USA, V103, P3869, DOI 10.1073/pnas.0600316103; LEHRMAN MA, 1987, J BIOL CHEM, V262, P401; LEHRMAN MA, 1986, P NATL ACAD SCI USA, V83, P3679, DOI 10.1073/pnas.83.11.3679; LEHRMAN MA, 1985, SCIENCE, V227, P140, DOI 10.1126/science.3155573; LEHRMAN MA, 1987, J BIOL CHEM, V262, P3354; LEHRMAN MA, 1985, CELL, V41, P735, DOI 10.1016/S0092-8674(85)80054-4; LEHRMAN MA, 1987, CELL, V48, P827, DOI 10.1016/0092-8674(87)90079-1; Li JM, 1997, P NATL ACAD SCI USA, V94, P3554, DOI 10.1073/pnas.94.8.3554; Li JM, 1996, SCIENCE, V272, P398, DOI 10.1126/science.272.5260.398; Li-Hawkins J, 2000, J BIOL CHEM, V275, P16543, DOI 10.1074/jbc.M001810200; Li-Hawkins J, 2002, J CLIN INVEST, V110, P1191, DOI 10.1172/JCI200216309; Li-Hawkins J, 2000, J BIOL CHEM, V275, P16536, DOI 10.1074/jbc.M001811200; Liu CL, 2011, NATURE, V475, P519, DOI 10.1038/nature10226; Liu SY, 2013, IMMUNITY, V38, P92, DOI 10.1016/j.immuni.2012.11.005; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Lund EG, 1999, P NATL ACAD SCI USA, V96, P7238, DOI 10.1073/pnas.96.13.7238; Lund EG, 2003, J BIOL CHEM, V278, P22980, DOI 10.1074/jbc.M303415200; Lund EG, 1998, J BIOL CHEM, V273, P34316, DOI 10.1074/jbc.273.51.34316; Mahendroo MS, 1999, MOL ENDOCRINOL, V13, P981, DOI 10.1210/me.13.6.981; Mahendroo MS, 2001, ENDOCRINOLOGY, V142, P4652, DOI 10.1210/en.142.11.4652; Martin E, 2013, AM J HUM GENET, V92, P238, DOI 10.1016/j.ajhg.2012.11.021; McDonald JG, 2012, J LIPID RES, V53, P1399, DOI 10.1194/jlr.D022285; MOORE RJ, 1976, J BIOL CHEM, V251, P5895; NAGLICH JG, 1992, CELL, V69, P1051, DOI 10.1016/0092-8674(92)90623-K; Nevius E, 2015, J EXP MED, V212, P1931, DOI 10.1084/jem.20150088; NORMINGTON K, 1992, J BIOL CHEM, V267, P19548; OKAYAMA H, 1983, MOL CELL BIOL, V3, P280, DOI 10.1128/MCB.3.2.280; PALMITER RD, 1974, BIOCHEMISTRY-US, V13, P3606, DOI 10.1021/bi00714a032; Park K, 2010, J LEUKOCYTE BIOL, V88, P1081, DOI 10.1189/jlb.0610318; PEACOCK SL, 1988, J BIOL CHEM, V263, P7838; Pereira JP, 2010, INT IMMUNOL, V22, P413, DOI 10.1093/intimm/dxq047; Pikuleva IA, 1998, J BIOL CHEM, V273, P18153, DOI 10.1074/jbc.273.29.18153; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Reboldi A, 2014, SCIENCE, V345, P679, DOI 10.1126/science.1254790; Repa JJ, 2000, J BIOL CHEM, V275, P39685, DOI 10.1074/jbc.M007653200; ROBISHAW JD, 1986, P NATL ACAD SCI USA, V83, P1251, DOI 10.1073/pnas.83.5.1251; Russell DW, 2014, GENETIC STEROID DISORDERS, P199, DOI 10.1016/B978-0-12-416006-4.00014-4; RUSSELL DW, 1984, CELL, V37, P577, DOI 10.1016/0092-8674(84)90388-X; RUSSELL DW, 1983, NATURE, V304, P652, DOI 10.1038/304652a0; RUSSELL DW, 1978, J BIOL CHEM, V253, P6647; RUSSELL DW, 1986, MOL CELL BIOL, V6, P4281, DOI 10.1128/MCB.6.12.4281; RUSSELL DW, 1979, ANAL BIOCHEM, V93, P238; RUSSELL DW, 1979, J BIOL CHEM, V254, P8796; RUSSELL DW, 1983, P NATL ACAD SCI-BIOL, V80, P7501, DOI 10.1073/pnas.80.24.7501; RUSSELL DW, 1983, J BIOL CHEM, V258, P2674; RUSSELL DW, 1980, ARCH BIOCHEM BIOPHYS, V201, P518, DOI 10.1016/0003-9861(80)90540-8; Schwarz M, 2000, J CLIN INVEST, V106, P1175, DOI 10.1172/JCI10902; Schwarz M, 1996, J BIOL CHEM, V271, P18024, DOI 10.1074/jbc.271.30.18017; Schwarz M, 1997, J BIOL CHEM, V272, P23995, DOI 10.1074/jbc.272.38.23995; Setchell KDR, 1998, J CLIN INVEST, V102, P1690, DOI 10.1172/JCI2962; Setchell KDR, 2013, GASTROENTEROLOGY, V144, P945, DOI 10.1053/j.gastro.2013.02.004; Shaw G, 2006, ENDOCRINOLOGY, V147, P2368, DOI 10.1210/en.2005-1251; Shea HC, 2007, P NATL ACAD SCI USA, V104, P11526, DOI 10.1073/pnas.0705089104; Shibata N, 2013, J BIOL CHEM, V288, P35812, DOI 10.1074/jbc.M113.519637; SPERRAZZA JM, 1980, BIOCHEMISTRY-US, V19, P1053, DOI 10.1021/bi00547a001; SUDHOF TC, 1987, CELL, V48, P1061, DOI 10.1016/0092-8674(87)90713-6; SUDHOF TC, 1985, SCIENCE, V228, P815, DOI 10.1126/science.2988123; THIGPEN AE, 1993, J BIOL CHEM, V268, P17404; THIGPEN AE, 1992, J BIOL CHEM, V267, P8577; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Tian H, 1997, DEV DYNAM, V209, P117; Tian H, 1998, GENE DEV, V12, P3320, DOI 10.1101/gad.12.21.3320; VALENZUELA DM, 1982, J BIOL CHEM, V257, P7712; Vance DE, 2017, J BIOL CHEM, V292, P17169, DOI 10.1074/jbc.X117.815100; WEIFFENBACH B, 1983, P NATL ACAD SCI-BIOL, V80, P3401, DOI 10.1073/pnas.80.11.3401; WILLIAMSON VM, 1983, MOL CELL BIOL, V3, P20, DOI 10.1128/MCB.3.1.20; YAMAMOTO T, 1986, SCIENCE, V232, P1230, DOI 10.1126/science.3010466; YAMAMOTO T, 1984, CELL, V39, P27, DOI 10.1016/0092-8674(84)90188-0; Yildiz Y, 2006, J CLIN INVEST, V116, P2985, DOI 10.1172/JCI29224; Zhou YD, 1997, P NATL ACAD SCI USA, V94, P713, DOI 10.1073/pnas.94.2.713; Zhu JG, 2013, P NATL ACAD SCI USA, V110, P15650, DOI 10.1073/pnas.1315006110	139	4	4	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2018	293	49					18804	18827		10.1074/jbc.X118.005918	http://dx.doi.org/10.1074/jbc.X118.005918			24	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NY	30530852	Green Published, hybrid			2022-12-28	WOS:000458467400001
J	Singh, SP; Kukshal, V; Galletto, R				Singh, Saurabh P.; Kukshal, Vandna; Galletto, Roberto			A stable tetramer is not the only oligomeric state that mitochondrial single-stranded DNA binding proteins can adopt	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA-binding protein; oligomerization; analytical ultracentrifugation; fluorescence; biophysics; mitochondria; DNA replication	PLASMODIUM-FALCIPARUM SSB; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; MODE TRANSITIONS; COMPLEXES; IDENTIFICATION; EQUILIBRIUM; MULTIPLE; MUTANT; ACIDS	Mitochondrial single-stranded DNA (ssDNA)-binding proteins (mtSSBs) are required for mitochondrial DNA replication and stability and are generally assumed to form homotetramers, and this species is proposed to be the one active for ssDNA binding. However, we recently reported that the mtSSB from Saccharomyces cerevisiae (ScRim1) forms homotetramers at high protein concentrations, whereas at low protein concentrations, it dissociates into dimers that bind ssDNA with high affinity. In this work, using a combination of analytical ultracentrifugation techniques and DNA binding experiments with fluorescently labeled DNA oligonucleotides, we tested whether the ability of ScRim1 to form dimers is unique among mtSSBs. Although human mtSSBs and those from Schizosaccharomyces pombe, Xenopus laevis, and Xenopus tropicalis formed stable homotetramers, the mtSSBs from Candida albicans and Candida parapsilosis formed stable homodimers. Moreover, the mtSSBs from Candida nivariensis and Candida castellii formed tetramers at high protein concentrations, whereas at low protein concentrations, they formed dimers, as did ScRim1. Mutational studies revealed that the ability to form either stable tetramers or dimers depended on a complex interplay of more than one amino acid at the dimer-dimer interface and the C-terminal unstructured tail. In conclusion, our findings indicate that mtSSBs can adopt different oligomeric states, ranging from stable tetramers to stable dimers, and suggest that a dimer of mtSSB may be a physiologically relevant species that binds to ssDNA in some yeast species.	[Singh, Saurabh P.; Kukshal, Vandna; Galletto, Roberto] Washington Univ, Dept Biochem & Mol Biophys, Sch Med, St Louis, MO 63110 USA	Washington University (WUSTL)	Galletto, R (corresponding author), Washington Univ, Dept Biochem & Mol Biophys, Sch Med, St Louis, MO 63110 USA.	galletto@biochem.wustl.edu	Singh, Saurabh Pratap/AAI-2988-2020	Singh, Saurabh Pratap/0000-0001-7604-645X; Galletto, Roberto/0000-0001-6435-122X	NIGMS, National Institutes of Health [2R01GM098509]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098509] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIGMS, National Institutes of Health (2R01GM098509 to R. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Antony E, 2012, J MOL BIOL, V420, P284, DOI 10.1016/j.jmb.2012.04.022; Antony E, 2012, J MOL BIOL, V420, P269, DOI 10.1016/j.jmb.2012.04.021; BARAT M, 1981, CHROMOSOMA, V82, P583, DOI 10.1007/BF00295014; BUJALOWSKI W, 1988, J BIOL CHEM, V263, P4629; BUJALOWSKI W, 1986, BIOCHEMISTRY-US, V25, P7799, DOI 10.1021/bi00372a003; BUJALOWSKI W, 1991, J BIOL CHEM, V266, P1616; Carlini L, 1998, FEBS LETT, V430, P197, DOI 10.1016/S0014-5793(98)00655-3; KHAMIS MI, 1987, J BIOL CHEM, V262, P10938; KHAMIS MI, 1987, FEBS LETT, V211, P155, DOI 10.1016/0014-5793(87)81427-8; Landwehr M, 2002, BIOL CHEM, V383, P1325, DOI 10.1515/BC.2002.151; LOHMAN TM, 1985, J BIOL CHEM, V260, P3594; LOHMAN TM, 1994, ANNU REV BIOCHEM, V63, P527, DOI 10.1146/annurev.biochem.63.1.527; LOHMAN TM, 1988, BIOCHEM PHARMACOL, V37, P1781, DOI 10.1016/0006-2952(88)90443-1; Nishio M, 2006, DNA SEQUENCE, V17, P287, DOI 10.1080/10425170600857608; Nosek J, 1999, J BIOL CHEM, V274, P8850, DOI 10.1074/jbc.274.13.8850; Qian YF, 2017, J BIOL CHEM, V292, P13068, DOI 10.1074/jbc.M117.791392; Raghunathan S, 1997, P NATL ACAD SCI USA, V94, P6652, DOI 10.1073/pnas.94.13.6652; Ramanagoudr-Bhojappa R, 2013, NUCLEIC ACIDS RES, V41, P1029, DOI 10.1093/nar/gks1088; Roy R, 2007, J MOL BIOL, V369, P1244, DOI 10.1016/j.jmb.2007.03.079; Singh SP, 2018, NUCLEIC ACIDS RES, V46, P7193, DOI 10.1093/nar/gky530; Tomaska L, 1997, J BIOL CHEM, V272, P3049, DOI 10.1074/jbc.272.5.3049; Tomaska L, 2001, J MOL BIOL, V305, P61, DOI 10.1006/jmbi.2000.4254; VANDYCK E, 1992, EMBO J, V11, P3421, DOI 10.1002/j.1460-2075.1992.tb05421.x; Webster G, 1997, FEBS LETT, V411, P313, DOI 10.1016/S0014-5793(97)00747-3; Wong TS, 2009, NUCLEIC ACIDS RES, V37, P568, DOI 10.1093/nar/gkn974; Yang C, 1997, NAT STRUCT BIOL, V4, P153, DOI 10.1038/nsb0297-153	26	3	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					4137	4144		10.1074/jbc.RA118.007048	http://dx.doi.org/10.1074/jbc.RA118.007048			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30617184	Green Published, hybrid			2022-12-28	WOS:000461854400025
J	Geronimo, I; Ntarima, P; Piens, K; Gudmundsson, M; Hansson, H; Sandgren, M; Payne, CM				Geronimo, Inacrist; Ntarima, Patricia; Piens, Kathleen; Gudmundsson, Mikael; Hansson, Henrik; Sandgren, Mats; Payne, Christina M.			Kinetic and molecular dynamics study of inhibition and transglycosylation in Hypocrea jecorina family 3-glucosidases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycoside hydrolase; carbohydrate-binding protein; inhibition mechanism; enzyme kinetics; molecular dynamics; cellulose; biofuel; transglycosylation	3 BETA-GLUCOSIDASE; ASPERGILLUS-NIGER; TRICHODERMA-REESEI; CRYSTAL-STRUCTURES; ENZYMES; MODEL; OLIGOSACCHARIDES; RESIDUE; CLONING; CEL3A	-Glucosidases enhance enzymatic biomass conversion by relieving cellobiose inhibition of endoglucanases and cellobiohydrolases. However, the susceptibility of these enzymes to inhibition and transglycosylation at high glucose or cellobiose concentrations severely limits their activity and, consequently, the overall efficiency of enzyme mixtures. We determined the impact of these two processes on the hydrolytic activity of the industrially relevant family 3 -glucosidases from Hypocrea jecorina, HjCel3A and HjCel3B, and investigated the underlying molecular mechanisms through kinetic studies, binding free energy calculations, and molecular dynamics (MD) simulations. HjCel3B had a 7-fold higher specificity for cellobiose than HjCel3A but greater tendency for glucose inhibition. Energy decomposition analysis indicated that cellobiose has relatively weak electrostatic interactions with binding site residues, allowing it to be easily displaced by glucose and free to inhibit other hydrolytic enzymes. HjCel3A is, thus, preferable as an industrial -glucosidase despite its lower activity caused by transglycosylation. This competing pathway to hydrolysis arises from binding of glucose or cellobiose at the product site after formation of the glycosyl-enzyme intermediate. MD simulations revealed that binding is facilitated by hydrophobic interactions with Trp-37, Phe-260, and Tyr-443. Targeting these aromatic residues for mutation to reduce substrate affinity at the product site would therefore potentially mitigate transglycosidic activity. Engineering improved variants of HjCel3A and other structurally similar -glucosidases would have a significant economic effect on enzymatic biomass conversion in terms of yield and production cost as the process can be consequently conducted at higher substrate loadings.	[Geronimo, Inacrist; Payne, Christina M.] Univ Kentucky, Dept Chem & Mat Engn, 177 F Paul Anderson Tower, Lexington, KY 40506 USA; [Ntarima, Patricia; Piens, Kathleen] Univ Ghent, Dept Biochem & Microbiol, B-9000 Ghent, Belgium; [Gudmundsson, Mikael; Hansson, Henrik; Sandgren, Mats; Payne, Christina M.] Swedish Univ Agr Sci, Dept Mol Sci, Box 7015, S-75007 Uppsala, Sweden; [Piens, Kathleen] Oxyrane, B-9000 Ghent, Belgium	University of Kentucky; Ghent University; Swedish University of Agricultural Sciences	Payne, CM (corresponding author), Univ Kentucky, Dept Chem & Mat Engn, 177 F Paul Anderson Tower, Lexington, KY 40506 USA.; Sandgren, M (corresponding author), Swedish Univ Agr Sci, Dept Mol Sci, Box 7015, S-75007 Uppsala, Sweden.	mats.sandgren@slu.se; christy.payne@uky.edu	Payne, Christina/ABE-8330-2020; Geronimo, Inacrist/D-3383-2018	Payne, Christina/0000-0001-5264-0964; Geronimo, Inacrist/0000-0002-4968-500X; Gudmundsson, Mikael/0000-0002-8095-4423; Hansson, Henrik/0000-0002-6003-2982; Sandgren, Mats/0000-0002-2358-4534	Swedish University of Agricultural Sciences August T. Larsson Guest Researcher Programme; National Science Foundation Experimental Program [1355438]; Swedish Governmental Agency for Innovation Systems (VINNOVA) [2015-04835]	Swedish University of Agricultural Sciences August T. Larsson Guest Researcher Programme; National Science Foundation Experimental Program; Swedish Governmental Agency for Innovation Systems (VINNOVA)(Vinnova)	This work was supported in part by the Swedish University of Agricultural Sciences August T. Larsson Guest Researcher Programme (to C.M.P.), National Science Foundation Experimental Program to Stimulate Competitive Research Grant 1355438 (to I.G.), and Swedish Governmental Agency for Innovation Systems (VINNOVA) Grant 2015-04835. The authors declare that they have no conflicts of interest with the contents of this article.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BARNETT CC, 1991, BIO-TECHNOL, V9, P562, DOI 10.1038/nbt0691-562; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Bhatia Y, 2002, CRIT REV BIOTECHNOL, V22, P375, DOI 10.1080/07388550290789568; Bohlin C, 2013, APPL MICROBIOL BIOT, V97, P159, DOI 10.1007/s00253-012-3875-9; Bohlin C, 2010, BIOTECHNOL BIOENG, V107, P943, DOI 10.1002/bit.22885; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chauve M, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-3; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Decker CH, 2000, J AGR FOOD CHEM, V48, P4929, DOI 10.1021/jf000434d; Deng YQ, 2006, J CHEM THEORY COMPUT, V2, P1255, DOI 10.1021/ct060037v; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; DURELL SR, 1994, J PHYS CHEM-US, V98, P2198, DOI 10.1021/j100059a038; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Foreman PK, 2003, J BIOL CHEM, V278, P31988, DOI 10.1074/jbc.M304750200; Geronimo I, 2018, ORG BIOMOL CHEM, V16, P316, DOI 10.1039/c7ob02558k; Gruno M, 2004, BIOTECHNOL BIOENG, V86, P503, DOI 10.1002/bit.10838; Gudmundsson M, 2016, ACTA CRYSTALLOGR D, V72, P860, DOI 10.1107/S2059798316008482; Guo B, 2016, APPL MICROBIOL BIOT, V100, P4959, DOI 10.1007/s00253-016-7342-x; Guvench O, 2011, J CHEM THEORY COMPUT, V7, P3162, DOI 10.1021/ct200328p; Guvench O, 2009, J CHEM THEORY COMPUT, V5, P2353, DOI 10.1021/ct900242e; Hakkinen M, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-134; Jiang W, 2009, J CHEM THEORY COMPUT, V5, P2583, DOI 10.1021/ct900223z; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Joshi MD, 2001, BIOCHEMISTRY-US, V40, P10115, DOI 10.1021/bi0105429; Karkehabadi S, 2014, J BIOL CHEM, V289, P31624, DOI 10.1074/jbc.M114.587766; Kawai R, 2004, CARBOHYD RES, V339, P2851, DOI 10.1016/j.carres.2004.09.019; Korotkova OG, 2009, BIOCHEMISTRY-MOSCOW+, V74, P569, DOI 10.1134/S0006297909050137; Kristensen JB, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-11; Krogh KBRM, 2010, APPL MICROBIOL BIOT, V86, P143, DOI 10.1007/s00253-009-2181-7; Langston J, 2006, BBA-PROTEINS PROTEOM, V1764, P972, DOI 10.1016/j.bbapap.2006.03.009; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mallajosyula SS, 2012, J CHEM THEORY COMPUT, V8, P759, DOI 10.1021/ct200792v; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Nielsen JE, 2001, PROTEIN ENG, V14, P505, DOI 10.1093/protein/14.7.505; Ntarima P, 2000, BIOCHEM J, V347, P865, DOI 10.1042/0264-6021:3470865; Packer NH, 1998, GLYCOCONJUGATE J, V15, P737, DOI 10.1023/A:1006983125913; Payne CM, 2015, CHEM REV, V115, P1308, DOI 10.1021/cr500351c; Payne CM, 2013, J AM CHEM SOC, V135, P18831, DOI 10.1021/ja407287f; PERLACK R.D., 2005, DOEGO1020052135 OAK; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Raman EP, 2010, J PHYS CHEM B, V114, P12981, DOI 10.1021/jp105758h; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; SCHNEIDER T, 1978, PHYS REV B, V17, P1302, DOI 10.1103/PhysRevB.17.1302; Seidle HF, 2006, ARCH BIOCHEM BIOPHYS, V455, P110, DOI 10.1016/j.abb.2006.09.016; Seidle HF, 2005, ARCH BIOCHEM BIOPHYS, V444, P66, DOI 10.1016/j.abb.2005.09.013; Seidle HF, 2005, ARCH BIOCHEM BIOPHYS, V436, P254, DOI 10.1016/j.abb.2005.02.017; Seidle HF, 2004, PROTEIN J, V23, P11, DOI 10.1023/B:JOPC.0000016254.58189.2a; Shirts MR, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2978177; Sorensen A, 2013, BIOMOLECULES, V3, DOI 10.3390/biom3030612; Suzuki K, 2013, BIOCHEM J, V452, P211, DOI 10.1042/BJ20130054; Tengborg C, 2001, BIOTECHNOL PROGR, V17, P110, DOI 10.1021/bp000145+; Teugjas H, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-105; TOMME P, 1988, METHOD ENZYMOL, V160, P187; VANTILBEURGH H, 1988, METHOD ENZYMOL, V160, P45; Vinzant TB, 2001, APPL BIOCHEM BIOTECH, V91-3, P99, DOI 10.1385/ABAB:91-93:1-9:99; Vuong TV, 2010, BIOTECHNOL BIOENG, V107, P195, DOI 10.1002/bit.22838	61	3	3	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2019	294	9					3169	3180		10.1074/jbc.RA118.007027	http://dx.doi.org/10.1074/jbc.RA118.007027			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU0SA	30602567	Green Published, hybrid			2022-12-28	WOS:000464980100016
J	Peris, E; Micallef, P; Paul, A; Palsdottir, V; Enejder, A; Bauza-Thorbrugge, M; Olofsson, CS; Asterholm, IW				Peris, Eduard; Micallef, Peter; Paul, Alexandra; Palsdottir, Vilborg; Enejder, Annika; Bauza-Thorbruegge, Marco; Olofsson, Charlotta S.; Asterholm, Ingrid Wernstedt			Antioxidant treatment induces reductive stress associated with mitochondrial dysfunction in adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						reactive oxygen species (ROS); adipose tissue; adrenergic receptor; antioxidant; vitamin E; mitochondria; oxidative stress; adipocyte; metabolism; browning; glutathione; N-acetylcysteine	INCREASED OXIDATIVE STRESS; GLUTATHIONE; ROS; DIFFERENTIATION; EXPRESSION; NRF2; CELL	beta-Adrenergic stimulation of adipose tissue increases mitochondrial density and activity (browning) that are associated with improved whole-body metabolism. Whereas chronically elevated levels of reactive oxygen species (ROS) in adipose tissue contribute to insulin resistance, transient ROS elevation stimulates physiological processes such as adipogenesis. Here, using a combination of biochemical and cell and molecular biology-based approaches, we studied whether ROS or antioxidant treatment affects beta 3-adrenergic receptor (beta 3-AR) stimulation-induced adipose tissue browning. We found that beta 3-AR stimulation increases ROS levels in cultured adipocytes, but, unexpectedly, pretreatment with different antioxidants (N-acetylcysteine, vitamin E, or GSH ethyl ester) did not prevent this ROS increase. Using fluorescent probes, we discovered that the antioxidant treatments instead enhanced beta 3-AR stimulation-induced mitochondrial ROS production. This pro-oxidant effect of antioxidants was, even in the absence of beta 3-AR stimulation, associated with decreased oxygen consumption and increased lactate production in adipocytes. We observed similar antioxidant effects in WT mice: N-acetylcysteine blunted beta 3-AR stimulation-induced browning of white adipose tissue and reduced mitochondrial activity in brown adipose tissue even in the absence of beta 3-AR stimulation. Furthermore, N-acetylcysteine increased the levels of peroxiredoxin 3 and superoxide dismutase 2 in adipose tissue, indicating increased mitochondrial oxidative stress. We interpret this negative impact of antioxidants on oxygen consumption in vitro and adipose tissue browning in vivo as essential adaptations that prevent a further increase in mitochondrial ROS production. In summary, these results suggest that chronic antioxidant supplementation can produce a paradoxical increase in oxidative stress associated with mitochondrial dysfunction in adipocytes.	[Peris, Eduard; Micallef, Peter; Palsdottir, Vilborg; Bauza-Thorbruegge, Marco; Olofsson, Charlotta S.; Asterholm, Ingrid Wernstedt] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Physiol Metab Physiol, Box 432, SE-40530 Gothenburg, Sweden; [Paul, Alexandra; Enejder, Annika] Chalmers Univ Technol, Dept Biol & Biol Engn, Div Chem Biol, SE-41296 Gothenburg, Sweden	University of Gothenburg; Chalmers University of Technology	Asterholm, IW (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Metab Physiol, Medicinaregatan 11,POB 434, SE-40530 Gothenburg, Sweden.	IWA@neuro.gu.se	Thorbrügge, Marco Bauzá/J-5792-2019; Paul, Alexandra/L-8289-2017; Asterholm, Ingrid Wernstedt/AAK-3682-2020; Pálsdóttir, Vilborg/AAH-3259-2020	Thorbrügge, Marco Bauzá/0000-0002-2147-9386; Paul, Alexandra/0000-0002-8368-9880; Pálsdóttir, Vilborg/0000-0002-5796-6047; Olofsson, Charlotta/0000-0001-8824-3151; Wernstedt Asterholm, Ingrid/0000-0002-0755-5784; Peris Franquet, Eduard/0000-0002-9237-3263	Swedish Research Council [2012-1601, 2013-7107, 2017-00792]; Novo Nordisk Foundation Excellence project; VINNOVA (Swedish Governmental Agency for Innovation Systems); Swedish Diabetes Foundation; Diabetes Wellness Research Foundation; Ake Wiberg Foundation; IngaBritt and Arne Lundberg Foundation; Magnus Bergvall Foundation; European Union [607842]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Novo Nordisk Foundation Excellence project; VINNOVA (Swedish Governmental Agency for Innovation Systems)(Vinnova); Swedish Diabetes Foundation; Diabetes Wellness Research Foundation; Ake Wiberg Foundation; IngaBritt and Arne Lundberg Foundation; Magnus Bergvall Foundation; European Union(European Commission)	This work was supported by Swedish Research Council Grants 2012-1601, 2013-7107, and 2017-00792; a Novo Nordisk Foundation Excellence project grant; VINNOVA (Swedish Governmental Agency for Innovation Systems); the Swedish Diabetes Foundation; the Diabetes Wellness Research Foundation; the Ake Wiberg Foundation; the IngaBritt and Arne Lundberg Foundation; the Magnus Bergvall Foundation; and the European Union's Seventh Framework Programme (FP7/2007-2013, Grant 607842). The authors declare that they have no conflicts of interest with the contents of this article.	Arsenijevic T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037517; Asterholm IW, 2014, CELL METAB, V20, P103, DOI 10.1016/j.cmet.2014.05.005; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Brannmark C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113620; Bryan HK, 2013, BIOCHEM PHARMACOL, V85, P705, DOI 10.1016/j.bcp.2012.11.016; Calzadilla P, 2011, INT J MOL SCI, V12, P6936, DOI 10.3390/ijms12106936; Castro JP, 2016, BIOL CHEM, V397, P709, DOI 10.1515/hsz-2015-0305; Chevtzoff C, 2010, J BIOL CHEM, V285, P1733, DOI 10.1074/jbc.M109.019570; Enejder A, 2010, IEEE J SEL TOP QUANT, V16, P506, DOI 10.1109/JSTQE.2009.2032512; Eruslanov E, 2010, METHODS MOL BIOL, V594, P57, DOI 10.1007/978-1-60761-411-1_4; Frank M, 2012, BBA-MOL CELL RES, V1823, P2297, DOI 10.1016/j.bbamcr.2012.08.007; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI21625, 10.1172/JCI20042162S]; Gurtler A, 2013, ANAL BIOCHEM, V433, P105, DOI 10.1016/j.ab.2012.10.010; Hamanaka RB, 2010, TRENDS BIOCHEM SCI, V35, P505, DOI 10.1016/j.tibs.2010.04.002; Han CY, 2012, J BIOL CHEM, V287, P10379, DOI 10.1074/jbc.M111.304998; Korge P, 2015, BBA-BIOENERGETICS, V1847, P514, DOI 10.1016/j.bbabio.2015.02.012; Krawczyk SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034904; Lee H, 2009, J BIOL CHEM, V284, P10601, DOI 10.1074/jbc.M808742200; Li PP, 2005, AM J PHYSIOL-ENDOC M, V289, pE617, DOI 10.1152/ajpendo.00010.2005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; Maity S, 2016, CELL REP, V16, P851, DOI 10.1016/j.celrep.2016.06.025; Matsuzawa-Nagata N, 2008, METABOLISM, V57, P1071, DOI 10.1016/j.metabol.2008.03.010; Oparka M, 2016, METHODS, V109, P3, DOI 10.1016/j.ymeth.2016.06.008; Polster BM, 2014, METHOD ENZYMOL, V547, P225, DOI 10.1016/B978-0-12-801415-8.00013-8; Ristow M, 2009, P NATL ACAD SCI USA, V106, P8665, DOI 10.1073/pnas.0903485106; Sayin VI, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007653; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Singh F, 2015, BBA-MOL CELL RES, V1853, P1574, DOI 10.1016/j.bbamcr.2015.03.006; Wang T, 2010, OBESITY, V18, P1493, DOI 10.1038/oby.2009.456; Wu J, 2013, GENE DEV, V27, P234, DOI 10.1101/gad.211649.112; Zhang HL, 2012, FASEB J, V26, P1442, DOI 10.1096/fj.11-199869	33	20	21	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2019	294	7					2340	2352		10.1074/jbc.RA118.004253	http://dx.doi.org/10.1074/jbc.RA118.004253			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL7CN	30559295	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000458895400012
J	Stomberski, CT; Zhou, HL; Wang, LW; van den Akker, F; Stamler, JS				Stomberski, Colin T.; Zhou, Hua-Lin; Wang, Liwen; van den Akker, Focco; Stamler, Jonathan S.			Molecular recognition of S-nitrosothiol substrate by its cognate protein denitrosylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						S-nitrosylation; coenzyme A (CoA); enzyme kinetics; mutagenesis; nitric oxide; denitrosylase; denitrosylation; SCoR; SNO-CoA	ALDEHYDE REDUCTASE; NITRIC-OXIDE; NITROSYLATION; PURIFICATION; SUPERFAMILY; INTERPLAY; GENOMICS	Protein S-nitrosylation mediates a large part of nitric oxide's influence on cellular function by providing a fundamental mechanism to control protein function across different species and cell types. At steady state, cellular S-nitrosylation reflects dynamic equilibria between S-nitrosothiols (SNOs) in proteins and small molecules (low-molecular-weight SNOs) whose levels are regulated by dedicated S-nitrosylases and denitrosylases. S-Nitroso-CoA (SNO-CoA) and its cognate denitrosylases, SNO-CoA reductases (SCoRs), are newly identified determinants of protein S-nitrosylation in both yeast and mammals. Because SNO-CoA is a minority species among potentially thousands of cellular SNOs, SCoRs must preferentially recognize this SNO substrate. However, little is known about the molecular mechanism by which cellular SNOs are recognized by their cognate enzymes. Using mammalian cells, molecular modeling, substrate-capture assays, and mutagenic analyses, we identified a single conserved surface Lys (Lys-127) residue as well as active-site interactions of the SNO group that mediate recognition of SNO-CoA by SCoR. Comparing SCoRK127A versus SCoRWT HEK293 cells, we identified a SNO-CoA-dependent nitrosoproteome, including numerous metabolic protein substrates. Finally, we discovered that the SNO-CoA/SCoR system has a role in mitochondrial metabolism. Collectively, our findings provide molecular insights into the basis of specificity in SNO-CoA-mediated metabolic signaling and suggest a role for SCoR-regulated S-nitrosylation in multiple metabolic processes.	[Stomberski, Colin T.; Zhou, Hua-Lin; Stamler, Jonathan S.] Case Western Reserve Univ, Inst Transformat Mol Med, Cleveland, OH 44106 USA; [Stomberski, Colin T.; van den Akker, Focco] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Stamler, Jonathan S.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Wang, Liwen] Case Western Reserve Univ, Ctr Prote & Bioinformat, Dept Nutr, Cleveland, OH 44106 USA; [Stamler, Jonathan S.] Univ Hosp Cleveland Med Ctr, Harrington Discovery Inst, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland	Stamler, JS (corresponding author), Harrington Discovery Inst, 10900 Euclid Ave,LC 7294, Cleveland, OH 44106 USA.; Stamler, JS (corresponding author), Inst Transformat Mol Med, 10900 Euclid Ave,LC 7294, Cleveland, OH 44106 USA.	jonathan.stamler@case.edu		Stamler, Jonathan/0000-0002-6866-1572; Stomberski, Colin/0000-0002-3362-9345	National Institutes of Health [R01DK119506, R01HL126900, P01HL075443, P01HL128192]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR002549] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL126900, P01HL128192, P01HL075443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK119506] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01DK119506 (to J. S. S.), R01HL126900 (to J. S. S.), P01HL075443 (to J. S. S.), and P01HL128192 (to J. S. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abunimer A, 2014, GENES-BASEL, V5, P254, DOI 10.3390/genes5020254; AMVA Panel on Euthanasia, 2013, AVMA GUIDELINES EUTH; Anand P, 2014, P NATL ACAD SCI USA, V111, P18572, DOI 10.1073/pnas.1417816112; Anand P, 2012, J MOL MED, V90, P233, DOI 10.1007/s00109-012-0878-z; Barski OA, 1996, BIOCHEMISTRY-US, V35, P14276, DOI 10.1021/bi9619740; BARSKI OA, 1995, BIOCHEMISTRY-US, V34, P11264, DOI 10.1021/bi00035a036; Barski OA, 2008, DRUG METAB REV, V40, P553, DOI [10.1080/03602530802431439, 10.1080/03602530802431439 ]; Bateman RL, 2008, J BIOL CHEM, V283, P35756, DOI 10.1074/jbc.M807125200; Benhar M, 2015, BBA-GEN SUBJECTS, V1850, P2476, DOI 10.1016/j.bbagen.2015.09.010; Benhar M, 2009, NAT REV MOL CELL BIO, V10, P721, DOI 10.1038/nrm2764; BRANLANT G, 1980, EUR J BIOCHEM, V105, P611, DOI 10.1111/j.1432-1033.1980.tb04539.x; BROWN GC, 1994, FEBS LETT, V356, P295, DOI 10.1016/0014-5793(94)01290-3; Chouchani ET, 2013, NAT MED, V19, P753, DOI 10.1038/nm.3212; Committee for the Update of the Guide for the Care and Use of Laboratory Animals, 2011, GUIDE CARE USE LAB A, DOI [10.17226/12910, DOI 10.17226/12910]; Forrester MT, 2009, NAT BIOTECHNOL, V27, P557, DOI 10.1038/nbt.1545; Gabbay KH, 2010, J BIOL CHEM, V285, P19510, DOI 10.1074/jbc.M110.110247; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Jin Y, 2007, ANNU REV PHARMACOL, V47, P263, DOI 10.1146/annurev.pharmtox.47.120505.105337; Liu LM, 2001, NATURE, V410, P490, DOI 10.1038/35068596; Mindnich Rebekka D., 2009, Human Genomics, V3, P362; Park J, 2013, MOL CELL, V50, P919, DOI 10.1016/j.molcel.2013.06.001; Seth D, 2018, MOL CELL, V69, P451, DOI 10.1016/j.molcel.2017.12.025; Stomberski CT, 2019, ANTIOXID REDOX SIGN, V30, P1331, DOI 10.1089/ars.2017.7403; Talipov MR, 2013, J PHYS CHEM B, V117, P1827, DOI 10.1021/jp310664z; Timerghazin QK, 2007, ORG LETT, V9, P3049, DOI 10.1021/ol0711016; WERMUTH B, 1977, J BIOL CHEM, V252, P3821; Zhou HL, 2019, NATURE, V565, P96, DOI 10.1038/s41586-018-0749-z	27	17	18	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2019	294	5					1568	1578		10.1074/jbc.RA118.004947	http://dx.doi.org/10.1074/jbc.RA118.004947			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GC	30538128	Green Published, hybrid			2022-12-28	WOS:000457879200012
J	Hauck, AK; Huang, YM; Hertzel, AV; Bernlohr, DA				Hauck, Amy K.; Huang, Yimao; Hertzel, Ann V.; Bernlohr, David A.			Adipose oxidative stress and protein carbonylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						adipocyte; obesity; oxidative stress; lipid peroxidation; protein-lipid interaction; carbonylation	INSULIN-RESISTANCE; TISSUE; ADIPOCYTE; OXIDASE; ROLES; MITOCHONDRIA; PEROXIDATION; OBESITY; DELAYS; DAMAGE	Increased oxidative stress and abundance of reactive oxygen species (ROS) are positively correlated with a variety of pathophysiologies, including cardiovascular disease, type 2 diabetes, Alzheimer's disease, and neuroinflammation. In adipose biology, diabetic obesity is correlated with increased ROS in an age- and depot-specific manner and is mechanistically linked to mitochondrial dysfunction, endoplasmic reticulum (ER) stress, potentiated lipolysis, and insulin resistance. The cellular quality control systems that homeostatically regulate oxidative stress in the lean state are down-regulated in obesity as a consequence of inflammatory cytokine pressure leading to the accumulation of oxidized biomolecules. New findings have linked protein, DNA, and lipid oxidation at the biochemical level, and the structures and potential functions of protein adducts such as carbonylation that accumulate in stressed cells have been characterized. The sum total of such regulation and biochemical changes results in alteration of cellular metabolism and function in the obese state relative to the lean state and underlies metabolic disease progression. In this review, we discuss the molecular mechanisms and events underlying these processes and their implications for human health and disease.	[Hauck, Amy K.] Univ Penn, Perelman Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Huang, Yimao; Hertzel, Ann V.; Bernlohr, David A.] Univ Minnesota Twin Cities, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	University of Pennsylvania; Pennsylvania Medicine; University of Minnesota System; University of Minnesota Twin Cities	Bernlohr, DA (corresponding author), Univ Minnesota Twin Cities, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	bernl001@umn.edu			National Institutes of Health [DK053189]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK053189, R01DK053189] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant DK053189 (to D. A. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amer MA, 2011, GENET MOL RES, V10, P3722, DOI 10.4238/2011.October.31.14; Anderson EJ, 2018, J CLIN INVEST, V128, P5280, DOI 10.1172/JCI94307; Atri C, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061801; Babizhayev MA, 2009, AM J THER, V16, P517, DOI 10.1097/MJT.0b013e318195e327; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Brigelius-Flohe R, 2006, BIOL CHEM, V387, P1329, DOI 10.1515/BC.2006.166; Cadenas S, 2018, BBA-BIOENERGETICS, V1859, P940, DOI 10.1016/j.bbabio.2018.05.019; Chattopadhyay M, 2015, MOL CELL BIOCHEM, V399, P95, DOI 10.1007/s11010-014-2236-7; Chen H, 2012, MOL CELL BIOCHEM, V363, P85, DOI 10.1007/s11010-011-1160-3; Chouchani ET, 2016, NATURE, V532, P112, DOI 10.1038/nature17399; Curtis JM, 2012, J BIOL CHEM, V287, P32967, DOI 10.1074/jbc.M112.400663; Curtis JM, 2010, DIABETES, V59, P1132, DOI 10.2337/db09-1105; Den Hartigh LJ, 2017, ARTERIOSCL THROM VAS, V37, P466, DOI 10.1161/ATVBAHA.116.308749; dos Santos KG, 2006, DIS MARKERS, V22, P355, DOI 10.1155/2006/983408; England K, 2004, CELL DEATH DIFFER, V11, P252, DOI 10.1038/sj.cdd.4401338; Fisher-Wellman KH, 2012, TRENDS ENDOCRIN MET, V23, P142, DOI 10.1016/j.tem.2011.12.008; Frohnert BI, 2014, ADIPOCYTE, V3, P224, DOI [10.2337/db13-0777, 10.4161/adip.28851]; Frohnert BI, 2011, OBESITY, V19, P1735, DOI 10.1038/oby.2011.115; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI21625, 10.1172/JCI20042162S]; Grimsrud PA, 2008, J BIOL CHEM, V283, P21837, DOI 10.1074/jbc.R700019200; Han CY, 2016, DIABETES METAB J, V40, P272, DOI 10.4093/dmj.2016.40.4.272; Han CY, 2012, J BIOL CHEM, V287, P10379, DOI 10.1074/jbc.M111.304998; Han YH, 2016, DIABETES, V65, P2639, DOI 10.2337/db16-0283; Hauck AK, 2018, J BIOL CHEM, V293, P13464, DOI 10.1074/jbc.RA118.003469; Hauck AK, 2016, J LIPID RES, V57, P1976, DOI 10.1194/jlr.R066597; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Kwon J, 2004, P NATL ACAD SCI USA, V101, P16419, DOI 10.1073/pnas.0407396101; Lee H, 2009, J BIOL CHEM, V284, P10601, DOI 10.1074/jbc.M808742200; Lei XG, 2016, PHYSIOL REV, V96, P307, DOI 10.1152/physrev.00010.2014; Li GY, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14020165; Lin Y, 2005, J BIOL CHEM, V280, P4617, DOI 10.1074/jbc.M411863200; Long EK, 2013, FREE RADICAL BIO MED, V63, P390, DOI 10.1016/j.freeradbiomed.2013.05.030; Makki Kassem, 2013, ISRN Inflamm, V2013, P139239, DOI 10.1155/2013/139239; Netto LES, 2016, MOL CELLS, V39, P65, DOI 10.14348/molcells.2016.2349; Nomura K, 2000, BIOCHEM J, V351, P183, DOI 10.1042/0264-6021:3510183; Nomura M, 2016, NAT IMMUNOL, V17, P216, DOI 10.1038/ni.3366; Pepping JK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181500; Salgado-Somoza A, 2010, AM J PHYSIOL-HEART C, V299, pH202, DOI 10.1152/ajpheart.00120.2010; Tan HY, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2795090; Tanase M, 2016, SCI REP-UK, V6, DOI 10.1038/srep19311; Tsushima Y, 2013, J BIOL CHEM, V288, P27138, DOI 10.1074/jbc.M113.485094; Yao X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139416; YOSHIDA A, 1984, P NATL ACAD SCI-BIOL, V81, P258, DOI 10.1073/pnas.81.1.258; Zhang L, 2011, AM J PHYSIOL-ENDOC M, V301, pE599, DOI 10.1152/ajpendo.00059.2011; Zheng JY, 2005, AGING CELL, V4, P209, DOI 10.1111/j.1474-9726.2005.00159.x; Zito E, 2015, FREE RADICAL BIO MED, V83, P299, DOI 10.1016/j.freeradbiomed.2015.01.011	46	55	57	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1083	1088		10.1074/jbc.R118.003214	http://dx.doi.org/10.1074/jbc.R118.003214			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30563836	hybrid, Green Published			2022-12-28	WOS:000457879500001
J	Ihara, H; Kakihana, Y; Yamakage, A; Kai, K; Shibata, T; Nishida, M; Yamada, K; Uchida, K				Ihara, Hideshi; Kakihana, Yuki; Yamakage, Akane; Kai, Kenji; Shibata, Takahiro; Nishida, Motohiro; Yamada, Ken-ichi; Uchida, Koji			2-Oxo-histidine-containing dipeptides are functional oxidation products	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antioxidant; mass spectrometry (MS); oxidative stress; peptides; histidine; 2-oxo-histidine-containing dipeptides; imidazole; neuroprotection	AMINO-ACID-RESIDUES; CATALYZED OXIDATION; IMIDAZOLE RING; COPPER-BINDING; HISTIDINE; CARNOSINE; INHIBITION; IDENTIFICATION; PROTEIN; HOMOCARNOSINE	Imidazole-containing dipeptides (IDPs), such as carnosine and anserine, are found exclusively in various animal tissues, especially in the skeletal muscles and nerves. IDPs have antioxidant activity because of their metal-chelating and free radical-scavenging properties. However, the underlying mechanisms that would fully explain IDP antioxidant effects remain obscure. Here, using HPLC-electrospray ionization-tandem MS analyses, we comprehensively investigated carnosine and its related small peptides in the soluble fractions of mouse tissue homogenates and ubiquitously detected 2-oxo-histidine-containing dipeptides (2-oxo-IDPs) in all examined tissues. We noted enhanced production of the 2-oxo-IDPs in the brain of a mouse model of sepsis-associated encephalopathy. Moreover, in SH-SY5Y human neuroblastoma cells stably expressing carnosine synthase, H2O2 exposure resulted in the intracellular production of 2-oxo-carnosine, which was associated with significant inhibition of the H2O2 cytotoxicity. Notably, 2-oxo-carnosine showed a better antioxidant activity than endogenous antioxidants such as GSH and ascorbate. Mechanistic studies indicated that carnosine monooxygenation is mediated through the formation of a histidyl-imidazole radical, followed by the addition of molecular oxygen. Our findings reveal that 2-oxo-IDPs are metal-catalyzed oxidation products present in vivo and provide a revised paradigm for understanding the antioxidant effects of the IDPs.	[Ihara, Hideshi; Kakihana, Yuki; Yamakage, Akane] Osaka Prefecture Univ, Grad Sch Sci, Dept Biol Sci, Sakai, Osaka 5998531, Japan; [Kai, Kenji] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Dept Biol Chem, Sakai, Osaka 5998531, Japan; [Shibata, Takahiro; Uchida, Koji] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Nishida, Motohiro] Natl Inst Physiol Sci, Div Cardiocirculatory Signaling, Okazaki, Aichi 4448787, Japan; [Yamada, Ken-ichi] Kyushu Univ, Fac Pharmaceut Sci, Phys Chem Life Sci Lab, Fukuoka, Fukuoka 8120054, Japan; [Yamada, Ken-ichi; Uchida, Koji] Japan Agcy Med Res & Dev, CREST, Tokyo 1020076, Japan; [Uchida, Koji] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan	Osaka Metropolitan University; Osaka Metropolitan University; Nagoya University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Kyushu University; Japan Science & Technology Agency (JST); University of Tokyo	Ihara, H (corresponding author), Osaka Prefecture Univ, Grad Sch Sci, Dept Biol Sci, Sakai, Osaka 5998531, Japan.; Uchida, K (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan.	ihara@b.s.osakafu-u.ac.jp; a-uchida@mail.ecc.u-tokyo.ac.jp	; Shibata, Takahiro/I-6872-2014	Kai, Kenji/0000-0002-4036-9959; Uchida, Koji/0000-0003-3894-5299; Shibata, Takahiro/0000-0003-3194-607X; Nishida, Motohiro/0000-0002-2587-5458	Japanese Ministry of Education, Sciences, Sports, Technology [17H06170, 16H04674, 16K13089, 26111011]; AMED-CREST from AMED; Smoking Research Foundation	Japanese Ministry of Education, Sciences, Sports, Technology; AMED-CREST from AMED; Smoking Research Foundation	This work was supported in part by Grant-in-Aid for Scientific Research (S) 17H06170) (to K. U.), Grant-in-Aid for Scientific Research (B) 16H04674 (to H. I.), Grant-in-Aid for Challenging Exploratory Research 16K13089 (to H. I.), and Grant-in-Aid for Scientific Research on Innovative Areas "Oxygen Biology: a new criterion for integrated understanding of life" 26111011 (to K. U., H. I., and M. N.) from the Japanese Ministry of Education, Sciences, Sports, Technology. This work was also supported by AMED-CREST from AMED (to K. Y. and K. U.) and the Smoking Research Foundation (to H. I.). The authors declare that they have no conflicts of interest with the contents of this article.	Berg RMG, 2011, J CEREBR BLOOD F MET, V31, P1532, DOI 10.1038/jcbfm.2011.48; Boldyrev AA, 2013, PHYSIOL REV, V93, P1803, DOI 10.1152/physrev.00039.2012; DAVEY CL, 1960, ARCH BIOCHEM BIOPHYS, V89, P303, DOI 10.1016/0003-9861(60)90059-X; Drozak J, 2015, J BIOL CHEM, V290, P17190, DOI 10.1074/jbc.M115.640037; Drozak J, 2010, J BIOL CHEM, V285, P9346, DOI 10.1074/jbc.M109.095505; GONZALEZESTRADA MT, 1980, BRAIN RES, V202, P373, DOI 10.1016/0006-8993(80)90149-3; Ihara H, 2012, BIOSCI BIOTECH BIOCH, V76, P1843, DOI 10.1271/bbb.120215; IKEDA T, 1980, J BIOCHEM-TOKYO, V87, P179, DOI 10.1093/oxfordjournals.jbchem.a132723; Kurahashi T, 2001, J AM CHEM SOC, V123, P9268, DOI 10.1021/ja015953r; Lee JW, 2006, NATURE, V440, P363, DOI 10.1038/nature04537; LENNEY JF, 1990, BIOL CHEM H-S, V371, P433, DOI 10.1515/bchm3.1990.371.1.433; LI SH, 1995, BIOCHEMISTRY-US, V34, P5762, DOI 10.1021/bi00017a008; MASAKI N, 1989, ARCH BIOCHEM BIOPHYS, V269, P390, DOI 10.1016/0003-9861(89)90122-7; Matoba T, 2003, ARTERIOSCL THROM VAS, V23, P1224, DOI 10.1161/01.ATV.0000078601.79536.6C; Requena JR, 2001, P NATL ACAD SCI USA, V98, P7170, DOI 10.1073/pnas.121190898; Retsky KL, 1999, FREE RADICAL BIO MED, V26, P90, DOI 10.1016/S0891-5849(98)00151-8; STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616; Stadtman ER, 2003, AMINO ACIDS, V25, P207, DOI 10.1007/s00726-003-0011-2; STEWART LC, 1987, BIOCHEMISTRY-US, V26, P5302, DOI 10.1021/bi00391a013; Tabakman R, 2004, J NEUROSCI RES, V75, P499, DOI 10.1002/jnr.20008; Tabakman R, 2002, J NEUROSCI RES, V68, P463, DOI 10.1002/jnr.10228; Teufel M, 2003, J BIOL CHEM, V278, P6521, DOI 10.1074/jbc.M209764200; Traore DAK, 2009, NAT CHEM BIOL, V5, P53, DOI 10.1038/nchembio.133; UCHIDA K, 1990, BIOCHIM BIOPHYS ACTA, V1034, P347, DOI 10.1016/0304-4165(90)90063-3; UCHIDA K, 1994, J BIOL CHEM, V269, P2405; Uchida K, 2003, AMINO ACIDS, V25, P249, DOI 10.1007/s00726-003-0015-y; UCHIDA K, 1993, FEBS LETT, V332, P208, DOI 10.1016/0014-5793(93)80632-5; UCHIDA K, 1986, BIOCHEM BIOPH RES CO, V138, P659, DOI 10.1016/S0006-291X(86)80547-2; UCHIDA K, 1989, BIOORG CHEM, V17, P330, DOI 10.1016/0045-2068(89)90035-7; Winter GEM, 1996, BIOCHEMISTRY-US, V35, P11805, DOI 10.1021/bi960381m; YOSHIDA T, 1989, CHEM PHARM BULL, V37, P1919; Zhao F, 1997, J BIOL CHEM, V272, P9019	32	22	23	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1279	1289		10.1074/jbc.RA118.006111	http://dx.doi.org/10.1074/jbc.RA118.006111			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30504220	Green Published, hybrid			2022-12-28	WOS:000457879500019
J	Bogdanovic, X; Schneider, S; Levanova, N; Wirth, C; Trillhaase, C; Steinemann, M; Hunte, C; Aktories, K; Jank, T				Bogdanovic, Xenia; Schneider, Silvia; Levanova, Nadezhda; Wirth, Christophe; Trillhaase, Christoph; Steinemann, Marcus; Hunte, Carola; Aktories, Klaus; Jank, Thomas			A cysteine protease-like domain enhances the cytotoxic effects of the Photorhabdus asymbiotica toxin PaTox	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial toxin; cysteine protease; protease; crystal structure; X-ray crystallography; AvrPphB; C58-like cysteine protease; papain-like protease; virulence-associated protein toxin; YopT	CATERPILLARS-FLOPPY MCF; ESCHERICHIA-COLI; SHUTTLE VECTORS; YEAST; APOPTOSIS; BEAMLINE; CLEAVAGE; INSECT; SYSTEM	The nematode mutualistic bacterium Photorhabdus asymbiotica produces a large virulence-associated multifunctional protein toxin named PaTox. A glycosyltransferase domain and a deamidase domain of this large toxin function as effectors that specifically target host Rho GTPases and heterotrimeric G proteins, respectively. Modification of these intracellular regulators results in toxicity toward insects and mammalian cells. In this study, we identified a cysteine protease-like domain spanning PaTox residues 1844-2114 (PaTox(P)), upstream of these two effector domains and characterized by three conserved amino acid residues (Cys-1865, His-1955, and Asp-1975). We determined the crystal structure of the PaTox(P) C1865A variant by native single-wavelength anomalous diffraction of sulfur atoms (sulfur-SAD). At 2.0 A resolution, this structure revealed a catalytic site typical for papain-like cysteine proteases, comprising a catalytic triad, oxyanion hole, and typical secondary structural elements. The PaTox(P) structure had highest similarity to that of the AvrPphB protease from Pseudomonas syringae classified as a C58-protease. Furthermore, we observed that PaTox(P) shares structural homology also with non-C58-cysteine proteases, deubiquitinases, and deamidases. Upon delivery into insect larvae, PaTox(P) alone without full-length PaTox had no toxic effects. Yet, PaTox(P) expression in mammalian cells was toxic and enhanced the apoptotic phenotype induced by PaTox in HeLa cells. We propose that PaTox(P) is a C58-like cysteine protease module that is essential for full PaTox activity.	[Bogdanovic, Xenia; Wirth, Christophe; Hunte, Carola] Univ Freiburg, Fac Med, ZBMZ, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany; [Schneider, Silvia; Levanova, Nadezhda; Trillhaase, Christoph; Steinemann, Marcus; Aktories, Klaus; Jank, Thomas] Univ Freiburg, Fac Med, Inst Expt & Clin Pharmacol & Toxicol, D-79104 Freiburg, Germany; [Hunte, Carola; Aktories, Klaus] Univ Freiburg, Ctr Biol Signalling Studies BIOSS, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg	Hunte, C (corresponding author), Univ Freiburg, Fac Med, ZBMZ, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany.; Aktories, K; Jank, T (corresponding author), Univ Freiburg, Fac Med, Inst Expt & Clin Pharmacol & Toxicol, D-79104 Freiburg, Germany.; Hunte, C; Aktories, K (corresponding author), Univ Freiburg, Ctr Biol Signalling Studies BIOSS, D-79106 Freiburg, Germany.	carola.hunte@biochemie.uni-freiburg.de; klaus.aktories@pharmakol.uni-freiburg.de; thomas.jank@pharmakol.uni-freiburg.de	Aktories, Klaus/CAJ-5682-2022; Hunte, Carola/E-4071-2015; Schneider, Silvia/C-5229-2015	Aktories, Klaus/0000-0002-5397-0436; Hunte, Carola/0000-0002-0826-3986; Schneider, Silvia/0000-0003-0698-8411; Wirth, Christophe/0000-0001-8864-6508	Deutsche Forschungsgemeinschaft Collaborative Research Center [746]; Deutsche Forschungsgemeinschaft [AK6/22-1]; Excellence Initiative of the German Federal Government [EXC 294 BIOSS]; Excellence Initiative of the German State Government [EXC 294 BIOSS]	Deutsche Forschungsgemeinschaft Collaborative Research Center(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Initiative of the German Federal Government; Excellence Initiative of the German State Government	This work was supported by grants from the Deutsche Forschungsgemeinschaft Collaborative Research Center 746 (to T. J., K. A., and C. H.), Deutsche Forschungsgemeinschaft Grant AK6/22-1 (to K. A.), and the Excellence Initiative of the German Federal and State Governments EXC 294 BIOSS (to K. A. and C. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agarwal S, 2015, INFECT IMMUN, V83, P4392, DOI 10.1128/IAI.00570-15; Agarwal S, 2015, CELL MICROBIOL, V17, P1494, DOI 10.1111/cmi.12451; Akey DL, 2016, ACTA CRYSTALLOGR D, V72, P296, DOI 10.1107/S2059798315021920; Blanke SR, 1996, P NATL ACAD SCI USA, V93, P8437, DOI 10.1073/pnas.93.16.8437; Brink T, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007248; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cianci M, 2017, J SYNCHROTRON RADIAT, V24, P323, DOI 10.1107/S1600577516016465; Daborn PJ, 2002, P NATL ACAD SCI USA, V99, P10742, DOI 10.1073/pnas.102068099; Dowling AJ, 2004, CELL MICROBIOL, V6, P345, DOI 10.1046/j.1462-5822.2003.00357.x; Dowling AJ, 2007, CELL MICROBIOL, V9, P2470, DOI 10.1111/j.1462-5822.2007.00974.x; Egerer M, 2007, J BIOL CHEM, V282, P25314, DOI 10.1074/jbc.M703062200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ffrench-Constant RH, 2007, TOXICON, V49, P436, DOI 10.1016/j.toxicon.2006.11.019; Gerrard JG, 2017, CURR TOP MICROBIOL, V402, P179, DOI 10.1007/82_2016_56; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Hapeshi A, 2017, CURR TOP MICROBIOL, V402, P159, DOI 10.1007/82_2016_29; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Jank T, 2008, TRENDS MICROBIOL, V16, P222, DOI 10.1016/j.tim.2008.01.011; Jank T, 2013, NAT STRUCT MOL BIOL, V20, P1273, DOI 10.1038/nsmb.2688; Jin C, 2002, NAT REV MOL CELL BIO, V3, P453, DOI 10.1038/nrm832; Jones MK, 2009, INFECT IMMUN, V77, P1723, DOI 10.1128/IAI.01046-08; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Lacey LA, 2015, J INVERTEBR PATHOL, V132, P1, DOI 10.1016/j.jip.2015.07.009; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Nurizzo D, 2006, J SYNCHROTRON RADIAT, V13, P227, DOI 10.1107/S0909049506004341; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Sanada T, 2012, NATURE, V483, P623, DOI 10.1038/nature10894; Schlieker C, 2007, MOL CELL, V25, P677, DOI 10.1016/j.molcel.2007.01.033; Shao F, 2002, CELL, V109, P575, DOI 10.1016/S0092-8674(02)00766-3; Shao F, 2003, SCIENCE, V301, P1230, DOI 10.1126/science.1085671; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SIKORSKI RS, 1989, GENETICS, V122, P19; Waterman DG, 2016, ACTA CRYSTALLOGR D, V72, P558, DOI 10.1107/S2059798316002187; Zhang DP, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-18	35	4	5	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2019	294	3					1035	1044		10.1074/jbc.RA118.005043	http://dx.doi.org/10.1074/jbc.RA118.005043			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL4FC	30478175	Green Published, hybrid			2022-12-28	WOS:000458670200026
J	Kumar, S; Rubino, FA; Mendoza, AG; Ruiz, N				Kumar, Sujeet; Rubino, Frederick A.; Mendoza, Alicia G.; Ruiz, Natividad			The bacterial lipid II flippase MurJ functions by an alternating-access mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane transport; cysteine-mediated cross-linking; lipid II; peptidoglycan; glycolipid; cell wall; antibacterial target; conformational dynamics; MOP exporter	CROSS-LINKING; PEPTIDOGLYCAN BIOGENESIS; LACTOSE PERMEASE; STRUCTURAL BASIS; MULTIDRUG; IDENTIFICATION; TRANSPORTERS; MVIN; BIOSYNTHESIS; PROXIMITY	The peptidoglycan (PG) cell wall is an essential extracytoplasmic glycopeptide polymer that safeguards bacteria against osmotic lysis and determines cellular morphology. Bacteria use multiprotein machineries for the synthesis of the PG cell wall during cell division and elongation that can be targeted by antibiotics such as the beta-lactams. Lipid II, the lipid-linked precursor for PG biogenesis, is synthesized in the inner leaflet of the cytoplasmic membrane and then translocated across the bilayer, where it is ultimately polymerized into PG. In Escherichia coli, MurJ, a member of the MOP exporter superfamily, has been recently shown to have lipid II flippase activity that depends on membrane potential. Because of its essentiality, MurJ could potentially be targeted by much needed novel antibiotics. Recent structural information suggests that a central cavity in MurJ alternates between inward- and outward-open conformations to flip lipid II, but how these conformational changes occur are unknown. Here, we utilized structure-guided cysteine cross-linking and proteolysis-coupled gel analysis to probe the conformational changes of MurJ in E. coli cells. We found that paired cysteine substitutions in transmembrane domains 2 and 8 and periplasmic loops of MurJ could be cross-linked with homobifunctional cysteine cross-linkers, indicating that MurJ can adopt both inward- and outward-facing conformations in vivo. Furthermore, we show that dissipating the membrane potential with an ionophore decreases the prevalence of the inward-facing, but not the outward-facing state. Our study provides in vivo evidence that MurJ uses an alternating-access mechanism during the lipid II transport cycle.	[Kumar, Sujeet; Mendoza, Alicia G.; Ruiz, Natividad] Ohio State Univ, Dept Microbiol, 484 W 12th Ave, Columbus, OH 43210 USA; [Rubino, Frederick A.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	University System of Ohio; Ohio State University; Harvard University	Ruiz, N (corresponding author), Ohio State Univ, Dept Microbiol, 484 W 12th Ave, Columbus, OH 43210 USA.	ruiz.82@osu.edu	kumar, sujeet/U-1351-2018	kumar, sujeet/0000-0002-8207-4358; Ruiz, Natividad/0000-0002-6369-2206; Mendoza, Alicia/0000-0001-5010-2951; Rubino, Frederick/0000-0002-7149-6088	NIGMS, National Institutes of Health [R01 GM1000951]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100051, R01GM100951, R01GM076710] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health Grant R01 GM1000951 (to N. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barreteau H, 2008, FEMS MICROBIOL REV, V32, P168, DOI 10.1111/j.1574-6976.2008.00104.x; Bolla JR, 2018, NAT CHEM, V10, P363, DOI [10.1038/NCHEM.2919, 10.1038/nchem.2919]; Bouhss A, 2008, FEMS MICROBIOL REV, V32, P208, DOI 10.1111/j.1574-6976.2007.00089.x; Butler EK, 2014, J BACTERIOL, V196, P4111, DOI 10.1128/JB.02172-14; Butler EK, 2013, J BACTERIOL, V195, P4639, DOI 10.1128/JB.00731-13; Chamakura KR, 2017, NAT MICROBIOL, V2, P1480, DOI 10.1038/s41564-017-0023-4; Dell A., 2010, INT J MICROBIOL, V2010, DOI [10.1074/jbc.RA117.001068, DOI 10.1155/2010/148178]; Egan AJF, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2015.0031; Elhenawy W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161587; Forrest LR, 2011, BBA-BIOENERGETICS, V1807, P167, DOI 10.1016/j.bbabio.2010.10.014; He XA, 2010, NATURE, V467, P991, DOI 10.1038/nature09408; Hennon SW, 2014, BIOCHEMISTRY-US, V53, P3278, DOI 10.1021/bi500257u; Huber J, 2009, CHEM BIOL, V16, P837, DOI 10.1016/j.chembiol.2009.05.012; Hvorup RN, 2003, EUR J BIOCHEM, V270, P799, DOI 10.1046/j.1432-1033.2003.03418.x; Inoue A, 2008, J BACTERIOL, V190, P7298, DOI 10.1128/JB.00551-08; Islam ST, 2014, CAN J MICROBIOL, V60, P697, DOI 10.1139/cjm-2014-0595; Kaback HR, 2015, P NATL ACAD SCI USA, V112, P1259, DOI 10.1073/pnas.1419325112; Krulwich TA, 2011, NAT REV MICROBIOL, V9, P330, DOI 10.1038/nrmicro2549; Kuk ACY, 2017, NAT STRUCT MOL BIOL, V24, P171, DOI 10.1038/nsmb.3346; Kuroda T, 2009, BBA-PROTEINS PROTEOM, V1794, P763, DOI 10.1016/j.bbapap.2008.11.012; Liu XL, 2018, MOL MICROBIOL, V109, DOI 10.1111/mmi.14104; Lovering AL, 2012, ANNU REV BIOCHEM, V81, P451, DOI 10.1146/annurev-biochem-061809-112742; Lu M, 2016, CHANNELS, V10, P88, DOI 10.1080/19336950.2015.1106654; Lu M, 2013, P NATL ACAD SCI USA, V110, P2099, DOI 10.1073/pnas.1219901110; Meeske AJ, 2015, P NATL ACAD SCI USA, V112, P6437, DOI 10.1073/pnas.1504967112; Mohamed YF, 2014, GLYCOBIOLOGY, V24, P564, DOI 10.1093/glycob/cwu025; Monteiro JM, 2018, NATURE, V554, P528, DOI 10.1038/nature25506; Mulligan C, 2017, METHOD ENZYMOL, V594, P165, DOI 10.1016/bs.mie.2017.05.012; PARENT L, 1992, J MEMBRANE BIOL, V125, P49; Paz A, 2018, P NATL ACAD SCI USA, V115, pE2742, DOI 10.1073/pnas.1718451115; Qiao Y, 2017, NAT CHEM BIOL, V13, P793, DOI 10.1038/nchembio.2388; Rubino FA, 2018, J AM CHEM SOC, V140, P4481, DOI 10.1021/jacs.8b00942; Ruiz N, 2008, P NATL ACAD SCI USA, V105, P15553, DOI 10.1073/pnas.0808352105; Ruiz N, 2016, CURR OPIN MICROBIOL, V34, P1, DOI 10.1016/j.mib.2016.07.010; Ruiz Natividad, 2015, Lipid Insights, V8, P21, DOI 10.4137/LPI.S31783; Schmid J, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00496; Sham LT, 2018, MOL MICROBIOL, V109, P633, DOI 10.1111/mmi.14002; Sham LT, 2014, SCIENCE, V345, P220, DOI 10.1126/science.1254522; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Sun JZ, 1997, BIOCHEMISTRY-US, V36, P11959, DOI 10.1021/bi971172k; Tanaka Y, 2013, NATURE, V496, P247, DOI 10.1038/nature12014; Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677; Wu JH, 1996, P NATL ACAD SCI USA, V93, P14498, DOI 10.1073/pnas.93.25.14498; Wu JH, 1999, BIOCHEMISTRY-US, V38, P1715, DOI 10.1021/bi982342b; Wu T, 2006, P NATL ACAD SCI USA, V103, P11754, DOI 10.1073/pnas.0604744103; Zheng SD, 2018, P NATL ACAD SCI USA, V115, P6709, DOI 10.1073/pnas.1802192115	47	20	20	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2019	294	3					981	990		10.1074/jbc.RA118.006099	http://dx.doi.org/10.1074/jbc.RA118.006099			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL4FC	30482840	hybrid, Green Published			2022-12-28	WOS:000458670200022
J	De, R; Sarkar, S; Mazumder, S; Debsharma, S; Siddiqui, AA; Saha, SJ; Banerjee, C; Nag, S; Saha, D; Pramanik, S; Bandyopadhyay, U				De, Rudranil; Sarkar, Souvik; Mazumder, Somnath; Debsharma, Subhashis; Siddiqui, Asim Azhar; Saha, Shubhra Jyoti; Banerjee, Chinmoy; Nag, Shiladitya; Saha, Debanjan; Pramanik, Saikat; Bandyopadhyay, Uday			Macrophage migration inhibitory factor regulates mitochondrial dynamics and cell growth of human cancer cell lines through CD74-NF-kappa B signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer biology; mitochondria; apoptosis; NF-B; gene silencing	KAPPA-B; GASTRIC-CANCER; FISSION; CD74; EXPRESSION; APOPTOSIS; ACID; MICROENVIRONMENT; STRESS	The indispensable role of macrophage migration inhibitory factor (MIF) in cancer cell proliferation is unambiguous, although which specific roles the cytokine plays to block apoptosis by preserving cell growth is still obscure. Using different cancer cell lines (AGS, HepG2, HCT116, and HeLa), here we report that the silencing of MIF severely deregulated mitochondrial structural dynamics by shifting the balance toward excess fission, besides inducing apoptosis with increasing sub-G(0) cells. Furthermore, enhanced mitochondrial Bax translocation along with cytochrome c release, down-regulation of Bcl-xL, and Bcl-2 as well as up-regulation of Bad, Bax, and p53 indicated the activation of a mitochondrial pathway of apoptosis upon MIF silencing. The data also indicate a concerted down-regulation of Opa1 and Mfn1 along with a significant elevation of Drp1, cumulatively causing mitochondrial fragmentation upon MIF silencing. Up-regulation of Drp1 was found to be further coupled with fissogenic serine 616 phosphorylation and serine 637 dephosphorylation, thus ensuring enhanced mitochondrial translocation. Interestingly, MIF silencing was found to be associated with decreased NF-B activation. In fact, NF-B knockdown in turn increased mitochondrial fission and cell death. In addition, the silencing of CD74, the cognate receptor of MIF, remarkably increased mitochondrial fragmentation in addition to preventing cell proliferation, inducing mitochondrial depolarization, and increasing apoptotic cell death. This indicates the active operation of a MIF-regulated CD74-NF-B signaling axis for maintaining mitochondrial stability and cell growth. Thus, we propose that MIF, through CD74, constitutively activates NF-B to control mitochondrial dynamics and stability for promoting carcinogenesis via averting apoptosis.	[De, Rudranil; Sarkar, Souvik; Mazumder, Somnath; Debsharma, Subhashis; Siddiqui, Asim Azhar; Saha, Shubhra Jyoti; Banerjee, Chinmoy; Nag, Shiladitya; Saha, Debanjan; Pramanik, Saikat; Bandyopadhyay, Uday] Indian Inst Chem Biol, CSIR, Div Infect Dis & Immunol, 4 Raja SC Mullick Rd, Kolkata 700032, W Bengal, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Bandyopadhyay, U (corresponding author), Indian Inst Chem Biol, CSIR, Div Infect Dis & Immunol, 4 Raja SC Mullick Rd, Kolkata 700032, W Bengal, India.	ubandyo_1964@yahoo.com		De, Rudranil/0000-0001-5846-3479; SAHA, SHUBHRA JYOTI/0000-0001-6536-6060	Council of Scientific and Industrial Research, New Delhi [BSC 0206]; J.C. Bose Fellowship from the Department of Science and Technology, Ministry of Science and Technology (DST) [SB/S2/JCB-54/2014]	Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); J.C. Bose Fellowship from the Department of Science and Technology, Ministry of Science and Technology (DST)	This work was supported by a fellowship (to R.D.) and Research Grants BEnD and BSC 0206 from the Council of Scientific and Industrial Research, New Delhi. This work also was supported by J.C. Bose Fellowship SB/S2/JCB-54/2014 from the Department of Science and Technology, Ministry of Science and Technology (DST). The authors declare that they have no conflicts of interest with the contents of this article.	Alavi MV, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-32; Alirol E, 2006, ONCOGENE, V25, P4706, DOI 10.1038/sj.onc.1209600; Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298; Andas A Reenaa Joys, 2015, Asian Pac J Cancer Prev, V16, P4311; Baumann R, 2003, FASEB J, V17, P2221, DOI 10.1096/fj.03-0110com; Berkova Z, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/s13046-014-0080-y; Bossy-Wetzel E, 2003, CURR OPIN CELL BIOL, V15, P706, DOI 10.1016/j.ceb.2003.10.015; Catz SD, 2001, ONCOGENE, V20, P7342, DOI 10.1038/sj.onc.1204926; Chen HC, 2017, CELL METAB, V26, P39, DOI 10.1016/j.cmet.2017.05.016; Cheng SP, 2015, ENDOCR-RELAT CANCER, V22, P179, DOI 10.1530/ERC-14-0269; Dai XY, 2016, ONCOTARGET, V7, P10841, DOI 10.18632/oncotarget.7460; de Arriba G, 2013, TOXICOL LETT, V218, P30, DOI 10.1016/j.toxlet.2013.01.007; De R, 2017, FREE RADICAL BIO MED, V113, P424, DOI 10.1016/j.freeradbiomed.2017.10.009; Fan S, 2015, ONCOTARGET, V6, P14885, DOI 10.18632/oncotarget.3659; Fischer TD, 2016, FRONT SYST NEUROSCI, V10, DOI [10.3389/fnsys.2016.00029, 10.3389/fnsys.2010.00020]; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Galloway CA, 2013, ANTIOXID REDOX SIGN, V19, P415, DOI 10.1089/ars.2012.4779; He LJ, 2015, WORLD J GASTROENTERO, V21, P9916, DOI 10.3748/wjg.v21.i34.9916; Herst PM, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00296; Hira E, 2005, CANCER, V103, P588, DOI 10.1002/cncr.20818; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; Hudson JD, 1999, J EXP MED, V190, P1375, DOI 10.1084/jem.190.10.1375; Jezierska-Drutel A, 2013, ADV CANCER RES, V119, P107, DOI 10.1016/B978-0-12-407190-2.00003-4; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; Kasama T, 2010, ARTHRITIS, DOI 10.1155/2010/106202; Kaufman JL, 2013, BRIT J HAEMATOL, V163, P478, DOI 10.1111/bjh.12565; Kindt N, 2014, J CANCER RES CLIN, V140, P937, DOI 10.1007/s00432-014-1648-9; Kotiadis VN, 2014, BBA-GEN SUBJECTS, V1840, P1254, DOI 10.1016/j.bbagen.2013.10.041; Laforge M, 2016, CELL DEATH DIFFER, V23, P89, DOI 10.1038/cdd.2015.42; Lantner F, 2007, BLOOD, V110, P4303, DOI 10.1182/blood-2007-04-087486; Li N, 2012, ONCOL REP, V28, P2016, DOI 10.3892/or.2012.2062; Li XJ, 2013, WORLD J GASTROENTERO, V19, P8619, DOI 10.3748/wjg.v19.i46.8619; Martin P, 2015, LEUKEMIA LYMPHOMA, V56, P3065, DOI 10.3109/10428194.2015.1028052; Morris KT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098656; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Pagliari LJ, 2000, MOL CELL BIOL, V20, P8855, DOI 10.1128/MCB.20.23.8855-8865.2000; Panngom K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.168; Parsons MJ, 2010, ESSAYS BIOCHEM, V47, P99, DOI [10.1042/BSE0470099, 10.1042/bse0470099]; Patten DA, 2014, EMBO J, V33, P2676, DOI 10.15252/embj.201488349; Sarkar S, 2015, J AGR FOOD CHEM, V63, P4988, DOI 10.1021/acs.jafc.5b00921; Schrepfer E, 2016, MOL CELL, V61, P683, DOI 10.1016/j.molcel.2016.02.022; Shimwell NJ, 2012, BRIT J CANCER, V107, P1595, DOI 10.1038/bjc.2012.405; Starlets D, 2006, BLOOD, V107, P4807, DOI 10.1182/blood-2005-11-4334; Subbannayya T, 2016, J CELL COMMUN SIGNAL, V10, P165, DOI 10.1007/s12079-016-0326-x; Wai T, 2016, TRENDS ENDOCRIN MET, V27, P105, DOI 10.1016/j.tem.2015.12.001; Waterborg J H, 1984, Methods Mol Biol, V1, P1, DOI 10.1385/0-89603-062-8:1; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Wilson JM, 2005, GASTROENTEROLOGY, V129, P1485, DOI 10.1053/j.gastro.2005.07.061; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Zhao J, 2013, ONCOGENE, V32, P4814, DOI 10.1038/onc.2012.494; Zheng C, 2011, CELL RES, V21, P183, DOI 10.1038/cr.2010.171; Zhu GQ, 2014, NEOPLASIA, V16, P168, DOI 10.1593/neo.132034	52	18	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19740	19760		10.1074/jbc.RA118.003935	http://dx.doi.org/10.1074/jbc.RA118.003935			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30366984	hybrid, Green Published			2022-12-28	WOS:000454294900020
J	Sugita, S; Watanabe, K; Hashimoto, K; Niwa, T; Uemura, E; Taguchi, H; Watanabe, Y				Sugita, Saori; Watanabe, Kumiko; Hashimoto, Kana; Niwa, Tatsuya; Uemura, Eri; Taguchi, Hideki; Watanabe, Yo-hei			Electrostatic interactions between middle domain motif-1 and the AAA1 module of the bacterial ClpB chaperone are essential for protein disaggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein aggregation; ATPases associated with diverse cellular activities (AAA); chaperone; protein conformation; protein cross-linking; protein dynamic; structure-function; mass spectrometry (MS); disaggregation; Hsp104	AMINO-TERMINAL DOMAIN; MOLECULAR CHAPERONE; DNAJ COMPLEX; ATP BINDING; HSP104; HSP70; GRPE; MUTAGENESIS; MECHANISM; SYSTEM	ClpB, a bacterial homologue of heat shock protein 104 (Hsp104), can disentangle aggregated proteins with the help of the DnaK, a bacterial Hsp70, and its co-factors. As a member of the expanded superfamily of ATPases associated with diverse cellular activities (AAA(+)), ClpB forms a hexameric ring structure, with each protomer containing two AAA(+) modules, AAA1 and AAA2. A long coiled-coil middle domain (MD) is present in the C-terminal region of the AAA1 and surrounds the main body of the ring. The MD is subdivided into two oppositely directed short coiled-coils, called motif-1 and motif-2. The MD represses the ATPase activity of ClpB, and this repression is reversed by the binding of DnaK to motif-2. To better understand how the MD regulates ClpB activity, here we investigated the roles of motif-1 in ClpB from Thermus thermophilus (TClpB). Using systematic alanine substitution of the conserved charged residues, we identified functionally important residues in motif-1, and using a photoreactive cross-linker and LC-MS/MS analysis, we further explored potential interacting residues. Moreover, we constructed TClpB mutants in which functionally important residues in motif-1 and in other candidate regions were substituted by oppositely charged residues. These analyses revealed that the intra-subunit pair Glu-401-Arg-532 and the inter-subunit pair Asp-404-Arg-180 are functionally important, electrostatically interacting pairs. Considering these structural findings, we conclude that the Glu-401-Arg-532 interaction shifts the equilibrium of the MD conformation to stabilize the activated form and that the Arg-180-Asp-404 interaction contributes to intersubunit signal transduction, essential for ClpB chaperone activities.	[Sugita, Saori; Watanabe, Kumiko; Hashimoto, Kana; Watanabe, Yo-hei] Konan Univ, Fac Sci & Engn, Dept Biol, Okamoto 8-9-1, Kobe, Hyogo 6588501, Japan; [Watanabe, Yo-hei] Konan Univ, Inst Integrat Neurobiol, Okamoto 8-9-1, Kobe, Hyogo 6588501, Japan; [Niwa, Tatsuya; Uemura, Eri; Taguchi, Hideki] Tokyo Inst Technol, Inst Innovat Res, Ctr Cell Biol, Midori Ku, 4259 Nagatsuta Cho, Yokohama, Kanagawa 2268503, Japan	Konan University; Konan University; Tokyo Institute of Technology	Watanabe, Y (corresponding author), Konan Univ, Fac Sci & Engn, Dept Biol, Okamoto 8-9-1, Kobe, Hyogo 6588501, Japan.	ywatanab@center.konan-u.ac.jp	Taguchi, Hideki/B-6946-2009; taguchi, hideki/AAM-2663-2021	Taguchi, Hideki/0000-0002-6612-9339; taguchi, hideki/0000-0002-6612-9339; Niwa, Tatsuya/0000-0002-1330-8974	JSPS KAKENHI Grants [24241048, 26440085]	JSPS KAKENHI Grants	This work was supported by JSPS KAKENHI Grants 24241048 and 26440085. The authors declare that they have no conflicts of interest with the contents of this article.	Acebron SP, 2009, FEBS LETT, V583, P2991, DOI 10.1016/j.febslet.2009.08.020; Fernandez-Higuero JA, 2011, J BIOL CHEM, V286, P25547, DOI 10.1074/jbc.M111.231365; Barnett ME, 2005, J BIOL CHEM, V280, P34940, DOI 10.1074/jbc.M505653200; Carroni M, 2014, ELIFE, V3, DOI 10.7554/eLife.02481; Deville C, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1701726; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; Franzmann TM, 2011, J BIOL CHEM, V286, P17992, DOI 10.1074/jbc.M110.216176; Gates SN, 2017, SCIENCE, V357, P273, DOI 10.1126/science.aan1052; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Goloubinoff P, 1999, P NATL ACAD SCI USA, V96, P13732, DOI 10.1073/pnas.96.24.13732; Haslberger T, 2007, MOL CELL, V25, P247, DOI 10.1016/j.molcel.2006.11.008; Hayashi S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08917-8; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Kityk R, 2012, MOL CELL, V48, P863, DOI 10.1016/j.molcel.2012.09.023; Lee S, 2003, CELL, V115, P229, DOI 10.1016/S0092-8674(03)00807-9; Lipinska N, 2013, J BIOL CHEM, V288, P2857, DOI 10.1074/jbc.M112.387589; Masuda T, 2009, MOL CELL PROTEOMICS, V8, P2770, DOI 10.1074/mcp.M900240-MCP200; Mizuno S, 2012, FEBS J, V279, P1474, DOI 10.1111/j.1742-4658.2012.08540.x; Mizutani T, 2009, GENES CELLS, V14, P1405, DOI 10.1111/j.1365-2443.2009.01357.x; Motohashi K, 1999, P NATL ACAD SCI USA, V96, P7184, DOI 10.1073/pnas.96.13.7184; Motohashi K, 1996, J BIOL CHEM, V271, P17343, DOI 10.1074/jbc.271.29.17343; Motohashi K, 1997, FEBS LETT, V412, P633, DOI 10.1016/S0014-5793(97)00847-8; Oguchi Y, 2012, NAT STRUCT MOL BIOL, V19, P1338, DOI 10.1038/nsmb.2441; Rosenzweig R, 2013, SCIENCE, V339, P1080, DOI 10.1126/science.1233066; SANCHEZ Y, 1990, SCIENCE, V248, P1112, DOI 10.1126/science.2188365; Thomas JG, 1998, J BACTERIOL, V180, P5165, DOI 10.1128/JB.180.19.5165-5172.1998; Uchihashi T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04587-w; Watanabe Y, 2005, J BIOL CHEM, V280, P24562, DOI 10.1074/jbc.M414623200; Watanabe Y, 2004, J BIOL CHEM, V279, P15723, DOI 10.1074/jbc.M308782200; Watanabe YH, 2002, J BIOL CHEM, V277, P5804, DOI 10.1074/jbc.M109349200; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; Yamasaki T, 2015, J BIOL CHEM, V290, P9789, DOI 10.1074/jbc.M114.617696; Yang B, 2012, NAT METHODS, V9, P904, DOI 10.1038/nmeth.2099; Yokom AL, 2016, NAT STRUCT MOL BIOL, V23, P830, DOI 10.1038/nsmb.3277; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606; Zhuravleva A, 2012, CELL, V151, P1296, DOI 10.1016/j.cell.2012.11.002; Zolkiewski M, 1999, J BIOL CHEM, V274, P28083, DOI 10.1074/jbc.274.40.28083	38	5	5	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2018	293	50					19228	19239		10.1074/jbc.RA118.005496	http://dx.doi.org/10.1074/jbc.RA118.005496			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HE6RA	30327424	Green Published, hybrid			2022-12-28	WOS:000453537300007
J	Patil, R; Mohanty, B; Liu, BA; Chandrashekaran, IR; Headey, SJ; Williams, ML; Clements, CS; Ilyichova, O; Doak, BC; Genissel, P; Weaver, RJ; Vuillard, L; Halls, ML; Porter, CJH; Scanlon, MJ				Patil, Rahul; Mohanty, Biswaranjan; Liu, Bonan; Chandrashekaran, Indu R.; Headey, Stephen J.; Williams, Martin L.; Clements, Craig S.; Ilyichova, Olga; Doak, Bradley C.; Genissel, Patrick; Weaver, Richard J.; Vuillard, Laurent; Halls, Michelle L.; Porter, Christopher J. H.; Scanlon, Martin J.			A ligand-induced structural change in fatty acid-binding protein 1 is associated with potentiation of peroxisome proliferator-activated receptor agonists	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein structure; fatty acid-binding protein; nuclear magnetic resonance (NMR); peroxisome proliferator-activated receptor (PPAR); drug delivery; nuclear receptor; transcription factor; GW7647; PPAR agonist	NMR STRUCTURE DETERMINATION; TORSION ANGLE DYNAMICS; RETINOIC ACID; AMIDE-PROTON; DRUG-BINDING; ASSIGNMENT; PROGRAM; ALPHA; IDENTIFICATION; LOCALIZATION	Peroxisome proliferator-activated receptor (PPAR) is a transcriptional regulator of lipid metabolism. GW7647 is a potent PPAR agonist that must reach the nucleus to activate this receptor. In cells expressing human fatty acid-binding protein 1 (FABP1), GW7647 treatment increases FABP1's nuclear localization and potentiates GW7647-mediated PPAR activation; GW7647 is less effective in cells that do not express FABP1. To elucidate the underlying mechanism, here we substituted residues in FABP1 known to dictate lipid signaling by other intracellular lipid-binding proteins. Substitutions of Lys-20 and Lys-31 to Ala in the FABP1 helical cap affected neither its nuclear localization nor PPAR activation. In contrast, Ala substitution of Lys-57, Glu-77, and Lys-96, located in the loops adjacent to the ligand-binding portal region, abolished both FABP1 nuclear localization and GW7647-induced PPAR activation but had little effect on GW7647-FABP1 binding affinity. Using solution NMR spectroscopy, we determined the WT FABP1 structure and analyzed the dynamics in the apo and GW7647-bound structures of both the WT and the K57A/E77A/K96A triple mutant. We found that GW7647 binding causes little change in the FABP1 backbone, but solvent exposes several residues in the loops around the portal region, including Lys-57, Glu-77, and Lys-96. These residues also become more solvent-exposed upon binding of FABP1 with the endogenous PPAR agonist oleic acid. Together with previous observations, our findings suggest that GW7647 binding stabilizes a FABP1 conformation that promotes its interaction with PPAR. We conclude that full PPAR agonist activity of GW7647 requires FABP1-dependent transport and nuclear localization processes.	[Patil, Rahul; Mohanty, Biswaranjan; Chandrashekaran, Indu R.; Headey, Stephen J.; Williams, Martin L.; Clements, Craig S.; Ilyichova, Olga; Doak, Bradley C.; Scanlon, Martin J.] Monash Univ, Monash Inst Pharmaceut Sci, Med Chem, 381 Royal Parade, Parkville, Vic 3052, Australia; [Liu, Bonan; Porter, Christopher J. H.] Monash Univ, Monash Inst Pharmaceut Sci, Drug Delivery Disposit & Dynam, 381 Royal Parade, Parkville, Vic 3052, Australia; [Halls, Michelle L.] Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol, 381 Royal Parade, Parkville, Vic 3052, Australia; [Genissel, Patrick; Weaver, Richard J.; Vuillard, Laurent] Inst Rech Servier, 125 Chemin Ronde, F-78290 Croissy Sur Seine, France	Monash University; Monash University; Monash University; Servier; Institut de Recherches Internationales Servier	Scanlon, MJ (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Med Chem, 381 Royal Parade, Parkville, Vic 3052, Australia.; Porter, CJH (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Drug Delivery Disposit & Dynam, 381 Royal Parade, Parkville, Vic 3052, Australia.; Halls, ML (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol, 381 Royal Parade, Parkville, Vic 3052, Australia.	michelle.halls@monash.edu; chris.porter@monash.edu; martin.scanlon@monash.edu	Doak, Bradley C/A-4313-2013; Porter, Christopher JH/C-6333-2011; Weaver, Richard J/GLT-0453-2022; Mohanty, Biswaranjan/E-2080-2018	Doak, Bradley C/0000-0001-8422-675X; Porter, Christopher JH/0000-0003-3474-7551; Weaver, Richard J/0000-0001-6439-6030; Chandrashekaran, Indu/0000-0002-7080-427X; Mohanty, Biswaranjan/0000-0002-6921-343X; Williams, Martin/0000-0002-9483-3008; Headey, Stephen/0000-0001-8015-7064	Les Laboratories Servier; ARC [DP120102930, DP150102587]; Monash Graduate Scholarship (MGS); Monash International Postgraduate Research Scholarship (MIPRS); National Health and Medical Research Council of Australia RD Wright Fellowship [1061687]	Les Laboratories Servier(Servier); ARC(Australian Research Council); Monash Graduate Scholarship (MGS)(Monash University); Monash International Postgraduate Research Scholarship (MIPRS)(Monash University); National Health and Medical Research Council of Australia RD Wright Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by funding from Les Laboratories Servier and by ARC Grants DP120102930 and DP150102587. P. G., R. J. W., and L. V. were employed by Les Laboratories Servier, a commercial company, at the time this study was conducted.; Supported by Monash Graduate Scholarship (MGS) and Monash International Postgraduate Research Scholarship (MIPRS).; Supported by National Health and Medical Research Council of Australia RD Wright Fellowship 1061687.	Armstrong EH, 2014, J BIOL CHEM, V289, P14941, DOI 10.1074/jbc.M113.514646; Ayers SD, 2007, BIOCHEMISTRY-US, V46, P6744, DOI 10.1021/bi700047a; Budhu A, 2001, J MOL BIOL, V305, P939, DOI 10.1006/jmbi.2000.4340; Cai J, 2012, BIOPHYS J, V102, P2585, DOI 10.1016/j.bpj.2012.04.039; Chmurzynska A, 2006, J APPL GENET, V47, P39, DOI 10.1007/BF03194597; Chuang S, 2008, J MED CHEM, V51, P3755, DOI 10.1021/jm701192w; D'Onofrio M, 2017, BBA-PROTEINS PROTEOM, V1865, P1152, DOI 10.1016/j.bbapap.2017.06.025; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dong D, 1999, J BIOL CHEM, V274, P23695, DOI 10.1074/jbc.274.34.23695; Fiorito F, 2008, J BIOMOL NMR, V42, P23, DOI 10.1007/s10858-008-9259-x; Gillilan RE, 2007, J MOL BIOL, V372, P1246, DOI 10.1016/j.jmb.2007.07.040; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; He Y, 2011, BIOCHEMISTRY-US, V50, P1283, DOI 10.1021/bi101307h; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Hodsdon ME, 1997, BIOCHEMISTRY-US, V36, P1450, DOI 10.1021/bi961890r; Huang H, 2014, FEBS J, V281, P2266, DOI 10.1111/febs.12780; Hughes MLR, 2015, J BIOL CHEM, V290, P13895, DOI 10.1074/jbc.M114.605998; Hwang TL, 1998, J BIOMOL NMR, V11, P221, DOI 10.1023/A:1008276004875; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KAIKAUS RM, 1990, EXPERIENTIA, V46, P617, DOI 10.1007/BF01939701; Kay Lewis E, 2011, J Magn Reson, V213, P423, DOI 10.1016/j.jmr.2011.09.004; Keller R., 2004, COMPUTER AIDED RESON, V1; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Koradi R, 2000, COMPUT PHYS COMMUN, V124, P139, DOI 10.1016/S0010-4655(99)00436-1; Orekhov VY, 2011, PROG NUCL MAG RES SP, V59, P271, DOI 10.1016/j.pnmrs.2011.02.002; Patil R, 2014, ACS CHEM BIOL, V9, P2526, DOI 10.1021/cb5005178; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Sessler RJ, 2005, MOL CELL, V18, P343, DOI 10.1016/j.molcel.2005.03.026; Sharma A, 2011, J BIOL CHEM, V286, P31924, DOI 10.1074/jbc.M111.270165; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Tan NS, 2002, MOL CELL BIOL, V22, P5114, DOI 10.1128/MCB.22.14.5114-5127.2002; Thompson J, 1997, J BIOL CHEM, V272, P7140, DOI 10.1074/jbc.272.11.7140; Velkov T, 2007, CHEM BIOL, V14, P453, DOI 10.1016/j.chembiol.2007.03.009; Volk J, 2008, J BIOMOL NMR, V41, P127, DOI 10.1007/s10858-008-9243-5; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Wolfrum C, 2001, P NATL ACAD SCI USA, V98, P2323, DOI 10.1073/pnas.051619898; Zimmerman AW, 2001, INT J BIOCHEM CELL B, V33, P865, DOI 10.1016/S1357-2725(01)00070-X	40	6	7	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3720	3734		10.1074/jbc.RA118.006848	http://dx.doi.org/10.1074/jbc.RA118.006848			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30598509	hybrid, Green Published			2022-12-28	WOS:000461853900033
J	Starr, ML; Sparks, RP; Arango, AS; Hurst, LR; Zhao, ZY; Lihan, M; Jenkins, JL; Tajkhorshid, E; Fratti, RA				Starr, Matthew L.; Sparks, Robert P.; Arango, Andres S.; Hurst, Logan R.; Zhao, Zhiyu; Lihan, Muyun; Jenkins, Jermaine L.; Tajkhorshid, Emad; Fratti, Rutilio A.			Phosphatidic acid induces conformational changes in Sec18 protomers that prevent SNARE priming	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphatidic acid; diacylglycerol; SNARE proteins; membrane fusion; membrane lipid; Lipin1; NSF; Pah1; Sec17; Sec18	SENSITIVE FUSION PROTEIN; PARTICLE MESH EWALD; MEMBRANE-FUSION; YEAST VACUOLE; MOLECULAR-DYNAMICS; REGULATORY LIPIDS; SPONTANEOUS CURVATURE; PHOSPHOLIPASE D1; BINDING-SITES; ALPHA-SNAP	Eukaryotic cell homeostasis requires transfer of cellular components among organelles and relies on membrane fusion catalyzed by SNARE proteins. Inactive SNARE bundles are reactivated by hexameric N-ethylmaleimide-sensitive factor, vesicle-fusing ATPase (Sec18/NSF)-driven disassembly that enables a new round of membrane fusion. We previously found that phosphatidic acid (PA) binds Sec18 and thereby sequesters it from SNAREs and that PA dephosphorylation dissociates Sec18 from the membrane, allowing it to engage SNARE complexes. We now report that PA also induces conformational changes in Sec18 protomers and that hexameric Sec18 cannot bind PA membranes. Molecular dynamics (MD) analyses revealed that the D1 and D2 domains of Sec18 contain PA-binding sites and that the residues needed for PA binding are masked in hexameric Sec18. Importantly, these simulations also disclosed that a major conformational change occurs in the linker region between the D1 and D2 domains, which is distinct from the conformational changes that occur in hexameric Sec18 during SNARE priming. Together, these findings indicate that PA regulates Sec18 function by altering its architecture and stabilizing membrane-bound Sec18 protomers.	[Starr, Matthew L.; Sparks, Robert P.; Hurst, Logan R.; Tajkhorshid, Emad; Fratti, Rutilio A.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Arango, Andres S.; Zhao, Zhiyu; Lihan, Muyun; Tajkhorshid, Emad; Fratti, Rutilio A.] Univ Illinois, Ctr Biophys & Quantitat Biol, Urbana, IL 61801 USA; [Tajkhorshid, Emad] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Jenkins, Jermaine L.] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Rochester	Fratti, RA (corresponding author), Univ Illinois, Dept Biochem, Urbana, IL 61801 USA.	rfratti@illinois.edu	Tajkhorshid, Emad/AAN-8323-2021	Zhao, Zhiyu/0000-0001-9758-5073; Sparks, Robert/0000-0002-0485-8317	National Institutes of Health [R01-GM101132, P41-GM104601, U01-GM111251, U54-GM087519]; National Science Foundation [MCB 1818310]; Office of Naval Research ONR [N0001416-1-2535]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101132, P41GM104601] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Office of Naval Research ONR(Office of Naval Research); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01-GM101132 (to R. A. F.), and P41-GM104601, U01-GM111251, and U54-GM087519 (to E T.), National Science Foundation Grant MCB 1818310 (to R. A. F.), and the Office of Naval Research ONR Grant N0001416-1-2535 (to E. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Beauchamp KA, 2011, J CHEM THEORY COMPUT, V7, P3412, DOI 10.1021/ct200463m; BLOCK MR, 1988, P NATL ACAD SCI USA, V85, P7852, DOI 10.1073/pnas.85.21.7852; Boeddinghaus C, 2002, J CELL BIOL, V157, P79, DOI 10.1083/jcb.200112098; Capelluto DGS, 2014, BIOPHYS J, V106, P1101, DOI 10.1016/j.bpj.2014.01.032; Caumont AS, 1998, J BIOL CHEM, V273, P1373, DOI 10.1074/jbc.273.3.1373; Chang LF, 2012, NAT STRUCT MOL BIOL, V19, P268, DOI 10.1038/nsmb.2237; Churchward MA, 2008, BIOPHYS J, V94, P3976, DOI 10.1529/biophysj.107.123984; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Fleming KG, 1998, J BIOL CHEM, V273, P15675, DOI 10.1074/jbc.273.25.15675; Fratti RA, 2004, J CELL BIOL, V167, P1087, DOI 10.1083/jcb.200409068; Fratti RA, 2007, J BIOL CHEM, V282, P14861, DOI 10.1074/jbc.M700971200; Fratti RA, 2007, J BIOL CHEM, V282, P13133, DOI 10.1074/jbc.M700584200; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Haas A, 1996, EMBO J, V15, P3296, DOI 10.1002/j.1460-2075.1996.tb00694.x; Halgren TA, 2009, J CHEM INF MODEL, V49, P377, DOI 10.1021/ci800324m; Hew K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143947; HEYDUK T, 1989, BIOCHEMISTRY-US, V28, P6914, DOI 10.1021/bi00443a021; Horchani H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113484; Huang J, 2017, NAT METHODS, V14, P71, DOI [10.1038/NMETH.4067, 10.1038/nmeth.4067]; Huang P, 2005, MOL BIOL CELL, V16, P2614, DOI 10.1091/mbc.E04-12-1124; Humphrey W., 1996, J MOL GRAPHICS, V14, P33; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jo SW, 2014, ADV PROTEIN CHEM STR, V96, P235, DOI 10.1016/bs.apcsb.2014.06.002; Jun Y, 2004, J BIOL CHEM, V279, P53186, DOI 10.1074/jbc.M411363200; Jun Y, 2006, EMBO J, V25, P5260, DOI 10.1038/sj.emboj.7601413; Karunakaran S, 2013, TRAFFIC, V14, P650, DOI 10.1111/tra.12064; Karunakaran S, 2012, J CELL SCI, V125, P1683, DOI 10.1242/jcs.091900; Kato M, 2001, EMBO J, V20, P4035, DOI 10.1093/emboj/20.15.4035; Kooijman EE, 2005, BIOCHEMISTRY-US, V44, P2097, DOI 10.1021/bi0478502; Lam AD, 2008, MOL BIOL CELL, V19, P485, DOI 10.1091/mbc.E07-02-0148; Lenzen CU, 1998, CELL, V94, P525, DOI 10.1016/S0092-8674(00)81593-7; Liu S, 2007, TRAFFIC, V8, P1630, DOI 10.1111/j.1600-0854.2007.00628.x; Lobingier BT, 2014, ELIFE, V3, DOI 10.7554/eLife.02272; Manifava M, 2001, J BIOL CHEM, V276, P8987, DOI 10.1074/jbc.M010308200; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Matveeva EA, 1997, J BIOL CHEM, V272, P26413, DOI 10.1074/jbc.272.42.26413; Mayer A, 2000, MOL BIOL CELL, V11, P807, DOI 10.1091/mbc.11.3.807; Mayer A, 1996, CELL, V85, P83, DOI 10.1016/S0092-8674(00)81084-3; Mima J, 2008, EMBO J, V27, P2031, DOI 10.1038/emboj.2008.139; Mima J, 2009, J BIOL CHEM, V284, P27114, DOI 10.1074/jbc.M109.010223; Miner GE, 2017, TRAFFIC, V18, P315, DOI 10.1111/tra.12479; Miner GE, 2016, J BIOL CHEM, V291, P17651, DOI 10.1074/jbc.M116.725366; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Nakanishi H, 2006, J CELL SCI, V119, P1406, DOI 10.1242/jcs.02841; Nakanishi H, 2004, MOL BIOL CELL, V15, P1802, DOI 10.1091/mbc.e03-11-0798; Ozalp VC, 2010, J BIOL CHEM, V285, P37579, DOI 10.1074/jbc.M110.155119; Pande VS, 2010, METHODS, V52, P99, DOI 10.1016/j.ymeth.2010.06.002; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Qi YF, 2015, BIOPHYS J, V109, P2012, DOI 10.1016/j.bpj.2015.10.008; Roberts RL, 1999, J CELL SCI, V112, P3667; Rogasevskaia TP, 2015, J BIOL CHEM, V290, P28683, DOI 10.1074/jbc.M115.681429; Ryu JK, 2015, SCIENCE, V347, P1485, DOI 10.1126/science.aaa5267; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sasser T, 2012, J BIOL CHEM, V287, P2221, DOI 10.1074/jbc.M111.317420; Schreiner E, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-190; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Sparks RP, 2019, METHODS MOL BIOL, V1860, P199, DOI 10.1007/978-1-4939-8760-3_12; Sparks RP, 2019, METHODS MOL BIOL, V1860, P191, DOI 10.1007/978-1-4939-8760-3_11; Sparks RP, 2016, BIOCHEM BIOPH RES CO, V479, P551, DOI 10.1016/j.bbrc.2016.09.108; Starr ML, 2016, TRAFFIC, V17, P1091, DOI 10.1111/tra.12423; Stroupe C, 2006, EMBO J, V25, P1579, DOI 10.1038/sj.emboj.7601051; Stroupe C, 2009, P NATL ACAD SCI USA, V106, P17626, DOI 10.1073/pnas.0903801106; Studier FW, 2014, METHODS MOL BIOL, V1091, P17, DOI 10.1007/978-1-62703-691-7_2; Thorngren N, 2004, EMBO J, V23, P2765, DOI 10.1038/sj.emboj.7600286; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Ungermann C, 2005, J CELL SCI, V118, P3819, DOI 10.1242/jcs.02561; Vermaas JV, 2017, BIOCHEMISTRY-US, V56, P281, DOI 10.1021/acs.biochem.6b00468; Vitale N, 2002, J CELL BIOL, V159, P79, DOI 10.1083/jcb.200203027; Vitale N, 2001, EMBO J, V20, P2424, DOI 10.1093/emboj/20.10.2424; Vollrath F, 2014, SCI REP-UK, V4, DOI 10.1038/srep05625; WHITEHEART SW, 1994, J CELL BIOL, V126, P945, DOI 10.1083/jcb.126.4.945; WILSON DW, 1992, J CELL BIOL, V117, P531, DOI 10.1083/jcb.117.3.531; Xu ZY, 1998, CELL, V93, P1125, DOI 10.1016/S0092-8674(00)81457-9; Yavuz H, 2018, J BIOL CHEM, V293, P8645, DOI 10.1074/jbc.RA118.003313; Yu RC, 1998, NAT STRUCT BIOL, V5, P803, DOI 10.1038/1843; Zeniou-Meyer M, 2007, J BIOL CHEM, V282, P21746, DOI 10.1074/jbc.M702968200; Zhao ML, 2016, J MOL BIOL, V428, P1912, DOI 10.1016/j.jmb.2015.10.026; Zhao ML, 2015, NATURE, V518, P61, DOI 10.1038/nature14148; Zick M, 2013, MOL BIOL CELL, V24, P3746, DOI 10.1091/mbc.E13-07-0419	85	12	12	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2019	294	9					3100	3116		10.1074/jbc.RA118.006552	http://dx.doi.org/10.1074/jbc.RA118.006552			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU0SA	30617180	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000464980100011
J	Tambaro, S; Galan-Acosta, L; Leppert, A; Chen, GF; Biverstal, H; Presto, J; Nilsson, P; Johansson, J				Tambaro, Simone; Galan-Acosta, Lorena; Leppert, Axel; Chen, Gefei; Biverstal, Henrik; Presto, Jenny; Nilsson, Per; Johansson, Jan			Blood-brain and blood-cerebrospinal fluid passage of BRICHOS domains from two molecular chaperones in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein assembly; protein domain; protein misfolding; neuroscience; neurodegenerative disease; protein aggregation	AMYLOID-BETA-PEPTIDE; SP-C GENE; MOUSE MODEL; PROTEIN-C; BARRIER; EXPRESSION; DEMENTIA; NEURODEGENERATION; PERMEABILITY; TOXICITY	Targeting toxicity associated with beta-amyloid (A beta) misfolding and aggregation is a promising therapeutic strategy for preventing or managing Alzheimer's disease. The BRICHOS domains from human prosurfactant protein C (proSP-C) and integral membrane protein 2B (Bri2) efficiently reduce neurotoxicity associated with A beta 42 fibril formation both in vitro and in vivo. In this study, we evaluated the serum half-lives and permeability into the brain and cerebrospinal fluid (CSF) of recombinant human (rh) proSP-C and Bri2 BRICHOS domains injected intravenously into WT mice. We found that rh proSP-C BRICHOS has a longer blood serum half-life compared with rh Bri2 BRICHOS and passed into the CSF but not into the brain parenchyma. As judged by Western blotting, immunohistochemistry, and ELISA, rh Bri2 BRICHOS passed into both the CSF and brain. Intracellular immunostaining for rh Bri2 BRICHOS was observed in the choroid plexus epithelium as well as in the cerebral cortex. Our results indicate that intravenously administered rh proSP-C and Bri2 BRICHOS domains have different pharmacokinetic properties and blood-brain/blood-CSF permeability in mice. The finding that rh Bri2 BRICHOS can reach the brain parenchyma after peripheral administration may be harnessed in the search for new therapeutic strategies for managing Alzheimer's disease.	[Tambaro, Simone; Galan-Acosta, Lorena; Leppert, Axel; Chen, Gefei; Biverstal, Henrik; Presto, Jenny; Nilsson, Per; Johansson, Jan] Karolinska Inst, Div Neurogeriatr, Dept Neurobiol Care Sci & Soc, S-14183 Huddinge, Sweden	Karolinska Institutet	Johansson, J (corresponding author), Karolinska Inst, Div Neurogeriatr, Dept Neurobiol Care Sci & Soc, S-14183 Huddinge, Sweden.	janne.johansson@ki.se	Chen, Gefei/J-2919-2013; Tambaro, Simone/ABF-9304-2020	Chen, Gefei/0000-0002-5543-5963; Galan-Acosta, Lorena/0000-0002-6340-3398; Leppert, Axel/0000-0001-6223-3350; Johansson, Jan/0000-0002-8719-4703; Tambaro, Simone/0000-0001-7000-7556	Swedish Research Council; Center for Innovative Medicine at Karolinska Institutet; Stockholm City Council; Hallstens forskningsstiftelse; Alzheimerfonden	Swedish Research Council(Swedish Research CouncilEuropean Commission); Center for Innovative Medicine at Karolinska Institutet; Stockholm City Council; Hallstens forskningsstiftelse; Alzheimerfonden	This work was supported by the Swedish Research Council, Center for Innovative Medicine at Karolinska Institutet and Stockholm City Council, Hallstens forskningsstiftelse, and Alzheimerfonden. The authors declare that they have no conflicts of interest with the contents of this article.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Arosio P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10948; Banks WA, 2002, PEPTIDES, V23, P2223, DOI 10.1016/S0196-9781(02)00261-9; BARBER TW, 1970, ACTA NEUROL SCAND, V46, P85, DOI 10.1111/j.1600-0404.1970.tb05606.x; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Baron BW, 2017, APPL IMMUNOHISTO M M, V25, P489, DOI 10.1097/PAI.0000000000000329; Biverstal H, 2015, BBA-PROTEINS PROTEOM, V1854, P835, DOI 10.1016/j.bbapap.2015.04.005; Brasnjevic I, 2009, PROG NEUROBIOL, V87, P212, DOI 10.1016/j.pneurobio.2008.12.002; Brkic M, 2015, J NEUROSCI, V35, P12766, DOI 10.1523/JNEUROSCI.0006-15.2015; BROADWELL RD, 1993, EXP NEUROL, V120, P245, DOI 10.1006/exnr.1993.1059; Casals C, 2008, FEBS J, V275, P536, DOI 10.1111/j.1742-4658.2007.06220.x; Chen GF, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02056-4; Cohen SIA, 2015, NAT STRUCT MOL BIOL, V22, P207, DOI 10.1038/nsmb.2971; Collins-Praino LE, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0083-0; Cummings JL, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt269; Del Campo M, 2014, NEUROBIOL AGING, V35, P1596, DOI 10.1016/j.neurobiolaging.2014.01.007; DeMattos RB, 2002, J NEUROCHEM, V81, P229, DOI 10.1046/j.1471-4159.2002.00889.x; Dolfe L, 2018, J ALZHEIMERS DIS REP, V2, P27, DOI 10.3233/ADR-170051; GLASSER SW, 1990, J BIOL CHEM, V265, P21986; GLASSER SW, 1991, AM J PHYSIOL, V261, pL349, DOI 10.1152/ajplung.1991.261.4.L349; Goure WF, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt272; Hedlund Joel, 2009, BMC Res Notes, V2, P180, DOI 10.1186/1756-0500-2-180; Hermansson E, 2014, DIS MODEL MECH, V7, P659, DOI 10.1242/dmm.014787; Johanson CE, 2011, METHODS MOL BIOL, V686, P101, DOI 10.1007/978-1-60761-938-3_4; Johansson H, 2009, J MOL BIOL, V389, P227, DOI 10.1016/j.jmb.2009.04.021; Johansson H, 2006, J BIOL CHEM, V281, P21032, DOI 10.1074/jbc.M603001200; Juul SE, 2004, BIOL NEONATE, V85, P138, DOI 10.1159/000074970; Kallberg Y, 2001, J BIOL CHEM, V276, P12945, DOI 10.1074/jbc.M010402200; Karran E, 2016, J NEUROCHEM, V139, P237, DOI 10.1111/jnc.13632; Khan A, 2017, EXPERT REV NEUROTHER, V17, P697, DOI 10.1080/14737175.2017.1326819; Kim J, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-15; Knight SD, 2013, BIOCHEMISTRY-US, V52, P7523, DOI 10.1021/bi400908x; Kurudenkandy FR, 2014, J NEUROSCI, V34, P11416, DOI 10.1523/JNEUROSCI.1195-14.2014; Lashley T, 2008, NEUROPATH APPL NEURO, V34, P492, DOI 10.1111/j.1365-2990.2008.00935.x; Liddelow SA, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00032; Lipinski CA, 2000, J PHARMACOL TOX MET, V44, P235, DOI 10.1016/S1056-8719(00)00107-6; Mohandas E, 2009, Indian J Psychiatry, V51, P55, DOI 10.4103/0019-5545.44908; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Muchowskil PJ, 2002, NEURON, V35, P9, DOI 10.1016/S0896-6273(02)00761-4; Nerelius C, 2009, BIOCHEMISTRY-US, V48, P3778, DOI 10.1021/bi900135c; Pardridge WA, 2009, ALZHEIMERS DEMENT, V5, P427, DOI 10.1016/j.jalz.2009.06.003; Peng SW, 2010, BIOCHEM BIOPH RES CO, V393, P356, DOI 10.1016/j.bbrc.2009.12.122; Poska H, 2016, BIOCHEM J, V473, P3683, DOI 10.1042/BCJ20160277; Sanchez-Covarrubias L, 2014, CURR PHARM DESIGN, V20, P1422, DOI 10.2174/13816128113199990463; Sanchez-Pulido L, 2002, TRENDS BIOCHEM SCI, V27, P329, DOI 10.1016/S0968-0004(02)02134-5; Serot JM, 2000, ACTA NEUROPATHOL, V99, P105, DOI 10.1007/PL00007412; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; Sevigny J, 2016, NATURE, V537, P50, DOI 10.1038/nature19323; Tambaro S, 2013, NEUROPHARMACOLOGY, V70, P268, DOI 10.1016/j.neuropharm.2013.02.009; UENO M, 1994, ACTA NEUROL SCAND, V90, P400; Ueno M, 2000, ACTA NEUROPATHOL, V99, P385, DOI 10.1007/s004010051140; Villasenor R, 2017, J CEREBR BLOOD F MET, V37, P3683, DOI 10.1177/0271678X17697340; Willander H, 2012, J BIOL CHEM, V287, P31608, DOI 10.1074/jbc.M112.393157; Willander H, 2012, P NATL ACAD SCI USA, V109, P2325, DOI 10.1073/pnas.1114740109; Yerbury JJ, 2010, CELL STRESS CHAPERON, V15, P115, DOI 10.1007/s12192-009-0122-0; You JS, 2005, PROTEOMICS, V5, P290, DOI 10.1002/pmic.200400889	56	7	7	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2606	2615		10.1074/jbc.RA118.004538	http://dx.doi.org/10.1074/jbc.RA118.004538			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30598503	hybrid, Green Published			2022-12-28	WOS:000459601600004
J	Marrella, SA; Brown, KA; Mansouri-Noori, F; Porat, J; Wilson, DJ; Bayfield, MA				Marrella, Stefano A.; Brown, Kerene A.; Mansouri-Noori, Farnaz; Porat, Jennifer; Wilson, Derek J.; Bayfield, Mark A.			An interdomain bridge influences RNA binding of the human La protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA-binding protein; precursor tRNA (pre-tRNA); RNA processing; intracellular trafficking; protein domain; mass spectrometry (MS); RNA-protein interaction; La protein; Sjogren syndrome antigen B; SSB	STRUCTURAL-ANALYSIS; CHAPERONE ACTIVITY; MASS-SPECTROMETRY; POLIOVIRUS RNA; RECOGNITION; TRANSLATION; REVEALS; COMPLEXES; DOMAIN; PHOSPHORYLATION	La proteins are RNA chaperones that perform various functions depending on distinct RNA-binding modes and their subcellular localization. In the nucleus, they help process UUU-3 ' OH-tailed nascent RNA polymerase III transcripts, such as pre-tRNAs, whereas in the cytoplasm they contribute to translation of poly(A)-tailed mRNAs. La accumulation in the nucleus and cytoplasm is controlled by several trafficking elements, including a canonical nuclear localization signal in the extreme C terminus and a nuclear retention element (NRE) in the RNA recognition motif 2 (RRM2) domain. Previous findings indicate that cytoplasmic export of La due to mutation of the NRE can be suppressed by mutations in RRM1, but the mechanism by which the RRM1 and RRM2 domains functionally cooperate is poorly understood. In this work, we use electromobility shift assays (EMSA) to show that mutations in the NRE and RRM1 affect binding of human La to pre-tRNAs but not UUU-3 ' OH or poly(A) sequences, and we present compensatory mutagenesis data supporting a direct interaction between the RRM1 and RRM2 domains. Moreover, we use collision-induced unfolding and time-resolved hydrogen-deuterium exchange MS analyses to study the conformational dynamics that occur when this interaction is intact or disrupted. Our results suggest that the intracellular distribution of La may be linked to its RNA-binding modes and provide the first evidence for a direct protein-protein interdomain interaction in La proteins.	[Marrella, Stefano A.; Mansouri-Noori, Farnaz; Porat, Jennifer; Bayfield, Mark A.] York Univ, Dept Biol, Toronto, ON M3J 1P3, Canada; [Brown, Kerene A.; Wilson, Derek J.] York Univ, Dept Chem, Toronto, ON M3J 1P3, Canada; [Marrella, Stefano A.; Brown, Kerene A.; Mansouri-Noori, Farnaz; Porat, Jennifer; Wilson, Derek J.; Bayfield, Mark A.] York Univ, Ctr Res Biomol Interact, Toronto, ON M3J 1P3, Canada; [Brown, Kerene A.; Wilson, Derek J.] York Univ, Ctr Res Mass Spectrometry, Toronto, ON M3J 1P3, Canada	York University - Canada; York University - Canada; York University - Canada; York University - Canada	Bayfield, MA (corresponding author), York Univ, Dept Biol, Toronto, ON M3J 1P3, Canada.; Wilson, DJ (corresponding author), York Univ, Dept Chem, Toronto, ON M3J 1P3, Canada.; Wilson, DJ; Bayfield, MA (corresponding author), York Univ, Ctr Res Biomol Interact, Toronto, ON M3J 1P3, Canada.; Wilson, DJ (corresponding author), York Univ, Ctr Res Mass Spectrometry, Toronto, ON M3J 1P3, Canada.	dkwilson@yorku.ca; bayfield@yorku.ca		Bayfield, Mark/0000-0002-8971-7598	Canadian Institutes of Health Research's Institute of Genetics; Natural Sciences and Engineering Council of Canada [DG-544760]; Collaborative Research and Development Program Grant [CRD-485321-15]	Canadian Institutes of Health Research's Institute of Genetics; Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Collaborative Research and Development Program Grant	This work was supported by an open operating grant from the Canadian Institutes of Health Research's Institute of Genetics (to M. A. B.), Natural Sciences and Engineering Council of Canada Discovery Program Grant DG-544760, and Collaborative Research and Development Program Grant CRD-485321-15. The authors declare that they have no conflicts of interest with the contents of this article.	Alfano C, 2004, NAT STRUCT MOL BIOL, V11, P323, DOI 10.1038/nsmb747; Allison TM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9551; Bayfield MA, 2007, MOL CELL BIOL, V27, P3303, DOI 10.1128/MCB.00026-07; Bayfield MA, 2009, NAT STRUCT MOL BIOL, V16, P430, DOI 10.1038/nsmb.1573; Brenet F, 2009, ONCOGENE, V28, P128, DOI 10.1038/onc.2008.376; Brown KA, 2017, ANALYST, V142, P2874, DOI 10.1039/c7an00662d; Brown KA, 2016, BIOCHEMISTRY-US, V55, P7141, DOI 10.1021/acs.biochem.6b00995; Cardinali B, 2003, J BIOL CHEM, V278, P35145, DOI 10.1074/jbc.M300722200; Fan H, 1998, MOL CELL BIOL, V18, P3201, DOI 10.1128/MCB.18.6.3201; Fok V, 2006, J CELL BIOL, V173, P319, DOI 10.1083/jcb.200601026; Goodier JL, 1997, MOL CELL BIOL, V17, P5823, DOI 10.1128/MCB.17.10.5823; Hopper JTS, 2009, J AM SOC MASS SPECTR, V20, P1851, DOI 10.1016/j.jasms.2009.06.010; Huang Y, 2006, NAT STRUCT MOL BIOL, V13, P611, DOI 10.1038/nsmb1110; Hussain RH, 2013, NUCLEIC ACIDS RES, V41, P8715, DOI 10.1093/nar/gkt649; Inada M, 2004, P NATL ACAD SCI USA, V101, P434, DOI 10.1073/pnas.0307425100; Intine RV, 2003, MOL CELL, V12, P1301, DOI 10.1016/S1097-2765(03)00429-5; Intine RV, 2002, MOL CELL, V9, P1113, DOI 10.1016/S1097-2765(02)00533-6; Jacks A, 2003, STRUCTURE, V11, P833, DOI 10.1016/S0969-2126(03)00121-7; Kim YK, 2001, NUCLEIC ACIDS RES, V29, P5009, DOI 10.1093/nar/29.24.5009; Kotik-Kogan O, 2008, STRUCTURE, V16, P852, DOI 10.1016/j.str.2008.02.021; Kuehnert J, 2015, NUCLEIC ACIDS RES, V43, P581, DOI 10.1093/nar/gku1309; Lento C, 2015, CAN J CHEM, V93, P7, DOI 10.1139/cjc-2014-0260; Liuni P, 2010, RAPID COMMUN MASS SP, V24, P315, DOI 10.1002/rcm.4391; Martino L, 2012, NUCLEIC ACIDS RES, V40, P1381, DOI 10.1093/nar/gkr890; MEEROVITCH K, 1993, J VIROL, V67, P3798, DOI 10.1128/JVI.67.7.3798-3807.1993; MEEROVITCH K, 1989, GENE DEV, V3, P1026, DOI 10.1101/gad.3.7.1026; Naeeni AR, 2012, J BIOL CHEM, V287, P5472, DOI 10.1074/jbc.M111.276071; Niu S, 2015, PROTEIN SCI, V24, P1272, DOI 10.1002/pro.2699; Niu S, 2013, CURR OPIN CHEM BIOL, V17, P809, DOI 10.1016/j.cbpa.2013.06.019; Petz M, 2012, NUCLEIC ACIDS RES, V40, P290, DOI 10.1093/nar/gkr717; Rey M, 2014, STRUCTURE, V22, P1538, DOI 10.1016/j.str.2014.08.013; SIMONS FHM, 1994, J CELL BIOL, V125, P981, DOI 10.1083/jcb.125.5.981; Singh M, 2013, RNA BIOL, V10, P353, DOI 10.4161/rna.23608; Singh M, 2012, MOL CELL, V47, P16, DOI 10.1016/j.molcel.2012.05.018; Sommer G, 2011, ONCOGENE, V30, P434, DOI 10.1038/onc.2010.425; STEFANO JE, 1984, CELL, V36, P145, DOI 10.1016/0092-8674(84)90083-7; Teplova M, 2006, MOL CELL, V21, P75, DOI 10.1016/j.molcel.2005.10.027; Trotta R, 2003, CANCER CELL, V3, P145, DOI 10.1016/S1535-6108(03)00020-5; Vakiloroayaei A, 2017, NUCLEIC ACIDS RES, V45, P11341, DOI 10.1093/nar/gkx764; van Duijn E, 2009, J AM CHEM SOC, V131, P1452, DOI 10.1021/ja8055134; Vinayak J, 2018, NUCLEIC ACIDS RES, V46, P4228, DOI 10.1093/nar/gky090; Wolin SL, 2002, ANNU REV BIOCHEM, V71, P375, DOI 10.1146/annurev.biochem.71.090501.150003; Zhang J, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.015032	43	9	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2019	294	5					1529	1540		10.1074/jbc.RA118.003995	http://dx.doi.org/10.1074/jbc.RA118.003995			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GC	30530494	Green Published, hybrid			2022-12-28	WOS:000457879200009
J	Spencer, C; Bensing, BA; Mishra, NN; Sullam, PM				Spencer, Cierra; Bensing, Barbara A.; Mishra, Nagendra N.; Sullam, Paul M.			Membrane trafficking of the bacterial adhesin GspB and the accessory Sec transport machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lipid-protein interaction; protein translocation; liposome; protein targeting; Streptococcus; adhesin; accessory Sec system; anionic lipids; electrostatic interactions; signal peptide; adhesion	SURFACE GLYCOPROTEIN GSPB; STREPTOCOCCUS-GORDONII; SIGNAL PEPTIDES; BINDING; EXPORT; GLYCOSYLATION; SYSTEM; GLYCOLIPIDS; COMPONENTS; SUBSTRATE	The serine-rich repeat (SRR) glycoproteins of Gram-positive bacteria are large, cell wall-anchored adhesins that mediate binding to many host cells and proteins and are associated with bacterial virulence. SRR glycoproteins are exported to the cell surface by the accessory Sec (aSec) system comprising SecA2, SecY2, and 3-5 additional proteins (Asp1 to Asp5) that are required for substrate export. These adhesins typically have a 90-amino acid-long signal peptide containing an elongated N-region and a hydrophobic core. Previous studies of GspB (the SRR adhesin of Streptococcus gordonii) have shown that a glycine-rich motif in its hydrophobic core is essential for selective, aSec-mediated transport. However, the role of this extended N-region in transport is poorly understood. Here, using protein-lipid co-flotation assays and site-directed mutagenesis, we report that the N-region of the GspB signal peptide interacts with anionic lipids through electrostatic forces and that this interaction is necessary for GspB preprotein trafficking to lipid membranes. Moreover, we observed that protein-lipid binding is required for engagement of GspB with SecA2 and for aSec-mediated transport. We further found that SecA2 and Asp1 to Asp3 also localize selectively to liposomes that contain anionic lipids. These findings suggest that the GspB signal peptide electrostatically binds anionic lipids at the cell membrane, where it encounters SecA2. After SecA2 engagement with the signal peptide, Asp1 to Asp3 promote SecA2 engagement with the mature domain, which activates GspB translocation.	[Spencer, Cierra; Bensing, Barbara A.; Sullam, Paul M.] San Francisco VA Med Ctr, Div Infect Dis, San Francisco, CA 94121 USA; [Spencer, Cierra; Bensing, Barbara A.; Sullam, Paul M.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Mishra, Nagendra N.] Los Angeles Biomed Res Inst, Div Infect Dis, Torrance, CA 90502 USA; [Mishra, Nagendra N.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Sullam, PM (corresponding author), Vet Affairs Med Ctr, Div Infect Dis, San Francisco, CA 94121 USA.	paul.sullam@ucsf.edu		Spencer, Cierra/0000-0001-9723-0766	American Heart Association postdoctoral fellowship; NIAID, National Institutes of Health [5 T32 AI060537-13, R01AI41513]; LA Biomed-Harbor UCLA [31604-01]; Merck; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041513, T32AI060537] Funding Source: NIH RePORTER	American Heart Association postdoctoral fellowship(American Heart Association); NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); LA Biomed-Harbor UCLA; Merck(Merck & Company); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by an American Heart Association postdoctoral fellowship (to C. S.); NIAID, National Institutes of Health, Postdoctoral Training Grant 5 T32 AI060537-13 (to C. S.) and Grant R01AI41513 (to P. M. S.); Merck (to N. N. M.); and LA Biomed-Harbor UCLA, Intramural Research Grant 31604-01 (to N. N. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams HM, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.02552-16; Ahn T, 2002, J BIOL CHEM, V277, P26157, DOI 10.1074/jbc.M203445200; Bandara M, 2016, J BIOL CHEM, V291, P21474, DOI 10.1074/jbc.M116.729806; Bensing BA, 2005, MOL MICROBIOL, V58, P1468, DOI 10.1111/j.1365-2958.2005.04919.x; Bensing BA, 2004, INFECT IMMUN, V72, P6528, DOI 10.1128/IAI.72.11.6528-6537.2004; Bensing BA, 2002, MOL MICROBIOL, V44, P1081, DOI 10.1046/j.1365-2958.2002.02949.x; Bensing BA, 2007, J BACTERIOL, V189, P3846, DOI 10.1128/JB.00027-07; Bensing BA, 2016, GLYCOBIOLOGY, V26, P1222, DOI 10.1093/glycob/cww042; Bensing BA, 2012, J BIOL CHEM, V287, P24438, DOI 10.1074/jbc.M112.378059; Bensing BA, 2010, J BACTERIOL, V192, P4223, DOI 10.1128/JB.00373-10; Bensing BA, 2009, J BACTERIOL, V191, P3482, DOI 10.1128/JB.00365-09; BRUNDISH DE, 1966, BIOCHEM J, V99, P546; BRUNDISH DE, 1965, BIOCHEM J, V97, P158; BRUNDISH DE, 1965, BIOCHEM J, V97, pC37, DOI 10.1042/bj0970037C; Chen Q, 2006, FEMS MICROBIOL LETT, V264, P174, DOI 10.1111/j.1574-6968.2006.00455.x; Chen Y, 2016, P NATL ACAD SCI USA, V113, pE1190, DOI 10.1073/pnas.1600494113; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Deng LQ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004540; DOSSANTO.JM, 1970, J BACTERIOL, V104, P611, DOI 10.1128/JB.104.2.611-619.1970; FISCHER W, 1977, BIOCHIM BIOPHYS ACTA, V487, P89, DOI 10.1016/0005-2760(77)90046-7; FISCHER W, 1970, BIOCHEM BIOPH RES CO, V41, P731, DOI 10.1016/0006-291X(70)90074-4; HOYT DW, 1991, BIOCHEMISTRY-US, V30, P10155, DOI 10.1021/bi00106a012; Jiang YL, 2017, J BIOL CHEM, V292, P6213, DOI 10.1074/jbc.M116.770446; KELLER RCA, 1992, BIOCHEMISTRY-US, V31, P1672, DOI 10.1021/bi00121a014; KOMARATAT P, 1975, BIOCHIM BIOPHYS ACTA, V398, P464, DOI 10.1016/0005-2760(75)90197-6; MACRINA FL, 1983, GENE, V25, P145; MCKNIGHT CJ, 1989, J BIOL CHEM, V264, P17293; Meiers M, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-12; Mishra NN, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.02435-16; Pyburn TM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002112; Samen U, 2007, INFECT IMMUN, V75, P5405, DOI 10.1128/IAI.00717-07; Seepersaud R, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006558; Seepersaud R, 2012, J BACTERIOL, V194, P5564, DOI 10.1128/JB.01000-12; Seepersaud R, 2010, MOL MICROBIOL, V78, P490, DOI 10.1111/j.1365-2958.2010.07346.x; Seo HS, 2013, J BIOL CHEM, V288, P35982, DOI 10.1074/jbc.M113.513358; Seo HS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002947; SHAW N, 1970, Bacteriological Reviews, V34, P365; Shivshankar P, 2009, MOL MICROBIOL, V73, P663, DOI 10.1111/j.1365-2958.2009.06796.x; Takamatsu D, 2005, J BACTERIOL, V187, P3878, DOI 10.1128/JB.187.11.3878-3883.2005; Takamatsu D, 2004, J BACTERIOL, V186, P7100, DOI 10.1128/JB.186.21.7100-7111.2004; Takamatsu D, 2004, MOL MICROBIOL, V52, P189, DOI 10.1111/j.1365-2958.2004.03978.x; UMEMOTO Y, 1978, AGR BIOL CHEM TOKYO, V42, P213, DOI 10.1080/00021369.1978.10862960; Xiong YQ, 2008, MICROB PATHOGENESIS, V45, P297, DOI 10.1016/j.micpath.2008.06.004; Yen YT, 2013, J BACTERIOL, V195, P682, DOI 10.1128/JB.01742-12; Yen YT, 2011, J BACTERIOL, V193, P3165, DOI 10.1128/JB.00057-11; Young TS, 2010, J BIOL CHEM, V285, P11039, DOI 10.1074/jbc.R109.091306; Zhang J, 2018, J BIOL CHEM, V293, P4366, DOI 10.1074/jbc.M117.814327; Zhu F, 2016, J BIOL CHEM, V291, P27354, DOI 10.1074/jbc.M116.752998	48	3	3	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2019	294	5					1502	1515		10.1074/jbc.RA118.005657	http://dx.doi.org/10.1074/jbc.RA118.005657			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GC	30514759	Green Published, hybrid			2022-12-28	WOS:000457879200007
J	Lillehoj, EP; Guang, W; Hyun, SW; Liu, AU; Hegerle, N; Simon, R; Cross, AS; Ishida, H; Luzina, IG; Atamas, SP; Goldblum, SE				Lillehoj, Erik P.; Guang, Wei; Hyun, Sang W.; Liu, Anguo; Hegerle, Nicolas; Simon, Raphael; Cross, Alan S.; Ishida, Hideharu; Luzina, Irina G.; Atamas, Sergei P.; Goldblum, Simeon E.			Neuraminidase 1-mediated desialylation of the mucin 1 ectodomain releases a decoy receptor that protects against Pseudomonas aeruginosa lung infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Pseudomonas aeruginosa (P; aeruginosa); adhesin; sialidase; sialic acid; mucin 1; cell surface associated (MUC1); virulence; decoy protein; flagellin; neuraminidase	CARCINOMA-ASSOCIATED ANTIGEN; AIRWAY EPITHELIAL-CELLS; O-LINKED GLYCOSYLATION; LYSOSOMAL SIALIDASE; CYSTIC-FIBROSIS; NEU1 SIALIDASE; ELASTIN RECEPTOR; PLASMA-MEMBRANE; C-SRC; EXPRESSION	Pseudomonas aeruginosa (Pa) expresses an adhesin, flagellin, that engages the mucin 1 (MUC1) ectodomain (ED) expressed on airway epithelia, increasing association of MUC1-ED with neuraminidase 1 (NEU1) and MUC1-ED desialylation. The MUC1-ED desialylation unmasks both cryptic binding sites for Pa and a protease recognition site, permitting its proteolytic release as a hyperadhesive decoy receptor for Pa. We found here that intranasal administration of Pa strain K (PAK) to BALB/c mice increases MUC1-ED shedding into the bronchoalveolar compartment. MUC1-ED levels increased as early as 12 h, peaked at 24-48 h with a 7.8-fold increase, and decreased by 72 h. The a-type flagellin-expressing PAK strain and the b-type flagellin-expressing PAO1 strain stimulated comparable levels of MUC1-ED shedding. A flagellin-deficient PAK mutant provoked dramatically reduced MUC1-ED shedding compared with the WT strain, and purified flagellin recapitulated the WT effect. In lung tissues, Pa increased association of NEU1 and protective protein/cathepsin A with MUC1-ED in reciprocal co-immunoprecipitation assays and stimulated MUC1-ED desialylation. NEU1-selective sialidase inhibition protected against Pa-induced MUC1-ED desialylation and shedding. In Pa-challenged mice, MUC1-ED-enriched bronchoalveolar lavage fluid (BALF) inhibited flagellin binding and Pa adhesion to human airway epithelia by up to 44% and flagellin-driven motility by >30%. Finally, Pa co-administration with recombinant human MUC1-ED dramatically diminished lung and BALF bacterial burden, proinflammatory cytokine levels, and pulmonary leukostasis and increased 5-day survival from 0% to 75%. We conclude that Pa flagellin provokes NEU1-mediated airway shedding of MUC1-ED, which functions as a decoy receptor protecting against lethal Pa lung infection.	[Lillehoj, Erik P.; Guang, Wei] Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 20201 USA; [Hyun, Sang W.; Liu, Anguo; Hegerle, Nicolas; Simon, Raphael; Cross, Alan S.; Luzina, Irina G.; Atamas, Sergei P.; Goldblum, Simeon E.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 20201 USA; [Goldblum, Simeon E.] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 20201 USA; [Hegerle, Nicolas; Simon, Raphael; Cross, Alan S.] Univ Maryland, Sch Med, Inst Global Hlth, Baltimore, MD 20201 USA; [Hyun, Sang W.; Liu, Anguo; Luzina, Irina G.; Atamas, Sergei P.; Goldblum, Simeon E.] US Dept Vet Affairs, Vet Affairs Med Ctr, Baltimore, MD 20201 USA; [Ishida, Hideharu] Gifu Univ, Dept Appl Bioorgan Chem, Gifu 5011193, Japan	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; US Department of Veterans Affairs; Veterans Health Administration (VHA); Gifu University	Lillehoj, EP (corresponding author), Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 20201 USA.	elillehoj@som.umaryland.edu		Lillehoj, Erik/0000-0002-2710-1704; , Erik/0000-0003-0910-6074	Maryland Technology Development Corporation Grant [0117-005]; U.S. Department of Veterans Affairs [I01BX002352]; National Institutes of Health [AI-110627, HL-086933, HL-126897]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL126897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI110627] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002352] Funding Source: NIH RePORTER	Maryland Technology Development Corporation Grant; U.S. Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by Maryland Technology Development Corporation Grant 0117-005 (to E. P. L.), U.S. Department of Veterans Affairs Grant I01BX002352 (to S. E. G.), and National Institutes of Health Grants AI-110627 (to R. S.), HL-086933 (to A. S. C.), and HL-126897 (to S. P. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adamo R, 2004, AM J RESP CELL MOL, V30, P627, DOI 10.1165/rcmb.2003-0260OC; Ali M, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-4; ALLISON JS, 1985, INFECT IMMUN, V49, P770, DOI 10.1128/IAI.49.3.770-774.1985; Amith SR, 2010, CELL SIGNAL, V22, P314, DOI 10.1016/j.cellsig.2009.09.038; [Anonymous], 2010, MANDELL DOUGLAS BENN; Arabkhari M, 2010, GLYCOBIOLOGY, V20, P603, DOI 10.1093/glycob/cwq010; Bonten E, 1996, GENE DEV, V10, P3156, DOI 10.1101/gad.10.24.3156; Burchell JM, 2001, J MAMMARY GLAND BIOL, V6, P355, DOI 10.1023/A:1011331809881; BURMEISTER WP, 1993, STRUCTURE, V1, P19, DOI 10.1016/0969-2126(93)90005-2; Champigny MJ, 2003, GENE, V319, P177, DOI 10.1016/S0378-1119(03)00808-4; Chmiel JF, 2003, RESPIR RES, V4, DOI 10.1186/1465-9921-4-8; Cross AS, 2012, J BIOL CHEM, V287, P15966, DOI 10.1074/jbc.M112.346817; D'Avila F, 2013, J CELL BIOCHEM, V114, P204, DOI 10.1002/jcb.24355; Dasgupta N, 2004, PSEUDOMONAS, VOL 1: GENOMICS, LIFE STYLE AND MOLECULAR ARCHITECTURE, P675; Duca L, 2007, J BIOL CHEM, V282, P12484, DOI 10.1074/jbc.M609505200; Erhardt M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000299; GOLDBLUM SE, 1985, J APPL PHYSIOL, V59, P1978, DOI 10.1152/jappl.1985.59.6.1978; Hallstrand TS, 2014, CLIN IMMUNOL, V151, P1, DOI 10.1016/j.clim.2013.12.003; Hattrup CL, 2008, ANNU REV PHYSIOL, V70, P431, DOI 10.1146/annurev.physiol.70.113006.100659; Hegerle N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203143; HILKENS J, 1992, TRENDS BIOCHEM SCI, V17, P359, DOI 10.1016/0968-0004(92)90315-Z; Hinek A, 2008, AM J PATHOL, V173, P1042, DOI 10.2353/ajpath.2008.071081; Hsiao YS, 2009, BIOCHEM BIOPH RES CO, V380, P467, DOI 10.1016/j.bbrc.2009.01.108; Hyun SW, 2016, GLYCOBIOLOGY, V26, P834, DOI 10.1093/glycob/cww060; Julian J, 2009, J CELL BIOCHEM, V108, P802, DOI 10.1002/jcb.22292; Kesimer M, 2009, AM J PHYSIOL-LUNG C, V296, pL92, DOI 10.1152/ajplung.90388.2008; Khow Orawan, 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P159, DOI 10.1016/S2221-1691(11)60213-X; KIM KC, 1987, P NATL ACAD SCI USA, V84, P9304, DOI 10.1073/pnas.84.24.9304; Lacunza E, 2009, RES VET SCI, V86, P68, DOI 10.1016/j.rvsc.2008.05.011; Lee C, 2014, J BIOL CHEM, V289, P9121, DOI 10.1074/jbc.M114.555888; Li YQ, 2001, J BIOL CHEM, V276, P35239, DOI 10.1074/jbc.C100359200; Li YQ, 2001, J BIOL CHEM, V276, P6061, DOI 10.1074/jbc.C000754200; Liang F, 2006, J BIOL CHEM, V281, P27526, DOI 10.1074/jbc.M605633200; Lillehoj EP, 2003, BIOCHEM BIOPH RES CO, V307, P743, DOI 10.1016/S0006-291X(03)01260-9; Lillehoj EP, 2004, AM J PHYSIOL-LUNG C, V287, pL809, DOI 10.1152/ajplung.00385.2003; Lillehoj EP, 2002, AM J PHYSIOL-LUNG C, V282, pL751, DOI 10.1152/ajplung.00383.2001; Lillehoj EP, 2001, AM J PHYSIOL-LUNG C, V280, pL181, DOI 10.1152/ajplung.2001.280.1.L181; Lillehoj EP, 2015, J BIOL CHEM, V290, P18316, DOI 10.1074/jbc.M115.657114; Lillehoj EP, 2013, INT REV CEL MOL BIO, V303, P139, DOI 10.1016/B978-0-12-407697-6.00004-0; Lillehoj EP, 2012, J BIOL CHEM, V287, P8214, DOI 10.1074/jbc.M111.292888; Linden SK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000617; LITVINOV SV, 1993, J BIOL CHEM, V268, P21364; Lu WJ, 2006, J IMMUNOL, V176, P3890, DOI 10.4049/jimmunol.176.7.3890; Lukong KE, 2001, J BIOL CHEM, V276, P46172, DOI 10.1074/jbc.M104547200; LUZAR MA, 1985, INFECT IMMUN, V50, P577, DOI 10.1128/IAI.50.2.577-582.1985; Luzina IG, 2016, AM J PHYSIOL-LUNG C, V310, pL940, DOI 10.1152/ajplung.00346.2015; Magesh S, 2008, BIOORG MED CHEM LETT, V18, P532, DOI 10.1016/j.bmcl.2007.11.084; MAHENTHIRALINGAM E, 1994, INFECT IMMUN, V62, P596, DOI 10.1128/IAI.62.2.596-605.1994; Maurice P, 2016, SCI REP-UK, V6, DOI 10.1038/srep38363; MEINDL P, 1969, H-S Z PHYSIOL CHEM, V350, P1088, DOI 10.1515/bchm2.1969.350.2.1088; Mori Y, 2015, J BIOL CHEM, V290, P26125, DOI 10.1074/jbc.M115.651489; Muller S, 1999, J BIOL CHEM, V274, P18165, DOI 10.1074/jbc.274.26.18165; Nan XL, 2007, J LEUKOCYTE BIOL, V81, P284, DOI 10.1189/jlb.1105692; Oberg CT, 2011, CHIMIA, V65, P18, DOI 10.2533/chimia.2011.18; Palmer KL, 2005, J BACTERIOL, V187, P5267, DOI 10.1128/JB.187.15.5267-5277.2005; PLOTKOWSKI MC, 1993, EUR RESPIR J, V6, P903; POLLACK M, 1984, REV INFECT DIS, V6, pS617; Price MR, 1998, TUMOR BIOL, V19, P1, DOI 10.1159/000056500; PRINCE A, 1992, MICROB PATHOGENESIS, V13, P251, DOI 10.1016/0882-4010(92)90035-M; Pshezhetsky AV, 2013, BIOCHEMISTRY-MOSCOW+, V78, P736, DOI 10.1134/S0006297913070067; Ramasamy S, 2007, MOL CELL, V27, P992, DOI 10.1016/j.molcel.2007.07.031; Ramos HC, 2004, TRENDS MICROBIOL, V12, P509, DOI 10.1016/j.tim.2004.09.002; Shanks KK, 2010, CLIN VACCINE IMMUNOL, V17, P1196, DOI 10.1128/CVI.00167-10; Simon R, 2014, PROTEIN EXPRES PURIF, V102, P1, DOI 10.1016/j.pep.2014.07.005; Song JA, 2010, TOX RESEARCH, V26, P203, DOI 10.5487/TR.2010.26.3.203; Soong G, 2006, J CLIN INVEST, V116, P2828, DOI 10.1172/JCI27920C1; Storr SJ, 2008, GLYCOBIOLOGY, V18, P456, DOI 10.1093/glycob/cwn022; Sumida M, 2015, J BIOL CHEM, V290, P13202, DOI 10.1074/jbc.M115.638759; Thathiah A, 2004, BIOCHEM J, V382, P363, DOI 10.1042/BJ20040513; Thathiah A, 2003, J BIOL CHEM, V278, P3386, DOI 10.1074/jbc.M208326200; TOTTEN PA, 1990, J BACTERIOL, V172, P7188, DOI 10.1128/jb.172.12.7188-7199.1990; TSANG KWT, 1994, EUR RESPIR J, V7, P1746, DOI 10.1183/09031936.94.07101746; Varki A., 2009, ESSENTIALS GLYCOBIOL; Vasta GR, 2012, ADV EXP MED BIOL, V946, P21, DOI 10.1007/978-1-4614-0106-3_2; Wolfgang MC, 2004, P NATL ACAD SCI USA, V101, P6664, DOI 10.1073/pnas.0307553101; Yamamoto M, 1997, J BIOL CHEM, V272, P12492, DOI 10.1074/jbc.272.19.12492; Yogalingam G, 2008, DEV CELL, V15, P74, DOI 10.1016/j.devcel.2008.05.005; ZACHARIAE COC, 1993, ACTA DERM-VENEREOL, P1; Zelova H, 2013, INFLAMM RES, V62, P641, DOI 10.1007/s00011-013-0633-0	80	10	11	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2019	294	2					662	678		10.1074/jbc.RA118.006022	http://dx.doi.org/10.1074/jbc.RA118.006022			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HI2GP	30429216	hybrid, Green Published			2022-12-28	WOS:000456263600022
J	Uno, SP; Kimura, H; Murai, M; Miyoshi, H				Uno, Shinpei; Kimura, Hironori; Murai, Masatoshi; Miyoshi, Hideto			Exploring the quinone/inhibitor-binding pocket in mitochondrial respiratory complex I by chemical biology approaches	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bioenergetics; mitochondria; Complex I; ubiquinone; enzyme inhibitor; chemical biology; photoaffinity labeling; amilorides; NADH-quinone oxidoreductase	NADH-UBIQUINONE OXIDOREDUCTASE; BOVINE HEART-MITOCHONDRIA; NADHUBIQUINONE OXIDOREDUCTASE; PROTON PUMP; 49 KDA; CRYSTAL-STRUCTURE; REDUCTION; SITE; SUPEROXIDE; INHIBITORS	NADH-quinone oxidoreductase (respiratory complex I) couples NADH-to-quinone electron transfer to the translocation of protons across the membrane. Even though the architecture of the quinone-access channel in the enzyme has been modeled by X-ray crystallography and cryo-EM, conflicting findings raise the question whether the models fully reflect physiologically relevant states present throughout the catalytic cycle. To gain further insights into the structural features of the binding pocket for quinone/inhibitor, we performed chemical biology experiments using bovine heart sub-mitochondrial particles. We synthesized ubiquinones that are oversized (SF-UQs) or lipid-like (PC-UQs) and are highly unlikely to enter and transit the predicted narrow channel. We found that SF-UQs and PC-UQs can be catalytically reduced by complex I, albeit only at moderate or low rates. Moreover, quinone-site inhibitors completely blocked the catalytic reduction and the membrane potential formation coupled to this reduction. Photoaffinity-labeling experiments revealed that amiloride-type inhibitors bind to the interfacial domain of multiple core subunits (49 kDa, ND1, and PSST) and the 39-kDa supernumerary subunit, although the latter does not make up the channel cavity in the current models. The binding of amilorides to the multiple target subunits was remarkably suppressed by other quinone-site inhibitors and SF-UQs. Taken together, the present results are difficult to reconcile with the current channel models. On the basis of comprehensive interpretations of the present results and of previous findings, we discuss the physiological relevance of these models.	[Uno, Shinpei; Kimura, Hironori; Murai, Masatoshi; Miyoshi, Hideto] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kyoto 6068502, Japan	Kyoto University	Miyoshi, H (corresponding author), Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kyoto 6068502, Japan.	miyoshi@kais.kyoto-u.ac.jp		Miyoshi, Hideto/0000-0002-1792-554X; Murai, Masatoshi/0000-0001-6601-2854	JSPS KAKENHI [JP26292060, JP18H02147, JP18K05458]; Uehara Memorial Foundation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Uehara Memorial Foundation(Uehara Memorial Foundation)	This work was supported by JSPS KAKENHI Grants JP26292060 and JP18H02147 (to H. M.), Grant JP18K05458 (to M. M.), and by The Uehara Memorial Foundation (to M. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Agip ANA, 2018, NAT STRUCT MOL BIOL, V25, P548, DOI 10.1038/s41594-018-0073-1; Babot M, 2014, BBA-BIOENERGETICS, V1837, P929, DOI 10.1016/j.bbabio.2014.02.013; Bajda S, 2017, INSECT BIOCHEM MOLEC, V80, P79, DOI 10.1016/j.ibmb.2016.11.010; Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; BENZ R, 1983, BIOPHYS J, V41, P381, DOI 10.1016/S0006-3495(83)84449-X; Blaza JN, 2018, STRUCTURE, V26, P312, DOI 10.1016/j.str.2017.12.014; CHAZOTTE B, 1989, J BIOL CHEM, V264, P4978; CHAZOTTE B, 1988, J BIOL CHEM, V263, P14359; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; Colombini M, 2009, TRENDS BIOCHEM SCI, V34, P382, DOI 10.1016/j.tibs.2009.05.001; Crichton PG, 2015, J BIOL CHEM, V290, P8206, DOI 10.1074/jbc.M114.616607; Di Luca A, 2017, P NATL ACAD SCI USA, V114, pE6314, DOI 10.1073/pnas.1706278114; ESTORNELL E, 1993, FEBS LETT, V332, P127, DOI 10.1016/0014-5793(93)80498-J; Fato R, 1996, BIOCHEMISTRY-US, V35, P2705, DOI 10.1021/bi9516034; FEARNLEY IM, 1991, BIOCHEM J, V278, P821, DOI 10.1042/bj2780821; Fedor JG, 2017, P NATL ACAD SCI USA, V114, P12737, DOI 10.1073/pnas.1714074114; Fiedorczuk K, 2016, NATURE, V538, P406, DOI 10.1038/nature19794; Galkin A, 2005, J BIOL CHEM, V280, P30129, DOI 10.1074/jbc.M504709200; Gamiz-Hernandez AP, 2017, J AM CHEM SOC, V139, P16282, DOI 10.1021/jacs.7b08486; Guo RY, 2017, CELL, V170, P1247, DOI 10.1016/j.cell.2017.07.050; Haapanen O, 2018, BBA-BIOENERGETICS, V1859, P510, DOI 10.1016/j.bbabio.2018.04.001; Hiller S, 2010, TRENDS BIOCHEM SCI, V35, P514, DOI 10.1016/j.tibs.2010.03.005; Hirst J, 2013, ANNU REV BIOCHEM, V82, P551, DOI 10.1146/annurev-biochem-070511-103700; Ito T, 2017, J BIOL CHEM, V292, P7727, DOI 10.1074/jbc.M117.781393; Ito T, 2015, BIOCHEMISTRY-US, V54, P3677, DOI 10.1021/acs.biochem.5b00385; King MS, 2009, BIOCHEMISTRY-US, V48, P2053, DOI 10.1021/bi802282h; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lambert AJ, 2004, J BIOL CHEM, V279, P39414, DOI 10.1074/jbc.M406576200; Letts JA, 2016, J BIOL CHEM, V291, P24657, DOI 10.1074/jbc.M116.735142; Masuya T, 2017, BIOCHEMISTRY-US, V56, P4279, DOI 10.1021/acs.biochem.7b00612; Masuya T, 2016, BIOSCI BIOTECH BIOCH, V80, P1464, DOI 10.1080/09168451.2016.1179095; Masuya T, 2014, BIOCHEMISTRY-US, V53, P7816, DOI 10.1021/bi501342w; MATSUNOYAGI A, 1985, J BIOL CHEM, V260, P4424; MIYOSHI H, 1987, BIOCHIM BIOPHYS ACTA, V891, P293, DOI 10.1016/0005-2728(87)90224-6; MIYOSHI H, 1990, BIOCHIM BIOPHYS ACTA, V1016, P99, DOI 10.1016/0005-2728(90)90011-R; Murai M, 2015, BIOSCI BIOTECH BIOCH, V79, P1061, DOI 10.1080/09168451.2015.1010479; Murai M, 2015, BIOCHEMISTRY-US, V54, P2739, DOI 10.1021/acs.biochem.5b00187; Murai M, 2011, BIOCHEMISTRY-US, V50, P6901, DOI 10.1021/bi200883c; Murai M, 2009, BIOCHEMISTRY-US, V48, P688, DOI 10.1021/bi8019977; Nakamaru-Ogiso E, 2003, FEBS LETT, V549, P43, DOI 10.1016/S0014-5793(03)00766-X; Nakanishi S, 2011, BBA-BIOENERGETICS, V1807, P1170, DOI 10.1016/j.bbabio.2011.05.012; Ohshima M, 1998, BIOCHEMISTRY-US, V37, P6436, DOI 10.1021/bi9800202; Okuda K, 2016, BIOCHEMISTRY-US, V55, P470, DOI 10.1021/acs.biochem.5b01090; Rais I, 2004, PROTEOMICS, V4, P2567, DOI 10.1002/pmic.200400829; Rey M, 2012, BIOCHEMISTRY-US, V51, P9727, DOI 10.1021/bi300759x; Sakamoto K, 1998, BIOCHEMISTRY-US, V37, P15106, DOI 10.1021/bi981193u; Sazanov LA, 2015, NAT REV MOL CELL BIO, V16, P375, DOI 10.1038/nrm3997; Sharma V, 2015, P NATL ACAD SCI USA, V112, P11571, DOI 10.1073/pnas.1503761112; Shiraishi Y, 2012, BIOCHEMISTRY-US, V51, P1953, DOI 10.1021/bi300047h; Steuber J, 2014, NATURE, V516, P62, DOI 10.1038/nature14003; Stolpe S, 2004, J BIOL CHEM, V279, P18377, DOI 10.1074/jbc.M311242200; Stroud DA, 2013, J BIOL CHEM, V288, P1685, DOI 10.1074/jbc.C112.436766; Wirth C, 2016, BBA-BIOENERGETICS, V1857, P902, DOI 10.1016/j.bbabio.2016.02.013; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Wong HS, 2017, J BIOL CHEM, V292, P16804, DOI 10.1074/jbc.R117.789271; Wu M, 2016, CELL, V167, P1598, DOI 10.1016/j.cell.2016.11.012; Zhu JP, 2016, NATURE, V536, P354, DOI 10.1038/nature19095; Zickermann V, 2015, SCIENCE, V347, P44, DOI 10.1126/science.1259859	58	20	20	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2019	294	2					679	696		10.1074/jbc.RA118.006056	http://dx.doi.org/10.1074/jbc.RA118.006056			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HI2GP	30425100	Green Published, hybrid			2022-12-28	WOS:000456263600023
J	Patino-Ruiz, M; Dwivedi, M; Calinescu, O; Karabel, M; Padan, E; Fendler, K				Patino-Ruiz, Miyer; Dwivedi, Manish; Calinescu, Octavian; Karabel, Mehmet; Padan, Etana; Fendler, Klaus			Replacement of Lys-300 with a glutamine in the NhaA Na+/H+ antiporter of Escherichia coli yields a functional electrogenic transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane transport; sodium-proton exchange; electrophysiology; fluorescence; site-directed mutagenesis	CATION-BINDING; ALKALINE PH; MECHANISM; EXCHANGER; TRANSLOCATION; STABILITY; RESIDUES; PROTEIN; GENE	Much of the research on Na+/H+ exchange has been done in prokaryotic models, mainly on the NhaA Na+/H+-exchanger from Escherichia coli (EcNhaA). Two conserved aspartate residues, Asp-163 and Asp-164, are essential for transport and are candidates for possible binding sites for the two H+ that are exchanged for one Na+ to make the overall transport process electrogenic. More recently, a proposed mechanism of transport for EcNhaA has suggested direct binding of one of the transported H+ to the conserved Lys-300 residue, a salt bridge partner of Asp-163. This contention is supported by a study reporting that substitution of the equivalent residue, Lys-305, of a related Na+/H+ antiporter, NapA from Thermus thermophilus, renders the transporter electroneutral. In this work, we sought to establish whether the Lys-300 residue and its partner Asp-163 are essential for the electrogenicity of EcNhaA. To that end, we replaced Lys-300 with Gln, either alone or together with the simultaneous substitution of Asp-163 with Asn, and characterized these transporter variants in electrophysiological experiments combined with H+ transport measurements and stability analysis. We found that K300Q EcNhaA can still support electrogenic Na+/H+ antiport in EcNhaA, but has reduced thermal stability. A parallel electrophysiological investigation of the K305Q variant of TtNapA revealed that it is also electrogenic. Furthermore, replacement of both salt bridge partners in the ion-binding site of EcNhaA produced an electrogenic variant (D163N/K300Q). Our findings indicate that alternative mechanisms sustain EcNhaA activity in the absence of canonical ion-binding residues and that the conserved lysines confer structural stability.	[Patino-Ruiz, Miyer; Calinescu, Octavian; Karabel, Mehmet; Fendler, Klaus] Max Planck Inst Biophys, D-60438 Frankfurt, Germany; [Dwivedi, Manish; Padan, Etana] Hebrew Univ Jerusalem, Inst Life Sci, IL-91904 Jerusalem, Israel; [Calinescu, Octavian] Carol Davila Univ Med & Pharm, Dept Biophys, Bucharest 050474, Romania	Max Planck Society; Hebrew University of Jerusalem; Carol Davila University of Medicine & Pharmacy	Fendler, K (corresponding author), Max Planck Inst Biophys, Dept Biol Chem, Max von Laue Str 3, D-60438 Frankfurt, Germany.	fendler@biophys.mpg.de	Calinescu, Octavian/P-4278-2014; DWIVEDI, MANISH/AAI-8940-2021	Calinescu, Octavian/0000-0001-8003-0442; DWIVEDI, MANISH/0000-0001-5217-9039; Fendler, Klaus/0000-0002-5699-7060; Patino-Ruiz, Miyer Fabian/0000-0003-0607-4281	DIP (DFG, German-Israeli Project Cooperation Grant) [LA3655/1-1]; PBC, Council for Higher Education; Hebrew University; Ministry of Research and Innovation, CNCS-UEFISCDI within PNCDI III [PN-III-P1-1.1-PD-2016-0802]; Israel Science Foundation [284/12, 939/14]	DIP (DFG, German-Israeli Project Cooperation Grant); PBC, Council for Higher Education; Hebrew University; Ministry of Research and Innovation, CNCS-UEFISCDI within PNCDI III; Israel Science Foundation(Israel Science Foundation)	Supported by DIP (DFG, German-Israeli Project Cooperation Grant LA3655/1-1).; Supported by the PBC, Council for Higher Education, and the Hebrew University Program for Fellowships for Outstanding Postdoctoral Fellows from China and India (2015). Present address: Amity Institute of Biotechnology, Amity University Uttar Pradesh Malhaur, Lucknow-226028, India.; Supported by Ministry of Research and Innovation, CNCS-UEFISCDI, Project No. PN-III-P1-1.1-PD-2016-0802, within PNCDI III.; Supported by Israel Science Foundation Grants 284/12 and 939/14.	Alkoby D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093200; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; Calinescu O, 2017, J BIOL CHEM, V292, P7932, DOI 10.1074/jbc.M117.778175; Calinescu O, 2015, BIOL CHEM, V396, P1091, DOI 10.1515/hsz-2014-0278; Calinescu O, 2014, FEBS LETT, V588, P3111, DOI 10.1016/j.febslet.2014.05.066; Coincon M, 2016, NAT STRUCT MOL BIOL, V23, P248, DOI 10.1038/nsmb.3164; Dwivedi M, 2016, SCI REP-UK, V6, DOI 10.1038/srep23339; Furrer EM, 2007, FEBS LETT, V581, P572, DOI 10.1016/j.febslet.2006.12.059; GOLDBERG EB, 1987, P NATL ACAD SCI USA, V84, P2615, DOI 10.1073/pnas.84.9.2615; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Harms MJ, 2011, P NATL ACAD SCI USA, V108, P18954, DOI 10.1073/pnas.1104808108; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; INOUE H, 1995, FEBS LETT, V363, P264, DOI 10.1016/0014-5793(95)00331-3; Kozachkov L, 2007, BIOCHEMISTRY-US, V46, P2419, DOI 10.1021/bi602393s; Lee C, 2014, J GEN PHYSIOL, V144, P529, DOI 10.1085/jgp.201411219; Lee C, 2013, NATURE, V501, P573, DOI 10.1038/nature12484; Lentes CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101575; Maes M, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.391128; Mager T, 2011, J BIOL CHEM, V286, P23570, DOI 10.1074/jbc.M111.230235; Olkhova E, 2009, PROTEINS, V76, P548, DOI 10.1002/prot.22368; Orlowski J, 2004, PFLUG ARCH EUR J PHY, V447, P549, DOI 10.1007/s00424-003-1110-3; Orlowski J, 2007, CURR OPIN CELL BIOL, V19, P483, DOI 10.1016/j.ceb.2007.06.001; Padan E, 2005, BBA-BIOMEMBRANES, V1717, P67, DOI 10.1016/j.bbamem.2005.09.010; Padan E, 2001, BBA-BIOENERGETICS, V1505, P144, DOI 10.1016/S0005-2728(00)00284-X; PINNER E, 1993, J BIOL CHEM, V268, P1729; Putney LK, 2002, ANNU REV PHARMACOL, V42, P527, DOI 10.1146/annurev.pharmtox.42.092001.143801; Rimon A, 2007, J BIOL CHEM, V282, P26810, DOI 10.1074/jbc.M704469200; Rimon A, 2018, J MOL BIOL, V430, P867, DOI 10.1016/j.jmb.2018.01.014; ROSEN BP, 1986, METHOD ENZYMOL, V125, P328; SCHULDINER S, 1978, BIOCHEMISTRY-US, V17, P706, DOI 10.1021/bi00597a023; Schulz P, 2008, METHODS, V46, P97, DOI 10.1016/j.ymeth.2008.07.002; TAGLICHT D, 1991, J BIOL CHEM, V266, P11289; TAGLICHT D, 1993, J BIOL CHEM, V268, P5382; Uzdavinys P, 2017, P NATL ACAD SCI USA, V114, pE1101, DOI 10.1073/pnas.1614521114; Venturi M, 2003, MEMBRANE PROTEIN PUR, P179; Wakabayashi S, 2003, J BIOL CHEM, V278, P11828, DOI 10.1074/jbc.M213243200; Weichel M, 2008, BIOPROCESS INT, P42; Zuber D, 2005, BBA-BIOENERGETICS, V1709, P240, DOI 10.1016/j.bbabio.2005.07.009	38	12	12	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2019	294	1					246	256		10.1074/jbc.RA118.004903	http://dx.doi.org/10.1074/jbc.RA118.004903			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG6PT	30409911	hybrid, Green Published			2022-12-28	WOS:000455105500027
J	Tang, Y; Joo, D; Liu, GN; Tu, HL; You, J; Jin, JP; Zhao, XQ; Hung, MC; Lin, X				Tang, Yong; Joo, Donghyun; Liu, Guangna; Tu, Hailin; You, Jeffrey; Jin, Jianping; Zhao, Xueqiang; Hung, Mien-Chie; Lin, Xin			Linear ubiquitination of cFLIP induced by LUBAC contributes to TNF-induced apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; ubiquitylation (ubiquitination); tumor necrosis factor (TNF); caspase; cell death; cFLIP; linear ubiquitination; LUBAC; RNF31	NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; C-FLIP; EMBRYONIC LETHALITY; MEDIATED APOPTOSIS; CELL-DEATH; RECEPTOR; SHARPIN; ACTIVATION; PROTEIN	The linear ubiquitin chain assembly complex (LUBAC) regulates NF-B activation by modifying proteins with linear (M1-linked) ubiquitination chains. Although LUBAC also regulates the apoptosis pathway, the precise mechanism by which LUBAC regulates apoptosis remains not fully defined. Here, we report that LUBAC-mediated M1-linked ubiquitination of cellular FLICE-like inhibitory protein (cFLIP), an anti-apoptotic molecule, contributes to tumor necrosis factor (TNF) -induced apoptosis. We found that deficiency of RNF31, the catalytic subunit of the LUBAC complex, promoted cFLIP degradation in a proteasome-dependent manner. Moreover, we observed RNF31 directly interact with cFLIP, and LUBAC further conjugated M1-linked ubiquitination chains at Lys-351 and Lys-353 of cFLIP to stabilize cFLIP, thereby protecting cells from TNF-induced apoptosis. Together, our study identifies a new substrate of LUBAC and reveals a new molecular mechanism through which LUBAC regulates TNF-induced apoptosis via M1-linked ubiquitination.	[Tang, Yong; Liu, Guangna; Tu, Hailin; Zhao, Xueqiang; Lin, Xin] Tsinghua Univ, Sch Med, Inst Immunol, Beijing 100084, Peoples R China; [Joo, Donghyun; You, Jeffrey; Hung, Mien-Chie] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Jin, Jianping] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China	Tsinghua University; University of Texas System; UTMD Anderson Cancer Center; Zhejiang University	Lin, X (corresponding author), Tsinghua Univ, Sch Med, Inst Immunol, Beijing 100084, Peoples R China.	linxin307@tsinghua.edu.cn	Hung, Mien-Chie/ABD-5911-2021	Hung, Mien-Chie/0000-0003-4317-4740; Liu, Guangna/0000-0003-4148-4534	National Natural Science Foundation of China [81570211, 81630058]; National Institutes of Health [R01A111672211]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Grants 81570211 and 81630058 from National Natural Science Foundation of China (to X. L.) and Grant R01A111672211 from the National Institutes of Health (to M.-C. H.).The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aksentijevich I, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00399; Bachmann F, 2001, J INVEST DERMATOL, V117, P59, DOI 10.1046/j.0022-202x.2001.01380.x; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Boisson B, 2015, J EXP MED, V212, P939, DOI 10.1084/jem.20141130; Boisson B, 2012, NAT IMMUNOL, V13, P1178, DOI 10.1038/ni.2457; Brenner D, 2015, NAT REV IMMUNOL, V15, P362, DOI 10.1038/nri3834; Budd RC, 2006, NAT REV IMMUNOL, V6, P196, DOI 10.1038/nri1787; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Fujita H, 2018, CELL REP, V23, P1192, DOI 10.1016/j.celrep.2018.03.112; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Goto E, 2017, BIOCHEM BIOPH RES CO, V485, P152, DOI [10.1016/J.bbrc.2017.02.040, 10.1016/j.bbrc.2017.02.040]; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Iwai K, 2014, NAT REV MOL CELL BIO, V15, P503, DOI 10.1038/nrm3836; Iwai K, 2009, EMBO REP, V10, P706, DOI 10.1038/embor.2009.144; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kumari S, 2014, ELIFE, V3, DOI 10.7554/eLife.03422; Lee EW, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1981; Liang YH, 2011, J INVEST DERMATOL, V131, P141, DOI 10.1038/jid.2010.259; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Ofengeim D, 2013, NAT REV MOL CELL BIO, V14, P727, DOI 10.1038/nrm3683; Panayotova-Dimitrova D, 2013, CELL REP, V5, P397, DOI 10.1016/j.celrep.2013.09.035; Park Y, 2016, NAT IMMUNOL, V17, P286, DOI 10.1038/ni.3352; Peltzer N, 2018, NATURE, V557, P112, DOI 10.1038/s41586-018-0064-8; Peltzer N, 2014, CELL REP, V9, P153, DOI 10.1016/j.celrep.2014.08.066; Poukkula M, 2005, J BIOL CHEM, V280, P27345, DOI 10.1074/jbc.M504019200; Rickard JA, 2014, ELIFE, V3, DOI 10.7554/eLife.03464; Rieser E, 2013, TRENDS BIOCHEM SCI, V38, P94, DOI 10.1016/j.tibs.2012.11.007; Rodgers MA, 2014, J EXP MED, V211, P1331, DOI 10.1084/jem.20132486; Schmidt-Supprian M, 2000, MOL CELL, V5, P981, DOI 10.1016/S1097-2765(00)80263-4; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Sohn D, 2006, MOL CELL BIOL, V26, P1967, DOI 10.1128/MCB.26.5.1967-1978.2006; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; Tanaka M, 1999, IMMUNITY, V10, P421, DOI 10.1016/S1074-7613(00)80042-4; Tang Y, 2018, J IMMUNOL, V200, P4117, DOI 10.4049/jimmunol.1800172; Teh CE, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13353; Tokunaga F, 2011, NATURE, V471, P633, DOI 10.1038/nature09815; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Weinlich R, 2013, CELL REP, V5, P340, DOI 10.1016/j.celrep.2013.08.045; Wilkie-Grantham RP, 2013, J BIOL CHEM, V288, P12777, DOI 10.1074/jbc.M112.431320; Yang YK, 2016, J BIOL CHEM, V291, P25921, DOI 10.1074/jbc.M116.754028; Yeh WC, 2000, IMMUNITY, V12, P633, DOI 10.1016/S1074-7613(00)80214-9; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhang JK, 1998, NATURE, V392, P296, DOI 10.1038/32681	49	25	25	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					20062	20072		10.1074/jbc.RA118.005449	http://dx.doi.org/10.1074/jbc.RA118.005449			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30361438	Green Published, hybrid			2022-12-28	WOS:000454685900016
J	del Cano-Ochoa, F; Grande-Garcia, A; Reverte-Lopez, M; D'Abramo, M; Ramon-Maiques, S				del Cano-Ochoa, Francisco; Grande-Garcia, Araceli; Reverte-Lopez, Maria; D'Abramo, Marco; Ramon-Maiques, Santiago			Characterization of the catalytic flexible loop in the dihydroorotase domain of the human multi-enzymatic protein CAD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; ASPARTATE TRANSCARBAMOYLASE; NUCLEOTIDE BIOSYNTHESIS; PYRIMIDINE BIOSYNTHESIS; MULTIFUNCTIONAL PROTEIN; INHIBITORS; PURIFICATION; EFFICIENT; MOVEMENT; SYSTEM	The dihydroorotase (DHOase) domain of the multifunctional protein carbamoyl-phosphate synthetase 2, aspartate transcarbamoylase, and dihydroorotase (CAD) catalyzes the third step in the de novo biosynthesis of pyrimidine nucleotides in animals. The crystal structure of the DHOase domain of human CAD (huDHOase) revealed that, despite evolutionary divergence, its active site components are highly conserved with those in bacterial DHOases, encoded as monofunctional enzymes. An important element for catalysis, conserved from Escherichia coli to humans, is a flexible loop that closes as a lid over the active site. Here, we combined mutagenic, structural, biochemical, and molecular dynamics analyses to characterize the function of the flexible loop in the activity of CAD's DHOase domain. A huDHOase chimera bearing the E. coli DHOase flexible loop was inactive, suggesting the presence of distinctive elements in the flexible loop of huDHOase that cannot be replaced by the bacterial sequence. We pinpointed Phe-1563, a residue absolutely conserved at the tip of the flexible loop in CAD's DHOase domain, as a critical element for the conformational equilibrium between the two catalytic states of the protein. Substitutions of Phe-1563 with Ala, Leu, or Thr prevented the closure of the flexible loop and inactivated the protein, whereas substitution with Tyr enhanced the interactions of the loop in the closed position and reduced fluctuations and the reaction rate. Our results confirm the importance of the flexible loop in CAD's DHOase domain and explain the key role of Phe-1563 in configuring the active site and in promoting substrate strain and catalysis.	[del Cano-Ochoa, Francisco; Reverte-Lopez, Maria; Ramon-Maiques, Santiago] Ctr Biol Mol Severo Ochoa CSIC UAM, Dept Genome Dynam & Funct, Madrid 28049, Spain; [Grande-Garcia, Araceli] Spanish Natl Canc Res Ctr CNIO, Struct Biol Programme, Madrid 28029, Spain; [D'Abramo, Marco] Sapienza Univ Rome, Dept Chem, I-00185 Rome, Italy	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Centro Nacional de Investigaciones Oncologicas (CNIO); Sapienza University Rome	Ramon-Maiques, S (corresponding author), Ctr Biol Mol Severo Ochoa CSIC UAM, Dept Genome Dynam & Funct, Madrid 28049, Spain.	santiago.ramon@cbm.csic.es	Ramon-Maiques, Santiago/R-2533-2019; Grande-García, Araceli/ABH-3169-2020; Reverte-López, María/ABB-8276-2020; D'Abramo, Marco/B-7035-2008	Grande-García, Araceli/0000-0003-2619-5013; Reverte-López, María/0000-0002-6854-7446; D'Abramo, Marco/0000-0001-6020-8581; Ramon-Maiques, Santiago/0000-0001-9674-8088; del Cano-Ochoa, Francisco/0000-0003-3093-3103	Spanish Ministry of Science, Innovation and Universities (AEI/FEDER, UE) [BFU2016-80570-R]; European Community [283570]; Spanish National Cancer Research Centre (CNIO) Intramural Programme	Spanish Ministry of Science, Innovation and Universities (AEI/FEDER, UE); European Community(European Commission); Spanish National Cancer Research Centre (CNIO) Intramural Programme	This work was supported by the Spanish Ministry of Science, Innovation and Universities (BFU2016-80570-R; AEI/FEDER, UE), by the European Community's Seventh Framework Programme (FP7/2007-2013) under BioStruct-X (Grant 283570) and by the Spanish National Cancer Research Centre (CNIO) Intramural Programme. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; BROOKE J, 1990, CANCER RES, V50, P7793; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Cassera MB, 2011, CURR TOP MED CHEM, V11, P2103; Christopherson RI, 2002, ACCOUNTS CHEM RES, V35, P961, DOI 10.1021/ar0000509; CHRISTOPHERSON RI, 1979, J BIOL CHEM, V254, P2506; COLEMAN PF, 1977, J BIOL CHEM, V252, P6379; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans DR, 2004, J BIOL CHEM, V279, P33035, DOI 10.1074/jbc.R400007200; Evans HG, 2014, PROTEIN SCI, V23, P100, DOI 10.1002/pro.2396; Fields C., 1999, PATHS PYRIMIDINES, V7, P49; Grande-Garcia A, 2014, STRUCTURE, V22, P185, DOI 10.1016/j.str.2013.10.016; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; JONES ME, 1980, ANNU REV BIOCHEM, V49, P253, DOI 10.1146/annurev.bi.49.070180.001345; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Koshland DE, 1998, NAT MED, V4, P1112, DOI 10.1038/2605; Lallous N, 2012, ACTA CRYSTALLOGR F, V68, P1341, DOI 10.1107/S1744309112038857; LEE L, 1985, P NATL ACAD SCI USA, V82, P6802, DOI 10.1073/pnas.82.20.6802; Lee M, 2005, J MOL BIOL, V348, P523, DOI 10.1016/j.jmb.2005.01.067; Lee M, 2007, BIOCHEMISTRY-US, V46, P10538, DOI 10.1021/bi701098e; Lee M, 2007, J MOL BIOL, V370, P812, DOI 10.1016/j.jmb.2007.05.019; Li YC, 2005, BIOORG CHEM, V33, P470, DOI 10.1016/j.bioorg.2005.08.001; Malde AK, 2011, J CHEM THEORY COMPUT, V7, P4026, DOI 10.1021/ct200196m; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Porter TN, 2004, BIOCHEMISTRY-US, V43, P16285, DOI 10.1021/bi048308g; Rice AJ, 2016, BIOORGAN MED CHEM, V24, P4536, DOI 10.1016/j.bmc.2016.07.055; Ruiz-Ramos A, 2015, ENCY INORGANIC BIOIN, DOI [10.1002/9781119951438.eibc2321, DOI 10.1002/9781119951438.EIBC2321]; Schmid N, 2011, EUR BIOPHYS J BIOPHY, V40, P843, DOI 10.1007/s00249-011-0700-9; Schroeder PE, 2008, DRUG METAB DISPOS, V36, P1780, DOI 10.1124/dmd.108.021626; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Seibert CM, 2005, BIOCHEMISTRY-US, V44, P6383, DOI 10.1021/bi047326v; Thoden JB, 2001, BIOCHEMISTRY-US, V40, P6989, DOI 10.1021/bi010682i; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WYATT PJ, 1993, ANAL CHIM ACTA, V272, P1, DOI 10.1016/0003-2670(93)80373-S; Zhang PF, 2009, BIOCHEMISTRY-US, V48, P766, DOI 10.1021/bi801831r	40	11	11	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2018	293	49					18903	18913		10.1074/jbc.RA118.005494	http://dx.doi.org/10.1074/jbc.RA118.005494			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NY	30315107	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000458467400008
J	Eswarappa, SM; Potdar, AA; Sahoo, S; Sankar, S; Fox, PL				Eswarappa, Sandeep M.; Potdar, Alka A.; Sahoo, Sarthak; Sankar, Santhosh; Fox, Paul L.			Metabolic origin of the fused aminoacyl-tRNA synthetase, glutamyl-prolyl-tRNA synthetase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-SUBTILIS; TRANSCRIPTION ANTITERMINATION; GENE-REGULATION; EVOLUTION; COMPLEX; EXPRESSION; COMPONENT; GROWTH; MODEL; CYCLE	About 1 billion years ago, in a single-celled holozoan ancestor of all animals, a gene fusion of two tRNA synthetases formed the bifunctional enzyme, glutamyl-prolyl-tRNA synthetase (EPRS). We propose here that a confluence of metabolic, biochemical, and environmental factors contributed to the specific fusion of glutamyl- (ERS) and prolyl- (PRS) tRNA synthetases. To test this idea, we developed a mathematical model that centers on the precursor-product relationship of glutamic acid and proline, as well as metabolic constraints on free glutamic acid availability near the time of the fusion event. Our findings indicate that proline content increased in the proteome during the emergence of animals, thereby increasing demand for free proline. Together, these constraints contributed to a marked cellular depletion of glutamic acid and its products, with potentially catastrophic consequences. In response, an ancient organism invented an elegant solution in which genes encoding ERS and PRS fused to form EPRS, forcing coexpression of the two enzymes and preventing lethal dysregulation. The substantial evolutionary advantage of this coregulatory mechanism is evidenced by the persistence of EPRS in nearly all extant animals.	[Eswarappa, Sandeep M.; Sahoo, Sarthak; Sankar, Santhosh] Indian Inst Sci, Dept Biochem, Bengaluru 560012, India; [Potdar, Alka A.] Cedars Sinai Med Ctr, F Widjaja Fdn Inflammatory Bowel, Los Angeles, CA 90048 USA; [Potdar, Alka A.] Cedars Sinai Med Ctr, Immunobiol Res Inst, Los Angeles, CA 90048 USA; [Fox, Paul L.] Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44195 USA	Indian Institute of Science (IISC) - Bangalore; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cleveland Clinic Foundation	Eswarappa, SM (corresponding author), Indian Inst Sci, Dept Biochem, Bengaluru 560012, India.; Fox, PL (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44195 USA.	sandeep@iisc.ac.in; foxp@ccf.org	Eswarappa, Sandeep/AFG-1997-2022	Fox, Paul/0000-0002-6033-1528	National Institutes of Health [P01HL029582, P01HL076491, R01GM115476]; Wellcome Trust-Department of Biotechnology, India Alliance Intermediate Fellowship [IA/I/15/1/501833]; Department of Science and Technology-Science and Engineering Research Board, India [YSS/2015/000989]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL029582, P01HL076491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115476] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust-Department of Biotechnology, India Alliance Intermediate Fellowship; Department of Science and Technology-Science and Engineering Research Board, India; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants P01HL029582, P01HL076491, and R01GM115476 (to P. L. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Recipient of Wellcome Trust-Department of Biotechnology, India Alliance Intermediate Fellowship IA/I/15/1/501833 and Start-up Grant for Young Scientists YSS/2015/000989 from the Department of Science and Technology-Science and Engineering Research Board, India.	Arif A, 2017, NATURE, V542, P357, DOI 10.1038/nature21380; Arif A, 2009, MOL CELL, V35, P164, DOI 10.1016/j.molcel.2009.05.028; BAICH A, 1977, SOMAT CELL GENET, V3, P529, DOI 10.1007/BF01539123; BANDYOPADHYAY AK, 1971, J MOL BIOL, V60, P113, DOI 10.1016/0022-2836(71)90451-7; Bergman NM, 2004, AM J SCI, V304, P397, DOI 10.2475/ajs.304.5.397; Berthonneau E, 2000, FEBS LETT, V470, P300, DOI 10.1016/S0014-5793(00)01343-0; CERINI C, 1991, EMBO J, V10, P4267, DOI 10.1002/j.1460-2075.1991.tb05005.x; Condon C, 1996, BIOCHIMIE, V78, P381, DOI 10.1016/0300-9084(96)84744-4; Eswarappa SM, 2013, TRENDS BIOCHEM SCI, V38, P222, DOI 10.1016/j.tibs.2013.01.005; Exposito JY, 2002, ANAT RECORD, V268, P302, DOI 10.1002/ar.10162; Fidler AL, 2017, ELIFE, V6, DOI 10.7554/eLife.24176; Gray MW, 2010, SCIENCE, V330, P920, DOI 10.1126/science.1198594; GRUNDY FJ, 1993, CELL, V74, P475, DOI 10.1016/0092-8674(93)80049-K; Guo M, 2013, NAT CHEM BIOL, V9, P145, DOI [10.1038/nchembio.1158, 10.1038/NCHEMBIO.1158]; Han JM, 2006, J BIOL CHEM, V281, P38663, DOI 10.1074/jbc.M605211200; Havrylenko S, 2015, INT J MOL SCI, V16, P6571, DOI 10.3390/ijms16036571; Havrylenko S, 2011, J BIOL CHEM, V286, P28476, DOI 10.1074/jbc.M111.254037; Heino J, 2009, INT J BIOCHEM CELL B, V41, P341, DOI 10.1016/j.biocel.2008.08.021; Kaminska M, 2009, J BIOL CHEM, V284, P6053, DOI 10.1074/jbc.M809636200; Kondrashov FA, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-31; LAZARD M, 1987, FEBS LETT, V216, P27, DOI 10.1016/0014-5793(87)80750-0; LAZARD M, 1987, J BIOL CHEM, V262, P3982; Lee SW, 2004, J CELL SCI, V117, P3725, DOI 10.1242/jcs.01342; Long M, 2003, NAT REV GENET, V4, P865, DOI 10.1038/nrg1204; Luo D, 1997, J BACTERIOL, V179, P2472, DOI 10.1128/jb.179.8.2472-2478.1997; Lynch M, 2007, P NATL ACAD SCI USA, V104, P8597, DOI 10.1073/pnas.0702207104; MESTICHELLI LJJ, 1979, J BIOL CHEM, V254, P640; Mills DB, 2014, BIOESSAYS, V36, P1145, DOI 10.1002/bies.201400101; Mukhopadhyay R, 2009, TRENDS BIOCHEM SCI, V34, P324, DOI 10.1016/j.tibs.2009.03.004; Nakano MM, 1998, J BACTERIOL, V180, P3304, DOI 10.1128/JB.180.13.3304-3311.1998; Norcum MT, 1998, PROTEIN SCI, V7, P79, DOI 10.1002/pro.5560070108; Perez-Arellano I, 2010, PROTEIN SCI, V19, P372, DOI 10.1002/pro.340; PUTZER H, 1995, MOL MICROBIOL, V16, P709, DOI 10.1111/j.1365-2958.1995.tb02432.x; Ray PS, 2007, TRENDS BIOCHEM SCI, V32, P158, DOI 10.1016/j.tibs.2007.02.003; Ray PS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098493; Ray PS, 2011, MOL BIOL EVOL, V28, P437, DOI 10.1093/molbev/msq246; Ryckelynck M, 2005, BIOCHIMIE, V87, P835, DOI 10.1016/j.biochi.2005.02.014; Sampath P, 2004, CELL, V119, P195, DOI 10.1016/j.cell.2004.09.030; Sebe-Pedros A, 2013, ELIFE, V2, DOI 10.7554/eLife.01287; Stoltzfus A, 1999, J MOL EVOL, V49, P169, DOI 10.1007/PL00006540; Tekaia F, 2002, GENE, V297, P51, DOI 10.1016/S0378-1119(02)00871-5; TING SM, 1994, J BIOL CHEM, V269, P8993; VALLE D, 1973, BIOCHEM BIOPH RES CO, V54, P1418, DOI 10.1016/0006-291X(73)91144-3; van de Guchte MV, 2001, MICROBIOL-SGM, V147, P1223, DOI 10.1099/00221287-147-5-1223; Webster KA, 2003, J EXP BIOL, V206, P2911, DOI 10.1242/jeb.00516; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108	46	8	8	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2018	293	49					19148	19156		10.1074/jbc.RA118.004276	http://dx.doi.org/10.1074/jbc.RA118.004276			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NY	30309984	Green Published, hybrid			2022-12-28	WOS:000458467400027
J	Gong, X; Liu, WG; Wu, LL; Ma, ZF; Wang, YZ; Yu, SY; Zhang, J; Xie, H; Wei, GY; Ma, F; Lu, L; Chen, LM				Gong, Xue; Liu, Weiguang; Wu, Lele; Ma, Zhifang; Wang, Yuzhi; Yu, Shiyi; Zhang, Jun; Xie, Hao; Wei, Guanyun; Ma, Fei; Lu, Ling; Chen, Liming			Transcriptional repressor GATA binding 1-mediated repression of SRY-box 2 expression suppresses cancer stem cell functions and tumor initiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELF-RENEWAL; BREAST; SOX2; TRPS1; DIFFERENTIATION; GENES; MUTAGENESIS; MAINTAINS; NETWORK; FATE	Cancer stem cells (CSCs) have been reported in a variety of cancers. SRY-box 2 (SOX2) is a member of the SOX family of transcription factors and has been shown to play a critical role in maintaining the functions of CSCs and promoting tumor initiation. However, the underlying mechanisms for the transcriptional regulation of the SOX2 gene in CSCs are unclear. In this study, using in silico and experimental approaches, we identified transcriptional repressor GATA binding 1 (TRPS1), an atypical GATA-type transcription factor, as a critical transcriptional regulator that represses SOX2 expression and thereby suppresses cancer stemness and tumorigenesis. Mechanistically, TRPS1 repressed SOX2 expression by directly targeting the consensus GATA-binding element in the SOX2 promoter as elucidated by ChIP and luciferase reporter assays. Of note, in vitro mammosphere formation assays in culture and in vivo xenograft tumor initiation experiments in mouse models revealed that TRPS1-mediated repression of SOX2 expression suppresses CSC functions and tumor initiation. Taken together, our study provides detailed mechanistic insights into CSC functions and tumor initiation by the TRPS1-SOX2 axis.	[Gong, Xue; Wang, Yuzhi; Xie, Hao; Chen, Liming] Southeast Univ, Inst Life Sci, Nanjing 210096, Jiangsu, Peoples R China; [Gong, Xue; Liu, Weiguang; Wu, Lele; Ma, Zhifang; Wang, Yuzhi; Yu, Shiyi; Zhang, Jun; Wei, Guanyun; Ma, Fei; Chen, Liming] Nanjing Normal Univ, Jiangsu Key Lab Mol & Med Biotechnol, Coll Life Sci, Nanjing 210023, Jiangsu, Peoples R China; [Lu, Ling] Nanjing Med Univ, Dept Otolaryngol Head & Neck Surg, DrumTower Clin Med Coll, Nanjing 210008, Jiangsu, Peoples R China; [Lu, Ling] Nanjing Univ, Dept Otolaryngol Head & Neck Surg, Nanjing Drum Tower Hosp, Sch Med, Nanjing 210008, Jiangsu, Peoples R China	Southeast University - China; Nanjing Normal University; Nanjing Medical University; Nanjing University	Chen, LM (corresponding author), Southeast Univ, Inst Life Sci, Nanjing 210096, Jiangsu, Peoples R China.; Chen, LM (corresponding author), Nanjing Normal Univ, Jiangsu Key Lab Mol & Med Biotechnol, Coll Life Sci, Nanjing 210023, Jiangsu, Peoples R China.	chenliming1981@njnu.edu.cn	gong, xue/GYQ-8649-2022	Xie, Hao/0000-0002-0683-6883	National Natural Science Foundation of China [81772956, 81572712]; National Basic Research Program of China 973 Program [2015CB965000]; Key University Science Research Project of Jiangsu Province [17KJA320002]; Natural Science Foundation of Jiangsu Province [SBK2016030027]; Priority Academic Program and the Development of Jiangsu Higher Education Institutions; Jiangsu Provincial Medical Youth Talent of the Project of Invigorating Health Care through Science, Technology and Education Grant [QNRC2016002]; National Science Foundation for Young Scientists of China [81700913]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China 973 Program(National Basic Research Program of China); Key University Science Research Project of Jiangsu Province; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Priority Academic Program and the Development of Jiangsu Higher Education Institutions; Jiangsu Provincial Medical Youth Talent of the Project of Invigorating Health Care through Science, Technology and Education Grant; National Science Foundation for Young Scientists of China	This work was supported by National Natural Science Foundation of China Grants 81772956 and 81572712, National Basic Research Program of China 973 Program Grant 2015CB965000, Key University Science Research Project of Jiangsu Province Grant 17KJA320002, Natural Science Foundation of Jiangsu Province Grant SBK2016030027, funds from the Priority Academic Program and the Development of Jiangsu Higher Education Institutions, Jiangsu Provincial Medical Youth Talent of the Project of Invigorating Health Care through Science, Technology and Education Grant QNRC2016002, and National Science Foundation for Young Scientists of China Grant 81700913. The authors declare that they have no conflicts of interest with the contents of this article.	Annovazzi L, 2011, CANCER GENOM PROTEOM, V8, P139; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Basu-Roy U, 2012, ONCOGENE, V31, P2270, DOI 10.1038/onc.2011.405; Boumahdi S, 2014, NATURE, V511, P246, DOI 10.1038/nature13305; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Chen Jie Qing, 2011, Hormones & Cancer, V2, P132, DOI 10.1007/s12672-011-0067-5; Chen LM, 2017, P NATL ACAD SCI USA, V114, pE2215, DOI 10.1073/pnas.1701512114; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Dontu G, 2003, CELL PROLIFERAT, V36, P59, DOI 10.1046/j.1365-2184.36.s.1.6.x; Fantauzzo KA, 2012, DEVELOPMENT, V139, P203, DOI 10.1242/dev.069971; Fujikura J, 2002, GENE DEV, V16, P784, DOI 10.1101/gad.968802; Haase A, 2009, CELL STEM CELL, V5, P434, DOI 10.1016/j.stem.2009.08.021; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Itoh S, 2008, GENES CELLS, V13, P355, DOI 10.1111/j.1365-2443.2008.01170.x; Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Leis O, 2012, ONCOGENE, V31, P1354, DOI 10.1038/onc.2011.338; Lentjes MHFM, 2016, EXPERT REV MOL MED, V18, DOI 10.1017/erm.2016.2; Liu KC, 2013, CELL SIGNAL, V25, P1264, DOI 10.1016/j.cellsig.2013.02.013; Liu SL, 2014, STEM CELL REP, V2, P78, DOI 10.1016/j.stemcr.2013.11.009; Malik TH, 2001, EMBO J, V20, P1715, DOI 10.1093/emboj/20.7.1715; Papapetrou EP, 2009, P NATL ACAD SCI USA, V106, P12759, DOI 10.1073/pnas.0904825106; Piva M, 2014, EMBO MOL MED, V6, P66, DOI 10.1002/emmm.201303411; Rangel R, 2016, P NATL ACAD SCI USA, V113, pE7749, DOI 10.1073/pnas.1613859113; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rodriguez-Pinilla SM, 2007, MODERN PATHOL, V20, P474, DOI 10.1038/modpathol.3800760; Santini R, 2014, ONCOGENE, V33, P4697, DOI 10.1038/onc.2014.71; Savinainen KJ, 2004, BRIT J CANCER, V90, P1041, DOI 10.1038/sj.bjc.6601648; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; Shaw FL, 2012, J MAMMARY GLAND BIOL, V17, P111, DOI 10.1007/s10911-012-9255-3; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Turbendian HK, 2013, DEVELOPMENT, V140, P1639, DOI 10.1242/dev.093260; Usary J, 2004, ONCOGENE, V23, P7669, DOI 10.1038/sj.onc.1207966; Vidal SJ, 2014, ONCOGENE, V33, P4451, DOI 10.1038/onc.2013.411; Wang YZ, 2018, BREAST CANCER RES, V20, DOI 10.1186/s13058-018-1018-7; Wu LL, 2014, ONCOTARGET, V5, P7677, DOI 10.18632/oncotarget.2291; Yu SY, 2017, INT J BIOL SCI, V13, P505, DOI 10.7150/ijbs.18834; Zhang C, 2007, STEM CELLS DEV, V16, P605, DOI 10.1089/scd.2006.0077; Zhao HX, 2010, DIFFERENTIATION, V80, P123, DOI 10.1016/j.diff.2010.03.002; Zheng Rena, 2010, Genes Cancer, V1, P1178, DOI 10.1177/1947601911404223	40	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2018	293	48					18646	18654		10.1074/jbc.RA118.003983	http://dx.doi.org/10.1074/jbc.RA118.003983			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NX	30315105	Green Published, hybrid			2022-12-28	WOS:000458467300019
J	Chua, NK; Brown, AJ				Chua, Ngee Kiat; Brown, Andrew J.			Mallostery: Filling a niche between quality and metabolic control (vol 293, pg 14951, 2018)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Chua NK, 2018, J BIOL CHEM, V293, P14951, DOI 10.1074/jbc.H118.005031	1	0	0	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2018	293	42					16176	16176		10.1074/jbc.AAC118.006017	http://dx.doi.org/10.1074/jbc.AAC118.006017			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GX5ZA	30341216	hybrid, Green Published			2022-12-28	WOS:000447833600006
J	Brewer, PD; Romenskaia, I; Mastick, CC				Brewer, Paul Duffield; Romenskaia, Irina; Mastick, Cynthia Corley			A high-throughput chemical-genetics screen in murine adipocytes identifies insulin-regulatory pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adipocyte; insulin; membrane trafficking; glucose transporter type 4 (GLUT4); drug discovery; chemical genetics; drug repurposing; library screening; small molecule	GLUCOSE-TRANSPORT; GLUT4 TRANSLOCATION; MAMMALIAN TARGET; ADIPOSE-TISSUE; AKT SUBSTRATE; PLASMA-MEMBRANE; RAB-GAP; PROTEIN; 3T3-L1; RAPAMYCIN	Pathways linking activation of the insulin receptor to downstream targets of insulin have traditionally been studied using a candidate gene approach. To elucidate additional pathways regulating insulin activity, we performed a forward chemical-genetics screen based on translocation of a glucose transporter 4 (Glut4) reporter expressed in murine 3T3-L1 adipocytes. To identify compounds with known targets, we screened drug-repurposing and natural product libraries. We identified, confirmed, and validated 64 activators and 65 inhibitors that acutely increase or rapidly decrease cell-surface Glut4 in adipocytes stimulated with submaximal insulin concentrations. These agents were grouped by target, chemical class, and mechanism of action. All groups contained multiple hits from a single drug class, and several comprised multiple structurally unrelated hits for a single target. Targets include the -adrenergic and adenosine receptors. Agonists of these receptors increased and inverse agonists/antagonists decreased cell-surface Glut4 independently of insulin. Additional activators include insulin sensitizers (thiazolidinediones), insulin mimetics, dis-inhibitors (the mTORC1 inhibitor rapamycin), cardiotonic steroids (the Na+/K+-ATPase inhibitor ouabain), and corticosteroids (dexamethasone). Inhibitors include heterocyclic amines (tricyclic antidepressants) and 21 natural product supplements and herbal extracts. Mechanisms of action include effects on Glut4 trafficking, signal transduction, inhibition of protein synthesis, and dissipation of proton gradients. Two pathways that acutely regulate Glut4 translocation were discovered: de novo protein synthesis and endocytic acidification. The mechanism of action of additional classes of activators (tanshinones, dalbergiones, and coumarins) and inhibitors (flavonoids and resveratrol) remains to be determined. These tools are among the most sensitive, responsive, and reproducible insulin-activity assays described to date.	[Brewer, Paul Duffield; Romenskaia, Irina; Mastick, Cynthia Corley] Univ Nevada, Reno Sch Med, Dept Pharmacol, Mailstop 318, Reno, NV 89557 USA; [Brewer, Paul Duffield] AnaptysBio Inc, San Diego, CA 92121 USA; [Romenskaia, Irina] Univ Nevada, Dept Biochem, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; Nevada System of Higher Education (NSHE); University of Nevada Reno	Mastick, CC (corresponding author), Univ Nevada, Reno Sch Med, Dept Pharmacol, Mailstop 318, Reno, NV 89557 USA.	cmastick@unr.edu	Mastick, Cynthia/G-9841-2017	Mastick, Cynthia/0000-0003-4769-5412	National Institutes of Health from NIGMS [P20 GM103440]; American Diabetes Association [1-12-BS-132]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103440] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant P20 GM103440 from NIGMS and American Diabetes Association Grant 1-12-BS-132. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmadian M, 2007, FUTURE LIPIDOL, V2, P229, DOI 10.2217/17460875.2.2.229; Alves DS, 2015, J AM SOC NEPHROL, V26, P2765, DOI 10.1681/ASN.2013101040; Baker JG, 2010, BRIT J PHARMACOL, V160, P1048, DOI 10.1111/j.1476-5381.2010.00754.x; Basit A, 2012, VASC HEALTH RISK MAN, V8, P463, DOI 10.2147/HIV.S33194; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Bogan JS, 2012, J BIOL CHEM, V287, P23932, DOI 10.1074/jbc.M112.339457; Bogan JS, 2010, CURR OPIN CELL BIOL, V22, P506, DOI 10.1016/j.ceb.2010.03.012; Bogan JS, 2001, MOL CELL BIOL, V21, P4785, DOI 10.1128/MCB.21.14.4785-4806.2001; Brewer PD, 2016, BIOCHEM J, V473, P1315, DOI 10.1042/BCJ20160020; Brewer PD, 2016, J BIOL CHEM, V291, P773, DOI 10.1074/jbc.M115.694919; Brewer PD, 2014, J BIOL CHEM, V289, P17280, DOI 10.1074/jbc.M114.555714; Brewer PD, 2011, J BIOL CHEM, V286, P26287, DOI 10.1074/jbc.M111.253880; CAIN CC, 1988, J CELL BIOL, V106, P269, DOI 10.1083/jcb.106.2.269; CAIN CC, 1989, P NATL ACAD SCI USA, V86, P544, DOI 10.1073/pnas.86.2.544; CAIN CC, 1986, J CELL PHYSIOL, V129, P65, DOI 10.1002/jcp.1041290110; Chaurasia B, 2015, TRENDS ENDOCRIN MET, V26, P538, DOI 10.1016/j.tem.2015.07.006; Chen YC, 2007, J AFFECT DISORDERS, V103, P257, DOI 10.1016/j.jad.2007.01.023; Chen Y, 2012, J CELL BIOL, V198, P545, DOI 10.1083/jcb.201111091; Chernogubova E, 2004, ENDOCRINOLOGY, V145, P269, DOI 10.1210/en.2003-0857; Dragunow M, 2007, J BIOMOL SCREEN, V12, P999, DOI 10.1177/1087057107306502; ECKEL J, 1990, BIOCHEM J, V272, P691, DOI 10.1042/bj2720691; Edwards SR, 2007, J BIOL CHEM, V282, P13395, DOI 10.1074/jbc.M700498200; Foley K, 2011, BIOCHEMISTRY-US, V50, P3048, DOI 10.1021/bi2000356; Frojdo S, 2007, BIOCHEM J, V406, P511, DOI 10.1042/BJ20070236; FUCHS R, 1989, P NATL ACAD SCI USA, V86, P539, DOI 10.1073/pnas.86.2.539; FUJIWARA T, 1988, DIABETES, V37, P1549, DOI 10.2337/diabetes.37.11.1549; Furusawa Chikara, 2005, Biophysics (Nagoya-shi), V1, P25, DOI 10.2142/biophysics.1.25; Ghaeli P, 2004, J CLIN PSYCHOPHARM, V24, P386, DOI 10.1097/01.jcp.0000132441.27854.0d; Goldman SDB, 2009, BIOANALYSIS, V1, P1445, DOI 10.4155/BIO.09.128; Gomez-Zorita S, 2013, J PHYSIOL BIOCHEM, V69, P585, DOI 10.1007/s13105-012-0229-0; Griggs RB, 2015, PAIN, V156, P469, DOI 10.1097/01.j.pain.0000460333.79127.be; Habtemichael EN, 2011, J BIOL CHEM, V286, P10115, DOI 10.1074/jbc.M111.217935; Herman M., 2012, ASBMB TODAY, V2012, P30; Hino K, 2011, J BIOMOL SCREEN, V16, P628, DOI 10.1177/1087057111403474; Hu X, 2011, BIOORG MED CHEM LETT, V21, P4441, DOI 10.1016/j.bmcl.2011.06.020; HUNDAL HS, 1992, J BIOL CHEM, V267, P5040; Ishikura S, 2007, BIOCHEM BIOPH RES CO, V353, P1074, DOI 10.1016/j.bbrc.2006.12.140; JAMES DE, 1988, NATURE, V333, P183, DOI 10.1038/333183a0; JEWELL EA, 1991, J BIOL CHEM, V266, P16925; Jiang L, 2008, J BIOL CHEM, V283, P8508, DOI 10.1074/jbc.M708688200; JOOST HG, 1985, BIOCHEM PHARMACOL, V34, P649, DOI 10.1016/0006-2952(85)90259-X; Kandror KV, 2011, TRAFFIC, V12, P665, DOI 10.1111/j.1600-0854.2011.01175.x; KASHIWAGI A, 1982, BIOCHEM BIOPH RES CO, V107, P1151, DOI 10.1016/0006-291X(82)90642-8; KASHIWAGI A, 1983, J BIOL CHEM, V258, P3685; Kawazoe Y, 2004, CHEM BIOL, V11, P907, DOI 10.1016/j.chembiol.2004.04.017; KLETZIEN RF, 1992, MOL PHARMACOL, V41, P393; Klip A, 2014, AM J PHYSIOL-CELL PH, V306, pC879, DOI 10.1152/ajpcell.00069.2014; Krebs M, 2007, DIABETES, V56, P1600, DOI 10.2337/db06-1016; Kuo T, 2015, ADV EXP MED BIOL, V872, P99, DOI 10.1007/978-1-4939-2895-8_5; Lahrita L, 2015, J ETHNOPHARMACOL, V168, P229, DOI 10.1016/j.jep.2015.03.082; Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135; Lanzerstorfer P, 2014, BRIT J PHARMACOL, V171, P5237, DOI 10.1111/bph.12845; Larance M, 2005, J BIOL CHEM, V280, P37803, DOI 10.1074/jbc.M503897200; Lebeck J, 2014, J MOL ENDOCRINOL, V52, pR165, DOI 10.1530/JME-13-0268; Leroyer SN, 2006, J BIOL CHEM, V281, P13141, DOI 10.1074/jbc.M512943200; Liao TV, 2014, DRUGS, V74, P183, DOI 10.1007/s40265-013-0171-7; Lingrel JB, 2010, ANNU REV PHYSIOL, V72, P395, DOI 10.1146/annurev-physiol-021909-135725; Liu F, 2009, BIOCHEM J, V418, P413, DOI 10.1042/BJ20082051; Liu Q, 2010, J STEROID BIOCHEM, V120, P155, DOI 10.1016/j.jsbmb.2010.03.090; Lopez JA, 2009, MOL BIOL CELL, V20, P3918, DOI 10.1091/mbc.E09-03-0187; Loubatieres-Mariani Marie-Madeleine, 2007, Journal de la Societe de Biologie, V201, P121, DOI 10.1051/jbio:2007014; Malide D, 2000, J CELL SCI, V113, P4203; Merlin J, 2018, CELL SIGNAL, V42, P54, DOI 10.1016/j.cellsig.2017.09.023; Miinea CP, 2005, BIOCHEM J, V391, P87, DOI 10.1042/BJ20050887; Montagut G, 2010, J NUTR BIOCHEM, V21, P961, DOI 10.1016/j.jnutbio.2009.08.001; Moraes LA, 2010, J THROMB HAEMOST, V8, P577, DOI 10.1111/j.1538-7836.2009.03732.x; Mukaida S, 2017, PHARMACOL RES, V116, P87, DOI 10.1016/j.phrs.2016.12.022; MULLER G, 1995, DIABETES RES CLIN PR, V28, pS115, DOI 10.1016/0168-8227(95)01089-V; Muretta JM, 2008, J BIOL CHEM, V283, P311, DOI 10.1074/jbc.M705756200; Nakabayashi H, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-453; OMATSUKANBE M, 1992, FEBS LETT, V314, P246, DOI 10.1016/0014-5793(92)81481-Z; Pereira MJ, 2012, MOL CELL ENDOCRINOL, V355, P96, DOI 10.1016/j.mce.2012.01.024; Pinent M, 2004, ENDOCRINOLOGY, V145, P4985, DOI 10.1210/en.2004-0764; Pinent M, 2005, J AGR FOOD CHEM, V53, P5932, DOI 10.1021/jf050601f; Qatanani M, 2007, GENE DEV, V21, P1443, DOI 10.1101/gad.1550907; Qiang GF, 2014, DIABETES, V63, P1394, DOI 10.2337/db13-0334; REED BC, 1981, P NATL ACAD SCI-BIOL, V78, P2908, DOI 10.1073/pnas.78.5.2908; Reed SE, 2013, J CELL SCI, V126, P1931, DOI 10.1242/jcs.104307; Rutkowski JM, 2015, J CELL BIOL, V208, P501, DOI 10.1083/jcb.201409063; Sacramento JF, 2015, EUR J PHARM SCI, V70, P107, DOI 10.1016/j.ejps.2015.01.011; Sadacca LA, 2013, MOL BIOL CELL, V24, P2544, DOI 10.1091/mbc.E13-02-0103; Sakamoto K, 2008, AM J PHYSIOL-ENDOC M, V295, pE29, DOI 10.1152/ajpendo.90331.2008; SALANS LB, 1974, J CLIN INVEST, V53, P848, DOI 10.1172/JCI107625; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Sano H, 2008, BIOCHEM J, V411, P89, DOI 10.1042/BJ20071318; Sano H, 2007, CELL METAB, V5, P293, DOI 10.1016/j.cmet.2007.03.001; Sennoune S, 2000, EUR J BIOCHEM, V267, P2071, DOI 10.1046/j.1432-1327.2000.01211.x; Shearer J, 2014, NUTR REV, V72, P121, DOI 10.1111/nure.12124; Shimizu M, 1996, PHARMACOL TOXICOL, V78, P254, DOI 10.1111/j.1600-0773.1996.tb00214.x; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; Stockli J, 2011, J CELL SCI, V124, P4147, DOI 10.1242/jcs.097063; Swinney DC, 2011, NAT REV DRUG DISCOV, V10, P507, DOI 10.1038/nrd3480; Syamsudin Inawati, 2008, RES J PHARM, V2, P20; Thomas I, 2017, PEDIATR DIABETES, V18, P10, DOI 10.1111/pedi.12473; Tordjman J, 2003, J BIOL CHEM, V278, P18785, DOI 10.1074/jbc.M206999200; Tremblay F, 2005, ENDOCRINOLOGY, V146, P1328, DOI 10.1210/en.2004-0777; Van Goor F, 2006, AM J PHYSIOL-LUNG C, V290, pL1117, DOI 10.1152/ajplung.00169.2005; Vazirani RP, 2016, DIABETES, V65, P1577, DOI 10.2337/db15-1128; Vijayakumar MV, 2010, J BIOSCIENCES, V35, P525, DOI 10.1007/s12038-010-0060-0; VRIJSEN R, 1986, J BIOL CHEM, V261, P505; Wang F, 2015, INT J IMMUNOPATH PH, V28, P362, DOI 10.1177/0394632015598849; Xu YK, 2016, J CELL SCI, V129, P2085, DOI 10.1242/jcs.174805; Xu YK, 2011, J CELL BIOL, V193, P643, DOI 10.1083/jcb.201008135; Zhang B, 1999, SCIENCE, V284, P974, DOI 10.1126/science.284.5416.974; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	106	8	8	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					4103	4118		10.1074/jbc.RA118.006986	http://dx.doi.org/10.1074/jbc.RA118.006986			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30591588	Green Published, hybrid			2022-12-28	WOS:000461854400023
J	Avci, D; Malchus, NS; Heidasch, R; Lorenz, H; Richter, K; Nessling, M; Lemberg, MK				Avci, Doenem; Malchus, Nicole S.; Heidasch, Ronny; Lorenz, Holger; Richter, Karsten; Nessling, Michelle; Lemberg, Marius K.			The intramembrane protease SPP impacts morphology of the endoplasmic reticulum by triggering degradation of morphogenic proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						intramembrane proteolysis; endoplasmic reticulum-associated protein degradation (ERAD); organelle; proteolysis; cellular regulation; organelle morphology; substrate identification; tail-anchored protein	SIGNAL PEPTIDE PEPTIDASE; HOMOTYPIC FUSION; MEMBRANES; EXPRESSION; CELLS; IDENTIFICATION; ORGANIZATION; INHIBITION; SECRETION; SUBSTRATE	The endoplasmic reticulum (ER), as a multifunctional organelle, plays crucial roles in lipid biosynthesis and calcium homeostasis as well as the synthesis and folding of secretory and membrane proteins. Therefore, it is of high importance to maintain ER homeostasis and to adapt ER function and morphology to cellular needs. Here, we show that signal peptide peptidase (SPP) modulates the ER shape through degradation of morphogenic proteins. Elevating SPP activity induces rapid rearrangement of the ER and formation of dynamic ER clusters. Inhibition of SPP activity rescues the phenotype without the need for new protein synthesis, and this rescue depends on a pre-existing pool of proteins in the Golgi. With the help of organelle proteomics, we identified certain membrane proteins to be diminished upon SPP expression and further show that the observed morphology changes depend on SPP-mediated cleavage of ER morphogenic proteins, including the SNARE protein syntaxin-18. Thus, we suggest that SPP-mediated protein abundance control by a regulatory branch of ER-associated degradation (ERAD-R) has a role in shaping the early secretory pathway.	[Avci, Doenem; Malchus, Nicole S.; Heidasch, Ronny; Lorenz, Holger; Lemberg, Marius K.] Heidelberg Univ ZMBH, DKFZ ZMBH Alliance, Ctr Mol Biol, D-69120 Heidelberg, Germany; [Richter, Karsten; Nessling, Michelle] German Canc Res Ctr, Cent Unit Elect Microscopy, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Lemberg, MK (corresponding author), Heidelberg Univ ZMBH, DKFZ ZMBH Alliance, Ctr Mol Biol, D-69120 Heidelberg, Germany.	m.lemberg@zmbh.uni-heidelberg.de	Lemberg, Marius K/B-8881-2016	Lemberg, Marius K/0000-0002-0996-1268	Deutsche Forschungsgemeinschaft [LE 2749/2-1, ZUK 49/2 6.1 DKFZ-ZMBH-Alliance, INST 35/1485-1 FUGG]; Boehringer Ingelheim Fonds fellowship	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Boehringer Ingelheim Fonds fellowship(Boehringer Ingelheim)	This work was supported by Deutsche Forschungsgemeinschaft Grants LE 2749/2-1, ZUK 49/2 6.1 DKFZ-ZMBH-Alliance, and INST 35/1485-1 FUGG and a Boehringer Ingelheim Fonds fellowship (to N. S. M.). The authors declare that they have no conflicts of interest with the contents of this article.	ANDERSON RGW, 1983, J CELL SCI, V63, P1; Avci D, 2015, TRENDS CELL BIOL, V25, P611, DOI 10.1016/j.tcb.2015.07.003; Avci D, 2014, MOL CELL, V56, P630, DOI 10.1016/j.molcel.2014.10.012; Balut CM, 2011, FASEB J, V25, P3938, DOI 10.1096/fj.11-187005; Baumann O, 2001, INT REV CYTOL, V205, P149, DOI 10.1016/S0074-7696(01)05004-5; Bian X, 2011, P NATL ACAD SCI USA, V108, P3976, DOI 10.1073/pnas.1101643108; Boname JM, 2014, J CELL BIOL, V205, P847, DOI 10.1083/jcb.201312009; Chen CY, 2014, EMBO J, V33, P2492, DOI 10.15252/embj.201488208; Chen SL, 2013, CURR OPIN CELL BIOL, V25, P428, DOI 10.1016/j.ceb.2013.02.006; Chen SL, 2012, NAT CELL BIOL, V14, P707, DOI 10.1038/ncb2523; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Christianson JC, 2014, NAT STRUCT MOL BIOL, V21, P325, DOI 10.1038/nsmb.2793; Cole NB, 1996, SCIENCE, V273, P797, DOI 10.1126/science.273.5276.797; Costantini LM, 2012, TRAFFIC, V13, P643, DOI 10.1111/j.1600-0854.2012.01336.x; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cui-Wang TT, 2012, CELL, V148, P309, DOI 10.1016/j.cell.2011.11.056; De Craene JO, 2006, MOL BIOL CELL, V17, P3009, DOI 10.1091/mbc.e06-01-0080; Dev KK, 2006, EUR J PHARMACOL, V540, P10, DOI 10.1016/j.ejphar.2006.04.011; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Fecher-Trost C, 2013, J BIOL CHEM, V288, P16629, DOI 10.1074/jbc.M113.469726; Fidzianska A, 2004, ACTA NEUROPATHOL, V107, P197, DOI 10.1007/s00401-003-0794-y; Fleig L, 2012, MOL CELL, V47, P558, DOI 10.1016/j.molcel.2012.06.008; Friedman JR, 2010, J CELL BIOL, V190, P363, DOI 10.1083/jcb.200911024; Friedmann E, 2004, J BIOL CHEM, V279, P50790, DOI 10.1074/jbc.M407898200; Gillingham AK, 2014, DEV CELL, V31, P358, DOI 10.1016/j.devcel.2014.10.007; Gong FC, 1996, P NATL ACAD SCI USA, V93, P2219, DOI 10.1073/pnas.93.5.2219; Gonzalez-Alegre P, 2004, J NEUROSCI, V24, P2593, DOI 10.1523/JNEUROSCI.4461-03.2004; Hegde RS, 2011, NAT REV MOL CELL BIO, V12, P787, DOI 10.1038/nrm3226; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Hsu FF, 2019, ONCOGENE, V38, P1688, DOI 10.1038/s41388-018-0539-y; Hu JJ, 2009, CELL, V138, P549, DOI 10.1016/j.cell.2009.05.025; Valenzuela JI, 2011, MOL CELL NEUROSCI, V48, P269, DOI 10.1016/j.mcn.2011.07.001; Kano F, 2005, GENES CELLS, V10, P989, DOI 10.1111/j.1365-2443.2005.00894.x; Korkhov VM, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-59; Lee M, 2015, J CELL BIOL, V210, P451, DOI 10.1083/jcb.201501043; Lemberg MK, 2011, TRAFFIC, V12, P1109, DOI 10.1111/j.1600-0854.2011.01219.x; Lenormand C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060813; Lippincott-Schwartz J, 2000, ANNU REV CELL DEV BI, V16, P557, DOI 10.1146/annurev.cellbio.16.1.557; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Meissner C, 2011, J NEUROCHEM, V117, P856, DOI 10.1111/j.1471-4159.2011.07253.x; Mentrup T, 2017, EUR J CELL BIOL, V96, P372, DOI 10.1016/j.ejcb.2017.03.002; Miyazaki K, 2012, J CELL SCI, V125, P5658, DOI 10.1242/jcs.105304; Nakajima K, 2004, EMBO J, V23, P3216, DOI 10.1038/sj.emboj.7600333; Nixon-Abell J, 2016, SCIENCE, V354, DOI 10.1126/science.aaf3928; Omi K, 2005, BIOCHEM BIOPH RES CO, V338, P1229, DOI 10.1016/j.bbrc.2005.10.061; Orso G, 2009, NATURE, V460, P978, DOI 10.1038/nature08280; Park SH, 2010, EMBO REP, V11, P515, DOI 10.1038/embor.2010.92; PARMLEY RT, 1976, CANCER RES, V36, P1717; Pendin D, 2011, CURR OPIN CELL BIOL, V23, P435, DOI 10.1016/j.ceb.2011.04.007; Piper RC, 2011, TRENDS CELL BIOL, V21, P647, DOI 10.1016/j.tcb.2011.08.007; Renvoise B, 2010, CURR OPIN NEUROBIOL, V20, P531, DOI 10.1016/j.conb.2010.07.001; Richter K, 2005, EXP CELL RES, V303, P128, DOI 10.1016/j.yexcr.2004.09.022; Shibata Y, 2009, ANNU REV CELL DEV BI, V25, P329, DOI 10.1146/annurev.cellbio.042308.113324; Simmen T, 2018, CURR OPIN CELL BIOL, V53, P61, DOI 10.1016/j.ceb.2018.04.014; Snapp EL, 2006, P NATL ACAD SCI USA, V103, P6536, DOI 10.1073/pnas.0510657103; Snapp EL, 2003, J CELL BIOL, V163, P257, DOI 10.1083/jcb.200306020; Stechmann B, 2010, CELL, V141, P231, DOI 10.1016/j.cell.2010.01.043; Stefanovic-Barrett S, 2018, EMBO REP, V19, DOI 10.15252/embr.201745603; Tang ZF, 2017, NUCLEIC ACIDS RES, V45, pW98, DOI 10.1093/nar/gkx247; TERASAKI M, 1986, J CELL BIOL, V103, P1557, DOI 10.1083/jcb.103.4.1557; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Uchiyama K, 2002, J CELL BIOL, V159, P855, DOI 10.1083/jcb.200208112; Vedrenne C, 2006, TRAFFIC, V7, P639, DOI 10.1111/j.1600-0854.2006.00419.x; Vedrenne C, 2005, MOL BIOL CELL, V16, P1928, DOI 10.1091/mbc.E04-07-0554; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Voss M, 2012, J BIOL CHEM, V287, P43401, DOI 10.1074/jbc.M112.371369; Wei JW, 2017, CNS NEUROSCI THER, V23, P257, DOI 10.1111/cns.12672; Weihofen A, 2003, J BIOL CHEM, V278, P16528, DOI 10.1074/jbc.M301372200; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Westrate LM, 2015, ANNU REV BIOCHEM, V84, P791, DOI 10.1146/annurev-biochem-072711-163501; Wunderle L, 2016, SCI REP-UK, V6, DOI 10.1038/srep27342; Zhang ZR, 2013, CELL, V154, P609, DOI 10.1016/j.cell.2013.06.038	72	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2786	2800		10.1074/jbc.RA118.005642	http://dx.doi.org/10.1074/jbc.RA118.005642			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30578301	hybrid, Green Published			2022-12-28	WOS:000459601600018
J	Gutgsell, AR; Ghodge, SV; Bowers, AA; Neher, SB				Gutgsell, Aspen R.; Ghodge, Swapnil V.; Bowers, Albert A.; Neher, Saskia B.			Mapping the sites of the lipoprotein lipase (LPL)-angiopoietin-like protein 4 (ANGPTL4) interaction provides mechanistic insight into LPL inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lipase; hydrogen exchange mass spectrometry; mutagenesis; peptides; protein-protein interaction; lipid metabolism; triglyceride; angiopoietin-like protein 4; lipoprotein lipase	ANGIOPOIETIN-LIKE PROTEINS; METABOLISM; DOMAIN; HYPERTRIGLYCERIDEMIA; VARIANTS; BINDING; TISSUES; PLASMA; RISK	Cardiovascular disease has been the leading cause of death throughout the world for nearly 2 decades. Hypertriglyceridemia affects more than one-third of the population in the United States and is an independent risk factor for cardiovascular disease. Despite the frequency of hypertriglyceridemia, treatment options are primarily limited to diet and exercise. Lipoprotein lipase (LPL) is an enzyme responsible for clearing triglycerides from circulation, and its activity alone can directly control plasma triglyceride concentrations. Therefore, LPL is a good target for triglyceride-lowering therapeutics. One approach for treating hypertriglyceridemia may be to increase the amount of enzymatically active LPL by preventing its inhibition by angiopoietin-like protein 4 (ANGPTL4). However, little is known about how these two proteins interact. Therefore, we used hydrogen-deuterium exchange MS to identify potential binding sites between LPL and ANGPTL4. We validated sites predicted to be located at the protein-protein interface by using chimeric variants of LPL and an LPL peptide mimetic. We found that ANGPTL4 binds LPL near the active site at the lid domain and a nearby alpha-helix. Lipase lid domains cover the active site to control both enzyme activation and substrate specificity. Our findings suggest that ANGPTL4 specifically inhibits LPL by binding the lid domain, which could prevent substrate catalysis at the active site. The structural details of the LPL-ANGPTL4 interaction uncovered here may inform the development of therapeutics targeted to disrupt this interaction for the management of hypertriglyceridemia.	[Gutgsell, Aspen R.; Neher, Saskia B.] Univ N Carolina, Dept Biochem & Biophys, 120 Mason Farm Rd,CB7260, Chapel Hill, NC 27599 USA; [Ghodge, Swapnil V.; Bowers, Albert A.] Univ N Carolina, Eshelman Sch Pharm, Div Chem Biol & Med Chem, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Neher, SB (corresponding author), Univ N Carolina, Dept Biochem & Biophys, 120 Mason Farm Rd,CB7260, Chapel Hill, NC 27599 USA.	neher@email.unc.edu		Neher, Saskia/0000-0003-4165-6674	National Institutes of Health [R01HL125654, R35GM125005]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL125654] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM125005] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01HL125654 (to S. B. N.) and R35GM125005 (to A. A. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Backhed F, 2007, P NATL ACAD SCI USA, V104, P606, DOI 10.1073/pnas.0605957104; BENGTSSON G, 1979, BIOCHIM BIOPHYS ACTA, V575, P471, DOI 10.1016/0005-2760(79)90118-8; Bengtsson-Olivecrona P., 1991, METHOD ENZYMOL, V197, P345; Bergo M, 1996, BIOCHEM J, V313, P893, DOI 10.1042/bj3130893; Biterova E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25237-7; Brahm AJ, 2015, NAT REV ENDOCRINOL, V11, P352, DOI 10.1038/nrendo.2015.26; Dallinga-Thie GM, 2016, CURR CARDIOL REP, V18, DOI 10.1007/s11886-016-0745-6; DAVIS RC, 1992, J BIOL CHEM, V267, P21499; Desai U, 2007, P NATL ACAD SCI USA, V104, P11766, DOI 10.1073/pnas.0705041104; Dewey FF, 2016, NEW ENGL J MED, V374, P1123, DOI 10.1056/NEJMoa1510926; Dijk W, 2016, J LIPID RES, V57, P1949, DOI 10.1194/jlr.M067363ERR; Dijk W, 2014, TRENDS ENDOCRIN MET, V25, P146, DOI 10.1016/j.tem.2013.12.005; DUGI KA, 1995, J BIOL CHEM, V270, P25396, DOI 10.1074/jbc.270.43.25396; Fang J, 2011, INT J MASS SPECTROM, V302, P19, DOI 10.1016/j.ijms.2010.06.039; Ge HF, 2004, J BIOL CHEM, V279, P2038, DOI 10.1074/jbc.M307583200; Goldberg IJ, 1996, J LIPID RES, V37, P693; Graham MJ, 2017, NEW ENGL J MED, V377, P222, DOI 10.1056/NEJMoa1701329; Griffon N, 2006, J LIPID RES, V47, P1803, DOI 10.1194/jlr.M500552-JLR200; Gusarova V, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04611-z; Hayne CK, 2018, BIOCHEMISTRY-US, V57, P241, DOI 10.1021/acs.biochem.7b01009; Hayne CK, 2017, BIOCHEMISTRY-US, V56, P525, DOI 10.1021/acs.biochem.6b00945; Karalis D, 2017, ADV THER, V34, P300, DOI 10.1007/s12325-016-0462-y; Karpe F, 1998, J LIPID RES, V39, P2387; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Koster A, 2005, ENDOCRINOLOGY, V146, P4943, DOI 10.1210/en.2005-0476; Lafferty MJ, 2013, J BIOL CHEM, V288, P28524, DOI 10.1074/jbc.M113.497602; Lee EC, 2009, J BIOL CHEM, V284, P13735, DOI 10.1074/jbc.M807899200; Li Y, 2014, ATHEROSCLEROSIS, V237, P597, DOI 10.1016/j.atherosclerosis.2014.10.016; Li YC, 2014, J DRUG TARGET, V22, P679, DOI 10.3109/1061186X.2014.928715; Lichtenstein L, 2007, ARTERIOSCL THROM VAS, V27, P2420, DOI 10.1161/ATVBAHA.107.151894; Lichtenstein L, 2010, CELL METAB, V12, P580, DOI 10.1016/j.cmet.2010.11.002; Mead JR, 2002, J MOL MED, V80, P753, DOI 10.1007/s00109-002-0384-9; Miida T, 2010, CURR OPIN LIPIDOL, V21, P70, DOI 10.1097/MOL.0b013e328333269e; Myocardial IG, 2016, NEW ENGL J MED, V374, P1134, DOI DOI 10.1056/NEJM0A1507652; Mysling S, 2016, ELIFE, V5, DOI 10.7554/eLife.20958; Mysling S, 2016, ELIFE, V5, DOI 10.7554/eLife.12095; NEVILLE MC, 1991, J LIPID RES, V32, P251; Nilsson SK, 2012, BBA-MOL CELL BIOL L, V1821, P1370, DOI 10.1016/j.bbalip.2012.06.003; Noto D, 2017, ACTA DIABETOL, V54, P111, DOI 10.1007/s00592-016-0931-4; Oganesyan I, 2018, METHODS, V144, P27, DOI 10.1016/j.ymeth.2018.04.023; Peng J, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0625-0; Rader DJ, 2016, CELL METAB, V23, P405, DOI 10.1016/j.cmet.2016.01.005; Reimund M, 2017, J LIPID RES, V58, P279, DOI 10.1194/jlr.D071787; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Sandoval JC, 2010, J ATHEROSCLER THROMB, V17, P914, DOI 10.5551/jat.4929; SANTAMARINAFOJO S, 1994, INT J CLIN LAB RES, V24, P143, DOI 10.1007/BF02592444; Segel I., 1993, ENZYME KINETICS BEHA, P125; Shan L, 2009, J BIOL CHEM, V284, P1419, DOI 10.1074/jbc.M808477200; Sniderman AD, 2018, J LIPID RES, V59, P1266, DOI 10.1194/jlr.R082271; Stitziel NO, 2017, J AM COLL CARDIOL, V69, P2054, DOI 10.1016/j.jacc.2017.02.030; Sukonina V, 2006, P NATL ACAD SCI USA, V103, P17450, DOI 10.1073/pnas.0604026103; Tenenbaum A, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0159-y; Vadas O, 2017, METHOD ENZYMOL, V583, P143, DOI 10.1016/bs.mie.2016.09.008; Wu MJ, 2018, J LIPID RES, V59, P2456, DOI 10.1194/jlr.D086793; Yau MH, 2009, J BIOL CHEM, V284, P11942, DOI 10.1074/jbc.M809802200; Yin W, 2009, J BIOL CHEM, V284, P13213, DOI 10.1074/jbc.M900553200; Yuan G, 2007, CAN MED ASSOC J, V176, P1113, DOI 10.1503/cmaj.060963; Zhang R, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.150272; Zhu PC, 2012, BIOSCIENCE REP, V32, P211, DOI 10.1042/BSR20110102	60	25	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2678	2689		10.1074/jbc.RA118.005932	http://dx.doi.org/10.1074/jbc.RA118.005932			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30591589	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000459601600010
J	Tian, MY; Zeng, TL; Liu, MD; Han, S; Lin, HY; Lin, Q; Li, L; Jiang, TT; Li, G; Lin, H; Zhang, T; Kang, QF; Deng, XM; Wang, HR				Tian, Maoyuan; Zeng, Taoling; Liu, Mingdong; Han, Shang; Lin, Huayue; Lin, Qi; Li, Li; Jiang, Tingting; Li, Gao; Lin, Hong; Zhang, Ting; Kang, Qiaofeng; Deng, Xianming; Wang, Hong-Rui			A cell-based high-throughput screening method based on a ubiquitin-reference technique for identifying modulators of E3 ligases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						high-throughput screening (HTS); E3 ubiquitin ligase; ubiquitylation (ubiquitination); inhibitor; cellular regulation; protein degradation; epithelial-mesenchymal transition (EMT); auto-ubiquitination; chemical screen; HECT domain; SMAD ubiquitin regulatory factor 1 (SMURF1); ubiquitin-reference technique (URT)	TGF-BETA; PROTEASOME INHIBITORS; PROTEIN; SMURF2; DEGRADATION; RECEPTOR; POLARITY; PATHWAY; TARGETS; CANCER	Accumulating evidence indicates that a wide range of E3 ubiquitin ligases are involved in the development of many human diseases. Searching for small-molecule modulators of these E3 ubiquitin ligases is emerging as a promising drug discovery strategy. Here, we report the development of a cell-based high-throughput screening method to identify modulators of E3 ubiquitin ligases by integrating the ubiquitin-reference technique (URT), based on a fusion protein of ubiquitin located between a protein of interest and a reference protein moiety, with a Dual-Luciferase system. Using this method, we screened for small-molecule modulators of SMAD ubiquitin regulatory factor 1 (SMURF1), which belongs to the NEDD4 family of E3 ubiquitin ligases and is an attractive therapeutic target because of its roles in tumorigenesis. Using RAS homolog family member B (RHOB) as a SMURF1 substrate in this screen, we identified a potent SMURF1 inhibitor and confirmed that it also blocks SMURF1-dependent degradation of SMAD family member 1 (SMAD1) and RHOA. An in vitro auto-ubiquitination assay indicated that this compound inhibits both SMURF1 and SMURF2 activities, indicating that it may be an antagonist of the catalytic activity of the HECT domain in SMURF1/2. Moreover, cell functional assays revealed that this compound effectively inhibits protrusive activity in HEK293T cells and blocks transforming growth factor beta (TGF beta)-induced epithelial-mesenchymal transition (EMT) in MDCK cells, similar to the effects on these processes caused by SMURF1 loss. In summary, the screening approach presented here may have great practical potential for identifying modulators of E3 ubiquitin ligases.	[Tian, Maoyuan; Zeng, Taoling; Liu, Mingdong; Han, Shang; Lin, Huayue; Lin, Qi; Li, Li; Jiang, Tingting; Li, Gao; Lin, Hong; Zhang, Ting; Kang, Qiaofeng; Deng, Xianming; Wang, Hong-Rui] Xiamen Univ, Sch Life Sci, Innovat Ctr Cell Biol, State Key Lab Cellular Stress Biol, Xiamen 361102, Fujian, Peoples R China	Xiamen University	Deng, XM; Wang, HR (corresponding author), Xiamen Univ, Sch Life Sci, Xiamen 361102, Fujian, Peoples R China.	xmdeng@xmu.edu.cn; wanghr@xmu.edu.cn	LIN, QI/HDO-8145-2022	Deng, Xianming/0000-0002-9354-5864; Li, Li/0000-0002-7720-6731; Wang, Hong-Rui/0000-0002-2916-8849	National Natural Science Foundation of China [U1605222, 81472459, 31070771, 31601132, U1405223]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China U1605222, 81472459, and 31070771 (to H.-R. W.); 31601132 (to T. Z.); and U1405223 (to X. D.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams J, 2004, CANCER INVEST, V22, P304, DOI 10.1081/CNV-120030218; BACHMAIR A, 1989, CELL, V56, P1019, DOI 10.1016/0092-8674(89)90635-1; Cao Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep04965; David D, 2013, BBA-REV CANCER, V1835, P119, DOI 10.1016/j.bbcan.2012.11.003; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Foote Peter K, 2017, Curr Protoc Chem Biol, V9, P174, DOI 10.1002/cpch.24; Gandolfi S, 2017, CANCER METAST REV, V36, P561, DOI 10.1007/s10555-017-9707-8; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hoodless PA, 1996, CELL, V85, P489, DOI 10.1016/S0092-8674(00)81250-7; Karlsson R, 2009, BBA-REV CANCER, V1796, P91, DOI 10.1016/j.bbcan.2009.03.003; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Levy F, 1996, P NATL ACAD SCI USA, V93, P4907, DOI 10.1073/pnas.93.10.4907; Lin X, 2000, J BIOL CHEM, V275, P36818, DOI 10.1074/jbc.C000580200; Mani A, 2005, J CLIN ONCOL, V23, P4776, DOI 10.1200/JCO.2005.05.081; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Murakami G, 2003, MOL BIOL CELL, V14, P2809, DOI 10.1091/mbc.E02-07-0441; Ogunjimi AA, 2005, MOL CELL, V19, P297, DOI 10.1016/j.molcel.2005.06.028; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Roeten MSF, 2018, CANCER CHEMOTH PHARM, V81, P227, DOI 10.1007/s00280-017-3489-0; Salvat C, 2004, J BIOL CHEM, V279, P18935, DOI 10.1074/jbc.M312201200; Senft D, 2018, NAT REV CANCER, V18, P69, DOI 10.1038/nrc.2017.105; Tasaki T, 2005, MOL CELL BIOL, V25, P7120, DOI 10.1128/MCB.25.16.7120-7136.2005; Varshavsky A, 2005, TRENDS BIOCHEM SCI, V30, P283, DOI 10.1016/j.tibs.2005.04.005; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Varshavsky A, 2005, METHOD ENZYMOL, V399, P777, DOI 10.1016/S0076-6879(05)99051-4; Varshavsky A, 2017, ANNU REV BIOCHEM, V86, P123, DOI 10.1146/annurev-biochem-061516-044859; Wang D, 2017, CANCER METAST REV, V36, P683, DOI 10.1007/s10555-017-9703-z; Wang HR, 2006, METHOD ENZYMOL, V406, P437, DOI 10.1016/S0076-6879(06)06032-0; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Wang ML, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5901; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Yi S, 2005, METHOD ENZYMOL, V399, P654, DOI 10.1016/S0076-6879(05)99043-5; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang Y, 2001, P NATL ACAD SCI USA, V98, P974, DOI 10.1073/pnas.98.3.974; Zhang Y, 2017, ONCOTARGET, V8, P50521, DOI 10.18632/oncotarget.10648; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293; Zou X, 2015, BBA-REV CANCER, V1856, P91, DOI 10.1016/j.bbcan.2015.06.005	39	19	20	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2880	2891		10.1074/jbc.RA118.003822	http://dx.doi.org/10.1074/jbc.RA118.003822			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30587574	Green Published, hybrid			2022-12-28	WOS:000459601600025
J	Windgassen, TA; Leroux, M; Sandler, SJ; Keck, JL				Windgassen, Tricia A.; Leroux, Maxime; Sandler, Steven J.; Keck, James L.			Function of a strand-separation pin element in the PriA DNA replication restart helicase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA helicase; DNA repair; DNA replication; DNA-protein interaction; DNA damage response; protein complex; protein cross-linking; DNA replication restart; DNA strand-separation mechanisms; PriA; primosome assembly; strand-separation pin	ESCHERICHIA-COLI K-12; PHI X174-TYPE PRIMOSOME; CRYSTAL-STRUCTURE; STRUCTURAL MECHANISMS; COMPLEX-FORMATION; HIGH-THROUGHPUT; LAGGING-STRAND; SOS EXPRESSION; PROTEIN PRIA; NUCLEIC-ACID	DNA helicases are motor proteins that couple the chemical energy of nucleoside triphosphate hydrolysis to the mechanical functions required for DNA unwinding. Studies of several helicases have identified strand-separating "pin" structures that are positioned to intercept incoming dsDNA and promote strand separation during helicase translocation. However, pin structures vary among helicases and it remains unclear whether they confer a conserved unwinding mechanism. Here, we tested the biochemical and cellular roles of a putative pin element within the Escherichia coli PriA DNA helicase. PriA orchestrates replication restart in bacteria by unwinding the lagging-strand arm of abandoned DNA replication forks and reloading the replicative helicase with the help of protein partners that combine with PriA to form what is referred to as a primosome complex. Using in vitro protein-DNA cross-linking, we localized the putative pin (a beta-hairpin within a zinc-binding domain in PriA) near the ssDNA-dsDNA junction of the lagging strand in a PriA-DNA replication fork complex. Removal of residues at the tip of the beta-hairpin eliminated PriA DNA unwinding, interaction with the primosome protein PriB, and cellular function. We isolated a spontaneous intragenic suppressor mutant of the priA beta-hairpin deletion mutant in which 22 codons around the deletion site were duplicated. This suppressor variant and an Ala-substituted beta-hairpin PriA variant displayed wildtype levels of DNA unwinding and PriB binding in vitro. These results suggest essential but sequence nonspecific roles for the PriA pin element and coupling of PriA DNA unwinding to its interaction with PriB.	[Windgassen, Tricia A.; Keck, James L.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, Madison, WI 53706 USA; [Leroux, Maxime; Sandler, Steven J.] Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA	University of Wisconsin System; University of Wisconsin Madison; University of Massachusetts System; University of Massachusetts Amherst	Keck, JL (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, Madison, WI 53706 USA.	jlkeck@wisc.edu		Keck, James/0000-0002-5961-0220	National Science Foundation [DGE-1256259]; National Institutes of Health [GM098885]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098885] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation Graduate Research Fellowship Grant DGE-1256259 (to T. A. W.) and National Institutes of Health Grant GM098885 (to J. L. K. and S. J. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aarattuthodiyil S, 2014, NUCLEIC ACIDS RES, V42, P11707, DOI 10.1093/nar/gku845; Bhattacharyya B, 2014, PROTEIN SCI, V23, P1498, DOI 10.1002/pro.2533; Bhattacharyya B, 2014, P NATL ACAD SCI USA, V111, P1373, DOI 10.1073/pnas.1318001111; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; Bleichert F, 2017, SCIENCE, V355, DOI 10.1126/science.aah6317; Buttner K, 2007, NAT STRUCT MOL BIOL, V14, P647, DOI 10.1038/nsmb1246; BUJALOWSKI W, 1995, BIOCHEMISTRY-US, V34, P8513, DOI 10.1021/bi00027a001; Cadman CJ, 2005, J BIOL CHEM, V280, P39693, DOI 10.1074/jbc.M508521200; Cadman CJ, 2004, NUCLEIC ACIDS RES, V32, P6378, DOI 10.1093/nar/gkh980; Chen HW, 2004, J BIOL CHEM, V279, P38503, DOI 10.1074/jbc.M404769200; Chin JW, 2002, CHEMBIOCHEM, V3, P1135, DOI 10.1002/1439-7633(20021104)3:11<1135::AID-CBIC1135>3.0.CO;2-M; Cox MM, 2001, ANNU REV GENET, V35, P53, DOI 10.1146/annurev.genet.35.102401.090016; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dillingham MS, 2001, P NATL ACAD SCI USA, V98, P8381, DOI 10.1073/pnas.131009598; Eoff RL, 2005, BIOCHEM SOC T, V33, P1474, DOI 10.1042/BST0331474; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Flores MJ, 2002, MOL MICROBIOL, V44, P783, DOI 10.1046/j.1365-2958.2002.02913.x; Forne I, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.012088; Fujiyama S, 2014, FEBS J, V281, P5356, DOI 10.1111/febs.13080; Fujiyama S, 2014, BBA-PROTEINS PROTEOM, V1844, P299, DOI 10.1016/j.bbapap.2013.10.015; GALARDY RE, 1973, NATURE-NEW BIOL, V242, P127, DOI 10.1038/newbio242127a0; George NP, 2012, J BIOL CHEM, V287, P22123, DOI 10.1074/jbc.M112.367573; Heller RC, 2005, MOL CELL, V17, P733, DOI 10.1016/j.molcel.2005.01.019; Heller RC, 2005, J BIOL CHEM, V280, P34143, DOI 10.1074/jbc.M507224200; Helmrich A, 2013, NAT STRUCT MOL BIOL, V20, P412, DOI 10.1038/nsmb.2543; Huang CY, 2006, NUCLEIC ACIDS RES, V34, P3878, DOI 10.1093/nar/gkl536; Huang YH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/195162; Huang YH, 2013, GENES CELLS, V18, P1007, DOI 10.1111/gtc.12095; Huang YH, 2012, GENES CELLS, V17, P837, DOI 10.1111/gtc.12001; Jones JM, 2001, J MOL BIOL, V312, P935, DOI 10.1006/jmbi.2001.4930; Jones JM, 1999, J MOL BIOL, V289, P503, DOI 10.1006/jmbi.1999.2783; Kitano K, 2010, STRUCTURE, V18, P177, DOI 10.1016/j.str.2009.12.011; Kogoma T, 1996, J BACTERIOL, V178, P1258, DOI 10.1128/jb.178.5.1258-1264.1996; Lam AMI, 2003, J BIOL CHEM, V278, P44514, DOI 10.1074/jbc.M306444200; LEE EH, 1991, P NATL ACAD SCI USA, V88, P3029, DOI 10.1073/pnas.88.8.3029; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; Liu J, 1996, J BIOL CHEM, V271, P15656, DOI 10.1074/jbc.271.26.15656; Liu Z, 2014, NUCLEIC ACIDS RES, V42, P9470, DOI 10.1093/nar/gku633; Lopper M, 2004, STRUCTURE, V12, P1967, DOI 10.1016/j.str.2004.09.004; Lopper M, 2007, MOL CELL, V26, P781, DOI 10.1016/j.molcel.2007.05.012; Lu YB, 1996, P NATL ACAD SCI USA, V93, P12902, DOI 10.1073/pnas.93.23.12902; Mangiameli SM, 2017, ELIFE, V6, DOI 10.7554/eLife.19848; Manthei KA, 2015, P NATL ACAD SCI USA, V112, P4292, DOI 10.1073/pnas.1416746112; Marceau AH, 2011, EMBO J, V30, P4236, DOI 10.1038/emboj.2011.305; Masai H, 1999, BIOCHIMIE, V81, P847, DOI 10.1016/S0300-9084(99)00211-4; Massoni SC, 2013, DNA REPAIR, V12, P1072, DOI 10.1016/j.dnarep.2013.09.003; McCool JD, 2004, MOL MICROBIOL, V53, P1343, DOI 10.1111/j.1365-2958.2004.04225.x; McCool JD, 2001, P NATL ACAD SCI USA, V98, P8203, DOI 10.1073/pnas.121007698; Michel B, 2018, MICROBIOL MOL BIOL R, V82, DOI 10.1128/MMBR.00013-18; Michel B, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00102-17; Mizukoshi T, 2003, J BIOL CHEM, V278, P42234, DOI 10.1074/jbc.C300285200; Ng JY, 1996, J BIOL CHEM, V271, P15642, DOI 10.1074/jbc.271.26.15642; NURSE P, 1991, J BACTERIOL, V173, P6686, DOI 10.1128/jb.173.21.6686-6693.1991; Paintdakhi A, 2016, MOL MICROBIOL, V99, P767, DOI 10.1111/mmi.13264; Pike ACW, 2015, P NATL ACAD SCI USA, V112, P4286, DOI 10.1073/pnas.1417594112; Pike ACW, 2009, P NATL ACAD SCI USA, V106, P1039, DOI 10.1073/pnas.0806908106; Ryu YH, 2006, NAT METHODS, V3, P263, DOI 10.1038/NMETH864; Sandler SJ, 2000, GENETICS, V155, P487; Sandler SJ, 1999, MOL MICROBIOL, V34, P91, DOI 10.1046/j.1365-2958.1999.01576.x; Sandler SJ, 1996, GENETICS, V143, P5; Sandler SJ, 2001, MOL MICROBIOL, V41, P697, DOI 10.1046/j.1365-2958.2001.02547.x; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Sliusarenko O, 2011, MOL MICROBIOL, V80, P612, DOI 10.1111/j.1365-2958.2011.07579.x; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Stylianidou S, 2016, MOL MICROBIOL, V102, P690, DOI 10.1111/mmi.13486; Swan MK, 2014, ACTA CRYSTALLOGR D, V70, P1465, DOI 10.1107/S139900471400501X; Szymanski MR, 2010, J MOL BIOL, V402, P344, DOI 10.1016/j.jmb.2010.07.008; Szymanski MR, 2010, J MOL BIOL, V398, P8, DOI 10.1016/j.jmb.2010.02.009; Szymanski MR, 2010, J BIOL CHEM, V285, P9683, DOI 10.1074/jbc.M109.094789; Tanaka T, 2003, GENES CELLS, V8, P251, DOI 10.1046/j.1365-2443.2003.00630.x; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; von Hippel PH, 2004, NAT STRUCT MOL BIOL, V11, P494, DOI 10.1038/nsmb0604-494; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; WILLETTS NS, 1969, J BACTERIOL, V97, P244, DOI 10.1128/JB.97.1.244-249.1969; Windgassen TA, 2018, P NATL ACAD SCI USA, V115, pE9075, DOI 10.1073/pnas.1809842115; Windgassen TA, 2018, NUCLEIC ACIDS RES, V46, P504, DOI 10.1093/nar/gkx1203; Windgassen TA, 2016, NUCLEIC ACIDS RES, V44, P9745, DOI 10.1093/nar/gkw690; Winkelman JT, 2015, MOL CELL, V59, P768, DOI 10.1016/j.molcel.2015.06.037; ZAVITZ KH, 1993, J BIOL CHEM, V268, P4337	81	15	15	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2801	2814		10.1074/jbc.RA118.006870	http://dx.doi.org/10.1074/jbc.RA118.006870			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30593500	Green Published, hybrid			2022-12-28	WOS:000459601600019
J	Ogawa, S; Matsuoka, Y; Takada, M; Matsui, K; Yamane, F; Kubota, E; Yasuhara, S; Hieda, K; Kanayama, N; Hatano, N; Tokumitsu, H; Magari, M				Ogawa, Sayaka; Matsuoka, Yukiko; Takada, Miho; Matsui, Kazue; Yamane, Fumihiro; Kubota, Eri; Yasuhara, Shiori; Hieda, Kentaro; Kanayama, Naoki; Hatano, Naoya; Tokumitsu, Hiroshi; Magari, Masaki			Interleukin 34 (IL-34) cell-surface localization regulated by the molecular chaperone 78-kDa glucose-regulated protein facilitates the differentiation of monocytic cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						monocyte; cell differentiation; interleukin; cytokine; chaperone; GRP78; cell surface protein; plasma membrane; CRISPR/Cas; Western blot; colony-stimulating factor-1 receptor; follicular dendritic cell; interleukin 34	LYMPHOTOXIN BETA-RECEPTOR; ENDOPLASMIC-RETICULUM CHAPERONE; FOLLICULAR DENDRITIC CELLS; LANGERHANS CELLS; GERMINAL-CENTERS; GRP78; EXPRESSION; CSF-1; MACROPHAGES; NETWORKS	Interleukin 34 (IL-34) constitutes a cytokine that shares a common receptor, colony-stimulating factor-1 receptor (CSF-1R), with CSF-1. We recently identified a novel type of monocytic cell termed follicular dendritic cell-induced monocytic cells (FDMCs), whose differentiation depended on CSF-1R signaling through the IL-34 produced from a follicular dendritic cell line, FL-Y. Here, we report the functional mechanisms of the IL-34-mediated CSF-1R signaling underlying FDMC differentiation. CRIPSR/Cas9-mediated knockout of the Il34 gene confirmed that the ability of FL-Y cells to induce FDMCs completely depends on the IL-34 expressed by FL-Y cells. Transwell culture experiments revealed that FDMC differentiation requires a signal from a membrane-anchored form of IL-34 on the FL-Y cell surface, but not from a secreted form, in a direct interaction between FDMC precursor cells and FL-Y cells. Furthermore, flow cytometric analysis using an anti-IL-34 antibody indicated that IL-34 was also expressed on the FL-Y cell surface. Thus, we explored proteins interacting with IL-34 in FL-Y cells. Mass spectrometry analysis and pulldown assay identified that IL-34 was associated with the molecular chaperone 78-kDa glucose-regulated protein (GRP78) in the plasma membrane fraction of FL-Y cells. Consistent with this finding, GRP78-heterozygous FL-Y cells expressed a lower level of IL-34 protein on their cell surface and exhibited a reduced competency to induce FDMC differentiation compared with the original FL-Y cells. These results indicated a novel GRP78-dependent localization and specific function of IL-34 in FL-Y cells related to monocytic cell differentiation.	[Ogawa, Sayaka; Matsuoka, Yukiko; Takada, Miho; Matsui, Kazue; Yamane, Fumihiro; Yasuhara, Shiori; Hieda, Kentaro; Kanayama, Naoki; Tokumitsu, Hiroshi; Magari, Masaki] Okayama Univ, Grad Sch Nat Sci & Technol, Div Med Bioengn, Kita Ku, Okayama 7008530, Japan; [Kubota, Eri] Okayama Univ, Fac Engn, Dept Appl Chem & Biotechnol, Kita Ku, Okayama 7008530, Japan; [Kanayama, Naoki; Hatano, Naoya; Tokumitsu, Hiroshi; Magari, Masaki] Okayama Univ, Grad Sch Interdisciplinary Sci & Engn Hlth Syst, Lab Appl Cell Biol, Kita Ku, Tsushima Naka 3-1-1, Okayama 7008530, Japan	Okayama University; Okayama University; Okayama University	Magari, M (corresponding author), Okayama Univ, Grad Sch Interdisciplinary Sci & Engn Hlth Syst, Lab Appl Cell Biol, Kita Ku, Tsushima Naka 3-1-1, Okayama 7008530, Japan.	magari@cc.okayama-u.ac.jp	MAGARI, Masaki/B-2555-2011; Kanayama, Naoki/G-1518-2010; Tokumitsu, Hiroshi/M-3978-2015	Kanayama, Naoki/0000-0003-1778-2005; Tokumitsu, Hiroshi/0000-0002-2193-6794; Magari, Masaki/0000-0002-4624-0160	Ministry of Education, Culture, Sports, Science, and Technology of Japan [25460590]; Ryobi Teien Foundation; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ryobi Teien Foundation(Ryobi Teien Memory Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by Grant-in-aid for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan 25460590 and funds from the Ryobi Teien Foundation and the Takeda Science Foundation (to M. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Allen CDC, 2008, SEMIN IMMUNOL, V20, P14, DOI 10.1016/j.smim.2007.12.001; Arakawa H, 2001, BMC Biotechnol, V1, P7, DOI 10.1186/1472-6750-1-7; Arap MA, 2004, CANCER CELL, V6, P275, DOI 10.1016/j.ccr.2004.08.018; Aungier SR, 2015, IMMUNOLOGY, V144, P34, DOI 10.1111/imm.12342; Boulakirba S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18433-4; Chihara T, 2010, CELL DEATH DIFFER, V17, P1917, DOI 10.1038/cdd.2010.60; Chihara T, 2012, J IMMUNOL, V188, P3620, DOI 10.4049/jimmunol.1101593; Ciccia F, 2013, RHEUMATOLOGY, V52, P1009, DOI 10.1093/rheumatology/kes435; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; Endres R, 1999, J EXP MED, V189, P159, DOI 10.1084/jem.189.1.159; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Ginhoux F, 2006, NAT IMMUNOL, V7, P265, DOI 10.1038/ni1307; Gonzalez-Gronow M, 2009, ANTIOXID REDOX SIGN, V11, P2299, DOI [10.1089/ars.2009.2568, 10.1089/ARS.2009.2568]; Greter M, 2012, IMMUNITY, V37, P1050, DOI 10.1016/j.immuni.2012.11.001; Hamilton JA, 2013, TRENDS IMMUNOL, V34, P81, DOI 10.1016/j.it.2012.08.006; Hatano N, 2008, J PROTEOME RES, V7, P809, DOI 10.1021/pr700566d; Hume DA, 2008, J IMMUNOL, V181, P5829, DOI 10.4049/jimmunol.181.9.5829; Hwang SJ, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3693; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Knowlton ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013587; Kosco-Vilbois MH, 2003, NAT REV IMMUNOL, V3, P764, DOI 10.1038/nri1179; Lin HS, 2008, SCIENCE, V320, P807, DOI 10.1126/science.1154370; Liu M, 2009, TRENDS IMMUNOL, V30, P173, DOI 10.1016/j.it.2009.01.007; Ma XL, 2012, STRUCTURE, V20, P676, DOI 10.1016/j.str.2012.02.010; Mackay F, 1998, NATURE, V395, P26, DOI 10.1038/25630; Magari M, 2011, J IMMUNOL, V187, P4210, DOI 10.4049/jimmunol.1100934; Miao YR, 2013, CLIN CANCER RES, V19, P2107, DOI 10.1158/1078-0432.CCR-12-2991; Miharada K, 2011, CELL STEM CELL, V9, P330, DOI 10.1016/j.stem.2011.07.016; Misra UK, 2006, J BIOL CHEM, V281, P13694, DOI 10.1074/jbc.M511694200; Misra UK, 2005, J BIOL CHEM, V280, P26278, DOI 10.1074/jbc.M414467200; Misra UK, 2004, CELL SIGNAL, V16, P929, DOI 10.1016/j.cellsig.2004.01.003; Nain M, 2017, J VIROL, V91, DOI [10.1128/jvi.02274-16, 10.1128/JVI.02274-16]; NAKOINZ I, 1990, J IMMUNOL, V145, P860; Nandi S, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M112.442731; Ni M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006868; Nishikawa Y, 2006, J IMMUNOL, V177, P5204, DOI 10.4049/jimmunol.177.8.5204; Oida T, 2010, J IMMUNOL, V185, P3529, DOI 10.4049/jimmunol.0904121; Park CS, 2005, IMMUNOLOGY, V114, P2, DOI 10.1111/j.1365-2567.2004.02075.x; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Reddy RK, 2003, J BIOL CHEM, V278, P20915, DOI 10.1074/jbc.M212328200; Segaliny AI, 2015, BBA-MOL CELL RES, V1853, P1010, DOI 10.1016/j.bbamcr.2015.01.023; Shani G, 2008, MOL CELL BIOL, V28, P666, DOI 10.1128/MCB.01716-07; Skerra A, 2000, METHOD ENZYMOL, V326, P271; Sun FC, 2006, BIOCHEM J, V396, P31, DOI 10.1042/BJ20051916; Tokumitsu H, 2001, BIOCHEMISTRY-US, V40, P13925, DOI 10.1021/bi010863k; Tokumitsu H, 2011, BIOCHEMISTRY-US, V50, P8193, DOI 10.1021/bi201005g; Triantafilou K, 2002, J VIROL, V76, P633, DOI 10.1128/JVI.76.2.633-643.2002; Tsai YL, 2018, P NATL ACAD SCI USA, V115, pE4245, DOI 10.1073/pnas.1714866115; Vinuesa CG, 2009, NAT REV IMMUNOL, V9, P845, DOI 10.1038/nri2637; Wang HX, 2017, MOLECULES, V22, DOI 10.3390/molecules22010035; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360; Wei SW, 2010, J LEUKOCYTE BIOL, V88, P495, DOI 10.1189/jlb.1209822; WITMERPACK MD, 1993, J CELL SCI, V104, P1021; Yamane F, 2014, J LEUKOCYTE BIOL, V95, P19, DOI 10.1189/jlb.0613311; Yu WF, 2008, J LEUKOCYTE BIOL, V84, P852, DOI 10.1189/jlb.0308171; Zhang MH, 2004, NAT IMMUNOL, V5, P1124, DOI 10.1038/ni1130; Zhang TT, 2017, ELIFE, V6, DOI 10.7554/eLife.19552; Zhang Y, 2010, J BIOL CHEM, V285, P15065, DOI 10.1074/jbc.M109.087445; Zhou RP, 2016, IMMUNOLOGY, V149, P362, DOI 10.1111/imm.12660	61	7	7	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2019	294	7					2386	2396		10.1074/jbc.RA118.006226	http://dx.doi.org/10.1074/jbc.RA118.006226			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL7CN	30573681	Green Published, hybrid			2022-12-28	WOS:000458895400016
J	Opitz, C; Ahrne, E; Goldie, KN; Schmidt, A; Grzesiek, S				Opitz, Christian; Ahrne, Erik; Goldie, Kenneth N.; Schmidt, Alexander; Grzesiek, Stephan			Deuterium induces a distinctive Escherichia coli proteome that correlates with the reduction in growth rate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						isotope effect; cell growth; hydrogen-deuterium exchange; protein stability; enzyme kinetics; proteomics; clusters of orthologous groups database; deuteration; gene ontology database; isotope labeling; kinetic isotope effect; biomolecular stability; minimal medium	OXIDE HEAVY-WATER; HYDROGEN-BONDS; ELECTRON-TRANSFER; GENE ONTOLOGY; PTK2 CELLS; ISOTOPE; D2O; H2O; DENATURATION; IDENTIFICATION	Substitution of protium (H) for deuterium (D) strongly affects biological systems. Whereas higher eukaryotes such as plants and mammals hardly survive a deuterium content of >30%, many microorganisms can grow on fully deuterated media, albeit at reduced rates. Very little is known about how the H/D replacement influences life at the systems level. Here, we used MS-based analysis to follow the adaptation of a large part of the Escherichia coli proteome from growth on a protonated full medium, over a protonated minimal medium, to a completely deuterated minimal medium. We could quantify >1800 proteins under all conditions, several 100 of which exhibited strong regulation during both adaptation processes. The adaptation to minimal medium strongly up-regulated amino acid synthesis and sugar metabolism and down-regulated translational proteins on average by 9%, concomitant with a reduction in growth rate from 1.8 to 0.67 h(-1). In contrast, deuteration caused a very wide proteomic response over many cell functional categories, together with an additional down-regulation of the translational proteins by 5%. The latter coincided with a further reduction in growth rate to 0.37 h(-1), revealing a clear linear correlation between growth rate and abundance of translational proteins. No significant morphological effects are observed under light and electron microscopies. Across all protein categories, about 80% of the proteins up-regulated under deuteration are enzymes with hydrogen transfer functions. Thus, the H/D kinetic isotope effect appears as the major limiting factor of cellular functions under deuteration.	[Opitz, Christian; Ahrne, Erik; Schmidt, Alexander; Grzesiek, Stephan] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Goldie, Kenneth N.] Univ Basel, Biozentrum, Ctr Cellular Imaging & Nanoanalyt, CH-4058 Basel, Switzerland	University of Basel; University of Basel	Grzesiek, S (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.	Stephan.Grzesiek@unibas.ch		Grzesiek, Stephan/0000-0003-1998-4225	Swiss National Science Foundation [31-149927, 31-173089]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation Grants 31-149927 and 31-173089 (to S. G.). The authors declare that they have no conflicts of interest with the contents of this article.	ANTONINO LC, 1991, P NATL ACAD SCI USA, V88, P7715, DOI 10.1073/pnas.88.17.7715; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beranova L, 2012, PHYS CHEM CHEM PHYS, V14, P14516, DOI 10.1039/c2cp41275f; Brooks SC, 1937, SCIENCE, V86, P497, DOI 10.1126/science.86.2239.497; Carbon S, 2017, NUCLEIC ACIDS RES, V45, pD331, DOI 10.1093/nar/gkw1108; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; CHANCE HL, 1946, J BACTERIOL, V51, P547, DOI 10.1128/JB.51.4.547-551.1946; Chellgren BW, 2004, J AM CHEM SOC, V126, P14734, DOI 10.1021/ja045425q; Cho Y, 2009, J AM CHEM SOC, V131, P15188, DOI 10.1021/ja9040785; CUPANE A, 1980, NUCLEIC ACIDS RES, V8, P4283, DOI 10.1093/nar/8.18.4283; Daegelen P, 2009, J MOL BIOL, V394, P634, DOI 10.1016/j.jmb.2009.09.022; Dassain M, 1999, BIOCHIMIE, V81, P889, DOI 10.1016/S0300-9084(99)00207-2; Evans BR, 2015, METHOD ENZYMOL, V565, P213, DOI 10.1016/bs.mie.2015.07.014; Farver O, 2001, P NATL ACAD SCI USA, V98, P4426, DOI 10.1073/pnas.071043798; FLAUMENHAFT E., 1965, INT REV CYTOL, V18, P313, DOI 10.1016/S0074-7696(08)60557-4; Glatter T, 2012, J PROTEOME RES, V11, P5145, DOI 10.1021/pr300273g; GROSS PR, 1960, SCIENCE, V131, P37, DOI 10.1126/science.131.3392.37; GUARDFRIAR D, 1985, J PHYS CHEM-US, V89, P1810, DOI 10.1021/j100255a054; Guzzi R, 1998, J PHYS CHEM B, V102, P1021, DOI 10.1021/jp9724380; HATTORI A, 1965, BIOCHEMISTRY-US, V4, P1213, DOI 10.1021/bi00883a002; Haynes W.M., 2009, CRC HDB CHEM PHYS; Hochuli M, 2000, J BIOMOL NMR, V17, P33, DOI 10.1023/A:1008329124672; Hohlefelder LS, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/592745; Huyghues-Despointes BMP, 1999, NAT STRUCT BIOL, V6, P910; IZZO V, 1975, NUCLEIC ACIDS RES, V2, P1805, DOI 10.1093/nar/2.10.1805; Jackson DW, 2002, J BACTERIOL, V184, P3406, DOI 10.1128/JB.184.12.3406-3410.2002; Jaravine VA, 2004, J BIOMOL NMR, V29, P309, DOI 10.1023/B:JNMR.0000032516.87434.35; KATZ JJ, 1966, SCIENCE, V151, P1187, DOI 10.1126/science.151.3715.1187; Knapp MJ, 2002, J AM CHEM SOC, V124, P3865, DOI 10.1021/ja012205t; KNOLL W, 1981, CHEM PHYS LIPIDS, V28, P337, DOI 10.1016/0009-3084(81)90019-0; Krezel A, 2004, J INORG BIOCHEM, V98, P161, DOI 10.1016/j.jinorgbio.2003.10.001; KUCHITSU K, 1962, J CHEM PHYS, V36, P2470, DOI 10.1063/1.1732910; Kuhlman B, 1998, PROTEIN SCI, V7, P2405, DOI 10.1002/pro.5560071118; LAMPRECHT J, 1991, J CELL SCI, V98, P463; LAMPRECHT J, 1989, EUR J CELL BIOL, V50, P360; Layfield JP, 2014, CHEM REV, V114, P3466, DOI 10.1021/cr400400p; Lee J, 2010, J APPL MICROBIOL, V108, P2088, DOI 10.1111/j.1365-2672.2009.04611.x; MAKHATADZE GI, 1995, NAT STRUCT BIOL, V2, P852, DOI 10.1038/nsb1095-852; Mugridge JS, 2010, ANGEW CHEM INT EDIT, V49, P3635, DOI 10.1002/anie.200906569; OLSON ER, 1991, J BACTERIOL, V173, P234, DOI 10.1128/jb.173.1.234-244.1991; Panda D, 2000, BIOCHEMISTRY-US, V39, P5075, DOI 10.1021/bi992217f; PARK SJ, 1994, J BACTERIOL, V176, P5086, DOI 10.1128/jb.176.16.5086-5092.1994; Piszczek G, 2011, ARCH BIOCHEM BIOPHYS, V507, P332, DOI 10.1016/j.abb.2010.12.022; Ranieri A, 2012, LANGMUIR, V28, P15087, DOI 10.1021/la303363h; Schmidt A, 2016, NAT BIOTECHNOL, V34, P104, DOI 10.1038/nbt.3418; SCHROETER D, 1992, EUR J CELL BIOL, V58, P365; Scott M, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145379; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Sommer C, 2011, I S BIOMED IMAGING, P230, DOI 10.1109/ISBI.2011.5872394; STEINER T, 1994, ACTA CRYSTALLOGR B, V50, P348, DOI 10.1107/S0108768193011966; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; UBBELOHDE AR, 1955, ACTA CRYSTALLOGR, V8, P71, DOI 10.1107/S0365110X55000340; UNNO K, 1988, CHEM PHARM BULL, V36, P1828; Urey HC, 1932, PHYS REV, V39, P164, DOI 10.1103/PhysRev.39.164; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; WESTHEIMER FH, 1961, CHEM REV, V61, P265, DOI 10.1021/cr60211a004; Wisniewski JR, 2014, MOL CELL PROTEOMICS, V13, P3497, DOI 10.1074/mcp.M113.037309; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Zhang XS, 2007, J BACTERIOL, V189, P3051, DOI 10.1128/JB.01832-06	60	9	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2019	294	7					2279	2292		10.1074/jbc.RA118.006914	http://dx.doi.org/10.1074/jbc.RA118.006914			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL7CN	30545941	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000458895400007
J	Chen, L; Liu, QH; Tang, Q; Kuang, JY; Li, H; Pu, SY; Wu, T; Yang, XP; Li, R; Zhang, JH; Zhang, ZJ; Huang, Y; Li, YP; Zou, M; Jiang, W; Li, T; Gong, M; Zhang, L; Wang, H; Qu, AJ; Xie, W; He, JH				Chen, Lei; Liu, Qinhui; Tang, Qin; Kuang, Jiangying; Li, Hong; Pu, Shiyun; Wu, Tong; Yang, Xuping; Li, Rui; Zhang, Jinhang; Zhang, Zijing; Huang, Ya; Li, Yanping; Zou, Min; Jiang, Wei; Li, Tao; Gong, Meng; Zhang, Lu; Wang, Hua; Qu, Aijuan; Xie, Wen; He, Jinhan			Hepatocyte-specific Sirt6 deficiency impairs ketogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fatty acid metabolism; liver; liver metabolism; lipogenesis; lipid metabolism; lipid droplet; lipid; metabolic disease; transcription regulation	ACTIVATED RECEPTOR-ALPHA; FATTY-ACID OXIDATION; ELEMENT-BINDING PROTEIN; TRANSCRIPTION FACTOR; HEPATIC STEATOSIS; KETONE-BODIES; CREBH; LIPOLYSIS; FSP27; INFLAMMATION	Sirt6 is an NADH (NAD(+))-dependent deacetylase with a critical role in hepatic lipid metabolism. Ketogenesis is controlled by a signaling network of hepatic lipid metabolism. However, how Sirt6 functions in ketogenesis remains unclear. Here, we demonstrated that Sirt6 functions as a mediator of ketogenesis in response to a fasting and ketogenic diet (KD). The KD-fed hepatocyte-specific Sirt6 deficiency (HKO) mice exhibited impaired ketogenesis, which was due to enhanced Fsp27 (fat-specific induction of protein 27), a protein known to regulate lipid metabolism. In contrast, overexpression of Sirt6 in mouse primary hepatocytes promoted ketogenesis. Mechanistically, Sirt6 repressed Fsp27 beta expression by interacting with Crebh (cAMP response element-binding protein H) and preventing its recruitment to the Fsp27 beta gene promoter. The KD-fed HKO mice also showed exacerbated hepatic steatosis and inflammation. Finally, Fsp27 silencing rescued hypoketonemia and other metabolic phenotypes in KD-fed HKO mice. Our data suggest that the Sirt6-Crebh-Fsp27 axis is pivotal for hepatic lipid metabolism and inflammation. Sirt6 may be a pharmacological target to remedy metabolic diseases.	[Chen, Lei; Tang, Qin; Kuang, Jiangying; Li, Hong; Pu, Shiyun; Wu, Tong; Yang, Xuping; Li, Rui; Zhang, Jinhang; Zhang, Zijing; Huang, Ya; Li, Yanping; Zou, Min; He, Jinhan] Sichuan Univ, West China Hosp, Dept Pharm, Chengdu 610041, Sichuan, Peoples R China; [Chen, Lei; Liu, Qinhui; Tang, Qin; Kuang, Jiangying; Li, Hong; Pu, Shiyun; Wu, Tong; Yang, Xuping; Li, Rui; Zhang, Jinhang; Zhang, Zijing; Huang, Ya; Li, Yanping; He, Jinhan] Sichuan Univ, West China Hosp, Lab Clin Pharm & Adverse Drug React, State Key Lab Biotherapy, Chengdu 610041, Sichuan, Peoples R China; [Jiang, Wei] Sichuan Univ, West China Hosp, Mol Med Res Ctr, Chengdu 610041, Sichuan, Peoples R China; [Li, Tao; Gong, Meng; Zhang, Lu] Sichuan Univ, West China Hosp, West China Washington Mitochondria & Metab Ctr, Chengdu 610041, Sichuan, Peoples R China; [Li, Tao; Gong, Meng; Zhang, Lu] Sichuan Univ, West China Hosp, Lab Anesthesiol, Chengdu 610041, Sichuan, Peoples R China; [Wang, Hua] Anhui Med Univ, Affiliated Hosp 1, Dept Oncol, Hefei 230022, Anhui, Peoples R China; [Qu, Aijuan] Capital Med Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Beijing 100069, Peoples R China; [Xie, Wen] Univ Pittsburgh, Ctr Pharmacogenet, Pittsburgh, PA 15260 USA; [Xie, Wen] Univ Pittsburgh, Dept Pharmaceut Sci, Pittsburgh, PA 15260 USA	Sichuan University; Sichuan University; Sichuan University; Sichuan University; Sichuan University; Anhui Medical University; Capital Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Xie, W (corresponding author), Univ Pittsburgh, Ctr Pharmacogenet, Pittsburgh, PA 15260 USA.; Xie, W (corresponding author), Univ Pittsburgh, Dept Pharmaceut Sci, Pittsburgh, PA 15260 USA.; He, JH (corresponding author), Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu, Sichuan, Peoples R China.; He, JH (corresponding author), Sichuan Univ, West China Hosp, Canc Ctr, Chengdu, Sichuan, Peoples R China.; He, JH (corresponding author), Collaborat Innovat Ctr Biotherapy, Chengdu, Sichuan, Peoples R China.	wex6@pitt.edu; jinhanhe@scu.edu.cn	Gong, Meng/AAQ-9126-2021; li, yan/GTI-4638-2022; Li, Tao/ADA-1377-2022; Xie, Wen/M-1768-2016	Gong, Meng/0000-0002-1203-5820; 	National Natural Science Foundation of China [81471068, 81603035]; Young Scientist Fellowship of Sichuan University [2017SCU11026]; Postdoctoral Fellowship of Sichuan University [2017SCU12036]; China Postdoctoral Fellowship [2017M612981]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Young Scientist Fellowship of Sichuan University; Postdoctoral Fellowship of Sichuan University; China Postdoctoral Fellowship	This work was supported by National Natural Science Foundation of China Grants 81471068 and 81603035, China Postdoctoral Fellowship 2017M612981, Young Scientist Fellowship of Sichuan University 2017SCU11026, and Postdoctoral Fellowship of Sichuan University 2017SCU12036. The authors declare that they have no conflicts of interest with the contents of this article.	Boehm EA, 2001, AM J PHYSIOL-HEART C, V280, pH977, DOI 10.1152/ajpheart.2001.280.3.H977; Cheng SH, 2017, AM J PATHOL, V187, P808, DOI 10.1016/j.ajpath.2016.12.013; Cotter DG, 2014, J CLIN INVEST, V124, P5175, DOI 10.1172/JCI76388; d'Avignon DA, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99762; Elhanati S, 2013, CELL REP, V4, P905, DOI 10.1016/j.celrep.2013.08.006; Flach RJR, 2011, J BIOL CHEM, V286, P22195, DOI 10.1074/jbc.M110.210237; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fukao T, 2014, J INHERIT METAB DIS, V37, P541, DOI 10.1007/s10545-014-9704-9; Grabacka M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122093; Grahn THM, 2014, J BIOL CHEM, V289, P12029, DOI 10.1074/jbc.M113.539890; He JH, 2015, METABOLISM, V64, P826, DOI 10.1016/j.metabol.2015.02.005; Jiang H, 2013, NATURE, V496, P110, DOI 10.1038/nature12038; Ka SO, 2017, FASEB J, V31, P3999, DOI 10.1096/fj.201700098RR; Kanfi Y, 2008, FEBS LETT, V582, P543, DOI [10.1016/j.febslet.2008.01.019, 10.1016/j.febslet.2008.06.005]; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kennedy AR, 2007, AM J PHYSIOL-ENDOC M, V292, pE1724, DOI 10.1152/ajpendo.00717.2006; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Kim HS, 2010, CELL METAB, V12, P224, DOI 10.1016/j.cmet.2010.06.009; Kim H, 2015, MOL CELL BIOL, V35, P4121, DOI 10.1128/MCB.00665-15; Kim H, 2014, ENDOCRINOLOGY, V155, P769, DOI 10.1210/en.2013-1490; Kuang JY, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00135; Kuang JY, 2017, DIABETES, V66, P1159, DOI 10.2337/db16-1225; Langhi C, 2015, HEPATOLOGY, V61, P1227, DOI 10.1002/hep.27607; Lee JH, 2011, NAT MED, V17, P812, DOI 10.1038/nm.2347; Meex RCR, 2009, AM J PHYSIOL-REG I, V297, pR913, DOI 10.1152/ajpregu.91053.2008; Najt CP, 2016, AM J PHYSIOL-GASTR L, V310, pG726, DOI 10.1152/ajpgi.00436.2015; Newman JC, 2014, TRENDS ENDOCRIN MET, V25, P42, DOI 10.1016/j.tem.2013.09.002; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Puchalska P, 2017, CELL METAB, V25, P262, DOI 10.1016/j.cmet.2016.12.022; Puri V, 2008, J CLIN INVEST, V118, P2693, DOI 10.1172/JCI36554; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Qiao Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/869186; Reid BN, 2008, J BIOL CHEM, V283, P13087, DOI 10.1074/jbc.M800533200; Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584; Severgnini M, 2012, CYTOTECHNOLOGY, V64, P187, DOI 10.1007/s10616-011-9407-0; Shimazu T, 2010, CELL METAB, V12, P654, DOI 10.1016/j.cmet.2010.11.003; Tanaka N, 2015, BBA-MOL BASIS DIS, V1852, P1242, DOI 10.1016/j.bbadis.2015.02.012; Tao RY, 2013, J BIOL CHEM, V288, P29252, DOI 10.1074/jbc.M113.481473; Tao RY, 2013, J LIPID RES, V54, P2745, DOI 10.1194/jlr.M039339; Tasselli L, 2017, TRENDS ENDOCRIN MET, V28, P168, DOI 10.1016/j.tem.2016.10.002; Wang M, 2016, MOL MED REP, V13, P1455, DOI 10.3892/mmr.2015.4749; Wang YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072315; WILLIAMSON JR, 1969, J BIOL CHEM, V244, P4617; Xiao CY, 2012, J BIOL CHEM, V287, P41903, DOI 10.1074/jbc.M112.415182; Xu MJ, 2015, GASTROENTEROLOGY, V149, P1030, DOI 10.1053/j.gastro.2015.06.009; Xu X, 2015, HEPATOLOGY, V61, P857, DOI 10.1002/hep.27371; Yoo H, 2004, J LIPID RES, V45, P1324, DOI 10.1194/jlr.M400031-JLR200; Zhang CB, 2012, HEPATOLOGY, V55, P1070, DOI 10.1002/hep.24783; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040; Zhang XD, 2014, DIABETES, V63, P934, DOI 10.2337/db13-1422; Zheng Z, 2011, METHOD ENZYMOL, V489, P329, DOI 10.1016/B978-0-12-385116-1.00019-4	51	12	12	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2019	294	5					1579	1589		10.1074/jbc.RA118.005309	http://dx.doi.org/10.1074/jbc.RA118.005309			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GC	30530497	Green Published, hybrid			2022-12-28	WOS:000457879200013
J	Liang, C; Zhang, ZL; Chen, QF; Yan, HY; Zhang, M; Xiang, XF; Yi, Q; Pan, X; Cheng, HK; Wang, FW				Liang, Cai; Zhang, Zhenlei; Chen, Qinfu; Yan, Haiyan; Zhang, Miao; Xiang, Xingfeng; Yi, Qi; Pan, Xuan; Cheng, Hankun; Wang, Fangwei			A positive feedback mechanism ensures proper assembly of the functional inner centromere during mitosis in human cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitosis; centromere; kinetochore; chromosomes; histone modification; chromosomal passenger complex; cohesin; Haspin; Sgo1; sister chromatid cohesion	SISTER-CHROMATID COHESION; PROTEIN PHOSPHATASE 2A; B KINASE-ACTIVITY; AURORA B; CENP-B; THR-3 PHOSPHORYLATION; MITOTIC CHROMOSOME; ERROR-CORRECTION; SHUGOSHIN; HASPIN	The inner centromere region of a mitotic chromosome critically regulates sister chromatid cohesion and kinetochore-microtubule attachments. However, the molecular mechanism underlying inner centromere assembly remains elusive. Here, using CRISPR/Cas9-based gene editing in HeLa cells, we disrupted the interaction of Shugoshin 1 (Sgo1) with histone H2A phosphorylated on Thr-120 (H2ApT120) to selectively release Sgo1 from mitotic centromeres. Interestingly, cells expressing the H2ApT120-binding defective mutant of Sgo1 have an elevated rate of chromosome missegregation accompanied by weakened centromeric cohesion and decreased centromere accumulation of the chromosomal passenger complex (CPC), an integral part of the inner centromere and a key player in the correction of erroneous kinetochore-microtubule attachments. When artificially tethered to centromeres, a Sgo1 mutant defective in binding protein phosphatase 2A (PP2A) is not able to support proper centromeric cohesion and CPC accumulation, indicating that the Sgo1-PP2A interaction is essential for the integrity of mitotic centromeres. We further provide evidence indicating that Sgo1 protects centromeric cohesin to create a binding site for the histone H3-associated protein kinase Haspin, which not only inhibits the cohesin release factor Wapl and thereby strengthens centromeric cohesion but also phosphorylates histone H3 at Thr-3 to position CPC at inner centromeres. Taken together, our findings reveal a positive feedback-based mechanism that ensures proper assembly of the functional inner centromere during mitosis. They further suggest a causal link between centromeric cohesion defects and chromosomal instability in cancer cells.	[Liang, Cai; Zhang, Zhenlei; Chen, Qinfu; Yan, Haiyan; Zhang, Miao; Xiang, Xingfeng; Yi, Qi; Pan, Xuan; Cheng, Hankun; Wang, Fangwei] Zhejiang Univ, Life Sci Inst, MOE Lab Biosyst Homeostasis & Protect & Innovat, Ctr Cell Signaling Network, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University	Wang, FW (corresponding author), Zhejiang Univ, Life Sci Inst, MOE Lab Biosyst Homeostasis & Protect & Innovat, Ctr Cell Signaling Network, Hangzhou 310058, Zhejiang, Peoples R China.	fwwang@zju.edu.cn		Chen, Qinfu/0000-0003-4581-5329; Wang, Fangwei/0000-0001-5617-282X; Cai, Liang/0000-0002-1885-4237; zhang, zhenlei/0000-0001-9288-9908	National Key Research and Development Program of China [2017YFA0503600]; Natural Science Foundation of Zhejiang Province [LR13C070001, LY17C070003]; National Natural Science Foundation of China [31771499, 31571393, 31561130155, 31322032, 31371359]; Newton Advanced Fellowship [NA140075]; Fundamental Research Funds for the Central Universities	National Key Research and Development Program of China; Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Newton Advanced Fellowship; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work is supported by National Key Research and Development Program of China Grant 2017YFA0503600 (to F. W.); Natural Science Foundation of Zhejiang Province Grant LZ19C070001 (to F. W.); National Natural Science Foundation of China Grants 31771499, 31571393, 31561130155, 31322032, and 31371359 (to F. W.); Newton Advanced Fellowship NA140075 (to F. W.); Natural Science Foundation of Zhejiang Province Grants LR13C070001 (to F. W.) and LY17C070003 (to H.Y); and Fundamental Research Funds for the Central Universities. The authors declare that they have no conflicts of interest with the contents of this article.	Abe Y, 2016, DEV CELL, V36, P487, DOI 10.1016/j.devcel.2016.02.008; Barber TD, 2008, P NATL ACAD SCI USA, V105, P3443, DOI 10.1073/pnas.0712384105; Baron AP, 2016, ELIFE, V5, DOI 10.7554/eLife.12187; Canudas S, 2009, J CELL BIOL, V187, P165, DOI 10.1083/jcb.200903096; Carmena M, 2012, NAT REV MOL CELL BIO, V13, P789, DOI 10.1038/nrm3474; Carretero M, 2013, EMBO J, V32, P2938, DOI 10.1038/emboj.2013.230; Dai J, 2005, GENE DEV, V19, P472, DOI 10.1101/gad.1267105; Dai J, 2006, DEV CELL, V11, P741, DOI 10.1016/j.devcel.2006.09.018; Daum JR, 2011, CURR BIOL, V21, P1018, DOI 10.1016/j.cub.2011.05.032; De Koninck M, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026476; EARNSHAW WC, 1987, J CELL BIOL, V104, P817, DOI 10.1083/jcb.104.4.817; Gandhi R, 2006, CURR BIOL, V16, P2406, DOI 10.1016/j.cub.2006.10.061; Gimenez-Abian JF, 2004, CURR BIOL, V14, P1187, DOI 10.1016/j.cub.2004.06.052; Gorbsky GJ, 2013, CURR BIOL, V23, pR986, DOI 10.1016/j.cub.2013.08.017; Goto Y, 2017, CURR BIOL, V27, P1005, DOI 10.1016/j.cub.2017.02.066; Gregan J, 2011, TRENDS CELL BIOL, V21, P374, DOI 10.1016/j.tcb.2011.01.003; Haarhuis JHI, 2014, DEV CELL, V31, P7, DOI 10.1016/j.devcel.2014.09.010; Hara K, 2014, NAT STRUCT MOL BIOL, V21, P864, DOI 10.1038/nsmb.2880; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Higgins JMG, 2016, DEV CELL, V36, P477, DOI 10.1016/j.devcel.2016.02.019; Higgins JMG, 2013, CURR BIOL, V23, pR883, DOI 10.1016/j.cub.2013.08.026; Hindriksen S, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00112; Kawashima SA, 2007, GENE DEV, V21, P420, DOI 10.1101/gad.1497307; Kawashima SA, 2010, SCIENCE, V327, P172, DOI 10.1126/science.1180189; Kelly AE, 2010, SCIENCE, V330, P235, DOI 10.1126/science.1189505; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Kitajima TS, 2005, CURR BIOL, V15, P353, DOI 10.1016/j.cub.2004.12.044; Kleyman M, 2014, J CELL SCI, V127, P4225, DOI 10.1242/jcs.151613; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Lampson MA, 2004, NAT CELL BIOL, V6, P232, DOI 10.1038/ncb1102; Lampson MA, 2011, TRENDS CELL BIOL, V21, P133, DOI 10.1016/j.tcb.2010.10.007; Lara-Gonzalez P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049041; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Leiserson MDM, 2015, NAT GENET, V47, P106, DOI 10.1038/ng.3168; Liang C, 2018, EMBO REP, V19, P43, DOI 10.15252/embr.201744737; Liu H, 2015, MOL CELL, V59, P426, DOI 10.1016/j.molcel.2015.06.018; Liu H, 2013, CURR BIOL, V23, P1927, DOI 10.1016/j.cub.2013.07.078; Liu H, 2013, NAT CELL BIOL, V15, P40, DOI 10.1038/ncb2637; Losada A, 2002, GENE DEV, V16, P3004, DOI 10.1101/gad.249202; Losada A, 2014, NAT REV CANCER, V14, P389, DOI 10.1038/nrc3743; Makrantoni V, 2018, CURR BIOL, V28, pR688, DOI 10.1016/j.cub.2018.05.019; Marston AL, 2015, MOL CELL BIOL, V35, P634, DOI 10.1128/MCB.01176-14; MASUMOTO H, 1989, J CELL BIOL, V109, P1963, DOI 10.1083/jcb.109.5.1963; McGuinness BE, 2005, PLOS BIOL, V3, P433, DOI 10.1371/journal.pbio.0030086; Meppelink A, 2015, CELL REP, V11, P508, DOI 10.1016/j.celrep.2015.03.052; Morales C, 2018, CURR OPIN CELL BIOL, V52, P51, DOI 10.1016/j.ceb.2018.01.010; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Nishiyama T, 2013, P NATL ACAD SCI USA, V110, P13404, DOI 10.1073/pnas.1305020110; Nishiyama T, 2010, CELL, V143, P737, DOI 10.1016/j.cell.2010.10.031; Ouyang ZQ, 2016, MOL CELL, V62, P248, DOI 10.1016/j.molcel.2016.02.033; Ouyang ZQ, 2013, P NATL ACAD SCI USA, V110, P11355, DOI 10.1073/pnas.1304594110; Perera D, 2007, DEV CELL, V13, P566, DOI 10.1016/j.devcel.2007.08.008; Perera D, 2010, J CELL SCI, V123, P653, DOI 10.1242/jcs.059501; Peters JM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011130; PLUTA AF, 1992, J CELL BIOL, V116, P1081, DOI 10.1083/jcb.116.5.1081; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ricke RM, 2012, J CELL BIOL, V199, P931, DOI 10.1083/jcb.201205115; Riedel CG, 2006, NATURE, V441, P53, DOI 10.1038/nature04664; Salic A, 2004, CELL, V118, P567, DOI 10.1016/j.cell.2004.08.016; Shintomi K, 2009, GENE DEV, V23, P2224, DOI 10.1101/gad.1844309; Skoufias DA, 2006, J BIOL CHEM, V281, P17559, DOI 10.1074/jbc.M511735200; Solomon DA, 2013, NAT GENET, V45, P1428, DOI 10.1038/ng.2800; Solomon DA, 2011, SCIENCE, V333, P1039, DOI 10.1126/science.1203619; Stevens D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022969; Sumara I, 2002, MOL CELL, V9, P515, DOI 10.1016/S1097-2765(02)00473-2; Tang ZY, 2006, DEV CELL, V10, P575, DOI 10.1016/j.devcel.2006.03.010; Tang ZY, 2004, P NATL ACAD SCI USA, V101, P18012, DOI 10.1073/pnas.0408600102; Tanno Y, 2010, GENE DEV, V24, P2169, DOI 10.1101/gad.1945310; Thompson SL, 2010, CURR BIOL, V20, pR285, DOI 10.1016/j.cub.2010.01.034; Trivedi P, 2016, TRENDS BIOCHEM SCI, V41, P160, DOI 10.1016/j.tibs.2015.11.002; Tsukahara T, 2010, NATURE, V467, P719, DOI 10.1038/nature09390; van der Lehr P, 2017, ELIFE, V6, DOI 10.7554/eLife.26980; Wang FW, 2010, SCIENCE, V330, P231, DOI 10.1126/science.1189435; Welburn JPI, 2010, MOL CELL, V38, P383, DOI 10.1016/j.molcel.2010.02.034; Xu Z, 2009, MOL CELL, V35, P426, DOI 10.1016/j.molcel.2009.06.031; Yamagishi Y, 2010, SCIENCE, V330, P239, DOI 10.1126/science.1194498; Zasadil LM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007965; Zhou LL, 2017, CURR BIOL, V27, P992, DOI 10.1016/j.cub.2017.02.019	82	6	6	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2019	294	5					1437	1450		10.1074/jbc.RA118.006046	http://dx.doi.org/10.1074/jbc.RA118.006046			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GC	30498087	Green Published, hybrid			2022-12-28	WOS:000457879200001
J	Wasserman, SS; Shteiman-Kotler, A; Harris, K; Iliadi, KG; Persaud, A; Zhong, Y; Zhang, Y; Fang, XD; Boulianne, GL; Stewart, B; Rotin, D				Wasserman, Samantha S.; Shteiman-Kotler, Alina; Harris, Kathryn; Iliadi, Konstantin G.; Persaud, Avinash; Zhong, Yvonne; Zhang, Yi; Fang, Xuedong; Boulianne, Gabrielle L.; Stewart, Bryan; Rotin, Daniela			Regulation of SH3PX1 by dNedd4-long at the Drosophila neuromuscular junction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E3 ubiquitin ligase; sorting nexin (SNX); synapse; ubiquitin; protein degradation	SORTING NEXIN; AXONAL GUIDANCE; C2 DOMAIN; NEDD4; ENDOCYTOSIS; SUBSTRATE; PROTEINS; DSH3PX1; FAMILY	Drosophila Nedd4 (dNedd4) is a HECT E3 ubiquitin ligase present in two major isoforms: short (dNedd4S) and long (dNedd4Lo), with the latter containing two unique regions (N terminus and Middle). Although dNedd4S promotes neuromuscular synaptogenesis (NMS), dNedd4Lo inhibits it and impairs larval locomotion. To explain how dNedd4Lo inhibits NMS, MS analysis was performed to find its binding partners and identified SH3PX1, which binds dNedd4Lo unique Middle region. SH3PX1 contains SH3, PX, and BAR domains and is present at neuromuscular junctions, where it regulates active zone ultrastructure and presynaptic neurotransmitter release. Here, we demonstrate direct binding of SH3PX1 to the dNedd4Lo Middle region (which contains a Pro-rich sequence) in vitro and in cells, via the SH3PX1-SH3 domain. In Drosophila S2 cells, dNedd4Lo overexpression reduces SH3PX1 levels at the cell periphery. In vivo overexpression of dNedd4Lo post-synaptically, but not pre-synaptically, reduces SH3PX1 levels at the subsynaptic reticulum and impairs neurotransmitter release. Unexpectedly, larvae that overexpress dNedd4Lo post-synaptically and are heterozygous for a null mutation in SH3PX1 display increased neurotransmission compared with dNedd4Lo or SH3PX1 mutant larvae alone, suggesting a compensatory effect from the remaining SH3PX1 allele. These results suggest a post-synaptic-specific regulation of SH3PX1 by dNedd4Lo.	[Wasserman, Samantha S.; Shteiman-Kotler, Alina; Iliadi, Konstantin G.; Persaud, Avinash; Zhong, Yvonne; Boulianne, Gabrielle L.; Rotin, Daniela] Univ Toronto, Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 0A4, Canada; [Wasserman, Samantha S.; Shteiman-Kotler, Alina; Iliadi, Konstantin G.; Persaud, Avinash; Zhong, Yvonne; Boulianne, Gabrielle L.; Rotin, Daniela] Univ Toronto, Hosp Sick Children, Dev & Stem Cell Biol Program, Toronto, ON M5G 0A4, Canada; [Wasserman, Samantha S.; Shteiman-Kotler, Alina; Zhong, Yvonne; Rotin, Daniela] Univ Toronto, Dept Biochem, Toronto, ON M5G 0A4, Canada; [Harris, Kathryn; Stewart, Bryan] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON M5G 0A4, Canada; [Boulianne, Gabrielle L.] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 0A4, Canada; [Zhang, Yi; Fang, Xuedong] Jilin Univ, Dept Gastrointestinal Surg, Changchun 130033, Jilin, Peoples R China	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; Jilin University	Rotin, D (corresponding author), Hosp Sick Children, PGCRL 19-9715,686 Bay St, Toronto, ON M5G 0A4, Canada.	drotin@sickkids.ca		Harris, Kathryn/0000-0003-1769-2587; Zhong, Yunan/0000-0001-9008-5893; Boulianne, Gabrielle/0000-0002-2964-2344; Stewart, Bryan/0000-0003-2520-3632	Ontario Graduate Scholarship; NSERC [RGPIN-201706475, RGPIN 250078-12, RGPIN05229, RGPAS462171]; RESTRA-COMP studentship	Ontario Graduate Scholarship(Ontario Graduate Scholarship); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); RESTRA-COMP studentship	This work was supported by a Ontario Graduate Scholarship and RESTRA-COMP studentship (to S. W.), and NSERC Discovery Grants RGPIN-201706475 (to D. R.), RGPIN 250078-12 (to B. S.), and RGPIN05229 and RGPAS462171 (to G. L. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Baumann C, 2010, FEBS J, V277, P2803, DOI 10.1111/j.1742-4658.2010.07698.x; Brent Jonathan R, 2009, J Vis Exp, DOI 10.3791/1107; BROADIE KS, 1993, J NEUROSCI, V13, P144; Dunn R, 2004, J CELL BIOL, V165, P135, DOI 10.1083/jcb.200309026; FENG SB, 1994, SCIENCE, V266, P1241, DOI 10.1126/science.7526465; Frank CA, 2014, NEUROPHARMACOLOGY, V78, P63, DOI 10.1016/j.neuropharm.2013.06.015; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Hicks L, 2015, BIOL OPEN, V4, P1448, DOI 10.1242/bio.013755; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; Ing B, 2007, MOL CELL BIOL, V27, P481, DOI 10.1128/MCB.00463-06; JOHANSEN J, 1989, J NEUROSCI, V9, P4318; Kanelis V, 2006, STRUCTURE, V14, P543, DOI 10.1016/j.str.2005.11.018; KESHISHIAN H, 1993, J NEUROBIOL, V24, P757, DOI 10.1002/neu.480240606; Lundmark R, 2003, J BIOL CHEM, V278, P46772, DOI 10.1074/jbc.M307334200; McCabe BD, 2004, NEURON, V41, P891, DOI 10.1016/S0896-6273(04)00073-X; Menon KP, 2013, WIRES DEV BIOL, V2, P647, DOI 10.1002/wdev.108; Persaud A, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005290; Plant PJ, 2000, J CELL BIOL, V149, P1473, DOI 10.1083/jcb.149.7.1473; Pylypenko O, 2007, EMBO J, V26, P4788, DOI 10.1038/sj.emboj.7601889; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Safi F, 2016, MOL BIOL CELL, V27, P907, DOI 10.1091/mbc.E15-06-0420; Sakata T, 2004, CURR BIOL, V14, P2228, DOI 10.1016/j.cub.2004.12.028; Shin N, 2007, J BIOL CHEM, V282, P28939, DOI 10.1074/jbc.M700283200; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; Teasdale RD, 2012, BIOCHEM J, V441, P39, DOI 10.1042/BJ20111226; Ukken FP, 2016, J CELL SCI, V129, P166, DOI 10.1242/jcs.178699; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Worby CA, 2002, J BIOL CHEM, V277, P9422, DOI 10.1074/jbc.M110172200; Worby CA, 2001, J BIOL CHEM, V276, P41782, DOI 10.1074/jbc.M107080200; Yarar D, 2007, DEV CELL, V13, P43, DOI 10.1016/j.devcel.2007.04.014; Zhong YA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027007	33	3	3	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2019	294	5					1739	1752		10.1074/jbc.RA118.005161	http://dx.doi.org/10.1074/jbc.RA118.005161			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GC	30518551	Green Published, hybrid			2022-12-28	WOS:000457879200034
J	Vo, TM; Burchett, R; Brun, M; Monckton, EA; Poon, HY; Godbout, R				The Minh Vo; Burchett, Rebecca; Brun, Miranda; Monckton, Elizabeth A.; Poon, Ho-Yin; Godbout, Roseline			Effects of nuclear factor I phosphorylation on calpastatin (CAST) gene variant expression and subcellular distribution in malignant glioma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glioblastoma; transcription factor; calpain; cancer biology; protein phosphorylation; chromatin immunoprecipitation (ChIP); gene regulation; cysteine protease; gel shifts; immunofluorescence; malignant glioma; nuclear factor I; calpastatin; calcineurin; brain tumor; cell signaling	CALPAIN-MEDIATED PROTEOLYSIS; ACID-BINDING PROTEIN; DNA-BINDING; B-FABP; BRAIN; TRANSCRIPTION; CALCINEURIN; LOCALIZATION; GLIOBLASTOMA; MEMBRANE	Malignant glioma (MG) is the most lethal primary brain tumor. In addition to having inherent resistance to radiation treatment and chemotherapy, MG cells are highly infiltrative, rendering focal therapies ineffective. Genes involved in MG cell migration and glial cell differentiation are up-regulated by hypophosphorylated nuclear factor I (NFI), which is dephosphorylated by the phosphatase calcineurin in MG cells. Calcineurin is cleaved and thereby activated by calpain proteases, which are, in turn, inhibited by calpastatin (CAST). Here, we show that the CAST gene is a target of NFI and has NFI-binding sites in its intron 3 region. We also found that NFI-mediated regulation of CAST depends on NFI's phosphorylation state. We noted that occupation of CAST intron 3 by hypophosphorylated NFI results in increased activation of an alternative promoter. This activation resulted in higher levels of CAST transcript variants, leading to increased levels of CAST protein that lacks the N-terminal XL domain. CAST was primarily present in the cytoplasm of NFI-hypophosphorylated MG cells, with a predominantly perinuclear immunostaining pattern. NFI knockdown in NFI-hypophosphorylated MG cells increased CAST levels at the plasma membrane. These results suggest that NFI plays an integral role in the regulation of CAST variants and CAST subcellular distribution. Along with the previous findings indicating that NFI activity is regulated by calcineurin, these results provide a foundation for further investigations into the possibility of regulatory cross-talk between NFI and the CAST/calpain/calcineurin signaling pathway in MG cells.	[The Minh Vo; Burchett, Rebecca; Brun, Miranda; Monckton, Elizabeth A.; Poon, Ho-Yin; Godbout, Roseline] Univ Alberta, Cross Canc Inst, Dept Oncol, 11560 Univ Ave, Edmonton, AB T6G 1Z2, Canada	University of Alberta	Godbout, R (corresponding author), Univ Alberta, Cross Canc Inst, Dept Oncol, 11560 Univ Ave, Edmonton, AB T6G 1Z2, Canada.	rgodbout@ualberta.ca	; Godbout, Roseline/I-4639-2016	Burchett, Rebecca/0000-0002-0328-2336; Godbout, Roseline/0000-0002-4779-9265	Canadian Institutes of Health Research Grant [130314]	Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant 130314. The authors declare that they have no conflicts of interest with the contents of this article.	ADACHI Y, 1988, BIOL CHEM H-S, V369, P223; Alevizopoulos A, 1997, J BIOL CHEM, V272, P23597, DOI 10.1074/jbc.272.38.23597; Averna M, 2003, CELL MOL LIFE SCI, V60, P2669, DOI 10.1007/s00018-003-3288-0; Averna M, 2001, BIOCHEM J, V354, P25, DOI 10.1042/0264-6021:3540025; Baek KH, 2016, ONCOTARGET, V7, P30831, DOI 10.18632/oncotarget.8791; Baghdiguian S, 1999, NAT MED, V5, P503, DOI 10.1038/8385; Becker-Santos DD, 2017, EBIOMEDICINE, V22, P2, DOI 10.1016/j.ebiom.2017.05.027; Bisgrove DA, 2000, J BIOL CHEM, V275, P30668, DOI 10.1074/jbc.M003828200; Brun M, 2018, NEOPLASIA, V20, P1023, DOI 10.1016/j.neo.2018.08.007; Brun M, 2013, J BIOL CHEM, V288, P24104, DOI 10.1074/jbc.M113.455832; Brun M, 2009, J MOL BIOL, V391, P282, DOI 10.1016/j.jmb.2009.06.041; Chan KT, 2010, J BIOL CHEM, V285, P11418, DOI 10.1074/jbc.M109.090746; Claes A, 2007, ACTA NEUROPATHOL, V114, P443, DOI 10.1007/s00401-007-0293-7; Cong M, 1998, J BIOL CHEM, V273, P660, DOI 10.1074/jbc.273.1.660; Cortesio CL, 2008, J CELL BIOL, V180, P957, DOI 10.1083/jcb.200708048; de Groot JF, 2010, NEURO-ONCOLOGY, V12, P233, DOI 10.1093/neuonc/nop027; De Rosa A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052113; De Tullio R, 2007, ARCH BIOCHEM BIOPHYS, V465, P148, DOI 10.1016/j.abb.2007.05.007; Deneen B, 2006, NEURON, V52, P953, DOI 10.1016/j.neuron.2006.11.019; Ding FR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155504; EMORI Y, 1988, J BIOL CHEM, V263, P2364; Franco S, 2004, EXP CELL RES, V299, P179, DOI 10.1016/j.yexcr.2004.05.021; Gil-Parrado S, 2003, J BIOL CHEM, V278, P16336, DOI 10.1074/jbc.M208657200; Godbout R, 1998, ONCOGENE, V16, P1955, DOI 10.1038/sj.onc.1201740; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Gronostajski RM, 2000, GENE, V249, P31, DOI 10.1016/S0378-1119(00)00140-2; GRONOSTAJSKI RM, 1987, NUCLEIC ACIDS RES, V15, P5545, DOI 10.1093/nar/15.14.5545; GRONOSTAJSKI RM, 1986, NUCLEIC ACIDS RES, V14, P9117, DOI 10.1093/nar/14.22.9117; Heng YHE, 2012, NEUROSIGNALS, V20, P159, DOI 10.1159/000330651; Kallenberg K, 2013, J NEURO-ONCOL, V112, P217, DOI 10.1007/s11060-013-1049-y; Kaloshi G, 2007, J NEURO-ONCOL, V84, P245, DOI 10.1007/s11060-007-9377-4; Kang P, 2012, NEURON, V74, P79, DOI 10.1016/j.neuron.2012.01.024; Kim MJ, 2002, P NATL ACAD SCI USA, V99, P9870, DOI 10.1073/pnas.152336999; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; KRUSE U, 1994, FEBS LETT, V348, P46, DOI 10.1016/0014-5793(94)00585-0; Lal S, 2012, J NEUROSCI RES, V90, P769, DOI 10.1002/jnr.22794; LANE RD, 1992, EXP CELL RES, V203, P5, DOI 10.1016/0014-4827(92)90033-5; Lebart MC, 2006, FEBS J, V273, P3415, DOI 10.1111/j.1742-4658.2006.05350.x; LEE WJ, 1992, J BIOL CHEM, V267, P8437; Leloup L, 2010, J BIOL CHEM, V285, P33549, DOI 10.1074/jbc.M110.123604; Liang Y, 2005, P NATL ACAD SCI USA, V102, P5814, DOI 10.1073/pnas.0402870102; Mason S, 2009, MOL NEUROBIOL, V39, P10, DOI 10.1007/s12035-008-8048-6; Mason W P, 2007, Curr Oncol, V14, P110, DOI 10.3747/co.2007.119; Mita R, 2007, NEOPLASIA, V9, P734, DOI 10.1593/neo.07439; Mita R, 2010, J BIOL CHEM, V285, P37005, DOI 10.1074/jbc.M110.170076; Namihira M, 2009, DEV CELL, V16, P245, DOI 10.1016/j.devcel.2008.12.014; NILSSON E, 1990, NEUROBIOL AGING, V11, P425, DOI 10.1016/0197-4580(90)90009-O; Norden AD, 2008, NEUROLOGY, V70, P779, DOI 10.1212/01.wnl.0000304121.57857.38; OBRIEN RM, 1995, MOL CELL BIOL, V15, P1747; Ogura K, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-97; Omuro A, 2013, JAMA-J AM MED ASSOC, V310, P1842, DOI 10.1001/jama.2013.280319; Ostrom QT, 2015, NEURO-ONCOLOGY, V17, P1, DOI [10.1093/neuonc/nov189, 10.1093/neuonc/noaa200, 10.1093/neuonc/noab200]; Parr T, 2001, ARCH BIOCHEM BIOPHYS, V395, P1, DOI 10.1006/abbi.2001.2546; Perrin BJ, 2006, MOL BIOL CELL, V17, P239, DOI 10.1091/mbc.e05-06-0488; Perrin BJ, 2002, INT J BIOCHEM CELL B, V34, P722, DOI 10.1016/S1357-2725(02)00009-2; Pillai Smitha, 2009, V523, P323, DOI 10.1007/978-1-59745-190-1_22; Roulet E, 2000, J MOL BIOL, V297, P833, DOI 10.1006/jmbi.2000.3614; Santos DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033468; Schoch KM, 2012, EXP NEUROL, V236, P371, DOI 10.1016/j.expneurol.2012.04.022; Shankar A, 2014, CHIN J CANCER, V33, P148, DOI 10.5732/cjc.013.10095; Shao HS, 2006, MOL CELL BIOL, V26, P5481, DOI 10.1128/MCB.02243-05; Stifanese R, 2010, J BIOL CHEM, V285, P631, DOI 10.1074/jbc.M109.031674; Takano J, 2000, J BIOCHEM, V128, P83, DOI 10.1093/oxfordjournals.jbchem.a022733; Tangmansakulchai K, 2016, MITOCHONDRION, V30, P151, DOI 10.1016/j.mito.2016.07.009; Tremper-Wells B, 2005, J BIOL CHEM, V280, P2165, DOI 10.1074/jbc.M410591200; Wendt A, 2004, BIOL CHEM, V385, P465, DOI 10.1515/BC.2004.054; Wu HY, 2007, ACTA MED OKAYAMA, V61, P123; Wu HY, 2004, J BIOL CHEM, V279, P4929, DOI 10.1074/jbc.M309767200	68	3	3	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1173	1188		10.1074/jbc.RA118.004787	http://dx.doi.org/10.1074/jbc.RA118.004787			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30504225	Green Published, hybrid			2022-12-28	WOS:000457879500010
J	Darris, C; Revert, F; Revert-Ros, F; Gozalbo-Rovira, R; Feigley, A; Fidler, A; Lopez-Pascual, E; Saus, J; Hudson, BG				Darris, Carl; Revert, Fernando; Revert-Ros, Francisco; Gozalbo-Rovira, Roberto; Feigley, Andrew; Fidler, Aaron; Lopez-Pascual, Ernesto; Saus, Juan; Hudson, Billy G.			Unicellular ancestry and mechanisms of diversification of Goodpasture antigen-binding protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						evolution; basement membrane; extracellular matrix; extracellular matrix protein; genomics	CERAMIDE TRANSFER PROTEIN; NONVESICULAR TRAFFICKING; EXTRACELLULAR-MATRIX; GENE DUPLICATION; STRUCTURAL BASIS; SPLICED VARIANT; COLLAGEN-IV; PHOSPHORYLATES; EXPRESSION; DROSOPHILA	The emergence of the basement membrane (BM), a specialized form of extracellular matrix, was essential in the unicellular transition to multicellularity. However, the mechanism is unknown. Goodpasture antigen-binding protein (GPBP), a BM protein, was uniquely poised to play diverse roles in this transition owing to its multiple isoforms (GPBP-1, -2, and -3) with varied intracellular and extracellular functions (ceramide trafficker and protein kinase). We sought to determine the evolutionary origin of GPBP isoforms. Our findings reveal the presence of GPBP in unicellular protists, with GPBP-2 as the most ancient isoform. In vertebrates, GPBP-1 assumed extracellular function that is further enhanced by membrane-bound GPBP-3 in mammalians, whereas GPBP-2 retained intracellular function. Moreover, GPBP-2 possesses a dual intracellular/extracellular function in cnidarians, an early nonbilaterian group. We conclude that GPBP functioning both inside and outside the cell was of fundamental importance for the evolutionary transition to animal multicellularity and tissue evolution.	[Darris, Carl; Feigley, Andrew; Fidler, Aaron; Hudson, Billy G.] Vanderbilt Univ, Div Nephrol & Hypertens, Dept Med, Nashville, TN 37232 USA; [Darris, Carl; Feigley, Andrew; Fidler, Aaron; Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Nashville, TN 37232 USA; [Revert, Fernando; Revert-Ros, Francisco; Gozalbo-Rovira, Roberto; Lopez-Pascual, Ernesto; Saus, Juan] Univ Valencia, Fibrostatin SL, Sci Pk, Valencia 46980, Spain; [Saus, Juan] Univ Valencia, Fac Med & Dent, Dept Biochem & Mol Biol, Valencia 46010, Spain; [Feigley, Andrew; Fidler, Aaron; Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Aspirnaut Program, Nashville, TN 37232 USA; [Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Ctr Matrix Biol, Nashville, TN 37232 USA; [Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Dept Biochem, Nashville, TN 37232 USA; [Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA; [Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; University of Valencia; University of Valencia; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Darris, C (corresponding author), Vanderbilt Univ, Med Ctr, Div Nephrol, S-3223 MCN,1161 21st Ave South, Nashville, TN 37232 USA.; Hudson, BG (corresponding author), Vanderbilt Univ, Med Ctr, Nashville, TN 37232 USA.	carl.darris@vanderbilt.edu; billy.hudson@vanderbilt.edu	Revert-Ros, Francisco/AAB-7055-2019; REVERT, FERNANDO/ABF-8171-2021; Rovira, Roberto Gozalbo/A-8852-2016; Fidler, Aaron L./C-4031-2014	REVERT, FERNANDO/0000-0002-7304-5846; Rovira, Roberto Gozalbo/0000-0003-3427-3800; Fidler, Aaron L./0000-0002-2519-8864; Saus, Juan/0000-0003-2082-1597; Hudson, Billy/0000-0002-5420-4100; Darris, Carl/0000-0002-1320-7612; Revert-Ros, Francisco/0000-0002-6162-3370	NIDDK, National Institutes of Health [R01DK 28381-46S1, R01DK18381]; University of Valencia; El Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion [RTC-2014-2415-1]; Conselleria de Educacio of Generalitat Valenciana [PROMETEOII/2014/048]; Aspirnaut Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R25DK096999, R01DK018381] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); University of Valencia; El Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion; Conselleria de Educacio of Generalitat Valenciana; Aspirnaut Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIDDK, National Institutes of Health, Grants R01DK 28381-46S1 and R01DK18381; Atraccio de Talent from the University of Valencia; El Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Grant RTC-2014-2415-1; and Conselleria de Educacio of Generalitat Valenciana Grant PROMETEOII/2014/048; and The Aspirnaut Program (to Julie K. Hudson and B. G. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson DP, 2016, ELIFE, V5, DOI 10.7554/eLife.10147; Bhave G, 2012, NAT CHEM BIOL, V8, P784, DOI [10.1038/NCHEMBIO.1038, 10.1038/nchembio.1038]; Brown KL, 2017, PROTEIN SCI, V26, P2151, DOI 10.1002/pro.3283; CURRAN J, 1988, EMBO J, V7, P245, DOI 10.1002/j.1460-2075.1988.tb02806.x; Daley WP, 2013, CURR OPIN GENET DEV, V23, P408, DOI 10.1016/j.gde.2013.05.005; Fidler AL, 2018, J CELL SCI, V131, DOI 10.1242/jcs.203950; Fidler AL, 2017, ELIFE, V6, DOI 10.7554/eLife.24176; Granero F, 2005, FEBS J, V272, P5291, DOI 10.1111/j.1742-4658.2005.04925.x; Granero-Molto F, 2008, J BIOL CHEM, V283, P20495, DOI 10.1074/jbc.M801806200; Gubbiotti MA, 2017, MATRIX BIOL, V57-58, P285, DOI 10.1016/j.matbio.2016.09.003; Hammesfahr B, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-77; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hanada K, 2014, BBA-MOL CELL BIOL L, V1841, P704, DOI 10.1016/j.bbalip.2013.06.006; Hatje Klas, 2011, BMC Res Notes, V4, P265, DOI 10.1186/1756-0500-4-265; Horne-Badovinac S, 2014, INTEGR COMP BIOL, V54, P667, DOI 10.1093/icb/icu067; Hughes AL, 2005, P NATL ACAD SCI USA, V102, P8791, DOI 10.1073/pnas.0503922102; Hynes RO, 2012, J CELL BIOL, V196, P671, DOI 10.1083/jcb.201109041; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Iozzo RV, 2018, MATRIX BIOL, V71-72, P1, DOI 10.1016/j.matbio.2018.03.023; Irimia M, 2012, GENOME RES, V22, P2356, DOI 10.1101/gr.139725.112; Jayadev R, 2017, CURR BIOL, V27, pR207, DOI 10.1016/j.cub.2017.02.006; Jones-Paris CR, 2017, MATRIX BIOL, V57-58, P347, DOI 10.1016/j.matbio.2016.09.005; Keeley DP, 2019, MATRIX BIOL, V75-76, P58, DOI 10.1016/j.matbio.2018.05.009; Kudo N, 2008, P NATL ACAD SCI USA, V105, P488, DOI 10.1073/pnas.0709191105; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; Lopez-Jimenez AJ, 2017, J BIOL CHEM, V292, P16970, DOI 10.1074/jbc.M117.798603; Mencarelli C, 2012, J BIOL CHEM, V287, P14897, DOI 10.1074/jbc.M111.299545; Morrissey MA, 2015, J CELL SCI, V128, P1661, DOI 10.1242/jcs.168021; Muhlhausen S, 2015, BIOINFORMATICS, V31, P1302, DOI 10.1093/bioinformatics/btu798; Odronitz Florian, 2008, BMC Genomics, V9, P422, DOI 10.1186/1471-2164-9-422; Pastor-Pareja JC, 2011, DEV CELL, V21, P245, DOI 10.1016/j.devcel.2011.06.026; Pozzi A, 2017, MATRIX BIOL, V57-58, P1, DOI 10.1016/j.matbio.2016.12.009; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Ramos-Lewis W, 2019, MATRIX BIOL, V75-76, P72, DOI 10.1016/j.matbio.2018.04.004; Rao RP, 2007, P NATL ACAD SCI USA, V104, P11364, DOI 10.1073/pnas.0705049104; Raya A, 1999, J BIOL CHEM, V274, P12642, DOI 10.1074/jbc.274.18.12642; Raya A, 2000, J BIOL CHEM, V275, P40392, DOI 10.1074/jbc.M002769200; Revert F, 2008, J BIOL CHEM, V283, P30246, DOI 10.1074/jbc.M805026200; Revert F, 2007, AM J PATHOL, V171, P1419, DOI 10.2353/ajpath.2007.070205; Revert Fernando, 2018, Oncotarget, V9, P11020, DOI 10.18632/oncotarget.24280; Revert-Ros F, 2011, J BIOL CHEM, V286, P35030, DOI 10.1074/jbc.M111.249458; Richter DJ, 2018, ELIFE, V7, DOI 10.7554/eLife.34226; Richter DJ, 2013, ANNU REV GENET, V47, P509, DOI 10.1146/annurev-genet-111212-133456; Rokas A, 2008, ANNU REV GENET, V42, P235, DOI 10.1146/annurev.genet.42.110807.091513; Roth C, 2007, J EXP ZOOL PART B, V308B, P58, DOI 10.1002/jez.b.21124; Sebe-Pedros A, 2013, ELIFE, V2, DOI 10.7554/eLife.01287; Sekiguchi R, 2018, CURR TOP DEV BIOL, V130, P143, DOI 10.1016/bs.ctdb.2018.02.005; Song JJ, 2011, TRENDS MOL MED, V17, P424, DOI 10.1016/j.molmed.2011.03.005; Sugiki T, 2018, J BIOL CHEM, V293, P11206, DOI 10.1074/jbc.RA118.002465; Sugiki T, 2012, J BIOL CHEM, V287, P33706, DOI 10.1074/jbc.M112.367730; Swanton C, 2007, CANCER CELL, V11, P498, DOI 10.1016/j.ccr.2007.04.011; Tucker RP, 2011, INVERTEBR BIOL, V130, P11, DOI 10.1111/j.1744-7410.2010.00219.x; VRACKO R, 1974, AM J PATHOL, V77, P314; Wernersson R, 2006, NUCLEIC ACIDS RES, V34, pW385, DOI 10.1093/nar/gkl252; Yurchenco PD, 2015, CURR TOP MEMBR, V76, P1, DOI 10.1016/bs.ctm.2015.05.001; Yurchenco PD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004911	56	3	3	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2019	294	3					759	769		10.1074/jbc.RA118.006225	http://dx.doi.org/10.1074/jbc.RA118.006225			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL4FC	30377252	Green Published, hybrid			2022-12-28	WOS:000458670200002
J	Klyuyeva, A; Tuganova, A; Kedishvili, N; Popov, KM				Klyuyeva, Alla; Tuganova, Alina; Kedishvili, Natalia; Popov, Kirill M.			Tissue-specific kinase expression and activity regulate flux through the pyruvate dehydrogenase complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						pyruvate dehydrogenase complex (PDC); pyruvate dehydrogenase kinase (PDC kinase); mitochondria; carbohydrate metabolism; protein phosphorylation; carbohydrate metabolism; mitochondria; oxidative decarboxylation of pyruvate; protein kinase; protein phosphorylation; metabolic flux	GLUCOSE-HOMEOSTASIS; METABOLISM; INHIBITION; MECHANISMS; HEART; PHOSPHORYLATION; PROTEIN; PHOSPHATASE; ISOENZYME; ISOFORMS	The pyruvate dehydrogenase complex (PDC) is a multienzyme assembly that converts pyruvate to acetyl-CoA. As pyruvate and acetyl-CoA play central roles in cellular metabolism, understanding PDC regulation is pivotal to understanding the larger metabolic network. The activity of mammalian PDC is regulated through reversible phosphorylation governed by at least four isozymes of pyruvate dehydrogenase kinase (PDK). Deciphering which kinase regulates PDC in organisms at specific times or places has been challenging. In this study, we analyzed mouse strains carrying targeted mutations of individual isozymes to explore their role in regulating PDC activity. Analysis of protein content of PDK isozymes in major metabolic tissues revealed that PDK1 and PDK2 were ubiquitously expressed, whereas PDK3 and PDK4 displayed a rather limited tissue distribution. Measurement of kinase activity showed that PDK1 is the principal isozyme regulating hepatic PDC. PDK2 was largely responsible for inactivation of PDC in tissues of muscle origin and brown adipose tissue (BAT). PDK3 was the principal kinase regulating pyruvate dehydrogenase activity in kidney and brain. In a well-fed state, the tissue levels of PDK4 protein were fairly low. In most tissues tested, PDK4 ablation had little effect on the overall rates of inactivation of PDC in kinase reaction. Taken together, these data strongly suggest that the activity of PDC is regulated by different isozymes in different tissues. Furthermore, it appears that the overall flux through PDC in a given tissue largely reflects the properties of the PDK isozyme that is principally responsible for the regulation of PDC activity in that tissue.	[Tuganova, Alina; Kedishvili, Natalia; Popov, Kirill M.] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Sch Med, KAUL 440A,720 20th St S, Birmingham, AL 35294 USA; [Tuganova, Alina; Kedishvili, Natalia; Popov, Kirill M.] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Sch Dent, KAUL 440A,720 20th St S, Birmingham, AL 35294 USA; [Klyuyeva, Alla] Avanti Polar Lipids Inc, 700 Ind Pk Dr, Alabaster, AL 35007 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Popov, KM (corresponding author), Univ Alabama Birmingham, Dept Biochem & Mol Genet, Sch Med, KAUL 440A,720 20th St S, Birmingham, AL 35294 USA.; Popov, KM (corresponding author), Univ Alabama Birmingham, Dept Biochem & Mol Genet, Sch Dent, KAUL 440A,720 20th St S, Birmingham, AL 35294 USA.	kpopov@uab.edu			NIGMS, National Institutes of Health [GM51262]	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health, Grant GM51262. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baker JC, 2000, J BIOL CHEM, V275, P15773, DOI 10.1074/jbc.M909488199; Boussouar F, 2004, TRENDS ENDOCRIN MET, V15, P345, DOI 10.1016/j.tem.2004.07.003; Bowker-Kinley MM, 1998, BIOCHEM J, V329, P191, DOI 10.1042/bj3290191; Chih CP, 2003, J CEREBR BLOOD F MET, V23, P1263, DOI 10.1097/01.WCB.0000081369.51727.6F; Desagher S, 1997, J NEUROSCI, V17, P9060; Dunford EC, 2011, AM J PHYSIOL-REG I, V300, pR1487, DOI 10.1152/ajpregu.00498.2010; Gerich JE, 2001, DIABETES CARE, V24, P382, DOI 10.2337/diacare.24.2.382; GUDI R, 1995, J BIOL CHEM, V270, P28989, DOI 10.1074/jbc.270.48.28989; Harris RA, 1997, J BIOL CHEM, V272, P19746, DOI 10.1074/jbc.272.32.19746; Hinoi E, 2006, MOL PHARMACOL, V70, P925, DOI 10.1124/mol.106.024398; Hollidge-Horvat MG, 1999, AM J PHYSIOL-ENDOC M, V277, pE647, DOI 10.1152/ajpendo.1999.277.4.E647; HOLNESS MJ, 1989, BIOCHEM J, V258, P529, DOI 10.1042/bj2580529; Huang BL, 1998, J BIOL CHEM, V273, P17680, DOI 10.1074/jbc.273.28.17680; Jeoung NH, 2006, BIOCHEM J, V397, P417, DOI 10.1042/BJ20060125; Jeoung NH, 2012, BIOCHEM J, V443, P829, DOI 10.1042/BJ20112197; Karpova T, 2003, BBA-PROTEINS PROTEOM, V1652, P126, DOI 10.1016/j.bbapap.2003.08.010; Kato M, 2007, STRUCTURE, V15, P992, DOI 10.1016/j.str.2007.07.001; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kolobova E, 2001, BIOCHEM J, V358, P69, DOI 10.1042/0264-6021:3580069; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee YJ, 2003, MICROVASC RES, V66, P91, DOI 10.1016/S0026-2862(03)00052-9; LINN TC, 1969, P NATL ACAD SCI USA, V64, P227, DOI 10.1073/pnas.64.1.227; Martin E, 2005, J NEUROSCI RES, V79, P240, DOI 10.1002/jnr.20293; Mohanty I, 2002, MOL CELL BIOCHEM, V238, P129, DOI 10.1023/A:1019961922260; ODONNELLTORMEY J, 1987, J EXP MED, V165, P500, DOI DOI 10.1074/jbc.RA117.001068; Ohlrogge J, 2000, BIOCHEM SOC T, V28, P567, DOI 10.1042/BST0280567; Patel MS, 2006, BIOCHEM SOC T, V34, P217, DOI 10.1042/BST0340217; PATEL MS, 1990, FASEB J, V4, P3224, DOI 10.1096/fasebj.4.14.2227213; Perrin A, 2002, BIOCHIMIE, V84, P1003, DOI 10.1016/S0300-9084(02)00008-1; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Pithukpakorn M, 2005, MOL GENET METAB, V85, P243, DOI 10.1016/j.ymgme.2005.06.006; Popov K M, 1991, Protein Expr Purif, V2, P278, DOI 10.1016/1046-5928(91)90084-V; POPOV KM, 1994, J BIOL CHEM, V269, P29720; PRIESTMAN DA, 1992, FEBS LETT, V308, P83, DOI 10.1016/0014-5793(92)81056-R; Rajendran P, 2011, CRIT REV BIOCHEM MOL, V46, P181, DOI 10.3109/10409238.2011.557713; Roche TE, 2007, CELL MOL LIFE SCI, V64, P830, DOI 10.1007/s00018-007-6380-z; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rowles J, 1996, J BIOL CHEM, V271, P22376, DOI 10.1074/jbc.271.37.22376; SALE GJ, 1982, BIOCHEM J, V203, P99, DOI 10.1042/bj2030099; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Soga T, 2013, CANCER SCI, V104, P275, DOI 10.1111/cas.12085; Story J A, 1984, Lab Res Methods Biol Med, V10, P217; Sugden Mary C., 2006, Archives of Physiology and Biochemistry, V112, P139, DOI 10.1080/13813450600935263; Sugden MC, 2003, OBES RES, V11, P167, DOI 10.1038/oby.2003.26; SUGDEN PH, 1978, BIOCHEM J, V169, P433, DOI 10.1042/bj1690433; Thangaraju M, 2009, BIOCHEM J, V417, P379, DOI 10.1042/BJ20081132; TONKS NK, 1982, EUR J BIOCHEM, V122, P549; Wagman AS, 2001, CURR PHARM DESIGN, V7, P417, DOI 10.2174/1381612013397915; Wahren J, 2007, ANNU REV NUTR, V27, P329, DOI 10.1146/annurev.nutr.27.061406.093806; Woolbright BL, 2018, MOL CANCER THER, V17, P2004, DOI 10.1158/1535-7163.MCT-18-0063; Wu PF, 1998, BIOCHEM J, V329, P197, DOI 10.1042/bj3290197	51	19	20	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2019	294	3					838	851		10.1074/jbc.RA118.006433	http://dx.doi.org/10.1074/jbc.RA118.006433			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL4FC	30482839	hybrid, Green Published			2022-12-28	WOS:000458670200010
J	Cervantes-Villagrana, RD; Adame-Garcia, SR; Garcia-Jimenez, I; Color-Aparicio, VM; Beltran-Navarro, YM; Konig, GM; Kostenis, E; Reyes-Cruz, G; Gutkind, JS; Vazquez-Prado, J				Daniel Cervantes-Villagrana, Rodolfo; Rafael Adame-Garcia, Sendi; Garcia-Jimenez, Irving; Manuel Color-Aparicio, Victor; Mabell Beltran-Navarro, Yarely; Koenig, Gabriele M.; Kostenis, Evi; Reyes-Cruz, Guadalupe; Gutkind, J. Silvio; Vazquez-Prado, Jose			G signaling to the chemotactic effector P-REX1 and mammalian cell migration is directly regulated by G(q) and G(13) proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein; G protein-coupled receptor (GPCR); heterotrimeric G protein; regulator of G protein signaling (RGS); cell migration; guanine nucleotide exchange factor (GEF); cell signaling; Rho (Rho GTPase); Ras-related C3 botulinum toxin substrate 1 (Rac1); FR900359; G13; Gbetagamma; Gq; P-REX1	NUCLEOTIDE EXCHANGE FACTOR; HETEROTRIMERIC G-PROTEINS; BETA-GAMMA-SUBUNITS; COUPLED RECEPTORS; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; RAC ACTIVATION; ALPHA-SUBUNIT; RHO; PATHWAYS	G protein-coupled receptors stimulate Rho guanine nucleotide exchange factors that promote mammalian cell migration. Rac and Rho GTPases exert opposing effects on cell morphology and are stimulated downstream of G and G(12/13) or G(q), respectively. These G subunits might in turn favor Rho pathways by preventing G signaling to Rac. Here, we investigated whether G signaling to phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchange factor 1 (P-REX1), a key G chemotactic effector, is directly controlled by Rho-activating G subunits. We show that pharmacological inhibition of G(q) makes P-REX1 activation by G(q)/G(i)-coupled lysophosphatidic acid receptors more effective. Moreover, chemogenetic control of G(i) and G(q) by designer receptors exclusively activated by designer drugs (DREADDs) confirmed that G(i) differentially activates P-REX1. GTPase-deficient G(q)QL and G(13)QL variants formed stable complexes with G, impairing its interaction with P-REX1. The N-terminal regions of these variants were essential for stable interaction with G. Pulldown assays revealed that chimeric G(13-i2)QL interacts with G unlike to G(i2-13)QL, the reciprocal chimera, which similarly to G(i2)QL could not interact with G. Moreover, G was part of tetrameric G-G(q)QL-RGS2 and G-G(13-i2)QL-RGS4 complexes, whereas G(13)QL dissociated from G to interact with the PDZ-RhoGEF-RGS domain. Consistent with an integrated response, G and AKT kinase were associated with active SDF-1/CXCL12-stimulated P-REX1. This pathway was inhibited by G(q)QL and G(13)QL, which also prevented CXCR4-dependent cell migration. We conclude that a coordinated mechanism prioritizes G(q)- and G(13)-mediated signaling to Rho over a G-dependent Rac pathway, attributed to heterotrimeric G(i) proteins.	[Daniel Cervantes-Villagrana, Rodolfo; Manuel Color-Aparicio, Victor; Mabell Beltran-Navarro, Yarely; Vazquez-Prado, Jose] IPN, CINVESTAV, Natl Polytech Inst, Ctr Res & Adv Studies,Dept Pharmacol, Mexico City 07360, DF, Mexico; [Rafael Adame-Garcia, Sendi; Garcia-Jimenez, Irving; Reyes-Cruz, Guadalupe] Natl Polytech Inst CINVESTAV IPN, Ctr Res & Adv Studies, Dept Cell Biol, Mexico City 07360, DF, Mexico; [Koenig, Gabriele M.; Kostenis, Evi] Univ Bonn, Inst Pharmaceut Biol, D-53115 Bonn, Germany; [Gutkind, J. Silvio] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Gutkind, J. Silvio] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; University of Bonn; University of California System; University of California San Diego; University of California System; University of California San Diego	Vazquez-Prado, J (corresponding author), IPN, CINVESTAV, Dept Pharmacol, Av Inst Politecn Nacl 2508, Mexico City 14740, DF, Mexico.	jvazquez@cinvestav.mx	Cervantes-Villagrana, Rodolfo Daniel/T-6458-2019; Gutkind, J. Silvio/J-1201-2016; Cervantes-Villagrana, Rodolfo Daniel/E-6804-2019; VAZQUEZ-PRADO, JOSE/C-1630-2017	Gutkind, J. Silvio/0000-0002-5150-4482; Cervantes-Villagrana, Rodolfo Daniel/0000-0002-6599-7994; VAZQUEZ-PRADO, JOSE/0000-0001-5797-6643	Consejo Nacional de Ciencia y Tecnologia (Mexico) [286274, 240119]; Consejo Nacional de Ciencia y Tecnologia; Deutsche Forschungsgemeinschaft [FOR2372]; National Institutes of Health/NCI [CA221289]; NATIONAL CANCER INSTITUTE [R01CA221289] Funding Source: NIH RePORTER	Consejo Nacional de Ciencia y Tecnologia (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institutes of Health/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Consejo Nacional de Ciencia y Tecnologia (Mexico) Grants 286274 (to J. V.-P.) and 240119 (to G. R.-C.), by fellowships from the Consejo Nacional de Ciencia y Tecnologia (to R. D. C.-V., S. R. A.-G., I. G.-J., V. M. C.-A., and Y. M. B.-N.), by Deutsche Forschungsgemeinschaft Grant FOR2372 (to E. K. and G. M. K.), and by National Institutes of Health/NCI Grant CA221289 (to J. S. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aittaleb M, 2010, MOL PHARMACOL, V77, P111, DOI 10.1124/mol.109.061234; Arai H, 1997, P NATL ACAD SCI USA, V94, P14495, DOI 10.1073/pnas.94.26.14495; Bodmann EL, 2017, FASEB J, V31, P3663, DOI 10.1096/fj.201700026R; Brown SL, 2006, J IMMUNOL, V177, P3242, DOI 10.4049/jimmunol.177.5.3242; Bunemann M, 1998, J BIOL CHEM, V273, P31186, DOI 10.1074/jbc.273.47.31186; Carretero-Ortega J, 2010, MOL PHARMACOL, V77, P435, DOI 10.1124/mol.109.060400; Chavez-Vargas L, 2016, J BIOL CHEM, V291, P6182, DOI 10.1074/jbc.M115.712216; Conklin BR, 2008, NAT METHODS, V5, P673, DOI 10.1038/nmeth.1232; Coward P, 1998, P NATL ACAD SCI USA, V95, P352, DOI 10.1073/pnas.95.1.352; Dbouk HA, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003264; Devreotes P, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a005959; Dillenburg-Pilla P, 2015, FASEB J, V29, P1056, DOI 10.1096/fj.14-260083; Donald S, 2004, FEBS LETT, V572, P172, DOI 10.1016/j.febslet.2004.06.096; Dror RO, 2015, SCIENCE, V348, P1361, DOI 10.1126/science.aaa5264; Flock T, 2015, NATURE, V524, P173, DOI 10.1038/nature14663; Fukuhara S, 2001, ONCOGENE, V20, P1661, DOI 10.1038/sj.onc.1204182; Fukuhara S, 2000, FEBS LETT, V485, P183, DOI 10.1016/S0014-5793(00)02224-9; Fukuhara S, 1999, J BIOL CHEM, V274, P5868, DOI 10.1074/jbc.274.9.5868; Gao Jianjiong, SCI SIGNAL, V6, DOI [10.1126/scisignal.2004088, DOI 10.1126/SCISIGNAL.2004088]; Garcia-Regalado A, 2008, MOL BIOL CELL, V19, P4188, DOI 10.1091/mbc.E07-10-1089; Guilluy C, 2011, NAT PROTOC, V6, P2050, DOI 10.1038/nprot.2011.411; Hao F, 2007, BBA-MOL CELL BIOL L, V1771, P883, DOI 10.1016/j.bbalip.2007.04.010; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Hepler John R, 2014, Cell Logist, V4, pe29392; Hernandez-Negrete I, 2007, J BIOL CHEM, V282, P23708, DOI 10.1074/jbc.M703771200; Hewavitharana T, 2012, CELL SIGNAL, V24, P25, DOI 10.1016/j.cellsig.2011.08.014; Heximer SP, 1997, P NATL ACAD SCI USA, V94, P14389, DOI 10.1073/pnas.94.26.14389; Hill K, 2005, J BIOL CHEM, V280, P4166, DOI 10.1074/jbc.M411262200; Houslay DM, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aae0453; Jin T, 2013, CURR OPIN CELL BIOL, V25, P532, DOI 10.1016/j.ceb.2013.06.007; KALINEC G, 1992, MOL CELL BIOL, V12, P4687, DOI 10.1128/MCB.12.10.4687; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Katoh H, 1998, J BIOL CHEM, V273, P28700, DOI 10.1074/jbc.273.44.28700; Kehrl JH, 2016, BIOCHEM PHARMACOL, V114, P40, DOI 10.1016/j.bcp.2016.04.005; Khan SM, 2016, PHARMACOL RES, V111, P434, DOI 10.1016/j.phrs.2016.06.026; Kim EK, 2011, ONCOGENE, V30, P2954, DOI 10.1038/onc.2011.22; Kitamura T, 2015, NAT REV IMMUNOL, V15, P73, DOI 10.1038/nri3789; Kozasa T, 2011, J BIOCHEM, V150, P357, DOI 10.1093/jb/mvr105; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Leopoldt D, 1998, J BIOL CHEM, V273, P7024, DOI 10.1074/jbc.273.12.7024; Li Z, 2003, CELL, V114, P215, DOI 10.1016/S0092-8674(03)00559-2; Guzman-Hernandez ML, 2009, J BIOL CHEM, V284, P18334, DOI 10.1074/jbc.M109.008839; Lutz S, 2005, J BIOL CHEM, V280, P11134, DOI 10.1074/jbc.M411322200; Moolenaar WH, 2004, BIOESSAYS, V26, P870, DOI 10.1002/bies.20081; Murga C, 2000, J BIOL CHEM, V275, P12069, DOI 10.1074/jbc.275.16.12069; Murga C, 1998, J BIOL CHEM, V273, P19080, DOI 10.1074/jbc.273.30.19080; Nance MR, 2013, STRUCTURE, V21, P438, DOI 10.1016/j.str.2012.12.016; Neptune ER, 1999, J BIOL CHEM, V274, P2824, DOI 10.1074/jbc.274.5.2824; Neptune ER, 1997, P NATL ACAD SCI USA, V94, P14489, DOI 10.1073/pnas.94.26.14489; Nishimura A, 2010, P NATL ACAD SCI USA, V107, P13666, DOI 10.1073/pnas.1003553107; O'Hayre M, 2013, NAT REV CANCER, V13, P412, DOI 10.1038/nrc3521; Park JS, 2014, P NATL ACAD SCI USA, V111, P5896, DOI 10.1073/pnas.1402087111; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Reinhard NR, 2017, MOL BIOL CELL, V28, P3371, DOI 10.1091/mbc.E17-03-0136; Robles-Molina E, 2014, BIOCHEM BIOPH RES CO, V444, P218, DOI 10.1016/j.bbrc.2014.01.044; Rojas RJ, 2007, J BIOL CHEM, V282, P29201, DOI 10.1074/jbc.M703458200; Rosenfeldt H, 2004, FEBS LETT, V572, P167, DOI 10.1016/j.febslet.2004.06.097; Schrage R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10156; Senarath K, 2018, J BIOL CHEM, V293, P2974, DOI 10.1074/jbc.RA117.000872; Smrcka AV, 2008, CELL MOL LIFE SCI, V65, P2191, DOI 10.1007/s00018-008-8006-5; Song XS, 2001, J BIOL CHEM, V276, P34651, DOI 10.1074/jbc.M105894200; Sosa MS, 2010, MOL CELL, V40, P877, DOI 10.1016/j.molcel.2010.11.029; Sotsios Y, 1999, J IMMUNOL, V163, P5954; Sprang SR, 2016, BIOPOLYMERS, V105, P449, DOI 10.1002/bip.22836; Stephens LR, 1997, CELL, V89, P105, DOI 10.1016/S0092-8674(00)80187-7; Sugimoto N, 2003, MOL CELL BIOL, V23, P1534, DOI 10.1128/MCB.23.5.1534-1545.2003; Surve CR, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad8163; Tan WF, 2006, J BIOL CHEM, V281, P39542, DOI 10.1074/jbc.M609062200; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; To JY, 2018, J BIOL CHEM, V293, P1570, DOI 10.1074/jbc.RA117.000964; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Vazquez-Prado J, 2004, J BIOL CHEM, V279, P54283, DOI 10.1074/jbc.M410594200; Vazquez-Prado J, 2016, MOL PHARMACOL, V90, P573, DOI 10.1124/mol.116.105338; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Wang HY, 2002, J BIOL CHEM, V277, P3530, DOI 10.1074/jbc.M107031200; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5; XU NZ, 1993, P NATL ACAD SCI USA, V90, P6741, DOI 10.1073/pnas.90.14.6741; Yagi H, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002221; Yoda A, 2015, NAT MED, V21, P71, DOI 10.1038/nm.3751	80	21	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2019	294	2					531	546		10.1074/jbc.RA118.006254	http://dx.doi.org/10.1074/jbc.RA118.006254			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HI2GP	30446620	Green Published, hybrid			2022-12-28	WOS:000456263600013
J	Billon, C; Murray, MH; Avdagic, A; Burris, TP				Billon, Cyrielle; Murray, Meghan H.; Avdagic, Amer; Burris, Thomas P.			ROR regulates the NLRP3 inflammasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nuclear receptor; interleukin 1 (IL-1); innate immunity; inflammasome; liver; liver injury; transcription factor; drug discovery; macrophage	GAMMA; INHIBITION; DIFFERENTIATION; IDENTIFICATION; GALACTOSAMINE; PATHOLOGY; PROTECTS; DISEASE; MICE	RAR-related orphan receptor (ROR) is a nuclear receptor that plays an essential role in the development of T helper 17 (T(h)17) cells of the adaptive immune system. The NLRP3 inflammasome is a component of the innate immune system that processes interleukin (IL)-1 into a mature cytokine. Elevated activity of the NLRP3 inflammasome contributes to the progression of an array of inflammatory diseases. Bone marrow-derived macrophages (BMDMs) isolated from ROR-null mice displayed reduced capacity to secrete IL-1, and they also displayed a reduction in Nlrp3 and Il1b gene expression. Examination of the promoters of the Il1b and Nlrp3 genes revealed multiple putative ROR response elements (ROREs) that were occupied by ROR. ROR inverse agonists were effective inhibitors of the inflammasome. ROR inverse agonists suppressed lipopolysaccharide (LPS)/ATP-stimulated IL-1 secretion and expression of Il1b and Nlrp3 in BMDMs. Additionally, the ability of the ROR inverse agonists to suppress IL-1 secretion was lost in Nlrp3-null macrophages. The potential for targeting the NLRP3 inflammasome in vivo using ROR inverse agonists was examined in two models: LPS-induced sepsis and fulminant hepatitis. Pharmacological inhibition of ROR activity reduced plasma IL-1 as well as IL-1 production by peritoneal macrophages in a model of LPS-induced sepsis. Additionally, ROR inverse agonists reduced mortality in an LPS/d-galactosamine-induced fulminant hepatitis mouse model. These results illustrate a major role for ROR in regulation of innate immunity via modulation of NLRP3 inflammasome activity. Furthermore, these data suggest that inhibiting the NLRP3 inflammasome with ROR inverse agonists may be an effective method to treat NLRP3-associated diseases.	[Billon, Cyrielle; Avdagic, Amer; Burris, Thomas P.] Washington Univ, Sch Med, Ctr Clin Pharmacol, 2 Pharm Pl, St Louis, MO 63110 USA; [Billon, Cyrielle; Avdagic, Amer; Burris, Thomas P.] St Louis Coll Pharm, 2 Pharm Pl, St Louis, MO 63110 USA; [Murray, Meghan H.] St Louis Univ, Sch Med, Dept Physiol & Pharmacol, St Louis, MO 63104 USA	Washington University (WUSTL); Saint Louis University	Burris, TP (corresponding author), Washington Univ, Sch Med, Ctr Clin Pharmacol, 2 Pharm Pl, St Louis, MO 63110 USA.; Burris, TP (corresponding author), St Louis Coll Pharm, 2 Pharm Pl, St Louis, MO 63110 USA.	burristhomas@wustl.edu	Burris, Thomas P/B-3886-2016	Burris, Thomas P/0000-0003-2922-4449	National Institutes of Health [R01MH092769]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092769] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health Grant R01MH092769 (to T.P.B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Banerjee D, 2016, IMMUNOLOGY, V147, P399, DOI 10.1111/imm.12570; Billon C, 2016, MOL METAB, V5, P997, DOI 10.1016/j.molmet.2016.07.001; Bronner SM, 2017, EXPERT OPIN THER PAT, V27, P101, DOI 10.1080/13543776.2017.1236918; Chang MR, 2014, ARTHRITIS RHEUMATOL, V66, P579, DOI 10.1002/art.38272; Cyr P, 2016, BIOORG MED CHEM LETT, V26, P4387, DOI 10.1016/j.bmcl.2016.08.012; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Furuya S, 2015, J SURG RES, V199, P487, DOI 10.1016/j.jss.2015.05.060; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Hu CY, 2015, P NATL ACAD SCI USA, V112, P11318, DOI 10.1073/pnas.1513509112; Huh JR, 2011, NATURE, V472, P486, DOI 10.1038/nature09978; Imaeda AB, 2009, J CLIN INVEST, V119, P305, DOI 10.1172/JCI35958; Jetten Anton M, 2009, Nucl Recept Signal, V7, pe003, DOI 10.1621/nrs.07003; Kim SJ, 2013, FREE RADICAL BIO MED, V65, P997, DOI 10.1016/j.freeradbiomed.2013.08.178; Klecha AJ, 2006, J ENDOCRINOL, V189, P45, DOI 10.1677/joe.1.06137; Kojetin DJ, 2014, NAT REV DRUG DISCOV, V13, P197, DOI 10.1038/nrd4100; Kumar N, 2012, ACS CHEM BIOL, V7, P672, DOI 10.1021/cb200496y; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Pourcet B, 2018, GASTROENTEROLOGY, V154, P1449, DOI 10.1053/j.gastro.2017.12.019; Solt LA, 2012, ACS CHEM BIOL, V7, P1515, DOI 10.1021/cb3002649; Solt LA, 2011, NATURE, V472, P491, DOI 10.1038/nature10075; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; van der Heijden T, 2017, ARTERIOSCL THROM VAS, V37, P1457, DOI 10.1161/ATVBAHA.117.309575; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Vande Walle L, 2014, NATURE, V512, P69, DOI 10.1038/nature13322; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	27	16	16	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2019	294	1					10	19		10.1074/jbc.AC118.002127	http://dx.doi.org/10.1074/jbc.AC118.002127			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG6PT	30455347	Green Published, hybrid			2022-12-28	WOS:000455105500002
J	Nguyen, KT; Lee, CS; Mun, SH; Truong, NT; Park, SK; Hwang, CS				Kha The Nguyen; Lee, Chang-Seok; Mun, Sang-Hyeon; Nhung Thimy Truong; Park, Sang Ki; Hwang, Cheol-Sang			N-terminal acetylation and the N-end rule pathway control degradation of the lipid droplet protein PLIN2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ubiquitin; proteolysis; E3 ubiquitin ligase; proteasome; lipid droplet; Ac; N-end rule; metabolism; N-end rule; N-terminal acetylation; perilipin 2	DIFFERENTIATION-RELATED PROTEIN; UBIQUITIN LIGASE; CELLULAR-PROTEINS; SPLIT-UBIQUITIN; ACETYLTRANSFERASE; METHIONINE; PERILIPIN; INSIGHTS; QUALITY	Perilipin 2 (PLIN2) is a major lipid droplet (LD)-associated protein that regulates intracellular lipid homeostasis and LD formation. Under lipid-deprived conditions, the LD-unbound (free) form of PLIN2 is eliminated in the cytosol by an as yet unknown ubiquitin (Ub)-proteasome pathway that is associated with the N-terminal or near N-terminal residues of the protein. Here, using HeLa, HEK293T, and HepG2 human cell lines, cycloheximide chase, in vivo ubiquitylation, split-Ub yeast two-hybrid, and chemical cross-linking-based reciprocal co-immunoprecipitation assays, we found that TEB4 (MARCH6), an E3 Ub ligase and recognition component of the Ac/N-end rule pathway, directly targets the N-terminal acetyl moiety of N-terminally acetylated PLIN2 for its polyubiquitylation and degradation by the 26S proteasome. We also show that the TEB4-mediated Ac/N-end rule pathway reduces intracellular LD accumulation by degrading PLIN2. Collectively, these findings identify PLIN2 as a substrate of the Ac/N-end rule pathway and indicate a previously unappreciated role of the Ac/N-end rule pathway in LD metabolism.	[Kha The Nguyen; Lee, Chang-Seok; Mun, Sang-Hyeon; Nhung Thimy Truong; Park, Sang Ki; Hwang, Cheol-Sang] Pohang Univ Sci & Technol, Dept Life Sci, Pohang 37673, Gyeongbuk, South Korea	Pohang University of Science & Technology (POSTECH)	Hwang, CS (corresponding author), Pohang Univ Sci & Technol, Dept Life Sci, Pohang 37673, Gyeongbuk, South Korea.	cshwang@postech.ac.kr	Hwang, Cheol-Sang/Q-7391-2019	Hwang, Cheol-Sang/0000-0002-0105-5957	Samsung Science & Technology Foundation [SSTF-BA1401-17]; National Research Foundation of Korea (NRF) - Korean Government(MSIP) [NRF-2017R1A5A1015366]; BK21 Plus Program; POSCO Green Science and Innovation Grant	Samsung Science & Technology Foundation(Samsung); National Research Foundation of Korea (NRF) - Korean Government(MSIP); BK21 Plus Program; POSCO Green Science and Innovation Grant	This work was supported by Samsung Science & Technology Foundation Grant SSTF-BA1401-17, National Research Foundation of Korea (NRF) grant funded by Korean Government(MSIP) Grant NRF-2017R1A5A1015366), the BK21 Plus Program, and the POSCO Green Science and Innovation Grant. The authors declare that they have no conflicts of interest with the contents of this article.	Aksnes H, 2016, TRENDS BIOCHEM SCI, V41, P746, DOI 10.1016/j.tibs.2016.07.005; Aksnes H, 2015, INT REV CEL MOL BIO, V316, P267, DOI 10.1016/bs.ircmb.2015.01.001; Bersuker K, 2017, BBA-MOL CELL BIOL L, V1862, P1166, DOI 10.1016/j.bbalip.2017.06.006; Bienvenut WV, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.015131; Carr RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097118; Cha-Molstad H, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00085-7; Chen SJ, 2017, SCIENCE, V355, DOI 10.1126/science.aal3655; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Conte M, 2016, TRENDS ENDOCRIN MET, V27, P893, DOI 10.1016/j.tem.2016.09.001; Dissmeyer N, 2018, NEW PHYTOL, V218, P929, DOI 10.1111/nph.14619; Foresti O, 2013, ELIFE, V2, DOI 10.7554/eLife.00953; Gao J, 1999, J BIOL CHEM, V274, P16825, DOI 10.1074/jbc.274.24.16825; Goetze S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000236; Hassink G, 2005, BIOCHEM J, V388, P647, DOI 10.1042/BJ20041241; Helbig AO, 2010, MOL CELL PROTEOMICS, V9, P928, DOI 10.1074/mcp.M900463-MCP200; Hwang CS, 2010, SCIENCE, V327, P973, DOI 10.1126/science.1183147; Imamura M, 2002, AM J PHYSIOL-ENDOC M, V283, pE775, DOI 10.1152/ajpendo.00040.2002; Itabe H, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0473-y; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; JOHNSSON N, 1994, P NATL ACAD SCI USA, V91, P10340, DOI 10.1073/pnas.91.22.10340; Kats I, 2018, MOL CELL, V70, P488, DOI 10.1016/j.molcel.2018.03.033; Kaushik S, 2015, NAT CELL BIOL, V17, P759, DOI 10.1038/ncb3166; Nguyen KT, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0097-y; Kim HK, 2014, CELL, V156, P158, DOI 10.1016/j.cell.2013.11.031; Kory N, 2015, DEV CELL, V34, P351, DOI 10.1016/j.devcel.2015.06.007; Lee KE, 2016, MOL CELLS, V39, P169, DOI 10.14348/molcells.2016.2329; Loregger A, 2016, MOL CELL BIOL, V36, P285, DOI 10.1128/MCB.00890-15; Mashiko D, 2013, SCI REP-UK, V3, DOI 10.1038/srep03355; Masuda Y, 2006, J LIPID RES, V47, P87, DOI 10.1194/jlr.M500170-JLR200; Mockli N, 2007, BIOTECHNIQUES, V42, P725, DOI 10.2144/000112455; Park SE, 2015, SCIENCE, V347, P1249, DOI 10.1126/science.aaa3844; Qian SB, 2006, J BIOL CHEM, V281, P392, DOI 10.1074/jbc.M509126200; Ree R, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0116-z; Ruggiano A, 2016, EMBO J, V35, P1644, DOI 10.15252/embj.201593106; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Senthivinayagam S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073696; Shemorry A, 2013, MOL CELL, V50, P540, DOI 10.1016/j.molcel.2013.03.018; SHERMAN F, 1991, P3; Takahashi Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep20975; Turner GC, 2000, SCIENCE, V289, P2117, DOI 10.1126/science.289.5487.2117; Van Damme P, 2012, P NATL ACAD SCI USA, V109, P12449, DOI 10.1073/pnas.1210303109; Varshavsky A, 2011, PROTEIN SCI, V20, P1298, DOI 10.1002/pro.666; Wadas B, 2016, J BIOL CHEM, V291, P17178, DOI 10.1074/jbc.M116.734640; Xiao Q, 2010, BIOCHEMISTRY-US, V49, P5588, DOI 10.1021/bi1005464; Xu F, 2015, PLANT CELL, V27, P1547, DOI 10.1105/tpc.15.00173; Xu GH, 2006, BBA-MOL CELL BIOL L, V1761, P83, DOI 10.1016/j.bbalip.2005.12.005; Xu GH, 2005, J BIOL CHEM, V280, P42841, DOI 10.1074/jbc.M506569200; Yeom J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06314-9; Zelcer N, 2014, MOL CELL BIOL, V34, P1262, DOI 10.1128/MCB.01140-13	49	34	35	1	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2019	294	1					379	388		10.1074/jbc.RA118.005556	http://dx.doi.org/10.1074/jbc.RA118.005556			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG6PT	30425097	hybrid, Green Published			2022-12-28	WOS:000455105500039
J	Ni, J; Waldman, A; Khachigian, LM				Ni, Jun; Waldman, Alla; Khachigian, Levon M.			RETRACTION: Withdrawal: c-Jun regulates shear- and injury-inducible Egr-1 expression, vein graft stenosis after autologous end-to-side transplantation in rabbits, and intimal hyperplasia in human saphenous veins. (Retraction of Vol 285, Pg 4038, 2010)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction													Khachigian, Levon/AAZ-7458-2020					Ni J, 2010, J BIOL CHEM, V285, P4038, DOI 10.1074/jbc.M109.078345	1	0	0	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					20307	20307		10.1074/jbc.W118.007069	http://dx.doi.org/10.1074/jbc.W118.007069			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30593535	hybrid, Green Published			2022-12-28	WOS:000454685900035
J	Ricarte, FR; Le Henaff, C; Kolupaeva, VG; Gardella, TJ; Partridge, NC				Ricarte, Florante R.; Le Henaff, Carole; Kolupaeva, Victoria G.; Gardella, Thomas J.; Partridge, Nicola C.			Parathyroid hormone(1-34) and its analogs differentially modulate osteoblastic Rankl expression via PKA/SIK2/SIK3 and PP1/PP2A-CRTC3 signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						osteoblast; parathyroid hormone; osteoporosis; protein kinase A (PKA); phosphoprotein phosphatase; abaloparatide; age-related diseases; parathyroid hormone-related protein; Rankl; salt-inducible kinases	PROTEIN PHOSPHATASE 2A; KAPPA-B LIGAND; INCREASED BONE MASS; RECEPTOR ACTIVATOR; GENE-EXPRESSION; POSTMENOPAUSAL WOMEN; C-ALPHA; PTH; PHOSPHORYLATION; BINDING	Osteoporosis can result from the loss of sex hormones and/or aging. Abaloparatide (ABL), an analog of parathyroid hormone-related protein (PTHrP(1-36)), is the second osteoanabolic therapy approved by the United States Food and Drug Administration after teriparatide (PTH(1-34)). All three peptides bind PTH/PTHrP receptor type 1 (PTHR1), but the effects of PTHrP(1-36) or ABL in the osteoblast remain unclear. We show that, in primary calvarial osteoblasts, PTH(1-34) promotes a more robust cAMP response than PTHrP(1-36) and ABL and causes a greater activation of protein kinase A (PKA) and cAMP response element-binding protein (CREB). All three peptides similarly inhibited sclerostin (Sost). Interestingly, the three peptides differentially modulated two other PKA target genes, c-Fos and receptor activator of NF-B ligand (Rankl), and the latter both in vitro and in vivo. Knockdown of salt-inducible kinases (SIKs) 2 and 3 and CREB-regulated transcription coactivator 3 (CRTC3), indicated that all three are part of the pathway that regulates osteoblastic Rankl expression. We also show that the peptides differentially regulate the nuclear localization of CRTC2 and CRTC3, and that this correlates with PKA activation. Moreover, inhibition of protein phosphatases 1 and 2A (PP1/PP2A) activity revealed that they play a major role in both PTH-induced Rankl expression and the effects of PTH(1-34) on CRTC3 localization. In summary, in the osteoblast, the effects of PTH(1-34), PTHrP(1-36), and ABL on Rankl are mediated by differential stimulation of cAMP/PKA signaling and by their downstream effects on SIK2 and -3, PP1/PP2A, and CRTC3.	[Ricarte, Florante R.; Partridge, Nicola C.] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA; [Le Henaff, Carole; Kolupaeva, Victoria G.; Partridge, Nicola C.] NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, 345 East 24th St,902A, New York, NY 10010 USA; [Gardella, Thomas J.] Harvard Med Sch, Endocrine Unit, Massachusetts Gen Hosp, Boston, MA 02114 USA	New York University; New York University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Partridge, NC (corresponding author), NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, 345 East 24th St,902A, New York, NY 10010 USA.	ncp234@nyu.edu		Partridge, Nicola/0000-0002-5406-4814	National Institutes of Health [DK47420, DK4742051, T32 GM066704]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047420, R56DK047420] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066704] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants DK47420, DK4742051, and T32 GM066704. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aggen JB, 2000, CHEM BIOL, V7, pR13, DOI 10.1016/S1074-5521(00)00069-7; Ahn JH, 2007, P NATL ACAD SCI USA, V104, P2979, DOI 10.1073/pnas.0611532104; Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Baron R, 2012, J CLIN ENDOCR METAB, V97, P311, DOI 10.1210/jc.2011-2332; Cheloha RW, 2015, NAT REV ENDOCRINOL, V11, P712, DOI 10.1038/nrendo.2015.139; Dean T, 2006, MOL ENDOCRINOL, V20, P931, DOI 10.1210/me.2005-0349; Dean T, 2008, MOL ENDOCRINOL, V22, P156, DOI 10.1210/me.2007-0274; Doyle N, 2018, OSTEOPOROSIS INT, V29, P685, DOI 10.1007/s00198-017-4323-6; Ferrandon S, 2009, NAT CHEM BIOL, V5, P734, DOI 10.1038/nchembio.206; Feschenko MS, 2002, J PHARMACOL EXP THER, V302, P111, DOI 10.1124/jpet.302.1.111; Fu Q, 2002, J BIOL CHEM, V277, P48868, DOI 10.1074/jbc.M208494200; Fu Q, 2006, MOL CELL BIOL, V26, P6453, DOI 10.1128/MCB.00356-06; Galli C, 2009, J BIOL CHEM, V284, P12654, DOI 10.1074/jbc.M806628200; Gardella TJ, 2015, PHARMACOL REV, V67, P310, DOI 10.1124/pr.114.009464; Harvey N, 2010, NAT REV RHEUMATOL, V6, P99, DOI 10.1038/nrrheum.2009.260; Hattersley G, 2016, ENDOCRINOLOGY, V157, P141, DOI 10.1210/en.2015-1726; Henriksson E, 2015, J CELL SCI, V128, P472, DOI 10.1242/jcs.153932; Henriksson E, 2012, BIOCHEM J, V444, P503, DOI 10.1042/BJ20111932; Hodsman AB, 2005, ENDOCR REV, V26, P688, DOI 10.1210/er.2004-0006; Huang JC, 2004, J BONE MINER RES, V19, P235, DOI 10.1359/JBMR.0301226; Itoh Y, 2015, J BIOL CHEM, V290, P17879, DOI 10.1074/jbc.M115.640821; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Keller H, 2005, BONE, V37, P148, DOI 10.1016/j.bone.2005.03.018; Kim JH, 2017, P NATL ACAD SCI USA, V114, P11739, DOI 10.1073/pnas.1712616114; Kim S, 2007, MOL ENDOCRINOL, V21, P197, DOI 10.1210/me.2006-0315; Kozhemyakina E, 2009, MOL CELL BIOL, V29, P5751, DOI 10.1128/MCB.00415-09; Kraenzlin ME, 2011, NAT REV ENDOCRINOL, V7, P647, DOI 10.1038/nrendo.2011.108; Lee CW, 2014, J BIOL CHEM, V289, P21108, DOI 10.1074/jbc.M113.540229; Li X, 2007, J BIOL CHEM, V282, P33086, DOI 10.1074/jbc.M705194200; Lombardi MS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185426; MACKINTOSH C, 1988, FEBS LETT, V234, P189, DOI 10.1016/0014-5793(88)81331-0; Martowicz ML, 2011, J CELL BIOCHEM, V112, P2030, DOI 10.1002/jcb.23123; Miller PD, 2016, JAMA-J AM MED ASSOC, V316, P722, DOI 10.1001/jama.2016.11136; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Obri A, 2014, J CELL BIOL, V205, P771, DOI 10.1083/jcb.201403138; Okamura H, 2013, FEBS LETT, V587, P48, DOI 10.1016/j.febslet.2012.10.041; Okamura H, 2011, BONE, V49, P368, DOI 10.1016/j.bone.2011.06.004; Onal M, 2016, J BONE MINER RES, V31, P416, DOI 10.1002/jbmr.2698; Patel K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5535; Pearman AT, 1996, J BIOL CHEM, V271, P25715, DOI 10.1074/jbc.271.41.25715; Rosen CJ, 2001, J CLIN ENDOCR METAB, V86, P957, DOI 10.1210/jc.86.3.957; Saini V, 2013, J BIOL CHEM, V288, P20122, DOI 10.1074/jbc.M112.441360; Sasagawa S, 2012, DEVELOPMENT, V139, P1153, DOI 10.1242/dev.072652; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Shimizu E, 2014, J BIOL CHEM, V289, P21340, DOI 10.1074/jbc.M114.550699; Shimizu E, 2010, J BIOL CHEM, V285, P9616, DOI 10.1074/jbc.M109.094862; St John HC, 2015, BONE, V72, P81, DOI 10.1016/j.bone.2014.11.010; Tseng W, 2010, J BIOL CHEM, V285, P29925, DOI 10.1074/jbc.M110.117366; Tyson DR, 1999, ENDOCRINOLOGY, V140, P1255, DOI 10.1210/en.140.3.1255; URENA P, 1993, ENDOCRINOLOGY, V133, P617, DOI 10.1210/en.133.2.617; Usui H, 1998, FEBS LETT, V430, P312, DOI 10.1016/S0014-5793(98)00684-X; Varela A, 2017, BONE, V95, P143, DOI 10.1016/j.bone.2016.11.027; Wein MN, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13176; Wein Marc N, 2015, J Bone Miner Res, V30, P400, DOI 10.1002/jbmr.2381; Weir EC, 1996, P NATL ACAD SCI USA, V93, P10240, DOI 10.1073/pnas.93.19.10240; Xiong JH, 2012, J BONE MINER RES, V27, P499, DOI 10.1002/jbmr.1547; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Yang D, 2007, BONE, V40, P1453, DOI 10.1016/j.bone.2007.02.001; Yang DC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001540	60	35	37	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					20200	20213		10.1074/jbc.RA118.004751	http://dx.doi.org/10.1074/jbc.RA118.004751			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30377251	Green Published, hybrid			2022-12-28	WOS:000454685900026
J	Ulens, C				Ulens, Chris			Structure of a transporter domain emerges	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							PROTEIN	Magnesium homeostasis relies on transporters like the CNNM family, but little information on these proteins' structure and regulation limits our understanding of their biology and functions in disease. New characterization of a conserved cytoplasmic domain now confirms the presence of a self-liganded architecture that is indispensable for Mg2+ efflux and suggests a possible role for a dimeric assembly.	[Ulens, Chris] Katholieke Univ Leuven, Dept Cellular & Mol Med, Lab Struct Neurobiol, B-3000 Leuven, Belgium	KU Leuven	Ulens, C (corresponding author), Katholieke Univ Leuven, Dept Cellular & Mol Med, Lab Struct Neurobiol, B-3000 Leuven, Belgium.	chris.ulens@kuleuven.be			 [KU Leuven C1-grant C14/17/093]		This work was supported by KU Leuven C1-grant C14/17/093. The author declares that he has no conflicts of interest with the contents of this article.	Brelidze TI, 2012, NATURE, V481, P530, DOI 10.1038/nature10735; Chen YS, 2018, J BIOL CHEM, V293, P19998, DOI 10.1074/jbc.RA118.005672; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Lee CH, 2017, CELL, V168, P111, DOI 10.1016/j.cell.2016.12.023; Li MH, 2017, NATURE, V542, P60, DOI 10.1038/nature20819; MCKAY DB, 1981, NATURE, V290, P744, DOI 10.1038/290744a0; Parry DA, 2009, AM J HUM GENET, V84, P266, DOI 10.1016/j.ajhg.2009.01.009; Rehmann H, 2006, NATURE, V439, P625, DOI 10.1038/nature04468; Wang WW, 2017, CELL, V169, P422, DOI 10.1016/j.cell.2017.03.048; Whicher JR, 2016, SCIENCE, V353, P664, DOI 10.1126/science.aaf8070	10	0	0	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					20008	20009		10.1074/jbc.H118.006869	http://dx.doi.org/10.1074/jbc.H118.006869			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30593530	Green Published, hybrid			2022-12-28	WOS:000454685900007
J	Lin, YB; Deepak, RNVK; Zheng, JZ; Fan, H; Zheng, L				Lin, Yibin; Deepak, R. N. V. Krishna; Zheng, Jonathan Zixiang; Fan, Hao; Zheng, Lei			A dual substrate-accessing mechanism of a major facilitator superfamily protein facilitates lysophospholipid flipping across the cell membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lysophospholipid; transporter; homology modeling; structural model; substrate specificity; protein-lipid interaction; phospholipid turnover; structure-function; lipid transport; lipid flipping; LplT; major facilitator superfamily; structure-function study; transport mechanism	MULTIPLE SEQUENCE ALIGNMENT; TRANSPORT MECHANISM; CRYSTAL-STRUCTURE; LYSOPHOSPHATIDYLCHOLINE; PREDICTION; MFSD2A; SYSTEM	Lysophospholipid transporter (LplT) is a member of the major facilitator superfamily present in many Gram-negative bacteria. LplT catalyzes flipping of lysophospholipids (LPLs) across the bacterial inner membrane, playing an important role in bacterial membrane homeostasis. We previously reported that LplT promotes both uptake of exogenous LPLs and intramembranous LPL flipping across the bilayer. To gain mechanistic insight into this dual LPL-flipping activity, here we implemented a combination of computational approaches and LPL transport analyses to study LPL binding of and translocation by LplT. Our results suggest that LplT translocates LPLs through an elongated cavity exhibiting an extremely asymmetric polarity. We found that two D(E)N motifs form a head group-binding site, in which the carboxylate group of Asp-30 is important for LPL head group recognition. Substitutions of residues in the head group-binding site disrupted both LPL uptake and flipping activities. However, alteration of hydrophobic residues on the interface between the N- and C-terminal domains impaired LPL flipping specifically, resulting in LPLs accumulation in the membrane, but LPL uptake remained active. These results suggest a dual substrate-accessing mechanism, in which LplT recruits LPLs to its substrate-binding site via two routes, either from its extracellular entry or through a membrane-embedded groove between transmembrane helices, and then moves them toward the inner membrane leaflet. This LPL-flipping mechanism is likely conserved in many bacterial species, and our findings illustrate how LplT adjusts the major facilitator superfamily translocation pathway to perform its versatile lipid homeostatic functions.	[Lin, Yibin; Zheng, Jonathan Zixiang; Zheng, Lei] Univ Texas Hlth Sci Ctr Houston, Dept Biochem & Mol Biol, McGovern Med Sch, Ctr Membrane Biol, Houston, TX 77030 USA; [Deepak, R. N. V. Krishna; Fan, Hao] ASTAR, Bioinformat Inst BII, Singapore 138671, Singapore; [Fan, Hao] Natl Univ Singapore, DBS, Singapore 117558, Singapore; [Fan, Hao] DUKE NUS Med Sch, Ctr Computat Biol, Singapore 169857, Singapore	University of Texas System; University of Texas Health Science Center Houston; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); National University of Singapore; National University of Singapore	Fan, H (corresponding author), ASTAR, Bioinformat Inst BII, Singapore 138671, Singapore.; Fan, H (corresponding author), Natl Univ Singapore, DBS, Singapore 117558, Singapore.; Fan, H (corresponding author), DUKE NUS Med Sch, Ctr Computat Biol, Singapore 169857, Singapore.; Zheng, L (corresponding author), Univ Texas Houston, McGovern Med Sch, Dept Biochem & Mol Biol, Ctr Membrane Biol, 6431 Fannin St, Houston, TX 77030 USA.	fanh@bii.a-star.edu.sg; lei.zheng@uth.tmc.edu	Krishna Deepak, Rama Nagesh Venkata/AAX-7774-2020; Lin, B.Y./AAA-7774-2020	Zheng, Lei/0000-0001-7789-5234; KRISHNA DEEPAK, RAMA NAGESH VENKATA/0000-0001-6629-8450	National Institutes of Health [R01GM097290, R01GM098572]; American Heart Association [18TPA34230046]; Biomedical Research Council of A*STAR; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097290, R01GM098572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Biomedical Research Council of A*STAR(Agency for Science Technology & Research (A*STAR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01GM097290 and R01GM098572 and American Heart Association Grant 18TPA34230046 (to L. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the Biomedical Research Council of A*STAR. To whom correspondence may be addressed. Tel.: 65-64788500; E-mail: fanh@bii.a-star.edu.sg.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ben-Zvi A, 2014, NATURE, V509, P507, DOI 10.1038/nature13324; Celniker G, 2013, ISR J CHEM, V53, P199, DOI 10.1002/ijch.201200096; Deng D, 2014, NATURE, V510, P121, DOI 10.1038/nature13306; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fuller N, 2001, BIOPHYS J, V81, P243, DOI 10.1016/S0006-3495(01)75695-0; Gelis-Jeanvoine S, 2015, MOL MICROBIOL, V95, P692, DOI 10.1111/mmi.12897; Harvat EM, 2005, J BIOL CHEM, V280, P12028, DOI 10.1074/jbc.M414368200; Holthuis JCM, 2014, NATURE, V510, P48, DOI 10.1038/nature13474; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; JACKOWSKI S, 1986, J BIOL CHEM, V261, P1328; Jiang DH, 2013, P NATL ACAD SCI USA, V110, P14664, DOI 10.1073/pnas.1308127110; Jurrus E, 2018, PROTEIN SCI, V27, P112, DOI 10.1002/pro.3280; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Lin YB, 2018, J BIOL CHEM, V293, P3386, DOI 10.1074/jbc.RA117.001231; Lin YB, 2016, J BIOL CHEM, V291, P2136, DOI 10.1074/jbc.M115.700419; Morein S, 1996, J BIOL CHEM, V271, P6801, DOI 10.1074/jbc.271.12.6801; Mysinger MM, 2010, J CHEM INF MODEL, V50, P1561, DOI 10.1021/ci100214a; Nguyen LN, 2014, NATURE, V509, P503, DOI 10.1038/nature13241; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pomorski T, 2006, CELL MOL LIFE SCI, V63, P2908, DOI 10.1007/s00018-006-6167-7; Quek DQY, 2016, J BIOL CHEM, V291, P9383, DOI 10.1074/jbc.M116.721035; Quistgaard EM, 2016, NAT REV MOL CELL BIO, V17, P123, DOI 10.1038/nrm.2015.25; Riederer M, 2010, J LIPID RES, V51, P2957, DOI 10.1194/jlr.M006536; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanyat S, 2009, ACS CHEM BIOL, V4, P895, DOI 10.1021/cb900163d; Shapovalov MV, 2011, STRUCTURE, V19, P844, DOI 10.1016/j.str.2011.03.019; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Simossis VA, 2005, NUCLEIC ACIDS RES, V33, pW289, DOI 10.1093/nar/gki390; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; STAFFORD RE, 1989, BIOCHEMISTRY-US, V28, P5113, DOI 10.1021/bi00438a031; Stamm M, 2014, NUCLEIC ACIDS RES, V42, pW246, DOI 10.1093/nar/gku291; Wu MS, 2013, P NATL ACAD SCI USA, V110, P11367, DOI 10.1073/pnas.1302515110; Yan N, 2015, ANNU REV BIOPHYS, V44, P257, DOI 10.1146/annurev-biophys-060414-033901; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839; Zhao Z, 2014, NEURON, V82, P728, DOI 10.1016/j.neuron.2014.05.012; Zheng L, 2017, BBA-MOL CELL BIOL L, V1862, P1404, DOI 10.1016/j.bbalip.2016.11.015	41	6	6	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19919	19931		10.1074/jbc.RA118.005548	http://dx.doi.org/10.1074/jbc.RA118.005548			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30373772	hybrid, Green Published			2022-12-28	WOS:000454294900035
J	Yien, YY; Shi, JH; Chen, CY; Cheung, JTM; Grillo, AS; Shrestha, R; Li, LT; Zhang, XD; Kafina, MD; Kingsley, PD; King, MJ; Ablain, J; Li, HJ; Zon, LI; Palis, J; Burke, MD; Bauer, DE; Orkin, SH; Koehler, CM; Phillips, JD; Kaplan, J; Ward, DM; Lodish, HF; Paw, BH				Yien, Yvette Y.; Shi, Jiahai; Chen, Caiyong; Cheung, Jesmine T. M.; Grillo, Anthony S.; Shrestha, Rishna; Li, Liangtao; Zhang, Xuedi; Kafina, Martin D.; Kingsley, Paul D.; King, Matthew J.; Ablain, Julien; Li, Hojun; Zon, Leonard I.; Palis, James; Burke, Martin D.; Bauer, Daniel E.; Orkin, Stuart H.; Koehler, Carla M.; Phillips, John D.; Kaplan, Jerry; Ward, Diane M.; Lodish, Harvey F.; Paw, Barry H.			FAM210B is an erythropoietin target and regulates erythroid heme synthesis by controlling mitochondrial iron import and ferrochelatase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						heme; iron metabolism; cell metabolism; erythrocyte; erythropoiesis; red blood cell	TRANSFERRIN RECEPTOR; 5-AMINOLEVULINATE SYNTHASE; FUNCTIONAL DISSECTION; GENE; IDENTIFICATION; PROTEIN; RED; BIOSYNTHESIS; TRANSPORTER; ANEMIA	Erythropoietin (EPO) signaling is critical to many processes essential to terminal erythropoiesis. Despite the centrality of iron metabolism to erythropoiesis, the mechanisms by which EPO regulates iron status are not well-understood. To this end, here we profiled gene expression in EPO-treated 32D pro-B cells and developing fetal liver erythroid cells to identify additional iron regulatory genes. We determined that FAM210B, a mitochondrial inner-membrane protein, is essential for hemoglobinization, proliferation, and enucleation during terminal erythroid maturation. Fam210b deficiency led to defects in mitochondrial iron uptake, heme synthesis, and iron-sulfur cluster formation. These defects were corrected with a lipid-soluble, small-molecule iron transporter, hinokitiol, in Fam210b-deficient murine erythroid cells and zebrafish morphants. Genetic complementation experiments revealed that FAM210B is not a mitochondrial iron transporter but is required for adequate mitochondrial iron import to sustain heme synthesis and iron-sulfur cluster formation during erythroid differentiation. FAM210B was also required for maximal ferrochelatase activity in differentiating erythroid cells. We propose that FAM210B functions as an adaptor protein that facilitates the formation of an oligomeric mitochondrial iron transport complex, required for the increase in iron acquisition for heme synthesis during terminal erythropoiesis. Collectively, our results reveal a critical mechanism by which EPO signaling regulates terminal erythropoiesis and iron metabolism.	[Yien, Yvette Y.; Zhang, Xuedi] Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA; [Yien, Yvette Y.; Chen, Caiyong; Kafina, Martin D.; King, Matthew J.; Paw, Barry H.] Harvard Med Sch, Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; [Shi, Jiahai; Li, Hojun; Lodish, Harvey F.] MIT, Whitehead Inst, Cambridge, MA 02139 USA; [Shi, Jiahai; Li, Hojun; Lodish, Harvey F.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Cheung, Jesmine T. M.; Koehler, Carla M.] UCLA, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Grillo, Anthony S.; Burke, Martin D.] Univ Illinois, Dept Chem & Biochem, Urbana, IL 61801 USA; [Shrestha, Rishna; Li, Liangtao; Kaplan, Jerry; Ward, Diane M.] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84112 USA; [Kingsley, Paul D.; Palis, James] Univ Rochester, Med Ctr, Dept Pediat, Ctr Pediat Biomed Res, Rochester, NY 14642 USA; [Ablain, Julien; Zon, Leonard I.; Bauer, Daniel E.; Orkin, Stuart H.; Paw, Barry H.] Harvard Med Sch, Boston Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Zon, Leonard I.; Bauer, Daniel E.; Orkin, Stuart H.; Paw, Barry H.] Harvard Med Sch, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Phillips, John D.; Paw, Barry H.] Univ Utah, Sch Med, Div Hematol & Hematol Malignancy, Salt Lake City, UT 84112 USA; [Shi, Jiahai] City Univ Hong Kong, Hong Kong, Peoples R China; [Chen, Caiyong] Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Kafina, Martin D.] St Georges Univ, Sch Med, Dept Med, St Georges, Grenada; [King, Matthew J.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA	University of Delaware; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); University of California System; University of California Los Angeles; University of Illinois System; University of Illinois Urbana-Champaign; Utah System of Higher Education; University of Utah; University of Rochester; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Utah System of Higher Education; University of Utah; City University of Hong Kong; Zhejiang University; University of Texas System; University of Texas Health San Antonio	Yien, YY (corresponding author), Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA.	yyien@udel.edu		Palis, James/0000-0001-7324-1049; Ablain, Julien/0000-0002-4509-3568; Koehler, Carla/0000-0001-8685-2412	National Institutes of Health [U54 DK110858, P30 DK34854]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL032262, R01HL116364] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070838, U54DK110805, U54DK110858, F32DK098866, R01DK030534, R03DK118307, U54DK083909, P30DK034854, R37DK030534, K08DK093705, R01DK020503, K01DK106156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061721, R35GM118185, R01GM073981] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD017870] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Iman Schultz for assistance on bioinformatics analysis, Johannes Wittig for assistance with model figure preparation, and Nicholas Huston for assistance with initial morpholino injections. We thank Mahnaz Paktinat for training on the use of the BD FACSCanto cell sorter. We also thank Bingbing Yuan for help with processing and analyzing the microarray data. The DS19 MEL clones were obtained from Arthur Skoultchi (Albert Einstein College of Medicine). We thank Eva Buys and her crew for the zebrafish animal husbandry. We also thank Harry Dailey and Amy Medlock for their critical feedback on the manuscript and Stashauna Carter for technical assistance. Fluorescence confocal microscopy was performed at the Harvard Digestive Disease Center Imaging Facility (Boston Children's Hospital, supported by National Institutes of Health Grant P30 DK34854) with assistance from Ramiro Massol. HPLC analyses of porphyrins were performed at the University of Utah Center for Iron and Heme Disorders supported by National Institutes of Health Grant U54 DK110858.	Amigo JD, 2011, MOL CELL BIOL, V31, P1344, DOI 10.1128/MCB.01010-10; Andrews NC, 2008, BLOOD, V112, P219, DOI 10.1182/blood-2007-12-077388; Canver MC, 2014, J BIOL CHEM, V289, P21312, DOI 10.1074/jbc.M114.564625; Chami N, 2016, AM J HUM GENET, V99, P8, DOI 10.1016/j.ajhg.2016.05.007; Chen CY, 2013, CELL METAB, V17, P343, DOI 10.1016/j.cmet.2013.01.013; Chen CY, 2012, BBA-MOL CELL RES, V1823, P1459, DOI 10.1016/j.bbamcr.2012.01.003; Chen W, 2010, BLOOD, V116, P628, DOI 10.1182/blood-2009-12-259614; Chen W, 2009, P NATL ACAD SCI USA, V106, P16263, DOI 10.1073/pnas.0904519106; Cheng AW, 2014, BLOOD, V124, P598, DOI 10.1182/blood-2013-12-542209; Christenson ET, 2018, J BIOL CHEM, V293, P3819, DOI 10.1074/jbc.M117.817478; Chung J, 2017, ELIFE, V6, DOI 10.7554/eLife.24767; Chung J, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa5903; Chung J, 2014, J BIOL CHEM, V289, P7835, DOI 10.1074/jbc.M114.547778; Cioffi AG, 2015, J AM CHEM SOC, V137, P10096, DOI 10.1021/jacs.5b05765; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; COX TC, 1991, EMBO J, V10, P1891, DOI 10.1002/j.1460-2075.1991.tb07715.x; Crooks DR, 2010, BLOOD, V115, P860, DOI 10.1182/blood-2009-09-243105; DAILEY HA, 1983, J BIOL CHEM, V258, P1453; Feng D, 2012, MOL CELL, V47, P158, DOI 10.1016/j.molcel.2012.06.026; Fleming MD, 1997, NAT GENET, V16, P383, DOI 10.1038/ng0897-383; Fleming MD, 1998, P NATL ACAD SCI USA, V95, P1148, DOI 10.1073/pnas.95.3.1148; Froschauer EM, 2013, BIOCHEM J, V455, P57, DOI 10.1042/BJ20130144; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Gammella E, 2015, AM J PHYSIOL-REG I, V308, pR330, DOI 10.1152/ajpregu.00410.2014; Ganesh SK, 2009, NAT GENET, V41, P1191, DOI 10.1038/ng.466; Ganis JJ, 2012, DEV BIOL, V366, P185, DOI 10.1016/j.ydbio.2012.03.021; Girvan HM, 2013, J BIOL CHEM, V288, P13194, DOI 10.1074/jbc.R112.422642; Grillo AS, 2017, SCIENCE, V356, P608, DOI 10.1126/science.aah3862; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Hammerschmidt M, 1996, DEVELOPMENT, V123, P95; Handschin C, 2005, CELL, V122, P505, DOI 10.1016/j.cell.2005.06.040; Hattangadi SM, 2010, BLOOD, V115, P4853, DOI 10.1182/blood-2009-07-235093; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Huang JL, 2016, DEV CELL, V36, P9, DOI 10.1016/j.devcel.2015.12.014; Kardon JR, 2015, CELL, V161, P858, DOI 10.1016/j.cell.2015.04.017; Kingsley PD, 2013, BLOOD, V121, pE5, DOI 10.1182/blood-2012-04-422394; Kondo A, 2016, INT J HEMATOL, V103, P387, DOI 10.1007/s12185-016-1968-4; Lange H, 1999, J BIOL CHEM, V274, P18989, DOI 10.1074/jbc.274.27.18989; Levy JE, 1999, NAT GENET, V21, P396, DOI 10.1038/7727; Li LT, 2001, J BIOL CHEM, V276, P29515, DOI 10.1074/jbc.M103944200; Lim JE, 2005, NAT GENET, V37, P1270, DOI 10.1038/ng1659; Lu XH, 2008, J BIOL CHEM, V283, P5258, DOI 10.1074/jbc.M707125200; Maio N, 2015, BBA-MOL CELL RES, V1853, P1493, DOI 10.1016/j.bbamcr.2014.09.009; Martinkova M, 2013, J BIOL CHEM, V288, P27702, DOI 10.1074/jbc.R113.473249; Matak P, 2016, P NATL ACAD SCI USA, V113, P3428, DOI 10.1073/pnas.1519473113; Medlock AE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135896; Metzendorf C, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-68; Muhlenhoff U, 2003, J BIOL CHEM, V278, P40612, DOI 10.1074/jbc.M307847200; Nai A, 2016, BLOOD, V127, P2327, DOI 10.1182/blood-2015-11-681494; Napier I, 2005, BLOOD, V105, P1867, DOI 10.1182/blood-2004-10-3856; Ning B, 2011, J BIOL CHEM, V286, P37196, DOI 10.1074/jbc.M111.258129; Ohgami RS, 2005, NAT GENET, V37, P1264, DOI 10.1038/ng1658; Paradkar PN, 2009, MOL CELL BIOL, V29, P1007, DOI 10.1128/MCB.01685-08; Philpott CC, 2012, BBA-MOL CELL RES, V1823, P1509, DOI 10.1016/j.bbamcr.2012.01.012; PROULX KL, 1993, PROTEIN SCI, V2, P1092, DOI 10.1002/pro.5560020703; Ramsey AJ, 1996, J BIOL CHEM, V271, P24395, DOI 10.1074/jbc.271.40.24395; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reischauer S, 2016, NATURE, V535, P294, DOI 10.1038/nature18614; Richardson DR, 2010, P NATL ACAD SCI USA, V107, P10775, DOI 10.1073/pnas.0912925107; Richmond TD, 2005, TRENDS CELL BIOL, V15, P146, DOI 10.1016/j.tcb.2005.01.007; ROSSI E, 1988, CLIN CHEM, V34, P2481; Roy CN, 1999, J BIOL CHEM, V274, P9022, DOI 10.1074/jbc.274.13.9022; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512; Socolovsky M, 1999, CELL, V98, P181, DOI 10.1016/S0092-8674(00)81013-2; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; STAINIER DYR, 1995, DEVELOPMENT, V121, P3141; Sun SJ, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.273; Surinya KH, 1997, J BIOL CHEM, V272, P26585, DOI 10.1074/jbc.272.42.26585; Troadec MB, 2011, BLOOD, V117, P5494, DOI 10.1182/blood-2010-11-319483; Ulirsch JC, 2016, CELL, V165, P1530, DOI 10.1016/j.cell.2016.04.048; Visconte V, 2015, LEUKEMIA, V29, P188, DOI 10.1038/leu.2014.170; Wang YM, 2011, EXP HEMATOL, V39, P784, DOI 10.1016/j.exphem.2011.05.003; Wingert RA, 2005, NATURE, V436, P1035, DOI 10.1038/nature03887; Wolff NA, 2014, FASEB J, V28, P2134, DOI 10.1096/fj.13-240564; Wong P, 2011, BLOOD, V118, pE128, DOI 10.1182/blood-2011-03-341404; Ye H, 2010, BIOCHEMISTRY-US, V49, P4945, DOI 10.1021/bi1004798; Yien YY, 2014, J CLIN INVEST, V124, P4294, DOI 10.1172/JCI76979; Yu M, 2009, MOL CELL, V36, P682, DOI 10.1016/j.molcel.2009.11.002; Zhang J, 2003, BLOOD, V102, P3938, DOI 10.1182/blood-2003-05-1479	81	18	19	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19797	19811		10.1074/jbc.RA118.002742	http://dx.doi.org/10.1074/jbc.RA118.002742			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30366982	hybrid, Green Published			2022-12-28	WOS:000454294900024
J	Takahashi, A; Mulati, M; Saito, M; Numata, H; Kobayashi, Y; Ochi, H; Sato, S; Kaldis, P; Okawa, A; Inose, H				Takahashi, Akira; Mulati, Mieradili; Saito, Masanori; Numata, Hoashi; Kobayashi, Yutaka; Ochi, Hiroki; Sato, Shingo; Kaldis, Philipp; Okawa, Atsushi; Inose, Hiroyuki			Loss of cyclin-dependent kinase 1 impairs bone formation, but does not affect the bone-anabolic effects of parathyroid hormone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bone; cell cycle; osteoblast; osteoporosis; parathyroid hormone; cyclin-dependent kinase (CDK); bone loss; bony union; osteoblastogenesis	OSTEOBLAST PROLIFERATION; CDK1; PTH; PHOSPHORYLATION; DIFFERENTIATION; PROGRESSION; APOPTOSIS; NONUNION; ROLES	Bone mass is maintained by a balance between osteoblast-mediated bone formation and osteoclast-mediated bone resorption. Although recent genetic studies have uncovered various mechanisms that regulate osteoblast differentiation, the molecular basis of osteoblast proliferation remains unclear. Here, using an osteoblast-specific loss-of-function mouse model, we demonstrate that cyclin-dependent kinase 1 (Cdk1) regulates osteoblast proliferation and differentiation. Quantitative RT-PCR analyses revealed that Cdk1 is highly expressed in bone and is down-regulated upon osteoblast differentiation. We also noted that Cdk1 is dispensable for the bone-anabolic effects of parathyroid hormone (PTH). Cdk1 deletion in osteoblasts led to osteoporosis in adult mice due to low bone formation, but did not affect osteoclast formation in vivo. Cdk1 overexpression in osteoblasts promoted proliferation, and conversely, Cdk1 knockdown inhibited osteoblast proliferation and promoted differentiation. Of note, we provide direct evidence that PTH's bone-anabolic effects occur without enhancing osteoblast proliferation in vivo. Furthermore, we found that Cdk1 expression in osteoblasts is essential for bone fracture repair. These findings may help reduce the risk of nonunion after bone fracture and identify patients at higher risk for nonresponse to PTH treatment. Collectively, our results indicate that Cdk1 is essential for osteoblast proliferation and that it functions as a molecular switch that shifts osteoblast proliferation to maturation. We therefore conclude that Cdk1 plays an important role in bone formation.	[Takahashi, Akira; Mulati, Mieradili; Saito, Masanori; Numata, Hoashi; Kobayashi, Yutaka; Okawa, Atsushi; Inose, Hiroyuki] Tokyo Med & Dent Univ, Grad Sch, Dept Orthoped, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan; [Ochi, Hiroki; Sato, Shingo] Tokyo Med & Dent Univ, Dept Physiol & Cell Biol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan; [Kaldis, Philipp] Agcy Sci Technol & Res, Inst Mol & Cell Biol, Singapore 138673, Singapore; [Kaldis, Philipp] Natl Univ Singapore, Dept Biochem, Singapore 117597, Singapore	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore	Inose, H (corresponding author), Tokyo Med & Dent Univ, Grad Sch, Dept Orthoped, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	inose.orth@tmd.ac.jp	Saito, Masanori/GRR-1714-2022; Kaldis, Philipp/G-2714-2010	Kaldis, Philipp/0000-0002-7247-7591; Saito, Masanori/0000-0002-4139-4013; Sato, Shingo/0000-0002-6227-5910; INOSE, HIROYUKI/0000-0003-4195-2545	Japan Society for the Promotion of Science (JSPS) [15H05681]; Agency for Science, Technology and Research (A*STAR), Japan Agency for Medical Research and Development (AMED); Nakatomi Foundation	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Agency for Science, Technology and Research (A*STAR), Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Nakatomi Foundation	This work was supported by Japan Society for the Promotion of Science (JSPS) Grant 15H05681, Agency for Science, Technology and Research (A*STAR), Japan Agency for Medical Research and Development (AMED), and the Nakatomi Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Almeida Maria, 2012, Bonekey Rep, V1; Augustine M, 2013, CURR OSTEOPOROS REP, V11, P400, DOI 10.1007/s11914-013-0171-2; Davey RA, 2012, TRANSGENIC RES, V21, P885, DOI 10.1007/s11248-011-9581-z; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Diril MK, 2012, P NATL ACAD SCI USA, V109, P3826, DOI 10.1073/pnas.1115201109; Eastaugh-Waring SJ, 2009, CLIN ORTHOP RELAT R, V467, P1986, DOI 10.1007/s11999-009-0775-0; Elraiyah Tarig, 2016, Bone Rep, V4, P17, DOI 10.1016/j.bonr.2015.11.001; Inose H, 2018, SPINE, V43, pE29, DOI 10.1097/BRS.0000000000001995; Inose H, 2009, P NATL ACAD SCI USA, V106, P20794, DOI 10.1073/pnas.0909311106; Jilka RL, 1999, J CLIN INVEST, V104, P439, DOI 10.1172/JCI6610; Jilka RL, 2009, BONE, V44, P275, DOI 10.1016/j.bone.2008.10.037; Karsenty G, 2009, ANNU REV CELL DEV BI, V25, P629, DOI 10.1146/annurev.cellbio.042308.113308; Karuppaiah K, 2016, DEVELOPMENT, V143, P1811, DOI 10.1242/dev.131722; Krege JH, 2014, OSTEOPOROSIS INT, V25, P2159, DOI 10.1007/s00198-014-2646-0; Lian JB, 2012, NAT REV ENDOCRINOL, V8, P212, DOI 10.1038/nrendo.2011.234; LIBERMAN UA, 1995, NEW ENGL J MED, V333, P1437, DOI 10.1056/NEJM199511303332201; Lim SH, 2013, DEVELOPMENT, V140, P3079, DOI 10.1242/dev.091744; Lindsay R, 2007, J BONE MINER RES, V22, P495, DOI 10.1359/JBMR.070104; Marsell R, 2011, INJURY, V42, P551, DOI 10.1016/j.injury.2011.03.031; McClung MR, 2014, NEW ENGL J MED, V370, P412, DOI 10.1056/NEJMoa1305224; Morley P, 2001, CURR PHARM DESIGN, V7, P671, DOI 10.2174/1381612013397780; Obernosterer G, 2007, NAT PROTOC, V2, P1508, DOI 10.1038/nprot.2007.153; Onishi T, 1997, J BONE MINER RES, V12, P1596, DOI 10.1359/jbmr.1997.12.10.1596; Pettway GJ, 2008, BONE, V42, P806, DOI 10.1016/j.bone.2007.11.017; Qin L, 2005, J BIOL CHEM, V280, P3104, DOI 10.1074/jbc.M409846200; Rajgopal A, 2007, J CELL BIOCHEM, V100, P1509, DOI 10.1002/jcb.21137; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Saito M, 2016, SCI REP-UK, V6, DOI 10.1038/srep20622; Satyanarayana A, 2008, DEVELOPMENT, V135, P3389, DOI 10.1242/dev.024919; Shirakawa J, 2016, CALCIFIED TISSUE INT, V98, P306, DOI 10.1007/s00223-015-0083-5; Suryadinata R, 2010, BIOSCIENCE REP, V30, P243, DOI 10.1042/BSR20090171; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; Thomas DM, 2001, MOL CELL, V8, P303, DOI 10.1016/S1097-2765(01)00327-6; Vassilev LT, 2006, CELL CYCLE, V5, P2555, DOI 10.4161/cc.5.22.3463; Wang YH, 2007, AM J PHYSIOL-ENDOC M, V292, pE594, DOI 10.1152/ajpendo.00216.2006; Zhang WW, 2011, J CELL BIOCHEM, V112, P942, DOI 10.1002/jcb.23010; Zura R, 2017, BONE, V95, P26, DOI 10.1016/j.bone.2016.11.006	37	7	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2018	293	50					19387	19399		10.1074/jbc.RA118.004834	http://dx.doi.org/10.1074/jbc.RA118.004834			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HE6RA	30366983	Green Published, hybrid			2022-12-28	WOS:000453537300020
J	Pellock, SJ; Walton, WG; Biernat, KA; Torres-Rivera, D; Creekmore, BC; Xu, YM; Liu, J; Tripathy, A; Stewart, LJ; Redinbo, MR				Pellock, Samuel J.; Walton, William G.; Biernat, Kristen A.; Torres-Rivera, Dariana; Creekmore, Benjamin C.; Xu, Yongmei; Liu, Jian; Tripathy, Ashutosh; Stewart, Lance J.; Redinbo, Matthew R.			Three structurally and functionally distinct beta-glucuronidases from the human gut microbe Bacteroides uniformis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-ACTIVE ENZYMES; INHIBITION; PROTEIN; INTESTINE; RECEPTOR; ENTEROPATHY; REVEALS	The glycoside hydrolases encoded by the human gut microbiome play an integral role in processing a variety of exogenous and endogenous glycoconjugates. Here we present three structurally and functionally distinct beta-glucuronidase (GUS) glycoside hydrolases from a single human gut commensal microbe, Bacteroides uniformis. We show using nine crystal structures, biochemical, and biophysical data that whereas these three proteins share similar overall folds, they exhibit different structural features that create three structurally and functionally unique enzyme active sites. Notably, quaternary structure plays an important role in creating distinct active site features that are hard to predict via structural modeling methods. The enzymes display differential processing capabilities toward glucuronic acid-containing polysaccharides and SN-38-glucuronide, a metabolite of the cancer drug irinotecan. We also demonstrate that GUS-specific and nonselective inhibitors exhibit varying potencies toward each enzyme. Together, these data highlight the diversity of GUS enzymes within a single Bacteroides gut commensal and advance our understanding of how structural details impact the specific roles microbial enzymes play in processing drug-glucuronide and glycan substrates.	[Pellock, Samuel J.; Walton, William G.; Biernat, Kristen A.; Torres-Rivera, Dariana; Creekmore, Benjamin C.; Redinbo, Matthew R.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; [Xu, Yongmei; Liu, Jian] Univ N Carolina, Dept Chem Biol & Med Chem, Chapel Hill, NC 27599 USA; [Tripathy, Ashutosh; Redinbo, Matthew R.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Redinbo, Matthew R.] Univ N Carolina, Dept Microbiol, Chapel Hill, NC 27599 USA; [Redinbo, Matthew R.] Univ N Carolina, Dept Immunol, Chapel Hill, NC 27599 USA; [Redinbo, Matthew R.] Univ N Carolina, Integrat Program Biol & Genome Sci, Chapel Hill, NC 27599 USA; [Stewart, Lance J.] Univ Washington, Dept Biochem, Inst Prot Design, Seattle, WA 98195 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Washington; University of Washington Seattle	Redinbo, MR (corresponding author), Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA.	redinbo@unc.edu		Creekmore, Benjamin/0000-0001-7973-9438	National Institutes of Health [CA098468, CA207416, GM102137, HL094463]; NATIONAL CANCER INSTITUTE [R01CA207416, R01CA098468] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM102137] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health Grants CA098468 and CA207416 (to M. R. R.) and GM102137 and HL094463 (to J. L.). M. R. R. is the scientific founder of Symberix, Inc., which is developing microbiome-targeted therapeutics. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Andberg M, 2012, J BIOL CHEM, V287, P17662, DOI 10.1074/jbc.M111.335240; Boelsterli UA, 2013, TOXICOL SCI, V131, P654, DOI 10.1093/toxsci/kfs310; CONCHIE J, 1967, BIOCHEM J, V102, P929, DOI 10.1042/bj1020929; Dong RZ, 2018, BIOINFORMATICS, V34, P1719, DOI 10.1093/bioinformatics/btx828; El Kaoutari A, 2013, NAT REV MICROBIOL, V11, P497, DOI 10.1038/nrmicro3050; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flint HJ, 2012, GUT MICROBES, V3, P289, DOI 10.4161/gmic.19897; Jain S, 1996, NAT STRUCT BIOL, V3, P375, DOI 10.1038/nsb0496-375; LoGuidice A, 2012, J PHARMACOL EXP THER, V341, P447, DOI 10.1124/jpet.111.191122; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lombard V, 2010, BIOCHEM J, V432, P437, DOI 10.1042/BJ20101185; Mani S, 2014, ANNU REV PHARMACOL, V54, P559, DOI 10.1146/annurev-pharmtox-011613-140007; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; MCNEIL NI, 1984, AM J CLIN NUTR, V39, P338, DOI 10.1093/ajcn/39.2.338; Ndeh D, 2017, NATURE, V544, P65, DOI 10.1038/nature21725; Ovchinnikov S, 2018, PROTEINS, V86, P113, DOI 10.1002/prot.25390; Park H, 2018, P NATL ACAD SCI USA, V115, P3054, DOI 10.1073/pnas.1719115115; Park H, 2018, PROTEINS, V86, P283, DOI 10.1002/prot.25387; Pellock SJ, 2017, J BIOL CHEM, V292, P8569, DOI 10.1074/jbc.R116.767434; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pluznick JL, 2013, P NATL ACAD SCI USA, V110, P4410, DOI 10.1073/pnas.1215927110; Pollet RM, 2017, STRUCTURE, V25, P967, DOI 10.1016/j.str.2017.05.003; Roberts AB, 2013, MOL PHARMACOL, V84, P208, DOI 10.1124/mol.113.085852; Saitta KS, 2014, XENOBIOTICA, V44, P28, DOI 10.3109/00498254.2013.811314; SALYERS AA, 1977, APPL ENVIRON MICROB, V33, P319, DOI 10.1128/AEM.33.2.319-322.1977; Samuel BS, 2008, P NATL ACAD SCI USA, V105, P16767, DOI 10.1073/pnas.0808567105; Schallus T, 2008, MOL BIOL CELL, V19, P3404, DOI 10.1091/mbc.E08-04-0354; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Wallace BD, 2015, CHEM BIOL, V22, P1238, DOI 10.1016/j.chembiol.2015.08.005; Wallace BD, 2013, CURR OPIN CHEM BIOL, V17, P379, DOI 10.1016/j.cbpa.2013.04.011; Wallace BD, 2010, SCIENCE, V330, P831, DOI 10.1126/science.1191175; Xu YM, 2014, NAT CHEM BIOL, V10, P248, DOI [10.1038/NCHEMBIO.1459, 10.1038/nchembio.1459]; Zitomersky NL, 2011, INFECT IMMUN, V79, P2012, DOI 10.1128/IAI.01348-10	37	37	38	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2018	293	48					18559	18573		10.1074/jbc.RA118.005414	http://dx.doi.org/10.1074/jbc.RA118.005414			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NX	30301767	Green Published, hybrid			2022-12-28	WOS:000458467300012
J	Rani, R; Kumar, S; Sharma, A; Mohanty, SK; Donnelly, B; Tiao, GM; Gandhi, CR				Rani, Richa; Kumar, Sudhir; Sharma, Akanksha; Mohanty, Sujit K.; Donnelly, Bryan; Tiao, Gregory M.; Gandhi, Chandrashekhar R.			Mechanisms of concanavalin A-induced cytokine synthesis by hepatic stellate cells: Distinct roles of interferon regulatory factor-1 in liver injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KUPFFER CELLS; MEDIATED HEPATITIS; DNA-SYNTHESIS; T-CELLS; ENDOTOXIN; FIBROSIS; HEPATOCYTES; INDUCTION; INFLAMMATION; PATHWAY	Mice depleted of hepatic stellate cells (HSCs) are protected from concanavalin A (ConA)-induced liver injury that is mediated by the activation of interferon regulatory factor 1 (IRF1). The aim of this study was to determine the mechanisms of ConA-mediated signaling and synthesis/release of mediators by HSCs that damage hepatocytes. Primary cultures of wildtype (WT) and IRF1-knockout (KO) HSCs and hepatocytes were used, and ConA-induced liver damage in interferon (IFN) alpha beta receptor-deficient (IFN alpha beta R-KO) mice was determined. Specific binding of ConA to HSCs induced rapid activation of JAK2 and STAT1. ConA-induced expression of IRF1, IFN beta, tumor necrosis factor alpha, and CXCL1 was abrogated by selective inhibition of JAK2 and STAT1. Despite activating JAK2/STAT1, ConA failed to stimulate expression of inflammatory cytokines in HSCs from IRF1-KO mice. ConA-conditioned WT-HSC medium caused activation of JNK and caspase 3, and apoptosis of hepatocytes from WT but not from IRF1-KO or IFN alpha beta R-KO mice. Conversely, ConA-conditioned medium of IRF1-KO HSCs failed to cause apoptosis of WT or IRF1-KO hepatocytes. IFN alpha beta R-KO mice were protected from ConA-induced liver damage, and ConA-induced hepatic expression of IRF1 and pro-inflammatory cytokines and chemokines, and infiltration of neutrophils were significantly lower in IFN alpha beta R-KO than in WT mice. These results demonstrate distinct roles of IRF1 in hepatic inflammation (HSCs) and injury (hepatocytes) and can be an important target for intervention in acute liver injury.	[Rani, Richa; Kumar, Sudhir; Sharma, Akanksha; Mohanty, Sujit K.; Donnelly, Bryan; Tiao, Gregory M.; Gandhi, Chandrashekhar R.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA; [Rani, Richa; Kumar, Sudhir; Gandhi, Chandrashekhar R.] Cincinnati Vet Affairs Med Ctr, Cincinnati, OH 45220 USA; [Gandhi, Chandrashekhar R.] Univ Cincinnati, Dept Surg, Cincinnati, OH 45220 USA	Cincinnati Children's Hospital Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center; University System of Ohio; University of Cincinnati	Gandhi, CR (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Gastroenterol Hepatol & Nutr, 3333 Burnett Ave, Cincinnati, OH 45229 USA.	chandrashekhar.gandhi@cchmc.org	Kumar, Sudhir/J-3844-2019; Sharma, Akanksha/ABI-4027-2020	Sharma, Akanksha/0000-0001-6321-0564; Mohanty, Sujit/0000-0001-9559-4638	U.S. Department of Veterans Affairs (VA) Merit Review Award [1IO1BX001174]; U.S. Department of Defense (DOD) [W81XWH-14-PRMRP-IIRA]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001174] Funding Source: NIH RePORTER	U.S. Department of Veterans Affairs (VA) Merit Review Award(US Department of Veterans Affairs); U.S. Department of Defense (DOD)(United States Department of Defense); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by U.S. Department of Veterans Affairs (VA) Merit Review Award 1IO1BX001174 (to C. R. G.) and U.S. Department of Defense (DOD) Grant W81XWH-14-PRMRP-IIRA. The authors declare that they have no conflicts of interest with the contents of this article.	Afonso V, 2006, FREE RADICAL BIO MED, V41, P709, DOI 10.1016/j.freeradbiomed.2006.05.014; [Anonymous], 2011, NAT RES COUNC GUID C, V8th; Bhattacharya A, 2015, IMMUNITY, V43, P974, DOI 10.1016/j.immuni.2015.10.013; Chambers JW, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.223602; Chen L, 2011, HEPATOB PANCREAT DIS, V10, P171, DOI 10.1016/S1499-3872(11)60027-1; Dangi A, 2016, J CELL PHYSIOL, V231, P94, DOI 10.1002/jcp.25055; Dangi A, 2012, J IMMUNOL, V188, P3667, DOI 10.4049/jimmunol.1102460; Deng SY, 2017, INT J MOL MED, V40, P1261, DOI 10.3892/ijmm.2017.3110; Dhupar R, 2011, SHOCK, V35, P293, DOI 10.1097/SHK.0b013e3181f6aab0; Ferayorni L. S, 1983, ISOLATION CHARACTERI, P271; Friedman SL, 2015, DIGEST DIS, V33, P504, DOI 10.1159/000374098; Gandhi CR, 2015, STELLATE CELLS IN HEALTH AND DISEASE, P209, DOI 10.1016/B978-0-12-800134-9.00013-0; Gandhi CR, 2015, STELLATE CELLS IN HEALTH AND DISEASE, P227, DOI 10.1016/B978-0-12-800134-9.00014-2; Goritzka M, 2014, J VIROL, V88, P6128, DOI 10.1128/JVI.00333-14; Harvey SAK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082159; Heymann F, 2015, LAB ANIM-UK, V49, P12, DOI 10.1177/0023677215572841; Hong F, 2002, J CLIN INVEST, V110, P1503, DOI 10.1172/JCI200215841; Jaruga B, 2004, AM J PHYSIOL-GASTR L, V287, pG1044, DOI 10.1152/ajpgi.00184.2004; Kanda N, 2007, EUR J IMMUNOL, V37, P338, DOI 10.1002/eji.200636420; Knolle PA, 1996, HEPATOLOGY, V24, P824, DOI 10.1002/hep.510240413; Kumar S, 2017, AM J PATHOL, V187, P1356, DOI 10.1016/j.ajpath.2017.01.021; Kumar S, 2017, J LEUKOCYTE BIOL, V101, P429, DOI 10.1189/jlb.2A0516-239R; Kumar S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147864; Kusters S, 1996, GASTROENTEROLOGY, V111, P462, DOI 10.1053/gast.1996.v111.pm8690213; Leist M, 1996, J HEPATOL, V25, P948, DOI 10.1016/S0168-8278(96)80301-1; Mizuhara H, 1998, HEPATOLOGY, V27, P513, DOI 10.1002/hep.510270227; MIZUHARA H, 1994, J EXP MED, V179, P1529, DOI 10.1084/jem.179.5.1529; Morita A, 2003, HEPATOL RES, V27, P143, DOI 10.1016/S1386-6346(03)00206-7; Radaeva S, 2002, GASTROENTEROLOGY, V122, P1020, DOI 10.1053/gast.2002.32388; Rani R, 2017, AM J PATHOL, V187, P2008, DOI 10.1016/j.ajpath.2017.05.015; Riera H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127571; ROTH RA, 1983, BIOCHEM BIOPH RES CO, V115, P245, DOI 10.1016/0006-291X(83)90996-8; Scharf JG, 1998, HEPATOLOGY, V27, P1275, DOI 10.1002/hep.510270513; Schumann J, 2000, AM J PATHOL, V157, P1671, DOI 10.1016/S0002-9440(10)64804-3; Schuppan D, 2015, CLIN RES HEPATOL GAS, V39, pS51, DOI 10.1016/j.clinre.2015.05.005; Siebler J, 2003, HEPATOLOGY, V38, P1573, DOI 10.1016/j.hep.2003.09.020; Stewart RK, 2014, J HEPATOL, V60, P298, DOI 10.1016/j.jhep.2013.09.013; Sumpter TL, 2012, J IMMUNOL, V189, P3848, DOI 10.4049/jimmunol.1200819; Thirunavukkarasu C, 2005, J CELL PHYSIOL, V204, P654, DOI 10.1002/jcp.20366; Thirunavukkarasu C, 2006, HEPATOLOGY, V44, P389, DOI 10.1002/hep.21254; Tiegs G, 2007, Z GASTROENTEROL, V45, P63, DOI 10.1055/s-2006-927397; TIEGS G, 1992, J CLIN INVEST, V90, P196, DOI 10.1172/JCI115836; Trautwein C, 2015, J HEPATOL, V62, pS15, DOI 10.1016/j.jhep.2015.02.039; Tsung A, 2006, AM J PHYSIOL-GASTR L, V290, pG1261, DOI 10.1152/ajpgi.00460.2005; Uemura T, 2001, BRIT J PHARMACOL, V133, P1125, DOI 10.1038/sj.bjp.0704151; Vandenbon A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S10-S4; Vila-del Sol V, 2008, J IMMUNOL, V181, P4461, DOI 10.4049/jimmunol.181.7.4461; Winau F, 2007, IMMUNITY, V26, P117, DOI 10.1016/j.immuni.2006.11.011	48	16	16	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2018	293	48					18466	18476		10.1074/jbc.RA118.005583	http://dx.doi.org/10.1074/jbc.RA118.005583			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NX	30348900	Green Published, hybrid			2022-12-28	WOS:000458467300005
J	Henen, MA; Mahlawat, P; Zwieb, C; Kodali, RB; Hinck, CS; Hanna, RD; Krzysiak, TC; Ilangovan, U; Cano, KE; Hinck, G; Vonberg, M; McCabe, M; Hinck, AP				Henen, Morkos A.; Mahlawat, Pardeep; Zwieb, Christian; Kodali, Ravindra B.; Hinck, Cynthia S.; Hanna, Ramsey D.; Krzysiak, Troy C.; Ilangovan, Udayar; Cano, Kristin E.; Hinck, Garrett; Vonberg, Machell; McCabe, Megan; Hinck, Andrew P.			TGF-2 uses the concave surface of its extended finger region to bind betaglycan's ZP domain via three residues specific to TGF- and inhibin-	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						transforming growth factor (TGF-B); cell surface receptor; cell signaling; cardiac development; endocrinology; nuclear magnetic resonance (NMR); betaglycan; finger region; ILV methyl labeling	GROWTH-FACTOR-BETA; CRYSTAL-STRUCTURE; NMR-SPECTROSCOPY; LIGAND-BINDING; SECONDARY STRUCTURE; STRUCTURAL BASIS; CHEMICAL-SHIFTS; METHYL-GROUPS; RECEPTOR; PROTEIN	Betaglycan (BG) is a membrane-bound co-receptor of the TGF- family that selectively binds transforming growth factor- (TGF-) isoforms and inhibin A (InhA) to enable temporal-spatial patterns of signaling essential for their functions in vivo. Here, using NMR titrations of methyl-labeled TGF-2 with BG's C-terminal binding domain, BG(ZP-C), and surface plasmon resonance binding measurements with TGF-2 variants, we found that the BG(ZP-C)-binding site on TGF-2 is located on the inner surface of its extended finger region. Included in this binding site are Ile-92, Lys-97, and Glu-99, which are entirely or mostly specific to the TGF- isoforms and the InhA -subunit, but they are unconserved in other TGF- family growth factors (GFs). In accord with the proposed specificity-determining role of these residues, BG bound bone morphogenetic protein 2 (BMP-2) weakly or not at all, and TGF-2 variants with the corresponding residues from BMP-2 bound BG(ZP-C) more weakly than corresponding alanine variants. The BG(ZP-C)-binding site on InhA previously was reported to be located on the outside of the extended finger region, yet at the same time to include Ser-112 and Lys-119, homologous to TGF-2 Ile-92 and Lys-97, on the inside of the fingers. Therefore, it is likely that both TGF-2 and InhA bind BG(ZP-C) through a site on the inside of their extended finger regions. Overall, these results identify the BG(ZP-C)-binding site on TGF-2 and shed light on the specificity of BG for select TGF--type GFs and the mechanisms by which BG influences their signaling.	[Henen, Morkos A.; Mahlawat, Pardeep; Kodali, Ravindra B.; Hinck, Cynthia S.; Krzysiak, Troy C.; Hinck, Garrett; Hinck, Andrew P.] Univ Pittsburgh, Dept Struct Biol, Pittsburgh, PA 15260 USA; [Hanna, Ramsey D.] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA; [Henen, Morkos A.; Mahlawat, Pardeep; Zwieb, Christian; Hinck, Cynthia S.; Ilangovan, Udayar; Cano, Kristin E.; Hinck, Garrett; Vonberg, Machell; McCabe, Megan; Hinck, Andrew P.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem & Struct Biol, San Antonio, TX 78229 USA; [Henen, Morkos A.] Mansoura Univ, Fac Pharm, El Goumhria St, Mansoura 35516, Egypt	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Texas System; University of Texas Health San Antonio; Egyptian Knowledge Bank (EKB); Mansoura University	Hinck, AP (corresponding author), Univ Pittsburgh, Sch Med, Dept Struct Biol, Biomed Sci Tower 3,Rm 2051,3501 Fifth Ave, Pittsburgh, PA 15260 USA.	ahinck@pitt.edu	Henen, Morkos/M-5995-2018	Henen, Morkos/0000-0003-4835-5583; Hinck, Andrew/0000-0003-3320-8054	National Institutes of Health NIGMS [P41-GM103311]	National Institutes of Health NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	David Brinkman is thanked for the initial efforts to generate and characterize several TGF-2 variants; Erich Hellemann for measuring the mass of the TGF-2 variants; Mike Delk for maintaining the NMR instruments, and Profs. Craig Harrison and Daniel Bernard for providing valuable comments on the manuscript. Molecular graphics and analyses were performed with UCSF Chimera. Chimera is developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by National Institutes of Health NIGMS Grant P41-GM103311).	Alva V, 2016, NUCLEIC ACIDS RES, V44, pW410, DOI 10.1093/nar/gkw348; Amero C, 2011, J BIOMOL NMR, V50, P229, DOI 10.1007/s10858-011-9513-5; Baardsnes J, 2009, BIOCHEMISTRY-US, V48, P2146, DOI 10.1021/bi8019004; Bernard DJ, 2002, MOL ENDOCRINOL, V16, P207, DOI 10.1210/me.16.2.207; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bocharov EV, 2000, J BIOMOL NMR, V16, P179, DOI 10.1023/A:1008315600134; BOYD FT, 1989, J BIOL CHEM, V264, P2272; Brown CB, 1999, SCIENCE, V283, P2080, DOI 10.1126/science.283.5410.2080; CHEIFETZ S, 1990, J BIOL CHEM, V265, P20533; CHEIFETZ S, 1992, J BIOL CHEM, V267, P19027; CLUBB RT, 1992, J MAGN RESON, V97, P213, DOI 10.1016/0022-2364(92)90252-3; Cull MG, 2000, METHOD ENZYMOL, V326, P430; DAOPIN S, 1992, SCIENCE, V257, P369, DOI 10.1126/science.1631557; Daopin Sun, 1993, Proteins Structure Function and Genetics, V17, P176, DOI 10.1002/prot.340170207; De Crescenzo G, 2006, J MOL BIOL, V355, P47, DOI 10.1016/j.jmb.2005.10.022; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Diestel U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067214; Eghbalnia HR, 2005, J BIOMOL NMR, V32, P71, DOI 10.1007/s10858-005-5705-1; Esparza-Lopez J, 2001, J BIOL CHEM, V276, P14588, DOI 10.1074/jbc.M008866200; Gans P, 2010, ANGEW CHEM INT EDIT, V49, P1958, DOI 10.1002/anie.200905660; Goto NK, 1999, J BIOMOL NMR, V13, P369, DOI 10.1023/A:1008393201236; Groppe J, 2002, NATURE, V420, P636, DOI 10.1038/nature01245; Groppe J, 2008, MOL CELL, V29, P157, DOI 10.1016/j.molcel.2007.11.039; GRZESIEK S, 1992, J MAGN RESON, V96, P432, DOI 10.1016/0022-2364(92)90099-S; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; Hart PJ, 2002, NAT STRUCT BIOL, V9, P203, DOI 10.1038/nsb766; Hata A, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a022061; Heldin CH, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a022053; Hinck AP, 1996, BIOCHEMISTRY-US, V35, P8517, DOI 10.1021/bi9604946; Huang T, 2016, METHODS MOL BIOL, V1344, P63, DOI 10.1007/978-1-4939-2966-5_4; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Katagiri T, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a021899; KAY LE, 1990, J MAGN RESON, V89, P496, DOI 10.1016/0022-2364(90)90333-5; Kerfah R, 2015, CURR OPIN STRUC BIOL, V32, P113, DOI 10.1016/j.sbi.2015.03.009; Kerfah R, 2015, J BIOMOL NMR, V61, P73, DOI 10.1007/s10858-014-9887-2; Kim SK, 2017, J BIOL CHEM, V292, P7173, DOI 10.1074/jbc.M116.768754; Kirkbride KC, 2008, J BIOL CHEM, V283, P7628, DOI 10.1074/jbc.M704883200; LAIHO M, 1990, J BIOL CHEM, V265, P18518; LAIHO M, 1991, J BIOL CHEM, V266, P9108; Lee W, 2015, BIOINFORMATICS, V31, P1325, DOI 10.1093/bioinformatics/btu830; Lewis KA, 2000, NATURE, V404, P411, DOI 10.1038/35006129; Liang YF, 2014, ANGEW CHEM INT EDIT, V53, P548, DOI 10.1002/anie.201308698; Lin SJ, 2011, P NATL ACAD SCI USA, V108, P5232, DOI 10.1073/pnas.1010689108; LOPEZCASILLAS F, 1994, J CELL BIOL, V124, P557, DOI 10.1083/jcb.124.4.557; LOPEZCASILLAS F, 1993, CELL, V73, P1435, DOI 10.1016/0092-8674(93)90368-Z; MacConell LA, 2002, ENDOCRINOLOGY, V143, P1066, DOI 10.1210/en.143.3.1066; Makanji Y, 2008, J BIOL CHEM, V283, P16743, DOI 10.1074/jbc.M801045200; Mendoza V, 2009, BIOCHEMISTRY-US, V48, P11755, DOI 10.1021/bi901528w; Morikawa M, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a021873; Namwanje M, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a021881; Pederson K, 2017, J BIOMOL NMR, V68, P225, DOI 10.1007/s10858-017-0123-8; Pellaud J, 1999, J BIOL CHEM, V274, P7699, DOI 10.1074/jbc.274.12.7699; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Radaev S, 2010, J BIOL CHEM, V285, P14806, DOI 10.1074/jbc.M109.079921; Saito T, 2017, CELL REP, V19, P1917, DOI 10.1016/j.celrep.2017.05.011; Sanford LP, 1997, DEVELOPMENT, V124, P2659; SCHLUNEGGER MP, 1992, NATURE, V358, P430, DOI 10.1038/358430a0; Stenvers KL, 2003, MOL CELL BIOL, V23, P4371, DOI 10.1128/MCB.23.12.4371-4385.2003; Thompson TB, 2005, DEV CELL, V9, P535, DOI 10.1016/j.devcel.2005.09.008; Tugarinov V, 2003, J AM CHEM SOC, V125, P13868, DOI 10.1021/ja030345s; Villarreal MM, 2016, BIOCHEMISTRY-US, V55, P6880, DOI 10.1021/acs.biochem.6b00566; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wiater E, 2003, J BIOL CHEM, V278, P7934, DOI 10.1074/jbc.M209710200; Wiater E, 2006, J BIOL CHEM, V281, P17011, DOI 10.1074/jbc.M601459200; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; WOODRUFF TK, 1993, ENDOCRINOLOGY, V133, P2998, DOI 10.1210/en.133.6.2998; Zhang YE, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022129; Zhu J, 2012, J BIOL CHEM, V287, P8060, DOI 10.1074/jbc.M111.293381	69	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2019	294	9					3065	3080		10.1074/jbc.RA118.005210	http://dx.doi.org/10.1074/jbc.RA118.005210			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU0SA	30598510	Green Published, hybrid			2022-12-28	WOS:000464980100008
J	Zheng, SL; Krump, NA; McKenna, MM; Li, YH; Hannemann, A; Garrett, LJ; Gibson, JS; Bodine, DM; Low, PS				Zheng, Suilan; Krump, Nathan A.; McKenna, Mary M.; Li, Yen-Hsing; Hannemann, Anke; Garrett, Lisa J.; Gibson, John S.; Bodine, David M.; Low, Philip S.			Regulation of erythrocyte Na+/K+/2Cl(-) cotransport by an oxygen-switched kinase cascade	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						erythrocyte; hemoglobin; Na-K-Cl cotransporter (NKCC); protein-protein interaction; protein phosphorylation; band 3-deoxyhemoglobin interactions; O2 regulation of cation transport; OSR1; WNK1	K-CL COTRANSPORTER; RED-BLOOD-CELLS; PROTEIN-PHOSPHORYLATION; POTASSIUM-TRANSPORT; NA+-K+-2CL(-) COTRANSPORT; MEMBRANE TRANSPORTERS; CYTOPLASMIC DOMAIN; SPAK/OSR1 KINASES; O-2 REGULATION; ION-TRANSPORT	Many erythrocyte processes and pathways, including glycolysis, the pentose phosphate pathway (PPP), KCl cotransport, ATP release, Na+/K+-ATPase activity, ankyrin-band 3 interactions, and nitric oxide (NO) release, are regulated by changes in O-2 pressure that occur as a red blood cell (RBC) transits between the lungs and tissues. The O-2 dependence of glycolysis, PPP, and ankyrin-band 3 interactions (affecting RBC rheology) are controlled by O-2-dependent competition between deoxyhemoglobin (deoxyHb), but not oxyhemoglobin (oxyHb), and other proteins for band 3. We undertook the present study to determine whether the O-2 dependence of Na+/K+/2Cl(-) cotransport (catalyzed by Na+/K+/2Cl(-) cotransporter 1 [NKCC1]) might similarly originate from competition between deoxyHb and a protein involved in NKCC1 regulation for a common binding site on band 3. Using three transgenic mouse strains having mutated deoxyhemoglobin-binding sites on band 3, we found that docking of deoxyhemoglobin at the N terminus of band 3 displaces the protein with no lysine kinase 1 (WNK1) from its overlapping binding site on band 3. This displacement enabled WNK1 to phosphorylate oxidative stress-responsive kinase 1 (OSR1), which, in turn, phosphorylated and activated NKCC1. Under normal solution conditions, the NKCC1 activation increased RBC volume and thereby induced changes in RBC rheology. Because the deoxyhemoglobin-mediated WNK1 displacement from band 3 in this O-2 regulation pathway may also occur in the regulation of other O-2-regulated ion transporters, we hypothesize that the NKCC1-mediated regulatory mechanism may represent a general pattern of O-2 modulation of ion transporters in erythrocytes.	[Zheng, Suilan; Li, Yen-Hsing; Low, Philip S.] Purdue Univ, Inst Drug Discovery, W Lafayette, IN 47907 USA; [Zheng, Suilan; Li, Yen-Hsing; Low, Philip S.] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; [Krump, Nathan A.; McKenna, Mary M.; Bodine, David M.] NHGRI, Hematopoiesis Sect, NIH, Bethesda, MD 20815 USA; [Garrett, Lisa J.] NHGRI, Embryon Stem Cell & Transgen Mouse Core Facil, NIH, Bethesda, MD 20815 USA; [Hannemann, Anke; Gibson, John S.] Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Cambridge	Low, PS (corresponding author), Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA.; Bodine, DM (corresponding author), NHGRI, Genet & Mol Biol Branch, NIH, Bethesda, MD 20892 USA.	tedyaz@mail.nih.gov; plow@purdue.edu	Hannemann, Anke/AAE-2445-2019; Zheng, Suilan/AAW-6471-2021	Hannemann, Anke/0000-0002-2925-1124; 	NIGMS, National Institutes of Health [R01GM24417]; National Human Genome Research Institute, National Institutes of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200339, ZICHG200349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024417] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Human Genome Research Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health Grant R01GM24417 (to P. S. L.) and National Human Genome Research Institute, National Institutes of Health intramural funds (to D. M. B). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alessi DR, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005365; [Anonymous], 2004, NAT METHODS, V1, P275, DOI DOI 10.1038/NMETH1204-275; Barvitenko NN, 2005, CELL PHYSIOL BIOCHEM, V15, P1, DOI 10.1159/000083634; BENNETT V, 1979, NATURE, V281, P597, DOI 10.1038/281597a0; Berenbrink M, 2000, J PHYSIOL-LONDON, V526, P69, DOI 10.1111/j.1469-7793.2000.t01-1-00069.x; Bogdanova A, 2003, ADV EXP MED BIOL, V536, P231; Bogdanova A, 2009, ACTA PHYSIOL, V195, P305, DOI 10.1111/j.1748-1716.2008.01934.x; Bogdanova AY, 2003, J MEMBRANE BIOL, V195, P33, DOI 10.1007/s00232-003-2042-8; Bordin L, 2002, BLOOD, V100, P276, DOI 10.1182/blood.V100.1.276; BROSIUS FC, 1989, J BIOL CHEM, V264, P7784; Brunati AM, 2000, BLOOD, V96, P1550, DOI 10.1182/blood.V96.4.1550.h8001550_1550_1557; Campanella ME, 2008, BLOOD, V112, P3900, DOI 10.1182/blood-2008-03-146159; Campanella ME, 2005, P NATL ACAD SCI USA, V102, P2402, DOI 10.1073/pnas.0409741102; Caro Colin G., 1995, Perfusion, V10, P131, DOI 10.1177/026765919501000302; Chu HY, 2008, BLOOD, V111, P932, DOI 10.1182/blood-2007-07-100180; Chu HY, 2006, BIOCHEM J, V400, P143, DOI 10.1042/BJ20060792; Chu HY, 2016, BLOOD, V128, P2708, DOI 10.1182/blood-2016-01-692079; Cordat E, 2014, CURR TOP MEMBR, V73, P1, DOI 10.1016/B978-0-12-800223-0.00001-3; Darman RB, 2002, J BIOL CHEM, V277, P37542, DOI 10.1074/jbc.M206293200; de los Heros P, 2006, P NATL ACAD SCI USA, V103, P1976, DOI DOI 10.1073/pnas.0510947103; de los Heros P, 2014, BIOCHEM J, V458, P559, DOI 10.1042/BJ20131478; DING Y, 1994, J BIOL CHEM, V269, P32201; Drew C, 2004, BIOELECTROCHEMISTRY, V62, P153, DOI 10.1016/j.bioelechem.2003.07.003; DUNHAM PB, 1981, J PHYSIOL-LONDON, V318, P511; Ellsworth ML, 2012, J PHYSIOL-LONDON, V590, P4985, DOI 10.1113/jphysiol.2012.233106; Ellsworth ML, 2004, MED SCI SPORT EXER, V36, P35, DOI 10.1249/01.MSS.0000106284.80300.B2; FAIRBANKS G, 1971, BIOCHEMISTRY-US, V10, P2606, DOI 10.1021/bi00789a030; Flatman PW, 2005, J PHYSIOL-LONDON, V563, P421, DOI 10.1113/jphysiol.2004.080507; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; GARDNER K, 1986, J BIOL CHEM, V261, P1339; Gibson JS, 2000, J EXP BIOL, V203, P1395; Gibson JS, 1998, J PHYSIOL-LONDON, V511, P225, DOI 10.1111/j.1469-7793.1998.225bi.x; GOODMAN SR, 1982, J BIOL CHEM, V257, P4564; HAAS M, 1985, J GEN PHYSIOL, V85, P649, DOI 10.1085/jgp.85.5.649; HAAS M, 1982, J GEN PHYSIOL, V80, P125, DOI 10.1085/jgp.80.1.125; Haas M, 1998, J BIOENERG BIOMEMBR, V30, P161, DOI 10.1023/A:1020521308985; Hadchouel J, 2016, ANNU REV PHYSIOL, V78, P367, DOI 10.1146/annurev-physiol-021115-105431; JENKINS JD, 1984, J BIOL CHEM, V259, P9374; Joiner CH, 2001, BLOOD CELL MOL DIS, V27, P158, DOI 10.1006/bcmd.2000.0365; JONES SA, 1995, ANN BIOMED ENG, V23, P21, DOI 10.1007/BF02368297; Kahle KT, 2013, TRENDS NEUROSCI, V36, P726, DOI 10.1016/j.tins.2013.08.006; Kahle KT, 2010, BBA-MOL BASIS DIS, V1802, P1150, DOI 10.1016/j.bbadis.2010.07.009; Kahle KT, 2003, NAT GENET, V35, P372, DOI 10.1038/ng1271; KANIEWSKI WS, 1994, BIORHEOLOGY, V31, P91; Khan AI, 2004, BIOELECTROCHEMISTRY, V62, P141, DOI 10.1016/j.bioelechem.2003.07.005; Kristensen K, 2007, J EXP BIOL, V210, P2290, DOI 10.1242/jeb.002824; Lang F, 2014, ANTIOXID REDOX SIGN, V21, P138, DOI 10.1089/ars.2013.5747; Lewis IA, 2009, P NATL ACAD SCI USA, V106, P18515, DOI 10.1073/pnas.0905999106; Lux S. E., 1995, BLOOD PRINCIPLES PRA, P1709; Matskevich L, 2005, BBA-BIOMEMBRANES, V1714, P25, DOI 10.1016/j.bbamem.2005.06.001; Messana I, 1996, FEBS LETT, V390, P25, DOI 10.1016/0014-5793(96)00624-2; Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200; Mount DB, 1998, J EXP BIOL, V201, P2091; Muzyamba MC, 1999, J PHYSIOL-LONDON, V517, P421, DOI 10.1111/j.1469-7793.1999.0421t.x; ORSKOV SL, 1954, ACTA PHYSIOL SCAND, V31, P221, DOI 10.1111/j.1748-1716.1954.tb01133.x; PALFREY HC, 1993, PFLUG ARCH EUR J PHY, V425, P321, DOI 10.1007/BF00374182; Pang AJ, 2008, BIOCHEMISTRY-US, V47, P4510, DOI 10.1021/bi702149b; Pedersen SF, 2004, J EXP ZOOL PART A, V301A, P569, DOI 10.1002/jez.a.47; Perrotta S, 2005, BLOOD, V106, P4359, DOI 10.1182/blood-2005-07-2806; PEWITT EB, 1990, J BIOL CHEM, V265, P20747; Piala AT, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005050; REITHMEIER RAF, 1989, ANN NY ACAD SCI, V574, P75; Richardson C, 2008, J CELL SCI, V121, P3293, DOI 10.1242/jcs.029223; Rinehart J, 2009, CELL, V138, P525, DOI 10.1016/j.cell.2009.05.031; Roper D., 2011, DACIE LEWIS PRACTICA, P245; Russell JM, 2000, PHYSIOL REV, V80, P211, DOI 10.1152/physrev.2000.80.1.211; Sega MF, 2012, BIOCHEMISTRY-US, V51, P3264, DOI 10.1021/bi201623v; Shekarabi M, 2017, CELL METAB, V25, P285, DOI 10.1016/j.cmet.2017.01.007; Sprague RS, 2012, MICROCIRCULATION, V19, P430, DOI 10.1111/j.1549-8719.2011.00158.x; STECK TL, 1974, J CELL BIOL, V62, P1, DOI 10.1083/jcb.62.1.1; Stefanovic M, 2013, BIOCHEM J, V449, P143, DOI 10.1042/BJ20120869; Tejero J, 2012, J BIOL CHEM, V287, P18262, DOI 10.1074/jbc.M111.298927; TOSTESON DC, 1956, J CELL COMPAR PHYSL, V47, P147, DOI 10.1002/jcp.1030470110; Vitari AC, 2006, BIOCHEM J, V397, P223, DOI 10.1042/BJ20060220; Vitari AC, 2005, BIOCHEM J, V391, P17, DOI 10.1042/BJ20051180; WALDER JA, 1984, J BIOL CHEM, V259, P238; Wang CC, 1997, BLOOD, V89, P3019, DOI 10.1182/blood.V89.8.3019; Wei HS, 2016, NEURON, V91, P851, DOI 10.1016/j.neuron.2016.07.016; Zagorska A, 2007, J CELL BIOL, V176, P89, DOI 10.1083/jcb.200605093	79	8	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2019	294	7					2519	2528		10.1074/jbc.RA118.006393	http://dx.doi.org/10.1074/jbc.RA118.006393			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL7CN	30563844	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000458895400026
J	Bachu, M; Tamura, T; Chen, C; Narain, A; Nehru, V; Sarai, N; Ghosh, SB; Ghosh, A; Kavarthapu, R; Dufau, ML; Ozato, K				Bachu, Mahesh; Tamura, Tomohiko; Chen, Chao; Narain, Ankur; Nehru, Vishal; Sarai, Naoyuki; Ghosh, Sukhendu B.; Ghosh, Anu; Kavarthapu, Raghuveer; Dufau, Maria L.; Ozato, Keiko			A versatile mouse model of epitope-tagged histone H3.3 to study epigenome dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						interferon; transcription; epigenetics; chromatin; ChIP-sequencing (ChIP-seq); H3; 3; Histone variant	VARIANT H3.3; TRANSCRIPTION ELONGATION; CHROMATIN; EXPRESSION; DEPOSITION; MUTATIONS; LOCI	The variant histone H3.3 is incorporated into the genome in a transcription-dependent manner. This histone is thus thought to play a role in epigenetic regulation. However, our understanding of how H3.3 controls gene expression and epigenome landscape has remained incomplete. This is partly because precise localization of H3.3 in the genome has been difficult to decipher particularly for cells in vivo. To circumvent this difficulty, we generated knockin mice, by homologous recombination, to replace both of the two H3.3 loci (H3f3a and H3f3b) with the hemagglutinin-tagged H3.3 cDNA cassette, which also contained a GFP gene. We show here that the hemagglutinin-tagged H3.3 and GFP are expressed in the majority of cells in all adult tissues tested. ChIP-seq data, combined with RNA-seq, revealed a striking correlation between the level of transcripts and that of H3.3 accumulation in expressed genes. Finally, we demonstrate that H3.3 deposition is markedly enhanced upon stimulation by interferon on interferon-stimulated genes, highlighting transcription-coupled H3.3 dynamics. Together, these H3.3 knockin mice serve as a useful experimental model to study epigenome regulation in development and in various adult cells in vivo.	[Bachu, Mahesh; Tamura, Tomohiko; Chen, Chao; Narain, Ankur; Nehru, Vishal; Sarai, Naoyuki; Ghosh, Sukhendu B.; Ghosh, Anu; Ozato, Keiko] NICHD, Div Dev Biol, NIH, Bethesda, MD 20892 USA; [Kavarthapu, Raghuveer; Dufau, Maria L.] NICHD, Sect Mol Endocrinol, NIH, Bethesda, MD 20892 USA; [Tamura, Tomohiko] Yokohama City Univ, Grad Sch Med, Dept Immunol, Yokohama, Kanagawa 2360004, Japan; [Narain, Ankur] Natl Univ Ireland, Sch Nat Sci, Ctr Chromosome Biol Biochem, Galway H91 TK33, Ireland; [Ghosh, Sukhendu B.; Ghosh, Anu] Bhabha Atom Res Ctr, Mumbai 400085, Maharashtra, India	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Yokohama City University; Bhabha Atomic Research Center (BARC)	Ozato, K (corresponding author), NICHD, Div Dev Biol, NIH, Bethesda, MD 20892 USA.	ozatok@nih.gov	Ghosh, Anu/ABF-4180-2020; Kavarthapu, Raghuveer/ABA-8485-2020; Bachu, Mahesh/I-4343-2015; Nehru, Vishal/X-9950-2019; Kavarthapu, Raghuveer/ABA-8497-2020	Kavarthapu, Raghuveer/0000-0002-2198-2029; Bachu, Mahesh/0000-0002-6494-6642; Chen, Chao/0000-0001-9526-0099; Ghosh, Anu/0000-0003-4528-8602	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000150] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Adam S, 2013, CELL, V155, P94, DOI 10.1016/j.cell.2013.08.029; Aihara K, 2014, NEURO-ONCOLOGY, V16, P140, DOI 10.1093/neuonc/not144; Allis CD, 2016, NAT REV GENET, V17, P487, DOI 10.1038/nrg.2016.59; Banaszynski LA, 2013, CELL, V155, P107, DOI 10.1016/j.cell.2013.08.061; Bush KM, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-7; Criscione SW, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-583; Delbarre E, 2010, MOL BIOL CELL, V21, P1872, DOI 10.1091/mbc.E09-09-0839; Elsaesser SJ, 2010, COLD SH Q B, V75, P27, DOI 10.1101/sqb.2010.75.008; Gielen GH, 2013, AM J CLIN PATHOL, V139, P345, DOI 10.1309/AJCPABOHBC33FVMO; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Guo R, 2014, MOL CELL, V56, P298, DOI 10.1016/j.molcel.2014.08.022; Ivanauskiene K, 2014, GENOME RES, V24, P1584, DOI 10.1101/gr.173831.114; Jang CW, 2015, GENE DEV, V29, P1377, DOI 10.1101/gad.264150.115; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kraushaar DC, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r121; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maze I, 2015, NEURON, V87, P77, DOI 10.1016/j.neuron.2015.06.014; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Ng RK, 2008, NAT CELL BIOL, V10, P102, DOI 10.1038/ncb1674; Orsi GA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003285; Pchelintsev NA, 2013, CELL REP, V3, P1012, DOI 10.1016/j.celrep.2013.03.026; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Ray-Gallet D, 2011, MOL CELL, V44, P928, DOI 10.1016/j.molcel.2011.12.006; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sarai N, 2013, EMBO J, V32, P2392, DOI 10.1038/emboj.2013.176; Schneiderman JI, 2012, P NATL ACAD SCI USA, V109, P19721, DOI 10.1073/pnas.1206629109; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Sitbon D, 2017, COLD SH Q B, V82, P1, DOI 10.1101/sqb.2017.82.033753; Talbert PB, 2017, NAT REV MOL CELL BIO, V18, P115, DOI 10.1038/nrm.2016.148; Tamura T, 2009, J BIOL CHEM, V284, P12217, DOI 10.1074/jbc.M805651200; Voon HPJ, 2015, CELL REP, V11, P405, DOI 10.1016/j.celrep.2015.03.036; Wen DC, 2014, GENESIS, V52, P959, DOI 10.1002/dvg.22827; Wen H, 2014, NATURE, V508, P263, DOI 10.1038/nature13045; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Yuen BTK, 2014, DEVELOPMENT, V141, P3483, DOI 10.1242/dev.106450	36	5	5	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2019	294	6					1904	1914		10.1074/jbc.RA118.005550	http://dx.doi.org/10.1074/jbc.RA118.005550			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM8EO	30552116	Green Published, hybrid			2022-12-28	WOS:000459711400011
J	Yang, JW; Murray, B; Barbier-Torres, L; Liu, T; Liu, ZQ; Yang, HP; Fan, W; Wang, JH; Li, Y; Seki, E; Mato, JM; Lu, SC				Yang, Jin Won; Murray, Ben; Barbier-Torres, Lucia; Liu, Ting; Liu, Zhenqiu; Yang, Heping; Fan, Wei; Wang, Jiaohong; Li, Yuan; Seki, Ekihiro; Mato, Jose M.; Lu, Shelly C.			The mitochondrial chaperone Prohibitin 1 negatively regulates interleukin-8 in human liver cancers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						c-Jun N-terminal kinase (JNK); NF-B; migration; invasion; hepatocellular carcinoma; interleukin-8; prohibitin 1	HEPATOCELLULAR-CARCINOMA; MESSENGER-RNA; EXPRESSION; FIBROSIS; NUCLEUS; PROTEIN; KINASE; INJURY; GENE; P53	Prohibitin 1 (PHB1) is a mitochondrial chaperone whose expression is dysregulated in cancer. In liver cancer, PHB1 acts as a tumor suppressor, but the mechanisms of tumor suppression are incompletely understood. Here we aimed to determine PHB1 target genes to better understand how PHB1 influences liver tumorigenesis. Using RNA-Seq analysis, we found interleukin-8 (IL-8) to be one of the most highly up-regulated genes following PHB1 silencing in HepG2 cells. Induction of IL-8 expression also occurred in multiple liver and nonliver cancer cell lines. We examined samples from 178 patients with hepatocellular carcinoma (HCC) and found that IL-8 mRNA levels were increased, whereas PHB1 mRNA levels were decreased, in the tumors compared with adjacent nontumorous tissues. Notably, HCC patients with high IL-8 expression have significantly reduced survival. An inverse correlation between PHB1 and IL-8 mRNA levels is found in HCCs with reduced PHB1 expression. To understand the molecular basis for these observations, we altered PHB1 levels in liver cancer cells. Overexpression of PHB1 resulted in lowered IL-8 expression and secretion. Silencing PHB1 increased c-Jun N-terminal kinase (JNK) and NF-B activity, induced nuclear accumulation of c-JUN and p65, and enhanced their binding to the IL-8 promoter containing AP-1 and NF-B elements. Conditioned medium from PHB1-silenced HepG2 cells increased migration and invasion of parental HepG2 and SK-hep-1 cells, and this was blocked by co-treatment with neutralizing IL-8 antibody. In summary, our findings show that reduced PHB1 expression induces IL-8 transcription by activating NF-B and AP-1, resulting in enhanced IL-8 expression and release to promote tumorigenesis.	[Yang, Jin Won; Murray, Ben; Barbier-Torres, Lucia; Yang, Heping; Fan, Wei; Wang, Jiaohong; Li, Yuan; Seki, Ekihiro; Lu, Shelly C.] Cedars Sinai Med Ctr, Div Digest & Liver Dis, Los Angeles, CA 90048 USA; [Yang, Jin Won] Woosuk Univ, Coll Pharm, Wonju, South Korea; [Liu, Ting; Li, Yuan] Cent S Univ, Xiangya Hosp, Dept Gastroenterol, Changsha, Hunan, Peoples R China; [Liu, Zhenqiu] Penn State Coll Med, Dept Publ Hlth Sci, Hershey, PA 17033 USA; [Mato, Jose M.] Ctr Invest Biomed Red Enfermedades Hepat & Digest, CIC bioGUNE, Technol Pk Bizkaia, Derio 48160, Spain	Cedars Sinai Medical Center; Woosuk University; Central South University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; CIC bioGUNE	Lu, SC (corresponding author), Cedars Sinai Med Ctr, Davis Bldg,Rm 2097,8700 Beverly Blvd, Los Angeles, CA 90048 USA.	shelly.lu@cshs.org	MATO, JOSE/A-5187-2011; Seki, Ekihiro/K-2481-2016; Li, Yuan/GXV-1310-2022; Lu, Shelly/AAH-5937-2021	MATO, JOSE/0000-0003-1264-3153; Seki, Ekihiro/0000-0002-9472-6085; Lu, Shelly/0000-0003-2128-5407; FAN, WEI/0000-0001-6462-7425	National Institutes of Health [R01CA172086]; Plan Nacional of I + D [SAF2017-88041-R]; Innovative Medicines Initiative (IMI) Grant [777377-LITMUS-H2020-JTI-IMI2-2016-09]; Instituto de Salud Carlos III Grant CIBERehd MAT-3; Centers of Excellence Severo Ochoa Grant [SEV-2016-0644]; NATIONAL CANCER INSTITUTE [R01CA172086] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Plan Nacional of I + D; Innovative Medicines Initiative (IMI) Grant; Instituto de Salud Carlos III Grant CIBERehd MAT-3; Centers of Excellence Severo Ochoa Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant R01CA172086 (to S.C.L., H.P.Y., and J.M.M.), Plan Nacional of I + D SAF2017-88041-R, Innovative Medicines Initiative (IMI) Grant 777377-LITMUS-H2020-JTI-IMI2-2016-09, Instituto de Salud Carlos III Grant CIBERehd MAT-3, and Centers of Excellence Severo Ochoa Grant SEV-2016-0644 (to J.M.M.). J.M.M. is a consultant for Abbott. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anaya J, 2016, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.67; Anaya Jordan, 2015, PeerJ, V3, pe1499, DOI 10.7717/peerj.1499; Barbier-Torres L, 2015, HEPATOLOGY, V62, P1237, DOI 10.1002/hep.27959; Bhattacharyya S, 2011, AM J PHYSIOL-LUNG C, V300, pL81, DOI 10.1152/ajplung.00051.2010; Choi D, 2008, ONCOGENE, V27, P1716, DOI 10.1038/sj.onc.1210806; Chowdhury I, 2013, APOPTOSIS, V18, P1513, DOI 10.1007/s10495-013-0901-z; Eun JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110744; Fan W, 2017, HEPATOLOGY, V65, P1249, DOI 10.1002/hep.28964; Fernando RI, 2011, CANCER RES, V71, P5296, DOI 10.1158/0008-5472.CAN-11-0156; Fusaro G, 2003, J BIOL CHEM, V278, P47853, DOI 10.1074/jbc.M305171200; Gamble SC, 2004, ONCOGENE, V23, P2996, DOI 10.1038/sj.onc.1207444; Gangwani MR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135633; Guan XX, 2014, BIOCHEM BIOPH RES CO, V443, P1239, DOI 10.1016/j.bbrc.2013.12.124; Gui Ting, 2012, J Signal Transduct, V2012, P289243, DOI 10.1155/2012/289243; Huang WJ, 2015, GASTROENTEROLOGY, V149, P1053, DOI 10.1053/j.gastro.2015.05.058; Jiang L, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.40; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Jundi K, 2015, BIOMOLECULES, V5, P1386, DOI 10.3390/biom5031386; Kathiria AS, 2012, CANCER RES, V72, P5778, DOI 10.1158/0008-5472.CAN-12-0603; Ko KS, 2010, HEPATOLOGY, V52, P2096, DOI 10.1002/hep.23919; Koushyar S, 2015, CANCER LETT, V369, P316, DOI 10.1016/j.canlet.2015.09.012; Krause A, 1998, J BIOL CHEM, V273, P23681, DOI 10.1074/jbc.273.37.23681; Liu T, 2009, CANCER LETT, V273, P233, DOI 10.1016/j.canlet.2008.08.003; Liu T, 2018, GASTROENTEROLOGY, V155, P557, DOI 10.1053/j.gastro.2018.04.032; Liu YH, 2017, VIROLOGY, V506, P64, DOI 10.1016/j.virol.2017.03.009; Mantovani A, 2010, CYTOKINE GROWTH F R, V21, P27, DOI 10.1016/j.cytogfr.2009.11.007; MCCLUNG JK, 1989, BIOCHEM BIOPH RES CO, V164, P1316, DOI 10.1016/0006-291X(89)91813-5; Nijtmans LGJ, 2002, CELL MOL LIFE SCI, V59, P143, DOI 10.1007/s00018-002-8411-0; Omori E, 2012, P NATL ACAD SCI USA, V109, P3365, DOI 10.1073/pnas.1116188109; Patel N, 2010, P NATL ACAD SCI USA, V107, P2503, DOI 10.1073/pnas.0910649107; Peng XJ, 2006, CANCER RES, V66, P7361, DOI 10.1158/0008-5472.CAN-06-1004; Peng YT, 2015, APOPTOSIS, V20, P1135, DOI 10.1007/s10495-015-1143-z; Rajalingam K, 2005, NAT CELL BIOL, V7, P837, DOI 10.1038/ncb1283; Ramani K, 2016, J BIOL CHEM, V291, P24148, DOI 10.1074/jbc.M116.744045; Ren Y, 2003, CLIN CANCER RES, V9, P5996; Sato S, 2011, CHEM BIOL, V18, P131, DOI 10.1016/j.chembiol.2010.10.017; Shi SL, 2009, J CELL BIOCHEM, V108, P926, DOI 10.1002/jcb.22324; Theiss AL, 2009, MOL BIOL CELL, V20, P4412, DOI 10.1091/mbc.E09-05-0361; Wang S, 2002, ONCOGENE, V21, P8388, DOI 10.1038/sj.onc.1205944; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Xie KP, 2001, CYTOKINE GROWTH F R, V12, P375, DOI 10.1016/S1359-6101(01)00016-8; Yang HP, 2015, ANTIOXID REDOX SIGN, V22, P259, DOI 10.1089/ars.2014.6027	42	12	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2019	294	6					1984	1996		10.1074/jbc.RA118.004863	http://dx.doi.org/10.1074/jbc.RA118.004863			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM8EO	30523154	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000459711400018
J	Zhang, Z; Parker, MP; Graw, S; Novikova, LV; Fedosyuk, H; Fontes, JD; Koestler, DC; Peterson, KR; Slawson, C				Zhang, Zhen; Parker, Matthew P.; Graw, Stefan; Novikova, Lesya V.; Fedosyuk, Halyna; Fontes, Joseph D.; Koestler, Devin C.; Peterson, Kenneth R.; Slawson, Chad			O-GlcNAc homeostasis contributes to cell fate decisions during hematopoiesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						O-GlcNAcylation; O-linked N-acetylglucosamine (O-GlcNAc) transferase (OGT); hematopoiesis; GATA transcription factor; gene regulation; differentiation; post-translational modification; transcription; erythropoiesis; myelopoiesis; G1E-ER4; FOG-1	IN-VITRO; ERYTHROID-DIFFERENTIATION; CHROMATIN OCCUPANCY; TRANSCRIPTION; GENE; PROTEIN; GLCNACYLATION; PHOSPHORYLATION; TRANSFERASE; EXPRESSION	The addition of a single beta-d-GlcNAc sugar (O-GlcNAc) by O-GlcNAc-transferase (OGT) and O-GlcNAc removal by O-GlcNAcase (OGA) maintain homeostatic O-GlcNAc levels on cellular proteins. Changes in protein O-GlcNAcylation regulate cellular differentiation and cell fate decisions, but how these changes affect erythropoiesis, an essential process in blood cell formation, remains unclear. Here, we investigated the role of O-GlcNAcylation in erythropoiesis by using G1E-ER4 cells, which carry the erythroid-specific transcription factor GATA-binding protein 1 (GATA-1) fused to the estrogen receptor (GATA-1-ER) and therefore undergo erythropoiesis after beta-estradiol (E-2) addition. We observed that during G1E-ER4 differentiation, overall O-GlcNAc levels decrease, and physical interactions of GATA-1 with both OGT and OGA increase. RNA-Seq-based transcriptome analysis of G1E-ER4 cells differentiated in the presence of the OGA inhibitor Thiamet-G (TMG) revealed changes in expression of 433 GATA-1 target genes. ChIP results indicated that the TMG treatment decreases the occupancy of GATA-1, OGT, and OGA at the GATA-binding site of the lysosomal protein transmembrane 5 (Laptm5) gene promoter. TMG also reduced the expression of genes involved in differentiation of NB4 and HL60 human myeloid leukemia cells, suggesting that O-GlcNAcylation is involved in the regulation of hematopoietic differentiation. Sustained treatment of G1E-ER4 cells with TMG before differentiation reduced hemoglobin-positive cells and increased stem/progenitor cell surface markers. Our results show that alterations in O-GlcNAcylation disrupt transcriptional programs controlling erythropoietic lineage commitment, suggesting a role for O-GlcNAcylation in regulating hematopoietic cell fate.	[Zhang, Zhen; Parker, Matthew P.; Novikova, Lesya V.; Fedosyuk, Halyna; Fontes, Joseph D.; Peterson, Kenneth R.; Slawson, Chad] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, 3901 Rainbow Blvd, Kansas City, KS 66160 USA; [Peterson, Kenneth R.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, 3901 Rainbow Blvd, Kansas City, KS 66160 USA; [Graw, Stefan; Koestler, Devin C.] Univ Kansas, Med Ctr, Dept Biostat, Kansas City, KS 66160 USA; [Fontes, Joseph D.; Koestler, Devin C.; Peterson, Kenneth R.; Slawson, Chad] Univ Kansas, Med Ctr, Canc Ctr, 3901 Rainbow Blvd, Kansas City, KS 66160 USA; [Zhang, Zhen] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Epigenet Inst, Philadelphia, PA 19104 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Pennsylvania; Pennsylvania Medicine	Peterson, KR; Slawson, C (corresponding author), Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.; Peterson, KR (corresponding author), Univ Kansas, Med Ctr, Dept Anat & Cell Biol, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.; Peterson, KR; Slawson, C (corresponding author), Univ Kansas, Med Ctr, Canc Ctr, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.	kpeterson@kumc.edu; cslawson@kumc.edu		Graw, Stefan/0000-0002-6386-8267; Fontes, Joseph/0000-0003-4796-343X	NIDDK, National Institutes of Health [R01DK100595, R01HL111264]; University of Kansas Medical Center (KUMC) Biomedical Research Training Program; NIGMS, National Institutes of Health [P20GM103549, P30GM118247, P20GM103418]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111264] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM118247, P20GM103418] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); University of Kansas Medical Center (KUMC) Biomedical Research Training Program; NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIDDK, National Institutes of Health Grants R01DK100595 (to C. S. and K. R. P.) and R01HL111264 (to K. R. P.) and a University of Kansas Medical Center (KUMC) Biomedical Research Training Program grant (to Z. Z.). Partial support was provided by NIGMS, National Institutes of Health Grants P20GM103549, P30GM118247, and P20GM103418. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adra CN, 1996, GENOMICS, V35, P328, DOI 10.1006/geno.1996.0364; Andres-Bergos J, 2012, J BIOL CHEM, V287, P33615, DOI 10.1074/jbc.M112.354241; Baines KJ, 2011, THORAX, V66, P942, DOI 10.1136/thx.2010.157719; Boyes J, 1998, NATURE, V396, P594, DOI 10.1038/25166; Bresnick EH, 2010, J BIOL CHEM, V285, P31087, DOI 10.1074/jbc.R110.159079; Chen Q, 2013, NATURE, V493, P561, DOI 10.1038/nature11742; Cheng Y, 2009, GENOME RES, V19, P2172, DOI 10.1101/gr.098921.109; Chu CS, 2014, P NATL ACAD SCI USA, V111, P1355, DOI 10.1073/pnas.1323226111; Deplus R, 2013, EMBO J, V32, P645, DOI 10.1038/emboj.2012.357; Dey A, 2012, SCIENCE, V337, P1541, DOI 10.1126/science.1221711; DRACH J, 1993, CANCER RES, V53, P2100; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Ferrer CM, 2016, J MOL BIOL, V428, P3282, DOI 10.1016/j.jmb.2016.05.028; Fujiwara T, 2009, MOL CELL, V36, P667, DOI 10.1016/j.molcel.2009.11.001; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Gambetta MC, 2015, CHROMOSOMA, V124, P429, DOI 10.1007/s00412-015-0513-1; Glowacka WK, 2012, J BIOL CHEM, V287, P27691, DOI 10.1074/jbc.M112.355917; Goode DK, 2016, DEV CELL, V36, P572, DOI 10.1016/j.devcel.2016.01.024; Grass JA, 2006, MOL CELL BIOL, V26, P7056, DOI 10.1128/MCB.01033-06; Hardiville S, 2014, CELL METAB, V20, P208, DOI 10.1016/j.cmet.2014.07.014; Hart GW, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00183; Hastings NB, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0181-0; Howerton CL, 2013, P NATL ACAD SCI USA, V110, P5169, DOI 10.1073/pnas.1300065110; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Kadri Z, 2015, GENE DEV, V29, P2603, DOI 10.1101/gad.267633.115; Kim HS, 2009, FEBS LETT, V583, P2474, DOI 10.1016/j.febslet.2009.06.052; Kingsley PD, 2013, BLOOD, V121, pE5, DOI 10.1182/blood-2012-04-422394; Koyama T, 2015, EXP CELL RES, V338, P194, DOI 10.1016/j.yexcr.2015.08.009; Lamonica JM, 2006, BLOOD, V108, P3736, DOI 10.1182/blood-2006-07-032847; Lamonica JM, 2011, P NATL ACAD SCI USA, V108, pE159, DOI 10.1073/pnas.1102140108; Lee HY, 2009, MOL CELL, V36, P984, DOI 10.1016/j.molcel.2009.11.005; Lewis BA, 2016, J BIOL CHEM, V291, P14056, DOI 10.1074/jbc.M115.684365; Li LQ, 2013, BLOOD, V121, P4575, DOI 10.1182/blood-2013-01-479451; Manavathi B, 2012, J BIOL CHEM, V287, P5600, DOI 10.1074/jbc.M111.289843; Maurya JJP, 2015, STEM CELL RES, V15, P182, DOI 10.1016/j.scr.2015.06.007; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nakajima O, 1999, EMBO J, V18, P6282, DOI 10.1093/emboj/18.22.6282; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Ogawa M, 2012, BBA-GEN SUBJECTS, V1820, P24, DOI 10.1016/j.bbagen.2011.10.011; Olivier-Van Stichelen S, 2015, CURR OPIN CLIN NUTR, V18, P339, DOI 10.1097/MCO.0000000000000188; ORKIN SH, 1992, BLOOD, V80, P575; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; Ranuncolo SM, 2012, J BIOL CHEM, V287, P23549, DOI 10.1074/jbc.M111.330910; Resto M, 2016, J BIOL CHEM, V291, P22703, DOI 10.1074/jbc.M116.751420; Rouillard AD, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw100; Sakabe K, 2010, P NATL ACAD SCI USA, V107, P19915, DOI 10.1073/pnas.1009023107; Saleque S, 2002, GENE DEV, V16, P301, DOI 10.1101/gad.959102; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Sohn KC, 2014, J DERMATOL SCI, V75, P10, DOI 10.1016/j.jdermsci.2014.04.010; Soler E, 2010, GENE DEV, V24, P277, DOI 10.1101/gad.551810; Speakman CM, 2014, STEM CELLS, V32, P2605, DOI 10.1002/stem.1761; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tan EP, 2017, J BIOL CHEM, V292, P14940, DOI 10.1074/jbc.M117.797944; Tripic T, 2009, BLOOD, V113, P2191, DOI 10.1182/blood-2008-07-169417; Villen J, 2007, P NATL ACAD SCI USA, V104, P1488, DOI 10.1073/pnas.0609836104; Wang Z, 2011, AUTOPHAGY, V7, P401, DOI 10.4161/auto.7.4.14397; Welch JJ, 2004, BLOOD, V104, P3136, DOI 10.1182/blood-2004-04-1603; Wu WS, 2011, GENOME RES, V21, P1659, DOI 10.1101/gr.125088.111; YAMAMOTO M, 1990, GENE DEV, V4, P1650, DOI 10.1101/gad.4.10.1650; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3; Yoon SG, 2013, CANCER RES TREAT, V45, P126, DOI 10.4143/crt.2013.45.2.126; Yu M, 2009, MOL CELL, V36, P682, DOI 10.1016/j.molcel.2009.11.002; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96; Yuzwa SA, 2012, NAT CHEM BIOL, V8, P393, DOI [10.1038/nchembio.797, 10.1038/NCHEMBIO.797]; Zhang Y, 2009, LEUKEMIA RES, V33, P166, DOI 10.1016/j.leukres.2008.05.021; Zhang Z, 2016, J BIOL CHEM, V291, P15628, DOI 10.1074/jbc.M116.721928	67	21	23	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1363	1379		10.1074/jbc.RA118.005993	http://dx.doi.org/10.1074/jbc.RA118.005993			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30523150	hybrid, Green Published			2022-12-28	WOS:000457879500026
J	Gayle, SS; Sahni, JM; Webb, BM; Weber-Bonk, KL; Shively, MS; Spina, R; Bar, EE; Summers, MK; Keri, RA				Gayle, Sylvia S.; Sahni, Jennifer M.; Webb, Bryan M.; Weber-Bonk, Kristen L.; Shively, Melyssa S.; Spina, Raffaella; Bar, Eli E.; Summers, Mathew K.; Keri, Ruth A.			Targeting BCL-xL improves the efficacy of bromodomain and extra-terminal protein inhibitors in triple-negative breast cancer by eliciting the death of senescent cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; breast cancer; bromodomain-containing protein 4 (BRD4); senescence; B-cell lymphoma 2 (Bcl-2) family; B-cell lymphoma-extra large; BCL-xL; BET inhibitor; senolytic agent	CELLULAR SENESCENCE; EXPRESSION; OVEREXPRESSION; RESISTANCE; APOPTOSIS; BCL-X(L); BAX; PHOSPHORYLATION; CHEMOTHERAPY; DISRUPTION	Inhibitors of bromodomain and extra-terminal proteins (BETi) suppress oncogenic gene expression and have been shown to be efficacious in many in vitro and murine models of cancer, including triple-negative breast cancer (TNBC), a highly aggressive disease. However, in most cancer models, responses to BETi can be highly variable. We previously reported that TNBC cells either undergo senescence or apoptosis in response to BETi, but the specific mechanisms dictating these two cell fates remain unknown. Using six human TNBC cell lines, we show that the terminal response of TNBC cells to BETi is dictated by the intrinsic expression levels of the anti-apoptotic protein B-cell lymphoma-extra large (BCL-xL). BCL-xL levels were higher in cell lines that senesce in response to BETi compared with lines that primarily die in response to these drugs. Moreover, BCL-xL expression was further reduced in cells that undergo BETi-mediated apoptosis. Forced BCL-xL overexpression in cells that normally undergo apoptosis following BETi treatment shifted them to senescence without affecting the reported mechanism of action of BETi in TNBC, that is, mitotic catastrophe. Most importantly, pharmacological or genetic inhibition of BCL-xL induced apoptosis in response to BETi, and inhibiting BCL-xL, even after BETi-induced senescence had already occurred, still induced cell death. These results indicate that BCL-xL provides a senescent cell death-inducing or senolytic target that may be exploited to improve therapeutic outcomes of TNBC in response to BETi. They also suggest that the basal levels of BCL-xL should be predictive of tumor responses to BETi in current clinical trials.	[Gayle, Sylvia S.; Sahni, Jennifer M.; Webb, Bryan M.; Weber-Bonk, Kristen L.; Shively, Melyssa S.; Keri, Ruth A.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Spina, Raffaella; Bar, Eli E.] Case Western Reserve Univ, Dept Neurol Surg, Cleveland, OH 44106 USA; [Keri, Ruth A.] Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA; [Keri, Ruth A.] Case Western Reserve Univ, Div Gen Med Sci Oncol, Cleveland, OH 44106 USA; [Summers, Mathew K.] Ohio State Univ, Dept Radiat Oncol, Columbus, OH 43210 USA; [Summers, Mathew K.] Ohio State Univ, Comprehens Canc Ctr, Columbus, OH 43210 USA; [Sahni, Jennifer M.] NY Univ, Sch Med, Dept Pathol, New York, NY 10016 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Keri, RA (corresponding author), 2109 Adelbert Rd, Cleveland, OH 44106 USA.	keri@case.edu	Keri, Ruth/ABF-2209-2021	Keri, Ruth/0000-0002-1640-3088; Roberts, Melyssa/0000-0001-6864-779X; Sahni, Jennifer/0000-0002-2735-1789	National Institutes of Health [T32 CA059366, F32CA210426, F99CA212460, F31CA224809, RO1CA187780, R01GM112895, R01GM108743, R01CA206505]; NATIONAL CANCER INSTITUTE [F32CA210426, R01CA187780, F99CA212460, R01CA206505, F31CA224809, T32CA059366] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR002549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250, R01GM112895, R01GM108743] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants T32 CA059366 (to S.S.G. and J.M.S.), F32CA210426 (to S.S.G.), F99CA212460 (to J.M.S.), F31CA224809 (to B.M.W.), RO1CA187780 (to E.E.B.), R01GM112895 (to M.K.S.), R01GM108743 (to M.K.S.), and R01CA206505 (to R.A.K.).	Badve S, 2011, MODERN PATHOL, V24, P157, DOI 10.1038/modpathol.2010.200; Bai LC, 2017, CANCER RES, V77, P2476, DOI 10.1158/0008-5472.CAN-16-2622; Bauer KR, 2007, CANCER, V109, P1721, DOI 10.1002/cncr.22618; Belkina AC, 2013, J IMMUNOL, V190, P3670, DOI 10.4049/jimmunol.1202838; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Chang JH, 2016, NAT MED, V22, P78, DOI 10.1038/nm.4010; Chen X, 2012, CANCER INFORM, V11, P147, DOI 10.4137/CIN.S9983; Conery AR, 2016, CANCER RES, V76, P1313, DOI 10.1158/0008-5472.CAN-15-1458; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Craig DW, 2013, MOL CANCER THER, V12, P104, DOI 10.1158/1535-7163.MCT-12-0781; da Motta LL, 2017, ONCOGENE, V36, P122, DOI 10.1038/onc.2016.184; Demaria M, 2017, CANCER DISCOV, V7, P165, DOI 10.1158/2159-8290.CD-16-0241; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Fernandez Y, 2000, CELL DEATH DIFFER, V7, P350, DOI 10.1038/sj.cdd.4400662; Ghaneh Paula, 2002, J Hepatobiliary Pancreat Surg, V9, P1, DOI 10.1007/s005340200000; Giatromanolaki A, 2011, MED ONCOL, V28, P745, DOI 10.1007/s12032-010-9530-3; Gobe G, 2002, CANCER INVEST, V20, P324, DOI 10.1081/CNV-120001177; Harley ME, 2010, EMBO J, V29, P2407, DOI 10.1038/emboj.2010.112; Irvin WJ, 2008, EUR J CANCER, V44, P2799, DOI 10.1016/j.ejca.2008.09.034; Kassam F, 2009, CLIN BREAST CANCER, V9, P29, DOI 10.3816/CBC.2009.n.005; Khongkow P, 2016, ONCOGENE, V35, P990, DOI 10.1038/onc.2015.152; Korb E, 2015, NAT NEUROSCI, V18, P1464, DOI 10.1038/nn.4095; Krajewska M, 1996, AM J PATHOL, V148, P1567; Liu R, 1999, AM J PATHOL, V155, P1861, DOI 10.1016/S0002-9440(10)65505-8; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Ma F, 2014, CANCER LETT, V353, P153, DOI 10.1016/j.canlet.2014.06.022; Minn AJ, 1996, GENE DEV, V10, P2621, DOI 10.1101/gad.10.20.2621; Olopade OI, 1997, CANCER J SCI AM, V3, P230; Park SS, 2007, BIOCHEM BIOPH RES CO, V363, P1044, DOI 10.1016/j.bbrc.2007.09.037; Reuben JM, 2011, EUR J CANCER, V47, P1527, DOI 10.1016/j.ejca.2011.01.011; Roberson RS, 2005, CANCER RES, V65, P2795, DOI 10.1158/0008-5472.CAN-04-1270; Sahni JM, 2017, CANCER RES, V77, P5395, DOI 10.1158/0008-5472.CAN-17-1571; Sahni JM, 2016, J BIOL CHEM, V291, P23756, DOI 10.1074/jbc.M116.738666; Shi J, 2014, CANCER CELL, V25, P210, DOI 10.1016/j.ccr.2014.01.028; Shu SK, 2016, NATURE, V529, P413, DOI 10.1038/nature16508; Storchova Z, 2008, J CELL SCI, V121, P3859, DOI 10.1242/jcs.039537; Stratikopoulos EE, 2015, CANCER CELL, V27, P837, DOI 10.1016/j.ccell.2015.05.006; Terrano DT, 2010, MOL CELL BIOL, V30, P640, DOI 10.1128/MCB.00882-09; Vitale I, 2011, NAT REV MOL CELL BIO, V12, P384, DOI 10.1038/nrm3115; Wang LQ, 2017, CELL REP, V21, P773, DOI 10.1016/j.celrep.2017.09.085; Wang NS, 2001, J BIOL CHEM, V276, P44117, DOI 10.1074/jbc.M101958200; Wang Q, 2011, INT J CANCER, V128, P1546, DOI 10.1002/ijc.25482; Watanabe J, 2002, INT J ONCOL, V21, P515; Yosef R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11190	44	32	32	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2019	294	3					875	886		10.1074/jbc.RA118.004712	http://dx.doi.org/10.1074/jbc.RA118.004712			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL4FC	30482844	Green Published, hybrid			2022-12-28	WOS:000458670200014
J	Crickard, JB; Kwon, Y; Sung, P; Greene, EC				Crickard, J. Brooks; Kwon, Youngho; Sung, Patrick; Greene, Eric C.			Dynamic interactions of the homologous pairing 2 (Hop2)-meiotic nuclear divisions 1 (Mnd1) protein complex with meiotic presynaptic filaments in budding yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						meiosis; homologous recombination; DNA recombination; DNA; DNA enzyme; Dmc1; Hop2-Mnd1; Rad51; DNA curtains; DNA repair; yeast; DNA-protein interaction; recombinase	DNA END-RESECTION; DOUBLE-STRAND BREAK; MITOTIC RECOMBINATION; MECHANISTIC INSIGHTS; SEQUENCE ALIGNMENT; CRYSTAL-STRUCTURE; RAD51; HOP2; DMC1; MEIOSIS	Homologous recombination (HR) is a universally conserved DNA repair pathway that can result in the exchange of genetic material. In eukaryotes, HR has evolved into an essential step in meiosis. During meiosis many eukaryotes utilize a two-recombinase pathway. This system consists of Rad51 and the meiosis-specific recombinase Dmc1. Both recombinases have distinct activities during meiotic HR, despite being highly similar in sequence and having closely related biochemical activities, raising the question of how these two proteins can perform separate functions. A likely explanation for their differential regulation involves the meiosis-specific recombination proteins Hop2 and Mnd1, which are part of a highly conserved eukaryotic protein complex that participates in HR, albeit through poorly understood mechanisms. To better understand how Hop2-Mnd1 functions during HR, here we used DNA curtains in conjunction with single-molecule imaging to measure and quantify the binding of the Hop2-Mnd1 complex from Saccharomyces cerevisiae to recombination intermediates comprising Rad51- and Dmc1-ssDNA in real time. We found that yeast Hop2-Mnd1 bound rapidly to Dmc1-ssDNA filaments with high affinity and remained bound for approximate to 1.3 min before dissociating. We also observed that this binding interaction was highly specific for Dmc1 and found no evidence for an association of Hop2-Mnd1 with Rad51-ssDNA or RPA-ssDNA. Our findings provide new quantitative insights into the binding dynamics of Hop2-Mnd1 with the meiotic presynaptic complex. On the basis of these findings, we propose a model in which recombinase specificities for meiotic accessory proteins enhance separation of the recombinases' functions during meiotic HR.	[Crickard, J. Brooks; Greene, Eric C.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Kwon, Youngho; Sung, Patrick] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Kwon, Youngho; Sung, Patrick] Univ Texas Hlth San Antonio, Dept Biochem & Struct Biol, San Antonio, TX 78229 USA	Columbia University; Yale University; University of Texas System; University of Texas Health San Antonio	Greene, EC (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA.	ecg2108@cumc.columbia.edu	Classen, Scott/AAY-8176-2020		National Institutes of Health [R35 GM118026, R01 ES007061, RO1 CA220123, P30 CA054174, PO1 CA092584]; National Science Foundation (NSF) [MCB1154511]; NATIONAL CANCER INSTITUTE [P30CA054174, R01CA220123, P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118026] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by National Institutes of Health Grants R35 GM118026 (to E.C.G.), R01 ES007061, RO1 CA220123, and P30 CA054174 (to P.S.), and PO1 CA092584 (to E.C.G. and P.S.) and National Science Foundation (NSF) Grant MCB1154511 (to E.C.G.). The authors declare they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anand RP, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010397; Bernstein KA, 2010, ANNU REV GENET, V44, P393, DOI 10.1146/annurev-genet-102209-163602; BISHOP DK, 1994, CELL, V79, P1081, DOI 10.1016/0092-8674(94)90038-8; Bishop DK, 2012, CELL CYCLE, V11, P4105, DOI 10.4161/cc.22396; Brown MS, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005653; Brown MS, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016659; Busygina V, 2008, GENE DEV, V22, P786, DOI 10.1101/gad.1638708; Busygina V, 2013, DNA REPAIR, V12, P707, DOI 10.1016/j.dnarep.2013.05.004; Busygina V, 2012, J BIOL CHEM, V287, P1566, DOI 10.1074/jbc.M111.297309; Bzymek M, 2010, NATURE, V464, P937, DOI 10.1038/nature08868; Callender TL, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006226; Cejka P, 2010, NATURE, V467, P112, DOI 10.1038/nature09355; Chan YL, 2014, J BIOL CHEM, V289, P18076, DOI 10.1074/jbc.M114.558601; Chang HY, 2015, J BIOL CHEM, V290, P19863, DOI 10.1074/jbc.M115.666289; Chen H, 2013, MOL CELL, V50, P589, DOI 10.1016/j.molcel.2013.04.032; Chen YK, 2004, P NATL ACAD SCI USA, V101, P10572, DOI 10.1073/pnas.0404195101; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Chi P, 2009, DNA REPAIR, V8, P279, DOI 10.1016/j.dnarep.2008.10.012; Cho NW, 2014, CELL, V159, P108, DOI 10.1016/j.cell.2014.08.030; Cloud V, 2012, SCIENCE, V337, P1222, DOI 10.1126/science.1219379; Collins BE, 2014, METHOD CELL BIOL, V123, P217, DOI 10.1016/B978-0-12-420138-5.00012-4; Conway AB, 2004, NAT STRUCT MOL BIOL, V11, P791, DOI 10.1038/nsmb795; Cox MM, 2007, NAT REV MOL CELL BIO, V8, P127, DOI 10.1038/nrm2099; Crickard JB, 2018, J BIOL CHEM, V293, P4191, DOI 10.1074/jbc.RA117.001143; Crickard JB, 2018, EMBO J, V37, DOI 10.15252/embj.201798728; De Tullio L, 2018, METHOD ENZYMOL, V600, P407, DOI 10.1016/bs.mie.2017.12.004; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Gerton JL, 2005, NAT REV GENET, V6, P477, DOI 10.1038/nrg1614; Gerton JL, 2002, P NATL ACAD SCI USA, V99, P6895, DOI 10.1073/pnas.102167899; Gibb B, 2014, NAT STRUCT MOL BIOL, V21, P893, DOI 10.1038/nsmb.2886; Gibb B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087922; Greene EC, 2016, J BIOL CHEM, V291, P11572, DOI 10.1074/jbc.R116.724807; Haber JE, 2012, GENETICS, V191, P33, DOI 10.1534/genetics.111.134577; Henry JM, 2006, MOL CELL BIOL, V26, P2913, DOI 10.1128/MCB.26.8.2913-2923.2006; Heyer WD, 2006, NUCLEIC ACIDS RES, V34, P4115, DOI 10.1093/nar/gkl481; Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955; Hong ERL, 2001, J BIOL CHEM, V276, P41906, DOI 10.1074/jbc.M105563200; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Hunter N, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016618; Kang HA, 2015, NUCLEIC ACIDS RES, V43, P3841, DOI 10.1093/nar/gkv172; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Keeney Scott, 2008, V2, P81, DOI 10.1007/7050_2007_026; Kowalczykowski SC, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016410; Lao JP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003978; Lee JY, 2015, SCIENCE, V349, P977, DOI 10.1126/science.aab2666; Lee MH, 2005, J BIOL CHEM, V280, P40980, DOI 10.1074/jbc.M505896200; Leu JY, 1998, CELL, V94, P375, DOI 10.1016/S0092-8674(00)81480-4; Li X, 2007, NUCLEIC ACIDS RES, V35, P4124, DOI 10.1093/nar/gkm412; Lin ZG, 2006, P NATL ACAD SCI USA, V103, P10328, DOI 10.1073/pnas.0604232103; Liu J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004755; Ma CJ, 2017, METHOD ENZYMOL, V582, P193, DOI 10.1016/bs.mie.2016.08.005; Matos J, 2014, DNA REPAIR, V19, P176, DOI 10.1016/j.dnarep.2014.03.013; Mimitou EP, 2017, SCIENCE, V355, P40, DOI 10.1126/science.aak9704; Mitchel K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003340; Moktan H, 2014, J BIOL CHEM, V289, P14682, DOI 10.1074/jbc.M114.548180; Morrical SW, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016444; Niu H, 2007, MOL CELL BIOL, V27, P5456, DOI 10.1128/MCB.00416-07; Niu HY, 2010, NATURE, V467, P108, DOI 10.1038/nature09318; Niu HY, 2009, MOL CELL, V36, P393, DOI 10.1016/j.molcel.2009.09.029; Peng Min, 2013, Genes Cancer, V4, P26, DOI 10.1177/1947601913486345; Pezza RJ, 2007, GENE DEV, V21, P1758, DOI 10.1101/gad.1562907; Pezza RJ, 2006, J BIOL CHEM, V281, P18426, DOI 10.1074/jbc.M601073200; Pezza RJ, 2014, NUCLEIC ACIDS RES, V42, P2346, DOI 10.1093/nar/gkt1234; Prakash R, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016600; Qi Z, 2016, METHODS, V105, P62, DOI 10.1016/j.ymeth.2016.03.027; Qi Z, 2015, CELL, V160, P856, DOI 10.1016/j.cell.2015.01.029; Renkawitz J, 2014, NAT REV MOL CELL BIO, V15, P369, DOI 10.1038/nrm3805; Sheridan S, 2006, GENE DEV, V20, P1685, DOI 10.1101/gad.1447606; Sheridan SD, 2008, NUCLEIC ACIDS RES, V36, P4057, DOI 10.1093/nar/gkn352; SUNG P, 1994, SCIENCE, V265, P1241, DOI 10.1126/science.8066464; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Symington LS, 2016, CRIT REV BIOCHEM MOL, V51, P195, DOI 10.3109/10409238.2016.1172552; Symington LS, 2014, GENETICS, V198, P795, DOI 10.1534/genetics.114.166140; Symington LS, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016436; Tsubouchi H, 2003, DEV CELL, V5, P915, DOI 10.1016/S1534-5807(03)00357-5; Tsubouchi H, 2002, MOL CELL BIOL, V22, P3078, DOI 10.1128/MCB.22.9.3078-3088.2002; Tsubouchi H, 2006, GENE DEV, V20, P1766, DOI 10.1101/gad.1422506; Wright WD, 2014, MOL CELL, V53, P420, DOI 10.1016/j.molcel.2013.12.027; Xu JF, 2017, NAT STRUCT MOL BIOL, V24, P40, DOI 10.1038/nsmb.3336; Zhao WX, 2015, NUCLEIC ACIDS RES, V43, P4055, DOI 10.1093/nar/gkv259; Zhao WX, 2014, NUCLEIC ACIDS RES, V42, P906, DOI 10.1093/nar/gkt924; Zickler D., 2015, COLD SPRING HARB PER, V7, DOI DOI 10.1101/CSHPERSPECT.A016626	82	11	11	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2019	294	2					490	501		10.1074/jbc.RA118.006146	http://dx.doi.org/10.1074/jbc.RA118.006146			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HI2GP	30420424	Green Published, hybrid			2022-12-28	WOS:000456263600010
J	Gallo, GL; Valko, A; Aramburu, SI; Etchegaray, E; Volker, C; Parodi, AJ; D'Alessio, C				Gallo, Giovanna L.; Valko, Ayelen; Aramburu, Sofia I.; Etchegaray, Emiliana; Voelker, Christof; Parodi, Armando J.; D'Alessio, Cecilia			Abrogation of glucosidase I-mediated glycoprotein deglucosylation results in a sick phenotype in fission yeasts: Model for the human MOGS-CDG disorder	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum (ER); N-linked glycosylation; Schizosaccharomyces pombe; yeast; glycoprotein; CDG-IIb; congenital disorders of glycosylation; glucosidase I; glycan; MOGS-CDG	SCHIZOSACCHAROMYCES-POMBE; UDP-GLC; OLIGOSACCHARYLTRANSFERASE COMPLEX; ENDOPLASMIC-RETICULUM; N-GLYCOSYLATION; PROTEIN; GLUCOSYLTRANSFERASE; OLIGOSACCHARIDE; BIOSYNTHESIS; DEGRADATION	Glucosidase I (GI) removes the outermost glucose from protein-linked Glc(3)Man(9)GlcNAc(2) (G3M9) in the endoplasmic reticulum (ER). Individuals with congenital disorders of glycosylation MOGS-CDG bear mutations in the GI-encoding gene (gls1). Although GI absence has been reported to produce lethality in Schizosaccharomyces pombe yeasts, here we obtained two viable gls1 mutants, one with a very sick but not lethal phenotype (gls1-S) and the other with a healthier one (gls1-H). The sick strain displayed only G3M9 as an ER protein-linked oligosaccharide, whereas the healthier strain had both G3M9 and Man(9)GlcNAc(2). The lipid-linked oligosaccharide patterns of the two strains revealed that the most abundantly formed glycans were G3M9 in gls1-S and Glc(2)Man(9)GlcNAc(2) in gls1-H, suggesting reduced Alg10p glucosyltransferase activity in the gls1-H strain. A mutation in the alg10(+) gene was indeed observed in this strain. Our results indicated that abrogated G3M9 deglucosylation was responsible for the severe defects observed in gls1-S cells. Further studies disclosed that the defects could not be ascribed to disruption of glycoprotein entrance into calnexin-folding cycles, inhibition of the oligosaccharyltransferase by transfer reaction products, or reduced proteasomal degradation of misfolded glycoproteins. Lack of triglucosylated glycoprotein deglucosylation neither significantly prevented glycan elongation in the Golgi nor modified the overall cell wall monosaccharide composition. Nevertheless, it resulted in a distorted cell wall and in the absence of underlying ER membranes. Furthermore, Golgi expression of human endomannosidase partially restored normal growth in gls1-S cells. We propose that accumulation of G3M9-bearing glycoproteins is toxic and at least partially responsible for defects observed in MOGS-CDG.	[Gallo, Giovanna L.; Valko, Ayelen; Aramburu, Sofia I.; Etchegaray, Emiliana; Parodi, Armando J.; D'Alessio, Cecilia] Consejo Nacl Invest Cient & Tecn, Fdn Inst Leloir IIBBA, C1405BWE, Buenos Aires, DF, Argentina; [Voelker, Christof] Univ Bonn, Fac Med, Inst Biochem & Mol Biol, D-53115 Bonn, Germany; [D'Alessio, Cecilia] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fisiol Biol Mol & Celular, C1428EGA, Buenos Aires, DF, Argentina; [Parodi, Armando J.; D'Alessio, Cecilia] Natl Res Council CONICET, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; University of Bonn; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	D'Alessio, C (corresponding author), Fdn Inst Leloir, Ave Patricias Argentinas 435,C1405BWE, Buenos Aires, DF, Argentina.	cdalessio@leloir.org.ar	Gallo, Giovanna/GXH-4399-2022; Gallo, Giovanna/GXF-5113-2022	Gallo, Giovanna/0000-0002-1102-7108; D'Alessio, Cecilia/0000-0001-7371-5080; Valko, Ayelen/0000-0002-1296-0178	National Research Council (CONIC ET, Argentina) [PIP-11220150100759]	National Research Council (CONIC ET, Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported in part by the National Research Council (CONIC ET, Argentina) Grant PIP-11220150100759. The authors declare that they have no conflicts of interest with the contents of this article.	Aebi M, 2013, BBA-MOL CELL RES, V1833, P2430, DOI 10.1016/j.bbamcr.2013.04.001; Alfa C., 1993, EXPT FISSION YEAST L; Bredeston LM, 2017, GLYCOBIOLOGY, V27, P64, DOI 10.1093/glycob/cww092; Burda P, 1998, GLYCOBIOLOGY, V8, P455, DOI 10.1093/glycob/8.5.455; Buschhorn BA, 2004, FEBS LETT, V577, P422, DOI 10.1016/j.febslet.2004.10.039; Caramelo JJ, 2003, P NATL ACAD SCI USA, V100, P86, DOI 10.1073/pnas.262661199; Chavan M, 2003, P NATL ACAD SCI USA, V100, P15381, DOI 10.1073/pnas.2536561100; Chino A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009652; D'Alessio C, 1999, J BIOL CHEM, V274, P25899, DOI 10.1074/jbc.274.36.25899; D'Alessio C, 2003, J BIOL CHEM, V278, P22379, DOI 10.1074/jbc.M300892200; D'Alessio C, 2010, SEMIN CELL DEV BIOL, V21, P491, DOI 10.1016/j.semcdb.2009.12.014; De Praeter CM, 2000, AM J HUM GENET, V66, P1744, DOI 10.1086/302948; Fanchiotti S, 1998, J CELL BIOL, V143, P625, DOI 10.1083/jcb.143.3.625; Fernandez F, 1996, EMBO J, V15, P705, DOI 10.1002/j.1460-2075.1996.tb00406.x; FERNANDEZ FS, 1994, J BIOL CHEM, V269, P30701; Freeze HH, 2015, ESSENTIALS GLYCOBIOL, P569; Hagan I. M., 2016, FISSION YEAST LAB MA; Hardt B, 2005, BIOCHIMIE, V87, P169, DOI 10.1016/j.biochi.2004.11.004; Herscovics A, 1999, BBA-GEN SUBJECTS, V1426, P275, DOI 10.1016/S0304-4165(98)00129-9; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Hossain TJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151891; Katoh T, 2013, GLYCOBIOLOGY, V23, P1142, DOI 10.1093/glycob/cwt051; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; LUBAS WA, 1987, J BIOL CHEM, V262, P3775; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; McDowall MD, 2015, NUCLEIC ACIDS RES, V43, pD656, DOI 10.1093/nar/gku1040; Mohorko E, 2011, J INHERIT METAB DIS, V34, P869, DOI 10.1007/s10545-011-9337-1; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nasab FP, 2008, MOL BIOL CELL, V19, P3758, DOI 10.1091/mbc.E08-05-0467; Nunez A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121059; Osumi M, 2012, J ELECTRON MICROSC, V61, P343, DOI 10.1093/jmicro/dfs082; Parodi AJ, 2000, ANNU REV BIOCHEM, V69, P69, DOI 10.1146/annurev.biochem.69.1.69; PARODI AJ, 1993, GLYCOBIOLOGY, V3, P193, DOI 10.1093/glycob/3.3.193; Piel M, 2009, CURR BIOL, V19, pR823, DOI 10.1016/j.cub.2009.08.012; R Development Core Team, 2009, R LANG ENV STAT COMP; Roux AE, 2006, AGING CELL, V5, P345, DOI 10.1111/j.1474-9726.2006.00225.x; Sadat MA, 2014, NEW ENGL J MED, V370, P1615, DOI 10.1056/NEJMoa1302846; Sambrook J., 2001, MOL CLONING LAB MANU; Sato M, 2005, YEAST, V22, P583, DOI 10.1002/yea.1233; SOUSA MC, 1992, BIOCHEMISTRY-US, V31, P97, DOI 10.1021/bi00116a015; Soussillane P, 2009, GLYCOCONJUGATE J, V26, P597, DOI 10.1007/s10719-008-9201-1; Stigliano ID, 2011, MOL BIOL CELL, V22, P1810, DOI 10.1091/mbc.E11-01-0019; Stigliano ID, 2009, MOL BIOL CELL, V20, P3974, DOI 10.1091/mbc.E09-04-0316; Szathmary R, 2005, MOL CELL, V19, P765, DOI 10.1016/j.molcel.2005.08.015; Varki A, 2015, GLYCOBIOLOGY, V25, P1323, DOI 10.1093/glycob/cwv091; Volker C, 2002, GLYCOBIOLOGY, V12, P473, DOI 10.1093/glycob/cwf050; Wild R, 2018, SCIENCE, V359, P545, DOI 10.1126/science.aar5140; Wood V, 2012, NUCLEIC ACIDS RES, V40, pD695, DOI 10.1093/nar/gkr853	49	4	4	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					19957	19973		10.1074/jbc.RA118.004844	http://dx.doi.org/10.1074/jbc.RA118.004844			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30389790	Green Published, hybrid			2022-12-28	WOS:000454685900002
J	Wang, WX; Zhang, JH; Liu, X; Li, D; Li, Y; Tian, YQ; Tan, HR				Wang, Wenxi; Zhang, Jihui; Liu, Xiang; Li, Dong; Li, Yue; Tian, Yuqing; Tan, Huarong			Identification of a butenolide signaling system that regulates nikkomycin biosynthesis in Streptomyces	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						molecular genetics; receptor; transcription regulation; antibiotics; signal transduction; secondary metabolism; butenolide signaling molecules; gene cluster; nikkomycin; Streptomyces	ANTIBIOTIC PRODUCTION; SECONDARY METABOLISM; MORPHOLOGICAL-DIFFERENTIATION; AUTOREGULATOR-RECEPTOR; LANKAMYCIN PRODUCTION; MOLECULAR REGULATION; A-FACTOR; COELICOLOR; GENE; ADPA	Butenolides are an emerging family of signaling molecules in Streptomyces. They control complex physiological traits, such as morphological differentiation and antibiotic production. However, how butenolides regulate these processes is poorly investigated because of obstacles in obtaining these signaling molecules. This study reports the identification of a butenolide-type signaling system for nikkomycin biosynthesis in Streptomyces ansochromogenes with distinct features. We identified a gene cluster, sab, consisting of three genes, sabAPD, for butenolide biosynthesis and two regulator genes, sabR1 and sabR2, and characterized three butenolides (SAB1, -2, and -3) by heterologous expression of sabAPD. sabA disruption abolished nikkomycin production, which could be restored by the addition of SABs or by deletion of sabR1 in sabA. Electrophoretic mobility-shift assays and transcriptional analyses indicated that SabR1 indirectly represses the transcription of nikkomycin biosynthetic genes, but directly represses sabA and sabR1. In the presence of SABs, the SabR1 transcriptional regulator dissociated from its target genes, verifying that SabR1 is the cognate receptor of SABs. Genome-wide scanning with the conserved SabR1-binding sequence revealed another SabR1 target gene, cprC, whose transcription was strongly repressed by SabR1. Intriguingly, CprC positively regulated the pleiotropic regulatory gene adpA by binding to its promoter and, in turn, activated nikkomycin biosynthesis. This is the first report that butenolide-type signaling molecules and their cognate receptor SabR1 can regulate adpA via a newly identified activator, CprC, to control nikkomycin production. These findings pave the way for further studies seeking to unravel the regulatory mechanism and functions of the butenolide signaling system in Streptomyces.	[Wang, Wenxi; Zhang, Jihui; Liu, Xiang; Li, Dong; Li, Yue; Tian, Yuqing; Tan, Huarong] Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing 100101, Peoples R China; [Wang, Wenxi; Liu, Xiang; Li, Dong; Tian, Yuqing; Tan, Huarong] Univ Chinese Acad Sci, Coll Life Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, JH; Tan, HR (corresponding author), Chinese Acad Sci, Inst Microbiol, Beijing 100101, Peoples R China.	zhang.jihui@im.ac.cn; tanhr@im.ac.cn		Zhang, Jihui/0000-0001-5029-0833; Wang, Wenxi/0000-0001-6152-0403	Ministry of Science and Technology of China [2015CB150600]; National Natural Science Foundation of China [31571281,31771378, 31470206]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Ministry of Science and Technology of China Grant 2015CB150600 and National Natural Science Foundation of China Grants 31571281,31771378, and 31470206. The authors declare that they have no conflicts of interest with the contents of this article.	Arakawa K, 2007, MICROBIOL-SGM, V153, P1817, DOI 10.1099/mic.0.2006/002170-0; Arakawa K, 2012, CHEMBIOCHEM, V13, P1447, DOI 10.1002/cbic.201200149; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; BRAUN D, 1995, FEMS MICROBIOL LETT, V126, P37, DOI 10.1111/j.1574-6968.1995.tb07387.x; Corre C, 2008, P NATL ACAD SCI USA, V105, P17510, DOI 10.1073/pnas.0805530105; Gomez-Escribano JP, 2011, MICROB BIOTECHNOL, V4, P207, DOI 10.1111/j.1751-7915.2010.00219.x; He XH, 2010, MICROBIOL-SGM, V156, P828, DOI 10.1099/mic.0.033605-0; Higo A, 2012, DNA RES, V19, P259, DOI 10.1093/dnares/dss010; Horinouchi S, 2007, P JPN ACAD B-PHYS, V83, P277, DOI [10.2183/pjab.83.277, 10.2183/pjab/83.277]; Kato JY, 2007, P NATL ACAD SCI USA, V104, P2378, DOI 10.1073/pnas.0607472104; Kitani S, 2011, P NATL ACAD SCI USA, V108, P16410, DOI 10.1073/pnas.1113908108; Li JJ, 2018, CELL CHEM BIOL, V25, P143, DOI 10.1016/j.chembiol.2017.10.012; Li Y, 2017, SCI CHINA LIFE SCI, V60, P935, DOI 10.1007/s11427-017-9115-x; Li Y, 2016, J BIOL CHEM, V291, P5406, DOI 10.1074/jbc.M115.695874; Liu G, 2005, MOL MICROBIOL, V55, P1855, DOI 10.1111/j.1365-2958.2005.04512.x; Liu G, 2013, MICROBIOL MOL BIOL R, V77, P112, DOI 10.1128/MMBR.00054-12; Lu C, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0359-5; Myronovskyi M, 2011, APPL ENVIRON MICROB, V77, P5370, DOI 10.1128/AEM.00434-11; Niu GQ, 2016, FEMS MICROBIOL REV, V40, P554, DOI 10.1093/femsre/fuw012; Onaka H, 1998, MOL MICROBIOL, V28, P743, DOI 10.1046/j.1365-2958.1998.00832.x; Paget MSB, 1999, J BACTERIOL, V181, P204, DOI 10.1128/JB.181.1.204-211.1999; Pan YY, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-164; Pan YY, 2009, MOL MICROBIOL, V72, P710, DOI 10.1111/j.1365-2958.2009.06681.x; Sidda JD, 2016, ORG BIOMOL CHEM, V14, P6390, DOI 10.1039/c6ob00840b; Sultan SP, 2016, APPL MICROBIOL BIOT, V100, P9581, DOI 10.1007/s00253-016-7781-4; Suzuki T, 2010, BIOSCI BIOTECH BIOCH, V74, P819, DOI 10.1271/bbb.90927; Takano E, 2001, MOL MICROBIOL, V41, P1015, DOI 10.1046/j.1365-2958.2001.02562.x; Nguyen TB, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.02791-17; Wang WS, 2014, P NATL ACAD SCI USA, V111, P5688, DOI 10.1073/pnas.1324253111; Xu GM, 2010, J BIOL CHEM, V285, P27440, DOI 10.1074/jbc.M110.143081; Xu JJ, 2017, J BIOL CHEM, V292, P19708, DOI 10.1074/jbc.M117.809145; Zhong XY, 2013, SCI CHINA LIFE SCI, V56, P609, DOI 10.1007/s11427-013-4506-0; Zhu JY, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02577; Zhu JY, 2016, MOL MICROBIOL, V102, P562, DOI 10.1111/mmi.13479; Zou ZZ, 2014, MOL MICROBIOL, V94, P490, DOI 10.1111/mmi.12752	36	11	13	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					20029	20040		10.1074/jbc.RA118.005667	http://dx.doi.org/10.1074/jbc.RA118.005667			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30355730	Green Published, hybrid			2022-12-28	WOS:000454685900013
J	Murata, H; Khine, CC; Nishikawa, A; Yamamoto, K; Kinoshita, R; Sakaguchi, M				Murata, Hitoshi; Khine, Cho Cho; Nishikawa, Akane; Yamamoto, Ken-ichi; Kinoshita, Rie; Sakaguchi, Masakiyo			c-Jun N-terminal kinase (JNK)-mediated phosphorylation of SARM1 regulates NAD(+) cleavage activity to inhibit mitochondrial respiration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AXONAL DEGENERATION; CELL-DEATH; ACTIVATION; INJURY; PINK1; DELETION; UBIQUITIN; TRIGGERS; PARKIN; LINKS	Mitochondrial dysfunction is a key pathological feature of many different types of neurodegenerative disease. Sterile alpha and Toll/interleukin receptor motif-containing protein 1 (SARM1) has been attracting much attention as an important molecule for inducing axonal degeneration and neuronal cell death by causing loss of NAD (NADH). However, it has remained unclear what exactly regulates the SARM1 activity. Here, we report that NAD(+) cleavage activity of SARM1 is regulated by its own phosphorylation at serine 548. The phosphorylation of SARM1 was mediated by c-jun N-terminal kinase (JNK) under oxidative stress conditions, resulting in inhibition of mitochondrial respiration concomitant with enhanced activity of NAD(+) cleavage. Nonphosphorylatable mutation of Ser-548 or treatment with a JNK inhibitor decreased SARM1 activity. Furthermore, neuronal cells derived from a familial Parkinson's disease (PD) patient showed a congenitally increased level of SARM1 phosphorylation compared with that in neuronal cells from a healthy person and were highly sensitive to oxidative stress. These results indicate that JNK-mediated phosphorylation of SARM1 at Ser-548 is a regulator of SARM1 leading to inhibition of mitochondrial respiration. These findings suggest that an abnormal regulation of SARM1 phosphorylation is involved in the pathogenesis of Parkinson's disease and possibly other neurodegenerative diseases.	[Murata, Hitoshi; Khine, Cho Cho; Nishikawa, Akane; Yamamoto, Ken-ichi; Kinoshita, Rie; Sakaguchi, Masakiyo] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cell Biol, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan; [Khine, Cho Cho] Univ Med, Hosp UM1, Yangon 11131, Myanmar	Okayama University	Sakaguchi, M (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cell Biol, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	masa-s@md.okayama-u.ac.jp	MURATA, Hitoshi/B-2327-2011	Lin, Li Juan/0000-0003-2522-9306	Japan Science and Technology Agency Grant [16K19037]; Japan Agency for Medical Research and Development [JP17km0908001]	Japan Science and Technology Agency Grant; Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This work was supported by Japan Science and Technology Agency Grant 16K19037 and Japan Agency for Medical Research and Development Grant JP17km0908001 (to H.M.). The authors declare that they have no conflicts of interest with the contents of this article.	Burke RE, 2013, EXP NEUROL, V246, P72, DOI 10.1016/j.expneurol.2012.01.011; Choi SW, 2009, J NEUROCHEM, V109, P1179, DOI 10.1111/j.1471-4159.2009.06055.x; Conforti L, 2014, NAT REV NEUROSCI, V15, P394, DOI 10.1038/nrn3680; Deng H, 2018, AGEING RES REV, V42, P72, DOI 10.1016/j.arr.2017.12.007; Di Lisa F, 2001, J BIOL CHEM, V276, P2571, DOI 10.1074/jbc.M006825200; Essuman K, 2017, NEURON, V93, P1334, DOI 10.1016/j.neuron.2017.02.022; Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419; Geisler S, 2016, BRAIN, V139, P3092, DOI 10.1093/brain/aww251; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Gerdts J, 2016, NEURON, V89, P449, DOI 10.1016/j.neuron.2015.12.023; Gerdts J, 2015, SCIENCE, V348, P453, DOI 10.1126/science.1258366; Gerdts J, 2013, J NEUROSCI, V33, P13569, DOI 10.1523/JNEUROSCI.1197-13.2013; Gilley J, 2017, CELL REP, V21, P10, DOI 10.1016/j.celrep.2017.09.027; Gilley J, 2015, CELL REP, V10, P1974, DOI 10.1016/j.celrep.2015.02.060; Henninger N, 2016, BRAIN, V139, P1094, DOI 10.1093/brain/aww001; Imaizumi Y, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-35; Ito Y, 2016, SCIENCE, V353, P603, DOI 10.1126/science.aaf6803; Jin Y, 2012, ONCOL REP, V27, P695, DOI 10.3892/or.2011.1543; Kandan NM, 2013, EXP NEUROL, V246, P44, DOI 10.1016/j.expneurol.2012.06.003; Kane LA, 2014, J CELL BIOL, V205, P143, DOI 10.1083/jcb.201402104; Kim YH, 2007, J EXP MED, V204, P2063, DOI 10.1084/jem.20070868; Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Mukherjee P, 2015, J IMMUNOL, V195, P4913, DOI 10.4049/jimmunol.1500953; Mukherjee P, 2013, IMMUNITY, V38, P705, DOI 10.1016/j.immuni.2013.02.013; Murata H, 2013, MOL BIOL CELL, V24, P2772, DOI 10.1091/mbc.E13-01-0016; Murata H, 2011, J BIOL CHEM, V286, P7182, DOI 10.1074/jbc.M110.179390; Osterloh JM, 2012, SCIENCE, V337, P481, DOI 10.1126/science.1223899; Panneerselvam P, 2013, CELL DEATH DIFFER, V20, P478, DOI 10.1038/cdd.2012.144; Panneerselvam P, 2012, BIOCHEM J, V442, P263, DOI 10.1042/BJ20111653; Peng J, 2010, EUR J IMMUNOL, V40, P1738, DOI 10.1002/eji.200940034; Sakaguchi M, 2014, MOL BIOTECHNOL, V56, P621, DOI 10.1007/s12033-014-9738-0; Shiba-Fukushima K, 2012, SCI REP-UK, V2, DOI 10.1038/srep01002; Su KG, 2009, CURR NEUROL NEUROSCI, V9, P411, DOI 10.1007/s11910-009-0060-3; Summers DW, 2016, P NATL ACAD SCI USA, V113, pE6271, DOI 10.1073/pnas.1601506113; Summers DW, 2014, J NEUROSCI, V34, P9338, DOI 10.1523/JNEUROSCI.0877-14.2014; Turkiew E, 2017, J PERIPHER NERV SYST, V22, P162, DOI 10.1111/jns.12219; Veriepe J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8319; Walker LJ, 2017, ELIFE, V6, DOI 10.7554/eLife.22540; Yang J, 2015, CELL, V160, P161, DOI 10.1016/j.cell.2014.11.053; Zhang T, 2012, CHEM BIOL, V19, P140, DOI 10.1016/j.chembiol.2011.11.010	41	39	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2018	293	49					18933	18943		10.1074/jbc.RA118.004578	http://dx.doi.org/10.1074/jbc.RA118.004578			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NY	30333228	hybrid, Green Published			2022-12-28	WOS:000458467400010
J	Lv, JJ; Su, W; Yu, QY; Zhang, M; Di, CX; Lin, XL; Wu, M; Xia, ZW				Lv, Jiajia; Su, Wen; Yu, Qianying; Zhang, Meng; Di, Caixia; Lin, Xiaoliang; Wu, Min; Xia, Zhenwei			Heme oxygenase-1 protects airway epithelium against apoptosis by targeting the proinflammatory NLRP3-RXR axis in asthma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOID-X-RECEPTOR; CARBON-MONOXIDE SUPPRESS; NUCLEAR EXPORT; UP-REGULATION; CELLS; INFLAMMASOME; DIFFERENTIATION; RESPONSES; PATHWAY; HO-1	Asthma is thought to be caused by malfunction of type 2 T helper cell (Th2)-mediated immunity, causing excessive inflammation, mucus overproduction, and apoptosis of airway epithelial cells. Heme oxygenase-1 (HO-1) functions in heme catabolism and is both cytoprotective and anti-inflammatory. We hypothesized that this dual function may be related to asthma's etiology. Using primary airway epithelial cells (pAECs) and an asthma mouse model, we demonstrate that severe lung inflammation is associated with rapid pAEC apoptosis. Surprisingly, NOD-like receptor protein 3 (NLRP3) inhibition, retinoid X receptor (RXR) deficiency, and HO-1 induction were associated with abrogated apoptosis. MCC950, a selective small-molecule inhibitor of canonical and noncanonical NLRP3 activation, reduced RXR expression, leading to decreased pAEC apoptosis that was reversed by the RXR agonist adapalene. Of note, HO-1 induction in a mouse model of ovalbumin-induced eosinophilic asthma suppressed Th2 responses and reduced apoptosis of pulmonary pAECs. In vitro, HO-1 induction desensitized cultured pAECs to ovalbumin-induced apoptosis, confirming the in vivo observations. Critically, the HO-1 products carbon monoxide and bilirubin suppressed the NLRP3-RXR axis in pAECs. Furthermore, HO-1 impaired production of NLRP3-RXR-induced cytokines (interleukin [IL]-25, IL-33, thymic stromal lymphopoietin, and granulocyte-macrophage colony-stimulating factor) in pAECs and lungs. Finally, we demonstrate that HO-1 binds to the NACHT domain of NLRP3 and the RXR alpha and RXR beta subunits and that this binding is not reversed by Sn-protoporphyrin. Our findings indicate that HO-1 and its products are essential for pAEC survival to maintain airway epithelium homeostasis during NLRP3-RXR-mediated apoptosis and inflammation.	[Lv, Jiajia; Su, Wen; Yu, Qianying; Zhang, Meng; Di, Caixia; Lin, Xiaoliang; Xia, Zhenwei] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Pediat, Shanghai 200025, Peoples R China; [Lv, Jiajia; Su, Wen; Yu, Qianying; Zhang, Meng; Di, Caixia; Lin, Xiaoliang; Xia, Zhenwei] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Pulm & Crit Care Med, Shanghai 200025, Peoples R China; [Wu, Min] Univ North Dakota, Sch Med & Hlth Sci, Dept Biomed Sci, Grand Forks, ND 58202 USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; University of North Dakota Grand Forks	Xia, ZW (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Pediat, Shanghai 200025, Peoples R China.; Xia, ZW (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Pulm & Crit Care Med, Shanghai 200025, Peoples R China.	xzw10484@rjh.com.cn		Wu, Min/0000-0003-1205-982X; Lv, Jiajia/0000-0002-0016-7981	National Natural Science Foundation of China [91542202, 81470217, 81200016]; National Institutes of Health [R01 AI109317-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI109317] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Natural Science Foundation of China Grants 91542202, 81470217, and 81200016 and by National Institutes of Health Grant R01 AI109317-01A1. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Anderson OA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067263; Bakhautdin B, 2014, J HEPATOL, V61, P1029, DOI 10.1016/j.jhep.2014.06.007; Besnard AG, 2011, ALLERGY, V66, P1047, DOI 10.1111/j.1398-9995.2011.02586.x; Bi Y, 2010, DEV GROWTH DIFFER, V52, P419, DOI 10.1111/j.1440-169X.2010.01182.x; Bruder-Nascimento T, 2016, CIRCULATION, V134, P1866, DOI 10.1161/CIRCULATIONAHA.116.024369; Bushue N, 2010, ADV DRUG DELIVER REV, V62, P1285, DOI 10.1016/j.addr.2010.07.003; Cao XH, 2004, MOL CELL BIOL, V24, P9705, DOI 10.1128/MCB.24.22.9705-9725.2004; Chora AA, 2007, J CLIN INVEST, V117, P438, DOI 10.1172/JCI28844; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; Decherf S, 2013, MOL CELL ENDOCRINOL, V381, P115, DOI 10.1016/j.mce.2013.07.016; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; Grenningloh R, 2006, J IMMUNOL, V176, P5161, DOI 10.4049/jimmunol.176.9.5161; Henderson WR, 1996, J EXP MED, V184, P1483, DOI 10.1084/jem.184.4.1483; Hu XY, 2017, INT IMMUNOPHARMACOL, V52, P185, DOI 10.1016/j.intimp.2017.09.007; Jiang L, 2016, INFLAMM RES, V65, P905, DOI 10.1007/s00011-016-0973-7; Kadoya H, 2015, FASEB J, V29, P3899, DOI 10.1096/fj.15-271734; Kim RY, 2017, AM J RESP CRIT CARE, V196, P283, DOI 10.1164/rccm.201609-1830OC; Koonin EV, 2000, TRENDS BIOCHEM SCI, V25, P223, DOI 10.1016/S0968-0004(00)01577-2; Lambrecht BN, 2015, NAT IMMUNOL, V16, P45, DOI 10.1038/ni.3049; Lambrecht BN, 2013, NEW ENGL J MED, V369, P1964, DOI 10.1056/NEJMcibr1311045; Li Y, 2017, J IMMUNOL, V199, P761, DOI 10.4049/jimmunol.1601416; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; Lin XL, 2017, ALLERGY, V72, P1972, DOI 10.1111/all.13216; Linhoff MW, 2001, MOL CELL BIOL, V21, P3001, DOI 10.1128/MCB.21.9.3001-3011.2001; Martinon F, 2008, J LEUKOCYTE BIOL, V83, P507, DOI 10.1189/jlb.0607362; Mridha AR, 2017, J HEPATOL, V66, P1037, DOI 10.1016/j.jhep.2017.01.022; Nakamura M, 2004, AM J PATHOL, V164, P1949, DOI 10.1016/S0002-9440(10)63755-8; Nunez V, 2010, P NATL ACAD SCI USA, V107, P10626, DOI 10.1073/pnas.0913545107; Ocker M, 2003, INT J CANCER, V107, P453, DOI 10.1002/ijc.11410; Pamplona A, 2007, NAT MED, V13, P703, DOI 10.1038/nm1586; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10919, DOI 10.1073/pnas.94.20.10919; Rushworth SA, 2008, BLOOD, V111, P3793, DOI 10.1182/blood-2007-07-104042; Rushworth SA, 2010, CANCER RES, V70, P2973, DOI 10.1158/0008-5472.CAN-09-3407; Saito-Hakoda A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141960; Saxon JA, 2016, J IMMUNOL, V196, P1891, DOI 10.4049/jimmunol.1501555; Schmitz N, 2003, EUR J IMMUNOL, V33, P991, DOI 10.1002/eji.200323801; Shankaranarayanan P, 2009, CANCER CELL, V16, P220, DOI 10.1016/j.ccr.2009.07.029; Tenaud I, 2007, EXP DERMATOL, V16, P500, DOI 10.1111/j.1600-0625.2007.00552.x; Tesfaigzi Y, 2006, AM J RESP CELL MOL, V34, P537, DOI 10.1165/rcmb.2006-0014OC; Tesfaigzi Y, 2002, J IMMUNOL, V169, P5919, DOI 10.4049/jimmunol.169.10.5919; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Vignola AM, 1998, AM J RESP CRIT CARE, V157, P403, DOI 10.1164/ajrccm.157.2.96-08040; Vignola AM, 1999, J ALLERGY CLIN IMMUN, V103, P563, DOI 10.1016/S0091-6749(99)70225-3; Wadsworth SJ, 2010, J ALLERGY CLIN IMMUN, V126, P366, DOI 10.1016/j.jaci.2010.05.015; Wagener FADTG, 2001, BLOOD, V98, P1802, DOI 10.1182/blood.V98.6.1802; Xia ZW, 2007, AM J PATHOL, V171, P1904, DOI 10.2353/ajpath.2007.070096; Xia ZW, 2006, J IMMUNOL, V177, P5936, DOI 10.4049/jimmunol.177.9.5936; Yang SM, 2014, DIABETOLOGIA, V57, P424, DOI 10.1007/s00125-013-3115-6; Yasui Y, 2007, BIOCHEM BIOPH RES CO, V354, P485, DOI 10.1016/j.bbrc.2006.12.228; You YJ, 2002, AM J PHYSIOL-LUNG C, V283, pL1315, DOI 10.1152/ajplung.00169.2002; Zimmerman TL, 2006, J BIOL CHEM, V281, P15434, DOI 10.1074/jbc.M508277200; Zwerina J, 2005, FASEB J, V19, P2011, DOI 10.1096/fj.05-4278fje	55	32	32	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2018	293	48					18454	18465		10.1074/jbc.RA118.004950	http://dx.doi.org/10.1074/jbc.RA118.004950			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NX	30333233	hybrid, Green Published			2022-12-28	WOS:000458467300004
J	Kim, HS; Hwang, JT; Yun, H; Chi, SG; Lee, SJ; Kang, I; Yoon, KS; Choe, WJ; Kim, SS; Ha, J				Kim, Hak-Su; Hwang, Jin-Taek; Yun, Hee; Chi, Sung-Gil; Lee, Su-Jae; Kang, Insug; Yoon, Kyung-Sik; Choe, Won-Jae; Kim, Sung-Soo; Ha, Joohun			RETRACTION: Inhibition of AMP-activated protein kinase sensitizes cancer cells to cisplatin-induced apoptosis via hyper-induction of p53. (Retraction of Vol 283, Pg 3731, 2008)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction													Yoon, KyungSik/AAI-2991-2020; Kim, Sung Soo/S-2540-2017	Yoon, KyungSik/0000-0002-2473-4493; Kim, Sung Soo/0000-0002-6817-7668				Kim HS, 2008, J BIOL CHEM, V283, P3731, DOI 10.1074/jbc.M704432200	1	0	0	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2018	293	46					18015	18015		10.1074/jbc.W118.006429	http://dx.doi.org/10.1074/jbc.W118.006429			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HA6SG	30446605	hybrid, Green Published			2022-12-28	WOS:000450409500032
J	Liu, ZK; Li, C; Kang, NL; Malhi, H; Shah, VH; Maiers, JL				Liu, Zhikui; Li, Chao; Kang, Ningling; Malhi, Harmeet; Shah, Vijay H.; Maiers, Jessica L.			Transforming growth factor (TGF) cross-talk with the unfolded protein response is critical for hepatic stellate cell activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fibrosis; endoplasmic reticulum stress (ER stress); collagen; fibronectin; apoptosis signal-regulating kinase 1 (ASK1); c-Jun N-terminal kinase (JNK); cell signaling; adefovir dipivoxil; C; EBP; IRE1; p300	ENDOPLASMIC-RETICULUM STRESS; TRANSCRIPTIONAL INHIBITORY PROTEIN; BETA C/EBP-BETA; MESSENGER-RNA; ER STRESS; LIVER; EXPRESSION; FIBROSIS; REVERSAL; PATHWAY	Transforming growth factor (TGF) potently activates hepatic stellate cells (HSCs), which promotes production and secretion of extracellular matrix (ECM) proteins and hepatic fibrogenesis. Increased ECM synthesis and secretion in response to TGF is associated with endoplasmic reticulum (ER) stress and the unfolded protein response (UPR). TGF and UPR signaling pathways are tightly intertwined during HSC activation, but the regulatory mechanism that connects these two pathways is poorly understood. Here, we found that TGF treatment of immortalized HSCs (i.e. LX-2 cells) induces phosphorylation of the UPR sensor inositol-requiring enzyme 1 (IRE1) in a SMAD2/3-procollagen I-dependent manner. We further show that IRE1 mediates HSC activation downstream of TGF and that its role depends on activation of a signaling cascade involving apoptosis signaling kinase 1 (ASK1) and c-Jun N-terminal kinase (JNK). ASK1-JNK signaling promoted phosphorylation of the UPR-associated transcription factor CCAAT/enhancer binding protein (C/EBP), which is crucial for TGF- or IRE1-mediated LX-2 activation. Pharmacological inhibition of C/EBP expression with the antiviral drug adefovir dipivoxil attenuated TGF-mediated activation of LX-2 or primary rat HSCs in vitro and hepatic fibrogenesis in vivo. Finally, we identified a critical relationship between C/EBP and the transcriptional regulator p300 during HSC activation. p300 knockdown disrupted TGF- or UPR-induced HSC activation, and pharmacological inhibition of the C/EBP-p300 complex decreased TGF-induced HSC activation. These results indicate that TGF-induced IRE1 signaling is critical for HSC activation through a C/EBP-p300-dependent mechanism and suggest C/EBP as a druggable target for managing fibrosis.	[Liu, Zhikui; Li, Chao; Malhi, Harmeet; Shah, Vijay H.; Maiers, Jessica L.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA; [Kang, Ningling] Univ Minnesota, Hormel Inst, Tumor Microenvironm & Metastasis, 801 16th Ave NE, Austin, MN 55912 USA; [Liu, Zhikui; Li, Chao] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, 277 Yanta West Rd, Xian 710061, Shaanxi, Peoples R China	Mayo Clinic; University of Minnesota System; Xi'an Jiaotong University	Maiers, JL (corresponding author), Mayo Clin, Dept Gastroenterol & Hepatol, Rochester, MN 55905 USA.	maiers.jessica1@mayo.edu	Maiers, Jessica/AAL-8037-2021	Malhi, Harmeet/0000-0002-0882-4990	NIDDK, National Institutes of Health [K01 DK112915, RO1 DK111378, R01 DK59615, P30DK084567]; NCI, National Institutes of Health [R01 CA160069]; China Scholarship Council; NATIONAL CANCER INSTITUTE [R01CA160069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK084567, R01DK111378, K01DK112915] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); China Scholarship Council(China Scholarship Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIDDK, National Institutes of Health, Grants K01 DK112915, RO1 DK111378, R01 DK59615, and P30DK084567; NCI, National Institutes of Health, Grant R01 CA160069; and a research fellowship from the China Scholarship Council. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Attard FA, 2000, ARCH BIOCHEM BIOPHYS, V378, P57, DOI 10.1006/abbi.2000.1803; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cui TX, 2011, MOL ENDOCRINOL, V25, P681, DOI 10.1210/me.2010-0232; Cui TX, 2005, MOL ENDOCRINOL, V19, P2175, DOI 10.1210/me.2004-0502; Darling NJ, 2014, BBA-MOL CELL RES, V1843, P2150, DOI 10.1016/j.bbamcr.2014.01.009; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Dodig M, 2007, AM J PHYSIOL-GASTR L, V293, pG154, DOI 10.1152/ajpgi.00432.2006; Dou CW, 2018, GASTROENTEROLOGY, V154, P2209, DOI 10.1053/j.gastro.2018.02.015; Drinane MC, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92821; Elsharkawy AM, 2005, APOPTOSIS, V10, P927, DOI 10.1007/s10495-005-1055-4; Fabregat I, 2016, FEBS J, V283, P2219, DOI 10.1111/febs.13665; Feig JL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188135; Friedman SL, 2006, HEPATOLOGY, V43, pS82, DOI 10.1002/hep.20974; Garcia-Trevijano ER, 1999, HEPATOLOGY, V29, P960, DOI 10.1002/hep.510290346; Heindryckx F, 2016, EMBO MOL MED, V8, P729, DOI 10.15252/emmm.201505925; Hernandez-Gea V, 2013, J HEPATOL, V59, P98, DOI 10.1016/j.jhep.2013.02.016; Hu P, 2006, MOL CELL BIOL, V26, P3071, DOI 10.1128/MCB.26.8.3071-3084.2006; Iraburu MJ, 2000, HEPATOLOGY, V31, P1086, DOI 10.1053/he.2000.5981; Iredale JP, 1998, J CLIN INVEST, V102, P538, DOI 10.1172/JCI1018; Iwaisako K, 2014, P NATL ACAD SCI USA, V111, pE3297, DOI 10.1073/pnas.1400062111; Jakobs A, 2016, J BIOL CHEM, V291, P26098, DOI 10.1074/jbc.M116.748129; Jiang Joy X, 2013, Curr Pathobiol Rep, V1, P215; Kakazu E, 2016, J LIPID RES, V57, P233, DOI 10.1194/jlr.M063412; Kim RS, 2016, SCI REP-UK, V6, DOI 10.1038/srep39342; Kisseleva T, 2006, J GASTROEN HEPATOL, V21, pS84, DOI 10.1111/j.1440-1746.2006.04584.x; Koo JH, 2016, GASTROENTEROLOGY, V150, P181, DOI 10.1053/j.gastro.2015.09.039; Li Y, 2008, J BIOL CHEM, V283, P22443, DOI 10.1074/jbc.M801046200; Lipson KL, 2006, CELL METAB, V4, P245, DOI 10.1016/j.cmet.2006.07.007; Loomba R, 2018, HEPATOLOGY, V67, P549, DOI 10.1002/hep.29514; Maiers JL, 2017, HEPATOLOGY, V65, P983, DOI 10.1002/hep.28921; Mederacke I, 2015, NAT PROTOC, V10, P305, DOI 10.1038/nprot.2015.017; Mink S, 1997, MOL CELL BIOL, V17, P6609, DOI 10.1128/MCB.17.11.6609; Moore KA, 2012, ANNU REV GENET, V46, P165, DOI 10.1146/annurev-genet-110711-155644; NAKAJIMA T, 1993, P NATL ACAD SCI USA, V90, P2207, DOI 10.1073/pnas.90.6.2207; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/bj20020508; de Galarreta MR, 2016, BBA-MOL CELL RES, V1863, P2115, DOI 10.1016/j.bbamcr.2016.05.002; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Tirasophon W, 2000, GENE DEV, V14, P2725, DOI 10.1101/gad.839400; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Uemura A, 2009, J CELL SCI, V122, P2877, DOI 10.1242/jcs.040584; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang FM, 2011, BIOCHEM J, V433, P245, DOI 10.1042/BJ20101293; Wang JQ, 2013, TOXICOL APPL PHARM, V266, P307, DOI 10.1016/j.taap.2012.11.007; Weiskirchen R, 2005, METH MOLEC MED, V117, P99; Yang JQ, 2016, CURR MED CHEM, V23, P4706, DOI 10.2174/0929867323666160927142349; Yaqoob U, 2012, CANCER RES, V72, P4047, DOI 10.1158/0008-5472.CAN-11-3907; Younossi ZM, 2018, LIVER INT, V38, P1849, DOI 10.1111/liv.13706; Zaini MA, 2017, SCI REP-UK, V7, DOI 10.1038/srep42603; Zhang KZ, 2011, EMBO J, V30, P1357, DOI 10.1038/emboj.2011.52	50	25	28	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2019	294	9					3137	3151		10.1074/jbc.RA118.005761	http://dx.doi.org/10.1074/jbc.RA118.005761			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU0SA	30610118	Green Published, hybrid			2022-12-28	WOS:000464980100014
J	Moritzer, AC; Minges, H; Prior, T; Frese, M; Sewald, N; Niemann, HH				Moritzer, Ann-Christin; Minges, Hannah; Prior, Tina; Frese, Marcel; Sewald, Norbert; Niemann, Hartmut H.			Structure-based switch of regioselectivity in the flavin-dependent tryptophan 6-halogenase Thal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; enzyme structure; enzyme catalysis; flavoprotein; protein engineering; tryptophan; biocatalysis; enzyme design; enzyme engineering; FAD-dependent halogenase; enzyme structure; protein design	ENZYMATIC HALOGENATION; 7-HALOGENASE PRNA; BIOCATALYTIC SCOPE; DIRECTED EVOLUTION; BIOSYNTHESIS; REBH; CHLORINATION; REFINEMENT; MECHANISM; PHENIX	Flavin-dependent halogenases increasingly attract attention as biocatalysts in organic synthesis, facilitating environmentally friendly halogenation strategies that require only FADH(2), oxygen, and halide salts. Different flavin-dependent tryptophan halogenases regioselectively chlorinate or brominate trypto-phan's indole moiety at C5, C6, or C7. Here, we present the first substrate-bound structure of a tryptophan 6-halogenase, namely Thal, also known as ThdH, from the bacterium Streptomyces albogriseolus at 2.55 angstrom resolution. The structure revealed that the C6 of tryptophan is positioned next to the epsilon-amino group of a conserved lysine, confirming the hypothesis that proximity to the catalytic residue determines the site of electrophilic aromatic substitution. Although Thal is more similar in sequence and structure to the tryptophan 7-halogenase RebH than to the tryptophan 5-halogenase PyrH, the indole binding pose in the Thal active site more closely resembled that of PyrH than that of RebH. The difference in indole orientation between Thal and RebH appeared to be largely governed by residues positioning the Trp backbone atoms. The sequences of Thal and RebH lining the substrate binding site differ in only few residues. Therefore, we exchanged five amino acids in the Thal active site with the corresponding counterparts in RebH, generating the quintuple variant Thal-RebH5. Overall conversion of l-Trp by the Thal-RebH5 variant resembled that of WT Thal, but its regioselectivity of chlorination and bromination was almost completely switched from C6 to C7 as in RebH. We conclude that structure-based protein engineering with targeted substitution of a few residues is an efficient approach to tailoring flavin-dependent halogenases.	[Moritzer, Ann-Christin; Prior, Tina; Niemann, Hartmut H.] Bielefeld Univ, Struct Biochem Grp, Dept Chem, Univ Str 25, D-33615 Bielefeld, Germany; [Minges, Hannah; Frese, Marcel; Sewald, Norbert] Bielefeld Univ, Organ & Bioorgan Chem Res Grp, Dept Chem, Univ Str 25, D-33615 Bielefeld, Germany	University of Bielefeld; University of Bielefeld	Niemann, HH (corresponding author), Bielefeld Univ, Struct Biochem Grp, Dept Chem, Univ Str 25, D-33615 Bielefeld, Germany.	hartmut.niemann@uni-bielefeld.de	Niemann, Hartmut/F-7947-2011; Sewald, Norbert/A-2541-2012	Niemann, Hartmut/0000-0002-8582-0360; Sewald, Norbert/0000-0002-0309-2655; Frese, Marcel/0000-0002-2232-7755				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agarwal V, 2014, NAT CHEM BIOL, V10, P640, DOI 10.1038/nchembio.1564; Almeida C, 2018, J NAT PROD, V81, P1488, DOI 10.1021/acs.jnatprod.8b00041; Andorfer MC, 2018, ANNU REV BIOCHEM, V87, P159, DOI 10.1146/annurev-biochem-062917-012042; Andorfer MC, 2016, CHEM SCI, V7, P3720, DOI 10.1039/c5sc04680g; Belsare KD, 2017, ACS SYNTH BIOL, V6, P416, DOI 10.1021/acssynbio.6b00297; Bitto E, 2008, PROTEINS, V70, P289, DOI 10.1002/prot.21627; Chang FY, 2013, P NATL ACAD SCI USA, V110, P2478, DOI 10.1073/pnas.1218073110; Chankhamjon P, 2016, ANGEW CHEM INT EDIT, V55, P11955, DOI 10.1002/anie.201604516; Cianci M, 2017, J SYNCHROTRON RADIAT, V24, P323, DOI 10.1107/S1600577516016465; Dong CJ, 2005, SCIENCE, V309, P2216, DOI 10.1126/science.1116510; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fraley AE, 2017, J AM CHEM SOC, V139, P12060, DOI 10.1021/jacs.7b06773; Frese M, 2016, CHEMCATCHEM, V8, P1799, DOI 10.1002/cctc.201600317; Frese M, 2015, ANGEW CHEM INT EDIT, V54, P298, DOI 10.1002/anie.201408561; Frese M, 2014, CHEMCATCHEM, V6, P1270, DOI 10.1002/cctc.201301090; Glenn WS, 2011, J AM CHEM SOC, V133, P19346, DOI 10.1021/ja2089348; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Hammer PE, 1997, APPL ENVIRON MICROB, V63, P2147, DOI 10.1128/AEM.63.6.2147-2154.1997; Heemstra JR, 2008, J AM CHEM SOC, V130, P14024, DOI 10.1021/ja806467a; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keller S, 2000, ANGEW CHEM INT EDIT, V39, P2300, DOI 10.1002/1521-3773(20000703)39:13<2300::AID-ANIE2300>3.0.CO;2-I; Kirner S, 1998, J BACTERIOL, V180, P1939, DOI 10.1128/JB.180.7.1939-1943.1998; Kovalevskiy O, 2018, ACTA CRYSTALLOGR D, V74, P215, DOI 10.1107/S2059798318000979; Lang A, 2011, ANGEW CHEM INT EDIT, V50, P2951, DOI 10.1002/anie.201007896; Latham J, 2018, CHEM REV, V118, P232, DOI 10.1021/acs.chemrev.7b00032; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Menon BRK, 2017, ANGEW CHEM INT EDIT, V56, P11841, DOI 10.1002/anie.201706342; Menon BRK, 2016, ORG BIOMOL CHEM, V14, P9354, DOI 10.1039/c6ob01861k; Milbredt D, 2014, CHEMBIOCHEM, V15, P1011, DOI 10.1002/cbic.201400016; Neubauer PR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196797; Ortega MA, 2017, ACS CHEM BIOL, V12, P548, DOI 10.1021/acschembio.6b01031; Payne JT, 2015, ANGEW CHEM INT EDIT, V54, P4226, DOI 10.1002/anie.201411901; Payne JT, 2013, ANGEW CHEM INT EDIT, V52, P5271, DOI 10.1002/anie.201300762; Poor CB, 2014, CHEMBIOCHEM, V15, P1286, DOI 10.1002/cbic.201300780; Runguphan W, 2010, NATURE, V468, P461, DOI 10.1038/nature09524; Schnepel C, 2017, CHEM-EUR J, V23, P12064, DOI 10.1002/chem.201701209; Schnepel C, 2016, ANGEW CHEM INT EDIT, V55, P14159, DOI 10.1002/anie.201605635; Seibold C, 2006, BIOCATAL BIOTRANSFOR, V24, P401, DOI 10.1080/10242420601033738; Shepherd SA, 2016, CHEMBIOCHEM, V17, P821, DOI 10.1002/cbic.201600051; Shepherd SA, 2015, CHEM SCI, V6, P3454, DOI 10.1039/c5sc00913h; Smith DRM, 2017, ACS CHEM BIOL, V12, P1281, DOI 10.1021/acschembio.6b01115; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; van Pee KH, 2001, ARCH MICROBIOL, V175, P250, DOI 10.1007/s002030100263; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yeh E, 2007, BIOCHEMISTRY-US, V46, P1284, DOI 10.1021/bi0621213; Zeng J, 2013, BIOORG MED CHEM LETT, V23, P1001, DOI 10.1016/j.bmcl.2012.12.038; Zeng J, 2011, BIOTECHNOL LETT, V33, P1607, DOI 10.1007/s10529-011-0595-7; Zeng J, 2010, CHEMBIOCHEM, V11, P2119, DOI 10.1002/cbic.201000439; Zhu T, 2013, METAB ENG, V19, P69, DOI 10.1016/j.ymben.2013.06.003; Zhu XF, 2009, J MOL BIOL, V391, P74, DOI 10.1016/j.jmb.2009.06.008	53	28	30	3	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2019	294	7					2529	2542		10.1074/jbc.RA118.005393	http://dx.doi.org/10.1074/jbc.RA118.005393			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL7CN	30559288	Green Published, hybrid			2022-12-28	WOS:000458895400027
J	Lakshman, B; Messing, S; Schmid, EM; Clogston, JD; Gillette, WK; Esposito, D; Kessing, B; Fletcher, DA; Nissley, DV; McCormick, F; Stephen, AG; Jean-Francois, FL				Lakshman, Bindu; Messing, Simon; Schmid, Eva M.; Clogston, Jeffrey D.; Gillette, William K.; Esposito, Dominic; Kessing, Bailey; Fletcher, Daniel A.; Nissley, Dwight V.; McCormick, Frank; Stephen, Andrew G.; Jean-Francois, Frantz L.			Quantitative biophysical analysis defines key components modulating recruitment of the GTPase KRAS to the plasma membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein-lipid interaction; liposome; lipid raft; Raf kinase; Ras protein; surface plasmon resonance (SPR); mitogen-activated protein kinase (MAPK); MAPK pathway; GTPase	K-RAS; H-RAS; LIPID RAFTS; PHOSPHATIDIC-ACID; BCL-XL; BINDING; SIGNAL; PEPTIDES; DYNAMICS; PROMOTES	The gene encoding the GTPase KRAS is frequently mutated in pancreatic, lung, and colorectal cancers. The KRAS fraction in the plasma membrane (PM) correlates with activation of the mitogen-activated protein kinase (MAPK) pathway and subsequent cellular proliferation. Understanding KRAS's interaction with the PM is challenging given the complexity of the cellular environment. To gain insight into key components necessary for KRAS signal transduction at the PM, we used synthetic membranes such as liposomes and giant unilamellar vesicles. Using surface plasmon resonance (SPR) spectroscopy, we demonstrated that KRAS and Raf-1 proto-oncogene Ser/Thr kinase (RAF1) domains interact with these membranes primarily through electrostatic interactions with negatively charged lipids reinforced by additional interactions involving phosphatidyl ethanolamine and cholesterol. We found that the RAF1 region spanning RBD through CRD (RBDCRD) interacts with the membrane significantly more strongly than the isolated RBD or CRD domains and synergizes KRAS partitioning to the membrane. We also found that calmodulin and phosphodiesterase 6 delta (PDE6), but not galectin3 previously proposed to directly interact with KRAS, passively sequester KRAS and prevent it from partitioning into the PM. RAF1 RBDCRD interacted with membranes preferentially at nonraft lipid domains. Moreover, a C-terminal O-methylation was crucial for KRAS membrane localization. These results contribute to a better understanding of how the KRAS-membrane interaction is tuned by multiple factors whose identification could inform drug discovery efforts to disrupt this critical interaction in diseases such as cancer.	[Lakshman, Bindu; Messing, Simon; Gillette, William K.; Esposito, Dominic; Kessing, Bailey; Nissley, Dwight V.; McCormick, Frank; Stephen, Andrew G.; Jean-Francois, Frantz L.] Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, Canc Res Technol Program, NCI RAS Initiat, Frederick, MD 21702 USA; [Schmid, Eva M.; Fletcher, Daniel A.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Clogston, Jeffrey D.] Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, Canc Res Technol Program, Nanotechnol Characterizat Lab, Frederick, MD 21702 USA; [Fletcher, Daniel A.] Lawrence Berkeley Natl Lab, Div Biol Syst & Engn, Berkeley, CA 94720 USA; [Fletcher, Daniel A.] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA; [McCormick, Frank] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94158 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of California System; University of California Berkeley; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Jean-Francois, FL (corresponding author), POB B, Frederick, MD 21702 USA.	Frantz.jean-francois@nih.gov	Clogston, Jeffrey/E-1872-2013; Jean-Francois, Frantz/AAH-9429-2019; Stephen, Andrew/W-2636-2019; Clogston, Jeffrey Dean/AAE-8982-2022; Nanotechnology Characterization Lab, (NCL)/K-8454-2012	Stephen, Andrew/0000-0002-8259-621X; Clogston, Jeffrey Dean/0000-0003-1860-9271; Gillette, William/0000-0002-8592-3642; Esposito, Dominic/0000-0002-9987-1687	NCI, National Institutes of Health [HHSN261200800001E]	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project has been funded in whole or in part with Federal funds from the NCI, National Institutes of Health, under contract number HHSN261200800001E. The authors declare that they have no conflicts of interest with the contents of this article. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does the mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.	Abankwa D, 2008, EMBO J, V27, P727, DOI 10.1038/emboj.2008.10; Abankwa D, 2010, P NATL ACAD SCI USA, V107, P1130, DOI 10.1073/pnas.0903907107; Abraham SJ, 2009, BIOCHEMISTRY-US, V48, P7575, DOI 10.1021/bi900769j; Alvarez-Moya B, 2010, ONCOGENE, V29, P5911, DOI 10.1038/onc.2010.298; ANGELOVA MI, 1986, FARADAY DISCUSS, V81, P303, DOI 10.1039/dc9868100303; BenTal N, 1996, BIOPHYS J, V71, P561, DOI 10.1016/S0006-3495(96)79280-9; Besenicar M, 2006, CHEM PHYS LIPIDS, V141, P169, DOI 10.1016/j.chemphyslip.2006.02.010; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; Blazevits O, 2016, SCI REP-UK, V6, DOI 10.1038/srep24165; Cho KJ, 2016, MOL CELL BIOL, V36, P3086, DOI 10.1128/MCB.00365-16; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; Dharmaiah S, 2016, P NATL ACAD SCI USA, V113, pE6766, DOI 10.1073/pnas.1615316113; Elad-Sfadia G, 2004, J BIOL CHEM, V279, P34922, DOI 10.1074/jbc.M312697200; Erwin N, 2017, BIOL CHEM, V398, P547, DOI 10.1515/hsz-2016-0289; Erwin N, 2016, PHYS CHEM CHEM PHYS, V18, P8954, DOI 10.1039/c6cp00563b; Esposito Dominic, 2009, V498, P31, DOI 10.1007/978-1-59745-196-3_3; Figueira TN, 2017, SCI REP-UK, V7, DOI 10.1038/srep45647; FINKELSTEIN AV, 1989, PROTEIN ENG, V3, P1, DOI 10.1093/protein/3.1.1; Fivaz M, 2005, J CELL BIOL, V170, P429, DOI 10.1083/jcb.200409157; GHOMASHCHI F, 1995, BIOCHEMISTRY-US, V34, P11910, DOI 10.1021/bi00037a032; Ghosh S, 1996, J BIOL CHEM, V271, P8472, DOI 10.1074/jbc.271.14.8472; GHOSH SJ, 1994, J BIOL CHEM, V269, P10000; Gillette WK, 2015, SCI REP-UK, V5, DOI 10.1038/srep15916; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; HANCOCK JF, 1991, EMBO J, V10, P641, DOI 10.1002/j.1460-2075.1991.tb07992.x; Inder K, 2008, MOL BIOL CELL, V19, P4776, DOI 10.1091/mbc.E08-04-0407; Janosi L, 2012, P NATL ACAD SCI USA, V109, P8097, DOI 10.1073/pnas.1200773109; Jansen JM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174706; Jean-Francois F, 2008, BIOCHEMISTRY-US, V47, P6394, DOI 10.1021/bi800448h; Jean-Francois F, 2009, FASEB J, V23, P3692, DOI 10.1096/fj.09-135574; Kraft CA, 2008, J BIOL CHEM, V283, P36636, DOI 10.1074/jbc.M804633200; Mazhab-Jafari MT, 2015, P NATL ACAD SCI USA, V112, P6625, DOI 10.1073/pnas.1419895112; Mizutani S, 2001, FEBS LETT, V507, P295, DOI 10.1016/S0014-5793(01)02992-1; Moravcevic K, 2010, CELL, V143, P966, DOI 10.1016/j.cell.2010.11.028; Nan XL, 2015, P NATL ACAD SCI USA, V112, P7996, DOI 10.1073/pnas.1509123112; Pike LJ, 2003, J LIPID RES, V44, P655, DOI 10.1194/jlr.R200021-JLR200; Prakash P, 2016, BIOPHYS J, V110, P1125, DOI 10.1016/j.bpj.2016.01.019; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; Roy S, 1999, NAT CELL BIOL, V1, P98, DOI 10.1038/10067; Sampaio JL, 2011, P NATL ACAD SCI USA, V108, P1903, DOI 10.1073/pnas.1019267108; Schmick M, 2014, CELL, V157, P459, DOI 10.1016/j.cell.2014.02.051; Schmid EM, 2015, METHOD CELL BIOL, V128, P319, DOI 10.1016/bs.mcb.2015.02.004; Seguin L, 2014, NAT CELL BIOL, V16, P457, DOI 10.1038/ncb2953; Shalom-Feuerstein R, 2008, CANCER RES, V68, P6608, DOI 10.1158/0008-5472.CAN-08-1117; Sidhu RS, 2003, BIOCHEM BIOPH RES CO, V304, P655, DOI 10.1016/S0006-291X(03)00635-1; SILVIUS JR, 1993, BIOCHEMISTRY-US, V32, P3153, DOI 10.1021/bi00063a030; SILVIUS JR, 1994, BIOCHEMISTRY-US, V33, P3014, DOI 10.1021/bi00176a034; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Sperlich B, 2016, BIOPHYS J, V111, P113, DOI 10.1016/j.bpj.2016.05.042; Sung PJ, 2013, P NATL ACAD SCI USA, V110, P20593, DOI 10.1073/pnas.1306431110; Teres S, 2012, P NATL ACAD SCI USA, V109, P8489, DOI 10.1073/pnas.1118349109; Tian TH, 2010, BIOPHYS J, V99, P534, DOI 10.1016/j.bpj.2010.04.055; Travers T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26832-4; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Villalonga P, 2001, MOL CELL BIOL, V21, P7345, DOI 10.1128/MCB.21.21.7345-7354.2001; Wang MT, 2015, CELL, V163, P1237, DOI 10.1016/j.cell.2015.10.041; Wang TY, 2000, BIOPHYS J, V79, P919, DOI 10.1016/S0006-3495(00)76347-8; Weise K, 2012, J AM CHEM SOC, V134, P11503, DOI 10.1021/ja305518h; Weise K, 2011, J AM CHEM SOC, V133, P880, DOI 10.1021/ja107532q; Werkmuller A, 2013, CHEMPHYSCHEM, V14, P3698, DOI 10.1002/cphc.201300617; WHITTINGTON SG, 1975, J CHEM PHYS, V63, P779, DOI 10.1063/1.431357; WIENER MC, 1992, BIOPHYS J, V61, P434, DOI 10.1016/S0006-3495(92)81849-0; Yin XL, 2009, CELL PHYSIOL BIOCHEM, V24, P219, DOI 10.1159/000233248; Zhou Y, 2017, CELL, V168, P239, DOI 10.1016/j.cell.2016.11.059; Zhou Y, 2015, SCIENCE, V349, P873, DOI 10.1126/science.aaa5619; Zhou Y, 2015, BBA-MOL CELL RES, V1853, P841, DOI 10.1016/j.bbamcr.2014.09.008; Zhou Y, 2014, MOL CELL BIOL, V34, P862, DOI 10.1128/MCB.01227-13	69	24	24	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2019	294	6					2193	2207		10.1074/jbc.RA118.005669	http://dx.doi.org/10.1074/jbc.RA118.005669			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM8EO	30559287	Green Published, hybrid			2022-12-28	WOS:000459711400038
J	Xie, LH; Jakob, U				Xie, Lihan; Jakob, Ursula			Inorganic polyphosphate, a multifunctional polyanionic protein scaffold	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						chaperone; protein aggregation; amyloid; protein folding; stress; neurodegeneration; polyphosphate; proteostasis	PRO-INFLAMMATORY RESPONSES; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; TRYPANOSOMA-BRUCEI; DICTYOSTELIUM-DISCOIDEUM; MEMBRANE DISRUPTION; ALZHEIMERS-DISEASE; CADMIUM TOLERANCE; AMYLOID FIBRILS; RNA-POLYMERASE	Polyphosphate (polyP) consists of a linear arrangement of inorganic phosphates and defies its structural simplicity with an astounding number of different activities in the cell. Already well known for its ability to partake in phosphate, calcium, and energy metabolism, polyP recently gained a new functional dimension with the discovery that it serves as a stabilizing scaffold for protein-folding intermediates. In this review, we summarize and discuss the recent studies that have identified polyP not only as a potent protein-like chaperone that protects cells against stress-induced protein aggregation, but also as a robust modifier of amyloidogenic processes that shields neuronal cells from amyloid toxicity. We consider some of the most pressing questions in the field, the obstacles faced, and the potential avenues to take to provide a complete picture about the working mechanism and physiological relevance of this intriguing biopolymer.	[Xie, Lihan; Jakob, Ursula] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Jakob, Ursula] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Jakob, U (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA.; Jakob, U (corresponding author), Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA.	ujakob@umich.edu		Xie, Lihan/0000-0003-0760-5806	National Institutes of Health [R35GM122506, R21AG055090]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM122506] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG055090] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants R35GM122506 and R21AG055090. This is the tenth article in the JBC Reviews series "Molecular chaperones and protein quality control." The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abramov AY, 2007, P NATL ACAD SCI USA, V104, P18091, DOI 10.1073/pnas.0708959104; AHN KH, 1990, J BIOL CHEM, V265, P11734; AKIYAMA M, 1993, J BIOL CHEM, V268, P633; Alvarez S, 2004, APPL ENVIRON MICROB, V70, P5177, DOI 10.1128/AEM.70.9.5177-5182.2004; Alzheimer's Association, 2016, Alzheimers Dement, V12, P459; Andreeva N, 2014, FOLIA MICROBIOL, V59, P381, DOI 10.1007/s12223-014-0310-x; Andreeva N, 2013, FEMS YEAST RES, V13, P463, DOI 10.1111/1567-1364.12049; Angelova PR, 2018, GLIA, V66, P2126, DOI 10.1002/glia.23466; Angelova PR, 2014, ACS CHEM BIOL, V9, P2101, DOI 10.1021/cb5000696; Aschar-Sobbi R, 2008, J FLUORESC, V18, P859, DOI 10.1007/s10895-008-0315-4; Ault-Riche D, 1998, J BACTERIOL, V180, P1841; Azevedo C, 2018, ACS CHEM BIOL, V13, P1958, DOI 10.1021/acschembio.8b00357; Azevedo C, 2015, MOL CELL, V58, P71, DOI 10.1016/j.molcel.2015.02.010; Bae JS, 2012, J THROMB HAEMOST, V10, P1145, DOI 10.1111/j.1538-7836.2012.04671.x; Bardwell JCA, 2012, TRENDS BIOCHEM SCI, V37, P517, DOI 10.1016/j.tibs.2012.08.006; Bentley-DeSousa A, 2018, CELL REP, V22, P3427, DOI 10.1016/j.celrep.2018.02.104; Brown MRW, 2004, P NATL ACAD SCI USA, V101, P16085, DOI 10.1073/pnas.0406909101; Bru S, 2017, DNA REPAIR, V57, P171, DOI 10.1016/j.dnarep.2017.08.001; Bru S, 2016, MOL MICROBIOL, V101, P367, DOI 10.1111/mmi.13396; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; CHASHEL M, 1969, NATURE, V221, P838, DOI 10.1038/221838a0; Chiti F, 2017, ANNU REV BIOCHEM, V86, P27, DOI 10.1146/annurev-biochem-061516-045115; Choi SH, 2010, BIOCHEMISTRY-US, V49, P9935, DOI 10.1021/bi1014437; Clerico EM, 2015, J MOL BIOL, V427, P1575, DOI 10.1016/j.jmb.2015.02.004; Cordeiro CD, 2017, MOL MICROBIOL, V106, P319, DOI 10.1111/mmi.13766; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; Cremers CM, 2016, MOL CELL, V63, P768, DOI 10.1016/j.molcel.2016.07.016; CROOKE E, 1994, J BIOL CHEM, V269, P6290; Dahl JU, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.267; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Dinarvand P, 2014, BLOOD, V123, P935, DOI 10.1182/blood-2013-09-529602; Docter BE, 2016, NUCLEIC ACIDS RES, V44, P4835, DOI 10.1093/nar/gkw291; Dueholm MS, 2010, MOL MICROBIOL, V77, P1009, DOI 10.1111/j.1365-2958.2010.07269.x; DURR M, 1979, ARCH MICROBIOL, V121, P169, DOI 10.1007/BF00689982; Eisele YS, 2015, NAT REV DRUG DISCOV, V14, P759, DOI 10.1038/nrd4593; Ellis R. J., 2007, MOL ASPECTS STRESS R, P1; Fang JM, 2007, BIOCHEM J, V407, P161, DOI 10.1042/BJ20070612; Fraley CD, 2007, P NATL ACAD SCI USA, V104, P3526, DOI 10.1073/pnas.0609733104; GABEL NW, 1971, J NEUROCHEM, V18, P1229, DOI 10.1111/j.1471-4159.1971.tb00222.x; Galizzi M, 2013, MOL MICROBIOL, V90, P699, DOI 10.1111/mmi.12392; Ghosh S, 2013, BLOOD, V122, P1478, DOI 10.1182/blood-2013-01-481549; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; Gomes FM, 2012, J INSECT PHYSIOL, V58, P211, DOI 10.1016/j.jinsphys.2011.09.008; Gomez-Garcia MR, 2004, P NATL ACAD SCI USA, V101, P15876, DOI 10.1073/pnas.0406923101; Gray MJ, 2015, CURR OPIN MICROBIOL, V24, P1, DOI 10.1016/j.mib.2014.12.004; Gray MJ, 2014, MOL CELL, V53, P689, DOI 10.1016/j.molcel.2014.01.012; Gray MJ, 2013, J BIOL CHEM, V288, P13789, DOI 10.1074/jbc.M113.454421; Groitl B, 2017, MOL MICROBIOL, V106, P335, DOI 10.1111/mmi.13768; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hassanian SM, 2015, J THROMB HAEMOST, V13, P860, DOI 10.1111/jth.12899; Holmstrom KM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2364; Hothorn M, 2009, SCIENCE, V324, P513, DOI 10.1126/science.1168120; Hou QM, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aal4045; Ihse E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08720-5; Ishige K, 2002, P NATL ACAD SCI USA, V99, P16684, DOI 10.1073/pnas.262655299; Jain NK, 2009, PROTEIN SCI, V18, P24, DOI 10.1002/pro.3; Janson J, 1999, DIABETES, V48, P491, DOI 10.2337/diabetes.48.3.491; Jimenez-Nunez MD, 2012, HAEMATOL-HEMATOL J, V97, P1264, DOI 10.3324/haematol.2011.051409; Keasling JD, 1996, APPL ENVIRON MICROB, V62, P743, DOI 10.1128/AEM.62.2.743-746.1996; Kim D, 2007, J NEUROSCI, V27, P6500, DOI 10.1523/JNEUROSCI.0623-07.2007; Kim KS, 2002, P NATL ACAD SCI USA, V99, P7675, DOI 10.1073/pnas.112210499; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Koldewey P, 2017, J BIOL CHEM, V292, P12010, DOI 10.1074/jbc.R117.796862; KORNBERG A, 1995, J BACTERIOL, V177, P491, DOI 10.1128/jb.177.3.491-496.1995; Kornberg A, 1999, ANNU REV BIOCHEM, V68, P89, DOI 10.1146/annurev.biochem.68.1.89; KUMBLE KD, 1995, J BIOL CHEM, V270, P5818, DOI 10.1074/jbc.270.11.5818; Kuroda A, 1997, J BIOL CHEM, V272, P21240, DOI 10.1074/jbc.272.34.21240; Kusano S, 1997, GENES CELLS, V2, P433, DOI 10.1046/j.1365-2443.1997.13203301320330.x; Lander N, 2013, J BIOL CHEM, V288, P34205, DOI 10.1074/jbc.M113.518993; Li YL, 2009, J BIOL CHEM, V284, P4324, DOI 10.1074/jbc.M804818200; Livermore TM, 2016, P NATL ACAD SCI USA, V113, P996, DOI 10.1073/pnas.1519440113; Lonetti A, 2011, J BIOL CHEM, V286, P31966, DOI 10.1074/jbc.M111.266320; Lorenz B, 1997, BBA-GEN SUBJECTS, V1335, P51, DOI 10.1016/S0304-4165(96)00121-3; Maciag A, 2011, NUCLEIC ACIDS RES, V39, P5338, DOI 10.1093/nar/gkr129; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Martins IC, 2008, EMBO J, V27, P224, DOI 10.1038/sj.emboj.7601953; McInerney P, 2006, MOL MICROBIOL, V60, P438, DOI 10.1111/j.1365-2958.2006.05103.x; Moreno-Sanchez D, 2012, J BIOL CHEM, V287, P28435, DOI 10.1074/jbc.M112.385823; Muller WEG, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102154; Mullan A, 2002, MICROB ECOL, V44, P69, DOI 10.1007/s00248-002-3004-x; Muller F, 2009, CELL, V139, P1143, DOI 10.1016/j.cell.2009.11.001; Nahalka J, 2009, ORG BIOMOL CHEM, V7, P1778, DOI 10.1039/b822549b; Naiki H, 1999, METHOD ENZYMOL, V309, P305; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Negreiros RS, 2018, MOL MICROBIOL, V110, P973, DOI 10.1111/mmi.14131; Nocek B, 2008, P NATL ACAD SCI USA, V105, P17730, DOI 10.1073/pnas.0807563105; NORDSTEDT C, 1994, J BIOL CHEM, V269, P30773; Ogawa N, 2000, MOL BIOL CELL, V11, P4309, DOI 10.1091/mbc.11.12.4309; Omelon S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005634; Pavlov E, 2005, FEBS LETT, V579, P5187, DOI 10.1016/j.febslet.2005.08.032; Pavlov E, 2010, J BIOL CHEM, V285, P9420, DOI 10.1074/jbc.M109.013011; Pfluger K, 2007, FEMS MICROBIOL LETT, V277, P79, DOI 10.1111/j.1574-6968.2007.00941.x; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rao NN, 2009, ANNU REV BIOCHEM, V78, P605, DOI 10.1146/annurev.biochem.77.083007.093039; Rao NN, 1998, J BACTERIOL, V180, P2186, DOI 10.1128/JB.180.8.2186-2193.1998; Rao NN, 1996, J BACTERIOL, V178, P1394, DOI 10.1128/jb.178.5.1394-1400.1996; Rashid MH, 2000, P NATL ACAD SCI USA, V97, P4885, DOI 10.1073/pnas.060030097; Rashid MH, 2000, J BACTERIOL, V182, P225, DOI 10.1128/JB.182.1.225-227.2000; Rashid MH, 2000, P NATL ACAD SCI USA, V97, P9636, DOI 10.1073/pnas.170283397; Roberts HL, 2015, BIOMOLECULES, V5, P282, DOI 10.3390/biom5020282; Rochin L, 2013, P NATL ACAD SCI USA, V110, P10658, DOI 10.1073/pnas.1220748110; Rudat AK, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00697-17; Ruiz FA, 2004, J BIOL CHEM, V279, P44250, DOI 10.1074/jbc.M406261200; Ruiz FA, 2001, J BIOL CHEM, V276, P26114, DOI 10.1074/jbc.M102402200; Saibil H, 2013, NAT REV MOL CELL BIO, V14, P630, DOI 10.1038/nrm3658; Saio T, 2014, SCIENCE, V344, P597, DOI 10.1126/science.1250494; Segawa S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023278; Seidlmayer LK, 2012, J GEN PHYSIOL, V139, P321, DOI 10.1085/jgp.201210788; SELKOE DJ, 1982, SCIENCE, V215, P1243, DOI 10.1126/science.6120571; Shi XB, 2004, P NATL ACAD SCI USA, V101, P17061, DOI 10.1073/pnas.0407787101; Shiba T, 2003, J BIOL CHEM, V278, P26788, DOI 10.1074/jbc.M303468200; Shiba T, 1997, P NATL ACAD SCI USA, V94, P11210, DOI 10.1073/pnas.94.21.11210; Silby MW, 2012, APPL ENVIRON MICROB, V78, P4533, DOI 10.1128/AEM.07836-11; Smith SA, 2010, BLOOD, V116, P4353, DOI 10.1182/blood-2010-01-266791; Stotz SC, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-42; Tamas MJ, 2014, BIOMOLECULES, V4, P252, DOI 10.3390/biom4010252; Tipping KW, 2015, P NATL ACAD SCI USA, V112, P5691, DOI 10.1073/pnas.1423174112; Trilisenko L, 2017, J BASIC MICROB, V57, P982, DOI 10.1002/jobm.201700257; Vagenende V, 2009, BIOCHEMISTRY-US, V48, P11084, DOI 10.1021/bi900649t; Verma M, 2015, ANN INDIAN ACAD NEUR, V18, P138, DOI 10.4103/0972-2327.144284; Wang LH, 2003, P NATL ACAD SCI USA, V100, P11249, DOI 10.1073/pnas.1534805100; Wang L, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00782; Wang SY, 2009, APPL ENVIRON MICROB, V75, P6110, DOI 10.1128/AEM.00914-09; WIDRA A, 1959, J BACTERIOL, V78, P664, DOI 10.1128/JB.78.5.664-670.1959; Yoo NG, 2018, J MOL BIOL, V430, P4195, DOI 10.1016/j.jmb.2018.08.016; Zakharian E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005404; Zhang HY, 2007, P NATL ACAD SCI USA, V104, P16486, DOI 10.1073/pnas.0706847104; Zhang HY, 2005, P NATL ACAD SCI USA, V102, P2731, DOI 10.1073/pnas.0500023102; Zhang HY, 2002, P NATL ACAD SCI USA, V99, P16678, DOI 10.1073/pnas.262655199	132	67	69	4	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2019	294	6					2180	2190		10.1074/jbc.REV118.002808	http://dx.doi.org/10.1074/jbc.REV118.002808			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM8EO	30425096	Green Published, hybrid			2022-12-28	WOS:000459711400035
J	Subbaramaiah, K; Iyengar, NM; Morrow, M; Elemento, O; Zhou, XK; Dannenberg, AJ				Subbaramaiah, Kotha; Iyengar, Neil M.; Morrow, Monica; Elemento, Olivier; Zhou, Xi Kathy; Dannenberg, Andrew J.			Prostaglandin E-2 down-regulates sirtuin 1 (SIRT1), leading to elevated levels of aromatase, providing insights into the obesity-breast cancer connection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						estrogen; obesity; adipose tissue; prostaglandin; sirtuin; hypoxia-inducible factor (HIF); aromatase	ADIPOSE-TISSUE; STROMAL CELLS; EXPRESSION; INFLAMMATION; HYPOXIA; ASSOCIATION; TRANSCRIPTS; WOMEN; OCCUR; RISK	Obesity increases the risk of hormone receptor-positive breast cancer in postmenopausal women. Levels of aromatase, the rate-limiting enzyme in estrogen biosynthesis, are increased in the breast tissue of obese women. Both prostaglandin E-2 (PGE(2)) and hypoxia-inducible factor 1 (HIF-1) contribute to the induction of aromatase in adipose stromal cells (ASCs). Sirtuin 1 (SIRT1) binds, deacetylates, and thereby inactivates HIF-1. Here, we sought to determine whether SIRT1 also plays a role in regulating aromatase expression. We demonstrate that reduced SIRT1 levels are associated with elevated levels of acetyl-HIF-1, HIF-1, and aromatase in breast tissue of obese compared with lean women. To determine whether these changes were functionally linked, ASCs were utilized. In ASCs, treatment with PGE(2), which is increased in obese individuals, down-regulated SIRT1 levels, leading to elevated acetyl-HIF-1 and HIF-1 levels and enhanced aromatase gene transcription. Chemical SIRT1 activators (SIRT1720 and resveratrol) suppressed the PGE(2)-mediated induction of acetyl-HIF-1, HIF-1, and aromatase. Silencing of p300/CBP-associated factor (PCAF), which acetylates HIF-1, blocked PGE(2)-mediated increases in acetyl-HIF-1, HIF-1, and aromatase. SIRT1 overexpression or PCAF silencing inhibited the interaction between HIF-1 and p300, a coactivator of aromatase expression, and suppressed p300 binding to the aromatase promoter. PGE(2) acted via prostaglandin E2 receptor 2 (EP2) and EP4 to induce activating transcription factor 3 (ATF3), a repressive transcription factor, which bound to a CREB site within the SIRT1 promoter and reduced SIRT1 levels. These findings suggest that reduced SIRT1-mediated deacetylation of HIF-1 contributes to the elevated levels of aromatase in breast tissues of obese women.	[Subbaramaiah, Kotha; Dannenberg, Andrew J.] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Elemento, Olivier] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10065 USA; [Elemento, Olivier] Weill Cornell Med Coll, Caryl & Israel Englander Inst Precis Med, New York, NY 10065 USA; [Zhou, Xi Kathy] Weill Cornell Med Coll, Dept Healthcare Policy & Res, New York, NY 10065 USA; [Iyengar, Neil M.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Morrow, Monica] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10065 USA	Cornell University; Cornell University; Cornell University; Cornell University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Subbaramaiah, K; Dannenberg, AJ (corresponding author), Weill Cornell Med Coll, 525 E 68th St,Rm E-803, New York, NY 10065 USA.	ksubba@med.cornell.edu; ajdannen@med.cornell.edu			National Institutes of Health [R01CA215797, U54 CA210184]; Breast Cancer Research Foundation; Botwinick-Wolfensohn Foundation; NATIONAL CANCER INSTITUTE [P30CA008748, R01CA215797, U54CA210184] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Research Foundation; Botwinick-Wolfensohn Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or part, by National Institutes of Health Grants R01CA215797 and U54 CA210184, the Breast Cancer Research Foundation, and the Botwinick-Wolfensohn Foundation (in memory of Mr. and Mrs. Benjamin Botwinick). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BULUN SE, 1993, J CLIN ENDOCR METAB, V77, P1622, DOI 10.1210/jc.77.6.1622; Bulun SE, 1996, J CLIN ENDOCR METAB, V81, P1273, DOI 10.1210/jc.81.3.1273; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Carter JM, 2018, CANCER PREV RES, V11, P113, DOI 10.1158/1940-6207.CAPR-17-0245; Chang HC, 2014, TRENDS ENDOCRIN MET, V25, P138, DOI 10.1016/j.tem.2013.12.001; de Kreutzenberg SV, 2010, DIABETES, V59, P1006, DOI 10.2337/db09-1187; Elangovan S, 2011, CANCER RES, V71, P6654, DOI 10.1158/0008-5472.CAN-11-1446; Ewertz M, 2011, J CLIN ONCOL, V29, P25, DOI 10.1200/JCO.2010.29.7614; Geng H, 2012, J BIOL CHEM, V287, P35496, DOI 10.1074/jbc.M112.400697; Gillum MP, 2011, TRENDS MOL MED, V17, P8, DOI 10.1016/j.molmed.2010.09.005; Herbert BS, 2010, ONCOTARGET, V1, P405; Holloway KR, 2013, MOL ENDOCRINOL, V27, P480, DOI 10.1210/me.2012-1347; Hui XY, 2017, EMBO REP, V18, P645, DOI 10.15252/embr.201643184; Iyengar NM, 2016, CLIN CANCER RES, V22, P2283, DOI 10.1158/1078-0432.CCR-15-2239; Iyengar NM, 2015, ANNU REV MED, V66, P297, DOI 10.1146/annurev-med-050913-022228; Koivisto E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105168; Kurylowicz A, 2016, INT J OBESITY, V40, P1635, DOI 10.1038/ijo.2016.131; Liang FX, 2009, NAT REV ENDOCRINOL, V5, P367, DOI 10.1038/nrendo.2009.101; Lim JH, 2010, MOL CELL, V38, P864, DOI 10.1016/j.molcel.2010.05.023; Lin N, 2016, J CLIN INVEST, V126, P3661, DOI 10.1172/JCI84426; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Morris PG, 2013, CANCER PREV RES, V6, P428, DOI 10.1158/1940-6207.CAPR-12-0431; Morris PG, 2011, CANCER PREV RES, V4, P1021, DOI 10.1158/1940-6207.CAPR-11-0110; Munsell MF, 2014, EPIDEMIOL REV, V36, P114, DOI 10.1093/epirev/mxt010; Noriega LG, 2011, EMBO REP, V12, P1069, DOI 10.1038/embor.2011.151; Pedersen SB, 2008, INT J OBESITY, V32, P1250, DOI 10.1038/ijo.2008.78; Protani M, 2010, BREAST CANCER RES TR, V123, P627, DOI 10.1007/s10549-010-0990-0; Rahman S, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-11; Rey S, 2010, CARDIOVASC RES, V86, P236, DOI 10.1093/cvr/cvq045; Rohan TE, 2013, J CANCER EPIDEMIOL, V2013, DOI 10.1155/2013/754815; Samarajeewa NU, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3410; Sasano H, 2003, J STEROID BIOCHEM, V86, P239, DOI 10.1016/S0960-0760(03)00363-7; SHAY JW, 1995, MOL CELL BIOL, V15, P425, DOI 10.1128/MCB.15.1.425; SIMPSON ER, 1994, ENDOCR REV, V15, P342, DOI 10.1210/er.15.3.342; Song YS, 2013, DIABETES RES CLIN PR, V101, P341, DOI 10.1016/j.diabres.2013.07.002; Sparano JA, 2015, J CLIN ONCOL, V33, P2353, DOI 10.1200/JCO.2015.60.9271; Subbaramaiah K, 2008, J BIOL CHEM, V283, P3433, DOI 10.1074/jbc.M705409200; Subbaramaiah K, 2016, J BIOL CHEM, V291, P16011, DOI 10.1074/jbc.M115.698902; Subbaramaiah K, 2012, CANCER DISCOV, V2, P356, DOI 10.1158/2159-8290.CD-11-0241; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Thompson MR, 2009, J MOL MED, V87, P1053, DOI 10.1007/s00109-009-0520-x; TrenthamDietz A, 1997, AM J EPIDEMIOL, V145, P1011, DOI 10.1093/oxfordjournals.aje.a009057; Zahid H, 2018, INT J OBESITY, V42, P711, DOI 10.1038/ijo.2017.273	44	14	16	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2019	294	1					361	371		10.1074/jbc.RA118.005866	http://dx.doi.org/10.1074/jbc.RA118.005866			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG6PT	30409902	hybrid, Green Published			2022-12-28	WOS:000455105500037
J	Meng, MY; Li, L; Li, RH; Wang, WJ; Chen, Y; Xie, YH; Han, R; Zhu, K; Huang, WW; Yang, LL; Li, S; Shi, JL; Tan, WW; Gao, H; Zhao, YY; Yang, L; Tan, J; Hou, ZL				Meng, Mingyao; Li, Lin; Li, Ruhong; Wang, Wenju; Chen, Yang; Xie, Yanhua; Han, Rui; Zhu, Kai; Huang, Wenwen; Yang, Lili; Li, Shuo; Shi, Jianlin; Tan, Weiwei; Gao, Hui; Zhao, Yiyi; Yang, Li; Tan, Jing; Hou, Zongliu			A dynamic transcriptomic atlas of cytokine-induced killer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						immunotherapy; tumor therapy; bioinformatics; immunology; computational biology; cytokine-induced killer cells; deep sequencing; cytotoxicity; WGCNA; safety; cytokine; CD8; anticancer treatment	TUMOR-INFILTRATING LYMPHOCYTES; SRC-FAMILY KINASES; ADOPTIVE TRANSFER; T-CELLS; CANCER; IMMUNOTHERAPY; ANTIGENS; PROTEIN; INTERLEUKIN-2; CYTOTOXICITY	Several clinical immunotherapy trials with cytokine-induced killer (CIK) cells have been reported. However, molecular evidence of cell expansion, acquisition of tumor cytotoxicity, and safety of CIK cells is required before putting them to clinical use. Here, we performed dynamic transcriptomic analyses of CIKs generated from primary peripheral blood mononuclear cells exposed to interferon-, OKT3, and interleukin-2. CIK mRNAs were extracted and sequenced at days 0, 1, 7, and 14 and subjected to bioinformatics analyses. Using weighted correlation network analysis (WGCNA), we identified two major gene modules that mediate immune cell activation and mitosis. We found that activation and cytotoxicity of CIK cells likely rely on cluster of differentiation 8 (CD8) and its protein partner LCK proto-oncogene, Src family tyrosine kinase (LCK). A time-course series analysis revealed that CIK cells have relatively low immunogenicity because of decreased expression of some self-antigens. Importantly, we identified several crucial activating receptors and auxiliary adhesion receptors expressed on CIK cells that may function as tumor sensors. Interestingly, cytotoxicity-associated genes, including those encoding PRF1, GZMB, FASL, and several cytokines, were up-regulated in mature CIK cells. Most immune-checkpoint molecules and inflammatory tumor-promoting factors were down-regulated in the CIK cells, suggesting efficacy and safety in future clinical trials. Notably, insulin-like growth factor 1 (IGF-1) was highly expressed in CIK cells and may promote cytotoxicity, although it also could facilitate tumorigenesis. The transcriptomic atlas of CIK cells presented here may inform efforts to improve CIK-associated tumor cytotoxicity and safety in clinical trials.	[Meng, Mingyao; Li, Lin; Li, Ruhong; Wang, Wenju; Xie, Yanhua; Han, Rui; Zhu, Kai; Huang, Wenwen; Yang, Lili; Li, Shuo; Shi, Jianlin; Tan, Weiwei; Gao, Hui; Zhao, Yiyi; Yang, Li; Tan, Jing; Hou, Zongliu] Kunming Med Univ, Yanan Affiliated Hosp, 245 East Renmin Rd, Kunming 650051, Yunnan, Peoples R China; [Meng, Mingyao; Li, Lin; Li, Ruhong; Wang, Wenju; Xie, Yanhua; Han, Rui; Zhu, Kai; Huang, Wenwen; Yang, Lili; Li, Shuo; Shi, Jianlin; Tan, Weiwei; Gao, Hui; Zhao, Yiyi; Yang, Li; Tan, Jing; Hou, Zongliu] Key Lab Tumor Immunol Prevent & Treatment Yunnan, Kunming 650051, Yunnan, Peoples R China; [Chen, Yang] Tsinghua Univ, Minist Educ MOE, Key Lab Bioinformat, Bioinformat Div, Beijing 100084, Peoples R China; [Chen, Yang] Tsinghua Univ, Ctr Synthet & Syst Biol, BNRist, Dept Automat, Beijing 100084, Peoples R China	Kunming Medical University; Tsinghua University; Tsinghua University	Tan, J; Hou, ZL (corresponding author), Kunming Med Univ, Yanan Affiliated Hosp, 245 East Renmin Rd, Kunming 650051, Yunnan, Peoples R China.	kmtjing@sina.com; hzl579@163.com	huang, wen/GXW-0661-2022; Huang, WW/GXH-0977-2022		National Natural Science Foundation of China [81360245, 81660477, 81460436]; Yunnan Province Science and Technology Department and Kunming Medical University [2015FA008]; Health and Family Planning Commission of Yunnan Province [2014NS212]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Province Science and Technology Department and Kunming Medical University; Health and Family Planning Commission of Yunnan Province	This work is supported by National Natural Science Foundation of China Grants 81360245, 81660477, and 81460436 and "Special and Joint Program" of Yunnan Province Science and Technology Department and Kunming Medical University Grant 2015FA008. This study is also funded by Health and Family Planning Commission of Yunnan Province Grant 2014NS212.	Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Basso S, 2011, J CANCER, V2, P341, DOI 10.7150/jca.2.341; Besser MJ, 2013, CLIN CANCER RES, V19, P4792, DOI 10.1158/1078-0432.CCR-13-0380; Borrego F, 1998, J EXP MED, V187, P813, DOI 10.1084/jem.187.5.813; Cantoni C, 1998, EUR J IMMUNOL, V28, P327, DOI 10.1002/(SICI)1521-4141(199801)28:01<327::AID-IMMU327>3.0.CO;2-O; Cappuzzello E, 2017, CYTOKINE GROWTH F R, V36, P99, DOI 10.1016/j.cytogfr.2017.06.003; Carmeliet P, 2005, ONCOLOGY-BASEL, V69, P4, DOI 10.1159/000088478; Chandran SS, 2017, LANCET ONCOL, V18, P792, DOI 10.1016/S1470-2045(17)30251-6; EISEMAN E, 1990, CANCER CELL-MON REV, V2, P303; Fisher JPH, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.27572; Garfall AL, 2015, NEW ENGL J MED, V373, P1040, DOI 10.1056/NEJMoa1504542; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Guillerey C, 2016, NAT IMMUNOL, V17, P1025, DOI 10.1038/ni.3518; Harris MA, 2006, NUCLEIC ACIDS RES, V34, pD322, DOI 10.1093/nar/gkj021; Jakel CE, 2014, EXPERT OPIN BIOL TH, V14, P905, DOI 10.1517/14712598.2014.900537; Jiang JT, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-83; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kawasaki Y, 2010, GLYCOBIOLOGY, V20, P1373, DOI 10.1093/glycob/cwq116; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lankry D, 2013, EUR J IMMUNOL, V43, P2151, DOI 10.1002/eji.201343433; Li XD, 2012, CLIN TRANSL ONCOL, V14, P102, DOI 10.1007/s12094-012-0768-4; Linn YC, 2012, CYTOTHERAPY, V14, P851, DOI 10.3109/14653249.2012.694419; Lucas DP, 2015, TRANSPLANTATION, V99, P77, DOI 10.1097/TP.0000000000000355; Maher J, 2004, BRIT J CANCER, V91, P817, DOI 10.1038/sj.bjc.6602022; Matsumoto G, 1998, J IMMUNOL, V160, P5781; Mesiano G, 2017, MOL MED, V23, P235, DOI 10.2119/molmed.2017.00084; Musgrave BL, 2003, J INTERF CYTOK RES, V23, P67, DOI 10.1089/107999003321455462; Ni F, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2484; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Nika K, 2010, IMMUNITY, V32, P766, DOI 10.1016/j.immuni.2010.05.011; OSHIMI K, 1990, J IMMUNOL, V144, P3312; Oykhman P, 2013, INFECT IMMUN, V81, P3912, DOI 10.1128/IAI.00533-13; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Poh SL, 2016, CANCER IMMUNOL IMMUN, V65, P525, DOI 10.1007/s00262-016-1815-8; ROSENBERG SA, 1985, NEW ENGL J MED, V313, P1485, DOI 10.1056/NEJM198512053132327; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Rosenberg SA, 2011, NAT REV CLIN ONCOL, V8, P577, DOI 10.1038/nrclinonc.2011.116; Sakhdari A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040146; Schmidt-Wolf IGH, 1999, BRIT J CANCER, V81, P1009, DOI 10.1038/sj.bjc.6690800; SCHMIDTWOLF IGH, 1991, J EXP MED, V174, P139, DOI 10.1084/jem.174.1.139; Shao JY, 2016, SCAND J IMMUNOL, V84, P182, DOI 10.1111/sji.12455; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq622; Wang WJ, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-49; Watzl Carsten, 2010, Curr Protoc Immunol, VChapter 11, DOI 10.1002/0471142735.im1109bs90; Wordeman L, 2010, SEMIN CELL DEV BIOL, V21, P260, DOI 10.1016/j.semcdb.2010.01.018; Wright SE, 2012, J IMMUNOTHER, V35, P196, DOI 10.1097/CJI.0b013e318243f213; Zhao X, 2015, CANCER LETT, V362, P192, DOI 10.1016/j.canlet.2015.03.043; Zou C, 2017, ONCOTARGET, V8, P8900, DOI 10.18632/oncotarget.13051; Zwirner NW, 1998, IMMUNOGENETICS, V47, P139	50	7	7	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19600	19612		10.1074/jbc.RA118.003280	http://dx.doi.org/10.1074/jbc.RA118.003280			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30333226	Green Published, hybrid			2022-12-28	WOS:000454294900009
J	Xia, P; Liu, YN; Chen, JR; Coates, S; Liu, DX; Cheng, ZK				Xia, Peng; Liu, Yuening; Chen, Jingrui; Coates, Shelby; Liu, David X.; Cheng, Zhaokang			Inhibition of cyclin-dependent kinase 2 protects against doxorubicin-induced cardiomyocyte apoptosis and cardiomyopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						anticancer drug; cardiovascular disease; cyclin-dependent kinase (CDK); cell cycle; cell death; mitochondria; anthracycline; Bim; cardiotoxicity; chemotherapy	HYPOXIA-INDUCED APOPTOSIS; CELL-DEATH; SELICICLIB CYC202; R-ROSCOVITINE; ACTIVATION; PHOSPHORYLATION; CARDIOTOXICITY; GROWTH; CDK2; BIM	With the rapid increase in cancer survival because of improved diagnosis and therapy in the past decades, cancer treatment-related cardiotoxicity is becoming an urgent healthcare concern. The anthracycline doxorubicin (DOX), one of the most effective chemotherapeutic agents to date, causes cardiomyopathy by inducing cardiomyocyte apoptosis. We demonstrated previously that overexpression of the cyclin-dependent kinase (CDK) inhibitor p21 promotes resistance against DOX-induced cardiomyocyte apoptosis. Here we show that DOX exposure provokes cardiac CDK2 activation and cardiomyocyte cell cycle S phase reentry, resulting in enhanced cellular sensitivity to DOX. Genetic or pharmacological inhibition of CDK2 markedly suppressed DOX-induced cardiomyocyte apoptosis. Conversely, CDK2 overexpression augmented DOX-induced apoptosis. We also found that DOX-induced CDK2 activation in the mouse heart is associated with up-regulation of the pro-apoptotic BCL2 family member BCL2-like 11 (Bim), a BH3-only protein essential for triggering Bax/Bak-dependent mitochondrial outer membrane permeabilization. Further experiments revealed that DOX induces cardiomyocyte apoptosis through CDK2-dependent expression of Bim. Inhibition of CDK2 with roscovitine robustly repressed DOX-induced mitochondrial depolarization. In a cardiotoxicity model of chronic DOX exposure (5 mg/kg weekly for 4 weeks), roscovitine administration significantly attenuated DOX-induced contractile dysfunction and ventricular remodeling. These findings identify CDK2 as a key determinant of DOX-induced cardiotoxicity. CDK2 activation is necessary for DOX-induced Bim expression and mitochondrial damage. Our results suggest that pharmacological inhibition of CDK2 may be a cardioprotective strategy for preventing anthracycline-induced heart damage.	[Xia, Peng; Liu, Yuening; Chen, Jingrui; Liu, David X.; Cheng, Zhaokang] Washington State Univ, Dept Pharmaceut Sci, 205 E Spokane Falls Blvd, Spokane, WA 99210 USA; [Coates, Shelby] Pacific Lutheran Univ, Dept Biol, Tacoma, WA 98477 USA	Washington State University; Pacific Lutheran University	Cheng, ZK (corresponding author), Washington State Univ, Dept Pharmaceut Sci, 205 E Spokane Falls Blvd, Spokane, WA 99210 USA.	zhaokang.cheng@wsu.edu	Liu, Yuening/GYQ-7182-2022	Liu, Yuening/0000-0002-6891-0006; Cheng, Zhaokang/0000-0002-9646-4824	National Institutes of Health [R00HL119605]; Washington State University College of Pharmacy; NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL119605] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Washington State University College of Pharmacy; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NHLBI, National Institutes of Health Grant R00HL119605 (to Z.C.) and the Washington State University College of Pharmacy. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Adachi S, 2001, CIRC RES, V88, P408, DOI 10.1161/01.res.88.4.408; Appleyard MVCL, 2009, INT J CANCER, V124, P465, DOI 10.1002/ijc.23938; Bergmann O, 2015, CELL, V161, P1566, DOI 10.1016/j.cell.2015.05.026; Bourke E, 2010, ONCOGENE, V29, P616, DOI 10.1038/onc.2009.340; Chaudhry HW, 2004, J BIOL CHEM, V279, P35858, DOI 10.1074/jbc.M404975200; Chen ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep29090; Cheng Z, 2014, J MOL CELL CARDIOL, V67, P1, DOI 10.1016/j.yjmcc.2013.12.002; Ellenrieder C, 2001, DNA CELL BIOL, V20, P413, DOI 10.1089/104454901750361479; Flores O, 2010, ENDOCRINOLOGY, V151, P896, DOI 10.1210/en.2009-1116; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Harvey KJ, 2000, J CELL BIOL, V148, P59, DOI 10.1083/jcb.148.1.59; Hauck L, 2002, CIRC RES, V91, P782, DOI 10.1161/01.RES.0000041030.98642.41; Huang HJ, 2006, SCIENCE, V314, P294, DOI 10.1126/science.1130512; Ichikawa Y, 2014, J CLIN INVEST, V124, P617, DOI 10.1172/JCI72931; Jabbour-Leung NA, 2016, MOL CANCER THER, V15, P593, DOI 10.1158/1535-7163.MCT-15-0519; Jay SM, 2013, CIRCULATION, V128, P152, DOI 10.1161/CIRCULATIONAHA.113.002203; Kruman II, 2004, NEURON, V41, P549, DOI 10.1016/S0896-6273(04)00017-0; Lambert LA, 2008, CANCER RES, V68, P7966, DOI 10.1158/0008-5472.CAN-08-1333; Lenneman CG, 2016, CIRC RES, V118, P1008, DOI 10.1161/CIRCRESAHA.115.303633; Li DL, 2016, CIRCULATION, V133, P1668, DOI 10.1161/CIRCULATIONAHA.115.017443; Liao HS, 2001, CIRC RES, V88, P443; Liem DA, 2008, J MOL CELL CARDIOL, V45, P610, DOI 10.1016/j.yjmcc.2008.07.003; Ling YH, 1996, MOL PHARMACOL, V49, P832; Liu WJ, 2014, DEV BIOL, V392, P108, DOI 10.1016/j.ydbio.2014.04.018; Luke JJ, 2012, CLIN CANCER RES, V18, P2638, DOI 10.1158/1078-0432.CCR-11-3203; Malumbres M, 2014, GENOME BIOL, V15, DOI 10.1186/gb4184; Miller KD, 2016, CA-CANCER J CLIN, V66, P271, DOI 10.3322/caac.21349; Mollova M, 2013, P NATL ACAD SCI USA, V110, P1446, DOI 10.1073/pnas.1214608110; Pang BX, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2921; Qian L, 2011, J EXP MED, V208, P549, DOI 10.1084/jem.20101547; Raje N, 2005, BLOOD, V106, P1042, DOI 10.1182/blood-2005-01-0320; Rathos MJ, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-29; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; Sarkar S, 2004, J BIOL CHEM, V279, P52630, DOI 10.1074/jbc.M402037200; Sarosiek KA, 2013, MOL CELL, V51, P751, DOI 10.1016/j.molcel.2013.08.048; Senyo SE, 2013, NATURE, V493, P433, DOI 10.1038/nature11682; Shapiro SD, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007668; Teitz T, 2018, J EXP MED, V215, P1187, DOI 10.1084/jem.20172246; Vella S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166233; Xia P, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/9583268; Zhang J, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.167; Zhang S, 2012, NAT MED, V18, P1639, DOI 10.1038/nm.2919	43	29	30	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19672	19685		10.1074/jbc.RA118.004673	http://dx.doi.org/10.1074/jbc.RA118.004673			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30361442	Green Published, hybrid			2022-12-28	WOS:000454294900015
J	Yoon, MK; Kim, BY; Lee, JY; Ha, JH; Kim, SA; Lee, DH; Lee, MS; Lee, MK; Choi, JS; Cho, JH; Kim, JH; Kim, S; Song, J; Park, SG; Park, BC; Bae, KH; Choi, SU; Chi, SW				Yoon, Mi-Kyung; Kim, Bu-Yeon; Lee, Ji-Young; Ha, Ji-Hyang; Kim, Sung Ah; Lee, Dong-Hwa; Lee, Min-Sung; Lee, Mi-Kyung; Choi, Jin Sun; Cho, Jin Hwa; Kim, Jeong-Hoon; Kim, Sunhong; Song, Jaewhan; Park, Sung Goo; Park, Byoung Chul; Bae, Kwang-Hee; Choi, Sang Un; Chi, Seung-Wook			Cytoplasmic pro-apoptotic function of the tumor suppressor p73 is mediated through a modified mode of recognition of the anti-apoptotic regulator Bcl-X-L	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; protein-protein interaction; protein structure; p73; tumor suppressor gene; cancer; Bcl-XL; BCL2L1; BH3-interacting domain death agonist; transactivation domain	PROTEIN COMPLEXES; CHEMICAL-SHIFT; P53; FAMILY; TRANSACTIVATION; MDM2; BAX; NUCLEAR; ACTIVATION; RESTRAINTS	In response to genotoxic stress, the tumor suppressor protein p73 induces apoptosis and cell cycle arrest. Despite extensive studies on p73-mediated apoptosis, little is known about the cytoplasmic apoptotic function of p73. Here, using H1299 lung cancer cells and diverse biochemical approaches, including colony formation, DNA fragmentation, GST pulldown, and apoptosis assays along with NMR spectroscopy, we show that p73 induces transcription-independent apoptosis via its transactivation domain (TAD) through a mitochondrial pathway and that this apoptosis is mediated by the interaction between p73-TAD and the anti-apoptotic protein B-cell lymphoma-extra large (Bcl-X-L or BCL2L1). This binding disrupted an interaction between Bcl-X-L and the pro-apoptotic protein BH3-interacting domain death agonist (Bid). In particular, we found that a 16-mer p73-TAD peptide motif (p73-TAD16) mediates transcription-independent apoptosis, accompanied by cytochrome c release from the mitochondria, by interacting with Bcl-X-L. Interestingly, the structure of the Bcl-X-L-p73-TAD16 peptide complex revealed a novel mechanism of Bcl-X-L recognition by p73-TAD. We observed that the -helical p73-TAD16 peptide binds to a noncanonical site in Bcl-X-L, comprising the BH1, BH2, and BH3 domains in an orientation opposite to those of pro-apoptotic BH3 peptides. Taken together, our results indicate that the cytoplasmic apoptotic function of p73 is mediated through a noncanonical mode of Bcl-X-L recognition. This finding sheds light on a critical transcription-independent, p73-mediated mechanism for apoptosis induction, which has potential implications for anticancer therapy.	[Yoon, Mi-Kyung; Ha, Ji-Hyang; Kim, Sung Ah; Lee, Dong-Hwa; Lee, Min-Sung; Lee, Mi-Kyung; Choi, Jin Sun; Cho, Jin Hwa; Kim, Jeong-Hoon; Kim, Sunhong; Park, Sung Goo; Park, Byoung Chul; Chi, Seung-Wook] KRIBB, Dis Target Struct Res Ctr, Daejeon 34141, South Korea; [Bae, Kwang-Hee] KRIBB, Metab Regulat Res Ctr, Daejeon 34141, South Korea; [Kim, Sung Ah; Lee, Min-Sung; Kim, Jeong-Hoon; Kim, Sunhong; Park, Sung Goo; Park, Byoung Chul; Bae, Kwang-Hee; Chi, Seung-Wook] Korea Univ Sci & Technol, Sch Biosci, KRIBB, Daejeon 34113, South Korea; [Kim, Bu-Yeon; Lee, Ji-Young; Choi, Sang Un] Korea Res Inst Chem Technol, Bio & Drug Discovery Div, Daejeon 34114, South Korea; [Song, Jaewhan] Yonsei Univ, Dept Biochem, Seoul 03722, South Korea; [Choi, Jin Sun] Chungnam Natl Univ, Res Inst Med Sci, Daejeon, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Science & Technology (UST); Korea Research Institute of Chemical Technology (KRICT); Yonsei University; Chungnam National University	Chi, SW (corresponding author), KRIBB, Dis Target Struct Res Ctr, Daejeon 34141, South Korea.; Choi, SU (corresponding author), Korea Res Inst Chem Technol, Bio & Drug Discovery Div, Daejeon 34114, South Korea.	suchoi@krict.re.kr; swchi@kribb.re.kr		Bae, Kwang-Hee/0000-0002-5868-2556	National Research Foundation of Korea - Korean Government (MSIT) [NRF-2017R1E1A1A01074403, NRF-2017M3A9C4092979, NRF-2017R1A2B4006378]; KRIBB Research Initiative Program; Technology Innovation Program of Korea Evaluation Institute of Industrial Technology - Ministry of Trade, Industry & Energy, Republic of Korea [10038744]	National Research Foundation of Korea - Korean Government (MSIT); KRIBB Research Initiative Program; Technology Innovation Program of Korea Evaluation Institute of Industrial Technology - Ministry of Trade, Industry & Energy, Republic of Korea	This work was supported by Grants NRF-2017R1E1A1A01074403, NRF-2017M3A9C4092979, and NRF-2017R1A2B4006378 from the National Research Foundation of Korea funded by the Korean Government (MSIT) and by the KRIBB Research Initiative Program. This work was also supported by Grant 10038744 from the Technology Innovation Program of Korea Evaluation Institute of Industrial Technology funded by Ministry of Trade, Industry & Energy, Republic of Korea. The authors declare that they have no conflicts of interest with the contents of this article.	Aqeilan RI, 2004, P NATL ACAD SCI USA, V101, P4401, DOI 10.1073/pnas.0400805101; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burge S, 2009, P NATL ACAD SCI USA, V106, P3142, DOI 10.1073/pnas.0900383106; Chipuk JE, 2005, SCIENCE, V309, P1732, DOI 10.1126/science.1114297; Chipuk JE, 2003, CANCER CELL, V4, P371, DOI 10.1016/S1535-6108(03)00272-1; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Clore GM, 2003, J AM CHEM SOC, V125, P2902, DOI 10.1021/ja028893d; CLORE GM, 1983, J MAGN RESON, V53, P423, DOI 10.1016/0022-2364(83)90215-9; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; De Laurenzi V, 2000, J BIOL CHEM, V275, P15226, DOI 10.1074/jbc.275.20.15226; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Dotsch V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004887; Follis AV, 2014, NAT STRUCT MOL BIOL, V21, P535, DOI 10.1038/nsmb.2829; Follis AV, 2013, NAT CHEM BIOL, V9, P163, DOI [10.1038/NCHEMBIO.1166, 10.1038/nchembio.1166]; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Ha JH, 2013, J BIOL CHEM, V288, P7387, DOI 10.1074/jbc.M112.400754; Ha JH, 2011, J AM CHEM SOC, V133, P1244, DOI 10.1021/ja109521f; John K, 2011, CELL DEATH DIFFER, V18, P874, DOI 10.1038/cdd.2010.153; Jost CA, 1997, NATURE, V389, P191, DOI 10.1038/38298; Keller R, 2004, THE COMPUTER AIDED R; Kojima K, 2006, CELL CYCLE, V5, P2778, DOI 10.4161/cc.5.23.3520; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee EF, 2009, ANGEW CHEM INT EDIT, V48, P4318, DOI 10.1002/anie.200805761; Lessene G, 2008, NAT REV DRUG DISCOV, V7, P989, DOI 10.1038/nrd2658; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Liu T, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.203; Melino G, 2002, NAT REV CANCER, V2, P605, DOI 10.1038/nrc861; Melino G, 2004, J BIOL CHEM, V279, P8076, DOI 10.1074/jbc.M307469200; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Min B, 2015, BIOCHEM BIOPH RES CO, V467, P316, DOI 10.1016/j.bbrc.2015.09.163; Moldoveanu T, 2014, TRENDS BIOCHEM SCI, V39, P101, DOI 10.1016/j.tibs.2013.12.006; Moldoveanu T, 2013, NAT STRUCT MOL BIOL, V20, P589, DOI 10.1038/nsmb.2563; Nyman U, 2005, J BIOL CHEM, V280, P34159, DOI 10.1074/jbc.M500394200; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; PASCAL SM, 1994, J MAGN RESON SER B, V103, P197, DOI 10.1006/jmrb.1994.1031; Petros AM, 2000, PROTEIN SCI, V9, P2528, DOI 10.1017/S096183680000331X; Rajan S, 2015, PROTEINS, V83, P1262, DOI 10.1002/prot.24816; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Sayan AE, 2008, ONCOGENE, V27, P4363, DOI 10.1038/onc.2008.64; Sayan BS, 2006, J BIOL CHEM, V281, P13566, DOI 10.1074/jbc.M512467200; Schilling T, 2009, BIOCHEM BIOPH RES CO, V387, P399, DOI 10.1016/j.bbrc.2009.07.063; Schwarzinger S, 2001, J AM CHEM SOC, V123, P2970, DOI 10.1021/ja003760i; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shin JS, 2015, CELL CYCLE, V14, P533, DOI 10.1080/15384101.2014.998056; Tamiola K, 2010, J AM CHEM SOC, V132, P18000, DOI 10.1021/ja105656t; Vassilev LT, 2007, TRENDS MOL MED, V13, P23, DOI 10.1016/j.molmed.2006.11.002; Xu HB, 2009, BIOCHEMISTRY-US, V48, P12159, DOI 10.1021/bi901188s; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; Yoon MK, 2015, BMB REP, V48, P81, DOI 10.5483/BMBRep.2015.48.2.255; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zeng XY, 1999, MOL CELL BIOL, V19, P3257; Zhang HY, 2003, J BIOMOL NMR, V25, P173, DOI 10.1023/A:1022836027055; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	55	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19546	19558		10.1074/jbc.RA118.003061	http://dx.doi.org/10.1074/jbc.RA118.003061			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30429221	Green Published, hybrid			2022-12-28	WOS:000454294900005
J	Sadleir, KR; Popovic, J; Vassar, R				Sadleir, Katherine R.; Popovic, Jelena; Vassar, Robert			ER stress is not elevated in the 5XFAD mouse model of Alzheimer's disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM; MEMORY DEFICITS; TRANSGENIC MICE; PATHOGENIC MUTATION; AMYLOID PLAQUES; BETA-SECRETASE; TAU PATHOLOGY; NEURON LOSS; PC12 CELLS	Alzheimer's disease mouse models that overexpress amyloid precursor protein (APP) and presenilin 1 (PS1) form beta-amyloid (A beta) plaques, a hallmark Alzheimer's disease lesion. It has been assumed that the neuroinflammation, synaptic dysfunction, neurodegeneration, and cognitive impairment observed in these mice are caused by cerebral A beta accumulation. However, it is also possible that accumulation of the overexpressed transmembrane proteins APP and PS1 in the endoplasmic reticulum (ER) triggers chronic ER stress and activation of the unfolded protein response (UPR). The 5XFAD mouse, a widely used amyloid pathology model, overexpresses APP and PS1, displays aggressive amyloid pathology, and has been reported to exhibit ER stress. To systematically evaluate whether 5XFAD mice have increased ER stress, here we used biochemical approaches to assess a comprehensive panel of UPR markers. We report that APPand PS1 levels are 1.8- and 1.5-fold, respectively, of those in 5XFAD compared with nontransgenic brains, indicating that transgenes are not massively overexpressed in 5XFAD mice. Using immunoblotting, we quantified UPR protein levels in nontransgenic, 5XFAD, and 5XFAD; BACE1(-/-) mice at 4, 6, and 9 months of age. Importantly, we did not observe elevation of the ER stress markers p-eIF2 alpha, ATF4, CHOP, p-IRE1 alpha, or BiP at any age in 5XFAD or 5XFAD; BACE1(-/-) compared with nontransgenic mice. Despite lacking A beta generation, 5XFAD; BACE1(-/-) mice still expressed APP and PS1 transgenes, indicating that their overexpression does not cause ER stress. These results reveal the absence of ER stress in 5XFAD mice, suggesting that artifactual phenotypes associated with overexpression-induced ER stress are not a concern in this model.	[Sadleir, Katherine R.; Popovic, Jelena; Vassar, Robert] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Vassar, R (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA.	r-vassar@northwestern.edu	Sadleir, Katherine R/N-1199-2019	Sadleir, Katherine R/0000-0001-8310-841X	National Institutes of Health [R01 AG030142, R01 AG1022560]; NATIONAL INSTITUTE ON AGING [R01AG030142] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants R01 AG030142 and R01 AG1022560. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALLINQUANT B, 1995, J CELL BIOL, V128, P919, DOI 10.1083/jcb.128.5.919; Briggs DI, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0025-17.2017; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Chan SL, 2000, J BIOL CHEM, V275, P18195, DOI 10.1074/jbc.M000040200; Chang RCC, 2002, NEUROREPORT, V13, P2429, DOI 10.1097/00001756-200212200-00011; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; Cisse M, 2017, MOL PSYCHIATR, V22, P1562, DOI 10.1038/mp.2016.152; Citron M, 1998, NEUROBIOL DIS, V5, P107, DOI 10.1006/nbdi.1998.0183; Devi L, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.59; Devi L, 2014, NEUROBIOL AGING, V35, P2272, DOI 10.1016/j.neurobiolaging.2014.04.031; Devi L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077335; Devi L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012974; Eckman CB, 1997, HUM MOL GENET, V6, P2087, DOI 10.1093/hmg/6.12.2087; Eimer WA, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-2; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; Gerakis Y, 2018, FEBS J, V285, P995, DOI 10.1111/febs.14332; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Guo Q, 1996, NEUROREPORT, V8, P379, DOI 10.1097/00001756-199612200-00074; Hashimoto S, 2018, J BIOL CHEM, V293, P3118, DOI 10.1074/jbc.M117.811315; Ho YS, 2012, J ALZHEIMERS DIS, V28, P839, DOI 10.3233/JAD-2011-111037; Hoozemans JJM, 2012, NEURODEGENER DIS, V10, P212, DOI 10.1159/000334536; Hoozemans JJM, 2009, AM J PATHOL, V174, P1241, DOI 10.2353/ajpath.2009.080814; Hoozemans JJM, 2005, ACTA NEUROPATHOL, V110, P165, DOI 10.1007/s00401-005-1038-0; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Kadowaki H, 2013, GENES-BASEL, V4, P306, DOI 10.3390/genes4030306; Kim S, 2016, MOL PSYCHIATR, V21, P707, DOI 10.1038/mp.2015.97; Kohler C, 2014, NEUROBIOL DIS, V71, P169, DOI 10.1016/j.nbd.2014.07.006; Lauritzen I, 2016, ACTA NEUROPATHOL, V132, P257, DOI 10.1007/s00401-016-1577-6; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; Nijholt DAT, 2012, J PATHOL, V226, P693, DOI 10.1002/path.3969; O'Connor T, 2008, NEURON, V60, P988, DOI 10.1016/j.neuron.2008.10.047; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Ohno M, 2006, EUR J NEUROSCI, V23, P251, DOI 10.1111/j.1460-9568.2005.04551.x; Ohno M, 2007, NEUROBIOL DIS, V26, P134, DOI 10.1016/j.nbd.2006.12.008; Rodrigues EM, 2012, HUM MOL GENET, V21, P4587, DOI 10.1093/hmg/dds297; Rutten BR, 2003, NEUROBIOL DIS, V12, P110, DOI 10.1016/S0969-9961(02)00015-3; Sadleir KR, 2015, MOL NEURODEGENER, V10, DOI 10.1186/1750-1326-10-1; Sadleir KR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101643; Sadleir KR, 2013, CURR ALZHEIMER RES, V10, P785; Saito T, 2016, J NEUROSCI, V36, P9933, DOI 10.1523/JNEUROSCI.1907-16.2016; Sasaguri H, 2017, EMBO J, V36, P2473, DOI 10.15252/embj.201797397; Scheper W, 2015, ACTA NEUROPATHOL, V130, P315, DOI 10.1007/s00401-015-1462-8; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Stutzbach LD, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-31; Stutzmann GE, 2004, J NEUROSCI, V24, P508, DOI 10.1523/JNEUROSCI.4386-03.2004; Tanzi Rudolph E, 2012, Cold Spring Harb Perspect Med, V2, DOI 10.1101/cshperspect.a006296; Thinakaran G, 1998, NEUROBIOL DIS, V4, P438, DOI 10.1006/nbdi.1998.0171; Unterberger U, 2006, J NEUROPATH EXP NEUR, V65, P348, DOI 10.1097/01.jnen.0000218445.30535.6f; Zhao J, 2007, J NEUROSCI, V27, P3639, DOI 10.1523/JNEUROSCI.4396-06.2007	52	25	25	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2018	293	48					18434	18443		10.1074/jbc.RA118.005769	http://dx.doi.org/10.1074/jbc.RA118.005769			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NX	30315100	hybrid, Green Published			2022-12-28	WOS:000458467300002
J	Zhelay, T; Wieczerzak, KB; Beesetty, P; Alter, GM; Matsushita, M; Kozak, JA				Zhelay, Tetyana; Wieczerzak, Krystyna B.; Beesetty, Pavani; Alter, Gerald M.; Matsushita, Masayuki; Kozak, J. Ashot			Depletion of plasma membrane-associated phosphoinositides mimics inhibition of TRPM7 channels by cytosolic Mg2+, spermine, and pH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						channel activation; phosphoinositide; polyamine; magnesium; transfection; transient receptor potential channels (TRP channels); mutant; gain-of-function mutation; TRPM; voltage-sensitive phosphatase	VOLTAGE-SENSING PHOSPHATASE; POTENTIAL MELASTATIN 7; CI-VSP; POLYVALENT CATIONS; KINASE-ACTIVITY; MIC CHANNELS; ATP; PIP2; SENSITIVITY; MAGNESIUM	Transient receptor potential cation channel subfamily M member 7 (TRPM7) is an ion channel/protein kinase belonging to the TRP melastatin and eEF2 kinase families. Under physiological conditions, most native TRPM7 channels are inhibited by cytoplasmic Mg2+, protons, and polyamines. Currents through these channels (I-TRPM7) are robustly potentiated when the cell interior is exchanged with low Mg2+-containing buffers. I-TRPM7 is also potentiated by phosphatidyl inositol bisphosphate (PI(4,5)P-2) and suppressed by its hydrolysis. Here we characterized internal Mg2+- and pH-mediated inhibition of TRPM7 channels in HEK293 cells overexpressing WT voltage-sensing phospholipid phosphatase (VSP) or its catalytically inactive variant VSP-C363S. VSP-mediated depletion of membrane phosphoinositides significantly increased channel sensitivity to Mg2+ and pH. Proton concentrations that were too low to inhibit I-TRPM7 when the VSP-C363S variant was expressed (pH 8.2) became inhibitory in WT VSP-expressing cells. At pH 6.5, protons inhibited I-TRPM7 both in WT and VSP C363S-expressing cells but with a faster time course in the WT VSP-expressing cells. Inhibition by 150 m Mg2+ was also significantly faster in the WT VSP-expressing cells. Cellular PI(4,5)P-2 depletion increased the sensitivity of TRPM7 channels to the inhibitor 2-aminoethyl diphenyl borinate, which acidifies the cytosol. Single substitutions at Ser-1107 of TRPM7, reducing its sensitivity to Mg2+, also decreased its inhibition by spermine and acidic pH. Furthermore, these channel variants were markedly less sensitive to VSP-mediated PI(4,5)P-2 depletion than the WT. We conclude that the internal Mg2+-, polyamine-, and pH-mediated inhibition of TRPM7 channels is not direct but, rather, reflects electrostatic screening and resultant disruption of PI(4,5)P-2-channel interactions.	[Zhelay, Tetyana; Wieczerzak, Krystyna B.; Beesetty, Pavani; Kozak, J. Ashot] Wright State Univ, Dept Neurosci Cell Biol & Physiol, Biol Sci Bldg 2,Rm 251, Dayton, OH 45435 USA; [Alter, Gerald M.] Wright State Univ, Dept Biochem & Mol Biol, Dayton, OH 45435 USA; [Matsushita, Masayuki] Univ Ryukyus, Grad Sch Med, Dept Mol & Cellular Physiol, Nishihara, Okinawa 9030215, Japan	University System of Ohio; Wright State University Dayton; University System of Ohio; Wright State University Dayton; University of the Ryukyus	Kozak, JA (corresponding author), Wright State Univ, Dept Neurosci Cell Biol & Physiol, Biol Sci Bldg 2,Rm 251, Dayton, OH 45435 USA.	juliusz.kozak@wright.edu			NIAID, National Institutes of Health [1R15AI090613, 1R01AI114804]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI090613, R01AI114804] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIAID, National Institutes of Health grants 1R15AI090613 and 1R01AI114804 (to J.A.K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Babai N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008602; Badheka D, 2015, J GEN PHYSIOL, V146, P65, DOI 10.1085/jgp.201411336; Ballester LY, 2007, CHANNELS, V1, P209, DOI 10.4161/chan.4770; Brandao K, 2013, IMMUNOL RES, V55, P261, DOI 10.1007/s12026-012-8371-x; Cabezas-Bratesco D, 2015, CURR MED CHEM, V22, P2943, DOI 10.2174/0929867322666150716115644; Cai N, 2017, SCI REP-UK, V7, DOI 10.1038/srep42739; Chaigne-Delalande B, 2014, TRENDS IMMUNOL, V35, P332, DOI 10.1016/j.it.2014.05.001; Chokshi R, 2012, CHANNELS, V6, P362, DOI 10.4161/chan.21628; Chokshi R, 2012, AM J PHYSIOL-CELL PH, V302, pC1642, DOI 10.1152/ajpcell.00037.2012; Chokshi R, 2012, AM J PHYSIOL-CELL PH, V302, pC1004, DOI 10.1152/ajpcell.00422.2011; CHOTHIA C, 1976, J MOL BIOL, V105, P1, DOI 10.1016/0022-2836(76)90191-1; Chubanov Vladimir, 2014, Cells, V3, P1089, DOI 10.3390/cells3041089; Demeuse P, 2006, J GEN PHYSIOL, V127, P421, DOI 10.1085/jgp.200509410; Du XO, 2004, J BIOL CHEM, V279, P37271, DOI 10.1074/jbc.M403413200; Fliegert R, 2007, FEBS J, V274, P704, DOI 10.1111/j.1742-4658.2006.05614.x; Grubbs RD, 2002, BIOMETALS, V15, P251, DOI 10.1023/A:1016026831789; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gwanyanya A, 2006, AM J PHYSIOL-CELL PH, V291, pC627, DOI 10.1152/ajpcell.00074.2006; Halaszovich CR, 2009, J BIOL CHEM, V284, P2106, DOI 10.1074/jbc.M803543200; Hilgemann DW, 1997, ANNU REV PHYSIOL, V59, P193, DOI 10.1146/annurev.physiol.59.1.193; Hille B, 2015, BBA-MOL CELL BIOL L, V1851, P844, DOI 10.1016/j.bbalip.2014.09.010; Hofmann T, 2014, PFLUG ARCH EUR J PHY, V466, P2177, DOI 10.1007/s00424-014-1488-0; Hossain MI, 2008, J BIOL CHEM, V283, P18248, DOI 10.1074/jbc.M706184200; Hsu K, 2010, BIOPHYS J, V99, P1718, DOI 10.1016/j.bpj.2010.07.027; Inoue H, 2014, FREE RADICAL BIO MED, V72, P257, DOI 10.1016/j.freeradbiomed.2014.04.015; Iwasaki H, 2008, P NATL ACAD SCI USA, V105, P7970, DOI 10.1073/pnas.0803936105; Jiang XP, 2003, J BIOL CHEM, V278, P42867, DOI 10.1074/jbc.M304487200; Kaitsuka T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05718; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kerschbaum HH, 2003, BIOPHYS J, V84, P2293, DOI 10.1016/S0006-3495(03)75035-8; Kim TY, 2012, BIOCHEM BIOPH RES CO, V417, P1030, DOI 10.1016/j.bbrc.2011.12.085; Kozak JA, 2005, J GEN PHYSIOL, V126, P499, DOI 10.1085/jgp.200509324; Kozak JA, 2003, BIOPHYS J, V84, P922, DOI 10.1016/S0006-3495(03)74909-1; Kozak JA, 2002, J GEN PHYSIOL, V120, P221, DOI 10.1085/jgp.20028601; Kunert-Keil C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-159; Lee J, 2005, J GEN PHYSIOL, V126, P439, DOI 10.1085/jgp.200509314; Li MJ, 2007, J BIOL CHEM, V282, P25817, DOI 10.1074/jbc.M608972200; Lindner M, 2011, J PHYSIOL-LONDON, V589, P3149, DOI 10.1113/jphysiol.2011.208983; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; Macianskiene R, 2008, CELL PHYSIOL BIOCHEM, V22, P109, DOI 10.1159/000149788; Marius P, 2008, BIOPHYS J, V94, P1689, DOI 10.1529/biophysj.107.117507; Matsushita M, 2005, J BIOL CHEM, V280, P20793, DOI 10.1074/jbc.M413671200; Mezulis S, 2016, J MOL BIOL, V428, P702, DOI 10.1016/j.jmb.2015.10.017; Middelbeek J, 2010, CELL MOL LIFE SCI, V67, P875, DOI 10.1007/s00018-009-0215-z; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Murata Y, 2007, J PHYSIOL-LONDON, V583, P875, DOI 10.1113/jphysiol.2007.134775; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Nilius B, 2007, BIOCHEM SOC T, V35, P105, DOI 10.1042/BST0350105; Prakriya M, 2002, J GEN PHYSIOL, V119, P487, DOI 10.1085/jgp.20028551; Qin X, 2013, BRIT J PHARMACOL, V168, P1294, DOI 10.1111/bph.12012; RAE J, 1991, J NEUROSCI METH, V37, P15, DOI 10.1016/0165-0270(91)90017-T; Rjasanow A, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00127; Romagnani A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01960-z; Runnels LW, 2011, CURR PHARM BIOTECHNO, V12, P42; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; Sakata S, 2014, J PHYSIOL-LONDON, V592, P899, DOI 10.1113/jphysiol.2013.263640; Sakata S, 2011, J PHYSIOL-LONDON, V589, P2687, DOI 10.1113/jphysiol.2011.208165; Saleem F, 2009, BRIT J PHARMACOL, V156, P143, DOI 10.1111/j.1476-5381.2008.00011.x; Schmitz C, 2003, CELL, V114, P191, DOI 10.1016/S0092-8674(03)00556-7; Shyng SL, 2000, J GEN PHYSIOL, V116, P599, DOI 10.1085/jgp.116.5.599; Srivastava J, 2007, PHYSIOLOGY, V22, P30, DOI 10.1152/physiol.00035.2006; Suh BC, 2007, J GEN PHYSIOL, V130, P241, DOI 10.1085/jgp.200709821; Takezawa R, 2004, P NATL ACAD SCI USA, V101, P6009, DOI 10.1073/pnas.0307565101; Thomas Philip, 2005, Journal of Pharmacological and Toxicological Methods, V51, P187, DOI 10.1016/j.vascn.2004.08.014; Visser D, 2014, EUR J CELL BIOL, V93, P455, DOI 10.1016/j.ejcb.2014.07.001; Wang YH, 2014, CHEM PHYS LIPIDS, V182, P38, DOI 10.1016/j.chemphyslip.2014.01.001; Xie J, 2011, SCI REP-UK, V1, DOI 10.1038/srep00146; Yamaguchi H, 2001, MOL CELL, V7, P1047, DOI 10.1016/S1097-2765(01)00256-8; Yee Nelson S, 2014, Cells, V3, P751, DOI 10.3390/cells3030751; Yogi A, 2009, AM J PHYSIOL-REG I, V296, pR201, DOI 10.1152/ajpregu.90602.2008; Zakharian E, 2011, FASEB J, V25, P3915, DOI 10.1096/fj.11-184630; Zamyatnin A A, 1972, Prog Biophys Mol Biol, V24, P107, DOI 10.1016/0079-6107(72)90005-3; Zhang YH, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0282-4; Zhang Z, 2014, J BIOL CHEM, V289, P5217, DOI 10.1074/jbc.M113.512285; Zheng J, 2013, COMPR PHYSIOL, V3, P221, DOI 10.1002/cphy.c120001; Zierler S, 2016, J PHYSIOL-LONDON, V594, P2957, DOI 10.1113/JP271564	76	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2018	293	47					18151	18167		10.1074/jbc.RA118.004066	http://dx.doi.org/10.1074/jbc.RA118.004066			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8XM	30305398	Green Published, hybrid			2022-12-28	WOS:000451375200011
J	Miikkulainen, P; Hogel, H; Seyednasrollah, F; Rantanen, K; Elo, LL; Jaakkola, PM				Miikkulainen, Petra; Hogel, Heidi; Seyednasrollah, Fatemeh; Rantanen, Krista; Elo, Laura L.; Jaakkola, Panu M.			Hypoxia-inducible factor (HIF)-prolyl hydroxylase 3 (PHD3) maintains high HIF2A mRNA levels in clear cell renal cell carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer; cancer biology; hypoxia; hypoxia-inducible factor (HIF); mRNA decay; ccRCC; Egl-9 family hypoxia-inducible factor 3 (EGLN3); post-transcriptional regulation; prolyl hydroxylase PHD3; renal cell carcinoma	PROLYL HYDROXYLASES; GENE-EXPRESSION; TRANSCRIPTION; HIF-1-ALPHA; PROTEIN; TRANSLATION; PROTEASOME; STABILITY; CANCER; HIF-1	Most clear cell renal cell carcinomas (ccRCCs) have inactivation of the von Hippel-Lindau tumor suppressor protein (pVHL), resulting in the accumulation of hypoxia-inducible factor -subunits (HIF-) and their downstream targets. HIF-2 expression is particularly high in ccRCC and is associated with increased ccRCC growth and aggressiveness. In the canonical HIF signaling pathway, HIF-prolyl hydroxylase 3 (PHD3) suppresses HIF-2 protein by post-translational hydroxylation under sufficient oxygen availability. Here, using immunoblotting and immunofluorescence staining, qRT-PCR, and siRNA-mediated gene silencing, we show that unlike in the canonical pathway, PHD3 silencing in ccRCC cells leads to down-regulation of HIF-2 protein and mRNA. Depletion of other PHD family members had no effect on HIF-2 expression, and PHD3 knockdown in non-RCC cells resulted in the expected increase in HIF-2 protein expression. Accordingly, PHD3 knockdown decreased HIF-2 target gene expression in ccRCC cells and expression was restored upon forced HIF-2 expression. The effect of PHD3 depletion was pinpointed to HIF2A mRNA stability. In line with these in vitro results, a strong positive correlation of PHD3 and HIF2A mRNA expression in ccRCC tumors was detected. Our results suggest that in contrast to the known negative regulation of HIF-2 in most cell types, high PHD3 expression in ccRCC cells maintains elevated HIF-2 expression and that of its target genes, which may enhance kidney cancer aggressiveness.	[Miikkulainen, Petra; Hogel, Heidi; Seyednasrollah, Fatemeh; Rantanen, Krista; Elo, Laura L.; Jaakkola, Panu M.] Univ Turku, Turku Ctr Biotechnol, Tykistokatu 6, FIN-20520 Turku, Finland; [Miikkulainen, Petra; Hogel, Heidi; Seyednasrollah, Fatemeh; Rantanen, Krista; Elo, Laura L.; Jaakkola, Panu M.] Abo Akad Univ, Tykistokatu 6, FIN-20520 Turku, Finland; [Miikkulainen, Petra; Hogel, Heidi; Jaakkola, Panu M.] Univ Turku, Fac Med, Dept Med Biochem, Kiinamyllynkatu 10, FIN-20520 Turku, Finland; [Seyednasrollah, Fatemeh] Univ Turku, Dept Math & Stat, Vesilinnantie 5, FIN-20520 Turku, Finland; [Jaakkola, Panu M.] Univ Helsinki, Helsinki Univ Hosp Canc Ctr, Haartmaninkatu 4, FIN-00290 Helsinki, Finland; [Jaakkola, Panu M.] Univ Helsinki, Dept Oncol, Haartmaninkatu 4, FIN-00290 Helsinki, Finland; [Hogel, Heidi] Univ Turku, Turku PET Ctr, Kiinamyllynkatu 4-8, FIN-20520 Turku, Finland; [Hogel, Heidi] Turku Univ Hosp, Kiinamyllynkatu 4-8, FIN-20520 Turku, Finland	University of Turku; Abo Akademi University; University of Turku; University of Turku; University of Helsinki; University of Helsinki; University of Turku; University of Turku	Jaakkola, PM (corresponding author), Univ Turku, Turku Ctr Biotechnol, Tykistokatu 6, FIN-20520 Turku, Finland.; Jaakkola, PM (corresponding author), Abo Akad Univ, Tykistokatu 6, FIN-20520 Turku, Finland.; Jaakkola, PM (corresponding author), Univ Turku, Fac Med, Dept Med Biochem, Kiinamyllynkatu 10, FIN-20520 Turku, Finland.; Jaakkola, PM (corresponding author), Univ Helsinki, Helsinki Univ Hosp Canc Ctr, Haartmaninkatu 4, FIN-00290 Helsinki, Finland.; Jaakkola, PM (corresponding author), Univ Helsinki, Dept Oncol, Haartmaninkatu 4, FIN-00290 Helsinki, Finland.	panjaa@utu.fi	Jaakkola, Panu M/B-4355-2012; Högel, Heidi/A-1814-2019; Elo, Laura/A-9449-2015	Högel, Heidi/0000-0001-6592-5723; Elo, Laura/0000-0001-5648-4532; Jaakkola, Panu/0000-0002-2365-4985	Cancer Foundation Finland; Sigrid Juselius Foundation; Turku University Hospital [EVO1303]; Helsinki University Hospital; University of Turku Graduate School; Finnish Cultural Foundation Varsinais-Suomi Regional fund	Cancer Foundation Finland; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Turku University Hospital; Helsinki University Hospital; University of Turku Graduate School; Finnish Cultural Foundation Varsinais-Suomi Regional fund(Finnish Cultural Foundation)	This work was supported by Cancer Foundation Finland (to P. M. and P. M. J.), The Sigrid Juselius Foundation (to P. M. J.), Turku University Hospital (EVO1303) (to P. M., H. H. and P. M. J.), Helsinki University Hospital (to P. M. and P. M. J.), The University of Turku Graduate School (to P. M.), and Finnish Cultural Foundation Varsinais-Suomi Regional fund (to P. M.). The authors declare that they have no conflicts of interest with the contents of this article. This article contains Figs. S1-S4 and Table S1.	Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Aprelikova O, 2004, J CELL BIOCHEM, V92, P491, DOI 10.1002/jcb.20067; Bento CF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015062; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bremm A, 2014, EMBO REP, V15, P1268, DOI 10.15252/embr.201438850; Courtney KD, 2018, J CLIN ONCOL, V36, P867, DOI 10.1200/JCO.2017.74.2627; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Cui XG, 2017, ONCOTARGET, V8, P24840, DOI 10.18632/oncotarget.15266; D'Angelo G, 2003, J BIOL CHEM, V278, P38183, DOI 10.1074/jbc.M302244200; del Peso L, 2003, J BIOL CHEM, V278, P48690, DOI 10.1074/jbc.M308862200; Demidenko ZN, 2005, ONCOGENE, V24, P4829, DOI 10.1038/sj.onc.1208636; Fu LP, 2015, MOL CANCER RES, V13, P870, DOI 10.1158/1541-7786.MCR-14-0423; Galban S, 2008, MOL CELL BIOL, V28, P93, DOI 10.1128/MCB.00973-07; Gonzalez-Flores A, 2014, ONCOGENE, V33, P891, DOI 10.1038/onc.2013.9; Gordan JD, 2008, CANCER CELL, V14, P435, DOI 10.1016/j.ccr.2008.10.016; Henze AT, 2010, CANCER RES, V70, P357, DOI 10.1158/0008-5472.CAN-09-1876; Hogel H, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0410-5; Hogel H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027112; Hubbi ME, 2013, J BIOL CHEM, V288, P10703, DOI 10.1074/jbc.M112.414771; Ivan M, 2017, MOL CELL, V66, P772, DOI 10.1016/j.molcel.2017.06.002; Jaakkola PM, 2013, BIOL CHEM, V394, P449, DOI 10.1515/hsz-2012-0330; Jewell UR, 2001, FASEB J, V15, P1312, DOI 10.1096/fj.00-0732fje; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; KOELLER DM, 1991, P NATL ACAD SCI USA, V88, P7778, DOI 10.1073/pnas.88.17.7778; Kong XG, 2007, J BIOL CHEM, V282, P15498, DOI 10.1074/jbc.M700704200; Li LJ, 2011, HEMATOL ONCOL CLIN N, V25, P667, DOI 10.1016/j.hoc.2011.04.004; Liu XD, 2015, ONCOGENE, V34, P2450, DOI 10.1038/onc.2014.199; Mandriota SJ, 2002, CANCER CELL, V1, P459, DOI 10.1016/S1535-6108(02)00071-5; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Miikkulainen P, 2017, CANCER METAB, V5, DOI 10.1186/s40170-017-0167-y; Minton DR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120649; Mohlin S, 2015, CANCER RES, V75, P4617, DOI 10.1158/0008-5472.CAN-15-0708; Moniz S, 2015, J CELL SCI, V128, P3082, DOI 10.1242/jcs.168864; Nayak BK, 2013, ONCOGENE, V32, P3147, DOI 10.1038/onc.2012.333; Newton R, 1997, FEBS LETT, V418, P135, DOI 10.1016/S0014-5793(97)01362-8; OHH M, 1995, J CELL BIOCHEM, V59, P202, DOI 10.1002/jcb.240590210; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sala MA, 2018, J BIOL CHEM, V293, P271, DOI 10.1074/jbc.RA117.000440; Sato E, 2008, CLIN CANCER RES, V14, P6916, DOI 10.1158/1078-0432.CCR-08-0466; Schepens B, 2005, NUCLEIC ACIDS RES, V33, P6884, DOI 10.1093/nar/gki1000; Schodel J, 2016, EUR UROL, V69, P646, DOI 10.1016/j.eururo.2015.08.007; Semenza GL, 2007, J BIOENERG BIOMEMBR, V39, P231, DOI 10.1007/s10863-007-9081-2; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Shen C, 2011, CANCER DISCOV, V1, P222, DOI 10.1158/2159-8290.CD-11-0098; Tanaka T, 2011, J CANCER RES CLIN, V137, P789, DOI 10.1007/s00432-010-0940-6; Turner KJ, 2002, CANCER RES, V62, P2957; Xue J, 2010, GASTROENTEROLOGY, V138, P606, DOI 10.1053/j.gastro.2009.09.049; Yao TT, 2012, SEMIN CELL DEV BIOL, V23, P523, DOI 10.1016/j.semcdb.2012.02.006	50	15	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3760	3771		10.1074/jbc.RA118.004902	http://dx.doi.org/10.1074/jbc.RA118.004902			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30617181	Green Published, hybrid			2022-12-28	WOS:000461853900036
J	Delbecq, SP; Klevit, RE				Delbecq, Scott P.; Klevit, Rachel E.			HSPB5 engages multiple states of a destabilized client to enhance chaperone activity in a stress-dependent manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						small heat shock protein (sHSP); protein aggregation; molecular chaperone; crystallin; stress response; unfolded protein response (UPR); -lactalbumin; B-crystallin; client binding; HSPB5; wHsp16; 9	ALPHA-B-CRYSTALLIN; HEAT-SHOCK-PROTEIN; MOLECULAR CHAPERONE; MOLTEN GLOBULE; PHOSPHORYLATION; SUBSTRATE; POLYDISPERSITY; ACTIVATION; MECHANISM; MUTATION	Small heat shock proteins (sHSPs) delay protein aggregation in an ATP-independent manner by interacting with client proteins that are in states susceptible to aggregation, including destabilized states related to cellular stress. Up-regulation of sHSPs under stress conditions supports their critical role in cellular viability. Widespread distribution of sHSPs in most organisms implies conservation of function, but it remains unclear whether sHSPs implement common or distinct mechanisms to delay protein aggregation. Comparisons among various studies are confounded by the use of different model client proteins, different assays for both aggregation and sHSP/client interactions, and variable experimental conditions used to mimic cellular stress. To further define sHSP/client interactions and their relevance to sHSP chaperone function, we implemented multiple strategies to characterize sHSP interactions with -lactalbumin, a model client whose aggregation pathway is well defined. We compared the chaperone activity of human B-crystallin (HSPB5) with HSPB5 variants that mimic states that arise under conditions of cellular stress or disease. The results show that these closely related sHSPs vary not only in their activity under identical conditions but also in their interactions with clients. Importantly, under nonstress conditions, WT HSPB5 delays client aggregation solely through transient interactions early in the aggregation pathway, whereas HSPB5 mutants that mimic stress-activated conditions can also intervene at later stages of the aggregation pathway to further delay client protein aggregation.	[Delbecq, Scott P.; Klevit, Rachel E.] Univ Washington, Dept Biochem, Box 357350, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Klevit, RE (corresponding author), Univ Washington, Dept Biochem, Box 357350, Seattle, WA 98195 USA.	klevit@uw.edu	Klevit, Rachel/AAI-7038-2021	Klevit, Rachel/0000-0002-3476-969X	NEI, National Institutes of Health [5R01 EY017370]; NIGMS, National Institutes of Health [2T32 GM008268]; NATIONAL EYE INSTITUTE [R01EY017370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008268] Funding Source: NIH RePORTER	NEI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NEI, National Institutes of Health Grant 5R01 EY017370. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by NIGMS, National Institutes of Health 2T32 GM008268.	Aquilina JA, 2003, P NATL ACAD SCI USA, V100, P10611, DOI 10.1073/pnas.1932958100; Baldwin AJ, 2011, J MOL BIOL, V413, P297, DOI 10.1016/j.jmb.2011.07.016; Basha E, 2006, J BIOL CHEM, V281, P39943, DOI 10.1074/jbc.M607677200; Bjorkdahl C, 2008, J NEUROSCI RES, V86, P1343, DOI 10.1002/jnr.21589; Bova MP, 1999, P NATL ACAD SCI USA, V96, P6137, DOI 10.1073/pnas.96.11.6137; Bumagina ZM, 2010, BIOPHYS CHEM, V146, P108, DOI 10.1016/j.bpc.2009.11.002; Cheng GL, 2008, J BIOL CHEM, V283, P26634, DOI 10.1074/jbc.M802946200; Clouser AF, 2017, CELL STRESS CHAPERON, V22, P569, DOI 10.1007/s12192-017-0783-z; de Thonel A, 2012, INT J BIOCHEM CELL B, V44, P1593, DOI 10.1016/j.biocel.2012.06.012; Delbecq SP, 2015, BIOCHEMISTRY-US, V54, P4276, DOI 10.1021/acs.biochem.5b00490; Delbecq SP, 2012, EMBO J, V31, P4587, DOI 10.1038/emboj.2012.318; Ecroyd H, 2007, BIOCHEM J, V401, P129, DOI 10.1042/BJ20060981; Fleckenstein T, 2015, MOL CELL, V58, P1067, DOI 10.1016/j.molcel.2015.04.019; Gast K, 1998, PROTEIN SCI, V7, P2004, DOI 10.1002/pro.5560070917; Goldstein LE, 2003, LANCET, V361, P1258, DOI 10.1016/S0140-6736(03)12981-9; Haley DA, 1998, J MOL BIOL, V277, P27, DOI 10.1006/jmbi.1997.1611; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Ito K, 2001, J BIOL CHEM, V276, P5346, DOI 10.1074/jbc.M009004200; Jehle S, 2010, NAT STRUCT MOL BIOL, V17, P1037, DOI 10.1038/nsmb.1891; Kato K, 2001, J NEUROCHEM, V76, P730, DOI 10.1046/j.1471-4159.2001.00038.x; Koteiche HA, 2003, J BIOL CHEM, V278, P10361, DOI 10.1074/jbc.M211851200; Laskowska E, 2010, CURR PHARM BIOTECHNO, V11, P146, DOI 10.2174/138920110790909669; Lee GJ, 1998, METHOD ENZYMOL, V290, P350, DOI 10.1016/S0076-6879(98)90031-3; Lee GJ, 1997, EMBO J, V16, P659, DOI 10.1093/emboj/16.3.659; Lindner RA, 1997, J BIOL CHEM, V272, P27722, DOI 10.1074/jbc.272.44.27722; Moreau KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037256; Mymrikov EV, 2017, J BIOL CHEM, V292, P672, DOI 10.1074/jbc.M116.760413; Nefedova VV, 2015, BIOCHEMISTRY-MOSCOW+, V80, P1734, DOI 10.1134/S000629791513009X; Pasta SY, 2004, MOL VIS, V10, P655; Rajagopal P, 2015, ELIFE, V4, DOI 10.7554/eLife.07304; Taylor RP, 2005, J MOL CELL CARDIOL, V38, P433, DOI 10.1016/j.yjmcc.2004.12.014; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; Velotta JB, 2011, ANN THORAC SURG, V91, P1907, DOI 10.1016/j.athoracsur.2011.02.072; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765	34	7	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2019	294	9					3261	3270		10.1074/jbc.RA118.003156	http://dx.doi.org/10.1074/jbc.RA118.003156			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU0SA	30567736	Green Published, hybrid			2022-12-28	WOS:000464980100023
J	Ryan, P; Forrester, TJB; Wroblewski, C; Kenney, TMG; Kitova, EN; Klassen, JS; Kimber, MS				Ryan, Patrick; Forrester, Taylor J. B.; Wroblewski, Charles; Kenney, Tristan M. G.; Kitova, Elena N.; Klassen, John S.; Kimber, Matthew S.			The small RbcS-like domains of the beta-carboxysome structural protein CcmM bind RubisCO at a site distinct from that binding the RbcS subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ribulose-1,5-bisphosphate carboxylase/oxygenase (RubisCO); carboxysome; cyanobacteria; protein complex; carbon fixation; crystal structure; photosynthesis; protein-protein interaction; CcmM	SYNECHOCOCCUS PCC7942 REVEALS; GAMMA-CARBONIC ANHYDRASE; BACTERIAL MICROCOMPARTMENT; CRYSTAL-STRUCTURES; SHELL; CONSERVATION; EVOLUTION; FIXATION; FORMS	Carboxysomes are compartments in bacterial cells that promote efficient carbon fixation by sequestering RubisCO and carbonic anhydrase within a protein shell that impedes CO2 escape. The key to assembling this protein complex is CcmM, a multidomain protein whose C-terminal region is required for RubisCO recruitment. This CcmM region is built as a series of copies (generally 3-5) of a small domain, CcmM(S), joined by unstructured linkers. CcmM(S) domains have weak, but significant, sequence identity to RubisCO's small subunit, RbcS, suggesting that CcmM binds RubisCO by displacing RbcS. We report here the 1.35-A structure of the first Thermosynechococcus elongatus CcmM(S) domain, revealing that it adopts a compact, well-defined structure that resembles that of RbcS. CcmM(S), however, lacked key RbcS RubisCO-binding determinants, most notably an extended N-terminal loop. Nevertheless, individual CcmM(S) domains are able to bind RubisCO in vitro with 1.16 mu m affinity. Two or four linked CcmM(S) domains did not exhibit dramatic increases in this affinity, implying that short, disordered linkers may frustrate successive CcmM(S) domains attempting to simultaneously bind a single RubisCO oligomer. Size-exclusion chromatography-coupled right-angled light scattering (SEC-RALS) and native MS experiments indicated that multiple CcmM(S) domains can bind a single RubisCO holoenzyme and, moreover, that RbcS is not released from these complexes. CcmM(S) bound equally tightly to a RubisCO variant in which the alpha/beta domain of RbcS was deleted, suggesting that CcmM(S) binds RubisCO independently of its RbcS subunit. We propose that, instead, the electropositive CcmM(S) may bind to an extended electronegative pocket between RbcL dimers.	[Ryan, Patrick; Forrester, Taylor J. B.; Wroblewski, Charles; Kenney, Tristan M. G.; Kimber, Matthew S.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Kitova, Elena N.; Klassen, John S.] Univ Alberta, Alberta Glyc Ctr, Edmonton, AB T6G 2G2, Canada; [Kitova, Elena N.; Klassen, John S.] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada	University of Guelph; University of Alberta; University of Alberta	Kimber, MS (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	mkimber@uoguelph.ca	Kimber, Matthew/Q-8144-2019; Ryan, Patrick/HDO-1133-2022	Klassen, John/0000-0002-3389-7112; Forrester, Taylor/0000-0002-5609-1453; Kimber, Matthew/0000-0001-9454-5586	Natural Sciences and Engineering Research Council of Canada (NSERC) [04045-2015]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Natural Sciences and Engineering Research Council of Canada (NSERC) Grant 04045-2015 (to M. S. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Andersson I, 2008, PLANT PHYSIOL BIOCH, V46, P275, DOI 10.1016/j.plaphy.2008.01.001; Bathellier C, 2018, PLANT CELL ENVIRON, V41, P705, DOI 10.1111/pce.13149; Cai F, 2013, J BIOL CHEM, V288, P16055, DOI 10.1074/jbc.M113.456897; Cameron JC, 2013, CELL, V155, P1131, DOI 10.1016/j.cell.2013.10.044; Chen AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056551; Cot SSW, 2008, J BACTERIOL, V190, P936, DOI 10.1128/JB.01283-07; de Araujo C, 2014, PHOTOSYNTH RES, V121, P135, DOI 10.1007/s11120-014-0018-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Espie GS, 2011, PHOTOSYNTH RES, V109, P7, DOI 10.1007/s11120-011-9656-y; Fang Y, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00739; FUKUZAWA H, 1992, P NATL ACAD SCI USA, V89, P4437, DOI 10.1073/pnas.89.10.4437; Hayer-Hartl M, 2017, PROTEIN SCI, V26, P2324, DOI 10.1002/pro.3309; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaneko Y, 2006, J BACTERIOL, V188, P805, DOI 10.1128/JB.188.2.805-808.2006; Keeling TJ, 2014, PHOTOSYNTH RES, V121, P125, DOI 10.1007/s11120-014-9973-z; Kerfeld CA, 2005, SCIENCE, V309, P936, DOI 10.1126/science.1113397; Kerfeld CA, 2016, CURR OPIN PLANT BIOL, V31, P66, DOI 10.1016/j.pbi.2016.03.009; Kimber MS, 2014, SUBCELL BIOCHEM, V75, P89, DOI 10.1007/978-94-007-7359-2_6; Kinney JN, 2012, J BIOL CHEM, V287, P17729, DOI 10.1074/jbc.M112.355305; Kostov RV, 1997, PHOTOSYNTH RES, V54, P127, DOI 10.1023/A:1005967106993; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Larsson AM, 2017, J EXP BOT, V68, P3857, DOI 10.1093/jxb/erx070; Long BM, 2007, J BIOL CHEM, V282, P29323, DOI 10.1074/jbc.M703896200; Long BM, 2011, PHOTOSYNTH RES, V109, P33, DOI 10.1007/s11120-011-9659-8; Long BM, 2010, PLANT PHYSIOL, V153, P285, DOI 10.1104/pp.110.154948; Mahinthichaichan P, 2018, J PHYS CHEM B, V122, P9110, DOI 10.1021/acs.jpcb.8b06822; McGurn LD, 2016, BIOCHEM J, V473, P4559, DOI 10.1042/BCJ20160773; Niederhuber MJ, 2017, MOL BIOL CELL, V28, P2734, DOI 10.1091/mbc.E17-01-0069; Pena KL, 2010, P NATL ACAD SCI USA, V107, P2455, DOI 10.1073/pnas.0910866107; Price GD, 2011, PHOTOSYNTH RES, V109, P47, DOI 10.1007/s11120-010-9608-y; PRICE GD, 1993, J BACTERIOL, V175, P2871, DOI 10.1128/JB.175.10.2871-2879.1993; Rae BD, 2017, J EXP BOT, V68, P3717, DOI 10.1093/jxb/erx133; Rae BD, 2013, MICROBIOL MOL BIOL R, V77, P357, DOI 10.1128/MMBR.00061-12; Rae BD, 2013, J MOL MICROB BIOTECH, V23, P300, DOI 10.1159/000351342; Rae BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043871; Samborska B, 2012, STRUCTURE, V20, P1353, DOI 10.1016/j.str.2012.05.013; Spreitzer RJ, 2003, ARCH BIOCHEM BIOPHYS, V414, P141, DOI 10.1016/S0003-9861(03)00171-1; Sutter M, 2017, SCIENCE, V356, P1293, DOI 10.1126/science.aan3289; Sutter M, 2013, PHOTOSYNTH RES, V118, P9, DOI 10.1007/s11120-013-9909-z; Tanaka S, 2008, SCIENCE, V319, P1083, DOI 10.1126/science.1151458; Tanaka S, 2009, PROTEIN SCI, V18, P108, DOI 10.1002/pro.14	43	28	29	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2593	2603		10.1074/jbc.RA118.006330	http://dx.doi.org/10.1074/jbc.RA118.006330			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30591587	Green Published, hybrid			2022-12-28	WOS:000459601600002
J	Yin, L; Harwood, CS				Yin, Liang; Harwood, Caroline S.			Functional divergence of annotated l-isoaspartate O-methyltransferases in an alpha-proteobacterium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacteria; bacterial metabolism; bioinformatics; enzyme catalysis; enzyme kinetics; enzyme purification; bacterial longevity; methyltransferase; protein damage; protein repair; Rhodopseudomonas palustris	PROTEIN REPAIR METHYLTRANSFERASE; SWISS-MODEL; CARBOXYL METHYLTRANSFERASE; STRESS-SURVIVAL; ACCUMULATION; DEAMIDATION; SEQUENCE; ASPARTYL; OVEREXPRESSION; ASPARAGINYL	Spontaneous formation of isoaspartates (isoDs) often causes protein damage. l-Isoaspartate O-methyltransferase (PIMT) repairs isoD residues by catalyzing the formation of an unstable l-isoaspartyl methyl ester that spontaneously converts to an l-aspartyl residue. PIMTs are widely distributed in all three domains of life and have been studied most intensively in connection with their role in protein repair and aging in plants and animals. Studies of bacterial PIMTs have been limited to Escherichia coli, which has one PIMT. The alpha-proteobacterium Rhodopseudomonas palustris has three annotated PIMT genes, one of which (rpa2580) has been found to be important for cellular longevity in a growth-arrested state. However, the biochemical activities of these three R. palustris PIMTs are unknown. Here, we expressed and characterized all three annotated PIMT proteins, finding that two of them, RPA0376 and RPA2838, had PIMT activity, whereas RPA2580 did not. RPA0376 and RPA2838 single- and double-deletion mutants did not differ in longevity from WT R. palustris and did not exhibit elevated levels of isoD residues in aged cells. Comparative sequence analyses revealed that RPA2580 belongs to a separate phylogenetic group of annotated PIMT proteins present in the alpha-proteobacteria. Our results suggest that this group of proteins is not involved in repair of protein isoD residues. In addition, the bona fide bacterial PIMT enzymes may play a different or subtler role in bacterial physiology than previously suggested.	[Yin, Liang; Harwood, Caroline S.] Univ Washington, Dept Microbiol, HSB K-340B,1705 NE Pacific St, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Harwood, CS (corresponding author), Univ Washington, Dept Microbiol, HSB K-340B,1705 NE Pacific St, Seattle, WA 98195 USA.	csh5@uw.edu	Yin, Liang/H-8171-2013	Yin, Liang/0000-0001-6957-6903; Harwood, Caroline/0000-0003-4450-5177	U.S. Army Research Office (ARO) [W911NF-15-1-0150]	U.S. Army Research Office (ARO)	This work was supported by Grant W911NF-15-1-0150 from the U.S. Army Research Office (ARO). The authors declare that they have no conflicts of interest with the contents of this article.	Bennett EJ, 2003, BIOCHEMISTRY-US, V42, P12844, DOI 10.1021/bi034891+; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; BRENNAN TV, 1994, J BIOL CHEM, V269, P24586; Chavous DA, 2001, P NATL ACAD SCI USA, V98, P14814, DOI 10.1073/pnas.251446498; Doyle HA, 2003, J IMMUNOL, V171, P2840, DOI 10.4049/jimmunol.171.6.2840; Fixen KR, 2014, P NATL ACAD SCI USA, V111, pE237, DOI 10.1073/pnas.1322410111; FU JC, 1991, J BIOL CHEM, V266, P14562; GALLETTI P, 1988, BIOCHEMISTRY-US, V27, P1752, DOI 10.1021/bi00405a055; GEIGER T, 1987, J BIOL CHEM, V262, P785; Gerlt JA, 2015, BBA-PROTEINS PROTEOM, V1854, P1019, DOI 10.1016/j.bbapap.2015.04.015; Griffith SC, 2001, J MOL BIOL, V313, P1103, DOI 10.1006/jmbi.2001.5095; Grigoriev IV, 2012, NUCLEIC ACIDS RES, V40, pD26, DOI 10.1093/nar/gkr947; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Halliday NM, 2010, ANAL BIOCHEM, V403, P20, DOI 10.1016/j.ab.2010.04.021; Hicks WM, 2005, MICROBIOL-SGM, V151, P2151, DOI 10.1099/mic.0.27835-0; JOHNSON BA, 1987, J BIOL CHEM, V262, P12283; Kagan RM, 1997, ARCH BIOCHEM BIOPHYS, V348, P320, DOI 10.1006/abbi.1997.0362; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kim E, 1997, P NATL ACAD SCI USA, V94, P6132, DOI 10.1073/pnas.94.12.6132; Kindrachuk J, 2003, J BIOL CHEM, V278, P50880, DOI 10.1074/jbc.M308423200; Kumar GNM, 1999, PLANT PHYSIOL, V119, P89, DOI 10.1104/pp.119.1.89; Larimer FW, 2004, NAT BIOTECHNOL, V22, P55, DOI 10.1038/nbt923; LOWENSON JD, 1991, J BIOL CHEM, V266, P19396; Markowitz VM, 2014, NUCLEIC ACIDS RES, V42, pD568, DOI 10.1093/nar/gkt919; Mudgett MB, 1997, PLANT PHYSIOL, V115, P1481, DOI 10.1104/pp.115.4.1481; Patananan AN, 2014, J BIOL CHEM, V289, P16936, DOI 10.1074/jbc.M114.564385; Pechter KB, 2017, MBIO, V8, DOI 10.1128/mBio.01726-17; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; QUANDT J, 1993, GENE, V127, P15, DOI 10.1016/0378-1119(93)90611-6; Reissner KJ, 2003, CELL MOL LIFE SCI, V60, P1281, DOI 10.1007/s00018-003-2287-5; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; STEPHENSON RC, 1989, J BIOL CHEM, V264, P6164; Szymanska G, 1998, J BIOL CHEM, V273, P28516, DOI 10.1074/jbc.273.43.28516; VandenBerg KE, 2016, APPL ENVIRON MICROB, V82, P5444, DOI 10.1128/AEM.00623-16; Villa ST, 2006, PHYSIOL PLANTARUM, V128, P581, DOI 10.1111/j.1399-3054.2006.00772.x; Visick JE, 1998, FEMS MICROBIOL LETT, V167, P19, DOI 10.1111/j.1574-6968.1998.tb13202.x; Visick JE, 1998, J BACTERIOL, V180, P2623, DOI 10.1128/JB.180.10.2623-2629.1998	38	3	3	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2854	2861		10.1074/jbc.RA118.006546	http://dx.doi.org/10.1074/jbc.RA118.006546			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30578298	hybrid, Green Published			2022-12-28	WOS:000459601600023
J	Reinke, AA; Li, SH; Warnock, M; Shaydakov, ME; Guntaka, NS; Su, EJ; Diaz, JA; Emal, CD; Lawrence, DA				Reinke, Ashley A.; Li, Shih-Hon; Warnock, Mark; Shaydakov, Maxim E.; Guntaka, Naga Sandhya; Su, Enming J.; Diaz, Jose A.; Emal, Cory D.; Lawrence, Daniel A.			Dual-reporter high-throughput screen for small-molecule in vivo inhibitors of plasminogen activator inhibitor type-1 yields a clinical lead candidate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						serpin; high-throughput screening (HTS); small molecule; thrombosis; plasminogen; pharmacokinetics; inhibitor; drug discovery; PAI-1; serpin E1; vitronectin	INSULIN-RESISTANCE; CRYSTAL-STRUCTURE; PAI-1 INHIBITOR; MECHANISM; MICE; HYPERLIPIDEMIA; POLYPHENOLS; OBESITY; ASSAYS; MODEL	Plasminogen activator inhibitor type-1 (PAI-1) is a serine protease inhibitor (serpin) implicated in numerous pathological processes, including coronary heart disease, arterial and venous thrombosis, and chronic fibrotic diseases. These associations have made PAI-1 an attractive pharmaceutical target. However, the complexity of the serpin inhibitory mechanism, the inherent metastability of serpins, and the high-affinity association of PAI-1 with vitronectin in vivo have made it difficult to identify pharmacologically effective small-molecule inhibitors. Moreover, the majority of current small-molecule PAI-1 inhibitors are poor pharmaceutical candidates. To this end and to find leads that can be efficiently applied to in vivo settings, we developed a dual-reporter high-throughput screen (HTS) that reduced the rate of nonspecific and promiscuous hits and identified leads that inhibit human PAI-1 in the high-protein environments present in vivo. Using this system, we screened >152,000 pure compounds and 27,000 natural product extracts (NPEs), reducing the apparent hit rate by almost 10-fold compared with previous screening approaches. Furthermore, screening in a high-protein environment permitted the identification of compounds that retained activity in both ex vivo plasma and in vivo. Following lead identification, subsequent medicinal chemistry and structure-activity relationship (SAR) studies identified a lead clinical candidate, MDI-2268, having excellent pharmacokinetics, potent activity against vitronectin-bound PAI-1 in vivo, and efficacy in a murine model of venous thrombosis. This rigorous HTS approach eliminates promiscuous candidate leads, significantly accelerates the process of identifying PAI-1 inhibitors that can be rapidly deployed in vivo, and has enabled identification of a potent lead compound.	[Reinke, Ashley A.; Warnock, Mark; Su, Enming J.; Lawrence, Daniel A.] Univ Michigan, Dept Internal Med, Div Cardiovasc Med, Ann Arbor, MI 48109 USA; [Li, Shih-Hon] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Shaydakov, Maxim E.; Diaz, Jose A.] Univ Michigan, Dept Surg, Sect Vasc Surg, Ann Arbor, MI 48109 USA; [Guntaka, Naga Sandhya; Emal, Cory D.] Eastern Michigan Univ, Dept Chem, Ypsilanti, MI 48197 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Eastern Michigan University	Lawrence, DA (corresponding author), Univ Michigan, Dept Internal Med, Div Cardiovasc Med, Ann Arbor, MI 48109 USA.	dlawrenc@med.umich.edu	Shaydakov, Maxim/X-4250-2019; Guntaka, Naga Sandhya/I-7671-2019	Guntaka, Naga Sandhya/0000-0002-3753-6277; Lawrence, Daniel/0000-0003-3126-1935; Shaydakov, Maxim/0000-0002-1186-8556; Diaz, MD, Jose Antonio/0000-0001-5205-2118	University of Michigan Cancer Center Grant [G011130]; NHLBI, National Institutes of Health [HL55374, HL089407, T32HL007853]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007853, R01HL055374] Funding Source: NIH RePORTER	University of Michigan Cancer Center Grant; NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by University of Michigan Cancer Center Grant G011130 and NHLBI, National Institutes of Health, Grants HL55374 and HL089407 (to D. A. L.) and T32HL007853 (to A. A. R.). D. A. L., C. D. E., and E. J. S. have an equity interest in MDI Therapeutics, which holds an option to license MDI-2268 from the University of Michigan. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baxi S, 2008, THROMB HAEMOSTASIS, V99, P749, DOI 10.1160/TH07-11-0669; BOOTH NA, 1988, BRIT J HAEMATOL, V70, P327, DOI 10.1111/j.1365-2141.1988.tb02490.x; Bothra A, 1998, J BIOMOL STRUCT DYN, V15, P959, DOI 10.1080/07391102.1998.10508216; Bremer AA, 2013, J OBES, V2013, DOI 10.1155/2013/393192; Cale JM, 2010, J BIOL CHEM, V285, P7892, DOI 10.1074/jbc.M109.067967; Cheng XH, 2003, J BIOMOL SCREEN, V8, P292, DOI 10.1177/1087057103008003007; Diaz JA, 2012, J VASC SURG, V55, P815, DOI 10.1016/j.jvs.2011.08.038; Egelund R, 2001, J BIOL CHEM, V276, P13077, DOI 10.1074/jbc.M009024200; Eitzman DT, 1996, J CLIN INVEST, V97, P232, DOI 10.1172/JCI118396; Eitzman DT, 2000, BLOOD, V95, P577, DOI 10.1182/blood.V95.2.577; Eren M, 2014, P NATL ACAD SCI USA, V111, P7090, DOI 10.1073/pnas.1321942111; Eschelbach JW, 2011, J BIOMOL SCREEN, V16, P1112, DOI 10.1177/1087057111416237; Flevaris P, 2017, SEMIN THROMB HEMOST, V43, P169, DOI 10.1055/s-0036-1586228; Ghosh AK, 2012, J CELL PHYSIOL, V227, P493, DOI 10.1002/jcp.22783; Gorlatova NV, 2007, J BIOL CHEM, V282, P9288, DOI 10.1074/jbc.M611642200; Grant SK, 2002, J BIOMOL SCREEN, V7, P531, DOI 10.1177/1087057102238627; Henrich CJ, 2013, NAT PROD REP, V30, P1284, DOI 10.1039/c3np70052f; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; Izuhara Y, 2008, ARTERIOSCL THROM VAS, V28, P672, DOI 10.1161/ATVBAHA.107.157479; Izuhara Y, 2010, J CEREBR BLOOD F MET, V30, P904, DOI 10.1038/jcbfm.2009.272; Khan SS, 2017, SCI ADV, V3, DOI 10.1126/sciadv.aao1617; Latruffe N, 2014, MOLECULES, V19, P17066, DOI 10.3390/molecules191117066; Li SH, 2013, P NATL ACAD SCI USA, V110, pE4941, DOI 10.1073/pnas.1216499110; Li SH, 2011, METHOD ENZYMOL, V501, P177, DOI 10.1016/B978-0-12-385950-1.00009-2; Liang A, 2005, THROMB RES, V115, P341, DOI 10.1016/j.thromres.2004.09.021; LOTTENBERG R, 1983, BIOCHIM BIOPHYS ACTA, V742, P558, DOI 10.1016/0167-4838(83)90273-X; Lucking AJ, 2010, J THROMB HAEMOST, V8, P1333, DOI 10.1111/j.1538-7836.2010.03872.x; Ma LJ, 2004, DIABETES, V53, P336, DOI 10.2337/diabetes.53.2.336; Miyata Y, 2010, J BIOMOL SCREEN, V15, P1211, DOI 10.1177/1087057110380571; Palmer OR, 2018, RES PRACT THROMB HAE, V2, P266, DOI 10.1002/rth2.12074; Pautus S, 2016, SCI REP-UK, V6, DOI 10.1038/srep36462; Piao L, 2016, BRIT J PHARMACOL, V173, P2622, DOI 10.1111/bph.13541; Placencio VR, 2015, CANCER RES, V75, P2969, DOI 10.1158/0008-5472.CAN-15-0876; Rouch A, 2015, EUR J MED CHEM, V92, P619, DOI 10.1016/j.ejmech.2015.01.010; SAIFUKU K, 1978, CLIN CHIM ACTA, V84, P85; Schafer K, 2001, FASEB J, V15, P1840, DOI 10.1096/fj.00-0750fje; Simeonov A, 2008, J MED CHEM, V51, P2363, DOI 10.1021/jm701301m; Soares S, 2007, J AGR FOOD CHEM, V55, P6726, DOI 10.1021/jf070905x; Sobel BE, 2003, ARTERIOSCL THROM VAS, V23, P1979, DOI 10.1161/01.ATV.0000091250.53231.4D; Tamura Y, 2014, ENDOCRINOLOGY, V155, P1708, DOI 10.1210/en.2013-1888; Wu Qingyu, 2002, Current Drug Targets - Cardiovascular and Haematological Disorders, V2, P27, DOI 10.2174/1568006023337727; Xue YF, 1998, STRUCT FOLD DES, V6, P627, DOI 10.1016/S0969-2126(98)00064-1; Yamaoka N, 2018, BIOORG MED CHEM LETT, V28, P809, DOI 10.1016/j.bmcl.2017.11.016; Ye B, 2003, BIOORG MED CHEM LETT, V13, P3361, DOI 10.1016/S0960-894X(03)00686-3; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zuck P, 2005, ANAL BIOCHEM, V342, P254, DOI 10.1016/j.ab.2005.04.029	46	6	6	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2019	294	5					1464	1477		10.1074/jbc.RA118.004885	http://dx.doi.org/10.1074/jbc.RA118.004885			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GC	30510136	Green Published, hybrid			2022-12-28	WOS:000457879200003
J	Yi, XN; Verbeke, EJ; Chang, YR; Dickinson, DJ; Taylor, DW				Yi, Xiunan; Verbeke, Eric J.; Chang, Yiran; Dickinson, Daniel J.; Taylor, David W.			Electron microscopy snapshots of single particles from single cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cryo-electron microscopy; ribosome; proteasome; single-particle analysis; Caenorhabditis elegans (C. elegans)	CRYOELECTRON MICROSCOPY	Cryo-electron microscopy (cryo-EM) has become an indispensable tool for structural studies of biological macromolecules. Two additional predominant methods are available for studying the architectures of multiprotein complexes: 1) single-particle analysis of purified samples and 2) tomography of whole cells or cell sections. The former can produce high-resolution structures but is limited to highly purified samples, whereas the latter can capture proteins in their native state but has a low signal-to-noise ratio and yields lower-resolution structures. Here, we present a simple, adaptable method combining microfluidic single-cell extraction with single-particle analysis by EM to characterize protein complexes from individual Caenorhabditis elegans embryos. Using this approach, we uncover 3D structures of ribosomes directly from single embryo extracts. Moreover, we investigated structural dynamics during development by counting the number of ribosomes per polysome in early and late embryos. This approach has significant potential applications for counting protein complexes and studying protein architectures from single cells in developmental, evolutionary, and disease contexts.	[Yi, Xiunan; Verbeke, Eric J.; Chang, Yiran; Dickinson, Daniel J.; Taylor, David W.] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; [Yi, Xiunan; Verbeke, Eric J.; Chang, Yiran; Dickinson, Daniel J.; Taylor, David W.] Univ Texas Austin, Ctr Syst & Synthet Biol, Austin, TX 78712 USA; [Yi, Xiunan; Verbeke, Eric J.; Chang, Yiran; Dickinson, Daniel J.; Taylor, David W.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Taylor, David W.] Dell Med Sch, LIVESTRONG Canc Inst, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Dickinson, DJ; Taylor, DW (corresponding author), Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA.	daniel.dickinson@austin.utexas.edu; dtaylor@utexas.edu		Chang, Yiran/0000-0001-8306-4402; Taylor, David/0000-0002-6198-1194	Welch Foundation [F-1938]; NIH [R00 GM115964]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM115964] Funding Source: NIH RePORTER	Welch Foundation(The Welch Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by a Welch Foundation Grant F-1938 (to D. W. T.) and NIH R00 GM115964 (D. J. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Afonina ZA, 2013, BIOCHEMISTRY-MOSCOW+, V78, P445, DOI 10.1134/S0006297913050027; Arnold SA, 2017, J STRUCT BIOL, V197, P220, DOI 10.1016/j.jsb.2016.11.002; Beck M, 2016, TRENDS CELL BIOL, V26, P825, DOI 10.1016/j.tcb.2016.08.006; Brandt F, 2009, CELL, V136, P261, DOI 10.1016/j.cell.2008.11.016; Cianfrocco MA, 2015, ELIFE, V4, DOI 10.7554/eLife.06664; Dickinson AJ, 2013, ANAL CHEM, V85, P4797, DOI 10.1021/ac4005887; Dickinson DJ, 2017, DEV CELL, V42, P416, DOI 10.1016/j.devcel.2017.07.024; EDGAR LG, 1994, DEVELOPMENT, V120, P443; Galaz-Montoya Jesus G, 2017, Biophys Rep, V3, P17, DOI 10.1007/s41048-017-0040-0; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Hillier LW, 2009, GENOME RES, V19, P657, DOI 10.1101/gr.088112.108; Huang B, 2007, SCIENCE, V315, P81, DOI 10.1126/science.1133992; Kastritis PL, 2017, MOL SYST BIOL, V13, DOI 10.15252/msb.20167412; Kemmerling S, 2013, J STRUCT BIOL, V183, P467, DOI 10.1016/j.jsb.2013.06.012; Kovarik ML, 2011, TRENDS BIOTECHNOL, V29, P222, DOI 10.1016/j.tibtech.2011.01.003; Kuhlbrandt W, 2014, SCIENCE, V343, P1443, DOI 10.1126/science.1251652; Kumar P, 2017, DEVELOPMENT, V144, P17, DOI 10.1242/dev.133058; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Malyutin AG, 2017, EMBO J, V36, P854, DOI 10.15252/embj.201696012; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Roseman AM, 2004, J STRUCT BIOL, V145, P91, DOI 10.1016/j.jsb.2003.11.007; Scaiola A, 2018, EMBO J, V37, DOI 10.15252/embj.201798499; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schorb M, 2014, ULTRAMICROSCOPY, V143, P24, DOI 10.1016/j.ultramic.2013.10.015; SEYDOUX G, 1994, DEVELOPMENT, V120, P2823; Shaw D, 2008, J MOL BIOL, V383, P885, DOI 10.1016/j.jmb.2008.08.086; Shen PS, 2015, SCIENCE, V347, P75, DOI 10.1126/science.1259724; Slavov N, 2015, CELL REP, V13, P865, DOI 10.1016/j.celrep.2015.09.056; Sone T, 2004, J BIOL CHEM, V279, P28807, DOI 10.1074/jbc.M403165200; Verbeke EJ, 2018, CELL REP, V24, P259, DOI 10.1016/j.celrep.2018.06.022; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Zhan Xuanzhi, 2015, Curr Protoc Pharmacol, V68, DOI 10.1002/0471141755.ph0212s68	33	10	10	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2019	294	5					1602	1608		10.1074/jbc.RA118.006686	http://dx.doi.org/10.1074/jbc.RA118.006686			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GC	30541924	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000457879200015
J	Mizoi, J; Kanazawa, N; Kidokoro, S; Takahashi, F; Qin, F; Morimoto, K; Shinozaki, K; Yamaguchi-Shinozaki, K				Mizoi, Junya; Kanazawa, Natsumi; Kidokoro, Satoshi; Takahashi, Fuminori; Qin, Feng; Morimoto, Kyoko; Shinozaki, Kazuo; Yamaguchi-Shinozaki, Kazuko			Heat-induced inhibition of phosphorylation of the stress-protective transcription factor DREB2A promotes thermotolerance of Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						plant molecular biology; transcription factor; protein degradation; post-translational modification; protein phosphorylation; abiotic stress response; drought tolerance; thermotolerance	CASEIN KINASE-I; ABIOTIC STRESS; PROTEINS FUNCTION; BINDING DOMAIN; ABSCISIC-ACID; MAP KINASE; E3 LIGASE; GENE; DROUGHT; EXPRESSION	Plants have evolved complex systems to rapidly respond to severe stress conditions, such as heat, cold, and dehydration. Dehydration-responsive element-binding protein 2A (DREB2A) is a key transcriptional activator that induces many heat- and drought-responsive genes, increases tolerance to both heat and drought stress, and suppresses plant growth in Arabidopsis thaliana. DREB2A expression is induced by stress, but stabilization of the DREB2A protein in response to stress is essential for activating the expression of downstream stress-inducible genes. Under nonstress growth conditions, an integral negative regulatory domain (NRD) destabilizes DREB2A, but the mechanism by which DREB2A is stabilized in response to stress remains unclear. Here, based on bioinformatics, mutational, MS, and biochemical analyses, we report that Ser/Thr residues in the NRD are phosphorylated under nonstress growth conditions and that their phosphorylation decreases in response to heat. Furthermore, we found that this phosphorylation is likely mediated by casein kinase 1 and is essential for the NRD-dependent, proteasomal degradation of DREB2A under nonstress conditions. These observations suggest that inhibition of NRD phosphorylation stabilizes and activates DREB2A in response to heat stress to enhance plant thermotolerance. Our study reveals the molecular basis for the coordination of stress tolerance and plant growth through stress-dependent transcriptional regulation, which may allow the plants to rapidly respond to fluctuating environmental conditions.	[Mizoi, Junya; Kanazawa, Natsumi; Kidokoro, Satoshi; Morimoto, Kyoko; Yamaguchi-Shinozaki, Kazuko] Univ Tokyo, Grad Sch Agr & Life Sci, Lab Plant Mol Physiol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan; [Takahashi, Fuminori; Shinozaki, Kazuo] RIKEN Ctr Sustainable Resource Sci, Gene Discovery Res Grp, Yokohama, Kanagawa 2300045, Japan; [Qin, Feng] Japan Int Res Ctr Agr Sci, Biol Resources & Postharvest Div, Tsukuba, Ibaraki 3058686, Japan; [Qin, Feng] Chinese Acad Sci, Inst Bot, Key Lab Plant Mol Physiol, Beijing 100093, Peoples R China; [Morimoto, Kyoko] Univ Oxford, Dept Plant Sci, Plant Chemet Lab, South Parks Rd, Oxford OX1 3RB, England	University of Tokyo; RIKEN; Japan International Research Center for Agricultural Sciences; Chinese Academy of Sciences; Institute of Botany, CAS; University of Oxford	Yamaguchi-Shinozaki, K (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Lab Plant Mol Physiol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	akys@mail.ecc.u-tokyo.ac.jp	Takahashi, Fuminori/D-6200-2017; Shinozaki, Kazuo/AAB-4945-2019; Mizoi, Junya/Y-6261-2019; Yamaguchi-Shinozaki, Kazuko/K-9004-2015; Shinozaki, Kazuo/G-4202-2013	Takahashi, Fuminori/0000-0001-8817-8652; Shinozaki, Kazuo/0000-0002-6317-9867; Mizoi, Junya/0000-0002-3383-8059; Yamaguchi-Shinozaki, Kazuko/0000-0002-0249-8258; Shinozaki, Kazuo/0000-0002-6317-9867; Qin, Feng/0000-0001-9134-4711	JSPS KAKENHI [JP21780314, JP15K18652, JP15H05960]; Program for the Promotion of Basic Research Activities for Innovative Biosciences (BRAIN) of Japan	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Program for the Promotion of Basic Research Activities for Innovative Biosciences (BRAIN) of Japan	This work was financially supported through JSPS KAKENHI Grant Numbers JP21780314, JP15K18652 (to J.M.) and JP15H05960 (to K.Y.-S) and the Program for the Promotion of Basic Research Activities for Innovative Biosciences (BRAIN) of Japan (to K.S. and K.Y.-S.). The authors declare that they have no conflicts of interest with the contents of this article.	ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Badura L, 2007, J PHARMACOL EXP THER, V322, P730, DOI 10.1124/jpet.107.122846; Ben-Nissan G, 2008, PLANT PHYSIOL, V148, P1897, DOI 10.1104/pp.108.129346; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Chen LY, 2015, MOL PLANT, V8, P242, DOI 10.1016/j.molp.2014.10.004; Chen LY, 2013, PLANT CELL, V25, P2253, DOI 10.1105/tpc.112.107292; Claeys H, 2013, PLANT PHYSIOL, V162, P1768, DOI 10.1104/pp.113.220921; Dai C, 2010, EMBO J, V29, P1916, DOI 10.1038/emboj.2010.75; Davuluri RV, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-25; De Rybel B, 2009, CHEM BIOL, V16, P594, DOI 10.1016/j.chembiol.2009.04.008; GALLIE DR, 1987, NUCLEIC ACIDS RES, V15, P3257, DOI 10.1093/nar/15.8.3257; Garcia-Alai MM, 2006, STRUCTURE, V14, P309, DOI 10.1016/j.str.2005.11.012; Guan QM, 2014, PLANT CELL, V26, P438, DOI 10.1105/tpc.113.118927; Hori K, 2013, PLANT J, V76, P36, DOI 10.1111/tpj.12268; Inobe T, 2011, NAT CHEM BIOL, V7, P161, DOI 10.1038/NCHEMBIO.521; Kidokoro S, 2009, PLANT PHYSIOL, V151, P2046, DOI 10.1104/pp.109.147033; Kim JS, 2012, PLANT CELL, V24, P3393, DOI 10.1105/tpc.112.100933; Kim JS, 2011, PLANT CELL PHYSIOL, V52, P2136, DOI 10.1093/pcp/pcr143; Kinoshita E, 2011, PROTEOMICS, V11, P319, DOI 10.1002/pmic.201000472; KLIMCZAK LJ, 1995, PLANT PHYSIOL, V109, P687, DOI 10.1104/pp.109.2.687; Knippschild U, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00096; Kuromori T, 2015, MOL BIOL, V4, P1, DOI [10.1007/2F978-1-4939-0263-7_7-1, DOI 10.1007/2F978-1-4939-0263-7_7-1]; Kwon CT, 2014, PLANT CELL ENVIRON, V37, P101, DOI 10.1111/pce.12134; Lechner E, 2011, DEV CELL, V21, P1116, DOI 10.1016/j.devcel.2011.10.018; Lee JY, 2005, PLANT CELL, V17, P2817, DOI 10.1105/tpc.105.034330; Li Z, 2012, NEW PHYTOL, V195, P85, DOI 10.1111/j.1469-8137.2012.04131.x; Link V, 2002, FEBS LETT, V531, P179, DOI 10.1016/S0014-5793(02)03498-1; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Mittler R, 2006, TRENDS PLANT SCI, V11, P15, DOI 10.1016/j.tplants.2005.11.002; Mizoi J, 2013, PLANT PHYSIOL, V161, P346, DOI 10.1104/pp.112.204875; Mogami J, 2015, PLANT PHYSIOL, V167, P1039, DOI 10.1104/pp.114.249870; Morimoto K, 2017, P NATL ACAD SCI USA, V114, pE8528, DOI 10.1073/pnas.1704189114; Morimoto K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080457; Ohama N, 2017, TRENDS PLANT SCI, V22, P53, DOI 10.1016/j.tplants.2016.08.015; Ohama N, 2016, PLANT CELL, V28, P181, DOI 10.1105/tpc.15.00435; Park HJ, 2008, J BIOL CHEM, V283, P23264, DOI 10.1074/jbc.M801720200; Penrose KJ, 2004, J BIOL CHEM, V279, P22430, DOI 10.1074/jbc.M314340200; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Qin F, 2008, PLANT CELL, V20, P1693, DOI 10.1105/tpc.107.057380; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; ROACH PJ, 1991, J BIOL CHEM, V266, P14139; Sakuma Y, 2006, PLANT CELL, V18, P1292, DOI 10.1105/tpc.105.035881; Sakuma Y, 2006, P NATL ACAD SCI USA, V103, P18822, DOI 10.1073/pnas.0605639103; Sangwan V, 2002, PLANT J, V31, P629, DOI 10.1046/j.1365-313X.2002.01384.x; SCHARF KD, 1982, CELL, V30, P427, DOI 10.1016/0092-8674(82)90240-9; Tan ST, 2014, CELL REP, V9, P1692, DOI 10.1016/j.celrep.2014.10.047; Tan ST, 2013, PLANT CELL, V25, P2618, DOI 10.1105/tpc.113.114322; Tanaka H, 2012, PLANT J, V70, P599, DOI 10.1111/j.1365-313X.2012.04901.x; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Turck F, 1998, MOL CELL BIOL, V18, P2038, DOI 10.1128/MCB.18.4.2038; Venerando A, 2014, BIOCHEM J, V460, P141, DOI 10.1042/BJ20140178; Wang Z, 2015, P NATL ACAD SCI USA, V112, P8487, DOI 10.1073/pnas.1423325112; Weber H, 2009, FEBS J, V276, P6624, DOI 10.1111/j.1742-4658.2009.07373.x; Wu AH, 2012, PLANT CELL, V24, P482, DOI 10.1105/tpc.111.090894; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251; Yaron A, 1998, NATURE, V396, P590, DOI 10.1038/25159; Yoshida T, 2011, MOL GENET GENOMICS, V286, P321, DOI 10.1007/s00438-011-0647-7; Zandalinas SI, 2018, PHYSIOL PLANTARUM, V162, P2, DOI 10.1111/ppl.12540; Zhao SS, 2016, PLANT CELL, V28, P1422, DOI 10.1105/tpc.16.00078; Zhu JK, 2016, CELL, V167, P313, DOI 10.1016/j.cell.2016.08.029	61	36	41	5	51	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2019	294	3					902	917		10.1074/jbc.RA118.002662	http://dx.doi.org/10.1074/jbc.RA118.002662			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL4FC	30487287	Green Published, hybrid			2022-12-28	WOS:000458670200016
J	Zhong, YD; Huang, W; Du, J; Wang, ZK; He, JB; Luo, LF				Zhong, Yadong; Huang, Wei; Du, Jiang; Wang, Zekun; He, Jianbo; Luo, Lingfei			Improved Tol2-mediated enhancer trap identifies weakly expressed genes during liver and beta cell development and regeneration in zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						zebrafish; liver; pancreas; development; regeneration; Cre/loxP; endoderm; enhancer trap; gene expression profiling; transposon; pancreatic beta cell	IN-VIVO; PANCREAS; CONVERSION; ORGANOGENESIS; ABLATION; DISEASE; GENOME; MODEL; RAB3D; TOOL	The liver and pancreas are two major digestive organs, and among the different cell types in them, hepatocytes and the insulin-producing beta cells have roles in both health and diseases. Accordingly, clinicians and researchers are very interested in the mechanisms underlying the development and regeneration of liver and pancreatic beta cells. Gene and enhancer traps such as the Tol2 transposon-based system are useful for identifying genes potentially involved in developmental processes in the zebrafish model. Here, we developed a strategy that combines a Tol2-mediated enhancer trap and the Cre/loxP system by using loxP-flanked reporters driven by beta cell- or hepatocyte-specific promoters and the upstream activating sequence (UAS)-driving Cre. Two double-transgenic reporter lines, Tg(ins:loxP-CFPNTR-loxP-DsRed; 10xUAS:Cre, cryaa:Venus) and Tg(fabp10:loxP-CFPNTR-loxP-DsRed; 10xUAS:Cre, cryaa:Venus), were established to label pancreatic beta cells and hepatocytes, respectively. These two double-transgenic lines were each crossed with the Tol2-enhancer trap founder lines to screen for and identify genes expressed in the beta cell and hepatocytes during development. This trap system coupled with application of nitroreductase (NTR)/metronidazole (Mtz)-mediated cell ablation could identify genes expressed during regeneration. Of note, pilot enhancer traps captured transiently and weakly expressed genes such as rab3da and ensab with higher efficiencies than traditional enhancer trap systems. In conclusion, through permanent genetic labeling by Cre/loxP, this improved Tol2-mediated enhancer trap system provides a promising method to identify transiently or weakly expressed, but potentially important, genes during development and regeneration.	[Zhong, Yadong; Huang, Wei; Du, Jiang; Wang, Zekun; He, Jianbo; Luo, Lingfei] Southwest Univ, Minist Educ, Key Lab Freshwater Fish Reprod & Dev, Chongqing 400715, Peoples R China; [Zhong, Yadong; Huang, Wei; Du, Jiang; Wang, Zekun; He, Jianbo; Luo, Lingfei] Southwest Univ, Lab Mol Dev Biol, Sch Life Sci, Chongqing 400715, Peoples R China	Southwest University - China; Southwest University - China	Luo, LF (corresponding author), Southwest Univ, Minist Educ, Key Lab Freshwater Fish Reprod & Dev, Chongqing 400715, Peoples R China.; Luo, LF (corresponding author), Southwest Univ, Lab Mol Dev Biol, Sch Life Sci, Chongqing 400715, Peoples R China.	lluo@swu.edu.cn		Huang, Wei/0000-0003-4882-1409; Du, Jiang/0000-0001-8041-1405	National Key Basic Research Program of China [2015CB942800]; National Natural Science Foundation of China [31730060, 31801214, 91539201]; National Key Research and Development Program of China [2017YFA0106600]; 111 Program [B14037]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; 111 Program(Ministry of Education, China - 111 Project)	This work was supported by National Key Basic Research Program of China Grant 2015CB942800; National Natural Science Foundation of China Grants 31730060, 31801214, and 91539201; National Key Research and Development Program of China Grant 2017YFA0106600; and 111 Program Grant B14037. The authors declare that they have no conflicts of interest with the contents of this article.	Andreeva V, 2011, GENESIS, V49, P360, DOI 10.1002/dvg.20712; Asakawa K, 2008, P NATL ACAD SCI USA, V105, P1255, DOI 10.1073/pnas.0704963105; Chen XQ, 2003, J BIOL CHEM, V278, P50053, DOI 10.1074/jbc.M309910200; Chepelev I, 2012, CELL RES, V22, P490, DOI 10.1038/cr.2012.15; Chera S, 2014, NATURE, V514, P503, DOI 10.1038/nature13633; Choi TY, 2014, GASTROENTEROLOGY, V146, P776, DOI 10.1053/j.gastro.2013.10.019; Chu J, 2009, HEPATOLOGY, V50, P1656, DOI 10.1002/hep.23157; Curado S, 2008, NAT PROTOC, V3, P948, DOI 10.1038/nprot.2008.58; Curado S, 2007, DEV DYNAM, V236, P1025, DOI 10.1002/dvdy.21100; Dhawan A, 2010, NAT REV GASTRO HEPAT, V7, P288, DOI 10.1038/nrgastro.2010.44; Dong PDS, 2007, NAT GENET, V39, P397, DOI 10.1038/ng1961; Edlund H, 2002, NAT REV GENET, V3, P524, DOI 10.1038/nrg841; Fujita H, 2002, J BIOL CHEM, V277, P45428, DOI 10.1074/jbc.M208090200; Gale EAM, 2001, DIABETES, V50, P217, DOI 10.2337/diabetes.50.2.217; Gharbi-Ayachi A, 2010, SCIENCE, V330, P1673, DOI 10.1126/science.1197048; Goessling W, 2015, GASTROENTEROLOGY, V149, P1361, DOI 10.1053/j.gastro.2015.08.034; Grise F, 2012, HEPATOLOGY, V55, P1766, DOI 10.1002/hep.25568; He JB, 2014, GASTROENTEROLOGY, V146, P789, DOI 10.1053/j.gastro.2013.11.045; Heng JIT, 2008, NATURE, V455, P114, DOI 10.1038/nature07198; Her GM, 2003, FEBS LETT, V538, P125, DOI 10.1016/S0014-5793(03)00157-1; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Huang HG, 2001, MOL CELL ENDOCRINOL, V177, P117, DOI 10.1016/S0303-7207(01)00408-7; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; Kim HJ, 2006, MOL ENDOCRINOL, V20, P194, DOI 10.1210/me.2005-0189; Kimmel RA, 2016, METHOD CELL BIOL, V134, P431, DOI 10.1016/bs.mcb.2016.02.009; Kogel T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057321; Li JJ, 2011, DEV CELL, V20, P409, DOI 10.1016/j.devcel.2011.04.001; Liu C, 2016, IMMUNITY, V44, P1162, DOI 10.1016/j.immuni.2016.03.008; Lu HQ, 2013, DEV CELL, V24, P543, DOI 10.1016/j.devcel.2013.01.021; Malhi H, 2006, HEPATOLOGY, V43, pS31, DOI 10.1002/hep.21062; Mochida S, 2010, SCIENCE, V330, P1670, DOI 10.1126/science.1195689; Ober EA, 2006, NATURE, V442, P688, DOI 10.1038/nature04888; Okada T, 2015, NAT CELL BIOL, V17, P81, DOI 10.1038/ncb3082; Picardi A, 2006, DIABETES-METAB RES, V22, P274, DOI 10.1002/dmrr.636; Poon KL, 2010, DEV DYNAM, V239, P914, DOI 10.1002/dvdy.22203; Riedel D, 2002, MOL CELL BIOL, V22, P6487, DOI 10.1128/MCB.22.18.6487-6497.2002; Scott EK, 2007, NAT METHODS, V4, P323, DOI 10.1038/NMETH1033; Shi WC, 2015, SCI CHINA LIFE SCI, V58, P343, DOI 10.1007/s11427-015-4838-z; Shih HP, 2013, ANNU REV CELL DEV BI, V29, P81, DOI 10.1146/annurev-cellbio-101512-122405; Tang YC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091551; Tao T, 2009, J GENET GENOMICS, V36, P325, DOI 10.1016/S1673-8527(08)60121-6; Tehrani Z, 2011, CELL CYCLE, V10, P3466, DOI 10.4161/cc.10.20.17764; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Zorn AM, 2009, ANNU REV CELL DEV BI, V25, P221, DOI 10.1146/annurev.cellbio.042308.113344	45	5	6	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2019	294	3					932	940		10.1074/jbc.RA118.005568	http://dx.doi.org/10.1074/jbc.RA118.005568			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL4FC	30504219	Green Published, hybrid			2022-12-28	WOS:000458670200018
J	Roder, K; Kabakov, A; Moshal, KS; Murphy, KR; Xie, A; Dudley, S; Turan, NN; Lu, YC; MacRae, CA; Koren, G				Roder, Karim; Kabakov, Anatoli; Moshal, Karni S.; Murphy, Kevin R.; Xie, An; Dudley, Samuel; Turan, Niluefer N.; Lu, Yichun; MacRae, Calum A.; Koren, Gideon			Trafficking of the human ether-a-go-go-related gene (hERG) potassium channel is regulated by the ubiquitin ligase rififylin (RFFL)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hERG; ubiquitin ligase; ubiquitin; single-nucleotide polymorphism (SNP); trafficking; endoplasmic-reticulum-associated protein degradation (ERAD); protein degradation; ubiquitylation (ubiquitination); action potential duration; heart disease; QT interval; RFFL; ventricular arrhythmia	QT INTERVAL DURATION; QUALITY-CONTROL; RING FINGER; COMMON VARIANTS; ENCODE PROJECT; DEGRADATION; PROTEINS; ASSOCIATION; EXPRESSION; DEATH	The QT interval is an important diagnostic feature on surface electrocardiograms because it reflects the duration of the ventricular action potential. A previous genome-wide association study has reported a significant linkage between a single-nucleotide polymorphism approximate to 11.7 kb downstream of the gene encoding the RING finger ubiquitin ligase rififylin (RFFL) and variability in the QT interval. This, along with results in animal studies, suggests that RFFL may have effects on cardiac repolarization. Here, we sought to determine the role of RFFL in cardiac electrophysiology. Adult rabbit cardiomyocytes with adenovirus-expressed RFFL exhibited reduced rapid delayed rectifier current (I-Kr). Neonatal rabbit cardiomyocytes transduced with RFFL-expressing adenovirus exhibited reduced total expression of the potassium channel ether-a-go-go-related gene (rbERG). Using transfections of 293A cells and Western blotting experiments, we observed that RFFL and the core-glycosylated form of the human ether-a-go-go-related gene (hERG) potassium channel interact. Furthermore, RFFL overexpression led to increased polyubiquitination and proteasomal degradation of hERG protein and to an almost complete disappearance of I-Kr, which depended on the intact RING domain of RFFL. Blocking the ER-associated degradation (ERAD) pathway with a dominant-negative form of the ERAD core component, valosin-containing protein (VCP), in 293A cells partially abolished RFFL-mediated hERG degradation. We further substantiated the link between RFFL and ERAD by showing an interaction between RFFL and VCP in vitro. We conclude that RFFL is an important regulator of voltage-gated hERG potassium channel activity and therefore cardiac repolarization and that this ubiquitination-mediated regulation requires parts of the ERAD pathway.	[Roder, Karim; Kabakov, Anatoli; Moshal, Karni S.; Murphy, Kevin R.; Turan, Niluefer N.; Lu, Yichun; Koren, Gideon] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Dept Med,Div Cardiol,Cardiovasc Res Ctr, Providence, RI 02903 USA; [Xie, An; Dudley, Samuel] Univ Minnesota, Dept Med, Cardiovasc Div, Box 736 UMHC, Minneapolis, MN 55455 USA; [MacRae, Calum A.] Harvard Med Sch, Cardiovasc Div, Brigham & Womens Hosp, Boston, MA 02115 USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Koren, G (corresponding author), Brown Univ, Warren Alpert Med Sch, Rhode Isl Hosp, 1 Hoppin St, Providence, RI 02903 USA.	gideon_koren@brown.edu	Dudley, Samuel C/A-7085-2009; Dudley, Samuel/AAR-7950-2021; Koren, Gideon/AAG-7726-2019	Dudley, Samuel/0000-0001-5843-5961; Koren, Gideon/0000-0002-9234-0875; Murphy, Kevin/0000-0003-2791-5801	Common Fund of the Office of the Director of the National Institutes of Health; NCI; National Human Genome Research Institute (NHGRI); NHLBI; NIDA; NIMH; NINDS; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL134706, R01HL110791] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG041688] Funding Source: NIH RePORTER	Common Fund of the Office of the Director of the National Institutes of Health; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are indebted to Drs. Wafik S. El-Deiry (Fox Chase Cancer Center, Department of Hematology/Oncology, Philadelphia, PA) for the RFFL plasmid, Ted Dawson (Johns Hopkins University, Institute for Cell Engineering, Baltimore, MD) for the ubiquitin plasmid, and Nico Dantuma (Karolinska Institutet, Department of Cell and Molecular Biology, Stockholm, Sweden) for the VCP expression plasmids. The data used for the analyses described in this article were obtained (on 10/2/2017) from the GTEx Portal (https://www.gtexportal.org/home/).<SUP>4</SUP> The Genotype-Tissue Expression (GTEx) Project was supported by the Common Fund of the Office of the Director of the National Institutes of Health, and the NCI, National Human Genome Research Institute (NHGRI), NHLBI, NIDA, NIMH, and NINDS.	Akylbekova EL, 2009, CIRC-ARRHYTHMIA ELEC, V2, P427, DOI 10.1161/CIRCEP.109.858894; Apaja PM, 2013, MOL BIOL CELL, V24, P3787, DOI 10.1091/mbc.E13-07-0417; Araki K, 2003, J NEUROCHEM, V86, P749, DOI 10.1046/j.1471-4159.2003.01875.x; Araki Kazutaka, 2012, Cold Spring Harb Perspect Biol, V4, pa015438, DOI 10.1101/cshperspect.a015438; Arking DE, 2014, NAT GENET, V46, P826, DOI 10.1038/ng.3014; Brunner M, 2008, J CLIN INVEST, V118, P2246, DOI 10.1172/JCI33578; Cheng JH, 2004, ACTA PHARMACOL SIN, V25, P137; Christianson JC, 2014, NAT STRUCT MOL BIOL, V21, P325, DOI 10.1038/nsmb.2793; Ciechanover A, 2006, EXP BIOL MED, V231, P1197; Coumailleau F, 2004, MOL BIOL CELL, V15, P4444, DOI 10.1091/mbc.E04-04-0274; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Farnham PJ, 2012, J BIOL CHEM, V287, P30885, DOI 10.1074/jbc.R112.365940; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Fenteany G, 1998, J BIOL CHEM, V273, P8545, DOI 10.1074/jbc.273.15.8545; Foo B, 2016, J PHYSIOL-LONDON, V594, P2469, DOI 10.1113/JP270531; Fry WHD, 2011, MOL CELL BIOL, V31, P3009, DOI 10.1128/MCB.05105-11; Gan XQ, 2012, NAT CELL BIOL, V14, P686, DOI 10.1038/ncb2507; Gopalakrishnan K, 2011, HYPERTENSION, V57, P764, DOI 10.1161/HYPERTENSIONAHA.110.165803; Guo J, 2012, J BIOL CHEM, V287, P33132, DOI 10.1074/jbc.M112.389643; Hantouche C, 2017, J BIOL CHEM, V292, P2287, DOI 10.1074/jbc.M116.752618; HOMEWOOD CA, 1972, NATURE, V235, P50, DOI 10.1038/235050a0; Hong Y, 2001, CLIN GENET, V59, P171, DOI 10.1034/j.1399-0004.2001.590305.x; Iwai C, 2013, CARDIOVASC RES, V100, P520, DOI 10.1093/cvr/cvt200; Kang YD, 2015, BIOCHEM J, V472, P71, DOI 10.1042/BJ20141282; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Li Matthew, 2017, P T, V42, P473; Liao W, 2008, CURR BIOL, V18, P641, DOI 10.1016/j.cub.2008.04.017; Liu F, 2016, P NATL ACAD SCI USA, V113, P4859, DOI 10.1073/pnas.1521577113; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Marjamaa A, 2009, J INTERN MED, V265, P448, DOI 10.1111/j.1365-2796.2008.02026.x; McDonald ER, 2004, P NATL ACAD SCI USA, V101, P6170, DOI 10.1073/pnas.0307459101; Mitchell GF, 1998, AM J PHYSIOL-HEART C, V274, pH747, DOI 10.1152/ajpheart.1998.274.3.H747; Morito D, 2008, MOL BIOL CELL, V19, P1328, DOI 10.1091/mbc.E07-06-0601; Newton-Cheh C, 2005, HEART RHYTHM, V2, P277, DOI 10.1016/j.hrthm.2004.11.009; Newton-Cheh C, 2009, NAT GENET, V41, P399, DOI 10.1038/ng.364; Niwa N, 2010, J MOL CELL CARDIOL, V48, P12, DOI 10.1016/j.yjmcc.2009.07.013; Okiyoneda T, 2018, DEV CELL, V44, P694, DOI 10.1016/j.devcel.2018.02.001; Organ-Darling LE, 2013, AM J PHYSIOL-HEART C, V304, pH589, DOI 10.1152/ajpheart.00385.2012; Pfeufer A, 2009, NAT GENET, V41, P407, DOI 10.1038/ng.362; Rautaharju PM, 2009, J AM COLL CARDIOL, V53, P982, DOI 10.1016/j.jacc.2008.12.014; Ren XQ, 2010, AM J PHYSIOL-HEART C, V299, pH1525, DOI 10.1152/ajpheart.00479.2009; Roder K, 2014, J BIOL CHEM, V289, P33730, DOI 10.1074/jbc.M114.592295; SANGUINETTI MC, 1990, J GEN PHYSIOL, V96, P195, DOI 10.1085/jgp.96.1.195; SEED WA, 1987, BRIT HEART J, V57, P32; Simsek D, 2011, NATURE, V471, P245, DOI 10.1038/nature09794; Thomas DJ, 2007, NUCLEIC ACIDS RES, V35, pD663, DOI 10.1093/nar/gkl1017; TOMASELLI GF, 1994, CIRCULATION, V90, P2534, DOI 10.1161/01.CIR.90.5.2534; Tsubuki S, 1996, J BIOCHEM-TOKYO, V119, P572, DOI 10.1093/oxfordjournals.jbchem.a021280; van Noord C, 2010, BRIT J CLIN PHARMACO, V70, P16, DOI 10.1111/j.1365-2125.2010.03660.x; Walker VE, 2010, J BIOL CHEM, V285, P3319, DOI 10.1074/jbc.M109.024000; Xu HD, 1999, J GEN PHYSIOL, V113, P661, DOI 10.1085/jgp.113.5.661; Yang W, 2008, CELL CYCLE, V7, P670, DOI 10.4161/cc.7.5.5701; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Zheng N, 2017, ANNU REV BIOCHEM, V86, P129, DOI 10.1146/annurev-biochem-060815-014922	55	6	6	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2019	294	1					351	360		10.1074/jbc.RA118.003852	http://dx.doi.org/10.1074/jbc.RA118.003852			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG6PT	30401747	hybrid, Green Published			2022-12-28	WOS:000455105500036
J	Pulugulla, SH; Workman, R; Rutter, NW; Yang, ZY; Adamik, J; Lupish, B; Macar, DA; el Abdouni, S; Esposito, EX; Galson, DL; Camacho, CJ; Madura, JD; Auron, PE				Pulugulla, Sree H.; Workman, Riley; Rutter, Nathan W.; Yang, Zhiyong; Adamik, Juraj; Lupish, Brian; Macar, David A.; el Abdouni, Samir; Esposito, Emilio Xavier; Galson, Deborah L.; Camacho, Carlos J.; Madura, Jeffry D.; Auron, Philip E.			A combined computational and experimental approach reveals the structure of a C/EBP-Spi1 interaction required for IL1B gene transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						interleukin 1 (IL-1); ETS transcription factor family; CCAAT-enhancer-binding protein (C; EBP); gene transcription; protein-protein interaction; molecular docking; molecular dynamics; inflammation; cytokine	CONSERVED ETS DOMAIN; PROTEIN-PROTEIN; INTERLEUKIN-1-BETA GENE; FACTORS NF-IL6; FORCE-FIELD; DNA-BINDING; FACTOR PU.1; WEB SERVER; ACTIVATION; EXPRESSION	We previously reported that transcription of the human IL1B gene, encoding the proinflammatory cytokine interleukin 1, depends on long-distance chromatin looping that is stabilized by a mutual interaction between the DNA-binding domains (DBDs) of two transcription factors: Spi1 proto-oncogene at the promoter and CCAAT enhancer-binding protein (C/EBP) at a far-upstream enhancer. We have also reported that the C-terminal tail sequence beyond the C/EBP leucine zipper is critical for its association with Spi1 via an exposed residue (Arg-232) located within a pocket at one end of the Spi1 DNA-recognition helix. Here, combining in vitro interaction studies with computational docking and molecular dynamics of existing X-ray structures for the Spi1 and C/EBP DBDs, along with the C/EBP C-terminal tail sequence, we found that the tail sequence is intimately associated with Arg-232 of Spi1. The Arg-232 pocket was computationally screened for small-molecule binding aimed at IL1B transcription inhibition, yielding l-arginine, a known anti-inflammatory amino acid, revealing a potential for disrupting the C/EBP-Spi1 interaction. As evaluated by ChIP, cultured lipopolysaccharide (LPS)-activated THP-1 cells incubated with l-arginine had significantly decreased IL1B transcription and reduced C/EBP's association with Spi1 on the IL1B promoter. No significant change was observed in direct binding of either Spi1 or C/EBP to cognate DNA and in transcription of the C/EBP-dependent IL6 gene in the same cells. These results support the notion that disordered sequences extending from a leucine zipper can mediate protein-protein interactions and can serve as druggable targets for regulating gene promoter activity.	[Pulugulla, Sree H.; Lupish, Brian; Macar, David A.; Madura, Jeffry D.; Auron, Philip E.] Duquesne Univ, Dept Biol Sci, Pittsburgh, PA 15282 USA; [Workman, Riley; Rutter, Nathan W.; Madura, Jeffry D.] Duquesne Univ, Dept Chem & Biochem, Pittsburgh, PA 15282 USA; [Yang, Zhiyong] Harvard Med Sch, Dept Med, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Adamik, Juraj; Galson, Deborah L.] Univ Pittsburgh, Dept Med, Hillman Canc Ctr, UPMC, 930 Scaife Hall, Pittsburgh, PA 15213 USA; [el Abdouni, Samir; Camacho, Carlos J.] Univ Pittsburgh, Dept Computat & Syst Biol, Pittsburgh, PA 15260 USA; [Esposito, Emilio Xavier] ExeResearch, E Lansing, MI 48823 USA; [Galson, Deborah L.; Auron, Philip E.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA 15219 USA; [Yang, Zhiyong] Janssen Res & Dev, Cardiovasc & Metab, Boston, MA 02115 USA	Duquesne University; Duquesne University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Auron, PE (corresponding author), Duquesne Univ, Dept Biol Sci, Pittsburgh, PA 15282 USA.	auronp@duq.edu	Galson, Deborah L./E-9370-2010; Pulugulla, Sree/AAV-5319-2021	Galson, Deborah L./0000-0002-2045-8807; Esposito, Emilio Xavier/0000-0002-6193-0485; Pulugulla, Sree/0000-0002-6474-1129	National Science Foundation [CHE1126465, CHE1726824]; Gaussian, Inc. (Wallimabrd, CT); NATIONAL CANCER INSTITUTE [R01CA068544] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R25DA032519] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Gaussian, Inc. (Wallimabrd, CT); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Emily Cribas, Christopher Osburi, Scott Boesch, and Megan Bean for contributions to this work. Duquesne University Center Pr Computational Science and Jeffrey Evanseck are acknowledged for computational facilities. Duquesne University Center Jiff Computational Science is supported by National Science Foundation Grants CHE1126465 and CHE1726824 (to Jeffrey Evanseck) and by funds from Gaussian, Inc. (Wallimabrd, CT).	Adamik J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070622; Baccam M, 2003, J IMMUNOL, V170, P3099, DOI 10.4049/jimmunol.170.6.3099; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Donner AJ, 2010, NAT STRUCT MOL BIOL, V17, P194, DOI 10.1038/nsmb.1752; Edelsbrunner H, 1992, WEIGHTED ALPHA SHAPE, DOI DOI 10.5555/871114; Edelsbrunner H., 1995, P 28 HAW INT C SYST; Everett BM, 2018, J AM COLL CARDIOL, V71, P2392, DOI 10.1016/j.jacc.2018.03.002; Fritz JH, 2013, INFECT IMMUN, V81, P3500, DOI 10.1128/IAI.00789-13; GALSON DL, 1993, MOL CELL BIOL, V13, P2929, DOI 10.1128/MCB.13.5.2929; GERBER PR, 1995, J COMPUT AID MOL DES, V9, P251, DOI 10.1007/BF00124456; GRAY JG, 1993, MOL CELL BIOL, V13, P6678, DOI 10.1128/MCB.13.11.6678; HAGEMEIER C, 1993, P NATL ACAD SCI USA, V90, P1580, DOI 10.1073/pnas.90.4.1580; Hollenhorst PC, 2011, ANNU REV BIOCHEM, V80, P437, DOI 10.1146/annurev.biochem.79.081507.103945; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Janin J, 2007, ACTA CRYSTALLOGR D, V63, P1, DOI 10.1107/S090744490603575X; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kodandapani R, 1996, NATURE, V380, P456, DOI 10.1038/380456a0; KOMINATO Y, 1995, MOL CELL BIOL, V15, P58; Labute P, 2010, J CHEM INF MODEL, V50, P792, DOI 10.1021/ci900508k; Lam SY, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001027; Law V, 2014, NUCLEIC ACIDS RES, V42, pD1091, DOI 10.1093/nar/gkt1068; Linton B, 1999, CURR OPIN CHEM BIOL, V3, P307, DOI 10.1016/S1367-5931(99)80047-7; Listman JA, 2005, J BIOL CHEM, V280, P41421, DOI 10.1074/jbc.M509143200; Meraro D, 1999, J IMMUNOL, V163, P6468; Morris SM, 2016, J NUTR, V146, P2579, DOI 10.3945/jn.115.226621; Munde M, 2014, NUCLEIC ACIDS RES, V42, P1379, DOI 10.1093/nar/gkt955; NAGULAPALLI S, 1995, J IMMUNOL, V155, P4330; Perkel JM, 1998, J IMMUNOL, V160, P241; Petosa C, 2006, MOL CELL, V21, P565, DOI 10.1016/j.molcel.2006.01.006; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pierce BG, 2014, BIOINFORMATICS, V30, P1771, DOI 10.1093/bioinformatics/btu097; Pugh BF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149339; Ridker PM, 2017, LANCET, V390, P1833, DOI 10.1016/S0140-6736(17)32247-X; SAPSE AM, 1984, INT J QUANTUM CHEM, V26, P91, DOI 10.1002/qua.560260107; Shimokawa T, 2005, BLOOD, V106, P2534, DOI 10.1182/blood-2004-06-2413; Shimokawa T, 2013, BBA-GENE REGUL MECH, V1829, P1207, DOI 10.1016/j.bbagrm.2013.09.004; Shimokawa T, 2010, BIOCHEM J, V430, P129, DOI 10.1042/BJ20091742; SHIRAKAWA F, 1993, MOL CELL BIOL, V13, P1332, DOI 10.1128/MCB.13.3.1332; Tahirov TH, 2002, CELL, V108, P57, DOI 10.1016/S0092-8674(01)00636-5; TSUKADA J, 1994, MOL CELL BIOL, V14, P7285, DOI 10.1128/MCB.14.11.7285; Tsukada J, 2011, CYTOKINE, V54, P6, DOI 10.1016/j.cyto.2010.12.019; Turkistany SA, 2011, ARCH IMMUNOL THER EX, V59, P431, DOI 10.1007/s00005-011-0147-9; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; Wara-Aswapati N, 1999, MOL CELL BIOL, V19, P6803; Wojciechowski M, 2004, J PHYS CHEM B, V108, P18368, DOI 10.1021/jp046748b; Yang ZY, 2000, J BIOL CHEM, V275, P21272, DOI 10.1074/jbc.M000145200; ZHANG YH, 1994, P NATL ACAD SCI USA, V91, P2225, DOI 10.1073/pnas.91.6.2225	52	3	3	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					19942	19956		10.1074/jbc.RA118.005627	http://dx.doi.org/10.1074/jbc.RA118.005627			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30355733	hybrid, Green Published			2022-12-28	WOS:000454685900001
J	Schmidt, K; Ralle, M; Schaffer, T; Jayakanthan, S; Bari, B; Muchenditsi, A; Lutsenko, S				Schmidt, Katharina; Ralle, Martina; Schaffer, Thomas; Jayakanthan, Samuel; Bari, Bilal; Muchenditsi, Abigael; Lutsenko, Svetlana			ATP7A and ATP7B copper transporters have distinct functions in the regulation of neuronal dopamine--hydroxylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						copper transport; vesicles; dopamine--hydroxylase; cellular regulation; intracellular trafficking; ATP7A; ATP7B; SH-SY5Y cells; noradrenergic; locus coeruleus; constitutive secretion; Wilson's disease; Menkes disease	WILSON DISEASE PROTEIN; BETA-HYDROXYLASE; CEREBROSPINAL-FLUID; NERVOUS-SYSTEM; NMDA RECEPTOR; ATPASE ATP7B; IN-VITRO; EXPRESSION; GENE; HOMEOSTASIS	The copper (Cu) transporters ATPase copper-transporting alpha (ATP7A) and ATPase copper-transporting beta (ATP7B) are essential for the normal function of the mammalian central nervous system. Inactivation of ATP7A or ATP7B causes the severe neurological disorders, Menkes disease and Wilson disease, respectively. In both diseases, Cu imbalance is associated with abnormal levels of the catecholamine-type neurotransmitters dopamine and norepinephrine. Dopamine is converted to norepinephrine by dopamine--hydroxylase (DBH), which acquires its essential Cu cofactor from ATP7A. However, the role of ATP7B in catecholamine homeostasis is unclear. Here, using immunostaining of mouse brain sections and cultured cells, we show that DBH-containing neurons express both ATP7A and ATP7B. The two transporters are located in distinct cellular compartments and oppositely regulate the export of soluble DBH from cultured neuronal cells under resting conditions. Down-regulation of ATP7A, overexpression of ATP7B, and pharmacological Cu depletion increased DBH retention in cells. In contrast, ATP7B inactivation elevated extracellular DBH. Proteolytic processing and the specific activity of exported DBH were not affected by changes in ATP7B levels. These results establish distinct regulatory roles for ATP7A and ATP7B in neuronal cells and explain, in part, the lack of functional compensation between these two transporters in human disorders of Cu imbalance.	[Schmidt, Katharina; Jayakanthan, Samuel; Muchenditsi, Abigael; Lutsenko, Svetlana] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Ralle, Martina] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA; [Schaffer, Thomas] Johns Hopkins Univ, Dept Biol Chem, Baltimore, MD 21205 USA; [Bari, Bilal] Johns Hopkins Univ, Brain Sci Inst, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University; Oregon Health & Science University; Johns Hopkins University; Johns Hopkins University	Lutsenko, S (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA.	lutsenko@jhmi.edu	Ralle, Martina/H-2936-2019	Bari, Bilal/0000-0002-8381-3802; Lutsenko, Svetlana/0000-0001-5275-2587	U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101502, T32GM007445] Funding Source: NIH RePORTER	U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Hippocampal neurons were provided by Dr. Kirill Gorshkov. Use of the Advanced Photon Source at Argonne National Laboratory was supported by the U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract DE-AC02-06CH11357. We thank Evan Maxey and Dr. Stefan Vogt for user support and assistance at the Advanced Photon Source. We thank Dr. Betty Eipper for expert advice and the kind gift of the antibody. We thank members of the Lutsenko laboratory for critical reading of the manuscript and helpful comments.	ASH DE, 1984, J BIOL CHEM, V259, P3395; Banci L, 2005, J BIOL CHEM, V280, P38259, DOI 10.1074/jbc.M506219200; Banci L, 2009, J BIOL CHEM, V284, P9354, DOI 10.1074/jbc.M805981200; Bartee MY, 2009, BIOCHEMISTRY-US, V48, P5573, DOI 10.1021/bi900325k; Barthel H, 2001, EUR J NUCL MED, V28, P1656, DOI 10.1007/s002590100623; Benhamla T, 2007, ENCEPHALE, V33, P924, DOI 10.1016/j.encep.2006.08.009; Braiterman L, 2011, AM J PHYSIOL-GASTR L, V301, pG69, DOI 10.1152/ajpgi.00038.2011; Cunnane SC, 2014, J HUM EVOL, V77, P88, DOI 10.1016/j.jhevol.2014.05.001; Davies KM, 2014, NEUROBIOL AGING, V35, P858, DOI 10.1016/j.neurobiolaging.2013.09.034; Dodani SC, 2014, P NATL ACAD SCI USA, V111, P16280, DOI 10.1073/pnas.1409796111; Doreulee N, 1997, HIPPOCAMPUS, V7, P666, DOI 10.1002/(SICI)1098-1063(1997)7:6<666::AID-HIPO8>3.3.CO;2-6; Fu S, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00022; Gaier ED, 2014, J NEUROPHYSIOL, V111, P1927, DOI 10.1152/jn.00631.2013; Gaier ED, 2013, J NEUROSCI RES, V91, P2, DOI 10.1002/jnr.23143; Gaier ED, 2013, J NEUROCHEM, V127, P605, DOI 10.1111/jnc.12438; Gao C, 2014, J TRACE ELEM MED BIO, V28, P344, DOI 10.1016/j.jtemb.2014.04.004; Gerbasi V, 2003, NEUROCHEM RES, V28, P867, DOI 10.1023/A:1023219308890; Goldstein DS, 2009, NEUROCHEM RES, V34, P1464, DOI 10.1007/s11064-009-9933-8; Gupta A, 2011, P NATL ACAD SCI USA, V108, P5390, DOI 10.1073/pnas.1014959108; Han H, 2009, BIOL TRACE ELEM RES, V129, P130, DOI 10.1007/s12011-008-8293-6; Hasan NM, 2012, J BIOL CHEM, V287, P36041, DOI 10.1074/jbc.M112.370403; Hatori Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10640; Hegde S, 2010, NEUROL INDIA, V58, P708, DOI 10.4103/0028-3886.72172; Hendy GN, 2006, MOL ENDOCRINOL, V20, P1935, DOI 10.1210/me.2005-0398; Jayakanthan S, 2017, J BIOL CHEM, V292, P18760, DOI 10.1074/jbc.M117.807263; KALER SG, 1993, ANN NEUROL, V33, P171, DOI 10.1002/ana.410330206; KALER SG, 1993, J INHERIT METAB DIS, V16, P907, DOI 10.1007/BF00714295; Kaler SG, 2013, ADV PHARMACOL, V68, P223, DOI 10.1016/B978-0-12-411512-5.00011-7; Kovalevich J, 2013, METHODS MOL BIOL, V1078, P9, DOI 10.1007/978-1-62703-640-5_2; MANGOLD JB, 1984, J BIOL CHEM, V259, P7772; Naeve GS, 1999, NEUROSCIENCE, V93, P1179, DOI 10.1016/S0306-4522(99)00175-X; NAGATSU T, 1972, CLIN CHEM, V18, P980; Niciu MJ, 2007, NEUROBIOL DIS, V27, P278, DOI 10.1016/j.nbd.2007.05.004; Nishihara E, 1998, NEUROREPORT, V9, P3259, DOI 10.1097/00001756-199810050-00023; OCONNOR DT, 1994, CLIN SCI, V86, P149, DOI 10.1042/cs0860149; OYARCE AM, 1991, ARCH BIOCHEM BIOPHYS, V290, P503, DOI 10.1016/0003-9861(91)90573-2; Pilankatta Rajendra, 2011, J Biol Chem, V286, P7389, DOI 10.1074/jbc.M110.171454; Popescu BFG, 2011, CNS NEUROSCI THER, V17, P256, DOI 10.1111/j.1755-5949.2010.00149.x; Qian YC, 1997, MOL BRAIN RES, V48, P60, DOI 10.1016/S0169-328X(97)00083-1; SABBAN EL, 1983, J BIOL CHEM, V258, P7812; Saito T, 1996, NEUROSCI LETT, V216, P195, DOI 10.1016/S0304-3940(96)13041-X; Salazar-Weber Nina L, 2011, Int J Alzheimers Dis, V2011, P864753, DOI 10.4061/2011/864753; SAXENA A, 1983, J BIOL CHEM, V258, P4147; Scheiber IF, 2014, PROG NEUROBIOL, V116, P33, DOI 10.1016/j.pneurobio.2014.01.002; Schlief ML, 2005, J NEUROSCI, V25, P239, DOI 10.1523/JNEUROSCI.3699-04.2005; Slanina H, 2012, J MOL MICROB BIOTECH, V22, P245, DOI 10.1159/000342909; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; Veldhuis NA, 2009, INT J BIOCHEM CELL B, V41, P2403, DOI 10.1016/j.biocel.2009.06.008; Vogt S, 2003, J PHYS IV, V104, P635, DOI 10.1051/jp4:20030160; Woerwag-Mehta S, 2011, BMJ Case Rep, V2011, DOI 10.1136/bcr.01.2010.2628; Xiao T, 2018, NAT CHEM BIOL, V14, P655, DOI 10.1038/s41589-018-0062-z; Zecca L, 2004, P NATL ACAD SCI USA, V101, P9843, DOI 10.1073/pnas.0403495101; Zhang JW, 2015, BIOCHEM BIOPH RES CO, V458, P82, DOI 10.1016/j.bbrc.2015.01.071	53	37	37	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					20085	20098		10.1074/jbc.RA118.004889	http://dx.doi.org/10.1074/jbc.RA118.004889			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30341172	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000454685900018
J	Cattin, ME; Deeke, SA; Dick, SA; Verret-Borsos, ZJA; Tennakoon, G; Gupta, R; Mak, E; Roeske, CL; Weldrick, JJ; Megeney, LA; Burgon, PG				Cattin, Marie-Elodie; Deeke, Shelley A.; Dick, Sarah A.; Verret-Borsos, Zachary J. A.; Tennakoon, Gayashan; Gupta, Rishi; Mak, Esther; Roeske, Cassandra L.; Weldrick, Jonathan J.; Megeney, Lynn A.; Burgon, Patrick G.			Expression of murine muscle-enriched A-type lamin-interacting protein (MLIP) is regulated by tissue-specific alternative transcription start sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						alternative splicing; brain; heart; gene expression; intracellular trafficking; protein-protein interaction; skeletal muscle; cellular localization; MLIP; transcriptional start site; muscle-enriched lamin-interacting protein; transcriptional regulation; splice variant; tissue-specific expression; protein isoform	IDENTIFICATION; CIP	Muscle-enriched lamin-interacting protein (Mlip) is an alternatively spliced gene whose splicing specificity is dictated by tissue type. MLIP is most abundantly expressed in brain, cardiac, and skeletal muscle. In the present study, we systematically mapped the transcriptional start and stop sites of murine Mlip. Rapid amplification of cDNA ends (RACE) of Mlip transcripts from the brain, heart, and skeletal muscle revealed two transcriptional start sites (TSSs), exon 1a and exon 1b, and only one transcriptional termination site. RT-PCR analysis of the usage of the two identified TSSs revealed that the heart utilizes only exon 1a for MLIP expression, whereas the brain exclusively uses exon 1b TSS. Loss of Mlip exon 1a in mice resulted in a 7-fold increase in the prevalence of centralized nuclei in muscle fibers with the Mlip exon1a-deficient satellite cells on single fibers exhibiting a significant delay in commitment to a MYOD-positive phenotype. Furthermore, we demonstrate that the A-type lamin-binding domain in MLIP is encoded in exon 1a, indicating that MLIP isoforms generated with exon 1b TSS lack the A-type lamin-binding domain. Collectively these findings suggest that Mlip tissue-specific expression and alternative splicing play a critical role in determining MLIP's functions in mice.	[Cattin, Marie-Elodie; Deeke, Shelley A.; Verret-Borsos, Zachary J. A.; Tennakoon, Gayashan; Gupta, Rishi; Mak, Esther; Roeske, Cassandra L.; Weldrick, Jonathan J.; Burgon, Patrick G.] Univ Ottawa, Heart Inst, 40 Ruskin St, Ottawa, ON K1Y 4W7, Canada; [Dick, Sarah A.; Megeney, Lynn A.] Ottawa Hosp, Sprott Ctr Stem Cell Res, Regenerat Med Program, Res Inst, Ottawa, ON K1H 8L6, Canada; [Deeke, Shelley A.; Dick, Sarah A.; Weldrick, Jonathan J.; Megeney, Lynn A.; Burgon, Patrick G.] Univ Ottawa, Fac Med, Dept Cellular & Mol Med, Ottawa, ON K1N 6N5, Canada; [Megeney, Lynn A.; Burgon, Patrick G.] Univ Ottawa, Fac Med, Dept Med, Ottawa, ON K1N 6N5, Canada; [Cattin, Marie-Elodie] Servier Res Inst, 125 Chemin Ronde, F-78290 Croissy Sur Seine, France	University of Ottawa; University of Ottawa Heart Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; Servier; Institut de Recherches Internationales Servier	Burgon, PG (corresponding author), Univ Ottawa, Heart Inst, 40 Ruskin St, Ottawa, ON K1Y 4W7, Canada.	patrick.burgon@icloud.com	Burgon, Patrick/ABB-1027-2021	Megeney, Lynn/0000-0002-6824-8569; Dick, Sarah A/0000-0003-0683-2900	Canadian Institutes of Health Research; Ontario Graduate Scholarship in Science and Technology fellowship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship in Science and Technology fellowship	This work was supported by the Canadian Institutes of Health Research (to P.G.B. & L.A.M.) and an Ontario Graduate Scholarship in Science and Technology fellowship (to J.J.W.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahmady E, 2011, J BIOL CHEM, V286, P19702, DOI 10.1074/jbc.M110.165548; Cattin ME, 2015, J BIOL CHEM, V290, P26699, DOI 10.1074/jbc.M115.678433; de Hoon M, 2008, BIOTECHNIQUES, V44, P627, DOI 10.2144/000112802; de Klerk E, 2015, TRENDS GENET, V31, P128, DOI 10.1016/j.tig.2015.01.001; Dick SA, 2015, P NATL ACAD SCI USA, V112, pE5246, DOI 10.1073/pnas.1512869112; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Esslinger U, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172995; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Hestand MS, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq602; Huang ZP, 2015, J CLIN INVEST, V125, P4122, DOI 10.1172/JCI82423; Huang ZP, 2012, CIRC RES, V110, P818, DOI 10.1161/CIRCRESAHA.111.259663; Kelemen O, 2013, GENE, V514, P1, DOI 10.1016/j.gene.2012.07.083; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Wakamatsu A, 2009, DNA RES, V16, P371, DOI 10.1093/dnares/dsp022	15	7	7	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19761	19770		10.1074/jbc.RA118.003758	http://dx.doi.org/10.1074/jbc.RA118.003758			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30389785	Green Published, hybrid			2022-12-28	WOS:000454294900021
J	Gong, QM; Stump, MR; Zhou, ZF				Gong, Qiuming; Stump, Matthew R.; Zhou, Zhengfeng			Regulation of Kv11.1 potassium channel C-terminal isoform expression by the RNA-binding proteins HuR and HuD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						potassium channel; ELAV-like protein 1 (HuR (human antigen R)); polyadenylation; RNA binding protein; RNA interference (RNAi); alternative polyadenylation; hERG; KCNH2; Kv11; 1; Hu proteins	MESSENGER-RNA; K+ CHANNEL; CARDIAC-ARRHYTHMIA; UP-REGULATION; POLYADENYLATION; HERG; RECTIFIER; LONG; IDENTIFICATION; MECHANISM	The potassium voltage-gated channel subfamily H member 2 (KCNH2) gene encodes the Kv11.1 potassium channel, which conducts the rapidly activating delayed rectifier current in the heart. KCNH2 pre-mRNA undergoes alternative polyadenylation and forms a functional, full-length Kv11.1a isoform if exon 15 is polyadenylated or a nonfunctional, C-terminally truncated Kv11.1a-USO isoform if intron 9 is polyadenylated. The molecular mechanisms that regulate Kv11.1 isoform expression are poorly understood. In this study, using HEK293 cells and reporter gene expression, pulldown assays, and RNase protection assays, we identified the RNA-binding proteins Hu antigen R (HuR) and Hu antigen D (HuD) as regulators of Kv11.1 isoform expression. We show that HuR and HuD inhibit activity at the intron 9 polyadenylation site. When co-expressed with the KCNH2 gene, HuR and HuD increased levels of the Kv11.1a isoform and decreased the Kv11.1a-USO isoform in the RNase protection assays and immunoblot analyses. In patch clamp experiments, HuR and HuD significantly increased the Kv11.1 current. siRNA-mediated knockdown of HuR protein decreased levels of the Kv11.1a isoform and increased those of the Kv11.1a-USO isoform. Our findings suggest that the relative expression levels of Kv11.1 C-terminal isoforms are regulated by the RNA-binding HuR and HuD proteins.	[Gong, Qiuming; Zhou, Zhengfeng] Oregon Hlth & Sci Univ, Knight Cardiovasc Inst, Portland, OR 97239 USA; [Stump, Matthew R.] George Fox Univ, Dept Biol, Newberg, OR 97132 USA	Oregon Health & Science University	Zhou, ZF (corresponding author), 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	zhouzh@ohsu.edu		Zhou, Zhengfeng/0000-0002-2629-425X; Stump, Matthew/0000-0001-9259-5491	National Institutes of Health [R01 HL068854]; American Heart Association [15GRNT23020018]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068854] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by the National Institutes of Health Grant R01 HL068854 and American Heart Association Grant 15GRNT23020018. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdelmohsen K, 2009, EMBO J, V28, P1271, DOI 10.1038/emboj.2009.67; Alvarez Maria Fernanda, 2017, F1000Res, V6, P390, DOI 10.12688/f1000research.11078.1; Anderson KD, 2000, J NEUROCHEM, V75, P1103, DOI 10.1046/j.1471-4159.2000.0751103.x; Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021; Barker A, 2012, J BIOCHEM, V151, P423, DOI 10.1093/jb/mvs010; Barnhart MD, 2013, CELL REP, V5, P909, DOI 10.1016/j.celrep.2013.10.012; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Dai WJ, 2012, NUCLEIC ACIDS RES, V40, P787, DOI 10.1093/nar/gkr783; Dickson AM, 2012, J BIOL CHEM, V287, P36229, DOI 10.1074/jbc.M112.371203; Gong QM, 2018, GENE, V641, P220, DOI 10.1016/j.gene.2017.10.063; Gong QM, 2014, J MOL CELL CARDIOL, V76, P26, DOI 10.1016/j.yjmcc.2014.08.007; Gong QM, 2014, CIRC-CARDIOVASC GENE, V7, P482, DOI 10.1161/CIRCGENETICS.114.000586; Gong QM, 2010, J BIOL CHEM, V285, P32233, DOI 10.1074/jbc.M109.095695; Govindaraju Suman, 2013, World J Biol Chem, V4, P111, DOI 10.4331/wjbc.v4.i4.111; Gu L, 2017, ANTIOXID REDOX SIGN, V27, P1013, DOI 10.1089/ars.2016.6880; Guasti L, 2008, MOL CELL BIOL, V28, P5043, DOI 10.1128/MCB.00304-08; Hall-Pogar T, 2007, RNA, V13, P1103, DOI 10.1261/rna.577707; Ince-Dunn G, 2012, NEURON, V75, P1067, DOI 10.1016/j.neuron.2012.07.009; Kupershmidt S, 1998, J BIOL CHEM, V273, P27231, DOI 10.1074/jbc.273.42.27231; La Rosa P, 2016, ELIFE, V5, DOI 10.7554/eLife.20750; Larsen AP, 2010, PFLUG ARCH EUR J PHY, V460, P803, DOI 10.1007/s00424-010-0855-8; LeesMiller JP, 1997, CIRC RES, V81, P719; London B, 1997, CIRC RES, V81, P870; Mansfield KD, 2012, NUCLEIC ACIDS RES, V40, P2734, DOI 10.1093/nar/gkr1114; Masuda K, 2009, AGING-US, V1, P681, DOI 10.18632/aging.100073; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; SCHWARTZ PJ, 1978, CIRCULATION, V57, P1074, DOI 10.1161/01.CIR.57.6.1074; Stump MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042552; Tian B, 2013, TRENDS BIOCHEM SCI, V38, P312, DOI 10.1016/j.tibs.2013.03.005; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Wang WG, 2001, MOL CELL BIOL, V21, P5889, DOI 10.1128/MCB.21.17.5889-5898.2001; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; Zhou ZF, 1998, BIOPHYS J, V74, P230, DOI 10.1016/S0006-3495(98)77782-3; Zhu H, 2007, J BIOL CHEM, V282, P2203, DOI 10.1074/jbc.M609349200	35	2	2	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19624	19632		10.1074/jbc.RA118.003720	http://dx.doi.org/10.1074/jbc.RA118.003720			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30377250	Green Published, hybrid			2022-12-28	WOS:000454294900011
J	Huang, JL; Liu, PP; Wang, G				Huang, Jinliang; Liu, Peipei; Wang, Geng			Regulation of mitochondrion-associated cytosolic ribosomes by mammalian mitochondrial ribonuclease T2 (RNASET2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitochondria; mitochondrial metabolism; RNA turnover; RNA transport; enzyme; cytosolic ribosome; mitochondrial RNA import; mtRNA degradation; ribosomal RNA degradation; synchronized translation	PROTEIN-SYNTHESIS; MESSENGER-RNAS; IMPORT; TRANSLATION; T2; LOCALIZATION; COMPONENT; SEQUENCE; VICINITY; COMPLEX	Mitochondrial proteins are encoded in both mitochondrial and nuclear genomes. The expression levels of these two pools of mitochondrial genes are co-regulated and synchronized. Import and assembly of the nucleus-encoded oxidative phosphorylation (OXPHOS) subunits affect protein synthesis in the mitochondrial matrix by engaging the mitochondrial ribosomes. How the ribosomes at the outside of mitochondria are regulated by mitochondria, however, remains mostly unexplored. Here, using an array of biochemical assays and genetic knockdown and overexpression in HEK293 or mouse cells, we show that cytosolic rRNAs that are associated with the mitochondrial outer membrane have very different decay patterns from those of both endoplasmic reticulum-associated and -nonassociated cytosolic rRNAs. Mitochondrial intermembrane space RNase T2 (RNASET2), which has been previously shown to degrade mitochondrial RNAs, is also responsible for selective degradation of the cytosolic rRNAs on the outer membrane. We noted that the degradation activity also has a positive effect on nuclear transcription of rRNAs, suggesting a compensatory feedback mechanism, and affects protein translations in and out of mitochondria. These findings establish a mechanism for the co-regulation of gene expression programs inside and outside of mitochondria in mammalian cells.	[Huang, Jinliang; Liu, Peipei; Wang, Geng] Tsinghua Univ, Sch Life Sci, Cell Biol & Dev Ctr, Minist Educ,Key Lab Bioinformat, Beijing 100084, Peoples R China	Tsinghua University	Wang, G (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.	wangeng@biomed.tsinghua.edu.cn		Huang, Jinliang/0000-0002-8729-7817	Priority Research Program of the Ministry of Science and Technology of China [2017YFA0504600]; National Natural Science Foundation of the People's Republic of China [31371439, 91649103]; Ministry of Education of the People's Republic of China 1000 Talents Youth Program	Priority Research Program of the Ministry of Science and Technology of China; National Natural Science Foundation of the People's Republic of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of the People's Republic of China 1000 Talents Youth Program	This work was supported by Grant 2017YFA0504600 from the Priority Research Program of the Ministry of Science and Technology of China, by Grants 31371439 and 91649103 from the National Natural Science Foundation of the People's Republic of China, and by funds from the Ministry of Education of the People's Republic of China 1000 Talents Youth Program. The authors declare that they have no conflicts of interest with the contents of this article.	Acquati F, 2011, P NATL ACAD SCI USA, V108, P1104, DOI 10.1073/pnas.1013746108; Amunts A, 2015, SCIENCE, V348, P95, DOI 10.1126/science.aaa1193; Andersen KL, 2012, MOL BIOL CELL, V23, P36, DOI 10.1091/mbc.E11-08-0689; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Besse F, 2008, NAT REV MOL CELL BIO, V9, P971, DOI 10.1038/nrm2548; Borowski LS, 2013, NUCLEIC ACIDS RES, V41, P1223, DOI 10.1093/nar/gks1130; Bruni F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064670; Campomenosi P, 2006, ARCH BIOCHEM BIOPHYS, V449, P17, DOI 10.1016/j.abb.2006.02.022; Chandel NS, 2015, CELL METAB, V22, P204, DOI 10.1016/j.cmet.2015.05.013; CHANG DD, 1989, CELL, V56, P131, DOI 10.1016/0092-8674(89)90991-4; Cheng Y, 2018, CELL REP, V24, P2589, DOI 10.1016/j.celrep.2018.08.003; Couvillion MT, 2016, NATURE, V533, P499, DOI 10.1038/nature18015; Crowley KS, 1998, J BIOL CHEM, V273, P17278, DOI 10.1074/jbc.273.27.17278; Dennerlein S, 2017, TRENDS CELL BIOL, V27, P712, DOI 10.1016/j.tcb.2017.05.004; Duchene AM, 2009, CURR GENET, V55, P1, DOI 10.1007/s00294-008-0223-9; Gehrke S, 2015, CELL METAB, V21, P95, DOI 10.1016/j.cmet.2014.12.007; Greber BJ, 2015, SCIENCE, V348, P303, DOI 10.1126/science.aaa3872; Haud N, 2011, P NATL ACAD SCI USA, V108, P1099, DOI 10.1073/pnas.1009811107; Hillwig MS, 2011, P NATL ACAD SCI USA, V108, P1093, DOI 10.1073/pnas.1009809108; Holt CE, 2009, SCIENCE, V326, P1212, DOI 10.1126/science.1176488; Koehler CM, 2004, ANNU REV CELL DEV BI, V20, P309, DOI 10.1146/annurev.cellbio.20.010403.105057; Levy S, 2016, NUCLEIC ACIDS RES, V44, P1813, DOI 10.1093/nar/gkw050; Liu PP, 2017, PROTEIN CELL, V8, P735, DOI 10.1007/s13238-017-0448-9; Margeot A, 2005, GENE, V354, P64, DOI 10.1016/j.gene.2005.04.022; MASTERS BS, 1987, CELL, V51, P89, DOI 10.1016/0092-8674(87)90013-4; Mercer TR, 2011, CELL, V146, P645, DOI 10.1016/j.cell.2011.06.051; Mick DU, 2012, CELL, V151, P1528, DOI 10.1016/j.cell.2012.11.053; Morita M, 2015, CELL CYCLE, V14, P473, DOI 10.4161/15384101.2014.991572; Mukhopadhyay A, 2004, BIOCHEM J, V382, P385, DOI 10.1042/BJ20040065; Nierhaus KH, 2014, J BACTERIOL, V196, P3817, DOI 10.1128/JB.02297-14; Noh JH, 2016, GENE DEV, V30, P1224, DOI 10.1101/gad.276022.115; Reid DW, 2014, CELL, V158, P1362, DOI 10.1016/j.cell.2014.08.012; Richter-Dennerlein R, 2016, CELL, V167, P471, DOI 10.1016/j.cell.2016.09.003; Rorbach J, 2011, NUCLEIC ACIDS RES, V39, P7750, DOI 10.1093/nar/gkr470; Ruan LH, 2017, NATURE, V543, P443, DOI 10.1038/nature21695; Salinas T, 2006, P NATL ACAD SCI USA, V103, P18362, DOI 10.1073/pnas.0606449103; Sanchez CG, 2016, CELL STEM CELL, V18, P276, DOI 10.1016/j.stem.2015.11.004; Smirnov A, 2011, GENE DEV, V25, P1289, DOI 10.1101/gad.624711; Sylvestre J, 2003, MOL BIOL CELL, V14, P3848, DOI 10.1091/mbc.E03-02-0074; Wang G, 2010, CELL, V142, P456, DOI 10.1016/j.cell.2010.06.035; Williams CC, 2014, SCIENCE, V346, P748, DOI 10.1126/science.1257522; Zhang Q, 2014, SCIENCE, V343, P298, DOI 10.1126/science.1246384; Zhang XR, 2014, CELL, V158, P607, DOI 10.1016/j.cell.2014.05.047	43	11	11	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19633	19644		10.1074/jbc.RA118.005433	http://dx.doi.org/10.1074/jbc.RA118.005433			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30385512	Green Published, hybrid			2022-12-28	WOS:000454294900012
J	Huang, PCJ; Low, PY; Wang, I; Hsu, STD; Angata, T				Huang, Po-Chun Jimmy; Low, Penk-Yeir; Wang, Iren; Hsu, Shang-Te Danny; Angata, Takashi			Soluble Siglec-14 glycan-recognition protein is generated by alternative splicing and suppresses myeloid inflammatory responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biomarker; alternative splicing; G-quadruplex; inflammation; sialic acid; toll-like receptor (TLR); Siglec; soluble receptor; transmembrane signaling	G-QUADRUPLEXES; SMALL-MOLECULE; RECEPTOR; DNA; IDENTIFICATION; CLONING; MECHANISMS; EXPRESSION; BIOMARKER; PROMOTER	Human sialic acid-binding immunoglobulin-like lectin 14 (Siglec-14) is a glycan-recognition protein that is expressed on myeloid cells, recognizes bacterial pathogens, and elicits pro-inflammatory responses. Although Siglec-14 is a transmembrane protein, a soluble form of Siglec-14 is also present in human blood. However, the mechanism that generates soluble Siglec-14 and what role this protein form may play remain unknown. Here, investigating the generation and function of soluble Siglec-14, we found that soluble Siglec-14 is derived from an alternatively spliced mRNA that retains intron 5, containing a termination codon and thus preventing the translation of exon 6, which encodes Siglec-14's transmembrane domain. We also note that the translated segment in intron 5 encodes a unique C-terminal 7-amino acid extension, which allowed the specific antibody-mediated detection of this isoform in human blood. Moreover, soluble Siglec-14 dose-dependently suppressed pro-inflammatory responses of myeloid cells that expressed membrane-bound Siglec-14, likely by interfering with the interaction between membrane-bound Siglec-14 and Toll-like receptor 2 on the cell surface. We also found that intron 5 contains a G-rich segment that assumes an RNA tertiary structure called a G-quadruplex, which may regulate the efficiency of intron 5 splicing. Taken together, we propose that soluble Siglec-14 suppresses pro-inflammatory responses triggered by membrane-bound Siglec-14.	[Huang, Po-Chun Jimmy; Low, Penk-Yeir; Wang, Iren; Hsu, Shang-Te Danny; Angata, Takashi] Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan; [Huang, Po-Chun Jimmy; Hsu, Shang-Te Danny; Angata, Takashi] Natl Taiwan Univ, Inst Biochem Sci, Taipei 106, Taiwan; [Wang, Iren] United BioPharma, Hsinchu 30351, Taiwan	Academia Sinica - Taiwan; National Taiwan University	Angata, T (corresponding author), Natl Taiwan Univ, Inst Biochem Sci, Taipei 106, Taiwan.	angata@gate.sinica.edu.tw	Hsu, Shang-Te Danny/L-2826-2014; Hsu, Shang-Te Danny/B-2324-2009	Hsu, Shang-Te Danny/0000-0002-7231-0185	Ministry of Science and Technology, Republic of China [MOST 104-2321-B-001-070, 105-2321-B-001-051, 1062321- B-001-032]; Institute of Biological Chemistry, Academia Sinica	Ministry of Science and Technology, Republic of China; Institute of Biological Chemistry, Academia Sinica(Academia Sinica - Taiwan)	This work was supported by Ministry of Science and Technology, Republic of China, Grants MOST 104-2321-B-001-070, 105-2321-B-001-051, and 1062321- B-001-032 (to T.A.) and intramural funding from the Institute of Biological Chemistry, Academia Sinica (to S.T.D.H. and T.A.). The authors declare that they have no conflicts of interest with the contents of this article.	Ali SR, 2014, J EXP MED, V211, P1231, DOI 10.1084/jem.20131853; Angata T, 2006, FASEB J, V20, P1964, DOI 10.1096/fj.06-5800com; Angata T, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12069; Angata T, 2015, TRENDS PHARMACOL SCI, V36, P645, DOI 10.1016/j.tips.2015.06.008; Angata T, 2014, GLYCOBIOLOGY, V24, P785, DOI 10.1093/glycob/cwu043; Angata T, 2013, CELL MOL LIFE SCI, V70, P3199, DOI 10.1007/s00018-013-1311-7; Biedermann B, 2007, LEUKEMIA RES, V31, P211, DOI 10.1016/j.leukres.2006.05.026; Bugaut A, 2010, ORG BIOMOL CHEM, V8, P2771, DOI 10.1039/c002418j; Chang LY, 2017, J PROTEOME RES, V16, P3929, DOI 10.1021/acs.jproteome.7b00625; Chen G. W., 2014, XINJIANG RECLAIM SCI, V1, P3, DOI DOI 10.7554/ELIFE.04066; Connolly NP, 2002, BRIT J HAEMATOL, V119, P221, DOI 10.1046/j.1365-2141.2002.03808.x; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Dash J, 2008, J AM CHEM SOC, V130, P15950, DOI 10.1021/ja8046552; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Forster K, 2018, AM J RESP CRIT CARE, V197, P1076, DOI 10.1164/rccm.201706-1218LE; Furtig B, 2003, CHEMBIOCHEM, V4, P936, DOI 10.1002/cbic.200300700; Hansel-Hertsch R, 2017, NAT REV MOL CELL BIO, V18, P279, DOI 10.1038/nrm.2017.3; Higgins RD, 2018, J PEDIATR-US, V197, P300, DOI 10.1016/j.jpeds.2018.01.043; Hsu STD, 2009, J AM CHEM SOC, V131, P13399, DOI 10.1021/ja904007p; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Ishikawa J, 2016, BONE, V83, P210, DOI 10.1016/j.bone.2015.11.012; Jones SA, 2001, FASEB J, V15, P43, DOI 10.1096/fj.99-1003rev; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kitzig F, 2002, BIOCHEM BIOPH RES CO, V296, P355, DOI 10.1016/S0006-291X(02)00885-9; Kumari S, 2007, NAT CHEM BIOL, V3, P218, DOI 10.1038/nchembio864; Levine SJ, 2008, J BIOL CHEM, V283, P14177, DOI 10.1074/jbc.R700052200; Lugade AA, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00010; Macauley MS, 2014, NAT REV IMMUNOL, V14, P653, DOI 10.1038/nri3737; Matsubara K, 2015, J NEUROSCI, V35, P2452, DOI 10.1523/JNEUROSCI.4088-14.2015; Patel DJ, 2007, NUCLEIC ACIDS RES, V35, P7429, DOI 10.1093/nar/gkm711; Pepin M, 2016, SCI REP-UK, V6, DOI 10.1038/srep37953; Pillai S, 2012, ANNU REV IMMUNOL, V30, P357, DOI 10.1146/annurev-immunol-020711-075018; Ramasamy R, 2009, J LEUKOCYTE BIOL, V86, P505, DOI 10.1189/jlb.0409230; Ryan RM, 2008, CLIN REV ALLERG IMMU, V34, P174, DOI 10.1007/s12016-007-8031-4; Shimojima C, 2016, J IMMUNOL, V196, P4164, DOI 10.4049/jimmunol.1501457; Shuto T, 2001, P NATL ACAD SCI USA, V98, P8774, DOI 10.1073/pnas.151236098; STEIS RG, 1988, BLOOD, V71, P1304; Takei Y, 1997, CYTOGENET CELL GENET, V78, P295, DOI 10.1159/000134676; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; Varki A, 2006, GLYCOBIOLOGY, V16, p1R, DOI 10.1093/glycob/cwj008; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Waller ZAE, 2009, J AM CHEM SOC, V131, P12628, DOI 10.1021/ja901892u; Wang ZF, 2016, NUCLEIC ACIDS RES, V44, P3958, DOI 10.1093/nar/gkw145; Wang ZF, 2014, NUCLEIC ACIDS RES, V42, P4723, DOI 10.1093/nar/gku083; Weldon C, 2018, NUCLEIC ACIDS RES, V46, P886, DOI 10.1093/nar/gkx1122; Weldon C, 2017, NAT CHEM BIOL, V13, P18, DOI [10.1038/nchembio.2228, 10.1038/NCHEMBIO.2228]; Yamanaka M, 2009, GLYCOBIOLOGY, V19, P841, DOI 10.1093/glycob/cwp052; Yasui K, 2011, BRIT J HAEMATOL, V153, P794, DOI 10.1111/j.1365-2141.2010.08488.x; Ye W, 2014, RESPIROLOGY, V19, P501, DOI 10.1111/resp.12270; Yonchuk JG, 2015, AM J RESP CRIT CARE, V192, P785, DOI 10.1164/rccm.201501-0137PP; Zearfoss NR, 2013, RNA, V19, P948, DOI 10.1261/rna.036780.112; Zearfoss NR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001269; Zhao LX, 2010, P NATL ACAD SCI USA, V107, P19061, DOI 10.1073/pnas.1007487107	53	8	9	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19645	19658		10.1074/jbc.RA118.005676	http://dx.doi.org/10.1074/jbc.RA118.005676			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30377253	Green Published, hybrid			2022-12-28	WOS:000454294900013
J	Munro, AW				Munro, Andrew W.			Cytochrome P450 1A1 opens up to new substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							POLYCYCLIC AROMATIC-HYDROCARBONS; ACTIVATION; ERLOTINIB; INHIBITOR; DRUG	The cytochromes P450 (CYPs) oxidatively transform a huge number of substrates in both prokaryotic and eukaryotic organisms, but the mechanisms by which they accommodate these diverse molecules remain unclear. A new study by Bart and Scott reports two co-crystal structures of CYP1A1 that reveal structural rearrangements and flexible interaction networks that explain how the active site cavity shapes itself around new ligands. These data open the door to an increased understanding of fundamental enzyme behavior and improved searches for anti-cancer compounds.	[Munro, Andrew W.] Univ Manchester, Dept Chem, Manchester Inst Biotechnol, Manchester M13 9PL, Lancs, England	University of Manchester	Munro, AW (corresponding author), Univ Manchester, Dept Chem, Manchester Inst Biotechnol, Manchester M13 9PL, Lancs, England.	Andrew.Munro@Manchester.ac.uk	Munro, Andrew/G-5639-2019	Munro, Andrew/0000-0002-4642-180X	Biotechnology and Biological Sciences Research Council [BB/P010180/1, BB/R009961/1]; BBSRC [BB/M017702/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grants BB/P010180/1 and BB/R009961/1. The author declares that he has no conflicts of interest with the contents of this article.	Bart AG, 2018, J BIOL CHEM, V293, P19201, DOI 10.1074/jbc.RA118.005588; Bruno RD, 2007, BIOORGAN MED CHEM, V15, P5047, DOI 10.1016/j.bmc.2007.05.046; Li XH, 2010, DRUG METAB DISPOS, V38, P1238, DOI 10.1124/dmd.109.030361; Ling J, 2006, DRUG METAB DISPOS, V34, P420, DOI 10.1124/dmd.105.007765; Munro AW, 2013, TRENDS BIOCHEM SCI, V38, P140, DOI 10.1016/j.tibs.2012.11.006; Sansen S, 2007, J BIOL CHEM, V282, P14348, DOI 10.1074/jbc.M611692200; Shimada T, 2004, CANCER SCI, V95, P1, DOI 10.1111/j.1349-7006.2004.tb03162.x; Shimada T, 1996, CANCER RES, V56, P2979; Walsh AA, 2013, J BIOL CHEM, V288, P12932, DOI 10.1074/jbc.M113.452953; Wang A, 2011, J BIOL CHEM, V286, P5736, DOI 10.1074/jbc.M110.204420	10	2	2	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2018	293	50					19211	19212		10.1074/jbc.H118.006715	http://dx.doi.org/10.1074/jbc.H118.006715			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HE6RA	30552114	hybrid, Green Published			2022-12-28	WOS:000453537300005
J	Sorrentino, ZA; Vijayaraghavan, N; Gorion, KM; Riffe, CJ; Strang, KH; Caldwell, J; Giasson, BI				Sorrentino, Zachary A.; Vijayaraghavan, Niran; Gorion, Kimberly-Marie; Riffe, Cara J.; Strang, Kevin H.; Caldwell, Jason; Giasson, Benoit I.			Physiological C-terminal truncation of alpha-synuclein potentiates the prion-like formation of pathological inclusions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN NEUROBLASTOMA-CELLS; TRANSGENIC MOUSE MODEL; PARKINSONS-DISEASE; FIBRIL FORMATION; LEWY BODIES; IN-VITRO; AMYLOID FIBRILLOGENESIS; MEMBRANE-BINDING; CARBOXY-TERMINUS; AGGREGATION	alpha-Synuclein (alpha syn) aggregates into toxic fibrils in multiple neurodegenerative diseases where these fibrils form characteristic pathological inclusions such as Lewy bodies (LBs). The mechanisms initiating alpha syn aggregation into fibrils are unclear, but ubiquitous post-translational modifications of alpha syn present in LBs may play a role. Specific C-terminally (C)-truncated forms of alpha syn are present within human pathological inclusions and form under physiological conditions likely in lysosome-associated pathways, but the roles for these C-truncated forms of alpha syn in inclusion formation and disease are not well understood. Herein, we characterized the in vitro aggregation properties, amyloid fibril structures, and ability to induce full-length (FL) alpha syn aggregation through prion-like mechanisms for eight of the most common physiological C-truncated forms of alpha syn (1-115, 1-119, 1-122, 1-124, 1-125, 1-129, 1-133, and 1-135). In vitro, C-truncated alpha syn aggregated more readily than FL alpha syn and formed fibrils with unique morphologies. The presence of C-truncated alpha syn potentiated aggregation of FL alpha syn in vitro through co-polymerization. Specific C-truncated forms of alpha syn in cells also exacerbated seeded aggregation of alpha syn. Furthermore, in primary neuronal cultures, co-polymers of C-truncated and FL alpha syn were potent prion-like seeds, but polymers composed solely of the C-truncated protein were not. These experiments indicated that specific physiological C-truncated forms of alpha syn have distinct aggregation properties, including the ability to modulate the prion-like aggregation and seeding activity of FL alpha syn. Proteolytic formation of these C-truncated species may have an important role in both the initiation of alpha syn pathological inclusions and further progression of disease with strain-like properties.	[Sorrentino, Zachary A.; Vijayaraghavan, Niran; Gorion, Kimberly-Marie; Riffe, Cara J.; Strang, Kevin H.; Caldwell, Jason; Giasson, Benoit I.] Univ Florida, Coll Med, Dept Neurosci, Gainesville, FL 32610 USA; [Sorrentino, Zachary A.; Vijayaraghavan, Niran; Gorion, Kimberly-Marie; Riffe, Cara J.; Strang, Kevin H.; Caldwell, Jason; Giasson, Benoit I.] Univ Florida, Coll Med, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32610 USA; [Giasson, Benoit I.] Univ Florida, Coll Med, McKnight Brain Inst, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Giasson, BI (corresponding author), BMS J483 CTRND,1275 Ctr Dr, Gainesville, FL 32610 USA.	bgiasson@ufl.edu		Sorrentino, Zachary/0000-0001-8835-0432	National Institutes of Health [R01NS089022, R21NS102685]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS089622, T32NS082168, R21NS102685] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants R01NS089022 and R21NS102685. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdelmotilib H, 2017, NEUROBIOL DIS, V105, P84, DOI 10.1016/j.nbd.2017.05.014; Afitska K, 2017, BIOPHYS J, V113, P2182, DOI 10.1016/j.bpj.2017.08.027; Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Ayers JI, 2018, J VIROL, V92, DOI 10.1128/JVI.00586-18; Baba M, 1998, AM J PATHOL, V152, P879; Bae EJ, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.283; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Bousset L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3575; Buell AK, 2014, P NATL ACAD SCI USA, V111, P7671, DOI 10.1073/pnas.1315346111; Chen M, 2007, J BIOL CHEM, V282, P24970, DOI 10.1074/jbc.M700368200; Choi DH, 2011, J BIOL CHEM, V286, P14168, DOI 10.1074/jbc.M111.222430; Conway KA, 2000, BIOCHEMISTRY-US, V39, P2552, DOI 10.1021/bi991447r; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; Crowther RA, 1998, FEBS LETT, V436, P309, DOI 10.1016/S0014-5793(98)01146-6; Crystal AS, 2003, J NEUROCHEM, V86, P1359, DOI 10.1046/j.1471-4159.2003.01949.x; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Daher JPL, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-34; Deng H, 2018, AGEING RES REV, V42, P72, DOI 10.1016/j.arr.2017.12.007; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Dhillon JKS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184731; Duda JE, 2000, J NEUROPATH EXP NEUR, V59, P830, DOI 10.1093/jnen/59.9.830; Duda JE, 2002, ANN NEUROL, V52, P205, DOI 10.1002/ana.10279; Dufty BM, 2007, AM J PATHOL, V170, P1725, DOI 10.2353/ajpath.2007.061232; DUNN SD, 1986, ANAL BIOCHEM, V157, P144, DOI 10.1016/0003-2697(86)90207-1; El-Turk F, 2016, BIOCHEMISTRY-US, V55, P3116, DOI 10.1021/acs.biochem.6b00149; Emmer KL, 2011, J BIOL CHEM, V286, P35104, DOI 10.1074/jbc.M111.247965; Fernandes HJR, 2016, STEM CELL REP, V6, P342, DOI 10.1016/j.stemcr.2016.01.013; Garcia-Reitbock P, 2010, BRAIN, V133, P2032, DOI 10.1093/brain/awq132; Gath J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090659; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Giasson BI, 2000, J NEUROSCI RES, V59, P528, DOI 10.1002/(SICI)1097-4547(20000215)59:4<528::AID-JNR8>3.0.CO;2-0; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; Goedert M, 2017, BRAIN, V140, P266, DOI 10.1093/brain/aww230; Goedert M, 2013, NAT REV NEUROL, V9, P13, DOI 10.1038/nrneurol.2012.242; Grassi D, 2018, P NATL ACAD SCI USA, V115, pE2634, DOI 10.1073/pnas.1713849115; Greenbaum EA, 2005, J BIOL CHEM, V280, P7800, DOI 10.1074/jbc.M411638200; Guerrero-Ferreira R, 2018, ELIFE, V7, DOI 10.7554/eLife.36402; Guo JL, 2013, CELL, V154, P103, DOI 10.1016/j.cell.2013.05.057; Hall K, 2015, EXP NEUROL, V264, P8, DOI 10.1016/j.expneurol.2014.11.003; Hossain S, 2001, J ALZHEIMERS DIS, V3, P577, DOI 10.3233/JAD-2001-3608; Hoyer W, 2004, BIOCHEMISTRY-US, V43, P16233, DOI 10.1021/bi048453u; Hoyer WG, 2004, J MOL BIOL, V340, P127, DOI 10.1016/j.jmb.2004.04.051; Iljina M, 2016, P NATL ACAD SCI USA, V113, pE1206, DOI 10.1073/pnas.1524128113; Iyer A, 2017, J AM CHEM SOC, V139, P15392, DOI 10.1021/jacs.7b07403; Izawa Y, 2012, BRAIN BEHAV, V2, P595, DOI 10.1002/brb3.86; Jang A, 2010, J NEUROCHEM, V113, P1263, DOI 10.1111/j.1471-4159.2010.06695.x; Kaushik S, 2018, NAT REV MOL CELL BIO, V19, P365, DOI 10.1038/s41580-018-0001-6; Kellie J. F, 2014, SCI REP, V4, P5791; Khalaf O, 2014, J BIOL CHEM, V289, P21856, DOI 10.1074/jbc.M114.553297; Klein AD, 2018, BRAIN, V141, P2255, DOI 10.1093/brain/awy147; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Lemkau LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049750; Levitan K, 2011, J MOL BIOL, V411, P329, DOI 10.1016/j.jmb.2011.05.046; Li WX, 2005, P NATL ACAD SCI USA, V102, P2162, DOI 10.1073/pnas.0406976102; Li YW, 2018, CELL RES, V28, P897, DOI 10.1038/s41422-018-0075-x; Lim S, 2016, BRAIN PATHOL, V26, P404, DOI 10.1111/bpa.12371; Liu CW, 2005, J BIOL CHEM, V280, P22670, DOI 10.1074/jbc.M501508200; Luk KC, 2016, CELL REP, V16, P3373, DOI 10.1016/j.celrep.2016.08.053; Masaracchia C, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0578-1; McGlinchey RP, 2015, P NATL ACAD SCI USA, V112, P9322, DOI 10.1073/pnas.1500937112; McLean PJ, 2002, NEUROSCI LETT, V323, P219, DOI 10.1016/S0304-3940(02)00154-4; Meuvis J, 2010, BIOCHEMISTRY-US, V49, P9345, DOI 10.1021/bi1010927; Michell AW, 2007, CELL TRANSPLANT, V16, P461, DOI 10.3727/000000007783464911; Mishizen-Eberz AJ, 2005, BIOCHEMISTRY-US, V44, P7818, DOI 10.1021/bi047846q; Muntane G, 2012, NEUROSCIENCE, V200, P106, DOI 10.1016/j.neuroscience.2011.10.042; Murray IVJ, 2003, BIOCHEMISTRY-US, V42, P8530, DOI 10.1021/bi027363r; Park S, 2016, J BIOMOL STRUCT DYN, V34, P376, DOI 10.1080/07391102.2015.1033016; Park SM, 2002, BIOCHEMISTRY-US, V41, P4137, DOI 10.1021/bi015961k; Park SM, 2002, J BIOL CHEM, V277, P28512, DOI 10.1074/jbc.M111971200; Peng C, 2018, NATURE, V557, P558, DOI 10.1038/s41586-018-0104-4; Periquet M, 2007, J NEUROSCI, V27, P3338, DOI 10.1523/JNEUROSCI.0285-07.2007; Pieri L, 2016, BBA-GEN SUBJECTS, V1860, P8, DOI 10.1016/j.bbagen.2015.10.007; Pinotsi D, 2014, NANO LETT, V14, P339, DOI 10.1021/nl4041093; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Prasad K, 2012, BRAIN PATHOL, V22, P811, DOI 10.1111/j.1750-3639.2012.00597.x; Prusiner SB, 2015, P NATL ACAD SCI USA, V112, pE5308, DOI 10.1073/pnas.1514475112; Qin Z, 2007, BIOCHEMISTRY-US, V46, P13322, DOI 10.1021/bi7014053; Robak LA, 2017, BRAIN, V140, P3191, DOI 10.1093/brain/awx285; Rutherford NJ, 2017, HUM MOL GENET, V26, P4906, DOI 10.1093/hmg/ddx371; Sacino AN, 2017, J NEUROCHEM, V140, P662, DOI 10.1111/jnc.13743; Sacino AN, 2014, P NATL ACAD SCI USA, V111, P10732, DOI 10.1073/pnas.1321785111; Sacino AN, 2014, ACTA NEUROPATHOL, V127, P645, DOI 10.1007/s00401-014-1268-0; Sacino AN, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-38; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; Sevlever D, 2008, BIOCHEMISTRY-US, V47, P9678, DOI 10.1021/bi800699v; Sorrentino ZA, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0182-z; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Strang KH, 2018, J BIOL CHEM, V293, P2408, DOI 10.1074/jbc.M117.815357; Strang KH, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0458-0; Sugeno N, 2014, J BIOL CHEM, V289, P18137, DOI 10.1074/jbc.M113.529461; Terada M, 2018, J BIOL CHEM, V293, P13910, DOI 10.1074/jbc.RA118.001862; Tofaris GK, 2006, J NEUROSCI, V26, P3942, DOI 10.1523/JNEUROSCI.4965-05.2006; Tsujimura A, 2015, NEUROBIOL DIS, V73, P244, DOI 10.1016/j.nbd.2014.10.011; Tuttle MD, 2016, NAT STRUCT MOL BIOL, V23, P409, DOI 10.1038/nsmb.3194; Uchihara T, 2016, ACTA NEUROPATHOL, V131, P49, DOI 10.1007/s00401-015-1485-1; Ulusoy A, 2010, EUR J NEUROSCI, V32, P409, DOI 10.1111/j.1460-9568.2010.07284.x; Valdinocci D, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020469; Vamvaca K, 2011, J NEUROCHEM, V119, P389, DOI 10.1111/j.1471-4159.2011.07431.x; Vilar M, 2008, P NATL ACAD SCI USA, V105, P8637, DOI 10.1073/pnas.0712179105; Wakamatsu M, 2008, NEUROBIOL AGING, V29, P574, DOI 10.1016/j.neurobiolaging.2006.11.017; Waxman EA, 2008, ACTA NEUROPATHOL, V116, P37, DOI 10.1007/s00401-008-0375-1; Waxman EA, 2011, J NEUROSCI, V31, P7604, DOI 10.1523/JNEUROSCI.0297-11.2011; Waxman EA, 2010, J NEUROCHEM, V113, P374, DOI 10.1111/j.1471-4159.2010.06592.x; Wong YC, 2017, NAT MED, V23, P151, DOI 10.1038/nm.4269; Wong YC, 2016, MOVEMENT DISORD, V31, P1610, DOI 10.1002/mds.26802; Yap TL, 2011, BIOCHEMISTRY-US, V50, P1963, DOI 10.1021/bi2000824; Zhang ZT, 2017, NAT STRUCT MOL BIOL, V24, P632, DOI 10.1038/nsmb.3433; Zibaee S, 2007, J MOL BIOL, V374, P454, DOI 10.1016/j.jmb.2007.09.039	110	47	47	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2018	293	49					18914	18932		10.1074/jbc.RA118.005603	http://dx.doi.org/10.1074/jbc.RA118.005603			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NY	30327435	hybrid, Green Published			2022-12-28	WOS:000458467400009
J	Gerner, EW; Bruckheimer, E; Cohen, A				Gerner, Eugene W.; Bruckheimer, Elizabeth; Cohen, Alfred			Cancer pharmacoprevention: Targeting polyamine metabolism to manage risk factors for colon cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ORNITHINE-DECARBOXYLASE ACTIVITY; ALPHA-DIFLUOROMETHYLORNITHINE; C-MYC; IRREVERSIBLE INHIBITOR; ESCHERICHIA-COLI; COMBINATION CHEMOPREVENTION; INTESTINAL CARCINOGENESIS; SYNTHESIZE PUTRESCINE; TRANSPORT INHIBITORS; COLORECTAL-CANCER	Cancer is a set of diseases characterized by uncontrolled cell growth. In certain cancers of the gastrointestinal tract, the adenomatous polyposis coli (APC) tumor suppressor gene is altered in either germline or somatic cells and causes formation of risk factors, such as benign colonic or intestinal neoplasia, which can progress to invasive cancer. APC is a key component of the WNT pathway, contributing to normal GI tract development, and APC alteration results in dysregulation of the pathway for production of polyamines, which are ubiquitous cations essential for cell growth. Studies with mice have identified nonsteroidal anti-inflammatory drugs (NSAIDs) and difluoromethylornithine (DFMO), an inhibitor of polyamine synthesis, as potent inhibitors of colon carcinogenesis. Moreover, gene expression profiling has uncovered that NSAIDs activate polyamine catabolism and export. Several DFMO-NSAID combination strategies are effective and safe methods for reducing risk factors in clinical trials with patients having genetic or sporadic risk of colon cancer. These strategies affect cancer stem cells, inflammation, immune surveillance, and the microbiome. Pharmacotherapies consisting of drug combinations targeting the polyamine pathway provide a complementary approach to surgery and cytotoxic cancer treatments for treating patients with cancer risk factors. In this Minireview, we discuss the role of polyamines in colon cancer and highlight the mechanisms of select pharmacoprevention agents to delay or prevent carcinogenesis in humans.	[Gerner, Eugene W.; Bruckheimer, Elizabeth; Cohen, Alfred] Canc Prevent Pharmaceut, Tucson, AZ 85718 USA; [Gerner, Eugene W.] Univ Arizona, Dept Cell & Mol Med, Tucson, AZ 85711 USA	University of Arizona	Gerner, EW (corresponding author), Canc Prevent Pharmaceut, 1760 E River Rd, Tucson, AZ 85716 USA.	egerner@canprevent.com						ABOUELELA SH, 1989, CANCER RES, V49, P1434; Alexander ET, 2017, ONCOTARGET, V8, P84140, DOI 10.18632/oncotarget.20493; Babbar N, 2007, BIOCHEM SOC T, V35, P300, DOI 10.1042/BST0350300; Babbar N, 2006, BIOCHEM J, V394, P317, DOI 10.1042/BJ20051298; Babbar N, 2003, J BIOL CHEM, V278, P47762, DOI 10.1074/jbc.M307265200; Babbar N, 2011, RECENT RESULTS CANC, V188, P49, DOI 10.1007/978-3-642-10858-7_4; Balfour J A, 2001, Am J Clin Dermatol, V2, P197; BARTHOLEYNS J, 1984, CANCER RES, V44, P4972; Bassiri H, 2015, TRANSL PEDIATR, V4, P226, DOI 10.3978/j.issn.2224-4336.2015.04.06; Basu I, 2011, J BIOL CHEM, V286, P4902, DOI 10.1074/jbc.M110.198374; Baxter NN, 2009, ANN INTERN MED, V150, P1, DOI 10.7326/0003-4819-150-1-200901060-00306; BELLOFERNANDEZ C, 1993, P NATL ACAD SCI USA, V90, P7804, DOI 10.1073/pnas.90.16.7804; Bettess MD, 2005, MOL CELL BIOL, V25, P7868, DOI 10.1128/MCB.25.17.7868-7878.2005; Bistulfi G, 2016, ONCOTARGET, V7, P14380, DOI 10.18632/oncotarget.7486; Brooks WH, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00091; Burke CA, 2016, BMC GASTROENTEROL, V16, DOI 10.1186/s12876-016-0494-4; Burns MR, 2009, J MED CHEM, V52, P1983, DOI 10.1021/jm801580w; Cani PD, 2018, GUT, V67, P1716, DOI 10.1136/gutjnl-2018-316723; Cantor JR, 2012, CANCER DISCOV, V2, P881, DOI 10.1158/2159-8290.CD-12-0345; Chaturvedi R, 2015, ONCOGENE, V34, P3429, DOI 10.1038/onc.2014.273; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Daniel SG, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00065-17; Dejea CM, 2018, SCIENCE, V359, P592, DOI 10.1126/science.aah3648; DYKSTRA WG, 1965, SCIENCE, V149, P428, DOI 10.1126/science.149.3682.428; Engle SJ, 2002, CANCER RES, V62, P6362; Erdman SH, 1999, CARCINOGENESIS, V20, P1709, DOI 10.1093/carcin/20.9.1709; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Fultz KE, 2002, MOL CARCINOGEN, V34, P10, DOI 10.1002/mc.10043; Gardner RA, 2004, J MED CHEM, V47, P6055, DOI 10.1021/jm0497040; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; Giardiello FM, 1997, CANCER RES, V57, P199; GIARDIELLO FM, 1993, NEW ENGL J MED, V328, P1313, DOI 10.1056/NEJM199305063281805; Gitto SB, 2018, MOL PHARMACEUT, V15, P369, DOI 10.1021/acs.molpharmaceut.7b00718; Gogoi M, 2016, CURR OPIN MICROBIOL, V29, P43, DOI 10.1016/j.mib.2015.10.005; Green JE, 2005, NAT REV CANCER, V5, P184, DOI 10.1038/nrc1565; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; Gurpinar E, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00181; HAFNER EW, 1979, J BIOL CHEM, V254, P2419; Halberg RB, 2000, P NATL ACAD SCI USA, V97, P3461, DOI 10.1073/pnas.050585597; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hardbower DM, 2016, AMINO ACIDS, V48, P2375, DOI 10.1007/s00726-016-2231-2; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hesterberg Rebecca S, 2018, Med Sci (Basel), V6, DOI 10.3390/medsci6010022; Hiramatsu K, 2005, CLIN CANCER RES, V11, P2986, DOI 10.1158/1078-0432.CCR-04-2275; Ignatenko NA, 2006, CANCER BIOL THER, V5, P1658, DOI 10.4161/cbt.5.12.3376; Ignatenko NA, 2006, NUTR CANCER, V56, P172, DOI 10.1207/s15327914nc5602_8; Ignatenko NA, 2008, NUTR CANCER, V60, P30, DOI 10.1080/01635580802401317; Ignaternko NA, 2004, MOL CARCINOGEN, V39, P221, DOI 10.1002/mc.20008; Janakiram NB, 2016, SCI REP-UK, V6, DOI 10.1038/srep37046; Jell J, 2007, J BIOL CHEM, V282, P8404, DOI 10.1074/jbc.M610265200; Johnson CH, 2015, CELL METAB, V21, P891, DOI 10.1016/j.cmet.2015.04.011; Kee K, 2004, J BIOL CHEM, V279, P40076, DOI 10.1074/jbc.M406002200; KINGSNORTH AN, 1983, CANCER RES, V43, P2545; Kramer DL, 2008, J BIOL CHEM, V283, P4241, DOI 10.1074/jbc.M706806200; Lawson KR, 2000, CANCER EPIDEM BIOMAR, V9, P1155; Li H, 1999, CARCINOGENESIS, V20, P425, DOI 10.1093/carcin/20.3.425; LUK GD, 1980, SCIENCE, V210, P195, DOI 10.1126/science.6774420; LUK GD, 1984, NEW ENGL J MED, V311, P80, DOI 10.1056/NEJM198407123110202; Lynch PM, 2016, GUT, V65, P286, DOI 10.1136/gutjnl-2014-307235; Madeo F, 2018, SCIENCE, V359, P410, DOI 10.1126/science.aan2788; MAMONT PS, 1978, BIOCHEM BIOPH RES CO, V81, P58, DOI 10.1016/0006-291X(78)91630-3; METCALF BW, 1978, J AM CHEM SOC, V100, P2551, DOI 10.1021/ja00476a050; Meyskens FL, 1999, CLIN CANCER RES, V5, P945; Meyskens FL, 2008, CANCER PREV RES, V1, P32, DOI 10.1158/1940-6207.CAPR-08-0042; Mokdad AH, 2018, JAMA-J AM MED ASSOC, V319, P1444, DOI 10.1001/jama.2018.0158; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Muth A, 2014, J MED CHEM, V57, P348, DOI 10.1021/jm401174a; Nightingale S L, 1991, JAMA, V265, P1229, DOI 10.1001/jama.265.10.1229; NIGRO ND, 1986, J NATL CANCER I, V77, P1309; O'Shaughnessy JA, 2002, CLIN CANCER RES, V8, P314; OBRIEN TG, 1975, CANCER RES, V35, P1662; Park MH, 2018, J BIOL CHEM, V293, P18710, DOI 10.1074/jbc.TM118.003341; Paz EA, 2014, MOL CARCINOGEN, V53, pE96, DOI 10.1002/mc.22051; PRAKASH NJ, 1980, LIFE SCI, V26, P181, DOI 10.1016/0024-3205(80)90292-1; RAINA A, 1966, BIOCHIM BIOPHYS ACTA, V123, P197, DOI 10.1016/0005-2787(66)90173-0; Raj KP, 2013, BRIT J CANCER, V108, P512, DOI 10.1038/bjc.2013.15; RUSSELL D, 1968, P NATL ACAD SCI USA, V60, P1420, DOI 10.1073/pnas.60.4.1420; Samal K, 2013, INT J CANCER, V133, P1323, DOI 10.1002/ijc.28139; SARHAN S, 1989, ANTICANCER RES, V9, P215; Selamnia M, 1998, BIOCHEM PHARMACOL, V55, P1241, DOI 10.1016/S0006-2952(97)00572-8; SPORN MB, 1980, NATURE, V287, P107, DOI 10.1038/287107a0; Stewart TM, 2018, J BIOL CHEM, V293, P18736, DOI 10.1074/jbc.TM118.003337; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; SUNKARA PS, 1987, CANCER RES, V47, P933; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; TABOR CW, 1982, FED PROC, V41, P3084; Tabor CW, 1999, ANNU REV BIOCHEM, V68, P1, DOI 10.1146/annurev.biochem.68.1.1; TABOR H, 1980, J BACTERIOL, V144, P952, DOI 10.1128/JB.144.3.952-956.1980; TABOR H, 1981, J BACTERIOL, V147, P702, DOI 10.1128/JB.147.2.702-704.1981; Tang BQ, 2018, CANCER RES, V78, P4386, DOI 10.1158/0008-5472.CAN-18-0814; Thompson PA, 2010, GASTROENTEROLOGY, V139, P797, DOI 10.1053/j.gastro.2010.06.005; Tu HC, 2015, GENE DEV, V29, P1074, DOI 10.1101/gad.256693.114; Vargas AJ, 2014, NUTR CANCER, V66, P1144, DOI 10.1080/01635581.2014.949801; Vargas AJ, 2012, AM J CLIN NUTR, V96, P133, DOI 10.3945/ajcn.111.030353; VERMA AK, 1980, CANCER RES, V40, P308; Von Hoff DD, 1998, CLIN CANCER RES, V4, P1079; WALLON UM, 1994, MOL CARCINOGEN, V11, P138, DOI 10.1002/mc.2940110304; WEEKS CE, 1982, P NATL ACAD SCI-BIOL, V79, P6028, DOI 10.1073/pnas.79.19.6028; Wen FS, 2013, CANCER RES, V73, P4256, DOI 10.1158/0008-5472.CAN-12-3287; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Xie XZ, 1997, J BIOL CHEM, V272, P20484, DOI 10.1074/jbc.272.33.20484; Yerushalmi HF, 2006, MOL CARCINOGEN, V45, P764, DOI 10.1002/mc.20246; Zhang DW, 2012, GENE DEV, V26, P461, DOI 10.1101/gad.182998.111; Zhao TY, 2012, CELL CYCLE, V11, P4517, DOI 10.4161/cc.22772; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033; Zoumas-Morse C, 2007, J AM DIET ASSOC, V107, P1024, DOI 10.1016/j.jada.2007.03.012	109	47	52	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2018	293	48					18770	18778		10.1074/jbc.TM118.003343	http://dx.doi.org/10.1074/jbc.TM118.003343			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NX	30355737	hybrid, Green Published			2022-12-28	WOS:000458467300032
J	Lee, M; Hwang, JT; Lee, HJ; Jung, SN; Kang, I; Chi, SG; Kim, SS; Ha, J				Lee, Minyoung; Hwang, Jin-Taek; Lee, Hye-Jeong; Jung, Seung-Nam; Kang, Insug; Chi, Sung-Gil; Kim, Sung-Soo; Ha, Joohun			RETRACTION: AMP-activated protein kinase activity is critical for hypoxia-inducible factor-1 transcriptional activity and its target gene expression under hypoxic conditions in DU145 cells. (Retraction of Vol 278, Pg 39653, 2003)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction													Kim, Sung Soo/S-2540-2017	Kim, Sung Soo/0000-0002-6817-7668				Lee M, 2003, J BIOL CHEM, V278, P39653, DOI 10.1074/jbc.M306104200	1	0	0	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2018	293	46					18013	18013		10.1074/jbc.W118.006427	http://dx.doi.org/10.1074/jbc.W118.006427			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HA6SG	30446603	Green Published, hybrid			2022-12-28	WOS:000450409500030
J	Kolliopoulos, C; Raja, E; Razmara, M; Heldin, P; Heldin, CH; Moustakas, A; van der Heide, LP				Kolliopoulos, Constantinos; Raja, Erna; Razmara, Masoud; Heldin, Paraskevi; Heldin, Carl-Henrik; Moustakas, Aristidis; van der Heide, Lars P.			Transforming growth factor (TGF) induces NUAK kinase expression to fine-tune its signaling output	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated kinase (AMPK); cell cycle; epithelial-mesenchymal transition (EMT); myofibroblast; SMAD transcription factor; signal transduction; transforming growth factor beta (TGF-beta); cell signaling; NUAK family kinase	FACTOR-BETA; NEGATIVE REGULATION; PROTEIN; SNARK; DIFFERENTIATION; IDENTIFICATION; COMPLEX; CELLS; ARK5; LKB1	TGF signaling via SMAD proteins and protein kinase pathways up- or down-regulates the expression of many genes and thus affects physiological processes, such as differentiation, migration, cell cycle arrest, and apoptosis, during developmental or adult tissue homeostasis. We here report that NUAK family kinase 1 (NUAK1) and NUAK2 are two TGF target genes. NUAK1/2 belong to the AMP-activated protein kinase (AMPK) family, whose members control central and protein metabolism, polarity, and overall cellular homeostasis. We found that TGF-mediated transcriptional induction of NUAK1 and NUAK2 requires SMAD family members 2, 3, and 4 (SMAD2/3/4) and mitogen-activated protein kinase (MAPK) activities, which provided immediate and early signals for the transient expression of these two kinases. Genomic mapping identified an enhancer element within the first intron of the NUAK2 gene that can recruit SMAD proteins, which, when cloned, could confer induction by TGF. Furthermore, NUAK2 formed protein complexes with SMAD3 and the TGF type I receptor. Functionally, NUAK1 suppressed and NUAK2 induced TGF signaling. This was evident during TGF-induced epithelial cytostasis, mesenchymal differentiation, and myofibroblast contractility, in which NUAK1 or NUAK2 silencing enhanced or inhibited these responses, respectively. In conclusion, we have identified a bifurcating loop during TGF signaling, whereby transcriptional induction of NUAK1 serves as a negative checkpoint and NUAK2 induction positively contributes to signaling and terminal differentiation responses to TGF activity.	[Kolliopoulos, Constantinos; Heldin, Paraskevi; Heldin, Carl-Henrik; Moustakas, Aristidis] Uppsala Univ, Sci Life Lab, Dept Med Biochem & Microbiol, Biomed Ctr, Box 582, S-75123 Uppsala, Sweden; [Kolliopoulos, Constantinos; Raja, Erna; Razmara, Masoud; Heldin, Paraskevi; Heldin, Carl-Henrik; Moustakas, Aristidis; van der Heide, Lars P.] Uppsala Univ, Sci Life Lab, Ludwig Inst Canc Res, Biomed Ctr, Box 595, S-75124 Uppsala, Sweden; [Razmara, Masoud] Uppsala Univ, Dept Med Sci, Rudbeck Lab, S-75185 Uppsala, Sweden	Uppsala University; Ludwig Institute for Cancer Research; Uppsala University; Uppsala University	Moustakas, A (corresponding author), Uppsala Univ, Sci Life Lab, Dept Med Biochem & Microbiol, Biomed Ctr, Box 582, S-75123 Uppsala, Sweden.; van der Heide, LP (corresponding author), Univ Amsterdam, Swammardam Inst Life Sci, Sci Pk 904, NL-1098 XH Amsterdam, Netherlands.	aris.moustakas@imbim.uu.se; L.P.vanderHeide@uva.nl		van der Heide, Lars P./0000-0003-1779-425X; KOLLIOPOULOS, KONSTANTINOS/0000-0001-9564-2900	Ludwig Cancer Research Ltd.; Swedish Research Council [K2010-67X-14936-07-3, K2013-66X-14936-10-5, 2015-02757]; Swedish Cancer Society [CAN 2009/900, CAN 2012/438, CAN 2015/438, CAN 2016/435]; Wenner-Gren Society, Sweden; Marie Curie Research Training Network "EpiPlastCarcinoma" under the European Union FP6 program [MRTN-2005-005428]	Ludwig Cancer Research Ltd.; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Wenner-Gren Society, Sweden; Marie Curie Research Training Network "EpiPlastCarcinoma" under the European Union FP6 program	This work was supported by Ludwig Cancer Research Ltd.; Swedish Research Council Grants K2010-67X-14936-07-3, K2013-66X-14936-10-5, and 2015-02757; and Swedish Cancer Society Grants CAN 2009/900, CAN 2012/438, CAN 2015/438, and CAN 2016/435. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Wenner-Gren Society, Sweden.; Supported by the Marie Curie Research Training Network "EpiPlastCarcinoma" under the European Union FP6 program (Project MRTN-2005-005428).	Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Banerjee S, 2014, BIOCHEM J, V461, P233, DOI 10.1042/BJ20140408; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Bright NJ, 2009, ACTA PHYSIOL, V196, P15, DOI 10.1111/j.1748-1716.2009.01971.x; Chang XZ, 2012, J CANCER RES CLIN, V138, P247, DOI 10.1007/s00432-011-1102-1; Gal A, 2008, ONCOGENE, V27, P1218, DOI 10.1038/sj.onc.1210741; Goto K, 2013, J HEPATOL, V59, P942, DOI 10.1016/j.jhep.2013.06.025; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hou X, 2011, ONCOGENE, V30, P2933, DOI 10.1038/onc.2011.19; Humbert N, 2010, EMBO J, V29, P376, DOI 10.1038/emboj.2009.342; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Inazuka F, 2012, J BIOL CHEM, V287, P16379, DOI 10.1074/jbc.M111.302687; Kang JS, 2009, TRENDS CELL BIOL, V19, P385, DOI 10.1016/j.tcb.2009.05.008; Katajisto P, 2008, NAT GENET, V40, P455, DOI 10.1038/ng.98; Koinuma D, 2009, MOL CELL BIOL, V29, P172, DOI 10.1128/MCB.01038-08; Kowanetz M, 2004, MOL CELL BIOL, V24, P4241, DOI 10.1128/MCB.24.10.4241-4254.2004; Kowanetz M, 2008, J CELL BIOL, V182, P655, DOI 10.1083/jcb.200804107; Kuga W, 2008, BIOCHEM BIOPH RES CO, V377, P1062, DOI 10.1016/j.bbrc.2008.10.143; Kurisaki K, 2003, MOL CELL BIOL, V23, P4494, DOI 10.1128/MCB.23.13.4494-4510.2003; Landesman Y, 1997, CELL SIGNAL, V9, P291, DOI 10.1016/S0898-6568(97)89890-7; Lasagna-Reeves CA, 2016, NEURON, V92, P407, DOI 10.1016/j.neuron.2016.09.022; Lefebvre DL, 2005, BBA-GEN SUBJECTS, V1724, P71, DOI 10.1016/j.bbagen.2005.03.015; Legembre P, 2004, J BIOL CHEM, V279, P46742, DOI 10.1074/jbc.M404334200; Lessard SJ, 2016, J CLIN INVEST, V126, P560, DOI 10.1172/JCI79197; Liu D, 2001, GENE DEV, V15, P2950, DOI 10.1101/gad.925901; Liu LD, 2012, NATURE, V483, P608, DOI 10.1038/nature10927; Lonn P, 2012, J BIOL CHEM, V287, P12867, DOI 10.1074/jbc.M111.307249; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; Moren A, 2003, J BIOL CHEM, V278, P33571, DOI 10.1074/jbc.M300159200; Moren A, 2011, J BIOL CHEM, V286, P341, DOI 10.1074/jbc.M110.190660; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Namiki T, 2015, CANCER RES, V75, P2708, DOI 10.1158/0008-5472.CAN-13-3209; Namiki T, 2011, P NATL ACAD SCI USA, V108, P6597, DOI 10.1073/pnas.1007694108; Ohmura T, 2012, DEV DYNAM, V241, P1350, DOI 10.1002/dvdy.23816; Pardali E, 2010, TRENDS CELL BIOL, V20, P556, DOI 10.1016/j.tcb.2010.06.006; ROSEN CF, 1995, AM J PHYSIOL-CELL PH, V268, pC846, DOI 10.1152/ajpcell.1995.268.4.C846; Suzuki A, 2004, MOL CELL BIOL, V24, P3526, DOI 10.1128/MCB.24.8.3526-3535.2004; Suzuki A, 2003, J BIOL CHEM, V278, P48, DOI 10.1074/jbc.M206025200; Vaahtomeri K, 2011, FEBS LETT, V585, P944, DOI 10.1016/j.febslet.2010.12.034; Vallenius T, 2011, J CELL SCI, V124, P384, DOI 10.1242/jcs.072660; van der Heide LP, 2011, J BIOL CHEM, V286, P5003, DOI 10.1074/jbc.M110.167379; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Zagorska A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000616	44	14	15	5	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					4119	4136		10.1074/jbc.RA118.004984	http://dx.doi.org/10.1074/jbc.RA118.004984			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30622137	Green Published, hybrid			2022-12-28	WOS:000461854400024
J	Santerre, M; Bagashev, A; Gorecki, L; Lysek, KZ; Wang, Y; Shrestha, J; Del Carpio-Cano, F; Mukerjee, R; Sawaya, BE				Santerre, Maryline; Bagashev, Asen; Gorecki, Laura; Lysek, Kyle Z.; Wang, Ying; Shrestha, Jenny; Del Carpio-Cano, Fabiola; Mukerjee, Ruma; Sawaya, Bassel E.			HIV-1 Tat protein promotes neuronal dysregulation by inhibiting E2F transcription factor 3 (E2F3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						human immunodeficiency virus (HIV); neurodegeneration; neurite outgrowth; microRNA (miRNA); E2F transcription factor; CREB promoter; E2F3; miR-34a; neurodegenerative disease; cognitive disorder; brain derived neurotropic factor	VIRUS TYPE-1 TAT; ELEMENT-BINDING PROTEIN; NEURITE RETRACTION; OXIDATIVE STRESS; ALZHEIMERS-DISEASE; TUMOR-SUPPRESSOR; CALCIUM-CHANNEL; TNF-ALPHA; EXPRESSION; CREB	Individuals who are infected with HIV-1 accumulate damage to cells and tissues (e.g. neurons) that are not directly infected by the virus. These include changes known as HIV-associated neurodegenerative disorder (HAND), leading to the loss of neuronal functions, including synaptic long-term potentiation (LTP). Several mechanisms have been proposed for HAND, including direct effects of viral proteins such as the Tat protein. Searching for the mechanisms involved, we found here that HIV-1 Tat inhibits E2F transcription factor 3 (E2F3), CAMP-responsive element-binding protein (CREB), and brain-derived neurotropic factor (BDNF) by up-regulating the microRNA miR-34a. These changes rendered murine neurons dysfunctional by promoting neurite retraction, and we also demonstrate that E2F3 is a specific target of miR-34a. Interestingly, bioinformatics analysis revealed the presence of an E2F3-binding site within the CREB promoter, which we validated with ChIP and transient transfection assays. Of note, luciferase reporter assays revealed that E2F3 up-regulates CREB expression and that Tat interferes with this up-regulation. Further, we show that miR-34a inhibition or E2F3 overexpression neutralizes Tat's effects and restores normal distribution of the synaptic protein synaptophysin, confirming that Tat alters these factors, leading to neurite retraction inhibition. Our results suggest that E2F3 is a key player in neuronal functions and may represent a good target for preventing the development of HAND.	[Santerre, Maryline; Bagashev, Asen; Gorecki, Laura; Lysek, Kyle Z.; Wang, Ying; Shrestha, Jenny; Del Carpio-Cano, Fabiola; Mukerjee, Ruma; Sawaya, Bassel E.] Temple Univ, Sch Med, Mol Studies Neurodegenerat Dis Lab, FELS Inst Canc Res & Mol Biol, Philadelphia, PA 19140 USA; [Bagashev, Asen; Sawaya, Bassel E.] Temple Univ, Sch Med, Dept Anat & Cell Biol, Philadelphia, PA 19140 USA; [Sawaya, Bassel E.] Temple Univ, Sch Med, Dept Neurol, Philadelphia, PA 19140 USA; [Bagashev, Asen] Childrens Hosp Philadelphia, Dept Canc Pathobiol, 4300 Colket Translat Res Bldg,3501 Civ Ctr Blvd, Philadelphia, PA 19104 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Sawaya, BE (corresponding author), Temple Univ, Fels Inst Canc Res, Lewis Katz Sch Med, 3307 N Broad St, Philadelphia, PA 19140 USA.	sawaya@temple.edu	Santerre, Maryline/V-3933-2019; Bagashev, Asen/D-2913-2011	Santerre, Maryline/0000-0003-4650-6552; Bagashev, Asen/0000-0001-9900-8106	National Institutes of Health [R01-NS059327, R01-NS076402, R01-MH093331, R01-AG054411]; NATIONAL INSTITUTE ON AGING [R01AG054411] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants R01-NS059327, R01-NS076402, R01-MH093331, and R01-AG054411 (to B. E. S.). The authors declare that they havenoconflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2007, GENE, V397, P84, DOI 10.1016/j.gene.2007.04.020; Agostini M, 2011, P NATL ACAD SCI USA, V108, P21099, DOI 10.1073/pnas.1112063108; Amini S, 2005, MOL CELL BIOL, V25, P8126, DOI 10.1128/MCB.25.18.8126-8138.2005; Aranha MM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-514; Aslanian A, 2004, GENE DEV, V18, P1413, DOI 10.1101/gad.1196704; Bagashev A, 2014, APOPTOSIS, V19, P1202, DOI 10.1007/s10495-014-1003-2; Chang JR, 2011, J BIOL CHEM, V286, P41125, DOI 10.1074/jbc.M111.268466; Chang SJ, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-65; Cheng J, 1998, NEUROSCIENCE, V82, P97, DOI 10.1016/S0306-4522(97)00174-7; DAILEY ME, 1994, J NEUROSCI, V14, P1060, DOI 10.1523/JNEUROSCI.14-03-01060.1994; del Palacio M, 2012, REV MED VIROL, V22, P33, DOI 10.1002/rmv.711; Dijkhuizen PA, 2005, J NEUROBIOL, V62, P278, DOI 10.1002/neu.20100; Edelmann E, 2014, NEUROPHARMACOLOGY, V76, P610, DOI 10.1016/j.neuropharm.2013.05.043; ENSOLI B, 1993, J VIROL, V67, P277, DOI 10.1128/JVI.67.1.277-287.1993; EVERALL I, 1995, J NEUROVIROL, V1, P126, DOI 10.3109/13550289509111017; Fitting S, 2008, BRAIN RES, V1232, P139, DOI 10.1016/j.brainres.2008.07.032; Goldschneider D, 2003, CANCER LETT, V197, P99, DOI 10.1016/S0304-3835(03)00089-2; Gorantla S, 2012, TRENDS NEUROSCI, V35, P197, DOI 10.1016/j.tins.2011.12.006; HAYMAN M, 1993, NEUROSCIENCE, V53, P1, DOI 10.1016/0306-4522(93)90278-N; Hoe HS, 2009, J NEUROSCI, V29, P7459, DOI 10.1523/JNEUROSCI.4872-08.2009; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Impagnatiello F, 1998, P NATL ACAD SCI USA, V95, P15718, DOI 10.1073/pnas.95.26.15718; Khanna A, 2011, AGING-US, V3, P223, DOI 10.18632/aging.100276; Kida Satoshi, 2012, Exp Neurobiol, V21, P136, DOI 10.5607/en.2012.21.4.136; Kim AH, 2010, SCHIZOPHR RES, V124, P183, DOI 10.1016/j.schres.2010.07.002; Kim BO, 2003, AM J PATHOL, V162, P1693, DOI 10.1016/S0002-9440(10)64304-0; Klein A, 2011, NEUROBIOL DIS, V41, P209, DOI 10.1016/j.nbd.2010.09.008; Koleske AJ, 2013, NAT REV NEUROSCI, V14, P536, DOI 10.1038/nrn3486; KOLSON DL, 1994, J GEN VIROL, V75, P1927, DOI 10.1099/0022-1317-75-8-1927; Kuhla B, 2006, J NEUROSCI RES, V83, P1591, DOI 10.1002/jnr.20838; Kwon M, 2011, J NEUROSCI, V31, P9735, DOI 10.1523/JNEUROSCI.6785-10.2011; Lesiak A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064658; Leuba G, 2008, NEUROBIOL DIS, V30, P408, DOI 10.1016/j.nbd.2008.02.012; Li HD, 2011, NAT NEUROSCI, V14, P1001, DOI 10.1038/nn.2866; Li WX, 2009, NEUROTOX RES, V16, P205, DOI 10.1007/s12640-009-9047-8; LIPTON SA, 1994, MOL NEUROBIOL, V8, P181, DOI 10.1007/BF02780669; LIPTON SA, 1994, DEV NEUROSCI-BASEL, V16, P145, DOI 10.1159/000112101; Marambaud P, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-20; Mayne M, 2000, J IMMUNOL, V164, P6538, DOI 10.4049/jimmunol.164.12.6538; Miller FD, 2000, CELL DEATH DIFFER, V7, P880, DOI 10.1038/sj.cdd.4400736; Mukerjee R, 2008, CELL CYCLE, V7, P2682, DOI 10.4161/cc.7.17.6450; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; O'Dell RS, 2015, J NEUROSCI, V35, P10659, DOI 10.1523/JNEUROSCI.1629-15.2015; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Plowey ED, 2008, J NEUROCHEM, V105, P1048, DOI 10.1111/j.1471-4159.2008.05217.x; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Reimer D, 2011, ONCOGENE, V30, P4038, DOI 10.1038/onc.2011.119; Sakamoto K, 2011, J NEUROCHEM, V116, P1, DOI 10.1111/j.1471-4159.2010.07080.x; Sayas CL, 1999, J BIOL CHEM, V274, P37046, DOI 10.1074/jbc.274.52.37046; Self RL, 2004, BRAIN RES, V995, P39, DOI 10.1016/j.brainres.2003.09.052; Shaywitz AJ, 2000, MOL CELL BIOL, V20, P9409, DOI 10.1128/MCB.20.24.9409-9422.2000; Shi B, 1998, J NEUROVIROL, V4, P281, DOI 10.3109/13550289809114529; Sun Y, 2011, MOL CELLS, V31, P483, DOI 10.1007/s10059-011-1036-0; Tabuchi A, 2002, J BIOL CHEM, V277, P35920, DOI 10.1074/jbc.M204784200; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O; TIMMUSK T, 1994, NEUROCHEM INT, V25, P11, DOI 10.1016/0197-0186(94)90046-9; Truettner JS, 2013, BRAIN RES, V1533, P122, DOI 10.1016/j.brainres.2013.08.011; Valcour Victor G, 2013, Top Antivir Med, V21, P119; WALKER WH, 1995, ENDOCRINOLOGY, V136, P3534, DOI 10.1210/en.136.8.3534; Wang XY, 2009, BRAIN RES BULL, V80, P268, DOI 10.1016/j.brainresbull.2009.08.006; Webber CA, 2013, NEUROSCIENCE, V252, P512, DOI 10.1016/j.neuroscience.2013.07.046; Weeber EJ, 2002, J BIOL CHEM, V277, P39944, DOI 10.1074/jbc.M205147200; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293; Woronowicz A, 2007, GLYCOBIOLOGY, V17, P725, DOI 10.1093/glycob/cwm034; Zhao YN, 2013, BIOCHEM BIOPH RES CO, V435, P597, DOI 10.1016/j.bbrc.2013.05.025	65	16	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3618	3633		10.1074/jbc.RA118.003744	http://dx.doi.org/10.1074/jbc.RA118.003744			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30591585	hybrid, Green Published			2022-12-28	WOS:000461853900025
J	Schelde, KK; Nicholls, K; Dagnaes-Hansen, F; Bunting, K; Rawsthorne, H; Andersen, B; Finnis, CJA; Williamson, M; Cameron, J; Howard, KA				Schelde, Karen Kraemmer; Nicholls, Karl; Dagnaes-Hansen, Frederik; Bunting, Karen; Rawsthorne, Helen; Andersen, Birgitte; Finnis, Christopher J. A.; Williamson, Miranda; Cameron, Jason; Howard, Kenneth A.			A new class of recombinant human albumin with multiple surface thiols exhibits stable conjugation and enhanced FcRn binding and blood circulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						albumin; protein engineering; site-directed mutagenesis; Fc receptor; multidrug transporter; multifunctional protein; cysteine-mediated cross-linking; pharmacokinetics; drug delivery; neonatal Fc receptor	HUMAN SERUM-ALBUMIN; DRUG-DELIVERY; HALF-LIFE; RECEPTOR; PHARMACOKINETICS; GENERATION; INSIGHTS; MOUSE	Human serum albumin is an endogenous ligand transport protein whose long circulatory half-life is facilitated by engagement with the human cellular recycling neonatal Fc receptor (hFcRn). The single free thiol located at Cys-34 in domain I of albumin has been exploited for monoconjugation of drugs. In this work, we increased the drug-to-albumin ratio potential by engineering recombinant human albumin (rHSA) variants with varying hFcRn affinity to contain three free, conjugation-competent cysteines. Structural analysis was used to identify positions for cysteine introduction to maximize rHSA stability and formation of the conjugated product without affecting hFcRn binding. The thiol rHSA variants exhibited up to 95% monomeric stability over 24 months and retained hFcRn engagement compared with a WT unconjugated control demonstrated by Biolayer Interferometry. The additional cysteines were further introduced into a panel of rHSA variants engineered with different affinities for hFcRn. After conjugation with three Alexa Fluor 680 (AF680) fluorophores, hFcRn binding was similar to that of the original triple-thiol nonconjugated rHSA variants (0.88 and 0.25 m for WT albumin with or without 3xAF680 respectively, and 0.04 and 0.02 m for a high hFcRn-binding variant with or without 3xAF680, respectively). We also observed a 1.3-fold increase in the blood circulatory half-life of a high hFcRn-binding triple-thiol variant conjugated with AF680 (t(1/2) = 22.4 h) compared with its WT counterpart (t(1/2) = 17.3 h) in mice. Potential high drug-to-albumin ratios combined with high hFcRn engagement are attractive features of this new class of albumins that offer a paradigm shift for albumin-based drug delivery.	[Schelde, Karen Kraemmer; Howard, Kenneth A.] Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, Dept Mol Biol & Genet, DK-8000 Aarhus C, Denmark; [Dagnaes-Hansen, Frederik] Aarhus Univ, Dept Biomed, DK-8000 Aarhus C, Denmark; [Nicholls, Karl; Bunting, Karen; Rawsthorne, Helen; Finnis, Christopher J. A.; Williamson, Miranda; Cameron, Jason] Albumedix Ltd, Nottingham NG7 1FD, England; [Andersen, Birgitte] Novozymes AS, Krogshoejvej 36, DK-2880 Bagsvaerd, Denmark	Aarhus University; Aarhus University; Novozymes	Howard, KA (corresponding author), Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, Dept Mol Biol & Genet, DK-8000 Aarhus C, Denmark.	kenh@inano.au.dk		Howard, Kenneth/0000-0002-9407-278X	Innovation Fund Denmark [102-2014-3]	Innovation Fund Denmark	This work was supported by Innovation Fund Denmark Grant 102-2014-3. K. N., H. R., and J. C. are employees of Albumedix Ltd., who manufacture and supply albumin for pharmaceutical use.	Andersen JT, 2014, J BIOL CHEM, V289, P13492, DOI 10.1074/jbc.M114.549832; Andersen JT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1607; Andersen JT, 2010, J BIOL CHEM, V285, P4826, DOI 10.1074/jbc.M109.081828; Bienk K, 2016, J CONTROL RELEASE, V232, P143, DOI 10.1016/j.jconrel.2016.04.013; Caspersen MB, 2017, THER DELIV, V8, P511, DOI 10.4155/tde-2017-0038; Chaudhury C, 2003, J EXP MED, V197, P315, DOI 10.1084/jem.20021829; Curry S, 1999, BBA-MOL CELL BIOL L, V1441, P131, DOI 10.1016/S1388-1981(99)00148-1; Evans L, 2010, PROTEIN EXPRES PURIF, V73, P113, DOI 10.1016/j.pep.2010.05.009; Howard KA, 2015, THER DELIV, V6, P265, DOI [10.4155/tde.14.124, 10.4155/TDE.14.124]; Kim JH, 2006, AM J PHYSIOL-GASTR L, V290, pG352, DOI 10.1152/ajpgi.00286.2005; Kratz F, 2000, J MED CHEM, V43, P1253, DOI 10.1021/jm9905864; Krieger E, 2014, BIOINFORMATICS, V30, P2981, DOI 10.1093/bioinformatics/btu426; Kuhlmann M, 2017, MOL THER-NUCL ACIDS, V9, P284, DOI 10.1016/j.omtn.2017.10.004; Larsen MT, 2018, J CONTROL RELEASE, V287, P132, DOI 10.1016/j.jconrel.2018.07.023; Larsen Maja Thim, 2016, Mol Cell Ther, V4, P3, DOI 10.1186/s40591-016-0048-8; Miyamura S, 2016, J PHARM SCI-US, V105, P1043, DOI 10.1016/j.xphs.2015.12.015; Oganesyan V, 2014, J BIOL CHEM, V289, P7812, DOI 10.1074/jbc.M113.537563; Petersen SS, 2016, MOL PHARMACEUT, V13, P677, DOI 10.1021/acs.molpharmaceut.5b00605; Roopenian DC, 2015, MABS-AUSTIN, V7, P344, DOI 10.1080/19420862.2015.1008345; Sand KMK, 2014, J BIOL CHEM, V289, P34583, DOI 10.1074/jbc.M114.587675; Schmidt EGW, 2017, J BIOL CHEM, V292, P13312, DOI 10.1074/jbc.M117.794248; Schmidt MM, 2013, STRUCTURE, V21, P1966, DOI 10.1016/j.str.2013.08.022; Schmokel J, 2017, NANOTECHNOLOGY, V28, DOI 10.1088/1361-6528/aa6a9b; Sleep D, 2015, EXPERT OPIN DRUG DEL, V12, P793, DOI 10.1517/17425247.2015.993313; Smith MEB, 2015, ORG BIOMOL CHEM, V13, P7946, DOI 10.1039/c5ob01205h; Viuff D, 2016, J CONTROL RELEASE, V223, P22, DOI 10.1016/j.jconrel.2015.12.019	26	13	14	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3735	3743		10.1074/jbc.RA118.005870	http://dx.doi.org/10.1074/jbc.RA118.005870			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30602565	Green Published, hybrid			2022-12-28	WOS:000461853900034
J	Suvarna, K; Honda, K; Muroi, M; Kondoh, Y; Osada, H; Watanabe, N				Suvarna, Kruthi; Honda, Kaori; Muroi, Makoto; Kondoh, Yasumitsu; Osada, Hiroyuki; Watanabe, Nobumoto			A small-molecule ligand of valosin-containing protein/p97 inhibits cancer cell-accelerated fibroblast migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell migration; small molecule; cancer; tumor metastasis; chemical biology; tumor microenvironment; extracellular matrix; cancer-associated fibroblast (CAF); p97; valosin-containing protein (VCP)	COLORECTAL-CANCER; VCP; IDENTIFICATION; METASTASIS; ACTIVATION; STRESS; DRIVES; STROMA; UBXD1	Carcinoma-associated fibroblasts are fibroblasts activated by surrounding cancer cells. Carcinoma-associated fibroblasts exhibit enhanced cell migration, which plays an important role in cancer metastasis. Previously, we demonstrated enhanced migration of NIH3T3 fibroblasts when they were cultured in the presence of MCF7 breast cancer cells. Human fibroblasts displayed a similar phenomenon even when they were co-cultured with cancer cells other than MCF7 cells. In this study, we screened approximate to 16,000 compounds from the RIKEN Natural Products Depository chemical library for inhibitors of enhanced NIH3T3 cell migration in the presence of MCF7. We identified NPD8733 as an inhibitor of cancer cell-enhanced fibroblast migration. This inhibition was observed not only in a wound-healing co-culture assay but also in a Transwell migration assay. Using NPD8733 and a structurally similar but inactive derivative, NPD8126, on immobilized beads, we found that NPD8733, but not NPD8126, specifically binds to valosin-containing protein (VCP)/p97, a member of the ATPase-associated with diverse cellular activities (AAA+) protein family. Using VCP truncation variants, we found that NPD8733 binds to the D1 domain of VCP. Because VCP's D1 domain is important for its function, we concluded that NPD8733 may act on VCP by binding to this domain. siRNA-mediated silencing of VCP in NIH3T3 fibroblasts, but not in MCF7 cells, reduced the migration of the co-cultured NIH3T3 fibroblasts. These results indicate that MCF7 activates the migration of NIH3T3 cells through VCP and that NPD8733 binds VCP and thereby inhibits its activity.	[Suvarna, Kruthi; Honda, Kaori; Watanabe, Nobumoto] RIKEN, Ctr Sustainable Resource Sci, Bioact Cpds Discovery Res Unit, Saitama 3510198, Japan; [Honda, Kaori; Muroi, Makoto; Kondoh, Yasumitsu; Osada, Hiroyuki] RIKEN, Ctr Sustainable Resource Sci, Chem Biol Res Grp, Saitama 3510198, Japan; [Osada, Hiroyuki; Watanabe, Nobumoto] RIKEN, Ctr Sustainable Resource Sci, RIKEN Max Planck Joint Res Div, Saitama 3510198, Japan; [Suvarna, Kruthi; Watanabe, Nobumoto] Tokyo Med Dent Univ, Tokyo 1138510, Japan	RIKEN; RIKEN; RIKEN; Tokyo Medical & Dental University (TMDU)	Watanabe, N (corresponding author), RIKEN, Ctr Sustainable Resource Sci, RIKEN Max Planck Joint Res Div, Bioprobe Applicat Res Unit, Wako, Saitama 3510198, Japan.	nwatanab@riken.jp	Osada, Hiroyuki/N-4305-2014; Osada, Hiroyuki/AAY-6254-2020; Watanabe, Nobumoto/N-6959-2015; Suvarna, Kruthi Sharanjeet/HHC-2905-2022	Watanabe, Nobumoto/0000-0002-2130-1334; Suvarna, Kruthi/0000-0002-4778-0986; MUROI, Makoto/0000-0002-4323-9527	JSPS KAKENHI [JP16H06276, JP17H06412, JP18H03945, JP17K07783]; NARO Bio-oriented Technology Research Advancement Institution; RIKEN International Program Associate; AMED [JP18cm0106112]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NARO Bio-oriented Technology Research Advancement Institution; RIKEN International Program Associate; AMED	This work was supported in part by JSPS KAKENHI Grants JP16H06276, JP17H06412, JP18H03945, and JP17K07783; AMEDGrant JP18cm0106112, and the NARO Bio-oriented Technology Research Advancement Institution (Research Program on Development of Innovative Technology). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the RIKEN International Program Associate.	Amornsupak K, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-955; Asai T, 2002, JPN J CANCER RES, V93, P296, DOI 10.1111/j.1349-7006.2002.tb02172.x; Buchsbaum RJ, 2016, CANCERS, V8, DOI 10.3390/cancers8020019; Chapman E, 2015, MOLECULES, V20, P4357, DOI 10.3390/molecules20034357; Chen XM, 2019, NAT REV DRUG DISCOV, V18, P99, DOI 10.1038/s41573-018-0004-1; Chevet E, 2015, CANCER DISCOV, V5, P586, DOI 10.1158/2159-8290.CD-14-1490; Cirri P, 2011, AM J CANCER RES, V1, P482; Truong D, 2016, SCI REP-UK, V6, DOI 10.1038/srep34094; DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972; Fu QF, 2016, MOL CELL BIOCHEM, V418, P189, DOI 10.1007/s11010-016-2746-6; Gascard P, 2016, GENE DEV, V30, P1002, DOI 10.1101/gad.279737.116; Henriksson ML, 2011, AM J PATHOL, V178, P1387, DOI 10.1016/j.ajpath.2010.12.008; Kanoh N, 2005, ANGEW CHEM INT EDIT, V44, P3559, DOI 10.1002/anie.200462370; Kawatani M, 2008, P NATL ACAD SCI USA, V105, P11691, DOI 10.1073/pnas.0712239105; Kojima Y, 2010, P NATL ACAD SCI USA, V107, P20009, DOI 10.1073/pnas.1013805107; LeBeau AM, 2009, MOL CANCER THER, V8, P1378, DOI 10.1158/1535-7163.MCT-08-1170; Lundgren K, 2011, J MOL DIAGN, V13, P340, DOI 10.1016/j.jmoldx.2011.01.009; Magnaghi P, 2013, NAT CHEM BIOL, V9, P548, DOI [10.1038/nchembio.1313, 10.1038/NCHEMBIO.1313]; Martinez-Outschoorn UE, 2010, CELL CYCLE, V9, P3256, DOI 10.4161/cc.9.16.12553; Meyer H, 2014, J CELL SCI, V127, P3877, DOI 10.1242/jcs.093831; Papadopoulos C, 2017, EMBO J, V36, P135, DOI 10.15252/embj.201695148; Ritz D, 2011, NAT CELL BIOL, V13, P1116, DOI 10.1038/ncb2301; Santos AM, 2009, J CLIN INVEST, V119, P3613, DOI 10.1172/JCI38988; Sasazawa Y, 2012, ACS CHEM BIOL, V7, P892, DOI 10.1021/cb200492h; Shiga K, 2015, CANCERS, V7, P2443, DOI 10.3390/cancers7040902; Song CC, 2003, J BIOL CHEM, V278, P3648, DOI 10.1074/jbc.M208422200; Suvarna K, 2018, CANCER MED-US, V7, P883, DOI 10.1002/cam4.1339; Tashimo Hiroyuki, 2007, Allergol Int, V56, P241, DOI 10.2332/allergolint.O-06-456; Togo Shinsaku, 2013, Cancers (Basel), V5, P149, DOI 10.3390/cancers5010149; Valle CW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029073; Wang QY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015479; Yeo BK, 2016, ANIM CELLS SYST, V20, P303, DOI 10.1080/19768354.2016.1259181	32	10	10	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2019	294	9					2988	2996		10.1074/jbc.RA118.004741	http://dx.doi.org/10.1074/jbc.RA118.004741			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU0SA	30610116	Green Published, hybrid			2022-12-28	WOS:000464980100002
J	Pobre, KFR; Poet, GJ; Hendershot, LM				Pobre, Kristine Faye R.; Poet, Greg J.; Hendershot, Linda M.			The endoplasmic reticulum (ER) chaperone BiP is a master regulator of ER functions: Getting by with a little help from ERdj friends	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						heat shock protein (HSP); endoplasmic reticulum (ER); endoplasmic reticulum-associated protein degradation (ERAD); GRP78; ATPase; molecular chaperone; protein misfolding; protein folding; stress response; unfolded protein response (UPR); BiP; ER-localized DnaJ proteins	PROTEIN DISULFIDE-ISOMERASE; POLYPEPTIDE-BINDING SITE; CO-CHAPERONE; CELLULAR INHIBITOR; DNAJ HOMOLOG; IN-VITRO; UNFOLDED PROTEINS; CRYSTAL-STRUCTURE; RESIDENT PROTEIN; YEAST HSP40	The endoplasmic reticulum (ER) represents the entry point into the secretory pathway where nascent proteins encounter a specialized environment for their folding and maturation. Inherent to these processes is a dedicated quality-control system that detects proteins that fail to mature properly and targets them for cytosolic degradation. An imbalance in protein folding and degradation can result in the accumulation of unfolded proteins in the ER, resulting in the activation of a signaling cascade that restores proper homeostasis in this organelle. The ER heat shock protein 70 (Hsp70) family member BiP is an ATP-dependent chaperone that plays a critical role in these processes. BiP interacts with specific ER-localized DnaJ family members (ERdjs), which stimulate BiP's ATP-dependent substrate interactions, with several ERdjs also binding directly to unfolded protein clients. Recent structural and biochemical studies have provided detailed insights into the allosteric regulation of client binding by BiP and have enhanced our understanding of how specific ERdjs enable BiP to perform its many functions in the ER. In this review, we discuss how BiP's functional cycle and interactions with ERdjs enable it to regulate protein homeostasis in the ER and ensure protein quality control.	[Pobre, Kristine Faye R.; Poet, Greg J.; Hendershot, Linda M.] St Jude Childrens Res Hosp, Dept Tumor Cell Biol, 332 N Lauderdale St, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Hendershot, LM (corresponding author), St Jude Childrens Res Hosp, Dept Tumor Cell Biol, 332 N Lauderdale St, Memphis, TN 38105 USA.	linda.hendershot@stjude.org	Pobre, Kristine Faye R./Q-4074-2019; Hendershot, Linda/N-8124-2018	Hendershot, Linda/0000-0002-5473-0274; Poet, Greg/0000-0002-9923-5218	American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital; National Institutes of Health NIGMS [5R01GM054068-20]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054068] Funding Source: NIH RePORTER	American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); National Institutes of Health NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital and National Institutes of Health NIGMS Grant 5R01GM054068-20 (to L. M. H.). This is the third article in the JBC Reviews series "Molecular chaperones and protein quality control." The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amin-Wetzel N, 2017, CELL, V171, P1625, DOI 10.1016/j.cell.2017.10.040; Athanasiou D, 2014, HUM MOL GENET, V23, P6594, DOI 10.1093/hmg/ddu385; Behnke J, 2016, MOL CELL, V63, P739, DOI 10.1016/j.molcel.2016.07.012; Behnke J, 2015, J MOL BIOL, V427, P1589, DOI 10.1016/j.jmb.2015.02.011; Benedix J, 2010, J BIOL CHEM, V285, P36427, DOI 10.1074/jbc.M110.143263; Berger BJ, 2003, EXP CELL RES, V290, P82, DOI 10.1016/S0014-4827(03)00316-1; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Blau M, 2005, NAT STRUCT MOL BIOL, V12, P1015, DOI 10.1038/nsmb998; BLONDELGUINDI S, 1993, CELL, V75, P717, DOI 10.1016/0092-8674(93)90492-9; Bonomo J, 2010, BIOPHYS CHEM, V149, P58, DOI 10.1016/j.bpc.2010.04.001; Braakman I, 2011, ANNU REV BIOCHEM, V80, P71, DOI 10.1146/annurev-biochem-062209-093836; BRODSKY JL, 1993, J CELL BIOL, V123, P1355, DOI 10.1083/jcb.123.6.1355; Buck TM, 2010, MOL BIOL CELL, V21, P1047, DOI 10.1091/mbc.E09-11-0944; CARLSSON L, 1983, P NATL ACAD SCI-BIOL, V80, P4664, DOI 10.1073/pnas.80.15.4664; Cheetham ME, 1998, CELL STRESS CHAPERON, V3, P28, DOI 10.1379/1466-1268(1998)003<0028:SFAEOD>2.3.CO;2; Chen KC, 2017, EMBO J, V36, P2296, DOI 10.15252/embj.201695616; Cunnea PM, 2003, J BIOL CHEM, V278, P1059, DOI 10.1074/jbc.M206995200; Dejgaard K, 2010, J PROTEOME RES, V9, P1763, DOI 10.1021/pr900900x; Dong M, 2008, MOL BIOL CELL, V19, P2620, DOI 10.1091/mbc.E07-07-0674; Dudek J, 2005, NAT STRUCT MOL BIOL, V12, P1008, DOI 10.1038/nsmb1007; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Ellgaard L, 2018, TRENDS BIOCHEM SCI, V43, P32, DOI 10.1016/j.tibs.2017.10.006; Fedeles SV, 2015, J CLIN INVEST, V125, P1955, DOI 10.1172/JCI78863; Feige MJ, 2009, MOL CELL, V34, P569, DOI 10.1016/j.molcel.2009.04.028; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; FREIDEN PJ, 1992, EMBO J, V11, P63, DOI 10.1002/j.1460-2075.1992.tb05028.x; Fritz JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107473; Fritz JM, 2014, MOL BIOL CELL, V25, P431, DOI 10.1091/mbc.E13-06-0319; Genereux JC, 2015, EMBO J, V34, P4, DOI 10.15252/embj.201488896; Guo F, 2013, J CELL SCI, V126, P1429, DOI 10.1242/jcs.118182; Hagiwara M, 2011, MOL CELL, V41, P432, DOI 10.1016/j.molcel.2011.01.021; Ham H, 2014, J BIOL CHEM, V289, P36059, DOI 10.1074/jbc.M114.612515; Hassdenteufel S, 2018, CELL REP, V23, P1373, DOI 10.1016/j.celrep.2018.03.122; He KY, 2015, CRIT REV BIOCHEM MOL, V50, P477, DOI 10.3109/10409238.2015.1085826; HENDERSHOT LM, 1988, MOL CELL BIOL, V8, P4250, DOI 10.1128/MCB.8.10.4250; Hosoda A, 2003, J BIOL CHEM, V278, P2669, DOI 10.1074/jbc.M208346200; Hosoda A, 2010, BIOCHEM J, V425, P117, DOI 10.1042/BJ20091269; Hughes SJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154862; Inoue T, 2015, J VIROL, V89, P8897, DOI 10.1128/JVI.00941-15; Jin Y, 2008, EMBO J, V27, P2873, DOI 10.1038/emboj.2008.207; Jin Y, 2009, BIOCHEMISTRY-US, V48, P41, DOI 10.1021/bi8015923; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; KARTENBECK J, 1989, J CELL BIOL, V109, P2721, DOI 10.1083/jcb.109.6.2721; Khodayari N, 2017, J CELL BIOCHEM, V118, P3090, DOI 10.1002/jcb.26069; Kityk R, 2018, MOL CELL, V69, P227, DOI 10.1016/j.molcel.2017.12.003; Kityk R, 2012, MOL CELL, V48, P863, DOI 10.1016/j.molcel.2012.09.023; Lai CW, 2012, J BIOL CHEM, V287, P7969, DOI 10.1074/jbc.M111.311290; Lang S, 2012, J CELL SCI, V125, P1958, DOI 10.1242/jcs.096727; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; LEE TG, 1994, MOL CELL BIOL, V14, P2331, DOI 10.1128/MCB.14.4.2331; LEE TG, 1990, P NATL ACAD SCI USA, V87, P6208, DOI 10.1073/pnas.87.16.6208; Leidig C, 2013, NAT STRUCT MOL BIOL, V20, P23, DOI 10.1038/nsmb.2447; Li JZ, 2003, STRUCTURE, V11, P1475, DOI 10.1016/j.str.2003.10.012; Li Y, 2004, J CELL BIOL, V164, P35, DOI 10.1083/jcb.200307010; Maegawa K, 2017, STRUCTURE, V25, P846, DOI 10.1016/j.str.2017.04.001; Marcinowski M, 2011, NAT STRUCT MOL BIOL, V18, P150, DOI 10.1038/nsmb.1970; Marcus NY, 2007, ARCH BIOCHEM BIOPHYS, V468, P147, DOI 10.1016/j.abb.2007.10.001; Mayer MP, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0183; Mayer MP, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00058; Meunier L, 2002, MOL BIOL CELL, V13, P4456, DOI 10.1091/mbc.E02-05-0311; Misselwitz B, 1998, MOL CELL, V2, P593, DOI 10.1016/S1097-2765(00)80158-6; Nishikawa S, 2001, J CELL BIOL, V153, P1061, DOI 10.1083/jcb.153.5.1061; Ohta M, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.28194; Oka OBV, 2013, MOL CELL, V50, P793, DOI 10.1016/j.molcel.2013.05.014; Otero JH, 2014, J BIOL CHEM, V289, P27504, DOI 10.1074/jbc.M114.587147; Oyadomari S, 2006, CELL, V126, P727, DOI 10.1016/j.cell.2006.06.051; Petrova K, 2008, EMBO J, V27, P2862, DOI 10.1038/emboj.2008.199; Preissler S, 2017, ELIFE, V6, DOI 10.7554/eLife.29428; Preissler S, 2017, NAT STRUCT MOL BIOL, V24, P23, DOI 10.1038/nsmb.3337; Preissler S, 2015, ELIFE, V4, DOI 10.7554/eLife.12621; Prols F, 2001, EXP CELL RES, V269, P42, DOI 10.1006/excr.2001.5294; PUIG A, 1994, J BIOL CHEM, V269, P19128; Qi RF, 2013, NAT STRUCT MOL BIOL, V20, P900, DOI 10.1038/nsmb.2583; Roobol A, 2015, BIOCHEM J, V465, P213, DOI 10.1042/BJ20140852; Rudiger S, 2001, EMBO J, V20, P1042, DOI 10.1093/emboj/20.5.1042; Rutkowski DT, 2007, MOL BIOL CELL, V18, P3681, DOI 10.1091/mbc.e07-03-0272; Sanyal A, 2015, J BIOL CHEM, V290, P8482, DOI 10.1074/jbc.M114.618348; Shen Y, 2005, MOL BIOL CELL, V16, P40, DOI 10.1091/mbc.E04-05-0434; Shen Y, 2002, J BIOL CHEM, V277, P15947, DOI 10.1074/jbc.M112214200; Svard M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022337; Tan YL, 2014, CHEM BIOL, V21, P967, DOI 10.1016/j.chembiol.2014.06.008; Tang NM, 1996, J BIOL CHEM, V271, P28660, DOI 10.1074/jbc.271.45.28660; Tao JH, 2010, J MOL BIOL, V397, P1307, DOI 10.1016/j.jmb.2010.02.028; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; Ushioda R, 2008, SCIENCE, V321, P569, DOI 10.1126/science.1159293; Ushioda R, 2016, P NATL ACAD SCI USA, V113, pE6055, DOI 10.1073/pnas.1605818113; van Galen P, 2014, NATURE, V510, P268, DOI 10.1038/nature13228; Vanhove M, 2001, IMMUNITY, V15, P105, DOI 10.1016/S1074-7613(01)00163-7; WEI JY, 1995, J BIOL CHEM, V270, P26677, DOI 10.1074/jbc.270.44.26677; Weitzmann A, 2007, FEBS J, V274, P5175, DOI 10.1111/j.1742-4658.2007.06039.x; Wieteska L, 2017, ELIFE, V6, DOI 10.7554/eLife.29430.001; Williams JM, 2013, MOL BIOL CELL, V24, P785, DOI 10.1091/mbc.E12-07-0522; Wittke S, 2000, MOL BIOL CELL, V11, P3859, DOI 10.1091/mbc.11.11.3859; Wu YK, 2005, J MOL BIOL, V346, P1005, DOI 10.1016/j.jmb.2004.12.040; Yan W, 2002, P NATL ACAD SCI USA, V99, P15920, DOI 10.1073/pnas.252341799; Yang J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01310-z; Yang J, 2015, STRUCTURE, V23, P2191, DOI 10.1016/j.str.2015.10.012; Yu M, 2000, J BIOL CHEM, V275, P24984, DOI 10.1074/jbc.M000739200; Zahedi RP, 2009, PROTEOMICS, V9, P3463, DOI 10.1002/pmic.200800722; Zhuravleva A, 2012, CELL, V151, P1296, DOI 10.1016/j.cell.2012.11.002	102	147	152	21	80	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2019	294	6					2098	2108		10.1074/jbc.REV118.002804	http://dx.doi.org/10.1074/jbc.REV118.002804			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM8EO	30563838	hybrid, Green Published			2022-12-28	WOS:000459711400028
J	Schiano-di-Cola, C; Rojel, N; Jensen, K; Kari, J; Sorensen, TH; Borch, K; Westh, P				Schiano-di-Cola, Corinna; Rojel, Nanna; Jensen, Kenneth; Kari, Jeppe; Sorensen, Trine Holst; Borch, Kim; Westh, Peter			Systematic deletions in the cellobiohydrolase (CBH) Cel7A from the fungus Trichoderma reesei reveal flexible loops critical for CBH activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein engineering; cellulase; cellobiohydrolase; cellulose; enzyme kinetics; Trichoderma reesei; Cel7A; Cel7B; endoglucanase; loop engineering	CELLULOSE HYDROLYSIS; ENZYMATIC-HYDROLYSIS; PRODUCT INHIBITION; CRYSTAL-STRUCTURES; ENDOGLUCANASE-I; CATALYTIC CORE; CELLULASES; KINETICS; MECHANISM; ACID	Glycoside hydrolase family 7 (GH7) cellulases are some of the most efficient degraders of cellulose, making them particularly relevant for industries seeking to produce renewable fuels from lignocellulosic biomass. The secretome of the cellulolytic model fungus Trichoderma reesei contains two GH7s, termed TrCel7A and TrCel7B. Despite having high structural and sequence similarities, the two enzymes are functionally quite different. TrCel7A is an exolytic, processive cellobiohydrolase (CBH), with high activity on crystalline cellulose, whereas TrCel7B is an endoglucanase (EG) with a preference for more amorphous cellulose. At the structural level, these functional differences are usually ascribed to the flexible loops that cover the substrate-binding areas. TrCel7A has an extensive tunnel created by eight peripheral loops, and the absence of four of these loops in TrCel7B makes its catalytic domain a more open cleft. To investigate the structure-function relationships of these loops, here we produced and kinetically characterized several variants in which four loops unique to TrCel7A were individually deleted to resemble the arrangement in the TrCel7B structure. Analysis of a range of kinetic parameters consistently indicated that the B2 loop, covering the substrate-binding subsites -3 and -4 in TrCel7A, was a key determinant for the difference in CBH- or EG-like behavior between TrCel7A and TrCel7B. Conversely, the B3 and B4 loops, located closer to the catalytic site in TrCel7A, were less important for these activities. We surmise that these results could be useful both in further mechanistic investigations and for guiding engineering efforts of this industrially important enzyme family.	[Schiano-di-Cola, Corinna; Rojel, Nanna; Kari, Jeppe; Sorensen, Trine Holst] Roskilde Univ, Dept Sci & Environm, Univ Vej 1,Bldg 28, DK-4000 Roskilde, Denmark; [Jensen, Kenneth; Borch, Kim] Novozymes AS, Krogshojvej 36, DK-2880 Bagsvaerd, Denmark; [Schiano-di-Cola, Corinna; Rojel, Nanna; Westh, Peter] Tech Univ Denmark, Dept Biotechnol & Biomed, Bldg 224, DK-2800 Lyngby, Denmark	Roskilde University; Novozymes; Technical University of Denmark	Westh, P (corresponding author), Tech Univ Denmark, Dept Biotechnol & Biomed, Bldg 224, DK-2800 Lyngby, Denmark.	petwe@dtu.dk	Jensen, Kenneth/G-3638-2011; Westh, Peter/AAR-9731-2021; Kari, Jeppe/AAP-6649-2021	Jensen, Kenneth/0000-0001-6286-5577; Kari, Jeppe/0000-0003-3792-3856; Sorensen, Trine Holst/0000-0002-2045-7580; Westh, Peter/0000-0002-6185-0637; Schiano-di-Cola, Corinna/0000-0002-6720-1734; Rojel, Nanna/0000-0003-2887-3738	Innovation Fund Denmark [5150-00020B]; Novo Nordisk Foundation [NNF15OC0016606]	Innovation Fund Denmark; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	This work was supported by Innovation Fund Denmark Grant 5150-00020B to P.W.) and Novo Nordisk Foundation Grant NNF15OC0016606. K.J. and K.B. are employed by Novozymes, a major enzyme-producing company.	Akpa OM, 2011, DESALINATION, V272, P20, DOI 10.1016/j.desal.2010.12.057; Alasepp K, 2014, LANGMUIR, V30, P7134, DOI 10.1021/la500161e; Andersen M, 2018, MATH BIOSCI, V296, P93, DOI 10.1016/j.mbs.2017.11.011; Badino SF, 2017, BBA-PROTEINS PROTEOM, V1865, P1739, DOI 10.1016/j.bbapap.2017.08.013; BAILEY CJ, 1989, BIOCHEM J, V262, P1001; Bezerra RMF, 2004, APPL BIOCHEM BIOTECH, V112, P173, DOI 10.1385/ABAB:112:3:173; Borch K., 2014, WIPO patent, Patent No. 2014138672; Bu LT, 2013, J BIOL CHEM, V288, P12175, DOI 10.1074/jbc.M113.462465; Bu LT, 2012, J BIOL CHEM, V287, P24807, DOI 10.1074/jbc.M112.365510; Cruys-Bagger N, 2013, FEBS J, V280, P3952, DOI 10.1111/febs.12397; Cruys-Bagger N, 2012, J BIOL CHEM, V287, P18451, DOI 10.1074/jbc.M111.334946; Divne C, 1998, J MOL BIOL, V275, P309, DOI 10.1006/jmbi.1997.1437; DIVNE C, 1994, SCIENCE, V265, P524, DOI 10.1126/science.8036495; HENRISSAT B, 1985, BIO-TECHNOL, V3, P722, DOI 10.1038/nbt0885-722; Herpoel-Gimbert I, 2008, BIOTECHNOL BIOFUELS, V1, DOI 10.1186/1754-6834-1-18; Hobdey SE, 2016, APPL ENVIRON MICROB, V82, P3395, DOI 10.1128/AEM.00163-16; Jalak J, 2012, J BIOL CHEM, V287, P28802, DOI 10.1074/jbc.M112.381624; Jalak J, 2010, BIOTECHNOL BIOENG, V106, P871, DOI 10.1002/bit.22779; Kari J, 2017, ACS CATAL, V7, P4904, DOI 10.1021/acscatal.7b00838; Kari J, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.604264; Kletting P, 2009, PHYS MED BIOL, V54, pN501, DOI 10.1088/0031-9155/54/21/N01; Kleywegt GJ, 1997, J MOL BIOL, V272, P383, DOI 10.1006/jmbi.1997.1243; Knott BC, 2014, J AM CHEM SOC, V136, P321, DOI 10.1021/ja410291u; Kostylev M, 2012, BIOFUELS-UK, V3, P61, DOI 10.4155/BFS.11.150; Kurasin M, 2011, J BIOL CHEM, V286, P169, DOI 10.1074/jbc.M110.161059; LEVER M, 1973, BIOCHEM MED METAB B, V7, P274, DOI 10.1016/0006-2944(73)90083-5; MEINKE A, 1995, J BIOL CHEM, V270, P4383, DOI 10.1074/jbc.270.9.4383; Mertz B, 2009, BIOPOLYMERS, V91, P478, DOI 10.1002/bip.21154; Momeni MH, 2013, J BIOL CHEM, V288, P5861, DOI 10.1074/jbc.M112.440891; Murphy L, 2013, ENZYME MICROB TECH, V52, P163, DOI 10.1016/j.enzmictec.2013.01.002; Olsen JP, 2017, ENZYME MICROB TECH, V105, P45, DOI 10.1016/j.enzmictec.2017.06.009; Olsen JP, 2016, BIOTECHNOL BIOENG, V113, P1178, DOI 10.1002/bit.25900; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pellegrini VOA, 2014, LANGMUIR, V30, P12602, DOI 10.1021/la5024423; PENTTILA M, 1986, GENE, V45, P253, DOI 10.1016/0378-1119(86)90023-5; Praestgaard E, 2011, FEBS J, V278, P1547, DOI 10.1111/j.1742-4658.2011.08078.x; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rosgaard L, 2007, BIOTECHNOL PROGR, V23, P1270, DOI 10.1021/bp070329p; Saloheimo M, 2012, MICROBIOL-SGM, V158, P46, DOI 10.1099/mic.0.053132-0; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Silveira RL, 2018, PHYS CHEM CHEM PHYS, V20, P7498, DOI 10.1039/c8cp00101d; Sorensen TH, 2015, J BIOL CHEM, V290, P22193, DOI 10.1074/jbc.M115.658930; Stahlberg J, 1996, J MOL BIOL, V264, P337, DOI 10.1006/jmbi.1996.0644; STAHLBERG J, 1993, BIOCHIM BIOPHYS ACTA, V1157, P107, DOI 10.1016/0304-4165(93)90085-M; Taylor CB, 2013, J PHYS CHEM B, V117, P4924, DOI 10.1021/jp401410h; Teugjas H, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-104; Valjamae P, 1999, EUR J BIOCHEM, V266, P327, DOI 10.1046/j.1432-1327.1999.00853.x; Velleste R, 2010, CELLULOSE, V17, P125, DOI 10.1007/s10570-009-9356-3; von Ossowski I, 2003, J MOL BIOL, V333, P817, DOI 10.1016/S0022-2836(03)00881-7; Zhang YHP, 2006, BIOMACROMOLECULES, V7, P644, DOI 10.1021/bm050799c; Zhang YHP, 2004, BIOTECHNOL BIOENG, V88, P797, DOI 10.1002/bit.20282	51	23	24	4	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2019	294	6					1807	1815		10.1074/jbc.RA118.006699	http://dx.doi.org/10.1074/jbc.RA118.006699			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM8EO	30538133	Green Published, hybrid			2022-12-28	WOS:000459711400004
J	Raychaudhury, P; Marians, KJ				Raychaudhury, Paromita; Marians, Kenneth J.			The recombination mediator proteins RecFOR maintain RecA* levels for maximal DNA polymerase V Mut activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA damage; DNA polymerase; DNA repair; DNA recombination; nucleic acid enzymology; lesion bypass; RecA; recombination mediator protein; translesion synthesis	SINGLE-STRANDED-DNA; EXCISION-DEFECTIVE STRAIN; ESCHERICHIA-COLI; BIOCHEMICAL BASIS; POL-V; III HOLOENZYME; SOS; MUTAGENESIS; BINDING; MUTATIONS	DNA template damage can potentially block DNA replication. Cells have therefore developed different strategies to repair template lesions. Activation of the bacterial lesion bypass DNA polymerase V (Pol V) requires both the cleavage of the UmuD subunit to UmuD ' and the acquisition of a monomer of activated RecA recombinase, forming Pol V Mut. Both of these events are mediated by the generation of RecA* via the formation of a RecA-ssDNA filament during the SOS response. Formation of RecA* is itself modulated by competition with the ssDNA-binding protein (SSB) for binding to ssDNA. Previous observations have demonstrated that RecA filament formation on SSB-coated DNA can be favored in the presence of the recombination mediator proteins RecF, RecO, and RecR. We show here using purified proteins that in the presence of SSB and RecA, a stable RecA-ssDNA filament is not formed, although sufficient RecA* is generated to support some activation of Pol V. The presence of RecFOR increased RecA* generation and allowed Pol V to synthesize longer DNA products and to elongate from an unpaired primer terminus opposite template damage, also without the generation of a stable RecA-ssDNA filament.	[Raychaudhury, Paromita; Marians, Kenneth J.] Mem Sloan Kettering Canc Ctr, Mol Biol Program, 1275 York Ave, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Marians, KJ (corresponding author), Mem Sloan Kettering Canc Ctr, Mol Biol Program, 1275 York Ave, New York, NY 10065 USA.	kmarians@sloankettering.edu	Raychaudhury, Paromita/AAE-9186-2020	Raychaudhury, Paromita/0000-0003-1087-1240	National Institutes of Health [R01 GM34557, R35 GM126907]; Cancer Center Support Grant NCI [P30CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034557, R35GM126907] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support Grant NCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in whole or in part by National Institutes of Health Grants R01 GM34557 and R35 GM126907 (to K.J.M.) and Cancer Center Support Grant NCI P30CA008748 (to the Memorial Sloan Kettering Cancer Center). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arad G, 2008, J BIOL CHEM, V283, P8274, DOI 10.1074/jbc.M710290200; Bork JM, 2001, EMBO J, V20, P7313, DOI 10.1093/emboj/20.24.7313; CASTELLAZZI M, 1972, MOL GEN GENET, V119, P139, DOI 10.1007/BF00269133; DUTREIX M, 1989, J BACTERIOL, V171, P2415, DOI 10.1128/jb.171.5.2415-2423.1989; Eggler AL, 2003, J BIOL CHEM, V278, P16389, DOI 10.1074/jbc.M212920200; Erdem AL, 2014, ELIFE, V3, DOI 10.7554/eLife.02384; Fijalkowska IJ, 2012, FEMS MICROBIOL REV, V36, P1105, DOI 10.1111/j.1574-6976.2012.00338.x; Fuchs RP, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012682; Fujii S, 2006, EMBO J, V25, P5754, DOI 10.1038/sj.emboj.7601474; Fujii S, 2009, P NATL ACAD SCI USA, V106, P14825, DOI 10.1073/pnas.0905855106; Gabbai CB, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.613257; Giese KC, 2008, J MOL BIOL, V377, P148, DOI 10.1016/j.jmb.2007.12.025; Goodman MF, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010363; HEGDE S, 1995, MOL GEN GENET, V246, P254, DOI 10.1007/BF00294689; Jiang QF, 2009, NATURE, V460, P359, DOI 10.1038/nature08178; JOHANSON KO, 1986, J BIOL CHEM, V261, P1460; Karata K, 2012, DNA REPAIR, V11, P431, DOI 10.1016/j.dnarep.2012.01.012; KATO T, 1977, MOL GEN GENET, V156, P121, DOI 10.1007/BF00283484; LAVERY PE, 1992, J BIOL CHEM, V267, P20648; LAVERY PE, 1988, J MOL BIOL, V203, P861, DOI 10.1016/0022-2836(88)90112-X; LAVERY PE, 1990, J BIOL CHEM, V265, P4004; LITTLE JW, 1980, P NATL ACAD SCI-BIOL, V77, P3225, DOI 10.1073/pnas.77.6.3225; LU C, 1987, J MOL BIOL, V196, P497, DOI 10.1016/0022-2836(87)90027-1; Maor-Shoshani A, 2002, BIOCHEMISTRY-US, V41, P14438, DOI 10.1021/bi0262909; McHenry CS, 2011, ANNU REV BIOCHEM, V80, P403, DOI 10.1146/annurev-biochem-061208-091655; MINDEN JS, 1986, J BIOL CHEM, V261, P1906; Morimatsu K, 2003, MOL CELL, V11, P1337, DOI 10.1016/S1097-2765(03)00188-6; Napolitano R, 2000, EMBO J, V19, P6259, DOI 10.1093/emboj/19.22.6259; Patel M, 2010, CRIT REV BIOCHEM MOL, V45, P171, DOI 10.3109/10409238.2010.480968; Pritchard AE, 2000, EMBO J, V19, P6536, DOI 10.1093/emboj/19.23.6536; RECKMANN B, 1985, EUR J BIOCHEM, V152, P633, DOI 10.1111/j.1432-1033.1985.tb09242.x; Reuven NB, 1999, J BIOL CHEM, V274, P31763, DOI 10.1074/jbc.274.45.31763; RUPP WD, 1968, J MOL BIOL, V31, P291, DOI 10.1016/0022-2836(68)90445-2; Rupp WD, 2005, DNA REPAIR, V4, P620; SASSANFAR M, 1990, J MOL BIOL, V212, P79, DOI 10.1016/0022-2836(90)90306-7; Schlacher K, 2005, MOL CELL, V17, P561, DOI 10.1016/j.molcel.2005.01.006; Schlacher K, 2006, NATURE, V442, P883, DOI 10.1038/nature05042; STEINBORN G, 1978, MOL GEN GENET, V165, P87, DOI 10.1007/BF00270380; Tang MJ, 2000, NATURE, V404, P1014, DOI 10.1038/35010020; Tang MJ, 1999, P NATL ACAD SCI USA, V96, P8919, DOI 10.1073/pnas.96.16.8919; UMEZU K, 1993, P NATL ACAD SCI USA, V90, P3875, DOI 10.1073/pnas.90.9.3875; UMEZU K, 1994, J BIOL CHEM, V269, P30005; Wagner J, 1999, MOL CELL, V4, P281, DOI 10.1016/S1097-2765(00)80376-7; Webb BL, 1997, CELL, V91, P347, DOI 10.1016/S0092-8674(00)80418-3; WHITBY MC, 1995, MOL GEN GENET, V246, P174, DOI 10.1007/BF00294680; WITKIN EM, 1982, MOL GEN GENET, V185, P43, DOI 10.1007/BF00333788; WITKIN EM, 1976, BACTERIOL REV, V40, P869, DOI 10.1128/MMBR.40.4.869-907.1976; Xu LW, 2003, MOL CELL, V11, P817, DOI 10.1016/S1097-2765(03)00061-3; Yeeles JTP, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012815; Yeeles JTP, 2011, SCIENCE, V334, P235, DOI 10.1126/science.1209111; YU X, 1993, J MOL BIOL, V231, P29, DOI 10.1006/jmbi.1993.1254	51	5	5	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2019	294	3					852	860		10.1074/jbc.RA118.005726	http://dx.doi.org/10.1074/jbc.RA118.005726			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL4FC	30482842	Green Published, hybrid			2022-12-28	WOS:000458670200011
J	Forero-Quintero, LS; Ames, S; Schneider, HP; Thyssen, A; Boone, CD; Andring, JT; McKenna, R; Casey, JR; Deitmer, JW; Becker, HM				Forero-Quintero, Linda S.; Ames, Samantha; Schneider, Hans-Peter; Thyssen, Anne; Boone, Christopher D.; Andring, Jacob T.; McKenna, Robert; Casey, Joseph R.; Deitmer, Joachim W.; Becker, Holger M.			Membrane-anchored carbonic anhydrase IV interacts with monocarboxylate transporters via their chaperones CD147 and GP70	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						electrophysiology; energy metabolism; ion-sensitive electrode; lactic acid; membrane transport; pH regulation; protein complex; protein expression; proton transport; Xenopus	CELL RECOGNITION MOLECULE; XENOPUS-LAEVIS OOCYTES; IMMUNOGLOBULIN SUPERFAMILY; LACTATE TRANSPORT; PLASMA-MEMBRANE; RETINAL-PIGMENT; BASIGIN CD147; TRANSMEMBRANE GLYCOPROTEIN; ANCILLARY PROTEIN; CRYSTAL-STRUCTURE	Monocarboxylate transporters (MCTs) mediate the proton-coupled exchange of high-energy metabolites, including lactate and pyruvate, between cells and tissues. The transport activity of MCT1, MCT2, and MCT4 can be facilitated by the extracellular carbonic anhydrase IV (CAIV) via a noncatalytic mechanism. Combining physiological measurements in HEK-293 cells and Xenopus oocytes with pulldown experiments, we analyzed the direct interaction between CAIV and the two MCT chaperones basigin (CD147) and embigin (GP70). Our results show that facilitation of MCT transport activity requires direct binding of CAIV to the transporters chaperones. We found that this binding is mediated by the highly conserved His-88 residue in CAIV, which is also the central residue of the enzyme's intramolecular proton shuttle, and a charged amino acid residue in the Ig1 domain of the chaperone. Although the position of the CAIV-binding site in the chaperone was conserved, the amino acid residue itself varied among different species. In human CD147, binding of CAIV was mediated by the negatively charged Glu-73 and in rat CD147 by the positively charged Lys-73. In rat GP70, we identified the positively charged Arg-130 as the binding site. Further analysis of the CAIV-binding site revealed that the His-88 in CAIV can either act as H donor or H acceptor for the hydrogen bond, depending on the charge of the binding residue in the chaperone. Our results suggest that the CAIV-mediated increase in MCT transport activity requires direct binding between CAIV-His-88 and a charged amino acid in the extracellular domain of the transporter's chaperone.	[Forero-Quintero, Linda S.; Ames, Samantha; Schneider, Hans-Peter; Thyssen, Anne; Deitmer, Joachim W.; Becker, Holger M.] Univ Kaiserlautern, Dept Biol, Div Gen Zool, D-67653 Kaiserslautern, Germany; [Boone, Christopher D.; Andring, Jacob T.; McKenna, Robert] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Casey, Joseph R.] Univ Alberta, Membrane Prot Dis Res Grp, Dept Biochem, Edmonton, AB T6G 2E1, Canada; [Becker, Holger M.] Univ Vet Med Hannover, Inst Physiol Chem, D-30559 Hannover, Germany	State University System of Florida; University of Florida; University of Alberta; University of Veterinary Medicine Hannover, Foundation	Becker, HM (corresponding author), Univ Vet Med Hannover, Inst Physiol Chem, D-30559 Hannover, Germany.	Holger.Becker@tiho-hannover.de	Becker, Holger/AAB-4322-2020	Becker, Holger/0000-0002-2700-6117; Forero, Linda/0000-0002-6724-5315	Deutsche Forschungsgemeinschaft [BE 4310/6-1]; Stiftung Rheinland-Pfalz fur Innovation Grant [961-386261/957]; Research Initiative BioComp; Landesschwerpunkt Membrantransport; International Research Training Group 1830	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Stiftung Rheinland-Pfalz fur Innovation Grant; Research Initiative BioComp; Landesschwerpunkt Membrantransport; International Research Training Group 1830	This work was supported by Deutsche Forschungsgemeinschaft Grant BE 4310/6-1 (to H. M. B.), International Research Training Group 1830 (to L. S. F.-Q., J. R. C., J. W. D., and H. M. B.), Stiftung Rheinland-Pfalz fur Innovation Grant 961-386261/957 (to H. M. B.), the Research Initiative BioComp (to J. W. D. and H. M. B.), and the Landesschwerpunkt Membrantransport (to J. W. D. and H. M. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Adelroth P, 2004, BBA-BIOENERGETICS, V1655, P102, DOI 10.1016/j.bbabio.2003.10.018; Almquist J, 2010, J COMPUT SCI SYST BI, V3, P107, DOI DOI 10.4172/JCSB.1000066; Alvarez BV, 2003, BIOCHEMISTRY-US, V42, P12321, DOI 10.1021/bi0353124; Ames Samantha, 2018, Oncotarget, V9, P27940, DOI 10.18632/oncotarget.25371; Becker HM, 2004, BIOPHYS J, V86, P235, DOI 10.1016/S0006-3495(04)74099-0; Becker HM, 2005, J BIOL CHEM, V280, P39882, DOI 10.1074/jbc.M503081200; Becker HM, 2008, J BIOL CHEM, V283, P21655, DOI 10.1074/jbc.M802134200; Becker HM, 2014, NEUROMETHODS, V90, P25, DOI 10.1007/978-1-4939-1059-5_2; Becker HM, 2011, P NATL ACAD SCI USA, V108, P3071, DOI 10.1073/pnas.1014293108; Becker HM, 2010, J MEMBRANE BIOL, V234, P125, DOI 10.1007/s00232-010-9240-y; Bergersen L, 2001, EXP BRAIN RES, V136, P523, DOI 10.1007/s002210000600; Branden M, 2006, P NATL ACAD SCI USA, V103, P19766, DOI 10.1073/pnas.0605909103; Broer S, 1997, J BIOL CHEM, V272, P30096, DOI 10.1074/jbc.272.48.30096; Broer S, 1999, BIOCHEM J, V341, P529, DOI 10.1042/0264-6021:3410529; Broer S, 1998, BIOCHEM J, V333, P167, DOI 10.1042/bj3330167; BRUCE LJ, 1995, BLOOD, V85, P541; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chao FM, 2015, ONCOTARGET, V6, P23496, DOI 10.18632/oncotarget.4360; DEITMER JW, 1991, J GEN PHYSIOL, V98, P637, DOI 10.1085/jgp.98.3.637; Dimmer KS, 2000, BIOCHEM J, V350, P219, DOI 10.1042/0264-6021:3500219; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FADOOL JM, 1993, DEV DYNAM, V196, P252, DOI 10.1002/aja.1001960406; FOSSUM S, 1991, EUR J IMMUNOL, V21, P671, DOI 10.1002/eji.1830210320; Friedman R, 2005, BIOPHYS J, V89, P768, DOI 10.1529/biophysj.105.058917; Gallagher SM, 2007, CANCER RES, V67, P4182, DOI 10.1158/0008-5472.CAN-06-3184; GARCIA CK, 1995, J BIOL CHEM, V270, P1843, DOI 10.1074/jbc.270.4.1843; Grollman EF, 2000, BIOCHEMISTRY-US, V39, P9351, DOI 10.1021/bi000464+; Guenette RS, 1997, DEV GENET, V21, P268, DOI 10.1002/(SICI)1520-6408(1997)21:4<268::AID-DVG4>3.0.CO;2-5; Halestrap AP, 2013, MOL ASPECTS MED, V34, P337, DOI 10.1016/j.mam.2012.05.003; Halestrap AP, 2012, IUBMB LIFE, V64, P1, DOI 10.1002/iub.573; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; Igakura T, 1998, DEV BIOL, V194, P152, DOI 10.1006/dbio.1997.8819; Isom DG, 2011, P NATL ACAD SCI USA, V108, P5260, DOI 10.1073/pnas.1010750108; Jackson VN, 1996, J BIOL CHEM, V271, P861, DOI 10.1074/jbc.271.2.861; Jackson VN, 1997, BIOCHEM J, V324, P447, DOI 10.1042/bj3240447; Jarolim P, 1998, BLOOD, V92, P4836, DOI 10.1182/blood.V92.12.4836.424k24_4836_4843; Jung DE, 2016, MOL CARCINOGEN, V55, P633, DOI 10.1002/mc.22309; Kirk P, 2000, EMBO J, V19, P3896, DOI 10.1093/emboj/19.15.3896; Klier M, 2014, J BIOL CHEM, V289, P2765, DOI 10.1074/jbc.M113.537043; Klier M, 2011, J BIOL CHEM, V286, P27781, DOI 10.1074/jbc.M111.255331; Lain E, 2009, J BIOL CHEM, V284, P8921, DOI 10.1074/jbc.M809491200; Manoharan C, 2006, MOL MEMBR BIOL, V23, P486, DOI 10.1080/09687860600841967; MAREN TH, 1967, PHYSIOL REV, V47, P595, DOI 10.1152/physrev.1967.47.4.595; Martinez C, 2010, FRONT NEUROENERGETIC, V2, P27, DOI DOI 10.3389/FNENE.2010.00027; Muramatsu T, 2003, HISTOL HISTOPATHOL, V18, P981, DOI 10.14670/HH-18.981; Muramatsu T, 2016, J BIOCHEM, V159, P481, DOI 10.1093/jb/mvv127; Nabeshima K, 2006, PATHOL INT, V56, P359, DOI 10.1111/j.1440-1827.2006.01972.x; Noor SI, 2018, ELIFE, V7, DOI 10.7554/eLife.35176; Noor SI, 2017, FEBS J, V284, P149, DOI 10.1111/febs.13964; Noor SI, 2015, J BIOL CHEM, V290, P4476, DOI 10.1074/jbc.M114.624577; Ovens MJ, 2010, BIOCHEM J, V431, P217, DOI 10.1042/BJ20100890; Pellerin L, 1998, DEV NEUROSCI-BASEL, V20, P291, DOI 10.1159/000017324; Pellerin L, 1998, P NATL ACAD SCI USA, V95, P3990, DOI 10.1073/pnas.95.7.3990; Philp NJ, 2001, AM J PHYSIOL-CELL PH, V280, pC1319, DOI 10.1152/ajpcell.2001.280.5.C1319; Philp NJ, 1998, AM J PHYSIOL-REG I, V274, pR1824, DOI 10.1152/ajpregu.1998.274.6.R1824; Pierre K, 2005, J NEUROCHEM, V94, P1, DOI 10.1111/j.1471-4159.2005.03168.x; Pinheiro C, 2012, J BIOENERG BIOMEMBR, V44, P127, DOI 10.1007/s10863-012-9428-1; Pinheiro C, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/427694; Pushkarsky T, 2007, BIOCHEM BIOPH RES CO, V363, P495, DOI 10.1016/j.bbrc.2007.08.192; Redzic JS, 2011, J MOL BIOL, V411, P68, DOI 10.1016/j.jmb.2011.04.060; Saxena DK, 2002, REPRODUCTION, V123, P435, DOI 10.1530/rep.0.1230435; SCHLOSSHAUER B, 1991, DEVELOPMENT, V113, P129; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shinobu A, 2009, J PHYS CHEM A, V113, P7253, DOI 10.1021/jp8102047; Shnitsar V, 2013, J BIOL CHEM, V288, P33848, DOI 10.1074/jbc.M113.511865; Stams T, 1996, P NATL ACAD SCI USA, V93, P13589, DOI 10.1073/pnas.93.24.13589; Sterling D, 1999, BIOCHEM J, V344, P221, DOI 10.1042/0264-6021:3440221; Sterling D, 2002, BIOCHEM CELL BIOL, V80, P483, DOI 10.1139/O02-152; Sterling D, 2002, J BIOL CHEM, V277, P25239, DOI 10.1074/jbc.M202562200; Stridh MH, 2012, J PHYSIOL-LONDON, V590, P2333, DOI 10.1113/jphysiol.2011.220152; Svichar N, 2009, J NEUROSCI, V29, P3252, DOI 10.1523/JNEUROSCI.0036-09.2009; Wilson MC, 2009, J BIOL CHEM, V284, P20011, DOI 10.1074/jbc.M109.014217; Wilson MC, 2005, J BIOL CHEM, V280, P27213, DOI 10.1074/jbc.M411950200; Wilson MC, 2002, J BIOL CHEM, V277, P3666, DOI 10.1074/jbc.M109658200; Wilson MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077512; Wu Q, 1998, J MEMBRANE BIOL, V162, P31, DOI 10.1007/s002329900339; Yoon HY, 1997, BIOCHEM BIOPH RES CO, V234, P90, DOI 10.1006/bbrc.1997.6588; Yu XL, 2008, J BIOL CHEM, V283, P18056, DOI 10.1074/jbc.M802694200; ZHU XL, 1990, J BIOL CHEM, V265, P8795	79	20	20	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2019	294	2					593	607		10.1074/jbc.RA118.005536	http://dx.doi.org/10.1074/jbc.RA118.005536			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HI2GP	30446621	Green Published, hybrid			2022-12-28	WOS:000456263600017
J	Katamune, C; Koyanagi, S; Hashikawa, K; Kusunose, N; Akamine, T; Matsunaga, N; Ohdo, S				Katamune, Chiharu; Koyanagi, Satoru; Hashikawa, Ken-ichi; Kusunose, Naoki; Akamine, Takahiro; Matsunaga, Naoya; Ohdo, Shigehiro			Mutation of the gene encoding the circadian clock component PERIOD2 in oncogenic cells confers chemoresistance by up-regulating the Aldh3a1 gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						clock gene; chemoresistance; anticancer drug; chromatin modification; reactive oxygen species (ROS); Aldh3a1; Period2; chemotherapy; oncogene; circadian rhythm; cancer; aldehyde dehydrogenase	ALDEHYDE DEHYDROGENASE; DNA-DAMAGE; P53; TRANSCRIPTION; CHEMOSENSITIVITY; EXPRESSION; CHEMOTHERAPY; MODULATION; MECHANISMS; PROTEIN	Disruption of circadian rhythms has been implicated in an increased risk for cancer development. The Period2 (Per2) gene encodes one of the major components of the mammalian circadian clock, which plays a key role in controlling the circadian rhythms in physiology and behavior. PER2 has also been reported to suppress the malignant transformation of cells, but its role in the regulation of cancer susceptibility to chemotherapeutic drugs remains unclear. In this study, we found that oncogene-transformed embryonic fibroblasts prepared from Per2-mutant (Per2(m/m)) mice, which are susceptible to both spontaneous and radiation-induced tumorigenesis, were resistant against common chemotherapeutic drugs and that this resistance is associated with up-regulation of the aldehyde dehydrogenase 3a1 (Aldh3a1) gene. Co-expression of the oncogenes H-ras(V12) and SV40 large T-antigen induced malignant transformation of both WT and Per2(m/m) cells, but the cytotoxic effects of the chemotherapeutic agents methotrexate, gemcitabine, etoposide, vincristine, and oxaliplatin were significantly alleviated in the oncogene-transformed Per2(m/m) cells. Although introduction of the two oncogenes increased the expression of Aldh3a1 in both WT and Per2(m/m) cells, the ALDH3A1 protein levels in the Per2(m/m) cells were approximate to 7-fold higher than in WT cells. The elevated ALDH3A1 levels in the oncogene-transformed Per2(m/m) cells were sufficient to prevent chemotherapeutic drug-induced accumulation of reactive oxygen species. Consequently, shRNA-mediated suppression of Aldh3a1 expression relieved the chemoresistance of the Per2(m/m) cells. These results suggest a role for mutated PER2 in the development of multiple drug resistance and may inform therapeutic strategies for cancer management.	[Katamune, Chiharu; Koyanagi, Satoru; Hashikawa, Ken-ichi; Kusunose, Naoki; Akamine, Takahiro; Matsunaga, Naoya; Ohdo, Shigehiro] Kyushu Univ, Fac Pharmaceut Sci, Dept Pharmaceut, Higashi Ku, 3-1-1 Maidashi, Fukuoka, Fukuoka 8128582, Japan; [Koyanagi, Satoru; Matsunaga, Naoya] Kyushu Univ, Fac Pharmaceut Sci, Dept Glocal Healthcare Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka, Fukuoka 8128582, Japan; [Akamine, Takahiro] Oita Univ, Fac Med, Dept Ophthalmol, 1-1 Idaigaoka Hasamamachi, Yufu, Oita 8795593, Japan	Kyushu University; Kyushu University; Oita University	Ohdo, S (corresponding author), Kyushu Univ, Fac Pharmaceut Sci, Dept Pharmaceut, Higashi Ku, 3-1-1 Maidashi, Fukuoka, Fukuoka 8128582, Japan.	ohdo@phar.kyushu-u.ac.jp	Koyanagi, Satoru/AAE-6843-2020	matsunaga2, naoya2/0000-0001-6226-8473; Koyanagi, Satoru/0000-0003-4849-2377	KAKENHI from the Japan Society for the Promotion of Science (JSPS) [16H02636, 17H06262, 26670317]	KAKENHI from the Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by KAKENHI Grants-in-aid for Scientific Research 16H02636 and 17H06262 (to S. O.) and 26670317 (to S. K.) from the Japan Society for the Promotion of Science (JSPS). The authors declare that they have no conflicts of interest with the contents of this article.	Akashi M, 2005, NAT STRUCT MOL BIOL, V12, P441, DOI 10.1038/nsmb925; Awad O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013943; Burchiel SW, 2007, TOXICOL APPL PHARM, V221, P203, DOI 10.1016/j.taap.2007.02.020; Buro-Auriemma LJ, 2013, HUM MOL GENET, V22, P4726, DOI 10.1093/hmg/ddt326; Cascorbi I, 2006, PHARMACOL THERAPEUT, V112, P457, DOI 10.1016/j.pharmthera.2006.04.009; Chen Hong Ping, 2015, Critical Reviews in Oncogenesis, V20, P35; Cheng MY, 2002, NATURE, V417, P405, DOI 10.1038/417405a; Climent J, 2010, J CLIN ONCOL, V28, P3770, DOI 10.1200/JCO.2009.27.0215; Duong HA, 2014, NAT STRUCT MOL BIOL, V21, P126, DOI 10.1038/nsmb.2746; El-Deiry WS, 2003, ONCOGENE, V22, P7486, DOI 10.1038/sj.onc.1206949; Filipski E, 2005, JNCI-J NATL CANCER I, V97, P507, DOI 10.1093/jnci/dji083; Fojo T, 2002, DRUG RESIST UPDATE, V5, P209, DOI 10.1016/S1368-7646(02)00119-X; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Fujimoto A, 2016, NAT GENET, V48, P500, DOI 10.1038/ng.3547; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Geyfman M, 2012, P NATL ACAD SCI USA, V109, P11758, DOI 10.1073/pnas.1209592109; Guo XL, 2014, CANCER LETT, V346, P278, DOI 10.1016/j.canlet.2014.01.011; Duong HQ, 2017, ANTIOXIDANTS-BASEL, V6, DOI 10.3390/antiox6030052; Hwang-Verslues WW, 2013, P NATL ACAD SCI USA, V110, P12331, DOI 10.1073/pnas.1222684110; Katamune C, 2016, J BIOL CHEM, V291, P10541, DOI 10.1074/jbc.M115.706481; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kloog I, 2009, CHRONOBIOL INT, V26, P108, DOI 10.1080/07420520802694020; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lahti TA, 2008, INT J CANCER, V123, P2148, DOI 10.1002/ijc.23566; Lee JH, 2011, P NATL ACAD SCI USA, V108, P10668, DOI 10.1073/pnas.1106284108; Lee S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010995; Liu B, 2008, FREE RADICAL BIO MED, V44, P1529, DOI 10.1016/j.freeradbiomed.2008.01.011; Ma I, 2011, STEM CELL REV REP, V7, P292, DOI 10.1007/s12015-010-9208-4; Maemura K, 2000, J BIOL CHEM, V275, P36847, DOI 10.1074/jbc.C000629200; Marchitti SA, 2008, EXPERT OPIN DRUG MET, V4, P697, DOI [10.1517/17425255.4.6.697, 10.1517/17425255.4.6.697 ]; Masri S, 2015, CURR OPIN ONCOL, V27, P50, DOI 10.1097/CCO.0000000000000153; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; Momma T, 2017, ONCOL LETT, V14, P5319, DOI 10.3892/ol.2017.6876; Muzio G, 2006, FREE RADICAL BIO MED, V40, P1929, DOI 10.1016/j.freeradbiomed.2006.01.020; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Raha D, 2014, CANCER RES, V74, P3579, DOI 10.1158/0008-5472.CAN-13-3456; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rice JC, 2001, CURR OPIN CELL BIOL, V13, P263, DOI 10.1016/S0955-0674(00)00208-8; Ripperger JA, 2000, GENE DEV, V14, P679; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Tian CQ, 2012, GYNECOL ONCOL, V124, P575, DOI 10.1016/j.ygyno.2011.11.022; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Wehbe H, 2006, J PHARMACOL EXP THER, V319, P1153, DOI 10.1124/jpet.106.109835; Xie YQQ, 1996, NUCLEIC ACIDS RES, V24, P4185, DOI 10.1093/nar/24.21.4185; Xu GW, 2005, INT J CANCER, V116, P187, DOI 10.1002/ijc.21071; Zeng ZL, 2014, CLIN CANCER RES, V20, P1042, DOI 10.1158/1078-0432.CCR-13-0171; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118; ZHU JY, 1991, J VIROL, V65, P6872, DOI 10.1128/JVI.65.12.6872-6880.1991	49	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2019	294	2					547	558		10.1074/jbc.RA118.004942	http://dx.doi.org/10.1074/jbc.RA118.004942			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HI2GP	30429219	hybrid, Green Published			2022-12-28	WOS:000456263600014
J	Yamamoto, WR; Bone, RN; Sohn, P; Syed, F; Reissaus, CA; Mosley, AL; Wijeratne, AB; True, JD; Tong, X; Kono, T; Evans-Molina, C				Yamamoto, Wataru R.; Bone, Robert N.; Sohn, Paul; Syed, Farooq; Reissaus, Christopher A.; Mosley, Amber L.; Wijeratne, Aruna B.; True, Jason D.; Tong, Xin; Kono, Tatsuyoshi; Evans-Molina, Carmella			Endoplasmic reticulum stress alters ryanodine receptor function in the murine pancreatic cell	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						beta cell (B-cell); ryanodine receptor; inositol trisphosphate receptor (InsP3R); endoplasmic reticulum stress (ER stress); diabetes; calcium signaling; endoplasmic reticulum calcium; glucose-induced calcium oscillations; unfolded protein response; inositol 1; 4; 5-triphosphate (IP3) receptor	CA2+-INDUCED CA2+ RELEASE; CALCIUM-RELEASE; BETA-CELLS; ISLET FUNCTION; ACTIVATION; MECHANISMS; CYTOKINES; CHANNELS; TYPE-1; MICE	Alterations in endoplasmic reticulum (ER) calcium (Ca2+) levels diminish insulin secretion and reduce -cell survival in both major forms of diabetes. The mechanisms responsible for ER Ca2+ loss in cells remain incompletely understood. Moreover, a specific role for either ryanodine receptor (RyR) or inositol 1,4,5-triphosphate receptor (IP3R) dysfunction in the pathophysiology of diabetes remains largely untested. To this end, here we applied intracellular and ER Ca2+ imaging techniques in INS-1 cells and isolated islets to determine whether diabetogenic stressors alter RyR or IP3R function. Our results revealed that the RyR is sensitive mainly to ER stress-induced dysfunction, whereas cytokine stress specifically alters IP3R activity. Consistent with this observation, pharmacological inhibition of the RyR with ryanodine and inhibition of the IP3R with xestospongin C prevented ER Ca2+ loss under ER and cytokine stress conditions, respectively. However, RyR blockade distinctly prevented -cell death, propagation of the unfolded protein response (UPR), and dysfunctional glucose-induced Ca2+ oscillations in tunicamycin-treated INS-1 cells and mouse islets and Akita islets. Monitoring at the single-cell level revealed that ER stress acutely increases the frequency of intracellular Ca2+ transients that depend on both ER Ca2+ leakage from the RyR and plasma membrane depolarization. Collectively, these findings indicate that RyR dysfunction shapes ER Ca2+ dynamics in cells and regulates both UPR activation and cell death, suggesting that RyR-mediated loss of ER Ca2+ may be an early pathogenic event in diabetes.	[Yamamoto, Wataru R.; Sohn, Paul; Evans-Molina, Carmella] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA; [Bone, Robert N.; Kono, Tatsuyoshi; Evans-Molina, Carmella] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Mosley, Amber L.; Wijeratne, Aruna B.; True, Jason D.; Evans-Molina, Carmella] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Syed, Farooq; Reissaus, Christopher A.; Evans-Molina, Carmella] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Evans-Molina, Carmella] Roudebush Vet Affairs Med Ctr, Indianapolis, IN 46202 USA; [Tong, Xin] Vanderbilt Univ, Dept Mol Physiol & Biophys, 221 Kirkland Hall, Nashville, TN 37235 USA; [True, Jason D.] Ball State Univ, Dept Biol, Muncie, IN 47306 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; Vanderbilt University; Ball State University	Evans-Molina, C (corresponding author), 635 Barnhill Dr,MS 2031A, Indianapolis, IN 46202 USA.	cevansmo@iu.edu	Syed, Farooq/AAK-6781-2020; tong, xin/AAE-7096-2021	Syed, Farooq/0000-0002-0284-0631; Yamamoto, Wataru/0000-0003-1158-9781; tong, xin/0000-0003-4408-3832; Bone, Robert/0000-0003-3222-8918; Mosley, Amber/0000-0001-5822-2894; Kono, Tatsuyoshi/0000-0002-7524-6836	Islet and Physiology Core of the Indiana Diabetes Research Center [P30DK097512]; Indiana University Proteomics Core; Imaging Core of the Indiana Diabetes Research Center [P30DK097512]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093954, P30DK097512] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001733] Funding Source: NIH RePORTER	Islet and Physiology Core of the Indiana Diabetes Research Center; Indiana University Proteomics Core; Imaging Core of the Indiana Diabetes Research Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	We acknowledge the support of the Islet and Physiology and Imaging Cores of the Indiana Diabetes Research Center (P30DK097512) and the Indiana University Proteomics Core.	Beauvois MC, 2004, J PHYSIOL-LONDON, V559, P141, DOI 10.1113/jphysiol.2004.067454; Cardozo AK, 2005, DIABETES, V54, P452, DOI 10.2337/diabetes.54.2.452; Chen MC, 2001, DIABETOLOGIA, V44, P325, DOI 10.1007/s001250051622; Cheng CW, 2017, CELL, V168, P775, DOI 10.1016/j.cell.2017.01.040; Del Prete D, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-21; Dinarello CA, 2010, CURR OPIN ENDOCRINOL, V17, P314, DOI 10.1097/MED.0b013e32833bf6dc; Dixit SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058655; Evans-Molina C, 2013, DIABETES OBES METAB, V15, P159, DOI 10.1111/dom.12163; Evans-Molina C, 2009, MOL CELL BIOL, V29, P2053, DOI 10.1128/MCB.01179-08; Ferreiro E, 2006, NEUROBIOL DIS, V23, P669, DOI 10.1016/j.nbd.2006.05.011; Fulda Simone, 2010, Int J Cell Biol, V2010, P370835, DOI 10.1155/2010/370835; Gardner BM, 2011, SCIENCE, V333, P1891, DOI 10.1126/science.1209126; Gilon P, 2014, CELL CALCIUM, V56, P340, DOI 10.1016/j.ceca.2014.09.001; Guest PC, 1997, BIOCHEM J, V323, P445, DOI 10.1042/bj3230445; Holz GG, 1999, J BIOL CHEM, V274, P14147, DOI 10.1074/jbc.274.20.14147; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Johnson JD, 2004, FASEB J, V18, P878, DOI 10.1096/fj.03-1280fje; Johnson JS, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.575191; Kang GX, 2001, J PHYSIOL-LONDON, V536, P375, DOI 10.1111/j.1469-7793.2001.0375c.xd; Kim JY, 2012, J PHARMACOL SCI, V118, P65, DOI 10.1254/jphs.11072FP; Kono T, 2012, MOL ENDOCRINOL, V26, P257, DOI 10.1210/me.2011-1181; Kyrychenko S, 2013, CARDIOVASC RES, V97, P666, DOI 10.1093/cvr/cvs425; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; Landstrom AP, 2017, CIRC RES, V120, P1969, DOI 10.1161/CIRCRESAHA.117.310083; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Li N, 2017, INT J CARDIOL, V227, P668, DOI 10.1016/j.ijcard.2016.10.078; Liu M, 2007, P NATL ACAD SCI USA, V104, P15841, DOI 10.1073/pnas.0702697104; Lu SM, 2014, P NATL ACAD SCI USA, V111, pE5292, DOI 10.1073/pnas.1421055111; Luciani DS, 2009, DIABETES, V58, P422, DOI 10.2337/db07-1762; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Marhfour I, 2012, DIABETOLOGIA, V55, P2417, DOI 10.1007/s00125-012-2604-3; Marks AR, 2013, J CLIN INVEST, V123, P46, DOI 10.1172/JCI62834; Marmugi A, 2016, DIABETES, V65, P1009, DOI 10.2337/db15-1334; Mekahli D, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004317; Michalak M, 2002, CELL CALCIUM, V32, P269, DOI 10.1016/S0143416002001884; Mitchell KJ, 2001, J CELL BIOL, V155, P41, DOI 10.1083/jcb.200103145; MONTERO M, 1995, EMBO J, V14, P5467, DOI 10.1002/j.1460-2075.1995.tb00233.x; Ogihara T, 2010, J BIOL CHEM, V285, P5392, DOI 10.1074/jbc.M109.064659; Papa FR, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007666; Plotkin JL, 2013, J NEUROPHYSIOL, V110, P2325, DOI 10.1152/jn.00422.2013; Priori SG, 2001, CIRCULATION, V103, P196; Protasi F, 2002, FRONT BIOSCI, V7, pD650, DOI 10.2741/protasi; Ramadan JW, 2011, CELL CALCIUM, V50, P481, DOI 10.1016/j.ceca.2011.08.005; Ravier MA, 2011, DIABETES, V60, P2533, DOI 10.2337/db10-1543; Santos CXC, 2009, ANTIOXID REDOX SIGN, V11, P2409, DOI 10.1089/ARS.2009.2625; Santulli G, 2017, J PHYSIOL-LONDON, V595, P3041, DOI 10.1113/JP272781; Santulli G, 2015, J CLIN INVEST, V125, P4316, DOI 10.1172/JCI84937; Spranger J, 2003, DIABETES, V52, P812, DOI 10.2337/diabetes.52.3.812; Stull ND, 2012, JOVE-J VIS EXP, DOI 10.3791/4137; Takasawa S, 1998, J BIOL CHEM, V273, P2497, DOI 10.1074/jbc.273.5.2497; Tang YJ, 2012, CIRC RES, V110, P968, DOI 10.1161/CIRCRESAHA.111.256560; Tarasov AI, 2012, CELL CALCIUM, V52, P28, DOI 10.1016/j.ceca.2012.03.003; Tersey SA, 2012, DIABETES, V61, P818, DOI 10.2337/db11-1293; Tong X, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.154; Tong X, 2016, DIABETES, V65, P3039, DOI 10.2337/db16-0084; Tovey Stephen C, 2013, Cold Spring Harb Protoc, V2013, P930, DOI 10.1101/pdb.prot073072; Turner RC, 1999, JAMA-J AM MED ASSOC, V281, P2005, DOI 10.1001/jama.281.21.2005; van Raalte DH, 2017, DIABETES OBES METAB, V19, P1205, DOI 10.1111/dom.12935; Waning DL, 2015, NAT MED, V21, P1262, DOI 10.1038/nm.3961; Wehrens XHT, 2003, CELL, V113, P829, DOI 10.1016/S0092-8674(03)00434-3; Wu RF, 2010, MOL CELL BIOL, V30, P3553, DOI 10.1128/MCB.01445-09; Zhao FY, 2001, J BIOL CHEM, V276, P13810, DOI 10.1074/jbc.M006104200	62	21	21	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2019	294	1					168	181		10.1074/jbc.RA118.005683	http://dx.doi.org/10.1074/jbc.RA118.005683			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG6PT	30420428	hybrid, Green Published			2022-12-28	WOS:000455105500021
J	Wei, Y; Toth, JI; Blanco, GA; Bobkov, AA; Petroski, MD				Wei, Yang; Toth, Julia I.; Blanco, Gabrielle A.; Bobkov, Andrey A.; Petroski, Matthew D.			Adapted ATPase domain communication overcomes the cytotoxicity of p97 inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ubiquitin; proteasome; ATPases associated with diverse cellular activities (AAA); protein degradation; protein homeostasis; protein quality control; protein unfolding	AAA-ATPASE; NUCLEOTIDE-BINDING; P97/VCP ATPASE; PAGET-DISEASE; D1 RING; MUTATIONS; MECHANISM; UBIQUITIN; CANCER; CONFORMATION	The AAA(+) ATPase p97 regulates ubiquitin-dependent protein homeostasis and has been pursued as a cancer drug target. The ATP-competitive inhibitor CB-5083 and allosteric inhibitor NMS-873 are the most advanced p97 inhibitors described to date. Previous studies have reported that their cytotoxicity can be readily overcome and involves single p97 mutations in the linker between the D1 and D2 ATPase domains and within D2. We report here that the proline 472 to leucine (P472L) mutation, in the D1-D2 linker and identified in CB-5083-resistant cells, desensitizes p97 to both inhibitor classes. This mutation does not disrupt the distinct D2-binding sites of the inhibitors. Instead, P472L changes ATPase domain communication within the p97 hexamer. P472L enhances cooperative D2 ATP binding and hydrolysis. This mechanism alters the function of the D1-D2 linker in the control of D2 activity involving the ATP-bound state of D1. Although increased D2 activity is sufficient to desensitize the P472L mutant to NMS-873, the mutant's desensitization to CB-5083 also requires D1 ATPase domain function. Our study highlights the remarkable adaptability of p97 ATPase domain communication that enables escape from mechanistically distinct classes of cytotoxic p97 inhibitors.	[Wei, Yang; Toth, Julia I.; Blanco, Gabrielle A.; Bobkov, Andrey A.; Petroski, Matthew D.] Sanford Burnham Prebys Med Discovery Inst, NCI Designated Canc Ctr, 10901 North Torrey Pines Rd, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Petroski, MD (corresponding author), Sanford Burnham Prebys Med Discovery Inst, NCI Designated Canc Ctr, 10901 North Torrey Pines Rd, La Jolla, CA 92037 USA.	petroski@sbpdiscovery.org			Padres Pedal the Cause Postdoctoral Fellowship; National Institutes of Health [R01CA180150, R01CA185300]; Sanford Burnham Prebys NCI Cancer Center Support Grant from the National Institutes of Health [P30 CA030199]; NATIONAL CANCER INSTITUTE [R01CA185300, P30CA030199, R01CA180150] Funding Source: NIH RePORTER	Padres Pedal the Cause Postdoctoral Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sanford Burnham Prebys NCI Cancer Center Support Grant from the National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by a Padres Pedal the Cause Postdoctoral Fellowship (to Y. W.), National Institutes of Health Grants R01CA180150 and R01CA185300 (to M. D. P.), and Sanford Burnham Prebys NCI Cancer Center Support Grant P30 CA030199 from the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson DJ, 2015, CANCER CELL, V28, P653, DOI 10.1016/j.ccell.2015.10.002; Banerjee S, 2016, SCIENCE, V351, P871, DOI 10.1126/science.aad7974; Bastola P, 2017, CELL DEATH DISCOV, V3, DOI 10.1038/cddiscovery.2017.65; Blythe EE, 2017, P NATL ACAD SCI USA, V114, pE4380, DOI 10.1073/pnas.1706205114; Bodnar NO, 2018, NAT STRUCT MOL BIOL, V25, P616, DOI 10.1038/s41594-018-0085-x; Bodnar NO, 2017, CELL, V169, P722, DOI 10.1016/j.cell.2017.04.020; Briggs LC, 2008, J BIOL CHEM, V283, P13745, DOI 10.1074/jbc.M709632200; Bulfer SL, 2016, ACS CHEM BIOL, V11, P2112, DOI 10.1021/acschembio.6b00350; Chapman E, 2015, MOLECULES, V20, P3027, DOI 10.3390/molecules20023027; Chou TF, 2014, J MOL BIOL, V426, P2886, DOI 10.1016/j.jmb.2014.05.022; Chou TF, 2011, J BIOL CHEM, V286, P16546, DOI 10.1074/jbc.M110.215319; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972; Deshaies RJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0094-0; Hanzelmann P, 2016, STRUCTURE, V24, P127, DOI 10.1016/j.str.2015.10.026; Halawani D, 2009, MOL CELL BIOL, V29, P4484, DOI 10.1128/MCB.00252-09; Her NG, 2016, CELL CHEM BIOL, V23, P517, DOI 10.1016/j.chembiol.2016.03.012; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Huyton T, 2003, J STRUCT BIOL, V144, P337, DOI 10.1016/j.jsb.2003.10.007; Ju JS, 2008, J BIOL CHEM, V283, P30289, DOI 10.1074/jbc.M805517200; Locke M, 2014, BIOCHEM J, V459, P205, DOI 10.1042/BJ20120662; Magnaghi P, 2013, NAT CHEM BIOL, V9, P548, DOI [10.1038/nchembio.1313, 10.1038/NCHEMBIO.1313]; Manno A, 2010, GENES CELLS, V15, P911, DOI 10.1111/j.1365-2443.2010.01428.x; Meyer H, 2014, J CELL SCI, V127, P3877, DOI 10.1242/jcs.093831; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Niwa H, 2012, J BIOL CHEM, V287, P8561, DOI 10.1074/jbc.M111.302778; Ritz D, 2011, NAT CELL BIOL, V13, P1116, DOI 10.1038/ncb2301; Schuetz AK, 2016, ELIFE, V5, DOI 10.7554/eLife.20143; Song CC, 2003, J BIOL CHEM, V278, P3648, DOI 10.1074/jbc.M208422200; Stach L, 2017, BIOCHEM J, V474, P2953, DOI 10.1042/BCJ20160783; Tang WK, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00079; Tang WK, 2013, J BIOL CHEM, V288, P36624, DOI 10.1074/jbc.M113.488924; Tang WK, 2010, EMBO J, V29, P2217, DOI 10.1038/emboj.2010.104; van den Boom J, 2018, MOL CELL, V69, P182, DOI 10.1016/j.molcel.2017.10.028; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wang Q, 2005, J BIOL CHEM, V280, P40515, DOI 10.1074/jbc.M509636200; Wang Q, 2003, J BIOL CHEM, V278, P32784, DOI 10.1074/jbc.M303869200; Wang Q, 2003, BIOCHEM BIOPH RES CO, V300, P253, DOI 10.1016/S0006-291X(02)02840-1; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Weihl CC, 2006, HUM MOL GENET, V15, P189, DOI 10.1093/hmg/ddi426; Wendler P, 2012, BBA-MOL CELL RES, V1823, P2, DOI 10.1016/j.bbamcr.2011.06.014; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00039; Zhang XY, 2015, P NATL ACAD SCI USA, V112, pE1705, DOI 10.1073/pnas.1418820112; Zhou HJ, 2015, J MED CHEM, V58, P9480, DOI 10.1021/acs.jmedchem.5b01346	45	5	5	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					20169	20180		10.1074/jbc.RA118.004301	http://dx.doi.org/10.1074/jbc.RA118.004301			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30381397	Green Published, hybrid			2022-12-28	WOS:000454685900024
J	Holm, T; Kopicki, JD; Busch, C; Olschewski, S; Rosenthal, M; Uetrecht, C; Gunther, S; Reindl, S				Holm, Tobias; Kopicki, Janine-Denise; Busch, Carola; Olschewski, Silke; Rosenthal, Maria; Uetrecht, Charlotte; Guenther, Stephan; Reindl, Sophia			Biochemical and structural studies reveal differences and commonalities among cap-snatching endonucleases from segmented negative-strand RNA viruses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						negative-strand RNA virus; viral transcription; endonuclease; enzyme structure; metal ion-protein interaction; recombinant protein expression; small-angle X-ray scattering (SAXS); structure-function; cap-snatching; nairovirus	X-RAY SOLUTION; INFLUENZA-VIRUS; REPLICATION; DOMAIN; TRANSCRIPTION; SYSTEM	Viruses rely on many host cell processes, including the cellular transcription machinery. Segmented negative-strand RNA viruses (sNSV) in particular cannot synthesize the 5-cap structure for their mRNA but cleave off cellular caps and use the resulting oligonucleotides as primers for their transcription. This cap-snatching mechanism, involving a viral cap-binding site and RNA endonuclease, is both virus-specific and essential for viral proliferation and therefore represents an attractive drug target. Here, we present biochemical and structural results on the putative cap-snatching endonuclease of Crimean-Congo hemorrhagic fever virus (CCHFV), a highly pathogenic bunyavirus belonging to the Nairoviridae family, and of two additional nairoviruses, Erve virus (EREV) and Nairobi sheep disease virus (NSDV). Our findings are presented in the context of other cap-snatching endonucleases, such as the enzymatically active endonuclease from Rift Valley fever virus (RVFV), from Arenaviridae and Bunyavirales, belonging to the His- and His+ endonucleases, respectively, according to the absence or presence of a metal ion-coordinating histidine in the active site. Mutational and metal-binding experiments revealed the presence of only acidic metal-coordinating residues in the active site of the CCHFV domain and a unique active-site conformation that was intermediate between those of His+ and His- endonucleases. On the basis of small-angle X-ray scattering (SAXS) and homology modeling results, we propose a protein topology for the CCHFV domain that, despite its larger size, has a structure overall similar to those of related endonucleases. These results suggest structural and functional conservation of the cap-snatching mechanism among sNSVs.	[Holm, Tobias; Busch, Carola; Olschewski, Silke; Rosenthal, Maria; Guenther, Stephan; Reindl, Sophia] Bernhard Nocht Inst Trop Med, Dept Virol, D-20359 Hamburg, Germany; [Kopicki, Janine-Denise; Uetrecht, Charlotte] Leibniz Inst Expt Virol, Heinrich Pette Inst, D-20251 Hamburg, Germany; [Uetrecht, Charlotte] European XFEL GmbH, D-22869 Schenefeld, Germany	Bernhard Nocht Institut fur Tropenmedizin; Heinrich Pette Institute; European XFEL	Reindl, S (corresponding author), Bernhard Nocht Inst Trop Med, Dept Virol, D-20359 Hamburg, Germany.	reindl@bnitm.de	Uetrecht, Charlotte/D-1883-2010; Rosenthal, Maria/M-1857-2019	Uetrecht, Charlotte/0000-0002-1991-7922; Rosenthal, Maria/0000-0003-2986-936X; Gunther, Stephan/0000-0002-6562-0230; Kopicki, Janine-Denise/0000-0001-9806-5352	iNEXT - Horizon 2020 program of the European Union [653706]; Deutsche Forschungsgemeinschaft [RE 3712/1-1, GU883/4-1]	iNEXT - Horizon 2020 program of the European Union; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by iNEXT Project 653706 funded by the Horizon 2020 program of the European Union. This work was also supported by Deutsche Forschungsgemeinschaft Grants RE 3712/1-1 (to T.H. and S.R.) and GU883/4-1 (to S.G.). The authors declare that they have no conflicts of interest with the contents of this article.	Bawono P, 2014, METHODS MOL BIOL, V1079, P245, DOI 10.1007/978-1-62703-646-7_16; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Blanchet CE, 2015, J APPL CRYSTALLOGR, V48, P431, DOI 10.1107/S160057671500254X; Boivin S, 2016, METHODS, V95, P70, DOI 10.1016/j.ymeth.2015.08.003; Crepin T, 2010, J VIROL, V84, P9096, DOI 10.1128/JVI.00995-10; Cummings MD, 2006, J BIOMOL SCREEN, V11, P854, DOI 10.1177/1087057106292746; Devignot S, 2015, J VIROL, V89, P5957, DOI 10.1128/JVI.03691-14; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; Ergonul O, 2006, LANCET INFECT DIS, V6, P203, DOI 10.1016/S1473-3099(06)70435-2; Fernandez-Garcia Y, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005635; Ferron F, 2017, VIRUS RES, V234, P118, DOI 10.1016/j.virusres.2017.01.018; Franke D, 2017, J APPL CRYSTALLOGR, V50, P1212, DOI 10.1107/S1600576717007786; Guterres A, 2017, INFECT GENET EVOL, V49, P164, DOI 10.1016/j.meegid.2017.01.019; Hass M, 2008, J VIROL, V82, P10207, DOI 10.1128/JVI.00220-08; Kieny MP, 2017, LANCET, V389, P2469, DOI 10.1016/S0140-6736(17)31635-5; Klemm C, 2013, J VIROL, V87, P8205, DOI 10.1128/JVI.00371-13; Koszalka P, 2017, INFLUENZA OTHER RESP, V11, P240, DOI 10.1111/irv.12446; Kowalinski E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002831; Lelke M, 2010, J VIROL, V84, P1934, DOI 10.1128/JVI.01657-09; Leney AC, 2017, J AM SOC MASS SPECTR, V28, P5, DOI 10.1007/s13361-016-1545-3; Li C, 2015, ELIFE, V4, DOI [10.7554/eLife.06587, 10.1155/2015/757269]; Lukashev AN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166744; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Morin B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001038; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pflug A, 2017, VIRUS RES, V234, P103, DOI 10.1016/j.virusres.2017.01.013; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Reguera J, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005636; Reguera J, 2016, CURR OPIN STRUC BIOL, V36, P75, DOI 10.1016/j.sbi.2016.01.002; Reguera J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001101; Saez-Ayala M, 2018, IUCRJ, V5, P223, DOI 10.1107/S2052252518001021; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scholte FEM, 2017, CELL REP, V20, P2396, DOI 10.1016/j.celrep.2017.08.040; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; TOMASSINI J, 1994, ANTIMICROB AGENTS CH, V38, P2827, DOI 10.1128/AAC.38.12.2827; Uetrecht C, 2011, ANGEW CHEM INT EDIT, V50, P8248, DOI 10.1002/anie.201008120; van den Heuvel RHH, 2006, ANAL CHEM, V78, P7473, DOI 10.1021/ac061039a; Vieth S, 2004, VIROLOGY, V318, P153, DOI 10.1016/j.virol.2003.09.009; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wallat GD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087577; Zimmermann L, 2018, J MOL BIOL, V430, P2237, DOI 10.1016/j.jmb.2017.12.007; Zivcec M, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8040106	43	20	20	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19686	19698		10.1074/jbc.RA118.004373	http://dx.doi.org/10.1074/jbc.RA118.004373			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30348898	Green Published, hybrid			2022-12-28	WOS:000454294900016
J	Deppe, JP; Rabbat, R; Hortensteiner, S; Keller, B; Martinoia, E; Lopez-Marques, RL				Deppe, Johannes P.; Rabbat, Ritta; Hortensteiner, Stefan; Keller, Beat; Martinoia, Enrico; Lopez-Marques, Rosa L.			The wheat ABC transporter Lr34 modifies the lipid environment at the plasma membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE FUNGAL PATHOGENS; PROTEIN-KINASE-C; PHOSPHATIDIC-ACID; ARABIDOPSIS-THALIANA; PLANT-GROWTH; CELL-DEATH; RESISTANCE; YEAST; EXPRESSION; DOMAINS	Phospholipids (PLs) are emerging as important factors that initiate signal transduction cascades at the plasma membrane. Their distribution within biological membranes is tightly regulated, e.g. by ATP-binding cassette (ABC) transporters, which preferably translocate PLs from the cytoplasmic to the exoplasmic membrane leaflet and are therefore called PL-floppases. Here, we demonstrate that a plant ABC transporter, Lr34 from wheat (Triticum aestivum), is involved in plasma membrane remodeling characterized by an intracellular accumulation of phosphatidic acid and enhanced outward translocation of phosphatidylserine. In addition, the content of phosphatidylinositol 4,5-bisphosphate in the cytoplasmic leaflet of the plasma membrane was reduced in the presence of the ABC transporter. When heterologously expressed in Saccharomyces cerevisiae, Lr34 promoted oil body formation in a mutant defective in PL-transfer in the secretory pathway. Our results suggest that PL redistribution by Lr34 potentially affects the membrane-bound proteome and contributes to the previously reported stimuli-independent activation of biotic and abiotic stress responses and neutral lipid accumulation in transgenic Lr34-expressing barley plants.	[Deppe, Johannes P.; Rabbat, Ritta; Hortensteiner, Stefan; Keller, Beat; Martinoia, Enrico] Univ Zurich UZH, Dept Plant & Microbial Biol, Zollikerstr 107, CH-8008 Zurich, Switzerland; [Lopez-Marques, Rosa L.] Univ Copenhagen, Dept Plant & Environm Sci, Thorvaldsensvej 40, DK-1871 Frederiksberg C, Denmark	University of Zurich; University of Copenhagen	Deppe, JP (corresponding author), Univ Zurich UZH, Dept Plant & Microbial Biol, Zollikerstr 107, CH-8008 Zurich, Switzerland.; Lopez-Marques, RL (corresponding author), Univ Copenhagen, Dept Plant & Environm Sci, Thorvaldsensvej 40, DK-1871 Frederiksberg C, Denmark.	johannes.deppe@botinst.uzh.ch; rlo@plen.ku.dk	Lopez-Marques, Rosa L/F-8536-2014; Martinoia, Enrico/AAH-8712-2021; Keller, Beat/K-3093-2019; Marques, Rosa Laura Lopez/AAI-8071-2020	Lopez-Marques, Rosa L/0000-0002-5663-7903; Keller, Beat/0000-0003-2379-9225; Marques, Rosa Laura Lopez/0000-0002-5663-7903	University of Zurich; ERC [249996]	University of Zurich; ERC(European Research Council (ERC)European Commission)	This work was supported by University of Zurich and ERC Advanced Grant Durable Resistance 249996. The authors declare that they have no conflicts of interest with the contents of this article.	Alder-Baerens N, 2006, MOL BIOL CELL, V17, P1632, DOI 10.1091/mbc.E05-10-0912; Ananthanarayanan B, 2002, J BIOL CHEM, V277, P3568, DOI 10.1074/jbc.M109705200; Andjelic CD, 2008, MAR DRUGS, V6, P528, DOI 10.3390/md20080027; Anthony RG, 2004, EMBO J, V23, P572, DOI 10.1038/sj.emboj.7600068; BANKAITIS VA, 1989, J CELL BIOL, V108, P1271, DOI 10.1083/jcb.108.4.1271; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; Bucher R. R., 2017, THESIS; Campos-Salinas J, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002179; Chauhan H, 2015, PLANT J, V84, P202, DOI 10.1111/tpj.13001; Chen W, 2009, J MICROBIOL METH, V77, P41, DOI 10.1016/j.mimet.2009.01.001; Chung E, 2004, PLANTA, V220, P286, DOI 10.1007/s00425-004-1372-9; Colon-Gonzalez F, 2006, BBA-MOL CELL BIOL L, V1761, P827, DOI 10.1016/j.bbalip.2006.05.001; Creutz CE, 1998, J BIOL CHEM, V273, P1393, DOI 10.1074/jbc.273.3.1393; Crouzet J, 2013, PLANT MOL BIOL, V82, P181, DOI 10.1007/s11103-013-0053-0; Dawson AP, 1997, CURR BIOL, V7, pR544, DOI 10.1016/S0960-9822(06)00277-6; de Jong CF, 2004, PLANT J, V39, P1, DOI 10.1111/j.1365-313X.2004.02110.x; Decottignies A, 1998, J BIOL CHEM, V273, P12612, DOI 10.1074/jbc.273.20.12612; Dries DR, 2007, J BIOL CHEM, V282, P826, DOI 10.1074/jbc.C600268200; Geertsma ER, 2011, BIOCHEMISTRY-US, V50, P3272, DOI 10.1021/bi200178z; Grefen C, 2010, PLANT J, V64, P355, DOI 10.1111/j.1365-313X.2010.04322.x; Hanson PK, 2003, J BIOL CHEM, V278, P36041, DOI 10.1074/jbc.M305263200; Higgins CF, 2001, RES MICROBIOL, V152, P205, DOI 10.1016/S0923-2508(01)01193-7; Hulbert SH, 2007, PHYTOPATHOLOGY, V97, P1083, DOI 10.1094/PHYTO-97-9-1083; JACKOWSKI S, 1994, J BIOL CHEM, V269, P3858; Jambunathan N, 2001, PLANT CELL, V13, P2225, DOI 10.1105/tpc.13.10.2225; Johnson JE, 2000, BIOCHEMISTRY-US, V39, P11360, DOI 10.1021/bi000902c; KAISER WM, 1982, PLANTA, V154, P538, DOI 10.1007/BF00402997; Kang J, 2010, P NATL ACAD SCI USA, V107, P2355, DOI 10.1073/pnas.0909222107; Kobae Y, 2006, PLANT CELL PHYSIOL, V47, P309, DOI 10.1093/pcp/pcj001; Krattinger SG, 2016, PLANT BIOTECHNOL J, V14, P1261, DOI 10.1111/pbi.12491; Krattinger SG, 2009, SCIENCE, V323, P1360, DOI 10.1126/science.1166453; Ludwig AA, 2005, P NATL ACAD SCI USA, V102, P10736, DOI 10.1073/pnas.0502954102; MARKI F, 1991, BIOCHEM PHARMACOL, V42, P2027, DOI 10.1016/0006-2952(91)90604-4; Miao YS, 2007, NAT PROTOC, V2, P2348, DOI 10.1038/nprot.2007.360; Mishra G, 2006, SCIENCE, V312, P264, DOI 10.1126/science.1123769; MORITZ A, 1992, J BIOL CHEM, V267, P7207; Munnik T, 2009, J LIPID RES, V50, pS260, DOI 10.1194/jlr.R800098-JLR200; Murphy DJ, 1999, TRENDS BIOCHEM SCI, V24, P109, DOI 10.1016/S0968-0004(98)01349-8; NAGATA T, 1992, INT REV CYTOL, V132, P1, DOI 10.1016/S0074-7696(08)62452-3; Parsons AB, 2006, CELL, V126, P611, DOI 10.1016/j.cell.2006.06.040; Risk JM, 2013, PLANT BIOTECHNOL J, V11, P847, DOI 10.1111/pbi.12077; SAUER N, 1994, PLANT J, V6, P67, DOI 10.1046/j.1365-313X.1994.6010067.x; Simon MLA, 2014, PLANT J, V77, P322, DOI 10.1111/tpj.12358; Smriti, 2002, YEAST, V19, P303, DOI 10.1002/yea.818; Sucher J, 2017, PLANT BIOTECHNOL J, V15, P489, DOI 10.1111/pbi.12647; Testerink C, 2011, J EXP BOT, V62, P2349, DOI 10.1093/jxb/err079; Thompson JR, 1998, YEAST, V14, P565, DOI 10.1002/(SICI)1097-0061(19980430)14:6<565::AID-YEA251>3.0.CO;2-B; Wang XM, 2005, PLANT PHYSIOL, V139, P566, DOI 10.1104/pp.105.068809; Weingartner A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042070; Woehlecke H, 2003, BIOCHEM J, V376, P489, DOI 10.1042/BJ20030886; Xue H, 2007, CURR OPIN PLANT BIOL, V10, P483, DOI 10.1016/j.pbi.2007.07.003; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Zhao J, 2015, J EXP BOT, V66, P1721, DOI 10.1093/jxb/eru540; Zou BH, 2016, GENOME, V59, P565, DOI 10.1139/gen-2016-0015	55	13	15	1	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2018	293	48					18667	18679		10.1074/jbc.RA118.002532	http://dx.doi.org/10.1074/jbc.RA118.002532			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NX	30327425	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000458467300021
J	Nichols, CG; Lee, SJ				Nichols, Colin G.; Lee, Sun-joo			Polyamines and potassium channels: A 25-year romance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							RECTIFIER K+ CHANNELS; INWARD RECTIFICATION; CRYSTAL-STRUCTURE; CYTOPLASMIC PORE; STRUCTURAL BASIS; MOLECULAR-BASIS; FUNCTIONAL EXPRESSION; VOLTAGE SENSITIVITY; SPERMINE BINDING; XENOPUS OOCYTES	Potassium channels that exhibit the property of inward rectification (Kir channels) are present in most cells. Cloning of the first Kir channel genes 25 years ago led to recognition that inward rectification is a consequence of voltage-dependent block by cytoplasmic polyamines, which are also ubiquitously present in animal cells. Uponcellular depolarization, these polycationic metabolites enter the Kir channel pore from the intracellular side, blocking the movement of K+ ions through the channel. As a consequence, high K+ conductance at rest can provide very stable negative resting potentials, but polyamine-mediated blockade at depolarized potentials ensures, for instance, the long plateau phase of the cardiac action potential, an essential feature for a stable cardiac rhythm. Despite much investigation of the polyamine block, where exactly polyamines get to within the Kir channel pore and how the steep voltage dependence arises remain unclear. This Minireview will summarize current understanding of the relevance and molecular mechanisms of polyamine block and offer some ideas to try to help resolve the fundamental issue of the voltage dependence of polyamine block.	[Nichols, Colin G.; Lee, Sun-joo] Washington Univ, Sch Med, Dept Cell Biol & Physiol, Ctr Invest Membrane Excitabil Dis, St Louis, MO 63110 USA	Washington University (WUSTL)	Nichols, CG (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, Ctr Invest Membrane Excitabil Dis, St Louis, MO 63110 USA.	cnichols@wustl.edu			National Institutes of Health [HL140024]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R35HL140024] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant HL140024 (to C. G. N). This article is part of a series on "Polyamines," written in honor of Dr. Herbert Tabor's 100th birthday. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abrams CJ, 1996, J PHYSIOL-LONDON, V493, P643, DOI 10.1113/jphysiol.1996.sp021411; Amoros I, 2013, BIOCHEM PHARMACOL, V86, P267, DOI 10.1016/j.bcp.2013.04.023; ARMSTRON.CM, 1969, J GEN PHYSIOL, V54, P553, DOI 10.1085/jgp.54.5.553; Baronas VA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00325; Bavro VN, 2012, NAT STRUCT MOL BIOL, V19, P158, DOI 10.1038/nsmb.2208; Bianchi L, 1996, J BIOL CHEM, V271, P6114, DOI 10.1074/jbc.271.11.6114; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; Bowie D, 2018, J BIOL CHEM, V293, P18789, DOI 10.1074/jbc.TM118.003794; BRISMAR T, 1989, BRAIN RES, V480, P249, DOI 10.1016/0006-8993(89)90190-X; Casero RA, 2018, NAT REV CANCER, V18, P681, DOI 10.1038/s41568-018-0050-3; Cheng WWL, 2009, J GEN PHYSIOL, V133, P295, DOI 10.1085/jgp.200810125; CIANI S, 1988, J MEMBRANE BIOL, V103, P171, DOI 10.1007/BF01870947; Clarke OB, 2010, CELL, V141, P1018, DOI 10.1016/j.cell.2010.05.003; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Enkvetchakul D, 2003, J PHYSIOL-LONDON, V553, P95, DOI 10.1113/jphysiol.2003.047910; Fakler B, 1996, PFLUG ARCH EUR J PHY, V433, P77, DOI 10.1007/s004240050251; FAKLER B, 1994, FEBS LETT, V356, P199, DOI 10.1016/0014-5793(94)01258-X; FAKLER B, 1995, CELL, V80, P149, DOI 10.1016/0092-8674(95)90459-X; FEUERSTEIN BG, 1992, CANCER RES, V52, P6782; FICKER E, 1994, SCIENCE, V266, P1068, DOI 10.1126/science.7973666; Fujiwara Y, 2006, J GEN PHYSIOL, V127, P401, DOI 10.1085/jgp.200509434; GIEBISCH G, 1990, J PHYSIOL-LONDON, V420, P313, DOI 10.1113/jphysiol.1990.sp017914; GLOWATZKI E, 1995, P ROY SOC B-BIOL SCI, V261, P251, DOI 10.1098/rspb.1995.0145; Guo DL, 2000, J GEN PHYSIOL, V116, P561, DOI 10.1085/jgp.116.4.561; Guo DL, 2000, J GEN PHYSIOL, V115, P799, DOI 10.1085/jgp.115.6.799; Guo DL, 2003, J GEN PHYSIOL, V122, P485, DOI 10.1085/jgp.200308890; Guo DL, 2003, J GEN PHYSIOL, V121, P261, DOI 10.1085/jgp.200208771; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Hesterberg Rebecca S, 2018, Med Sci (Basel), V6, DOI 10.3390/medsci6010022; HESTRIN S, 1987, J PHYSIOL-LONDON, V390, P319, DOI 10.1113/jphysiol.1987.sp016703; Hille B., 1992, IONIC CHANNELS EXCIT; HO K, 1993, NATURE, V362, P31, DOI 10.1038/362031a0; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; Huang Y, 2009, ESSAYS BIOCHEM, V46, P95, DOI [10.1042/BSE0460007, 10.1042/bse0460007]; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; KATZ B, 1949, ARCH SCI PHYSIOL, V3, P285; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; Kubo Y, 2001, J PHYSIOL-LONDON, V531, P645, DOI 10.1111/j.1469-7793.2001.0645h.x; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; Kucheryavykh YV, 2007, CHANNELS, V1, P172, DOI 10.4161/chan.4389; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Kurata HT, 2008, BIOPHYS J, V95, P3827, DOI 10.1529/biophysj.108.133256; Kurata HT, 2007, J GEN PHYSIOL, V130, P145, DOI 10.1085/jgp.200709742; Kurata HT, 2010, J GEN PHYSIOL, V135, P495, DOI 10.1085/jgp.200910253; Kurata HT, 2006, J GEN PHYSIOL, V127, P467, DOI 10.1085/jgp.200509467; Kurata HT, 2004, J GEN PHYSIOL, V124, P541, DOI 10.1085/jgp.200409159; Lee SJ, 2016, J GEN PHYSIOL, V148, P227, DOI 10.1085/jgp.201611616; Lopatin AN, 2000, J MOL CELL CARDIOL, V32, P2007, DOI 10.1006/jmcc.2000.1232; Lopatin AN, 1996, J GEN PHYSIOL, V108, P105, DOI 10.1085/jgp.108.2.105; LOPATIN AN, 1995, J GEN PHYSIOL, V106, P923, DOI 10.1085/jgp.106.5.923; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; Loussouarn G, 2005, MOL PHARMACOL, V68, P298, DOI 10.1124/mol.105.012377; Lu Z, 1999, J GEN PHYSIOL, V113, P35, DOI 10.1085/jgp.113.1.35; Lu Z, 2004, ANNU REV PHYSIOL, V66, P103, DOI 10.1146/annurev.physiol.66.032102.150822; LU Z, 1994, NATURE, V371, P243, DOI 10.1038/371243a0; Makary SMY, 2005, J PHYSIOL-LONDON, V568, P749, DOI 10.1113/jphysiol.2005.085746; MATSUDA H, 1987, NATURE, V325, P156, DOI 10.1038/325156a0; MATSUDA H, 1989, J PHYSIOL-LONDON, V413, P139, DOI 10.1113/jphysiol.1989.sp017646; MATSUDA H, 1988, J PHYSIOL-LONDON, V397, P237, DOI 10.1113/jphysiol.1988.sp016998; NAKAJIMA Y, 1988, P NATL ACAD SCI USA, V85, P3643, DOI 10.1073/pnas.85.10.3643; NEWMAN EA, 1993, J NEUROSCI, V13, P3333; NICHOLS CG, 1994, J PHYSIOL-LONDON, V476, P399, DOI 10.1113/jphysiol.1994.sp020141; Nichols CG, 1996, CIRC RES, V78, P1, DOI 10.1161/01.RES.78.1.1; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Nishida M, 2002, CELL, V111, P957, DOI 10.1016/S0092-8674(02)01227-8; Nishida M, 2007, EMBO J, V26, P4005, DOI 10.1038/sj.emboj.7601828; OLIVA C, 1990, J GEN PHYSIOL, V96, P299, DOI 10.1085/jgp.96.2.299; Panama BK, 2006, J PHYSIOL-LONDON, V571, P287, DOI 10.1113/jphysiol.2005.097741; Panama BK, 2007, AM J PHYSIOL-HEART C, V293, pH3558, DOI 10.1152/ajpheart.00419.2007; Pearson WL, 1998, J GEN PHYSIOL, V112, P351, DOI 10.1085/jgp.112.3.351; Pegan S, 2005, NAT NEUROSCI, V8, P279, DOI 10.1038/nn1411; Pegg AE, 2016, J BIOL CHEM, V291, P14904, DOI 10.1074/jbc.R116.731661; Phillips LR, 2003, J GEN PHYSIOL, V122, P795, DOI 10.1085/jgp.200308953; Priori SG, 2005, CIRC RES, V96, P800, DOI 10.1161/01.RES.0000162101.76263.8c; Robertson JL, 2008, J GEN PHYSIOL, V132, P613, DOI 10.1085/jgp.200810068; RUPPERSBERG JP, 1994, SEMIN NEUROSCI, V6, P87; Seiler N., 1994, NEUROPHARMACOLOGY PO, P1; Shieh RC, 1996, J PHYSIOL-LONDON, V494, P363, DOI 10.1113/jphysiol.1996.sp021498; Shin HG, 2005, J GEN PHYSIOL, V126, P123, DOI 10.1085/jgp.200509296; Shin HG, 2005, J GEN PHYSIOL, V125, P413, DOI 10.1085/jgp.200409242; Shyng SL, 1997, J GEN PHYSIOL, V110, P141, DOI 10.1085/jgp.110.2.141; Shyng SL, 1997, J GEN PHYSIOL, V110, P655, DOI 10.1085/jgp.110.6.655; Shyng SL, 1996, P NATL ACAD SCI USA, V93, P12014, DOI 10.1073/pnas.93.21.12014; STEGLICH C, 1982, J BIOL CHEM, V257, P4603; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; TAGLIALATELA M, 1995, EMBO J, V14, P5532, DOI 10.1002/j.1460-2075.1995.tb00240.x; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Tristani-Firouzi M, 2010, PFLUG ARCH EUR J PHY, V460, P289, DOI 10.1007/s00424-010-0820-6; Tsai KL, 2013, CELL PHYSIOL BIOCHEM, V31, P938, DOI 10.1159/000350112; Twomey EC, 2018, NEURON, V99, P956, DOI 10.1016/j.neuron.2018.07.027; VANDENBERG CA, 1987, P NATL ACAD SCI USA, V84, P2560, DOI 10.1073/pnas.84.8.2560; Whorton MR, 2011, CELL, V147, P199, DOI 10.1016/j.cell.2011.07.046; WIBLE BA, 1994, NATURE, V371, P246, DOI 10.1038/371246a0; WOODHULL AM, 1973, J GEN PHYSIOL, V61, P687, DOI 10.1085/jgp.61.6.687; Xie LH, 2002, J GEN PHYSIOL, V120, P53, DOI 10.1085/jgp.20028576; Xu YP, 2009, NAT STRUCT MOL BIOL, V16, P1252, DOI 10.1038/nsmb.1717; YANG J, 1995, NEURON, V14, P1047, DOI 10.1016/0896-6273(95)90343-7; Yi BA, 2001, NEURON, V29, P657, DOI 10.1016/S0896-6273(01)00241-0; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009; Zhu QS, 2012, AMINO ACIDS, V42, P887, DOI 10.1007/s00726-011-1004-1	102	29	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2018	293	48					18779	18788		10.1074/jbc.TM118.003344	http://dx.doi.org/10.1074/jbc.TM118.003344			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NX	30333230	Green Published, hybrid			2022-12-28	WOS:000458467300033
J	Karki, P; Ke, YB; Tian, YF; Ohmura, T; Sitikov, A; Sarich, N; Montgomery, CP; Birukova, AA				Karki, Pratap; Ke, Yunbo; Tian, Yufeng; Ohmura, Tomomi; Sitikov, Albert; Sarich, Nicolene; Montgomery, Christopher P.; Birukova, Anna A.			Staphylococcus aureus-induced endothelial permeability and inflammation are mediated by microtubule destabilization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endothelium; lung injury; inflammation; reactive oxygen species (ROS); histone deacetylase 6 (HDAC6); Staphylococcus aureus (S; aureus); microtubule; barrier disruption; CLASP2; GEF-H1	ACUTE LUNG INJURY; BARRIER DYSFUNCTION; CELLS; EPIDEMIOLOGY; ACTIVATION; PATHWAY; GEF-H1; CLASP2; EXPRESSION; HDAC6	Staphylococcus aureus is a major etiological agent of sepsis and induces endothelial cell (EC) barrier dysfunction and inflammation, two major hallmarks of acute lung injury. However, the molecular mechanisms of bacterial pathogen-induced EC barrier disruption are incompletely understood. Here, we investigated the role of microtubules (MT) in the mechanisms of EC barrier compromise caused by heat-killed S. aureus (HKSA). Using a customized monolayer permeability assay in human pulmonary EC and MT fractionation, we observed that HKSA-induced barrier disruption is accompanied by MT destabilization and increased histone deacetylase-6 (HDAC6) activity resulting from elevated reactive oxygen species (ROS) production. Molecular or pharmacological HDAC6 inhibition rescued barrier function in HKSA-challenged vascular endothelium. The HKSA-induced EC permeability was associated with impaired MT-mediated delivery of cytoplasmic linker-associated protein 2 (CLASP2) to the cell periphery, limiting its interaction with adherens junction proteins. HKSA-induced EC barrier dysfunction was also associated with increased Rho GTPase activity via activation of MT-bound Rho-specific guanine nucleotide exchange factor-H1 (GEF-H1) and was abolished by HDAC6 down-regulation. HKSA activated the NF-B proinflammatory pathway and increased the expression of intercellular and vascular cell adhesion molecules in EC, an effect that was also HDAC6-dependent and mediated, at least in part, by a GEF-H1/Rho-dependent mechanism. Of note, HDAC6 knockout mice or HDAC6 inhibitor-treated WT mice were partially protected from vascular leakage and inflammation caused by both HKSA or methicillin-resistant S. aureus (MRSA). Our results indicate that S. aureus-induced, ROS-dependent up-regulation of HDAC6 activity destabilizes MT and thereby activates the GEF-H1/Rho pathway, increasing both EC permeability and inflammation.	[Karki, Pratap; Birukova, Anna A.] Univ Maryland, Sch Med, Div Pulm & Crit Care Med, Dept Med, Baltimore, MD 21201 USA; [Ke, Yunbo] Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA; [Tian, Yufeng; Ohmura, Tomomi; Sitikov, Albert; Sarich, Nicolene; Montgomery, Christopher P.] Univ Chicago, Dept Med, Sect Pulm & Crit Care Med, Chicago, IL 60637 USA; [Montgomery, Christopher P.] Nationwide Childrens Hosp, Dept Crit Care Med, Columbus, OH 43205 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Chicago; University System of Ohio; Ohio State University; Nationwide Childrens Hospital	Birukova, AA (corresponding author), Univ Maryland, Sch Med, Pulm & Crit Care Med, 20 Penn St,HSF 2,Rm S143, Baltimore, MD 21201 USA.	abirukova@som.umaryland.edu		Montgomery, Christopher/0000-0001-7247-0683	National Institutes of Health from NHLBI [HL107920, HL130431]; National Institutes of Health from NIGMS [GM114171]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL130431, R01HL107920] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114171] Funding Source: NIH RePORTER	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants HL107920 and HL130431 from NHLBI and GM114171 from NIGMS. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akhshi TK, 2014, CYTOSKELETON, V71, P1, DOI 10.1002/cm.21150; Alieva IB, 2013, J CELL BIOCHEM, V114, P2258, DOI 10.1002/jcb.24575; Anwar KN, 2004, J IMMUNOL, V173, P6965, DOI 10.4049/jimmunol.173.11.6965; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Birukova AA, 2004, MICROVASC RES, V67, P64, DOI 10.1016/j.mvr.2003.09.007; Birukova AA, 2006, AM J PHYSIOL-LUNG C, V290, pL540, DOI 10.1152/ajplung.00259.2005; Birukova AA, 2005, J CELL PHYSIOL, V204, P934, DOI 10.1002/jcp.20359; Birukova AA, 2004, FASEB J, V18, P1879, DOI 10.1096/fj.04-2328com; Birukova AA, 2005, AM J PHYSIOL-LUNG C, V289, pL75, DOI 10.1152/ajplung.00447.2004; Birukova AA, 2004, J CELL PHYSIOL, V201, P55, DOI 10.1002/jcp.20055; Birukova AA, 2007, AM J PHYSIOL-LUNG C, V293, pL199, DOI 10.1152/ajplung.00020.2007; Birukova AA, 2015, BBA-MOL BASIS DIS, V1852, P778, DOI 10.1016/j.bbadis.2014.12.016; Birukova AA, 2013, TRANSL RES, V161, P495, DOI 10.1016/j.trsl.2012.12.008; Birukova AA, 2010, AM J PHYSIOL-LUNG C, V298, pL837, DOI 10.1152/ajplung.00263.2009; Birukova AA, 2010, MICROVASC RES, V79, P128, DOI 10.1016/j.mvr.2009.11.007; Bogatcheva NV, 2007, AM J PHYSIOL-LUNG C, V292, pL487, DOI 10.1152/ajplung.00217.2006; Borgas D, 2016, AM J RESP CELL MOL, V54, P683, DOI 10.1165/rcmb.2015-0149OC; Cetinkaya M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126028; Chang YC, 2008, MOL BIOL CELL, V19, P2147, DOI 10.1091/mbc.E07-12-1269; Dauphinee SM, 2006, LAB INVEST, V86, P9, DOI 10.1038/labinvest.3700366; Demos-Davies KM, 2014, AM J PHYSIOL-HEART C, V307, pH252, DOI 10.1152/ajpheart.00149.2014; Dubrovskyi O, 2013, LAB INVEST, V93, P254, DOI 10.1038/labinvest.2012.159; Engel U, 2014, CYTOSKELETON, V71, P195, DOI 10.1002/cm.21164; Fu P, 2009, EUR RESPIR J, V33, P612, DOI 10.1183/09031936.00014808; Fu PF, 2011, CRIT CARE MED, V39, P2711, DOI 10.1097/CCM.0b013e3182284a5f; Garcia-Mata R, 2006, METHOD ENZYMOL, V406, P425, DOI 10.1016/S0076-6879(06)06031-9; Gorshkov BA, 2012, VASC PHARMACOL, V56, P56, DOI 10.1016/j.vph.2011.10.002; Guo F, 2012, MOL IMMUNOL, V50, P98, DOI 10.1016/j.molimm.2011.12.009; Heron Melonie, 2016, Natl Vital Stat Rep, V65, P1; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Johnson ER, 2010, J AEROSOL MED PULM D, V23, P243, DOI 10.1089/jamp.2009.0775; Joshi AD, 2015, AM J PHYSIOL-LUNG C, V309, pL1410, DOI 10.1152/ajplung.00180.2015; Kakiashvili E, 2009, J BIOL CHEM, V284, P11454, DOI 10.1074/jbc.M805933200; Kempe S, 2005, NUCLEIC ACIDS RES, V33, P5308, DOI 10.1093/nar/gki836; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kratzer E, 2012, AM J RESP CELL MOL, V47, P688, DOI 10.1165/rcmb.2012-0161OC; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Lansbergen G, 2006, DEV CELL, V11, P21, DOI 10.1016/j.devcel.2006.05.012; Li LF, 2015, SCI REP-UK, V5, DOI 10.1038/srep08895; Maki T, 2015, J MOL BIOL, V427, P2379, DOI 10.1016/j.jmb.2015.05.012; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; Mayr FB, 2014, VIRULENCE, V5, P4, DOI 10.4161/viru.27372; McLoughlin A, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12664; Meliton AY, 2015, AM J PHYSIOL-LUNG C, V308, pL550, DOI 10.1152/ajplung.00248.2014; Ni YF, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-33; Nogales E, 2000, ANNU REV BIOCHEM, V69, P277, DOI 10.1146/annurev.biochem.69.1.277; Pai AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049209; Paulsen J, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0849-4; Perez-Moreno M, 2006, CELL, V124, P631, DOI 10.1016/j.cell.2005.11.043; Petrache I, 2003, AM J RESP CELL MOL, V28, P574, DOI 10.1165/rcmb.2002-0075OC; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; Saito S, 2011, BIOCHEM BIOPH RES CO, V408, P630, DOI 10.1016/j.bbrc.2011.04.075; Shahbazi Marta N, 2014, Bioarchitecture, V4, P25, DOI 10.4161/bioa.28177; Shahbazi MN, 2013, J CELL BIOL, V203, P1043, DOI 10.1083/jcb.201306019; Shimada H, 2010, J BIOL CHEM, V285, P12536, DOI 10.1074/jbc.M109.099630; Smurova K M, 2008, Tsitologiia, V50, P49; Spindler V, 2010, CARDIOVASC RES, V87, P243, DOI 10.1093/cvr/cvq086; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Tian XY, 2012, FASEB J, V26, P3862, DOI 10.1096/fj.12-207746; Tian YF, 2015, BBA-MOL BASIS DIS, V1852, P104, DOI 10.1016/j.bbadis.2014.10.012; Tian YF, 2014, MOL CELL BIOL, V34, P3546, DOI 10.1128/MCB.00248-14; Tsvetkov AS, 2007, CELL MOTIL CYTOSKEL, V64, P519, DOI 10.1002/cm.20201; Vandenbroucke E, 2008, ANN NY ACAD SCI, V1123, P134, DOI 10.1196/annals.1420.016; Verin AD, 2001, AM J PHYSIOL-LUNG C, V281, pL565, DOI 10.1152/ajplung.2001.281.3.L565; Woske HJ, 2001, CRIT CARE, V5, P167, DOI 10.1186/cc1017; Wu TH, 2013, TRANSL RES, V162, P45, DOI 10.1016/j.trsl.2013.03.005; Xing JJ, 2011, J APPL PHYSIOL, V110, P213, DOI 10.1152/japplphysiol.00284.2010; Zhang L, 2010, WORLD J SURG, V34, P1676, DOI 10.1007/s00268-010-0493-5; Zhu HQ, 2010, J BIOL CHEM, V285, P9429, DOI 10.1074/jbc.M109.071274; Zilberman Y, 2009, J CELL SCI, V122, P3531, DOI 10.1242/jcs.046813	70	24	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3369	3384		10.1074/jbc.RA118.004030	http://dx.doi.org/10.1074/jbc.RA118.004030			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30622143	Green Published, hybrid			2022-12-28	WOS:000461853900006
J	Xu, ZW; Isaji, T; Fukuda, T; Wang, YQ; Gu, JG				Xu, Zhiwei; Isaji, Tomoya; Fukuda, Tomohiko; Wang, Yuqin; Gu, Jianguo			O-GlcNAcylation regulates integrin-mediated cell adhesion and migration via formation of focal adhesion complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycosylation; O-GlcNAcylation; O-linked N-acetylglucosamine (O-GlcNAc) transferase (OGT); cell migration; cell adhesion; integrin; focal adhesions	GLCNAC; CANCER; KINASE; PHOSPHORYLATION; ACTIVATION; FAK; PROTEINS; DYNAMICS; PAXILLIN; NUCLEAR	O-GlcNAcylation is a post-translational modification of a protein serine or threonine residue catalyzed by O-GlcNAc transferase (OGT) in the nucleus and cytoplasm. O-GlcNAcylation plays important roles in the cellular signaling that affect the different biological functions of cells, depending upon cell type. However, whether or not O-GlcNAcylation regulates cell adhesion and migration remains unclear. Here, we used the doxycycline-inducible short hairpin RNA (shRNA) system to establish an OGT knockdown (KD) HeLa cell line and found that O-GlcNAcylation is a key regulator for cell adhesion, migration, and focal adhesion (FA) complex formation. The expression levels of OGT and O-GlcNAcylation were remarkably suppressed 24 h after induction of doxycycline. Knockdown of OGT significantly promoted cell adhesion, but it suppressed the cell migration on fibronectin. The immunostaining with paxillin, a marker for FA plaque, clearly showed that the number of FAs was increased in the KD cells compared with that in the control cells. The O-GlcNAcylation levels of paxillin, talin, and focal adhesion kinase were down-regulated in KD cells. Interestingly, the complex formation between integrin 1, focal adhesion kinase, paxillin, and talin was greatly increased in KD cells. Consistently, levels of active integrin 1 were significantly enhanced in KD cells, whereas they were decreased in cells overexpressing OGT. The data suggest a novel regulatory mechanism for O-GlcNAcylation during FA complex formation, which thereby affects integrin activation and integrin-mediated functions such as cell adhesion and migration.	[Xu, Zhiwei; Isaji, Tomoya; Fukuda, Tomohiko; Gu, Jianguo] Tohoku Med & Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Regulatory Glycobiol, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan; [Wang, Yuqin] Nantong Univ, Pharm Coll, Dept Pharmacol, Nantong 226001, Jiangsu, Peoples R China	Tohoku Medical & Pharmaceutical University; Nantong University	Gu, JG (corresponding author), Tohoku Med & Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Regulatory Glycobiol, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan.	jgu@tohoku-mpu.ac.jp	Gu, Jianguo/ABC-9257-2020; Isaji, Tomoya/ABC-9285-2021		Japan Society for the Promotion of Science [15H04354]; National Natural Science Foundation of China [31670807, 18H04868]; Ministry of Education, Culture, Sports, Science, and Technology of Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research 15H04354; National Natural Science Foundation of China Grant 31670807; and Grant-in-Aid for Scientific Research on Innovative Areas 18H04868 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Anthis NJ, 2011, TRENDS BIOCHEM SCI, V36, P191, DOI 10.1016/j.tibs.2010.11.002; Askari JA, 2010, J CELL BIOL, V188, P891, DOI 10.1083/jcb.200907174; Berginski ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022025; Bianchi M, 2005, BIOCHEM J, V391, P359, DOI 10.1042/BJ20050282; Caldwell SA, 2010, ONCOGENE, V29, P2831, DOI 10.1038/onc.2010.41; CHEN HC, 1995, J BIOL CHEM, V270, P16995, DOI 10.1074/jbc.270.28.16995; Collins C, 2015, CURR OPIN CELL BIOL, V36, P62, DOI 10.1016/j.ceb.2015.07.004; Comer FI, 2000, J BIOL CHEM, V275, P29179, DOI 10.1074/jbc.R000010200; Copeland RJ, 2013, PROTEOM CLIN APPL, V7, P597, DOI 10.1002/prca.201300001; Ding M, 1996, J BIOL CHEM, V271, P12555, DOI 10.1074/jbc.271.21.12555; Du J, 2011, P NATL ACAD SCI USA, V108, P9466, DOI 10.1073/pnas.1106467108; Ferrer CM, 2017, ONCOGENE, V36, P559, DOI 10.1038/onc.2016.228; Ferrer CM, 2014, MOL CELL, V54, P820, DOI 10.1016/j.molcel.2014.04.026; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Franz CM, 2002, DEV CELL, V2, P153, DOI 10.1016/S1534-5807(02)00120-X; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Grace EA, 2003, J NEUROSCI, V23, P493, DOI 10.1523/JNEUROSCI.23-02-00493.2003; Grigera PR, 2005, J CELL SCI, V118, P4931, DOI 10.1242/jcs.02696; Gu YC, 2010, CANCER RES, V70, P6344, DOI 10.1158/0008-5472.CAN-09-1887; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; HAGMANN J, 1992, J BIOL CHEM, V267, P14424; Hang QL, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00558-16; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Horzum U, 2014, METHODSX, V1, P56, DOI 10.1016/j.mex.2014.06.004; Ilic Dusko, 1995, Nature (London), V377, P539, DOI 10.1038/377539a0; Isaji T, 2014, J BIOL CHEM, V289, P20694, DOI 10.1074/jbc.M113.542688; Itkonen HM, 2013, CANCER RES, V73, P5277, DOI 10.1158/0008-5472.CAN-13-0549; Ji S, 2011, AMINO ACIDS, V40, P809, DOI 10.1007/s00726-010-0698-9; Jiang MZ, 2019, ONCOGENE, V38, P301, DOI 10.1038/s41388-018-0435-5; Kwak TK, 2010, J BIOL CHEM, V285, P36021, DOI 10.1074/jbc.M110.129601; Lachen-Montes M, 2016, J PROTEOMICS, V148, P149, DOI 10.1016/j.jprot.2016.07.032; Luk CT, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14360; Ma A, 2001, MOL BIOL CELL, V12, P1; McFarlane S, 2015, ONCOTARGET, V6, P36762, DOI 10.18632/oncotarget.5461; Mi WY, 2011, BBA-MOL BASIS DIS, V1812, P514, DOI 10.1016/j.bbadis.2011.01.009; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Parsons JT, 2000, ONCOGENE, V19, P5606, DOI 10.1038/sj.onc.1203877; Quizi JL, 2013, ONCOGENE, V32, P4656, DOI 10.1038/onc.2012.488; Rao XJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9468; Rondas D, 2011, DIABETES, V60, P1146, DOI 10.2337/db10-0946; Sakabe K, 2010, J BIOL CHEM, V285, P34460, DOI 10.1074/jbc.M110.158170; Segarra M, 2005, FASEB J, V19, P1875, DOI 10.1096/fj.04-3574fje; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Singh JP, 2015, CANCER LETT, V356, P244, DOI 10.1016/j.canlet.2014.04.014; Slawson C, 2011, NAT REV CANCER, V11, P678, DOI 10.1038/nrc3114; Tan EP, 2017, BIOCHEM SOC T, V45, P313, DOI 10.1042/BST20160145; Valdembri D, 2012, CURR OPIN CELL BIOL, V24, P582, DOI 10.1016/j.ceb.2012.08.004; Vosseller K, 2002, CURR OPIN CHEM BIOL, V6, P851, DOI 10.1016/S1367-5931(02)00384-8; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Wolfenson H, 2013, DEV CELL, V24, P447, DOI 10.1016/j.devcel.2013.02.012; Wolfram T, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-64; Xie ZG, 2003, CELL, V114, P469, DOI 10.1016/S0092-8674(03)00605-6; Xu WQ, 2017, J HEPATOL, V67, P310, DOI 10.1016/j.jhep.2017.03.017; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Yang XY, 2017, NAT REV MOL CELL BIO, V18, P452, DOI 10.1038/nrm.2017.22; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007; Zhang X, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15280	58	16	16	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2019	294	9					3117	3124		10.1074/jbc.RA118.005923	http://dx.doi.org/10.1074/jbc.RA118.005923			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU0SA	30587575	hybrid, Green Published			2022-12-28	WOS:000464980100012
J	Miyawaki, S; Uemura, Y; Hongo, K; Kawata, Y; Mizobata, T				Miyawaki, Shiori; Uemura, Yumi; Hongo, Kunihiro; Kawata, Yasushi; Mizobata, Tomohiro			Acid-denatured small heat shock protein HdeA from Escherichia coli forms reversible fibrils with an atypical secondary structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						molecular chaperone; protein folding; Gram-negative bacteria; protein aggregation; small heat shock protein (sHsp); amyloid; acid denaturation; periplasm; protein fibrillogenesis; reversible fibrillation	PERIPLASMIC CHAPERONE HDEA; SEQUENCE DETERMINANTS; ALPHA-SYNUCLEIN; RESISTANCE; DOMAIN; GROEL; IDENTIFICATION; PREDICTION; BINDING	The periplasmic small heat shock protein HdeA from Escherichia coli is inactive under normal growth conditions (at pH 7) and activated only when E. coli cells are subjected to a sudden decrease in pH, converting HdeA into an acid-denatured active state. Here, using in vitro fibrillation assays, transmission EM, atomic-force microscopy, and CD analyses, we found that when HdeA is active as a molecular chaperone, it is also capable of forming inactive aggregates that, at first glance, resemble amyloid fibrils. We noted that the molecular chaperone activity of HdeA takes precedence over fibrillogenesis under acidic conditions, as the presence of denatured substrate protein was sufficient to suppress HdeA fibril formation. Further experiments suggested that the secondary structure of HdeA fibrils deviates somewhat from typical amyloid fibrils and contains alpha-helices. Strikingly, HdeA fibrils that formed at pH 2 were immediately resolubilized by a simple shift to pH 7 and from there could regain molecular chaperone activity upon a return to pH 1. HdeA, therefore, provides an unusual example of a "reversible" form of protein fibrillation with an atypical secondary structure composition. The competition between active assistance of denatured polypeptides (its "molecular chaperone" activity) and the formation of inactive fibrillary deposits (its "fibrillogenic" activity) provides a unique opportunity to probe the relationship among protein function, structure, and aggregation in detail.	[Miyawaki, Shiori; Hongo, Kunihiro; Kawata, Yasushi; Mizobata, Tomohiro] Tottori Univ, Grad Sch Sustainabil Sci, Tottori 6808552, Japan; [Uemura, Yumi; Hongo, Kunihiro; Kawata, Yasushi; Mizobata, Tomohiro] Tottori Univ, Dept Engn, 4-101 Koyama Minami, Tottori, Tottori 6808552, Japan; [Hongo, Kunihiro; Kawata, Yasushi; Mizobata, Tomohiro] Tottori Univ, Ctr Res Green Sustainable Chem, Tottori 6808552, Japan	Tottori University; Tottori University; Tottori University	Mizobata, T (corresponding author), Tottori Univ, Dept Engn, 4-101 Koyama Minami, Tottori, Tottori 6808552, Japan.	mizobata@tottori-u.ac.jp	Kawata, Yasushi/ABA-9608-2021; Mizobata, Tomohiro/V-6672-2019	Mizobata, Tomohiro/0000-0002-7808-2099; Kawata, Yasushi/0000-0002-2744-1506	Tottori University, Japan Agency for Medical Research and Development (AMED) [JP18dm0107073]; Skylark Food Science Institute	Tottori University, Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Skylark Food Science Institute	This work was partially supported by Tottori University, Japan Agency for Medical Research and Development (AMED) Grant JP18dm0107073 and the Skylark Food Science Institute. The authors declare that they have no conflicts of interest with the contents of this article.	Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; Dahl JU, 2015, J BIOL CHEM, V290, P65, DOI 10.1074/jbc.M114.612986; de la Paz ML, 2004, P NATL ACAD SCI USA, V101, P87, DOI 10.1073/pnas.2634884100; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Foit L, 2013, P NATL ACAD SCI USA, V110, pE1254, DOI 10.1073/pnas.1222458110; Fukui N, 2016, J BIOL CHEM, V291, P25217, DOI 10.1074/jbc.M116.751925; Gajiwala KS, 2000, J MOL BIOL, V295, P605, DOI 10.1006/jmbi.1999.3347; Galzitskaya OV, 2006, PLOS COMPUT BIOL, V2, P1639, DOI 10.1371/journal.pcbi.0020177; GOORMAGHTIGH E, 1990, EUR J BIOCHEM, V193, P409, DOI 10.1111/j.1432-1033.1990.tb19354.x; GORDEN J, 1993, INFECT IMMUN, V61, P364, DOI 10.1128/IAI.61.1.364-367.1993; Hamodrakas SJ, 2007, INT J BIOL MACROMOL, V41, P295, DOI 10.1016/j.ijbiomac.2007.03.008; Hong WZ, 2005, J BIOL CHEM, V280, P27029, DOI 10.1074/jbc.M503934200; Kern R, 2007, J BACTERIOL, V189, P603, DOI 10.1128/JB.01522-06; Kim C, 2009, NUCLEIC ACIDS RES, V37, pW469, DOI 10.1093/nar/gkp351; Lazar KL, 2005, BIOCHEMISTRY-US, V44, P12681, DOI 10.1021/bi0509705; Lee AS, 2003, J MOL BIOL, V327, P699, DOI 10.1016/S0022-2836(03)00175-X; Luo F, 2018, NAT STRUCT MOL BIOL, V25, P341, DOI 10.1038/s41594-018-0050-8; Machida K, 2009, BBA-PROTEINS PROTEOM, V1794, P1344, DOI 10.1016/j.bbapap.2008.12.003; Malki A, 2008, J BIOL CHEM, V283, P13679, DOI 10.1074/jbc.M800869200; Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]; McGlinchey RP, 2018, J MOL BIOL, V430, P3696, DOI 10.1016/j.jmb.2018.06.011; Micsonai A, 2018, NUCLEIC ACIDS RES, V46, pW315, DOI 10.1093/nar/gky497; Micsonai A, 2015, P NATL ACAD SCI USA, V112, pE3095, DOI 10.1073/pnas.1500851112; O'Donnell CW, 2011, BIOINFORMATICS, V27, pI34, DOI 10.1093/bioinformatics/btr238; Ojha B, 2016, SCI REP-UK, V6, DOI 10.1038/srep31041; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Salmon L, 2018, J MOL BIOL, V430, P33, DOI 10.1016/j.jmb.2017.11.002; Tapley TL, 2010, P NATL ACAD SCI USA, V107, P1071, DOI 10.1073/pnas.0911610107; Tapley TL, 2009, P NATL ACAD SCI USA, V106, P5557, DOI 10.1073/pnas.0811811106; Tayeb-Fligelman E, 2017, SCIENCE, V355, P831, DOI 10.1126/science.aaf4901; Tian J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S45; Tsolis AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054175; Uversky VN, 2001, J BIOL CHEM, V276, P10737, DOI 10.1074/jbc.M010907200; VASSAR PS, 1959, ARCH PATHOL, V68, P487; Wang WJ, 2012, J MOL BIOL, V415, P538, DOI 10.1016/j.jmb.2011.11.026; Waterman SR, 1996, MOL MICROBIOL, V21, P925, DOI 10.1046/j.1365-2958.1996.00058.x; Wu YE, 2008, BIOCHEM J, V412, P389, DOI 10.1042/BJ20071682; Yang F, 1998, NAT STRUCT BIOL, V5, P763, DOI 10.1038/1796; YOSHIDA T, 1993, MOL GEN GENET, V237, P113, DOI 10.1007/BF00282791; Yu XC, 2017, BIOCHEMISTRY-US, V56, P5748, DOI 10.1021/acs.biochem.7b00724; Zhang S, 2016, P NATL ACAD SCI USA, V113, P10872, DOI 10.1073/pnas.1606360113; Zhang ZQ, 2007, BIOINFORMATICS, V23, P2218, DOI 10.1093/bioinformatics/btm325; Zibaee S, 2007, PROTEIN SCI, V16, P906, DOI 10.1110/ps.062624507	43	4	4	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2019	294	5					1590	1601		10.1074/jbc.RA118.005611	http://dx.doi.org/10.1074/jbc.RA118.005611			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GC	30530490	Green Published, hybrid			2022-12-28	WOS:000457879200014
J	Tan, JZA; Gleeson, PA				Tan, Jing Zhi A.; Gleeson, Paul A.			The trans-Golgi network is a major site for alpha-secretase processing of amyloid precursor protein in primary neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						beta-secretase 1 (BACE1); amyloid precursor protein (APP); membrane trafficking; enzyme processing; protein trafficking (Golgi); neurodegenerative disease; secretion; adaptor protein; secretase; alpha-secretase; trans-Golgi network	ALZHEIMERS-DISEASE; CELL-SURFACE; GAMMA-SECRETASE; BETA-SECRETASE; CLEAVAGE; APP; ADAPTER; TRAFFICKING; ENDOSOMES; ADAM10	Amyloid precursor protein (APP) is processed along the amyloidogenic pathway by the beta-secretase, BACE1, generating beta-amyloid (A beta), or along the nonamyloidogenic pathway by alpha-secretase, precluding A beta production. The plasma membrane is considered the major site for alpha-secretase-mediated APP cleavage, but other cellular locations have not been rigorously investigated. Here, we report that APP is processed by endogenous alpha-secretase at the trans-Golgi network (TGN) of both transfected HeLa cells and mouse primary neurons. We have previously shown the adaptor protein complex, AP-4, and small G protein ADP-ribosylation factor-like GTPase 5b (Arl5b) are required for efficient post-Golgi transport of APP to endosomes. We found here that AP-4 or Arl5b depletion results in Golgi accumulation of APP and increased secretion of the soluble alpha-secretase cleavage product sAPP alpha. Moreover, inhibition of gamma-secretase following APP accumulation in the TGN increases the levels of the membrane-bound C-terminal fragments of APP from both alpha-secretase cleavage (alpha-CTF, named C83 according to its band size) and BACE1 cleavage (beta-CTF/C99). The level of C83 was similar to 4 times higher than that of C99, indicating that alpha-secretase processing is the major pathway and that BACE1 processing is the minor pathway in the TGN. AP-4 silencing in mouse primary neurons also resulted in the accumulation of endogenous APP in the TGN and enhanced alpha-secretase processing. These findings identify the TGN as a major site for alpha-secretase processing in HeLa cells and primary neurons and indicate that both APP processing pathways can occur within the TGN compartment along the secretory pathway.	[Tan, Jing Zhi A.; Gleeson, Paul A.] Univ Melbourne, Bio21 Mol Sci & Biotechnol Inst, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia	University of Melbourne	Gleeson, PA (corresponding author), Univ Melbourne, Bio21 Mol Sci & Biotechnol Inst, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia.	pgleeson@unimelb.edu.au	Tan, Jing Zhi Anson/GNH-6481-2022	Tan, Jing Zhi Anson/0000-0002-6537-1166; Gleeson, Paul/0000-0002-5336-6503	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by the National Health and Medical Research Council of Australia. The authors declare that they have no conflicts of interest with the contents of this article.	Bauereiss A, 2015, TRAFFIC, V16, P655, DOI 10.1111/tra.12270; Baulac S, 2003, NEUROBIOL DIS, V14, P194, DOI 10.1016/S0969-9961(03)00123-2; Boncompain Gaelle, 2012, Curr Protoc Cell Biol, VChapter 15, DOI 10.1002/0471143030.cb1519s57; Boncompain G, 2012, NAT METHODS, V9, P493, DOI [10.1038/NMETH.1928, 10.1038/nmeth.1928]; Borg JP, 1996, MOL CELL BIOL, V16, P6229; Brisco MJ, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks588; Burgos PV, 2010, DEV CELL, V18, P425, DOI 10.1016/j.devcel.2010.01.015; Caster AH, 2013, J BIOL CHEM, V288, P28567, DOI 10.1074/jbc.M113.481101; Chaufty J, 2012, J NEUROSCI, V32, P9613, DOI 10.1523/JNEUROSCI.0602-12.2012; Chia PZC, 2011, J CELL SCI, V124, P2401, DOI 10.1242/jcs.083782; Choy RWY, 2012, P NATL ACAD SCI USA, V109, pE2077, DOI 10.1073/pnas.1208635109; Corrigan F, 2014, J NEUROCHEM, V128, P196, DOI 10.1111/jnc.12391; De Pace R, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007363; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Dunning CJR, 2016, J NEUROCHEM, V137, P518, DOI 10.1111/jnc.13571; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; Goud B, 2010, TRENDS CELL BIOL, V20, P329, DOI 10.1016/j.tcb.2010.02.006; Guo XL, 2013, DEV CELL, V27, P353, DOI 10.1016/j.devcel.2013.10.006; Guo YS, 2014, ANNU REV CELL DEV BI, V30, P169, DOI 10.1146/annurev-cellbio-100913-013012; Gutwein P, 2002, FASEB J, V16, P292, DOI 10.1096/fj.02-0430fje; HAASS C, 1993, J BIOL CHEM, V268, P3021; Hefter D, 2016, J NEUROSCI, V36, P8356, DOI 10.1523/JNEUROSCI.4130-15.2016; Heuer D, 2009, NATURE, V457, P731, DOI 10.1038/nature07578; Hirst J, 1999, MOL BIOL CELL, V10, P2787, DOI 10.1091/mbc.10.8.2787; Houghton FJ, 2012, EXP CELL RES, V318, P464, DOI 10.1016/j.yexcr.2011.12.023; Huse JT, 2002, J BIOL CHEM, V277, P16278, DOI 10.1074/jbc.M111141200; Jorissen E, 2010, J NEUROSCI, V30, P4833, DOI 10.1523/JNEUROSCI.5221-09.2010; KANG J, 1990, BIOCHEM BIOPH RES CO, V166, P1192, DOI 10.1016/0006-291X(90)90992-V; Kimura A, 2016, J BIOL CHEM, V291, P24041, DOI 10.1074/jbc.M116.744722; Kinoshita A, 2003, J CELL SCI, V116, P3339, DOI 10.1242/jcs.00643; Koike H, 1999, BIOCHEM J, V343, P371, DOI 10.1042/0264-6021:3430371; Koo EH, 1996, J CELL SCI, V109, P991; KOOY J, 1992, J BIOL CHEM, V267, P20255; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; LAI A, 1995, J BIOL CHEM, V270, P3565, DOI 10.1074/jbc.270.8.3565; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Lichtenthaler SF, 2011, J NEUROCHEM, V116, P10, DOI 10.1111/j.1471-4159.2010.07081.x; Luke MR, 2003, J BIOL CHEM, V278, P4216, DOI 10.1074/jbc.M210387200; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Matsuda S, 2008, NEURON, V57, P730, DOI 10.1016/j.neuron.2008.02.012; McLoughlin DM, 1999, EUR J NEUROSCI, V11, P1988, DOI 10.1046/j.1460-9568.1999.00610.x; NINOMIYA H, 1994, J NEUROCHEM, V63, P495; Parvathy S, 1999, BIOCHEMISTRY-US, V38, P9728, DOI 10.1021/bi9906827; Penke B, 2017, MOLECULES, V22, DOI 10.3390/molecules22101692; Perez RG, 1999, J BIOL CHEM, V274, P18851, DOI 10.1074/jbc.274.27.18851; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Rogelj B, 2006, BRAIN RES REV, V52, P305, DOI 10.1016/j.brainresrev.2006.04.005; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; Shrivastava-Ranjan P, 2008, MOL BIOL CELL, V19, P51, DOI 10.1091/mbc.E07-05-0465; Siman R, 2003, J NEUROCHEM, V84, P1143, DOI 10.1046/j.1471-4159.2003.01616.x; SISODIA SS, 1992, P NATL ACAD SCI USA, V89, P6075, DOI 10.1073/pnas.89.13.6075; Skovronsky DM, 2000, J BIOL CHEM, V275, P2568, DOI 10.1074/jbc.275.4.2568; Slack BE, 2001, BIOCHEM J, V357, P787, DOI 10.1042/0264-6021:3570787; Small SA, 2006, NEURON, V52, P15, DOI 10.1016/j.neuron.2006.09.001; SMITHSWINTOSKY VL, 1994, J NEUROCHEM, V63, P781, DOI 10.1046/j.1471-4159.1994.63020781.x; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Tanahashi H, 1999, BIOCHEM BIOPH RES CO, V255, P663, DOI 10.1006/bbrc.1999.0265; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Toh WH, 2018, MOL BIOL CELL, V29, P191, DOI 10.1091/mbc.E17-05-0270; Toh WH, 2017, TRAFFIC, V18, P159, DOI 10.1111/tra.12465; Tomita S, 1998, J BIOL CHEM, V273, P6277, DOI 10.1074/jbc.273.11.6277; Verkerk AJMH, 2009, AM J HUM GENET, V85, P40, DOI 10.1016/j.ajhg.2009.06.004; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Vincent B, 2016, BRAIN RES BULL, V126, P154, DOI 10.1016/j.brainresbull.2016.03.020; Woodcroft BJ, 2009, CYTOM PART A, V75A, P941, DOI 10.1002/cyto.a.20786; Xu HX, 1997, P NATL ACAD SCI USA, V94, P3748, DOI 10.1073/pnas.94.8.3748	67	27	27	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2019	294	5					1618	1631		10.1074/jbc.RA118.005222	http://dx.doi.org/10.1074/jbc.RA118.005222			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GC	30545942	Green Published, hybrid			2022-12-28	WOS:000457879200017
J	El Ouaamari, A; O-Sullivan, I; Shirakawa, J; Basile, G; Zhang, WW; Roger, S; Thomou, T; Xu, SS; Qiang, GF; Liew, CW; Kulkarni, RN; Unterman, TG				El Ouaamari, Abdelfattah; O-Sullivan, InSug; Shirakawa, Jun; Basile, Giorgio; Zhang, Wenwei; Roger, Sandra; Thomou, Thomas; Xu, Shanshan; Qiang, Guifen; Liew, Chong Wee; Kulkarni, Rohit N.; Unterman, Terry G.			Forkhead box protein O1 (FoxO1) regulates hepatic serine protease inhibitor B1 (serpinB1) expression in a non-cell-autonomous fashion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						beta-cell; cell proliferation; FOXO; serpin; diabetes; beta-cell proliferation; diabetes; FoxO1; insulin resistance; SerpinB1	INSULIN-PRODUCING CELLS; PANCREATIC BETA-CELLS; RESISTANCE; TISSUE; ALPHA; LIVER; PHOSPHORYLATION; METABOLISM; GENERATION; BINDING	FoxO proteins are major targets of insulin action, and FoxO1 mediates the effects of insulin on hepatic glucose metabolism. We reported previously that serpinB1 is a liver-secreted factor (hepatokine) that promotes adaptive beta-cell proliferation in response to insulin resistance in the liver-specific insulin receptor knockout (LIRKO) mouse. Here we report that FoxO1 plays a critical role in promoting serpinB1 expression in hepatic insulin resistance in a non-cell-autonomous manner. Mice lacking both the insulin receptor and FoxO1 (LIRFKO) exhibit reduced beta-cell mass compared with LIRKO mice because of attenuation of beta-cell proliferation. Although hepatic expression of serpinB1 mRNA and protein levels was increased in LIRKO mice, both the mRNA and protein levels returned to control levels in LIRFKO mice. Furthermore, liver-specific expression of constitutively active FoxO1 in transgenic mice induced an increase in hepatic serpinB1 mRNA and protein levels in refed mice. Conversely, serpinB1 mRNA and protein levels were reduced in mice lacking FoxO proteins in the liver. ChIP studies demonstrated that FoxO1 binds to three distinct sites located similar to 9 kb upstream of the serpinb1 gene in primary mouse hepatocytes and that this binding is enhanced in hepatocytes from LIRKO mice. However, adenoviral expression of WT or constitutively active FoxO1 and insulin treatment are sufficient to regulate other FoxO1 target genes (IGFBP-1 and PEPCK) but not serpinB1 expression in mouse primary hepatocytes. These results indicate that liver FoxO1 promotes serpinB1 expression in hepatic insulin resistance and that non-cell-autonomous factors contribute to FoxO1-dependent effects on serpinB1 expression in the liver.	[El Ouaamari, Abdelfattah; Shirakawa, Jun; Basile, Giorgio; Roger, Sandra; Kulkarni, Rohit N.] Harvard Med Sch, Harvard Stem Cell Inst, Islet Cell & Regenerat Biol Joslin Diabet Ctr, Dept Med, Boston, MA 02215 USA; [O-Sullivan, InSug; Zhang, Wenwei; Unterman, Terry G.] Univ Illinois, Div Endocrinol Diabet & Metab, Dept Med, Chicago, IL 60612 USA; [O-Sullivan, InSug; Zhang, Wenwei; Unterman, Terry G.] Jesse Brown Vet Affairs Med Ctr, Med Res Serv, Chicago, IL 60612 USA; [Thomou, Thomas] Harvard Med Sch, Sect Integrat Physiol & Metab, Joslin Diabet Ctr, Boston, MA 02215 USA; [Xu, Shanshan; Qiang, Guifen; Liew, Chong Wee] Univ Illinois, Coll Med, Dept Physiol & Biophys, Chicago, IL 60612 USA; [El Ouaamari, Abdelfattah] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Med, Div Endocrinol Metab & Nutr, New Brunswick, NJ 08901 USA; [Shirakawa, Jun] Yokohama City Univ, Grad Sch Med, Dept Endocrinol & Metab, Yokohama, Kanagawa 2360027, Japan; [Liew, Chong Wee] Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100006, Peoples R China; [Liew, Chong Wee] Peking Union Med Coll, Beijing 100006, Peoples R China; [Liew, Chong Wee] Beijing Key Lab Drug Target & Screening Res, Beijing 100006, Peoples R China	Harvard University; Harvard Medical School; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Rutgers State University New Brunswick; Rutgers State University Medical Center; Yokohama City University; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Kulkarni, RN (corresponding author), Harvard Med Sch, Harvard Stem Cell Inst, Islet Cell & Regenerat Biol Joslin Diabet Ctr, Dept Med, Boston, MA 02215 USA.; Unterman, TG (corresponding author), Univ Illinois, Div Endocrinol Diabet & Metab, Dept Med, Chicago, IL 60612 USA.; Unterman, TG (corresponding author), Jesse Brown Vet Affairs Med Ctr, Med Res Serv, Chicago, IL 60612 USA.	rohit.kulkarni@joslin.harvard.edu; unterman@uic.edu	Basile, Giorgio/AAD-2202-2022	Basile, Giorgio/0000-0001-9900-4922; Liew, Chong Wee/0000-0001-9904-0958; Shirakawa, Jun/0000-0002-0822-8750; O-Sullivan, InSug/0000-0003-0161-2028	Societe Francophone du Diabete; Association Francaise des Diabetiques; American Diabetes Association; JDRF [3-APF-2014-182-A-N]; National Institutes of Health [NIH R00 DK090210, R01 DK109015, RO1 DK103215]; Joslin DRC [PO36836]; Department of Veterans Affairs; Novo Nordisk Research Foundation;  [RO1 DK67536]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK109015, P30DK036836, R01DK103215, P30DK020595] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001968] Funding Source: NIH RePORTER	Societe Francophone du Diabete; Association Francaise des Diabetiques; American Diabetes Association(American Diabetes Association); JDRF(Juvenile Diabetes Research Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Joslin DRC; Department of Veterans Affairs(US Department of Veterans Affairs); Novo Nordisk Research Foundation(Novo Nordisk Foundation); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	Supported by the Societe Francophone du Diabete, Association Francaise des Diabetiques, American Diabetes Association, and JDRF (3-APF-2014-182-A-N). Present address: Dept. of Medicine, Division of Endocrinology, Metabolism, and Nutrition, Robert Wood Johnson Medical School, Rutgers, State University of New Jersey, New Brunswick, NJ 08901. Supported by National Institutes of Health Grants NIH R00 DK090210 and R01 DK109015. Present address: State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College and Beijing Key Laboratory of Drug Target and Screening Research, Beijing 100006, China. Supported by National Institutes of Health Grant RO1 DK103215 and in part by RO1 DK67536 and Joslin DRC Grant PO36836. To whom correspondence may be addressed. Tel.: 617-309-3460; Fax: 617-309-3476; E-mail:rohit.kulkarni@joslin.harvard.edu. Supported by the Department of Veterans Affairs Merit Review Program and the Novo Nordisk Research Foundation. To whom correspondence may be addressed. Tel.: 312-569-7427; Fax: 312-569-8114; E-mail: unterman@uic.edu.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Ariyachet C, 2016, CELL STEM CELL, V18, P410, DOI 10.1016/j.stem.2016.01.003; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Bastie CC, 2005, J BIOL CHEM, V280, P14222, DOI 10.1074/jbc.M413625200; Ben-Othman N, 2017, CELL, V168, P73, DOI 10.1016/j.cell.2016.11.002; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Chera S, 2016, CURR OPIN GENET DEV, V40, P1, DOI 10.1016/j.gde.2016.05.010; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; Cnop M, 2011, DIABETES OBES METAB, V13, P39, DOI 10.1111/j.1463-1326.2011.01443.x; Cnop M, 2010, DIABETOLOGIA, V53, P321, DOI 10.1007/s00125-009-1562-x; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Dhawan S, 2016, DIABETES, V65, P1208, DOI 10.2337/db15-1331; Dirice E, 2016, DIABETES, V65, P1660, DOI 10.2337/db15-1127; El Ouaamari A, 2016, CELL METAB, V23, P194, DOI 10.1016/j.cmet.2015.12.001; El Ouaamari A, 2015, J PROTEOME RES, V14, P3111, DOI 10.1021/acs.jproteome.5b00587; El Ouaamari A, 2013, CELL REP, V3, P401, DOI 10.1016/j.celrep.2013.01.007; Guo SD, 1999, J BIOL CHEM, V274, P17184, DOI 10.1074/jbc.274.24.17184; Haeusler RA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6190; Henquin JC, 2011, DIABETOLOGIA, V54, P1720, DOI 10.1007/s00125-011-2118-4; Herberts CA, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-29; KLOPPEL G, 1985, SURV SYN PATHOL RES, V4, P110; Kondegowda NG, 2015, CELL METAB, V22, P77, DOI 10.1016/j.cmet.2015.05.021; Le Lay J, 2010, PHYSIOL REV, V90, P1, DOI 10.1152/physrev.00018.2009; Li WD, 2014, NAT BIOTECHNOL, V32, P1223, DOI 10.1038/nbt.3082; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; O-Sullivan I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8079; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Pagliuca FW, 2014, CELL, V159, P428, DOI 10.1016/j.cell.2014.09.040; Perry RJ, 2015, CELL, V160, P745, DOI 10.1016/j.cell.2015.01.012; Rees DD, 1999, AM J RESP CELL MOL, V20, P69, DOI 10.1165/ajrcmb.20.1.3306; Rezania A, 2014, NAT BIOTECHNOL, V32, P1121, DOI 10.1038/nbt.3033; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Stolovich-Rain M, 2012, J BIOL CHEM, V287, P27407, DOI 10.1074/jbc.M112.350736; Talchai C, 2012, NAT GENET, V44, P406, DOI 10.1038/ng.2215; Titchenell PM, 2016, CELL METAB, V23, P1154, DOI 10.1016/j.cmet.2016.04.022; Titchenell PM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8078; Wang P, 2015, NAT MED, V21, P383, DOI 10.1038/nm.3820; Wang P, 2015, NAT REV ENDOCRINOL, V11, P201, DOI 10.1038/nrendo.2015.9; Yalley A, 2016, J BIOL CHEM, V291, P8848, DOI 10.1074/jbc.M115.677583; Zhang W, 2016, CELL REP, V15, P349, DOI 10.1016/j.celrep.2016.03.021; Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200; Zhao XS, 2004, BIOCHEM J, V378, P839, DOI 10.1042/BJ20031450	43	7	7	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2019	294	3					1059	1069		10.1074/jbc.RA118.006031	http://dx.doi.org/10.1074/jbc.RA118.006031			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL4FC	30459233	hybrid, Green Published			2022-12-28	WOS:000458670200028
J	Junkunlo, K; Soderhall, K; Soderhall, I				Junkunlo, Kingkamon; Soederhaell, Kenneth; Soderhall, Irene			Transglutaminase inhibition stimulates hematopoiesis and reduces aggressive behavior of crayfish, Pacifastacus leniusculus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hematopoietic stem cells; hematopoiesis; extracellular matrix; transglutaminase; invertebrate; crustacean; blood cell; cystamine; arthropod; hemocyte; hemolymph	CLOTTING PROTEIN; CYSTAMINE; TISSUE; CYSTEAMINE; SHRIMP; INCREASE; DISEASE; CLONING; SYSTEM; LINK	Transglutaminase (TGase) is a Ca2+-dependent cross-linking enzyme, which has both enzymatic and nonenzymatic properties. TGase is involved in several cellular activities, including adhesion, migration, survival, apoptosis, and extracellular matrix (ECM) organization. In this study, we focused on the role of the TGase enzyme in controlling hematopoiesis in the crayfish, Pacifastacus leniusculus. We hypothesized that a high TGase activity could mediate an interaction of progenitor cells with the ECM to maintain cells in an undifferentiated stage in the hematopoietic tissue (HPT). We found here that the reversible inhibitor cystamine decreases the enzymatic activity of TGase from crayfish HPT, as well as from guinea pig, in a concentration-dependent manner. Cystamine injection decreased TGase activity in HPT without affecting production of reactive oxygen species. Moreover, the decrease in TGase activity in the HPT increased the number of circulating hemocytes. Interestingly the cystamine-mediated TGase inhibition reduced aggressive behavior and movement in crayfish. In conclusion, we show that cystamine-mediated TGase inhibition directly releases HPT progenitor cells from the HPT into the peripheral circulation in the hemolymph and strongly reduces aggressive behavior in crayfish.	[Junkunlo, Kingkamon] Uppsala Univ, Dept Comparat Physiol, Norbyvagen 18A, S-75236 Uppsala, Sweden; [Soederhaell, Kenneth; Soderhall, Irene] Uppsala Univ, Dept Comparat Physiol, Sci Life Lab, Norbyvagen 18A, S-75236 Uppsala, Sweden	Uppsala University; Uppsala University	Soderhall, I (corresponding author), Uppsala Univ, Dept Comparat Physiol, Sci Life Lab, Norbyvagen 18A, S-75236 Uppsala, Sweden.	Irene.Soderhall@ebc.uu.se	Soderhall, Irene/AAS-5433-2020		Svenska Forskningsradet Formas (Swedish Research Council Formas) [2011-601]; Vetenskapsradet (VR) [621-2011-4797, 621-2012-2418]	Svenska Forskningsradet Formas (Swedish Research Council Formas)(Swedish Research Council Formas); Vetenskapsradet (VR)(Swedish Research Council)	This work was supported by Svenska Forskningsradet Formas (Swedish Research Council Formas) Grant 2011-601 (to K. S.) and Vetenskapsradet (VR) Grants 621-2011-4797 (to I. S.) and 621-2012-2418 (to K. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Al-Jallad HF, 2006, MATRIX BIOL, V25, P135, DOI 10.1016/j.matbio.2005.11.001; BIRCKBICHLER PJ, 1981, P NATL ACAD SCI-BIOL, V78, P5005, DOI 10.1073/pnas.78.8.5005; Borrell-Pages M, 2006, J CLIN INVEST, V116, P1410, DOI 10.1172/JCI27607; Bousquet M, 2010, J NEUROCHEM, V114, P1651, DOI 10.1111/j.1471-4159.2010.06874.x; Cerenius L, 2011, J INNATE IMMUN, V3, P3, DOI 10.1159/000322066; Chaga O, 1995, ANIM BIOL, V4, P50; Chang YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052419; Chen MY, 2005, DEV COMP IMMUNOL, V29, P1003, DOI 10.1016/j.dci.2005.03.012; Chen YN, 2014, FISH SHELLFISH IMMUN, V37, P30, DOI 10.1016/j.fsi.2014.01.010; Cisbani G, 2015, NEUROBIOL DIS, V82, P430, DOI 10.1016/j.nbd.2015.07.012; Eckert RL, 2014, PHYSIOL REV, V94, P383, DOI 10.1152/physrev.00019.2013; Gao JH, 2015, EXP HEMATOL ONCOL, V4, DOI 10.1186/s40164-015-0024-z; Gibrat C, 2011, PROG NEURO-PSYCHOPH, V35, P380, DOI 10.1016/j.pnpbp.2010.11.023; Gibrat C, 2010, PROG NEURO-PSYCHOPH, V34, P193, DOI 10.1016/j.pnpbp.2009.11.005; Hall M, 1999, P NATL ACAD SCI USA, V96, P1965, DOI 10.1073/pnas.96.5.1965; HAROUTUNIAN V, 1987, BRAIN RES, V403, P234, DOI 10.1016/0006-8993(87)90060-6; Hoffman CM, 2014, MOL ENDOCRINOL, V28, P1592, DOI 10.1210/me.2014-1079; Huang CC, 2004, DEV COMP IMMUNOL, V28, P279, DOI 10.1016/j.dci.2003.08.005; Ikle J, 2008, DEV DYNAM, V237, P2090, DOI 10.1002/dvdy.21624; Junkunlo K, 2018, DEV COMP IMMUNOL, V78, P132, DOI 10.1016/j.dci.2017.09.017; Junkunlo K, 2017, STEM CELLS DEV, V26, P1449, DOI 10.1089/scd.2017.0086; Junkunlo K, 2016, J BIOL CHEM, V291, P17593, DOI 10.1074/jbc.M116.741348; Kawabata S., 2015, TRANSGLUTAMINASES MU, P117; Klock C, 2012, PROTEIN SCI, V21, P1781, DOI 10.1002/pro.2162; Lin XH, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-58; Lin YT, 2015, NEUROTOX RES, V27, P259, DOI 10.1007/s12640-014-9506-8; LORAND L, 1984, MOL CELL BIOCHEM, V58, P9, DOI 10.1007/BF00240602; Martin A., 2011, INT J ALZHEIMERS DIS, V2011; Min B, 2018, BMB REP, V51, P5, DOI 10.5483/BMBRep.2018.51.1.227; Nikolajsen CL, 2014, J BIOL CHEM, V289, P6526, DOI 10.1074/jbc.M113.517904; Noonin C, 2012, STEM CELLS DEV, V21, P3173, DOI 10.1089/scd.2012.0077; Nurminskaya MV, 2012, INT REV CEL MOL BIO, V294, P1, DOI 10.1016/B978-0-12-394305-7.00001-X; Odii BO, 2014, SCI WORLD J, DOI 10.1155/2014/714561; Siegel M, 2007, PHARMACOL THERAPEUT, V115, P232, DOI 10.1016/j.pharmthera.2007.05.003; SLAUGHTER TF, 1992, ANAL BIOCHEM, V205, P166, DOI 10.1016/0003-2697(92)90594-W; TOKUNAGA F, 1993, J BIOL CHEM, V268, P262; Wang R, 2001, FISH SHELLFISH IMMUN, V11, P623, DOI 10.1006/fsim.2001.0341; Yeh MS, 2009, FISH SHELLFISH IMMUN, V27, P748, DOI 10.1016/j.fsi.2009.09.006	38	8	8	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2019	294	2					708	715		10.1074/jbc.RA118.005489	http://dx.doi.org/10.1074/jbc.RA118.005489			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HI2GP	30425101	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000456263600025
J	Tamberg, T; Hong, Z; De Schepper, D; Skovbjerg, S; Dupont, DM; Vitved, L; Schar, CR; Skjoedt, K; Vogel, LK; Jensen, JK				Tamberg, Trine; Hong, Zebin; De Schepper, Daphne; Skovbjerg, Signe; Dupont, Daniel M.; Vitved, Lars; Schar, Christine R.; Skjoedt, Karsten; Vogel, Lotte K.; Jensen, Jan K.			Blocking the proteolytic activity of zymogen matriptase with antibody-based inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epitope mapping; cancer therapy; enzyme kinetics; enzyme inhibitor; surface plasmon resonance (SPR); serine protease; matriptase; multi-domain protein; TTSP; zymogen	HEPATOCYTE GROWTH-FACTOR; FACTOR ACTIVATOR INHIBITOR-1; EPITHELIAL DEVELOPMENT; PLASMINOGEN-ACTIVATOR; PROTEASE MATRIPTASE; CRYSTAL-STRUCTURE; POTENT; CLEAVAGE; SURVIVAL; COMPLEX	Matriptase is a member of the type-II transmembrane serine protease (TTSP) family and plays a crucial role in the development and maintenance of epithelial tissues. As all chymotrypsin-like serine proteases, matriptase is synthesized as a zymogen (proform), requiring a cleavage event for full activity. Recent studies suggest that the zymogen of matriptase possesses enough catalytic activity to not only facilitate autoactivation, but also carry out its in vivo functions, which include activating several proteolytic and signaling cascades. Inhibition of zymogen matriptase may therefore be a highly effective approach for limiting matriptase activity. To this end, here we sought to characterize the catalytic activity of human zymogen matriptase and to develop mAb inhibitors against this enzyme form. Using a mutated variant of matriptase in which the serine protease domain is locked in the zymogen conformation, we confirmed that the zymogen form of human matriptase has catalytic activity. Moreover, the crystal structure of the catalytic domain of zymogen matriptase was solved to 2.5 angstrom resolution to characterize specific antibody-based matriptase inhibitors and to further structure-based studies. Finally, we describe the first antibody-based competitive inhibitors that target both the zymogen and activated forms of matriptase. We propose that these antibodies provide a more efficient way to regulate matriptase activity by targeting the protease both before and after its activation and may be of value for both research and preclinical applications.	[Tamberg, Trine; Hong, Zebin; De Schepper, Daphne; Dupont, Daniel M.; Schar, Christine R.; Jensen, Jan K.] Aarhus Univ, Dept Mol Biol & Genet, Danish Chinese Ctr Proteases & Canc, Gustav Wieds Vej 10C, DK-8000 Aarhus, Denmark; [Vitved, Lars; Skjoedt, Karsten] Univ Southern Denmark, Dept Canc & Inflammat, DK-5230 Odense, Denmark; [Skovbjerg, Signe; Vogel, Lotte K.] Univ Copenhagen, Dept Cellular & Mol Med, DK-1165 Copenhagen, Denmark	Aarhus University; University of Southern Denmark; University of Copenhagen	Jensen, JK (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Danish Chinese Ctr Proteases & Canc, Gustav Wieds Vej 10C, DK-8000 Aarhus, Denmark.	jkj@mbg.au.dk	Dupont, Daniel M./H-7556-2019	Vogel, Lotte K./0000-0001-9920-0982; Skovbjerg, Signe/0000-0002-7228-9398; Dupont, Daniel Miotto/0000-0003-1378-1670; Skjodt, Karsten/0000-0002-9161-8185	Danish Cancer Society; Danish Cancer Research Foundation	Danish Cancer Society(Danish Cancer Society); Danish Cancer Research Foundation	This work was supported by the Danish Cancer Society and the Danish Cancer Research Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Basel-Vanagaite L, 2007, AM J HUM GENET, V80, P467, DOI 10.1086/512487; Berg JM, 2012, BIOCHEMISTRY; Bugge TH, 2009, J BIOL CHEM, V284, P23177, DOI 10.1074/jbc.R109.021006; Colombo E, 2012, ACS MED CHEM LETT, V3, P530, DOI 10.1021/ml3000534; Copeland R. A., 2004, ENZYMES PRACTICAL IN; Farady CJ, 2010, CHEMBIOCHEM, V11, P2341, DOI 10.1002/cbic.201000442; Friis S, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0384-4; Friis S, 2013, J BIOL CHEM, V288, P19028, DOI 10.1074/jbc.M113.469932; Godiksen S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077146; Gray K, 2014, THROMB HAEMOSTASIS, V112, P402, DOI 10.1160/TH13-11-0895; Hong ZB, 2016, J BIOL CHEM, V291, P14340, DOI 10.1074/jbc.M115.707240; HUBER R, 1978, ACCOUNTS CHEM RES, V11, P114, DOI 10.1021/ar50123a006; Inouye K, 2010, J BIOCHEM, V147, P485, DOI 10.1093/jb/mvp190; Kataoka H, 2018, PATHOL INT, V68, P145, DOI 10.1111/pin.12647; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Lee SL, 2000, J BIOL CHEM, V275, P36720, DOI 10.1074/jbc.M007802200; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj.onc.1205502; List K, 2005, GENE DEV, V19, P1934, DOI 10.1101/gad.1300705; List K, 2009, FUTURE ONCOL, V5, P97, DOI 10.2217/14796694.5.1.97; MADISON EL, 1993, SCIENCE, V262, P419, DOI 10.1126/science.8211162; Miller GS, 2013, CELL TISSUE RES, V351, P245, DOI 10.1007/s00441-012-1348-1; Nonboe AW, 2017, TRAFFIC, V18, P378, DOI 10.1111/tra.12482; Oberst MD, 2003, J BIOL CHEM, V278, P26773, DOI 10.1074/jbc.M304282200; Pozzi N, 2013, J BIOL CHEM, V288, P11601, DOI 10.1074/jbc.M113.451542; READING CL, 1982, J IMMUNOL METHODS, V53, P261, DOI 10.1016/0022-1759(82)90175-2; Sales KU, 2015, ONCOGENE, V34, P4664, DOI 10.1038/onc.2014.391; Sales KU, 2015, ONCOGENE, V34, P288, DOI 10.1038/onc.2013.563; Schneider EL, 2012, J MOL BIOL, V415, P699, DOI 10.1016/j.jmb.2011.11.036; Szabo R, 2007, ONCOGENE, V26, P1546, DOI 10.1038/sj.onc.1209966; Szabo R, 2008, J BIOL CHEM, V283, P29495, DOI 10.1074/jbc.M801970200; Szabo R, 2009, DEVELOPMENT, V136, P2653, DOI 10.1242/dev.038430; Takeuchi T, 2000, J BIOL CHEM, V275, P26333, DOI 10.1074/jbc.M002941200; Tanabe LM, 2017, FEBS J, V284, P1421, DOI 10.1111/febs.13971; Tseng IC, 2010, J BIOL CHEM, V285, P3261, DOI 10.1074/jbc.M109.055640; Ustach CV, 2010, CANCER RES, V70, P9631, DOI 10.1158/0008-5472.CAN-10-0511; WANG DC, 1985, J MOL BIOL, V185, P595, DOI 10.1016/0022-2836(85)90074-9; Wu CJ, 2017, J CLIN INVEST, V127, P623, DOI 10.1172/JCI88428; Xu ZH, 2011, J MED CHEM, V54, P7567, DOI 10.1021/jm200920s; Zhao BY, 2013, J BIOL CHEM, V288, P11155, DOI 10.1074/jbc.M113.454611	39	8	8	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2019	294	1					314	326		10.1074/jbc.RA118.004126	http://dx.doi.org/10.1074/jbc.RA118.004126			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG6PT	30409910	Green Published, hybrid			2022-12-28	WOS:000455105500033
J	Trease, AJ; Li, HJ; Spagnol, G; Zheng, L; Stauch, KL; Sorgen, PL				Trease, Andrew J.; Li, Hanjun; Spagnol, Gaelle; Zheng, Li; Stauch, Kelly L.; Sorgen, Paul L.			Regulation of Connexin32 by ephrin receptors and T-cell protein-tyrosine phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gap junction; protein phosphorylation; intrinsically disordered protein; nuclear magnetic resonance (NMR); connexin; TC-PTP; EphB1; EphA1; intercellular communication; tyrosine kinase; ephrin	GAP-JUNCTION PROTEIN; MICE DEFICIENT; PHOSPHORYLATION; KINASE; SECRETION; CX43; COMMUNICATION; PERMEABILITY; CONDUCTANCE; EXPRESSION	Gap junctions are intercellular conduits that permit the passage of ions, small metabolites, and signaling molecules between cells. Connexin32 (Cx32) is a major gap junction protein in the liver and brain. Phosphorylation is integral to regulating connexin assembly, degradation, and electrical and metabolic coupling, as well as to interactions with molecular partners. Cx32 contains two intracellular tyrosine residues, and tyrosine phosphorylation of Cx32 has been detected after activation of the epidermal growth factor receptor; however, the specific tyrosine residue and the functional implication of this phosphorylation remain unknown. To address the limited available information on Cx32 regulation by tyrosine kinases, here we used the Cx32 C-terminal (CT) domain in an in vitro kinase-screening assay, which identified ephrin (Eph) receptor family members as tyrosine kinases that phosphorylate Cx32. We found that EphB1 and EphA1 phosphorylate the Cx32CT domain residue Tyr(243). Unlike for Cx43, the tyrosine phosphorylation of the Cx32CT increased gap junction intercellular communication. We also demonstrated that T-cell protein-tyrosine phosphatase dephosphorylates pTyr(243). The data presented above along with additional examples throughout the literature of gap junction regulation by kinases, indicate that one cannot extrapolate the effect of a kinase on one connexin to another.	[Trease, Andrew J.; Li, Hanjun; Spagnol, Gaelle; Zheng, Li; Stauch, Kelly L.; Sorgen, Paul L.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Li, Hanjun] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Sorgen, PL (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.	psorgen@unmc.edu		Spagnol, Gaelle/0000-0002-3201-4840; Trease, Andrew/0000-0003-4912-6926	NIGMS, National Institutes of Health [GM072631, GM103427]; NHLBI, National Institutes of Health [HL131712]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL131712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103427, R01GM072631] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health, Grants GM072631 and GM103427 and by Grant HL131712 from NHLBI, National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ambrosi C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157073; ATKINSON MM, 1981, J CELL BIOL, V91, P573, DOI 10.1083/jcb.91.2.573; ATKINSON MM, 1988, AM J PHYSIOL, V255, pC674, DOI 10.1152/ajpcell.1988.255.5.C674; BURT JM, 1988, AM J PHYSIOL, V254, pH1206, DOI 10.1152/ajpheart.1988.254.6.H1206; Chanson M, 1998, J CELL BIOL, V141, P1267, DOI 10.1083/jcb.141.5.1267; Coulthard MG, 2012, AM J PATHOL, V181, P1493, DOI 10.1016/j.ajpath.2012.06.043; Davy A, 2006, PLOS BIOL, V4, P1763, DOI 10.1371/journal.pbio.0040315; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Diez JA, 1995, ANN NY ACAD SCI, V766, P477, DOI 10.1111/j.1749-6632.1995.tb26699.x; Diez JA, 1998, MOL CELL BIOCHEM, V187, P201, DOI 10.1023/A:1006884600724; Fowler SL, 2009, CELL COMMUN ADHES, V16, P117, DOI 10.3109/15419060903267539; Funk SD, 2013, PHARMACOL RES, V67, P42, DOI 10.1016/j.phrs.2012.10.008; Ishii M, 2011, BASIC RES CARDIOL, V106, P1057, DOI 10.1007/s00395-011-0219-3; Jacobsen NL, 2017, J CELL SCI, V130, P3308, DOI 10.1242/jcs.202572; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; King TJ, 2004, CARCINOGENESIS, V25, P669, DOI 10.1093/carcin/bgh071; King TJ, 2004, CANCER RES, V64, P7191, DOI 10.1158/0008-5472.CAN-04-0624; Kleopa KA, 2012, BRAIN RES, V1487, P198, DOI 10.1016/j.brainres.2012.03.068; Konstantinova I, 2007, CELL, V129, P359, DOI 10.1016/j.cell.2007.02.044; Lau AF, 1996, J BIOENERG BIOMEMBR, V28, P359, DOI 10.1007/BF02110112; Leykauf K, 2006, J CELL SCI, V119, P3634, DOI 10.1242/jcs.03149; Li HJ, 2016, J BIOL CHEM, V291, P15867, DOI 10.1074/jbc.M116.727008; Li HJ, 2014, J CELL SCI, V127, P3269, DOI 10.1242/jcs.145193; Lisabeth EM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009159; Liu HJ, 2011, P NATL ACAD SCI USA, V108, P18536, DOI 10.1073/pnas.1111597108; Locke D, 2006, FASEB J, V20, P1221, DOI 10.1096/fj.05-5309fje; Mellitzer G, 1999, NATURE, V400, P77, DOI 10.1038/21907; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Peracchia C, 2000, J MEMBRANE BIOL, V178, P55, DOI 10.1007/s002320010015; Peracchia C, 2000, J BIOL CHEM, V275, P26220, DOI 10.1074/jbc.M004007200; Peters GH, 2000, J BIOL CHEM, V275, P18201, DOI 10.1074/jbc.M910273199; Peters NS, 2000, J CARDIOVASC ELECTR, V11, P488, DOI 10.1111/j.1540-8167.2000.tb00348.x; Poliakov A, 2004, DEV CELL, V7, P465, DOI 10.1016/j.devcel.2004.09.006; Remo BF, 2011, CIRC RES, V108, P1459, DOI 10.1161/CIRCRESAHA.111.244046; Ren LG, 2011, BIOCHEMISTRY-US, V50, P2339, DOI 10.1021/bi1014453; SAEZ JC, 1990, EUR J BIOCHEM, V192, P263, DOI 10.1111/j.1432-1033.1990.tb19223.x; Scherer SS, 1998, GLIA, V24, P8, DOI 10.1002/(SICI)1098-1136(199809)24:1<8::AID-GLIA2>3.0.CO;2-3; Scherer Steven S, 2012, J Peripher Nerv Syst, V17 Suppl 3, P9, DOI 10.1111/j.1529-8027.2012.00424.x; Seo MS, 2006, J VET MED SCI, V68, P567, DOI 10.1292/jvms.68.567; Solan JL, 2008, CELL COMMUN ADHES, V15, P75, DOI 10.1080/15419060802014016; Solan JL, 2007, J CELL BIOL, V179, P1301, DOI 10.1083/jcb.200707060; Solan JL, 2016, SEMIN CELL DEV BIOL, V50, P40, DOI 10.1016/j.semcdb.2015.12.010; Solan JL, 2014, FEBS LETT, V588, P1423, DOI 10.1016/j.febslet.2014.01.049; Spagnol G, 2016, J BIOL CHEM, V291, P7637, DOI 10.1074/jbc.M115.701417; Stauch K, 2012, J BIOL CHEM, V287, P27771, DOI 10.1074/jbc.M112.382572; TAKEDA A, 1987, FEBS LETT, V210, P169, DOI 10.1016/0014-5793(87)81330-3; Temme A, 1997, CURR BIOL, V7, P713, DOI 10.1016/S0960-9822(06)00302-2; Temme A, 2001, PFLUG ARCH EUR J PHY, V442, P961, DOI 10.1007/s004240100623; Thul PJ, 2018, PROTEIN SCI, V27, P233, DOI 10.1002/pro.3307; Trease AJ, 2017, J MOL CELL CARDIOL, V111, P69, DOI 10.1016/j.yjmcc.2017.07.010; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; van Veen TAB, 2000, CARDIOVASC RES, V46, P496, DOI 10.1016/S0008-6363(00)00047-X	52	2	2	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2019	294	1					341	350		10.1074/jbc.RA118.003883	http://dx.doi.org/10.1074/jbc.RA118.003883			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG6PT	30401746	hybrid, Green Published			2022-12-28	WOS:000455105500035
J	Dexter, JP; Ward, PS; Dasgupta, T; Hosios, AM; Gunawardena, J; Vander Heiden, MG				Dexter, Joseph P.; Ward, Patrick S.; Dasgupta, Tathagata; Hosios, Aaron M.; Gunawardena, Jeremy; Vander Heiden, Matthew G.			Lack of evidence for substrate channeling or flux between wildtype and mutant isocitrate dehydrogenase to produce the oncometabolite 2-hydroxyglutarate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer biology; glioblastoma; isotopic tracer; mathematical modeling; systems biology; tumor metabolism; isocitrate dehydrogenase; metabolic compartmentalization; oncometabolite; substrate channeling	MOLECULAR-MECHANISMS; IDH2 MUTATIONS; LEUKEMIA; NADPH; INHIBITORS; DISEASE; REVEAL; CELLS	Monoallelic point mutations in the gene encoding the cytosolic, NADP(+)-dependent enzyme isocitrate dehydrogenase 1 (IDH1) cause increased production of the oncometabolite 2-hydroxyglutarate (2-HG) in multiple cancers. Most IDH1 mutant tumors retain one wildtype (WT) IDH1 allele. Several studies have proposed that retention of this WT allele is protumorigenic by facilitating substrate channeling through a WT-mutant IDH1 heterodimer, with the WT subunit generating a local supply of -ketoglutarate and NADPH that is then consumed by the mutant subunit to produce 2-HG. Here, we confirmed that coexpression of WT and mutant IDH1 subunits leads to formation of WT-mutant hetero-oligomers and increases 2-HG production. An analysis of a recently reported crystal structure of the WT-R132H IDH1 heterodimer and of in vitro kinetic parameters for 2-HG production, however, indicated that substrate channeling between the subunits is biophysically implausible. We also found that putative carbon-substrate flux between WT and mutant IDH1 subunits is inconsistent with the results of isotope tracing experiments in cancer cells harboring an endogenous monoallelic IDH1 mutation. Finally, using a mathematical model of WT-mutant IDH1 heterodimers, we estimated that the NADPH:NADP(+) ratio is higher in the cytosol than in the mitochondria, suggesting that NADPH is unlikely to be limiting for 2-HG production in the cytosol. These findings argue against supply of either substrate being limiting for 2-HG production by a cytosolic IDH1 mutant and suggest that the retention of a WT allele in IDH1 mutant tumors is not due to a requirement for carbon or cofactor flux between WT and mutant IDH1.	[Dexter, Joseph P.; Dasgupta, Tathagata; Gunawardena, Jeremy] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA; [Ward, Patrick S.] Univ Penn, Perelman Sch Med, Med Scientist Training Program, Philadelphia, PA 19104 USA; [Ward, Patrick S.; Hosios, Aaron M.; Vander Heiden, Matthew G.] MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Hosios, Aaron M.; Vander Heiden, Matthew G.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Vander Heiden, Matthew G.] Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; University of Pennsylvania; Pennsylvania Medicine; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute	Gunawardena, J (corresponding author), Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA.; Vander Heiden, MG (corresponding author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Vander Heiden, MG (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Vander Heiden, MG (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.	jeremy@hms.harvard.edu; mvh@mit.edu	; Ward, Patrick/H-2361-2014	Dexter, Joseph/0000-0001-8524-5792; Vander Heiden, Matthew/0000-0002-6702-4192; Ward, Patrick/0000-0001-6437-8174; Gunawardena, Jeremy/0000-0002-7280-1152	National Science Foundation (NSF) Graduate Research Fellowship [DGE1144152]; University of Pennsylvania Medical Scientist Training Program; NSF [1462629]; Stand Up To Cancer (SU2C); Massachusetts Institute of Technology (MIT) Center for Precision Cancer Medicine; Ludwig Center at MIT; NCI, National Institutes of Health; Howard Hughes Medical Institute	National Science Foundation (NSF) Graduate Research Fellowship(National Science Foundation (NSF)); University of Pennsylvania Medical Scientist Training Program; NSF(National Science Foundation (NSF)); Stand Up To Cancer (SU2C); Massachusetts Institute of Technology (MIT) Center for Precision Cancer Medicine; Ludwig Center at MIT; NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by National Science Foundation (NSF) Graduate Research Fellowship DGE1144152 (to J. P. D.); the University of Pennsylvania Medical Scientist Training Program (to P. S. W.); NSF Grant 1462629 (to J. G.); and Stand Up To Cancer (SU2C), the Massachusetts Institute of Technology (MIT) Center for Precision Cancer Medicine, the Ludwig Center at MIT, the NCI, National Institutes of Health, and a faculty scholars award from the Howard Hughes Medical Institute (to M. G. V. H.). M. G. V. H. is a consultant for and member of the scientific advisory board of Agios Pharmaceuticals and Aeglea Biotherapeutics. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABRAHAM MH, 1987, CHROMATOGRAPHIA, V23, P243, DOI 10.1007/BF02311772; Amary MF, 2011, J PATHOL, V224, P334, DOI 10.1002/path.2913; Borger DR, 2014, CLIN CANCER RES, V20, P1884, DOI 10.1158/1078-0432.CCR-13-2649; Borger DR, 2012, ONCOLOGIST, V17, P72, DOI 10.1634/theoncologist.2011-0386; Bralten LBC, 2011, ANN NEUROL, V69, P455, DOI 10.1002/ana.22390; Brooks E, 2014, J BIOMOL SCREEN, V19, P1193, DOI 10.1177/1087057114541148; Cassago A, 2012, P NATL ACAD SCI USA, V109, P1092, DOI 10.1073/pnas.1112495109; Castellana M, 2014, NAT BIOTECHNOL, V32, P1011, DOI 10.1038/nbt.3018; Chen WW, 2016, CELL, V166, P1324, DOI 10.1016/j.cell.2016.07.040; Cornish-Bowden A, 2004, FUNDAMENTALS ENZYME, P169; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; de la Fuente MI, 2016, NEURO-ONCOLOGY, V18, P283, DOI 10.1093/neuonc/nov307; Dexter JP, 2013, J BIOL CHEM, V288, P5770, DOI 10.1074/jbc.M112.339226; DiNardo CD, 2018, NEW ENGL J MED, V378, P2386, DOI 10.1056/NEJMoa1716984; Fack F, 2017, EMBO MOL MED, V9, P1681, DOI 10.15252/emmm.201707729; Fernandez CA, 1996, J MASS SPECTROM, V31, P255, DOI 10.1002/(SICI)1096-9888(199603)31:3<255::AID-JMS290>3.0.CO;2-3; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Gelman SJ, 2018, CELL REP, V22, P512, DOI 10.1016/j.celrep.2017.12.050; Gross S, 2010, J EXP MED, V207, P339, DOI 10.1084/jem.20092506; HASINOFF BB, 1983, BIOCHEMISTRY-US, V22, P58, DOI 10.1021/bi00270a008; Intlekofer AM, 2018, NATURE, V559, P125, DOI 10.1038/s41586-018-0251-7; Jin GL, 2013, CANCER RES, V73, P496, DOI 10.1158/0008-5472.CAN-12-2852; Leonardi R, 2012, J BIOL CHEM, V287, P14615, DOI 10.1074/jbc.C112.353946; Lewis CA, 2014, MOL CELL, V55, P253, DOI 10.1016/j.molcel.2014.05.008; Li SC, 2013, NEURO-ONCOLOGY, V15, P57, DOI 10.1093/neuonc/nos261; Manrai AK, 2008, BIOPHYS J, V95, P5533, DOI 10.1529/biophysj.108.140632; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Matteo DA, 2017, J BIOL CHEM, V292, P7971, DOI 10.1074/jbc.M117.776179; Pansuriya TC, 2011, NAT GENET, V43, P1256, DOI 10.1038/ng.1004; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pichler MM, 2011, BRIT J HAEMATOL, V152, P669, DOI 10.1111/j.1365-2141.2010.08404.x; Pietrak B, 2011, BIOCHEMISTRY-US, V50, P4804, DOI 10.1021/bi200499m; Popovici-Muller J, 2018, ACS MED CHEM LETT, V9, P300, DOI 10.1021/acsmedchemlett.7b00421; Rendina AR, 2013, BIOCHEMISTRY-US, V52, P4563, DOI 10.1021/bi400514k; Robinson Gemma L, 2016, Cancer Res Front, V2, P311, DOI 10.17980/2016.311; Salamanca-Cardona L, 2017, CELL METAB, V26, P830, DOI 10.1016/j.cmet.2017.10.001; SAMEC Z, 1994, J PHYS CHEM-US, V98, P6352, DOI 10.1021/j100076a020; SOUTHARD MZ, 1991, PHARMACEUT RES, V8, P1489, DOI 10.1023/A:1015886131198; Stein EM, 2017, BLOOD, V130, P722, DOI 10.1182/blood-2017-04-779405; Ward PS, 2013, J BIOL CHEM, V288, P3804, DOI 10.1074/jbc.M112.435495; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Xie XL, 2017, STRUCTURE, V25, P506, DOI 10.1016/j.str.2016.12.017; Xu X, 2004, J BIOL CHEM, V279, P33946, DOI 10.1074/jbc.M404298200; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yang B, 2010, CELL RES, V20, P1188, DOI 10.1038/cr.2010.145; Yen K, 2017, CANCER DISCOV, V7, P478, DOI 10.1158/2159-8290.CD-16-1034; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944	47	10	10	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					20051	20061		10.1074/jbc.RA118.004278	http://dx.doi.org/10.1074/jbc.RA118.004278			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30381394	Green Published, hybrid			2022-12-28	WOS:000454685900015
J	Hu, S; Han, RH; Shi, JS; Zhu, XD; Qin, WS; Zeng, CH; Bao, H; Liu, ZH				Hu, Shuai; Han, Runhong; Shi, Jingsong; Zhu, Xiaodong; Qin, Weisong; Zeng, Caihong; Bao, Hao; Liu, Zhihong			The long noncoding RNA LOC105374325 causes podocyte injury in individuals with focal segmental glomerulosclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nephrology; podocyte; long noncoding RNA (long ncRNA; lncRNA); microRNA (miRNA); apoptosis; focal segmental glomerulosclerosis; kidney disease; nephrotic syndrome; posttranscriptional regulation	PROMOTES CELL-PROLIFERATION; DOWN-REGULATION; ANGIOTENSIN-II; P38 MAPK; ACTIVATION; KIDNEY; APOPTOSIS; PROTEINURIA; INHIBITION; MALAT1	Focal segmental glomerulosclerosis (FSGS) is a common kidney disease that results in nephrotic syndrome. FSGS arises from dysfunction and apoptosis of podocytes in the glomerulus of the kidney, leading to podocytopathy. The molecular mechanisms underlying podocyte apoptosis remain incompletely understood. Using an array of gene expression profiling, PCR, and in situ hybridization assay, we found here that the levels of the long noncoding RNA LOC105374325 were elevated in the renal podocytes of individuals with FSGS. We also observed that the microRNAs miR-34c and miR-196a/b down-regulated the expression of the apoptosis regulators BCL2-associated X, apoptosis regulator (Bax), and BCL2 antagonist/killer 1 (Bak) in podocytes. Competitive binding between LOC105374325 and miR-34c or miR-196a/b increased Bax and Bak levels and caused podocyte apoptosis. Of note, the mitogen-activated protein kinase P38 and the transcription factor CCAAT enhancer-binding protein (C/EBP) up-regulated LOC105374325 expression. P38 inhibition or C/EBP silencing decreased LOC105374325 levels and inhibited apoptosis in adriamycin-treated podocytes. LOC105374325 overexpression decreased miR-34c and miR-196a/b levels, increased Bax and Bak levels, and induced proteinuria and focal segmental lesions in mice. In conclusion, activation of the P38/C/EBP pathway stimulates the expression of LOC105374325, which, in turn, increases Bax and Bak levels and causes apoptosis by competitively binding to miR-34c and miR-196a/b in the podocytes of individuals with FSGS.	[Hu, Shuai; Han, Runhong; Shi, Jingsong; Zhu, Xiaodong; Qin, Weisong; Zeng, Caihong; Bao, Hao; Liu, Zhihong] Nanjing Univ, Sch Med, Natl Clin Res Ctr Kidney Dis, Jinling Hosp, 305 East Zhong Shan Rd, Nanjing 210002, Jiangsu, Peoples R China; [Han, Runhong] Southeast Univ, Sch Med, Nanjing 210009, Peoples R China	Nanjing University; Southeast University - China	Bao, H; Liu, ZH (corresponding author), Nanjing Univ, Sch Med, Natl Clin Res Ctr Kidney Dis, Jinling Hosp, 305 East Zhong Shan Rd, Nanjing 210002, Jiangsu, Peoples R China.	bhao@nju.edu.cn; zhihong-liu@hotmail.com			National Natural Science Foundation of China [81873610, 81200516]; Natural Science Foundation of Jiangsu Province [BK20171330, BK2012372]; Fundamental Research Funds for the Central Universities [021414380347]; National Key Research and Development Program of China [2016YFC0904100]; Major International (Regional) Joint Research Project [81320108007]; Key Research and Development Program of Jiangsu Province [BE2016747]; Nanjing University [2015-105]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Key Research and Development Program of China; Major International (Regional) Joint Research Project; Key Research and Development Program of Jiangsu Province; Nanjing University(Nanjing University)	This work was supported by National Natural Science Foundation of China Grants 81873610 and 81200516, Natural Science Foundation of Jiangsu Province Grants BK20171330 and BK2012372, Deng Feng Scholars of Nanjing University Grant 2015-105, Fundamental Research Funds for the Central Universities Grant 021414380347, National Key Research and Development Program of China Grant 2016YFC0904100, Major International (Regional) Joint Research Project Grant 81320108007, and Key Research and Development Program of Jiangsu Province Grant BE2016747. The authors declare that they have no conflicts of interest with the contents of this article.	Adams BD, 2017, J CLIN INVEST, V127, P761, DOI 10.1172/JCI84424; Alexopoulos E, 2000, NEPHROL DIAL TRANSPL, V15, P1348, DOI 10.1093/ndt/15.9.1348; Bao H, 2014, KIDNEY INT, V85, P624, DOI 10.1038/ki.2013.469; Bao H, 2014, BIOCHEM BIOPH RES CO, V444, P455, DOI 10.1016/j.bbrc.2014.01.065; Bao H, 2012, KIDNEY INT, V81, P662, DOI 10.1038/ki.2011.443; Bao WDN, 2016, SCI REP-UK, V6, DOI 10.1038/srep22579; Burlaka I, 2016, KIDNEY INT, V90, P135, DOI 10.1016/j.kint.2016.03.026; Cao DL, 2015, BIOCHEM BIOPH RES CO, V457, P1, DOI 10.1016/j.bbrc.2014.11.085; Catuogno S, 2013, ONCOGENE, V32, P341, DOI 10.1038/onc.2012.51; Chen HH, 2016, SCI REP-UK, V6, DOI 10.1038/srep27945; Chen YT, 2017, BIOCHEM BIOPH RES CO, V486, P423, DOI 10.1016/j.bbrc.2017.03.057; D'Agati VD, 2011, NEW ENGL J MED, V365, P2398, DOI 10.1056/NEJMra1106556; Floege J, 2016, LANCET, V387, P2036, DOI 10.1016/S0140-6736(16)00272-5; Gong RJ, 2008, LIFE SCI, V83, P725, DOI 10.1016/j.lfs.2008.09.015; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Hu MS, 2017, J CELL MOL MED, V21, P2732, DOI 10.1111/jcmm.13189; Hu S, 2015, FEBS LETT, V589, P4019, DOI 10.1016/j.febslet.2015.10.033; Ilatovskaya DV, 2014, KIDNEY INT, V86, P506, DOI 10.1038/ki.2014.71; Ilatovskaya DV, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00406-2; Jiang XY, 2017, EPIGENOMICS-UK, V9, P1233, DOI 10.2217/epi-2017-0020; Koshikawa M, 2005, J AM SOC NEPHROL, V16, P2690, DOI 10.1681/ASN.2004121084; Kriz W, 1998, KIDNEY INT, V54, P687, DOI 10.1046/j.1523-1755.1998.00044.x; Lei J, 2018, CELL PHYSIOL BIOCHEM, V45, P2431, DOI 10.1159/000488231; Li CB, 2016, J PATHOL, V239, P23, DOI 10.1002/path.4692; Li ZG, 2015, MOL GENET GENOMICS, V290, P863, DOI 10.1007/s00438-014-0960-z; Ling L, 2018, INT J MOL MED, V41, P2704, DOI 10.3892/ijmm.2018.3457; Liu ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071366; Liu WT, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.335; Liu XD, 2015, INT J CLIN EXP PATHO, V8, P4525; Long JY, 2016, J CLIN INVEST, V126, P4205, DOI 10.1172/JCI87927; Lv XB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063516; Ma MZ, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.541; Maidannyk V. G., 2014, PHARM INNOVATION J, V3, P43, DOI [10.7897/2277-4572.031104, DOI 10.7897/2277-4572.031104]; Meng J, 2016, J AM SOC NEPHROL, V27, P3006, DOI 10.1681/ASN.2015040422; Nonne N, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1100; Puthanveetil P, 2015, J CELL MOL MED, V19, P1418, DOI 10.1111/jcmm.12576; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Shankland SJ, 2006, KIDNEY INT, V69, P2131, DOI 10.1038/sj.ki.5000410; Sun SF, 2018, DIABETES, V67, P731, DOI 10.2337/db17-0816; Tang X, 2013, CLIN NEPHROL, V80, P130, DOI 10.5414/CN107607; Trempolec N, 2013, CELL, V152, P656, DOI [10.1016/j.cell.2013.01.029, 10.1016/j.cell.2013.01.047]; Van Laethem A, 2004, FASEB J, V18, P1946, DOI 10.1096/fj.04-2285fje; Wang HL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11248-3; Wang P, 2015, CELL SIGNAL, V27, P275, DOI 10.1016/j.cellsig.2014.11.011; Wu JB, 2014, J ETHNOPHARMACOL, V151, P1124, DOI 10.1016/j.jep.2013.12.028; Wu JN, 2014, J AM SOC NEPHROL, V25, P92, DOI 10.1681/ASN.2012111101; Xiao B, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0569-y; Zea AH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157907; Zhang CM, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1470-2; Zhang WF, 2014, CLIN J AM SOC NEPHRO, V9, P1545, DOI 10.2215/CJN.11561113	51	19	21	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					20227	20239		10.1074/jbc.RA118.005579	http://dx.doi.org/10.1074/jbc.RA118.005579			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30389788	Green Published, hybrid			2022-12-28	WOS:000454685900028
J	Abdelaziz, DH; Thapa, S; Brandon, J; Maybee, J; Vankuppeveld, L; McCorkell, R; Schatzl, HM				Abdelaziz, Dalia H.; Thapa, Simrika; Brandon, Jenna; Maybee, Justine; Vankuppeveld, Lauren; McCorkell, Robert; Schaetzl, Hermann M.			Recombinant prion protein vaccination of transgenic elk PrP mice and reindeer overcomes self-tolerance and protects mice against chronic wasting disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						prion; prion disease; vaccine; neurodegeneration; transgenic mice; bovine spongiform encephalopathy; cervid prion protein; chronic wasting disease; Creutzfeldt-Jakob disease; transgenic elk mice	WHITE-TAILED DEER; MULE DEER; IMMUNIZATION; TRANSMISSION; REPLICATION; ANTIBODIES; EMERGENCE	Chronic wasting disease (CWD) is a fatal neurodegenerative disease that affects cervids in North America and now Europe. No effective measures are available to control CWD. We hypothesized that active vaccination with homologous and aggregation-prone recombinant prion protein (PrP) could overcome self-tolerance and induce autoantibody production against the cellular isoform of PrP (PrPC), which would be protective against CWD infection from peripheral routes. Five groups of transgenic mice expressing elk PrP (TgElk) were vaccinated with either the adjuvant CpG alone or one of four recombinant PrP immunogens: deer dimer (Ddi); deer monomer (Dmo); mouse dimer (Mdi); and mouse monomer (Mmo). Mice were then challenged intraperitoneally with elk CWD prions. All vaccinated mice developed ELISA-detectable antibody titers against PrP. Importantly, all four vaccinated groups survived longer than the control group, with the Mmo-immunized group exhibiting 60% prolongation of mean survival time compared with the control group (183 versus 114 days post-inoculation). We tested for prion infection in brain and spleen of all clinically sick mice. Notably, the attack rate was 100% as revealed by positive CWD signals in all tested tissues when assessed with Western blotting, real-time quaking-induced conversion, and immunohistochemistry. Our pilot study in reindeer indicated appreciable humoral immune responses to Mdi and Ddi immunogens, and the post-immune sera from the Ddi-vaccinated reindeer mitigated CWD propagation in a cell culture model (CWD-RK13). Taken together, our study provides very promising vaccine candidates against CWD, but further studies in cervids are required to investigate vaccine efficacy in the natural CWD hosts.	[Abdelaziz, Dalia H.; Thapa, Simrika; Brandon, Jenna; Maybee, Justine; Vankuppeveld, Lauren; McCorkell, Robert; Schaetzl, Hermann M.] Univ Calgary, Dept Comparat Biol & Expt Med, Calgary, AB T2N 4Z6, Canada; [Abdelaziz, Dalia H.; Thapa, Simrika; Schaetzl, Hermann M.] Univ Calgary, Calgary Prion Res Unit, Calgary, AB T2N 4Z6, Canada; [Abdelaziz, Dalia H.] Helwan Univ, Fac Pharm, Dept Biochem & Mol Biol, Cairo 11795, Egypt; [Abdelaziz, Dalia H.; Thapa, Simrika] Univ Calgary Eyes High, Calgary, AB, Canada	University of Calgary; University of Calgary; Egyptian Knowledge Bank (EKB); Helwan University	Schatzl, HM (corresponding author), Univ Calgary, Fac Vet Med, TRW 2D10,3280 Hosp Dr NW, Calgary, AB T2N 4Z6, Canada.	hschaetz@ucalgary.ca		Schatzl, Hermann/0000-0003-4972-8740	Alberta Prion Research Institute (APRI) [201300013, 201600013]; APRI [201600010]	Alberta Prion Research Institute (APRI); APRI	This work was supported by Alberta Prion Research Institute (APRI) Grants 201300013 and 201600013 and was performed within the framework of the Calgary Prion Research Unit through APRI Grant 201600010. The authors declare that they have no conflicts of interest with the contents of this article.	Abdelaziz DH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11235-8; Aguzzi A, 2008, ANNU REV PATHOL-MECH, V3, P11, DOI 10.1146/annurev.pathmechdis.3.121806.154326; Argue CK, 2007, CAN VET J, V48, P1241; Benestad SL, 2016, VET RES, V47, DOI 10.1186/s13567-016-0375-4; Bian JF, 2014, P NATL ACAD SCI USA, V111, P6028, DOI 10.1073/pnas.1322377111; Carreno JM, 2016, VACCINE, V34, P4263, DOI 10.1016/j.vaccine.2016.05.036; DeVivo MT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186512; Edmunds DR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161127; Ertmer A, 2004, J BIOL CHEM, V279, P41918, DOI 10.1074/jbc.M405652200; Gilch S, 2003, J BIOL CHEM, V278, P18524, DOI 10.1074/jbc.M210723200; Gilch S, 2011, TOP CURR CHEM, V305, P51, DOI 10.1007/128_2011_159; Goni F, 2015, VACCINE, V33, P726, DOI 10.1016/j.vaccine.2014.11.035; Haley NJ, 2015, ANNU REV ANIM BIOSCI, V3, P305, DOI 10.1146/annurev-animal-022114-111001; Hannaoui S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006553; Heppner FL, 2001, SCIENCE, V294, P178, DOI 10.1126/science.1063093; Herbst A, 2017, EMERG INFECT DIS, V23, P1598, DOI [10.3201/eid2309.161474, 10.3201/eid2309.161747]; Jeon YC, 2013, J VET SCI, V14, P21, DOI 10.4142/jvs.2013.14.1.21; John TR, 2013, PRION, V7, P253, DOI 10.4161/pri.24430; Kaiser-Schulz G, 2007, J IMMUNOL, V179, P2797, DOI 10.4049/jimmunol.179.5.2797; Kim TY, 2005, J VET MED SCI, V67, P753, DOI 10.1292/jvms.67.753; Klyubin I, 2014, J NEUROSCI, V34, P6140, DOI 10.1523/JNEUROSCI.3526-13.2014; LaFauci G, 2006, J GEN VIROL, V87, P3773, DOI 10.1099/vir.0.82137-0; Li JL, 2010, SCIENCE, V327, P869, DOI 10.1126/science.1183218; Marsh RF, 2005, J VIROL, V79, P13794, DOI 10.1128/JVI.79.21.13794-13796.2005; Mathiason CK, 2006, SCIENCE, V314, P133, DOI 10.1126/science.1132661; Mitchell GB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039055; Orru CD, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8050140; Pilon JL, 2013, J WILDLIFE DIS, V49, P694, DOI 10.7589/2012-07-200; Polymenidou M, 2004, P NATL ACAD SCI USA, V101, P14670, DOI 10.1073/pnas.0404772101; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Pulford B, 2012, J WILDLIFE DIS, V48, P425, DOI 10.7589/0090-3558-48.2.425; Race B, 2018, J VIROL, V92, DOI [10.1128/JVI.00550-18, 10.1128/jvi.00550-18]; Race B, 2014, EMERG INFECT DIS, V20, P833, DOI 10.3201/eid2005.130778; Race B, 2009, EMERG INFECT DIS, V15, P1366, DOI 10.3201/eid1509.090253; Saunders SE, 2012, EMERG INFECT DIS, V18, P369, DOI 10.3201/eid1803.110685; Schwarz A, 2003, NEUROSCI LETT, V350, P187, DOI 10.1016/S0304-3940(03)00907-8; Sigurdson CJ, 2007, BBA-MOL BASIS DIS, V1772, P610, DOI 10.1016/j.bbadis.2006.10.010; Sigurdsson EM, 2003, NEUROSCI LETT, V336, P185, DOI 10.1016/S0304-3940(02)01192-8; Taschuk R, 2017, PRION, V11, P368, DOI 10.1080/19336896.2017.1367083; Velasquez CD, 2015, J VIROL, V89, P12362, DOI 10.1128/JVI.02010-15; Waddell L, 2018, TRANSBOUND EMERG DIS, V65, P37, DOI 10.1111/tbed.12612; White AR, 2003, NATURE, V422, P80, DOI 10.1038/nature01457; WILLIAMS ES, 1982, J WILDLIFE DIS, V18, P465, DOI 10.7589/0090-3558-18.4.465; Williams ES, 2005, VET PATHOL, V42, P530, DOI 10.1354/vp.42-5-530; WILLIAMS ES, 1980, J WILDLIFE DIS, V16, P89, DOI 10.7589/0090-3558-16.1.89; Wisniewski T, 2010, EXPERT REV VACCINES, V9, P1441, DOI [10.1586/erv.10.131, 10.1586/ERV.10.131]; Zabel MD, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004624	48	10	10	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19812	19822		10.1074/jbc.RA118.004810	http://dx.doi.org/10.1074/jbc.RA118.004810			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30397182	Green Published, hybrid			2022-12-28	WOS:000454294900025
J	Cai, YH; Yu, XH; Liu, Q; Liu, CJ; Shanklin, J				Cai, Yuanheng; Yu, Xiao-Hong; Liu, Qun; Liu, Chang-Jun; Shanklin, John			Two clusters of residues contribute to the activity and substrate specificity of Fm1, a bifunctional oleate and linoleate desaturase of fungal origin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						structure-function; substrate specificity; fatty acid metabolism; dehydrogenase; lipid metabolism; 12 and 3 desaturases; Fm1; polyunsaturated fatty acid; structural determinants; substrate specificity; phospholipid; regioselectivity; bifunctional desaturase	FATTY-ACID DESATURASES; REGIOSELECTIVITY; CRYPTOREGIOCHEMISTRY; DELTA-12; SEQUENCE; ENZYME; BRAIN; TOOL	Polyunsaturated fatty acids (PUFAs) have important industrial, physiological, and nutritional properties. Plants use the sequential activities of FAD2 and FAD3 desaturases to convert 18:19 to the important PUFA 18:39,12,15, whereas the fungus Fusarium verticillioides 7600 uses the bifunctional desaturase Fm1 for both reactions. Here, we used a combination of sequence comparisons, structural modeling, and mutagenesis experiments to investigate Fm1's regioselectivity and identified two functionally relevant clusters of residues that contribute to Fm1 activity. We found that cluster I (Leu(153), Phe(157), and His(194)), located near the catalytic iron ions, predominantly affects activity, whereas cluster II (Tyr(280), His(284), and Leu(287)), located in a helix forming the entrance to the substrate-binding pocket, mainly specifies 15-desaturation. Individual or combined substitutions of cluster II residues substantially reduced 15-desaturation. The combination of F157W from cluster I with Y280L, H284V, and L287T from cluster II created an increased-activity variant that almost completely lost the ability to desaturate at C15 and acted almost exclusively as a 12-desaturase. No variants were identified in which 15-desaturation occurred in the absence of 12-desaturation. Fm1 displayed only traces of activity with C16 substrate, but several cluster I variants exhibited increased activity with both 18:1 and 16:1 substrates, converting 16:19 to 16:39,12,15, consistent with Fm1 performing sequential v + 3 desaturation reactions at C12 and then C15. We propose that cluster II residues interact with the substrate headgroup when the acyl chain contains both 9 and 12 double bonds, in which case C15 becomes positioned adjacent to the di-iron site enabling a second v + 3 desaturation.	[Cai, Yuanheng; Yu, Xiao-Hong; Shanklin, John] SUNY Stony Brook, Biochem & Cell Biol Dept, Stony Brook, NY 11794 USA; [Liu, Qun; Liu, Chang-Jun; Shanklin, John] Brookhaven Natl Lab, Biol Dept, Upton, NY 11973 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; United States Department of Energy (DOE); Brookhaven National Laboratory	Shanklin, J (corresponding author), Brookhaven Natl Lab, Biol Dept, Upton, NY 11973 USA.	shanklin@bnl.gov	Liu, Qun/A-8757-2011	Liu, Qun/0000-0002-1179-290X; Yu, Xiao-Hong/0000-0003-2352-2023	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences, United States Department of Energy [DOE KC0304000]; National Science Foundation Plant Genome Grant [IOS-1339385]; National Science Foundation [DBI 1117680]	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences, United States Department of Energy(United States Department of Energy (DOE)); National Science Foundation Plant Genome Grant; National Science Foundation(National Science Foundation (NSF))	This work was supported by Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences, United States Department of Energy Grant DOE KC0304000 (to J.S.); National Science Foundation Plant Genome Grant IOS-1339385 (to J.S.); and National Science Foundation Grant DBI 1117680 (to Y.C. and X.Y.). The authors declare that they have no conflicts of interest with the contents of this article.	Bai YH, 2015, NATURE, V524, P252, DOI 10.1038/nature14549; Bazinet RP, 2014, NAT REV NEUROSCI, V15, P771, DOI 10.1038/nrn3820; BROWSE J, 1993, J BIOL CHEM, V268, P16345; BROWSE J, 1991, ANNU REV PLANT PHYS, V42, P467, DOI 10.1146/annurev.pp.42.060191.002343; Burdge GC, 2006, PROSTAG LEUKOTR ESS, V75, P161, DOI 10.1016/j.plefa.2006.05.013; Christie W.W., 2012, LIPID ANAL, P145, DOI [10.1533/9780857097866.145, DOI 10.1533/9780857097866.145]; Damude HG, 2006, P NATL ACAD SCI USA, V103, P9446, DOI 10.1073/pnas.0511079103; Dennis EA, 2015, NAT REV IMMUNOL, V15, P511, DOI 10.1038/nri3859; Grote A, 2005, NUCLEIC ACIDS RES, V33, pW526, DOI 10.1093/nar/gki376; Hoffmann M, 2007, J BIOL CHEM, V282, P26666, DOI 10.1074/jbc.M705068200; KEARNS EV, 1991, ARCH BIOCHEM BIOPHYS, V284, P431, DOI 10.1016/0003-9861(91)90319-E; Kihara A, 2012, J BIOCHEM, V152, P387, DOI 10.1093/jb/mvs105; Kumar R, 2006, PLANT J, V48, P920, DOI 10.1111/j.1365-313X.2006.02925.x; Kumar R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031370; Lee JM, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010023; Li DD, 2016, COMPUT STRUCT BIOTEC, V14, P341, DOI 10.1016/j.csbj.2016.08.003; Lou Y, 2014, J BIOL CHEM, V289, P17996, DOI 10.1074/jbc.M114.572883; Martinez M, 1995, J INHERIT METAB DIS, V18, P61, DOI 10.1007/BF00711429; Mayer KM, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-284; McCartney AW, 2004, PLANT J, V37, P156, DOI 10.1111/j.1365-313X.2004.01949.x; Meesapyodsuk D, 2000, BIOCHEMISTRY-US, V39, P11948, DOI 10.1021/bi000756a; Meesapyodsuk D, 2000, BIOCHEM SOC T, V28, P632, DOI 10.1042/BST0280632; Meesapyodsuk D, 2007, J BIOL CHEM, V282, P20191, DOI 10.1074/jbc.M702196200; Pan ZQ, 2007, J BIOL CHEM, V282, P4326, DOI 10.1074/jbc.M606343200; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Racine RA, 2007, CURR OPIN CLIN NUTR, V10, P123, DOI 10.1097/MCO.0b013e3280129652; Sayanova O, 2006, J BIOL CHEM, V281, P36533, DOI 10.1074/jbc.M605158200; Shanklin J, 1998, ANNU REV PLANT PHYS, V49, P611, DOI 10.1146/annurev.arplant.49.1.611; SHANKLIN J, 1994, BIOCHEMISTRY-US, V33, P12787, DOI 10.1021/bi00209a009; Shanklin J, 2009, J BIOL CHEM, V284, P18559, DOI 10.1074/jbc.R900009200; SMITH MA, 1990, BIOCHEM J, V272, P23, DOI 10.1042/bj2720023; Soucek MD, 2012, PROG ORG COAT, V73, P435, DOI 10.1016/j.porgcoat.2011.08.021; Stillwell W, 2005, REPROD NUTR DEV, V45, P559, DOI 10.1051/rnd:2005046; Wang H, 2015, NAT STRUCT MOL BIOL, V22, P581, DOI 10.1038/nsmb.3049	34	9	9	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19844	19853		10.1074/jbc.RA118.005972	http://dx.doi.org/10.1074/jbc.RA118.005972			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30348899	hybrid, Green Published			2022-12-28	WOS:000454294900028
J	Bowie, D				Bowie, Derek			Polyamine-mediated channel block of ionotropic glutamate receptors and its regulation by auxiliary proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CALCIUM-PERMEABLE AMPA; LONG-TERM POTENTIATION; CGMP-GATED CHANNEL; RNA IN-VITRO; KAINATE RECEPTORS; INWARD RECTIFICATION; SUBUNIT COMPOSITION; CA2+ PERMEABILITY; RECOMBINANT AMPA; DEVELOPMENTAL REGULATION	Most excitatory neurotransmission in the mammalian brain is mediated by a family of plasma membrane-bound signaling proteins called ionotropic glutamate receptors (iGluRs). iGluRs assemble at central synapses as tetramers, forming a central ion-channel pore whose primary function is to rapidly transport Na+ and Ca2(+) in response to binding the neurotransmitter L-glutamic acid. The pore of iGluRs is also accessible to bulkier cytoplasmic cations, such as the polyamines spermine, spermidine, and putrescine, which are drawn into the permeation pathway, but get stuck and block the movement of other ions. The degree of this polyamine- mediated channel block is highly regulated by processes that control the free cytoplasmic polyamine concentration, the membrane potential, or the iGluR subunit composition. Recently, an additional regulation by auxiliary proteins, most notably transmembrane AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptor regulatory proteins (TARPs), cornichons, and neuropilin and tolloid-like proteins (NETOs), has been identified. Here, I review what we have learned of polyamine block of iGluRs and its regulation by auxiliary subunits. TARPs, cornichons, and NETOs attenuate the channel block by enabling polyamines to exit the pore. As a result, polyamine permeation occurs at more negative and physiologically relevant membrane potentials. The structural basis for enhanced polyamine transport remains unresolved, although alterations in both channel architecture and charge-screening mechanisms have been proposed. That auxiliary subunits can attenuate the polyamine block reveals an unappreciated impact of polyamine permeation in shaping the signaling properties of neuronal AMPA-and kainate-type iGluRs. Moreover, enhanced polyamine transport through iGluRs may have a role in regulating cellular polyamine levels.	[Bowie, Derek] McGill Univ, Dept Pharmacol & Therapeut, Bellini Bldg,Rm 164, Montreal, PQ H3G 0B1, Canada	McGill University	Bowie, D (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, Bellini Bldg,Rm 164, Montreal, PQ H3G 0B1, Canada.	derek.bowie@mcgill.ca		Bowie, Derek/0000-0001-9491-8768	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Canadian Institutes of Health Research (to D. B.). This article is part of a series on "Polyamines," written in honor of Dr. Herbert Tabor's 100th birthday. The author declares that he has no conflicts of interest with the contents of this article.	Aizenman CD, 2002, NEURON, V34, P623, DOI 10.1016/S0896-6273(02)00674-8; Akgul G, 2016, J PHYSIOL-LONDON, V594, P5471, DOI 10.1113/JP271764; Alam A, 2009, NAT STRUCT MOL BIOL, V16, P30, DOI 10.1038/nsmb.1531; Anderson D, 2014, ANTON LEEUW INT J G, V106, P3, DOI 10.1007/s10482-014-0152-1; Angulo MC, 1997, J NEUROSCI, V17, P6685; Bahring R, 1997, J PHYSIOL-LONDON, V502, P575, DOI 10.1111/j.1469-7793.1997.575bj.x; Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; Baronas VA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00325; BENNETT JA, 1995, NEURON, V14, P373, DOI 10.1016/0896-6273(95)90293-7; BENVENISTE M, 1993, J PHYSIOL-LONDON, V464, P131, DOI 10.1113/jphysiol.1993.sp019627; Bernard V, 1997, J NEUROSCI, V17, P819; BOCHET P, 1994, NEURON, V12, P383, DOI 10.1016/0896-6273(94)90279-8; Bowie D., 1999, V141, P251; Bowie D, 2002, J NEUROSCI, V22, P3392; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; Bowie D, 1998, J NEUROSCI, V18, P8175; Bowie D, 2012, J PHYSIOL-LONDON, V590, P49, DOI 10.1113/jphysiol.2011.221689; Briand C. L, 1976, J CHEM PHYS, V64, P14; Brown PMGE, 2018, J GEN PHYSIOL, V150, P67, DOI 10.1085/jgp.201711895; Brown PMGE, 2016, J PHYSIOL-LONDON, V594, P1821, DOI 10.1113/JP271690; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; Burnashev N, 1996, J PHYSIOL-LONDON, V496, P165, DOI 10.1113/jphysiol.1996.sp021674; BURNASHEV N, 1992, SCIENCE, V256, P1566, DOI 10.1126/science.1317970; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Casero R. A. Jr, 2018, NAT REV CANC, V2018; Casero RA, 2009, BIOCHEM J, V421, P323, DOI 10.1042/BJ20090598; Cason AL, 2003, EUR J HUM GENET, V11, P937, DOI 10.1038/sj.ejhg.5201072; Chen GQ, 1999, NATURE, V402, P817, DOI 10.1038/45568; Collins MO, 2014, NEURON, V84, P1, DOI 10.1016/j.neuron.2014.09.018; Coombs ID, 2012, J NEUROSCI, V32, P9796, DOI 10.1523/JNEUROSCI.0345-12.2012; Copits BA, 2012, NAT REV NEUROSCI, V13, P675, DOI 10.1038/nrn3335; Copits BA, 2011, J NEUROSCI, V31, P7334, DOI 10.1523/JNEUROSCI.0100-11.2011; Cull-Candy S, 2006, CURR OPIN NEUROBIOL, V16, P288, DOI 10.1016/j.conb.2006.05.012; CURUTCHET P, 1992, BIOCHEM BIOPH RES CO, V182, P1089, DOI 10.1016/0006-291X(92)91843-F; Daniels BA, 2013, J PHYSIOL-LONDON, V591, P3873, DOI 10.1113/jphysiol.2013.253666; Dawe GB, 2016, NEURON, V89, P1264, DOI 10.1016/j.neuron.2016.01.038; DINGLEDINE R, 1992, J NEUROSCI, V12, P4080; Dingledine R, 1999, PHARMACOL REV, V51, P7; DONEVAN SD, 1995, P NATL ACAD SCI USA, V92, P9298, DOI 10.1073/pnas.92.20.9298; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Dudley HW, 1927, BIOCHEM J, V21, P97, DOI 10.1042/bj0210097; Dudley HW, 1924, BIOCHEM J, V18, P1263, DOI 10.1042/bj0181263; Elegheert J, 2016, SCIENCE, V353, P295, DOI 10.1126/science.aae0104; Fisher JL, 2012, J NEUROSCI, V32, P12928, DOI 10.1523/JNEUROSCI.2211-12.2012; Fu LY, 2012, CHANNELS, V6, P41, DOI 10.4161/chan.19001; Fuchs EC, 2007, NEURON, V53, P591, DOI 10.1016/j.neuron.2007.01.031; Garcia-Nafria J, 2016, J PHYSIOL-LONDON, V594, P5449, DOI 10.1113/JP271844; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; GOMEZ M, 1995, PFLUG ARCH EUR J PHY, V430, P501, DOI 10.1007/BF00373886; Greger IH, 2017, NEURON, V94, P713, DOI 10.1016/j.neuron.2017.04.009; Griffith TN, 2015, J PHYSIOL-LONDON, V593, P4815, DOI 10.1113/JP271103; Guo DL, 2000, J GEN PHYSIOL, V115, P783, DOI 10.1085/jgp.115.6.783; Haering SC, 2014, MEMBRANES, V4, P469, DOI 10.3390/membranes4030469; Haghighi AP, 1998, J NEUROSCI, V18, P4050; Henley JM, 2016, NAT REV NEUROSCI, V17, P337, DOI 10.1038/nrn.2016.37; Herguedas B, 2016, SCIENCE, V352, DOI 10.1126/science.aad3873; HERLITZE S, 1993, NEURON, V10, P1131, DOI 10.1016/0896-6273(93)90061-U; Herner A, 2011, INT J CANCER, V129, P2349, DOI 10.1002/ijc.25898; Herring BE, 2016, ANNU REV PHYSIOL, V78, P351, DOI 10.1146/annurev-physiol-021014-071753; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; HIGUCHI M, 1993, CELL, V75, P1361, DOI 10.1016/0092-8674(93)90622-W; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Howe JR, 2015, J PHYSIOL-LONDON, V593, P61, DOI 10.1113/jphysiol.2014.273904; Hu HX, 2014, ONCOTARGET, V5, P8853, DOI 10.18632/oncotarget.2593; Huettner JE, 2015, J PHYSIOL-LONDON, V593, P49, DOI 10.1113/jphysiol.2014.272724; HUME RI, 1991, SCIENCE, V253, P1028, DOI 10.1126/science.1653450; Isaac JTR, 2007, NEURON, V54, P859, DOI 10.1016/j.neuron.2007.06.001; Jackson AC, 2011, NEURON, V70, P178, DOI 10.1016/j.neuron.2011.04.007; Jacobi E, 2017, CURR OPIN NEUROBIOL, V45, P32, DOI 10.1016/j.conb.2017.03.001; Jatzke C, 2003, J PHYSIOL-LONDON, V549, P439, DOI 10.1113/jphysiol.2002.034413; KAMBOJ SK, 1995, J PHYSIOL-LONDON, V486, P297, DOI 10.1113/jphysiol.1995.sp020812; Kato AS, 2008, NEURON, V59, P986, DOI 10.1016/j.neuron.2008.07.034; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; Kerschbaum HH, 2003, BIOPHYS J, V84, P2293, DOI 10.1016/S0006-3495(03)75035-8; Kessels HW, 2009, NAT NEUROSCI, V12, P888, DOI 10.1038/nn.2340; KOH DS, 1995, J PHYSIOL-LONDON, V486, P305, DOI 10.1113/jphysiol.1995.sp020813; Koike M, 1997, NEUROSCI RES, V29, P27, DOI 10.1016/S0168-0102(97)00067-9; Kresge N, 2007, J BIOL CHEM, V282, pE26; Kubo Y, 1996, JPN HEART J, V37, P631; Kumar SS, 2002, J NEUROSCI, V22, P3005, DOI 10.1523/JNEUROSCI.22-08-03005.2002; Kuner T, 2001, J NEUROSCI, V21, P4162, DOI 10.1523/JNEUROSCI.21-12-04162.2001; Kuner T, 2003, TRENDS NEUROSCI, V26, P27, DOI 10.1016/S0166-2236(02)00010-3; Ladenburg A, 1888, BER DTSCH CHEM GES, V21, P758, DOI DOI 10.1002/CBER.188802101139; Lewenhoeck D. A., 1677, PHIL T, V12, P1040; Lisman J, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0260; Liu SQJ, 2002, J NEUROSCI, V22, P3881, DOI 10.1523/JNEUROSCI.22-10-03881.2002; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; Lu Z, 1999, J GEN PHYSIOL, V113, P35, DOI 10.1085/jgp.113.1.35; MACKINNON R, 1995, NEURON, V14, P889, DOI 10.1016/0896-6273(95)90327-5; MacLean DM, 2011, J PHYSIOL-LONDON, V589, P5383, DOI 10.1113/jphysiol.2011.219485; Magazanik LG, 1997, J PHYSIOL-LONDON, V505, P655, DOI 10.1111/j.1469-7793.1997.655ba.x; Mahanty NK, 1998, NATURE, V394, P683, DOI 10.1038/29312; Mansour M, 2001, NEURON, V32, P841, DOI 10.1016/S0896-6273(01)00520-7; MARCUS Y, 1988, CHEM REV, V88, P1475, DOI 10.1021/cr00090a003; Mayer ML, 2004, ANNU REV PHYSIOL, V66, P161, DOI 10.1146/annurev.physiol.66.050802.084104; McDonald AJ, 1996, NEUROSCI LETT, V208, P175, DOI 10.1016/0304-3940(96)12585-4; McGee TP, 2015, J NEUROSCI, V35, P16171, DOI 10.1523/JNEUROSCI.2152-15.2015; MELCHER T, 1995, J BIOL CHEM, V270, P8566, DOI 10.1074/jbc.270.15.8566; Menuz K, 2007, SCIENCE, V318, P815, DOI 10.1126/science.1146317; Meucci O, 1996, J NEUROSCI, V16, P519; MILLER C, 1982, J GEN PHYSIOL, V79, P869, DOI 10.1085/jgp.79.5.869; Miller-Fleming L, 2015, J MOL BIOL, V427, P3389, DOI 10.1016/j.jmb.2015.06.020; Morkve SH, 2002, J PHYSIOL-LONDON, V542, P147, DOI 10.1113/jphysiol.2002.020305; Musgaard M, 2016, J CHEM INF MODEL, V56, P1787, DOI 10.1021/acs.jcim.6b00297; Ng D, 2009, PLOS BIOL, V7, P278, DOI 10.1371/journal.pbio.1000041; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Osswald IK, 2007, J PHYSIOL-LONDON, V582, P95, DOI 10.1113/jphysiol.2007.127894; OTIS TS, 1995, J PHYSIOL-LONDON, V482, P309, DOI 10.1113/jphysiol.1995.sp020519; Panchenko VA, 1999, J PHYSIOL-LONDON, V520, P337, DOI 10.1111/j.1469-7793.1999.t01-1-00337.x; Panchenko VA, 2001, J GEN PHYSIOL, V117, P345, DOI 10.1085/jgp.117.4.345; PATNEAU DK, 1993, J NEUROSCI, V13, P3496; Pegg AE, 2016, J BIOL CHEM, V291, P14904, DOI 10.1074/jbc.R116.731661; Pegg AE, 2009, IUBMB LIFE, V61, P880, DOI 10.1002/iub.230; Pelkey KA, 2015, NEURON, V85, P1257, DOI 10.1016/j.neuron.2015.02.020; PELLEGRINIGIAMPIETRO DE, 1992, NEUROSCI LETT, V144, P65, DOI 10.1016/0304-3940(92)90717-L; Perrais D, 2009, J NEUROSCI, V29, P15499, DOI 10.1523/JNEUROSCI.2724-09.2009; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; Poulin R, 2012, AMINO ACIDS, V42, P711, DOI 10.1007/s00726-011-0987-y; Prickett TD, 2012, CLIN CANCER RES, V18, P4240, DOI 10.1158/1078-0432.CCR-11-1217; Priel A, 2005, J NEUROSCI, V25, P2682, DOI 10.1523/JNEUROSCI.4834-04.2005; PRIESTLEY T, 1989, BRIT J PHARMACOL, V97, P1315, DOI 10.1111/j.1476-5381.1989.tb12594.x; RADITSCH M, 1993, FEBS LETT, V324, P63, DOI 10.1016/0014-5793(93)81533-6; Reiner A, 2012, CELL REP, V1, P234, DOI 10.1016/j.celrep.2012.01.003; REYNOLDS IJ, 1991, BRIT J PHARMACOL, V103, P1373, DOI 10.1111/j.1476-5381.1991.tb09796.x; Ripka S, 2010, NEOPLASIA, V12, P659, DOI 10.1593/neo.10486; ROOT MJ, 1994, SCIENCE, V265, P1852, DOI 10.1126/science.7522344; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; Rosenthal JJC, 2012, NEURON, V74, P432, DOI 10.1016/j.neuron.2012.04.010; ROSENTHAL SM, 1956, J PHARMACOL EXP THER, V116, P131; Rozov A, 1999, NATURE, V401, P594, DOI 10.1038/44151; Rozov A, 1998, J PHYSIOL-LONDON, V511, P361, DOI 10.1111/j.1469-7793.1998.361bh.x; RUETER SM, 1995, SCIENCE, V267, P1491, DOI 10.1126/science.7878468; Rzeski W, 2002, BIOCHEM PHARMACOL, V64, P1195, DOI 10.1016/S0006-2952(02)01218-2; SAKMANN B, 1983, NATURE, V303, P250, DOI 10.1038/303250a0; Sans N, 2003, J NEUROSCI, V23, P9367; Schneggenburger R, 1997, NEURON, V18, P167, DOI 10.1016/S0896-6273(01)80055-6; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Schwenk J, 2012, NEURON, V74, P621, DOI 10.1016/j.neuron.2012.03.034; Schwenk J, 2009, SCIENCE, V323, P1313, DOI 10.1126/science.1167852; SEEBURG PH, 1993, TRENDS PHARMACOL SCI, V14, P297, DOI 10.1016/0165-6147(93)90047-N; Seeburg PH, 2002, NEURON, V35, P17, DOI 10.1016/S0896-6273(02)00760-2; Shanks NF, 2012, CELL REP, V1, P590, DOI 10.1016/j.celrep.2012.05.004; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Smith TC, 2000, NAT NEUROSCI, V3, P992, DOI 10.1038/79931; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Soler-Llavina GJ, 2006, NAT NEUROSCI, V9, P798, DOI 10.1038/nn1698; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; Soto D, 2007, NAT NEUROSCI, V10, P1260, DOI 10.1038/nn1966; Soto D, 2014, J NEUROSCI, V34, P11673, DOI 10.1523/JNEUROSCI.0383-14.2014; Stepulak A, 2007, CANCER BIOL THER, V6, P1908, DOI 10.4161/cbt.6.12.4965; Straub C, 2011, NAT NEUROSCI, V14, P866, DOI 10.1038/nn.2837; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; TABOR CW, 1985, MICROBIOL REV, V49, P81, DOI 10.1128/MMBR.49.1.81-99.1985; Tabor CW, 1999, ANNU REV BIOCHEM, V68, P1, DOI 10.1146/annurev.biochem.68.1.1; TABOR CW, 1956, J PHARMACOL EXP THER, V116, P139; TABOR CW, 1976, ANNU REV BIOCHEM, V45, P285, DOI 10.1146/annurev.bi.45.070176.001441; TABOR H, 1964, PHARMACOL REV, V16, P245; TABOR H, 1958, J BIOL CHEM, V233, P907; Talos DM, 2006, J COMP NEUROL, V497, P42, DOI 10.1002/cne.20972; Tang M, 2011, J NEUROSCI, V31, P10009, DOI 10.1523/JNEUROSCI.6617-10.2011; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Tomita S, 2006, P NATL ACAD SCI USA, V103, P10064, DOI 10.1073/pnas.0603128103; Tomita S, 2012, J PHYSIOL-LONDON, V590, P2217, DOI 10.1113/jphysiol.2011.221101; Toth K, 1998, NAT NEUROSCI, V1, P572, DOI 10.1038/2807; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Turrigiano GG, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0258; Twomey EC, 2018, NEURON, V99, P956, DOI 10.1016/j.neuron.2018.07.027; Twomey EC, 2017, NATURE, V549, P60, DOI 10.1038/nature23479; Twomey EC, 2017, NEURON, V94, P569, DOI 10.1016/j.neuron.2017.04.025; VERDOORN TA, 1991, SCIENCE, V252, P1715, DOI 10.1126/science.1710829; VILLARROEL A, 1995, BIOPHYS J, V68, P866, DOI 10.1016/S0006-3495(95)80263-8; von Roemeling CA, 2014, CANCER RES, V74, P4796, DOI 10.1158/0008-5472.CAN-14-0210; Washburn MS, 1997, J NEUROSCI, V17, P9393; Watanabe J, 2002, J NEUROSCI, V22, P10209; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Wilding TJ, 2010, J GEN PHYSIOL, V136, P339, DOI 10.1085/jgp.201010442; Williams K, 1997, BIOCHEM J, V325, P289, DOI 10.1042/bj3250289; Wollmuth LP, 1998, J GEN PHYSIOL, V112, P623, DOI 10.1085/jgp.112.5.623; YANG JH, 1995, NATURE, V374, P77, DOI 10.1038/374077a0; Yelshanskaya MV, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01146-z; Zhang W, 2008, J NEUROSCI, V28, P932, DOI 10.1523/JNEUROSCI.3309-07.2008; Zhang W, 2017, BIOPHYS J, V113, P2218, DOI 10.1016/j.bpj.2017.07.030; Zhang W, 2009, NEURON, V61, P385, DOI 10.1016/j.neuron.2008.12.014; Zheng J, 1997, J GEN PHYSIOL, V110, P101, DOI 10.1085/jgp.110.2.101; Zheng J, 1998, J GEN PHYSIOL, V112, P457, DOI 10.1085/jgp.112.4.457; Zhu JJ, 2000, NAT NEUROSCI, V3, P1098, DOI 10.1038/80614	193	25	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2018	293	48					18789	18802		10.1074/jbc.TM118.003794	http://dx.doi.org/10.1074/jbc.TM118.003794			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NX	30333231	Green Published, hybrid			2022-12-28	WOS:000458467300034
J	Yang, JW; Larson, G; Konrad, L; Shetty, M; Holy, M; Jantsch, K; Kastein, M; Heo, S; Erdem, FA; Lubec, G; Vaughan, RA; Sitte, HH; Foster, JD				Yang, Jae-Won; Larson, Garret; Konrad, Lisa; Shetty, Madhur; Holy, Marion; Jaentsch, Kathrin; Kastein, Mirja; Heo, Seok; Erdem, Fatma Asli; Lubec, Gert; Vaughan, Roxanne A.; Sitte, Harald H.; Foster, James D.			Dephosphorylation of human dopamine transporter at threonine 48 by protein phosphatase PP1/2A up-regulates transport velocity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						dopamine transporter; protein phosphatase; phosphorylation; mass spectrometry (MS); protein-protein interaction; post-translational modification (PTM); dephosphorylation; neurotransmission; okadaic acid; palmitoylation; synaptic transmission	FUNCTIONAL REGULATION; PHOSPHORYLATION; TRAFFICKING; COCAINE; MECHANISMS; EXPRESSION; COMPLEXES	Several protein kinases, including protein kinase C, Ca2+/calmodulin-dependent protein kinase II, and extracellular signal-regulated kinase, play key roles in the regulation of dopamine transporter (DAT) functions. These functions include surface expression, internalization, and forward and reverse transport, with phosphorylation sites for these kinases being linked to distinct regions of the DAT N terminus. Protein phosphatases (PPs) also regulate DAT activity, but the specific residues associated with their activities have not yet been elucidated. In this study, using co-immunoprecipitation followed by MS and immunoblotting analyses, we demonstrate the association of DAT with PP1 and PP2A in the mouse brain and heterologous cell systems. By applying MS in conjunction with a metabolic labeling method, we defined a PP1/2A-sensitive phosphorylation site at Thr-48 in human DAT, a residue that has not been previously reported to be involved in DAT phosphorylation. Site-directed mutagenesis of Thr-48 to Ala (T48A) to prevent phosphorylation enhanced dopamine transport kinetics, supporting a role for this residue in regulating DAT activity. Moreover, T48A-DAT displayed increased palmitoylation, suggesting that phosphorylation/dephosphorylation at this site has an additional regulatory role and reinforcing a previously reported reciprocal relationship between C-terminal palmitoylation and N-terminal phosphorylation.	[Yang, Jae-Won; Konrad, Lisa; Holy, Marion; Jaentsch, Kathrin; Kastein, Mirja; Erdem, Fatma Asli; Sitte, Harald H.] Med Univ Vienna, Ctr Physiol & Pharmacol, Inst Pharmacol, Waehringerstr 13a, A-1090 Vienna, Austria; [Heo, Seok] Med Univ Vienna, Dept Pediat, A-1090 Vienna, Austria; [Larson, Garret; Shetty, Madhur; Vaughan, Roxanne A.; Foster, James D.] Univ North Dakota, Sch Med & Hlth Sci, Dept Biomed Sci, Grand Forks, ND 58202 USA; [Lubec, Gert] Paracelsus Med Univ Salzburg, A-5020 Salzburg, Austria	Medical University of Vienna; Medical University of Vienna; University of North Dakota Grand Forks; Paracelsus Private Medical University	Sitte, HH (corresponding author), Med Univ Vienna, Ctr Physiol & Pharmacol, Inst Pharmacol, Waehringerstr 13a, A-1090 Vienna, Austria.; Foster, JD (corresponding author), Univ North Dakota, Sch Med & Hlth Sci, Dept Biomed Sci, Grand Forks, ND 58202 USA.	harald.sitte@meduniwien.ac.at; d.foster@med.und.edu	; Konrad, Lisa K./I-7852-2018; Sitte, Harald/N-2681-2013	Shetty, Madhur/0000-0002-6476-2261; Yang, Jae-Won/0000-0001-8928-0130; Erdem, Fatma A./0000-0003-1381-5009; Heo, Seok/0000-0001-6585-9594; Konrad, Lisa K./0000-0001-8725-3139; Sitte, Harald/0000-0002-1339-7444	Austrian Science Fund (FWF) [F3506, P23670]; National Institutes of Health from the COBRE program of the NIGMS [R15 DA031991, R01 DA13147, P20 GM104360]; National Institutes of Health from the INBRE program of the NIGMS [P20 GM103442]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103442, P20GM104360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R15DA031991] Funding Source: NIH RePORTER	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); National Institutes of Health from the COBRE program of the NIGMS; National Institutes of Health from the INBRE program of the NIGMS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by Austrian Science Fund (FWF) Grants F3506 (to H. H. S.) and P23670 (to J.-W. Y.) and National Institutes of Health Grants R15 DA031991 (to J. D. F.), R01 DA13147 (to R. A. V.), and P20 GM104360 (to U. N. D.) from the COBRE program and Grant P20 GM103442 (to U. N. D.) from the INBRE program of the NIGMS. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Batchelor M, 1998, J NEUROSCI, V18, P10304; Bauman AL, 2000, J NEUROSCI, V20, P7571; Copeland BJ, 1996, J PHARMACOL EXP THER, V277, P1527; Fog JU, 2006, NEURON, V51, P417, DOI 10.1016/j.neuron.2006.06.028; Foster JD, 2012, J BIOL CHEM, V287, P29702, DOI 10.1074/jbc.M112.367706; Foster JD, 2011, J BIOL CHEM, V286, P5175, DOI 10.1074/jbc.M110.187872; Foster JD, 2003, MOL BRAIN RES, V110, P100, DOI 10.1016/S0169-328X(02)00645-9; Foster JD, 2002, J BIOL CHEM, V277, P25178, DOI 10.1074/jbc.M200294200; Gorentla BK, 2009, BIOCHEMISTRY-US, V48, P1067, DOI 10.1021/bi801696n; Granas C, 2003, J BIOL CHEM, V278, P4990, DOI 10.1074/jbc.M205058200; Hadlock GC, 2011, J NEUROSCI METH, V196, P303, DOI 10.1016/j.jneumeth.2011.01.023; Hamilton PJ, 2014, NAT CHEM BIOL, V10, P582, DOI [10.1038/NCHEMBIO.1545, 10.1038/nchembio.1545]; Juraszek B, 2016, J NEUROCHEM, V139, P537, DOI 10.1111/jnc.13777; Maiya R, 2007, GENES BRAIN BEHAV, V6, P97, DOI 10.1111/j.1601-183X.2006.00236.x; Melikian HE, 1999, J NEUROSCI, V19, P7699; Moritz AE, 2015, J BIOL CHEM, V290, P29095, DOI 10.1074/jbc.M115.667055; Moritz AE, 2013, J BIOL CHEM, V288, P20, DOI 10.1074/jbc.M112.407874; Mortensen OV, 2003, EUR J PHARMACOL, V479, P159, DOI 10.1016/j.ejphar.2003.08.066; Olsen JV, 2013, MOL CELL PROTEOMICS, V12, P3444, DOI 10.1074/mcp.O113.034181; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Page G, 2004, NEUROCHEM INT, V45, P627, DOI 10.1016/j.neuint.2004.04.002; Pristupa ZB, 1998, SYNAPSE, V30, P79, DOI 10.1002/(SICI)1098-2396(199809)30:1<79::AID-SYN10>3.3.CO;2-I; Ramamoorthy S, 2011, PHARMACOL THERAPEUT, V129, P220, DOI 10.1016/j.pharmthera.2010.09.009; Rastedt DE, 2017, J CHEM NEUROANAT, V83, P3, DOI 10.1016/j.jchemneu.2017.01.002; Salzer I, 2017, J PHYSIOL-LONDON, V595, P759, DOI 10.1113/JP273274; Samuvel DJ, 2008, J PHARMACOL EXP THER, V325, P293, DOI 10.1124/jpet.107.130534; Savitski MM, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003830; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Steinkellner T, 2012, J BIOL CHEM, V287, P29627, DOI 10.1074/jbc.M112.367219; SULZER D, 1995, J NEUROSCI, V15, P4102; Sung U, 2005, BIOCHEM BIOPH RES CO, V333, P671, DOI 10.1016/j.bbrc.2005.05.165; Vaughan RA, 2005, J NEUROSCI METH, V143, P33, DOI 10.1016/j.jneumeth.2004.09.022; Vaughan RA, 1997, J BIOL CHEM, V272, P15541, DOI 10.1074/jbc.272.24.15541; Vaughan RA, 2013, TRENDS PHARMACOL SCI, V34, P489, DOI 10.1016/j.tips.2013.07.005; Wang Q, 2016, NEUROSCI LETT, V622, P78, DOI 10.1016/j.neulet.2016.04.051; Yang JW, 2007, P NATL ACAD SCI USA, V104, P20055, DOI 10.1073/pnas.0708574104; Zhang L, 1997, BIOCHEM PHARMACOL, V53, P677, DOI 10.1016/S0006-2952(96)00898-2; Zhuang XX, 2005, J NEUROSCI METH, V143, P27, DOI 10.1016/j.jneumeth.2004.09.020	38	4	4	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3419	3431		10.1074/jbc.RA118.005251	http://dx.doi.org/10.1074/jbc.RA118.005251			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30587577	hybrid, Green Published			2022-12-28	WOS:000461853900010
J	Yao, QY; Liu, J; Xiao, L; Wang, NP				Yao, Qinyu; Liu, Jia; Xiao, Lei; Wang, Nanping			Sonic hedgehog signaling instigates high-fat diet-induced insulin resistance by targeting PPAR stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						sonic hedgehog (SHH); peroxisome proliferator-activated receptor (PPAR); protein degradation; ubiquitylation (ubiquitination); obesity; insulin resistance; type 2 diabetes; NEDD4-1	ADIPOSE-TISSUE; PEROXISOME PROLIFERATOR; NUCLEAR RECEPTORS; GAMMA ACTIVITY; PRIMARY CILIA; OBESITY; LIVER; ACTIVATION; ADIPOCYTES; INFLAMMATION	Obesity is a major risk for patients with chronic metabolic disorders including type 2 diabetes. Sonic hedgehog (Shh) is a morphogen that regulates the pancreas and adipose tissue formation during embryonic development. Peroxisome proliferator-activated receptor (PPAR) is a member of the nuclear receptor superfamily and one of the most important regulators of insulin action. Here, we evaluated the role and mechanism of Shh signaling in obesity-associated insulin resistance and characterized its effect on PPAR. We showed that Shh expression was up-regulated in subcutaneous fat from obese mice. In differentiated 3T3-L1 and primary cultured adipocytes from rats, recombinant Shh protein and SAG (an agonist of Shh signaling) activated an extracellular signal-regulated kinase (ERK)-dependent noncanonical pathway and induced PPAR phosphorylation at serine 112, which decreased PPAR activity. Meanwhile, Shh signaling degraded PPAR protein via binding of PPAR to neural precursor cell-expressed developmentally down-regulated protein 4-1 (NEDD4-1). Furthermore, vismodegib, an inhibitor of Shh signaling, attenuated ERK phosphorylation induced by a high fat diet (HFD) and restored PPAR protein level, thus ameliorating glucose intolerance and insulin resistance in obese mice. Our finding suggests that Shh in subcutaneous fat decreases PPAR activity and stability via activation of an ERK-dependent noncanonical pathway, resulting in impaired insulin action. Inhibition of Shh may serve as a potential therapeutic approach to treat obesity-related diabetes.	[Yao, Qinyu; Liu, Jia; Xiao, Lei] Xi An Jiao Tong Univ, Sch Basic Med Sci, Cardiovasc Res Ctr, Xian 710061, Shaanxi, Peoples R China; [Wang, Nanping] Dalian Med Univ, Adv Inst Med Sci, Dalian 116044, Peoples R China	Xi'an Jiaotong University; Dalian Medical University	Wang, NP (corresponding author), Dalian Med Univ, Adv Inst Med Sci, Dalian 116044, Peoples R China.	nanpingwang2003@yahoo.com			National Science Foundation of China [81830015, 81500345, 31430045, 81470373, 81600389, 81770497, 2015M582674, 2016T90928]; China Postdoctoral Science Foundation	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by National Science Foundation of China Grants 81830015, 81500345, 31430045, 81470373, 81600389, and 81770497 and General Financial Grants 2015M582674 and 2016T90928 from the China Postdoctoral Science Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	ABATE N, 1995, J CLIN INVEST, V96, P88, DOI 10.1172/JCI118083; Boase NA, 2015, GENE, V557, P113, DOI 10.1016/j.gene.2014.12.020; Braune J, 2017, DIABETOLOGIA, V60, P889, DOI 10.1007/s00125-017-4223-5; Bushman W, 2016, J DEV BIOL, V4, DOI 10.3390/jdb4040030; Chandrahas VK, 2018, CURR TOP MICROBIOL, V414, P103, DOI 10.1007/82_2017_41; Chao L, 2000, J CLIN INVEST, V106, P1221, DOI 10.1172/JCI11245; Chapouly C, 2016, CARDIOVASC RES, V109, P217, DOI 10.1093/cvr/cvv263; Chinchilla P, 2010, CELL CYCLE, V9, P570, DOI 10.4161/cc.9.3.10591; Choi JH, 2011, NATURE, V477, P477, DOI 10.1038/nature10383; Egawa K, 1999, J BIOL CHEM, V274, P14306, DOI 10.1074/jbc.274.20.14306; Emanuel AL, 2017, ARTERIOSCL THROM VAS, V37, P411, DOI 10.1161/ATVBAHA.116.308670; Faulds MH, 2010, CURR OPIN PHARMACOL, V10, P692, DOI 10.1016/j.coph.2010.07.003; Fernandes-Silva H, 2017, J DEV BIOL, V5, DOI 10.3390/jdb5010003; Gould SE, 2014, EXPERT OPIN DRUG DIS, V9, P969, DOI 10.1517/17460441.2014.920816; Han LM, 2013, PROTEIN CELL, V4, P310, DOI 10.1007/s13238-013-2124-z; He J, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0252-x; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Hevener AL, 2003, NAT MED, V9, P1491, DOI 10.1038/nm956; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Ji S, 2012, BIOCHEM BIOPH RES CO, V417, P1158, DOI 10.1016/j.bbrc.2011.12.086; Kabir A, 2019, CURR DIABETES REV, V15, P49, DOI 10.2174/1573399814666180403164529; Kilroy G, 2012, ENDOCRINOLOGY, V153, P1206, DOI 10.1210/en.2011-1725; Kim JH, 2014, CELL DEATH DIFFER, V21, P594, DOI 10.1038/cdd.2013.181; Koren D, 2018, METABOLISM, V84, P67, DOI 10.1016/j.metabol.2018.04.001; Kwon H, 2016, HEPATOLOGY, V63, P1155, DOI 10.1002/hep.28289; Landsman L, 2011, P NATL ACAD SCI USA, V108, P17010, DOI 10.1073/pnas.1105404108; Lau J, 2010, DIABETES, V59, P1211, DOI 10.2337/db09-0914; Lee KW, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.31; Lefterova MI, 2014, TRENDS ENDOCRIN MET, V25, P293, DOI 10.1016/j.tem.2014.04.001; Li JJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep38550; Li PS, 2017, DIABETES, V66, P300, DOI 10.2337/db16-0743; Lu M, 2011, NAT MED, V17, P618, DOI 10.1038/nm.2332; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Page MM, 2018, TRENDS ENDOCRIN MET, V29, P389, DOI 10.1016/j.tem.2018.03.018; Pathi S, 2001, MECH DEVELOP, V106, P107, DOI 10.1016/S0925-4773(01)00427-0; Pospisilik JA, 2010, CELL, V140, P148, DOI 10.1016/j.cell.2009.12.027; Preidis GA, 2017, J CLIN INVEST, V127, P1193, DOI [10.1172/jci88893, 10.1172/JCI88893]; Quinlan RJ, 2008, CURR TOP DEV BIOL, V84, P249, DOI 10.1016/S0070-2153(08)00605-4; Quintana MT, 2015, BMC ENDOCR DISORD, V15, DOI 10.1186/s12902-015-0028-z; Redonnet A, 2001, METABOLISM, V50, P1161, DOI 10.1053/meta.2001.26759; Seppala M, 2017, J DEV BIOL, V5, DOI 10.3390/jdb5020006; Shao W, 2012, CELL METAB, V16, P414, DOI 10.1016/j.cmet.2012.09.002; Shi Y, 2017, ELIFE, V6, DOI [10.7554/elife.31649, 10.7554/eLife.31649]; Song DK, 2018, DIABETES METAB J, V42, P117, DOI 10.4093/dmj.2018.42.2.117; Sugii S, 2009, P NATL ACAD SCI USA, V106, P22504, DOI 10.1073/pnas.0912487106; Suh JM, 2006, CELL METAB, V3, P25, DOI 10.1016/j.cmet.2005.11.012; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011; Teperino R, 2012, CELL, V151, P414, DOI 10.1016/j.cell.2012.09.021; Thomas MK, 2000, DIABETES, V49, P2039, DOI 10.2337/diabetes.49.12.2039; Tokarz VL, 2018, J CELL BIOL, V217, P2273, DOI 10.1083/jcb.201802095; Xu Y, 2016, CARCINOGENESIS, V37, P215, DOI 10.1093/carcin/bgv252; Yam PT, 2009, NEURON, V62, P349, DOI 10.1016/j.neuron.2009.03.022; Yao QY, 2014, BLOOD, V123, P2429, DOI 10.1182/blood-2013-06-508689; Yin RY, 2015, FREE RADICAL BIO MED, V89, P895, DOI 10.1016/j.freeradbiomed.2015.10.406	56	14	16	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2019	294	9					3284	3293		10.1074/jbc.RA118.004411	http://dx.doi.org/10.1074/jbc.RA118.004411			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU0SA	30573683	Green Published, hybrid			2022-12-28	WOS:000464980100025
J	Harold, LK; Antoney, J; Ahmed, FH; Hards, K; Carr, PD; Rapson, T; Greening, C; Jackson, CJ; Cook, GM				Harold, Liam K.; Antoney, James; Ahmed, F. Hafna; Hards, Kiel; Carr, Paul D.; Rapson, Trevor; Greening, Chris; Jackson, Colin J.; Cook, Gregory M.			FAD-sequestering proteins protect mycobacteria against hypoxic and oxidative stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						reactive oxygen species (ROS); mycobacteria; Mycobacterium smegmatis; hypoxia; flavin; flavin adenine dinucleotide (FAD); bacterial genetics; oxidative stress; anoxia; dos regulon; DosR; oxidoreductase	ELECTRON-TRANSFER; SMEGMATIS; FLAVODOXIN; DODECIN; SYSTEM; OXYGEN; DOSR	The ability to persist in the absence of growth triggered by low oxygen levels is a critical process for the survival of mycobacterial species in many environmental niches. MSMEG_5243 (fsq), a gene of unknown function in Mycobacterium smegmatis, is up-regulated in response to hypoxia and regulated by DosRDosS/DosT, an oxygen- and redox-sensing two-component system that is highly conserved in mycobacteria. In this communication, we demonstrate that MSMEG_5243 is a flavin-sequestering protein and henceforth refer to it as Fsq. Using an array of biochemical and structural analyses, we show that Fsq is a member of the diverse superfamily of flavin- and deazaflavin-dependent oxidoreductases (FDORs) and is widely distributed in mycobacterial species. We created a markerless deletion mutant of fsq and demonstrate that fsq is required for cell survival during hypoxia. Using fsq deletion and overexpression, we found that fsq enhances cellular resistance to hydrogen peroxide treatment. The X-ray crystal structure of Fsq, solved to 2.7 A, revealed a homodimeric organization with FAD bound noncovalently. The Fsq structure also uncovered no potential substrate-binding cavities, as the FAD is fully enclosed, and electrochemical studies indicated that the Fsq:FAD complex is relatively inert and does not share common properties with electron-transfer proteins. Taken together, our results suggest that Fsq reduces the formation of reactive oxygen species (ROS) by sequestering free FAD during recovery from hypoxia, thereby protecting the cofactor from undergoing autoxidation to produce ROS. This finding represents a new paradigm in mycobacterial adaptation to hypoxia.	[Harold, Liam K.; Hards, Kiel; Cook, Gregory M.] Univ Otago, Sch Biomed Sci, Dept Microbiol & Immunol, Dunedin 9054, New Zealand; [Harold, Liam K.; Cook, Gregory M.] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Private Bag 92019, Auckland 1042, New Zealand; [Antoney, James; Ahmed, F. Hafna; Carr, Paul D.; Jackson, Colin J.] Australian Natl Univ, Res Sch Chem, Canberra, ACT, Australia; [Antoney, James; Ahmed, F. Hafna; Rapson, Trevor; Greening, Chris] CSIRO, Land & Water Flagship, Canberra, ACT, Australia; [Greening, Chris] Monash Univ, Sch Biol Sci, Melbourne, Vic, Australia	University of Otago; University of Auckland; Australian National University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Monash University	Cook, GM (corresponding author), Univ Otago, Sch Biomed Sci, Dept Microbiol & Immunol, Dunedin 9054, New Zealand.; Cook, GM (corresponding author), Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Private Bag 92019, Auckland 1042, New Zealand.; Jackson, CJ (corresponding author), Australian Natl Univ, Res Sch Chem, Canberra, ACT, Australia.; Greening, C (corresponding author), CSIRO, Land & Water Flagship, Canberra, ACT, Australia.; Greening, C (corresponding author), Monash Univ, Sch Biol Sci, Melbourne, Vic, Australia.	chris.greening@monash.edu; colin.jackson@anu.edu.au; greg.cook@otago.ac.nz	Cook, Gregory/ABF-4208-2020; Greening, Chris/J-4408-2019; Ahmed, F. Hafna/I-4930-2019; Antoney, James/AAB-8005-2021; Hards, Kiel J/L-1942-2018; Ahmed, F. Hafna/B-7734-2019; Jackson, Colin J/C-1500-2008; Rapson, Trevor/B-3510-2012	Greening, Chris/0000-0001-7616-0594; Ahmed, F. Hafna/0000-0002-9153-2699; Antoney, James/0000-0003-4033-6898; Hards, Kiel J/0000-0002-7887-4977; Ahmed, F. Hafna/0000-0002-9153-2699; Jackson, Colin J/0000-0001-6150-3822; Rapson, Trevor/0000-0003-1289-0146; Harold, Liam/0000-0002-7570-7348	Maurice Wilkins Centre for Molecular Biodiscovery; Marsden Fund, Royal Society, NewZealand; University of Otago; Sandy Smith Scholarship; CSIRO OCE Postdoctoral Fellowship; ARC DECRA Fellowship [DE170100310]; NHMRC [APP1139832, APP1128929]	Maurice Wilkins Centre for Molecular Biodiscovery; Marsden Fund, Royal Society, NewZealand; University of Otago; Sandy Smith Scholarship; CSIRO OCE Postdoctoral Fellowship; ARC DECRA Fellowship(Australian Research Council); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Maurice Wilkins Centre for Molecular Biodiscovery and the Marsden Fund, Royal Society, NewZealand. This work was also supported by a University of Otago Doctoral Scholarship and a Sandy Smith Scholarship (to L. K. H.) and by a CSIRO OCE Postdoctoral Fellowship, ARC DECRA Fellowship DE170100310, and NHMRC New Investigator Grant APP1139832 (to C. G.). In addition, this workwassupported byNHMRCProject Grant APP1128929 (to C. J. J., C. G., and G. M. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahmed FH, 2016, PROTEIN SCI, V25, P1692, DOI 10.1002/pro.2975; Ahmed FH, 2015, J MOL BIOL, V427, P3554, DOI 10.1016/j.jmb.2015.09.021; Atkinson HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004345; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berney M, 2014, P NATL ACAD SCI USA, V111, P11479, DOI 10.1073/pnas.1407034111; Berney M, 2014, ENVIRON MICROBIOL, V16, P318, DOI 10.1111/1462-2920.12320; Berney M, 2012, MOL MICROBIOL, V84, P664, DOI 10.1111/j.1365-2958.2012.08053.x; Blokpoel MCJ, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni023; Bourdeaux F, 2018, ACS INFECT DIS, V4, P1082, DOI 10.1021/acsinfecdis.7b00237; Buchmeier N, 2006, FEMS MICROBIOL LETT, V264, P74, DOI 10.1111/j.1574-6968.2006.00441.x; Buckel W, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00401; Cabrita LD, 2007, PROTEIN SCI, V16, P2360, DOI 10.1110/ps.072822507; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chauviac FX, 2012, J BIOL CHEM, V287, P44372, DOI 10.1074/jbc.M112.406264; Cowtan K, 2008, ACTA CRYSTALLOGR D, V64, P83, DOI 10.1107/S0907444907033938; Doerks T, 2002, GENOME RES, V12, P47, DOI 10.1101/gr.203201; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Florczyk MA, 2003, INFECT IMMUN, V71, P5332, DOI 10.1128/IAI.71.9.5332-5343.2003; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Gebhard S, 2006, MICROBIOL-SGM, V152, P3453, DOI 10.1099/mic.0.29201-0; Goran JM, 2013, LANGMUIR, V29, P13605, DOI 10.1021/la403020y; Grininger M, 2009, J BIOL CHEM, V284, P13068, DOI 10.1074/jbc.M808063200; Heering HA, 1996, J ELECTROANAL CHEM, V404, P249, DOI 10.1016/0022-0728(95)04248-2; Heuts DPHM, 2009, FEBS J, V276, P3405, DOI 10.1111/j.1742-4658.2009.07053.x; Jeuken LJC, 2002, J AM CHEM SOC, V124, P5702, DOI 10.1021/ja012638w; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kumar A, 2007, P NATL ACAD SCI USA, V104, P11568, DOI 10.1073/pnas.0705054104; Liu FX, 2011, J STRUCT BIOL, V175, P31, DOI 10.1016/j.jsb.2011.04.013; Macheroux P, 2011, FEBS J, V278, P2625, DOI 10.1111/j.1742-4658.2011.08202.x; Mashalidis EH, 2015, PROTEIN SCI, V24, P729, DOI 10.1002/pro.2645; MASSEY V, 1994, J BIOL CHEM, V269, P22459; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MILLER DM, 1990, FREE RADICAL BIO MED, V8, P95, DOI 10.1016/0891-5849(90)90148-C; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; NEILL MA, 1988, J EXP MED, V167, P30, DOI 10.1084/jem.167.1.30; Ng VH, 2004, MOL MICROBIOL, V52, P1291, DOI 10.1111/j.1365-2958.2004.04078.x; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; Piddington DL, 2001, INFECT IMMUN, V69, P4980, DOI 10.1128/IAI.69.8.4980-4987.2001; Robson J, 2009, J MOL BIOL, V390, P353, DOI 10.1016/j.jmb.2009.05.006; Safo MK, 2000, STRUCTURE, V8, P751, DOI 10.1016/S0969-2126(00)00162-3; Segal HM, 2017, PROTEIN SCI, V26, P1984, DOI 10.1002/pro.3236; Smeulders MJ, 1999, J BACTERIOL, V181, P270, DOI 10.1128/JB.181.1.270-283.1999; Sousa EHS, 2007, PROTEIN SCI, V16, P1708, DOI 10.1110/ps.072897707; WALSH C, 1980, ACCOUNTS CHEM RES, V13, P148, DOI 10.1021/ar50149a004; Wisedchaisri G, 2008, J MOL BIOL, V378, P227, DOI 10.1016/j.jmb.2008.02.029	48	6	7	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2903	2912		10.1074/jbc.RA118.006237	http://dx.doi.org/10.1074/jbc.RA118.006237			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30567740	Green Published, hybrid			2022-12-28	WOS:000459601600027
J	Loerch, S; Leach, JR; Horner, SW; Maji, D; Jenkins, JL; Pulvino, MJ; Kielkopf, CL				Loerch, Sarah; Leach, Justin R.; Horner, Steven W.; Maji, Debanjana; Jenkins, Jermaine L.; Pulvino, Mary J.; Kielkopf, Clara L.			The pre-mRNA splicing and transcription factor Tat-SF1 is a functional partner of the spliceosome SF3b1 subunit via a U2AF homology motif interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						X-ray crystallography; protein-protein interaction; isothermal titration calorimetry (ITC); RNA splicing; protein structure; RNA-binding protein; protein domain; gene regulation	N-TERMINAL DOMAIN; BRANCH POINT; P-TEFB; RECOGNITION; COMPLEX; BINDING; PHOSPHORYLATION; ELONGATION; REQUIREMENT; SF1	The transcription elongation and pre-mRNA splicing factor Tat-SF1 associates with the U2 small nuclear ribonucleoprotein (snRNP) of the spliceosome. However, the direct binding partner and underlying interactions mediating the Tat-SF1-U2 snRNP association remain unknown. Here, we identified SF3b1 as a Tat-SF1-interacting subunit of the U2 snRNP. Our 1.1 A resolution crystal structure revealed that Tat-SF1 contains a U2AF homology motif (UHM) protein-protein interaction module. We demonstrated that Tat-SF1 preferentially and directly binds the SF3b1 subunit compared with other U2AF ligand motif (ULM)-containing splicing factors, and further established that SF3b1 association depends on the integrity of the Tat-SF1 UHM. We next compared the Tat-SF1-binding affinities for each of the five known SF3b1 ULMs and then determined the structures of representative high- and low-affinity SF3b1 ULM complexes with the Tat-SF1 UHM at 1.9 A and 2.1 A resolutions, respectively. These structures revealed a canonical UHM-ULM interface, comprising a Tat-SF1 binding pocket for a ULM tryptophan (SF3b1 Trp(338)) and electrostatic interactions with a basic ULM tail. Importantly, we found that SF3b1 regulates Tat-SF1 levels and that these two factors influence expression of overlapping representative transcripts, consistent with a functional partnership of Tat-SF1 and SF3b1. Altogether, these results define a new molecular interface of the Tat-SF1-U2 snRNP complex for gene regulation.	[Loerch, Sarah; Leach, Justin R.; Horner, Steven W.; Maji, Debanjana; Jenkins, Jermaine L.; Pulvino, Mary J.; Kielkopf, Clara L.] Univ Rochester, Sch Med & Dent, Ctr RNA Biol, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Loerch, Sarah] Janelia Res Campus, Ashburn, VA 20147 USA; [Horner, Steven W.] Broad Inst, Cambridge, MA 02142 USA	University of Rochester; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Kielkopf, CL (corresponding author), Univ Rochester, Sch Med & Dent, Ctr RNA Biol, Dept Biochem & Biophys, Rochester, NY 14642 USA.	clara_kielkopf@urmc.rochester.edu		Loerch, Sarah/0000-0002-1731-516X	United States Dept. of Energy [DE-AC02-76SF00515]; NIH [P41 GM103393]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070503, P41GM103393, R01GM117005] Funding Source: NIH RePORTER	United States Dept. of Energy; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Manuel Ares (University of California, Santa Cruz) and Aaron Hoskins (University of Wisconsin, Madison, WI) for stimulating discussions and sharing unpublished data. We appreciate the skilled technical assistance of Nazish Jeffery and Eliezra Glasser. SSRL is supported by the United States Dept. of Energy under Contract No. DE-AC02-76SF00515 and NIH Grant P41 GM103393.	Abramczuk MK, 2017, DEVELOPMENT, V144, P3932, DOI 10.1242/dev.152199; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2015, ACTA CRYSTALLOGR D, V71, P646, DOI 10.1107/S1399004714028132; Agafonov DE, 2011, MOL CELL BIOL, V31, P2667, DOI 10.1128/MCB.05266-11; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; Cass DM, 2006, BIOCHEMISTRY-US, V45, P10092, DOI 10.1021/bi060429o; Chathoth KT, 2014, MOL CELL, V53, P779, DOI 10.1016/j.molcel.2014.01.017; Chatrikhi R, 2016, BIOPHYS J, V111, P2570, DOI 10.1016/j.bpj.2016.11.007; Chen YX, 2009, GENE DEV, V23, P2765, DOI 10.1101/gad.1834709; Corrionero A, 2011, GENE DEV, V25, P445, DOI 10.1101/gad.2014311; Corsini L, 2007, NAT STRUCT MOL BIOL, V14, P620, DOI 10.1038/nsmb1260; Corsini L, 2009, J BIOL CHEM, V284, P630, DOI 10.1074/jbc.M805395200; Corsini NS, 2018, CELL STEM CELL, V22, P143, DOI 10.1016/j.stem.2018.01.012; de Chiara C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008372; Diella F, 2008, NUCLEIC ACIDS RES, V36, pD240, DOI 10.1093/nar/gkm772; Dolatshad H, 2015, LEUKEMIA, V29, P1798, DOI 10.1038/leu.2015.178; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Finci LI, 2018, GENE DEV, V32, P309, DOI 10.1101/gad.311043.117; Fong YW, 2000, MOL CELL BIOL, V20, P5897, DOI 10.1128/MCB.20.16.5897-5907.2000; Fong YW, 2001, NATURE, V414, P929, DOI 10.1038/414929a; Guth S, 1999, MOL CELL BIOL, V19, P8263; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; HOROVITZ A, 1990, J MOL BIOL, V216, P1031, DOI 10.1016/S0022-2836(99)80018-7; Huang YM, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0558-8; Jablonski JA, 2010, NUCLEIC ACIDS RES, V38, P1249, DOI 10.1093/nar/gkp1105; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kielkopf CL, 2001, CELL, V106, P595, DOI 10.1016/S0092-8674(01)00480-9; Kim JB, 1999, MOL CELL BIOL, V19, P5960; Konde E, 2010, BIOCHEMISTRY-US, V49, P8020, DOI 10.1021/bi101153w; Lee Y, 2015, ANNU REV BIOCHEM, V84, P291, DOI 10.1146/annurev-biochem-060614-034316; Li XY, 1998, GENE DEV, V12, P2992, DOI 10.1101/gad.12.19.2992; Loerch S, 2016, RNA, V22, P1795, DOI 10.1261/rna.057950.116; Loerch S, 2014, J BIOL CHEM, V289, P17325, DOI 10.1074/jbc.M114.558825; Manceau V, 2006, FEBS J, V273, P577, DOI 10.1111/j.1742-4658.2005.05091.x; Manceau V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043946; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller HB, 2011, RNA, V17, P665, DOI 10.1261/rna.2462011; Miller HB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005710; Ozbabacan SEA, 2011, PROTEIN ENG DES SEL, V24, P635, DOI 10.1093/protein/gzr025; Pacheco TR, 2006, MOL CELL BIOL, V26, P8183, DOI 10.1128/MCB.00350-06; Paolella BR, 2017, ELIFE, V6, DOI 10.7554/eLife.23268; Parada CA, 1999, EMBO J, V18, P3688, DOI 10.1093/emboj/18.13.3688; Perriman R, 2003, P NATL ACAD SCI USA, V100, P13857, DOI 10.1073/pnas.2036312100; Perriman R, 2000, GENE DEV, V14, P97; Perriman RJ, 2007, GENE DEV, V21, P811, DOI 10.1101/gad.1524307; Popp MWL, 2013, ANNU REV GENET, V47, P139, DOI 10.1146/annurev-genet-111212-133424; Rodgers ML, 2016, RNA, V22, P225, DOI 10.1261/rna.052233.115; Rosel-Hillgartner TD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003856; RUSKIN B, 1988, CELL, V52, P207, DOI 10.1016/0092-8674(88)90509-0; Selenko P, 2003, MOL CELL, V11, P965, DOI 10.1016/S1097-2765(03)00115-1; Soltis SM, 2008, ACTA CRYSTALLOGR D, V64, P1210, DOI 10.1107/S0907444908030564; Spadaccini R, 2006, RNA, V12, P410, DOI 10.1261/rna.2271406; Thickman KR, 2006, J MOL BIOL, V356, P664, DOI 10.1016/j.jmb.2005.11.067; Turunen JJ, 2013, RNA, V19, P380, DOI 10.1261/rna.036715.112; Valcarcel J, 1996, SCIENCE, V273, P1706, DOI 10.1126/science.273.5282.1706; Wang WH, 2013, STRUCTURE, V21, P197, DOI 10.1016/j.str.2012.10.020; Webb CJ, 2005, MOL BIOL CELL, V16, P584, DOI 10.1091/mbc.E04-09-0768; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yan D, 1998, MOL CELL BIOL, V18, P5000, DOI 10.1128/MCB.18.9.5000; Yoshida H, 2015, GENE DEV, V29, P1649, DOI 10.1101/gad.267104.115; ZAMORE PD, 1991, EMBO J, V10, P207, DOI 10.1002/j.1460-2075.1991.tb07937.x; ZAMORE PD, 1992, NATURE, V355, P609, DOI 10.1038/355609a0; Zhang Y, 2013, NUCLEIC ACIDS RES, V41, P1343, DOI 10.1093/nar/gks1097; Zhou Q, 1998, EMBO J, V17, P3681, DOI 10.1093/emboj/17.13.3681; Zhou QA, 1996, SCIENCE, V274, P605, DOI 10.1126/science.274.5287.605	65	21	21	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2892	2902		10.1074/jbc.RA118.006764	http://dx.doi.org/10.1074/jbc.RA118.006764			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30567737	hybrid, Green Published			2022-12-28	WOS:000459601600026
J	Hennessy, M; Granade, ME; Hassaninasab, A; Wang, DN; Kwiatek, JM; Han, GS; Harris, TE; Carman, GM				Hennessy, Meagan; Granade, Mitchell E.; Hassaninasab, Azam; Wang, Dana; Kwiatek, Joanna M.; Han, Gil-Soo; Harris, Thurl E.; Carman, George M.			Casein kinase II-mediated phosphorylation of lipin 1 beta phosphatidate phosphatase at Ser-285 and Ser-287 regulates its interaction with 14-3-3 beta protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphatidate; diacylglycerol; triacylglycerol; 14-3-3 protein; protein kinase; protein phosphorylation; phosphatase; casein kinase II; cell signaling; lipid droplet; lipin 1 PA phosphatase; membrane phospholipid	PHOSPHOLIPASE-D ACTIVITY; SUBCELLULAR-LOCALIZATION; PHOSPHOPROTEOME REVEALS; ACID PHOSPHATASE; SACCHAROMYCES-CEREVISIAE; ACETYL-COENZYME; CROSS-TALK; FAT-CELLS; INSULIN; SITES	The mammalian lipin 1 phosphatidate phosphatase is a key regulatory enzyme in lipid metabolism. By catalyzing phosphatidate dephosphorylation, which produces diacylglycerol, the enzyme plays a major role in the synthesis of triacylglycerol and membrane phospholipids. The importance of lipin 1 to lipid metabolism is exemplified by cellular defects and lipid-based diseases associated with its loss or overexpression. Phosphorylation of lipin 1 governs whether it is associated with the cytoplasm apart from its substrate or with the endoplasmic reticulum membrane where its enzyme reaction occurs. Lipin 1 beta is phosphorylated on multiple sites, but less than 10% of them are ascribed to a specific protein kinase. Here, we demonstrate that lipin 1 beta is a bona fide substrate for casein kinase II (CKII), a protein kinase that is essential to viability and cell cycle progression. Phosphoamino acid analysis and phosphopeptide mapping revealed that lipin 1 beta is phosphorylated by CKII on multiple serine and threonine residues, with the former being major sites. Mutational analysis of lipin 1 beta and its peptides indicated that Ser-285 and Ser-287 are both phosphorylated by CKII. Substitutions of Ser-285 and Ser-287 with nonphosphorylatable alanine attenuated the interaction of lipin 1 beta with 14-3-3 beta protein, a regulatory hub that facilitates the cytoplasmic localization of phosphorylated lipin 1. These findings advance our understanding of how phosphorylation of lipin 1 beta phosphatidate phosphatase regulates its interaction with 14-3-3 beta protein and intracellular localization and uncover a mechanism by which CKII regulates cellular physiology.	[Hennessy, Meagan; Hassaninasab, Azam; Kwiatek, Joanna M.; Han, Gil-Soo; Carman, George M.] Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, Dept Food Sci, New Brunswick, NJ 08901 USA; [Hennessy, Meagan; Hassaninasab, Azam; Kwiatek, Joanna M.; Han, Gil-Soo; Carman, George M.] Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA; [Granade, Mitchell E.; Wang, Dana; Harris, Thurl E.] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of Virginia	Carman, GM (corresponding author), Rutgers State Univ, Dept Food Sci, 61 Dudley Rd, New Brunswick, NJ 08901 USA.	gcarman@rutgers.edu		Carman, George/0000-0003-4951-8233; Hennessy, Meagan/0000-0002-1297-7623; Granade, Mitchell/0000-0003-3134-858X; Kwiatek, Joanna/0000-0001-8934-0922	National Institutes of Health from the United States Public Health Service [GM050679, DK101946]; National Institutes of Health [T32 GM008715]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050679, T32GM008715] Funding Source: NIH RePORTER	National Institutes of Health from the United States Public Health Service; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM050679 (to G. M. C.) and DK101946 (to T. E. H.) from the United States Public Health Service. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Training Grant T32 GM008715.	Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Aulchenko YS, 2007, DIABETES, V56, P3020, DOI 10.2337/db07-0338; Baron CL, 2002, SCIENCE, V295, P325, DOI 10.1126/science.1066759; Blackwood RA, 1997, AM J PHYSIOL-CELL PH, V272, pC1279, DOI 10.1152/ajpcell.1997.272.4.C1279; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Bodenmiller B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001182; Boroda S, 2017, J BIOL CHEM, V292, P20481, DOI 10.1074/jbc.M117.786574; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Brindley DN, 2009, BBA-MOL CELL BIOL L, V1791, P956, DOI 10.1016/j.bbalip.2009.02.007; Brindley DN, 1996, CHEM PHYS LIPIDS, V80, P45, DOI 10.1016/0009-3084(96)02545-5; Brognard J, 2011, CURR OPIN GENET DEV, V21, P4, DOI 10.1016/j.gde.2010.10.012; Brohee L, 2015, ONCOTARGET, V6, P11264, DOI 10.18632/oncotarget.3595; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Carman GM, 2006, TRENDS BIOCHEM SCI, V31, P694, DOI 10.1016/j.tibs.2006.10.003; Carman GM, 2019, J BIOL CHEM, V294, P1681, DOI 10.1074/jbc.TM118.004159; Carman GM, 2009, J BIOL CHEM, V284, P2593, DOI 10.1074/jbc.R800059200; Chen ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051320; CHERNOMORDIK L, 1995, J MEMBRANE BIOL, V146, P1; Chi A, 2007, P NATL ACAD SCI USA, V104, P2193, DOI 10.1073/pnas.0607084104; Choi HS, 2012, J BIOL CHEM, V287, P11290, DOI 10.1074/jbc.M112.346023; Choi HS, 2011, J BIOL CHEM, V286, P1486, DOI 10.1074/jbc.M110.155598; Collet JF, 1999, J BIOL CHEM, V274, P33985, DOI 10.1074/jbc.274.48.33985; Collet JF, 1998, J BIOL CHEM, V273, P14107, DOI 10.1074/jbc.273.23.14107; Csaki LS, 2013, PROG LIPID RES, V52, P305, DOI 10.1016/j.plipres.2013.04.001; DIGGLE TA, 1991, BIOCHEM J, V279, P545, DOI 10.1042/bj2790545; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; Fan XY, 2018, CANCER MED-US, V7, P2541, DOI 10.1002/cam4.1483; Faust M, 2000, CELL TISSUE RES, V301, P329, DOI 10.1007/s004410000256; Ferguson PJ, 2005, J MED GENET, V42, P551, DOI 10.1136/jmg.2005.030759; Ferguson PJ, 2007, CURR OPIN RHEUMATOL, V19, P492, DOI 10.1097/BOR.0b013e32825f5492; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; Glover CVC, 1998, PROG NUCLEIC ACID RE, V59, P95; Gnad F, 2009, PROTEOMICS, V9, P4642, DOI 10.1002/pmic.200900144; Goni FM, 1999, PROG LIPID RES, V38, P1, DOI 10.1016/S0163-7827(98)00021-6; Granade ME, 2018, METHOD ENZYMOL, V607, P373, DOI 10.1016/bs.mie.2018.04.028; Grimsey N, 2008, J BIOL CHEM, V283, P29166, DOI 10.1074/jbc.M804278200; Grimsrud PA, 2012, CELL METAB, V16, P672, DOI 10.1016/j.cmet.2012.10.004; Gruhler A, 2005, MOL CELL PROTEOMICS, V4, P310, DOI 10.1074/mcp.M400219-MCP200; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2010, J BIOL CHEM, V285, P14628, DOI 10.1074/jbc.M110.117747; Harris TE, 2007, J BIOL CHEM, V282, P277, DOI 10.1074/jbc.M609537200; Havriluk T, 2008, ANAL BIOCHEM, V373, P392, DOI 10.1016/j.ab.2007.08.037; He JQ, 2017, FASEB J, V31, P2893, DOI 10.1096/fj.201601353R; Heesom KJ, 1998, BIOCHEM J, V336, P39, DOI 10.1042/bj3360039; Helbig AO, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-685; Hsieh LS, 2016, J BIOL CHEM, V291, P9974, DOI 10.1074/jbc.M116.726588; Hsieh LS, 2015, J BIOL CHEM, V290, P11467, DOI 10.1074/jbc.M115.648659; Hu M, 2013, HEPATOLOGY, V58, P1953, DOI 10.1002/hep.26589; Huffman TA, 2002, P NATL ACAD SCI USA, V99, P1047, DOI 10.1073/pnas.022634399; Humphrey SJ, 2013, CELL METAB, V17, P1009, DOI 10.1016/j.cmet.2013.04.010; Kim KH, 1997, ANNU REV NUTR, V17, P77, DOI 10.1146/annurev.nutr.17.1.77; KOTER M, 1978, BIOCHIM BIOPHYS ACTA, V514, P255, DOI 10.1016/0005-2736(78)90296-1; Kourti M, 2015, CELL SIGNAL, V27, P1129, DOI 10.1016/j.cellsig.2015.02.017; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEHEL C, 1995, J BIOL CHEM, V270, P19651, DOI 10.1074/jbc.270.33.19651; Li TY, 2018, NAT COMMUN, V9, DOI [10.1038/s41467-018-04363, 10.1038/s41467-018-04363-w]; Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j; LIAO MJ, 1979, BIOCHIM BIOPHYS ACTA, V550, P157, DOI 10.1016/0005-2736(79)90204-9; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Liu GH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007031; Lundby A, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003506; MACDONALD JIS, 1994, J BIOL CHEM, V269, P10529; Maissel A, 2006, CELL SIGNAL, V18, P1127, DOI 10.1016/j.cellsig.2005.09.003; Meana C, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.97506; Morris AJ, 2007, BIOCHEM SOC SYMP, V74, P247, DOI 10.1042/BSS2007c20; Nadra K, 2008, GENE DEV, V22, P1647, DOI 10.1101/gad.1638008; Navratil AR, 2015, ATHEROSCLEROSIS, V242, P424, DOI 10.1016/j.atherosclerosis.2015.08.012; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Pascual F, 2013, BBA-MOL CELL BIOL L, V1831, P514, DOI 10.1016/j.bbalip.2012.08.006; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Peterfy M, 2010, J BIOL CHEM, V285, P3857, DOI 10.1074/jbc.M109.072488; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Phan J, 2005, CELL METAB, V1, P73, DOI 10.1016/j.cmet.2004.12.002; Pinna L A, 1997, Prog Cell Cycle Res, V3, P77; Poole A, 2005, MOL CELL BIOCHEM, V274, P163, DOI 10.1007/s11010-005-2945-z; Prasad TSK, 2009, METHODS MOL BIOL, V577, P67, DOI 10.1007/978-1-60761-232-2_6; Reue K, 2008, J LIPID RES, V49, P2493, DOI 10.1194/jlr.R800019-JLR200; Reue K, 2008, FEBS LETT, V582, P90, DOI 10.1016/j.febslet.2007.11.014; Reue K, 2007, DIABETES, V56, P2842, DOI 10.2337/db07-1288; Reue K, 2009, CURR OPIN LIPIDOL, V20, P165, DOI 10.1097/MOL.0b013e32832adee5; Reue K, 2009, J LIPID RES, V50, pS109, DOI 10.1194/jlr.R800052-JLR200; Roth MG, 2008, TRAFFIC, V9, P1233, DOI 10.1111/j.1600-0854.2008.00742.x; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Shen Z, 2010, AM J PHYSIOL-GASTR L, V298, pG364, DOI 10.1152/ajpgi.00456.2009; Shimizu K, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aah4117; SMITH SW, 1957, J BIOL CHEM, V228, P915; Smolka MB, 2007, P NATL ACAD SCI USA, V104, P10364, DOI 10.1073/pnas.0701622104; Soufi B, 2009, MOL BIOSYST, V5, P1337, DOI 10.1039/b902256b; Soulard A, 2010, MOL BIOL CELL, V21, P3475, DOI 10.1091/mbc.E10-03-0182; Su WM, 2014, J BIOL CHEM, V289, P18818, DOI 10.1074/jbc.M114.581462; Su WM, 2012, J BIOL CHEM, V287, P33364, DOI 10.1074/jbc.M112.402339; Swaney DL, 2013, NAT METHODS, V10, P676, DOI [10.1038/NMETH.2519, 10.1038/nmeth.2519]; Takeuchi K, 2009, AM J PHYSIOL-ENDOC M, V296, pE1195, DOI 10.1152/ajpendo.90958.2008; Vance D.E., 2004, GLYCEROLIPID BIOSYNT, P153; Vance JE, 2018, J LIPID RES, V59, P923, DOI 10.1194/jlr.R084004; Vozenilek AE, 2018, ARTERIOSCL THROM VAS, V38, P324, DOI 10.1161/ATVBAHA.117.310455; Wang JY, 2016, SCI REP-UK, V6, DOI 10.1038/srep34117; Weigert R, 1999, NATURE, V402, P429, DOI 10.1038/46587; Wiedmann S, 2008, DIABETES, V57, P209, DOI 10.2337/db07-0083; Wilkins MR, 1999, METH MOL B, V112, P531; WITTERS LA, 1983, J BIOL CHEM, V258, P5643; YANG WL, 1995, J BIOL CHEM, V270, P14983, DOI 10.1074/jbc.270.25.14983; Zanivan S, 2008, J PROTEOME RES, V7, P5314, DOI 10.1021/pr800599n; Zeharia A, 2008, AM J HUM GENET, V83, P489, DOI 10.1016/j.ajhg.2008.09.002; Zhang PX, 2014, CELL METAB, V20, P267, DOI 10.1016/j.cmet.2014.05.003	106	5	6	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2019	294	7					2365	2374		10.1074/jbc.RA118.007246	http://dx.doi.org/10.1074/jbc.RA118.007246			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL7CN	30617183	hybrid, Green Published			2022-12-28	WOS:000458895400014
J	Boyd, SD; Calvo, JS; Liu, L; Ullrich, MS; Skopp, A; Meloni, G; Winkler, DD				Boyd, Stefanie D.; Calvo, Jenifer S.; Liu, Li; Ullrich, Morgan S.; Skopp, Amelie; Meloni, Gabriele; Winkler, Duane D.			The yeast copper chaperone for copper-zinc superoxide dismutase (CCS1) is a multifunctional chaperone promoting all levels of SOD1 maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chaperone; copper transport; superoxide dismutase (SOD); protein complex; metallo-protein; metal ion-protein interaction; multifunctional enzyme; post-translational modification (PTM); oxidative stress; CCS1; dual chaperone; enzyme maturation; metallo-chaperone; copper-zinc superoxide dismutase (SOD1)	AMYOTROPHIC-LATERAL-SCLEROSIS; CU,ZN-SUPEROXIDE DISMUTASE; HUMAN METALLOCHAPERONE; CRYSTAL-STRUCTURE; HSOD1 MATURATION; DOMAIN 1; ACTIVATION; MECHANISM; PROTEIN; BINDING	Copper (Cu) is essential for the survival of aerobic organisms through its interaction with molecular oxygen (O-2). However, Cu's chemical properties also make it toxic, requiring specific cellular mechanisms for Cu uptake and handling, mediated by Cu chaperones. CCS1, the budding yeast (S. cerevisiae) Cu chaperone for Cu-zinc (Zn) superoxide dismutase (SOD1) activates by directly promoting both Cu delivery and disulfide formation in SOD1. The complete mechanistic details of this transaction along with recently proposed molecular chaperone-like functions for CCS1 remain undefined. Here, we present combined structural, spectroscopic, kinetic, and thermodynamic data that suggest a multifunctional chaperoning role(s) for CCS1 during SOD1 activation. We observed that CCS1 preferentially binds a completely immature form of SOD1 and that the SOD1<bold>CCS</bold>1 interaction promotes high-affinity Zn(II) binding in SOD1. Conserved aromatic residues within the CCS1 C-terminal domain are integral in these processes. Previously, we have shown that CCS1 delivers Cu(I) to an entry site at the SOD1<bold>CCS</bold>1 interface upon binding. We show here that Cu(I) is transferred from CCS1 to the entry site and then to the SOD1 active site by a thermodynamically driven affinity gradient. We also noted that efficient transfer from the entry site to the active site is entirely dependent upon the oxidation of the conserved intrasubunit disulfide bond in SOD1. Our results herein provide a solid foundation for proposing a complete molecular mechanism for CCS1 activity and reclassification as a first-of-its-kind dual chaperone.	[Boyd, Stefanie D.; Liu, Li; Ullrich, Morgan S.; Skopp, Amelie; Winkler, Duane D.] Univ Texas Dallas, Dept Biol Sci, 800 W Campbell Rd, Richardson, TX 75080 USA; [Calvo, Jenifer S.; Meloni, Gabriele] Univ Texas Dallas, Dept Chem & Biochem, Richardson, TX 75080 USA	University of Texas System; University of Texas Dallas; University of Texas System; University of Texas Dallas	Winkler, DD (corresponding author), Univ Texas Dallas, Dept Biol Sci, 800 W Campbell Rd, Richardson, TX 75080 USA.	duane.winkler@utdallas.edu	; Calvo, Jenifer/S-7772-2018	Winkler, Duane D./0000-0003-1045-0323; Meloni, Gabriele/0000-0003-4976-1401; Calvo, Jenifer/0000-0002-0938-2602	National Institutes of Health [R01 GM120252]; Robert A. Welch Foundation [AT-1935-20170325]; NIGMS, National Institutes of Health [R35GM128704]; University of Texas at Dallas; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM128704, R01GM120252] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of Texas at Dallas; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part by National Institutes of Health Grant R01 GM120252 (to D.D.W.). This work was also supported by Robert A. Welch Foundation Grant AT-1935-20170325 and by NIGMS, National Institutes of Health, Grant R35GM128704 (to G.M.) and by funds from the University of Texas at Dallas. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allen S, 2012, BIOCHEMISTRY-US, V51, P1439, DOI 10.1021/bi201370r; Aller SG, 2006, P NATL ACAD SCI USA, V103, P3627, DOI 10.1073/pnas.0509929103; Arnesano F, 2004, J BIOL CHEM, V279, P47998, DOI 10.1074/jbc.M406021200; Banci L, 2013, CHEMBIOCHEM, V14, P1839, DOI 10.1002/cbic.201300042; Banci L, 2012, P NATL ACAD SCI USA, V109, P13555, DOI 10.1073/pnas.1207493109; Boal AK, 2009, CHEM REV, V109, P4760, DOI 10.1021/cr900104z; Boyd Stefanie D, 2018, J Proteomics Bioinform, V11, DOI 10.4172/jpb.1000473; Brown NM, 2004, P NATL ACAD SCI USA, V101, P5518, DOI 10.1073/pnas.0401175101; Caruano-Yzermans AL, 2006, J BIOL CHEM, V281, P13581, DOI 10.1074/jbc.M601580200; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; DANCIS A, 1994, J BIOL CHEM, V269, P25660; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; Doucette PA, 2004, J BIOL CHEM, V279, P54558, DOI 10.1074/jbc.M409744200; Elam JS, 2002, ADV PROTEIN CHEM, V60, P151; Fetherolf MM, 2017, METALLOMICS, V9, P1047, DOI 10.1039/c6mt00298f; Fetherolf MM, 2017, J BIOL CHEM, V292, P12025, DOI 10.1074/jbc.M117.775981; FRIDOVICH I, 1989, J BIOL CHEM, V264, P7761; Furukawa Y, 2004, EMBO J, V23, P2872, DOI 10.1038/sj.emboj.7600276; Furukawa Y, 2006, ANTIOXID REDOX SIGN, V8, P847, DOI 10.1089/ars.2006.8.847; Hart PJ, 1999, BIOCHEMISTRY-US, V38, P2167, DOI 10.1021/bi982284u; Huffman DL, 2001, ANNU REV BIOCHEM, V70, P677, DOI 10.1146/annurev.biochem.70.1.677; Jakob U, 2000, J BIOL CHEM, V275, P38302, DOI 10.1074/jbc.M005957200; Jensen LT, 2005, J BIOL CHEM, V280, P41373, DOI 10.1074/jbc.M509142200; Jonsson PA, 2006, BRAIN, V129, P451, DOI 10.1093/brain/awh704; Karch CM, 2009, P NATL ACAD SCI USA, V106, P7774, DOI 10.1073/pnas.0902505106; Kirby K, 2008, J BIOL CHEM, V283, P35393, DOI 10.1074/jbc.M807131200; Lamb AL, 2001, NAT STRUCT BIOL, V8, P751, DOI 10.1038/nsb0901-751; Lamb AL, 1999, NAT STRUCT BIOL, V6, P724; Lamb AL, 2000, BIOCHEMISTRY-US, V39, P14720, DOI 10.1021/bi002207a; Lindberg MJ, 2004, P NATL ACAD SCI USA, V101, P15893, DOI 10.1073/pnas.0403979101; LoPachin RM, 2012, CHEM RES TOXICOL, V25, P239, DOI 10.1021/tx2003257; Luchinat E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17815-y; Luchinat E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6502; PEARSON RG, 1990, COORDIN CHEM REV, V100, P403, DOI 10.1016/0010-8545(90)85016-L; POUNTNEY DL, 1994, BIOCHEMISTRY-US, V33, P9699, DOI 10.1021/bi00198a040; Proescher JB, 2008, HUM MOL GENET, V17, P1728, DOI 10.1093/hmg/ddn063; Rae TD, 2001, J BIOL CHEM, V276, P5166, DOI 10.1074/jbc.M008005200; Robinson NJ, 2010, ANNU REV BIOCHEM, V79, P537, DOI 10.1146/annurev-biochem-030409-143539; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rosenzweig AC, 2000, CURR OPIN CHEM BIOL, V4, P140, DOI 10.1016/S1367-5931(99)00066-6; Rosenzweig AC, 1999, STRUCTURE, V7, P605, DOI 10.1016/S0969-2126(99)80082-3; Rosenzweig AC, 2001, ACCOUNTS CHEM RES, V34, P119, DOI 10.1021/ar000012p; Schmidt PJ, 2000, J BIOL CHEM, V275, P33771, DOI 10.1074/jbc.M006254200; Schmidt PJ, 1999, J BIOL CHEM, V274, P23719, DOI 10.1074/jbc.274.34.23719; Sea K, 2015, J BIOL CHEM, V290, P2405, DOI 10.1074/jbc.M114.588798; Seetharaman SV, 2010, BIOCHEMISTRY-US, V49, P5714, DOI 10.1021/bi100314n; SOLOMON EI, 1993, SCIENCE, V259, P1575, DOI 10.1126/science.8384374; TAINER JA, 1983, NATURE, V306, P284, DOI 10.1038/306284a0; Wernimont AK, 2000, NAT STRUCT BIOL, V7, P766; Winkler DD, 2012, METHOD ENZYMOL, V512, P243, DOI 10.1016/B978-0-12-391940-3.00011-1; Winkler DD, 2009, BIOCHEMISTRY-US, V48, P3436, DOI 10.1021/bi8021735; Wright GSA, 2016, SCI REP-UK, V6, DOI 10.1038/srep27691; Xiao ZG, 2011, J BIOL CHEM, V286, P11047, DOI 10.1074/jbc.M110.213074; Zhu HN, 2000, BIOCHEMISTRY-US, V39, P5413, DOI 10.1021/bi992727+	54	15	15	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2019	294	6					1956	1966		10.1074/jbc.RA118.005283	http://dx.doi.org/10.1074/jbc.RA118.005283			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM8EO	30530491	Green Published, hybrid			2022-12-28	WOS:000459711400016
J	Haslbeck, M; Weinkauf, S; Buchner, J				Haslbeck, Martin; Weinkauf, Sevil; Buchner, Johannes			Small heat shock proteins: Simplicity meets complexity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						protein aggregation; molecular chaperone; protein folding; crystallin; heat shock protein (HSP); -crystallin; cell stress; non-native protein; oligomer dynamics	ALPHA-B-CRYSTALLIN; MASS-SPECTROMETRY REVEALS; ESCHERICHIA-COLI PROTEINS; C-TERMINAL EXTENSIONS; CHAPERONE ACTIVITY; MOLECULAR CHAPERONES; STRUCTURAL BASIS; IN-VIVO; HETEROOLIGOMERIC COMPLEXES; CRYOELECTRON MICROSCOPY	Small heat shock proteins (sHsps) are a ubiquitous and ancient family of ATP-independent molecular chaperones. A key characteristic of sHsps is that they exist in ensembles of iso-energetic oligomeric species differing in size. This property arises from a unique mode of assembly involving several parts of the subunits in a flexible manner. Current evidence suggests that smaller oligomers are more active chaperones. Thus, a shift in the equilibrium of the sHsp ensemble allows regulating the chaperone activity. Different mechanisms have been identified that reversibly change the oligomer equilibrium. The promiscuous interaction with non-native proteins generates complexes that can form aggregate-like structures from which native proteins are restored by ATP-dependent chaperones such as Hsp70 family members. In recent years, this basic paradigm has been expanded, and new roles and new cofactors, as well as variations in structure and regulation of sHsps, have emerged.	[Haslbeck, Martin; Weinkauf, Sevil; Buchner, Johannes] Tech Univ Munich, Dept Chem, Lichtenbergstr 4, D-85748 Garching, Germany; Tech Univ Munich, Ctr Integrated Prot Sci, Lichtenbergstr 4, D-85748 Garching, Germany	Technical University of Munich; Technical University of Munich	Haslbeck, M; Weinkauf, S; Buchner, J (corresponding author), Tech Univ Munich, Dept Chem, Lichtenbergstr 4, D-85748 Garching, Germany.	martin.haslbeck@tum.de; sevil.weinkauf@tum.de; johannes.buchner@tum.de	Haslbeck, Martin/A-4413-2013; Buchner, Johannes/A-2651-2010	Buchner, Johannes/0000-0003-1282-7737	Deutsche Forschungsgemeinschaft [SFB 1035]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 1035. This is the fifth article in the JBC Reviews series "Molecular chaperones and protein quality control." The authors declare that they have no conflicts of interest with the contents of this article.	Ahrman E, 2007, PROTEIN SCI, V16, P1464, DOI 10.1110/ps.072831607; Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Alderson TR, 2017, CELL STRESS CHAPERON, V22, P639, DOI 10.1007/s12192-017-0791-z; ALLEN SP, 1992, J BACTERIOL, V174, P6938, DOI 10.1128/JB.174.21.6938-6947.1992; Andley UP, 2001, FASEB J, V15, P221, DOI 10.1096/fj.00-0296com; Aquilina JA, 2007, BIOCHEM BIOPH RES CO, V353, P1115, DOI 10.1016/j.bbrc.2006.12.176; Aquilina JA, 2013, J BIOL CHEM, V288, P13602, DOI 10.1074/jbc.M112.443812; Aquilina JA, 2005, J BIOL CHEM, V280, P14485, DOI 10.1074/jbc.M500135200; Aquilina JA, 2004, J BIOL CHEM, V279, P28675, DOI 10.1074/jbc.M403348200; Aquilina JA, 2003, P NATL ACAD SCI USA, V100, P10611, DOI 10.1073/pnas.1932958100; Arrigo AP, 2012, CURR MOL MED, V12, P1151, DOI 10.2174/156652412803306693; Arrigo AP, 2007, ADV EXP MED BIOL, V594, P14; Arrigo AP, 2017, CELL STRESS CHAPERON, V22, P517, DOI 10.1007/s12192-017-0765-1; Arrigo AP, 2014, CANCERS, V6, P333, DOI 10.3390/cancers6010333; Arrigo AP, 2013, INT J HYPERTHER, V29, P409, DOI 10.3109/02656736.2013.792956; Arrigo AP, 2013, FEBS LETT, V587, P1959, DOI 10.1016/j.febslet.2013.05.011; ARRIGO AP, 1988, MOL CELL BIOL, V8, P5059, DOI 10.1128/MCB.8.12.5059; Bagneris C, 2009, J MOL BIOL, V392, P1242, DOI 10.1016/j.jmb.2009.07.069; Bakthisaran R, 2015, BBA-PROTEINS PROTEOM, V1854, P291, DOI 10.1016/j.bbapap.2014.12.019; Baldwin AJ, 2012, J AM CHEM SOC, V134, P15343, DOI 10.1021/ja307874r; Baldwin AJ, 2011, J MOL BIOL, V413, P310, DOI 10.1016/j.jmb.2011.07.017; Baldwin AJ, 2011, J MOL BIOL, V413, P297, DOI 10.1016/j.jmb.2011.07.016; Basha E, 2004, EUR J BIOCHEM, V271, P1426, DOI 10.1111/j.1432-1033.2004.04033.x; Basha E, 2004, J BIOL CHEM, V279, P7566, DOI 10.1074/jbc.M310684200; Basha E, 2013, J MOL BIOL, V425, P1683, DOI 10.1016/j.jmb.2013.02.011; Basha E, 2012, TRENDS BIOCHEM SCI, V37, P106, DOI 10.1016/j.tibs.2011.11.005; Basha E, 2010, J BIOL CHEM, V285, P11489, DOI 10.1074/jbc.M109.074088; Basha E, 2006, J BIOL CHEM, V281, P39943, DOI 10.1074/jbc.M607677200; Benesch JLP, 2008, J BIOL CHEM, V283, P28513, DOI 10.1074/jbc.M804729200; Benesch JLP, 2010, CHEM BIOL, V17, P1008, DOI 10.1016/j.chembiol.2010.06.016; Bepperling A, 2012, P NATL ACAD SCI USA, V109, P20407, DOI 10.1073/pnas.1209565109; Bova MP, 1999, P NATL ACAD SCI USA, V96, P6137, DOI 10.1073/pnas.96.11.6137; Braun N, 2011, P NATL ACAD SCI USA, V108, P20491, DOI 10.1073/pnas.1111014108; Bukach OV, 2004, EUR J BIOCHEM, V271, P291, DOI 10.1046/j.1432-1033.2003.03928.x; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Candido E Peter M, 2002, Prog Mol Subcell Biol, V28, P61; CARVER JA, 1992, FEBS LETT, V311, P143, DOI 10.1016/0014-5793(92)81386-Z; Cashikar AG, 2005, J BIOL CHEM, V280, P23869, DOI 10.1074/jbc.M502854200; CASPERS GJ, 1995, J MOL EVOL, V40, P238, DOI 10.1007/BF00163229; Cheng GL, 2008, J BIOL CHEM, V283, P26634, DOI 10.1074/jbc.M802946200; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; Clark AR, 2011, J MOL BIOL, V408, P118, DOI 10.1016/j.jmb.2011.02.020; Clark AR, 2018, J MOL BIOL, V430, P3297, DOI 10.1016/j.jmb.2018.06.047; Clark AR, 2012, INT J BIOCHEM CELL B, V44, P1687, DOI 10.1016/j.biocel.2012.02.015; Cox D, 2016, J BIOL CHEM, V291, P22618, DOI 10.1074/jbc.M116.739250; de Jong WW, 1998, INT J BIOL MACROMOL, V22, P151, DOI 10.1016/S0141-8130(98)00013-0; DEJONG WW, 1993, MOL BIOL EVOL, V10, P103; Delbecq SP, 2013, FEBS LETT, V587, P1073, DOI 10.1016/j.febslet.2013.01.021; Delbecq SP, 2012, EMBO J, V31, P4587, DOI 10.1038/emboj.2012.318; Ehrnsperger M, 1998, ANAL BIOCHEM, V259, P218, DOI 10.1006/abio.1998.2630; Ehrnsperger M, 1997, EMBO J, V16, P221, DOI 10.1093/emboj/16.2.221; Escusa-Toret S, 2013, NAT CELL BIOL, V15, P1231, DOI 10.1038/ncb2838; Fleckenstein T, 2015, MOL CELL, V58, P1067, DOI 10.1016/j.molcel.2015.04.019; Franzmann TM, 2008, MOL CELL, V29, P207, DOI 10.1016/j.molcel.2007.11.025; Friedrich KL, 2004, J BIOL CHEM, V279, P1080, DOI 10.1074/jbc.M311104200; Fu XM, 2013, J BIOL CHEM, V288, P31646, DOI 10.1074/jbc.M113.501817; Gaestel M, 2002, Prog Mol Subcell Biol, V28, P151; Garrido C, 2012, INT J BIOCHEM CELL B, V44, P1588, DOI 10.1016/j.biocel.2012.02.022; Ghosh JG, 2007, BIOCHEMISTRY-US, V46, P6308, DOI 10.1021/bi700149h; Giese KC, 2004, J BIOL CHEM, V279, P32674, DOI 10.1074/jbc.M404455200; Giese KC, 2002, J BIOL CHEM, V277, P46310, DOI 10.1074/jbc.M208926200; Graw J, 2009, EXP EYE RES, V88, P173, DOI 10.1016/j.exer.2008.10.011; Grousl T, 2018, J CELL BIOL, V217, P1269, DOI 10.1083/jcb.201708116; Hanazono Y, 2013, STRUCTURE, V21, P220, DOI 10.1016/j.str.2012.11.015; Hanazono Y, 2012, J MOL BIOL, V422, P100, DOI 10.1016/j.jmb.2012.05.017; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Haslbeck M, 1999, EMBO J, V18, P6744, DOI 10.1093/emboj/18.23.6744; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Haslbeck M, 2004, EMBO J, V23, P638, DOI 10.1038/sj.emboj.7600080; Haslbeck M, 2005, J BIOL CHEM, V280, P23861, DOI 10.1074/jbc.M502697200; Haslbeck M., 2015, BIG BOOK SMALL HEAT, P155, DOI [10.1007/978-3-319-16077-1_6, DOI 10.1007/978-3-319-16077-1_6]; Haslbeck M, 2016, BBA-GEN SUBJECTS, V1860, P149, DOI 10.1016/j.bbagen.2015.06.008; Haslbeck M, 2015, J MOL BIOL, V427, P1537, DOI 10.1016/j.jmb.2015.02.002; Hayes D, 2009, J BIOL CHEM, V284, P18801, DOI 10.1074/jbc.M109.011353; Heirbaut M., 2015, BIG BOOK SMALL HEAT, P197; Hilario E, 2011, J MOL BIOL, V408, P74, DOI 10.1016/j.jmb.2011.02.004; Hilton GR, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0405; Hochberg G.K.A., 2015, BIG BOOK SMALL HEAT, P87, DOI [10.1007/978-3-319-16077-1_3, DOI 10.1007/978-3-319-16077-1_3]; Hochberg GKA, 2018, SCIENCE, V359, P930, DOI 10.1126/science.aam7229; Hochberg GKA, 2014, PROG BIOPHYS MOL BIO, V115, P11, DOI 10.1016/j.pbiomolbio.2014.03.003; Hochberg GKA, 2014, P NATL ACAD SCI USA, V111, pE1562, DOI 10.1073/pnas.1322673111; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Horwitz J, 2003, EXP EYE RES, V76, P145, DOI 10.1016/S0014-4835(02)00278-6; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Irobi J, 2004, NAT GENET, V36, P597, DOI 10.1038/ng1328; Ito H, 1999, FEBS LETT, V446, P269, DOI 10.1016/S0014-5793(99)00242-2; Ito H, 1997, J BIOL CHEM, V272, P29934, DOI 10.1074/jbc.272.47.29934; Ito K, 2001, J BIOL CHEM, V276, P5346, DOI 10.1074/jbc.M009004200; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Jehle S, 2011, P NATL ACAD SCI USA, V108, P6409, DOI 10.1073/pnas.1014656108; Jehle S, 2010, NAT STRUCT MOL BIOL, V17, P1037, DOI 10.1038/nsmb.1891; Jiao WW, 2005, J MOL BIOL, V347, P871, DOI 10.1016/j.jmb.2005.01.029; Johnson C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.005751; Jovcevski B, 2018, CELL STRESS CHAPERON, V23, P827, DOI 10.1007/s12192-018-0889-y; Kampinga HH, 2012, INT J BIOCHEM CELL B, V44, P1706, DOI 10.1016/j.biocel.2012.06.005; KAMPINGA HH, 1995, EXP CELL RES, V219, P536, DOI 10.1006/excr.1995.1262; KAMPINGA HH, 1994, BIOCHEM BIOPH RES CO, V204, P1170, DOI 10.1006/bbrc.1994.2586; Kang SH, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-286; Kannan R, 2012, PROG RETIN EYE RES, V31, P576, DOI 10.1016/j.preteyeres.2012.06.001; Kappe G, 2004, PROTEINS, V57, P109, DOI 10.1002/prot.20220; Kappe Guido, 2002, Prog Mol Subcell Biol, V28, P1; Kato K, 1998, J BIOL CHEM, V273, P28346, DOI 10.1074/jbc.273.43.28346; KATO K, 1994, J BIOL CHEM, V269, P11274; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; Kim MV, 2004, BIOCHEM BIOPH RES CO, V315, P796, DOI 10.1016/j.bbrc.2004.01.130; Kim R, 2003, P NATL ACAD SCI USA, V100, P8151, DOI 10.1073/pnas.1032940100; Kokke BPA, 1998, FEBS LETT, V433, P228, DOI 10.1016/S0014-5793(98)00917-X; Kriehuber T, 2010, FASEB J, V24, P3633, DOI 10.1096/fj.10-156992; Kumar MS, 2009, FEBS LETT, V583, P175, DOI 10.1016/j.febslet.2008.11.047; Laganowsky A, 2010, PROTEIN SCI, V19, P1978, DOI 10.1002/pro.471; Laganowsky A, 2010, PROTEIN SCI, V19, P1031, DOI 10.1002/pro.380; Laskowska E, 1996, BIOCHIMIE, V78, P117, DOI 10.1016/0300-9084(96)82643-5; Lee GJ, 1997, EMBO J, V16, P659, DOI 10.1093/emboj/16.3.659; Lee U, 2005, PLANT CELL, V17, P559, DOI 10.1105/tpc.104.027540; Lentze N, 2004, BIOCHEM BIOPH RES CO, V325, P401, DOI 10.1016/j.bbrc.2004.10.043; Lentze N, 2004, EUR J BIOCHEM, V271, P2494, DOI 10.1111/j.1432-1033.2004.04180.x; Leroux MR, 1997, J BIOL CHEM, V272, P12847, DOI 10.1074/jbc.272.19.12847; Lindner RA, 1998, EUR J BIOCHEM, V258, P170, DOI 10.1046/j.1432-1327.1998.2580170.x; Litt M, 1998, HUM MOL GENET, V7, P471, DOI 10.1093/hmg/7.3.471; Liu L, 2015, STRUCTURE, V23, P2066, DOI 10.1016/j.str.2015.08.015; Mainz A, 2015, NAT STRUCT MOL BIOL, V22, P898, DOI 10.1038/nsmb.3108; Makley LN, 2015, SCIENCE, V350, P674, DOI 10.1126/science.aac9145; Mani N, 2016, SCI REP-UK, V6, DOI 10.1038/srep24019; Marklund EG, 2018, CELL STRESS CHAPERON, V23, P723, DOI 10.1007/s12192-018-0884-3; McDonald ET, 2012, BIOCHEMISTRY-US, V51, P1257, DOI 10.1021/bi2017624; Mchaourab HS, 2012, BIOCHEMISTRY-US, V51, P5105, DOI 10.1021/bi300525x; Mchaourab HS, 2009, BIOCHEMISTRY-US, V48, P3828, DOI 10.1021/bi900212j; Mchaourab HS, 2002, J BIOL CHEM, V277, P40557, DOI 10.1074/jbc.M206250200; Miller SBM, 2015, J MOL BIOL, V427, P1564, DOI 10.1016/j.jmb.2015.02.006; Mishra S, 2018, STRUCTURE, V26, P1116, DOI 10.1016/j.str.2018.05.015; Mitzelfelt K. A., 2015, BIG BOOK SMALL HEAT, P269; Mogk A, 1999, EMBO J, V18, P6934, DOI 10.1093/emboj/18.24.6934; Mogk A, 2003, MOL MICROBIOL, V50, P585, DOI 10.1046/j.1365-2958.2003.03710.x; Mogk A, 2003, J BIOL CHEM, V278, P31033, DOI 10.1074/jbc.M303587200; Mogk A, 2018, MOL CELL, V69, P214, DOI 10.1016/j.molcel.2018.01.004; Mymrikov EV, 2017, J BIOL CHEM, V292, P672, DOI 10.1074/jbc.M116.760413; Mymrikov EV, 2015, EXPERT REV PROTEOMIC, V12, P295, DOI 10.1586/14789450.2015.1039993; Mymrikov EV, 2012, CELL STRESS CHAPERON, V17, P157, DOI 10.1007/s12192-011-0296-0; Mymrikov EV, 2011, PHYSIOL REV, V91, P1123, DOI 10.1152/physrev.00023.2010; Nillegoda NB, 2018, TRENDS BIOCHEM SCI, V43, P285, DOI 10.1016/j.tibs.2018.02.003; Nillegoda NB, 2015, NATURE, V524, P247, DOI 10.1038/nature14884; Ojha J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016550; Pasta SY, 2004, MOL VIS, V10, P655; Peschek J, 2013, P NATL ACAD SCI USA, V110, pE3780, DOI 10.1073/pnas.1308898110; Rajagopal P, 2015, J BIOMOL NMR, V63, P223, DOI 10.1007/s10858-015-9973-0; Rajasekaran NS, 2007, CELL, V130, P427, DOI 10.1016/j.cell.2007.06.044; Ratajczak E, 2009, J MOL BIOL, V386, P178, DOI 10.1016/j.jmb.2008.12.009; Rauch JN, 2017, J MOL BIOL, V429, P128, DOI 10.1016/j.jmb.2016.11.013; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Rogalla T, 1999, J BIOL CHEM, V274, P18947, DOI 10.1074/jbc.274.27.18947; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; Rubio MP, 2004, BIOCHEM J, V379, P395, DOI 10.1042/bj20031797; Saji H, 2008, PROTEINS, V71, P771, DOI 10.1002/prot.21762; Shashidharamurthy R, 2005, J BIOL CHEM, V280, P5281, DOI 10.1074/jbc.M407236200; Shi J, 2013, J BIOL CHEM, V288, P4819, DOI 10.1074/jbc.M112.388132; Shi J, 2006, J BIOL CHEM, V281, P40420, DOI 10.1074/jbc.M608322200; Slingsby C, 2013, PROTEIN SCI, V22, P367, DOI 10.1002/pro.2229; Sluchanko NN, 2017, STRUCTURE, V25, P305, DOI 10.1016/j.str.2016.12.005; Sobott F, 2002, J BIOL CHEM, V277, P38921, DOI 10.1074/jbc.M206060200; Specht S, 2011, J CELL BIOL, V195, P617, DOI 10.1083/jcb.201106037; Stamler R, 2005, J MOL BIOL, V353, P68, DOI 10.1016/j.jmb.2005.08.025; STEGE GJJ, 1994, INT J HYPERTHER, V10, P659, DOI 10.3109/02656739409022446; Stengel F, 2010, P NATL ACAD SCI USA, V107, P2007, DOI 10.1073/pnas.0910126107; STOKOE D, 1992, FEBS LETT, V313, P307, DOI 10.1016/0014-5793(92)81216-9; Stromer T, 2003, J BIOL CHEM, V278, P18015, DOI 10.1074/jbc.M301640200; Studer S, 2002, EUR J BIOCHEM, V269, P3578, DOI 10.1046/j.1432-1033.2002.03049.x; Sugiyama Y, 2000, J BIOL CHEM, V275, P1095, DOI 10.1074/jbc.275.2.1095; Sun Y, 2005, FEBS J, V272, P2613, DOI 10.1111/j.1742-4658.2005.04708.x; Takeda K, 2011, J STRUCT BIOL, V174, P92, DOI 10.1016/j.jsb.2010.12.006; Thornell E, 2015, CELL MOL LIFE SCI, V72, P4127, DOI 10.1007/s00018-015-1996-x; Treweek TM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001046; Treweek TM, 2015, CELL MOL LIFE SCI, V72, P429, DOI 10.1007/s00018-014-1754-5; Treweek TM, 2010, EXP EYE RES, V91, P691, DOI 10.1016/j.exer.2010.08.015; Uhart M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055703; Ungelenk S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13673; van de Klundert FAJM, 1998, EUR J BIOCHEM, V258, P1014, DOI 10.1046/j.1432-1327.1998.2581014.x; van den Ijssel PRLA, 1998, BIOCHEM BIOPH RES CO, V247, P518, DOI 10.1006/bbrc.1998.8699; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; Veinger L, 1998, J BIOL CHEM, V273, P11032, DOI 10.1074/jbc.273.18.11032; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Walther DM, 2015, CELL, V161, P919, DOI 10.1016/j.cell.2015.03.032; Waters ER, 2013, J EXP BOT, V64, P391, DOI 10.1093/jxb/ers355; Waters ER, 1999, MOL BIOL EVOL, V16, P127, DOI 10.1093/oxfordjournals.molbev.a026033; Waters ER, 1996, J EXP BOT, V47, P325, DOI 10.1093/jxb/47.3.325; Weeks SD, 2014, J STRUCT BIOL, V185, P342, DOI 10.1016/j.jsb.2013.12.009; Wintrode PL, 2003, BIOCHEMISTRY-US, V42, P10667, DOI 10.1021/bi034117m; Yang HM, 1999, PROTEIN SCI, V8, P174; Zhao L, 2015, NATURE, V523, P607, DOI 10.1038/nature14650; Zwirowski S, 2017, EMBO J, V36, P783, DOI 10.15252/embj.201593378	189	107	109	4	58	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2019	294	6					2121	2132		10.1074/jbc.REV118.002809	http://dx.doi.org/10.1074/jbc.REV118.002809			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM8EO	30385502	Green Published, hybrid			2022-12-28	WOS:000459711400030
J	Lai, JI; Nachun, D; Petrosyan, L; Throesch, B; Campau, E; Gao, FY; Baldwin, KK; Coppola, G; Gottesfeld, JM; Soragni, E				Lai, Jiun-I; Nachun, Daniel; Petrosyan, Lina; Throesch, Benjamin; Campau, Erica; Gao, Fuying; Baldwin, Kristin K.; Coppola, Giovanni; Gottesfeld, Joel M.; Soragni, Elisabetta			Transcriptional profiling of isogenic Friedreich ataxia neurons and effect of an HDAC inhibitor on disease signatures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Friedreich ataxia; induced pluripotent stem cell (iPS cell) (iPSC); transcriptomics; histone deacetylase inhibitor (HDAC inhibitor); neuron; gene editing; neurodegeneration; repeat expansion	PLURIPOTENT STEM-CELLS; KIKO MOUSE MODEL; OXIDATIVE STRESS; FRATAXIN DEFICIENCY; REPEAT EXPANSION; EXPRESSION; METABOLISM; MECHANISM; MUTATION; REVEALS	Friedreich ataxia (FRDA) is a neurodegenerative disorder caused by transcriptional silencing of the frataxin (FXN) gene, resulting in loss of the essential mitochondrial protein frataxin. Based on the knowledge that a GAA<bold>TTC repeat expansion in the first intron of FXN induces heterochromatin</bold>, we previously showed that 2-aminobenzamide-type histone deacetylase inhibitors (HDACi) increase FXN mRNA levels in induced pluripotent stem cell (iPSC)-derived FRDA neurons and in circulating lymphocytes from patients after HDACi oral administration. How the reduced expression of frataxin leads to neurological and other systemic symptoms in FRDA patients remains unclear. Similar to other triplet-repeat disorders, it is unknown why FRDA affects only specific cell types, primarily the large sensory neurons of the dorsal root ganglia and cardiomyocytes. The combination of iPSC technology and genome-editing techniques offers the unique possibility to address these questions in a relevant cell model of FRDA, obviating confounding effects of variable genetic backgrounds. Here, using scarless gene-editing methods, we created isogenic iPSC lines that differ only in the length of the GAA<bold>TTC repeats</bold>. To uncover the gene expression signatures due to the GAA<bold>TTC repeat expansion in FRDA neuronal cells and the effect of HDACi on these changes</bold>, we performed RNA-seq-based transcriptomic analysis of iPSC-derived central nervous system (CNS) and isogenic sensory neurons. We found that cellular pathways related to neuronal function, regulation of transcription, extracellular matrix organization, and apoptosis are affected by frataxin loss in neurons of the CNS and peripheral nervous system and that these changes are partially restored by HDACi treatment.	[Lai, Jiun-I; Petrosyan, Lina; Campau, Erica; Gottesfeld, Joel M.; Soragni, Elisabetta] Scripps Res Inst, Dept Mol Med, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA; [Throesch, Benjamin; Baldwin, Kristin K.] Scripps Res Inst, Dept Neurosci, La Jolla, CA 92037 USA; [Nachun, Daniel; Gao, Fuying; Coppola, Giovanni] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA; [Lai, Jiun-I] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan	Scripps Research Institute; Scripps Research Institute; University of California System; University of California Los Angeles; National Yang Ming Chiao Tung University	Soragni, E (corresponding author), Scripps Res Inst, Dept Mol Med, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	soragni@scripps.edu	Lai, Jiun-I/ABA-2904-2021	Lai, Jiun-I/0000-0002-8233-5466; Baldwin, Kristin/0000-0002-6137-030X	National Institutes of Health NINDS [5R01 NS062856]; Friedreich's Ataxia Research Alliance; Bio-Marin Pharmaceutical, Inc.; National Institutes of Health NINDS Informatics Center for Neurogenetics and Neurogenomics [P30 NS062691]; National Institutes of Health NIDCD [DC012592]; NIMH [MH102698]; NIA [DP1 AG055944]; Dorris Neuroscience Center; BioMarin Pharmaceuticals; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH102698] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS062691, R01NS062856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [DP1AG055944] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC012592] Funding Source: NIH RePORTER	National Institutes of Health NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Friedreich's Ataxia Research Alliance; Bio-Marin Pharmaceutical, Inc.; National Institutes of Health NINDS Informatics Center for Neurogenetics and Neurogenomics; National Institutes of Health NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Dorris Neuroscience Center; BioMarin Pharmaceuticals; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported in part by National Institutes of Health NINDS Grant 5R01 NS062856, the Friedreich's Ataxia Research Alliance (to E.S.), Bio-Marin Pharmaceutical, Inc. (to the Gottesfeld lab), National Institutes of Health NINDS Informatics Center for Neurogenetics and Neurogenomics Grant P30 NS062691, and National Institutes of Health NIDCD Grant DC012592, NIMH Grant MH102698, and NIA Grant DP1 AG055944, and the Dorris Neuroscience Center (to the Baldwin lab). J.M.G. serves as a consultant to BioMarin Pharmaceutical for the development of histone deacetylase inhibitors as therapeutics and is an inventor on patents licensed by The Scripps Research Institute to BioMarin Pharmaceutical. E.S. is supported in part by BioMarin Pharmaceuticals. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aizawa E, 2012, MOL THER, V20, P424, DOI 10.1038/mt.2011.266; Al-Mahdawi S, 2006, GENOMICS, V88, P580, DOI 10.1016/j.ygeno.2006.06.015; Aranca TV, 2016, NEURODEGENER DIS MAN, V6, P49, DOI 10.2217/nmt.15.73; Blanchard JW, 2015, NAT NEUROSCI, V18, P25, DOI 10.1038/nn.3887; Boland MJ, 2009, NATURE, V461, P91, DOI 10.1038/nature08310; Bolinches-Amoros A, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00124; Burnett R, 2006, P NATL ACAD SCI USA, V103, P11497, DOI 10.1073/pnas.0604939103; Carletti B, 2014, INT J MOL SCI, V15, P5789, DOI 10.3390/ijms15045789; Chambers SM, 2012, NAT BIOTECHNOL, V30, P715, DOI 10.1038/nbt.2249; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chan PK, 2013, HUM MOL GENET, V22, P2662, DOI 10.1093/hmg/ddt115; Chandran V, 2017, ELIFE, V6, DOI 10.7554/eLife.30054; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chen KC, 2016, ELIFE, V5, DOI 10.7554/eLife.20732; Chen KC, 2016, ELIFE, V5, DOI 10.7554/eLife.16043; Chiang S, 2018, NEUROCHEM INT, V117, P35, DOI 10.1016/j.neuint.2017.08.002; Chou CJ, 2008, J BIOL CHEM, V283, P35402, DOI 10.1074/jbc.M807045200; Cnop M, 2012, ANN NEUROL, V72, P971, DOI 10.1002/ana.23698; Codazzi F, 2016, HUM MOL GENET, V25, P4847, DOI 10.1093/hmg/ddw308; Coppola G, 2006, NEUROBIOL DIS, V22, P302, DOI 10.1016/j.nbd.2005.11.014; Coppola G, 2011, ANN NEUROL, V70, P790, DOI 10.1002/ana.22526; Coppola G, 2009, HUM MOL GENET, V18, P2452, DOI 10.1093/hmg/ddp183; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Du JT, 2012, J BIOL CHEM, V287, P29861, DOI 10.1074/jbc.M112.391961; Erwin GS, 2017, SCIENCE, V358, P1617, DOI 10.1126/science.aan6414; Falk A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029597; Flegel C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128951; Frobel J, 2014, STEM CELL REP, V3, P414, DOI 10.1016/j.stemcr.2014.07.003; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Greene E, 2005, GENOMICS, V85, P221, DOI 10.1016/j.ygeno.2004.10.013; Haugen AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000812; Herman D, 2006, NAT CHEM BIOL, V2, P551, DOI 10.1038/nchembio815; Herzig S, 2018, NAT REV MOL CELL BIO, V19, P121, DOI 10.1038/nrm.2017.95; Hick A, 2013, DIS MODEL MECH, V6, P608, DOI 10.1242/dmm.010900; Holkers M, 2014, NAT METHODS, V11, P1051, DOI [10.1038/NMETH.3075, 10.1038/nmeth.3075]; Huang MLH, 2009, P NATL ACAD SCI USA, V106, P16381, DOI 10.1073/pnas.0906784106; Igoillo-Esteve M, 2015, HUM MOL GENET, V24, P2274, DOI 10.1093/hmg/ddu745; Jager L, 2009, NAT PROTOC, V4, P547, DOI 10.1038/nprot.2009.4; Kearney M, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007791.pub3; Kitsak M, 2016, SCI REP-UK, V6, DOI 10.1038/srep35241; Koeppen AH, 2017, J NEUROPATH EXP NEUR, V76, P101, DOI 10.1093/jnen/nlw111; Koeppen AH, 2013, J NEUROPATH EXP NEUR, V72, P78, DOI 10.1097/NEN.0b013e31827e5762; Koeppen AH, 2011, J NEUROL SCI, V303, P1, DOI 10.1016/j.jns.2011.01.010; Ku S, 2010, CELL STEM CELL, V7, P631, DOI 10.1016/j.stem.2010.09.014; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Li L, 2018, CELL TISSUE RES, V371, P143, DOI 10.1007/s00441-017-2713-x; Li LD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10606; Li XJ, 2018, NAT REV MOL CELL BIO, V19, P563, DOI 10.1038/s41580-018-0029-7; Lin H, 2017, DIS MODEL MECH, V10, P1529, DOI 10.1242/dmm.030049; Lin H, 2017, DIS MODEL MECH, V10, P1343, DOI 10.1242/dmm.030502; Liu GH, 2011, CELL STEM CELL, V8, P688, DOI 10.1016/j.stem.2011.04.019; Lo Sardo V, 2017, NAT BIOTECHNOL, V35, P69, DOI 10.1038/nbt.3749; Loria F, 2015, NEUROBIOL DIS, V76, P1, DOI 10.1016/j.nbd.2014.12.017; Lupoli F, 2018, FEBS LETT, V592, P718, DOI 10.1002/1873-3468.12928; Mertens J, 2016, NAT REV NEUROSCI, V17, P424, DOI 10.1038/nrn.2016.46; Mertens J, 2015, CELL STEM CELL, V17, P705, DOI 10.1016/j.stem.2015.09.001; Miller JD, 2013, CELL STEM CELL, V13, P691, DOI 10.1016/j.stem.2013.11.006; Mincheva-Tasheva S, 2014, HUM MOL GENET, V23, P1829, DOI 10.1093/hmg/ddt576; Mitani K, 2014, METHODS MOL BIOL, V1114, P163, DOI 10.1007/978-1-62703-761-7_10; Molla B, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00264; Nachun D, 2018, HUM MOL GENET, V27, P2965, DOI 10.1093/hmg/ddy198; Nair M, 2017, CURR MED CHEM, V24, P4368, DOI 10.2174/0929867324666170727100508; Napierala JS, 2017, DIS MODEL MECH, V10, P1353, DOI 10.1242/dmm.030536; Nityanandam A, 2015, STEM CELLS DEV, V24, P1265, DOI 10.1089/scd.2015.0044; Obis E, 2014, FREE RADICAL BIO MED, V73, P21, DOI 10.1016/j.freeradbiomed.2014.04.016; Ohbayashi F, 2005, P NATL ACAD SCI USA, V102, P13628, DOI 10.1073/pnas.0506598102; Palmer D, 2003, MOL THER, V8, P846, DOI 10.1016/j.ymthe.2003.08.014; Palomo GM, 2011, HUM MOL GENET, V20, P2807, DOI 10.1093/hmg/ddr187; Pandolfo M, 2009, J NEUROL, V256, P3, DOI 10.1007/s00415-009-1002-3; Panopoulos AD, 2017, STEM CELL REP, V8, P1086, DOI 10.1016/j.stemcr.2017.03.012; Pastore A, 2013, J NEUROCHEM, V126, P43, DOI 10.1111/jnc.12220; Quesada MP, 2015, EXP CELL RES, V335, P51, DOI 10.1016/j.yexcr.2015.04.013; Perdomini M, 2014, NAT MED, V20, P546, DOI 10.1038/nm.3510; Piermarini E, 2016, HUM MOL GENET, V25, P4288, DOI 10.1093/hmg/ddw260; Piguet F, 2018, MOL THER, V26, P1940, DOI 10.1016/j.ymthe.2018.05.006; Poon A, 2017, NEW BIOTECHNOL, V39, P190, DOI 10.1016/j.nbt.2017.05.009; Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818; Quiros PM, 2016, NAT REV MOL CELL BIO, V17, P213, DOI 10.1038/nrm.2016.23; Rai M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001958; Rai M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008825; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rocca CJ, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaj2347; Rufini A, 2015, NEUROBIOL DIS, V75, P91, DOI 10.1016/j.nbd.2014.12.011; Sandi C, 2011, NEUROBIOL DIS, V42, P496, DOI 10.1016/j.nbd.2011.02.016; Schwartzentruber J, 2018, NAT GENET, V50, P54, DOI 10.1038/s41588-017-0005-8; Seznec H, 2005, HUM MOL GENET, V14, P463, DOI 10.1093/hmg/ddi042; Soragni E, 2014, ANN NEUROL, V76, P489, DOI 10.1002/ana.24260; Sparaco M, 2009, J NEUROL SCI, V287, P111, DOI 10.1016/j.jns.2009.08.052; Sterneckert JL, 2014, NAT REV GENET, V15, P625, DOI 10.1038/nrg3764; Stram AR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178354; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tamarit J, 2016, FREE RADICAL BIO MED, V100, P138, DOI 10.1016/j.freeradbiomed.2016.06.007; Tan GL, 2003, HUM MOL GENET, V12, P1699, DOI 10.1093/hmg/ddg187; Thomason Lynn C, 2014, Curr Protoc Mol Biol, V106, DOI 10.1002/0471142727.mb0116s106; Vyas PM, 2012, HUM MOL GENET, V21, P1230, DOI 10.1093/hmg/ddr554; Wagner GR, 2012, HUM MOL GENET, V21, P2688, DOI 10.1093/hmg/dds095; Wellen KE, 2012, NAT REV MOL CELL BIO, V13, P270, DOI 10.1038/nrm3305; Wong A, 1999, HUM MOL GENET, V8, P425, DOI 10.1093/hmg/8.3.425; Zagami CJ, 2009, J CELL BIOCHEM, V107, P1063, DOI 10.1002/jcb.22221	102	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2019	294	6					1846	1859		10.1074/jbc.RA118.006515	http://dx.doi.org/10.1074/jbc.RA118.006515			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM8EO	30552117	Green Published, hybrid			2022-12-28	WOS:000459711400007
J	Vangala, JR; Radhakrishnan, SK				Vangala, Janakiram R.; Radhakrishnan, Senthil K.			Nrf1-mediated transcriptional regulation of the proteasome requires a functional TIP60 complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						proteasome; transcription coactivator; transcription regulation; cancer; proteostasis; NFE2L1; Nrf1; RUVBL1; TIP60	FACTOR NRF1; INHIBITORS; PONTIN; GENE; IDENTIFICATION; ACETYLATION; DEGRADATION; ONCOPROTEIN; EXPRESSION; CHROMATIN	Inhibition of the proteasome leads to proteotoxic stress, which is characterized by the buildup of ubiquitinated proteins that cannot be degraded properly. The transcription factor Nrf1 (also called NFE2L1) counteracts proteotoxic stress by inducing transcription of proteasome subunit genes, resulting in the restoration of proteasome activity. Further understanding of the Nrf1 pathway is therefore of interest in both neurodegeneration, where proteasome activity could be enhanced, and cancer, where suppression of this pathway could potentiate the cell-killing effect mediated by proteasome inhibitor drugs. Here, to identify novel regulators of Nrf1, we performed an RNAi screen in an engineered cell line, reporting on Nrf1 transcriptional activity. In addition to validating known regulators, we discovered that the AAA+ ATPase RUVBL1 is necessary for Nrf1's transcriptional activity. Given that RUVBL1 is part of different multisubunit complexes that play key roles in transcription, we dissected this phenomenon further and found that the TIP60 chromatin-regulatory complex is essential for Nrf1-dependent transcription of proteasome genes. Consistent with these observations, Nrf1, RUVBL1, and TIP60 proteins were co-recruited to the promoter regions of proteasome genes after proteasome inhibitor treatments. More importantly, depletion of RUVBL1 or TIP60 in various cancer cells sensitized them to cell death induced by proteasome inhibition. Overall, our study provides a framework for manipulating the TIP60-Nrf1 axis to alter proteasome function in various human diseases, including cancer.	[Vangala, Janakiram R.; Radhakrishnan, Senthil K.] Virginia Commonwealth Univ, Dept Pathol, Med Coll Virginia Campus, Richmond, VA 23298 USA; [Vangala, Janakiram R.; Radhakrishnan, Senthil K.] Virginia Commonwealth Univ, Massey Canc Ctr, Med Coll Virginia Campus, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University	Radhakrishnan, SK (corresponding author), Virginia Commonwealth Univ, Dept Pathol, Med Coll Virginia Campus, Richmond, VA 23298 USA.	senthil.radhakrishnan@vcuhealth.org			National Cancer Institute [R00CA154884]; Grace Science Foundation	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Grace Science Foundation	Supported by a K99/R00 award from the National Cancer Institute (R00CA154884) and by a grant from the Grace Science Foundation. To whom correspondence should be addressed. E-mail: senthil.radhakrishnan@vcuhealth.org.	Biswas M, 2010, TOXICOL APPL PHARM, V244, P16, DOI 10.1016/j.taap.2009.07.034; Chatr-aryamontri A, 2017, NUCLEIC ACIDS RES, V45, pD369, DOI 10.1093/nar/gkw1102; de la Vega MR, 2018, CANCER CELL, V34, P21, DOI 10.1016/j.ccell.2018.03.022; Elkaim J, 2014, BIOORG MED CHEM LETT, V24, P2512, DOI 10.1016/j.bmcl.2014.04.003; Elkaim J, 2012, BIOCHEM J, V443, P549, DOI 10.1042/BJ20111779; Frankland-Searby S, 2012, BBA-REV CANCER, V1825, P64, DOI 10.1016/j.bbcan.2011.10.003; Gao CD, 2014, SCI REP-UK, V4, DOI 10.1038/srep04712; Gaughan L, 2002, J BIOL CHEM, V277, P25904, DOI 10.1074/jbc.M203423200; Gnatovskiy L, 2013, MOL CELL BIOL, V33, P3817, DOI 10.1128/MCB.01562-12; Izumi N, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000468; Jha S, 2013, MOL CELL BIOL, V33, P1164, DOI 10.1128/MCB.01567-12; Kim HM, 2016, GENE, V584, P17, DOI 10.1016/j.gene.2016.03.002; Kim JH, 2005, NATURE, V434, P921, DOI 10.1038/nature03452; Koizumi S, 2016, ELIFE, V5, DOI 10.7554/eLife.18357; Le Moigne R, 2017, MOL CANCER THER, V16, P2375, DOI 10.1158/1535-7163.MCT-17-0233; Lee CS, 2013, FEBS J, V280, P3609, DOI 10.1111/febs.12350; Lee CS, 2011, P NATL ACAD SCI USA, V108, P8408, DOI 10.1073/pnas.1019209108; Lehrbach NJ, 2016, ELIFE, V5, DOI 10.7554/eLife.17721; Levy C, 2010, MOL CELL, V40, P841, DOI 10.1016/j.molcel.2010.11.020; Lindquist SL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004507; Magnaghi P, 2013, NAT CHEM BIOL, V9, P548, DOI [10.1038/nchembio.1313, 10.1038/NCHEMBIO.1313]; Mao YQ, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00058; Orlowski RZ, 2008, CLIN CANCER RES, V14, P1649, DOI 10.1158/1078-0432.CCR-07-2218; Patel JH, 2004, MOL CELL BIOL, V24, P10826, DOI 10.1128/MCB.24.24.10826-10834.2004; Perez-Perri JI, 2016, CELL REP, V16, P37, DOI 10.1016/j.celrep.2016.05.082; Petrocca F, 2013, CANCER CELL, V24, P182, DOI 10.1016/j.ccr.2013.07.008; Qiu ZJ, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0238-5; Radhakrishnan SK, 2014, ELIFE, V3, DOI [10.7554/elife.01856, 10.7554/eLife.01856]; Radhakrishnan SK, 2010, MOL CELL, V38, P17, DOI 10.1016/j.molcel.2010.02.029; Rajendra E, 2014, NUCLEIC ACIDS RES, V42, P13736, DOI 10.1093/nar/gku1230; Roeten MSF, 2018, CANCER CHEMOTH PHARM, V81, P227, DOI 10.1007/s00280-017-3489-0; Rousseau A, 2018, NAT REV MOL CELL BIO, V19, P697, DOI 10.1038/s41580-018-0040-z; Rowe A, 2008, NEOPLASIA, V10, P1421, DOI 10.1593/neo.08850; Ru BB, 2018, NUCLEIC ACIDS RES, V46, pD918, DOI 10.1093/nar/gkx877; Sapountzi V, 2006, INT J BIOCHEM CELL B, V38, P1496, DOI 10.1016/j.biocel.2006.03.003; Schmidt M, 2014, BBA-MOL CELL RES, V1843, P13, DOI 10.1016/j.bbamcr.2013.08.012; Sekine H, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00252-18; Steffen J, 2010, MOL CELL, V40, P147, DOI 10.1016/j.molcel.2010.09.012; Tarangelo A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10028; Taubert S, 2004, MOL CELL BIOL, V24, P4546, DOI 10.1128/MCB.24.10.4546-4556.2004; Tomlin FM, 2017, ACS CENTRAL SCI, V3, P1143, DOI 10.1021/acscentsci.7b00224; Tsuchiya Y, 2011, MOL CELL BIOL, V31, P4500, DOI 10.1128/MCB.05663-11; Vangala JR, 2016, CURR BIOL, V26, pR834, DOI 10.1016/j.cub.2016.08.008; Venteicher AS, 2008, CELL, V132, P945, DOI 10.1016/j.cell.2008.01.019; Zhao LJ, 2016, VIROLOGY, V499, P178, DOI 10.1016/j.virol.2016.09.005	45	12	14	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2019	294	6					2036	2045		10.1074/jbc.RA118.006290	http://dx.doi.org/10.1074/jbc.RA118.006290			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM8EO	30559296	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000459711400022
J	Wang, T; Rodina, A; Dunphy, MP; Corben, A; Modi, S; Guzman, ML; Gewirth, DT; Chiosis, G				Wang, Tai; Rodina, Anna; Dunphy, Mark P.; Corben, Adriana; Modi, Shanu; Guzman, Monica L.; Gewirth, Daniel T.; Chiosis, Gabriela			Chaperome heterogeneity and its implications for cancer study and treatment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						cancer biology; chaperone; chemical biology; stress response; biomarker; cancer therapy; heat shock protein 90 (Hsp90); 70 kilodalton heat shock protein (Hsp70); chaperome; chemical probes; epichaperome; protein networks	SHOCK-PROTEIN 90; ENDOPLASMIC-RETICULUM HSP90; PLANT-SPECIFIC THIOREDOXIN; TARGET RESIDENCE TIME; CONFORMATIONAL DYNAMICS; POSTTRANSLATIONAL MODIFICATIONS; INTERACTION NETWORK; ALLOSTERIC SITE; DRUG DISCOVERY; INHIBITORS	The chaperome is the collection of proteins in the cell that carry out molecular chaperoning functions. Changes in the interaction strength between chaperome proteins lead to an assembly that is functionally and structurally distinct from each constituent member. In this review, we discuss the epichaperome, the cellular network that forms when the chaperome components of distinct chaperome machineries come together as stable, functionally integrated, multimeric complexes. In tumors, maintenance of the epichaperome network is vital for tumor survival, rendering them vulnerable to therapeutic interventions that target critical epichaperome network components. We discuss how the epichaperome empowers an approach for precision medicine cancer trials where a new target, biomarker, and relevant drug candidates can be correlated and integrated. We introduce chemical biology methods to investigate the heterogeneity of the chaperome in a given cellular context. Lastly, we discuss how ligand-protein binding kinetics are more appropriate than equilibrium binding parameters to characterize and unravel chaperome targeting in cancer and to gauge the selectivity of ligands for specific tumor-associated chaperome pools.	[Wang, Tai; Rodina, Anna; Chiosis, Gabriela] Mem Sloan Kettering Canc Ctr, Chem Biol Program, New York, NY 10065 USA; [Dunphy, Mark P.] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10065 USA; [Modi, Shanu; Chiosis, Gabriela] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Corben, Adriana] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA; [Guzman, Monica L.] Weill Cornell Med Coll, Dept Med, Hematol & Med Oncol, New York, NY 10065 USA; [Gewirth, Daniel T.] Hauptman Woodward Med Res Inst, Buffalo, NY 14203 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Icahn School of Medicine at Mount Sinai; Cornell University; Hauptman Woodward Medical Research Institute	Chiosis, G (corresponding author), Mem Sloan Kettering Canc Ctr, Chem Biol Program, New York, NY 10065 USA.; Chiosis, G (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA.	chiosisg@mskcc.org		Wang, Tai/0000-0001-9984-9634	Lymphoma Research Foundation; National Institutes of Health [R01 CA172546, R56 AG061869, R01 CA155226, P01 CA186866, P30 CA08748, P50 CA192937, R01 CA102031]; Irma T. Hirschl/Monique Weill-Caulier Trust; Commonwealth Foundation for Cancer Research; Experimental Therapeutics Center of the Memorial Sloan Kettering Cancer Center; Unravel Pediatric Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA102031, P01CA186866, P30CA008748, R01CA172546, P50CA192937] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002384] Funding Source: NIH RePORTER	Lymphoma Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irma T. Hirschl/Monique Weill-Caulier Trust; Commonwealth Foundation for Cancer Research; Experimental Therapeutics Center of the Memorial Sloan Kettering Cancer Center; Unravel Pediatric Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Supported by the Lymphoma Research Foundation.; Supported by National Institutes of Health Grants R01 CA172546 and R01 CA102031 and the Irma T. Hirschl/Monique Weill-Caulier Trust and Unravel Pediatric Cancer Foundation.; Supported by National Institutes of Health Grant P01 CA186866. 4 Supported by the National Institutes of Health Grants R01 CA172546, R56 AG061869, R01 CA155226, P01 CA186866, P30 CA08748, and P50 CA192937 and the Mr. William H. Goodwin and Mrs. Alice Goodwin and the Commonwealth Foundation for Cancer Research and the Experimental Therapeutics Center of the Memorial Sloan Kettering Cancer Center.	Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; Amaral M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02258-w; Angelidis CE, 1999, EUR J BIOCHEM, V259, P505, DOI 10.1046/j.1432-1327.1999.00078.x; Bhagwat N, 2014, BLOOD, V123, P2075, DOI 10.1182/blood-2014-01-547760; Bhat R, 2014, J MED CHEM, V57, P8718, DOI 10.1021/jm500823a; Bracher A, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00010; Brehme M, 2016, DIS MODEL MECH, V9, P823, DOI 10.1242/dmm.024703; Brehme M, 2014, CELL REP, V9, P1135, DOI 10.1016/j.celrep.2014.09.042; Brough PA, 2005, BIOORG MED CHEM LETT, V15, P5197, DOI 10.1016/j.bmcl.2005.08.091; Brough PA, 2008, J MED CHEM, V51, P196, DOI 10.1021/jm701018h; Brough PA, 2009, J MED CHEM, V52, P4794, DOI 10.1021/jm900357y; Bruce NJ, 2018, CURR OPIN STRUC BIOL, V49, P1, DOI 10.1016/j.sbi.2017.10.001; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Bussenius J, 2012, BIOORG MED CHEM LETT, V22, P5396, DOI 10.1016/j.bmcl.2012.07.052; Butler LM, 2015, MOL CANCER RES, V13, P1445, DOI 10.1158/1541-7786.MCR-15-0234; Calderwood SK, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/217513; Casale E, 2014, BIOORGAN MED CHEM, V22, P4135, DOI 10.1016/j.bmc.2014.05.056; Cha JY, 2013, PLANT PHYSIOL BIOCH, V70, P368, DOI 10.1016/j.plaphy.2013.05.039; Chadli A, 1999, J BIOL CHEM, V274, P4133, DOI 10.1074/jbc.274.7.4133; Chang HCJ, 1997, MOL CELL BIOL, V17, P318, DOI 10.1128/MCB.17.1.318; CHANG HCJ, 1994, J BIOL CHEM, V269, P24983; Chatterjee S, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091978; Chiosis G, 2001, CHEM BIOL, V8, P289, DOI 10.1016/S1074-5521(01)00015-1; Corben AD, 2014, JOVE-J VIS EXP, DOI 10.3791/52157; CSERMELY P, 1993, J BIOL CHEM, V268, P1901; Cusack KP, 2015, BIOORG MED CHEM LETT, V25, P2019, DOI 10.1016/j.bmcl.2015.02.027; DAHMER MK, 1984, ANNU REV PHYSIOL, V46, P67; Darby JF, 2011, NATURE, V478, P334, DOI 10.1038/478334b; Davies NGM, 2012, BIOORGAN MED CHEM, V20, P6770, DOI 10.1016/j.bmc.2012.08.050; de Witte WEA, 2016, TRENDS PHARMACOL SCI, V37, P831, DOI 10.1016/j.tips.2016.06.008; Dey B, 1996, MOL BIOL CELL, V7, P91, DOI 10.1091/mbc.7.1.91; Dollins DE, 2005, J BIOL CHEM, V280, P30438, DOI 10.1074/jbc.M503761200; Echeverria PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026044; Echtenkamp FJ, 2012, BBA-MOL CELL RES, V1823, P668, DOI 10.1016/j.bbamcr.2011.08.011; Ernst JT, 2014, J MED CHEM, V57, P3382, DOI 10.1021/jm500042s; Esfahani AH, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1005890; Ferraro M, 2019, J MED CHEM, V62, P60, DOI 10.1021/acs.jmedchem.8b00825; Finka A, 2013, CELL STRESS CHAPERON, V18, P591, DOI 10.1007/s12192-013-0413-3; Finka A, 2011, CELL STRESS CHAPERON, V16, P15, DOI 10.1007/s12192-010-0216-8; Folmer RHA, 2018, DRUG DISCOV TODAY, V23, P12, DOI 10.1016/j.drudis.2017.07.016; FREIDEN PJ, 1992, EMBO J, V11, P63, DOI 10.1002/j.1460-2075.1992.tb05028.x; Gewirth DT, 2016, CURR TOP MED CHEM, V16, P2779, DOI 10.2174/1568026616666160413141154; Goeckeler JL, 2002, MOL BIOL CELL, V13, P2760, DOI 10.1091/mbc.02-04-0051; Goldstein RL, 2015, J CLIN INVEST, V125, P4559, DOI 10.1172/JCI80714; Hatayama T, 1998, BIOCHEM BIOPH RES CO, V248, P395, DOI 10.1006/bbrc.1998.8979; He HZ, 2006, J MED CHEM, V49, P381, DOI 10.1021/jm0508078; Hiller S, 2018, J MAGN RESON, V289, P142, DOI 10.1016/j.jmr.2017.12.008; Horwich AL, 2013, J BIOL CHEM, V288, P23622, DOI 10.1074/jbc.X113.497321; Hothersall JD, 2016, DRUG DISCOV TODAY, V21, P90, DOI 10.1016/j.drudis.2015.07.015; HUTCHISON KA, 1992, J BIOL CHEM, V267, P13952; Huth JR, 2007, CHEM BIOL DRUG DES, V70, P1, DOI 10.1111/j.1747-0285.2007.00535.x; Immormino RM, 2006, J MED CHEM, V49, P4953, DOI 10.1021/jm060297x; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Joshi S, 2018, NAT REV CANCER, V18, P562, DOI 10.1038/s41568-018-0020-9; Kakihara Y, 2012, BBA-MOL CELL RES, V1823, P101, DOI 10.1016/j.bbamcr.2011.08.016; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kanamaru C, 2014, J TOXICOL SCI, V39, P59, DOI 10.2131/jts.39.59; Kang YL, 2014, J MED CHEM, V57, P1188, DOI 10.1021/jm401551n; Khandelwal A, 2016, MED RES REV, V36, P92, DOI 10.1002/med.21351; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Kishinevsky S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06486-6; Kitson RRA, 2013, NAT CHEM, V5, P307, DOI [10.1038/NCHEM.1596, 10.1038/nchem.1596]; Koldewey P, 2017, J BIOL CHEM, V292, P12010, DOI 10.1074/jbc.R117.796862; Kourtis N, 2018, NAT MED, V24, P1157, DOI 10.1038/s41591-018-0105-8; Krukenberg KA, 2011, Q REV BIOPHYS, V44, P229, DOI 10.1017/S0033583510000314; Kucine N, 2015, BLOOD, V126, P2479, DOI 10.1182/blood-2015-03-635821; Kumar S, 2016, CANCER LETT, V374, P156, DOI 10.1016/j.canlet.2016.01.056; Kuznetsov G, 1996, P NATL ACAD SCI USA, V93, P8584, DOI 10.1073/pnas.93.16.8584; Lackie RE, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00254; Lee JR, 2009, P NATL ACAD SCI USA, V106, P5978, DOI 10.1073/pnas.0811231106; Lee SS, 2015, INT J MOL SCI, V16, P27302, DOI 10.3390/ijms161126019; Lepvrier E, 2015, ANAL CHEM, V87, P7043, DOI 10.1021/acs.analchem.5b00051; Li J, 2012, BBA-MOL CELL RES, V1823, P624, DOI 10.1016/j.bbamcr.2011.09.003; Li XK, 2016, CURR TOP MED CHEM, V16, P2729, DOI 10.2174/1568026616666160413140911; Li Z, 2013, NAT STRUCT MOL BIOL, V20, P929, DOI 10.1038/nsmb.2608; Lindberg I, 2015, J NEUROSCI, V35, P13853, DOI 10.1523/JNEUROSCI.2600-15.2015; Liu XD, 1999, J BIOL CHEM, V274, P26654, DOI 10.1074/jbc.274.38.26654; McBride CM, 2014, J MED CHEM, V57, P9124, DOI 10.1021/jm501107q; Miller SBM, 2015, J MOL BIOL, V427, P1564, DOI 10.1016/j.jmb.2015.02.006; Miyata Y, 2013, CURR PHARM DESIGN, V19, P347, DOI 10.2174/138161213804143725; Mollapour M, 2012, BBA-MOL CELL RES, V1823, P648, DOI 10.1016/j.bbamcr.2011.07.018; Moulick K, 2011, NAT CHEM BIOL, V7, P818, DOI 10.1038/nchembio.670; Murray CW, 2010, J MED CHEM, V53, P5942, DOI 10.1021/jm100059d; Nayar U, 2013, BLOOD, V122, P2837, DOI 10.1182/blood-2013-01-479972; Nemoto T, 1998, BIOCHEM J, V330, P989, DOI 10.1042/bj3300989; Nemoto TK, 2001, BIOCHEM J, V354, P663, DOI 10.1042/0264-6021:3540663; Obermann WMJ, 1998, J CELL BIOL, V143, P901, DOI 10.1083/jcb.143.4.901; Ojala PM, 2013, BLOOD, V122, P2767, DOI 10.1182/blood-2013-08-522425; Padhan N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01516-7; Palotai R, 2008, IUBMB LIFE, V60, P10, DOI 10.1002/iub.8; Patel HJ, 2015, J MED CHEM, V58, P3922, DOI 10.1021/acs.jmedchem.5b00197; Patel HJ, 2011, EXPERT OPIN DRUG DIS, V6, P559, DOI 10.1517/17460441.2011.563296; Patel PD, 2013, NAT CHEM BIOL, V9, P677, DOI [10.1038/NCHEMBIO.1335, 10.1038/nchembio.1335]; Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007; Proisy N, 2006, CHEM BIOL, V13, P1203, DOI 10.1016/j.chembiol.2006.09.015; Radons J., 2016, BR J MED MED RES, V14, P1, DOI [10.9734/BJMMR/2016/24631, DOI 10.9734/BJMMR/2016/24631]; Rizzolo K, 2019, J BIOL CHEM, V294, P2142, DOI 10.1074/jbc.TM118.002805; Rodina A, 2016, NATURE, V538, P397, DOI 10.1038/nature19807; Rodina A, 2014, ACS CHEM BIOL, V9, P1698, DOI 10.1021/cb500256u; Rodina A, 2013, CHEM BIOL, V20, P1469, DOI 10.1016/j.chembiol.2013.10.008; Roughley SD, 2011, J MED CHEM, V54, P3989, DOI 10.1021/jm200350g; Sarah Kishinevsky AC, 2013, J ALZHEMERS DIS S10, ps10, DOI DOI 10.4172/2161-0460.S10-007; Schopf FH, 2017, NAT REV MOL CELL BIO, V18, P345, DOI 10.1038/nrm.2017.20; Shaner L, 2007, CELL STRESS CHAPERON, V12, P1, DOI 10.1379/CSC-245R.1; Shrestha L, 2016, CURR TOP MED CHEM, V16, P2753, DOI 10.2174/1568026616666160413141911; Shrestha L, 2016, CELL CHEM BIOL, V23, P158, DOI 10.1016/j.chembiol.2015.12.006; Sontag EM, 2017, ANNU REV BIOCHEM, V86, P97, DOI 10.1146/annurev-biochem-060815-014616; Speranza G, 2018, INVEST NEW DRUG, V36, P230, DOI 10.1007/s10637-017-0495-3; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Suda A, 2012, BIOORG MED CHEM LETT, V22, P1136, DOI 10.1016/j.bmcl.2011.11.100; Taipale M, 2014, CELL, V158, P434, DOI 10.1016/j.cell.2014.05.039; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Taldone T, 2016, J LABELLED COMPD RAD, V59, P129, DOI 10.1002/jlcr.3369; Taldone T, 2014, TRENDS PHARMACOL SCI, V35, P48, DOI 10.1016/j.tips.2014.09.001; Taldone T, 2014, J MED CHEM, V57, P1208, DOI 10.1021/jm401552y; Taldone T, 2013, J MED CHEM, V56, P6803, DOI 10.1021/jm400619b; Taldone T, 2013, BEILSTEIN J ORG CHEM, V9, P544, DOI 10.3762/bjoc.9.60; Taldone T, 2013, HETEROCYCLES, V87, P91, DOI 10.3987/COM-12-12613; Taldone T, 2011, BIOORG MED CHEM LETT, V21, P5347, DOI 10.1016/j.bmcl.2011.07.026; Taldone T, 2011, BIOORGAN MED CHEM, V19, P2603, DOI 10.1016/j.bmc.2011.03.013; Tautermann CS, 2016, CURR OPIN PHARMACOL, V30, P22, DOI 10.1016/j.coph.2016.07.004; Thompson AD, 2012, CELL STRESS CHAPERON, V17, P313, DOI 10.1007/s12192-011-0307-1; Tonge PJ, 2018, ACS CHEM NEUROSCI, V9, P29, DOI 10.1021/acschemneuro.7b00185; Vallee F, 2011, J MED CHEM, V54, P7206, DOI 10.1021/jm200784m; Vilenchik M, 2004, CHEM BIOL, V11, P787, DOI 10.1016/j.chembiol.2004.04.008; Wallace EWJ, 2015, CELL, V162, P1286, DOI 10.1016/j.cell.2015.08.041; Wang T, 2014, J MED CHEM, V57, P2524, DOI 10.1021/jm401801t; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Weidenauer L, 2017, EXPERT REV PROTEOMIC, V14, P1105, DOI 10.1080/14789450.2017.1389649; Woodford MR, 2016, ADV CANCER RES, V129, P31, DOI 10.1016/bs.acr.2015.09.002; Wright L, 2004, CHEM BIOL, V11, P775, DOI 10.1016/j.chembiol.2004.03.033; Wu ZX, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.016675; Yonehara M, 1996, J BIOL CHEM, V271, P2641, DOI 10.1074/jbc.271.5.2641; Zhao RM, 2007, ADV EXP MED BIOL, V594, P27; Zhou D, 2013, TOXICOL APPL PHARM, V273, P401, DOI 10.1016/j.taap.2013.09.018; Zong HL, 2015, CELL REP, V13, P2159, DOI 10.1016/j.celrep.2015.10.073; Zuehlke AD, 2018, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0527	139	27	28	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2019	294	6					2162	2179		10.1074/jbc.REV118.002811	http://dx.doi.org/10.1074/jbc.REV118.002811			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM8EO	30409908	hybrid, Green Published			2022-12-28	WOS:000459711400034
J	Mnatsakanyan, N; Li, YX; Weber, J				Mnatsakanyan, Nelli; Li, Yunxiang; Weber, Joachim			Identification of two segments of the gamma subunit of ATP synthase responsible for the different affinities of the catalytic nucleotide-binding sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP synthase; enzyme mechanism; ATPase; bioenergetics; enzyme catalysis; ligand-binding protein; conformational change; oxidative phosphorylation; proton translocation	ESCHERICHIA-COLI; BETA-SUBUNIT; ROTATIONAL CATALYSIS; TORQUE TRANSMISSION; DELSEED LOOP; CATCH-LOOP; F-1-ATPASE; MECHANISM; F1-ATPASE; COMPLEX	ATP synthase uses a rotary mechanism to couple transmembrane proton translocation to ATP synthesis and hydrolysis, which occur at the catalytic sites in the beta subunits. In the presence of Mg2+, the three catalytic sites of ATP synthase have vastly different affinities for nucleotides, and the position of the central gamma subunit determines which site has high, medium, or low affinity. Affinity differences and their changes as rotation progresses underpin the ATP synthase catalytic mechanism. Here, we used a series of variants with up to 45- and 60-residue-long truncations of the N- and C-terminal helices of the gamma subunit, respectively, to identify the segment(s) responsible for the affinity differences of the catalytic sites. We found that each helix carries an affinity-determining segment of similar to 10 residues. Our findings suggest that the affinity regulation by these segments is transmitted to the catalytic sites by the DELSEED loop in the C-terminal domain of the beta subunits. For the N-terminal truncation variants, presence of the affinity-determining segment and therefore emergence of a high-affinity binding site resulted in WT-like catalytic activity. At the C terminus, additional residues outside of the affinity-determining segment were required for optimal enzymatic activity. Alanine substitutions revealed that the affinity changes of the catalytic sites required no specific interactions between amino acid side chains in the gamma and alpha(3)beta(3) subunits but were caused by the presence of the helices themselves. Our findings help unravel the molecular basis for the affinity changes of the catalytic sites during ATP synthase rotation.	[Weber, Joachim] Texas Tech Univ, Dept Chem & Biochem, Box 41061, Lubbock, TX 79409 USA; Texas Tech Univ, Hlth Sci Ctr, Ctr Membrane Prot Res, Lubbock, TX 79430 USA; [Mnatsakanyan, Nelli] Yale Univ, Sch Med, Dept Internal Med, 333 Cedar St, New Haven, CT 06520 USA; [Li, Yunxiang] Texas Womans Univ, Dept Chem & Biochem, Denton, TX 76204 USA	Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Yale University; Texas Womans University	Weber, J (corresponding author), Texas Tech Univ, Dept Chem & Biochem, Box 41061, Lubbock, TX 79409 USA.	joachim.weber@ttu.edu		Li, Yunxiang/0000-0001-8035-4690	National Institutes of Health [GM071462]; American Recovery and Reinvestment Act Administrative Supplement	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Recovery and Reinvestment Act Administrative Supplement	Part of this work was supported by National Institutes of Health Grant GM071462 (including American Recovery and Reinvestment Act Administrative Supplement) (to J. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adachi K, 2003, METHOD ENZYMOL, V361, P211; Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; Boltz KW, 2006, BIOCHEMISTRY-US, V45, P11190, DOI 10.1021/bi052592+; Boltz KW, 2005, BIOCHEMISTRY-US, V44, P9497, DOI 10.1021/bi050070o; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cingolani G, 2011, NAT STRUCT MOL BIOL, V18, P701, DOI 10.1038/nsmb.2058; Furuike S, 2008, SCIENCE, V319, P955, DOI 10.1126/science.1151343; Gao YQ, 2005, CELL, V123, P195, DOI 10.1016/j.cell.2005.10.001; Gibbons C, 2000, NAT STRUCT BIOL, V7, P1055; Greene MD, 2003, J BIOL CHEM, V278, P51594, DOI 10.1074/jbc.M309948200; Hara KY, 2000, J BIOL CHEM, V275, P14260, DOI 10.1074/jbc.275.19.14260; Hossain MD, 2008, BIOPHYS J, V95, P4837, DOI 10.1529/biophysj.108.140061; Hossain MD, 2006, BIOPHYS J, V90, P4195, DOI 10.1529/biophysj.105.079087; IWAMOTO A, 1990, J BIOL CHEM, V265, P5043; Junge W, 2015, ANNU REV BIOCHEM, V84, P631, DOI 10.1146/annurev-biochem-060614-034124; Kaibara C, 1996, J BIOL CHEM, V271, P2433, DOI 10.1074/jbc.271.5.2433; Kohori A, 2011, BIOPHYS J, V101, P188, DOI 10.1016/j.bpj.2011.05.008; LUMB KJ, 1994, BIOCHEMISTRY-US, V33, P7361, DOI 10.1021/bi00189a042; Mao HZ, 2007, P NATL ACAD SCI USA, V104, P18478, DOI 10.1073/pnas.0709322104; MATSUI T, 1995, BBA-BIOENERGETICS, V1231, P139, DOI 10.1016/0005-2728(95)00070-Y; MIWA K, 1989, P NATL ACAD SCI USA, V86, P6484, DOI 10.1073/pnas.86.17.6484; Mnatsakanyan N, 2011, J BIOL CHEM, V286, P29788, DOI 10.1074/jbc.M111.254730; Mnatsakanyan N, 2009, J BIOL CHEM, V284, P26519, DOI 10.1074/jbc.M109.030528; Mnatsakanyan N, 2009, J BIOL CHEM, V284, P11336, DOI 10.1074/jbc.M900374200; Nakamoto RK, 2008, ARCH BIOCHEM BIOPHYS, V476, P43, DOI 10.1016/j.abb.2008.05.004; Nakanishi-Matsui M, 2016, BBA-BIOENERGETICS, V1857, P129, DOI 10.1016/j.bbabio.2015.11.005; Nishizaka T, 2004, NAT STRUCT MOL BIOL, V11, P142, DOI 10.1038/nsmb721; Pu JZ, 2008, P NATL ACAD SCI USA, V105, P1192, DOI 10.1073/pnas.0708746105; Ren HM, 2006, BIOCHEMISTRY-US, V45, P6222, DOI 10.1021/bi060232w; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Scanlon JAB, 2008, J BIOL CHEM, V283, P26228, DOI 10.1074/jbc.M804858200; Scanlon JAB, 2007, BIOCHEMISTRY-US, V46, P8785, DOI 10.1021/bi700610m; Shimabukuro K, 2003, P NATL ACAD SCI USA, V100, P14731, DOI 10.1073/pnas.2434983100; Shirakihara Y, 1997, STRUCTURE, V5, P825, DOI 10.1016/S0969-2126(97)00236-0; STEFFENS K, 1987, J BIOL CHEM, V262, P6334; Tanigawara M, 2012, BIOPHYS J, V103, P970, DOI 10.1016/j.bpj.2012.06.054; TAUSSKY HH, 1953, J BIOL CHEM, V202, P675; Uchihashi T, 2011, SCIENCE, V333, P755, DOI 10.1126/science.1205510; von Ballmoos C, 2009, ANNU REV BIOCHEM, V78, P649, DOI 10.1146/annurev.biochem.78.081307.104803; Watanabe R, 2015, BIOPHYS J, V108, P1144, DOI 10.1016/j.bpj.2015.01.017; Watanabe R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4486; Watanabe R, 2013, FEBS LETT, V587, P1030, DOI 10.1016/j.febslet.2013.01.063; Watanabe R, 2010, NAT CHEM BIOL, V6, P814, DOI 10.1038/NCHEMBIO.443; Weber J, 2004, METHOD ENZYMOL, V380, P132; Weber J, 2003, FEBS LETT, V545, P61, DOI 10.1016/S0014-5793(03)00394-6; WEBER J, 1993, J BIOL CHEM, V268, P20126; Weber J, 2010, NAT CHEM BIOL, V6, P794, DOI 10.1038/nchembio.458; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513	49	4	4	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1152	1160		10.1074/jbc.RA118.002504	http://dx.doi.org/10.1074/jbc.RA118.002504			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30510135	Green Published, hybrid			2022-12-28	WOS:000457879500008
J	Yang, YZ; Ma, FG; Liu, ZS; Su, Q; Liu, YX; Liu, ZX; Li, Y				Yang, Yunzhi; Ma, Fengguang; Liu, Zhengshuai; Su, Qian; Liu, Yuxiao; Liu, Zhixue; Li, Yu			The ER-localized Ca2+-binding protein calreticulin couples ER stress to autophagy by associating with microtubule-associated protein 1A/1B light chain 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum stress (ER stress); autophagy; unfolded protein response (UPR); chaperone; proteostasis; protein misfolding; calreticulin; LC3; LC3-interacting region (LIR motif)	ENDOPLASMIC-RETICULUM STRESS; ATTENUATES HEPATIC STEATOSIS; STRUCTURAL BASIS; MICE; PROTEOSTASIS; DEGRADATION; RECOGNITION; SENSITIVITY; ACTIVATION; EXPRESSION	Autophagy is of key importance for eliminating aggregated proteins during the maintenance of cellular proteostasis in response to endoplasmic reticulum (ER) stress. However, the upstream signaling that mediates autophagy activation in response to ER stress is incompletely understood. In this study, in vivo and in vitro approaches were utilized that include gain- and loss-of-function assays and mouse livers and human cell lines with tunicamycin-induced pharmacological ER stress. We report that calreticulin, a quality control chaperone that binds to misfolded glycoproteins for refolding in the ER, is induced under ER stress. Calreticulin overexpression stimulated the formation of autophagosomes and increased autophagic flux. Interestingly, calreticulin was sufficient for attenuating ER stress in tunicamycin- or thapsigargin-treated HeLa cells, whereas lentivirus-mediated shRNA calreticulin knockdown exacerbated ER stress. Mechanistically, we noted that calreticulin induces autophagy by interacting with microtubule-associated protein 1A/1B-light chain 3 (LC3). Confocal microscopy revealed that the colocalization of calreticulin and LC3 at the autophagosome was enhanced under ER stress conditions. Importantly, a conserved LC3-interacting region was necessary for calreticulin-mediated stimulation of autophagy and for reducing ER stress. These findings indicate a calreticulin-based mechanism that couples ER stress to autophagy activation, which, in turn, attenuates cellular stress, likely by alleviating the formation of aberrantly folded proteins. Pharmacological or genetic approaches that activate calreticulin-autophagy signaling may have potential for managing ER stress and related cellular disorders.	[Yang, Yunzhi; Ma, Fengguang; Liu, Zhengshuai; Su, Qian; Liu, Yuxiao; Liu, Zhixue; Li, Yu] Univ Chinese Acad Sci, Chinese Acad Sci, CAS Key Lab Nutr Metab & Food Safety, Shanghai Inst Nutr & Hlth,Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Nutrition & Health, CAS; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS	Li, Y (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Nutr & Hlth, 320 Yue Yang Rd,Life Sci Res Bldg A1816, Shanghai 200031, Peoples R China.	liyu@sibs.ac.cn		Li, Yu/0000-0001-6910-5933; yang, yunzhi/0000-0002-3320-1533	National Key R&D Program of China [2017YFC0909601]; National Natural Science Foundation of China [31471129, 31671224]; Chinese Academy of Sciences [ZDBS-SSW-DQC-02]; K. C. Wong Education Foundation	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); K. C. Wong Education Foundation	This work was supported by National Key R&D Program of China Grant 2017YFC0909601, National Natural Science Foundation of China Grants 31471129 and 31671224, Chinese Academy of Sciences Grant ZDBS-SSW-DQC-02, and the K. C. Wong Education Foundation (to Y. Li) The authors declare that they have no conflicts of interest with the contents of this article.	Birgisdottir AB, 2013, J CELL SCI, V126, P3237, DOI 10.1242/jcs.126128; Burton LJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164115; Chakrabarti A, 2011, BIOTECHNOL BIOENG, V108, P2777, DOI 10.1002/bit.23282; Chen XQ, 2016, DIABETES, V65, P1904, DOI 10.2337/db15-1637; Cnop M, 2012, TRENDS MOL MED, V18, P59, DOI 10.1016/j.molmed.2011.07.010; Fu SN, 2012, CELL METAB, V15, P623, DOI 10.1016/j.cmet.2012.03.007; Fujita E, 2007, HUM MOL GENET, V16, P618, DOI 10.1093/hmg/ddm002; Gelebart P, 2005, INT J BIOCHEM CELL B, V37, P260, DOI 10.1016/j.biocel.2004.02.030; Gong Q, 2016, HEPATOLOGY, V64, P425, DOI 10.1002/hep.28523; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hetz C, 2013, NAT REV DRUG DISCOV, V12, P703, DOI 10.1038/nrd3976; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hetz C, 2011, PHYSIOL REV, V91, P1219, DOI 10.1152/physrev.00001.2011; Hoyer-Hansen M, 2007, CELL DEATH DIFFER, V14, P1576, DOI 10.1038/sj.cdd.4402200; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Huang R, 2015, MOL CELL, V57, P456, DOI 10.1016/j.molcel.2014.12.013; Hung SY, 2015, NEUROPHARMACOLOGY, V93, P243, DOI 10.1016/j.neuropharm.2015.02.003; Kaufman RJ, 2002, NAT REV MOL CELL BIO, V3, P411, DOI 10.1038/nrm829; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984; Kozlov G, 2010, J BIOL CHEM, V285, P38612, DOI 10.1074/jbc.M110.168294; Labbadia J, 2015, ANNU REV BIOCHEM, V84, P435, DOI 10.1146/annurev-biochem-060614-033955; Lange PS, 2008, J EXP MED, V205, P1227, DOI 10.1084/jem.20071460; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li HY, 2016, AUTOPHAGY, V12, P1472, DOI 10.1080/15548627.2016.1190071; Li Y, 2014, GASTROENTEROLOGY, V146, P539, DOI 10.1053/j.gastro.2013.10.059; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Li Y, 2011, FASEB J, V25, P1664, DOI 10.1096/fj.10-173492; Lo S, 2013, ANN SURG, V257, P352, DOI 10.1097/SLA.0b013e318269d0e2; Lu KF, 2014, CELL, V158, P549, DOI 10.1016/j.cell.2014.05.048; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Morris S, 2011, J IMMUNOL, V187, P3953, DOI 10.4049/jimmunol.1100524; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Pei JJ, 2016, AUTOPHAGY, V12, P1738, DOI 10.1080/15548627.2016.1196318; Peng M, 2017, NATURE, V543, P433, DOI 10.1038/nature21378; Peng WX, 2015, EXP THER MED, V9, P1271, DOI 10.3892/etm.2015.2266; Pyo JO, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3300; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkevich LA, 2011, CURR OPIN CELL BIOL, V23, P157, DOI 10.1016/j.ceb.2010.10.011; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Salvado L, 2015, TRENDS ENDOCRIN MET, V26, P438, DOI 10.1016/j.tem.2015.05.007; Schardt JA, 2010, J CELL MOL MED, V14, P1509, DOI 10.1111/j.1582-4934.2009.00870.x; Scheper W, 2011, AUTOPHAGY, V7, P910, DOI 10.4161/auto.7.8.15761; Senft D, 2015, TRENDS BIOCHEM SCI, V40, P141, DOI 10.1016/j.tibs.2015.01.002; Sun YX, 2018, BRIT J PHARMACOL, V175, P374, DOI 10.1111/bph.14079; Suzuki H, 2014, STRUCTURE, V22, P47, DOI 10.1016/j.str.2013.09.023; Tang DL, 2010, J CELL BIOL, V190, P881, DOI 10.1083/jcb.200911078; Tanida I, 2004, J BIOL CHEM, V279, P36268, DOI 10.1074/jbc.M401461200; Wang SK, 2014, EMBO REP, V15, P1053, DOI 10.15252/embr.201338343; Wild P, 2014, J CELL SCI, V127, P3, DOI 10.1242/jcs.140426; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yamamoto K, 2010, MOL BIOL CELL, V21, P2975, DOI 10.1091/mbc.E09-02-0133; Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200; Zhang FF, 2018, HEPATOLOGY, V68, P1361, DOI 10.1002/hep.29926; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	58	32	35	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2019	294	3					772	782		10.1074/jbc.RA118.005166	http://dx.doi.org/10.1074/jbc.RA118.005166			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL4FC	30429217	Green Published, hybrid			2022-12-28	WOS:000458670200004
J	Zhao, GY; Cheng, YB; Gui, P; Cui, MY; Liu, W; Wang, WW; Wang, XY; Ali, M; Dou, Z; Niu, LW; Liu, HY; Anderson, L; Ruan, K; Hong, JJ; Yao, XB				Zhao, Gangyin; Cheng, Yubao; Gui, Ping; Cui, Meiying; Liu, Wei; Wang, Wenwen; Wang, Xueying; Ali, Mahboob; Dou, Zhen; Niu, Liwen; Liu, Haiyan; Anderson, Leonard; Ruan, Ke; Hong, Jingjun; Yao, Xuebiao			Dynamic acetylation of the kinetochore-associated protein HEC1 ensures accurate microtubule-kinetochore attachment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitosis; microtubule; kinetochore; protein acylation; mitotic spindle; chromosomal segregation; HEC1; NDC80 complex; NUF2; TIP60; spindle assembly	NDC80 COMPLEX; AURORA-B; SKA COMPLEX; KINASE; BINDING; PHOSPHORYLATION; MPS1; ACTIVATION; IDENTIFICATION; ARCHITECTURE	Faithful chromosome segregation during mitosis is critical for maintaining genome integrity in cell progeny and relies on accurate and robust kinetochore-microtubule attachments. The NDC80 complex, a tetramer comprising kinetochore protein HEC1 (HEC1), NDC80 kinetochore complex component NUF2 (NUF2), NDC80 kinetochore complex component SPC24 (SPC24), and SPC25, plays a critical role in kinetochore-microtubule attachment. Mounting evidence indicates that phosphorylation of HEC1 is important for regulating the binding of the NDC80 complex to microtubules. However, it remains unclear whether other post-translational modifications, such as acetylation, regulate NDC80-microtubule attachment during mitosis. Here, using pulldown assays with HeLa cell lysates and site-directed mutagenesis, we show that HEC1 is a bona fide substrate of the lysine acetyltransferase Tat-interacting protein, 60 kDa (TIP60) and that TIP60-mediated acetylation of HEC1 is essential for accurate chromosome segregation in mitosis. We demonstrate that TIP60 regulates the dynamic interactions between NDC80 and spindle microtubules during mitosis and observed that TIP60 acetylates HEC1 at two evolutionarily conserved residues, Lys-53 and Lys-59. Importantly, this acetylation weakened the phosphorylation of the N-terminal HEC1(1-80) region at Ser-55 and Ser-62, which is governed by Aurora B and regulates NDC80-microtubule dynamics, indicating functional cross-talk between these two post-translation modifications of HEC1. Moreover, the TIP60-mediated acetylation was specifically reversed by sirtuin 1 (SIRT1). Taken together, our results define a conserved signaling hierarchy, involving HEC1, TIP60, Aurora B, and SIRT1, that integrates dynamic HEC1 acetylation and phosphorylation for accurate kinetochore-microtubule attachment in the maintenance of genomic stability during mitosis.	[Zhao, Gangyin; Cheng, Yubao; Gui, Ping; Cui, Meiying; Liu, Wei; Wang, Wenwen; Wang, Xueying; Ali, Mahboob; Dou, Zhen; Niu, Liwen; Liu, Haiyan; Ruan, Ke; Hong, Jingjun; Yao, Xuebiao] Univ Sci & Technol China, Chinese Acad Sci, Hefei Natl Sci Ctr Phys Sci Microscale, Sch Life Sci,Ctr Excellence Mol Cell Sci,Div Mol, Hefei 230027, Anhui, Peoples R China; [Gui, Ping; Liu, Wei; Wang, Wenwen; Wang, Xueying; Dou, Zhen; Anderson, Leonard] Morehouse Sch Med, Keck Ctr Cellular Dynam & Organoids Plast, Atlanta, GA 30310 USA	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Morehouse School of Medicine	Hong, JJ; Yao, XB (corresponding author), Univ Sci & Technol China, Chinese Acad Sci, Hefei Natl Sci Ctr Phys Sci Microscale, Sch Life Sci,Ctr Excellence Mol Cell Sci,Div Mol, Hefei 230027, Anhui, Peoples R China.	jjhong@ustc.edu.cn; yaoxb@ustc.edu.cn	Hong, Jingjun/V-7281-2019; DOU, ZHEN/N-2022-2013; Ruan, Ke/N-1995-2013; Yao, Xuebiao/P-5771-2014; WANG, WENWEN/AAF-1080-2020	WANG, WENWEN/0000-0002-1545-4369; Zhao, Gangyin/0000-0003-2872-8143; Gui, Ping/0000-0003-2049-3001; Ruan, Ke/0000-0001-9358-0451; DOU, ZHEN/0000-0003-3303-9393; Cheng, Yubao/0000-0001-6967-1433	National Key Research and Development Program of China [2017YFA0503600, 2016YFA0100500]; Natural Science Foundation of China [31320103904, 31430054, 91313303, 31470792, 31621002, 31301120, 31671405, 31601097, B1661138004]; "Strategic Priority Research Program" of the Chinese Academy of Sciences [XDB19000000, XDB08030102]; 973 project [2012CB917204, 2014CB964803, 2002CB713703, 2012CB910304]; Chinese Academy of Sciences Center of Excellence in Molecular and Cell Sciences Grant [2015HSC-UE010]; MOE Innovative Team Grant [IRT_17R102]; National Institutes of Health [DK56292, DK115812, CA146133]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK115812] Funding Source: NIH RePORTER	National Key Research and Development Program of China; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "Strategic Priority Research Program" of the Chinese Academy of Sciences(Chinese Academy of Sciences); 973 project(National Basic Research Program of China); Chinese Academy of Sciences Center of Excellence in Molecular and Cell Sciences Grant; MOE Innovative Team Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Key Research and Development Program of China Grants 2017YFA0503600 and 2016YFA0100500; Natural Science Foundation of China Grants 31320103904, 31430054, 91313303, 31470792, 31621002, 31301120, 31671405, 31601097, and B1661138004; "Strategic Priority Research Program" of the Chinese Academy of Sciences Grants XDB19000000 and XDB08030102; 973 project Grants 2012CB917204, 2014CB964803, 2002CB713703, and 2012CB910304; Chinese Academy of Sciences Center of Excellence in Molecular and Cell Sciences Grant 2015HSC-UE010; MOE Innovative Team Grant IRT_17R102; and National Institutes of Health Grants DK56292, DK115812, and CA146133. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akram S, 2018, J MOL CELL BIOL, V10, P527, DOI 10.1093/jmcb/mjy040; Bao XL, 2018, J MOL CELL BIOL, V10, P18, DOI 10.1093/jmcb/mjx045; Bar-Even A, 2011, BIOCHEMISTRY-US, V50, P4402, DOI 10.1021/bi2002289; Bharadwaj R, 2004, J BIOL CHEM, V279, P13076, DOI 10.1074/jbc.M310224200; Black BE, 2010, COLD SH Q B, V75, P403, DOI 10.1101/sqb.2010.75.038; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Cheng Z, 2008, ONCOGENE, V27, P931, DOI 10.1038/sj.onc.1210710; Ciferri C, 2005, J BIOL CHEM, V280, P29088, DOI 10.1074/jbc.M504070200; Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020; Ciferri C, 2007, FEBS LETT, V581, P2862, DOI 10.1016/j.febslet.2007.05.012; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; DALZIEL K, 1962, NATURE, V196, P1203, DOI 10.1038/1961203b0; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; DeLuca KF, 2011, J CELL SCI, V124, P622, DOI 10.1242/jcs.072629; Dou Z, 2015, P NATL ACAD SCI USA, V112, pE4546, DOI 10.1073/pnas.1508791112; Du J, 2008, ONCOGENE, V27, P4107, DOI 10.1038/onc.2008.34; Emanuele MJ, 2008, J CELL BIOL, V181, P241, DOI 10.1083/jcb.200710019; Fang C, 2017, J MOL CELL BIOL, V9, P504, DOI 10.1093/jmcb/mjx043; Guimaraes GJ, 2008, CURR BIOL, V18, P1778, DOI 10.1016/j.cub.2008.08.012; Helgeson LA, 2018, P NATL ACAD SCI USA, V115, P2740, DOI 10.1073/pnas.1718553115; Hiruma Y, 2015, SCIENCE, V348, P1264, DOI 10.1126/science.aaa4055; Hua SS, 2011, J BIOL CHEM, V286, P1627, DOI 10.1074/jbc.M110.174946; Janke C, 2001, EMBO J, V20, P777, DOI 10.1093/emboj/20.4.777; Ji ZJ, 2015, SCIENCE, V348, P1260, DOI 10.1126/science.aaa4029; Jiang H, 2015, J BIOL CHEM, V290, P28272, DOI 10.1074/jbc.M115.668855; Kinoshita E, 2009, NAT PROTOC, V4, P1513, DOI 10.1038/nprot.2009.154; Liu D, 2016, J MOL CELL BIOL, V8, P144, DOI 10.1093/jmcb/mjv066; Long AF, 2017, CURR BIOL, V27, P1692, DOI 10.1016/j.cub.2017.04.058; Maure JF, 2011, CURR BIOL, V21, P207, DOI 10.1016/j.cub.2010.12.050; McCleland ML, 2004, CURR BIOL, V14, P131, DOI 10.1016/j.cub.2003.12.058; McCleland ML, 2003, GENE DEV, V17, P101, DOI 10.1101/gad.1040903; McKinley KL, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.5; Miller SA, 2008, CURR BIOL, V18, P1785, DOI 10.1016/j.cub.2008.11.007; Mo F, 2016, NAT CHEM BIOL, V12, P226, DOI [10.1038/NCHEMBIO.2017, 10.1038/nchembio.2017]; Murr R, 2006, NAT CELL BIOL, V8, P91, DOI 10.1038/ncb1343; Neumann H, 2008, NAT CHEM BIOL, V4, P232, DOI 10.1038/nchembio.73; Neumann H, 2009, MOL CELL, V36, P153, DOI 10.1016/j.molcel.2009.07.027; Patel H, 2016, J MOL CELL BIOL, V8, P338, DOI 10.1093/jmcb/mjw009; Petrovic A, 2010, J CELL BIOL, V190, P835, DOI 10.1083/jcb.201002070; Rack JGM, 2015, MOL CELL, V59, P309, DOI 10.1016/j.molcel.2015.06.013; Sun YL, 2009, NAT CELL BIOL, V11, P1376, DOI 10.1038/ncb1982; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Umbreit NT, 2012, P NATL ACAD SCI USA, V109, P16113, DOI 10.1073/pnas.1209615109; Wang HW, 2008, J MOL BIOL, V383, P894, DOI 10.1016/j.jmb.2008.08.077; Wei RR, 2007, NAT STRUCT MOL BIOL, V14, P54, DOI 10.1038/nsmb1186; Wei RR, 2005, P NATL ACAD SCI USA, V102, P5363, DOI 10.1073/pnas.0501168102; Wigge PA, 2001, J CELL BIOL, V152, P349, DOI 10.1083/jcb.152.2.349; Wu Q, 2009, J BIOL CHEM, V284, P8738, DOI 10.1074/jbc.M807590200; Xia P, 2012, P NATL ACAD SCI USA, V109, P16564, DOI 10.1073/pnas.1202639109; Yan MM, 2015, SCI REP-UK, V5, DOI 10.1038/srep10449; Yang Y, 2018, J MOL CELL BIOL, V10, P89, DOI 10.1093/jmcb/mjx048; Yu TT, 2017, J MOL CELL BIOL, V9, P144, DOI 10.1093/jmcb/mjw042; Zaytsev AV, 2015, MOL BIOL CELL, V26, P1829, DOI 10.1091/mbc.E14-11-1539; Zhang G, 2012, J CELL SCI, V125, P3243, DOI 10.1242/jcs.104208; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zheng L, 1999, MOL CELL BIOL, V19, P5417; Zhou RH, 2003, J BIOL CHEM, V278, P35651, DOI 10.1074/jbc.M303416200; Zhu TG, 2013, J BIOL CHEM, V288, P36149, DOI 10.1074/jbc.M113.507970	58	13	14	0	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2019	294	2					576	592		10.1074/jbc.RA118.003844	http://dx.doi.org/10.1074/jbc.RA118.003844			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HI2GP	30409912	Green Published, hybrid			2022-12-28	WOS:000456263600016
J	Setty, TG; Mowers, JC; Hobbs, AG; Maiya, SP; Syed, S; Munson, RS; Apicella, MA; Subramanian, R				Setty, Thanuja Gangi; Mowers, Jonathan C.; Hobbs, Aaron G.; Maiya, Shubha P.; Syed, Sanaa; Munson, Robert S., Jr.; Apicella, Michael A.; Subramanian, Ramaswamy			Molecular characterization of the interaction of sialic acid with the periplasmic binding protein from Haemophilus ducreyi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; isothermal titration calorimetry (ITC); ABC transporter; energetics; sugar transport; enthalpy; entropy; nutrient sequestration; sialic acid; virulence; Haemophilus ducreyi; periplasmic binding protein	CYTOLETHAL DISTENDING TOXIN; HUMAN FORESKIN FIBROBLASTS; ABC TRANSPORTER; INFLUENZAE; EVOLUTION; LIPOPOLYSACCHARIDE; IDENTIFICATION; CYTOTOXIN; HEMOLYSIN; SUBSTRATE	The primary role of bacterial periplasmic binding proteins is sequestration of essential metabolites present at a low concentration in the periplasm and making them available for active transporters that transfer these ligands into the bacterial cell. The periplasmic binding proteins (SiaPs) from the tripartite ATP-independent periplasmic (TRAP) transport system that transports mammalian host-derived sialic acids have been well studied from different pathogenic bacteria, including Haemophilus influenzae, Fusobacterium nucleatum, Pasteurella multocida, and Vibrio cholerae. SiaPs bind the sialic acid N-acetylneuraminic acid (Neu5Ac) with nanomolar affinity by forming electrostatic and hydrogen-bonding interactions. Here, we report the crystal structure of a periplasmic binding protein (SatA) of the ATP-binding cassette (ABC) transport system from the pathogenic bacterium Haemophilus ducreyi. The structure of Hd-SatA in the native form and sialic acid-bound forms (with Neu5Ac and N-glycolylneuraminic acid (Neu5Gc)), determined to 2.2, 1.5, and 2.5 resolutions, respectively, revealed a ligand-binding site that is very different from those of the SiaPs of the TRAP transport system. A structural comparison along with thermodynamic studies suggested that similar affinities are achieved in the two classes of proteins through distinct mechanisms, one enthalpically driven and the other entropically driven. In summary, our structural and thermodynamic characterization of Hd-SatA reveals that it binds sialic acids with nanomolar affinity and that this binding is an entropically driven process. This information is important for future structure-based drug design against this pathogen and related bacteria.	[Setty, Thanuja Gangi; Maiya, Shubha P.; Syed, Sanaa; Subramanian, Ramaswamy] Inst Stem Cell Biol & Regenerat Med, GKVK Post, Bangalore 560065, Karnataka, India; [Mowers, Jonathan C.; Hobbs, Aaron G.; Subramanian, Ramaswamy] Univ Iowa, Carver Coll Med, Dept Biochem, Iowa City, IA 52242 USA; [Apicella, Michael A.] Univ Iowa, Carver Coll Med, Dept Microbiol & Immunol, Iowa City, IA 52242 USA; [Munson, Robert S., Jr.] Ohio State Univ, Ctr Microbial Interface Biol, Columbus, OH 43210 USA; [Setty, Thanuja Gangi] Univ Trans Disciplinary Hlth Sci & Technol TDU, Bengaluru 560064, Karnataka, India	Department of Biotechnology (DBT) India; Institute for Stem Cell Biology & Regenerative Medicine - inStem; University of Iowa; University of Iowa; University System of Ohio; Ohio State University	Subramanian, R (corresponding author), Inst Stem Cell Biol & Regenerat Med, GKVK Post, Bangalore 560065, Karnataka, India.	ramas@instem.res.in	Subramanian, Ramaswamy/Q-8671-2019	Subramanian, Ramaswamy/0000-0002-6709-190X; Hobbs, Aaron/0000-0002-4751-9681	Department of Biotechnology Grant [BT/INF/22/SP22660/2017]; DBT [BT/PR5081/INF/156/2012]	Department of Biotechnology Grant; DBT(Department of Biotechnology (DBT) India)	We thank the ESRF Access Program of RCB (supported by Department of Biotechnology Grant BT/INF/22/SP22660/2017). We thank the Advance Photon Source (IMCA-CAT beamline 17-ID) and Advanced Light Source (beamline 4.2.2, MBC) for providing the beam time for this project. The NCBS X-ray Facility was supported by Grant BT/PR5081/INF/156/2012 from the DBT.	Alfa MJ, 1997, MICROB PATHOGENESIS, V22, P39, DOI 10.1006/mpat.1996.0089; Alfa MJ, 1996, INFECT IMMUN, V64, P2349, DOI 10.1128/IAI.64.6.2349-2352.1996; Almagro-Moreno S, 2009, INFECT IMMUN, V77, P3807, DOI 10.1128/IAI.00279-09; [Anonymous], 2011, MOL IMMUNOLOGY COMPL, DOI 10.1007/978-1-4419-7877-6_28; [Anonymous], 2018, PYMOL MOL GRAPHICS S; Apicella MA, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00019; Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; Ceelen LM, 2006, MICROBIOL RES, V161, P109, DOI 10.1016/j.micres.2005.04.002; Cohen MS, 1998, LANCET, V351, P5, DOI 10.1016/S0140-6736(98)90002-2; Cope LD, 1997, P NATL ACAD SCI USA, V94, P4056, DOI 10.1073/pnas.94.8.4056; Cortes-Bratti X, 1999, J CLIN INVEST, V103, P107, DOI 10.1172/JCI3831; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; De Las Rivas J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000807; Doublie S, 1996, FEBS LETT, V384, P219, DOI 10.1016/0014-5793(96)00316-X; Du X, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020144; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; DUNTEN P, 1995, PROTEIN SCI, V4, P2327, DOI 10.1002/pro.5560041110; El Sahili A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005071; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Felder CB, 1999, AAPS PHARMSCI, V1; Fukami-Kobayashi K, 1999, J MOL BIOL, V286, P279, DOI 10.1006/jmbi.1998.2454; Gibson BW, 1997, J BACTERIOL, V179, P5062, DOI 10.1128/jb.179.16.5062-5071.1997; Haines-Menges BL, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MBP-0005-2014; Hayakawa T, 2001, P NATL ACAD SCI USA, V98, P11399, DOI 10.1073/pnas.191268198; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; Hood DW, 1999, MOL MICROBIOL, V33, P679, DOI 10.1046/j.1365-2958.1999.01509.x; Hood DW, 2001, MOL MICROBIOL, V39, P341, DOI 10.1046/j.1365-2958.2001.02204.x; Houtman JCD, 2007, PROTEIN SCI, V16, P30, DOI 10.1110/ps.062558507; Inamadar Arun C, 2002, Indian J Dermatol Venereol Leprol, V68, P5; Johnston JW, 2008, J BIOL CHEM, V283, P855, DOI 10.1074/jbc.M706603200; Kuzmanov U, 2013, GENOME MED, V5, DOI 10.1186/gm441; Levdikov VM, 2005, J MOL BIOL, V345, P879, DOI 10.1016/j.jmb.2004.10.089; Liu TY, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002326; Maqbool A, 2015, BIOCHEM SOC T, V43, P1011, DOI 10.1042/BST20150135; Melaugh W, 1996, J BACTERIOL, V178, P564, DOI 10.1128/jb.178.2.564-570.1996; Muller A, 2006, J BIOL CHEM, V281, P22212, DOI 10.1074/jbc.M603463200; OH BH, 1993, J BIOL CHEM, V268, P11348; Oldham ML, 2008, CURR OPIN STRUC BIOL, V18, P726, DOI 10.1016/j.sbi.2008.09.007; Pawson T, 2000, GENE DEV, V14, P1027; Post DMB, 2005, INFECT IMMUN, V73, P6727, DOI 10.1128/IAI.73.10.6727-6735.2005; Saini R. D., 2017, J PROTEINS PROTEOMIC, V8, P205; Setty TG, 2014, ACTA CRYSTALLOGR D, V70, P1801, DOI 10.1107/S139900471400830X; Severi E, 2007, MICROBIOL-SGM, V153, P2817, DOI 10.1099/mic.0.2007/009480-0; Sevimoglu T, 2014, COMPUT STRUCT BIOTEC, V11, P22, DOI 10.1016/j.csbj.2014.08.008; Spinola SM, 2002, INFECT IMMUN, V70, P1667, DOI 10.1128/IAI.70.4.1667-1676.2002; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Thomas GH, 2016, BIOCHEM SOC T, V44, P760, DOI 10.1042/BST20160056; Thomson J, 1998, BIOPHYS CHEM, V70, P101, DOI 10.1016/S0301-4622(97)00113-0; Varki A, 2009, ESSENTIALS GLYCOBIOL, P1; Varki A, 2008, TRENDS MOL MED, V14, P351, DOI 10.1016/j.molmed.2008.06.002; Varki A, 2010, P NATL ACAD SCI USA, V107, P8939, DOI 10.1073/pnas.0914634107; Vergauwen B, 2010, P NATL ACAD SCI USA, V107, P13270, DOI 10.1073/pnas.1005198107; Vimr ER, 2004, MICROBIOL MOL BIOL R, V68, P132, DOI 10.1128/MMBR.68.1.132-153.2004; Wood GE, 1999, INFECT IMMUN, V67, P3740, DOI 10.1128/IAI.67.8.3740-3749.1999	54	4	4	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					20073	20084		10.1074/jbc.RA118.005151	http://dx.doi.org/10.1074/jbc.RA118.005151			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30315109	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000454685900017
J	Choveau, FS; De la Rosa, V; Bierbower, SM; Hernandez, CC; Shapiro, MS				Choveau, Frank S.; De la Rosa, Victor; Bierbower, Sonya M.; Hernandez, Ciria C.; Shapiro, Mark S.			Phosphatidylinositol 4,5-bisphosphate (PIP2) regulates KCNQ3 K+ channels by interacting with four cytoplasmic channel domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						potassium channel; phospholipid; structure-function; signal transduction; neuroscience; ion channel gating; ion channel modulation; KCNQ; lipid signaling; M current; PIP2	RECEPTOR-MEDIATED INHIBITION; GATED POTASSIUM CHANNELS; PROXIMAL C-TERMINUS; STRUCTURAL BASIS; VOLTAGE SENSOR; MUSCARINIC MODULATION; CRYSTAL-STRUCTURE; I-KS; SENSITIVITY; ACTIVATION	Phosphatidylinositol 4,5-bisphosphate (PIP2) in the plasma membrane regulates the function of many ion channels, including M-type (potassium voltage-gated channel subfamily Q member (KCNQ), K(v)7) K+ channels; however, the molecular mechanisms involved remain unclear. To this end, we here focused on the KCNQ3 subtype that has the highest apparent affinity for PIP2 and performed extensive mutagenesis in regions suggested to be involved in PIP2 interactions among the KCNQ family. Using perforated patch-clamp recordings of heterologously transfected tissue culture cells, total internal reflection fluorescence microscopy, and the zebrafish (Danio rerio) voltage-sensitive phosphatase to deplete PIP2 as a probe, we found that PIP2 regulates KCNQ3 channels through four different domains: 1) the A-B helix linker that we previously identified as important for both KCNQ2 and KCNQ3, 2) the junction between S6 and the A helix, 3) the S2-S3 linker, and 4) the S4-S5 linker. We also found that the apparent strength of PIP2 interactions within any of these domains was not coupled to the voltage dependence of channel activation. Extensive homology modeling and docking simulations with the WT or mutant KCNQ3 channels and PIP2 were consistent with the experimental data. Our results indicate that PIP2 modulates KCNQ3 channel function by interacting synergistically with a minimum of four cytoplasmic domains.	[Choveau, Frank S.; De la Rosa, Victor; Bierbower, Sonya M.; Shapiro, Mark S.] Univ Texas Hlth San Antonio, Dept Cell & Integrat Physiol, San Antonio, TX 78229 USA; [Hernandez, Ciria C.] Vanderbilt Univ, Med Ctr, Dept Neurol, Nashville, TN 37232 USA; [Hernandez, Ciria C.] Univ Michigan, Inst Life Sci, Rm 6115,210 Washtenaw Ave, Ann Arbor, MI 48109 USA; [Bierbower, Sonya M.] William Paterson Univ, Dept Biol, Coll Sci & Hlth, Wayne, NJ 07470 USA	University of Texas System; University of Texas Health San Antonio; Vanderbilt University; University of Michigan System; University of Michigan	Hernandez, CC (corresponding author), Univ Michigan, Inst Life Sci, Rm 6115,210 Washtenaw Ave, Ann Arbor, MI 48109 USA.; Shapiro, MS (corresponding author), Univ Texas Hlth San Antonio, Dept Cell & Integrat Physiol, South Texas Res Facil, MC 8253,8403 Floyd Curl Dr, San Antonio, TX 78229 USA.	ciria@umich.edu; shapirom@uthscsa.edu	De la Rosa, Victor/AAM-8583-2021; Choveau, Frank/AFI-6500-2022; Choveau, Frank/AAF-3858-2022	De la Rosa, Victor/0000-0001-5161-3083; 	National Institutes of Health [R01 NS150305, R01 NS094461, R56 NS153503]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS094461] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants R01 NS150305, R01 NS094461, and R56 NS153503 (to M. S. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abderemane-Ali F, 2012, J BIOL CHEM, V287, P36158, DOI 10.1074/jbc.M112.382085; Aivar P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047263; Axelrod D, 2003, METHOD ENZYMOL, V361, P1; Bender K, 2002, FEBS LETT, V529, P356, DOI 10.1016/S0014-5793(02)03426-9; Boyer Stephanie B, 2010, Commun Integr Biol, V3, P343; Chambard JM, 2005, PFLUG ARCH EUR J PHY, V450, P34, DOI 10.1007/s00424-004-1366-2; Chen XR, 2010, P NATL ACAD SCI USA, V107, P11352, DOI 10.1073/pnas.1000142107; Choveau FS, 2012, BIOPHYS J, V102, P2489, DOI 10.1016/j.bpj.2012.04.018; Choveau FS, 2011, J BIOL CHEM, V286, P707, DOI 10.1074/jbc.M110.146324; Cui JM, 2016, BIOPHYS J, V110, P14, DOI 10.1016/j.bpj.2015.11.023; Eckey K, 2014, J BIOL CHEM, V289, P22749, DOI 10.1074/jbc.M114.589796; Etxeberria A, 2004, J NEUROSCI, V24, P9146, DOI 10.1523/JNEUROSCI.3194-04.2004; Falkenburger BH, 2010, J GEN PHYSIOL, V135, P81, DOI 10.1085/jgp.200910344; Gamper N, 2005, MOL BIOL CELL, V16, P3538, DOI 10.1091/mbc.E04-09-0849; Gamper N, 2003, J GEN PHYSIOL, V122, P17, DOI 10.1085/jgp.200208783; Gamper N, 2007, NAT REV NEUROSCI, V8, P921, DOI 10.1038/nrn2257; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Hernandez CC, 2008, J GEN PHYSIOL, V132, P361, DOI 10.1085/jgp.200810007; Hernandez CC, 2009, J GEN PHYSIOL, V134, P437, DOI 10.1085/jgp.200910313; Hoshi N, 2003, NAT NEUROSCI, V6, P564, DOI 10.1038/nn1062; Hou PP, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01911-8; Itsuki K, 2012, CHANNELS, V6, P206, DOI 10.4161/chan.20883; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Kasimova MA, 2015, SCI REP-UK, V5, DOI 10.1038/srep07474; Khalili-Araghi F, 2010, BIOPHYS J, V98, P2189, DOI 10.1016/j.bpj.2010.02.056; Kosenko A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082290; Kruse M, 2012, J GEN PHYSIOL, V140, P189, DOI 10.1085/jgp.201210806; Labro AJ, 2011, J BIOL CHEM, V286, P717, DOI 10.1074/jbc.M110.146977; Li Y, 2005, J NEUROSCI, V25, P9825, DOI 10.1523/JNEUROSCI.2597-05.2005; Li Y, 2011, P NATL ACAD SCI USA, V108, P9095, DOI 10.1073/pnas.1100872108; Logothetis DE, 2007, PFLUG ARCH EUR J PHY, V455, P83, DOI 10.1007/s00424-007-0276-5; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Lopes CMB, 2005, J PHYSIOL-LONDON, V564, P117, DOI 10.1113/jphysiol.2004.081935; Loussouarn G, 2003, EMBO J, V22, P5412, DOI 10.1093/emboj/cdg526; Murata Y, 2007, J PHYSIOL-LONDON, V583, P875, DOI 10.1113/jphysiol.2007.134775; Nakajo K, 2005, J PHYSIOL-LONDON, V569, P59, DOI 10.1113/jphysiol.2005.094995; Park KH, 2005, CIRC RES, V96, P730, DOI 10.1161/01.RES.0000161451.04649.a8; Peroz D, 2008, J PHYSIOL-LONDON, V586, P1785, DOI 10.1113/jphysiol.2007.148254; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RAE J, 1991, J NEUROSCI METH, V37, P15, DOI 10.1016/0165-0270(91)90017-T; Rodriguez-Menchaca AA, 2012, P NATL ACAD SCI USA, V109, pE2399, DOI 10.1073/pnas.1207901109; Sachyani D, 2014, STRUCTURE, V22, P1582, DOI 10.1016/j.str.2014.07.016; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Schuler LD, 2001, J COMPUT CHEM, V22, P1205, DOI 10.1002/jcc.1078; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Selyanko AA, 1999, BIOPHYS J, V77, P701, DOI 10.1016/S0006-3495(99)76925-0; Shamgar L, 2006, CIRC RES, V98, P1055, DOI 10.1161/01.RES.0000218979.40770.69; Shapiro MS, 2000, J NEUROSCI, V20, P1710; Smith CA, 2008, J MOL BIOL, V380, P742, DOI 10.1016/j.jmb.2008.05.023; Suh BC, 2002, NEURON, V35, P507, DOI 10.1016/S0896-6273(02)00790-0; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; Sun J, 2017, CELL, V169, P1042, DOI 10.1016/j.cell.2017.05.019; Telezhkin V, 2013, PFLUG ARCH EUR J PHY, V465, P945, DOI 10.1007/s00424-012-1199-3; Telezhkin V, 2012, J BIOL CHEM, V287, P10001, DOI 10.1074/jbc.M111.322552; Thomas AM, 2011, J BIOL CHEM, V286, P2088, DOI 10.1074/jbc.M110.153551; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tobelaim WS, 2017, CHANNELS, V11, P686, DOI 10.1080/19336950.2017.1388478; Tobelaim WS, 2017, P NATL ACAD SCI USA, V114, pE869, DOI 10.1073/pnas.1612622114; Tombola F, 2005, NEURON, V48, P719, DOI 10.1016/j.neuron.2005.11.024; Whorton MR, 2011, CELL, V147, P199, DOI 10.1016/j.cell.2011.07.046; Winks JS, 2005, J NEUROSCI, V25, P3400, DOI 10.1523/JNEUROSCI.3231-04.2005; Yarov-Yarovoy V, 2006, P NATL ACAD SCI USA, V103, P7292, DOI 10.1073/pnas.0602350103; Zaika O, 2008, BIOPHYS J, V95, P5121, DOI 10.1529/biophysj.108.137604; Zaika O, 2007, J NEUROSCI, V27, P8914, DOI 10.1523/JNEUROSCI.1739-07.2007; Zaydman MA, 2014, ELIFE, V3, DOI 10.7554/eLife.03606; Zaydman MA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00195; Zaydman MA, 2013, P NATL ACAD SCI USA, V110, P13180, DOI 10.1073/pnas.1305167110; Zhang C, 1997, J MOL BIOL, V267, P707, DOI 10.1006/jmbi.1996.0859; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9; Zhang QS, 2013, P NATL ACAD SCI USA, V110, P20093, DOI 10.1073/pnas.1312483110; Zhou PZ, 2013, P NATL ACAD SCI USA, V110, P8726, DOI 10.1073/pnas.1302167110	73	24	24	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2018	293	50					19411	19428		10.1074/jbc.RA118.005401	http://dx.doi.org/10.1074/jbc.RA118.005401			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HE6RA	30348901	Green Published, hybrid			2022-12-28	WOS:000453537300022
J	El Jellas, K; Johansson, BB; Fjeld, K; Antonopoulos, A; Immervoll, H; Choi, MH; Hoem, D; Lowe, ME; Lombardo, D; Njolstad, PR; Dell, A; Mas, E; Haslam, SM; Molven, A				El Jellas, Khadija; Johansson, Bente B.; Fjeld, Karianne; Antonopoulos, Aristotelis; Immervoll, Heike; Choi, Man H.; Hoem, Dag; Lowe, Mark E.; Lombardo, Dominique; Njolstad, Pal R.; Dell, Anne; Mas, Eric; Haslam, Stuart M.; Molven, Anders			The mucinous domain of pancreatic carboxyl-ester lipase (CEL) contains core 1/core 2 O-glycans that can be modified by ABO blood group determinants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						pancreas; pancreatic cancer; glycomics; pathology; immunohistochemistry; lipase; glycoprotein; ABO blood group; carboxyl-ester lipase; O-glycans; Tn antigen; CEL; BSDL	SALT-STIMULATED LIPASE; N-LINKED OLIGOSACCHARIDES; GENOME-WIDE ASSOCIATION; ACTIVATED LIPASE; GENETIC-VARIANTS; SECRETOR STATUS; RISK-FACTORS; GLYCOSYLATION; PROTEIN; MILK	Carboxyl-ester lipase (CEL) is a pancreatic fat-digesting enzyme associated with human disease. Rare mutations in the CEL gene cause a syndrome of pancreatic exocrine and endocrine dysfunction denoted MODY8, whereas a recombined CEL allele increases the risk for chronic pancreatitis. Moreover, CEL has been linked to pancreatic ductal adenocarcinoma (PDAC) through a postulated oncofetal CEL variant termed feto-acinar pancreatic protein (FAPP). The monoclonal antibody mAb16D10 was previously reported to detect a glycotope in the highly O-glycosylated, mucin-like C terminus of CEL/FAPP. We here assessed the expression of human CEL in malignant pancreatic lesions and cell lines. CEL was not detectably expressed in neoplastic cells, implying that FAPP is unlikely to be a glycoisoform of CEL in pancreatic cancer. Testing of the mAb16D10 antibody in glycan microarrays then demonstrated that it recognized structures containing terminal GalNAc-1,3(Fuc-1,2)Gal (blood group A antigen) and also repeated protein sequences containing GalNAc residues linked to Ser/Thr (Tn antigen), findings that were supported by immunostainings of human pancreatic tissue. To examine whether the CEL glycoprotein might be modified by blood group antigens, we used high-sensitivity MALDI-TOF MS to characterize the released O-glycan pool of CEL immunoprecipitated from human pancreatic juice. We found that the O-glycome of CEL consisted mainly of core 1/core 2 structures with a composition depending on the subject's FUT2 and ABO gene polymorphisms. Thus, among digestive enzymes secreted by the pancreas, CEL is a glycoprotein with some unique characteristics, supporting the view that it could serve additional biological functions to its cholesteryl esterase activity in the duodenum.	[El Jellas, Khadija; Immervoll, Heike; Choi, Man H.; Molven, Anders] Univ Bergen, Dept Clin Med, Gade Lab Pathol, N-5020 Bergen, Norway; [El Jellas, Khadija; Choi, Man H.; Molven, Anders] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway; [El Jellas, Khadija; Johansson, Bente B.; Fjeld, Karianne; Njolstad, Pal R.; Molven, Anders] Univ Bergen, Dept Clin Sci, KG Jebsen Ctr Diabet Res, N-5020 Bergen, Norway; [Johansson, Bente B.; Njolstad, Pal R.] Haukeland Hosp, Dept Pediat & Adolescent Med, N-5021 Bergen, Norway; [Fjeld, Karianne] Haukeland Hosp, Ctr Med Genet, N-5021 Bergen, Norway; [Antonopoulos, Aristotelis; Dell, Anne; Haslam, Stuart M.] Imperial Coll London, Dept Life Sci, South Kensington Campus, London SW7 2AZ, England; [Immervoll, Heike] Alesund Hosp, Dept Pathol, N-6017 Alesund, Norway; [Hoem, Dag] Haukeland Hosp, Dept Gastrointestinal Surg, N-5021 Bergen, Norway; [Lowe, Mark E.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Lombardo, Dominique; Mas, Eric] Aix Marseille Univ, INSERM, Ctr Res Biol Oncol & Oncopharmacol, CRO2, F-13284 Marseille 07, France	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; Imperial College London; University of Bergen; Haukeland University Hospital; Washington University (WUSTL); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Molven, A (corresponding author), Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway.	anders.molven@uib.no	Mas, Eric/O-9569-2017; Mas, Eric/AAC-9837-2022; Fjeld, Karianne/Q-7122-2018; Johansson, Bente Berg/AAE-7666-2022	Mas, Eric/0000-0002-8925-9195; Fjeld, Karianne/0000-0003-0441-1475; Antonopoulos, Aristotelis/0000-0002-1592-4092; Choi, Man Hung/0000-0001-6204-1690	Western Norway Regional Health Authority (Helse Vest) [911831, 912057]; Stiftelsen Kristian Gerhard Jebsen; Research Council of Norway's FRIMEDBIO Program; Biotechnology and Biological Sciences Research Council [BB/K016164/1]; BBSRC [BB/K016164/1] Funding Source: UKRI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097241, U01DK108334] Funding Source: NIH RePORTER	Western Norway Regional Health Authority (Helse Vest); Stiftelsen Kristian Gerhard Jebsen; Research Council of Norway's FRIMEDBIO Program(Research Council of Norway); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Ph.D. fellowship 911831 (to K. E. J.) and Research Grant 912057 (to A. M.) from Western Norway Regional Health Authority (Helse Vest). The work was also supported by grants from the Gade Legacy (to K. E. J.), Stiftelsen Kristian Gerhard Jebsen (to P. R. N.), Research Council of Norway's FRIMEDBIO Program (to A. M.), and by Biotechnology and Biological Sciences Research Council Grant BB/K016164/1 (to A. D. and S. M. H.). The authors declare that they have no conflicts of interest with the contents of this article.	ALBERS GHR, 1990, AM J CLIN PATHOL, V93, P14, DOI 10.1093/ajcp/93.1.14; ALBERS GHR, 1987, DIFFERENTIATION, V34, P210, DOI 10.1111/j.1432-0436.1987.tb00068.x; Amundadottir L, 2009, NAT GENET, V41, P986, DOI 10.1038/ng.429; BABA T, 1991, BIOCHEMISTRY-US, V30, P500, DOI 10.1021/bi00216a028; Benkoel L, 2009, MOL CANCER THER, V8, P282, DOI 10.1158/1535-7163.MCT-08-0471; Bergstrom KSB, 2013, GLYCOBIOLOGY, V23, P1026, DOI 10.1093/glycob/cwt045; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Chen JCH, 1998, BIOCHEMISTRY-US, V37, P5107, DOI 10.1021/bi972989g; Childs EJ, 2015, NAT GENET, V47, P911, DOI 10.1038/ng.3341; Crescence L, 2012, J IMMUNOL, V189, P3386, DOI 10.4049/jimmunol.1102647; Dalva M, 2017, PANCREATOLOGY, V17, P83, DOI 10.1016/j.pan.2016.10.006; Deer EL, 2010, PANCREAS, V39, P425, DOI 10.1097/MPA.0b013e3181c15963; DOWNS D, 1994, BIOCHEMISTRY-US, V33, P7979, DOI 10.1021/bi00192a001; Dube DH, 2005, NAT REV DRUG DISCOV, V4, P477, DOI 10.1038/nrd1751; El Jellas K, 2017, CANCER MED-US, V6, P1531, DOI 10.1002/cam4.1097; ESCRIBANO MJ, 1985, BRIT J CANCER, V51, P187, DOI 10.1038/bjc.1985.28; ESCRIBANO MJ, 1986, INT J CANCER, V38, P155, DOI 10.1002/ijc.2910380202; Fjeld K, 2015, NAT GENET, V47, P518, DOI 10.1038/ng.3249; Greer JB, 2011, PANCREAS, V40, P1188, DOI 10.1097/MPA.0b013e3182232975; Hanisch FA, 2001, BIOL CHEM, V382, P143, DOI 10.1515/BC.2001.022; HANSSON L, 1993, J BIOL CHEM, V268, P26692; HERNELL O, 1994, J PEDIATR-US, V125, pS56, DOI 10.1016/S0022-3476(06)80737-7; Hofmann BT, 2014, CLIN CANCER RES, V20, P6117, DOI 10.1158/1078-0432.CCR-14-0716; Holmes RS, 2011, CHOLESTEROL, DOI 10.1155/2011/781643; Johansson BB, 2018, PANCREATOLOGY, V18, P12, DOI 10.1016/j.pan.2017.12.001; Johansson BB, 2011, J BIOL CHEM, V286, P34593, DOI 10.1074/jbc.M111.222679; Ju TZ, 2013, PROTEOM CLIN APPL, V7, P618, DOI 10.1002/prca.201300024; Kirsten H, 2016, GUT, V65, P184, DOI 10.1136/gutjnl-2015-309521; Kodvawala A, 2005, J BIOL CHEM, V280, P38592, DOI 10.1074/jbc.M502266200; Landberg E, 1997, ARCH BIOCHEM BIOPHYS, V344, P94, DOI 10.1006/abbi.1997.0188; Lindquist S, 2002, EUR J BIOCHEM, V269, P759, DOI 10.1046/j.0014-2956.2001.02666.x; LOMBARDO D, 1978, BIOCHIM BIOPHYS ACTA, V527, P142, DOI 10.1016/0005-2744(78)90263-2; Loomes KM, 1999, EUR J BIOCHEM, V266, P105, DOI 10.1046/j.1432-1327.1999.00824.x; Makivuokko H, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-94; Marionneau S, 2002, GASTROENTEROLOGY, V122, P1967, DOI 10.1053/gast.2002.33661; Martinez E, 2017, ONCOTARGET, V8, P536, DOI 10.18632/oncotarget.11777; MAS E, 1993, BIOCHEM J, V289, P609, DOI 10.1042/bj2890609; MAS E, 1993, EUR J BIOCHEM, V216, P807, DOI 10.1111/j.1432-1033.1993.tb18201.x; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Mechref Y, 1999, GLYCOBIOLOGY, V9, P227, DOI 10.1093/glycob/9.3.227; Molven A, 2016, GASTROENTEROLOGY, V150, P1515, DOI 10.1053/j.gastro.2016.04.019; Panicot-Dubois L, 2004, NEOPLASIA, V6, P713, DOI 10.1593/neo.04298; Raeder H, 2006, NAT GENET, V38, P54, DOI 10.1038/ng1708; Ragvin A, 2013, PANCREATOLOGY, V13, P29, DOI 10.1016/j.pan.2012.12.059; Reuss R, 2006, INT J ONCOL, V29, P649; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Rossez Y, 2012, GLYCOBIOLOGY, V22, P1193, DOI 10.1093/glycob/cws072; Ruvoen-Clouet N, 2006, BIOCHEM J, V393, P627, DOI 10.1042/BJ20050898; Shindo K, 2017, ONCOTARGET, V8, P50824, DOI 10.18632/oncotarget.15137; SPRINGER GF, 1995, CANCER DETECT PREV, V19, P173; Stanley P, 2017, ESSENTIALS GLYCOBIOL, P161, DOI DOI 10.1101/GLYCOBIOLOGY.3E.014; Stowell SR, 2015, ANNU REV PATHOL-MECH, V10, P473, DOI 10.1146/annurev-pathol-012414-040438; SUGO T, 1993, EUR J BIOCHEM, V216, P799, DOI 10.1111/j.1432-1033.1993.tb18200.x; Tailford LE, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00081; TAN MH, 1986, CANCER INVEST, V4, P15, DOI 10.3109/07357908609039823; Torsvik J, 2014, J BIOL CHEM, V289, P29097, DOI 10.1074/jbc.M114.574244; Torsvik J, 2010, HUM GENET, V127, P55, DOI 10.1007/s00439-009-0740-8; Varki A, 2009, PROTEOMICS, V9, P5398, DOI 10.1002/pmic.200900708; WANG CS, 1995, BIOCHEMISTRY-US, V34, P10639, DOI 10.1021/bi00033a039; Weiss FU, 2016, GUT, V65, P353, DOI 10.1136/gutjnl-2015-309682; Weiss FU, 2015, GUT, V64, P646, DOI 10.1136/gutjnl-2014-306930; Whitcomb DC, 2007, DIGEST DIS SCI, V52, P1, DOI 10.1007/s10620-006-9589-z; Wolpin BM, 2014, NAT GENET, V46, P994, DOI 10.1038/ng.3052; Wolpin BM, 2010, CANCER EPIDEM BIOMAR, V19, P3140, DOI 10.1158/1055-9965.EPI-10-0751; Xiao XJ, 2016, J BIOL CHEM, V291, P23224, DOI 10.1074/jbc.M116.734384	66	9	9	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2018	293	50					19476	19491		10.1074/jbc.RA118.001934	http://dx.doi.org/10.1074/jbc.RA118.001934			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HE6RA	30315106	Green Published, hybrid			2022-12-28	WOS:000453537300027
J	Amos, RA; Pattathil, S; Yang, JY; Atmodjo, MA; Urbanowicz, BR; Moremen, KW; Mohnen, D				Amos, Robert A.; Pattathil, Sivakumar; Yang, Jeong-Yeh; Atmodjo, Melani A.; Urbanowicz, Breeanna R.; Moremen, Kelley W.; Mohnen, Debra			A two-phase model for the non-processive biosynthesis of homogalacturonan polysaccharides by the GAUT1:GAUT7 complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEISSERIA-MENINGITIDIS SEROGROUP; CELL-WALL; FUNCTIONAL IDENTIFICATION; ARABIDOPSIS-THALIANA; POLYGALACTURONATE 4-ALPHA-GALACTURONOSYLTRANSFERASE; SUCCESSIVE GLYCOSYLTRANSFER; PECTIN BIOSYNTHESIS; HEPAROSAN SYNTHASE; CAPSULE POLYMERASE; GALACTURONIC ACID	Homogalacturonan (HG) is a pectic glycan in the plant cell wall that contributes to plant growth and development and cell wall structure and function, and interacts with other glycans and proteoglycans in the wall. HGis synthesized by the galacturonosyltransferase (GAUT) gene family. Two members of this family, GAUT1 and GAUT7, form a heteromeric enzyme complex in Arabidopsis thaliana. Here, we established a heterologous GAUT expression system in HEK293 cells and show that coexpression of recombinant GAUT1 with GAUT7 results in the production of a soluble GAUT1:GAUT7 complex that catalyzes elongation of HG products in vitro. The reaction rates, progress curves, and product distributions exhibited major differences dependent upon small changes in the degree of polymerization (DP) of the oligosaccharide acceptor. GAUT1:GAUT7 displayed >45-fold increased catalytic efficiency with DP11 acceptors relative to DP7 acceptors. Although GAUT1:GAUT7 synthesized high-molecular-weight polymeric HG (>100 kDa) in a substrate concentration-dependent manner typical of distributive (nonprocessive) glycosyltransferases with DP11 acceptors, reactions primed with short-chain acceptors resulted in a bimodal product distribution of glycan products that has previously been reported as evidence for a processive model of GT elongation. As an alternative to the processive glycosyltransfer model, a two-phase distributive elongation model is proposed in which a slow phase, which includes the de novo initiation of HG and elongation of short-chain acceptors, is distinguished from a phase of rapid elongation of intermediate- and long-chain acceptors. Upon reaching a critical chain length of DP11, GAUT1:GAUT7 elongates HG to high-molecular-weight products.	[Amos, Robert A.; Pattathil, Sivakumar; Yang, Jeong-Yeh; Atmodjo, Melani A.; Urbanowicz, Breeanna R.; Moremen, Kelley W.; Mohnen, Debra] Univ Georgia, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA; [Amos, Robert A.; Atmodjo, Melani A.; Moremen, Kelley W.; Mohnen, Debra] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Pattathil, Sivakumar] Mascoma LLC, Lallemand Inc, 67 Etna Rd 200, Lebanon, NH 03766 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Mascoma Corporation	Mohnen, D (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA.	dmohnen@ccrc.uga.edu	Moremen, Kelley/AAD-4661-2019	Mohnen, Debra/0000-0001-5249-635X; , Breeanna/0000-0001-5247-4513	Office of Biological and Environmental Research in the Department of Energy's Office of Science; Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy [DE-FG02-12ER16324]; National Science Foundation [DBI-0421683, RCN 009281]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM107012, P41GM103390] Funding Source: NIH RePORTER	Office of Biological and Environmental Research in the Department of Energy's Office of Science; Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Z. A. Wood for technical support and guidance with enzyme kinetics experiments, M. G. Hahn for providing monoclonal antibodies, M. A. O'Neill for technical support, and the members of the Mohnen laboratory, including L. Tan, A. K Biswal, and K. A. Engle, for training and helpful research discussions. The BioEnergy Science Center and the Center for Bioenergy Innovation are United States Department of Energy Bioenergy Research Centers supported by the Office of Biological and Environmental Research in the Department of Energy's Office of Science. We also acknowledge the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy through Grant DE-FG02-12ER16324 for funding structural studies of pectin. Generation of the CCRC series of monoclonal antibodies used in this work was supported by National Science Foundation Plant Genome Program Grant DBI-0421683. Distribution of JIM antibodies used in this work was supported in part by National Science Foundation Grants DBI-0421683 and RCN 009281.	Akita K, 2002, PLANT PHYSIOL, V130, P374, DOI 10.1104/pp.005587; Atmodjo MA, 2013, ANNU REV PLANT BIOL, V64, P747, DOI 10.1146/annurev-arplant-042811-105534; Atmodjo MA, 2011, P NATL ACAD SCI USA, V108, P20225, DOI 10.1073/pnas.1112816108; Bambara RA, 1995, METHOD ENZYMOL, V262, P270; Basu D, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0670-7; Basu D, 2013, J BIOL CHEM, V288, P10132, DOI 10.1074/jbc.M112.432609; Benen JAE, 1999, EUR J BIOCHEM, V259, P577, DOI 10.1046/j.1432-1327.1999.00080.x; Biswal AK, 2018, NAT BIOTECHNOL, V36, P249, DOI 10.1038/nbt.4067; Biswal AK, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-017-1002-y; Biswal AK, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0218-y; Bloom L, 2001, MONOGR SOC RES CHILD, V66, pVII, DOI 10.1111/1540-5834.00162; Breyer WA, 2001, PROTEIN SCI, V10, P1699, DOI 10.1110/ps.10301; Chaikuad A, 2011, P NATL ACAD SCI USA, V108, P21028, DOI 10.1073/pnas.1113921108; Chavaroche AAE, 2010, APPL MICROBIOL BIOT, V85, P1881, DOI 10.1007/s00253-009-2214-2; Chiniquy D, 2012, P NATL ACAD SCI USA, V109, P17117, DOI 10.1073/pnas.1202079109; Chung D, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/s13068-014-0147-1; Cornish-Bowden A., 2012, FUNDAMENTALS ENZYME, P210; Cosgrove DJ, 2016, F1000RESEARCH, V5, pF1000, DOI [10.12688/f1000research.7180.1, DOI 10.12688/F1000]; Culbertson A. T, 2015, JSM ENZYMOL PROTEIN, V1, P1004; Culbertson AT, 2016, PLANT PHYSIOL, V171, P1893, DOI 10.1104/pp.16.00361; Davis J, 2010, PLANT J, V64, P1028, DOI 10.1111/j.1365-313X.2010.04392.x; DeAngelis PL, 2002, J BIOL CHEM, V277, P7209, DOI 10.1074/jbc.M112130200; Dick-Perez M, 2011, BIOCHEMISTRY-US, V50, P989, DOI 10.1021/bi101795q; Dilokpimol A, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-90; DOONG RL, 1995, PLANT PHYSIOL, V109, P141, DOI 10.1104/pp.109.1.141; Doong RL, 1998, PLANT J, V13, P363, DOI 10.1046/j.1365-313X.1998.00042.x; Fiebig T, 2018, J BIOL CHEM, V293, P953, DOI 10.1074/jbc.RA117.000488; Fiebig T, 2014, J BIOL CHEM, V289, P19395, DOI 10.1074/jbc.M114.575142; Fiebig T, 2014, GLYCOBIOLOGY, V24, P150, DOI 10.1093/glycob/cwt102; Forsee WT, 2006, J BIOL CHEM, V281, P6283, DOI 10.1074/jbc.M511124200; Geshi N, 2013, PLANT J, V76, P128, DOI 10.1111/tpj.12281; Gibbons BJ, 2002, J MOL BIOL, V319, P463, DOI 10.1016/S0022-2836(02)00305-4; Halmo SM, 2017, J BIOL CHEM, V292, P2101, DOI 10.1074/jbc.M116.764712; Ishii T, 2002, PLANT CELL PHYSIOL, V43, P1386, DOI 10.1093/pcp/pcf150; Jacobs A, 2001, ANAL CHEM, V73, P405, DOI 10.1021/ac001222i; Jiang N, 2016, PLANT PHYSIOL, V170, P1999, DOI 10.1104/pp.15.01777; Kellokumpu S, 2016, CELL MOL LIFE SCI, V73, P305, DOI 10.1007/s00018-015-2066-0; Keys TG, 2014, NAT CHEM BIOL, V10, P437, DOI 10.1038/nchembio.1501; Knoch E, 2013, PLANT J, V76, P1016, DOI 10.1111/tpj.12353; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laursen T, 2018, PLANT J, V94, P340, DOI 10.1111/tpj.13860; Lee C, 2012, PLANT CELL PHYSIOL, V53, P1204, DOI 10.1093/pcp/pcs064; Levengood MR, 2011, J AM CHEM SOC, V133, P12758, DOI 10.1021/ja204448t; LILJEBJELKE K, 1995, ANAL BIOCHEM, V225, P296, DOI 10.1006/abio.1995.1158; Lionetti V, 2010, P NATL ACAD SCI USA, V107, P616, DOI 10.1073/pnas.0907549107; Litschko C, 2015, J BIOL CHEM, V290, P24355, DOI 10.1074/jbc.M115.678094; Liwanag AJM, 2012, PLANT CELL, V24, P5024, DOI 10.1105/tpc.112.106625; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Ly HD, 2002, BIOCHEMISTRY-US, V41, P5075, DOI 10.1021/bi012031s; Meng L, 2013, J BIOL CHEM, V288, P34680, DOI 10.1074/jbc.M113.519041; Moremen KW, 2018, NAT CHEM BIOL, V14, P156, DOI [10.1038/NCHEMBIO.2539, 10.1038/nchembio.2539]; Morgan JLW, 2013, NATURE, V493, P181, DOI 10.1038/nature11744; MORT AJ, 1991, CARBOHYD RES, V215, P219, DOI 10.1016/0008-6215(91)84022-7; NARDONE G, 1986, J BIOL CHEM, V261, P2128; Ogawa-Ohnishi M, 2015, PLANT J, V81, P736, DOI 10.1111/tpj.12764; Oikawa A, 2013, TRENDS PLANT SCI, V18, P49, DOI 10.1016/j.tplants.2012.07.002; Pattathil Sivakumar, 2012, Methods Mol Biol, V908, P61, DOI 10.1007/978-1-61779-956-3_6; Pattathil S, 2010, PLANT PHYSIOL, V153, P514, DOI 10.1104/pp.109.151985; Pauly M, 2016, ANNU REV PLANT BIOL, V67, P235, DOI 10.1146/annurev-arplant-043015-112222; Persson K, 2001, NAT STRUCT BIOL, V8, P166, DOI 10.1038/84168; Petersen BL, 2009, GLYCOCONJUGATE J, V26, P1235, DOI 10.1007/s10719-009-9242-0; Piszkiewicz D, 1977, KINETICS CHEM ENZYME, P97; Praissman JL, 2016, ELIFE, V5, DOI 10.7554/eLife.14473; Praissman JL, 2014, ELIFE, V3, DOI 10.7554/eLife.03943; Raga-Carbajal E, 2016, GLYCOBIOLOGY, V26, P377, DOI 10.1093/glycob/cwv112; Rennie EA, 2012, PLANT PHYSIOL, V159, P1408, DOI 10.1104/pp.112.200964; Scheller HV, 1999, PLANTA, V207, P512, DOI 10.1007/s004250050511; Sheikh MO, 2017, GLYCOBIOLOGY, V27, P206, DOI 10.1093/glycob/cww114; Sterling JD, 2006, P NATL ACAD SCI USA, V103, P5236, DOI 10.1073/pnas.0600120103; Sterling JD, 2005, ANAL BIOCHEM, V343, P231, DOI 10.1016/j.ab.2005.05.037; Subedi GP, 2015, JOVE-J VIS EXP, DOI 10.3791/53568; Tan L, 2013, PLANT CELL, V25, P270, DOI 10.1105/tpc.112.107334; Urbanowicz BR, 2017, PLANT J, V91, P931, DOI 10.1111/tpj.13628; Urbanowicz BR, 2014, PLANT J, V80, P197, DOI 10.1111/tpj.12643; Vionnet J, 2007, GLYCOBIOLOGY, V17, P735, DOI 10.1093/glycob/cwm032; Voxeur A, 2016, GLYCOBIOLOGY, V26, P950, DOI 10.1093/glycob/cww029; Vuttipongchaikij S, 2012, NEW PHYTOL, V195, P585, DOI 10.1111/j.1469-8137.2012.04196.x; Wang T, 2016, J EXP BOT, V67, P503, DOI 10.1093/jxb/erv416; Wang T, 2012, BIOCHEMISTRY-US, V51, P9846, DOI 10.1021/bi3015532; Weigel PH, 2017, GLYCOBIOLOGY, V27, P536, DOI 10.1093/glycob/cwx012; Weigel PH, 2015, GLYCOBIOLOGY, V25, P632, DOI 10.1093/glycob/cwv006; Wu YY, 2010, J BIOL CHEM, V285, P13638, DOI 10.1074/jbc.M110.102715; Yasui K, 2009, PECTINS AND PECTINASES, P167; Yin YB, 2010, PLANT PHYSIOL, V153, P1729, DOI 10.1104/pp.110.154229; Zeng W, 2016, PLANT PHYSIOL, V171, P93, DOI 10.1104/pp.15.01919	85	24	24	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2018	293	49					19047	19063		10.1074/jbc.RA118.004463	http://dx.doi.org/10.1074/jbc.RA118.004463			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NY	30327429	hybrid, Green Published			2022-12-28	WOS:000458467400019
J	Paolini-Bertrand, M; Cerini, F; Martins, E; Scurci, I; Hartley, O				Paolini-Bertrand, Marianne; Cerini, Fabrice; Martins, Elsa; Scurci, Ilaria; Hartley, Oliver			Rapid and low-cost multiplex synthesis of chemokine analogs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMICAL-SYNTHESIS; HIGHLY POTENT; RECEPTOR 5; PROTEIN; INHIBITION; ENTRY; IDENTIFICATION; TRANSMISSION; PURIFICATION; EXPRESSION	Peptides represent a promising source of new medicines, but improved technologies are needed to facilitate discovery and optimization campaigns. In particular, longer peptides with multiple disulfide bridges are challenging to produce, and producing large numbers of structurally related variants is dissuasively costly and time-consuming. The principal cost and time drivers are the multiple column chromatography purification steps that are used during the multistep chemical synthesis procedure, which involves both ligation and oxidative refolding steps. In this study, we developed a method for multiplex parallel synthesis of complex peptide analogs in which the structurally variant region of the molecule is produced as a small peptide on a 384-well synthesizer with subsequent ligation to the longer, structurally invariant region and oxidative refolding carried out in-well without any column purification steps. To test the method, we used a panel of 96 analogs of the chemokine RANTES (regulated on activation normal T cell expressed and secreted)/CCL5 (69 residues, two disulfide bridges), which had been synthesized using standard approaches and characterized pharmacologically in an earlier study. Although, as expected, the multiplex method generated chemokine analogs of lower purity than those produced in the original study, it was nonetheless possible to closely match the pharmacological attributes (anti-HIV potency, capacity to elicit G protein signaling, and capacity to elicit intracellular receptor sequestration) of each chemokine analog to reference data from the earlier study. This rapid, low-cost approach has the potential to support discovery and optimization campaigns based on analogs of other chemokines as well as those of other complex peptide and small protein targets of a similar size.	[Paolini-Bertrand, Marianne; Cerini, Fabrice; Martins, Elsa; Scurci, Ilaria; Hartley, Oliver] Univ Geneva, Fac Med, Dept Pathol & Immunol, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland	University of Geneva	Hartley, O (corresponding author), Univ Geneva, Fac Med, Dept Pathol & Immunol, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	oliver.hartley@unige.ch		hartley, oliver/0000-0002-2283-8379	Swiss National Science Foundation [310030_163085]; Orion Biotechnology Switzerland	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Orion Biotechnology Switzerland	We acknowledge support from the Swiss National Science Foundation (grant 310030_163085 to O. H). O. H. is the inventor of the chemokine analogs described in this study and a shareholder of Orion Biotechnology Switzerland, to whom the rights to the invention have been assigned.	Allen SJ, 2007, ANNU REV IMMUNOL, V25, P787, DOI 10.1146/annurev.immunol.24.021605.090529; Angelini A, 2015, METHODS MOL BIOL, V1319, P3, DOI 10.1007/978-1-4939-2748-7_1; Bang D, 2004, ANGEW CHEM INT EDIT, V43, P2534, DOI 10.1002/anie.200353540; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Bonsch C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125396; Breitling F, 2009, MOL BIOSYST, V5, P224, DOI 10.1039/b819850k; Cerini F, 2008, JAIDS-J ACQ IMM DEF, V49, P472, DOI 10.1097/QAI.0b013e31818c953f; Cerini F, 2017, AIDS RES HUM RETROV, V33, P768, DOI [10.1089/aid.2016.0199, 10.1089/AID.2016.0199]; Cerini F, 2016, PROTEIN EXPRES PURIF, V119, P1, DOI 10.1016/j.pep.2015.10.011; Chevigne A, 2011, BIOCHEM PHARMACOL, V82, P1438, DOI 10.1016/j.bcp.2011.07.091; ClarkLewis I, 1997, METHOD ENZYMOL, V287, P233; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Colin P, 2013, P NATL ACAD SCI USA, V110, P9475, DOI 10.1073/pnas.1222205110; Dawson PE, 1997, METHOD ENZYMOL, V287, P34; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; Dorgham K, 2016, METHOD ENZYMOL, V570, P47, DOI 10.1016/bs.mie.2015.09.014; Engelhard M, 2016, J PEPT SCI, V22, P246, DOI 10.1002/psc.2880; Escola JM, 2010, J BIOL CHEM, V285, P41772, DOI 10.1074/jbc.M110.153460; Fosgerau K, 2015, DRUG DISCOV TODAY, V20, P122, DOI 10.1016/j.drudis.2014.10.003; Gaertner H, 2008, PROTEIN ENG DES SEL, V21, P65, DOI 10.1093/protein/gzm079; Gaertner H, 2008, P NATL ACAD SCI USA, V105, P17706, DOI 10.1073/pnas.0805098105; Hartley O, 2005, CURR PROTEIN PEPT SC, V6, P207, DOI 10.2174/1389203054065400; Hartley O, 2004, P NATL ACAD SCI USA, V101, P16460, DOI 10.1073/pnas.0404802101; Hartley O, 2003, J VIROL, V77, P6637, DOI 10.1128/JVI.77.12.6637-6644.2003; Henninot A, 2018, J MED CHEM, V61, P1382, DOI 10.1021/acs.jmedchem.7b00318; Hesselgesser J, 1997, METHOD ENZYMOL, V287, P59; Horuk R, 1997, METHOD ENZYMOL, V287, P3; Kenakin T, 2002, NAT REV DRUG DISCOV, V1, P103, DOI 10.1038/nrd722; Koehn Jim, 2009, V498, P1, DOI 10.1007/978-1-59745-196-3_1; Kufareva I, 2015, IMMUNOL CELL BIOL, V93, P372, DOI 10.1038/icb.2015.15; Lau JL, 2018, BIOORGAN MED CHEM, V26, P2700, DOI 10.1016/j.bmc.2017.06.052; Lederman MM, 2004, SCIENCE, V306, P485, DOI 10.1126/science.1099288; Loibl SF, 2016, CHEM SCI, V7, P6753, DOI 10.1039/c6sc01883a; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Monk PN, 2007, BRIT J PHARMACOL, V152, P429, DOI 10.1038/sj.bjp.0707332; Muir TW, 2003, ANNU REV BIOCHEM, V72, P249, DOI 10.1146/annurev.biochem.72.121801.161900; Namkung Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12178; Ollivier N, 2010, ORG LETT, V12, P5238, DOI 10.1021/ol102273u; Pande J, 2010, BIOTECHNOL ADV, V28, P849, DOI 10.1016/j.biotechadv.2010.07.004; Pleskoff O, 1997, SCIENCE, V276, P1874, DOI 10.1126/science.276.5320.1874; Pluckthun A, 2012, METHODS MOL BIOL, V805, P3, DOI 10.1007/978-1-61779-379-0_1; Raibaut L, 2015, TOP CURR CHEM, V363, P103, DOI 10.1007/128_2014_609; Ramli S, 2009, PROTEIN PEPTIDE LETT, V16, P810, DOI 10.2174/092986609788681706; Simmons G, 1997, SCIENCE, V276, P276, DOI 10.1126/science.276.5310.276; Veazey RS, 2009, J INFECT DIS, V199, P1525, DOI 10.1086/598685; Vlieghe P, 2010, DRUG DISCOV TODAY, V15, P40, DOI 10.1016/j.drudis.2009.10.009; Wells TNC, 1996, J LEUKOCYTE BIOL, V59, P53, DOI 10.1002/jlb.59.1.53; Zheng Y, 2017, IMMUNITY, V46, P1005, DOI 10.1016/j.immuni.2017.05.002	48	4	4	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2018	293	49					19092	19100		10.1074/jbc.RA118.004370	http://dx.doi.org/10.1074/jbc.RA118.004370			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NY	30305389	Green Published, hybrid			2022-12-28	WOS:000458467400022
J	Moon, TM; D'Andrea, ED; Lee, CW; Soares, A; Jakoncic, J; Desbonnet, C; Garcia-Solache, M; Rice, LB; Page, R; Peti, W				Moon, Thomas M.; D'Andrea, Everton D.; Lee, Christopher W.; Soares, Alexei; Jakoncic, Jean; Desbonnet, Charlene; Garcia-Solache, Monica; Rice, Lou B.; Page, Rebecca; Peti, Wolfgang			The structures of penicillin-binding protein 4 (PBP4) and PBP5 from Enterococci provide structural insights into beta-lactam resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ANTIBIOTICS; EXPRESSION; PATHOGENS; FAECIUM	The final steps of cell-wall biosynthesis in bacteria are carried out by penicillin-binding proteins (PBPs), whose transpeptidase domains form the cross-links in peptidoglycan chains that define the bacterial cell wall. These enzymes are the targets of beta-lactam antibiotics, as their inhibition reduces the structural integrity of the cell wall. Bacterial resistance to antibiotics is a rapidly growing concern; however, the structural underpinnings of PBP-derived antibiotic resistance are poorly understood. PBP4 and PBP5 are low-affinity, class B transpeptidases that confer antibiotic resistance to Enterococcus faecalis and Enterococcus faecium, respectively. Here, we report the crystal structures of PBP4 (1.8 angstrom) and PBP5 (2.7 angstrom) in their apo and acyl-enzyme complexes with the beta-lactams benzylpenicillin, imipenem, and ceftaroline. We found that, although these three beta-lactams adopt geometries similar to those observed in other class B PBP structures, there are small, but significant, differences that likely decrease antibiotic efficacy. Further, we also discovered that the N-terminal domain extensions in this class of PBPs undergo large rigid-body rotations without impacting the structure of the catalytic transpeptidase domain. Together, our findings are defining the subtle functional and structural differences in the Enterococcus PBPs that allow them to support transpeptidase activity while also conferring bacterial resistance to antibiotics that function as substrate mimics.	[Moon, Thomas M.; D'Andrea, Everton D.; Page, Rebecca; Peti, Wolfgang] Univ Arizona, Dept Chem & Biochem, Coll Med, Tucson, AZ 85721 USA; [Lee, Christopher W.] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA; [Soares, Alexei; Jakoncic, Jean] Brookhaven Natl Lab, Photon Sci, Upton, NY 11973 USA; [Desbonnet, Charlene; Garcia-Solache, Monica; Rice, Lou B.] Brown Univ, Dept Med, Warren Alpert Sch Med, Providence, RI 02903 USA; [Desbonnet, Charlene; Garcia-Solache, Monica; Rice, Lou B.] Brown Univ, Dept Microbiol & Immunol, Warren Alpert Sch Med, Providence, RI 02903 USA	University of Arizona; Brown University; United States Department of Energy (DOE); Brookhaven National Laboratory; Brown University; Brown University	Peti, W (corresponding author), Univ Arizona, Dept Chem & Biochem, Tucson, AZ 85721 USA.	wolfgangpeti@email.arizona.edu	D'Andréa, Éverton D/O-6796-2016; Garcia-Solache, Monica/M-4461-2019; Moon, Thomas/F-4896-2013	Garcia-Solache, Monica/0000-0003-0696-7653; Jakoncic, Jean/0000-0002-6315-0933; Moon, Thomas/0000-0003-1568-8808	National Institutes of Health [R56AI045626]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI045626] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R56AI045626 (to L. B. R. and W. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arbeloa A, 2004, J BIOL CHEM, V279, P41546, DOI 10.1074/jbc.M407149200; Arias CA, 2012, NAT REV MICROBIOL, V10, P266, DOI 10.1038/nrmicro2761; Aymanns S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019822; CHAMBERS H F, 1988, Clinical Microbiology Reviews, V1, P173; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; ELIOPOULOS GM, 1982, ANTIMICROB AGENTS CH, V22, P295, DOI 10.1128/AAC.22.2.295; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fedarovich A, 2012, J MOL BIOL, V418, P316, DOI 10.1016/j.jmb.2012.02.021; Frere JM, 2014, CURR OPIN PHARMACOL, V18, P112, DOI 10.1016/j.coph.2014.09.012; GHUYSEN JM, 1991, ANNU REV MICROBIOL, V45, P37, DOI 10.1146/annurev.mi.45.100191.000345; Gonzolez A, 2010, AUTOXDS; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; JAWETZ E, 1966, NEW ENGL J MED, V274, P710, DOI 10.1056/NEJM196603312741304; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Lim D, 2002, NAT STRUCT BIOL, V9, P870, DOI 10.1038/nsb858; Macheboeuf P, 2006, FEMS MICROBIOL REV, V30, P673, DOI 10.1111/j.1574-6976.2006.00024.x; MOELLERIRC, 1971, J CLIN INVEST, V50, P2580, DOI DOI 10.1172/JCI106758; Otero LH, 2013, P NATL ACAD SCI USA, V110, P16808, DOI 10.1073/pnas.1300118110; Peti W, 2007, PROTEIN EXPRES PURIF, V51, P1, DOI 10.1016/j.pep.2006.06.024; Ren JS, 2016, FEBS LETT, V590, P288, DOI 10.1002/1873-3468.12054; Rice LB, 2004, ANTIMICROB AGENTS CH, V48, P3028, DOI 10.1128/AAC.48.8.3028-3032.2004; Rice LB, 2008, J INFECT DIS, V197, P1079, DOI 10.1086/533452; Rice LB, 2018, MBIO, V9, DOI 10.1128/mBio.00361-18; Sauvage E, 2002, CELL MOL LIFE SCI, V59, P1223, DOI 10.1007/s00018-002-8500-0; Stein BJ, 2016, STRUCTURE, V24, P232, DOI 10.1016/j.str.2015.12.008; Teplitsky E, 2015, J STRUCT BIOL, V191, P49, DOI 10.1016/j.jsb.2015.05.006; Weiner LM, 2016, INFECT CONT HOSP EP, V37, P1288, DOI 10.1017/ice.2016.174; WILLIAMSON R, 1983, J GEN MICROBIOL, V129, P813; WILLIAMSON R, 1985, J GEN MICROBIOL, V131, P1933; Yamada M, 2007, ANTIMICROB AGENTS CH, V51, P3902, DOI 10.1128/AAC.00743-07; Zapun A, 2008, FEMS MICROBIOL REV, V32, P361, DOI 10.1111/j.1574-6976.2007.00095.x	33	23	25	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2018	293	48					18574	18584		10.1074/jbc.RA118.006052	http://dx.doi.org/10.1074/jbc.RA118.006052			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NX	30355734	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000458467300013
J	Ding, GJ; Chen, PL; Zhang, H; Huang, XJ; Zang, Y; Li, JW; Li, J; Wong, JM				Ding, Guangjin; Chen, Peilin; Zhang, Hui; Huang, Xiaojie; Zang, Yi; Li, Jiwen; Li, Jia; Wong, Jiemin			Regulation of ubiquitin-like with plant homeodomain and RING finger domain 1 (UHRF1) protein stability by heat shock protein 90 chaperone machinery (vol 291, pg 20125, 2016)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction														Wong, Jiemin/0000-0002-5311-842X				Ding GJ, 2016, J BIOL CHEM, V291, P20125, DOI 10.1074/jbc.M116.727214	1	0	0	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2018	293	45					17661	17662		10.1074/jbc.AAC118.006310	http://dx.doi.org/10.1074/jbc.AAC118.006310			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ9EI	30413528	hybrid, Green Published			2022-12-28	WOS:000449799000028
J	Huang, YC; Chanou, A; Kranz, G; Pan, M; Kohlbauer, V; Ettinger, A; Gires, O				Huang, Yuanchi; Chanou, Anna; Kranz, Gisela; Pan, Min; Kohlbauer, Vera; Ettinger, Andreas; Gires, Olivier			Membrane-associated epithelial cell adhesion molecule is slowly cleaved by -secretase prior to efficient proteasomal degradation of its intracellular domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epithelial cell adhesion molecule (EpCAM); gamma-secretase; proteasome degradation; regulated intramembrane proteolysis; protein processing; live-cell imaging; sheddase; cell adhesion; proteolytic processing; transmembrane protein; cell signaling	REGULATED INTRAMEMBRANE PROTEOLYSIS; AMYLOID PRECURSOR PROTEIN; GAMMA-SECRETASE; EPCAM EXPRESSION; EP-CAM; ANTIGEN; TUMOR; CANCER; CONTRIBUTES; MAINTENANCE	Regulated intramembrane proteolysis (RIP) is a key mechanism for activating transmembrane proteins such as epithelial cell adhesion molecule (EpCAM) for cellular signaling and degradation. EpCAM is highly expressed in carcinomas and progenitor and embryonic stem cells and is involved in the regulation of cell adhesion, proliferation, and differentiation. Strictly sequential cleavage of EpCAM through RIP involves initial shedding of the extracellular domain by -secretase (ADAM) and -secretase (BACE) sheddases, generating a membrane-tethered C-terminal fragment EpCTF. Subsequently, the rate-limiting -secretase complex catalyzes intramembrane cleavage of EpCTF, generating an extracellular EpCAM-A-like fragment and an intracellular EpICD fragment involved in nuclear signaling. Here, we have combined biochemical approaches with live-cell imaging of fluorescent protein tags to investigate the kinetics of -secretase-mediated intramembrane cleavage of EpCTF. We demonstrate that -secretase-mediated proteolysis of exogenously and endogenously expressed EpCTF is a slow process with a 50% protein turnover in cells ranging from 45 min to 5.5 h. The slow cleavage was dictated by -secretase activity and not by EpCTF species, as indicated by cross-species swapping experiments. Furthermore, both human and murine EpICDs generated from EpCTF by -secretase were degraded efficiently (94-99%) by the proteasome. Hence, proteolytic cleavage of EpCTF is a comparably slow process, and EpICD generation does not appear to be suited for rapidly transducing extracellular cues into nuclear signaling, but appears to provide steady signals that can be further controlled through efficient proteasomal degradation. Our approach provides an unbiased bioassay to investigate proteolytic processing of EpCTF in single living cells.	[Huang, Yuanchi; Chanou, Anna; Kranz, Gisela; Pan, Min; Kohlbauer, Vera; Gires, Olivier] Ludwig Maximilians Univ Munchen, Dept Otorhinolaryngol Head & Neck Surg, Grosshadern Med Ctr, Marchioninistr 15, D-81377 Munich, Germany; [Huang, Yuanchi] Xi An Jiao Tong Univ, Honghui Hosp, Dept Spinal Surg, Xian 710054, Shaanxi, Peoples R China; [Ettinger, Andreas] Inst Epigenet & Stem Cells, Marchioninistr 25, D-81377 Munich, Germany; [Gires, Olivier] Helmholtz Zentrum Munchen, Clin Cooperat Grp Personalized Radiotherapy Head, D-85764 Neuherberg, Germany	University of Munich; Xi'an Jiaotong University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Huang, YC; Gires, O (corresponding author), Ludwig Maximilians Univ Munchen, Dept Otorhinolaryngol Head & Neck Surg, Grosshadern Med Ctr, Marchioninistr 15, D-81377 Munich, Germany.	huangychell@163.com; olivier.gires@med.uni-muenchen.de	Pan, Min/HDM-7621-2022	Pan, Min/0000-0002-8419-9357; Ettinger, Andreas/0000-0001-6436-010X	Deutsche Forschungsgemeinschaft [GI 540/3-1, GI 540/3-2]; ERC-StG Grant [280840]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ERC-StG Grant	This work was funded in part by Deutsche Forschungsgemeinschaft Grants GI 540/3-1 and GI 540/3-2 (to O.G.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported in part by ERC-StG Grant 280840 (to M. E. Torres-Padilla).	Baeuerle PA, 2007, BRIT J CANCER, V96, P417, DOI 10.1038/sj.bjc.6603494; Balzar M, 1999, J MOL MED, V77, P699, DOI 10.1007/s001099900038; Bolduc DM, 2014, P NATL ACAD SCI USA, V111, P14643, DOI 10.1073/pnas.1416637111; Chaves-Perez A, 2013, ONCOGENE, V32, P641, DOI 10.1038/onc.2012.75; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; Denzel S, 2012, INT J EXP PATHOL, V93, P341, DOI 10.1111/j.1365-2613.2012.00826.x; Denzel S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-402; Dickey SW, 2013, CELL, V155, P1270, DOI 10.1016/j.cell.2013.10.053; Driemel C, 2014, ONCOGENE, V33, P4904, DOI 10.1038/onc.2013.441; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Gaber A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31482-7; Gerlach JC, 2018, J CELL PHYSIOL, V233, P4841, DOI 10.1002/jcp.26286; Gires O, 2014, CELL MOL LIFE SCI, V71, P4393, DOI 10.1007/s00018-014-1693-1; Gonzalez B, 2009, STEM CELLS, V27, P1782, DOI 10.1002/stem.97; Gorges TM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-178; Hachmeister M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071836; Hsu YT, 2016, CANCER RES, V76, P6171, DOI 10.1158/0008-5472.CAN-16-0752; Huang HP, 2011, J BIOL CHEM, V286, P33520, DOI 10.1074/jbc.M111.256164; Kamp F, 2015, BIOPHYS J, V108, P1229, DOI 10.1016/j.bpj.2014.12.045; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Kuan II, 2017, SCI REP-UK, V7, DOI 10.1038/srep41852; Lal M, 2011, PHYSIOLOGY, V26, P34, DOI 10.1152/physiol.00028.2010; Liang KH, 2018, CANCER LETT, V433, P165, DOI 10.1016/j.canlet.2018.06.040; Lichtenthaler SF, 2018, EMBO J, V37, DOI 10.15252/embj.201899456; Lichtenthaler SF, 2011, J NEUROCHEM, V117, P779, DOI 10.1111/j.1471-4159.2011.07248.x; Lin CW, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.386235; LITVINOV SV, 1994, CELL ADHES COMMUN, V2, P417, DOI 10.3109/15419069409004452; LITVINOV SV, 1994, J CELL BIOL, V125, P437, DOI 10.1083/jcb.125.2.437; Lu PL, 2014, NATURE, V512, P166, DOI 10.1038/nature13567; Lu TY, 2010, J BIOL CHEM, V285, P8719, DOI 10.1074/jbc.M109.077081; Maaser K, 2008, BRIT J CANCER, V99, P1635, DOI 10.1038/sj.bjc.6604725; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; Medina M, 2003, CELL SIGNAL, V15, P829, DOI 10.1016/S0898-6568(03)00041-X; Munz M, 2004, ONCOGENE, V23, P5748, DOI 10.1038/sj.onc.1207610; Munz M, 2008, FRONT BIOSCI-LANDMRK, V13, P5195, DOI 10.2741/3075; Munz M, 2009, CANCER RES, V69, P5627, DOI 10.1158/0008-5472.CAN-09-0654; Pan M, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006624; Puram SV, 2017, CELL, V171, P1611, DOI 10.1016/j.cell.2017.10.044; Sankpal NV, 2017, ONCOGENE, V36, P3706, DOI 10.1038/onc.2016.504; Sankpal NV, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3070; Sankpal NV, 2009, CANCER RES, V69, P753, DOI 10.1158/0008-5472.CAN-08-2708; Sarrach S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20131-8; Sato T, 2007, J BIOL CHEM, V282, P33985, DOI 10.1074/jbc.M705248200; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Solanas G, 2011, NAT CELL BIOL, V13, P1100, DOI 10.1038/ncb2298; Tsaktanis T, 2015, J BIOL CHEM, V290, P24574, DOI 10.1074/jbc.M115.662700; Wang HX, 2017, ONCOTARGET, V8, P1884, DOI 10.18632/oncotarget.12242; Yu T, 2017, SCI REP-UK, V7, DOI 10.1038/srep46315	49	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2019	294	9					3051	3064		10.1074/jbc.RA118.005874	http://dx.doi.org/10.1074/jbc.RA118.005874			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU0SA	30598504	Green Published, hybrid			2022-12-28	WOS:000464980100007
J	Jia, WS; Liang, D; Li, N; Liu, MJ; Dong, ZJ; Li, JY; Dong, XH; Yue, YY; Hu, P; Yao, JH; Zhao, QS				Jia, Wenshuang; Liang, Dong; Li, Nan; Liu, Meijing; Dong, Zhangji; Li, Jingyun; Dong, Xiaohua; Yue, Yunyun; Hu, Ping; Yao, Jihua; Zhao, Qingshun			Zebrafish microRNA miR-210-5p inhibits primitive myelopoiesis by silencing foxj1b and slc3a2a mRNAs downstream of gata4/5/6 transcription factor genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						zebrafish; microRNA (miRNA); microRNA mechanism; post-transcriptional regulation; transcription factor; foxj1b; gata4/5/6; miR-210-5p; primitive myelopoiesis; slc3a2a	CELL-DEVELOPMENT; HYPOXIA; EXPRESSION; PROGNOSIS	Zebrafish gata4/5/6 genes encode transcription factors that lie on the apex of the regulatory hierarchy in primitive myelopoiesis. However, little is known about the roles of microRNAs in gata4/5/6-regulated processes. Performing RNA-Seq deep sequencing analysis of the expression changes of microRNAs in gata4/5/6-knockdown embryos, we identified miR-210-5p as a regulator of zebrafish primitive myelopoiesis. Knocking down gata4/5/6 (generating gata5/6 morphants) significantly increased miR-210-5p expression, whereas gata4/5/6 overexpression greatly reduced its expression. Consistent with inhibited primitive myelopoiesis in the gata5/6 morphants, miR-210-5p overexpression repressed primitive myelopoiesis, indicated by reduced numbers of granulocytes and macrophages. Moreover, knocking out miR-210 partially rescued the defective primitive myelopoiesis in zebrafish gata4/5/6-knockdown embryos. Furthermore, we show that the restrictive role of miR-210-5p in zebrafish primitive myelopoiesis is due to impaired differentiation of hemangioblast into myeloid progenitor cells. By comparing the set of genes with reduced expression levels in the gata5/6 morphants to the predicted target genes of miR-210-5p, we found that foxj1b and slc3a2a, encoding a forkhead box transcription factor and a solute carrier family 3 protein, respectively, are two direct downstream targets of miR-210-5p that mediate its inhibitory roles in zebrafish primitive myelopoiesis. In summary, our results reveal that miR-210-5p has an important role in the genetic network controlling zebrafish primitive myelopoiesis.	[Jia, Wenshuang; Li, Nan; Liu, Meijing; Dong, Zhangji; Li, Jingyun; Dong, Xiaohua; Yue, Yunyun; Zhao, Qingshun] Nanjing Univ, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, Nanjing 210061, Jiangsu, Peoples R China; [Liang, Dong; Hu, Ping] Nanjing Med Univ, Dept Prenatal Diag, Obstet & Gynecol Hosp, Nanjing Matern & Child Hlth Care Hosp, Nanjing 210004, Jiangsu, Peoples R China; [Yao, Jihua] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China	Nanjing University; Nanjing Medical University; Fudan University	Liang, D (corresponding author), Nanjing Med Univ, Dept Prenatal Diag, Obstet & Gynecol Hosp, Nanjing Matern & Child Hlth Care Hosp, Nanjing 210004, Jiangsu, Peoples R China.; Zhao, QS (corresponding author), Nanjing Univ, Model Anim Res Ctr, 12 Xuefu Rd, Nanjing 210061, Jiangsu, Peoples R China.	liangdong@njmu.edu.cn; qingshun@nju.edu.cn			National Natural Science Foundation of China [31271569, 31471355, 81500244]; State Key Laboratory of Genetic Engineering, Fudan University [SKLGE-1408]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Genetic Engineering, Fudan University	This work was supported by National Natural Science Foundation of China Grants 31271569, 31471355, and 81500244 and State Key Laboratory of Genetic Engineering, Fudan University Grant SKLGE-1408. The authors declare that they have no conflicts of interest with the contents of this article.	Alemdehy MF, 2012, BLOOD, V119, P4723, DOI 10.1182/blood-2011-10-386359; Becker AM, 2012, BLOOD, V119, P2003, DOI 10.1182/blood-2011-06-364976; Bennett CM, 2001, BLOOD, V98, P643, DOI 10.1182/blood.V98.3.643; Bissels U, 2012, HAEMATOL-HEMATOL J, V97, P160, DOI 10.3324/haematol.2011.051730; Borthwick F, 2010, CLIN SCI, V119, P265, DOI 10.1042/CS20100266; Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Cicchillitti L, 2012, J BIOL CHEM, V287, P44761, DOI 10.1074/jbc.M112.421255; Davidson AJ, 2004, ONCOGENE, V23, P7233, DOI 10.1038/sj.onc.1207943; Dong ZJ, 2014, INT J BIOCHEM CELL B, V55, P329, DOI 10.1016/j.biocel.2014.08.020; Fan HB, 2014, BLOOD, V124, P1320, DOI 10.1182/blood-2013-12-545012; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Fogelstrand P, 2009, J EXP MED, V206, P2397, DOI 10.1084/jem.20082845; Ghani S, 2011, BLOOD, V118, P2275, DOI 10.1182/blood-2011-02-335141; Giannakakis A, 2008, CANCER BIOL THER, V7, P255, DOI 10.4161/cbt.7.2.5297; Gomes I, 2002, BLOOD, V100, P107, DOI 10.1182/blood.V100.1.107; Hsia N, 2005, EXP HEMATOL, V33, P1007, DOI 10.1016/j.exphem.2005.06.013; Hu P, 2008, DEV DYNAM, V237, P3798, DOI 10.1002/dvdy.21801; Ivan M, 2008, J CELL MOL MED, V12, P1426, DOI 10.1111/j.1582-4934.2008.00398.x; Jeyaseelan K, 2008, STROKE, V39, P959, DOI 10.1161/STROKEAHA.107.500736; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Karsunky H, 2002, NAT GENET, V30, P295, DOI 10.1038/ng831; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Kurkewich JL, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006887; Lee TY, 2013, J INTERF CYTOK RES, V33, P34, DOI 10.1089/jir.2012.0062; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Liang D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030865; Lieschke GJ, 2002, DEV BIOL, V246, P274, DOI 10.1006/dbio.2002.0657; Markou A, 2014, CLIN CHEM, V60, P197, DOI 10.1373/clinchem.2013.210542; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Mei YY, 2014, CANCER SCI, V105, P463, DOI 10.1111/cas.12370; Peterkin T, 2007, DEV BIOL, V311, P623, DOI 10.1016/j.ydbio.2007.08.018; Peterkin T, 2009, DEVELOPMENT, V136, P1465, DOI 10.1242/dev.032748; Shalaby SM, 2016, IUBMB LIFE, V68, P673, DOI 10.1002/iub.1529; Sumanas S, 2008, BLOOD, V111, P4500, DOI 10.1182/blood-2007-09-110569; Sweetman D, 2006, DEV DYNAM, V235, P2185, DOI 10.1002/dvdy.20881; Takesono A, 2012, P NATL ACAD SCI USA, V109, P3371, DOI 10.1073/pnas.1200642109; Tang Xiaoqiong, 2015, Med Sci Monit, V21, P3427; Tian T, 2009, BIOCHEM BIOPH RES CO, V380, P537, DOI 10.1016/j.bbrc.2009.01.111; van Rooij E, 2008, CIRC RES, V103, P919, DOI 10.1161/CIRCRESAHA.108.183426; Velu CS, 2009, BLOOD, V113, P4720, DOI 10.1182/blood-2008-11-190215; Volinia S, 2012, P NATL ACAD SCI USA, V109, P3024, DOI 10.1073/pnas.1200010109; Vosa U, 2013, INT J CANCER, V132, P2884, DOI 10.1002/ijc.27981; White K, 2015, EMBO MOL MED, V7, P695, DOI 10.15252/emmm.201404511; Ying Q, 2011, HEPATOLOGY, V54, P2064, DOI 10.1002/hep.24614	45	5	5	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2732	2743		10.1074/jbc.RA118.005079	http://dx.doi.org/10.1074/jbc.RA118.005079			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30593510	hybrid, Green Published			2022-12-28	WOS:000459601600014
J	Xi, G; Shen, XC; Wai, C; White, MF; Clemmons, DR				Xi, Gang; Shen, Xinchun; Wai, Christine; White, Morris F.; Clemmons, David R.			Hyperglycemia induces vascular smooth muscle cell dedifferentiation by suppressing insulin receptor substrate-1-mediated p53/KLF4 complex stabilization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						insulin receptor substrate 1 (IRS-1); p53; insulin resistance; myocardin; Kruppel-like factor 4 (KLF4); atherosclerosis; inflammation; metabolic regulation; cardiovascular disease; smooth muscle	MAMMALIAN TARGET; DOWN-REGULATION; DIFFERENTIATION MARKERS; SUBSTRATE 1; ACTIVATION; P53; PROLIFERATION; GENE; ATHEROSCLEROSIS; MYOCARDIN	Hyperglycemia and insulin resistance accelerate atherosclerosis by an unclear mechanism. The two factors down-regulate insulin receptor substrate-1 (IRS-1), an intermediary of the insulin/IGF-I signaling system. We previously reported that IRS-1 down-regulation leads to vascular smooth muscle cell (VSMC) dedifferentiation and that IRS-1 deletion from VSMCs in normoglycemic mice replicates this response. However, we did not determine IRS-1's role in mediating differentiation. Here, we sought to define the mechanism by which IRS-1 maintains VSMC differentiation. High glucose or IRS-1 knockdown decreased p53 levels by enhancing MDM2 proto-oncogene (MDM2)-mediated ubiquitination, resulting in decreased binding of p53 to Kruppel-like factor 4 (KLF4). Exposure to nutlin-3, which dissociates MDM2/p53, decreased p53 ubiquitination and enhanced the p53/KLF4 association and differentiation marker protein expression. IRS-1 overexpression in high glucose inhibited the MDM2/p53 association, leading to increased p53 and p53/KLF4 levels, thereby increasing differentiation. Nutlin-3 treatment of diabetic or Irs1(-/-) mice enhanced p53/KLF4 and the expression of p21, smooth muscle protein 22 (SM22), and myocardin and inhibited aortic VSMC proliferation. Injecting normoglycemic mice with a peptide disrupting the IRS-1/p53 association reduced p53, p53/KLF4, and differentiation. Analyzing atherosclerotic lesions in hypercholesterolemic, diabetic pigs, we found that p53, IRS-1, SM22, myocardin, and KLF4/p53 levels are significantly decreased compared with their expression in nondiabetic pigs. We conclude that IRS-1 is critical for maintaining VSMC differentiation. Hyperglycemia- or insulin resistance-induced IRS-1 down-regulation decreases the p53/KLF4 association and enhances dedifferentiation and proliferation. Our results suggest that enhancing IRS-1-dependent p53 stabilization could attenuate the progression of atherosclerotic lesions in hyperglycemia and insulin-resistance states.	[Xi, Gang; Wai, Christine; Clemmons, David R.] Univ N Carolina, Dept Med, Div Endocrinol, Sch Med, Chapel Hill, NC 27599 USA; [Shen, Xinchun] Nanjing Univ Finance & Econ, Coll Food Sci & Engn, Nanjing 210023, Jiangsu, Peoples R China; [White, Morris F.] Harvard Med Sch, Childrens Hosp, Dept Med, Div Endocrinol, Boston, MA 02115 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Nanjing University of Finance & Economics; Harvard University; Boston Children's Hospital; Harvard Medical School	Clemmons, DR (corresponding author), Univ N Carolina, Div Endocrinol, CB 7170,8024 Burnett Womack, Chapel Hill, NC 27599 USA.	david_clemmons@med.unc.edu			National Institutes of Health [AG02331]; National Natural Science Foundation of China [21476103]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098655] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant AG02331. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Natural Science Foundation of China Grant 21476103.	Baroni MG, 1999, ARTERIOSCL THROM VAS, V19, P2975, DOI 10.1161/01.ATV.19.12.2975; Cao RY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175061; Chistiakov DA, 2015, ACTA PHYSIOL, V214, P33, DOI 10.1111/apha.12466; DeStefano MA, 2013, BIOCHEM SOC T, V41, P896, DOI 10.1042/BST20130018; Ding M, 2011, ARTERIOSCL THROM VAS, V31, P1403, DOI 10.1161/ATVBAHA.110.216804; Frismantiene A, 2016, CELL SIGNAL, V28, P516, DOI 10.1016/j.cellsig.2016.02.014; GOCKERMAN A, 1995, CIRC RES, V76, P514, DOI 10.1161/01.RES.76.4.514; Guevara NV, 1999, NAT MED, V5, P335, DOI 10.1038/6585; Hakuno F, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00073; Hancer NJ, 2014, J BIOL CHEM, V289, P12467, DOI 10.1074/jbc.M114.554162; Hayashi K, 2004, J BIOL CHEM, V279, P40807, DOI 10.1074/jbc.M405100200; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Lazo PA, 2017, CELL SIGNAL, V33, P49, DOI 10.1016/j.cellsig.2017.02.005; Li G, 2015, CARDIOVASC RES, V105, P75, DOI 10.1093/cvr/cvu235; Liu Y, 2005, J BIOL CHEM, V280, P9719, DOI 10.1074/jbc.M412862200; Maile LA, 2017, ATHEROSCLEROSIS, V258, P40, DOI 10.1016/j.atherosclerosis.2017.01.030; Maile LA, 2008, DIABETES, V57, P2637, DOI 10.2337/db08-0326; Maile LA, 2007, ENDOCRINOLOGY, V148, P2435, DOI 10.1210/en.2006-1440; Mercer J, 2005, CIRC RES, V96, P667, DOI 10.1161/01.RES.0000161069.15577.ca; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Nemoto S, 2014, ATHEROSCLEROSIS, V233, P64, DOI 10.1016/j.atherosclerosis.2013.12.032; Nguyen AT, 2013, CIRC RES, V112, P17, DOI 10.1161/CIRCRESAHA.112.281048; Pidkovka NA, 2007, CIRC RES, V101, P792, DOI 10.1161/CIRCRESAHA.107.152736; Radhakrishnan Y, 2008, J BIOL CHEM, V283, P16320, DOI 10.1074/jbc.M801687200; Radhakrishnan Y, 2011, MOL ENDOCRINOL, V25, P1636, DOI 10.1210/me.2011-0035; Radhakrishnan Y, 2010, J BIOL CHEM, V285, P15682, DOI 10.1074/jbc.M109.092270; SAAD MJA, 1992, J CLIN INVEST, V90, P1839, DOI 10.1172/JCI116060; Sadagurski M, 2013, ENDOCRIN METAB CLIN, V42, P127, DOI 10.1016/j.ecl.2012.11.008; Sentinelli F, 2006, J ENDOCRINOL, V188, P271, DOI 10.1677/joe.1.06290; Shamhart PE, 2009, AM J PHYSIOL-ENDOC M, V297, pE1147, DOI 10.1152/ajpendo.00327.2009; Shi JH, 2012, J BIOL CHEM, V287, P10799, DOI 10.1074/jbc.M111.321836; Taniyama Y, 2005, ARTERIOSCL THROM VAS, V25, P1142, DOI 10.1161/01.ATV.0000164313.17167.df; Tsuchiya K, 2007, J ATHEROSCLER THROMB, V14, P303, DOI 10.5551/jat.E525; Turner EC, 2013, BBA-GENE REGUL MECH, V1829, P1191, DOI 10.1016/j.bbagrm.2013.09.002; Wang CCL, 2003, DIABETES, V52, P2562, DOI 10.2337/diabetes.52.10.2562; Wassmann K, 2010, MOL CELL BIOCHEM, V333, P33, DOI 10.1007/s11010-009-0201-7; Wassmann S, 2007, J MOL CELL CARDIOL, V43, P301, DOI 10.1016/j.yjmcc.2007.06.001; Wu GZ, 2014, CIRCULATION, V130, P1452, DOI 10.1161/CIRCULATIONAHA.114.011675; Wu WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094957; Xi G, 2008, MOL ENDOCRINOL, V22, P2162, DOI 10.1210/me.2008-0079; Xi G, 2017, J BIOL CHEM, V292, P2009, DOI 10.1074/jbc.M116.758987; Xi G, 2015, FASEB J, V29, P4772, DOI 10.1096/fj.15-275453; Xi G, 2012, DIABETES, V61, P104, DOI 10.2337/db11-0990; Yoshida T, 2008, CIRC RES, V102, P1548, DOI 10.1161/CIRCRESAHA.108.176974; Yoshida T, 2014, J BIOL CHEM, V289, P26107, DOI 10.1074/jbc.M114.582809; Yoshida T, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000230; Yoshida T, 2008, AM J PHYSIOL-CELL PH, V295, pC1175, DOI 10.1152/ajpcell.00288.2008; Zhang WQ, 2000, J BIOL CHEM, V275, P18391, DOI 10.1074/jbc.C000062200; Zheng B, 2010, IUBMB LIFE, V62, P132, DOI 10.1002/iub.298; Zheng XL, 2014, ARCH BIOCHEM BIOPHYS, V543, P48, DOI 10.1016/j.abb.2013.12.015	50	14	15	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2019	294	7					2407	2421		10.1074/jbc.RA118.005398	http://dx.doi.org/10.1074/jbc.RA118.005398			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL7CN	30578299	hybrid, Green Published			2022-12-28	WOS:000458895400018
J	Mao, PZ; Wortham, AM; Enns, CA; Zhang, AS				Mao, Peizhong; Wortham, Aaron M.; Enns, Caroline A.; Zhang, An-Sheng			The catalytic, stem, and transmembrane portions of matriptase-2 are required for suppressing the expression of the iron-regulatory hormone hepcidin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						iron metabolism; liver; serine protease; bone morphogenetic protein (BMP); receptor; hemojuvelin; hepcidin; HFE; matriptase-2; transferrin receptor-2	SERINE-PROTEASE TMPRSS6; DEFICIENCY ANEMIA; GENE-EXPRESSION; DOWN-REGULATION; CLEAVAGE SITES; HEMOJUVELIN; MUTATIONS; LIVER; IDENTIFICATION; HOMEOSTASIS	Matriptase-2 (MT2) is a type-II transmembrane, trypsin-like serine protease that is predominantly expressed in the liver. It is a key suppressor for the expression of hepatic hepcidin, an iron-regulatory hormone that is induced via the bone morphogenetic protein signaling pathway. A current model predicts that MT2 suppresses hepcidin expression by cleaving multiple components of the induction pathway. MT2 is synthesized as a zymogen that undergoes autocleavage for activation and shedding. However, the biologically active form of MT2 and, importantly, the contributions of different MT2 domains to its function are largely unknown. Here we examined the activities of truncated MT2 that were generated by site-directed mutagenesis or Gibson assembly master mix, and found that the stem region of MT2 determines the specificity and efficacy for substrate cleavage. The transmembrane domain allowed MT2 activation after reaching the plasma membrane, and the cytoplasmic domain facilitated these processes. Further in vivo rescue studies indicated that the entire extracellular and transmembrane domains of MT2 are required to correct the low-hemoglobin, low-serum iron, and high-hepcidin status in MT2(-/-) mice. Unlike in cell lines, no autocleavage of MT2 was detected in vivo in the liver, implying that MT2 may also function independently of its proteolytic activity. In conjunction with our previous studies implicating the cytoplasmic domain as an intracellular iron sensor, these observations reveal the importance of each MT2 domain for MT2-mediated substrate cleavage and for its biological function.	[Mao, Peizhong; Wortham, Aaron M.; Enns, Caroline A.; Zhang, An-Sheng] Oregon Hlth & Sci Univ, Dept Cell Dev & Canc Biol, Portland, OR 97239 USA	Oregon Health & Science University	Zhang, AS (corresponding author), OHSU, Dept Cell Dev & Canc Biol, L215,3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	zhanga@ohsu.edu			National Institutes of Health [R01DK102791, R01DK072166]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072166, R37DK054488, R01DK102791] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01DK102791 (to A. S. Z.) and R01DK072166 (to C. A. E.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Bartnikas TB, 2013, HAEMATOLOGICA, V98, P854, DOI 10.3324/haematol.2012.074617; Beckmann AM, 2016, CHEMBIOCHEM, V17, P595, DOI 10.1002/cbic.201500651; Beliveau F, 2011, J BIOL CHEM, V286, P29035, DOI 10.1074/jbc.M111.223461; Camaschella C, 2015, NEW ENGL J MED, V373, P485, DOI 10.1056/NEJMc1507104; Canali S, 2017, AM J HEMATOL, V92, P1204, DOI 10.1002/ajh.24888; Canali S, 2017, BLOOD, V129, P405, DOI 10.1182/blood-2016-06-721571; De Falco L, 2014, HUM MUTAT, V35, P1321, DOI 10.1002/humu.22632; Du X, 2008, SCIENCE, V320, P1088, DOI 10.1126/science.1157121; Enns CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060534; Finberg KE, 2008, NAT GENET, V40, P569, DOI 10.1038/ng.130; Finberg KE, 2010, BLOOD, V115, P3817, DOI 10.1182/blood-2009-05-224808; Folgueras AR, 2008, BLOOD, V112, P2539, DOI 10.1182/blood-2008-04-149773; Friis S, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0384-4; Friis S, 2016, J BIOL CHEM, V291, P2577, DOI 10.1074/jbc.C115.706721; Ganz T, 2012, BBA-MOL CELL RES, V1823, P1434, DOI 10.1016/j.bbamcr.2012.01.014; Gao JW, 2010, BLOOD, V115, P3374, DOI 10.1182/blood-2009-09-245209; Gurieva I, 2017, BLOOD CELL MOL DIS, V64, P1, DOI 10.1016/j.bcmd.2017.02.007; Jiang J, 2014, J BIOL CHEM, V289, P19500, DOI 10.1074/jbc.M114.555110; Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354; Kodama K, 2014, PEDIATR INT, V56, pE41, DOI 10.1111/ped.12395; Krijt J, 2011, BLOOD CELL MOL DIS, V47, P133, DOI 10.1016/j.bcmd.2011.04.009; Larsen BR, 2013, EXP CELL RES, V319, P918, DOI 10.1016/j.yexcr.2013.01.008; Lin L, 2008, BLOOD CELL MOL DIS, V40, P122, DOI 10.1016/j.bcmd.2007.06.023; Maurer E, 2013, BIOCHEM J, V450, P583, DOI 10.1042/BJ20121518; Maxson JE, 2010, J BIOL CHEM, V285, P39021, DOI 10.1074/jbc.M110.183160; Maxson JE, 2009, BLOOD, V113, P1786, DOI 10.1182/blood-2008-08-174565; Mayeur C, 2014, BLOOD, V124, P2116, DOI 10.1182/blood-2014-04-572644; McDonald CJ, 2015, AM J PHYSIOL-CELL PH, V308, pC539, DOI 10.1152/ajpcell.00264.2014; Meynard D, 2011, BLOOD, V118, P747, DOI 10.1182/blood-2011-04-348698; Muckenthaler MU, 2017, CELL, V168, P344, DOI 10.1016/j.cell.2016.12.034; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Papanikolaou G, 2004, NAT GENET, V36, P77, DOI 10.1038/ng1274; Ramsay AJ, 2009, HAEMATOL-HEMATOL J, V94, P840, DOI 10.3324/haematol.2008.001867; Rausa M, 2015, J CELL MOL MED, V19, P879, DOI 10.1111/jcmm.12462; Roetto A, 2003, NAT GENET, V33, P21, DOI 10.1038/ng1053; Sal E, 2016, PEDIATR HEMAT ONCOL, V33, P226, DOI 10.3109/08880018.2016.1157229; Silvestri L, 2008, CELL METAB, V8, P502, DOI 10.1016/j.cmet.2008.09.012; Silvestri L, 2009, BLOOD, V113, P5605, DOI 10.1182/blood-2008-12-195594; Steinbicker AU, 2011, BLOOD, V118, P4224, DOI 10.1182/blood-2011-03-339952; Stirnberg M, 2010, BIOCHEM J, V430, P87, DOI 10.1042/BJ20091565; Szabo R, 2016, DEVELOPMENT, V143, P2818, DOI 10.1242/dev.137968; Velasco G, 2002, J BIOL CHEM, V277, P37637, DOI 10.1074/jbc.M203007200; Wahedi M, 2017, J BIOL CHEM, V292, P18354, DOI 10.1074/jbc.M117.801795; Wang CY, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00114; Wang RH, 2005, CELL METAB, V2, P399, DOI 10.1016/j.cmet.2005.10.010; Yaish HM, 2017, BLOOD CELL MOL DIS, V65, P38, DOI 10.1016/j.bcmd.2017.04.002; YU JX, 1995, J BIOL CHEM, V270, P13483, DOI 10.1074/jbc.270.22.13483; Zhang AS, 2011, BLOOD, V117, P1687, DOI 10.1182/blood-2010-06-287292; Zhang AS, 2010, J BIOL CHEM, V285, P16416, DOI 10.1074/jbc.M110.109488; Zhang AS, 2009, J BIOL CHEM, V284, P22580, DOI 10.1074/jbc.M109.027318; Zhang AS, 2004, BLOOD, V103, P1509, DOI 10.1182/blood-2003-07-2378; Zhao NN, 2016, J BIOL CHEM, V291, P12322, DOI 10.1074/jbc.M116.721191; Zhao NN, 2015, J BIOL CHEM, V290, P4432, DOI 10.1074/jbc.M114.611913	54	7	8	4	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2019	294	6					2060	2073		10.1074/jbc.RA118.006468	http://dx.doi.org/10.1074/jbc.RA118.006468			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM8EO	30559294	Green Published, hybrid			2022-12-28	WOS:000459711400024
J	Gunther, LK; Rohde, JA; Tang, WJ; Walton, SD; Unrath, WC; Trivedi, DV; Muretta, JM; Thomas, DD; Yengo, CM				Gunther, Laura K.; Rohde, John A.; Tang, Wanjian; Walton, Shane D.; Unrath, William C.; Trivedi, Darshan V.; Muretta, Joseph M.; Thomas, David D.; Yengo, Christopher M.			Converter domain mutations in myosin alter structural kinetics and motor function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						myosin; actin; muscle; fluorescence resonance energy transfer (FRET); cardiomyopathy; ATPase; mechanochemistry; motor protein; structural kinetics	REAL-TIME DETECTION; DILATED CARDIOMYOPATHY; CARDIAC MYOSIN; ACTIN-BINDING; MUSCLE MYOSIN; MECHANISM; FORCE; INSIGHTS; STATES; REVEAL	Myosins are molecular motors that use a conserved ATPase cycle to generate force. We investigated two mutations in the converter domain of myosin V (R712G and F750L) to examine how altering specific structural transitions in the motor ATPase cycle can impair myosin mechanochemistry. The corresponding mutations in the human beta-cardiac myosin gene are associated with hypertrophic and dilated cardiomyopathy, respectively. Despite similar steady-state actin-activated ATPase and unloaded in vitro motility-sliding velocities, both R712G and F750L were less able to overcome frictional loads measured in the loaded motility assay. Transient kinetic analysis and stopped-flow FRET demonstrated that the R712G mutation slowed the maximum ATP hydrolysis and recovery-stroke rate constants, whereas the F750L mutation enhanced these steps. In both mutants, the fast and slow power-stroke as well as actin-activated phosphate release rate constants were not significantly different from WT. Time-resolved FRET experiments revealed that R712G and F750L populate the pre- and post-power-stroke states with similar FRET distance and distance distribution profiles. The R712G mutant increased the mole fraction in the post-power-stroke conformation in the strong actin-binding states, whereas the F750L decreased this population in the actomyosin ADP state. We conclude that mutations in key allosteric pathways can shift the equilibrium and/or alter the activation energy associated with key structural transitions without altering the overall conformation of the pre- and post-power-stroke states. Thus, therapies designed to alter the transition between structural states may be able to rescue the impaired motor function induced by disease mutations.	[Gunther, Laura K.; Tang, Wanjian; Walton, Shane D.; Unrath, William C.; Trivedi, Darshan V.; Yengo, Christopher M.] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA; [Rohde, John A.; Muretta, Joseph M.; Thomas, David D.] Univ Minnesota, Dept Biochem Biophys & Mol Biol, Minneapolis, MN 55455 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Minnesota System; University of Minnesota Twin Cities	Yengo, CM (corresponding author), Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA.	cmy11@psu.edu		Gunther, Laura/0000-0003-4588-2572; Walton, Shane/0000-0002-6779-8112; Tang, Wanjian/0000-0001-7374-6442; Yengo, Christopher/0000-0003-3987-9019	National Institutes of Health [HL127699, R01AR32961, R37AG26160]; American Heart Association [14SDG20480032]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL127699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007612, R01AR032961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG026160] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grant HL127699 (to C. M. Y.) and Grants R01AR32961 and R37AG26160 (to D. D. T.) and American Heart Association Grant 14SDG20480032 (to J. M. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aksel T, 2015, CELL REP, V11, P910, DOI 10.1016/j.celrep.2015.04.006; Bloemink MJ, 2016, J BIOL CHEM, V291, P1763, DOI 10.1074/jbc.M115.688002; Brenner B, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00392; BRISSETTE P, 1989, ANAL BIOCHEM, V181, P234, DOI 10.1016/0003-2697(89)90235-2; Chinthalapudi K, 2017, ELIFE, V6, DOI 10.7554/eLife.32742; CRIDDLE AH, 1985, BIOCHEM J, V232, P343, DOI 10.1042/bj2320343; De la Cruz EM, 2000, BIOCHEMISTRY-US, V39, P14196, DOI 10.1021/bi001701b; De la Cruz EM, 2000, BIOPHYS J, V79, P1524, DOI 10.1016/S0006-3495(00)76403-4; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; De La Cruz EM, 2004, CURR OPIN CELL BIOL, V16, P61, DOI 10.1016/j.ceb.2003.11.011; De La Cruz EM, 2009, METHOD ENZYMOL, V455, P157, DOI 10.1016/S0076-6879(08)04206-7; Debold EP, 2007, AM J PHYSIOL-HEART C, V293, pH284, DOI 10.1152/ajpheart.00128.2007; Enjuto M, 2000, J MOL CELL CARDIOL, V32, P2307, DOI 10.1006/jmcc.2000.1260; Fenn WO, 1924, J PHYSIOL-LONDON, V58, P0373, DOI 10.1113/jphysiol.1924.sp002141; Fischer S, 2005, P NATL ACAD SCI USA, V102, P6873, DOI 10.1073/pnas.0408784102; Greenberg MJ, 2016, BIOPHYS J, V110, P2568, DOI 10.1016/j.bpj.2016.05.021; Greenberg MJ, 2015, P NATL ACAD SCI USA, V112, pE3337, DOI 10.1073/pnas.1506633112; Heissler Sarah M, 2014, Bioarchitecture, V4, P169, DOI 10.1080/19490992.2015.1054092; Heissler SM, 2011, J BIOL CHEM, V286, P21191, DOI 10.1074/jbc.M110.212290; Homburger JR, 2016, P NATL ACAD SCI USA, V113, P6701, DOI 10.1073/pnas.1606950113; Houdusse A, 2000, P NATL ACAD SCI USA, V97, P11238, DOI 10.1073/pnas.200376897; Houdusse A, 2016, TRENDS BIOCHEM SCI, V41, P989, DOI 10.1016/j.tibs.2016.09.006; Jacobs DJ, 2011, J MOL BIOL, V407, P716, DOI 10.1016/j.jmb.2011.02.001; Kamisago M, 2000, NEW ENGL J MED, V343, P1688, DOI 10.1056/NEJM200012073432304; Kawana M, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1601959; Kohler J, 2002, P NATL ACAD SCI USA, V99, P3557, DOI 10.1073/pnas.062415899; Kovacs M, 2003, J BIOL CHEM, V278, P38132, DOI 10.1074/jbc.M305453200; Kronert WA, 2014, J BIOL CHEM, V289, P12779, DOI 10.1074/jbc.M114.550673; Liu YY, 2015, BIOCHEMISTRY-US, V54, P1963, DOI 10.1021/bi5015166; Llinas P, 2015, DEV CELL, V33, P401, DOI 10.1016/j.devcel.2015.03.025; Manstein DJ, 2004, PHILOS T ROY SOC B, V359, P1907, DOI 10.1098/rstb.2004.1565; Maron BJ, 2016, AM J MED, V129, P1170, DOI 10.1016/j.amjmed.2016.02.031; Maron BJ, 2013, LANCET, V381, P242, DOI 10.1016/S0140-6736(12)60397-3; MARSTON SB, 1980, J MOL BIOL, V139, P573, DOI 10.1016/0022-2836(80)90050-9; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Mentes A, 2018, P NATL ACAD SCI USA, V115, P1292, DOI 10.1073/pnas.1718316115; Muretta JM, 2015, P NATL ACAD SCI USA, V112, P14272, DOI 10.1073/pnas.1514859112; Muretta JM, 2013, P NATL ACAD SCI USA, V110, P7211, DOI 10.1073/pnas.1222257110; Muretta JM, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3480647; Nesmelov YE, 2011, P NATL ACAD SCI USA, V108, P1891, DOI 10.1073/pnas.1012320108; Nyitrai M, 2004, PHILOS T R SOC B, V359, P1867, DOI 10.1098/rstb.2004.1560; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Park HY, 2017, KOREAN CIRC J, V47, P291, DOI 10.4070/kcj.2016.0017; Preller M, 2013, STRUCTURE, V21, P1911, DOI 10.1016/j.str.2013.09.015; Rief M, 2000, P NATL ACAD SCI USA, V97, P9482, DOI 10.1073/pnas.97.17.9482; Sasaki N, 1998, ADV BIOPHYS, V35, P1; Schmitt JP, 2006, P NATL ACAD SCI USA, V103, P14525, DOI 10.1073/pnas.0606383103; Seebohm B, 2009, BIOPHYS J, V97, P806, DOI 10.1016/j.bpj.2009.05.023; Semsarian C, 2015, J AM COLL CARDIOL, V65, P1249, DOI 10.1016/j.jacc.2015.01.019; Shuman H, 2014, P NATL ACAD SCI USA, V111, P2116, DOI 10.1073/pnas.1321022111; Spudich JA, 2014, BIOPHYS J, V106, P1236, DOI 10.1016/j.bpj.2014.02.011; Sweeney HL, 2010, ANNU REV BIOPHYS, V39, P539, DOI 10.1146/annurev.biophys.050708.133751; Sweeney HL, 2004, PHILOS T R SOC B, V359, P1829, DOI 10.1098/rstb.2004.1576; Swenson AM, 2014, J BIOL CHEM, V289, P23977, DOI 10.1074/jbc.M114.562231; Syamaladevi DP, 2012, BIOINFORM BIOL INSIG, V6, P11, DOI 10.4137/BBI.S8451; Takagi Y, 2008, J BIOL CHEM, V283, P8527, DOI 10.1074/jbc.M709150200; Tayal U, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0410-8; Trivedi DV, 2015, P NATL ACAD SCI USA, V112, P14593, DOI 10.1073/pnas.1517566112; Trivedi DV, 2013, BIOCHEMISTRY-US, V52, P4710, DOI 10.1021/bi4004364; Trivedi DV, 2012, BIOPHYS J, V102, P2545, DOI 10.1016/j.bpj.2012.04.025; Trybus KM, 2008, CELL MOL LIFE SCI, V65, P1378, DOI 10.1007/s00018-008-7507-6; Trybus KM, 1999, J BIOL CHEM, V274, P27448, DOI 10.1074/jbc.274.39.27448; Wang F, 2003, J BIOL CHEM, V278, P27439, DOI 10.1074/jbc.M302510200; Watkins H, 2011, NEW ENGL J MED, V364, P1643, DOI 10.1056/NEJMra0902923; White HD, 1997, BIOCHEMISTRY-US, V36, P11828, DOI 10.1021/bi970540h; WHITTAKER M, 1995, NATURE, V378, P748, DOI 10.1038/378748a0; Wulf SF, 2016, P NATL ACAD SCI USA, V113, pE1844, DOI 10.1073/pnas.1516598113; Yengo CM, 2004, BIOCHEMISTRY-US, V43, P2605, DOI 10.1021/bi035510v; Yengo CM, 2002, BIOCHEMISTRY-US, V41, P8508, DOI 10.1021/bi015969u	69	12	12	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2019	294	5					1554	1567		10.1074/jbc.RA118.006128	http://dx.doi.org/10.1074/jbc.RA118.006128			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GC	30518549	Green Published, hybrid			2022-12-28	WOS:000457879200011
J	Lu, M; Williamson, N; Mishra, A; Michel, CH; Kaminski, CF; Tunnacliffe, A; Schierle, GSK				Lu, Meng; Williamson, Neil; Mishra, Ajay; Michel, Claire H.; Kaminski, Clemens F.; Tunnacliffe, Alan; Schierle, Gabriele S. Kaminski			Structural progression of amyloid-beta Arctic mutant aggregation in cells revealed by multiparametric imaging	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein aggregation; amyloid-beta (A beta); molecular dynamics; microscopic imaging; structural model; 3D structure of amyloid aggregates; Alzheimer's disease; amyloid-beta; Arctic mutant; neurodegeneration; SIM	A-BETA; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; ACCUMULATION; MORPHOLOGY; MUTATION; OLIGOMERIZATION; DEGRADATION; KINETICS; PICALM	The 42-amino-acid beta-amyloid (A beta 42) is a critical causative agent in the pathology of Alzheimer's disease. The hereditary Arctic mutation of A beta 42 (E22G) leads to increased intracellular accumulation of beta-amyloid in early-onset Alzheimer's disease. However, it remains largely unknown how the Arctic mutant variant leads to aggressive protein aggregation and increased intracellular toxicity. Here, we constructed stable cell lines expressing fluorescent-tagged wildtype (WT) and E22G A beta 42 to study the aggregation kinetics of the Arctic A beta 42 mutant peptide and its heterogeneous structural forms. Arctic-mutant peptides assemble and form fibrils at a much faster rate than WT peptides. We identified five categories of intracellular aggregate-oligomers, single fibrils, fibril bundles, clusters, and aggresomes-that underline the heterogeneity of these A beta 42 aggregates and represent the progression of A beta 42 aggregation within the cell. Fluorescence-lifetime imaging (FLIM) and 3D structural illumination microscopy (SIM) showed that all aggregate species displayed highly compact structures with strong affinity between individual fibrils. We also found that aggregates formed by Arctic mutant A beta 42 were more resistant to intracellular degradation than their WT counterparts. Our findings uncover the structural basis of the progression of Arctic mutant A beta 42 aggregation in the cell.	[Lu, Meng; Mishra, Ajay; Kaminski, Clemens F.; Tunnacliffe, Alan; Schierle, Gabriele S. Kaminski] Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge Infinitus Res Ctr, Cambridge CB3 0AS, England; [Lu, Meng; Williamson, Neil; Mishra, Ajay; Michel, Claire H.; Kaminski, Clemens F.; Schierle, Gabriele S. Kaminski] Univ Cambridge, Dept Chem Engn & Biotechnol, West Cambridge Site,Philippa Fawcett Dr, Cambridge CB3 0AS, England; [Williamson, Neil] Bactevo Ltd, Merrifield Ctr, Rosemary Lane, Cambridge CB1 3LQ, England	University of Cambridge; University of Cambridge	Schierle, GSK (corresponding author), Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge CB2 3RA, England.	gsk20@cam.ac.uk	; Kaminski, Clemens/G-7488-2016	mishra, ajay/0000-0001-8201-4067; Kaminski, Clemens/0000-0002-5194-0962	Infinitus (China) Company Ltd.; European Research Council Advanced Investigator Award [AdG233232]; Wellcome Trust; Alzheimer Research UK (ARUK); UK Medical Research Council (MRC); BBSRC [BB/H023917/1] Funding Source: UKRI; EPSRC [EP/H018301/1] Funding Source: UKRI; MRC [MR/K015850/1, MC_G1000734, MR/K02292X/1, MR/N012453/1, G0902243] Funding Source: UKRI	Infinitus (China) Company Ltd.; European Research Council Advanced Investigator Award(European Research Council (ERC)); Wellcome Trust(Wellcome TrustEuropean Commission); Alzheimer Research UK (ARUK)(Alzheimer's Research UK (ARUK)); UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Infinitus (China) Company Ltd. and European Research Council Advanced Investigator Award AdG233232 (to A. T.) and Wellcome Trust, UK Medical Research Council (MRC), and Alzheimer Research UK (ARUK) funding (to G. S. K. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Chen WY, 2017, NANO LETT, V17, P143, DOI 10.1021/acs.nanolett.6b03686; Cohen SIA, 2013, P NATL ACAD SCI USA, V110, P9758, DOI 10.1073/pnas.1218402110; D'Andrea MR, 2001, HISTOPATHOLOGY, V38, P120, DOI 10.1046/j.1365-2559.2001.01082.x; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Esbjorner EK, 2014, CHEM BIOL, V21, P732, DOI 10.1016/j.chembiol.2014.03.014; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kassler K, 2010, J MOL MODEL, V16, P1011, DOI 10.1007/s00894-009-0611-1; Kawarabayashi T, 2004, J NEUROSCI, V24, P3801, DOI 10.1523/JNEUROSCI.5543-03.2004; Kim SI, 2006, J CELL BIOCHEM, V99, P878, DOI 10.1002/jcb.20978; Kinoshita A, 2003, J CELL SCI, V116, P3339, DOI 10.1242/jcs.00643; Knobloch M, 2007, NEUROBIOL AGING, V28, P1297, DOI 10.1016/j.neurobiolaging.2006.06.019; Kruitwagen T, 2015, ELIFE, V4, DOI 10.7554/eLife.10396; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lin YS, 2012, BIOPHYS J, V103, pL47, DOI 10.1016/j.bpj.2012.11.009; Lord A, 2006, NEUROBIOL AGING, V27, P67, DOI 10.1016/j.neurobiolaging.2004.12.007; Lu M, 2015, J BIOL CHEM, V290, P27986, DOI 10.1074/jbc.M115.676437; Lu M, 2015, BIOTECHNOL BIOENG, V112, P1883, DOI 10.1002/bit.25606; Michel CH, 2014, J BIOL CHEM, V289, P956, DOI 10.1074/jbc.M113.515445; MIZUGUCHI M, 1992, BRAIN RES, V584, P219, DOI 10.1016/0006-8993(92)90898-J; Morel E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3250; Murphy MP, 2010, J ALZHEIMERS DIS, V19, P311, DOI [10.3233/JAD-2009-1221, 10.3233/JAD-2010-1221]; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Norlin N, 2012, J STRUCT BIOL, V180, P174, DOI 10.1016/j.jsb.2012.06.010; Oddo S, 2006, AM J PATHOL, V168, P184, DOI 10.2353/ajpath.2006.050593; ONEIL KT, 1990, SCIENCE, V250, P646, DOI 10.1126/science.2237415; Pensalfini A, 2014, NEUROBIOL DIS, V71, P53, DOI 10.1016/j.nbd.2014.07.011; Peralvarez-Marin A, 2009, BIOPHYS J, V97, P277, DOI 10.1016/j.bpj.2009.04.017; Pinotsi D, 2014, NANO LETT, V14, P339, DOI 10.1021/nl4041093; Ripoli C, 2014, J NEUROSCI, V34, P12893, DOI 10.1523/JNEUROSCI.1201-14.2014; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Schaefer PM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168157; Schierle GSK, 2011, J AM CHEM SOC, V133, P12902, DOI 10.1021/ja201651w; Schreiner B, 2015, J ALZHEIMERS DIS, V43, P369, DOI 10.3233/JAD-132543; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Tanik SA, 2013, J BIOL CHEM, V288, P15194, DOI 10.1074/jbc.M113.457408; Verhoef LGGC, 2002, HUM MOL GENET, V11, P2689, DOI 10.1093/hmg/11.22.2689; Walsh DM, 2000, BIOCHEMISTRY-US, V39, P10831, DOI 10.1021/bi001048s; Warren SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070687; WERTKIN AM, 1993, P NATL ACAD SCI USA, V90, P9513, DOI 10.1073/pnas.90.20.9513; XU HX, 1995, J BIOL CHEM, V270, P23243, DOI 10.1074/jbc.270.40.23243; Young LJ, 2016, JOVE-J VIS EXP, DOI 10.3791/53988; Zhao Z, 2015, NAT NEUROSCI, V18, P978, DOI 10.1038/nn.4025	44	17	17	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2019	294	5					1478	1487		10.1074/jbc.RA118.004511	http://dx.doi.org/10.1074/jbc.RA118.004511			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GC	30504224	Green Published, hybrid			2022-12-28	WOS:000457879200004
J	Wilson, C; Lee, MD; Heathcote, HR; Zhang, X; Buckley, C; Girkin, JM; Saunter, CD; McCarron, JG				Wilson, Calum; Lee, Matthew D.; Heathcote, Helen R.; Zhang, Xun; Buckley, Charlotte; Girkin, John M.; Saunter, Christopher D.; McCarron, John G.			Mitochondrial ATP production provides long-range control of endothelial inositol trisphosphate-evoked calcium signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endothelial cell; inositol 1,4,5-trisphosphate (IP3); calcium imaging; endoplasmic reticulum (ER); mitochondria; cell signaling; fluorescence imaging; inositol trisphosphate; mesenteric artery; reactive oxygen species (ROS); endothelium; ATP; Ca2+signaling; myoendothelial junction	MYOENDOTHELIAL GAP-JUNCTIONS; PROTEIN S-GLUTATHIONYLATION; SMOOTH-MUSCLE; ENDOPLASMIC-RETICULUM; 1,4,5-TRISPHOSPHATE RECEPTOR; CA2+ RELEASE; SARCOPLASMIC-RETICULUM; MESENTERIC-ARTERIES; IP3 RECEPTORS; K-CA	Endothelial cells are reported to be glycolytic and to minimally rely on mitochondria for ATP generation. Rather than providing energy, mitochondria in endothelial cells may act as signaling organelles that control cytosolic Ca2+ signaling or modify reactive oxygen species (ROS). To control Ca2+ signaling, these organelles are often observed close to influx and release sites and may be tethered near Ca2+ transporters. In this study, we used high-resolution, wide-field fluorescence imaging to investigate the regulation of Ca2+ signaling by mitochondria in large numbers of endothelial cells (similar to 50 per field) in intact arteries from rats. We observed that mitochondria were mostly spherical or short-rod structures and were distributed widely throughout the cytoplasm. The density of these organelles did not increase near contact sites with smooth muscle cells. However, local inositol trisphosphate (IP3)-mediated Ca2+ signaling predominated near these contact sites and required polarized mitochondria. Of note, mitochondrial control of Ca2+ signals occurred even when mitochondria were far from Ca2+ release sites. Indeed, the endothelial mitochondria were mobile and moved throughout the cytoplasm. Mitochondrial control of Ca2+ signaling was mediated by ATP production, which, when reduced by mitochondrial depolarization or ATP synthase inhibition, eliminated local IP3-mediated Ca2+ release events. ROS buffering did not significantly alter local Ca2+ release events. These results highlight the importance of mitochondrial ATP production in providing long-range control of endothelial signaling via IP3-evoked local Ca2+ release in intact endothelium.	[Wilson, Calum; Lee, Matthew D.; Heathcote, Helen R.; Zhang, Xun; Buckley, Charlotte; McCarron, John G.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, SIPBS Bldg,161 Cathedral St, Glasgow G4 0RE, Lanark, Scotland; [Girkin, John M.; Saunter, Christopher D.] Univ Durham, Dept Phys, Biophys Sci Inst, Ctr Adv Instrumentat, South Rd, Durham DH1 3LE, England	University of Strathclyde; Durham University	Wilson, C; McCarron, JG (corresponding author), Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, SIPBS Bldg,161 Cathedral St, Glasgow G4 0RE, Lanark, Scotland.	c.wilson@strath.ac.uk; john.mccarron@strath.ac.uk	Wilson, Calum/AAI-1541-2019; Wilson, Calum/AAC-9114-2020	Wilson, Calum/0000-0003-2500-0632; ZHANG, XUN/0000-0003-0790-4291; Girkin, John/0000-0003-2568-3576; Lee, Matthew D/0000-0001-8265-382X; Buckley, Charlotte/0000-0002-7961-4544	Wellcome Trust [202924/Z/16/Z]; British Heart Foundation [PG/16/54/32230, PG16/82/32439]	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation)	This work was supported by Wellcome Trust Grant 202924/Z/16/Z and British Heart Foundation Grants PG/16/54/32230 and PG16/82/32439. The authors declare that they have no conflicts of interest with the contents of this article.	Al-Mehdi AB, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002712; Anzai K, 2000, ANTIOXID REDOX SIGN, V2, P35, DOI 10.1089/ars.2000.2.1-35; Arnaudeau S, 2001, J BIOL CHEM, V276, P29430, DOI 10.1074/jbc.M103274200; Bansaghi S, 2014, J BIOL CHEM, V289, P8170, DOI 10.1074/jbc.M113.504159; Barstow KL, 2004, NEUROSCIENCE, V124, P327, DOI 10.1016/j.neuroscience.2003.12.010; BEZPROZVANNY I, 1993, NEURON, V10, P1175, DOI 10.1016/0896-6273(93)90065-Y; BIRD GS, 1993, J BIOL CHEM, V268, P17917; Boerman EM, 2016, AM J PHYSIOL-HEART C, V310, pH1091, DOI 10.1152/ajpheart.00038.2016; Boitier E, 1999, J CELL BIOL, V145, P795, DOI 10.1083/jcb.145.4.795; Boncompagni S, 2009, MOL BIOL CELL, V20, P1058, DOI 10.1091/mbc.E08-07-0783; BOOTMAN MD, 1992, J BIOL CHEM, V267, P25113; Bruce JIE, 2004, J BIOL CHEM, V279, P12909, DOI 10.1074/jbc.M309070200; Budd SL, 1996, J NEUROCHEM, V66, P403, DOI 10.1046/j.1471-4159.1996.66010403.x; Bultynck G, 2004, BIOCHEM J, V381, P87, DOI 10.1042/BJ20040072; Chalmers S, 2008, J CELL SCI, V121, P75, DOI 10.1242/jcs.014522; Chalmers S, 2016, J PHYSIOL-LONDON, V594, P4283, DOI 10.1113/JP271942; Chalmers S, 2015, SCI REP-UK, V5, DOI 10.1038/srep16875; Chalmers S, 2012, ARTERIOSCL THROM VAS, V32, P3000, DOI 10.1161/ATVBAHA.112.255174; Chalmers S, 2009, CELL CALCIUM, V46, P107, DOI 10.1016/j.ceca.2009.05.007; Cheranov SY, 2004, J PHYSIOL-LONDON, V556, P755, DOI 10.1113/jphysiol.2003.059568; Chidgey J, 2016, FREE RADICAL BIO MED, V97, P274, DOI 10.1016/j.freeradbiomed.2016.06.010; Collins TJ, 2000, BIOCHEM J, V347, P593, DOI 10.1042/0264-6021:3470593; Coutelle O, 2014, EMBO MOL MED, V6, P624, DOI 10.1002/emmm.201303016; Csordas G, 1999, EMBO J, V18, P96, DOI 10.1093/emboj/18.1.96; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Culic O, 1997, AM J PHYSIOL-CELL PH, V273, pC205, DOI 10.1152/ajpcell.1997.273.1.C205; Dai JZ, 2005, CELL CALCIUM, V37, P333, DOI 10.1016/j.ceca.2004.12.002; De Bock K, 2013, CELL, V154, P651, DOI 10.1016/j.cell.2013.06.037; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; De Giorgi F, 2000, CELL CALCIUM, V28, P365, DOI 10.1054/ceca.2000.0177; DOBRINA A, 1983, BIOCHIM BIOPHYS ACTA, V762, P295, DOI 10.1016/0167-4889(83)90084-8; Dora KA, 2003, J VASC RES, V40, P480, DOI 10.1159/000074549; Dranka BP, 2010, FREE RADICAL BIO MED, V48, P905, DOI 10.1016/j.freeradbiomed.2010.01.015; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Eelen G, 2018, PHYSIOL REV, V98, P3, DOI 10.1152/physrev.00001.2017; Eelen G, 2015, CIRC RES, V116, P1231, DOI 10.1161/CIRCRESAHA.116.302855; ERDAHL WL, 1994, BIOPHYS J, V66, P1678, DOI 10.1016/S0006-3495(94)80959-2; FERRIS CD, 1990, P NATL ACAD SCI USA, V87, P2147, DOI 10.1073/pnas.87.6.2147; FERRIS CD, 1991, P NATL ACAD SCI USA, V88, P2232, DOI 10.1073/pnas.88.6.2232; Fitzgerald G, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00100; Francis M, 2016, CIRC RES, V118, P1078, DOI 10.1161/CIRCRESAHA.115.308141; French JB, 2016, SCIENCE, V351, P733, DOI 10.1126/science.aac6054; Groschner LN, 2012, PFLUG ARCH EUR J PHY, V464, P63, DOI 10.1007/s00424-012-1085-z; Guillery O, 2008, NEUROMUSCULAR DISORD, V18, P319, DOI 10.1016/j.nmd.2007.12.008; Haak LL, 2002, J NEUROCHEM, V80, P405, DOI 10.1046/j.0022-3042.2001.00727.x; Hajnoczky G, 1999, J BIOL CHEM, V274, P14157, DOI 10.1074/jbc.274.20.14157; Hajnoczky G, 2000, J PHYSIOL-LONDON, V529, P69, DOI 10.1111/j.1469-7793.2000.00069.x; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; IINO M, 1991, J GEN PHYSIOL, V98, P681, DOI 10.1085/jgp.98.4.681; Kamishima T, 1998, BIOPHYS J, V75, P1767, DOI 10.1016/S0006-3495(98)77618-0; Katakam PVG, 2013, ARTERIOSCL THROM VAS, V33, P752, DOI 10.1161/ATVBAHA.112.300560; KAUFFMAN RF, 1980, J BIOL CHEM, V255, P2735; Khan SA, 2013, BIOCHEM J, V451, P177, DOI 10.1042/BJ20121600; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Koziel A, 2012, PFLUG ARCH EUR J PHY, V464, P657, DOI 10.1007/s00424-012-1156-1; KRUTZFELDT A, 1990, J MOL CELL CARDIOL, V22, P1393, DOI 10.1016/0022-2828(90)90984-A; Landolfi B, 1998, J CELL BIOL, V142, P1235, DOI 10.1083/jcb.142.5.1235; Lapel M, 2017, AM J PHYSIOL-CELL PH, V312, pC56, DOI 10.1152/ajpcell.00250.2016; Ledoux J, 2008, P NATL ACAD SCI USA, V105, P9627, DOI 10.1073/pnas.0801963105; LEIGHTON B, 1987, FEBS LETT, V225, P93, DOI 10.1016/0014-5793(87)81137-7; Lock JT, 2012, J PHYSIOL-LONDON, V590, P3431, DOI [10.1113/jphysiol.2012.230656, 10.1113/jphysiol.2012.232645]; Lock JT, 2011, AM J PHYSIOL-HEART C, V300, pH493, DOI 10.1152/ajpheart.01073.2010; Maarouf N, 2017, MICROCIRCULATION, V24, DOI 10.1111/micc.12330; MacMillan D, 2005, J PHYSIOL-LONDON, V569, P533, DOI 10.1113/jphysiol.2005.096529; MAEDA N, 1991, J BIOL CHEM, V266, P1109; Makino A, 2010, DIABETOLOGIA, V53, P1783, DOI 10.1007/s00125-010-1770-4; Mannella CA, 1998, BIOFACTORS, V8, P225, DOI 10.1002/biof.5520080309; Marchant JS, 2002, AM J PHYSIOL-CELL PH, V282, pC1374, DOI 10.1152/ajpcell.00446.2001; MAYRLEITNER M, 1991, CELL CALCIUM, V12, P505, DOI 10.1016/0143-4160(91)90032-A; McCarron JG, 2004, J BIOL CHEM, V279, P8417, DOI 10.1074/jbc.M311797200; McCarron JG, 1999, J PHYSIOL-LONDON, V516, P149, DOI 10.1111/j.1469-7793.1999.149aa.x; McCarron JG, 2000, J PHYSIOL-LONDON, V525, P113, DOI 10.1111/j.1469-7793.2000.00113.x; McCarron JG, 2017, TRENDS PHARMACOL SCI, V38, P322, DOI 10.1016/j.tips.2017.01.008; McCarron JG, 2013, J VASC RES, V50, P357, DOI 10.1159/000353883; McCarron JG, 2010, J CELL PHYSIOL, V224, P334, DOI 10.1002/jcp.22103; McCarron JG, 2009, J GEN PHYSIOL, V133, P439, DOI 10.1085/jgp.200810189; MERTENS S, 1990, AM J PHYSIOL, V258, pH689, DOI 10.1152/ajpheart.1990.258.3.H689; Mitra K, 2009, P NATL ACAD SCI USA, V106, P11960, DOI 10.1073/pnas.0904875106; Mumtaz S, 2011, CELL CALCIUM, V49, P66, DOI 10.1016/j.ceca.2010.11.010; NICHOLLS DG, 1980, FEBS LETT, V111, P261, DOI 10.1016/0014-5793(80)80806-4; NIXON GF, 1994, J MUSCLE RES CELL M, V15, P682, DOI 10.1007/BF00121075; Oancea E, 1996, J BIOL CHEM, V271, P17253, DOI 10.1074/jbc.271.29.17253; Olson ML, 2012, BIOCHEM SOC T, V40, P158, DOI 10.1042/BST20110705; Olson ML, 2010, J BIOL CHEM, V285, P2040, DOI 10.1074/jbc.M109.027094; Paltauf-Doburzynska J, 2004, J CARDIOVASC PHARM, V44, P423, DOI 10.1097/01.fjc.0000139449.64337.1b; Parker I, 1996, J PHYSIOL-LONDON, V491, P663, DOI 10.1113/jphysiol.1996.sp021247; Pathak T, 2018, PHARMACOL THERAPEUT, V192, P112, DOI 10.1016/j.pharmthera.2018.07.001; Peng JY, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002212; Peters K, 2009, CELL PHYSIOL BIOCHEM, V24, P483, DOI 10.1159/000257490; Piquereau J, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00102; Quintero M, 2006, P NATL ACAD SCI USA, V103, P5379, DOI 10.1073/pnas.0601026103; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; RIZZUTO R, 1994, J CELL BIOL, V126, P1183, DOI 10.1083/jcb.126.5.1183; RIZZUTO R, 1993, SCIENCE, V262, P744, DOI 10.1126/science.8235595; Sandow SL, 2006, J ANAT, V209, P689, DOI 10.1111/j.1469-7580.2006.00647.x; Sandow SL, 2000, CIRC RES, V86, P341, DOI 10.1161/01.RES.86.3.341; Scheitlin CG, 2016, AM J PHYSIOL-CELL PH, V310, pC479, DOI 10.1152/ajpcell.00171.2015; Shenouda SM, 2011, CIRCULATION, V124, P444, DOI 10.1161/CIRCULATIONAHA.110.014506; Shoshan-Barmatz V, 2004, BBA-BIOENERGETICS, V1657, P105, DOI 10.1016/j.bbabio.2004.02.009; Shuai JW, 2005, CELL CALCIUM, V37, P283, DOI 10.1016/j.ceca.2004.10.008; Simmen T, 2005, EMBO J, V24, P717, DOI 10.1038/sj.emboj.7600559; Simpson PB, 1996, J BIOL CHEM, V271, P33493, DOI 10.1074/jbc.271.52.33493; Simpson PB, 1997, J BIOL CHEM, V272, P22654, DOI 10.1074/jbc.272.36.22654; SMITH JB, 1985, J BIOL CHEM, V260, P4413; Sonkusare SK, 2012, SCIENCE, V336, P597, DOI 10.1126/science.1216283; Straub AC, 2012, NATURE, V491, P473, DOI 10.1038/nature11626; Straub SV, 2000, J GEN PHYSIOL, V116, P547, DOI 10.1085/jgp.116.4.547; SUPATTAPONE S, 1988, P NATL ACAD SCI USA, V85, P8747, DOI 10.1073/pnas.85.22.8747; Sward K, 2002, CIRC RES, V90, P792, DOI 10.1161/01.RES.0000015214.40360.84; Szabadkai G, 2006, J CELL BIOL, V175, P901, DOI 10.1083/jcb.200608073; Szado T, 2003, FASEB J, V17, P28, DOI 10.1096/fj.02-0334com; Tinevez JY, 2017, METHODS, V115, P80, DOI 10.1016/j.ymeth.2016.09.016; Vaur S, 2000, GEN PHYSIOL BIOPHYS, V19, P265; Walsh C, 2009, BBA-BIOENERGETICS, V1787, P1374, DOI 10.1016/j.bbabio.2009.01.007; Wang Q, 2005, FASEB J, V19, P837, DOI 10.1096/fj.04-2657fje; Wilson C, 2016, J VASC RES, V53, P358, DOI 10.1159/000454811; Wilson C, 2016, J PHYSIOL-LONDON, V594, P7267, DOI 10.1113/JP272927; Wilson C, 2016, FASEB J, V30, P2000, DOI 10.1096/fj.201500090; Wilson C, 2015, J PHYSIOL-LONDON, V593, P5231, DOI 10.1113/JP271157; Zhou LF, 2011, J MOL CELL CARDIOL, V51, P632, DOI 10.1016/j.yjmcc.2011.05.007; Zimmermann B, 2000, J PHYSIOL-LONDON, V525, P707, DOI 10.1111/j.1469-7793.2000.t01-1-00707.x	121	26	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2019	294	3					737	758		10.1074/jbc.RA118.005913	http://dx.doi.org/10.1074/jbc.RA118.005913			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL4FC	30498088	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000458670200001
J	Maeoka, Y; Wu, Y; Okamoto, T; Kanemoto, S; Guo, XP; Saito, A; Asada, R; Matsuhisa, K; Masaki, T; Imaizumi, K; Kaneko, M				Maeoka, Yujiro; Wu, Yan; Okamoto, Takumi; Kanemoto, Soshi; Guo, Xiao Peng; Saito, Atsushi; Asada, Rie; Matsuhisa, Koji; Masaki, Takao; Imaizumi, Kazunori; Kaneko, Masayuki			NFAT5 up-regulates expression of the kidney-specific ubiquitin ligase gene Rnf183 under hypertonic conditions in inner-medullary collecting duct cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						kidney; NFAT transcription factor; promoter; transcription regulation; ubiquitin ligase; hypertonic stress; NFAT5; renal cell; RNF family; RNF183	ENHANCER-BINDING PROTEIN; TRANSCRIPTIONAL ACTIVATOR; STIMULATES TRANSCRIPTION; ENDOTHELIAL-CELLS; INDUCTION; TONEBP; IDENTIFICATION; RECEPTOR; APOPTOSIS; SURVIVAL	We previously reported that among the 37 RING finger protein (RNF) family members, RNF183 mRNA is specifically expressed in the kidney under normal conditions. However, the mechanism supporting its kidney-specific expression pattern remains unclear. In this study, we elucidated the mechanism of the transcriptional activation of murine Rnf183 in inner-medullary collecting duct cells. Experiments with anti-RNF183 antibody revealed that RNF183 is predominantly expressed in the renal medulla. Among the 37 RNF family members, Rnf183 mRNA expression was specifically increased in hypertonic conditions, a hallmark of the renal medulla. RNF183 up-regulation was consistent with the activation of nuclear factor of activated T cells 5 (NFAT5), a transcription factor essential for adaptation to hypertonic conditions. Accordingly, siRNA-mediated knockdown of NFAT5 down-regulated RNF183 expression. Furthermore, the -3,466 to -3,136-bp region upstream of the mouse Rnf183 promoter containing the NFAT5-binding motif is conserved among mammals. A luciferase-based reporter vector containing the NFAT5-binding site was activated in response to hypertonic stress, but was inhibited by a mutation at the NFAT5-binding site. ChIP assays revealed that the binding of NFAT5 to this DNA site is enhanced by hypertonic stress. Of note, siRNA-mediated RNF183 knockdown increased hypertonicity-induced caspase-3 activation and decreased viability of mIMCD-3 cells. These results indicate that (i) RNF183 is predominantly expressed in the normal renal medulla, (ii) NFAT5 stimulates transcriptional activation of Rnf183 by binding to its cognate binding motif in the Rnf183 promoter, and (iii) RNF183 protects renal medullary cells from hypertonicity-induced apoptosis.	[Maeoka, Yujiro; Wu, Yan; Okamoto, Takumi; Kanemoto, Soshi; Guo, Xiao Peng; Asada, Rie; Imaizumi, Kazunori; Kaneko, Masayuki] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Biochem, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan; [Maeoka, Yujiro; Masaki, Takao] Hiroshima Univ Hosp, Dept Nephrol, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan; [Kanemoto, Soshi] Asahikawa Med Univ, Dept Funct Anat & Neurosci, 2-1-1-1 Midorigaoka Higashi, Asahikawa, Hokkaido 0788510, Japan; [Saito, Atsushi; Matsuhisa, Koji] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Stress Prot Proc, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan; [Asada, Rie] Washington Univ, Sch Med, Dept Med, Div Endocrinol Metab & Lipid Res, St Louis, MO 63110 USA	Hiroshima University; Hiroshima University; Asahikawa Medical College; Hiroshima University; Washington University (WUSTL)	Imaizumi, K; Kaneko, M (corresponding author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Biochem, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.	imaizumi@hiroshima-u.ac.jp; mkaneko@hiroshima-u.ac.jp	Kaneko, Masayuki/F-9302-2011	Kaneko, Masayuki/0000-0002-0477-0171; Matsuhisa, Koji/0000-0003-0707-9025; Kitamura, Rie/0000-0001-8347-6909; Maeoka, Yujiro/0000-0003-1808-2772	Ministry of Education, Culture, Sports, Science, and Technology, Japan [17H06416, 15K21706, 26460099]; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This study was supported by Grants-in-Aid for Scientific Research (KAKENHI) 17H06416, 15K21706, and 26460099 from the Ministry of Education, Culture, Sports, Science, and Technology, Japan and also supported by the Takeda Science Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Alfieri RR, 2002, J PHYSIOL-LONDON, V540, P499, DOI 10.1113/jphysiol.2001.013395; BANKIR L, 1989, BAILLIERE CLIN ENDOC, V3, P249, DOI 10.1016/S0950-351X(89)80005-9; Bell LM, 2000, J BIOL CHEM, V275, P25262, DOI 10.1074/jbc.M002076200; Berga-Bolanos R, 2013, P NATL ACAD SCI USA, V110, P16091, DOI 10.1073/pnas.1215934110; Berga-Bolanos R, 2010, J IMMUNOL, V185, P6624, DOI 10.4049/jimmunol.1001232; BREZIS M, 1995, NEW ENGL J MED, V332, P647, DOI 10.1056/NEJM199503093321006; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Buxade M, 2012, J EXP MED, V209, P379, DOI 10.1084/jem.20111569; Cha JH, 2001, J AM SOC NEPHROL, V12, P2221, DOI 10.1681/ASN.V12112221; Chen SC, 2009, J CLIN INVEST, V119, P1647, DOI 10.1172/JCI35314; Cheung Chris Yk, 2013, J Mol Signal, V8, P5, DOI 10.1186/1750-2187-8-5; Choudhury NR, 2013, GENE DEV, V27, P24, DOI 10.1101/gad.199190.112; Dahl SC, 2001, AM J PHYSIOL-CELL PH, V280, pC248, DOI 10.1152/ajpcell.2001.280.2.C248; Dmitrieva N, 2000, J BIOL CHEM, V275, P18243, DOI 10.1074/jbc.M000522200; Do Lee S, 2011, AM J PHYSIOL-RENAL, V300, pF707, DOI 10.1152/ajprenal.00227.2010; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Geng R, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.400; Grabbe C, 2011, NAT REV MOL CELL BIO, V12, P295, DOI 10.1038/nrm3099; Hasler U, 2008, J BIOL CHEM, V283, P28095, DOI 10.1074/jbc.M801071200; Hasler U, 2006, J AM SOC NEPHROL, V17, P1521, DOI 10.1681/ASN.2005121317; Heo JI, 2006, EXP MOL MED, V38, P295, DOI 10.1038/emm.2006.35; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2001, CELL, V106, P527, DOI 10.1016/S0092-8674(01)00485-8; Holleman J, 2014, MOL BIOL CELL, V25, P1892, DOI 10.1091/mbc.E13-10-0612; Hong JH, 2015, MOL CELL PROTEOMICS, V14, P674, DOI 10.1074/mcp.M114.042168; Ito T, 2004, BIOCHEM J, V382, P177, DOI 10.1042/BJ20031838; Ito T, 2007, MOL PHARMACOL, V72, P173, DOI 10.1124/mol.106.033480; JAMISON RL, 1982, URINARY CONCENTRATIN; Jantsch J, 2015, CELL METAB, V21, P493, DOI 10.1016/j.cmet.2015.02.003; Kaneko M, 2016, SCI REP-UK, V6, DOI 10.1038/srep30955; Kleinewietfeld M, 2013, NATURE, V496, P518, DOI 10.1038/nature11868; Ko BCB, 2000, BIOCHEM BIOPH RES CO, V270, P52, DOI 10.1006/bbrc.2000.2376; Ko BCB, 1997, J BIOL CHEM, V272, P16431, DOI 10.1074/jbc.272.26.16431; Lanaspa MA, 2010, J BIOL CHEM, V285, P31694, DOI 10.1074/jbc.M109.093690; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; Lopez-Rodriguez C, 2004, P NATL ACAD SCI USA, V101, P2392, DOI 10.1073/pnas.0308703100; Lopez-Rodriguez C, 2001, IMMUNITY, V15, P47, DOI 10.1016/S1074-7613(01)00165-0; Machnik A, 2009, NAT MED, V15, P545, DOI 10.1038/nm.1960; Maxfield KE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9840; Michea L, 2000, AM J PHYSIOL-RENAL, V278, pF209, DOI 10.1152/ajprenal.2000.278.2.F209; Miyakawa H, 1999, P NATL ACAD SCI USA, V96, P2538, DOI 10.1073/pnas.96.5.2538; Na KY, 2003, J AM SOC NEPHROL, V14, P283, DOI 10.1097/01.ASN.0000045050.19544.B2; Nakamura N, 2011, MEMBRANES-BASEL, V1, P354, DOI 10.3390/membranes1040354; Omura T, 2006, J NEUROCHEM, V99, P1456, DOI 10.1111/j.1471-4159.2006.04155.x; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Petronini PG, 2000, AM J PHYSIOL-REG I, V279, pR1580, DOI 10.1152/ajpregu.2000.279.5.R1580; Rim JS, 1998, J BIOL CHEM, V273, P20615, DOI 10.1074/jbc.273.32.20615; Roth I, 2010, MOL BIOL CELL, V21, P3459, DOI 10.1091/mbc.E10-02-0133; Santos BC, 1998, AM J PHYSIOL-RENAL, V274, pF1167, DOI 10.1152/ajprenal.1998.274.6.F1167; Shapiro L, 1995, P NATL ACAD SCI USA, V92, P12230, DOI 10.1073/pnas.92.26.12230; Sheen MR, 2009, KIDNEY INT, V75, P518, DOI 10.1038/ki.2008.601; Shim EH, 2002, EMBO REP, V3, P857, DOI 10.1093/embo-reports/kvf175; Woo SK, 2002, PFLUG ARCH EUR J PHY, V444, P579, DOI 10.1007/s00424-002-0849-2; Woo SK, 2002, MOL CELL BIOL, V22, P5753, DOI 10.1128/MCB.22.16.5753-5760.2002; Wu Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190407; Yu Q, 2016, J CROHNS COLITIS, V10, P713, DOI 10.1093/ecco-jcc/jjw023	56	8	8	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2019	294	1					101	115		10.1074/jbc.RA118.002896	http://dx.doi.org/10.1074/jbc.RA118.002896			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG6PT	30413537	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000455105500016
J	Zhu, FX; Yi, G; Liu, X; Zhu, FM; Zhao, AN; Wang, AT; Zhu, RH; Chen, ZJ; Zhao, BB; Fang, SJ; Yu, X; Lin, RR; Liang, R; Li, D; Zhao, WY; Zhang, ZZ; Guo, WZ; Zhang, SJ; Ge, SF; Fan, XQ; Zhao, G; Li, B				Zhu, Fuxiang; Yi, Gang; Liu, Xu; Zhu, Fangming; Zhao, Anna; Wang, Aiting; Zhu, Ruihong; Chen, Zuojia; Zhao, Binbin; Fang, Sijie; Yu, Xiao; Lin, Ruirong; Liang, Rui; Li, Dan; Zhao, Wenyi; Zhang, Zizhen; Guo, Wenzhi; Zhang, Shuijun; Ge, Shengfang; Fan, Xianqun; Zhao, Gang; Li, Bin			Ring finger protein 31-mediated atypical ubiquitination stabilizes forkhead box P3 and thereby stimulates regulatory T-cell function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						forkhead box P3 (FOXP3); T-cell; gastric cancer; immunosuppression; protein stability; human regulatory T cells; multi-monoubiquitination; Positive regulator; RNF31	NF-KAPPA-B; TRANSCRIPTION FACTOR FOXP3; LUBAC; ACTIVATION; EXPRESSION; COMPLEX; GENE; INFLAMMATION; INSTABILITY; GENERATION	The CD4(+)CD25(+)FOXP3(+) regulatory T (Treg) cells are critical for maintaining immune tolerance in healthy individuals and are reported to restrict anti-inflammatory responses and thereby promote tumor progression, suggesting them as a target in the development of antitumor immunotherapy. Forkhead box P3 (FOXP3) is a key transcription factor governing Treg lineage differentiation and their immune-suppressive function. Here, using Treg cells, as well as HEK-293T and Jurkat T cells, we report that the stability of FOXP3 is directly and positively regulated by the E3 ubiquitin ligase ring finger protein 31 (RNF31), which catalyzes the conjugation of atypical ubiquitin chains to the FOXP3 protein. We observed that shRNA-mediated RNF31 knockdown in human Treg cells decreases FOXP3 protein levels and increases levels of interferon-, resulting in a Th1 helper cell-like phenotype. Human Treg cells that ectopically expressed RNF31 displayed stronger immune-suppressive capacity, suggesting that RNF31 positively regulates both FOXP3 stability and Treg cell function. Moreover, we found that RNF31 is up-regulated in Treg cells that infiltrate human gastric tumor tissues compared with their counterparts residing in peripheral and normal tissue. We also found that elevated RNF31 expression in intratumoral Treg cells is associated with poor survival of gastric cancer patients, suggesting that RNF31 supports the immune-suppressive functions of Treg cells. Our results suggest that RNF31 could be a potential therapeutic target in immunity-based interventions against human gastric cancer.	[Zhu, Fuxiang; Yi, Gang; Zhao, Anna; Wang, Aiting; Zhao, Binbin; Liang, Rui; Li, Dan; Li, Bin] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Immunol, Shanghai 200025, Peoples R China; [Zhu, Fuxiang; Yi, Gang; Zhao, Anna; Wang, Aiting; Zhao, Binbin; Liang, Rui; Li, Dan; Li, Bin] Shanghai Jiao Tong Univ, Sch Med, Dept Immunol & Microbiol, Shanghai 200025, Peoples R China; [Zhu, Fuxiang; Wang, Aiting; Zhu, Ruihong; Chen, Zuojia; Zhao, Binbin] Univ Chinese Acad Sci, Inst Pasteur Shanghai, Unit Mol Immunol, Shanghai 200025, Peoples R China; [Yi, Gang; Zhu, Fangming] Shanghai Univ, Sch Life Sci, Shanghai Key Lab Bioenergy Crops, Shanghai 200025, Peoples R China; [Liu, Xu; Zhao, Wenyi; Zhang, Zizhen; Zhao, Gang] Shanghai Jiao Tong Univ, Sch Med, RenJi Hosp, Dept Gastrointestinal Surg, Shanghai 200025, Peoples R China; [Fang, Sijie; Ge, Shengfang; Fan, Xianqun] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Ophthalmol, Shanghai 200025, Peoples R China; [Yu, Xiao; Guo, Wenzhi; Zhang, Shuijun] Zhengzhou Univ, Henan Key Lab Digest Organ Transplantat, Affiliated Hosp 1, Dept Hepatobiliary & Pancreat Surg, Zhengzhou 450052, Henan, Peoples R China; [Lin, Ruirong] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Biliary Pancreat Surg, Shanghai 200025, Peoples R China	Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Shanghai University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Zhengzhou University; Shanghai Jiao Tong University	Zhao, G (corresponding author), 160 Pujian Rd, Shanghai 200127, Peoples R China.; Li, B (corresponding author), 280 South Chongqing Rd, Shanghai 200026, Peoples R China.	Zhaogang74313@126.com; binli@shsmu.edu.cn	Fang, Sijie/AAD-5505-2019; Chen, Zuojia/AAM-9465-2020; lI, Bin/AAR-4966-2021	lI, Bin/0000-0002-7640-8884	National Natural Science Foundation of China [NSFC 31525008, 81330072, 3187050011, 31670911, 31370863]; Science and Technology Commission of Shanghai Municipality (SMCST) [14JC1406100]; Shanghai Academic Research Leader [16XD1403800]; National Institutes of Health NSFC collaborative Grant [81161120417]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality (SMCST); Shanghai Academic Research Leader; National Institutes of Health NSFC collaborative Grant	This work was supported by National Natural Science Foundation of China NSFC 31525008, 81330072, 3187050011, 31670911, and 31370863, Science and Technology Commission of Shanghai Municipality (SMCST) Grant 14JC1406100, Shanghai Academic Research Leader Grant 16XD1403800, and National Institutes of Health NSFC collaborative Grant 81161120417. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bailey-Bucktrout SL, 2013, IMMUNITY, V39, P949, DOI 10.1016/j.immuni.2013.10.016; Chen ZJ, 2013, IMMUNITY, V39, P272, DOI 10.1016/j.immuni.2013.08.006; Cho JH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13373; Courtney AH, 2018, TRENDS BIOCHEM SCI, V43, P108, DOI 10.1016/j.tibs.2017.11.008; Damgaard RB, 2012, MOL CELL, V46, P746, DOI 10.1016/j.molcel.2012.04.014; Duarte JH, 2009, EUR J IMMUNOL, V39, P948, DOI 10.1002/eji.200839196; Dubois SM, 2014, BLOOD, V123, P2199, DOI 10.1182/blood-2013-05-504019; Fujita H, 2014, MOL CELL BIOL, V34, P1322, DOI 10.1128/MCB.01538-13; Gao YY, 2015, P NATL ACAD SCI USA, V112, pE3246, DOI 10.1073/pnas.1421463112; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Jana S, 2009, EUR J IMMUNOL, V39, P2571, DOI 10.1002/eji.200939201; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kindlund B, 2017, GASTRIC CANCER, V20, P116, DOI 10.1007/s10120-015-0591-z; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Li YY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13559; Luo XR, 2015, J BIOL CHEM, V290, P28675, DOI 10.1074/jbc.M115.661611; Ogawa C, 2014, J IMMUNOL, V192, P475, DOI 10.4049/jimmunol.1301892; Ohkura N, 2012, IMMUNITY, V37, P785, DOI 10.1016/j.immuni.2012.09.010; Overacre-Delgoffe AE, 2017, CELL, V169, P1130, DOI 10.1016/j.cell.2017.05.005; Park Y, 2016, NAT IMMUNOL, V17, P286, DOI 10.1038/ni.3352; Plitas G, 2016, IMMUNITY, V45, P1122, DOI 10.1016/j.immuni.2016.10.032; Rodgers MA, 2014, J EXP MED, V211, P1331, DOI 10.1084/jem.20132486; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Sasaki Y, 2013, EMBO J, V32, P2463, DOI 10.1038/emboj.2013.184; Smit JJ, 2012, EMBO J, V31, P3833, DOI 10.1038/emboj.2012.217; Stieglitz B, 2012, EMBO REP, V13, P840, DOI 10.1038/embor.2012.105; Tanaka A, 2017, CELL RES, V27, P109, DOI 10.1038/cr.2016.151; Teh CE, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13353; Tokunaga F, 2011, NATURE, V471, P633, DOI 10.1038/nature09815; van Loosdregt J, 2013, IMMUNITY, V39, P259, DOI 10.1016/j.immuni.2013.05.018; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; Wang XW, 2015, J BIOL CHEM, V290, P29086, DOI 10.1074/jbc.M115.664573; Wei TF, 2015, AM J CANCER RES, V5, P2190; Zeng H, 2008, J BIOL CHEM, V283, P24392, DOI 10.1074/jbc.M802344200; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774; Zhu J, 2014, ONCOGENE, V33, P4340, DOI 10.1038/onc.2013.573; Zinngrebe J, 2016, J EXP MED, V213, P2671, DOI 10.1084/jem.20160041	41	28	30	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					20099	20111		10.1074/jbc.RA118.005802	http://dx.doi.org/10.1074/jbc.RA118.005802			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30389786	Green Published, hybrid			2022-12-28	WOS:000454685900019
J	Pausch, P; Steinchen, W; Wieland, M; Klaus, T; Freibert, SA; Altegoer, F; Wilson, DN; Bange, G				Pausch, Patrick; Steinchen, Wieland; Wieland, Maximiliane; Klaus, Thomas; Freibert, Sven-Andreas; Altegoer, Florian; Wilson, Daniel N.; Bange, Gert			Structural basis for (p)ppGpp-mediated inhibition of the GTPase RbgA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						GTPase; X-ray crystallography; ribosome assembly; inhibition mechanism; enzyme kinetics; (p)ppGpp; alarmone; cell stress; RbgA; stringent response	BINDING PROTEIN; YLQF; BIOGENESIS; PRECURSOR; (P)PPGPP; DOMAINS; RPL10P; GROWTH; NMD3P	Efficient adaptation to environmental changes is pivotal for all bacterial cells. Almost all bacterial species depend on the conserved stringent response system to prompt timely transcriptional and metabolic responses according to stress conditions and nutrient depletion. The stringent response relies on the stress-dependent synthesis of the second messenger nucleotides and alarmones (p)ppGpp, which pleiotropically target and reprogram processes that consume cellular resources, such as ribosome biogenesis. Here we show that (p)ppGpp acts on the ribosome biogenesis GTPase A (RbgA) of Gram-positive bacteria. Using X-ray crystallography, hydrogen-deuterium exchange MS (HDX-MS) and kinetic analysis, we demonstrate that the alarmones (p)ppGpp bind to RbgA in a manner similar to that of binding by GDP and GTP and thereby act as competitive inhibitors. Our structural analysis of Staphylococcus aureus RbgA bound to ppGpp and pppGpp at 1.8 and 1.65 resolution, respectively, suggested that the alarmones (p)ppGpp prevent the active GTPase conformation of RbgA by sterically blocking the association of its G2 motif via their 3-pyrophosphate moieties. Taken together, our structural and biochemical characterization of RbgA in the context of the alarmone-mediated stringent response reveals how (p)ppGpp affects the function of RbgA and reprograms this GTPase to arrest the ribosomal large subunit.	[Pausch, Patrick; Steinchen, Wieland; Klaus, Thomas; Altegoer, Florian; Bange, Gert] Philipps Univ Marburg, Dept Chem, D-35043 Marburg, Germany; [Freibert, Sven-Andreas] Philipps Univ Marburg, Inst Cytobiol & Cytopathol, D-35043 Marburg, Germany; [Pausch, Patrick; Steinchen, Wieland; Klaus, Thomas; Freibert, Sven-Andreas; Altegoer, Florian; Bange, Gert] Synmikro Ctr Synthet Microbiol, D-35043 Marburg, Germany; [Wieland, Maximiliane; Wilson, Daniel N.] Univ Hamburg, Inst Biochem & Mol Biol, D-20146 Hamburg, Germany	Philipps University Marburg; Philipps University Marburg; University of Hamburg	Pausch, P; Bange, G (corresponding author), Philipps Univ Marburg, Dept Chem, D-35043 Marburg, Germany.; Pausch, P; Bange, G (corresponding author), Synmikro Ctr Synthet Microbiol, D-35043 Marburg, Germany.	Patrick.Pausch@synmikro.uni-marburg.de; Gert.Bange@synmikro.uni-marburg.de	Bange, Gert/AAB-3734-2021; Wilson, Daniel/AAE-8504-2019; Altegoer, Florian/AAM-1354-2020	Wilson, Daniel/0000-0003-3816-3828; Altegoer, Florian/0000-0002-6012-9047; Bange, Gert/0000-0002-7826-0932	Deutsche Forschungsgemeinschaft [SPP1879]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Program SPP1879 (to G. B. and D. N. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Achila D, 2012, J BIOL CHEM, V287, P8417, DOI 10.1074/jbc.M111.331322; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anand B, 2006, NUCLEIC ACIDS RES, V34, P2196, DOI 10.1093/nar/gkl178; Britton RA, 2009, ANNU REV MICROBIOL, V63, P155, DOI 10.1146/annurev.micro.091208.073225; Chen SS, 2012, MOL BIOSYST, V8, P3325, DOI 10.1039/c2mb25310k; Corrigan RM, 2016, P NATL ACAD SCI USA, V113, pE1710, DOI 10.1073/pnas.1522179113; Davis JH, 2016, CELL, V167, P1610, DOI 10.1016/j.cell.2016.11.020; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gabadinho J, 2010, J SYNCHROTRON RADIAT, V17, P700, DOI 10.1107/S0909049510020005; Geromanos SJ, 2009, PROTEOMICS, V9, P1683, DOI 10.1002/pmic.200800562; Gulati M, 2013, NUCLEIC ACIDS RES, V41, P3217, DOI 10.1093/nar/gks1475; Hauryliuk V, 2015, NAT REV MICROBIOL, V13, P298, DOI 10.1038/nrmicro3448; Hedges J, 2005, EMBO J, V24, P567, DOI 10.1038/sj.emboj.7600547; Jerabek-Willemsen M, 2011, ASSAY DRUG DEV TECHN, V9, P342, DOI 10.1089/adt.2011.0380; Jomaa A, 2014, NUCLEIC ACIDS RES, V42, P3419, DOI 10.1093/nar/gkt1295; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kanjee U, 2012, MOL MICROBIOL, V85, P1029, DOI 10.1111/j.1365-2958.2012.08177.x; Karniel A, 2018, J MOL BIOL, V430, P1607, DOI 10.1016/j.jmb.2018.04.017; Kim DJ, 2008, PROTEINS, V72, P1363, DOI 10.1002/prot.22112; Li GZ, 2009, PROTEOMICS, V9, P1696, DOI 10.1002/pmic.200800564; Li NN, 2013, NUCLEIC ACIDS RES, V41, P7073, DOI 10.1093/nar/gkt423; Malyutin AG, 2017, EMBO J, V36, P854, DOI 10.15252/embj.201696012; Matsuo Y, 2006, J BIOL CHEM, V281, P8110, DOI 10.1074/jbc.M512556200; Matsuo Y, 2007, J BIOL CHEM, V282, P25270, DOI 10.1074/jbc.M703894200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mier P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169750; Morimoto T, 2002, MICROBIOL-SGM, V148, P3539, DOI 10.1099/00221287-148-11-3539; Patacq C, 2018, ANAL CHEM, V90, P10715, DOI 10.1021/acs.analchem.8b00829; Pausch P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8494; Schaper S, 2017, P NATL ACAD SCI USA, V114, pE4822, DOI 10.1073/pnas.1702435114; Shajani Z, 2011, ANNU REV BIOCHEM, V80, P501, DOI 10.1146/annurev-biochem-062608-160432; Steinchen W, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20634-4; Steinchen W, 2016, MOL MICROBIOL, V101, P531, DOI 10.1111/mmi.13412; Steinchen W, 2015, P NATL ACAD SCI USA, V112, P13348, DOI 10.1073/pnas.1505271112; Uicker WC, 2006, MOL MICROBIOL, V59, P528, DOI 10.1111/j.1365-2958.2005.04948.x; Varik V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10988-6; Wales TE, 2008, ANAL CHEM, V80, P6815, DOI 10.1021/ac8008862; West M, 2005, MOL CELL BIOL, V25, P3802, DOI 10.1128/MCB.25.9.3802-3813.2005; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wittinghofer A, 2011, ANNU REV BIOCHEM, V80, P943, DOI 10.1146/annurev-biochem-062708-134043	40	23	23	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19699	19709		10.1074/jbc.RA118.003070	http://dx.doi.org/10.1074/jbc.RA118.003070			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30366986	Green Published, hybrid			2022-12-28	WOS:000454294900017
J	Sun, PC; Li, JL; Zhang, XL; Guan, ZY; Xiao, QJ; Zhao, CJ; Song, MX; Zhou, YX; Mou, LQ; Ke, M; Guo, L; Geng, J; Deng, D				Sun, Pengcheng; Li, Jialu; Zhang, Xialin; Guan, Zeyuan; Xiao, Qingjie; Zhao, Changjian; Song, Mengxiao; Zhou, Yanxia; Mou, Luqiu; Ke, Meng; Guo, Li; Geng, Jia; Deng, Dong			Crystal structure of the bacterial acetate transporter SatP reveals that it forms a hexameric channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						structural biology; ion channel; organic anion channel; membrane protein; electrophysiology; protein structure; acetate uptake; SatP; hexamer; membrane channel; monocarboxylate transport	UREA CHANNEL; PERMEASE; IDENTIFICATION; PROTEIN; MODEL; ACID	Acetate is found ubiquitously in the natural environment and can be used as an exogenous carbon source by bacteria, fungi, and mammalian cells. A representative member of the acetate uptake transporter (AceTr) family named SatP (also yaaH) has been preliminarily identified as a succinate-acetate/proton symporter in Escherichia coli. However, the molecular mechanism of acetate uptake by SatP still remains elusive. Here, we report the crystal structure of SatP from E. coli at 2.8 resolution, determined with a molecular replacement approach using a previously developed predicted model algorithm, which revealed a hexameric UreI-like channel structure. Structural analysis identified six transmembrane (TM) helices surrounding the central channel pore in each protomer and three conserved hydrophobic residues, FLY, located in the middle of the TM region for pore constriction. According to single-channel conductance recordings, performed with purified SatP reconstituted into lipid bilayer, three conserved polar residues in the TM1 facing to the periplasmic side are closely associated with acetate translocation activity. These analyses provide critical insights into the mechanism of acetate translocation in bacteria and a first glimpse of a structure of an AceTr family transporter.	[Li, Jialu; Zhang, Xialin; Xiao, Qingjie; Zhao, Changjian; Song, Mengxiao; Zhou, Yanxia; Mou, Luqiu; Guo, Li; Geng, Jia; Deng, Dong] Sichuan Univ, West China Hosp 2, Key Lab Birth Defects & Related Dis Women & Child, Div Obstet,MOE,State Key Lab Biotherapy, Chengdu 610041, Sichuan, Peoples R China; [Zhang, Xialin; Zhao, Changjian; Song, Mengxiao; Geng, Jia] Sichuan Univ, West China Hosp, Dept Lab Med, Chengdu 610041, Sichuan, Peoples R China; [Sun, Pengcheng; Ke, Meng] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Guan, Zeyuan] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan 430070, Hubei, Peoples R China; [Guan, Zeyuan] Huazhong Agr Univ, Natl Ctr Plant Gene Res, Wuhan 430070, Hubei, Peoples R China	Sichuan University; Sichuan University; Tsinghua University; Huazhong Agricultural University; Huazhong Agricultural University	Geng, J; Deng, D (corresponding author), Sichuan Univ, West China Hosp 2, Key Lab Birth Defects & Related Dis Women & Child, Div Obstet,MOE,State Key Lab Biotherapy, Chengdu 610041, Sichuan, Peoples R China.; Geng, J (corresponding author), Sichuan Univ, West China Hosp, Dept Lab Med, Chengdu 610041, Sichuan, Peoples R China.	geng.jia@scu.edu.cn; dengd@scu.edu.cn	li, jia/GVT-7587-2022; Geng, Jia/AAR-2192-2021; Geng, Jia/G-4332-2010	Geng, Jia/0000-0003-4753-1039; Zhang, Xialin/0000-0002-2234-3106; Sun, Pengcheng/0000-0002-7549-1161; Ke, Meng/0000-0002-9213-7439; Deng, Dong/0000-0002-8590-9525	National Key R&D Program of China [2016YFA0502700]; Scientific Department of Sichuan Province [2017JQ0007]	National Key R&D Program of China; Scientific Department of Sichuan Province	This work was supported by funds from National Key R&D Program of China Grant 2016YFA0502700 and Scientific Department of Sichuan Province Grant 2017JQ0007. The authors declare that they have no conflicts of interest with the contents of this article.	Accardi A, 2010, BBA-BIOMEMBRANES, V1798, P1457, DOI 10.1016/j.bbamem.2010.02.022; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AURORA R, 1994, SCIENCE, V264, P1126, DOI 10.1126/science.8178170; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bernal V, 2016, APPL MICROBIOL BIOT, V100, P8985, DOI 10.1007/s00253-016-7832-x; Casal M, 1996, MICROBIOL-UK, V142, P1385, DOI 10.1099/13500872-142-6-1385; Casal M, 2008, FEMS MICROBIOL REV, V32, P974, DOI 10.1111/j.1574-6976.2008.00128.x; Comerford SA, 2014, CELL, V159, P1591, DOI 10.1016/j.cell.2014.11.020; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gimenez R, 2003, J BACTERIOL, V185, P6448, DOI 10.1128/JB.185.21.6448-6455.2003; Gutsmann T, 2015, NAT PROTOC, V10, P188, DOI 10.1038/nprot.2015.003; Halestrap AP, 2013, COMPR PHYSIOL, V3, P1611, DOI 10.1002/cphy.c130008; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; Herzig S, 2012, SCIENCE, V337, P93, DOI 10.1126/science.1218530; Huysmans GHM, 2012, BIOCHEM J, V445, P157, DOI 10.1042/BJ20120169; Jayaram H, 2008, P NATL ACAD SCI USA, V105, P11194, DOI 10.1073/pnas.0804503105; Lee Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7112; Lyssiotis CA, 2014, CELL, V159, P1492, DOI 10.1016/j.cell.2014.12.009; Mashimo T, 2014, CELL, V159, P1603, DOI 10.1016/j.cell.2014.11.025; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Ovchinnikov S, 2015, ELIFE, V4, DOI 10.7554/eLife.09248; Paiva S, 2004, YEAST, V21, P201, DOI 10.1002/yea.1056; Park E, 2018, ELIFE, V7, DOI 10.7554/eLife.36629; Qiu B, 2018, CELL RES, V28, P644, DOI 10.1038/s41422-018-0032-8; Sa-Pessoa J, 2013, BIOCHEM J, V454, P585, DOI 10.1042/BJ20130412; SMART OS, 1993, BIOPHYS J, V65, P2455, DOI 10.1016/S0006-3495(93)81293-1; Strugatsky D, 2013, NATURE, V493, P255, DOI 10.1038/nature11684; SUPPMANN B, 1994, MOL MICROBIOL, V11, P965, DOI 10.1111/j.1365-2958.1994.tb00375.x; Wang Y, 2009, NATURE, V462, P467, DOI 10.1038/nature08610; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005	32	19	19	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2018	293	50					19492	19500		10.1074/jbc.RA118.003876	http://dx.doi.org/10.1074/jbc.RA118.003876			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HE6RA	30333234	hybrid, Green Published			2022-12-28	WOS:000453537300028
J	Menard, C; Folacci, M; Brunello, L; Charreton, M; Collet, C; Mary, R; Rousset, M; Thibaud, JB; Vignes, M; Charnet, P; Cens, T				Menard, Claudine; Folacci, Mathilde; Brunello, Lorene; Charreton, Mercedes; Collet, Claude; Mary, Rosanna; Rousset, Matthieu; Thibaud, Jean-Baptiste; Vignes, Michel; Charnet, Pierre; Cens, Thierry			Multiple combinations of RDL subunits diversify the repertoire of GABA receptors in the honey bee parasite Varroa destructor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED ION-CHANNEL; SMALL BROWN PLANTHOPPER; FUNCTIONAL EXPRESSION; MOLECULAR-CLONING; ANTENNAL LOBE; GENE FAMILY; RESISTANCE; MUTATION; CHLORIDE; INSECTICIDES	In insects, gamma-aminobutyric acid (GABA) is the major inhibitory neurotransmitter, and GABA-gated ion channels are the target of different classes of insecticides, including fipronil. We report here the cloning of six subunits (four RDL, one LCCH3, and one GRD) that constitute the repertoire of the GABA-gated ion channel family of the Varroa mite (Varroa destructor), a honey bee ectoparasite. We also isolated a truncated GRD subunit with a premature stop codon. We found that when expressed in Xenopus laevis oocytes, three of the four RDL subunits (VdesRDL1, VdesRDL2, and VdesRDL3) formed functional, homomultimeric anionic receptors, whereas GRD and LCCH3 produced heteromultimeric cationic receptors. These receptors displayed specific sensitivities toward GABA and fipronil, and VdesRDL1 was the most resistant to the insecticide. We identified specific residues in the VdesRDL1 pore-lining region that explain its high resistance to fipronil. VdesRDL4 did not form a functional receptor when expressed alone, but it assembled with VdesRDL1 to form a heteromultimeric receptor with properties distinct from those of the VdesRDL1 homomultimeric receptor. Moreover, VdesRDL1 physically interacted with VdesRDL3, generating a heteromultimeric receptor combining properties of both subunits. On the other hand, we did not detect any functional interaction between VdesLCCH3 and the VdesRDL subunits, an observation that differed from what was previously reported for Drosophila melanogaster. In conclusion, this study provides insights relevant to improve our understanding of the precise role of GABAergic signaling in insects and new tools for the development of Varroa mite-specific insecticidal agents that do not harm honey bees.	[Menard, Claudine; Folacci, Mathilde; Brunello, Lorene; Mary, Rosanna; Rousset, Matthieu; Thibaud, Jean-Baptiste; Vignes, Michel; Charnet, Pierre; Cens, Thierry] Univ Montpellier, Inst Biomol Max Mousseron, CNRS, UMR5247, F-34095 Montpellier 5, France; [Charreton, Mercedes; Collet, Claude] INRA UR 406 Abeilles & Environm, F-84914 Avignon 9, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; INRAE	Cens, T (corresponding author), CRBM, 1919 Route Mende, F-34293 Montpellier, France.	thierry.cens@inserm.fr	Cens, Thierry/M-3337-2017; Vignes, Michel/AAA-7693-2019	Cens, Thierry/0000-0002-4109-2779; Vignes, Michel/0000-0003-0969-2966; THIBAUD, Jean-Baptiste/0000-0002-0824-6465; Folacci, Mathilde/0000-0001-8393-7517; Rousset, Matthieu/0000-0003-2064-2791	INSERM, CNRS; Universite de Montpellier; Agence Nationale de la Recherche [ANR-13-BSV7-0010]	INSERM, CNRS; Universite de Montpellier; Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by INSERM, CNRS, the Universite de Montpellier, and Agence Nationale de la Recherche Grant ANR-13-BSV7-0010 (bee channel). The authors declare that they have no conflicts of interest with the contents of this article.	Aronstein K, 1996, INVERTEBR NEUROSCI, V2, P115, DOI 10.1007/BF02214114; Ashby JA, 2012, BIOPHYS J, V103, P2071, DOI 10.1016/j.bpj.2012.10.016; Buckingham SD, 2005, MOL PHARMACOL, V68, P942, DOI 10.1124/mol.105.015313; Casida JE, 2015, PESTIC BIOCHEM PHYS, V121, P22, DOI 10.1016/j.pestbp.2014.11.006; Cens T, 1996, FEBS LETT, V391, P232, DOI 10.1016/0014-5793(96)00704-1; Cens T, 2015, INSECT BIOCHEM MOLEC, V58, P12, DOI 10.1016/j.ibmb.2015.01.005; Choudhary AF, 2012, EUR J NEUROSCI, V35, P1718, DOI 10.1111/j.1460-9568.2012.08090.x; Chung BY, 2009, CURR BIOL, V19, P386, DOI 10.1016/j.cub.2009.01.040; Comitani F, 2016, J CHEM THEORY COMPUT, V12, P3398, DOI 10.1021/acs.jctc.6b00303; Dermauw W, 2012, INSECT BIOCHEM MOLEC, V42, P455, DOI 10.1016/j.ibmb.2012.03.002; Dong XF, 2017, GIGASCIENCE, V6, DOI 10.1093/gigascience/gix008; Dupuis JP, 2010, J NEUROPHYSIOL, V103, P458, DOI 10.1152/jn.00798.2009; Fairbrother A, 2014, ENVIRON TOXICOL CHEM, V33, P719, DOI 10.1002/etc.2527; Feyereisen R, 2015, PESTIC BIOCHEM PHYS, V121, P61, DOI 10.1016/j.pestbp.2015.01.004; FFRENCHCONSTANT RH, 1993, NATURE, V363, P449, DOI 10.1038/363449a0; Francis RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057540; Garrood WT, 2017, PESTIC BIOCHEM PHYS, V142, P1, DOI 10.1016/j.pestbp.2017.01.007; Gisselmann G, 2004, BRIT J PHARMACOL, V142, P409, DOI 10.1038/sj.bjp.0705818; Hawthorne DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026796; Jones Andrew K., 2006, Invertebrate Neuroscience, V6, P123, DOI 10.1007/s10158-006-0026-y; Knipple DC, 2010, PESTIC BIOCHEM PHYS, V97, P140, DOI 10.1016/j.pestbp.2009.09.002; Le Conte Y, 2010, APIDOLOGIE, V41, P353, DOI 10.1051/apido/2010017; Nakao T, 2017, NEUROTOXICOLOGY, V60, P293, DOI 10.1016/j.neuro.2016.03.009; Nakao T, 2012, J PESTIC SCI, V37, P37, DOI 10.1584/jpestics.D11-018; Narusuye K, 2007, INSECT MOL BIOL, V16, P723, DOI 10.1111/j.1365-2583.2007.00766.x; Nicholl GCB, 2017, BRIT J PHARMACOL, V174, P781, DOI 10.1111/bph.13736; Nys M, 2013, BIOCHEM PHARMACOL, V86, P1042, DOI 10.1016/j.bcp.2013.07.001; Ozoe Y, 2013, ADV INSECT PHYSIOL, V44, P211, DOI 10.1016/B978-0-12-394389-7.00004-1; Price KL, 2014, INSECT BIOCHEM MOLEC, V55, P19, DOI 10.1016/j.ibmb.2014.10.002; Priestley CM, 2003, BRIT J PHARMACOL, V140, P1363, DOI 10.1038/sj.bjp.0705542; Raimondo JV, 2017, CURR OPIN NEUROBIOL, V43, P35, DOI 10.1016/j.conb.2016.11.012; Remnant EJ, 2014, INSECT BIOCHEM MOLEC, V54, P11, DOI 10.1016/j.ibmb.2014.08.008; Sheng CW, 2018, INSECT BIOCHEM MOLEC, V94, P18, DOI 10.1016/j.ibmb.2018.01.003; Shimizu K, 2017, FRONT NEURAL CIRCUIT, V11, DOI 10.3389/fncir.2017.00030; Taylor-Wells J, 2017, NEUROTOXICOLOGY, V60, P207, DOI 10.1016/j.neuro.2016.06.007; Wei Q, 2017, PESTIC BIOCHEM PHYS, V136, P34, DOI 10.1016/j.pestbp.2016.08.007; Wei Q, 2015, ARCH INSECT BIOCHEM, V88, P249, DOI 10.1002/arch.21232; Wolff Mark A., 1998, Invertebrate Neuroscience, V3, P305, DOI 10.1007/BF02577690; Yu LL, 2010, GENOME, V53, P688, DOI [10.1139/g10-056, 10.1139/G10-056]; Yuan GR, 2010, ARCH INSECT BIOCHEM, V74, P81, DOI 10.1002/arch.20361; Yuan Q, 2014, NAT NEUROSCI, V17, P81, DOI 10.1038/nn.3581; ZHANG HG, 1995, MOL PHARMACOL, V48, P835; Zheng Y, 2003, INSECT BIOCHEM MOLEC, V33, P595, DOI 10.1016/S0965-1748(03)00038-9	43	14	14	3	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2018	293	49					19012	19024		10.1074/jbc.RA118.005365	http://dx.doi.org/10.1074/jbc.RA118.005365			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NY	30333227	Green Published, hybrid			2022-12-28	WOS:000458467400016
J	Watanabe, SM; Medina, GN; Eastep, GN; Ghanam, RH; Vlach, J; Saad, JS; Carter, CA				Watanabe, Susan M.; Medina, Gisselle N.; Eastep, Gunnar N.; Ghanam, Ruba H.; Vlach, Jiri; Saad, Jamil S.; Carter, Carol A.			The matrix domain of the Gag protein from avian sarcoma virus contains a PI(4,5)P-2-binding site that targets Gag to the cell periphery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PLECKSTRIN HOMOLOGY DOMAINS; MEMBRANE-BINDING; PLASMA-MEMBRANE; TYPE-1 GAG; ESCRT-II; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; SPROUTY PROTEINS; UBIQUITINATION; PHOSPHOINOSITIDES	The Gag protein of avian sarcoma virus (ASV) lacks an N-myristoyl (myr) group, but contains structural domains similar to those of HIV-1 Gag. Similarly to HIV-1, ASV Gag accumulates on the plasma membrane (PM) before egress; however, it is unclear whether the phospholipid PI(4,5)P-2 binds directly to the matrix (MA) domain of ASV Gag, as is the case for HIV-1 Gag. Moreover, the role of PI(4,5)P-2 in ASV Gag localization and budding has been controversial. Here, we report that substitution of residues that define the PI(4,5)P-2-binding site in the ASV MA domain (reported in an accompanying paper) interfere with Gag localization to the cell periphery and inhibit the production of virus-like particles (VLPs). We show that co-expression of Sprouty2 (Spry2) or the pleckstrin homology domain of phospholipase C delta (PH-PLC), two proteins that bind PI(4,5)P-2, affects ASV Gag trafficking to the PM and budding. Replacement of the N-terminal 32 residues of HIV-1 MA, which encode its N-terminal myr signal and its PI(4,5)P-2-binding site, with the structurally equivalent N-terminal 24 residues of ASV MA created a chimera that localized at the PM and produced VLPs. In contrast, the homologous PI(4,5)P-2-binding signal in ASV MA could target HIV-1 Gag to the PM when substituted, but did not support budding. Collectively, these findings reveal a basic patch in both ASV and HIV-1 Gag capable of mediating PM binding and budding for ASV but not for HIV-1 Gag. We conclude that PI(4,5)P-2 is a strong determinant of ASV Gag targeting to the PM and budding.	[Watanabe, Susan M.; Medina, Gisselle N.; Carter, Carol A.] SUNY Stony Brook, Dept Mol Genet & Microbiol, Life Sci Bldg,Rm 248, Stony Brook, NY 11794 USA; [Eastep, Gunnar N.; Ghanam, Ruba H.; Vlach, Jiri; Saad, Jamil S.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Alabama System; University of Alabama Birmingham	Carter, CA (corresponding author), SUNY Stony Brook, Dept Mol Genet & Microbiol, Life Sci Bldg,Rm 248, Stony Brook, NY 11794 USA.	carol.carter@stonybrook.edu	Medina, Gisselle N/AAO-3560-2021; Medina, Gisselle N/ACU-5726-2022	Vlach, Jiri/0000-0002-0874-2055; Eastep, Gunnar/0000-0003-3567-8500; Saad, Jamil/0000-0001-9503-6484	National Institutes of Health (NIH) [R01GM111028]; NIH [R01GM117837]; NIGMS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048294, R01GM117837, R01GM111028] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health (NIH), Grant R01GM111028 and NIH Grants R01GM117837 (to C. A. C.) and R01GM117837 (to J. S. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akbulut S, 2010, MOL BIOL CELL, V21, P3487, DOI 10.1091/mbc.E10-02-0123; Alfadhli A, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00253; Ayada T, 2009, ONCOGENE, V28, P1076, DOI 10.1038/onc.2008.464; Cabrita MA, 2006, J BIOL CHEM, V281, P29201, DOI 10.1074/jbc.M603921200; Callahan EM, 2000, J VIROL, V74, P11222, DOI 10.1128/JVI.74.23.11222-11229.2000; Chan J, 2011, J VIROL, V85, P10851, DOI 10.1128/JVI.00760-11; Chukkapalli V, 2008, J VIROL, V82, P2405, DOI 10.1128/JVI.01614-07; Dalton AK, 2005, J VIROL, V79, P6227, DOI 10.1128/JVI.79.10.6227-6238.2005; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Dick RA, 2015, J VIROL, V89, P10371, DOI 10.1128/JVI.01628-15; Dick RA, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00187; Dilley KA, 2010, J VIROL, V84, P6276, DOI 10.1128/JVI.00238-10; Doktorova M, 2017, BIOPHYS J, V113, P2004, DOI 10.1016/j.bpj.2017.08.055; Egan JE, 2002, P NATL ACAD SCI USA, V99, P6041, DOI 10.1073/pnas.052090899; Ehrlich LS, 2011, J MOL BIOL, V410, P716, DOI 10.1016/j.jmb.2011.04.069; Fernandes F, 2011, TRAFFIC, V12, P438, DOI 10.1111/j.1600-0854.2010.01153.x; Ghanam RH, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00055; Gottwein E, 2005, J VIROL, V79, P9134, DOI 10.1128/JVI.79.14.9134-9144.2005; Hahn S, 2011, J IMMUNOL, V186, P5706, DOI 10.4049/jimmunol.1003764; Hamard-Peron E, 2010, J VIROL, V84, P503, DOI 10.1128/JVI.01134-09; HARLAN JE, 1994, NATURE, V371, P168, DOI 10.1038/371168a0; Inlora J, 2014, MBIO, V5, DOI 10.1128/mBio.02202-14; Inlora J, 2011, J VIROL, V85, P3802, DOI 10.1128/JVI.02383-10; Jager S, 2007, J VIROL, V81, P9193, DOI 10.1128/JVI.00044-07; Kikonyogo A, 2001, P NATL ACAD SCI USA, V98, P11199, DOI 10.1073/pnas.201268998; Kim HJ, 2007, CURR BIOL, V17, P455, DOI 10.1016/j.cub.2007.01.059; Kolay S, 2016, BIOCHEM J, V473, P1681, DOI 10.1042/BCJ20160069; Langelier C, 2006, J VIROL, V80, P9465, DOI 10.1128/JVI.01049-06; Lim J, 2002, MOL CELL BIOL, V22, P7953, DOI 10.1128/MCB.22.22.7953-7966.2002; Maldonado JO, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00302; Martin-Serrano J, 2004, J VIROL, V78, P5554, DOI 10.1128/JVI.78.11.5554-5563.2004; Medina GN, 2011, J VIROL, V85, P7353, DOI 10.1128/JVI.00141-11; Meng B, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0197-x; Murray PS, 2005, STRUCTURE, V13, P1521, DOI 10.1016/j.str.2005.07.010; Nadaraia-Hoke S, 2013, J VIROL, V87, P3609, DOI 10.1128/JVI.03059-12; Olety B, 2014, VIRUS RES, V193, P108, DOI 10.1016/j.virusres.2014.06.015; Ono A, 2004, P NATL ACAD SCI USA, V101, P14889, DOI 10.1073/pnas.0405596101; Parent LJ, 1996, J VIROL, V70, P1016, DOI 10.1128/JVI.70.2.1016-1026.1996; Pincetic A, 2008, J BIOL CHEM, V283, P29822, DOI 10.1074/jbc.M804157200; Saad JS, 2008, J MOL BIOL, V382, P434, DOI 10.1016/j.jmb.2008.07.027; Saad JS, 2006, P NATL ACAD SCI USA, V103, P11364, DOI 10.1073/pnas.0602818103; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Vana ML, 2004, J VIROL, V78, P13943, DOI 10.1128/JVI.78.24.13943-13953.2004; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Vlach J, 2018, J BIOL CHEM, V293, P18828, DOI 10.1074/jbc.RA118.003944; Vlach J, 2013, P NATL ACAD SCI USA, V110, P3525, DOI 10.1073/pnas.1216655110; Wen Y, 2016, J VIROL, V90, P9518, DOI 10.1128/JVI.01102-16; Wong ESM, 2002, EMBO J, V21, P4796, DOI 10.1093/emboj/cdf493; Zhang ZL, 2016, J VIROL, V90, P1824, DOI 10.1128/JVI.02814-15; ZHOU WJ, 1994, J VIROL, V68, P2556, DOI 10.1128/JVI.68.4.2556-2569.1994; Zhou WJ, 1996, J VIROL, V70, P8540, DOI 10.1128/JVI.70.12.8540-8548.1996	51	6	6	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2018	293	49					18841	18853		10.1074/jbc.RA118.003947	http://dx.doi.org/10.1074/jbc.RA118.003947			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NY	30309982	hybrid, Green Published			2022-12-28	WOS:000458467400003
J	Kahana, C				Kahana, Chaim			The antizyme family for regulating polyamines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ORNITHINE-DECARBOXYLASE-ANTIZYME; PROTEASOMAL DEGRADATION; REQUIRES INTERACTION; HOMOLOGOUS PROTEIN; STRUCTURAL BASIS; MESSENGER-RNA; GENE ENCODES; INHIBITOR 2; EXPRESSION; CELLS	The polyamines spermidine, spermine, and their precursor putrescine are organic polycations involved in various cellular processes and are absolutely essential for cellular proliferation. Because of their crucial function in the cell, their intracellular concentration must be maintained at optimal levels. To a large extent, this regulation is achieved through the activity of an autoregulatory loop that involves two proteins, antizyme (Az) and antizyme inhibitor (AzI), that regulate the first enzyme in polyamine biosynthesis, ornithine decarboxylase (ODC), and polyamine uptake activity in response to intracellular polyamine levels. In this Minireview, I will discuss what has been learned about the mechanism of Az expression and its physical interaction with both ODC and AzI in the regulation of polyamines.	[Kahana, Chaim] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Kahana, C (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	chaim.kahana@weizmann.ac.il			Israel Academy of Science and Humanities	Israel Academy of Science and Humanities	This work was supported by grant from the Israel Academy of Science and Humanities. This article is part of a series on "Polyamines," written in honor of Dr. Herbert Tabor's 100th birthday. The author declares that he has no conflicts of interest with the contents of this article.	Albeck S, 2008, PROTEIN SCI, V17, P793, DOI 10.1110/ps.073427208; Almrud JJ, 2000, J MOL BIOL, V295, P7, DOI 10.1006/jmbi.1999.3331; AUVINEN M, 1992, NATURE, V360, P355, DOI 10.1038/360355a0; Battaglia V, 2014, AMINO ACIDS, V46, P511, DOI 10.1007/s00726-013-1529-6; Bercovich Z, 2004, J BIOL CHEM, V279, P54097, DOI 10.1074/jbc.M410234200; Bercovich Z, 2011, J BIOL CHEM, V286, P33778, DOI 10.1074/jbc.M111.270637; Casero RA, 2009, BIOCHEM J, V421, P323, DOI 10.1042/BJ20090598; Chen H, 2002, J BIOL CHEM, V277, P45957, DOI 10.1074/jbc.M206799200; Chen LL, 2013, NAT MED, V19, P209, DOI 10.1038/nm.3043; Chin SF, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r215; Choi KS, 2005, BIOCHEM BIOPH RES CO, V328, P206, DOI 10.1016/j.bbrc.2004.11.172; Coffino P, 2001, BIOCHIMIE, V83, P319, DOI 10.1016/S0300-9084(01)01252-4; Crews LA, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-014-0370-3; Dulloo I, 2010, P NATL ACAD SCI USA, V107, P4902, DOI 10.1073/pnas.0906782107; Feng F., 2017, TUMOUR BIOL, V39; FUJITA K, 1982, BIOCHEM J, V204, P647, DOI 10.1042/bj2040647; Gandre S, 2003, MITOCHONDRION, V2, P245, DOI 10.1016/S1567-7249(02)00105-8; Gandre S, 2002, EUR J BIOCHEM, V269, P1316, DOI 10.1046/j.1432-1033.2002.02774.x; GHODA L, 1989, SCIENCE, V243, P1493, DOI 10.1126/science.2928784; GHODA L, 1990, J BIOL CHEM, V265, P11823; Gruendler C, 2001, J BIOL CHEM, V276, P46533, DOI 10.1074/jbc.M105500200; Hayashi S, 1996, TRENDS BIOCHEM SCI, V21, P27, DOI 10.1016/0968-0004(96)80882-6; Hoshino K, 2005, J BIOL CHEM, V280, P42801, DOI 10.1074/jbc.M505445200; Hoyt MA, 2003, J BIOL CHEM, V278, P12135, DOI 10.1074/jbc.M211802200; Ikeguchi Y, 2006, J BIOCHEM, V139, P1, DOI 10.1093/jb/mvj019; Ivanov IP, 2000, P NATL ACAD SCI USA, V97, P4808, DOI 10.1073/pnas.070055897; Ivanov IP, 1998, GENOMICS, V52, P119, DOI 10.1006/geno.1998.5434; Ivanov IP, 2000, NUCLEIC ACIDS RES, V28, P3185, DOI 10.1093/nar/28.17.3185; Ivanov IP, 2000, EMBO J, V19, P1907, DOI 10.1093/emboj/19.8.1907; Ivanov IP, 2008, P NATL ACAD SCI USA, V105, P10079, DOI 10.1073/pnas.0801590105; Ivanov IP, 2007, NUCLEIC ACIDS RES, V35, P1842, DOI 10.1093/nar/gkm035; Ivanov IP, 2018, MOL CELL, V70, P254, DOI 10.1016/j.molcel.2018.03.015; Jung MH, 2000, GENOMICS, V69, P281, DOI 10.1006/geno.2000.6338; Kahana C, 2009, CELL MOL LIFE SCI, V66, P2479, DOI 10.1007/s00018-009-0033-3; Kanerva K, 2008, BIOCHEM J, V409, P187, DOI 10.1042/BJ20071004; Kanerva K, 2010, EXP CELL RES, V316, P1896, DOI 10.1016/j.yexcr.2010.02.021; Kanerva K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006858; Keren-Paz A, 2006, ONCOGENE, V25, P5163, DOI 10.1038/sj.onc.1209521; KITANI T, 1989, BIOCHIM BIOPHYS ACTA, V991, P44, DOI 10.1016/0304-4165(89)90026-3; Kurian L, 2011, NATURE, V477, P490, DOI 10.1038/nature10393; Lambertos A, 2018, BBA-GEN SUBJECTS, V1862, P365, DOI 10.1016/j.bbagen.2017.11.007; LI XQ, 1993, MOL CELL BIOL, V13, P2377, DOI 10.1128/MCB.13.4.2377; LI XQ, 1994, MOL CELL BIOL, V14, P87, DOI 10.1128/MCB.14.1.87; LI XQ, 1992, MOL CELL BIOL, V12, P3556, DOI 10.1128/MCB.12.8.3556; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; Lim SK, 2007, ONCOGENE, V26, P6593, DOI 10.1038/sj.onc.1210482; Liu YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019253; LOETSCHER P, 1991, J BIOL CHEM, V266, P11213; Lopez-Contreras AJ, 2008, J BIOL CHEM, V283, P20761, DOI 10.1074/jbc.M801024200; Lopez-Contreras AJ, 2006, J BIOL CHEM, V281, P30896, DOI 10.1074/jbc.M602840200; Lopez-Garcia C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069188; Makitie LT, 2009, HISTOCHEM CELL BIOL, V132, P633, DOI 10.1007/s00418-009-0636-7; MAMROUDKIDRON E, 1994, EUR J BIOCHEM, V226, P547, DOI 10.1111/j.1432-1033.1994.tb20079.x; Mangold U, 2005, IUBMB LIFE, V57, P671, DOI 10.1080/15216540500307031; MATSUFUJI S, 1995, CELL, V80, P51, DOI 10.1016/0092-8674(95)90450-6; MITCHELL JLA, 1994, BIOCHEM J, V299, P19, DOI 10.1042/bj2990019; Murai N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21189-0; MURAKAMI Y, 1989, BIOCHEM J, V259, P839, DOI 10.1042/bj2590839; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; Murakami Y, 1996, J BIOL CHEM, V271, P3340, DOI 10.1074/jbc.271.7.3340; Newman RM, 2004, J BIOL CHEM, V279, P41504, DOI 10.1074/jbc.M407349200; Olsen RR, 2012, AMINO ACIDS, V42, P549, DOI 10.1007/s00726-011-1032-x; Olsen RR, 2011, MOL CANCER RES, V9, P1285, DOI 10.1158/1541-7786.MCR-11-0178; Palanimurugan R, 2004, EMBO J, V23, P4857, DOI 10.1038/sj.emboj.7600473; Pegg AE, 2008, AM J PHYSIOL-ENDOC M, V294, pE995, DOI 10.1152/ajpendo.90217.2008; Pegg AE, 2006, J BIOL CHEM, V281, P14529, DOI 10.1074/jbc.R500031200; Pegg AE, 2016, J BIOL CHEM, V291, P14904, DOI 10.1074/jbc.R116.731661; Pegg AE, 2014, IUBMB LIFE, V66, P8, DOI 10.1002/iub.1237; Pegg AE, 2009, ESSAYS BIOCHEM, V46, P25, DOI [10.1042/BSE0460003, 10.1042/bse0460003]; Pegg AE, 2010, CELL MOL LIFE SCI, V67, P113, DOI 10.1007/s00018-009-0165-5; Petros LM, 2005, BIOCHEM BIOPH RES CO, V338, P1478, DOI 10.1016/j.bbrc.2005.10.115; Pitkanen LT, 2001, BIOCHEM BIOPH RES CO, V287, P1051, DOI 10.1006/bbrc.2001.5703; POULIN R, 1992, J BIOL CHEM, V267, P150; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Prakash S, 2009, NAT CHEM BIOL, V5, P29, DOI 10.1038/nchembio.130; Qin YR, 2014, CANCER RES, V74, P840, DOI 10.1158/0008-5472.CAN-13-2545; Rasila T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151175; ROM E, 1994, P NATL ACAD SCI USA, V91, P3959, DOI 10.1073/pnas.91.9.3959; ROSENBERGHASSON Y, 1991, BIOCHEM J, V277, P683, DOI 10.1042/bj2770683; ROSENBERGHASSON Y, 1991, EUR J BIOCHEM, V196, P647, DOI 10.1111/j.1432-1033.1991.tb15861.x; Schaner ME, 2003, MOL BIOL CELL, V14, P4376, DOI 10.1091/mbc.e03-05-0279; Shigeyasu K, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99976; Snapir Z, 2008, BIOCHEM J, V410, P613, DOI 10.1042/BJ20071423; Snapir Z, 2009, BIOCHEM J, V419, P99, DOI 10.1042/BJ20081874; SOLANO F, 1985, FEBS LETT, V190, P324, DOI 10.1016/0014-5793(85)81311-9; Su KL, 2009, J BIOL CHEM, V284, P26768, DOI 10.1074/jbc.M109.007807; SUZUKI T, 1994, P NATL ACAD SCI USA, V91, P8930, DOI 10.1073/pnas.91.19.8930; Takeuchi J, 2007, EMBO J, V26, P123, DOI 10.1038/sj.emboj.7601476; TOBIAS KE, 1993, BIOCHEMISTRY-US, V32, P5842, DOI 10.1021/bi00073a017; Tosaka Y, 2000, GENES CELLS, V5, P265, DOI 10.1046/j.1365-2443.2000.00324.x; van Duin M, 2005, GENE CHROMOSOME CANC, V44, P438, DOI 10.1002/gcc.20259; Wu DD, 2015, MED GAS RES, V5, DOI 10.1186/s13618-014-0022-y; Wu HY, 2015, P NATL ACAD SCI USA, V112, P11229, DOI 10.1073/pnas.1508187112; Yordanova MM, 2015, J BIOL CHEM, V290, P17863, DOI 10.1074/jbc.M115.647065; Zhang MS, 2003, EMBO J, V22, P1488, DOI 10.1093/emboj/cdg158; Zhu C, 1999, J BIOL CHEM, V274, P26425, DOI 10.1074/jbc.274.37.26425	96	32	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2018	293	48					18730	18735		10.1074/jbc.TM118.003339	http://dx.doi.org/10.1074/jbc.TM118.003339			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NX	30355739	Green Published, hybrid			2022-12-28	WOS:000458467300028
J	Kresge, N; Simoni, RD; Hill, RL				Kresge, Nicole; Simoni, Robert D.; Hill, Robert L.			Peter Reichard and the reduction of ribonucleosides (vol 281, e13, 2006)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Kresge N, 2006, J BIOL CHEM, V281	1	0	0	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2018	293	48					18680	18680		10.1074/jbc.AAC118.006606	http://dx.doi.org/10.1074/jbc.AAC118.006606			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NX	30504283	Green Published, hybrid			2022-12-28	WOS:000458467300022
J	Thapa, D; Wu, KY; Stoner, MW; Xie, BX; Zhang, ML; Manning, JR; Lu, ZP; Li, JH; Chen, Y; Gucek, M; Playford, MP; Mehta, NN; Harmon, D; O'Doherty, RM; Jurczak, MJ; Sack, MN; Scott, I				Thapa, Dharendra; Wu, Kaiyuan; Stoner, Michael W.; Xie, Bingxian; Zhang, Manling; Manning, Janet R.; Lu, Zhongping; Li, Jian H.; Chen, Yong; Gucek, Marjan; Playford, Martin P.; Mehta, Nehal N.; Harmon, Daniel; O'Doherty, Robert M.; Jurczak, Michael J.; Sack, Michael N.; Scott, Iain			The protein acetylase GCN5L1 modulates hepatic fatty acid oxidation activity via acetylation of the mitochondrial beta-oxidation enzyme HADHA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetylation; mitochondria; mitochondrial metabolism; fatty acid oxidation; post-translational modification (PTM); GCN5L1; HADHA; liver metabolism; lipid metabolism	SIRT3; METABOLISM; HYPERACETYLATION; SUCCINYLATION; BIOGENESIS; DISEASE; OBESITY; LIVER; HEART	Sirtuin 3 (SIRT3) deacetylates and activates several mitochondrial fatty acid oxidation enzymes in the liver. Here, we investigated whether the protein acetylase GCN5 general control of amino acid synthesis 5-like 1 (GCN5L1), previously shown to oppose SIRT3 activity, is involved in the regulation of hepatic fatty acid oxidation. We show that GCN5L1 abundance is significantly up-regulated in response to an acute high-fat diet (HFD). Transgenic GCN5L1 overexpression in the mouse liver increased protein acetylation levels, and proteomic detection of specific lysine residues identified numerous sites that are co-regulated by GCN5L1 and SIRT3. We analyzed several fatty acid oxidation proteins identified by the proteomic screen and found that hyperacetylation of hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit (HADHA) correlates with increased GCN5L1 levels. Stable GCN5L1 knockdown in HepG2 cells reduced HADHA acetylation and increased activities of fatty acid oxidation enzymes. Mice with a liver-specific deletion of GCN5L1 were protected from hepatic lipid accumulation following a chronic HFD and did not exhibit hyperacetylation of HADHA compared with WT controls. Finally, we found that GCN5L1-knockout mice lack HADHA that is hyperacetylated at three specific lysine residues (Lys-350, Lys-383, and Lys-406) and that acetylation at these sites is significantly associated with increased HADHA activity. We conclude that GCN5L1-mediated regulation of mitochondrial protein acetylation plays a role in hepatic metabolic homeostasis.	[Thapa, Dharendra; Stoner, Michael W.; Xie, Bingxian; Zhang, Manling; Manning, Janet R.; Scott, Iain] Univ Pittsburgh, Dept Med, Div Cardiol, BST E1256,200 Lothrop St, Pittsburgh, PA 15261 USA; [Thapa, Dharendra; Stoner, Michael W.; Xie, Bingxian; Zhang, Manling; Manning, Janet R.; Scott, Iain] Univ Pittsburgh, Dept Med, Vasc Med Inst, 930 Scaife Hall, Pittsburgh, PA 15261 USA; [Xie, Bingxian; Harmon, Daniel; O'Doherty, Robert M.; Jurczak, Michael J.] Univ Pittsburgh, Dept Med, Div Endocrinol, 930 Scaife Hall, Pittsburgh, PA 15261 USA; [Thapa, Dharendra; Stoner, Michael W.; Xie, Bingxian; Zhang, Manling; Manning, Janet R.; Harmon, Daniel; O'Doherty, Robert M.; Jurczak, Michael J.; Scott, Iain] Univ Pittsburgh, Ctr Metab & Mitochondrial Med, Pittsburgh, PA 15261 USA; [Wu, Kaiyuan; Lu, Zhongping; Li, Jian H.; Chen, Yong; Gucek, Marjan; Playford, Martin P.; Mehta, Nehal N.; Sack, Michael N.] NHLBI, Div Intramural Res, NIH, Bldg 10, Bethesda, MD 20892 USA; [Lu, Zhongping] George Washington Univ, Vet Adm Med Ctr, Washington, DC 20422 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); George Washington University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Scott, I (corresponding author), Univ Pittsburgh, Dept Med, Div Cardiol, BST E1256,200 Lothrop St, Pittsburgh, PA 15261 USA.	scotti2@upmc.edu	Xie, Bingxian/Y-6487-2019; Thapa, Dharendra/AAL-7293-2021; wu, kaiyuan/AAD-6635-2020; Mehta, Nehal N/W-4669-2019	Thapa, Dharendra/0000-0002-1157-5534; Mehta, Nehal N/0000-0003-4939-5130; wu, kaiyuan/0000-0001-7395-4524; chen, yong/0000-0003-1528-3456; Manning, Janet/0000-0001-5763-7713	National Institutes of Health Award [P30CA047904]; NATIONAL CANCER INSTITUTE [P30CA047904] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005102, K22HL116728, ZIAHL006047, ZICHL005903, R56HL132917, T32HL110849, R01HL132917, ZIAHL005199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007052] Funding Source: NIH RePORTER	National Institutes of Health Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Drs. Liang Guo (University of Michigan) and Qi-Qun Tang (Fudan University) for the kind gift of the Ac-HADHA (Lys-350/Lys-383/Lys-406) antibody. This project used the UPMC Hillman Cancer Center and Tissue and Research Pathology/Health Sciences Tissue Bank shared resource, which is supported in part by National Institutes of Health Award P30CA047904.	Alrob OA, 2014, CARDIOVASC RES, V103, P485, DOI 10.1093/cvr/cvu156; Bao JJ, 2010, FREE RADICAL BIO MED, V49, P1230, DOI 10.1016/j.freeradbiomed.2010.07.009; Carrico C, 2018, CELL METAB, V27, P497, DOI 10.1016/j.cmet.2018.01.016; Donato V, 2017, NAT CELL BIOL, V19, P341, DOI 10.1038/ncb3491; Fukushima A, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99239; Fukushima A, 2016, AM J PHYSIOL-HEART C, V311, pH347, DOI 10.1152/ajpheart.00900.2015; Guo L, 2016, MOL CELL BIOL, V36, P2553, DOI 10.1128/MCB.00227-16; Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Kendrick AA, 2011, BIOCHEM J, V433, P505, DOI 10.1042/BJ20100791; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Koliaki C, 2016, ANNU REV NUTR, V36, P337, DOI 10.1146/annurev-nutr-071715-050656; Lee J, 2016, CELL REP, V16, P201, DOI 10.1016/j.celrep.2016.05.062; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Mansouri A, 2018, GASTROENTEROLOGY, V155, P629, DOI 10.1053/j.gastro.2018.06.083; Nassir F, 2018, J LIPID RES, V59, P967, DOI 10.1194/jlr.M080952; Niwa S, 2017, CURR BIOL, V27, P2569, DOI 10.1016/j.cub.2017.07.013; Pougovkina O, 2014, HUM MOL GENET, V23, P3513, DOI 10.1093/hmg/ddu059; Schwer B, 2002, J CELL BIOL, V158, P647, DOI 10.1083/jcb.200205057; Scott I, 2018, TRENDS CELL BIOL, V28, P346, DOI 10.1016/j.tcb.2018.01.007; Scott I, 2014, J BIOL CHEM, V289, P2864, DOI 10.1074/jbc.M113.521641; Scott I, 2012, BIOCHEM J, V443, P655, DOI 10.1042/BJ20120118; Thapa D, 2017, AM J PHYSIOL-HEART C, V313, pH265, DOI 10.1152/ajpheart.00752.2016; Wagner GR, 2013, J BIOL CHEM, V288, P29036, DOI 10.1074/jbc.M113.486753; Wang LD, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00521-8; Wiedemann N, 2004, J BIOL CHEM, V279, P14473, DOI 10.1074/jbc.R400003200	26	38	39	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2018	293	46					17676	17684		10.1074/jbc.AC118.005462	http://dx.doi.org/10.1074/jbc.AC118.005462			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HA6SG	30323061	hybrid, Green Published			2022-12-28	WOS:000450409500002
J	Bradford, STJ; Ranghini, EJ; Grimley, E; Lee, PH; Dressler, GR				Bradford, Shayna T. J.; Ranghini, Egon J.; Grimley, Edward; Lee, Pil H.; Dressler, Gregory R.			High-throughput screens for agonists of bone morphogenetic protein (BMP) signaling identify potent benzoxazole compounds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bone morphogenetic protein (BMP); BMP signaling; chemical biology; fibrosis; small molecule; SMAD transcription factor; TGF-beta signaling; acute kidney disease; chronic kidney disease; end-stage renal disease; high-throughput screening; sb4	KIELIN/CHORDIN-LIKE PROTEIN; TERMINAL DOMAIN PHOSPHATASES; SMALL-MOLECULE; RENAL FIBROSIS; EXPRESSION; INHIBITION; DISCOVERY; GREMLIN; PATHWAY; TARGETS	Bone morphogenetic protein (BMP) signaling is critical in renal development and disease. In animal models of chronic kidney disease (CKD), re-activation of BMP signaling is reported to be protective by promoting renal repair and regeneration. Clinical use of recombinant BMPs, however, requires harmful doses to achieve efficacy and is costly because of BMPs' complex synthesis. Therefore, alternative strategies are needed to harness the beneficial effects of BMP signaling in CKD. Key aspects of the BMP signaling pathway can be regulated by both extracellular and intracellular molecules. In particular, secreted proteins like noggin and chordin inhibit BMP activity, whereas kielin/chordin-like proteins (KCP) enhance it and attenuate kidney fibrosis or CKD. Clinical development of KCP, however, is precluded by its size and complexity. Therefore, we propose an alternative strategy to enhance BMP signaling by using small molecules, which are simpler to synthesize and more cost-effective. To address our objective, here we developed a small-molecule high-throughput screen (HTS) with human renal cells having an integrated luciferase construct highly responsive to BMPs. We demonstrate the activity of a potent benzoxazole compound, sb4, that rapidly stimulated BMP signaling in these cells. Activation of BMP signaling by sb4 increased the phosphorylation of key second messengers (SMAD-1/5/9) and also increased expression of direct target genes (inhibitors of DNA binding, Id1 and Id3) in canonical BMP signaling. Our results underscore the feasibility of utilizing HTS to identify compounds that mimic key downstream events of BMP signaling in renal cells and have yielded a lead BMP agonist.	[Bradford, Shayna T. J.; Ranghini, Egon J.; Grimley, Edward; Dressler, Gregory R.] Univ Michigan, Coll Pharm, Dept Pathol, 428 Church St, Ann Arbor, MI 48109 USA; [Bradford, Shayna T. J.; Grimley, Edward] Univ Michigan, Coll Pharm, Sch Med, Mol & Cellular Pathol Grad Program, 428 Church St, Ann Arbor, MI 48109 USA; [Lee, Pil H.] Univ Michigan, Coll Pharm, Dept Med Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Dressler, GR (corresponding author), Dept Pathol, BSRB 2049,109 Zina Pitcher Dr, Ann Arbor, MI 48109 USA.	dressler@umich.edu		Grimley, Edward/0000-0003-0438-506X; Lee, Pil/0000-0003-2989-8371; Bradford, Shayna/0000-0003-4049-7384	NIDDK, National Institutes of Health [5R01DK054740-16, 3R01DK054740-1651]; University of Michigan Center for the Discovery of New Medicines; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054740, R01DK073722] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); University of Michigan Center for the Discovery of New Medicines(University of Michigan System); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIDDK, National Institutes of Health, Grants 5R01DK054740-16 and 3R01DK054740-1651. Funding was also provided by the University of Michigan Center for the Discovery of New Medicines directed by V. Groppi. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Aragon E, 2011, GENE DEV, V25, P1275, DOI 10.1101/gad.2060811; Baek SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120150; Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bosukonda D, 2000, KIDNEY INT, V58, P1902, DOI 10.1046/j.1523-1755.2000.00362.x; Bruce DL, 2012, FEBS LETT, V586, P1897, DOI 10.1016/j.febslet.2012.02.001; Cao Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep04965; Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023; Chen HY, 2004, DEVELOPMENT, V131, P2219, DOI 10.1242/dev.01094; Chen NF, 2010, J NEUROSURG-SPINE, V12, P40, DOI 10.3171/2009.4.SPINE0876; Chung YH, 2018, LAB INVEST, V98, P999, DOI 10.1038/s41374-018-0069-9; Cuny GD, 2008, BIOORG MED CHEM LETT, V18, P4388, DOI 10.1016/j.bmcl.2008.06.052; Dolan V, 2005, AM J KIDNEY DIS, V45, P1034, DOI 10.1053/j.ajkd.2005.03.014; Feng LL, 2016, CELL REP, V15, P2063, DOI 10.1016/j.celrep.2016.04.066; Genthe JR, 2017, ACS CHEM BIOL, V12, P2436, DOI 10.1021/acschembio.7b00527; Gomez-Puerto MC, 2019, J PATHOL, V247, P9, DOI 10.1002/path.5170; Grimley E, 2017, ACS CHEM BIOL, V12, P724, DOI 10.1021/acschembio.6b00782; Hao J, 2010, ACS CHEM BIOL, V5, P245, DOI 10.1021/cb9002865; Hill AP, 2010, DRUG DISCOV TODAY, V15, P648, DOI 10.1016/j.drudis.2010.05.016; Himmelfarb J, 2018, J AM SOC NEPHROL, V29, P670, DOI 10.1681/ASN.2017020217; Hollnagel A, 1999, J BIOL CHEM, V274, P19838, DOI 10.1074/jbc.274.28.19838; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jacob RT, 2012, J BIOMOL SCREEN, V17, P1080, DOI 10.1177/1087057112450186; Kato S, 2011, MOL CELL BIOCHEM, V349, P97, DOI 10.1007/s11010-010-0664-6; Kim MJ, 2018, BIOORG MED CHEM LETT, V28, P684, DOI 10.1016/j.bmcl.2018.01.021; Knockaert M, 2006, P NATL ACAD SCI USA, V103, P11940, DOI 10.1073/pnas.0605133103; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Lee KW, 2010, STEM CELLS DEV, V19, P557, DOI 10.1089/scd.2009.0147; Lin JM, 2005, NAT MED, V11, P387, DOI 10.1038/nm1217; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Long L, 2015, NAT MED, V21, P777, DOI 10.1038/nm.3877; LUO G, 1995, GENE DEV, V9, P2808, DOI 10.1101/gad.9.22.2808; Manson SR, 2015, VITAM HORM, V99, P91, DOI 10.1016/bs.vh.2015.05.003; Meyers EA, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022244; Mezzano S, 2007, NEPHROL DIAL TRANSPL, V22, P1882, DOI 10.1093/ndt/gfm145; Miyazono Kohei, 2002, Sci STKE, V2002, ppe40, DOI 10.1126/stke.2002.151.pe40; Morrissey J, 2002, J AM SOC NEPHROL, V13, pS14; Muchow Ryan D, 2010, Spine J, V10, pe1, DOI 10.1016/j.spinee.2010.06.020; Myllarniemi M, 2008, AM J RESP CRIT CARE, V177, P321, DOI 10.1164/rccm.200706-945OC; Okada M, 2009, CELL BIOCHEM FUNCT, V27, P526, DOI 10.1002/cbf.1615; Oxburgh L, 2005, DEV BIOL, V286, P637, DOI 10.1016/j.ydbio.2005.08.024; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; Rudnicki M, 2007, KIDNEY INT, V71, P325, DOI 10.1038/sj.ki.5002043; Salazar VS, 2016, NAT REV ENDOCRINOL, V12, P203, DOI 10.1038/nrendo.2016.12; Sapkota G, 2007, MOL CELL, V25, P441, DOI 10.1016/j.molcel.2007.01.006; Sapkota G, 2006, J BIOL CHEM, V281, P40412, DOI 10.1074/jbc.M610172200; Seth K, 2014, ACS MED CHEM LETT, V5, P512, DOI 10.1021/ml400500e; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Soofi A, 2017, J BIOL CHEM, V292, P9051, DOI 10.1074/jbc.M116.771428; Soofi A, 2016, AM J PHYSIOL-GASTR L, V311, pG587, DOI 10.1152/ajpgi.00165.2016; Soofi A, 2013, J AM SOC NEPHROL, V24, P897, DOI 10.1681/ASN.2012070759; Spiekerkoetter E, 2013, J CLIN INVEST, V123, P3600, DOI 10.1172/JCI65592; Taylor KR, 2014, CANCER RES, V74, P4565, DOI 10.1158/0008-5472.CAN-14-1298; Turk T, 2009, J HISTOCHEM CYTOCHEM, V57, P623, DOI 10.1369/jhc.2009.953224; Voelker J, 2017, J AM SOC NEPHROL, V28, P953, DOI 10.1681/ASN.2015111230; Vrijens K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059045; Wang RN, 2014, GENES DIS, V1, P87, DOI 10.1016/j.gendis.2014.07.005; Wang XW, 2012, NUCLEIC ACIDS RES, V40, pD1144, DOI 10.1093/nar/gkr1013; Williams E, 2018, BONE, V109, P251, DOI 10.1016/j.bone.2017.09.004; Xu B, 2011, DEVELOPMENT, V138, P925, DOI 10.1242/dev.062687; Yu PB, 2008, NAT MED, V14, P1363, DOI 10.1038/nm.1888; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zeisberg M, 2003, AM J PHYSIOL-RENAL, V285, pF1060, DOI 10.1152/ajprenal.00191.2002; Zeisberg M, 2008, PEDIATR NEPHROL, V23, P1395, DOI 10.1007/s00467-008-0818-x; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	68	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2019	294	9					3125	3136		10.1074/jbc.RA118.006817	http://dx.doi.org/10.1074/jbc.RA118.006817			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU0SA	30602563	Green Published, hybrid			2022-12-28	WOS:000464980100013
J	Anaokar, S; Kodali, R; Jonik, B; Renne, MF; Brouwers, JFHM; Lager, I; de Kroon, AIPM; Patton-Vogt, J				Anaokar, Sanket; Kodali, Ravindra; Jonik, Benjamin; Renne, Mike F.; Brouwers, Jos F. H. M.; Lager, Ida; de Kroon, Anton I. P. M.; Patton-Vogt, Jana			The glycerophosphocholine acyltransferase Gpc1 is part of a phosphatidylcholine (PC)-remodeling pathway that alters PC species in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphatidylcholine; phospholipid metabolism; acyltransferase; yeast; membrane turnover; Ale1; glycerophosphocholine; Gpc1; lipid remodeling	SACCHAROMYCES-CEREVISIAE; MASS-SPECTROMETRY; GENE-EXPRESSION; GLOBAL ANALYSIS; METABOLISM; IDENTIFICATION; TRANSCRIPTION; GLYCEROPHOSPHOINOSITOL; GLYCEROLIPIDS; BIOSYNTHESIS	Phospholipase B-mediated hydrolysis of phosphatidylcholine (PC) results in the formation of free fatty acids and glycerophosphocholine (GPC) in the yeast Saccharomyces cerevisiae. GPC can be reacylated by the glycerophosphocholine acyltransferase Gpc1, which produces lysophosphatidylcholine (LPC), and LPC can be converted to PC by the lysophospholipid acyltransferase Ale1. Here, we further characterized the regulation and function of this distinct PC deacylation/reacylation pathway in yeast. Through in vitro and in vivo experiments, we show that Gpc1 and Ale1 are the major cellular GPC and LPC acyltransferases, respectively. Importantly, we report that Gpc1 activity affects the PC species profile. Loss of Gpc1 decreased the levels of monounsaturated PC species and increased those of diunsaturated PC species, whereas Gpc1 overexpression had the opposite effects. Of note, Gpc1 loss did not significantly affect phosphatidylethanolamine, phosphatidylinositol, and phosphatidylserine profiles. Our results indicate that Gpc1 is involved in postsynthetic PC remodeling that produces more saturated PC species. qRT-PCR analyses revealed that GPC1 mRNA abundance is regulated coordinately with PC biosynthetic pathways. Inositol availability, which regulates several phospholipid biosynthetic genes, down-regulated GPC1 expression at the mRNA and protein levels and, as expected, decreased levels of monounsaturated PC species. Finally, loss of GPC1 decreased stationary phase viability in inositol-free medium. These results indicate that Gpc1 is part of a postsynthetic PC deacylation/reacylation remodeling pathway (PC-DRP) that alters the PC species profile, is regulated in coordination with other major lipid biosynthetic pathways, and affects yeast growth.	[Anaokar, Sanket; Jonik, Benjamin; Patton-Vogt, Jana] Duquesne Univ, Dept Biol Sci, Pittsburgh, PA 15282 USA; [Kodali, Ravindra] Duquesne Univ, Dept Chem & Biochem, Pittsburgh, PA 15282 USA; [Renne, Mike F.; de Kroon, Anton I. P. M.] Univ Utrecht, Bijvoet Ctr, Dept Membrane Biochem & Biophys, NL-3584 CH Utrecht, Netherlands; [Renne, Mike F.; de Kroon, Anton I. P. M.] Univ Utrecht, Inst Biomembranes, NL-3584 CH Utrecht, Netherlands; [Brouwers, Jos F. H. M.] Univ Utrecht, Inst Biomembranes, Dept Biochem & Cell Biol, NL-3584 CH Utrecht, Netherlands; [Lager, Ida] Swedish Univ Agr Sci, Dept Plant Breeding, SE-23053 Alnarp, Sweden	Duquesne University; Duquesne University; Utrecht University; Utrecht University; Utrecht University; Swedish University of Agricultural Sciences	Patton-Vogt, J (corresponding author), Duquesne Univ, Dept Biol Sci, Pittsburgh, PA 15282 USA.	pattonvogt@duq.edu	de Kroon, Anton I/O-4119-2016; Brouwers, Jos F/AAH-1444-2019	Brouwers, Jos F/0000-0003-2924-3279; de Kroon, Anton/0000-0003-1209-756X	National Science Foundation [MRIDBI-0821401]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM104876] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The purchase of mass spectrometers was supported by National Science Foundation Grant MRIDBI-0821401 to Duquesne University. We thank Dr. Amrah Weijn for help with the MS sample preparation.	Almaguer C, 2003, EUKARYOT CELL, V2, P729, DOI 10.1128/EC.2.4.729-736.2003; Almaguer C, 2006, CURR GENET, V50, P367, DOI 10.1007/s00294-006-0096-8; Amberg D. C., 2005, METHODS YEAST GENETI, P109; Ausubel F. M., 1999, SHORT PROTOCOLS MOL; Benghezal M, 2007, J BIOL CHEM, V282, P30845, DOI 10.1074/jbc.M702719200; Boumann HA, 2003, BIOCHEMISTRY-US, V42, P3054, DOI 10.1021/bi026801r; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; Casanovas A, 2015, CHEM BIOL, V22, P412, DOI 10.1016/j.chembiol.2015.02.007; Chen QL, 2007, FEBS LETT, V581, P5511, DOI 10.1016/j.febslet.2007.10.061; Cornell RB, 2015, PROG LIPID RES, V59, P147, DOI 10.1016/j.plipres.2015.07.001; De Smet CH, 2013, BBA-MOL CELL BIOL L, V1831, P1167, DOI 10.1016/j.bbalip.2013.03.002; De Smet CH, 2012, MOL BIOL CELL, V23, P1146, DOI 10.1091/mbc.E11-07-0624; DONAHUE TF, 1981, J BIOL CHEM, V256, P7077; Dowd SR, 2001, J BIOL CHEM, V276, P3756, DOI 10.1074/jbc.M003694200; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; Ernst R, 2016, J MOL BIOL, V428, P4776, DOI 10.1016/j.jmb.2016.08.013; Fagone P, 2013, BBA-MOL CELL BIOL L, V1831, P523, DOI 10.1016/j.bbalip.2012.09.009; Fernandez-Murray JP, 2009, J BIOL CHEM, V284, P36034, DOI 10.1074/jbc.M109.063958; Fernandez-Murray JP, 2005, J BIOL CHEM, V280, P38290, DOI 10.1074/jbc.M507700200; Fisher E, 2005, J BIOL CHEM, V280, P36110, DOI 10.1074/jbc.M507051200; Gaspar ML, 2006, J BIOL CHEM, V281, P22773, DOI 10.1074/jbc.M603548200; Glab B, 2016, J BIOL CHEM, V291, P25066, DOI 10.1074/jbc.M116.743062; Hanscho M, 2012, FEMS YEAST RES, V12, P796, DOI 10.1111/j.1567-1364.2012.00830.x; Henry SA, 2014, CHEM PHYS LIPIDS, V180, P23, DOI 10.1016/j.chemphyslip.2013.12.013; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; Hishikawa D, 2014, J LIPID RES, V55, P2444, DOI 10.1194/jlr.R046094ERR; Hofbauer HF, 2014, DEV CELL, V29, P729, DOI 10.1016/j.devcel.2014.04.025; Hoppen J, 2005, YEAST, V22, P601, DOI 10.1002/yea.1209; Jain S, 2007, J BIOL CHEM, V282, P30562, DOI 10.1074/jbc.M706326200; Jasieniecka-Gazarkiewicz K, 2016, LIPIDS, V51, P15, DOI 10.1007/s11745-015-4102-0; Kishino H, 2014, BIOCHEM BIOPH RES CO, V445, P289, DOI 10.1016/j.bbrc.2014.01.136; Klose C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035063; Klug L, 2014, FEMS YEAST RES, V14, P369, DOI 10.1111/1567-1364.12141; KODAKI T, 1987, J BIOL CHEM, V262, P15428; Lager I, 2015, PLANTA, V241, P347, DOI 10.1007/s00425-014-2184-1; LANDS WEM, 1960, J BIOL CHEM, V235, P2233; LANDS WEM, 1965, ANNU REV BIOCHEM, V34, P313, DOI 10.1146/annurev.bi.34.070165.001525; Laplante M, 2009, CURR BIOL, V19, pR1046, DOI 10.1016/j.cub.2009.09.058; Lee JCM, 2011, J NEUROCHEM, V116, P813, DOI 10.1111/j.1471-4159.2010.07033.x; LEE KS, 1994, J BIOL CHEM, V269, P19725; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Marchan R, 2012, CELL CYCLE, V11, P4499, DOI 10.4161/cc.22544; Morisada S, 2018, FEBS LETT, V592, P1829, DOI 10.1002/1873-3468.13103; Moser R, 2014, MOL MICROBIOL, V91, P736, DOI 10.1111/mmi.12492; Patton-Vogt J, 2007, BBA-MOL CELL BIOL L, V1771, P337, DOI 10.1016/j.bbalip.2006.04.013; Patton-Vogt JL, 1998, GENETICS, V149, P1707; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reimand J, 2010, NUCLEIC ACIDS RES, V38, P4768, DOI 10.1093/nar/gkq232; Renne MF, 2018, FEBS LETT, V592, P1330, DOI 10.1002/1873-3468.12944; Renne Mike F, 2015, Lipid Insights, V8, P33, DOI 10.4137/LPI.S31780; Riekhof WR, 2007, J BIOL CHEM, V282, P36853, DOI 10.1074/jbc.M706718200; Riekhof WR, 2007, J BIOL CHEM, V282, P28344, DOI 10.1074/jbc.M705256200; Robinson KA, 2000, NUCLEIC ACIDS RES, V28, P1499, DOI 10.1093/nar/28.7.1499; Salsaa M, 2017, J BIOL CHEM, V292, P18729, DOI 10.1074/jbc.H117.809970; SCHNEIDER BL, 1995, YEAST, V11, P1265, DOI 10.1002/yea.320111306; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Sreenivas A, 1998, J BIOL CHEM, V273, P16635, DOI 10.1074/jbc.273.27.16635; Stalberg K, 2008, J LIPID RES, V49, P1794, DOI 10.1194/jlr.M800129-JLR200; Surlow BA, 2014, J BIOL CHEM, V289, P31591, DOI 10.1074/jbc.M114.581157; Tamaki H, 2007, J BIOL CHEM, V282, P34288, DOI 10.1074/jbc.M704509200; Tanaka K, 2008, BBA-MOL CELL BIOL L, V1781, P391, DOI 10.1016/j.bbalip.2008.06.001; VOLLAND C, 1994, J BIOL CHEM, V269, P9833; WAGNER S, 1994, YEAST, V10, P1429, DOI 10.1002/yea.320101106; Wykoff DD, 2001, GENETICS, V159, P1491; Yamashita A, 2014, PROG LIPID RES, V53, P18, DOI 10.1016/j.plipres.2013.10.001; Yang K, 2011, METABOLITES, V1, P21, DOI 10.3390/metabo1010021; Zheng B, 2003, P NATL ACAD SCI USA, V100, P1745, DOI 10.1073/pnas.0337605100; Zhu X, 2015, GENETICS, V201, P525, DOI 10.1534/genetics.115.178293	70	7	7	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1189	1201		10.1074/jbc.RA118.005232	http://dx.doi.org/10.1074/jbc.RA118.005232			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30514764	Green Published, hybrid			2022-12-28	WOS:000457879500011
J	Karlsson, E; Andersson, E; Dogan, J; Gianni, S; Jemth, P; Camilloni, C				Karlsson, Elin; Andersson, Eva; Dogan, Jakob; Gianni, Stefano; Jemth, Per; Camilloni, Carlo			A structurally heterogeneous transition state underlies coupled binding and folding of disordered proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						intrinsically disordered protein; pre-steady-state kinetics; protein folding; protein-protein interaction; molecular dynamics	NUCLEATION-CONDENSATION MECHANISM; MOLECULAR RECOGNITION; DOMAIN; MODEL; KINETICS; KIX; ASSOCIATION; FRUSTRATION; BEHAVIOR; ENZYME	Many intrinsically disordered proteins (IDPs) attain a well-defined structure in a coupled folding and binding reaction with another protein. Such reactions may involve early to late formation of different native structural regions along the reaction pathway. To obtain insights into the transition state for a coupled binding and folding reaction, we performed restrained molecular dynamics simulations using previously determined experimental binding phi(b) values of the interaction between two IDP domains: the activation domain from the p160 transcriptional co-activator for thyroid hormone and retinoid receptors (ACTR) and the nuclear co-activator binding domain (NCBD) of CREB-binding protein, each forming three well-defined alpha-helices upon binding. These simulations revealed that both proteins are largely disordered in the transition state for complex formation, except for two helices, one from each domain, that display a native-like structure. The overall transition state structure was extended and largely dynamic with many weakly populated contacts. To test the transition state model, we combined site-directed mutagenesis with kinetic experiments, yielding results consistent with overall diffuse interactions and formation of native intramolecular interactions in the third NCBD helix during the binding reaction. Our findings support the view that the transition state and, by inference, any encounter complex in coupled binding and folding reactions are structurally heterogeneous and largely independent of specific interactions. Furthermore, experimental phi(b) values and Bronsted plots suggested that the transition state is globally robust with respect to most mutations but can display more native-like features for some highly destabilizing mutations, possibly because of Hammond behavior or ground-state effects.	[Karlsson, Elin; Andersson, Eva; Jemth, Per] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden; [Dogan, Jakob] Stockholm Univ, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden; [Gianni, Stefano] Sapienza Univ Roma, Ist Pasteur, Fdn Cenci Bolognetti, I-00185 Rome, Italy; [Gianni, Stefano] Sapienza Univ Roma, Ist Biol Patol & Mol, CNR, Dipartimento Sci Biochim A Rossi Fanelli, I-00185 Rome, Italy; [Camilloni, Carlo] Univ Milan, Dipartimento Biosci, I-20133 Milan, Italy	Uppsala University; Stockholm University; Fondazione Cenci Bolognetti; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome; University of Milan	Jemth, P (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden.; Camilloni, C (corresponding author), Univ Milan, Dipartimento Biosci, I-20133 Milan, Italy.	Per.Jemth@imbim.uu.se; carlo.camilloni@unimi.it	Camilloni, Carlo/A-4395-2009	Camilloni, Carlo/0000-0002-9923-8590; Karlsson, Elin/0000-0001-5526-4968; Jemth, Per/0000-0003-1516-7228	Swedish Research Council [2016-04965]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by Swedish Research Council Grant 2016-04965 (to P. J.). The authors declare that they have no conflicts of interest with the contents of this article.	Abascal JLF, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2121687; ABKEVICH VI, 1994, BIOCHEMISTRY-US, V33, P10026, DOI 10.1021/bi00199a029; ABKEVICH VI, 1995, J MOL BIOL, V252, P460, DOI 10.1006/jmbi.1995.0511; Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; BASHFORD D, 1984, J BIOMOL STRUCT DYN, V1, P1243, DOI 10.1080/07391102.1984.10507515; Best RB, 2010, J PHYS CHEM B, V114, P14916, DOI 10.1021/jp108618d; Bonetti D, 2017, BIOCHEMISTRY-US, V56, P3780, DOI 10.1021/acs.biochem.7b00350; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chemes LB, 2011, J MOL BIOL, V412, P267, DOI 10.1016/j.jmb.2011.07.015; COHEN FE, 1980, NATURE, V286, P632, DOI 10.1038/286632a0; Crabtree MD, 2018, J BIOL CHEM, V293, P9718, DOI 10.1074/jbc.RA118.002791; Dahal L, 2017, BIOPHYS J, V113, P2713, DOI 10.1016/j.bpj.2017.10.016; Demarest SJ, 2002, NATURE, V415, P549, DOI 10.1038/415549a; Dogan J, 2016, BIOCHEMISTRY-US, V55, P5289, DOI 10.1021/acs.biochem.6b00573; Dogan J, 2015, BIOCHEMISTRY-US, V54, P4741, DOI 10.1021/acs.biochem.5b00520; Dogan J, 2013, SCI REP-UK, V3, DOI 10.1038/srep02076; Dogan J, 2012, J BIOL CHEM, V287, P34316, DOI 10.1074/jbc.M112.399436; Fersht AR, 2004, P NATL ACAD SCI USA, V101, P7976, DOI 10.1073/pnas.0402684101; FERSHT AR, 1995, P NATL ACAD SCI USA, V92, P10869, DOI 10.1073/pnas.92.24.10869; Fuxreiter M, 2019, CURR OPIN STRUC BIOL, V54, P19, DOI 10.1016/j.sbi.2018.09.008; Fuxreiter M, 2018, J MOL BIOL, V430, P2278, DOI 10.1016/j.jmb.2018.02.015; Gianni S, 2007, P NATL ACAD SCI USA, V104, P128, DOI 10.1073/pnas.0602770104; Gianni S, 2016, CURR OPIN STRUC BIOL, V36, P18, DOI 10.1016/j.sbi.2015.11.012; Gianni S, 2014, P NATL ACAD SCI USA, V111, P14141, DOI 10.1073/pnas.1405233111; Giri R, 2013, P NATL ACAD SCI USA, V110, P14942, DOI 10.1073/pnas.1307337110; Parra RG, 2016, NUCLEIC ACIDS RES, V44, pW356, DOI 10.1093/nar/gkw304; HAMMOND GS, 1955, J AM CHEM SOC, V77, P334, DOI 10.1021/ja01607a027; Haq SR, 2012, J AM CHEM SOC, V134, P599, DOI 10.1021/ja209341w; Hultqvist G, 2017, ELIFE, V6, DOI 10.7554/eLife.16059; Iesmantavicius V, 2014, ANGEW CHEM INT EDIT, V53, P1548, DOI 10.1002/anie.201307712; ITZHAKI LS, 1995, J MOL BIOL, V254, P260, DOI 10.1006/jmbi.1995.0616; Jemth P, 2014, J BIOL CHEM, V289, P5528, DOI 10.1074/jbc.M113.537068; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KARPLUS M, 1976, NATURE, V260, P404, DOI 10.1038/260404a0; Kjaergaard M, 2013, BIOCHEMISTRY-US, V52, P1686, DOI 10.1021/bi4001062; Kjaergaard M, 2010, P NATL ACAD SCI USA, V107, P12535, DOI 10.1073/pnas.1001693107; Knott M, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4873710; Kragelj J, 2015, P NATL ACAD SCI USA, V112, P3409, DOI 10.1073/pnas.1419528112; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; LEFFLER JE, 1953, SCIENCE, V117, P340, DOI 10.1126/science.117.3039.340; Lindorff-Larsen K, 2004, NAT STRUCT MOL BIOL, V11, P443, DOI 10.1038/nsmb765; Lindstrom I, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26213-x; Lindstrom I, 2017, BIOCHEMISTRY-US, V56, P4145, DOI 10.1021/acs.biochem.7b00428; Malatesta F, 2005, BIOPHYS CHEM, V116, P251, DOI 10.1016/j.bpc.2005.04.006; MATOUSCHEK A, 1993, P NATL ACAD SCI USA, V90, P7814, DOI 10.1073/pnas.90.16.7814; Paci E, 2003, P NATL ACAD SCI USA, V100, P394, DOI 10.1073/pnas.232704999; Paci E, 2002, J MOL BIOL, V324, P151, DOI 10.1016/S0022-2836(02)00944-0; Rogers JM, 2014, P NATL ACAD SCI USA, V111, P15420, DOI 10.1073/pnas.1409122111; Sanchez IE, 2003, J MOL BIOL, V327, P867, DOI 10.1016/S0022-2836(03)00171-2; Schneider R, 2015, J AM CHEM SOC, V137, P1220, DOI 10.1021/ja511066q; Sturzenegger F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07043-x; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; TONEY MD, 1989, SCIENCE, V243, P1485, DOI 10.1126/science.2538921; Toto A, 2016, BIOCHEMISTRY-US, V55, P3957, DOI 10.1021/acs.biochem.6b00505; Toto A, 2016, SCI REP-UK, V6, DOI 10.1038/srep21994; Tribello GA, 2014, COMPUT PHYS COMMUN, V185, P604, DOI 10.1016/j.cpc.2013.09.018; Uversky VN, 2012, ANAL CHEM, V84, P2096, DOI 10.1021/ac203096k; Vendruscolo M, 2001, NATURE, V409, P641, DOI 10.1038/35054591; WINTER G, 1982, NATURE, V299, P756, DOI 10.1038/299756a0; Zhang WH, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002353; Zosel F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05725-0	61	26	26	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1230	1239		10.1074/jbc.RA118.005854	http://dx.doi.org/10.1074/jbc.RA118.005854			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30514761	Green Published, hybrid			2022-12-28	WOS:000457879500014
J	Dahal-Koirala, S; Ciacchi, L; Petersen, J; Risnes, LF; Neumann, RS; Christophersen, A; Lundin, KEA; Reid, HH; Qiao, SW; Rossjohn, J; Sollid, LM				Dahal-Koirala, Shiva; Ciacchi, Laura; Petersen, Jan; Risnes, Louise Fremgaard; Neumann, Ralf Stefan; Christophersen, Asbjorn; Lundin, Knut E. A.; Reid, Hugh H.; Qiao, Shuo-Wang; Rossjohn, Jamie; Sollid, Ludvig M.			Discriminative T-cell receptor recognition of highly homologous HLA-DQ2-bound gluten epitopes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						T-cell; T-cell receptor (TCR); major histocompatibility complex (MHC); crystal structure; surface plasmon resonance (SPR); human; flow cytometry; Celiac Disease; Gluten; gluten intolerance; Immune response; immunodominant epitope	CELIAC-DISEASE; GLIADIN PEPTIDES; USAGE; SEQUENCE; BLOOD	Celiac disease (CeD) provides an opportunity to study the specificity underlying human T-cell responses to an array of similar epitopes presented by the same human leukocyte antigen II (HLA-II) molecule. Here, we investigated T-cell responses to the two immunodominant and highly homologous HLA-DQ2.5-restricted gluten epitopes, DQ2.5-glia-alpha 1a (PFPQPELPY) and DQ2.5-glia-omega 1 (PFPQPEQPF). Using HLA-DQ2.5-DQ2.5-glia-alpha 1a and HLA-DQ2.5-DQ2.5-glia-omega 1 tetramers and single-cell alpha beta T-cell receptor (TCR) sequencing, we observed that despite similarity in biased variable-gene usage in the TCR repertoire responding to these nearly identical peptide-HLA-II complexes, most of the T cells are specific for either of the two epitopes. To understand the molecular basis of this exquisite fine specificity, we undertook Ala substitution assays revealing that the p7 residue (Leu/Gln) is critical for specific epitope recognition by both DQ2.5-glia-alpha 1a- and DQ2.5-glia-omega 1-reactive T-cell clones. We determined high-resolution binary crystal structures of HLA-DQ2.5 bound to DQ2.5-glia-alpha 1a (2.0 A) and DQ2.5-glia-omega 1 (2.6 A). These structures disclosed that differences around the p7 residue subtly alter the neighboring substructure and electrostatic properties of the HLA-DQ2.5-peptide complex, providing the fine specificity underlying the responses against these two highly homologous gluten epitopes. This study underscores the ability of TCRs to recognize subtle differences in the peptide-HLA-II landscape in a human disease setting.	[Dahal-Koirala, Shiva; Risnes, Louise Fremgaard; Qiao, Shuo-Wang; Sollid, Ludvig M.] Univ Oslo, Dept Immunol, N-0372 Oslo, Norway; [Dahal-Koirala, Shiva; Risnes, Louise Fremgaard; Qiao, Shuo-Wang; Sollid, Ludvig M.] Oslo Univ Hosp, Rikshosp, N-0372 Oslo, Norway; [Dahal-Koirala, Shiva; Risnes, Louise Fremgaard; Neumann, Ralf Stefan; Christophersen, Asbjorn; Lundin, Knut E. A.; Qiao, Shuo-Wang; Sollid, Ludvig M.] Univ Oslo, KG Jebsen Ctr Coeliac Dis Res, N-0424 Oslo, Norway; [Ciacchi, Laura; Petersen, Jan; Reid, Hugh H.; Rossjohn, Jamie] Monash Univ, Infect & Immun Program, Clayton, Vic 3800, Australia; [Ciacchi, Laura; Petersen, Jan; Reid, Hugh H.; Rossjohn, Jamie] Monash Univ, Dept Biochem & Mol Biol, Biomed Discovery Inst, Clayton, Vic 3800, Australia; [Ciacchi, Laura; Petersen, Jan; Reid, Hugh H.; Rossjohn, Jamie] Monash Univ, ARC, Ctr Excellence Adv Mol Imaging, Clayton, Vic 3800, Australia; [Lundin, Knut E. A.] Oslo Univ Hosp, Rikshosp, Dept Gastroenterol, N-0372 Oslo, Norway; [Rossjohn, Jamie] Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff CF14 4XN, S Glam, Wales	University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; Monash University; Monash University; Monash University; University of Oslo; National Hospital Norway; Cardiff University	Sollid, LM (corresponding author), Univ Oslo, Dept Immunol, N-0372 Oslo, Norway.; Sollid, LM (corresponding author), Oslo Univ Hosp, Rikshosp, N-0372 Oslo, Norway.; Rossjohn, J (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Biomed Discovery Inst, Clayton, Vic 3800, Australia.; Rossjohn, J (corresponding author), Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic 3800, Australia.	Jamie.rossjohn@monash.edu; l.m.sollid@medisin.uio.no	Rossjohn, Jamie/F-9032-2013; Qiao, Shuo-Wang/ABE-8148-2020; Lundin, Knut E. A./AAW-9519-2021	Rossjohn, Jamie/0000-0002-2020-7522; Qiao, Shuo-Wang/0000-0002-0935-8397; Lundin, Knut E. A./0000-0003-1713-5545; Dahal-Koirala, Shiva/0000-0002-0165-5098; Ciacchi, Laura/0000-0002-9708-1526	Stiftelsen Kristian Gerhard Jebsen Project [SKGJ-MED-017]; Research Council of Norway through the Centre of Excellence funding scheme [179573/V40, 233885]; South-Eastern Norway Regional Health Authority Projects [2011050, 2013046, 2015009]	Stiftelsen Kristian Gerhard Jebsen Project; Research Council of Norway through the Centre of Excellence funding scheme(Research Council of Norway); South-Eastern Norway Regional Health Authority Projects	This work was supported by grants from Stiftelsen Kristian Gerhard Jebsen Project SKGJ-MED-017, by the Research Council of Norway Project 179573/V40 through the Centre of Excellence funding scheme and Project 233885, and by South-Eastern Norway Regional Health Authority Projects 2011050, 2013046, and 2015009. The authors declare that they have no conflicts of interest with the contents of this article.	Arentz-Hansen H, 2000, J EXP MED, V191, P603, DOI 10.1084/jem.191.4.603; Bromilow S, 2017, J PROTEOMICS, V163, P67, DOI 10.1016/j.jprot.2017.03.026; Broughton SE, 2012, IMMUNITY, V37, P611, DOI 10.1016/j.immuni.2012.07.013; Christophersen A, 2016, J IMMUNOL, V196, P2819, DOI 10.4049/jimmunol.1501152; Christophersen A, 2014, UNITED EUR GASTROENT, V2, P268, DOI 10.1177/2050640614540154; Dahal-Koirala S, 2016, MUCOSAL IMMUNOL, V9, P587, DOI 10.1038/mi.2015.147; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Han A, 2014, NAT BIOTECHNOL, V32, P684, DOI 10.1038/nbt.2938; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kersh GJ, 2001, J IMMUNOL, V166, P3345, DOI 10.4049/jimmunol.166.5.3345; Kim CY, 2004, P NATL ACAD SCI USA, V101, P4175, DOI 10.1073/pnas.0306885101; Lefranc MP, 1999, NUCLEIC ACIDS RES, V27, P209, DOI 10.1093/nar/27.1.209; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Molberg O, 1998, NAT MED, V4, P713, DOI 10.1038/nm0698-713; Petersen J, 2016, STRUCTURE, V24, P1643, DOI 10.1016/j.str.2016.07.010; Petersen J, 2015, J IMMUNOL, V194, P6112, DOI 10.4049/jimmunol.1500161; Petersen J, 2014, NAT STRUCT MOL BIOL, V21, P480, DOI 10.1038/nsmb.2817; Qiao SW, 2014, INT IMMUNOL, V26, P13, DOI 10.1093/intimm/dxt037; Qiao SW, 2011, J IMMUNOL, V187, P3064, DOI 10.4049/jimmunol.1101526; Quarsten H, 2001, J IMMUNOL, V167, P4861, DOI 10.4049/jimmunol.167.9.4861; Risnes LF, 2018, J CLIN INVEST, V128, P2642, DOI 10.1172/JCI98819; Rossjohn J, 2015, ANNU REV IMMUNOL, V33, P169, DOI 10.1146/annurev-immunol-032414-112334; Sarna VK, 2018, GASTROENTEROLOGY, V154, P886, DOI 10.1053/j.gastro.2017.11.006; Sollid LM, 2013, NAT REV IMMUNOL, V13, P294, DOI 10.1038/nri3407; Sollid LM, 2012, IMMUNOGENETICS, V64, P455, DOI 10.1007/s00251-012-0599-z; Tye-Din JA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001012; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	28	21	21	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2019	294	3					941	952		10.1074/jbc.RA118.005736	http://dx.doi.org/10.1074/jbc.RA118.005736			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL4FC	30455354	hybrid, Green Published, Green Submitted, Green Accepted			2022-12-28	WOS:000458670200019
J	Hur, WS; Mazinani, N; Lu, XJD; Byrnes, JR; Ho, L; Yeon, JH; Filipenko, S; Wolberg, AS; Jefferies, WA; Kastrup, CJ				Hur, Woosuk S.; Mazinani, Nima; Lu, X. J. David; Byrnes, James R.; Ho, Laura; Yeon, Ju Hun; Filipenko, Sam; Wolberg, Alisa S.; Jefferies, Wilfred A.; Kastrup, Christian J.			Coagulation factor XIIIa cross-links amyloid beta into dimers and oligomers and to blood proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; CEREBRAL-HEMORRHAGE; MUTATION; PEPTIDE; PRECURSOR; TRANSGLUTAMINASE; ACCUMULATION; ACTIVATION; FIBRINOGEN; PLATELETS	In cerebral amyloid angiopathy (CAA) and Alzheimer's disease (AD), the amyloid beta (A beta) peptide deposits along the vascular lumen, leading to degeneration and dysfunction of surrounding tissues. Activated coagulation factor XIIIa (FXIIIa) covalently cross-links proteins in blood and vasculature, such as in blood clots and on the extracellular matrix. Although FXIIIa co-localizes with A beta in CAA, the ability of FXIIIa to cross-link A beta has not been demonstrated. Using Western blotting, kinetic assays, and micro-fluidic analyses, we show that FXIIIa covalently cross-links A beta 40 into dimers and oligomers (k(cat)/K-m = 1.5 x 10(5) M-1 s(-1)), as well as to fibrin, platelet proteins, and blood clots under flow in vitro. A beta 40 also increased the stiffness of platelet-rich plasma clots in the presence of FXIIIa. These results suggest that FXIIIa-mediated cross-linking may contribute to the formation of A beta deposits in CAA and Alzheimer's disease.	[Hur, Woosuk S.; Mazinani, Nima; Lu, X. J. David; Ho, Laura; Yeon, Ju Hun; Filipenko, Sam; Jefferies, Wilfred A.; Kastrup, Christian J.] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada; [Hur, Woosuk S.; Mazinani, Nima; Lu, X. J. David; Ho, Laura; Yeon, Ju Hun; Filipenko, Sam; Jefferies, Wilfred A.; Kastrup, Christian J.] Univ British Columbia, Ctr Blood Res, Vancouver, BC V6T 1Z4, Canada; [Hur, Woosuk S.; Mazinani, Nima; Lu, X. J. David; Kastrup, Christian J.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z4, Canada; [Jefferies, Wilfred A.] Univ British Columbia, Dept Microbiol & Immunol, Djavad Mowafaghian Ctr Brain Hlth, Vancouver Prostate Ctr, Vancouver, BC V6T 1Z4, Canada; [Jefferies, Wilfred A.] Univ British Columbia, Dept Med Genet, Djavad Mowafaghian Ctr Brain Hlth, Vancouver Prostate Ctr, Vancouver, BC V6T 1Z4, Canada; [Jefferies, Wilfred A.] Univ British Columbia, Dept Zool, Djavad Mowafaghian Ctr Brain Hlth, Vancouver Prostate Ctr, Vancouver, BC V6T 1Z4, Canada; [Jefferies, Wilfred A.] Univ British Columbia, Dept Urol, Djavad Mowafaghian Ctr Brain Hlth, Vancouver Prostate Ctr, Vancouver, BC V6T 1Z4, Canada; [Byrnes, James R.; Wolberg, Alisa S.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27514 USA	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of North Carolina; University of North Carolina Chapel Hill	Kastrup, CJ (corresponding author), 2185 East Mall, Vancouver, BC V6T 1Z4, Canada.	ckastrup@msl.ubc.ca		Hur, Woosuk Steve/0000-0001-5074-6423; Yefet, Leo/0000-0003-1504-1772	Canadian Foundation for Innovation [31928, 36305]; BC Knowledge Development Fund [31928]; Natural Sciences and Engineering Research Council [2018-04918]; Canadian Institutes of Health Research [FDN-148370, MOP-119426, MSH-130166, GSD-146294, OP-133635]; Michael Smith Foundation for Health Research [16498]; National Institutes of Health [R01HL126974]; National Science Foundation [DGE-1144081]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL126974] Funding Source: NIH RePORTER	Canadian Foundation for Innovation(Canada Foundation for Innovation); BC Knowledge Development Fund(General Electric); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by Canadian Foundation for Innovation Grants 31928 and 36305 (to C. J. K.); BC Knowledge Development Fund Grant 31928 (to C. J. K.); Natural Sciences and Engineering Research Council Grant 2018-04918 (to C. J. K.); Canadian Institutes of Health Research Grants FDN-148370, MOP-119426, and MSH-130166 (to C. J. K.), GSD-146294 (to W. S. H. and C. J. K.), and OP-133635 (to W. A. J.); Michael Smith Foundation for Health Research Grant 16498 (to C. J. K.); National Institutes of Health Grant R01HL126974 (to A. S. W.); and National Science Foundation Grant DGE-1144081 (to J. R. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahn HJ, 2014, J EXP MED, V211, P1049, DOI 10.1084/jem.20131751; Ahn HJ, 2010, P NATL ACAD SCI USA, V107, P21812, DOI 10.1073/pnas.1010373107; Alonzo NC, 1998, J NEUROPATH EXP NEUR, V57, P353, DOI 10.1097/00005072-199804000-00008; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Biere AL, 1996, J BIOL CHEM, V271, P32916, DOI 10.1074/jbc.271.51.32916; Bochsen L, 2011, BLOOD COAGUL FIBRIN, V22, P167, DOI 10.1097/MBC.0b013e3283424911; Bugiani O, 2010, ARCH NEUROL-CHICAGO, V67, P987, DOI 10.1001/archneurol.2010.178; Canobbio I, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00065; Dale GL, 2002, NATURE, V415, P175, DOI 10.1038/415175a; de Jager M, 2016, NEUROPATH APPL NEURO, V42, P255, DOI 10.1111/nan.12244; Donner L, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf6240; FERNANDEZMADRID I, 1991, ANN NEUROL, V30, P730, DOI 10.1002/ana.410300516; Gerardino L, 2006, NEUROL RES, V28, P807, DOI 10.1179/016164106X110454; Grabowski TJ, 2001, ANN NEUROL, V49, P697, DOI 10.1002/ana.1009; Hartley DM, 2008, J BIOL CHEM, V283, P16790, DOI 10.1074/jbc.M802215200; HENDRIKS L, 1992, NAT GENET, V1, P218, DOI 10.1038/ng0692-218; Hur WS, 2015, BLOOD, V126, P2329, DOI 10.1182/blood-2015-07-650713; Kucheryavykh LY, 2017, BRAIN RES BULL, V128, P98, DOI 10.1016/j.brainresbull.2016.11.008; Lewis KB, 1997, BIOCHEMISTRY-US, V36, P995, DOI 10.1021/bi961636z; LI QX, 1994, BLOOD, V84, P133, DOI 10.1182/blood.V84.1.133.133; Love S, 2009, FRONT BIOSCI-LANDMRK, V14, P4778, DOI 10.2741/3567; Milojevic J, 2014, J ALZHEIMERS DIS, V38, P753, DOI 10.3233/JAD-131169; Murphy MP, 2010, J ALZHEIMERS DIS, V19, P311, DOI [10.3233/JAD-2009-1221, 10.3233/JAD-2010-1221]; Muszbek L, 2011, PHYSIOL REV, V91, P931, DOI 10.1152/physrev.00016.2010; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Sonkar VK, 2014, FASEB J, V28, P1819, DOI 10.1096/fj.13-243691; Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058; Yeon JH, 2017, SCI REP-UK, V7, DOI 10.1038/srep42119; Zamolodchikov D, 2016, J THROMB HAEMOST, V14, P995, DOI 10.1111/jth.13209; Zamolodchikov D, 2012, BLOOD, V119, P3342, DOI 10.1182/blood-2011-11-389668	30	15	15	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2019	294	2					390	396		10.1074/jbc.RA118.005352	http://dx.doi.org/10.1074/jbc.RA118.005352			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HO9XB	30409906	Green Published, hybrid			2022-12-28	WOS:000461318000001
J	Nganga, R; Oleinik, N; Kim, J; Selvam, SP; De Palma, R; Johnson, KA; Parikh, RY; Gangaraju, V; Peterson, Y; Dany, M; Stahelin, RV; Voelkel-Johnson, C; Szulc, ZM; Bieberich, E; Ogretmen, B				Nganga, Rose; Oleinik, Natalia; Kim, Jisun; Selvam, Shanmugam Panneer; De Palma, Ryan; Johnson, Kristen A.; Parikh, Rasesh Y.; Gangaraju, Vamsi; Peterson, Yuri; Dany, Mohammed; Stahelin, Robert V.; Voelkel-Johnson, Christina; Szulc, Zdzislaw M.; Bieberich, Erhard; Ogretmen, Besim			Receptor-interacting Ser/Thr kinase 1 (RIPK1) and myosin IIA-dependent ceramidosomes form membrane pores that mediate blebbing and necroptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ceramide; necrosis (necrotic death); sphingolipid; membrane lipid; lipid binding protein; ceramide-enriched membrane pores; ceramidosome; FTY720; myosin; RIPK1	STEM-CELL NICHE; LONGEVITY ASSURANCE GENE-1; TUMOR SUPPRESSION; STRUCTURAL BASIS; ORAL FINGOLIMOD; DRUG FTY720; DROSOPHILA; GROWTH; PROTEIN; DEATH	Formation of membrane pores/channels regulates various cellular processes, such as necroptosis or stem cell niche signaling. However, the roles of membrane lipids in the formation of pores and their biological functions are largely unknown. Here, using the cellular stress model evoked by the sphingolipid analog drug FTY720, we show that formation of ceramide-enriched membrane pores, referred to here as ceramidosomes, is initiated by a receptor-interacting Ser/Thr kinase 1 (RIPK1)-ceramide complex transported to the plasma membrane by nonmuscle myosin IIA-dependent trafficking in human lung cancer cells. Molecular modeling/simulation coupled with site-directed mutagenesis revealed that Asp(147) or Asn(169) of RIPK1 are key for ceramide binding and that Arg(258) or Leu(293) residues are involved in the myosin IIA interaction, leading to ceramidosome formation and necroptosis. Moreover, generation of ceramidosomes independently of any external drug/stress stimuli was also detected in the plasma membrane of germ line stem cells in ovaries during the early stages of oogenesis in Drosophila melanogaster. Inhibition of ceramidosome formation via myosin IIA silencing limited germ line stem cell signaling and abrogated oogenesis. In conclusion, our findings indicate that the RIPK1-ceramide complex forms large membrane pores we named ceramidosomes. They further suggest that, in addition to their roles in stress-mediated necroptosis, these ceramide-enriched pores also regulate membrane integrity and signaling and might also play a role in D. melanogaster ovary development.	[Nganga, Rose; Oleinik, Natalia; Kim, Jisun; Selvam, Shanmugam Panneer; De Palma, Ryan; Parikh, Rasesh Y.; Gangaraju, Vamsi; Dany, Mohammed; Szulc, Zdzislaw M.; Ogretmen, Besim] Med Univ South Carolina, Dept Biochem & Mol Biol, 86 Jonathan Lucas St,Rm 512A, Charleston, SC 29425 USA; [Nganga, Rose; Oleinik, Natalia; Kim, Jisun; Selvam, Shanmugam Panneer; De Palma, Ryan; Dany, Mohammed; Voelkel-Johnson, Christina; Ogretmen, Besim] Med Univ South Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA; [Peterson, Yuri] Med Univ South Carolina, Coll Pharm Pharmaceut & Biomed Sci, Charleston, SC 29425 USA; [Johnson, Kristen A.] Univ Notre Dame, Dept Chem & Biochem, South Bend, IN 46617 USA; [Stahelin, Robert V.] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA; [Bieberich, Erhard] Augusta Univ, Dept Neurosci & Regenerat Med, Augusta, GA 30912 USA; [Bieberich, Erhard] Univ Kentucky, Dept Physiol, Lexington, KY 40506 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; University of Notre Dame; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University System of Georgia; Augusta University; University of Kentucky	Ogretmen, B (corresponding author), Med Univ South Carolina, Dept Biochem & Mol Biol, 86 Jonathan Lucas St,Rm 512A, Charleston, SC 29425 USA.	ogretmen@musc.edu		Johnson, Kristen/0000-0003-2635-7406; De Palma, Ryan/0000-0001-7460-5676	Cell Evaluation and Therapy Shared Resources, Hollings Cancer Center, Medical University of South Carolina [P30 CA138313]; National Institutes of Health [CA173687, CA088932, DE016572, 1PO1 CA203628]; SmartState Endowment in Lipidomics and Drug Discovery; Notre Dame Integrated Imaging Facility; NATIONAL CANCER INSTITUTE [P30CA138313, R01CA088932, R01CA214461, R01CA173687, P01CA203628] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS095215] Funding Source: NIH RePORTER	Cell Evaluation and Therapy Shared Resources, Hollings Cancer Center, Medical University of South Carolina; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SmartState Endowment in Lipidomics and Drug Discovery; Notre Dame Integrated Imaging Facility; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported in part by the Lipidomics, Cell, and Molecular Imaging and the Cell Evaluation and Therapy Shared Resources, Hollings Cancer Center, Medical University of South Carolina (P30 CA138313). This work was also supported by research grants from the National Institutes of Health (CA173687, CA088932, DE016572, and 1PO1 CA203628) and the SmartState Endowment in Lipidomics and Drug Discovery (to B. O.) and partially supported by the Notre Dame Integrated Imaging Facility (to K. A. J. and R. V. S.). B. O. is the founder and Chief Executive Officer of Lipo-Immuno Tech, LLC, and Z. M. S. is the director of synthetic chemistry of Lipo-Immuno Tech, LLC. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aldaz S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2763; Allingham JS, 2005, NAT STRUCT MOL BIOL, V12, P378, DOI 10.1038/nsmb908; Allsopp RC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00732-5; Berdyshev EV, 2009, J BIOL CHEM, V284, P5467, DOI 10.1074/jbc.M805186200; Bielawski J, 2009, METHODS MOL BIOL, V579, P443, DOI 10.1007/978-1-60761-322-0_22; Billich A, 2003, J BIOL CHEM, V278, P47408, DOI 10.1074/jbc.M307687200; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Burgert A, 2017, ANGEW CHEM INT EDIT, V56, P6131, DOI 10.1002/anie.201700570; Chen HY, 2013, CELL STEM CELL, V13, P73, DOI 10.1016/j.stem.2013.05.003; Cheng JC, 2013, J CLIN INVEST, V123, P4344, DOI 10.1172/JCI64791; Cinamon G, 2004, NAT IMMUNOL, V5, P713, DOI 10.1038/ni1083; Coaxum SD, 2017, ONCOTARGET, V8, P22991, DOI 10.18632/oncotarget.14967; Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; Cowart LA, 2002, J LIPID RES, V43, P2042, DOI 10.1194/jlr.M200241-JLR200; Dany M, 2016, BLOOD, V128, P1944, DOI 10.1182/blood-2016-04-708750; Dillon CP, 2014, CELL, V157, P1189, DOI 10.1016/j.cell.2014.04.018; Dworski S, 2017, BBA-MOL BASIS DIS, V1863, P386, DOI 10.1016/j.bbadis.2016.11.031; Fast EM, 2011, SCIENCE, V334, P990, DOI 10.1126/science.1209609; Fekry B, 2016, J BIOL CHEM, V291, P16586, DOI 10.1074/jbc.M116.716902; Gangaraju VK, 2011, NAT GENET, V43, P153, DOI 10.1038/ng.743; Garris CS, 2014, IMMUNOLOGY, V142, P347, DOI 10.1111/imm.12272; Gong YN, 2017, CELL CYCLE, V16, P1748, DOI 10.1080/15384101.2017.1371889; Gong YN, 2017, CELL, V169, P286, DOI 10.1016/j.cell.2017.03.020; Hait NC, 2014, NAT NEUROSCI, V17, P971, DOI 10.1038/nn.3728; Hampoelz B, 2016, CELL, V166, P664, DOI 10.1016/j.cell.2016.06.015; Hannun YA, 2018, NAT REV MOL CELL BIO, V19, P175, DOI 10.1038/nrm.2017.107; Harris PA, 2016, J MED CHEM, V59, P2163, DOI 10.1021/acs.jmedchem.5b01898; Harris PA, 2013, ACS MED CHEM LETT, V4, P1238, DOI 10.1021/ml400382p; Inaba M, 2015, NATURE, V523, P329, DOI 10.1038/nature14602; Jennemann R, 2012, HUM MOL GENET, V21, P586, DOI 10.1093/hmg/ddr494; Ji YBA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1759; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; Karam JA, 2017, J BIOL CHEM, V292, P6039, DOI 10.1074/jbc.C117.777730; Konig A, 2011, EMBO J, V30, P1549, DOI 10.1038/emboj.2011.73; Koybasi S, 2004, J BIOL CHEM, V279, P44311, DOI 10.1074/jbc.M406920200; Kozakov D, 2010, PROTEINS, V78, P3124, DOI 10.1002/prot.22835; Krishnamurthy K, 2007, J LIPID RES, V48, P968, DOI 10.1194/jlr.D600043-JLR200; Ku HY, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005813; Lahiri S, 2009, J BIOL CHEM, V284, P16090, DOI 10.1074/jbc.M807438200; Lang KS, 2004, CELL DEATH DIFFER, V11, P231, DOI 10.1038/sj.cdd.4401311; Laviad EL, 2012, J BIOL CHEM, V287, P21025, DOI 10.1074/jbc.M112.363580; Ledgerwood LG, 2008, NAT IMMUNOL, V9, P42, DOI 10.1038/ni1534; Lee S, 2008, MECH DEVELOP, V125, P768, DOI 10.1016/j.mod.2008.06.012; Li Y, 2018, ONCOL REP, V39, P565, DOI 10.3892/or.2017.6111; Liang J, 2013, CANCER CELL, V23, P107, DOI 10.1016/j.ccr.2012.11.013; Lin CP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11814; LIN HF, 1995, DEV GENET, V16, P6, DOI 10.1002/dvg.1020160104; Liu GW, 2010, NAT IMMUNOL, V11, P1047, DOI 10.1038/ni.1939; Maeshima K, 2010, NAT STRUCT MOL BIOL, V17, P1065, DOI 10.1038/nsmb.1878; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Milberg O, 2017, J CELL BIOL, V216, P1925, DOI 10.1083/jcb.201612126; Najjar M, 2016, IMMUNITY, V45, P46, DOI 10.1016/j.immuni.2016.06.007; Najjar M, 2015, CELL REP, V10, P1850, DOI 10.1016/j.celrep.2015.02.052; Nakai R, 2009, CANCER RES, V69, P3901, DOI 10.1158/0008-5472.CAN-08-4373; Neviani P, 2013, J CLIN INVEST, V123, P4144, DOI 10.1172/JCI68951; Ogretmen B, 2002, J BIOL CHEM, V277, P12960, DOI 10.1074/jbc.M110699200; Ogretmen B, 2018, NAT REV CANCER, V18, P33, DOI 10.1038/nrc.2017.96; Ohno-Iwashita Y, 2010, SUBCELL BIOCHEM, V51, P597, DOI 10.1007/978-90-481-8622-8_22; Omar HA, 2011, HEPATOLOGY, V53, P1943, DOI 10.1002/hep.24293; Pelletier D, 2012, NEW ENGL J MED, V366, P339, DOI 10.1056/NEJMct1101691; Pellettieri J, 2002, SCIENCE, V298, P1946, DOI 10.1126/science.1072162; Peng JC, 2016, NAT GENET, V48, P283, DOI 10.1038/ng.3486; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Quarato G, 2016, MOL CELL, V61, P589, DOI 10.1016/j.molcel.2016.01.011; Rabionet M, 2008, J BIOL CHEM, V283, P13357, DOI 10.1074/jbc.M800870200; Saddoughi SA, 2013, EMBO MOL MED, V5, P105, DOI 10.1002/emmm.201201283; Sainath R, 2015, DEV NEUROBIOL, V75, P757, DOI 10.1002/dneu.22246; Schilling WP, 1999, AM J PHYSIOL-CELL PH, V277, pC766, DOI 10.1152/ajpcell.1999.277.4.C766; Schramek D, 2014, SCIENCE, V343, P309, DOI 10.1126/science.1248627; Selvam SP, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa4998; Senkal CE, 2011, J BIOL CHEM, V286, P42446, DOI 10.1074/jbc.M111.287383; Senol O, 2015, ONCOGENE, V34, P1790, DOI 10.1038/onc.2014.120; Sentelle RD, 2012, NAT CHEM BIOL, V8, P831, DOI 10.1038/NCHEMBIO.1059; Sezgin E, 2012, NAT PROTOC, V7, P1042, DOI 10.1038/nprot.2012.059; Shen HY, 2014, NAT CELL BIOL, V16, P652, DOI 10.1038/ncb2987; Siskind LJ, 2008, J BIOL CHEM, V283, P6622, DOI 10.1074/jbc.M706115200; Siskind LJ, 2000, J BIOL CHEM, V275, P38640, DOI 10.1074/jbc.C000587200; Sorge RE, 2012, NAT MED, V18, P595, DOI 10.1038/nm.2710; Strelow A, 2000, J EXP MED, V192, P601, DOI 10.1084/jem.192.5.601; Tanaka K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7337; Tepper AD, 2000, J CELL BIOL, V150, P155, DOI 10.1083/jcb.150.1.155; Thomas RJ, 2017, EMBO MOL MED, V9, P1030, DOI 10.15252/emmm.201607088; Tran DT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10098; Tsapras P, 2016, METHODS MOL BIOL, V1457, P97, DOI 10.1007/978-1-4939-3795-0_7; Vanwalleghem G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9078; Venkataraman K, 2002, J BIOL CHEM, V277, P35642, DOI 10.1074/jbc.M205211200; Vilar S, 2008, CURR TOP MED CHEM, V8, P1555, DOI 10.2174/156802608786786624; Visentin B, 2006, CANCER CELL, V9, P225, DOI 10.1016/j.ccr.2006.02.023; Wang YH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01805-9; Weinlich R, 2017, NAT REV MOL CELL BIO, V18, P127, DOI 10.1038/nrm.2016.149; Wodarz A, 2002, NAT CELL BIOL, V4, pE39, DOI 10.1038/ncb0202-e39; Yatim N, 2015, SCIENCE, V350, P328, DOI 10.1126/science.aad0395; Zhang YY, 2018, CELL RES, V28, P9, DOI 10.1038/cr.2017.133; Zhu XP, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-17	94	13	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2019	294	2					502	519		10.1074/jbc.RA118.005865	http://dx.doi.org/10.1074/jbc.RA118.005865			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HI2GP	30420430	Green Published, hybrid			2022-12-28	WOS:000456263600011
J	Chen, WF; Wei, XB; Rety, S; Huang, LY; Liu, NN; Dou, SX; Xi, XG				Chen, Wei-Fei; Wei, Xiao-Bin; Rety, Stephane; Huang, Ling-Yun; Liu, Na-Nv; Dou, Shuo-Xing; Xi, Xu-Guang			Structural analysis reveals a "molecular calipers" mechanism for a LATERAL ORGAN BOUNDARIES DOMAIN transcription factor protein from wheat	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						structural biology; transcription factor; plant molecular biology; small-angle X-ray scattering (SAXS); zinc finger; cooperative binding; LBD proteins; LOB domain; molecular model; TtRa2LD	ZINC-BINDING MOTIF; DNA-BINDING; LOB-DOMAIN; ARABIDOPSIS-THALIANA; RESOLUTION STRUCTURE; CRYSTAL-STRUCTURE; ROOT DEVELOPMENT; NMR STRUCTURE; GENE FAMILY; MAIZE	LATERAL ORGAN BOUNDARIES DOMAIN (LBD) proteins, a family of plant-specific transcription factors harboring a conserved Lateral Organ Boundaries (LOB) domain, are regulators of plant organ development. Recent studies have unraveled additional pivotal roles of the LBD protein family beyond defining lateral organ boundaries, such as pollen development and nitrogen metabolism. The structural basis for the molecular network of LBD-dependent processes remains to be deciphered. Here, we solved the first structure of the homodimeric LOB domain of Ramosa2 from wheat (TtRa2LD) to 1.9 angstrom resolution. Our crystal structure reveals structural features shared with other zinc-finger transcriptional factors, as well as some features unique to LBD proteins. Formation of the TtRa2LD homodimer relied on hydrophobic interactions of its coiled-coil motifs. Several specific motifs/domains of the LBD protein were also involved in maintaining its overall conformation. The intricate assembly within and between the monomers determined the precise spatial configuration of the two zinc fingers that recognize palindromic DNA sequences. Biochemical, molecular modeling, and small-angle X-ray scattering experiments indicated that dimerization is important for cooperative DNA binding and discrimination of palindromic DNA through a molecular calipers mechanism. Along with previously published data, this study enables us to establish an atomic-scale mechanistic model for LBD proteins as transcriptional regulators in plants.	[Chen, Wei-Fei; Wei, Xiao-Bin; Huang, Ling-Yun; Liu, Na-Nv; Xi, Xu-Guang] Northwest A&F Univ, Coll Life Sci, State Key Lab Crop Stress Biol Arid Areas, Yangling 712100, Shaanxi, Peoples R China; [Wei, Xiao-Bin] Henan Univ Urban Construct, Sch Life Sci & Engn, Pingdingshan 467044, Henan, Peoples R China; [Rety, Stephane] Univ Claude Bernard, Univ Lyon, ENS Lyon, CNRS UMR 5239,INSERM U1210,LBMC, 46 Allee Italie Site Jacques Monod, F-69007 Lyon, France; [Dou, Shuo-Xing] Chinese Acad Sci, Inst Phys, Beijing Natl Lab Condensed Matter Phys, Beijing 100190, Peoples R China; [Dou, Shuo-Xing] Chinese Acad Sci, Inst Phys, CAS Key Lab Soft Matter Phys, Beijing 100190, Peoples R China; [Xi, Xu-Guang] Univ Paris Saclay, CNRS, Ecole Normale Super Paris Saclay, LBPA, 61 Ave President Wilson, F-94235 Cachan, France	Northwest A&F University - China; Henan University of Urban Construction; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet; Chinese Academy of Sciences; Institute of Physics, CAS; Chinese Academy of Sciences; Institute of Physics, CAS; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Xi, XG (corresponding author), Northwest A&F Univ, Coll Life Sci, State Key Lab Crop Stress Biol Arid Areas, Yangling 712100, Shaanxi, Peoples R China.; Rety, S (corresponding author), Univ Claude Bernard, Univ Lyon, ENS Lyon, CNRS UMR 5239,INSERM U1210,LBMC, 46 Allee Italie Site Jacques Monod, F-69007 Lyon, France.; Xi, XG (corresponding author), Univ Paris Saclay, CNRS, Ecole Normale Super Paris Saclay, LBPA, 61 Ave President Wilson, F-94235 Cachan, France.	stephane.rety@ens-lyon.fr; xxi01@ens-cachan.fr	Rety, Stephane/L-9870-2019; Xi, Xu Guang/AAK-4511-2020	Rety, Stephane/0000-0002-2089-6727; Dou, Shuo-Xing/0000-0002-7201-2081	National Natural Science Foundation of China [31370798, 11304252, 11574252, 31301632]; Northwest A F University [Z101021102]; International Associated Laboratory (LIA, "G-quadruplex-HELI")	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Northwest A F University; International Associated Laboratory (LIA, "G-quadruplex-HELI")	This work was supported by National Natural Science Foundation of China Grants 31370798, 11304252, 11574252, and 31301632, Northwest A & F University Startup Funding Grant Z101021102, and the International Associated Laboratory (LIA, "G-quadruplex-HELI"). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allen MD, 1998, EMBO J, V17, P5484, DOI 10.1093/emboj/17.18.5484; Ashworth J, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp242; Bell EM, 2012, P NATL ACAD SCI USA, V109, P21146, DOI 10.1073/pnas.1210789109; Berckmans B, 2011, PLANT CELL, V23, P3671, DOI 10.1105/tpc.111.088377; Bernstein DA, 2003, EMBO J, V22, P4910, DOI 10.1093/emboj/cdg500; Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; Bortiri E, 2006, PLANT CELL, V18, P574, DOI 10.1105/tpc.105.039032; Brookes E, 2016, J APPL CRYSTALLOGR, V49, P1827, DOI 10.1107/S1600576716011201; David G, 2009, J APPL CRYSTALLOGR, V42, P892, DOI 10.1107/S0021889809029288; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ernst HA, 2004, EMBO REP, V5, P297, DOI 10.1038/sj.embor.7400093; Fukushima S., 2012, J AMINO ACIDS, V2012; Ge LF, 2014, PLANT PHYSIOL, V164, P216, DOI 10.1104/pp.113.229914; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hu Y, 2014, P NATL ACAD SCI USA, V111, pE521, DOI 10.1073/pnas.1313271111; HUNT IF, 1984, AM J CLIN NUTR, V40, P508, DOI 10.1093/ajcn/40.3.508; Husbands A, 2007, NUCLEIC ACIDS RES, V35, P6663, DOI 10.1093/nar/gkm775; Isernia C, 2003, CHEMBIOCHEM, V4, P171, DOI 10.1002/cbic.200390028; Iwakawa H, 2002, PLANT CELL PHYSIOL, V43, P467, DOI 10.1093/pcp/pcf077; Jin JP, 2014, NUCLEIC ACIDS RES, V42, pD1182, DOI 10.1093/nar/gkt1016; Jun JH, 2010, PLANT CELL, V22, P62, DOI 10.1105/tpc.109.070763; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim MJ, 2015, PLANT J, V81, P794, DOI 10.1111/tpj.12767; Koppolu R, 2013, P NATL ACAD SCI USA, V110, P13198, DOI 10.1073/pnas.1221950110; Krishna SS, 2003, NUCLEIC ACIDS RES, V31, P532, DOI 10.1093/nar/gkg161; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lakshmi B, 2014, PROTEIN SCI, V23, P843, DOI 10.1002/pro.2468; Lee BI, 2004, EMBO J, V23, P2029, DOI 10.1038/sj.emboj.7600222; Lee HW, 2015, PLANT PHYSIOL, V168, P1792, DOI 10.1104/pp.15.00578; Lee HW, 2013, MOL PLANT, V6, P1722, DOI 10.1093/mp/sst037; Leiros I, 2005, EMBO J, V24, P906, DOI 10.1038/sj.emboj.7600582; Li SP, 2016, PLANT CELL, V28, P1025, DOI 10.1105/tpc.16.00018; Liu JC, 2014, PLANT CELL, V26, P1081, DOI 10.1105/tpc.114.122887; Majer C, 2012, PHILOS T R SOC B, V367, P1542, DOI 10.1098/rstb.2011.0238; Majer C, 2011, TRENDS PLANT SCI, V16, P47, DOI 10.1016/j.tplants.2010.09.009; Mangeon A, 2012, PLANT SIGNAL BEHAV, V7, P1544, DOI 10.4161/psb.22320; Mangeon A, 2011, J EXP BOT, V62, P221, DOI 10.1093/jxb/erq259; MARMORSTEIN R, 1992, NATURE, V356, P408, DOI 10.1038/356408a0; Muthreich N, 2013, PLANT PHYSIOL, V163, P419, DOI 10.1104/pp.113.221481; Okushima Y, 2007, PLANT CELL, V19, P118, DOI 10.1105/tpc.106.047761; OMICHINSKI JG, 1993, SCIENCE, V261, P438, DOI 10.1126/science.8332909; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Ren H, 2008, BIOCHEM J, V412, P425, DOI 10.1042/BJ20071150; RIDDLES PW, 1983, METHOD ENZYMOL, V91, P49; Boer DR, 2014, CELL, V156, P577, DOI 10.1016/j.cell.2013.12.027; Rubin G, 2009, PLANT CELL, V21, P3567, DOI 10.1105/tpc.109.067041; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Semiarti E, 2001, DEVELOPMENT, V128, P1771; Shuai B, 2002, PLANT PHYSIOL, V129, P747, DOI 10.1104/pp.010926; Soyano T, 2008, PLANT CELL, V20, P3359, DOI 10.1105/tpc.108.061796; Sugimoto K, 2010, DEV CELL, V18, P463, DOI 10.1016/j.devcel.2010.02.004; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Takatsuji H, 1998, CELL MOL LIFE SCI, V54, P582, DOI 10.1007/s000180050186; Thatcher LF, 2012, PLANT PHYSIOL, V160, P407, DOI 10.1104/pp.112.199067; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; Vollbrecht E, 2005, NATURE, V436, P1119, DOI 10.1038/nature03892; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu C, 2016, TRENDS PLANT SCI, V21, P159, DOI 10.1016/j.tplants.2015.10.010; Xu CZ, 2015, NEW PHYTOL, V207, P1123, DOI 10.1111/nph.13420; Yamasaki K, 2005, PLANT CELL, V17, P944, DOI 10.1105/tpc.104.026435; Yamasaki K, 2004, PLANT CELL, V16, P3448, DOI 10.1105/tpc.104.026112; Yamasaki K, 2004, J MOL BIOL, V337, P49, DOI 10.1016/j.jmb.2004.01.015; Yang Y, 2006, MOL PHYLOGENET EVOL, V39, P248, DOI 10.1016/j.ympev.2005.09.016; Yordanov YS, 2010, PLANT CELL, V22, P3662, DOI 10.1105/tpc.110.078634; Zhang YM, 2014, J GENET, V93, P79, DOI 10.1007/s12041-014-0342-7	70	11	13	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2019	294	1					142	156		10.1074/jbc.RA118.003956	http://dx.doi.org/10.1074/jbc.RA118.003956			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG6PT	30425099	Green Published, hybrid			2022-12-28	WOS:000455105500019
J	Malik, N; Dantu, SC; Shukla, S; Kombrabail, M; Ghosh, SK; Krishnamoorthy, G; Kumar, A				Malik, Nikita; Dantu, Sarath Chandra; Shukla, Shivangi; Kombrabail, Mamta; Ghosh, Santanu Kumar; Krishnamoorthy, Guruswamy; Kumar, Ashutosh			Conformational flexibility of histone variant CENP-A(Cse4) is regulated by histone H4: A mechanism to stabilize soluble Cse4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						centromere; histone; structural biology; molecular dynamics; fluorescence anisotropy; cell division; histone tails; histone variants; protein-protein interactions; kinetochore assembly; centromeric protein A; chromosome	E3 UBIQUITIN LIGASE; H3 VARIANT; MOLECULAR-DYNAMICS; STRUCTURAL DETERMINANTS; CENTROMERIC NUCLEOSOME; FOLD DOMAIN; N-TERMINUS; YEAST; PROTEIN; CORE	The histone variant CENP-A(Cse4) is a core component of the specialized nucleosome at the centromere in budding yeast and is required for genomic integrity. Accordingly, the levels of Cse4 in cells are tightly regulated, primarily by ubiquitin-mediated proteolysis. However, structural transitions in Cse4 that regulate its centromeric localization and interaction with regulatory components are poorly understood. Using time-resolved fluorescence, NMR, and molecular dynamics simulations, we show here that soluble Cse4 can exist in a closed conformation, inaccessible to various regulatory components. We further determined that binding of its obligate partner, histone H4, alters the interdomain interaction within Cse4, enabling an open state that is susceptible to proteolysis. This dynamic model allows kinetochore formation only in the presence of H4, as the Cse4 N terminus, which is required for interaction with other centromeric components, is unavailable in the absence of H4. The specific requirement of H4 binding for the conformational regulation of Cse4 suggests a structure-based regulatory mechanism for Cse4 localization. Our data suggested a novel structural transition-based mechanism where conformational flexibility of the Cse4 N terminus can control Cse4 levels in the yeast cell and prevent Cse4 from interacting with kinetochore components at ectopic locations for formation of premature kinetochore assembly.	[Malik, Nikita; Dantu, Sarath Chandra; Shukla, Shivangi; Ghosh, Santanu Kumar; Kumar, Ashutosh] Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India; [Krishnamoorthy, Guruswamy] Indian Inst Technol, Dept Chem, Bombay 400076, Maharashtra, India; [Kombrabail, Mamta; Krishnamoorthy, Guruswamy] Tata Inst Fundamental Res, Dept Chem Sci, Bombay 400005, Maharashtra, India; [Dantu, Sarath Chandra] Brunel Univ London, Dept Comp Sci, Synthet Biol Theme, Uxbridge UB8 3PH, Middx, England	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Tata Institute of Fundamental Research (TIFR); Brunel University	Kumar, A (corresponding author), Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India.; Krishnamoorthy, G (corresponding author), Indian Inst Technol, Dept Chem, Bombay 400076, Maharashtra, India.; Krishnamoorthy, G (corresponding author), Tata Inst Fundamental Res, Dept Chem Sci, Bombay 400005, Maharashtra, India.	gk@tifr.res.in; ashutoshk@iitb.ac.in	Dantu, Sarath/AAB-7883-2020	DANTU, SARATH CHANDRA/0000-0003-2019-5311	Council of Scientific and Industrial Research, India; Indian Institute of Technology Bombay, Government of India [BT/PR21656/BRB/10/1562/2016]; Department of Biotechnology, Government of India [BT/PR21656/BRB/10/1562/2016]	Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Indian Institute of Technology Bombay, Government of India; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by the Council of Scientific and Industrial Research, India (to N.M.) and Indian Institute of Technology Bombay and Department of Biotechnology, Government of India Seed Grant BT/PR21656/BRB/10/1562/2016 (to A.K.).	[Anonymous], 2008, J BIOMED OPT, DOI [10.1117/1.2904580, DOI 10.1117/1.2904580]; Au WC, 2013, GENETICS, V194, P513, DOI 10.1534/genetics.113.149898; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bevington P. R, 1969, DATA REDUCTION ERROR; Black BE, 2004, NATURE, V430, P578, DOI 10.1038/nature02766; Black BE, 2007, MOL CELL, V25, P309, DOI 10.1016/j.molcel.2006.12.018; Blau C, 2013, COMPUT PHYS COMMUN, V184, P2856, DOI 10.1016/j.cpc.2013.07.018; Bloom K, 2006, CURR BIOL, V16, pR276, DOI 10.1016/j.cub.2006.03.054; Boeckmann L, 2013, MOL BIOL CELL, V24, P2034, DOI 10.1091/mbc.E12-12-0893; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chen YH, 2000, MOL CELL BIOL, V20, P7037, DOI 10.1128/MCB.20.18.7037-7048.2000; Cheng HL, 2016, J BIOL CHEM, V291, P10372, DOI 10.1074/jbc.M115.701813; Cho US, 2011, P NATL ACAD SCI USA, V108, P9367, DOI 10.1073/pnas.1106389108; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Collins KA, 2004, CURR BIOL, V14, P1968, DOI 10.1016/j.cub.2004.10.024; Dechassa ML, 2014, NUCLEIC ACIDS RES, V42, P5532, DOI 10.1093/nar/gku205; Deyter GMR, 2017, GENETICS, V205, P113, DOI 10.1534/genetics.116.194027; Feenstra KA, 1999, J COMPUT CHEM, V20, P786, DOI 10.1002/(SICI)1096-987X(199906)20:8<786::AID-JCC5>3.0.CO;2-B; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Furuyama S, 2007, P NATL ACAD SCI USA, V104, P14706, DOI 10.1073/pnas.0706985104; Haase J, 2013, CURR BIOL, V23, P1939, DOI 10.1016/j.cub.2013.07.083; Henikoff S, 2010, COLD SH Q B, V75, P51, DOI 10.1101/sqb.2010.75.001; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Heun P, 2006, DEV CELL, V10, P303, DOI 10.1016/j.devcel.2006.01.014; Hewawasam G, 2010, MOL CELL, V40, P444, DOI 10.1016/j.molcel.2010.10.014; Hu H, 2011, GENE DEV, V25, P901, DOI 10.1101/gad.2045111; Jha A, 2009, J MOL BIOL, V393, P735, DOI 10.1016/j.jmb.2009.08.053; Keith KC, 1999, MOL CELL BIOL, V19, P6130; Kumar A, 2006, J MOL BIOL, V361, P180, DOI 10.1016/j.jmb.2006.06.003; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mahoney MW, 2000, J CHEM PHYS, V112, P8910, DOI 10.1063/1.481505; Malik N, 2016, J BIOMOL NMR, V66, P21, DOI 10.1007/s10858-016-0054-9; Meluh PB, 1997, GENE DEV, V11, P3401, DOI 10.1101/gad.11.24.3401; Meluh PB, 1998, CELL, V94, P607, DOI 10.1016/S0092-8674(00)81602-5; Mishra PK, 2015, MOL BIOL CELL, V26, P2067, DOI 10.1091/mbc.E14-08-1335; Morey L, 2004, EUKARYOT CELL, V3, P1533, DOI 10.1128/EC.3.6.1533-1543.2004; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; Ohkuni K, 2014, GENETICS, V196, P1041, DOI 10.1534/genetics.114.161224; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Ranjitkar P, 2010, MOL CELL, V40, P455, DOI 10.1016/j.molcel.2010.09.025; Samel A, 2012, P NATL ACAD SCI USA, V109, P9029, DOI 10.1073/pnas.1120968109; Santra MK, 2003, J BIOL CHEM, V278, P21336, DOI 10.1074/jbc.M301303200; Saxena A, 2005, SPR S FLUOR, V3, P163; Schwarzinger S, 2000, J BIOMOL NMR, V18, P43, DOI 10.1023/A:1008386816521; Schwarzinger S, 2001, J AM CHEM SOC, V123, P2970, DOI 10.1021/ja003760i; STOLER S, 1995, GENE DEV, V9, P573, DOI 10.1101/gad.9.5.573; SULLIVAN KF, 1994, J CELL BIOL, V127, P581, DOI 10.1083/jcb.127.3.581; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Zhang WG, 2007, CELL, V129, P1047, DOI 10.1016/j.cell.2007.05.054; Zhou Z, 2011, NATURE, V472, P234, DOI 10.1038/nature09854	54	1	1	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					20273	20284		10.1074/jbc.RA118.004141	http://dx.doi.org/10.1074/jbc.RA118.004141			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30381395	Green Published, hybrid			2022-12-28	WOS:000454685900032
J	Belyy, A; Santecchia, I; Renault, L; Bourigault, B; Ladant, D; Mechold, U				Belyy, Alexander; Santecchia, Ignacio; Renault, Louis; Bourigault, Blandine; Ladant, Daniel; Mechold, Undine			The extreme C terminus of the Pseudomonas aeruginosa effector ExoY is crucial for binding to its eukaryotic activator, F-actin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actin; bacterial toxin; protein-protein interaction; cyclic nucleotide; Pseudomonas aeruginosa (P; aeruginosa); confocal microscopy; protein cross-linking; type III secretion system (T3SS); ExoY	PERTUSSIS ADENYLYL-CYCLASE; STRUCTURAL BASIS; YEAST ACTIN; PROTEIN; FILAMENTS; DOMAINS; GTPASES; TOXIN; GENES	Bacterial nucleotidyl cyclase toxins are potent virulence factors that upon entry into eukaryotic cells are stimulated by endogenous cofactors to catalyze the production of large amounts of 35-cyclic nucleoside monophosphates. The activity of the effector ExoY from Pseudomonas aeruginosa is stimulated by the filamentous form of actin (F-actin). Utilizing yeast phenotype analysis, site-directed mutagenesis, functional biochemical assays, and confocal microscopy, we demonstrate that the last nine amino acids of the C terminus of ExoY are crucial for the interaction with F-actin and, consequently, for ExoY's enzymatic activity in vitro and toxicity in a yeast model. We observed that isolated C-terminal sequences of P. aeruginosa ExoY that had been fused to a carrier protein bind to F-actin and that synthetic peptides corresponding to the extreme ExoY C terminus inhibit ExoY enzymatic activity in vitro and compete with the full-length enzyme for F-actin binding. Interestingly, we noted that various P. aeruginosa isolates of the PA14 family, including highly virulent strains, harbor ExoY variants with a mutation altering the C terminus of this effector. We found that these naturally occurring ExoY variants display drastically reduced enzymatic activity and toxicity. Our findings shed light on the molecular basis of the ExoY-F-actin interaction, revealing that the extreme C terminus of ExoY is critical for binding to F-actin in target cells and that some P. aeruginosa isolates carry C-terminally mutated, low-activity ExoY variants.	[Belyy, Alexander; Ladant, Daniel; Mechold, Undine] Inst Pasteur, CNRS UMR 3528, Unite Biochim Interact Macromol, Dept Biol Struct & Chim, 25-28 Rue Dr Roux, F-75724 Paris 15, France; [Santecchia, Ignacio] Inst Pasteur, Unite Biol & Genet Paroi Bacterienne, Dept Microbiol, F-75724 Paris 15, France; [Renault, Louis; Bourigault, Blandine] Univ Paris Saclay, Univ Paris Sud, Inst Integrat Biol Cell I2BC, CEA,CNRS, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Belyy, A; Mechold, U (corresponding author), Inst Pasteur, CNRS UMR 3528, Unite Biochim Interact Macromol, Dept Biol Struct & Chim, 25-28 Rue Dr Roux, F-75724 Paris 15, France.	alexander.belyy@pasteur.fr; undine.mechold@pasteur.fr	Mechold, Undine/GYV-3918-2022	Mechold, Undine/0000-0002-6019-0972; LADANT, Daniel/0000-0003-1955-548X; Belyy, Alexander/0000-0003-3106-6574; RENAULT, Louis/0000-0003-1722-074X	French National Research Agency [ANR 10-INSB-04-01]	French National Research Agency(French National Research Agency (ANR))	A. B. thanks Dr. Cosmin Saveanu, Dr. Ina Attree, and Dr. Yury Belyi for fruitful discussions. We thank Dorothee Raoux-Barbot for technical support, Dr. Violaine David for critical reading, Dr. Alexandre Chenal for help in peptide design, and Prof. Sabine Rospert for the anti-RPS9 serum. We acknowledge the Imagopole France-BioImaging infrastructure, which is supported by French National Research Agency Grant ANR 10-INSB-04-01 (Investments for the Future), for advice and access to the Leica TCS SP5 system.	Arnoldo A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000005; Balczon R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074343; Belyy A, 2018, TOXICON, V149, P65, DOI 10.1016/j.toxicon.2017.12.046; Belyy A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13582; Berube BJ, 2016, CURR GENET, V62, P109, DOI 10.1007/s00294-015-0522-x; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Drum CL, 2002, NATURE, V415, P396, DOI 10.1038/415396a; Feltman H, 2001, MICROBIOL-SGM, V147, P2659, DOI 10.1099/00221287-147-10-2659; FU H, 1993, P NATL ACAD SCI USA, V90, P2320, DOI 10.1073/pnas.90.6.2320; Galle M, 2012, CURR PROTEIN PEPT SC, V13, P831, DOI 10.2174/138920312804871210; Ganter MT, 2009, AM J RESP CELL MOL, V40, P108, DOI 10.1165/rcmb.2007-0454OC; Gellatly SL, 2013, PATHOG DIS, V67, P159, DOI 10.1111/2049-632X.12033; Gendrin C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002637; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Goode BL, 2002, METHOD ENZYMOL, V351, P433; Guo Q, 2005, EMBO J, V24, P3190, DOI 10.1038/sj.emboj.7600800; Haghi F, 2018, MICROB PATHOGENESIS, V115, P251, DOI 10.1016/j.micpath.2017.12.052; Hayward RD, 1999, EMBO J, V18, P4926, DOI 10.1093/emboj/18.18.4926; He CX, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00239-17; Huber P, 2014, CELL MOL LIFE SCI, V71, P1927, DOI 10.1007/s00018-013-1451-9; Jeon J, 2017, FEBS J, V284, P3392, DOI 10.1111/febs.14199; Jiwani S, 2013, J BACTERIOL, V195, P708, DOI 10.1128/JB.01768-12; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Khanppnavar B, 2018, BBA-GEN SUBJECTS, V1862, P2090, DOI 10.1016/j.bbagen.2018.05.021; Klockgether Jens, 2017, F1000Res, V6, P1261, DOI 10.12688/f1000research.10506.1; Kloth C, 2018, TOXINS, V10, DOI 10.3390/toxins10050185; KRON SJ, 1992, P NATL ACAD SCI USA, V89, P4466, DOI 10.1073/pnas.89.10.4466; Lilic M, 2003, SCIENCE, V301, P1918, DOI 10.1126/science.1088433; Maresso A. W., 2006, COMPREHENSIVE SOURCE, P257, DOI [DOI 10.1016/B978-012088445-2/50019-6, 10.1016/B978-012088445-2/50019-6]; MILLER CJ, 1995, BIOCHEMISTRY-US, V34, P2694, DOI 10.1021/bi00008a037; Myeni SK, 2010, J BIOL CHEM, V285, P13357, DOI 10.1074/jbc.M109.094045; Nishimura M, 2015, SCI REP-UK, V5, DOI 10.1038/srep10870; O'Brien DP, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2004486; Sato H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103127; Sayner SL, 2004, CIRC RES, V95, P196, DOI 10.1161/01.RES.0000134922.25721.d9; Selwa E, 2014, J BIOL CHEM, V289, P21131, DOI 10.1074/jbc.M113.530410; Shen YQ, 2005, EMBO J, V24, P929, DOI 10.1038/sj.emboj.7600574; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Stevens TC, 2014, AM J PHYSIOL-LUNG C, V306, pL915, DOI 10.1152/ajplung.00135.2013; Tessmer MH, 2017, J BIOL CHEM, V292, P3411, DOI 10.1074/jbc.M116.760074; Wattam AR, 2017, NUCLEIC ACIDS RES, V45, pD535, DOI 10.1093/nar/gkw1017; Yahr TL, 1998, P NATL ACAD SCI USA, V95, P13899, DOI 10.1073/pnas.95.23.13899; Yasmin L, 2010, BIOCHEM J, V427, P217, DOI 10.1042/BJ20100043	45	9	10	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19785	19796		10.1074/jbc.RA118.003784	http://dx.doi.org/10.1074/jbc.RA118.003784			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30377256	Green Published, hybrid			2022-12-28	WOS:000454294900023
J	Mallette, E; Kimber, MS				Mallette, Evan; Kimber, Matthew S.			Structural and kinetic characterization of (S)-1-amino-2-propanol kinase from the aminoacetone utilization microcompartment of Mycobacterium smegmatis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein structure; enzyme kinetics; bioinformatics; biodegradation; microbiology; aminoacetone utilization microcompartment; aminopropanol kinase	MICROBIAL-METABOLISM; AMINO-ALCOHOLS; PHOSPHO-LYASE; ENZYME; PROTEINS; BINDING; 1-AMINOPROPAN-2-OL; PHOSPHOTRANSFERASE; DEHYDROGENASE; ORGANELLES	Bacterial microcompartments encapsulate enzymatic pathways that generate small, volatile, aldehyde intermediates. The Rhodococcus and Mycobacterium microcompartment (RMM) operon from Mycobacterium smegmatis encodes four enzymes, including (S)-1-amino-2-propanol dehydrogenase and a likely propionaldehyde dehydrogenase. We show here that a third enzyme (and its nonmicrocompartment-associated paralog) is a moderately specific (S)-1-amino-2-propanol kinase. We determined the structure of apo-aminopropanol kinase at 1.35 , revealing that it has structural similarity to hexosamine kinases, choline kinases, and aminoglycoside phosphotransferases. We modeled substrate binding, and tested our model by characterizing key enzyme variants. Bioinformatics analysis established that this enzyme is widespread in Actinobacteria, Proteobacteria, and Firmicutes, and is very commonly associated with a candidate phospholyase. In Rhizobia, aminopropanol kinase is generally associated with aromatic degradation pathways. In the RMM (and the parallel pathway that includes the second paralog), aminopropanol kinase likely degrades aminoacetone through a propanolamine-phosphate phospho-lyase-dependent pathway. These enzymatic activities were originally described in Pseudomonas, but the proteins responsible have not been previously identified. Bacterial microcompartments typically co-encapsulate enzymes which can regenerate required co-factors, but the RMM enzymes require four biochemically distinct co-factors with no overlap. This suggests that either the RMM shell can uniquely transport multiple co-factors in stoichiometric quantities, or that all enzymes except the phospho-lyase reside outside of the shell. In summary, aminopropanol kinase is a novel enzyme found in diverse bacteria and multiple metabolic pathways; its presence in the RMM implies that this microcompartment degrades aminoacetone, using a pathway that appears to violate some established precepts as to how microcompartments function.	[Mallette, Evan; Kimber, Matthew S.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Kimber, MS (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	mkimber@uoguelph.ca	Kimber, Matthew/Q-8144-2019	Kimber, Matthew/0000-0001-9454-5586	National Science and Engineering Council of Canada [04045-2015]	National Science and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by National Science and Engineering Council of Canada Grant 04045-2015 (to M. S. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Axen SD, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003898; BRENNER S, 1987, NATURE, V329, P21, DOI 10.1038/329021a0; Chowdhury C, 2014, MICROBIOL MOL BIOL R, V78, P438, DOI 10.1128/MMBR.00009-14; Craciun S, 2012, P NATL ACAD SCI USA, V109, P21307, DOI 10.1073/pnas.1215689109; Cuetos A, 2016, CHEMBIOCHEM, V17, P2308, DOI 10.1002/cbic.201600482; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erbilgin O, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002399; Espie GS, 2011, PHOTOSYNTH RES, V109, P7, DOI 10.1007/s11120-011-9656-y; Fan CG, 2012, P NATL ACAD SCI USA, V109, P14995, DOI 10.1073/pnas.1207516109; Fan CG, 2011, J BACTERIOL, V193, P5623, DOI 10.1128/JB.05661-11; Fan CG, 2010, P NATL ACAD SCI USA, V107, P7509, DOI 10.1073/pnas.0913199107; FAULKNER A, 1974, BIOCHEM J, V138, P263, DOI 10.1042/bj1380263; Fong DH, 2010, J BIOL CHEM, V285, P9545, DOI 10.1074/jbc.M109.038364; Fuchs G, 2011, NAT REV MICROBIOL, V9, P803, DOI 10.1038/nrmicro2652; Gerlt JA, 2015, BBA-PROTEINS PROTEOM, V1854, P1019, DOI 10.1016/j.bbapap.2015.04.015; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huseby DL, 2013, J BACTERIOL, V195, P2864, DOI 10.1128/JB.02179-12; JONES A, 1973, BIOCHEM J, V134, P959, DOI 10.1042/bj1340959; Jorda J, 2013, PROTEIN SCI, V22, P179, DOI 10.1002/pro.2196; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kataoka M, 2006, LETT APPL MICROBIOL, V43, P430, DOI 10.1111/j.1472-765X.2006.01970.x; Kerfeld CA, 2016, CURR OPIN PLANT BIOL, V31, P66, DOI 10.1016/j.pbi.2016.03.009; Mallette E, 2018, BIOCHEMISTRY-US, V57, P3780, DOI 10.1021/acs.biochem.8b00464; Mallette E, 2017, J BIOL CHEM, V292, P1197, DOI 10.1074/jbc.M116.754093; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Scheeff ED, 2005, PLOS COMPUT BIOL, V1, P359, DOI 10.1371/journal.pcbi.0010049; Schiroli D, 2015, FEBS J, V282, P183, DOI 10.1111/febs.13122; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shi K, 2011, BIOCHEMISTRY-US, V50, P6237, DOI 10.1021/bi200747f; Sutter M, 2017, SCIENCE, V356, P1293, DOI 10.1126/science.aan3289; Tuck LR, 2016, SCI REP-UK, V6, DOI 10.1038/srep22108; Urano N, 2011, APPL MICROBIOL BIOT, V89, P739, DOI 10.1007/s00253-010-2924-5; Wang KC, 2014, ACTA CRYSTALLOGR D, V70, P1401, DOI 10.1107/S1399004714004209; Yeates TO, 2013, J MOL MICROB BIOTECH, V23, P290, DOI 10.1159/000351347; Zarzycki J, 2015, APPL ENVIRON MICROB, V81, P8315, DOI 10.1128/AEM.02587-15	36	11	11	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19909	19918		10.1074/jbc.RA118.005485	http://dx.doi.org/10.1074/jbc.RA118.005485			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30361441	Green Published, hybrid			2022-12-28	WOS:000454294900034
J	Zhao, J; Ueda, K; Riera, M; Kim, HJ; Sparrow, JR				Zhao, Jin; Ueda, Keiko; Riera, Marina; Kim, Hye Jin; Sparrow, Janet R.			Bisretinoids mediate light sensitivity resulting in photoreceptor cell degeneration in mice lacking the receptor tyrosine kinase Mer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						retina; retinal degeneration; receptor tyrosine kinase; phagocytosis; photoreceptor; bisretinoid; lipofuscin; Mertk; Mertk-; -; photodegradation; retinal pigment epithelium	INHERITED RETINAL DYSTROPHY; QUANTITATIVE FUNDUS AUTOFLUORESCENCE; PIGMENT EPITHELIAL-CELLS; SHORT-WAVELENGTH AUTOFLUORESCENCE; OPTICAL COHERENCE TOMOGRAPHY; ROD-CONE DYSTROPHY; STARGARDT-DISEASE; MOUSE MODELS; IN-VIVO; RCS RAT	The receptor tyrosine kinase Mer is expressed by retinal pigment epithelial (RPE) cells and participates in photoreceptor outer-segment phagocytosis, a process enabling membrane renewal. Mutations in the gene encoding MERTK cause blinding retinitis pigmentosa in humans. Targeted Mertk disruption in mice causes defective RPE-mediated phagocytosis of the outer segments, leading to deposition of autofluorescent debris at the RPE-photoreceptor cell interface, followed by photoreceptor cell degeneration. Here, we show that retinaldehyde adducts (bisretinoid fluorophores) that form in photoreceptor outer segments occupy the unphagocytosed outer-segment debris that accumulates in Mertk(-/-) mice. Bisretinoids measured by HPLC were elevated in Mertk(-/-) mice compared with WT animals. Bisretinoids were also more abundant in albino Mertk(-/-) mice expressing leucine at position 450 of the isomerase RPE65 (Rpe65-Leu450) rather than the variant methionine (Rpe65-450Met) that yields lower bisretinoid levels. In Royal College of Surgeons rats having dysfunctional Mertk, bisretinoids were higher than in WT rats. Intensities of in vivo fundus autofluorescence were higher in Mertk(-/-) mice than in WT mice and peaked earlier in albino Mertk(-/-)/Rpe65-Leu450 mice than in albino Mertk(-/-)/Rpe65-450Met mice. Of note, the rate of photoreceptor cell degeneration was more rapid in albino Mertk(-/-) mice exposed to higher levels of intraocular light (albino versus pigmented mice) and in mice carrying Rpe65-Leu450 than in Rpe65-450Met mice, revealing a link between bisretinoid accumulation and light-mediated acceleration of photoreceptor cell degeneration. In conclusion, the light sensitivity of photoreceptor cell degeneration arising from Mertk deficiency is consistent with the known phototoxicity of bisretinoids.	[Zhao, Jin; Ueda, Keiko; Riera, Marina; Kim, Hye Jin; Sparrow, Janet R.] Columbia Univ, Med Ctr, Dept Ophthalmol, New York, NY 10032 USA; [Sparrow, Janet R.] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Riera, Marina] Inst Ocular Microsurg, Dept Genet, Barcelona 08035, Spain	Columbia University; Columbia University	Sparrow, JR (corresponding author), Columbia Univ, Dept Ophthalmol, 635 W 165th St, New York, NY 10032 USA.	jrs88@columbia.edu		Zhao, Jin/0000-0002-1934-6445	National Institutes of Health [EY12951]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY012951, P30EY019007] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in whole or in part by National Institutes of Health Grant EY12951 (to J. R. S.) and by unrestricted funds from Research to Prevent Blindness (to the Department of Ophthalmology, Columbia University). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aizawa S, 2010, CLIN EXP OPHTHALMOL, V38, P597, DOI 10.1111/j.1442-9071.2010.02321.x; Akhmedov NB, 2000, P NATL ACAD SCI USA, V97, P5551, DOI 10.1073/pnas.97.10.5551; ANDERSON RE, 1970, BIOCHEMISTRY-US, V9, P3624, DOI 10.1021/bi00820a019; BATTELLE BA, 1978, EXP EYE RES, V26, P487, DOI 10.1016/0014-4835(78)90134-3; Ben-Shabat S, 2002, J BIOL CHEM, V277, P7183, DOI 10.1074/jbc.M108981200; BOK D, 1971, J CELL BIOL, V49, P664, DOI 10.1083/jcb.49.3.664; Boyer NP, 2012, J BIOL CHEM, V287, P22276, DOI 10.1074/jbc.M111.329235; BURDEN EM, 1971, EXP EYE RES, V11, P140; Burke TR, 2014, INVEST OPHTH VIS SCI, V55, P2841, DOI 10.1167/iovs.13-13624; Chen XT, 2013, J NEUROPATH EXP NEUR, V72, P782, DOI 10.1097/NEN.0b013e31829e8375; Cukras CA, 2012, ARCH OPHTHALMOL-CHIC, V130, P171, DOI 10.1001/archophthalmol.2011.332; D'Cruz PM, 2000, HUM MOL GENET, V9, P645, DOI 10.1093/hmg/9.4.645; Danciger M, 2000, MAMM GENOME, V11, P422, DOI 10.1007/s003350010081; DELMELLE M, 1975, EXP EYE RES, V21, P369, DOI 10.1016/0014-4835(75)90047-0; DELORI FC, 1995, INVEST OPHTH VIS SCI, V36, P2327; Delori FC, 2001, INVEST OPHTH VIS SCI, V42, P1855; DOWLING JE, 1962, J CELL BIOL, V14, P73, DOI 10.1083/jcb.14.1.73; Dunaief JL, 2002, ARCH OPHTHALMOL-CHIC, V120, P1435, DOI 10.1001/archopht.120.11.1435; Duncan JL, 2003, INVEST OPHTH VIS SCI, V44, P826, DOI 10.1167/iovs.02-0438; Duncker T, 2013, INVEST OPHTH VIS SCI, V54, P585, DOI 10.1167/iovs.12-11176; EAGLE RC, 1980, OPHTHALMOLOGY, V87, P1189; Eldred G. E., 1991, FLUOROPHORES RCS RAT; FEENEYBURNS L, 1984, INVEST OPHTH VIS SCI, V25, P195; Feng W, 2002, J BIOL CHEM, V277, P17016, DOI 10.1074/jbc.M107876200; Flynn E, 2014, INVEST OPHTH VIS SCI, V55, P5643, DOI 10.1167/iovs.14-14136; Gal A, 2000, NAT GENET, V26, P270, DOI 10.1038/81555; Greenberg JP, 2013, INVEST OPHTH VIS SCI, V54, P5684, DOI 10.1167/iovs.13-12445; Hao WS, 2002, NAT GENET, V32, P254, DOI 10.1038/ng984; HECKENLIVELY JR, 1991, ARCH OPHTHALMOL-CHIC, V109, P84, DOI 10.1001/archopht.1991.01080010086038; HERRON WL, 1969, INVEST OPHTH VISUAL, V8, P595; HERRON WL, 1974, INVEST OPHTH VISUAL, V13, P87; Huber G, 2009, INVEST OPHTH VIS SCI, V50, P5888, DOI 10.1167/iovs.09-3724; Issa PC, 2009, BRIT J OPHTHALMOL, V93, P920, DOI 10.1136/bjo.2008.147397; Issa PC, 2012, INVEST OPHTH VIS SCI, V53, P1066, DOI 10.1167/iovs.11-8767; Jang YP, 2005, J BIOL CHEM, V280, P39732, DOI 10.1074/jbc.M504933200; Kane MA, 2008, ANAL BIOCHEM, V378, P71, DOI 10.1016/j.ab.2008.03.038; KATZ ML, 1987, MECH AGEING DEV, V39, P81, DOI 10.1016/0047-6374(87)90088-1; Kim HJ, 2018, J LIPID RES, V59, P1620, DOI 10.1194/jlr.M084459; Kim SR, 2007, P NATL ACAD SCI USA, V104, P19273, DOI 10.1073/pnas.0708714104; Kim SR, 2007, BIOCHEMISTRY-US, V46, P10122, DOI 10.1021/bi7009635; Kim SR, 2006, EXP EYE RES, V82, P828, DOI 10.1016/j.exer.2005.10.004; Kim SR, 2010, VISION RES, V50, P729, DOI 10.1016/j.visres.2009.09.015; Kim SR, 2004, P NATL ACAD SCI USA, V101, P11668, DOI 10.1073/pnas.0403499101; Koh S, 2018, J NEUROSCI, V38, P2923, DOI 10.1523/JNEUROSCI.1532-17.2018; LAVAIL MM, 1975, EXP EYE RES, V21, P167, DOI 10.1016/0014-4835(75)90080-9; LAVAIL MM, 1981, INVEST OPHTH VIS SCI, V21, P658; LI LX, 1988, EXP EYE RES, V47, P911, DOI 10.1016/0014-4835(88)90073-5; LOLLEY RN, 1976, EXP EYE RES, V22, P477, DOI 10.1016/0014-4835(76)90185-8; Lyubarsky AL, 2005, BIOCHEMISTRY-US, V44, P9880, DOI 10.1021/bi0505363; Maddox DM, 2011, INVEST OPHTH VIS SCI, V52, P4703, DOI 10.1167/iovs.10-7077; Maeda A, 2005, J BIOL CHEM, V280, P18822, DOI 10.1074/jbc.M501757200; Maeda A, 2008, J BIOL CHEM, V283, P26684, DOI 10.1074/jbc.M804505200; Maeda A, 2012, NAT CHEM BIOL, V8, P170, DOI 10.1038/nchembio.759; Mata NL, 2000, P NATL ACAD SCI USA, V97, P7154, DOI 10.1073/pnas.130110497; Matthes M T, 1989, Prog Clin Biol Res, V314, P315; McHenry CL, 2004, INVEST OPHTH VIS SCI, V45, P1456, DOI 10.1167/iovs.03-0909; MULLEN RJ, 1976, SCIENCE, V192, P799, DOI 10.1126/science.1265483; Naash ML, 1996, INVEST OPHTH VIS SCI, V37, P775; Nagasaki T, 2003, INVEST OPHTH VIS SCI, V44, P558, DOI 10.1167/iovs.02-0705; Nusinowitz S, 2003, EXP EYE RES, V77, P627, DOI 10.1016/S0014-4835(03)00217-3; Organisciak DT, 1999, CURR EYE RES, V19, P188, DOI 10.1076/ceyr.19.2.188.5333; Paavo M, 2018, INVEST OPHTH VIS SCI, V59, P2459, DOI 10.1167/iovs.18-24213; Parish CA, 1998, P NATL ACAD SCI USA, V95, P14609, DOI 10.1073/pnas.95.25.14609; PENN JS, 1986, EXP EYE RES, V43, P915, DOI 10.1016/0014-4835(86)90070-9; Popovic P, 2005, GRAEF ARCH CLIN EXP, V243, P1018, DOI 10.1007/s00417-005-1186-x; Prasad D, 2006, MOL CELL NEUROSCI, V33, P96, DOI 10.1016/j.mcn.2006.06.011; Robson AG, 2008, BRIT J OPHTHALMOL, V92, P95, DOI 10.1136/bjo.2007.124008; Robson AG, 2003, INVEST OPHTH VIS SCI, V44, P3544, DOI 10.1167/iovs.02-1278; Salvador GA, 1998, LIPIDS, V33, P853, DOI 10.1007/s11745-998-0281-z; Schuerch K, 2017, INVEST OPHTH VIS SCI, V58, P1843, DOI 10.1167/iovs.16-21302; Secondi R, 2012, INVEST OPHTH VIS SCI, V53, P5190, DOI 10.1167/iovs.12-9672; Seeliger MW, 2005, VISION RES, V45, P3512, DOI 10.1016/j.visres.2005.08.014; Sparrow J., 2007, ATLAS AUTOFLUORESCEN, P1; Sparrow JR, 2015, INVEST OPHTH VIS SCI, V56, P5029, DOI 10.1167/iovs.15-16763; Sparrow JR, 2013, INVEST OPHTH VIS SCI, V54, P2812, DOI 10.1167/iovs.12-11490; Sparrow JR, 2012, PROG RETIN EYE RES, V31, P121, DOI 10.1016/j.preteyeres.2011.12.001; Sparrow JR, 2010, PHOTOCH PHOTOBIO SCI, V9, P1480, DOI 10.1039/c0pp00207k; Sparrow JR, 2010, METHODS MOL BIOL, V652, P315, DOI 10.1007/978-1-60327-325-1_18; Sparrow JR, 2003, J BIOL CHEM, V278, P18207, DOI 10.1074/jbc.M300457200; Sparrow JR, 2000, INVEST OPHTH VIS SCI, V41, P1981; Strick DJ, 2010, EXP EYE RES, V91, P786, DOI 10.1016/j.exer.2010.05.006; Tombran-Tink J, 2007, RETINAL DEGENERATION, P213; Tschernutter M, 2006, BRIT J OPHTHALMOL, V90, P718, DOI 10.1136/bjo.2005.084897; Ueda K, 2016, P NATL ACAD SCI USA, V113, P6904, DOI 10.1073/pnas.1524774113; Vollrath D, 2001, P NATL ACAD SCI USA, V98, P12584, DOI 10.1073/pnas.221364198; von Ruckmann A, 1999, GRAEF ARCH CLIN EXP, V237, P1, DOI 10.1007/s004170050186; Wang JY, 2009, J CELL PHYSIOL, V220, P119, DOI 10.1002/jcp.21742; Wang NK, 2009, BRIT J OPHTHALMOL, V93, P1234, DOI 10.1136/bjo.2008.153577; WEITER JJ, 1986, INVEST OPHTH VIS SCI, V27, P145; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Wenzel A, 2003, INVEST OPHTH VIS SCI, V44, P2798, DOI 10.1167/iovs.02-1134; Wenzel A, 2001, J NEUROSCI, V21, P53, DOI 10.1523/JNEUROSCI.21-01-00053.2001; WING GL, 1978, INVEST OPHTH VIS SCI, V17, P601; Wu L, 2010, ADV EXP MED BIOL, V664, P533, DOI 10.1007/978-1-4419-1399-9_61; Wu YL, 2010, P NATL ACAD SCI USA, V107, P7275, DOI 10.1073/pnas.0913112107; Wu Y, 2009, J BIOL CHEM, V284, P20155, DOI 10.1074/jbc.M109.021345; Xu HP, 2008, AGING CELL, V7, P58, DOI 10.1111/j.1474-9726.2007.00351.x; Yamamoto K, 2011, INVEST OPHTH VIS SCI, V52, P9084, DOI 10.1167/iovs.11-8632; Yoon KD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041309; Zhou YD, 2011, EXP EYE RES, V93, P636, DOI 10.1016/j.exer.2011.07.017	100	12	12	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2018	293	50					19400	19410		10.1074/jbc.RA118.005949	http://dx.doi.org/10.1074/jbc.RA118.005949			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HE6RA	30352873	hybrid, Green Published			2022-12-28	WOS:000453537300021
J	Zou, GZ; Kosikova, M; Kim, SR; Kotian, S; Wu, WW; Shen, RF; Powers, DN; Agarabi, C; Xie, H; Ju, TZ				Zou, Guozhang; Kosikova, Martina; Kim, Su-Ryun; Kotian, Shweta; Wu, Wells W.; Shen, Rongfong; Powers, David N.; Agarabi, Cyrus; Xie, Hang; Ju, Tongzhong			Comprehensive analysis of N-glycans in IgG purified from ferrets with or without influenza A virus infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						N-linked glycosylation; IgG; glycosylation; influenza; MS; ferret; fucosylation; immunity; UPLC; vaccine development	FC-GAMMA-RIII; VACCINE EFFECTIVENESS; GLYCOMIC CHARACTERIZATION; RECEPTOR-BINDING; IMMUNOGLOBULIN-G; LINKED GLYCANS; LC-MS/MS; ANTIBODY; FRAGMENTATION; GLYCOFORMS	Influenza viruses cause contagious respiratory infections, resulting in significant economic burdens to communities. Production of influenza-specific Igs, specifically IgGs, is one of the major protective immune mechanisms against influenza viruses. In humans, N-glycosylation of IgGs plays a critical role in antigen binding and effector functions. The ferret is the most commonly used animal model for studying influenza pathogenesis, virus transmission, and vaccine development, but its IgG structure and functions remain largely undefined. Here we show that ferret IgGs are N-glycosylated and that their N-glycan structures are diverse. Using a comprehensive strategy based on MS and ultra-HPLC analyses in combination with exoglycosidase digestions, we assigned 42 N-glycan structures in ferret IgGs. We observed that N-glycans of ferret IgGs consist mainly of complex-type glycans, including some high-mannose and hybrid glycans, similar to those observed in human IgG. The complex-type glycans of ferret IgGs were primarily core-fucosylated. Furthermore, a fraction of N-glycans carried bisecting GlcNAc. Ferret IgGs also had a minor fraction of glycans carrying 2-6Neu5Ac(s). We noted that, unlike human IgG, ferret IgGs have Gal epitopes on some N-glycans. Interestingly, influenza A infection caused prominent changes in the N-glycans of ferret IgG, mainly because of an increase in bisecting GlcNAc and F1A2G0 and a corresponding decrease in F1A2G1. This suggests that the glycosylation of virus-specific IgG may play a role in its functionality. Our study highlights the need to further elucidate the structure-function relationships of IgGs in universal influenza vaccine development.	[Zou, Guozhang; Kim, Su-Ryun; Kotian, Shweta; Powers, David N.; Agarabi, Cyrus; Ju, Tongzhong] US FDA, Off Biotechnol Prod, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA; [Kosikova, Martina; Xie, Hang] US FDA, Off Vaccines Res & Review, Silver Spring, MD 20993 USA; [Wu, Wells W.; Shen, Rongfong] US FDA, Facil Biotechnol Resources, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Ju, TZ (corresponding author), US FDA, Off Biotechnol Prod, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA.; Xie, H (corresponding author), US FDA, Off Vaccines Res & Review, Silver Spring, MD 20993 USA.	hang.xie@fda.hhs.gov; tongzhong.ju@fda.hhs.gov	Kotian, Shweta/GMX-3418-2022; Xie, Hang/AAC-9092-2019	Xie, Hang/0000-0001-8318-5554; Ju, Tongzhong/0000-0002-4429-1976	Food and Drug Administration intramural funds	Food and Drug Administration intramural funds	This work is supported by Food and Drug Administration intramural funds. This project was supported in part by an appointment to the Internship/Research Participation Program at the Office of Biotechnology Products, Food and Drug Administration, administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the Department of Energy and Food and Drug Administration. The authors declare that they have no conflicts of interest with the contents of this article. The views expressed in this article are those of the authors, and do not necessarily reflect the official policy or position of the U.S. Food and Drug Administration and the Dept. of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.	Abe Y, 2004, J VIROL, V78, P9605, DOI 10.1128/JVI.78.18.9605-9611.2004; Ackerman ME, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005315; Ackerman ME, 2013, J CLIN INVEST, V123, P2183, DOI 10.1172/JCI65708; Adamczyk B, 2014, CARBOHYD RES, V389, P174, DOI 10.1016/j.carres.2014.01.018; Alley WR, 2010, ANAL CHEM, V82, P5095, DOI 10.1021/ac100131e; Barr IG, 2010, VACCINE, V28, P1156, DOI 10.1016/j.vaccine.2009.11.043; Chen ZY, 2010, J VIROL, V84, P44, DOI 10.1128/JVI.02106-09; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; DiLillo DJ, 2016, J CLIN INVEST, V126, P605, DOI 10.1172/JCI84428; DiLillo DJ, 2014, NAT MED, V20, P143, DOI 10.1038/nm.3443; Ferrara C, 2011, P NATL ACAD SCI USA, V108, P12669, DOI 10.1073/pnas.1108455108; Flannery B, 2015, MMWR-MORBID MORTAL W, V64, P10; FUJII S, 1990, J BIOL CHEM, V265, P6009; GALILI U, 1984, J EXP MED, V160, P1519, DOI 10.1084/jem.160.5.1519; Gornik O, 2009, GLYCOBIOLOGY, V19, P1547, DOI 10.1093/glycob/cwp134; Halim A, 2014, J PROTEOME RES, V13, P6024, DOI 10.1021/pr500898r; Harvey DJ, 2005, J AM SOC MASS SPECTR, V16, P647, DOI 10.1016/j.jasms.2005.01.006; Harvey DJ, 2004, RAPID COMMUN MASS SP, V18, P2997, DOI 10.1002/rcm.1709; Hensley SE, 2014, CURR OPIN VIROL, V8, P85, DOI 10.1016/j.coviro.2014.07.007; Irie A, 1998, J BIOL CHEM, V273, P15866, DOI 10.1074/jbc.273.25.15866; Jennewein MF, 2017, TRENDS IMMUNOL, V38, P358, DOI 10.1016/j.it.2017.02.004; Jia N, 2014, J BIOL CHEM, V289, P28489, DOI 10.1074/jbc.M114.588541; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Kang P, 2005, RAPID COMMUN MASS SP, V19, P3421, DOI 10.1002/rcm.2210; Kirchenbaum GA, 2017, J IMMUNOL, V199, P3798, DOI 10.4049/jimmunol.1701174; Koel BF, 2013, SCIENCE, V342, P976, DOI 10.1126/science.1244730; Kosikova M, 2018, CLIN INFECT DIS, V67, P1523, DOI 10.1093/cid/ciy327; Li GM, 2012, P NATL ACAD SCI USA, V109, P9047, DOI 10.1073/pnas.1118979109; Li TZ, 2017, P NATL ACAD SCI USA, V114, P3485, DOI 10.1073/pnas.1702173114; Li Y, 2013, J EXP MED, V210, P1493, DOI 10.1084/jem.20130212; Maamary J, 2017, P NATL ACAD SCI USA, V114, P10172, DOI 10.1073/pnas.1707950114; Mucha E, 2018, ANGEW CHEM INT EDIT, V57, P7440, DOI 10.1002/anie.201801418; Nesspor TC, 2014, INFLUENZA OTHER RESP, V8, P596, DOI 10.1111/irv.12273; Ng PSK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6750; Popova L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041895; Pucic M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010090; Raju TS, 2000, GLYCOBIOLOGY, V10, P477, DOI 10.1093/glycob/10.5.477; Russell CA, 2008, VACCINE, V26, pD31, DOI 10.1016/j.vaccine.2008.07.078; SANDRIN MS, 1993, P NATL ACAD SCI USA, V90, P11391, DOI 10.1073/pnas.90.23.11391; Selman MHJ, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014563; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Shivatare VS, 2018, J AM CHEM SOC, V140, P5202, DOI 10.1021/jacs.8b00896; Skowronski DM, 2016, CLIN INFECT DIS, V63, P21, DOI 10.1093/cid/ciw176; Skowronski DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092153; Sullivan SG, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.43.17-00707; Tripp RA, 2009, CURR TOP MICROBIOL, V333, P397, DOI 10.1007/978-3-540-92165-3_19; Umana P, 1999, NAT BIOTECHNOL, V17, P176, DOI 10.1038/6179; Vidarsson G, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00520; Wang TT, 2015, CELL, V162, P160, DOI 10.1016/j.cell.2015.06.026; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Xie H, 2017, CLIN INFECT DIS, V65, P259, DOI 10.1093/cid/cix269; Xie H, 2015, SCI REP-UK, V5, DOI 10.1038/srep15279; Zhou SY, 2017, ANAL CHEM, V89, P6590, DOI 10.1021/acs.analchem.7b00747; Zhou SY, 2017, ANAL BIOANAL CHEM, V409, P453, DOI 10.1007/s00216-016-9996-8; Zou GZ, 2017, ANAL CHEM, V89, P5364, DOI 10.1021/acs.analchem.7b00062; Zou GZ, 2011, J AM CHEM SOC, V133, P18975, DOI 10.1021/ja208390n	56	7	7	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2018	293	50					19277	19289		10.1074/jbc.RA118.005294	http://dx.doi.org/10.1074/jbc.RA118.005294			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HE6RA	30315103	Green Published, hybrid			2022-12-28	WOS:000453537300011
J	Dever, TE; Ivanov, IP				Dever, Thomas E.; Ivanov, Ivaylo P.			Roles of polyamines in translation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							OPEN READING FRAME; S-ADENOSYLMETHIONINE DECARBOXYLASE; ANTIZYME MESSENGER-RNA; SPERMIDINE-SPERMINE N-1-ACETYLTRANSFERASE; SYNTHESIS INITIATION-FACTORS; ORNITHINE-DECARBOXYLASE; PROTEIN-SYNTHESIS; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; DEOXYHYPUSINE SYNTHASE	Polyamines are organic polycations that bind to a variety of cellular molecules, including nucleic acids. Within cells, polyamines contribute to both the efficiency and fidelity of protein synthesis. In addition to directly acting on the translation apparatus to stimulate protein synthesis, the polyamine spermidine serves as a precursor for the essential post-translational modification of the eukaryotic translation factor 5A (eIF5A), which is required for synthesis of proteins containing problematic amino acid sequence motifs, including polyproline tracts, and for termination of translation. The impact of polyamines on translation is highlighted by autoregulation of the translation of mRNAs encoding key metabolic and regulatory proteins in the polyamine biosynthesis pathway, including S-adenosylmethionine decarboxylase (AdoMetDC), antizyme (OAZ), and antizyme inhibitor 1 (AZIN1). Here, we highlight the roles of polyamines in general translation and also in the translational regulation of polyamine biosynthesis.	[Dever, Thomas E.; Ivanov, Ivaylo P.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Dever, TE; Ivanov, IP (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD 20892 USA.	thomas.dever@nih.gov; ivaylo.ivanov@nih.gov	Dever, Thomas/GSE-0966-2022	Ivanov, Ivaylo/0000-0002-6008-3261; Dever, Thomas/0000-0001-7120-9678	Intramural Research Program of the NICHD, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001010] Funding Source: NIH RePORTER	Intramural Research Program of the NICHD, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Intramural Research Program of the NICHD, National Institutes of Health. This article is part of a series on "Polyamines," written in honor of Dr. Herbert Tabor's 100th birthday. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amarantos I, 2001, BIOCHEMISTRY-US, V40, P7641, DOI 10.1021/bi010010s; ATKINS JF, 1975, J BIOL CHEM, V250, P5688; Atkins JF, 2016, NUCLEIC ACIDS RES, V44, P7007, DOI 10.1093/nar/gkw530; BALASUNDARAM D, 1994, J BACTERIOL, V176, P7126, DOI 10.1128/JB.176.22.7126-7128.1994; BALASUNDARAM D, 1994, P NATL ACAD SCI USA, V91, P172, DOI 10.1073/pnas.91.1.172; BELCOURT MF, 1990, CELL, V62, P339, DOI 10.1016/0092-8674(90)90371-K; BENNE R, 1978, J BIOL CHEM, V253, P3078; Butcher NJ, 2007, J BIOL CHEM, V282, P28530, DOI 10.1074/jbc.M701265200; BYERS TL, 1994, BIOCHEM J, V303, P363, DOI 10.1042/bj3030363; Chattopadhyay MK, 2008, P NATL ACAD SCI USA, V105, P6554, DOI 10.1073/pnas.0710970105; Chattopadhyay MK, 2003, P NATL ACAD SCI USA, V100, P13869, DOI 10.1073/pnas.1835918100; Christian BE, 2010, BIOCHEM BIOPH RES CO, V391, P942, DOI 10.1016/j.bbrc.2009.11.169; COHEN SS, 1960, J BIOL CHEM, V235, P2112; Dever TE, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a032649; Dever TE, 2014, CRIT REV BIOCHEM MOL, V49, P413, DOI 10.3109/10409238.2014.939608; FARABAUGH PJ, 1993, CELL, V74, P93, DOI 10.1016/0092-8674(93)90297-4; GERNER EW, 1986, BIOCHEM J, V239, P379, DOI 10.1042/bj2390379; Gupta R, 2001, P NATL ACAD SCI USA, V98, P10620, DOI 10.1073/pnas.181341298; Gutierrez E, 2013, MOL CELL, V51, P35, DOI 10.1016/j.molcel.2013.04.021; Hanfrey C, 2005, J BIOL CHEM, V280, P39229, DOI 10.1074/jbc.M509340200; Harger JW, 2002, TRENDS BIOCHEM SCI, V27, P448, DOI 10.1016/S0968-0004(02)02149-7; Hellen CUT, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a032656; HELLER JS, 1976, P NATL ACAD SCI USA, V73, P1858, DOI 10.1073/pnas.73.6.1858; HERSHKO A, 1961, BIOCHEM BIOPH RES CO, V5, P46, DOI 10.1016/0006-291X(61)90078-X; Hetrick B, 2010, BIOCHEMISTRY-US, V49, P7179, DOI 10.1021/bi1009776; Hinnebusch AG, 2014, ANNU REV BIOCHEM, V83, P779, DOI 10.1146/annurev-biochem-060713-035802; Hinnebusch AG, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011544; Hinnebusch AG, 2011, MICROBIOL MOL BIOL R, V75, P434, DOI 10.1128/MMBR.00008-11; Howard MT, 2001, GENES CELLS, V6, P931, DOI 10.1046/j.1365-2443.2001.00477.x; Hoyt MA, 2000, MOL CELL BIOL, V20, P2760, DOI 10.1128/MCB.20.8.2760-2773.2000; HRYNIEWICZ MM, 1983, MOL GEN GENET, V190, P336, DOI 10.1007/BF00330661; HUNTER AR, 1977, EUR J BIOCHEM, V75, P149, DOI 10.1111/j.1432-1033.1977.tb11512.x; Hyvonen MT, 2006, RNA, V12, P1569, DOI 10.1261/rna.39806; IGARASHI K, 1982, EUR J BIOCHEM, V128, P597; IGARASHI K, 1973, BIOCHIM BIOPHYS ACTA, V299, P325, DOI 10.1016/0005-2787(73)90356-0; IGARASHI K, 1974, EUR J BIOCHEM, V48, P495, DOI 10.1111/j.1432-1033.1974.tb03790.x; Igarashi K, 1979, BIOCHEM BIOPH RES CO, V91, P440; Igarashi K, 2015, IUBMB LIFE, V67, P160, DOI 10.1002/iub.1363; ITO K, 1990, J BIOL CHEM, V265, P13036; Ivanov IP, 2000, P NATL ACAD SCI USA, V97, P4808, DOI 10.1073/pnas.070055897; Ivanov IP, 1998, GENOMICS, V52, P119, DOI 10.1006/geno.1998.5434; Ivanov IP, 2000, NUCLEIC ACIDS RES, V28, P3185, DOI 10.1093/nar/28.17.3185; Ivanov IP, 2006, RNA, V12, P332, DOI 10.1261/rna.2245906; Ivanov IP, 2004, J MOL BIOL, V339, P495, DOI 10.1016/j.jmb.2004.03.082; Ivanov IP, 2000, EMBO J, V19, P1907, DOI 10.1093/emboj/19.8.1907; Ivanov IP, 1998, RNA, V4, P1230, DOI 10.1017/S1355838298980864; Ivanov IP, 2008, P NATL ACAD SCI USA, V105, P10079, DOI 10.1073/pnas.0801590105; Ivanov IP, 2007, NUCLEIC ACIDS RES, V35, P1842, DOI 10.1093/nar/gkm035; Ivanov IP, 2018, MOL CELL, V70, P254, DOI 10.1016/j.molcel.2018.03.015; Ivanov IP, 2010, J MOL EVOL, V70, P289, DOI 10.1007/s00239-010-9331-5; Ivanov IP, 2010, NUCLEIC ACIDS MOL BI, V24, P281, DOI 10.1007/978-0-387-89382-2_13; Ivanov IP, 2010, NUCLEIC ACIDS RES, V38, P353, DOI 10.1093/nar/gkp1037; Kahana C, 2018, J BIOL CHEM, V293, P18730, DOI 10.1074/jbc.TM118.003339; Kahana C, 2009, CELL MOL LIFE SCI, V66, P2479, DOI 10.1007/s00018-009-0033-3; KAMEJI T, 1987, J BIOL CHEM, V262, P2427; Karamysheva ZN, 2003, NUCLEIC ACIDS RES, V31, P5949, DOI 10.1093/nar/gkg789; KEMPER WM, 1976, J BIOL CHEM, V251, P5551; KONECKI D, 1975, ARCH BIOCHEM BIOPHYS, V169, P192, DOI 10.1016/0003-9861(75)90332-X; Kurian L, 2011, NATURE, V477, P490, DOI 10.1038/nature10393; Landau G, 2012, J BIOL CHEM, V287, P35825, DOI 10.1074/jbc.M112.381335; Landau G, 2010, J BIOL CHEM, V285, P12474, DOI 10.1074/jbc.M110.106419; Law GL, 2001, J BIOL CHEM, V276, P38036; Lee CH, 2000, BIOCHEM J, V352, P851, DOI 10.1042/0264-6021:3520851; LI XQ, 1992, MOL CELL BIOL, V12, P3556, DOI 10.1128/MCB.12.8.3556; Mandal S, 2013, P NATL ACAD SCI USA, V110, P2169, DOI 10.1073/pnas.1219002110; MARTIN RG, 1962, P NATL ACAD SCI USA, V48, P2171, DOI 10.1073/pnas.48.12.2171; MATSUFUJI S, 1995, CELL, V80, P51, DOI 10.1016/0092-8674(95)90450-6; MATSUFUJI S, 1990, J BIOCHEM-TOKYO, V108, P365, DOI 10.1093/oxfordjournals.jbchem.a123207; Matsufuji S, 1996, EMBO J, V15, P1360, DOI 10.1002/j.1460-2075.1996.tb00478.x; MCCAUGHAN KK, 1995, P NATL ACAD SCI USA, V92, P5431, DOI 10.1073/pnas.92.12.5431; MCMURRY LM, 1986, EUR J BIOCHEM, V155, P383, DOI 10.1111/j.1432-1033.1986.tb09502.x; Melnikov S, 2016, J MOL BIOL, V428, P3570, DOI 10.1016/j.jmb.2016.05.011; Mize GJ, 1998, J BIOL CHEM, V273, P32500, DOI 10.1074/jbc.273.49.32500; Mize GJ, 2001, RNA, V7, P374, DOI 10.1017/S1355838201001972; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; Murakami Y, 1996, J BIOL CHEM, V271, P3340, DOI 10.1074/jbc.271.7.3340; Namy O, 2008, NAT CELL BIOL, V10, P1069, DOI 10.1038/ncb1766; NATHANS D, 1961, P NATL ACAD SCI USA, V47, P497, DOI 10.1073/pnas.47.4.497; NILSSON L, 1983, BIOCHIM BIOPHYS ACTA, V740, P460, DOI 10.1016/0167-4781(83)90095-7; Nishimura K, 2005, BIOCHEM J, V385, P779, DOI 10.1042/BJ20041477; Noeske J, 2015, NAT STRUCT MOL BIOL, V22, P336, DOI 10.1038/nsmb.2994; OGASAWARA T, 1989, J BIOCHEM-TOKYO, V105, P164, DOI 10.1093/oxfordjournals.jbchem.a122633; Palanimurugan R, 2004, EMBO J, V23, P4857, DOI 10.1038/sj.emboj.7600473; Park MH, 1998, J BIOL CHEM, V273, P1677, DOI 10.1074/jbc.273.3.1677; PARK MH, 1981, P NATL ACAD SCI-BIOL, V78, P2869, DOI 10.1073/pnas.78.5.2869; Park MH, 2018, J BIOL CHEM, V293, P18710, DOI 10.1074/jbc.TM118.003341; PARRY L, 1995, BIOCHEM J, V305, P451, DOI 10.1042/bj3050451; Pavitt GD, 2018, WIRES RNA, V9, DOI 10.1002/wrna.1491; Pegg AE, 2009, IUBMB LIFE, V61, P880, DOI 10.1002/iub.230; Perez-Leal O, 2012, MOL CELL BIOL, V32, P1453, DOI 10.1128/MCB.06444-11; PERSSON L, 1986, FEBS LETT, V205, P175, DOI 10.1016/0014-5793(86)80892-4; Petros LM, 2005, BIOCHEM BIOPH RES CO, V338, P1478, DOI 10.1016/j.bbrc.2005.10.115; POOLE ES, 1995, EMBO J, V14, P151, DOI 10.1002/j.1460-2075.1995.tb06985.x; QUIGLEY GJ, 1978, P NATL ACAD SCI USA, V75, P64, DOI 10.1073/pnas.75.1.64; Raney A, 2002, J BIOL CHEM, V277, P5988, DOI 10.1074/jbc.M108375200; Raney A, 2000, J BIOL CHEM, V275, P24444, DOI 10.1074/jbc.M003364200; Rato C, 2011, NUCLEIC ACIDS RES, V39, P4587, DOI 10.1093/nar/gkq1349; Rodnina MV, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a032664; Ruan HJ, 1996, J BIOL CHEM, V271, P29576, DOI 10.1074/jbc.271.47.29576; RUAN HJ, 1994, J BIOL CHEM, V269, P17905; Saini P, 2009, NATURE, V459, P118, DOI 10.1038/nature08034; Sasaki K, 1996, FEBS LETT, V384, P151, DOI 10.1016/0014-5793(96)00310-9; Schmidt C, 2016, NUCLEIC ACIDS RES, V44, P1944, DOI 10.1093/nar/gkv1517; SCHNIER J, 1991, MOL CELL BIOL, V11, P3105, DOI 10.1128/MCB.11.6.3105; SCHREIER MH, 1977, J MOL BIOL, V116, P727, DOI 10.1016/0022-2836(77)90268-6; Schuller AP, 2017, MOL CELL, V66, P194, DOI 10.1016/j.molcel.2017.03.003; Shantz LM, 1999, INT J BIOCHEM CELL B, V31, P107, DOI 10.1016/S1357-2725(98)00135-6; Shin BS, 2017, NUCLEIC ACIDS RES, V45, P8392, DOI 10.1093/nar/gkx532; Sundararajan A, 1999, MOL CELL, V4, P1005, DOI 10.1016/S1097-2765(00)80229-4; TABOR H, 1981, J BACTERIOL, V147, P702, DOI 10.1128/JB.147.2.702-704.1981; TABOR H, 1982, P NATL ACAD SCI-BIOL, V79, P7087, DOI 10.1073/pnas.79.23.7087; TAKEDA Y, 1969, J BIOCHEM-TOKYO, V66, P345, DOI 10.1093/oxfordjournals.jbchem.a129152; Xaplanteri MA, 2005, NUCLEIC ACIDS RES, V33, P2792, DOI 10.1093/nar/gki557; Yordanova MM, 2015, J BIOL CHEM, V290, P17863, DOI 10.1074/jbc.M115.647065	114	43	43	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2018	293	48					18719	18729		10.1074/jbc.TM118.003338	http://dx.doi.org/10.1074/jbc.TM118.003338			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NX	30323064	Green Published, hybrid			2022-12-28	WOS:000458467300027
J	Pan, J; Di, YQ; Li, YB; Chen, CH; Wang, JX; Zhao, XF				Pan, Jing; Di, Yu-Qin; Li, Yong-Bo; Chen, Cai-Hua; Wang, Jin-Xing; Zhao, Xiao-Fan			Insulin and 20-hydroxyecdysone oppose each other in the regulation of phosphoinositide-dependent kinase-1 expression during insect pupation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; DOUBLE-STRANDED-RNA; ECDYSONE RECEPTOR; PROTHORACICOTROPIC HORMONE; LARVAL MIDGUT; DROSOPHILA; GROWTH; APOPTOSIS; AUTOPHAGY; FOXO	Insulin promotes larval growth of insects by stimulating the synthesis of the steroid hormone 20-hydroxyecdysone (20E), which induces pupation and apoptosis. However, the mechanism underlying the coordinate regulation of insect pupation and apoptosis by these two functionally opposing hormones is still unclear. Here, using the lepidopteran insect and serious agricultural pest Helicoverpa armigera (cotton bollworm) as a model, we report that phosphoinositide- dependent kinase-1 (PDK1) and forkhead box O (FoxO) play key roles in these processes. We found that the transcript levels of the PDK1 gene are increased during the larval feeding stages. Moreover, PDK1 expression was increased by insulin, but repressed by 20E. dsRNA-mediated PDK1 knockdown in the H. armigera larvae delayed pupation and resulted in small pupae and also decreased Akt/protein kinase B expression and increased FoxO expression. Furthermore, thePDK1knockdown blocked midgut remodeling and decreased 20E levels in the larvae. Of note, injecting larvae with 20E overcame the effect of the PDK1 knockdown and restored midgut remodeling. FoxO overexpression in an H. armigera epidermal cell line (HaEpi) did not induce apoptosis, but promoted autophagy and repressed cell proliferation. These results reveal cross-talk between insulin and 20E and that both hormones oppose each other's activities in the regulation of insect pupation and apoptosis by controlling PDK1 expression and, in turn, FoxO expression. We conclude that sufficiently high 20E levels are a key factor for inducing apoptosis during insect pupation.	[Pan, Jing; Di, Yu-Qin; Li, Yong-Bo; Chen, Cai-Hua; Wang, Jin-Xing; Zhao, Xiao-Fan] Shandong Univ, Shandong Prov Key Lab Anim Cells & Dev Biol, Sch Life Sci, Jinan 250100, Shandong, Peoples R China	Shandong University	Zhao, XF (corresponding author), Shandong Univ, Shandong Prov Key Lab Anim Cells & Dev Biol, Sch Life Sci, Jinan 250100, Shandong, Peoples R China.	xfzhao@sdu.edu.cn	Wang, Jin-Xing/AAU-1514-2021; Zhao, Xiao-Fan/AGW-9886-2022	Chen, Cai-Hua/0000-0002-2900-9530; Wang, Jin-Xing/0000-0003-0283-3930	National Natural Science Foundation of China [31730083, 31572328]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grants 31730083 and 31572328. The authors declare that they have no conflicts of interest with the contents of this article.	Anderson KE, 1998, CURR BIOL, V8, P684, DOI 10.1016/S0960-9822(98)70274-X; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; BALDWIN KM, 1991, TISSUE CELL, V23, P411, DOI 10.1016/0040-8166(91)90058-2; Battiprolu PK., 2010, DRUG DISCOV TODAY DI, V7, pE135, DOI [10.1016/j.ddmec.2010.08.001, DOI 10.1016/J.DDMEC.2010.08.001]; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Cai MJ, 2016, DEVELOPMENT, V143, P1005, DOI 10.1242/dev.128694; Chen CH, 2017, P NATL ACAD SCI USA, V114, pE7121, DOI 10.1073/pnas.1704999114; Cho KS, 2001, P NATL ACAD SCI USA, V98, P6144, DOI 10.1073/pnas.101596998; Colombani J, 2005, SCIENCE, V310, P667, DOI 10.1126/science.1119432; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219; Hakim RS, 2010, ANNU REV ENTOMOL, V55, P593, DOI 10.1146/annurev-ento-112408-085450; Hossain MS, 2013, INSECT BIOCHEM MOLEC, V43, P829, DOI 10.1016/j.ibmb.2013.06.007; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Kasprzak A, 2017, MUTAT RES-REV MUTAT, V772, P78, DOI 10.1016/j.mrrev.2016.08.007; Keshan B, 2017, GEN COMP ENDOCR, V241, P108, DOI 10.1016/j.ygcen.2016.06.022; Kondo H, 1996, J MOL BIOL, V259, P926, DOI 10.1006/jmbi.1996.0370; Koyama T, 2014, ELIFE, V3, DOI 10.7554/eLife.03091; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Kumar D, 2008, EUR J ENTOMOL, V105, P591, DOI 10.14411/eje.2008.079; Lan Q, 1999, MOL CELL BIOL, V19, P4897; Lapierre LR, 2015, AUTOPHAGY, V11, P867, DOI 10.1080/15548627.2015.1034410; Li YB, 2017, CELL CALCIUM, V68, P24, DOI 10.1016/j.ceca.2017.10.004; Li YB, 2016, INSECT BIOCHEM MOLEC, V79, P73, DOI 10.1016/j.ibmb.2016.10.004; Lin X., 2018, PEPTIDES, DOI 10.1016/j.peptides.2018.02.001; Liu CY, 2015, CELL CYCLE, V14, P3045, DOI 10.1080/15384101.2015.1053664; Liu CY, 2013, APOPTOSIS, V18, P171, DOI 10.1007/s10495-012-0784-4; Liu W, 2014, J BIOL CHEM, V289, P13026, DOI 10.1074/jbc.M113.547018; Matsui H, 2012, J INSECT PHYSIOL, V58, P1575, DOI 10.1016/j.jinsphys.2012.09.012; Matsuzaki Y, 2003, J INVEST DERMATOL, V120, P308, DOI 10.1046/j.1523-1747.2003.12044.x; McBrayer Z, 2007, DEV CELL, V13, P857, DOI 10.1016/j.devcel.2007.11.003; Mirth CK, 2007, BIOESSAYS, V29, P344, DOI 10.1002/bies.20552; Mizoguchi A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00217; NAGASAWA H, 1984, SCIENCE, V226, P1344, DOI 10.1126/science.226.4680.1344; Nassel DR, 2016, CELL MOL LIFE SCI, V73, P271, DOI 10.1007/s00018-015-2063-3; Orme MH, 2005, CELL METAB, V2, P277, DOI 10.1016/j.cmet.2005.10.005; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Riddiford LM, 2003, INSECT BIOCHEM MOLEC, V33, P1327, DOI 10.1016/j.ibmb.2003.06.001; Rintelen F, 2001, P NATL ACAD SCI USA, V98, P15020, DOI 10.1073/pnas.011318098; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Shao HL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003127; Shpilka T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-226; Sonksen P, 2000, BRIT J ANAESTH, V85, P69, DOI 10.1093/bja/85.1.69; Sui YP, 2009, INSECT MOL BIOL, V18, P443, DOI 10.1111/j.1365-2583.2009.00884.x; Tavallai S, 2014, CANCER BIOL THER, V15, P578, DOI 10.4161/cbt.28163; Tettamanti G, 2007, AUTOPHAGY, V3, P630, DOI 10.4161/auto.4908; Tettamanti G, 2007, CELL TISSUE RES, V330, P345, DOI 10.1007/s00441-007-0449-8; THOMAS HE, 1993, NATURE, V362, P471, DOI 10.1038/362471a0; Tian L, 2013, AUTOPHAGY, V9, P1172, DOI 10.4161/auto.24731; Umezaki Y, 2018, CURR BIOL, V28, P779, DOI 10.1016/j.cub.2018.01.060; Urbich C, 2005, FASEB J, V19, P974, DOI 10.1096/fj.04-2727fje; Vilaplana L, 2007, INSECT BIOCHEM MOLEC, V37, P1241, DOI 10.1016/j.ibmb.2007.07.013; Wang D, 2016, CELL CALCIUM, V60, P1, DOI 10.1016/j.ceca.2016.05.003; Wang JL, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-76; Xiao YJ, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12271; Xie K, 2016, AUTOPHAGY, V12, P381, DOI 10.1080/15548627.2015.1134079; Xu J, 2016, GENES-BASEL, V7, DOI 10.3390/genes7100088; YAO TP, 1992, CELL, V71, P63, DOI 10.1016/0092-8674(92)90266-F; Yun HM, 2017, SCI REP-UK, V7, DOI 10.1038/srep44724; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zhang XB, 2011, BBA-MOL CELL RES, V1813, P1978, DOI 10.1016/j.bbamcr.2011.03.010; Zhao WL, 2014, J MOL ENDOCRINOL, V53, P93, DOI 10.1530/JME-14-0019; Zhao XF, 1998, INSECT BIOCHEM MOLEC, V28, P259, DOI 10.1016/S0965-1748(98)00015-0; Zhou XF, 2002, DEVELOPMENT, V129, P2259; Zhou Z, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/iev102	66	17	21	5	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2018	293	48					18613	18623		10.1074/jbc.RA118.004891	http://dx.doi.org/10.1074/jbc.RA118.004891			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NX	30305395	Green Published, hybrid			2022-12-28	WOS:000458467300016
J	Nguyen-Tu, MS; Xavier, GD; Leclerc, I; Rutter, GA				Nguyen-Tu, Marie-Sophie; Xavier, Gabriela da Silva; Leclerc, Isabelle; Rutter, Guy A.			Transcription factor-7-like 2 (TCF7L2) gene acts downstream of the Lkb1/Stk11 kinase to control mTOR signaling,beta cell growth, and insulin secretion (vol 293, pg 14178, 2018)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction														Leclerc, Isabelle/0000-0003-0044-7921; Rutter, Guy/0000-0001-6360-0343; da Silva Xavier, Gabriela/0000-0002-0678-012X	MRC [MR/K001981/1] Funding Source: UKRI; Medical Research Council [MR/K001981/1] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Nguyen-Tu MS, 2018, J BIOL CHEM, V293, P14178, DOI 10.1074/jbc.RA118.003613	1	0	0	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2018	293	47					18420	18420		10.1074/jbc.AAC118.006541	http://dx.doi.org/10.1074/jbc.AAC118.006541			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8XM	30470729	Green Published, hybrid			2022-12-28	WOS:000451375200034
J	Malik, R; Meng, H; Wongkongkathep, P; Corrales, CI; Sepanj, N; Atlasi, RS; Klarner, FG; Schrader, T; Spencer, MJ; Loo, JA; Wiedau, M; Bitan, G				Malik, Ravinder; Meng, Helen; Wongkongkathep, Piriya; Corrales, Christian I.; Sepanj, Niki; Atlasi, Ryan S.; Klaerner, Frank-Gerrit; Schrader, Thomas; Spencer, Melissa J.; Loo, Joseph A.; Wiedau, Martina; Bitan, Gal			The molecular tweezer CLR01 inhibits aberrant superoxide dismutase 1 (SOD1) self-assembly in vitro and in the G93A-SOD1 mouse model of ALS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						superoxide dismutase (SOD); amyotrophic lateral sclerosis (ALS) (Lou Gehrig disease); protein aggregation; mouse; inhibitor; neurodegeneration; amyloid; protein misfolding; molecular tweezer; motor neuron	AMYOTROPHIC-LATERAL-SCLEROSIS; FIBRIL FORMATION; PROTEIN; MICE; AGGREGATION; TOXICITY; STRATEGIES; PHENOTYPE; SURVIVAL; NEURONS	Mutations in superoxide dismutase 1 (SOD1) cause 15-20% of familial amyotrophic lateral sclerosis (fALS) cases. The resulting amino acid substitutions destabilize SOD1's protein structure, leading to its self-assembly into neurotoxic oligomers and aggregates, a process hypothesized to cause the characteristic motor-neuron degeneration in affected individuals. Currently, effective disease-modifying therapy is not available for ALS. Molecular tweezers prevent formation of toxic protein assemblies, yet their protective action has not been tested previously on SOD1 or in the context of ALS. Here, we tested the molecular tweezer CLR01-a broad-spectrum inhibitor of the self-assembly and toxicity of amyloid proteins-as a potential therapeutic agent for ALS. Using recombinant WT and mutant SOD1, we found that CLR01 inhibited the aggregation of all tested SOD1 forms in vitro. Next, we examined whether CLR01 could prevent the formation of misfolded SOD1 in the G93A-SOD1 mouse model of ALS and whether such inhibition would have a beneficial therapeutic effect. CLR01 treatment decreased misfolded SOD1 in the spinal cord significantly. However, these histological findings did not correlate with improvement of the disease phenotype. A small, dose-dependent decrease in disease duration was found in CLR01-treated mice, relative to vehicle-treated animals, yet motor function did not improve in any of the treatment groups. These results demonstrate that CLR01 can inhibit SOD1 misfolding and aggregation both in vitro and in vivo, but raise the question whether such inhibition is sufficient for achieving a therapeutic effect. Additional studies in other less aggressive ALS models may be needed to determine the therapeutic potential of this approach.	[Malik, Ravinder; Meng, Helen; Corrales, Christian I.; Sepanj, Niki; Atlasi, Ryan S.; Spencer, Melissa J.; Wiedau, Martina; Bitan, Gal] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Wongkongkathep, Piriya; Loo, Joseph A.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Loo, Joseph A.] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; [Spencer, Melissa J.; Wiedau, Martina; Bitan, Gal] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA; [Loo, Joseph A.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Klaerner, Frank-Gerrit; Schrader, Thomas] Univ Duisburg Essen, Fac Chem, D-47057 Essen, Germany	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Duisburg Essen	Wiedau, M; Bitan, G (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA.	mwiedau@mednet.ucla.edu; gbitan@mednet.ucla.edu	Wongkongkathep, Piriya/E-7139-2011; Bitan, Gal/U-2204-2019	Wongkongkathep, Piriya/0000-0003-0751-8622; Bitan, Gal/0000-0001-7046-3754	Judith and Jean Pape Adams Charitable Foundation; David Vickter Foundation; Prize4Life; RGK Foundation [20143057]; National Institutes of Health/NINDS F32 Fellowship [NS087858]; National Institutes of Health/NIAMS [P30 AR057230]; National Institutes of Health/NIGMS [R01 GM103479]; National Institutes of Health/NCRR [S10 RR028893]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057230] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM103479] Funding Source: NIH RePORTER	Judith and Jean Pape Adams Charitable Foundation; David Vickter Foundation; Prize4Life; RGK Foundation; National Institutes of Health/NINDS F32 Fellowship; National Institutes of Health/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Judith and Jean Pape Adams Charitable Foundation grant (to G. B.), the David Vickter Foundation (to M. W.), Prize4Life (to G. B. and M. W.), RGK Foundation Grant 20143057 (G. B.), National Institutes of Health/NINDS F32 Fellowship NS087858 (to C. F.), National Institutes of Health/NIAMS Grant P30 AR057230 (to M. J. S.), National Institutes of Health/NIGMS Grant R01 GM103479 (to J. A. L.), and National Institutes of Health/NCRR Grant S10 RR028893 (to J. A. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Acharya S, 2014, J BIOL CHEM, V289, P10727, DOI 10.1074/jbc.M113.524520; Atlasi RS, 2018, ACS CHEM BIOL, V13, P2794, DOI 10.1021/acschembio.8b00729; Attar A, 2014, CURR PHARM DESIGN, V20, P2469, DOI 10.2174/13816128113199990496; Attar A, 2014, BMC PHARMACOL TOXICO, V15, DOI 10.1186/2050-6511-15-23; Attar A, 2012, BRAIN, V135, P3735, DOI 10.1093/brain/aws289; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Brooks SP, 2009, NAT REV NEUROSCI, V10, P519, DOI 10.1038/nrn2652; Brotherton TE, 2012, P NATL ACAD SCI USA, V109, P5505, DOI 10.1073/pnas.1115009109; Capote J, 2016, J CELL BIOL, V213, P275, DOI 10.1083/jcb.201510086; Chattopadhyay M, 2008, P NATL ACAD SCI USA, V105, P18663, DOI 10.1073/pnas.0807058105; Chio A, 2013, NEUROEPIDEMIOLOGY, V41, P118, DOI 10.1159/000351153; Ferreira N, 2014, NEUROTHERAPEUTICS, V11, P450, DOI 10.1007/s13311-013-0256-8; Giehm L, 2010, ANAL BIOCHEM, V400, P270, DOI 10.1016/j.ab.2010.02.001; GRALLA EB, 1991, J BACTERIOL, V173, P5918, DOI 10.1128/jb.173.18.5918-5920.1991; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; HALLEWELL RA, 1987, BIO-TECHNOL, V5, P363, DOI 10.1038/nbt0487-363; Hayward LJ, 2002, J BIOL CHEM, V277, P15923, DOI 10.1074/jbc.M112087200; Heiman-Patterson TD, 2005, J NEUROL SCI, V236, P1, DOI 10.1016/j.jns.2005.02.006; Hilton JB, 2017, SCI REP-UK, V7, DOI 10.1038/srep42292; Ida M, 2016, J BIOCHEM, V159, P247, DOI 10.1093/jb/mvv091; Ivanova MI, 2014, P NATL ACAD SCI USA, V111, P197, DOI 10.1073/pnas.1320786110; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Kim RB, 2016, AMYOTROPH LAT SCL FR, V17, P1, DOI 10.3109/21678421.2015.1047455; Liu TY, 2012, CHEMMEDCHEM, V7, P359, DOI 10.1002/cmdc.201100585; Malik R, 2018, METHODS MOL BIOL, V1777, P369, DOI 10.1007/978-1-4939-7811-3_24; MARTIN D, 1993, EUR J PHARMACOL, V250, P473, DOI 10.1016/0014-2999(93)90037-I; Nichols NL, 2013, RESP PHYSIOL NEUROBI, V189, P429, DOI 10.1016/j.resp.2013.05.016; Nowak RJ, 2010, J MED CHEM, V53, P2709, DOI 10.1021/jm901062p; Nshanian M, 2019, J AM SOC MASS SPECTR, V30, P16, DOI 10.1007/s13361-018-2027-6; Prabhudesai S, 2012, NEUROTHERAPEUTICS, V9, P464, DOI 10.1007/s13311-012-0105-1; Rakhit R, 2006, BBA-MOL BASIS DIS, V1762, P1025, DOI 10.1016/j.bbadis.2006.05.004; Ratovitski T, 1999, HUM MOL GENET, V8, P1451, DOI 10.1093/hmg/8.8.1451; Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43; Richter F, 2017, NEUROTHERAPEUTICS, V14, P1107, DOI 10.1007/s13311-017-0544-9; ROGERS DR, 1965, AM J CLIN PATHOL, V44, P59; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Sawada H, 2017, EXPERT OPIN PHARMACO, V18, P735, DOI 10.1080/14656566.2017.1319937; Schrader T, 2016, CHEM COMMUN, V52, P11318, DOI 10.1039/c6cc04640a; Scott S, 2008, AMYOTROPH LATERAL SC, V9, P4, DOI 10.1080/17482960701856300; Siddique T, 2011, Acta Myol, V30, P117; Sinha S, 2012, ACS CHEM NEUROSCI, V3, P451, DOI 10.1021/cn200133x; Sinha S, 2011, J AM CHEM SOC, V133, P16958, DOI 10.1021/ja206279b; Sreedharan J, 2013, ANN NEUROL, V74, P309, DOI 10.1002/ana.24012; Talbiersky P, 2008, J AM CHEM SOC, V130, P9824, DOI 10.1021/ja801441j; Trippier PC, 2014, ACS CHEM NEUROSCI, V5, P823, DOI 10.1021/cn500147v; van Es MA, 2010, J NEUROL NEUROSUR PS, V81, P562, DOI 10.1136/jnnp.2009.181453; Vopel T, 2017, J AM CHEM SOC, V139, P5640, DOI 10.1021/jacs.6b11039; Wei JPJ, 2001, J BIOL CHEM, V276, P44798, DOI 10.1074/jbc.M104708200; Xia GY, 2011, J MED CHEM, V54, P2409, DOI 10.1021/jm101549k; Xu N, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006182; Zheng XY, 2015, J PHYS CHEM B, V119, P4831, DOI 10.1021/acs.jpcb.5b00692	52	20	20	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3501	3513		10.1074/jbc.RA118.005940	http://dx.doi.org/10.1074/jbc.RA118.005940			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30602569	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000461853900017
J	Murphy, JG; Hoffman, DA				Murphy, Jonathan G.; Hoffman, Dax A.			A polybasic motif in alternatively spliced KChIP2 isoforms prevents Ca2+ regulation of Kv4 channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						potassium channel; calcium; dendrite; patch clamp; ion channel; A-type current; EF hand protein; K channel interacting protein; voltage-gated channel	METAL-BINDING PROPERTIES; INTERACTING PROTEINS; POTASSIUM CHANNELS; K+ CHANNELS; ALPHA-SUBUNITS; DNA-BINDING; EXPRESSION; MODULATION; PALMITOYLATION; EXCITABILITY	The Kv4 family of A-type voltage-gated K+ channels regulates the excitability in hippocampal pyramidal neuron dendrites and are key determinants of dendritic integration, spike timing-dependent plasticity, long-term potentiation, and learning. Kv4.2 channel expression is down-regulated following hippocampal seizures and in epilepsy, suggesting A-type currents as therapeutic targets. In addition to pore-forming Kv4 subunits, modulatory auxiliary subunits called K+ channel-interacting proteins (KChIPs) modulate Kv4 expression and activity and are required to recapitulate native hippocampal A-type currents in heterologous expression systems. KChIP mRNAs contain multiple start sites and alternative exons that generate considerable N-terminal variation and functional diversity in shaping Kv4 currents. As members of the EF-hand domain-containing neuronal Ca2+ sensor protein family, KChIP auxiliary proteins may convey Ca2+ sensitivity upon Kv4 channels; however, to what degree intracellular Ca2+ regulates KChIP-Kv4.2 complexes is unclear. To answer this question, we expressed KChIP2 with Kv4.2 in HEK293T cells, and, with whole-cell patch-clamp electrophysiology, measured an approximate to 1.5-fold increase in Kv4.2 current density in the presence of elevated intracellular Ca2+. Intriguingly, the Ca2+ regulation of Kv4 current was specific to KChIP2b and KChIP2c splice isoforms that lack a putative polybasic domain that is present in longer KChIP2a1 and KChIP2a isoforms. Site-directed acidification of the basic residues within the polybasic motif of KChIP2a1 rescued Ca2+-mediated regulation of Kv4 current density. These results support divergent Ca2+ regulation of Kv4 channels mediated by alternative splicing of KChIP2 isoforms. They suggest that distinct KChIP-Kv4 interactions may differentially control excitability and function of hippocampal dendrites.	[Murphy, Jonathan G.] NIGMS, Bethesda, MD 20892 USA; [Murphy, Jonathan G.; Hoffman, Dax A.] NICHD, Sect Mol Neurophysiol, NIH, Rm 3C-905,Bldg 35,35 Lincoln Dr, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of General Medical Sciences (NIGMS); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Hoffman, DA (corresponding author), NICHD, Sect Mol Neurophysiol, NIH, Rm 3C-905,Bldg 35,35 Lincoln Dr, Bethesda, MD 20892 USA.; Murphy, JG (corresponding author), NIGMS, NIH, Rm 3C-908,Bldg 35,35 Lincoln Dr, Bethesda, MD 20892 USA.	jonathan.murphy@nih.gov; hoffmand@mail.nih.gov	Murphy, Jonathan/AAD-6655-2019; Hoffman, Dax/E-5155-2011	Murphy, Jonathan/0000-0001-6485-5727; Hoffman, Dax/0000-0001-6999-2157	National Institutes of Health Intramural Funds [FI2 GM120004]; NIGMS [Z01 HD008755]; NICHD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [FI2GM120004] Funding Source: NIH RePORTER	National Institutes of Health Intramural Funds(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Intramural Funds FI2 GM120004 from NIGMS (to J. G. M.) and Z01 HD008755 from NICHD (to D. A. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Anderson D, 2010, NAT NEUROSCI, V13, P333, DOI 10.1038/nn.2493; Bahring R, 2018, CHANNELS, V12, P187, DOI 10.1080/19336950.2018.1491243; Bahring R, 2001, J BIOL CHEM, V276, P23888, DOI 10.1074/jbc.M101320200; Barnwell LFS, 2009, EPILEPSIA, V50, P1741, DOI 10.1111/j.1528-1167.2009.02086.x; Beck EJ, 2002, J PHYSIOL-LONDON, V538, P691, DOI 10.1113/jphysiol.2001.013127; Ben-Johny M, 2014, CELL, V157, P1657, DOI 10.1016/j.cell.2014.04.035; Bernard C, 2004, SCIENCE, V305, P532, DOI 10.1126/science.1097065; Cembrowski MS, 2016, ELIFE, V5, DOI 10.7554/eLife.14997; Chang LS, 2003, BIOCHEM BIOPH RES CO, V311, P258, DOI 10.1016/j.bbrc.2003.09.204; Chen CP, 2006, PROTEIN J, V25, P345, DOI 10.1007/s10930-006-9020-9; Chen XX, 2006, J NEUROSCI, V26, P12143, DOI 10.1523/JNEUROSCI.2667-06.2006; Craig TA, 2002, J BIOL CHEM, V277, P10955, DOI 10.1074/jbc.M109660200; Foeger NC, 2010, J BIOL CHEM, V285, P33413, DOI 10.1074/jbc.M110.145185; Gebauer M, 2004, BIOPHYS J, V86, P210, DOI 10.1016/S0006-3495(04)74097-7; Gonzalez WG, 2014, J BIOL CHEM, V289, P32201, DOI 10.1074/jbc.M114.577528; Groen C, 2017, PFLUG ARCH EUR J PHY, V469, P1457, DOI 10.1007/s00424-017-2039-2; Hasdemir B, 2005, J CELL BIOL, V171, P459, DOI 10.1083/jcb.200506005; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Jeffries O, 2012, J BIOL CHEM, V287, P1468, DOI 10.1074/jbc.M111.224840; Jerng HH, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00082; Jerng HH, 2008, J BIOL CHEM, V283, P36046, DOI 10.1074/jbc.M806852200; Jerng HH, 2005, J PHYSIOL-LONDON, V568, P767, DOI 10.1113/jphysiol.2005.087858; Johnston D, 2003, PHILOS T ROY SOC B, V358, P667, DOI 10.1098/rstb.2002.1248; Kim J, 2005, J PHYSIOL-LONDON, V569, P41, DOI 10.1113/jphysiol.2005.095042; Kunjilwar K, 2013, J NEUROCHEM, V126, P462, DOI 10.1111/jnc.12309; Lee L, 2009, PROTEIN PEPTIDE LETT, V16, P1081, DOI 10.2174/092986609789055368; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Liang P, 2009, J BIOL CHEM, V284, P4960, DOI 10.1074/jbc.M807704200; Licatalosi DD, 2006, NEURON, V52, P93, DOI 10.1016/j.neuron.2006.09.017; Lin L, 2011, J NEUROSCI, V31, P1323, DOI 10.1523/JNEUROSCI.5383-10.2011; Lin YL, 2004, BIOCHEM BIOPH RES CO, V321, P606, DOI 10.1016/j.bbrc.2004.07.006; Lipscombe D, 2005, CURR OPIN NEUROBIOL, V15, P358, DOI 10.1016/j.conb.2005.04.002; Lockridge A, 2011, HIPPOCAMPUS, V21, P1152, DOI 10.1002/hipo.20877; Lusin JD, 2008, BIOCHEMISTRY-US, V47, P2252, DOI 10.1021/bi7017267; Marionneau C, 2009, CHANNELS, V3, P284; Matthews EA, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00048; Morohashi Y, 2002, J BIOL CHEM, V277, P14965, DOI 10.1074/jbc.M200897200; Nadal MS, 2003, NEURON, V37, P449, DOI 10.1016/S0896-6273(02)01185-6; Osawa M, 2005, J BIOL CHEM, V280, P18008, DOI 10.1074/jbc.M500338200; Piazza M, 2017, BIOCHEMISTRY-US, V56, P944, DOI 10.1021/acs.biochem.6b01296; Pioletti M, 2006, NAT STRUCT MOL BIOL, V13, P987, DOI 10.1038/nsmb1164; Pruunsild P, 2005, GENOMICS, V86, P581, DOI 10.1016/j.ygeno.2005.07.001; Ramachandran PL, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.398495; Ramakers GMJ, 2002, P NATL ACAD SCI USA, V99, P10144, DOI 10.1073/pnas.152620399; Rhodes KJ, 2004, J NEUROSCI, V24, P7903, DOI 10.1523/JNEUROSCI.0776-04.2004; Scannevin RH, 2004, NEURON, V41, P587, DOI 10.1016/S0896-6273(04)00049-2; Serodio P, 1998, J NEUROPHYSIOL, V79, P1081, DOI 10.1152/jn.1998.79.2.1081; SERODIO P, 1994, J NEUROPHYSIOL, V72, P1516, DOI 10.1152/jn.1994.72.4.1516; Shibata R, 2003, J BIOL CHEM, V278, P36445, DOI 10.1074/jbc.M306142200; Takimoto K, 2002, J BIOL CHEM, V277, P26904, DOI 10.1074/jbc.M203651200; Wang HY, 2007, NAT NEUROSCI, V10, P32, DOI 10.1038/nn1822; Wang K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139332; Wang K, 2014, NEURON, V81, P379, DOI 10.1016/j.neuron.2013.11.004; Yao JJ, 2016, J BIOL CHEM, V291, P17369, DOI 10.1074/jbc.M115.708883	55	5	5	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3683	3695		10.1074/jbc.RA118.006549	http://dx.doi.org/10.1074/jbc.RA118.006549			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30622142	Green Published, hybrid			2022-12-28	WOS:000461853900030
J	Batchelor, M; Wolny, M; Baker, EG; Paci, E; Kalverda, AP; Peckham, M				Batchelor, Matthew; Wolny, Marcin; Baker, Emily G.; Paci, Emanuele; Kalverda, Arnout P.; Peckham, Michelle			Dynamic ion pair behavior stabilizes single -helices in proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytoskeleton; myosin; protein conformation; molecular dynamics; protein domain; NMR; alpha-helix; nuclear magnetic resonance; salt bridges	HETERONUCLEAR NMR-SPECTROSCOPY; NUCLEAR-MAGNETIC-RESONANCE; ARGININE SIDE-CHAINS; X-RAY SOLUTION; CHEMICAL-SHIFT; ALPHA-HELICES; SALT BRIDGES; HYDROGEN-BONDS; ASSIGNMENT; DOMAIN	Ion pairs are key stabilizing interactions between oppositely charged amino acid side chains in proteins. They are often depicted as single conformer salt bridges (hydrogen-bonded ion pairs) in crystal structures, but it is unclear how dynamic they are in solution. Ion pairs are thought to be particularly important in stabilizing single -helix (SAH) domains in solution. These highly stable domains are rich in charged residues (such as Arg, Lys, and Glu) with potential ion pairs across adjacent turns of the helix. They provide a good model system to investigate how ion pairs can contribute to protein stability. Using NMR spectroscopy, small-angle X-ray light scattering (SAXS), and molecular dynamics simulations, we provide here experimental evidence that ion pairs exist in a SAH in murine myosin 7a (residues 858-935), but that they are not fixed or long lasting. In silico modeling revealed that the ion pairs within this -helix exhibit dynamic behavior, rapidly forming and breaking and alternating between different partner residues. The low-energy helical state was compatible with a great variety of ion pair combinations. Flexible ion pair formation utilizing a subset of those available at any one time avoided the entropic penalty of fixing side chain conformations, which likely contributed to helix stability overall. These results indicate the dynamic nature of ion pairs in SAHs. More broadly, thermodynamic stability in other proteins is likely to benefit from the dynamic behavior of multi-option solvent-exposed ion pairs.	[Batchelor, Matthew; Wolny, Marcin; Paci, Emanuele; Kalverda, Arnout P.; Peckham, Michelle] Univ Leeds, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England; [Batchelor, Matthew; Wolny, Marcin; Paci, Emanuele; Kalverda, Arnout P.; Peckham, Michelle] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England; [Baker, Emily G.] Univ Bristol, Sch Chem, Bristol BS8 1TS, Avon, England	University of Leeds; University of Leeds; University of Bristol	Peckham, M (corresponding author), Univ Leeds, Fac Biol Sci, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England.	m.peckham@leeds.ac.uk	Peckham, Michelle/J-4991-2015; Paci, Emanuele/B-1893-2010	Peckham, Michelle/0000-0002-3754-2028; Paci, Emanuele/0000-0002-4891-2768; Wolny, Marcin/0000-0003-1030-7607; Batchelor, Matthew/0000-0001-6338-5698	Wellcome Trust [FC001029, WT094232]; University of Leeds; Cancer Research UK [FC001029]; UK Medical Research Council [FC001029]; Francis Crick Institute; BBSRC [BB/M005615/1, BB/I007423/1, BB/M009114/1] Funding Source: UKRI; MRC [MC_U117533887] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); University of Leeds; Cancer Research UK(Cancer Research UK); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Francis Crick Institute; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Chi Trinh and Sam Hickman (University of Leeds) collected SAXS data. We thank Derek N. Woolfson (University of Bristol) for facilitating AUC measurements and Peter J. Knight (University of Leeds) for useful discussions on the paper. This work was undertaken on ARC2, part of the High Performance Computing facilities at the University of Leeds. The Wellcome Trust (WT094232) funded the CD spectropolarimeter. For access to the 950-MHz spectrometers, we acknowledge the Astbury BioStructure Laboratory BioNMR Facility, which was funded by the University of Leeds, and the Francis Crick Institute through provision of access to the MRC Biomedical NMR Centre. The Francis Crick Institute receives its core funding from Cancer Research UK (FC001029), the UK Medical Research Council (FC001029), and the Wellcome Trust (FC001029).	Ahlner A, 2013, J BIOMOL NMR, V56, P191, DOI 10.1007/s10858-013-9737-7; Ahmed MC, 2018, PEERJ, V6, DOI 10.7717/peerj.4967; Baker EG, 2015, NAT CHEM BIOL, V11, P221, DOI 10.1038/nchembio.1739; Batchelor M, 2015, BIOCHEM SOC T, V43, P58, DOI 10.1042/BST20140302; Bermel W, 2006, J AM CHEM SOC, V128, P3918, DOI 10.1021/ja0582206; Bermel W, 2013, J BIOMOL NMR, V55, P231, DOI 10.1007/s10858-013-9704-3; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Birdsall B, 2000, BIOCHEMISTRY-US, V39, P9819, DOI 10.1021/bi000728s; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Camilloni C, 2012, BIOCHEMISTRY-US, V51, P2224, DOI 10.1021/bi3001825; Carter P, 2003, NUCLEIC ACIDS RES, V31, P3293, DOI 10.1093/nar/gkg626; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P29, DOI 10.1016/B978-012164491-8/50004-X; Cordier F, 1999, J AM CHEM SOC, V121, P1601, DOI 10.1021/ja983945d; Cordier F, 2008, NAT PROTOC, V3, P235, DOI 10.1038/nprot.2007.498; Nguyen D, 2017, BIOCHEMISTRY-US, V56, P5866, DOI 10.1021/acs.biochem.7b00885; Debiec KT, 2014, J PHYS CHEM B, V118, P6561, DOI 10.1021/jp500958r; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Favier A, 2011, J BIOMOL NMR, V49, P9, DOI 10.1007/s10858-010-9461-5; Gaspari Z, 2012, BBA-PROTEINS PROTEOM, V1824, P637, DOI 10.1016/j.bbapap.2012.01.012; Gerecht K, 2017, CHEM COMMUN, V53, P10062, DOI 10.1039/c7cc04821a; Ghosh T, 2003, BIOPHYS J, V85, P3187, DOI 10.1016/S0006-3495(03)74736-5; Gorbet G, 2014, BIOPHYS J, V106, P1741, DOI 10.1016/j.bpj.2014.02.022; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; GRZESIEK S, 1993, J MAGN RESON SER B, V101, P114, DOI 10.1006/jmrb.1993.1019; Helmus JJ, 2013, J BIOMOL NMR, V55, P355, DOI 10.1007/s10858-013-9718-x; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iwahara J, 2007, J AM CHEM SOC, V129, P2971, DOI 10.1021/ja0683436; Jie J, 2015, J BIOL CHEM, V290, P23863, DOI 10.1074/jbc.M115.649715; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KAY LE, 1990, J MAGN RESON, V89, P496, DOI 10.1016/0022-2364(90)90333-5; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Knight PJ, 2005, J BIOL CHEM, V280, P34702, DOI 10.1074/jbc.M504887200; Lang PT, 2010, PROTEIN SCI, V19, P1420, DOI 10.1002/pro.423; Lescop E, 2007, J MAGN RESON, V187, P163, DOI 10.1016/j.jmr.2007.04.002; Li JC, 2017, STRUCTURE, V25, P579, DOI 10.1016/j.str.2017.02.002; Linge JP, 2003, BIOINFORMATICS, V19, P315, DOI 10.1093/bioinformatics/19.2.315; Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2; Liu AZ, 2000, J BIOMOL NMR, V17, P305, DOI 10.1023/A:1008390813387; Lu Q, 2012, P NATL ACAD SCI USA, V109, P17388, DOI 10.1073/pnas.1208642109; Mackenzie HW, 2017, J BIOMOL NMR, V69, P123, DOI 10.1007/s10858-017-0137-2; MARION D, 1989, J AM CHEM SOC, V111, P1515, DOI 10.1021/ja00186a066; MONTELIONE GT, 1992, J AM CHEM SOC, V114, P10974, DOI 10.1021/ja00053a051; Niklasson M, 2017, J BIOMOL NMR, V69, P93, DOI 10.1007/s10858-017-0141-6; Nilges M, 1997, J MOL BIOL, V269, P408, DOI 10.1006/jmbi.1997.1044; ODA Y, 1994, BIOCHEMISTRY-US, V33, P5275, DOI 10.1021/bi00183a034; PASCAL SM, 1995, BIOCHEMISTRY-US, V34, P11353, DOI 10.1021/bi00036a008; Peckham M, 2009, SOFT MATTER, V5, P2493, DOI 10.1039/b822339d; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Piana S, 2011, BIOPHYS J, V100, pL47, DOI 10.1016/j.bpj.2011.03.051; Platzer G, 2014, J BIOMOL NMR, V60, P109, DOI 10.1007/s10858-014-9862-y; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Ropars V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12456; Schwarzinger S, 2001, J AM CHEM SOC, V123, P2970, DOI 10.1021/ja003760i; Seeber M, 2011, J COMPUT CHEM, V32, P1183, DOI 10.1002/jcc.21688; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105; Shen Y, 2009, J BIOMOL NMR, V43, P63, DOI 10.1007/s10858-008-9288-5; Simm D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174639; Simm D, 2015, BIOINFORMATICS, V31, P767, DOI 10.1093/bioinformatics/btu700; Sivaramakrishnan S, 2008, P NATL ACAD SCI USA, V105, P13356, DOI 10.1073/pnas.0806256105; Solyom Z, 2013, J BIOMOL NMR, V55, P311, DOI 10.1007/s10858-013-9715-0; Spink BJ, 2008, NAT STRUCT MOL BIOL, V15, P591, DOI 10.1038/nsmb.1429; Suveges D, 2009, PROTEINS, V74, P905, DOI 10.1002/prot.22183; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Swanson CJ, 2014, J BIOL CHEM, V289, P25460, DOI 10.1074/jbc.R114.583906; Tollinger M, 2002, J AM CHEM SOC, V124, P5714, DOI 10.1021/ja020066p; Tomlinson JH, 2009, J AM CHEM SOC, V131, P4674, DOI 10.1021/ja808223p; Trbovic N, 2009, J AM CHEM SOC, V131, P615, DOI 10.1021/ja806475k; Ulrich AKC, 2016, STRUCTURE, V24, P1972, DOI 10.1016/j.str.2016.09.007; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; WAGNER G, 1983, J AM CHEM SOC, V105, P5948, DOI 10.1021/ja00356a056; Werbeck ND, 2013, ANGEW CHEM INT EDIT, V52, P3145, DOI 10.1002/anie.201209385; Williamson MP, 2013, CHEM COMMUN, V49, P9824, DOI 10.1039/c3cc45602a; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q; Wolny M, 2017, SCI REP-UK, V7, DOI 10.1038/srep44341; Wolny M, 2014, J BIOL CHEM, V289, P27825, DOI 10.1074/jbc.M114.585679; Worrall JAR, 2002, BIOCHEMISTRY-US, V41, P11721, DOI 10.1021/bi026296y; Yoshimura Y, 2017, ANGEW CHEM INT EDIT, V56, P239, DOI 10.1002/anie.201609605; Zandarashvili L, 2016, J PHYS CHEM LETT, V7, P820, DOI 10.1021/acs.jpclett.6b00019; Zandarashvili L, 2011, J AM CHEM SOC, V133, P9192, DOI 10.1021/ja202219n	81	6	6	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2019	294	9					3219	3234		10.1074/jbc.RA118.006752	http://dx.doi.org/10.1074/jbc.RA118.006752			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU0SA	30593502	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000464980100020
J	Tirumuru, N; Wu, L				Tirumuru, Nagaraja; Wu, Li			HIV-1 envelope proteins up-regulate N-6-methyladenosine levels of cellular RNA independently of viral replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						human immunodeficiency virus (HIV); infection; RNA methylation; gene expression; gene regulation; RNA modification; CD4+T-cells; HIV-1 envelope proteins; HIV-1 production; recombinant gp120; up-regulation	HUMAN-IMMUNODEFICIENCY-VIRUS; M(6)A METHYLTRANSFERASE; MONOCLONAL-ANTIBODIES; MESSENGER-RNAS; DC-SIGN; EXPRESSION; N6-METHYLADENOSINE; TYPE-1; CD4; IDENTIFICATION	N-6-methyladenosine (m(6)A) modification of HIV-1 RNA regulates viral replication and protein expression. The m(6)A modification is regulated by two groups of cellular proteins named writers and erasers that add or remove m(6)A, respectively. HIV-1 infection of CD4(+) T-cells increases m(6)A levels of cellular mRNA, but the underlying mechanism is unknown. Here, we show that HIV-1 infection of CD4(+) primary T-cells or Jurkat cells significantly increases m(6)A levels of cellular RNA independently of viral replication. Compared with HIV-1-infected CD4(+) T-cells, similar m(6)A up-regulation was detected in total RNA from HIV-1-infected cells treated with a reverse-transcriptase inhibitor or with heat-inactivated HIV-1. Compared with mock controls, significantly increased m(6)A levels were detected in total RNA from Jurkat cells infected by single-cycle HIV-1 pseudotyped with an HIV-1 envelope (Env) glycoprotein, but not with vesicular stomatitis virus glycoprotein G (VSV-G). Overexpression of HIV-1 Env in HEK293T cells did not affect m(6)A levels of cellular RNA, suggesting that de novo synthesis of Env is not required for m(6)A up-regulation. Interestingly, treatment of Jurkat cells with recombinant gp120 of HIV-1 Env significantly increased m(6)A levels of cellular RNA, which was reduced by a gp120-neutralizing antibody. Preincubation of Jurkat cells with a CD4 receptor-neutralizing antibody blocked HIV-1-induced up-regulation of m(6)A levels in cellular RNA. Moreover, HIV-1 infection or gp120 treatment did not alter the protein expression of m(6)A writers and erasers in cells. Our findings suggest that HIV-1 gp120 binding to the CD4 receptor is required for m(6)A up-regulation in cells.	[Tirumuru, Nagaraja; Wu, Li] Ohio State Univ, Ctr Retrovirus Res, Dept Vet Biosci, 1900 Coffey Rd, Columbus, OH 43210 USA; [Tirumuru, Nagaraja; Wu, Li] Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Wu, L (corresponding author), Ohio State Univ, Ctr Retrovirus Res, Dept Vet Biosci, 1900 Coffey Rd, Columbus, OH 43210 USA.	wu.840@osu.edu	Wu, Li/ABB-2813-2020	Wu, Li/0000-0002-5468-2487	National Institutes of Health [GM128212, AI120209]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM128212] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM128212 and AI120209 (to L. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BEEMON K, 1977, J MOL BIOL, V113, P165, DOI 10.1016/0022-2836(77)90047-X; Brocard M, 2017, J GEN VIROL, V98, P2207, DOI 10.1099/jgv.0.000910; BURTON DR, 1991, P NATL ACAD SCI USA, V88, P10134, DOI 10.1073/pnas.88.22.10134; CANAANI D, 1979, NUCLEIC ACIDS RES, V6, P2879, DOI 10.1093/nar/6.8.2879; Checkley MA, 2011, J MOL BIOL, V410, P582, DOI 10.1016/j.jmb.2011.04.042; Chen SL, 2018, P NATL ACAD SCI USA, V115, pE3798, DOI 10.1073/pnas.1801213115; Chung NPY, 2010, J BIOL CHEM, V285, P2100, DOI 10.1074/jbc.M109.030619; Clark WC, 2016, RNA, V22, P1771, DOI 10.1261/rna.056531.116; CUMMINS LM, 1991, BLOOD, V77, P1111; DREYER EB, 1990, SCIENCE, V248, P364, DOI 10.1126/science.2326646; Fantuzzi L, 2004, J VIROL, V78, P9763, DOI 10.1128/JVI.78.18.9763-9772.2004; Freed EO, 2015, NAT REV MICROBIOL, V13, P484, DOI 10.1038/nrmicro3490; Fu Y, 2014, NAT REV GENET, V15, P293, DOI 10.1038/nrg3724; Gelais CS, 2015, AIDS RES HUM RETROV, V31, P806, DOI [10.1089/aid.2014.0313, 10.1089/AID.2014.0313]; Gelais CS, 2014, J VIROL, V88, P5834, DOI 10.1128/JVI.00155-14; Goff SP, 2007, NAT REV MICROBIOL, V5, P253, DOI 10.1038/nrmicro1541; Gokhale NS, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006188; HASHIMOTO S, 1976, J VIROL, V20, P425, DOI 10.1128/JVI.20.2.425-435.1976; Herbein G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-34; HERRIN DL, 1988, BIOTECHNIQUES, V6, P196; Janas Alicia M, 2009, Curr Protoc Cell Biol, VChapter 26, DOI 10.1002/0471143030.cb2605s43; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Kennedy EM, 2017, J VIROL, V91, DOI 10.1128/JVI.02263-16; Kennedy EM, 2016, CELL HOST MICROBE, V19, P675, DOI 10.1016/j.chom.2016.04.002; Kinter AL, 2003, J IMMUNOL, V170, P2449, DOI 10.4049/jimmunol.170.5.2449; KRUG RM, 1976, J VIROL, V20, P45, DOI 10.1128/JVI.20.1.45-53.1976; Lichinchi G, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.11, 10.1038/nmicrobiol.2016.11]; Lu WX, 2018, J BIOL CHEM, V293, P12992, DOI 10.1074/jbc.RA118.004215; MCCALLUS DE, 1992, VIRAL IMMUNOL, V5, P163, DOI 10.1089/vim.1992.5.163; Melikyan GB, 2017, J BIOL CHEM, V292, P16511, DOI 10.1074/jbc.H117.791731; Meyer KD, 2017, ANNU REV CELL DEV BI, V33, P319, DOI 10.1146/annurev-cellbio-100616-060758; Meyer KD, 2014, NAT REV MOL CELL BIO, V15, P313, DOI 10.1038/nrm3785; Mishima E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143756; Moir S, 2011, ANNU REV PATHOL-MECH, V6, P223, DOI 10.1146/annurev-pathol-011110-130254; MORIKAWA Y, 1990, AIDS RES HUM RETROV, V6, P765, DOI 10.1089/aid.1990.6.765; ORAVECZ T, 1993, AIDS RES HUM RETROV, V9, P945, DOI 10.1089/aid.1993.9.945; Pendleton KE, 2017, CELL, V169, P824, DOI 10.1016/j.cell.2017.05.003; Riquelme-Barrios S, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2018.00576; Roundtree IA, 2017, CELL, V169, P1187, DOI 10.1016/j.cell.2017.05.045; Santosuosso M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018465; Tan B, 2018, REV MED VIROL, V28, DOI 10.1002/rmv.1983; Tirumuru N, 2016, ELIFE, V5, DOI [10.7554/eLife.15528, 10.7554/eLife.31482]; Wang CY, 2016, JOVE-J VIS EXP, DOI 10.3791/54672; Warda AS, 2017, EMBO REP, V18, P2004, DOI 10.15252/embr.201744940; Wilen CB, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006866; Wu L, 2002, J VIROL, V76, P5905, DOI 10.1128/JVI.76.12.5905-5914.2002; Wu YT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000520	48	18	21	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2019	294	9					3249	3260		10.1074/jbc.RA118.005608	http://dx.doi.org/10.1074/jbc.RA118.005608			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU0SA	30617182	Green Published, hybrid			2022-12-28	WOS:000464980100022
J	Nagashima, A; Higaki, T; Koeduka, T; Ishigami, K; Hosokawa, S; Watanabe, H; Matsui, K; Hasezawa, S; Touhara, K				Nagashima, Ayumi; Higaki, Takumi; Koeduka, Takao; Ishigami, Ken; Hosokawa, Satoko; Watanabe, Hidenori; Matsui, Kenji; Hasezawa, Seiichiro; Touhara, Kazushige			Transcriptional regulators involved in responses to volatile organic compounds in plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						receptor; plant biochemistry; ligand-binding protein; transcription regulation; transcription corepressor; odorant; chemical sensing; plant volatile perception; volatile organic compounds (VOCs); defense induction; transcriptional co-repressor protein; transcription factor; gene regulation; olfaction	METHYL JASMONATE; TOPLESS; COMMUNICATION; GENOME; GENES; REPRESSION; RESISTANCE; INDUCTION; NEMATODES; EVOLUTION	Field studies have shown that plants growing next to herbivore-infested plants acquire higher resistance to herbivore damage. This increased resistance is partly due to regulation of plant gene expression by volatile organic compounds (VOCs) released by plants that sense environmental challenges such as herbivores. The molecular basis for VOC sensing in plants, however, is poorly understood. Here, we report the identification of TOPLESS-like proteins (TPLs) that have VOC-binding activity and are involved in VOC sensing in tobacco. While screening for volatiles that induce stress-responsive gene expression in tobacco BY-2 cells and tobacco plants, we found that some sesquiterpenes induce the expression of stress-responsive genes. These results provided evidence that plants sense these VOCs and motivated us to analyze the mechanisms underlying volatile sensing using tobacco as a model system. Using a pulldown assay with caryophyllene derivative-linked beads, we identified TPLs as transcriptional co-repressors that bind volatile caryophyllene analogs. Overexpression of TPLs in cultured BY-2 cells or tobacco leaves reduced caryophyllene-induced gene expression, indicating that TPLs are involved in the responses to caryophyllene analogs in tobacco. We propose that unlike animals, which use membrane receptors for sensing odorants, a transcriptional co-repressor plays a role in sensing and mediating VOC signals in plant cells.	[Nagashima, Ayumi; Ishigami, Ken; Hosokawa, Satoko; Watanabe, Hidenori; Touhara, Kazushige] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo 2778562, Japan; [Nagashima, Ayumi; Touhara, Kazushige] Univ Tokyo, Japan Sci & Technol Agcy JST, ERATO Touhara Chemosensory Signal Project, Tokyo 2778562, Japan; [Higaki, Takumi; Hasezawa, Seiichiro] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Tokyo 2778562, Japan; [Koeduka, Takao; Matsui, Kenji] Yamaguchi Univ, Fac Agr, Dept Biol Chem, Yamaguchi 7538515, Japan; [Koeduka, Takao; Matsui, Kenji] Yamaguchi Univ, Grad Sch Sci & Technol Innovat, Div Agr Sci, Yamaguchi 7538515, Japan; [Touhara, Kazushige] Univ Tokyo, Inst Adv Study, Int Res Ctr Neurointelligence WPI IRCN, Tokyo 1130033, Japan; [Nagashima, Ayumi] Tokyo Inst Technol, Ctr Biol Resources & Informat, Yokohama, Kanagawa 2268501, Japan; [Higaki, Takumi] Kumamoto Univ, Int Res Org Adv Sci & Technol, Kumamoto 8608555, Japan; [Ishigami, Ken] Tokyo Univ Agr, Fac Life Sci, Dept Chem Life Sci & Agr, Tokyo 1568502, Japan	University of Tokyo; Japan Science & Technology Agency (JST); University of Tokyo; University of Tokyo; Yamaguchi University; Yamaguchi University; University of Tokyo; Tokyo Institute of Technology; Kumamoto University; Tokyo University of Agriculture	Touhara, K (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo 1138657, Japan.	ktouhara@mail.ecc.u-tokyo.ac.jp	Ishigami, Ken/V-8090-2019	Ishigami, Ken/0000-0002-6917-1532; Nagashima, Ayumi/0000-0002-0736-0928; Touhara, Kazushige/0000-0001-7856-0786	ERATO Touhara Chemosensory Signal Project from the Japan Science and Technology Agency (JST), Japan [JPMJER1202]; Ministry of Education, Culture, Sports, Science, and Technology, Japan	ERATO Touhara Chemosensory Signal Project from the Japan Science and Technology Agency (JST), Japan(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by the ERATO Touhara Chemosensory Signal Project from the Japan Science and Technology Agency (JST), Japan (Grant JPMJER1202) and by a Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (to K. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Adebesin F, 2017, SCIENCE, V356, P1386, DOI 10.1126/science.aan0826; Arimura G, 2000, NATURE, V406, P512, DOI 10.1038/35020072; Banks JA, 2011, SCIENCE, V332, P960, DOI 10.1126/science.1203810; Causier B, 2012, PLANT SIGNAL BEHAV, V7, P325, DOI 10.4161/psb.19283; Causier B, 2012, PLANT PHYSIOL, V158, P423, DOI 10.1104/pp.111.186999; De Moraes CM, 2001, NATURE, V410, P577, DOI 10.1038/35069058; Degenhardt J, 2009, P NATL ACAD SCI USA, V106, P13213, DOI 10.1073/pnas.0906365106; Delphia CM, 2007, J CHEM ECOL, V33, P997, DOI 10.1007/s10886-007-9273-6; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; FARMER EE, 1990, P NATL ACAD SCI USA, V87, P7713, DOI 10.1073/pnas.87.19.7713; Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551; Heil M, 2010, TRENDS ECOL EVOL, V25, P137, DOI 10.1016/j.tree.2009.09.010; Imanishi S, 1998, PLANT MOL BIOL, V38, P1101, DOI 10.1023/A:1006058700949; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Ki SW, 2000, J BIOL CHEM, V275, P39231, DOI 10.1074/jbc.M006192200; Komsta L., 2011, TESTS OUTLIERS R PAC; LAWTON K, 1992, PLANT MOL BIOL, V19, P735, DOI 10.1007/BF00027070; Libault M, 2009, PLANT PHYSIOL, V151, P991, DOI 10.1104/pp.109.144105; Matsui K, 2016, CURR OPIN PLANT BIOL, V32, P24, DOI 10.1016/j.pbi.2016.05.005; Mirabella R, 2015, PLANT J, V83, P1082, DOI 10.1111/tpj.12953; Muller P, 2000, TETRAHEDRON, V56, P1725, DOI 10.1016/S0040-4020(00)00076-4; NAGATA T, 1992, INT REV CYTOL, V132, P1, DOI 10.1016/S0074-7696(08)62452-3; Nakagawa T, 2007, BIOSCI BIOTECH BIOCH, V71, P2095, DOI 10.1271/bbb.70216; Pauwels L, 2010, NATURE, V464, P788, DOI 10.1038/nature08854; Perez AC, 2013, PLANT CELL ENVIRON, V36, P2071, DOI 10.1111/pce.12121; Petre B, 2015, MOL PLANT MICROBE IN, V28, P689, DOI 10.1094/MPMI-01-15-0003-R; Rasmann S, 2005, NATURE, V434, P732, DOI 10.1038/nature03451; RCore Team, 2017, R LANG ENV STAT COMP; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Runyon JB, 2006, SCIENCE, V313, P1964, DOI 10.1126/science.1131371; Seol W, 1996, SCIENCE, V272, P1336, DOI 10.1126/science.272.5266.1336; Shulaev V, 1997, NATURE, V385, P718, DOI 10.1038/385718a0; Subramanyam K, 2012, PLANTA, V236, P1909, DOI 10.1007/s00425-012-1733-8; Szemenyei H, 2008, SCIENCE, V319, P1384, DOI 10.1126/science.1151461; Taddese B, 2014, PLANT PHYSIOL, V164, P287, DOI 10.1104/pp.113.228874; Ton J, 2007, PLANT J, V49, P16, DOI 10.1111/j.1365-313X.2006.02935.x; Widhalm JR, 2015, TRENDS PLANT SCI, V20, P545, DOI 10.1016/j.tplants.2015.06.009; Zou An, 2015, Nucl Receptor Res, V2	39	29	30	4	60	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2019	294	7					2256	2266		10.1074/jbc.RA118.005843	http://dx.doi.org/10.1074/jbc.RA118.005843			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL7CN	30593507	hybrid, Green Published			2022-12-28	WOS:000458895400005
J	Yan, YH; Zhou, AW; Carrell, RW; Read, RJ				Yan, Yahui; Zhou, Aiwu; Carrell, Robin W.; Read, Randy J.			Structural basis for the specificity of renin-mediated angiotensinogen cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						renin angiotensin system; serpin; crystal structure; conformational change; site-directed mutagenesis; kinetics; proteolysis; aspartic protease; hypertension; angiotensinogen	CORTICOSTEROID-BINDING GLOBULIN; AMINO-ACID-RESIDUES; SPECIES-SPECIFICITY; CRYSTAL-STRUCTURES; TRANSGENIC MICE; GLYCOSYLATION; MECHANISM; KINETICS; SYSTEM; SITE	The renin-angiotensin cascade is a hormone system that regulates blood pressure and fluid balance. Renin-mediated cleavage of the angiotensin I peptide from the N terminus of angiotensinogen (AGT) is the rate-limiting step of this cascade; however, the detailed molecular mechanism underlying this step is unclear. Here, we solved the crystal structures of glycosylated human AGT (2.30 A resolution), its encounter complex with renin (2.55 A), AGT cleaved in its reactive center loop (RCL; 2.97 A), and spent AGT from which the N-terminal angiotensin peptide was removed (2.63 A). These structures revealed that AGT undergoes profound conformational changes and binds renin through a tail-into-mouth allosteric mechanism that inserts the N terminus into a pocket equivalent to a hormone-binding site on other serpins. These changes fully extended the N-terminal tail, with the scissile bond for angiotensin release docked in renin's active site. Insertion of the N terminus into this pocket accompanied a complete unwinding of helix H of AGT, which, in turn, formed key interactions with renin in the complementary binding interface. Mutagenesis and kinetic analyses confirmed that renin-mediated production of angiotensin I is controlled by interactions of amino acid residues and glycan components outside renin's active-site cleft. Our findings indicate that AGT adapts unique serpin features for hormone delivery and binds renin through concerted movements in the N-terminal tail and in its main body to modulate angiotensin release. These insights provide a structural basis for the development of agents that attenuate angiotensin release by targeting AGT's hormone binding pocket.	[Yan, Yahui; Carrell, Robin W.; Read, Randy J.] Univ Cambridge, Cambridge Inst Med Res, Dept Haematol, Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 0XY, England; [Zhou, Aiwu] Shanghai Jiao Tong Univ, Sch Med, Chinese Minist Educ,Hongqiao Int Inst Med, Shanghai Tongren Hosp,Fac Basic Med,Key Lab Cell, Shanghai 200025, Peoples R China	University of Cambridge; Shanghai Jiao Tong University	Read, RJ (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Dept Haematol, Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 0XY, England.; Zhou, AW (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Hongqiao Int Inst Med, Shanghai 200025, Peoples R China.	aiwu.zhou@googlemail.com; rjr27@cam.ac.uk	Read, Randy J/L-1418-2013	Read, Randy J/0000-0001-8273-0047; Yan, Yahui/0000-0001-6934-9874; ZHOU, Aiwu/0000-0002-2555-5091	British Heart Foundation [PG/12/41/29679]; Wellcome Trust [082961/Z/07/Z, 100140]; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; National Natural Science Foundation of China [31370727, 81870309]	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by British Heart Foundation Grant PG/12/41/29679 and Wellcome Trust Principal Research Fellowship 082961/Z/07/Z (to R. J. R.). The research was facilitated by Wellcome Trust Strategic Award 100140 (to the Cambridge Institute for Medical Research). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning and by National Natural Science Foundation of China Grants 31370727 and 81870309.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andreeva NS, 2001, PROTEIN SCI, V10, P2439, DOI 10.1110/ps.ps.25801; BARRETT JD, 1979, J CLIN ENDOCR METAB, V48, P96, DOI 10.1210/jcem-48-1-96; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bras NF, 2012, PHYS CHEM CHEM PHYS, V14, P12605, DOI 10.1039/c2cp41422h; BURTON J, 1988, BIOCHIM BIOPHYS ACTA, V952, P8, DOI 10.1016/0167-4838(88)90095-7; Celerier J, 2002, HYPERTENSION, V39, P224, DOI 10.1161/hy0202.103441; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Crowley SD, 2012, EXP CELL RES, V318, P1049, DOI 10.1016/j.yexcr.2012.02.023; CUMIN F, 1987, BIOCHIM BIOPHYS ACTA, V913, P10, DOI 10.1016/0167-4838(87)90226-3; D'Arcy A, 2007, ACTA CRYSTALLOGR D, V63, P550, DOI 10.1107/S0907444907007652; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; DHANARAJ V, 1992, NATURE, V357, P466, DOI 10.1038/357466a0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Fournier D, 2012, J MOL MED, V90, P495, DOI 10.1007/s00109-012-0894-z; FUKAMIZU A, 1993, J BIOL CHEM, V268, P11617; Fyhrquist F, 2008, J INTERN MED, V264, P224, DOI 10.1111/j.1365-2796.2008.01981.x; GANTEN D, 1992, P NATL ACAD SCI USA, V89, P7806, DOI 10.1073/pnas.89.16.7806; GENAIN C, 1984, J CLIN ENDOCR METAB, V59, P478, DOI 10.1210/jcem-59-3-478; Gimenez-Roqueplo AP, 1998, J BIOL CHEM, V273, P21232, DOI 10.1074/jbc.273.33.21232; HATAE T, 1994, MOL CELL BIOCHEM, V131, P43, DOI 10.1007/BF01075723; INOUE I, 1995, J BIOL CHEM, V270, P11430, DOI 10.1074/jbc.270.19.11430; Inui Y, 1998, BIOSCI BIOTECH BIOCH, V62, P1612, DOI 10.1271/bbb.62.1612; Iwata H, 2008, BIOSCI BIOTECH BIOCH, V72, P179, DOI 10.1271/bbb.70541; JEUNEMAITRE X, 1992, CELL, V71, P169, DOI 10.1016/0092-8674(92)90275-H; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lu H, 2016, ARTERIOSCL THROM VAS, V36, P256, DOI 10.1161/ATVBAHA.115.306740; Lutteke T, 2009, ACTA CRYSTALLOGR D, V65, P156, DOI 10.1107/S0907444909001905; Lutteke T, 2005, NUCLEIC ACIDS RES, V33, pD242; Mangan MSJ, 2016, J BIOL CHEM, V291, P3626, DOI 10.1074/jbc.M115.699298; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nabi AHMN, 2005, INT J MOL MED, V16, P103; Pol-Fachin L, 2011, PROTEINS, V79, P2735, DOI 10.1002/prot.23102; Qi XQ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.171082; Rahgozar S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135905; RAHUEL J, 1991, J STRUCT BIOL, V107, P227, DOI 10.1016/1047-8477(91)90048-2; Rong P, 2003, HYPERTENSION, V42, P523, DOI 10.1161/01.HYP.0000093383.18302.A7; RUDD PM, 1995, BBA-PROTEIN STRUCT M, V1248, P1, DOI 10.1016/0167-4838(94)00230-E; SCHECHTER I, 1968, BIOCHEM BIOPH RES CO, V32, P898, DOI 10.1016/0006-291X(68)90326-4; Selo I, 1996, J IMMUNOL METHODS, V199, P127, DOI 10.1016/S0022-1759(96)00173-1; STEIN PE, 1989, BIOCHEM J, V262, P103, DOI 10.1042/bj2620103; Sumer-Bayraktar Z, 2016, J BIOL CHEM, V291, P17727, DOI 10.1074/jbc.M116.735258; TAKAHASHI S, 1991, BIOCHEM BIOPH RES CO, V180, P1103, DOI 10.1016/S0006-291X(05)81180-5; Wang YJ, 2011, FEBS LETT, V585, P2395, DOI 10.1016/j.febslet.2011.06.021; WARD K, 1993, NAT GENET, V4, P59, DOI 10.1038/ng0593-59; Wei H, 2016, J BIOL CHEM, V291, P24900, DOI 10.1074/jbc.M116.725895; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Zhou AW, 2008, J MOL BIOL, V380, P244, DOI 10.1016/j.jmb.2008.05.012; Zhou AW, 2006, P NATL ACAD SCI USA, V103, P13321, DOI 10.1073/pnas.0604080103; Zhou AW, 2010, NATURE, V468, P108, DOI 10.1038/nature09505	54	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2019	294	7					2353	2364		10.1074/jbc.RA118.006608	http://dx.doi.org/10.1074/jbc.RA118.006608			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL7CN	30563843	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000458895400013
J	Barayeu, U; Lange, M; Mendez, L; Arnhold, J; Shadyro, OI; Fedorova, M; Flemmig, J				Barayeu, Uladzimir; Lange, Mike; Mendez, Lucia; Arnhold, Juergen; Shadyro, Oleg I.; Fedorova, Maria; Flemmig, Joerg			Cytochrome c autocatalyzed carbonylation in the presence of hydrogen peroxide and cardiolipins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytochrome c; cardiolipin; peroxidase; mitochondria; apoptosis; proteomics; carbonylation; lipid hydroperoxides; oxidation; peroxidase activity; self-inactivation; auto-inactivation	STRUCTURAL TRANSITIONS; KEY ROLE; MITOCHONDRIA; PROTEIN; OXIDATION; MEMBRANE; RELEASE; ANTIOXIDANT; ACTIVATION; MECHANISMS	Cytochrome c (cyt c) is a small hemoprotein involved in electron shuttling in the mitochondrial respiratory chain and is now also recognized as an important mediator of apoptotic cell death. Its role in inducing programmed cell death is closely associated with the formation of a complex with the mitochondrion-specific phospholipid cardiolipin (CL), leading to a gain of peroxidase activity. However, the molecular mechanisms behind this gain and eventual cyt c autoinactivation via its release from mitochondrial membranes remain largely unknown. Here, we examined the kinetics of the H2O2-mediated peroxidase activity of cyt c both in the presence and absence of tetraoleoyl cardiolipin (TOCL)- and tetralinoleoyl cardiolipin (TLCL)-containing liposomes to evaluate the role of cyt c-CL complex formation in the induction and stimulation of cyt c peroxidase activity. Moreover, we examined peroxide-mediated cyt c heme degradation to gain insights into the mechanisms by which cyt c self-limits its peroxidase activity. Bottom-up proteomics revealed >50 oxidative modifications on cyt c upon peroxide reduction. Of note, one of these by-products was the Tyr-based cofactor trihydroxyphenylalanine quinone (TPQ) capable of inducing deamination of Lys E-amino groups and formation of the carbonylated product aminoadipic semialdehyde. In view of these results, we propose that autoinduced carbonylation, and thus removal of a positive charge in Lys, abrogates binding of cyt c to negatively charged CL. The proposed mechanism may be responsible for release of cyt c from mitochondrial membranes and ensuing inactivation of its peroxidase activity.	[Barayeu, Uladzimir; Lange, Mike; Mendez, Lucia; Fedorova, Maria] Univ Leipzig, Fac Chem & Mineral, Inst Bioanalyt Chem, D-04103 Leipzig, Germany; [Barayeu, Uladzimir; Lange, Mike; Mendez, Lucia; Fedorova, Maria] Univ Leipzig, Ctr Biotechnol & Biomed, D-04103 Leipzig, Germany; [Barayeu, Uladzimir; Arnhold, Juergen; Flemmig, Joerg] Univ Leipzig, Med Fac, Inst Med Phys & Biophys, Hartelstr 16-18, D-04107 Leipzig, Germany; [Mendez, Lucia] Spanish Council Sci Res IIM CSIC, Inst Marine Res, Vigo 36208, Spain; [Shadyro, Oleg I.] Belarusian State Univ, Dept Chem, Minsk 220030, BELARUS	Leipzig University; Leipzig University; Leipzig University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM); Belarusian State University	Flemmig, J (corresponding author), Univ Leipzig, Med Fac, Inst Med Phys & Biophys, Hartelstr 16-18, D-04107 Leipzig, Germany.; Fedorova, M (corresponding author), Univ Leipzig, Biotechnol Biomed Zentrum, Fac Chem & Mineral, Inst Bioanalyt Chem, Deutsch Pl 5, D-04103 Leipzig, Germany.	maria.fedorova@bbz.uni-leipzig.de; joerg.flemmig@medizin.uni-leipzig.de	Méndez, Lucía/AAA-9264-2020; Méndez, Lucía/T-7016-2017; Barayeu, Uladzimir/AAC-7522-2019; Fedorova, Maria/GWD-0509-2022	Méndez, Lucía/0000-0002-9711-2994; Méndez, Lucía/0000-0002-9711-2994; Barayeu, Uladzimir/0000-0001-8426-166X; Fedorova, Maria/0000-0002-4692-3885; Flemmig, Jorg/0000-0001-5872-3373; Shadyro, Oleg/0000-0002-8589-4490	German Federal Ministry of Education and Research (BMBF); Deutsche Forschungsgemeinschaft (DFG) [FE-1236/3-1]; European Regional Development Fund (ERDF; European Union) [100146238, 100121468]; European Regional Development Fund (ERDF; Free State Saxony) [100146238, 100121468]; Xunta de Galicia postdoctoral scholarship	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Regional Development Fund (ERDF; European Union); European Regional Development Fund (ERDF; Free State Saxony); Xunta de Galicia postdoctoral scholarship	This work was supported by the German Federal Ministry of Education and Research (BMBF) within the framework of the e:Med research and funding concept for the SysMedOS project, Deutsche Forschungsgemeinschaft (DFG) Grant FE-1236/3-1 (to M.F.), European Regional Development Fund (ERDF; European Union and Free State Saxony) Grants 100146238 and 100121468 (to M.F.), and a Xunta de Galicia postdoctoral scholarship (to L.M.). The authors declare that they have no conflicts of interest with the contents of this article.	Aluri HS, 2014, BBA-GEN SUBJECTS, V1840, P3199, DOI 10.1016/j.bbagen.2014.07.017; Alvarez-Paggi D, 2017, CHEM REV, V117, P13382, DOI 10.1021/acs.chemrev.7b00257; Annibal A, 2016, J CHROMATOGR B, V1019, P147, DOI 10.1016/j.jchromb.2015.12.022; Ascenzi P, 2015, IUBMB LIFE, V67, P98, DOI 10.1002/iub.1350; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; Basova LV, 2007, BIOCHEMISTRY-US, V46, P3423, DOI 10.1021/bi061854k; BEERS RF, 1952, J BIOL CHEM, V195, P133; Belikova NA, 2006, BIOCHEMISTRY-US, V45, P4998, DOI 10.1021/bi0525573; Bergstrom CL, 2013, P NATL ACAD SCI USA, V110, P6269, DOI 10.1073/pnas.1303819110; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen YR, 2004, J BIOL CHEM, V279, P18054, DOI 10.1074/jbc.M307706200; Fedorova M., 2017, PROTEIN CARBONYLATIO, P48; Firsov AM, 2016, FEBS LETT, V590, P2836, DOI 10.1002/1873-3468.12319; Firsov AM, 2015, BBA-BIOMEMBRANES, V1848, P767, DOI 10.1016/j.bbamem.2014.11.027; Garcia-Heredia JM, 2010, BBA-BIOENERGETICS, V1797, P981, DOI 10.1016/j.bbabio.2010.03.009; Giorgio Marco, 2007, Nat Rev Mol Cell Biol, V8, P722, DOI 10.1038/nrm2240; Gose M, 2015, BIOMACROMOLECULES, V16, P757, DOI 10.1021/bm5016688; Griesser E, 2017, REDOX BIOL, V11, P438, DOI 10.1016/j.redox.2016.12.028; HAREL S, 1988, FREE RADICAL RES COM, V5, P11, DOI 10.3109/10715768809068554; Huttemann M, 2011, MITOCHONDRION, V11, P369, DOI 10.1016/j.mito.2011.01.010; Isom AL, 2004, J AM SOC MASS SPECTR, V15, P1136, DOI 10.1016/j.jasms.2004.03.013; Josephs TM, 2014, BIOCHEM J, V458, P259, DOI 10.1042/BJ20131386; Kagan VE, 2009, FREE RADICAL BIO MED, V46, P1439, DOI 10.1016/j.freeradbiomed.2009.03.004; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Kim NH, 2006, MOL CELLS, V22, P220; Klema VJ, 2012, INT J MOL SCI, V13, P5375, DOI 10.3390/ijms13055375; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Maitra D, 2011, FREE RADICAL BIO MED, V51, P364, DOI 10.1016/j.freeradbiomed.2011.03.040; Mandal A, 2015, BIOPHYS J, V109, P1873, DOI 10.1016/j.bpj.2015.09.016; Mandal B, 2016, ANAL SCI, V32, P571, DOI 10.2116/analsci.32.571; MARGOLIASH E, 1959, BIOCHEM J, V71, P570, DOI 10.1042/bj0710570; Mignotte B, 1998, EUR J BIOCHEM, V252, P1, DOI 10.1046/j.1432-1327.1998.2520001.x; Miyamoto S, 2012, PHOTOCH PHOTOBIO SCI, V11, P1536, DOI 10.1039/c2pp25119a; Mohammadyani D, 2018, BBA-BIOMEMBRANES, V1860, P1057, DOI 10.1016/j.bbamem.2018.01.009; Moreno-Beltran B, 2017, P NATL ACAD SCI USA, V114, pE3041, DOI 10.1073/pnas.1618008114; NAKAMURA T, 1991, LIPIDS, V26, P765, DOI 10.1007/BF02535628; NOBLE RW, 1970, J BIOL CHEM, V245, P2409; Ott M, 2002, P NATL ACAD SCI USA, V99, P1259, DOI 10.1073/pnas.241655498; Pandiscia LA, 2015, J PHYS CHEM B, V119, P1334, DOI 10.1021/jp5104752; Patriarca A, 2009, BIOCHEMISTRY-US, V48, P3279, DOI 10.1021/bi801837e; Puchkov MN, 2013, BBA-BIOMEMBRANES, V1828, P208, DOI 10.1016/j.bbamem.2012.10.002; RADI R, 1991, ARCH BIOCHEM BIOPHYS, V288, P118, DOI 10.1016/0003-9861(91)90172-F; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sinibaldi F, 2017, J BIOL INORG CHEM, V22, P19, DOI 10.1007/s00775-016-1404-5; STOOKEY LL, 1970, ANAL CHEM, V42, P779, DOI 10.1021/ac60289a016; Tyurina YY, 2006, MOL PHARMACOL, V70, P706, DOI 10.1124/mol.106.022731; Vemula V, 2015, REDOX BIOL, V5, P195, DOI 10.1016/j.redox.2015.04.006; Yin V, 2017, J AM CHEM SOC, V139, P15701, DOI 10.1021/jacs.7b07106; Yurkova R, 2009, CHEM PHYS LIPIDS, V158, P16, DOI 10.1016/j.chemphyslip.2008.09.005; Zschaler J, 2015, FREE RADICAL BIO MED, V85, P148, DOI 10.1016/j.freeradbiomed.2015.04.015	51	14	14	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2019	294	6					1816	1830		10.1074/jbc.RA118.004110	http://dx.doi.org/10.1074/jbc.RA118.004110			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM8EO	30541920	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000459711400005
J	Hara, S; Fukumura, S; Ichinose, H				Hara, Satoshi; Fukumura, Soichiro; Ichinose, Hiroshi			Reversible S-glutathionylation of human 6-pyruvoyl tetrahydropterin synthase protects its enzymatic activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						redox regulation; glutathionylation; thiol; oxidative stress; tetrahydrobiopterin (BH4); macrophage; 6-pyruvoyl tetrahydropterin synthase; immune cell; neopterin	GTP-CYCLOHYDROLASE-I; REACTIVE OXYGEN; IMMUNE-SYSTEM; NEOPTERIN; TETRAHYDROBIOPTERIN; CELL; BIOSYNTHESIS; IDENTIFICATION; NITROSYLATION; INFLAMMATION	6-Pyruvoyl tetrahydropterin synthase (PTS) converts 7,8-dihydroneopterin triphosphate into 6-pyruvoyltetrahydropterin and is a critical enzyme for the de novo synthesis of tetrahydrobiopterin, an essential cofactor for aromatic amino acid hydroxylases and nitric-oxide synthases. Neopterin derived from 7,8-dihydroneopterin triphosphate is secreted by monocytes/macrophages, and is a well-known biomarker for cellular immunity. Because PTS activity in the cell can be a determinant of neopterin production, here we used recombinant human PTS protein to investigate how its activity is regulated, especially depending on redox conditions. Human PTS has two cysteines: Cys-43 at the catalytic site and Cys-10 at the N terminus. PTS can be oxidized and consequently inactivated by H2O2 treatment, oxidized GSH, or S-nitrosoglutathione, and determining the oxidized modifications of PTS induced by each oxidant by MALDI-TOF MS, we show that PTS is S-glutathionylated in the presence of GSH and H2O2. S-Glutathionylation at Cys-43 protected PTS from H2O2-induced irreversible sulfinylation and sulfonylation. We also found that PTS expressed in HeLa and THP-1 cells is reversibly modified under oxidative stress conditions. Our findings suggest that PTS activity and S-glutathionylation is regulated by the cellular redox environment and that reversible S-glutathionylation protects PTS against oxidative stress.	[Hara, Satoshi; Fukumura, Soichiro; Ichinose, Hiroshi] Tokyo Inst Technol, Sch Life Sci & Technol, Yokohama, Kanagawa 2268501, Japan	Tokyo Institute of Technology	Ichinose, H (corresponding author), Tokyo Inst Technol, Yokohama, Kanagawa 2268501, Japan.	hichinos@bio.titech.ac.jp	Hara, Satoshi/C-1341-2015; Ichinose, Hiroshi/D-8986-2015	Hara, Satoshi/0000-0001-6275-6469; Ichinose, Hiroshi/0000-0001-6008-6860	Ministry of Education, Culture, Sports, Science, and Technology of Japan [15H01422, 17H05555]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, Adaptive circuit shift Grants 15H01422 and 17H05555. The authors declare that they have no conflicts of interest with the contents of this article.	BECKSPEIER I, 1988, FEBS LETT, V227, P1, DOI 10.1016/0014-5793(88)81401-7; Bhaskar A, 2015, J BIOL CHEM, V290, P1020, DOI 10.1074/jbc.M114.588913; BLAU N, 1989, EUR J CANCER CLIN ON, V25, P603, DOI 10.1016/0277-5379(89)90192-2; BURGISSER DM, 1995, J MOL BIOL, V253, P358, DOI 10.1006/jmbi.1995.0558; BURGISSER DM, 1994, EUR J BIOCHEM, V219, P497, DOI 10.1111/j.1432-1033.1994.tb19964.x; Cirillo P, 2006, J THROMB HAEMOST, V4, P2248, DOI 10.1111/j.1538-7836.2006.02125.x; Claiborne A, 1999, BIOCHEMISTRY-US, V38, P15407, DOI 10.1021/bi992025k; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; Deng J, 2012, J IMMUNOL, V188, P5734, DOI 10.4049/jimmunol.1101323; Dickinson DA, 2002, BIOCHEM PHARMACOL, V64, P1019, DOI 10.1016/S0006-2952(02)01172-3; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Duggan S, 2002, BBA-MOL CELL RES, V1591, P139, DOI 10.1016/S0167-4889(02)00272-0; FUCHS D, 1988, IMMUNOL TODAY, V9, P150, DOI 10.1016/0167-5699(88)91203-0; Ghisoni K, 2016, BRAIN BEHAV IMMUN, V56, P156, DOI 10.1016/j.bbi.2016.02.019; Gieche J, 2001, BBA-MOL CELL RES, V1538, P321, DOI 10.1016/S0167-4889(01)00083-0; Hazeldine J, 2014, AGING CELL, V13, P690, DOI 10.1111/acel.12222; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hoffmann G, 2003, INFLAMM RES, V52, P313, DOI 10.1007/s00011-003-1181-9; Hoffmann G, 1996, FEBS LETT, V391, P181, DOI 10.1016/0014-5793(96)00729-6; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Kalinina EV, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1493, DOI 10.1134/S0006297908130099; Kaneko R, 2003, J MASS SPECTROM, V38, P526, DOI 10.1002/jms.466; Khan MA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03257-z; Klatt P, 2000, EUR J BIOCHEM, V267, P4928, DOI 10.1046/j.1432-1327.2000.01601.x; Kobayashi T, 1997, P NATL ACAD SCI USA, V94, P11857, DOI 10.1073/pnas.94.22.11857; Liang Y, 2013, BIOCHEM BIOPH RES CO, V442, P72, DOI 10.1016/j.bbrc.2013.11.002; Lonn ME, 2008, ANTIOXID REDOX SIGN, V10, P547, DOI 10.1089/ars.2007.1821; MANNERVIK B, 1980, BIOCHEM J, V190, P125, DOI 10.1042/bj1900125; Martins RD, 2018, FREE RADICAL BIO MED, V115, P371, DOI 10.1016/j.freeradbiomed.2017.11.022; Mittal M, 2014, ANTIOXID REDOX SIGN, V20, P1126, DOI 10.1089/ars.2012.5149; Nakamura H, 1997, ANNU REV IMMUNOL, V15, P351, DOI 10.1146/annurev.immunol.15.1.351; Ploom T, 1999, J MOL BIOL, V286, P851, DOI 10.1006/jmbi.1998.2511; Reddie KG, 2008, CURR OPIN CHEM BIOL, V12, P746, DOI 10.1016/j.cbpa.2008.07.028; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Schobersberger W, 1996, FEBS LETT, V397, P263, DOI 10.1016/S0014-5793(96)01194-5; Stamler JS, 1998, NAT STRUCT BIOL, V5, P247, DOI 10.1038/nsb0498-247; Subramani J, 2016, J BIOL CHEM, V291, P23374, DOI 10.1074/jbc.M116.745034; TAKIKAWA SI, 1986, EUR J BIOCHEM, V161, P295, DOI 10.1111/j.1432-1033.1986.tb10446.x; TANI Y, 1993, J CHROMATOGR-BIOMED, V617, P249, DOI 10.1016/0378-4347(93)80495-P; Tao RK, 2017, NAT METHODS, V14, P720, DOI 10.1038/nmeth.4306; Thony B, 2000, BIOCHEM J, V347, P1, DOI 10.1042/0264-6021:3470001; WEISS G, 1993, FEBS LETT, V321, P89, DOI 10.1016/0014-5793(93)80627-7; WERNER ER, 1990, J BIOL CHEM, V265, P3189; Werner ER, 2011, BIOCHEM J, V438, P397, DOI 10.1042/BJ20110293	44	3	3	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1420	1427		10.1074/jbc.RA118.005280	http://dx.doi.org/10.1074/jbc.RA118.005280			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30514762	Green Published, hybrid			2022-12-28	WOS:000457879500030
J	Hill, BL; Mascarenhas, R; Patel, HP; Diez, MDA; Wu, R; Iglesias, AA; Liu, DL; Ballicora, MA				Hill, Benjamin L.; Mascarenhas, Romila; Patel, Hiral P.; Asencion Diez, Matias D.; Wu, Rui; Iglesias, Alberto A.; Liu, Dali; Ballicora, Miguel A.			Structural analysis reveals a pyruvate-binding activator site in the Agrobacterium tumefaciens ADP-glucose pyrophosphorylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycogen; allosteric regulation; glucose; enzyme structure; pyruvate; allosterism; glucose-1-phosphate adenylyltransferase; glycogen biosynthesis; pyruvate; starch biosynthesis; enzyme evolution; pyrophosphorylase; polyglucan synthesis	ESCHERICHIA-COLI; DIRECTED MUTAGENESIS; REGULATORY ENZYME; SYNTHETASE; STARCH	The pathways for biosynthesis of glycogen in bacteria and starch in plants are evolutionarily and biochemically related. They are regulated primarily by ADP-glucose pyrophosphorylase, which evolved to satisfy metabolic requirements of a particular organism. Despite the importance of these two pathways, little is known about the mechanism that controls pyrophosphorylase activity or the location of its allosteric sites. Here, we report pyruvate-bound crystal structures of ADP-glucose pyrophosphorylase from the bacterium Agrobacterium tumefaciens, identifying a previously elusive activator site for the enzyme. We found that the tetrameric enzyme binds two molecules of pyruvate in a planar conformation. Each binding site is located in a crevice between the C-terminal domains of two subunits where they stack via a distinct beta-helix region. Pyruvate interacts with the side chain of Lys-43 and with the peptide backbone of Ser-328 and Gly-329 from both subunits. These structural insights led to the design of two variants with altered regulatory properties. In one variant (K43A), the allosteric effect was absent, whereas in the other (G329D), the introduced Asp mimicked the presence of pyruvate. The latter generated an enzyme that was preactivated and insensitive to further activation by pyruvate. Our study furnishes a deeper understanding of how glycogen biosynthesis is regulated in bacteria and the mechanism by which transgenic plants increased their starch production. These insights will facilitate rational approaches to enzyme engineering for starch production in crops of agricultural interest and will promote further study of allosteric signal transmission and molecular evolution in this important enzyme family.	[Hill, Benjamin L.; Mascarenhas, Romila; Patel, Hiral P.; Asencion Diez, Matias D.; Wu, Rui; Liu, Dali; Ballicora, Miguel A.] Loyola Univ, Dept Chem & Biochem, 1068 W Sheridan Rd, Chicago, IL 60660 USA; [Asencion Diez, Matias D.; Iglesias, Alberto A.] UNL, Consejo Nacl Invest Cient & Tecn,Inst Agrobiotech, Ctr Cient Tecnol CCT Santa Fe,Inst Agrobiotecnol, CONICET,Fac Bioquim & Ciencias Biol FBCB Paraje E, Colectora Ruta Nacl,168 Km 0, RA-3000 Santa Fe, Argentina; [Mascarenhas, Romila] Univ Michigan, Med Sch, Dept Biol Chem, Ann Arbor, MI 48109 USA	Loyola University Chicago; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of the Littoral; University of Michigan System; University of Michigan	Ballicora, MA (corresponding author), Loyola Univ, Dept Chem & Biochem, 1068 W Sheridan Rd, Chicago, IL 60660 USA.	mballic@luc.edu	; Liu, Dali/D-2571-2014	Iglesias, Alberto/0000-0001-9729-7338; Liu, Dali/0000-0002-7587-703X; Asencion Diez, Matias Damian/0000-0001-6495-387X	United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]	United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE))	For some of this work, we thank Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. Argonne is operated by the University of Chicago Argonne, LLC, for the United States Department of Energy, Office of Biological and Environmental Research under Contract DE-AC02-06CH11357. We thank John C. Hawkins (Writing Center, Loyola University Chicago) for assistance in proofreading the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Asencion Diez M. D., 2014, PLOS ONE, V9; Diez MDA, 2012, J BACTERIOL, V194, P1485, DOI 10.1128/JB.06377-11; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BALL K, 1994, J BIOL CHEM, V269, P24706; Ballicora MA, 2005, J BIOL CHEM, V280, P10189, DOI 10.1074/jbc.M413540200; Ballicora MA, 1998, PLANT PHYSIOL, V118, P265, DOI 10.1104/pp.118.1.265; Ballicora MA, 2004, PHOTOSYNTH RES, V79, P1, DOI 10.1023/B:PRES.0000011916.67519.58; Ballicora MA, 2002, BIOCHEMISTRY-US, V41, P9431, DOI 10.1021/bi025793b; Ballicora MA, 2003, MICROBIOL MOL BIOL R, V67, P213, DOI 10.1128/MMBR.67.2.213-225.2003; Batsanov SS, 2001, INORG MATER+, V37, P871, DOI 10.1023/A:1011625728803; Bejar CM, 2006, J BIOL CHEM, V281, P40473, DOI 10.1074/jbc.M607088200; Cereijo AE, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00830; Cifuente JO, 2016, STRUCTURE, V24, P1613, DOI 10.1016/j.str.2016.06.023; Comino N, 2017, J BIOL CHEM, V292, P6255, DOI 10.1074/jbc.M116.773408; Cupp-Vickery JR, 2008, BIOCHEMISTRY-US, V47, P4439, DOI 10.1021/bi701933q; DeLano W.L., 2015, PYMOL MOL GRAPHICS S; Ebrecht AC, 2017, FRONT CHEM, V5, DOI 10.3389/fchem.2017.00041; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Figueroa CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066824; Figueroa CM, 2011, BIOCHIMIE, V93, P1816, DOI 10.1016/j.biochi.2011.06.029; Frueauf JB, 2001, J BIOL CHEM, V276, P46319, DOI 10.1074/jbc.M107408200; Fusari C, 2006, ANAL BIOCHEM, V352, P145, DOI 10.1016/j.ab.2006.01.024; GARDIOL A, 1990, ARCH BIOCHEM BIOPHYS, V280, P175, DOI 10.1016/0003-9861(90)90533-5; Gomez-Casati DF, 2001, BIOCHEMISTRY-US, V40, P10169, DOI 10.1021/bi002615e; Hill BL, 2015, PROTEIN SCI, V24, P714, DOI 10.1002/pro.2644; Jin XS, 2005, EMBO J, V24, P694, DOI 10.1038/sj.emboj.7600551; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE YM, 1986, J BIOL CHEM, V261, P1058; Meyer CR, 1998, ARCH BIOCHEM BIOPHYS, V353, P152, DOI 10.1006/abbi.1998.0648; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sheng J, 1996, BIOCHEMISTRY-US, V35, P3115, DOI 10.1021/bi952359j; STARK DM, 1992, SCIENCE, V258, P287, DOI 10.1126/science.258.5080.287; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	38	8	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1338	1348		10.1074/jbc.RA118.004246	http://dx.doi.org/10.1074/jbc.RA118.004246			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30401744	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000457879500024
J	Brixius-Anderko, S; Scott, EE				Brixius-Anderko, Simone; Scott, Emily E.			Structure of human cortisol-producing cytochrome P450 11B1 bound to the breast cancer drug fadrozole provides insights for drug design	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytochrome P450; membrane enzyme; steroidogenesis; aldosterone; X-ray crystallography; enzyme inhibitor; 11-hydroxylase; aldosterone synthase; Cushing's disease; CYP11B1; CYP11B2; membrane protein; cortisol; fadrozole	CONGENITAL ADRENAL-HYPERPLASIA; SELECTIVE CYP11B1 INHIBITORS; 11-BETA-HYDROXYLASE INHIBITOR; CUSHINGS-DISEASE; POTENT; OPTIMIZATION; HYPERTENSION; EXPRESSION; AROMATASE; MODELS	Human cytochrome P450 11B1 (CYP11B1) is responsible for the final step generating the steroid hormone cortisol, which controls stress and immune responses and glucose homeostasis. CYP11B1 is a promising drug target to manage Cushing's disease, a disorder arising from excessive cortisol production. However, the design of selective inhibitors has been hampered because structural information for CYP11B1 is unavailable and the enzyme has high amino acid sequence identity (93%) to a closely related enzyme, the aldosterone-producing CYP11B2. Here we report the X-ray crystal structure of human CYP11B1 (at 2.1 resolution) in complex with fadrozole, a racemic compound normally used to treat breast cancer by inhibiting estrogen-producing CYP19A1. Comparison of fadrozole-bound CYP11B1 with fadrozole-bound CYP11B2 revealed that despite conservation of the active-site residues, the overall structures and active sites had structural rearrangements consistent with distinct protein functions and inhibition. Whereas fadrozole binds to both CYP11B enzymes by coordinating the heme iron, CYP11B2 binds to the R enantiomer of fadrozole, and CYP11B1 binds to the S enantiomer, each with distinct orientations and interactions. These results provide insights into the cross-reactivity of drugs across multiple steroidogenic cytochrome P450 enzymes, provide a structural basis for understanding human steroidogenesis, and pave the way for the design of more selective inhibitors of each human CYP11B enzyme.	[Brixius-Anderko, Simone; Scott, Emily E.] Univ Michigan, Dept Med Chem, 428 Church St, Ann Arbor, MI 48109 USA; [Scott, Emily E.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Scott, Emily E.] Univ Michigan, Program Biophys, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Scott, EE (corresponding author), Univ Michigan, Dept Med Chem, 428 Church St, Ann Arbor, MI 48109 USA.	scottee@umich.edu		Brixius-Anderko, Simone/0000-0002-3036-9285	United States Department of Energy Office of Biological and Environmental Research; National Institutes of Health, NCRR; National Institutes of Health, Biomedical Technology Program; National Institutes of Health, NIGMS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM076343] Funding Source: NIH RePORTER	United States Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health, Biomedical Technology Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	X-ray data were collected at the Stanford Synchrotron Radiation Lightsource (SSRL). The SSRL Structural Molecular Biology Program is supported by the United States Department of Energy Office of Biological and Environmental Research and by the National Institutes of Health, NCRR, Biomedical Technology Program, and NIGMS. Linda Blake assisted with the design of the original CYP11B1 expression construct and established an initial expression and purification protocol. Constructs for expression of adrenodoxin and adrenodoxin reductase were gifts from Dr. Richard Auchus (University of Michigan).	Abbaszadegan MR, 2013, ENDOCRINE, V44, P212, DOI 10.1007/s12020-012-9861-2; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ballinger TJ, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00308; Bechtel S, 2002, EUR J BIOCHEM, V269, P1118, DOI 10.1046/j.1432-1033.2002.02729.x; Bellavance MA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00136; Bernhardt R, 2016, EXPERT OPIN THER TAR, V20, P923, DOI 10.1517/14728222.2016.1151873; Bertagna X, 2014, J CLIN ENDOCR METAB, V99, P1375, DOI 10.1210/jc.2013-2117; Bottner B, 1998, EUR J BIOCHEM, V252, P458, DOI 10.1046/j.1432-1327.1998.2520458.x; BROWNE LJ, 1991, J MED CHEM, V34, P725, DOI 10.1021/jm00106a038; COGHLAN VM, 1989, P NATL ACAD SCI USA, V86, P835, DOI 10.1073/pnas.86.3.835; Curnow KM, 1997, NAT STRUCT BIOL, V4, P32, DOI 10.1038/nsb0197-32; Delano W.L., 2017, PYMOL MOL GRAPHICS S; Denver RJ, 2009, ANN NY ACAD SCI, V1163, P1, DOI 10.1111/j.1749-6632.2009.04433.x; Emmerich J, 2018, EUR J MED CHEM, V143, P591, DOI 10.1016/j.ejmech.2017.11.018; Emmerich J, 2017, J MED CHEM, V60, P5086, DOI 10.1021/acs.jmedchem.7b00437; Emmerich J, 2013, J MED CHEM, V56, P6022, DOI 10.1021/jm400240r; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FURET P, 1993, J MED CHEM, V36, P1393, DOI 10.1021/jm00062a012; Hille UE, 2011, ACS MED CHEM LETT, V2, P559, DOI 10.1021/ml100283h; Hille UE, 2011, ACS MED CHEM LETT, V2, P2, DOI 10.1021/ml100071J; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Khattab A, 2017, P NATL ACAD SCI USA, V114, pE1933, DOI 10.1073/pnas.1621082114; Kirk LF, 2000, AM FAM PHYSICIAN, V62, P1119; Lackland DT, 2015, CAN J CARDIOL, V31, P569, DOI 10.1016/j.cjca.2015.01.009; Martin RE, 2015, J MED CHEM, V58, P8054, DOI 10.1021/acs.jmedchem.5b00851; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Panagiotakopoulos L, 2014, FRONT NEUROENDOCRIN, V35, P285, DOI 10.1016/j.yfrne.2014.03.002; Piaditis G, 2015, EUR J ENDOCRINOL, V172, pR191, DOI 10.1530/EJE-14-0537; Pivonello R, 2008, ENDOCRIN METAB CLIN, V37, P135, DOI 10.1016/j.ecl.2007.10.010; Rigel DF, 2010, J PHARMACOL EXP THER, V334, P232, DOI 10.1124/jpet.110.167148; Roumen L, 2007, J COMPUT AID MOL DES, V21, P455, DOI 10.1007/s10822-007-9128-9; SAGARA Y, 1993, BIOL PHARM BULL, V16, P627; Strushkevich N, 2013, MOL ENDOCRINOL, V27, P315, DOI 10.1210/me.2012-1287; te Riet L, 2015, CIRC RES, V116, P960, DOI 10.1161/CIRCRESAHA.116.303587; Unuane D, 2011, BEST PRACT RES CL EN, V25, P861, DOI 10.1016/j.beem.2011.08.001; Yu R, 2015, MOLECULES, V20, P1014, DOI 10.3390/molecules20011014; Zhu WX, 2016, CURR MED CHEM, V23, P623, DOI 10.2174/0929867323666160122114947	37	19	19	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2019	294	2					453	460		10.1074/jbc.RA118.006214	http://dx.doi.org/10.1074/jbc.RA118.006214			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HI2GP	30425102	Green Published, hybrid			2022-12-28	WOS:000456263600007
J	Helmstetter, F; Arnold, P; Hoger, B; Petersen, LM; Beitz, E				Helmstetter, Folknand; Arnold, Philipp; Hoeger, Bastian; Petersen, Lea Madlen; Beitz, Eric			Formate-nitrite transporters carrying nonprotonatable amide amino acids instead of a central histidine maintain pH-dependent transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						transporter; membrane transport; membrane biophysics; proton motive force; lactic acid; protozoan; malaria; Bacillus; electron microscopy (EM); liposome; acetate; Entamoeba histolytica; formate; proton transfer	CHANNEL; MECHANISM; GENOME; AQUAGLYCEROPORIN; RESIDUES; SEQUENCE; PK(A); NIRC	Microbial formate-nitrite transporter-type proteins (FNT) exhibit dual transport functionality. At neutral pH, electrogenic anion currents are detectable, whereas upon acidification transport of the neutral, protonated monoacid predominates. Physiologically, FNT-mediated proton co-transport is vital when monocarboxylic acid products of the energy metabolism, such as l-lactate, are released from the cell. Accordingly, Plasmodium falciparum malaria parasites can be killed by small-molecule inhibitors of PfFNT. Two opposing hypotheses on the site of substrate protonation are plausible. The proton relay mechanism postulates proton transfer from a highly conserved histidine centrally positioned in the transport path. The dielectric slide mechanism assumes decreasing acidity of substrates entering the lipophilic vestibules and protonation via the bulk water. Here, we defined the transport mechanism of the FNT from the amoebiasis parasite Entamoeba histolytica, EhFNT, and also show that BtFdhC from Bacillus thuringiensis is a functional formate transporter. Both FNTs carry a nonprotonatable amide amino acid, asparagine or glutamine, respectively, at the central histidine position. Despite having a nonprotonatable residue, EhFNT displayed the same substrate selectivity for larger monocarboxylates including l-lactate, a low substrate affinity as is typical for FNTs, and, strikingly, proton motive force-dependent transport as observed for PfFNT harboring a central histidine. These results argue against a proton relay mechanism, indicating that substrate protonation must occur outside of the central histidine region, most likely in the vestibules. Furthermore, EhFNT is the sole annotated FNT in the Entamoeba genome suggesting that it could be a putative new drug target with similar utility as that of the malarial PfFNT.	[Helmstetter, Folknand; Hoeger, Bastian; Petersen, Lea Madlen; Beitz, Eric] Christian Albrechts Univ Kiel, Dept Pharmaceut & Med Chem, Gutenbergstr 76, D-24118 Kiel, Germany; [Arnold, Philipp] Christian Albrechts Univ Kiel, Anat Inst, D-24118 Kiel, Germany	University of Kiel; University of Kiel	Beitz, E (corresponding author), Christian Albrechts Univ Kiel, Dept Pharmaceut & Med Chem, Gutenbergstr 76, D-24118 Kiel, Germany.	ebeitz@pharmazie.uni-kiel.de			German Research Foundation Deutsche Forschungsgemeinschaft (DFG) Research Grant [Be2253/8-1]	German Research Foundation Deutsche Forschungsgemeinschaft (DFG) Research Grant(German Research Foundation (DFG))	This work was supported by German Research Foundation Deutsche Forschungsgemeinschaft (DFG) Research Grant Be2253/8-1 (to E. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Arnold P, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-42; Atkovska K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11437-0; Beitz E, 2000, BIOINFORMATICS, V16, P135, DOI 10.1093/bioinformatics/16.2.135; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Challacombe JF, 2007, J BACTERIOL, V189, P3680, DOI 10.1128/JB.00241-07; Czyzewski BK, 2012, NATURE, V483, P494, DOI 10.1038/nature10881; Erler H, 2018, J BIOL CHEM, V293, P17622, DOI 10.1074/jbc.RA118.003801; Golldack A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006172; Hapuarachchi SV, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006180; HARPAZ Y, 1994, STRUCTURE, V2, P641, DOI 10.1016/S0969-2126(00)00065-4; Holm-Bertelsen J, 2016, PROTEIN EXPRES PURIF, V126, P109, DOI 10.1016/j.pep.2016.06.008; Jia WJ, 2009, BIOCHEM J, V417, P297, DOI 10.1042/BJ20080746; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; Lu W, 2013, BIOL CHEM, V394, P715, DOI 10.1515/hsz-2012-0339; Lu W, 2012, P NATL ACAD SCI USA, V109, P18395, DOI 10.1073/pnas.1210793109; Lu W, 2012, P NATL ACAD SCI USA, V109, P13254, DOI 10.1073/pnas.1204201109; Lu W, 2011, SCIENCE, V332, P352, DOI 10.1126/science.1199098; Lv XY, 2013, BIOPHYS J, V105, P2714, DOI 10.1016/j.bpj.2013.11.006; Marchetti RV, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7721; Muller-Lucks A, 2013, NEW BIOTECHNOL, V30, P545, DOI 10.1016/j.nbt.2013.03.007; Muller-Lucks A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042186; Mukherjee M, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3947-4; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Radnedge L, 2003, APPL ENVIRON MICROB, V69, P2755, DOI 10.1128/AEM.69.5.2755-2764.2003; Rothert M, 2017, J BIOL CHEM, V292, P9358, DOI 10.1074/jbc.M117.782516; Sawers RG, 2005, BIOCHEM SOC T, V33, P42, DOI 10.1042/BST0330042; Song J, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005436; Song J, 2012, BBA-BIOMEMBRANES, V1818, P1218, DOI 10.1016/j.bbamem.2012.01.025; Stanton CL, 2008, J CHEM THEORY COMPUT, V4, P951, DOI 10.1021/ct8000014; Tan KP, 2013, NUCLEIC ACIDS RES, V41, pW314, DOI 10.1093/nar/gkt503; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Waight AB, 2010, NAT STRUCT MOL BIOL, V17, P31, DOI 10.1038/nsmb.1740; Wang Y, 2009, NATURE, V462, P467, DOI 10.1038/nature08610; Wiechert M, 2017, CHANNELS, V11, P365, DOI 10.1080/19336950.2017.1329999; Wiechert M, 2017, FEBS J, V284, P2663, DOI 10.1111/febs.14117; Wiechert M, 2017, EMBO J, V36, P949, DOI 10.15252/embj.201695776; Wu BH, 2010, J BIOL CHEM, V285, P40081, DOI 10.1074/jbc.M110.184457; Wu B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7468	39	13	13	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2019	294	2					623	631		10.1074/jbc.RA118.006340	http://dx.doi.org/10.1074/jbc.RA118.006340			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HI2GP	30455351	Green Published, hybrid			2022-12-28	WOS:000456263600019
J	Chatterjee, S; Prados-Rosales, R; Tan, S; Phan, VC; Chrissian, C; Itin, B; Wang, H; Khajo, A; Magliozzo, RS; Casadevall, A; Stark, RE				Chatterjee, Subhasish; Prados-Rosales, Rafael; Tan, Sindy; Van Chanh Phan; Chrissian, Christine; Itin, Boris; Wang, Hsin; Khajo, Abdelahad; Magliozzo, Richard S.; Casadevall, Arturo; Stark, Ruth E.			The melanization road more traveled by: Precursor substrate effects on melanin synthesis in cell-free and fungal cell systems	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						melanogenesis; fungi; biophysics; catecholamine; cell wall; nuclear magnetic resonance (NMR); polysaccharide; solid state NMR; electron paramagnetic resonance (EPR); melanin; melanization; pigment formation	SOLID-STATE NMR; MAGNETIC-RESONANCE-SPECTROSCOPY; HUMAN HAIR MELANIN; CRYPTOCOCCUS-NEOFORMANS; CROSS-POLARIZATION; EUMELANINS; C-13; CATECHOLAMINES; ORGANIZATION; ACID	Natural brown-black eumelanin pigments confer structural coloration in animals and potently block ionizing radiation and antifungal drugs. These functions also make them attractive for bioinspired materials design, including coating materials for drug-delivery vehicles, strengthening agents for adhesive hydrogel materials, and free-radical scavengers for soil remediation. Nonetheless, the molecular determinants of the melanin developmental road traveled and the resulting architectural features have remained uncertain because of the insoluble, heterogeneous, and amorphous characteristics of these complex polymeric assemblies. Here, we used 2D solid-state NMR, EPR, and dynamic nuclear polarization spectroscopic techniques, assisted in some instances by the use of isotopically enriched precursors, to address several open questions regarding the molecular structures and associated functions of eumelanin. Our findings uncovered: 1) that the identity of the available catecholamine precursor alters the structure of melanin pigments produced either in Cryptococcus neoformans fungal cells or under cell-free conditions; 2) that the identity of the available precursor alters the scaffold organization and membrane lipid content of melanized fungal cells; 3) that the fungal cells are melanized preferentially by an l-DOPA precursor; and 4) that the macromolecular carbon- and nitrogen-based architecture of cell-free and fungal eumelanins includes indole, pyrrole, indolequinone, and open-chain building blocks that develop depending on reaction time. In conclusion, the availability of catecholamine precursors plays an important role in eumelanin development by affecting the efficacy of pigment formation, the melanin molecular structure, and its underlying scaffold in fungal systems.	[Chatterjee, Subhasish; Tan, Sindy; Chrissian, Christine; Wang, Hsin; Stark, Ruth E.] CUNY City Coll, Dept Chem & Biochem, MR-1024, New York, NY 10031 USA; [Chatterjee, Subhasish; Tan, Sindy; Chrissian, Christine; Wang, Hsin; Stark, Ruth E.] CUNY, Inst Macromol Assemblies, New York, NY 10031 USA; [Prados-Rosales, Rafael] Yeshiva Univ, Dept Microbiol & Immunol, Albert Einstein Coll Med, Bronx, NY 10461 USA; [Prados-Rosales, Rafael] CIC bioGUNE, Vizcaya 48160, Spain; [Van Chanh Phan] CUNY Hostos Community Coll, Dept Nat Sci, Bronx, NY 10451 USA; [Chrissian, Christine; Magliozzo, Richard S.; Stark, Ruth E.] CUNY, PhD Program Biochem, New York, NY 10036 USA; [Itin, Boris] New York Struct Biol Ctr, New York, NY 10027 USA; [Khajo, Abdelahad; Magliozzo, Richard S.] CUNY Brooklyn Coll, Dept Chem, Brooklyn, NY 11210 USA; [Khajo, Abdelahad; Magliozzo, Richard S.; Stark, Ruth E.] CUNY, PhD Program Chem, New York, NY 10036 USA; [Casadevall, Arturo] Johns Hopkins Univ, Dept Mol Microbiol & Immunol, Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA	City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System; Yeshiva University; Albert Einstein College of Medicine; CIC bioGUNE; City University of New York (CUNY) System; City University of New York (CUNY) System; City University of New York (CUNY) System; Brooklyn College (CUNY); City University of New York (CUNY) System; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Stark, RE (corresponding author), CUNY City Coll, Dept Chem & Biochem, MR-1024, New York, NY 10031 USA.; Chatterjee, S (corresponding author), Columbia Univ, Dept Chem, Barnard Coll, New York, NY 10027 USA.	rstark@ccny.cuny.edu	Prados-Rosales, Rafael/D-5840-2019; Chatterjee, Subhasish/AAT-6069-2020	Prados-Rosales, Rafael/0000-0001-5964-0166; Chatterjee, Subhasish/0000-0003-1351-3537; Chrissian, Christine/0000-0003-2858-4864	National Institute on Minority Health and Health Disparities of the National Institutes of Health [3G12MD007603-30S2]; New York State Office of Science, Technology and Academic Research; National Institutes of Health Office of Research Infrastructure Program Facility Improvement Grant [CO6RR015495]; National Institutes of Health Equipment Grant [S10RR029249]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015495, S10RR029249] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052733] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007603] Funding Source: NIH RePORTER	National Institute on Minority Health and Health Disparities of the National Institutes of Health; New York State Office of Science, Technology and Academic Research; National Institutes of Health Office of Research Infrastructure Program Facility Improvement Grant; National Institutes of Health Equipment Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The 600 MHz NMR facilities used in this work are operated by The City College and the CUNY Institute for Macromolecular Assemblies, with additional infrastructural support provided by National Institutes of Health Grant 3G12MD007603-30S2 from the National Institute on Minority Health and Health Disparities of the National Institutes of Health. R. E. S. is a member of the New York Structural Biology Center (NYSBC); data collection at that facility was made possible by a grant from the New York State Office of Science, Technology and Academic Research, an National Institutes of Health Office of Research Infrastructure Program Facility Improvement Grant CO6RR015495, and an National Institutes of Health Equipment Grant S10RR029249.	Adhyaru BB, 2003, MAGN RESON CHEM, V41, P466, DOI 10.1002/mrc.1193; Aime S, 1996, ADV NEUROL, V69, P263; Alfieri ML, 2018, ACS APPL MATER INTER, V10, P7670, DOI 10.1021/acsami.7b09662; Banks IR, 2005, EUKARYOT CELL, V4, P1902, DOI 10.1128/EC.4.11.1902-1912.2005; Buszman E, 2003, APPL MAGN RESON, V24, P401, DOI 10.1007/BF03166942; Camacho E, 2017, MICROBIOL-SGM, V163, P1540, DOI 10.1099/mic.0.000552; Chatterjee S, 2015, J BIOL CHEM, V290, P13779, DOI 10.1074/jbc.M114.618389; Chatterjee S, 2014, ORG BIOMOL CHEM, V12, P6730, DOI 10.1039/c4ob01066c; Chatterjee S, 2012, BIOCHEMISTRY-US, V51, P6080, DOI 10.1021/bi300325m; CRAWFORD TB, 1970, BRIT J PHARMACOL, V38, P56, DOI 10.1111/j.1476-5381.1970.tb10336.x; CRESCENZI O, 1994, LIEBIGS ANN CHEM, P563; d'Ischia M, 2009, ANGEW CHEM INT EDIT, V48, P3914, DOI 10.1002/anie.200803786; Della Vecchia NF, 2013, ADV FUNCT MATER, V23, P1331, DOI 10.1002/adfm.201202127; Eisenman HC, 2005, BIOCHEMISTRY-US, V44, P3683, DOI 10.1021/bi047731m; Eisenman HC, 2007, MICROBIOL-SGM, V153, P3954, DOI 10.1099/mic.0.2007/011049-0; Eisenman HC, 2012, APPL MICROBIOL BIOT, V93, P931, DOI 10.1007/s00253-011-3777-2; Eisenman HC, 2009, MICROBIOL-SGM, V155, P3860, DOI 10.1099/mic.0.032854-0; FOLCH J, 1957, J BIOL CHEM, V226, P497; Free SJ, 2013, ADV GENET, V81, P33, DOI 10.1016/B978-0-12-407677-8.00002-6; Frost R., 1920, MOUNTAIN INTERVAL; FUKAMIZO T, 1986, ARCH BIOCHEM BIOPHYS, V249, P15, DOI 10.1016/0003-9861(86)90555-2; Fung BM, 2000, J MAGN RESON, V142, P97, DOI 10.1006/jmre.1999.1896; Garcia-Rivera J, 2005, FUNGAL GENET BIOL, V42, P989, DOI 10.1016/j.fgb.2005.09.003; Ghiani S, 2008, MAGN RESON CHEM, V46, P471, DOI 10.1002/mrc.2202; Gow NAR, 2017, MICROBIOL SPECTR, V5, DOI 10.1128/microbiolspec.FUNK-0035-2016; Grossman NT, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.02108-16; HAHN EL, 1950, PHYS REV, V80, P580, DOI 10.1103/PhysRev.80.580; Harris RK, 2001, PURE APPL CHEM, V73, P1795, DOI 10.1351/pac200173111795; Henson JM, 1999, ANNU REV PHYTOPATHOL, V37, P447, DOI 10.1146/annurev.phyto.37.1.447; HING AW, 1992, J MAGN RESON, V96, P205, DOI 10.1016/0022-2364(92)90305-Q; Ito S, 2003, PIGM CELL RES, V16, P230, DOI 10.1034/j.1600-0749.2003.00037.x; Jaroniec CP, 2002, J AM CHEM SOC, V124, P10728, DOI 10.1021/ja026385y; Jastrzebska M, 2002, J PHOTOCH PHOTOBIO B, V66, P201, DOI 10.1016/S1011-1344(02)00268-3; Ju KY, 2011, BIOMACROMOLECULES, V12, P625, DOI 10.1021/bm101281b; Kang X, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05199-0; Kramer KJ, 1995, INSECT BIOCHEM MOLEC, V25, P1067, DOI 10.1016/0965-1748(95)00053-4; LI KL, 1993, BIOCHEMISTRY-US, V32, P9926, DOI 10.1021/bi00089a008; Meng S, 2008, BIOPHYS J, V94, P2095, DOI 10.1529/biophysj.107.121087; Meredith P, 2013, REP PROG PHYS, V76, DOI 10.1088/0034-4885/76/3/034501; METZ G, 1994, J MAGN RESON SER A, V110, P219, DOI 10.1006/jmra.1994.1208; Morcombe CR, 2004, J AM CHEM SOC, V126, P7196, DOI 10.1021/ja047919t; Morcombe CR, 2003, J MAGN RESON, V162, P479, DOI 10.1016/S1090-7807(03)00082-X; Napolitano A, 1996, RAPID COMMUN MASS SP, V10, P468, DOI 10.1002/(SICI)1097-0231(19960315)10:4<468::AID-RCM506>3.3.CO;2-Y; Nosanchuk JD, 2000, LANCET, V355, P2049, DOI 10.1016/S0140-6736(00)02356-4; Nosanchuk JD, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01463; Panzella L, 2013, ANGEW CHEM INT EDIT, V52, P12684, DOI 10.1002/anie.201305747; POLACHECK I, 1990, INFECT IMMUN, V58, P2919, DOI 10.1128/IAI.58.9.2919-2922.1990; Proks V, 2013, MACROMOL CHEM PHYS, V214, P499, DOI 10.1002/macp.201200505; Prota G., 1992, MELANINS MELANOGENES, P88; Rosas AL, 2000, INFECT IMMUN, V68, P2845, DOI 10.1128/IAI.68.5.2845-2853.2000; Simon JD, 2010, ACCOUNTS CHEM RES, V43, P1452, DOI 10.1021/ar100079y; STATES DJ, 1982, J MAGN RESON, V48, P286, DOI 10.1016/0022-2364(82)90279-7; Takegoshi K, 2001, CHEM PHYS LETT, V344, P631, DOI 10.1016/S0009-2614(01)00791-6; Tian SY, 2003, BIOCHEMISTRY-US, V42, P8105, DOI 10.1021/bi0341859; Wang YL, 1996, INFECT IMMUN, V64, P2420, DOI 10.1128/IAI.64.7.2420-2424.1996; Watt AAR, 2009, SOFT MATTER, V5, P3754, DOI 10.1039/b902507c; Zhong JY, 2008, BIOCHEMISTRY-US, V47, P4701, DOI 10.1021/bi702093r	57	13	13	2	23	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					20157	20168		10.1074/jbc.RA118.005791	http://dx.doi.org/10.1074/jbc.RA118.005791			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30385508	Green Published, hybrid			2022-12-28	WOS:000454685900023
J	Demasi, M; Cleland, LG; Cook-Johnson, RJ; Caughey, GE; James, MJ				Demasi, Maryanne; Cleland, Leslie G.; Cook-Johnson, Rebecca J.; Caughey, Gillian E.; James, Michael J.			RETRACTION: Effects of hypoxia on monocyte inflammatory mediator production: Dissociation between changes in cyclooxygenase-2 expression and eicosanoid synthesis. (Retraction of Vol 278, Pg 38607, 2003)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Demasi M, 2003, J BIOL CHEM, V278, P38607, DOI 10.1074/jbc.M305944200	1	0	0	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					20013	20013		10.1074/jbc.RX118.007017	http://dx.doi.org/10.1074/jbc.RX118.007017			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30593534	hybrid, Green Published			2022-12-28	WOS:000454685900011
J	Fink, BD; Bai, F; Yu, LP; Sheldon, RD; Sharma, A; Taylor, EB; Sivitz, WI				Fink, Brian D.; Bai, Fan; Yu, Liping; Sheldon, Ryan D.; Sharma, Arpit; Taylor, Eric B.; Sivitz, William I.			Oxaloacetic acid mediates ADP-dependent inhibition of mitochondrial complex II-driven respiration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bioenergetics; mitochondria; mitochondrial metabolism; mitochondrial respiratory chain complex; skeletal muscle; ADP; ATP; nuclear magnetic resonance (NMR); oxaloacetate; succinate; succinate dehydrogenase	REACTIVE OXYGEN; OXIDATIVE-PHOSPHORYLATION; EXTRA-MITOCHONDRIAL; ELECTRON-TRANSPORT; BRAIN; LIVER; DYSFUNCTION; SUPEROXIDE; ACTIVATION; GENERATION	We recently reported a previously unrecognized mitochondrial respiratory phenomenon. When [ADP] was held constant (clamped) at sequentially increasing concentrations in succinate-energized muscle mitochondria in the absence of rotenone (commonly used to block complex I), we observed a biphasic, increasing then decreasing, respiratory response. Here we investigated the mechanism. We confirmed decades-old reports that oxaloacetate (OAA) inhibits succinate dehydrogenase (SDH). We then used an NMR method to assess OAA concentrations (known as difficult to measure by MS) as well as those of malate, fumarate, and citrate in isolated succinate-respiring mitochondria. When these mitochondria were incubated at varying clamped ADP concentrations, respiration increased at low [ADP] as expected given the concurrent reduction in membrane potential. With further increments in [ADP], respiration decreased associated with accumulation of OAA. Moreover, a low pyruvate concentration, that alone was not enough to drive respiration, was sufficient to metabolize OAA to citrate and completely reverse the loss of succinate-supported respiration at high [ADP]. Further, chemical or genetic inhibition of pyruvate uptake prevented OAA clearance and preserved respiration. In addition, we measured the effects of incremental [ADP] on NADH, superoxide, and H2O2 (a marker of reverse electron transport from complex II to I). In summary, our findings, taken together, support a mechanism (detailed within) wherein succinate-energized respiration as a function of increasing [ADP] is initially increased by [ADP]-dependent effects on membrane potential but subsequently decreased at higher [ADP] by inhibition of succinate dehydrogenase by OAA. The physiologic relevance is discussed.	[Fink, Brian D.; Bai, Fan; Sivitz, William I.] Univ Iowa, Dept Internal Med Endocrinol & Metab, Iowa City, IA 52242 USA; [Yu, Liping; Sheldon, Ryan D.; Sharma, Arpit; Taylor, Eric B.] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA; [Yu, Liping] Univ Iowa, NMR Core Facil, Iowa City, IA 52242 USA; [Yu, Liping] Iowa City Vet Affairs Med Ctr, Iowa City, IA 52242 USA; [Bai, Fan] Emory Univ, Dept Biochem, Atlanta, GA 30322 USA	University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; Emory University	Sivitz, WI (corresponding author), 422GH,200 Hawkins Dr, Iowa City, IA 52242 USA.	william-sivitz@uiowa.edu	Sharma, Arpit/AAE-2638-2022	Sheldon, Ryan/0000-0002-1573-9719; SHARMA, ARPIT/0000-0002-6132-1129; Fink, Brian/0000-0002-1149-7935; Sivitz, William/0000-0002-7829-0189	National Institutes of Health [R01 DK104998, F32 DK116522]; Fraternal Order of the Eagles; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK116522, R01DK104998] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fraternal Order of the Eagles; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by resources and the use of facilities at the Department of Veterans Affairs Iowa City Health Care System, by National Institutes of Health Grants R01 DK104998 and F32 DK116522 (to E. B. H.), and by the Fraternal Order of the Eagles (to W. I. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al Kadhi O, 2017, J ANAL METHODS CHEM, V2017, DOI 10.1155/2017/5391832; AZZONE GF, 1960, NATURE, V188, P552, DOI 10.1038/188552a0; Bai F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154982; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Brand MD, 2004, BIOCHEM SOC SYMP, V71, P203; BRAWAND F, 1980, BIOCHIM BIOPHYS ACTA, V590, P285, DOI 10.1016/0005-2728(80)90199-1; CHANCE B, 1960, NATURE, V185, P666, DOI 10.1038/185666a0; CHANCE B, 1955, J BIOL CHEM, V217, P409; CHANCE B, 1962, J BIOL CHEM, V237, P3540; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fink BD, 2016, AM J PHYSIOL-REG I, V311, pR756, DOI 10.1152/ajpregu.00232.2016; Gray LR, 2015, CELL METAB, V22, P669, DOI 10.1016/j.cmet.2015.07.027; Herlein JA, 2009, ENDOCRINOLOGY, V150, P46, DOI 10.1210/en.2008-0404; Hildyard JCW, 2005, BBA-BIOENERGETICS, V1707, P221, DOI 10.1016/j.bbabio.2004.12.005; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KUSTER U, 1976, BIOCHIM BIOPHYS ACTA, V440, P391, DOI 10.1016/0005-2728(76)90073-6; Lambert AJ, 2004, J BIOL CHEM, V279, P39414, DOI 10.1074/jbc.M406576200; Li SJ, 2005, P NATL ACAD SCI USA, V102, P1082, DOI 10.1073/pnas.0409103102; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; MCEVILY AJ, 1985, ARCH BIOCHEM BIOPHYS, V238, P229, DOI 10.1016/0003-9861(85)90160-2; O'Malley Y, 2006, J BIOL CHEM, V281, P39766, DOI 10.1074/jbc.M608268200; Panov AV, 2010, B EXP BIOL MED+, V149, P187, DOI 10.1007/s10517-010-0904-5; Panov A, 2009, J BIOL CHEM, V284, P14448, DOI 10.1074/jbc.M900985200; Panov AV, 2011, AM J PHYSIOL-REG I, V300, pR844, DOI 10.1152/ajpregu.00528.2010; PRIEGNITZ A, 1973, BIOCHEM BIOPH RES CO, V51, P1034, DOI 10.1016/0006-291X(73)90031-4; Rhee SG, 2010, MOL CELLS, V29, P539, DOI 10.1007/s10059-010-0082-3; SCHOLLMEYER P, 1961, BIOCHEM BIOPH RES CO, V4, P43, DOI 10.1016/0006-291X(61)90252-2; Scialo F, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00428; Sivitz WI, 2010, ANTIOXID REDOX SIGN, V12, P537, DOI 10.1089/ars.2009.2531; Skulachev VP, 1998, BBA-BIOENERGETICS, V1363, P100, DOI 10.1016/S0005-2728(97)00091-1; Votyakova TV, 2001, J NEUROCHEM, V79, P266, DOI 10.1046/j.1471-4159.2001.00548.x; WANDERS RJA, 1984, EUR J BIOCHEM, V142, P417, DOI 10.1111/j.1432-1033.1984.tb08303.x; WOJTCZAK L, 1972, ACTA BIOCHIM POL, V19, P227; Yu Liping, 2015, Methods Mol Biol, V1264, P149, DOI 10.1007/978-1-4939-2257-4_14; Yu LP, 2014, J BIOENERG BIOMEMBR, V46, P33, DOI 10.1007/s10863-013-9530-z; Yu LP, 2013, DIABETES, V62, P1833, DOI 10.2337/db12-1152; Zimmermann M, 2014, ANAL CHEM, V86, P3232, DOI 10.1021/ac500472c	37	18	18	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19932	19941		10.1074/jbc.RA118.005144	http://dx.doi.org/10.1074/jbc.RA118.005144			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30385511	hybrid, Green Published			2022-12-28	WOS:000454294900036
J	Argenzio, E; Klarenbeek, J; Kedziora, KM; Nahidiazar, L; Isogai, T; Perrakis, A; Jalink, K; Moolenaar, WH; Innocenti, M				Argenzio, Elisabetta; Klarenbeek, Jeffrey; Kedziora, Katarzyna M.; Nahidiazar, Leila; Isogai, Tadamoto; Perrakis, Anastassis; Jalink, Kees; Moolenaar, Wouter H.; Innocenti, Metello			Profilin binding couples chloride intracellular channel protein CLIC4 to RhoA-mDia2 signaling and filopodium formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane trafficking; G protein-coupled receptor; Rho (Rho GTPase); profilin; actin; G-actin; formin; epidermal growth factor (EGF); cell adhesion; cell motility; filopodia; lysophosphatidic acid	ACTIN CYTOSKELETON; CRYSTAL-STRUCTURE; SOLUBLE FORM; COMPLEXES; NUCLEAR; IDENTIFICATION; ACTIVATION	Chloride intracellular channel 4 (CLIC4) is a cytosolic protein implicated in diverse actin-based processes, including integrin trafficking, cell adhesion, and tubulogenesis. CLIC4 is rapidly recruited to the plasma membrane by RhoA-activating agonists and then partly colocalizes with 1 integrins. Agonist-induced CLIC4 translocation depends on actin polymerization and requires conserved residues that make up a putative binding groove. However, the mechanism and significance of CLIC4 trafficking have been elusive. Here, we show that RhoA activation by either lysophosphatidic acid (LPA) or epidermal growth factor is necessary and sufficient for CLIC4 translocation to the plasma membrane and involves regulation by the RhoA effector mDia2, a driver of actin polymerization and filopodium formation. We found that CLIC4 binds the G-actin-binding protein profilin-1 via the same residues that are required for CLIC4 trafficking. Consistently, shRNA-induced profilin-1 silencing impaired agonist-induced CLIC4 trafficking and the formation of mDia2-dependent filopodia. Conversely, CLIC4 knockdown increased filopodium formation in an integrin-dependent manner, a phenotype rescued by wild-type CLIC4 but not by the trafficking-incompetent mutant CLIC4(C35A). Furthermore, CLIC4 accelerated LPA-induced filopodium retraction. We conclude that through profilin-1 binding, CLIC4 functions in a RhoA-mDia2-regulated signaling network to integrate cortical actin assembly and membrane protrusion. We propose that agonist-induced CLIC4 translocation provides a feedback mechanism that counteracts formin-driven filopodium formation.	[Argenzio, Elisabetta; Klarenbeek, Jeffrey; Kedziora, Katarzyna M.; Nahidiazar, Leila; Jalink, Kees; Moolenaar, Wouter H.] Netherlands Canc Inst, Div Cell Biol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands; [Isogai, Tadamoto; Innocenti, Metello] Netherlands Canc Inst, Div Mol Genet, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands; [Perrakis, Anastassis] Netherlands Canc Inst, Div Biochem, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute	Moolenaar, WH (corresponding author), Netherlands Canc Inst, Div Cell Biol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.; Innocenti, M (corresponding author), Netherlands Canc Inst, Div Mol Genet, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	w.moolenaar@nki.nl; metelloinnocenti@gmail.com	Isogai, Tadamoto/K-4656-2019; Innocenti, Metello/X-2182-2019; Perrakis, Anastassis/E-8704-2013	Isogai, Tadamoto/0000-0003-0511-0156; Innocenti, Metello/0000-0002-7455-2559; Moolenaar, Wouter/0000-0001-7545-198X; Kedziora, Katarzyna/0000-0001-6524-7731; Perrakis, Anastassis/0000-0002-1151-6227	FP7 WeNMR [261572]; H2020 West-Life [675858]; National GRID Initiatives of Belgium; National GRID Initiatives of France; National GRID Initiatives of Italy; National GRID Initiatives of Germany; National GRID Initiatives of the Netherlands; National GRID Initiatives of Poland; National GRID Initiatives of Portugal; National GRID Initiatives of Spain; National GRID Initiatives of United Kingdom; National GRID Initiatives of South Africa; National GRID Initiatives of Malaysia; National GRID Initiatives of Taiwan; United States Open Science Grid	FP7 WeNMR; H2020 West-Life; National GRID Initiatives of Belgium; National GRID Initiatives of France; National GRID Initiatives of Italy; National GRID Initiatives of Germany; National GRID Initiatives of the Netherlands; National GRID Initiatives of Poland; National GRID Initiatives of Portugal; National GRID Initiatives of Spain; National GRID Initiatives of United Kingdom; National GRID Initiatives of South Africa; National GRID Initiatives of Malaysia; National GRID Initiatives of Taiwan; United States Open Science Grid	We thank Tatjana Heidebrecht for providing recombinant proteins for biophysical experiments performed by Alexander Fish at the NKI Protein Facility and Alexandre Bonvin for advice using HADDOCK. We also thank Guillaume Jacquemet and Hadrien Mary for advice on the use of FiloQuant and Filament-Detector ImageJ plugins, respectively. The FP7 WeNMR (project no. 261572) and H2020 West-Life (project no. 675858) European e-Infrastructure projects are acknowledged for the use of their web portals, which make use of the EGI infrastructure and the DIRAC4EGI service with the dedicated support of CESNET-MetaCloud, INFN-PADOVA, NCG-INGRID-PT, RAL-LCG2, TW-NCHC, IFCA-LCG2, SURFsara, and NIKHEF and the additional support of the National GRID Initiatives of Belgium, France, Italy, Germany, the Netherlands, Poland, Portugal, Spain, United Kingdom, South Africa, Malaysia, Taiwan, and the United States Open Science Grid.	Al Khamici H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115699; Alkam D, 2017, CELL MOL LIFE SCI, V74, P967, DOI 10.1007/s00018-016-2372-1; Argenzio E, 2016, J CELL SCI, V129, P4165, DOI 10.1242/jcs.189795; Argenzio E, 2014, J CELL SCI, V127, P5189, DOI 10.1242/jcs.150623; Beli P, 2008, NAT CELL BIOL, V10, P849, DOI 10.1038/ncb1745; Berryman M, 2004, J BIOL CHEM, V279, P34794, DOI 10.1074/jbc.M402835200; Berryman M, 2000, MOL BIOL CELL, V11, P1509, DOI 10.1091/mbc.11.5.1509; Cao LY, 2018, ELIFE, V7, DOI 10.7554/eLife.34176; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; Chou SY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10412; Dozynkiewicz MA, 2012, DEV CELL, V22, P131, DOI 10.1016/j.devcel.2011.11.008; Dulhunty A, 2001, J BIOL CHEM, V276, P3319, DOI 10.1074/jbc.M007874200; Ferron F, 2007, EMBO J, V26, P4597, DOI 10.1038/sj.emboj.7601874; Folling J, 2008, NAT METHODS, V5, P943, DOI 10.1038/nmeth.1257; Galovic M, 2011, J CELL SCI, V124, P2001, DOI 10.1242/jcs.081182; Harrop SJ, 2001, J BIOL CHEM, V276, P44993, DOI 10.1074/jbc.M107804200; Hernandez-Fernaud JR, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14206; Innocenti M, 2004, NAT CELL BIOL, V6, P319, DOI 10.1038/ncb1105; Innocenti M, 2018, CELL ADHES MIGR, V12, P401, DOI 10.1080/19336918.2018.1448352; Isogai T, 2016, BIOCHEM SOC T, V44, P1701, DOI 10.1042/BST20160187; Isogai T, 2016, J PROTEOME RES, V15, P4624, DOI 10.1021/acs.jproteome.6b00718; Isogai T, 2015, J CELL SCI, V128, P3796, DOI 10.1242/jcs.176768; Isogai T, 2015, SCI REP-UK, V5, DOI 10.1038/srep09802; Isogai T, 2015, MOL CELL PROTEOMICS, V14, P1064, DOI 10.1074/mcp.M114.043885; Jacquemet G, 2017, J CELL BIOL, V216, P3387, DOI 10.1083/jcb.201704045; Jiang L, 2014, BBA-BIOMEMBRANES, V1838, P643, DOI 10.1016/j.bbamem.2013.05.025; Kedziora KM, 2016, J BIOL CHEM, V291, P4323, DOI 10.1074/jbc.M115.695940; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Lawson CD, 2018, J CELL BIOL, V217, P447, DOI 10.1083/jcb.201612069; Leyton-Puig D, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16068; Leyton-Puig D, 2016, BIOL OPEN, V5, P1001, DOI 10.1242/bio.019570; Littler DR, 2008, PROTEINS, V71, P364, DOI 10.1002/prot.21704; Littler DR, 2010, FEBS LETT, V584, P2093, DOI 10.1016/j.febslet.2010.01.027; Littler DR, 2005, FEBS J, V272, P4996, DOI 10.1111/j.1742-4658.2005.04909.x; Mahoney NM, 1997, NAT STRUCT BIOL, V4, P953, DOI 10.1038/nsb1197-953; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Medeiros NA, 2006, NAT CELL BIOL, V8, P215, DOI 10.1038/ncb1367; Ovesny M, 2014, BIOINFORMATICS, V30, P2389, DOI 10.1093/bioinformatics/btu202; Padmakumar VC, 2012, AM J PATHOL, V181, P74, DOI 10.1016/j.ajpath.2012.03.025; Ponsioen B, 2009, MOL BIOL CELL, V20, P4664, DOI 10.1091/mbc.E09-06-0529; Rizvi SA, 2009, CHEM BIOL, V16, P1158, DOI 10.1016/j.chembiol.2009.10.006; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Rotty JD, 2015, DEV CELL, V32, P54, DOI 10.1016/j.devcel.2014.10.026; Shibue T, 2012, CANCER DISCOV, V2, P706, DOI 10.1158/2159-8290.CD-11-0239; Shukla A, 2009, NAT CELL BIOL, V11, P777, DOI 10.1038/ncb1885; Ulmasov B, 2009, AM J PATHOL, V174, P1084, DOI 10.2353/ajpath.2009.080625; van der Kammen R, 2017, DEVELOPMENT, V144, P4588, DOI 10.1242/dev.156323; van der Wal J, 2001, J BIOL CHEM, V276, P15337, DOI 10.1074/jbc.M007194200; van Dijk M, 2012, J CHEM THEORY COMPUT, V8, P3463, DOI 10.1021/ct300102d; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; Wilkinson S, 2005, NAT CELL BIOL, V7, P255, DOI 10.1038/ncb1230; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Witke W, 2004, TRENDS CELL BIOL, V14, P461, DOI 10.1016/j.tcb.2004.07.003; Wu CH, 2012, NATURE, V488, P499, DOI 10.1038/nature11280	55	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2018	293	50					19161	19176		10.1074/jbc.RA118.002779	http://dx.doi.org/10.1074/jbc.RA118.002779			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HE6RA	30381396	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000453537300001
J	Pegg, AE				Pegg, Anthony E.			Introduction to the Thematic Minireview Series: Sixty plus years of polyamine research	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							S-ADENOSYLMETHIONINE DECARBOXYLASE; DEFICIENT SACCHAROMYCES-CEREVISIAE; TARGETING ORNITHINE-DECARBOXYLASE; ADENOSYL-L-METHIONINE; ESCHERICHIA-COLI; SPERMIDINE BIOSYNTHESIS; 1,4-DIAMINOBUTANE PUTRESCINE; SYNTHESIZE PUTRESCINE; PROENZYME FORM; AEROBIC GROWTH	Polyamines have a long history in biochemistry and physiology, dating back to 1678 when Leeuwenhoek first reported crystals that were composed of spermine phosphate in seminal fluid. Their quantification and biosynthetic pathway were first described by Herb and Celia Tabor in collaboration with Sanford Rosenthal in the late 1950s. This work led to immense interest in their physiological functions. The 11 Minireviews in this collection illustrate many of the wide-ranging biochemical effects of the polyamines. This series provides a fitting tribute to Herb Tabor on the occasion of his 100th birthday, demonstrating clearly the importance and growth of the research field that he pioneered in the late 1950s and has contributed to for many years. His studies of the synthesis, function, and toxicity of polyamines have yielded multiple insights into fundamental biochemical processes and formed the basis of successful and continuing drug development. This Minireview series reviews the highly diverse properties of polyamines in bacteria, protozoa, and mammals, highlighting the importance of these molecules in growth, development, and response to the environment, and their involvement in diseases, including cancer, and those caused by parasitic protozoans.	[Pegg, Anthony E.] Penn State Univ, Milton S Hershey Med Ctr, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA; [Pegg, Anthony E.] Penn State Univ, Milton S Hershey Med Ctr, Coll Med, Dept Pharmacol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Pegg, AE (corresponding author), Penn State Univ, Milton S Hershey Med Ctr, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA.; Pegg, AE (corresponding author), Penn State Univ, Milton S Hershey Med Ctr, Coll Med, Dept Pharmacol, Hershey, PA 17033 USA.	apegg@psu.edu						BACCHI CJ, 1980, SCIENCE, V210, P332, DOI 10.1126/science.6775372; Bachmann AS, 2018, J BIOL CHEM, V293, P18757, DOI 10.1074/jbc.TM118.003336; BACHRACH U, 1963, BIOCHIM BIOPHYS ACTA, V78, P768, DOI 10.1016/0006-3002(63)91055-2; BALASUNDARAM D, 1993, P NATL ACAD SCI USA, V90, P4693, DOI 10.1073/pnas.90.10.4693; Balasundaram D, 1999, ANTIMICROB AGENTS CH, V43, P1314, DOI 10.1128/AAC.43.5.1314; Balasundaram D, 1996, J BACTERIOL, V178, P2721, DOI 10.1128/jb.178.9.2721-2724.1996; BALASUNDARAM D, 1991, P NATL ACAD SCI USA, V88, P5872, DOI 10.1073/pnas.88.13.5872; BALASUNDARAM D, 1994, J BACTERIOL, V176, P6407, DOI 10.1128/jb.176.20.6407-6409.1994; BALASUNDARAM D, 1994, J BACTERIOL, V176, P7126, DOI 10.1128/JB.176.22.7126-7128.1994; BALASUNDARAM D, 1994, P NATL ACAD SCI USA, V91, P172, DOI 10.1073/pnas.91.1.172; Bowie D, 2018, J BIOL CHEM, V293, P18789, DOI 10.1074/jbc.TM118.003794; BOWMAN WH, 1973, J BIOL CHEM, V248, P2480; CASARA P, 1989, J AM CHEM SOC, V111, P9111, DOI 10.1021/ja00207a024; Casero RA, 2018, NAT REV CANCER, V18, P681, DOI 10.1038/s41568-018-0050-3; Chattopadhyay MK, 2008, P NATL ACAD SCI USA, V105, P6554, DOI 10.1073/pnas.0710970105; Chattopadhyay MK, 2015, J BIOL CHEM, V290, P17809, DOI 10.1074/jbc.M115.655688; Chattopadhyay MK, 2013, J BIOL CHEM, V288, P33559, DOI 10.1074/jbc.M113.510552; Chattopadhyay MK, 2013, FEMS MICROBIOL LETT, V338, P132, DOI 10.1111/1574-6968.12035; Chattopadhyay MK, 2009, YEAST, V26, P531, DOI 10.1002/yea.1703; Chattopadhyay MK, 2009, J BACTERIOL, V191, P5549, DOI 10.1128/JB.00381-09; Chattopadhyay MK, 2003, P NATL ACAD SCI USA, V100, P2261, DOI 10.1073/pnas.2627990100; Chattopadhyay MK, 2003, P NATL ACAD SCI USA, V100, P13869, DOI 10.1073/pnas.1835918100; Cohen S. S, 1998, GUIDE POLYAMINES, P512; COHN MS, 1977, J BIOL CHEM, V252, P8212; Dever TE, 2018, J BIOL CHEM, V293, P18719, DOI 10.1074/jbc.TM118.003338; Dudley HW, 1924, BIOCHEM J, V18, P1263, DOI 10.1042/bj0181263; Eperon G, 2014, EXPERT REV ANTI-INFE, V12, P1407, DOI 10.1586/14787210.2014.959496; Fuell C, 2010, PLANT PHYSIOL BIOCH, V48, P513, DOI 10.1016/j.plaphy.2010.02.008; GALE EF, 1953, BRIT MED BULL, V9, P135, DOI 10.1093/oxfordjournals.bmb.a074329; Gale EF, 1940, BIOCHEM J, V34, P853, DOI 10.1042/bj0340853; Gerner EW, 2018, J BIOL CHEM, V293, P18770, DOI 10.1074/jbc.TM118.003343; Gupta R, 2001, P NATL ACAD SCI USA, V98, P10620, DOI 10.1073/pnas.181341298; HAFNER EW, 1979, J BIOL CHEM, V254, P2419; Hamasaki-Katagiri N, 1998, GENE, V210, P195, DOI 10.1016/S0378-1119(98)00027-4; HamasakiKatagiri N, 1997, GENE, V187, P35, DOI 10.1016/S0378-1119(96)00660-9; Hanfrey C, 2001, PLANT J, V27, P551, DOI 10.1046/j.1365-313X.2001.01100.x; Hanzawa Y, 2000, EMBO J, V19, P4248, DOI 10.1093/emboj/19.16.4248; HIBASAMI H, 1980, J BIOL CHEM, V255, P6675; Igarashi K, 2018, J BIOL CHEM, V293, P18702, DOI 10.1074/jbc.TM118.003465; Igarashi K, 2010, PLANT PHYSIOL BIOCH, V48, P506, DOI 10.1016/j.plaphy.2010.01.017; Imai A, 2004, PLANT PHYSIOL, V135, P1565, DOI 10.1104/pp.104.041699; Kahana C, 2018, J BIOL CHEM, V293, P18730, DOI 10.1074/jbc.TM118.003339; KASHIWAGI K, 1990, J BIOL CHEM, V265, P22321; Kresge N, 2005, J BIOL CHEM, V280; Kresge N, 2007, J BIOL CHEM, V282, pE26; Leeuwenhoek A., 1678, PHILOS T ROY SOC LON, V12, P1040; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; MARKHAM GD, 1982, J BIOL CHEM, V257, P2063; MCCANN PP, 1981, MED BIOL, V59, P434; MCCANN PP, 1992, PHARMACOL THERAPEUT, V54, P195, DOI 10.1016/0163-7258(92)90032-U; METCALF BW, 1978, J AM CHEM SOC, V100, P2551, DOI 10.1021/ja00476a050; Michael AJ, 2018, J BIOL CHEM, V293, P18693, DOI 10.1074/jbc.TM118.005670; Michael AJ, 2016, BIOCHEM J, V473, P2315, DOI 10.1042/BCJ20160185; MINTON KW, 1990, P NATL ACAD SCI USA, V87, P2851, DOI 10.1073/pnas.87.7.2851; MORRIS DR, 1966, J BIOL CHEM, V241, P3129; Mounce BC, 2017, MICROBIOL MOL BIOL R, V81, DOI 10.1128/MMBR.00029-17; Nichols CG, 2018, J BIOL CHEM, V293, P18779, DOI 10.1074/jbc.TM118.003344; Nilsson JA, 2005, CANCER CELL, V7, P433, DOI 10.1016/j.ccr.2005.03.036; Palanimurugan R, 2018, METHODS MOL BIOL, V1694, P309, DOI 10.1007/978-1-4939-7398-9_26; Palanimurugan R, 2004, EMBO J, V23, P4857, DOI 10.1038/sj.emboj.7600473; Park MH, 2018, J BIOL CHEM, V293, P18710, DOI 10.1074/jbc.TM118.003341; PEGG AE, 1969, J BIOL CHEM, V244, P682; PEGG AE, 1968, BIOCHEM J, V109, pP32, DOI 10.1042/bj1090032Pb; PEGG AE, 1969, BIOCHEM J, V115, P241, DOI 10.1042/bj1150241; PEGG AE, 1982, AM J PHYSIOL, V243, pC212, DOI 10.1152/ajpcell.1982.243.5.C212; PEGG AE, 1982, BIOCHEM J, V202, P519, DOI 10.1042/bj2020519; PEGG AE, 1970, BIOCHEM J, V117, P17, DOI 10.1042/bj1170017; PEGG AE, 1992, PHARMACOL THERAPEUT, V56, P359, DOI 10.1016/0163-7258(92)90025-U; Pegg AE, 2009, ESSAYS BIOCHEM, V46, P25, DOI [10.1042/BSE0460003, 10.1042/bse0460003]; Pegg Anthony E, 2009, Commun Integr Biol, V2, P271; Pegg AE, 2010, CELL MOL LIFE SCI, V67, P113, DOI 10.1007/s00018-009-0165-5; Phillips MA, 2018, J BIOL CHEM, V293, P18746, DOI 10.1074/jbc.TM118.003342; Poulin R, 2012, AMINO ACIDS, V42, P711, DOI 10.1007/s00726-011-0987-y; Rounbehler RJ, 2009, CANCER RES, V69, P547, DOI 10.1158/0008-5472.CAN-08-2968; RUSSELL DH, 1969, MOL PHARMACOL, V5, P253; Schwartz CE, 2011, METHODS MOL BIOL, V720, P437, DOI 10.1007/978-1-61779-034-8_28; Sjoerdsma A, 2008, STARTING SEROTONIN, P266; Stewart TM, 2018, J BIOL CHEM, V293, P18736, DOI 10.1074/jbc.TM118.003337; TABOR CW, 1954, J BIOL CHEM, V208, P645; TABOR CW, 1987, J BIOL CHEM, V262, P16037; Tabor CW, 1999, ANNU REV BIOCHEM, V68, P1, DOI 10.1146/annurev.biochem.68.1.1; TABOR CW, 1966, J BIOL CHEM, V241, P3714; TABOR CW, 1978, J BIOL CHEM, V253, P3671; TABOR CW, 1964, J BIOL CHEM, V239, P2194; TABOR CW, 1976, ANNU REV BIOCHEM, V45, P285, DOI 10.1146/annurev.bi.45.070176.001441; TABOR H, 1975, J BIOL CHEM, V250, P2648; TABOR H, 1964, PHARMACOL REV, V16, P245; TABOR H, 1972, ADV ENZYMOL RAMB, V36, P203; TABOR H, 1981, J BACTERIOL, V147, P702, DOI 10.1128/JB.147.2.702-704.1981; TABOR H, 1958, J BIOL CHEM, V233, P907; Terui Y, 2018, INT J BIOCHEM CELL B, V99, P147, DOI 10.1016/j.biocel.2018.04.008; Thomas TJ, 2018, INT J BIOL MACROMOL, V109, P36, DOI 10.1016/j.ijbiomac.2017.12.076; Tolbert WD, 2003, BIOCHEMISTRY-US, V42, P2386, DOI 10.1021/bi0268854; Toms AV, 2004, J BIOL CHEM, V279, P33837, DOI 10.1074/jbc.M403369200; Urano K, 2005, FEBS LETT, V579, P1557, DOI 10.1016/j.febslet.2005.01.048; WICKNER RB, 1970, J BIOL CHEM, V245, P2132; WILLIAMS-ASHMAN H. G., 1965, INVEST UROL, V2, P605; Wrede F, 1927, H-S Z PHYSIOL CHEM, V163, P219, DOI 10.1515/bchm2.1927.163.4-6.219; Wu H, 2008, J BIOL CHEM, V283, P16135, DOI 10.1074/jbc.M710323200; XIE QW, 1993, GENE, V126, P115, DOI 10.1016/0378-1119(93)90598-W; Yamaguchi K, 2006, FEBS LETT, V580, P6783, DOI 10.1016/j.febslet.2006.10.078	101	15	15	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2018	293	48					18681	18692		10.1074/jbc.TM118.006291	http://dx.doi.org/10.1074/jbc.TM118.006291			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NX	30377254	Green Published, hybrid			2022-12-28	WOS:000458467300023
J	Rangel, LP; Ferretti, GDS; Costa, CL; Andrade, SMMV; Carvalho, RS; Costa, DCF; Silva, JL				Rangel, Luciana P.; Ferretti, Giulia D. S.; Costa, Caroline L.; Andrade, Sarah M. M. V.; Carvalho, Renato S.; Costa, Danielly C. F.; Silva, Jerson L.			p53 reactivation with induction of massive apoptosis-1 (PRIMA-1) inhibits amyloid aggregation of mutant p53 in cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid; protein aggregation; p53; anticancer drug; protein misfolding	PRION-LIKE AGGREGATION; TUMOR-SUPPRESSOR P53; BREAST-CANCER; SMALL MOLECULES; WILD-TYPE; GAIN; BINDING; P63; STABILITY; RESISTANCE	p53 mutants can form amyloid-like structures that accumulate in cells. p53 reactivation with induction of massive apoptosis-1 (PRIMA-1) and its primary active metabolite, 2-methylene-3-quinuclidinone (MQ), can restore unfolded p53 mutants to a native conformation that induces apoptosis and activates several p53 target genes. However, whether PRIMA-1 can clear p53 aggregates is unclear. In this study, we investigated whether PRIMA-1 can restore aggregated mutant p53 to a native form. We observed that the p53 mutant protein is more sensitive to both PRIMA-1 and MQ aggregation inhibition than WT p53. The results of anti-amyloid oligomer antibody assays revealed that PRIMA-1 reverses mutant p53 aggregate accumulation in cancer cells. Size-exclusion chromatography of the lysates from mutant p53-containing breast cancer and ovarian cell lines confirmed that PRIMA-1 substantially decreases p53 aggregates. We also show that MDA-MB-231 cell lysates can seed aggregation of the central core domain of recombinant WT p53, corroborating the prion-like behavior of mutant p53. We also noted that this aggregation effect was inhibited by MQ and PRIMA-1. This study provides the first demonstration that PRIMA-1 can rescue amyloid-state p53 mutants, a strategy that could be further explored as a cancer treatment.	[Rangel, Luciana P.; Andrade, Sarah M. M. V.; Carvalho, Renato S.] Univ Fed Rio de Janeiro, Fac Farm, BR-21941902 Rio De Janeiro, Brazil; [Rangel, Luciana P.; Ferretti, Giulia D. S.; Costa, Caroline L.; Costa, Danielly C. F.; Silva, Jerson L.] Univ Fed Rio de Janeiro, Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, BR-21941902 Rio De Janeiro, Brazil; [Ferretti, Giulia D. S.; Costa, Caroline L.; Silva, Jerson L.] Univ Fed Rio de Janeiro, Programa Biol Estrutural, Inst Bioquim Med Leopoldo Meis, BR-21941902 Rio De Janeiro, Brazil; [Costa, Danielly C. F.] Univ Estado Rio de Janeiro, Dept Nutr Basica & Expt, Inst Nutr, BR-20550013 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade do Estado do Rio de Janeiro	Rangel, LP (corresponding author), Univ Fed Rio de Janeiro, Fac Farm, BR-21941902 Rio De Janeiro, Brazil.; Rangel, LP; Silva, JL (corresponding author), Univ Fed Rio de Janeiro, Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, BR-21941902 Rio De Janeiro, Brazil.; Silva, JL (corresponding author), Univ Fed Rio de Janeiro, Programa Biol Estrutural, Inst Bioquim Med Leopoldo Meis, BR-21941902 Rio De Janeiro, Brazil.	lprangel@pharma.ufrj.br; jerson@bioqmed.ufrj.br	Silva, Jerson/J-8984-2014; Rangel, Luciana/E-7861-2018; SILVA, JERSON Lima/GRF-1442-2022; Carvalho, Renato/AAK-3890-2020	Silva, Jerson/0000-0001-9523-9441; SILVA, JERSON Lima/0000-0001-9523-9441; /0000-0002-6154-0815; Diniz da Silva Ferretti, Giulia/0000-0002-1205-6090	Serrapilheira Institute [Serra-1708-15204]; Fundacao do Cancer; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [465395/2014-7, 402321/2016-2]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro Grant [202955/2015]; Ministerio da Saude; Financiadora de Estudos e Projetos of Brazil	Serrapilheira Institute; Fundacao do Cancer; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro Grant; Ministerio da Saude; Financiadora de Estudos e Projetos of Brazil	This work was supported by Serrapilheira Institute Grant Serra-1708-15204 (to L. P. R.), Fundacao do Cancer, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico Grants 465395/2014-7 and 402321/2016-2 (to J. L. S.), Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro Grant 202955/2015 (to J. L. S.), Ministerio da Saude, and Financiadora de Estudos e Projetos of Brazil. The authors declare that they have no conflicts of interest with the contents of this article.	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Alexandrova EM, 2015, NATURE, V523, P352, DOI 10.1038/nature14430; Antony H, 2012, CANCER METAST REV, V31, P1, DOI 10.1007/s10555-011-9325-9; BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; Blandino G, 1999, ONCOGENE, V18, P477, DOI 10.1038/sj.onc.1202314; Bom APDA, 2012, J BIOL CHEM, V287, P28152, DOI 10.1074/jbc.M112.340638; Buhlmann S, 2008, BBA-REV CANCER, V1785, P207, DOI 10.1016/j.bbcan.2008.01.002; Bullock AN, 1997, P NATL ACAD SCI USA, V94, P14338, DOI 10.1073/pnas.94.26.14338; Bykov VJN, 2005, J BIOL CHEM, V280, P30384, DOI 10.1074/jbc.M501664200; Bykov VJN, 2005, ONCOGENE, V24, P3484, DOI 10.1038/sj.onc.1208419; Bykov VJN, 2003, EUR J CANCER, V39, P1828, DOI 10.1016/S0959-8049(03)00454-4; Bykov VJN, 2002, CARCINOGENESIS, V23, P2011, DOI 10.1093/carcin/23.12.2011; Bykov VJN, 2002, NAT MED, V8, P282, DOI 10.1038/nm0302-282; Bykov VJN, 2018, NAT REV CANCER, V18, P89, DOI 10.1038/nrc.2017.109; Bykov VJN, 2014, FEBS LETT, V588, P2622, DOI 10.1016/j.febslet.2014.04.017; Chemes LB, 2013, J BIOL CHEM, V288, P18923, DOI 10.1074/jbc.M113.467316; Chen ZL, 2017, BIOCHEM BIOPH RES CO, V489, P130, DOI 10.1016/j.bbrc.2017.05.111; Cino EA, 2016, SCI REP-UK, V6, DOI 10.1038/srep32535; Costa DCF, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a023614; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Ghosh S, 2017, CELL DEATH DIFFER, V24, P1784, DOI 10.1038/cdd.2017.105; Grob TJ, 2001, CELL DEATH DIFFER, V8, P1213, DOI 10.1038/sj.cdd.4400962; Herzog G, 2015, BIOCHEMISTRY-US, V54, P3729, DOI 10.1021/bi501092p; Ishimaru D, 2003, BIOCHEMISTRY-US, V42, P9022, DOI 10.1021/bi034218k; Ishimaru D, 2009, BIOCHEMISTRY-US, V48, P6126, DOI 10.1021/bi9003028; JUVEN T, 1993, ONCOGENE, V8, P3411; Kaar JL, 2010, PROTEIN SCI, V19, P2267, DOI 10.1002/pro.507; Kehrloesser S, 2016, CELL DEATH DIFFER, V23, P1952, DOI 10.1038/cdd.2016.75; Kirilyuk A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048243; Lambert JMR, 2010, ONCOGENE, V29, P1329, DOI 10.1038/onc.2009.425; Lambert JMR, 2009, CANCER CELL, V15, P376, DOI 10.1016/j.ccr.2009.03.003; Lasagna-Reeves CA, 2013, BIOCHEM BIOPH RES CO, V430, P963, DOI 10.1016/j.bbrc.2012.11.130; Latonen L, 2011, ONCOGENE, V30, P790, DOI 10.1038/onc.2010.469; Lehmann S, 2012, J CLIN ONCOL, V30, P3633, DOI 10.1200/JCO.2011.40.7783; Levy CB, 2011, INT J BIOCHEM CELL B, V43, P60, DOI 10.1016/j.biocel.2010.10.017; Liang YY, 2009, INT J ONCOL, V35, P1015, DOI 10.3892/ijo_00000416; Liu DS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14844; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Mizejewski GJ, 2017, BREAST CANCER-TARGET, V9, DOI 10.2147/BCTT.S131394; Mohell N, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.143; Muller PAJ, 2014, CANCER CELL, V25, P304, DOI 10.1016/j.ccr.2014.01.021; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Peng X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.417; PERRY ME, 1993, P NATL ACAD SCI USA, V90, P11623, DOI 10.1073/pnas.90.24.11623; Piantino CB, 2013, CLINICS, V68, P297, DOI 10.6061/clinics/2013(03)OA03; Pozniak CD, 2000, SCIENCE, V289, P304, DOI 10.1126/science.289.5477.304; Rieber M, 2012, BIOCHEM PHARMACOL, V84, P1563, DOI 10.1016/j.bcp.2012.09.003; Rokaeus N, 2007, ONCOGENE, V26, P982, DOI 10.1038/sj.onc.1209858; Rokaeus N, 2010, ONCOGENE, V29, P6442, DOI 10.1038/onc.2010.382; Russo D, 2010, BIOCHEM BIOPH RES CO, V402, P345, DOI 10.1016/j.bbrc.2010.10.031; Schilling T, 2010, BIOCHEM BIOPH RES CO, V394, P817, DOI 10.1016/j.bbrc.2010.03.082; Silva JL, 2018, ACCOUNTS CHEM RES, V51, P181, DOI 10.1021/acs.accounts.7b00473; Silva JL, 2014, TRENDS BIOCHEM SCI, V39, P260, DOI 10.1016/j.tibs.2014.04.001; Soragni A, 2016, CANCER CELL, V29, P90, DOI 10.1016/j.ccell.2015.12.002; Synnott NC, 2017, INT J CANCER, V140, P234, DOI 10.1002/ijc.30425; Takagi K, 2013, CANCER SCI, V104, P1532, DOI 10.1111/cas.12239; Vieira TCRG, 2014, FASEB J, V28, P2667, DOI 10.1096/fj.13-246777; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wang GZ, 2017, P NATL ACAD SCI USA, V114, pE2634, DOI 10.1073/pnas.1700308114; Wassman CD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2361; Wiech M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051426; Wilcken R, 2012, P NATL ACAD SCI USA, V109, P13584, DOI 10.1073/pnas.1211550109; Wong RPC, 2007, MOL CANCER THER, V6, P1054, DOI 10.1158/1535-7163.MCT-06-0336; Xu J, 2011, NAT CHEM BIOL, V7, P285, DOI 10.1038/nchembio.546; Zhang Q, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0463-7; Zhu JJ, 2015, NATURE, V525, P206, DOI 10.1038/nature15251	67	36	38	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3670	3682		10.1074/jbc.RA118.004671	http://dx.doi.org/10.1074/jbc.RA118.004671			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30602570	Green Published, hybrid			2022-12-28	WOS:000461853900029
J	Rajan, S; Jagatheesan, G; Petrashevskaya, N; Biesiadecki, BJ; Warren, CM; Riddle, T; Liggett, S; Wolska, BM; Solaro, RJ; Wieczorek, DF				Rajan, Sudarsan; Jagatheesan, Ganapathy; Petrashevskaya, Natalia; Biesiadecki, Brandon J.; Warren, Chad M.; Riddle, Tara; Liggett, Stephen; Wolska, Beata M.; Solaro, R. John; Wieczorek, David F.			Tropomyosin pseudo-phosphorylation results in dilated cardiomyopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						tropomyosin; phosphorylation; cardiomyopathy; muscle physiology; transgenic mice; cardiac muscle; casein kinase; myofilament; phosphomimetic	ALPHA-TROPOMYOSIN; RABBIT SKELETAL; THIN FILAMENT; KINASE; MYOSIN; DEPHOSPHORYLATION; RELAXATION; STRESS; CELLS	Phosphorylation of cardiac sarcomeric proteins plays a major role in the regulation of the physiological performance of the heart. Phosphorylation of thin filament proteins, such as troponin I and T, dramatically affects calcium sensitivity of the myofiber and systolic and diastolic functions. Phosphorylation of the regulatory protein tropomyosin (Tpm) results in altered biochemical properties of contraction; however, little is known about the physiological effect of Tpm phosphorylation on cardiac function. To address the in vivo significance of Tpm phosphorylation, here we generated transgenic mouse lines having a phosphomimetic substitution in the phosphorylation site of alpha-Tpm (S283D). High expression of Tpm S283D variant in one transgenic mouse line resulted in an increased heart:body weight ratio, coupled with a severe dilated cardiomyopathic phenotype resulting in death within 1 month of birth. Moderate Tpm S283D mice expression in other lines caused mild myocyte hypertrophy and fibrosis, did not affect lifespan, and was coupled with decreased expression of extracellular signal-regulated kinase 1/2 kinase signaling. Physiological analysis revealed that the transgenic mice exhibit impaired diastolic function, without changes in systolic performance. Surprisingly, we observed no alterations in calcium sensitivity of the myofibers, cooperativity, or calcium-ATPase activity in the myofibers. Our experiments also disclosed that casein kinase 2 plays an integral role in Tpm phosphorylation. In summary, increased expression of pseudo-phosphorylated Tpm impairs diastolic function in the intact heart, without altering calcium sensitivity or cooperativity of myofibers. Our findings provide the first extensive in vivo assessment of Tpm phosphorylation in the heart and its functional role in cardiac performance.	[Rajan, Sudarsan; Jagatheesan, Ganapathy; Riddle, Tara; Wieczorek, David F.] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, 231 Albert Sabin Way, Cincinnati, OH 45267 USA; [Petrashevskaya, Natalia; Liggett, Stephen] Univ Maryland, Dept Med, Baltimore, MD 21201 USA; [Biesiadecki, Brandon J.; Warren, Chad M.; Wolska, Beata M.; Solaro, R. John] Univ Illinois, Chicago Coll Med, Dept Physiol & Biophys, Chicago, IL 60612 USA; [Biesiadecki, Brandon J.] Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Biesiadecki, Brandon J.] Ohio State Univ, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Wolska, Beata M.] Univ Illinois, Dept Med, Div Cardiol, Chicago, IL 60612 USA; [Rajan, Sudarsan] Temple Univ, Lewis Katz Sch Med, Ctr Translat Med, 3500 N Broad St, Philadelphia, PA 19140 USA; [Jagatheesan, Ganapathy] Univ Louisville, Inst Mol Cardiol, Dept Med, 580 S Preston St, Louisville, KY 40202 USA; [Petrashevskaya, Natalia] NIA, Lab Cardiovasc Sci, Biomed Res Ctr, NIH, Baltimore, MD 21224 USA; [Liggett, Stephen] Univ S Florida, Morsani Coll Med, Ctr Personalized Med & Genom, Dept Pharmacol & Physiol, 12901 Bruce B Downs Blvd, Tampa, FL 33612 USA	University System of Ohio; University of Cincinnati; University System of Maryland; University of Maryland Baltimore; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Louisville; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); State University System of Florida; University of South Florida	Wieczorek, DF (corresponding author), Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, 231 Albert Sabin Way, Cincinnati, OH 45267 USA.	david.wieczorek@uc.edu		Liggett, Stephen B./0000-0002-0128-3669	National Institutes of Health [HL081680, HL128468, HL062426, HL114940]; American Heart Association Scientist Development Grant [11SDG4980029]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114940, P01HL062426, R01HL128468] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Scientist Development Grant(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grants HL081680 (to D. F. W.), HL128468 and HL062426 (to R. J. S. and B. M. W.), and HL114940 (to B. J. B.), and American Heart Association Scientist Development Grant 11SDG4980029 (to S. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alves ML, 2017, CARDIOVASC RES, V113, P915, DOI 10.1093/cvr/cvx068; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Heeley D., 2014, J MUSCLE RES CELL M, V24, P233; HEELEY DA, 1982, FEBS LETT, V146, P115, DOI 10.1016/0014-5793(82)80716-3; HEELEY DH, 1989, J BIOL CHEM, V264, P2424; HEELEY DH, 1994, EUR J BIOCHEM, V221, P129, DOI 10.1111/j.1432-1033.1994.tb18721.x; Houle FO, 2003, MOL BIOL CELL, V14, P1418, DOI 10.1091/mbc.E02-04-0235; Houle F, 2007, J CELL SCI, V120, P3666, DOI 10.1242/jcs.003251; Jagatheesan G, 2003, J BIOL CHEM, V278, P23204, DOI 10.1074/jbc.M303073200; Kehat I, 2011, CIRC RES, V108, P176, DOI 10.1161/CIRCRESAHA.110.231514; Kehat I, 2010, ANN NY ACAD SCI, V1188, P96, DOI 10.1111/j.1749-6632.2009.05088.x; Kentish JC, 2001, CIRC RES, V88, P1059, DOI 10.1161/hh1001.091640; LEHRER SS, 1982, J BIOL CHEM, V257, P8073; Lehrer SS, 1998, J MOL BIOL, V277, P1081, DOI 10.1006/jmbi.1998.1654; Linke WA, 2014, CIRC RES, V114, P1052, DOI 10.1161/CIRCRESAHA.114.301286; Lu XY, 2010, J MUSCLE RES CELL M, V31, P93, DOI 10.1007/s10974-010-9213-x; MAK A, 1978, P NATL ACAD SCI USA, V75, P3588, DOI 10.1073/pnas.75.8.3588; Miyata Y, 2008, MOL CELL BIOCHEM, V316, P127, DOI 10.1007/s11010-008-9818-1; MONTGOMERY K, 1984, J BIOL CHEM, V259, P5555; MUTHUCHAMY M, 1993, MOL CELL BIOL, V13, P3311, DOI 10.1128/MCB.13.6.3311; Muthuchamy M, 1995, J BIOL CHEM, V270, P30593, DOI 10.1074/jbc.270.51.30593; Nixon BR, 2013, ARCH BIOCHEM BIOPHYS, V535, P30, DOI 10.1016/j.abb.2012.11.010; Nuesch JPF, 2007, P NATL ACAD SCI USA, V104, P12482, DOI 10.1073/pnas.0705533104; Prabhakar R, 2001, J MOL CELL CARDIOL, V33, P1815, DOI 10.1006/jmcc.2001.1445; Prasad SVN, 2005, NAT CELL BIOL, V7, P785, DOI 10.1038/ncb1278; Rajan S, 2007, CIRC RES, V101, P205, DOI 10.1161/CIRCRESAHA.107.148379; Rajan S, 2010, CIRCULATION, V121, P410, DOI 10.1161/CIRCULATIONAHA.109.889725; Rao VS, 2011, J BIOL CHEM, V286, P24135, DOI 10.1074/jbc.M110.167957; Rao VS, 2009, CELL MOTIL CYTOSKEL, V66, P10, DOI 10.1002/cm.20321; Schulz EM, 2013, J BIOL CHEM, V288, P28925, DOI 10.1074/jbc.M113.466466; Schulz EM, 2012, J BIOL CHEM, V287, P44478, DOI 10.1074/jbc.M112.402040; Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005; SUBRAMANIAM A, 1991, J BIOL CHEM, V266, P24613; Sumandea MP, 2004, ANN NY ACAD SCI, V1015, P39, DOI 10.1196/annals.1302.004; Vahebi S, 2007, CIRC RES, V100, P408, DOI 10.1161/01.RES.0000258116.60404.ad; Warren CM, 2008, PROTEOMICS, V8, P100, DOI 10.1002/pmic.200700772; Wolska BM, 1999, CIRC RES, V84, P745; Wong YH, 2007, NUCLEIC ACIDS RES, V35, pW588, DOI 10.1093/nar/gkm322; Wu SC, 2007, J BIOL CHEM, V282, P30691, DOI 10.1074/jbc.M703670200; Yuen M, 2015, HUM MOL GENET, V24, P6278, DOI 10.1093/hmg/ddv334	40	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2913	2923		10.1074/jbc.RA118.004879	http://dx.doi.org/10.1074/jbc.RA118.004879			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30567734	hybrid, Green Published			2022-12-28	WOS:000459601600028
J	Adachi, N; Hess, DT; Kaku, M; Ueda, C; Numa, C; Saito, N				Adachi, Naoko; Hess, Douglas T.; Kaku, Mika; Ueda, Chie; Numa, Chisato; Saito, Naoaki			Differential S-palmitoylation of the human and rodent beta(3)-adrenergic receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein acylation; G protein-coupled receptor (GPCR); adrenergic receptor; protein palmitoylation; receptor regulation; acyl-RAC; ADRB3; beta 3-adrenergic receptor; lipidation; S-palmitoylation	G-PROTEIN; BETA-3-ADRENERGIC RECEPTOR; TAIL; ACYLATION; AGONIST; SITES	With few reported exceptions, G protein-coupled receptors (GPCRs) are modified by Cys palmitoylation (S-palmitoylation). In multiple GPCRs, S-palmitoylation targets a canonical site within the C-terminal cytoplasmic tail adjacent to the C terminus of the seventh transmembrane domain, but modification of additional sites is exemplified by the beta-adrenergic receptors (beta ARs). The beta(1)AR is S-palmitoylated at a second, more distal site within the C-terminal tail, and the beta(2)AR is modified at a second site within the third intracellular loop, neither of which is conserved in other beta AR isoforms. The functional roles of S-palmitoylation of disparate sites are incompletely characterized for any GPCR family. Here, we describe S-palmitoylation of the beta(3)AR. We compared mouse and human beta(3)ARs and found that both were S-palmitoylated at the canonical site within the C-terminal tail, Cys-358 and Cys-361/363 in mouse and human beta(3)ARs, respectively. Surprisingly, the human beta(3)AR was S-palmitoylated at two additional sites, Cys-153 and Cys-292 within the second and third intracellular loops, respectively. Cys-153 is apparently unique to the human beta(3)AR, and Cys-292 is conserved primarily in primates. Mutational substitution of C-tail Cys in human but not mouse beta(3)ARs resulted in diminished ligand-induced cAMP production. Substitution of Cys-153, Cys-292, or Cys-361/363 within the human beta(3)AR diminished membrane-receptor abundance, but only Cys-361/363 substitution diminished membrane-receptor half-life. Thus, S-palmitoylation of different sites differentially regulates the human beta(3)AR, and differential S-palmitoylation distinguishes human and rodent beta(3)ARs, potentially contributing to species-specific differences in the clinical efficacy of beta(3)AR-directed pharmacological approaches to disease.	[Adachi, Naoko; Kaku, Mika; Ueda, Chie; Numa, Chisato; Saito, Naoaki] Kobe Univ, Biosignal Res Ctr, Kobe, Hyogo 6578501, Japan; [Hess, Douglas T.] Case Western Reserve Univ, Sch Med, Inst Transformat Mol Med, Cleveland, OH 44106 USA; [Hess, Douglas T.] Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA	Kobe University; Case Western Reserve University; Case Western Reserve University	Adachi, N (corresponding author), Kobe Univ, Biosignal Res Ctr, Kobe, Hyogo 6578501, Japan.	na@gold.kobe-u.ac.jp		Adachi, Naoko/0000-0002-8797-0717	Japan Society for the Promotion of Science (JSPS), KAKENHI [JP15K18988, JP16KK0181, JP17K08595]; National Institutes of Health [P01 HL128129]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL128129] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science (JSPS), KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Japan Society for the Promotion of Science (JSPS) AR (9), whereas the KAKENHI Grants JP15K18988, JP16KK0181, and JP17K08595 with additional support from National Institutes of Health Grant P01 HL128129 (to D. T. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adachi N, 2016, J BIOL CHEM, V291, P20232, DOI 10.1074/jbc.M116.725762; Amici SA, 2012, J BIOL CHEM, V287, P23119, DOI 10.1074/jbc.M111.328294; Blaskovic S, 2013, FEBS J, V280, P2766, DOI 10.1111/febs.12263; Cannavo A, 2017, J CARDIOVASC PHARM, V69, P71, DOI 10.1097/FJC.0000000000000444; Chen SY, 2017, NATURE, V549, P399, DOI 10.1038/nature23887; Chini B, 2009, J MOL ENDOCRINOL, V42, P371, DOI 10.1677/JME-08-0114; Collins MO, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04580-1; Dessy C, 2004, CIRCULATION, V110, P948, DOI 10.1161/01.CIR.0000139331.85766.AF; Ebersole B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140661; EMORINE LJ, 1989, SCIENCE, V245, P1118, DOI 10.1126/science.2570461; Ernst AM, 2018, DEV CELL, V47, P479, DOI 10.1016/j.devcel.2018.10.024; Evans BA, 1999, BRIT J PHARMACOL, V127, P1525, DOI 10.1038/sj.bjp.0702688; Forrester MT, 2011, J LIPID RES, V52, P393, DOI 10.1194/jlr.D011106; Gottlieb CD, 2017, BIOCHEM SOC T, V45, P923, DOI 10.1042/BST20160304; GUAN XM, 1992, J BIOL CHEM, V267, P21995; Hainer V, 2016, EXPERT OPIN PHARMACO, V17, P2125, DOI 10.1080/14656566.2016.1233177; KRIEF S, 1993, J CLIN INVEST, V91, P344, DOI 10.1172/JCI116191; NANTEL F, 1993, MOL PHARMACOL, V43, P548; ODOWD BF, 1989, J BIOL CHEM, V264, P7564; Papoucheva E, 2004, J BIOL CHEM, V279, P3280, DOI 10.1074/jbc.M308177200; Ponimaskin EG, 2002, J BIOL CHEM, V277, P2534, DOI 10.1074/jbc.M106529200; Qanbar R, 2003, PHARMACOL THERAPEUT, V97, P1, DOI 10.1016/S0163-7258(02)00300-5; Reid HM, 2007, CELL SIGNAL, V19, P1056, DOI 10.1016/j.cellsig.2006.12.001; Takasu T, 2007, J PHARMACOL EXP THER, V321, P642, DOI 10.1124/jpet.106.115840; Uribe A, 2008, BIOL REPROD, V78, P869, DOI 10.1095/biolreprod.107.063925; Won SJ, 2018, CRIT REV BIOCHEM MOL, V53, P83, DOI 10.1080/10409238.2017.1409191; Zhang X, 2016, BIOCHEM BIOPH RES CO, V479, P398, DOI 10.1016/j.bbrc.2016.09.094; Zhang XW, 2016, BBA-BIOMEMBRANES, V1858, P2152, DOI 10.1016/j.bbamem.2016.06.021; Zheng H, 2012, BMC CELL BIOL, V13, DOI 10.1186/1471-2121-13-6; Zuckerman DM, 2011, J BIOL CHEM, V286, P19014, DOI 10.1074/jbc.M110.189977	30	5	5	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2019	294	7					2569	2578		10.1074/jbc.RA118.004978	http://dx.doi.org/10.1074/jbc.RA118.004978			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL7CN	30541923	Green Published, hybrid			2022-12-28	WOS:000458895400030
J	Cuesta, R; Berman, AY; Alayev, A; Holz, MK				Cuesta, Rafael; Berman, Adi Y.; Alayev, Anya; Holz, Marina K.			Estrogen receptor alpha promotes protein synthesis by fine-tuning the expression of the eukaryotic translation initiation factor 3 subunit f (eIF3f)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						breast cancer; translation; estrogen receptor; eukaryotic translation initiation; gene expression; eIF3f; ER alpha; mTORC1	PHOSPHORYLATION; BINDING; STIMULATION; ACTIVATION; RESISTANCE; MECHANISM; COMPLEX; EIF4G; MTOR	Approximately two thirds of all breast cancer cases are estrogen receptor (ER)-positive. The treatment of this breast cancer subtype with endocrine therapies is effective in the adjuvant and recurrent settings. However, their effectiveness is compromised by the emergence of intrinsic or acquired resistance. Thus, identification of new molecular targets can significantly contribute to the development of novel therapeutic strategies. In recent years, many studies have implicated aberrant levels of translation initiation factors in cancer etiology and provided evidence that identifies these factors as promising therapeutic targets. Accordingly, we observed reduced levels of the eIF3 subunit eIF3f in ER-positive breast cancer cells compared with ER-negative cells, and determined that low eIF3f levels are required for proper proliferation and survival of ER-positive MCF7 cells. The expression of eIF3f is tightly controlled by ER alpha at the transcriptional (genomic pathway) and translational (nongenomic pathway) level. Specifically, estrogen-bound ER alpha represses transcription of the EIF3F gene, while promoting eIF3f mRNA translation. To regulate translation, estrogen activates the mTORC1 pathway, which enhances the binding of eIF3 to the eIF4F complex and, consequently, the assembly of the 48S preinitiation complexes and protein synthesis. We observed preferential translation of mRNAs with highly structured 5 '-UTRs that usually encode factors involved in cell proliferation and survival (e.g. cyclin D1 and survivin). Our results underscore the importance of estrogen-ER alpha-mediated control of eIF3f expression for the proliferation and survival of ER-positive breast cancer cells. These findings may provide rationale for the development of new therapies to treat ER-positive breast cancer.	[Cuesta, Rafael; Holz, Marina K.] New York Med Coll, Dept Cell Biol & Anat, Valhalla, NY 10595 USA; [Berman, Adi Y.; Alayev, Anya] Yeshiva Univ, Dept Biol, New York, NY 10016 USA; [Holz, Marina K.] Albert Einstein Canc Ctr, Bronx, NY 10461 USA	New York Medical College; Yeshiva University; Yeshiva University	Holz, MK (corresponding author), New York Med Coll, Dept Cell Biol & Anat, Valhalla, NY 10595 USA.; Holz, MK (corresponding author), Albert Einstein Canc Ctr, Bronx, NY 10461 USA.	mholz@nymc.edu		Holz, Marina/0000-0001-5030-7973	American Cancer Society [RSG-13-287-01-TBE]; NIGMS, National Institutes of Health [GM128675]; NCI, National Institutes of Health [CA151112]; Atol Charitable Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM128675] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Atol Charitable Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by American Cancer Society Grant RSG-13-287-01-TBE; NIGMS, National Institutes of Health Grant GM128675; NCI, National Institutes of Health Grant CA151112; and a research award from the Atol Charitable Trust (to M. K. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alayev A, 2016, CELL CYCLE, V15, P3230, DOI 10.1080/15384101.2016.1241927; Altucci L, 1996, ONCOGENE, V12, P2315; Bhat M, 2015, NAT REV DRUG DISCOV, V14, P261, DOI 10.1038/nrd4505; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Chu J, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a032995; Chu J, 2016, TRENDS CELL BIOL, V26, P918, DOI 10.1016/j.tcb.2016.06.005; Chu J, 2015, BBA-GENE REGUL MECH, V1849, P781, DOI 10.1016/j.bbagrm.2014.09.006; Csibi A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008994; Cuesta R, 2016, ONCOTARGET, V7, P27567, DOI 10.18632/oncotarget.8375; de la Parra C, 2018, CURR OPIN GENET DEV, V48, P82, DOI 10.1016/j.gde.2017.11.001; De Marchi T, 2016, DRUG DISCOV TODAY, V21, P1181, DOI 10.1016/j.drudis.2016.05.012; Echeverria PC, 2010, BBA-MOL CELL RES, V1803, P641, DOI 10.1016/j.bbamcr.2009.11.012; Gao BC, 2015, BBA-GENE REGUL MECH, V1849, P753, DOI 10.1016/j.bbagrm.2014.11.006; Guertin MJ, 2014, MOL ENDOCRINOL, V28, P1522, DOI 10.1210/me.2014-1130; Harris TE, 2006, EMBO J, V25, P1659, DOI 10.1038/sj.emboj.7601047; Hershey JWB, 2015, BBA-GENE REGUL MECH, V1849, P792, DOI 10.1016/j.bbagrm.2014.10.005; Hershey JWB, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011528; Hinnebusch AG, 2014, ANNU REV BIOCHEM, V83, P779, DOI 10.1146/annurev-biochem-060713-035802; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Kruger M, 2001, MOL CELL BIOL, V21, P8357, DOI 10.1128/MCB.21.24.8357-8364.2001; Lee ASY, 2016, NATURE, V536, P96, DOI 10.1038/nature18954; Lee ASY, 2015, NATURE, V522, P111, DOI 10.1038/nature14267; Levin ER, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2016.122; Liang J, 2013, ANNU REV PHYSIOL, V75, P225, DOI 10.1146/annurev-physiol-030212-183708; Lu CW, 2016, EXPERT REV MOL MED, V18, DOI 10.1017/erm.2015.20; Maruani DM, 2012, ONCOGENE, V31, P5073, DOI 10.1038/onc.2011.657; Miller TW, 2011, J CLIN ONCOL, V29, P4452, DOI 10.1200/JCO.2010.34.4879; Miller WR, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr2931; Musgrove EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002987; Nishidate T, 2004, INT J ONCOL, V25, P797; Rondon-Lagos M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081357; Saint-Andre V, 2011, NAT STRUCT MOL BIOL, V18, P337, DOI 10.1038/nsmb.1995; Shi J, 2006, ONCOGENE, V25, P4923, DOI 10.1038/sj.onc.1209495; Shi JQ, 2009, FEBS LETT, V583, P971, DOI 10.1016/j.febslet.2009.02.028; Truitt ML, 2016, NAT REV CANCER, V16, P288, DOI 10.1038/nrc.2016.27; Vaklavas C, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00158; Valasek LS, 2017, NUCLEIC ACIDS RES, V45, P10948, DOI 10.1093/nar/gkx805; Villa N, 2013, J BIOL CHEM, V288, P32932, DOI 10.1074/jbc.M113.517011; Wagner S, 2016, NUCLEIC ACIDS RES, V44, P10772, DOI 10.1093/nar/gkw972; Wagner S, 2014, MOL CELL BIOL, V34, P3041, DOI 10.1128/MCB.00663-14; Wen FS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034194; Wendel HG, 2007, GENE DEV, V21, P3232, DOI 10.1101/gad.1604407; Zhang LL, 2008, J BIOL CHEM, V283, P24047, DOI 10.1074/jbc.M800956200; Zhang LL, 2007, J BIOL CHEM, V282, P5790, DOI 10.1074/jbc.M606284200; Zhao WP, 2017, MED SCI MONITOR, V23, DOI 10.12659/MSM.906389	45	13	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2019	294	7					2267	2278		10.1074/jbc.RA118.004383	http://dx.doi.org/10.1074/jbc.RA118.004383			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL7CN	30573685	Green Published, hybrid			2022-12-28	WOS:000458895400006
J	Tan, C; Byrne, EFX; Ah-Cann, C; Call, MJ; Call, ME				Tan, Cyrus; Byrne, Eamon F. X.; Ah-Cann, Casey; Call, Melissa J.; Call, Matthew E.			A serine in the first transmembrane domain of the human E3 ubiquitin ligase MARCH9 is critical for down-regulation of its protein substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						immunology; receptor endocytosis; ubiquitin ligase; membrane protein; nuclear magnetic resonance (NMR); major histocompatibility complex (MHC); T-cell; E3 ligase; membrane-associated RING-CH (MARCH); transmembrane domain	COMPLEX CLASS-I; ANTIGEN PRESENTATION; CELL SELECTION; EXPRESSION; RECOGNITION; ASSOCIATION; INHIBITION; SURFACE; MODEL; DIMER	The membrane-associated RING-CH (MARCH) family of membrane-bound E3 ubiquitin ligases regulates the levels of cell-surface membrane proteins, many of which are involved in immune responses. Although their role in ubiquitin-dependent endocytosis and degradation of cell-surface proteins is extensively documented, the features of MARCH proteins and their substrates that drive the molecular recognition events leading to ubiquitin transfer remain poorly defined. In this study, we sought to determine the features of human MARCH9 that are required for regulating the surface levels of its substrate proteins. Consistent with previous studies of other MARCH proteins, we found that susceptibility to MARCH9 activity is encoded in the transmembrane (TM) domains of its substrates. Accordingly, substitutions at specific residues and motifs within MARCH9's TM domains resulted in varying degrees of functional impairment. Most notably, a single serine-to-alanine substitution in the first of its two TM domains rendered MARCH9 completely unable to alter the surface levels of two different substrates: the major histocompatibility class I molecule HLA-A2 and the T-cell co-receptor CD4. Solution NMR analysis of a MARCH9 fragment encompassing the two TM domains and extracellular connecting loop revealed that the residues contributing most to MARCH9 activity are located in the alpha-helical portions of TM1 and TM2 that are closest to the extracellular face of the lipid bilayer. This observation defines a key region required for substrate regulation. In summary, our biochemical and structural findings demonstrate that specific sequences in the alpha-helical MARCH9 TM domains make crucial contributions to its ability to down-regulate its protein substrates.	[Tan, Cyrus; Call, Melissa J.; Call, Matthew E.] Walter & Eliza Hall Inst Med Res, Struct Biol Div, Parkville, Vic 3052, Australia; [Tan, Cyrus; Ah-Cann, Casey; Call, Melissa J.; Call, Matthew E.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Byrne, Eamon F. X.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Ah-Cann, Casey] Walter & Eliza Hall Inst Med Res, ACRF Stem Cells & Canc Div, Parkville, Vic 3052, Australia	Walter & Eliza Hall Institute; University of Melbourne; Stanford University; Walter & Eliza Hall Institute	Call, MJ; Call, ME (corresponding author), Walter & Eliza Hall Inst Med Res, Struct Biol Div, Parkville, Vic 3052, Australia.; Call, MJ; Call, ME (corresponding author), Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia.	call@wehi.edu.au; call@wehi.edu.au	Call, Melissa/HHZ-6671-2022	Call, Melissa/0000-0001-7684-5841; Ah-Cann, Casey/0000-0001-9210-3776; Call, Matthew/0000-0001-5846-6469; Byrne, Eamon/0000-0001-7513-5944	Australian National Health and Medical Research Council [GNT1030902]; IRIISS Infrastructure Support and Human Frontier Science Program [RGP0064/2011]; University of Melbourne; Australian Research Council Future Fellowship [FT120100145]; QEII Fellowship from the Australian Research Council [DP110104369]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); IRIISS Infrastructure Support and Human Frontier Science Program; University of Melbourne(University of Melbourne); Australian Research Council Future Fellowship(Australian Research Council); QEII Fellowship from the Australian Research Council(Australian Research Council)	This work was supported in part by Australian National Health and Medical Research Council Grant GNT1030902 and IRIISS Infrastructure Support and Human Frontier Science Program Grant RGP0064/2011. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Melbourne Research and Fee Remission Scholarships (University of Melbourne).; Supported by Australian Research Council Future Fellowship FT120100145.; Supported by QEII Fellowship DP110104369 from the Australian Research Council.	Aubrey BJ, 2015, CELL REP, V10, P1422, DOI 10.1016/j.celrep.2015.02.002; Baravalle G, 2011, J IMMUNOL, V187, P2966, DOI 10.4049/jimmunol.1101643; Bartee E, 2004, J VIROL, V78, P1109, DOI 10.1128/JVI.78.3.1109-1120.2004; Bauer J, 2017, NEW BIOTECHNOL, V38, P7, DOI 10.1016/j.nbt.2016.12.002; Bayer-Santos E, 2016, CELL HOST MICROBE, V20, P584, DOI 10.1016/j.chom.2016.10.007; Call ME, 2006, CELL, V127, P355, DOI 10.1016/j.cell.2006.08.044; Call ME, 2010, NAT IMMUNOL, V11, P1023, DOI 10.1038/ni.1943; Cheng J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068001; Chipot C, 2018, CHEM REV, V118, P3559, DOI 10.1021/acs.chemrev.7b00570; Choma C, 2000, NAT STRUCT BIOL, V7, P161; Corcoran K, 2011, J BIOL CHEM, V286, P37168, DOI 10.1074/jbc.M110.204040; Coscoy L, 2000, P NATL ACAD SCI USA, V97, P8051, DOI 10.1073/pnas.140129797; Coscoy L, 2001, J CELL BIOL, V155, P1265, DOI 10.1083/jcb.200111010; Coscoy L, 2001, J CLIN INVEST, V107, P1599, DOI 10.1172/JCI12432; De Gassart A, 2008, P NATL ACAD SCI USA, V105, P3491, DOI 10.1073/pnas.0708874105; Dodd RB, 2004, J BIOL CHEM, V279, P53840, DOI 10.1074/jbc.M409662200; Elazar A, 2016, ELIFE, V5, DOI 10.7554/eLife.12125; Fatehchand K, 2016, J BIOL CHEM, V291, P3895, DOI 10.1074/jbc.M115.701151; Feng JW, 2006, PLOS BIOL, V4, P768, DOI 10.1371/journal.pbio.0040142; Fujita H, 2013, J CELL SCI, V126, P2798, DOI 10.1242/jcs.119909; Furuta K, 2013, P NATL ACAD SCI USA, V110, P20188, DOI 10.1073/pnas.1312994110; Goto E, 2003, J BIOL CHEM, V278, P14657, DOI 10.1074/jbc.M211285200; Gratkowski H, 2001, P NATL ACAD SCI USA, V98, P880, DOI 10.1073/pnas.98.3.880; Han SO, 2012, J CELL BIOL, V199, P817, DOI 10.1083/jcb.201208192; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Hoer S, 2007, FEBS LETT, V581, P45, DOI 10.1016/j.febslet.2006.11.075; Hor S, 2009, MOL CELL PROTEOMICS, V8, P1959, DOI 10.1074/mcp.M900174-MCP200; Ishido S, 2000, IMMUNITY, V13, P365, DOI 10.1016/S1074-7613(00)00036-4; Ishido S, 2000, J VIROL, V74, P5300, DOI 10.1128/JVI.74.11.5300-5309.2000; Jabbour M, 2009, J IMMUNOL, V183, P6500, DOI 10.4049/jimmunol.0901521; Jahnke M, 2012, J BIOL CHEM, V287, P28779, DOI 10.1074/jbc.M112.381541; Kajikawa M, 2012, J VIROL, V86, P5288, DOI 10.1128/JVI.00219-12; KAY LE, 1990, J MAGN RESON, V89, P496, DOI 10.1016/0022-2364(90)90333-5; Knoblich K, 2015, CELL REP, V11, P1184, DOI 10.1016/j.celrep.2015.04.045; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lapaque N, 2009, J BIOL CHEM, V284, P7007, DOI 10.1074/jbc.M805736200; Liu HY, 2016, J EXP MED, V213, P1695, DOI 10.1084/jem.20160312; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; Matsuki Y, 2007, EMBO J, V26, P846, DOI 10.1038/sj.emboj.7601556; Nagarajan A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12639; Nice TJ, 2010, J IMMUNOL, V185, P5369, DOI 10.4049/jimmunol.1000247; Oh J, 2013, J EXP MED, V210, P1069, DOI 10.1084/jem.20122695; Ohmura-Hoshino M, 2006, J BIOCHEM, V140, P147, DOI 10.1093/jb/mvj160; Ohmura-Hoshino M, 2006, J IMMUNOL, V177, P341, DOI 10.4049/jimmunol.177.1.341; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Salzmann M, 1999, J BIOMOL NMR, V15, P181, DOI 10.1023/A:1008358030477; Sanchez DJ, 2002, J BIOL CHEM, V277, P6124, DOI 10.1074/jbc.M110265200; Sharma P, 2013, JOVE-J VIS EXP, DOI 10.3791/50141; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Stevenson PG, 2000, P NATL ACAD SCI USA, V97, P8455, DOI 10.1073/pnas.150240097; Trenker R, 2015, J AM CHEM SOC, V137, P15676, DOI 10.1021/jacs.5b11354; Tze LE, 2011, J EXP MED, V208, P149, DOI 10.1084/jem.20092203; von Rohrscheidt J, 2016, J EXP MED, V213, P1685, DOI 10.1084/jem.20160316; Walseng E, 2010, J BIOL CHEM, V285, P41749, DOI 10.1074/jbc.M110.157586; Young LJ, 2008, NAT IMMUNOL, V9, P1244, DOI 10.1038/ni.1665; Zhou FX, 2001, P NATL ACAD SCI USA, V98, P2250, DOI 10.1073/pnas.041593698; Zhou FX, 2000, NAT STRUCT BIOL, V7, P154	58	6	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2019	294	7					2470	2485		10.1074/jbc.RA118.004836	http://dx.doi.org/10.1074/jbc.RA118.004836			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL7CN	30554144	Green Published, hybrid			2022-12-28	WOS:000458895400023
J	Dionne, KL; Bergeron, D; Landry-Voyer, AM; Bachand, F				Dionne, Kiersten L.; Bergeron, Danny; Landry-Voyer, Anne-Marie; Bachand, Francois			The 40S ribosomal protein uS5 (RPS2) assembles into an extraribosomal complex with human ZNF277 that competes with the PRMT3-uS5 interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						zinc finger; ribosome; proteomics; protein-protein interaction; protein complex; PRMT3; ribosomal protein; RPS2; uS5; ZNF277	NUCLEAR IMPORT; P53; METHYLTRANSFERASE; TRANSCRIPTION; INHIBITION; BIOGENESIS; EXPRESSION; MATURATION; SUBSTRATE; CHAPERONE	Ribosomal (r)-proteins are generally viewed as ubiquitous, constitutive proteins that simply function to maintain ribosome integrity. However, findings in the past decade have led to the idea that r-proteins have evolved specialized functions beyond the ribosome. For example, the 40S ribosomal protein uS5 (RPS2) is known to form an extraribosomal complex with the protein arginine methyltransferase PRMT3 that is conserved from fission yeast to humans. However, the full scope of uS5's extraribosomal functions, including whether uS5 interacts with any other proteins, is not known. In this study, we identify the conserved zinc finger protein 277 (ZNF277) as a new uS5-associated protein by using quantitative proteomics approaches in human cells. As previously shown for PRMT3, we found that ZNF277 uses a C2H2-type zinc finger domain to recognize uS5. Analysis of protein-protein interactions in living cells indicated that the ZNF277-uS5 complex is found in the cytoplasm and the nucleolus. Furthermore, we show that ZNF277 and PRMT3 compete for uS5 binding, because overexpression of PRMT3 inhibited the formation of the ZNF277-uS5 complex, whereas depletion of cellular ZNF277 resulted in increased levels of uS5-PRMT3. Notably, our results reveal that ZNF277 recognizes nascent uS5 in the course of mRNA translation, suggesting cotranslational assembly of the ZNF277-uS5 complex. Our findings thus unveil an intricate network of evolutionarily conserved protein-protein interactions involving extraribosomal uS5, suggesting a key role for uS5 beyond the ribosome.	[Dionne, Kiersten L.; Bergeron, Danny; Landry-Voyer, Anne-Marie; Bachand, Francois] Univ Sherbrooke, Dept Biochem, RNA Grp, Sherbrooke, PQ J1E 4K8, Canada	University of Sherbrooke	Bachand, F (corresponding author), Univ Sherbrooke, Dept Biochem, RNA Grp, Sherbrooke, PQ J1E 4K8, Canada.	f.bachand@usherbrooke.ca			Canadian Institutes of Health Research Grant [MOP-273292]; Natural Sciences and Engineering Research Council of Canada	Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by Canadian Institutes of Health Research Grant MOP-273292 (to F.B.) and by a graduate scholarship from the Natural Sciences and Engineering Research Council of Canada (to A.-M. L.-V.). The authors declare that they have no conflicts of interest with the contents of this article.	Bachand F, 2004, EMBO J, V23, P2641, DOI 10.1038/sj.emboj.7600265; Bergeron D, 2015, MOL CELL BIOL, V35, P2503, DOI 10.1128/MCB.00070-15; Ceroni F, 2014, EUR J HUM GENET, V22, P1165, DOI 10.1038/ejhg.2014.4; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Nguyen D, 2015, CELL REP, V13, P2244, DOI 10.1016/j.celrep.2015.11.003; Frank Joachim, 2017, F1000Res, V6, P198, DOI 10.12688/f1000research.9760.1; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Grade M, 2011, INT J CANCER, V128, P1069, DOI 10.1002/ijc.25453; Henras AK, 2015, WIRES RNA, V6, P225, DOI 10.1002/wrna.1269; Holzer S, 2013, J MOL BIOL, V425, P4154, DOI 10.1016/j.jmb.2013.08.022; Horn HF, 2008, ONCOGENE, V27, P5774, DOI 10.1038/onc.2008.189; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Jakel S, 1998, EMBO J, V17, P4491, DOI 10.1093/emboj/17.15.4491; Jin A, 2004, MOL CELL BIOL, V24, P7669, DOI 10.1128/MCB.24.17.7669-7680.2004; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; Koch B, 2012, J BIOL CHEM, V287, P21806, DOI 10.1074/jbc.M112.365791; Kressler D, 2012, SCIENCE, V338, P666, DOI 10.1126/science.1226960; Landry-Voyer AM, 2016, MOL CELL BIOL, V36, P3019, DOI 10.1128/MCB.00303-16; Li H, 2018, CELL SYST, V6, P90, DOI 10.1016/j.cels.2017.10.016; Liliensiek B, 1998, BLOOD, V92, P3394, DOI 10.1182/blood.V92.9.3394.421k33_3394_3404; Lindstrom MS, 2007, MOL CELL BIOL, V27, P1056, DOI 10.1128/MCB.01307-06; Lindstrom MS, 2009, BIOCHEM BIOPH RES CO, V379, P167, DOI 10.1016/j.bbrc.2008.12.083; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Mallet PL, 2013, TRAFFIC, V14, P282, DOI 10.1111/tra.12036; Minakhina S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147631; Mitterer V, 2016, SCI REP-UK, V6, DOI 10.1038/srep36714; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Negishi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012373; Nerurkar P, 2015, INT REV CEL MOL BIO, V319, P107, DOI 10.1016/bs.ircmb.2015.07.002; O'Donohue MF, 2010, J CELL BIOL, V190, P853, DOI 10.1083/jcb.201005117; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Pausch P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8494; Pena C, 2017, NAT STRUCT MOL BIOL, V24, P689, DOI 10.1038/nsmb.3454; Perreault A, 2008, NUCLEIC ACIDS RES, V36, P6132, DOI 10.1093/nar/gkn625; Perreault A, 2009, J BIOL CHEM, V284, P15026, DOI 10.1074/jbc.M109.004812; Pillet B, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201600153; Pillet B, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005565; Ramanathan M, 2018, NAT METHODS, V15, P207, DOI [10.1038/NMETH.4601, 10.1038/nmeth.4601]; Renaux A, 2018, NUCLEIC ACIDS RES, V46, P2699, DOI 10.1093/nar/gky092; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Stelter P, 2015, MOL CELL, V58, P854, DOI 10.1016/j.molcel.2015.03.029; Swiercz R, 2005, BIOCHEM J, V386, P85, DOI 10.1042/BJ20041466; Thomson E, 2013, J CELL SCI, V126, P4815, DOI 10.1242/jcs.111948; Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321; Ting YH, 2017, J BIOL CHEM, V292, P585, DOI 10.1074/jbc.M116.747634; Uhlen M, 2017, SCIENCE, V357, P660, DOI 10.1126/science.aan2507; Wang M, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-6; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Warner JR, 2001, COLD SPRING HARB SYM, V66, P567, DOI 10.1101/sqb.2001.66.567; Weirauch MT, 2011, SUBCELL BIOCHEM, V52, P25, DOI 10.1007/978-90-481-9069-0_3; Williams NK, 2018, BIOCHEM SOC T, V46, P197, DOI 10.1042/BST20170451; Woolford JL, 2013, GENETICS, V195, P643, DOI 10.1534/genetics.113.153197; Wyant GA, 2018, SCIENCE, V360, P751, DOI 10.1126/science.aar2663; Wyler E, 2014, FEBS LETT, V588, P3685, DOI 10.1016/j.febslet.2014.08.013	55	14	14	3	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2019	294	6					1944	1955		10.1074/jbc.RA118.004928	http://dx.doi.org/10.1074/jbc.RA118.004928			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM8EO	30530495	Green Published, hybrid			2022-12-28	WOS:000459711400015
J	Kontur, WS; Olmsted, CN; Yusko, LM; Niles, AV; Walters, KA; Beebe, ET; Vander Meulen, KA; Karlen, SD; Gall, DL; Noguera, DR; Donohue, TJ				Kontur, Wayne S.; Olmsted, Charles N.; Yusko, Larissa M.; Niles, Alyssa V.; Walters, Kevin A.; Beebe, Emily T.; Vander Meulen, Kirk A.; Karlen, Steven D.; Gall, Daniel L.; Noguera, Daniel R.; Donohue, Timothy J.			A heterodimeric glutathione S-transferase that stereospecifically breaks lignin's (R)-aryl ether bond reveals the diversity of bacterial -etherases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lignin degradation; stereoselectivity; protein evolution; bacterial metabolism; enzyme mutation; -aryl ether bond; -etherase; glutathione S-transferase; Novosphingobium aromaticivorans; sphingomonads	BETA-ARYL ETHER; ENZYMATIC CLEAVAGE; ESCHERICHIA-COLI; STRAIN; DEPOLYMERIZATION; CATABOLISM; EVOLUTION; CHEMICALS; HYDROGEN; GUAIACYL	Lignin is a heterogeneous polymer of aromatic subunits that is a major component of lignocellulosic plant biomass. Understanding how microorganisms deconstruct lignin is important for understanding the global carbon cycle and could aid in developing systems for processing plant biomass into valuable commodities. Sphingomonad bacteria use stereospecific glutathione S-transferases (GSTs) called -etherases to cleave the -aryl ether (-O-4) bond, the most common bond between aromatic subunits in lignin. Previously characterized bacterial -etherases are homodimers that fall into two distinct GST subclasses: LigE homologues, which cleave the (R) stereoisomer of the bond, and LigF homologues, which cleave the (S) stereoisomer. Here, we report on a heterodimeric -etherase (BaeAB) from the sphingomonad Novosphingobium aromaticivorans that stereospecifically cleaves the (R)-aryl ether bond of the di-aromatic compound -(2-methoxyphenoxy)--hydroxypropiovanillone (MPHPV). BaeAB's subunits are phylogenetically distinct from each other and from other -etherases, although they are evolutionarily related to LigF, despite the fact that BaeAB and LigF cleave different -aryl ether bond stereoisomers. We identify amino acid residues in BaeAB's BaeA subunit important for substrate binding and catalysis, including an asparagine that is proposed to activate the GSH cofactor. We also show that BaeAB homologues from other sphingomonads can cleave (R)-MPHPV and that they may be as common in bacteria as LigE homologues. Our results suggest that the ability to cleave the -aryl ether bond arose independently at least twice in GSTs and that BaeAB homologues may be important for cleaving the (R)-aryl ether bonds of lignin-derived oligomers in nature.	[Kontur, Wayne S.; Olmsted, Charles N.; Yusko, Larissa M.; Niles, Alyssa V.; Walters, Kevin A.; Beebe, Emily T.; Vander Meulen, Kirk A.; Karlen, Steven D.; Gall, Daniel L.; Noguera, Daniel R.; Donohue, Timothy J.] Univ Wisconsin, Wisconsin Energy Inst, Madison, WI 53706 USA; [Kontur, Wayne S.; Olmsted, Charles N.; Yusko, Larissa M.; Niles, Alyssa V.; Walters, Kevin A.; Beebe, Emily T.; Vander Meulen, Kirk A.; Karlen, Steven D.; Gall, Daniel L.; Noguera, Daniel R.; Donohue, Timothy J.] Univ Wisconsin, Great Lakes Bioenergy Res Ctr, Dept Energy, Madison, WI 53706 USA; [Beebe, Emily T.; Vander Meulen, Kirk A.; Karlen, Steven D.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Noguera, Daniel R.] Univ Wisconsin, Dept Civil & Environm Engn, Madison, WI 53706 USA; [Donohue, Timothy J.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Donohue, TJ (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.	tdonohue@bact.wisc.edu	Donohue, Timothy/C-3273-2015	Donohue, Timothy/0000-0001-8738-2467; Walters, Kevin/0000-0001-7063-6651; Noguera, Daniel/0000-0003-0372-3063	United States Department of Energy (DOE) Great Lakes Bioenergy Research Center (DOE Office of Science Biological and Environmental Research (BER)) [DE-FC02-07ER64494, DE-SC0018409]	United States Department of Energy (DOE) Great Lakes Bioenergy Research Center (DOE Office of Science Biological and Environmental Research (BER))(United States Department of Energy (DOE))	This work was supported by the United States Department of Energy (DOE) Great Lakes Bioenergy Research Center (DOE Office of Science Biological and Environmental Research (BER) Grants DE-FC02-07ER64494 and DE-SC0018409). The authors declare that they have no conflicts of interest with the contents of this article.	ADLER E, 1977, WOOD SCI TECHNOL, V11, P169, DOI 10.1007/BF00365615; Allocati N, 2009, FEBS J, V276, P58, DOI 10.1111/j.1742-4658.2008.06743.x; Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x; Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Azadi P, 2013, RENEW SUST ENERG REV, V21, P506, DOI 10.1016/j.rser.2012.12.022; Bienert S, 2017, NUCLEIC ACIDS RES, V45, pD313, DOI 10.1093/nar/gkw1132; Chen Z, 2017, RENEW SUST ENERG REV, V73, P610, DOI 10.1016/j.rser.2017.01.166; DOHERTY AJ, 1995, NUCLEIC ACIDS RES, V23, P2074, DOI 10.1093/nar/23.11.2074; Fabrini R, 2009, BIOCHEMISTRY-US, V48, P10473, DOI 10.1021/bi901238t; FREDRICKSON JK, 1991, APPL ENVIRON MICROB, V57, P796, DOI 10.1128/AEM.57.3.796-803.1991; FREDRICKSON JK, 1995, APPL ENVIRON MICROB, V61, P1917, DOI 10.1128/AEM.61.5.1917-1922.1995; Gall DL, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.02076-17; Gall DL, 2014, ENVIRON SCI TECHNOL, V48, P12454, DOI 10.1021/es503886d; Goren MA, 2009, METHOD ENZYMOL, V463, P647, DOI 10.1016/S0076-6879(09)63037-8; Helmich KE, 2016, J BIOL CHEM, V291, P5234, DOI 10.1074/jbc.M115.694307; Husarcikova J, 2018, APPL MICROBIOL BIOT, V102, P5391, DOI 10.1007/s00253-018-9040-3; Jarecki BW, 2013, SCI REP-UK, V3, DOI 10.1038/srep01040; Kamimura N, 2017, ENV MICROBIOL REP, V9, P679, DOI 10.1111/1758-2229.12597; Kanai T, 2006, J BIOCHEM, V140, P703, DOI 10.1093/jb/mvj199; Kontur WS, 2018, J BIOL CHEM, V293, P4955, DOI 10.1074/jbc.RA117.001268; Lal R, 2008, ENERG ENVIRON SCI, V1, P86, DOI 10.1039/b809492f; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Llado S, 2017, MICROBIOL MOL BIOL R, V81, DOI 10.1128/MMBR.00063-16; Makino SI, 2014, METHODS MOL BIOL, V1091, P161, DOI 10.1007/978-1-62703-691-7_11; Marinovic M, 2018, ACS SUSTAIN CHEM ENG, V6, P2878, DOI 10.1021/acssuschemeng.7b03619; Masai E, 2003, J BACTERIOL, V185, P1768, DOI 10.1128/JB.185.6.1768-1775.2003; Masai E, 2007, BIOSCI BIOTECH BIOCH, V71, P1, DOI 10.1271/bbb.60437; Mashiyama ST, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001843; Mathieu Y, 2012, J BIOL CHEM, V287, P39001, DOI 10.1074/jbc.M112.402776; Meux E, 2012, FEBS LETT, V586, P3944, DOI 10.1016/j.febslet.2012.09.036; Morel M, 2009, CELL MOL LIFE SCI, V66, P3711, DOI 10.1007/s00018-009-0104-5; Ohta Y, 2018, GENOME ANNOUNCEMENTS, V6, DOI 10.1128/genomeA.00267-18; Ohta Y, 2017, CHEMSUSCHEM, V10, P425, DOI 10.1002/cssc.201601235; Ohta Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep15105; Palamuru S, 2015, APPL ENVIRON MICROB, V81, P8164, DOI 10.1128/AEM.01573-15; Picart P, 2017, APPL MICROBIOL BIOT, V101, P6277, DOI 10.1007/s00253-017-8360-z; Picart P, 2015, GREEN CHEM, V17, P4931, DOI [10.1039/C5GC01078K, 10.1039/c5gc01078k]; Picart P, 2014, CHEMSUSCHEM, V7, P3164, DOI 10.1002/cssc.201402465; Ralph John, 2004, Phytochemistry Reviews, V3, P29, DOI 10.1023/B:PHYT.0000047809.65444.a4; Reiter J, 2013, GREEN CHEM, V15, P1373, DOI 10.1039/c3gc40295a; Rosini E, 2016, CATAL SCI TECHNOL, V6, P2195, DOI 10.1039/c5cy01591j; Sato Y, 2009, APPL ENVIRON MICROB, V75, P5195, DOI 10.1128/AEM.00880-09; Schutyser W, 2018, CHEM SOC REV, V47, P852, DOI 10.1039/c7cs00566k; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; SISTROM WR, 1962, J GEN MICROBIOL, V28, P607, DOI 10.1099/00221287-28-4-607; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tanamura K, 2011, BIOSCI BIOTECH BIOCH, V75, P2404, DOI 10.1271/bbb.110525; Thuillier A, 2013, FEBS LETT, V587, P2125, DOI 10.1016/j.febslet.2013.05.031; United States Department of Energy, 2015, DOESC0170; United States Department of Energy, 2008, CARB CYCL BIOS MARCH; van der Wal A, 2013, FEMS MICROBIOL REV, V37, P477, DOI 10.1111/1574-6976.12001; WOOD WB, 1966, J MOL BIOL, V16, P118, DOI 10.1016/S0022-2836(66)80267-X	54	23	23	4	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2019	294	6					1877	1890		10.1074/jbc.RA118.006548	http://dx.doi.org/10.1074/jbc.RA118.006548			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM8EO	30541921	hybrid, Green Published			2022-12-28	WOS:000459711400009
J	Johnson, SR; Bhat, WW; Bibik, J; Turmo, A; Hamberger, B; Hamberger, B				Johnson, Sean R.; Bhat, Wajid Waheed; Bibik, Jacob; Turmo, Aiko; Hamberger, Britta; Hamberger, Bjoern		Evolutionary Mint Genomics	A database-driven approach identifies additional diterpene synthase activities in the mint family (Lamiaceae)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						secondary metabolism; terpenoid; plant biochemistry; transcriptomics; biosynthesis; chemotaxonomy; diterpene synthase; enzymes; Lamiaceae; phytochemistry	INSECT ANTIFEEDANT ACTIVITY; SINGLE RESIDUE SWITCH; MEDICINAL-PLANT; CLERODANE DITERPENES; DIPHOSPHATE SYNTHASE; BIOSYNTHESIS; LABDANE; CATALYZES; METABOLISM; EXPRESSION	Members of the mint family (Lamiaceae) accumulate a wide variety of industrially and medicinally relevant diterpenes. We recently sequenced leaf transcriptomes from 48 phylogenetically diverse Lamiaceae species. Here, we summarize the available chemotaxonomic and enzyme activity data for diterpene synthases (diTPSs) in the Lamiaceae and leverage the new transcriptomes to explore the diTPS sequence and functional space. Candidate genes were selected with an intent to evenly sample the sequence homology space and to focus on species in which diTPS transcripts were found, yet from which no diterpene structures have been previously reported. We functionally characterized nine class II diTPSs and 10 class I diTPSs from 11 distinct plant species and found five class II activities, including two novel activities, as well as a spectrum of class I activities. Among the class II diTPSs, we identified a neo-cleroda-4(18),13E-dienyl diphosphate synthase from Ajuga reptans, catalyzing the likely first step in the biosynthesis of a variety of insect-antifeedant compounds. Among the class I diTPSs was a palustradiene synthase from Origanum majorana, leading to the discovery of specialized diterpenes in that species. Our results provide insights into the diversification of diterpene biosynthesis in the mint family and establish a comprehensive foundation for continued investigation of diterpene biosynthesis in the Lamiaceae.	[Johnson, Sean R.; Bhat, Wajid Waheed; Bibik, Jacob; Turmo, Aiko; Hamberger, Britta; Hamberger, Bjoern] Dept Biochem & Mol Biol, 603 Wilson Rd,Rm 212, E Lansing, MI 48824 USA; [Bhat, Wajid Waheed] Dept Pharmacol & Toxicol, E Lansing, MI 48824 USA; [Evolutionary Mint Genomics] Michigan State Univ, E Lansing, MI 48824 USA	Michigan State University	Hamberger, B (corresponding author), Dept Biochem & Mol Biol, 603 Wilson Rd,Rm 212, E Lansing, MI 48824 USA.; Hamberger, B (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, 603 Wilson Rd,Rm 212, E Lansing, MI 48824 USA.	hamberge@msu.edu	Bhat, Wajid Waheed/E-6645-2012; Hamberger, Bjoern/I-2122-2012	Bhat, Wajid Waheed/0000-0002-7049-8671; Henry, Laura/0000-0003-0037-2114; Hamberger, Bjoern/0000-0003-1249-1807; Johnson, Sean/0000-0001-8261-9015	Michigan State University Strategic Partnership Grant program; Science and Engineering Research Board (SERB), Department of Science and Technology, Government of India; Indo-US Science and Technology Forum (IUSSTF) Indo-US postdoctoral fellowship; United States Department of Energy-Great Lakes Bioenergy Research Center [DE-FC02-07ER64494, DE-SC0018409]; Michigan State University Strategic Partnership Grant program "Plant-inspired Chemical Diversity"; Department of Molecular Biology and Biochemistry, Michigan State University; Michigan State University AgBioResearch Grant [MICL02454]; National Science Foundation [1737898]	Michigan State University Strategic Partnership Grant program; Science and Engineering Research Board (SERB), Department of Science and Technology, Government of India(Department of Science & Technology (India)Science Engineering Research Board (SERB), India); Indo-US Science and Technology Forum (IUSSTF) Indo-US postdoctoral fellowship; United States Department of Energy-Great Lakes Bioenergy Research Center; Michigan State University Strategic Partnership Grant program "Plant-inspired Chemical Diversity"; Department of Molecular Biology and Biochemistry, Michigan State University; Michigan State University AgBioResearch Grant; National Science Foundation(National Science Foundation (NSF))	This work was primarily supported by the Michigan State University Strategic Partnership Grant program ("Evolutionary-Driven Genome Mining of Plant Biosynthetic Pathways"). Bjorn Hamberger, W. W. B., and S. R. J. report a potential conflict of interest: they have filed a patent application (United States Patent Application Serial No. 62/714,216) covering the genes reported in this study. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation.; Supported by the Science and Engineering Research Board (SERB), Department of Science and Technology, Government of India and the Indo-US Science and Technology Forum (IUSSTF) Indo-US postdoctoral fellowship.; Supported by United States Department of Energy-Great Lakes Bioenergy Research Center Cooperative Agreements DE-FC02-07ER64494 and DE-SC0018409; the Michigan State University Strategic Partnership Grant program "Plant-inspired Chemical Diversity"; startup funding from the Department of Molecular Biology and Biochemistry, Michigan State University; and Michigan State University AgBioResearch Grant MICL02454 and supported in part by National Science Foundation Grant 1737898. To whom correspondence should be addressed: Dept. of Biochemistry and Molecular Biology, Michigan State University, 603 Wilson Rd., Rm. 212, East Lansing, MI 48824. E-mail: hamberge@msu.edu.	Alvarenga SAV, 2001, PHYTOCHEMISTRY, V56, P583, DOI 10.1016/S0031-9422(00)00424-6; Andersen-Ranberg J, 2016, ANGEW CHEM INT EDIT, V55, P2142, DOI 10.1002/anie.201510650; ANDERSON JC, 1989, TETRAHEDRON LETT, V30, P4737, DOI 10.1016/S0040-4039(01)80789-9; [Anonymous], 2018, DICTIONARY OF NATURA; Arima Y, 2007, TETRAHEDRON-ASYMMETR, V18, P1701, DOI 10.1016/j.tetasy.2007.07.010; Banerjee A, 2018, PHYTOCHEM REV, V17, P81, DOI 10.1007/s11101-017-9530-4; BARTON DH, 1961, J CHEM SOC, P5061, DOI 10.1039/jr9610005061; BELLES X, 1985, J CHEM ECOL, V11, P1439, DOI 10.1007/BF01012143; Benson DA, 2014, NUCLEIC ACIDS RES, V42, pD32, DOI [10.1093/nar/gkp1024, 10.1093/nar/gkt1030, 10.1093/nar/gks1195, 10.1093/nar/gkw1070, 10.1093/nar/gkq1079, 10.1093/nar/gkn723, 10.1093/nar/gkr1202, 10.1093/nar/gkx1094]; Boachon B, 2018, MOL PLANT, V11, P1084, DOI 10.1016/j.molp.2018.06.002; Boalino DM, 2004, J NAT PROD, V67, P714, DOI 10.1021/np030480i; BOHLMANN F, 1979, PHYTOCHEMISTRY, V18, P115, DOI 10.1016/S0031-9422(00)90926-9; Busta L, 2018, PHYTOCHEM REV, V17, P1275, DOI 10.1007/s11101-017-9542-0; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Caniard A, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-119; Challis GL, 2008, J MED CHEM, V51, P2618, DOI 10.1021/jm700948z; Chau MD, 2004, ARCH BIOCHEM BIOPHYS, V430, P237, DOI 10.1016/j.abb.2004.07.013; Chen F, 2011, PLANT J, V66, P212, DOI 10.1111/j.1365-313X.2011.04520.x; Chen XY, 2017, J EXP BOT, V68, P1109, DOI 10.1093/jxb/erw493; Chen YL, 2008, J NAT PROD, V71, P1207, DOI 10.1021/np800147z; Coll Josep, 2008, Phytochemistry Reviews, V7, P25, DOI 10.1007/s11101-006-9023-3; Cui GH, 2015, PLANT PHYSIOL, V169, P1607, DOI 10.1104/pp.15.00695; Dairi T, 2001, J BACTERIOL, V183, P6085, DOI 10.1128/JB.183.20.6085-6094.2001; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Ennajdaoui H, 2010, PLANT MOL BIOL, V73, P673, DOI 10.1007/s11103-010-9648-x; Federhen S, 2012, NUCLEIC ACIDS RES, V40, pD136, DOI 10.1093/nar/gkr1178; Fischedick JT, 2015, PHYTOCHEMISTRY, V113, P87, DOI 10.1016/j.phytochem.2014.11.020; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Gao W, 2009, ORG LETT, V11, P5170, DOI 10.1021/ol902051v; Gebbinck EAK, 2002, PHYTOCHEMISTRY, V61, P737, DOI 10.1016/S0031-9422(02)00174-7; GEUSKENS RBM, 1983, EXPERIENTIA, V39, P403, DOI 10.1007/BF01963148; GONZALEZ AG, 1991, PHYTOCHEMISTRY, V30, P4067, DOI 10.1016/0031-9422(91)83468-Z; Gray CA, 2003, PHYTOCHEMISTRY, V63, P409, DOI 10.1016/S0031-9422(03)00156-0; Gunnewich N, 2013, PHYTOCHEMISTRY, V91, P93, DOI 10.1016/j.phytochem.2012.07.019; Guo J, 2013, P NATL ACAD SCI USA, V110, P12108, DOI 10.1073/pnas.1218061110; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hamano Y, 2002, J BIOL CHEM, V277, P37098, DOI 10.1074/jbc.M206382200; Hamberger B, 2011, PLANT PHYSIOL, V157, P1677, DOI 10.1104/pp.111.185843; Hamberger B, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0426; Han QB, 2006, ORG LETT, V8, P4727, DOI 10.1021/ol061757j; Hansen NL, 2017, PHYTOCHEMISTRY, V138, P52, DOI [10.1016/j.phytochem.2017.02.022, 10.1016/j.p]; Harris LJ, 2005, PLANT MOL BIOL, V59, P881, DOI 10.1007/s11103-005-1674-8; Heller SR, 2015, J CHEMINFORMATICS, V7, DOI 10.1186/s13321-015-0068-4; Helliwell CA, 2001, P NATL ACAD SCI USA, V98, P2065, DOI 10.1073/pnas.041588998; Heskes AM, 2018, PLANT J, V93, P943, DOI 10.1111/tpj.13822; Hillwig ML, 2011, PLANT J, V68, P1051, DOI 10.1111/j.1365-313X.2011.04756.x; Huerta-Cepas J, 2016, MOL BIOL EVOL, V33, P1635, DOI 10.1093/molbev/msw046; Ikeda H, 2016, J IND MICROBIOL BIOT, V43, P325, DOI 10.1007/s10295-015-1694-6; Jia MR, 2018, ACS CATAL, V8, P3133, DOI 10.1021/acscatal.8b00121; Jia M, 2017, ACS CHEM BIOL, V12, P862, DOI 10.1021/acschembio.6b01075; Jia MR, 2016, METAB ENG, V37, P24, DOI 10.1016/j.ymben.2016.04.001; Jin BL, 2017, PLANT PHYSIOL, V174, P943, DOI 10.1104/pp.17.00202; Keeling CI, 2011, J BIOL CHEM, V286, P21145, DOI 10.1074/jbc.M111.245951; Kirby J, 2010, PHYTOCHEMISTRY, V71, P1466, DOI 10.1016/j.phytochem.2010.06.001; Kodama Y, 2012, NUCLEIC ACIDS RES, V40, pD54, DOI 10.1093/nar/gkr854; Kuhn S., 2012, J CHEMINFORMATICS, V4, P52, DOI [10.1186/1758-2946-4-S1-P52, DOI 10.1186/1758-2946-4-S1-P52]; Li B, 2016, SCI REP-UK, V6, DOI 10.1038/srep34343; Li JL, 2012, PHYTOCHEMISTRY, V76, P32, DOI 10.1016/j.phytochem.2011.12.021; Li LM, 2009, J NAT PROD, V72, P1851, DOI 10.1021/np900406c; Li RT, 2016, NAT PROD REP, V33, P1166, DOI 10.1039/c5np00137d; Li XN, 2010, J NAT PROD, V73, P1803, DOI 10.1021/np1004328; Lopez-Perez JL, 2007, BIOINFORMATICS, V23, P3256, DOI 10.1093/bioinformatics/btm516; LOUB WD, 1985, J CHEM INF COMP SCI, V25, P99, DOI 10.1021/ci00046a009; Mafu S, 2015, CHEM COMMUN, V51, P13485, DOI 10.1039/c5cc05754j; Mann FM, 2010, J BIOL CHEM, V285, P20558, DOI 10.1074/jbc.M110.123307; Monaco P., 1982, REND ACCAD SCI FIS, V48, P465; Nutzmann HW, 2016, NEW PHYTOL, V211, P771, DOI 10.1111/nph.13981; OHSAKI A, 1994, BIOORG MED CHEM LETT, V4, P2889, DOI 10.1016/S0960-894X(01)80834-9; Ondari ME, 2008, J AM CHEM SOC, V130, P17187, DOI 10.1021/ja8067534; Pateraki I, 2017, ELIFE, V6, DOI 10.7554/eLife.23001; Pateraki I, 2014, PLANT PHYSIOL, V164, P1222, DOI 10.1104/pp.113.228429; Pelot KA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176507; Pelot KA, 2017, PLANT J, V89, P885, DOI 10.1111/tpj.13427; Peters RJ, 2010, NAT PROD REP, V27, P1521, DOI 10.1039/c0np00019a; Peters RJ, 2000, BIOCHEMISTRY-US, V39, P15592, DOI 10.1021/bi001997l; Potter K, 2014, ANGEW CHEM INT EDIT, V53, P7198, DOI 10.1002/anie.201402911; Potter KC, 2016, ANGEW CHEM INT EDIT, V55, P634, DOI 10.1002/anie.201509060; Roengsumran S, 1999, PHYTOCHEMISTRY, V50, P449, DOI 10.1016/S0031-9422(98)00604-9; RUDI A, 1992, J NAT PROD, V55, P1408, DOI 10.1021/np50088a004; Sainsbury F, 2009, PLANT BIOTECHNOL J, V7, P682, DOI 10.1111/j.1467-7652.2009.00434.x; Schalk M, 2012, J AM CHEM SOC, V134, P18900, DOI 10.1021/ja307404u; Schulte S, 2018, BIOCHEMISTRY-US, V57, P3473, DOI 10.1021/acs.biochem.8b00193; Scotti MT, 2018, MOLECULES, V23, DOI 10.3390/molecules23010103; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Sun H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174804; SUZUKI H, 1983, PHYTOCHEMISTRY, V22, P1294, DOI 10.1016/0031-9422(83)80249-0; URONES JG, 1994, PHYTOCHEMISTRY, V35, P713, DOI 10.1016/S0031-9422(00)90593-4; Wu CL, 1997, PHYTOCHEMISTRY, V44, P101; Xiang W, 2004, HELV CHIM ACTA, V87, P2860, DOI 10.1002/hlca.200490257; Xu MM, 2007, P NATL ACAD SCI USA, V104, P7397, DOI 10.1073/pnas.0611454104; Yamada Y, 2016, J ANTIBIOT, V69, P515, DOI 10.1038/ja.2015.147; Zerbe P, 2015, PLANT J, V83, P783, DOI 10.1111/tpj.12925; Zerbe P, 2015, TRENDS BIOTECHNOL, V33, P419, DOI 10.1016/j.tibtech.2015.04.006; Zerbe P, 2014, PLANT J, V79, P914, DOI 10.1111/tpj.12589; Zhan X, 2015, PLANT PHYSIOL BIOCH, V96, P110, DOI 10.1016/j.plaphy.2015.07.011; Zi JC, 2014, ANNU REV PLANT BIOL, V65, P259, DOI 10.1146/annurev-arplant-050213-035705	97	31	31	11	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1349	1362		10.1074/jbc.RA118.006025	http://dx.doi.org/10.1074/jbc.RA118.006025			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30498089	Green Published, hybrid			2022-12-28	WOS:000457879500025
J	Marcelo, F; Supekar, N; Corzana, F; van der Horst, JC; Vuist, IM; Live, D; Boons, GJPH; Smith, DF; van Vliet, SJ				Marcelo, Filipa; Supekar, Nitin; Corzana, Francisco; van der Horst, Joost C.; Vuist, Ilona M.; Live, David; Boons, Geert-Jan P. H.; Smith, David F.; van Vliet, Sandra J.			Identification of a secondary binding site in human macrophage galactose-type lectin by microarray studies: Implications for the molecular recognition of its ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						molecular modeling; microarray; peptide array; alternative splicing; mutant; C-type lectin; carbohydrate specificity; MGL; Tn antigen; splice variant; glycopeptide; glycan; carbohydrate recognition domain	C-TYPE LECTIN; DENDRITIC CELLS; THREONINE GLYCOSYLATION; STRUCTURAL ELEMENTS; EXPRESSION; RECEPTOR; MGL; ANTIGEN; GLYCOPEPTIDES; ANTIBODY	The human macrophage galactose-type lectin (MGL) is a C-type lectin characterized by a unique specificity for terminal GalNAc residues present in the tumor-associated Tn antigen (alpha GalNAc-Ser/Thr) and its sialylated form, the sialyl-Tn antigen. However, human MGL has multiple splice variants, and whether these variants have distinct ligand-binding properties is unknown. Here, using glycan microarrays, we compared the binding properties of the short MGL 6C (MGL(short)) and the long MGL 6B (MGL(long)) splice variants, as well as of a histidine-to-threonine mutant (MGL(short) H259T). Although the MGL(short) and MGL(long) variants displayed similar binding properties on the glycan array, the MGL(short) H259T mutant failed to interact with the sialyl-Tn epitope. As the MGL(short) H259T variant could still bind a single GalNAc monosaccharide on this array, we next investigated its binding characteristics to Tn-containing glycopeptides derived from the MGL ligands mucin 1 (MUC1), MUC2, and CD45. Strikingly, in the glycopeptide microarray, the MGL(short) H259T variant lost high-affinity binding toward Tn-containing glycopeptides, especially at low probing concentrations. Moreover, MGL(short) H259T was unable to recognize cancer-associated Tn epitopes on tumor cell lines. Molecular dynamics simulations indicated that in WT MGL(short), His(259) mediates H bonds directly or engages the Tn-glycopeptide backbone through water molecules. These bonds were lost in MGL(short) H259T, thus explaining its lower binding affinity. Together, our results suggest that MGL not only connects to the Tn carbohydrate epitope, but also engages the underlying peptide via a secondary binding pocket within the MGL carbohydrate recognition domain containing the His(259) residue.	[Marcelo, Filipa] REQUIMTE, UCIBIO, Fac Ciencias & Tecnol, Dept Quim, P-2829516 Caparica, Portugal; [Supekar, Nitin; Live, David; Boons, Geert-Jan P. H.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Corzana, Francisco] Univ La Rioja, Ctr Invest Sintesis Quim, Dept Quim, E-26006 Logrono, Spain; [van der Horst, Joost C.; Vuist, Ilona M.; van Vliet, Sandra J.] Vrije Univ Amsterdam, Amsterdam Infect & Immun Inst, Dept Mol Cell Biol & Immunol, Canc Ctr Amsterdam,Amsterdam UMC, NL-1081 HZ Amsterdam, Netherlands; [Smith, David F.] Emory Univ, Sch Med, Emory Comprehens Glyc Ctr, Dept Biochem, Atlanta, GA 30322 USA; [Vuist, Ilona M.] Univ Amsterdam, Swammerdam Inst Life Sci, NL-1098 XH Amsterdam, Netherlands; [Boons, Geert-Jan P. H.] Univ Utrecht, Dept Pharmaceut Sci & Chem, NL-3584 CG Utrecht, Netherlands	University System of Georgia; University of Georgia; Universidad de La Rioja; University of Amsterdam; Vrije Universiteit Amsterdam; Emory University; University of Amsterdam; Utrecht University	van Vliet, SJ (corresponding author), Locat VU Univ, Med Ctr, Amsterdam UMC, Dept Mol Cell Biol & Immunol, POB 7057, NL-1007 MB Amsterdam, Netherlands.	s.vanvliet@vumc.nl	Boons, Geert-Jan P H/J-3211-2016; Van Vliet, Sandra/AAO-9534-2020; Marcelo, Filipa/C-9588-2013; Supekar, Nitin/K-5737-2019; Smith, David/GQQ-8257-2022; Corzana, Francisco/B-1310-2015	Boons, Geert-Jan P H/0000-0003-3111-5954; Marcelo, Filipa/0000-0001-5049-8511; Supekar, Nitin/0000-0002-7006-7177; van Vliet, Sandra/0000-0003-1811-2687; Corzana, Francisco/0000-0001-5597-8127	National Institutes of Health [U54GM62116, P41GM103390]; FCT-Portugal IF project [IF/00780/2015]; UCIBIO funding [UID/Multi/04378/2013]; FEDER [POCI-01-0145-FEDER-007728]; Ministerio de Economia y Competitividad Projects [CTQ2015-67727-R, UNLR13-4E-1931]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103390] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FCT-Portugal IF project; UCIBIO funding; FEDER(European Commission); Ministerio de Economia y Competitividad Projects; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a bridging grant under National Institutes of Health Grant U54GM62116 (to the Consortium for Functional Glycomics) and P41GM103390 (to the Research Resource for Integrated Glycotechnology). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the FCT-Portugal IF project (IF/00780/2015) and the UCIBIO funding UID/Multi/04378/2013, co-financed by the FEDER (POCI-01-0145-FEDER-007728).; Supported by Ministerio de Economia y Competitividad Projects CTQ2015-67727-R and UNLR13-4E-1931.	Agravat SB, 2014, BIOINFORMATICS, V30, P3417, DOI 10.1093/bioinformatics/btu559; ANDREA TA, 1983, J CHEM PHYS, V79, P4576, DOI 10.1063/1.446373; Artigas G, 2017, J MED CHEM, V60, P9012, DOI 10.1021/acs.jmedchem.7b01242; Beatson R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125994; Bermejo IA, 2018, J AM CHEM SOC, V140, P9952, DOI 10.1021/jacs.8b04801; Borgert A, 2012, ACS CHEM BIOL, V7, P1031, DOI 10.1021/cb300076s; Brockhausen I., 2009, ESSENTIALS GLYCOBIOL; Brooks CL, 2010, P NATL ACAD SCI USA, V107, P10056, DOI 10.1073/pnas.0915176107; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Che MI, 2014, ONCOTARGET, V5, P3673, DOI 10.18632/oncotarget.1981; Corzana F, 2007, J AM CHEM SOC, V129, P9458, DOI 10.1021/ja072181b; Corzana F, 2006, J AM CHEM SOC, V128, P14640, DOI 10.1021/ja064539u; Dam TK, 2010, GLYCOBIOLOGY, V20, P270, DOI 10.1093/glycob/cwp186; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DELL A, 1995, J BIOL CHEM, V270, P24116, DOI 10.1074/jbc.270.41.24116; Drickamer K, 2015, CURR OPIN STRUC BIOL, V34, P26, DOI 10.1016/j.sbi.2015.06.003; Feinberg H, 2009, J MOL BIOL, V394, P613, DOI 10.1016/j.jmb.2009.10.006; FIETE D, 1991, CELL, V67, P1103, DOI 10.1016/0092-8674(91)90287-9; Freire T, 2010, BLOOD, V116, P3526, DOI 10.1182/blood-2010-04-279133; Gibadullin R, 2017, ACS CHEM BIOL, V12, P2172, DOI 10.1021/acschembio.7b00471; HAKOMORI S, 1977, P NATL ACAD SCI USA, V74, P3023, DOI 10.1073/pnas.74.7.3023; Higashi N, 2002, J BIOL CHEM, V277, P20686, DOI 10.1074/jbc.M202104200; Hirano K, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/981627; Iida SI, 1999, J BIOL CHEM, V274, P10697, DOI 10.1074/jbc.274.16.10697; Jegouzo SAF, 2013, GLYCOBIOLOGY, V23, P853, DOI 10.1093/glycob/cwt022; Joo EJ, 2014, OMICS, V18, P231, DOI 10.1089/omi.2013.0128; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Kolatkar AR, 1996, J BIOL CHEM, V271, P6679, DOI 10.1074/jbc.271.12.6679; Lenos K, 2015, ONCOTARGET, V6, P26278, DOI 10.18632/oncotarget.4495; Li DP, 2012, J EXP MED, V209, P109, DOI 10.1084/jem.20110399; Liao JH, 2016, J AM CHEM SOC, V138, P4787, DOI 10.1021/jacs.6b00111; Liu M, 2005, CARBOHYD RES, V340, P2111, DOI 10.1016/j.carres.2005.05.023; Madariaga D, 2015, ACS CHEM BIOL, V10, P747, DOI 10.1021/cb500855x; Madariaga D, 2014, CHEM-EUR J, V20, P12616, DOI 10.1002/chem.201403700; Marcelo F, 2014, CHEM-EUR J, V20, P16147, DOI 10.1002/chem.201404566; Marionneau S, 2002, GLYCOBIOLOGY, V12, P851, DOI 10.1093/glycob/cwf103; Martinez-Saez N, 2017, CHEM SOC REV, V46, P7154, DOI 10.1039/c6cs00858e; Mortezai N, 2013, GLYCOBIOLOGY, V23, P844, DOI 10.1093/glycob/cwt021; Movahedin M, 2017, GLYCOBIOLOGY, V27, P677, DOI 10.1093/glycob/cww131; Napoletano C, 2007, CANCER RES, V67, P8358, DOI 10.1158/0008-5472.CAN-07-1035; Rodriguez E, 2018, NAT REV IMMUNOL, V18, P204, DOI 10.1038/nri.2018.3; Saeland E, 2007, CANCER IMMUNOL IMMUN, V56, P1225, DOI 10.1007/s00262-006-0274-z; Sakakura M, 2008, J BIOL CHEM, V283, P33665, DOI 10.1074/jbc.M804067200; Singh SK, 2009, MOL IMMUNOL, V46, P1240, DOI 10.1016/j.molimm.2008.11.021; Suzuki N, 1996, J IMMUNOL, V156, P128; Tsuiji M, 2002, J BIOL CHEM, V277, P28892, DOI 10.1074/jbc.M203774200; van Vliet SJ, 2006, IMMUNOBIOLOGY, V211, P577, DOI 10.1016/j.imbio.2006.05.022; van Vliet SJ, 2006, NAT IMMUNOL, V7, P1200, DOI 10.1038/ni1390; van Vliet SJ, 2013, J BIOL CHEM, V288, P27519, DOI 10.1074/jbc.M113.471045; van Vliet SJ, 2005, INT IMMUNOL, V17, P661, DOI 10.1093/intimm/dxh246; Ward SE, 2018, BLOOD, V131, P911, DOI 10.1182/blood-2017-06-787853; York WS, 2014, GLYCOBIOLOGY, V24, P402, DOI 10.1093/glycob/cwu018; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x	55	17	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1300	1311		10.1074/jbc.RA118.004957	http://dx.doi.org/10.1074/jbc.RA118.004957			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30504228	hybrid, Green Published			2022-12-28	WOS:000457879500021
J	Winzeler, EA				Winzeler, Elizabeth A.			An improbable journey: Creativity helped me make the transition from art to curing malaria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Biographical-Item						malaria; drug development; genomics; chemical biology; microbiology; career choices; diversity in science; imposter syndrome; education; Plasmodium	FALCIPARUM; DISCOVERY; ASSAY	I was recently awarded the Alice and C. C. Wang Award in Molecular Parasitology for my contributions to antimalarial drug development, including laying the groundbreaking work that has led to two new molecular methods for curing malaria. This award means a great deal to me because I have spent much of my scientific career feeling like an imposterone with the wrong sort of background and poor credentials. I am grateful for the recognition, and I am beginning to recognize that having an atypical background can be an advantage because it gives you a different perspective on a challenge. More generally, diversity in educational and cultural backgrounds is important because it can stimulate new ways of thinking and discovery.	[Winzeler, Elizabeth A.] Univ Calif San Diego, Sch Med, Dept Pediat, 9500 Gilman Dr,MC0760, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Winzeler, EA (corresponding author), Univ Calif San Diego, Sch Med, Dept Pediat, 9500 Gilman Dr,MC0760, La Jolla, CA 92093 USA.	ewinzeler@ucsd.edu	Winzeler, Elizabeth/AAP-6752-2020	Winzeler, Elizabeth/0000-0002-4049-2113	National Institutes of Health [5R01AI090141, R01AI103058, P50GM085764]; Bill and Melinda Gates Foundation [OPP1086217, OPP1141300]; Medicines for Malaria Venture (MMV); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090141] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM085764] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Medicines for Malaria Venture (MMV); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants 5R01AI090141, R01AI103058, and P50GM085764, by Bill and Melinda Gates Foundation Grants OPP1086217 and OPP1141300, and by Medicines for Malaria Venture (MMV). The author declares that she has no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Antonova-Koch Y, 2018, SCIENCE, V362, DOI 10.1126/science.aat9446; Baragana B, 2015, NATURE, V522, P315, DOI 10.1038/nature14451; Bopp SER, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003293; Dharia NV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r21; Harrison N, 2015, LANCET INFECT DIS, V15, P1143, DOI 10.1016/S1473-3099(15)00246-7; Hoepfner D, 2012, CELL HOST MICROBE, V11, P654, DOI 10.1016/j.chom.2012.04.015; Kato N, 2016, NATURE, V538, P344, DOI 10.1038/nature19804; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; McNamara CW, 2013, NATURE, V504, P248, DOI 10.1038/nature12782; Meister S, 2011, SCIENCE, V334, P1372, DOI 10.1126/science.1211936; Plouffe D, 2008, P NATL ACAD SCI USA, V105, P9059, DOI 10.1073/pnas.0802982105; Plouffe DM, 2016, CELL HOST MICROBE, V19, P114, DOI 10.1016/j.chom.2015.12.001; Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115; Rottmann M, 2010, SCIENCE, V329, P1175, DOI 10.1126/science.1193225; Swann J, 2016, ACS INFECT DIS, V2, P281, DOI 10.1021/acsinfecdis.5b00143; White NJ, 2016, NEW ENGL J MED, V375, P1152, DOI 10.1056/NEJMoa1602250; White NJ, 2014, NEW ENGL J MED, V371, P403, DOI 10.1056/NEJMoa1315860; Winzeler EA, 1998, SCIENCE, V281, P1194, DOI 10.1126/science.281.5380.1194; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Young JA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-70	20	0	0	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2019	294	2					405	409		10.1074/jbc.AW118.005229	http://dx.doi.org/10.1074/jbc.AW118.005229			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HI2GP	30401750	Green Published, hybrid			2022-12-28	WOS:000456263600002
J	Trindade, IB; Silva, JM; Fonseca, BM; Catarino, T; Fujita, M; Matias, PM; Moe, E; Louro, RO				Trindade, Ines B.; Silva, Jose M.; Fonseca, Bruno M.; Catarino, Teresa; Fujita, Masaki; Matias, Pedro M.; Moe, Elin; Louro, Ricardo O.			Structure and reactivity of a siderophore-interacting protein from the marine bacterium Shewanella reveals unanticipated functional versatility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						flavoprotein; iron; nuclear magnetic resonance (NMR); X-ray crystallography; enzyme kinetics; electron transfer; ferredoxin; ferrozine; Shewanella; siderophore	IRON ACQUISITION; FERRIC REDUCTASE; SYSTEM; ONEIDENSIS; OXIDOREDUCTASE; IDENTIFICATION; EXPRESSION; ALCALIGIN; PATHWAYS; KINETICS	Siderophores make iron accessible under iron-limited conditions and play a crucial role in the survival of microorganisms. Because of their remarkable metal-scavenging properties and ease in crossing cellular envelopes, siderophores hold great potential in biotechnological applications, raising the need for a deeper knowledge of the molecular mechanisms underpinning the siderophore pathway. Here, we report the structural and functional characterization of a siderophore-interacting protein from the marine bacterium Shewanella frigidimarina NCIBM400 (SfSIP). SfSIP is a flavin-containing ferric-siderophore reductase with FAD- and NAD(P)H-binding domains that have high homology with other characterized SIPs. However, we found here that it mechanistically departs from what has been described for this family of proteins. Unlike other FAD-containing SIPs, SfSIP did not discriminate between NADH and NADPH. Furthermore, SfSIP required the presence of the Fe2+-scavenger, ferrozine, to use NAD(P)H to drive the reduction of Shewanella-produced hydroxamate ferric-siderophores. Additionally, this is the first SIP reported that also uses a ferredoxin as electron donor, and in contrast to NAD(P)H, its utilization did not require the mediation of ferrozine, and electron transfer occurred at fast rates. Finally, FAD oxidation was thermodynamically coupled to deprotonation at physiological pH values, enhancing the solubility of ferrous iron. On the basis of these results and the location of the SfSIP gene downstream of a sequence for putative binding of aerobic respiration control protein A (ArcA), we propose that SfSIP contributes an additional layer of regulation that maintains cellular iron homeostasis according to environmental cues of oxygen availability and cellular iron demand.	[Trindade, Ines B.; Silva, Jose M.; Fonseca, Bruno M.; Catarino, Teresa; Matias, Pedro M.; Moe, Elin; Louro, Ricardo O.] Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier ITQB NOVA, Ave Republ EAN, P-2780157 Oeiras, Portugal; [Catarino, Teresa] Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Quim, Caparica, Portugal; [Fujita, Masaki] Hokkaido Univ, Fac Fisheries Sci, 3-1-1 Minato Cho, Hakodate, Hokkaido 0418611, Japan; [Matias, Pedro M.] iBET, Apartado 12, P-2780901 Oeiras, Portugal	Universidade Nova de Lisboa; Universidade Nova de Lisboa; Hokkaido University	Louro, RO (corresponding author), ITQB NOVA, Ave Republ EAN, P-2780157 Oeiras, Portugal.	louro@itqb.unl.pt	Moe, Elin/J-4367-2013; Moe, Elin/Q-6131-2019; Matias, Pedro M/B-7180-2008; , TIMB3/AAD-6259-2021; Louro, Ricardo O./AAB-4601-2020; Catarino, Teresa/A-9267-2012	Moe, Elin/0000-0002-7923-1471; Moe, Elin/0000-0002-7923-1471; Matias, Pedro M/0000-0001-6170-451X; Louro, Ricardo O./0000-0002-2392-6450; Fonseca, Bruno/0000-0003-1364-5871; Trindade, Ines/0000-0002-6746-8455; Catarino, Teresa/0000-0003-3782-4014; Malanho Silva, Jose/0000-0001-6255-3960	FEDER funds through COMPETE2020-Programa Operacional Competitividade e Internacionalizacao (POCI) [LISBOA-01-0145-FEDER-007660]; European Community [283570]	FEDER funds through COMPETE2020-Programa Operacional Competitividade e Internacionalizacao (POCI); European Community(European Commission)	We thank Isabel Pacheco for help in the purification of SfSIP and Dr. Americo Duarte for providing ferredoxin. We also thank all members of the Inorganic Biochemistry and NMR Laboratory for discussions and comments and feedback regarding the preparation of the manuscript. The NMR experiments were performed at CERMAX (Centro de Ressonancia Magnetica Antonio Xavier) and was financially supported by Project LISBOA-01-0145-FEDER-007660 (Microbiologia Molecular, Estrutural e Celular) funded by FEDER funds through COMPETE2020-Programa Operacional Competitividade e Internacionalizacao (POCI), the European Community's Seventh Framework Program (FP7/2007-2013)) under Grant Agreement 283570 (BioStruct-X), Beamtime at I04 at the Diamond Light Source and assistance from the beamline staff during the synchrotron data collections are gratefully acknowledged.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Armstrong FA, 1997, CHEM SOC REV, V26, P169, DOI 10.1039/cs9972600169; Atkinson JT, 2016, BIOCHEMISTRY-US, V55, P7047, DOI 10.1021/acs.biochem.6b00831; Baysse C, 2003, MICROBIOL-SGM, V149, P3543, DOI 10.1099/mic.0.26566-0; Beliaev AS, 2005, J BACTERIOL, V187, P7138, DOI 10.1128/JB.187.20.7138-7145.2005; Boukhalfa H, 2002, BIOMETALS, V15, P325, DOI 10.1023/A:1020218608266; Bowman JP, 1997, INT J SYST BACTERIOL, V47, P1040, DOI 10.1099/00207713-47-4-1040; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; BUTTERTON JR, 1994, J BACTERIOL, V176, P5631, DOI 10.1128/JB.176.18.5631-5638.1994; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; COVES J, 1993, EUR J BIOCHEM, V211, P635, DOI 10.1111/j.1432-1033.1993.tb17591.x; Díaz-Anaya Adriana María, 2017, Rev Salud Anim., P1; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fonseca BM, 2013, BIOCHEM J, V449, P101, DOI 10.1042/BJ20121467; Fonseca BM, 2012, FEBS LETT, V586, P504, DOI 10.1016/j.febslet.2011.08.019; FONTECAVE M, 1994, BIOMETALS, V7, P3; Fourmond V, 2016, ANAL CHEM, V88, P5050, DOI 10.1021/acs.analchem.6b00224; Friis EP, 1998, ELECTROCHIM ACTA, V43, P1113; Fujita MJ, 2014, MAR DRUGS, V12, P4799, DOI 10.3390/md12094799; Gao HC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-42; Ghosal D, 2005, FEMS MICROBIOL REV, V29, P361, DOI 10.1016/j.fmrre.2004.12.007; Gralnick JA, 2005, MOL MICROBIOL, V56, P1347, DOI 10.1111/j.1365-2958.2005.04628.x; Holden VI, 2015, METALLOMICS, V7, P986, DOI 10.1039/c4mt00333k; Hou ZG, 1998, INORG CHEM, V37, P6630, DOI 10.1021/ic9810182; Janda J. M., 2014, Clinical Microbiology Newsletter, V36, P25, DOI 10.1016/j.clinmicnews.2014.01.006; Janda JM, 2014, CRIT REV MICROBIOL, V40, P293, DOI 10.3109/1040841X.2012.726209; Jeitner TM, 2014, ANAL BIOCHEM, V454, P36, DOI 10.1016/j.ab.2014.02.026; Jeuken LJC, 2002, J PHYS CHEM B, V106, P2304, DOI 10.1021/jp0134291; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kobylarz MJ, 2017, ACS CHEM BIOL, V12, P1778, DOI 10.1021/acschembio.7b00203; Koebnik R, 2005, TRENDS MICROBIOL, V13, P343, DOI 10.1016/j.tim.2005.06.005; Li KH, 2015, BIOCHEMISTRY-US, V54, P3989, DOI 10.1021/acs.biochem.5b00354; Linares D, 2016, ENV MICROBIOL REP, V8, P110, DOI 10.1111/1758-2229.12358; Louro RO, 1996, J BIOL INORG CHEM, V1, P34, DOI 10.1007/s007750050020; MARTIN JH, 1988, DEEP-SEA RES, V35, P177, DOI 10.1016/0198-0149(88)90035-0; Martin JH, 1990, PALEOCEANOGRAPHY, V5, P1, DOI 10.1029/PA005i001p00001; Miethke M, 2007, MICROBIOL MOL BIOL R, V71, P413, DOI 10.1128/MMBR.00012-07; Miethke M, 2011, BIOCHEMISTRY-US, V50, P10951, DOI 10.1021/bi201517h; Miethke M, 2011, J BIOL CHEM, V286, P2245, DOI 10.1074/jbc.M110.192468; Moore CM, 2013, NAT GEOSCI, V6, P701, DOI [10.1038/NGEO1765, 10.1038/ngeo1765]; Moore JK, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002762; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pierre JL, 2002, BIOMETALS, V15, P341, DOI 10.1023/A:1020259021641; Rutschlin S, 2017, CELL CHEM BIOL, V24, P598, DOI 10.1016/j.chembiol.2017.03.017; Sedlacek V, 2009, MICROBIOL-SGM, V155, P1294, DOI 10.1099/mic.0.022715-0; Spasojevic I, 1999, INORG CHEM, V38, P449, DOI 10.1021/ic980635n; Sturm G, 2015, ISME J, V9, P1802, DOI 10.1038/ismej.2014.264; Trindade IB, 2016, ACTA CRYSTALLOGR F, V72, P667, DOI 10.1107/S2053230X16011419; Tu J, 2014, VET MICROBIOL, V168, P395, DOI 10.1016/j.vetmic.2013.11.027; Velankar S, 2011, NUCLEIC ACIDS RES, V39, pD402, DOI [10.1093/nar/gkq985, 10.1093/nar/gkp916]; Viollier E, 2000, APPL GEOCHEM, V15, P785, DOI 10.1016/S0883-2927(99)00097-9; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Xu N, 2014, RES MICROBIOL, V165, P252, DOI 10.1016/j.resmic.2014.03.001; Yang YF, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-131; Yousafzai FK, 2002, J BIOL CHEM, V277, P34067, DOI 10.1074/jbc.M204305200	58	6	6	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2019	294	1					157	167		10.1074/jbc.RA118.005041	http://dx.doi.org/10.1074/jbc.RA118.005041			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG6PT	30420426	Green Published, hybrid			2022-12-28	WOS:000455105500020
J	Ohashi, H; Nishioka, K; Nakajima, S; Kim, S; Suzuki, R; Aizaki, H; Fukasawa, M; Kamisuki, S; Sugawara, F; Ohtani, N; Muramatsu, M; Wakita, T; Watashi, K				Ohashi, Hirofumi; Nishioka, Kazane; Nakajima, Syo; Kim, Sulyi; Suzuki, Ryosuke; Aizaki, Hideki; Fukasawa, Masayoshi; Kamisuki, Shinji; Sugawara, Fumio; Ohtani, Naoko; Muramatsu, Masamichi; Wakita, Takaji; Watashi, Koichi			The aryl hydrocarbon receptor-cytochrome P450 1A1 pathway controls lipid accumulation and enhances the permissiveness for hepatitis C virus assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aryl hydrocarbon receptor (AhR) (AHR); cytochrome P450; Hepatitis C virus (HCV); lipid droplet; hepatocyte; virus assembly; fatty acid metabolism; triglyceride; CYP1A1; hepatitis	FATTY-ACID-METABOLISM; CORE PROTEIN; HEPATOCELLULAR-CARCINOMA; NONALCOHOLIC STEATOHEPATITIS; RISK-FACTOR; EXPRESSION; STEATOSIS; ACTIVATION; AHR; REPLICATION	Viruses hijack and modify host cell functions to maximize viral proliferation. Hepatitis C virus (HCV) reorganizes host cell metabolism to produce specialized membrane structures and to modify organelles such as double-membrane vesicles and enlarged lipid droplets (LDs), thereby enabling virus replication and assembly. However, the molecular bases of these host-HCV interactions are largely unknown. Here, using a chemical screen, we demonstrate that the benzamide derivative flutamide reduces the host capacity to produce infectious HCV. Flutamide disrupted the formation of enlarged LDs in HCV-infected cells, thereby abolishing HCV assembly. We also report that aryl hydrocarbon receptor (AhR), a known flutamide target, plays a key role in mediating LD accumulation and HCV production. This AhR function in lipid production was also observed in HCV-uninfected Huh-7 cells and primary human hepatocytes, suggesting that AhR signaling regulates lipid accumulation independently of HCV infection. We further observed that a downstream activity, that of cytochrome P450 1A1 (CYP1A1), was the primary regulator of AhR-mediated lipid production. Specifically, blockade of AhR-induced CYP1A1 up-regulation counteracted LD overproduction, and overproduction of CYP1A1, but not of CYP1B1, in AhR-inactivated cells restored lipid accumulation. Of note, HCV infection up-regulated the AhR-CYP1A1 pathway, resulting in the accumulation of enlarged LDs. In conclusion, we demonstrate that the AhR-CYP1A1 pathway has a significant role in lipid accumulation, a hallmark of HCV infection that maximizes progeny virus production. Our chemical-genetic analysis reveals a new strategy and lead compounds to control hepatic lipid accumulation as well as HCV infection.	[Ohashi, Hirofumi; Nishioka, Kazane; Nakajima, Syo; Kim, Sulyi; Suzuki, Ryosuke; Aizaki, Hideki; Muramatsu, Masamichi; Wakita, Takaji; Watashi, Koichi] Natl Inst Infect Dis, Dept Virol 2, Tokyo 1628640, Japan; [Fukasawa, Masayoshi] Natl Inst Infect Dis, Dept Biochem & Cell Biol, Tokyo 1628640, Japan; [Ohashi, Hirofumi; Nishioka, Kazane; Nakajima, Syo; Kamisuki, Shinji; Sugawara, Fumio; Ohtani, Naoko; Watashi, Koichi] Tokyo Univ Sci, Grad Sch Sci & Technol, Noda, Chiba 2788510, Japan; [Watashi, Koichi] Japan Sci & Technol Agcy JST, CREST, Kawaguchi, Saitama 3320012, Japan	National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID); Tokyo University of Science; Japan Science & Technology Agency (JST)	Watashi, K (corresponding author), Natl Inst Infect Dis, Dept Virol 2, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.	kwatashi@nih.go.jp	Fukasawa, Masayoshi/ABD-7655-2020; Ohtani, Naoko/AAB-1891-2021	Fukasawa, Masayoshi/0000-0002-0702-0691; Ohtani, Naoko/0000-0001-8934-0797	Japan Society for the Promotion of Science KAKENHI [JP17H04085, JP18J14277, JP66KT0111]; JST CREST program; Japan Agency for Medical Research and Development (AMED) [JP18fk0310114j0002, JP18fk0310101j1002, JP18fk0310103j0202, JP18fm0208019j0002, JP18fk0210036j0001]; Suzuken Memorial Foundation; Fuji Foundation for Protein Research; Japan Food Chemical Research Foundation	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JST CREST program(Core Research for Evolutional Science and Technology (CREST)Japan Science & Technology Agency (JST)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Suzuken Memorial Foundation; Fuji Foundation for Protein Research(Fuji Foundation for Protein Research); Japan Food Chemical Research Foundation(Japan Food Chemical Research Foundation)	This study was supported by Japan Society for the Promotion of Science KAKENHI Grants JP17H04085, JP18J14277, and JP66KT0111; the JST CREST program; Japan Agency for Medical Research and Development (AMED) Grants JP18fk0310114j0002, JP18fk0310101j1002, JP18fk0310103j0202, JP18fm0208019j0002, and JP18fk0210036j0001; the Suzuken Memorial Foundation; the Fuji Foundation for Protein Research; and the Japan Food Chemical Research Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Akazawa D, 2007, J VIROL, V81, P5036, DOI 10.1128/JVI.01573-06; Amako Y, 2011, J BIOL CHEM, V286, P11265, DOI 10.1074/jbc.M110.182097; Arnold C, 2010, PHARMACOL REP, V62, P536, DOI 10.1016/S1734-1140(10)70311-X; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; Boulant S, 2007, J GEN VIROL, V88, P2204, DOI 10.1099/vir.0.82898-0; Camus G, 2013, J BIOL CHEM, V288, P9915, DOI 10.1074/jbc.M112.434910; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; Fujii-Kuriyama Y, 2005, BIOCHEM BIOPH RES CO, V338, P311, DOI 10.1016/j.bbrc.2005.08.162; He JH, 2013, MOL CELL BIOL, V33, P2047, DOI 10.1128/MCB.01658-12; Hsu NY, 2010, CELL, V141, P799, DOI 10.1016/j.cell.2010.03.050; Ishida Y, 2015, AM J PATHOL, V185, P1275, DOI 10.1016/j.ajpath.2015.01.028; Iwamoto M, 2014, BIOCHEM BIOPH RES CO, V443, P808, DOI 10.1016/j.bbrc.2013.12.052; Jiang JY, 2009, J VIROL, V83, P12680, DOI 10.1128/JVI.01476-09; Jin UH, 2012, J PHARMACOL EXP THER, V343, P333, DOI 10.1124/jpet.112.195339; Kato T, 2008, HEPATOLOGY, V48, P732, DOI 10.1002/hep.22422; Kim S, 2014, HEPATOLOGY, V60, P1838, DOI 10.1002/hep.27197; Kress S, 1998, EUR J BIOCHEM, V258, P803, DOI 10.1046/j.1432-1327.1998.2580803.x; Kurosaki M, 2010, HEPATOL RES, V40, P870, DOI 10.1111/j.1872-034X.2010.00692.x; Lahoti TS, 2014, J PHARMACOL EXP THER, V348, P236, DOI 10.1124/jpet.113.209726; Larrea E, 2007, J VIROL, V81, P3662, DOI 10.1128/JVI.02248-06; Lee AJ, 2003, ENDOCRINOLOGY, V144, P3382, DOI 10.1210/en.2003-0192; Lee JH, 2010, GASTROENTEROLOGY, V139, P653, DOI 10.1053/j.gastro.2010.03.033; Lerat H, 2002, GASTROENTEROLOGY, V122, P352, DOI 10.1053/gast.2002.31001; LUDWIG J, 1980, MAYO CLIN PROC, V55, P434; Macedo LF, 2006, CANCER RES, V66, P7775, DOI 10.1158/0008-5472.CAN-05-3984; Marlowe JL, 2005, J CELL BIOCHEM, V96, P1174, DOI 10.1002/jcb.20656; Masaki T, 2014, J VIROL, V88, P7541, DOI 10.1128/JVI.03170-13; McIntosh AL, 2014, AM J PHYSIOL-GASTR L, V307, pG164, DOI 10.1152/ajpgi.00369.2013; Meertens L, 2006, J VIROL, V80, P11571, DOI 10.1128/JVI.01717-06; Miller S, 2008, NAT REV MICROBIOL, V6, P363, DOI 10.1038/nrmicro1890; Mimura J, 2003, BBA-GEN SUBJECTS, V1619, P263, DOI 10.1016/S0304-4165(02)00485-3; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Moriya K, 1997, J GEN VIROL, V78, P1527, DOI 10.1099/0022-1317-78-7-1527; Moriya K, 1998, NAT MED, V4, P1065, DOI 10.1038/2053; Nakajima S, 2016, J VIROL, V90, P9058, DOI 10.1128/JVI.00856-16; Nebert DW, 2000, BIOCHEM PHARMACOL, V59, P65, DOI 10.1016/S0006-2952(99)00310-X; Nebert DW, 2004, J BIOL CHEM, V279, P23847, DOI 10.1074/jbc.R400004200; Ohata K, 2003, CANCER-AM CANCER SOC, V97, P3036, DOI 10.1002/cncr.11427; Patel RD, 2006, TOXICOL SCI, V89, P75, DOI 10.1093/toxsci/kfi344; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Rendic S, 2012, CHEM RES TOXICOL, V25, P1316, DOI 10.1021/tx300132k; Shavinskaya A, 2007, J BIOL CHEM, V282, P37158, DOI 10.1074/jbc.M707329200; Shimada T, 2001, DRUG METAB DISPOS, V29, P1176; Shimba S, 2009, BIOCHEM PHARMACOL, V77, P560, DOI 10.1016/j.bcp.2008.09.040; Stevens EA, 2009, IMMUNOLOGY, V127, P299, DOI 10.1111/j.1365-2567.2009.03054.x; Syed GH, 2010, TRENDS ENDOCRIN MET, V21, P33, DOI 10.1016/j.tem.2009.07.005; Tscherne DM, 2006, J VIROL, V80, P1734, DOI 10.1128/JVI.80.4.1734-1741.2006; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Vorrink SU, 2014, TOXICOL APPL PHARM, V274, P408, DOI 10.1016/j.taap.2013.12.002; Wada T, 2016, J BIOL CHEM, V291, P7004, DOI 10.1074/jbc.M115.693655; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430; Watashi K, 2003, HEPATOLOGY, V38, P1282, DOI 10.1053/jhep.2003.50449; Wells MA, 2016, PROSTAG OTH LIPID M, V125, P19, DOI 10.1016/j.prostaglandins.2016.07.002; Welte MA, 2015, CURR BIOL, V25, pR470, DOI 10.1016/j.cub.2015.04.004; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	58	25	26	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19559	19571		10.1074/jbc.RA118.005033	http://dx.doi.org/10.1074/jbc.RA118.005033			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30381393	Green Published, hybrid			2022-12-28	WOS:000454294900006
J	Godbole, M; Togar, T; Patel, K; Dharavath, B; Yadav, N; Janjuha, S; Gardi, N; Tiwary, K; Terwadkar, P; Desai, S; Prasad, R; Dhamne, H; Karve, K; Salunkhe, S; Kawle, D; Chandrani, P; Dutt, S; Gupta, S; Badwe, RA; Dutt, A				Godbole, Mukul; Togar, Trupti; Patel, Kuldeep; Dharavath, Bhasker; Yadav, Neelima; Janjuha, Sharan; Gardi, Nilesh; Tiwary, Kanishka; Terwadkar, Prachi; Desai, Sanket; Prasad, Ratnam; Dhamne, Hemant; Karve, Kunal; Salunkhe, Sameer; Kawle, Dhananjay; Chandrani, Pratik; Dutt, Shilpee; Gupta, Sudeep; Badwe, Rajendra A.; Dutt, Amit			Up-regulation of the kinase gene SGK1 by progesterone activates the AP-1-NDRG1 axis in both PR-positive and -negative breast cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						progesterone; breast cancer; functional genomics; cell signaling; microRNA (miRNA); N-Myc-downstream regulated gene 1 (NDRG1); post-transcriptional regulation; Serum- and glucocorticoid-regulated kinase 1 (SGK1); transcription factor AP-1	METASTASIS SUPPRESSOR NDRG1; GROWTH-STIMULATING FACTOR; PRIMARY TUMOR REMOVAL; READ ALIGNMENT; RECEPTOR; TRANSCRIPTION; SERUM; PROLIFERATION; PATHWAYS; PROSTATE	Preoperative progesterone intervention has been shown to confer a survival benefit to breast cancer patients independently of their progesterone receptor (PR) status. This observation raises the question how progesterone affects the outcome of PR-negative cancer. Here, using microarray and RNA-Seq-based gene expression profiling and ChIP-Seq analyses of breast cancer cells, we observed that the serum- and glucocorticoid-regulated kinase gene (SGK1) and the tumor metastasis-suppressor gene N-Myc downstream regulated gene 1 (NDRG1) are up-regulated and that the microRNAs miR-29a and miR-101-1 targeting the 3-UTR of SGK1 are down-regulated in response to progesterone. We further demonstrate a dual-phase transcriptional and post-transcriptional regulation of SGK1 in response to progesterone, leading to an up-regulation of NDRG1 that is mediated by a set of genes regulated by the transcription factor AP-1. We found that NDRG1, in turn, inactivates a set of kinases, impeding the invasion and migration of breast cancer cells. In summary, we propose a model for the mode of action of progesterone in breast cancer. This model helps decipher the molecular basis of observations in a randomized clinical trial of the effect of progesterone on breast cancer and has therefore the potential to improve the prognosis of breast cancer patients receiving preoperative progesterone treatment.	[Godbole, Mukul; Togar, Trupti; Patel, Kuldeep; Dharavath, Bhasker; Yadav, Neelima; Janjuha, Sharan; Gardi, Nilesh; Tiwary, Kanishka; Terwadkar, Prachi; Desai, Sanket; Prasad, Ratnam; Dhamne, Hemant; Karve, Kunal; Kawle, Dhananjay; Chandrani, Pratik; Dutt, Amit] Tata Mem Hosp, Tata Mem Ctr, Integrated Canc Genom Lab, Navi Mumbai 410210, Maharashtra, India; [Salunkhe, Sameer; Dutt, Shilpee] Tata Mem Hosp, Tata Mem Ctr, Shilpee Lab, Adv Ctr Treatment Res & Educ Canc, Navi Mumbai 410210, Maharashtra, India; [Gupta, Sudeep] Tata Mem Hosp, Tata Mem Ctr, Dept Med Oncol, Navi Mumbai 410210, Maharashtra, India; [Badwe, Rajendra A.] Tata Mem Hosp, Tata Mem Ctr, Dept Surg Oncol, Navi Mumbai 410210, Maharashtra, India; [Godbole, Mukul; Togar, Trupti; Dharavath, Bhasker; Yadav, Neelima; Gardi, Nilesh; Desai, Sanket; Salunkhe, Sameer; Dutt, Shilpee; Dutt, Amit] Homi Bhabha Natl Inst, Training Sch Complex, Bombay 400094, Maharashtra, India	Tata Memorial Centre (TMC); Tata Memorial Hospital; Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital; Tata Memorial Centre (TMC); Tata Memorial Hospital; Tata Memorial Centre (TMC); Tata Memorial Hospital; Homi Bhabha National Institute	Dutt, A (corresponding author), Tata Mem Hosp, Integrated Canc Genom Lab, Adv Ctr Treatment Res & Educ Canc, Navi Mumbai 410210, Maharashtra, India.	adutt@actrec.gov.in	Dutt, Amit/I-1911-2013; Godbole, Mukul S./AAT-4330-2021; Chandrani, Pratik/AAV-9081-2021	Dutt, Amit/0000-0002-1119-4774; Godbole, Mukul S./0000-0003-0711-8696; Chandrani, Pratik/0000-0003-2572-0189; Janjuha, Sharan/0000-0002-5910-2912; Desai, Sanket/0000-0002-7929-8684; patel, kuldeep/0000-0003-4323-4264	Wellcome Trust/Department of Biotechnology India Alliance [IA/I/11/2500278]; Department of Biotechnology Grant [BT/MED/30/VNCI-Hr-RCA/2015]; Homi Bhabha National Institute (HBNI), ACTREC-TMC; intramural grants (IRB project) [2712]	Wellcome Trust/Department of Biotechnology India Alliance(Wellcome Trust DBT India Alliance); Department of Biotechnology Grant; Homi Bhabha National Institute (HBNI), ACTREC-TMC; intramural grants (IRB project)	This work was supported by Wellcome Trust/Department of Biotechnology India Alliance Grant IA/I/11/2500278 (to A. D.), intramural grants (IRB project 2712 to A. D.), and Department of Biotechnology Grant BT/MED/30/VNCI-Hr-RCA/2015 (to A. D.). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a research fellowship from the Homi Bhabha National Institute (HBNI), ACTREC-TMC.	Azeez JM, 2015, DRUG DES DEV THER, V9, P5987, DOI 10.2147/DDDT.S89390; Badwe R, 2011, J CLIN ONCOL, V29, P2845, DOI 10.1200/JCO.2010.33.0738; Bandyopadhyay S, 2004, CANCER RES, V64, P7655, DOI 10.1158/0008-5472.CAN-04-1623; Bartlett JMS, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2604; Bethke A, 2009, SCIENCE, V324, P95, DOI 10.1126/science.1164899; Blaes J, 2014, J NEURO-ONCOL, V117, P25, DOI 10.1007/s11060-013-1357-2; Castellano L, 2009, P NATL ACAD SCI USA, V106, P15732, DOI 10.1073/pnas.0906947106; Catalanotto C, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101712; Chatterjee S, 2018, BREAST CANCER RES TR, V170, P431, DOI 10.1007/s10549-018-4749-3; Clough E, 2016, METHODS MOL BIOL, V1418, P93, DOI 10.1007/978-1-4939-3578-9_5; Cochrane DR, 2012, MOL CELL ENDOCRINOL, V355, P15, DOI 10.1016/j.mce.2011.12.020; Dixon KM, 2013, BRIT J CANCER, V108, P409, DOI 10.1038/bjc.2012.582; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; Firestone GL, 2003, CELL PHYSIOL BIOCHEM, V13, P1, DOI 10.1159/000070244; FISHER B, 1989, CANCER RES, V49, P2002; FISHER B, 1989, CANCER RES, V49, P1996; Godbole M, 2017, CANCER BIOL THER, V18, P801, DOI 10.1080/15384047.2017.1373216; Godbole M, 2017, CELL ONCOL, V40, P411, DOI 10.1007/s13402-017-0330-z; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hahn MW, 2002, EVOL DEV, V4, P73, DOI 10.1046/j.1525-142X.2002.01069.x; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hosoya N, 2013, BBA-PROTEINS PROTEOM, V1834, P2630, DOI 10.1016/j.bbapap.2013.08.009; Kolesnikov N, 2015, NUCLEIC ACIDS RES, V43, pD1113, DOI 10.1093/nar/gku1057; Kondili M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02464-y; Kovacevic Z, 2016, J BIOL CHEM, V291, P1029, DOI 10.1074/jbc.M115.689653; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lopez-Bergami P, 2010, NAT REV CANCER, V10, P65, DOI 10.1038/nrc2681; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ma W, 2015, MOL MED REP, V12, P1050, DOI 10.3892/mmr.2015.3492; Maillot G, 2009, CANCER RES, V69, P8332, DOI 10.1158/0008-5472.CAN-09-2206; Malet C, 2000, J STEROID BIOCHEM, V73, P171, DOI 10.1016/S0960-0760(00)00061-3; Mansley MK, 2010, BRIT J PHARMACOL, V161, P571, DOI 10.1111/j.1476-5381.2010.00898.x; Marzook H, 2017, ONCOGENE, V36, P5263, DOI 10.1038/onc.2017.19; Mattick JS, 2004, NAT REV GENET, V5, P316, DOI 10.1038/nrg1321; Menezes SV, 2017, J BIOL CHEM, V292, P12772, DOI 10.1074/jbc.R117.776393; Mohammed H, 2015, NATURE, V523, P313, DOI 10.1038/nature14583; Need EF, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1819-3; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Salnikow K, 2002, MOL CELL BIOL, V22, P1734, DOI 10.1128/MCB.22.6.1734-1741.2002; Shalgi R, 2007, PLOS COMPUT BIOL, V3, P1291, DOI 10.1371/journal.pcbi.0030131; Singhal H, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501924; Sun J, 2013, CARCINOGENESIS, V34, P1943, DOI 10.1093/carcin/bgt163; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Zhang P, 2007, CANCER RES, V67, P9125, DOI 10.1158/0008-5472.CAN-07-1525	47	15	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2018	293	50					19263	19276		10.1074/jbc.RA118.002894	http://dx.doi.org/10.1074/jbc.RA118.002894			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HE6RA	30337371	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000453537300010
J	Mishra, LN; Hayes, JJ				Mishra, Laxmi Narayan; Hayes, Jeffrey J.			A nucleosome-free region locally abrogates histone H1-dependent restriction of linker DNA accessibility in chromatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromatin; chromatin structure; chromatin regulation; histone; histone acetylation; nucleosome; epigenetics; gene regulation; histone H1; linker histone; nucleosome free region	PIONEER TRANSCRIPTION FACTORS; H4 TAIL DOMAIN; SELF-ASSOCIATION; H1; ORGANIZATION; ARRAYS; MECHANISM; DYNAMICS; BINDING; FIBER	Eukaryotic genomes are packaged into linker-oligonucleosome assemblies, providing compaction of genomic DNA and contributing to gene regulation and genome integrity. To define minimal requirements for initial steps in the transition of compact, closed chromatin to a transcriptionally active, open state, we developed a model in vitro system containing a single, unique, target nucleosome in the center of a 25-nucleosome array and evaluated the accessibility of the linker DNA adjacent to this target nucleosome. We found that condensation of H1-lacking chromatin results in approximate to 60-fold reduction in linker DNA accessibility and that mimics of acetylation within all four core histone tail domains of the target nucleosome synergize to increase accessibility approximate to 3-fold. Notably, stoichiometric binding of histone H1 caused >2 orders of magnitude reduction in accessibility that was marginally diminished by histone acetylation mimics. Remarkably, a nucleosome-free region (NFR) in place of the target nucleosome completely abrogated H1-dependent restriction of linker accessibility in the immediate vicinity of the NFR. Our results suggest that linker DNA is as inaccessible as DNA within the nucleosome core in fully condensed, H1-containing chromatin. They further imply that an unrecognized function of NFRs in gene promoter regions is to locally abrogate the severe restriction of linker DNA accessibility imposed by H1s.	[Mishra, Laxmi Narayan; Hayes, Jeffrey J.] Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Mishra, Laxmi Narayan] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA	University of Rochester; Yeshiva University; Albert Einstein College of Medicine	Hayes, JJ (corresponding author), Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA.	Jeffrey_Hayes@urmc.rochester.edu	MISHRA, LAXMI NARAYAN/P-7740-2018	MISHRA, LAXMI NARAYAN/0000-0002-6596-9651; Hayes, Jeffrey/0000-0001-6981-1803	National Institutes of Health [R01GM052426]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052426] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01GM052426 (to J. J. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allahverdi A, 2015, SCI REP-UK, V5, DOI 10.1038/srep08512; Allahverdi A, 2011, NUCLEIC ACIDS RES, V39, P1680, DOI 10.1093/nar/gkq900; ALLAN J, 1982, J CELL BIOL, V93, P285, DOI 10.1083/jcb.93.2.285; Bai L, 2010, TRENDS GENET, V26, P476, DOI 10.1016/j.tig.2010.08.003; Bednar J, 2017, MOL CELL, V66, P384, DOI 10.1016/j.molcel.2017.04.012; Bernstein BE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r62; BRESNICK EH, 1992, NUCLEIC ACIDS RES, V20, P273, DOI 10.1093/nar/20.2.273; Cao Kaixiang, 2013, PLoS Genet, V9, pe1003417, DOI 10.1371/journal.pgen.1003417; Carruthers LM, 1998, BIOCHEMISTRY-US, V37, P14776, DOI 10.1021/bi981684e; Caterino TL, 2011, MOL CELL BIOL, V31, P2341, DOI 10.1128/MCB.05145-11; Chafin DR, 2000, EMBO J, V19, P5492, DOI 10.1093/emboj/19.20.5492; CHEN W, 1985, EMBO J, V4, P3273, DOI 10.1002/j.1460-2075.1985.tb04077.x; Chereji RV, 2018, BIOPHYS J, V114, P2279, DOI 10.1016/j.bpj.2018.03.015; Chereji RV, 2017, MOL CELL, V65, P565, DOI 10.1016/j.molcel.2016.12.009; CLARK DJ, 1990, J MOL BIOL, V211, P883, DOI 10.1016/0022-2836(90)90081-V; CLARK DJ, 1988, EUR J BIOCHEM, V178, P225, DOI 10.1111/j.1432-1033.1988.tb14447.x; Cutter AR, 2017, BIOCHEM CELL BIOL, V95, P171, DOI 10.1139/bcb-2016-0097; DONG F, 1991, P NATL ACAD SCI USA, V88, P10596, DOI 10.1073/pnas.88.23.10596; Dorigo B, 2004, SCIENCE, V306, P1571, DOI 10.1126/science.1103124; Dorigo B, 2003, J MOL BIOL, V327, P85, DOI 10.1016/S0022-2836(03)00025-1; Fan YH, 2005, CELL, V123, P1199, DOI 10.1016/j.cell.2005.10.028; Fan YH, 2003, MOL CELL BIOL, V23, P4559, DOI 10.1128/MCB.23.13.4559-4572.2003; Faye G, 2005, J BIOL CHEM, V280, P33701, DOI 10.1074/jbc.M507048200; FLETCHER TM, 1995, J BIOL CHEM, V270, P25359, DOI 10.1074/jbc.270.43.25359; GRUNSTEIN M, 1992, SCI AM, V267, P68, DOI 10.1038/scientificamerican1092-68; HAN M, 1988, CELL, V55, P1137, DOI 10.1016/0092-8674(88)90258-9; Hansen JC, 2002, ANNU REV BIOPH BIOM, V31, P361, DOI 10.1146/annurev.biophys.31.101101.140858; HANSEN JC, 1989, BIOCHEMISTRY-US, V28, P9129, DOI 10.1021/bi00449a026; HANSEN JC, 1993, J BIOL CHEM, V268, P5840; Hashimoto H, 2010, NUCLEIC ACIDS RES, V38, P3533, DOI 10.1093/nar/gkq076; Hayes JJ, 1996, J BIOL CHEM, V271, P25817, DOI 10.1074/jbc.271.42.25817; HAYES JJ, 1990, P NATL ACAD SCI USA, V87, P7405, DOI 10.1073/pnas.87.19.7405; Hill DA, 2000, BIOCHEMISTRY-US, V39, P11649, DOI 10.1021/bi001330z; Huynh VAT, 2005, J MOL BIOL, V345, P957, DOI 10.1016/j.jmb.2004.10.075; Iwafuchi-Doi M, 2016, DEVELOPMENT, V143, P1833, DOI 10.1242/dev.133900; Izzo A, 2013, CELL REP, V3, P2142, DOI 10.1016/j.celrep.2013.05.003; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Kan PY, 2007, MOL CELL BIOL, V27, P2084, DOI 10.1128/MCB.02181-06; Kan PY, 2009, MOL CELL BIOL, V29, P538, DOI 10.1128/MCB.01343-08; LAYBOURN PJ, 1991, SCIENCE, V254, P238, DOI 10.1126/science.1718039; Maeshima K, 2016, EMBO J, V35, P1115, DOI 10.15252/embj.201592660; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Millan-Arino L, 2014, NUCLEIC ACIDS RES, V42, P4474, DOI 10.1093/nar/gku079; Mishra LN, 2016, SCI REP-UK, V6, DOI 10.1038/srep34808; Mishra LN, 2018, EPIGENET CHROMATIN, V11, DOI 10.1186/s13072-018-0214-0; Ocampo J, 2016, NUCLEIC ACIDS RES, V44, P4625, DOI 10.1093/nar/gkw068; ONEILL TE, 1995, NUCLEIC ACIDS RES, V23, P1075, DOI 10.1093/nar/23.6.1075; Pan CY, 2016, BBA-GENE REGUL MECH, V1859, P496, DOI 10.1016/j.bbagrm.2015.12.002; Pepenella S, 2014, J BIOL CHEM, V289, P27342, DOI 10.1074/jbc.M114.595140; Poirier MG, 2008, J MOL BIOL, V379, P772, DOI 10.1016/j.jmb.2008.04.025; Polach KJ, 1996, J MOL BIOL, V258, P800, DOI 10.1006/jmbi.1996.0288; POLACH KJ, 1995, J MOL BIOL, V254, P130, DOI 10.1006/jmbi.1995.0606; Schwarz PM, 1996, BIOCHEMISTRY-US, V35, P4009, DOI 10.1021/bi9525684; Shen XT, 1996, CELL, V86, P475, DOI 10.1016/S0092-8674(00)80120-8; SHIMAMURA A, 1989, MOL CELL BIOL, V9, P5573, DOI 10.1128/MCB.9.12.5573; SIMPSON RT, 1985, CELL, V42, P799, DOI 10.1016/0092-8674(85)90276-4; Soufi A, 2015, CELL, V161, P555, DOI 10.1016/j.cell.2015.03.017; Syed SH, 2010, P NATL ACAD SCI USA, V107, P9620, DOI 10.1073/pnas.1000309107; THOMA F, 1979, J CELL BIOL, V83, P403, DOI 10.1083/jcb.83.2.403; Tse C, 1998, MOL CELL BIOL, V18, P4629, DOI 10.1128/MCB.18.8.4629; Vitolo JM, 2004, MOL CELL BIOL, V24, P697, DOI 10.1128/MCB.24.2.697-707.2004; Wang XD, 2008, MOL CELL BIOL, V28, P227, DOI 10.1128/MCB.01245-07; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Woodcock CL, 2006, CHROMOSOME RES, V14, P17, DOI 10.1007/s10577-005-1024-3; Woodcock CL, 2001, CURR OPIN GENET DEV, V11, P130, DOI 10.1016/S0959-437X(00)00169-6; Zaret KS, 2016, CURR OPIN GENET DEV, V37, P76, DOI 10.1016/j.gde.2015.12.003; Zhang ZH, 2011, SCIENCE, V332, P977, DOI 10.1126/science.1200508; Zinchenko A, 2018, NUCLEIC ACIDS RES, V46, P635, DOI 10.1093/nar/gkx1135	68	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2018	293	50					19191	19200		10.1074/jbc.RA118.005721	http://dx.doi.org/10.1074/jbc.RA118.005721			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HE6RA	30373774	Green Published, hybrid			2022-12-28	WOS:000453537300003
J	Zhang, JX; Chen, SR; Chen, H; Pan, HL				Zhang, Jixiang; Chen, Shao-Rui; Chen, Hong; Pan, Hui-Lin			RE1-silencing transcription factor controls the acute-to-chronic neuropathic pain transition and Chrm2 receptor gene expression in primary sensory neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINAL-CORD; HISTONE DEACETYLASE; ALZHEIMERS-DISEASE; GLUTAMATE RELEASE; UP-REGULATION; ANALGESIA; SUBTYPES; PROTEIN; REST; REPRESSION	Neuropathic pain is associated with persistent changes in gene expression in primary sensory neurons, but the underlying epigenetic mechanisms that cause these changes remain unclear. The muscarinic cholinergic receptors (mAChRs), particularly the M2 subtype (encoded by the cholinergic receptor muscarinic 2 (Chrm2) gene), are critically involved in the regulation of spinal nociceptive transmission. However, little is known about how Chrm2 expression is transcriptionally regulated. Here we show that nerve injury persistently increased the expression of RE1-silencing transcription factor (REST, also known as neuron-restrictive silencing factor [NRSF]), a gene-silencing transcription factor, in the dorsal root ganglion (DRG). Remarkably, nerve injury-induced chronic but not acute pain hypersensitivity was attenuated in mice with Rest knockout in DRG neurons. Also, siRNA-mediated Rest knockdown reversed nerve injury-induced chronic pain hypersensitivity in rats. Nerve injury persistently reduced Chrm2 expression in the DRG and diminished the analgesic effect of muscarine. The RE1 binding site on the Chrm2 promoter is required for REST-mediated Chrm2 repression, and nerve injury increased the enrichment of REST in the Chrm2 promoter in the DRG. Furthermore, Rest knockdown or genetic ablation in DRG neurons normalized Chrm2 expression and augmented muscarine's analgesic effect on neuropathic pain and fully reversed the nerve injury-induced reduction in the inhibitory effect of muscarine on glutamatergic input to spinal dorsal horn neurons. Our findings indicate that nerve injury-induced REST up-regulation in DRG neurons plays an important role in the acute-to-chronic pain transition and is essential for the transcriptional repression of Chrm2 in neuropathic pain.	[Zhang, Jixiang; Chen, Shao-Rui; Chen, Hong; Pan, Hui-Lin] Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Perioperat Med, Ctr Neurosci & Pain Res, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Pan, HL (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Perioperat Med, Unit 110, 1515 Holcombe Blvd, Houston, TX 77030 USA.	huilinpan@mdanderson.org	Zhang, Jixiang/T-9327-2019	Pan, Hui-Lin/0000-0001-8444-3770; Zhang, Jixiang/0000-0002-1641-8650	National Institutes of Health [GM120844, NS101880]; N. G. and Helen T. Hawkins Endowment; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM120844] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS101880] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); N. G. and Helen T. Hawkins Endowment; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institutes of Health (GM120844 and NS101880) and by the N. G. and Helen T. Hawkins Endowment (to H.-L. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andres ME, 1999, P NATL ACAD SCI USA, V96, P9873, DOI 10.1073/pnas.96.17.9873; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Cai YQ, 2009, J NEUROCHEM, V111, P1000, DOI 10.1111/j.1471-4159.2009.06396.x; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen JJ, 2018, CELL REP, V22, P2307, DOI 10.1016/j.celrep.2018.02.021; Chen SR, 2014, J BIOL CHEM, V289, P14321, DOI 10.1074/jbc.M114.550384; Chen SR, 2005, J PHARMACOL EXP THER, V313, P765, DOI 10.1124/jpet.104.082537; Chen SR, 2004, NEUROSCIENCE, V125, P141, DOI 10.1016/j.neuroscience.2004.01.015; Chen SR, 2001, ANESTHESIOLOGY, V95, P525, DOI 10.1097/00000542-200108000-00039; Ciallella JR, 1998, EXP NEUROL, V152, P11, DOI 10.1006/exnr.1998.6831; da Silva S, 2011, P NATL ACAD SCI USA, V108, P3395, DOI 10.1073/pnas.1014411108; Duttaroy A, 2002, MOL PHARMACOL, V62, P1084, DOI 10.1124/mol.62.5.1084; FRANCEL PC, 1987, J NEUROCHEM, V48, P1624, DOI 10.1111/j.1471-4159.1987.tb05711.x; Gao ZL, 2011, J NEUROSCI, V31, P9772, DOI 10.1523/JNEUROSCI.1604-11.2011; Garriga J, 2018, J NEUROSCI, V38, P6090, DOI 10.1523/JNEUROSCI.2616-17.2018; Gomeza J, 1999, P NATL ACAD SCI USA, V96, P1692, DOI 10.1073/pnas.96.4.1692; Gonzalez-Castaneda RE, 2013, GENET MOL BIOL, V36, P28, DOI 10.1590/S1415-47572013000100005; Hood DD, 1997, J PHARMACOL EXP THER, V282, P86; Hoover DB, 1996, HISTOCHEM J, V28, P771, DOI 10.1007/BF02272150; Huang YF, 1999, NAT NEUROSCI, V2, P867, DOI 10.1038/13165; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; KIM SH, 1992, PAIN, V50, P355, DOI 10.1016/0304-3959(92)90041-9; Kohno T, 1999, J PHYSIOL-LONDON, V518, P803, DOI 10.1111/j.1469-7793.1999.0803p.x; Laedermann CJ, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-19; LANGE KW, 1992, J NEUROL, V239, P103, DOI 10.1007/BF00862983; Laumet G, 2015, NAT NEUROSCI, V18, P1746, DOI 10.1038/nn.4165; Li DP, 2002, J PHYSIOL-LONDON, V543, P807, DOI 10.1113/jphysiol.2002.020644; Li LY, 2016, CELL REP, V15, P1376, DOI 10.1016/j.celrep.2016.04.039; Luo MC, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-29; Luo ZD, 2002, J PHARMACOL EXP THER, V303, P1199, DOI 10.1124/jpet.102.041574; MASH DC, 1985, SCIENCE, V228, P1115, DOI 10.1126/science.3992249; McClelland S, 2014, ELIFE, V3, DOI 10.7554/eLife.01267; Mieda M, 1997, J BIOL CHEM, V272, P5854, DOI 10.1074/jbc.272.9.5854; Mori N, 2002, NEUROBIOL AGING, V23, P255, DOI 10.1016/S0197-4580(01)00286-X; Mulligan P, 2008, MOL CELL, V32, P718, DOI 10.1016/j.molcel.2008.10.025; Naruse Y, 1999, P NATL ACAD SCI USA, V96, P13691, DOI 10.1073/pnas.96.24.13691; Noh KM, 2012, P NATL ACAD SCI USA, V109, pE962, DOI 10.1073/pnas.1121568109; O'Hern PJ, 2017, ELIFE, V6, DOI 10.7554/eLife.20752; Palm K, 1998, J NEUROSCI, V18, P1280; Pan HL, 2008, PHARMACOL THERAPEUT, V117, P141, DOI 10.1016/j.pharmthera.2007.09.003; Pan YZ, 2004, J NEUROPHYSIOL, V91, P2413, DOI 10.1152/jn.01242.2003; RINNE JO, 1989, BRAIN RES, V483, P402, DOI 10.1016/0006-8993(89)90188-1; Roopra A, 2004, MOL CELL, V14, P727, DOI 10.1016/j.molcel.2004.05.026; Rose K, 2011, PAIN, V152, P742, DOI 10.1016/j.pain.2010.12.028; Saffen D, 1999, LIFE SCI, V64, P479, DOI 10.1016/S0024-3205(98)00591-8; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Singh SK, 2008, NATURE, V453, P223, DOI 10.1038/nature06863; Tian B, 2012, METHODS MOL BIOL, V809, P105, DOI 10.1007/978-1-61779-376-9_7; Uchida H, 2010, NEUROSCIENCE, V166, P1, DOI 10.1016/j.neuroscience.2009.12.021; Uchida H, 2010, J NEUROSCI, V30, P4806, DOI 10.1523/JNEUROSCI.5541-09.2010; Wang H, 2002, NEUROSCIENCE, V114, P529, DOI 10.1016/S0306-4522(02)00341-X; Wang L, 2018, J NEUROCHEM, V147, P526, DOI 10.1111/jnc.14588; Weng YL, 2017, NEURON, V94, P337, DOI 10.1016/j.neuron.2017.03.034; Wess J, 2004, ANNU REV PHARMACOL, V44, P423, DOI 10.1146/annurev.pharmtox.44.101802.121622; Wood IC, 1996, J BIOL CHEM, V271, P14221, DOI 10.1074/jbc.271.24.14221; Zhang HM, 2007, J NEUROPHYSIOL, V97, P102, DOI 10.1152/jn.00586.2006; Zhang YH, 2016, J BIOL CHEM, V291, P8475, DOI 10.1074/jbc.M115.711812; Zhang YH, 2015, J BIOL CHEM, V290, P14647, DOI 10.1074/jbc.M115.650218; Zhou X, 2010, P NATL ACAD SCI USA, V107, P9424, DOI 10.1073/pnas.0914725107; ZHUO M, 1991, PAIN, V46, P211, DOI 10.1016/0304-3959(91)90078-C; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219	62	20	20	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2018	293	49					19078	19091		10.1074/jbc.RA118.005846	http://dx.doi.org/10.1074/jbc.RA118.005846			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NY	30327427	hybrid, Green Published			2022-12-28	WOS:000458467400021
J	Guan, XG; Luo, ZM; Sun, WJ				Guan, Xingang; Luo, Zhimin; Sun, Wujin			A peptide delivery system sneaks CRISPR into cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								The CRISPR-Cas9 system has developed into a powerful platform for genome editing in various types of cells and tissues with single-nucleotide precision, but limited delivery options hamper its application in real-world settings. A new study by Shen et al. describes the use of an amphipathic peptide to deliver Cas9/sgRNA ribonucleoprotein complexes, leading to the disruption of GFP genes in cells and mice. Disruption of the Nrip1 gene in isolated pre-adipocytes led to a browning phenotype, pointing to new options in the fight against diabetes and obesity.	[Guan, Xingang; Luo, Zhimin; Sun, Wujin] Univ Calif Los Angeles, Ctr Minimally Invas Therapeut, Calif Nanosyst Inst, Dept Bioengn, Los Angeles, CA 90095 USA; [Guan, Xingang] Beihua Univ, Coll Med Technol, Jilin 132013, Jilin, Peoples R China; [Luo, Zhimin] Xi An Jiao Tong Univ, Sch Pharm, Xian 710061, Shanxi, Peoples R China	University of California System; University of California Los Angeles; Beihua University; Xi'an Jiaotong University	Sun, WJ (corresponding author), Univ Calif Los Angeles, Ctr Minimally Invas Therapeut, Calif Nanosyst Inst, Dept Bioengn, Los Angeles, CA 90095 USA.	sunwj@ucla.edu	Luo, Zhi-min/ACN-2648-2022; Guan, Xingang/A-9307-2016	Luo, Zhi-min/0000-0001-5071-4325; Guan, Xingang/0000-0003-3776-1818				Glass Z, 2018, TRENDS BIOTECHNOL, V36, P173, DOI 10.1016/j.tibtech.2017.11.006; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jiang FG, 2017, ANNU REV BIOPHYS, V46, P505, DOI 10.1146/annurev-biophys-062215-010822; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Liu C, 2017, J CONTROL RELEASE, V266, P17, DOI 10.1016/j.jconrel.2017.09.012; Shen YF, 2018, J BIOL CHEM, V293, P17291, DOI 10.1074/jbc.RA118.004554; Staahl BT, 2017, NAT BIOTECHNOL, V35, P431, DOI 10.1038/nbt.3806; Sun WJ, 2015, ANGEW CHEM INT EDIT, V54, P12029, DOI 10.1002/anie.201506030; Swiech L, 2015, NAT BIOTECHNOL, V33, P102, DOI 10.1038/nbt.3055; Wang HX, 2017, CHEM REV, V117, P9874, DOI 10.1021/acs.chemrev.6b00799	10	8	9	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2018	293	44					17306	17307		10.1074/jbc.H118.006147	http://dx.doi.org/10.1074/jbc.H118.006147			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ5MI	30389791	Green Published, hybrid			2022-12-28	WOS:000449466500028
J	Sanchez, J; Huma, ZE; Lane, JR; Liu, XY; Bridgford, JL; Payne, RJ; Canals, M; Stone, MJ				Sanchez, Julie; Huma, Zil E.; Lane, J. Robert; Liu, Xuyu; Bridgford, Jessica L.; Payne, Richard J.; Canals, Meritxell; Stone, Martin J.			Evaluation and extension of the two-site, two-step model for binding and activation of the chemokine receptor CCR1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chemokine; receptor structure-function; G protein-coupled receptor (GPCR); molecular pharmacology; signaling; cytokine; innate immunity; binding; CCR1; chemokine receptor; receptor activation; three-step model	N-TERMINAL DOMAIN; TYROSINE SULFATION; PHARMACOLOGICAL CHARACTERIZATION; SULFOTYROSINE RECOGNITION; STRUCTURAL BASIS; MCP-1 RECEPTOR; PROTEIN; LIGAND; RANTES; CXCR4	Interactions between secreted immune proteins called chemokines and their cognate G protein-coupled receptors regulate the trafficking of leukocytes in inflammatory responses. The two-site, two-step model describes these interactions. It involves initial binding of the chemokine N-loop/3 region to the receptor's N-terminal region and subsequent insertion of the chemokine N-terminal region into the transmembrane helical bundle of the receptor concurrent with receptor activation. Here, we test aspects of this model with C-C motif chemokine receptor 1 (CCR1) and several chemokine ligands. First, we compared the chemokine-binding affinities of CCR1 with those of peptides corresponding to the CCR1 N-terminal region. Relatively low affinities of the peptides and poor correlations between CCR1 and peptide affinities indicated that other regions of the receptor may contribute to binding affinity. Second, we evaluated the contributions of the two CCR1-interacting regions of the cognate chemokine ligand CCL7 (formerly monocyte chemoattractant protein-3 (MCP-3)) using chimeras between CCL7 and the non-cognate ligand CCL2 (formerly MCP-1). The results revealed that the chemokine N-terminal region contributes significantly to binding affinity but that differences in binding affinity do not completely account for differences in receptor activation. On the basis of these observations, we propose an elaboration of the two-site, two-step modelthe three-step modelin which initial interactions of the first site result in low-affinity, nonspecific binding; rate-limiting engagement of the second site enables high-affinity, specific binding; and subsequent conformational rearrangement gives rise to receptor activation.	[Sanchez, Julie; Huma, Zil E.; Bridgford, Jessica L.; Stone, Martin J.] Monash Univ, Infect & Immun Program, Monash Biomed Discovery Inst, Clayton, Vic 3800, Australia; [Sanchez, Julie; Huma, Zil E.; Bridgford, Jessica L.; Stone, Martin J.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Sanchez, Julie; Huma, Zil E.; Lane, J. Robert; Bridgford, Jessica L.; Canals, Meritxell] Monash Univ, Drug Discovery Biol Program, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Liu, Xuyu; Payne, Richard J.] Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia; [Lane, J. Robert; Canals, Meritxell] Univ Nottingham, Ctr Membrane Prot & Receptors, Nottingham NG7 2UH, England	Monash University; Monash University; Monash University; University of Sydney; University of Nottingham	Stone, MJ (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.; Canals, M (corresponding author), Univ Nottingham, Ctr Membrane Prot & Receptors, Nottingham NG7 2UH, England.	meritxell.canals@nottingham.ac.uk; martin.stone@monash.edu	Payne, Richard/AAH-3666-2021; Liu, Xuyu/AAV-8725-2021; Stone, Martin/C-2492-2012	Liu, Xuyu/0000-0003-4096-3090; Sanchez, Julie/0000-0002-5765-4342; Payne, Richard/0000-0002-3618-9226; Bridgford, Jessica/0000-0001-8381-1121; Lane, J. Robert/0000-0002-7361-7875; Stone, Martin/0000-0002-6468-4427	National Health and Medical Research Council [APP1140874]; Australian Research Council [DP130101984]; Monash Institute of Pharmaceutical Sciences Large Grant Support Scheme; Monash University Joint Medicine-Pharmacy Grant [JMP16-18]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Monash Institute of Pharmaceutical Sciences Large Grant Support Scheme; Monash University Joint Medicine-Pharmacy Grant	This work was supported by National Health and Medical Research Council Project Grant APP1140874 (to M. J. S., M. C., and J. R. L.), Australian Research Council Discovery Grant DP130101984 (to R. J. P. and M. J. S.), the Monash Institute of Pharmaceutical Sciences Large Grant Support Scheme (to M. C.), and Monash University Joint Medicine-Pharmacy Grant JMP16-18 (to M. J. S. and M. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Ayoub MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119803; Baggiolini M, 2001, J INTERN MED, V250, P91, DOI 10.1046/j.1365-2796.2001.00867.x; Burg JS, 2015, SCIENCE, V347, P1113, DOI 10.1126/science.aaa5026; Chaudhuri A, 2013, J PHYS CHEM B, V117, P1225, DOI 10.1021/jp3095352; Choe H, 2005, MOL MICROBIOL, V55, P1413, DOI 10.1111/j.1365-2958.2004.04478.x; Chou CC, 2002, BRIT J PHARMACOL, V137, P663, DOI 10.1038/sj.bjp.0704907; Christopoulos A, 1998, TRENDS PHARMACOL SCI, V19, P351, DOI 10.1016/S0165-6147(98)01240-1; COMBADIERE C, 1995, J BIOL CHEM, V270, P29671; Corbisier J, 2015, J BIOL CHEM, V290, P9542, DOI 10.1074/jbc.M114.596098; Coulin F, 1997, EUR J BIOCHEM, V248, P507, DOI 10.1111/j.1432-1033.1997.00507.x; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; Duma L, 2007, J MOL BIOL, V365, P1063, DOI 10.1016/j.jmb.2006.10.040; Escher SE, 2004, J PEPT RES, V63, P36, DOI 10.1046/j.1399-3011.2004.00102.x; Fernando H, 2007, FEBS J, V274, P241, DOI 10.1111/j.1742-4658.2006.05579.x; GAO JL, 1993, J EXP MED, V177, P1421, DOI 10.1084/jem.177.5.1421; Gladue Ronald P, 2004, Curr Opin Investig Drugs, V5, P499; Haldar S, 2010, BBA-BIOMEMBRANES, V1798, P1056, DOI 10.1016/j.bbamem.2010.02.029; Hollins B, 2009, CELL SIGNAL, V21, P1015, DOI 10.1016/j.cellsig.2009.02.017; Horuk R, 2001, J BIOL CHEM, V276, P4199, DOI 10.1074/jbc.M007457200; Hoshino A, 2010, J BIOL CHEM, V285, P28826, DOI 10.1074/jbc.M109.099424; HUFF S, 1994, J BIOL CHEM, V269, P15563; Huma ZE, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aai8529; Karash AR, 2011, FUTURE MED CHEM, V3, P1889, DOI [10.4155/fmc.11.144, 10.4155/FMC.11.144]; Kleist AB, 2016, BIOCHEM PHARMACOL, V114, P53, DOI 10.1016/j.bcp.2016.04.007; Liu J, 2008, AM J RESP CELL MOL, V38, P738, DOI 10.1165/rcmb.2007-0118OC; Ludeman JP, 2015, ORG BIOMOL CHEM, V13, P2162, DOI 10.1039/c4ob02262a; Mantovani A, 2006, NAT REV IMMUNOL, V6, P907, DOI 10.1038/nri1964; Mayer MR, 2001, J BIOL CHEM, V276, P13911, DOI 10.1074/jbc.M011202200; Millard CJ, 2014, STRUCTURE, V22, P1571, DOI 10.1016/j.str.2014.08.023; Monteclaro FS, 1996, J BIOL CHEM, V271, P19084, DOI 10.1074/jbc.271.32.19084; Moser B, 2004, TRENDS IMMUNOL, V25, P75, DOI 10.1016/j.it.2003.12.005; Ninichuk V, 2005, AM J NEPHROL, V25, P365, DOI 10.1159/000087185; Paavola CD, 1998, J BIOL CHEM, V273, P33157, DOI 10.1074/jbc.273.50.33157; Pease JE, 1998, J BIOL CHEM, V273, P19972, DOI 10.1074/jbc.273.32.19972; Qin L, 2015, SCIENCE, V347, P1117, DOI 10.1126/science.1261064; Rajagopal S, 2013, J BIOL CHEM, V288, P35039, DOI 10.1074/jbc.M113.479113; Rajarathnam K, 2006, BIOCHEMISTRY-US, V45, P7882, DOI 10.1021/bi0605944; Ribeiro S, 2005, PHARMACOL THERAPEUT, V107, P44, DOI 10.1016/j.pharmthera.2005.01.004; Schmidt PM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037779; Schnur E, 2013, FEBS J, V280, P2068, DOI 10.1111/febs.12230; Scholten DJ, 2012, BRIT J PHARMACOL, V166, P898, DOI 10.1111/j.1476-5381.2011.01648.x; Simpson LS, 2009, CHEM BIOL, V16, P153, DOI 10.1016/j.chembiol.2008.12.007; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Stone MJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020342; Stone MJ, 2015, ACCOUNTS CHEM RES, V48, P2251, DOI 10.1021/acs.accounts.5b00255; Tak PP, 2013, ANN RHEUM DIS, V72, P337, DOI 10.1136/annrheumdis-2011-201605; Taleski D, 2011, CHEM-ASIAN J, V6, P1316, DOI 10.1002/asia.201100232; Tan JHY, 2013, J BIOL CHEM, V288, P10024, DOI 10.1074/jbc.M112.447359; Tan JHY, 2012, J BIOL CHEM, V287, P14692, DOI 10.1074/jbc.M111.334201; Trebst C, 2001, AM J PATHOL, V159, P1701, DOI 10.1016/S0002-9440(10)63017-9; Vallet S, 2011, EXPERT OPIN THER TAR, V15, P1037, DOI 10.1517/14728222.2011.586634; Veldkamp CT, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160755; Veldkamp CT, 2006, J MOL BIOL, V359, P1400, DOI 10.1016/j.jmb.2006.04.052; Vilardaga JP, 2010, J RECEPT SIG TRANSD, V30, P304, DOI 10.3109/10799893.2010.509728; Xanthou G, 2003, EUR J IMMUNOL, V33, P2927, DOI 10.1002/eji.200324235; Zhu JZ, 2011, BIOCHEMISTRY-US, V50, P1524, DOI 10.1021/bi101240v; Ziarek JJ, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aah5756; Zweemer AJM, 2013, MOL PHARMACOL, V84, P551, DOI 10.1124/mol.113.086850	58	14	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3464	3475		10.1074/jbc.RA118.006535	http://dx.doi.org/10.1074/jbc.RA118.006535			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30567735	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000461853900014
J	Hada, K; Hirota, K; Inanobe, A; Kako, K; Miyata, M; Araoi, S; Matsumoto, M; Ohta, R; Arisawa, M; Daitoku, H; Hanada, T; Fukamizu, A				Hada, Kazumasa; Hirota, Keiko; Inanobe, Ai; Kako, Koichiro; Miyata, Mai; Araoi, Sho; Matsumoto, Masaki; Ohta, Reiya; Arisawa, Mitsuhiro; Daitoku, Hiroaki; Hanada, Toshikatsu; Fukamizu, Akiyoshi			Tricarboxylic acid cycle activity suppresses acetylation of mitochondrial proteins during early embryonic development in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						polyamine; Caenorhabditis elegans (C; elegans); tricarboxylic acid cycle (TCA cycle) (Krebs cycle); post-translational modification (PTM); acetyl coenzyme A (acetyl-CoA); citrate synthase; deacetylase; early embryogenesis; mitochondrial protein acetylation; sirtuin	PROGRESSION; SPERMIDINE; METABOLISM; INHIBITORS; AUTOPHAGY; DISEASES	The tricarboxylic acid (TCA) cycle (or citric acid cycle) is responsible for the complete oxidation of acetyl-CoA and formation of intermediates required for ATP production and other anabolic pathways, such as amino acid synthesis. Here, we uncovered an additional mechanism that may help explain the essential role of the TCA cycle in the early embryogenesis of Caenorhabditis elegans. We found that knockdown of citrate synthase (cts-1), the initial and rate-limiting enzyme of the TCA cycle, results in early embryonic arrest, but that this phenotype is not because of ATP and amino acid depletions. As a possible alternative mechanism explaining this developmental deficiency, we observed that cts-1 RNAi embryos had elevated levels of intracellular acetyl-CoA, the starting metabolite of the TCA cycle. Of note, we further discovered that these embryos exhibit hyperacetylation of mitochondrial proteins. We found that supplementation with acetylase-inhibiting polyamines, including spermidine and putrescine, counteracted the protein hyperacetylation and developmental arrest in the cts-1 RNAi embryos. Contrary to the hypothesis that spermidine acts as an acetyl sink for elevated acetyl-CoA, the levels of three forms of acetylspermidine, N-1-acetylspermidine, N-8-acetylspermidine, and N-1,N-8-diacetylspermidine, were not significantly increased in embryos treated with exogenous spermidine. Instead, we demonstrated that the mitochondrial deacetylase sirtuin 4 (encoded by the sir-2.2 gene) is required for spermidine's suppression of protein hyperacetylation and developmental arrest in the cts-1 RNAi embryos. Taken together, these results suggest the possibility that during early embryogenesis, acetyl-CoA consumption by the TCA cycle in C. elegans prevents protein hyperacetylation and thereby protects mitochondrial function.	[Hada, Kazumasa; Daitoku, Hiroaki; Fukamizu, Akiyoshi] Univ Tsukuba, Tsukuba Adv Res Alliance, Life Sci Ctr Survival Dynam, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058577, Japan; [Hada, Kazumasa; Hanada, Toshikatsu] Oita Univ, Fac Med, Dept Cell Biol, 1-1 Hasama Machi, Yufu, Oita 8795593, Japan; [Hirota, Keiko; Kako, Koichiro] Univ Tsukuba, PhD Program Human Biol, Sch Integrat & Global Majors, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058572, Japan; [Fukamizu, Akiyoshi] Univ Tsukuba, Fac Life & Environm Sci, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058572, Japan; [Hirota, Keiko] Tokyo Womens Med Univ, Dept Hyg & Publ Hlth, Sch Med, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan; [Inanobe, Ai; Miyata, Mai; Araoi, Sho] Univ Tsukuba, Grad Sch Life & Environm Sci, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058572, Japan; [Matsumoto, Masaki] Kyushu Univ, Med Inst Bioregulat, 3-1-1 Maidashi, Fukuoka, Fukuoka 8128582, Japan; [Ohta, Reiya; Arisawa, Mitsuhiro] Osaka Univ, Grad Sch Pharmaceut Sci, 1-6 Yamada Oka, Suita, Osaka 5650871, Japan; [Fukamizu, Akiyoshi] Univ Tsukuba, Int Inst Integrat Sleep Med WPI IIIS, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058575, Japan	University of Tsukuba; Oita University; University of Tsukuba; University of Tsukuba; Tokyo Women's Medical University; University of Tsukuba; Kyushu University; Osaka University; University of Tsukuba	Fukamizu, A (corresponding author), Univ Tsukuba, Tsukuba Adv Res Alliance, Life Sci Ctr Survival Dynam, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058577, Japan.	akif@tara.tsukuba.ac.jp	Arisawa, Mitsuhiro/D-9098-2012; Ohta, Reiya/J-8064-2016	Ohta, Reiya/0000-0003-4932-9440	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [23116001]; Japan Society for the Promotion of Science [26450119, 17K07746, 26350957, 17K01942, 17K08193];  [17H01519]	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); 	This work was supported by Grant-in-Aid Project 23116001 (Scientific Research on Innovative Areas) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) (to A. F.) and the Japan and Grants-in-Aid for Scientific Research (A) 17H01519 (to A. F.); Grants-in-Aid for Scientific Research (C) 26450119 and 17K07746 (to K. H.), 26350957 and 17K01942 (to K. K.), and 17K08193 (to H. D.) from the Japan Society for the Promotion of Science. The authors declare that they have no conflicts of interest with the contents of this article.	Anderson KA, 2012, ESSAYS BIOCHEM, V52, P23, DOI [10.1042/BSE0520023, 10.1042/bse0520023]; Baeza J, 2016, TRENDS BIOCHEM SCI, V41, P231, DOI 10.1016/j.tibs.2015.12.006; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Ghanta S, 2013, CRIT REV BIOCHEM MOL, V48, P561, DOI 10.3109/10409238.2013.838204; Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019; Iacobazzi V, 2014, BIOL CHEM, V395, P387, DOI 10.1515/hsz-2013-0271; Jonassen T, 2002, J BIOL CHEM, V277, P45020, DOI 10.1074/jbc.M204758200; KANE MT, 1977, J REPROD FERTIL, V49, P261, DOI 10.1530/jrf.0.0490261; Lee SJ, 2009, CELL METAB, V10, P379, DOI 10.1016/j.cmet.2009.10.003; Lundby A, 2012, CELL REP, V2, P419, DOI 10.1016/j.celrep.2012.07.006; McDonnell E, 2015, TRENDS ENDOCRIN MET, V26, P486, DOI 10.1016/j.tem.2015.06.001; Morselli E, 2011, J CELL BIOL, V192, P615, DOI 10.1083/jcb.201008167; Park MH, 2013, BIOMOL THER, V21, P1, DOI 10.4062/biomolther.2012.097; Pegg AE, 2008, AM J PHYSIOL-ENDOC M, V294, pE995, DOI 10.1152/ajpendo.90217.2008; Rahman MM, 2014, P NATL ACAD SCI USA, V111, P2602, DOI 10.1073/pnas.1311635111; Rustin P, 1997, BBA-MOL BASIS DIS, V1361, P185, DOI 10.1016/S0925-4439(97)00035-5; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; THOMSON JL, 1967, EXP CELL RES, V46, P252, DOI 10.1016/0014-4827(67)90063-8; Tsuchiya Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097693; Verdin E, 2015, NAT REV MOL CELL BIO, V16, P258, DOI 10.1038/nrm3931; Wirth M, 2013, MITOCHONDRION, V13, P705, DOI 10.1016/j.mito.2013.02.002	21	8	8	5	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2019	294	9					3091	3099		10.1074/jbc.RA118.004726	http://dx.doi.org/10.1074/jbc.RA118.004726			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU0SA	30606736	hybrid, Green Published			2022-12-28	WOS:000464980100010
J	Alshawi, A; Agius, L				Alshawi, Ahmed; Agius, Loranne			Low metformin causes a more oxidized mitochondrial NADH/NAD redox state in hepatocytes and inhibits gluconeogenesis by a redox-independent mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						metformin; metabolic regulation; metabolic disease; gluconeogenesis; redox regulation; dimethylbiguanide; mitochondrial glycerophosphate dehydrogenase; phosphofructokinase-1	REDUCING-EQUIVALENT SHUTTLES; ACTIVATED PROTEIN-KINASE; GENE-EXPRESSION; GLUCOSE-PRODUCTION; FATTY-ACID; MICE; DEHYDROGENASE; GLUCOKINASE; LIVER; PHOSPHORYLATION	The mechanisms by which metformin (dimethylbiguanide) inhibits hepatic gluconeogenesis at concentrations relevant for type 2 diabetes therapy remain debated. Two proposed mechanisms are 1) inhibition of mitochondrial Complex 1 with consequent compromised ATP and AMP homeostasis or 2) inhibition of mitochondrial glycerophosphate dehydrogenase (mGPDH) and thereby attenuated transfer of reducing equivalents from the cytoplasm to mitochondria, resulting in a raised lactate/pyruvate ratio and redox-dependent inhibition of gluconeogenesis from reduced but not oxidized substrates. Here, we show that metformin has a biphasic effect on the mitochondrial NADH/NAD redox state in mouse hepatocytes. A low cell dose of metformin (therapeutic equivalent: <2 nmol/mg) caused a more oxidized mitochondrial NADH/NAD state and an increase in lactate/pyruvate ratio, whereas a higher metformin dose (>= 5 nmol/mg) caused a more reduced mitochondrial NADH/NAD state similar to Complex 1 inhibition by rotenone. The low metformin dose inhibited gluconeogenesis from both oxidized (dihydroxyacetone) and reduced (xylitol) substrates by preferential partitioning of substrate toward glycolysis by a redox-independent mechanism that is best explained by allosteric regulation at phosphofructokinase-1 (PFK1) and/or fructose 1,6-bisphosphatase (FBP1) in association with a decrease in cell glycerol 3-phosphate, an inhibitor of PFK1, rather than by inhibition of transfer of reducing equivalents. We conclude that at a low pharmacological load, the metformin effects on the lactate/pyruvate ratio and glucose production are explained by attenuation of transmitochondrial electrogenic transport mechanisms with consequent compromised malate-aspartate shuttle and changes in allosteric effectors of PFK1 and FBP1.	[Alshawi, Ahmed; Agius, Loranne] Newcastle Univ, Inst Cellular Med, Med Sch, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Alshawi, Ahmed] Al Furat AL Awsat Tech Univ, Kufa Inst, Clin Pathol Dept, Kufa, Iraq	Newcastle University - UK; Al-Furat Al-Awsat Technical University	Agius, L (corresponding author), Newcastle Univ, Inst Cellular Med, Med Sch, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	loranne.agius@ncl.ac.uk	Alshawi, Ahmed/J-1256-2019	Alshawi, Ahmed/0000-0002-0328-3486; Agius, Loranne/0000-0002-6419-6503	Higher Committee for Education Development (HCED) Iraq; Diabetes UK [13/0004701]	Higher Committee for Education Development (HCED) Iraq; Diabetes UK(Diabetes UK)	Supported by Higher Committee for Education Development (HCED) Iraq Grant 2015-2019.; Supported by Diabetes UK Grant 13/0004701.	AGIUS L, 1986, DIABETES, V35, P1286, DOI 10.2337/diabetes.35.11.1286; Al-Oanzi ZH, 2017, DIABETES OBES METAB, V19, P1078, DOI 10.1111/dom.12910; Arden C, 2012, BIOCHEM J, V443, P111, DOI 10.1042/BJ20111280; Arden C, 2011, DIABETES, V60, P3110, DOI 10.2337/db11-0061; ARGAUD D, 1993, EUR J BIOCHEM, V213, P1341, DOI 10.1111/j.1432-1033.1993.tb17886.x; Bailey CJ, 2017, DIABETOLOGIA, V60, P1566, DOI 10.1007/s00125-017-4318-z; Barbera A, 2003, DIABETOLOGIA, V46, P1394, DOI 10.1007/s00125-003-1206-5; Baur JA, 2014, CELL METAB, V20, P197, DOI 10.1016/j.cmet.2014.07.013; BERRY MN, 1994, EUR J BIOCHEM, V225, P557, DOI 10.1111/j.1432-1033.1994.00557.x; BERRY MN, 1992, BIOCHIM BIOPHYS ACTA, V1136, P223, DOI 10.1016/0167-4889(92)90110-W; Bridges HR, 2014, BIOCHEM J, V462, P475, DOI 10.1042/BJ20140620; Brown LJ, 2002, J BIOL CHEM, V277, P32892, DOI 10.1074/jbc.M202408200; Cao J, 2014, J BIOL CHEM, V289, P20435, DOI 10.1074/jbc.M114.567271; CLAUS TH, 1982, J BIOL CHEM, V257, P7541; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Dang Q, 2009, J MED CHEM, V52, P2880, DOI 10.1021/jm900078f; DAVIS EJ, 1980, J BIOL CHEM, V255, P2277; DAWSON AP, 1969, BIOCHEM J, V111, P27, DOI 10.1042/bj1110027; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Foretz M, 2014, CELL METAB, V20, P953, DOI 10.1016/j.cmet.2014.09.018; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Fulgencio JP, 2001, BIOCHEM PHARMACOL, V62, P439, DOI 10.1016/S0006-2952(01)00679-7; Gouaref I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172053; Harndahl L, 2006, FEBS J, V273, P336, DOI 10.1111/j.1742-4658.2005.05067.x; He L, 2015, CELL METAB, V21, P159, DOI 10.1016/j.cmet.2015.01.003; Heishi M, 2006, DIABETOLOGIA, V49, P1647, DOI 10.1007/s00125-006-0271-y; HERS HG, 1983, ANNU REV BIOCHEM, V52, P617, DOI 10.1146/annurev.bi.52.070183.003153; Hirst J, 2013, ANNU REV BIOCHEM, V82, P551, DOI 10.1146/annurev-biochem-070511-103700; Hunter RW, 2018, NAT MED, V24, P1395, DOI 10.1038/s41591-018-0159-7; Kawaguchi T, 2002, J BIOL CHEM, V277, P3829, DOI 10.1074/jbc.M107895200; LANOUE KF, 1974, J BIOL CHEM, V249, P7514; Madiraju AK, 2018, NAT MED, V24, P1384, DOI 10.1038/s41591-018-0125-4; Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270; Maldonado EN, 2016, J BIOL CHEM, V291, P19642, DOI 10.1074/jbc.M116.734814; MCCUNE SA, 1989, BIOCHEM J, V259, P925, DOI 10.1042/bj2590925; Miller RA, 2013, NATURE, V494, P256, DOI 10.1038/nature11808; Mracek T, 2013, BBA-BIOENERGETICS, V1827, P401, DOI 10.1016/j.bbabio.2012.11.014; Natali A, 2006, DIABETOLOGIA, V49, P434, DOI 10.1007/s00125-006-0141-7; NOMURA T, 1983, BIOCHIM BIOPHYS ACTA, V754, P315; Orr AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089938; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Pelantova H, 2016, MOL CELL ENDOCRINOL, V431, P88, DOI 10.1016/j.mce.2016.05.003; Qi HY, 2018, DIABETOLOGIA, V61, P445, DOI 10.1007/s00125-017-4445-6; Qiu BY, 2010, DIABETES, V59, P256, DOI 10.2337/db09-0223; Rena G, 2017, DIABETOLOGIA, V60, P1577, DOI 10.1007/s00125-017-4342-z; Saheki T, 2007, J BIOL CHEM, V282, P25041, DOI 10.1074/jbc.M702031200; SIBILLE B, 1995, EUR J BIOCHEM, V231, P498, DOI 10.1111/j.1432-1033.1995.tb20724.x; STAPPENBECK R, 1990, J AUTOM CHEM, V12, P213, DOI 10.1155/S1463924690000281; Taleux N, 2009, J BIOL CHEM, V284, P4308, DOI 10.1074/jbc.M806187200; VINCENT MF, 1989, FASEB J, V3, P1855, DOI 10.1096/fasebj.3.7.2523832; von Morze C, 2018, MAGN RESON MED, V79, P1862, DOI 10.1002/mrm.27054; WILCOCK C, 1994, XENOBIOTICA, V24, P49, DOI 10.3109/00498259409043220; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; WILLIAMSON JR, 1969, J BIOL CHEM, V244, P4607; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505; Zorova LD, 2018, ANAL BIOCHEM, V552, P50, DOI 10.1016/j.ab.2017.07.009	56	37	37	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2839	2853		10.1074/jbc.RA118.006670	http://dx.doi.org/10.1074/jbc.RA118.006670			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30591586	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000459601600022
J	Robinett, NG; Culbertson, EM; Peterson, RL; Sanchez, H; Andes, DR; Nett, JE; Culotta, VC				Robinett, Natalie G.; Culbertson, Edward M.; Peterson, Ryan L.; Sanchez, Hiram; Andes, David R.; Nett, Jeniel E.; Culotta, Valeria C.			Exploiting the vulnerable active site of a copper-only superoxide dismutase to disrupt fungal pathogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						copper; yeast; superoxide dismutase (SOD); superoxide ion; fungi; Candida; Cu-only SOD; metalloenzyme; mycocide; virulence; fungi; virulence	CANDIDA-ALBICANS; ZINC PYRITHIONE; PLATE ASSAY; BINDING; INSIGHTS; MUTANTS; ATPASE; ERYTHROCUPREIN; PROLIFERATION; ALZHEIMERS	Copper-only superoxide dismutases (SODs) represent a new class of SOD enzymes that are exclusively extracellular and unique to fungi and oomycetes. These SODs are essential for virulence of fungal pathogens in pulmonary and disseminated infections, and we show here an additional role for copper-only SODs in promoting survival of fungal biofilms. The opportunistic fungal pathogen Candida albicans expresses three copper-only SODs, and deletion of one of them, SOD5, eradicated candidal biofilms on venous catheters in a rodent model. Fungal copper-only SODs harbor an irregular active site that, unlike their Cu,Zn-SOD counterparts, contains a copper co-factor unusually open to solvent and lacks zinc for stabilizing copper binding, making fungal copper-only SODs highly vulnerable to metal chelators. We found that unlike mammalian Cu,Zn-SOD1, C. albicans SOD5 indeed rapidly loses its copper to metal chelators such as EDTA, and binding constants for Cu(II) predict that copper-only SOD5 has a much lower affinity for copper than does Cu,Zn-SOD1. We screened compounds with a variety of indications and identified several metal-binding compounds, including the ionophore pyrithione zinc (PZ), that effectively inhibit C. albicans SOD5 but not mammalian Cu,Zn-SOD1. We observed that PZ both acts as an ionophore that promotes uptake of toxic metals and inhibits copper-only SODs. The pros and cons of a vulnerable active site for copper-only SODs and the possible exploitation of this vulnerability in antifungal drug design are discussed.	[Robinett, Natalie G.; Culbertson, Edward M.; Peterson, Ryan L.; Culotta, Valeria C.] Johns Hopkins Bloomberg Sch Publ, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA; [Sanchez, Hiram; Andes, David R.; Nett, Jeniel E.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Madison, WI 53726 USA; [Sanchez, Hiram; Andes, David R.; Nett, Jeniel E.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med Microbiol & Immunol, Madison, WI 53726 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Culotta, VC (corresponding author), Johns Hopkins Bloomberg Sch Publ, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA.	vculott1@jhu.edu	Andes, David/ABE-8033-2020	Andes, David/0000-0002-7927-9950	National Institutes of Health [RO1GM50016, RO1 AI119949, R01 AI073289, F31 DK111114, F32 GM112320]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073289, R01AI119949, K08AI108727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F31DK111114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050016] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1GM50016 and RO1 AI119949 (to V. C. C.), R01 AI073289 (to D. R. A.), F31 DK111114 (to E. M. C.), and F32 GM112320 (to R. L. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Antonyuk SV, 2009, J MOL BIOL, V388, P310, DOI 10.1016/j.jmb.2009.03.026; BANCI L, 1991, EUR J BIOCHEM, V196, P123, DOI 10.1111/j.1432-1033.1991.tb15794.x; Banci L, 2010, NATURE, V465, P645, DOI 10.1038/nature09018; BARNETT BL, 1977, INORG CHEM, V16, P1834, DOI 10.1021/ic50174a002; Barry AN, 2011, J BIOL CHEM, V286, P26585, DOI 10.1074/jbc.M111.229039; Battistoni A, 1998, J BIOL CHEM, V273, P5655, DOI 10.1074/jbc.273.10.5655; Broxton CN, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005295; Bush AI, 2002, NEUROBIOL AGING, V23, P1031, DOI 10.1016/S0197-4580(02)00120-3; Chong CR, 2006, NAT CHEM BIOL, V2, P415, DOI 10.1038/nchembio806; COCCO D, 1981, J BIOL CHEM, V256, P8983; COWART RE, 1993, ANAL BIOCHEM, V211, P151, DOI 10.1006/abio.1993.1246; Crow JP, 1997, J NEUROCHEM, V69, P1936; Dalecki AG, 2017, ADV MICROB PHYSIOL, V70, P193, DOI 10.1016/bs.ampbs.2017.01.007; Ding XQ, 2011, J NUTR BIOCHEM, V22, P301, DOI 10.1016/j.jnutbio.2010.06.010; Djoko KY, 2015, ANTIMICROB AGENTS CH, V59, P6444, DOI 10.1128/AAC.01289-15; Dong XW, 2016, CHEM SCI, V7, P6251, DOI 10.1039/c6sc01272h; Doose CA, 2004, J CHROMATOGR A, V1052, P103, DOI 10.1016/j.chroma.2004.08.028; Duggan S, 2015, VIRULENCE, V6, P316, DOI 10.4161/21505594.2014.988096; Ellerby LM, 1996, J AM CHEM SOC, V118, P6556, DOI 10.1021/ja953845x; Fenlon LA, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00437-17; Ferrada E, 2007, NEUROTOXICOLOGY, V28, P445, DOI 10.1016/j.neuro.2007.02.004; FISHER CL, 1994, PROTEINS, V19, P24, DOI 10.1002/prot.340190105; Fisher CL, 1997, PROTEINS, V29, P103, DOI 10.1002/(SICI)1097-0134(199709)29:1<103::AID-PROT8>3.0.CO;2-G; Fradin C, 2005, MOL MICROBIOL, V56, P397, DOI 10.1111/j.1365-2958.2005.04557.x; Frohner IE, 2009, MOL MICROBIOL, V71, P240, DOI 10.1111/j.1365-2958.2008.06528.x; Gabbianelli R, 2004, BIOL CHEM, V385, P749, DOI 10.1515/BC.2004.091; Garcia-Santamarina S, 2015, J BIOL CHEM, V290, P18945, DOI 10.1074/jbc.R115.649129; Geddes-McAlister J, 2019, ANN NY ACAD SCI, V1435, P57, DOI 10.1111/nyas.13739; GETZOFF ED, 1983, NATURE, V306, P287, DOI 10.1038/306287a0; GETZOFF ED, 1992, NATURE, V358, P347, DOI 10.1038/358347a0; Gleason JE, 2014, P NATL ACAD SCI USA, V111, P5866, DOI 10.1073/pnas.1400137111; GORDGE MP, 1995, BRIT J PHARMACOL, V114, P1083, DOI 10.1111/j.1476-5381.1995.tb13317.x; Haas KL, 2009, CHEM REV, V109, P4921, DOI 10.1021/cr900134a; Hayward LJ, 2002, J BIOL CHEM, V277, P15923, DOI 10.1074/jbc.M112087200; Helsel ME, 2017, METALLOMICS, V9, P69, DOI [10.1039/C6MT00172F, 10.1039/c6mt00172f]; Hider RC, 2015, DALTON T, V44, P5197, DOI 10.1039/c5dt00063g; HIROSE J, 1982, ARCH BIOCHEM BIOPHYS, V218, P179, DOI 10.1016/0003-9861(82)90334-4; HJALMARSSON K, 1987, P NATL ACAD SCI USA, V84, P6340, DOI 10.1073/pnas.84.18.6340; Jeney V, 2005, CIRC RES, V96, P723, DOI 10.1161/01.RES.0000162001.57896.66; Jimenez-Lopez C, 2013, EUKARYOT CELL, V12, P91, DOI 10.1128/EC.00290-12; Johnson CJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005884; Juarez JC, 2006, CLIN CANCER RES, V12, P4974, DOI 10.1158/1078-0432.CCR-06-0171; Kim J, 2011, J MICROBIOL, V49, P171, DOI 10.1007/s12275-011-1064-7; Kiss T, 1998, J INCLUS PHENOM MOL, V32, P385, DOI 10.1023/A:1008046330815; Kodama H, 1997, LIFE SCI, V61, P899, DOI 10.1016/S0024-3205(97)00592-4; Kohn B, 2018, BIOPHYS J, V115, P1007, DOI 10.1016/j.bpj.2018.07.040; KOMSHIAN SV, 1989, REV INFECT DIS, V11, P379; Lee REB, 2005, J ANTIMICROB CHEMOTH, V55, P655, DOI 10.1093/jac/dki105; Li CH, 2010, J ALZHEIMERS DIS, V21, P1249, DOI 10.3233/JAD-2010-100024; Lind SE, 2009, TRANSL RES, V154, P153, DOI 10.1016/j.trsl.2009.06.002; Linder MC, 2016, METALLOMICS, V8, P887, DOI 10.1039/c6mt00103c; Mackie J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158683; MARKLUND SL, 1984, BIOCHEM J, V220, P269, DOI 10.1042/bj2200269; MARKS R, 1985, BRIT J DERMATOL, V112, P415, DOI 10.1111/j.1365-2133.1985.tb02314.x; Martchenko M, 2004, MOL BIOL CELL, V15, P456, DOI 10.1091/mbc.E03-03-0179; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Miramon P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052850; Miranda LN, 2009, J HOSP INFECT, V72, P9, DOI 10.1016/j.jhin.2009.02.009; MISRA HP, 1979, J BIOL CHEM, V254, P1623; Morgan MT, 2017, J BIOL CHEM, V292, P21558, DOI 10.1074/jbc.M117.817452; Nagai M, 2012, FREE RADICAL BIO MED, V52, P2142, DOI 10.1016/j.freeradbiomed.2012.03.017; Naldi L, 2015, BMJ CLIN EVID, V2015, P1713; Nett JE, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MB-0008-2014; Nett JE, 2015, INFECT IMMUN, V83, P4630, DOI 10.1128/IAI.00931-15; Nett JE, 2011, J CLIN MICROBIOL, V49, P1426, DOI 10.1128/JCM.02273-10; Osman D, 2013, MOL MICROBIOL, V87, P466, DOI 10.1111/mmi.12107; PANTOLIANO MW, 1982, J INORG BIOCHEM, V17, P325, DOI 10.1016/S0162-0134(00)80093-8; Park M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30588-2; Percival SL, 2015, J MED MICROBIOL, V64, P323, DOI 10.1099/jmm.0.000032; Peskin AV, 2017, FREE RADICAL BIO MED, V103, P188, DOI 10.1016/j.freeradbiomed.2016.12.033; Peskin AV, 2000, CLIN CHIM ACTA, V293, P157, DOI 10.1016/S0009-8981(99)00246-6; Peterson RL, 2016, J BIOL CHEM, V291, P20911, DOI 10.1074/jbc.M116.748251; Potter SZ, 2007, J AM CHEM SOC, V129, P4575, DOI 10.1021/ja066690+; Pushie MJ, 2014, J INORG BIOCHEM, V133, P50, DOI 10.1016/j.jinorgbio.2014.01.003; Qin ZY, 2006, FASEB J, V20, P334, DOI 10.1096/fj.05-4564fje; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Reeder NL, 2011, BRIT J DERMATOL, V165, P9, DOI 10.1111/j.1365-2133.2011.10571.x; Reeder NL, 2011, ANTIMICROB AGENTS CH, V55, P5753, DOI 10.1128/AAC.00724-11; Richet H, 2002, CLIN MICROBIOL INFEC, V8, P405, DOI 10.1046/j.1469-0691.2002.00446.x; Robinett NG, 2018, J BIOL CHEM, V293, P4636, DOI 10.1074/jbc.TM117.000182; Rossi DCP, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006763; Sanders NG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105817; Schatzman SS, 2018, ACS INFECT DIS, V4, P893, DOI 10.1021/acsinfecdis.8b00026; Seetharaman SV, 2010, BIOCHEMISTRY-US, V49, P5714, DOI 10.1021/bi100314n; Smirnova J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19873-2; Soma S, 2018, P NATL ACAD SCI USA, V115, P8161, DOI 10.1073/pnas.1806296115; Subissi A, 2010, DRUGS, V70, P2133, DOI 10.2165/11538110-000000000-00000; TAINER JA, 1982, J MOL BIOL, V160, P181, DOI 10.1016/0022-2836(82)90174-7; Tamayo D, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004481; VALENTINE JS, 1979, P NATL ACAD SCI USA, V76, P4245, DOI 10.1073/pnas.76.9.4245; VEIEN NK, 1980, CLIN EXP DERMATOL, V5, P53, DOI 10.1111/j.1365-2230.1980.tb01665.x; Xiao ZG, 2010, NAT PROD REP, V27, P768, DOI 10.1039/b906690j; You Z, 2018, J MYCOL MED, V28, P492, DOI 10.1016/j.mycmed.2018.03.007; Youseff BH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002713; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	95	10	10	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2700	2713		10.1074/jbc.RA118.007095	http://dx.doi.org/10.1074/jbc.RA118.007095			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30593499	Green Published, hybrid			2022-12-28	WOS:000459601600012
J	Adame-Garcia, SR; Cervantes-Villagrana, RD; Orduna-Castillo, LB; del Rio, JC; Gutkind, JS; Reyes-Cruz, G; Taylor, SS; Vazquez-Prado, J				Rafael Adame-Garcia, Sendi; Daniel Cervantes-Villagrana, Rodolfo; Beatriz Orduna-Castillo, Lennis; del Rio, Jason C.; Gutkind, J. Silvio; Reyes-Cruz, Guadalupe; Taylor, Susan S.; Vazquez-Prado, Jose			cAMP-dependent activation of the Rac guanine exchange factor P-REX1 by type I protein kinase A (PKA) regulatory subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyclic AMP (cAMP); protein kinase A (PKA); G protein-coupled receptor (GPCR); guanine nucleotide exchange factor (GEF); cell signaling; cell migration; endothelial cell; Rac (Rac GTPase); heterotrimeric G protein; chemotaxis; EP2 receptors; P-REX1; regulatory subunit alpha (RI alpha); Rho guanine nucleotide exchange factor (RhoGEF); wound healing	CELL-MIGRATION; MAMMALIAN TARGET; RI-ALPHA; ACRODYSOSTOSIS; LOCALIZATION; EXPRESSION; SUBSTRATE; RECEPTOR; GPCR	Regulatory subunits of protein kinase A (PKA) inhibit its kinase subunits. Intriguingly, their potential as cAMP-dependent signal transducers remains uncharacterized. We recently reported that type I PKA regulatory subunits (RI alpha) interact with phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchange factor 1 (P-REX1), a chemotactic Rac guanine exchange factor (RacGEF). Because P-REX1 is known to be phosphorylated and inhibited by PKA, its interaction with RI alpha suggests that PKA regulatory and catalytic subunits may fine-tune P-REX1 activity or those of its target pools. Here, we tested whether RI alpha acts as a cAMP-dependent factor promoting P-REX1-mediated Rac activation and cell migration. We observed that G(s)-coupled EP2 receptors indeed promote endothelial cell migration via RI alpha-activated P-REX1. Expression of the P-REX1-PDZ1 domain prevented RI alpha/P-REX1 interaction, P-REX1 activation, and EP2-dependent cell migration, and P-REX1 silencing abrogated RI alpha-dependent Rac activation. RI alpha-specific cAMP analogs activated P-REX1, but lost this activity in RI alpha-knockdown cells, and cAMP pulldown assays revealed that P-REX1 preferentially interacts with free RI alpha. Moreover, purified RI alpha directly activated P-REX1 in vitro. We also found that the RI alpha CNB-B domain is critical for the interaction with P-REX1, which was increased in RI alpha mutants, such as the acrodysostosis-associated mutant, that activate P-REX1 at basal cAMP levels. RI alpha and C alpha PKA subunits targeted distinct P-REX1 molecules, indicated by an absence of phosphorylation in the active fraction of P-REX1. This was in contrast to the inactive fraction in which phosphorylated P-REX1 was present, suggesting co-existence of dual stimulatory and inhibitory effects. We conclude that PKA's regulatory subunits are cAMP-dependent signal transducers.	[Rafael Adame-Garcia, Sendi; Beatriz Orduna-Castillo, Lennis; Reyes-Cruz, Guadalupe] IPN, CINVESTAV, Ctr Res & Adv Studies, Dept Cell Biol, Mexico City 07360, DF, Mexico; [Daniel Cervantes-Villagrana, Rodolfo; Vazquez-Prado, Jose] IPN, CINVESTAV, Ctr Res & Adv Studies, Dept Pharmacol, Mexico City 07360, DF, Mexico; [Gutkind, J. Silvio] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [del Rio, Jason C.; Gutkind, J. Silvio; Taylor, Susan S.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Taylor, Susan S.] Univ Calif San Diego, Dept Chem, La Jolla, CA 92093 USA; [Taylor, Susan S.] Univ Calif San Diego, Dept Biochem, La Jolla, CA 92093 USA	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Vazquez-Prado, J (corresponding author), IPN, CINVESTAV, Dept Pharmacol, Ave Inst Politecn Nacl 2508, Mexico City 07360, DF, Mexico.	jvazquez@cinvestav.mx	Gutkind, J. Silvio/J-1201-2016; Cervantes-Villagrana, Rodolfo Daniel/T-6458-2019; VAZQUEZ-PRADO, JOSE/C-1630-2017; Cervantes-Villagrana, Rodolfo Daniel/E-6804-2019	Gutkind, J. Silvio/0000-0002-5150-4482; VAZQUEZ-PRADO, JOSE/0000-0001-5797-6643; Cervantes-Villagrana, Rodolfo Daniel/0000-0002-6599-7994; Del Rio, Jason/0000-0001-8540-2065; Orduna Castillo, Lennis Beatriz/0000-0001-7013-861X	CONACyT (Consejo Nacional de Ciencia y Tecnologia, Mexico) [286274, 240119]; National Institutes of Health [R01 GM34921]; National Institutes of Health/NCI Grant [CA221289]; NATIONAL CANCER INSTITUTE [R01CA221289] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034921] Funding Source: NIH RePORTER	CONACyT (Consejo Nacional de Ciencia y Tecnologia, Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/NCI Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by CONACyT (Consejo Nacional de Ciencia y Tecnologia, Mexico) Grants 286274 (to J. V.-P.) and 240119 (to G. R.-C.) and National Institutes of Health Grant R01 GM34921 (to S. S. T). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by fellowships from CONACyT (Consejo Nacional de Ciencia y Tecnologia, Mexico).; Supported by the National Institutes of Health/NCI Grant CA221289.	Ledezma-Sanchez BA, 2010, BIOCHEM BIOPH RES CO, V391, P1647, DOI 10.1016/j.bbrc.2009.12.108; Bachmann VA, 2016, P NATL ACAD SCI USA, V113, P7786, DOI 10.1073/pnas.1608061113; Barber MA, 2012, BIOCHEM J, V443, P173, DOI 10.1042/BJ20112078; Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; BOSHART M, 1991, CELL, V66, P849, DOI 10.1016/0092-8674(91)90432-X; Bruystens JGH, 2016, J MOL BIOL, V428, P4890, DOI 10.1016/j.jmb.2016.10.033; Carretero-Ortega J, 2010, MOL PHARMACOL, V77, P435, DOI 10.1124/mol.109.060400; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Chavez-Vargas L, 2016, J BIOL CHEM, V291, P6182, DOI 10.1074/jbc.M115.712216; Cervantes-Villagrana RD, 2019, J BIOL CHEM, V294, P531, DOI 10.1074/jbc.RA118.006254; Guilluy C, 2011, NAT PROTOC, V6, P2050, DOI 10.1038/nprot.2011.411; Hernandez-Garcia R, 2015, VASC PHARMACOL, V74, P60, DOI 10.1016/j.vph.2015.10.003; Hernandez-Negrete I, 2007, J BIOL CHEM, V282, P23708, DOI 10.1074/jbc.M703771200; Howe AK, 2004, BBA-MOL CELL RES, V1692, P159, DOI 10.1016/j.bbamcr.2004.03.005; Kamiyama M, 2006, ONCOGENE, V25, P7019, DOI 10.1038/sj.onc.1209694; Keshwani MM, 2015, P NATL ACAD SCI USA, V112, P12681, DOI 10.1073/pnas.1516057112; Kim EK, 2011, ONCOGENE, V30, P2954, DOI 10.1038/onc.2011.22; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Lim CJ, 2007, NAT CELL BIOL, V9, P415, DOI 10.1038/ncb1561; Linglart A, 2011, NEW ENGL J MED, V364, P2218, DOI 10.1056/NEJMoa1012717; Lucato CM, 2015, J BIOL CHEM, V290, P20827, DOI 10.1074/jbc.M115.660456; Guzman-Hernandez ML, 2009, J BIOL CHEM, V284, P18334, DOI 10.1074/jbc.M109.008839; Mavrakis M, 2006, HUM MOL GENET, V15, P2962, DOI 10.1093/hmg/ddl239; Pan DX, 2016, J BIOL CHEM, V291, P6359, DOI 10.1074/jbc.M115.686592; Paulucci-Holthauzen AA, 2009, J BIOL CHEM, V284, P5956, DOI 10.1074/jbc.M805606200; Smith FD, 2010, NAT CELL BIOL, V12, P1242, DOI 10.1038/ncb2130; Stefan E, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1605; Taylor SS, 2013, BBA-PROTEINS PROTEOM, V1834, P1271, DOI 10.1016/j.bbapap.2013.03.007; Torres-Quesada O, 2017, CELL SIGNAL, V37, P1, DOI 10.1016/j.cellsig.2017.05.012; Vazquez-Prado J, 2016, MOL PHARMACOL, V90, P573, DOI 10.1124/mol.116.105338; Vigil D, 2004, BIOCHEMISTRY-US, V43, P5629, DOI 10.1021/bi0499157; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Welch Heidi C E, 2015, Small GTPases, V6, P49, DOI 10.4161/21541248.2014.973770; Yang LH, 2014, J NEUROSCI, V34, P4896, DOI 10.1523/JNEUROSCI.3460-13.2014	34	16	16	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2019	294	7					2232	2246		10.1074/jbc.RA118.006691	http://dx.doi.org/10.1074/jbc.RA118.006691			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL7CN	30530493	hybrid, Green Published			2022-12-28	WOS:000458895400002
J	Son, S; Bowie, LE; Maiuri, T; Hung, CLK; Desmond, CR; Xia, JR; Truant, R				Son, Susie; Bowie, Laura E.; Maiuri, Tamara; Hung, Claudia L. K.; Desmond, Carly R.; Xia, Jianrun; Truant, Ray			High-mobility group box 1 links sensing of reactive oxygen species by huntingtin to its nuclear entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Huntington disease; nuclear transport; reactive oxygen species (ROS); oxidative stress; DNA damage; neurodegenerative disease; high-mobility group box protein; N17 domain; PY-NLS; ROS sensing	N-17 DOMAIN; HMGB1; ASSOCIATION; PROTEINS; IDENTIFICATION; LOCALIZATION; AGGREGATION; INTERACTS; BINDING; STRESS	Huntington's disease (HD) is a neurodegenerative, age-onset disorder caused by a CAG DNA expansion in exon 1 of the HTT gene, resulting in a polyglutamine expansion in the huntingtin protein. Nuclear accumulation of mutant huntingtin is a hallmark of HD, resulting in elevated mutant huntingtin levels in cell nuclei. Huntingtin is normally retained at the endoplasmic reticulum via its N17 amphipathic -helix domain but is released by oxidation of Met-8 during reactive oxygen species (ROS) stress. Huntingtin enters the nucleus via an importin 1- and 2-dependent proline-tyrosine nuclear localization signal (PY-NLS), which has a unique intervening sequence in huntingtin. Here, we have identified the high-mobility group box 1 (HMGB1) protein as an interactor of the intervening sequence within the PY-NLS. Nuclear levels of HMGB1 positively correlated with varying levels of nuclear huntingtin in both HD and normal human fibroblasts. We also found that HMGB1 interacts with the huntingtin N17 region and that this interaction is enhanced by the presence of ROS and phosphorylation of critical serine residues in the N17 region. We conclude that HMGB1 is a huntingtin N17/PY-NLS ROS-dependent interactor, and this protein bridging is essential for relaying ROS sensing by huntingtin to its nuclear entry during ROS stress. ROS may therefore be a critical age-onset stress that triggers nuclear accumulation of mutant huntington in Huntington's disease.	[Son, Susie; Bowie, Laura E.; Maiuri, Tamara; Hung, Claudia L. K.; Desmond, Carly R.; Xia, Jianrun; Truant, Ray] McMaster Univ, Dept Biochem & Biomed Res, Hamilton, ON L8S 4L8, Canada	McMaster University	Truant, R (corresponding author), HSC4N54 1200 Main St West, Hamilton, ON L8N 3Z5, Canada.	truantr@mcmaster.ca	Surette, Michael G/AAE-8825-2020	Maiuri, Tamara/0000-0002-6103-5835; Hung, Claudia Lin-Kar/0000-0003-4811-5280	Canadian Institutes of Health Research Project [MOP-119391]; Krembil Foundation; Huntington Society of Canada	Canadian Institutes of Health Research Project(Canadian Institutes of Health Research (CIHR)); Krembil Foundation; Huntington Society of Canada	This work was supported by Canadian Institutes of Health Research Project Grant MOP-119391, The Krembil Foundation, and the Huntington Society of Canada. The authors declare that they have no conflicts of interest with the contents of this article.	Aiken CT, 2009, J BIOL CHEM, V284, P29427, DOI 10.1074/jbc.M109.013193; Anggayasti WL, 2016, BBA-PROTEINS PROTEOM, V1864, P1620, DOI 10.1016/j.bbapap.2016.07.008; Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; Atwal RS, 2011, NAT CHEM BIOL, V7, P453, DOI [10.1038/NCHEMBIO.582, 10.1038/nchembio.582]; Bowles KR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144864; BROUILLET E, 1993, J NEUROCHEM, V60, P356, DOI 10.1111/j.1471-4159.1993.tb05859.x; Caron NS, 2013, P NATL ACAD SCI USA, V110, P14610, DOI 10.1073/pnas.1301342110; Correia K, 2015, J HUNTINGTONS DIS, V4, P279, DOI 10.3233/JHD-150169; Desmond Carly R, 2013, Commun Integr Biol, V6, pe23318, DOI 10.4161/cib.23318; Desmond CR, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.412379; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; DiGiovanni LF, 2016, HUM MOL GENET, V25, P3937, DOI 10.1093/hmg/ddw234; Dintilhac A, 2002, J BIOL CHEM, V277, P7021, DOI 10.1074/jbc.M108417200; Dishinger JF, 2010, NAT CELL BIOL, V12, P703, DOI 10.1038/ncb2073; Farg MA, 2017, HUM MOL GENET, V26, P2882, DOI 10.1093/hmg/ddx170; Feng Z, 2006, ONCOGENE, V25, P1, DOI 10.1038/sj.onc.1209021; Fujita Kyota, 2017, Brain Nerve, V69, P925, DOI 10.11477/mf.1416200844; Gu XF, 2009, NEURON, V64, P828, DOI 10.1016/j.neuron.2009.11.020; Han YH, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002063; He SJ, 2017, ONCOTARGET, V8, P64534, DOI 10.18632/oncotarget.17885; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Hung CLK, 2018, MOL BIOL CELL, V29, P2809, DOI 10.1091/mbc.E18-09-0590; Ito H, 2015, EMBO MOL MED, V7, P78, DOI 10.15252/emmm.201404392; Jayaraman L, 1998, GENE DEV, V12, P462, DOI 10.1101/gad.12.4.462; Knapp S, 2004, BIOCHEMISTRY-US, V43, P11992, DOI 10.1021/bi049364k; Lee JM, 2015, CELL, V162, P516, DOI 10.1016/j.cell.2015.07.003; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Maiuri T, 2013, HUM MOL GENET, V22, P1383, DOI 10.1093/hmg/dds554; Maiuri T, 2017, HUM MOL GENET, V26, P395, DOI 10.1093/hmg/ddw395; Mende-Mueller LM, 2001, J NEUROSCI, V21, P1830, DOI 10.1523/JNEUROSCI.21-06-01830.2001; Michalek M, 2013, BIOPHYS J, V105, P699, DOI 10.1016/j.bpj.2013.06.030; Moss DJH, 2017, LANCET NEUROL, V16, P701, DOI 10.1016/S1474-4422(17)30161-8; Nath S, 2015, HUM MOL GENET, V24, P450, DOI 10.1093/hmg/ddu460; Qi ML, 2007, NAT CELL BIOL, V9, P402, DOI 10.1038/ncb1553; Suel KE, 2008, PLOS BIOL, V6, P1253, DOI 10.1371/journal.pbio.0060137; Tang DL, 2007, J LEUKOCYTE BIOL, V81, P741, DOI 10.1189/jlb.0806540; Tang DL, 2011, CELL METAB, V13, P701, DOI 10.1016/j.cmet.2011.04.008; Tang DL, 2011, ANTIOXID REDOX SIGN, V14, P1315, DOI 10.1089/ars.2010.3356; Tang DL, 2010, J CELL BIOL, V190, P881, DOI 10.1083/jcb.200911078; Thompson LM, 2009, J CELL BIOL, V187, P1083, DOI 10.1083/jcb.200909067; Vezzoli M, 2010, ANN NY ACAD SCI, V1209, P83, DOI 10.1111/j.1749-6632.2010.05748.x; Walker C, 2017, NAT NEUROSCI, V20, P1225, DOI 10.1038/nn.4604; Wang J, 2013, BIOCHEM BIOPH RES CO, V441, P701, DOI 10.1016/j.bbrc.2013.10.085; YU SS, 1977, EUR J BIOCHEM, V78, P497, DOI 10.1111/j.1432-1033.1977.tb11762.x	44	9	10	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2019	294	6					1915	1923		10.1074/jbc.RA117.001440	http://dx.doi.org/10.1074/jbc.RA117.001440			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM8EO	30538129	Green Published, hybrid			2022-12-28	WOS:000459711400012
J	Godlewska, U; Bilska, B; Zegar, A; Brzoza, P; Borek, A; Murzyn, K; Bochenska, O; Morytko, A; Kuleta, P; Kozik, A; Pyza, E; Osyczka, A; Zabel, BA; Cichy, J				Godlewska, Urszula; Bilska, Bernadetta; Zegar, Aneta; Brzoza, Piotr; Borek, Arkadiusz; Murzyn, Krzysztof; Bochenska, Oliwia; Morytko, Agnieszka; Kuleta, Patryk; Kozik, Andrzej; Pyza, Elzbieta; Osyczka, Artur; Zabel, Brian A.; Cichy, Joanna			The antimicrobial activity of chemerin-derived peptide p4 requires oxidative conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epidermis; antimicrobial peptide (AMP); bacteria; host defense; host-pathogen interaction; chemotaxis; adipokine; Staphylococcus aureus (S. aureus); skin; chemerin; MRSA	DENDRITIC CELLS; RECEPTOR	Chemerin is a leukocyte attractant, adipokine, and antimicrobial protein abundantly produced in the skin epidermis. Despite the fact that most of the bactericidal activity present in human skin exudates is chemerin-dependent, just how chemerin shapes skin defenses remains obscure. Here we demonstrate that p4, a potent antimicrobial human chemerin peptide derivative, displays killing activity against pathogenic methicillin-resistant Staphylococcus aureus strains and suppresses microbial growth in a topical skin infection model. Mechanistically, we show that p4 homodimerization is required for maximal bactericidal activity and that an oxidative environment, such as at the skin surface, facilitates p4 disulfide bridge formation, required for the dimerization. p4 led to rapid damage of the bacterial internal membrane and inhibited the interaction between the membranous cytochrome bc(1) complex and its redox partner, cytochrome c. These results suggest that a chemerin p4-based defense strategy combats bacterial challenges at the skin surface.	[Godlewska, Urszula; Zegar, Aneta; Brzoza, Piotr; Morytko, Agnieszka; Cichy, Joanna] Jagiellonian Univ, Dept Immunol, Fac Biochem Biophys & Biotechnol, PL-30387 Krakow, Poland; [Borek, Arkadiusz; Kuleta, Patryk; Osyczka, Artur] Jagiellonian Univ, Dept Mol Biophys, Fac Biochem Biophys & Biotechnol, PL-30387 Krakow, Poland; [Murzyn, Krzysztof] Jagiellonian Univ, Dept Computat Biophys & Bioinformat, Fac Biochem Biophys & Biotechnol, PL-30387 Krakow, Poland; [Bochenska, Oliwia; Kozik, Andrzej] Jagiellonian Univ, Dept Analyt Biochem, Fac Biochem Biophys & Biotechnol, PL-30387 Krakow, Poland; [Bilska, Bernadetta; Pyza, Elzbieta] Jagiellonian Univ, Inst Zool & Biomed Res, Dept Cell Biol & Imaging, PL-30387 Krakow, Poland; [Zabel, Brian A.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto Vet Inst Res, Palo Alto, CA 94304 USA	Jagiellonian University; Jagiellonian University; Jagiellonian University; Jagiellonian University; Jagiellonian University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Cichy, J (corresponding author), Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Gronostajowa 7 St, PL-30387 Krakow, Poland.	Joanna.Cichy@uj.edu.pl	Brzoza, Piotr/AAM-4252-2021	Brzoza, Piotr/0000-0003-0516-3266; Cichy, Joanna/0000-0002-0552-8344; Bilska, Bernadetta/0000-0001-6142-7575; Osyczka, Artur/0000-0002-1637-2365; Borek, Arkadiusz/0000-0003-3195-3579	Polish Ministry of Science and Higher Education	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	The Faculty of Biochemistry, Biophysics, and Biotechnology of the Jagiellonian University is a partner of the Leading National Research Center (KNOW) supported by the Polish Ministry of Science and Higher Education.	Albanesi C, 2009, J EXP MED, V206, P249, DOI 10.1084/jem.20080129; ATTAASAFOADJEI E, 1991, P NATL ACAD SCI USA, V88, P492, DOI 10.1073/pnas.88.2.492; Banas M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117830; Banas M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058709; Barnea G, 2008, P NATL ACAD SCI USA, V105, P64, DOI 10.1073/pnas.0710487105; Bozaoglu K, 2010, J CLIN ENDOCR METAB, V95, P2476, DOI 10.1210/jc.2010-0042; Godlewska U, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00353; Goralski KB, 2007, J BIOL CHEM, V282, P28175, DOI 10.1074/jbc.M700793200; Kracke F, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00575; Kulig P, 2007, J IMMUNOL, V178, P3713, DOI 10.4049/jimmunol.178.6.3713; Kulig P, 2011, J IMMUNOL, V187, P1403, DOI 10.4049/jimmunol.1002352; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEHRER RI, 1991, J IMMUNOL METHODS, V137, P167, DOI 10.1016/0022-1759(91)90021-7; Luangsay S, 2009, J IMMUNOL, V183, P6489, DOI 10.4049/jimmunol.0901037; Nagpal S, 1997, J INVEST DERMATOL, V109, P91, DOI 10.1111/1523-1747.ep12276660; OLIVA B, 1992, ANTIMICROB AGENTS CH, V36, P913, DOI 10.1128/AAC.36.5.913; Sarewicz M, 2015, PHYSIOL REV, V95, P219, DOI 10.1152/physrev.00006.2014; Sarewicz M, 2010, BBA-BIOENERGETICS, V1797, P1820, DOI 10.1016/j.bbabio.2010.07.005; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Takahashi M, 2011, SCI REP-UK, V1, DOI 10.1038/srep00123; TRUMPOWER BL, 1990, MICROBIOL REV, V54, P101, DOI 10.1128/MMBR.54.2.101-129.1990; Vermi W, 2005, J EXP MED, V201, P509, DOI 10.1084/jem.20041310; Watts SW, 2013, ARTERIOSCL THROM VAS, V33, P1320, DOI 10.1161/ATVBAHA.113.301476; Wittamer V, 2004, J BIOL CHEM, V279, P9956, DOI 10.1074/jbc.M313016200; Wittamer V, 2003, J EXP MED, V198, P977, DOI 10.1084/jem.20030382; Zabel BA, 2005, J BIOL CHEM, V280, P34661, DOI 10.1074/jbc.M504868200; Zabel BA, 2005, J IMMUNOL, V174, P244, DOI 10.4049/jimmunol.174.1.244; Zabel BA, 2008, J EXP MED, V205, P2207, DOI 10.1084/jem.20080300; Zabel BA, 2014, AM J CLIN EXP IMMUNO, V3, P1	29	10	10	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1267	1278		10.1074/jbc.RA118.005495	http://dx.doi.org/10.1074/jbc.RA118.005495			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30504221	Green Published, hybrid			2022-12-28	WOS:000457879500018
J	Cook, M; Delbecq, SP; Schweppe, TP; Guttman, M; Klevit, RE; Brzovic, PS				Cook, Matt; Delbecq, Scott P.; Schweppe, Thomas P.; Guttman, Miklos; Klevit, Rachel E.; Brzovic, Peter S.			The ubiquitin ligase SspH1 from Salmonella uses a modular and dynamic E3 domain to catalyze substrate ubiquitylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ubiquitin; ubiquitin ligase (E3 enzyme); ubiquitin-conjugating enzyme (E2 enzyme); ubiquitylation (ubiquitination); bacterial pathogenesis; bacterial effector; PKN1; Salmonella; SspH1; Ube2D; ubiquitin transfer	EVOLUTIONARY CONSERVATION; IPAH FAMILY; COMPLEX; MECHANISM; INSIGHTS; AUTOINHIBITION; EFFECTORS; REVEALS; SYSTEM; RECOGNITION	SspH/IpaH bacterial effector E3 ubiquitin (Ub) ligases, unrelated in sequence or structure to eukaryotic E3s, are utilized by a wide variety of Gram-negative bacteria during pathogenesis. These E3s function in a eukaryotic environment, utilize host cell E2 ubiquitin-conjugating enzymes of the Ube2D family, and target host proteins for ubiquitylation. Despite several crystal structures, details of Ube2D similar to Ub binding and the mechanism of ubiquitin transfer are poorly understood. Here, we show that the catalytic E3 ligase domain of SspH1 can be divided into two subdomains: an N-terminal subdomain that harbors the active-site cysteine and a C-terminal subdomain containing the Ube2D similar to Ub-binding site. SspH1 mutations designed to restrict subdomain motions show rapid formation of an E3 similar to Ub intermediate, but impaired Ub transfer to substrate. NMR experiments using paramagnetic spin labels reveal how SspH1 binds Ube2D similar to Ub and targets the E2 similar to Ub active site. Unexpectedly, hydrogen/deuterium exchange MS shows that the E2 similar to Ub-binding region is dynamic but stabilized in the E3 similar to Ub intermediate. Our results support a model in which both subunits of an Ube2D similar to Ub clamp onto a dynamic region of SspH1, promoting an E3 conformation poised for transthiolation. A conformational change is then required for Ub transfer from E3 similar to Ub to substrate.	[Cook, Matt; Delbecq, Scott P.; Schweppe, Thomas P.; Klevit, Rachel E.; Brzovic, Peter S.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Guttman, Miklos] Univ Washington, Dept Med Chem, Seattle, WA 98195 USA; [Delbecq, Scott P.] InBios Int Inc, 562 1st Ave S, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Brzovic, PS (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	brzovic@uw.edu	Klevit, Rachel/AAI-7038-2021	Klevit, Rachel/0000-0002-3476-969X	National Institutes of Health [R01GM098503, R01GM088055, T32GM826827]; University of Washington School of Medicine Hurd Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008268, R01GM088055, R01GM098503] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington School of Medicine Hurd Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01GM098503 (to P. S. B.), R01GM088055 (to R. E. K.), and T32GM826827 (to M. C.) and the University of Washington School of Medicine Hurd Fellowship (to M. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ashida H, 2017, CURR OPIN MICROBIOL, V35, P16, DOI 10.1016/j.mib.2016.11.001; Ashida H, 2014, NAT REV MICROBIOL, V12, P399, DOI 10.1038/nrmicro3259; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Brzovic PS, 2006, MOL CELL, V21, P873, DOI 10.1016/j.molcel.2006.02.008; Chalkley RJ, 2005, MOL CELL PROTEOMICS, V4, P1194, DOI 10.1074/mcp.D500002-MCP200; Chou YC, 2012, J BIOL CHEM, V287, P268, DOI 10.1074/jbc.M111.316265; Cui JX, 2011, TRENDS BIOCHEM SCI, V36, P532, DOI 10.1016/j.tibs.2011.07.003; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Delano W.L., 2017, PYMOL MOL GRAPHICS S; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P876, DOI 10.1038/nsmb.2379; Dove KK, 2017, STRUCTURE, V25, P890, DOI 10.1016/j.str.2017.04.013; Dove KK, 2016, EMBO REP, V17, P1221, DOI 10.15252/embr.201642641; Edwards DJ, 2014, J BIOL CHEM, V289, P34114, DOI 10.1074/jbc.M114.609164; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guttman M, 2016, METHOD ENZYMOL, V566, P405, DOI 10.1016/bs.mie.2015.05.021; Guttman M, 2013, J AM SOC MASS SPECTR, V24, P1906, DOI 10.1007/s13361-013-0727-5; Haraga A, 2006, CELL MICROBIOL, V8, P837, DOI 10.1111/j.1462-5822.2005.00670.x; Haraga A, 2003, INFECT IMMUN, V71, P4052, DOI 10.1128/IAI.71.7.4052-4058.2003; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Huibregtse J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004255; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kamadurai HB, 2009, MOL CELL, V36, P1095, DOI 10.1016/j.molcel.2009.11.010; Keszei AFA, 2017, P NATL ACAD SCI USA, V114, P1311, DOI 10.1073/pnas.1611595114; Keszei AFA, 2014, MOL CELL BIOL, V34, P362, DOI 10.1128/MCB.01360-13; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Levin I, 2010, P NATL ACAD SCI USA, V107, P2848, DOI 10.1073/pnas.0914821107; Lin DYW, 2012, P NATL ACAD SCI USA, V109, P1925, DOI 10.1073/pnas.1115025109; Perrett CA, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00143; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Pruneda JN, 2011, BIOCHEMISTRY-US, V50, P1624, DOI 10.1021/bi101913m; Quezada CM, 2009, P NATL ACAD SCI USA, V106, P4864, DOI 10.1073/pnas.0811058106; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Rohde JR, 2007, CELL HOST MICROBE, V1, P77, DOI 10.1016/j.chom.2007.02.002; Singer AU, 2008, NAT STRUCT MOL BIOL, V15, P1293, DOI 10.1038/nsmb.1511; Stewart MD, 2016, CELL RES, V26, P423, DOI 10.1038/cr.2016.35; Tanner K, 2015, CELL MICROBIOL, V17, P35, DOI 10.1111/cmi.12390; Weis DD, 2006, J AM SOC MASS SPECTR, V17, P1700, DOI 10.1016/j.jasms.2006.07.025; Yuan LM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00272-6; Zheng N, 2017, ANNU REV BIOCHEM, V86, P129, DOI 10.1146/annurev-biochem-060815-014922; Zhu YQ, 2008, NAT STRUCT MOL BIOL, V15, P1302, DOI 10.1038/nsmb.1517; Zouhir S, 2014, BIOCHEM J, V464, P135, DOI 10.1042/BJ20140587	44	3	3	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2019	294	3					783	793		10.1074/jbc.RA118.004247	http://dx.doi.org/10.1074/jbc.RA118.004247			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL4FC	30459234	Green Published, hybrid			2022-12-28	WOS:000458670200005
J	Lakshmi, SP; Reddy, AT; Zhang, Y; Sciurba, FC; Mallampalli, RK; Duncan, SR; Reddy, RC				Lakshmi, Sowmya P.; Reddy, Aravind T.; Zhang, Yingze; Sciurba, Frank C.; Mallampalli, Rama K.; Duncan, Steven R.; Reddy, Raju C.			RETRACTION: Retraction: Down-regulated peroxisome proliferator-activated receptor (PPAR) in lung epithelial cells promotes a PPAR agonist-reversible proinflammatory phenotype in chronic obstructive pulmonary disease (COPD). (Retraction of Vol 289, Pg 6383, 2014)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction													Sciurba, Frank/AAZ-9339-2021	sciurba, frank/0000-0001-7468-2225				Lakshmi SP, 2014, J BIOL CHEM, V289, P6383, DOI 10.1074/jbc.M113.536805	1	2	2	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2019	294	1					69	69		10.1074/jbc.RX118.007042	http://dx.doi.org/10.1074/jbc.RX118.007042			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG6PT	30610125	hybrid, Green Published			2022-12-28	WOS:000455105500012
J	Lu, M; Banetta, L; Young, LJ; Smith, EJ; Bates, GP; Zaccone, A; Schierle, GSK; Tunnacliffe, A; Kaminski, CF				Lu, Meng; Banetta, Luca; Young, Laurence J.; Smith, Edward J.; Bates, Gillian P.; Zaccone, Alessio; Schierle, Gabriele S. Kaminski; Tunnacliffe, Alan; Kaminski, Clemens F.			Live-cell super-resolution microscopy reveals a primary role for diffusion in polyglutamine-driven aggresome assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein aggregation; transport; molecular dynamics; molecular imaging; molecular modeling; protein misfolding; aggresome formation; amyloid protein; live cell SIM; passive transport	HUNTINGTIN FRAGMENTS; DNA-DAMAGE; AGGREGATION; ACCUMULATION; DEGRADATION; ELONGATION; PROTEINS; KINETICS; FIBRILS; DISEASE	The mechanisms leading to self-assembly of misfolded proteins into amyloid aggregates have been studied extensively in the test tube under well-controlled conditions. However, to what extent these processes are representative of those in the cellular environment remains unclear. Using super-resolution imaging of live cells, we show here that an amyloidogenic polyglutamine-containing protein first forms small, amorphous aggregate clusters in the cytosol, chiefly by diffusion. Dynamic interactions among these clusters limited their elongation and led to structures with a branched morphology, differing from the predominantly linear fibrils observed in vitro. Some of these clusters then assembled via active transport at the microtubule-organizing center and thereby initiated the formation of perinuclear aggresomes. Although it is widely believed that aggresome formation is entirely governed by active transport along microtubules, here we demonstrate, using a combined approach of advanced imaging and mathematical modeling, that diffusion is the principal mechanism driving aggresome expansion. We found that the increasing surface area of the expanding aggresome increases the rate of accretion caused by diffusion of cytosolic aggregates and that this pathway soon dominates aggresome assembly. Our findings lead to a different view of aggresome formation than that proposed previously. We also show that aggresomes mature over time, becoming more compacted as the structure grows. The presence of large perinuclear aggregates profoundly affects the behavior and health of the cell, and our super-resolution imaging results indicate that aggresome formation and development are governed by highly dynamic processes that could be important for the design of potential therapeutic strategies.	[Lu, Meng; Young, Laurence J.; Schierle, Gabriele S. Kaminski; Tunnacliffe, Alan; Kaminski, Clemens F.] Univ Cambridge, Cambridge Infinitus Res Ctr, Dept Chem Engn & Biotechnol, Cambridge CB3 0AS, England; [Banetta, Luca; Zaccone, Alessio] Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge CB3 0AS, England; [Smith, Edward J.; Bates, Gillian P.] UCL, Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London WC1N 3BG, England; [Smith, Edward J.; Bates, Gillian P.] UCL, Inst Neurol, Huntingtons Dis Ctr, London WC1N 3BG, England; [Young, Laurence J.] Fluid Analyt, Unit 5,Frenchs Rd, Cambridge CB4 3NP, England	University of Cambridge; University of Cambridge; University of London; University College London; University of London; University College London	Kaminski, CF (corresponding author), Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge CB2 3RA, England.	cfk23@cam.ac.uk	Banetta, Luca/GYV-1359-2022; Kaminski, Clemens/G-7488-2016; Bates, Gillian/E-1146-2012	Zaccone, Alessio/0000-0002-6673-7043; Kaminski, Clemens/0000-0002-5194-0962; Tunnacliffe, Alan/0000-0001-8570-125X; Banetta, Luca/0000-0003-2055-9584; Bates, Gillian/0000-0002-4041-6305	BBSRC [BB/H023917/1] Funding Source: UKRI; EPSRC [EP/H018301/1] Funding Source: UKRI; MRC [MR/K02292X/1, G0902243, MR/K015850/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H023917/1] Funding Source: Medline; Medical Research Council [MR/K015850/1, MR/K02292X/1, G0902243] Funding Source: Medline; Wellcome Trust [203249/Z/16/Z, 3-3249/Z/16/Z, 089703/Z/09/Z] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Bauerlein FJB, 2017, CELL, V171, P179, DOI 10.1016/j.cell.2017.08.009; Balint S, 2013, P NATL ACAD SCI USA, V110, P3375, DOI 10.1073/pnas.1219206110; Buchanan LE, 2014, P NATL ACAD SCI USA, V111, P5796, DOI 10.1073/pnas.1401587111; Ciechanover A, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2014.117; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Duim WC, 2014, ACS CHEM BIOL, V9, P2767, DOI 10.1021/cb500335w; Gandy S, 2005, PLOS MED, V2, P1228, DOI 10.1371/journal.pmed.0020417; Giuliano P, 2003, HUM MOL GENET, V12, P2301, DOI 10.1093/hmg/ddg242; Hoffner G, 2014, BRAIN SCI, V4, P91, DOI 10.3390/brainsci4010091; Howard J, 1997, NATURE, V389, P561, DOI 10.1038/39247; Huynen C, 2015, BBA-PROTEINS PROTEOM, V1854, P239, DOI 10.1016/j.bbapap.2014.12.002; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Juenemann K, 2013, J BIOL CHEM, V288, P27068, DOI 10.1074/jbc.M113.486076; JULLIEN R, 1987, CONTEMP PHYS, V28, P477, DOI 10.1080/00107518708213736; Kaminski CF, 2016, NEUROPHOTONICS, V3, DOI 10.1117/1.NPh.3.4.041807; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Lajoie P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015245; Leitman J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3753; Li L, 2016, ELIFE, V5, DOI 10.7554/eLife.17056; Li X, 2010, HUM MOL GENET, V19, P2445, DOI 10.1093/hmg/ddq127; Lu M, 2015, J BIOL CHEM, V290, P27986, DOI 10.1074/jbc.M115.676437; Lu M, 2015, BIOTECHNOL BIOENG, V112, P1883, DOI 10.1002/bit.25606; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Pinotsi D, 2016, P NATL ACAD SCI USA, V113, P3815, DOI 10.1073/pnas.1516546113; Pinotsi D, 2014, NANO LETT, V14, P339, DOI 10.1021/nl4041093; Ren PH, 2009, NAT CELL BIOL, V11, P219, DOI 10.1038/ncb1830; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sathasivam K, 2001, HUM MOL GENET, V10, P2425, DOI 10.1093/hmg/10.21.2425; Sathasivam K, 2010, HUM MOL GENET, V19, P65, DOI 10.1093/hmg/ddp467; Streets AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054541; Strohl F, 2015, METHODS APPL FLUORES, V3, DOI 10.1088/2050-6120/3/1/014002; Strtohl F, 2016, OPTICA, V3, P667, DOI 10.1364/OPTICA.3.000667; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; Verhey KJ, 2011, ANNU REV BIOPHYS, V40, P267, DOI 10.1146/annurev-biophys-042910-155310; Waelter S, 2001, MOL BIOL CELL, V12, P1393, DOI 10.1091/mbc.12.5.1393; Walters RH, 2012, J MOL BIOL, V421, P329, DOI 10.1016/j.jmb.2012.03.017; Wang HF, 2012, J BIOL CHEM, V287, P28576, DOI 10.1074/jbc.M111.299990; Young LJ, 2016, JOVE-J VIS EXP, DOI 10.3791/53988	40	13	13	3	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2019	294	1					257	268		10.1074/jbc.RA118.003500	http://dx.doi.org/10.1074/jbc.RA118.003500			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG6PT	30401748	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000455105500028
J	Feng, Y; Liang, Y; Zhu, XW; Wang, MJ; Gui, Y; Lu, QM; Gu, MR; Xue, X; Sun, XL; He, WC; Yang, JW; Johnson, RL; Dai, CS				Feng, Ye; Liang, Yan; Zhu, Xingwen; Wang, Mingjie; Gui, Yuan; Lu, Qingmiao; Gu, Mengru; Xue, Xian; Sun, Xiaoli; He, Weichun; Yang, Junwei; Johnson, Randy L.; Dai, Chunsun			The signaling protein Wnt5a promotes TGF1-mediated macrophage polarization and kidney fibrosis by inducing the transcriptional regulators Yap/Taz	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						kidney; fibrosis; Wnt signaling; Hippo pathway; macrophage; cell signaling; macrophage polarization; transforming growth factor; Wnt5a; Yap; Taz	FIBROBLAST ACTIVATION; HIPPO PATHWAY; TAZ; YAP; CANCER; CONTRIBUTES; TARGET; INJURY; CELLS; STAT6	M2 macrophage polarization is known to underlie kidney fibrosis. We previously reported that most of the members of the Wnt family of signaling proteins are induced in fibrotic kidneys. Dysregulation of the signaling protein Wnt5a is associated with fibrosis, but little is known about the role of Wnt5a in regulating M2 macrophage activation that results in kidney fibrosis. Here, using murine Raw 264.7 cells and bone marrow-derived macrophages, we found that Wnt5a enhanced transforming growth factor 1 (TGF1)-induced macrophage M2 polarization as well as expression of the transcriptional regulators Yes-associated protein (Yap)/transcriptional coactivator with PDZ-binding motif (Taz). Verteporfin blockade of Yap/Taz inhibited both Wnt5a- and TGF1-induced macrophage M2 polarization. In mouse models of kidney fibrosis, shRNA-mediated knockdown of Wnt5a expression diminished kidney fibrosis, macrophage Yap/Taz expression, and M2 polarization. Moreover, genetic ablation of Taz in macrophages attenuated kidney fibrosis and macrophage M2 polarization in mice. Collectively, these results indicate that Wnt5a promotes kidney fibrosis by stimulating Yap/Taz-mediated macrophage M2 polarization.	[Feng, Ye; Liang, Yan; Zhu, Xingwen; Wang, Mingjie; Gui, Yuan; Lu, Qingmiao; Gu, Mengru; Xue, Xian; Sun, Xiaoli; He, Weichun; Yang, Junwei; Dai, Chunsun] Nanjing Med Univ, Affiliated Hosp 2, Ctr Kidney Dis, 262 North Zhongshan Rd, Nanjing 210003, Jiangsu, Peoples R China; [Johnson, Randy L.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA	Nanjing Medical University; University of Texas System; UTMD Anderson Cancer Center	Dai, CS (corresponding author), Nanjing Med Univ, Affiliated Hosp 2, Ctr Kidney Dis, 262 North Zhongshan Rd, Nanjing 210003, Jiangsu, Peoples R China.	daichunsun@njmu.edu.cn			National Science Foundation of China [81570611/H0503, 81770675/H0503]; Science Foundation of Jiangsu Province [BK20140048]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of Jiangsu Province	This work was supported by National Science Foundation of China Grants 81570611/H0503 and 81770675/H0503 and Science Foundation of Jiangsu Province Grant BK20140048 (to C. D.). The authors declare that they have no conflicts of interest with the contents of this article.	Abraityte A, 2017, J MOL MED, V95, P767, DOI 10.1007/s00109-017-1529-1; Anorga S, 2018, FASEB J, V32, P2644, DOI 10.1096/fj.201700722R; Bergenfelz C, 2012, J IMMUNOL, V188, P5448, DOI 10.4049/jimmunol.1103378; Clements M, 2016, J AM SOC NEPHROL, V27, P159, DOI 10.1681/ASN.2014111138; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Dai CS, 2009, J AM SOC NEPHROL, V20, P1997, DOI 10.1681/ASN.2009010019; Feng Y, 2018, J AM SOC NEPHROL, V29, P182, DOI 10.1681/ASN.2017040391; Fu V, 2017, CURR OPIN CELL BIOL, V49, P99, DOI 10.1016/j.ceb.2017.12.012; Gao B, 2012, CURR TOP DEV BIOL, V101, P263, DOI 10.1016/B978-0-12-394592-1.00008-9; Geng J, 2017, NAT IMMUNOL, V18, P800, DOI 10.1038/ni.3748; Huang YJ, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0421-3; Kapoor N, 2015, J IMMUNOL, V194, P6011, DOI 10.4049/jimmunol.1402797; Kawakami T, 2013, J PATHOL, V229, P221, DOI 10.1002/path.4121; Li X, 2013, GENES CELLS, V18, P608, DOI 10.1111/gtc.12064; Liang M, 2017, J AM SOC NEPHROL, V28, P3277, DOI 10.1681/ASN.2015121354; Liang N, 2014, J EXP MED, V211, P2249, DOI 10.1084/jem.20140341; Liu F, 2015, AM J PHYSIOL-LUNG C, V308, pL344, DOI 10.1152/ajplung.00300.2014; Maiti G, 2012, P NATL ACAD SCI USA, V109, P16600, DOI 10.1073/pnas.1207789109; Martin K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12502; Miranda MZ, 2017, J BIOL CHEM, V292, P14902, DOI 10.1074/jbc.M117.780502; Murray PJ, 2017, ANNU REV PHYSIOL, V79, P541, DOI 10.1146/annurev-physiol-022516-034339; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Naskar D, 2014, J IMMUNOL, V192, P4386, DOI 10.4049/jimmunol.1302817; Panciera T, 2017, NAT REV MOL CELL BIO, V18, P758, DOI 10.1038/nrm.2017.87; Park HW, 2015, CELL, V162, P780, DOI 10.1016/j.cell.2015.07.013; Pereira C, 2008, ARTERIOSCL THROM VAS, V28, P504, DOI 10.1161/ATVBAHA.107.157438; Piccolo V, 2017, NAT IMMUNOL, V18, P530, DOI 10.1038/ni.3710; Pukrop T, 2006, P NATL ACAD SCI USA, V103, P5454, DOI 10.1073/pnas.0509703103; Rashid ST, 2012, J PROTEOME RES, V11, P4052, DOI 10.1021/pr3000927; Reginensi A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003380; Rydell-Tormanen K, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12727; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Szeto SG, 2016, J AM SOC NEPHROL, V27, P3117, DOI 10.1681/ASN.2015050499; Tariq M, 2017, ACTA PHARMACOL SIN, V38, P1501, DOI 10.1038/aps.2017.124; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748; Varelas X, 2010, DEV CELL, V19, P831, DOI 10.1016/j.devcel.2010.11.012; Vuga LJ, 2009, AM J RESP CELL MOL, V41, P583, DOI 10.1165/rcmb.2008-0201OC; Wang XB, 2016, CELL METAB, V24, P848, DOI 10.1016/j.cmet.2016.09.016; Wong JS, 2016, AM J PHYSIOL-RENAL, V311, pF241, DOI 10.1152/ajprenal.00500.2015; Xu J, 2016, CLIN SCI, V130, P349, DOI 10.1042/CS20150385; Zhao F, 2018, IMMUNITY, V48, P147, DOI 10.1016/j.immuni.2017.12.004; Zhao Y, 2014, J BIOL CHEM, V289, P21028, DOI 10.1074/jbc.M113.546523; Zhou D, 2017, J AM SOC NEPHROL, V28, P2322, DOI 10.1681/ASN.2016080902	44	67	72	3	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2018	293	50					19290	19302		10.1074/jbc.RA118.005457	http://dx.doi.org/10.1074/jbc.RA118.005457			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HE6RA	30333225	hybrid, Green Published			2022-12-28	WOS:000453537300012
J	Paul, S; Ghosh, S; Mandal, S; Sau, S; Pal, M				Paul, Soumyadip; Ghosh, Suvranil; Mandal, Sukhendu; Sau, Subrata; Pal, Mahadeb			NRF2 transcriptionally activates the heat shock factor 1 promoter under oxidative stress and affects survival and migration potential of MCF7 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Heat shock factor protein 1 (HSF1); Nuclear factor 2 (erythroid-derived 2-like factor) (NFE2L2) (Nrf2); gene regulation; oxidative stress; breast cancer; antioxidant response element; transcription factor; transcriptional regulation; heat shock factor 1; NRF2; heat shock response; arsenic stress	HEAT-SHOCK FACTOR-1; MESENCHYMAL TRANSITION; ANTIOXIDANT RESPONSE; MOLECULAR CHAPERONES; HEME OXYGENASE-1; HSF1; GENE; INDUCTION; EXPRESSION; MUTATIONS	Functional up-regulation of heat shock factor 1 (HSF1) activity through different posttranslational modifications has been implicated in the survival and proliferation of various cancers. It is increasingly recognized that the HSF1 gene is also up-regulated at the transcriptional level, a phenomenon correlated with poor prognosis for patients with different cancers, including breast cancer. Here, we analyzed the transcriptional up-regulation of HSF1 in human cells upon arsenite- or peroxide-induced oxidative stress. Sequential promoter truncation coupled with bioinformatics analysis revealed that this activation is mediated by two antioxidant response elements (AREs) located between 1707 and 1530 bp upstream of the transcription start site of the HSF1 gene. Using shRNA-mediated down-regulation, ChIP of NRF2, site-directed mutagenesis of the AREs, and DNase I footprinting of the HSF1 promoter, we confirmed that nuclear factor erythroid-derived 2-like 2 (NRF2, also known as NFE2L2) interacts with these AREs and up-regulates HSF1 expression. We also found that BRM/SWI2-related gene 1 (BRG1), a catalytic subunit of SWI2/SNF2-like chromatin remodeler, is involved in this process. We further show that NRF2-dependent HSF1 gene regulation plays a crucial role in cancer cell biology, as interference with NRF2-mediated HSF1 activation compromised survival, migration potential, and the epithelial-to-mesenchymal transition and autophagy in MCF7 breast cancer cells exposed to oxidative stress. Taken together, our findings unravel the mechanistic basis of HSF1 gene regulation in cancer cells and provide molecular evidence supporting a direct interaction between HSF1 and NRF2, critical regulators of two cytoprotective mechanisms exploited by cancer cells.	[Paul, Soumyadip; Ghosh, Suvranil; Pal, Mahadeb] Bose Inst, Div Mol Med, P1-12 CIT Scheme VIIM, Kolkata 700054, India; [Mandal, Sukhendu; Sau, Subrata] Bose Inst, Dept Biochem, P1-12 CIT Scheme VIIM, Kolkata 700054, India	Department of Science & Technology (India); Bose Institute; Department of Science & Technology (India); Bose Institute	Pal, M (corresponding author), Bose Inst, Div Mol Med, P1-12 CIT Scheme VIIM, Kolkata 700054, India.	palmahadeb@gmail.com	Mandal, Sukhendu/AAX-6423-2021	Mandal, Sukhendu/0000-0002-7752-0982; GHOSH, SUVRANIL/0000-0002-0003-349X; Paul, Dr Soumyadip/0000-0001-5207-9425	Science and Engineering Research Board (SERB); Department of Biotechnology (DBT), Ministry of Science and Technology; Bose Institute plan program IV	Science and Engineering Research Board (SERB); Department of Biotechnology (DBT), Ministry of Science and Technology(Department of Biotechnology (DBT) India); Bose Institute plan program IV(Department of Science & Technology (India))	This work was supported by the Science and Engineering Research Board (SERB) and the Department of Biotechnology (DBT), Ministry of Science and Technology and Bose Institute plan program IV. The authors declare that they have no conflicts of interest with the contents of this article.	Almeida DV, 2010, FISH PHYSIOL BIOCHEM, V36, P347, DOI 10.1007/s10695-008-9299-x; Arfmann-Knubel S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132978; Calderwood SK, 2012, CURR MOL MED, V12, P1102, DOI 10.2174/156652412803306675; Carey Michael F, 2013, Cold Spring Harb Protoc, V2013, P469, DOI 10.1101/pdb.prot074328; Chorley BN, 2012, NUCLEIC ACIDS RES, V40, P7416, DOI 10.1093/nar/gks409; Creighton CJ, 2010, J MAMMARY GLAND BIOL, V15, P253, DOI 10.1007/s10911-010-9173-1; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Dai CK, 2012, J CELL PHYSIOL, V227, P2982, DOI 10.1002/jcp.24017; de la Vega MR, 2018, CANCER CELL, V34, P21, DOI 10.1016/j.ccell.2018.03.022; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Desai S, 2013, J BIOL CHEM, V288, P9165, DOI 10.1074/jbc.M112.422071; Dokladny K, 2015, AUTOPHAGY, V11, P200, DOI 10.1080/15548627.2015.1009776; Fang F, 2012, CANCER-AM CANCER SOC, V118, P1782, DOI 10.1002/cncr.26482; Fung C, 2008, MOL BIOL CELL, V19, P797, DOI 10.1091/mbc.E07-10-1092; Gokmen-Polar Y, 2016, ONCOTARGET, V7, P84239, DOI 10.18632/oncotarget.12438; Gravdal K, 2007, CLIN CANCER RES, V13, P7003, DOI 10.1158/1078-0432.CCR-07-1263; Gugnoni M, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.415; Guo YL, 2001, J BIOL CHEM, V276, P45791, DOI 10.1074/jbc.M105931200; Hahn JS, 2004, MOL CELL BIOL, V24, P5249, DOI 10.1128/MCB.24.12.5249-5256.2004; Hayes JD, 2014, TRENDS BIOCHEM SCI, V39, P199, DOI 10.1016/j.tibs.2014.02.002; Hazra J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168165; Hensen SMM, 2013, BIOCHIMIE, V95, P1245, DOI 10.1016/j.biochi.2013.01.017; Hirotsu Y, 2012, NUCLEIC ACIDS RES, V40, P10228, DOI 10.1093/nar/gks827; Imhoff BR, 2010, CELL BIOL TOXICOL, V26, P541, DOI 10.1007/s10565-010-9162-6; Ishiwata J, 2012, INT J ONCOL, V40, P47, DOI 10.3892/ijo.2011.1178; Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976; Jiang T, 2010, CANCER RES, V70, P5486, DOI 10.1158/0008-5472.CAN-10-0713; Katoh Y, 2001, GENES CELLS, V6, P857, DOI 10.1046/j.1365-2443.2001.00469.x; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kimura M, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706863200; Labbadia J, 2015, ANNU REV BIOCHEM, V84, P435, DOI 10.1146/annurev-biochem-060614-033955; Lau A, 2013, J BIOCHEM MOL TOXIC, V27, P99, DOI 10.1002/jbt.21463; Li J, 2017, TRENDS CELL BIOL, V27, P895, DOI 10.1016/j.tcb.2017.08.002; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Maines MD, 1996, BIOL REPROD, V54, P1070, DOI 10.1095/biolreprod54.5.1070; Malhotra D, 2010, NUCLEIC ACIDS RES, V38, P5718, DOI 10.1093/nar/gkq212; Manda G, 2015, REDOX BIOL, V5, P347, DOI 10.1016/j.redox.2015.06.014; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; McMahon M, 2010, P NATL ACAD SCI USA, V107, P18838, DOI 10.1073/pnas.1007387107; Meakin PJ, 2014, MOL CELL BIOL, V34, P3305, DOI [10.1128/MCB.00677-1, 10.1128/MCB.00677-14]; Moloney JN, 2018, SEMIN CELL DEV BIOL, V80, P50, DOI 10.1016/j.semcdb.2017.05.023; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Naidu SD, 2015, TRENDS PHARMACOL SCI, V36, P6, DOI 10.1016/j.tips.2014.10.011; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nelson VK, 2016, ONCOTARGET, V7, P78281, DOI 10.18632/oncotarget.12930; Nioi P, 2005, MOL CELL BIOL, V25, P10895, DOI 10.1128/MCB.25.24.10895-10906.2005; Padmanabhan B, 2006, MOL CELL, V21, P689, DOI 10.1016/j.molcel.2006.01.013; Panieri E, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.105; PRESTERA T, 1995, MOL MED, V1, P827, DOI 10.1007/BF03401897; Santagata S, 2011, P NATL ACAD SCI USA, V108, P18378, DOI 10.1073/pnas.1115031108; Sasi BK, 2014, J MOL BIOL, V426, P116, DOI 10.1016/j.jmb.2013.09.008; Sekine H, 2016, MOL CELL BIOL, V36, P407, DOI 10.1128/MCB.00785-15; Shamovsky I, 2008, CELL MOL LIFE SCI, V65, P855, DOI 10.1007/s00018-008-7458-y; Shi YH, 1998, GENE DEV, V12, P654, DOI 10.1101/gad.12.5.654; Shibata T, 2008, P NATL ACAD SCI USA, V105, P13568, DOI 10.1073/pnas.0806268105; Suzuki T, 2015, FREE RADICAL BIO MED, V88, P93, DOI 10.1016/j.freeradbiomed.2015.06.006; Taguchi K, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00085; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Tebay LE, 2015, FREE RADICAL BIO MED, V88, P108, DOI 10.1016/j.freeradbiomed.2015.06.021; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; Thomson S, 2004, MOL CELL, V15, P585, DOI 10.1016/j.molcel.2004.08.002; Trinklein ND, 2004, MOL BIOL CELL, V15, P1254, DOI 10.1091/mbc.E03-10-0738; Vihervaara A, 2014, J CELL SCI, V127, P261, DOI 10.1242/jcs.132605; Wakabayashi N, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000762; Wang XJ, 2007, TOXICOL APPL PHARM, V225, P206, DOI 10.1016/j.taap.2007.07.016; Wang XT, 2007, HUM MOL GENET, V16, P1188, DOI 10.1093/hmg/ddm066; Yoo NJ, 2012, HISTOPATHOLOGY, V60, P943, DOI 10.1111/j.1365-2559.2012.04178.x; Zhang JY, 2006, MOL CELL BIOL, V26, P7942, DOI 10.1128/MCB.00700-06; Zhang LF, 2011, PROTEOMICS, V11, P4638, DOI 10.1002/pmic.201100242	71	27	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2018	293	50					19303	19316		10.1074/jbc.RA118.003376	http://dx.doi.org/10.1074/jbc.RA118.003376			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HE6RA	30309986	hybrid, Green Published			2022-12-28	WOS:000453537300013
J	Serban, AJ; Breen, IL; Bui, HQ; Levitus, M; Wachter, RM				Serban, Andrew J.; Breen, Isabella L.; Bui, Hoang Q.; Levitus, Marcia; Wachter, Rebekka M.			Assembly-disassembly is coupled to the ATPase cycle of tobacco Rubisco activase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein aggregation; ribulose-1; 5-bisphosphate carboxylase; oxygenase (Rubisco); ATPases associated with diverse cellular activities (AAA); fluorescence correlation spectroscopy (FCS); protein assembly; carbon fixation; energy transduction; equilibrium constants; filament formation; site asymmetry; subunit exchange	RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE RUBISCO; HIGH-TEMPERATURE; IDENTIFICATION; SPECTROSCOPY; RECOGNITION; PROTEINS; RESIDUES; REVEALS; ENZYMES; DOMAIN	The carbon-fixing activity of enzyme ribulose-1,5-bisphosphate carboxylase/oxygenase (Rubisco) is regulated by Rubisco activase (Rca), a ring-forming ATPase that catalyzes inhibitor release. For higher plant Rca, the catalytic roles played by different oligomeric species have remained obscure. Here, we utilized fluorescence-correlation spectroscopy to estimate dissociation constants for the dimer-tetramer, tetramer-hexamer, hexamer-12-mer, and higher-order assembly equilibria of tobacco Rca. A comparison of oligomer composition with ATPase activity provided evidence that assemblies larger than hexamers are hydrolytically inactive. Therefore, supramolecular aggregates may serve as storage forms at low-energy charge. We observed that the tetramer accumulates only when both substrate and product nucleotides are bound. During rapid ATP turnover, about one in six active sites was occupied by ADP, and approximate to 36% of Rca was tetrameric. The steady-state catalytic rate reached a maximum between 0.5 and 2.5 m Rca. In this range, significant amounts of dimers, tetramers, and hexamers coexisted, although none could fully account for the observed activity profile. Therefore, we propose that dynamic assembly-disassembly partakes in the ATPase cycle. According to this model, the association of dimers with tetramers generates a hexamer that forms a closed ring at high ATP and magnesium levels. Upon hydrolysis and product release, the toroid breaks open and dissociates into a dimer and tetramer, which may be coupled to Rubisco remodeling. Although a variant bearing the R294V substitution assembled in much the same way, highly stabilized states could be generated by binding of a transition-state analog. A tight-binding pre-hydrolysis state appears to become more accessible in thermally labile Rcas.	[Serban, Andrew J.; Breen, Isabella L.; Bui, Hoang Q.; Levitus, Marcia; Wachter, Rebekka M.] Arizona State Univ, Sch Mol Sci, Tempe, AZ 85287 USA; [Serban, Andrew J.; Breen, Isabella L.; Bui, Hoang Q.; Wachter, Rebekka M.] Arizona State Univ, Ctr Bioenergy & Photosynth, Tempe, AZ 85287 USA; [Serban, Andrew J.; Breen, Isabella L.; Bui, Hoang Q.; Wachter, Rebekka M.] Arizona State Univ, Biodesign Ctr Appl Struct Discovery, Tempe, AZ 85287 USA; [Levitus, Marcia] Arizona State Univ, Biodesign Ctr Single Mol Biophys, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Levitus, M; Wachter, RM (corresponding author), Arizona State Univ, Sch Mol Sci, Tempe, AZ 85287 USA.; Wachter, RM (corresponding author), Arizona State Univ, Ctr Bioenergy & Photosynth, Tempe, AZ 85287 USA.; Wachter, RM (corresponding author), Arizona State Univ, Biodesign Ctr Appl Struct Discovery, Tempe, AZ 85287 USA.; Levitus, M (corresponding author), Arizona State Univ, Biodesign Ctr Single Mol Biophys, Tempe, AZ 85287 USA.	mlevitus@asu.edu; rwachter@asu.edu	Wachter, Rebekka/A-7772-2015	Wachter, Rebekka/0000-0002-4693-4488	United States Department of Energy Office of Basic Energy Sciences and Photosynthetic Systems [DE-FG02-09-ER16123]	United States Department of Energy Office of Basic Energy Sciences and Photosynthetic Systems	This work was supported by a grant from the United States Department of Energy Office of Basic Energy Sciences and Photosynthetic Systems Grant DE-FG02-09-ER16123 (to R. M. W. and M. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Andersson I, 2008, J EXP BOT, V59, P1555, DOI 10.1093/jxb/ern091; Baker RT, 2005, METHOD ENZYMOL, V398, P540, DOI 10.1016/S0076-6879(05)98044-0; Bhat JY, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00020; Bracher A, 2017, ANNU REV PLANT BIOL, V68, P29, DOI 10.1146/annurev-arplant-043015-111633; Bracher A, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2014.2, 10.1038/nplants.2014.2]; Carmo-Silva AE, 2013, PLANT PHYSIOL, V161, P1645, DOI 10.1104/pp.112.213348; Catanzariti AM, 2004, PROTEIN SCI, V13, P1331, DOI 10.1110/ps.04618904; Chakraborty M, 2012, BIOPHYS J, V103, P949, DOI 10.1016/j.bpj.2012.07.034; CHATELIER RC, 1987, BIOPHYS CHEM, V28, P121, DOI 10.1016/0301-4622(87)80081-9; Gendron PO, 2008, J FLUORESC, V18, P1093, DOI 10.1007/s10895-008-0357-7; Hasse D, 2015, ACTA CRYSTALLOGR D, V71, P800, DOI 10.1107/S1399004715001182; Hayer-Hartl M, 2017, PROTEIN SCI, V26, P2324, DOI 10.1002/pro.3309; Hazra S, 2015, J BIOL CHEM, V290, P24222, DOI 10.1074/jbc.M115.651745; Henderson JN, 2013, BBA-PROTEINS PROTEOM, V1834, P87, DOI 10.1016/j.bbapap.2012.09.006; Henderson JN, 2011, J BIOL CHEM, V286, P35683, DOI 10.1074/jbc.C111.289595; Kanno DM, 2014, J PHYS CHEM B, V118, P12404, DOI 10.1021/jp507741r; Keown JR, 2014, BIOCHEM J, V464, P413, DOI 10.1042/BJ20140676; Keown JR, 2013, J BIOL CHEM, V288, P20607, DOI 10.1074/jbc.M113.466383; Kuriata AM, 2014, BIOCHEMISTRY-US, V53, P7232, DOI 10.1021/bi500968h; Li CH, 2005, J BIOL CHEM, V280, P24864, DOI 10.1074/jbc.M503547200; Li CS, 2006, ARCH BIOCHEM BIOPHYS, V450, P176, DOI 10.1016/j.abb.2006.04.002; Mueller-Cajar O, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00031; Mueller-Cajar O, 2011, NATURE, V479, P194, DOI 10.1038/nature10568; Olivares AO, 2016, NAT REV MICROBIOL, V14, P33, DOI 10.1038/nrmicro.2015.4; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Parry MAJ, 2013, J EXP BOT, V64, P717, DOI 10.1093/jxb/ers336; Perdomo JA, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00490; Peterson-Forbrook DS, 2017, BIOCHEMISTRY-US, V56, P4906, DOI 10.1021/acs.biochem.7b00574; Portis AR, 2003, PHOTOSYNTH RES, V75, P11, DOI 10.1023/A:1022458108678; Portis AR, 2008, J EXP BOT, V59, P1597, DOI 10.1093/jxb/erm240; Rodriguez-Aliaga P, 2016, NAT STRUCT MOL BIOL, V23, P974, DOI 10.1038/nsmb.3298; Scales JC, 2014, PHOTOSYNTH RES, V119, P355, DOI 10.1007/s11120-013-9964-5; Sharkey TD, 2010, J INTEGR PLANT BIOL, V52, P712, DOI 10.1111/j.1744-7909.2010.00975.x; Shivhare D, 2017, PLANT PHYSIOL, V174, P1505, DOI 10.1104/pp.17.00554; Snider J, 2008, BIOCHEM SOC T, V36, P72, DOI 10.1042/BST0360072; Stotz M, 2011, NAT STRUCT MOL BIOL, V18, P1366, DOI 10.1038/nsmb.2171; Sutter M, 2015, SCI REP-UK, V5, DOI 10.1038/srep16243; Tsai YCC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9883; vandeLoo FJ, 1996, BIOCHEMISTRY-US, V35, P8143, DOI 10.1021/bi9604901; Wachter RM, 2013, PHOTOSYNTH RES, V117, P557, DOI 10.1007/s11120-013-9827-0; Wang Q, 2018, J CHEM PHYS, V148, DOI 10.1063/1.5005930	42	7	7	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2018	293	50					19451	19465		10.1074/jbc.RA118.005047	http://dx.doi.org/10.1074/jbc.RA118.005047			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HE6RA	30352875	Green Published, hybrid			2022-12-28	WOS:000453537300025
J	Singh, SS; Naiyer, S; Bharadwaj, R; Kumar, A; Singh, YP; Ray, AK; Subbarao, N; Bhattacharya, A; Bhattacharya, S				Singh, Shashi Shekhar; Naiyer, Sarah; Bharadwaj, Ravi; Kumar, Amarjeet; Singh, Yatendra Pratap; Ray, Ashwini Kumar; Subbarao, Naidu; Bhattacharya, Alok; Bhattacharya, Sudha			Stress-induced nuclear depletion of Entamoeba histolytica 3 '-5 ' exoribonuclease EhRrp6 and its role in growth and erythrophagocytosis (vol 293, pg 16242, 2018)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Bharadwaj, Ravi/ABE-6055-2021; Subbarao, Prof Naidu/AAZ-1832-2020	Subbarao, Prof Naidu/0000-0002-1720-2165	DST-PURSE	DST-PURSE	This work was supported in part by DST-PURSE (to N. S.).	Singh SS, 2018, J BIOL CHEM, V293, P16242, DOI [10.1074/jbc.RA118.004632, 10.1074/jbc.ra118.004632]	1	0	0	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2018	293	50					19510	19510		10.1074/jbc.AAC118.006754	http://dx.doi.org/10.1074/jbc.AAC118.006754			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HE6RA	30552115	hybrid, Green Published			2022-12-28	WOS:000453537300030
J	Wang, J; Yan, CS; Xu, CQ; Chua, BT; Li, P; Chen, FJ				Wang, Jia; Yan, Chengsong; Xu, Chenqi; Chua, Boon Tin; Li, Peng; Chen, Feng-Jung			Polybasic RKKR motif in the linker region of lipid droplet (LD)-associated protein CIDEC inhibits LD fusion activity by interacting with acidic phospholipids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lipid metabolism; lipid droplet; adipose tissue; lipid-protein interaction; phospholipid; CIDEC; inhibitory regulation; lipid droplet fusion; lipid storage; polybasic RKKR motif	FAT STORAGE; BINDING; MEMBRANE; GROWTH; DOMAIN; REVEALS; FAMILY; ER; ACTIVATION; RESISTANT	Lipid droplets (LDs) are intracellular organelles and a central site for lipid synthesis, storage, and mobilization. The size of LDs reflects the dynamic regulation of lipid metabolism in cells. Previously, we found that cell death-inducing DFFA-like effector C (CIDEC) mediates LD fusion and growth by lipid transfer through LD-LD contact sites in adipocytes and hepatocytes. The CIDE-N domains of CIDEC molecules form homodimers, whereas the CIDE-C domain plays an important role in LD targeting and enrichment. Here, using targeted protein deletions and GFP expression coupled with fluorescence microscopy, we identified a polybasic RKKR motif in the linker region that connects the CIDE-N and CIDE-C domains of CIDEC and functions as a regulatory motif for LD fusion. We found that deletion of the linker region or mutation of the RKKR motif increases the formation of supersized LDs compared with LD formation in cells with WT CIDEC. This enhanced LD fusion activity required the interaction between CIDE-N domains. Mechanistically, we found that the RKKR motif interacts with acidic phospholipids via electrostatic attraction. Loss of this motif disrupted the protein-lipid interaction, resulting in enhanced lipid droplet fusion activity and thus formation of larger LDs. In summary, we have uncovered a CIDEC domain that regulates LD fusion activity, a finding that provides insights into the inhibitory regulation of LD fusion through CIDEC-lipid interactions.	[Wang, Jia; Li, Peng; Chen, Feng-Jung] Tsinghua Univ, Sch Life Sci, State Key Lab Membrane Biol, Beijing 100084, Peoples R China; [Wang, Jia; Li, Peng; Chen, Feng-Jung] Tsinghua Univ, Sch Life Sci, Tsinghua Peking Ctr Life Sci, Beijing Adv Innovat Ctr Struct Biol, Beijing 100084, Peoples R China; [Yan, Chengsong; Xu, Chenqi] Chinese Acad Sci, Univ Chinese Acad Sci, State Key Lab Mol Biol,Shanghai Inst Biochem & Ce, Shanghai Sci Res Ctr,Ctr Excellence Mol Cell Sci, 320 Yueyang Rd, Shanghai 200031, Peoples R China; [Chua, Boon Tin; Chen, Feng-Jung] Fudan Univ, Inst Metab & Integrat Biol, Shanghai 200438, Peoples R China	Tsinghua University; Tsinghua University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Fudan University	Li, P; Chen, FJ (corresponding author), Tsinghua Univ, Sch Life Sci, State Key Lab Membrane Biol, Beijing 100084, Peoples R China.; Li, P; Chen, FJ (corresponding author), Tsinghua Univ, Sch Life Sci, Tsinghua Peking Ctr Life Sci, Beijing Adv Innovat Ctr Struct Biol, Beijing 100084, Peoples R China.; Chen, FJ (corresponding author), Fudan Univ, Inst Metab & Integrat Biol, Shanghai 200438, Peoples R China.	li-peng@mail.tsinghua.edu.cn; derrick.eo93g@gmail.com		Wang, Jia/0000-0002-8356-464X	National Basic Research Program [2018YFA0506901, 2016YFA0502002]; National Natural Science Foundation of China [31430040, 31690103, 31621063]	National Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program Grants 2018YFA0506901 and 2016YFA0502002 (to P. L.) and National Natural Science Foundation of China Grants 31430040, 31690103, and 31621063 (to P. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Aguilar HC, 2007, J VIROL, V81, P4520, DOI 10.1128/JVI.02205-06; Barneda D, 2015, ELIFE, V4, DOI 10.7554/eLife.07485; Bartz R, 2007, J LIPID RES, V48, P837, DOI 10.1194/jlr.M600413-JLR200; Boroda S, 2017, J BIOL CHEM, V292, P20481, DOI 10.1074/jbc.M117.786574; Chitraju C, 2012, J LIPID RES, V53, P2141, DOI 10.1194/jlr.M028902; Choudhary V, 2015, J CELL BIOL, V211, P261, DOI 10.1083/jcb.201505067; Fairn GD, 2011, J CELL BIOL, V194, P257, DOI 10.1083/jcb.201012028; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; Fei WH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002201; Fujimoto Y, 2007, J LIPID RES, V48, P1280, DOI 10.1194/jlr.M700050-JLR200; Gambhir A, 2004, BIOPHYS J, V86, P2188, DOI 10.1016/S0006-3495(04)74278-2; Gao GG, 2017, BBA-MOL CELL BIOL L, V1862, P1197, DOI 10.1016/j.bbalip.2017.06.009; Gong JY, 2011, J CELL BIOL, V195, P953, DOI 10.1083/jcb.201104142; Gong JY, 2009, CURR OPIN LIPIDOL, V20, P121, DOI 10.1097/MOL.0b013e328328d0bb; Greenberg AS, 2011, J CLIN INVEST, V121, P2102, DOI 10.1172/JCI46069; Gross DA, 2014, CRIT REV BIOCHEM MOL, V49, P304, DOI 10.3109/10409238.2014.931337; Gross DA, 2011, P NATL ACAD SCI USA, V108, P19581, DOI 10.1073/pnas.1110817108; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Inohara N, 1998, EMBO J, V17, P2526, DOI 10.1093/emboj/17.9.2526; Jack ER, 2008, MOL MEMBR BIOL, V25, P14, DOI 10.1080/09687680701494007; Jacquier N, 2011, J CELL SCI, V124, P2424, DOI 10.1242/jcs.076836; Jambunathan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028614; Kaadige MR, 2006, J BIOL CHEM, V281, P28831, DOI 10.1074/jbc.M605624200; Keller P, 2008, J BIOL CHEM, V283, P14355, DOI 10.1074/jbc.M708323200; Khandelia H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012811; Krahmer N, 2013, EMBO MOL MED, V5, P973, DOI 10.1002/emmm.201100671; Krahmer N, 2011, CELL METAB, V14, P504, DOI 10.1016/j.cmet.2011.07.013; Lee SM, 2013, BIOCHEM BIOPH RES CO, V439, P564, DOI 10.1016/j.bbrc.2013.09.018; Li JZ, 2007, DIABETES, V56, P2523, DOI 10.2337/db07-0040; Li LY, 2014, TRENDS BIOCHEM SCI, V39, P130, DOI 10.1016/j.tibs.2014.01.002; Liu L, 2015, CELL, V160, P177, DOI 10.1016/j.cell.2014.12.019; Modha R, 2008, J BIOL CHEM, V283, P1492, DOI 10.1074/jbc.M706760200; Murray DH, 2009, BIOCHEMISTRY-US, V48, P4617, DOI 10.1021/bi9003217; Nian ZQ, 2010, J BIOL CHEM, V285, P9604, DOI 10.1074/jbc.M109.043786; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Ohsaki Y, 2008, J CELL SCI, V121, P2415, DOI 10.1242/jcs.025452; Qian H, 2017, J CLIN INVEST, V127, P1353, DOI 10.1172/JCI85963; Rajamoorthi A, 2018, ATHEROSCLEROSIS, V275, P43, DOI 10.1016/j.atherosclerosis.2018.05.045; Rajamoorthi A, 2017, J LIPID RES, V58, P2127, DOI 10.1194/jlr.M077941; Rubio-Cabezas O, 2009, EMBO MOL MED, V1, P280, DOI 10.1002/emmm.200900037; Sengupta P, 2009, BIOPHYS J, V96, P4887, DOI 10.1016/j.bpj.2009.03.027; Sun ZQ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2581; Thiam AR, 2013, NAT REV MOL CELL BIO, V14, P775, DOI 10.1038/nrm3699; Toh SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002890; Wu LZ, 2014, DEV CELL, V30, P378, DOI 10.1016/j.devcel.2014.07.005; Xu CQ, 2008, CELL, V135, P702, DOI 10.1016/j.cell.2008.09.044; Xu DJ, 2018, J CELL BIOL, V217, P975, DOI 10.1083/jcb.201704184; Xu L, 2012, ARTERIOSCL THROM VAS, V32, P1094, DOI 10.1161/ATVBAHA.111.241489; Xu WY, 2016, J BIOL CHEM, V291, P4282, DOI 10.1074/jbc.M115.701094; Ye J, 2009, CELL METAB, V9, P177, DOI 10.1016/j.cmet.2008.12.013; Zanghellini J, 2010, J THEOR BIOL, V264, P952, DOI 10.1016/j.jtbi.2010.02.025; Zhang LJ, 2014, J LIPID RES, V55, P1279, DOI 10.1194/jlr.M046482; Zhang SS, 2014, MOL CELL BIOL, V34, P1827, DOI 10.1128/MCB.01723-13; Zhang WY, 2003, J BIOL CHEM, V278, P21459, DOI 10.1074/jbc.M301652200; Zhou LK, 2012, HEPATOLOGY, V56, P95, DOI 10.1002/hep.25611; Zhou ZH, 2003, NAT GENET, V35, P49, DOI 10.1038/ng1225	56	5	5	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2018	293	50					19330	19343		10.1074/jbc.RA118.004892	http://dx.doi.org/10.1074/jbc.RA118.004892			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HE6RA	30361435	hybrid, Green Published			2022-12-28	WOS:000453537300015
J	Camilleri, ET; Dudakovic, A; Riester, SM; Galeano-Garces, C; Paradise, CR; Bradley, EW; McGee-Lawrence, ME; Im, HJ; Karperien, M; Krych, AJ; Westendorf, JJ; Larson, AN; van Wijnen, AJ				Camilleri, Emily T.; Dudakovic, Amel; Riester, Scott M.; Galeano-Garces, Catalina; Paradise, Christopher R.; Bradley, Elizabeth W.; McGee-Lawrence, Meghan E.; Im, Hee-Jeong; Karperien, Marcel; Krych, Aaron J.; Westendorf, Jennifer J.; Larson, A. Noelle; van Wijnen, Andre J.			Loss of histone methyltransferase Ezh2 stimulates an osteogenic transcriptional program in chondrocytes but does not affect cartilage development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-FORMATION; SKELETAL GROWTH; CRE RECOMBINASE; DIFFERENTIATION; EXPRESSION; OSTEOARTHRITIS; PROLIFERATION; SPECIFICATION; INHIBITION; CHROMATIN	Ezh2 is a histone methyltransferase that suppresses osteoblast maturation and skeletal development. We evaluated the role of Ezh2 in chondrocyte lineage differentiation and endochondral ossification. Ezh2 was genetically inactivated in the mesenchymal, osteoblastic, and chondrocytic lineages in mice using the Prrx1-Cre, Osx1-Cre, and Col2a1-Cre drivers, respectively. WT and conditional knockout mice were phenotypically assessed by gross morphology, histology, and micro-CT imaging. Ezh2-deficient chondrocytes in micromass culture models were evaluated using RNA-Seq, histologic evaluation, and Western blotting. Aged mice with Ezh2 deficiency were also evaluated for premature development of osteoarthritis using radiographic analysis. Ezh2 deficiency in murine chondrocytes reduced bone density at 4 weeks of age but caused no other gross developmental effects. Knockdown of Ezh2 in chondrocyte micromass cultures resulted in a global reduction in trimethylation of histone 3 lysine 27 (H3K27me3) and altered differentiation in vitro. RNA-Seq analysis revealed enrichment of an osteogenic gene expression profile in Ezh2-deficient chondrocytes. Joint development proceeded normally in the absence of Ezh2 in chondrocytes without inducing excessive hypertrophy or premature osteoarthritis in vivo. In summary, loss of Ezh2 reduced H3K27me3 levels, increased the expression of osteogenic genes in chondrocytes, and resulted in a transient post-natal bone phenotype. Remarkably, Ezh2 activity is dispensable for normal chondrocyte maturation and endochondral ossification in vivo, even though it appears to have a critical role during early stages of mesenchymal lineage commitment.	[Camilleri, Emily T.; Dudakovic, Amel; Riester, Scott M.; Galeano-Garces, Catalina; Paradise, Christopher R.; Bradley, Elizabeth W.; Krych, Aaron J.; Westendorf, Jennifer J.; Larson, A. Noelle; van Wijnen, Andre J.] Mayo Clin, Dept Orthoped Surg, Rochester, MN 55901 USA; [Paradise, Christopher R.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55901 USA; [Westendorf, Jennifer J.; van Wijnen, Andre J.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55901 USA; [McGee-Lawrence, Meghan E.] Augusta Univ, Med Coll Georgia, Dept Cellular Biol & Anat, Augusta, GA 30912 USA; [Im, Hee-Jeong] Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA; [Karperien, Marcel] Univ Twente, Dept Dev BioEngn, NL-7522 NB Enschede, Netherlands; [Camilleri, Emily T.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; University System of Georgia; Augusta University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; University of Twente; University of Minnesota System; University of Minnesota Twin Cities	van Wijnen, AJ (corresponding author), Mayo Clin, Dept Orthoped Surg, Med Sci Bldg,Rm 3-69,200 1st St SW, Rochester, MN 55905 USA.	vanwijnen.andre@mayo.edu	Larson, A. Noelle/AAC-7158-2019; van Wijnen, Andre J./AAG-3578-2019; Galeano-Garces, Catalina/I-9155-2019; Karperien, Marcel/R-3270-2018	van Wijnen, Andre J./0000-0002-4458-0946; Karperien, Marcel/0000-0003-0751-0604; Camilleri, Emily/0000-0001-8982-6770; Dudakovic, Amel/0000-0002-8850-3977; Krych, Aaron/0000-0003-3248-8007; Bradley, Elizabeth/0000-0002-8814-5524	National Institutes of Health [R01 AR049069, R03 AR066342, F32 AR066508, K01 AR065397, R01 AR068103]; Center for Regenerative Medicine at the Mayo Clinic and Mayo Graduate School (Clinical and Translational Sciences Track); Center for Clinical and Translational Science [UL1 TR000135]; NIAMS; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR066508, R03AR066342, R01AR049069, R01AR068103, K01AR065397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Regenerative Medicine at the Mayo Clinic and Mayo Graduate School (Clinical and Translational Sciences Track); Center for Clinical and Translational Science; NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NIAMS, National Institutes of Health Grants R01 AR049069 (to A. J. v. W.), R03 AR066342 (to A. N. L.), F32 AR066508 (to A. D.), K01 AR065397 (to E. W. B.), and R01 AR068103 (to J. J. W.) as well as by intramural grants from the Center for Regenerative Medicine at the Mayo Clinic and Mayo Graduate School (Clinical and Translational Sciences Track) and the Center for Clinical and Translational Science (UL1 TR000135). We also appreciate generous philanthropic support from William H. and Karen J. Eby and the charitable foundation in their name. A. J. K. is a paid consultant for Arthrex, Inc., and M. K. is a founder and chair holder of Hy2Care B.V. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arrowsmith CH, 2012, NAT REV DRUG DISCOV, V11, P384, DOI 10.1038/nrd3674; Barter MJ, 2012, OSTEOARTHR CARTILAGE, V20, P339, DOI 10.1016/j.joca.2011.12.012; Bradley EW, 2015, PHYSIOL REV, V95, P1359, DOI 10.1152/physrev.00004.2015; Bradley EW, 2015, J BIOL CHEM, V290, P118, DOI 10.1074/jbc.M114.596247; Bradley EW, 2013, J BIOL CHEM, V288, P9572, DOI 10.1074/jbc.M112.423723; Camilleri ET, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0370-8; Caplan AI, 2016, J CELL PHYSIOL, V231, P1413, DOI 10.1002/jcp.25255; Carpio LR, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf3273; Chen LW, 2016, SCI REP-UK, V6, DOI 10.1038/srep29176; Cohen ASA, 2016, HUM MUTAT, V37, P301, DOI 10.1002/humu.22946; Deng ZL, 2008, FRONT BIOSCI-LANDMRK, V13, P2001, DOI 10.2741/2819; Dudakovic A, 2018, J BIOL CHEM, V293, P12894, DOI 10.1074/jbc.RA118.002983; Dudakovic A, 2017, GENE, V609, P28, DOI 10.1016/j.gene.2017.01.019; Dudakovic A, 2015, J BIOL CHEM, V290, P27604, DOI 10.1074/jbc.M115.672345; Dudakovic A, 2015, J CELL PHYSIOL, V230, P52, DOI 10.1002/jcp.24680; Dudakovic A, 2014, J CELL BIOCHEM, V115, P1816, DOI 10.1002/jcb.24852; Dudakovic A, 2013, J BIOL CHEM, V288, P28783, DOI 10.1074/jbc.M113.489732; Fang C, 2016, J IMMUNOL, V196, P4452, DOI 10.4049/jimmunol.1501466; Goldring MB, 2012, TRENDS MOL MED, V18, P109, DOI 10.1016/j.molmed.2011.11.005; Gordon JAR, 2015, BONE, V81, P739, DOI 10.1016/j.bone.2015.03.011; Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95; Hemming S, 2017, FASEB J, V31, P1011, DOI 10.1096/fj.201600748R; Hemming S, 2016, STEM CELLS DEV, V25, P909, DOI 10.1089/scd.2015.0384; Hemming S, 2014, STEM CELLS, V32, P802, DOI 10.1002/stem.1573; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ideno H, 2013, GENE EXPR PATTERNS, V13, P84, DOI 10.1016/j.gep.2013.01.002; Jing H, 2016, MOL THER, V24, P217, DOI 10.1038/mt.2015.152; Khani F, 2017, J CELL BIOCHEM, V118, P1262, DOI 10.1002/jcb.25787; Lawson KA, 2013, J BIOL CHEM, V288, P32119, DOI 10.1074/jbc.M113.473827; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Lui JC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13685; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; Meyer MB, 2016, J BIOL CHEM, V291, P17829, DOI 10.1074/jbc.M116.736538; Mirzamohammadi F, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12047; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Nakatani T, 2016, BONE, V90, P142, DOI 10.1016/j.bone.2016.06.010; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Ovchinnikov DA, 2000, GENESIS, V26, P145, DOI 10.1002/(SICI)1526-968X(200002)26:2<145::AID-GENE14>3.0.CO;2-C; Pike JW, 2015, BONE, V81, P757, DOI 10.1016/j.bone.2015.03.012; Riester SM, 2017, STEM CELL TRANSL MED, V6, P910, DOI 10.5966/sctm.2016-0097; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwarz D, 2014, DEVELOPMENT, V141, P867, DOI 10.1242/dev.094342; Spaapen F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058083; Wang HR, 2016, SCI REP-UK, V6, DOI 10.1038/srep36988; Wu H, 2017, BBA-GENE REGUL MECH, V1860, P438, DOI 10.1016/j.bbagrm.2017.01.003; Wyngaarden LA, 2011, DEVELOPMENT, V138, P3759, DOI 10.1242/dev.063180; Zhang F, 2015, J MOL CELL BIOL, V7, P23, DOI 10.1093/jmcb/mjv003	49	33	34	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2018	293	49					19001	19011		10.1074/jbc.RA118.003909	http://dx.doi.org/10.1074/jbc.RA118.003909			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NY	30327434	Green Published, hybrid			2022-12-28	WOS:000458467400015
J	Leng, F; Saxena, L; Hoang, N; Zhang, CX; Lee, L; Li, WJ; Gong, XS; Lu, F; Sun, H; Zhang, H				Leng, Feng; Saxena, Lovely; Hoang, Nam; Zhang, Chunxiao; Lee, Logan; Li, Wenjing; Gong, Xiaoshan; Lu, Fei; Sun, Hong; Zhang, Hui			Proliferating cell nuclear antigen interacts with the CRL4 ubiquitin ligase subunit CDT2 in DNA synthesis-induced degradation of CDT1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE INHIBITOR XIC1; PROTEOLYSIS; PCNA; REPLICATION; PROTEINS; DESTRUCTION; CUL4-ROC1; COMPLEX	During DNA replication or repair, the DNA polymerase cofactor, proliferating cell nuclear antigen (PCNA), homotrimerizes and encircles the replicating DNA, thereby acting as a DNA clamp that promotes DNA polymerase processivity. The formation of the PCNA trimer is also essential for targeting the replication-licensing protein, chromatin-licensing, and DNA replication factor 1 (CDT1), for ubiquitin-dependent proteolysis to prevent chromosomal DNA re-replication. CDT1 uses its PCNA-interacting peptide box (PIP box) to interact with PCNA, and the CRL4 E3 ubiquitin ligase subunit CDT2 is recruited through the formation of PCNA-CDT1 complexes. However, it remains unclear how CDT1 and many other PIP box-containing proteins are marked for degradation by the CRL4(CDT2) ubiquitin ligase during DNA replication or damage. Here, using recombinant protein expression coupled with site-directed mutagenesis, we report that CDT2 and PCNA directly interact and this interaction depends on the presence of a highly conserved, C-terminal PIP box-like region in CDT2. Deletion or mutation of this region abolished the CDT2-PCNA interaction between CDT2 and PCNA both in vitro and in vivo. Moreover, PCNA-dependent CDT1 degradation in response to DNA damage and replication during the cell cycle requires an intact PIP box in CDT2. The requirement of the PIP boxes in both CDT2 and its substrate CDT1 suggests that the formation of the PCNA trimeric clamp around DNA during DNA replication and repair may bring together CDT1 and CRL4(CDT2) ubiquitin E3 ligase to target CDT1 for proteolysis in a DNA synthesis-dependent manner.	[Leng, Feng; Zhang, Chunxiao; Li, Wenjing; Lu, Fei] Peking Univ, Shenzhen Grad Sch, Sch Chem Biol & Biotechnol, Shenzhen 518055, Guangdong, Peoples R China; [Leng, Feng; Saxena, Lovely; Hoang, Nam; Zhang, Chunxiao; Lee, Logan; Li, Wenjing; Gong, Xiaoshan; Sun, Hong; Zhang, Hui] Univ Nevada, Dept Chem & Biochem, Las Vegas, NV 89154 USA	Peking University; University Town of Shenzhen; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Zhang, H (corresponding author), 4505 S Maryland Pkwy,SEB 4138, Las Vegas, NV 89154 USA.	hui.zhang@unlv.edu	zhang, chunxiao/AAH-3229-2019; Leng, Feng/AAP-7294-2020	Zhang, Chunxiao/0000-0001-5543-4509; Li, Wenjing/0000-0001-9151-9219; Zhang, Hui/0000-0001-6028-2554; Sun, Hong/0000-0003-2100-1451	National Institutes of Health [R15 NS096694, R15GM116087, R15GM131255]; Cancer Research Gift Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM116087, R15GM131255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS096694] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Gift Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants R15 NS096694 (to H. S.), R15GM116087 and R15GM131255 (to H. Z.) and the Cancer Research Gift Fund to the College of Sciences at University of Nevada, Las Vegas (to H. S. and H. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Arias EE, 2006, NAT CELL BIOL, V8, P84, DOI 10.1038/ncb1346; Arias EE, 2007, GENE DEV, V21, P497, DOI 10.1101/gad.1508907; Chuang LC, 2005, J BIOL CHEM, V280, P35299, DOI 10.1074/jbc.M506429200; Gilljam KM, 2009, J CELL BIOL, V186, P645, DOI 10.1083/jcb.200903138; Havens CG, 2012, J BIOL CHEM, V287, P11410, DOI 10.1074/jbc.M111.337683; He YZJ, 2006, GENE DEV, V20, P2949, DOI 10.1101/gad.1483206; Higa LA, 2006, CELL CYCLE, V5, P71, DOI 10.4161/cc.5.1.2266; Higa LAA, 2003, NAT CELL BIOL, V5, P1008, DOI 10.1038/ncb1061; Higa LA, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-5; Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490; Higa LA, 2006, CELL CYCLE, V5, P1675, DOI 10.4161/cc.5.15.3149; Jackson S, 2009, TRENDS BIOCHEM SCI, V34, P562, DOI 10.1016/j.tibs.2009.07.002; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Kim DH, 2010, MOL CELL BIOL, V30, P4120, DOI 10.1128/MCB.01135-09; Lu F, 2016, BIOL OPEN, V5, P1449, DOI 10.1242/bio.019729; Mailand N, 2013, NAT REV MOL CELL BIO, V14, P269, DOI 10.1038/nrm3562; Mihaylov IS, 2002, MOL CELL BIOL, V22, P1868, DOI 10.1128/MCB.22.6.1868-1880.2002; Pacaud R, 2014, SCI REP-UK, V4, DOI 10.1038/srep04230; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Qin WH, 2011, NUCLEUS-PHILA, V2, P392, DOI 10.4161/nucl.2.5.17928; Senga T, 2006, J BIOL CHEM, V281, P6246, DOI 10.1074/jbc.M512705200; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; Yin F, 2014, MOL CELL BIOL, V34, P158, DOI 10.1128/MCB.00631-13; Zhang CX, 2018, J BIOL CHEM, V293, P3663, DOI 10.1074/jbc.RA117.000342; Zhang XM, 2013, CELL REP, V5, P445, DOI 10.1016/j.celrep.2013.09.018	26	11	11	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2018	293	49					18879	18889		10.1074/jbc.RA118.003049	http://dx.doi.org/10.1074/jbc.RA118.003049			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NY	30301766	Green Published, hybrid			2022-12-28	WOS:000458467400006
J	Choi, E; Hwang, J				Choi, Eunsil; Hwang, Jihwan			The GTPase BipA expressed at low temperature in Escherichia coli assists ribosome assembly and has chaperone-like activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Escherichia coli (E. coli); ribosome assembly; GTPase; cyclic AMP (cAMP); chaperone; cold adaptation; CRP	CATABOLITE ACTIVATOR PROTEIN; EF-G; SHOCK RESPONSE; G-DOMAIN; IN-VIVO; GENE; TRANSCRIPTION; BINDING; PPGPP; RNA	BPI-inducible protein A (BipA) is a conserved ribosome-associated GTPase in bacteria that is structurally similar to other GTPases associated with protein translation, including IF2, EF-Tu, and EF-G. Its binding site on the ribosome appears to overlap those of these translational GTPases. Mutations in the bipA gene cause a variety of phenotypes, including cold and antibiotics sensitivities and decreased pathogenicity, implying that BipA may participate in diverse cellular processes by regulating translation. According to recent studies, a bipA-deletion strain of Escherichia coli displays a ribosome assembly defect at low temperature, suggesting that BipA might be involved in ribosome assembly. To further investigate BipA's role in ribosome biogenesis, here, we compared and analyzed the ribosomal protein compositions of MG1655 WT and bipA-deletion strains at 20 degrees C. Aberrant 50S ribosomal subunits (i.e. 44S particles) accumulated in the bipA-deletion strain at 20 degrees C, and the ribosomal protein L6 was absent in these 44S particles. Furthermore, bipA expression was significantly stimulated at 20 degrees C, suggesting that it encodes a cold shock-inducible GTPase. Moreover, the transcriptional regulator cAMP receptor protein (CRP) positively promoted bipA expression only at 20 degrees C. Importantly, GFP and -glucosidase refolding assays revealed that BipA has chaperone activity. Our findings indicate that BipA is a cold shock-inducible GTPase that participates in 50S ribosomal subunit assembly by incorporating the L6 ribosomal protein into the 44S particle during the assembly.	[Choi, Eunsil; Hwang, Jihwan] Pusan Natl Univ, Dept Microbiol, Busan 46241, South Korea	Pusan National University	Hwang, J (corresponding author), Pusan Natl Univ, Dept Microbiol, Busan 46241, South Korea.	hwangjh@pusan.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology [NRF-2015R1A2A2A01005881]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology	This work was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by Ministry of Education, Science, and Technology Grant NRF-2015R1A2A2A01005881. The authors declare that they have no conflicts of interest with the contents of this article.	Artsimovitch I, 2004, CELL, V117, P299, DOI 10.1016/S0092-8674(04)00401-5; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barria C, 2013, MICROBIOL-SGM, V159, P2437, DOI 10.1099/mic.0.052209-0; Beckering CL, 2002, J BACTERIOL, V184, P6395, DOI 10.1128/JB.184.22.6395-6402.2002; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BOSL A, 1981, MOL GEN GENET, V182, P358, DOI 10.1007/BF00269684; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Busby S, 1999, J MOL BIOL, V293, P199, DOI 10.1006/jmbi.1999.3161; Caldas T, 2000, J BIOL CHEM, V275, P855, DOI 10.1074/jbc.275.2.855; Caldas TD, 1998, J BIOL CHEM, V273, P11478, DOI 10.1074/jbc.273.19.11478; Canny G, 2002, P NATL ACAD SCI USA, V99, P3902, DOI 10.1073/pnas.052533799; Choi E, 2016, J BACTERIOL, V198, P2284, DOI 10.1128/JB.00384-16; Choudhury P, 2015, J BACTERIOL, V197, P1819, DOI 10.1128/JB.00023-15; Conrad J, 1998, J BIOL CHEM, V273, P18562, DOI 10.1074/jbc.273.29.18562; De Lay N, 2009, J BACTERIOL, V191, P461, DOI 10.1128/JB.01157-08; deLivron MA, 2008, J BACTERIOL, V190, P5944, DOI 10.1128/JB.00763-08; Deutscher J, 2008, CURR OPIN MICROBIOL, V11, P87, DOI 10.1016/j.mib.2008.02.007; DONINI P, 1978, MOL BIOL REP, V4, P15, DOI 10.1007/BF00775174; Donovan GT, 2013, INFECT IMMUN, V81, P249, DOI 10.1128/IAI.00796-12; Elsbach P, 1998, J LEUKOCYTE BIOL, V64, P14, DOI 10.1002/jlb.64.1.14; Ero R, 2016, RNA BIOL, V13, P1258, DOI 10.1080/15476286.2016.1201627; Farris M, 1998, MOL MICROBIOL, V28, P265, DOI 10.1046/j.1365-2958.1998.00793.x; Feng S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058829; Freestone P, 1998, J MOL BIOL, V279, P1045, DOI 10.1006/jmbi.1998.1836; GALLANT J, 1977, CELL, V11, P181, DOI 10.1016/0092-8674(77)90329-4; Gibbs MR, 2017, P NATL ACAD SCI USA, V114, P980, DOI 10.1073/pnas.1613665114; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Grant AJ, 2003, MOL MICROBIOL, V48, P507, DOI 10.1046/j.1365-2958.2003.t01-1-03447.x; Gulati M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004694; Gutierrez-Rios RM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-53; HAMEL E, 1976, EUR J BIOCHEM, V63, P431, DOI 10.1111/j.1432-1033.1976.tb10245.x; Handke LD, 2008, J BACTERIOL, V190, P798, DOI 10.1128/JB.01115-07; Hansen AM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003403; Huang LX, 1998, BIOCHEMISTRY-US, V37, P15951, DOI 10.1021/bi981002n; Hwang J, 2008, J BACTERIOL, V190, P3236, DOI 10.1128/JB.01758-07; Hwang J, 2006, MOL MICROBIOL, V61, P1660, DOI 10.1111/j.1365-2958.2006.05348.x; IKEHARA K, 1984, J BIOCHEM-TOKYO, V95, P895, DOI 10.1093/oxfordjournals.jbchem.a134684; Ilan O, 1999, EMBO J, V18, P3241, DOI 10.1093/emboj/18.12.3241; ISHIHAMA A, 1993, J BACTERIOL, V175, P2483, DOI 10.1128/JB.175.9.2483-2489.1993; ISHIHAMA A, 1992, MOL MICROBIOL, V6, P3283, DOI 10.1111/j.1365-2958.1992.tb02196.x; Jackson DW, 2002, J BACTERIOL, V184, P3406, DOI 10.1128/JB.184.12.3406-3410.2002; Jones PG, 1996, MOL MICROBIOL, V21, P1207, DOI 10.1111/j.1365-2958.1996.tb02582.x; JONES PG, 1994, MOL MICROBIOL, V11, P811, DOI 10.1111/j.1365-2958.1994.tb00359.x; Kaczanowska M, 2007, MICROBIOL MOL BIOL R, V71, P477, DOI 10.1128/MMBR.00013-07; Kiss E, 2004, MOL PLANT MICROBE IN, V17, P235, DOI 10.1094/MPMI.2004.17.3.235; KOLB A, 1993, ANNU REV BIOCHEM, V62, P749, DOI 10.1146/annurev.bi.62.070193.003533; Krishnan K, 2008, J BACTERIOL, V190, P7675, DOI 10.1128/JB.00835-08; Kumar V, 2016, J BIOL CHEM, V291, P12943, DOI 10.1074/jbc.M116.725945; Kumar V, 2015, P NATL ACAD SCI USA, V112, P10944, DOI 10.1073/pnas.1513216112; Landis L, 1999, GENE DEV, V13, P3081, DOI 10.1101/gad.13.23.3081; Lawson CL, 2004, CURR OPIN STRUC BIOL, V14, P10, DOI 10.1016/j.sbi.2004.01.012; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Levin M, 2000, LANCET, V356, P961, DOI 10.1016/S0140-6736(00)02712-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macvanin M, 2000, MOL MICROBIOL, V37, P98, DOI 10.1046/j.1365-2958.2000.01967.x; Magnusson LU, 2005, TRENDS MICROBIOL, V13, P236, DOI 10.1016/j.tim.2005.03.008; Mares RE, 2011, INT J MOL SCI, V12, P4625, DOI 10.3390/ijms12074625; Margus T, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-15; Miller J. H., 1992, SHORT COURSE BACTERI, P263; Milon P, 2006, P NATL ACAD SCI USA, V103, P13962, DOI 10.1073/pnas.0606384103; Mitkevich VA, 2010, J MOL BIOL, V402, P838, DOI 10.1016/j.jmb.2010.08.016; Muller CM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000303; Neidig A, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-77; OSSWALD M, 1990, NUCLEIC ACIDS RES, V18, P6755; Pfennig PL, 2001, MOL GENET GENOMICS, V266, P313, DOI 10.1007/s004380100559; Phadtare S, 2005, J BACTERIOL, V187, P6584, DOI 10.1128/JB.187.18.6584-6589.2005; QI SY, 1995, MOL MICROBIOL, V17, P523, DOI 10.1111/j.1365-2958.1995.mmi_17030523.x; Reva ON, 2006, J BACTERIOL, V188, P4079, DOI 10.1128/JB.00101-06; ROJAS AM, 1984, MOL GEN GENET, V197, P36, DOI 10.1007/BF00327920; RON EZ, 1966, SCIENCE, V153, P1119, DOI 10.1126/science.153.3740.1119; Rowe S, 2000, J BACTERIOL, V182, P2741, DOI 10.1128/JB.182.10.2741-2745.2000; SARMIENTOS P, 1983, CELL, V32, P1337, DOI 10.1016/0092-8674(83)90314-8; Shajani Z, 2011, ANNU REV BIOCHEM, V80, P501, DOI 10.1146/annurev-biochem-062608-160432; SHAND RF, 1989, J BACTERIOL, V171, P737, DOI 10.1128/jb.171.2.737-743.1989; Shigeno Y, 2016, BIOCHEM BIOPH RES CO, V473, P237, DOI 10.1016/j.bbrc.2016.03.085; Shimizu K, 2014, METABOLITES, V4, P1, DOI 10.3390/metabo4010001; Starosta AL, 2014, FEMS MICROBIOL REV, V38, P1172, DOI 10.1111/1574-6976.12083; Uppal S, 2008, FEMS MICROBIOL LETT, V279, P83, DOI 10.1111/j.1574-6968.2007.01009.x; Uppal S, 2015, ARCH MICROBIOL, V197, P497, DOI 10.1007/s00203-015-1085-4; Uppal S, 2014, J BACTERIOL, V196, P1569, DOI 10.1128/JB.01476-13; Uppal S, 2011, J BACTERIOL, V193, P6142, DOI 10.1128/JB.05728-11; Wang F, 2008, PLANT CELL ENVIRON, V31, P982, DOI 10.1111/j.1365-3040.2008.01810.x; WEBER MJ, 1966, P NATL ACAD SCI USA, V55, P1224, DOI 10.1073/pnas.55.5.1224; YOSHIDA M, 1972, FEBS LETT, V23, P163, DOI 10.1016/0014-5793(72)80331-4; Zhang DD, 2012, NUCLEIC ACIDS RES, V40, P10851, DOI 10.1093/nar/gks833; Zhang ZG, 2005, J BACTERIOL, V187, P980, DOI 10.1128/JB.187.3.980-990.2005; Zheng DL, 2004, NUCLEIC ACIDS RES, V32, P5874, DOI 10.1093/nar/gkh908	87	15	16	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2018	293	47					18404	18419		10.1074/jbc.RA118.002295	http://dx.doi.org/10.1074/jbc.RA118.002295			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8XM	30305394	Green Published, hybrid			2022-12-28	WOS:000451375200033
J	Huibregtse, JM				Huibregtse, Jon M.			A proteasomal partner goes missing in Angelman syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							UBIQUITIN-PROTEIN LIGASE; UBE3A; MUTATIONS; BINDING; AUTISM; E6	Loss-of-function mutations in the UBE3A ubiquitin ligase are associated with Angelman syndrome (AS), a severe neurologic disorder. A new study defines the role of mutations in an N-terminal AZUL domain as mediating direct binding to a proteasomal subunit and shows that this interaction is correlated with the ability of UBE3A to promote Wnt/-catenin signaling. These results provide new insights into a central biomolecule in AS and suggest that defects in Wnt/-catenin signaling may underlie some AS phenotypes.	[Huibregtse, Jon M.] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; [Huibregtse, Jon M.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Huibregtse, JM (corresponding author), Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA.; Huibregtse, JM (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA.	huibregtse@austin.utexas.edu		Huibregtse, Jon/0000-0002-9210-3343	National Institutes of Health [RO1 GM103619, RO1 AI096090]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI096090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM103619] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants RO1 GM103619 and RO1 AI096090. The author declares that he has no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Cooper EM, 2004, J BIOL CHEM, V279, P41208, DOI 10.1074/jbc.M401302200; Crosas B, 2006, CELL, V127, P1401, DOI 10.1016/j.cell.2006.09.051; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P4918, DOI 10.1128/MCB.13.8.4918; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Kuhnle S, 2018, J BIOL CHEM, V293, P18387, DOI 10.1074/jbc.RA118.004653; Lee SY, 2014, CELL MOL LIFE SCI, V71, P2747, DOI 10.1007/s00018-013-1526-7; Lemak A, 2011, J BIOMOL NMR, V51, P185, DOI 10.1007/s10858-011-9552-y; Malzac P, 1998, AM J HUM GENET, V62, P1353, DOI 10.1086/301877; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Yi JJ, 2017, J BIOL CHEM, V292, P12503, DOI 10.1074/jbc.M117.788448	10	0	0	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2018	293	47					18400	18401		10.1074/jbc.H118.006328	http://dx.doi.org/10.1074/jbc.H118.006328			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8XM	30470726	hybrid, Green Published			2022-12-28	WOS:000451375200030
J	Laschet, C; Dupuis, N; Hanson, J				Laschet, Celine; Dupuis, Nadine; Hanson, Julien			A dynamic and screening-compatible nanoluciferase-based complementation assay enables profiling of individual GPCR-G protein interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein-coupled receptor (GPCR); G protein; high-throughput screening; drug screening; pharmacology; biased signaling; complementation assay; dopamine; functional selectivity; Nanoluciferase	COUPLED RECEPTOR ACTIVATION; RESONANCE ENERGY-TRANSFER; DRUG DISCOVERY; DOPAMINE-D-2 RECEPTOR; INTERNATIONAL UNION; PARKINSONS-DISEASE; AGONIST REGULATION; SELECTIVITY; REPORTER; ACCURATE	G protein-coupled receptors (GPCRs) are currently the target of more than 30% of the marketed medicines. However, there is an important medical need for ligands with improved pharmacological activities on validated drug targets. Moreover, most of these ligands remain poorly characterized, notably because of a lack of pharmacological tools. Thus, there is an important demand for innovative assays that can detect and drive the design of compounds with novel or improved pharmacological properties. In particular, a functional and screening-compatible GPCR-G protein interaction assay is still unavailable. Here, we report on a nanoluciferase-based complementation technique to detect ligands that promote a GPCR-G protein interaction. We demonstrate that our system can be used to profile compounds with regard to the G proteins they activate through a given GPCR. Furthermore, we established a proof of applicability of screening for distinct G proteins on dopamine receptor D-2 whose differential coupling to G(i/o) family members has been extensively studied. In a D-2-G(i1)versus D-2-G(o) screening, we retrieved five agonists that are currently being used in antiparkinsonian medications. We determined that in this assay, piribedil and pergolide are full agonists for the recruitment of G(i1) but are partial agonists for G(o), that the agonist activity of ropinirole is biased in favor of G(i1) recruitment, and that the agonist activity of apomorphine is biased for G(o). We propose that this newly developed assay could be used to develop molecules that selectively modulate a particular G protein pathway.	[Laschet, Celine; Dupuis, Nadine; Hanson, Julien] Univ Liege, GIGA Mol Biol Dis, Lab Mol Pharmacol, B-4000 Liege, Belgium; [Hanson, Julien] Univ Liege, Liege CHU, CIRM Drug Target & Lead Discovery, Lab Med Chem, B34 4, B-4000 Liege, Belgium	University of Liege; University of Liege	Hanson, J (corresponding author), Univ Liege, GIGA, Lab Mol Pharmacol, CHU, B34 4,11 Ave Hop, B-4000 Liege, Belgium.	j.hanson@uliege.be	Hanson, Julien/A-8242-2008	Hanson, Julien/0000-0001-7063-7590	Fonds pour la Recherche Scientifique (F.R.S.-FNRS) [F.4510.14]; Leon Fredericq Foundation; University of Liege (Fonds Speciaux)	Fonds pour la Recherche Scientifique (F.R.S.-FNRS)(Fonds de la Recherche Scientifique - FNRS); Leon Fredericq Foundation; University of Liege (Fonds Speciaux)(University of Liege)	This work was supported by the Fonds pour la Recherche Scientifique (F.R.S.-FNRS) Incentive Grant F.4510.14 for Scientific Research, University of Liege (Fonds Speciaux), and the Leon Fredericq Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Beaulieu JM, 2015, BRIT J PHARMACOL, V172, P1, DOI 10.1111/bph.12906; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Boute N, 2002, TRENDS PHARMACOL SCI, V23, P351, DOI 10.1016/S0165-6147(02)02062-X; Cordeaux Y, 2001, J BIOL CHEM, V276, P28667, DOI 10.1074/jbc.M008644200; Davenport AP, 2013, PHARMACOL REV, V65, P967, DOI 10.1124/pr.112.007179; DEKEYSER J, 1995, PROG NEURO-PSYCHOPH, V19, P1147, DOI 10.1016/0278-5846(95)00232-4; Dixon AS, 2016, ACS CHEM BIOL, V11, P400, DOI 10.1021/acschembio.5b00753; Dupuis N, 2017, MOL PHARMACOL, V91, P595, DOI 10.1124/mol.116.107714; England CG, 2016, BIOCONJUGATE CHEM, V27, P1175, DOI 10.1021/acs.bioconjchem.6b00112; FREEDMAN SB, 1994, J PHARMACOL EXP THER, V268, P417; Gales C, 2005, NAT METHODS, V2, P177, DOI 10.1038/NMETH743; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Gazi L, 2003, BRIT J PHARMACOL, V138, P775, DOI 10.1038/sj.bjp.0705116; Gilissen J, 2016, PHARMACOL THERAPEUT, V159, P56, DOI 10.1016/j.pharmthera.2016.01.008; Gilissen J, 2015, BIOCHEM PHARMACOL, V98, P381, DOI 10.1016/j.bcp.2015.09.010; GUAN XM, 1992, J BIOL CHEM, V267, P21995; Hall MP, 2012, ACS CHEM BIOL, V7, P1848, DOI 10.1021/cb3002478; Harding SD, 2018, NUCLEIC ACIDS RES, V46, pD1091, DOI 10.1093/nar/gkx1121; Hattori M, 2013, MOL BIOSYST, V9, P957, DOI 10.1039/c2mb25443c; Hauser AS, 2017, NAT REV DRUG DISCOV, V16, P829, DOI 10.1038/nrd.2017.178; Hein P, 2005, EMBO J, V24, P4106, DOI 10.1038/sj.emboj.7600870; Hoffmann C, 2005, NAT METHODS, V2, P171, DOI 10.1038/NMETH742; Inoue A, 2012, NAT METHODS, V9, P1021, DOI [10.1038/nmeth.2172, 10.1038/NMETH.2172]; Kenakin T, 2012, ACS CHEM NEUROSCI, V3, P193, DOI 10.1021/cn200111m; Kenakin TP, 2012, BRIT J PHARMACOL, V165, P1659, DOI 10.1111/j.1476-5381.2011.01749.x; Kostenis E, 2005, TRENDS PHARMACOL SCI, V26, P595, DOI 10.1016/j.tips.2005.09.007; Lane JR, 2007, MOL PHARMACOL, V71, P1349, DOI 10.1124/mol.106.032722; Laschet C, 2018, BIOCHEM PHARMACOL, V153, P62, DOI 10.1016/j.bcp.2018.02.016; Liu RF, 2016, BIOCHEM PHARMACOL, V114, P103, DOI 10.1016/j.bcp.2016.02.010; Lohse MJ, 2012, PHARMACOL REV, V64, P299, DOI 10.1124/pr.110.004309; Ma Q, 2017, EXPERT OPIN DRUG DIS, V12, P511, DOI 10.1080/17460441.2017.1303473; Machleidt T, 2015, ACS CHEM BIOL, V10, P1797, DOI 10.1021/acschembio.5b00143; Magliery TJ, 2005, J AM CHEM SOC, V127, P146, DOI 10.1021/ja046699g; Masuho I, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab4068; Michnick SW, 2007, NAT REV DRUG DISCOV, V6, P569, DOI 10.1038/nrd2311; Milligan G, 2006, BRIT J PHARMACOL, V147, pS46, DOI 10.1038/sj.bjp.0706405; Milligan G, 2003, TRENDS PHARMACOL SCI, V24, P87, DOI 10.1016/S0165-6147(02)00027-5; Ngo T, 2016, BRIT J PHARMACOL, V173, P2934, DOI 10.1111/bph.13452; Obeso JA, 2010, NAT MED, V16, P653, DOI 10.1038/nm.2165; Oertel W, 2016, J NEUROCHEM, V139, P325, DOI 10.1111/jnc.13750; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Panula P, 2015, PHARMACOL REV, V67, P601, DOI 10.1124/pr.114.010249; Rajagopal S, 2017, CELL SIGNAL, V41, P9, DOI 10.1016/j.cellsig.2017.01.024; Roth BL, 2015, J BIOL CHEM, V290, P19471, DOI 10.1074/jbc.R115.654764; Sauliere A, 2012, NAT CHEM BIOL, V8, P622, DOI [10.1038/NCHEMBIO.961, 10.1038/nchembio.961]; Schroder R, 2010, NAT BIOTECHNOL, V28, P943, DOI 10.1038/nbt.1671; Sriram K, 2018, MOL PHARMACOL, V93, P251, DOI 10.1124/mol.117.111062; Szpakowska M, 2018, BRIT J PHARMACOL, V175, P1419, DOI 10.1111/bph.14132; Wan QW, 2018, J BIOL CHEM, V293, P7466, DOI 10.1074/jbc.RA118.001975; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Williams C, 2004, NAT REV DRUG DISCOV, V3, P125, DOI 10.1038/nrd1306; Winpenny D, 2016, BRIT J PHARMACOL, V173, P1393, DOI 10.1111/bph.13441; Yano H, 2018, BIOTECHNIQUES, V65, P9, DOI 10.2144/btn-2018-0039; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	54	26	29	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					4079	4090		10.1074/jbc.RA118.006231	http://dx.doi.org/10.1074/jbc.RA118.006231			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30593506	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000461854400021
J	Shu, PC; Wu, C; Liu, W; Ruan, XB; Liu, C; Hou, L; Zeng, Y; Fu, HY; Wang, M; Chen, P; Zhang, XL; Yin, B; Yuan, JG; Qiang, BQ; Peng, XZ				Shu, Pengcheng; Wu, Chao; Liu, Wei; Ruan, Xiangbin; Liu, Chang; Hou, Lin; Zeng, Yi; Fu, Hongye; Wang, Ming; Chen, Pan; Zhang, Xiaoling; Yin, Bin; Yuan, Jiangang; Qiang, Boqin; Peng, Xiaozhong			The spatiotemporal expression pattern of microRNAs in the developing mouse nervous system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						microRNA (miRNA); neurodevelopment; central nervous system (CNS); brain; mouse; embryo; gene expression; expression pattern; in situ hybridization	INTERKINETIC NUCLEAR MIGRATION; SINGLE-CELL ANALYSIS; IN-SITU DETECTION; NONCODING RNAS; NEURONS; ATLAS; HETEROGENEITY; REGULATORS; DYNAMICS; CLUSTER	MicroRNAs (miRNAs) control various biological processes by inducing translational repression and transcript degradation of the target genes. In mammalian development, knowledge of the timing and expression pattern of each miRNA is important to determine and predict its function in vivo. So far, no systematic analyses of the spatiotemporal expression pattern of miRNAs during mammalian neurodevelopment have been performed. Here, we isolated total RNAs from the embryonic dorsal forebrain of mice at different developmental stages and subjected these RNAs to microarray analyses. We selected 279 miRNAs that exhibited high signal intensities or ascending or descending expression dynamics. To ascertain the expression patterns of these miRNAs, we used locked nucleic acid (LNA)-modified miRNA probes in in situ hybridization experiments. Multiple miRNAs exhibited spatially restricted/enriched expression in anatomically distinct regions or in specific neuron subtypes in the embryonic brain and spinal cord, such as in the ventricular area, the striatum (and other basal ganglia), hypothalamus, choroid plexus, and the peripheral nervous system. These findings provide new insights into the expression and function of miRNAs during the development of the nervous system and could be used as a resource to facilitate studies in neurodevelopment.	[Shu, Pengcheng; Wu, Chao; Liu, Wei; Ruan, Xiangbin; Liu, Chang; Hou, Lin; Zeng, Yi; Fu, Hongye; Wang, Ming; Chen, Pan; Zhang, Xiaoling; Yin, Bin; Yuan, Jiangang; Qiang, Boqin; Peng, Xiaozhong] Chinese Acad Med Sci, Dept Mol Biol, State Key Lab Med Mol Biol,Sch Basic Med,Peking U, Inst Basic Med Sci,Med Primates Res Ctr,Neurosci, Beijing 100005, Peoples R China; [Shu, Pengcheng; Wu, Chao; Liu, Wei; Ruan, Xiangbin; Liu, Chang; Hou, Lin; Zeng, Yi; Fu, Hongye; Wang, Ming; Chen, Pan; Zhang, Xiaoling; Yin, Bin; Yuan, Jiangang; Qiang, Boqin; Peng, Xiaozhong] Chinese Acad Med Sci, Dept Biochem, State Key Lab Med Mol Biol,Sch Basic Med,Peking U, Inst Basic Med Sci,Med Primates Res Ctr,Neurosci, Beijing 100005, Peoples R China; [Peng, Xiaozhong] Chinese Acad Med Sci, Inst Med Biol, Kunming 650118, Yunnan, Peoples R China; [Peng, Xiaozhong] Peking Union Med Coll, Kunming 650118, Yunnan, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Peng, XZ (corresponding author), Chinese Acad Med Sci, Dept Mol Biol & Biochem, Inst Basic Med Sci, 5 Dongdan San Tiao, Beijing 100005, Peoples R China.; Peng, XZ (corresponding author), Peking Union Med Coll, 5 Dongdan San Tiao, Beijing 100005, Peoples R China.	pengxiaozhong@pumc.edu.cn	Ruan, Xiangbin/A-7239-2013; Shu, Pengcheng/D-7023-2015	Ruan, Xiangbin/0000-0002-6895-2070; Shu, Pengcheng/0000-0002-3091-2559	National Key Research and Development Program of China [2016YFA0100702, 2016YFC0902502]; National Natural Science Foundation of China [31670789]; CAMS Innovation Fund for Medical Sciences (CIFMS) [2016-I2M-2-001, 2016-I2M-1-004, 2017-I2M-1-004]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAMS Innovation Fund for Medical Sciences (CIFMS)	This work was supported by National Key Research and Development Program of China Grants 2016YFA0100702 and 2016YFC0902502, National Natural Science Foundation of China Grant 31670789, and CAMS Innovation Fund for Medical Sciences (CIFMS) Grants 2016-I2M-2-001, 2016-I2M-1-004, and 2017-I2M-1-004. The authors declare that they have no conflicts of interest with the contents of this article.	Aldrich BT, 2009, NEUROSCIENCE, V164, P711, DOI 10.1016/j.neuroscience.2009.08.033; Allaway KC, 2017, DEV BIOL, V421, P1, DOI 10.1016/j.ydbio.2016.11.007; Amin ND, 2015, SCIENCE, V350, P1525, DOI 10.1126/science.aad2509; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Bakken TE, 2016, NATURE, V535, P367, DOI 10.1038/nature18637; Bernard A, 2012, NEURON, V73, P1083, DOI 10.1016/j.neuron.2012.03.002; Busskamp V, 2014, NEURON, V83, P586, DOI 10.1016/j.neuron.2014.06.020; Diez-Roux G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000582; Dore LC, 2008, P NATL ACAD SCI USA, V105, P3333, DOI 10.1073/pnas.0712312105; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Fan JG, 2017, P NATL ACAD SCI USA, V114, pE4271, DOI 10.1073/pnas.1619442114; Fertuzinhos S, 2014, CELL REP, V6, P938, DOI 10.1016/j.celrep.2014.01.036; Gao P, 2014, CELL, V159, P775, DOI 10.1016/j.cell.2014.10.027; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gray PA, 2004, SCIENCE, V306, P2255, DOI 10.1126/science.1104935; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Hu P, 2017, MOL CELL, V68, P1006, DOI 10.1016/j.molcel.2017.11.017; Johnson MB, 2015, NAT NEUROSCI, V18, P637, DOI 10.1038/nn.3980; Jonas S, 2015, NAT REV GENET, V16, P421, DOI 10.1038/nrg3965; Kloosterman WP, 2006, NAT METHODS, V3, P27, DOI 10.1038/NMETH843; Kosodo Y, 2011, EMBO J, V30, P1690, DOI 10.1038/emboj.2011.81; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Lein E, 2017, SCIENCE, V358, P64, DOI 10.1126/science.aan6827; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lewis MA, 2009, NAT GENET, V41, P614, DOI 10.1038/ng.369; Liu SJ, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0932-1; Lun MP, 2015, NAT REV NEUROSCI, V16, P445, DOI 10.1038/nrn3921; Magdaleno S, 2006, PLOS BIOL, V4, P497, DOI 10.1371/journal.pbio.0040086; McKee AE, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-14; Mencia A, 2009, NAT GENET, V41, P609, DOI 10.1038/ng.355; Miller FD, 2007, NEURON, V54, P357, DOI 10.1016/j.neuron.2007.04.019; Molyneaux BJ, 2015, NEURON, V85, P275, DOI 10.1016/j.neuron.2014.12.024; Nowakowski TJ, 2017, SCIENCE, V358, P1318, DOI 10.1126/science.aap8809; Obernosterer G, 2007, NAT PROTOC, V2, P1508, DOI 10.1038/nprot.2007.153; Pauli A, 2011, NAT REV GENET, V12, P136, DOI 10.1038/nrg2904; Peng CG, 2017, SCIENCE, V356, P1168, DOI 10.1126/science.aam7671; Piwecka M, 2017, SCIENCE, V357, DOI 10.1126/science.aam8526; Pollen AA, 2014, NAT BIOTECHNOL, V32, P1053, DOI 10.1038/nbt.2967; Poulin JF, 2016, NAT NEUROSCI, V19, P1131, DOI 10.1038/nn.4366; Rajman M, 2017, DEVELOPMENT, V144, P2310, DOI 10.1242/dev.144337; Rasmussen KD, 2010, J EXP MED, V207, P1351, DOI 10.1084/jem.20100458; Redshaw N, 2009, BRAIN RES, V1250, P20, DOI 10.1016/j.brainres.2008.11.020; Rowitch DH, 2010, NATURE, V468, P214, DOI 10.1038/nature09611; Shekhar K, 2016, CELL, V166, P1308, DOI 10.1016/j.cell.2016.07.054; Shu PC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08450-8; Silahtaroglu AN, 2007, NAT PROTOC, V2, P2520, DOI 10.1038/nprot.2007.313; Sokol NS, 2012, CURR OPIN GENET DEV, V22, P368, DOI 10.1016/j.gde.2012.04.001; Son DJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms4000; Spear PC, 2012, DEV GROWTH DIFFER, V54, P306, DOI 10.1111/j.1440-169X.2012.01342.x; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Thiebes KP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8718; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; Zhong Y, 2004, CEREB CORTEX, V14, P1144, DOI 10.1093/cercor/bhh074; Zhou JJ, 2017, BBA-GENE REGUL MECH, V1860, P1159, DOI 10.1016/j.bbagrm.2017.10.002; Zhuo S, 2016, DIABETES, V65, P3276, DOI 10.2337/db16-0166	56	13	15	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3444	3453		10.1074/jbc.RA118.004390	http://dx.doi.org/10.1074/jbc.RA118.004390			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30578296	Green Published, hybrid			2022-12-28	WOS:000461853900012
J	Yu, XC; Hu, YF; Ding, J; Li, HW; Jin, CW				Yu, Xing-Chi; Hu, Yunfei; Ding, Jienv; Li, Hongwei; Jin, Changwen			Structural basis and mechanism of the unfolding-induced activation of HdeA, a bacterial acid response chaperone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chaperone; nuclear magnetic resonance (NMR); protein dynamic; intrinsically disordered protein; protein structure; protein-protein interaction; acid resistance; conditional disorder	DISORDERED PROTEINS; PERIPLASMIC PROTEIN; INTRINSIC DISORDER; NMR; PH; BINDING; FLEXIBILITY; RESISTANCE; EXCHANGE; STATES	The role of protein structural disorder in biological functions has gained increasing attention in the past decade. The bacterial acid-resistant chaperone HdeA belongs to a group of conditionally disordered proteins, because it is inactive in its well-structured state and becomes activated via an order-to-disorder transition under acid stress. However, the mechanism for unfolding-induced activation remains unclear because of a lack of experimental information on the unfolded state conformation and the chaperone-client interactions. Herein, we used advanced solution NMR methods to characterize the activated-state conformation of HdeA under acidic conditions and identify its client-binding sites. We observed that the structure of activated HdeA becomes largely disordered and exposes two hydrophobic patches essential for client interactions. Furthermore, using the pH-dependent chemical exchange saturation transfer (CEST) NMR method, we identified three acid-sensitive regions that act as structural locks in regulating the exposure of the two client-binding sites during the activation process, revealing a multistep activation mechanism of HdeA's chaperone function at the atomic level. Our results highlight the role of intrinsic protein disorder in chaperone function and the self-inhibitory role of ordered structures under nonstress conditions, offering new insights for improving our understanding of protein structure-function paradigms.	[Yu, Xing-Chi; Hu, Yunfei; Li, Hongwei; Jin, Changwen] Peking Univ, Coll Chem & Mol Engn, Beijing 100871, Peoples R China; [Yu, Xing-Chi; Hu, Yunfei; Ding, Jienv; Li, Hongwei; Jin, Changwen] Peking Univ, Beijing Nucl Magnet Resonance Ctr, Beijing 100871, Peoples R China; [Ding, Jienv; Jin, Changwen] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China; [Jin, Changwen] Peking Univ, Beijing Natl Lab Mol Sci, Beijing 100871, Peoples R China; [Ding, Jienv] NIH, Dept Hlth & Human Serv, 1050 Boyles St, Frederick, MD 21702 USA	Peking University; Peking University; Peking University; Chinese Academy of Sciences; Peking University; National Institutes of Health (NIH) - USA	Hu, YF (corresponding author), Soochow Univ, Med Coll, Suzhou 215123, Peoples R China.; Jin, CW (corresponding author), Peking Univ, Coll Chem & Mol Engn, Coll Life Sci, Beijing Nucl Magnet Resonance Ctr, Beijing 100871, Peoples R China.	yunfei_hu@suda.edu.cn; changwen@pku.edu.cn	Yu, Xing-Chi/AAO-2375-2020		National Key R&D Program of China [2016YFA0501201]; National Natural Science Foundation of China [31370718]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Grant 2016YFA0501201 from the National Key R&D Program of China (to C. J.) and Grant 31370718 from the National Natural Science Foundation of China (to Y. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahlstrom LS, 2015, J MOL BIOL, V427, P1670, DOI 10.1016/j.jmb.2015.01.002; Ahlstrom LS, 2013, J PHYS CHEM B, V117, P13219, DOI 10.1021/jp403264s; Bah A, 2016, J BIOL CHEM, V291, P6696, DOI 10.1074/jbc.R115.695056; Bardwell JCA, 2012, TRENDS BIOCHEM SCI, V37, P517, DOI 10.1016/j.tibs.2012.08.006; Burmann BM, 2015, PROG NUCL MAG RES SP, V86-87, P41, DOI 10.1016/j.pnmrs.2015.02.004; Crowley PB, 2012, CHEM COMMUN, V48, P10681, DOI 10.1039/c2cc35347d; Dahl JU, 2015, J BIOL CHEM, V290, P65, DOI 10.1074/jbc.M114.612986; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dickson A, 2016, J COMPUT CHEM, V37, P587, DOI 10.1002/jcc.24004; Ding JN, 2015, SCI REP-UK, V5, DOI 10.1038/srep16856; Foit L, 2013, P NATL ACAD SCI USA, V110, pE1254, DOI 10.1073/pnas.1222458110; Franzmann TM, 2008, MOL CELL, V29, P207, DOI 10.1016/j.molcel.2007.11.025; Gajiwala KS, 2000, J MOL BIOL, V295, P605, DOI 10.1006/jmbi.1999.3347; Garrison MA, 2014, PROTEIN SCI, V23, P167, DOI 10.1002/pro.2402; GOTO Y, 1990, BIOCHEMISTRY-US, V29, P3480, DOI 10.1021/bi00466a009; GOTO Y, 1989, BIOCHEMISTRY-US, V28, P945, DOI 10.1021/bi00429a004; Gu S, 2017, BBA-PROTEINS PROTEOM, V1865, P1255, DOI 10.1016/j.bbapap.2017.07.006; Hingorani KS, 2013, P NATL ACAD SCI USA, V110, P5279, DOI 10.1073/pnas.1303297110; Hong WZ, 2012, TRENDS MICROBIOL, V20, P328, DOI 10.1016/j.tim.2012.03.001; Hong WZ, 2005, J BIOL CHEM, V280, P27029, DOI 10.1074/jbc.M503934200; Huang CD, 2016, NATURE, V537, P202, DOI 10.1038/nature18965; Jaya N, 2009, P NATL ACAD SCI USA, V106, P15604, DOI 10.1073/pnas.0902177106; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kern R, 2007, J BACTERIOL, V189, P603, DOI 10.1128/JB.01522-06; Kitevski-LeBlanc JL, 2012, PROG NUCL MAG RES SP, V62, P1, DOI 10.1016/j.pnmrs.2011.06.003; Malki A, 2008, J BIOL CHEM, V283, P13679, DOI 10.1074/jbc.M800869200; Marin M, 2013, PLANT CELL, V25, P3153, DOI 10.1105/tpc.113.116319; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; Panchal SC, 2001, J BIOMOL NMR, V20, P135, DOI 10.1023/A:1011239023422; Reichmann D, 2012, CELL, V148, P947, DOI 10.1016/j.cell.2012.01.045; Saio T, 2014, SCIENCE, V344, P597, DOI 10.1126/science.1250494; Salmon L, 2018, J MOL BIOL, V430, P33, DOI 10.1016/j.jmb.2017.11.002; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schwarzinger S, 2000, J BIOMOL NMR, V18, P43, DOI 10.1023/A:1008386816521; Sekhar A, 2013, P NATL ACAD SCI USA, V110, P12867, DOI 10.1073/pnas.1305688110; Socher E, 2016, J PHYS CHEM B, V120, P11845, DOI 10.1021/acs.jpcb.6b06091; Tapley TL, 2010, P NATL ACAD SCI USA, V107, P1071, DOI 10.1073/pnas.0911610107; Tapley TL, 2009, P NATL ACAD SCI USA, V106, P5557, DOI 10.1073/pnas.0811811106; Tompa P, 2012, TRENDS BIOCHEM SCI, V37, P509, DOI 10.1016/j.tibs.2012.08.004; Toth-Petroczy A, 2016, CELL, V167, P158, DOI 10.1016/j.cell.2016.09.010; Vallurupalli P, 2012, J AM CHEM SOC, V134, P8148, DOI 10.1021/ja3001419; Wang WJ, 2012, J MOL BIOL, V415, P538, DOI 10.1016/j.jmb.2011.11.026; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Wu YE, 2008, BIOCHEM J, V412, P389, DOI 10.1042/BJ20071682; Yang F, 1998, NAT STRUCT BIOL, V5, P763, DOI 10.1038/1796; Yu BH, 2016, SCI REP-UK, V6, DOI 10.1038/srep34171; Yu XC, 2017, BIOCHEMISTRY-US, V56, P5748, DOI 10.1021/acs.biochem.7b00724; Yuwen TR, 2017, J BIOMOL NMR, V67, P295, DOI 10.1007/s10858-017-0104-y; Zhai ZN, 2016, CHEM SCI, V7, P2222, DOI 10.1039/c5sc04297f; Zhang BW, 2011, J AM CHEM SOC, V133, P19393, DOI 10.1021/ja2060066; Zhang M, 2011, NAT CHEM BIOL, V7, P671, DOI [10.1038/NCHEMBIO.644, 10.1038/nchembio.644]; Zhang S, 2016, P NATL ACAD SCI USA, V113, P10872, DOI 10.1073/pnas.1606360113	52	10	12	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2019	294	9					3192	3206		10.1074/jbc.RA118.006398	http://dx.doi.org/10.1074/jbc.RA118.006398			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU0SA	30573682	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000464980100018
J	Dent, AT; Mourino, S; Huang, WL; Wilks, A				Dent, Alecia T.; Mourino, Susana; Huang, Weiliang; Wilks, Angela			Post-transcriptional regulation of the Pseudomonas aeruginosa heme assimilation system (Has) fine-tunes extracellular heme sensing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						heme; bacterial signal transduction; bacterial transcription; sigma receptor; Pseudomonas aeruginosa (P. aeruginosa); extracytoplasmic function (ECF) function; heme assimilation system; post-transcriptional regulation	MEMBRANE RECEPTORS PHUR; OUTER-MEMBRANE; SERRATIA-MARCESCENS; HEMOPHORE HASAP; IRON TRANSPORT; SIGMA-FACTOR; GENE; ACQUISITION; EXPRESSION; IDENTIFICATION	Pseudomonas aeruginosa is an opportunistic pathogen that utilizes heme as a primary iron source within the host. Extracellular heme is sensed via a heme assimilation system (has) that encodes an extracytoplasmic function (ECF) sigma factor system. Herein, using has deletion mutants, quantitative PCR analyses, and immunoblotting, we show that the activation of the sigma factor HasI requires heme release from the hemophore HasAp to the outer-membrane receptor HasR. Using RT-PCR and 5 '-RACE, we observed that following transcriptional activation of the co-transcribed hasRAp, it is further processed into specific mRNAs varying in stability. We noted that the processing and variation in stability of the hasAp and hasR mRNAs in response to heme provide a mechanism for differential expression from co-transcribed genes. The multiple layers of post-transcriptional regulation of the ECF signaling cascade, including the previously reported post-transcriptional regulation of HasAp by the heme metabolites biliverdin IX beta and IX delta, allow fine-tuning of the cell-surface signaling system in response to extracellular heme levels. We hypothesize that the complex post-transcriptional regulation of the Has system provides P. aeruginosa an advantage in colonizing a variety of physiological niches in the host.	[Dent, Alecia T.; Mourino, Susana; Huang, Weiliang; Wilks, Angela] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, HSF 2,20 Penn St, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Wilks, A (corresponding author), Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, HSF 2,20 Penn St, Baltimore, MD 21201 USA.	awilks@rx.umaryland.edu		Dent, Alecia/0000-0002-6376-7482	National Institutes of Health [R01 AI102883, AI134886]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI134886, R01AI102883] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health Grants R01 AI102883 and AI134886 (to A. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alontaga AY, 2009, BIOCHEMISTRY-US, V48, P96, DOI 10.1021/bi801860g; Beare PA, 2003, MOL MICROBIOL, V47, P195, DOI 10.1046/j.1365-2958.2003.03288.x; Benevides-Matos N, 2008, J BACTERIOL, V190, P21, DOI 10.1128/JB.01389-07; Benevides-Matos N, 2010, MICROBIOL-SGM, V156, P1749, DOI 10.1099/mic.0.034405-0; Biville F, 2004, MOL MICROBIOL, V53, P1267, DOI 10.1111/j.1365-2958.2004.04207.x; Caillet-Saguy C, 2012, J BIOL CHEM, V287, P26932, DOI 10.1074/jbc.M112.366385; Commichau FM, 2009, MOL CELL PROTEOMICS, V8, P1350, DOI 10.1074/mcp.M800546-MCP200; Contreras H, 2014, CURR OPIN CHEM BIOL, V19, P34, DOI 10.1016/j.cbpa.2013.12.014; Costerton JW, 2001, TRENDS MICROBIOL, V9, P50, DOI 10.1016/S0966-842X(00)01918-1; CUNLIFFE HE, 1995, J BACTERIOL, V177, P2744, DOI 10.1128/jb.177.10.2744-2750.1995; Cwerman H, 2006, J BACTERIOL, V188, P3357, DOI 10.1128/JB.188.9.3357-3364.2006; DeLoughery A, 2018, P NATL ACAD SCI USA, V115, pE5585, DOI 10.1073/pnas.1803283115; Deniau C, 2003, BIOCHEMISTRY-US, V42, P10627, DOI 10.1021/bi030015k; Fuhrhop J. H., 1975, PORPHYRINS METALLOPO, P804; GAMPER M, 1993, GENE, V129, P119, DOI 10.1016/0378-1119(93)90706-9; GAMPER M, 1992, J MOL BIOL, V226, P943, DOI 10.1016/0022-2836(92)91044-P; Ganz T, 2009, CURR OPIN IMMUNOL, V21, P63, DOI 10.1016/j.coi.2009.01.011; Gaudin CFM, 2011, BIOCHEMISTRY-US, V50, P5443, DOI 10.1021/bi200369p; Grigg JC, 2011, J MOL BIOL, V413, P684, DOI 10.1016/j.jmb.2011.08.047; HEINRICHS DE, 1991, INFECT IMMUN, V59, P3680, DOI 10.1128/IAI.59.10.3680-3684.1991; Helmann JD, 2002, ADV MICROB PHYSIOL, V46, P47; Hoang TT, 2000, PLASMID, V43, P59, DOI 10.1006/plas.1999.1441; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Huang WL, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1112-5; Huang WL, 2017, ANNU REV BIOCHEM, V86, P799, DOI 10.1146/annurev-biochem-060815-014214; Hunter RC, 2013, MBIO, V4, DOI 10.1128/mBio.00557-13; Jepkorir G, 2010, J AM CHEM SOC, V132, P9857, DOI 10.1021/ja103498z; Krieg S, 2009, P NATL ACAD SCI USA, V106, P1045, DOI 10.1073/pnas.0809406106; Kumar R, 2014, BIOCHEMISTRY-US, V53, P2112, DOI 10.1021/bi500030p; Leoni L, 2000, J BACTERIOL, V182, P1481, DOI 10.1128/JB.182.6.1481-1491.2000; Leoni L, 1996, J BACTERIOL, V178, P2299, DOI 10.1128/jb.178.8.2299-2313.1996; Letoffe S, 1998, MOL MICROBIOL, V28, P1223, DOI 10.1046/j.1365-2958.1998.00885.x; Letoffe S, 2001, MOL MICROBIOL, V41, P439, DOI 10.1046/j.1365-2958.2001.02530.x; Llamas MA, 2014, FEMS MICROBIOL REV, V38, P569, DOI 10.1111/1574-6976.12078; Marvig RL, 2014, MBIO, V5, DOI 10.1128/mBio.00966-14; Mascher T, 2013, CURR OPIN MICROBIOL, V16, P148, DOI 10.1016/j.mib.2013.02.001; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Mourino S, 2016, J BIOL CHEM, V291, P20503, DOI 10.1074/jbc.M116.728527; Nguyen AT, 2014, J BACTERIOL, V196, P2265, DOI 10.1128/JB.01491-14; Ochsner UA, 2002, MOL MICROBIOL, V45, P1277, DOI 10.1046/j.1365-2958.2002.03084.x; Ochsner UA, 1996, P NATL ACAD SCI USA, V93, P4409, DOI 10.1073/pnas.93.9.4409; Ochsner UA, 2000, MICROBIOL-UK, V146, P185, DOI 10.1099/00221287-146-1-185; Oglesby AG, 2008, J BIOL CHEM, V283, P15558, DOI 10.1074/jbc.M707840200; Oglesby-Sherrouse AG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009930; OTTO BR, 1992, CRIT REV MICROBIOL, V18, P217, DOI 10.3109/10408419209114559; Payne SM, 2016, MICROBIOL MOL BIOL R, V80, P69, DOI 10.1128/MMBR.00046-15; Ratliff M, 2001, J BACTERIOL, V183, P6394, DOI 10.1128/JB.183.21.6394-6403.2001; Redly GA, 2003, J BACTERIOL, V185, P1261, DOI 10.1128/JB.185.4.1261-1265.2003; Redly GA, 2005, J BACTERIOL, V187, P5648, DOI 10.1128/JB.187.16.5648-5657.2005; Reinhart AA, 2015, INFECT IMMUN, V83, P863, DOI 10.1128/IAI.02707-14; Rossi MS, 2003, MOL MICROBIOL, V48, P1467, DOI 10.1046/j.1365-2958.2003.03516.x; Royt P W, 1990, Biol Met, V3, P28, DOI 10.1007/BF01141174; Sadikot RT, 2005, AM J RESP CRIT CARE, V171, P1209, DOI 10.1164/rccm.200408-1044SO; Sheldon JR, 2015, FEMS MICROBIOL REV, V39, P592, DOI 10.1093/femsre/fuv009; Sineva E, 2017, CURR OPIN MICROBIOL, V36, P128, DOI 10.1016/j.mib.2017.05.004; Smith AD, 2015, BIOCHEMISTRY-US, V54, P2601, DOI 10.1021/acs.biochem.5b00017; Smith AD, 2015, J BIOL CHEM, V290, P7756, DOI 10.1074/jbc.M114.633495; Vanderpool CK, 2003, J BACTERIOL, V185, P909, DOI 10.1128/JB.185.3.909-917.2003; Wilderman PJ, 2004, P NATL ACAD SCI USA, V101, P9792, DOI 10.1073/pnas.0403423101; Yukl ET, 2010, BIOCHEMISTRY-US, V49, P6646, DOI 10.1021/bi100692f	60	18	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2771	2785		10.1074/jbc.RA118.006185	http://dx.doi.org/10.1074/jbc.RA118.006185			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30593511	hybrid, Green Published			2022-12-28	WOS:000459601600017
J	Wu, H; Li, MJ; Guo, HJ; Zhou, H; Li, B; Xu, Q; Xu, CY; Yu, F; He, JH				Wu, Hai; Li, Minjun; Guo, Haojie; Zhou, Huan; Li, Bing; Xu, Qin; Xu, Chunyan; Yu, Feng; He, Jianhua			Crystal structure of the Vibrio cholerae VqmA-ligand-DNA complex provides insight into ligand-binding mechanisms relevant for drug design	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						quorum sensing; transcription promoter; protein-DNA interaction; protein structure; X-ray crystallography; DPO; ligand binding; Vibrio cholerae; virulence; VqmA	TO-CELL COMMUNICATION; LUXR-LUXI FAMILY; QUORUM; PROTEIN; EXPRESSION; REGULATOR; AUTOINDUCER; REPRESSION; FEATURES; DOMAIN	VqmA is a highly conserved transcriptional regulator of the quorum-sensing system of Vibrio cholerae, a major human pathogen that continues to imperil human health. VqmA represses biofilm formation and plays an important role in V. cholerae pathogenicity in the human host. Although VqmA's biological function is well understood, the molecular mechanisms by which its specific ligand (and effector), 3,5-dimethylpyrazine-2-ol (DPO), controls transcription of the target gene, vqmR, remain obscure. To elucidate the molecular mechanism of DPO binding, we used structural analyses and biochemical assays to study the V. cholerae VqmA-DPO-DNA complex. These analyses revealed that VqmA contains an N-terminal homodimer domain (PAS) and a C-terminal DNA-binding domain (DBD). We observed that VqmA directly binds to a DPO molecule via a compact hydrophobic pocket, consisting of a six-stranded antiparallel beta-sheet and several alpha-helices. We also found that the VqmA dimer interacts with the quasi-palindromic sequence of the vqmR promoter through its DBD. The results of the biochemical studies indicated that a water atom and VqmA residues Phe-67 and Lys-101 play a key role in effector recognition, which is also assisted by Tyr-36 and Phe-99. This is the first molecular level view of the VqmA dimer bound to DPO and DNA. The structure-function analyses presented here improve our understanding of the complex mechanisms in the transcriptional regulation of VqmA in Vibrio spp. and may inform the design of drugs to manage V. cholerae infections.	[Wu, Hai; Li, Minjun; Guo, Haojie; Zhou, Huan; Li, Bing; Xu, Qin; Xu, Chunyan; Yu, Feng; He, Jianhua] Chinese Acad Sci, Shanghai Inst Appl Phys, Shanghai 201800, Peoples R China; [Wu, Hai; Guo, Haojie; Li, Bing; Xu, Qin] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Applied Physics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yu, F; He, JH (corresponding author), Chinese Acad Sci, Shanghai Inst Appl Phys, Shanghai 201800, Peoples R China.	yufeng@sinap.ac.cn; hejianhua@sinap.ac.cn	zhou, huan/GYJ-4398-2022		National Natural Science Foundation [31570740, 81330076]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation Grants 31570740 and 81330076. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Antonova ES, 2011, FEMS MICROBIOL LETT, V322, P68, DOI 10.1111/j.1574-6968.2011.02328.x; Bardill JP, 2011, MOL MICROBIOL, V80, P1381, DOI 10.1111/j.1365-2958.2011.07655.x; BASSLER BL, 1994, MOL MICROBIOL, V13, P273, DOI 10.1111/j.1365-2958.1994.tb00422.x; Bassler BL, 2006, CELL, V125, P237, DOI 10.1016/j.cell.2006.04.001; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; BRENNAN RG, 1989, J BIOL CHEM, V264, P1903; Brudler R, 2000, BIOCHEMISTRY-US, V39, P13478, DOI 10.1021/bi0009946; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; Chen GZ, 2011, MOL CELL, V42, P199, DOI 10.1016/j.molcel.2011.04.003; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fuqua C, 2001, ANNU REV GENET, V35, P439, DOI 10.1146/annurev.genet.35.102401.090913; Fuqua C, 1996, ANNU REV MICROBIOL, V50, P727, DOI 10.1146/annurev.micro.50.1.727; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; Gong WM, 1998, P NATL ACAD SCI USA, V95, P15177, DOI 10.1073/pnas.95.26.15177; Gong WM, 2000, BIOCHEMISTRY-US, V39, P3955, DOI 10.1021/bi992346w; Hammer BK, 2007, P NATL ACAD SCI USA, V104, P11145, DOI 10.1073/pnas.0703860104; Hurley A, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006826; Jung SA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004837; Kim BS, 2018, MBIO, V9, DOI 10.1128/mBio.02262-17; Kim T, 2014, ACTA CRYSTALLOGR D, V70, P694, DOI 10.1107/S1399004713032355; Koh S, 2016, J BIOL CHEM, V291, P8575, DOI 10.1074/jbc.M116.718841; Liu Z, 2006, J BACTERIOL, V188, P2446, DOI 10.1128/JB.188.7.2446-2453.2006; Luscombe NM, 2000, GENOME BIOL, V1; Miller MB, 2002, CELL, V110, P303, DOI 10.1016/S0092-8674(02)00829-2; Ness SR, 2004, STRUCTURE, V12, P1753, DOI 10.1016/j.str.2004.07.018; Papenfort K, 2017, NAT CHEM BIOL, V13, DOI 10.1038/nchembio.2336; Papenfort K, 2015, P NATL ACAD SCI USA, V112, pE766, DOI 10.1073/pnas.1500203112; Qi SQ, 2010, CELL, V141, P446, DOI 10.1016/j.cell.2010.03.017; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Silpe J. E., 2019, CELL, V176, P1, DOI [10.1016/j.cell.2018.1010.1059, DOI 10.1016/J.CELL.2018.1010.1059]; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Vannini A, 2002, EMBO J, V21, P4393, DOI 10.1093/emboj/cdf459; Wang QS, 2018, NUCL SCI TECH, V29, DOI 10.1007/s41365-018-0398-9; Waters CA, 2008, J BACTERIOL, V190, P2527, DOI 10.1128/JB.01756-07; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Wysoczynski-Horita CL, 2018, MOL MICROBIOL, V108, P240, DOI 10.1111/mmi.13930; Xu C, 1997, J BIOL CHEM, V272, P15734, DOI 10.1074/jbc.272.25.15734; Yamada S, 2009, STRUCTURE, V17, P1333, DOI 10.1016/j.str.2009.07.016; Yao Y, 2006, J MOL BIOL, V355, P262, DOI 10.1016/j.jmb.2005.10.041; Zhang RG, 2002, NATURE, V417, P971, DOI 10.1038/nature00833	45	10	11	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2580	2592		10.1074/jbc.RA118.006082	http://dx.doi.org/10.1074/jbc.RA118.006082			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30610119	Green Published, hybrid			2022-12-28	WOS:000459601600001
J	Li, JL; Paris, SA; Thakur, H; Kapiloff, MS; Dodge-Kafka, KL				Li, Jinliang; Paris, Shania Aponte; Thakur, Hrishikesh; Kapiloff, Michael S.; Dodge-Kafka, Kimberly L.			Muscle A-kinase-anchoring protein-beta-bound calcineurin toggles active and repressive transcriptional complexes of myocyte enhancer factor 2D	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphatase; skeletal muscle; signal transduction; scaffold protein; phosphorylation; calcineurin; histone deacetylase; mAKAP beta; MEF2D; HDAC5; transcription factor; gene regulation; myoblast; A-kinase-anchoring protein; signalosome	IIA HISTONE DEACETYLASES; MAKAP-BETA; DEPENDENT REGULATION; MEF2; PHOSPHORYLATION; SCAFFOLD; DIFFERENTIATION; HYPERTROPHY; CONTRIBUTES; ACTIVATION	Myocyte enhancer factor 2 (MEF2) transcription factors are key regulators of the development and adult phenotype of diverse tissues, including skeletal and cardiac muscles. Controlled by multiple post-translational modifications, MEF2D is an effector for the Ca2+/calmodulin-dependent protein phosphatase calcineurin (CaN, PP2B, and PPP3). CaN-catalyzed dephosphorylation promotes the desumoylation and acetylation of MEF2D, increasing its transcriptional activity. Both MEF2D and CaN bind the scaffold protein muscle A-kinase-anchoring protein beta (mAKAP beta), which is localized to the nuclear envelope, such that C2C12 skeletal myoblast differentiation and neonatal rat ventricular myocyte hypertrophy are inhibited by mAKAP beta signalosome targeting. Using immunoprecipitation and DNA-binding assays, we now show that the formation of mAKAP beta signalosomes is required for MEF2D dephosphorylation, desumoylation, and acetylation in C2C12 cells. Reduced MEF2D phosphorylation was coupled to a switch from type IIa histone deacetylase to p300 histone acetylase binding that correlated with increased MEF2D-dependent gene expression and ventricular myocyte hypertrophy. Together, these results highlight the importance of mAKAP beta signalosomes for regulating MEF2D activity in striated muscle, affirming mAKAP beta as a nodal regulator in the myocyte intracellular signaling network.	[Li, Jinliang; Thakur, Hrishikesh; Kapiloff, Michael S.] Stanford Univ, Dept Ophthalmol, Byers Eye Inst, Palo Alto, CA 94304 USA; [Li, Jinliang; Thakur, Hrishikesh; Kapiloff, Michael S.] Stanford Univ, Dept Cardiovasc Med, Byers Eye Inst, Palo Alto, CA 94304 USA; [Li, Jinliang; Thakur, Hrishikesh; Kapiloff, Michael S.] Stanford Univ, Stanford Cardiovasc Inst, Spencer Ctr Vis Res, Palo Alto, CA 94304 USA; [Paris, Shania Aponte; Dodge-Kafka, Kimberly L.] Univ Connecticut, Ctr Hlth, Calhoun Ctr Cardiol, Farmington, CT 06030 USA	Stanford University; Stanford University; Stanford University; University of Connecticut	Kapiloff, MS (corresponding author), Stanford Univ, Dept Ophthalmol, Palo Alto, CA 94304 USA.; Kapiloff, MS (corresponding author), Stanford Univ, Dept Cardiovasc Med, Palo Alto, CA 94304 USA.; Dodge-Kafka, KL (corresponding author), Univ Connecticut, Ctr Hlth, Dept Cell Biol, Farmington, CT 06030 USA.; Dodge-Kafka, KL (corresponding author), Univ Connecticut, Ctr Hlth, Ctr Cardiol, Farmington, CT 06030 USA.	kapiloff@stanford.edu; dodge@uchc.edu		Kapiloff, Michael/0000-0002-7005-6953; Li, Jinliang/0000-0002-3018-0570	State of Connecticut Department of Public Health [2014-0133]; National Institutes of Health [HL126825, HL126950, EY026766, EY026877]; NATIONAL EYE INSTITUTE [P30EY026877, R01EY026766] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL126825, R01HL126950] Funding Source: NIH RePORTER	State of Connecticut Department of Public Health; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by State of Connecticut Department of Public Health Grant 2014-0133 (to K. D. K.) and National Institutes of Health Grants HL126825 (to K. D. K. and M. S. K.) and HL126950, EY026766, and EY026877 (to M. S. K). K. L. D.-K., J. L., and M. S. K. are co-inventors of patented intellectual property concerning the targeting of mAKAP for the treatment of heart failure. M. S. K. owns equity in Anchored RSK3 Inhibitors, LLC, and Cardiac RSK3 Inhibitors, LLC, companies interested in developing mAKAP beta-based therapies. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ayaydin F, 2004, MOL BIOL CELL, V15, P5208, DOI 10.1091/mbc.E04-07-0589; Bueno OF, 2004, CIRC RES, V94, P91, DOI 10.1161/01.RES.0000107197.99679.77; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Dewenter M, 2017, CIRC RES, V121, P1000, DOI 10.1161/CIRCRESAHA.117.310355; Dietrich JB, 2013, CELL TISSUE RES, V352, P179, DOI 10.1007/s00441-013-1565-2; Dodge KL, 2001, EMBO J, V20, P1921, DOI 10.1093/emboj/20.8.1921; Dodge-Kafka KL, 2018, J MOL CELL CARDIOL, V118, P13, DOI 10.1016/j.yjmcc.2018.03.001; Dodge-Kafka KL, 2010, J BIOL CHEM, V285, P11078, DOI 10.1074/jbc.M109.034868; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; GLASS CK, 1988, CELL, V54, P313, DOI 10.1016/0092-8674(88)90194-8; Gong XM, 2003, NEURON, V38, P33, DOI 10.1016/S0896-6273(03)00191-0; Gregoire S, 2005, MOL CELL BIOL, V25, P2273, DOI 10.1128/MCB.25.6.2273-2287.2005; Gregoire S, 2006, J BIOL CHEM, V281, P4423, DOI 10.1074/jbc.M509471200; Gregoire S, 2007, MOL CELL BIOL, V27, P1280, DOI 10.1128/MCB.00882-06; Holmqvist PH, 2013, TRANSCR-AUSTIN, V4, P18, DOI 10.4161/trns.22601; Kapiloff MS, 2009, J BIOL CHEM, V284, P23540, DOI 10.1074/jbc.M109.030072; Kapiloff MS, 1999, J CELL SCI, V112, P2725; Kim Y, 2008, J CLIN INVEST, V118, P124, DOI 10.1172/JCI33255; Kritzer MD, 2014, CIRC-HEART FAIL, V7, P663, DOI 10.1161/CIRCHEARTFAILURE.114.001266; Lee SW, 2015, SCI REP-UK, V5, DOI 10.1038/srep16523; Li JL, 2013, EXP CELL RES, V319, P447, DOI 10.1016/j.yexcr.2012.12.016; Li JL, 2010, J MOL CELL CARDIOL, V48, P387, DOI 10.1016/j.yjmcc.2009.10.023; Lindqvist J, 2017, J CELL SCI, V130, P2833, DOI 10.1242/jcs.202226; Liu N, 2014, P NATL ACAD SCI USA, V111, P4109, DOI 10.1073/pnas.1401732111; Marx SO, 2001, J CELL BIOL, V153, P699, DOI 10.1083/jcb.153.4.699; Meissner JD, 2007, J CELL PHYSIOL, V211, P138, DOI 10.1002/jcp.20916; Michel JJC, 2005, MOL CELL, V20, P661, DOI 10.1016/j.molcel.2005.10.013; Mihaylova MM, 2011, CELL, V145, P607, DOI 10.1016/j.cell.2011.03.043; Molinari S, 2004, MOL CELL BIOL, V24, P2944, DOI 10.1128/MCB.24.7.2944-2957.2004; Pare GC, 2005, J CELL SCI, V118, P5637, DOI 10.1242/jcs.02675; Pare GC, 2005, EXP CELL RES, V303, P388, DOI 10.1016/j.yexcr.2004.10.009; Parra V, 2017, J MOL CELL CARDIOL, V103, P121, DOI 10.1016/j.yjmcc.2016.12.006; Passariello CL, 2015, J CARDIOVASC PHARM, V65, P218, DOI 10.1097/FJC.0000000000000206; Passariello CL, 2013, AM J PHYSIOL-HEART C, V305, pH1010, DOI 10.1152/ajpheart.00237.2013; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Shibasaki F, 1996, NATURE, V382, P370, DOI 10.1038/382370a0; Taylor MV, 2017, SEMIN CELL DEV BIOL, V72, P33, DOI 10.1016/j.semcdb.2017.11.020; Vargas MAX, 2012, CELL SIGNAL, V24, P1496, DOI 10.1016/j.cellsig.2012.03.017; Xie M, 2013, TRENDS CARDIOVAS MED, V23, P229, DOI 10.1016/j.tcm.2012.12.006; Zhang LH, 2013, CELL, V153, P216, DOI 10.1016/j.cell.2013.02.047; Zhang LH, 2011, J BIOL CHEM, V286, P23012, DOI 10.1074/jbc.M111.231993; Zhao X, 2005, MOL CELL BIOL, V25, P8456, DOI 10.1128/MCB.25.19.8456-8464.2005	44	8	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2019	294	7					2543	2554		10.1074/jbc.RA118.005465	http://dx.doi.org/10.1074/jbc.RA118.005465			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL7CN	30523159	Green Published, hybrid			2022-12-28	WOS:000458895400028
J	Sharpe, LJ; Howe, V; Scott, NA; Luu, W; Phan, L; Berk, JM; Hochstrasser, M; Brown, AJ				Sharpe, Laura J.; Howe, Vicky; Scott, Nicola A.; Luu, Winnie; Phan, Lisa; Berk, Jason M.; Hochstrasser, Mark; Brown, Andrew J.			Cholesterol increases protein levels of the E3 ligase MARCH6 and thereby stimulates protein degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein stability; E3 ubiquitin ligase; protein degradation; post-transcriptional regulation; cholesterol; proteasome; INSIG-2; RGS2; squalene monooxygenase; TEB4; Type 2 iodothyronine deiodinase	STEROL-SENSING DOMAIN; PICK C1 PROTEIN; UBIQUITIN LIGASE; 3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE; SQUALENE MONOOXYGENASE; DEPENDENT UBIQUITINATION; ENDOPLASMIC-RETICULUM; MEDIATED DEGRADATION; MEMBRANE TOPOLOGY; BINDING	The E3 ligase membrane-associated ring-CH-type finger 6 (MARCH6) is a polytopic enzyme bound to the membranes of the endoplasmic reticulum. It controls levels of several known protein substrates, including a key enzyme in cholesterol synthesis, squalene monooxygenase. However, beyond its own autodegradation, little is known about how MARCH6 itself is regulated. Using CRISPR/Cas9 gene-editing, MARCH6 overexpression, and immunoblotting, we found here that cholesterol stabilizes MARCH6 protein endogenously and in HEK293 cells that stably express MARCH6. Conversely, MARCH6-deficient HEK293 and HeLa cells lost their ability to degrade squalene monooxygenase in a cholesterol-dependent manner. The ability of cholesterol to boost MARCH6 did not seem to involve a putative sterol-sensing domain in this E3 ligase, but was abolished when either membrane extraction by valosin-containing protein (VCP/p97) or proteasomal degradation was inhibited. Furthermore, cholesterol-mediated stabilization was absent in two MARCH6 mutants that are unable to degrade themselves, indicating that cholesterol stabilizes MARCH6 protein by preventing its autodegradation. Experiments with chemical chaperones suggested that this likely occurs through a conformational change in MARCH6 upon cholesterol addition. Moreover, cholesterol reduced the levels of at least three known MARCH6 substrates, indicating that cholesterol-mediated MARCH6 stabilization increases its activity. Our findings highlight an important new role for cholesterol in controlling levels of proteins, extending the known repertoire of cholesterol homeostasis players.	[Sharpe, Laura J.; Howe, Vicky; Scott, Nicola A.; Luu, Winnie; Phan, Lisa; Brown, Andrew J.] UNSW Sydney, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia; [Berk, Jason M.; Hochstrasser, Mark] Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA	University of New South Wales Sydney; Yale University	Brown, AJ (corresponding author), UNSW Sydney, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia.	aj.brown@unsw.edu.au		Hochstrasser, Mark/0000-0002-1131-5484; Sharpe, Laura/0000-0002-9896-294X; Howe, Vicky/0000-0002-7319-0664	National Health and Medical Research Council [1060515]; Australian Research Council [DP170101178]; Gold Star award from UNSW Sydney; National Institutes of Health [R01 GM046904, F32 GM113456]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM046904, R01GM046904, F32GM113456] Funding Source: NIH RePORTER	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Gold Star award from UNSW Sydney; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Health and Medical Research Council Grant 1060515 (to A. J. B.), Australian Research Council Grant DP170101178 (to A. J. B.), a Gold Star award from UNSW Sydney (to A. J. B.), and in part by National Institutes of Health Grants R01 GM046904 (to M. H.) and F32 GM113456 (to J. M. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Brown A. J., 2015, BIOCH LIPIDS LIPOPRO, P327; Brown AJ, 2002, MOL CELL, V10, P237, DOI 10.1016/S1097-2765(02)00591-9; Brown MS, 2018, ANNU REV BIOCHEM, V87, P783, DOI 10.1146/annurev-biochem-062917-011852; Bug M, 2012, J STRUCT BIOL, V179, P78, DOI 10.1016/j.jsb.2012.03.003; Burke R, 1999, CELL, V99, P803, DOI 10.1016/S0092-8674(00)81677-3; Cao X, 2006, ONCOGENE, V25, P3719, DOI 10.1038/sj.onc.1209408; Cook ECL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172721; Davies JP, 2000, J BIOL CHEM, V275, P24367, DOI 10.1074/jbc.M002184200; Fitzky BU, 2001, J CLIN INVEST, V108, P905, DOI 10.1172/JCI200112103; Freson K, 2007, J HYPERTENS, V25, P117, DOI 10.1097/HJH.0b013e3280109c6c; Gemmill RM, 1998, P NATL ACAD SCI USA, V95, P9572, DOI 10.1073/pnas.95.16.9572; Gill S, 2011, CELL METAB, V13, P260, DOI 10.1016/j.cmet.2011.01.015; Hassink G, 2005, BIOCHEM J, V388, P647, DOI 10.1042/BJ20041241; Howe V, 2017, BBA-MOL CELL BIOL L, V1862, P647, DOI 10.1016/j.bbalip.2017.03.009; Howe V, 2015, J BIOL CHEM, V290, P27533, DOI 10.1074/jbc.M115.675181; Huang EY, 2018, MOL BIOL CELL, V29, P1021, DOI 10.1091/mbc.E17-08-0514; Hulce JJ, 2013, NAT METHODS, V10, P259, DOI [10.1038/nmeth.2368, 10.1038/NMETH.2368]; Irisawa M, 2009, J BIOL CHEM, V284, P28995, DOI 10.1074/jbc.M109.041376; Jiang LY, 2018, J BIOL CHEM, V293, P4047, DOI 10.1074/jbc.RA117.001260; Jo Y, 2011, P NATL ACAD SCI USA, V108, P20503, DOI 10.1073/pnas.1112831108; Kawakami T, 2002, DEVELOPMENT, V129, P5753, DOI 10.1242/dev.00178; Nguyen KT, 2019, J BIOL CHEM, V294, P379, DOI 10.1074/jbc.RA118.005556; Kielar D, 2001, CLIN CHEM, V47, P2089; Kreft SG, 2006, J BIOL CHEM, V281, P4646, DOI 10.1074/jbc.M512215200; Kuwabara PE, 2002, TRENDS GENET, V18, P193, DOI 10.1016/S0168-9525(02)02640-9; Lee JP, 2010, MOL CANCER RES, V8, P93, DOI 10.1158/1541-7786.MCR-08-0491; Lee JN, 2006, J BIOL CHEM, V281, P39308, DOI 10.1074/jbc.M608999200; Libby AE, 2018, J LIPID RES, V59, P1482, DOI 10.1194/jlr.M086249; Loregger A, 2016, MOL CELL BIOL, V36, P285, DOI 10.1128/MCB.00890-15; Miller BT, 2012, ENDOCRINOLOGY, V153, P4039, DOI 10.1210/en.2012-1117; Nakamura N, 2014, EXP CELL RES, V328, P207, DOI 10.1016/j.yexcr.2014.07.025; Nohturfft A, 1998, P NATL ACAD SCI USA, V95, P12848, DOI 10.1073/pnas.95.22.12848; Ohgami N, 2004, P NATL ACAD SCI USA, V101, P12473, DOI 10.1073/pnas.0405255101; Park SE, 2015, SCIENCE, V347, P1249, DOI 10.1126/science.aaa3844; Prabhu AV, 2016, PROG LIPID RES, V64, P138, DOI 10.1016/j.plipres.2016.09.003; Prabhu AV, 2016, J BIOL CHEM, V291, P8363, DOI 10.1074/jbc.M115.699546; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Sartori M, 2008, METABOLISM, V57, P421, DOI 10.1016/j.metabol.2007.10.021; Schultz ML, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06115-2; Sever N, 2003, J BIOL CHEM, V278, P52479, DOI 10.1074/jbc.M310053200; Sever N, 2003, MOL CELL, V11, P25, DOI 10.1016/S1097-2765(02)00822-5; Song BL, 2005, CELL METAB, V1, P179, DOI 10.1016/j.cmet.2005.01.001; Song BL, 2004, J BIOL CHEM, V279, P28798, DOI 10.1074/jbc.M402442200; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Stefanovic-Barrett S, 2018, EMBO REP, V19, DOI 10.15252/embr.201745603; Strutt H, 2001, CURR BIOL, V11, P608, DOI 10.1016/S0960-9822(01)00179-8; Wang J, 2009, J LIPID RES, V50, P1653, DOI 10.1194/jlr.M800669-JLR200; Wang L, 2008, HEPATOLOGY, V48, P1558, DOI 10.1002/hep.22499; Wangeline MA, 2018, J BIOL CHEM, V293, P14937, DOI 10.1074/jbc.RA118.001808; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Yabe D, 2002, P NATL ACAD SCI USA, V99, P16672, DOI 10.1073/pnas.262669399; Zattas D, 2016, J BIOL CHEM, V291, P12105, DOI 10.1074/jbc.M116.726877; Zavacki AM, 2009, MOL CELL BIOL, V29, P5339, DOI 10.1128/MCB.01498-08; Zelcer N, 2014, MOL CELL BIOL, V34, P1262, DOI 10.1128/MCB.01140-13; Zelcer N, 2009, SCIENCE, V325, P100, DOI 10.1126/science.1168974; Zerenturk EJ, 2012, BBA-MOL CELL BIOL L, V1821, P1350, DOI 10.1016/j.bbalip.2012.07.006; Zhang L, 2017, ELIFE, V6, DOI 10.7554/eLife.28766.001	58	20	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2019	294	7					2436	2448		10.1074/jbc.RA118.005069	http://dx.doi.org/10.1074/jbc.RA118.005069			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL7CN	30545937	Green Published, hybrid			2022-12-28	WOS:000458895400020
J	Yu, SMW; Jean-Charles, PY; Abraham, DM; Kaur, S; Gareri, C; Mao, L; Rockman, HA; Shenoy, SK				Yu, Samuel Mon-Wei; Jean-Charles, Pierre-Yves; Abraham, Dennis M.; Kaur, Suneet; Gareri, Clarice; Mao, Lan; Rockman, Howard A.; Shenoy, Sudha K.			The deubiquitinase ubiquitin-specific protease 20 is a positive modulator of myocardial beta(1)-adrenergic receptor expression and signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ubiquitylation (ubiquitination); protein kinase A (PKA); lysosome; G protein-coupled receptor (GPCR); endocytosis	IN-VIVO; CARDIAC DYSFUNCTION; BETA(2)-ADRENERGIC RECEPTOR; PHOSPHOINOSITIDE 3-KINASE; PLASMA NOREPINEPHRINE; ADRENERGIC-RECEPTORS; CONTRACTILE FUNCTION; TARGETED DISRUPTION; HEART-FAILURE; KINASE 1	Reversible ubiquitination of G protein-coupled receptors regulates their trafficking and signaling; whether deubiquitinases regulate myocardial beta(1)-adrenergic receptors (beta(1)ARs) is unknown. We report that ubiquitin-specific protease 20 (USP20) deubiquitinates and attenuates lysosomal trafficking of the beta(1)AR. beta(1)AR-induced phosphorylation of USP20 Ser-333 by protein kinase A-alpha (PKA alpha) was required for optimal USP20-mediated regulation of beta(1)AR lysosomal trafficking. Both phosphomimetic (S333D) and phosphorylation-impaired (S333A) USP20 possess intrinsic deubiquitinase activity equivalent to WT activity. However, unlike USP20 WT and S333D, the S333A mutant associated poorly with the beta(1)AR and failed to deubiquitinate the beta(1)AR. USP20-KO mice showed normal baseline systolic function but impaired beta(1)AR-induced contractility and relaxation. Dobutamine stimulation did not increase cAMP in USP20-KO left ventricles (LVs), whereas NKH477-induced adenylyl cyclase activity was equivalent to WT. The USP20 homolog USP33, which shares redundant roles with USP20, had no effect on beta(1)AR ubiquitination, but USP33 was up-regulated in USP20-KO hearts suggesting compensatory regulation. Myocardial beta(1)AR expression in USP20-KO was drastically reduced, whereas beta(2)AR expression was maintained as determined by radioligand binding in LV sarcolemmal membranes. Phospho-USP20 was significantly increased in LVs of wildtype (WT) mice after a 1-week catecholamine infusion and a 2-week chronic pressure overload induced by transverse aortic constriction (TAC). Phospho-USP20 was undetectable in beta(1)AR KO mice subjected to TAC, suggesting a role for USP20 phosphorylation in cardiac response to pressure overload. We conclude that USP20 regulates beta(1)AR signaling in vitro and in vivo. Additionally, beta(1)AR-induced USP20 phosphorylation may serve as a feed-forward mechanism to stabilize beta(1)AR expression and signaling during pathological insults to the myocardium.	[Yu, Samuel Mon-Wei; Jean-Charles, Pierre-Yves; Abraham, Dennis M.; Kaur, Suneet; Gareri, Clarice; Mao, Lan; Rockman, Howard A.; Shenoy, Sudha K.] Duke Univ, Med Ctr, Div Cardiol, Dept Med, Durham, NC 27710 USA	Duke University	Shenoy, SK (corresponding author), Duke Univ, Med Ctr, Rm 412,SANDS Bldg,POB 103204,303 Res Dr, Durham, NC 27710 USA.	skshenoy@dm.duke.edu	Kaur, Suneet/ABB-4807-2020; gareri, clarice/AAC-3127-2019; Shenoy, Sudha/AAN-4075-2021	Kaur, Suneet/0000-0001-9271-8519; gareri, clarice/0000-0002-4859-8780; Shenoy, Sudha/0000-0002-2565-4663; Holloway, Courtney Jean/0000-0003-3661-1957	National Institutes of Health [HL118369, HL125905, HL56687, P01 HL75443]; American Heart Association [15GRNT25550051]; Mandel Center for Hypertension and Atherosclerosis Research; Duke O'Brien Center for Kidney Research National Institutes of Health/NIDDK Award [P30-DK096493]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL075443, R01HL118369, K08HL125905, R01HL056687] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK096493] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Mandel Center for Hypertension and Atherosclerosis Research; Duke O'Brien Center for Kidney Research National Institutes of Health/NIDDK Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants HL118369 (to S. K. S.), HL125905 (to D. A.), and HL56687 and P01 HL75443 (to H. A. R.), American Heart Association Grant 15GRNT25550051(to S. K. S.), the Mandel Center for Hypertension and Atherosclerosis Research, and Duke O'Brien Center for Kidney Research National Institutes of Health/NIDDK Award P30-DK096493. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AARONS RD, 1982, J PHARMACOL EXP THER, V221, P439; Asano K, 2001, J CARDIOVASC PHARM, V37, P678, DOI 10.1097/00005344-200106000-00005; Bernstein D, 2005, AM J PHYSIOL-HEART C, V289, pH2441, DOI 10.1152/ajpheart.00005.2005; Berthouze M, 2009, EMBO J, V28, P1684, DOI 10.1038/emboj.2009.128; Bohm M, 1998, CARDIOVASC RES, V40, P146, DOI 10.1016/S0008-6363(98)00099-6; Borodovsky A, 2005, CHEMBIOCHEM, V6, P287, DOI 10.1002/cbic.200400236; Bristow MR, 1997, CARDIOVASC DRUG THER, V11, P291, DOI 10.1023/A:1007748131847; BRISTOW MR, 1986, CIRC RES, V59, P297, DOI 10.1161/01.RES.59.3.297; BRISTOW MR, 1982, NEW ENGL J MED, V307, P205, DOI 10.1056/NEJM198207223070401; CHIDSEY CA, 1965, AM J MED, V39, P442, DOI 10.1016/0002-9343(65)90211-1; Chruscinski AJ, 1999, J BIOL CHEM, V274, P16694, DOI 10.1074/jbc.274.24.16694; Cleland JGF, 2006, J AM COLL CARDIOL, V47, P1603, DOI 10.1016/j.jacc.2005.11.069; Colomer JM, 2003, MOL ENDOCRINOL, V17, P183, DOI 10.1210/me.2002-0350; Dargie HJ, 2001, LANCET, V357, P1385, DOI 10.1016/s0140-6736(00)04560-8; Devic E, 2001, MOL PHARMACOL, V60, P577; Dores MR, 2012, MOL PHARMACOL, V82, P563, DOI 10.1124/mol.112.079418; Engelhardt S, 1996, J AM COLL CARDIOL, V27, P146, DOI 10.1016/0735-1097(95)00425-4; Feuerstein G, 1998, EUR J PHARMACOL, V351, P341, DOI 10.1016/S0014-2999(98)00326-4; Flesch M, 2001, CARDIOVASC RES, V49, P371, DOI 10.1016/S0008-6363(00)00277-7; FRANCIS GS, 1982, AM J CARDIOL, V49, P1152, DOI 10.1016/0002-9149(82)90039-X; GINSBURG R, 1983, AM HEART J, V106, P535, DOI 10.1016/0002-8703(83)90698-1; Han SO, 2012, J CELL BIOL, V199, P817, DOI 10.1083/jcb.201208192; Hara MR, 2011, NATURE, V477, P349, DOI 10.1038/nature10368; Harding VB, 2001, P NATL ACAD SCI USA, V98, P5809, DOI 10.1073/pnas.091102398; Hegde A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116458; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hewings DS, 2017, FEBS J, V284, P1555, DOI 10.1111/febs.14039; Iaccarino G, 1998, CIRCULATION, V98, P1783, DOI 10.1161/01.CIR.98.17.1783; Jean-Charles PY, 2016, PROG MOL BIOL TRANSL, V141, P1, DOI 10.1016/bs.pmbts.2016.05.001; Jean-Charles PY, 2018, ARTERIOSCL THROM VAS, V38, P2295, DOI 10.1161/ATVBAHA.118.311071; Jean-Charles PY, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.95998; Jean-Charles PY, 2017, J CARDIOVASC PHARM, V70, P142, DOI 10.1097/FJC.0000000000000482; Jean-Charles PY, 2016, J BIOL CHEM, V291, P7450, DOI 10.1074/jbc.M115.687129; Keys JR, 2003, AM J PHYSIOL-HEART C, V285, pH2201, DOI 10.1152/ajpheart.00112.2003; KOCH WJ, 1995, SCIENCE, V268, P1350, DOI 10.1126/science.7761854; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kommaddi RP, 2015, J BIOL CHEM, V290, P8888, DOI 10.1074/jbc.M114.630541; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Mangmool S, 2010, J CELL BIOL, V189, P573, DOI 10.1083/jcb.200911047; Morisco C, 2000, J BIOL CHEM, V275, P14466, DOI 10.1074/jbc.275.19.14466; Morisco C, 2008, CARDIOVASC RES, V78, P36, DOI 10.1093/cvr/cvn008; Naik E, 2016, J IMMUNOL, V196, P3438, DOI 10.4049/jimmunol.1403165; Nienaber JJ, 2003, J CLIN INVEST, V112, P1067, DOI 10.1172/JCI200318213; Noma T, 2007, J CLIN INVEST, V117, P2445, DOI 10.1172/JCI31901; Oudit GY, 2003, CIRCULATION, V108, P2147, DOI 10.1161/01.CIR.0000091403.62293.2B; Perrino C, 2005, CIRCULATION, V111, P2579, DOI 10.1161/CIRCULATIONAHA.104.508796; Perrino C, 2007, CIRCULATION, V116, P2571, DOI 10.1161/CIRCULATIONAHA.107.706515; Perrino C, 2006, J CLIN INVEST, V116, P1547, DOI 10.1172/JCI25397; Prasad SVN, 2001, J BIOL CHEM, V276, P18953, DOI 10.1074/jbc.M102376200; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Rockman HA, 1998, J BIOL CHEM, V273, P18180, DOI 10.1074/jbc.273.29.18180; Rockman HA, 1998, P NATL ACAD SCI USA, V95, P7000, DOI 10.1073/pnas.95.12.7000; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; Rohrer DK, 1998, ANNU REV PHARMACOL, V38, P351, DOI 10.1146/annurev.pharmtox.38.1.351; Rohrer DK, 1999, J BIOL CHEM, V274, P16701, DOI 10.1074/jbc.274.24.16701; Rohrer DK, 1996, P NATL ACAD SCI USA, V93, P7375, DOI 10.1073/pnas.93.14.7375; Rohrer DK, 1998, AM J PHYSIOL-HEART C, V274, pH1184, DOI 10.1152/ajpheart.1998.274.4.H1184; Sahtoe DD, 2015, TRENDS BIOCHEM SCI, V40, P456, DOI 10.1016/j.tibs.2015.05.002; Salazar NC, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-64; Shcherbakova OG, 2007, J CELL BIOL, V176, P521, DOI 10.1083/jcb.200604167; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shenoy SK, 2008, J BIOL CHEM, V283, P22166, DOI 10.1074/jbc.M709668200; Shenoy SK, 2009, P NATL ACAD SCI USA, V106, P6650, DOI 10.1073/pnas.0901083106; Sigmund M, 1996, EUR J CLIN PHARMACOL, V51, P127, DOI 10.1007/s002280050172; Skavdahl M, 2005, AM J PHYSIOL-HEART C, V288, pH469, DOI 10.1152/ajpheart.00723.2004; Tachibana H, 2006, BIOCHEM BIOPH RES CO, V343, P1060, DOI 10.1016/j.bbrc.2006.03.065; Tachibana H, 2005, CIRCULATION, V111, P591, DOI 10.1161/01.CIR.0000142291.70954.DF; THOMAS JA, 1978, AM J CARDIOL, V41, P233, DOI 10.1016/0002-9149(78)90162-5; UNGERER M, 1993, CIRCULATION, V87, P454, DOI 10.1161/01.CIR.87.2.454; Xiang Y, 2003, SCIENCE, V300, P1530, DOI 10.1126/science.1079206; Xiao KH, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.203091; Yoo B, 2009, AM J PHYSIOL-HEART C, V297, pH1377, DOI 10.1152/ajpheart.00504.2009; Yoshikawa T, 1996, EUR HEART J, V17, P8, DOI 10.1093/eurheartj/17.suppl_B.8; YUE TL, 1992, EUR J PHARMACOL, V214, P277; Zhao MM, 2011, AM J PHYSIOL-HEART C, V301, pH1461, DOI 10.1152/ajpheart.00453.2010; Zhou JB, 2010, J CLIN INVEST, V120, P2280, DOI 10.1172/JCI41407	77	10	10	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2019	294	7					2500	2518		10.1074/jbc.RA118.004926	http://dx.doi.org/10.1074/jbc.RA118.004926			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL7CN	30538132	Green Published, hybrid			2022-12-28	WOS:000458895400025
J	Zhang, Y; Lu, J; Ma, J; Liu, XQ				Zhang, You; Lu, Jing; Ma, Jing; Liu, Xinqi			Insulin-induced gene 1 (INSIG1) inhibits HIV-1 production by degrading Gag via activity of the ubiquitin ligase TRC8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						virus; virology; viral protein; protein degradation; protein expression; insulin-induced gene 1 (INSIG1); HIV-1 production; TRC8; Gag protein; lysosome pathway degradation; ubiquitin ligase; endosome; ring finger protein 139 (RNF139); HIV replication	LIPID RAFTS; CHOLESTEROL-SYNTHESIS; INNATE IMMUNITY; DEGRADATION; PROTEIN; BINDING; TARGET; REPLICATION; METABOLISM; REGULATOR	Insulin-induced gene 1 (INSIG1) regulates sterol synthesis by mediating the activation of sterol regulatory element-binding protein (SREBP) and the degradation of the HMG-CoA reductase (HMGCR). INSIG1 is up-regulated during HIV-1 infection, but its role in HIV-1 infection is unknown. In this report, using pseudovirus production, protein overexpression, and gene knockouts, we found that INSIG1 inhibits HIV-1 production by accelerating the degradation of the HIV-1 Gag protein. Unlike the degradation of HMGCR via the E3 ubiquitin ligase autocrine motility factor receptor (AMFR), a process that depends on the proteasome, INSIG1 coordinated with another ligase, translocation in renal carcinoma chromosome 8 (TRC8), and promoted Gag degradation through the lysosome pathway. We conclude that INSIG1 functions as a sentinel responsive to HIV-1 production and inhibits HIV-1 replication by degrading Gag, a process occurring at intracellular membrane sites such as the endoplasmic reticulum and endosomes where both INSIG1 and Gag may be located.	[Zhang, You; Lu, Jing; Ma, Jing; Liu, Xinqi] Nankai Univ, Coll Life Sci, Dept Biochem & Mol Biol, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China	Nankai University	Liu, XQ (corresponding author), Nankai Univ, Coll Life Sci, Dept Biochem & Mol Biol, Tianjin 300071, Peoples R China.	liu2008@nankai.edu.cn	Zhang, You/GYU-9078-2022; Ma, Jing/GQH-0676-2022	Ma, Jing/0000-0002-8096-4832; liu, xinqi/0000-0002-6045-718X; Zhang, You/0000-0002-5401-4593	Tianjin Natural Science Foundation Grant [17JCZDJC31900]; National Key Research and Development Program of China [2017YFD0200900]; Nankai University [63185024]	Tianjin Natural Science Foundation Grant; National Key Research and Development Program of China; Nankai University	Supported by Tianjin Natural Science Foundation Grant 17JCZDJC31900, National Key Research and Development Program of China Grant 2017YFD0200900, and Nankai University Intramural Funding Grant 63185024. To whom correspondence should be addressed: Dept. of Biochemistry and Molecular Biology, College of Life Sciences, Nankai University, Tianjin 300071, China. Tel.: 86-22-23505130; E-mail: liu2008@nankai.edu.cn.	Altfeld M, 2015, NAT IMMUNOL, V16, P554, DOI 10.1038/ni.3157; Brauweiler A, 2007, ONCOGENE, V26, P2263, DOI 10.1038/sj.onc.1210017; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; BRYANT M, 1990, P NATL ACAD SCI USA, V87, P523, DOI 10.1073/pnas.87.2.523; Chazal N, 2003, MICROBIOL MOL BIOL R, V67, P226, DOI 10.1128/MMBR.67.2.226-237.2003; Dong XY, 2010, PEPTIDES, V31, P2145, DOI 10.1016/j.peptides.2010.07.020; Feramisco JD, 2004, J BIOL CHEM, V279, P8487, DOI 10.1074/jbc.M312623200; Gao DX, 2013, SCIENCE, V341, P903, DOI 10.1126/science.1240933; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Gong Y, 2006, P NATL ACAD SCI USA, V103, P6154, DOI 10.1073/pnas.0601923103; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Jakobsen MR, 2013, P NATL ACAD SCI USA, V110, pE4571, DOI 10.1073/pnas.1311669110; Jo Y, 2011, P NATL ACAD SCI USA, V108, P20503, DOI 10.1073/pnas.1112831108; Jouve M, 2007, CELL HOST MICROBE, V2, P85, DOI 10.1016/j.chom.2007.06.011; Kim DY, 2013, MOL CELL, V49, P632, DOI 10.1016/j.molcel.2012.12.012; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lee JP, 2010, MOL CANCER RES, V8, P93, DOI 10.1158/1541-7786.MCR-08-0491; Levy DN, 2004, P NATL ACAD SCI USA, V101, P4204, DOI 10.1073/pnas.0306764101; Ma WF, 2013, EMBO J, V32, P926, DOI 10.1038/emboj.2013.41; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Munger J, 2008, NAT BIOTECHNOL, V26, P1179, DOI 10.1038/nbt.1500; Nayak DP, 2002, ADV VIRUS RES, V58, P1, DOI 10.1016/S0065-3527(02)58001-5; Nityanandam R, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004151; Ravid T, 2000, J BIOL CHEM, V275, P35840, DOI 10.1074/jbc.M004793200; Sato R, 2010, ARCH BIOCHEM BIOPHYS, V501, P177, DOI 10.1016/j.abb.2010.06.004; Sever N, 2003, MOL CELL, V11, P25, DOI 10.1016/S1097-2765(02)00822-5; Sharpe LJ, 2013, J BIOL CHEM, V288, P18707, DOI 10.1074/jbc.R113.479808; Shimano H, 2017, NAT REV ENDOCRINOL, V13, P710, DOI 10.1038/nrendo.2017.91; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; STEINMAN RM, 1983, J CELL BIOL, V96, P1, DOI 10.1083/jcb.96.1.1; Sun LP, 2005, J BIOL CHEM, V280, P26483, DOI 10.1074/jbc.M504041200; Suomalainen M, 2002, TRAFFIC, V3, P705, DOI 10.1034/j.1600-0854.2002.31002.x; van 't Wout AB, 2005, J VIROL, V79, P10053, DOI 10.1128/JVI.79.15.10053-10058.2005; Wang Q, 2014, IMMUNITY, V41, P919, DOI 10.1016/j.immuni.2014.11.011; Yabe D, 2002, P NATL ACAD SCI USA, V99, P12753, DOI 10.1073/pnas.162488899; Zheng YH, 2003, P NATL ACAD SCI USA, V100, P8460, DOI 10.1073/pnas.1437453100	38	4	4	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2019	294	6					2046	2059		10.1074/jbc.RA118.004630	http://dx.doi.org/10.1074/jbc.RA118.004630			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM8EO	30563842	Green Published, hybrid			2022-12-28	WOS:000459711400023
J	Jeong, J; Choi, J; Kim, W; Dann, P; Takyar, F; Gefter, JV; Friedman, PA; Wysolmerski, JJ				Jeong, Jaekwang; Choi, Jungmin; Kim, Wonnam; Dann, Pamela; Takyar, Farzin; Gefter, Julia V.; Friedman, Peter A.; Wysolmerski, John J.			Inhibition of ezrin causes PKC alpha-mediated internalization of erbb2/HER2 tyrosine kinase in breast cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ezrin; scaffold protein; breast cancer; heat shock protein 90 (Hsp90); PDZ domain; protein kinase C (PKC); ErbB2/HER2; NHERF1; PMCA2	PROTEIN; ASSOCIATION; RECEPTORS; LOCALIZATION; NHERF1/EBP50; ACTIVATION; INTERACTS; REVEALS; PRODUCT; COMPLEX	Unlike other ErbB family members, HER2 levels are maintained on the cell surface when the receptor is activated, allowing prolonged signaling and contributing to its transforming ability. Interactions between HER2, HSP90, PMCA2, and NHERF1 within specialized plasma membrane domains contribute to the membrane retention of HER2. We hypothesized that the scaffolding protein ezrin, which has been shown to interact with NHERF1, might also help stabilize the HER2-PMCA2-NHERF1 complex at the plasma membrane. Therefore, we examined ezrin expression and its relationship with HER2, NHERF1, and PMCA2 levels in murine and human breast cancers. We also used genetic knockdown and/or pharmacologic inhibition of ezrin, HSP90, NHERF1, PMCA2, and HER2 to examine the functional relationships between these factors and membrane retention of HER2. We found ezrin to be expressed at low levels at the apical surface of normal mammary epithelial cells, but its expression is up-regulated and correlates with HER2 expression in hyperplasia and tumors in murine mammary tumor virus-Neu mice, in human HER2-positive breast cancer cell lines, and in ductal carcinoma in situ and invasive breast cancers from human patients. In breast cancer cells, ezrin co-localizes and interacts with HER2, NHERF1, PMCA2, and HSP90 in specialized membrane domains, and inhibiting ezrin disrupts interactions between HER2, PMCA2, NHERF1, and HSP90, inhibiting HER2 signaling and causing PKC alpha-mediated internalization and degradation of HER2. Inhibition of ezrin synergizes with lapatinib in a PKC alpha-dependent fashion to inhibit proliferation and promote apoptosis in HER2-positive breast cancer cells. We conclude that ezrin stabilizes a multiprotein complex that maintains active HER2 at the cell surface.	[Jeong, Jaekwang; Kim, Wonnam; Dann, Pamela; Takyar, Farzin; Wysolmerski, John J.] Yale Univ, Sch Med, Dept Internal Med, Sect Endocrinol & Metab, New Haven, CT 06510 USA; [Choi, Jungmin] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Kim, Wonnam] Semyung Univ, Coll Korean Med, Div Pharmacol, Jecheon 27136, South Korea; [Gefter, Julia V.; Friedman, Peter A.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA	Yale University; Yale University; Semyung University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wysolmerski, JJ (corresponding author), Yale Sch Med, TAC S123a,Box 208020, New Haven, CT 06520 USA.	john.wysolmerski@yale.edu		Choi, Jungmin/0000-0002-8614-0973; JEONG, JAEKWANG/0000-0001-8865-2545	National Institutes of Health [CA153702, HD076248]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD076248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK111427] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants CA153702 and HD076248 (to J.J.W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Antelmi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075113; Ardura JA, 2011, PHARMACOL REV, V63, P882, DOI 10.1124/pr.110.004176; Arteaga CL, 2014, CANCER CELL, V25, P282, DOI 10.1016/j.ccr.2014.02.025; Arteaga CL, 2012, NAT REV CLIN ONCOL, V9, P16, DOI 10.1038/nrclinonc.2011.177; Asp N, 2016, ONCOTARGET, V7, P25443, DOI 10.18632/oncotarget.8327; Bailey TA, 2014, J BIOL CHEM, V289, P30443, DOI 10.1074/jbc.M114.608992; Bellizzi A, 2010, BREAST CARE, V5, P86, DOI 10.1159/000298962; Bertelsen V, 2014, MEMBRANES, V4, P424, DOI 10.3390/membranes4030424; Borg JP, 2000, NAT CELL BIOL, V2, P407, DOI 10.1038/35017038; Bretscher A, 2000, ANNU REV CELL DEV BI, V16, P113, DOI 10.1146/annurev.cellbio.16.1.113; Bulut G, 2012, ONCOGENE, V31, P269, DOI 10.1038/onc.2011.245; CAO HN, 1991, ONCOGENE, V6, P705; Cardone RA, 2007, MOL BIOL CELL, V18, P1768, DOI 10.1091/mbc.E06-07-0617; CARRAWAY CAC, 1993, J BIOL CHEM, V268, P5582; Castagnola P, 2016, ONCOTARGET, V7, P85411, DOI 10.18632/oncotarget.13392; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Clucas J, 2015, J CELL SCI, V128, P1253, DOI 10.1242/jcs.170027; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; DOBASHI K, 1989, DNA-J MOLEC CELL BIO, V8, P723, DOI 10.1089/dna.1989.8.723; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Georgescu MM, 2008, CURR MOL MED, V8, P459, DOI 10.2174/156652408785748031; Georgescu MM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1992; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; Hansen MC, 2014, BIOTECHNIQUES, V56, P217, DOI 10.2144/000114164; Hommelgaard AM, 2004, MOL BIOL CELL, V15, P1557, DOI 10.1091/mbc.E03-08-0596; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Isakov N, 2018, SEMIN CANCER BIOL, V48, P36, DOI 10.1016/j.semcancer.2017.04.012; Ivanova JL, 2012, BIOCHIMIE, V94, P1833, DOI 10.1016/j.biochi.2012.04.011; Jaulin-Bastard F, 2001, J BIOL CHEM, V276, P15256, DOI 10.1074/jbc.M010032200; Jeong J, 2017, J BIOL CHEM, V292, P6555, DOI 10.1074/jbc.M116.770883; Jeong J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174849; Jeong J, 2016, P NATL ACAD SCI USA, V113, pE282, DOI 10.1073/pnas.1516138113; Karn T, 2011, BREAST CANCER RES TR, V130, P409, DOI 10.1007/s10549-010-1333-x; Kawaguchi K, 2017, BIOL PHARM BULL, V40, P381, DOI 10.1248/bpb.b16-01011; Lazar CS, 2004, MOL BIOL CELL, V15, P5470, DOI 10.1091/mbc.E04-03-0239; Lei CT, 2017, CELL PHYSIOL BIOCHEM, V42, P281, DOI 10.1159/000477329; Li JW, 2015, SCI REP-UK, V5, DOI 10.1038/srep17903; Liu ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080721; Ma LF, 2013, ONCOL REP, V30, P1899, DOI 10.3892/or.2013.2641; Magnifico A, 2007, CANCER RES, V67, P5308, DOI 10.1158/0008-5472.CAN-06-3936; Mangia A, 2009, HISTOPATHOLOGY, V55, P600, DOI 10.1111/j.1365-2559.2009.03424.x; Maudsley S, 2000, MOL CELL BIOL, V20, P8352, DOI 10.1128/MCB.20.22.8352-8363.2000; MORI S, 1987, VIRCHOWS ARCH B, V54, P8, DOI 10.1007/BF02899192; Newton AC, 2018, SEMIN CANCER BIOL, V48, P18, DOI 10.1016/j.semcancer.2017.04.017; Nourry Claire, 2003, Sci STKE, V2003, pRE7; Pan Y, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1846; Ponuwei GA, 2016, J BIOMED SCI, V23, DOI 10.1186/s12929-016-0246-3; Sarrio D, 2006, BREAST CANCER RES TR, V98, P71, DOI 10.1007/s10549-005-9133-4; Scaltriti M, 2009, ONCOGENE, V28, P803, DOI 10.1038/onc.2008.432; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; STERN DF, 1986, MOL CELL BIOL, V6, P1729, DOI 10.1128/MCB.6.5.1729; United States Cancer Statistics Working Group, 2017, US CANC STAT 1999 20; Ursini-Siegel J, 2007, NAT REV CANCER, V7, P389, DOI 10.1038/nrc2127; Vaquero J, 2017, ONCOGENE, V36, P3067, DOI 10.1038/onc.2016.462; Weinman EJ, 2006, ANNU REV PHYSIOL, V68, P491, DOI 10.1146/annurev.physiol.68.040104.131050; Zagouri F, 2013, BREAST, V22, P569, DOI 10.1016/j.breast.2013.06.003	57	12	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2019	294	3					887	901		10.1074/jbc.RA118.004143	http://dx.doi.org/10.1074/jbc.RA118.004143			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL4FC	30463939	hybrid, Green Published			2022-12-28	WOS:000458670200015
J	Fu, JS; Xiong, ZH; Huang, CZ; Li, J; Yang, WJ; Han, YN; Paiboonrungruan, C; Major, MB; Chen, KN; Kang, XZ; Chen, XX				Fu, Junsheng; Xiong, Zhaohui; Huang, Caizhi; Li, Jing; Yang, Wenjun; Han, Yuning; Paiboonrungruan, Chorlada; Major, Michael B.; Chen, Ke-Neng; Kang, Xiaozheng; Chen, Xiaoxin			Hyperactivity of the transcription factor Nrf2 causes metabolic reprogramming in mouse esophagus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						metabolism; epithelium; Nuclear factor 2 (erythroid-derived 2-like factor) (NFE2L2) (Nrf2); pentose phosphate pathway (PPP); proliferation; Esophagus; Keap1; PKM2	PYRUVATE-KINASE; CANCER METABOLISM; SIGNALING PATHWAY; BINDING-SITES; LUNG-CANCER; KEAP1; ISOFORM; IDENTIFICATION; SURVIVAL; PROTEIN	Mutations in the genes encoding nuclear factor (erythroid-derived 2)-like 2 (NRF2), Kelch-like ECH-associated protein 1 (KEAP1), and cullin 3 (CUL3) are commonly observed in human esophageal squamous cell carcinoma (ESCC) and result in activation of the NRF2 signaling pathway. Moreover, hyperactivity of the transcription factor Nrf2 has been found to cause esophageal hyperproliferation and hyperkeratosis in mice. However, the underlying mechanism is unclear. In this study, we aimed to understand the molecular mechanisms of esophageal hyperproliferation in mice due to hyperactive Nrf2. Esophageal tissues were obtained from genetically modified mice that differed in the status of the Nrf2 gene and genes in the same pathway (Nrf2(-/-), Keap1(-/-), K5Cre;Pkm2(fl/fl);Keap1(-/-), and WT) and analyzed for metabolomic profiles, Nrf2 ChIP-seq, and gene expression. We found that hyperactive Nrf2 causes metabolic reprogramming and up-regulation of metabolic genes in the mouse esophagus. One of the glycolysis genes encoding pyruvate kinase M2 (Pkm2) was not only differentially up-regulated, but also glycosylated and oligomerized, resulting in increased ATP biosynthesis. However, constitutive knockout of Pkm2 failed to inhibit this esophageal phenotype in vivo, and this failure may have been due to compensation by Pkm1 up-regulation. Transient inhibition of NRF2 or glycolysis inhibited the growth of human ESCC cells in which NRF2 is hyperactive in vitro. In summary, hyperactive Nrf2 causes metabolic reprogramming in the mouse esophagus through its transcriptional regulation of metabolic genes. Blocking glycolysis transiently inhibits cell proliferation and may therefore have therapeutically beneficial effects on NRF2(high) ESCC in humans.	[Fu, Junsheng] Fujian Agr & Forestry Univ, Coll Life Sci, Fuzhou 350002, Fujian, Peoples R China; [Fu, Junsheng; Xiong, Zhaohui; Huang, Caizhi; Paiboonrungruan, Chorlada; Chen, Xiaoxin] North Carolina Cent Univ, Canc Res Program, Julius L Chambers Biomed Biotechnol Res Inst, 700 George St, Durham, NC 27707 USA; [Li, Jing; Han, Yuning] Ningxia Med Univ, Gen Hosp, Dept Thorac Surg, Yinchuan 750004, Ningxia, Peoples R China; [Yang, Wenjun] Ningxia Med Univ, Key Lab Fertil Preservat & Maintenance, Minist Educ, Canc Inst,Gen Hosp, Yinchuan 750004, Ningxia, Peoples R China; [Major, Michael B.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA; [Chen, Ke-Neng; Kang, Xiaozheng] Peking Univ, Dept Thorac Surg 1, Key Lab Carcinogenesis & Translat Res, Minist Educ,Canc Hosp & Inst, Beijing 100142, Peoples R China; [Chen, Xiaoxin] Univ N Carolina, Div Gastroenterol & Hepatol, Dept Med, Ctr Esophageal Dis & Swallowing, Chapel Hill, NC 27599 USA	Fujian Agriculture & Forestry University; University of North Carolina; North Carolina Central University; Ningxia Medical University; Ningxia Medical University; University of North Carolina; University of North Carolina Chapel Hill; Peking University; University of North Carolina; University of North Carolina Chapel Hill	Chen, XX (corresponding author), North Carolina Cent Univ, Canc Res Program, Julius L Chambers Biomed Biotechnol Res Inst, 700 George St, Durham, NC 27707 USA.; Kang, XZ (corresponding author), Peking Univ, Dept Thorac Surg 1, Key Lab Carcinogenesis & Translat Res, Minist Educ,Canc Hosp & Inst, Beijing 100142, Peoples R China.	kangxz@hsc.pku.edu.cn; lchen@nccu.edu	Kang, Xiaozheng/CAF-6485-2022	Kang, Xiaozheng/0000-0003-0334-1487; Yang, Wenjun/0000-0001-5671-1344; Major, Michael/0000-0002-6753-8513	China Scholarship Council [201608350016]; National Institutes of Health Research [U54 AA019765, U54 CA156735, U54 MD012392]; Beijing Municipal Administration of Hospitals Youth Program Grant [QML20171106]; NATIONAL CANCER INSTITUTE [U54CA156735, U54CA156733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U54AA019765] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD012392] Funding Source: NIH RePORTER	China Scholarship Council(China Scholarship Council); National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beijing Municipal Administration of Hospitals Youth Program Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by China Scholarship Council Grant 201608350016, National Institutes of Health Research Grants U54 AA019765, U54 CA156735, and U54 MD012392, and Beijing Municipal Administration of Hospitals Youth Program Grant QML20171106. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Camp ND, 2012, J BIOL CHEM, V287, P6539, DOI 10.1074/jbc.M111.316471; Chen H, 2014, GUT, V63, P711, DOI 10.1136/gutjnl-2012-303731; Chen H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036504; Chen J, 2011, ONCOGENE, V30, P4297, DOI 10.1038/onc.2011.137; Chen M, 2012, NAT STRUCT MOL BIOL, V19, P346, DOI 10.1038/nsmb.2219; Chen WM, 2009, MOL CELL, V34, P663, DOI 10.1016/j.molcel.2009.04.029; Chorley BN, 2012, NUCLEIC ACIDS RES, V40, P7416, DOI 10.1093/nar/gks409; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Cortes-Cros M, 2013, P NATL ACAD SCI USA, V110, P489, DOI 10.1073/pnas.1212780110; Dayton TL, 2018, CANCER METAB, V6, DOI 10.1186/s40170-018-0179-2; Dayton TL, 2016, EMBO REP, V17, P1721, DOI 10.15252/embr.201643300; Dayton TL, 2016, GENE DEV, V30, P1020, DOI 10.1101/gad.278549.116; DeBerardinis RJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600200; DeNicola GM, 2015, NAT GENET, V47, P1475, DOI 10.1038/ng.3421; Du PN, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14909-5; Gao YB, 2014, NAT GENET, V46, P1097, DOI 10.1038/ng.3076; Hast BE, 2013, CANCER RES, V73, P2199, DOI 10.1158/0008-5472.CAN-12-4400; Hayes JD, 2006, MOL CELL, V21, P732, DOI 10.1016/j.molcel.2006.03.004; Hirotsu Y, 2012, NUCLEIC ACIDS RES, V40, P10228, DOI 10.1093/nar/gks827; Holmstrom Kira M., 2016, Current Opinion in Toxicology, V1, P80, DOI 10.1016/j.cotox.2016.10.002; Israelsen WJ, 2013, CELL, V155, P397, DOI 10.1016/j.cell.2013.09.025; Jaramillo MC, 2013, GENE DEV, V27, P2179, DOI 10.1101/gad.225680.113; Kamburov A, 2011, NUCLEIC ACIDS RES, V39, pD712, DOI 10.1093/nar/gkq1156; Kamburov A, 2009, NUCLEIC ACIDS RES, V37, pD623, DOI 10.1093/nar/gkn698; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kensler TW, 2013, TOP CURR CHEM, V329, P163, DOI 10.1007/128_2012_339; Khan AU, 2016, EBIOMEDICINE, V3, P43, DOI 10.1016/j.ebiom.2015.11.045; Kitamura H, 2018, CANCER SCI, V109, P900, DOI 10.1111/cas.13537; Kobayashi EH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11624; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Krail EB, 2017, ELIFE, V6, DOI [10.7554/eLife.18970, 10.7554/eLife.33173]; Lan AX, 2016, ONCOTARGET, V7, P53502, DOI 10.18632/oncotarget.10609; Lau AN, 2017, CANCER METAB, V5, DOI 10.1186/s40170-017-0172-1; Lin DC, 2014, NAT GENET, V46, P467, DOI 10.1038/ng.2935; Lo SC, 2006, J BIOL CHEM, V281, P37893, DOI 10.1074/jbc.M606539200; Ludtmann MHR, 2014, BIOCHEM J, V457, P415, DOI 10.1042/BJ20130863; Lunt SY, 2015, MOL CELL, V57, P95, DOI 10.1016/j.molcel.2014.10.027; Ma JL, 2012, MOL CELL BIOL, V32, P1506, DOI 10.1128/MCB.06271-11; Ma Q, 2012, PHARMACOL REV, V64, P1055, DOI 10.1124/pr.110.004333; Ma SH, 2018, ANN NY ACAD SCI, V1434, P164, DOI 10.1111/nyas.13681; Malhotra D, 2010, NUCLEIC ACIDS RES, V38, P5718, DOI 10.1093/nar/gkq212; Mayers JR, 2017, CANCER RES, V77, P3131, DOI 10.1158/0008-5472.CAN-17-0165; Mitsuishi Y, 2012, CANCER CELL, V22, P66, DOI 10.1016/j.ccr.2012.05.016; Mulvaney KM, 2016, J BIOL CHEM, V291, P23719, DOI 10.1074/jbc.M116.729418; Padmanabhan B, 2006, MOL CELL, V21, P689, DOI 10.1016/j.molcel.2006.01.013; Ramadori P, 2016, FREE RADICAL BIO MED, V91, P114, DOI 10.1016/j.freeradbiomed.2015.12.014; Rolfs F, 2015, CANCER RES, V75, P4817, DOI 10.1158/0008-5472.CAN-15-0614; Romero R, 2017, NAT MED, V23, P1362, DOI 10.1038/nm.4407; Sabouny R, 2017, ANTIOXID REDOX SIGN, V27, P1447, DOI 10.1089/ars.2016.6855; Saito T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12030; Sano S, 1999, EMBO J, V18, P4657, DOI 10.1093/emboj/18.17.4657; Sayin VI, 2017, ELIFE, V6, DOI 10.7554/eLife.28083; Shibata T, 2011, NEOPLASIA, V13, P864, DOI 10.1593/neo.11750; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Sporn MB, 2012, NAT REV CANCER, V12, P564, DOI 10.1038/nrc3278; Su CH, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00466-16; Su H, 2011, CLIN CANCER RES, V17, P2955, DOI 10.1158/1078-0432.CCR-10-2724; Sui SJH, 2005, NUCLEIC ACIDS RES, V33, P3154, DOI 10.1093/nar/gki624; Suzuki T, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14577; Tamborero D, 2013, SCI REP-UK, V3, DOI 10.1038/srep02650; Uruno A, 2016, MOL CELL BIOL, V36, P1655, DOI 10.1128/MCB.01095-15; Vander Heiden MG, 2017, CELL, V168, DOI 10.1016/j.cell.2016.12.039; Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248; Wang H, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad6095; Wang Y, 2017, P NATL ACAD SCI USA, V114, P13732, DOI 10.1073/pnas.1704145115; Wang YH, 2014, CELL, V158, P1309, DOI 10.1016/j.cell.2014.07.048; Wu XC, 2007, CANCER CAUSE CONTROL, V18, P585, DOI 10.1007/s10552-007-9000-1; Yamamoto M, 2018, PHYSIOL REV, V98, P1169, DOI 10.1152/physrev.00023.2017; Zhang DS, 2014, CANCER LETT, V355, P176, DOI 10.1016/j.canlet.2014.09.003; Zhu JY, 2016, FREE RADICAL BIO MED, V99, P544, DOI 10.1016/j.freeradbiomed.2016.09.010	71	31	31	1	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2019	294	1					327	340		10.1074/jbc.RA118.005963	http://dx.doi.org/10.1074/jbc.RA118.005963			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG6PT	30409900	Green Published, hybrid			2022-12-28	WOS:000455105500034
J	Matsuda, K; Kobayakawa, T; Tsuchiya, K; Hattori, S; Nomura, W; Gatanaga, H; Yoshimura, K; Oka, S; Endo, Y; Tamamura, H; Mitsuya, H; Maeda, K				Matsuda, Kouki; Kobayakawa, Takuya; Tsuchiya, Kiyoto; Hattori, Shin-ichiro; Nomura, Wataru; Gatanaga, Hiroyuki; Yoshimura, Kazuhisa; Oka, Shinichi; Endo, Yasuyuki; Tamamura, Hirokazu; Mitsuya, Hiroaki; Maeda, Kenji			Benzolactam-related compounds promote apoptosis of HIV-infected human cells via protein kinase C-induced HIV latency reversal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; retrovirus; human immunodeficiency virus (HIV); antiviral agent; protein kinase C (PKC); benzolactam; HIV cure; latency-reversing agents; latent infection; PKC activator	CD4(+) T-CELLS; HISTONE DEACETYLASE INHIBITOR; VORINOSTAT; RESERVOIR; POTENT; CLARIFICATION; PERSISTENCE; TELEOCIDIN; STRATEGIES; CHALLENGE	Latency-reversing agents (LRAs) are considered a potential strategy for curing cells of HIV-1 infection. Certain protein kinase C (PKC) activators have been previously reported to be LRAs because they can reverse HIV latency. In the present study, we examined the activities of a panel of benzolactam derivatives against cells latently infected with HIV. Using determination of p24 antigen in cell supernatants or altered intracellular GFP expression to measure HIV reactivation from latently infected cells along with a cytotoxicity assay, we found that some of the compounds exhibited latency-reversing activity, which was followed by enhanced release of HIV particles from the cells. One derivative, BL-V8-310, displayed activity in ACH-2 and J-Lat cells latently infected with HIV at a concentration of 10 nm or higher, which was superior to the activity of another highly active PKC activator, prostratin. These results were confirmed with peripheral blood cells from HIV-infected patients. We also found that these drugs up-regulate the expression of caspase 3 and enhance apoptosis specifically in latently HIV-infected cells. Moreover, combining BL-V8-310 with a bromodomain-containing 4 (BRD4) inhibitor, JQ1, not only enhanced HIV latency-reversing activity, but also reduced the effect on cytotoxic cytokine secretion from CD4(+) T-cells induced by BL-V8-310 alone. Our results suggest that BL-V8-310 and its related benzolactam derivatives are potential LRA lead compounds that are effective in reversing HIV latency and reducing viral reservoirs in HIV-positive individuals with few adverse effects.	[Matsuda, Kouki; Hattori, Shin-ichiro; Mitsuya, Hiroaki; Maeda, Kenji] Natl Ctr Global Hlth & Med Res Inst, Tokyo 1628655, Japan; [Kobayakawa, Takuya; Nomura, Wataru; Tamamura, Hirokazu] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo 1010062, Japan; [Tsuchiya, Kiyoto; Gatanaga, Hiroyuki; Oka, Shinichi] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo 1628655, Japan; [Yoshimura, Kazuhisa] Natl Inst Infect Dis, AIDS Res Ctr, Tokyo 1628640, Japan; [Yoshimura, Kazuhisa] Kumamoto Univ, Ctr AIDS Res, Kumamoto 8600811, Japan; [Endo, Yasuyuki] Tohoku Med & Pharmaceut Univ, Fac Pharmaceut Sci, Sendai, Miyagi 9818558, Japan; [Mitsuya, Hiroaki] NCI, Expt Retrovirol Sect, HIV & AIDS Malignancy Branch, NIH, Bethesda, MD 20892 USA	Tokyo Medical & Dental University (TMDU); National Center for Global Health & Medicine - Japan; National Institute of Infectious Diseases (NIID); Kumamoto University; Tohoku Medical & Pharmaceutical University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Maeda, K (corresponding author), Natl Ctr Global Hlth & Med Res Inst, Tokyo 1628655, Japan.	kmaeda@ri.ncgm.go.jp	Maeda, Kenji/B-7708-2019; Tsuchiya, Kiyoto/L-8650-2013	Maeda, Kenji/0000-0002-9424-1491; Tsuchiya, Kiyoto/0000-0002-8233-6653; Kobayakawa, Takuya/0000-0001-9786-2608	AMED [JP18fk0410015]; Intramuural Research Program of the NCI, National Institutes of Health; National Center for Global Health and Medicine, Japan [2921010]; National Institutes of Health [SC006738]; JSPS KAKENHI [JP16K08826]	AMED; Intramuural Research Program of the NCI, National Institutes of Health; National Center for Global Health and Medicine, Japan; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by AMED Grant JP18fk0410015 (to K. T., H. T., and K. Maeda). This work was also supported by the Intramuural Research Program of the NCI, National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Center for Global Health and Medicine, Japan, Grant 2921010.; Supported by National Institutes of Health Grant SC006738.; Supported by JSPS KAKENHI Grant JP16K08826.	Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Boehm D, 2013, CELL CYCLE, V12, P452, DOI 10.4161/cc.23309; Bullen CK, 2014, NAT MED, V20, P425, DOI 10.1038/nm.3489; Chun TW, 1999, NATURE, V401, P874, DOI 10.1038/44755; Cillo AR, 2014, P NATL ACAD SCI USA, V111, P7078, DOI 10.1073/pnas.1402873111; Donahue DA, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-11; Duffey MO, 2012, J MED CHEM, V55, P197, DOI 10.1021/jm2011172; Elliott JH, 2015, LANCET HIV, V2, pE520, DOI 10.1016/S2352-3018(15)00226-X; ENDO Y, 1994, BIOL PHARM BULL, V17, P1147; ENDO Y, 1994, BIOORG MED CHEM LETT, V4, P491, DOI 10.1016/0960-894X(94)80023-5; Endo Y, 1998, J MED CHEM, V41, P1476, DOI 10.1021/jm970704s; Endo Y, 1996, J AM CHEM SOC, V118, P1841, DOI 10.1021/ja953578v; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Geeraert L, 2008, ANNU REV MED, V59, P487, DOI 10.1146/annurev.med.59.062806.123001; Hamer DH, 2004, CURR HIV RES, V2, P99, DOI 10.2174/1570162043484915; Hassa PO, 2009, FRONT BIOSCI-LANDMRK, V14, P72, DOI 10.2741/3232; Hattori S, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02022; Hattori S, 2009, ANTIMICROB AGENTS CH, V53, P3887, DOI 10.1128/AAC.00270-09; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Jiang GC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005066; Jordan A, 2003, EMBO J, V22, P1868, DOI 10.1093/emboj/cdg188; Jordan A, 2001, EMBO J, V20, P1726, DOI 10.1093/emboj/20.7.1726; Katlama C, 2013, LANCET, V381, P2109, DOI 10.1016/S0140-6736(13)60104-X; Kim Y, 2018, CELL HOST MICROBE, V23, P14, DOI 10.1016/j.chom.2017.12.004; Laird GM, 2015, J CLIN INVEST, V125, P1901, DOI 10.1172/JCI80142; Lu PF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04210-w; Lucera MB, 2014, J VIROL, V88, P10803, DOI 10.1128/JVI.00320-14; Mach UR, 2006, CHEMMEDCHEM, V1, P307, DOI 10.1002/cmdc.200500068; Mackay HJ, 2007, NAT REV CANCER, V7, P554, DOI 10.1038/nrc2168; Margolis David M, 2007, Curr HIV/AIDS Rep, V4, P60, DOI 10.1007/s11904-007-0009-6; Matsuda K, 2015, BIOCHEM BIOPH RES CO, V457, P288, DOI 10.1016/j.bbrc.2014.12.102; Mbonye U, 2017, ANNU REV VIROL, V4, P261, DOI 10.1146/annurev-virology-101416-041646; Nakagawa Y, 2006, J MED CHEM, V49, P2681, DOI 10.1021/jm050857c; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.43.25526; Ouyang L, 2012, CELL PROLIFERAT, V45, P487, DOI 10.1111/j.1365-2184.2012.00845.x; Pache L, 2015, CELL HOST MICROBE, V18, P345, DOI 10.1016/j.chom.2015.08.009; Rasmussen TA, 2014, LANCET HIV, V1, pE13, DOI 10.1016/S2352-3018(14)70014-1; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; Saleh S, 2007, BLOOD, V110, P4161, DOI 10.1182/blood-2007-06-097907; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Tamamura H, 2000, J MED CHEM, V43, P3209, DOI 10.1021/jm990613q; Tripathy MK, 2015, J VIROL, V89, P8392, DOI 10.1128/JVI.00572-15; Wang PF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07157-0; Williams SA, 2004, J BIOL CHEM, V279, P42008, DOI 10.1074/jbc.M402124200	44	14	15	3	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2019	294	1					116	129		10.1074/jbc.RA118.005798	http://dx.doi.org/10.1074/jbc.RA118.005798			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG6PT	30413535	Green Published, hybrid			2022-12-28	WOS:000455105500017
J	Wofford, JD; Bolaji, N; Dziuba, N; Outten, FW; Lindahl, PA				Wofford, Joshua D.; Bolaji, Naimah; Dziuba, Nathaniel; Outten, F. Wayne; Lindahl, Paul A.			Evidence that a respiratory shield in Escherichia coli protects a low-molecular-mass Fe-II pool from O-2-dependent oxidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mossbauer spectroscopy; metal homeostasis; mitochondria; electron paramagnetic resonance (EPR); iron metabolism; chemiosmotic coupling; cyanide; labile iron pool; cyanide; iron homeostasis; ferric uptake regulator; ferritin	SACCHAROMYCES-CEREVISIAE CELLS; SULFUR CLUSTER BIOGENESIS; FERRIC UPTAKE REGULATOR; MOSSBAUER-SPECTROSCOPY; IRON-METABOLISM; MAGNETIC-PROPERTIES; DNA-DAMAGE; FUR; GROWTH; COMPLEXES	Iron is critical for virtually all organisms, yet major questions remain regarding the systems-level understanding of iron in whole cells. Here, we obtained Mossbauer and EPR spectra of Escherichia coli cells prepared under different nutrient iron concentrations, carbon sources, growth phases, and O-2 concentrations to better understand their global iron content. We investigated WT cells and those lacking Fur, FtnA, Bfr, and Dps proteins. The coarse-grain iron content of exponentially growing cells consisted of iron-sulfur clusters, variable amounts of nonheme high-spin Fe-II species, and an unassigned residual quadrupole doublet. The iron in stationary-phase cells was dominated by magnetically ordered Fe-III ions due to oxyhydroxide nanoparticles. Analysis of cytosolic extracts by size-exclusion chromatography detected by an online inductively coupled plasma mass spectrometer revealed a low-molecular-mass (LMM) Fe-II pool consisting of two iron complexes with masses of approximate to 500 (major) and approximate to 1300 (minor) Da. They appeared to be high-spin Fe-II species with mostly oxygen donor ligands, perhaps a few nitrogen donors, and probably no sulfur donors. Surprisingly, the iron content of E. coli and its reactivity with O-2 were remarkably similar to those of mitochondria. In both cases, a respiratory shield composed of membrane-bound iron-rich respiratory complexes may protect the LMM Fe-II pool from reacting with O-2. When exponentially growing cells transition to stationary phase, the shield deactivates as metabolic activity declines. Given the universality of oxidative phosphorylation in aerobic biology, the iron content and respiratory shield in other aerobic prokaryotes might be similar to those of E. coli and mitochondria.	[Wofford, Joshua D.; Lindahl, Paul A.] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA; [Dziuba, Nathaniel; Lindahl, Paul A.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Bolaji, Naimah; Outten, F. Wayne] Univ South Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; University of South Carolina System; University of South Carolina Columbia	Lindahl, PA (corresponding author), Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA.	lindahl@chem.tamu.edu		Outten, Franklin/0000-0002-9095-0194	National Institutes of Health [R35 GM127021, R01 GM112919]; Robert A. Welch Foundation [A1170]; Welch Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112919, R35GM127021] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R35 GM127021 (to P.A.L.) and R01 GM112919 (to F.W.O.) and Robert A. Welch Foundation Grant A1170 (to P.A.L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the Welch Foundation.	Abdul-Tehrani H, 1999, J BACTERIOL, V181, P1415, DOI 10.1128/JB.181.5.1415-1428.1999; Al-Attar S, 2013, COORDIN CHEM REV, V257, P64, DOI 10.1016/j.ccr.2012.05.022; Arras T, 1998, J BACTERIOL, V180, P2133, DOI 10.1128/JB.180.8.2133-2136.1998; BAGG A, 1987, BIOCHEMISTRY-US, V26, P5471, DOI 10.1021/bi00391a039; BAUMINGER ER, 1980, BIOCHIM BIOPHYS ACTA, V623, P237, DOI 10.1016/0005-2795(80)90252-4; Beauchene NA, 2017, P NATL ACAD SCI USA, V114, P12261, DOI 10.1073/pnas.1707189114; Beilschmidt LK, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15124; Benda R, 2002, BIOCHEMISTRY-US, V41, P15000, DOI 10.1021/bi026590q; BOHNKE R, 1995, BIOMETALS, V8, P223; Boughammoura A, 2008, J BACTERIOL, V190, P1518, DOI 10.1128/JB.01640-07; Bradley JM, 2016, J BIOL INORG CHEM, V21, P13, DOI 10.1007/s00775-016-1336-0; Braymer JJ, 2017, J BIOL CHEM, V292, P12754, DOI 10.1074/jbc.R117.787101; Carvalho DS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134988; Clemente-Juan JM, 2002, INORG CHEM, V41, P1478, DOI 10.1021/ic010787+; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Ferreira IGD, 2016, BIOMETALS, V29, P851, DOI 10.1007/s10534-016-9956-y; DICKSON DPE, 1979, EUR J BIOCHEM, V101, P291, DOI 10.1111/j.1432-1033.1979.tb04242.x; Dziuba N, 2018, METALLOMICS, V10, P802, DOI 10.1039/c8mt00055g; Escolar L, 1999, J BACTERIOL, V181, P6223, DOI 10.1128/JB.181.20.6223-6229.1999; Fillat MF, 2014, ARCH BIOCHEM BIOPHYS, V546, P41, DOI 10.1016/j.abb.2014.01.029; FONTECAVE M, 1991, BIOL MET, V4, P133, DOI 10.1007/BF01141302; Gutlich P, 2011, MOSSBAUER SPECTROSCOPY AND TRANSITION METAL CHEMISTRY: FUNDAMENTALS AND APPLICATIONS, P1; HAMED MY, 1993, J INORG BIOCHEM, V50, P193, DOI 10.1016/0162-0134(93)80025-5; Hohle TH, 2016, MOL MICROBIOL, V101, P152, DOI 10.1111/mmi.13381; Hristova D, 2008, BIOCHEMISTRY-US, V47, P3989, DOI 10.1021/bi702408k; HUDSON AJ, 1993, EUR J BIOCHEM, V218, P985, DOI 10.1111/j.1432-1033.1993.tb18457.x; Jacques JF, 2006, MOL MICROBIOL, V62, P1181, DOI 10.1111/j.1365-2958.2006.05439.x; Jhurry ND, 2012, BIOCHEMISTRY-US, V51, P5276, DOI 10.1021/bi300382d; KADIR FHA, 1991, J INORG BIOCHEM, V43, P753, DOI 10.1016/0162-0134(91)80046-K; Keyer K, 1996, P NATL ACAD SCI USA, V93, P13635, DOI 10.1073/pnas.93.24.13635; Kiley PJ, 1998, FEMS MICROBIOL REV, V22, P341, DOI 10.1111/j.1574-6976.1998.tb00375.x; Lane N, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a015982; Lau CKY, 2016, FEMS MICROBIOL REV, V40, P273, DOI 10.1093/femsre/fuv049; Lemercier G, 2004, INORG CHEM, V43, P2105, DOI 10.1021/ic034907k; Lopez-Torrejon G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11426; Ma Z, 2012, MOL MICROBIOL, V86, P1144, DOI 10.1111/mmi.12049; MATZANKE BF, 1989, EUR J BIOCHEM, V183, P371, DOI 10.1111/j.1432-1033.1989.tb14938.x; McCormick SP, 2015, BIOCHEMISTRY-US, V54, P3442, DOI 10.1021/bi5015437; McHugh JP, 2003, J BIOL CHEM, V278, P29478, DOI 10.1074/jbc.M303381200; Mettert EL, 2015, ANNU REV MICROBIOL, V69, P505, DOI 10.1146/annurev-micro-091014-104457; Miao R, 2011, BIOCHEMISTRY-US, V50, P2660, DOI 10.1021/bi102015s; Miao R, 2009, BIOCHEMISTRY-US, V48, P9556, DOI 10.1021/bi901110n; Mills SA, 2005, BIOCHEMISTRY-US, V44, P13553, DOI 10.1021/bi0507579; Moore MJ, 2018, BIOCHEMISTRY-US, V57, P672, DOI 10.1021/acs.biochem.7b01034; Munck E., 2000, PHYS METHODS BIOINOR, P287; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Outten FW, 2009, ANTIOXID REDOX SIGN, V11, P1029, DOI [10.1089/ars.2008.2296, 10.1089/ARS.2008.2296]; Paalme T, 1997, ANTON LEEUW INT J G, V71, P217, DOI 10.1023/A:1000198404007; Papaefthymiou GC, 2010, BBA-GEN SUBJECTS, V1800, P886, DOI 10.1016/j.bbagen.2010.03.018; Park J, 2013, BIOCHEMISTRY-US, V52, P9413, DOI 10.1021/bi4010304; POOLE RK, 1994, ANTON LEEUW INT J G, V65, P289, DOI 10.1007/BF00872215; Popescu CV, 1998, P NATL ACAD SCI USA, V95, P13431, DOI 10.1073/pnas.95.23.13431; REIFF WM, 1973, CHEM PHYS LETT, V22, P124, DOI 10.1016/0009-2614(73)80549-4; Reisner E, 2007, INORG CHEM, V46, P10754, DOI 10.1021/ic701663j; Rouault TA, 2005, NAT REV MOL CELL BIO, V6, P345, DOI 10.1038/nrm1620; Tachezy J, 2001, MOL BIOL EVOL, V18, P1919, DOI 10.1093/oxfordjournals.molbev.a003732; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; Wofford JD, 2016, METALLOMICS, V8, P692, DOI 10.1039/c6mt00070c; Wofford JD, 2015, J BIOL CHEM, V290, P26968, DOI 10.1074/jbc.M115.676668; Woodmansee AN, 2002, J BIOL CHEM, V277, P34055, DOI 10.1074/jbc.M203977200; Woodmansee AN, 2002, METHOD ENZYMOL, V349, P3, DOI 10.1016/S0076-6879(02)49316-0	61	20	20	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2019	294	1					50	62		10.1074/jbc.RA118.005233	http://dx.doi.org/10.1074/jbc.RA118.005233			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG6PT	30337367	hybrid, Green Published			2022-12-28	WOS:000455105500006
J	Chen, YS; Kozlov, G; Fakih, R; Funato, Y; Miki, H; Gehring, K				Chen, Yu Seby; Kozlov, Guennadi; Fakih, Rayan; Funato, Yosuke; Miki, Hiroaki; Gehring, Kalle			The cyclic nucleotide-binding homology domain of the integral membrane protein CNNM mediates dimerization and is required for Mg2+ efflux activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						magnesium; transporter; crystal structure; dimerization; biophysics; structural biology; X-ray crystallography; analytical ultracentrifugation; CNNM; cyclic nucleotide-binding homology domain	CARBOXY-TERMINAL REGION; CONE-ROD DYSTROPHY; STRUCTURAL BASIS; NA+/MG2+ EXCHANGERS; JALILI SYNDROME; MAGNESIUM; ULTRACENTRIFUGATION; REFINEMENT; MUTATIONS; FEATURES	Proteins of the cyclin M family (CNNMs; also called ancient conserved domain proteins, or ACDPs) are represented by four integral membrane proteins that have been proposed to function as Mg2+ transporters. CNNMs are associated with a number of genetic diseases affecting ion movement and cancer via their association with highly oncogenic phosphatases of regenerating liver (PRLs). Structurally, CNNMs contain an N-terminal extracellular domain, a transmembrane domain (DUF21), and a large cytosolic region containing a cystathionine--synthase (CBS) domain and a putative cyclic nucleotide-binding homology (CNBH) domain. Although the CBS domain has been extensively characterized, little is known about the CNBH domain. Here, we determined the first crystal structures of the CNBH domains of CNNM2 and CNNM3 at 2.6 and 1.9 resolutions. Contrary to expectation, these domains did not bind cyclic nucleotides, but mediated dimerization both in crystals and in solution. Analytical ultracentrifugation experiments revealed an inverse correlation between the propensity of the CNBH domains to dimerize and the ability of CNNMs to mediate Mg2+ efflux. CNBH domains from active family members were observed as both dimers and monomers, whereas the inactive member, CNNM3, was observed only as a dimer. Mutational analysis revealed that the CNBH domain was required for Mg2+ efflux activity of CNNM4. This work provides a structural basis for understanding the function of CNNM proteins in Mg2+ transport and associated diseases.	[Chen, Yu Seby; Kozlov, Guennadi; Fakih, Rayan; Gehring, Kalle] McGill Univ, Dept Biochem, 3649 Promenade Sir William Osler,Rm 469, Montreal, PQ H3G 0B1, Canada; [Chen, Yu Seby; Kozlov, Guennadi; Fakih, Rayan; Gehring, Kalle] McGill Univ, Struct Biol Ctr, Montreal, PQ H3G 0B1, Canada; [Funato, Yosuke; Miki, Hiroaki] Osaka Univ, Microbial Dis Res Inst, Dept Cellular Regulat, Suita, Osaka 5650871, Japan	McGill University; McGill University; Osaka University	Gehring, K (corresponding author), McGill Univ, Dept Biochem, 3649 Promenade Sir William Osler,Rm 469, Montreal, PQ H3G 0B1, Canada.	kalle.gehring@mcgill.ca	Gehring, Kalle/I-4403-2013	Gehring, Kalle/0000-0001-6500-1184; Chen, Yu/0000-0002-0793-2391	National Science Foundation [DMR-0225180]; National Institutes of Health/NCRR Grant [RR-01646]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health/NCRR Grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank Veronique Sauve and Jean-Francois Trempe for assistance,with crystallographic data collection, Nadeem Siddiqui for advice on AUC data processing, and Alexei Gorelik for advice on crystallographic data processing. Crystallographic data were acquired at the Canadian Light Source (CLS) and at the Macromolecular Diffraction (MacCHESS) facility at the Cornell High Energy Synchrotron,Source (CHESS). CHESS is supported by National Science Foundation award DMR-0225180 and National Institutes of Health/NCRR Grant RR-01646.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Corral-Rodriguez MA, 2014, BIOCHEM J, V464, P23, DOI 10.1042/BJ20140409; Arjona FJ, 2018, J PHYSIOL-LONDON, V596, P747, DOI 10.1113/JP275249; Brautigam CA, 2015, METHOD ENZYMOL, V562, P109, DOI 10.1016/bs.mie.2015.05.001; Brelidze TI, 2012, NATURE, V481, P530, DOI 10.1038/nature10735; Brookes E, 2010, MACROMOL BIOSCI, V10, P746, DOI 10.1002/mabi.200900474; Clayton GM, 2004, CELL, V119, P615, DOI 10.1016/j.cell.2004.10.030; de Baaij JHF, 2015, PHYSIOL REV, V95, P1, DOI 10.1152/physrev.00012.2014; de Baaij JHF, 2012, J BIOL CHEM, V287, P13644, DOI 10.1074/jbc.M112.342204; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Flynn GE, 2007, STRUCTURE, V15, P671, DOI 10.1016/j.str.2007.04.008; Funato Y, 2018, J PHYSIOL-LONDON, V596, P743, DOI 10.1113/JP275248; Funato Y, 2014, J CLIN INVEST, V124, P5398, DOI 10.1172/JCI76614; Gimenez-Mascarell P, 2017, J BIOL CHEM, V292, P786, DOI 10.1074/jbc.M116.759944; Goddard D., 2008, SPARKY 3; Gulerez I, 2016, EMBO REP, V17, P1890, DOI 10.15252/embr.201643393; Haitin Y, 2013, NATURE, V501, P444, DOI 10.1038/nature12487; Hardy S, 2015, ONCOGENE, V34, P986, DOI 10.1038/onc.2014.33; Hirata Y, 2014, J BIOL CHEM, V289, P14731, DOI 10.1074/jbc.M114.551176; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jahnen-Dechent W, 2012, CLIN KIDNEY J, V5, P3, DOI 10.1093/ndtplus/sfr163; James ZM, 2018, J GEN PHYSIOL, V150, P225, DOI 10.1085/jgp.201711898; Kesters D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116369; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laue T., 1993, ANAL ULTRACENTRIFUGA, P90; Li FY, 2011, NATURE, V475, P471, DOI 10.1038/nature10246; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Parry DA, 2009, AM J HUM GENET, V84, P266, DOI 10.1016/j.ajhg.2009.01.009; Payandeh J, 2013, BBA-BIOMEMBRANES, V1828, P2778, DOI 10.1016/j.bbamem.2013.08.002; Pessoa J, 2014, J GEN PHYSIOL, V144, P39, DOI 10.1085/jgp.201311145; Polok B, 2009, AM J HUM GENET, V84, P259, DOI 10.1016/j.ajhg.2009.01.006; Rude RK, 1998, J BONE MINER RES, V13, P749, DOI 10.1359/jbmr.1998.13.4.749; Saha S, 2001, SCIENCE, V294, P1343, DOI 10.1126/science.1065817; Schaffers OJM, 2018, AM J PHYSIOL-RENAL, V314, pF1027, DOI 10.1152/ajprenal.00634.2017; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Stuiver M, 2011, AM J HUM GENET, V88, P333, DOI 10.1016/j.ajhg.2011.02.005; Topcu V, 2017, OPHTHALMIC GENET, V38, P161, DOI 10.3109/13816810.2016.1164192; VanSchouwen B., 2016, NONCANONICAL CYCLIC, P123; Wang CY, 2003, GENE, V306, P37, DOI 10.1016/S0378-1119(02)01210-6; WEBER IT, 1987, J MOL BIOL, V198, P311, DOI 10.1016/0022-2836(87)90315-9; Wong K, 2015, J BIOL CHEM, V290, P24727, DOI 10.1074/jbc.M115.671263; Yamazaki D, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003983; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zhang HZ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00147-2	50	20	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					19998	20007		10.1074/jbc.RA118.005672	http://dx.doi.org/10.1074/jbc.RA118.005672			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30341174	Green Published, hybrid			2022-12-28	WOS:000454685900006
J	Li, ZL; Lim, SK; Liang, X; Lim, YP				Li, Zilin; Lim, Shen Kiat; Liang, Xu; Lim, Yoon Pin			The transcriptional coactivator WBP2 primes triple-negative breast cancer cells for responses to Wnt signaling via the JNK/Jun kinase pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						transcription coactivator; oncogene; axin; Wnt signaling; cell signaling; breast cancer; precision medicine; therapy; TNIK; WW domain-binding protein 2	COMPREHENSIVE MOLECULAR PORTRAITS; EPITHELIAL-MESENCHYMAL TRANSITION; DOMAIN BINDING PROTEIN-2; GENOME-WIDE SCREEN; BETA-CATENIN; C-JUN; WW-DOMAIN; GENE-EXPRESSION; FEEDBACK LOOP; TARGET GENES	The transcriptional coactivator WW domain-binding protein 2 (WBP2) is an emerging oncogene and serves as a node between the signaling protein Wnt and other signaling molecules and pathways, including epidermal growth factor receptor, estrogen receptor/progesterone receptor, and the Hippo pathway. The upstream regulation of WBP2 is well-studied, but its downstream activity remains unclear. Here, we elucidated WBP2's role in triple-negative breast cancer (TNBC), in which Wnt signaling is predominantly activated. Using RNAi coupled with RNA-Seq and MS analyses to identify Wnt/WBP2- and WBP2-dependent targets in MDA-MB-231 TNBC cells, we found that WBP2 is required for the expression of a core set of genes in Wnt signaling. These included AXIN2, which was essential for Wnt/WBP2-mediated breast cancer growth and migration. WBP2 also regulated a much larger set of genes and proteins independently of Wnt, revealing that WBP2 primes cells to Wnt activity by up-regulating G protein pathway suppressor 1 (GPS1) and TRAF2- and NCK-interacting kinase (TNIK). GPS1 activated the c-Jun N-terminal kinase (JNK)/Jun pathway, resulting in a positive feedback loop with TNIK that mediated Wnt-induced AXIN2 expression. WBP2 promoted TNBC growth by integrating JNK with Wnt signaling, and its expression profoundly influenced the sensitivity of TNBC to JNK/TNIK inhibitors. In conclusion, WBP2 links JNK to Wnt signaling in TNBC. GPS1 and TNIK are constituents of a WBP2-initiated cascade that primes responses to Wnt ligands and are also important for TNBC biology. We propose that WBP2 is a potential drug target for JNK/TNIK-based precision medicine for managing TNBC.	[Li, Zilin; Lim, Shen Kiat; Liang, Xu; Lim, Yoon Pin] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, MD4,01-03D,5 Sci Dr 2, Singapore 117545, Singapore; [Lim, Yoon Pin] Natl Univ Canc Inst, Singapore 119082, Singapore; [Lim, Yoon Pin] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117456, Singapore; [Li, Zilin] Natl Inst Biol Sci, 7 Sci Pk Rd,ZGC Life Sci Pk, Beijing 102206, Peoples R China; [Liang, Xu] NERI CREATE, 1 Create Way,Res Wing 06-06-07-08, Singapore 138602, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; National Institute of Biological Sciences, Beijing	Lim, YP (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, MD4,01-03D,5 Sci Dr 2, Singapore 117545, Singapore.	bchlyp@nus.edu.sg			Ministry of Education of Singapore [MOE2016-T2-2-007]	Ministry of Education of Singapore(Ministry of Education, Singapore)	This work was supported by Ministry of Education of Singapore Grant MOE2016-T2-2-007. The authors declare that they have no conflicts of interest with the contents of this article.	Aihara A, 2016, CANCER SCI, V107, P1858, DOI 10.1111/cas.13095; Austreid E, 2014, EXPERT OPIN PHARMACO, V15, P681, DOI 10.1517/14656566.2014.885952; Azzolin L, 2014, CELL, V158, P157, DOI 10.1016/j.cell.2014.06.013; Azzolin L, 2012, CELL, V151, P1443, DOI 10.1016/j.cell.2012.11.027; Bogoyevitch MA, 2006, MICROBIOL MOL BIOL R, V70, P1061, DOI 10.1128/MMBR.00025-06; Bozatzi P, 2018, EMBO REP, V19, DOI 10.15252/embr.201744807; Buffa L, 2013, IUBMB LIFE, V65, P76, DOI 10.1002/iub.1105; Buniello A, 2016, EMBO MOL MED, V8, P191, DOI 10.15252/emmm.201505523; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chan SW, 2011, ONCOGENE, V30, P600, DOI 10.1038/onc.2010.438; CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; Chen YH, 2007, MOL CELL PROTEOMICS, V6, P2072, DOI 10.1074/mcp.M700395-MCP200; Ciriello G, 2015, CELL, V163, P506, DOI 10.1016/j.cell.2015.09.033; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dhananjayan SC, 2006, MOL ENDOCRINOL, V20, P2343, DOI 10.1210/me.2005-0533; Dimeo TA, 2009, CANCER RES, V69, P5364, DOI 10.1158/0008-5472.CAN-08-4135; Eilers A, 1998, J NEUROSCI, V18, P1713; Eirew P, 2015, NATURE, V518, P422, DOI 10.1038/nature13952; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Fu CA, 1999, J BIOL CHEM, V274, P30729, DOI 10.1074/jbc.274.43.30729; Gandin V, 2010, BBA-MOL CELL RES, V1803, P826, DOI 10.1016/j.bbamcr.2010.03.016; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Geyer FC, 2011, MODERN PATHOL, V24, P209, DOI 10.1038/modpathol.2010.205; Gui JH, 2011, HUM CELL, V24, P121, DOI 10.1007/s13577-011-0023-2; Guzman C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092444; Hayakawa J, 2004, MOL CELL, V16, P521, DOI 10.1016/j.molcel.2004.10.024; Hergovich A, 2010, DEV CELL, V18, P508, DOI 10.1016/j.devcel.2010.04.003; Hsu JM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04313-6; Huang PY, 2017, NAT GENET, V49, P1624, DOI 10.1038/ng.3957; Huang YW, 2009, CANCER RES, V69, P9038, DOI 10.1158/0008-5472.CAN-09-1499; Hughes-Large JM, 2016, DATA BRIEF, V6, P899, DOI 10.1016/j.dib.2016.01.039; Hwang SG, 2005, FEBS LETT, V579, P4837, DOI 10.1016/j.febslet.2005.07.067; Imajo M, 2012, EMBO J, V31, P1109, DOI 10.1038/emboj.2011.487; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kayahara M, 2005, MOL CELL BIOL, V25, P3784, DOI 10.1128/MCB.25.9.3784-3792.2005; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kohn AD, 2005, CELL CALCIUM, V38, P439, DOI 10.1016/j.ceca.2005.06.022; Kosaki R, 1999, CANCER RES, V59, P1141; Labbe E, 2007, CANCER RES, V67, P75, DOI 10.1158/0008-5472.CAN-06-2559; Leung JY, 2002, J BIOL CHEM, V277, P21657, DOI 10.1074/jbc.M200139200; Li JY, 2007, CELL SIGNAL, V19, P1185, DOI 10.1016/j.cellsig.2006.12.010; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Lim SK, 2016, CANCER RES, V76, P6278, DOI 10.1158/0008-5472.CAN-15-3537; Lim SK, 2011, FASEB J, V25, P3004, DOI 10.1096/fj.10-169136; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Mahmoudi T, 2009, EMBO J, V28, P3329, DOI 10.1038/emboj.2009.285; Mann B, 1999, P NATL ACAD SCI USA, V96, P1603, DOI 10.1073/pnas.96.4.1603; Martelotto LG, 2015, J PATHOL, V237, P179, DOI 10.1002/path.4573; Masuda M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12586; Maubant S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122333; McCarthy DJ, 2009, BIOINFORMATICS, V25, P765, DOI 10.1093/bioinformatics/btp053; Minet E, 2001, EXP CELL RES, V265, P114, DOI 10.1006/excr.2001.5180; Nadruz W, 2004, AM J PHYSIOL-HEART C, V286, pH760, DOI 10.1152/ajpheart.00430.2003; Nateri AS, 2005, NATURE, V437, P281, DOI 10.1038/nature03914; Ndoye A, 2017, CANCER RES, V77, P5873, DOI 10.1158/0008-5472.CAN-17-0907; Nitsch R, 2004, BIOCHEM J, V377, P553, DOI 10.1042/BJ20031233; Pereira B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11479; Pongor L, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0228-1; Qiu WM, 2011, BIOCHEM BIOPH RES CO, V413, P98, DOI 10.1016/j.bbrc.2011.08.061; Railo A, 2009, EXP CELL RES, V315, P2690, DOI 10.1016/j.yexcr.2009.06.021; Ren YQ, 2017, CANCER CHEMOTH PHARM, V79, P1003, DOI 10.1007/s00280-017-3302-0; Riedl A, 2017, J CELL SCI, V130, P203, DOI 10.1242/jcs.188102; Rosenbluh J, 2012, CELL, V151, P1457, DOI 10.1016/j.cell.2012.11.026; Rosso SB, 2005, NAT NEUROSCI, V8, P34, DOI 10.1038/nn1374; Shannan B, 2016, PIGM CELL MELANOMA R, V29, P317, DOI 10.1111/pcmr.12465; Shkoda A, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001376; Staal FJT, 2004, J IMMUNOL, V172, P1099, DOI 10.4049/jimmunol.172.2.1099; Toualbi K, 2007, ONCOGENE, V26, P3492, DOI 10.1038/sj.onc.1210133; Udabage L, 2005, EXP CELL RES, V310, P205, DOI 10.1016/j.yexcr.2005.07.026; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Walko G, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14744; Wu XM, 2008, CELL, V133, P340, DOI 10.1016/j.cell.2008.01.052; Wu ZQ, 2012, P NATL ACAD SCI USA, V109, P11312, DOI 10.1073/pnas.1203015109; Yochum GS, 2008, MOL CELL BIOL, V28, P7368, DOI 10.1128/MCB.00744-08; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540; Zhang JC, 2012, CANCER RES, V72, P4597, DOI 10.1158/0008-5472.CAN-12-1045; Zhang T, 2012, CHEM BIOL, V19, P140, DOI 10.1016/j.chembiol.2011.11.010; Zhang X, 2011, CELL DEATH DIFFER, V18, P1346, DOI 10.1038/cdd.2011.6; Zhang Y, 1999, J BIOL CHEM, V274, P35247, DOI 10.1074/jbc.274.49.35247; Zhuo Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135810	84	12	12	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					20014	20028		10.1074/jbc.RA118.005796	http://dx.doi.org/10.1074/jbc.RA118.005796			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30442712	Green Published, hybrid			2022-12-28	WOS:000454685900012
J	Alexander, JAN; Chatterjee, SS; Hamilton, SM; Eltis, LD; Chambers, HF; Strynadka, NCJ				Alexander, J. Andrew N.; Chatterjee, Som S.; Hamilton, Stephanie M.; Eltis, Lindsay D.; Chambers, Henry F.; Strynadka, Natalie C. J.			Structural and kinetic analyses of penicillin-binding protein 4 (PBP4)-mediated antibiotic resistance in Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibiotic resistance; Methicillin-resistant Staphylococcus aureus (MRSA); X-ray crystallography; peptidoglycan; enzyme kinetics; Gram-positive bacteria; microbiology; -lactam antibiotics; multidrug resistance; penicillin-binding protein 4 (PBP4); resistance gene	BETA-LACTAM RESISTANCE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; STRUCTURE REFINEMENT; IN-VITRO; CEPHALOSPORINS; IDENTIFICATION; CEFTOBIPROLE; FEATURES; SERVER	Methicillin-resistant Staphylococcus aureus (MRSA) causes serious community-acquired and nosocomial infections worldwide. MRSA strains are resistant to a variety of antibiotics, including the classic penicillin and cephalosporin classes of -lactams, making them intractable to treatment. Although -lactam resistance in MRSA has been ascribed to the acquisition and activity of penicillin-binding protein 2a (PBP2a, encoded by mecA), it has recently been observed that resistance can also be mediated by penicillin-binding protein 4 (PBP4). Previously, we have shown that broad-spectrum -lactam resistance can arise following serial passaging of a mecA-negative COL strain of S. aureus, creating the CRB strain. This strain has two missense mutations in pbp4 and a mutation in the pbp4 promoter, both of which play an instrumental role in -lactam resistance. To better understand PBP4's role in resistance, here we have characterized its kinetics and structure with clinically relevant -lactam antibiotics. We present the first crystallographic PBP4 structures of apo and acyl-enzyme intermediate forms complexed with three late-generation -lactam antibiotics: ceftobiprole, ceftaroline, and nafcillin. In parallel, we characterized the structural and kinetic effects of the PBP4 mutations present in the CRB strain. Localized within the transpeptidase active-site cleft, the two substitutions appear to have different effects depending on the drug. With ceftobiprole, the missense mutations impaired the K-m value 150-fold, decreasing the proportion of inhibited PBP4. However, ceftaroline resistance appeared to be mediated by other factors, possibly including mutation of the pbp4 promoter. Our findings provide evidence that S. aureus CRB has at least two PBP4-mediated resistance mechanisms.	[Alexander, J. Andrew N.; Eltis, Lindsay D.; Strynadka, Natalie C. J.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Alexander, J. Andrew N.; Strynadka, Natalie C. J.] Univ British Columbia, Ctr Blood Res, Vancouver, BC V6T 1Z3, Canada; [Eltis, Lindsay D.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; [Chatterjee, Som S.; Hamilton, Stephanie M.; Chambers, Henry F.] San Francisco Gen Hosp, Dept Med, Div Infect Dis, San Francisco, CA 94110 USA	University of British Columbia; University of British Columbia; University of British Columbia; San Francisco General Hospital Medical Center	Strynadka, NCJ (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Life Sci Ctr, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	ncjs@mail.ubc.ca		Alexander, J. Andrew/0000-0002-8759-1389	Canada Foundation for Innovation; Natural Sciences and Engineering Research Council of Canada; University of Saskatchewan; Government of Saskatchewan; Western Economic Diversification Canada; National Research Council Canada; Canadian Institutes of Health Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100291] Funding Source: NIH RePORTER	Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Saskatchewan; Government of Saskatchewan; Western Economic Diversification Canada; National Research Council Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The research described in this paper was performed using beam lines 08B1-1 and 08ID-1 at the Canadian Light Source, which is supported by the Canada Foundation for Innovation, Natural Sciences and Engineering Research Council of Canada, the University of Saskatchewan, the Government of Saskatchewan, Western Economic Diversification Canada, the National Research Council Canada, and the Canadian Institutes of Health Research.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Argudin MA, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.00091-18; Baneriee R, 2008, ANTIMICROB AGENTS CH, V52, P2089, DOI 10.1128/AAC.01403-07; Banerjee R, 2010, ANTIMICROB AGENTS CH, V54, P4900, DOI 10.1128/AAC.00594-10; Basuino L, 2018, J ANTIMICROB CHEMOTH, V73, P1177, DOI 10.1093/jac/dkx531; Becker K, 2016, J CLIN MICROBIOL, V54, P180, DOI 10.1128/JCM.02081-15; CHAMBERS HF, 1994, BIOCHEM J, V301, P139, DOI 10.1042/bj3010139; Chambers HF, 1997, CLIN MICROBIOL REV, V10, P781, DOI 10.1128/CMR.10.4.781; Chan LC, 2016, ANTIMICROB AGENTS CH, V60, P3934, DOI 10.1128/AAC.00358-16; Chatterjee SS, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.00932-17; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen Y, 2009, J AM CHEM SOC, V131, P14345, DOI 10.1021/ja903773f; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Dessen A, 2001, J BIOL CHEM, V276, P45106, DOI 10.1074/jbc.M107608200; DYKE KGH, 1966, LANCET, V1, P835; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Greninger AL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149541; Griffiths JM, 2012, ANTIMICROB AGENTS CH, V56, P579, DOI 10.1128/AAC.05148-11; Hamilton SM, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.02727-16; Hebeisen P, 2001, ANTIMICROB AGENTS CH, V45, P825, DOI 10.1128/AAC.45.3.825-836.2001; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Joosten RP, 2014, IUCRJ, V1, P213, DOI 10.1107/S2052252514009324; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Katayama Y, 2003, J BACTERIOL, V185, P5465, DOI 10.1128/JB.185.18.5465-5472.2003; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lahiri SD, 2016, J ANTIMICROB CHEMOTH, V71, P3050, DOI 10.1093/jac/dkw282; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Laudano JB, 2011, J ANTIMICROB CHEMOTH, V66, pIII11, DOI 10.1093/jac/dkr095; Loskill P, 2014, BIOPHYS J, V107, P1082, DOI 10.1016/j.bpj.2014.07.029; Lovering AL, 2007, SCIENCE, V315, P1402, DOI 10.1126/science.1136611; Lovering AL, 2012, ANNU REV BIOCHEM, V81, P451, DOI 10.1146/annurev-biochem-061809-112742; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Memmi G, 2008, ANTIMICROB AGENTS CH, V52, P3955, DOI 10.1128/AAC.00049-08; Morlot C, 2005, J BIOL CHEM, V280, P15984, DOI 10.1074/jbc.M408446200; Navratna V, 2010, J BACTERIOL, V192, P134, DOI 10.1128/JB.00822-09; Nicholas RA, 2003, J BIOL CHEM, V278, P52826, DOI 10.1074/jbc.M310177200; Nicola G, 2005, BIOCHEM J, V392, P55, DOI 10.1042/BJ20050449; Nicola G, 2005, BIOCHEMISTRY-US, V44, P8207, DOI 10.1021/bi0473004; Nicola G, 2010, BIOCHEMISTRY-US, V49, P8094, DOI 10.1021/bi100879m; Ourghanlian C, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.02510-16, 10.1128/aac.02510-16]; Page MG, 2004, EXPERT OPIN INV DRUG, V13, P973, DOI 10.1517/13543784.13.8.973; Qiao Y, 2014, J AM CHEM SOC, V136, P14678, DOI 10.1021/ja508147s; Queenan AM, 2007, ANTIMICROB AGENTS CH, V51, P3089, DOI 10.1128/AAC.00218-07; Reed P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004891; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Schweizer ML, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-279; Sobhanifar S, 2013, CURR OPIN STRUC BIOL, V23, P695, DOI 10.1016/j.sbi.2013.07.008; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Tomberg J, 2012, BIOCHEMISTRY-US, V51, P2775, DOI 10.1021/bi2017987; Welsh MA, 2017, J AM CHEM SOC, V139, P17727, DOI 10.1021/jacs.7b10170; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter G, 2013, ACTA CRYSTALLOGR D, V69, P1260, DOI 10.1107/S0907444913015308; World Health Organization, 2017, GLOBAL PRIORITY LIST, DOI DOI 10.1016/S1473-3099(09)70222-1; Zapun A., 2017, ANTIMICROBIAL DRUG R, P177	58	27	27	1	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19854	19865		10.1074/jbc.RA118.004952	http://dx.doi.org/10.1074/jbc.RA118.004952			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30366985	Green Published, hybrid			2022-12-28	WOS:000454294900029
J	Tandon, A; Pathak, M; Harioudh, MK; Ahmad, S; Sayeed, M; Afshan, T; Siddiqi, MI; Mitra, K; Bhattacharya, SM; Ghosh, JK				Tandon, Anshika; Pathak, Manisha; Harioudh, Munesh Kumar; Ahmad, Sabahuddin; Sayeed, Mohd; Afshan, Tayyaba; Siddiqi, M. I.; Mitra, Kalyan; Bhattacharya, Shailja M.; Ghosh, Jimut Kanti			A TLR4-derived non-cytotoxic, self-assembling peptide functions as a vaccine adjuvant in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Toll-like receptor 4 (TLR4); vaccine; NF-kappaB (NF-KB); peptide; antibody; adjuvant; pro-inflammatory cytokine; self-assembly of peptide; TEM; TLR4-agonist; antibody	MONOPHOSPHORYL-LIPID-A; IMMUNE-RESPONSES; NANOPARTICLES; AGONIST; ANTIGEN; POTENT; ENDOTOXIN; INJECTION; PROGRAM; DISPLAY	Vaccination is devised/formulated to stimulate specific and prolonged immune responses for long-term protection against infection or disease. A vaccine component, namely adjuvant, enhances antigen recognition by the host immune system and thereby stimulates its cellular and adaptive responses. Especially synthetic Toll-like receptor (TLR) agonists having self-assembling properties are considered as good candidates for adjuvant development. Here, a human TLR4-derived 20-residue peptide (TR-433), present in the dimerization interface of the TLR4-myeloid differentiation protein-2 (MD2) complex, displayed self-assembly and adopted a nanostructure. Both in vitro studies and in vivo experiments in mice indicated that TR-433 is nontoxic. TR-433 induced pro-inflammatory responses in THP-1 monocytes and HEK293T cells that were transiently transfected with TLR4/CD14/MD2 and also in BALB/c mice. In light of the self-assembly and pro-inflammatory properties of TR-433, we immunized with a mixture of TR-433 and either ovalbumin or filarial antigen trehalose-6-phosphate phosphatase (TPP). A significant amount of IgG titers was produced, suggesting adjuvanting capability of TR-433 that was comparable with that of Freund's complete adjuvant (FCA) and appreciably higher than that of alum. We found that TR-433 preferentially activates type 1 helper T cell (T(h)1) response rather than type 2 helper T cell (T(h)2) response. To our knowledge, this is the first report on the identification of a short TLR4-derived peptide that possesses both self-assembling and pro-inflammatory properties and has significant efficacy as an adjuvant, capable of activating cellular responses in mice. These results indicate that TR-433 possesses significant potential for development as a new adjuvant in therapeutic application.	[Tandon, Anshika; Harioudh, Munesh Kumar; Ahmad, Sabahuddin; Sayeed, Mohd; Afshan, Tayyaba; Siddiqi, M. I.; Ghosh, Jimut Kanti] Cent Drug Res Inst, CSIR, Mol & Struct Biol Div, Sect 10,Sitapur Rd, Lucknow 226031, Uttar Pradesh, India; [Pathak, Manisha; Bhattacharya, Shailja M.] Cent Drug Res Inst, CSIR, Div Parasitol, Sect 10,Sitapur Rd, Lucknow 226031, Uttar Pradesh, India; [Mitra, Kalyan] Cent Drug Res Inst, CSIR, SAIF Div, Electron Microscopy Unit, Sect 10,Sitapur Rd, Lucknow 226031, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Ghosh, JK (corresponding author), Cent Drug Res Inst, CSIR, Mol & Struct Biol Div, Sect 10,Sitapur Rd, Lucknow 226031, Uttar Pradesh, India.	jk_ghosh@cdri.res.in		Ahmad, Sabahuddin/0000-0002-8762-4670	CSIR network project BioDiscovery	CSIR network project BioDiscovery	This work was supported by the CSIR network project BioDiscovery. This is CSIR-CDRI communication number 9759. The authors declare that they have no conflicts of interest with the contents of this article.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Aimanianda V, 2009, TRENDS PHARMACOL SCI, V30, P287, DOI 10.1016/j.tips.2009.03.005; Alving CR, 2012, CURR OPIN IMMUNOL, V24, P310, DOI 10.1016/j.coi.2012.03.008; Arias MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041144; Bakou M, 2017, J BIOL CHEM, V292, P14587, DOI 10.1074/jbc.M117.774893; BenMohamed L, 1997, EUR J IMMUNOL, V27, P1242, DOI 10.1002/eji.1830270528; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Boato F, 2007, ANGEW CHEM INT EDIT, V46, P9015, DOI 10.1002/anie.200702805; Bortolini C, 2014, SOFT MATTER, V10, P5656, DOI 10.1039/c4sm01065e; Brown F., 1998, MODULATION IMMUNE RE, P13; Casella CR, 2008, CELL MOL LIFE SCI, V65, P3231, DOI 10.1007/s00018-008-8228-6; Cauwelaert ND, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146372; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Chiu YC, 2016, ACS APPL MATER INTER, V8, P18722, DOI 10.1021/acsami.6b06275; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Danhier F, 2012, J CONTROL RELEASE, V161, P505, DOI 10.1016/j.jconrel.2012.01.043; Reboucas JD, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/474605; Dunne A, 2015, MUCOSAL IMMUNOL, V8, P607, DOI 10.1038/mi.2014.93; Duthie MS, 2011, IMMUNOL REV, V239, P178, DOI 10.1111/j.1600-065X.2010.00978.x; Freund J, 1937, P SOC EXP BIOL MED, V37, P509; Huang ZH, 2012, J AM CHEM SOC, V134, P8730, DOI 10.1021/ja211725s; Ireton GC, 2013, EXPERT REV VACCINES, V12, P793, DOI 10.1586/14760584.2013.811204; Kurihara Y, 2013, MOL MED REP, V7, P1739, DOI 10.3892/mmr.2013.1419; Kushwaha S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072585; Kushwaha S, 2012, MICROBES INFECT, V14, P1330, DOI 10.1016/j.micinf.2012.08.006; Li M, 2016, MOL PHARMACEUT, V13, P885, DOI 10.1021/acs.molpharmaceut.5b00802; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marrack P, 2009, NAT REV IMMUNOL, V9, P287, DOI 10.1038/nri2510; Means TK, 2000, LIFE SCI, V68, P241, DOI 10.1016/S0024-3205(00)00939-5; Miconnet I, 2001, J IMMUNOL, V166, P4612, DOI 10.4049/jimmunol.166.7.4612; Moyle PM, 2013, CHEMMEDCHEM, V8, P360, DOI 10.1002/cmdc.201200487; Nempont C, 2008, J IMMUNOL, V181, P2036, DOI 10.4049/jimmunol.181.3.2036; O'Garra A, 2000, TRENDS CELL BIOL, V10, P542, DOI 10.1016/S0962-8924(00)01856-0; Othoro C, 2009, INFECT IMMUN, V77, P739, DOI 10.1128/IAI.00974-08; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Petrovsky N, 2004, IMMUNOL CELL BIOL, V82, P488, DOI 10.1111/j.0818-9641.2004.01272.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Puffer EB, 2007, ACS CHEM BIOL, V2, P252, DOI 10.1021/cb600489g; Rahimian S, 2015, J CONTROL RELEASE, V203, P16, DOI 10.1016/j.jconrel.2015.02.006; Rallabhandi Prasad, 2010, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1416s91; Reed SG, 2013, NAT MED, V19, P1597, DOI 10.1038/nm.3409; Rudra JS, 2012, BIOMATERIALS, V33, P6476, DOI 10.1016/j.biomaterials.2012.05.041; Rudra JS, 2012, ACS NANO, V6, P1557, DOI 10.1021/nn204530r; Rudra JS, 2010, P NATL ACAD SCI USA, V107, P622, DOI 10.1073/pnas.0912124107; Sarroukh R, 2013, BBA-BIOMEMBRANES, V1828, P2328, DOI 10.1016/j.bbamem.2013.04.012; Schijns VEJC, 2000, CURR OPIN IMMUNOL, V12, P456, DOI 10.1016/S0952-7915(00)00120-5; SCHNEERSON R, 1991, J IMMUNOL, V147, P2136; Schroeder U, 2009, J MOL BIOL, V386, P1368, DOI 10.1016/j.jmb.2008.11.023; Scott WRP, 1999, J PHYS CHEM A, V103, P3596, DOI 10.1021/jp984217f; Shanmugam A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030839; Steinhagen F, 2011, VACCINE, V29, P3341, DOI 10.1016/j.vaccine.2010.08.002; Stills HF, 2005, ILAR J, V46, P280, DOI 10.1093/ilar.46.3.280; Stoll LL, 2006, CURR PHARM DESIGN, V12, P4229, DOI 10.2174/138161206778743501; STUARTHA.CH, 1969, B WORLD HEALTH ORGAN, V41, P617; Tian J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S45; Vogel F.R., 1995, VACCINE DESIGN SUBUN, P234; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Zhang L, 2016, ACS APPL MATER INTER, V8, P34933, DOI 10.1021/acsami.6b10470	58	12	13	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19874	19885		10.1074/jbc.RA118.002768	http://dx.doi.org/10.1074/jbc.RA118.002768			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30385503	Green Published, hybrid			2022-12-28	WOS:000454294900031
J	Cejas, RB; Lorenz, V; Garay, YC; Irazoqui, FJ				Cejas, Romina B.; Lorenz, Virginia; Garay, Yohana C.; Irazoqui, Fernando J.			Biosynthesis of O-N-acetylgalactosamine glycans in the human cell nucleus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycobiology; glycoconjugate; glycoprotein biosynthesis; nucleus; enzyme catalysis; substrate specificity; glycosylation; epigenetics; biosynthesis; O-GalNAc glycans; polypeptide N-acetylgalactosaminyltransferase 3; post-translational modification; proteins	GLCNAC TRANSFERASE; DNA-DAMAGE; LAMIN B1; GLYCOSYLATION; GENOME; CANCER; ACETYLGLUCOSAMINE; PHOSPHORYLATION; GLYCOPROTEOME; GLCNACYLATION	Biological functions of nuclear proteins are regulated by post-translational modifications (PTMs) that modulate gene expression and cellular physiology. However, the role of O-linked glycosylation (O-GalNAc) as a PTM of nuclear proteins in the human cell has not been previously reported. Here, we examined in detail the initiation of O-GalNAc glycan biosynthesis, representing a novel PTM of nuclear proteins in the nucleus of human cells, with an emphasis on HeLa cells. Using soluble nuclear fractions from purified nuclei, enzymatic assays, fluorescence microscopy, affinity chromatography, MS, and FRET analyses, we identified all factors required for biosynthesis of O-GalNAc glycans in nuclei: the donor substrate (UDP-GalNAc), nuclear polypeptide GalNAc -transferase activity, and a GalNAc transferase (polypeptide GalNAc-T3). Moreover, we identified O-GalNAc glycosylated proteins in the nucleus and present solid evidence for O-GalNAc glycan synthesis in this organelle. The demonstration of O-GalNAc glycosylation of nuclear proteins in mammalian cells reported here has important implications for cell and chemical biology.	[Cejas, Romina B.; Garay, Yohana C.; Irazoqui, Fernando J.] Univ Nacl Cordoba, Ctr Invest Quim Biol Cordoba, CIQUIBIC, CONICET, Ciudad Univ,X5000HUA, Cordoba, Argentina; [Cejas, Romina B.; Garay, Yohana C.] Univ Nacl Cordoba, Dept Quim Biol Ranwel Caputto, Fac Ciencias Quim, Ciudad Univ,X5000HUA, Cordoba, Argentina; [Lorenz, Virginia] Univ Nacl Litoral, Inst Salud & Ambiente Litoral, ISAL, CONICET, S3000ZAA, Santa Fe, Argentina; [Lorenz, Virginia] Univ Nacl Litoral, Fac Bioquim & Ciencias Biol, S3000ZAA, Santa Fe, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; National University of Cordoba; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of the Littoral; National University of the Littoral	Irazoqui, FJ (corresponding author), Univ Nacl Cordoba, Ctr Invest Quim Biol Cordoba, CIQUIBIC, CONICET, Ciudad Univ,X5000HUA, Cordoba, Argentina.	irazoqui@fcq.unc.edu.ar		Cejas, Romina/0000-0002-5484-4722	CONICET [PIP 11220150100226]; SeCyT, UNC Grant [05/C422]	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); SeCyT, UNC Grant	This work was supported by CONICET Grant PIP 11220150100226 and SeCyT, UNC Grant 05/C422 (to F.J.I.). The authors declare that they have no conflicts of interest with the contents of this article.	Adamson B, 2012, NAT CELL BIOL, V14, P318, DOI 10.1038/ncb2426; Aktas T, 2017, NATURE, V544, P115, DOI 10.1038/nature21715; Amendola M, 2014, CURR OPIN CELL BIOL, V28, P61, DOI 10.1016/j.ceb.2014.03.003; Banerjee PS, 2016, MOL ASPECTS MED, V51, P1, DOI 10.1016/j.mam.2016.05.005; Bennett EP, 1996, J BIOL CHEM, V271, P17006, DOI 10.1074/jbc.271.29.17006; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Bond MR, 2015, J CELL BIOL, V208, P869, DOI 10.1083/jcb.201501101; Brockhausen I, 2006, EMBO REP, V7, P599, DOI 10.1038/sj.embor.7400705; Camps J, 2015, NUCLEUS-PHILA, V6, P8, DOI 10.1080/19491034.2014.1003510; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Collas P, 2014, BIOESSAYS, V36, P75, DOI 10.1002/bies.201300138; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Drickamer K, 2015, CURR OPIN STRUC BIOL, V34, P26, DOI 10.1016/j.sbi.2015.06.003; Fox AH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000687; Gambetta MC, 2015, CHROMOSOMA, V124, P429, DOI 10.1007/s00412-015-0513-1; Gill DJ, 2013, P NATL ACAD SCI USA, V110, pE3152, DOI 10.1073/pnas.1305269110; Hanover JA, 2012, NAT REV MOL CELL BIO, V13, P312, DOI 10.1038/nrm3334; Hart G. W., 2009, ESSENTIALS GLYCOBIOL, P263; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Irazoqui FJ, 2005, BIOCHEM BIOPH RES CO, V336, P14, DOI 10.1016/j.bbrc.2005.08.028; Irazoqui FJ, 1999, GLYCOBIOLOGY, V9, P59, DOI 10.1093/glycob/9.1.59; KINGSLEY DM, 1986, CELL, V44, P749, DOI 10.1016/0092-8674(86)90841-X; Klymenko T, 2018, LEUKEMIA, V32, P364, DOI 10.1038/leu.2017.255; Kumar SR, 2005, CLIN CANCER RES, V11, P6868, DOI 10.1158/1078-0432.CCR-05-0146; Lloyd JT, 2018, J CELL PHYSIOL, V233, P1877, DOI 10.1002/jcp.26010; Lorenz V, 2016, J BIOL CHEM, V291, P25339, DOI 10.1074/jbc.M116.740795; Love DC, 2003, J CELL SCI, V116, P647, DOI 10.1242/jcs.00246; Nilsson T, 2009, FEBS LETT, V583, P3764, DOI 10.1016/j.febslet.2009.10.064; Prokocimer M, 2009, J CELL MOL MED, V13, P1059, DOI [10.1111/j.1582-4934.2009.00676.x, 10.1111/j.1582-4934.2008.00676.x]; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Simon DN, 2013, MOL BIOL CELL, V24, P342, DOI 10.1091/mbc.E12-07-0527; Skalska L, 2017, NAT REV MOL CELL BIO, V18, P1, DOI 10.1038/nrm.2017.12; Snider NT, 2014, NAT REV MOL CELL BIO, V15, P163, DOI 10.1038/nrm3753; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Torvaldson E, 2015, NUCLEUS-PHILA, V6, P166, DOI 10.1080/19491034.2015.1017167; Trapannone R, 2016, BIOCHEM J, V473, P1693, DOI 10.1042/BCJ20160092; Tschochner H, 2003, TRENDS CELL BIOL, V13, P255, DOI 10.1016/S0962-8924(03)00054-0; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Varki A., 2009, ESSENTIALS GLYCOBIOL, P37; Vilcaes AA, 2011, J BIOL CHEM, V286, P31437, DOI 10.1074/jbc.M111.257196; Wang ZH, 2010, MOL CELL PROTEOMICS, V9, P153, DOI 10.1074/mcp.M900268-MCP200; Wollaston-Hayden Edith E, 2014, Front Endocrinol (Lausanne), V5, P223, DOI 10.3389/fendo.2014.00223; Xie W, 2016, CURR BIOL, V26, pR348, DOI 10.1016/j.cub.2016.01.055; Yadavilli S, 2007, DNA REPAIR, V6, P1453, DOI 10.1016/j.dnarep.2007.04.009; Yang Z, 2014, MOL CELL PROTEOMICS, V13, P3224, DOI 10.1074/mcp.M114.041541; Yu LG, 2007, J BIOL CHEM, V282, P773, DOI 10.1074/jbc.M606862200; Zhu YP, 2016, J MOL CELL BIOL, V8, P2, DOI 10.1093/jmcb/mjv033	49	17	17	0	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2019	294	9					2997	3011		10.1074/jbc.RA118.005524	http://dx.doi.org/10.1074/jbc.RA118.005524			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU0SA	30591584	Green Published, hybrid			2022-12-28	WOS:000464980100003
J	Ma, WZ; Chen, XJ; Cerne, R; Syed, SK; Ficorilli, JV; Cabrera, O; Obukhov, AG; Efanov, AM				Ma, Wenzhen; Chen, Xingjuan; Cerne, Rok; Syed, Samreen K.; Ficorilli, James V.; Cabrera, Over; Obukhov, Alexander G.; Efanov, Alexander M.			Catechol estrogens stimulate insulin secretion in pancreatic beta-cells via activation of the transient receptor potential A1 (TRPA1) channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						estrogen; ion channel; transient receptor potential channels (TRP channels); insulin secretion; pancreatic islet	CATION CHANNELS; 17-BETA-ESTRADIOL; ESTRADIOL; PROTEIN; METABOLITES; INHIBITION; APOPTOSIS; PITUITARY; RELEASE; BINDING	Estrogen hormones play an important role in controlling glucose homeostasis and pancreatic beta-cell function. Despite the significance of estrogen hormones for regulation of glucose metabolism, little is known about the roles of endogenous estrogen metabolites in modulating pancreatic beta-cell function. In this study, we evaluated the effects of major natural estrogen metabolites, catechol estrogens, on insulin secretion in pancreatic beta-cells. We show that catechol estrogens, hydroxylated at positions C2 and C4 of the steroid A ring, rapidly potentiated glucose-induced insulin secretion via a nongenomic mechanism. 2-Hydroxyestrone, the most abundant endogenous estrogen metabolite, was more efficacious in stimulating insulin secretion than any other tested catechol estrogens. In insulin-secreting cells, catechol estrogens produced rapid activation of calcium influx and elevation in cytosolic free calcium. Catechol estrogens also generated sustained elevations in cytosolic free calcium and evoked inward ion current in HEK293 cells expressing the transient receptor potential A1 (TRPA1) cation channel. Calcium influx and insulin secretion stimulated by estrogen metabolites were dependent on the TRPA1 activity and inhibited with the channel-specific pharmacological antagonists or the siRNA. Our results suggest the role of estrogen metabolism in a direct regulation of TRPA1 activity with potential implications for metabolic diseases.	[Ma, Wenzhen; Cerne, Rok; Syed, Samreen K.; Ficorilli, James V.; Cabrera, Over; Efanov, Alexander M.] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA; [Chen, Xingjuan; Obukhov, Alexander G.] Indiana Univ, Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA	Eli Lilly; Indiana University System; Indiana University-Purdue University Indianapolis	Efanov, AM (corresponding author), Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA.	efanov_alexander@lilly.com	chen, xingjuan/V-4064-2019; Efanov, Alexander/R-3630-2019; Obukhov, Alexander G./C-7246-2008	chen, xingjuan/0000-0002-7380-8399; Efanov, Alexander/0000-0002-8630-1503; Obukhov, Alexander G./0000-0002-3862-6004				Alonso-Magdalena P, 2013, DIABETES, V62, P2015, DOI 10.2337/db12-1562; Anand P, 2010, CHEM-BIOL INTERACT, V186, P72, DOI 10.1016/j.cbi.2010.03.044; BALL P, 1978, J CLIN ENDOCR METAB, V47, P732, DOI 10.1210/jcem-47-4-732; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bautista DM, 2013, ANNU REV PHYSIOL, V75, P181, DOI 10.1146/annurev-physiol-030212-183811; Beckmann H, 2017, CELL CALCIUM, V66, P10, DOI 10.1016/j.ceca.2017.05.012; Cao DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038005; Castagnetta LAM, 2002, CLIN CANCER RES, V8, P3146; Chen J, 2011, PAIN, V152, P1165, DOI 10.1016/j.pain.2011.01.049; Chen XJ, 2017, J BIOL CHEM, V292, P898, DOI 10.1074/jbc.M116.755470; Chepurny OG, 2016, SCI REP-UK, V6, DOI 10.1038/srep28934; Colsoul B, 2011, REV PHYSIOL BIOCH P, V161, P87, DOI 10.1007/112_2011_2; COSTRINI NV, 1971, J CLIN INVEST, V50, P992, DOI 10.1172/JCI106593; De Cree C, 1997, J APPL PHYSIOL, V82, P364, DOI 10.1152/jappl.1997.82.1.364; DECUPIS A, 1995, BRIT J PHARMACOL, V116, P2391; Dennis MK, 2009, NAT CHEM BIOL, V5, P421, DOI 10.1038/nchembio.168; Emery EC, 2015, DIABETES, V64, P1202, DOI 10.2337/db14-0737; Filardo EJ, 2000, MOL ENDOCRINOL, V14, P1649, DOI 10.1210/me.14.10.1649; Fillingim RB, 2009, J PAIN, V10, P447, DOI 10.1016/j.jpain.2008.12.001; FISHMAN J, 1983, ANNU REV PHYSIOL, V45, P61, DOI 10.1146/annurev.ph.45.030183.000425; Fuhrman BJ, 2014, CANCER EPIDEM BIOMAR, V23, P2649, DOI 10.1158/1055-9965.EPI-14-0438; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Irnaten M, 2008, CELL CALCIUM, V44, P441, DOI 10.1016/j.ceca.2008.02.007; Irnaten M, 2009, STEROIDS, V74, P642, DOI 10.1016/j.steroids.2009.02.002; Islam MS, 2011, ADV EXP MED BIOL, V704, P811, DOI 10.1007/978-94-007-0265-3_42; Kelly MJ, 2001, TRENDS ENDOCRIN MET, V12, P152, DOI 10.1016/S1043-2760(01)00377-0; Kilic G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087941; Kim MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071603; Kumar A, 2015, GEN COMP ENDOCR, V220, P23, DOI 10.1016/j.ygcen.2014.10.004; Kumar S, 2012, J CELL PHYSIOL, V227, P1408, DOI 10.1002/jcp.22855; Le May C, 2006, P NATL ACAD SCI USA, V103, P9232, DOI 10.1073/pnas.0602956103; Lee AJ, 2003, ENDOCRINOLOGY, V144, P3382, DOI 10.1210/en.2003-0192; Liu SH, 2009, DIABETES, V58, P2292, DOI 10.2337/db09-0257; LONGCOPE C, 1982, J CLIN ENDOCR METAB, V54, P374, DOI 10.1210/jcem-54-2-374; Losel RM, 2003, PHYSIOL REV, V83, P965, DOI 10.1152/physrev.00003.2003; Majeed Y, 2011, BRIT J PHARMACOL, V162, P1509, DOI 10.1111/j.1476-5381.2010.01136.x; Majeed Y, 2010, BRIT J PHARMACOL, V161, P430, DOI 10.1111/j.1476-5381.2010.00892.x; Majeed Y, 2012, CELL CALCIUM, V51, P1, DOI 10.1016/j.ceca.2011.09.005; Markides CSA, 2005, J ENDOCRINOL, V185, P235, DOI 10.1677/joe.1.06014; Martensson UEA, 2009, ENDOCRINOLOGY, V150, P687, DOI 10.1210/en.2008-0623; Mauvais-Jarvis F, 2013, ENDOCR REV, V34, P309, DOI 10.1210/er.2012-1055; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Numazawa S, 2012, BIOL PHARM BULL, V35, P346, DOI 10.1248/bpb.35.346; Obukhov AG, 1998, NEUROSCIENCE, V85, P487, DOI 10.1016/S0306-4522(97)00616-7; Rogan EG, 2003, CARCINOGENESIS, V24, P697, DOI 10.1093/carcin/bgg004; SCHAEFFER JM, 1980, J BIOL CHEM, V255, P9838; Standop J, 2003, TOXICOL PATHOL, V31, P506, DOI 10.1080/01926230390226041; Wagner TFJ, 2008, NAT CELL BIOL, V10, P1421, DOI 10.1038/ncb1801; Yuchi Y, 2015, DIABETES, V64, P3218, DOI 10.2337/db14-1798; Zhou ZQ, 2018, J BIOL CHEM, V293, P4735, DOI 10.1074/jbc.M117.805069; Zhu BT, 1998, CARCINOGENESIS, V19, P1, DOI 10.1093/carcin/19.1.1	51	13	13	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2935	2946		10.1074/jbc.RA118.005504	http://dx.doi.org/10.1074/jbc.RA118.005504			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30587572	Green Published, hybrid			2022-12-28	WOS:000459601600030
J	Bandini, G; Leon, DR; Hoppe, CM; Zhang, Y; Agop-Nersesian, C; Shears, MJ; Mahal, LK; Routier, FH; Costello, CE; Samuelson, J				Bandini, Giulia; Leon, Deborah R.; Hoppe, Carolin M.; Zhang, Yue; Agop-Nersesian, Carolina; Shears, Melanie J.; Mahal, Lara K.; Routier, Francoise H.; Costello, Catherine E.; Samuelson, John			O-Fucosylation of thrombospondin-like repeats is required for processing of microneme protein 2 and for efficient host cell invasion by Toxoplasma gondii tachyzoites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						invasion; Toxoplasma gondii; fucosyltransferase; glycosylation; glycoprotein secretion; apicomplexa parasite; MIC2; O-fucosylation; protein glycosylation; thrombospondin-like repeat	C-MANNOSYLATION; STRUCTURAL BASIS; TYPE-1 REPEATS; GDP-FUCOSE; SECRETION; GROWTH; MIC2; IDENTIFICATION; GLYCOSYLATION; CARBOHYDRATE	Toxoplasma gondii is an intracellular parasite that causes disseminated infections that can produce neurological damage in fetuses and immunocompromised individuals. Microneme protein 2 (MIC2), a member of the thrombospondin-related anonymous protein (TRAP) family, is a secreted protein important for T. gondii motility, host cell attachment, invasion, and egress. MIC2 contains six thrombospondin type I repeats (TSRs) that are modified by C-mannose and O-fucose in Plasmodium spp. and mammals. Here, using MS analysis, we found that the four TSRs in T. gondii MIC2 with protein O-fucosyltransferase 2 (POFUT2) acceptor sites are modified by a dHexHex disaccharide, whereas Trp residues within three TSRs are also modified with C-mannose. Disruption of genes encoding either POFUT2 or the putative GDP-fucose transporter (NST2) resulted in loss of MIC2 O-fucosylation, as detected by an antibody against the GlcFuc disaccharide, and in markedly reduced cellular levels of MIC2. Furthermore, in 10-15% of the pofut2 or nst2 vacuoles, MIC2 accumulated earlier in the secretory pathway rather than localizing to micronemes. Dissemination of tachyzoites in human foreskin fibroblasts was reduced for these knockouts, which both exhibited defects in attachment to and invasion of host cells comparable with the mic2 phenotype. These results, indicating that O-fucosylation of TSRs is required for efficient processing of MIC2 and for normal parasite invasion, are consistent with the recent demonstration that Plasmodium falciparum pofut2 strain has decreased virulence and also support a conserved role for this glycosylation pathway in quality control of TSR-containing proteins in eukaryotes.	[Bandini, Giulia; Agop-Nersesian, Carolina; Samuelson, John] Boston Univ, Dept Mol & Cell Biol, Goldman Sch Dent Med, 72 E Concord St, Boston, MA 02118 USA; [Leon, Deborah R.; Costello, Catherine E.] Boston Univ, Dept Biochem, Ctr Biomed Mass Spectrometry, Sch Med, Boston, MA 02118 USA; [Hoppe, Carolin M.; Routier, Francoise H.] Hannover Med Sch, Dept Clin Biochem OE4340, D-30625 Hannover, Germany; [Zhang, Yue; Mahal, Lara K.] NYU, Dept Chem, Biomed Chem Inst, New York, NY USA; [Shears, Melanie J.] Johns Hopkins Malaria Res Inst, Baltimore, MD 21205 USA; [Shears, Melanie J.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA	Boston University; Boston University; Hannover Medical School; New York University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Samuelson, J (corresponding author), Boston Univ, Dept Mol & Cell Biol, Goldman Sch Dent Med, 72 E Concord St, Boston, MA 02118 USA.	jsamuels@bu.edu	Bandini, Giulia/ABC-4413-2021; Mahal, Lara/GRY-7287-2022	Routier, Francoise/0000-0002-7163-0590; Costello, Catherine/0000-0003-1594-5122; Bandini, Giulia/0000-0002-8885-3643; Mahal, Lara/0000-0003-4791-8524; Shears, Melanie/0000-0002-8226-4354	Boston College Imaging Core (National Science Foundation) [1626072]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI110638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM104603] Funding Source: NIH RePORTER	Boston College Imaging Core (National Science Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Prof. Maryse Lebrun for the AMA4 antibody and Prof. Markus Meissner, Prof. Vern Carruthers, and Prof. Marc Jan Gubbels for reagents and helpful discussions. We thank Bret Judson and the Boston College Imaging Core for infrastructure and support (National Science Foundation Grant 1626072).	Adams JC, 2011, CSH PERSPECT BIOL, V3, DOI [10.1101/cshperspect.a009712, 10.1016/j.biocel.2004.01.004]; Bandini G, 2016, P NATL ACAD SCI USA, V113, P11567, DOI 10.1073/pnas.1613653113; Barragan A, 2005, CELL MICROBIOL, V7, P561, DOI 10.1111/j.1462-5822.2005.00486.x; Benz BA, 2016, DEV BIOL, V416, P111, DOI 10.1016/j.ydbio.2016.05.038; Buettner FFR, 2013, MOL CELL, V50, P295, DOI 10.1016/j.molcel.2013.03.003; Carruthers VB, 1999, CELL MICROBIOL, V1, P225, DOI 10.1046/j.1462-5822.1999.00023.x; Carruthers VB, 2000, J BIOL CHEM, V275, P14346, DOI 10.1074/jbc.275.19.14346; Carruthers VB, 1999, MOL MICROBIOL, V31, P421, DOI 10.1046/j.1365-2958.1999.01174.x; Carruthers VB, 2000, INFECT IMMUN, V68, P4005, DOI 10.1128/IAI.68.7.4005-4011.2000; Doucey MA, 1998, MOL BIOL CELL, V9, P291, DOI 10.1091/mbc.9.2.291; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Duk M, 1997, ANAL BIOCHEM, V253, P98, DOI 10.1006/abio.1997.9994; Ferguson DJP, 2004, INT J PARASITOL, V34, P347, DOI 10.1016/j.ijpara.2003.11.024; Gajria B, 2008, NUCLEIC ACIDS RES, V36, pD553, DOI 10.1093/nar/gkm981; Gas-Pascual E, 2019, J BIOL CHEM, V294, P1104, DOI 10.1074/jbc.RA118.006072; Gras Simon, 2017, Wellcome Open Res, V2, P32, DOI [10.12688/wellcomeopenres.11594.2, 10.12688/wellcomeopenres.11594.1]; Guther MLS, 2006, MOL BIOL CELL, V17, P5265, DOI 10.1091/mbc.E06-08-0702; Harper JM, 2006, MOL BIOL CELL, V17, P4551, DOI 10.1091/mbc.E06-01-0064; Harper JM, 2004, MOL BIOCHEM PARASIT, V134, P201, DOI 10.1016/j.molbiopara.2003.12.001; Hofsteenge J, 2001, J BIOL CHEM, V276, P6485, DOI 10.1074/jbc.M008073200; HOFSTEENGE J, 1994, BIOCHEMISTRY-US, V33, P13524, DOI 10.1021/bi00250a003; Hoppe CM, 2018, GLYCOBIOLOGY, V28, P333, DOI 10.1093/glycob/cwy013; Hu H, 2016, GLYCOCONJUGATE J, V33, P285, DOI 10.1007/s10719-015-9633-3; Huynh MH, 2003, EMBO J, V22, P2082, DOI 10.1093/emboj/cdg217; Huynh MH, 2015, J BIOL CHEM, V290, P1432, DOI 10.1074/jbc.M114.613646; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Ishikawa HO, 2010, J BIOL CHEM, V285, P4122, DOI 10.1074/jbc.M109.016964; Kaltgrad E, 2007, CHEMBIOCHEM, V8, P1455, DOI 10.1002/cbic.200700225; Kappe S, 1999, J CELL BIOL, V147, P937, DOI 10.1083/jcb.147.5.937; Khurana S, 2019, J BIOL CHEM, V294, P1541, DOI 10.1074/jbc.RA118.005357; Kozma K, 2006, J BIOL CHEM, V281, P36742, DOI 10.1074/jbc.M605912200; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lopaticki S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00571-y; Lu LC, 2010, J BIOL CHEM, V285, P36245, DOI 10.1074/jbc.M110.126003; Luo Y, 2006, J BIOL CHEM, V281, P9393, DOI 10.1074/jbc.M511975200; Martinez-Duncker I, 2003, GLYCOBIOLOGY, V13, p1C, DOI 10.1093/glycob/cwg113; Huynh MH, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00012-16; Ouologuem DT, 2014, J CELL SCI, V127, P3320, DOI 10.1242/jcs.147736; Parker JL, 2017, NATURE, V551, P521, DOI 10.1038/nature24464; Rabenau KE, 2001, MOL MICROBIOL, V41, P537, DOI 10.1046/j.1365-2958.2001.02513.x; Rahman K, 2017, J BIOL CHEM, V292, P18644, DOI 10.1074/jbc.M117.809301; Rahman K, 2016, J BIOL CHEM, V291, P4268, DOI 10.1074/jbc.M115.703751; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; Saeij JPJ, 2005, INFECT IMMUN, V73, P695, DOI 10.1128/IAI.73.2.695-702.2005; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shcherbakova A, 2017, P NATL ACAD SCI USA, V114, P2574, DOI 10.1073/pnas.1613165114; Sheiner L, 2010, MOL MICROBIOL, V77, P912, DOI 10.1111/j.1365-2958.2010.07255.x; Sidik SM, 2016, CELL, V166, P1423, DOI 10.1016/j.cell.2016.08.019; Sidik SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100450; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Siupka P, 2015, GENES IMMUN, V16, P405, DOI 10.1038/gene.2015.22; Swearingen KE, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005606; Torgerson PR, 2013, B WORLD HEALTH ORGAN, V91, P501, DOI 10.2471/BLT.12.111732; Torrey EF, 2013, TRENDS PARASITOL, V29, P380, DOI 10.1016/j.pt.2013.06.001; Valero-Gonzalez J, 2016, NAT CHEM BIOL, V12, P240, DOI [10.1038/NCHEMBIO.2019, 10.1038/nchembio.2019]; Vasudevan D, 2015, CURR BIOL, V25, P286, DOI 10.1016/j.cub.2014.11.049; Vasudevan D, 2014, GLYCOCONJUGATE J, V31, P417, DOI 10.1007/s10719-014-9556-4; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wang LW, 2007, J BIOL CHEM, V282, P17024, DOI 10.1074/jbc.M701065200; Wang LW, 2009, J BIOL CHEM, V284, P30004, DOI 10.1074/jbc.M109.038059; Wang Y, 2001, J BIOL CHEM, V276, P40338, DOI 10.1074/jbc.M107849200; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wuhrer M, 2011, MASS SPECTROM REV, V30, P664, DOI 10.1002/mas.20337; Zhou XW, 2004, MOL CELL PROTEOMICS, V3, P565, DOI 10.1074/mcp.M300123-MCP200	65	13	15	1	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2019	294	6					1967	1983		10.1074/jbc.RA118.005179	http://dx.doi.org/10.1074/jbc.RA118.005179			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM8EO	30538131	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000459711400017
J	Nishtala, SN; Arora, A; Reyes, J; Akabas, MH				Nishtala, Sita Nirupama; Arora, Avish; Reyes, Jorge; Akabas, Myles H.			Accessibility of substituted cysteines in TM2 and TM10 transmembrane segments in the Plasmodium falciparum equilibrative nucleoside transporter PfENT1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adenosine; malaria; membrane transport; purine; nucleoside; nucleotide transport; sulfhydryl; antimalarial drug; substituted cysteine accessibility method (SCAM); water accessibility	NUCLEOBASE TRANSPORT; CHANNEL STRUCTURE; PLASMA-MEMBRANE; PURINE SALVAGE; IDENTIFICATION; PFNT1; RESISTANCE; PATHWAYS; TARGET; GATE	Infection with Plasmodium species parasites causes malaria. Plasmodium parasites are purine auxotrophic. They import purines via an equilibrative nucleoside transporter (ENT). In P. falciparum, the most virulent species, the equilibrative nucleoside transporter 1 (PfENT1) represents the primary purine uptake pathway. This transporter is a potential target for the development of antimalarial drugs. In the absence of a high-resolution structure for either PfENT1 or a homologous ENT, we used the substituted cysteine accessibility method (SCAM) to investigate the membrane-spanning domain structure of PfENT1 to identify potential inhibitor-binding sites. We previously used SCAM to identify water-accessible residues that line the permeation pathway in transmembrane segment 11 (TM11). TM2 and TM10 lie adjacent to TM11 in an ab initio model of a homologous Leishmania donovani nucleoside transporter. To identify TM2 and TM10 residues in PfENT1 that are at least transiently on the water-accessible transporter surface, we assayed the reactivity of single cysteine-substitution mutants with three methanethiosulfonate (MTS) derivatives. Cysteines substituted for 12 of 14 TM2 segment residues reacted with MTS-ethyl-ammonium-biotin (MTSEA-biotin). At eight positions, MTSEA-biotin inhibited transport, and at four positions substrate transport was potentiated. On an helical wheel projection of TM2, the four positions where potentiation occurred were located in a cluster on one side of the helix. In contrast, although MTSEA-biotin inhibited 9 of 10 TM10 cysteine-substituted mutants, the reactive residues did not form a pattern consistent with either an helix or sheet. These results may help identify the binding site(s) of PfENT1 inhibitors.	[Nishtala, Sita Nirupama; Arora, Avish; Reyes, Jorge; Akabas, Myles H.] Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA; [Akabas, Myles H.] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA; [Akabas, Myles H.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Reyes, Jorge] Princeton Univ, Princeton, NJ 08544 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Princeton University	Akabas, MH (corresponding author), 1300 Morris Pk Ave, Bronx, NY 10461 USA.	myles.akabas@einstein.yu.edu		Akabas, Myles/0000-0001-8781-7846; Reyes, Jorge/0000-0002-2084-1013	National Institutes of Health [R01-AI116665]; GlaxoSmithKline (GSK) as part of the GSK Discovery Fast Track Competition; GSK; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI116665] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GlaxoSmithKline (GSK) as part of the GSK Discovery Fast Track Competition; GSK(GlaxoSmithKline); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01-AI116665 (to M.H.A.). In 2015, Dr. Akabas received a one-year unrestricted research grant from GlaxoSmithKline (GSK) as part of the GSK Discovery Fast Track Competition to fund the performance of hit validation assays in Dr. Akabas' laboratory related to the high throughput screen GSK performed with our yeast based assay to identify inhibitors of PfENT1 as potential starting points for the development of novel antimalarial drugs. The only connection between the work supported by GSK and the current work is that they both involve PfENT1. Dr. Akabas holds patents on derivatives of the hits identified by GSK. GSK has no interests in the patents or subsequent work.	AKABAS MH, 1994, NEURON, V13, P919, DOI 10.1016/0896-6273(94)90257-7; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Akabas MH, 2015, ADV EXP MED BIOL, V869, P25, DOI 10.1007/978-1-4939-2845-3_3; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Baldwin SA, 2004, PFLUG ARCH EUR J PHY, V447, P735, DOI 10.1007/s00424-003-1103-2; Bera AK, 2002, J BIOL CHEM, V277, P43002, DOI 10.1074/jbc.M206321200; Blasco B, 2017, NAT MED, V23, P917, DOI 10.1038/nm.4381; Carter NS, 2000, J BIOL CHEM, V275, P10683, DOI 10.1074/jbc.275.14.10683; Cassera MB, 2011, CURR TOP MED CHEM, V11, P2103; Downie MJ, 2008, INT J PARASITOL, V38, P203, DOI 10.1016/j.ijpara.2007.07.005; Downie MJ, 2008, EUKARYOT CELL, V7, P1231, DOI 10.1128/EC.00159-08; Downie MJ, 2006, MOL MICROBIOL, V60, P738, DOI 10.1111/j.1365-2958.2006.05125.x; El Bissati K, 2008, MOL BIOCHEM PARASIT, V161, P130, DOI 10.1016/j.molbiopara.2008.06.012; El Bissati K, 2006, P NATL ACAD SCI USA, V103, P9286, DOI 10.1073/pnas.0602590103; Frame IJ, 2015, ANN NY ACAD SCI, V1342, P19, DOI 10.1111/nyas.12568; Frame IJ, 2015, ACS CHEM BIOL, V10, P775, DOI 10.1021/cb500981y; Harrington SE, 2009, STRUCTURE, V17, P1092, DOI 10.1016/j.str.2009.06.009; HILL J, 1991, NUCLEIC ACIDS RES, V19, P5791, DOI 10.1093/nar/19.20.5791; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Kirk K, 2009, TRENDS PARASITOL, V25, P246, DOI 10.1016/j.pt.2009.03.006; Landfear SM, 2004, EUKARYOT CELL, V3, P245, DOI 10.1128/EC.3.2.245-254.2004; Lu F, 2017, NEW ENGL J MED, V376, P991, DOI 10.1056/NEJMc1612765; Parker MD, 2000, BIOCHEM J, V349, P67, DOI 10.1042/0264-6021:3490067; Riegelhaupt PM, 2010, J BIOL CHEM, V285, P17001, DOI 10.1074/jbc.M110.115758; Riegelhaupt PM, 2010, MOL BIOCHEM PARASIT, V169, P40, DOI 10.1016/j.molbiopara.2009.10.001; ROBERTS DD, 1986, BIOCHEMISTRY-US, V25, P5595, DOI 10.1021/bi00367a038; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Sa JM, 2011, ESSAYS BIOCHEM, V51, P137, DOI [10.1042/BSE0510137, 10.1042/bse0510137]; Sundaram M, 2001, J BIOL CHEM, V276, P45270, DOI 10.1074/jbc.M107169200; Sutherland CJ, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.02382-16, 10.1128/aac.02382-16]; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Valdes R, 2014, J BIOL CHEM, V289, P8799, DOI 10.1074/jbc.M113.546960; Valdes R, 2012, J BIOL CHEM, V287, P44036, DOI 10.1074/jbc.M112.414433; Valdes R, 2009, J BIOL CHEM, V284, P19067, DOI 10.1074/jbc.M109.017947; Yao SYM, 2002, J BIOL CHEM, V277, P24938, DOI 10.1074/jbc.M200966200; Zhang M, 2018, SCIENCE, V360, P506, DOI 10.1126/science.aap7847	37	1	2	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2019	294	6					1924	1935		10.1074/jbc.RA118.006547	http://dx.doi.org/10.1074/jbc.RA118.006547			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM8EO	30541922	hybrid, Green Published			2022-12-28	WOS:000459711400013
J	Kaye, Y; Huang, WC; Clowez, S; Saroussi, S; Idoine, A; Sanz-Luque, E; Grossman, AR				Kaye, Yuval; Huang, Weichao; Clowez, Sophie; Saroussi, Shai; Idoine, Adam; Sanz-Luque, Emanuel; Grossman, Arthur R.			The mitochondrial alternative oxidase from Chlamydomonas reinhardtii enables survival in high light	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						algae; photosynthesis; electron transport system (ETS); chloroplast; mitochondrial respiratory chain complex; molecular imaging; respiration; reactive oxygen species (ROS); AOX; chloroplast-mitochondria; electron transport; high light; redox; oxidative stress	GREEN-ALGA CHLAMYDOMONAS; CYCLIC ELECTRON FLOW; CHLOROPHYLL FLUORESCENCE; STATE TRANSITIONS; OXIDATIVE STRESS; PHOTOSYNTHETIC PERFORMANCE; PLANT-MITOCHONDRIA; NICOTIANA-TABACUM; RESPIRATORY-CHAIN; OXYGEN PRODUCTION	Photosynthetic organisms often experience extreme light conditions that can cause hyper-reduction of the chloroplast electron transport chain, resulting in oxidative damage. Accumulating evidence suggests that mitochondrial respiration and chloroplast photosynthesis are coupled when cells are absorbing high levels of excitation energy. This coupling helps protect the cells from hyper-reduction of photosynthetic electron carriers and diminishes the production of reactive oxygen species (ROS). To examine this cooperative protection, here we characterized Chlamydomonas reinhardtii mutants lacking the mitochondrial alternative terminal respiratory oxidases, CrAOX1 and CrAOX2. Using fluorescent fusion proteins, we experimentally demonstrated that both enzymes localize to mitochondria. We also observed that the mutant strains were more sensitive than WT cells to high light under mixotrophic and photoautotrophic conditions, with the aox1 strain being more sensitive than aox2. Additionally, the lack of CrAOX1 increased ROS accumulation, especially in very high light, and damaged the photosynthetic machinery, ultimately resulting in cell death. These findings indicate that the Chlamydomonas AOX proteins can participate in acclimation of C. reinhardtii cells to excess absorbed light energy. They suggest that when photosynthetic electron carriers are highly reduced, a chloroplast-mitochondria coupling allows safe dissipation of photosynthetically derived electrons via the reduction of O-2 through AOX (especially AOX1)-dependent mitochondrial respiration.	[Kaye, Yuval; Huang, Weichao; Clowez, Sophie; Saroussi, Shai; Idoine, Adam; Sanz-Luque, Emanuel; Grossman, Arthur R.] Carnegie Inst Sci, Dept Plant Biol, 260 Panama St, Stanford, CA 94305 USA	Carnegie Institution for Science	Kaye, Y (corresponding author), Carnegie Inst Sci, Dept Plant Biol, 260 Panama St, Stanford, CA 94305 USA.	ykaye@carnegiescience.edu	Saroussi, Shai/Y-2163-2019; Sanz-Luque, Emanuel/Z-2166-2019	Saroussi, Shai/0000-0003-0422-6165; Sanz-Luque, Emanuel/0000-0002-7300-9730	Carnegie Institution for Science; United States Department of Energy [0000229381, 0000235290]	Carnegie Institution for Science; United States Department of Energy(United States Department of Energy (DOE))	This work was supported by the Carnegie Institution for Science and by United States Department of Energy Grants 0000229381 and 0000235290. The authors declare that they have no conflicts of interest with the contents of this article.	Affourtit C, 2002, FEBS LETT, V510, P121, DOI 10.1016/S0014-5793(01)03261-6; Aksoy M, 2014, PLANT CELL, V26, P4214, DOI 10.1105/tpc.114.129270; Albury MS, 2009, PHYSIOL PLANTARUM, V137, P316, DOI 10.1111/j.1399-3054.2009.01270.x; Andersson ME, 1999, FEBS LETT, V449, P17, DOI 10.1016/S0014-5793(99)00376-2; Andrews SC, 2010, BBA-GEN SUBJECTS, V1800, P691, DOI 10.1016/j.bbagen.2010.05.010; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; Bailleul B, 2015, NATURE, V524, P366, DOI 10.1038/nature14599; Baker NR, 2008, ANNU REV PLANT BIOL, V59, P89, DOI 10.1146/annurev.arplant.59.032607.092759; Baurain D, 2003, PLANT PHYSIOL, V131, P1418, DOI 10.1104/pp.013409; BENNOUN P, 1982, P NATL ACAD SCI-BIOL, V79, P4352, DOI 10.1073/pnas.79.14.4352; Berthold DA, 2000, BBA-BIOENERGETICS, V1460, P241, DOI 10.1016/S0005-2728(00)00149-3; Berthold DA, 2003, ANNU REV PLANT BIOL, V54, P497, DOI 10.1146/annurev.arplant.54.031902.134915; Blaby IK, 2014, TRENDS PLANT SCI, V19, P672, DOI 10.1016/j.tplants.2014.05.008; Brettel K, 2001, BBA-BIOENERGETICS, V1507, P100, DOI 10.1016/S0005-2728(01)00202-X; Calhoun LN, 2011, J APPL MICROBIOL, V110, P375, DOI 10.1111/j.1365-2672.2010.04890.x; Cardol P, 2003, PLANT PHYSIOL, V133, P2010, DOI 10.1104/pp.103.028076; Cardol P, 2009, P NATL ACAD SCI USA, V106, P15979, DOI 10.1073/pnas.0908111106; Clowez S, 2015, J BIOL CHEM, V290, P8666, DOI 10.1074/jbc.M114.632588; Dahal K, 2015, NEW PHYTOL, V208, P382, DOI 10.1111/nph.13479; Dahal K, 2014, PLANT PHYSIOL, V166, P1560, DOI 10.1104/pp.114.247866; Dang KV, 2014, PLANT CELL, V26, P3036, DOI 10.1105/tpc.114.126375; Dietzel L, 2008, FEBS J, V275, P1080, DOI 10.1111/j.1742-4658.2008.06264.x; Dinant M, 2001, CURR GENET, V39, P101, DOI 10.1007/s002940000183; Djajanegara I, 1999, FEBS LETT, V454, P220, DOI 10.1016/S0014-5793(99)00808-X; Dutilleul C, 2003, PLANT PHYSIOL, V131, P264, DOI 10.1104/pp.011155; Erickson E, 2015, PLANT J, V82, P449, DOI 10.1111/tpj.12825; Finnegan PM, 2004, ADV PHOTO RESPIRAT, V17, P163; Florez-Sarasa I, 2016, PLANT PHYSIOL, V172, P2176, DOI 10.1104/pp.16.01025; Florez-Sarasa I, 2011, PLANT CELL ENVIRON, V34, P1373, DOI 10.1111/j.1365-3040.2011.02337.x; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Giraud E, 2008, PLANT PHYSIOL, V147, P595, DOI 10.1104/pp.107.115121; Grant N, 2009, PLANT PHYSIOL, V150, P987, DOI 10.1104/pp.109.139394; Haferkamp I, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00002; Haferkamp I, 2011, TRENDS PLANT SCI, V16, P507, DOI 10.1016/j.tplants.2011.04.001; Harris EH, 2001, ANNU REV PLANT PHYS, V52, P363, DOI 10.1146/annurev.arplant.52.1.363; HEINEKE D, 1991, PLANT PHYSIOL, V95, P1131, DOI 10.1104/pp.95.4.1131; Heinnickel M, 2016, P NATL ACAD SCI USA, V113, P2774, DOI 10.1073/pnas.1524040113; Hilal M, 1998, PLANT PHYSIOL, V117, P695, DOI 10.1104/pp.117.2.695; Hohmann-Marriott MF, 2011, ANNU REV PLANT BIOL, V62, P515, DOI 10.1146/annurev-arplant-042110-103811; Holtzapffel RC, 2003, BBA-BIOENERGETICS, V1606, P153, DOI 10.1016/S0005-2728(03)00112-9; Johnson X, 2013, EUKARYOT CELL, V12, P776, DOI 10.1128/EC.00318-12; Kleine T, 2015, BBA-BIOENERGETICS, V1847, P786, DOI 10.1016/j.bbabio.2014.12.009; Kramer DM, 2011, PLANT PHYSIOL, V155, P70, DOI 10.1104/pp.110.166652; Krieger-Liszkay A, 2008, PHOTOSYNTH RES, V98, P551, DOI 10.1007/s11120-008-9349-3; KROMER S, 1995, ANNU REV PLANT PHYS, V46, P45, DOI 10.1146/annurev.pp.46.060195.000401; Kropat J, 2011, PLANT J, V66, P770, DOI 10.1111/j.1365-313X.2011.04537.x; LEMAIRE C, 1988, P NATL ACAD SCI USA, V85, P1344, DOI 10.1073/pnas.85.5.1344; Mackinder LCM, 2016, P NATL ACAD SCI USA, V113, P5958, DOI 10.1073/pnas.1522866113; Massoz S, 2015, J BIOTECHNOL, V215, P27, DOI 10.1016/j.jbiotec.2015.05.009; Mathy G, 2010, J PROTEOME RES, V9, P2825, DOI 10.1021/pr900866e; Maxwell DP, 1999, P NATL ACAD SCI USA, V96, P8271, DOI 10.1073/pnas.96.14.8271; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Mettler T, 2014, PLANT CELL, V26, P2310, DOI 10.1105/tpc.114.124537; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Molen TA, 2006, PHYSIOL PLANTARUM, V127, P74, DOI 10.1111/j.1399-3054.2006.00643.x; MOORE AL, 1995, J BIOENERG BIOMEMBR, V27, P367, DOI 10.1007/BF02109999; Moore AL, 2013, ANNU REV PLANT BIOL, V64, P637, DOI 10.1146/annurev-arplant-042811-105432; Murakami Y, 2008, PLANT BIOTECHNOL-NAR, V25, P361, DOI 10.5511/plantbiotechnology.25.361; Neupert J, 2009, PLANT J, V57, P1140, DOI 10.1111/j.1365-313X.2008.03746.x; Nguyen HM, 2011, PROTEOMICS, V11, P4266, DOI 10.1002/pmic.201100114; Niyogi KK, 2000, CURR OPIN PLANT BIOL, V3, P455, DOI 10.1016/S1369-5266(00)00113-8; Noguchi K, 2008, MITOCHONDRION, V8, P87, DOI 10.1016/j.mito.2007.09.003; Ogilby PR, 2010, CHEM SOC REV, V39, P3181, DOI 10.1039/b926014p; Ostroukhova M, 2017, EUR J PROTISTOL, V58, P1, DOI 10.1016/j.ejop.2016.11.005; Padua M, 1999, PLANT PHYSIOL BIOCH, V37, P131, DOI 10.1016/S0981-9428(99)80074-6; Peers G, 2009, NATURE, V462, P518, DOI 10.1038/nature08587; Peltier G, 2016, ANNU REV PLANT BIOL, V67, P55, DOI 10.1146/annurev-arplant-043014-114752; Peltier G, 2010, PHOTOSYNTH RES, V106, P19, DOI 10.1007/s11120-010-9575-3; Polukhina I, 2016, PLANT PHYSIOL, V172, P1494, DOI 10.1104/pp.16.01310; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Rachmilevitch S, 2007, PHYSIOL PLANTARUM, V129, P163, DOI 10.1111/j.1399-3054.2006.00784.x; Rasala BA, 2013, PLANT J, V74, P545, DOI 10.1111/tpj.12165; Rasmusson AG, 2009, PHYSIOL PLANTARUM, V137, P371, DOI 10.1111/j.1399-3054.2009.01252.x; Rhoads DM, 2007, MITOCHONDRION, V7, P177, DOI 10.1016/j.mito.2007.01.002; Salinas T, 2014, BIOCHIMIE, V100, P207, DOI 10.1016/j.biochi.2013.10.006; Saroussi S, 2017, CURR OPIN PLANT BIOL, V39, P114, DOI 10.1016/j.pbi.2017.06.002; Saroussi SI, 2016, PLANT PHYSIOL, V170, P1975, DOI 10.1104/pp.15.02014; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schonfeld C, 2004, J BIOL CHEM, V279, P50366, DOI 10.1074/jbc.M408477200; Selinski J, 2019, PLANT BIOLOGY, V21, P21, DOI 10.1111/plb.12869; Selinski J, 2017, PLANT PHYSIOL, V174, P2113, DOI 10.1104/pp.17.00681; Selinski J, 2018, PLANT PHYSIOL, V176, P1423, DOI 10.1104/pp.17.01331; Selinski J, 2016, PHYSIOL PLANTARUM, V157, P264, DOI 10.1111/ppl.12418; SIEDOW JN, 1995, FEBS LETT, V362, P10, DOI 10.1016/0014-5793(95)00196-G; Sweetlove LJ, 2006, P NATL ACAD SCI USA, V103, P19587, DOI 10.1073/pnas.0607751103; Takahashi H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2954; Tardif M, 2012, MOL BIOL EVOL, V29, P3625, DOI 10.1093/molbev/mss178; Triantaphylides C, 2009, TRENDS PLANT SCI, V14, P219, DOI 10.1016/j.tplants.2009.01.008; Uhmeyer A, 2017, PLANT PHYSIOL, V174, P1399, DOI 10.1104/pp.16.00946; Vanlerberghe GC, 1997, PLANT PHYSIOL, V113, P657, DOI 10.1104/pp.113.2.657; Vanlerberghe GC, 2013, INT J MOL SCI, V14, P6805, DOI 10.3390/ijms14046805; Vishwakarma A, 2015, ANN BOT-LONDON, V116, P555, DOI 10.1093/aob/mcv122; Vishwakarma A, 2014, PLANT PHYSIOL BIOCH, V81, P44, DOI 10.1016/j.plaphy.2014.01.019; Wang J, 2011, PHYSIOL PLANTARUM, V142, P339, DOI 10.1111/j.1399-3054.2011.01471.x; Wang QJ, 2016, PLANT BIOTECHNOL J, V14, P1986, DOI 10.1111/pbi.12556; Whelan J, 1997, PLANT MOL BIOL, V33, P771, DOI 10.1023/A:1005755505738; Wobbe L, 2013, NUCLEIC ACIDS RES, V41, P6553, DOI 10.1093/nar/gkt313; Yang FJ, 2006, NATURE, V442, P700, DOI 10.1038/nature04942; Yang WQ, 2014, PLANT CELL, V26, P4499, DOI 10.1105/tpc.114.129965; Yoshida K, 2007, PLANT CELL PHYSIOL, V48, P606, DOI 10.1093/pcp/pcm033; Yoshida K, 2011, PLANT CELL ENVIRON, V34, P618, DOI 10.1111/j.1365-3040.2010.02267.x; Zalutskaya Z, 2017, J PLANT PHYSIOL, V219, P123, DOI 10.1016/j.jplph.2017.10.004; Zalutskaya Z, 2016, ENVIRON EXP BOT, V130, P133, DOI 10.1016/j.envexpbot.2016.05.015; Zalutskaya Z, 2015, PLANT PHYSIOL BIOCH, V97, P229, DOI 10.1016/j.plaphy.2015.10.014; Zhang LT, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-40	109	15	15	2	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1380	1395		10.1074/jbc.RA118.004667	http://dx.doi.org/10.1074/jbc.RA118.004667			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30510139	Green Published, hybrid			2022-12-28	WOS:000457879500027
J	Patel, A; Sibbet, GJ; Huang, DT				Patel, Amrita; Sibbet, Gary J.; Huang, Danny T.			Structural insights into non-covalent ubiquitin activation of the cIAP1-UbcH5B similar to ubiquitin complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ubiquitin; ubiquitin ligase; allosteric regulation; structural biology; ubiquitin-conjugating enzyme (E2 enzyme); ubiquitylation (ubiquitination); E3 ubiquitin ligase; activation; cIAP1; non-covalent; RING E3; UbcH5B; activation; protein degradation; apoptosis	E3 LIGASE; CATALYTIC ACTIVATION; CRYSTAL-STRUCTURE; CELL-SURVIVAL; RING DOMAIN; CIAP1; MECHANISM; INHIBITOR; DEGRADATION; PROTEINS	Ubiquitin (Ub)-conjugating enzymes and Ub ligases control protein degradation and regulate many cellular processes in eukaryotes. Cellular inhibitor of apoptosis protein-1 (cIAP1) plays a central role in apoptosis and tumor necrosis factor signaling. It harbors a C-terminal RING domain that homodimerizes to recruit E2 similar to Ub (where similar to denotes a thioester bond) complex to catalyze Ub transfer. Noncovalent Ub binding to the backside of the E2 Ub-conjugating enzyme UbcH5 has previously been shown to enhance RING domain activity, but the molecular basis for this enhancement is unclear. To investigate how dimeric cIAP1 RING activates E2 similar to Ub for Ub transfer and what role noncovalently bound Ub has in Ub transfer, here we determined the crystal structure of the cIAP1 RING dimer bound to both UbcH5B covalently linked to Ub (UbcH5B-Ub) and a noncovalent Ub to 1.7 A resolution. The structure along with biochemical analyses revealed that the cIAP1 RING domain interacts with UbcH5B-Ub and thereby promotes the formation of a closed UbcH5B-Ub conformation that primes the thioester bond for Ub transfer. We observed that the noncovalent Ub binds to the backside of UbcH5B and abuts UbcH5B's alpha 1 beta 1-loop, which, in turn, stabilizes the closed UbcH5B-Ub conformation. Our results disclose the mechanism by which cIAP1 RING dimer activates UbcH5B similar to Ub and indicate that noncovalent Ub binding further stabilizes the cIAP1-UbcH5B similar to Ub complex in the active conformation to stimulate Ub transfer.	[Patel, Amrita; Sibbet, Gary J.; Huang, Danny T.] Canc Res UK Beatson Inst, Garscube Estate,Switchback Rd, Glasgow G61 1BD, Lanark, Scotland; [Patel, Amrita; Sibbet, Gary J.; Huang, Danny T.] Univ Glasgow, Inst Canc Sci, Glasgow G61 1BD, Lanark, Scotland	Beatson Institute; University of Glasgow	Huang, DT (corresponding author), Canc Res UK Beatson Inst, Garscube Estate,Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.	d.huang@beatson.gla.ac.uk	Huang, Danny/AAM-3631-2021	Huang, Danny/0000-0002-6192-259X	Cancer Research UK [A23278]; European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program [647849]	Cancer Research UK(Cancer Research UK); European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program(European Research Council (ERC))	This work was supported by Cancer Research UK Grant A23278 and the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (Grant Agreement 647849). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Bertrand MJM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022356; Bosanac I, 2011, J MOL BIOL, V408, P420, DOI 10.1016/j.jmb.2011.03.011; Branigan E, 2015, NAT STRUCT MOL BIOL, V22, P597, DOI 10.1038/nsmb.3052; Brzovic PS, 2006, MOL CELL, V21, P873, DOI 10.1016/j.molcel.2006.02.008; Buetow L, 2016, NAT REV MOL CELL BIO, V17, P626, DOI 10.1038/nrm.2016.91; Buetow L, 2015, MOL CELL, V58, P297, DOI 10.1016/j.molcel.2015.02.017; Cheung HH, 2008, MOL BIOL CELL, V19, P2729, DOI 10.1091/mbc.E08-01-0107; Choi YE, 2009, J BIOL CHEM, V284, P12772, DOI 10.1074/jbc.M807550200; Dawidziak DM, 2017, PROTEINS, V85, P1957, DOI 10.1002/prot.25348; Dou H, 2013, NAT STRUCT MOL BIOL, V20, P982, DOI 10.1038/nsmb.2621; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P876, DOI 10.1038/nsmb.2379; Dueber EC, 2011, SCIENCE, V334, P376, DOI 10.1126/science.1207862; Dye BT, 2007, ANNU REV BIOPH BIOM, V36, P131, DOI 10.1146/annurev.biophys.36.040306.132820; Dynek JN, 2013, CANCER LETT, V332, P206, DOI 10.1016/j.canlet.2010.06.013; Dynek JN, 2010, EMBO J, V29, P4198, DOI 10.1038/emboj.2010.300; Eckelman BP, 2006, J BIOL CHEM, V281, P3254, DOI 10.1074/jbc.M510863200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feltham R, 2011, J BIOL CHEM, V286, P17015, DOI 10.1074/jbc.M111.222919; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hu SM, 2003, J BIOL CHEM, V278, P10055, DOI 10.1074/jbc.M207197200; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaiser SE, 2011, NAT METHODS, V8, P691, DOI [10.1038/NMETH.1649, 10.1038/nmeth.1649]; Koliopoulos MG, 2016, EMBO J, V35, P1204, DOI 10.15252/embj.201593741; Li SJ, 2015, J BIOL CHEM, V290, P30225, DOI 10.1074/jbc.M115.685867; Lopez J, 2011, MOL CELL, V42, P569, DOI 10.1016/j.molcel.2011.04.008; Mace PD, 2008, J BIOL CHEM, V283, P31633, DOI 10.1074/jbc.M804753200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Middleton AJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01665-3; Nakatani Y, 2013, BIOCHEM J, V450, P629, DOI 10.1042/BJ20121702; Nomura K, 2017, NAT STRUCT MOL BIOL, V24, P578, DOI 10.1038/nsmb.3414; Peltzer N, 2016, TRENDS CELL BIOL, V26, P445, DOI 10.1016/j.tcb.2016.01.006; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Pruneda JN, 2012, MOL CELL, V47, P933, DOI 10.1016/j.molcel.2012.07.001; Ranaweera RS, 2013, J BIOL CHEM, V288, P18939, DOI 10.1074/jbc.M113.454470; Saha A, 2011, MOL CELL, V42, P75, DOI 10.1016/j.molcel.2011.03.016; Sakata E, 2010, STRUCTURE, V18, P138, DOI 10.1016/j.str.2009.11.007; Sanchez JG, 2016, CELL REP, V16, P1315, DOI 10.1016/j.celrep.2016.06.070; Siepmann TJ, 2003, J BIOL CHEM, V278, P9448, DOI 10.1074/jbc.M211240200; Silke J, 2005, P NATL ACAD SCI USA, V102, P16182, DOI 10.1073/pnas.0502828102; Tokunaga F, 2011, NATURE, V471, P633, DOI 10.1038/nature09815; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200; Wickliffe KE, 2011, CELL, V144, P769, DOI 10.1016/j.cell.2011.01.035; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Wright JD, 2016, NAT STRUCT MOL BIOL, V23, P45, DOI 10.1038/nsmb.3142; Yin Q, 2009, NAT STRUCT MOL BIOL, V16, P658, DOI 10.1038/nsmb.1605	52	8	8	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1240	1249		10.1074/jbc.RA118.006045	http://dx.doi.org/10.1074/jbc.RA118.006045			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30523153	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000457879500015
J	Yarychkivska, O; Shahabuddin, Z; Comfort, N; Boulard, M; Bestor, TH				Yarychkivska, Olya; Shahabuddin, Zoha; Comfort, Nicole; Boulard, Mathieu; Bestor, Timothy H.			BAH domains and a histone-like motif in DNA methyltransferase 1 (DNMT1) regulate de novo and maintenance methylation in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA enzyme; DNA methylation; chromatin; chromatin modification; chromatin regulation; epigenetics; 5-methylcytosine; DNA methylation; DNA methyltransferase; DNA methyltransferase-1 (DNMT1); genomic imprinting; acetylation; histone; BAH domain; gene regulation	MOUSE CELLS; SRA DOMAIN; GERM-CELLS; UHRF1; EXPRESSION; PROTEINS; REVEALS; DIFFERENTIATION; ESTABLISHMENT; REPLICATION	DNA methyltransferase 1 (DNMT1) is a multidomain protein believed to be involved only in the passive transmission of genomic methylation patterns via maintenance methylation. The mechanisms that regulate DNMT1 activity and targeting are complex and poorly understood. We used embryonic stem (ES) cells to investigate the function of the uncharacterized bromo-adjacent homology (BAH) domains and the glycine-lysine (GK) repeats that join the regulatory and catalytic domains of DNMT1. We removed the BAH domains by means of a CRISPR/Cas9-mediated deletion within the endogenous Dnmt1 locus. The internally deleted protein failed to associate with replication foci during S phase in vivo and lost the ability to mediate maintenance methylation. The data indicate that ablation of the BAH domains causes DNMT1 to be excluded from replication foci even in the presence of the replication focus-targeting sequence (RFTS). The GK repeats resemble the N-terminal tails of histones H2A and H4 and are normally acetylated. Substitution of lysines within the GK repeats with arginines to prevent acetylation did not alter the maintenance activity of DNMT1 but unexpectedly activated de novo methylation of paternal imprinting control regions (ICRs) in mouse ES cells; maternal ICRs remained unmethylated. We propose a model under which DNMT1 deposits paternal imprints in male germ cells in an acetylation-dependent manner. These data reveal that DNMT1 responds to multiple regulatory inputs that control its localization as well as its activity and is not purely a maintenance methyltransferase but can participate in the de novo methylation of a small but essential compartment of the genome.	[Yarychkivska, Olya; Shahabuddin, Zoha; Bestor, Timothy H.] Columbia Univ Coll Phys & Surg, Dept Genet & Dev, 701 W 168t St, New York, NY 10032 USA; [Comfort, Nicole] Columbia Univ Coll Phys & Surg, Dept Environm Hlth Sci, New York, NY 10032 USA; [Boulard, Mathieu] European Mol Biol Lab, I-00015 Rome, Italy	Columbia University; Columbia University; European Molecular Biology Laboratory (EMBL)	Bestor, TH (corresponding author), Columbia Univ Coll Phys & Surg, Dept Genet & Dev, 701 W 168t St, New York, NY 10032 USA.	THB12@cumc.columbia.edu	Comfort, Nicole/AAY-6714-2020; Boulard, Matthieu/H-8923-2017	Comfort, Nicole/0000-0002-6827-3043; Shahabuddin, Zoha/0000-0003-4641-7146; Boulard, Matthieu/0000-0001-5135-8529	National Institutes of Health [5R21 HG009187]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG009187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007322] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Grant 5R21 HG009187 (to T. H. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arita K, 2008, NATURE, V455, P818, DOI 10.1038/nature07249; Avvakumov GV, 2008, NATURE, V455, P822, DOI 10.1038/nature07273; BESTOR T, 1988, J MOL BIOL, V203, P971, DOI 10.1016/0022-2836(88)90122-2; Bewick AJ, 2017, MOL BIOL EVOL, V34, P654, DOI 10.1093/molbev/msw264; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Bourc'his D, 2006, CYTOGENET GENOME RES, V113, P36, DOI 10.1159/000090813; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Cheng JD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8023; Damelin M, 2007, MOL CELL BIOL, V27, P3891, DOI 10.1128/MCB.00036-07; Edwards JR, 2017, EPIGENET CHROMATIN, V10, DOI 10.1186/s13072-017-0130-8; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Hashimoto H, 2008, NATURE, V455, P826, DOI 10.1038/nature07280; Hiura H, 2006, GENES CELLS, V11, P353, DOI 10.1111/j.1365-2443.2006.00943.x; HOLLIDAY R, 1975, SCIENCE, V187, P226, DOI 10.1126/science.1111098; Ishiyama S, 2017, MOL CELL, V68, P350, DOI 10.1016/j.molcel.2017.09.037; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; KELLER G, 1993, MOL CELL BIOL, V13, P473, DOI 10.1128/MCB.13.1.473; Kim J, 2014, MOL PLANT, V7, P1470, DOI 10.1093/mp/ssu079; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kouzminova E, 2001, EMBO J, V20, P4309, DOI 10.1093/emboj/20.15.4309; La Salle S, 2004, DEV BIOL, V268, P403, DOI 10.1016/j.ydbio.2003.12.031; Lei H, 1996, DEVELOPMENT, V122, P3195; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LI E, 1993, COLD SPRING HARB SYM, V58, P297, DOI 10.1101/SQB.1993.058.01.035; Li T, 2018, NUCLEIC ACIDS RES, V46, P3218, DOI 10.1093/nar/gky104; Liu XL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2562; Long HK, 2013, BIOCHEM SOC T, V41, P727, DOI 10.1042/BST20130028; Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129; McGraw S, 2015, NUCLEIC ACIDS RES, V43, P1485, DOI 10.1093/nar/gku1386; Nakamura T, 2007, NAT CELL BIOL, V9, P64, DOI 10.1038/ncb1519; Nishiyama A, 2013, NATURE, V502, P249, DOI 10.1038/nature12488; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Proudhon C, 2012, MOL CELL, V47, P909, DOI 10.1016/j.molcel.2012.07.010; RIGGS AD, 1975, CYTOGENET CELL GENET, V14, P9, DOI 10.1159/000130315; ROBERTSON E, 1986, NATURE, V323, P445, DOI 10.1038/323445a0; Rothbart SB, 2012, NAT STRUCT MOL BIOL, V19, P1155, DOI 10.1038/nsmb.2391; Sakai Y, 2001, CELL STRUCT FUNCT, V26, P685, DOI 10.1247/csf.26.685; Schulz R, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001214; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Song JK, 2011, SCIENCE, V331, P1036, DOI 10.1126/science.1195380; Takada S, 2002, HUM MOL GENET, V11, P77, DOI 10.1093/hmg/11.1.77; Takebayashi S, 2007, MOL CELL BIOL, V27, P8243, DOI 10.1128/MCB.00899-07; Takeshita K, 2011, P NATL ACAD SCI USA, V108, P9055, DOI 10.1073/pnas.1019629108; Tremblay KD, 1997, MOL CELL BIOL, V17, P4322, DOI 10.1128/MCB.17.8.4322; Tucker KL, 1996, GENE DEV, V10, P1008, DOI 10.1101/gad.10.8.1008; Watanabe T, 2011, SCIENCE, V332, P848, DOI 10.1126/science.1203919; Yang N, 2013, CRIT REV BIOCHEM MOL, V48, P211, DOI 10.3109/10409238.2012.742035; Yarychkivska O, 2018, EPIGENET CHROMATIN, V11, DOI 10.1186/s13072-018-0179-z; Yoder JA, 1997, J MOL BIOL, V270, P385, DOI 10.1006/jmbi.1997.1125; Zhang ZM, 2015, J MOL BIOL, V427, P2520, DOI 10.1016/j.jmb.2015.06.001	52	27	29	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2018	293	50					19466	19475		10.1074/jbc.RA118.004612	http://dx.doi.org/10.1074/jbc.RA118.004612			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HE6RA	30341171	Green Published, hybrid			2022-12-28	WOS:000453537300026
J	Jarrett, SG; Carter, KM; Bautista, RM; He, DH; Wang, C; D'Orazio, JA				Jarrett, Stuart G.; Carter, Katharine M.; Bautista, Robert-Marlo; He, Daheng; Wang, Chi; D'Orazio, John A.			Sirtuin 1-mediated deacetylation of XPA DNA repair protein enhances its interaction with ATR protein and promotes cAMP-induced DNA repair of UV damage (Publication with Expression of Concern. See vol. 295, pg. 14249, 2020) (Withdrawn Publication. See vol. 296, 2021)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Withdrawn Publication							NUCLEOTIDE EXCISION-REPAIR; IONIZING-RADIATION; RECEPTOR MC1R; CANCER-CELLS; S PHASE; GROUP-A; KINASE; MELANOMA; SKIN; PHOSPHORYLATION	Blunted melanocortin 1 receptor (MC1R) signaling promotes melanocyte genomic instability in part by attenuating cAMP-mediated DNA repair responses, particularly nucleotide excision repair (NER), which recognizes and clears mutagenic photodamage. cAMP-enhanced NER is mediated by interactions between the ataxia telangiectasia-mutated and Rad3-related (ATR) and xeroderma pigmentosum complementation group A (XPA) proteins. We now report a critical role for sirtuin 1 (SIRT1) in regulating ATR-mediated phosphorylation of XPA. SIRT1 deacetylates XPA at residues Lys-63, Lys-67, and Lys-215 to promote interactions with ATR. Mutant XPA containing acetylation mimetics at residues Lys-63, Lys-67, and Lys-215 exhibit blunted UV-dependent ATR-XPA interactions even in the presence of cAMP signals. ATR-mediated phosphorylation of XPA on Ser-196 enhances cAMP-mediated optimization of NER and is promoted by SIRT1-mediated deacetylation of XPA on Lys-63, Lys-67, and Lys-215. Interference with ATR-mediated XPA phosphorylation at Ser-196 by persistent acetylation of XPA at Lys-63, Lys-67, and Lys-215 delays repair of UV-induced DNA damage and attenuates cAMP-enhanced NER. Our study identifies a regulatory ATR-SIRT1-XPA axis in cAMP-mediated regulation melanocyte genomic stability, involving SIRT1-mediated deacetylation (Lys-63, Lys-67, and Lys-215) and ATR-dependent phosphorylation (Ser-196) post-translational modifications of the core NER factor XPA.	[Jarrett, Stuart G.; Carter, Katharine M.; He, Daheng; Wang, Chi; D'Orazio, John A.] Univ Kentucky, Coll Med, Markey Canc Ctr, Lexington, KY 40536 USA; [Jarrett, Stuart G.; D'Orazio, John A.] Univ Kentucky, Coll Med, Dept Toxicol & Canc Biol, Lexington, KY 40536 USA; [Bautista, Robert-Marlo] Univ Kentucky, Coll Med, Dept Surg, Lexington, KY 40536 USA; [He, Daheng; Wang, Chi] Univ Kentucky, Coll Med, Dept Biostat & Bioinformat, Lexington, KY 40536 USA; [D'Orazio, John A.] Univ Kentucky, Coll Med, Dept Pediat, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky	Jarrett, SG; D'Orazio, JA (corresponding author), Univ Kentucky, Coll Med, Markey Canc Ctr, Dept Toxicol & Canc Biol, Combs Res Bldg 217,800 Rose St, Lexington, KY 40536 USA.	stuart.jarrett@uky.edu; jdorazio@uky.edu		Carter, Katharine/0000-0002-6332-1886; Jarrett, Stuart/0000-0001-8029-1554; Bautista, Robert-Marlo/0000-0001-8760-6221; D'Orazio, John/0000-0003-1008-6234	National Institutes of Health [R01 CA131075, P30 CA177558, T32 CA165990]; Melanoma Research Alliance; Regina Drury Pediatric Research Endowed Chair Fund; DanceBlue Golden Matrix Fund; Markey Cancer Foundation; NATIONAL CANCER INSTITUTE [T32CA160003, T32CA165990, R01CA131075, P30CA177558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM121327] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melanoma Research Alliance; Regina Drury Pediatric Research Endowed Chair Fund; DanceBlue Golden Matrix Fund; Markey Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 CA131075, P30 CA177558, and T32 CA165990, the Melanoma Research Alliance, the Regina Drury Pediatric Research Endowed Chair Fund, the DanceBlue Golden Matrix Fund, and the Markey Cancer Foundation. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Auclair Y, 2009, CELL CYCLE, V8, P1865, DOI 10.4161/cc.8.12.8800; Auclair Y, 2008, P NATL ACAD SCI USA, V105, P17896, DOI 10.1073/pnas.0801585105; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bentley NJ, 1996, EMBO J, V15, P6641, DOI 10.1002/j.1460-2075.1996.tb01054.x; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Castejon-Grinan M, 2018, ONCOGENE, V37, P3631, DOI 10.1038/s41388-018-0216-1; Chen CF, 2017, CELL REP, V18, P2331, DOI 10.1016/j.celrep.2017.02.040; Choi JY, 2015, ONCOTARGET, V6, P22575, DOI 10.18632/oncotarget.4610; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Cliby WA, 1998, EMBO J, V17, P159, DOI 10.1093/emboj/17.1.159; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; D'Orazio JA, 2006, NATURE, V443, P340, DOI 10.1038/nature05098; Robles-Espinoza CD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12064; Dobbin MM, 2013, NAT NEUROSCI, V16, P1008, DOI 10.1038/nn.3460; Donninger H, 2015, MOL CELL BIOL, V35, P277, DOI 10.1128/MCB.00202-14; Eggermont AMM, 2014, LANCET, V383, P816, DOI 10.1016/S0140-6736(13)60802-8; Fan W, 2010, MOL CELL, V39, P247, DOI 10.1016/j.molcel.2010.07.006; Feltes BC, 2015, MUTAT RES-REV MUTAT, V763, P306, DOI 10.1016/j.mrrev.2014.12.002; Flynn RL, 2011, TRENDS BIOCHEM SCI, V36, P133, DOI 10.1016/j.tibs.2010.09.005; Gamper AM, 2013, NUCLEIC ACIDS RES, V41, P10334, DOI 10.1093/nar/gkt833; Garcia-Borron JC, 2005, PIGM CELL RES, V18, P393, DOI 10.1111/j.1600-0749.2005.00278.x; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; He HQ, 2017, CELL REP, V20, P2010, DOI 10.1016/j.celrep.2017.08.016; Herraiz C, 2017, BBA-MOL BASIS DIS, V1863, P2448, DOI 10.1016/j.bbadis.2017.02.027; Hilton BA, 2015, MOL CELL, V60, P35, DOI 10.1016/j.molcel.2015.08.008; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Jagirdar K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078075; Jarrett SG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12056-5; Jarrett SG, 2016, NUCLEIC ACIDS RES, V44, P10711, DOI 10.1093/nar/gkw871; Jarrett SG, 2014, MOL CELL, V54, P999, DOI 10.1016/j.molcel.2014.05.030; Kadekaro AL, 2010, FASEB J, V24, P3850, DOI 10.1096/fj.10-158485; Kang TH, 2011, NUCLEIC ACIDS RES, V39, P3176, DOI 10.1093/nar/gkq1318; Kennedy C, 2001, J INVEST DERMATOL, V117, P294, DOI 10.1046/j.0022-202x.2001.01421.x; Lee TH, 2014, ONCOGENE, V33, P19, DOI 10.1038/onc.2012.539; Lewis KA, 2005, CANCER RES, V65, P7091, DOI 10.1158/0008-5472.CAN-05-1019; Li CL, 2015, MOL CELL, V59, P1025, DOI 10.1016/j.molcel.2015.08.012; Li ZK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068297; Li ZK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028326; Marechal Alexandre, 2013, Cold Spring Harb Perspect Biol, V5, DOI 10.1101/cshperspect.a012716; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Ming M, 2015, ONCOGENE, V34, P281, DOI 10.1038/onc.2013.583; Ming M, 2010, P NATL ACAD SCI USA, V107, P22623, DOI 10.1073/pnas.1010377108; Nguyen TA, 2010, DNA REPAIR, V9, P813, DOI 10.1016/j.dnarep.2010.04.005; Nin V, 2012, J BIOL CHEM, V287, P23489, DOI 10.1074/jbc.M112.365874; Oliva ABP, 2009, HUM MUTAT, V30, P811, DOI 10.1002/humu.20971; Rees JL, 2003, ANNU REV GENET, V37, P67, DOI 10.1146/annurev.genet.37.110801.143233; Saldivar JC, 2017, NAT REV MOL CELL BIO, V18, P622, DOI 10.1038/nrm.2017.67; Santos L, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/9831825; Scharer Orlando D, 2013, Cold Spring Harb Perspect Biol, V5, pa012609, DOI 10.1101/cshperspect.a012609; Shain AH, 2016, NEW ENGL J MED, V374, P995, DOI 10.1056/NEJMc1515834; Shell SM, 2005, BIOCHEMISTRY-US, V44, P971, DOI 10.1021/bi048208a; Shell SM, 2009, J BIOL CHEM, V284, P24213, DOI 10.1074/jbc.M109.000745; Sugitani N, 2016, DNA REPAIR, V44, P123, DOI 10.1016/j.dnarep.2016.05.018; Suzuki I, 1997, J INVEST DERMATOL, V108, P838, DOI 10.1111/1523-1747.ep12292572; Swope V, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12252; Swope VB, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00146; Unsal-Kacmaz K, 2004, MOL CELL BIOL, V24, P1292, DOI 10.1128/MCB.24.3.1292-1300.2003; Valverde P, 1996, HUM MOL GENET, V5, P1663, DOI 10.1093/hmg/5.10.1663; VALVERDE P, 1995, NAT GENET, V11, P328, DOI 10.1038/ng1195-328; Wright JA, 1998, P NATL ACAD SCI USA, V95, P7445, DOI 10.1073/pnas.95.13.7445; Wu X, 2007, ONCOGENE, V26, P757, DOI 10.1038/sj.onc.1209828; Wu XM, 2006, CANCER RES, V66, P2997, DOI 10.1158/0008-5472.CAN-05-3403; Yang ZG, 2006, BIOCHEMISTRY-US, V45, P15921, DOI 10.1021/bi061626q; Zhao MM, 2017, CELL REP, V20, P1997, DOI 10.1016/j.celrep.2017.08.015; ZHENG XF, 1995, CELL, V82, P121, DOI 10.1016/0092-8674(95)90058-6	65	28	29	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2018	293	49					19025	19037		10.1074/jbc.RA118.003940	http://dx.doi.org/10.1074/jbc.RA118.003940			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NY	30327428	Green Published, hybrid			2022-12-28	WOS:000458467400017
J	Stewart, TM; Dunston, TT; Woster, PM; Casero, RA				Stewart, Tracy Murray; Dunston, Tiffany T.; Woster, Patrick M.; Casero, Robert A., Jr.			Polyamine catabolism and oxidative damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							SERUM AMINE OXIDASE; SPERMINE SYNTHASE DEFICIENCY; GASTRIC-CANCER RISK; ESCHERICHIA-COLI; HELICOBACTER-PYLORI; SPERMIDINE/SPERMINE N-1-ACETYLTRANSFERASE; EPITHELIAL-CELLS; ACROLEIN PRODUCTION; SPE2-DELTA MUTANT; METABOLISM	Polyamines (PAs) are indispensable polycations ubiquitous to all living cells. Among their many critical functions, PAs contribute to the oxidative balance of the cell. Beginning with studies by the Tabor laboratory in bacteria and yeast, the requirement for PAs as protectors against oxygen radical-mediated damage has been well established in many organisms, including mammals. However, PAs also serve as substrates for oxidation reactions that produce hydrogen peroxide (H2O2) both intra- and extracellularly. As intracellular concentrations of PAs can reach millimolar concentrations, the H2O2 amounts produced through their catabolism, coupled with a reduction in protective PAs, are sufficient to cause the oxidative damage associated with many pathologies, including cancer. Thus, the maintenance of intracellular polyamine homeostasis may ultimately contribute to the maintenance of oxidative homeostasis. Again, pioneering studies by Tabor and colleagues led the way in first identifying spermine oxidase in Saccharomyces cerevisiae. They also first purified the extracellular bovine serum amine oxidase and elucidated the products of its oxidation of primary amine groups of PAs when included in culture medium. These investigations formed the foundation for many polyamine-related studies and experimental procedures still performed today. This Minireview will summarize key innovative studies regarding PAs and oxidative damage, starting with those from the Tabor laboratory and including the most recent advances, with a focus on mammalian systems.	[Stewart, Tracy Murray; Dunston, Tiffany T.; Casero, Robert A., Jr.] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Sch Med, 1650 Orleans St,Bunting Blaustein Bldg,Rm 551, Baltimore, MD 21287 USA; [Woster, Patrick M.] Med Univ South Carolina, Dept Drug Discovery & Biomed Sci, Coll Pharm, Charleston, SC 29425 USA	Johns Hopkins University; Johns Hopkins Medicine; Medical University of South Carolina	Casero, RA (corresponding author), Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Sch Med, 1650 Orleans St,Bunting Blaustein Bldg,Rm 551, Baltimore, MD 21287 USA.	rcasero@jhmi.edu	Stewart, Tracy Murray/B-6137-2017; Woster, Patrick M/A-5604-2010	Stewart, Tracy Murray/0000-0001-8679-6414; Woster, Patrick M/0000-0002-9471-1916; Casero, Robert/0000-0001-5653-3306	National Institutes of Health [1 R01 CA204345]; Maryland Cigarette Restitution Fund; Samuel Waxman Cancer Research Foundation; Million Dollar Bike Ride; Doris Duke Charitable Foundation; NATIONAL CANCER INSTITUTE [R01CA204345] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maryland Cigarette Restitution Fund; Samuel Waxman Cancer Research Foundation; Million Dollar Bike Ride; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant 1 R01 CA204345, the Maryland Cigarette Restitution Fund, the Samuel Waxman Cancer Research Foundation, and the Million Dollar Bike Ride (to the Casero laboratory) and by National Institutes of Health Grant 1 R01 CA204345 and the Doris Duke Charitable Foundation (to the Woster laboratory). This article is part of a series on "Polyamines," written in honor of Dr. Herbert Tabor's 100th birthday. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agostinelli E, 1996, FREE RADICAL BIO MED, V20, P649, DOI 10.1016/0891-5849(95)02149-3; Agostinelli E, 2015, INT J ONCOL, V46, P5, DOI 10.3892/ijo.2014.2706; Agostinelli E, 2014, INT J ONCOL, V45, P1109, DOI 10.3892/ijo.2014.2502; ALARCON RA, 1961, ARCH BIOCHEM BIOPHYS, V94, P540, DOI 10.1016/0003-9861(61)90083-2; Arancia G, 2004, AMINO ACIDS, V26, P273, DOI 10.1007/s00726-003-0055-3; Averill-Bates DA, 2005, BIOCHEM PHARMACOL, V69, P1693, DOI 10.1016/j.bcp.2005.02.025; Averill-Bates DA, 2008, INT J ONCOL, V32, P79; AVERILLBATES DA, 1994, BIOCHEM CELL BIOL, V72, P36, DOI 10.1139/o94-006; AVERILLBATES DA, 1993, ARCH BIOCHEM BIOPHYS, V300, P75, DOI 10.1006/abbi.1993.1011; Babbar N, 2006, CANCER RES, V66, P11125, DOI 10.1158/0008-5472.CAN-06-3174; Babu GN, 2001, NEUROSCI LETT, V300, P17, DOI 10.1016/S0304-3940(01)01538-5; BACHRACH U, 1963, BIOCHIM BIOPHYS ACTA, V78, P768, DOI 10.1016/0006-3002(63)91055-2; BACHRACH U, 1970, ANN NY ACAD SCI, V171, P939, DOI 10.1111/j.1749-6632.1970.tb39400.x; BALASUNDARAM D, 1993, P NATL ACAD SCI USA, V90, P4693, DOI 10.1073/pnas.90.10.4693; BOLLINGER JM, 1995, J BIOL CHEM, V270, P14031, DOI 10.1074/jbc.270.23.14031; Bussiere FI, 2005, J BIOL CHEM, V280, P2409, DOI 10.1074/jbc.C400498200; Calcabrini A, 2002, INT J CANCER, V99, P43, DOI 10.1002/ijc.10310; CASERO RA, 1990, BIOCHEM J, V270, P615, DOI 10.1042/bj2700615; CASERO RA, 1993, FASEB J, V7, P653, DOI 10.1096/fasebj.7.8.8500690; Cervelli M, 2004, EUR J BIOCHEM, V271, P760, DOI 10.1111/j.1432-1033.2004.03979.x; Chattopadhyay MK, 2006, YEAST, V23, P751, DOI 10.1002/yea.1393; Chattopadhyay MK, 2009, YEAST, V26, P531, DOI 10.1002/yea.1703; Chattopadhyay MK, 2003, P NATL ACAD SCI USA, V100, P2261, DOI 10.1073/pnas.2627990100; Chattopadhyay MK, 2003, P NATL ACAD SCI USA, V100, P13869, DOI 10.1073/pnas.1835918100; Chaturvedi R, 2015, ONCOGENE, V34, P3429, DOI 10.1038/onc.2014.273; Chaturvedi R, 2014, GASTROENTEROLOGY, V146, P1739, DOI 10.1053/j.gastro.2014.02.005; Chaturvedi R, 2011, GASTROENTEROLOGY, V141, P1696, DOI 10.1053/j.gastro.2011.07.045; Chiang BY, 2010, J BIOL CHEM, V285, P25345, DOI 10.1074/jbc.M110.133363; Chopra S, 1998, BIOCHEM PHARMACOL, V55, P1119, DOI 10.1016/S0006-2952(97)00601-1; Das KC, 2004, MOL CELL BIOCHEM, V262, P127, DOI 10.1023/B:MCBI.0000038227.91813.79; Devereux W, 2003, CANCER CHEMOTH PHARM, V52, P383, DOI 10.1007/s00280-003-0662-4; FAIRLAMB AH, 1985, SCIENCE, V227, P1485, DOI 10.1126/science.3883489; Fujisawa S, 2005, ANTICANCER RES, V25, P965; GAUGAS JM, 1979, BRIT J CANCER, V39, P548, DOI 10.1038/bjc.1979.100; Gobert AP, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01242; Goodwin AC, 2008, PROSTATE, V68, P766, DOI 10.1002/pros.20735; Goodwin AC, 2011, P NATL ACAD SCI USA, V108, P15354, DOI 10.1073/pnas.1010203108; Ha HC, 1998, P NATL ACAD SCI USA, V95, P11140, DOI 10.1073/pnas.95.19.11140; Ha HC, 1998, BIOCHEM BIOPH RES CO, V244, P298, DOI 10.1006/bbrc.1998.8258; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hernandez SM, 2006, ACTA TROP, V98, P94, DOI 10.1016/j.actatropica.2006.02.005; HIGGINS ML, 1969, J CELL PHYSIOL, V74, P149, DOI 10.1002/jcp.1040740206; HIRSCH JG, 1953, J EXP MED, V97, P327, DOI 10.1084/jem.97.3.327; HIRSCH JG, 1952, J EXP MED, V95, P191, DOI 10.1084/jem.95.2.191; HIRSCH JG, 1953, J EXP MED, V97, P323, DOI 10.1084/jem.97.3.323; HIRSCH JG, 1953, J EXP MED, V97, P345, DOI 10.1084/jem.97.3.345; HOLTTA E, 1977, BIOCHEMISTRY-US, V16, P91, DOI 10.1021/bi00620a015; Hong SKS, 2010, INFLAMM BOWEL DIS, V16, P1557, DOI 10.1002/ibd.21224; HOUEN G, 1994, ACTA CHEM SCAND, V48, P52, DOI 10.3891/acta.chem.scand.48-0052; Hu TT, 2018, HEPATOL RES, V48, P967, DOI 10.1111/hepr.13206; Iarashi K, 2010, INT J BIOCHEM CELL B, V42, P39, DOI 10.1016/j.biocel.2009.07.009; Igarashi K, 2006, J BIOCHEM, V139, P11, DOI 10.1093/jb/mvj020; Jung IL, 2003, BIOCHEM BIOPH RES CO, V301, P915, DOI 10.1016/S0006-291X(03)00064-0; KHAN AU, 1992, P NATL ACAD SCI USA, V89, P11426, DOI 10.1073/pnas.89.23.11426; KHAN AU, 1992, P NATL ACAD SCI USA, V89, P11428, DOI 10.1073/pnas.89.23.11428; Kruger A, 2013, EMBO REP, V14, P1113, DOI 10.1038/embor.2013.165; Li C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01289-7; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Lord-Fontaine S, 2001, BIOCHEM CELL BIOL, V79, P165, DOI 10.1139/bcb-79-2-165; Mackintosh CA, 2000, BIOCHEM J, V351, P439, DOI 10.1042/0264-6021:3510439; Madeo F, 2018, SCIENCE, V359, P410, DOI 10.1126/science.aan2788; Masuko T, 2018, NEUROSCI LETT, V672, P118, DOI 10.1016/j.neulet.2018.01.054; MATSUI I, 1981, J BIOL CHEM, V256, P2454; MINTON KW, 1990, P NATL ACAD SCI USA, V87, P2851, DOI 10.1073/pnas.87.7.2851; Murata M, 2017, CURR EYE RES, V42, P1674, DOI 10.1080/02713683.2017.1359847; Murray-Stewart T, 2016, ONCOGENE, V35, P5480, DOI 10.1038/onc.2016.91; Murray-Stewart T, 2017, MED SCI, V5, pE38; Murray-Stewart T, 2008, FEBS J, V275, P2795, DOI 10.1111/j.1742-4658.2008.06419.x; Murray-Stewart T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202677; Murray-Stewart T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175917; Murray-Stewart TR, 2016, BIOCHEM J, V473, P2937, DOI 10.1042/BCJ20160383; Nakamura M, 2016, ATHEROSCLEROSIS, V244, P131, DOI 10.1016/j.atherosclerosis.2015.11.012; Nicoletti R, 2003, BRIT J OPHTHALMOL, V87, P1038, DOI 10.1136/bjo.87.8.1038; O'Hagan HM, 2011, CANCER CELL, V20, P606, DOI 10.1016/j.ccr.2011.09.012; Ou Y, 2016, P NATL ACAD SCI USA, V113, pE6806, DOI 10.1073/pnas.1607152113; Park MH, 2010, AMINO ACIDS, V38, P491, DOI 10.1007/s00726-009-0408-7; Pasini A, 2014, AMINO ACIDS, V46, P595, DOI 10.1007/s00726-013-1550-9; PEGG AE, 1982, AM J PHYSIOL, V243, pC212, DOI 10.1152/ajpcell.1982.243.5.C212; Pegg AE, 2008, AM J PHYSIOL-ENDOC M, V294, pE995, DOI 10.1152/ajpendo.90217.2008; Pegg AE, 2013, CHEM RES TOXICOL, V26, P1782, DOI 10.1021/tx400316s; Pegg AE, 2009, IUBMB LIFE, V61, P880, DOI 10.1002/iub.230; Pledgie A, 2005, J BIOL CHEM, V280, P39843, DOI 10.1074/jbc.M508177200; Pledgie-Tracy A, 2010, CANCER CHEMOTH PHARM, V65, P1067, DOI 10.1007/s00280-009-1112-8; Purcell RV, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171602; Rider JE, 2007, AMINO ACIDS, V33, P231, DOI 10.1007/s00726-007-0513-4; Routhu NK, 2018, MOL PHARMACEUT, V15, P4284, DOI 10.1021/acs.molpharmaceut.8b00068; Saiki R, 2011, BIOCHEM BIOPH RES CO, V404, P1044, DOI 10.1016/j.bbrc.2010.12.107; Sakamoto A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124883; Sakata K, 2003, BIOCHEM BIOPH RES CO, V305, P143, DOI 10.1016/S0006-291X(03)00716-2; Schmidt Armin, 2002, Current Topics in Medicinal Chemistry, V2, P1239, DOI 10.2174/1568026023393048; Schwartz CE, 2011, METHODS MOL BIOL, V720, P437, DOI 10.1007/978-1-61779-034-8_28; Sears CL, 2014, J CLIN INVEST, V124, P4166, DOI 10.1172/JCI72334; Sears CL, 2011, J INFECT DIS, V203, P306, DOI 10.1093/jinfdis/jiq061; Sharmin S, 2001, BIOCHEM BIOPH RES CO, V282, P228, DOI 10.1006/bbrc.2001.4569; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Sinigaglia G, 2012, INT J NANOMED, V7, P2249, DOI 10.2147/IJN.S28237; Smirnova OA, 2017, BIOCHEM BIOPH RES CO, V483, P904, DOI 10.1016/j.bbrc.2017.01.032; Smirnova OA, 2012, BIOCHIMIE, V94, P1876, DOI 10.1016/j.biochi.2012.04.023; Smith DJ, 1998, J EXP MED, V188, P17, DOI 10.1084/jem.188.1.17; Snezhkina AV, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2353560; TABOR CW, 1985, MICROBIOL REV, V49, P81, DOI 10.1128/MMBR.49.1.81-99.1985; TABOR CW, 1954, J BIOL CHEM, V208, P645; TABOR CW, 1956, J PHARMACOL EXP THER, V116, P139; TABOR CW, 1974, FED PROC, V33, P1567; TABOR CW, 1964, J BIOL CHEM, V239, P2194; TABOR H, 1975, J BIOL CHEM, V250, P2648; Tjalsma H, 2012, NAT REV MICROBIOL, V10, P575, DOI 10.1038/nrmicro2819; Tomitori H, 2005, STROKE, V36, P2609, DOI 10.1161/01.STR.0000190004.36793.2d; Uemura T, 2016, BIOCHEM BIOPH RES CO, V473, P630, DOI 10.1016/j.bbrc.2016.03.137; Venditti I, 2015, COLLOID SURFACE B, V134, P314, DOI 10.1016/j.colsurfb.2015.06.052; Vujcic S, 2003, BIOCHEM J, V370, P19, DOI 10.1042/BJ20021779; Vujcic S, 2002, BIOCHEM J, V367, P665, DOI 10.1042/BJ20020720; Wang LL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28648-8; Wang YL, 2005, CANCER CHEMOTH PHARM, V56, P83, DOI 10.1007/s00280-004-0936-5; Wang YL, 1998, J BIOL CHEM, V273, P34623, DOI 10.1074/jbc.273.51.34623; Wang YL, 2001, CANCER RES, V61, P5370; Wu TY, 2003, J BIOL CHEM, V278, P20514, DOI 10.1074/jbc.M302149200; Xie Y, 2017, J CONTROL RELEASE, V246, P110, DOI 10.1016/j.jconrel.2016.12.017; Zahedi K, 2007, AM J PHYSIOL-CELL PH, V292, pC1204, DOI 10.1152/ajpcell.00451.2006; Zahedi K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184570; Zahedi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110161; Zahedi K, 2012, AM J PHYSIOL-GASTR L, V303, pG546, DOI 10.1152/ajpgi.00431.2011; Zahedi K, 2010, AM J PHYSIOL-CELL PH, V299, pC164, DOI 10.1152/ajpcell.00512.2009; Zahedi K, 2010, J NEUROTRAUM, V27, P515, DOI 10.1089/neu.2009.1097; Zahedi K, 2009, AM J PHYSIOL-GASTR L, V296, pG899, DOI 10.1152/ajpgi.90507.2008	125	94	96	5	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2018	293	48					18736	18745		10.1074/jbc.TM118.003337	http://dx.doi.org/10.1074/jbc.TM118.003337			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NX	30333229	Green Published, hybrid			2022-12-28	WOS:000458467300029
J	Vigetti, D; Caon, I; Passi, A				Vigetti, Davide; Caon, Ilaria; Passi, Alberto			A nutrient sentinel stands guard outside the cell	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							AUTOPHAGY; DECORIN	Nutrient sensing is a critical cell function that regulates survival and growth by adjusting metabolism. During nutrient shortage, autophagy enables the recycling of major cellular components to prevent cell death. Understanding the mechanisms that trigger and control autophagy is of fundamental importance, as this degradative pathway plays a pivotal role in many diseases. Gubbiotti et al. report the identification of a new player, the proteoglycan decorin, which functions as a nutrient sensor in the extracellular matrix and controls autophagy in the heart.	[Vigetti, Davide; Caon, Ilaria; Passi, Alberto] Univ Insubria, Dept Med & Surg, I-21100 Varese, Italy	University of Insubria	Vigetti, D (corresponding author), Univ Insubria, Dept Med & Surg, I-21100 Varese, Italy.	davide.vigetti@uninsubria.it						Bond MR, 2015, J CELL BIOL, V208, P869, DOI 10.1083/jcb.201501101; Gubbiotti MA, 2018, J BIOL CHEM, V293, P16940, DOI 10.1074/jbc.RA118.004563; Gubbiotti MA, 2015, MATRIX BIOL, V48, P14, DOI 10.1016/j.matbio.2015.09.001; Jiang PD, 2014, CELL RES, V24, P69, DOI 10.1038/cr.2013.161; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Neill T, 2012, AM J PATHOL, V181, P380, DOI 10.1016/j.ajpath.2012.04.029; Ruan HB, 2017, GENE DEV, V31, P1655, DOI 10.1101/gad.305441.117; Vigetti D, 2014, BBA-GEN SUBJECTS, V1840, P2452, DOI 10.1016/j.bbagen.2014.02.001; Yuan HX, 2013, MOL CELL, V49, P379, DOI 10.1016/j.molcel.2013.01.019	9	3	3	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2018	293	43					16951	16952		10.1074/jbc.H118.006101	http://dx.doi.org/10.1074/jbc.H118.006101			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GY4FC	30366972	Green Published, hybrid			2022-12-28	WOS:000448515100034
J	Chen, KQ; Tang, P; Bao, ZY; He, TZ; Xiang, Y; Gong, WH; Yoshimura, T; Le, YY; Tessarollo, L; Chen, X; Wang, JM				Chen, Keqiang; Tang, Peng; Bao, Zhiyao; He, Tianzhen; Xiang, Yi; Gong, Wanghua; Yoshimura, Teizo; Le, Yingying; Tessarollo, Lino; Chen, Xin; Wang, Ji Ming			Deficiency in Fpr2 results in reduced numbers of Lin(-) cKit(+) Sca1(+) myeloid progenitor cells (vol 293, pg 13452, 2018)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Chen KQ, 2018, J BIOL CHEM, V293, P13452, DOI 10.1074/jbc.RA118.002683	1	0	0	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 19	2018	293	42					16175	16175		10.1074/jbc.AAC118.005966	http://dx.doi.org/10.1074/jbc.AAC118.005966			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GX5ZA	30341215	hybrid, Green Published			2022-12-28	WOS:000447833600005
J	Machovina, MM; Ellis, ES; Carney, TJ; Brushett, FR; DuBois, JL				Machovina, Melodie M.; Ellis, Emerald S.; Carney, Thomas J.; Brushett, Fikile R.; DuBois, Jennifer L.			How a cofactor-free protein environment lowers the barrier to O-2 reactivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						oxidation-reduction (redox); oxidase; electron transfer; antibiotics; radical; cofactor-independent; Marcus theory	INDEPENDENT MONOOXYGENASE SNOAB; ELECTRON-TRANSFER; OXYGEN ACTIVATION; REDOX POTENTIALS; OXIDATION; KINETICS; THERMODYNAMICS; CRYSTALLIZATION; BIOSYNTHESIS; PURIFICATION	Molecular oxygen (O-2)-utilizing enzymes are among the most important in biology. The abundance of O-2, its thermodynamic power, and the benign nature of its end products have raised interest in oxidases and oxygenases for biotechnological applications. Although most O-2-dependent enzymes have an absolute requirement for an O-2-activating cofactor, several classes of oxidases and oxygenases accelerate direct reactions between substrate and O-2 using only the protein environment. Nogalamycin monooxygenase (NMO) from Streptomyces nogalater is a cofactor-independent enzyme that catalyzes rate-limiting electron transfer between its substrate and O-2. Here, using enzyme-kinetic, cyclic voltammetry, and mutagenesis methods, we demonstrate that NMO initially activates the substrate, lowering its pK(a) by 1.0 unit (G* = 1.4 kcal mol(-1)). We found that the one-electron reduction potential, measured for the deprotonated substrate both inside and outside the protein environment, increases by 85 mV inside NMO, corresponding to a G(0) of 2.0 kcal mol(-1) (0.087 eV) and that the activation barrier, G(double dagger), is lowered by 4.8 kcal mol(-1) (0.21 eV). Applying the Marcus model, we observed that this suggests a sizable decrease of 28 kcal mol(-1) (1.4 eV) in the reorganization energy (), which constitutes the major portion of the protein environment's effect in lowering the reaction barrier. A similar role for the protein has been proposed in several cofactor-dependent systems and may reflect a broader trend in O-2-utilizing proteins. In summary, NMO's protein environment facilitates direct electron transfer, and NMO accelerates rate-limiting electron transfer by strongly lowering the reorganization energy.	[Machovina, Melodie M.; Ellis, Emerald S.; DuBois, Jennifer L.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59715 USA; [Carney, Thomas J.] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Brushett, Fikile R.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA	Montana State University System; Montana State University Bozeman; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	DuBois, JL (corresponding author), Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59715 USA.	jennifer.dubois1@montana.edu		Carney, Thomas/0000-0002-9250-1659	National Science Foundation [MCB1715176]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant MCB1715176. The authors declare that they havenoconflicts of interest with the contents of this article.	Adams MA, 2005, J BIOL CHEM, V280, P8358, DOI 10.1074/jbc.M412637200; Carney TJ, 2017, CHEM MATER, V29, P4801, DOI 10.1021/acs.chemmater.7b00616; Chaiyen P, 2012, TRENDS BIOCHEM SCI, V37, P373, DOI 10.1016/j.tibs.2012.06.005; Elgrishi N, 2018, J CHEM EDUC, V95, P197, DOI 10.1021/acs.jchemed.7b00361; Fetzner S, 2010, APPL MICROBIOL BIOT, V86, P791, DOI 10.1007/s00253-010-2455-0; Gadda G, 2012, BIOCHEMISTRY-US, V51, P2662, DOI 10.1021/bi300227d; Gray HB, 2009, CHEM PHYS LETT, V483, P1, DOI 10.1016/j.cplett.2009.10.051; Gray HB, 1996, ANNU REV BIOCHEM, V65, P537, DOI 10.1146/annurev.bi.65.070196.002541; Gray HB, 2005, P NATL ACAD SCI USA, V102, P3534, DOI 10.1073/pnas.0408029102; Grocholski T, 2010, BIOCHEMISTRY-US, V49, P934, DOI 10.1021/bi901985b; Hamdane D, 2008, PHOTOSYNTH RES, V98, P657, DOI 10.1007/s11120-008-9322-1; Kendrew SG, 2000, ACTA CRYSTALLOGR D, V56, P481, DOI 10.1107/S0907444900001189; Kendrew SG, 1997, J BACTERIOL, V179, P4305, DOI 10.1128/jb.179.13.4305-4310.1997; Khoshtariya DE, 2010, P NATL ACAD SCI USA, V107, P2757, DOI 10.1073/pnas.0910837107; Koskiniemi H, 2009, ACTA CRYSTALLOGR F, V65, P256, DOI 10.1107/S1744309109001389; Kulys J, 2000, J BIOL INORG CHEM, V5, P333, DOI 10.1007/PL00010662; Lee SY, 1999, BIOCHEMISTRY-US, V38, P4423, DOI 10.1021/bi982712w; Li C, 1999, J PHYS CHEM B, V103, P6653, DOI 10.1021/jp983819w; Machovina MM, 2016, J BIOL CHEM, V291, P17816, DOI 10.1074/jbc.M116.730051; Miller AF, 2004, CURR OPIN CHEM BIOL, V8, P162, DOI 10.1016/j.cbpa.2004.02.011; MOSER CC, 1992, NATURE, V355, P796, DOI 10.1038/355796a0; NOZAKI K, 1989, J ELECTROANAL CHEM, V270, P191, DOI 10.1016/0022-0728(89)85036-3; O'Reilly NJ, 2005, LANGMUIR, V21, P1009, DOI 10.1021/la048796t; Olshansky L, 2016, J AM CHEM SOC, V138, P1196, DOI 10.1021/jacs.5b09259; OTURAN MA, 1984, J ELECTROANAL CHEM, V161, P377, DOI 10.1016/S0022-0728(84)80194-1; Pavlishchuk VV, 2000, INORG CHIM ACTA, V298, P97, DOI 10.1016/S0020-1693(99)00407-7; Que L. Q., 2007, BIOL INORGANIC CHEM, P1; Roth HG, 2016, SYNLETT, V27, P714, DOI 10.1055/s-0035-1561297; Roth JP, 2003, P NATL ACAD SCI USA, V100, P62, DOI 10.1073/pnas.252644599; Roth JP, 2004, J AM CHEM SOC, V126, P15120, DOI 10.1021/ja047050e; Sciara G, 2003, EMBO J, V22, P205, DOI 10.1093/emboj/cdg031; Silverstein TP, 2012, J CHEM EDUC, V89, P1159, DOI 10.1021/ed1007712; Sirajuddin S, 2015, BIOCHEMISTRY-US, V54, P2283, DOI 10.1021/acs.biochem.5b00198; TAUBE H, 1965, J GEN PHYSIOL, V49, P29, DOI 10.1085/jgp.49.1.29; Verdolino V, 2008, J PHYS CHEM B, V112, P16860, DOI 10.1021/jp8068877; Visitsatthawong S, 2015, J AM CHEM SOC, V137, P9363, DOI 10.1021/jacs.5b04328; Warren JJ, 2010, CHEM REV, V110, P6961, DOI 10.1021/cr100085k	37	2	2	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3661	3669		10.1074/jbc.RA118.006144	http://dx.doi.org/10.1074/jbc.RA118.006144			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30602564	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000461853900028
J	Bruns, I; Sauer, B; Burger, MC; Eriksson, J; Hofmann, U; Braun, Y; Harter, PN; Luger, AL; Ronellenfitsch, MW; Steinbach, JP; Rieger, J				Bruns, Ines; Sauer, Benedikt; Burger, Michael C.; Eriksson, Jule; Hofmann, Ute; Braun, Yannick; Harter, Patrick N.; Luger, Anna-Luisa; Ronellenfitsch, Michael W.; Steinbach, Joachim P.; Rieger, Johannes			Disruption of peroxisome proliferator-activated receptor coactivator (PGC)-1 reverts key features of the neoplastic phenotype of glioma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glioblastoma; hypoxia; reactive oxygen species (ROS); transcription coactivator; tumor metabolism; peroxisome proliferator-activated receptor coactivator 1-(PGC-1) (PPARGC1A)	MITOCHONDRIAL BIOGENESIS; GLUCOSE TRANSPORTERS; GAMMA COACTIVATOR-1; MAMMALIAN TARGET; PROTECTS GLIOMA; CANCER-CELLS; EXPRESSION; RESPIRATION; METABOLISM; VEGF	The peroxisome proliferator-activated receptor coactivator (PGC)-1 is a master regulator of mitochondrial biogenesis and controls metabolism by coordinating transcriptional events. Here, we interrogated whether PGC-1 is involved in tumor growth and the metabolic flexibility of glioblastoma cells. PGC-1 was expressed in a subset of established glioma cell lines and primary glioblastoma cell cultures. Furthermore, a higher PGC-1 expression was associated with an adverse outcome in the TCGA glioblastoma dataset. Suppression of PGC-1 expression by shRNA in the PGC-1-positive U343MG glioblastoma line suppressed mitochondrial gene expression, reduced mitochondrial membrane potential, and diminished oxygen as well as glucose consumption, and lactate production. Compatible with the known PGC-1 functions in reactive oxygen species (ROS) metabolism, glioblastoma cells deficient in PGC-1 displayed ROS accumulation, had reduced RNA levels of proteins involved in ROS detoxification, and were more susceptible to death induction by H2O2 compared with control cells. PGC-1sh cells also had impaired proliferation and migration rates in vitro and displayed less stem cell characteristics. Complementary effects were observed in PGC-1-low LNT-229 cells engineered to overexpress PGC-1. In an in vivo xenograft experiment, tumors formed by U343MG PGC-1sh glioblastoma cells grew much slower than control tumors and were less invasive. Interestingly, the PGC-1 knockdown conferred protection against hypoxia-induced cell death, probably as a result of less active anabolic pathways, and this effect was associated with reduced epidermal growth factor expression and mammalian target of rapamycin signaling. In summary, PGC-1 modifies the neoplastic phenotype of glioblastoma cells toward more aggressive behavior and therefore makes PGC-1 a potential target for anti-glioblastoma therapies.	[Bruns, Ines; Sauer, Benedikt; Burger, Michael C.; Eriksson, Jule; Luger, Anna-Luisa; Ronellenfitsch, Michael W.; Steinbach, Joachim P.; Rieger, Johannes] Goethe Univ, Univ Hosp Frankfurt, Dr Senckenberg Inst Neurooncol, Schleusenweg 2-16, D-60528 Frankfurt, Germany; [Bruns, Ines; Sauer, Benedikt; Burger, Michael C.; Harter, Patrick N.; Luger, Anna-Luisa; Ronellenfitsch, Michael W.; Steinbach, Joachim P.] German Canc Consortium DKTK, Partner Site Frankfurt Mainz, D-60590 Frankfurt, Germany; [Bruns, Ines; Sauer, Benedikt; Burger, Michael C.; Harter, Patrick N.; Luger, Anna-Luisa; Ronellenfitsch, Michael W.; Steinbach, Joachim P.] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Bruns, Ines; Sauer, Benedikt; Burger, Michael C.; Harter, Patrick N.; Luger, Anna-Luisa; Ronellenfitsch, Michael W.; Steinbach, Joachim P.] Goethe Univ, Univ Hosp Frankfurt, Univ Canc Ctr UCT, D-60590 Frankfurt, Germany; [Eriksson, Jule] Univ Basel, Dept Neurol, CH-4031 Basel, Switzerland; [Hofmann, Ute] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-70376 Stuttgart, Germany; [Hofmann, Ute] Univ Tubingen, D-72074 Tubingen, Germany; [Braun, Yannick; Harter, Patrick N.] Goethe Univ, Univ Hosp Frankfurt, Edinger Inst, Inst Neurol, D-60528 Frankfurt, Germany; [Rieger, Johannes] Univ Hosp Tubingen, Hertie Inst Clin Brain Res, Interdisciplinary Div Neurooncol, D-72076 Tubingen, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Basel; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Ronellenfitsch, MW; Steinbach, JP (corresponding author), Goethe Univ, Univ Hosp Frankfurt, Dr Senckenberg Inst Neurooncol, Schleusenweg 2-16, D-60528 Frankfurt, Germany.	m.ronellenfitsch@gmx.net; joachim.steinbach@med.uni-frankfurt.de	Ronellenfitsch, Michael/AAW-8201-2020; Thiepold, Anna-Luisa/AAW-8310-2021	Ronellenfitsch, Michael/0000-0002-1402-6290; Rieger, Johannes/0000-0002-7918-1777; Harter, Patrick N./0000-0001-5530-6910	Deutsche Forschungsgemeinschaft (DFG) [RI2175/1-1]; Robert-Bosch Foundation, Stuttgart, Germany; University Cancer Center (UCT) Frankfurt; Frankfurt Research Funding within the framework of the "Sponsorship Model"; Else Kroner-Forschungskolleg (EKE) - Else Kroner-Fresenius Foundation; Medical Faculty, University Hospital Frankfurt Program "Nachwuchsforscher 2012"; Clinician Scientists Program	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Robert-Bosch Foundation, Stuttgart, Germany; University Cancer Center (UCT) Frankfurt; Frankfurt Research Funding within the framework of the "Sponsorship Model"; Else Kroner-Forschungskolleg (EKE) - Else Kroner-Fresenius Foundation; Medical Faculty, University Hospital Frankfurt Program "Nachwuchsforscher 2012"; Clinician Scientists Program	This work was supported in part by Grant RI2175/1-1 from the Deutsche Forschungsgemeinschaft (DFG) (to J.P.S. and J.R.). J.P.S. and J.R. have served as consultants for Roche Applied Science, the European distributor of bevacizumab.; Supported by the Robert-Bosch Foundation, Stuttgart, Germany.; Recipient of a fellowship from the University Cancer Center (UCT) Frankfurt.; Recipient of funding from Frankfurt Research Funding within the framework of the "Sponsorship Model" and a fellowship in the program "Clinician Scientist" by the Else Kroner-Forschungskolleg (EKE), which is supported by The Else Kroner-Fresenius Foundation.; Recipient of funding from the Medical Faculty, University Hospital Frankfurt Program "Nachwuchsforscher 2012" as well as "Clinician Scientists Program", and a fellowship from the University Cancer Center (UCT) Frankfurt.	Anderson RM, 2008, AGING CELL, V7, P101, DOI 10.1111/j.1474-9726.2007.00357.x; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Bowman RL, 2017, NEURO-ONCOLOGY, V19, P139, DOI 10.1093/neuonc/now247; Chen CH, 2001, J BIOL CHEM, V276, P9519, DOI 10.1074/jbc.M010144200; De Luca A, 2015, ONCOTARGET, V6, P14777, DOI 10.18632/oncotarget.4401; Di K, 2016, ONCOTARGET, V7, P77457, DOI 10.18632/oncotarget.12681; Dodd KM, 2015, ONCOGENE, V34, P2239, DOI 10.1038/onc.2014.164; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Evans A, 2008, CANCER CHEMOTH PHARM, V61, P377, DOI 10.1007/s00280-007-0480-1; Fu XF, 2016, J ZHEJIANG UNIV-SC B, V17, P136, DOI 10.1631/jzus.B1500158; GRADY JE, 1960, CANCER RES, V20, P1114; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Haq R, 2013, CANCER CELL, V23, P302, DOI 10.1016/j.ccr.2013.02.003; Hartel I, 2016, INT J ONCOL, V49, P173, DOI 10.3892/ijo.2016.3498; Hayashi M, 2004, J ENDOCRINOL, V183, P145, DOI 10.1677/joe.1.05599; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Keibler MA, 2016, CANCER METAB, V4, DOI 10.1186/s40170-016-0156-6; Keunen O, 2011, P NATL ACAD SCI USA, V108, P3749, DOI 10.1073/pnas.1014480108; Knutti D, 2001, TRENDS ENDOCRIN MET, V12, P360, DOI 10.1016/S1043-2760(01)00457-X; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; LeBleu VS, 2014, NAT CELL BIOL, V16, P992, DOI 10.1038/ncb3039; Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; Lin H, 2017, NEURO-ONCOLOGY, V19, P43, DOI 10.1093/neuonc/now128; Lin JD, 2003, J BIOL CHEM, V278, P30843, DOI 10.1074/jbc.M303643200; Liou GY, 2010, FREE RADICAL RES, V44, P479, DOI 10.3109/10715761003667554; Liu Y, 2009, BRAIN RES, V1304, P149, DOI 10.1016/j.brainres.2009.09.083; Maher EA, 2012, NMR BIOMED, V25, P1234, DOI 10.1002/nbm.2794; Mao XG, 2016, ONCOTARGET, V7, P47808, DOI 10.18632/oncotarget.10029; Marin-Valencia I, 2012, CELL METAB, V15, P827, DOI 10.1016/j.cmet.2012.05.001; Marmolino D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010025; Michael LF, 2001, P NATL ACAD SCI USA, V98, P3820, DOI 10.1073/pnas.061035098; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2005, INT J OBESITY, V29, pS5, DOI 10.1038/sj.ijo.0802905; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Ristow M, 2014, DOSE-RESPONSE, V12, P288, DOI 10.2203/dose-response.13-035.Ristow; Ronellenfitsch MW, 2009, BRAIN, V132, P1509, DOI 10.1093/brain/awp093; Santos JM, 2014, MED HYPOTHESES, V82, P748, DOI 10.1016/j.mehy.2014.03.018; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Shah K, 2012, INT J MOL SCI, V13, P12629, DOI 10.3390/ijms131012629; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Steinbach JP, 2004, CANCER RES, V64, P1575, DOI 10.1158/0008-5472.CAN-03-3775; Steinbach JP, 2003, CELL DEATH DIFFER, V10, P823, DOI 10.1038/sj.cdd.4401252; Teng CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026961; Thiepold AL, 2017, BRAIN, V140, P2623, DOI 10.1093/brain/awx196; Vannucci SJ, 1996, J CEREBR BLOOD F MET, V16, P77, DOI 10.1097/00004647-199601000-00009; Vazquez F, 2013, CANCER CELL, V23, P287, DOI 10.1016/j.ccr.2012.11.020; Wanka C, 2012, ONCOGENE, V31, P3764, DOI 10.1038/onc.2011.530; Wanka C, 2012, J BIOL CHEM, V287, P33436, DOI 10.1074/jbc.M112.384578; Wenz T, 2009, IUBMB LIFE, V61, P1051, DOI 10.1002/iub.261; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yeh WL, 2008, MOL PHARMACOL, V73, P170, DOI 10.1124/mol.107.038851; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhu LY, 2010, CELL RES, V20, P676, DOI 10.1038/cr.2010.46	58	12	12	3	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2019	294	9					3037	3050		10.1074/jbc.RA118.006993	http://dx.doi.org/10.1074/jbc.RA118.006993			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU0SA	30578297	hybrid, Green Published			2022-12-28	WOS:000464980100006
J	Mayer, MP; Gierasch, LM				Mayer, Matthias P.; Gierasch, Lila M.			Recent advances in the structural and mechanistic aspects of Hsp70 molecular chaperones	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						molecular chaperone; 70-kilodalton heat shock protein (Hsp70); protein folding; allosteric regulation; chaperone DnaK (DnaK); chaperone DnaJ (DnaJ); nanomachine; J-domain; protein homeostasis	NUCLEOTIDE EXCHANGE FACTOR; HEAT-SHOCK-PROTEIN; C-TERMINAL DOMAIN; SUBSTRATE-BINDING; CRYSTAL-STRUCTURE; CLATHRIN-COAT; FACTOR GRPE; MISFOLDED PROTEINS; HSP110 CHAPERONES; PEPTIDE-BINDING	Hsp70 chaperones are central hubs of the protein quality control network and collaborate with co-chaperones having a J-domain (an approximate to 70-residue-long helical hairpin with a flexible loop and a conserved His-Pro-Asp motif required for ATP hydrolysis by Hsp70s) and also with nucleotide exchange factors to facilitate many protein-folding processes that (re)establish protein homeostasis. The Hsp70s are highly dynamic nanomachines that modulate the conformation of their substrate polypeptides by transiently binding to short, mostly hydrophobic stretches. This interaction is regulated by an intricate allosteric mechanism. The J-domain co-chaperones target Hsp70 to their polypeptide substrates, and the nucleotide exchange factors regulate the lifetime of the Hsp70-substrate complexes. Significant advances in recent years are beginning to unravel the molecular mechanism of this chaperone machine and how they treat their substrate proteins.	[Mayer, Matthias P.] Heidelberg Univ ZMBH, Ctr Mol Biol, DKFZ ZMBH Alliance, Neuenheimer Feld 282, D-69120 Heidelberg, Germany; [Gierasch, Lila M.] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; [Gierasch, Lila M.] Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Mayer, MP (corresponding author), Heidelberg Univ ZMBH, Ctr Mol Biol, DKFZ ZMBH Alliance, Neuenheimer Feld 282, D-69120 Heidelberg, Germany.	m.mayer@zmbh.uni-heidelberg.de	Mayer, Matthias P./B-9340-2013	Mayer, Matthias P./0000-0002-7859-3112; Gierasch, Lila/0000-0002-5706-115X	NIGMS NIH HHS [R35 GM118161] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118161] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Albanese V, 2006, CELL, V124, P75, DOI 10.1016/j.cell.2005.11.039; Andreasson C, 2008, J BIOL CHEM, V283, P8877, DOI 10.1074/jbc.M710063200; Aprile FA, 2017, BIOCHEMISTRY-US, V56, P1177, DOI 10.1021/acs.biochem.6b01178; Ayuso-Tejedor S, 2010, J MOL BIOL, V400, P922, DOI 10.1016/j.jmb.2010.05.050; Banerjee R, 2016, FEBS J, V283, P2853, DOI 10.1111/febs.13769; Barends TRM, 2013, ACTA CRYSTALLOGR D, V69, P1540, DOI 10.1107/S0907444913010640; Bertelsen EB, 1999, PROTEIN SCI, V8, P343; Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106; BLONDELGUINDI S, 1993, CELL, V75, P717, DOI 10.1016/0092-8674(93)90492-9; Bocking T, 2014, STRUCTURE, V22, P819, DOI 10.1016/j.str.2014.04.002; Bocking T, 2011, NAT STRUCT MOL BIOL, V18, P295, DOI 10.1038/nsmb.1985; Bracher A, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00010; Brehmer D, 2004, J BIOL CHEM, V279, P27957, DOI 10.1074/jbc.M403558200; Brehmer D, 2001, NAT STRUCT BIOL, V8, P427, DOI 10.1038/87588; Calloni G, 2012, CELL REP, V1, P251, DOI 10.1016/j.celrep.2011.12.007; Cho HJ, 2018, EMBO J, V37, DOI 10.15252/embj.201899264; Clerico EM, 2015, J MOL BIOL, V427, P1575, DOI 10.1016/j.jmb.2015.02.004; De los Rios P, 2006, P NATL ACAD SCI USA, V103, P6166, DOI 10.1073/pnas.0510496103; De Los Rios P, 2014, ELIFE, V3, DOI 10.7554/eLife.02218; Deuerling E, 2003, MOL MICROBIOL, V47, P1317, DOI 10.1046/j.1365-2958.2003.03370.x; Deuerling E, 1999, NATURE, V400, P693, DOI 10.1038/23301; Dragovic Z, 2006, EMBO J, V25, P2519, DOI 10.1038/sj.emboj.7601138; Feige MJ, 2010, TRENDS BIOCHEM SCI, V35, P189, DOI 10.1016/j.tibs.2009.11.005; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; FRYDMAN J, 1994, NATURE, V370, P111, DOI 10.1038/370111a0; Gao XC, 2015, MOL CELL, V59, P781, DOI 10.1016/j.molcel.2015.07.012; Garcia VM, 2017, MOL BIOL CELL, V28, P2066, DOI 10.1091/mbc.E17-01-0070; Gassler CS, 2001, J BIOL CHEM, V276, P32538, DOI 10.1074/jbc.M105328200; Gauley J, 2008, COMP BIOCHEM PHYS A, V151, P133, DOI 10.1016/j.cbpa.2008.06.010; Goloubinoff P, 2018, NAT CHEM BIOL, V14, P388, DOI 10.1038/s41589-018-0013-8; Gorenberg EL, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00248; Gowda NKC, 2018, NAT STRUCT MOL BIOL, V25, P83, DOI 10.1038/s41594-017-0008-2; Gowda NKC, 2016, MOL BIOL CELL, V27, P1210, DOI 10.1091/mbc.E15-10-0697; Grimshaw JPA, 2003, J BIOL CHEM, V278, P19048, DOI 10.1074/jbc.M300924200; Grimshaw JPA, 2001, J BIOL CHEM, V276, P6098, DOI 10.1074/jbc.M009290200; Groemping Y, 2001, J MOL BIOL, V314, P167, DOI 10.1006/jmbi.2001.5116; Guisbert E, 2004, GENE DEV, V18, P2812, DOI 10.1101/gad.1219204; Harrison CJ, 1997, SCIENCE, V276, P431, DOI 10.1126/science.276.5311.431; Ishihara K, 1999, BBA-GENE STRUCT EXPR, V1444, P138, DOI 10.1016/S0167-4781(98)00254-1; Jiang YP, 1999, SCIENCE, V283, P543, DOI 10.1126/science.283.5401.543; Jores T, 2018, J CELL BIOL, V217, P3091, DOI 10.1083/jcb.201712029; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Karzai AW, 1996, J BIOL CHEM, V271, P11236, DOI 10.1074/jbc.271.19.11236; Kellner R, 2014, P NATL ACAD SCI USA, V111, P13355, DOI 10.1073/pnas.1407086111; Kimura A, 2016, ONCOTARGET, V7, P18415, DOI 10.18632/oncotarget.7821; Kirschke E, 2014, CELL, V157, P1685, DOI 10.1016/j.cell.2014.04.038; Kirstein J, 2017, AGING CELL, V16, P1414, DOI 10.1111/acel.12686; Kityk R, 2018, MOL CELL, V69, P227, DOI 10.1016/j.molcel.2017.12.003; Kityk R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9308; Kityk R, 2012, MOL CELL, V48, P863, DOI 10.1016/j.molcel.2012.09.023; Kundel F, 2018, ACS CHEM BIOL, V13, P636, DOI 10.1021/acschembio.7b01039; Lai AL, 2017, J BIOL CHEM, V292, P8773, DOI 10.1074/jbc.M116.770404; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; Lee JH, 2015, P NATL ACAD SCI USA, V112, pE4206, DOI 10.1073/pnas.1505173112; Li JZ, 2003, STRUCTURE, V11, P1475, DOI 10.1016/j.str.2003.10.012; Luders J, 2000, J BIOL CHEM, V275, P4613, DOI 10.1074/jbc.275.7.4613; Luengo TM, 2018, MOL CELL, V70, P545, DOI 10.1016/j.molcel.2018.03.028; Luk KC, 2008, BIOCHEMISTRY-US, V47, P12614, DOI 10.1021/bi801475r; Malinverni D, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004262; Mapa K, 2010, MOL CELL, V38, P89, DOI 10.1016/j.molcel.2010.03.010; Marcinowski M, 2013, J MOL BIOL, V425, P466, DOI 10.1016/j.jmb.2012.11.030; Marcinowski M, 2011, NAT STRUCT MOL BIOL, V18, P150, DOI 10.1038/nsmb.1970; Mashaghi A, 2016, NATURE, V539, P448, DOI 10.1038/nature20137; Mayer MP, 2000, NAT STRUCT BIOL, V7, P586; Mayer MP, 2005, REV PHYSIOL BIOCH P, V153, P1, DOI 10.1007/s10254-004-0025-5; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Mayer MP, 1999, J MOL BIOL, V289, P1131, DOI 10.1006/jmbi.1999.2844; Melville MW, 2003, MOL CELL BIOL, V23, P3141, DOI 10.1128/MCB.23.9.3141-3151.2003; Mogk A, 2018, MOL CELL, V69, P214, DOI 10.1016/j.molcel.2018.01.004; Morgner N, 2015, CELL REP, V11, P759, DOI 10.1016/j.celrep.2015.03.063; MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4; Neupert W, 2002, NAT REV MOL CELL BIO, V3, P555, DOI 10.1038/nrm878; Nillegoda NB, 2017, ELIFE, V6, DOI 10.7554/eLife.24560; Nillegoda NB, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00057; Nillegoda NB, 2015, NATURE, V524, P247, DOI 10.1038/nature14884; Niwa T, 2012, P NATL ACAD SCI USA, V109, P8937, DOI 10.1073/pnas.1201380109; Packschies L, 1997, BIOCHEMISTRY-US, V36, P3417, DOI 10.1021/bi962835l; Pellecchia M, 2000, NAT STRUCT BIOL, V7, P298; Pellecchia M, 1996, J MOL BIOL, V260, P236, DOI 10.1006/jmbi.1996.0395; Polier S, 2008, CELL, V133, P1068, DOI 10.1016/j.cell.2008.05.022; Polier S, 2010, J MOL BIOL, V401, P696, DOI 10.1016/j.jmb.2010.07.004; Preissler S, 2012, TRENDS BIOCHEM SCI, V37, P274, DOI 10.1016/j.tibs.2012.03.002; Qi RF, 2013, NAT STRUCT MOL BIOL, V20, P900, DOI 10.1038/nsmb.2583; Rampelt H, 2012, EMBO J, V31, P4221, DOI 10.1038/emboj.2012.264; Raviol H, 2006, FEBS LETT, V580, P168, DOI 10.1016/j.febslet.2005.11.069; Raviol H, 2006, EMBO J, V25, P2510, DOI 10.1038/sj.emboj.7601139; Rodriguez F, 2008, MOL CELL, V32, P347, DOI 10.1016/j.molcel.2008.09.016; Rosam M, 2018, NAT STRUCT MOL BIOL, V25, P90, DOI 10.1038/s41594-017-0012-6; Fernandez-Fernandez MR, 2017, FEBS LETT, V591, P2648, DOI 10.1002/1873-3468.12751; Rosenzweig R, 2013, SCIENCE, V339, P1080, DOI 10.1126/science.1233066; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Rudiger S, 2001, EMBO J, V20, P1042, DOI 10.1093/emboj/20.5.1042; Sarbeng EB, 2015, J BIOL CHEM, V290, P8849, DOI 10.1074/jbc.M114.596288; Schlecht R, 2011, NAT STRUCT MOL BIOL, V18, P345, DOI 10.1038/nsmb.2006; SCHLOSSMAN DM, 1984, J CELL BIOL, V99, P723, DOI 10.1083/jcb.99.2.723; SCHMID D, 1994, SCIENCE, V263, P971, DOI 10.1126/science.8310296; Schneider M, 2016, PROTEINS, V84, P1390, DOI 10.1002/prot.25084; SCHRODER H, 1993, EMBO J, V12, P4137, DOI 10.1002/j.1460-2075.1993.tb06097.x; Schumacher RJ, 1996, BIOCHEMISTRY-US, V35, P14889, DOI 10.1021/bi961825h; Sekhar A, 2018, ELIFE, V7, DOI 10.7554/eLife.32764; Sekhar A, 2015, P NATL ACAD SCI USA, V112, P10395, DOI 10.1073/pnas.1508504112; Sharma SK, 2010, NAT CHEM BIOL, V6, P914, DOI 10.1038/NCHEMBIO.455; Smith DF, 2008, MOL ENDOCRINOL, V22, P2229, DOI 10.1210/me.2008-0089; Smock RG, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.65; Sondermann H, 2001, SCIENCE, V291, P1553, DOI 10.1126/science.1057268; Sousa R, 2016, NAT STRUCT MOL BIOL, V23, P821, DOI 10.1038/nsmb.3272; Sousa R, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00026; Stankiewicz M, 2010, FEBS J, V277, P3353, DOI 10.1111/j.1742-4658.2010.07737.x; Stevens SY, 2003, PROTEIN SCI, V12, P2588, DOI 10.1110/ps.03269103; Suzuki H, 2010, BIOCHEMISTRY-US, V49, P8577, DOI 10.1021/bi100876n; Swain JF, 2007, MOL CELL, V26, P27, DOI 10.1016/j.molcel.2007.02.020; Tsuboyama K, 2018, MOL CELL, V70, P722, DOI 10.1016/j.molcel.2018.04.010; Ungelenk S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13673; Van Durme J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000475; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; WILBANKS SM, 1995, J BIOL CHEM, V270, P2251, DOI 10.1074/jbc.270.5.2251; Wu CC, 2012, J BIOL CHEM, V287, P21461, DOI 10.1074/jbc.M112.344358; Xing Y, 2010, EMBO J, V29, P655, DOI 10.1038/emboj.2009.383; Xu Z, 2008, NAT STRUCT MOL BIOL, V15, P1309, DOI 10.1038/nsmb.1518; Yan M, 2011, BIOCHEM J, V438, P447, DOI 10.1042/BJ20110500; Zahn M, 2013, J MOL BIOL, V425, P2463, DOI 10.1016/j.jmb.2013.03.041; Zhang PF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103518; Zhang YB, 2004, P NATL ACAD SCI USA, V101, P10272, DOI 10.1073/pnas.0401313101; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606; Zhuravleva A, 2012, CELL, V151, P1296, DOI 10.1016/j.cell.2012.11.002	126	133	137	26	108	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2019	294	6					2085	2097		10.1074/jbc.REV118.002810	http://dx.doi.org/10.1074/jbc.REV118.002810			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM8EO	30455352	Green Published, hybrid			2022-12-28	WOS:000459711400027
J	Chen, YD; Wang, P; Slep, KC				Chen, Yaodong; Wang, Ping; Slep, Kevin C.			Mapping multivalency in the CLIP-170-EB1 microtubule plus-end complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						microtubule; microtubule-associated protein (MAP); isothermal titration calorimetry (ITC); cytoskeleton; protein-protein interaction; tubulin; CAP-Gly; CLIP-170; EB1; SXIP	STRUCTURAL BASIS; TRACKING; EB1; P150(GLUED); PROTEINS; BINDING; CAP; POLYMERIZATION; RECONSTITUTION; AUTOINHIBITION	Cytoplasmic linker protein 170 (CLIP-170) is a microtubule plus-end factor that links vesicles to microtubules and recruits the dynein-dynactin complex to microtubule plus ends. CLIP-170 plus-end localization is end binding 1 (EB1)-dependent. CLIP-170 contains two N-terminal cytoskeleton-associated protein glycine-rich (CAP-Gly) domains flanked by serine-rich regions. The CAP-Gly domains are known EB1-binding domains, and the serine-rich regions have also been implicated in CLIP-170's microtubule plus-end localization mechanism. However, the determinants in these serine-rich regions have not been identified. Here we elucidated multiple EB1-binding modules in the CLIP-170 N-terminal region. Using isothermal titration calorimetry and size-exclusion chromatography, we mapped and biophysically characterized these EB1-binding modules, including the two CAP-Gly domains, a bridging SXIP motif, and a unique array of divergent SXIP-like motifs located N-terminally to the first CAP-Gly domain. We found that, unlike the EB1-binding mode of the CAP-Gly domain in the dynactin-associated protein p150(Glued), which dually engages the EB1 C-terminal EEY motif as well as the EB homology domain and sterically occludes SXIP motif binding, the CLIP-170 CAP-Gly domains engage only the EEY motif, enabling the flanking SXIP and SXIP-like motifs to bind the EB homology domain. These multivalent EB1-binding modules provided avidity to the CLIP-170-EB1 interaction, likely clarifying why CLIP-170 preferentially binds EB1 rather than the alpha-tubulin C-terminal EEY motif. Our finding that CLIP-170 has multiple non-CAP-Gly EB1-binding modules may explain why autoinhibition of CLIP-170 GAP-Gly domains does not fully abrogate its microtubule plus-end localization. This work expands our understanding of EB1-binding motifs and their multivalent networks.	[Chen, Yaodong] Northwest Univ, Coll Life Sci, Minist Educ, Key Lab Resources Biol & Biotechnol Western China, Xian 710069, Shaanxi, Peoples R China; [Chen, Yaodong; Slep, Kevin C.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Wang, Ping] Univ N Carolina, Dept Neurol, Chapel Hill, NC 27599 USA	Northwest University Xi'an; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Slep, KC (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA.	kslep@bio.unc.edu	Peptide Synthesis and Array Facility, High-Throughput/AFI-7866-2022; Chen, Yaodong/X-8923-2019	Chen, Yaodong/0000-0002-3751-0923	NIGMS, National Institutes of Health [R01GM094415]	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health Grant R01GM094415 (to K.C.S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akhmanova A, 2001, CELL, V104, P923, DOI 10.1016/S0092-8674(01)00288-4; Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Bieling P, 2007, NATURE, V450, P1100, DOI 10.1038/nature06386; Bieling P, 2008, J CELL BIOL, V183, P1223, DOI 10.1083/jcb.200809190; Bu W, 2003, J BIOL CHEM, V278, P49721, DOI 10.1074/jbc.M306194200; Buey RM, 2012, J BIOL CHEM, V287, P28227, DOI 10.1074/jbc.M112.373928; De Groot CO, 2010, J BIOL CHEM, V285, P5802, DOI 10.1074/jbc.M109.068130; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Dixit R, 2009, P NATL ACAD SCI USA, V106, P492, DOI 10.1073/pnas.0807614106; Duellberg C, 2014, NAT CELL BIOL, V16, P804, DOI 10.1038/ncb2999; Folker ES, 2005, MOL BIOL CELL, V16, P5373, DOI 10.1091/mbc.E04-12-1106; Goodson HV, 2003, CELL MOTIL CYTOSKEL, V55, P156, DOI 10.1002/cm.10114; Hayashi I, 2005, MOL CELL, V19, P449, DOI 10.1016/j.molcel.2005.06.034; Hayashi I, 2003, J BIOL CHEM, V278, P36430, DOI 10.1074/jbc.M305773200; Hayashi I, 2007, NAT STRUCT MOL BIOL, V14, P980, DOI 10.1038/nsmb1299; Honnappa S, 2005, EMBO J, V24, P261, DOI 10.1038/sj.emboj.7600529; Honnappa S, 2006, MOL CELL, V23, P663, DOI 10.1016/j.molcel.2006.07.013; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; Jiang K, 2012, CURR BIOL, V22, P1800, DOI 10.1016/j.cub.2012.07.047; Kumar A, 2017, STRUCTURE, V25, P924, DOI 10.1016/j.str.2017.04.010; Lansbergen G, 2004, J CELL BIOL, V166, P1003, DOI 10.1083/jcb.200402082; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee HS, 2010, MOL BIOL CELL, V21, P2661, DOI 10.1091/mbc.E09-12-1036; Maiato H, 2003, CELL, V113, P891, DOI 10.1016/S0092-8674(03)00465-3; Matsuo Y, 2016, J CELL SCI, V129, P4592, DOI 10.1242/jcs.197533; Maurer SP, 2012, CELL, V149, P371, DOI 10.1016/j.cell.2012.02.049; Mishima M, 2007, P NATL ACAD SCI USA, V104, P10346, DOI 10.1073/pnas.0703876104; Nakano A, 2010, NAT CELL BIOL, V12, P583, DOI 10.1038/ncb2060; Perez F, 1999, CELL, V96, P517, DOI 10.1016/S0092-8674(00)80656-X; PIERRE P, 1992, CELL, V70, P887, DOI 10.1016/0092-8674(92)90240-D; Slep KC, 2005, J CELL BIOL, V168, P587, DOI 10.1083/jcb.200410114; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; Stangier MM, 2018, STRUCTURE, V26, P607, DOI 10.1016/j.str.2018.03.003; Steinmetz MO, 2008, TRENDS BIOCHEM SCI, V33, P535, DOI 10.1016/j.tibs.2008.08.006; van der Vaart B, 2011, J CELL BIOL, V193, P1083, DOI 10.1083/jcb.201012179; Watson P, 2006, J CELL SCI, V119, P2758, DOI 10.1242/jcs.02999; Weisbrich A, 2007, NAT STRUCT MOL BIOL, V14, P959, DOI 10.1038/nsmb1291	37	11	11	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2019	294	3					918	931		10.1074/jbc.RA118.006125	http://dx.doi.org/10.1074/jbc.RA118.006125			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL4FC	30455356	hybrid, Green Published			2022-12-28	WOS:000458670200017
J	Kosciuczuk, EM; Mehrotra, S; Saleiro, D; Kroczynska, B; Majchrzak-Kita, B; Lisowski, P; Driehaus, C; Rogalska, A; Turner, A; Lienhoop, T; Gius, D; Fish, EN; Vassilopoulos, A; Platanias, LC				Kosciuczuk, Ewa M.; Mehrotra, Swarna; Saleiro, Diana; Kroczynska, Barbara; Majchrzak-Kita, Beata; Lisowski, Pawel; Driehaus, Caroline; Rogalska, Anna; Turner, Acara; Lienhoop, Thomas; Gius, David; Fish, Eleanor N.; Vassilopoulos, Athanassios; Platanias, Leonidas C.			Sirtuin 2-mediated deacetylation of cyclin-dependent kinase 9 promotes STAT1 signaling in type I interferon responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						signal transduction; post-translational modification (PTM); sirtuin; interferon; signal transducers and activators of transcription 1 (STAT1); innate immunity; histone deacetylase (HDAC); cytokine; deacetylation; immune regulation; SIRT2; STAT1; type I IFN	GENE-EXPRESSION; TRANSCRIPTION; ACETYLATION; PHOSPHORYLATION; TUMORIGENESIS; GLYCOLYSIS; INHIBITOR; PATHWAY; DIRECTS; ROLES	Type I interferons (IFNs) induce expression of multiple genes that control innate immune responses to invoke both antiviral and antineoplastic activities. Transcription of these interferon-stimulated genes (ISGs) occurs upon activation of the canonical Janus kinase (JAK)-signal transducer and activator of transcription (STAT) signaling pathways. Phosphorylation and acetylation are both events crucial to tightly regulate expression of ISGs. Here, using mouse embryonic fibroblasts and an array of biochemical methods including immunoblotting and kinase assays, we show that sirtuin 2 (SIRT2), a member of the NAD-dependent protein deacetylase family, is involved in type I IFN signaling. We found that SIRT2 deacetylates cyclin-dependent kinase 9 (CDK9) in a type I IFN-dependent manner and that the CDK9 deacetylation is essential for STAT1 phosphorylation at Ser-727. We also found that SIRT2 is subsequently required for the transcription of ISGs and for IFN-driven antiproliferative responses in both normal and malignant cells. These findings establish the existence of a previously unreported signaling pathway whose function is essential for the control of JAK-STAT signaling and the regulation of IFN responses. Our findings suggest that targeting sirtuin activities may offer an avenue in the development of therapies for managing immune-related diseases and cancer.	[Kosciuczuk, Ewa M.; Mehrotra, Swarna; Saleiro, Diana; Kroczynska, Barbara; Driehaus, Caroline; Rogalska, Anna; Turner, Acara; Lienhoop, Thomas; Gius, David; Vassilopoulos, Athanassios; Platanias, Leonidas C.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Kosciuczuk, Ewa M.; Mehrotra, Swarna; Saleiro, Diana; Platanias, Leonidas C.] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Hematol Oncol, Chicago, IL 60611 USA; [Kosciuczuk, Ewa M.; Platanias, Leonidas C.] Jesse Brown Vet Affairs Med Ctr, Dept Med, Div Hematol Oncol, Chicago, IL 60612 USA; [Majchrzak-Kita, Beata; Fish, Eleanor N.] Univ Hlth Network, Toronto Gen Hosp, Res Inst, Toronto, ON M5G 2MI, Canada; [Majchrzak-Kita, Beata; Fish, Eleanor N.] Univ Toronto, Dept Immunol, Toronto, ON M5G 2MI, Canada; [Lisowski, Pawel] Polish Acad Sci, Inst Genet & Anim Breeding, Dept Mol Biol, PL-05552 Jastrzebiec, Magdalenka, Poland; [Lisowski, Pawel] Warsaw Med Univ, Ctr Preclin Res & Technol CePT, Dept Med Genet, PL-02097 Warsaw, Poland; [Lisowski, Pawel] Max Delbruck Ctr Mol Med MDC, Helmholtz Assoc, iPS Cell Based Dis Modeling Grp, D-13092 Berlin, Germany; [Kroczynska, Barbara; Gius, David; Vassilopoulos, Athanassios] Northwestern Univ, Feinberg Sch Med, Dept Radiat Oncol, Chicago, IL 60611 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; Feinberg School of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; Institute of Genetics & Animal Biotechnology, Polish Academy of Sciences; Polish Academy of Sciences; Medical University of Warsaw; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Northwestern University; Feinberg School of Medicine	Platanias, LC (corresponding author), Robert H Lurie Comprehens Canc Ctr, 303 East Super St,Lurie 3-125, Chicago, IL 60611 USA.	l-platanias@northwestern.edu	Kosciuczuk, Ewa Maria/AAD-2815-2022	Turner, Acara/0000-0001-7464-6494	National Institutes of Health [CA77816, CA155566]; Department of Veterans Affairs [I01CX000916]; NATIONAL CANCER INSTITUTE [R01CA214025, R01CA182506, T32CA080621, R01CA077816] Funding Source: NIH RePORTER; Veterans Affairs [I01CX000916] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by National Institutes of Health Grants CA77816 and CA155566 and Grant I01CX000916 from the Department of Veterans Affairs. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Au-Yeung Nancy, 2013, JAKSTAT, V2, pe23931, DOI 10.4161/jkst.23931; Bancerek J, 2013, IMMUNITY, V38, P250, DOI 10.1016/j.immuni.2012.10.017; Bell O, 2011, NAT REV GENET, V12, P554, DOI 10.1038/nrg3017; Chang HM, 2004, P NATL ACAD SCI USA, V101, P9578, DOI 10.1073/pnas.0400567101; Choi JE, 2014, CURR OPIN GENET DEV, V26, P24, DOI 10.1016/j.gde.2014.05.005; Dryden SC, 2003, MOL CELL BIOL, V23, P3173, DOI 10.1128/MCB.23.9.3173-3185.2003; Fish EN, 2014, MOL CANCER RES, V12, P1691, DOI 10.1158/1541-7786.MCR-14-0450; Fuertes MB, 2013, TRENDS IMMUNOL, V34, P67, DOI 10.1016/j.it.2012.10.004; Ginter T, 2012, CELL SIGNAL, V24, P1453, DOI 10.1016/j.cellsig.2012.02.018; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Hervas-Stubbs S, 2011, CLIN CANCER RES, V17, P2619, DOI 10.1158/1078-0432.CCR-10-1114; Hoffmann G, 2014, J BIOL CHEM, V289, P5208, DOI 10.1074/jbc.M113.487736; Inoue T, 2007, ONCOGENE, V26, P945, DOI 10.1038/sj.onc.1209857; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Jing H, 2016, CANCER CELL, V29, P297, DOI 10.1016/j.ccell.2016.02.007; Kaur S, 2008, P NATL ACAD SCI USA, V105, P4808, DOI 10.1073/pnas.0710907105; Kaur S, 2014, J BIOL CHEM, V289, P6581, DOI 10.1074/jbc.M113.537852; Kiladjian JJ, 2011, BLOOD, V117, P4706, DOI 10.1182/blood-2010-08-258772; Kim HS, 2011, CANCER CELL, V20, P487, DOI 10.1016/j.ccr.2011.09.004; Kim HS, 2010, CELL METAB, V12, P224, DOI 10.1016/j.cmet.2010.06.009; Kosciuczuk EM, 2016, BLOOD, V128, P410, DOI 10.1182/blood-2016-02-698704; Kramer OH, 2009, GENE DEV, V23, P223, DOI 10.1101/gad.479209; Kroczynska B, 2009, MOL CELL BIOL, V29, P2865, DOI 10.1128/MCB.01537-08; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Li YZ, 2004, J BIOL CHEM, V279, P970, DOI 10.1074/jbc.M309927200; Liu PY, 2013, CELL DEATH DIFFER, V20, P503, DOI 10.1038/cdd.2012.147; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Nusinzon I, 2003, P NATL ACAD SCI USA, V100, P14742, DOI 10.1073/pnas.2433987100; O'Callaghan C, 2017, AGING CELL, V16, P1208, DOI 10.1111/acel.12685; Park SH, 2016, CANCER RES, V76, P3802, DOI 10.1158/0008-5472.CAN-15-2498; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Quentmeier H, 2006, LEUKEMIA, V20, P471, DOI 10.1038/sj.leu.2404081; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Rothgiesser KM, 2010, J CELL SCI, V123, P4251, DOI 10.1242/jcs.073783; Sadzak I, 2008, P NATL ACAD SCI USA, V105, P8944, DOI 10.1073/pnas.0801794105; Sakamoto S, 2004, J BIOL CHEM, V279, P40362, DOI 10.1074/jbc.M406400200; Saleiro D, 2015, CELL REP, V11, P605, DOI 10.1016/j.celrep.2015.03.056; Serrano L, 2013, GENE DEV, V27, P639, DOI 10.1101/gad.211342.112; Shakespear MR, 2011, TRENDS IMMUNOL, V32, P335, DOI 10.1016/j.it.2011.04.001; Song HY, 2016, ONCOTARGET, V7, P80336, DOI 10.18632/oncotarget.12015; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Tang XL, 2007, CELL, V131, P93, DOI 10.1016/j.cell.2007.07.034; Tripathi S, 2015, CELL HOST MICROBE, V18, P723, DOI 10.1016/j.chom.2015.11.002; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Yanagisawa K, 1998, BLOOD, V91, P641, DOI 10.1182/blood.V91.2.641.641_641_648; Zhang H, 2013, P NATL ACAD SCI USA, V110, P13546, DOI 10.1073/pnas.1301463110	48	21	21	3	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2019	294	3					827	837		10.1074/jbc.RA118.005956	http://dx.doi.org/10.1074/jbc.RA118.005956			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL4FC	30487288	Green Published, hybrid			2022-12-28	WOS:000458670200009
J	MacPherson, DJ; Mills, CL; Ondrechen, MJ; Hardy, JA				MacPherson, Derek J.; Mills, Caitlyn L.; Ondrechen, Mary Jo; Hardy, Jeanne A.			Tri-arginine exosite patch of caspase-6 recruits substrates for hydrolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cysteine protease; allosteric regulation; apoptosis; neurodegeneration; hydrogen-deuterium exchange; mass spectrometry; protein dynamic; substrate specificity; cancer; caspase-6; substrate recognition; tri-arginine exosite	EVOLUTIONARY CONSERVATION; CRYSTAL-STRUCTURE; CATHEPSIN-K; BONE-RESORPTION; ACTIVE-SITE; CLEAVAGE; DISTINCT; APOPTOSIS; CONSURF; ACTIVATION	Caspases are cysteine-aspartic proteases involved in the regulation of programmed cell death (apoptosis) and a number of other biological processes. Despite overall similarities in structure and active-site composition, caspases show striking selectivity for particular protein substrates. Exosites are emerging as one of the mechanisms by which caspases can recruit, engage, and orient these substrates for proper hydrolysis. Following computational analyses and database searches for candidate exosites, we utilized site-directed mutagenesis to identify a new exosite in caspase-6 at the hinge between the disordered N-terminal domain (NTD), residues 23-45, and core of the caspase-6 structure. We observed that substitutions of the tri-arginine patch Arg-42-Arg-44 or the R44K cancer-associated mutation in caspase-6 markedly alter its rates of protein substrate hydrolysis. Notably, turnover of protein substrates but not of short peptide substrates was affected by these exosite alterations, underscoring the importance of this region for protein substrate recruitment. Hydrogen-deuterium exchange MS-mediated interrogation of the intrinsic dynamics of these enzymes suggested the presence of a substrate-binding platform encompassed by the NTD and the 240's region (containing residues 236-246), which serves as a general exosite for caspase-6-specific substrate recruitment. In summary, we have identified an exosite on caspase-6 that is critical for protein substrate recognition and turnover and therefore highly relevant for diseases such as cancer in which caspase-6-mediated apoptosis is often disrupted, and in neurodegeneration in which caspase-6 plays a central role.	[MacPherson, Derek J.; Hardy, Jeanne A.] Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA; [Mills, Caitlyn L.; Ondrechen, Mary Jo] Northeastern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA	University of Massachusetts System; University of Massachusetts Amherst; Northeastern University	Hardy, JA (corresponding author), Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA.	hardy@chem.umass.edu		Hardy, Jeanne/0000-0002-3406-7997; Ondrechen, Mary Jo/0000-0003-2456-4313	National Institutes of Health [GM80532]; UMass Chemistry-Biology Interface Training Program (National Research Service Award from the National Institutes of Health) [T32 GM 08515]; PhRMA Foundation Fellowship; National Science Foundation (MPS) [CHE-1305655]; National Science Foundation Grant NSF (BIO) [MCB-1517290]; National Science Foundation Grant NSF (MPS) [CHE-1305655]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008515, R01GM080532] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UMass Chemistry-Biology Interface Training Program (National Research Service Award from the National Institutes of Health); PhRMA Foundation Fellowship; National Science Foundation (MPS); National Science Foundation Grant NSF (BIO); National Science Foundation Grant NSF (MPS); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM80532 (to J.A.H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by the UMass Chemistry-Biology Interface Training Program (National Research Service Award T32 GM 08515 from the National Institutes of Health).; Supported by a PhRMA Foundation Fellowship and National Science Foundation (MPS) CHE-1305655.; Supported by National Science Foundation Grant NSF (BIO) MCB-1517290 and National Science Foundation Grant NSF (MPS) CHE-1305655.	Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Babu MM, 2011, CURR OPIN STRUC BIOL, V21, P432, DOI 10.1016/j.sbi.2011.03.011; Baumgartner R, 2009, BIOCHEM J, V423, P429, DOI 10.1042/BJ20090540; Bode W, 2006, SEMIN THROMB HEMOST, V32, P16, DOI 10.1055/s-2006-939551; Boucher D, 2012, P NATL ACAD SCI USA, V109, P5669, DOI 10.1073/pnas.1200934109; Brodkin HR, 2015, PROTEIN SCI, V24, P762, DOI 10.1002/pro.2648; Cao Q, 2014, ACTA CRYSTALLOGR D, V70, P58, DOI 10.1107/S1399004713024218; Capra JA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000585; Carter WJ, 2005, J BIOL CHEM, V280, P2745, DOI 10.1074/jbc.M411606200; Celniker G, 2013, ISR J CHEM, V53, P199, DOI 10.1002/ijch.201200096; Coughlin SR, 1999, P NATL ACAD SCI USA, V96, P11023, DOI 10.1073/pnas.96.20.11023; Dagbay KB, 2017, P NATL ACAD SCI USA, V114, pE7977, DOI 10.1073/pnas.1704640114; Dagbay KB, 2017, J BIOL CHEM, V292, P4885, DOI 10.1074/jbc.M116.773499; Di Cera Enrico, 2006, Atti della Accademia Nazionali dei Lincei, Classe di Scienze Fisiche, Matematiche e Naturali, Rendiconti Lincei. Scienze Fisiche e Naturali, V17, P97, DOI 10.1007/BF02904503; Dix MM, 2012, CELL, V150, P426, DOI 10.1016/j.cell.2012.05.040; Du X, 2013, J BIOL CHEM, V288, P34871, DOI 10.1074/jbc.M113.510008; Dyson HJ, 2016, BIOPHYS J, V110, P1013, DOI 10.1016/j.bpj.2016.01.030; Ehrnhoefer DE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027680; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Eron SJ, 2017, STRUCTURE, V25, P27, DOI 10.1016/j.str.2016.11.001; Feldman T, 2012, MOL CELL, V47, P585, DOI 10.1016/j.molcel.2012.06.007; Friedlander RM, 2003, NEW ENGL J MED, V348, P1365, DOI 10.1056/NEJMra022366; Gauthier JY, 2008, BIOORG MED CHEM LETT, V18, P923, DOI 10.1016/j.bmcl.2007.12.047; Ghavami S, 2014, PROG NEUROBIOL, V112, P24, DOI 10.1016/j.pneurobio.2013.10.004; Giaime E, 2010, CELL DEATH DIFFER, V17, P158, DOI 10.1038/cdd.2009.116; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Graham RK, 2010, J NEUROSCI, V30, P15019, DOI 10.1523/JNEUROSCI.2071-10.2010; GREENBLATT MS, 1994, CANCER RES, V54, P4855; Grinshpon RD, 2018, PROTEIN SCI, V27, P1857, DOI 10.1002/pro.3494; Guo HS, 2004, AM J PATHOL, V165, P523, DOI 10.1016/S0002-9440(10)63317-2; Han GW, 2011, PROTEINS, V79, P2146, DOI 10.1002/prot.23035; Hill ME, 2016, ACS CHEM BIOL, V11, P1603, DOI 10.1021/acschembio.5b00971; Horiuchi KY, 1998, BIOCHEMISTRY-US, V37, P8879, DOI 10.1021/bi972731q; Houde D, 2011, J PHARM SCI-US, V100, P2071, DOI 10.1002/jps.22432; Huntington JA, 2005, J THROMB HAEMOST, V3, P1861, DOI 10.1111/j.1538-7836.2005.01363.x; Jabaiah AM, 2012, BIOL CHEM, V393, P933, DOI 10.1515/hsz-2012-0162; Julien O, 2017, CELL DEATH DIFFER, V24, P1380, DOI 10.1038/cdd.2017.44; Julien O, 2016, P NATL ACAD SCI USA, V113, pE2001, DOI 10.1073/pnas.1524900113; Ko JJ, 2005, PROTEINS, V59, P183, DOI 10.1002/prot.20418; Kornacker MG, 2005, BIOCHEMISTRY-US, V44, P11567, DOI 10.1021/bi050932l; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lee AW, 2010, J BIOL CHEM, V285, P31974, DOI 10.1074/jbc.M110.152744; Lee JW, 2006, APMIS, V114, P646, DOI 10.1111/j.1600-0463.2006.apm_417.x; Leung P, 2011, BONE, V49, P623, DOI 10.1016/j.bone.2011.06.014; Mahrus S, 2008, CELL, V134, P866, DOI 10.1016/j.cell.2008.08.012; MARGOLIS RL, 1994, BIOL PSYCHIAT, V35, P946, DOI 10.1016/0006-3223(94)91241-6; Martini C, 2017, BIOCHEMISTRY-US, V56, P5099, DOI 10.1021/acs.biochem.7b00298; McIlwain David R, 2015, Cold Spring Harb Perspect Biol, V7, DOI 10.1101/cshperspect.a026716; McStay GP, 2008, CELL DEATH DIFFER, V15, P322, DOI 10.1038/sj.cdd.4402260; Merck Newsroom Home, 2015, MERCK ANN DAT PIV PH; Mollica L, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00052; Muller I, 2011, BIOORG MED CHEM LETT, V21, P5244, DOI 10.1016/j.bmcl.2011.07.041; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Ondrechen MJ, 2001, P NATL ACAD SCI USA, V98, P12473, DOI 10.1073/pnas.211436698; Pakavathkumar P, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0166-z; Panwar P, 2016, BRIT J PHARMACOL, V173, P396, DOI 10.1111/bph.13383; Parasuram R, 2018, BIOCHEMISTRY-US, V57, P1063, DOI 10.1021/acs.biochem.7b01004; Pistritto G, 2016, AGING-US, V8, P603, DOI 10.18632/aging.100934; Plati J, 2008, J CELL BIOCHEM, V104, P1124, DOI 10.1002/jcb.21707; Ringe D, 2004, CELL MOL LIFE SCI, V61, P387, DOI 10.1007/s00018-003-3291-5; Robert G, 2012, CELL DEATH DIFFER, V19, P1769, DOI 10.1038/cdd.2012.55; Schilling O, 2008, NAT BIOTECHNOL, V26, P685, DOI 10.1038/nbt1408; Sharma V, 2015, BIOCHEM J, V465, P163, DOI 10.1042/BJ20140809; Shehadi IA, 2002, MOL BIOL REP, V29, P329, DOI 10.1023/A:1021220208562; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; Somarowthu S, 2011, BIOPOLYMERS, V95, P390, DOI 10.1002/bip.21589; Stennicke HR, 2000, BIOCHEM J, V350, P563, DOI 10.1042/0264-6021:3500563; Stoch SA, 2008, CLIN PHARMACOL THER, V83, P172, DOI 10.1038/sj.clpt.6100450; Takahashi A, 1996, P NATL ACAD SCI USA, V93, P8395, DOI 10.1073/pnas.93.16.8395; Talanian RV, 1997, J BIOL CHEM, V272, P9677; Thomsen ND, 2013, P NATL ACAD SCI USA, V110, P8477, DOI 10.1073/pnas.1306759110; Timmer JC, 2011, METHODS MOL BIOL, V753, P243, DOI 10.1007/978-1-61779-148-2_16; Tong WX, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000266; Vaidya S, 2011, BIOCHEMISTRY-US, V50, P3282, DOI 10.1021/bi2001664; Vaidya S, 2011, J MOL BIOL, V406, P75, DOI 10.1016/j.jmb.2010.11.031; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; Velazquez-Delgado EM, 2012, J BIOL CHEM, V287, P36000, DOI 10.1074/jbc.M112.397752; Walensky LD, 2006, CELL DEATH DIFFER, V13, P1339, DOI 10.1038/sj.cdd.4401992; Wales TE, 2006, MASS SPECTROM REV, V25, P158, DOI 10.1002/mas.20064; Wales TE, 2008, ANAL CHEM, V80, P6815, DOI 10.1021/ac8008862; Wang XJ, 2010, EMBO REP, V11, P841, DOI 10.1038/embor.2010.141; Wei YY, 2000, CHEM BIOL, V7, P423, DOI 10.1016/S1074-5521(00)00123-X; WELLS CM, 1992, BIOCHEMISTRY-US, V31, P11721, DOI 10.1021/bi00162a008; WU QY, 1991, P NATL ACAD SCI USA, V88, P6775, DOI 10.1073/pnas.88.15.6775	87	16	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2019	294	1					71	88		10.1074/jbc.RA118.005914	http://dx.doi.org/10.1074/jbc.RA118.005914			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG6PT	30420425	Green Published, hybrid			2022-12-28	WOS:000455105500014
J	Wang, F; Zhao, KL; Yu, SX; Xu, A; Han, W; Mei, YD				Wang, Fang; Zhao, Kailiang; Yu, Sixiang; Xu, An; Han, Wei; Mei, Yide			RNF12 catalyzes BRF1 ubiquitination and regulates RNA polymerase III-dependent transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA polymerase III; ubiquitin ligase; ubiquitylation (ubiquitination); signal transduction; post-translational modification (PTM); BRF1; RNF12	X-CHROMOSOME INACTIVATION; PHOSPHORYLATION; RECRUITMENT; ACTIVATION; MECHANISMS; CANCER; RLIM	RNA polymerase III (Pol III) is responsible for the production of small noncoding RNA species, including tRNAs and 5S rRNA. Pol III-dependent transcription is generally enhanced in transformed cells and tumors, but the underlying mechanisms remain not well-understood. It has been demonstrated that the BRF1 subunit of TFIIIB is essential for the accurate initiation of Pol III-dependent transcription. However, it is not known whether BRF1 undergoes ubiquitin modification and whether BRF1 ubiquitination regulates Pol III-dependent transcription. Here, we show that RNF12, a RING domain-containing ubiquitin E3 ligase, physically interacts with BRF1. Via direct interaction, RNF12 catalyzes Lys(27)- and Lys(33)-linked polyubiquitination of BRF1. Furthermore, RNF12 is able to negatively regulate Pol III-dependent transcription and cell proliferation via BRF1. These findings uncover a novel mechanism for the regulation of BRF1 and reveal RNF12 as an important regulator of Pol III-dependent transcription.	[Wang, Fang; Han, Wei] Chinese Acad Sci, Hefei Inst Phys Sci, Ctr Med Phys & Technol, Anhui Prov Key Lab Med Phys & Technol, Hefei 230031, Anhui, Peoples R China; [Wang, Fang; Zhao, Kailiang; Yu, Sixiang; Xu, An; Mei, Yide] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Key Lab Innate Immun & Chron Dis, Div Mol Med,Chinese Acad Sci,Sch Life Sci, Hefei 230026, Anhui, Peoples R China	Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Han, W (corresponding author), Chinese Acad Sci, Hefei Inst Phys Sci, Ctr Med Phys & Technol, Anhui Prov Key Lab Med Phys & Technol, Hefei 230031, Anhui, Peoples R China.; Mei, YD (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Key Lab Innate Immun & Chron Dis, Div Mol Med,Chinese Acad Sci,Sch Life Sci, Hefei 230026, Anhui, Peoples R China.	hanw@hfcas.ac.cn; meiyide@ustc.edu.cn	Yu, Sixiang/AFM-0114-2022; Mei, Yide/M-4468-2013; Zhao, Kailiang/AAE-2828-2021	Zhao, Kailiang/0000-0001-8149-1494; XU, AN/0000-0003-1776-7972	National Natural Science Foundation of China [31671487, 31422035, U1632145, 81227902]; Ministry of Science and Technology of China [2015CB553800]; Fundamental Research Funds for Central Universities [WK2070000047, WK2070000106, WK9110000007]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Jiangsu Provincial Key Laboratory of Radiation Medicine and Protection; Key Program of the 13th Five-year Plan, CASHIPS [KP-2017-25]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Fundamental Research Funds for Central Universities(Fundamental Research Funds for the Central Universities); Priority Academic Program Development of Jiangsu Higher Education Institutions; Jiangsu Provincial Key Laboratory of Radiation Medicine and Protection; Key Program of the 13th Five-year Plan, CASHIPS	This work was supported by National Natural Science Foundation of China Grants 31671487 and 31422035 (to Y. M.) and U1632145 and 81227902 (to W. H.), by Ministry of Science and Technology of China Grant 2015CB553800, by Fundamental Research Funds for Central Universities Grants WK2070000047, WK2070000106, and WK9110000007, and by a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions and Jiangsu Provincial Key Laboratory of Radiation Medicine and Protection and supported by the Key Program of the 13th Five-year Plan, CASHIPS, Grant KP-2017-25. The authors declare that they have no conflicts of interest with the contents of this article.	Akutsu M, 2016, J CELL SCI, V129, P875, DOI 10.1242/jcs.183954; Bach I, 1999, NAT GENET, V22, P394, DOI 10.1038/11970; Borck G, 2015, GENOME RES, V25, P155, DOI 10.1101/gr.176925.114; Bustos F, 2018, CELL REP, V23, P1599, DOI 10.1016/j.celrep.2018.04.022; Bywater MJ, 2013, NAT REV CANCER, V13, P299, DOI 10.1038/nrc3496; Crighton D, 2003, EMBO J, V22, P2810, DOI 10.1093/emboj/cdg265; Dieci G, 2013, BBA-GENE REGUL MECH, V1829, P296, DOI 10.1016/j.bbagrm.2012.09.010; Fairley JA, 2012, MOL CELL, V45, P541, DOI 10.1016/j.molcel.2011.11.030; Fang Z, 2017, MOL ONCOL, V11, P1752, DOI 10.1002/1878-0261.12141; Felton-Edkins ZA, 2003, EMBO J, V22, P2422, DOI 10.1093/emboj/cdg240; Felton-Edkins ZA, 2002, J BIOL CHEM, V277, P48182, DOI 10.1074/jbc.M201333200; Frints S. G. M., 2018, MOL PSYCHIAT; Gao K, 2016, CANCER LETT, V375, P133, DOI 10.1016/j.canlet.2016.02.013; Gao R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164086; Gomez-Roman N, 2003, NATURE, V421, P290, DOI 10.1038/nature01327; Gontan C, 2012, NATURE, V485, P386, DOI 10.1038/nature11070; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Her YR, 2009, J BIOL CHEM, V284, P8557, DOI 10.1074/jbc.M806702200; Hirsch HA, 2004, MOL CELL BIOL, V24, P5989, DOI 10.1128/MCB.24.13.5989-5999.2004; Hu P, 2004, MOL CELL, V16, P81, DOI 10.1016/j.molcel.2004.09.008; Huang X, 2013, EMBO J, V32, P2204, DOI 10.1038/emboj.2013.133; Huang YS, 2017, ONCOTARGET, V8, P83075, DOI 10.18632/oncotarget.20904; Johnsen SA, 2009, CANCER RES, V69, P128, DOI 10.1158/0008-5472.CAN-08-1630; Johnson SAS, 2008, J BIOL CHEM, V283, P19184, DOI 10.1074/jbc.M802872200; Jonkers I, 2009, CELL, V139, P999, DOI 10.1016/j.cell.2009.10.034; Kramer OH, 2003, EMBO J, V22, P3411, DOI 10.1093/emboj/cdg315; Lei Junxia, 2017, Liver Res, V1, P112, DOI 10.1016/j.livres.2017.08.005; Marshall L, 2008, CELL CYCLE, V7, P3327, DOI 10.4161/cc.7.21.6970; Marshall L, 2008, NAT REV CANCER, V8, P911, DOI 10.1038/nrc2539; Mei YD, 2010, MOL CELL, V37, P668, DOI 10.1016/j.molcel.2010.01.023; Nathan JA, 2013, EMBO J, V32, P552, DOI 10.1038/emboj.2012.354; Ostendorff HP, 2002, NATURE, V416, P99, DOI 10.1038/416099a; Pavon-Eternod M, 2009, NUCLEIC ACIDS RES, V37, P7268, DOI 10.1093/nar/gkp787; Rape M, 2018, NAT REV MOL CELL BIO, V19, P59, DOI 10.1038/nrm.2017.83; Schramm L, 2002, GENE DEV, V16, P2593, DOI 10.1101/gad.1018902; Shin J, 2010, NATURE, V467, P977, DOI 10.1038/nature09457; Sutcliffe JE, 2000, MOL CELL BIOL, V20, P9192, DOI 10.1128/MCB.20.24.9192-9202.2000; Swatek KN, 2016, CELL RES, V26, P399, DOI 10.1038/cr.2016.39; Turowski TW, 2016, BIOCHEM SOC T, V44, P1367, DOI 10.1042/BST20160062; Vannini A, 2012, MOL CELL, V45, P439, DOI 10.1016/j.molcel.2012.01.023; Wang XW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2533; White RJ, 2011, NAT REV GENET, V12, P459, DOI 10.1038/nrg3001; Winter AG, 2000, P NATL ACAD SCI USA, V97, P12619, DOI 10.1073/pnas.230224097; Woiwode A, 2008, MOL CELL BIOL, V28, P4204, DOI 10.1128/MCB.01912-07; Yang F, 2014, MOL CELL, V53, P88, DOI 10.1016/j.molcel.2013.11.004; Zhang L, 2012, MOL CELL, V46, P650, DOI 10.1016/j.molcel.2012.04.003; Zhang Q, 2011, ONCOGENE, V30, P3943, DOI 10.1038/onc.2011.105; Zhao KL, 2018, EMBO REP, V19, P305, DOI 10.15252/embr.201744465	48	9	9	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2019	294	1					130	141		10.1074/jbc.RA118.004524	http://dx.doi.org/10.1074/jbc.RA118.004524			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG6PT	30413534	Green Published, hybrid			2022-12-28	WOS:000455105500018
J	Abraham, A; Brasov, I; Thekkiniath, J; Kilian, N; Lawres, L; Gao, RY; DeBus, K; He, L; Yu, X; Zhu, G; Graham, MM; Liu, XR; Molestina, R; Ben Mamoun, C				Abraham, Amanah; Brasov, Ioana; Thekkiniath, Jose; Kilian, Nicole; Lawres, Lauren; Gao, Ruiyi; DeBus, Kai; He, Lan; Yu, Xue; Zhu, Guan; Graham, Morven M.; Liu, Xinran; Molestina, Robert; Ben Mamoun, Choukri			Establishment of a continuous in vitro culture of Babesia duncani in human erythrocytes reveals unusually high tolerance to recommended therapies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						parasitology; cell culture; infectious disease; inhibitor; erythrocyte; apicomplexa; Babesia duncani; human babesiosis; in vitro culture; red blood cells; tick-borne disease	WASHINGTON-STATE; INFECTION; MICROTI; WA1; APICOMPLEXA; PATHOLOGY	Human babesiosis is an emerging tick-borne disease caused by apicomplexan parasites of the genus Babesia. Clinical cases caused by Babesia duncani have been associated with high parasite burden, severe pathology, and death. In both mice and hamsters, the parasite causes uncontrolled fulminant infections, which ultimately lead to death. Resolving these infections requires knowledge of B. duncani biology, virulence, and susceptibility to anti-infectives, but little is known and further research is hindered by a lack of relevant model systems. Here, we report the first continuous in vitro culture of B. duncani in human red blood cells. We show that during its asexual cycle within human erythrocytes, B. duncani develops and divides to form four daughter parasites with parasitemia doubling every approximate to 22 h. Using this in vitro culture assay, we found that B. duncani has low susceptibility to the four drugs recommended for treatment of human babesiosis, atovaquone, azithromycin, clindamycin, and quinine, with IC50 values ranging between 500 nm and 20 m. These data suggest that current practices are of limited effect in treating the disease. We anticipate this new disease model will set the stage for a better understanding of the biology of this parasite and will help guide better therapeutic strategies to treat B. duncani-associated babesiosis.	[Abraham, Amanah; Thekkiniath, Jose; Kilian, Nicole; Lawres, Lauren; Gao, Ruiyi; DeBus, Kai; Ben Mamoun, Choukri] Yale Sch Med, Infect Dis Sect, Dept Internal Med, New Haven, CT 06520 USA; [Graham, Morven M.; Liu, Xinran] Yale Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; [Graham, Morven M.; Liu, Xinran] Yale Sch Med, CCMI Electron Microscopy Core Facil, New Haven, CT 06520 USA; [Brasov, Ioana; Molestina, Robert] Amer Type Culture Collect, BEI Resources, Manassas, VA 20110 USA; [He, Lan] Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan 430079, Hubei, Peoples R China; [Yu, Xue; Zhu, Guan] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Pathobiol, College Stn, TX 77845 USA	Yale University; Yale University; Yale University; Huazhong Agricultural University; Texas A&M University System; Texas A&M University College Station	Ben Mamoun, C (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, TAC S210,300 Cedar St, New Haven, CT 06520 USA.	choukri.benmamoun@yale.edu	Zhu, Guan/AFJ-2945-2022; ZHU, GUAN/GQB-0299-2022; He, Lan/AFU-5817-2022	Zhu, Guan/0000-0003-3888-0659; ZHU, GUAN/0000-0003-3888-0659; Kilian, Nicole/0000-0001-7489-9782	BEI Resources Program of NIAID, National Institutes of Health [HHSN 272201600013C]; National Institutes of Health [AI097218, GM110506, AI123321, R43AI136118]; Bill and Melinda Gates Foundation [OPP1021571]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R43AI136118] Funding Source: NIH RePORTER	BEI Resources Program of NIAID, National Institutes of Health; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the BEI Resources Program of NIAID, National Institutes of Health, Contract HHSN 272201600013C.; Supported by National Institutes of Health Grants AI097218, GM110506, AI123321, and R43AI136118 and Bill and Melinda Gates Foundation Grant OPP1021571.	Bloch EM, 2012, TRANSFUSION, V52, P1517, DOI 10.1111/j.1537-2995.2011.03467.x; Braga W, 2006, J PARASITOL, V92, P1104, DOI 10.1645/GE-712R.1; Conrad PA, 2006, INT J PARASITOL, V36, P779, DOI 10.1016/j.ijpara.2006.03.008; CULLEN JM, 1987, LAB ANIM SCI, V37, P640; Dahl EL, 2007, ANTIMICROB AGENTS CH, V51, P3485, DOI 10.1128/AAC.00527-07; Dao AH, 1996, LAB INVEST, V74, P853; Fang DC, 2016, TRANSFUS MED REV, V30, P132, DOI 10.1016/j.tmrv.2016.04.002; Gelfand Jeffrey A., 2003, Curr Infect Dis Rep, V5, P53, DOI 10.1007/s11908-003-0065-z; Glanternik JR, 2018, PEDIATR INFECT DIS J, V37, P269, DOI [10.1097/INF.0000000000001803, 10.1097/inf.0000000000001803]; Herwaldt BL, 1997, J INFECT DIS, V175, P1259, DOI 10.1086/593812; Kjemtrup AM, 2000, INT J PARASITOL, V30, P1323, DOI 10.1016/S0020-7519(00)00137-5; Kjemtrup AM, 2002, TRANSFUSION, V42, P1482, DOI 10.1046/j.1537-2995.2002.00245.x; Krause PJ, 2000, NEW ENGL J MED, V343, P1454, DOI 10.1056/NEJM200011163432004; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lawres LA, 2016, J EXP MED, V213, P1307, DOI 10.1084/jem.20151519; Leiby DA, 2011, CLIN MICROBIOL REV, V24, P14, DOI 10.1128/CMR.00022-10; Moro MH, 1998, INFECT IMMUN, V66, P492, DOI 10.1128/IAI.66.2.492-498.1998; Paul AS, 2016, ANTIMICROB AGENTS CH, V60, P5059, DOI 10.1128/AAC.00928-16; PERSING DH, 1995, NEW ENGL J MED, V332, P298, DOI 10.1056/NEJM199502023320504; QUICK RE, 1993, ANN INTERN MED, V119, P284, DOI 10.7326/0003-4819-119-4-199308150-00006; Rossouw I, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003711; SCHOLTENS RG, 1968, AM J TROP MED HYG, V17, P810, DOI 10.4269/ajtmh.1968.17.810; Scott JD, 2018, HEALTHCARE-BASEL, V6, DOI 10.3390/healthcare6020049; Swei A, 2019, INT J PARASITOL, V49, P95, DOI 10.1016/j.ijpara.2018.07.002; THOMFORD JW, 1994, J INFECT DIS, V169, P1050, DOI 10.1093/infdis/169.5.1050; Vannier EG, 2015, INFECT DIS CLIN N AM, V29, P357, DOI 10.1016/j.idc.2015.02.008; Wilson DW, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0162-0; Wozniak EJ, 1996, LAB ANIM SCI, V46, P507; Zamoto-Niikura A, 2014, EMERG INFECT DIS, V20, P1398, DOI 10.3201/eid2008.130061	29	22	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					19974	19981		10.1074/jbc.AC118.005771	http://dx.doi.org/10.1074/jbc.AC118.005771			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30463941	hybrid, Green Published			2022-12-28	WOS:000454685900003
J	Amaya, J; Ryan, VH; Fawzi, NL				Amaya, Joshua; Ryan, Veronica H.; Fawzi, Nicolas L.			The SH3 domain of Fyn kinase interacts with and induces liquid-liquid phase separation of the low-complexity domain of hnRNPA2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nuclear magnetic resonance (NMR); intrinsically disordered protein; heterogeneous nuclear ribonucleoprotein (hnRNP); RNA transport; structural biology; protein-protein interaction; liquid-liquid phase separation (LLPS); membraneless organelle; prion-like domain; stress granule; aggregation; hnRNPA2; Fyn-SH3	RNA-BINDING PROTEINS; NUCLEAR IMPORT RECEPTOR; PRION-LIKE DOMAINS; TRANSITIONS; MUTATIONS; FUS	Liquid-liquid phase separation of proteins and nucleic acids into membraneless organelles (MLOs) spatially organizes cellular components and reactions. The RNA-binding protein heterogeneous nuclear ribonucleoprotein A2 (hnRNPA2) carries mRNA targets in MLOs called transport granules in neurons and oligodendrocytes. At sites of local translation, hnRNPA2 is phosphorylated by the tyrosine protein kinase Fyn, releasing the mRNA for translation. Fyn recognizes targets through its SH3 domain (Fyn-SH3). However, hnRNPA2 lacks canonical SH3-binding sequences, raising the question of how Fyn-SH3 binds hnRNPA2 in phase-separated transport granules. Here, we characterize the structural details of the interaction of the hnRNPA2 low-complexity domain (LC) with Fyn-SH3 and the effect of Fyn-SH3 on hnRNPA2 phase separation. We combined in vitro microscopy and solution NMR spectroscopy to evaluate assembly of hnRNPA2 and Fyn-SH3 into in vitro phase-separated granules and probe the structural details of their interaction. We observed that Fyn-SH3 induces hnRNPA2 LC phase separation and that Fyn-SH3 is incorporated into in vitro hnRNPA2 LC granules. Moreover, we identified hnRNPA2 LC interaction sites on the surface of Fyn-SH3. Our data offer a structural view of how hnRNPA2 LC may interact with Fyn. To our knowledge, our study provides the first example of a single globular domain inducing phase separation of a disordered MLO scaffold protein.	[Amaya, Joshua; Fawzi, Nicolas L.] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA; [Ryan, Veronica H.] Brown Univ, Grad Program Neurosci, Providence, RI 02912 USA	Brown University; Brown University	Fawzi, NL (corresponding author), Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA.	nicolas_fawzi@brown.edu	Fawzi, Nicolas/E-2555-2013	Fawzi, Nicolas/0000-0001-5483-0577; Ryan, Veronica/0000-0001-5121-4672; Amaya, Joshua/0000-0003-2214-0429	NIGMS, National Institutes of Health [R01GM118530, P20GM104937]; Karen T. Romer Undergraduate Teaching and Research Awards; Robert J. and Nancy D. Carney Institute for Brain Science at Brown University [T32MH020068]; NINDS, National Institutes of Health [F31NS110301]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118530, P20GM104937] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS110301] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Karen T. Romer Undergraduate Teaching and Research Awards; Robert J. and Nancy D. Carney Institute for Brain Science at Brown University; NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by NIGMS, National Institutes of Health, Grants R01GM118530 (to N.L.F.) and P20GM104937. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by two summer Karen T. Romer Undergraduate Teaching and Research Awards.; Supported in part by T32MH020068, a Graduate Award from the Robert J. and Nancy D. Carney Institute for Brain Science at Brown University, and NINDS, National Institutes of Health, Grant F31NS110301.	Aguilera-Gomez A, 2017, DEV BIOL, V428, P310, DOI 10.1016/j.ydbio.2017.03.029; Banjade S, 2015, P NATL ACAD SCI USA, V112, pE6426, DOI 10.1073/pnas.1508778112; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Conicella AE, 2016, STRUCTURE, V24, P1537, DOI 10.1016/j.str.2016.07.007; Guo L, 2018, CELL, V173, P677, DOI 10.1016/j.cell.2018.03.002; Guo L, 2015, MOL CELL, V60, P189, DOI 10.1016/j.molcel.2015.10.006; Harmon TS, 2017, ELIFE, V6, DOI 10.7554/eLife.30294; Hofweber M, 2018, CELL, V173, P706, DOI 10.1016/j.cell.2018.03.004; Kang H, 2000, EMBO J, V19, P2889, DOI 10.1093/emboj/19.12.2889; Kapeli K, 2017, HUM GENET, V136, P1193, DOI 10.1007/s00439-017-1830-7; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; King OD, 2012, BRAIN RES, V1462, P61, DOI 10.1016/j.brainres.2012.01.016; Kramer-Albers EM, 2011, CELL MOL LIFE SCI, V68, P2003, DOI 10.1007/s00018-010-0616-z; Larson AG, 2017, NATURE, V547, P236, DOI 10.1038/nature22822; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Monahan Z, 2017, EMBO J, V36, P2951, DOI 10.15252/embj.201696394; Nott TJ, 2016, NAT CHEM, V8, P570, DOI [10.1038/NCHEM.2519, 10.1038/nchem.2519]; Polverini E, 2008, BIOCHEMISTRY-US, V47, P267, DOI 10.1021/bi701336n; Prusiner SB, 2013, ANNU REV GENET, V47, P601, DOI 10.1146/annurev-genet-110711-155524; Renzoni DA, 1996, BIOCHEMISTRY-US, V35, P15646, DOI 10.1021/bi9620969; Ryan VH, 2018, MOL CELL, V69, P465, DOI 10.1016/j.molcel.2017.12.022; Saksela K, 2012, FEBS LETT, V586, P2609, DOI 10.1016/j.febslet.2012.04.042; Shan JG, 2000, J BIOL CHEM, V275, P38286, DOI 10.1074/jbc.M007642200; Sheu-Gruttadauria J, 2018, CELL, V173, P946, DOI 10.1016/j.cell.2018.02.051; Shin Y, 2017, SCIENCE, V357, DOI 10.1126/science.aaf4382; Shin Y, 2017, CELL, V168, P159, DOI 10.1016/j.cell.2016.11.054; Shrestha P, 2017, BIOCHEM BIOPH RES CO, V490, P594, DOI 10.1016/j.bbrc.2017.06.083; Wang J, 2018, CELL, V174, P688, DOI 10.1016/j.cell.2018.06.006; Wegmann S, 2018, EMBO J, V37, DOI 10.15252/embj.201798049; White R, 2008, J CELL BIOL, V181, P579, DOI 10.1083/jcb.200706164; White R, 2014, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00284; Yoshizawa T, 2018, CELL, V173, P693, DOI 10.1016/j.cell.2018.03.003; Zarrinpar Ali, 2003, Sci STKE, V2003, pRE8, DOI 10.1126/stke.2003.179.re8	34	25	25	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19522	19531		10.1074/jbc.RA118.005120	http://dx.doi.org/10.1074/jbc.RA118.005120			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30397184	Green Published, hybrid			2022-12-28	WOS:000454294900002
J	Santhanagopalan, I; Degiacomi, MT; Shepherd, DA; Hochberg, GKA; Benesch, JLP; Vierling, E				Santhanagopalan, Indu; Degiacomi, Matteo T.; Shepherd, Dale A.; Hochberg, Georg K. A.; Benesch, Justin L. P.; Vierling, Elizabeth			It takes a dimer to tango: Oligomeric small heat shock proteins dissociate to capture substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chaperone; small heat shock protein (sHsp); small-angle X-ray scattering (SAXS); oligomerization; protein stability; protein design; protein engineering; chaperone efficiency; disulfides; dynamic light scattering (DLS); native mass spectrometry; substrate recognition; thermal stability; stress response; protein folding	ALPHA-B-CRYSTALLIN; CHAPERONE ACTIVITY; SUBUNIT EXCHANGE; QUATERNARY ORGANIZATION; A-CRYSTALLIN; COMPLEXES; DYNAMICS; HSP26; MECHANISM; REVEALS	Small heat-shock proteins (sHsps) are ubiquitous molecular chaperones, and sHsp mutations or altered expression are linked to multiple human disease states. sHsp monomers assemble into large oligomers with dimeric substructure, and the dynamics of sHsp oligomers has led to major questions about the form that captures substrate, a critical aspect of their mechanism of action. We show here that substructural dimers of two plant dodecameric sHsps, Ta16.9 and homologous Ps18.1, are functional units in the initial encounter with unfolding substrate. We introduced inter-polypeptide disulfide bonds at the two dodecameric interfaces, dimeric and nondimeric, to restrict how their assemblies can dissociate. When disulfide-bonded at the nondimeric interface, mutants of Ta16.9 and Ps18.1 (TaCT-ACD and Ps(CT-ACD)) were inactive but, when reduced, had WT-like chaperone activity, demonstrating that dissociation at nondimeric interfaces is essential for sHsp activity. Moreover, the size of the TaCT-ACD and Ps(CT-ACD) covalent unit defined a new tetrahedral geometry for these sHsps, different from that observed in the Ta16.9 X-ray structure. Importantly, oxidized Ta-dimer (disulfide bonded at the dimeric interface) exhibited greatly enhanced ability to protect substrate, indicating that strengthening the dimeric interface increases chaperone efficiency. Temperature-induced size and secondary structure changes revealed that folded sHsp dimers interact with substrate and that dimer stability affects chaperone efficiency. These results yield a model in which sHsp dimers capture substrate before assembly into larger, heterogeneous sHsp-substrate complexes for substrate refolding or degradation, and suggest that tuning the strength of the dimer interface can be used to engineer sHsp chaperone efficiency.	[Santhanagopalan, Indu; Vierling, Elizabeth] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; [Degiacomi, Matteo T.; Shepherd, Dale A.; Hochberg, Georg K. A.; Benesch, Justin L. P.] Univ Oxford, Dept Chem Phys & Theoret Chem, Chem Res Lab, Mansfield Rd, Oxford OX1 3TA, England; [Degiacomi, Matteo T.] Univ Durham, Dept Chem, South Rd, Durham DH1 3LE, England; [Santhanagopalan, Indu] Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England; [Shepherd, Dale A.] Waters Corp, Stamford Ave, Wilmslow SK9 4AX, Cheshire, England; [Hochberg, Georg K. A.] Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Oxford; Durham University; University of Cambridge; Waters UK; University of Chicago	Vierling, E (corresponding author), Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA.	vierling@biochem.umass.edu	Degiacomi, Matteo/M-4342-2017; Hochberg, Georg/AAC-4185-2021	Degiacomi, Matteo/0000-0003-4672-471X; Vierling, Elizabeth/0000-0002-0066-4881; Benesch, Justin/0000-0002-1507-3742; Cooper-Shepherd, Dale/0000-0001-9301-1777; Hochberg, Georg/0000-0002-7155-0451	Engineering and Physical Sciences Research Council [EP/J01835X/1, EP/P016499/1]; National Institutes of Health [RO1 GM42762]; BBSRC [BB/K004247/1, BB/J018082/1] Funding Source: UKRI; EPSRC [EP/P016499/1, EP/J01835X/1] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042762] Funding Source: NIH RePORTER	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Engineering and Physical Sciences Research Council Grants EP/J01835X/1 (to J.L.P.B.) and EP/P016499/1 (to M.T.D.) and National Institutes of Health Grant RO1 GM42762 (to E.V.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aquilina JA, 2005, J BIOL CHEM, V280, P14485, DOI 10.1074/jbc.M500135200; Arrigo AP, 2013, FEBS LETT, V587, P1959, DOI 10.1016/j.febslet.2013.05.011; Augusteyn RC, 2004, EXP EYE RES, V79, P781, DOI 10.1016/j.exer.2004.08.010; Baldwin AJ, 2011, STRUCTURE, V19, P1855, DOI 10.1016/j.str.2011.09.015; Baldwin AJ, 2011, J MOL BIOL, V413, P310, DOI 10.1016/j.jmb.2011.07.017; Baldwin AJ, 2011, J MOL BIOL, V413, P297, DOI 10.1016/j.jmb.2011.07.016; Basha E, 2013, J MOL BIOL, V425, P1683, DOI 10.1016/j.jmb.2013.02.011; Basha E, 2012, TRENDS BIOCHEM SCI, V37, P106, DOI 10.1016/j.tibs.2011.11.005; Basha E, 2010, J BIOL CHEM, V285, P11489, DOI 10.1074/jbc.M109.074088; Basha E, 2006, J BIOL CHEM, V281, P39943, DOI 10.1074/jbc.M607677200; Benesch JLP, 2003, ANAL CHEM, V75, P2208, DOI 10.1021/ac034132x; Benesch JLP, 2010, CHEM BIOL, V17, P1008, DOI 10.1016/j.chembiol.2010.06.016; Bepperling A, 2012, P NATL ACAD SCI USA, V109, P20407, DOI 10.1073/pnas.1209565109; Bova MP, 2000, J BIOL CHEM, V275, P1035, DOI 10.1074/jbc.275.2.1035; Bush MF, 2010, ANAL CHEM, V82, P9557, DOI 10.1021/ac1022953; CASPERS GJ, 1995, J MOL EVOL, V40, P238, DOI 10.1007/BF00163229; Charmpilas N, 2017, CELL STRESS CHAPERON, V22, P481, DOI 10.1007/s12192-016-0761-x; Cheng GL, 2008, J BIOL CHEM, V283, P26634, DOI 10.1074/jbc.M802946200; Dani VS, 2003, PROTEIN ENG, V16, P187, DOI 10.1093/proeng/gzg024; DEJONG WW, 1993, MOL BIOL EVOL, V10, P103; Delbecq SP, 2013, FEBS LETT, V587, P1073, DOI 10.1016/j.febslet.2013.01.021; Fischer H, 2004, PROTEIN SCI, V13, P2825, DOI 10.1110/ps.04688204; Fleckenstein T, 2015, MOL CELL, V58, P1067, DOI 10.1016/j.molcel.2015.04.019; Franzmann TM, 2005, J MOL BIOL, V350, P1083, DOI 10.1016/j.jmb.2005.05.034; Friedrich KL, 2004, J BIOL CHEM, V279, P1080, DOI 10.1074/jbc.M311104200; Fu XM, 2005, J BIOL CHEM, V280, P6337, DOI 10.1074/jbc.M406319200; Giese KC, 2002, J BIOL CHEM, V277, P46310, DOI 10.1074/jbc.M208926200; Hanazono Y, 2013, STRUCTURE, V21, P220, DOI 10.1016/j.str.2012.11.015; Hanazono Y, 2012, J MOL BIOL, V422, P100, DOI 10.1016/j.jmb.2012.05.017; Haslbeck M, 1999, EMBO J, V18, P6744, DOI 10.1093/emboj/18.23.6744; Haslbeck M, 2004, J MOL BIOL, V343, P445, DOI 10.1016/j.jmb.2004.08.048; Haslbeck M, 2015, J MOL BIOL, V427, P1537, DOI 10.1016/j.jmb.2015.02.002; Hochberg GKA, 2018, SCIENCE, V359, P930, DOI 10.1126/science.aam7229; Hochberg GKA, 2014, P NATL ACAD SCI USA, V111, pE1562, DOI 10.1073/pnas.1322673111; Indu S, 2011, PROTEINS, V79, P244, DOI 10.1002/prot.22878; Jackson SE, 2013, TOP CURR CHEM, V328, P69, DOI 10.1007/128_2012_324; Jaya N, 2009, P NATL ACAD SCI USA, V106, P15604, DOI 10.1073/pnas.0902177106; Kennaway CK, 2005, J BIOL CHEM, V280, P33419, DOI 10.1074/jbc.M504263200; Kim KP, 2011, BMB REP, V44, P816, DOI 10.5483/BMBRep.2011.44.12.816; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; Kirschner M, 2000, PLANT J, V24, P397, DOI 10.1046/j.1365-313x.2000.00887.x; Kondrat Frances D L, 2015, Methods Mol Biol, V1261, P349, DOI 10.1007/978-1-4939-2230-7_18; Makley LN, 2015, SCIENCE, V350, P674, DOI 10.1126/science.aac9145; Mani N, 2016, SCI REP-UK, V6, DOI 10.1038/srep24019; Mchaourab HS, 2009, BIOCHEMISTRY-US, V48, P3828, DOI 10.1021/bi900212j; Mymrikov EV, 2011, PHYSIOL REV, V91, P1123, DOI 10.1152/physrev.00023.2010; Painter AJ, 2008, CHEM BIOL, V15, P246, DOI 10.1016/j.chembiol.2008.01.009; Patel S, 2014, BIOPHYS J, V106, P2644, DOI 10.1016/j.bpj.2014.04.048; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Plater ML, 1996, J BIOL CHEM, V271, P28558, DOI 10.1074/jbc.271.45.28558; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Santhanagopalan I., 2015, BIG BOOK SMALL HEAT, P119, DOI [10.1007/978-3-319-16077-1_5, DOI 10.1007/978-3-319-16077-1_5]; Shashidharamurthy R, 2005, J BIOL CHEM, V280, P5281, DOI 10.1074/jbc.M407236200; Shi J, 2013, J BIOL CHEM, V288, P4819, DOI 10.1074/jbc.M112.388132; Sobott F, 2002, J BIOL CHEM, V277, P38921, DOI 10.1074/jbc.M206060200; Stengel F, 2012, CHEM BIOL, V19, P599, DOI 10.1016/j.chembiol.2012.04.007; Stengel F, 2010, P NATL ACAD SCI USA, V107, P2007, DOI 10.1073/pnas.0910126107; Stromer T, 2003, J BIOL CHEM, V278, P18015, DOI 10.1074/jbc.M301640200; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Tiroli AO, 2007, INT J BIOCHEM CELL B, V39, P818, DOI 10.1016/j.biocel.2007.01.014; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Van Montfort R, 2002, ADV PROTEIN CHEM, V59, P105; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; Waters ER, 2013, J EXP BOT, V64, P391, DOI 10.1093/jxb/ers355; White HE, 2004, J MOL BIOL, V336, P453, DOI 10.1016/j.jmb.2003.12.015; White HE, 2006, STRUCTURE, V14, P1197, DOI 10.1016/j.str.2006.05.021; Zhang KM, 2015, SCI REP-UK, V5, DOI 10.1038/srep08811; Zhao L, 2015, NATURE, V523, P607, DOI 10.1038/nature14650	68	29	31	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19511	19521		10.1074/jbc.RA118.005421	http://dx.doi.org/10.1074/jbc.RA118.005421			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30348902	Green Published, hybrid, Green Accepted, Green Submitted			2022-12-28	WOS:000454294900001
J	Iwaoka, R; Kataoka, K				Iwaoka, Ryo; Kataoka, Kohsuke			RETRACTION: Withdrawal: Glucose regulates MafA transcription factor abundance and insulin gene expression by inhibiting AMP-activated protein kinase in pancreatic beta-cells (Retraction of Vol 293, Pg 3524, 2018)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Iwaoka R, 2018, J BIOL CHEM, V293, P3524, DOI 10.1074/jbc.M117.817932	1	0	0	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2018	293	47					18403	18403		10.1074/jbc.W118.006474	http://dx.doi.org/10.1074/jbc.W118.006474			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8XM	30470728	hybrid, Green Published			2022-12-28	WOS:000451375200032
J	Young, J; Duong, F				Young, John; Duong, Franck			Investigating the stability of the SecA-SecYEG complex during protein translocation across the bacterial membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein translocation; membrane transport; protein-protein interaction; protein dynamic; lipid-protein interaction; ATPase; Sec translocon	BINDING; CHANNEL; NUCLEOTIDE; MOVEMENT; ACTIVATE; DOMAIN; LIPIDS; SITE	During posttranslational translocation in Escherichia coli, polypeptide substrates are driven across the membrane through the SecYEG protein-conducting channel using the ATPase SecA, which binds to SecYEG and couples nucleotide hydrolysis to polypeptide movement. Recent studies suggest that SecA is a highly dynamic enzyme, able to repeatedly bind and dissociate from SecYEG during substrate translocation, but other studies indicate that these dynamics, here referred to as SecA processivity, are not a requirement for transport. We employ a SecA mutant (PrlD23) that associates more tightly to membranes than WT SecA, in addition to a SecA-SecYEG cross-linked complex, to demonstrate that SecA-SecYEG binding and dissociation events are important for efficient transport of the periplasmic protein proPhoA. Strikingly however, we find that transport of the precursor of the outer membrane protein proOmpA does not depend on SecA processivity. By exchanging signal sequence and protein domains of similar size between PhoA and OmpA, we find that SecA processivity is not influenced by the sequence of the protein substrate. In contrast, using an extended proOmpA variant and a truncated derivative of proPhoA, we show that SecA processivity is affected by substrate length. These findings underscore the importance of the dynamic nature of SecA-SecYEG interactions as a function of the preprotein substrate, features that have not yet been reported using other biophysical or in vivo methods.	[Young, John; Duong, Franck] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Duong, F (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada.	fduong@mail.ubc.ca		Duong Van Hoa, Franck/0000-0001-7328-6124; Young, John/0000-0003-3541-509X	Canadian Institutes of Health Research Grant [MOP 201309]	Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant MOP 201309. The authors declare that they have no conflicts of interest with the contents of this article.	Alami M, 2007, EMBO J, V26, P1995, DOI 10.1038/sj.emboj.7601661; Allen WJ, 2016, ELIFE, V5, DOI 10.7554/eLife.15598; Bariya P, 2019, J BACTERIOL, V201, DOI 10.1128/JB.00493-18; Bauer BW, 2014, CELL, V157, P1416, DOI 10.1016/j.cell.2014.03.063; Carlson ML, 2018, ELIFE, V7, DOI 10.7554/eLife.34085; Chatzi KE, 2017, J CELL BIOL, V216, P1357, DOI 10.1083/jcb.201609022; Chatzi KE, 2014, BBA-MOL CELL RES, V1843, P1466, DOI 10.1016/j.bbamcr.2014.02.014; Collinson I, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2015.0025; Crane Jennine M, 2017, EcoSal Plus, V7, DOI 10.1128/ecosalplus.ESP-0002-2017; Cranford-Smith T, 2018, FEMS MICROBIOL LETT, V365, DOI 10.1093/femsle/fny093; Dalal K, 2012, P NATL ACAD SCI USA, V109, P4104, DOI 10.1073/pnas.1117783109; Dalal K, 2009, EMBO REP, V10, P762, DOI 10.1038/embor.2009.87; Dalal K, 2009, J BIOL CHEM, V284, P7897, DOI 10.1074/jbc.M808305200; Ding HY, 2003, BIOCHEMISTRY-US, V42, P13468, DOI 10.1021/bi035099b; Duong F, 1998, EMBO J, V17, P696, DOI 10.1093/emboj/17.3.696; Duong F, 1997, EMBO J, V16, P4871, DOI 10.1093/emboj/16.16.4871; Duong F, 2003, EMBO J, V22, P4375, DOI 10.1093/emboj/cdg418; Erlandson KJ, 2008, J BIOL CHEM, V283, P15709, DOI 10.1074/jbc.M710356200; Fessl T, 2018, ELIFE, V7, DOI 10.7554/eLife.35112; Gold VAM, 2013, BIOCHEM J, V449, P695, DOI 10.1042/BJ20121314; Gouridis G, 2013, MOL CELL, V52, P655, DOI 10.1016/j.molcel.2013.10.036; Klock Heath E., 2009, V498, P91, DOI 10.1007/978-1-59745-196-3_6; Koch S, 2016, J BIOL CHEM, V291, P22534, DOI 10.1074/jbc.M116.743831; Mao CF, 2013, P NATL ACAD SCI USA, V110, P11815, DOI 10.1073/pnas.1303289110; Morita K, 2012, J BIOL CHEM, V287, P455, DOI 10.1074/jbc.M111.301754; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-102312, 10.1146/annurev-biophys-050511-402312]; Robson A, 2007, J MOL BIOL, V374, P965, DOI 10.1016/j.jmb.2007.09.086; Schmidt M, 2000, J BIOL CHEM, V275, P15440, DOI 10.1074/jbc.M000605200; Sugano Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183434; Tomkiewicz D, 2006, J BIOL CHEM, V281, P15709, DOI 10.1074/jbc.M600205200; Tsirigotaki A, 2018, STRUCTURE, V26, P695, DOI 10.1016/j.str.2018.03.006; Tsukazaki T, 2011, NATURE, V474, P235, DOI 10.1038/nature09980; Whitehouse S, 2012, J CELL BIOL, V199, P919, DOI 10.1083/jcb.201205191	33	8	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3577	3587		10.1074/jbc.RA118.006447	http://dx.doi.org/10.1074/jbc.RA118.006447			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30602566	Green Published, hybrid			2022-12-28	WOS:000461853900022
J	Egnatchik, RA; Leamy, AK; Sacco, SA; Cheah, YE; Shiota, M; Young, JD				Egnatchik, Robert A.; Leamy, Alexandra K.; Sacco, Sarah A.; Cheah, Yi Ern; Shiota, Masakazu; Young, Jamey D.			Glutamate-oxaloacetate transaminase activity promotes palmitate lipotoxicity in rat hepatocytes by enhancing anaplerosis and citric acid cycle flux	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lipotoxicity; hepatocyte; anaplerosis; glutamine; fatty acid; tricarboxylic acid cycle; TCA cycle; Krebs cycle; fatty liver disease; metabolic flux analysis	NONALCOHOLIC STEATOHEPATITIS; INSULIN-RESISTANCE; RESPIRATORY-CHAIN; OXIDATIVE STRESS; 1 PROTECTS; TCA CYCLE; LIVER; METABOLISM; GLUTAMINASE; ACTIVATION	Hepatocyte lipotoxicity is characterized by aberrant mitochondrial metabolism, which predisposes cells to oxidative stress and apoptosis. Previously, we reported that translocation of calcium from the endoplasmic reticulum to mitochondria of palmitate-treated hepatocytes activates anaplerotic flux from glutamine to -ketoglutarate (KG), which subsequently enters the citric acid cycle (CAC) for oxidation. We hypothesized that increased glutamine anaplerosis fuels elevations in CAC flux and oxidative stress following palmitate treatment. To test this hypothesis, primary rat hepatocytes or immortalized H4IIEC3 rat hepatoma cells were treated with lipotoxic levels of palmitate while modulating anaplerotic pathways leading to KG. We found that culture media supplemented with glutamine, glutamate, or dimethyl-KG increased palmitate lipotoxicity compared with media that lacked these anaplerotic substrates. Knockdown of glutamate-oxaloacetate transaminase activity significantly reduced the lipotoxic effects of palmitate, whereas knockdown of glutamate dehydrogenase (Glud1) had no effect on palmitate lipotoxicity. C-13 flux analysis of H4IIEC3 cells co-treated with palmitate and the pan-transaminase inhibitor aminooxyacetic acid confirmed that reductions in lipotoxic markers were associated with decreases in anaplerosis, CAC flux, and oxygen consumption. Taken together, these results demonstrate that lipotoxic palmitate treatments enhance anaplerosis in cultured rat hepatocytes, causing a shift to aberrant transaminase metabolism that fuels CAC dysregulation and oxidative stress.	[Egnatchik, Robert A.; Leamy, Alexandra K.; Sacco, Sarah A.; Cheah, Yi Ern; Young, Jamey D.] Vanderbilt Univ, Chem & Biomol Engn, Nashville, TN 37235 USA; [Shiota, Masakazu; Young, Jamey D.] Vanderbilt Univ, Mol Physiol & Biophys, Nashville, TN 37235 USA; [Leamy, Alexandra K.] Univ Cincinnati, Coll Med, Cincinnati, OH 45267 USA	Vanderbilt University; Vanderbilt University; University System of Ohio; University of Cincinnati	Young, JD (corresponding author), Vanderbilt Univ, Chem & Biomol Engn, Nashville, TN 37235 USA.	j.d.young@vanderbilt.edu		Sacco, Sarah/0000-0001-8256-7884	National Science Foundation CAREER Award [CBET-0955251]; NIDDK, National Institutes of Health [R01 DK106348, R01 DK060667]; NSF Graduate Research Fellowship Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404, R01DK106348] Funding Source: NIH RePORTER	National Science Foundation CAREER Award(National Science Foundation (NSF)); NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NSF Graduate Research Fellowship Program(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Science Foundation CAREER Award CBET-0955251 and NIDDK, National Institutes of Health Grant R01 DK106348 (to J. D. Y). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the NSF Graduate Research Fellowship Program.; Supported by NIDDK, National Institutes of Health Grant R01 DK060667.	Akagi S, 2016, FASEB J, V30, P2027, DOI 10.1096/fj.201500149; Antoniewicz MR, 2006, METAB ENG, V8, P324, DOI 10.1016/j.ymben.2006.01.004; Bode BP, 2001, J NUTR, V131, p2475S, DOI 10.1093/jn/131.9.2475S; Boulange CL, 2013, J PROTEOME RES, V12, P1956, DOI 10.1021/pr400051s; Brosnan ME, 2009, AM J CLIN NUTR, V90, p857S, DOI 10.3945/ajcn.2009.27462Z; Cheng SS, 2012, CIRCULATION, V125, P2222, DOI 10.1161/CIRCULATIONAHA.111.067827; Cheng XP, 2018, P NATL ACAD SCI USA, V115, pE4111, DOI 10.1073/pnas.1721403115; Cho CS, 2018, HEPATOLOGY, V68, P1331, DOI 10.1002/hep.29742; Contreras L, 2009, J BIOL CHEM, V284, P7091, DOI 10.1074/jbc.M808066200; Egnatchik RA, 2014, MOL METAB, V3, P544, DOI 10.1016/j.molmet.2014.05.004; Egnatchik RA, 2014, METABOLISM, V63, P283, DOI 10.1016/j.metabol.2013.10.009; Fernandez CA, 1996, J MASS SPECTROM, V31, P255, DOI 10.1002/(SICI)1096-9888(199603)31:3<255::AID-JMS290>3.0.CO;2-3; Gellerich FN, 2010, BBA-BIOENERGETICS, V1797, P1018, DOI 10.1016/j.bbabio.2010.02.005; Han SJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep37468; He L, 2016, NUTRIENTS, V8, DOI 10.3390/nu8040215; Holzer RG, 2011, CELL, V147, P173, DOI 10.1016/j.cell.2011.08.034; Li H, 2011, J PROTEOME RES, V10, P2797, DOI 10.1021/pr200047c; Li ZZ, 2009, J BIOL CHEM, V284, P5637, DOI 10.1074/jbc.M807616200; Listenberger LL, 2001, J BIOL CHEM, V276, P14890, DOI 10.1074/jbc.M010286200; MATSUNO T, 1992, CANCER RES, V52, P1192; Miller RA, 2018, NAT MED, V24, P518, DOI 10.1038/nm.4514; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Noguchi Y, 2009, J BIOL CHEM, V284, P33425, DOI 10.1074/jbc.M109.049478; Park HW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5834; Park HW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5233; Perez-Carreras M, 2003, HEPATOLOGY, V38, P999, DOI 10.1053/jhep.2003.50398; Puri P, 2007, HEPATOLOGY, V46, P1081, DOI 10.1002/hep.21763; Qi YF, 2015, J BIOL CHEM, V290, P23282, DOI 10.1074/jbc.M115.677542; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; Satapati S, 2015, J CLIN INVEST, V125, P4447, DOI 10.1172/JCI82204; Satapati S, 2012, J LIPID RES, V53, P1080, DOI 10.1194/jlr.M023382; Serviddio G, 2008, EUR J CLIN INVEST, V38, P245, DOI 10.1111/j.1365-2362.2008.01936.x; SHIOTA M, 1995, AM J PHYSIOL-ENDOC M, V268, pE1184, DOI 10.1152/ajpendo.1995.268.6.E1184; Soga T, 2011, J HEPATOL, V55, P896, DOI 10.1016/j.jhep.2011.01.031; Sookoian S, 2012, WORLD J GASTROENTERO, V18, P3775, DOI 10.3748/wjg.v18.i29.3775; Sunny NE, 2011, CELL METAB, V14, P804, DOI 10.1016/j.cmet.2011.11.004; Young JD, 2014, BIOINFORMATICS, V30, P1333, DOI 10.1093/bioinformatics/btu015; Zhao NQ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23141-8; Zhou Y, 2016, CLIN GASTROENTEROL H, V14, P1463, DOI 10.1016/j.cgh.2016.05.046	39	15	15	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2019	294	9					3081	3090		10.1074/jbc.RA118.004869	http://dx.doi.org/10.1074/jbc.RA118.004869			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU0SA	30563841	hybrid, Green Published			2022-12-28	WOS:000464980100009
J	Yang, AL; Fan, HT; Zhao, YA; Chen, XN; Zhu, ZX; Zha, XJ; Zhao, YF; Chai, XY; Li, J; Tu, PF; Hu, ZD				Yang, Ailin; Fan, Haitao; Zhao, Yanan; Chen, Xiaonan; Zhu, Zhixiang; Zha, Xiaojun; Zhao, Yunfang; Chai, Xingyun; Li, Jun; Tu, Pengfei; Hu, Zhongdong			An immune-stimulating proteoglycan from the medicinal mushroom Huaier up-regulates NF-kappa B and MAPK signaling via Toll-like receptor 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						anticancer drug; proteoglycan; Toll-like receptor 4 (TLR4); NF-kappaB; mitogen-activated protein kinase (MAPK); immunotherapy; cytokine response; Huaier; immunomodulation; TPG-1; trametes; anti-tumor; TPG-1	HEPATOCELLULAR-CARCINOMA GROWTH; 4-DEPENDENT ACTIVATION; NITRIC-OXIDE; LAMIN B1; POLYSACCHARIDE; MACROPHAGE; PATHWAYS; PROTEIN; INNATE; TNF	Trametes robiniophila Murr. (Huaier) is a mushroom with a long history of use as a medicinal ingredient in China and exhibits good clinical efficacy in cancer management. However, the antitumor components of Huaier and the underlying molecular mechanisms remain poorly understood. Here, we isolated a proteoglycan with a molecular mass of similar to 5.59 x 10(4) Da from Huaier aqueous extract. We named this proteoglycan TPG-1, and using FTIR and additional biochemical analyses, we determined that its total carbohydrate and protein compositions are 43.9 and 41.2%, respectively. Using biochemical assays and immunoblotting, we found that exposing murine RAW264.7 macrophages to TPG-1 promotes the production of nitric oxide (NO), tumor necrosis factor alpha (TNF alpha), and interleukin-6 (IL-6) through Toll-like receptor 4 (TLR4)-dependent activation of NF-kappa B and mitogen-activated protein kinase (MAPK) signaling. Of note, the TPG-1 treatment significantly inhibited the tumorigenesis of human hepatoma HepG2 cells likely at least in part by increasing serum levels of TNF alpha and promoting leukocyte infiltration into tumors in nude mice. TPG-1 also exhibited good antitumor activity in hepatoma H22-bearing mice and had no obvious adverse effects in these mice. We conclude that TPG-1 exerts antitumor activity partially through an immune-potentiating effect due to activation of the TLR4-NF-kappa B/MAPK signaling cassette. Therefore, TPG-1 may be a promising candidate drug for cancer immunotherapy. This study has identified the TPG-1 proteoglycan as an antitumor agent and provided insights into TPG-1's molecular mechanism, suggesting a potential utility for applying this agent in cancer therapy.	[Yang, Ailin; Zhao, Yanan; Chen, Xiaonan; Zhu, Zhixiang; Zhao, Yunfang; Chai, Xingyun; Li, Jun; Tu, Pengfei; Hu, Zhongdong] Beijing Univ Chinese Med, Sch Chinese Mat Med, Modern Res Ctr Tradit Chinese Med, 11 North Third Ring Rd, Beijing 100029, Peoples R China; [Fan, Haitao] Beijing Polytech, Coll Bioengn, Beijing 100029, Peoples R China; [Zha, Xiaojun] Anhui Med Univ, Sch Basic Med, Dept Biochem & Mol Biol, Hefei 230032, Anhui, Peoples R China	Beijing University of Chinese Medicine; Beijing Polytechnic; Anhui Medical University	Tu, PF; Hu, ZD (corresponding author), Beijing Univ Chinese Med, Sch Chinese Mat Med, Modern Res Ctr Tradit Chinese Med, 11 North Third Ring Rd, Beijing 100029, Peoples R China.	pengfeitu@163.com; zdhu@bucm.edu.cn	Li, Jun/M-9884-2016	Li, Jun/0000-0001-8243-5267	National Natural Science Foundation of China [81403147]; Fundamental Research Funds for the Central Universities [2015-JYB-XYQ-004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Natural Science Foundation of China Grant 81403147 and Fundamental Research Funds for the Central Universities Grant 2015-JYB-XYQ-004. The authors declare that they have no conflicts of interest with the contents of this article.	Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; AKIRA S, 1990, FASEB J, V4, P2860, DOI 10.1096/fasebj.4.11.2199284; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Aktan F, 2004, LIFE SCI, V75, P639, DOI 10.1016/j.lfs.2003.10.042; AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Bukata SV, 2004, J ORTHOP RES, V22, P6, DOI 10.1016/S0736-0266(03)00153-0; Chang HH, 2009, J AGR FOOD CHEM, V57, P6129, DOI 10.1021/jf9011399; Chen Q, 2018, GUT, V67, P2006, DOI 10.1136/gutjnl-2018-315983; Chen XM, 2014, CARBOHYD POLYM, V105, P113, DOI 10.1016/j.carbpol.2014.01.056; Eggermont AMM, 2003, LANCET ONCOL, V4, P429, DOI 10.1016/S1470-2045(03)01141-0; Fisher M, 2002, ANTICANCER RES, V22, P1737; Guzman G, 2005, MODERN PATHOL, V18, P1498, DOI 10.1038/modpathol.3800458; Hu ZD, 2016, SCI REP-UK, V6, DOI 10.1038/srep31298; Hu ZD, 2015, J BIOL CHEM, V290, P25756, DOI 10.1074/jbc.M115.665208; Jin FQ, 2017, HUM MOL GENET, V26, P407, DOI 10.1093/hmg/ddw397; Karnjanapratum S, 2011, INT J BIOL MACROMOL, V48, P311, DOI 10.1016/j.ijbiomac.2010.12.002; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; KROSL G, 1994, CANCER LETT, V84, P43, DOI 10.1016/0304-3835(94)90356-5; Lee KY, 2006, J ETHNOPHARMACOL, V103, P372, DOI 10.1016/j.jep.2005.08.037; Li C, 2015, TUMOR BIOL, V36, P1739, DOI 10.1007/s13277-014-2775-2; Li C, 2015, INT J BIOL MACROMOL, V75, P115, DOI 10.1016/j.ijbiomac.2015.01.016; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Long TT, 2018, INT J BIOL MACROMOL, V111, P813, DOI 10.1016/j.ijbiomac.2018.01.070; Lu HL, 2011, CLIN CANCER RES, V17, P67, DOI 10.1158/1078-0432.CCR-10-1763; Matsunaga N, 2011, MOL PHARMACOL, V79, P34, DOI 10.1124/mol.110.068064; Medeiros R, 2010, BEHAV BRAIN RES, V209, P165, DOI 10.1016/j.bbr.2010.01.040; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nakao S, 2002, MOL CELL BIOCHEM, V238, P11, DOI 10.1023/A:1019927616000; OLD LJ, 1985, SCIENCE, V230, P630, DOI 10.1126/science.2413547; Ooi VEC, 2000, CURR MED CHEM, V7, P715; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Song XJ, 2015, ONCOL REP, V34, P12, DOI 10.3892/or.2015.3950; STAUB A. M., 1965, METHOD CARBOHYD CHEM, V5, P5; Sun QA, 2011, P NATL ACAD SCI USA, V108, P4129, DOI 10.1073/pnas.1014769108; Sun Y, 2013, CARBOHYD POLYM, V92, P577, DOI 10.1016/j.carbpol.2012.09.006; Tan BKH, 2004, CURR MED CHEM, V11, P1423, DOI 10.2174/0929867043365161; TROWBRIDGE IS, 1994, ANNU REV IMMUNOL, V12, P85, DOI 10.1146/annurev.iy.12.040194.000505; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wei W, 2016, J ETHNOPHARMACOL, V179, P243, DOI 10.1016/j.jep.2015.12.060; Wink DA, 2011, J LEUKOCYTE BIOL, V89, P873, DOI 10.1189/jlb.1010550; Yang AL, 2018, ONCOL REP, V39, P3055, DOI 10.3892/or.2018.6358; Yoon YD, 2003, INT IMMUNOPHARMACOL, V3, P1873, DOI 10.1016/j.intimp.2003.09.005; Yu Q, 2014, FOOD CHEM TOXICOL, V66, P14, DOI 10.1016/j.fct.2014.01.018; Zhang CX, 2011, FOOD CHEM TOXICOL, V49, P2961, DOI 10.1016/j.fct.2011.07.044; Zhang GL, 2001, J CLIN INVEST, V107, P13, DOI 10.1172/JCI11837; Zheng JS, 2014, INT J BIOL MACROMOL, V64, P106, DOI 10.1016/j.ijbiomac.2013.11.034; Zhou LJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep44822; Zong AZ, 2012, CARBOHYD POLYM, V90, P1395, DOI 10.1016/j.carbpol.2012.07.026	54	23	28	3	57	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2628	2641		10.1074/jbc.RA118.005477	http://dx.doi.org/10.1074/jbc.RA118.005477			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30602571	Green Published, hybrid			2022-12-28	WOS:000459601600006
J	Hara, S; Kawasaki, S; Yoshihara, M; Winegarner, A; Busch, C; Tsujikawa, M; Nishida, K				Hara, Susumu; Kawasaki, Satoshi; Yoshihara, Masahito; Winegarner, Andrew; Busch, Caleb; Tsujikawa, Motokazu; Nishida, Kohji			Transcription factor TFAP2B up-regulates human corneal endothelial cell-specific genes during corneal development and maintenance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cornea; regenerative medicine; cell surface protein; collagen; differentiation; eye; gene regulation; molecular cell biology; corneal endothelial cells; neural crest; TFAP2B; ZP4; transcriptional regulation; development; eye development	CRANIAL NEURAL CREST; CAUSE CHAR-SYNDROME; IDENTIFICATION; EXPRESSION; COL8A2; MUTATIONS; AP-2-BETA; MARKERS; CANCER; FOXC1	The corneal endothelium, which originates from the neural crest via the periocular mesenchyme (PM), is crucial for maintaining corneal transparency. The development of corneal endothelial cells (CECs) from the neural crest is accompanied by the expression of several transcription factors, but the contribution of some of these transcriptional regulators to CEC development is incompletely understood. Here, we focused on activating enhancer-binding protein 2 (TFAP2, AP-2), a neural crest-expressed transcription factor. Using semiquantitative/quantitative RT-PCR and reporter gene and biochemical assays, we found that, within the AP-2 family, the TFAP2B gene is the only one expressed in human CECs in vivo and that its expression is strongly localized to the peripheral region of the corneal endothelium. Furthermore, the TFAP2B protein was expressed both in vivo and in cultured CECs. During mouse development, TFAP2B expression began in the PM at embryonic day 11.5 and then in CECs during adulthood. siRNA-mediated knockdown of TFAP2B in CECs decreased the expression of the corneal endothelium-specific proteins type VIII collagen alpha 2 (COL8A2) and zona pellucida glycoprotein 4 (ZP4) and suppressed cell proliferation. Of note, we also found that TFAP2B binds to the promoter of the COL8A2 and ZP4 genes. Furthermore, CECs that highly expressed ZP4 also highly expressed both TFAP2B and COL8A2 and showed high cell proliferation. These findings suggest that TFAP2B transcriptionally regulates CEC-specific genes and therefore may be an important transcriptional regulator of corneal endothelial development and homeostasis.	[Hara, Susumu] Osaka Univ, Dept Stem Cells & Appl Med, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan; [Hara, Susumu; Kawasaki, Satoshi; Winegarner, Andrew; Busch, Caleb; Tsujikawa, Motokazu; Nishida, Kohji] Osaka Univ, Dept Ophthalmol, Grad Sch Med, Suita, Osaka 5650871, Japan; [Tsujikawa, Motokazu] Osaka Univ, Div Hlth Sci, Grad Sch Med, Area Med Technol & Sci,Dept Biomed Informat, Suita, Osaka 5650871, Japan; [Yoshihara, Masahito] RIKEN, Ctr Life Sci Technol, Div Genom Technol, Yokohama, Kanagawa 2300045, Japan; [Yoshihara, Masahito] Karolinska Inst, Dept Biosci & Nutr, S-14183 Huddinge, Sweden	Osaka University; Osaka University; Osaka University; RIKEN; Karolinska Institutet	Hara, S (corresponding author), Osaka Univ, Dept Stem Cells & Appl Med, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.; Hara, S; Nishida, K (corresponding author), Osaka Univ, Dept Ophthalmol, Grad Sch Med, Suita, Osaka 5650871, Japan.	susumu.hara@ophthal.med.osaka-u.ac.jp; knishida@ophthal.med.osaka-u.ac.jp	Yoshihara, Masahito/C-3711-2017	Yoshihara, Masahito/0000-0002-8915-9282; Winegarner, Andrew/0000-0001-9211-0861; Hara, Susumu/0000-0003-3377-0418; Busch, Caleb/0000-0003-0536-7832	Japan Society for the Promotion of Science (JSPS) KAKENHI [15K20259, JP 17K169680]; Japan Eye Bank Association; Karolinska Institutet Research Foundation; Scandinavia-Japan Sasakawa Foundation; Astellas Foundation for Research on Metabolic Disorders; Healthcare New Frontier Policy, Kanagawa Prefecture, Japan	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Eye Bank Association; Karolinska Institutet Research Foundation(Karolinska Institutet); Scandinavia-Japan Sasakawa Foundation; Astellas Foundation for Research on Metabolic Disorders; Healthcare New Frontier Policy, Kanagawa Prefecture, Japan	This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grants 15K20259 and JP 17K169680. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Japan Eye Bank Association, the Karolinska Institutet Research Foundation, the Scandinavia-Japan Sasakawa Foundation, the Astellas Foundation for Research on Metabolic Disorders, and the Healthcare New Frontier Policy, Kanagawa Prefecture, Japan.	BAHN CF, 1984, OPHTHALMOLOGY, V91, P558; Bonanno JA, 2003, PROG RETIN EYE RES, V22, P69, DOI 10.1016/S1350-9462(02)00059-9; Chen LS, 2016, INVEST OPHTH VIS SCI, V57, P1072, DOI 10.1167/iovs.15-18103; Chen P, 2015, EXP THER MED, V9, P351, DOI 10.3892/etm.2014.2103; Chen YY, 2013, HUM MOL GENET, V22, P1271, DOI 10.1093/hmg/dds527; Cheong YK, 2013, INVEST OPHTH VIS SCI, V54, P4538, DOI 10.1167/iovs.13-11754; Chng ZZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067546; da Cunha JPC, 2009, P NATL ACAD SCI USA, V106, P16752, DOI 10.1073/pnas.0907939106; DelMonte DW, 2011, J CATARACT REFR SURG, V37, P588, DOI 10.1016/j.jcrs.2010.12.037; Eckert D, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-246; Fu LY, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-89; Gottsch JD, 2005, INVEST OPHTH VIS SCI, V46, P1934, DOI 10.1167/iovs.04-0937; Hara S, 2014, STEM CELLS DEV, V23, P2190, DOI 10.1089/scd.2013.0387; Hatou S, 2013, STEM CELLS DEV, V22, DOI 10.1089/scd.2012.0286; He ZG, 2012, STEM CELLS, V30, P2523, DOI 10.1002/stem.1212; Hirata-Tominaga K, 2013, STEM CELLS, V31, P1396, DOI 10.1002/stem.1390; Hjalt TA, 2000, DEV DYNAM, V218, P195, DOI 10.1002/(SICI)1097-0177(200005)218:1<195::AID-DVDY17>3.0.CO;2-C; Hopfer U, 2005, FASEB J, V19, P1232, DOI 10.1096/fj.04-3019com; Joyce NC, 2012, MOL VIS, V18, P547; Ju CQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042378; Lin JM, 2018, DEV BIOL, V441, P67, DOI 10.1016/j.ydbio.2018.06.007; Liu X, 2015, CELL CYCLE, V14, P1197, DOI 10.1080/15384101.2015.1013667; Martino VB, 2016, DIS MODEL MECH, V9, P849, DOI 10.1242/dmm.025262; McCabe KL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145266; Mok JW, 2009, EYE, V23, P895, DOI 10.1038/eye.2008.116; Moser M, 1997, DEV DYNAM, V208, P115, DOI 10.1002/(SICI)1097-0177(199701)208:1<115::AID-AJA11>3.0.CO;2-5; MURAGAKI Y, 1991, EUR J BIOCHEM, V197, P615, DOI 10.1111/j.1432-1033.1991.tb15951.x; Nelms B.L., 2010, TRANSCRIPTIONAL CONT; Raap M, 2018, LAB INVEST, V98, P117, DOI 10.1038/labinvest.2017.106; Santagati F, 2003, NAT REV NEUROSCI, V4, P806, DOI 10.1038/nrn1221; Satoda M, 2000, NAT GENET, V25, P42, DOI 10.1038/75578; Semina EV, 1996, NAT GENET, V14, P392, DOI 10.1038/ng1296-392; Smith RS, 2000, HUM MOL GENET, V9, P1021, DOI 10.1093/hmg/9.7.1021; Strungaru MH, 2007, INVEST OPHTH VIS SCI, V48, P228, DOI 10.1167/iovs.06-0472; Swamynathan SK, 2013, J OPHTHALMOL, V2013, DOI 10.1155/2013/103947; Woodfield GW, 2010, GENE CHROMOSOME CANC, V49, P948, DOI 10.1002/gcc.20807; Yokoo S, 2005, INVEST OPHTH VIS SCI, V46, P1626, DOI 10.1167/iovs.04-1263; Yoshihara M, 2017, EBIOMEDICINE, V25, P175, DOI 10.1016/j.ebiom.2017.10.024; Yoshihara M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117581; Zeng YX, 1997, NAT GENET, V15, P78, DOI 10.1038/ng0197-78; Zhang K, 2014, STEM CELLS DEV, V23, P1340, DOI 10.1089/scd.2013.0510; Zhao F, 2001, AM J HUM GENET, V69, P695, DOI 10.1086/323410	42	8	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2019	294	7					2460	2469		10.1074/jbc.RA118.005527	http://dx.doi.org/10.1074/jbc.RA118.005527			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL7CN	30552118	hybrid, Green Published			2022-12-28	WOS:000458895400022
J	Bitra, A; Doukov, T; Destito, G; Croft, M; Zajonc, DM				Bitra, Aruna; Doukov, Tzanko; Destito, Giuseppe; Croft, Michael; Zajonc, Dirk M.			Crystal structure of the m4-1BB/4-1BBL complex reveals an unusual dimeric ligand that undergoes structural changes upon 4-1BB receptor binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						tumor necrosis factor (TNF); protein-protein interaction; protein structure; cell surface receptor; X-ray crystallography; 4-1BB; 4-1BB ligand; CD137; CD137L; TNFRSF9; immune cell	TNF; MEMBERS; UNIQUE; CELLS; ACTIVATION; PROGRAM; FAMILY; GITR	The interaction between the receptor 4-1BB and its ligand 4-1BBL provides co-stimulatory signals for T-cell activation and proliferation. However, differences in the mouse and human molecules might result in differential engagement of this pathway. Here, we report the crystal structure of mouse 4-1BBL and of the mouse 4-1BB/4-1BBL complex, which together provided insights into the molecular mechanism by which m4-1BBL and its cognate receptor recognize each other. Unlike all human or mouse tumor necrosis factor ligands that form noncovalent and mostly trimeric assemblies, the m4-1BBL structure formed a disulfide-linked dimeric assembly. The structure disclosed that certain differences in the amino acid composition along the intramolecular interface, together with two specific residues (Cys-246 and Ser-256) present exclusively in m4-1BBL, are responsible for this unique dimerization. Unexpectedly, upon m4-1BB binding, m4-1BBL undergoes structural changes within each protomer; moreover, the individual m4-1BBL protomers rotate relative to each other, yielding a dimerization interface with more inter-subunit interactions. We also observed that in the m4-1BB/4-1BBL complex, each receptor monomer binds exclusively to a single ligand subunit with contributions of cysteine-rich domain 1 (CRD1), CRD2, and CRD3. Furthermore, structure-guided mutagenesis of the binding interface revealed that novel binding interactions with the GH loop, rather than the DE loop, are energetically critical and define the m4-1BB receptor selectivity for m4-1BBL. A comparison with the human 4-1BB/4-1BBL complex highlighted several differences between the ligand- and receptor-binding interfaces, providing an explanation for the absence of inter-species cross-reactivity between human and mouse 4-1BB and 4-1BBL molecules.	[Bitra, Aruna; Croft, Michael; Zajonc, Dirk M.] La Jolla Inst Immunol LJI, Div Immune Regulat, La Jolla, CA 92037 USA; [Doukov, Tzanko] Stanford Synchrotron Radiat Lightsource, SLAC, Menlo Pk, CA 94025 USA; [Destito, Giuseppe] Kirin Kyowa Hakko Pharmaceut Res, La Jolla, CA 92037 USA; [Croft, Michael] Univ Calif San Diego, Dept Med, La Jolla, CA 92037 USA; [Zajonc, Dirk M.] Univ Ghent, Fac Med & Hlth Sci, Dept Internal Med, B-9000 Ghent, Belgium	La Jolla Institute for Immunology; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; University of California System; University of California San Diego; Ghent University	Zajonc, DM (corresponding author), La Jolla Inst Immunol, Div Immune Regulat, 9420 Athena Circle, La Jolla, CA 92037 USA.	dzajonc@lji.org		Bitra, Aruna/0000-0003-1675-3544; Zajonc, Dirk/0000-0001-7215-1981; Doukov, Tzanko/0000-0001-8625-2572	National Institutes of Health NIAID [AI110929]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER	National Institutes of Health NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health NIAID Grant AI110929 (to M.C. and D.M.Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	An HJ, 2011, J BIOL CHEM, V286, P11226, DOI 10.1074/jbc.M110.208215; Arch RH, 1998, MOL CELL BIOL, V18, P558, DOI 10.1128/MCB.18.1.558; Bitra A, 2018, J BIOL CHEM, V293, P9958, DOI 10.1074/jbc.RA118.003176; Bitra A, 2018, J BIOL CHEM, V293, P1317, DOI 10.1074/jbc.M117.814905; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Bricogne G., 2017, BUSTER; Cha SS, 2000, J BIOL CHEM, V275, P31171, DOI 10.1074/jbc.M004414200; Chattopadhyay K, 2008, P NATL ACAD SCI USA, V105, P635, DOI 10.1073/pnas.0710529105; Chattopadhyay K, 2007, P NATL ACAD SCI USA, V104, P19452, DOI 10.1073/pnas.0709264104; Chattopadhyay K, 2009, IMMUNOL REV, V229, P356, DOI 10.1111/j.1600-065X.2009.00778.x; Compaan DM, 2006, STRUCTURE, V14, P1321, DOI 10.1016/j.str.2006.06.015; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eun SY, 2015, J IMMUNOL, V194, P134, DOI 10.4049/jimmunol.1401383; Gilbreth RN, 2018, J BIOL CHEM, V293, P9880, DOI 10.1074/jbc.RA118.002803; Hymowitz SG, 1999, MOL CELL, V4, P563, DOI 10.1016/S1097-2765(00)80207-5; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Langstein J, 1998, J IMMUNOL, V160, P2488; Lee SW, 2009, ADV EXP MED BIOL, V647, P120, DOI 10.1007/978-0-387-89520-8_8; Lippert U, 2008, EUR J IMMUNOL, V38, P1024, DOI [10.1002/eji.200737800, 10.1002/eji.200890024]; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Luan XD, 2012, J IMMUNOL, V189, P245, DOI 10.4049/jimmunol.1103387; Madireddi S, 2014, J EXP MED, V211, P1425, DOI 10.1084/jem.20132687; Melero I, 1997, NAT MED, V3, P682, DOI 10.1038/nm0697-682; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Naismith JH, 1998, TRENDS BIOCHEM SCI, V23, P74, DOI 10.1016/S0968-0004(97)01164-X; POLLOK KE, 1994, EUR J IMMUNOL, V24, P367, DOI 10.1002/eji.1830240215; POLLOK KE, 1993, J IMMUNOL, V150, P771; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Rossmann MG, 2001, ACTA CRYSTALLOGR D, V57, P1360, DOI 10.1107/S0907444901009386; Sanchez-Paulete AR, 2016, EUR J IMMUNOL, V46, P513, DOI 10.1002/eji.201445388; Snell LM, 2011, IMMUNOL REV, V244, P197, DOI 10.1111/j.1600-065X.2011.01063.x; Tang QQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016129; Tickle I.J., 2018, STARANISO; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vinay DS, 1998, SEMIN IMMUNOL, V10, P481, DOI 10.1006/smim.1998.0157; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Watts AD, 1999, EMBO J, V18, P2119, DOI 10.1093/emboj/18.8.2119; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Won EY, 2010, J BIOL CHEM, V285, P9202, DOI 10.1074/jbc.M109.084442; Yi L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086337; Zhou ZC, 2008, P NATL ACAD SCI USA, V105, P641, DOI 10.1073/pnas.0711206105	44	10	11	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2019	294	6					1831	1845		10.1074/jbc.RA118.006297	http://dx.doi.org/10.1074/jbc.RA118.006297			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM8EO	30545939	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000459711400006
J	Stein, KC; Frydman, J				Stein, Kevin C.; Frydman, Judith			The stop-and-go traffic regulating protein biogenesis: How translation kinetics controls proteostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						chaperone; translation; protein folding; protein misfolding; ribosome function; cotranslational folding; elongation rate; nascent chain; translational fidelity	OPTIMAL CODONS ASSOCIATE; E3 UBIQUITIN LIGASE; QUALITY-CONTROL; MESSENGER-RNA; SYNONYMOUS MUTATIONS; STRUCTURAL BASIS; IN-VIVO; RIBOSOME; ELONGATION; USAGE	Generating a functional proteome requires the ribosome to carefully regulate disparate co-translational processes that determine the fate of nascent polypeptides. With protein synthesis being energetically expensive, the ribosome must balance the costs of efficiently making a protein with those of properly folding it. Emerging as a primary means of regulating this trade-off is the nonuniform rate of translation elongation that defines translation kinetics. The varying speeds with which the ribosome progresses along a transcript have been implicated in several aspects of protein biogenesis, including co-translational protein folding and translational fidelity, as well as gene expression by mediating mRNA decay and protein quality control pathways. The optimal translation kinetics required to efficiently execute these processes can be distinct. Thus, the ribosome is tasked with tightly regulating translation kinetics to balance these processes while maintaining adaptability for changing cellular conditions. In this review, we first discuss the regulatory role of translation elongation in protein biogenesis and what factors influence elongation kinetics. We then describe how changes in translation kinetics signal downstream pathways that dictate the fate of nascent polypeptides. By regulating these pathways, the kinetics of translation elongation has emerged as a critical tool for driving gene expression and maintaining proteostasis through varied mechanisms, including nascent chain folding and binding different ribosome-associated machinery. Indeed, a growing number of examples demonstrate the important role of local changes in elongation kinetics in modulating the pathophysiology of human disease.	[Stein, Kevin C.; Frydman, Judith] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Frydman, Judith] Stanford Univ, Dept Genet, Stanford, CA 94305 USA	Stanford University; Stanford University	Frydman, J (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.; Frydman, J (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	jfrydman@stanford.edu		, judith/0000-0003-2302-6943	National Institutes of Health [AG047126, GM056433]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM056433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG047126] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants AG047126 (to K. C. S.) and GM056433 (to J. F.). This is the first article in the JBC Reviews series "Molecular chaperones and protein quality control." The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Arribere JA, 2016, NATURE, V534, P719, DOI 10.1038/nature18308; Arthur LL, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14112; Bengtson MH, 2010, NATURE, V467, P470, DOI 10.1038/nature09371; Brandman O, 2016, NAT STRUCT MOL BIOL, V23, P7, DOI 10.1038/nsmb.3147; Brandman O, 2012, CELL, V151, P1042, DOI 10.1016/j.cell.2012.10.044; Brule CE, 2017, TRENDS GENET, V33, P283, DOI 10.1016/j.tig.2017.02.001; Buhr F, 2016, MOL CELL, V61, P341, DOI 10.1016/j.molcel.2016.01.008; Cabrita LD, 2016, NAT STRUCT MOL BIOL, V23, P278, DOI 10.1038/nsmb.3182; Chaney JL, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005531; Chaney JL, 2015, ANNU REV BIOPHYS, V44, P143, DOI 10.1146/annurev-biophys-060414-034333; Chartron JW, 2016, NATURE, V536, P224, DOI 10.1038/nature19309; Chiabudini M, 2014, MOL CELL BIOL, V34, P4062, DOI 10.1128/MCB.00799-14; Chiti F, 2017, ANNU REV BIOCHEM, V86, P27, DOI 10.1146/annurev-biochem-061516-045115; Choe YJ, 2016, NATURE, V531, P191, DOI 10.1038/nature16973; Choi J, 2018, ANNU REV BIOCHEM, V87, P421, DOI 10.1146/annurev-biochem-060815-014818; Chu D, 2014, EMBO J, V33, P21, DOI 10.1002/embj.201385651; Chu J, 2009, P NATL ACAD SCI USA, V106, P2097, DOI 10.1073/pnas.0812819106; Cymer F, 2013, P NATL ACAD SCI USA, V110, P14640, DOI 10.1073/pnas.1306787110; Dana A, 2014, NUCLEIC ACIDS RES, V42, P9171, DOI 10.1093/nar/gku646; Dimitrova LN, 2009, J BIOL CHEM, V284, P10343, DOI 10.1074/jbc.M808840200; Doerfel LK, 2013, SCIENCE, V339, P85, DOI 10.1126/science.1229017; Doring K, 2017, CELL, V170, P298, DOI 10.1016/j.cell.2017.06.038; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Duncan CDS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002398; Fedyunin I, 2012, FEBS LETT, V586, P3336, DOI 10.1016/j.febslet.2012.07.012; Fluitt A, 2007, COMPUT BIOL CHEM, V31, P335, DOI 10.1016/j.compbiolchem.2007.07.003; Frydman J, 1999, NAT STRUCT BIOL, V6, P697, DOI 10.1038/10754; FRYDMAN J, 1994, NATURE, V370, P111, DOI 10.1038/370111a0; Gamble CE, 2016, CELL, V166, P679, DOI 10.1016/j.cell.2016.05.070; Gardin J, 2014, ELIFE, V3, DOI 10.7554/eLife.03735; Geller R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04203-x; Gerashchenko MV, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku671; Gingold H, 2014, CELL, V158, P1281, DOI 10.1016/j.cell.2014.08.011; Gingold H, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.14; Goldman DH, 2015, SCIENCE, V348, P457, DOI 10.1126/science.1261909; Goodarzi H, 2016, CELL, V165, P1416, DOI 10.1016/j.cell.2016.05.046; Gutierrez E, 2013, MOL CELL, V51, P35, DOI 10.1016/j.molcel.2013.04.021; Hanson G, 2018, RNA, V24, P1377, DOI 10.1261/rna.066787.118; Hanson G, 2018, NAT REV MOL CELL BIO, V19, P20, DOI 10.1038/nrm.2017.91; Holtkamp W, 2015, SCIENCE, V350, P1104, DOI 10.1126/science.aad0344; Hunt RC, 2014, TRENDS GENET, V30, P308, DOI 10.1016/j.tig.2014.04.006; Hussmann JA, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005732; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Ishimura R, 2014, SCIENCE, V345, P455, DOI 10.1126/science.1249749; Joazeiro CAP, 2017, ANNU REV CELL DEV BI, V33, P343, DOI 10.1146/annurev-cellbio-111315-125249; Juszkiewicz S, 2018, MOL CELL, V72, P469, DOI 10.1016/j.molcel.2018.08.037; Juszkiewicz S, 2017, MOL CELL, V65, P743, DOI 10.1016/j.molcel.2016.11.039; Kaiser CM, 2018, J MOL BIOL, V430, P4580, DOI 10.1016/j.jmb.2018.06.050; Kaiser CM, 2011, SCIENCE, V334, P1723, DOI 10.1126/science.1209740; Keedy HE, 2018, P NATL ACAD SCI USA, V115, pE6731, DOI 10.1073/pnas.1721431115; Kim SJ, 2015, SCIENCE, V348, P444, DOI 10.1126/science.aaa3974; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kirchner S, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2000779; Komar AA, 2016, HUM MOL GENET, V25, pR77, DOI 10.1093/hmg/ddw207; Komar AA, 2009, TRENDS BIOCHEM SCI, V34, P16, DOI 10.1016/j.tibs.2008.10.002; Kosolapov A, 2009, NAT STRUCT MOL BIOL, V16, P405, DOI 10.1038/nsmb.1571; Kramer EB, 2010, RNA, V16, P1797, DOI 10.1261/rna.2201210; Kramer G, 2009, NAT STRUCT MOL BIOL, V16, P589, DOI 10.1038/nsmb.1614; Lee Y, 2010, PROTEOMICS, V10, P4163, DOI 10.1002/pmic.201000229; Letzring DP, 2013, RNA, V19, P1208, DOI 10.1261/rna.039446.113; Letzring DP, 2010, RNA, V16, P2516, DOI 10.1261/rna.2411710; Liu BT, 2013, MOL CELL, V49, P453, DOI 10.1016/j.molcel.2012.12.001; Lu JL, 2008, J MOL BIOL, V384, P73, DOI 10.1016/j.jmb.2008.08.089; Lu JL, 2005, NAT STRUCT MOL BIOL, V12, P1123, DOI 10.1038/nsmb1021; Lyumkis D, 2014, P NATL ACAD SCI USA, V111, P15981, DOI 10.1073/pnas.1413882111; Man O, 2007, NAT GENET, V39, P415, DOI 10.1038/ng1967; Marino J, 2016, FEBS LETT, V590, P655, DOI 10.1002/1873-3468.12098; Matsuo Y, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00188-1; Nedialkova DD, 2015, CELL, V161, P1606, DOI 10.1016/j.cell.2015.05.022; Netzer WJ, 1997, NATURE, V388, P343, DOI 10.1038/41024; Nilsson OB, 2015, CELL REP, V12, P1533, DOI 10.1016/j.celrep.2015.07.065; O'Brien EP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1850; Pechmann S, 2014, NAT STRUCT MOL BIOL, V21, P1100, DOI 10.1038/nsmb.2919; Pechmann S, 2013, MOL CELL, V49, P411, DOI 10.1016/j.molcel.2013.01.020; Pechmann S, 2013, NAT STRUCT MOL BIOL, V20, P237, DOI 10.1038/nsmb.2466; Preissler S, 2012, TRENDS BIOCHEM SCI, V37, P274, DOI 10.1016/j.tibs.2012.03.002; Presnyak V, 2015, CELL, V160, P1111, DOI 10.1016/j.cell.2015.02.029; Radhakrishnan A, 2016, CELL, V167, P122, DOI 10.1016/j.cell.2016.08.053; Richter JD, 2015, CELL, V163, P292, DOI 10.1016/j.cell.2015.09.041; Rodnina MV, 2016, PROTEIN SCI, V25, P1390, DOI 10.1002/pro.2950; Sabi R, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S10-S5; Sagi D, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006264; Sander IM, 2014, J AM CHEM SOC, V136, P858, DOI 10.1021/ja411302m; Schibich D, 2016, NATURE, V536, P219, DOI 10.1038/nature19070; Schuller AP, 2018, NAT REV MOL CELL BIO, V19, P526, DOI 10.1038/s41580-018-0011-4; Schuller AP, 2017, MOL CELL, V66, P194, DOI 10.1016/j.molcel.2017.03.003; Shalgi R, 2013, MOL CELL, V49, P439, DOI 10.1016/j.molcel.2012.11.028; Shao SC, 2015, MOL CELL, V57, P433, DOI 10.1016/j.molcel.2014.12.015; Shao S, 2013, MOL CELL, V50, P637, DOI 10.1016/j.molcel.2013.04.015; Shen PS, 2015, SCIENCE, V347, P75, DOI 10.1126/science.1259724; Shiber A, 2018, NATURE, V561, P268, DOI 10.1038/s41586-018-0462-y; Shoemaker CJ, 2012, NAT STRUCT MOL BIOL, V19, P594, DOI 10.1038/nsmb.2301; Simms CL, 2017, MOL CELL, V68, P361, DOI 10.1016/j.molcel.2017.08.019; Spencer PS, 2012, J MOL BIOL, V422, P328, DOI 10.1016/j.jmb.2012.06.010; Stadler M, 2011, RNA, V17, P2063, DOI 10.1261/rna.02890211; Sundaramoorthy E, 2017, MOL CELL, V65, P751, DOI 10.1016/j.molcel.2016.12.026; Supek F, 2014, CELL, V156, P1324, DOI 10.1016/j.cell.2014.01.051; Thommen M, 2017, CURR OPIN STRUC BIOL, V42, P83, DOI 10.1016/j.sbi.2016.11.020; Tsai CJ, 2008, J MOL BIOL, V383, P281, DOI 10.1016/j.jmb.2008.08.012; Tsuboi T, 2012, MOL CELL, V46, P518, DOI 10.1016/j.molcel.2012.03.013; Tuller T, 2010, CELL, V141, P344, DOI 10.1016/j.cell.2010.03.031; Warnecke T, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2009.94; Weinberg DE, 2016, CELL REP, V14, P1787, DOI 10.1016/j.celrep.2016.01.043; Wilson DN, 2016, CURR OPIN STRUC BIOL, V37, P123, DOI 10.1016/j.sbi.2016.01.008; Wohlgemuth I, 2008, J BIOL CHEM, V283, P32229, DOI 10.1074/jbc.M805316200; Wolf AS, 2015, RNA, V21, P935, DOI 10.1261/rna.049080.114; Woolstenhulme CJ, 2015, CELL REP, V11, P13, DOI 10.1016/j.celrep.2015.03.014; Yona AH, 2013, ELIFE, V2, DOI 10.7554/eLife.01339; Yonashiro R, 2016, ELIFE, V5, DOI 10.7554/eLife.11794; Yu CH, 2015, MOL CELL, V59, P744, DOI 10.1016/j.molcel.2015.07.018; Zaher HS, 2009, CELL, V136, P746, DOI 10.1016/j.cell.2009.01.036; Zhang G, 2009, NAT STRUCT MOL BIOL, V16, P274, DOI 10.1038/nsmb.1554; Zhou M, 2013, NATURE, V495, P111, DOI 10.1038/nature11833; Zhou T, 2009, MOL BIOL EVOL, V26, P1571, DOI 10.1093/molbev/msp070	117	61	62	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2019	294	6					2076	2084		10.1074/jbc.REV118.002814	http://dx.doi.org/10.1074/jbc.REV118.002814			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM8EO	30504455	Green Published, hybrid			2022-12-28	WOS:000459711400026
J	Naim, N; White, AD; Reece, JM; Wankhede, M; Zhang, XF; Vilardaga, JP; Altschuler, DL				Naim, Nyla; White, Alex D.; Reece, Jeff M.; Wankhede, Mamta; Zhang, Xuefeng; Vilardaga, Jean-Pierre; Altschuler, Daniel L.			Luminescence-activated nucleotide cyclase regulates spatial and temporal cAMP synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyclic AMP (cAMP); bioluminescence; optogenetics; fluorescence resonance energy transfer (FRET); signaling; second messenger; cell proliferation; thyroid; bPAC; compartmentalization; microdomains; nano-luciferase	PHOTOACTIVATED ADENYLYL-CYCLASE; THYROID-CELL PROLIFERATION; CYCLIC-AMP; CONSTITUTIVE ACTIVATION; ADENOSINE-MONOPHOSPHATE; PHOTO-DYNAMICS; RECEPTOR GENE; G-PROTEIN; IN-VITRO; PKA	cAMP is a ubiquitous second messenger that regulates cellular proliferation, differentiation, attachment, migration, and several other processes. It has become increasingly evident that tight regulation of cAMP accumulation and localization confers divergent yet specific signaling to downstream pathways. Currently, few tools are available that have sufficient spatial and temporal resolution to study location-biased cAMP signaling. Here, we introduce a new fusion protein consisting of a light-activated adenylyl cyclase (bPAC) and luciferase (nLuc). This construct allows dual activation of cAMP production through temporally precise photostimulation or chronic chemical stimulation that can be fine-tuned to mimic physiological levels and duration of cAMP synthesis to trigger downstream events. By targeting this construct to different compartments, we show that cAMP produced in the cytosol and nucleus stimulates proliferation in thyroid cells. The bPAC-nLuc fusion construct adds a new reagent to the available toolkit to study cAMP-regulated processes in living cells.	[Naim, Nyla; White, Alex D.; Reece, Jeff M.; Wankhede, Mamta; Zhang, Xuefeng; Vilardaga, Jean-Pierre; Altschuler, Daniel L.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Naim, Nyla; White, Alex D.] Univ Pittsburgh, Mol Pharmacol Training Program, Pittsburgh, PA 15261 USA; [Naim, Nyla] Univ Vermont, Coll Med, Dept Pharmacol, Burlington, VT 05405 USA; [Reece, Jeff M.] NIDDK, ALMIAC, NIH, Bethesda, MD 20814 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Vermont; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Altschuler, DL (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, W1346 Biomed Sci Tower,200 Lothrop St, Pittsburgh, PA 15261 USA.	altschul@pitt.edu		Vilardaga, Jean-Pierre/0000-0002-1217-1435	National Institutes of Health NIDDK grant; National Institutes of Health NIGMS grant; Molecular Pharmacology Training Program of the University of Pittsburgh under National Institutes of Health Awards [R01-GM09975, R01-DK102495, R01-DK111427, R01-DK116780]; National Institutes of Health [T32-GM008424, T32-GM00842419, T32-GM00842420, T32-GM00842421]; Winstar Morris' Cotswold Foundation Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK111427, R01DK116780, R01DK102495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008424, R01GM130612] Funding Source: NIH RePORTER	National Institutes of Health NIDDK grant; National Institutes of Health NIGMS grant; Molecular Pharmacology Training Program of the University of Pittsburgh under National Institutes of Health Awards; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Winstar Morris' Cotswold Foundation Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health NIDDK and NIGMS grants and the Molecular Pharmacology Training Program of the University of Pittsburgh under National Institutes of Health Awards R01-GM09975 (to D. L. A), R01-DK102495, R01-DK111427, and R01-DK116780 (to J. P. V.), National Institutes of Health Training Grants T32-GM008424 (to A. D. W.) and T32-GM00842419,20,21, and a Winstar Morris' Cotswold Foundation Fellowship (to N. N.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agarwal SR, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00332; Agarwal SR, 2017, BRIT J PHARMACOL, V174, P2784, DOI 10.1111/bph.13904; Agarwal SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095835; BAPTIST M, 1993, J CELL SCI, V105, P69; Berdeaux R, 2012, AM J PHYSIOL-ENDOC M, V303, pE1, DOI 10.1152/ajpendo.00555.2011; Berglund K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059759; Bindels DS, 2017, NAT METHODS, V14, P53, DOI [10.1038/NMETH.4074, 10.1038/nmeth.4074]; Boot AM, 2011, J CLIN ENDOCR METAB, V96, pE1197, DOI 10.1210/jc.2010-3031; BROOKER G, 1973, SCIENCE, V182, P933, DOI 10.1126/science.182.4115.933; Calebiro D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000172; Cui W, 2007, LEARN MEMORY, V14, P126, DOI 10.1101/lm.496007; Depry C, 2011, MOL BIOSYST, V7, P52, DOI 10.1039/c0mb00079e; DiPilato LM, 2004, P NATL ACAD SCI USA, V101, P16513, DOI 10.1073/pnas.0405973101; Dowlatshahi D, 1998, LANCET, V352, P1754, DOI 10.1016/S0140-6736(05)79827-5; DUMONT JE, 1992, PHYSIOL REV, V72, P667, DOI 10.1152/physrev.1992.72.3.667; Dwivedi Yogesh, 2008, Neuropsychiatr Dis Treat, V4, P161; Dyachok O, 2006, NATURE, V439, P349, DOI 10.1038/nature04410; Efetova M, 2013, J CELL SCI, V126, P778, DOI 10.1242/jcs.114140; Fajardo AM, 2014, CANCERS, V6, P436, DOI 10.3390/cancers6010436; Feinstein TN, 2011, NAT CHEM BIOL, V7, P278, DOI 10.1038/nchembio.545; Feinstein WP, 2012, AM J PHYSIOL-CELL PH, V302, pC839, DOI 10.1152/ajpcell.00361.2011; Ferrandon S, 2009, NAT CHEM BIOL, V5, P734, DOI 10.1038/nchembio.206; FUSCO A, 1987, MOL CELL BIOL, V7, P3365, DOI 10.1128/MCB.7.9.3365; Gasser C, 2014, P NATL ACAD SCI USA, V111, P8803, DOI 10.1073/pnas.1321600111; Gorshkov K, 2017, NAT CHEM BIOL, V13, P425, DOI 10.1038/nchembio.2298; HAISENLEDER DJ, 1992, ENDOCRINOLOGY, V131, P3027, DOI 10.1210/en.131.6.3027; Hall MP, 2012, ACS CHEM BIOL, V7, P1848, DOI 10.1021/cb3002478; Hochbaum D, 2008, J BIOL CHEM, V283, P4464, DOI 10.1074/jbc.C700171200; Hochbaum D, 2011, J BIOL CHEM, V286, P859, DOI 10.1074/jbc.M110.163816; Inda C, 2016, J CELL BIOL, V214, P181, DOI 10.1083/jcb.201512075; INSEL PA, 1976, MOL PHARMACOL, V12, P1062; Jansen V, 2015, ELIFE, V4, DOI 10.7554/eLife.05161; Jiang JY, 2017, CELL CALCIUM, V64, P47, DOI 10.1016/j.ceca.2017.02.010; Kapiloff MS, 2014, J GEN PHYSIOL, V143, P9, DOI 10.1085/jgp.201311020; Kimura T, 2001, ENDOCR REV, V22, P631, DOI 10.1210/er.22.5.631; Klarenbeek J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122513; Koschinski A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13021-y; KOSUGI S, 1994, FEBS LETT, V356, P291, DOI 10.1016/0014-5793(94)01286-5; Kuna RS, 2013, AM J PHYSIOL-ENDOC M, V305, pE161, DOI 10.1152/ajpendo.00551.2012; Le Gall S, 2004, MOL BIOL CELL, V15, P447, DOI 10.1091/mbc.E03-05-0325; Lohse C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174856; Merriam LA, 2013, J NEUROSCI, V33, P4614, DOI 10.1523/JNEUROSCI.4999-12.2013; Miller RA, 2013, NATURE, V494, P256, DOI 10.1038/nature11808; Min KS, 1998, J BIOL CHEM, V273, P34911, DOI 10.1074/jbc.273.52.34911; Neves SR, 2009, J BIOL CHEM, V284, P5445, DOI 10.1074/jbc.R800058200; Nicol X, 2007, NAT NEUROSCI, V10, P340, DOI 10.1038/nn1842; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; PARMA J, 1993, NATURE, V365, P649, DOI 10.1038/365649a0; Pavlos NJ, 2017, TRENDS ENDOCRIN MET, V28, P213, DOI 10.1016/j.tem.2016.10.007; Penzkofer A, 2011, CHEM PHYS, V387, P25, DOI 10.1016/j.chemphys.2011.05.028; Penzkofer A, 2015, J PHOTOCH PHOTOBIO B, V153, P90, DOI 10.1016/j.jphotobiol.2015.08.027; Perera RK, 2013, ACTA PHYSIOL, V207, P650, DOI 10.1111/apha.12077; Persani L, 2000, J CLIN ENDOCR METAB, V85, P2872, DOI 10.1210/jc.85.8.2872; Rich TC, 2001, P NATL ACAD SCI USA, V98, P13049, DOI 10.1073/pnas.221381398; ROSS EM, 1978, J BIOL CHEM, V253, P6401; Ryu MH, 2014, P NATL ACAD SCI USA, V111, P10167, DOI 10.1073/pnas.1324301111; Sample V, 2012, NAT CHEM BIOL, V8, P375, DOI [10.1038/NCHEMBIO.799, 10.1038/nchembio.799]; Saucerman JJ, 2006, P NATL ACAD SCI USA, V103, P12923, DOI 10.1073/pnas.0600137103; Sayner SL, 2006, CIRC RES, V98, P675, DOI 10.1161/01.RES.0000209516.84815.3e; Scheib U, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04428-w; Schroder-Lang S, 2007, NAT METHODS, V4, P39, DOI 10.1038/NMETH975; Shipunova VO, 2018, RUSS J BIOORG CHEM+, V44, P225, DOI 10.1134/S1068162018020085; Stacer AC, 2013, MOL IMAGING, V12, DOI 10.2310/7290.2013.00062; Stierl M, 2011, J BIOL CHEM, V286, P1181, DOI 10.1074/jbc.M110.185496; Surdo NC, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15031; SUTHERLAND EW, 1958, J BIOL CHEM, V232, P1077; Terrin A, 2006, J CELL BIOL, V175, P441, DOI 10.1083/jcb.200605050; Tian G, 2012, J CELL SCI, V125, P5084, DOI 10.1242/jcs.107201; Timney BL, 2016, J CELL BIOL, V215, P57, DOI 10.1083/jcb.201601004; Tsvetanova NG, 2014, NAT CHEM BIOL, V10, P1061, DOI 10.1038/nchembio.1665; Vedel L, 2015, J BIOMOL SCREEN, V20, P849, DOI 10.1177/1087057115580019; Vitalis EA, 2000, P NATL ACAD SCI USA, V97, P1861, DOI 10.1073/pnas.040545197; Wachten S, 2010, J CELL SCI, V123, P95, DOI 10.1242/jcs.058594; Wachter RM, 1999, CURR BIOL, V9, pR628, DOI 10.1016/S0960-9822(99)80408-4; WEINSTEIN LS, 1991, NEW ENGL J MED, V325, P1688, DOI 10.1056/NEJM199112123252403; Willoughby D, 2005, J BIOL CHEM, V280, P30864, DOI 10.1074/jbc.M414355200; Willoughby D, 2006, EMBO J, V25, P2051, DOI 10.1038/sj.emboj.7601113; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Yoshida K, 2017, J BIOL CHEM, V292, P7531, DOI 10.1074/jbc.M117.775569; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982; Zaccolo M, 2000, NAT CELL BIOL, V2, P25, DOI 10.1038/71345; Zhang XF, 2018, J BIOL CHEM, V293, P7659, DOI 10.1074/jbc.RA118.001779; Zippin JH, 2004, J CELL BIOL, V164, P527, DOI 10.1083/jcb.200311119	83	11	11	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1095	1103		10.1074/jbc.AC118.004905	http://dx.doi.org/10.1074/jbc.AC118.004905			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30559293	Green Published, hybrid			2022-12-28	WOS:000457879500003
J	Yamasaki, TR; Holmes, BB; Furman, JL; Dhavale, DD; Su, BW; Song, ES; Cairns, NJ; Kotzbauer, PT; Diamond, MI				Yamasaki, Tritia R.; Holmes, Brandon B.; Furman, Jennifer L.; Dhavale, Dhruva D.; Su, Bryant W.; Song, Eun-Suk; Cairns, Nigel J.; Kotzbauer, Paul T.; Diamond, Marc I.			Parkinson's disease and multiple system atrophy have distinct alpha-synuclein seed characteristics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						alpha-synuclein (alpha-synuclein); Parkinson disease; protein aggregation; biosensor; fluorescence resonance energy transfer (FRET); neurodegeneration; fibril; multiple system atrophy; prion strain	TO-NEURON TRANSMISSION; PRION STRAINS; NEUROPATHOLOGIC ASSESSMENT; ALZHEIMERS-DISEASE; TAU; PROPAGATION; INCLUSIONS; SCRAPIE; MECHANISMS; PATHOLOGY	Parkinson's disease (PD) and multiple system atrophy (MSA) are distinct clinical syndromes characterized by the pathological accumulation of alpha-synuclein (alpha-syn) protein fibrils in neurons and glial cells. These disorders and other neurodegenerative diseases may progress via prion-like mechanisms. The prion model of propagation predicts the existence of "strains" that link pathological aggregate structure and neuropathology. Prion strains are aggregated conformers that stably propagate in vivo and cause disease with defined incubation times and patterns of neuropathology. Indeed, tau prions have been well defined, and research suggests that both alpha-syn and beta-amyloid may also form strains. However, there is a lack of studies characterizing PD- versus MSA-derived alpha-syn strains or demonstrating stable propagation of these unique conformers between cells or animals. To fill this gap, we used an assay based on FRET that exploits a HEK293T "biosensor" cell line stably expressing alpha-syn (A53T)-CFP/YFP fusion proteins to detect alpha-syn seeds in brain extracts from PD and MSA patients. Both soluble and insoluble fractions of MSA extracts had robust seeding activity, whereas only the insoluble fractions of PD extracts displayed seeding activity. The morphology of MSA-seeded inclusions differed from PD-seeded inclusions. These differences persisted upon propagation of aggregation to second-generation biosensor cells. We conclude that PD and MSA feature alpha-syn conformers with very distinct biochemical properties that can be transmitted to alpha-syn monomers in a cell system. These findings are consistent with the idea that distinct alpha-syn strains underlie PD and MSA and offer possible directions for synucleinopathy diagnosis.	[Yamasaki, Tritia R.; Su, Bryant W.; Song, Eun-Suk] Univ Kentucky, Dept Neurol, Ste J401,740 S Limestone St, Lexington, KY 40536 USA; [Holmes, Brandon B.; Furman, Jennifer L.; Dhavale, Dhruva D.; Cairns, Nigel J.; Kotzbauer, Paul T.] Washington Univ, Dept Neurol, St Louis, MO 63110 USA; [Cairns, Nigel J.] Washington Univ, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Furman, Jennifer L.; Diamond, Marc I.] Univ Texas Southwestern Med Ctr Dallas, Peter ODonnell Jr Brain Inst, Ctr Alzheimers & Neurodegenerat Dis, Dallas, TX 75390 USA; [Holmes, Brandon B.] Univ Calif San Francisco, Dept Neurol, 505 Parnassus Ave, San Francisco, CA 94143 USA	University of Kentucky; Washington University (WUSTL); Washington University (WUSTL); University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Francisco	Yamasaki, TR (corresponding author), Univ Kentucky, Dept Neurol, Ste J401,740 S Limestone St, Lexington, KY 40536 USA.	tyamasaki@uky.edu	Cairns, Nigel/AAB-9713-2020; Dhavale, Dhruva/AAI-3934-2021; Yamasaki, Tritia/AAN-8831-2020	Cairns, Nigel/0000-0001-9858-3344; Dhavale, Dhruva/0000-0002-0096-1085; Yamasaki, Tritia/0000-0002-4046-274X; Holmes, Brandon/0000-0002-1153-840X	National Center for Advancing Translational Sciences [KL2 TR000116, 3857-77222B]; Mary E. Groff Charitable Trust; National Institute of Health NINDS [NS097799, NS075321, NS110436]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS097799, R01NS075321, U01NS110436] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG003991, P50AG005681] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Mary E. Groff Charitable Trust; National Institute of Health NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Center for Advancing Translational Sciences Grant KL2 TR000116 at the University of Kentucky, T32 Training Grant 3857-77222B at the Washington University School of Medicine, a Mary E. Groff Charitable Trust Grant, and National Institute of Health NINDS Grants NS097799, NS075321, and NS110436. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguzzi A, 2007, NAT REV MOL CELL BIO, V8, P552, DOI 10.1038/nrm2204; Angot E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039465; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Bagchi DP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055031; Bousset L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3575; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Cairns NJ, 2015, NEUROPATHOLOGY, V35, P390, DOI 10.1111/neup.12205; Chu WH, 2015, J MED CHEM, V58, P6002, DOI 10.1021/acs.jmedchem.5b00571; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; DICKINSON AG, 1969, GENET RES, V13, P213, DOI 10.1017/S0016672300002895; FRASER H, 1973, J COMP PATHOL, V83, P29, DOI 10.1016/0021-9975(73)90024-8; Freundt EC, 2012, ANN NEUROL, V72, P517, DOI 10.1002/ana.23747; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Furman JL, 2015, JOVE-J VIS EXP, DOI 10.3791/53205; Guo JL, 2014, NAT MED, V20, P130, DOI 10.1038/nm.3457; Guo JL, 2013, CELL, V154, P103, DOI 10.1016/j.cell.2013.05.057; Hansen C, 2011, J CLIN INVEST, V121, P715, DOI 10.1172/JCI43366; Hasegawa M, 2002, J BIOL CHEM, V277, P49071, DOI 10.1074/jbc.M208046200; Heilbronner G, 2013, EMBO REP, V14, P1017, DOI 10.1038/embor.2013.137; Holmes BB, 2014, P NATL ACAD SCI USA, V111, pE4376, DOI 10.1073/pnas.1411649111; Holmes BB, 2013, P NATL ACAD SCI USA, V110, pE3138, DOI 10.1073/pnas.1301440110; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Kordower JH, 2011, NEUROBIOL DIS, V43, P552, DOI 10.1016/j.nbd.2011.05.001; Kotzbauer PT, 2004, EXP NEUROL, V187, P279, DOI 10.1016/j.expneurol.2004.01.007; Langer F, 2011, J NEUROSCI, V31, P14488, DOI 10.1523/JNEUROSCI.3088-11.2011; Lee HJ, 2008, INT J BIOCHEM CELL B, V40, P1835, DOI 10.1016/j.biocel.2008.01.017; Lee HJ, 2005, J NEUROSCI, V25, P6016, DOI 10.1523/JNEUROSCI.0692-05.2005; Levine DJ, 2015, ACS CHEM BIOL, V10, P1269, DOI 10.1021/cb5006239; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Mao XB, 2016, SCIENCE, V353, DOI 10.1126/science.aah3374; Masuda-Suzukake M, 2013, BRAIN, V136, P1128, DOI 10.1093/brain/awt037; Melki R, 2015, J PARKINSON DIS, V5, P217, DOI 10.3233/JPD-150543; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; PAPP MI, 1989, J NEUROL SCI, V94, P79, DOI 10.1016/0022-510X(89)90219-0; Peelaerts W, 2015, NATURE, V522, P340, DOI 10.1038/nature14547; Peelaerts W, 2016, J NEUROCHEM, V139, P256, DOI 10.1111/jnc.13595; Peng C, 2018, NATURE, V557, P558, DOI 10.1038/s41586-018-0104-4; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Prusiner SB, 2015, P NATL ACAD SCI USA, V112, pE5308, DOI 10.1073/pnas.1514475112; Recasens A, 2014, ANN NEUROL, V75, P351, DOI 10.1002/ana.24066; Sacino AN, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-38; Sanders DW, 2016, NEURON, V89, P433, DOI 10.1016/j.neuron.2016.01.026; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; Solforosi L, 2013, PRION, V7, P99, DOI 10.4161/pri.23490; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Spillantini MG, 1998, NEUROSCI LETT, V251, P205, DOI 10.1016/s0304-3940(98)00504-7; Stefanova N, 2009, LANCET NEUROL, V8, P1172, DOI 10.1016/S1474-4422(09)70288-1; Watts JC, 2014, P NATL ACAD SCI USA, V111, P10323, DOI 10.1073/pnas.1408900111; Watts JC, 2013, P NATL ACAD SCI USA, V110, P19555, DOI 10.1073/pnas.1318268110; Woerman AL, 2015, P NATL ACAD SCI USA, V112, pE4949, DOI 10.1073/pnas.1513426112; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509	59	95	95	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2019	294	3					1045	1058		10.1074/jbc.RA118.004471	http://dx.doi.org/10.1074/jbc.RA118.004471			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL4FC	30478174	Green Published, hybrid			2022-12-28	WOS:000458670200027
J	Spiliotopoulos, A; Ferreras, LB; Densham, RM; Caulton, SG; Maddison, BC; Morris, JR; Dixon, JE; Gough, KC; Dreveny, I				Spiliotopoulos, Anastasios; Ferreras, Lia Blokpoel; Densham, Ruth M.; Caulton, Simon G.; Maddison, Ben C.; Morris, Joanna R.; Dixon, James E.; Gough, Kevin C.; Dreveny, Ingrid			Discovery of peptide ligands targeting a specific ubiquitin-like domain-binding site in the deubiquitinase USP11	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						peptide interaction; peptides; protease; crystal structure; ubiquitin; ubiquitin-dependent protease; phage display; DNA damage response; deubiquitylation (deubiquitination); cell-penetrating peptide (CPP); molecular recognition; USP11	DEUBIQUITYLATING ENZYMES; STRUCTURAL BASIS; INHIBITORS; STABILIZATION; RECOGNITION; SENSITIVITY; MECHANISM; RESPONSES; SELECTION; COMPLEX	Ubiquitin-specific proteases (USPs) reverse ubiquitination and regulate virtually all cellular processes. Defined noncatalytic domains in USP4 and USP15 are known to interact with E3 ligases and substrate recruitment factors. No such interactions have been reported for these domains in the paralog USP11, a key regulator of DNA double-strand break repair by homologous recombination. We hypothesized that USP11 domains adjacent to its protease domain harbor unique peptide-binding sites. Here, using a next-generation phage display (NGPD) strategy, combining phage display library screening with next-generation sequencing, we discovered unique USP11-interacting peptide motifs. Isothermal titration calorimetry disclosed that the highest affinity peptides (K-D of approximate to 10 m) exhibit exclusive selectivity for USP11 over USP4 and USP15 in vitro. Furthermore, a crystal structure of a USP11-peptide complex revealed a previously unknown binding site in USP11's noncatalytic ubiquitin-like (UBL) region. This site interacted with a helical motif and is absent in USP4 and USP15. Reporter assays using USP11-WT versus a binding pocket-deficient double mutant disclosed that this binding site modulates USP11's function in homologous recombination-mediated DNA repair. The highest affinity USP11 peptide binder fused to a cellular delivery sequence induced significant nuclear localization and cell cycle arrest in S phase, affecting the viability of different mammalian cell lines. The USP11 peptide ligands and the paralog-specific functional site in USP11 identified here provide a framework for the development of new biochemical tools and therapeutic agents. We propose that an NGPD-based strategy for identifying interacting peptides may be applied also to other cellular targets.	[Spiliotopoulos, Anastasios; Ferreras, Lia Blokpoel; Caulton, Simon G.; Dixon, James E.; Dreveny, Ingrid] Univ Nottingham, Sch Pharm, Ctr Biomol Sci, Nottingham NG7 2RD, England; [Spiliotopoulos, Anastasios; Gough, Kevin C.] Sch Vet Med & Sci, Sutton Bonington Campus,Coll Rd, Loughborough LE12 5RD, Leics, England; [Densham, Ruth M.; Morris, Joanna R.] Univ Birmingham, Birmingham Ctr Genome Biol, Birmingham B15 2TT, W Midlands, England; [Densham, Ruth M.; Morris, Joanna R.] Univ Birmingham, Inst Canc & Genom Sci, Med Sch, Birmingham B15 2TT, W Midlands, England; [Densham, Ruth M.; Morris, Joanna R.] Univ Birmingham, Inst Canc & Genom Sci, Dent Sch, Birmingham B15 2TT, W Midlands, England; [Maddison, Ben C.] Agr Dev & Advisory Serv, Sch Vet Med & Sci, Bonington Campus,Coll Rd, Loughborough LE12 5RD, Leics, England	University of Nottingham; University of Birmingham; University of Birmingham; University of Birmingham	Dreveny, I (corresponding author), Univ Nottingham, Sch Pharm, Ctr Biomol Sci, Nottingham NG7 2RD, England.; Gough, KC (corresponding author), Sch Vet Med & Sci, Sutton Bonington Campus,Coll Rd, Loughborough LE12 5RD, Leics, England.	kevin.gough@nottingham.ac.uk; ingrid.dreveny@nottingham.ac.uk	Dreveny, Ingrid/E-8939-2017; Morris, Joanna/AAK-3388-2021; Densham, Ruth/AAO-1971-2020	Dreveny, Ingrid/0000-0003-2256-642X; Densham, Ruth/0000-0003-4490-2842; Gough, Kevin/0000-0001-5211-2088; caulton, simon/0000-0001-7509-9728; Morris, Joanna/0000-0001-9762-8133	Biotechnology and Biological Sciences Research Council [BB/H012656/1]; BBSRC [BB/H012656/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council [Grant BB/H012656/1]. Crystallographic data were obtained with the support of Diamond Light Source, United Kingdom, and the European Synchrotron Radiation Facility (ESRF), Grenoble, France. We are grateful to colleagues at ESRF for providing assistance using beamline ID23-2 and at Diamond using beamline I02 and colleagues at the Advanced Data Analysis Centre, University of Nottingham, for advice on bioinformatics data analysis. We also thank the University of Birmingham Tech Hub Facility for FACS support.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Al-Salihi MA, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120063; Avvakumov GV, 2006, J BIOL CHEM, V281, P38061, DOI 10.1074/jbc.M606704200; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Burkhart RA, 2013, MOL CANCER RES, V11, P901, DOI 10.1158/1541-7786.MCR-12-0699; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng JD, 2015, PROTEIN CELL, V6, P849, DOI 10.1007/s13238-015-0192-y; Clague MJ, 2013, PHYSIOL REV, V93, P1289, DOI 10.1152/physrev.00002.2013; Clerici M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6399; Deng TG, 2018, P NATL ACAD SCI USA, V115, P4678, DOI 10.1073/pnas.1714938115; Dias-Neto E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008338; Dixon JE, 2016, P NATL ACAD SCI USA, V113, pE291, DOI 10.1073/pnas.1518634113; Dreveny I, 2004, EMBO J, V23, P1030, DOI 10.1038/sj.emboj.7600139; Elliott PR, 2011, FEBS LETT, V585, P3385, DOI 10.1016/j.febslet.2011.09.040; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; FELICI F, 1991, J MOL BIOL, V222, P301, DOI 10.1016/0022-2836(91)90213-P; Gough KC, 1999, J VIROL METHODS, V79, P169, DOI 10.1016/S0166-0934(99)00014-2; Harper S, 2014, BIOCHEMISTRY-US, V53, P2966, DOI 10.1021/bi500116x; Harper S, 2011, BIOCHEMISTRY-US, V50, P7995, DOI 10.1021/bi200726e; Hayes SD, 2012, J BIOL CHEM, V287, P43007, DOI 10.1074/jbc.M112.386938; Houtman JCD, 2007, PROTEIN SCI, V16, P30, DOI 10.1110/ps.062558507; Jacq X, 2013, CELL BIOCHEM BIOPHYS, V67, P25, DOI 10.1007/s12013-013-9635-3; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kategaya L, 2017, NATURE, V550, P534, DOI 10.1038/nature24006; Keller S, 2012, ANAL CHEM, V84, P5066, DOI 10.1021/ac3007522; Lamberto I, 2017, CELL CHEM BIOL, V24, P1490, DOI 10.1016/j.chembiol.2017.09.003; Lee EW, 2015, CELL DEATH DIFFER, V22, P1463, DOI 10.1038/cdd.2014.234; Liang Q, 2014, NAT CHEM BIOL, V10, P298, DOI [10.1038/nchembio.1455, 10.1038/NCHEMBIO.1455]; London N, 2010, STRUCTURE, V18, P188, DOI 10.1016/j.str.2009.11.012; Long L, 2014, J BIOL CHEM, V289, P8916, DOI 10.1074/jbc.M114.551754; Maertens GN, 2010, EMBO J, V29, P2553, DOI 10.1038/emboj.2010.129; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Naqid IA, 2016, SCI REP-UK, V6, DOI 10.1038/srep31186; Naqid IA, 2016, SCI REP-UK, V6, DOI 10.1038/srep24232; Nishi R, 2014, NAT CELL BIOL, V16, P1016, DOI 10.1038/ncb3028; Orthwein A, 2015, NATURE, V528, P422, DOI 10.1038/nature16142; Pei JM, 2014, METHODS MOL BIOL, V1079, P263, DOI 10.1007/978-1-62703-646-7_17; Pfoh R, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004950; Pozhidaeva A, 2017, CELL CHEM BIOL, V24, P1501, DOI 10.1016/j.chembiol.2017.09.004; Rebollo IR, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku940; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Schoenfeld AR, 2004, MOL CELL BIOL, V24, P7444, DOI 10.1128/MCB.24.17.7444-7455.2004; Sheng Y, 2006, NAT STRUCT MOL BIOL, V13, P285, DOI 10.1038/nsmb1067; Song EJ, 2010, GENE DEV, V24, P1434, DOI 10.1101/gad.1925010; Stark JM, 2004, MOL CELL BIOL, V24, P9305, DOI 10.1128/MCB.24.21.9305-9316.2004; Stockum A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190513; Suire CN, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193101; Ting JP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190850; Turnbull AP, 2017, NATURE, V550, P481, DOI 10.1038/nature24451; Vlasschaert C, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0511-1; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wiltshire TD, 2010, J BIOL CHEM, V285, P14565, DOI 10.1074/jbc.M110.104745; Yang L, 2017, TRANSL CANCER RES, V6, P218, DOI 10.21037/tcr.2017.01.16; Ye Y, 2009, MOL BIOSYST, V5, P1797, DOI 10.1039/b907669g; Zhang HK, 2011, P NATL ACAD SCI USA, V108, P13456, DOI 10.1073/pnas.1111218108; Zhang W, 2014, FEBS LETT, V588, P356, DOI 10.1016/j.febslet.2013.11.003; Zhang YN, 2013, NAT CHEM BIOL, V9, P51, DOI [10.1038/NCHEMBIO.1134, 10.1038/nchembio.1134]; Zhang ZM, 2015, CELL REP, V12, P1400, DOI 10.1016/j.celrep.2015.07.046; Zhu X, 2007, PROTEINS, V69, P1, DOI 10.1002/prot.21546; Zu XY, 2014, ANTIVIR RES, V104, P7, DOI 10.1016/j.antiviral.2014.01.011	61	17	17	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2019	294	2					424	436		10.1074/jbc.RA118.004469	http://dx.doi.org/10.1074/jbc.RA118.004469			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HI2GP	30373771	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000456263600004
J	Zhang, CX; Leng, F; Saxena, L; Hoang, N; Yu, JK; Alejo, S; Lee, L; Qi, DD; Lu, F; Sun, H; Zhang, H				Zhang, Chunxiao; Leng, Feng; Saxena, Lovely; Hoang, Nam; Yu, Jiekai; Alejo, Salvador; Lee, Logan; Qi, Dandan; Lu, Fei; Sun, Hong; Zhang, Hui			Proteolysis of methylated SOX2 protein is regulated by L3MBTL3 and CRL4(DCAF5) ubiquitin ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein methylation; ubiquitin ligase; stem cells; transcription regulation; pluripotency; CRL4DCAF5; L3MBTL3; SOX2; proteolysis	DOMAIN-CONTAINING PROTEINS; PLURIPOTENT STEM-CELLS; 20-LIKE 1 PHF20L1; LYSINE METHYLATION; SELF-RENEWAL; PHOSPHORYLATION SWITCH; LSD1; EXPRESSION; DIFFERENTIATION; MAINTENANCE	SOX2 is a dose-dependent master stem cell protein that controls the self-renewal and pluripotency or multipotency of embryonic stem (ES) cells and many adult stem cells. We have previously found that SOX2 protein is monomethylated at lysine residues 42 and 117 by SET7 methyltransferase to promote SOX2 proteolysis, whereas LSD1 and PHF20L1 act on both methylated Lys-42 and Lys-117 to prevent SOX2 proteolysis. However, the mechanism by which the methylated SOX2 protein is degraded remains unclear. Here, we report that L3MBTL3, a protein with the malignant-brain-tumor (MBT) methylation-binding domain, is required for SOX2 proteolysis. Our studies showed that L3MBTL3 preferentially binds to the methylated Lys-42 in SOX2, although mutation of Lys-117 also partially reduces the interaction between SOX2 and L3MBTL3. The direct binding of L3MBTL3 to the methylated SOX2 protein leads to the recruitment of the CRL4(DCAF5) ubiquitin E3 ligase to target SOX2 protein for ubiquitin-dependent proteolysis. Whereas loss of either LSD1 or PHF20L1 destabilizes SOX2 protein and impairs the self-renewal and pluripotency of mouse ES cells, knockdown of L3MBTL3 or DCAF5 is sufficient to restore the protein levels of SOX2 and rescue the defects of mouse ES cells caused by LSD1 or PHF20L1 deficiency. We also found that retinoic acid-induced differentiation of mouse ES cells is accompanied by the enhanced degradation of the methylated SOX2 protein at both Lys-42 and Lys-117. Our studies provide novel insights into the mechanism by which the methylation-dependent degradation of SOX2 protein is controlled by the L3MBTL3-CRL4(DCAF5) ubiquitin ligase complex.	[Zhang, Chunxiao; Leng, Feng; Saxena, Lovely; Hoang, Nam; Yu, Jiekai; Alejo, Salvador; Lee, Logan; Qi, Dandan; Sun, Hong; Zhang, Hui] Univ Nevada, Dept Chem & Biochem, 4505 S Maryland Pkwy,Box 454003, Las Vegas, NV 89154 USA; [Zhang, Chunxiao; Lu, Fei] Peking Univ, Sch Chem Biol & Biotechnol, Shenzhen Grad Sch, Shenzhen 518055, Guangdong, Peoples R China	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Peking University; University Town of Shenzhen	Zhang, H (corresponding author), Univ Nevada, Dept Chem & Biochem, 4505 S Maryland Pkwy,Box 454003, Las Vegas, NV 89154 USA.	hui.zhang@unlv.edu	Leng, Feng/AAP-7294-2020; zhang, chunxiao/AAH-3229-2019	Sun, Hong/0000-0003-2100-1451; Alejo, Salvador/0000-0002-1390-9892; Zhang, Chunxiao/0000-0001-5543-4509	National Institutes of Health [R15NS096694, R15GM131255]; Cancer Research Gift Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM131255] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Gift Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R15NS096694 (to H.S.) and R15GM131255 (to H.Z.) and a grant from the Cancer Research Gift Fund to the College of Sciences at the University of Nevada, Las Vegas (to H.S. and H.Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adachi K, 2010, GENES CELLS, V15, P455, DOI 10.1111/j.1365-2443.2010.01400.x; Adamo A, 2011, NAT CELL BIOL, V13, P652, DOI 10.1038/ncb2246; Andlauer TFM, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501678; Arai S, 2005, EMBO J, V24, P1863, DOI 10.1038/sj.emboj.7600654; Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; Boer B, 2007, NUCLEIC ACIDS RES, V35, P1773, DOI 10.1093/nar/gkm059; Bonasio R, 2010, SEMIN CELL DEV BIOL, V21, P221, DOI 10.1016/j.semcdb.2009.09.010; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Driessens G, 2011, CELL STEM CELL, V9, P283, DOI 10.1016/j.stem.2011.09.007; Elkouris M, 2016, CELL REP, V15, P2733, DOI 10.1016/j.celrep.2016.05.051; Episkopou V, 2005, TRENDS NEUROSCI, V28, P219, DOI 10.1016/j.tins.2005.03.003; Esteve PO, 2014, J BIOL CHEM, V289, P8277, DOI 10.1074/jbc.M113.525279; Esteve PO, 2011, NAT STRUCT MOL BIOL, V18, P42, DOI 10.1038/nsmb.1939; Esteve PO, 2009, P NATL ACAD SCI USA, V106, P5076, DOI 10.1073/pnas.0810362106; Fang L, 2014, MOL CELL, V55, P537, DOI 10.1016/j.molcel.2014.06.018; Fong HL, 2008, STEM CELLS, V26, P1931, DOI 10.1634/stemcells.2007-1002; Fu L, 2016, ELIFE, V5, DOI 10.7554/eLife.15690; Goolam M, 2016, CELL, V165, P61, DOI 10.1016/j.cell.2016.01.047; Higa LA, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-5; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; James LI, 2013, J MED CHEM, V56, P7358, DOI 10.1021/jm400919p; James LI, 2013, NAT CHEM BIOL, V9, P184, DOI [10.1038/NCHEMBIO.1157, 10.1038/nchembio.1157]; Jiang YY, 2016, MOL ONCOL, V10, P292, DOI 10.1016/j.molonc.2015.10.013; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Kar SP, 2016, CANCER DISCOV, V6, P1052, DOI 10.1158/2159-8290.CD-15-1227; Kim SK, 2014, CELL STEM CELL, V15, P735, DOI 10.1016/j.stem.2014.10.016; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Kontaki H, 2010, MOL CELL, V39, P152, DOI 10.1016/j.molcel.2010.06.006; Kopp JL, 2008, STEM CELLS, V26, P903, DOI 10.1634/stemcells.2007-0951; Lee P, 2012, HUM GENET, V131, P479, DOI 10.1007/s00439-011-1088-4; Lin SB, 2013, J BIOL CHEM, V288, P6238, DOI 10.1074/jbc.M112.429605; Lotta LA, 2017, NAT GENET, V49, P17, DOI 10.1038/ng.3714; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Nady N, 2012, J MOL BIOL, V423, P702, DOI 10.1016/j.jmb.2012.08.022; Northcott PA, 2009, NAT GENET, V41, P465, DOI 10.1038/ng.336; Oehl-Jaschkowitz B, 2014, AM J MED GENET A, V164, P620, DOI 10.1002/ajmg.a.36321; Pan KW, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07632-w; Reindl L, 2010, BRIT J HAEMATOL, V151, P25, DOI 10.1111/j.1365-2141.2010.08299.x; Rizzino A, 2016, BBA-GENE REGUL MECH, V1859, P780, DOI 10.1016/j.bbagrm.2016.03.006; Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Wang QQ, 2018, LAB INVEST, V98, P1627, DOI 10.1038/s41374-018-0106-8; Weina K, 2014, CLIN TRANSL MED, V3, DOI 10.1186/2001-1326-3-19; Xu WH, 2008, CANCER GENET CYTOGEN, V185, P43, DOI 10.1016/j.cancergencyto.2008.04.007; Yin F, 2014, MOL CELL BIOL, V34, P158, DOI 10.1128/MCB.00631-13; Zhang CX, 2018, J BIOL CHEM, V293, P3663, DOI 10.1074/jbc.RA117.000342; Zhang J, 2013, GENE DEV, V27, P749, DOI 10.1101/gad.210963.112; Zhang X, 2012, ACTA BIOCH BIOPH SIN, V44, P14, DOI 10.1093/abbs/gmr100; Zhang XM, 2013, CELL REP, V5, P445, DOI 10.1016/j.celrep.2013.09.018	51	15	17	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2019	294	2					476	489		10.1074/jbc.RA118.005336	http://dx.doi.org/10.1074/jbc.RA118.005336			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HI2GP	30442713	Green Published, hybrid			2022-12-28	WOS:000456263600009
J	Ronish, LA; Lillehoj, E; Fields, JK; Sundberg, EJ; Piepenbrink, KH				Ronish, Leslie A.; Lillehoj, Erik; Fields, James K.; Sundberg, Eric J.; Piepenbrink, Kurt H.			The structure of PilA from Acinetobacter baumannii AB5075 suggests a mechanism for functional specialization in Acinetobacter type IV pili	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						type IV pili; X-ray crystallography; bacterial adhesion; bacterial pathogenesis; electrostatics; biofilm; structural biology; host-pathogen interaction; Acinetobacter; twitching motility	MULTIDRUG-RESISTANT ACINETOBACTER; PSEUDOMONAS-AERUGINOSA; CRYOELECTRON MICROSCOPY; SP NOV.; GLYCOSYLATION; ADHERENCE; SEQUENCE; COMPLEX; PHENIX; RETRACTION	Type IV pili (T4P) are bacterial appendages composed of protein subunits, called pilins, noncovalently assembled into helical fibers. T4P are essential, in many bacterial species, for processes as diverse as twitching motility, natural competence, biofilm or microcolony formation, and host cell adhesion. The genes encoding type IV pili are found universally in the Gram-negative, aerobic, nonflagellated, and pathogenic coccobacillus Acinetobacter baumannii, but there is considerable variation in PilA, the major protein subunit, both in amino acid sequence and in glycosylation patterns. Here we report the X-ray crystal structure of PilA from AB5075, a recently characterized, highly virulent isolate, at 1.9 resolution and compare it to homologues from A. baumannii strains ACICU and BIDMC57, which are C-terminally glycosylated. These structural comparisons revealed that PilA(AB5075) exhibits a distinctly electronegative surface chemistry. To understand the functional consequences of this change in surface electrostatics, we complemented a pilA knockout strain with divergent pilA genes from ACICU, BIDMC57, and AB5075. The resulting transgenic strains showed differential twitching motility and biofilm formation while maintaining the ability to adhere to epithelial cells. PilA(AB5075) and PilA(ACICU), although structurally similar, promote different characteristics, favoring twitching motility and biofilm formation, respectively. These results support a model in which differences in pilus electrostatics affect the equilibrium of microcolony formation, which in turn alters the balance between motility and biofilm formation in Acinetobacter.	[Ronish, Leslie A.; Piepenbrink, Kurt H.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; [Piepenbrink, Kurt H.] Univ Nebraska, Dept Food Sci & Technol, Lincoln, NE 68588 USA; [Piepenbrink, Kurt H.] Univ Nebraska, Nebraska Food Hlth Ctr, Lincoln, NE 68588 USA; [Piepenbrink, Kurt H.] Univ Nebraska, Ctr Integrated Biomol Commun, Lincoln, NE 68588 USA; [Fields, James K.; Sundberg, Eric J.] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Lillehoj, Erik] Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA; [Sundberg, Eric J.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Sundberg, Eric J.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Piepenbrink, KH (corresponding author), Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA.; Piepenbrink, KH (corresponding author), Univ Nebraska, Dept Food Sci & Technol, Lincoln, NE 68588 USA.; Piepenbrink, KH (corresponding author), Univ Nebraska, Nebraska Food Hlth Ctr, Lincoln, NE 68588 USA.; Piepenbrink, KH (corresponding author), Univ Nebraska, Ctr Integrated Biomol Commun, Lincoln, NE 68588 USA.	kurt.piepenbrink@unl.edu		Fields, James/0000-0001-5923-108X; Lillehoj, Erik/0000-0002-2710-1704; Piepenbrink, Kurt/0000-0002-2527-0301; , Erik/0000-0003-0910-6074	NIAID NIH HHS [R01 AI114902, K22 AI123467] Funding Source: Medline; NIGMS NIH HHS [P20 GM113126] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI114902, K22AI123467] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM113126] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aas FE, 2007, MOL MICROBIOL, V65, P607, DOI 10.1111/j.1365-2958.2007.05806.x; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Allison TM, 2015, MICROBIOL-SGM, V161, P1780, DOI 10.1099/mic.0.000128; Antunes LCS, 2014, PATHOG DIS, V71, P292, DOI 10.1111/2049-632X.12125; Aranda J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-279; Biais N, 2008, PLOS BIOL, V6, P907, DOI 10.1371/journal.pbio.0060087; Cehovin A, 2010, VACCINE, V28, P4817, DOI 10.1016/j.vaccine.2010.04.065; Chabane YN, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-62; Chang HC, 2005, J CLIN MICROBIOL, V43, P1632, DOI 10.1128/JCM.43.4.1632-1639.2005; Chiang P, 2003, J BACTERIOL, V185, P2374, DOI 10.1128/JB.185.7.2374-2378.2003; Cosgaya C, 2016, INT J SYST EVOL MICR, V66, P4105, DOI 10.1099/ijsem.0.001318; Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885; Craig L, 2003, MOL CELL, V11, P1139, DOI 10.1016/S1097-2765(03)00170-9; Craig L, 2008, CURR OPIN STRUC BIOL, V18, P267, DOI 10.1016/j.sbi.2007.12.009; Craig L, 2006, MOL CELL, V23, P651, DOI 10.1016/j.molcel.2006.07.004; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Eijkelkamp BA, 2011, FEMS MICROBIOL LETT, V323, P44, DOI 10.1111/j.1574-6968.2011.02362.x; Ellison CK, 2017, SCIENCE, V358, P535, DOI 10.1126/science.aan5706; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Falagas ME, 2006, J HOSP INFECT, V64, P7, DOI 10.1016/j.jhin.2006.04.015; Gault J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005162; Gebhardt MJ, 2015, MBIO, V6, DOI 10.1128/mBio.01660-15; Gellatly SL, 2013, PATHOG DIS, V67, P159, DOI 10.1111/2049-632X.12033; Giltner CL, 2012, MICROBIOL MOL BIOL R, V76, P740, DOI 10.1128/MMBR.00035-12; Goeres DM, 2005, MICROBIOL-SGM, V151, P757, DOI 10.1099/mic.0.27709-0; Greene C, 2016, LETT APPL MICROBIOL, V63, P233, DOI 10.1111/lam.12627; Harding CM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005391; Harding CM, 2015, MOL MICROBIOL, V96, P1023, DOI 10.1111/mmi.12986; Harding CM, 2013, MBIO, V4, DOI 10.1128/mBio.00360-13; Hartung S, 2011, J BIOL CHEM, V286, P44254, DOI 10.1074/jbc.M111.297242; Harvey H, 2018, NAT MICROBIOL, V3, DOI 10.1038/s41564-017-0061-y; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; Howard A, 2012, VIRULENCE, V3, P243, DOI 10.4161/viru.19700; Iacono M, 2008, ANTIMICROB AGENTS CH, V52, P2616, DOI 10.1128/AAC.01643-07; Jacobs AC, 2014, MBIO, V5, DOI 10.1128/mBio.01076-14; Johnson TL, 2006, FEMS MICROBIOL LETT, V255, P175, DOI 10.1111/j.1574-6968.2006.00102.x; Jones A, 2006, LANCET INFECT DIS, V6, P317, DOI 10.1016/S1473-3099(06)70471-6; Jude BA, 2011, J STRUCT BIOL, V175, P1, DOI 10.1016/j.jsb.2011.04.008; Knutton S, 1999, MOL MICROBIOL, V33, P499, DOI 10.1046/j.1365-2958.1999.01495.x; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Lillehoj EP, 2015, J BIOL CHEM, V290, P18316, DOI 10.1074/jbc.M115.657114; Lillehoj EP, 2012, J BIOL CHEM, V287, P8214, DOI 10.1074/jbc.M111.292888; Marathe R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4759; Marceau M, 1998, MOL MICROBIOL, V27, P705, DOI 10.1046/j.1365-2958.1998.00706.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McPherson AS, 2017, J CLIN MICROBIOL, V55, P1313, DOI 10.1128/JCM.02403-16; Moon AF, 2010, PROTEIN SCI, V19, P901, DOI 10.1002/pro.368; Moon KH, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.00778-17; Muschiol S, 2017, J BIOL CHEM, V292, P14134, DOI 10.1074/jbc.M117.787671; Nemec A, 2015, INT J SYST EVOL MICR, V65, P934, DOI 10.1099/ijs.0.000043; Ng D, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006109; Oh MH, 2015, J MICROBIOL BIOTECHN, V25, P1390, DOI 10.4014/jmb.1504.04069; Oki H, 2018, P NATL ACAD SCI USA, V115, P7422, DOI 10.1073/pnas.1805671115; Pakharukova N, 2018, P NATL ACAD SCI USA, V115, P5558, DOI 10.1073/pnas.1800961115; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Piepenbrink KH, 2016, J BIOL CHEM, V291, P22924, DOI 10.1074/jbc.M116.751099; Piepenbrink KH, 2015, STRUCTURE, V23, P385, DOI 10.1016/j.str.2014.11.018; Piepenbrink KH, 2014, J BIOL CHEM, V289, P4334, DOI 10.1074/jbc.M113.534404; Poirel L, 2008, ANTIMICROB AGENTS CH, V52, P1252, DOI 10.1128/AAC.01304-07; Power PM, 2006, BIOCHEM BIOPH RES CO, V347, P904, DOI 10.1016/j.bbrc.2006.06.182; Rodgers K, 2011, INFECT IMMUN, V79, P3096, DOI 10.1128/IAI.00909-10; Sahl JW, 2015, SCI REP-UK, V5, DOI 10.1038/srep15188; Schmid B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-274; Shahapure R, 2014, MOL MICROBIOL, V91, P716, DOI 10.1111/mmi.12486; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smedley JG, 2005, INFECT IMMUN, V73, P7922, DOI 10.1128/IAI.73.12.7922-7931.2005; STIMSON E, 1995, MOL MICROBIOL, V17, P1201, DOI 10.1111/j.1365-2958.1995.mmi_17061201.x; STROM MS, 1993, ANNU REV MICROBIOL, V47, P565, DOI 10.1146/annurev.micro.47.1.565; Tayabali AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037024; Toma C, 2002, FEMS IMMUNOL MED MIC, V33, P35, DOI 10.1111/j.1574-695X.2002.tb00569.x; Vijayakumar S, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00105; Voisin S, 2007, J BACTERIOL, V189, P151, DOI 10.1128/JB.01224-06; Wang FB, 2017, STRUCTURE, V25, P1423, DOI 10.1016/j.str.2017.07.016; Wang YC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25661-9; Nguyen Y, 2015, J BIOL CHEM, V290, P601, DOI 10.1074/jbc.M114.616904; Zhan YH, 2011, J BACTERIOL, V193, P2672, DOI 10.1128/JB.00261-11	79	25	25	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2019	294	1					218	230		10.1074/jbc.RA118.005814	http://dx.doi.org/10.1074/jbc.RA118.005814			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG6PT	30413536	Green Published, hybrid			2022-12-28	WOS:000455105500025
J	Iqbal, J; McRae, S; Banaudha, K; Mai, T; Waris, G				Iqbal, Jawed; McRae, Steven; Banaudha, Krishna; Thi Mai; Waris, Gulam			RETRACTION: Withdrawal: Mechanism of hepatitis C virus (HCV)-induced osteopontin and its role in epithelial to mesenchymal transition of hepatocytes (Retraction of Vol 288, Pg 36994, 2013)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Iqbal J, 2013, J BIOL CHEM, V288, P36994, DOI 10.1074/jbc.M113.492314	1	2	2	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					20010	20010		10.1074/jbc.W118.006978	http://dx.doi.org/10.1074/jbc.W118.006978			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30593531	Green Published, hybrid			2022-12-28	WOS:000454685900008
J	Mi, JQ; Hooker, E; Balog, S; Zeng, H; Johnson, DT; He, YF; Yu, EJ; Wu, HQ; Le, V; Lee, DH; Aldahl, J; Gonzalgo, ML; Sun, ZJ				Mi, Jiaqi; Hooker, Erika; Balog, Steven; Zeng, Hong; Johnson, Daniel T.; He, Yongfeng; Yu, Eun-Jeong; Wu, Huiqing; Vien Le; Lee, Dong-Hoon; Aldahl, Joseph; Gonzalgo, Mark L.; Sun, Zijie			Activation of hepatocyte growth factor/MET signaling initiates oncogenic transformation and enhances tumor aggressiveness in the murine prostate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						prostate cancer; transgenic mice; gene knockout; tumor cell biology; androgen receptor; phosphatase and tensin homolog (PTEN); hepatocyte growth factor; scatter factor (HGF; SF); HGF; SF; Met; metastasis; tumorigenesis; PB-Cre4; prostatic intraepithelial neoplasia; epithelial-to-mesenchymal transition	C-MET; ANDROGEN RECEPTOR; GENE-EXPRESSION; MOUSE MODEL; MESENCHYMAL TRANSITION; GASTRIC-CANCER; N-CADHERIN; CELLS; METASTASIS; CARCINOMA	Emerging evidence has shown that the hepatocyte growth factor (HGF) and its receptor, MET proto-oncogene, receptor tyrosine kinase (MET), promote cell proliferation, motility, morphogenesis, and angiogenesis. Whereas up-regulation of MET expression has been observed in aggressive and metastatic prostate cancer, a clear understanding of MET function in prostate tumorigenesis remains elusive. Here, we developed a conditional Met transgenic mouse strain, H11(Met/+):PB-Cre4, to mimic human prostate cancer cells with increased MET expression in the prostatic luminal epithelium. We found that these mice develop prostatic intraepithelial neoplasia after HGF administration. To further assess the biological role of MET in prostate cancer progression, we bred H11(Met/+)/Pten(LoxP/LoxP):PBCre4 compound mice, in which transgenic Met expression and deletion of the tumor suppressor gene Pten occurred simultaneously only in prostatic epithelial cells. These compound mice exhibited accelerated prostate tumor formation and invasion as well as increased metastasis compared with Pten(LoxP/LoxP):PB-Cre4 mice. Moreover, prostatic sarcomatoid carcinomas and lesions resembling the epithelial-to-mesenchymal transition developed in tumor lesions of the compound mice. RNA-Seq and qRT-PCR analyses revealed a robust enrichment of known tumor progression and metastasis-promoting genes in samples isolated from H11(Met/+)/Pten(LoxP/LoxP):PB-Cre4 compound mice compared with those from Pten(LoxP/LoxP):PB-Cre4 littermate controls. HGF-induced cell proliferation and migration also increased in mouse embryonic fibroblasts (MEFs) from animals with both Met transgene expression and Pten deletion compared with Pten-null MEFs. The results from these newly developed mouse models indicate a role for MET in hastening tumorigenesis and metastasis when combined with the loss of tumor suppressors.	[Mi, Jiaqi; Hooker, Erika; Balog, Steven; He, Yongfeng; Yu, Eun-Jeong; Vien Le; Lee, Dong-Hoon; Aldahl, Joseph; Sun, Zijie] City Hope Natl Med Ctr, Dept Canc Biol, Beckman Res Inst, Duarte, CA 91010 USA; [Wu, Huiqing] City Hope Natl Med Ctr, Dept Pathol, Beckman Res Inst, Duarte, CA 91010 USA; [Hooker, Erika; Johnson, Daniel T.; He, Yongfeng; Yu, Eun-Jeong; Sun, Zijie] Stanford Univ, Sch Med, Dept Urol, Stanford, CA 94305 USA; [Zeng, Hong] Stanford Univ, Sch Med, Transgen Knockout & Tumor Model Ctr, Stanford, CA 94305 USA; [Gonzalgo, Mark L.] Univ Miami, Miller Sch Med, Dept Urol, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; Stanford University; Stanford University; University of Miami	Sun, ZJ (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Rm 2311,Beckman Bldg, Duarte, CA 91010 USA.	zjsun@coh.org	He, Yongfeng/AAR-8257-2020; Mi, Jiaqi/GVU-4732-2022	Mi, Jiaqi/0000-0002-6537-7795; Lee, Dong-Hoon/0000-0001-7466-6997; Hooker, Erika/0000-0002-4515-4041; Johnson, Daniel/0000-0003-4669-037X	National Institutes of Health [R01CA070297, R01CA151623, R01CA166894, R21CA190021, R01DK104941]; NATIONAL CANCER INSTITUTE [R01CA070297, R01CA151623, R21CA190021, R01CA166894] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK104941] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grants R01CA070297, R01CA151623, R01CA166894, R21CA190021, and R01DK104941. The authors declare that they have no conflicts of inter est with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adissu HA, 2015, PROSTATE, V75, P1831, DOI 10.1002/pros.23056; Alexopoulou AN, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-2; American Cancer Society, 2017, CANC FACTS FIG 2017; Armenia J, 2018, NAT GENET, V50, P645, DOI 10.1038/s41588-018-0078-z; Barbieri A, 2015, INT J ONCOL, V47, P527, DOI 10.3892/ijo.2015.3038; Beliakoff J, 2008, MOL CELL BIOL, V28, P282, DOI 10.1128/MCB.00771-07; Berish RB, 2018, NAT REV UROL, V15, P403, DOI 10.1038/s41585-018-0020-2; Bhardwaj A, 2008, MOL CELL BIOL, V28, P2138, DOI 10.1128/MCB.01170-07; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; BISCHOF P, 1986, ARCH ANDROLOGY, V16, P155, DOI 10.3109/01485018608986936; Boccaccio C, 2006, NAT REV CANCER, V6, P637, DOI 10.1038/nrc1912; Cannistraci A, 2017, ONCOGENE, V36, P3718, DOI 10.1038/onc.2016.505; Chang Wei-Chao, 2010, Int J Proteomics, V2010, P726968, DOI 10.1155/2010/726968; Chen C, 2015, PROSTATE, V75, P883, DOI 10.1002/pros.22971; Chen K, 2011, CANCER BIOL THER, V12, P1114, DOI 10.4161/cbt.12.12.18435; Chimento A, 2012, MOL CELL ENDOCRINOL, V355, P49, DOI 10.1016/j.mce.2012.01.017; Conant JL, 2011, J CLIN PATHOL, V64, P1088, DOI 10.1136/jclinpath-2011-200216; Das DK, 2016, EXP CELL RES, V348, P190, DOI 10.1016/j.yexcr.2016.09.021; Daudigeos-Dubus E, 2017, INT J ONCOL, V50, P203, DOI 10.3892/ijo.2016.3792; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; de Reynies A, 2014, CLIN CANCER RES, V20, P1323, DOI 10.1158/1078-0432.CCR-13-2429; Ding ZH, 2011, NATURE, V470, P269, DOI 10.1038/nature09677; Gong ZK, 2014, MOL GENET GENOMICS, V289, P1157, DOI 10.1007/s00438-014-0877-6; Grano M, 1996, P NATL ACAD SCI USA, V93, P7644, DOI 10.1073/pnas.93.15.7644; Gupta S, 2017, CLIN CANCER RES, V23, P1346, DOI 10.1158/1078-0432.CCR-16-1211; Hahn-Stromberg V, 2014, APMIS, V122, P636, DOI 10.1111/apm.12211; HOHAUS S, 1995, MOL CELL BIOL, V15, P5830; Hu P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024988; Hu ZQ, 2014, CELL REPROGRAM, V16, P266, DOI 10.1089/cell.2013.0086; HUMPHREY PA, 1995, AM J PATHOL, V147, P386; Ittmann M, 2013, CANCER RES, V73, P2718, DOI 10.1158/0008-5472.CAN-12-4213; Jeffers M, 1996, J MOL MED-JMM, V74, P505, DOI 10.1007/BF00204976; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kasai S, 1996, BIOCHEM BIOPH RES CO, V228, P646, DOI 10.1006/bbrc.1996.1710; Katoh M, 2003, INT J MOL MED, V11, P683; Kim JH, 2011, BMB REP, V44, P523, DOI 10.5483/BMBRep.2011.44.8.523; Knudsen BS, 2002, UROLOGY, V60, P1113, DOI 10.1016/S0090-4295(02)01954-4; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Kosuga M, 2000, CELL TRANSPLANT, V9, P675, DOI 10.1177/096368970000900513; Kozakowski N, 2014, TARGET ONCOL, V9, P359, DOI 10.1007/s11523-013-0298-1; Kurashige Junji, 2013, Fukuoka Acta Medica, V104, P344; Kwak MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053476; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lee AS, 2013, KIDNEY INT, V83, P50, DOI 10.1038/ki.2012.312; Lee JW, 2007, APMIS, V115, P47, DOI 10.1111/j.1600-0463.2007.apm_554.x; Lee SH, 2016, ONCOGENE, V35, P702, DOI 10.1038/onc.2015.117; Liu GL, 2014, ASIAN PAC J TROP MED, V7, P76, DOI 10.1016/S1995-7645(13)60196-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsumoto K, 1996, J BIOCHEM-TOKYO, V119, P591; Mulholland DJ, 2012, CANCER RES, V72, P1878, DOI 10.1158/0008-5472.CAN-11-3132; Nalla AK, 2011, EXP CELL RES, V317, P2512, DOI 10.1016/j.yexcr.2011.07.024; Nauseef JT, 2011, NAT REV UROL, V8, P428, DOI 10.1038/nrurol.2011.85; Nishi N, 1996, PROSTATE, V28, P139; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Peng Y, 2011, J BIOL CHEM, V286, P40331, DOI 10.1074/jbc.M111.302059; PISTERS LL, 1995, J UROLOGY, V154, P293, DOI 10.1016/S0022-5347(01)67297-5; Rao DS, 2002, J CLIN INVEST, V110, P351, DOI 10.1172/JCI200215529; Russo AL, 2009, CLIN CANCER RES, V15, P4292, DOI 10.1158/1078-0432.CCR-09-0599; Saeki N, 2009, GENE CHROMOSOME CANC, V48, P261, DOI 10.1002/gcc.20636; Sasnauskiene A, 2014, MED LITH, V50, P14, DOI 10.1016/j.medici.2014.05.002; Sathyanarayana UG, 2003, CLIN CANCER RES, V9, P6395; Schalken JA, 2003, UROLOGY, V62, P11, DOI 10.1016/S0090-4295(03)00758-1; Sharma M, 2002, J BIOL CHEM, V277, P30935, DOI 10.1074/jbc.M201919200; Singh V, 2015, OMICS, V19, P688, DOI 10.1089/omi.2015.0121; Stucke VM, 2007, MOL BIOL CELL, V18, P1744, DOI 10.1091/mbc.E06-11-0980; Su Q, 2017, ONCOGENE, V36, P618, DOI 10.1038/onc.2016.232; Sung CO, 2013, J CLIN PATHOL, V66, P601, DOI 10.1136/jclinpath-2012-201271; Tasic B, 2011, P NATL ACAD SCI USA, V108, P7902, DOI 10.1073/pnas.1019507108; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Vadnais C, 2014, BIOL OPEN, V3, P937, DOI 10.1242/bio.20148193; van Leenders G, 2002, PROSTATE, V51, P98, DOI 10.1002/pros.10073; van Leenders GJLH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026753; Varkaris A, 2011, EXPERT OPIN INV DRUG, V20, P1677, DOI 10.1517/13543784.2011.631523; Verras M, 2007, CANCER RES, V67, P967, DOI 10.1158/0008-5472.CAN-06-3552; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Watanabe M, 1999, CANCER LETT, V141, P173, DOI 10.1016/S0304-3835(99)00102-0; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; Xie L, 2004, WORLD J GASTROENTERO, V10, P1286; Xu CJ, 2017, BIOMED PHARMACOTHER, V91, P1167, DOI 10.1016/j.biopha.2017.05.056; Yan GB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09951-2; Yu EJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174357; Zhu CF, 2011, J BIOL CHEM, V286, P33478, DOI 10.1074/jbc.M111.269894	82	10	10	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					20123	20136		10.1074/jbc.RA118.005395	http://dx.doi.org/10.1074/jbc.RA118.005395			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30401749	Green Published, hybrid			2022-12-28	WOS:000454685900021
J	Kim, MJ; Park, IJ; Yun, H; Kang, I; Choe, W; Kim, SS; Ha, J				Kim, Min-Jung; Park, In-Ja; Yun, Hee; Kang, Insug; Choe, Wonchae; Kim, Sung-Soo; Ha, Joohun			AMP-activated protein kinase antagonizes pro-apoptotic extracellular signal-regulated kinase activation by inducing dual-specificity protein phosphatases in response to glucose deprivation in HCT116 carcinoma. (vol 285, pg 14617, 2010)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Kim, Sung Soo/S-2540-2017	Kim, Sung Soo/0000-0002-6817-7668				Kim MJ, 2010, J BIOL CHEM, V285, P14617, DOI 10.1074/jbc.M109.085456	1	0	0	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2018	293	46					18012	18012		10.1074/jbc.AAC118.006426	http://dx.doi.org/10.1074/jbc.AAC118.006426			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HA6SG	30446602	Green Published, hybrid			2022-12-28	WOS:000450409500029
J	Shiina, N				Shiina, Nobuyuki			Liquid- and solid-like RNA granules form through specific scaffold proteins and combine into biphasic granules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA binding protein; scaffold protein; molecular dynamics; fluorescence recovery after photobleaching (FRAP); cell permeabilization; core-shell; liquid; liquid-liquid phase separation (LLPS); RNA granule; solid	STRESS GRANULES; DENDRITIC LOCALIZATION; PHASE-SEPARATION; BINDING PROTEIN; MESSENGER-RNA; TRANSLATION; LINK	RNA granules consist of membrane-less RNA-protein assemblies and contain dynamic liquid-like shells and stable solid-like cores, which are thought to function in numerous processes in mRNA sorting and translational regulation. However, how these distinct substructures are formed, whether they are assembled by different scaffolds, and whether different RNA granule scaffolds induce these different substructures remains unknown. Here, using fluorescence microscopy-based morphological and molecular-dynamics analyses, we demonstrate that RNA granule scaffold proteins (scaffolds) can be largely classified into two groups, liquid and solid types, which induce the formation of liquid-like and solid-like granules, respectively, when expressed separately in cultured cells. We found that when co-expressed, the liquid-type and solid-type scaffolds combine and form liquid- and solid-like substructures in the same granules, respectively. The combination of the different types of scaffolds reduced the immobile fractions of the solid-type scaffolds and their dose-dependent ability to decrease nascent polypeptides in granules, but had little effect on the dynamics of the liquid-type scaffolds or their dose-dependent ability to increase nascent polypeptides in granules. These results suggest that solid- and liquid-type scaffolds form different substructures in RNA granules and differentially affect each other. Our findings provide detailed insight into the assembly mechanism and distinct dynamics and functions of core and shell substructures in RNA granules.	[Shiina, Nobuyuki] Natl Inst Basic Biol, Lab Neuronal Cell Biol, Okazaki, Aichi 4448585, Japan; [Shiina, Nobuyuki] Exploratory Res Ctr Life & Living Syst ExCELLS, Okazaki, Aichi 4448585, Japan; [Shiina, Nobuyuki] Grad Univ Adv Studies SOKENDAI, Dept Basic Biol, Okazaki, Aichi 4448585, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); National Institutes of Natural Sciences (NINS) - Japan; The Exploratory Research Center on Life & Living Systems (ExCELLS); Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okazaki Institute for Integrative Bioscience (OIIB)	Shiina, N (corresponding author), Natl Inst Basic Biol, Lab Neuronal Cell Biol, Okazaki, Aichi 4448585, Japan.	nshiina@nibb.ac.jp		Shiina, Nobuyuki/0000-0002-1854-4239	Takeda Science Foundation; Astellas Foundation for Research on Metabolic Disorders; Orion Project of Okazaki Institute for Integrative Bioscience	Takeda Science Foundation(Takeda Science Foundation (TSF)); Astellas Foundation for Research on Metabolic Disorders; Orion Project of Okazaki Institute for Integrative Bioscience	This work was supported by the Takeda Science Foundation, the Astellas Foundation for Research on Metabolic Disorders, and the Orion Project of Okazaki Institute for Integrative Bioscience to N. S. The author declares that he has no conflicts of interest with the contents of this article.	Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Banani SF, 2016, CELL, V166, P651, DOI 10.1016/j.cell.2016.06.010; Bramham CR, 2007, NAT REV NEUROSCI, V8, P776, DOI 10.1038/nrn2150; Brangwynne CP, 2011, P NATL ACAD SCI USA, V108, P4334, DOI 10.1073/pnas.1017150108; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; David A, 2011, J BIOL CHEM, V286, P20688, DOI 10.1074/jbc.M110.209452; Feric M, 2016, CELL, V165, P1686, DOI 10.1016/j.cell.2016.04.047; Fujii R, 2005, CURR BIOL, V15, P587, DOI 10.1016/j.cub.2005.01.058; Gadelmawla ES, 2002, J MATER PROCESS TECH, V123, P133, DOI 10.1016/S0924-0136(02)00060-2; Ganassi M, 2016, MOL CELL, V63, P796, DOI 10.1016/j.molcel.2016.07.021; Hyman AA, 2014, ANNU REV CELL DEV BI, V30, P39, DOI 10.1146/annurev-cellbio-100913-013325; Jain S, 2016, CELL, V164, P487, DOI 10.1016/j.cell.2015.12.038; Kedersha N, 2013, TRENDS BIOCHEM SCI, V38, P494, DOI 10.1016/j.tibs.2013.07.004; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Krichevsky AM, 2001, NEURON, V32, P683, DOI 10.1016/S0896-6273(01)00508-6; Lee KH, 2016, CELL, V167, P774, DOI 10.1016/j.cell.2016.10.002; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; Liu-Yesucevitz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013250; Mateju D, 2017, EMBO J, V36, P1669, DOI 10.15252/embj.201695957; Mazroui R, 2002, HUM MOL GENET, V11, P3007, DOI 10.1093/hmg/11.24.3007; Moon BU, 2016, LAB CHIP, V16, P2601, DOI 10.1039/c6lc00576d; Nakayama K, 2017, ELIFE, V6, DOI 10.7554/eLife.29677; Ramaswami M, 2013, CELL, V154, P727, DOI 10.1016/j.cell.2013.07.038; Reineke LC, 2012, MOL BIOL CELL, V23, P3499, DOI 10.1091/mbc.E12-05-0385; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shiina N, 2005, J NEUROSCI, V25, P4420, DOI 10.1523/JNEUROSCI.0382-05.2005; Shiina N, 2014, J BIOL CHEM, V289, P21163, DOI 10.1074/jbc.M114.556365; Shiina N, 2010, J NEUROSCI, V30, P12816, DOI 10.1523/JNEUROSCI.6386-09.2010; Shin Y, 2017, CELL, V168, P159, DOI 10.1016/j.cell.2016.11.054; Souquere S, 2009, J CELL SCI, V122, P3619, DOI 10.1242/jcs.054437; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Uversky VN, 2017, CURR OPIN STRUC BIOL, V44, P18, DOI 10.1016/j.sbi.2016.10.015; Vessey JP, 2006, J NEUROSCI, V26, P6496, DOI 10.1523/JNEUROSCI.0649-06.2006; Weber SC, 2012, CELL, V149, P1188, DOI 10.1016/j.cell.2012.05.022; Wheeler JR, 2016, ELIFE, V5, DOI 10.7554/eLife.18413; Wu YH, 2016, ACTA CRYSTALLOGR D, V72, P718, DOI 10.1107/S2059798316004903	37	27	27	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3532	3548		10.1074/jbc.RA118.005423	http://dx.doi.org/10.1074/jbc.RA118.005423			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30606735	Green Published, hybrid			2022-12-28	WOS:000461853900019
J	Sikimic, J; McMillen, TS; Bleile, C; Dastvan, F; Quast, U; Krippeit-Drews, P; Drews, G; Bryan, J				Sikimic, Jelena; McMillen, Timothy S.; Bleile, Cita; Dastvan, Frank; Quast, Ulrich; Krippeit-Drews, Peter; Drews, Gisela; Bryan, Joseph			ATP binding without hydrolysis switches sulfonylurea receptor 1 (SUR1) to outward-facing conformations that activate K-ATP channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP-binding cassette transporter subfamily C member 8 (ABCC8); ABC transporter; allosteric regulation; diabetes; ion channel; ATP-sensitive potassium channel; glibenclamide; hyperinsulinism; KCNJ11 (Kir6; 2); neonatal diabetes; K-ATP channel; SUR1; congenital hyperinsulinism; metabolic sensor	SENSITIVE POTASSIUM CHANNELS; BETA-CELL; TOLBUTAMIDE-SENSITIVITY; INSULIN SECRETAGOGUES; GLIBENCLAMIDE BINDING; NUCLEOTIDE REGULATION; STIMULATORY ACTION; ABC TRANSPORTERS; N-TERMINUS; MUTATIONS	Neuroendocrine-type ATP-sensitive K+ (K-ATP) channels are metabolite sensors coupling membrane potential with metabolism, thereby linking insulin secretion to plasma glucose levels. They are octameric complexes, (SUR1/Kir6.2)(4), comprising sulfonylurea receptor 1 (SUR1 or ABCC8) and a K+-selective inward rectifier (Kir6.2 or KCNJ11). Interactions between nucleotide-, agonist-, and antagonist-binding sites affect channel activity allosterically. Although it is hypothesized that opening these channels requires SUR1-mediated MgATP hydrolysis, we show here that ATP binding to SUR1, without hydrolysis, opens channels when nucleotide antagonism on Kir6.2 is minimized and SUR1 mutants with increased ATP affinities are used. We found that ATP binding is sufficient to switch SUR1 alone between inward- or outward-facing conformations with low or high dissociation constant, K-D, values for the conformation-sensitive channel antagonist [H-3]glibenclamide ([H-3]GBM), indicating that ATP can act as a pure agonist. Assembly with Kir6.2 reduced SUR1's K-D for [H-3]GBM. This reduction required the Kir N terminus (KNtp), consistent with KNtp occupying a transport cavity, thus positioning it to link ATP-induced SUR1 conformational changes to channel gating. Moreover, ATP/GBM site coupling was constrained in WT SUR1/WT Kir6.2 channels; ATP-bound channels had a lower K-D for [H-3]GBM than ATP-bound SUR1. This constraint was largely eliminated by the Q1179R neonatal diabetes-associated mutation in helix 15, suggesting that a swapped helix pair, 15 and 16, is part of a structural pathway connecting the ATP/GBM sites. Our results suggest that ATP binding to SUR1 biases K-ATP channels toward open states, consistent with SUR1 variants with lower K-D values causing neonatal diabetes, whereas increased K-D values cause congenital hyperinsulinism.	[Sikimic, Jelena; Bleile, Cita; Krippeit-Drews, Peter; Drews, Gisela] Univ Tubingen, Dept Pharmacol, Inst Pharm, D-72076 Tubingen, Germany; [McMillen, Timothy S.; Dastvan, Frank; Bryan, Joseph] Pacific Northwest Diabet Res Inst, 720 Broadway, Seattle, WA 98122 USA; [Quast, Ulrich] Eberhard Karls Univ Hosp & Clin, Dept Expt & Clin Pharmacol & Toxicol, D-72074 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Pacific Northwest Diabetes Research Institute (PNDRI); Eberhard Karls University of Tubingen	Bryan, J (corresponding author), Pacific Northwest Diabet Res Inst, 720 Broadway, Seattle, WA 98122 USA.	jbryan1941@outlook.com	RAHI, DEEPALI/GMW-8189-2022	RAHI, DEEPALI/0000-0002-4818-5572; McMillen, Timothy/0000-0001-5261-3229	National Institutes of Health [DK098647]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098647, P30DK017047] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant DK098647 (to J. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; Aguilar-Bryan L, 2008, ENDOCR REV, V29, P265, DOI 10.1210/er.2007-0029; AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; Akers D. L., 2001, MATH J, V8, P27; ALPER JS, 1993, TALANTA, V40, P355, DOI 10.1016/0039-9140(93)80246-N; ASHCROFT FM, 1989, DIABETOLOGIA, V32, P591; ASHCROFT FM, 1987, FEBS LETT, V215, P9, DOI 10.1016/0014-5793(87)80103-5; Babenko ADP, 2005, J MOL CELL CARDIOL, V39, P79, DOI 10.1016/j.yjmcc.2004.12.004; Babenko AP, 2008, J BIOL CHEM, V283, P8778, DOI 10.1074/jbc.C700243200; Babenko AP, 2006, NEW ENGL J MED, V355, P456, DOI 10.1056/NEJMoa055068; Babenko AP, 1999, J BIOL CHEM, V274, P11587, DOI 10.1074/jbc.274.17.11587; Babenko AP, 2002, J BIOL CHEM, V277, P43997, DOI 10.1074/jbc.M208085200; Babenko AP, 2001, J BIOL CHEM, V276, P49083, DOI 10.1074/jbc.M108763200; Baukrowitz T, 1998, SCIENCE, V282, P1141, DOI 10.1126/science.282.5391.1141; Baukrowitz T, 2000, BIOCHEM PHARMACOL, V60, P735, DOI 10.1016/S0006-2952(00)00267-7; Beguin P, 1999, EMBO J, V18, P4722, DOI 10.1093/emboj/18.17.4722; Bers DM, 2010, METHOD CELL BIOL, V99, P1, DOI [10.1016/S0091-679X(10)99001-8, 10.1016/B978-0-12-374841-6.00001-3]; Bienengraeber M, 2000, FASEB J, V14, P1943, DOI 10.1096/fj.00-0027com; Bowman P, 2012, DIABETOLOGIA, V55, P123, DOI 10.1007/s00125-011-2319-x; Branstrom R, 1998, J BIOL CHEM, V273, P31395, DOI 10.1074/jbc.273.47.31395; Bryan J, 2005, CURR PHARM DESIGN, V11, P2699, DOI 10.2174/1381612054546879; Bryan J, 2004, DIABETES, V53, pS104, DOI 10.2337/diabetes.53.suppl_3.S104; Bryan J, 2007, PFLUG ARCH EUR J PHY, V453, P703, DOI 10.1007/s00424-006-0116-z; Choi KH, 2008, J PHYS CHEM B, V112, P10314, DOI 10.1021/jp712088v; Christesen H. B. T., 2005, HORM RES, V64, P135; Christopoulos A, 1998, TRENDS PHARMACOL SCI, V19, P351, DOI 10.1016/S0165-6147(98)01240-1; Clement JP, 1997, NEURON, V18, P827, DOI 10.1016/S0896-6273(00)80321-9; COOK DL, 1984, NATURE, V311, P271, DOI 10.1038/311271a0; Dabrowski M, 2001, DIABETOLOGIA, V44, P747, DOI 10.1007/s001250051684; de Wet H, 2007, FEBS J, V274, P3532, DOI 10.1111/j.1742-4658.2007.05879.x; Dickinson KEJ, 1997, MOL PHARMACOL, V52, P473, DOI 10.1124/mol.52.3.473; DUNNE MJ, 1986, FEBS LETT, V208, P59, DOI 10.1016/0014-5793(86)81532-0; DUNNE MJ, 1987, J MEMBRANE BIOL, V99, P215, DOI 10.1007/BF01995702; Emdin CA, 2017, DIABETES, V66, P2310, DOI 10.2337/db17-0149; Fatehi M, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150143; Fatehi M, 2012, DIABETES, V61, P241, DOI 10.2337/db11-0371; Gribble FM, 1998, P NATL ACAD SCI USA, V95, P7185, DOI 10.1073/pnas.95.12.7185; Hambrock A, 2002, BRIT J PHARMACOL, V136, P995, DOI 10.1038/sj.bjp.0704801; Hambrock A, 1998, BRIT J PHARMACOL, V125, P577, DOI 10.1038/sj.bjp.0702109; Hansen AMK, 2005, BRIT J PHARMACOL, V144, P551, DOI 10.1038/sj.bjp.0706082; Hattersley AT, 2017, DIABETOLOGIA, V60, P769, DOI 10.1007/s00125-017-4226-2; Hattersley AT, 2005, DIABETES, V54, P2503, DOI 10.2337/diabetes.54.9.2503; HOPKINS WF, 1992, J MEMBRANE BIOL, V129, P287; Hu SL, 2000, J PHARMACOL EXP THER, V293, P444; Inagaki N, 1997, FEBS LETT, V409, P232, DOI 10.1016/S0014-5793(97)00488-2; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; KAKEI M, 1986, FEBS LETT, V208, P63, DOI 10.1016/0014-5793(86)81533-2; Koster JC, 1999, J GEN PHYSIOL, V114, P203, DOI 10.1085/jgp.114.2.203; Kuhner P, 2012, N-S ARCH PHARMACOL, V385, P299, DOI 10.1007/s00210-011-0709-8; LEBRUN P, 1989, J PHARMACOL EXP THER, V250, P1011; Lee KPK, 2017, ELIFE, V6, DOI 10.7554/eLife.32481; Lemelman MB, 2018, CLIN PERINATOL, V45, P41, DOI 10.1016/j.clp.2017.10.006; Li LH, 2000, BIOPHYS J, V79, P841, DOI 10.1016/S0006-3495(00)76340-5; Li NN, 2017, CELL, V168, P101, DOI 10.1016/j.cell.2016.12.028; Light PE, 2002, MOL ENDOCRINOL, V16, P2135, DOI 10.1210/me.2002-0084; Lin YF, 2008, NEUROSCIENCE, V152, P371, DOI 10.1016/j.neuroscience.2008.01.003; Linton KJ, 2007, PHYSIOLOGY, V22, P122, DOI 10.1152/physiol.00046.2006; Martin GM, 2017, ELIFE, V6, DOI 10.7554/eLife.31054; Martin GM, 2017, ELIFE, V6, DOI 10.7554/eLife.24149; Masia R, 2007, DIABETES, V56, P328, DOI 10.2337/db06-1275; Matsuo M, 1999, J BIOL CHEM, V274, P37479, DOI 10.1074/jbc.274.52.37479; Mikhailov MV, 2005, EMBO J, V24, P4166, DOI 10.1038/sj.emboj.7600877; Moody JE, 2002, J BIOL CHEM, V277, P21111, DOI 10.1074/jbc.C200228200; NIKI I, 1991, BIOCHIM BIOPHYS ACTA, V1133, P95, DOI 10.1016/0167-4889(91)90246-T; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Oldham ML, 2008, CURR OPIN STRUC BIOL, V18, P726, DOI 10.1016/j.sbi.2008.09.007; Orelle C, 2003, J BIOL CHEM, V278, P47002, DOI 10.1074/jbc.M308268200; Ortiz D, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00048; Ortiz D, 2013, J BIOL CHEM, V288, P18894, DOI 10.1074/jbc.M113.476887; Ortiz D, 2012, J BIOL CHEM, V287, P17985, DOI 10.1074/jbc.M112.349019; PANTEN U, 1990, N-S ARCH PHARMACOL, V342, P566; Pinney SE, 2008, J CLIN INVEST, V118, P2877, DOI 10.1172/JCI35414; Proks P, 2014, J GEN PHYSIOL, V144, P469, DOI 10.1085/jgp.201411222; Proks P, 2013, DIABETES, V62, P3909, DOI 10.2337/db13-0531; Quast U, 2004, DIABETES, V53, pS156, DOI 10.2337/diabetes.53.suppl_3.S156; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Reimann F, 1999, J PHYSIOL-LONDON, V518, P325, DOI 10.1111/j.1469-7793.1999.0325p.x; Rohacs T, 2003, P NATL ACAD SCI USA, V100, P745, DOI 10.1073/pnas.0236364100; SCHMIDANTOMARCHI H, 1987, J BIOL CHEM, V262, P15840; Schulze D, 2003, J PHYSIOL-LONDON, V552, P357, DOI 10.1113/jphysiol.2003.047035; SCHWANSTECHER M, 1994, J BIOL CHEM, V269, P17768; Schwanstecher M, 1998, EMBO J, V17, P5529, DOI 10.1093/emboj/17.19.5529; SCHWANSTECHER M, 1992, BRIT J PHARMACOL, V105, P531, DOI 10.1111/j.1476-5381.1992.tb09014.x; SCHWANSTECHER M, 1991, N-S ARCH PHARMACOL, V343, P83; Shyng SL, 1997, J GEN PHYSIOL, V110, P655, DOI 10.1085/jgp.110.6.655; Shyng SL, 1998, SCIENCE, V282, P1138, DOI 10.1126/science.282.5391.1138; SIEGEL S, 1956, NONPARAMETRIC STAT, P75; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Stephan D, 2006, DIABETOLOGIA, V49, P2039, DOI 10.1007/s00125-006-0307-3; STURGESS NC, 1988, BRIT J PHARMACOL, V95, P83, DOI 10.1111/j.1476-5381.1988.tb16551.x; STURGESS NC, 1985, LANCET, V2, P474; SWILLENS S, 1995, MOL PHARMACOL, V47, P1197; THOMAS PM, 1995, SCIENCE, V268, P426, DOI 10.1126/science.7716548; Tombline G, 2004, J BIOL CHEM, V279, P46518, DOI 10.1074/jbc.M408052200; TRUBE G, 1986, PFLUG ARCH EUR J PHY, V407, P493, DOI 10.1007/BF00657506; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; Vila-Carriles WH, 2007, FASEB J, V21, P18, DOI 10.1096/fj.06-6730hyp; Wu JX, 2018, PROTEIN CELL, V9, P553, DOI 10.1007/s13238-018-0530-y; Zingman LV, 2007, J APPL PHYSIOL, V103, P1888, DOI 10.1152/japplphysiol.00747.2007; Zingman LV, 2002, J BIOL CHEM, V277, P14206, DOI 10.1074/jbc.M109452200; Zingman LV, 2001, NEURON, V31, P233, DOI 10.1016/S0896-6273(01)00356-7; ZUNKLER BJ, 1988, N-S ARCH PHARMACOL, V337, P225	102	8	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3707	3719		10.1074/jbc.RA118.005236	http://dx.doi.org/10.1074/jbc.RA118.005236			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30587573	Green Published, hybrid			2022-12-28	WOS:000461853900032
J	Manta, B; Moller, MN; Bonilla, M; Deambrosi, M; Grunberg, K; Bellanda, M; Comini, MA; Ferrer-Sueta, G				Manta, Bruno; Moller, Matias N.; Bonilla, Mariana; Deambrosi, Matias; Grunberg, Karin; Bellanda, Massimo; Comini, Marcelo A.; Ferrer-Sueta, Gerardo			Kinetic studies reveal a key role of a redox-active glutaredoxin in the evolution of the thiol-redox metabolism of trypanosomatid parasites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						trypanosome; glutathionylation; oxidation-reduction (redox); enzyme catalysis; disulfide; thiol; fluorescence; trypanothione	PROTEIN DISULFIDE-ISOMERASE; NMR SOLUTION STRUCTURE; IRON-SULFUR CLUSTER; ESCHERICHIA-COLI; MIXED DISULFIDE; AFRICAN TRYPANOSOMES; DITHIOL GLUTAREDOXINS; GLUTATHIONE-REDUCTASE; CATALYTIC-PROPERTIES; ENZYMATIC MECHANISM	Trypanosomes are flagellated protozoan parasites (kinetoplastids) that have a unique redox metabolism based on the small dithiol trypanothione (T(SH)(2)). Although GSH may still play a biological role in trypanosomatid parasites beyond being a building block of T(SH)(2), most of its functions are replaced by T(SH)(2) in these organisms. Consequently, trypanosomes have several enzymes adapted to using T(SH)(2) instead of GSH, including the glutaredoxins (Grxs). However, the mechanistic basis of Grx specificity for T(SH)(2) is unknown. Here, we combined fast-kinetic and biophysical approaches, including NMR, MS, and fluorescent tagging, to study the redox function of Grx1, the only cytosolic redox-active Grx in trypanosomes. We observed that Grx1 reduces GSH-containing disulfides (including oxidized trypanothione) in very fast reactions (k > 5 x 10(5) m(-1) s(-1)). We also noted that disulfides without a GSH are much slower oxidants, suggesting a strongly selective binding of the GSH molecule. Not surprisingly, oxidized Grx1 was also reduced very fast by T(SH)(2) (4.8 x 10(6) m(-1) s(-1)); however, GSH-mediated reduction was extremely slow (39 m(-1) s(-1)). This kinetic selectivity in the reduction step of the catalytic cycle suggests that Grx1 uses preferentially a dithiol mechanism, forming a disulfide on the active site during the oxidative half of the catalytic cycle and then being rapidly reduced by T(SH)(2) in the reductive half. Thus, the reduction of glutathionylated substrates avoids GSSG accumulation in an organism lacking GSH reductase. These findings suggest that Grx1 has played an important adaptive role during the rewiring of the thiol-redox metabolism of kinetoplastids.	[Manta, Bruno; Bonilla, Mariana; Deambrosi, Matias; Grunberg, Karin; Comini, Marcelo A.] Inst Pasteur Montevideo, Grp Biol Redox Tripanosomas, Montevideo 11400, Uruguay; [Manta, Bruno; Moller, Matias N.; Bonilla, Mariana; Grunberg, Karin; Ferrer-Sueta, Gerardo] Univ Republica, Fac Ciencias, Inst Quim Biol, Lab Fisicoquim Biol, Montevideo 11400, Uruguay; [Bonilla, Mariana; Deambrosi, Matias] Univ Republica, Fac Ciencias, Inst Quim Biol, Lab Enzimol, Montevideo 11400, Uruguay; [Moller, Matias N.; Ferrer-Sueta, Gerardo] Univ Republica, Ctr Free Radical & Biomed Res, Montevideo, Uruguay; [Bellanda, Massimo] Univ Padua, Dipartimento Sci Chim, I-35131 Padua, Italy; [Manta, Bruno] New England Biolabs Inc, 240 Cty Rd, Ipswich, MA 01938 USA	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; University of Padua; New England Biolabs	Ferrer-Sueta, G (corresponding author), Fac Ciencias, Lab Fisicoquim Biol, Igua 4225, Montevideo 11400, Uruguay.	gferrer@fcien.edu.uy	Ferrer-Sueta, Gerardo/C-3316-2011	Ferrer-Sueta, Gerardo/0000-0002-8663-8480; Bonilla, Mariana/0000-0002-9206-345X; Deambrosi, Matias/0000-0001-9111-5898; Moller, Matias N./0000-0002-3486-8217; BELLANDA, MASSIMO/0000-0002-8187-0264; Comini, Marcelo/0000-0001-5000-1333	Comision Sectorial de Investigacion Cientifica Universidad de la Republica [C601-348]; International Centre for Genetic Engineering and Biotechnology [CRP/URU14-01]; PRAT Universita degli Studi di Padova [COF 03/11, CPDA137397/13]; European Comission [261863]; Fondo para la Convergencia Estructural del Mercosur	Comision Sectorial de Investigacion Cientifica Universidad de la Republica; International Centre for Genetic Engineering and Biotechnology; PRAT Universita degli Studi di Padova; European Comission(European CommissionEuropean Commission Joint Research Centre); Fondo para la Convergencia Estructural del Mercosur	This work was supported by Grant C601-348 from Comision Sectorial de Investigacion Cientifica Universidad de la Republica (to B. M. and G. F. S.), CRP/URU14-01 International Centre for Genetic Engineering and Biotechnology and Fondo para la Convergencia Estructural del Mercosur, COF 03/11 (to M. A. C.), and CPDA137397/13 from PRAT Universita degli Studi di Padova, and European Comission Project number 261863 Bio-NMR (to M. Bellanda). The authors declare that they have no conflicts of interest with the contents of this article.	Alvarez MN, 2002, METHOD ENZYMOL, V359, P353; Arias DG, 2013, FREE RADICAL BIO MED, V63, P65, DOI 10.1016/j.freeradbiomed.2013.04.036; Aslund F, 1997, J BIOL CHEM, V272, P30780, DOI 10.1074/jbc.272.49.30780; ASLUND F, 1994, P NATL ACAD SCI USA, V91, P9813, DOI 10.1073/pnas.91.21.9813; Attarian R, 2009, FEBS LETT, V583, P3215, DOI 10.1016/j.febslet.2009.09.007; Bao R, 2009, BBA-PROTEINS PROTEOM, V1794, P1218, DOI 10.1016/j.bbapap.2009.04.001; Begas P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14835; Berndt C, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00168; Bjornberg O, 2006, BIOCHEMISTRY-US, V45, P2362, DOI 10.1021/bi0522495; Bjornberg O, 1991, Protein Expr Purif, V2, P287, DOI 10.1016/1046-5928(91)90085-W; Bocedi A, 2018, FEBS J, V285, P3225, DOI 10.1111/febs.14609; Bonilla M, 2011, J BIOL CHEM, V286, P4959, DOI 10.1074/jbc.M110.170761; BUSHWELLER JH, 1994, J MOL BIOL, V235, P1585, DOI 10.1006/jmbi.1994.1108; Ceylan S, 2010, J BIOL CHEM, V285, P35224, DOI 10.1074/jbc.M110.165860; Chandrangsu P, 2018, ANTIOXID REDOX SIGN, V28, P445, DOI 10.1089/ars.2017.7057; Cheng ZY, 2007, BIOCHEMISTRY-US, V46, P7875, DOI 10.1021/bi700442r; Comini MA, 2007, BIOCHEM J, V402, P43, DOI 10.1042/BJ20061341; Comini MA, 2013, ANTIOXID REDOX SIGN, V19, P708, DOI 10.1089/ars.2012.4932; Couturier J, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00518; Couturier J, 2009, J BIOL CHEM, V284, P9299, DOI 10.1074/jbc.M807998200; Darby NJ, 1995, BIOCHEMISTRY-US, V34, P16770, DOI 10.1021/bi00051a027; Discola KF, 2009, J MOL BIOL, V385, P889, DOI 10.1016/j.jmb.2008.10.055; Dormeyer M, 2001, J BIOL CHEM, V276, P10602, DOI 10.1074/jbc.M010352200; Ebersoll S, 2018, REDOX BIOL, V15, P532, DOI 10.1016/j.redox.2018.01.011; ELLIS KJ, 1982, METHOD ENZYMOL, V87, P405; ERIKSSON SA, 1970, FEBS LETT, V7, P26, DOI 10.1016/0014-5793(70)80608-1; FAIRLAMB AH, 1992, ANNU REV MICROBIOL, V46, P695, DOI 10.1146/annurev.micro.46.1.695; Feng YG, 2006, BIOCHEMISTRY-US, V45, P7998, DOI 10.1021/bi060444t; Flohe L, 2013, BBA-GEN SUBJECTS, V1830, P3139, DOI 10.1016/j.bbagen.2012.10.020; Fueller F, 2012, J BIOL CHEM, V287, P8792, DOI 10.1074/jbc.M111.338285; Fyfe PK, 2012, P NATL ACAD SCI USA, V109, P11693, DOI 10.1073/pnas.1202593109; Gallogly MM, 2008, BIOCHEMISTRY-US, V47, P11144, DOI 10.1021/bi800966v; GAN ZR, 1987, J BIOL CHEM, V262, P6704; Gao XH, 2010, FEBS LETT, V584, P2242, DOI 10.1016/j.febslet.2010.04.034; GILBERT HF, 1995, METHOD ENZYMOL, V251, P8, DOI 10.1016/0076-6879(95)51107-5; Gonzalez-Chavez Z, 2015, BBA-GEN SUBJECTS, V1850, P263, DOI 10.1016/j.bbagen.2014.10.029; GRASSETTI DR, 1967, ARCH BIOCHEM BIOPHYS, V119, P41, DOI 10.1016/0003-9861(67)90426-2; GRAVINA SA, 1993, BIOCHEMISTRY-US, V32, P3368, DOI 10.1021/bi00064a021; HENDERSON GB, 1991, P NATL ACAD SCI USA, V88, P8769, DOI 10.1073/pnas.88.19.8769; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; HOLMGREN A, 1979, J BIOL CHEM, V254, P3672; HOLMGREN A, 1979, J BIOL CHEM, V254, P9113; Iversen R, 2010, BIOCHEMISTRY-US, V49, P810, DOI 10.1021/bi9015956; Jao SC, 2006, BIOCHEMISTRY-US, V45, P4785, DOI 10.1021/bi0516327; JENSEN EV, 1959, SCIENCE, V130, P1319, DOI 10.1126/science.130.3385.1319; Jensen KS, 2011, J AM CHEM SOC, V133, P3034, DOI 10.1021/ja1096539; Kanzok SM, 2001, SCIENCE, V291, P643, DOI 10.1126/science.291.5504.643; KRAUSE G, 1991, J BIOL CHEM, V266, P9494; Krauth-Siegel RL, 2008, BBA-GEN SUBJECTS, V1780, P1236, DOI 10.1016/j.bbagen.2008.03.006; Lillig CH, 2005, P NATL ACAD SCI USA, V102, P8168, DOI 10.1073/pnas.0500735102; Lundstrom-Ljung J, 1999, FEBS LETT, V443, P85, DOI 10.1016/S0014-5793(98)01698-6; Manta B, 2018, ANTIOXID REDOX SIGN, V28, P463, DOI 10.1089/ars.2017.7133; Manta B, 2013, ANTIOXID REDOX SIGN, V19, P665, DOI 10.1089/ars.2012.4859; Melchers J, 2007, J BIOL CHEM, V282, P8678, DOI 10.1074/jbc.M608140200; MENDES P, 1993, COMPUT APPL BIOSCI, V9, P563; MIEYAL JJ, 1991, BIOCHEMISTRY-US, V30, P8883, DOI 10.1021/bi00100a023; MOUTIEZ M, 1995, BIOCHEM J, V310, P433, DOI 10.1042/bj3100433; MOUTIEZ M, 1994, CHEM PHARM BULL, V42, P2641; Musunda B, 2015, MOL BIOCHEM PARASIT, V204, P93, DOI 10.1016/j.molbiopara.2016.02.001; NAGAI S, 1968, J BIOL CHEM, V243, P1942; Noguera ME, 2017, SCI REP-UK, V7, DOI 10.1038/srep42343; Nordstrand K, 1999, J MOL BIOL, V286, P541, DOI 10.1006/jmbi.1998.2444; Nordstrand K, 1999, FEBS LETT, V449, P196, DOI 10.1016/S0014-5793(99)00401-9; Peltoniemi MJ, 2006, J BIOL CHEM, V281, P33107, DOI 10.1074/jbc.M605602200; Portillo-Ledesma S, 2014, BIOCHEMISTRY-US, V53, P6113, DOI 10.1021/bi500389m; RABENSTEIN DL, 1995, BBA-PROTEIN STRUCT M, V1249, P29, DOI 10.1016/0167-4838(95)00067-5; RACKER E, 1955, J BIOL CHEM, V217, P867; Reckenfelderbaumer N, 2002, J BIOL CHEM, V277, P17548, DOI 10.1074/jbc.M112115200; Reyes AM, 2018, ANTIOXID REDOX SIGN, V28, P487, DOI 10.1089/ars.2017.7074; Sagemark J, 2007, PROTEINS, V68, P879, DOI 10.1002/prot.21416; Sardi F, 2013, ANAL BIOCHEM, V435, P74, DOI 10.1016/j.ab.2012.12.017; Schanda P, 2005, J BIOMOL NMR, V33, P199, DOI 10.1007/s10858-005-4425-x; Schmidt H, 2003, J BIOL CHEM, V278, P46329, DOI 10.1074/jbc.M305338200; Srinivasan U, 1997, BIOCHEMISTRY-US, V36, P3199, DOI 10.1021/bi962017t; Stefani M, 2016, BIOMOL NMR ASSIGN, V10, P85, DOI 10.1007/s12104-015-9643-x; Stroher E, 2012, BIOCHEM J, V446, P333, DOI 10.1042/BJ20112131; SZAJEWSKI RP, 1980, J AM CHEM SOC, V102, P2011, DOI 10.1021/ja00526a042; TSANG MLS, 1981, J BACTERIOL, V146, P1059, DOI 10.1128/JB.146.3.1059-1066.1981; Ulrich K, 2017, ANTIOXID REDOX SIGN, V27, P517, DOI 10.1089/ars.2016.6947; Van Laer K, 2014, PROTEIN SCI, V23, P238, DOI 10.1002/pro.2397; WILSON JM, 1977, J AM CHEM SOC, V99, P7922, DOI 10.1021/ja00466a027; Yang YW, 1998, BIOCHEMISTRY-US, V37, P17145, DOI 10.1021/bi9806504; Zaffagnini M, 2012, ANTIOXID REDOX SIGN, V16, P17, DOI 10.1089/ars.2011.3933; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718	84	8	10	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2019	294	9					3235	3248		10.1074/jbc.RA118.006366	http://dx.doi.org/10.1074/jbc.RA118.006366			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU0SA	30593501	Green Published, hybrid			2022-12-28	WOS:000464980100021
J	Chen, LP; Guo, P; Zhang, HY; Li, WX; Gao, C; Huang, ZL; Fan, JL; Zhang, YL; Li, X; Liu, XL; Wang, FP; Wang, S; Li, QY; He, ZN; Li, HY; Chen, S; Wu, XN; Ye, LZ; Li, Q; Tang, HW; Wang, Q; Dong, GH; Xiao, YM; Chen, W; Li, DC				Chen, Liping; Guo, Ping; Zhang, Haiyan; Li, Wenxue; Gao, Chen; Huang, Zhenlie; Fan, Junling; Zhang, Yuling; Li, Xue; Liu, Xiaoling; Wang, Fangping; Wang, Shan; Li, Qingye; He, Zhini; Li, Huiyao; Chen, Shen; Wu, Xiaonen; Ye, Lizhu; Li, Qiong; Tang, Huanwen; Wang, Qing; Dong, Guanghui; Xiao, Yongmei; Chen, Wen; Li, Daochuan			Benzene-induced mouse hematotoxicity is regulated by a protein phosphatase 2A complex that stimulates transcription of cytochrome P4502E1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						beta-catenin (beta-catenin); hematopoiesis; metabolism; phosphorylation; protein phosphatase 2 (PP2A); gene regulation; beta-catenin phosphorylation; benzene; cyp2e1; hematotoxicity; protein phosphatase 2A	BETA-CATENIN; MYELOID-LEUKEMIA; PP2A COMPLEXES; DNA-DAMAGE; EXPRESSION; SUBUNIT; ACTIVATION; WORKERS; ALPHA; PHOSPHORYLATION	Chronic benzene exposure is associated with hematotoxicity and the development of aplastic anemia and leukemia. However, the signaling pathways underlying benzene-induced hematotoxicity remain to be defined. Here, we investigated the role of protein phosphatase 2A (PP2A) in the regulation of benzene-induced hematotoxicity in a murine model. Male mice with a hepatocyte-specific homozygous deletion of the Ppp2r1a gene (encoding PP2A A alpha subunit) (HO) and matched wildtype (WT) mice were exposed to benzene via inhalation at doses of 1, 10, and 100 ppm for 28 days. Peripheral white blood cell counts and activation of bone marrow progenitors were attenuated in the HO mice, indicating that Ppp2r1a deletion protects against benzene-induced hematotoxicity. Moreover, elevation of urinary S-phenyl mercapturic acid, a benzene metabolite, was much greater in WT mice than in HO mice. Real-time exhalation analysis revealed more exhaled benzene but fewer benzene metabolites in HO mice than in WT mice, possibly because of the down-regulation of Cyp2e1, encoding cytochrome P4502E1, in hepatocytes of the HO mice. Loss-of-function screening disclosed that PP2A complexes containing the B56 alpha subunit participate in regulating Cyp2e1 expression. Notably, PP2A-B56 alpha suppression in HepG2 cells resulted in persistent beta-catenin phosphorylation at Ser(33)-Ser(37)-Thr(41) in response to CYP2E1 agonists. In parallel, nuclear translocation of beta-catenin was inhibited, concomitant with a remarkable decrease of Cyp2e1 expression. These findings support the notion that a regulatory cascade comprising PP2A-B56 alpha, beta-catenin, and Cyp2e1 is involved in benzene-induced hematotoxicity, providing critical insight into the role of PP2A in responses to the environmental chemicals.	[Chen, Liping; Guo, Ping; Zhang, Haiyan; Gao, Chen; Fan, Junling; Liu, Xiaoling; Wang, Fangping; Wang, Shan; Li, Qingye; Li, Huiyao; Chen, Shen; Wu, Xiaonen; Ye, Lizhu; Li, Qiong; Wang, Qing; Dong, Guanghui; Xiao, Yongmei; Chen, Wen; Li, Daochuan] Sun Yat Sen Univ, Sch Publ Hlth, Dept Toxicol, Guangdong Prov Key Lab Food Nutr & Hlth, Guangzhou 510080, Guangdong, Peoples R China; [Li, Wenxue] Guangzhou Ctr Dis Control & Prevent, Dept Toxicol, Guangzhou 510440, Guangdong, Peoples R China; [Huang, Zhenlie; He, Zhini] Southern Med Univ, Sch Publ Hlth, Food Safety & Hlth Res Ctr, Guangzhou 510515, Guangdong, Peoples R China; [Zhang, Yuling; Li, Xue] Jinan Univ, Inst Mass Spectrometer & Atmospher Environm, Guangzhou 510632, Guangdong, Peoples R China; [Tang, Huanwen] Guangdong Med Univ, Sch Publ Hlth, Dongguan Key Lab Environm Med, Dongguan 523808, Peoples R China	Sun Yat Sen University; Southern Medical University - China; Jinan University; Guangdong Medical University	Li, DC (corresponding author), Sun Yat Sen Univ, Dept Toxicol, Sch Publ Hlth, Guangzhou, Guangdong, Peoples R China.	lidchuan@mail.sysu.edu.cn	Liu, Xiaoling/HGD-3566-2022; Huang, Zhenlie/AAQ-9970-2020; Dong, Guanghui/AAN-4630-2020; wang, fang/GYD-4295-2022	Chen, Shen/0000-0001-8640-4492; Dong, Guang-Hui/0000-0002-2578-3369; He, Zhini/0000-0002-9185-5500; Huang, Zhenlie/0000-0001-9818-8192	Key Program of the National Natural Science Foundation of China [81430079]; Guangdong Provincial Natural Science Foundation Team Project [2018B030312005]; National Natural Science Foundation of China (NSFC) [31401213, 81602877, 81372962, 81402715, 81602882]; Fundamental Research Funds for the Central Universities [17ykpy13]; Natural Science Foundation of Guangdong Province Doctor Staring Program [2016A030310163]	Key Program of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Natural Science Foundation Team Project; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Natural Science Foundation of Guangdong Province Doctor Staring Program	This work was supported by Key Program of the National Natural Science Foundation of China Grant 81430079, Guangdong Provincial Natural Science Foundation Team Project Grant 2018B030312005, National Natural Science Foundation of China (NSFC) Grants 31401213, 81602877, 81372962, 81402715, and 81602882, the Fundamental Research Funds for the Central Universities Grant 17ykpy13, and the Natural Science Foundation of Guangdong Province Doctor Staring Program Grant 2016A030310163. The authors declare that they have no conflicts of interest with the contents of this article.	Arriazu E, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00078; Badham HJ, 2010, CHEM-BIOL INTERACT, V184, P218, DOI 10.1016/j.cbi.2009.11.005; Bahadar H, 2015, ENVIRON TOXICOL PHAR, V39, P1161, DOI 10.1016/j.etap.2015.04.010; Bahadar H, 2014, TOXICOL APPL PHARM, V276, P83, DOI 10.1016/j.taap.2014.02.012; Billet S, 2010, ARCH TOXICOL, V84, P99, DOI 10.1007/s00204-009-0478-z; Chen LP, 2014, J BIOL CHEM, V289, P22413, DOI 10.1074/jbc.M114.548677; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Chen WQ, 2011, AM J PATHOL, V178, P2333, DOI 10.1016/j.ajpath.2011.01.041; Cordeiro MH, 2018, INT J BIOCHEM CELL B, V96, P148, DOI 10.1016/j.biocel.2017.10.017; Engin A, 2017, ADV EXP MED BIOL, V960, P111, DOI 10.1007/978-3-319-48382-5_5; Environment Protection Agency, 2002, TOX REV BENZ NONC EF; Ganzenberg K, 2013, TOXICOLOGY, V308, P113, DOI 10.1016/j.tox.2013.03.019; Groll N, 2016, TOXICOLOGY, V350, P40, DOI 10.1016/j.tox.2016.05.004; Gut I, 1996, ARCH TOXICOL, V71, P45, DOI 10.1007/s002040050357; Heijne WHM, 2005, MUTAT RES-FUND MOL M, V575, P85, DOI 10.1016/j.mrfmmm.2005.02.003; Huang H, 2008, CURR OPIN CELL BIOL, V20, P119, DOI 10.1016/j.ceb.2008.01.009; Ishibashi K, 2018, CANCER GENOM PROTEOM, V15, P53, DOI 10.21873/cgp.20064; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Kanaar R, 1998, NATURE, V391, P335, DOI 10.1038/34790; Li JQ, 2018, TOXICOL IN VITRO, V46, P361, DOI 10.1016/j.tiv.2017.08.018; Li J, 2018, ENVIRON POLLUT, V234, P127, DOI 10.1016/j.envpol.2017.11.042; Li J, 2017, BIOMARKERS, V22, P470, DOI 10.1080/1354750X.2016.1274335; Liu C, 2013, J ALZHEIMERS DIS, V37, P483, DOI 10.3233/JAD-130503; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu WH, 2013, CARCINOGENESIS, V34, P818, DOI 10.1093/carcin/bgs409; McHale CM, 2011, ENVIRON HEALTH PERSP, V119, P628, DOI 10.1289/ehp.1002546; Mutoh S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003705; Neviani P, 2013, J CLIN INVEST, V123, P4144, DOI 10.1172/JCI68951; Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735; Ramaswamy K, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00016; Reynhout S, 2019, BBA-MOL CELL RES, V1866, P31, DOI 10.1016/j.bbamcr.2018.07.010; Ross D, 2000, J TOXICOL ENV HEAL A, V61, P357, DOI 10.1080/00984100050166361; Ruvolo PP, 2014, BBA-MOL CELL RES, V1843, P1969, DOI 10.1016/j.bbamcr.2014.05.006; Sablina AA, 2010, CANCER RES, V70, P10474, DOI 10.1158/0008-5472.CAN-10-2855; Schettgen T, 2008, J CHROMATOGR B, V863, P283, DOI 10.1016/j.jchromb.2008.01.024; Schnatter AR, 2012, J NATL CANCER I, V104, P1724, DOI 10.1093/jnci/djs411; Seeling JM, 1999, SCIENCE, V283, P2089, DOI 10.1126/science.283.5410.2089; Shi YG, 2009, SCI CHINA SER C, V52, P135, DOI 10.1007/s11427-009-0018-3; Shimoyama S, 2014, BBA-GENE REGUL MECH, V1839, P107, DOI 10.1016/j.bbagrm.2013.12.004; Snyder R, 2012, INT J ENV RES PUB HE, V9, P2875, DOI 10.3390/ijerph9082875; Stamos JL, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a007898; Sun RL, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13111068; Toop HD, 2016, ORG BIOMOL CHEM, V14, P4605, DOI 10.1039/c6ob00556j; Vlaanderen J, 2012, AM J IND MED, V55, P779, DOI 10.1002/ajim.22087; Yang J, 2003, DEVELOPMENT, V130, P5569, DOI 10.1242/dev.00762; Zhang LP, 2002, CRIT REV TOXICOL, V32, P1, DOI 10.1080/20024091064165; Zhang W, 2009, J BIOL CHEM, V284, P22649, DOI 10.1074/jbc.M109.013698; Zhang YL, 2017, CHEMOSPHERE, V184, P93, DOI 10.1016/j.chemosphere.2017.05.135; Zheng Y, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0226-x; Zhou J, 2003, BIOCHEM J, V369, P387, DOI 10.1042/BJ20021244; Zhu XN, 2014, CELL SIGNAL, V26, P825, DOI 10.1016/j.cellsig.2014.01.002	51	9	9	2	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2019	294	7					2486	2499		10.1074/jbc.RA118.006319	http://dx.doi.org/10.1074/jbc.RA118.006319			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL7CN	30567741	hybrid, Green Published			2022-12-28	WOS:000458895400024
J	Yi, Q; Chen, QF; Yan, HY; Zhang, M; Liang, C; Xiang, XF; Pan, X; Wang, FW				Yi, Qi; Chen, Qinfu; Yan, Haiyan; Zhang, Miao; Liang, Cai; Xiang, Xingfeng; Pan, Xuan; Wang, Fangwei			Aurora B kinase activity-dependent and -independent functions of the chromosomal passenger complex in regulating sister chromatid cohesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						centromere; mitosis; kinetochore; cell cycle; histone modification; chromosomal passenger complex; cohesin; Haspin; heterochromatin protein 1; sister chromatid cohesion; Aurora B; INCENP	PROTECTS CENTROMERIC COHESION; MICROTUBULE-BINDING; SPINDLE CHECKPOINT; MITOTIC CHROMOSOME; INNER CENTROMERE; HISTONE H3; CENP-B; THR-3 PHOSPHORYLATION; MPS1; BUB1	The chromosomal passenger complex (CPC) is a master regulator of mitosis. CPC consists of inner centromere protein (INCENP), Survivin, Borealin, and the kinase Aurora B and plays key roles in regulating kinetochore-microtubule attachments and spindle assembly checkpoint signaling. However, the role of CPC in sister chromatid cohesion, mediated by the cohesin complex, remains incompletely understood. Here, we show that Aurora B kinase activity contributes to centromeric cohesion protection partly through promoting kinetochore localization of the kinase Bub1. Interestingly, disrupting the interaction of INCENP with heterochromatin protein 1 (HP1) in HeLa cells selectively weakens cohesion at mitotic centromeres without detectably reducing the kinase activity of Aurora B. Thus, through this INCENP-HP1 interaction, the CPC also protects centromeric cohesion independently of Aurora B kinase activity. Moreover, the requirement for the INCENP-HP1 interaction in centromeric cohesion protection can be bypassed by tethering HP1 to centromeres or by depleting the cohesin release factor Wapl. We provide further evidence suggesting that the INCENP-HP1 interaction protects centromeric cohesion by promoting the centromere localization of Haspin, a protein kinase that antagonizes Wapl activity at centromeres. Taken together, this study identifies Aurora B kinase activity-dependent and -independent roles for the CPC in regulating centromeric cohesion during mitosis in human cells.	[Yi, Qi; Chen, Qinfu; Yan, Haiyan; Zhang, Miao; Liang, Cai; Xiang, Xingfeng; Pan, Xuan; Wang, Fangwei] Zhejiang Univ, MOE, Lab Biosyst Homeostasis & Protect, Hangzhou 310058, Zhejiang, Peoples R China; [Yi, Qi; Chen, Qinfu; Yan, Haiyan; Zhang, Miao; Liang, Cai; Xiang, Xingfeng; Pan, Xuan; Wang, Fangwei] Zhejiang Univ, Life Sci Inst, Innovat Ctr Cell Signaling Network, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Wang, FW (corresponding author), Zhejiang Univ, MOE, Lab Biosyst Homeostasis & Protect, Hangzhou 310058, Zhejiang, Peoples R China.; Wang, FW (corresponding author), Zhejiang Univ, Life Sci Inst, Innovat Ctr Cell Signaling Network, Hangzhou 310058, Zhejiang, Peoples R China.	fwwang@zju.edu.cn		Chen, Qinfu/0000-0003-4581-5329; Cai, Liang/0000-0002-1885-4237	National Key Research and Development Program of China [2017YFA0503600]; National Natural Science Foundation of China (NSFC) [31571393, 31771499, 31561130155, 31322032, 31371359]; Natural Science Foundation of Zhejiang Province [LZ19C070001, LR13C070001, LY17C070003]; Newton Advanced Fellowship [NA140075]; Fundamental Research Funds for the Central Universities	National Key Research and Development Program of China; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Newton Advanced Fellowship; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Key Research and Development Program of China Grant 2017YFA0503600 (to F. W.); National Natural Science Foundation of China (NSFC) Grants 31571393, 31771499, 31561130155, 31322032, and 31371359 (to F. W.); Natural Science Foundation of Zhejiang Province Grants LZ19C070001 and LR13C070001 (to F. W.) and LY17C070003 (to H. Y.); Newton Advanced Fellowship NA140075; and Fundamental Research Funds for the Central Universities. The authors declare that they have no conflicts of interest with the contents of this article.	Abe Y, 2016, DEV CELL, V36, P487, DOI 10.1016/j.devcel.2016.02.008; Adams RR, 2000, CURR BIOL, V10, P1075, DOI 10.1016/S0960-9822(00)00673-4; Ainsztein AM, 1998, J CELL BIOL, V143, P1763, DOI 10.1083/jcb.143.7.1763; Bakhoum SF, 2018, CELL, V174, P1347, DOI 10.1016/j.cell.2018.08.027; Bakhoum SF, 2018, NATURE, V553, P467, DOI 10.1038/nature25432; Baron AP, 2016, ELIFE, V5, DOI 10.7554/eLife.12187; Bishop JD, 2002, J BIOL CHEM, V277, P27577, DOI 10.1074/jbc.C200307200; Brasher SV, 2000, EMBO J, V19, P1587, DOI 10.1093/emboj/19.7.1587; Carmena M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001250; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Dai J, 2005, GENE DEV, V19, P472, DOI 10.1101/gad.1267105; Dai J, 2006, DEV CELL, V11, P741, DOI 10.1016/j.devcel.2006.09.018; Daum JR, 2011, CURR BIOL, V21, P1018, DOI 10.1016/j.cub.2011.05.032; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; DeLuca KF, 2011, J CELL SCI, V124, P622, DOI 10.1242/jcs.072629; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Dreier MR, 2011, J CELL SCI, V124, P2976, DOI 10.1242/jcs.085431; EARNSHAW WC, 1987, J CELL BIOL, V104, P817, DOI 10.1083/jcb.104.4.817; Gandhi R, 2006, CURR BIOL, V16, P2406, DOI 10.1016/j.cub.2006.10.061; Gimenez-Abian JF, 2004, CURR BIOL, V14, P1187, DOI 10.1016/j.cub.2004.06.052; Goto Y, 2017, CURR BIOL, V27, P1005, DOI 10.1016/j.cub.2017.02.066; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Hengeveld RCC, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15542; Hewitt L, 2010, J CELL BIOL, V190, P25, DOI 10.1083/jcb.201002133; Hiruma Y, 2015, SCIENCE, V348, P1264, DOI 10.1126/science.aaa4055; Honda R, 2003, MOL BIOL CELL, V14, P3325, DOI 10.1091/mbc.E02-11-0769; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Ji ZJ, 2015, SCIENCE, V348, P1260, DOI 10.1126/science.aaa4029; Kang J, 2011, MOL BIOL CELL, V22, P1181, DOI 10.1091/mbc.E11-01-0009; Kawashima SA, 2007, GENE DEV, V21, P420, DOI 10.1101/gad.1497307; Kawashima SA, 2010, SCIENCE, V327, P172, DOI 10.1126/science.1180189; Kelly AE, 2010, SCIENCE, V330, P235, DOI 10.1126/science.1189505; Kitajima TS, 2005, CURR BIOL, V15, P353, DOI 10.1016/j.cub.2004.12.044; Kitajima TS, 2004, NATURE, V427, P510, DOI 10.1038/nature02312; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Lampson MA, 2004, NAT CELL BIOL, V6, P232, DOI 10.1038/ncb1102; Lara-Gonzalez P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049041; Liang C, 2018, EMBO REP, V19, P43, DOI 10.15252/embr.201744737; Liu H, 2015, MOL CELL, V59, P426, DOI 10.1016/j.molcel.2015.06.018; Liu H, 2013, CURR BIOL, V23, P1927, DOI 10.1016/j.cub.2013.07.078; Liu X, 2014, J BIOL CHEM, V289, P20638, DOI 10.1074/jbc.M114.572842; London N, 2014, NAT REV MOL CELL BIO, V15, P735, DOI 10.1038/nrm3888; London N, 2014, GENE DEV, V28, P140, DOI 10.1101/gad.233700.113; London N, 2012, CURR BIOL, V22, P900, DOI 10.1016/j.cub.2012.03.052; Losada A, 2002, GENE DEV, V16, P3004, DOI 10.1101/gad.249202; Losada A, 2014, NAT REV CANCER, V14, P389, DOI 10.1038/nrc3743; Maison C, 2004, NAT REV MOL CELL BIO, V5, P296, DOI 10.1038/nrm1355; MASUMOTO H, 1989, J CELL BIOL, V109, P1963, DOI 10.1083/jcb.109.5.1963; McGuinness BE, 2005, PLOS BIOL, V3, P433, DOI 10.1371/journal.pbio.0030086; Meppelink A, 2015, CELL REP, V11, P508, DOI 10.1016/j.celrep.2015.03.052; Morales C, 2018, CURR OPIN CELL BIOL, V52, P51, DOI 10.1016/j.ceb.2018.01.010; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Nijenhuis W, 2013, J CELL BIOL, V201, P217, DOI 10.1083/jcb.201210033; Nishiyama T, 2013, P NATL ACAD SCI USA, V110, P13404, DOI 10.1073/pnas.1305020110; Nishiyama T, 2010, CELL, V143, P737, DOI 10.1016/j.cell.2010.10.031; Nozawa RS, 2010, NAT CELL BIOL, V12, P719, DOI 10.1038/ncb2075; PLUTA AF, 1992, J CELL BIOL, V116, P1081, DOI 10.1083/jcb.116.5.1081; Primorac I, 2013, ELIFE, V2, DOI 10.7554/eLife.01030; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ricke RM, 2012, J CELL BIOL, V199, P931, DOI 10.1083/jcb.201205115; Ruppert JG, 2018, EMBO J, V37, DOI 10.15252/embj.201797677; Salic A, 2004, CELL, V118, P567, DOI 10.1016/j.cell.2004.08.016; Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036; Sapkota H, 2018, MOL BIOL CELL, V29, P2601, DOI 10.1091/mbc.E18-05-0315; Saurin AT, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1319; Sessa F, 2005, MOL CELL, V18, P379, DOI 10.1016/j.molcel.2005.03.031; Shepperd LA, 2012, CURR BIOL, V22, P891, DOI 10.1016/j.cub.2012.03.051; Shimura M, 2011, J CELL BIOL, V194, P721, DOI 10.1083/jcb.201010118; Smothers JF, 2000, CURR BIOL, V10, P27, DOI 10.1016/S0960-9822(99)00260-2; Stevens D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022969; Sumara I, 2002, MOL CELL, V9, P515, DOI 10.1016/S1097-2765(02)00473-2; Tang ZY, 2004, P NATL ACAD SCI USA, V101, P18012, DOI 10.1073/pnas.0408600102; Tanno Y, 2010, GENE DEV, V24, P2169, DOI 10.1101/gad.1945310; Thiru A, 2004, EMBO J, V23, P489, DOI 10.1038/sj.emboj.7600088; Trivedi P, 2016, TRENDS BIOCHEM SCI, V41, P160, DOI 10.1016/j.tibs.2015.11.002; van der Waal MS, 2012, EMBO REP, V13, P847, DOI 10.1038/embor.2012.93; Wang FW, 2010, SCIENCE, V330, P231, DOI 10.1126/science.1189435; Welburn JPI, 2010, MOL CELL, V38, P383, DOI 10.1016/j.molcel.2010.02.034; Wood KW, 2010, P NATL ACAD SCI USA, V107, P5839, DOI 10.1073/pnas.0915068107; Yamagishi Y, 2008, NATURE, V455, P251, DOI 10.1038/nature07217; Yamagishi Y, 2012, NAT CELL BIOL, V14, P746, DOI 10.1038/ncb2515; Yamagishi Y, 2010, SCIENCE, V330, P239, DOI 10.1126/science.1194498; Yi Q, 2018, EMBO REP, V19, DOI 10.15252/embr.201745484; Zeitlin SG, 2001, J CELL BIOL, V155, P1147, DOI 10.1083/jcb.200108125; Zhou LL, 2017, CURR BIOL, V27, P992, DOI 10.1016/j.cub.2017.02.019; Zhu TG, 2013, J BIOL CHEM, V288, P36149, DOI 10.1074/jbc.M113.507970	92	13	14	0	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2019	294	6					2021	2035		10.1074/jbc.RA118.005978	http://dx.doi.org/10.1074/jbc.RA118.005978			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM8EO	30523151	Green Published, hybrid			2022-12-28	WOS:000459711400021
J	Scholz-Starke, J; Primo, C; Yang, J; Kandel, R; Gaxiola, RA; Hirschi, KD				Scholz-Starke, Joachim; Primo, Cecilia; Yang, Jian; Kandel, Raju; Gaxiola, Roberto A.; Hirschi, Kendal D.			The flip side of the Arabidopsis type I proton-pumping pyrophosphatase (AVP1): Using a transmembrane H+ gradient to synthesize pyrophosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arabidopsis thaliana; proton pump; Saccharomyces cerevisiae; vacuole; patch clamp; H+ pumping pyrophosphatase; pH gradient; PPi synthase; pyrophosphate (PPi); tonoplast	TRANSLOCATING PYROPHOSPHATASE; INORGANIC PYROPHOSPHATASE; FUNCTIONAL EXPRESSION; GENETIC MANIPULATION; MOLECULAR-CLONING; PPASE AVP1; V-ATPASE; TRANSPORT; ENERGY; PHLOEM	Energy partitioning and plant growth are mediated in part by a type I H+-pumping pyrophosphatase (H+-PPase). A canonical role for this transporter has been demonstrated at the tonoplast where it serves a job-sharing role with V-ATPase in vacuolar acidification. Here, we investigated whether the plant H+-PPase from Arabidopsis also functions in "reverse mode" to synthesize PPi using the transmembrane H+ gradient. Using patch-clamp recordings on Arabidopsis vacuoles, we observed inward currents upon P-i application on the cytosolic side. These currents were strongly reduced in vacuoles from two independent H+-PPase mutant lines (vhp1-1 and fugu5-1) lacking the classical PPi-induced outward currents related to H+ pumping, whereas they were significantly larger in vacuoles with engineered heightened expression of the H+-PPase. Current amplitudes related to reverse-mode H+ transport depended on the membrane potential, cytosolic P-i concentration, and magnitude of the pH gradient across the tonoplast. Of note, experiments on vacuolar membrane-enriched vesicles isolated from yeast expressing the Arabidopsis H+-PPase (AVP1) demonstrated P-i-dependent PPi synthase activity in the presence of a pH gradient. Our work establishes that a plant H+-PPase can operate as a PPi synthase beyond its canonical role in vacuolar acidification and cytosolic PPi scavenging. We propose that the PPi synthase activity of H+-PPase contributes to a cascade of events that energize plant growth.	[Scholz-Starke, Joachim] CNR, Inst Biophys, Via De Marini 6, I-16149 Genoa, Italy; [Primo, Cecilia; Yang, Jian; Hirschi, Kendal D.] Baylor Coll Med, Childrens Nutr Res Ctr, Houston, TX 77030 USA; [Kandel, Raju; Gaxiola, Roberto A.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); Baylor College of Medicine; Arizona State University; Arizona State University-Tempe	Scholz-Starke, J (corresponding author), CNR, Inst Biophys, Via De Marini 6, I-16149 Genoa, Italy.; Hirschi, KD (corresponding author), Baylor Coll Med, Childrens Nutr Res Ctr, Houston, TX 77030 USA.	joachim.scholzstarke@ge.ibf.cnr.it; kendalh@bcm.edu	hirschi, kendal/GNP-0351-2022; Primo Planta, Cecilia/AAU-1204-2021; Primo, Cecilia/AAT-8561-2021; Scholz-Starke, Joachim/A-2944-2014	Primo Planta, Cecilia/0000-0002-3305-5150; Gaxiola, Roberto/0000-0001-9348-9850; Scholz-Starke, Joachim/0000-0002-7376-6635	National Science Foundation [IOS 1557890]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant IOS 1557890 (to R. K., C. P., K. D. H., and R. A. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Alexandersson E, 2004, PLANT CELL PHYSIOL, V45, P1543, DOI 10.1093/pcp/pch209; Atwell BJ, 2015, NEW PHYTOL, V206, P36, DOI 10.1111/nph.13173; BALTSCHEFFSKY H, 1966, SCIENCE, V153, P1120, DOI 10.1126/science.153.3740.1120; Baltscheffsky M, 1998, BBA-BIOENERGETICS, V1364, P301, DOI 10.1016/S0005-2728(98)00062-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carpaneto A, 2017, EMBO REP, V18, P1100, DOI 10.15252/embr.201643814; Costa A, 2012, J PHYSIOL-LONDON, V590, P3421, DOI 10.1113/jphysiol.2012.230227; DAVIES JM, 1992, P NATL ACAD SCI USA, V89, P11701, DOI 10.1073/pnas.89.24.11701; Davies JM, 1997, TRENDS PLANT SCI, V2, P9, DOI 10.1016/S1360-1385(97)82732-X; Drake R, 2010, BIOCHEM J, V426, P147, DOI 10.1042/BJ20091491; Drozdowicz YM, 2001, TRENDS PLANT SCI, V6, P206, DOI 10.1016/S1360-1385(01)01923-9; Facanha AR, 1998, PLANT PHYSIOL, V116, P1487, DOI 10.1104/pp.116.4.1487; FALCO SC, 1983, GENETICS, V105, P843; Ferjani A, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01265; Ferjani A, 2011, PLANT CELL, V23, P2895, DOI 10.1105/tpc.111.085415; Fukuda M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00819; Gaxiola RA, 2002, PLANT PHYSIOL, V129, P967, DOI 10.1104/pp.020009; Gaxiola RA, 2016, TRENDS BIOTECHNOL, V34, P347, DOI 10.1016/j.tibtech.2015.12.016; Gaxiola RA, 2016, MOL PLANT, V9, P317, DOI 10.1016/j.molp.2015.09.008; Gaxiola RA, 2012, PLANT PHYSIOL, V159, P3, DOI 10.1104/pp.112.195701; GIAQUINTA R, 1977, PLANT PHYSIOL, V59, P750, DOI 10.1104/pp.59.4.750; Graus D, 2018, NEW PHYTOL, V219, P1421, DOI 10.1111/nph.15280; HEDRICH R, 1989, EMBO J, V8, P2835, DOI 10.1002/j.1460-2075.1989.tb08430.x; Hedrich R, 2012, PHYSIOL REV, V92, P1777, DOI 10.1152/physrev.00038.2011; Hill JE, 2000, BIOCHEM J, V351, P281, DOI 10.1042/0264-6021:3510281; Huang SB, 2008, TRENDS PLANT SCI, V13, P221, DOI 10.1016/j.tplants.2008.02.007; JONES EW, 1991, METHOD ENZYMOL, V194, P428; Khadilkar AS, 2016, PLANT PHYSIOL, V170, P401, DOI 10.1104/pp.15.01409; KIM EJ, 1995, J BIOL CHEM, V270, P2630, DOI 10.1074/jbc.270.6.2630; KIM EJ, 1994, P NATL ACAD SCI USA, V91, P6128, DOI 10.1073/pnas.91.13.6128; Kriegel A, 2015, PLANT CELL, V27, P3383, DOI 10.1105/tpc.15.00733; Labbe S, 1999, METHOD ENZYMOL, V306, P145; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li JS, 2005, SCIENCE, V310, P121, DOI 10.1126/science.1115711; Li KM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13596; Liu JL, 2015, P NATL ACAD SCI USA, V112, pE6571, DOI 10.1073/pnas.1514598112; Liu QX, 2010, PLANT MOL BIOL, V72, P47, DOI 10.1007/s11103-009-9549-z; Maeshima M, 2000, BBA-BIOMEMBRANES, V1465, P37, DOI 10.1016/S0005-2736(00)00130-9; Marmagne A, 2007, MOL CELL PROTEOMICS, V6, P1980, DOI 10.1074/mcp.M700099-MCP200; Marsh K, 2000, J AM SOC HORTIC SCI, V125, P420, DOI 10.21273/JASHS.125.4.420; Martinoia E, 2007, J EXP BOT, V58, P83, DOI 10.1093/jxb/erl183; MERTENS E, 1993, PARASITOL TODAY, V9, P122, DOI 10.1016/0169-4758(93)90169-G; Nakanishi Y, 1998, PLANT PHYSIOL, V116, P589, DOI 10.1104/pp.116.2.589; Obermeyer G, 1996, BBA-BIOMEMBRANES, V1284, P203, DOI 10.1016/S0005-2736(96)00130-7; Paez-Valencia J, 2013, PLANT PHYSIOL, V161, P1557, DOI 10.1104/pp.112.212852; Paez-Valencia J, 2011, PLANT SCI, V181, P23, DOI 10.1016/j.plantsci.2011.03.008; Perez-Castineira JR, 2011, BIOCHEM J, V437, P269, DOI 10.1042/BJ20110447; Pittman JK, 2005, FEBS LETT, V579, P2648, DOI 10.1016/j.febslet.2005.03.085; Pizzio GA, 2015, PLANT PHYSIOL, V167, P1541, DOI 10.1104/pp.114.254342; Rea P.A., 1990, METHODS PLANT BIOCH, V3, P385, DOI DOI 10.1016/B978-0-12-461013-2.50035-6; Regmi KC, 2016, PLANT SIGNAL BEHAV, V11, DOI 10.1080/15592324.2016.1231294; ROBERTS CJ, 1991, METHOD ENZYMOL, V194, P644; Schilling RK, 2017, TRENDS PLANT SCI, V22, P154, DOI 10.1016/j.tplants.2016.11.012; Segami S, 2018, PLANT CELL, V30, P1040, DOI 10.1105/tpc.17.00911; Shao E, 2004, J BIOL CHEM, V279, P48663, DOI 10.1074/jbc.M408278200; Stitt M, 1998, BOT ACTA, V111, P167, DOI 10.1111/j.1438-8677.1998.tb00692.x; Versaw WK, 2017, CURR OPIN PLANT BIOL, V39, P25, DOI 10.1016/j.pbi.2017.04.015; Viotti C, 2013, PLANT CELL, V25, P3434, DOI 10.1105/tpc.113.114827; Yang H, 2007, PLANT BIOTECHNOL J, V5, P735, DOI 10.1111/j.1467-7652.2007.00281.x	59	14	14	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1290	1299		10.1074/jbc.RA118.006315	http://dx.doi.org/10.1074/jbc.RA118.006315			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30510138	Green Published, hybrid			2022-12-28	WOS:000457879500020
J	Banerjee, A; Mahata, B; Dhir, A; Mandal, TK; Biswas, K				Banerjee, Avisek; Mahata, Barun; Dhir, Arjun; Mandal, Tapan Kumar; Biswas, Kaushik			Elevated histone H3 acetylation and loss of the Sp1-HDAC1 complex de-repress the GM2-synthase gene in renal cell carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						specificity protein 1 (Sp1); histone deacetylase 1 (HDAC1); epigenetics; acetylation; ganglioside; gene regulation; B4Galnt1; GM2-synthase; renal cell carcinoma; transcriptional repression	DNA METHYLATION; HUMAN-MELANOMA; MESSENGER-RNA; MOUSE-BRAIN; T-CELLS; EXPRESSION; SP1; TRANSCRIPTION; GANGLIOSIDES; GM2	GM2-synthase produces sialic acid-containing glycosphingolipids called gangliosides, and its mRNA overexpression and the gangliosides it generates are linked to tumor progression, migration, and suppression of tumor-specific host immune responses. However, the mechanism underlying GM2-synthase de-repression in renal cell carcinoma (RCC) is poorly understood. Here, we demonstrate that higher GM2-synthase mRNA expression levels in various cancer cells and in human RCC tumors correlate with higher histone acetylation levels (H3K9, H3K14, or both) at region +38/+187 relative to the transcription start site (TSS) of the GM2-synthase gene than in normal kidney epithelial (NKE) cells or healthy adjacent tissues. An increase in GM2-synthase mRNA expression in cells treated with a histone deacetylase (HDAC) inhibitor was accompanied by increased histone acetylation levels at this promoter region. DNA methylation around the TSS was absent in both RCC cell lines and NKE cells. Of note, both the transcription factor Sp1 and corepressor HDAC1 associated with the +38/+187 region when the GM2-synthase gene was repressed in NKE and tumor-adjacent tissues, indicating plausible site-specific repressive roles of HDAC1 and Sp1 in GM2-synthase mRNA expression. Site-directed mutagenesis of the Sp1-binding site within the +38/+187 region relieved repressed luciferase activity of this region by limiting HDAC1 recruitment. Moreover, Sp1 or HDAC1 knock down increased GM2-synthase transcription, and butyrate-mediated activation of GM2-synthase mRNA expression in SK-RC-45 cells was accompanied by Sp1 and HDAC1 loss from the +38/+187 region. Taken together, we have identified an epigenetic mechanism for the de-repression of the GM2-synthase gene in RCC.	[Banerjee, Avisek; Mahata, Barun; Dhir, Arjun; Biswas, Kaushik] Bose Inst, Div Mol Med, Kolkata 700054, W Bengal, India; [Mandal, Tapan Kumar] Nil Ratan Sircar Med Coll & Hosp, Dept Urol, Kolkata 700014, W Bengal, India	Department of Science & Technology (India); Bose Institute	Biswas, K (corresponding author), Bose Inst, Div Mol Med, Kolkata 700054, W Bengal, India.	kbiswas_1@yahoo.com	Biswas, Kaushik/AAR-1446-2020	Biswas, Kaushik/0000-0003-2502-9515; Mahata, Barun/0000-0002-1614-0791	Bose Institute, Kolkata, India; Department of Biotechnology, India [BT/PR5338/MED/30/989/2013, BT/469/NE/TBP/2013]; University Grants Commission; Council of Scientific and Industrial Research, India	Bose Institute, Kolkata, India(Department of Science & Technology (India)); Department of Biotechnology, India(Department of Biotechnology (DBT) India); University Grants Commission(University Grants Commission, India); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the Bose Institute, Kolkata, India, and the Department of Biotechnology, India Grants BT/PR5338/MED/30/989/2013 and BT/469/NE/TBP/2013. This work was also supported by Senior Research Fellowships from the University Grants Commission (to A. B.) and the Council of Scientific and Industrial Research, India (to B. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Abdelrahim M, 2005, MOL PHARMACOL, V68, P317, DOI 10.1124/mol.105.011825; Aoki H, 2004, FEBS LETT, V567, P203, DOI 10.1016/j.febslet.2004.04.060; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Biswas K, 2006, CANCER RES, V66, P6816, DOI 10.1158/0008-5472.CAN-06-0250; Biswas S, 2009, J IMMUNOL, V183, P5050, DOI 10.4049/jimmunol.0900259; Bonasio R, 2010, SCIENCE, V330, P612, DOI 10.1126/science.1191078; Cai BH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041742; Chahlavi A, 2005, CANCER RES, V65, P5428, DOI 10.1158/0008-5472.CAN-04-4395; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Doetzlhofer A, 1999, MOL CELL BIOL, V19, P5504; Furukawa K, 1996, J BIOL CHEM, V271, P20836, DOI 10.1074/jbc.271.34.20836; Harlalka GV, 2013, BRAIN, V136, P3618, DOI 10.1093/brain/awt270; Hassig CA, 1998, P NATL ACAD SCI USA, V95, P3519, DOI 10.1073/pnas.95.7.3519; HERMAN JG, 1994, P NATL ACAD SCI USA, V91, P9700, DOI 10.1073/pnas.91.21.9700; HOON DSB, 1993, J UROLOGY, V150, P2013, DOI 10.1016/S0022-5347(17)35956-6; HOON DSB, 1988, CELL IMMUNOL, V111, P410, DOI 10.1016/0008-8749(88)90104-9; Hung JJ, 2006, MOL CELL BIOL, V26, P1770, DOI 10.1128/MCB.26.5.1770-1785.2006; Jiang GC, 2007, J VIROL, V81, P10914, DOI 10.1128/JVI.01208-07; Karmodiya K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-424; Kou XX, 2013, CARCINOGENESIS, V34, P58, DOI 10.1093/carcin/bgs336; Krishnakumar R, 2010, MOL CELL, V39, P736, DOI 10.1016/j.molcel.2010.08.014; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; Kundu M, 2016, BBA-MOL CELL RES, V1863, P1472, DOI 10.1016/j.bbamcr.2016.04.004; Li CJ, 2005, J ANIM SCI, V83, P89; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Li RG, 1996, J BIOL CHEM, V271, P18925, DOI 10.1074/jbc.271.31.18925; Mahata B, 2015, SCI REP-UK, V5, DOI 10.1038/srep09048; Manfredi MG, 1999, CANCER RES, V59, P5392; Ngamukote S, 2007, J NEUROCHEM, V103, P2327, DOI 10.1111/j.1471-4159.2007.04910.x; Petesch SJ, 2008, CELL, V134, P74, DOI 10.1016/j.cell.2008.05.029; Petretti T, 2000, GUT, V46, P359, DOI 10.1136/gut.46.3.359; Prinetti A, 2010, GLYCOBIOLOGY, V20, P62, DOI 10.1093/glycob/cwp143; Shou YP, 1998, J BIOL CHEM, V273, P5716, DOI 10.1074/jbc.273.10.5716; Suzuki Y, 2011, J NEUROCHEM, V116, P874, DOI 10.1111/j.1471-4159.2010.07042.x; TAKI T, 1979, J BIOCHEM-TOKYO, V86, P1395, DOI 10.1093/oxfordjournals.jbchem.a132656; Tsai YT, 2014, J NEUROCHEM, V128, P101, DOI 10.1111/jnc.12456; TSUCHIDA T, 1987, J NATL CANCER I, V78, P55, DOI 10.1093/jnci/78.1.55; Waby JS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-275; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Won J, 2002, J BIOL CHEM, V277, P38230, DOI 10.1074/jbc.M206064200; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532; YUYAMA Y, 1995, CANCER, V75, P1273; Zaid A, 2001, EUR J BIOCHEM, V268, P5497, DOI 10.1046/j.0014-2956.2001.02453.x	43	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2019	294	3					1005	1018		10.1074/jbc.RA118.004485	http://dx.doi.org/10.1074/jbc.RA118.004485			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL4FC	30463940	Green Published, hybrid			2022-12-28	WOS:000458670200024
J	Yun, JH; Li, XX; Park, JH; Wang, Y; Ohki, M; Jin, ZY; Lee, W; Park, SY; Hu, H; Li, CF; Zatsepin, N; Hunter, MS; Sierra, RG; Koralek, J; Yoon, CH; Cho, HS; Weierstall, U; Tang, LH; Liu, HG; Lee, W				Yun, Ji-Hye; Li, Xuanxuan; Park, Jae-Hyun; Wang, Yang; Ohki, Mio; Jin, Zeyu; Lee, Wonbin; Park, Sam-Yong; Hu, Hao; Li, Chufeng; Zatsepin, Nadia; Hunter, Mark S.; Sierra, Raymond G.; Koralek, Jake; Yoon, Chun Hong; Cho, Hyun-Soo; Weierstall, Uwe; Tang, Leihan; Liu, Haiguang; Lee, Weontae			Non-cryogenic structure of a chloride pump provides crucial clues to temperature-dependent channel transport efficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chloride transport; X-ray crystallography; ultraviolet-visible spectroscopy (UV-Vis spectroscopy); circular dichroism (CD); structure-function; light-driven chloride pump; non-cryogenic condition; serial femtosecond crystallography; transport efficiency; X-ray free electron laser; anion pump; rhodopsin; temperature dependence; time-resolved XFEL	LIPIDIC CUBIC PHASE; CRYSTAL-STRUCTURE; MEMBRANE; BACTERIORHODOPSIN; CRYSTALLIZATION; STABILIZATION; CRYSTALLOGRAPHY; RHODOPSIN; IDENTIFICATION; REFINEMENT	Non-cryogenic protein structures determined at ambient temperature may disclose significant information about protein activity. Chloride-pumping rhodopsin (ClR) exhibits a trend to hyperactivity induced by a change in the photoreaction rate because of a gradual decrease in temperature. Here, to track the structural changes that explain the differences in CIR activity resulting from these temperature changes, we used serial femtosecond crystallography (SFX) with an X-ray free electron laser (XFEL) to determine the non-cryogenic structure of ClR at a resolution of 1.85 A, and compared this structure with a cryogenic ClR structure obtained with synchrotron X-ray crystallography. The XFEL-derived ClR structure revealed that the all-trans retinal (ATR) region and positions of two coordinated chloride ions slightly differed from those of the synchrotron-derived structure. Moreover, the XFEL structure enabled identification of one additional water molecule forming a hydrogen bond network with a chloride ion. Analysis of the channel cavity and a difference distance matrix plot (DDMP) clearly revealed additional structural differences. B-factor information obtained from the non-cryogenic structure supported a motility change on the residual main and side chains as well as of chloride and water molecules because of temperature effects. Our results indicate that non-cryogenic structures and time-resolved XFEL experiments could contribute to a better understanding of the chloride-pumping mechanism of ClR and other ion pumps.	[Yun, Ji-Hye; Park, Jae-Hyun; Jin, Zeyu; Lee, Wonbin; Lee, Weontae] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul 03722, South Korea; [Li, Xuanxuan; Wang, Yang; Tang, Leihan; Liu, Haiguang] Beijing Computat Sci Res Ctr, Complex Syst Div, 10 East Xibeiwang Rd, Beijing 100193, Peoples R China; [Li, Xuanxuan] Tsinghua Univ, Dept Engn Phys, Beijing 100086, Peoples R China; [Ohki, Mio; Park, Sam-Yong] Yokohama City Univ, Grad Sch Med Life Sci, Drug Design Lab, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Hu, Hao; Li, Chufeng; Zatsepin, Nadia; Weierstall, Uwe] Arizona State Univ, Phys Dept, Tempe, AZ 85287 USA; [Hu, Hao; Li, Chufeng; Zatsepin, Nadia; Weierstall, Uwe] Arizona State Univ, Biodesign Ctr Appl Struct Discovery, Tempe, AZ 85287 USA; [Hunter, Mark S.; Sierra, Raymond G.; Koralek, Jake; Yoon, Chun Hong] SLAC Natl Accelerator Lab, Linac Coherent Light Source, Menlo Pk, CA 94025 USA; [Cho, Hyun-Soo] Yonsei Univ, Dept Syst Biol, Seoul 03722, South Korea; [Cho, Hyun-Soo] Yonsei Univ, Div Life Sci, Seoul 03722, South Korea	Yonsei University; Chinese Academy of Engineering Physics; Beijing Computational Science Research Center (CSRC); Tsinghua University; Yokohama City University; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Yonsei University; Yonsei University	Lee, W (corresponding author), Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul 03722, South Korea.; Liu, HG (corresponding author), Beijing Computat Sci Res Ctr, Complex Syst Div, 10 East Xibeiwang Rd, Beijing 100193, Peoples R China.	hgliu@csrc.ac.cn; wlee@spin.yonsei.ac.kr	Tang, Lei-Han/ABB-3219-2020; LEE, WEON TAE/AAQ-9088-2021; Zatsepin, Nadia/AAF-2451-2019	Tang, Lei-Han/0000-0002-2925-4691; Yun, Ji-Hye/0000-0001-7570-369X; Zatsepin, Nadia/0000-0003-1757-0205; liu, haiguang/0000-0001-7324-6632; Jin, Zeyu/0000-0002-6478-2967	National Research Foundation of Korea (NRF) [NRF-2017R1A2B2008483, NRF-2017M3A9F6029755]; Basic Science Research Program through the Ministry of Education [NRF-2016R1A6A3A04010213]; Brain Korea Plus(BK +) program; National Natural Science Foundation of China [11575021, U1530401, U1430237]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Basic Science Research Program through the Ministry of Education; Brain Korea Plus(BK +) program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Research Foundation of Korea (NRF) Grants NRF-2017R1A2B2008483 (to W.L.), NRF-2017M3A9F6029755 (to H.C.), and the Basic Science Research Program NRF-2016R1A6A3A04010213 (to J.-H.Y.) through the Ministry of Education. This work was also supported by Brain Korea Plus(BK +) program (to J.-H.P.) and by National Natural Science Foundation of China Grants 11575021, U1530401, and U1430237 (to H.L.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Barty A, 2014, J APPL CRYSTALLOGR, V47, P1118, DOI 10.1107/S1600576714007626; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Boutet S, 2012, SCIENCE, V337, P362, DOI 10.1126/science.1217737; BRAIMAN MS, 1988, BIOCHEMISTRY-US, V27, P8516, DOI 10.1021/bi00423a002; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Chae PS, 2010, NAT METHODS, V7, P1003, DOI 10.1038/NMETH.1526; Chapman HN, 2011, NATURE, V470, P73, DOI 10.1038/nature09750; Chun E, 2012, STRUCTURE, V20, P967, DOI 10.1016/j.str.2012.04.010; Edlund P, 2016, SCI REP-UK, V6, DOI 10.1038/srep35279; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fenalti G, 2015, NAT STRUCT MOL BIOL, V22, P265, DOI 10.1038/nsmb.2965; Ginn HM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7435; Gushchin I, 2015, NAT STRUCT MOL BIOL, V22, P390, DOI 10.1038/nsmb.3002; Harris A, 2018, PHYS CHEM CHEM PHYS, V20, P3184, DOI 10.1039/c7cp06068h; Inoue K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2689; Iyer ESS, 2016, J AM CHEM SOC, V138, P12401, DOI 10.1021/jacs.6b05002; Kim K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12677; Kolbe M, 2000, SCIENCE, V288, P1390, DOI 10.1126/science.288.5470.1390; Kouyama T, 2010, J MOL BIOL, V396, P564, DOI 10.1016/j.jmb.2009.11.061; Kwon SK, 2013, GENOME BIOL EVOL, V5, P187, DOI 10.1093/gbe/evs134; Landau EM, 1996, P NATL ACAD SCI USA, V93, P14532, DOI 10.1073/pnas.93.25.14532; LANYI JK, 1995, NATURE, V375, P461, DOI 10.1038/375461a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liang MN, 2015, J SYNCHROTRON RADIAT, V22, P514, DOI 10.1107/S160057751500449X; Liu W, 2014, NAT PROTOC, V9, P2123, DOI 10.1038/nprot.2014.141; Liu W, 2013, SCIENCE, V342, P1521, DOI 10.1126/science.1244142; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mizan TI, 1996, J PHYS CHEM-US, V100, P403, DOI 10.1021/jp951561t; Nango E, 2016, SCIENCE, V354, P1552, DOI 10.1126/science.aah3497; Nogly P, 2018, SCIENCE, V361, DOI 10.1126/science.aat0094; Nogly P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12314; Nogly P, 2015, IUCRJ, V2, P168, DOI 10.1107/S2052252514026487; ORMOS P, 1980, BIOPHYS J, V31, P207, DOI 10.1016/S0006-3495(80)85051-X; OTTO H, 1989, P NATL ACAD SCI USA, V86, P9228, DOI 10.1073/pnas.86.23.9228; Park S, 2012, ANTON LEEUW INT J G, V102, P669, DOI 10.1007/s10482-012-9765-4; Prive GG, 2007, METHODS, V41, P388, DOI 10.1016/j.ymeth.2007.01.007; Ramachandraiah G, 2002, ACTA CRYSTALLOGR D, V58, P414, DOI 10.1107/S0907444901021497; Redecke L, 2013, SCIENCE, V339, P227, DOI 10.1126/science.1229663; RICHARDS FM, 1988, PROTEINS, V3, P71, DOI 10.1002/prot.340030202; SCHERRER P, 1989, BIOCHEMISTRY-US, V28, P829, DOI 10.1021/bi00428a063; Serrano-Vega MJ, 2009, MOL MEMBR BIOL, V26, P385, DOI 10.3109/09687680903208239; Spudich JL, 2000, ANNU REV CELL DEV BI, V16, P365, DOI 10.1146/annurev.cellbio.16.1.365; Steyaert J, 2011, CURR OPIN STRUC BIOL, V21, P567, DOI 10.1016/j.sbi.2011.06.011; Tate CG, 2009, CURR OPIN STRUC BIOL, V19, P386, DOI 10.1016/j.sbi.2009.07.004; Tenboer J, 2014, SCIENCE, V346, P1242, DOI 10.1126/science.1259357; Tian W, 2018, NUCLEIC ACIDS RES, V46, pW363, DOI 10.1093/nar/gky473; Tsukamoto T, 2017, J PHYS CHEM B, V121, P2027, DOI 10.1021/acs.jpcb.6b11101; Uervirojnangkoorn M, 2015, ELIFE, V4, DOI 10.7554/eLife.05421; Wagner S, 2008, P NATL ACAD SCI USA, V105, P14371, DOI 10.1073/pnas.0804090105; Watson J. D., 1965, MOL BIOL GENE; Weierstall U, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4309; White TA, 2016, J APPL CRYSTALLOGR, V49, P680, DOI 10.1107/S1600576716004751; Yoshizawa S, 2014, P NATL ACAD SCI USA, V111, P6732, DOI 10.1073/pnas.1403051111; Zhang HT, 2015, CELL, V161, P833, DOI 10.1016/j.cell.2015.04.011	56	10	10	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2019	294	3					794	804		10.1074/jbc.RA118.004038	http://dx.doi.org/10.1074/jbc.RA118.004038			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL4FC	30455349	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000458670200006
J	John, DS; Aschenbach, J; Kruger, B; Sendler, M; Weiss, FU; Mayerle, J; Lerch, MM; Aghdassi, AA				John, Daniel S.; Aschenbach, Julia; Krueger, Burkhard; Sendler, Matthias; Weiss, F. Ulrich; Mayerle, Julia; Lerch, Markus M.; Aghdassi, Ali A.			Deficiency of cathepsin C ameliorates severity of acute pancreatitis by reduction of neutrophil elastase activation and cleavage of E-cadherin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						pancreas; cell biology; cadherin-1 (CDH1) (epithelial cadherin) (E-cadherin); neutrophil; leukocyte; acute pancreatitis; cathepsin C (CTSC); dipeptidyl-peptidase I; lysosomal protease; neutrophil elastase	DIPEPTIDYL-PEPTIDASE-I; ACUTE NECROTIZING PANCREATITIS; SERINE PROTEASES; ADHERENS JUNCTIONS; INFLAMMATORY CELLS; ACINAR-CELLS; TRYPSINOGEN; GRANZYMES; GRANULES; DELETION	Acute pancreatitis is characterized by premature intracellular protease activation and infiltration of inflammatory cells, mainly neutrophil granulocytes and macrophages, into the organ. The lysosomal proteases cathepsin B, D, and L have been identified as regulators of early zymogen activation and thus modulators of the severity of pancreatitis. Cathepsin C (CTSC, syn. dipeptidly-peptidase I) is a widely expressed, exo-cystein-protease involved in the proteolytic processing of various other lysosomal enzymes. We have studied its role in pancreatitis. We used CTSC-deleted mice and their WT littermates in two experimental models of pancreatitis. The mild model involved eight hourly caerulein injections and the severe model partial duct ligation. Isolated pancreatic acini and spleen-derived leukocytes were used for ex vivo experiments. CTSC is expressed in the pancreas and in inflammatory cells. CTSC deletion reduced the severity of pancreatitis (more prominently in the milder model) without directly affecting intra-acinar cell trypsin activation in vitro. The absence of CTSC reduced infiltration of neutrophil granulocytes impaired their capacity for cleaving E-cadherin in adherens junctions between acinar cells and reduced the activity of neutrophil serine proteases polymorphonuclear (neutrophil) elastase, cathepsin G, and proteinase 3, but not neutrophil motility. Macrophage invasion was not dependent on the presence of CTSC. CTSC is a regulator and activator of various lysosomal enzymes such as cathepsin B, D, and L. Its loss mitigates the severity of pancreatitis not by reducing intra-acinar cell zymogen activation but by reducing infiltration of neutrophil granulocytes into the pancreas. In this context one of its key roles is that of an activator of neutrophil elastase.	[John, Daniel S.; Aschenbach, Julia; Sendler, Matthias; Weiss, F. Ulrich; Mayerle, Julia; Lerch, Markus M.; Aghdassi, Ali A.] Univ Med Greifswald, Dept Med A, Ferdinand Sauerbruch Str, D-17475 Greifswald, Germany; [Krueger, Burkhard] Univ Rostock, Div Med Biol, D-18051 Rostock, Germany; [Mayerle, Julia] Ludwigs Maximilians Univ Munich, Dept Med 2, D-80539 Munich, Germany	Greifswald Medical School; University of Rostock; University of Munich	Aghdassi, AA (corresponding author), Univ Med Greifswald, Dept Med A, Ferdinand Sauerbruch Str, D-17475 Greifswald, Germany.	aghdassi@uni-greifswald.de	Aghdassi, Ali/X-5836-2019; Mayerle, Julia/W-7907-2019; Sendler, Matthias/V-9341-2017; Lerch, Markus M./E-2206-2016	Lerch, Markus M./0000-0002-9643-8263; Weiss, Frank Ulrich/0000-0003-3369-6369; Sendler, Matthias/0000-0003-3554-9426; Mayerle, Julia/0000-0002-3666-6459; Sendler, Matthias/0000-0001-6494-4105; Aghdassi, Ali/0000-0002-0569-7316	Deutsche Forschungsgemeinschaft [AG 203/2-1]; Forschungsgemeinschaft [GRK1947(A3)]; European Union [ESF/14-BM-A55-0045/16]; state of Mecklenburg-Western Pomerania	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Forschungsgemeinschaft(German Research Foundation (DFG)); European Union(European Commission); state of Mecklenburg-Western Pomerania	This work was supported by Deutsche Forschungsgemeinschaft Grant AG 203/2-1 (to A. A. A.) with additional support from Forschungsgemeinschaft Grant GRK1947(A3) and PePPP (Protein misfolding, ER-stress and protein degradation) Project Grant ESF/14-BM-A55-0045/16 funded by the European Union and the state of Mecklenburg-Western Pomerania. The authors declare that they have no conflicts of interest with the contents of this article.	Adkison AM, 2002, J CLIN INVEST, V109, P363, DOI 10.1172/JCI13462; Aghdassi AA, 2018, J BIOL CHEM, V293, P1018, DOI 10.1074/jbc.M117.814772; BROWN GR, 1993, J IMMUNOL, V150, P4733; CAPUTO A, 1993, J BIOL CHEM, V268, P17672; Chiari H., 1896, ZEITSCHRIFTFURHEILKU, V17, P69; Dahl SW, 2001, BIOCHEMISTRY-US, V40, P1671, DOI 10.1021/bi001693z; Essin K, 2007, AM J PHYSIOL-CELL PH, V293, pC45, DOI 10.1152/ajpcell.00450.2006; Gorelick FS, 2017, CELL MOL GASTROENTER, V4, P250, DOI 10.1016/j.jcmgh.2017.05.007; Gukovskaya AS, 2002, GASTROENTEROLOGY, V122, P974, DOI 10.1053/gast.2002.32409; Halangk W, 2000, J CLIN INVEST, V106, P773, DOI 10.1172/JCI9411; Halangk W, 2002, AM J PHYSIOL-GASTR L, V282, pG367, DOI 10.1152/ajpgi.00315.2001; Hermant B, 2003, J BIOL CHEM, V278, P14002, DOI 10.1074/jbc.M300351200; Hofbauer B, 1998, AM J PHYSIOL-GASTR L, V275, pG352, DOI 10.1152/ajpgi.1998.275.2.G352; Hu Y, 2005, ARTHRITIS RHEUM-US, V52, P2553, DOI 10.1002/art.21192; JENNE DE, 1988, IMMUNOL REV, V103, P53, DOI 10.1111/j.1600-065X.1988.tb00749.x; Korkmaz B, 2013, SEMIN IMMUNOPATHOL, V35, P411, DOI 10.1007/s00281-013-0362-z; Lerch MM, 1997, GASTROENTEROLOGY, V113, P1355, DOI 10.1053/gast.1997.v113.pm9322531; LERCH MM, 1992, GASTROENTEROLOGY, V103, P205, DOI 10.1016/0016-5085(92)91114-J; LERCH MM, 1995, J CLIN INVEST, V95, P2222, DOI 10.1172/JCI117912; Mayerle J, 2005, GASTROENTEROLOGY, V129, P1251, DOI 10.1053/j.gastro.2005.08.002; Mayerle J, 2012, J GASTROEN HEPATOL, V27, P47, DOI 10.1111/j.1440-1746.2011.07011.x; MCGUIRE MJ, 1992, ARCH BIOCHEM BIOPHYS, V295, P280, DOI 10.1016/0003-9861(92)90519-3; Mooren FC, 2001, FASEB J, V15, P659, DOI 10.1096/fj.00-0172com; NIEDERAU C, 1985, GASTROENTEROLOGY, V88, P1192, DOI 10.1016/S0016-5085(85)80079-2; Pandol SJ, 2007, GASTROENTEROLOGY, V132, P1127, DOI 10.1053/j.gastro.2007.01.055; Pham CTN, 1999, P NATL ACAD SCI USA, V96, P8627, DOI 10.1073/pnas.96.15.8627; PLANTA RJ, 1964, BIOCHIM BIOPHYS ACTA, V89, P511, DOI 10.1016/0926-6569(64)90077-X; Rao NV, 1997, J BIOL CHEM, V272, P10260; ROWAN AD, 1992, J BIOL CHEM, V267, P15993; Saluja AK, 1997, GASTROENTEROLOGY, V113, P304, DOI 10.1016/S0016-5085(97)70108-2; Schnekenburger J, 2005, GUT, V54, P1445, DOI 10.1136/gut.2004.063164; Schreiber A, 2012, J AM SOC NEPHROL, V23, P470, DOI 10.1681/ASN.2010080892; Schutte K, 2008, BEST PRACT RES CL GA, V22, P75, DOI 10.1016/j.bpg.2007.10.013; Sendler M, 2018, GASTROENTEROLOGY, V154, P704, DOI 10.1053/j.gastro.2017.10.018; Sendler M, 2016, J BIOL CHEM, V291, P14717, DOI 10.1074/jbc.M116.718999; Sendler M, 2015, GASTROENTEROLOGY, V149, P765, DOI 10.1053/j.gastro.2015.05.012; Sendler M, 2013, GUT, V62, P430, DOI 10.1136/gutjnl-2011-300771; THIELE DL, 1990, J EXP MED, V172, P183, DOI 10.1084/jem.172.1.183; Turk B., 1998, HDB PROTEOLYTIC ENZY, P631; Turk D, 2001, EMBO J, V20, P6570, DOI 10.1093/emboj/20.23.6570; Wartmann T, 2010, GASTROENTEROLOGY, V138, P726, DOI 10.1053/j.gastro.2009.10.048; Zenker M, 2005, NAT GENET, V37, P1345, DOI 10.1038/ng1681	42	19	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2019	294	2					697	707		10.1074/jbc.RA118.004376	http://dx.doi.org/10.1074/jbc.RA118.004376			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HI2GP	30455353	hybrid, Green Published			2022-12-28	WOS:000456263600024
J	Kosman, DJ				Kosman, Daniel J.			Energy metabolism, oxygen flux, and iron in bacteria: The Mossbauer report	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								Iron is the most common transition metal cofactor across biological systems. As the earth transitioned from an anaerobic to aerobic environment, cellular mechanisms evolved to protect against iron-mediated oxidative damage, but the molecular details of these protective strategies remain unclear. In this report, the Lindahl group has combined spectroscopic, biochemical, and genetic approaches to inventory iron in Escherichia coli as a function of bacterial oxygen metabolism. Their results suggest that ferrous iron functions as an oxygen sink that is modulated by a respiratory shield of electron flux in the bacterial plasma membrane.	[Kosman, Daniel J.] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Biochem, Buffalo, NY 14203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Kosman, DJ (corresponding author), Jacobs Sch Med & Biomed Sci, Dept Biochem, Suite 4102,955 Main St, Buffalo, NY 14203 USA.	camkos@buffalo.edu		Kosman, Daniel/0000-0003-3570-7682	National Institute of Neurologic Diseases and Stroke of the Department of Health and Human Services [RO1NS102337]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS102337] Funding Source: NIH RePORTER	National Institute of Neurologic Diseases and Stroke of the Department of Health and Human Services; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Research in the Kosman Lab is supported by Grant RO1NS102337 from the National Institute of Neurologic Diseases and Stroke of the Department of Health and Human Services (to D.J.K.). The author declares that he has no conflicts of interest with the contents of this article. The content of this article is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Brochier-Armanet C, 2009, MOL BIOL EVOL, V26, P285, DOI 10.1093/molbev/msn246; Crichton RR, 2001, BIOMETALS, V14, P99, DOI 10.1023/A:1016710810701; Jhurry ND, 2012, BIOCHEMISTRY-US, V51, P5276, DOI 10.1021/bi300382d; Kosman DJ, 2013, COORDIN CHEM REV, V257, P210, DOI 10.1016/j.ccr.2012.06.030; Lopez-Torrejon G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11426; Lv HH, 2018, METALLOMICS, V10, P899, DOI 10.1039/c8mt00048d; Pandelia ME, 2015, BBA-MOL CELL RES, V1853, P1395, DOI 10.1016/j.bbamcr.2014.12.005; SAGAN L, 1967, J THEOR BIOL, V14, P225, DOI 10.1016/0022-5193(67)90079-3; Wofford JD, 2019, J BIOL CHEM, V294, P50, DOI 10.1074/jbc.RA118.005233	9	2	2	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2019	294	1					63	64		10.1074/jbc.H118.006703	http://dx.doi.org/10.1074/jbc.H118.006703			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG6PT	30610120	hybrid, Green Published			2022-12-28	WOS:000455105500007
J	Lee, CJ; Rana, MS; Bae, C; Li, Y; Banerjee, A				Lee, Chul-Jin; Rana, Mitra S.; Bae, Chanhyung; Li, Yan; Banerjee, Anirban			In vitro reconstitution of Wnt acylation reveals structural determinants of substrate recognition by the acyltransferase human Porcupine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane enzyme; post-translational modification (PTM); Wnt pathway; protein acylation; enzyme mechanism; enzyme purification; acyl selectivity; acyltransferase; MBOAT family; protein lipidation	PROTEIN; INHIBITION; GROWTH; DESATURASE; ASSAY	Wnt proteins regulate a large number of processes, including cellular growth, differentiation, and tissue homeostasis, through the highly conserved Wnt signaling pathway in metazoans. Porcupine (PORCN) is an endoplasmic reticulum (ER)-resident integral membrane enzyme that catalyzes posttranslational modification of Wnts with palmitoleic acid, an unsaturated lipid. This unique form of lipidation with palmitoleic acid is a vital step in the biogenesis and secretion of Wnt, and PORCN inhibitors are currently in clinical trials for cancer treatment. However, PORCN-mediated Wnt lipidation has not been reconstituted in vitro with purified enzyme. Here, we report the first successful purification of human PORCN and confirm, through in vitro reconstitution with the purified enzyme, that PORCN is necessary and sufficient for Wnt acylation. By systematically examining a series of substrate variants, we show that PORCN intimately recognizes the local structure of Wnt around the site of acylation. Our in vitro assay enabled us to examine the activity of PORCN with a range of fatty acyl-CoAs with varying length and unsaturation. The selectivity of human PORCN across a spectrum of fatty acyl-CoAs suggested that the kink in the unsaturated acyl chain is a key determinant of PORCN-mediated catalysis. Finally, we show that two putative PORCN inhibitors that were discovered with cell-based assays indeed target human PORCN. Together, these results provide discrete, high-resolution biochemical insights into the mechanism of PORCN-mediated Wnt acylation and pave the way for further detailed biochemical and structural studies.	[Lee, Chul-Jin; Rana, Mitra S.; Banerjee, Anirban] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Cell Biol & Neurobiol Branch, NIH, Bethesda, MD 20892 USA; [Bae, Chanhyung] NINDS, Mol Physiol & Biophys Sect, Porter Neurosci Res Ctr, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Li, Yan] NINDS, Prot Peptide Sequencing Facil, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Banerjee, A (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Cell Biol & Neurobiol Branch, NIH, Bethesda, MD 20892 USA.	anirban.banerjee@nih.gov	Banerjee, Anirban/AAC-4286-2020	Bae, Chanhyung/0000-0003-3407-2857; banerjee, anirban/0000-0003-1494-6801	Korean Biomedical Scientist Fellowship Program (KBSFP); Korean Research Institute of Bioscience and Biotechnology (KRIBB)	Korean Biomedical Scientist Fellowship Program (KBSFP); Korean Research Institute of Bioscience and Biotechnology (KRIBB)	A recipient of the Korean Biomedical Scientist Fellowship Program (KBSFP), supported by the Korean Research Institute of Bioscience and Biotechnology (KRIBB).	Asciolla JJ, 2017, J BIOL CHEM, V292, P13507, DOI 10.1074/jbc.C117.800136; Bai YH, 2015, NATURE, V524, P252, DOI 10.1038/nature14549; Brautigam CA, 2016, NAT PROTOC, V11, P882, DOI 10.1038/nprot.2016.044; Chan WC, 2000, PRACT APPROACH SER, V222, P41; Cheng Y, 2015, ONCOTARGET, V6, P14428, DOI 10.18632/oncotarget.3982; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Covey TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034532; Dhamdhere GR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083650; Dodge ME, 2012, J BIOL CHEM, V287, P23246, DOI 10.1074/jbc.M112.372029; Galli LM, 2007, DEVELOPMENT, V134, P3339, DOI 10.1242/dev.02881; Gao XX, 2014, NAT CHEM BIOL, V10, P61, DOI [10.1038/NCHEMBIO.1392, 10.1038/nchembio.1392]; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Hamel LD, 2014, ANAL BIOCHEM, V460, P1, DOI 10.1016/j.ab.2014.05.013; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Jennings BC, 2012, J BIOL CHEM, V287, P7236, DOI 10.1074/jbc.M111.337246; Kakugawa S, 2015, NATURE, V519, P187, DOI 10.1038/nature14259; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Konitsiotis AD, 2015, J BIOL CHEM, V290, P3293, DOI 10.1074/jbc.M114.614578; Lim XH, 2013, SCIENCE, V342, P1226, DOI 10.1126/science.1239730; Lim XH, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008029; Liu J, 2013, P NATL ACAD SCI USA, V110, P20224, DOI 10.1073/pnas.1314239110; Lorenz H, 2006, NAT PROTOC, V1, P276, DOI 10.1038/nprot.2006.42; Madan B, 2016, ONCOGENE, V35, P2197, DOI 10.1038/onc.2015.280; Matevossian A, 2015, J BIOL CHEM, V290, P2235, DOI 10.1074/jbc.M114.625764; Mitchell DA, 2010, J BIOL CHEM, V285, P38104, DOI 10.1074/jbc.M110.169102; Nile AH, 2016, NAT CHEM BIOL, V12, P60, DOI [10.1038/NCHEMBIO.2005, 10.1038/nchembio.2005]; Proffitt KD, 2012, J BIOL CHEM, V287, P34167, DOI 10.1074/jbc.M112.381970; Proffitt KD, 2013, CANCER RES, V73, P502, DOI 10.1158/0008-5472.CAN-12-2258; Rana MS, 2018, SCIENCE, V359, P176, DOI 10.1126/science.aao6326; Resh MD, 2013, CURR BIOL, V23, pR431, DOI 10.1016/j.cub.2013.04.024; Rios-Esteves J, 2014, J BIOL CHEM, V289, P17009, DOI 10.1074/jbc.M114.561209; Rios-Esteves J, 2013, CELL REP, V4, P1072, DOI 10.1016/j.celrep.2013.08.027; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Snapp EL, 2006, P NATL ACAD SCI USA, V103, P6536, DOI 10.1073/pnas.0510657103; STANLEY CJ, 1980, BIOCHEM J, V191, P147, DOI 10.1042/bj1910147; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Taylor MS, 2013, J BIOL CHEM, V288, P32211, DOI 10.1074/jbc.M113.510313; Ulrich A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053360; Wang H, 2015, NAT STRUCT MOL BIOL, V22, P581, DOI 10.1038/nsmb.3049; Wang JB, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007963; Wang XL, 2013, J MED CHEM, V56, P2700, DOI 10.1021/jm400159c; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Willert K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007864; Zhai L, 2004, J BIOL CHEM, V279, P33220, DOI 10.1074/jbc.M403407200	45	16	17	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2019	294	1					231	245		10.1074/jbc.RA118.005746	http://dx.doi.org/10.1074/jbc.RA118.005746			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG6PT	30420431	Green Published, hybrid			2022-12-28	WOS:000455105500026
J	Yadav, P; Goyal, VD; Gaur, NK; Kumar, A; Gokhale, SM; Jamdar, SN; Makde, RD				Yadav, Pooja; Goyal, Venuka Durani; Gaur, Neeraj Kailash; Kumar, Ashwani; Gokhale, Sadashiv M.; Jamdar, Sahayog N.; Makde, Ravindra D.			Carboxypeptidase in prolyl oligopeptidase family: Unique enzyme activation and substrate-screening mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						oligomerization; substrate specificity; carboxypeptidase; enzyme catalysis; peptidase; active site regulation; catalytic triad; POP family; serine carboxypeptidase; substrate screening; S9 peptidase; oligopeptidase; structure-function; S9C subfamily	PRELIMINARY-X-RAY; CRYSTAL-STRUCTURE; ACTIVE-SITE; ACYLPEPTIDE HYDROLASE; INDUCED-FIT; CRYSTALLIZATION; PEPTIDASE; SYSTEM; CRYSTALLOGRAPHY; EXPRESSION	Serine peptidases of the prolyl oligopeptidase (POP) family are of substantial therapeutic importance because of their involvement in diseases such as diabetes, cancer, neurological diseases, and autoimmune disorders. Proper annotation and knowledge of substrate specificity mechanisms in this family are highly valuable. Although endopeptidase, dipeptidyl peptidase, tripeptidyl peptidase, and acylaminoacyl peptidase activities have been reported previously, here we report the first instance of carboxypeptidase activity in a POP family member. We determined the crystal structures of this carboxypeptidase, an S9C subfamily member from Deinococcus radiodurans, in its active and inactive states at 2.3- resolution, providing an unprecedented view of assembly and disassembly of the active site mediated by an arginine residue. We observed that this residue is poised to bind substrate in the active structure and disrupts the catalytic triad in the inactive structure. The assembly of the active site is accompanied by the ordering of gating loops, which reduces the effective size of the oligomeric pore. This prevents the entry of larger peptides and constitutes a novel mechanism for substrate screening. Furthermore, we observed structural adaptations that enable its carboxypeptidase activity, with a unique loop and two arginine residues in the active site cavity orienting the peptide substrate for catalysis. Using these structural features, we identified homologs of this enzyme in the POP family and confirmed the presence of carboxypeptidase activity in one of them. In conclusion, we have identified a new type within POP enzymes that exhibits not only unique activity but also a novel substrate-screening mechanism.	[Yadav, Pooja; Goyal, Venuka Durani; Gaur, Neeraj Kailash; Kumar, Ashwani; Makde, Ravindra D.] Bhabha Atom Res Ctr, High Pressure & Synchrotron Radiat Phys Div, Bombay 400085, Maharashtra, India; [Jamdar, Sahayog N.] Bhabha Atom Res Ctr, Food Technol Div, Bombay 400085, Maharashtra, India; [Yadav, Pooja; Gokhale, Sadashiv M.] Devi Ahilya Univ, Sch Biochem, Indore 452001, Madhya Pradesh, India	Bhabha Atomic Research Center (BARC); Bhabha Atomic Research Center (BARC); Devi Ahilya University	Makde, RD (corresponding author), Bhabha Atom Res Ctr, High Pressure & Synchrotron Radiat Phys Div, Bombay 400085, Maharashtra, India.; Jamdar, SN (corresponding author), Bhabha Atom Res Ctr, Food Technol Div, Bombay 400085, Maharashtra, India.	snjam@barc.gov.in; ravimakde@rrcat.gov.in	Goyal, Venuka/AAR-7525-2020	Goyal, Venuka/0000-0001-7838-572X; kumar, ashwani/0000-0002-7526-1569; Gaur, Neeraj/0000-0002-5926-9966; Makde, Ravindra D./0000-0001-7020-0065	University Grants Commission National Fellowship for Other Backward Classes (UGC-NF-OBC) scholarship; Department of Science and Technology Innovation in Science Pursuit for Inspired Research (DST INSPIRE) faculty award	University Grants Commission National Fellowship for Other Backward Classes (UGC-NF-OBC) scholarship; Department of Science and Technology Innovation in Science Pursuit for Inspired Research (DST INSPIRE) faculty award	Supported by a University Grants Commission National Fellowship for Other Backward Classes (UGC-NF-OBC) scholarship.; Supported by a Department of Science and Technology Innovation in Science Pursuit for Inspired Research (DST INSPIRE) faculty award.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Are VN, 2014, ACTA CRYSTALLOGR F, V70, P1292, DOI 10.1107/S2053230X14017944; Banbula A, 1999, J BIOL CHEM, V274, P9246, DOI 10.1074/jbc.274.14.9246; Bar-Even A, 2011, BIOCHEMISTRY-US, V50, P4402, DOI 10.1021/bi2002289; Bartlam M, 2004, STRUCTURE, V12, P1481, DOI 10.1016/j.str.2004.05.019; Canning P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079349; CHAYEN NE, 1992, J CRYST GROWTH, V122, P176, DOI 10.1016/0022-0248(92)90241-A; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; D'Arcy A, 2007, ACTA CRYSTALLOGR D, V63, P550, DOI 10.1107/S0907444907007652; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; DOI E, 1981, ANAL BIOCHEM, V118, P173, DOI 10.1016/0003-2697(81)90175-5; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FEESE M, 1993, J MOL BIOL, V233, P546, DOI 10.1006/jmbi.1993.1531; Fulop V, 1998, CELL, V94, P161, DOI 10.1016/S0092-8674(00)81416-6; Harmat V, 2011, J BIOL CHEM, V286, P1987, DOI 10.1074/jbc.M110.169862; Hughes TE, 1999, BIOCHEMISTRY-US, V38, P11597, DOI 10.1021/bi990852f; JONES WM, 1986, BIOCHEM BIOPH RES CO, V139, P244, DOI 10.1016/S0006-291X(86)80105-X; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaszuba K, 2012, BIOCHIMIE, V94, P1398, DOI 10.1016/j.biochi.2012.03.012; KENNY AJ, 1976, BIOCHEM J, V157, P169, DOI 10.1042/bj1570169; KOBAYASHI K, 1987, J BIOL CHEM, V262, P11435; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar A, 2016, J SYNCHROTRON RADIAT, V23, P629, DOI 10.1107/S160057751600076X; Li M, 2010, J BIOL CHEM, V285, P21487, DOI 10.1074/jbc.M109.092692; Liebschner D, 2017, ACTA CRYSTALLOGR D, V73, P148, DOI 10.1107/S2059798316018210; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLuskey K, 2010, J BIOL CHEM, V285, P39249, DOI 10.1074/jbc.M110.156679; Menyhard DK, 2013, J BIOL CHEM, V288, P17884, DOI 10.1074/jbc.M113.451534; Morty RE, 2000, BIOCHEM PHARMACOL, V60, P1497, DOI 10.1016/S0006-2952(00)00459-7; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Polgar L, 2002, CELL MOL LIFE SCI, V59, P349, DOI 10.1007/s00018-002-8427-5; Polgar L, 1997, PROTEINS, V28, P375; Rasmussen HB, 2003, NAT STRUCT BIOL, V10, P19, DOI 10.1038/nsb882; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Santhoshkumar P, 2014, J BIOL CHEM, V289, P9039, DOI 10.1074/jbc.M113.510677; SCALONI A, 1992, J LAB CLIN MED, V120, P546; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Shan L, 2005, P NATL ACAD SCI USA, V102, P3599, DOI 10.1073/pnas.0408286102; Szeltner Z, 2003, J BIOL CHEM, V278, P48786, DOI 10.1074/jbc.M309555200; Szeltner Z, 2008, CURR PROTEIN PEPT SC, V9, P96; Szeltner Z, 2013, BBA-PROTEINS PROTEOM, V1834, P98, DOI 10.1016/j.bbapap.2012.08.012; Tan S, 2005, PROTEIN EXPRES PURIF, V40, P385, DOI 10.1016/j.pep.2004.12.002; Vogt AD, 2012, BIOCHEMISTRY-US, V51, P5894, DOI 10.1021/bi3006913; Voss NR, 2010, NUCLEIC ACIDS RES, V38, pW555, DOI 10.1093/nar/gkq395; WILK S, 1983, LIFE SCI, V33, P2149, DOI 10.1016/0024-3205(83)90285-0; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wright H, 2005, ACTA CRYSTALLOGR F, V61, P942, DOI 10.1107/S1744309105029222; Yamin R, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-33; Zeng Zhihong, 2017, DNA Repair (Amst), V58, P52, DOI 10.1016/j.dnarep.2017.08.008	50	12	12	3	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2019	294	1					89	100		10.1074/jbc.RA118.004254	http://dx.doi.org/10.1074/jbc.RA118.004254			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG6PT	30409909	Green Published, hybrid			2022-12-28	WOS:000455105500015
J	Jing, YP; An, HL; Zhang, SJ; Wang, NB; Zhou, ST				Jing, Yu-Pu; An, Hongli; Zhang, Shanjing; Wang, Ningbo; Zhou, Shutang			Protein kinase C mediates juvenile hormone-dependent phosphorylation of Na+/K+-ATPase to induce ovarian follicular patency for yolk protein uptake	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						juvenile hormone (JH); Na; K plus -ATPase; reproduction; insect; ovary; Vitellogenesis; vitellogenin	K+-ATPASE; ALPHA-1 SUBUNIT; TRANSCRIPTIONAL ACTIVATION; NA+,K+-ATPASE ACTIVITY; RHODNIUS-PROLIXUS; CELLS; INHIBITION; IDENTIFICATION; PATHWAY; VITELLOGENESIS	In oviparous animals, vitellogenesis is prerequisite to egg production and embryonic growth after oviposition. For successful insect vitellogenesis and oogenesis, vitellogenin (Vg) synthesized in the fat body (homologue to vertebrate liver and adipose tissue) must pass through the intercellular channels, a condition known as patency in the follicular epithelium, to reach the surface of oocytes. This process is controlled by juvenile hormone (JH) in many insect species, but the underlying mechanisms remain elusive. Previous work has suggested the possible involvement of Na+/K+-ATPase in patency initiation, but again, the regulatory cascade of Na+/K+-ATPase for patency initiation has been lacking. Using the migratory locust Locusta migratoria as a model system, we report here that RNAi-mediated knockdown of gene coding for Na+/K+-ATPase, inhibition of its phosphorylation, or suppression of its activity causes loss of patency, resulting in blocked Vg uptake, arrested oocyte maturation, and impaired ovarian growth. JH triggers G protein-coupled receptor (GPCR), receptor tyrosine kinase (RTK), phospholipase C (PLC), inositol trisphosphate receptor (IP3R), and protein kinase C (PKC) to phosphorylate Na+/K+-ATPase -subunit at amino acid residue Ser(8), consequently activating Na+/K+-ATPase for the induction of patency in vitellogenic follicular epithelium. Our results thus point to a previously unidentified mechanism by which JH induces the phosphorylation and activation of Na+/K+-ATPase via a signaling cascade of GPCR, RTK, PLC, IP3R, and PKC. The findings advance our understanding of JH regulation in insect vitellogenesis and oogenesis.	[Jing, Yu-Pu; An, Hongli; Zhang, Shanjing; Wang, Ningbo; Zhou, Shutang] Henan Univ, Sch Life Sci, State Key Lab Cotton Biol, Key Lab Plant Stress Biol, Kaifeng 475004, Peoples R China	Henan University	Zhou, ST (corresponding author), Henan Univ, Sch Life Sci, State Key Lab Cotton Biol, Key Lab Plant Stress Biol, Kaifeng 475004, Peoples R China.	szhou@henu.edu.cn	Jing, Yu-Pu/AAE-3531-2022		National Natural Science Foundation of China [31601896, 31630070]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China Grants 31601896 and 31630070. The authors declare that they have no conflicts of interest with the contents of this article.	ABUHAKIMA R, 1979, INSECT BIOCHEM, V9, P195, DOI 10.1016/0020-1790(79)90050-7; Agrahari S, 2008, PESTIC BIOCHEM PHYS, V92, P57, DOI 10.1016/j.pestbp.2008.06.003; Alevizopoulos K, 2014, CURR DRUG TARGETS, V15, P988, DOI 10.2174/1389450115666140908125025; BEGUIN P, 1994, J BIOL CHEM, V269, P24437; Belles X, 2005, REPRO BIOL, V12, P157; Cai MJ, 2014, J BIOL CHEM, V289, P26630, DOI 10.1074/jbc.M114.581876; Chakraborti S., 2016, NA K ATPASE PERSPECT, P3; [常静 Chang Jing], 2017, [农药, Agrochemicals], V56, P692; Charles JP, 2011, P NATL ACAD SCI USA, V108, P21128, DOI 10.1073/pnas.1116123109; DAVEY KG, 1993, INVERTEBR REPROD DEV, V24, P39, DOI 10.1080/07924259.1993.9672329; Davies TGE, 2007, INSECT MOL BIOL, V16, P361, DOI 10.1111/j.1365-2583.2007.00733.x; FAMBROUGH DM, 1994, AM J PHYSIOL, V266, pC579, DOI 10.1152/ajpcell.1994.266.3.C579; Feraille E, 2000, MOL BIOL CELL, V11, P39, DOI 10.1091/mbc.11.1.39; FISONE G, 1994, J BIOL CHEM, V269, P9368; Geletiova J., 2016, FASEB J, V30; GLINKA AV, 1995, BIOCHEM MOL BIOL INT, V35, P323; Guo W, 2019, FASEB J, V33, P917, DOI 10.1096/fj.201801068R; Guo W, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004702; Hall J. E., 2006, TXB MED PHYSL, P365; HURD H, 1997, J Insect Physiol, V43, P337; ILENCHUK TT, 1987, INSECT BIOCHEM, V17, P1085, DOI 10.1016/0020-1790(87)90125-9; Jindra M, 2015, CURR OPIN INSECT SCI, V11, P39, DOI 10.1016/j.cois.2015.08.004; Jindra M, 2013, ANNU REV ENTOMOL, V58, P181, DOI 10.1146/annurev-ento-120811-153700; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; KOCH RB, 1969, LIFE SCI PT 1 PHYSI, V8, P289, DOI 10.1016/0024-3205(69)90133-7; KUNKEL JG, 1995, BIOL BULL, V189, P197, DOI 10.1086/BBLv189n2p197; Li K, 2019, INSECT SCI, V26, P600, DOI 10.1111/1744-7917.12614; LINGREL JB, 1994, J BIOL CHEM, V269, P19659; Liu PC, 2015, P NATL ACAD SCI USA, V112, pE1871, DOI 10.1073/pnas.1423204112; Liu TB, 2016, AM J PHYSIOL-ENDOC M, V310, pE565, DOI 10.1152/ajpendo.00360.2015; Liu W, 2013, BBA-GEN SUBJECTS, V1830, P5184, DOI 10.1016/j.bbagen.2013.06.037; Liu X, 1998, AM J PHYSIOL-HEART C, V274, pH83, DOI 10.1152/ajpheart.1998.274.1.H83; LOCKE J, 1987, DNA-J MOLEC CELL BIO, V6, P331, DOI 10.1089/dna.1987.6.331; Logvinenko NS, 1996, P NATL ACAD SCI USA, V93, P9132, DOI 10.1073/pnas.93.17.9132; Luo MW, 2017, J BIOL CHEM, V292, P8823, DOI 10.1074/jbc.M117.780957; Marquezan BP, 2013, EPILEPSY RES, V105, P396, DOI 10.1016/j.eplepsyres.2013.03.007; McCormick Stephen D., 1995, V14, P285, DOI 10.1016/S1546-5098(08)60250-2; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; Ojani R, 2016, INSECT BIOCHEM MOLEC, V70, P44, DOI 10.1016/j.ibmb.2015.12.001; Orlov SN, 2019, CURR MED CHEM, V26, P564, DOI 10.2174/0929867324666170619105407; Pedemonte CH, 1997, MOL PHARMACOL, V52, P88, DOI 10.1124/mol.52.1.88; Pham B, 2017, ECOTOX ENVIRON SAFE, V143, P283, DOI 10.1016/j.ecoenv.2017.05.035; Pham D, 2016, COMP BIOCHEM PHYS B, V196, P27, DOI 10.1016/j.cbpb.2015.12.007; PRATT GE, 1972, J EXP BIOL, V56, P201; Pszczolkowski M. A., 2005, Pestycydy, P161; Pszczolkowski MA, 2005, J INSECT PHYSIOL, V51, P445, DOI 10.1016/j.jinsphys.2005.01.008; Pszczolkowski MA, 2008, J INSECT PHYSIOL, V54, P358, DOI 10.1016/j.jinsphys.2007.10.005; Raikhel A.S., 2005, P433; Rocco-Machado N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129604; Roy S, 2018, ANNU REV ENTOMOL, V63, P489, DOI 10.1146/annurev-ento-020117-043258; Sancho E, 1997, ECOTOX ENVIRON SAFE, V38, P132, DOI 10.1006/eesa.1997.1573; Sandtner W, 2011, J BIOL CHEM, V286, P38177, DOI 10.1074/jbc.M111.267682; SATOH T, 1993, AM J PHYSIOL, V265, pF399, DOI 10.1152/ajprenal.1993.265.3.F399; SEVALA VL, 1993, INVERTEBR REPROD DEV, V23, P189, DOI 10.1080/07924259.1993.9672314; SEVALA VL, 1989, EXPERIENTIA, V45, P355, DOI 10.1007/BF01957476; Silva LND, 2016, J MEMBRANE BIOL, V249, P459, DOI 10.1007/s00232-016-9886-1; SKOU JC, 1992, J BIOENERG BIOMEMBR, V24, P249; Soltoff SP, 2010, J BIOL CHEM, V285, P36330, DOI 10.1074/jbc.M110.136465; Sun BH, 1998, J NEUROCHEM, V71, P142; Wang YR, 1997, J INSECT PHYSIOL, V43, P675, DOI 10.1016/S0022-1910(97)00009-7; Wang ZM, 2017, INSECT BIOCHEM MOLEC, V82, P31, DOI 10.1016/j.ibmb.2017.01.009; Wu ZX, 2016, J BIOL CHEM, V291, P5418, DOI 10.1074/jbc.M115.698936; Wyatt GR, 1996, ADV INSECT PHYSIOL, V26, P1, DOI 10.1016/S0065-2806(08)60030-2; YADWAD VB, 1990, B ENVIRON CONTAM TOX, V44, P585, DOI 10.1007/BF01700880	64	30	31	2	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					20112	20122		10.1074/jbc.RA118.005692	http://dx.doi.org/10.1074/jbc.RA118.005692			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30385509	Green Published, hybrid			2022-12-28	WOS:000454685900020
J	Jiang, Y; Yan, L; Xia, LK; Lu, XY; Zhu, WL; Ding, DW; Du, MX; Zhang, D; Wang, HM; Hu, BY				Jiang, Yuan; Yan, Long; Xia, Longkuo; Lu, Xiaoyin; Zhu, Wenliang; Ding, Dewen; Du, Mingxia; Zhang, Da; Wang, Hongmei; Hu, Baoyang			Zinc finger E-box-binding homeobox 1 (ZEB1) is required for neural differentiation of human embryonic stem cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						embryonic stem cell; neuron; differentiation; adhesion; transplantation; ZEB1	DIRECTED DIFFERENTIATION; ICRISPR PLATFORM; IN-VITRO; NEURONS; SPECIFICATION; METASTASIS; PRECURSORS; EXPRESSION; INDUCTION	Human pluripotent stem cells hold great promise for improving regenerative medicine. However, a risk for tumor formation and difficulties in generating large amounts of subtype derivatives remain the major obstacles for clinical applications of stem cells. Here, we discovered that zinc finger E-box-binding homeobox 1 (ZEB1) is highly expressed upon differentiation of human embryonic stem cells (hESCs) into neuronal precursors. CRISPR/Cas9-mediated ZEB1 depletion did not impede neural fate commitment, but prevented hESC-derived neural precursors from differentiating into neurons, indicating that ZEB1 is required for neuronal differentiation. ZEB1 overexpression not only expedited neural differentiation and neuronal maturation, which ensured safer neural cell transplantation, but also facilitated the generation of excitatory cortical neurons, which were valuable for managing certain neurological disorders, such as Parkinson's disease (PD) and amyotrophic lateral sclerosis (ALS). Our study provides useful information on how human neural cells are generated, which may help in forming strategies for developing and improving replacement therapies for treating patients with neurological diseases.	[Jiang, Yuan; Yan, Long; Xia, Longkuo; Lu, Xiaoyin; Zhu, Wenliang; Ding, Dewen; Du, Mingxia; Zhang, Da; Wang, Hongmei; Hu, Baoyang] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China; [Jiang, Yuan; Xia, Longkuo; Zhu, Wenliang; Ding, Dewen; Wang, Hongmei; Hu, Baoyang] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, HM; Hu, BY (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China.; Wang, HM; Hu, BY (corresponding author), Univ Chinese Acad Sci, Beijing 100049, Peoples R China.	wanghm@ioz.ac.cn; byhu@ioz.ac.cn	jiang, anyi/GPT-0379-2022; Lu, Xiaoyin/AAO-5561-2021; Hu, Baoyang/R-8374-2016	Lu, Xiaoyin/0000-0002-9244-325X; Hu, Baoyang/0000-0003-3993-4014	Natural Science Foundation of China [31501102, 81225004, 31171430]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Natural Science Foundation of China Grants 31501102, 81225004, and 31171430. The authors declare that they have no conflicts of interest with the contents of this article.	Aubry L, 2008, P NATL ACAD SCI USA, V105, P16707, DOI 10.1073/pnas.0808488105; Chaffer CL, 2013, CELL, V154, P61, DOI 10.1016/j.cell.2013.06.005; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Crews L, 2010, J NEUROSCI, V30, P12252, DOI 10.1523/JNEUROSCI.1305-10.2010; Du ZW, 2013, DEVELOPMENT, V140, P2611, DOI 10.1242/dev.092809; Gonzalez F, 2014, CELL STEM CELL, V15, P215, DOI 10.1016/j.stem.2014.05.018; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Jiang Y, 2012, PROTEIN CELL, V3, P818, DOI 10.1007/s13238-012-2086-6; Johnson MA, 2007, J NEUROSCI, V27, P3069, DOI 10.1523/JNEUROSCI.4562-06.2007; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Liu HS, 2011, CELL MOL LIFE SCI, V68, P3995, DOI 10.1007/s00018-011-0770-y; Liu Y, 2013, NAT PROTOC, V8, P1670, DOI 10.1038/nprot.2013.106; Liu YQ, 2008, DEVELOPMENT, V135, P579, DOI 10.1242/dev.007047; Ma LX, 2012, CELL STEM CELL, V10, P455, DOI 10.1016/j.stem.2012.01.021; Miyoshi T, 2006, DEV DYNAM, V235, P1941, DOI 10.1002/dvdy.20799; Nitta KR, 2004, DEV BIOL, V275, P258, DOI 10.1016/j.ydbio.2004.08.010; Pankratz MT, 2007, STEM CELLS, V25, P1511, DOI 10.1634/stemcells.2006-0707; Postigo AA, 2003, EMBO J, V22, P2453, DOI 10.1093/emboj/cdg226; Sabourin JC, 2009, STEM CELLS, V27, P2722, DOI 10.1002/stem.226; Singh S, 2016, ELIFE, V5, DOI [10.7554/elife.12717, 10.7554/eLife.12717]; Spaderna S, 2008, CANCER RES, V68, P537, DOI 10.1158/0008-5472.CAN-07-5682; Spaderna S, 2006, GASTROENTEROLOGY, V131, P830, DOI 10.1053/j.gastro.2006.06.016; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Ullian EM, 2004, MOL CELL NEUROSCI, V25, P241, DOI 10.1016/j.mcn.2003.10.011; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Wichterle H, 2001, DEVELOPMENT, V128, P3759; Yen G, 2001, MOL BRAIN RES, V96, P59, DOI 10.1016/S0169-328X(01)00267-4; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; Zhang SC, 2006, BRAIN PATHOL, V16, P132, DOI 10.1111/j.1750-3639.2006.00008.x; Zhang XQ, 2010, CELL STEM CELL, V7, P90, DOI 10.1016/j.stem.2010.04.017; Zhu ZR, 2014, METHOD ENZYMOL, V546, P215, DOI 10.1016/B978-0-12-801185-0.00011-8	36	13	14	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2018	293	50					19317	19329		10.1074/jbc.RA118.005498	http://dx.doi.org/10.1074/jbc.RA118.005498			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HE6RA	30337365	hybrid, Green Published			2022-12-28	WOS:000453537300014
J	Vlach, J; Eastep, GN; Ghanam, RH; Watanabe, SM; Carter, CA; Saad, JS				Vlach, Jiri; Eastep, Gunnar N.; Ghanam, Ruba H.; Watanabe, Susan M.; Carter, Carol A.; Saad, Jamil S.			Structural basis for targeting avian sarcoma virus Gag polyprotein to the plasma membrane for virus assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV-1 MATRIX PROTEIN; TYPE-1 GAG; MOLECULAR DETERMINANTS; NMR STRUCTURE; M-DOMAIN; BINDING; PHOSPHATIDYLINOSITOL-(4,5)-BISPHOSPHATE; RNA; ELECTROSTATICS; ASSOCIATION	For most retroviruses, including HIV-1, binding of the Gag polyprotein to the plasma membrane (PM) is mediated by interactions between Gag's N-terminal myristoylated matrix (MA) domain and phosphatidylinositol 4,5-bisphosphate (PI(4,5)P-2) in the PM. The Gag protein of avian sarcoma virus (ASV) lacks the N-myristoylation signal but contains structural domains having functions similar to those of HIV-1 Gag. The molecular mechanism by which ASV Gag binds to the PM is incompletely understood. Here, we employed NMR techniques to elucidate the molecular determinants of the membrane-binding domain of ASV MA (MA(87)) to lipids and liposomes. We report that MA(87) binds to the polar head of phosphoinositides such as PI(4,5)P-2. We found that MA(87) binding to inositol phosphates (IPs) is significantly enhanced by increasing the number of phosphate groups, indicating that the MA(87)-IP binding is governed by charge-charge interactions. Using a sensitive NMR-based liposome-binding assay, we show that binding of MA(87) to liposomes is enhanced by incorporation of PI(4,5)P-2 and phosphatidylserine. We also show that membrane binding is mediated by a basic surface formed by Lys-6, Lys-13, Lys-23, and Lys-24. Substitution of these residues to glutamate abolished binding of MA(87) to both IPs and liposomes. In an accompanying paper, we further report that mutation of these lysine residues diminishes Gag assembly on the PM and inhibits ASV particle release. These findings provide a molecular basis for ASV Gag binding to the inner leaflet of the PM and advance our understanding of the basic mechanisms of retroviral assembly.	[Vlach, Jiri; Eastep, Gunnar N.; Ghanam, Ruba H.; Saad, Jamil S.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Watanabe, Susan M.; Carter, Carol A.] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA	University of Alabama System; University of Alabama Birmingham; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Saad, JS (corresponding author), 845 19th St South, Birmingham, AL 35294 USA.	saad@uab.edu		Saad, Jamil/0000-0001-9503-6484; Eastep, Gunnar/0000-0003-3567-8500; Vlach, Jiri/0000-0002-0874-2055	National Institutes of Health [5R01 GM117837]; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM117837, R01GM111028] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant 5R01 GM117837 (to J. S. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alfadhli A, 2011, J MOL BIOL, V410, P653, DOI 10.1016/j.jmb.2011.04.063; Alfadhli A, 2009, J VIROL, V83, P12196, DOI 10.1128/JVI.01197-09; Anraku K, 2010, BIOCHEMISTRY-US, V49, P5109, DOI 10.1021/bi9019274; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Behnia R, 2005, NATURE, V438, P597, DOI 10.1038/nature04397; Bodner CR, 2009, J MOL BIOL, V390, P775, DOI 10.1016/j.jmb.2009.05.066; Bouamr F, 2003, BIOCHEMISTRY-US, V42, P6408, DOI 10.1021/bi020692z; Brown LA, 2015, VIRUSES-BASEL, V7, P2210, DOI 10.3390/v7052210; Callahan EM, 2000, J VIROL, V74, P11222, DOI 10.1128/JVI.74.23.11222-11229.2000; Ceccon A, 2013, PROTEINS, V81, P1776, DOI 10.1002/prot.24329; Chan J, 2011, J VIROL, V85, P10851, DOI 10.1128/JVI.00760-11; Chukkapalli V, 2008, J VIROL, V82, P2405, DOI 10.1128/JVI.01614-07; Chukkapalli V, 2013, J VIROL, V87, P7155, DOI 10.1128/JVI.00075-13; Chukkapalli V, 2011, J MOL BIOL, V410, P512, DOI 10.1016/j.jmb.2011.04.015; Chukkapalli V, 2010, P NATL ACAD SCI USA, V107, P1600, DOI 10.1073/pnas.0908661107; Dalton AK, 2005, J VIROL, V79, P6227, DOI 10.1128/JVI.79.10.6227-6238.2005; Dalton AK, 2007, J VIROL, V81, P6434, DOI 10.1128/JVI.02757-06; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dick RA, 2016, J VIROL, V90, P2473, DOI 10.1128/JVI.02733-15; Dick RA, 2015, J VIROL, V89, P10371, DOI 10.1128/JVI.01628-15; Doktorova M, 2017, BIOPHYS J, V113, P2004, DOI 10.1016/j.bpj.2017.08.055; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Ehrlich LS, 2011, J MOL BIOL, V410, P716, DOI 10.1016/j.jmb.2011.04.069; Ehrlich LS, 1996, BIOCHEMISTRY-US, V35, P3933, DOI 10.1021/bi952337x; ERDIE CR, 1990, J VIROL, V64, P5204, DOI 10.1128/JVI.64.10.5204-5208.1990; Fernandes F, 2011, TRAFFIC, V12, P438, DOI 10.1111/j.1600-0854.2010.01153.x; Figueira Thais Rezende e Silva, 2012, BMC Res Notes, V5, P185, DOI 10.1186/1756-0500-5-185; Finzi A, 2007, J VIROL, V81, P7476, DOI 10.1128/JVI.00308-07; Freed EO, 2015, NAT REV MICROBIOL, V13, P484, DOI 10.1038/nrmicro3490; Ganser-Pornillos BK, 2008, CURR OPIN STRUC BIOL, V18, P203, DOI 10.1016/j.sbi.2008.02.001; Ghanam RH, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00055; Gousset K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000015; Guerry P, 2012, METHODS MOL BIOL, V831, P429, DOI 10.1007/978-1-61779-480-3_22; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hamard-Peron E, 2010, J VIROL, V84, P503, DOI 10.1128/JVI.01134-09; Hammond GRV, 2012, SCIENCE, V337, P727, DOI 10.1126/science.1222483; Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17; Hearps AC, 2008, BIOCHEMISTRY-US, V47, P2199, DOI 10.1021/bi701360j; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Inlora J, 2014, MBIO, V5, DOI 10.1128/mBio.02202-14; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Joshi A, 2009, J VIROL, V83, P5375, DOI 10.1128/JVI.00109-09; Jouvenet N, 2006, PLOS BIOL, V4, P2296, DOI 10.1371/journal.pbio.0040435; Keller R., 2004, COMPUTER AIDED RESON, V1; KINGSLEY PB, 1979, CHEM PHYS LIPIDS, V24, P135, DOI 10.1016/0009-3084(79)90083-5; Kolay S, 2016, BIOCHEM J, V473, P1681, DOI 10.1042/BCJ20160069; Kutluay SB, 2014, CELL, V159, P1096, DOI 10.1016/j.cell.2014.09.057; LADNER HK, 1975, J MAGN RESON, V20, P530, DOI 10.1016/0022-2364(75)90010-4; Li H, 2007, J VIROL, V81, P12899, DOI 10.1128/JVI.01280-07; Markley JL, 1998, J MOL BIOL, V280, P933, DOI 10.1006/jmbi.1998.1852; McDonnell JM, 1998, J MOL BIOL, V279, P921, DOI 10.1006/jmbi.1998.1788; Mercredi PY, 2016, J MOL BIOL, V428, P1637, DOI 10.1016/j.jmb.2016.03.005; Murray PS, 2005, STRUCTURE, V13, P1521, DOI 10.1016/j.str.2005.07.010; Nadaraia-Hoke S, 2013, J VIROL, V87, P3609, DOI 10.1128/JVI.03059-12; Nelle TD, 1996, J VIROL, V70, P2269, DOI 10.1128/JVI.70.4.2269-2276.1996; Ono A, 2004, P NATL ACAD SCI USA, V101, P14889, DOI 10.1073/pnas.0405596101; Ono A, 2004, J VIROL, V78, P1552, DOI 10.1128/JVI.78.3.1552-1563.2004; Ono A, 1999, J VIROL, V73, P4136, DOI 10.1128/JVI.73.5.4136-4144.1999; Ono A, 2000, J VIROL, V74, P2855, DOI 10.1128/JVI.74.6.2855-2866.2000; Prchal J, 2014, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00423; Prchal J, 2012, J MOL BIOL, V423, P427, DOI 10.1016/j.jmb.2012.07.021; Provitera P, 2000, J MOL BIOL, V296, P887, DOI 10.1006/jmbi.1999.3482; Purohit P, 2001, RNA, V7, P576, DOI 10.1017/S1355838201002023; RAPPE AK, 1992, J AM CHEM SOC, V114, P10024, DOI 10.1021/ja00051a040; Saad JS, 2008, J MOL BIOL, V382, P434, DOI 10.1016/j.jmb.2008.07.027; Saad JS, 2007, J MOL BIOL, V366, P574, DOI 10.1016/j.jmb.2006.11.068; Saad JS, 2006, P NATL ACAD SCI USA, V103, P11364, DOI 10.1073/pnas.0602818103; Scarlata S, 1998, J MOL BIOL, V277, P161, DOI 10.1006/jmbi.1997.1615; Stansell E, 2007, J VIROL, V81, P8977, DOI 10.1128/JVI.00657-07; Vlach J, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00232; Vlach J, 2013, P NATL ACAD SCI USA, V110, P3525, DOI 10.1073/pnas.1216655110; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Watanabe SM, 2018, J BIOL CHEM, V293, P18841, DOI 10.1074/jbc.RA118.003947; Welsch S, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030036; Wen Y, 2016, J VIROL, V90, P9518, DOI 10.1128/JVI.01102-16; Zhang ZL, 2016, J VIROL, V90, P1824, DOI 10.1128/JVI.02814-15; Zhou WJ, 1996, J VIROL, V70, P8540, DOI 10.1128/JVI.70.12.8540-8548.1996	79	12	12	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2018	293	49					18828	18840		10.1074/jbc.RA118.003944	http://dx.doi.org/10.1074/jbc.RA118.003944			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NY	30309983	Green Published, hybrid			2022-12-28	WOS:000458467400002
J	Zeng, F; Yang, CP; Gao, XY; Li, X; Zhang, Z; Gong, R				Zeng, Fang; Yang, Chunpeng; Gao, Xinyu; Li, Xuan; Zhang, Zhe; Gong, Rui			Comprehensive elucidation of the structural and functional roles of engineered disulfide bonds in antibody Fc fragment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNOGLOBULIN G; HUMAN IGG1; COLLOIDAL STABILITIES; CONSTANT DOMAINS; AGGREGATION; RECEPTOR; BINDING; DESIGN	Therapeutic monoclonal antibodies and Fc-fusion proteins containing antibody Fc fragment may tend to destabilize (e.g. unfold and aggregate), which leads to loss of functions and increase of adverse risks. Although engineering of an additional disulfide bond has been performed in Fc or Fc domains for optimization, the relationships between introduced disulfide bond and alteration of the stability, aggregation propensity and function were still unclear and should be addressed for achievement of better therapeutic outcome. Here, we constructed three human IgG1 Fc mutants including Fc(CH2-s-s-) (one engineered disulfide bond in CH2 domain), Fc(CH3-s-s-) (one engineered disulfide bond in CH3 domain), and Fc(CH3-s-s-)(CH2-s-s-) (two engineered disulfide bonds in CH2 and CH3 domains, respectively) for evaluation. As expected, each mutated domain shows obviously increased stability during thermo-induced unfolding, and Fc(CH3-s-s-)(CH2-s-s-) is most thermo-stable among wildtype Fc (wtFc) and three mutants. The order of overall stability against denaturant is Fc(CH3-s-s-)(CH2-s-s-) > Fc(CH2-s-s-) > Fc(CH3-s-s-) > wtFc. Then the aggregation propensity was compared among these four proteins. Under conditions of incubation at 60 degrees C, their aggregation resistance is in the order of Fc(CH3-s-s-)(CH2-s-s-) > Fc(CH2-s-s-) > Fc(CH3-s-s-) approximate to wtFc. In contrast, the order is Fc(CH3-s-s-)(CH2-s-s-) > Fc(CH3-s-s-) > Fc(CH2-s-s-) approximate to wtFc under acidic conditions. In addition, the Fc-mediated functions are not obviously affected by engineered disulfide bond. Our results give a comprehensive elucidation of structural and functional effects caused by additional disulfide bonds in the Fc fragment, which is important for Fc engineering toward the desired clinical performance.	[Zeng, Fang; Yang, Chunpeng; Gao, Xinyu; Li, Xuan; Zhang, Zhe; Gong, Rui] Chinese Acad Sci, Key Lab Special Pathogens & Biosafety, Wuhan Inst Virol, Wuhan 430071, Hubei, Peoples R China; [Zeng, Fang; Yang, Chunpeng; Gao, Xinyu] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Gong, R (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, Key Lab Special Pathogens & Biosafety, Ctr Emerging Infect Dis, 44 Xiao Hong Shan, Wuhan 430071, Hubei, Peoples R China.	gongr@wh.iov.cn			Key Program of Chinese Academy of Sciences Grant [ZDRW-ZS-2016-4]; National Key Research and Development Program of China [2016YFC1202902]; National Natural Science Foundation of China Young Scientists Program Grant [81302690]; Novo Nordisk-Chinese Academy of Sciences Research Fund [NNCAS-2014-10]	Key Program of Chinese Academy of Sciences Grant; National Key Research and Development Program of China; National Natural Science Foundation of China Young Scientists Program Grant; Novo Nordisk-Chinese Academy of Sciences Research Fund	This work was supported by Key Program of Chinese Academy of Sciences Grant ZDRW-ZS-2016-4, National Key Research and Development Program of China Grant 2016YFC1202902, National Natural Science Foundation of China Young Scientists Program Grant 81302690, and Novo Nordisk-Chinese Academy of Sciences Research Fund Grant NNCAS-2014-10. The authors declare that they have no conflicts of interest with the contents of this article.	Chen W, 2016, ACS CHEM BIOL, V11, P1852, DOI 10.1021/acschembio.5b01035; Chennamsetty N, 2009, P NATL ACAD SCI USA, V106, P11937, DOI 10.1073/pnas.0904191106; Dall'Acqua WF, 2006, J BIOL CHEM, V281, P23514, DOI 10.1074/jbc.M604292200; Demarest SJ, 2004, J MOL BIOL, V335, P41, DOI 10.1016/j.jmb.2003.10.040; EDELMAN GM, 1969, P NATL ACAD SCI USA, V63, P78, DOI 10.1073/pnas.63.1.78; Feige MJ, 2004, J MOL BIOL, V344, P107, DOI 10.1016/j.jmb.2004.09.033; Gong R, 2013, MOL PHARMACEUT, V10, P2642, DOI 10.1021/mp400075f; Gong R, 2011, J BIOL CHEM, V286, P27288, DOI 10.1074/jbc.M111.254219; Gong R, 2009, J BIOL CHEM, V284, P14203, DOI 10.1074/jbc.M900769200; Jacobsen FW, 2017, J BIOL CHEM, V292, P1865, DOI 10.1074/jbc.M116.748525; Latypov RF, 2012, J BIOL CHEM, V287, P1381, DOI 10.1074/jbc.M111.297697; MaAuley A, 2008, PROTEIN SCI, V17, P95, DOI 10.1110/ps.073134408; Majumdar R, 2015, MABS-AUSTIN, V7, P84, DOI 10.4161/19420862.2014.985494; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Sakurai K, 2015, BBA-PROTEINS PROTEOM, V1854, P1526, DOI 10.1016/j.bbapap.2015.02.020; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; Thies MJW, 2002, J MOL BIOL, V319, P1267, DOI 10.1016/S0022-2836(02)00375-3; Wozniak-Knopp G, 2012, ARCH BIOCHEM BIOPHYS, V526, P181, DOI 10.1016/j.abb.2012.03.024; Wozniak-Knopp G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030083; Yageta S, 2017, MOL PHARMACEUT, V14, P699, DOI 10.1021/acs.molpharmaceut.6b00983; Yageta S, 2015, MOL PHARMACEUT, V12, P1443, DOI 10.1021/mp500759p; Yang CP, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01860; Ying TL, 2014, MABS-AUSTIN, V6, P1201, DOI 10.4161/mabs.29835; Ying TL, 2013, J BIOL CHEM, V288, P25154, DOI 10.1074/jbc.M113.484154	25	8	8	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2018	293	49					19127	19135		10.1074/jbc.RA118.005367	http://dx.doi.org/10.1074/jbc.RA118.005367			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NY	30327432	hybrid, Green Published			2022-12-28	WOS:000458467400024
J	Bitew, MA; Khoo, CA; Neha, N; De Souza, DP; Tull, D; Wawegama, NK; Newton, HJ; Sansom, FM				Bitew, Mebratu A.; Khoo, Chen Ai; Neha, Nitika; De Souza, David P.; Tull, Dedreia; Wawegama, Nadeeka K.; Newton, Hayley J.; Sansom, Fiona M.			De novo NAD synthesis is required for intracellular replication of Coxiella burnetii, the causative agent of the neglected zoonotic disease Q fever	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-ASPARTATE OXIDASE; QUINOLINATE; BIOSYNTHESIS; METABOLISM	Coxiella burnetii is an intracellular Gram-negative bacterium responsible for the important zoonotic disease Q fever. Improved genetic tools and the ability to grow this bacterium in host cell-free media has advanced the study of C. burnetii pathogenesis, but the mechanisms that allow it to survive inside the hostile phagolysosome remain incompletely understood. Previous screening of a transposon mutant library for replication within HeLa cells has suggested that nadB, encoding a putative L-aspartate oxidase required for de novo NAD synthesis, is needed for intracellular replication. Here, using genetic complementation of two independent nadB mutants and intracellular replication assays, we confirmed this finding. Untargeted metabolite analyses demonstrated key changes in metabolites in the NAD biosynthetic pathway in the nadB mutant compared with the WT, confirming the involvement of NadB in de novo NAD synthesis. Bioinformatic analysis revealed the presence of a functionally conserved arginine residue at position 275. Using site-directed mutagenesis to substitute this residue with leucine, which abolishes the activity of Escherichia coli NadB, and expression of WT and R275L GST-NadB fusion proteins in E. coli JM109, we found that purified recombinant WT GST-NadB has L-aspartate oxidase activity and that the R275L NadB variant is inactive. Complementation of the C. burnetii nadB mutant with a plasmid expressing this inactive R275L NadB failed to restore replication to WT levels, confirming the link between de novo NAD synthesis and intracellular replication of C. burnetii. This suggests that targeting this prokaryotic-specific pathway could advance the development of therapeutics to combat C. burnetii infections.	[Bitew, Mebratu A.; Neha, Nitika; Wawegama, Nadeeka K.; Sansom, Fiona M.] Univ Melbourne, Asia Pacific Ctr Anim Hlth, Melbourne Vet Sch, Parkville, Vic 3010, Australia; [Neha, Nitika; De Souza, David P.; Tull, Dedreia] Univ Melbourne, Metabol Australia, Bio21 Inst Mol Sci & Biotechnol, Parkville, Vic 3010, Australia; [Khoo, Chen Ai; Newton, Hayley J.] Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Melbourne, Vic 3000, Australia	University of Melbourne; University of Melbourne; University of Melbourne	Sansom, FM (corresponding author), Univ Melbourne, Melbourne Vet Sch, Parkville, Vic 3010, Australia.	fsansom@unimelb.edu.au	De Souza, David P/O-9800-2016; Sansom, Fiona M/W-8445-2019; Wawegama, Nadeeka K/C-7253-2019	De Souza, David P/0000-0002-7225-2632; Wawegama, Nadeeka K/0000-0003-4426-5011; Tull, Dedreia/0000-0003-2546-6707; Sansom, Fiona/0000-0002-9433-2545; Bitew, Mebratu Asaye/0000-0003-3684-9316; Newton, Hayley/0000-0002-9240-2001	Australian National Health and Medical Research Council [APP1063646, APP1120344]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by Australian National Health and Medical Research Council Grants APP1063646 and APP1120344 (to H. J. N.). The authors declare that they have no conflicts of interest with the contents of this article.	Abu-Remaileh M, 2017, SCIENCE, V358, P807, DOI 10.1126/science.aan6298; Beare PA, 2012, ADV EXP MED BIOL, V984, P249, DOI 10.1007/978-94-007-4315-1_13; Beare PA, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00097; Beron W, 2002, INFECT IMMUN, V70, P5816, DOI 10.1128/IAI.70.10.5816-5821.2002; Best SA, 2018, CELL METAB, V27, P935, DOI 10.1016/j.cmet.2018.02.006; Boshoff HIM, 2008, J BIOL CHEM, V283, P19329, DOI 10.1074/jbc.M800694200; Brickman TJ, 2017, MOL MICROBIOL, V103, P423, DOI 10.1111/mmi.13566; Carey KL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002056; Coleman SA, 2004, J BACTERIOL, V186, P7344, DOI 10.1128/JB.186.21.7344-7352.2004; Coleman SA, 2007, INFECT IMMUN, V75, P290, DOI 10.1128/IAI.00883-06; Flannagan RS, 2012, ANNU REV PATHOL-MECH, V7, P61, DOI 10.1146/annurev-pathol-011811-132445; Gazzaniga F, 2009, MICROBIOL MOL BIOL R, V73, P529, DOI 10.1128/MMBR.00042-08; Howe D, 2000, INFECT IMMUN, V68, P3815, DOI 10.1128/IAI.68.7.3815-3821.2000; Howe D, 2003, ANN NY ACAD SCI, V990, P556, DOI 10.1111/j.1749-6632.2003.tb07426.x; Jaton K, 2013, New Microbes New Infect, V1, P6, DOI 10.1002/2052-2975.8; Kazar J, 2005, ANN NY ACAD SCI, V1063, P105, DOI 10.1196/annals.1355.018; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Marinoni I, 2008, FEBS J, V275, P5090, DOI 10.1111/j.1742-4658.2008.06641.x; Masukagami Y, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00055-17; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; Mesquita I, 2016, CELL MOL LIFE SCI, V73, P1225, DOI 10.1007/s00018-015-2119-4; Moffatt JH, 2015, CELL MICROBIOL, V17, P621, DOI 10.1111/cmi.12432; Newton HJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004286; Omsland A, 2011, ANNU REV MICROBIOL, V65, P111, DOI 10.1146/annurev-micro-090110-102927; Omsland A, 2009, P NATL ACAD SCI USA, V106, P4430, DOI 10.1073/pnas.0812074106; Osterman A, 2009, ECOSAL PLUS, V3; Prunier AL, 2007, MICROBIOL-SGM, V153, P2363, DOI 10.1099/mic.0.2007/006916-0; Rodionova IA, 2014, MBIO, V5, DOI 10.1128/mBio.00747-13; Seshadri R, 2003, P NATL ACAD SCI USA, V100, P5455, DOI 10.1073/pnas.0931379100; Sorci L, 2009, CHEM BIOL, V16, P849, DOI 10.1016/j.chembiol.2009.07.006; Tedeschi G, 2001, BIOCHEMISTRY-US, V40, P4738, DOI 10.1021/bi002406u; van Asseldonk MAPM, 2013, PREV VET MED, V112, P27, DOI 10.1016/j.prevetmed.2013.06.002; Yang ZR, 2003, J BIOL CHEM, V278, P8804, DOI 10.1074/jbc.M211892200	33	8	8	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2018	293	48					18636	18645		10.1074/jbc.RA118.005190	http://dx.doi.org/10.1074/jbc.RA118.005190			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NX	30315113	hybrid, Green Published			2022-12-28	WOS:000458467300018
J	Dinman, JD				Dinman, Jonathan D.			Shapeshifting RNAs guide innate immunity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								The innate immune system can distinguish between RNAs of viral and cellular origin, but the basis for this discrimination is not known. A new paper by Calderon and Conn demonstrates that conformational plasticity determines the ability of one RNA sequence to bind to and activate the pattern recognition receptor OAS1/RNase L. In identifying a novel mode through which the immune response is naturally controlled, this finding opens new avenues toward developing approaches for the management of a wide range of viral infections.	[Dinman, Jonathan D.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Dinman, JD (corresponding author), Univ Maryland, 4062 Campus Dr, College Pk, MD 20742 USA.	dinman@umd.edu		Dinman, Jonathan/0000-0002-2402-9698				Bhattacharyya S, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00292; Calderon BM, 2018, J BIOL CHEM, V293, P16115, DOI 10.1074/jbc.RA118.004747; Calderon BM, 2017, RNA, V23, P557, DOI 10.1261/rna.060269.116; Moomau C, 2016, J BIOL CHEM, V291, P15788, DOI 10.1074/jbc.M116.735613; Parlea LG, 2016, METHODS, V103, P99, DOI 10.1016/j.ymeth.2016.04.025; Peer E, 2017, CURR OPIN CHEM BIOL, V41, P93, DOI 10.1016/j.cbpa.2017.10.008; Schlee M, 2016, NAT REV IMMUNOL, V16, P566, DOI 10.1038/nri.2016.78; Sullivan LH, 1896, LIPPINCOTTS MAGAZINE, V57, P403; Talini G, 2011, BIOCHIMIE, V93, P1998, DOI 10.1016/j.biochi.2011.06.026; Yamamoto H, 2017, TRENDS BIOCHEM SCI, V42, P655, DOI 10.1016/j.tibs.2017.06.002	10	1	1	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2018	293	41					16125	16126		10.1074/jbc.H118.005799	http://dx.doi.org/10.1074/jbc.H118.005799			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW8UH	30315089	Green Published, hybrid			2022-12-28	WOS:000447256000032
J	Hayward, J; Sanchez, J; Perry, A; Huang, C; Valle, MR; Canals, M; Payne, RJ; Stone, MJ				Hayward, Jenni; Sanchez, Julie; Perry, Andrew; Huang, Cheng; Valle, Manuel Rodriguez; Canals, Meritxell; Payne, Richard J.; Stone, Martin J.			Ticks from diverse genera encode chemokine-inhibitory evasin proteins (vol 292, pg 15670, 2017)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction									[Valle, Manuel Rodriguez] Univ Queensland, Queensland Alliance Agr & Food Innovat, 306 Carmody Rd,Bldg 80,Level 3, St Lucia, Qld 4072, Australia	University of Queensland			Rodriguez-Valle, Manuel/AAA-3819-2021; Stone, Martin/C-2492-2012	Hayward, Jenni/0000-0001-8228-8797; Stone, Martin/0000-0002-6468-4427	Australian Research Council [LP120200836]	Australian Research Council(Australian Research Council)	The primary institutional affiliation of author Manuel Rodriguez Valle should have been the Queensland Alliance for Agriculture and Food Innovation, The University of Queensland, 306 Carmody Rd., Bldg. 80, Level 3, St. Lucia QLD 4072, Australia. The grant footnote should have stated that the Ixodes holocyclus transcriptome database was an outcome of the Australian Research Council Linkage project LP120200836 and collaboration with Elanco Animal Health at The University of Queensland. Several GenBank (TM) accession numbers were inadvertently omitted for the sequences from the Ixodes holocyclus and Rhipicephalus microplus transcriptomes in Table S1. This error has now been corrected online.	Hayward J, 2017, J BIOL CHEM, V292, P15670, DOI 10.1074/jbc.M117.807255	1	0	0	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2018	293	41					15888	15888		10.1074/jbc.AAC118.005871	http://dx.doi.org/10.1074/jbc.AAC118.005871			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GW8UH	30315086	hybrid, Green Published			2022-12-28	WOS:000447256000012
J	Dhingra, N; Wei, L; Zhao, XL				Dhingra, Nalini; Wei, Lei; Zhao, Xiaolan			Replication protein A (RPA) sumoylation positively influences the DNA damage checkpoint response in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA damage; DNA damage response; small ubiquitin-like modifier (SUMO); checkpoint control; Saccharomyces cerevisiae; DNA damage checkpoint; DNA damage induced sumoylation; RPA; sumoylation, Sgs1, checkpoint kinase activation	SUMO-MEDIATED REGULATION; SACCHAROMYCES-CEREVISIAE; IN-VIVO; REPAIR; RECOMBINATION; COMPLEX; SRS2; MEC1/ATR; RECOVERY; LIGASE	The DNA damage response relies on protein modifications to elicit physiological changes required for coping with genotoxic conditions. Besides canonical DNA damage checkpoint-mediated phosphorylation, DNA damage-induced sumoylation has recently been shown to promote genotoxin survival. Cross-talk between these two pathways exists in both yeast and human cells. In particular, sumoylation is required for optimal checkpoint function, but the underlying mechanisms are not well-understood. To address this question, we examined the sumoylation of the first responder to DNA lesions, the ssDNA-binding protein complex replication protein A (RPA) in budding yeast (Saccharomyces cerevisiae). We delineated the sumoylation sites of the RPA large subunit, Rfa1 on the basis of previous and new mapping data. Findings using a sumoylation-defective Rfa1 mutant suggested that Rfa1 sumoylation acts in parallel with the 9-1-1 checkpoint complex to enhance the DNA damage checkpoint response. Mechanistically, sumoylated Rfa1 fostered an interaction with a checkpoint adaptor protein, Sgs1, and contributed to checkpoint kinase activation. Our results suggest that SUMO-based modulation of a DNA damage sensor positively influences the checkpoint response.	[Dhingra, Nalini; Wei, Lei; Zhao, Xiaolan] Mem Sloan Kettering Canc Ctr, Mol Biol Program, New York, NY 10065 USA; [Wei, Lei] Princeton Univ, Mol Biol Dept, Princeton, NJ 08544 USA	Memorial Sloan Kettering Cancer Center; Princeton University	Zhao, XL (corresponding author), Mem Sloan Kettering Canc Ctr, Mol Biol Program, New York, NY 10065 USA.	zhaox1@mskcc.org		Zhao, Xiaolan/0000-0002-8302-6905; Dhingra, Nalini/0000-0003-0949-883X	NIGMS, National Institutes of Health [GM080670]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080670] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health Grant GM080670 (to X. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Almedawar S, 2012, CURR BIOL, V22, P1576, DOI 10.1016/j.cub.2012.06.046; Altmannova V, 2010, NUCLEIC ACIDS RES, V38, P4708, DOI 10.1093/nar/gkq195; Bae KH, 2003, NUCLEIC ACIDS RES, V31, P3006, DOI 10.1093/nar/gkg422; Ball HL, 2007, MOL CELL BIOL, V27, P3367, DOI 10.1128/MCB.02238-06; Bermejo R, 2007, GENE DEV, V21, P1921, DOI 10.1101/gad.432107; Bonner JN, 2016, CELL REP, V16, P368, DOI 10.1016/j.celrep.2016.06.015; BRILL SJ, 1991, GENE DEV, V5, P1589, DOI 10.1101/gad.5.9.1589; Burgess RC, 2007, MOL CELL BIOL, V27, P6153, DOI 10.1128/MCB.00787-07; Chung I, 2015, GENE DEV, V29, P1593, DOI 10.1101/gad.265058.115; Colavito S, 2009, NUCLEIC ACIDS RES, V37, P6754, DOI 10.1093/nar/gkp748; Cremona CA, 2012, MOL CELL, V45, P422, DOI 10.1016/j.molcel.2011.11.028; Cussiol JR, 2017, CHROMOSOMA, V126, P45, DOI 10.1007/s00412-016-0600-y; Davies AA, 2008, MOL CELL, V29, P625, DOI 10.1016/j.molcel.2007.12.016; Dou H, 2010, MOL CELL, V39, P333, DOI 10.1016/j.molcel.2010.07.021; Fan J, 2012, GENE DEV, V26, P2337, DOI 10.1101/gad.194787.112; Hall BM, 2009, BIOINFORMATICS, V25, P1564, DOI 10.1093/bioinformatics/btp253; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; Hegnauer AM, 2012, EMBO J, V31, P3768, DOI 10.1038/emboj.2012.195; James P, 1996, GENETICS, V144, P1425; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Klein H, 2001, GENETICS, V157, P557; Kumar S, 2013, GENE DEV, V27, P313, DOI 10.1101/gad.204750.112; Majka J, 2006, J BIOL CHEM, V281, P27855, DOI 10.1074/jbc.M605176200; Makhnevych T, 2009, MOL CELL, V33, P124, DOI 10.1016/j.molcel.2008.12.025; Marechal A, 2015, CELL RES, V25, P9, DOI 10.1038/cr.2014.147; Marini V, 2010, DNA REPAIR, V9, P268, DOI 10.1016/j.dnarep.2010.01.007; Navadgi-Patil VM, 2009, MOL CELL, V36, P743, DOI 10.1016/j.molcel.2009.10.014; Navadgi-Patil VM, 2008, J BIOL CHEM, V283, P35853, DOI 10.1074/jbc.M807435200; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Psakhye I, 2012, CELL, V151, P807, DOI 10.1016/j.cell.2012.10.021; Reid RJD, 2002, METHOD ENZYMOL, V350, P258; Sacher M, 2006, NAT CELL BIOL, V8, P1284, DOI 10.1038/ncb1488; Sarangi P, 2015, TRENDS BIOCHEM SCI, V40, P233, DOI 10.1016/j.tibs.2015.02.006; Schwartz MF, 2002, MOL CELL, V9, P1055, DOI 10.1016/S1097-2765(02)00532-4; Ulrich Hehe D., 2009, V497, P81, DOI 10.1007/978-1-59745-566-4_6; Vaze MB, 2002, MOL CELL, V10, P373, DOI 10.1016/S1097-2765(02)00593-2; Wei L, 2016, NAT STRUCT MOL BIOL, V23, P209, DOI 10.1038/nsmb.3173; Wu CS, 2014, GENE DEV, V28, P1472, DOI 10.1101/gad.238535.114; Xu H, 2004, MOL CELL BIOL, V24, P7082, DOI 10.1128/MCB.24.16.7082-7090.2004; Yeung M, 2011, DNA REPAIR, V10, P1213, DOI 10.1016/j.dnarep.2011.09.005; Zhao XL, 2018, MOL CELL, V71, P409, DOI 10.1016/j.molcel.2018.07.027; Zhao XL, 2005, P NATL ACAD SCI USA, V102, P4777, DOI 10.1073/pnas.0500537102; Zou L, 2013, GENE DEV, V27, P227, DOI 10.1101/gad.213306.113	45	13	14	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2690	2699		10.1074/jbc.RA118.006006	http://dx.doi.org/10.1074/jbc.RA118.006006			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30591583	Green Published, hybrid			2022-12-28	WOS:000459601600011
J	Sulistomo, HW; Nemoto, T; Yanagita, T; Takeya, R				Sulistomo, Hikmawan Wahyu; Nemoto, Takayuki; Yanagita, Toshihiko; Takeya, Ryu			Formin homology 2 domain-containing 3 (Fhod3) controls neural plate morphogenesis in mouse cranial neurulation by regulating multidirectional apical constriction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actin; adherens junction; cell junction; cell-cell interaction; epithelial cell; formin; neural development; morphogenesis; apical constriction; Fhod3; neural tube closure; neurulation; rhombomere	E-CADHERIN; ADHERENS JUNCTIONS; SPINAL NEURULATION; RAT EMBRYOS; ACTIN; PROTEIN; MECHANISMS; PATTERNS; EXPRESSION; DAAM1	Neural tube closure requires apical constriction during which contraction of the apical F-actin network forces the cell into a wedged shape, facilitating the folding of the neural plate into a tube. However, how F-actin assembly at the apical surface is regulated in mammalian neurulation remains largely unknown. We report here that formin homology 2 domain-containing 3 (Fhod3), a formin protein that mediates F-actin assembly, is essential for cranial neural tube closure in mouse embryos. We found that Fhod3 is expressed in the lateral neural plate but not in the floor region of the closing neural plate at the hindbrain. Consistently, in Fhod3-null embryos, neural plate bending at the midline occurred normally, but lateral plates seemed floppy and failed to flex dorsomedially. Because the apical accumulation of F-actin and constriction were impaired specifically at the lateral plates in Fhod3-null embryos, we concluded that Fhod3-mediated actin assembly contributes to lateral plate-specific apical constriction to advance closure. Intriguingly, Fhod3 expression at the hindbrain was restricted to neuromeric segments called rhombomeres. The rhombomere-specific accumulation of apical F-actin induced by the rhombomere-restricted expression of Fhod3 was responsible for the outward bulging of rhombomeres involving apical constriction along the anteroposterior axis, as rhombomeric bulging was less prominent in Fhod3-null embryos than in the wild type. Fhod3 thus plays a crucial role in the morphological changes associated with neural tube closure at the hindbrain by mediating apical constriction not only in the mediolateral but also in the anteroposterior direction, thereby contributing to tube closure and rhombomere segmentation, respectively.	[Sulistomo, Hikmawan Wahyu; Nemoto, Takayuki; Takeya, Ryu] Univ Miyazaki, Fac Med, Dept Pharmacol, Miyazaki 8891692, Japan; [Yanagita, Toshihiko] Univ Miyazaki, Fac Med, Sch Nursing, Dept Clin Pharmacol, Miyazaki 8891692, Japan	University of Miyazaki; University of Miyazaki	Takeya, R (corresponding author), Univ Miyazaki, Fac Med, Dept Pharmacol, Miyazaki 8891692, Japan.	takeya@med.miyazaki-u.ac.jp		Sulistomo, Hikmawan Wahyu/0000-0002-5343-6428	Japan Society for the Promotion of Science (JSPS) [JP18K06701, JP26460371]; Ministry of Education, Culture, Sports, Science, and Technology (MEXT); joint research program of the Biosignal Research Center, Kobe University; President's Strategic Priority Budget of the University of Miyazaki; Otsuka Toshimi Scholarship Foundation	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); joint research program of the Biosignal Research Center, Kobe University; President's Strategic Priority Budget of the University of Miyazaki; Otsuka Toshimi Scholarship Foundation(Otsuka Pharmaceutical)	This work was supported in part by Grants-in-aid for Scientific Research (C) JP18K06701 (to T. N.) and JP26460371 (to R. T.) from the Japan Society for the Promotion of Science (JSPS); a Grant-in-aid for Scientific Research on Innovative Areas, "Platform of Advanced Animal Model Support," (to R.T.) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT); the joint research program of the Biosignal Research Center, Kobe University (to R. T.); the President's Strategic Priority Budget of the University of Miyazaki (to R. T.); and a scholarship from the Otsuka Toshimi Scholarship Foundation (to H. W. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Acharya BR, 2017, CELL REP, V18, P2854, DOI 10.1016/j.celrep.2017.02.078; Arnold TR, 2017, EXP CELL RES, V358, P20, DOI 10.1016/j.yexcr.2017.03.053; Calzolari S, 2014, EMBO J, V33, P686, DOI 10.1002/embj.201386003; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Carramusa L, 2007, J CELL SCI, V120, P3870, DOI 10.1242/jcs.014365; Dahmann C, 2011, NAT REV GENET, V12, P43, DOI 10.1038/nrg2902; Filas BA, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/6/066007; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Grego-Bessa J, 2015, DEVELOPMENT, V142, P1305, DOI 10.1242/dev.115493; Grikscheit K, 2016, TRENDS BIOCHEM SCI, V41, P148, DOI 10.1016/j.tibs.2015.12.002; Grikscheit K, 2015, J CELL BIOL, V209, P367, DOI 10.1083/jcb.201412015; Gunning PW, 2015, J CELL SCI, V128, P2965, DOI 10.1242/jcs.172502; GUTHRIE S, 1991, J NEUROBIOL, V22, P742, DOI 10.1002/neu.480220709; Heisenberg CP, 2013, CELL, V153, P948, DOI 10.1016/j.cell.2013.05.008; Higashi T, 2019, MOL BIOL CELL, V30, P82, DOI 10.1091/mbc.E18-02-0133; Hildebrand JD, 1999, CELL, V99, P485, DOI 10.1016/S0092-8674(00)81537-8; Hirano S, 2012, PHYSIOL REV, V92, P597, DOI 10.1152/physrev.00014.2011; Homem CCF, 2008, DEVELOPMENT, V135, P1005, DOI 10.1242/dev.016337; Kan-o M, 2012, BIOL OPEN, V1, P889, DOI 10.1242/bio.20121370; Kanaya H, 2005, GENES CELLS, V10, P665, DOI 10.1111/j.1365-2443.2005.00867.x; Kida Y, 2004, DEV BRAIN RES, V153, P143, DOI 10.1016/j.devbrainres.2004.07.014; Kiecker C, 2005, NAT REV NEUROSCI, V6, P553, DOI 10.1038/nrn1702; Kobielak A, 2004, NAT CELL BIOL, V6, P21, DOI 10.1038/ncb1075; Kovacs EM, 2002, CURR BIOL, V12, P379, DOI 10.1016/S0960-9822(02)00661-9; Krumlauf R, 2016, CURR TOP DEV BIOL, V116, P581, DOI 10.1016/bs.ctdb.2015.12.011; Kuhn Sonja, 2014, Small GTPases, V5, pe29513, DOI 10.4161/sgtp.29513; Lecuit T, 2015, NAT CELL BIOL, V17, P533, DOI 10.1038/ncb3136; Lee HO, 2013, TRENDS CELL BIOL, V23, P141, DOI 10.1016/j.tcb.2012.11.001; Li DQ, 2011, DEVELOPMENT, V138, P303, DOI 10.1242/dev.055566; Marin F, 2008, DEV BIOL, V323, P230, DOI 10.1016/j.ydbio.2008.08.017; Martin AC, 2014, DEVELOPMENT, V141, P1987, DOI 10.1242/dev.102228; Massarwa R, 2013, DEVELOPMENT, V140, P226, DOI 10.1242/dev.085001; Massarwa R, 2009, DEV CELL, V16, P877, DOI 10.1016/j.devcel.2009.04.010; Matsuyama S, 2018, P NATL ACAD SCI USA, V115, pE4386, DOI 10.1073/pnas.1716498115; MORRISSKAY G, 1985, J EMBRYOL EXP MORPH, V88, P333; MORRISSKAY GM, 1981, J EMBRYOL EXP MORPH, V65, P225; NicholsonFlynn K, 1996, J NEUROSCI, V16, P6853; Nikolopoulou E, 2017, DEVELOPMENT, V144, P552, DOI 10.1242/dev.145904; Nishimura T, 2016, J CELL BIOL, V215, P559, DOI 10.1083/jcb.201603107; Nishimura T, 2012, CELL, V149, P1084, DOI 10.1016/j.cell.2012.04.021; Ohmura T, 2012, DEV DYNAM, V241, P1350, DOI 10.1002/dvdy.23816; Otani T, 2006, J CELL BIOL, V175, P135, DOI 10.1083/jcb.200605012; Phng LK, 2015, DEV CELL, V32, P123, DOI 10.1016/j.devcel.2014.11.017; Sandell LL, 2012, GENESIS, V50, P844, DOI 10.1002/dvg.22344; Sawyer JM, 2010, DEV BIOL, V341, P5, DOI 10.1016/j.ydbio.2009.09.009; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shum ASW, 1996, ANAT EMBRYOL, V194, P65; Skau CT, 2015, ANNU REV BIOPHYS, V44, P285, DOI 10.1146/annurev-biophys-060414-034308; Suzuki M, 2012, DEV GROWTH DIFFER, V54, P266, DOI 10.1111/j.1440-169X.2012.01346.x; Takeichi M, 2014, NAT REV MOL CELL BIO, V15, P397, DOI 10.1038/nrm3802; Tang VW, 2012, J CELL BIOL, V196, P115, DOI 10.1083/jcb.201103116; Ushijima T, 2018, J BIOL CHEM, V293, P148, DOI 10.1074/jbc.M117.813931; Vaage S, 1969, Ergeb Anat Entwicklungsgesch, V41, P3; Verma S, 2004, J BIOL CHEM, V279, P34062, DOI 10.1074/jbc.M404814200; Verma S, 2012, MOL BIOL CELL, V23, P4601, DOI 10.1091/mbc.E12-08-0574; Wallingford JB, 2013, SCIENCE, V339, P1011, DOI 10.1126/science.1222002; Williams M, 2014, DEV CELL, V29, P34, DOI 10.1016/j.devcel.2014.02.007; WILSON DB, 1995, J ANAT, V186, P209; Wu SK, 2014, NAT CELL BIOL, V16, P167, DOI 10.1038/ncb2900; Ybot-Gonzalez P, 1999, DEV DYNAM, V215, P273, DOI 10.1002/(SICI)1097-0177(199907)215:3<273::AID-AJA9>3.0.CO;2-H; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055	61	4	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2924	2934		10.1074/jbc.RA118.005471	http://dx.doi.org/10.1074/jbc.RA118.005471			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30573686	Green Published, hybrid			2022-12-28	WOS:000459601600029
J	Yang, CZ; Zang, WC; Ji, YP; Li, TT; Yang, YF; Zheng, XF				Yang, Chuanzhen; Zang, Weicheng; Ji, Yapeng; Li, Tingting; Yang, Yongfeng; Zheng, Xiaofeng			Ribosomal protein L6 (RPL6) is recruited to DNA damage sites in a poly(ADP-ribose) polymerase-dependent manner and regulates the DNA damage response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA damage response; ubiquitylation (ubiquitination); DNA repair; cell signaling; E3 ubiquitin ligase; histone; histone H2A; MDC1; PARP; Ribosomal Protein L6	P53; 53BP1; NUCLEOLUS; PATHWAY; ATM; ACTIVATION; COMPLEX; RNF168; REPAIR; RNF8	Ribosomal proteins are the building blocks of ribosome biogenesis. Beyond their known participation in ribosome assembly, the ribosome-independent functions of ribosomal proteins are largely unknown. Here, using immunoprecipitation, subcellular fractionation, His-ubiquitin pulldown, and immunofluorescence microscopy assays, along with siRNA-based knockdown approaches, we demonstrate that ribosomal protein L6 (RPL6) directly interacts with histone H2A and is involved in the DNA damage response (DDR). We found that in response to DNA damage, RPL6 is recruited to DNA damage sites in a poly(ADP-ribose) polymerase (PARP)-dependent manner, promoting its interaction with H2A. We also observed that RPL6 depletion attenuates the interaction between mediator of DNA damage checkpoint 1 (MDC1) and H2A histone family member X, phosphorylated (gamma H2AX), impairs the accumulation of MDC1 at DNA damage sites, and reduces both the recruitment of ring finger protein 168 (RNF168) and H2A Lys-15 ubiquitination (H2AK15ub). These RPL6 depletion-induced events subsequently inhibited the recruitment of the following downstream repair proteins: tumor protein P53-binding protein 1 (TP53BP1) and BRCA1, DNA repair-associated (BRCA1). Moreover, the RPL6 knockdown resulted in defects in the DNA damage-induced G(2)-M checkpoint, DNA damage repair, and cell survival. In conclusion, our study identifies RPL6 as a critical regulatory factor involved in the DDR. These findings expand our knowledge of the extraribosomal functions of ribosomal proteins in cell physiology and deepen our understanding of the molecular mechanisms underlying DDR regulation.	[Yang, Chuanzhen; Zang, Weicheng; Ji, Yapeng; Li, Tingting; Yang, Yongfeng; Zheng, Xiaofeng] Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China; [Yang, Chuanzhen; Zang, Weicheng; Ji, Yapeng; Li, Tingting; Yang, Yongfeng; Zheng, Xiaofeng] Peking Univ, Sch Life Sci, Dept Biochem & Mol Biol, Beijing 100871, Peoples R China	Peking University; Peking University	Zheng, XF (corresponding author), Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China.	xiaofengz@pku.edu.cn		Ji, Yapeng/0000-0003-2343-4365	National Science Foundation of China [81730080, 31670786, 31470754]; National Key Research and Development Program of China [2016YFC1302401]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China	This work was supported by National Science Foundation of China Grants 81730080, 31670786, and 31470754 and the National Key Research and Development Program of China Grant 2016YFC1302401. The authors declare that they have no conflicts of interest with the contents of this article.	Bai DM, 2014, NUCLEIC ACIDS RES, V42, P1799, DOI 10.1093/nar/gkt971; Bailly A, 2016, ONCOGENE, V35, P415, DOI 10.1038/onc.2015.104; Berkovich E, 2007, NAT CELL BIOL, V9, P683, DOI 10.1038/ncb1599; Bhat KP, 2004, EMBO J, V23, P2402, DOI 10.1038/sj.emboj.7600247; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Bohgaki Toshiyuki, 2010, Genome Integr, V1, P15, DOI 10.1186/2041-9414-1-15; Boulon S, 2010, MOL CELL, V40, P216, DOI 10.1016/j.molcel.2010.09.024; Chapman JR, 2008, EMBO REP, V9, P795, DOI 10.1038/embor.2008.103; Chapman JR, 2013, MOL CELL, V49, P858, DOI 10.1016/j.molcel.2013.01.002; Chen D, 2007, ONCOGENE, V26, P5029, DOI 10.1038/sj.onc.1210327; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cui D, 2014, ONCOGENE, V33, P2225, DOI 10.1038/onc.2013.170; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; de Marval PLM, 2011, ONCOTARGET, V2, P234; Deisenroth C, 2010, ONCOGENE, V29, P4253, DOI 10.1038/onc.2010.189; DiTullio RA, 2002, NAT CELL BIOL, V4, P998, DOI 10.1038/ncb892; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Finn K, 2012, CELL MOL LIFE SCI, V69, P1447, DOI 10.1007/s00018-011-0875-3; Fradet-Turcotte A, 2013, NATURE, V499, P50, DOI 10.1038/nature12318; Giglia-Mari G, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a000745; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Kim H, 2014, NATURE, V506, P334, DOI 10.1038/nature13039; Lee JH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01051-z; Li TT, 2014, J CELL SCI, V127, P2238, DOI 10.1242/jcs.138891; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Mattiroli F, 2012, CELL, V150, P1182, DOI 10.1016/j.cell.2012.08.005; Messner S, 2011, TRENDS CELL BIOL, V21, P534, DOI 10.1016/j.tcb.2011.06.001; Naganuma T, 2010, J BIOL CHEM, V285, P4747, DOI 10.1074/jbc.M109.068098; Nerurkar P, 2015, INT REV CEL MOL BIO, V319, P107, DOI 10.1016/bs.ircmb.2015.07.002; Nicolas E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11390; NOMURA M, 1984, ANNU REV BIOCHEM, V53, P75, DOI 10.1146/annurev.bi.53.070184.000451; Nowsheen S, 2018, NAT CELL BIOL, V20, P455, DOI 10.1038/s41556-018-0071-x; Pan WQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021625; Rodnina MV, 2009, CURR OPIN CELL BIOL, V21, P435, DOI 10.1016/j.ceb.2009.01.023; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Shibata A, 2010, MOL CELL BIOL, V30, P3371, DOI 10.1128/MCB.01644-09; Stepinski D, 2016, HISTOCHEM CELL BIOL, V146, P119, DOI 10.1007/s00418-016-1443-6; Tschochner H, 2003, TRENDS CELL BIOL, V13, P255, DOI 10.1016/S0962-8924(03)00054-0; Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182; Ward IM, 2003, MOL CELL BIOL, V23, P2556, DOI 10.1128/MCB.23.7.2556-2563.2003; Xiong X, 2011, ONCOGENE, V30, P1798, DOI 10.1038/onc.2010.569; Yadavilli S, 2009, DNA REPAIR, V8, P1215, DOI 10.1016/j.dnarep.2009.07.003; Yang CZ, 2018, CANCER RES, V78, P1069, DOI 10.1158/0008-5472.CAN-17-2143; Zhang J, 2014, ONCOGENE, V33, P246, DOI 10.1038/onc.2012.560; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024; Zhu P, 2007, MOL CELL, V27, P609, DOI 10.1016/j.molcel.2007.07.024	48	23	24	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2827	2838		10.1074/jbc.RA118.007009	http://dx.doi.org/10.1074/jbc.RA118.007009			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30598506	Green Published, hybrid			2022-12-28	WOS:000459601600021
J	Genest, O; Wickner, S; Doyle, SM				Genest, Olivier; Wickner, Sue; Doyle, Shannon M.			Hsp90 and Hsp70 chaperones: Collaborators in protein remodeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						chaperone DnaJ (DnaJ); chaperone DnaK (DnaK); protein folding; heat shock protein (HSP); conformational change; client protein; co-chaperone; Hop; Sti1; Hsp40; HtpG	ESCHERICHIA-COLI HSP90; HEAT-SHOCK GENE; THERMAL-STRESS MANAGEMENT; MOLECULAR CHAPERONE; CONFORMATIONAL DYNAMICS; SUBSTRATE-BINDING; CHARGED-LINKER; STRUCTURAL-ANALYSIS; CRYSTAL-STRUCTURE; CLIENT-BINDING	Heat shock proteins 90 (Hsp90) and 70 (Hsp70) are two families of highly conserved ATP-dependent molecular chaperones that fold and remodel proteins. Both are important components of the cellular machinery involved in protein homeostasis and participate in nearly every cellular process. Although Hsp90 and Hsp70 each carry out some chaperone activities independently, they collaborate in other cellular remodeling reactions. In eukaryotes, both Hsp90 and Hsp70 function with numerous Hsp90 and Hsp70 co-chaperones. In contrast, bacterial Hsp90 and Hsp70 are less complex; Hsp90 acts independently of co-chaperones, and Hsp70 uses two co-chaperones. In this review, we focus on recent progress toward understanding the basic mechanisms of Hsp90-mediated protein remodeling and the collaboration between Hsp90 and Hsp70, with an emphasis on bacterial chaperones. We describe the structure and conformational dynamics of these chaperones and their interactions with each other and with client proteins. The physiological roles of Hsp90 in Escherichia coli and other bacteria are also discussed. We anticipate that the information gained from exploring the mechanism of the bacterial chaperone system will provide the groundwork for understanding the more complex eukaryotic Hsp90 system and its modulation by Hsp90 co-chaperones.	[Genest, Olivier] Aix Marseille Univ, CNRS, Lab Bioenerget & Ingn Prot, F-13402 Marseille, France; [Wickner, Sue; Doyle, Shannon M.] NCI, Lab Mol Biol, NIH, Bethesda, MD 20892 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Wickner, S; Doyle, SM (corresponding author), NCI, Lab Mol Biol, NIH, Bethesda, MD 20892 USA.	ogenest@imm.cnrs.fr; wickners@mail.nih.gov; doyles@mail.nih.gov	Genest, Olivier/GQZ-3215-2022	Genest, Olivier/0000-0003-1240-2827	Intramural Research Program of the National Institutes of Health, NCI, Center for Cancer Research; Aix-Marseille Universite (AMU); Agence Nationale de la Recherche [ANR-16-CE11-0002-01]; Centre National de la Recherche Scientifique; NATIONAL CANCER INSTITUTE [ZIABC008710] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, NCI, Center for Cancer Research; Aix-Marseille Universite (AMU); Agence Nationale de la Recherche(French National Research Agency (ANR)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the Intramural Research Program of the National Institutes of Health, NCI, Center for Cancer Research, Centre National de la Recherche Scientifique, and Aix-Marseille Universite (AMU). This is the fourth article in the JBC Reviews series "Molecular chaperones and protein quality control." The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by Agence Nationale de la Recherche Grant ANR-16-CE11-0002-01. To whom correspondence may be addressed. E-mail: ogenest@imm.cnrs.fr.	Acebron SP, 2008, J BIOL CHEM, V283, P1381, DOI 10.1074/jbc.M706189200; Ahmad A, 2011, P NATL ACAD SCI USA, V108, P18966, DOI 10.1073/pnas.1111220108; Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Alvira S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6484; BARDWELL JCA, 1988, J BACTERIOL, V170, P2977, DOI 10.1128/jb.170.7.2977-2983.1988; Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106; Bracher A, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00010; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Butler LM, 2015, MOL CANCER RES, V13, P1445, DOI 10.1158/1541-7786.MCR-15-0234; Chang HCJ, 1997, MOL CELL BIOL, V17, P318, DOI 10.1128/MCB.17.1.318; Craig EA, 2017, TRENDS BIOCHEM SCI, V42, P355, DOI 10.1016/j.tibs.2017.02.007; Dang W, 2011, VET MICROBIOL, V152, P394, DOI 10.1016/j.vetmic.2011.05.030; Daturpalli S, 2013, J MOL BIOL, V425, P4614, DOI 10.1016/j.jmb.2013.08.006; Dollins DE, 2007, MOL CELL, V28, P41, DOI 10.1016/j.molcel.2007.08.024; Elnatan D, 2017, ELIFE, V6, DOI 10.7554/eLife.25235; English CA, 2017, J BIOL CHEM, V292, P14765, DOI 10.1074/jbc.M117.789313; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; Flom G, 2007, BIOCHEM J, V404, P159, DOI 10.1042/BJ20070084; Flom GA, 2008, MOL BIOL CELL, V19, P5249, DOI 10.1091/mbc.E08-04-0435; Flynn JM, 2015, J MOL BIOL, V427, P2904, DOI 10.1016/j.jmb.2015.03.017; Garcia-Descalzo L, 2011, CELL STRESS CHAPERON, V16, P203, DOI 10.1007/s12192-010-0233-7; Garcie C, 2016, J INFECT DIS, V214, P916, DOI 10.1093/infdis/jiw294; Gassler CS, 1998, P NATL ACAD SCI USA, V95, P15229, DOI 10.1073/pnas.95.26.15229; Genest O, 2015, J MOL BIOL, V427, P3877, DOI 10.1016/j.jmb.2015.10.010; Genest O, 2013, MOL CELL, V49, P464, DOI 10.1016/j.molcel.2012.11.017; Genest O, 2011, P NATL ACAD SCI USA, V108, P8206, DOI 10.1073/pnas.1104703108; Genevaux P, 2007, MOL MICROBIOL, V66, P840, DOI 10.1111/j.1365-2958.2007.05961.x; Graf Christian, 2014, Front Mol Biosci, V1, P4, DOI 10.3389/fmolb.2014.00004; GRAGEROV A, 1994, J MOL BIOL, V235, P848, DOI 10.1006/jmbi.1994.1043; Grudniak AM, 2018, FUTURE MICROBIOL, V13, P69, DOI 10.2217/fmb-2017-0111; Grudniak AM, 2013, MUTAT RES-FUND MOL M, V745, P1, DOI 10.1016/j.mrfmmm.2013.04.003; Hagn F, 2011, NAT STRUCT MOL BIOL, V18, P1086, DOI 10.1038/nsmb.2114; Hainzl O, 2009, J BIOL CHEM, V284, P22559, DOI 10.1074/jbc.M109.031658; Harris SF, 2004, STRUCTURE, V12, P1087, DOI 10.1016/j.str.2004.03.020; Harrison C, 2003, CELL STRESS CHAPERON, V8, P218, DOI 10.1379/1466-1268(2003)008<0218:GANEFF>2.0.CO;2; Hernandez MP, 2002, J BIOL CHEM, V277, P38294, DOI 10.1074/jbc.M206566200; Honore FA, 2017, CELL REP, V19, P680, DOI 10.1016/j.celrep.2017.03.082; Hossain M, 2003, CURR MICROBIOL, V46, P70, DOI 10.1007/s00284-002-3831-5; Hossain MM, 2002, CURR MICROBIOL, V44, P291, DOI 10.1007/s00284-001-0005-9; Huck JD, 2017, CELL REP, V20, P2800, DOI 10.1016/j.celrep.2017.08.079; Inoue T, 2007, J BACTERIOL, V189, P950, DOI 10.1128/JB.01294-06; Jahn M, 2018, STRUCTURE, V26, P96, DOI 10.1016/j.str.2017.11.023; Jahn M, 2014, P NATL ACAD SCI USA, V111, P17881, DOI 10.1073/pnas.1414073111; JAKOB U, 1995, J BIOL CHEM, V270, P7288, DOI 10.1074/jbc.270.13.7288; Johnson BD, 1998, J BIOL CHEM, V273, P3679, DOI 10.1074/jbc.273.6.3679; Johnson JL, 2012, BBA-MOL CELL RES, V1823, P607, DOI 10.1016/j.bbamcr.2011.09.020; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Karagoz GE, 2015, TRENDS BIOCHEM SCI, V40, P117, DOI 10.1016/j.tibs.2014.12.002; Karagoz GE, 2014, CELL, V156, P963, DOI 10.1016/j.cell.2014.01.037; Kirschke E, 2014, CELL, V157, P1685, DOI 10.1016/j.cell.2014.04.038; Kityk R, 2018, MOL CELL, V69, P227, DOI 10.1016/j.molcel.2017.12.003; Kityk R, 2012, MOL CELL, V48, P863, DOI 10.1016/j.molcel.2012.09.023; Kravats AN, 2018, P NATL ACAD SCI USA, V115, pE2210, DOI 10.1073/pnas.1719969115; Kravats AN, 2017, J MOL BIOL, V429, P858, DOI 10.1016/j.jmb.2016.12.014; Krukenberg KA, 2008, STRUCTURE, V16, P755, DOI 10.1016/j.str.2008.01.021; Krukenberg KA, 2009, J MOL BIOL, V390, P278, DOI 10.1016/j.jmb.2009.04.080; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; Lavery LA, 2014, MOL CELL, V53, P330, DOI 10.1016/j.molcel.2013.12.023; Li J, 2012, BBA-MOL CELL RES, V1823, P624, DOI 10.1016/j.bbamcr.2011.09.003; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Lorenz OR, 2014, MOL CELL, V53, P941, DOI 10.1016/j.molcel.2014.02.003; Luengo TM, 2018, MOL CELL, V70, P545, DOI 10.1016/j.molcel.2018.03.028; Mapa K, 2010, MOL CELL, V38, P89, DOI 10.1016/j.molcel.2010.03.010; Marcinowski M, 2013, J MOL BIOL, V425, P466, DOI 10.1016/j.jmb.2012.11.030; Marcinowski M, 2011, NAT STRUCT MOL BIOL, V18, P150, DOI 10.1038/nsmb.1970; Mashaghi A, 2016, NATURE, V539, P448, DOI 10.1038/nature20137; Mayer M, 2003, J MOL BIOL, V330, P137, DOI 10.1016/S0022-2836(03)00556-4; Mayer MP, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0183; Mayer MP, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00058; Mayer MP, 2015, MOL CELL, V58, P8, DOI 10.1016/j.molcel.2015.02.022; Mayer MP, 2013, TRENDS BIOCHEM SCI, V38, P507, DOI 10.1016/j.tibs.2013.08.001; Mayer MP, 2010, MOL CELL, V39, P321, DOI 10.1016/j.molcel.2010.07.012; Mayer MP, 1999, J MOL BIOL, V289, P1131, DOI 10.1006/jmbi.1999.2844; Mishra P, 2014, MOL CELL, V53, P344, DOI 10.1016/j.molcel.2013.12.024; Miyata Y, 2013, CURR PHARM DESIGN, V19, P347, DOI 10.2174/138161213804143725; Morgner N, 2015, CELL REP, V11, P759, DOI 10.1016/j.celrep.2015.03.063; Morishima Y, 2000, J BIOL CHEM, V275, P18054, DOI 10.1074/jbc.M000434200; Moro F, 2004, J BIOL CHEM, V279, P19600, DOI 10.1074/jbc.M400921200; Motojima-Miyazaki Y, 2010, BIOCHEM BIOPH RES CO, V400, P241, DOI 10.1016/j.bbrc.2010.08.047; Nakamoto H, 2014, J BIOL CHEM, V289, P6110, DOI 10.1074/jbc.M113.524801; Oroz J, 2017, NAT STRUCT MOL BIOL, V24, P407, DOI 10.1038/nsmb.3380; Park SJ, 2011, J MOL BIOL, V411, P158, DOI 10.1016/j.jmb.2011.05.030; Park SJ, 2011, NAT STRUCT MOL BIOL, V18, P537, DOI 10.1038/nsmb.2045; Press MO, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003631; Prodromou C, 2016, BIOCHEM J, V473, P2439, DOI 10.1042/BCJ20160005; Qi RF, 2013, NAT STRUCT MOL BIOL, V20, P900, DOI 10.1038/nsmb.2583; Radli M, 2018, J MOL BIOL, V430, P3029, DOI 10.1016/j.jmb.2018.05.026; Reidy M, 2018, GENETICS, V209, P1139, DOI 10.1534/genetics.118.301178; Reidy M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004720; Retzlaff M, 2010, MOL CELL, V37, P344, DOI 10.1016/j.molcel.2010.01.006; Rist W, 2006, J BIOL CHEM, V281, P16493, DOI 10.1074/jbc.M600847200; Rohl A, 2013, TRENDS BIOCHEM SCI, V38, P253, DOI 10.1016/j.tibs.2013.02.003; Rudiger S, 1997, NAT STRUCT BIOL, V4, P342, DOI 10.1038/nsb0597-342; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Saito M, 2008, BIOSCI BIOTECH BIOCH, V72, P1394, DOI 10.1271/bbb.80093; Sato T, 2010, MOL MICROBIOL, V76, P576, DOI 10.1111/j.1365-2958.2010.07139.x; Scheibel T, 1998, P NATL ACAD SCI USA, V95, P1495, DOI 10.1073/pnas.95.4.1495; Schlecht R, 2011, NAT STRUCT MOL BIOL, V18, P345, DOI 10.1038/nsmb.2006; Schmid AB, 2012, EMBO J, V31, P1506, DOI 10.1038/emboj.2011.472; Schopf FH, 2017, NAT REV MOL CELL BIO, V18, P345, DOI 10.1038/nrm.2017.20; SHAKNOVICH R, 1992, MOL CELL BIOL, V12, P5059, DOI 10.1128/MCB.12.11.5059; Shiau AK, 2006, CELL, V127, P329, DOI 10.1016/j.cell.2006.09.027; Sikor M, 2013, EMBO J, V32, P1639, DOI 10.1038/emboj.2013.89; Soroka J, 2012, MOL CELL, V45, P517, DOI 10.1016/j.molcel.2011.12.031; Southworth DR, 2008, MOL CELL, V32, P631, DOI 10.1016/j.molcel.2008.10.024; Street TO, 2012, J MOL BIOL, V415, P3, DOI 10.1016/j.jmb.2011.10.038; Suh WC, 1998, P NATL ACAD SCI USA, V95, P15223, DOI 10.1073/pnas.95.26.15223; Sung N, 2016, ACTA CRYSTALLOGR D, V72, P904, DOI 10.1107/S2059798316009906; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Tanaka N, 1999, FEBS LETT, V458, P117, DOI 10.1016/S0014-5793(99)01134-5; Thomas JG, 1998, J BACTERIOL, V180, P5165, DOI 10.1128/JB.180.19.5165-5172.1998; Tsuboyama K, 2018, MOL CELL, V70, P722, DOI 10.1016/j.molcel.2018.04.010; Tsutsumi S, 2012, P NATL ACAD SCI USA, V109, P2937, DOI 10.1073/pnas.1114414109; Tsutsumi S, 2009, NAT STRUCT MOL BIOL, V16, P1141, DOI 10.1038/nsmb.1682; Umehara K, 2018, MOLECULES, V23, DOI 10.3390/molecules23030528; Verba KA, 2017, TRENDS BIOCHEM SCI, V42, P799, DOI 10.1016/j.tibs.2017.07.002; Verba KA, 2016, SCIENCE, V352, P1542, DOI 10.1126/science.aaf5023; Verbrugghe E, 2015, VET RES, V46, DOI 10.1186/s13567-015-0261-5; Vivien E, 2005, FEMS MICROBIOL LETT, V251, P81, DOI 10.1016/j.femsle.2005.07.026; Watanabe S, 2007, BIOCHEM BIOPH RES CO, V352, P36, DOI 10.1016/j.bbrc.2006.10.144; Wegele H, 2006, J MOL BIOL, V356, P802, DOI 10.1016/j.jmb.2005.12.008; WIECH H, 1992, NATURE, V358, P169, DOI 10.1038/358169a0; Yosef I, 2011, P NATL ACAD SCI USA, V108, P20136, DOI 10.1073/pnas.1113519108; Young JC, 2000, EMBO J, V19, P5930, DOI 10.1093/emboj/19.21.5930; Zhang YB, 2004, P NATL ACAD SCI USA, V101, P10272, DOI 10.1073/pnas.0401313101; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606; Zhuravleva A, 2015, P NATL ACAD SCI USA, V112, pE2865, DOI 10.1073/pnas.1506692112; Zhuravleva A, 2012, CELL, V151, P1296, DOI 10.1016/j.cell.2012.11.002	128	145	148	30	134	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2019	294	6					2109	2120		10.1074/jbc.REV118.002806	http://dx.doi.org/10.1074/jbc.REV118.002806			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM8EO	30401745	Green Published, hybrid			2022-12-28	WOS:000459711400029
J	Hatakeyama, H; Morino, T; Ishii, T; Kanzaki, M				Hatakeyama, Hiroyasu; Morino, Taisuke; Ishii, Takuya; Kanzaki, Makoto			Cooperative actions of Tbc1d1 and AS160/Tbc1d4 in GLUT4-trafficking activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glucose transporter type 4 (GLUT4); GTPase activating protein (GAP); membrane trafficking; microscopic imaging; signal transduction; insulin; AMP-activated kinase (AMPK); Akt PKB	PHOSPHOTYROSINE-BINDING DOMAIN; STIMULATED GLUCOSE-UPTAKE; ACTIVATED PROTEIN-KINASE; RAT SKELETAL-MUSCLE; 160 KDA AS160; GLUT4 TRANSLOCATION; AKT SUBSTRATE; INSULIN; PHOSPHORYLATION; TRAFFICKING	AS160 and Tbc1d1 are key Rab GTPase-activating proteins (RabGAPs) that mediate release of static GLUT4 in response to insulin or exercise-mimetic stimuli, respectively, but their cooperative regulation and its underlying mechanisms remain unclear. By employing GLUT4 nanometry with cell-based reconstitution models, we herein analyzed the functional cooperative activities of the RabGAPs. When both RabGAPs are present, Tbc1d1 functionally dominates AS160, and stimuli-inducible GLUT4 release relies on Tbc1d1-evoking proximal stimuli, such as AICAR and intracellular Ca2+. Detailed functional assessments with varying expression ratios revealed that AS160 modulates sensitivity to external stimuli in Tbc1d1-mediated GLUT4 release. For example, Tbc1d1-governed GLUT4 release triggered by Ca2+ plus insulin occurred more efficiently than that in cells with little or no AS160. Series of mutational analyses revealed that these synergizing actions rely on the phosphotyrosine-binding 1 (PTB1) and calmodulin-binding domains of Tbc1d1 as well as key phosphorylation sites of both AS160 (Thr(642)) and Tbc1d1 (Ser(237) and Thr(596)). Thus, the emerging cooperative governance relying on the multiple regulatory nodes of both Tbc1d1 and AS160, functioning together, plays a key role in properly deciphering biochemical signals into a physical GLUT4 release process in response to insulin, exercise, and the two in combination.	[Hatakeyama, Hiroyasu] Tohoku Univ, Frontier Res Inst Interdisciplinary Sci, Sendai, Miyagi 9808579, Japan; [Hatakeyama, Hiroyasu; Kanzaki, Makoto] Tohoku Univ, Grad Sch Biomed Engn, Sendai, Miyagi 9808579, Japan; [Morino, Taisuke; Ishii, Takuya; Kanzaki, Makoto] Tohoku Univ, Dept Informat & Intelligent Syst, Sendai, Miyagi 9808579, Japan	Tohoku University; Tohoku University; Tohoku University	Kanzaki, M (corresponding author), Tohoku Univ, Grad Sch Biomed Engn, Aoba Ku, 6-6-04-110 Aoba, Sendai, Miyagi 9808579, Japan.	makoto.kanzaki.b1@tohoku.ac.jp	Kanzaki, Makoto/H-6680-2017	Kanzaki, Makoto/0000-0002-6884-2955	Japan Society for the Promotion of Science [17H02076]; Japan Agency for Medical Research and Development Grant [18058831]; Japan Diabetes Society; Program for Fostering Researchers for the Next Generation in the Project for Establishing a Consortium for the Development of Human Resources in Science and Technology	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and Development Grant(Japan Agency for Medical Research and Development (AMED)); Japan Diabetes Society; Program for Fostering Researchers for the Next Generation in the Project for Establishing a Consortium for the Development of Human Resources in Science and Technology	This work was supported in part by Japan Society for the Promotion of Science Grant 17H02076 (to M. K.), Japan Agency for Medical Research and Development Grant 18058831 (to M. K.), a grant from the Japan Diabetes Society (to H. H.), and the Program for Fostering Researchers for the Next Generation in the Project for Establishing a Consortium for the Development of Human Resources in Science and Technology (to H. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Arias EB, 2007, AM J PHYSIOL-ENDOC M, V292, pE1191, DOI 10.1152/ajpendo.00602.2006; Balsevich G, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01783-y; Bruss MD, 2005, DIABETES, V54, P41, DOI 10.2337/diabetes.54.1.41; Castorena CM, 2011, J APPL PHYSIOL, V111, P1106, DOI 10.1152/japplphysiol.00631.2011; Chavez JA, 2008, J BIOL CHEM, V283, P9187, DOI 10.1074/jbc.M708934200; Cheng KKY, 2014, DIABETES, V63, P3748, DOI 10.2337/db14-0337; Dash S, 2009, P NATL ACAD SCI USA, V106, P9350, DOI 10.1073/pnas.0900909106; Eguez L, 2005, CELL METAB, V2, P263, DOI 10.1016/j.cmet.2005.09.005; Fecchi K, 2006, FASEB J, V20, P705, DOI 10.1096/fj.05-4661fje; Fujita H, 2010, MOL BIOL CELL, V21, P2721, DOI 10.1091/mbc.E10-01-0029; Funai K, 2009, AM J PHYSIOL-ENDOC M, V297, pE242, DOI 10.1152/ajpendo.00194.2009; Funai K, 2008, J APPL PHYSIOL, V105, P1788, DOI 10.1152/japplphysiol.90838.2008; Gonzalez E, 2006, MOL BIOL CELL, V17, P4484, DOI 10.1091/mbc.E06-07-0585; Hatakeyama H, 2017, J PHYSIOL-LONDON, V595, P5603, DOI 10.1113/JP273985; Hatakeyama H, 2013, MOL BIOL CELL, V24, P809, DOI 10.1091/mbc.E12-10-0725; Hatakeyama H, 2011, TRAFFIC, V12, P1805, DOI 10.1111/j.1600-0854.2011.01279.x; HENRIKSEN EJ, 1990, AM J PHYSIOL, V259, pE593, DOI 10.1152/ajpendo.1990.259.4.E593; JAMES DE, 1985, J CLIN INVEST, V76, P657, DOI 10.1172/JCI112019; Jessen N, 2011, AM J PHYSIOL-ENDOC M, V301, pE164, DOI 10.1152/ajpendo.00042.2011; Kane S, 2005, BIOCHEM BIOPH RES CO, V335, P175, DOI 10.1016/j.bbrc.2005.07.056; Kane S, 2002, J BIOL CHEM, V277, P22115, DOI 10.1074/jbc.C200198200; Kanzaki M, 2001, J BIOL CHEM, V276, P42436, DOI 10.1074/jbc.M108297200; Koumanov F, 2011, J BIOL CHEM, V286, P16574, DOI 10.1074/jbc.M111.226092; Kramer HF, 2007, DIABETES, V56, P2854, DOI 10.2337/db07-0681; Mafakheri S, 2018, J BIOL CHEM, V293, P17853, DOI 10.1074/jbc.RA118.005040; Meyre D, 2008, HUM MOL GENET, V17, P1798, DOI 10.1093/hmg/ddn070; Nedachi T, 2008, AM J PHYSIOL-ENDOC M, V295, pE1191, DOI 10.1152/ajpendo.90280.2008; Oki K, 2018, APPL PHYSIOL NUTR ME, V43, P795, DOI 10.1139/apnm-2017-0858; Pehmoller C, 2012, DIABETES, V61, P2743, DOI 10.2337/db11-1572; Roach WG, 2007, BIOCHEM J, V403, P353, DOI 10.1042/BJ20061798; Stone S, 2006, HUM MOL GENET, V15, P2709, DOI 10.1093/hmg/ddl204; Tan SX, 2012, MOL CELL BIOL, V32, P4946, DOI 10.1128/MCB.00761-12; Taylor EB, 2008, J BIOL CHEM, V283, P9787, DOI 10.1074/jbc.M708839200; Thomas EC, 2018, BIOCHEM J, V475, P2969, DOI 10.1042/BCJ20180475; Treebak JT, 2010, AM J PHYSIOL-CELL PH, V298, pC377, DOI 10.1152/ajpcell.00297.2009; Vendelbo MH, 2014, J APPL PHYSIOL, V117, P289, DOI 10.1152/japplphysiol.00044.2014; Woo JR, 2017, INT J BIOL MACROMOL, V103, P965, DOI 10.1016/j.ijbiomac.2017.05.119	37	13	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1161	1172		10.1074/jbc.RA118.004614	http://dx.doi.org/10.1074/jbc.RA118.004614			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30482843	Green Published, hybrid			2022-12-28	WOS:000457879500009
J	Aditi; Mason, AC; Sharma, M; Dawson, TR; Wente, SR				Aditi; Mason, Aaron C.; Sharma, Manisha; Dawson, T. Renee; Wente, Susan R.			MAPK- and glycogen synthase kinase 3-mediated phosphorylation regulates the DEAD-box protein modulator Gle1 for control of stress granule dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						stress granule; phosphorylation; mitogen-activated protein kinase (MAPK); post-translational modification (PTM); translation regulation; glycogen synthase kinase 3 (GSK-3); neurodegeneration; stress response; DDX3; DEAD-box proteins; Gle1	MESSENGER-RNA EXPORT; CELL-FREE FORMATION; TRANSLATION INITIATION; PHASE-SEPARATION; HELICASE DDX3; INTRINSIC DISORDER; BINDING; ACTIVATION; MECHANISM; PATHWAYS	Rapid expression of critical stress response factors is a key survival strategy for diseased or stressed cells. During cell stress, translation is inhibited, and a pre-existing pool of cytoplasmic mRNA-protein complexes reversibly assembles into cytoplasmic stress granules (SGs). Gle1 is a conserved modulator of RNA-dependent DEAD-box proteins required for mRNA export, translation, and stress responses. Proper Gle1 function is critical as reflected by some human diseases such as developmental and neurodegenerative disorders and some cancers linked to gle1 mutations. However, the mechanism by which Gle1 controls SG formation is incompletely understood. Here, we show that human Gle1 is regulated by phosphorylation during heat shock stress. In HeLa cells, stress-induced Gle1 hyperphosphorylation was dynamic, primarily in the cytoplasmic pool, and followed changes in translation factors. MS analysis identified 14 phosphorylation sites in the Gle1A isoform, six of which clustered in an intrinsically disordered, low-complexity N-terminal region flanking the coil-coiled self-association domain. Of note, two mitogen-activated protein kinases (MAPKs), extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK), phosphorylated the Gle1A N-terminal domain, priming it for phosphorylation by glycogen synthase kinase 3 (GSK3). A phosphomimetic gle1A(6D) variant (in which six putative Ser/Thr phosphorylation sites were substituted with Asp) perturbed self-association and inhibited DEAD-box helicase 3 (X-linked) (DDX3) ATPase activity. Expression of alanine-substituted, phosphodeficient GFP-gle1A(6A) promoted SG assembly, whereas GFP-gle1A(6D) enhanced SG disassembly. We propose that MAPKs and GSK3 phosphorylate Gle1A and thereby coordinate SG dynamics by altering DDX3 function.	[Aditi; Mason, Aaron C.; Sharma, Manisha; Dawson, T. Renee; Wente, Susan R.] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, 3140A MRBIII, Nashville, TN 37240 USA	Vanderbilt University	Wente, SR (corresponding author), Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, 3140A MRBIII, Nashville, TN 37240 USA.	susan.wente@vanderbilt.edu	Gupta, Aditi/HGD-9632-2022	Sharma, Manisha/0000-0003-1892-9865	National Institutes of Health [RR027714, CA68485, DK20593, DK58404, DK59637, EY08126]; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020593, U2CDK059637, P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM051219] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Wente laboratory for technical assistance, discussions, and reading the manuscript. We acknowledge Kristie Rose, Ph.D., and the staff of the Proteomics Core in the Vanderbilt Mass Spectrometry Research Center for assistance with analysis of our samples. The LTQ Orbitrap Velos mass spectrometer used in these studies was purchased with funds from National Institutes of Health S10 Grant RR027714 awarded to the Vanderbilt Proteomics Shared Resource. Microscopy experiments were performed in part through the use of the Vanderbilt Cell Imaging Shared Resource, supported by National Institutes of Health Grants CA68485, DK20593, DK58404, DK59637, and EY08126.	Adams RL, 2017, TRAFFIC, V18, P776, DOI 10.1111/tra.12526; Aditi, 2016, Advances in Biological Regulation, V62, P25, DOI 10.1016/j.jbior.2015.11.001; Aditi, 2015, MOL BIOL CELL, V26, P1476, DOI 10.1091/mbc.E14-11-1523; ADZHUBEI AA, 1993, J MOL BIOL, V229, P472, DOI 10.1006/jmbi.1993.1047; Aguzzi A, 2016, TRENDS CELL BIOL, V26, P547, DOI 10.1016/j.tcb.2016.03.004; Al-Qattan MM, 2012, GENE, V500, P216, DOI 10.1016/j.gene.2012.03.009; Alcazar-Roman AR, 2006, NAT CELL BIOL, V8, P711, DOI 10.1038/ncb1427; Ambegaokar SS, 2011, HUM MOL GENET, V20, P4947, DOI 10.1093/hmg/ddr432; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Andreou AZ, 2014, J MOL BIOL, V426, P51, DOI 10.1016/j.jmb.2013.09.027; Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Bhinge A, 2017, STEM CELL REP, V8, P856, DOI 10.1016/j.stemcr.2017.02.019; Bley N, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1275; Bolger TA, 2011, J BIOL CHEM, V286, P39750, DOI 10.1074/jbc.M111.299321; Bolger Timothy A, 2008, Cell, V134, P624, DOI 10.1016/j.cell.2008.06.027; Buchan JR, 2013, CELL, V153, P1461, DOI 10.1016/j.cell.2013.05.037; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; de Munck E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162723; Folkmann AW, 2013, CELL, V155, P582, DOI 10.1016/j.cell.2013.09.023; Thomas MG, 2011, CELL SIGNAL, V23, P324, DOI 10.1016/j.cellsig.2010.08.011; Gasset-Rosa F, 2017, NEURON, V94, P48, DOI 10.1016/j.neuron.2017.03.027; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Hanazawa M, 2011, J CELL BIOL, V192, P929, DOI 10.1083/jcb.201010106; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Ingolia NT, 2016, CELL, V165, P22, DOI 10.1016/j.cell.2016.02.066; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jain S, 2016, CELL, V164, P487, DOI 10.1016/j.cell.2015.12.038; Jao LE, 2017, MOL BIOL CELL, V28, P120, DOI 10.1091/mbc.E16-09-0675; Kaneb HM, 2015, HUM MOL GENET, V24, P1363, DOI 10.1093/hmg/ddu545; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha N, 2013, TRENDS BIOCHEM SCI, V38, P494, DOI 10.1016/j.tibs.2013.07.004; Kendirgi F, 2003, J CELL BIOL, V160, P1029, DOI 10.1083/jcb.200211081; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Klammer M, 2012, MOL CELL PROTEOMICS, V11, P651, DOI 10.1074/mcp.M111.016410; Knott GJ, 2016, NUCLEIC ACIDS RES, V44, P3989, DOI 10.1093/nar/gkw271; KORNBERG A, 1951, J BIOL CHEM, V193, P481; Kwon I, 2013, CELL, V155, P1049, DOI 10.1016/j.cell.2013.10.033; Lin Y, 2015, MOL CELL, V60, P208, DOI 10.1016/j.molcel.2015.08.018; Mazroui R, 2006, MOL BIOL CELL, V17, P4212, DOI 10.1091/mbc.E06-04-0318; Mebratu Y, 2009, CELL CYCLE, V8, P1168, DOI 10.4161/cc.8.8.8147; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Monahan Z, 2017, EMBO J, V36, P2951, DOI 10.15252/embj.201696394; Montpetit B, 2011, NATURE, V472, P238, DOI 10.1038/nature09862; Morrison DK, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011254; Moujalled D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067433; Mugler CF, 2016, ELIFE, V5, DOI 10.7554/eLife.18746; Nishi H, 2011, STRUCTURE, V19, P1807, DOI 10.1016/j.str.2011.09.021; Nousiainen HO, 2008, NAT GENET, V40, P155, DOI 10.1038/ng.2007.65; Oh S, 2016, ONCOTARGET, V7, P28169, DOI 10.18632/oncotarget.8612; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Panas MD, 2016, J CELL BIOL, V215, P313, DOI 10.1083/jcb.201609081; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Pont MJ, 2016, CLIN CANCER RES, V22, P4185, DOI 10.1158/1078-0432.CCR-15-2307; Protter DSW, 2016, TRENDS CELL BIOL, V26, P668, DOI 10.1016/j.tcb.2016.05.004; Putnam AA, 2015, MOL CELL, V59, P541, DOI 10.1016/j.molcel.2015.06.030; Ramaswami M, 2013, CELL, V154, P727, DOI 10.1016/j.cell.2013.07.038; Rayala HJ, 2004, MOL CELL PROTEOMICS, V3, P145, DOI 10.1074/mcp.M300106-MCP200; Reineke LC, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00596-16; Ren SY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-452; Saad S, 2017, NAT CELL BIOL, V19, P1202, DOI 10.1038/ncb3600; Sama RRK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00091-1; Sharma K, 2014, CELL REP, V8, P1583, DOI 10.1016/j.celrep.2014.07.036; Sheinberger J, 2017, FEBS LETT, V591, P2534, DOI 10.1002/1873-3468.12765; Shih JW, 2008, ONCOGENE, V27, P700, DOI 10.1038/sj.onc.1210687; Shih JW, 2012, BIOCHEM J, V441, P119, DOI 10.1042/BJ20110739; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Soto-Rifo R, 2013, NUCLEIC ACIDS RES, V41, P6286, DOI 10.1093/nar/gkt306; Soto-Rifo R, 2013, WIRES RNA, V4, P369, DOI 10.1002/wrna.1165; Spriggs KA, 2010, MOL CELL, V40, P228, DOI 10.1016/j.molcel.2010.09.028; Stasyk T, 2007, MOL CELL PROTEOMICS, V6, P908, DOI 10.1074/mcp.M600463-MCP200; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Tyanova S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002842; Tzschach A, 2012, AM J MED GENET A, V158A, P1709, DOI 10.1002/ajmg.a.35398; Uversky VN, 2017, AUTOPHAGY, V13, P2115, DOI 10.1080/15548627.2017.1384889; Weirich CS, 2006, NAT CELL BIOL, V8, P668, DOI 10.1038/ncb1424; Wolozin B, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-56; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Xin FX, 2012, BIOINFORMATICS, V28, P2905, DOI 10.1093/bioinformatics/bts541; Yang YM, 2013, CELL STEM CELL, V12, P713, DOI 10.1016/j.stem.2013.04.003; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105; Zhou HJ, 2013, J PROTEOME RES, V12, P260, DOI 10.1021/pr300630k; ZINCK R, 1995, MOL CELL BIOL, V15, P4930	86	15	16	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2019	294	2					559	575		10.1074/jbc.RA118.005749	http://dx.doi.org/10.1074/jbc.RA118.005749			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HI2GP	30429220	Green Published, hybrid			2022-12-28	WOS:000456263600015
J	Randhawa, A; Kundu, D; Sharma, A; Prasad, R; Mondal, AK				Randhawa, Anmoldeep; Kundu, Debasree; Sharma, Anupam; Prasad, Rajendra; Mondal, Alok K.			Overexpression of the CORVET complex alleviates the fungicidal effects of fludioxonil on the yeast Saccharomyces cerevisiae expressing hybrid histidine kinase 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fungi; cell signaling; histidine kinase; p38 MAPK; yeast; mitogen-activated protein kinase (MAPK); Candida albicans; antifungal agent; fludioxonil; HOG; p38 pathway; hybrid histidine kinase 3; vesicle trafficking; filamentous growth; MAPK signaling	ACTIVATED PROTEIN-KINASE; CANDIDA-ALBICANS; TETHERING COMPLEXES; STRESS-ADAPTATION; DRUG-SENSITIVITY; EARLY ENDOSOME; GENE; RESISTANCE; OSMOREGULATION; DICARBOXIMIDE	The hybrid histidine kinase 3 (HHK3) is a highly conserved sensor kinase in fungi that regulates the downstream HOG/p38 mitogen-activated protein kinase (MAPK). In addition to its role in osmoadaptation, HHK3 is involved in hyphal morphogenesis, conidiation, virulence, and cellular adaptation to oxidative stress. However, the molecular mechanisms by which it controls these processes remain obscure. Moreover, HHK3 is a molecular target for antifungal agents such as fludioxonil, which thereby interferes with the HOG/p38 pathway, leading to the abnormal accumulation of glycerol and subsequent cell lysis. Here, we used a chemical genomics approach with the yeast Saccharomyces cerevisiae to better understand the fungicidal action of fludioxonil and the role of HHK3 in fungal growth and physiology. Our results indicated that the abnormal accumulation of glycerol is not the primary cause of fludioxonil toxicity. Fludioxonil appears to impair endosomal trafficking in the fungal cells. We found that the components of class C core vacuole/endosome tethering (CORVET) complex are essential for yeast viability in the presence of a subthreshold dose of fludioxonil and that their overexpression alleviates fludioxonil toxicity. We also noted that by impeding secretory vesicle trafficking, fludioxonil inhibits hyphal growth in the opportunistic fungal pathogen Candida albicans. Our results suggest that HHK3 regulates fungal hyphal growth by affecting vesicle trafficking. Together, our results reveal an important role of CORVET complex in the fungicidal action of fludioxonil downstream of HHK3.	[Randhawa, Anmoldeep; Kundu, Debasree; Sharma, Anupam] CSIR, Inst Microbial Technol, Sect 39A, Chandigarh 160036, India; [Kundu, Debasree; Mondal, Alok K.] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India; [Prasad, Rajendra] Amity Univ, Amity Inst Integrat Sci & Hlth, Gurgaon 122413, India; [Randhawa, Anmoldeep] CSIR, Chandigarh, India; [Kundu, Debasree] Univ Grants Commiss, New Delhi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); Jawaharlal Nehru University, New Delhi; Council of Scientific & Industrial Research (CSIR) - India	Mondal, AK (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India.	akmondal@mail.jnu.ac.in	MAHTO, ANUPAM SHARMA/CAG-1514-2022; Randhawa, Anmoldeep/AHB-8846-2022	MAHTO, ANUPAM SHARMA/0000-0002-9974-3001; Randhawa, Anmoldeep/0000-0002-8628-044X; Kundu, Debasree/0000-0002-2676-4936				Alex LA, 1996, P NATL ACAD SCI USA, V93, P3416, DOI 10.1073/pnas.93.8.3416; Alspaugh JA, 2016, CELL CHEM BIOL, V23, P1321, DOI 10.1016/j.chembiol.2016.11.001; Avenot H, 2005, CURR GENET, V47, P234, DOI 10.1007/s00294-005-0568-2; Bahn YS, 2006, MOL BIOL CELL, V17, P3122, DOI 10.1091/mbc.E06-02-0113; Braun BR, 1997, SCIENCE, V277, P105, DOI 10.1126/science.277.5322.105; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Cain CW, 2012, GENETICS, V190, P511, DOI 10.1534/genetics.111.134080; Catlett NL, 2003, EUKARYOT CELL, V2, P1151, DOI 10.1128/EC.2.6.1151-1161.2003; Chapeland-Leclerc F, 2007, EUKARYOT CELL, V6, P1782, DOI 10.1128/EC.00155-07; Corran A., 2008, MODERN CROP PROTECTI, P561; Cui W, 2002, FUNGAL GENET BIOL, V36, P187, DOI 10.1016/S1087-1845(02)00009-9; Defosse TA, 2015, MOL MICROBIOL, V95, P914, DOI 10.1111/mmi.12911; Denning DW, 2015, SCIENCE, V347, P1414, DOI 10.1126/science.aaa6097; Djordjevic JT, 2018, CELL CHEM BIOL, V25, P233, DOI 10.1016/j.chembiol.2018.02.015; Duan YB, 2013, MOL PLANT PATHOL, V14, P708, DOI 10.1111/mpp.12041; Epp N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067307; Ericson E, 2010, METHOD ENZYMOL, V470, P233, DOI 10.1016/S0076-6879(10)70010-0; Ferrigno P, 1998, EMBO J, V17, P5606, DOI 10.1093/emboj/17.19.5606; Furukawa K, 2012, FEBS LETT, V586, P2417, DOI 10.1016/j.febslet.2012.05.057; Gietz RD, 2007, NAT PROTOC, V2, P5, DOI 10.1038/nprot.2007.16; Golemis EA, 1997, ADV MOLEC BIOL, P43; Graziano BR, 2014, MOL BIOL CELL, V25, P1730, DOI 10.1091/mbc.E14-03-0850; Hagiwara D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080881; Hagiwara D, 2009, FUNGAL GENET BIOL, V46, P868, DOI 10.1016/j.fgb.2009.07.003; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jones LA, 2010, EUKARYOT CELL, V9, P1455, DOI 10.1128/EC.00109-10; Kaur H, 2014, J BIOL CHEM, V289, P20245, DOI 10.1074/jbc.M114.554303; Kilani J, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02014; Kojima K, 2006, MICROBIOL-SGM, V152, P591, DOI 10.1099/mic.0.28571-0; Lawry SM, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.01414-16; Levin DE, 2011, GENETICS, V189, P1145, DOI 10.1534/genetics.111.128264; Meena N, 2010, J BIOL CHEM, V285, P12121, DOI 10.1074/jbc.M109.075721; Mostafavi S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s4; Motoyama T, 2005, CURR GENET, V47, P298, DOI 10.1007/s00294-005-0572-6; Myung K, 2015, DRUG DISCOV TODAY, V20, P7, DOI 10.1016/j.drudis.2014.08.010; Neto H, 2011, BIOCHEM J, V437, P13, DOI 10.1042/BJ20110153; Nevoigt E, 1997, FEMS MICROBIOL REV, V21, P231, DOI 10.1111/j.1574-6976.1997.tb00352.x; Ochiai N, 2001, PEST MANAG SCI, V57, P437, DOI 10.1002/ps.302; Oshima Michiyo, 2006, Journal of General Plant Pathology, V72, P65, DOI 10.1007/s10327-005-0247-7; Palmer GE, 2003, EUKARYOT CELL, V2, P411, DOI 10.1128/EC.2.3.411-421.2003; Parsons AB, 2006, CELL, V126, P611, DOI 10.1016/j.cell.2006.06.040; Randhawa A, 2016, GENE, V577, P251, DOI 10.1016/j.gene.2015.12.002; Randhawa A, 2013, BIOCHEM BIOPH RES CO, V438, P140, DOI 10.1016/j.bbrc.2013.07.041; Riquelme M, 2013, ANNU REV MICROBIOL, V67, P587, DOI 10.1146/annurev-micro-092412-155652; Rispail N, 2010, MOL PLANT PATHOL, V11, P395, DOI [10.1111/J.1364-3703.2010.00612.X, 10.1111/j.1364-3703.2010.00612.x]; Roemer T, 2012, NAT CHEM BIOL, V8, P46, DOI 10.1038/nchembio.744; Scorzoni L, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00036; Solinger JA, 2013, FEBS J, V280, P2743, DOI 10.1111/febs.12151; Spang A, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00035; Steinberg G, 2014, CURR OPIN MICROBIOL, V20, P10, DOI 10.1016/j.mib.2014.04.001; Tanaka C, 2010, FUNGICIDES, P523; Vallen EA, 2000, MOL BIOL CELL, V11, P593, DOI 10.1091/mbc.11.2.593; Veses V, 2008, CURR OPIN MICROBIOL, V11, P503, DOI 10.1016/j.mib.2008.09.017; Wickner W, 2010, ANNU REV CELL DEV BI, V26, P115, DOI 10.1146/annurev-cellbio-100109-104131; Wiederkehr A, 2000, J CELL BIOL, V149, P397, DOI 10.1083/jcb.149.2.397; Yoshimi A, 2005, EUKARYOT CELL, V4, P1820, DOI 10.1128/EC.4.11.1820-1828.2005; Zhang Y, 2002, APPL ENVIRON MICROB, V68, P532, DOI 10.1128/AEM.68.2.532-538.2002; Zheng XD, 2003, MOL MICROBIOL, V49, P1391, DOI 10.1046/j.1365-2958.2003.03646.x; Zhu Y, 2000, P NATL ACAD SCI USA, V97, P7808, DOI 10.1073/pnas.97.14.7808; Zurita-Martinez SA, 2007, GENETICS, V176, P2139, DOI 10.1534/genetics.107.072835	61	7	8	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2019	294	2					461	475		10.1074/jbc.RA118.004736	http://dx.doi.org/10.1074/jbc.RA118.004736			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HI2GP	30446623	Green Published, hybrid			2022-12-28	WOS:000456263600008
J	Molakarimi, M; Gorman, MA; Mohseni, A; Pashandi, Z; Taghdir, M; Naderi-Manesh, H; Sajedi, RH; Parker, MW				Molakarimi, Maryam; Gorman, Michael A.; Mohseni, Ammar; Pashandi, Zaiddodine; Taghdir, Majid; Naderi-Manesh, Hossein; Sajedi, Reza H.; Parker, Michael W.			Reaction mechanism of the bioluminescent protein mnemiopsin1 revealed by X-ray crystallography and QM/MM simulations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bioluminescence; X-ray crystallography; molecular modeling; photobiology; protein structure; chromophore; coelenteramide; ctenophore; photoprotein; proton transfer	GREEN FLUORESCENT PROTEIN; SEMIEMPIRICAL METHODS; VIOLET BIOLUMINESCENCE; PHOTOPROTEIN BEROVIN; NDDO APPROXIMATIONS; CA2+-BINDING LOOPS; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURES; AUTOMATED DOCKING; SPATIAL STRUCTURE	Bioluminescence of a variety of marine organisms, mostly cnidarians and ctenophores, is carried out by Ca2+-dependent photoproteins. The mechanism of light emission operates via the same reaction in both animal families. Despite numerous studies on the ctenophore photoprotein family, the detailed catalytic mechanism and arrangement of amino acid residues surrounding the chromophore in this family are a mystery. Here, we report the crystal structure of Cd2+-loaded apo-mnemiopsin1, a member of the ctenophore family, at 2.15 resolution and used quantum mechanics/molecular mechanics (QM/MM) to investigate its reaction mechanism. The simulations suggested that an Asp-156-Arg-39-Tyr-202 triad creates a hydrogen-bonded network to facilitate the transfer of a proton from the 2-hydroperoxy group of the chromophore coelenterazine to bulk solvent. We identified a water molecule in the coelenteramide-binding cavity that forms a hydrogen bond with the amide nitrogen atom of coelenteramide, which, in turn, is hydrogen-bonded via another water molecule to Tyr-131. This observation supports the hypothesis that the function of the coelenteramide-bound water molecule is to catalyze the 2-hydroperoxycoelenterazine decarboxylation reaction by protonation of a dioxetanone anion, thereby triggering the bioluminescence reaction in the ctenophore photoprotein family.	[Molakarimi, Maryam; Mohseni, Ammar; Sajedi, Reza H.] Tarbiat Modares Univ, Fac Biol Sci, Dept Biochem, Tehran 14115154, Iran; [Pashandi, Zaiddodine; Taghdir, Majid; Naderi-Manesh, Hossein] Tarbiat Modares Univ, Fac Biol Sci, Dept Biophys, Tehran 14115175, Iran; [Gorman, Michael A.; Parker, Michael W.] Univ Melbourne, Bio21 Mol Sci & Biotechnol Inst, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia; [Gorman, Michael A.; Parker, Michael W.] St Vincents Inst Med Res, Australian Canc Res Fdn Rat Drug Discovery Ctr, Fitzroy, Vic 3065, Australia	Tarbiat Modares University; Tarbiat Modares University; University of Melbourne; St. Vincent's Institute of Medical Research	Sajedi, RH (corresponding author), Tarbiat Modares Univ, Fac Biol Sci, Dept Biochem, Tehran 14115154, Iran.; Parker, MW (corresponding author), Univ Melbourne, Bio21 Mol Sci & Biotechnol Inst, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia.	Sajedi_R@modares.ac.ir; mparker@svi.edu.au	Parker, Michael W/F-9069-2013; H. Sajedi, Reza/AAA-8355-2022	Parker, Michael W/0000-0002-3101-1138; Taghdir, Majid/0000-0002-6060-9921; Naderi-Manesh, Hossein/0000-0002-4227-171X	Research Council of Tarbiat Modares University; Victorian Government Operational Infrastructure Support Scheme	Research Council of Tarbiat Modares University; Victorian Government Operational Infrastructure Support Scheme	This work was supported by the Research Council of Tarbiat Modares University. This work was also supported with funding from the Victorian Government Operational Infrastructure Support Scheme to St. Vincent's Institute. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Aghamaali MR, 2011, PROTEIN J, V30, P566, DOI 10.1007/s10930-011-9363-8; Burakova LP, 2016, PHOTOCH PHOTOBIO SCI, V15, P691, DOI 10.1039/c6pp00050a; Burakova LP, 2016, J PHOTOCH PHOTOBIO B, V154, P57, DOI 10.1016/j.jphotobiol.2015.11.012; Case D.A., 2012, AMBER; Cates MS, 1999, STRUCTURE, V7, P1269, DOI 10.1016/S0969-2126(00)80060-X; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Contag CH, 2002, ANNU REV BIOMED ENG, V4, P235, DOI 10.1146/annurev.bioeng.4.111901.093336; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S10822-016-9944-X; Deng L, 2005, PROTEIN SCI, V14, P663, DOI 10.1110/ps.041142905; Deng L, 2001, FEBS LETT, V506, P281, DOI 10.1016/S0014-5793(01)02937-4; DiPilato LM, 2004, P NATL ACAD SCI USA, V101, P16513, DOI 10.1073/pnas.0405973101; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; GILSON MK, 1988, J COMPUT CHEM, V9, P327, DOI 10.1002/jcc.540090407; Gonzalez JE, 1998, CURR OPIN BIOTECH, V9, P624, DOI 10.1016/S0958-1669(98)80141-9; GOODSELL DS, 1990, PROTEINS, V8, P195, DOI 10.1002/prot.340080302; Hakiminia F, 2016, J MOL STRUCT, V1117, P287, DOI 10.1016/j.molstruc.2016.03.082; Head JF, 2000, NATURE, V405, P372, DOI 10.1038/35012659; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; KABSCH W, 1984, P NATL ACAD SCI-BIOL, V81, P1075, DOI 10.1073/pnas.81.4.1075; Kabsch W., 2006, INT TABLES CRYSTALLO, P218; Kain SR, 1999, DRUG DISCOV TODAY, V4, P304, DOI 10.1016/S1359-6446(99)01330-6; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Liu ZJ, 2006, P NATL ACAD SCI USA, V103, P2570, DOI 10.1073/pnas.0511142103; Liu ZJ, 2003, BIOCHEM BIOPH RES CO, V311, P433, DOI 10.1016/j.bbrc.2003.09.231; Mahdavi A, 2015, PHOTOCH PHOTOBIO SCI, V14, P792, DOI 10.1039/c4pp00191e; Mahdavi A, 2013, PHOTOCH PHOTOBIO SCI, V12, P467, DOI 10.1039/c2pp25320h; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Molakarimi M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182317; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Natashin PV, 2014, FEBS J, V281, P1432, DOI 10.1111/febs.12715; Natashin PV, 2014, ACTA CRYSTALLOGR D, V70, P720, DOI 10.1107/S1399004713032434; Pashandi Z, 2017, BIOCHEM BIOPH RES CO, V490, P265, DOI 10.1016/j.bbrc.2017.06.034; Pashandi Z, 2016, J PHOTOCH PHOTOBIO B, V165, P133, DOI 10.1016/j.jphotobiol.2016.10.018; PASTOR RW, 1988, MOL PHYS, V65, P1409, DOI 10.1080/00268978800101881; Ravindranath PA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004586; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SHIMOMURA O, 1972, BIOCHEMISTRY-US, V11, P1602, DOI 10.1021/bi00759a009; Shimomura O, 2012, BIOLUMINESCENCE CHEM; Stepanyuk GA, 2013, BBA-PROTEINS PROTEOM, V1834, P2139, DOI 10.1016/j.bbapap.2013.07.006; Stewart JJP, 2007, J MOL MODEL, V13, P1173, DOI 10.1007/s00894-007-0233-4; Stewart JJP, 2013, J MOL MODEL, V19, P1, DOI 10.1007/s00894-012-1667-x; STEWART JJP, 1989, J COMPUT CHEM, V10, P209, DOI 10.1002/jcc.540100208; Titushin MS, 2010, J BIOL CHEM, V285, P40891, DOI 10.1074/jbc.M110.133843; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vysotski ES, 2004, ACCOUNTS CHEM RES, V37, P405, DOI 10.1021/ar0400037; Vysotski ES, 2003, BIOCHEMISTRY-US, V42, P6013, DOI 10.1021/bi027258h; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Ward WW, 2000, METHOD ENZYMOL, V305, P672; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	56	7	7	0	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2019	294	1					20	27		10.1074/jbc.RA118.006053	http://dx.doi.org/10.1074/jbc.RA118.006053			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG6PT	30420427	hybrid, Green Published			2022-12-28	WOS:000455105500003
J	Matyszewski, M; Zheng, WL; Lueck, J; Antiochos, B; Egelman, EH; Sohn, J				Matyszewski, Mariusz; Zheng, Weili; Lueck, Jacob; Antiochos, Brendan; Egelman, Edward H.; Sohn, Jungsan			Cryo-EM structure of the NLRC4(CARD) filament provides insights into how symmetric and asymmetric supramolecular structures drive inflammasome assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						innate immunity; cryo-electron microscopy; nod-like receptor (NLR); inflammasome; biophysics; caspase; Monte Carlo simulation; NLRC4; pyroptosis	AIM2 INFLAMMASOME; SIGNAL-ACTIVATION; CRYSTAL-STRUCTURE; MECHANISM; NLRP3; VISUALIZATION; AUTOIMMUNITY; RECRUITMENT; REVEALS; SYSTEM	Inflammasomes are supramolecular signaling platforms integral to innate immune defense against invading pathogens. The NOD-like receptor (NLR) family apoptosis inhibitory protein (NAIP)NLR family caspase-recruiting domain (CARD) domain-containing 4 (NLRC4) inflammasome recognizes intracellular bacteria and induces the polymerization of the caspase-1 protease, which in turn executes maturation of interleukin-1 (IL-1) and pyroptosis. Several high-resolution structures of the fully assembled NAIPNLRC4 complex are available, but these structures do not resolve the architecture of the CARD filament in atomic detail. Here, we present the cryo-EM structure of the filament assembled by the CARD of human NLRC4 (NLRC4(CARD)) at 3.4 resolution. The structure revealed that the helical architecture of the NLRC4(CARD) filament is essentially identical to that of the downstream filament assembled by the CARD of caspase-1 (casp1(CARD)), but deviates from the split washer-like assembly of the NAIPNLRC4 oligomer. Our results suggest that architectural complementarity is a major driver for the recognition between upstream and downstream CARD assemblies in inflammasomes. Furthermore, a Monte Carlo simulation of the NLRC4(CARD) filament assembly rationalized why an (un)decameric NLRC4 oligomer is optimal for assembling the helical base of the NLRC4(CARD) filament. Together, our results explain how symmetric and asymmetric supramolecular assemblies enable high-fidelity signaling in inflammasomes.	[Matyszewski, Mariusz; Lueck, Jacob; Sohn, Jungsan] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Zheng, Weili; Egelman, Edward H.] Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; [Antiochos, Brendan] Johns Hopkins Univ, Sch Med, Div Rheumatol, Baltimore, MD 21205 USA	Johns Hopkins University; University of Virginia; Johns Hopkins University	Sohn, J (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA.; Egelman, EH (corresponding author), Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.	egelman@virginia.edu; jsohn@jhmi.edu		Matyszewski, Mariusz/0000-0003-1033-9270	National Institutes of Health [S10 OD016734]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM122510, R01GM035269] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Sohn lab members for discussion and the staff at NCI NCEF for cryo-EM data collection. The Johns Hopkins Microscope Facility was supported by National Institutes of Health Grant S10 OD016734.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bandera A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00214; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; David L, 2018, P NATL ACAD SCI USA, V115, P1499, DOI 10.1073/pnas.1721967115; De Nardo D, 2011, TRENDS IMMUNOL, V32, P373, DOI 10.1016/j.it.2011.05.004; Diebolder CA, 2015, STRUCTURE, V23, P2349, DOI 10.1016/j.str.2015.10.001; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Henao-Mejia J, 2014, ANNU REV PHYSIOL, V76, P57, DOI 10.1146/annurev-physiol-021113-170324; Hu ZH, 2015, SCIENCE, V350, P399, DOI 10.1126/science.aac5489; Hu ZH, 2013, SCIENCE, V341, P172, DOI 10.1126/science.1236381; Jin TC, 2013, ACTA CRYSTALLOGR F, V69, P482, DOI 10.1107/S1744309113010075; Kagan JC, 2014, NAT REV IMMUNOL, V14, P821, DOI 10.1038/nri3757; Kim S, 2010, EUR J IMMUNOL, V40, P1545, DOI 10.1002/eji.201040425; Lee S, 2017, AM J RESP CRIT CARE, V196, P713, DOI 10.1164/rccm.201604-0892OC; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; Li Y, 2018, P NATL ACAD SCI USA, V115, P10845, DOI 10.1073/pnas.1810524115; Lin C, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00271; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Lu A, 2016, NAT STRUCT MOL BIOL, V23, P416, DOI 10.1038/nsmb.3199; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Man SM, 2016, EUR J IMMUNOL, V46, P269, DOI 10.1002/eji.201545839; Maruzuru Y, 2018, CELL HOST MICROBE, V23, P254, DOI 10.1016/j.chom.2017.12.014; Matyszewski M, 2018, P NATL ACAD SCI USA, V115, pE1963, DOI 10.1073/pnas.1712860115; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Morrone SR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8827; Park HH, 2007, CELL, V128, P533, DOI 10.1016/j.cell.2007.01.019; Peisley A, 2014, NATURE, V509, P110, DOI 10.1038/nature13140; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Ruiz VMR, 2017, P NATL ACAD SCI USA, V114, P13242, DOI 10.1073/pnas.1710433114; Schulman BA, 1998, P NATL ACAD SCI USA, V95, P10453, DOI 10.1073/pnas.95.18.10453; Sohn J, 2004, P NATL ACAD SCI USA, V101, P16437, DOI 10.1073/pnas.0407663101; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tenthorey JL, 2017, SCIENCE, V358, P888, DOI 10.1126/science.aao1140; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Vance RE, 2015, CURR OPIN IMMUNOL, V32, P84, DOI 10.1016/j.coi.2015.01.010; Wang RYR, 2016, ELIFE, V5, DOI 10.7554/eLife.17219; Wu B, 2014, MOL CELL, V55, P511, DOI 10.1016/j.molcel.2014.06.010; Yang CA, 2015, J AUTOIMMUN, V61, P1, DOI 10.1016/j.jaut.2015.05.001; Yi YS, 2018, KOREAN J PHYSIOL PHA, V22, P1, DOI 10.4196/kjpp.2018.22.1.1; Zhang LM, 2015, SCIENCE, V350, P404, DOI 10.1126/science.aac5789; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	45	21	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					20240	20248		10.1074/jbc.RA118.006050	http://dx.doi.org/10.1074/jbc.RA118.006050			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30385506	Green Published, hybrid			2022-12-28	WOS:000454685900029
J	Dai, ZW; Locasale, JW				Dai, Ziwei; Locasale, Jason W.			Thermodynamic constraints on the regulation of metabolic fluxes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						metabolism; metabolic regulation; computational biology; thermodynamics; enzyme kinetics; metabolic control analysis	CONTROL COEFFICIENTS; GLYCOLYSIS; NETWORKS; PATHWAY	Nutrition and metabolism are fundamental to cellular function. Metabolic activity (i.e. rates of flow, most commonly referred to as flux) is constrained by thermodynamics and regulated by the activity of enzymes. The general principles that relate biological and physical variables to metabolic control are incompletely understood. Using metabolic control analysis and computer simulations in several models of simplified metabolic pathways, we derive analytical expressions that define relationships between thermodynamics, enzyme activity, and flux control. The relationships are further analyzed in a mathematical model of glycolysis as an example of a complex biochemical pathway. We show that metabolic pathways that are very far from equilibrium are controlled by the activity of upstream enzymes. However, in general, regulation of metabolic fluxes by an enzyme has a more adaptable pattern, which relies more on distribution of free energy among reaction steps in the pathway than on the thermodynamic properties of the given enzyme. These findings show how the control of metabolic pathways is shaped by thermodynamic constraints of the given pathway.	[Dai, Ziwei; Locasale, Jason W.] Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Duke University	Dai, ZW; Locasale, JW (corresponding author), Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	ziwei.dai@duke.edu; jason.locasale@duke.edu	Locasale, Jason W/ABE-6505-2020; Dai, Ziwei/O-3397-2019	Locasale, Jason W/0000-0002-7766-3502; Dai, Ziwei/0000-0002-0858-638X	National Institutes of Health [R01 CA193256, R00CA168997]; American Cancer Society [TBE-TBE434120]; NATIONAL CANCER INSTITUTE [R01CA193256, R00CA168997] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grants R01 CA193256 and R00CA168997 and American Cancer Society Grant TBE-TBE434120 (to J. W. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Achcar F, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002352; Bakker BM, 1999, J BIOL CHEM, V274, P14551, DOI 10.1074/jbc.274.21.14551; Bakker BM, 2000, P NATL ACAD SCI USA, V97, P2087, DOI 10.1073/pnas.030539197; BASSHAM JA, 1969, BIOCHIM BIOPHYS ACTA, V189, P207, DOI 10.1016/0005-2728(69)90048-6; Beard DA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000144; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; BROWN GC, 1990, EUR J BIOCHEM, V188, P321, DOI 10.1111/j.1432-1033.1990.tb15406.x; Brunk E, 2018, NAT BIOTECHNOL, V36, P272, DOI 10.1038/nbt.4072; Cascante M, 2002, NAT BIOTECHNOL, V20, P243, DOI 10.1038/nbt0302-243; Chandel NS., 2015, NAVIGATING METABOLIS; Chelliah V, 2015, NUCLEIC ACIDS RES, V43, pD542, DOI 10.1093/nar/gku1181; FELL DA, 1992, BIOCHEM J, V286, P313, DOI 10.1042/bj2860313; Forster J, 2003, GENOME RES, V13, P244, DOI 10.1101/gr.234503; GROEN AK, 1986, BIOCHEM J, V237, P379, DOI 10.1042/bj2370379; HEINRICH R, 1974, EUR J BIOCHEM, V42, P89, DOI 10.1111/j.1432-1033.1974.tb03318.x; Heinrich R., 1996, REGULATION CELLULAR; Jang C, 2018, CELL, V173, P822, DOI 10.1016/j.cell.2018.03.055; KACSER H, 1981, GENETICS, V97, P639; Kacser H, 1973, Symp Soc Exp Biol, V27, P65; Kummel A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100074; Liberti MV, 2017, CELL METAB, V26, P648, DOI 10.1016/j.cmet.2017.08.017; Liebermeister W., 2013, ARXIV13090267; Liu XJ, 2017, TRENDS BIOCHEM SCI, V42, P274, DOI 10.1016/j.tibs.2017.01.004; Locasale Jason W, 2018, Curr Opin Syst Biol, V8, P32, DOI 10.1016/j.coisb.2017.11.005; Moreno-Sanchez R, 2008, J BIOMED BIOTECHNOL, DOI 10.1155/2008/597913; Nelson DL, 2016, LEHNINGER PRINCIPLES; Noor E, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003483; Noor E, 2013, FEBS LETT, V587, P2772, DOI 10.1016/j.febslet.2013.07.028; Orth JD, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.65; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; PAGE RA, 1994, BBA-LIPID LIPID MET, V1210, P369, DOI 10.1016/0005-2760(94)90242-9; Park JO, 2016, NAT CHEM BIOL, V12, P482, DOI [10.1038/NCHEMBIO.2077, 10.1038/nchembio.2077]; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Qian H, 2005, BIOPHYS CHEM, V114, P213, DOI 10.1016/j.bpc.2004.12.001; REDER C, 1988, J THEOR BIOL, V135, P175, DOI 10.1016/S0022-5193(88)80073-0; Reid MA, 2017, NAT CELL BIOL, V19, P1298, DOI 10.1038/ncb3629; Reznik E, 2017, CELL REP, V20, P2666, DOI 10.1016/j.celrep.2017.08.066; Sauro Herbert M., 2003, OMICS A Journal of Integrative Biology, V7, P355, DOI 10.1089/153623103322637670; Shelley MD, 1996, BIOTECHNOL BIOENG, V51, P198, DOI 10.1002/(SICI)1097-0290(19960720)51:2&lt;198::AID-BIT9&gt;3.0.CO;2-E; Shestov AA, 2014, ELIFE, V3, DOI 10.7554/eLife.03342; VANDAM K, 1980, BIOCHIM BIOPHYS ACTA, V591, P240, DOI 10.1016/0005-2728(80)90156-5; WESTERHOFF HV, 1987, CELL BIOPHYS, V11, P239, DOI 10.1007/BF02797123; WESTERHOFF HV, 1984, BIOSCIENCE REP, V4, P1, DOI 10.1007/BF01120819; WESTERHOFF HV, 1984, EUR J BIOCHEM, V142, P425, DOI 10.1111/j.1432-1033.1984.tb08304.x; Xie JS, 2016, J BIOL CHEM, V291, P8987, DOI 10.1074/jbc.M115.704825; YASUMASU I, 1973, EXP CELL RES, V80, P361, DOI 10.1016/0014-4827(73)90308-X	46	8	8	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19725	19739		10.1074/jbc.RA118.004372	http://dx.doi.org/10.1074/jbc.RA118.004372			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30361440	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000454294900019
J	Michel-Souzy, S; Douzi, B; Cadoret, F; Raynaud, C; Quinton, L; Ball, G; Voulhoux, R				Michel-Souzy, Sandra; Douzi, Badreddine; Cadoret, Frederic; Raynaud, Claire; Quinton, Loic; Ball, Genevieve; Voulhoux, Rome			Direct interactions between the secreted effector and the T2SS components GspL and GspM reveal a new effector-sensing step during type 2 secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein-protein interaction; protein secretion; type II secretion system (T2SS); Pseudomonas aeruginosa (P; aeruginosa); protein assembly; protein complex; protein export; protein sorting; effector recognition; type 2 secretion; Xcp; Gsp	CYTOPLASMIC DOMAIN; PROTEIN SECRETION; CRYSTAL-STRUCTURE; VIBRIO-CHOLERAE; SYSTEM; MEMBRANE; BINDING; EPSL; PATHWAY; SPECIFICITY	In many Gram-negative bacteria, the type 2 secretion system (T2SS) plays an important role in virulence because of its capacity to deliver a large amount of fully folded protein effectors to the extracellular milieu. Despite our knowledge of most T2SS components, the mechanisms underlying effector recruitment and secretion by the T2SS remain enigmatic. Using complementary biophysical and biochemical approaches, we identified here two direct interactions between the secreted effector CbpD and two components, XcpY(L) and XcpZ(M), of the T2SS assembly platform (AP) in the opportunistic pathogen Pseudomonas aeruginosa. Competition experiments indicated that CbpD binding to XcpY(L) is XcpZ(M)-dependent, suggesting sequential recruitment of the effector by the periplasmic domains of these AP components. Using a bacterial two-hybrid system, we then tested the influence of the effector on the AP protein-protein interaction network. Our findings revealed that the presence of the effector modifies the AP interactome and, in particular, induces XcpZ(M) homodimerization and increases the affinity between XcpY(L) and XcpZ(M). The observed direct relationship between effector binding and T2SS dynamics suggests an additional synchronizing step during the type 2 secretion process, where the activation of the AP of the T2SS nanomachine is triggered by effector binding.	[Michel-Souzy, Sandra; Douzi, Badreddine; Cadoret, Frederic; Raynaud, Claire; Ball, Genevieve; Voulhoux, Rome] Aix Marseille Univ, CNRS, LISM, IMM,UMR7255, F-13009 Marseille, France; [Douzi, Badreddine; Raynaud, Claire; Ball, Genevieve; Voulhoux, Rome] Aix Marseille Univ, CNRS, IMM, LCB,UMR7283, F-13009 Marseille, France; [Quinton, Loic] Univ Liege, Dept Chem, Lab Mass Spectrometry MolSys, B-4000 Liege, Belgium	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; University of Liege	Voulhoux, R (corresponding author), Aix Marseille Univ, CNRS, LISM, IMM,UMR7255, F-13009 Marseille, France.; Voulhoux, R (corresponding author), Aix Marseille Univ, CNRS, IMM, LCB,UMR7283, F-13009 Marseille, France.	voulhoux@imm.cnrs.fr	Douzi, Badreddine/ABA-4540-2021; douzi, Badreddine/Z-5707-2019; Voulhoux, Rome/AAT-5333-2021	Douzi, Badreddine/0000-0003-3140-4713; Voulhoux, Rome/0000-0002-5258-5958; Loic, Quinton/0000-0001-8153-9590; Raynaud, Claire/0000-0002-7121-8424; Michel-Souzy, Sandra/0000-0003-4774-9417	Agence Nationale de la Recherche [ANR-14-CE09-0027-01]	Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by Agence Nationale de la Recherche Grant ANR-14-CE09-0027-01 (to R. V.). The authors declare that they have no conflicts of interest with the contents of this article.	Abendroth J, 2004, J MOL BIOL, V344, P619, DOI 10.1016/j.jmb.2004.09.062; Abendroth J, 2004, J MOL BIOL, V338, P585, DOI 10.1016/j.jmb.2004.01.064; Abendroth J, 2009, J STRUCT BIOL, V168, P313, DOI 10.1016/j.jsb.2009.07.022; Abendroth J, 2009, J STRUCT BIOL, V166, P303, DOI 10.1016/j.jsb.2009.03.009; Ball G, 2002, MOL MICROBIOL, V43, P475, DOI 10.1046/j.1365-2958.2002.02759.x; Ball G, 1999, J BACTERIOL, V181, P382, DOI 10.1128/JB.181.2.382-388.1999; Berry JL, 2015, FEMS MICROBIOL REV, V39, P134, DOI 10.1093/femsre/fuu001; Bouley J, 2001, J MOL BIOL, V308, P205, DOI 10.1006/jmbi.2001.4594; Cadoret F, 2014, J BACTERIOL, V196, P2376, DOI 10.1128/JB.01563-14; Camberg JL, 2007, EMBO J, V26, P19, DOI 10.1038/sj.emboj.7601481; Chen YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059123; Cianciotto NP, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00014-17; Cisneros DA, 2012, EMBO J, V31, P1041, DOI 10.1038/emboj.2011.454; Douzi B, 2017, MBIO, V8, DOI 10.1128/mBio.01185-17; Douzi B, 2016, SCI REP-UK, V6, DOI 10.1038/srep34405; Douzi B, 2012, PHILOS T R SOC B, V367, P1059, DOI 10.1098/rstb.2011.0204; Douzi B, 2011, J BIOL CHEM, V286, P40792, DOI 10.1074/jbc.M111.294843; Douzi B, 2009, J BIOL CHEM, V284, P34580, DOI 10.1074/jbc.M109.042366; Georgiadou M, 2012, MOL MICROBIOL, V84, P857, DOI 10.1111/j.1365-2958.2012.08062.x; Gerard-Vincent M, 2002, MOL MICROBIOL, V44, P1651, DOI 10.1046/j.1365-2958.2002.02991.x; Gray MD, 2011, MOL MICROBIOL, V79, P786, DOI 10.1111/j.1365-2958.2010.07487.x; Gu S, 2017, BBA-PROTEINS PROTEOM, V1865, P1255, DOI 10.1016/j.bbapap.2017.07.006; Hay ID, 2017, MBIO, V8, DOI 10.1128/mBio.01344-17; Henry JT, 2011, ANNU REV MICROBIOL, V65, P261, DOI 10.1146/annurev-micro-121809-151631; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Korotkov KV, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002228; Lallemand M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079562; Leighton TL, 2016, J BIOL CHEM, V291, P19923, DOI 10.1074/jbc.M116.738377; Login FH, 2006, J BIOL CHEM, V281, P33152, DOI 10.1074/jbc.M606245200; Lu C, 2014, J STRUCT BIOL, V187, P223, DOI 10.1016/j.jsb.2014.07.006; Miller J. H., 1972, EXPT MOL GENETICS, P156; Newman JR, 1999, GENE, V227, P197, DOI 10.1016/S0378-1119(98)00601-5; Nivaskumar M, 2016, MOL MICROBIOL, V101, P924, DOI 10.1111/mmi.13432; Nivaskumar M, 2014, STRUCTURE, V22, P685, DOI 10.1016/j.str.2014.03.001; Pineau C, 2014, MOL MICROBIOL, V94, P126, DOI 10.1111/mmi.12744; PUGSLEY AP, 1991, MOL MICROBIOL, V5, P343, DOI 10.1111/j.1365-2958.1991.tb02115.x; Reichow SL, 2011, CHANNELS, V5, P215, DOI 10.4161/chan.5.3.15268; Reichow SL, 2010, NAT STRUCT MOL BIOL, V17, P1226, DOI 10.1038/nsmb.1910; Sandkvist M, 1999, J BACTERIOL, V181, P3129, DOI 10.1128/JB.181.10.3129-3135.1999; Sandkvist M, 2001, MOL MICROBIOL, V40, P271, DOI 10.1046/j.1365-2958.2001.02403.x; Santos-Moreno J, 2017, J MOL BIOL, V429, P1746, DOI 10.1016/j.jmb.2017.04.005; Shevchik VE, 1997, EMBO J, V16, P3007, DOI 10.1093/emboj/16.11.3007; Shiue SJ, 2006, EMBO J, V25, P1426, DOI 10.1038/sj.emboj.7601036; Thomassin JL, 2017, MOL MICROBIOL, V105, P211, DOI 10.1111/mmi.13704; Voulhoux R, 2001, EMBO J, V20, P6735, DOI 10.1093/emboj/20.23.6735; Wang XH, 2012, J BIOL CHEM, V287, P19082, DOI 10.1074/jbc.M112.346338; Yan ZF, 2017, NAT STRUCT MOL BIOL, V24, P177, DOI 10.1038/nsmb.3350	48	9	10	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2018	293	50					19441	19450		10.1074/jbc.RA117.001127	http://dx.doi.org/10.1074/jbc.RA117.001127			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HE6RA	30337370	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000453537300024
J	Winter, AJ; Williams, C; Isupov, MN; Crocker, H; Gromova, M; Marsh, P; Wilkinson, OJ; Dillingham, MS; Harmer, NJ; Titball, RW; Crump, MP				Winter, Ashley J.; Williams, Christopher; Isupov, Michail N.; Crocker, Hannah; Gromova, Mariya; Marsh, Philip; Wilkinson, Oliver J.; Dillingham, Mark S.; Harmer, Nicholas J.; Titball, Richard W.; Crump, Matthew P.			The molecular basis of protein toxin HicA-dependent binding of the protein antitoxin HicB to DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						structural biology; X-ray crystallography; DNA-binding protein; protein-protein interaction; bacterial toxin; antibiotic resistance; conditional cooperativity; HicAB; persistence; toxin-antitoxin system; type II TA system	TRANSCRIPTIONAL REPRESSION; BACTERIAL PERSISTENCE; CRYSTAL-STRUCTURE; SYSTEM; MECHANISMS; RESOLUTION; INHIBITION; REFINEMENT; ALLOSTERY; DISORDER	Toxin-antitoxin (TA) systems are present in many bacteria and play important roles in bacterial growth, physiology, and pathogenicity. Those that are best studied are the type II TA systems, in which both toxins and antitoxins are proteins. The HicAB system is one of the prototypic TA systems, found in many bacterial species. Complex interactions between the protein toxin (HicA), the protein antitoxin (HicB), and the DNA upstream of the encoding genes regulate the activity of this system, but few structural details are available about how HicA destabilizes the HicB-DNA complex. Here, we determined the X-ray structures of HicB and the HicAB complex to 1.8 and 2.5 angstrom resolution, respectively, and characterized their DNA interactions. This revealed that HicB forms a tetramer and HicA and HicB form a heterooctameric complex that involves structural reorganization of the C-terminal (DNA-binding) region of HicB. Our observations indicated that HicA has a profound impact on binding of HicB to DNA sequences upstream of hicAB in a stoichiometric-dependent way. At low ratios of HicA:HicB, there was no effect on DNA binding, but at higher ratios, the affinity for DNA declined cooperatively, driving dissociation of the HicA:HicB:DNA complex. These results reveal the structural mechanisms by which HicA de-represses the HicB-DNA complex.	[Winter, Ashley J.; Williams, Christopher; Crocker, Hannah; Gromova, Mariya; Marsh, Philip; Crump, Matthew P.] Univ Bristol, Sch Chem, Cantocks Close, Bristol BS8 1TS, Avon, England; [Isupov, Michail N.; Harmer, Nicholas J.; Titball, Richard W.] Univ Exeter, Coll Life & Environm Sci, Biosci, Exeter EX4 4QD, Devon, England; [Wilkinson, Oliver J.; Dillingham, Mark S.] Univ Bristol, Sch Biochem, Biomed Sci Bldg, Bristol BS8 1TD, Avon, England	University of Bristol; University of Exeter; University of Bristol	Crump, MP (corresponding author), Univ Bristol, Sch Chem, Cantocks Close, Bristol BS8 1TS, Avon, England.; Titball, RW (corresponding author), Univ Exeter, Coll Life & Environm Sci, Biosci, Exeter EX4 4QD, Devon, England.	R.W.Titball@exeter.ac.uk; Matt.crump@bristol.ac.uk	Wiliams, Christopher/P-4904-2015; Isupov, Mikhail/AAA-8280-2019	Wiliams, Christopher/0000-0001-5806-9842; Crump, Matthew/0000-0002-7868-5818; Winter, Ash/0000-0003-3684-9383; Isupov, Michail/0000-0001-6842-4289; Dillingham, Mark/0000-0002-4612-7141	Biotechnology and Biological Sciences Research Council-funded South West Biosciences Doctoral Training Partnership Training Grant [BB/J014400/1]; Engineering and Physical Sciences Research Council [EP/K03927X/1] Funding Source: researchfish; BBSRC [BB/L01386X/1] Funding Source: UKRI; EPSRC [EP/K03927X/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council-funded South West Biosciences Doctoral Training Partnership Training Grant; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council-funded South West Biosciences Doctoral Training Partnership Training Grant BB/J014400/1. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afif H, 2001, MOL MICROBIOL, V41, P73, DOI 10.1046/j.1365-2958.2001.02492.x; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bibi-Triki S, 2014, J BACTERIOL, V196, P3712, DOI 10.1128/JB.01932-14; Boggild A, 2012, STRUCTURE, V20, P1641, DOI 10.1016/j.str.2012.08.017; Brown BL, 2013, J BIOL CHEM, V288, P1286, DOI 10.1074/jbc.M112.421008; Butt A, 2014, BIOCHEM J, V459, P333, DOI 10.1042/BJ20140073; Cheverton AM, 2016, MOL CELL, V63, P86, DOI 10.1016/j.molcel.2016.05.002; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; De Jonge N, 2009, MOL CELL, V35, P154, DOI 10.1016/j.molcel.2009.05.025; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Garcia-Pino A, 2016, NAT CHEM BIOL, V12, P490, DOI [10.1038/nchembio.2078, 10.1038/NCHEMBIO.2078]; Garcia-Pino A, 2010, CELL, V142, P101, DOI 10.1016/j.cell.2010.05.039; Gerdes K, 2012, ANNU REV MICROBIOL, V66, P103, DOI 10.1146/annurev-micro-092611-150159; GLATTER O, 1977, J APPL CRYSTALLOGR, V10, P415, DOI 10.1107/S0021889877013879; Goormaghtigh F, 2018, MBIO, V9, DOI 10.1128/mBio.01838-18; Hall AMJ, 2017, CURR OPIN MICROBIOL, V36, P102, DOI 10.1016/j.mib.2017.02.003; Harms A, 2018, MOL CELL, V70, P768, DOI 10.1016/j.molcel.2018.01.003; Harms A, 2016, SCIENCE, V354, DOI 10.1126/science.aaf4268; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Huang XY, 2003, J BIOMOL SCREEN, V8, P34, DOI 10.1177/1087057102239666; Johnson EP, 1996, J BACTERIOL, V178, P1420, DOI 10.1128/jb.178.5.1420-1429.1996; Jorgensen MG, 2009, J BACTERIOL, V191, P1191, DOI 10.1128/JB.01013-08; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kedzierska B, 2007, NUCLEIC ACIDS RES, V35, P325, DOI 10.1093/nar/gkl1028; Kedzierska B, 2016, MOLECULES, V21, DOI 10.3390/molecules21060790; Khoo SK, 2007, J BIOL CHEM, V282, P19606, DOI 10.1074/jbc.M701703200; Kim DH, 2018, NUCLEIC ACIDS RES, V46, P6371, DOI 10.1093/nar/gky469; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee KY, 2016, TOXINS, V8, DOI 10.3390/toxins8100305; Lewis ERG, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw070; Limmathurotsakul D, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2015.8, 10.1038/nmicrobiol.2015.8]; Lobato-Marquez D, 2016, FEMS MICROBIOL REV, V40, P592, DOI 10.1093/femsre/fuw022; Loris R, 2014, CHEM REV, V114, P6933, DOI 10.1021/cr400656f; Magnuson R, 1998, J BACTERIOL, V180, P6342; Makarova KS, 2006, BIOINFORMATICS, V22, P2581, DOI 10.1093/bioinformatics/btl418; Mate MJ, 2012, NUCLEIC ACIDS RES, V40, P3245, DOI 10.1093/nar/gkr1167; Mattison K, 2006, J BIOL CHEM, V281, P37942, DOI 10.1074/jbc.M605198200; Milo R, 2013, BIOESSAYS, V35, P1050, DOI 10.1002/bies.201300066; Monti MC, 2007, NUCLEIC ACIDS RES, V35, P1737, DOI 10.1093/nar/gkm073; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Muthuramalingam M, 2016, TOXINS, V8, DOI 10.3390/toxins8070214; Overgaard M, 2008, MOL MICROBIOL, V69, P841, DOI 10.1111/j.1365-2958.2008.06313.x; Page R, 2016, NAT CHEM BIOL, V12, P208, DOI [10.1038/NCHEMBIO.2044, 10.1038/nchembio.2044]; Pannu NS, 1998, ACTA CRYSTALLOGR D, V54, P1285, DOI 10.1107/S0907444998004119; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Ruangprasert A, 2014, J BIOL CHEM, V289, P20559, DOI 10.1074/jbc.M114.573006; Schneidman-Duhovny D, 2013, BIOPHYS J, V105, P962, DOI 10.1016/j.bpj.2013.07.020; Skubak P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3777; Song S, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00814; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; TAYYAB S, 1991, BIOCHEM EDUC, V19, P149, DOI 10.1016/0307-4412(91)90060-L; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Turnbull KJ, 2017, MOL MICROBIOL, V104, P781, DOI 10.1111/mmi.13662; Vagin AA, 2001, ACTA CRYSTALLOGR D, V57, P1451, DOI 10.1107/S0907444901012409; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Valentini E, 2015, NUCLEIC ACIDS RES, V43, pD357, DOI 10.1093/nar/gku1047; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wen YR, 2016, ANAL BIOANAL CHEM, V408, P5925, DOI 10.1007/s00216-016-9709-3; Wilbur JS, 2005, BIOCHEMISTRY-US, V44, P12515, DOI 10.1021/bi0511080; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Winther KS, 2012, NUCLEIC ACIDS RES, V40, P4347, DOI 10.1093/nar/gks029; Zorzini V, 2014, NUCLEIC ACIDS RES, V42, P6709, DOI 10.1093/nar/gku266	68	6	6	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2018	293	50					19429	19440		10.1074/jbc.RA118.005173	http://dx.doi.org/10.1074/jbc.RA118.005173			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HE6RA	30337369	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000453537300023
J	Zhou, JJ; Li, DP; Chen, SR; Luo, Y; Pan, HL				Zhou, Jing-Jing; Li, De-Pei; Chen, Shao-Rui; Luo, Yi; Pan, Hui-Lin			The 2-1-NMDA receptor coupling is essential for corticostriatal long-term potentiation and is involved in learning and memory	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						neurophysiology; neuroscience; neurotransmitter; electrophysiology; synaptic plasticity	NMDA RECEPTORS; BASAL GANGLIA; ALPHA(2)DELTA SUBUNIT; DORSOMEDIAL STRIATUM; SYNAPTIC PLASTICITY; CALCIUM-CHANNELS; DORSAL STRIATUM; UP-REGULATION; SPINAL-CORD; T-MAZE	The striatum receives extensive cortical input and plays a prominent role in motor learning and habit formation. Glutamate N-methyl-d-aspartate (NMDA) receptor (NMDAR)-mediated long-term potentiation (LTP) is a major synaptic plasticity involved in learning and memory. However, the molecular mechanism underlying NMDAR plasticity in corticostriatal LTP is unclear. Here, we show that theta-burst stimulation (TBS) consistently induced corticostriatal LTP and increased the coincident presynaptic and postsynaptic NMDAR activity of medium spiny neurons. We also found that 2-1 (previously known as a subunit of voltage-gated calcium channels; encoded by the Cacna2d1 gene) physically interacted with NMDARs in the striatum of mice and humans, indicating that this cross-talk is conserved across species. Strikingly, inhibiting 2-1 trafficking with gabapentin or disrupting the 2-1-NMDAR interaction with an 2-1 C terminus-interfering peptide abolished TBS-induced LTP. In Cacna2d1-knockout mice, TBS failed to induce corticostriatal LTP and the associated increases in presynaptic and postsynaptic NMDAR activities. Moreover, systemic gabapentin treatment, microinjection of 2-1 C terminus-interfering peptide into the dorsomedial striatum, or Cacna2d1 ablation impaired the alternation T-maze task and rotarod performance in mice. Our findings indicate that the interaction between 2-1 and NMDARs is of high physiological relevance and that a TBS-induced switch from 2-1-free to 2-1-bound NMDARs is critically involved in corticostriatal LTP and LTP-associated learning and memory. Gabapentinoids at high doses may adversely affect cognitive function by targeting 2-1-NMDAR complexes.	[Zhou, Jing-Jing; Li, De-Pei; Chen, Shao-Rui; Luo, Yi; Pan, Hui-Lin] Univ Texas MD Anderson Canc Ctr, Ctr Neurosci & Pain Res, Dept Anesthesiol & Perioperat Med, Houston, TX 77030 USA; [Luo, Yi] Wuhan Univ, Zhongnan Hosp, Dept Clin Lab Med, Wuhan 430071, Hubei, Peoples R China	University of Texas System; UTMD Anderson Cancer Center; Wuhan University	Pan, HL (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Perioperat Med, Unit 110, 1515 Holcombe Blvd, Houston, TX 77030 USA.	huilinpan@mdanderson.org		Pan, Hui-Lin/0000-0001-8444-3770	National Institutes of Health [GM120844, NS101880]; N. G. and Helen T. Hawkins Endowment; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM120844] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS101880] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); N. G. and Helen T. Hawkins Endowment; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health Grants GM120844 and NS101880 (to H.-L. P.) and by the N. G. and Helen T. Hawkins Endowment. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allison DW, 1998, J NEUROSCI, V18, P2423; Bliss TVP, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-5; Calabresi P, 1996, TRENDS NEUROSCI, V19, P19, DOI 10.1016/0166-2236(96)81862-5; Cassidy JS, 2014, P NATL ACAD SCI USA, V111, P8979, DOI 10.1073/pnas.1403731111; Charpier S, 1997, P NATL ACAD SCI USA, V94, P7036, DOI 10.1073/pnas.94.13.7036; Charpier S, 1999, NEUROSCIENCE, V91, P1209, DOI 10.1016/S0306-4522(98)00719-2; Chen JJ, 2018, CELL REP, V22, P2307, DOI 10.1016/j.celrep.2018.02.021; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Cole RL, 2005, J COMP NEUROL, V491, P246, DOI 10.1002/cne.20693; Costa RM, 2004, CURR BIOL, V14, P1124, DOI 10.1016/j.cub.2004.06.053; Dang MT, 2006, P NATL ACAD SCI USA, V103, P15254, DOI 10.1073/pnas.0601758103; Deacon RMJ, 2006, NAT PROTOC, V1, P122, DOI 10.1038/nprot.2006.20; DeCoteau WE, 2007, J NEUROPHYSIOL, V97, P3800, DOI 10.1152/jn.00108.2007; Dolphin AC, 2012, NAT REV NEUROSCI, V13, P542, DOI 10.1038/nrn3311; Eroglu C, 2009, CELL, V139, P380, DOI 10.1016/j.cell.2009.09.025; Felsted JA, 2017, CELL REP, V21, P2737, DOI 10.1016/j.celrep.2017.11.048; Friend DM, 2017, CELL METAB, V25, P312, DOI 10.1016/j.cmet.2016.12.001; Fuller-Bicer GA, 2009, AM J PHYSIOL-HEART C, V297, pH117, DOI 10.1152/ajpheart.00122.2009; Gee NS, 1996, J BIOL CHEM, V271, P5768, DOI 10.1074/jbc.271.10.5768; GRAYBIEL AM, 1990, TRENDS NEUROSCI, V13, P244, DOI 10.1016/0166-2236(90)90104-I; Harris KM, 2003, PHILOS T R SOC B, V358, P745, DOI 10.1098/rstb.2002.1254; HAUBER W, 1989, J NEURAL TRANSM-GEN, V78, P29, DOI 10.1007/BF01247111; Hawes SL, 2013, J NEUROPHYSIOL, V110, P2027, DOI 10.1152/jn.00115.2013; Hoppa MB, 2012, NATURE, V486, P122, DOI 10.1038/nature11033; Jia YS, 2010, J NEUROSCI, V30, P14440, DOI 10.1523/JNEUROSCI.3310-10.2010; KAWAGUCHI Y, 1989, J NEUROPHYSIOL, V62, P1052, DOI 10.1152/jn.1989.62.5.1052; Lana B, 2016, SCI REP-UK, V6, DOI 10.1038/srep24531; Larson J, 2015, BRAIN RES, V1621, P38, DOI 10.1016/j.brainres.2014.10.034; Lemay-Clermont J, 2011, BEHAV NEUROSCI, V125, P714, DOI 10.1037/a0025213; Lewis SJG, 2004, EUR J NEUROSCI, V19, P755, DOI 10.1111/j.1460-9568.2004.03108.x; Li DP, 2017, J NEUROSCI, V37, P10690, DOI 10.1523/JNEUROSCI.2141-17.2017; Li DP, 2014, J NEUROSCI, V34, P4309, DOI 10.1523/JNEUROSCI.4295-13.2014; Li LY, 2016, CELL REP, V15, P1376, DOI 10.1016/j.celrep.2016.04.039; Luo Y, 2018, STROKE, V49, P2464, DOI 10.1161/STROKEAHA.118.022330; Ma HJ, 2018, J NEUROSCI, V38, P6388, DOI 10.1523/JNEUROSCI.0447-18.2018; Ma HJ, 2018, J PHYSIOL-LONDON, V596, P4269, DOI 10.1113/JP276394; Mahon S, 2004, TRENDS NEUROSCI, V27, P460, DOI 10.1016/j.tins.2004.06.010; Moussa R, 2011, LEARN MEMORY, V18, P444, DOI 10.1101/lm.2123811; Muller CS, 2010, P NATL ACAD SCI USA, V107, P14950, DOI 10.1073/pnas.1005940107; Packard MG, 1997, BEHAV NEUROSCI, V111, P543, DOI 10.1037/0735-7044.111.3.543; Palencia CA, 2004, NEUROBIOL LEARN MEM, V82, P81, DOI 10.1016/j.nlm.2004.04.004; Park H, 2014, NEURON, V84, P1009, DOI 10.1016/j.neuron.2014.10.045; Partridge JG, 2000, J NEUROPHYSIOL, V84, P1422, DOI 10.1152/jn.2000.84.3.1422; Patel TP, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00349; Pennartz CMA, 2009, J NEUROSCI, V29, P12831, DOI 10.1523/JNEUROSCI.3177-09.2009; Reynolds JNJ, 2001, NATURE, V413, P67, DOI 10.1038/35092560; Schumacher TB, 1998, EPILEPSIA, V39, P355, DOI 10.1111/j.1528-1157.1998.tb01387.x; Segal M, 2005, NAT REV NEUROSCI, V6, P277, DOI 10.1038/nrn1649; Seibenhener ML, 2015, JOVE-J VIS EXP, DOI 10.3791/52434; Takao K, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-11; Taylor CP, 2008, NEUROSCIENCE, V155, P510, DOI 10.1016/j.neuroscience.2008.05.053; Tepper JM, 2004, CURR OPIN NEUROBIOL, V14, P685, DOI 10.1016/j.conb.2004.10.003; Tort ABL, 2008, P NATL ACAD SCI USA, V105, P20517, DOI 10.1073/pnas.0810524105; Tovar KR, 2002, NEURON, V34, P253; Yin HH, 2008, EUR J NEUROSCI, V28, P1437, DOI 10.1111/j.1460-9568.2008.06422.x; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919; Yin HH, 2009, NAT NEUROSCI, V12, P333, DOI 10.1038/nn.2261; Yin HH, 2005, EUR J NEUROSCI, V22, P505, DOI 10.1111/j.1460-9568.2005.04219.x; Yin HH, 2004, LEARN MEMORY, V11, P459, DOI 10.1101/lm.81004; Zhang FX, 2018, CELL REP, V22, P1956, DOI 10.1016/j.celrep.2018.01.073; Zhou HY, 2010, J NEUROSCI, V30, P4460, DOI 10.1523/JNEUROSCI.5857-09.2010; Zhou JJ, 2015, NEUROPHARMACOLOGY, V99, P481, DOI 10.1016/j.neuropharm.2015.08.012	62	25	27	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2018	293	50					19354	19364		10.1074/jbc.RA118.003977	http://dx.doi.org/10.1074/jbc.RA118.003977			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology	HE6RA	30355732	Green Published, hybrid			2022-12-28	WOS:000453537300017
J	Hintze, J; Ye, ZL; Narimatsu, Y; Madsen, TD; Joshi, HJ; Goth, CK; Linstedt, A; Bachert, C; Mandel, U; Bennett, EP; Vakhrushev, SY; Schjoldager, KT				Hintze, John; Ye, Zilu; Narimatsu, Yoshiki; Madsen, Thomas Daugbjerg; Joshi, Hiren J.; Goth, Christoffer K.; Linstedt, Adam; Bachert, Collin; Mandel, Ulla; Bennett, Eric P.; Vakhrushev, Sergey Y.; Schjoldager, Katrine T.			Probing the contribution of individual polypeptide GalNAc- transferase isoforms to the O-glycoproteome by inducible expression in isogenic cell lines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-ACETYLGALACTOSAMINYLTRANSFERASE FAMILY; ALPHA-D-GALACTOSAMINE; LINKED GLYCOSYLATION; UDP-GALNAC; SUBSTRATE SPECIFICITIES; 3 MEMBERS; LOCI; ASSOCIATION; ACTIVATION; INITIATION	The GalNAc-type O-glycoproteome is orchestrated by a large family of polypeptide GalNAc-transferase isoenzymes (GalNAc-Ts) with partially overlapping contributions to the O-glycoproteome besides distinct nonredundant functions. Increasing evidence indicates that individual GalNAc-Ts co-regulate and fine-tune specific protein functions in health and disease, and deficiencies in individual GALNT genes underlie congenital diseases with distinct phenotypes. Studies of GalNAc-T specificities have mainly been performed with in vitro enzyme assays using short peptide substrates, but recently quantitative differential O-glycoproteomics of isogenic cells with and without GALNT genes has enabled a more unbiased exploration of the nonredundant contributions of individual GalNAc-Ts. Both approaches suggest that fairly small subsets of O-glycosites are nonredundantly regulated by specific GalNAc-Ts, but how these isoenzymes orchestrate regulation among competing redundant substrates is unclear. To explore this, here we develop disogenic cell model systems with Tet-On inducible expression of two GalNAc-T genes, GALNT2 and GALNT11, in a knockout background in HEK293 cells. Using quantitative O-glycoproteomics with tandem-mass-tag (TMT) labeling, we found that isoform-specific glycosites are glycosylated in a dose-dependent manner and that induction of GalNAc-T2 or-T11 produces discrete glycosylation effects without affecting the major part of the O-glycoproteome. These results support previous findings indicating that individual GalNAc-T isoenzymes can serve in fine-tuned regulation of distinct protein functions.	[Hintze, John; Ye, Zilu; Narimatsu, Yoshiki; Madsen, Thomas Daugbjerg; Joshi, Hiren J.; Goth, Christoffer K.; Mandel, Ulla; Bennett, Eric P.; Vakhrushev, Sergey Y.; Schjoldager, Katrine T.] Univ Copenhagen, Fac Hlth Sci, Copenhagen Ctr Glyc, Dept Cellular Med, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark; [Hintze, John; Ye, Zilu; Narimatsu, Yoshiki; Madsen, Thomas Daugbjerg; Joshi, Hiren J.; Goth, Christoffer K.; Mandel, Ulla; Bennett, Eric P.; Vakhrushev, Sergey Y.; Schjoldager, Katrine T.] Univ Copenhagen, Fac Hlth Sci, Copenhagen Ctr Glyc, Dept Mol Med, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark; [Hintze, John; Ye, Zilu; Narimatsu, Yoshiki; Madsen, Thomas Daugbjerg; Joshi, Hiren J.; Goth, Christoffer K.; Mandel, Ulla; Bennett, Eric P.; Vakhrushev, Sergey Y.; Schjoldager, Katrine T.] Univ Copenhagen, Fac Hlth Sci, Sch Dent, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark; [Linstedt, Adam; Bachert, Collin] Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA	University of Copenhagen; University of Copenhagen; University of Copenhagen; Carnegie Mellon University	Schjoldager, KT (corresponding author), Univ Copenhagen, Copenhagen Ctr Glyc, Dept Cellular & Mol Med, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark.	schjoldager@sund.ku.dk	Bennett, Eric/AAG-6120-2020; Vakhrushev, Sergey Y/A-7638-2014; Joshi, Hiren/B-5739-2016; Narimatsu, Yoshiki/G-8388-2019	Bennett, Eric/0000-0002-4976-0647; Vakhrushev, Sergey Y/0000-0002-0418-5765; Ye, Zilu/0000-0001-8829-6579; Mandel, Ulla/0000-0001-7012-9836; Hintze, John/0000-0003-1420-7398; Goth, Christoffer/0000-0002-5766-1411; Madsen, Thomas Daugbjerg/0000-0002-7598-4636; Joshi, Hiren/0000-0002-8192-2829; Narimatsu, Yoshiki/0000-0003-1428-5695	Laege Sofus Carl Emil Friis og hustru Olga Doris Friis' Legat; Kirsten og Freddy Johansen Fonden; Lundbeck Foundation; Mizutani Foundation; Novo Nordisk Foundation; Danish Research Council Sapere Aude Research Talent Grant; Danish National Research Foundation [DNRF107]; A. P. Moller og Hustru Chastine Mc-Kinney Mollers Fond til Almene Formaal; NATIONAL CANCER INSTITUTE [U01CA230677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R21DE026714] Funding Source: NIH RePORTER	Laege Sofus Carl Emil Friis og hustru Olga Doris Friis' Legat; Kirsten og Freddy Johansen Fonden; Lundbeck Foundation(Lundbeckfonden); Mizutani Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Research Council Sapere Aude Research Talent Grant; Danish National Research Foundation(Danmarks Grundforskningsfond); A. P. Moller og Hustru Chastine Mc-Kinney Mollers Fond til Almene Formaal; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by Laege Sofus Carl Emil Friis og hustru Olga Doris Friis' Legat, Kirsten og Freddy Johansen Fonden, the Lundbeck Foundation, A. P. Moller og Hustru Chastine Mc-Kinney Mollers Fond til Almene Formaal, the Mizutani Foundation, the Novo Nordisk Foundation, the Danish Research Council Sapere Aude Research Talent Grant (to K. T. S.), and Danish National Research Foundation Grant DNRF107. The authors declare that they have no conflicts of interest with the contents of this article.	Bennett EP, 1996, J BIOL CHEM, V271, P17006, DOI 10.1074/jbc.271.29.17006; Bennett EP, 1998, J BIOL CHEM, V273, P30472, DOI 10.1074/jbc.273.46.30472; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Bennett EP, 2010, GLYCOCONJUGATE J, V27, P435, DOI 10.1007/s10719-010-9290-5; Boskovski MT, 2013, NATURE, V504, P456, DOI 10.1038/nature12723; Cavalli M, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0183-x; Chia PZC, 2014, TRAFFIC, V15, P572, DOI 10.1111/tra.12161; de las Rivas M, 2018, CHEM-EUR J, V24, P8382, DOI 10.1002/chem.201800701; DeKelver RC, 2010, GENOME RES, V20, P1133, DOI 10.1101/gr.106773.110; Duda K, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku251; Fujitani N, 2013, P NATL ACAD SCI USA, V110, P2105, DOI 10.1073/pnas.1214233110; Gerken TA, 2006, J BIOL CHEM, V281, P32403, DOI 10.1074/jbc.M605149200; Gerken TA, 2013, J BIOL CHEM, V288, P19900, DOI 10.1074/jbc.M113.477877; Gerken TA, 2011, J BIOL CHEM, V286, P14493, DOI 10.1074/jbc.M111.218701; Gorski M, 2015, KIDNEY INT, V87, P1017, DOI 10.1038/ki.2014.361; Goth CK, 2018, TRENDS BIOCHEM SCI, V43, P269, DOI 10.1016/j.tibs.2018.02.005; Hansen L, 2015, GLYCOBIOLOGY, V25, P211, DOI 10.1093/glycob/cwu104; Hassan H, 2000, J BIOL CHEM, V275, P38197, DOI 10.1074/jbc.M005783200; Hassinen A, 2011, J BIOL CHEM, V286, P38329, DOI 10.1074/jbc.M111.277681; Hirst J, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2004411; Ichikawa S, 2009, ENDOCRINOLOGY, V150, P2543, DOI 10.1210/en.2008-0877; Joshi HJ, 2018, GLYCOBIOLOGY, V28, P284, DOI 10.1093/glycob/cwy015; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kato K, 2006, J BIOL CHEM, V281, P18370, DOI 10.1074/jbc.M602469200; Khetarpal SA, 2016, CELL METAB, V24, P234, DOI 10.1016/j.cmet.2016.07.012; King SL, 2017, BLOOD ADV, V1, P429, DOI 10.1182/bloodadvances.2016002121; Kong Y, 2015, GLYCOBIOLOGY, V25, P55, DOI 10.1093/glycob/cwu089; Lavrsen K, 2018, J BIOL CHEM, V293, P1298, DOI 10.1074/jbc.M117.812826; Lira-Navarrete E, 2014, ANGEW CHEM INT EDIT, V53, P8206, DOI 10.1002/anie.201402781; Liu M, 2017, J BIOL CHEM, V292, P8412, DOI 10.1074/jbc.M117.779256; Lowe JB, 2003, ANNU REV BIOCHEM, V72, P643, DOI 10.1146/annurev.biochem.72.121801.161809; Mandel U, 1999, GLYCOBIOLOGY, V9, P43, DOI 10.1093/glycob/9.1.43; Maresca M, 2013, GENOME RES, V23, P539, DOI 10.1101/gr.145441.112; Maxson JE, 2014, J BIOL CHEM, V289, P5820, DOI 10.1074/jbc.M113.508440; McAlister GC, 2012, ANAL CHEM, V84, P7469, DOI 10.1021/ac301572t; Miwa HE, 2010, J BIOL CHEM, V285, P1208, DOI 10.1074/jbc.M109.035436; Moullan N, 2015, CELL REP, V10, P1681, DOI 10.1016/j.celrep.2015.02.034; Nakayama Y, 2014, GENE EXPR PATTERNS, V16, P1, DOI 10.1016/j.gep.2014.07.001; Nehrke K, 1998, GLYCOBIOLOGY, V8, P367, DOI 10.1093/glycob/8.4.367; Nykjaer A, 1999, CELL, V96, P507, DOI 10.1016/S0092-8674(00)80655-8; Pedersen NB, 2014, J BIOL CHEM, V289, P17312, DOI 10.1074/jbc.M113.545053; Pinto R, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx371; Puthenveedu MA, 2001, J CELL BIOL, V155, P227, DOI 10.1083/jcb.200105005; Quiros PM, 2017, J CELL BIOL, V216, P2027, DOI 10.1083/jcb.201702058; Revoredo L, 2016, GLYCOBIOLOGY, V26, P360, DOI 10.1093/glycob/cwv108; Roman TS, 2015, AM J HUM GENET, V97, P801, DOI 10.1016/j.ajhg.2015.10.016; Rottger S, 1998, J CELL SCI, V111, P45; Schjoldager KT, 2015, EMBO REP, V16, P1713, DOI 10.15252/embr.201540796; Schjoldager KTBG, 2012, BBA-GEN SUBJECTS, V1820, P2079, DOI 10.1016/j.bbagen.2012.09.014; Schjoldager KTBG, 2010, J BIOL CHEM, V285, P36293, DOI 10.1074/jbc.M110.156950; Schjoldager KTBG, 2012, P NATL ACAD SCI USA, V109, P9893, DOI 10.1073/pnas.1203563109; Schwientek T, 2002, J BIOL CHEM, V277, P22623, DOI 10.1074/jbc.M202684200; Song K, 2017, J BIOL CHEM, V292, P16491, DOI 10.1074/jbc.M117.798512; Song LN, 2014, J BIOL CHEM, V289, P30556, DOI 10.1074/jbc.M114.599563; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Steentoft C, 2011, NAT METHODS, V8, P977, DOI [10.1038/nmeth.1731, 10.1038/NMETH.1731]; Ten Hagen KG, 2003, GLYCOBIOLOGY, V13, p1R, DOI 10.1093/glycob/cwg007; Tenno M, 2007, MOL CELL BIOL, V27, P8783, DOI 10.1128/MCB.01204-07; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tian E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115861; Topaz O, 2004, NAT GENET, V36, P579, DOI 10.1038/ng1358; Tran DT, 2012, J BIOL CHEM, V287, P5243, DOI 10.1074/jbc.M111.306159; Varki A, 2017, GLYCOBIOLOGY, V27, P3, DOI 10.1093/glycob/cww086; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Walsh G, 2010, DRUG DISCOV TODAY, V15, P773, DOI 10.1016/j.drudis.2010.06.009; Wandall HH, 1997, J BIOL CHEM, V272, P23503, DOI 10.1074/jbc.272.38.23503; Wang SJ, 2018, J BIOL CHEM, V293, P7408, DOI 10.1074/jbc.M117.817981; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Yu HJ, 2015, NAT CHEM BIOL, V11, P847, DOI 10.1038/nchembio.1927	70	27	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2018	293	49					19064	19077		10.1074/jbc.RA118.004516	http://dx.doi.org/10.1074/jbc.RA118.004516			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NY	30327431	hybrid, Green Published			2022-12-28	WOS:000458467400020
J	Strakova, K; Kowalski-Jahn, M; Gybel, T; Valnohova, J; Dhople, VM; Harnos, J; Bernatik, O; Ganji, RS; Zdrahal, Z; Mulder, J; Lindskog, C; Bryja, V; Schulte, G				Strakova, Katerina; Kowalski-Jahn, Maria; Gybel, Tomas; Valnohova, Jana; Dhople, Vishnu M.; Harnos, Jakub; Bernatik, Ondrej; Ganji, Ranjani Sri; Zdrahal, Zbynek; Mulder, Jan; Lindskog, Cecilia; Bryja, Vitezslav; Schulte, Gunnar			Dishevelled enables casein kinase 1-mediated phosphorylation of Frizzled 6 required for cell membrane localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEP DOMAIN; FUNCTIONAL-ANALYSIS; PLANAR POLARITY; BETA-ARRESTINS; DIX DOMAIN; I-EPSILON; RECEPTOR; RECRUITMENT; COMPLEX; GROWTH	Frizzleds (FZDs) are receptors for secreted lipoglycoproteins of the Wingless/Int-1(WNT) family, initiating an important signal transduction network in multicellular organisms. FZDs are G protein-coupled receptors (GPCRs), which are well known to be regulated by phosphorylation, leading to specific downstream signaling or receptor desensitization. The role and underlying mechanisms of FZD phosphorylation remain largely unexplored. Here, we investigated the phosphorylation of human FZD(6). Using MS analysis and a phospho-state- and -site-specific antibody, we found that Ser-648, located in the FZD(6) C terminus, is efficiently phosphorylated by casein kinase 1 is an element of (CK1 is an element of) and that this phosphorylation requires the scaffolding protein Dishevelled (DVL). In an overexpression system, DVL1, -2, and -3 promoted CK1-mediated FZD(6) phosphorylation on Ser-648. This DVL activity required an intact DEP domain and FZD-mediated recruitment of this domain to the cell membrane. Substitution of the CK1 is an element of-targeted phosphomo-tif reduced FZD(6) surface expression, suggesting that Ser-648 phosphorylation controls membrane trafficking of FZD(6). Phos-pho-Ser-648 FZD(6) immunoreactivity in human fallopian tube epithelium was predominantly apical, associated with cilia in a subset of epithelial cells, compared with the total FZD(6) protein expression, suggesting that FZD(6) phosphorylation contributes to asymmetric localization of receptor function within the cell and to epithelial polarity. Given the key role of FZD(6) in planar cell polarity, our results raise the possibility that asymmetric phosphorylation of FZD(6) rather than asymmetric protein distribution accounts for polarized receptor signaling.	[Strakova, Katerina; Gybel, Tomas; Harnos, Jakub; Bernatik, Ondrej; Ganji, Ranjani Sri; Bryja, Vitezslav; Schulte, Gunnar] Masaryk Univ, Fac Sci, Lab WNT Signaling, Inst Expt Biol, Kotlarska 2, CS-61137 Brno, Czech Republic; [Strakova, Katerina; Kowalski-Jahn, Maria; Valnohova, Jana; Schulte, Gunnar] Karolinska Inst, Biomedicum 6D, Dept Physiol & Pharmacol, Sect Receptor Biol & Signaling, Tomtebodavagen 16, SE-17165 Stockholm, Sweden; [Dhople, Vishnu M.] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Dept Funct Genom, Friedrich Ludwig Jahn Str 15, D-17487 Greifswald, Germany; [Ganji, Ranjani Sri; Zdrahal, Zbynek] Masaryk Univ, Cent European Inst Technol, Kamenice 5, Brno 62500, Czech Republic; [Mulder, Jan] Karolinska Inst, Dept Neurosci, Sci Life Lab, Tomtebodavagen 16, S-17165 Stockholm, Sweden; [Lindskog, Cecilia] Uppsala Univ, Dept Immunol Genet & Pathol, Rudbeck Lab, Sci Life Lab, Dag Hammarskjolds Vag 20, S-75185 Uppsala, Sweden	Masaryk University Brno; Karolinska Institutet; Ernst Moritz Arndt Universitat Greifswald; Masaryk University Brno; Karolinska Institutet; Uppsala University	Bryja, V (corresponding author), Masaryk Univ, Fac Sci, Lab Cellular Commun, Dept Expt Biol, Kotlarska 2, CS-61137 Brno, Czech Republic.; Schulte, G (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Sect Receptor Biol & Signaling, S-17177 Stockholm, Sweden.	bryja@sci.muni.cz; gunnar.schulte@ki.se	Bryja, Vítězslav/P-4217-2019; Mulder, Jan/G-3909-2011; Ganji, Ranjani/AGD-5702-2022; Lindskog, Cecilia/AAE-5462-2019; Zdrahal, Zbynek/D-9491-2012; Lindskog, Cecilia/AAO-2441-2021; Mulder, Jan/AAG-9761-2021; Harnos, Jakub/AAE-7855-2021	Bryja, Vítězslav/0000-0002-9136-5085; Mulder, Jan/0000-0003-3717-5018; Gybel, Tomas/0000-0002-5244-1524; Harnos, Jakub/0000-0002-0752-9260; Schulte, Gunnar/0000-0002-2700-7013; Bernatik, Ondrej/0000-0002-2188-332X; Kowalski-Jahn, Maria/0000-0003-1442-3656; Lindskog, Cecilia/0000-0001-5611-1015; Zdrahal, Zbynek/0000-0003-3044-5548	Karolinska Institutet; Swedish Research Council [2013-5708, 2015-02899]; Science for Life Laboratory; Swedish Cancer Society [CAN2014/659, CAN2017/561]; Knut and Alice Wallenberg Foundation [KAW2008.0149]; Stiftelsen Olle Engkvist Byggmastare [2016/193]; Czech Science Foundation [13-32990S, GA17-16680S]; Program "KI-MU" [CZ.1.07/2.3.00/20.0180]; European Social Fund; state budget of the Czech Republic, Marie Curie ITN WntsApp Grant [608180]; Deutsche Forschungsgemeinschaft (DFG) German Research Foundation [KO 5463/1-1]	Karolinska Institutet(Karolinska Institutet); Swedish Research Council(Swedish Research CouncilEuropean Commission); Science for Life Laboratory; Swedish Cancer Society(Swedish Cancer Society); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Stiftelsen Olle Engkvist Byggmastare(Swedish Research Council); Czech Science Foundation(Grant Agency of the Czech Republic); Program "KI-MU"; European Social Fund(European Social Fund (ESF)); state budget of the Czech Republic, Marie Curie ITN WntsApp Grant; Deutsche Forschungsgemeinschaft (DFG) German Research Foundation(German Research Foundation (DFG))	The work was supported by the Karolinska Institutet, the Swedish Research Council Grants 2013-5708 and 2015-02899, the Science for Life Laboratory, Swedish Cancer Society Grants CAN2014/659 and CAN2017/561), Knut and Alice Wallenberg Foundation Grant KAW2008.0149, Stiftelsen Olle Engkvist Byggmastare Grant 2016/193, Czech Science Foundation Grants 13-32990S and GA17-16680S, Program "KI-MU" Grant CZ.1.07/2.3.00/20.0180 cofinanced by the European Social Fund and the state budget of the Czech Republic, Marie Curie ITN WntsApp Grant 608180, and Deutsche Forschungsgemeinschaft (DFG) German Research Foundation Grant KO 5463/1-1. The authors declare that they have no conflicts of interest with the contents of this article.	Arthofer E, 2016, MOL PHARMACOL, V90, P447, DOI 10.1124/mol.116.104919; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Balla S, 2006, NAT METHODS, V3, P175, DOI 10.1038/nmeth856; Bernatik O, 2014, J BIOL CHEM, V289, P23520, DOI 10.1074/jbc.M114.590638; Bernatik O, 2011, J BIOL CHEM, V286, P10396, DOI 10.1074/jbc.M110.169870; Bryja V, 2007, J CELL SCI, V120, P586, DOI 10.1242/jcs.03368; Bryja V, 2007, P NATL ACAD SCI USA, V104, P6690, DOI 10.1073/pnas.0611356104; Bryja V, 2007, CELL SIGNAL, V19, P610, DOI 10.1016/j.cellsig.2006.08.011; Bryja V, 2008, EMBO REP, V9, P1244, DOI 10.1038/embor.2008.193; Cervenka I, 2016, P NATL ACAD SCI USA, V113, P9304, DOI 10.1073/pnas.1608783113; Chen MY, 2009, J BIOL CHEM, V284, P35040, DOI 10.1074/jbc.M109.047456; Chen W, 2003, SCIENCE, V301, P1391, DOI 10.1126/science.1082808; Cong F, 2004, MOL CELL BIOL, V24, P2000, DOI 10.1128/MCB.24.5.2000-2011.2004; Corda G, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.69; Cui CY, 2013, J INVEST DERMATOL, V133, P1990, DOI 10.1038/jid.2013.84; Dijksterhuis JP, 2014, BRIT J PHARMACOL, V171, P1195, DOI 10.1111/bph.12364; Djiane A, 2005, CELL, V121, P621, DOI 10.1016/j.cell.2005.03.014; Fiedler M, 2011, P NATL ACAD SCI USA, V108, P1937, DOI 10.1073/pnas.1017063108; Frojmark AS, 2011, AM J HUM GENET, V88, P852, DOI 10.1016/j.ajhg.2011.05.013; Gammons MV, 2016, J CELL SCI, V129, P3892, DOI 10.1242/jcs.195685; Gammons MV, 2016, MOL CELL, V64, P92, DOI 10.1016/j.molcel.2016.08.026; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Golan T, 2004, J BIOL CHEM, V279, P14879, DOI 10.1074/jbc.M306421200; Guo N, 2004, P NATL ACAD SCI USA, V101, P9277, DOI 10.1073/pnas.0402802101; Hua ZL, 2014, DEVELOPMENT, V141, P3944, DOI 10.1242/dev.110189; Kaucka M, 2013, CANCER RES, V73, P1491, DOI 10.1158/0008-5472.CAN-12-1752; Kilander MBC, 2014, CELL SIGNAL, V26, P1943, DOI 10.1016/j.cellsig.2014.05.012; Kilander MBC, 2014, FASEB J, V28, P2293, DOI 10.1096/fj.13-246363; Komolov KE, 2017, CELL, V169, P407, DOI 10.1016/j.cell.2017.03.047; Koval A, 2011, BIOCHEM PHARMACOL, V82, P1311, DOI 10.1016/j.bcp.2011.06.005; Ma TJ, 2018, J BIOL CHEM, V293, P8410, DOI 10.1074/jbc.RA118.001906; Mlodzik M, 2016, CURR TOP DEV BIOL, V117, P75, DOI 10.1016/bs.ctdb.2015.11.027; Naz G, 2012, BRIT J DERMATOL, V166, P1088, DOI 10.1111/j.1365-2133.2011.10800.x; Onishi K, 2013, J NEUROSCI, V33, P19071, DOI 10.1523/JNEUROSCI.2800-13.2013; Paclikova P, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00145-17; Pau Milly S, 2015, J Mol Signal, V10, P5, DOI 10.5334/1750-2187-10-6; Petersen J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00253-9; Regard JB, 2008, CELL, V135, P561, DOI 10.1016/j.cell.2008.08.040; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Schulte G, 2010, GPCR MOL PHARM DRUG; Schulte G, 2007, TRENDS PHARMACOL SCI, V28, P518, DOI 10.1016/j.tips.2007.09.001; Schulte G, 2010, PHARMACOL REV, V62, P632, DOI 10.1124/pr.110.002931; Schulte G, 2010, BRIT J PHARMACOL, V159, P1051, DOI 10.1111/j.1476-5381.2009.00466.x; Schwarz-Romond T, 2007, NAT STRUCT MOL BIOL, V14, P484, DOI 10.1038/nsmb1247; Shafer B, 2011, DEV CELL, V20, P177, DOI 10.1016/j.devcel.2011.01.002; Simons M, 2009, NAT CELL BIOL, V11, P286, DOI 10.1038/ncb1836; Strakova K, 2017, CELL SIGNAL, V38, P85, DOI 10.1016/j.cellsig.2017.06.018; Strutt H, 2006, CURR BIOL, V16, P1329, DOI 10.1016/j.cub.2006.04.041; Tauriello DVF, 2012, P NATL ACAD SCI USA, V109, pE812, DOI 10.1073/pnas.1114802109; Tobin AB, 2008, BRIT J PHARMACOL, V153, pS167, DOI 10.1038/sj.bjp.0707662; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Umbhauer M, 2000, EMBO J, V19, P4944, DOI 10.1093/emboj/19.18.4944; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wang YS, 2016, CURR TOP DEV BIOL, V117, P113, DOI 10.1016/bs.ctdb.2015.11.028; Wang YF, 2006, J BIOL CHEM, V281, P11603, DOI 10.1074/jbc.M600713200; Wang YH, 2006, J NEUROSCI, V26, P2147, DOI 10.1523/JNEUROSCI.4698-05.2005; Wang YS, 2002, J NEUROSCI, V22, P8563; Witte F, 2010, FASEB J, V24, P2417, DOI 10.1096/fj.09-150615; Wong HC, 2000, NAT STRUCT BIOL, V7, P1178; Yang Z, 2017, MOL PHARMACOL, V92, P201, DOI 10.1124/mol.116.107839; Zhou XE, 2017, CELL, V170, P457, DOI 10.1016/j.cell.2017.07.002	61	9	9	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2018	293	48					18477	18493		10.1074/jbc.RA118.004656	http://dx.doi.org/10.1074/jbc.RA118.004656			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NX	30309985	Green Published, hybrid			2022-12-28	WOS:000458467300006
J	Quinlan, RA; Hogg, PJ				Quinlan, Roy A.; Hogg, Philip J.			gamma-Crystallin redox-detox in the lens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							PROTEIN	In the vertebrate eye, limiting oxidation of proteins and lipids is key to maintaining lens function and avoiding cataract formation. A study by Serebryany et al. identifies a surprising contributor to the eye's oxidative defense in their demonstration that D-crystallin (HD) functions as an oxidoreductase and uses disulfide exchange to initiate aggregation of mutant crystallins that mimic oxidative damage. These insights suggest a mechanism by which a dynamic pool of closely packed proteins might avoid oxidation-driven protein-folding traps, providing new avenues to understand the basis of a human disease with global impact.	[Quinlan, Roy A.] Univ Durham, Dept Biosci, Mountjoy Sci Site, Durham DH1 3LE, England; [Hogg, Philip J.] Univ Sydney, Sydney Med Sch, NHMRC Clin Trials Ctr, Centenary Inst, Sydney, NSW 2006, Australia	Durham University; University of Sydney; Centenary Institute	Quinlan, RA (corresponding author), Univ Durham, Dept Biosci, Mountjoy Sci Site, Durham DH1 3LE, England.; Hogg, PJ (corresponding author), Univ Sydney, Sydney Med Sch, NHMRC Clin Trials Ctr, Centenary Inst, Sydney, NSW 2006, Australia.	r.a.quinlan@durham.ac.uk; phil.hogg@sydney.edu.au	quinlan, roy/A-1348-2012	quinlan, roy/0000-0003-0644-4123; Hogg, Philip/0000-0001-6486-2863	Fight for Sight UK [1584/1585]; LDLensRad project from Euratom Research and Training Program 2014-2018 [662287]; National Health and Medical Research Council Research Fellowship [1110219]	Fight for Sight UK; LDLensRad project from Euratom Research and Training Program 2014-2018; National Health and Medical Research Council Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Fight for Sight UK Grants 1584/1585 and the LDLensRad project, which has received funding from the Euratom Research and Training Program 2014-2018 in the framework of the CONCERT grant agreement 662287 (to R. A. Q.) and National Health and Medical Research Council Research Fellowship 1110219 (to P. J. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Fan XJ, 2017, EXP EYE RES, V156, P103, DOI 10.1016/j.exer.2016.06.018; Friedrich MG, 2018, BBA-GEN SUBJECTS, V1862, P907, DOI 10.1016/j.bbagen.2018.01.003; Garner WH, 2016, INVEST OPHTH VIS SCI, V57, P2851, DOI 10.1167/iovs.15-18413; Kador PF, 2014, J OCUL PHARMACOL TH, V30, P593, DOI 10.1089/jop.2014.0016; Ramkumar S, 2018, BBA-MOL BASIS DIS, V1864, P3595, DOI 10.1016/j.bbadis.2018.08.021; Sagar V, 2017, STRUCTURE, V25, P1068, DOI 10.1016/j.str.2017.05.015; Serebryany E, 2018, J BIOL CHEM, V293, P17997, DOI 10.1074/jbc.RA118.004551; Serebryany E, 2014, PROG BIOPHYS MOL BIO, V115, P32, DOI 10.1016/j.pbiomolbio.2014.05.002; Slingsby C, 2014, PROG BIOPHYS MOL BIO, V115, P52, DOI 10.1016/j.pbiomolbio.2014.02.006; Stewart DN, 2013, MOL VIS, V19, P463; Wang Z, 2018, EXP EYE RES, V175, P83, DOI 10.1016/j.exer.2018.06.002	11	12	12	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2018	293	46					18010	18011		10.1074/jbc.H118.006240	http://dx.doi.org/10.1074/jbc.H118.006240			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HA6SG	30446601	hybrid, Green Published			2022-12-28	WOS:000450409500028
